PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Schaarschmidt, J; Nagel, MBM; Huth, S; Jaeschke, H; Moretti, R; Hintze, V; von Bergen, M; Kalkhof, S; Meiler, J; Paschke, R				Schaarschmidt, Joerg; Nagel, Marcus B. M.; Huth, Sandra; Jaeschke, Holger; Moretti, Rocco; Hintze, Vera; von Bergen, Martin; Kalkhof, Stefan; Meiler, Jens; Paschke, Ralf			Rearrangement of the Extracellular Domain/Extracellular Loop 1 Interface Is Critical for Thyrotropin Receptor Activation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						cell signaling; computer modeling; G protein-coupled receptor (GPCR); mass spectrometry (MS); protein cross-linking; receptor structure-function; site-directed mutagenesis; structural biology; surface plasmon resonance (SPR)	STIMULATING HORMONE-RECEPTOR; HUMAN CHORIONIC-GONADOTROPIN; TSH RECEPTOR; CRYSTAL-STRUCTURE; HINGE REGION; GLYCOPROTEIN HORMONES; TYROSINE SULFATION; LIGAND-BINDING; AMINO-ACIDS; PROTEIN	The thyroid stimulating hormone receptor (TSHR) is a G protein-coupled receptor (GPCR) with a characteristic large extracellular domain (ECD). TSHR activation is initiated by binding of the hormone ligand TSH to the ECD. How the extracellular binding event triggers the conformational changes in the transmembrane domain (TMD) necessary for intracellular G protein activation is poorly understood. To gain insight in this process, the knowledge on the relative positioning of ECD and TMD and the conformation of the linker region at the interface of ECD and TMD are of particular importance. To generate a structural model for the TSHR we applied an integrated structural biology approach combining computational techniques with experimental data. Chemical cross-linking followed by mass spectrometry yielded 17 unique distance restraints within the ECD of the TSHR, its ligand TSH, and the hormone-receptor complex. These structural restraints generally confirm the expected binding mode of TSH to the ECD as well as the general fold of the domains and were used to guide homology modeling of the ECD. Functional characterization of TSHR mutants confirms the previously suggested close proximity of Ser-281 and Ile-486 within the TSHR. Rigidifying this contact permanently with a disulfide bridge disrupts ligand-induced receptor activation and indicates that rearrangement of the ECD/extracellular loop 1 (ECL1) interface is a critical step in receptor activation. The experimentally verified contact of Ser-281 (ECD) and Ile-486 (TMD) was subsequently utilized in docking homology models of the ECD and the TMD to create a full-length model of a glycoprotein hormone receptor.	[Schaarschmidt, Joerg; Nagel, Marcus B. M.; Huth, Sandra; Jaeschke, Holger] Univ Leipzig, Dept Internal Med, D-04103 Leipzig, Germany; [Nagel, Marcus B. M.; von Bergen, Martin; Kalkhof, Stefan] Helmholtz Ctr Environm Res, Dept Prote, D-04318 Leipzig, Germany; [Moretti, Rocco; Meiler, Jens] Vanderbilt Univ, Dept Chem, Box 1583, Nashville, TN 37235 USA; [Moretti, Rocco; Meiler, Jens] Vanderbilt Univ, Struct Biol Ctr, Nashville, TN 37235 USA; [Hintze, Vera] Tech Univ Dresden, Inst Mat Sci, Max Bergmann Ctr Biomat, D-01069 Dresden, Germany; [von Bergen, Martin] Univ Leipzig, Inst Biochem, Fac Biosci Pharm & Psychol, D-04103 Leipzig, Germany; [von Bergen, Martin] Aalborg Univ, Dept Chem & Biosci, Fredrik Bajers Vej 7, DK-9220 Aalborg, Denmark; [Kalkhof, Stefan] Univ Appl Sci & Arts Coburg, Dept Bioanalyt, D-96450 Coburg, Germany; [Paschke, Ralf] Univ Calgary, Div Endocrinol & Metab, Calgary, AB T2N 1N4, Canada; [Paschke, Ralf] Univ Calgary, Arnie Charbonneau Canc Inst, Calgary, AB T2N 1N4, Canada	Leipzig University; Helmholtz Association; Helmholtz Center for Environmental Research (UFZ); Vanderbilt University; Vanderbilt University; Technische Universitat Dresden; Leipzig University; Aalborg University; University of Calgary; University of Calgary	Paschke, R (corresponding author), Univ Calgary, RRDTC, 1820 Richmond Rd SW, Calgary, AB T2T 5C7, Canada.	ralf.paschke@ucalgary.ca	Schaarschmidt, Joerg/A-9449-2017; von Bergen, Martin/D-7960-2011; Kalkhof, Stefan/Z-2000-2019	Schaarschmidt, Joerg/0000-0002-4389-2366; von Bergen, Martin/0000-0003-2732-2977; Kalkhof, Stefan/0000-0001-6121-7105; Meiler, Jens/0000-0001-8945-193X	Deutsche Forschungsgemeinschaft (DFG) [Ja 1927/1-2]; ESF Investigator group GPCR; Else Kroner-Fresenius-Stiftung [2012_A244]; Office Of Internatl Science &Engineering [1157751] Funding Source: National Science Foundation	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); ESF Investigator group GPCR; Else Kroner-Fresenius-Stiftung; Office Of Internatl Science &Engineering(National Science Foundation (NSF)NSF - Office of the Director (OD))	This work was supported by a grant from the Deutsche Forschungsgemeinschaft (DFG, Ja 1927/1-2), ESF Investigator group GPCR 2, and a grant from the Else Kroner-Fresenius-Stiftung (2012_A244). The authors declare that they have no conflicts of interest with the contents of this article.	BRAUN T, 1991, EMBO J, V10, P1885, DOI 10.1002/j.1460-2075.1991.tb07714.x; CARTER PJ, 1984, CELL, V38, P835, DOI 10.1016/0092-8674(84)90278-2; Chaudhury S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022477; Chazenbalk GD, 1999, ENDOCRINOLOGY, V140, P4516, DOI 10.1210/en.140.10.4516; Cornelis S, 2001, BIOCHEMISTRY-US, V40, P9860, DOI 10.1021/bi0107389; Costagliola S, 2002, EMBO J, V21, P504, DOI 10.1093/emboj/21.4.504; De Marco G, 2009, CLIN ENDOCRINOL, V70, P335, DOI 10.1111/j.1365-2265.2008.03333.x; Fan QR, 2005, NATURE, V433, P269, DOI 10.1038/nature03206; Fox KM, 2001, MOL ENDOCRINOL, V15, P378, DOI 10.1210/me.15.3.378; Gotze M, 2012, J AM SOC MASS SPECTR, V23, P76, DOI 10.1007/s13361-011-0261-2; Graves P, 1999, J CLIN ENDOCR METAB, V84, P2177, DOI 10.1210/jc.84.6.2177; Hamidi S, 2011, MOL ENDOCRINOL, V25, P184, DOI 10.1210/me.2010-0401; Hampf M, 2006, ANAL BIOCHEM, V356, P94, DOI 10.1016/j.ab.2006.04.046; Heitman LH, 2012, MOL CELL ENDOCRINOL, V351, P326, DOI 10.1016/j.mce.2012.01.010; Ho SC, 2008, THYROID, V18, P1313, DOI 10.1089/thy.2008.0240; Horovitz A, 1996, FOLD DES, V1, pR121, DOI 10.1016/S1359-0278(96)00056-9; Jaeschke H, 2006, ENDOCRINOLOGY, V147, P1753, DOI 10.1210/en.2005-1138; Jaeschke H, 2014, J CLIN ENDOCR METAB, V99, pE2051, DOI 10.1210/jc.2014-1436; Jaeschke H, 2011, ENDOCRINOLOGY, V152, P3986, DOI 10.1210/en.2011-1389; Jaschke H, 2006, J BIOL CHEM, V281, P9841, DOI 10.1074/jbc.C600014200; Jiang XL, 1995, STRUCTURE, V3, P1341, DOI 10.1016/S0969-2126(01)00272-6; Jiang XL, 2014, J BIOL CHEM, V289, P14273, DOI 10.1074/jbc.M114.549592; Jiang XL, 2014, MOL CELL ENDOCRINOL, V382, P424, DOI 10.1016/j.mce.2013.08.021; Jiang XL, 2012, P NATL ACAD SCI USA, V109, P12491, DOI 10.1073/pnas.1206643109; Kalkhof S, 2008, ANAL BIOANAL CHEM, V392, P305, DOI 10.1007/s00216-008-2231-5; Klco JM, 2006, J BIOL CHEM, V281, P12010, DOI 10.1074/jbc.M600548200; Kleinau G, 2008, FASEB J, V22, P2798, DOI 10.1096/fj.07-104711; Kleinau G, 2007, J BIOL CHEM, V282, P518, DOI 10.1074/jbc.M606176200; Kleinau G, 2013, ENDOCR REV, V34, P691, DOI 10.1210/er.2012-1072; Kleinau G, 2009, ENDOCR REV, V30, P133, DOI 10.1210/er.2008-0044; Kursawe R, 2007, TRENDS ENDOCRIN MET, V18, P199, DOI 10.1016/j.tem.2007.05.002; LAPTHORN AJ, 1994, NATURE, V369, P455, DOI 10.1038/369455a0; Leaver-Fay A, 2011, METHOD ENZYMOL, P545, DOI [10.1016/S0076-6879(11)87019-9, 10.1016/B978-0-12-381270-4.00019-6]; Li SC, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-25; Meiler J, 2001, J MOL MODEL, V7, P360, DOI 10.1007/s008940100038; Montanelli L, 2004, MOL ENDOCRINOL, V18, P2061, DOI 10.1210/me.2004-0036; Mueller S, 2008, J BIOL CHEM, V283, P18048, DOI 10.1074/jbc.M800449200; Mueller S, 2010, TRENDS ENDOCRIN MET, V21, P111, DOI 10.1016/j.tem.2009.09.001; Mueller S, 2009, J BIOL CHEM, V284, P16317, DOI 10.1074/jbc.M109.005710; Muller SA, 2015, J PROTEOMICS, V126, P34, DOI 10.1016/j.jprot.2015.05.011; Nagayama Y, 2000, J PHARMACOL EXP THER, V295, P404; Nakabayashi K, 2003, MOL CELL ENDOCRINOL, V202, P139, DOI 10.1016/S0303-7207(03)00075-3; Neumann S, 2012, THYROID, V22, P839, DOI 10.1089/thy.2011.0520; Nicholas HB, 1999, ENDOCRINE, V11, P285, DOI 10.1385/ENDO:11:3:285; PIERCE JG, 1981, ANNU REV BIOCHEM, V50, P465, DOI 10.1146/annurev.bi.50.070181.002341; Raman S, 2009, PROTEINS, V77, P89, DOI 10.1002/prot.22540; Sanders P, 2011, J MOL ENDOCRINOL, V46, P81, DOI 10.1530/JME-10-0127; Schaarschmidt J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111570; Song YF, 2013, STRUCTURE, V21, P1735, DOI 10.1016/j.str.2013.08.005; Stranges PB, 2013, PROTEIN SCI, V22, P74, DOI 10.1002/pro.2187; Tanaka K, 2000, ENDOCRINOLOGY, V141, P3573, DOI 10.1210/en.141.10.3573; Tegoni M, 1999, J MOL BIOL, V289, P1375, DOI 10.1006/jmbi.1999.2845; Urizar E, 2005, EMBO J, V24, P1954, DOI 10.1038/sj.emboj.7600686; Vlaeminck-Guillem V, 2002, MOL ENDOCRINOL, V16, P736, DOI 10.1210/me.16.4.736; WADSWORTH HL, 1990, SCIENCE, V249, P1423, DOI 10.1126/science.2169649; Weierstall U, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4309; WU H, 1994, STRUCTURE, V2, P545, DOI 10.1016/S0969-2126(00)00054-X; Zoenen M, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1991	58	13	14	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 1	2016	291	27					14095	14108		10.1074/jbc.M115.709659	http://dx.doi.org/10.1074/jbc.M115.709659			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DR5XG	27129207	Green Published, hybrid			2022-12-26	WOS:000379975100018
J	Recktenwald, CV; Hansson, GC				Recktenwald, Christian V.; Hansson, Gunnar C.			The Reduction-insensitive Bonds of the MUC2 Mucin Are Isopeptide Bonds	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						intestine; mass spectrometry (MS); mucin; mucus; transglutaminase	GAMMA-GLUTAMYL-TRANSPEPTIDASE; LS 174T CELLS; KERATINOCYTE TRANSGLUTAMINASE; INTESTINAL MUCUS; CROSS-LINKING; HUMAN COLON; C-TERMINUS; IDENTIFICATION; EXPRESSION; CLEAVAGE	The main structural component of the mucus in the gastrointestinal tract is the MUC2 mucin. It forms large networks that in colon build the loose outer mucous layer that provides the habitat for the commensal flora and the inner mucous layer that protects the epithelial cells by being impenetrable to bacteria. The epithelial cells in mice lacking MUC2 are not adequately protected from bacteria, resulting in inflammation and the development of colon cancer as found in human ulcerative colitis. Correct processing of the MUC2 mucin is the basis for the building of these protective networks. During the biosynthesis of the MUC2 mucin, post-translational modifications are formed resulting in reduction-insensitive bonds between MUC2 monomers. By the use of -glutamyltranspeptidase and isopeptidase activity in leech saliva, we could show that the molecular nature of these reduction-insensitive bonds is isopeptide bonds formed between side chains of lysine and glutamine. Transglutaminase 2 has an affinity to the MUC2 CysD2 domain in the nanomolar range and can catalyze its cross-linking. By using mass spectrometry, we identified MUC2 residues involved in this cross-linking. This shows for the first time that transamidation is not only stabilizing the skin and the fibrin clot, but is also important for the correct intracellular processing of MUC2 to generate protective mucus.	[Recktenwald, Christian V.; Hansson, Gunnar C.] Univ Gothenburg, Dept Med Biochem, Box 440, SE-40530 Gothenburg, Sweden	University of Gothenburg	Hansson, GC (corresponding author), Univ Gothenburg, Dept Med Biochem, Box 440, SE-40530 Gothenburg, Sweden.	gunnar.hansson@medkem.gu.se	Hansson, Gunnar C/A-1236-2009; Hansson, Gunnar C./AAF-7324-2019	Hansson, Gunnar C/0000-0002-1900-1869; Hansson, Gunnar C./0000-0002-1900-1869; Recktenwald, Christian Viktor/0000-0003-1710-1863	Swedish Research Council [746]; Swedish Cancer Foundation; Knut and Alice Wallenberg Foundation; IngaBritt and Arne Lundberg Foundation; Sahlgren's University Hospital (ALF); Wilhelm and Martina Lundgren's Foundation; Torsten Soderbergs Stiftelse; The Sahlgrenska Academy; National Institutes of Health from NIAID [U01AI095473]; Swedish Foundation for Strategic Research-The Mucus-Bacteria-Colitis Center of the Innate Immunity Program; Swedish Cystic Fibrosis Foundation; Erica Lederhausen's Foundation; Lederhausen's Center for Cystic Fibrosis Research; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U01AI095473] Funding Source: NIH RePORTER	Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Cancer Foundation; Knut and Alice Wallenberg Foundation(Knut & Alice Wallenberg Foundation); IngaBritt and Arne Lundberg Foundation; Sahlgren's University Hospital (ALF); Wilhelm and Martina Lundgren's Foundation; Torsten Soderbergs Stiftelse; The Sahlgrenska Academy; National Institutes of Health from NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Swedish Foundation for Strategic Research-The Mucus-Bacteria-Colitis Center of the Innate Immunity Program; Swedish Cystic Fibrosis Foundation; Erica Lederhausen's Foundation; Lederhausen's Center for Cystic Fibrosis Research; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by Swedish Research Council Grant 746, the Swedish Cancer Foundation, the Knut and Alice Wallenberg Foundation, the IngaBritt and Arne Lundberg Foundation, Sahlgren's University Hospital (ALF), the Wilhelm and Martina Lundgren's Foundation, Torsten Soderbergs Stiftelse, The Sahlgrenska Academy, National Institutes of Health Grant U01AI095473 from NIAID, the Swedish Foundation for Strategic Research-The Mucus-Bacteria-Colitis Center of the Innate Immunity Program, the Swedish Cystic Fibrosis Foundation, the Erica Lederhausen's Foundation, and the Lederhausen's Center for Cystic Fibrosis Research. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Adamczyk M, 2015, J CELL SCI, V128, P4615, DOI 10.1242/jcs.175968; ALLISON RD, 1981, J BIOL CHEM, V256, P2988; Ambort D, 2012, P NATL ACAD SCI USA, V109, P5645, DOI 10.1073/pnas.1120269109; Ambort D, 2011, BIOCHEM J, V436, P61, DOI 10.1042/BJ20102066; Atuma C, 2001, AM J PHYSIOL-GASTR L, V280, pG922, DOI 10.1152/ajpgi.2001.280.5.G922; Axelsson MAB, 1998, J BIOL CHEM, V273, P18864, DOI 10.1074/jbc.273.30.18864; BASKOVA I P, 1985, Biokhimiya, V50, P424; Belkin AM, 2011, FEBS J, V278, P4704, DOI 10.1111/j.1742-4658.2011.08346.x; CARLSTEDT I, 1993, J BIOL CHEM, V268, P18771; D'Argenio G, 2005, GUT, V54, P496, DOI 10.1136/gut.2004.049411; DARBOUY M, 1991, AM J PHYSIOL, V261, pC1130, DOI 10.1152/ajpcell.1991.261.6.C1130; Eckert RL, 2014, PHYSIOL REV, V94, P383, DOI 10.1152/physrev.00019.2013; Eckert RL, 2005, J INVEST DERMATOL, V124, P481, DOI 10.1111/j.0022-202X.2005.23627.x; Eckhart L, 2013, BBA-MOL CELL RES, V1833, P3471, DOI 10.1016/j.bbamcr.2013.06.010; Feng JF, 1996, J BIOL CHEM, V271, P16451, DOI 10.1074/jbc.271.28.16451; Fleckenstein B, 2002, J BIOL CHEM, V277, P34109, DOI 10.1074/jbc.M204521200; Friedrich T, 1998, EUR J BIOCHEM, V256, P297, DOI 10.1046/j.1432-1327.1998.2560297.x; Godl K, 2002, J BIOL CHEM, V277, P47248, DOI 10.1074/jbc.M208483200; Gotze M, 2015, J AM SOC MASS SPECTR, V26, P83, DOI 10.1007/s13361-014-1001-1; GUM JR, 1994, J BIOL CHEM, V269, P2440; HAGEN TM, 1990, AM J PHYSIOL, V259, pG530, DOI 10.1152/ajpgi.1990.259.4.G530; Hardy E, 2004, ANAL BIOCHEM, V328, P1, DOI 10.1016/j.ab.2004.02.017; Herrmann A, 2003, BIOCHIMIE, V85, P381, DOI 10.1016/S0300-9084(03)00064-6; Herrmann A, 1999, J BIOL CHEM, V274, P15828, DOI 10.1074/jbc.274.22.15828; HUBER M, 1995, SCIENCE, V267, P525, DOI 10.1126/science.7824952; Johansson MEV, 2015, CELL HOST MICROBE, V18, P582, DOI 10.1016/j.chom.2015.10.007; Johansson MEV, 2008, P NATL ACAD SCI USA, V105, P15064, DOI 10.1073/pnas.0803124105; Kiraly R, 2016, AMINO ACIDS, V48, P31, DOI 10.1007/s00726-015-2063-5; LICHTI U, 1985, J BIOL CHEM, V260, P1422; Lidell ME, 2003, BIOCHEM J, V372, P335, DOI 10.1042/BJ20030003; Lidell ME, 2003, J BIOL CHEM, V278, P13944, DOI 10.1074/jbc.M210069200; Lorand L, 2003, NAT REV MOL CELL BIO, V4, P140, DOI 10.1038/nrm1014; Nemes Z, 1999, P NATL ACAD SCI USA, V96, P8402, DOI 10.1073/pnas.96.15.8402; Ozpolat B, 2007, AUTOPHAGY, V3, P480, DOI 10.4161/auto.4349; Rappsilber J, 2003, ANAL CHEM, V75, P663, DOI 10.1021/ac026117i; Rodriguez-Pineiro AM, 2013, AM J PHYSIOL-GASTR L, V305, pG348, DOI 10.1152/ajpgi.00047.2013; SANE DC, 1990, J BIOL CHEM, V265, P3543; Schulz BL, 2002, ANAL CHEM, V74, P6088, DOI 10.1021/ac025890a; Schutte A, 2014, P NATL ACAD SCI USA, V111, P12396, DOI 10.1073/pnas.1407597111; Siegel M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001861; Stamnaes J, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0134922; Thomsson KA, 2011, METHODS MOL BIOL, V742, P127, DOI 10.1007/978-1-61779-120-8_8; Zaidi SMA, 2011, ALTERN MED REV, V16, P59	43	29	29	1	22	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 24	2016	291	26					13580	13590		10.1074/jbc.M116.726406	http://dx.doi.org/10.1074/jbc.M116.726406			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DR2YZ	27129250	Green Published, hybrid			2022-12-26	WOS:000379771100016
J	Sardos, J; Rouard, M; Hueber, Y; Cenci, A; Hyma, KE; van den Houwe, I; Hribova, E; Courtois, B; Roux, N				Sardos, Julie; Rouard, Mathieu; Hueber, Yann; Cenci, Alberto; Hyma, Katie E.; van den Houwe, Ines; Hribova, Eva; Courtois, Brigitte; Roux, Nicolas			A Genome-Wide Association Study on the Seedless Phenotype in Banana (Musa spp.) Reveals the Potential of a Selected Panel to Detect Candidate Genes in a Vegetatively Propagated Crop	PLOS ONE			English	Article							FEMALE GAMETOPHYTE DEVELOPMENT; ARABIDOPSIS HISTIDINE KINASE; MULTILOCUS GENOTYPE DATA; POPULATION-STRUCTURE; FRUIT-SET; PARTHENOCARPIC ABILITY; TOMATO; DIVERSITY; ACCURATE; INFERENCE	Banana (Musa sp.) is a vegetatively propagated, low fertility, potentially hybrid and polyploid crop. These qualities make the breeding and targeted genetic improvement of this crop a difficult and long process. The Genome-Wide Association Study (GWAS) approach is becoming widely used in crop plants and has proven efficient to detecting candidate genes for traits of interest, especially in cereals. GWAS has not been applied yet to a vegetatively propagated crop. However, successful GWAS in banana would considerably help unravel the genomic basis of traits of interest and therefore speed up this crop improvement. We present here a dedicated panel of 105 accessions of banana, freely available upon request, and their corresponding GBS data. A set of 5,544 highly reliable markers revealed high levels of admixture in most accessions, except for a subset of 33 individuals from Papua. A GWAS on the seedless phenotype was then successfully applied to the panel. By applying the Mixed Linear Model corrected for both kinship and structure as implemented in TASSEL, we detected 13 candidate genomic regions in which we found a number of genes potentially linked with the seedless phenotype (i.e. parthenocarpy combined with female sterility). An additional GWAS performed on the unstructured Papuan subset composed of 33 accessions confirmed six of these regions as candidate. Out of both sets of analyses, one strong candidate gene for female sterility, a putative orthologous gene to Histidine Kinase CKI1, was identified. The results presented here confirmed the feasibility and potential of GWAS when applied to small sets of banana accessions, at least for traits underpinned by a few loci. As phenotyping in banana is extremely space and time-consuming, this latest finding is of particular importance in the context of banana improvement.	[Sardos, Julie; Rouard, Mathieu; Hueber, Yann; Cenci, Alberto; Roux, Nicolas] Biovers Int, Parc Sci Agropolis 2, F-34397 Montpellier 5, France; [Hyma, Katie E.] Cornell Univ, Genom Div Facil, Inst Biotechnol, Ithaca, NY 14853 USA; [van den Houwe, Ines] Katholieke Univ Leuven, Biovers Int, B-3001 Leuven, Belgium; [Hribova, Eva] Ctr Reg Hana Biotechnol & Agr Res, Inst Expt Bot, Olomouc, Czech Republic; [Courtois, Brigitte] CIRAD, UMR AGAP, F-34398 Montpellier, France	Alliance; Bioversity International; Cornell University; Alliance; Bioversity International; KU Leuven; Czech Academy of Sciences; Institute of Experimental Botany of the Czech Academy of Sciences; CIRAD; Universite de Montpellier	Sardos, J (corresponding author), Biovers Int, Parc Sci Agropolis 2, F-34397 Montpellier 5, France.	j.sardos@cgiar.org	Rouard, Mathieu/H-5035-2017; Roux, Nicolas/ABG-4156-2020; COURTOIS, Brigitte/A-4004-2009; Cenci, Alberto/H-2823-2019	Rouard, Mathieu/0000-0003-0284-1885; COURTOIS, Brigitte/0000-0003-2118-7102; Cenci, Alberto/0000-0002-4390-5948; Hribova, Eva/0000-0002-6868-4344; Sardos, Julie/0000-0001-5505-9198	RTB; RTB, CGIAR Research Program on Roots, Tubers and bananas	RTB; RTB, CGIAR Research Program on Roots, Tubers and bananas	This study was funded by RTB, the CGIAR Research Program on Roots, Tubers and bananas (http://www.rtb.cgiar.org/) through the cross-cutting project entitled "Enhancing global RTB productivity through more targeted use of global RTB genetic Diversity" led by Dr. Augusto Becerra-Lopez-Lavalle (CIAT) and DR. Nicolas Roux (Bioversity International). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adeleke Martina T. V., 2004, Cytologia (Tokyo), V69, P387, DOI 10.1508/cytologia.69.387; Anisimova M, 2006, SYST BIOL, V55, P539, DOI 10.1080/10635150600755453; [Anonymous], 1962, EVOLUTION BANANAS; [Anonymous], 1996, 5000 CNRS UMR; Aranzana MJ, 2005, PLOS GENET, V1, P531, DOI 10.1371/journal.pgen.0010060; Balloux F, 2003, GENETICS, V164, P1635; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Beraldi D, 2004, THEOR APPL GENET, V108, P209, DOI 10.1007/s00122-003-1442-6; Brachi B, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-10-232; Browning SR, 2007, AM J HUM GENET, V81, P1084, DOI 10.1086/521987; Carreel F., 1994, GENET SEL EVOL, V26, P125; Cenci A, 2014, PLANT MOL BIOL, V85, P63, DOI 10.1007/s11103-013-0169-2; Courtois B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078037; D'Hont A, 2012, NATURE, V488, P213, DOI 10.1038/nature11241; de Jong M, 2011, J EXP BOT, V62, P617, DOI 10.1093/jxb/erq293; de Menezes CB, 2005, GENET MOL RES, V4, P39; Deng Y, 2010, PLANT CELL, V22, P1232, DOI 10.1105/tpc.108.065128; Dereeper A, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-134; DeYoung BJ, 2006, PLANT J, V45, P1, DOI 10.1111/j.1365-313X.2005.02592.x; Ding JG, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070080; Dita MA, 2011, GREENHOUSE BIOASSAY; Dodds K, J GENET; DODDS KS, 1948, HEREDITY, V2, P101, DOI 10.1038/hdy.1948.6; Douhovnikoff V, 2003, THEOR APPL GENET, V106, P1307, DOI 10.1007/s00122-003-1200-9; Droc G, 2013, DATABASE-OXFORD, DOI 10.1093/database/bat035; Elshire RJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019379; Falush D, 2003, GENETICS, V164, P1567; Fos M, 2000, PLANT PHYSIOL, V122, P471, DOI 10.1104/pp.122.2.471; Fu YB, 2014, G3-GENES GENOM GENET, V4, P891, DOI 10.1534/g3.114.010942; Glaubitz JC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090346; Gorguet B, 2008, THEOR APPL GENET, V116, P755, DOI 10.1007/s00122-007-0708-9; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Hejatko J, 2003, MOL GENET GENOMICS, V269, P443, DOI 10.1007/s00438-003-0858-7; Hippolyte I, 2012, ANN BOT-LONDON, V109, P937, DOI 10.1093/aob/mcs010; Huang XH, 2010, NAT GENET, V42, P961, DOI 10.1038/ng.695; Katoh K, 2005, NUCLEIC ACIDS RES, V33, P511, DOI 10.1093/nar/gki198; KHALIFAH RA, 1966, PLANT PHYSIOL, V41, P771, DOI 10.1104/pp.41.5.771; KIM IS, 1992, SCI HORTIC-AMSTERDAM, V52, P1, DOI 10.1016/0304-4238(92)90002-T; Korte A, 2013, PLANT METHODS, V9, DOI 10.1186/1746-4811-9-29; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Meirmans PG, 2004, MOL ECOL NOTES, V4, P792, DOI 10.1111/j.1471-8286.2004.00770.x; Miyatake K, 2012, THEOR APPL GENET, V124, P1403, DOI 10.1007/s00122-012-1796-8; Morris GP, 2013, G3-GENES GENOM GENET, V3, P2085, DOI 10.1534/g3.113.008417; Ozga JA, 2002, PLANT PHYSIOL, V128, P1379, DOI 10.1104/pp.010800; Pasam RK, 2012, BMC PLANT BIOL, V12, DOI 10.1186/1471-2229-12-16; Pascual L, 2009, BMC PLANT BIOL, V9, DOI 10.1186/1471-2229-9-67; Perrier X., 2006, DARWIN SOFTWARE; Perrier X., 2003, GENETIC DIVERSITY CU, P43; Perrier X, 2011, P NATL ACAD SCI USA, V108, P11311, DOI 10.1073/pnas.1102001108; Pischke MS, 2002, P NATL ACAD SCI USA, V99, P15800, DOI 10.1073/pnas.232580499; Pritchard JK, 2000, GENETICS, V155, P945; Rouard M, 2011, NUCLEIC ACIDS RES, V39, pD1095, DOI 10.1093/nar/gkq811; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Sardos J, DART WHOLE GEN UNPUB; Shepherd K, 1999, CYTOGENETICS OF THE; SIMMONDS NW, 1953, J EXP BOT, V4, P87, DOI 10.1093/jxb/4.1.87; Sokal R, 1958, I KANSAS SCI B, V38, p[1409, 127]; Staswick PE, 2005, PLANT CELL, V17, P616, DOI 10.1105/tpc.104.026690; Sun L, 2006, GENET EPIDEMIOL, V30, P519, DOI 10.1002/gepi.20164; Sundberg E, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a001628; Talavera G, 2007, SYST BIOL, V56, P564, DOI 10.1080/10635150701472164; TALON M, 1990, PHYSIOL PLANTARUM, V79, P400, DOI 10.1034/j.1399-3054.1990.790227.x; TALON M, 1992, PLANT PHYSIOL, V99, P1575, DOI 10.1104/pp.99.4.1575; Tian F, 2011, NAT GENET, V43, P159, DOI 10.1038/ng.746; Tiwari A, 2011, BMC PLANT BIOL, V11, DOI 10.1186/1471-2229-11-143; WEIR BS, 1984, EVOLUTION, V38, P1358, DOI 10.1111/j.1558-5646.1984.tb05657.x; Xiao H, 2009, PLANT J, V59, P789, DOI 10.1111/j.1365-313X.2009.03913.x; Zila CT, 2013, G3-GENES GENOM GENET, V3, P2095, DOI 10.1534/g3.113.007328	69	38	40	8	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 4	2016	11	5							e0154448	10.1371/journal.pone.0154448	http://dx.doi.org/10.1371/journal.pone.0154448			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DL5KR	27144345	Green Published, gold, Green Submitted			2022-12-26	WOS:000375676400046
J	Tao-Cheng, JH; Toy, D; Winters, CA; Reese, TS; Dosemeci, A				Tao-Cheng, Jung-Hwa; Toy, Dana; Winters, Christine A.; Reese, Thomas S.; Dosemeci, Ayse			Zinc Stabilizes Shank3 at the Postsynaptic Density of Hippocampal Synapses	PLOS ONE			English	Article							AUTISM SPECTRUM DISORDERS; DIFFERENTIAL EXPRESSION; AMPA RECEPTORS; NEURONS; PROTEIN; PROSAP/SHANK; FAMILY; SCAFFOLD; BRAIN; NMDA	Shank3 is a postsynaptic density (PSD) scaffold protein of the Shank family. Here we use pre-embedding immunogold electron microscopy to investigate factors influencing the distribution of Shank3 at the PSD. In dissociated rat hippocampal cultures under basal conditions, label for Shank3 was concentrated in a broad layer of the PSD, similar to 20-80 nm from the postsynaptic membrane. Upon depolarization with high K+ (90 mM, 2 min), or application of NMDA (50 mu M, 2 min), both the labeling intensity at the PSD and the median distance of label from the postsynaptic membrane increased significantly, indicating that Shank3 molecules are preferentially recruited to the distal layer of the PSD. Incubation in medium supplemented with zinc (50 mu M ZnCl2, 1 hr) also significantly increased labeling intensity for Shank3 at the PSD, but this addition of Shank3 was not preferential to the distal layer. When cells were incubated with zinc and then treated with NMDA, labeling intensity of Shank3 became higher than with either treatment alone and manifested a preference for the distal layer of the PSD. Without zinc supplementation, NMDA-induced accumulation of Shank3 at the PSD was transient, reversing within 30 min after return to control medium. However, when zinc was included in culture media throughout the experiment, the NMDA-induced accumulation of Shank3 was largely retained, including Shank3 molecules recruited to the distal layer of the PSD. These results demonstrate that activity induces accumulation of Shank3 at the PSD and that zinc stabilizes PSD-associated Shank3, possibly through strengthening of Shank-Shank association.	[Tao-Cheng, Jung-Hwa] NINDS, NINDS EM Facil, NIH, Bldg 36,Rm 4D04, Bethesda, MD 20892 USA; [Toy, Dana; Winters, Christine A.; Reese, Thomas S.; Dosemeci, Ayse] NINDS, Neurobiol Lab, NIH, Bldg 36,Rm 4D04, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Neurological Disorders & Stroke (NINDS); National Institutes of Health (NIH) - USA; NIH National Institute of Neurological Disorders & Stroke (NINDS)	Tao-Cheng, JH (corresponding author), NINDS, NINDS EM Facil, NIH, Bldg 36,Rm 4D04, Bethesda, MD 20892 USA.	chengs@ninds.nih.gov			National Institute of Neurological Disorders and Stroke; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [ZIANS003113] Funding Source: NIH RePORTER	National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This study was supported by National Institute of Neurological Disorders and Stroke intramural funds. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baron MK, 2006, SCIENCE, V311, P531, DOI 10.1126/science.1118995; Bockers TM, 2004, MOL CELL NEUROSCI, V26, P182, DOI 10.1016/j.mcn.2004.01.009; Boeckers TM, 1999, J NEUROSCI, V19, P6506; Burette AC, 2014, J COMP NEUROL, V522, P2164, DOI 10.1002/cne.23526; Dosemeci A, 2000, J NEUROSCI, V20, P3076, DOI 10.1523/JNEUROSCI.20-09-03076.2000; Dosemeci A, 2002, J NEUROCYTOL, V31, P605, DOI 10.1023/A:1025735410738; Durand CM, 2007, NAT GENET, V39, P25, DOI 10.1038/ng1933; Frederickson CJ, 2005, NAT REV NEUROSCI, V6, P449, DOI 10.1038/nrn1671; Fukata Y, 2013, J CELL BIOL, V202, P145, DOI 10.1083/jcb.201302071; Grabrucker AM, 2014, DEV NEUROBIOL, V74, P136, DOI 10.1002/dneu.22089; Grabrucker AM, 2011, EMBO J, V30, P569, DOI 10.1038/emboj.2010.336; Grabrucker S, 2014, BRAIN, V137, P137, DOI 10.1093/brain/awt303; Gundelfinger ED, 2006, TRENDS BIOCHEM SCI, V31, P366, DOI 10.1016/j.tibs.2006.05.007; Hayashi MK, 2009, CELL, V137, P159, DOI 10.1016/j.cell.2009.01.050; Jan HH, 2002, J NEUROCHEM, V83, P525, DOI 10.1046/j.1471-4159.2002.01093.x; Jiang YH, 2013, NEURON, V78, P8, DOI 10.1016/j.neuron.2013.03.016; Kuriu T, 2006, J NEUROSCI, V26, P7693, DOI 10.1523/JNEUROSCI.0522-06.2006; Lim S, 1999, J BIOL CHEM, V274, P29510, DOI 10.1074/jbc.274.41.29510; MacGillavry HD, 2013, NEURON, V78, P615, DOI 10.1016/j.neuron.2013.03.009; Marger L, 2014, BIOCHEM PHARMACOL, V91, P426, DOI 10.1016/j.bcp.2014.08.002; Mei Y, 2016, NATURE, V530, P481, DOI 10.1038/nature16971; Nair D, 2013, J NEUROSCI, V33, P13204, DOI 10.1523/JNEUROSCI.2381-12.2013; Paoletti P, 2009, NEUROSCIENCE, V158, P126, DOI 10.1016/j.neuroscience.2008.01.061; Peca J, 2011, NATURE, V472, P437, DOI 10.1038/nature09965; Peters A., 1991, FINE STRUCTURE NERVO; PETERS S, 1987, SCIENCE, V236, P589, DOI 10.1126/science.2883728; Qualmann B, 2004, J NEUROSCI, V24, P2481, DOI 10.1523/JNEUROSCI.5479-03.2004; Rostaing P, 2006, EUR J NEUROSCI, V24, P3463, DOI 10.1111/j.1460-9568.2006.05234.x; Roussignol G, 2005, J NEUROSCI, V25, P3560, DOI 10.1523/JNEUROSCI.4354-04.2005; Sala C, 2015, J NEUROCHEM, V135, P849, DOI 10.1111/jnc.13232; Scita G, 2008, TRENDS CELL BIOL, V18, P52, DOI 10.1016/j.tcb.2007.12.002; Sheng M, 2000, J CELL SCI, V113, P1851; Tao-Cheng JH, 2014, NEUROSCIENCE, V266, P80, DOI 10.1016/j.neuroscience.2014.01.066; Tao-Cheng JH, 2010, NEUROSCIENCE, V168, P11, DOI 10.1016/j.neuroscience.2010.03.041; Tao-Cheng JH, 2007, J COMP NEUROL, V501, P731, DOI 10.1002/cne.21276; Tao-Cheng JH, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118750; Tao-Cheng JH, 2014, BIOCHEM BIOPH RES CO, V450, P808, DOI 10.1016/j.bbrc.2014.06.049; Verpelli C, 2011, J BIOL CHEM, V286, P34839, DOI 10.1074/jbc.M111.258384; Wendholt D, 2006, J BIOL CHEM, V281, P13805, DOI 10.1074/jbc.M601101200; WESTBROOK GL, 1987, NATURE, V328, P640, DOI 10.1038/328640a0	40	20	20	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 4	2016	11	5							e0153979	10.1371/journal.pone.0153979	http://dx.doi.org/10.1371/journal.pone.0153979			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DL5KR	27144302	Green Published, Green Submitted, gold			2022-12-26	WOS:000375676400035
J	Urquhart, EA; Jones, SH; Yu, JW; Schuster, BM; Marcinkiewicz, AL; Whistler, CA; Cooper, VS				Urquhart, Erin A.; Jones, Stephen H.; Yu, Jong W.; Schuster, Brian M.; Marcinkiewicz, Ashley L.; Whistler, Cheryl A.; Cooper, Vaughn S.			Environmental Conditions Associated with Elevated Vibrio parahaemolyticus Concentrations in Great Bay Estuary, New Hampshire	PLOS ONE			English	Article							MULTIPLEX PCR; NORTHERN GULF; OYSTERS; VULNIFICUS; WATERS; ABUNDANCE; CHOLERAE; COASTAL; TEMPERATURE; COMMUNITY	Reports from state health departments and the Centers for Disease Control and Prevention indicate that the annual number of reported human vibriosis cases in New England has increased in the past decade. Concurrently, there has been a shift in both the spatial distribution and seasonal detection of Vibrio spp. throughout the region based on limited monitoring data. To determine environmental factors that may underlie these emerging conditions, this study focuses on a long-term database of Vibrio parahaemolyticus concentrations in oyster samples generated from data collected from the Great Bay Estuary, New Hampshire over a period of seven consecutive years. Oyster samples from two distinct sites were analyzed for V. parahaemolyticus abundance, noting significant relationships with various biotic and abiotic factors measured during the same period of study. We developed a predictive modeling tool capable of estimating the likelihood of V. parahaemolyticus presence in coastal New Hampshire oysters. Results show that the inclusion of chlorophyll a concentration to an empirical model otherwise employing only temperature and salinity variables, offers improved predictive capability for modeling the likelihood of V. parahaemolyticus in the Great Bay Estuary.	[Urquhart, Erin A.; Jones, Stephen H.; Whistler, Cheryl A.] Univ New Hampshire, Northeast Ctr Vibrio Dis & Ecol, Durham, NH 03824 USA; [Urquhart, Erin A.; Yu, Jong W.; Schuster, Brian M.; Marcinkiewicz, Ashley L.; Whistler, Cheryl A.] Univ New Hampshire, Dept Mol Cellular & Biomed Sci, Durham, NH 03824 USA; [Jones, Stephen H.] Univ New Hampshire, Dept Nat Resources & Environm, Durham, NH 03824 USA; [Cooper, Vaughn S.] Univ Pittsburgh, Sch Med, Dept Nat Resources & Environm, Pittsburgh, PA USA; [Yu, Jong W.; Schuster, Brian M.] Seres Therapeut, Cambridge, MA USA	University System Of New Hampshire; University of New Hampshire; University System Of New Hampshire; University of New Hampshire; University System Of New Hampshire; University of New Hampshire; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Urquhart, EA (corresponding author), Univ New Hampshire, Northeast Ctr Vibrio Dis & Ecol, Durham, NH 03824 USA.; Urquhart, EA (corresponding author), Univ New Hampshire, Dept Mol Cellular & Biomed Sci, Durham, NH 03824 USA.	erin.urquhart@gmail.com		Marcinkiewicz, Ashley/0000-0003-1417-5699; Cooper, Vaughn/0000-0001-7726-0765	National Science Foundation [EPSCoR IIA-1330641]; USDA National Institute of Food and Agriculture [NH00574, NH00609, 233555, 1004199, NH00625]; National Oceanic and Atmospheric Administration College Sea Grant program; New Hampshire Sea Grant program [R/CE-137, R/SSS-2, R/HCE- 3]; Office of Integrative Activities [1330641] Funding Source: National Science Foundation	National Science Foundation(National Science Foundation (NSF)); USDA National Institute of Food and Agriculture(United States Department of Agriculture (USDA)); National Oceanic and Atmospheric Administration College Sea Grant program; New Hampshire Sea Grant program; Office of Integrative Activities(National Science Foundation (NSF)NSF - Office of the Director (OD))	This work was supported by the National Science Foundation (http://www.nsf.gov/funding/) EPSCoR IIA-1330641; the USDA National Institute of Food and Agriculture (http://nifa.usda.gov/grants) Hatch NH00574, NH00609 (accession 233555), and NH00625 (accession 1004199); and the National Oceanic and Atmospheric Administration College Sea Grant program (http://seagrant.noaa.gov/) and New Hampshire Sea Grant program (http://seagrant.unh.edu/) grants R/CE-137, R/SSS-2, R/HCE- 3. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors would like to thank Jennifer Mahoney, Megan Striplin, Crystal Ellis, Eliot Jones, Anna Tyzik, Rachel Donner, Matthew Gerding, Summer Morrill, Tucker Knowles, Michael Taylor, Feng Xu, Meghan Hartwick, Kelsey Chickering, Tom Gregory, Chris Peters, Jackie Lemaire, Sarah Richards, Emily Schulz, and Elizabeth Deyett for their help with sampling, sample processing, detection analysis, and database management. The authors gratefully acknowledge partial funding support from the National Science Foundation EPSCoR IIA-1330641, USDA National Institute of Food and Agriculture Hatch NH00574, NH00609 (accession 233555), and NH00625 (accession 1004199), and the National Oceanic and Atmospheric Administration College Sea Grant program and New Hampshire Sea Grant program grants R/CE-137, R/SSS-2, R/HCE- 3.	AKAIKE H, 1974, IEEE T AUTOMAT CONTR, VAC19, P716, DOI 10.1109/TAC.1974.1100705; Arar E. J., 1997, MARINE FRESH WATER A; BANERJEE S, 2015, AM SOC MICROBIOLOGY, V3, P1482, DOI DOI 10.1128/GEN0MEA.01482-14; BARTLEY CH, 1971, APPL MICROBIOL, V21, P965, DOI 10.1128/AEM.21.5.965-966.1971; Breiman L, 1996, TECHNICAL REPORT; Connecticut Department of Public Health, 2013, REP CAS CONN REP DIS; Cox AM, 2012, APPL ENVIRON MICROB, V78, P2996, DOI 10.1128/AEM.07519-11; Cruz CD, 2015, APPL ENVIRON MICROB, V81, P2320, DOI 10.1128/AEM.04020-14; Deepanjali A, 2005, APPL ENVIRON MICROB, V71, P3575, DOI 10.1128/AEM.71.7.3575-3580.2005; DePaola A, 2003, APPL ENVIRON MICROB, V69, P1521, DOI 10.1128/AEM.69.3.1521-1526.2003; Deter J, 2010, ENVIRON MICROBIOL, V12, P929, DOI 10.1111/j.1462-2920.2009.02136.x; EARLE PM, 1975, APPL MICROBIOL, V29, P635, DOI 10.1191/0309132505ph574pr; Ellis CN, 2012, APPL ENVIRON MICROB, V78, P3778, DOI 10.1128/AEM.07794-11; Froelich BA, 2015, APPL ENVIRON MICROB, V81, P1111, DOI 10.1128/AEM.03206-14; Hastie TJ, 1992, STAT MODELS S, P608; Hsieh JL, 2008, ENVIRON MICROBIOL, V10, P57, DOI 10.1111/j.1462-2920.2007.01429.x; HUQ A, 1983, APPL ENVIRON MICROB, V45, P275, DOI 10.1128/AEM.45.1.275-283.1983; Jacobs J, 2010, PREDICTING DISTRIBUT, P16; Johnson CN, 2010, APPL ENVIRON MICROB, V76, P7076, DOI 10.1128/AEM.00697-10; Johnson CN, 2012, APPL ENVIRON MICROB, V78, P7249, DOI 10.1128/AEM.01296-12; Jones JL, 2014, APPL ENVIRON MICROB, V80, P7667, DOI 10.1128/AEM.02820-14; Jones SH, 1998, J SHELLFISH RES, V17, P1665; Jones S, 2010, PROCEEDINGS OF THE 17TH INTERNATIONAL CONGRESS ON SOUND AND VIBRATION; KANEKO T, 1973, J BACTERIOL, V113, P24, DOI 10.1128/JB.113.1.24-32.1973; KANEKO T, 1975, APPL MICROBIOL, V29, P269, DOI 10.1128/AEM.29.2.269-274.1975; Kaysner C. A, 2004, BACTERIOLOGICAL ANAL; Louis V, 2003, APPL ENV MICROBIOL; Magny De G, 2009, ECOHEALTH; Mahoney JC, 2010, APPL ENVIRON MICROB, V76, P7459, DOI 10.1128/AEM.01450-10; Main CR, 2015, APPL ENVIRON MICROB, V81, P5703, DOI 10.1128/AEM.00580-15; Maine Department of Health and Human Services, 2014, INF DIS REP EP PROGR; Martinez-Urtaza J, 2008, APPL ENVIRON MICROB, V74, P265, DOI 10.1128/AEM.01307-07; Martinez-Urtaza J, 2013, NEW ENGL J MED, V369, P1573, DOI 10.1056/NEJMc1305535; Massachusetts Department of Public Health, 2014, ENT DIS MASS CONF CA; MATTHEWS BW, 1975, BIOCHIM BIOPHYS ACTA, V405, P442, DOI 10.1016/0005-2795(75)90109-9; Motes ML, 1998, APPL ENVIRON MICROB, V64, P1459; National Shellfish Sanitation Program, 2013, GUID CONTR MOLL SHEL; New Hampshire Department of Health and Human Services, 2014, REP COMM DIS NEW HAM; Newton A, 2014, MORBIDITY MORTALITY; Newton A, 2012, CLIN INFECT DIS, V54, pS391, DOI 10.1093/cid/cis243; Oberbeckmann S, 2012, MICROB ECOL, V63, P543, DOI 10.1007/s00248-011-9990-9; ONEILL KR, 1990, FEMS MICROBIOL LETT, V72, P163, DOI 10.1111/j.1574-6968.1990.tb03882.x; ONEILL KR, 1992, APPL ENVIRON MICROB, V58, P3257, DOI 10.1128/AEM.58.10.3257-3262.1992; Panicker G, 2004, APPL ENVIRON MICROB, V70, P7436, DOI 10.1128/AEM.70.12.7436-7444.2004; Paranjpye RN, 2015, FEMS MICROBIOL ECOL, V91; Parveen S, 2008, INT J FOOD MICROBIOL, V128, P354, DOI 10.1016/j.ijfoodmicro.2008.09.019; Parveen S, 2013, INT J FOOD MICROBIOL, V161, P1, DOI 10.1016/j.ijfoodmicro.2012.11.010; Pearson K., 1895, P R SOC LONDON; Phillips A, 2007, J FOOD PROTECT, V4, P820; Pruzzo C, 2008, ENVIRON MICROBIOL, V10, P1400, DOI 10.1111/j.1462-2920.2007.01559.x; R Statistical Software, 2015, R STAT SOFTWARE LANG; Shaw KS, 2014, FRONT MICROBIOL, V5, DOI 10.3389/fmicb.2014.00204; Takemura AE, 2014, FRONT MICROBIOL, V5, DOI 10.3389/fmicb.2014.00038; Urquhart E, 2014, UNCERTAINTY MODEL PR; Urquhart EA, 2015, J ENVIRON INFORM, V26, P1, DOI 10.3808/jei.201500307; USFDA, 2000, RISK ASS PU IN PRESS; [USFDA] United States Food and Drug Administration, 2005, QUANT RISK ASS PUBL; VENKATESWARAN K, 1990, FEMS MICROBIOL ECOL, V73, P159, DOI 10.1111/j.1574-6968.1990.tb03936.x; Vezzulli L, 2009, MICROB ECOL, V58, P808, DOI 10.1007/s00248-009-9542-8; WATKINS WD, 1985, APPL ENVIRON MICROB, V49, P1307, DOI 10.1128/AEM.49.5.1307-1313.1985; Whistler CA, 2015, J CLIN MICROBIOL, V53, P1864, DOI 10.1128/JCM.00034-15; World Health Organization, 2011, FOOD SAF VIBR RISK A; Xu F, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.00272	63	22	23	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 4	2016	11	5							e0155018	10.1371/journal.pone.0155018	http://dx.doi.org/10.1371/journal.pone.0155018			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DL5KR	27144925	Green Accepted, Green Published, gold, Green Submitted			2022-12-26	WOS:000375676400097
J	Ziemba, JL; Hickerson, CAM; Anthony, CD				Ziemba, Julie L.; Hickerson, Cari-Ann M.; Anthony, Carl D.			Invasive Asian Earthworms Negatively Impact Keystone Terrestrial Salamanders	PLOS ONE			English	Article							NORTHERN HARDWOOD FORESTS; SOIL ORGANIC-MATTER; AMYNTHAS-AGRESTIS; INTERFERENCE COMPETITION; PLETHODON-CINEREUS; MICROBIAL ACTIVITY; WATER-LOSS; BEHAVIOR; OLIGOCHAETA; TEMPERATE	Asian pheretimoid earthworms (e.g. Amynthas and Metaphire spp.) are invading North American forests and consuming the vital detrital layer that forest floor biota [including the keystone species Plethodon cinereus (Eastern Red-backed Salamander)], rely on for protection, food, and habitat. Plethodon cinereus population declines have been associated with leaf litter loss following the invasion of several exotic earthworm species, but there have been few studies on the specific interactions between pheretimoid earthworms and P. cinereus. Since some species of large and active pheretimoids spatially overlap with salamanders beneath natural cover objects and in detritus, they may distinctively compound the negative consequences of earthworm-mediated resource degradation by physically disturbing important salamander activities (foraging, mating, and egg brooding). We predicted that earthworms would exclude salamanders from high quality microhabitat, reduce foraging efficiency, and negatively affect salamander fitness. In laboratory trials, salamanders used lower quality microhabitat and consumed fewer flies in the presence of earthworms. In a natural field experiment, conducted on salamander populations from "non-invaded" and "pheretimoid invaded" sites in Ohio, salamanders and earthworms shared cover objects similar to 60% less than expected. Earthworm abundance was negatively associated with juvenile and male salamander abundance, but had no relationship with female salamander abundance. There was no effect of pheretimoid invasion on salamander body condition. Juvenile and non-resident male salamanders do not hold stable territories centered beneath cover objects such as rocks or logs, which results in reduced access to prey, greater risk of desiccation, and dispersal pressure. Habitat degradation and physical exclusion of salamanders from cover objects may hinder juvenile and male salamander performance, ultimately reducing recruitment and salamander abundance following Asian earthworm invasion.	[Ziemba, Julie L.; Hickerson, Cari-Ann M.; Anthony, Carl D.] John Carroll Univ, University Hts, OH USA	John Carroll University	Ziemba, JL (corresponding author), John Carroll Univ, University Hts, OH USA.	jziemba09@jcu.edu			John Carroll University Biology Department; Geauga Park District	John Carroll University Biology Department; Geauga Park District	The authors thank the John Carroll University Biology Department and the Geauga Park District for providing funding for this work. The Geauga Park District Small Research Grant was received by JLZ in the amount of $6000. Info can be found at http://www.geaugaparkdistrict.org/nrm/main.shtml or by contacting Paul Pira, Park Biologist 440-286-9516, ppira@geaugaparkdistrict.org. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson CB, 2007, OECOLOGIA, V154, P141, DOI 10.1007/s00442-007-0757-4; ANTHONY C. D., 2013, OHIO BIOL SURVEY B, V17, P335; Blakemore Robert J., 2003, Organisms Diversity & Evolution Electronic Supplement, V11, P1; Bohlen PJ, 2004, FRONT ECOL ENVIRON, V2, P427, DOI 10.1890/1540-9295(2004)002[0427:NIEAAO]2.0.CO;2; Brown GG, 2000, EUR J SOIL BIOL, V36, P177, DOI 10.1016/S1164-5563(00)01062-1; BUCHANAN BW, 1993, ANIM BEHAV, V45, P893, DOI 10.1006/anbe.1993.1109; Burtelow AE, 1998, APPL SOIL ECOL, V9, P197, DOI 10.1016/S0929-1393(98)00075-4; BURTON TM, 1975, COPEIA, P541; Butchart SHM, 2010, SCIENCE, V328, P1164, DOI 10.1126/science.1187512; Cabe PR, 2007, HEREDITY, V98, P53, DOI 10.1038/sj.hdy.6800905; Caceres-Charneco RI, 2010, POPUL ECOL, V52, P517, DOI 10.1007/s10144-010-0204-y; Callaham MA, 2003, PEDOBIOLOGIA, V47, P466, DOI 10.1078/0031-4056-00214; Callaham MA, 2006, BIOL INVASIONS, V8, P1317, DOI 10.1007/s10530-006-9016-6; Crooks JA, 2002, OIKOS, V97, P153, DOI 10.1034/j.1600-0706.2002.970201.x; Davalos A, 2015, BIOL CONSERV, V187, P173, DOI 10.1016/j.biocon.2015.04.025; DAWLEY EM, 1988, J MORPHOL, V198, P243, DOI 10.1002/jmor.1051980210; FRASER DF, 1976, ECOLOGY, V57, P459, DOI 10.2307/1936431; Frelich LE, 2006, BIOL INVASIONS, V8, P1235, DOI 10.1007/s10530-006-9019-3; GATES G E, 1982, Megadrilogica, V4, P12; GERGITS WF, 1990, J HERPETOL, V24, P93, DOI 10.2307/1564298; Gessner MO, 2010, TRENDS ECOL EVOL, V25, P372, DOI 10.1016/j.tree.2010.01.010; Gillette JR., 2003, THESIS U LOUISIANA; Goerres Josef H., 2014, Megadrilogica, V16, P9; Gorres JH, 2012, NORTHEAST NAT, V19, P313, DOI 10.1656/045.019.0212; Gorsuch JP, 2014, NORTHEAST NAT, V21, P652, DOI 10.1656/045.021.0415; Greiner HG, 2012, BIOL INVASIONS, V14, P2017, DOI 10.1007/s10530-012-0208-y; Greiner HG, 2010, PEDOBIOLOGIA, V53, P247, DOI 10.1016/j.pedobi.2009.12.004; Hale CM, 2006, ECOLOGY, V87, P1637, DOI 10.1890/0012-9658(2006)87[1637:CIHFUP]2.0.CO;2; Hale CM, 2005, ECOL APPL, V15, P848, DOI 10.1890/03-5345; Hale CM, 2007, EARTHWORMS GREAT LAK; Hendrix PF, 2008, ANNU REV ECOL EVOL S, V39, P593, DOI 10.1146/annurev.ecolsys.39.110707.173426; Hendrix PF, 2002, BIOSCIENCE, V52, P801, DOI 10.1641/0006-3568(2002)052[0801:EEIINA]2.0.CO;2; Hickerson CAM, 2004, BEHAV ECOL, V15, P679, DOI 10.1093/beheco/arh064; Hickerson CAM, 2012, AM MIDL NAT, V168, P30, DOI 10.1674/0003-0031-168.1.30; HIGHTON R, 1961, COPEIA, P95; Human KG, 1996, OECOLOGIA, V105, P405, DOI 10.1007/BF00328744; Ivanov K, 2011, BIOL INVASIONS, V13, P1945, DOI 10.1007/s10530-011-0021-z; JAEGER RG, 1993, HERPETOLOGICA, V49, P163; JAEGER RG, 1971, ECOLOGY, V52, P632, DOI 10.2307/1934151; JAEGER RG, 1983, ANIM BEHAV, V31, P191, DOI 10.1016/S0003-3472(83)80188-2; JAEGER RG, 1984, COPEIA, P309, DOI 10.2307/1445186; JAEGER RG, 1980, OECOLOGIA, V44, P335, DOI 10.1007/BF00545237; JAEGER RG, 1980, COPEIA, P265, DOI 10.2307/1444003; James S., 1998, P3; Jones CG, 1997, ECOLOGY, V78, P1946, DOI 10.1890/0012-9658(1997)078[1946:PANEOO]2.0.CO;2; JONES CG, 1994, OIKOS, V69, P373, DOI 10.2307/3545850; Jouquet P, 2008, GEODERMA, V146, P231, DOI 10.1016/j.geoderma.2008.05.030; Kefi S, 2012, ECOL LETT, V15, P291, DOI 10.1111/j.1461-0248.2011.01732.x; KLEEBERGER SR, 1982, COPEIA, P409, DOI 10.2307/1444622; Liebgold EB, 2011, MOL ECOL, V20, P249, DOI 10.1111/j.1365-294X.2010.04946.x; Loss SR, 2013, NAT AREA J, V33, P21, DOI 10.3375/043.033.0103; LOTTER F, 1977, COPEIA, P681, DOI 10.2307/1443166; Maerz JC, 2005, DIVERS DISTRIB, V11, P83, DOI 10.1111/j.1366-9516.2005.00125.x; Maerz JC, 2001, J CHEM ECOL, V27, P1333, DOI 10.1023/A:1010309108210; MAERZ JC, 2000, THESIS STATE U NEW Y; Maerz JC, 2009, CONSERV BIOL, V23, P975, DOI 10.1111/j.1523-1739.2009.01167.x; Marsh DM, 2004, ECOLOGY, V85, P3396, DOI 10.1890/03-0713; Mathis Alicia, 1995, Amphibian Biology, V2, P633; McLean MA, 1997, SOIL BIOL BIOCHEM, V29, P537, DOI 10.1016/S0038-0717(96)00178-2; Migge-Kleian S, 2006, BIOL INVASIONS, V8, P1275, DOI 10.1007/s10530-006-9021-9; Milanovich JR, 2013, J HERPETOL, V47, P544, DOI 10.1670/12-223; Neter J, 1990, APPL LINEAR STAT MOD; Peig J, 2009, OIKOS, V118, P1883, DOI 10.1111/j.1600-0706.2009.17643.x; Peterman WE, 2014, OECOLOGIA, V176, P357, DOI 10.1007/s00442-014-3041-4; Petranka JW., 1998, SALAMANDERS US CANAD, P335; Placyk JS, 2001, J HERPETOL, V35, P521; Ransom TS, 2012, ECOLOGY, V93, P2198, DOI 10.1890/11-2024.1; Ransom TS, 2012, BIOL INVASIONS, V14, P2601, DOI 10.1007/s10530-012-0255-4; Ransom TS, 2011, OECOLOGIA, V165, P745, DOI 10.1007/s00442-010-1775-1; Redmond CT, 2014, APPL SOIL ECOL, V75, P116, DOI 10.1016/j.apsoil.2013.11.005; Resner K, 2015, ECOSYSTEMS, V18, P89, DOI 10.1007/s10021-014-9814-0; Reynolds John Warren, 2008, Megadrilogica, V12, P157; Ricciardi A, 2003, FRESHWATER BIOL, V48, P972, DOI 10.1046/j.1365-2427.2003.01071.x; Richardson JB, 2015, SOIL BIOL BIOCHEM, V85, P190, DOI 10.1016/j.soilbio.2015.03.001; Schermaier AF, 2013, THESIS CLEVELAND STA; SCHOENER TW, 1979, ECOLOGY, V60, P1110, DOI 10.2307/1936958; Semlitsch RD, 2014, CAN J ZOOL, V92, P997, DOI 10.1139/cjz-2014-0141; Siddiqi A, 2004, J EXP BIOL, V207, P2471, DOI 10.1242/jeb.01047; Smith GR, 2015, AMPHIBIA-REPTILIA, V36, P170, DOI 10.1163/15685381-00002986; Snyder BA, 2009, SOIL BIOL BIOCHEM, V41, P1442, DOI 10.1016/j.soilbio.2009.03.023; SPOTILA JR, 1976, COMP BIOCHEM PHYS A, V55, P407, DOI 10.1016/0300-9629(76)90069-4; Test F. H., 1962, Copeia, V1962, P206, DOI 10.2307/1439501; Tiunov AV, 2006, BIOL INVASIONS, V8, P1223, DOI 10.1007/s10530-006-9018-4; Walton BM, 2013, HERPETOLOGICA, V69, P127, DOI 10.1655/HERPETOLOGICA-D-12-00029; Wiles GJ, 2003, CONSERV BIOL, V17, P1350, DOI 10.1046/j.1523-1739.2003.01526.x; WROBEL DJ, 1980, ECOLOGY, V61, P1034, DOI 10.2307/1936820; Zhang WX, 2010, ECOLOGY, V91, P2070, DOI 10.1890/09-0979.1; Ziemba JL, 2015, CAN J ZOOL	88	14	14	1	66	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 4	2016	11	5							e0151591	10.1371/journal.pone.0151591	http://dx.doi.org/10.1371/journal.pone.0151591			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DL5KR	27144403	Green Published, gold			2022-12-26	WOS:000375676400003
J	Chen, DL; Jin, Z; Zhang, JJ; Jiang, LL; Chen, K; He, XH; Song, YW; Ke, JJ; Wang, YL				Chen, Dongling; Jin, Zhe; Zhang, Jingjing; Jiang, Linlin; Chen, Kai; He, Xianghu; Song, Yinwei; Ke, Jianjuan; Wang, Yanlin			HO-1 Protects against Hypoxia/Reoxygenation-Induced Mitochondrial Dysfunction in H9c2 Cardiomyocytes	PLOS ONE			English	Article							ISCHEMIA-REPERFUSION INJURY; PERMEABILITY TRANSITION PORE; HEME OXYGENASE-1; INTESTINAL ISCHEMIA/REPERFUSION; OXIDATIVE STRESS; HEART-DISEASE; IN-VIVO; AUTOPHAGY; EXPRESSION; GENE	Background Mitochondrial dysfunction would ultimately lead to myocardial cell apoptosis and death during ischemia-reperfusion injuries. Autophagy could ameliorate mitochondrial dysfunction by autophagosome forming, which is a catabolic process to preserve the mitochondrial's structural and functional integrity. HO-1 induction and expression are important protective mechanisms. This study in order to investigate the role of HO-1 during mitochondrial damage and its mechanism. Methods and Results The H9c2 cardiomyocyte cell line were incubated by hypoxic and then reoxygenated for the indicated time (2, 6, 12, 18, and 24 h). Cell viability was tested with CCK-8 kit. The expression of endogenous HO-1(RT-PCR and Western blot) increased with the duration of reoxygenation and reached maximum levels after 2 hours of H/R; thereafter, the expression gradually decreased to a stable level. Mitochondrial dysfunction (Flow cytometry quantified the ROS generation and JC-1 staining) and autophagy (The Confocal microscopy measured the autophagy. RFP-GFP-LC3 double-labeled adenovirus was used for testing.) were induced after 6 hours of H/R. Then, genetic engineering technology was employed to construct an Lv-HO1-H9c2 cell line. When HO-1 was overexpressed, the LC3II levels were significantly increased after reoxygenation, p62 protein expression was significantly decreased, the level of autophagy was unchanged, the mitochondrial membrane potential was significantly increased, and the mitochondrial ROS level was significantly decreased. Furthermore, when the HO-1 inhibitor ZnPP was applied the level of autophagy after reoxygenation was significantly inhibited, and no significant improvement in mitochondrial dysfunction was observed. Conclusions During myocardial hypoxia-reoxygenation injury, HO-1 overexpression induces autophagy to protect the stability of the mitochondrial membrane and reduce the amount of mitochondrial oxidation products, thereby exerting a protective effect.	[Chen, Dongling; Jin, Zhe; Zhang, Jingjing; Jiang, Linlin; Chen, Kai; He, Xianghu; Ke, Jianjuan; Wang, Yanlin] Wuhan Univ, Zhongnan Hosp, Dept Anesthesiol, Wuhan 430072, Peoples R China; [Song, Yinwei] Huazhong Univ Sci & Technol, Tongji Med Coll, Dept Ophthalmol, Tongji Hosp, Wuhan 430074, Peoples R China	Wuhan University; Huazhong University of Science & Technology	Wang, YL (corresponding author), Wuhan Univ, Zhongnan Hosp, Dept Anesthesiol, Wuhan 430072, Peoples R China.	200532180364@whu.edu.cn			National Natural Science Foundation of China (NSFC) [81471858]	National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC))	The authors have declared that no financial relationship exists with a commercial entity that has an interest in the subject of this article. This study was supported by grant 81471858 from the National Natural Science Foundation of China (NSFC) with the funder Ke JianJuan.	Akamatsu Y, 2004, FASEB J, V18, P771, DOI 10.1096/fj.03-0921fje; Zaouali MA, 2014, WORLD J GASTROENTERO, V20, P16203, DOI 10.3748/wjg.v20.i43.16203; Bansal S, 2014, REDOX BIOL, V2, P273, DOI 10.1016/j.redox.2013.07.004; Bolisetty S, 2010, J AM SOC NEPHROL, V21, P1702, DOI 10.1681/ASN.2010030238; Cao L, 2016, BIOMED PHARMACOTHER, V78, P30, DOI 10.1016/j.biopha.2015.12.029; Gottlieb RA, 2011, AUTOPHAGY, V7, P1573, DOI 10.4161/auto.7.12.18175; Gottlieb RA, 2010, ANNU REV PHYSIOL, V72, P45, DOI 10.1146/annurev-physiol-021909-135757; Gozzelino R, 2010, ANNU REV PHARMACOL, V50, P323, DOI 10.1146/annurev.pharmtox.010909.105600; Gustafsson AB, 2009, CIRC RES, V104, P150, DOI 10.1161/CIRCRESAHA.108.187427; He XH, 2015, MED SCI MONITOR, V21, P1057, DOI 10.12659/MSM.893924; He XH, 2014, J SURG RES, V187, P77, DOI 10.1016/j.jss.2013.09.040; He XH, 2013, J CARDIOVASC PHARM, V62, P436, DOI 10.1097/FJC.0b013e3182a0b638; Hinkel R, 2015, J AM COLL CARDIOL, V66, P154, DOI 10.1016/j.jacc.2015.04.064; Kapturczak MH, 2004, AM J PATHOL, V165, P1045, DOI 10.1016/S0002-9440(10)63365-2; Kaul DK, 2013, AM J PHYSIOL-HEART C, V304, pH42, DOI 10.1152/ajpheart.00296.2012; Kim HP, 2008, AUTOPHAGY, V4, P887, DOI 10.4161/auto.6767; Lamb CA, 2013, NAT REV MOL CELL BIO, V14, P759, DOI 10.1038/nrm3696; Lin SH, 2015, GLIA, V63, P1270, DOI 10.1002/glia.22823; Loos B, 2013, AUTOPHAGY, V9, P1270, DOI 10.4161/auto.25560; Ma XC, 2012, AUTOPHAGY, V8, P1394, DOI 10.4161/auto.21036; Maines MD, 1997, ANNU REV PHARMACOL, V37, P517, DOI 10.1146/annurev.pharmtox.37.1.517; Matsui Y, 2007, CIRC RES, V100, P914, DOI 10.1161/01.RES.0000261924.76669.36; Meijer AJ, 2015, AMINO ACIDS, V47, P2037, DOI 10.1007/s00726-014-1765-4; Melo LG, 2002, CIRCULATION, V105, P602, DOI 10.1161/hc0502.103363; Morales CR, 2014, ANTIOXID REDOX SIGN, V20, P507, DOI 10.1089/ars.2013.5359; Morse D, 2009, FREE RADICAL BIO MED, V47, P1, DOI 10.1016/j.freeradbiomed.2009.04.007; Ohlmann A, 2003, EXP BIOL MED, V228, P584, DOI 10.1177/15353702-0322805-51; Ong SB, 2015, J MOL CELL CARDIOL, V78, P23, DOI 10.1016/j.yjmcc.2014.11.005; Paine A, 2010, BIOCHEM PHARMACOL, V80, P1895, DOI 10.1016/j.bcp.2010.07.014; Quinsay MN, 2010, AUTOPHAGY, V6, P855, DOI 10.4161/auto.6.7.13005; Takagi H, 2007, AUTOPHAGY, V3, P405, DOI 10.4161/auto.4281; Tannous P, 2008, CIRCULATION, V117, P3070, DOI 10.1161/CIRCULATIONAHA.107.763870; Unuma K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056526; Unuma K, 2013, HEPATOL RES, V43, P91, DOI 10.1111/j.1872-034X.2012.01049.x; Von Dobschuetz E, 2008, PANCREAS, V36, P377, DOI 10.1097/MPA.0b013e31815ceb0e; Wang YQ, 2014, J TRADIT CHIN MED, V34, P34, DOI 10.1016/S0254-6272(14)60051-0; Wang Y, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098834; Yun N, 2014, FREE RADICAL BIO MED, V68, P168, DOI 10.1016/j.freeradbiomed.2013.12.014; Zhang Y, 2013, FASEB J, V27, P4041, DOI 10.1096/fj.13-231225; Zheng H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058567	40	24	27	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 3	2016	11	5							e0153587	10.1371/journal.pone.0153587	http://dx.doi.org/10.1371/journal.pone.0153587			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DL5KK	27138700	Green Published, gold, Green Submitted			2022-12-26	WOS:000375675700010
J	Hossini, AM; Quast, AS; Plotz, M; Grauel, K; Exner, T; Kuchler, J; Stachelscheid, H; Eberle, J; Rabien, A; Makrantonaki, E; Zouboulis, CC				Hossini, Amir M.; Quast, Annika S.; Ploetz, Michael; Grauel, Katharina; Exner, Tarik; Kuechler, Judit; Stachelscheid, Harald; Eberle, Juergen; Rabien, Anja; Makrantonaki, Evgenia; Zouboulis, Christos C.			PI3K/AKT Signaling Pathway Is Essential for Survival of Induced Pluripotent Stem Cells	PLOS ONE			English	Article							FAMILIAL ALZHEIMERS-DISEASE; TRAIL-INDUCED APOPTOSIS; MELANOMA-CELLS; CHROMOSOMAL-ABERRATIONS; HUMAN FIBROBLASTS; SOMATIC-CELLS; IPS CELLS; INDUCTION; PHOSPHORYLATION; PROTEINS	Apoptosis is a highly conserved biochemical mechanism which is tightly controlled in cells. It contributes to maintenance of tissue homeostasis and normally eliminates highly proliferative cells with malignant properties. Induced pluripotent stem cells (iPSCs) have recently been described with significant functional and morphological similarities to embryonic stem cells. Human iPSCs are of great hope for regenerative medicine due to their broad potential to differentiate into specialized cell types in culture. They may be useful for exploring disease mechanisms and may provide the basis for future cell-based replacement therapies. However, there is only poor insight into iPSCs cell signaling as the regulation of apoptosis. In this study, we focused our attention on the apoptotic response of Alzheimer fibroblast-derived iPSCs and two other Alzheimer free iPSCs to five biologically relevant kinase inhibitors as well as to the death ligand TRAIL. To our knowledge, we are the first to report that the relatively high basal apoptotic rate of iPSCs is strongly suppressed by the pancaspase inhibitor QVD-Oph, thus underlining the dependency on proapoptotic caspase cascades. Furthermore, wortmannin, an inhibitor of phosphoinositid-3 kinase / Akt signaling (PI3K-AKT), dramatically and rapidly induced apoptosis in iPSCs. In contrast, parental fibroblasts as well as iPSC-derived neuronal cells were not responsive. The resulting condensation and fragmentation of DNA and decrease of the membrane potential are typical features of apoptosis. Comparable effects were observed with an AKT inhibitor (MK-2206). Wortmannin resulted in disappearance of phosphorylated AKT and activation of the main effector caspase-3 in iPSCs. These results clearly demonstrate for the first time that PI3K-AKT represents a highly essential survival signaling pathway in iPSCs. The findings provide improved understanding on the underlying mechanisms of apoptosis regulation in iPSCs.	[Hossini, Amir M.; Exner, Tarik; Makrantonaki, Evgenia; Zouboulis, Christos C.] Dessau Med Ctr, Dept Dermatol, Dessau, Germany; [Hossini, Amir M.; Exner, Tarik; Makrantonaki, Evgenia; Zouboulis, Christos C.] Dessau Med Ctr, Dept Venereol, Dessau, Germany; [Hossini, Amir M.; Exner, Tarik; Makrantonaki, Evgenia; Zouboulis, Christos C.] Dessau Med Ctr, Dept Allergol, Dessau, Germany; [Hossini, Amir M.; Exner, Tarik; Makrantonaki, Evgenia; Zouboulis, Christos C.] Dessau Med Ctr, Dept Immunol, Dessau, Germany; [Quast, Annika S.; Ploetz, Michael; Eberle, Juergen] Charite, Skin Canc Ctr Charite, Dept Dermatol & Allergy, D-13353 Berlin, Germany; [Grauel, Katharina] Charite, NeuroCure Cluster Excellence, D-13353 Berlin, Germany; [Grauel, Katharina] Free Univ Berlin, Inst Biol, Dept Biol, Chem,Pharm, Berlin, Germany; [Kuechler, Judit; Stachelscheid, Harald] Berlin Inst Health, Stem Cell Core Facil, Berlin, Germany; [Stachelscheid, Harald] Charite, Berlin Brandenburg Ctr Regenerat Therapies, D-13353 Berlin, Germany; [Rabien, Anja] Charite, Dept Urol, D-13353 Berlin, Germany; [Rabien, Anja] Charite, Berlin Inst Urol Res, D-13353 Berlin, Germany; [Makrantonaki, Evgenia] Charite, Res Geriatr Grp, D-13353 Berlin, Germany; [Makrantonaki, Evgenia] Univ Ulm Klinikum, Dept Dermatol & Allergol, Ulm, Germany	Dessau Medical Center; Dessau Medical Center; Dessau Medical Center; Dessau Medical Center; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Ulm University	Hossini, AM (corresponding author), Dessau Med Ctr, Dept Dermatol, Dessau, Germany.; Hossini, AM (corresponding author), Dessau Med Ctr, Dept Venereol, Dessau, Germany.; Hossini, AM (corresponding author), Dessau Med Ctr, Dept Allergol, Dessau, Germany.; Hossini, AM (corresponding author), Dessau Med Ctr, Dept Immunol, Dessau, Germany.	amir.hossini@klinikum-dessau.de	Zouboulis, Christos C./I-4493-2013; Exner, Tarik/AAW-6735-2020; Makrantonaki, Evgenia/G-1769-2010	Zouboulis, Christos C./0000-0003-1646-2608; Stachelscheid, Harald/0000-0002-9283-4605; Rabien, Anja/0000-0003-0124-4878; Eberle, Jurgen/0000-0001-8533-1519; Makrantonaki, Evgenia/0000-0001-8522-2128; Grauel, M. Katharina/0000-0003-3542-0606; Exner, Tarik/0000-0002-3131-2133	German Federal Ministry of Education and Research (BMBF) [01GN0807]	German Federal Ministry of Education and Research (BMBF)(Federal Ministry of Education & Research (BMBF))	C. C. Z. and E. M. received funding of the German Federal Ministry of Education and Research (BMBF), grant no. 01GN0807. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akter R, 2012, BREAST CANCER-TARGET, V4, P103, DOI 10.2147/BCTT.S31712; Amabile G, 2009, TRENDS MOL MED, V15, P59, DOI 10.1016/j.molmed.2008.12.003; Ashkenazi A, 2002, NAT REV CANCER, V2, P420, DOI 10.1038/nrc821; Bao SD, 2004, CANCER CELL, V5, P329, DOI 10.1016/S1535-6108(04)00081-9; Ben-David U, 2011, CELL STEM CELL, V9, P97, DOI 10.1016/j.stem.2011.06.013; Berger A, 2014, J INVEST DERMATOL, V134, P430, DOI 10.1038/jid.2013.347; Blum B, 2008, ADV CANCER RES, V100, P133, DOI 10.1016/S0065-230X(08)00005-5; Blum B, 2009, CELL CYCLE, V8, P3822, DOI 10.4161/cc.8.23.10067; Chen J, 2013, TISSUE ENG PART B-RE, V19, P516, DOI [10.1089/ten.teb.2012.0672, 10.1089/ten.TEB.2012.0672]; Chen MF, 2012, BIOMATERIALS, V33, P5514, DOI 10.1016/j.biomaterials.2012.04.001; Chen TT, 2011, AGING CELL, V10, P908, DOI 10.1111/j.1474-9726.2011.00722.x; Cherra SJ, 2010, J CELL BIOL, V190, P533, DOI 10.1083/jcb.201002108; Datta SR, CELL, V91, P231; DEL PL, 1997, SCIENCE, V278, P687; Eberle J, 2007, DRUG RESIST UPDATE, V10, P218, DOI 10.1016/j.drup.2007.09.001; Fecker LF, 2002, J INVEST DERMATOL, V118, P1019, DOI 10.1046/j.1523-1747.2002.01744.x; Fecker LF, 2010, EXP DERMATOL, V19, pE56, DOI 10.1111/j.1600-0625.2009.00977.x; Gerl R, 2005, CARCINOGENESIS, V26, P263, DOI 10.1093/carcin/bgh283; Greber B, 2010, CELL STEM CELL, V6, P215, DOI 10.1016/j.stem.2010.01.003; Gutierrez-Aranda I, 2010, STEM CELLS, V28, P1568, DOI 10.1002/stem.471; Hossini AM, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-1262-5; Hossini AM, 2008, BIOCHEM PHARMACOL, V76, P1612, DOI 10.1016/j.bcp.2008.08.013; Israel MA, 2012, NATURE, V482, P216, DOI 10.1038/nature10821; Kaech S, 2006, NAT PROTOC, V1, P2406, DOI 10.1038/nprot.2006.356; Kim C, 2014, BLOOD RES, V49, P7, DOI 10.5045/br.2014.49.1.7; Kumar R, 2005, INT J SURG, P268; Kurbanov BM, 2007, ONCOGENE, V26, P3364, DOI 10.1038/sj.onc.1210134; Li F, 2010, CELL STEM CELL, V7, P508, DOI 10.1016/j.stem.2010.09.003; Li J, 2014, J HEMATOL ONCOL, V7, DOI 10.1186/s13045-014-0050-z; Li YH, 2015, APOPTOSIS, V20, P787, DOI 10.1007/s10495-015-1114-4; Lindsay J, 2011, BBA-MOL CELL RES, V1813, P532, DOI 10.1016/j.bbamcr.2010.10.017; Los M, 2001, TRENDS IMMUNOL, V22, P31, DOI 10.1016/S1471-4906(00)01814-7; Malumbres M, 2014, EXPERT OPIN THER TAR, V18, P1377, DOI 10.1517/14728222.2014.956085; Mayshar Y, 2010, CELL STEM CELL, V7, P521, DOI 10.1016/j.stem.2010.07.017; Momcilovic O, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013410; Naujok O, 2010, STEM CELL REV REP, V6, P450, DOI 10.1007/s12015-010-9148-z; Ohi Y, 2011, NAT CELL BIOL, V13, P541, DOI 10.1038/ncb2239; Orlando L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030234; Pakzad M, 2010, STEM CELL REV REP, V6, P96, DOI 10.1007/s12015-009-9103-z; Panopoulos AD, 2012, CELL RES, V22, P168, DOI 10.1038/cr.2011.177; Park IH, 2008, NAT PROTOC, V3, P1180, DOI 10.1038/nprot.2008.92; Park SJ, 2014, STEM CELL RES, V12, P730, DOI 10.1016/j.scr.2014.03.002; Phanstiel DH, 2011, NAT METHODS, V8, P821, DOI [10.1038/NMETH.1699, 10.1038/nmeth.1699]; Polo JM, 2010, NAT BIOTECHNOL, V28, P848, DOI 10.1038/nbt.1667; Prigione A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027352; Quast SA, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.344; Raisova M, 2001, J INVEST DERMATOL, V117, P333, DOI 10.1046/j.0022-202x.2001.01409.x; Robinton DA, 2012, NATURE, V481, P295, DOI 10.1038/nature10761; Salakou S, 2007, IN VIVO, V21, P123; Soldner F, 2009, CELL, V136, P964, DOI 10.1016/j.cell.2009.02.013; Song G, 2005, J CELL MOL MED, V9, P59, DOI 10.1111/j.1582-4934.2005.tb00337.x; Stadtfeld M, 2008, SCIENCE, V322, P945, DOI 10.1126/science.1162494; Takahashi K, 2005, BIOCHEM SOC T, V33, P1522, DOI 10.1042/BST0331522; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Takase O, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056399; van Delft MF, 2006, CELL RES, V16, P203, DOI 10.1038/sj.cr.7310028; Wendel HG, 2004, NATURE, V428, P332, DOI 10.1038/nature02369; Yagi T, 2011, HUM MOL GENET, V20, P4530, DOI 10.1093/hmg/ddr394; Yang S, 2008, GENE CHROMOSOME CANC, V47, P665, DOI 10.1002/gcc.20574; Zhang WY., 2008, TERATOMA FORMATION T; Zhang YS, 2013, NEURON, V78, P785, DOI 10.1016/j.neuron.2013.05.029; Zhao ZY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033953; Zhu SY, 2010, CELL STEM CELL, V7, P651, DOI 10.1016/j.stem.2010.11.015	64	51	52	3	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 3	2016	11	5							e0154770	10.1371/journal.pone.0154770	http://dx.doi.org/10.1371/journal.pone.0154770			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DL5KK	27138223	Green Submitted, Green Published, gold			2022-12-26	WOS:000375675700066
J	Beggs, CB; Magnano, C; Belov, P; Krawiecki, J; Ramasamy, DP; Hagemeier, J; Zivadinov, R				Beggs, Clive B.; Magnano, Christopher; Belov, Pavel; Krawiecki, Jacqueline; Ramasamy, Deepa P.; Hagemeier, Jesper; Zivadinov, Robert			Internal Jugular Vein Cross-Sectional Area and Cerebrospinal Fluid Pulsatility in the Aqueduct of Sylvius: A Comparative Study between Healthy Subjects and Multiple Sclerosis Patients	PLOS ONE			English	Article							ENDOTHELIAL PROGENITOR CELLS; CEREBRAL VENOUS OUTFLOW; WHITE-MATTER; INTRACRANIAL-PRESSURE; ALZHEIMERS-DISEASE; HEAD ELEVATION; BRAIN ATROPHY; INSUFFICIENCY; MS; COMPRESSION	Objectives Constricted cerebral venous outflow has been linked with increased cerebrospinal fluid (CSF) pulsatility in the aqueduct of Sylvius inmultiple sclerosis (MS) patients and healthy individuals. This study investigates the relationship between CSF pulsatility and internal jugular vein (IJV) cross-sectional area (CSA) in these two groups, something previously unknown. Methods 65 relapsing-remitting MS patients (50.8% female; mean age = 43.8 years) and 74 healthy controls (HCs) (54.1% female; mean age = 43.9 years) were investigated. CSF flow quantification was performed on cine phase-contrast MRI, while IJV-CSA was calculated using magnetic resonance venography. Statistical analysis involved correlation, and partial least squares correlation analysis (PLSCA). Results PLSCA revealed a significant difference (p<0.001; effect size = 1.072) between MS patients and HCs in the positive relationship between CSF pulsatility and IJV-CSA at C5-T1, something not detected at C2-C4. Controlling for age and cardiovascular risk factors, statistical trends were identified in HCs between: increased net positive CSF flow (NPF) and increased IJV-CSA at C5-C6 (left: r = 0.374, p = 0.016; right: r = 0.364, p = 0.019) and C4 (left: r = 0.361, p = 0.020); and increased net negative CSF flow and increased left IJV-CSA at C5-C6 (r = -0.348, p = 0.026) and C4 (r = -0.324, p = 0.039), whereas in MS patients a trend was only identified between increased NPF and increased left IJV-CSA at C5-C6 (r = 0.351, p = 0.021). Overall, correlations were weaker in MS patients (p = 0.015). Conclusions In healthy adults, increased CSF pulsatility is associated with increased IJV-CSA in the lower cervix (independent of age and cardiovascular risk factors), suggesting a biomechanical link between the two. This relationship is altered in MS patients.	[Beggs, Clive B.; Magnano, Christopher; Belov, Pavel; Krawiecki, Jacqueline; Ramasamy, Deepa P.; Hagemeier, Jesper; Zivadinov, Robert] SUNY Buffalo, Sch Med & Biomed Sci, Dept Neurol, Buffalo Neuroimaging Anal Ctr, Buffalo, NY 14260 USA; [Magnano, Christopher; Ramasamy, Deepa P.; Zivadinov, Robert] SUNY Buffalo, Sch Med & Biomed Sci, MRI Clin Translat Res Ctr, Buffalo, NY 14260 USA; [Beggs, Clive B.] Leeds Beckett Univ, Carnegie Fac, Res Inst Sport Phys Act & Leisure, Leeds, W Yorkshire, England	State University of New York (SUNY) System; State University of New York (SUNY) Buffalo; State University of New York (SUNY) System; State University of New York (SUNY) Buffalo; Leeds Beckett University	Beggs, CB (corresponding author), SUNY Buffalo, Sch Med & Biomed Sci, Dept Neurol, Buffalo Neuroimaging Anal Ctr, Buffalo, NY 14260 USA.; Beggs, CB (corresponding author), Leeds Beckett Univ, Carnegie Fac, Res Inst Sport Phys Act & Leisure, Leeds, W Yorkshire, England.	c.beggs@leedsbeckett.ac.uk	Zivadinov, Robert/Q-2054-2019; Belov, Pavel/AAN-7857-2020; Ramasamy, Deepa/X-5780-2019	Zivadinov, Robert/0000-0002-7799-1485; Belov, Pavel/0000-0002-5107-2763; Hagemeier, Jesper/0000-0002-3286-5207	Annette Funicello Research Fund for Neurological Diseases; Jacquemin Family Foundation	Annette Funicello Research Fund for Neurological Diseases; Jacquemin Family Foundation	Clive Beggs received a travel grant from the Annette Funicello Research Fund for Neurological Diseases (no grant number) [http://www.annetteconnection.com/About-the-Research-Fund.php]. This work was also supported by the Jacquemin Family Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdi Herve, 2013, Methods Mol Biol, V930, P549, DOI 10.1007/978-1-62703-059-5_23; Beggs C, 2014, PHLEBOLOGY, V29, P191, DOI 10.1258/phleb.2012.012039; Beggs C.B, 2014, VEINS LYMPH, V3, DOI [10.4081/vl.2014.1867, DOI 10.4081/VL.2014.1867]; Beggs C, 2013, BMC NEUROL, V13, DOI 10.1186/1471-2377-13-157; Beggs CB, 2014, J MAGN RESON IMAGING, V40, P1215, DOI 10.1002/jmri.24468; Beggs CB, 2013, BMC MED, V11, DOI 10.1186/1741-7015-11-142; Chung CP, 2014, J ALZHEIMERS DIS, V39, P601, DOI 10.3233/JAD-131112; Chung CP, 2010, ULTRASOUND MED BIOL, V36, P1776, DOI 10.1016/j.ultrasmedbio.2010.07.006; Cooper, 1976, INTRACRANIAL PRESSUR, P259; Dalton CM, 2006, NEUROLOGY, V66, P693, DOI 10.1212/01.wnl.0000201183.87175.9f; Di Berardino F, 2015, PHLEBOLOGY, V30, P274, DOI 10.1177/0268355514526871; Dolic K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028062; Donahue SP, 2009, AM J EMERG MED, V27, P851, DOI 10.1016/j.ajem.2008.06.005; Farina M, 2013, BMC NEUROL, V13, DOI 10.1186/1471-2377-13-162; Filipo R, 2015, EUR ARCH OTO-RHINO-L, V272, P77, DOI 10.1007/s00405-013-2841-1; Ge YL, 2001, RADIOLOGY, V220, P606, DOI 10.1148/radiol.2203001776; Gorucu Y, 2011, FUNCT NEUROL, V26, P215; GRADY MS, 1986, J NEUROSURG, V65, P199, DOI 10.3171/jns.1986.65.2.0199; Hatt A, 2015, AM J NEURORADIOL, V36, P1971, DOI 10.3174/ajnr.A4361; Ho AMH, 2002, J TRAUMA, V53, P1185, DOI 10.1097/00005373-200212000-00028; Hutter R, 2012, MED CLIN N AM, V96, P93, DOI 10.1016/j.mcna.2012.01.008; Kappus N, 2016, J NEUROL NEUROSUR PS, V87, P181, DOI 10.1136/jnnp-2014-310051; KITANO M, 1964, J NUCL MED, V5, P613; Krishnan A, 2011, NEUROIMAGE, V56, P455, DOI 10.1016/j.neuroimage.2010.07.034; Krsmanovic Z, 2013, BMC NEUROL, V13, DOI 10.1186/1471-2377-13-90; KURTZKE JF, 1983, NEUROLOGY, V33, P1444, DOI 10.1212/WNL.33.11.1444; Lanzillo R, 2013, BMC NEUROL, V13, DOI 10.1186/1471-2377-13-20; Liu MJ, 2015, J VASC SURG, V61, P1511, DOI 10.1016/j.jvs.2014.02.021; Magnano C., 2014, VEINS LYMPHAT, V3, DOI [10.4081/vl.2014.4632, DOI 10.4081/VL.2014.4632]; Magnano C, 2012, J MAGN RESON IMAGING, V36, P825, DOI 10.1002/jmri.23730; Mavrocordatos P, 2000, J NEUROSURG ANESTH, V12, P10, DOI 10.1097/00008506-200001000-00003; McIntosh AR, 2013, ANNU REV PSYCHOL, V64, P499, DOI 10.1146/annurev-psych-113011-143804; McTaggart RA, 2012, AM J NEURORADIOL, V33, P1615, DOI 10.3174/ajnr.A3097; Robb AO, 2007, REPRODUCTION, V133, P1, DOI 10.1530/REP-06-0219; Roxburgh RHSR, 2005, NEUROLOGY, V64, P1144, DOI 10.1212/01.WNL.0000156155.19270.F8; Sieveking DP, 2010, CURR OPIN ENDOCRINOL, V17, P277, DOI 10.1097/MED.0b013e3283394e20; Stoquart-ElSankari S, 2009, J CEREBR BLOOD F MET, V29, P1208, DOI [10.1038/sj.jcbfm.jcbfm200929, 10.1038/jcbfm.2009.29]; Wack DS, 2013, BMC MED IMAGING, V13, DOI 10.1186/1471-2342-13-29; Zamboni P, 2009, J NEUROL NEUROSUR PS, V80, P392, DOI 10.1136/jnnp.2008.157164; Zamboni P, 2012, J VASC SURG, V56, P677, DOI 10.1016/j.jvs.2012.01.074; Zamboni P, 2009, FUNCT NEUROL, V24, P133; Zamboni P, 2009, CURR NEUROVASC RES, V6, P204, DOI 10.2174/156720209788970054; Zivadinov R, 2012, AM J NEURORADIOL, V33, P1913, DOI 10.3174/ajnr.A3112; Zivadinov R, 2011, NEUROLOGY, V77, P138, DOI 10.1212/WNL.0b013e318212a901; Zivadinov R, 2011, NEUROLOGY, V77, P1710, DOI 10.1212/WNL.0b013e318230b225	45	15	15	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 2	2016	11	5							e0153960	10.1371/journal.pone.0153960	http://dx.doi.org/10.1371/journal.pone.0153960			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DL5KB	27135831	Green Accepted, Green Published, gold, Green Submitted			2022-12-26	WOS:000375674800008
J	Zhang, L; Lu, L; Li, SM; Zhang, GL; Ouyang, LH; Robinson, K; Tang, YQ; Zhu, Q; Li, DY; Hu, YD; Liu, YP				Zhang, Long; Lu, Lu; Li, Siming; Zhang, Guolong; Ouyang, Linghua; Robinson, Kelsy; Tang, Yanqiang; Zhu, Qing; Li, Diyan; Hu, Yaodong; Liu, Yiping			1,25-Dihydroxyvitamin-D-3 Induces Avian beta-Defensin Gene Expression in Chickens	PLOS ONE			English	Article							VITAMIN-D-RECEPTOR; ANTIMICROBIAL PEPTIDE CATHELICIDIN; INTESTINAL EPITHELIAL-CELLS; TOLL-LIKE RECEPTORS; UP-REGULATION; ACTIVATION; D-3; ACETYLATION; MACROPHAGES; PROTECTION	Host defense peptides (HDPs) play a critical role in innate immunity. Specific modulation of endogenous HDP synthesis by dietary compounds has been regarded as a novel approach to boost immunity and disease resistance in animal production. 1,25-dihydroxy vitamin D-3 (1,25D(3)) is well known as a powerful HDP inducer in humans, but limited information about the effect of 1,25D(3) on HDPs in poultry is available. Here, we sought to examine whether 1,25D(3) could stimulate avian beta-defensin (AvBD) expression in chickens. We used chicken embryo intestinal epithelial cells (CEIEPCs) and peripheral blood mononuclear cells (PBMCs) to study the effect of 1,25D(3) on the expression of AvBDs. We observed that 1,25D(3) is able to up-regulate the expression of several AvBDs in CEIEPCs and PBMCs, whereas it increased the amounts of AvBD4 mRNA in CEIEPCs only in the presence of lipopolysaccharide (LPS). On the other hand, LPS treatment not only inhibited the expression of CYP24A1 but also altered the expression pattern of VDR in CEIEPCs. Furthermore, AvBDs were not directly regulated by 1,25D(3), as cycloheximide completely blocked 1,25D(3)-induced expression of AvBDs. Our observations suggest that 1,25D(3) is capable of inducing AvBD gene expression and is a potential antibiotic alternative through augmentation of host innate immunity as well as disease control in chickens.	[Zhang, Long; Lu, Lu; Zhu, Qing; Li, Diyan; Hu, Yaodong; Liu, Yiping] Sichuan Agr Univ, Farm Anim Genet Resources Explorat & Innovat Key, Chengdu 611130, Peoples R China; [Li, Siming; Ouyang, Linghua; Tang, Yanqiang] Jiangxi Acad Agr Sci, Inst Anim Husb & Vet, Nanchang 330200, Peoples R China; [Zhang, Guolong; Robinson, Kelsy] Oklahoma State Univ, Dept Anim Sci, Stillwater, OK 74078 USA	Sichuan Agricultural University; Oklahoma State University System; Oklahoma State University - Stillwater	Liu, YP (corresponding author), Sichuan Agr Univ, Farm Anim Genet Resources Explorat & Innovat Key, Chengdu 611130, Peoples R China.; Li, SM (corresponding author), Jiangxi Acad Agr Sci, Inst Anim Husb & Vet, Nanchang 330200, Peoples R China.	lisiming16@126.com; liuyp578@163.com	Zhang, Guolong/HCI-5587-2022; Zhang, Long/Q-8657-2019; Zhang, Guolong/AAU-8197-2020	Zhang, Long/0000-0003-3553-9738; Zhang, Guolong/0000-0003-4781-5816; Li, Diyan/0000-0001-7490-3550; LU, LU/0000-0002-0960-1529	National Natural Science Foundation of P. R. China [31160500]; Young scientists training plan of Jiangxi province [20112BCB23030]; International cooperation plan of Jiangxi province [20111BDH80036]; Foundation of Sichuan Province [2011NZ0099-6]	National Natural Science Foundation of P. R. China(National Natural Science Foundation of China (NSFC)); Young scientists training plan of Jiangxi province; International cooperation plan of Jiangxi province; Foundation of Sichuan Province	This work was supported by the National Natural Science Foundation of P. R. China (Grants No. 31160500), the Young scientists training plan of Jiangxi province (Grant No. 20112BCB23030), the International cooperation plan of Jiangxi province (Grant No. 20111BDH80036) and Foundation of Sichuan Province (2011NZ0099-6).	Abreu MT, 2001, J IMMUNOL, V167, P1609, DOI 10.4049/jimmunol.167.3.1609; Allen HK, 2013, TRENDS MICROBIOL, V21, P114, DOI 10.1016/j.tim.2012.11.001; Angrisano T, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-172; Aslam SM, 1998, POULTRY SCI, V77, P842, DOI 10.1093/ps/77.6.842; Athman R, 2005, CELL MICROBIOL, V7, P1109, DOI 10.1111/j.1462-5822.2005.00535.x; Aung HT, 2006, FASEB J, V20, P1315, DOI 10.1096/fj.05-5360com; Carlberg C, 2007, DERMATOL CLIN, V25, P515, DOI 10.1016/j.det.2007.06.004; Castanon JIR, 2007, POULTRY SCI, V86, P2466, DOI 10.3382/ps.2007-00249; Cuperus T, 2013, DEV COMP IMMUNOL, V41, P352, DOI 10.1016/j.dci.2013.04.019; D'Aldebert E, 2009, GASTROENTEROLOGY, V136, P1435, DOI 10.1053/j.gastro.2008.12.040; Dai XJ, 2010, J DERMATOL SCI, V60, P179, DOI 10.1016/j.jdermsci.2010.09.008; Tellez-Perez AD, 2012, VET MICROBIOL, V160, P91, DOI 10.1016/j.vetmic.2012.05.007; Dupont A, 2014, GUT MICROBES, V5, P761, DOI 10.4161/19490976.2014.972238; Gombart AF, 2009, FUTURE MICROBIOL, V4, P1151, DOI 10.2217/FMB.09.87; Gomez-Verduzco G, 2013, J POULT SCI, V50, P60, DOI 10.2141/jpsa.0120071; Guo CX, 2013, J NUTR BIOCHEM, V24, P754, DOI 10.1016/j.jnutbio.2012.04.002; Han FF, 2015, J IMMUNOL, V194, P1882, DOI 10.4049/jimmunol.1402300; Hancock REW, 2006, NAT BIOTECHNOL, V24, P1551, DOI 10.1038/nbt1267; Haussler MR, 2011, BEST PRACT RES CL EN, V25, P543, DOI 10.1016/j.beem.2011.05.010; Jones G, 1998, PHYSIOL REV, V78, P1193, DOI 10.1152/physrev.1998.78.4.1193; Kannaki TR, 2010, WORLD POULTRY SCI J, V66, P727, DOI 10.1017/S0043933910000693; Kogut MH, 2005, ANIM BIOTECHNOL, V16, P165, DOI 10.1080/10495390500264896; Lai YP, 2009, TRENDS IMMUNOL, V30, P131, DOI 10.1016/j.it.2008.12.003; Li SM, 2013, CZECH J ANIM SCI, V58, P1, DOI 10.17221/6519-CJAS; Liu PT, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005810; Liu PT, 2006, SCIENCE, V311, P1770, DOI 10.1126/science.1123933; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lu L, 2015, GENET MOL RES, V14, P3330, DOI 10.4238/2015.April.13.12; Lynn DJ, 2004, IMMUNOGENETICS, V56, P170, DOI 10.1007/s00251-004-0675-0; Marshall BM, 2011, CLIN MICROBIOL REV, V24, P718, DOI 10.1128/CMR.00002-11; Merriman KE, 2015, J STEROID BIOCHEM, V154, P120, DOI 10.1016/j.jsbmb.2015.08.002; Morris A, 2014, VET IMMUNOL IMMUNOP, V161, P265, DOI 10.1016/j.vetimm.2014.08.008; Mukherjee S, 2015, IMMUNITY, V42, P28, DOI 10.1016/j.immuni.2014.12.028; Nelson CD, 2010, J DAIRY SCI, V93, P1041, DOI 10.3168/jds.2009-2663; Nurminen V, 2015, BBA-GENE REGUL MECH, V1849, P300, DOI 10.1016/j.bbagrm.2014.12.001; Otte JM, 2004, GASTROENTEROLOGY, V126, P1054, DOI 10.1053/j.gastro.2004.01.007; Peterson LW, 2014, NAT REV IMMUNOL, V14, P141, DOI 10.1038/nri3608; Saunders-Blades JL, 2015, POULTRY SCI, V94, P1233, DOI 10.3382/ps/pev002; Schauber J, 2008, J INVEST DERMATOL, V128, P816, DOI 10.1038/sj.jid.5701102; Schwab M, 2008, IMMUNOLOGY, V125, P241, DOI 10.1111/j.1365-2567.2008.02834.x; Schwab M, 2007, MOL IMMUNOL, V44, P2107, DOI 10.1016/j.molimm.2006.09.016; Shojadoost B, 2015, RES VET SCI; Smith DL, 2005, PLOS MED, V2, P731, DOI 10.1371/journal.pmed.0020232; Sunkara LT, 2014, MOL IMMUNOL, V57, P171, DOI 10.1016/j.molimm.2013.09.003; Sunkara LT, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027225; Wang TT, 2004, J IMMUNOL, V173, P2909, DOI 10.4049/jimmunol.173.5.2909; Whittington CM, 2008, GENOME RES, V18, P986, DOI 10.1101/gr.7149808; Xiao YJ, 2004, BMC GENOMICS, V5, DOI 10.1186/1471-2164-5-56; Yedery RD, 2015, ANTIBIOTICS-BASEL, V4, P44, DOI 10.3390/antibiotics4010044; Zhang GW, 2011, J POULT SCI, V48, P254, DOI 10.2141/jpsa.010065; Zhang GL, 2014, PHARMACEUTICALS-BASE, V7, P220, DOI 10.3390/ph7030220; Zhang HW, 2015, MOL PHARMACEUT, V12, P1648, DOI 10.1021/acs.molpharmaceut.5b00069; Zhu SY, 2013, DEV COMP IMMUNOL, V39, P79, DOI 10.1016/j.dci.2012.02.011	53	15	16	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 2	2016	11	5							e0154546	10.1371/journal.pone.0154546	http://dx.doi.org/10.1371/journal.pone.0154546			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DL5KB	27135828	Green Published, gold			2022-12-26	WOS:000375674800028
J	Andreassen, R; Rangnes, F; Sivertsen, M; Chiang, M; Tran, M; Worren, MM				Andreassen, Rune; Rangnes, Fredrik; Sivertsen, Maria; Chiang, Michelle; Tran, Michelle; Worren, Merete Molton			Discovery of miRNAs and Their Corresponding miRNA Genes in Atlantic Cod (Gadus morhua): Use of Stable miRNAs as Reference Genes Reveals Subgroups of miRNAs That Are Highly Expressed in Particular Organs	PLOS ONE			English	Article							MICRORNA EXPRESSION; TRANSCRIPTOME ANALYSIS; RAINBOW-TROUT; PCR DATA; IDENTIFICATION; TISSUE; SKIN; BIOGENESIS; SELECTION; MATURITY	Background Atlantic cod (Gadus morhua) is among the economically most important species in the northern Atlantic Ocean and a model species for studying development of the immune system in vertebrates. MicroRNAs (miRNAs) are an abundant class of small RNA molecules that regulate fundamental biological processes at the post-transcriptional level. Detailed knowledge about a species miRNA repertoire is necessary to study how the miRNA transcriptome modulate gene expression. We have therefore discovered and characterized mature miRNAs and their corresponding miRNA genes in Atlantic cod. We have also performed a validation study to identify suitable reference genes for RT-qPCR analysis of miRNA expression in Atlantic cod. Finally, we utilized the newly characterized miRNA repertoire and the dedicated RT-qPCR method to reveal miRNAs that are highly expressed in certain organs. Results The discovery analysis revealed 490 mature miRNAs (401 unique sequences) along with precursor sequences and genomic location of the miRNA genes. Twenty six of these were novel miRNA genes. Validation studies ranked gmo-miR-17-1-5p or the two-gene combination gmo-miR25-3p and gmo-miR210-5p as most suitable qPCR reference genes. Analysis by RT-qPCR revealed 45 miRNAs with significantly higher expression in tissues from one or a few organs. Comparisons to other vertebrates indicate that some of these miRNAs may regulate processes like growth, lipid metabolism, immune response to microbial infections and scar damage repair. Three teleost-specific and three novel Atlantic cod miRNAs were among the differentially expressed miRNAs. Conclusions The number of known mature miRNAs was considerably increased by our identification of miRNAs and miRNA genes in Atlantic cod. This will benefit further functional studies of miRNA expression using deep sequencing methods. The validation study showed that stable miRNAs are suitable reference genes for RT-qPCR analysis of miRNA expression. Applying RT-qPCR we have identified several miRNAs likely to have important regulatory functions in particular organs.	[Andreassen, Rune; Rangnes, Fredrik; Sivertsen, Maria; Chiang, Michelle; Tran, Michelle] Fac Hlth Sci, Dept Pharm & Biomed Lab Sci, Oslo, Norway; [Andreassen, Rune; Rangnes, Fredrik; Sivertsen, Maria; Chiang, Michelle; Tran, Michelle] Akershus Univ, Coll Appl Sci, Oslo, Norway; [Worren, Merete Molton] Oslo Univ Hosp, Bioinformat Core Facil, Inst Med Informat, Oslo, Norway	Oslo Metropolitan University (OsloMet); University of Oslo	Andreassen, R (corresponding author), Fac Hlth Sci, Dept Pharm & Biomed Lab Sci, Oslo, Norway.; Andreassen, R (corresponding author), Akershus Univ, Coll Appl Sci, Oslo, Norway.	Rune.Andreassen@hioa.no						Ambros V, 2003, RNA, V9, P277, DOI 10.1261/rna.2183803; Andersen CL, 2004, CANCER RES, V64, P5245, DOI 10.1158/0008-5472.CAN-04-0496; Andreassen R, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-482; Banerjee J, 2011, PHYSIOL GENOMICS, V43, P543, DOI 10.1152/physiolgenomics.00157.2010; Barendse W, 2007, GENETICS, V176, P1893, DOI 10.1534/genetics.107.072637; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Baskerville S, 2005, RNA, V11, P241, DOI 10.1261/rna.7240905; Bizuayehu TT, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-1503-7; Bizuayehu TT, 2014, GENOME BIOL EVOL, V6, P1911, DOI 10.1093/gbe/evu151; Bizuayehu TT, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061378; Booman M, 2011, MAR BIOTECHNOL, V13, P733, DOI 10.1007/s10126-010-9335-6; Bowman S, 2011, MAR BIOTECHNOL, V13, P242, DOI 10.1007/s10126-010-9285-z; Bushati N, 2007, ANNU REV CELL DEV BI, V23, P175, DOI 10.1146/annurev.cellbio.23.090506.123406; Chekulaeva M, 2009, CURR OPIN CELL BIOL, V21, P452, DOI 10.1016/j.ceb.2009.04.009; Chen XM, 2007, J BIOL CHEM, V282, P28929, DOI 10.1074/jbc.M702633200; Dill H, 2012, GENE DEV, V26, P25, DOI 10.1101/gad.177774.111; Esquela-Kerscher A, 2006, NAT REV CANCER, V6, P259, DOI 10.1038/nrc1840; Farlora R, 2015, MOL REPROD DEV, V82, P651, DOI 10.1002/mrd.22499; Food and Agriculture Organization of the United Nations, GLOB CAPT PROD FISHS; Friedlander MR, 2008, NAT BIOTECHNOL, V26, P407, DOI 10.1038/nbt1394; Friedlander MR, 2012, NUCLEIC ACIDS RES, V40, P37, DOI 10.1093/nar/gkr688; Friedman RC, 2009, GENOME RES, V19, P92, DOI 10.1101/gr.082701.108; Griffiths-Jones S, 2006, NUCLEIC ACIDS RES, V34, pD140, DOI 10.1093/nar/gkj112; Guo ZY, 2014, SCI REP-UK, V4, DOI 10.1038/srep05150; Haflidadottir BS, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011574; Higgins B, 2009, MOL ECOL RESOUR, V9, P733, DOI 10.1111/j.1755-0998.2008.02475.x; Hubert S, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-191; Jiang QH, 2009, NUCLEIC ACIDS RES, V37, pD98, DOI 10.1093/nar/gkn714; Johansen Ilona, 2014, BMC Res Notes, V8, P945, DOI 10.1186/1756-0500-7-945; Kent OA, 2014, NUCLEIC ACIDS RES, V42, P7528, DOI 10.1093/nar/gku461; Lagos-Quintana M, 2002, CURR BIOL, V12, P735, DOI 10.1016/S0960-9822(02)00809-6; Li C, 2015, FEBS LETT, V589, P380, DOI 10.1016/j.febslet.2014.12.024; Li Y, 2012, NUCLEIC ACIDS RES, V40, P4298, DOI 10.1093/nar/gks043; Liang Y, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-166; Ma H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039649; Malachowicz M, 2015, MAR GENOM, V23, P37, DOI 10.1016/j.margen.2015.04.005; Mennigen JA, 2014, COMP BIOCHEM PHYS B, V169, P16, DOI 10.1016/j.cbpb.2013.12.002; Miyaki S, 2010, GENE DEV, V24, P1173, DOI 10.1101/gad.1915510; Moen T, 2008, BMC GENET, V9, DOI 10.1186/1471-2156-9-18; Nahid MA, 2011, CELL MOL IMMUNOL, V8, P388, DOI 10.1038/cmi.2011.26; Pasquinelli AE, 2000, NATURE, V408, P86, DOI 10.1038/35040556; Saal S, 2009, CURR OPIN NEPHROL HY, V18, P317, DOI 10.1097/MNH.0b013e32832c9da2; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Sonkoly E, 2008, SEMIN CANCER BIOL, V18, P131, DOI 10.1016/j.semcancer.2008.01.005; Star B, 2011, NATURE, V477, P207, DOI 10.1038/nature10342; Stefani G, 2008, NAT REV MOL CELL BIO, V9, P219, DOI 10.1038/nrm2347; Thatcher EJ, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-253; Trakooljul N, 2012, GENE, V500, P107, DOI 10.1016/j.gene.2012.03.028; Wang K, 2009, P NATL ACAD SCI USA, V106, P4402, DOI 10.1073/pnas.0813371106; Wienholds E, 2005, SCIENCE, V309, P310, DOI 10.1126/science.1114519; Winter J, 2009, NAT CELL BIOL, V11, P228, DOI 10.1038/ncb0309-228; Xu ZQ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054174; Yadetie F, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-481; Yan B, 2013, J CELL SCI, V126, P3401, DOI 10.1242/jcs.125831; YAN XU, 2012, ACTA ECOLOGICA SINIC, V7, P1; Yi R, 2010, CELL DEATH DIFFER, V17, P229, DOI 10.1038/cdd.2009.92; Zhang DD, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096132; Zhu X, 2015, INT J MOL SCI, V16, P8310, DOI 10.3390/ijms16048310	58	17	18	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 29	2016	11	4							e0153324	10.1371/journal.pone.0153324	http://dx.doi.org/10.1371/journal.pone.0153324			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DK8XM	27128807	Green Published, gold, Green Submitted			2022-12-26	WOS:000375212600003
J	Schrodi, SJ				Schrodi, Steven J.			The Use of Multiplicity Corrections, Order Statistics and Generalized Family-Wise Statistics with Application to Genome-Wide Studies	PLOS ONE			English	Article							SINGLE-NUCLEOTIDE POLYMORPHISMS; FALSE DISCOVERY RATE; GENETIC ASSOCIATION; SIGNIFICANCE THRESHOLDS; GAMMA-DISTRIBUTION; TESTING CORRECTION; REPLICATION; SCANS; TRAITS	The most important decision faced by large-scale studies, such as those presently encountered in human genetics, is to distinguish between those tests that are true positives from those that are not. In the context of genetics, this entails the determination of genetic markers that actually underlie medically-relevant phenotypes from a vast number of makers typically interrogated in genome-wide studies. A critical part of these decisions relies on the appropriate statistical assessment of data obtained from tests across numerous markers. Several methods have been developed to aid with such analyses, with family-wise approaches, such as the Bonferroni and Dunn-Sidak corrections, being popular. Conditions that motivate the use of family-wise corrections are explored. Although simple to implement, one major limitation of these approaches is that they assume that p-values are i.i.d. uniformly distributed under the null hypothesis. However, several factors may violate this assumption in genome-wide studies including effects from confounding by population stratification, the presence of related individuals, the correlational structure among genetic markers, and the use of limiting distributions for test statistics. Even after adjustment for such effects, the distribution of p-values can substantially depart from a uniform distribution under the null hypothesis. In this work, I present a decision theory for the use of family-wise corrections for multiplicity and a generalization of the Dunn-Sidak correction that relaxes the assumption of uniformly-distributed null p-values. The independence assumption is also relaxed and handled through calculating the effective number of independent tests. I also explicitly show the relationship between order statistics and family-wise correction procedures. This generalization may be applicable to multiplicity problems outside of genomics.	[Schrodi, Steven J.] Marshfield Clin Res Fdn, Ctr Human Genet, Marshfield, WI USA; [Schrodi, Steven J.] Univ Wisconsin, Computat & Informat Biol & Med, Madison, WI USA	University of Wisconsin System; University of Wisconsin Madison	Schrodi, SJ (corresponding author), Marshfield Clin Res Fdn, Ctr Human Genet, Marshfield, WI USA.; Schrodi, SJ (corresponding author), Univ Wisconsin, Computat & Informat Biol & Med, Madison, WI USA.	schrodi.steven@mcrf.mfldclin.edu	Schrodi, Steven J./O-4288-2019	Schrodi, Steven J./0000-0003-2304-8528	Marshfield Clinic Research Foundation; NIH-NCATS/University of Wisconsin-Madison Institute for Clinical & Translational Research [UL1TR000427]; NIMH [RO1MH097464]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000427] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH097464] Funding Source: NIH RePORTER	Marshfield Clinic Research Foundation; NIH-NCATS/University of Wisconsin-Madison Institute for Clinical & Translational Research; NIMH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was supported by generous donors to the Marshfield Clinic Research Foundation. Research reported in this publication was also supported by a pilot grant award from the NIH-NCATS/University of Wisconsin-Madison Institute for Clinical & Translational Research (UL1TR000427) and NIMH RO1MH097464. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Berndt SI, 2013, NAT GENET, V45, P501, DOI 10.1038/ng.2606; Bonferroni C.E., 1936, PUBBL R I SUP SCI EC, V8, P1; BOWMAN KO, 1982, COMMUN STAT B-SIMUL, V11, P377; Chen ZX, 2011, HUM HERED, V72, P1, DOI 10.1159/000330135; Cheverud JM, 2001, HEREDITY, V87, P52, DOI 10.1046/j.1365-2540.2001.00901.x; D'Agostino RB, 1986, GOODNESS OF FIT TECH; Dudbridge F, 2008, GENET EPIDEMIOL, V32, P227, DOI 10.1002/gepi.20297; DUNN OJ, 1961, J AM STAT ASSOC, V56, P52, DOI 10.2307/2282330; DUNN OJ, 1974, COMMUN STAT, V3, P101; Efron B, 2001, J AM STAT ASSOC, V96, P1151, DOI 10.1198/016214501753382129; Evans M., 1993, STAT DISTRIBUTIONS, V2nd; Feller W., 2008, INTRO PROBABILITY TH, V2; Gao XY, 2008, GENET EPIDEMIOL, V32, P361, DOI 10.1002/gepi.20310; Gao XY, 2011, GENET EPIDEMIOL, V35, P154, DOI 10.1002/gepi.20563; Gorlov IP, 2014, HUM GENET, V133, P1477, DOI 10.1007/s00439-014-1493-6; Han B, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000456; Hirschhorn JN, 2002, GENET MED, V4, P45, DOI 10.1097/00125817-200203000-00002; HOLM S, 1979, SCAND J STAT, V6, P65; Ioannidis JPA, 2005, PLOS MED, V2, P696, DOI 10.1371/journal.pmed.0020124; Ioannidis JPA, 2001, NAT GENET, V29, P306, DOI 10.1038/ng749; Li J, 2005, HEREDITY, V95, P221, DOI 10.1038/sj.hdy.6800717; Moskvina V, 2008, GENET EPIDEMIOL, V32, P567, DOI 10.1002/gepi.20331; Nyholt DR, 2004, AM J HUM GENET, V74, P765, DOI 10.1086/383251; Panagiotou OA, 2012, INT J EPIDEMIOL, V41, P273, DOI 10.1093/ije/dyr178; Romantsova YV., 1996, J MATH SCI, V81, P2759, DOI DOI 10.1007/BF02362475; Schrodi SJ, 2005, STAT APPL GENET MOL, V4; Scott JG, 2006, J STAT PLAN INFER, V136, P2144, DOI 10.1016/j.jspi.2005.08.031; Sellke T, 2001, AM STAT, V55, P62, DOI 10.1198/000313001300339950; SIDAK Z, 1967, J AM STAT ASSOC, V62, P626, DOI 10.2307/2283989; Son YS, 2006, COMMUN STAT-SIMUL C, V35, P285, DOI 10.1080/03610910600591925; SORIC B, 1989, J AM STAT ASSOC, V84, P608, DOI 10.2307/2289950; Storey JD, 2003, ANN STAT, V31, P2013, DOI 10.1214/aos/1074290335; Storey JD, 2002, J ROY STAT SOC B, V64, P479, DOI 10.1111/1467-9868.00346; Storey JD, 2003, P NATL ACAD SCI USA, V100, P9440, DOI 10.1073/pnas.1530509100; Todorov AA, 1997, GENET EPIDEMIOL, V14, P453, DOI 10.1002/(SICI)1098-2272(1997)14:5<453::AID-GEPI1>3.0.CO;2-2; Visscher PM, 2012, AM J HUM GENET, V90, P7, DOI 10.1016/j.ajhg.2011.11.029; Wakefield J, 2008, INT J EPIDEMIOL, V37, P641, DOI 10.1093/ije/dym257; Wakefield J, 2012, INT J EPIDEMIOL, V41, P286, DOI 10.1093/ije/dyr241	39	5	5	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 29	2016	11	4							e0154472	10.1371/journal.pone.0154472	http://dx.doi.org/10.1371/journal.pone.0154472			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DK8XM	27128491	Green Published, gold			2022-12-26	WOS:000375212600032
J	Demeyer, H; Burtin, C; Hornikx, M; Camillo, CA; Van Remoortel, H; Langer, D; Janssens, W; Troosters, T				Demeyer, Heleen; Burtin, Chris; Hornikx, Miek; Camillo, Carlos Augusto; Van Remoortel, Hans; Langer, Daniel; Janssens, Wim; Troosters, Thierry			The Minimal Important Difference in Physical Activity in Patients with COPD	PLOS ONE			English	Article							PULMONARY REHABILITATION; ACTIVITY MONITORS; OUTCOMES; HOSPITALIZATION; LIFE	Background Changes in physical activity (PA) are difficult to interpret because no framework of minimal important difference (MID) exists. We aimed to determine the minimal important difference (MID) in physical activity (PA) in patients with Chronic Obstructive Pulmonary Disease and to clinically validate this MID by evaluating its impact on time to first COPD-related hospitalization. Methods PA was objectively measured for one week in 74 patients before and after three months of rehabilitation (rehabilitation sample). In addition the intraclass correlation coefficient was measured in 30 patients (test-retest sample), by measuring PA for two consecutive weeks. Daily number of steps was chosen as outcome measurement. Different distribution and anchor based methods were chosen to calculate the MID. Time to first hospitalization due to an exacerbation was compared between patients exceeding the MID and those who did not. Results Calculation of the MID resulted in 599 (Standard Error of Measurement), 1029 (empirical rule effect size), 1072 (Cohen's effect size) and 1131 (0.5SD) steps.day(-1). An anchor based estimation could not be obtained because of the lack of a sufficiently related anchor. The time to the first hospital admission was significantly different between patients exceeding the MID and patients who did not, using the Standard Error of Measurement as cutoff. Conclusions The MID after pulmonary rehabilitation lies between 600 and 1100 steps.day(-1). The clinical importance of this change is supported by a reduced risk for hospital admission in those patients with more than 600 steps improvement.	[Demeyer, Heleen; Burtin, Chris; Hornikx, Miek; Camillo, Carlos Augusto; Van Remoortel, Hans; Langer, Daniel; Troosters, Thierry] KU Leuven Univ Leuven, Dept Rehabil Sci, B-3000 Leuven, Belgium; [Demeyer, Heleen; Camillo, Carlos Augusto; Van Remoortel, Hans; Langer, Daniel; Janssens, Wim; Troosters, Thierry] Univ Hosp Leuven, Dept Resp Dis, B-3000 Leuven, Belgium; [Demeyer, Heleen] Ctr Res Environm Epidemiol CREAL, Barcelona, Spain; [Burtin, Chris] Hasselt Univ, Fac Med & Life Sci, Biomed Res Inst, Rehabil Res Ctr, Diepenbeek, Belgium; [Hornikx, Miek] Univ Hosp Leuven, Dept Cardiovasc Dis, B-3000 Leuven, Belgium; [Van Remoortel, Hans] Red Cross Flanders, Ctr Evidence Based Practice, Mechelen, Belgium	KU Leuven; KU Leuven; University Hospital Leuven; Pompeu Fabra University; Hasselt University; KU Leuven; University Hospital Leuven	Troosters, T (corresponding author), KU Leuven Univ Leuven, Dept Rehabil Sci, B-3000 Leuven, Belgium.; Troosters, T (corresponding author), Univ Hosp Leuven, Dept Resp Dis, B-3000 Leuven, Belgium.	thierry.troosters@med.kuleuven.be	burtin, chris/B-3343-2015; Van Remoortel, Hans/AAH-2425-2019; Hornikx, Miek/ABI-5441-2020; Camillo, Carlos Augusto/G-6325-2012; Langer, Daniel/B-7307-2014	Camillo, Carlos Augusto/0000-0001-7648-8573; Langer, Daniel/0000-0001-8738-9482; Janssens, Wim/0000-0003-1830-2982; Demeyer, Heleen/0000-0001-8925-0564	Flemish Research Foundation [G.0871.13]; PROactive IMI-JU [115011]; CNPq/Brazil [202425/2011-8]; ERS/SEPAR Fellowship (LTRF)	Flemish Research Foundation(FWO); PROactive IMI-JU; CNPq/Brazil(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); ERS/SEPAR Fellowship (LTRF)	This work was supported by the Flemish Research Foundation (grant # G.0871.13) and PROactive IMI-JU # 115011. DL and WJ are post-doctoral research fellows of the FWO-Flanders. CAC is supported by CNPq/Brazil (202425/2011-8). Ms Heleen Demeyer is the recipient of a joint ERS/SEPAR Fellowship (LTRF 2015).	Bisca GW, 2014, J CARDIOPULM REHABIL, V34, P213, DOI 10.1097/HCR.0000000000000047; Brozek JL, 2006, HEALTH QUAL LIFE OUT, V4, DOI 10.1186/1477-7525-4-69; Demeyer H, 2014, CHEST, V146, P318, DOI 10.1378/chest.13-1968; Donaire-Gonzalez D, 2015, EUR RESP J; Durheim MT, 2015, ANN AM THORAC SOC, V12, P349, DOI DOI 10.1513/ANNALSATS.201408-3650C; Esteban C, 2014, RESPIROLOGY, V19, P330, DOI 10.1111/resp.12239; Garcia-Rio F, 2012, CHEST, V142, P338, DOI 10.1378/chest.11-2014; Gimeno-Santos E, 2015, EUR RESPIR J, V46, P988, DOI 10.1183/09031936.00183014; Gimeno-Santos E, 2014, THORAX, V69, P731, DOI 10.1136/thoraxjnl-2013-204763; GOLD, 2011, GLOB STRAT DIAGN MAN; Guyatt GH, 2002, MAYO CLIN PROC, V77, P371, DOI 10.4065/77.4.371; GUYATT GH, 1987, THORAX, V42, P773, DOI 10.1136/thx.42.10.773; Hill K, 2015, INTERN MED J, V45, P474, DOI 10.1111/imj.12570; Hornikx M, 2012, RESP RES, V13, DOI 10.1186/1465-9921-13-84; Langer D, 2009, THORAX, V64, P641, DOI 10.1136/thx.2008.112102; Mendoza L, 2015, EUR RESPIR J, V45, P347, DOI 10.1183/09031936.00084514; Miller MR, 2005, EUR RESPIR J, V26, P319, DOI 10.1183/09031936.05.00034805; Motl RW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073247; Moy Marilyn L, 2014, Ann Am Thorac Soc, V11, P149, DOI 10.1513/AnnalsATS.201307-243OC; Moy ML, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060400; Moy ML, 2015, CHEST IN PRESS; Ng LWC, 2012, CHRON RESP DIS, V9, P17, DOI 10.1177/1479972311430335; Pitta F, 2006, CHEST, V129, P536, DOI 10.1378/chest.129.3.536; Pitta F, 2008, CHEST, V134, P273, DOI 10.1378/chest.07-2655; Puhan MA, 2011, EUR RESPIR J, V37, P784, DOI 10.1183/09031936.00063810; Puhan MA, 2014, CLIN CHEST MED, V35, P295, DOI 10.1016/j.ccm.2014.02.001; QUANJER PH, 1993, EUR RESPIR J, V6, P5, DOI 10.1183/09041950.005s1693; Rabinovich RA, 2013, EUR RESPIR J, V42, P1205, DOI 10.1183/09031936.00134312; Redelmeier DA, 1997, AM J RESP CRIT CARE, V155, P1278, DOI 10.1164/ajrccm.155.4.9105067; Revicki DA, 2006, HEALTH QUAL LIFE OUT, V4, DOI 10.1186/1477-7525-4-70; Soler-Cataluna JJ, 2005, THORAX, V60, P925, DOI 10.1136/thx.2005.040527; Troosters T, 2011, EUR RESPIR J, V37, P755, DOI 10.1183/09031936.00156410; Tudor-Locke C, 2011, INT J BEHAV NUTR PHY, V8, DOI 10.1186/1479-5868-8-80; Van Remoortel H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039198; Waschki B, 2015, AM J RESP CRIT CARE; Watz H, 2014, EUR RESPIR J, V44, P1521, DOI 10.1183/09031936.00046814; Wyrwich KW, 1999, MED CARE, V37, P469, DOI 10.1097/00005650-199905000-00006	37	132	132	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 28	2016	11	4							e0154587	10.1371/journal.pone.0154587	http://dx.doi.org/10.1371/journal.pone.0154587			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DK8XE	27124297	Green Published, Green Accepted, gold			2022-12-26	WOS:000375211700107
J	Si, H; Lu, H; Yang, X; Mattox, A; Jang, M; Bian, Y; Sano, E; Viadiu, H; Yan, B; Yau, C; Ng, S; Lee, SK; Romano, RA; Davis, S; Walker, RL; Xiao, W; Sun, H; Wei, L; Sinha, S; Benz, CC; Stuart, JM; Meltzer, PS; Van Waes, C; Chen, Z				Si, H.; Lu, H.; Yang, X.; Mattox, A.; Jang, M.; Bian, Y.; Sano, E.; Viadiu, H.; Yan, B.; Yau, C.; Ng, S.; Lee, S. K.; Romano, R-A; Davis, S.; Walker, R. L.; Xiao, W.; Sun, H.; Wei, L.; Sinha, S.; Benz, C. C.; Stuart, J. M.; Meltzer, P. S.; Van Waes, C.; Chen, Z.			TNF-alpha modulates genome-wide redistribution of Delta Np63 alpha/TAp73 and NF-kappa B cREL interactive binding on TP53 and AP-1 motifs to promote an oncogenic gene program in squamous cancer	ONCOGENE			English	Article							CELL CARCINOMA; C-JUN; TRANSCRIPTION FACTORS; TUMOR SUPPRESSION; SIGNAL PATHWAYS; GROWTH-FACTOR; NECK-CANCER; P53 HOMOLOG; HUMAN HEAD; P63	The Cancer Genome Atlas (TCGA) network study of 12 cancer types (PanCancer 12) revealed frequent mutation of TP53, and amplification and expression of related TP63 isoform Delta Np63 in squamous cancers. Further, aberrant expression of inflammatory genes and TP53/p63/p73 targets were detected in the PanCancer 12 project, reminiscent of gene programs comodulated by cREL/Delta Np63/TAp73 transcription factors we uncovered in head and neck squamous cell carcinomas (HNSCCs). However, how inflammatory gene signatures and cREL/p63/p73 targets are comodulated genome wide is unclear. Here, we examined how the inflammatory factor tumor necrosis factor-alpha (TNF-alpha) broadly modulates redistribution of cREL with Delta Np63 alpha/TAp73 complexes and signatures genome wide in the HNSCC model UM-SCC46 using chromatin immunoprecipitation sequencing (ChIP-seq). TNF-alpha enhanced genome-wide co-occupancy of cREL with Delta Np63 alpha on TP53/p63 sites, while unexpectedly promoting redistribution of TAp73 from TP53 to activator protein-1 (AP-1) sites. cREL, Delta Np63 alpha and TAp73 binding and oligomerization on NF-kappa B-, TP53- or AP-1-specific sequences were independently validated by ChIP-qPCR (quantitative PCR), oligonucleotide-binding assays and analytical ultracentrifugation. Function of the binding activity was confirmed using TP53-, AP-1- and NF-kappa B-specific REs or p21, SERPINE1 and IL-6 promoter luciferase reporter activities. Concurrently, TNF-alpha regulated a broad gene network with cobinding activities for cREL, Delta Np63 alpha and TAp73 observed upon array profiling and reverse transcription-PCR. Overlapping target gene signatures were observed in squamous cancer subsets and in inflamed skin of transgenic mice overexpressing Delta Np63 alpha. Furthermore, multiple target genes identified in this study were linked to TP63 and TP73 activity and increased gene expression in large squamous cancer samples from PanCancer 12 TCGA by CircleMap. PARADIGM inferred pathway analysis revealed the network connection of TP63 and NF-kappa B complexes through an AP-1 hub, further supporting our findings. Thus, inflammatory cytokine TNF-a mediates genome-wide redistribution of the cREL/p63/p73, and AP-1 interactome, to diminish TAp73 tumor suppressor function and reciprocally activate NF-kappa B and AP-1 gene programs implicated in malignancy.	[Si, H.; Lu, H.; Yang, X.; Mattox, A.; Jang, M.; Bian, Y.; Lee, S. K.; Van Waes, C.; Chen, Z.] NIDCD, Tumor Biol Sect, Head & Neck Surg Branch, NIH, Bethesda, MD USA; [Lu, H.] Zhujiang Hosp Guangzhou, Orthopaed Ctr, Guangzhou, Guangdong, Peoples R China; [Sano, E.] Univ Calif San Diego, Dept Chem & Biochem, San Diego, CA 92103 USA; [Viadiu, H.] Univ Nacl Autonoma Mexico, Inst Quim, Ciudad Univ, Mexico City, DF, Mexico; [Yan, B.] Univ Hong Kong, LKS Fac Med, Hong Kong, Hong Kong, Peoples R China; [Yan, B.] Univ Hong Kong, LKS Fac Med, Sch Biomed Sci, Hong Kong, Hong Kong, Peoples R China; [Yan, B.] Univ Hong Kong, Ctr Genome Sci, Hong Kong, Hong Kong, Peoples R China; [Yau, C.; Benz, C. C.] Buck Inst Res Aging, Novato, CA USA; [Ng, S.; Stuart, J. M.] Univ Calif Santa Cruz, Ctr Biomol Sci & Engn, Dept Biomol Engn, Santa Cruz, CA 95064 USA; [Romano, R-A; Sinha, S.] SUNY Buffalo, Ctr Excellence Bioinformat & Life Sci, Dept Biochem, Buffalo, NY USA; [Davis, S.; Walker, R. L.] NCI, Canc Genet Branch, Bethesda, MD 20892 USA; [Xiao, W.] US FDA, Natl Ctr Toxicol Res, Div Bioinformat & Biostat, Jefferson, AK USA; [Sun, H.] NIAMSD, Biodata Min & Discovery Sect, Bethesda, MD 20892 USA; [Wei, L.] NEI, Clin Immunol Sect, NIH, Bethesda, MD 20892 USA; [Wei, L.] Sun Yat Sen Univ, Zhongshan Ophthalm Ctr, State Key Lab Ophthalmol, Guangzhou, Guangdong, Peoples R China	National Institutes of Health (NIH) - USA; NIH National Institute on Deafness & Other Communication Disorders (NIDCD); Southern Medical University - China; University of California System; University of California San Diego; Universidad Nacional Autonoma de Mexico; University of Hong Kong; University of Hong Kong; University of Hong Kong; Buck Institute for Research on Aging; University of California System; University of California Santa Cruz; State University of New York (SUNY) System; State University of New York (SUNY) Buffalo; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); US Food & Drug Administration (FDA); National Institutes of Health (NIH) - USA; NIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS); National Institutes of Health (NIH) - USA; NIH National Eye Institute (NEI); Sun Yat Sen University	Van Waes, C (corresponding author), NIDCD, NIH, Bldg 10-CRC,4-2732,10 Ctr Dr, Bethesda, MD 20892 USA.; Chen, Z (corresponding author), NIDCD, Clin Genom Unit, Head & Neck Surg Branch, NIH, Bldg 10-5D55,10 Ctr Dr, Bethesda, MD 20892 USA.	vanwaesc@nidcd.nih.gov; chenz@nidcd.nih.gov	Davis, Sean/AAD-1801-2021	Davis, Sean/0000-0002-8991-6458; Walker, Robert/0000-0001-8235-4686; Stuart, Joshua/0000-0002-2171-565X; /0000-0002-2168-3379; Lu, Hai/0000-0002-4212-3282	NIH [R01AR049238]; NCI [R01-CA180778, U24-CA143858]; Stand Up to Cancer; Prostate Cancer Foundation; Movember Foundation;  [ZIA-DC-000073];  [ZIA-DC-000074]; NATIONAL CANCER INSTITUTE [U24CA210990, U24CA143858, R01CA180778, ZIABC011091] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U54HG006097] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR049238] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM109031] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [ZIADC000073, Z01DC000073, ZIADC000016, ZIADC000074] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Stand Up to Cancer; Prostate Cancer Foundation; Movember Foundation; ; ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	We thank Dr Fan Yang (NCI/NIH), Dr Kairong Cui (NHLBI/NIH), Dr Bingmei Zhu (NIDDK/NIH), Jeffery Burnett (NIDCD/NIH), Jamie Coupar (NIDCD/NIH), Guanmei Liang (Thomas Jefferson High School for Science and Technology, Alexandria, VA, USA) and Eric Nicolson (Ithaca High School, Ithaca, New York, NY, USA) for their technical assistance and suggestions. The authors express appreciation to Drs James W Rocco and Leif W Ellisen (Harvard University) for providing Delta Np63 and TAp63 expression vectors, Dr Thomas Gilmore (Boston University) for cRel expression plasmids, Professor Gerry Melino (University of Leicester) for TAp73 alpha expression plasmids, Dr J Silvio Gutkind (NIDCR/NIH) for IL-6 promoter reporter plasmids, Dr Gourisankar Ghosh (UCSD) for the cRel expression plasmid, and Drs Michal Karin (University of California, San Diego), Cheng-Ming Chiang (University of Texas, Southwestern) and Xuan Liu (University of California, Riverside) for critique of and helpful suggestions for the manuscript. HL, HS, XY, AM, MJ, YB, CVW and ZC are supported by intramural projects ZIA-DC-000073, ZIA-DC-000074 and RAR and SS are supported by a grant from NIH (R01AR049238). JMS acknowledges support from NCI (R01-CA180778 and U24-CA143858), Stand Up to Cancer, Prostate Cancer Foundation and the Movember Foundation.	Andreasen PA, 2007, CURR DRUG TARGETS, V8, P1030, DOI 10.2174/138945007781662346; Bancroft CC, 2001, CLIN CANCER RES, V7, P435; Barenco M, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2009.84; Belyi VA, 2009, P NATL ACAD SCI USA, V106, P17609, DOI 10.1073/pnas.0910634106; Bid HK, 2014, CANCER RES, V74, P320, DOI 10.1158/0008-5472.CAN-13-0894; Boccaccio C, 2005, NATURE, V434, P396, DOI 10.1038/nature03357; Bunting K, 2007, J IMMUNOL, V178, P7097, DOI 10.4049/jimmunol.178.11.7097; Chatterjee A, 2010, CANCER RES, V70, P1419, DOI 10.1158/0008-5472.CAN-09-2613; Collavin L, 2010, CELL DEATH DIFFER, V17, P901, DOI 10.1038/cdd.2010.35; Cromer A, 2004, ONCOGENE, V23, P2484, DOI 10.1038/sj.onc.1207345; DeYoung MP, 2007, ONCOGENE, V26, P5169, DOI 10.1038/sj.onc.1210337; Dong G, 2004, ONCOGENE, V23, P6199, DOI 10.1038/sj.onc.1207851; Dong G, 2001, CANCER RES, V61, P5911; Du JH, 2014, J PATHOL, V232, P356, DOI 10.1002/path.4302; ELDEIRY WS, 1993, CELL, V75, P817, DOI 10.1016/0092-8674(93)90500-P; Hoadley KA, 2014, CELL, V158, P929, DOI 10.1016/j.cell.2014.06.049; Jiang H, 2010, BIOINFORMATICS, V26, P1781, DOI 10.1093/bioinformatics/btq286; KASTAN MB, 1992, CELL, V71, P587, DOI 10.1016/0092-8674(92)90593-2; King KE, 2008, CANCER RES, V68, P5122, DOI 10.1158/0008-5472.CAN-07-6123; Koeppel M, 2011, NUCLEIC ACIDS RES, V39, P6069, DOI 10.1093/nar/gkr028; Koshiba S, 2008, J PATHOL, V214, P75, DOI 10.1002/path.2266; LAWRENCE CE, 1993, SCIENCE, V262, P208, DOI 10.1126/science.8211139; Lawrence MS, 2015, NATURE, V517, P576, DOI 10.1038/nature14129; Leong CO, 2007, J CLIN INVEST, V117, P1370, DOI 10.1172/JCI30866; Leslie M, 2011, SCIENCE, V331, P1551, DOI 10.1126/science.331.6024.1551; Lu H, 2011, CANCER RES, V71, P6867, DOI 10.1158/0008-5472.CAN-11-2460; Machanick P, 2011, BIOINFORMATICS, V27, P1696, DOI 10.1093/bioinformatics/btr189; Marcel V, 2011, CELL DEATH DIFFER, V18, P1815, DOI 10.1038/cdd.2011.120; Natan E, 2012, J MOL BIOL, V415, P503, DOI 10.1016/j.jmb.2011.11.007; Ng S, 2012, BIOINFORMATICS, V28, pI640, DOI 10.1093/bioinformatics/bts402; Nottingham LK, 2014, ONCOGENE, V33, P1135, DOI 10.1038/onc.2013.49; O'Donnell RK, 2005, ONCOGENE, V24, P1244, DOI 10.1038/sj.onc.1208285; Ondrey FG, 1999, MOL CARCINOGEN, V26, P119, DOI 10.1002/(SICI)1098-2744(199910)26:2<119::AID-MC6>3.0.CO;2-N; Ortt K, 2006, FEBS LETT, V580, P4544, DOI 10.1016/j.febslet.2006.07.004; Perez CA, 2007, CELL CYCLE, V6, P246, DOI 10.4161/cc.6.3.3801; Rickman DS, 2008, ONCOGENE, V27, P6607, DOI 10.1038/onc.2008.251; Riley T, 2008, NAT REV MOL CELL BIO, V9, P402, DOI 10.1038/nrm2395; Rocco JW, 2006, CANCER CELL, V9, P45, DOI 10.1016/j.ccr.2005.12.013; Romano RA, 2011, INDIAN J EXP BIOL, V49, P721; Romano RA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005623; Rosenbluth JM, 2011, P NATL ACAD SCI USA, V108, P2076, DOI 10.1073/pnas.1011936108; Seiwert TY, 2015, CLIN CANCER RES, V21, P632, DOI 10.1158/1078-0432.CCR-13-3310; Sethi G, 2012, BIOSCIENCE REP, V32, P1, DOI 10.1042/BSR20100136; Shaulian E, 2002, NAT CELL BIOL, V4, pE131, DOI 10.1038/ncb0502-e131; Shin HJ, 2009, BIOINFORMATICS, V25, P2605, DOI 10.1093/bioinformatics/btp479; Smeenk L, 2008, NUCLEIC ACIDS RES, V36, P3639, DOI 10.1093/nar/gkn232; Soussi T, 2007, CANCER CELL, V12, P303, DOI 10.1016/j.ccr.2007.10.001; Toh WH, 2004, J BIOL CHEM, V279, P44713, DOI 10.1074/jbc.M407672200; Vaske CJ, 2010, BIOINFORMATICS, V26, pi237, DOI 10.1093/bioinformatics/btq182; Vayssade M, 2005, INT J CANCER, V116, P860, DOI 10.1002/ijc.21033; Vikhanskaya F, 2007, NAT CELL BIOL, V9, P698, DOI 10.1038/ncb1598; Wong CK, 2013, NUCLEIC ACIDS RES, V41, pW218, DOI 10.1093/nar/gkt473; Yang A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011572; Yang XP, 2011, CANCER RES, V71, P3688, DOI 10.1158/0008-5472.CAN-10-3445; Zhang Y, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-r137	55	23	24	0	9	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	NOV 3	2016	35	44					5781	5794		10.1038/onc.2016.112	http://dx.doi.org/10.1038/onc.2016.112			14	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	EA9XQ	27132513	Green Accepted, Green Submitted			2022-12-26	WOS:000386998400009
J	DeSantis, MC; Kim, JH; Song, HN; Klasse, PJ; Cheng, W				DeSantis, Michael C.; Kim, Jin H.; Song, Hanna; Klasse, Per Johan; Cheng, Wei			Quantitative Correlation between Infectivity and Gp120 Density on HIV-1 Virions Revealed by Optical Trapping Virometry	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; MEMBRANE-FUSION PROTEINS; ENVELOPE GLYCOPROTEIN; ENTRY; NEUTRALIZATION; ANTIBODY; SURFACE; FLUORESCENCE; CELLS; ENDOCYTOSIS	The envelope glycoprotein (Env) gp120/gp41 is required for HIV-1 infection of host cells. Although in general it has been perceived that more Env gives rise to higher infectivity, the precise quantitative dependence of HIV-1 virion infectivity on Env density has remained unknown. Here we have developed a method to examine this dependence. This method involves 1) production of a set of single-cycle HIV-1 virions with varied density of Env on their surface, 2) site-specific labeling of Env-specific antibody Fab with a fluorophore at high efficiency, and 3) optical trapping virometry to measure the number of gp120 molecules on individual HIV-1 virions. The resulting gp120 density per virion is then correlated with the infectivity of the virions measured in cell culture. In the presence of DEAE-dextran, the polycation known to enhance HIV-1 infectivity in cell culture, virion infectivity follows gp120 density as a sigmoidal dependence and reaches an apparent plateau. This quantitative dependence can be described by a Hill equation, with a Hill coefficient of 2.4 +/- 0.6. In contrast, in the absence of DEAE-dextran, virion infectivity increases monotonically with gp120 density and no saturation is observed under the experimental conditions. These results provide the first quantitative evidence that Env trimers cooperate on the virion surface to mediate productive infection by HIV-1. Moreover, as a result of the low number of Env trimers on individual virions, the number of additional Env trimers per virion that is required for the optimal infectivity will depend on the inclusion of facilitating agents during infection.	[DeSantis, Michael C.; Kim, Jin H.; Song, Hanna; Cheng, Wei] Univ Michigan, Sch Med, Dept Pharmaceut Sci, Coll Pharm, Ann Arbor, MI 48109 USA; [Cheng, Wei] Univ Michigan, Sch Med, Dept Biol Chem, Ann Arbor, MI 48109 USA; [Klasse, Per Johan] Cornell Univ, Dept Microbiol & Immunol, Weill Cornell Med, New York, NY 10065 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; Cornell University	Cheng, W (corresponding author), 428 Church St, Ann Arbor, MI 48109 USA.	chengwe@umich.edu	Klasse, P.J./AEX-0142-2022	Klasse, P.J./0000-0001-8222-278X; DeSantis, Michael/0000-0002-7214-2740	National Institutes of Health Director's New Innovator Award [1DP2OD008693-01]; National Science Foundation CAREER Award [CHE1149670]; March of Dimes Foundation [5-FY10-490]; National Institutes of Health [F32-GM109771, R37 AI36082]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R37AI036082] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [F32GM109771] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP2OD008693] Funding Source: NIH RePORTER	National Institutes of Health Director's New Innovator Award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation CAREER Award(National Science Foundation (NSF)); March of Dimes Foundation(March of Dimes); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported, in whole or in part, by National Institutes of Health Director's New Innovator Award 1DP2OD008693-01 (to W. C.), National Science Foundation CAREER Award CHE1149670 (to W. C.), and Research Grant 5-FY10-490 from the March of Dimes Foundation (to W. C.). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. The authors declare no competing financial interests.r Supported by National Institutes of Health postdoctoral fellowship award F32-GM109771.r Supported by National Institutes of Health Grant R37 AI36082.	Arunajadai SG, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059279; Barouch DH, 2005, J VIROL, V79, P8828, DOI 10.1128/JVI.79.14.8828-8834.2005; Behrens AJ, 2016, CELL REP, V14, P2695, DOI 10.1016/j.celrep.2016.02.058; Blumenthal R, 2012, J BIOL CHEM, V287, P40841, DOI 10.1074/jbc.R112.406272; Brandenberg OF, 2015, TRENDS MICROBIOL, V23, P763, DOI 10.1016/j.tim.2015.09.003; Brandenberg OF, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1004595; Cheng W, 2010, OPT LETT, V35, P2988, DOI 10.1364/OL.35.002988; Chertova E, 2002, J VIROL, V76, P5315, DOI 10.1128/JVI.76.11.5315-5325.2002; Chojnacki J, 2012, SCIENCE, V338, P524, DOI 10.1126/science.1226359; Coffman VC, 2012, TRENDS BIOCHEM SCI, V37, P499, DOI 10.1016/j.tibs.2012.08.002; Daecke J, 2005, J VIROL, V79, P1581, DOI 10.1128/JVI.79.3.1581-1594.2005; Evans R. D., 1969, ATOMIC NUCL, P774; Galimidi RP, 2015, CELL, V160, P433, DOI 10.1016/j.cell.2015.01.016; GILL SC, 1989, ANAL BIOCHEM, V182, P319, DOI 10.1016/0003-2697(89)90602-7; Hill AV, 1913, BIOCHEM J, V7, P471, DOI 10.1042/bj0070471; Hou XM, 2011, OPT LETT, V36, P3185, DOI 10.1364/OL.36.003185; Kielian M, 2006, NAT REV MICROBIOL, V4, P67, DOI 10.1038/nrmicro1326; Kim Joonseok, 2013, Case Rep Med, V2013, P131395, DOI 10.1155/2013/131395; Klasse PJ, 2007, VIROLOGY, V369, P245, DOI 10.1016/j.virol.2007.06.044; Klasse PJ, 2012, CELL MICROBIOL, V14, P1183, DOI 10.1111/j.1462-5822.2012.01812.x; Klasse PJ, 1996, J VIROL, V70, P3668, DOI 10.1128/JVI.70.6.3668-3677.1996; Klein JS, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000908; Lawrimore J, 2011, J CELL BIOL, V195, P573, DOI 10.1083/jcb.201106036; Li YX, 2011, J VIROL, V85, P8954, DOI 10.1128/JVI.00754-11; Magnus C, 2009, J VIROL, V83, P1523, DOI 10.1128/JVI.01764-08; Miyauchi K, 2009, CELL, V137, P433, DOI 10.1016/j.cell.2009.02.046; Mondor I, 1998, J VIROL, V72, P3623, DOI 10.1128/JVI.72.5.3623-3634.1998; Moore PL, 2006, J VIROL, V80, P2515, DOI 10.1128/JVI.80.5.2515-2528.2006; O'Doherty U, 2000, J VIROL, V74, P10074, DOI 10.1128/JVI.74.21.10074-10080.2000; Pang YJ, 2014, NAT NANOTECHNOL, V9, P624, DOI [10.1038/NNANO.2014.140, 10.1038/nnano.2014.140]; Parrish NF, 2013, P NATL ACAD SCI USA, V110, P6626, DOI 10.1073/pnas.1304288110; Platt EJ, 2010, J VIROL, V84, P3106, DOI 10.1128/JVI.01958-09; Sanders RW, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003618; Sougrat R, 2007, PLOS PATHOG, V3, P571, DOI 10.1371/journal.ppat.0030063; Tran EEH, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002797; White JM, 2008, CRIT REV BIOCHEM MOL, V43, P189, DOI [10.1080/10409230802058320, 10.1080/10409230802058320 ]; Wu XL, 2010, SCIENCE, V329, P856, DOI 10.1126/science.1187659; Wyman J, 1990, BINDING LINKAGE FUNC; Yasmeen A, 2014, RETROVIROLOGY, V11, DOI 10.1186/1742-4690-11-41; Yuste E, 2005, J VIROL, V79, P12455, DOI 10.1128/JVI.79.19.12455-12463.2005; Zhang YJ, 2002, J VIROL, V76, P6332, DOI 10.1128/JVI.76.12.6332-6343.2002; Zhu P, 2006, NATURE, V441, P847, DOI 10.1038/nature04817	42	24	26	1	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 17	2016	291	25					13088	13097		10.1074/jbc.M116.729210	http://dx.doi.org/10.1074/jbc.M116.729210			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DR2YT	27129237	Green Published, hybrid			2022-12-26	WOS:000379770500017
J	Cajander, S; Tina, E; Backman, A; Magnuson, A; Stralin, K; Soderquist, B; Kallman, J				Cajander, Sara; Tina, Elisabet; Backman, Anders; Magnuson, Anders; Stralin, Kristoffer; Soderquist, Bo; Kallman, Jan			Quantitative Real-Time Polymerase Chain Reaction Measurement of HLA-DRA Gene Expression in Whole Blood Is Highly Reproducible and Shows Changes That Reflect Dynamic Shifts in Monocyte Surface HLA-DR Expression during the Course of Sepsis	PLOS ONE			English	Article							ORGAN FAILURE; IMMUNOSUPPRESSION; IMMUNOTHERAPY; DEFINITIONS; MORTALITY	Introduction A decrease in the expression of monocyte surface protein HLA-DR (mHLA-DR), measured by flow cytometry (FCM), has been suggested as a marker of immunosuppression and negative outcome in severe sepsis. However, FCM is not always available due to sample preparation that limits its use to laboratory operational hours. In this prospective study we evaluated dynamic changes in mHLA-DR expression during sepsis in relation to changes in HLA-DRA gene expression and Class II transactivator (CIITA), measured by quantitative Real-Time Polymerase Chain Reaction (qRT-PCR). Aims The aims of this study were: 1. to validate the robustness of qRT-PCR measurement of HLA-DRA- and CIITA-mRNA expression, in terms of reproducibility; and 2. to see if changes in expression of these genes reflect changes in mHLA-DR expression during the course of severe and non-severe bacteraemic sepsis. Methods and Findings Blood samples were collected from 60 patients with bacteraemic sepsis on up to five occasions during Days 1-28 after hospital admission. We found the reproducibility of the qRT-PCR method to be high by demonstrating low threshold variations (<0.11 standard deviation (SD)) of the qRT-PCR system, low intra-assay variation of Ct-values within triplicates (<= 0.15 SD) and low inter-assay variations (12%) of the calculated target gene ratios. Our results also revealed dynamic HLA-DRA expression patterns during the course of sepsis that reflected those of mHLA-DR measured by FCM. Furthermore, HLA-DRA and mHLA-DR recovery slopes in patients with non-severe sepsis differed from those in patients with severe sepsis, shown by mixed model for repeated measurements (p<0.05). However, during the first seven days of sepsis, PCR-measurements showed a higher magnitude of difference between the two sepsis groups. Mean differences (95% CI) between severe sepsis (n = 20) and non-severe sepsis (n = 40) were; on day 1-2, HLA-DRA 0.40 (0.28-0.59) p<0.001, CIITA 0.48 (0.32-0.72) p = 0.005, mHLA-DR 0.63 (0.45-1.00) p = 0.04, day 7 HLA-DRA 0.59 (0.46-0.77) p<0.001, CIITA 0.56 (0.41-0.76) p<0.001, mHLA-DR 0.81 (0.66-1.00) p = 0.28. Conclusion We conclude that qRT-PCR measurement of HLA-DRA expression is robust, and that this method appears to be preferable to FCM in identifying patients with severe sepsis that may benefit from immunostimulation.	[Cajander, Sara; Kallman, Jan] Univ Orebro, Fac Med & Hlth, Dept Infect Dis, SE-70182 Orebro, Sweden; [Tina, Elisabet; Backman, Anders] Univ Orebro, Fac Med & Hlth, Dept Clin Res Lab, SE-70182 Orebro, Sweden; [Magnuson, Anders] Univ Orebro, Fac Med & Hlth, Clin Epidemiol & Biostat, SE-70182 Orebro, Sweden; [Stralin, Kristoffer] Karolinska Univ Hosp, Dept Infect Dis, Stockholm, Sweden; [Soderquist, Bo] Univ Orebro, Fac Med & Hlth, SE-70182 Orebro, Sweden	Orebro University; Orebro University; Orebro University; Karolinska Institutet; Karolinska University Hospital; Orebro University	Cajander, S (corresponding author), Univ Orebro, Fac Med & Hlth, Dept Infect Dis, SE-70182 Orebro, Sweden.	sara.cajander@regionorebrolan.se		Cajander, Sara/0000-0003-3921-4244; Soderquist, Bo/0000-0001-5939-2932	Nyckelfonden (Orebro, Sweden); research committee of Orebro County Council	Nyckelfonden (Orebro, Sweden); research committee of Orebro County Council	Research funding was provided by a grant from Nyckelfonden (Orebro, Sweden) and the research committee of Orebro County Council.	Angus D C, 2001, Crit Care Med, V29, P1303, DOI 10.1097/00003246-200107000-00002; Angus DC, 2013, NEW ENGL J MED, V369, P840, DOI [10.1056/NEJMc1312359, 10.1056/NEJMra1208623]; BONE RC, 1992, CHEST, V101, P1644, DOI 10.1378/chest.101.6.1644; Boomer JS, 2011, JAMA-J AM MED ASSOC, V306, P2594, DOI 10.1001/jama.2011.1829; Cajander S, 2013, CRIT CARE, V17, DOI 10.1186/cc13046; Cazalis MA, 2014, INTENS CARE MED EXP, V2, DOI 10.1186/s40635-014-0020-3; Cazalis MA, 2013, CRIT CARE, V17, DOI 10.1186/cc13150; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; Delsing CE, 2014, BMC INFECT DIS, V14, DOI 10.1186/1471-2334-14-166; Docke WD, 2005, CLIN CHEM, V51, P2341, DOI 10.1373/clinchem.2005.052639; Gouel-Cheron A, 2015, INTENSIVE CARE MED; Hanna S, 2014, J ALLERGY CLIN IMMUN, V134, P269, DOI 10.1016/j.jaci.2014.06.001; Hotchkiss RS, 2013, NAT REV IMMUNOL, V13, P862, DOI 10.1038/nri3552; Iwashyna TJ, 2010, JAMA-J AM MED ASSOC, V304, P1787, DOI 10.1001/jama.2010.1553; Kalil AC, 2009, CRIT CARE MED, V37, P2350, DOI 10.1097/CCM.0b013e3181a3aa43; Landelle C, 2010, INTENS CARE MED, V36, P1859, DOI 10.1007/s00134-010-1962-x; Levy MM, 2003, CRIT CARE MED, V31, P1250, DOI 10.1097/01.CCM.0000050454.01978.3B; Meisel C, 2009, AM J RESP CRIT CARE, V180, P640, DOI 10.1164/rccm.200903-0363OC; Monneret G, 2015, CYTOMETRY B; Pachot A, 2004, J BIOTECHNOL, V114, P121, DOI 10.1016/j.jbiotec.2004.07.001; Payen D, 2013, CRIT CARE, V17, DOI 10.1186/cc12490; Spies C, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0144003; Vincent JL, 1996, INTENS CARE MED, V22, P707, DOI 10.1007/BF01709751; Walton AH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098819	24	17	18	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 4	2016	11	5							e0154690	10.1371/journal.pone.0154690	http://dx.doi.org/10.1371/journal.pone.0154690			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DL5KR	27144640	Green Published, Green Submitted, gold			2022-12-26	WOS:000375676400061
J	Duarte, GT; Ribeiro, MC; Paglia, AP				Duarte, Gabriela Teixeira; Ribeiro, Milton Cezar; Paglia, Adriano Pereira			Ecosystem Services Modeling as a Tool for Defining Priority Areas for Conservation	PLOS ONE			English	Article							LAND-USE; BIODIVERSITY CONSERVATION; ENVIRONMENTAL SERVICES; FOREST FRAGMENTS; DECISION-MAKING; ATLANTIC FOREST; LANDSCAPE; PAYMENTS; BRAZIL; TRADEOFFS	Conservationists often have difficulty obtaining financial and social support for protected areas that do not demonstrate their benefits for society. Therefore, ecosystem services have gained importance in conservation science in the last decade, as these services provide further justification for appropriate management and conservation of natural systems. We used InVEST software and a set of GIS procedures to quantify, spatialize and evaluated the overlap between ecosystem services-carbon stock and sediment retention-and a biodiversity proxy-habitat quality. In addition, we proposed a method that serves as an initial approach of a priority areas selection process. The method considers the synergism between ecosystem services and biodiversity conservation. Our study region is the Iron Quadrangle, an important Brazilian mining province and a conservation priority area located in the interface of two biodiversity hotspots, the Cerrado and Atlantic Forest biomes. The resultant priority area for the maintenance of the highest values of ecosystem services and habitat quality was about 13% of the study area. Among those priority areas, 30% are already within established strictly protected areas, and 12% are in sustainable use protected areas. Following the transparent and highly replicable method we proposed in this study, conservation planners can better determine which areas fulfill multiple goals and can locate the trade-offs in the landscape. We also gave a step towards the improvement of the habitat quality model with a topography parameter. In areas of very rugged topography, we have to consider geomorfometric barriers for anthropogenic impacts and for species movement and we must think beyond the linear distances. Moreover, we used a model that considers the tree mortality caused by edge effects in the estimation of carbon stock. We found low spatial congruence among the modeled services, mostly because of the pattern of sediment retention distribution.	[Duarte, Gabriela Teixeira; Paglia, Adriano Pereira] Univ Fed Minas Gerais, Inst Ciencias Biol, Lab Ecol & Conservacao, Dept Biol Geral, Belo Horizonte, MG, Brazil; [Ribeiro, Milton Cezar] Univ Estadual Paulista Julio de Mesquita UNESP, Dept Ecol, Lab Ecol Espacial & Conservacao, Sao Paulo, Brazil	Universidade Federal de Minas Gerais	Duarte, GT (corresponding author), Univ Fed Minas Gerais, Inst Ciencias Biol, Lab Ecol & Conservacao, Dept Biol Geral, Belo Horizonte, MG, Brazil.	gabitduarte@gmail.com	Paglia, Adriano P/A-7965-2012	Paglia, Adriano P/0000-0001-9957-5506	Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico [312045/2013-1]; Fundacao de Amparo a Pesquisa do Estado de Sao Paulo [2013/50421-2]; Fundacao de Amparo a Pesquisa do Estado de Minas Gerais	Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Fundacao de Amparo a Pesquisa do Estado de Sao Paulo(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Fundacao de Amparo a Pesquisa do Estado de Minas Gerais(Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG))	GTD had her scholarship from Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior. MCR is funded by Conselho Nacional de Desenvolvimento Cientifico e Tecnologico research grant (process 312045/2013-1) and Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (process 2013/50421-2). The work was also funded by Fundacao de Amparo a Pesquisa do Estado de Minas Gerais. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams VM, 2010, BIOL CONSERV, V143, P439, DOI 10.1016/j.biocon.2009.11.011; [Anonymous], 2011, BIODIVERSITY HOTSPOT, DOI [10.1007/978-3-642-20992-5_21, DOI 10.1007/978-3-642-20992-5_21]; Balvanera P, 2006, ECOL LETT, V9, P1146, DOI 10.1111/j.1461-0248.2006.00963.x; BROWN S, 1984, SCIENCE, V223, P1290, DOI 10.1126/science.223.4642.1290; CBD, 2011, STRAT PLAN BIOD 2011, DOI DOI 10.1007/978-1-4020-6970-3_5; Chan KMA, 2006, PLOS BIOL, V4, P2138, DOI 10.1371/journal.pbio.0040379; Cidu R, 2009, J GEOCHEM EXPLOR, V100, P125, DOI 10.1016/j.gexplo.2008.02.003; Companhia de Saneamento de Minas Gerais COPASA, 2014, WAT PROD METR REG BE; Daily G. C., 1997, Nature's services: societal dependence on natural ecosystems., P113; Daily GC, 2008, P NATL ACAD SCI USA, V105, P9455, DOI 10.1073/pnas.0804960105; Davis EG, 2005, APA SUL RMBH PROJECT; Di Bitetti MS, 2006, J ZOOL, V270, P153, DOI 10.1111/j.1469-7998.2006.00102.x; Dirzo R, 2014, SCIENCE, V345, P401, DOI 10.1126/science.1251817; Drummond G.M., 2005, BIODIVERSITY MINAS G, V2nd edition.; Egoh B, 2009, BIOL CONSERV, V142, P553, DOI 10.1016/j.biocon.2008.11.009; Egoh B, 2008, AGR ECOSYST ENVIRON, V127, P135, DOI 10.1016/j.agee.2008.03.013; Egoh B, 2007, ECOL ECON, V63, P714, DOI 10.1016/j.ecolecon.2007.04.007; ESRI, 2013, ARCGIS 10 2; ESWARAN H, 1993, SOIL SCI SOC AM J, V57, P192, DOI 10.2136/sssaj1993.03615995005700010034x; Faleiro FV, 2013, DIVERS DISTRIB, V19, P977, DOI 10.1111/ddi.12072; Fernandes GW, 2014, NAT CONSERVACAO, V12, P162, DOI 10.1016/j.ncon.2014.08.003; Fisher B, 2009, ECOL ECON, V68, P643, DOI 10.1016/j.ecolecon.2008.09.014; FOSTER GR, 1981, J SOIL WATER CONSERV, V36, P355; Goldman RL, 2008, P NATL ACAD SCI USA, V105, P9445, DOI 10.1073/pnas.0800208105; Goldman RL, 2009, ANN NY ACAD SCI, V1162, P63, DOI 10.1111/j.1749-6632.2009.04151.x; Goldman-Benner RL, 2012, ORYX, V46, P55, DOI 10.1017/S0030605311001050; Goldstein JH, 2012, P NATL ACAD SCI USA, V109, P7565, DOI 10.1073/pnas.1201040109; Gray S, 2012, ECOL MODEL, V229, P88, DOI 10.1016/j.ecolmodel.2011.09.011; Guerry Anne D., 2012, International Journal of Biodiversity Science Ecosystem Services & Management, V8, P107, DOI 10.1080/21513732.2011.647835; Gurmendi AC, 2013, MINERAL IND BRAZIL 2, V3; Gustafson EJ, 2013, EXPERT KNOWLEDGE ITS, V28, P365, DOI DOI 10.1007/978-1-4614-1034-8; Hsu C.C, 2007, PRACT ASSESS RES EVA, V12, P1, DOI [DOI 10.7275/PDZ9-TH90, 10.7275/pdz9-th90]; Jacobi CM, 2008, AMBIO, V37, P324, DOI 10.1579/0044-7447(2008)37[324:TCOIOT]2.0.CO;2; JENSON SK, 1988, PHOTOGRAMM ENG REM S, V54, P1593; Knight AT, 2006, CONSERV BIOL, V20, P408, DOI 10.1111/j.1523-1739.2006.00305.x; Larsen FW, 2011, CONSERV LETT, V4, P355, DOI 10.1111/j.1755-263X.2011.00183.x; Laurance WF, 1997, SCIENCE, V278, P1117, DOI 10.1126/science.278.5340.1117; LEEC Spatial Ecology and Conservation Lab, 2015, POT BIOD IND VELH PA; Levin, 2013, ENCYCLOPEDIA OF BIOD, P347; Lyra-Jorge MC, 2010, EUR J WILDLIFE RES, V56, P359, DOI 10.1007/s10344-009-0324-x; Maes J, 2012, ECOSYST SERV, V1, P31, DOI 10.1016/j.ecoser.2012.06.004; McBride MF, 2007, CONSERV BIOL, V21, P1463, DOI 10.1111/j.1523-1739.2007.00832.x; Medeiros R, 2011, 10 YEARS NATL NATURE; Miles L, 2008, SCIENCE, V320, P1454, DOI 10.1126/science.1155358; Millennium Ecosystem Assessment, 2005, EC HUM WELL BEING SY; Morcatty TQ, 2013, ECOL RES, V28, P935, DOI 10.1007/s11284-013-1076-3; Moreira MC, 2008, REV BRAS CIENC SOLO, V32, P1349, DOI 10.1590/S0100-06832008000300042; Myers N, 2000, NATURE, V403, P853, DOI 10.1038/35002501; Naidoo R, 2008, P NATL ACAD SCI USA, V105, P9495, DOI 10.1073/pnas.0707823105; Naidoo R, 2006, PLOS BIOL, V4, P2153, DOI 10.1371/journal.pbio.0040360; Naidoo R, 2006, TRENDS ECOL EVOL, V21, P681, DOI 10.1016/j.tree.2006.10.003; Nelson E, 2009, FRONT ECOL ENVIRON, V7, P4, DOI 10.1890/080023; Nelson E, 2008, P NATL ACAD SCI USA, V105, P9471, DOI 10.1073/pnas.0706178105; Nelson Erik J, 2010, F1000 Biol Rep, V2, P53, DOI 10.3410/B2-53; Neteler M., 2013, OPEN SOURCE GIS GRAS; Numata I, 2011, ENVIRON RES LETT, V6, DOI 10.1088/1748-9326/6/4/044003; Polasky S, 2005, ECOL APPL, V15, P1387, DOI 10.1890/03-5423; Polasky S, 2008, BIOL CONSERV, V141, P1505, DOI 10.1016/j.biocon.2008.03.022; Polasky S, 2011, ENVIRON RESOUR ECON, V48, P219, DOI 10.1007/s10640-010-9407-0; Porter-Bolland L, 2012, FOREST ECOL MANAG, V268, P6, DOI 10.1016/j.foreco.2011.05.034; Price J, 2012, ECOL MODEL, V229, P76, DOI 10.1016/j.ecolmodel.2011.09.010; Robertson N., 2005, FRESH TRACKS FOREST; Safriel U., 2005, ECOSYSTEMS HUMAN WEL, P623; Saltelli A., 2008, GLOBAL SENSITIVITY A, DOI [10.1002/9780470725184, DOI 10.1002/9780470725184]; Santos BA, 2008, BIOL CONSERV, V141, P249, DOI 10.1016/j.biocon.2007.09.018; Seppelt R, 2011, J APPL ECOL, V48, P630, DOI 10.1111/j.1365-2664.2010.01952.x; Soares B, 2014, SCIENCE, V344, P363, DOI 10.1126/science.1246663; Sonter LJ, 2014, GLOBAL ENVIRON CHANG, V26, P63, DOI 10.1016/j.gloenvcha.2014.03.014; Sparovek G, 2010, ENVIRON SCI TECHNOL, V44, P6046, DOI 10.1021/es1007824; Strassburg BBN, 2010, CONSERV LETT, V3, P98, DOI 10.1111/j.1755-263X.2009.00092.x; Tabarelli M, 2008, BIOTROPICA, V40, P657, DOI 10.1111/j.1744-7429.2008.00454.x; Tallis EH, 2013, VEST 3 0 1 USERS GUI; Tallis EH, 2011, VEST 2 0 0 USERS GUI; TAYLOR PD, 1993, OIKOS, V68, P571, DOI 10.2307/3544927; Thornton I, 1996, APPL GEOCHEM, V11, P355, DOI 10.1016/0883-2927(95)00064-X; Vincent Regina de Castro, 2008, Braz. J. Bot., V31, P377, DOI 10.1590/S0100-84042008000300002; Walker, 2005, SOURCEBOOK LAND USE; Wendland KJ, 2010, ECOL ECON, V69, P2093, DOI 10.1016/j.ecolecon.2009.01.002; Wischmeier W. H., 1978, U. S. Department of Agriculture, Agriculture Handbook; Wunscher T, 2008, ECOL ECON, V65, P822, DOI 10.1016/j.ecolecon.2007.11.014; Wunder S, 2005, PAYMENTS ENV SERVICE, DOI DOI 10.17528/CIFOR/001760; Wunder S, 2008, ECOL ECON, V65, P834, DOI 10.1016/j.ecolecon.2008.03.010	82	50	55	11	144	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 4	2016	11	5							e0154573	10.1371/journal.pone.0154573	http://dx.doi.org/10.1371/journal.pone.0154573			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DL5KR	27145031	Green Published, gold			2022-12-26	WOS:000375676400053
J	Fu, ZYJ; Liu, Y; Chen, CH; Guo, Y; Ma, Y; Yang, Y; Hu, FP; Xu, XG; Wang, MG				Fu, Zhuyingjie; Liu, Yang; Chen, Chunhui; Guo, Yan; Ma, Ying; Yang, Yang; Hu, Fupin; Xu, Xiaogang; Wang, Minggui			Characterization of Fosfomycin Resistance Gene, fosB, in Methicillin-Resistant Staphylococcus aureus Isolates	PLOS ONE			English	Article							ESCHERICHIA-COLI; SEQUENCE; DETERMINANT; PREVALENCE	To investigate the prevalence, location and genetic environments of fosfomycin-resistance (fos) genes in methicillin-resistant Staphylococcus aureus (MRSA) clinical strains, 67 fosfomycin-resistant MRSA strains were isolated from the blood and cerebrospinal fluid samples at a teaching hospital in Shanghai. The presence of fos genes in these clinical strains was detected by PCR and sequencing. The locations of fos genes were determined by Southern blotting and genetic environments were analyzed by primer walking sequencing. Multiple locus sequence typing (MLST) was used to characterize genetic diversity. Conjugation was performed to evaluate the transferability of fos genes. Among 67 fosfomycin-resistant MRSA strains, nine high level fosfomycin resistant strains (>= 128 mu g/ml) were fosB-positive. Three new subtypes of fosB, designated as fosB4, fosB5, and fosB6, were identified. fosB1, fosB4 or fosB6 genes were located on small plasmids (ca. 2.5 kb) and flanked by an analogous replication gene (rep). Differently, the fosB5 gene was surrounded by a shorter rep gene and two copies of a transposon gene (tnp) that shared high identity with the IS257-like transposon. Four MLST types were found among the nine fosB-positive strains. Transconjugants with the fosB genes were resistant to fosfomycin with MIC 64 or 128 mu g/ml. In conclusion, different subtypes and genetic environment of fosB genes indicate that gene heterogeneity for fosfomycin resistance in MRSA isolates.	[Fu, Zhuyingjie; Liu, Yang; Chen, Chunhui; Guo, Yan; Ma, Ying; Yang, Yang; Hu, Fupin; Xu, Xiaogang; Wang, Minggui] Fudan Univ, Inst Antibiot, Huashan Hosp, Shanghai 200433, Peoples R China; [Fu, Zhuyingjie; Liu, Yang; Chen, Chunhui; Guo, Yan; Ma, Ying; Yang, Yang; Hu, Fupin; Xu, Xiaogang; Wang, Minggui] Minist Hlth, Key Lab Clin Pharmacol Antibiot, Shanghai, Peoples R China	Fudan University	Xu, XG (corresponding author), Fudan Univ, Inst Antibiot, Huashan Hosp, Shanghai 200433, Peoples R China.; Xu, XG (corresponding author), Minist Hlth, Key Lab Clin Pharmacol Antibiot, Shanghai, Peoples R China.	xuxiaogang@fudan.edu.cn	Hu, Fupin/AAR-8314-2020; XU, XIAOGANG/AAR-8657-2020; YANG, YANG/GQI-3680-2022; Wang, Minggui/AAR-8281-2020	Wang, Minggui/0000-0001-7682-5859	National Natural Science Foundation of China [81171613, 81120108024]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was supported by grants from the National Natural Science Foundation of China (81171613 to X. X. and 81120108024 to M. W.).	Aanensen DM, 2005, NUCLEIC ACIDS RES, V33, pW728, DOI 10.1093/nar/gki415; BARBERISMAINO L, 1987, GENE, V59, P107, DOI 10.1016/0378-1119(87)90271-X; Chen CC, 2014, J MED MICROBIOL, V63, P1484, DOI 10.1099/jmm.0.077701-0; Clinical and Laboratory Standards Institute, 2013, M100S23 CLIN LAB STA; Enright MC, 1999, TRENDS MICROBIOL, V7, P482, DOI 10.1016/S0966-842X(99)01609-1; ETIENNE J, 1991, FEMS MICROBIOL LETT, V84, P119; Fillgrove KL, 2007, BIOCHEMISTRY-US, V46, P8110, DOI 10.1021/bi700625p; FRANKE AE, 1981, J BACTERIOL, V145, P494, DOI 10.1128/JB.145.1.494-502.1981; Fu ZYJ, 2016, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.01544; GARCIA P, 1995, ANTIMICROB AGENTS CH, V39, P1569, DOI 10.1128/AAC.39.7.1569; Heilbronner S, 2013, MICROBIOL-SGM, V159, P2141, DOI 10.1099/mic.0.070292-0; Lee SY, 2012, J ANTIMICROB CHEMOTH, V67, P2843, DOI 10.1093/jac/dks319; Michalopoulos AS, 2011, INT J INFECT DIS, V15, pE732, DOI 10.1016/j.ijid.2011.07.007; Nakamura G, 2014, J CLIN MICROBIOL, V52, P3175, DOI 10.1128/JCM.01094-14; Needham C, 1995, PLASMID, V34, P198, DOI 10.1006/plas.1995.0005; Read TD, 2003, NATURE, V423, P81, DOI 10.1038/nature01586; ROUCH DA, 1987, J GEN MICROBIOL, V133, P3039; ROUCH DA, 1989, MOL MICROBIOL, V3, P161, DOI 10.1111/j.1365-2958.1989.tb01805.x; Takeuchi F, 1990, BACTERIOL, V187, P7292; Wang Y, 2015, J ANTIMICROB CHEMOTH, V70, P1261, DOI 10.1093/jac/dku488; Xu XJ, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0074849, 10.1371/journal.pone.0078106]; ZILHAO R, 1990, FEMS MICROBIOL LETT, V68, P267, DOI 10.1111/j.1574-6968.1990.tb13949.x	22	25	26	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 4	2016	11	5							e0154829	10.1371/journal.pone.0154829	http://dx.doi.org/10.1371/journal.pone.0154829			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DL5KR	27144405	Green Published, gold			2022-12-26	WOS:000375676400080
J	Massai, D; Isu, G; Madeddu, D; Cerino, G; Falco, A; Frati, C; Gallo, D; Deriu, MA; Labate, GFD; Quaini, F; Audenino, A; Morbiducci, U				Massai, Diana; Isu, Giuseppe; Madeddu, Denise; Cerino, Giulia; Falco, Angela; Frati, Caterina; Gallo, Diego; Deriu, Marco A.; Labate, Giuseppe Falvo D'Urso; Quaini, Federico; Audenino, Alberto; Morbiducci, Umberto			A Versatile Bioreactor for Dynamic Suspension Cell Culture. Application to the Culture of Cancer Cell Spheroids	PLOS ONE			English	Article							PLURIPOTENT STEM-CELLS; VESSEL BIOREACTOR; DIFFERENTIATION; EXPANSION; DESIGN; OPTIMIZATION; GENERATION; BIOPROCESS; MODEL	A versatile bioreactor suitable for dynamic suspension cell culture under tunable shear stress conditions has been developed and preliminarily tested culturing cancer cell spheroids. By adopting simple technological solutions and avoiding rotating components, the bioreactor exploits the laminar hydrodynamics establishing within the culture chamber enabling dynamic cell suspension in an environment favourable to mass transport, under a wide range of tunable shear stress conditions. The design phase of the device has been supported by multiphysics modelling and has provided a comprehensive analysis of the operating principles of the bioreactor. Moreover, an explanatory example is herein presented with multiphysics simulations used to set the proper bioreactor operating conditions for preliminary in vitro biological tests on a human lung carcinoma cell line. The biological results demonstrate that the ultralow shear dynamic suspension provided by the device is beneficial for culturing cancer cell spheroids. In comparison to the static suspension control, dynamic cell suspension preserves morphological features, promotes intercellular connection, increases spheroid size (2.4-fold increase) and number of cycling cells (1.58-fold increase), and reduces double strand DNA damage (1.5-fold reduction). It is envisioned that the versatility of this bioreactor could allow investigation and expansion of different cell types in the future.	[Massai, Diana; Isu, Giuseppe; Cerino, Giulia; Gallo, Diego; Audenino, Alberto; Morbiducci, Umberto] Politecn Torino, Dept Mech & Aerosp Engn, Turin, Italy; [Madeddu, Denise; Falco, Angela; Frati, Caterina; Quaini, Federico] Univ Parma, Dept Clin & Expt Med, I-43100 Parma, Italy; [Deriu, Marco A.] Univ Svizzera Italiana, Scuola Univ Profess Svizzera Italiana, Ist Dalle Molle Studi Intelligenza Artificial, Manno, Switzerland; [Labate, Giuseppe Falvo D'Urso] Bioexpansys Srl, Turin, Italy; [Massai, Diana] Hannover Med Sch, Leibniz Res Labs Biotechnol & Artificial Organ, Dept Cardiothorac Transplantat & Vasc Surg, Hannover, Germany; [Cerino, Giulia] Univ Basel, Dept Biomed, Basel, Switzerland; [Cerino, Giulia] Univ Basel Hosp, Dept Surg, CH-4031 Basel, Switzerland	Polytechnic University of Turin; University of Parma; University Hospital of Parma; Universita della Svizzera Italiana; Hannover Medical School; University of Basel; University of Basel	Massai, D (corresponding author), Politecn Torino, Dept Mech & Aerosp Engn, Turin, Italy.; Massai, D (corresponding author), Hannover Med Sch, Leibniz Res Labs Biotechnol & Artificial Organ, Dept Cardiothorac Transplantat & Vasc Surg, Hannover, Germany.	diana.massai@polito.it	Gallo, Diego/I-9386-2012; Deriu, Marco Agostino Agostino/GPW-8179-2022; Deriu, Marco Agostino/M-5161-2016; Massai, Diana/H-3036-2018; Audenino, Alberto L./O-6325-2015	Gallo, Diego/0000-0002-7409-7111; Deriu, Marco Agostino Agostino/0000-0003-1918-1772; Deriu, Marco Agostino/0000-0003-1918-1772; Massai, Diana/0000-0001-6339-7189; Audenino, Alberto L./0000-0002-4877-3630; Frati, Caterina/0000-0002-3343-6471	European FP7 Cooperation - Collaborative Project "Bioactive Highly Porous and Injectable Scaffolds Controlling Stem Cell Recruitment, Proliferation and Differentiation and Enabling Angiogenesis for Cardiovascular Engineered Tissues" - BIOSCENT [214539]; Italian National PRIN Project "A Bioprocess for the Optimization of 3D Cardiosphere-based constructs for Cardiac Regenerative Medicine" - BEAT3DHEART [20123E8FH4]; Bioexpansys Srl	European FP7 Cooperation - Collaborative Project "Bioactive Highly Porous and Injectable Scaffolds Controlling Stem Cell Recruitment, Proliferation and Differentiation and Enabling Angiogenesis for Cardiovascular Engineered Tissues" - BIOSCENT; Italian National PRIN Project "A Bioprocess for the Optimization of 3D Cardiosphere-based constructs for Cardiac Regenerative Medicine" - BEAT3DHEART; Bioexpansys Srl	This work received partial funding from (1) the European FP7 Cooperation - Collaborative Project "Bioactive Highly Porous and Injectable Scaffolds Controlling Stem Cell Recruitment, Proliferation and Differentiation and Enabling Angiogenesis for Cardiovascular Engineered Tissues" - BIOSCENT, 2009-2013 (ID 214539), and (2) the Italian National PRIN 2012 Project "A Bioprocess for the Optimization of 3D Cardiosphere-based constructs for Cardiac Regenerative Medicine" - BEAT3DHEART, 2014-2017 (20123E8FH4), as well as additional funding internal to Politecnico di Torino and Universita degli Studi di Parma. Bioexpansys Srl provided financial support in the form of salary for author GFDL and research materials, but had no additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of the authors are articulated in the 'author contributions' section.	Akins RE, 1999, TISSUE ENG, V5, P103, DOI 10.1089/ten.1999.5.103; Amit M, 2010, STEM CELL REV REP, V6, P248, DOI 10.1007/s12015-010-9149-y; Baghbaderani BA, 2008, BIOTECHNOL PROGR, V24, P859, DOI [10.1021/bp070324s, 10.1021/bp.070324s]; Burdge DA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092108; CHERRY RS, 1993, BIOTECHNOL ADV, V11, P279, DOI 10.1016/0734-9750(93)90043-M; Coanda H, 1932, COANDA H, V2; Consolo F, 2012, BIOMECH MODEL MECHAN, V11, P261, DOI 10.1007/s10237-011-0308-0; Consolo F, 2009, TISSUE ENG PART C-ME, V15, P41, DOI 10.1089/ten.tec.2008.0213; Dahlmann J, 2013, BIOMATERIALS, V34, P2463, DOI 10.1016/j.biomaterials.2012.12.024; dos Santos FF, 2013, BIOTECHNOL J, V8, P644, DOI 10.1002/biot.201200373; ECKMANN L, 1988, BRIT J CANCER, V58, P36; Frith JE, 2010, TISSUE ENG PART C-ME, V16, P735, DOI 10.1089/ten.TEC.2009.0432; Godara P, 2008, J CHEM TECHNOL BIOT, V83, P408, DOI 10.1002/jctb.1918; Hickman JA, 2014, BIOTECHNOL J, V9, P1115, DOI 10.1002/biot.201300492; Hwang YS, 2009, BIOMATERIALS, V30, P499, DOI 10.1016/j.biomaterials.2008.07.028; Ismadi MZ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106493; Kaul H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059671; Kempf H, 2014, STEM CELL REP, V3, P1132, DOI 10.1016/j.stemcr.2014.09.017; King JA, 2007, CURR OPIN CHEM BIOL, V11, P394, DOI 10.1016/j.cbpa.2007.05.034; Kropp C, STEM CELLS IN PRESS; Kumar A, 2015, BIOFABRICATION, V7, DOI 10.1088/1758-5090/7/4/044103; Lee J, 2008, TISSUE ENG PART B-RE, V14, P61, DOI 10.1089/teb.2007.0150; Maherali N, 2008, CELL STEM CELL, V3, P595, DOI 10.1016/j.stem.2008.11.008; Martin I, 2004, TRENDS BIOTECHNOL, V22, P80, DOI 10.1016/j.tibtech.2003.12.001; Mather JP, 1998, METHOD CELL BIOL, V57, P219; Olmer R, 2012, TISSUE ENG PART C-ME, V18, P772, DOI 10.1089/ten.tec.2011.0717; Orr DE, 2008, ANN BIOMED ENG, V36, P1228, DOI 10.1007/s10439-008-9505-0; Rodrigues CAV, 2011, BIOTECHNOL ADV, V29, P815, DOI 10.1016/j.biotechadv.2011.06.009; Schroeder M, 2005, BIOTECHNOL BIOENG, V92, P920, DOI 10.1002/bit.20668; Shen YS, 2015, SCI REP-UK, V5, DOI 10.1038/srep09293; Sikavitsas VI, 2002, J BIOMED MATER RES, V62, P136, DOI 10.1002/jbm.10150; Siti-Ismail N, 2012, TISSUE ENG PART C-ME, V18, P263, DOI [10.1089/ten.TEC.2011.0299, 10.1089/ten.tec.2011.0299]; Teo A, 2012, J REGENER MED TISSUE, V1, P4, DOI DOI 10.7243/2050-1218-1-4; Thouas GA, 2007, J BIOMED BIOTECHNOL, DOI 10.1155/2007/32754; Warnock JN, 2006, BIOTECHNOL APPL BIOC, V45, P1, DOI 10.1042/BA2005023; Wu JC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102486; Youn BS, 2006, BIOTECHNOL PROGR, V22, P801, DOI 10.1021/bp050430z; Yu B, 2011, BIOCHEM BIOPH RES CO, V414, P412, DOI 10.1016/j.bbrc.2011.09.103; Zweigerdt R, 2011, NAT PROTOC, V6, P689, DOI 10.1038/nprot.2011.318; Zweigerdt R, 2009, ADV BIOCHEM ENG BIOT, V114, P201, DOI 10.1007/10_2008_27	40	34	35	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 4	2016	11	5							e0154610	10.1371/journal.pone.0154610	http://dx.doi.org/10.1371/journal.pone.0154610			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DL5KR	27144306	Green Published, gold, Green Submitted			2022-12-26	WOS:000375676400057
J	Pettigrew, LC; Kryscio, RJ; Norris, CM				Pettigrew, L. Creed; Kryscio, Richard J.; Norris, Christopher M.			The TNF alpha-Transgenic Rat: Hippocampal Synaptic Integrity, Cognition, Function, and Post-Ischemic Cell Loss	PLOS ONE			English	Article							TUMOR-NECROSIS-FACTOR; LONG-TERM POTENTIATION; NF-KAPPA-B; CEREBRAL-ARTERY OCCLUSION; DENTATE GYRUS; PROINFLAMMATORY CYTOKINES; PROGENITOR PROLIFERATION; MUCOSAL TOLERANCE; FACTOR RECEPTOR-1; NERVOUS-SYSTEM	The cytokine, tumor necrosis factor alpha (TNF alpha), is a key regulator of neuroinflammation linked to numerous neurodegenerative conditions and diseases. The present study used transgenic rats that overexpress a murine TNF alpha gene, under the control of its own promoter, to investigate the impact of chronically elevated TNF alpha on hippocampal synaptic function. Neuronal viability and cognitive recovery in TNF alpha Tg rats were also determined following an ischemic insult arising from reversible middle cerebral artery occlusion (MCAO). Basal CA3-CA1 synaptic strength, recorded in acute brain slices, was not significantly different between eight-week-old TNF alpha Tg rats and non-Tg rats. In contrast, slices from TNF alpha Tg rats showed significantly greater levels of long-term potentiation (LTP) in response to 100 Hz stimulation, suggesting that synaptic networks may be hyperexcitable in the context of elevated TNF alpha. Cognitive and motor deficits (assessed on the Morris Water Maze and Rotarod task, respectively) were present in TNF alpha Tg rats in the absence of significant differences in the loss of cortical and hippocampal neurons. TNF overexpression exacerbated MCAO-dependent deficits on the rotarod, but ameliorated cortical neuron loss in response to MCAO.	[Pettigrew, L. Creed] Univ Kentucky, Paul G Blazer Jr Stroke Res Lab, Lexington, KY USA; [Pettigrew, L. Creed; Kryscio, Richard J.; Norris, Christopher M.] Univ Kentucky, Sanders Brown Ctr Aging, Lexington, KY 40536 USA; [Pettigrew, L. Creed] Univ Kentucky, Dept Neurol, Lexington, KY 40536 USA; [Pettigrew, L. Creed] Vet Adm VA Med Ctr, Lexington, KY USA; [Kryscio, Richard J.] Univ Kentucky, Dept Stat, Lexington, KY USA; [Kryscio, Richard J.] Univ Kentucky, Sch Publ Hlth, Lexington, KY USA; [Norris, Christopher M.] Univ Kentucky, Dept Pharmacol & Nutr Sci, Lexington, KY USA	University of Kentucky; University of Kentucky; University of Kentucky; US Department of Veterans Affairs; Veterans Health Administration (VHA); Lexington VA Medical Center; University of Kentucky; University of Kentucky; University of Kentucky	Pettigrew, LC (corresponding author), Univ Kentucky, Paul G Blazer Jr Stroke Res Lab, Lexington, KY USA.; Pettigrew, LC (corresponding author), Univ Kentucky, Sanders Brown Ctr Aging, Lexington, KY 40536 USA.; Pettigrew, LC (corresponding author), Univ Kentucky, Dept Neurol, Lexington, KY 40536 USA.; Pettigrew, LC (corresponding author), Vet Adm VA Med Ctr, Lexington, KY USA.	cpetti@email.uky.edu		Pettigrew, Luther Creed/0000-0001-7878-5803	NIH/NINDS [R01 NS047395]; Research & Development Office, Lexington VA Medical Center, Lexington, Kentucky; NIH/NIA [R01 AG027297]; Kentucky Spinal Cord and Head Injury Research Trust [12-10A]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS047395] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG027297] Funding Source: NIH RePORTER	NIH/NINDS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Research & Development Office, Lexington VA Medical Center, Lexington, Kentucky; NIH/NIA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Kentucky Spinal Cord and Head Injury Research Trust; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	NIH/NINDS grant R01 NS047395 and a McGeorge Neurological and Spinal Cord Grant awarded through the Research & Development Office, Lexington VA Medical Center, Lexington, Kentucky (L.C.P.). NIH/NIA grant R01 AG027297 and a Kentucky Spinal Cord and Head Injury Research Trust Award 12-10A (C.M.N.).	Albensi BC, 2000, SYNAPSE, V35, P151; Aloe L, 1999, BRAIN RES, V840, P125, DOI 10.1016/S0006-8993(99)01748-5; Arbusow V, 1998, J NEUROL, V245, P132, DOI 10.1007/s004150050192; Barnum CJ, 2014, J PARKINSON DIS, V4, P349, DOI 10.3233/JPD-140410; Barone FC, 1997, STROKE, V28, P1233, DOI 10.1161/01.STR.28.6.1233; Beattie EC, 2002, SCIENCE, V295, P2282, DOI 10.1126/science.1067859; Belayev L, 1996, STROKE, V27, P1616, DOI 10.1161/01.STR.27.9.1616; BELLINGER FP, 1995, NEUROSCI LETT, V198, P95, DOI 10.1016/0304-3940(95)11976-4; BELLINGER FP, 1993, BRAIN RES, V628, P227, DOI 10.1016/0006-8993(93)90959-Q; BLISS TVP, 1993, NATURE, V361, P31, DOI 10.1038/361031a0; Brambilla R, 2011, BRAIN, V134, P2736, DOI 10.1093/brain/awr199; Butler MP, 2004, NEUROSCIENCE, V124, P319, DOI 10.1016/j.neuroscience.2003.11.040; Butler MP, 2002, J NEUROSCI METH, V119, P185, DOI 10.1016/S0165-0270(02)00171-1; Candelario-Jalil E, 2005, J NEUROINFLAMM, V2, DOI 10.1186/1742-2094-2-3; Carlstedt F, 1997, J INTERN MED, V242, P361, DOI 10.1046/j.1365-2796.1997.00209.x; Chen Y, 2003, P NATL ACAD SCI USA, V100, P15107, DOI 10.1073/pnas.2436538100; Cunningham AJ, 1996, NEUROSCI LETT, V203, P17, DOI 10.1016/0304-3940(95)12252-4; DARCANGELO G, 1991, BRAIN RES, V564, P245, DOI 10.1016/0006-8993(91)91459-E; Dawson DA, 1996, NEUROSCI LETT, V218, P41, DOI 10.1016/S0304-3940(96)13116-5; de la Tremblaye PB, 2011, BEHAV BRAIN RES, V219, P227, DOI 10.1016/j.bbr.2011.01.009; De Paepe B, 2012, CLIN DEV IMMUNOL, DOI 10.1155/2012/369432; Dubal DB, 1998, J CEREBR BLOOD F MET, V18, P1253, DOI 10.1097/00004647-199811000-00012; Dumas TC, 2005, HIPPOCAMPUS, V15, P562, DOI 10.1002/hipo.20077; DUMAS TC, 1995, J NEUROPHYSIOL, V73, P1821, DOI 10.1152/jn.1995.73.5.1821; Dumas TC, 2012, HIPPOCAMPUS, V22, P188, DOI 10.1002/hipo.20881; Emsley HCA, 2002, J CEREBR BLOOD F MET, V22, P1399, DOI 10.1097/01.WCB.0000037880.62590.28; Foster TC, 2003, NEUROBIOL AGING, V24, P839, DOI 10.1016/S0197-4580(03)00014-9; Foster TC, 2001, J NEUROSCI, V21, P4066, DOI 10.1523/JNEUROSCI.21-11-04066.2001; Furman JL, 2016, J NEUROSCI, V36, P1502, DOI 10.1523/JNEUROSCI.1930-15.2016; Furman JL, 2012, J NEUROSCI, V32, P16129, DOI 10.1523/JNEUROSCI.2323-12.2012; Golan H, 2004, CEREB CORTEX, V14, P97, DOI 10.1093/cercor/bhg108; Greco A, 2014, AUTOIMMUN REV, V13, P1042, DOI 10.1016/j.autrev.2014.08.035; Grell M, 1998, P NATL ACAD SCI USA, V95, P570, DOI 10.1073/pnas.95.2.570; GRELL M, 1995, CELL, V83, P793, DOI 10.1016/0092-8674(95)90192-2; Hallenbeck JM, 2002, NAT MED, V8, P1363, DOI 10.1038/nm1202-1363; Hellmich HL, 2005, BRAIN RES, V1044, P144, DOI 10.1016/j.brainres.2005.02.054; Iosif RE, 2008, J CEREBR BLOOD F MET, V28, P1574, DOI 10.1038/jcbfm.2008.47; Iosif RE, 2006, J NEUROSCI, V26, P9703, DOI 10.1523/JNEUROSCI.2723-06.2006; KATSUKI H, 1990, EUR J PHARMACOL, V181, P323, DOI 10.1016/0014-2999(90)90099-R; Kielian T, 2008, J NEUROCHEM, V106, P1000, DOI 10.1111/j.1471-4159.2008.05405.x; Knapp LT, 2002, J NEUROSCI RES, V70, P1, DOI 10.1002/jnr.10371; Lavine SD, 1998, J CEREBR BLOOD F MET, V18, P52, DOI 10.1097/00004647-199801000-00005; LIU Y, 1994, J CEREBR BLOOD F MET, V14, P348, DOI 10.1038/jcbfm.1994.43; LONGA EZ, 1989, STROKE, V20, P84, DOI 10.1161/01.STR.20.1.84; Lotocki G, 2004, J NEUROSCI, V24, P11010, DOI 10.1523/JNEUROSCI.3823-04.2004; Marchetti L, 2004, J BIOL CHEM, V279, P32869, DOI 10.1074/jbc.M311766200; Mathis DM, 2011, JOVE-J VIS EXP, DOI 10.3791/2330; Mayne M, 2001, STROKE, V32, P240, DOI 10.1161/01.STR.32.1.240; McAlpine FE, 2009, NEUROBIOL DIS, V34, P163, DOI 10.1016/j.nbd.2009.01.006; Mccoy MK, 2006, J NEUROSCI, V26, P9365, DOI 10.1523/JNEUROSCI.1504-06.2006; Mccoy MK, 2008, J NEUROINFLAMM, V5, DOI 10.1186/1742-2094-5-45; MERRILL JE, 1992, WESTERN J MED, V156, P639; Nawashiro H, 1997, J CEREBR BLOOD F MET, V17, P229, DOI 10.1097/00004647-199702000-00013; Nawashiro H, 1997, J CEREBR BLOOD F MET, V17, P483, DOI 10.1097/00004647-199705000-00001; Norris CM, 2016, EXP NEUROL, V276, P5, DOI 10.1016/j.expneurol.2015.11.006; Norris CM, 2009, J NEUROTRAUM, V26, P2269, DOI 10.1089/neu.2009.1029; Norris CM, 1999, NEUROBIOL LEARN MEM, V71, P194, DOI 10.1006/nlme.1998.3864; Pettigrew LC, 2008, J NEUROINFLAMM, V5, DOI 10.1186/1742-2094-5-47; Probert L, 1996, J LEUKOCYTE BIOL, V59, P518, DOI 10.1002/jlb.59.4.518; PROBERT L, 1995, P NATL ACAD SCI USA, V92, P11294, DOI 10.1073/pnas.92.24.11294; RUDY JW, 1987, BEHAV NEUROSCI, V101, P62, DOI 10.1037/0735-7044.101.1.62; Ruetzler CA, 2001, J CEREBR BLOOD F MET, V21, P244, DOI 10.1097/00004647-200103000-00008; Sairanen T, 2001, STROKE, V32, P1750, DOI 10.1161/01.STR.32.8.1750; Sairanen TR, 2001, J NEUROL SCI, V186, P87, DOI 10.1016/S0022-510X(01)00508-1; Saito K, 1996, NEUROSCI LETT, V206, P149, DOI 10.1016/S0304-3940(96)12460-5; Sama DM, 2013, AGEING RES REV, V12, P982, DOI 10.1016/j.arr.2013.05.008; Sama DM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038170; Sama MA, 2008, J BIOL CHEM, V283, P21953, DOI 10.1074/jbc.M800148200; Serrano F, 2004, AGEING RES REV, V3, P431, DOI 10.1016/j.arr.2004.05.002; Solomon AJ, 2011, MULT SCLER J, V17, P1472, DOI 10.1177/1352458511412996; Steed PM, 2003, SCIENCE, V301, P1895, DOI 10.1126/science.1081297; Stellwagen D, 2006, NATURE, V440, P1054, DOI 10.1038/nature04671; Stellwagen D, 2005, J NEUROSCI, V25, P3219, DOI 10.1523/JNEUROSCI.4486-04.2005; Szymocha R, 2000, J VIROL, V74, P6433, DOI 10.1128/JVI.74.14.6433-6441.2000; Takeda H, 2002, STROKE, V33, P2156, DOI 10.1161/01.STR.0000029821.82531.8B; TANCREDI V, 1992, NEUROSCI LETT, V146, P176, DOI 10.1016/0304-3940(92)90071-E; Tejadilla D, 2010, NEUROSCIENCE, V169, P1178, DOI 10.1016/j.neuroscience.2010.05.074; Tomimoto H, 2003, ACTA NEUROPATHOL, V106, P527, DOI 10.1007/s00401-003-0749-3; Tomimoto H, 1996, ACTA NEUROPATHOL, V92, P281, DOI 10.1007/s004010050519; Vila N, 2000, STROKE, V31, P2325, DOI 10.1161/01.STR.31.10.2325; Wajant H, 2003, CELL DEATH DIFFER, V10, P45, DOI 10.1038/sj.cdd.4401189; Wakita H, 2008, J CEREBR BLOOD F MET, V28, P341, DOI 10.1038/sj.jcbfm.9600528; Wall AM, 2015, J NEUROSCI RES, V93, P815, DOI 10.1002/jnr.23540; Yang GY, 1998, NEUROREPORT, V9, P2131, DOI 10.1097/00001756-199806220-00041; Yulug B, 2004, BRAIN RES, V996, P76, DOI 10.1016/j.brainres.2003.10.012; Zaremba J, 2001, BIOMED PHARMACOTHER, V55, P258, DOI 10.1016/S0753-3322(01)00058-0	86	10	10	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 4	2016	11	5							e0154721	10.1371/journal.pone.0154721	http://dx.doi.org/10.1371/journal.pone.0154721			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DL5KR	27144978	Green Submitted, gold, Green Published			2022-12-26	WOS:000375676400064
J	Huhe; Borjigin, S; Buhebaoyin; Wu, YP; Li, MQ; Cheng, YX				Huhe; Borjigin, Shinchilelt; Buhebaoyin; Wu, Yanpei; Li, Minquan; Cheng, Yunxiang			Microbial Nitrogen-Cycle Gene Abundance in Soil of Cropland Abandoned for Different Periods	PLOS ONE			English	Article							AMMONIA-OXIDIZING ARCHAEA; DENITRIFIER COMMUNITIES; DIVERSITY; RHIZOSPHERE; CULTIVARS; FIXATION; WETLAND; NIRK; TIME	In Inner Mongolia, steppe grasslands face desertification or degradation because of human overuse and abandonment after inappropriate agricultural management. The soils in these abandoned croplands exist in heterogeneous environments characterized by widely fluctuating microbial growth. Quantitative polymerase chain reaction analysis of microbial genes encoding proteins involved in the nitrogen cycle was used to study Azotobacter species, nitrifiers, and denitrifiers in the soils from steppe grasslands and croplands abandoned for 2, 6, and 26 years. Except for nitrifying archaea and nitrous oxide-reducing bacteria, the relative genotypic abundance of microbial communities involved in nitrogen metabolism differed by approximately 2- to 10-fold between abandoned cropland and steppe grassland soils. Although nitrogen-cycle gene abundances varied with abandonment time, the abundance patterns of nitrogen-cycle genes separated distinctly into abandoned cropland versus light-grazing steppe grassland, despite the lack of any cultivation for over a quartercentury. Plant biomass and plant diversity exerted a significant effect on the abundance of microbial communities that mediate the nitrogen cycle (P < 0.002 and P < 0.03, respectively). The present study elucidates the ecology of bacteria that mediate the nitrogen cycle in recently abandoned croplands.	[Huhe] Gansu Acad Agr Sci, Inst Soil & Fertilizer & Save Water Agr, Lanzhou, Gansu, Peoples R China; [Borjigin, Shinchilelt] Univ Tsukuba, Grad Sch Life & Environm Sci, Tsukuba, Ibaraki, Japan; [Buhebaoyin] Chiba Univ, Grad Sch Sci, Chiba, Japan; [Wu, Yanpei; Cheng, Yunxiang] Lanzhou Univ, Coll Pastoral Agr Sci & Technol, State Key Lab Grassland Agroecosyst, Lanzhou 730000, Gansu, Peoples R China; [Li, Minquan] Gansu Acad Agr Sci, Lanzhou, Gansu, Peoples R China	University of Tsukuba; Chiba University; Lanzhou University	Cheng, YX (corresponding author), Lanzhou Univ, Coll Pastoral Agr Sci & Technol, State Key Lab Grassland Agroecosyst, Lanzhou 730000, Gansu, Peoples R China.	chengyx@lzu.edu.cn	周, 呼和/GXH-5843-2022	周, 呼和/0000-0002-7971-465X	State Key Laboratory of Grassland Agro-ecosystems grant [SKLGAE201407]; National Natural Science Foundation of China [31460029, 31402118]; Agricultural Science and Technology Innovation Program from Gansu Academy of Agricultural Sciences [2013GAAS04-04]	State Key Laboratory of Grassland Agro-ecosystems grant; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Agricultural Science and Technology Innovation Program from Gansu Academy of Agricultural Sciences	This research was funded by State Key Laboratory of Grassland Agro-ecosystems grant to H (SKLGAE201407), http://caoye.lzu.edu.cn/, the National Natural Science Foundation of China grant to H (31460029) and YC (31402118) http://www.nsfc.gov.cn/, the Agricultural Science and Technology Innovation Program from Gansu Academy of Agricultural Sciences grant to H (2013GAAS04-04) http://www.gsagr.ac.cn/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Bannert A, 2011, APPL ENVIRON MICROB, V77, P6109, DOI 10.1128/AEM.01751-10; Barta J, 2010, BIOGEOCHEMISTRY, V101, P123, DOI 10.1007/s10533-010-9430-9; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bremer C, 2007, APPL ENVIRON MICROB, V73, P6876, DOI 10.1128/AEM.01536-07; CHAN YK, 1994, FEMS MICROBIOL REV, V13, P95; Coelho MRR, 2009, APPL SOIL ECOL, V42, P48, DOI 10.1016/j.apsoil.2009.01.010; Coelho MRR, 2008, FEMS MICROBIOL LETT, V279, P15, DOI 10.1111/j.1574-6968.2007.00975.x; Cogger C, 2000, SOIL MANAGEMENT SMAL; Cogger C., 2000, SOIL MANAGEMENT SMAL, P24; Cuhel J, 2010, APPL ENVIRON MICROB, V76, P1870, DOI 10.1128/AEM.02484-09; Enwall K, 2005, APPL ENVIRON MICROB, V71, P8335, DOI 10.1128/AEM.71.12.8335-8343.2005; Garcia-Lledo A, 2011, WATER RES, V45, P5621, DOI 10.1016/j.watres.2011.08.025; Hai B, 2009, APPL ENVIRON MICROB, V75, P4993, DOI 10.1128/AEM.02917-08; Hall SJ, 2009, ECOSYSTEMS, V12, P654, DOI 10.1007/s10021-009-9249-1; He C, 2005, J ARID ENVIRON, V63, P814, DOI 10.1016/j.jaridenv.2005.03.028; Huang S, 2011, BIOGEOSCIENCES, V8, P3041, DOI 10.5194/bg-8-3041-2011; Huhe, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106714; Jones CM, 2010, ISME J, V4, P633, DOI 10.1038/ismej.2009.152; Jung J, 2012, J MICROBIOL, V50, P365, DOI 10.1007/s12275-012-1465-2; Kaye JP, 1997, TRENDS ECOL EVOL, V12, P139, DOI 10.1016/S0169-5347(97)01001-X; Kelly JJ, 2011, APPL ENVIRON MICROB, V77, P6551, DOI 10.1128/AEM.02608-10; Leininger S, 2006, NATURE, V442, P806, DOI 10.1038/nature04983; Li JH, 2007, PLANT ECOL, V191, P1, DOI 10.1007/s11258-006-9209-1; Matsuura K, 2009, TERRESTRIAL AIR TEMP; Nicol GW, 2008, ENVIRON MICROBIOL, V10, P2966, DOI 10.1111/j.1462-2920.2008.01701.x; Palmer K, 2012, ISME J, V6, P1058, DOI 10.1038/ismej.2011.172; Prieme A, 2002, APPL ENVIRON MICROB, V68, P1893, DOI 10.1128/AEM.68.4.1893-1900.2002; Reed SC, 2007, APPL SOIL ECOL, V36, P238, DOI 10.1016/j.apsoil.2007.02.002; Robertson GP, 2000, SCIENCE, V289, P1922, DOI 10.1126/science.289.5486.1922; Schimel JP, 2004, ECOLOGY, V85, P591, DOI 10.1890/03-8002; Shi S, 2009, THESIS LINCOLN U NZ; ter Braak C.J.F., 2002, CANOCO REFERENCE MAN, P500; Tong C, 2004, J ARID ENVIRON, V59, P133, DOI 10.1016/j.jaridenv.2004.01.004; Van der Putten WH, 2000, OECOLOGIA, V124, P91, DOI 10.1007/s004420050028; [薛智德 Xue Zhide], 2002, [西北林学院学报, Journal of Northwest Forestry College], V17, P26; Zhang Jin-tun, 2000, Journal of Plant Resources and Environment, V9, P34; ZOU HY, 1998, RES SOIL WATER CONSE, V5, P126	38	7	8	8	57	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 3	2016	11	5							e0154697	10.1371/journal.pone.0154697	http://dx.doi.org/10.1371/journal.pone.0154697			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DL5KK	27140199	Green Published, gold, Green Submitted			2022-12-26	WOS:000375675700057
J	Kerner, GSMA; Koole, MJB; Bongaerts, AHH; Pruim, J; Groen, HJM				Kerner, Gerald S. M. A.; Koole, Michel J. B.; Bongaerts, Alphons H. H.; Pruim, Jan; Groen, Harry J. M.		CTMM Air Force Consortium	Total Body Metabolic Tumor Response in ALK Positive Non-Small Cell Lung Cancer Patients Treated with ALK Inhibition	PLOS ONE			English	Article							POSITRON-EMISSION-TOMOGRAPHY; FUSION ONCOGENE; FDG-PET; ADENOCARCINOMA; CRIZOTINIB; EML4-ALK; RECOMMENDATIONS	Background In ALK-positive advanced NSCLC, crizotinib has a high response rate and effectively increases quality of life and survival. CT measurement of the tumor may insufficiently reflect the actual tumor load changes during targeted therapy with crizotinib. We explored whether F-18-FDG PET measured metabolic changes are different from CT based changes and studied the impact of these changes on disease progression. Methods F-18-FDG PET/CT was performed prior to and after 6 weeks of crizotinib treatment. Tumor response on CT was classified with RECIST 1.1, while F-18-FDG PET response was assessed according to the 1999 EORTC recommendations and PERCIST criteria. Agreement was assessed using McNemars test. During follow-up, patients received additional PET/CT during crizotinib treatment and second generation ALK inhibition. We assessed whether PET was able to detect progression earlier then CT. Results In this exploratory study 15 patients were analyzed who were treated with crizotinib. There was a good agreement in the applicability of CT and F-18-FDG PET/CT using the EORTC recommendations. During first line crizotinib and subsequent second line ALK inhibitors, PET was able to detect progression earlier then CT in 10/22 (45%) events of progression and in the others disease progression was detected simultaneously. Conclusion In advanced ALK positive NSCLC PET was able to detect progressive disease earlier than with CT in nearly half of the assessments while both imaging tests performed similar in the others.	[Kerner, Gerald S. M. A.; Groen, Harry J. M.] Univ Groningen, Univ Med Ctr Groningen, Dept Pulm Dis, NL-9713 AV Groningen, Netherlands; [Koole, Michel J. B.; Bongaerts, Alphons H. H.; Pruim, Jan] Univ Groningen, Univ Med Ctr Groningen, Dept Nucl Med & Mol Imaging, NL-9713 AV Groningen, Netherlands; [Pruim, Jan] Univ Stellenbosch, Dept Nucl Med, Tygerberg Hosp, ZA-7600 Stellenbosch, South Africa	University of Groningen; University of Groningen; Stellenbosch University; Tygerberg Hospital	Kerner, GSMA (corresponding author), Univ Groningen, Univ Med Ctr Groningen, Dept Pulm Dis, NL-9713 AV Groningen, Netherlands.	g.s.m.a.kerner@umcg.nl	Groen, Harry/AAP-2242-2021; van Herk, Marcel/P-6307-2015	Kerner, Gerald/0000-0003-3386-6831; Boellaard, Ronald/0000-0002-0313-5686; Koole, Michel/0000-0001-5862-640X; van Herk, Marcel/0000-0001-6448-898X	CTMM, the Center for Translational Molecular Medicine, project AIRFORCE [030103]; CTMM	CTMM, the Center for Translational Molecular Medicine, project AIRFORCE; CTMM	This research was performed within the framework of CTMM, the Center for Translational Molecular Medicine, project AIRFORCE (grant 030103) (http://www.ctmm.nl). CTMM paid for GK's salary and had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript. No other external funding sources for this study.	Boellaard R, 2010, EUR J NUCL MED MOL I, V37, P181, DOI 10.1007/s00259-009-1297-4; Boellaard R, 2008, EUR J NUCL MED MOL I, V35, P2320, DOI 10.1007/s00259-008-0874-2; Cheebsumon P, 2012, EJNMMI RES, V2, DOI 10.1186/2191-219X-2-56; Chen Z, 2010, CANCER RES, V70, P9827, DOI 10.1158/0008-5472.CAN-10-1671; Choi H, 2013, LUNG CANCER, V79, P242, DOI 10.1016/j.lungcan.2012.11.021; de Groot EH, 2013, EJNMMI RES, V3, DOI 10.1186/2191-219X-3-63; Eisenhauer EA, 2009, EUR J CANCER, V45, P228, DOI 10.1016/j.ejca.2008.10.026; Gadgeel SM, 2014, LANCET ONCOL, V15, P1119, DOI 10.1016/S1470-2045(14)70362-6; Katayama R, 2011, P NATL ACAD SCI USA, V108, P7535, DOI 10.1073/pnas.1019559108; Kobe C, 2012, EUR J NUCL MED MOL I, V39, P1117, DOI 10.1007/s00259-012-2118-8; Kwak EL, 2010, NEW ENGL J MED, V363, P1693, DOI 10.1056/NEJMoa1006448; Shaw AT, 2014, NEW ENGL J MED, V370, P2537, DOI 10.1056/NEJMc1404894; Shaw AT, 2013, NEW ENGL J MED, V368, P2385, DOI 10.1056/NEJMoa1214886; Sunaga N, 2008, LUNG CANCER, V59, P203, DOI 10.1016/j.lungcan.2007.08.012; Thunnissen E, 2012, VIRCHOWS ARCH, V461, P245, DOI 10.1007/s00428-012-1281-4; Tiseo M, 2014, CANCER CHEMOTH PHARM, V73, P299, DOI 10.1007/s00280-013-2356-x; Travis WD, 2011, J THORAC ONCOL, V6, P244, DOI 10.1097/JTO.0b013e318206a221; Treglia G, 2012, CLIN IMAG, V36, P167, DOI 10.1016/j.clinimag.2011.08.012; van Gool MH, 2014, ANN SURG ONCOL, V21, P2831, DOI 10.1245/s10434-014-3791-6; Wahl RL, 2009, J NUCL MED, V50, p122S, DOI 10.2967/jnumed.108.057307; Young H, 1999, EUR J CANCER, V35, P1773, DOI 10.1016/S0959-8049(99)00229-4	21	9	9	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 3	2016	11	5							e0149955	10.1371/journal.pone.0149955	http://dx.doi.org/10.1371/journal.pone.0149955			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DL5KK	27137772	Green Published, gold, Green Submitted			2022-12-26	WOS:000375675700002
J	Muller-Edenborn, B; Kania, G; Osto, E; Jakob, P; Krasniqi, N; Beck-Schimmer, B; Blyszczuk, P; Eriksson, U				Mueller-Edenborn, Bjoern; Kania, Gabriela; Osto, Elena; Jakob, Philipp; Krasniqi, Nazmi; Beck-Schimmer, Beatrice; Blyszczuk, Przemyslaw; Eriksson, Urs			Lidocaine Enhances Contractile Function of Ischemic Myocardial Regions in Mouse Model of Sustained Myocardial Ischemia	PLOS ONE			English	Article							PERFUSED RAT-HEART; WALL-MOTION; RANOLAZINE; INFARCTION; RABBIT; REPERFUSION; DYSFUNCTION; INJURY; PROTECTS; FAILURE	Rationale Perioperative myocardial ischemia is common in high-risk patients. The use of interventional revascularisation or even thrombolysis is limited in this patient subset due to exceedingly high bleeding risks. Blockade of voltage-gated sodium channels (VGSC) with lidocaine had been suggested to reduce infarct size and cardiomyocyte cell death in ischemia/reperfusion models. However, the impact of lidocaine on cardiac function during sustained ischemia still remains unclear. Methods Sustained myocardial ischemia was induced by ligation of the left anterior descending artery in 12-16 weeks old male BALB/c mice. Subcutaneous lidocaine (30 mg/kg) was used to block VGSC. Cardiac function was quantified at baseline and at 72h by conventional and speckle-tracking based echocardiography to allow high-sensitivity in vivo phenotyping. Infarct size and cardiomyocyte cell death were assessed post mortem histologically and indirectly using troponin measurements. Results Ischemia strongly impaired both, global systolic and diastolic function, which were partially rescued in lidocaine treated in mice. No differences regarding infarct size and cardiomyocyte cell death were observed. Mechanistically, and as shown with speckle-tracking analysis, lidocaine specifically improves residual contractility in the ischemic but not in the remote, non-ischemic myocardium. Conclusion VGSC blockade with lidocaine rescues function of ischemic myocardium as a potential bridging to revascularisation in the setting of perioperative myocardial ischemia.	[Mueller-Edenborn, Bjoern; Blyszczuk, Przemyslaw; Eriksson, Urs] Univ Zurich, Ctr Mol Cardiol, Cardioimmunol, Wagistr 12, CH-8952 Schlieren, Switzerland; [Kania, Gabriela] Univ Zurich Hosp, Div Rheumatol, Res Syst Autoimmune Dis, Wagistr 14, CH-8952 Schlieren, Switzerland; [Osto, Elena; Jakob, Philipp] Univ Zurich, Ctr Mol Cardiol, Wagistr 12, CH-8952 Schlieren, Switzerland; [Osto, Elena] Eidgenoss TH Zurich, Lab Translat Nutr Biol, Schorenstr 16, CH-8603 Schwerzenbach, Switzerland; [Mueller-Edenborn, Bjoern; Beck-Schimmer, Beatrice] Univ Zurich, Inst Physiol, Winterthurerstr 190, CH-8057 Zurich, Switzerland; [Krasniqi, Nazmi; Eriksson, Urs] GZO Zurich Reg Hlth Ctr, Dept Med, Spitalstr 66, CH-8620 Wetzikon, Switzerland; [Jakob, Philipp; Krasniqi, Nazmi; Eriksson, Urs] Univ Zurich Hosp, Univ Heart Ctr, Dept Cardiol, Raemistr 100, CH-8001 Zurich, Switzerland; [Beck-Schimmer, Beatrice] Univ Zurich Hosp, Univ Heart Ctr, Inst Anesthesiol, Raemistr 100, CH-8001 Zurich, Switzerland	University of Zurich; University Zurich Hospital; University of Zurich; University of Zurich; University Zurich Hospital; University of Zurich; University Zurich Hospital	Eriksson, U (corresponding author), Univ Zurich, Ctr Mol Cardiol, Cardioimmunol, Wagistr 12, CH-8952 Schlieren, Switzerland.; Eriksson, U (corresponding author), GZO Zurich Reg Hlth Ctr, Dept Med, Spitalstr 66, CH-8620 Wetzikon, Switzerland.; Eriksson, U (corresponding author), Univ Zurich Hosp, Univ Heart Ctr, Dept Cardiol, Raemistr 100, CH-8001 Zurich, Switzerland.	urs.eriksson@gzo.ch	Kania, Gabriela/E-8715-2017; Müller-Edenborn, Björn/AAX-4691-2020; Blyszczuk, Przemyslaw/J-2153-2019	Kania, Gabriela/0000-0003-3788-4594; Müller-Edenborn, Björn/0000-0002-8436-3591; Blyszczuk, Przemyslaw/0000-0003-2521-3232; Eriksson, Urs/0000-0003-1217-9696; Jakob, Philipp/0000-0002-2443-6090	Swiss Heart Foundation [75 000 CHF]	Swiss Heart Foundation	UE and BME received a grant from the Swiss Heart Foundation (75 000 CHF) for this project. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Badner NH, 1998, ANESTHESIOLOGY, V88, P572, DOI 10.1097/00000542-199803000-00005; Bauer M, 2011, CIRC RES, V108, P908, DOI 10.1161/CIRCRESAHA.110.239574; Dumont EAWJ, 2000, CIRCULATION, V102, P1564, DOI 10.1161/01.CIR.102.13.1564; Fearon IM, 2004, BIOCHEM BIOPH RES CO, V324, P1289, DOI 10.1016/j.bbrc.2004.09.188; Gao S, 2011, ECHOCARDIOGRAPHY MIC; GOTTLIEB RA, 1994, J CLIN INVEST, V94, P1621, DOI 10.1172/JCI117504; GRALINSKI MR, 1994, CARDIOVASC RES, V28, P1231, DOI 10.1093/cvr/28.8.1231; HAIGNEY MCP, 1994, CIRCULATION, V90, P391, DOI 10.1161/01.CIR.90.1.391; Hwang MW, 2001, J AM COLL CARDIOL, V38, P1546, DOI 10.1016/S0735-1097(01)01591-1; Imanishi Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069302; Iwai T, 2002, J MOL CELL CARDIOL, V34, P725, DOI 10.1006/jmcc.2002.2002; Jakob P, 2012, CIRCULATION, V126, P2962, DOI 10.1161/CIRCULATIONAHA.112.093906; Kaczmarek DJ, 2009, ANESTHESIOLOGY, V110, P1041, DOI 10.1097/ALN.0b013e31819dabda; Kariya N, 2012, EUR J PHARMACOL, V691, P110, DOI 10.1016/j.ejphar.2012.05.034; Kersten JR, 1997, ANESTHESIOLOGY, V87, P361, DOI 10.1097/00000542-199708000-00024; Lee EH, 2011, BRIT J ANAESTH, V106, P487, DOI 10.1093/bja/aeq416; Li YJ, 2013, J MOL CELL CARDIOL, V62, P227, DOI 10.1016/j.yjmcc.2013.06.007; Maruyama K, 2000, J PHARM PHARMACOL, V52, P709, DOI 10.1211/0022357001774381; Matsumura H, 1998, JPN J PHARMACOL, V77, P31, DOI 10.1254/jjp.77.31; Pogwizd SM, 2003, CARDIOVASC RES, V57, P887, DOI 10.1016/S0008-6363(02)00735-6; Pu Q, 1996, BRIT J PHARMACOL, V118, P1072, DOI 10.1111/j.1476-5381.1996.tb15508.x; Schwarzwald CC, 2009, J VET INTERN MED, V23, P643, DOI 10.1111/j.1939-1676.2009.0287.x; SILVERMAN HS, 1994, CARDIOVASC RES, V28, P581, DOI 10.1093/cvr/28.5.581; Soliman D, 2012, J PHARMACOL EXP THER, V343, P325, DOI 10.1124/jpet.112.196949; Unsold B, 2014, CARDIOVASC RES, V101, P97, DOI 10.1093/cvr/cvt235; Xiao XH, 1999, CIRC RES, V85, P723, DOI 10.1161/01.RES.85.8.723; Zhang Y, 2007, AM J PHYSIOL-HEART C, V292, pH1187, DOI 10.1152/ajpheart.00895.2006	27	4	5	2	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 3	2016	11	5							e0154699	10.1371/journal.pone.0154699	http://dx.doi.org/10.1371/journal.pone.0154699			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DL5KK	27140425	Green Accepted, gold, Green Submitted, Green Published			2022-12-26	WOS:000375675700058
J	Perez-Bosque, A; Miro, L; Maijo, M; Polo, J; Campbell, JM; Russell, L; Crenshaw, JD; Weaver, E; Moreto, M				Perez-Bosque, Anna; Miro, Lluisa; Maijo, Monica; Polo, Javier; Campbell, Joy M.; Russell, Louis; Crenshaw, Joe D.; Weaver, Eric; Moreto, Miquel			Oral Serum-Derived Bovine Immunoglobulin/Protein Isolate Has Immunomodulatory Effects on the Colon of Mice that Spontaneously Develop Colitis	PLOS ONE			English	Article							INFLAMMATORY-BOWEL-DISEASE; AUREUS ENTEROTOXIN-B; MOUSE MODEL; INTESTINAL INFLAMMATION; MDR1A(-/-) MICE; IMMUNE-RESPONSE; GENE-EXPRESSION; T-CELL; CHEMOKINE RECEPTORS; ULCERATIVE-COLITIS	Dietary immunoglobulin concentrates prepared from animal plasma can modulate the immune response of gut-associated lymphoid tissue (GALT). Previous studies have revealed that supplementation with serum-derived bovine immunoglobulin/protein isolate (SBI) ameliorates colonic barrier alterations in the mdr1a-/- genetic mouse model of IBD. Here, we examine the effects of SBI on mucosal inflammation in mdr1a-/- mice that spontaneously develop colitis. Wild type (WT) mice and mice lacking the mdr1a gene (KO) were fed diets supplemented with either SBI (2% w/w) or milk proteins (Control diet), from day 21 (weaning) until day 56. Leucocytes in mesenteric lymph nodes (MLN) and in lamina propria were determined, as was mucosal cytokine production. Neutrophil recruitment and activation in MLN and lamina propria of KO mice were increased, but were significantly reduced in both by SBI supplementation (p < 0.05). The increased neutrophil recruitment and activation observed in KO mice correlated with increased colon oxidative stress (p < 0.05) and SBI supplementation reduced this variable (p < 0.05). The Tact/Treg lymphocyte ratios in MLN and lamina propria were also increased in KO animals, but SBI prevented these changes (both p < 0.05). In the colon of KO mice, there was an increased production of mucosal proinflammatory cytokines such as IL-2 (2-fold), IL-6 (26-fold) and IL-17 (19-fold), and of chemokines MIP-1 beta (4.5-fold) and MCP-1 (7.2-fold). These effects were significantly prevented by SBI (p < 0.05). SBI also significantly increased TGF-beta secretion in the colon mucosa, suggesting a role of this anti-inflammatory cytokine in the modulation of GALT and the reduction of the severity of the inflammatory response during the onset of colitis.	[Perez-Bosque, Anna; Miro, Lluisa; Maijo, Monica; Moreto, Miquel] Univ Barcelona, Fac Farm & Ciencies Alimentacio, Dept Bioquim & Fisiol, Barcelona, Spain; [Perez-Bosque, Anna; Miro, Lluisa; Maijo, Monica; Moreto, Miquel] Univ Barcelona, Inst Nutr & Seguretat Alimentaria, Barcelona, Spain; [Polo, Javier] APC Europe SA, Granollers, Spain; [Campbell, Joy M.; Russell, Louis; Crenshaw, Joe D.] APC Inc, Ankeny, IA USA; [Weaver, Eric] EnteraHealth, Cary, NC USA	University of Barcelona; University of Barcelona	Perez-Bosque, A (corresponding author), Univ Barcelona, Fac Farm & Ciencies Alimentacio, Dept Bioquim & Fisiol, Barcelona, Spain.; Perez-Bosque, A (corresponding author), Univ Barcelona, Inst Nutr & Seguretat Alimentaria, Barcelona, Spain.	anna.perez@ub.edu	Perez-Bosque, Anna/R-6383-2019	Perez-Bosque, Anna/0000-0003-2175-9684	Spanish Ministry of Science and Innovation [TRA2009-0317]; CIDEM (Government of Catalonia, Spain) [RDITCRD07-1-0008]; Entera Health Inc.; APC Europe S.A.; APC Inc.	Spanish Ministry of Science and Innovation(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); CIDEM (Government of Catalonia, Spain); Entera Health Inc.; APC Europe S.A.; APC Inc.	All experimental animals, reagents and analyses were funded by grant TRA2009-0317 from the Spanish Ministry of Science and Innovation; http://www.idi.mineco.gob.es/portal/site/MICINN/ (M. Moreto), and by grant RDITCRD07-1-0008 from CIDEM (Government of Catalonia, Spain); http://accio.gencat.cat/cat/ (JP). Entera Health Inc., APC Europe S.A. and APC Inc. also partially funded this study. The funders provided support in the form of salaries for authors JP, JMC, LR, JDC and EW, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the author contributions section.	Ajuebor MN, 2004, EUR J PHARMACOL, V497, P343, DOI 10.1016/j.ejphar.2004.07.005; Andres PG, 2000, J IMMUNOL, V164, P6303, DOI 10.4049/jimmunol.164.12.6303; Annese V, 2006, WORLD J GASTROENTERO, V12, P3636, DOI 10.3748/wjg.v12.i23.3636; Atreya R, 2008, MUCOSAL IMMUNOL, V1, P175, DOI 10.1038/mi.2008.7; Banks C, 2003, J PATHOL, V199, P28, DOI 10.1002/path.1245; Banner KH, 2004, BRIT J PHARMACOL, V143, P590, DOI 10.1038/sj.bjp.0705982; Bassaganya-Riera J, 2004, GASTROENTEROLOGY, V127, P777, DOI 10.1053/j.gastro.2004.06.049; Bateman E, 2016, SUPPORT CARE CANCER, V24, P377, DOI 10.1007/s00520-015-2806-6; Baumgart DC, 2007, LANCET, V369, P1627, DOI 10.1016/S0140-6736(07)60750-8; Bernstein CN, 2014, NESTLE NUTR WORKS SE, V79, P83, DOI 10.1159/000360713; Bodammer P, 2011, J NUTR, V141, P1056, DOI 10.3945/jn.110.128702; Calder PC, 2015, BBA-MOL CELL BIOL L, V1851, P469, DOI 10.1016/j.bbalip.2014.08.010; Charo IF, 2006, NEW ENGL J MED, V354, P610, DOI 10.1056/NEJMra052723; Danese S, 2012, GUT, V61, P918, DOI 10.1136/gutjnl-2011-300904; Dinarello CA, 2009, BIOL BLOOD MARROW TR, V15, P134, DOI 10.1016/j.bbmt.2008.11.006; Dommels YEM, 2007, GENES NUTR, V2, P209, DOI 10.1007/s12263-007-0051-4; Eastaff-Leung N, 2010, J CLIN IMMUNOL, V30, P80, DOI 10.1007/s10875-009-9345-1; Fiocchi C, 2012, CURR OPIN GASTROEN, V28, P297, DOI 10.1097/MOG.0b013e328354d81c; Fuss IJ, 1996, J IMMUNOL, V157, P1261; Geremia A, 2014, AUTOIMMUN REV, V13, P3, DOI 10.1016/j.autrev.2013.06.004; Good L, 2015, WORLD J GASTROENTERO, V21, P3361, DOI 10.3748/wjg.v21.i11.3361; Halmos EP, 2015, NAT REV GASTRO HEPAT, V12, P133, DOI 10.1038/nrgastro.2015.11; Henderson AL, 2015, DIGEST DIS SCI, V60, P3293, DOI 10.1007/s10620-015-3726-5; Izcue A, 2009, ANNU REV IMMUNOL, V27, P313, DOI 10.1146/annurev.immunol.021908.132657; Li L, 2013, MOL MED REP, V8, P1125, DOI 10.3892/mmr.2013.1632; Li MO, 2007, IMMUNITY, V26, P579, DOI 10.1016/j.immuni.2007.03.014; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lopez-Posadas R, 2010, J NUTR, V140, P2014, DOI 10.3945/jn.109.118448; Maijo M, 2012, BRIT J NUTR, V107, P867, DOI 10.1017/S0007114511003655; Maijo M, 2012, J NUTR, V142, P264, DOI 10.3945/jn.111.149070; Motomura Y, 2006, GUT, V55, P662, DOI 10.1136/gut.2005.068429; Nones K, 2009, BRIT J NUTR, V101, P169, DOI 10.1017/S0007114508009847; Panwala CM, 1998, J IMMUNOL, V161, P5733; Perez-Bosque A, 2004, J NUTR, V134, P2667, DOI 10.1093/jn/134.10.2667; Perez-Bosque A, 2006, J NUTR, V136, P2838, DOI 10.1093/jn/136.11.2838; Perez-Bosque A, 2015, AM J PHYSIOL-GASTR L, V308, pG1012, DOI 10.1152/ajpgi.00378.2014; Perez-Bosque A, 2010, P NUTR SOC, V69, P447, DOI 10.1017/S0029665110001849; Perez-Bosque A, 2010, J NUTR, V140, P25, DOI 10.3945/jn.109.112466; Petschow BW, 2015, DIGEST DIS SCI, V60, P13, DOI 10.1007/s10620-014-3322-0; Pithadia AB, 2011, PHARMACOL REP, V63, P629, DOI 10.1016/S1734-1140(11)70575-8; Ren GW, 2010, J IMMUNOL, V184, P2321, DOI 10.4049/jimmunol.0902023; Resta-Lenert S, 2005, AM J PHYSIOL-GASTR L, V289, pG153, DOI 10.1152/ajpgi.00395.2004; Rutgeerts P, 2009, GASTROENTEROLOGY, V136, P1182, DOI 10.1053/j.gastro.2009.02.001; Sivalingam N, 2008, ARCH TOXICOL, V82, P471, DOI 10.1007/s00204-007-0263-9; Strober W, 2007, J CLIN INVEST, V117, P514, DOI 10.1172/JCI30587; Sturm A, 2008, CURR DRUG TARGETS, V9, P381, DOI 10.2174/138945008784221198; Thomas Saskia, 2012, Inflammopharmacology, V20, P1, DOI 10.1007/s10787-011-0104-6; Wan YY, 2008, J CLIN IMMUNOL, V28, P647, DOI 10.1007/s10875-008-9251-y; Weigmann B, 2007, NAT PROTOC, V2, P2307, DOI 10.1038/nprot.2007.315	49	11	11	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 3	2016	11	5							e0154823	10.1371/journal.pone.0154823	http://dx.doi.org/10.1371/journal.pone.0154823			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DL5KK	27139220	Green Published, gold			2022-12-26	WOS:000375675700073
J	Wang, YL; Hu, B; Du, SP; Gao, S; Chen, XW; Chen, DF				Wang, Yanlong; Hu, Bin; Du, Shipeng; Gao, Shan; Chen, Xiwen; Chen, Defu			Proteomic Analyses Reveal the Mechanism of Dunaliella salina Ds-26-16 Gene Enhancing Salt Tolerance in Escherichia coli	PLOS ONE			English	Article							STRESS-RESPONSIVE PROTEINS; OUTER-MEMBRANE; HETEROLOGOUS EXPRESSION; NITRATE REDUCTASE; AMINO-ACID; SALINITY; HALOPHYTE; TRANSPORT; DROUGHT; GROWTH	We previously screened the novel gene Ds-26-16 from a 4 M salt-stressed Dunaliella salina cDNA library and discovered that this gene conferred salt tolerance to broad-spectrum organisms, including E. coli (Escherichia coli), Haematococcus pluvialis and tobacco. To determine the mechanism of this gene conferring salt tolerance, we studied the proteome of E. coli overexpressing the full-length cDNA of Ds-26-16 using the iTRAQ (isobaric tags for relative and absolute quantification) approach. A total of 1,610 proteins were identified, which comprised 39.4% of the whole proteome. Of the 559 differential proteins, 259 were up-regulated and 300 were down-regulated. GO (gene ontology) and KEGG (Kyoto encyclopedia of genes and genomes) enrichment analyses identified 202 major proteins, including those involved in amino acid and organic acid metabolism, energy metabolism, carbon metabolism, ROS (reactive oxygen species) scavenging, membrane proteins and ABC (ATP binding cassette) transporters, and peptidoglycan synthesis, as well as 5 up-regulated transcription factors. Our iTRAQ data suggest that Ds-26-16 up-regulates the transcription factors in E. coli to enhance salt resistance through osmotic balance, energy metabolism, and oxidative stress protection. Changes in the proteome were also observed in E. coli overexpressing the ORF (open reading frame) of Ds-26-16. Furthermore, pH, nitric oxide and glycerol content analyses indicated that Ds-26-16 overexpression increases nitric oxide content but has no effect on glycerol content, thus confirming that enhanced nitric oxide synthesis via lower intercellular pH was one of the mechanisms by which Ds-26-16 confers salt tolerance to E. coli.	[Wang, Yanlong; Hu, Bin; Du, Shipeng; Chen, Defu] Nankai Univ, Coll Life Sci, Dept Genet & Cell Biol, Tianjin 300071, Peoples R China; [Chen, Xiwen] Nankai Univ, Coll Life Sci, Dept Biochem & Mol Biol, Tianjin 300071, Peoples R China; [Gao, Shan] Nankai Univ, Coll Life Sci, Dept Zool & Dev Biol, Tianjin 300071, Peoples R China	Nankai University; Nankai University; Nankai University	Chen, DF (corresponding author), Nankai Univ, Coll Life Sci, Dept Genet & Cell Biol, Tianjin 300071, Peoples R China.; Chen, XW (corresponding author), Nankai Univ, Coll Life Sci, Dept Biochem & Mol Biol, Tianjin 300071, Peoples R China.	xiwenchen@nankai.edu.cn; chendefu@nankai.edu.cn		wang, yanlong/0000-0001-8464-2681	National Natural Science Foundation of China [31570769]; Natural Science Foundation of Tianjin [14JCZDJC34100, 12JCZDJC22900]; 111 Project [B08011]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Tianjin(Natural Science Foundation of Tianjin); 111 Project(Ministry of Education, China - 111 Project)	This work was supported by the grant of the National Natural Science Foundation of China (no. 31570769), the Key Program of the Natural Science Foundation of Tianjin (no. 14JCZDJC34100, 12JCZDJC22900) and the 111 Project (no. B08011). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adnan M, 2010, MOL CELL BIOCHEM, V342, P207, DOI 10.1007/s11010-010-0485-7; BATISTA S, 1992, CAN J MICROBIOL, V38, P51, DOI 10.1139/m92-008; BELMANS D, 1987, PLANT CELL ENVIRON, V10, P185, DOI 10.1111/1365-3040.ep11602142; BENAMOTZ A, 1982, EXPERIENTIA, V38, P49, DOI 10.1007/BF01944527; BONGAERTS J, 1995, MOL MICROBIOL, V16, P521, DOI 10.1111/j.1365-2958.1995.tb02416.x; Cai M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062287; Chen Y, 2015, PLANT PHYSIOL BIOCH, V91, P49, DOI 10.1016/j.plaphy.2015.04.004; Corker H, 2003, J BIOL CHEM, V278, P31584, DOI 10.1074/jbc.M303282200; D'Ascenzo Mark, 2008, Briefings in Functional Genomics & Proteomics, V7, P127, DOI 10.1093/bfgp/eln007; Dressaire C, 2015, MBIO, V6, DOI [10. 1128/ mBio. 02352- 14, DOI 10.1128/MBI0.02352-14]; Fardini Y, 2009, MICROBIOL-SGM, V155, P1613, DOI 10.1099/mic.0.025155-0; Freire P, 2006, FEMS MICROBIOL LETT, V260, P106, DOI 10.1111/j.1574-6968.2006.00307.x; Gong WF, 2014, PLANT CELL TISS ORG, V117, P113, DOI 10.1007/s11240-014-0425-4; Graumann P, 1996, J BACTERIOL, V178, P4611, DOI 10.1128/jb.178.15.4611-4619.1996; Guo LQ, 2010, J AGRON CROP SCI, V196, P123, DOI 10.1111/j.1439-037X.2009.00397.x; Hartzendorf T, 2001, AQUAT BOT, V69, P195, DOI 10.1016/S0304-3770(01)00138-3; HAYASHI S, 1964, J BIOL CHEM, V239, P3098; He QH, 2007, J PLANT PHYSIOL, V164, P214, DOI 10.1016/j.jplph.2006.04.004; Hirakawa H, 2005, MOL MICROBIOL, V55, P1113, DOI 10.1111/j.1365-2958.2004.04449.x; Hondorp ER, 2004, PLOS BIOL, V2, P1738, DOI 10.1371/journal.pbio.0020336; Jacoby RP, 2013, J PROTEOME RES, V12, P4807, DOI 10.1021/pr400504a; KAUFMAN RJ, 1983, MOL CELL BIOL, V3, P1598, DOI 10.1128/MCB.3.9.1598; Kim SH, 2006, BIOTECHNOL BIOPROC E, V11, P32, DOI 10.1007/BF02931865; KNYPL JS, 1975, Z PFLANZENPHYSIOL, V74, P434, DOI 10.1016/S0044-328X(75)80153-X; Kovacs Z, 2012, SCI WORLD J, DOI 10.1100/2012/216521; Li HY, 2015, J PROTEOMICS, V127, P18, DOI 10.1016/j.jprot.2015.03.025; Liu LC, 2015, J IND MICROBIOL BIOT, V42, P601, DOI 10.1007/s10295-014-1579-0; Liu ST, 2014, PLANT CELL, V26, P164, DOI 10.1105/tpc.113.118687; Miyahara K, 1996, FEBS LETT, V399, P317, DOI 10.1016/S0014-5793(96)01353-1; Munns R, 2008, ANNU REV PLANT BIOL, V59, P651, DOI 10.1146/annurev.arplant.59.032607.092911; NIKAIDO H, 1983, J BACTERIOL, V153, P241, DOI 10.1128/JB.153.1.241-252.1983; Nikaido H, 2003, MICROBIOL MOL BIOL R, V67, P593, DOI 10.1128/MMBR.67.4.593-656.2003; Pan J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004422; Parida AK, 2005, ECOTOX ENVIRON SAFE, V60, P324, DOI 10.1016/j.ecoenv.2004.06.010; Paul S, 2015, PLANT SCI, V234, P133, DOI 10.1016/j.plantsci.2015.02.006; Perez-Rueda E, 2010, MOL BIOL EVOL, V27, P1449, DOI 10.1093/molbev/msq033; Piubelli L, 2013, MICROB CELL FACT, V12, DOI 10.1186/1475-2859-12-115; SADKA A, 1991, PLANT PHYSIOL, V95, P822, DOI 10.1104/pp.95.3.822; Saurin W, 1999, J MOL EVOL, V48, P22, DOI 10.1007/PL00006442; Shabala L, 2009, ENVIRON MICROBIOL, V11, P137, DOI 10.1111/j.1462-2920.2008.01748.x; Shalel-Levanon S, 2005, METAB ENG, V7, P364, DOI 10.1016/j.ymben.2005.07.001; Sheng M, 2011, MYCORRHIZA, V21, P423, DOI 10.1007/s00572-010-0353-z; Sperandeo P, 2007, J BACTERIOL, V189, P244, DOI 10.1128/JB.01126-06; Sperandio B, 2010, J BACTERIOL, V192, P3464, DOI 10.1128/JB.00119-10; Udawat P, 2014, GENE, V536, P163, DOI 10.1016/j.gene.2013.11.020; Wang HB, 2014, PLOS ONE, V9, DOI [10.1371/journal.pone.0113880, 10.1371/journal.pone.0089155, 10.1371/journal.pone.0091730]; Wang WX, 2003, PLANTA, V218, P1, DOI 10.1007/s00425-003-1105-5; Weber A, 2006, J BACTERIOL, V188, P7165, DOI 10.1128/JB.00508-06; Woodruff LBA, 2013, METAB ENG, V15, P124, DOI 10.1016/j.ymben.2012.10.007; Wu WW, 2006, J PROTEOME RES, V5, P651, DOI 10.1021/pr050405o; Xu JW, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0120978; Yan SP, 2005, PROTEOMICS, V5, P235, DOI 10.1002/pmic.200400853; Yang L, 2013, J PROTEOME RES, V12, P4931, DOI 10.1021/pr400177m; Yang XB, 2015, GENET MOL RES, V14, P11955, DOI 10.4238/2015.October.5.9; Yeo WS, 2006, MOL MICROBIOL, V61, P206, DOI 10.1111/j.1365-2958.2006.05220.x; Zhang YY, 2006, PLANTA, V224, P545, DOI 10.1007/s00425-006-0242-z; Zhang YY, 2008, J INTEGR PLANT BIOL, V50, P1327, DOI 10.1111/j.1744-7909.2008.00740.x; Zhao LN, 2013, PHYCOL RES, V61, P37, DOI 10.1111/j.1440-1835.2012.00669.x; Zhou ZF, 2011, MOL BIOSYST, V7, P1613, DOI 10.1039/c0mb00336k	59	10	10	0	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 2	2016	11	5							e0153640	10.1371/journal.pone.0153640	http://dx.doi.org/10.1371/journal.pone.0153640			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DL5KB	27135411	Green Published, Green Submitted, gold			2022-12-26	WOS:000375674800005
J	Zekri, ARN; Youssef, ASE; Lotfy, MM; Gabr, R; Ahmed, OS; Nassar, A; Hussein, N; Omran, D; Medhat, E; Eid, S; Hussein, MM; Ismail, MY; Alenzi, FQ; Bahnassy, AA				Zekri, Abdel-Rahman N.; Youssef, Amira Salah El-Din; Lotfy, Mai M.; Gabr, Reham; Ahmed, Ola S.; Nassar, Auhood; Hussein, Nehal; Omran, Dalia; Medhat, Eman; Eid, Salam; Hussein, Marwa Mahmoud; Ismail, Maha Yahia; Alenzi, Faris Q.; Bahnassy, Abeer A.			Circulating Serum miRNAs as Diagnostic Markers for Colorectal Cancer	PLOS ONE			English	Article							MICRORNAS; EXPRESSION; TUMOR; GENE; METASTASIS; BIOMARKERS; CLUSTER; FAMILY	Aim The study was designed to assess the possibility of using circulating miRNAs (serum miR-NAs) as diagnostic biomarkers in colorectal cancer (CRC) and to identify their possibility as candidates for targeted therapy. Methods The study involved two sample sets: 1-a training set which included 90 patients with colorectal related disease (30 with CRC, 18 with inflammatory bowel disease (IBD), 18 with colonic polyps (CP) and 24 with different colonic symptoms but without any colonoscopic abnormality who were enrolled as control group) and 2-a validation set which included 100 CRC patients. Serum miRNAs were extracted from all subjects to assess the expression profiles for the following miRNAs (miR-17, miR-18a, miR-19a, miR-19b, miR-20a, miR-21, miR-146a, miR-223, miR-24, miR-454, miR-183, miR-135a, miR-135b and miR-92a) using the custom miScript miRNA PCR-based sybergreen array. The area under the receiver operating characteristic curve (AUC) was used to evaluate the diagnostic performance of the studied miRNAs for colorectal cancer diagnosis. Results Data analysis of miRNA from the training set showed that; compared to control group, only miR-19b was significantly up-regulated in patients with IBD group (fold change = 5.24, p = 0.016), whereas in patients with colonic polyps, miR-18a was significantly up-regulated (fold change = 3.49, p-value = 0.018). On the other hand, miR-17, miR-19a, miR-20a and miR-223 were significantly up-regulated (fold change = 2.35, 3.07, 2.38 and 10.35; respectively and p-value = 0.02, 0.015, 0.017 and 0.016; respectively in CRC patients. However, the validation set showed that only miR-223 was significantly up-regulated in CRC patients (fold change = 4.06, p-value = 0.04). Conclusion Aberrant miRNA expressions are highly involved in the cascade of colorectal carcinogenesis. We have found that (miR-17, miR-19a, miR-20a and miR-223) could be used as diagnostic biomarkers for CRC. On the other hand, miR-19b and miR-18a could be used as diagnostic biomarkers for CP and IBD respectively.	[Zekri, Abdel-Rahman N.; Youssef, Amira Salah El-Din; Lotfy, Mai M.; Gabr, Reham; Ahmed, Ola S.; Nassar, Auhood; Hussein, Nehal] Cairo Univ, Natl Canc Inst, Dept Canc Biol, Mol Virol & Immunol Unit, Cairo, Egypt; [Omran, Dalia; Medhat, Eman] Cairo Univ, Kasr El Aini Hosp, Dept Trop Med, Fac Med, Cairo, Egypt; [Eid, Salam; Hussein, Marwa Mahmoud; Ismail, Maha Yahia] Cairo Univ, Natl Canc Inst, Dept Med Oncol, Cairo, Egypt; [Alenzi, Faris Q.] King Saud Univ, Coll Appl Med Sci, Dept Clin Lab Sci, Alkharaj, Saudi Arabia; [Bahnassy, Abeer A.] Cairo Univ, Natl Canc Inst, Dept Pathol, Cairo, Egypt	Egyptian Knowledge Bank (EKB); Cairo University; National Cancer Institute - Egypt; Egyptian Knowledge Bank (EKB); Cairo University; Egyptian Knowledge Bank (EKB); Cairo University; National Cancer Institute - Egypt; King Saud University; Egyptian Knowledge Bank (EKB); Cairo University; National Cancer Institute - Egypt	Zekri, ARN (corresponding author), Cairo Univ, Natl Canc Inst, Dept Canc Biol, Mol Virol & Immunol Unit, Cairo, Egypt.	ncizekri@yahoo.com	Lotfy, Mai/U-3152-2019; Hussein, Marwa Mahmoud/I-4842-2019; Zekri, Abdel-Rahman N/A-3768-2008	Lotfy, Mai/0000-0001-8282-8773; Zekri, Abdel-Rahman/0000-0003-3939-0416; Nassar, Auhood/0000-0002-5704-9281; Eid Salem, Salem/0000-0002-6204-5031; Youssef, Amira/0000-0003-3091-691X; Omran, Dalia/0000-0002-5513-6955				Anderson EC, 2010, GASTROENTEROLOGY, V139, P718, DOI 10.1053/j.gastro.2010.07.012; Arndt GM, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-374; Banin S, 1998, SCIENCE, V281, P1674, DOI 10.1126/science.281.5383.1674; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Calin GA, 2004, P NATL ACAD SCI USA, V101, P2999, DOI 10.1073/pnas.0307323101; Gereda JE, 2000, LANCET, V355, P1680, DOI 10.1016/S0140-6736(00)02239-X; Gilad S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003148; Huang ZH, 2010, INT J CANCER, V127, P118, DOI 10.1002/ijc.25007; Ivanovska I, 2008, MOL CELL BIOL, V28, P2167, DOI 10.1128/MCB.01977-07; Jemal A, 2011, CA-CANCER J CLIN, V61, P133, DOI [10.3322/caac.20105, 10.3322/caac.20073]; Kalla R, 2015, GUT, V64, P504, DOI 10.1136/gutjnl-2014-307891; Koga Y, 2010, CANCER PREV RES, V3, P1435, DOI 10.1158/1940-6207.CAPR-10-0036; Lawrence Toby, 2009, Cold Spring Harb Perspect Biol, V1, pa001651, DOI 10.1101/cshperspect.a001651; Li ZW, 2014, MED ONCOL, V31, DOI 10.1007/s12032-014-0256-5; McLaughlin SK, 2013, CANCER CELL, V24, P365, DOI 10.1016/j.ccr.2013.08.004; Motoyama K, 2009, INT J ONCOL, V34, P1069, DOI 10.3892/ijo_00000233; Mu P, 2009, GENE DEV, V23, P2806, DOI 10.1101/gad.1872909; Myatt SS, 2007, NAT REV CANCER, V7, P847, DOI 10.1038/nrc2223; Nagel R, 2008, CANCER RES, V68, P5795, DOI 10.1158/0008-5472.CAN-08-0951; Nakae J, 2003, DEV CELL, V4, P119, DOI 10.1016/S1534-5807(02)00401-X; O'Connell JB, 2004, JNCI-J NATL CANCER I, V96, P1420, DOI 10.1093/jnci/djh275; Peacock O, 2012, WORLD J SURG, V36, P1881, DOI 10.1007/s00268-012-1603-3; Schee K, 2010, AM J PATHOL, V177, P1592, DOI 10.2353/ajpath.2010.100024; Siegel R, 2012, CA-CANCER J CLIN, V62, P10, DOI 10.3322/caac.20138; Sun D, 2015, BRIT J CANCER, V112, P1491, DOI 10.1038/bjc.2015.107; Volinia S, 2006, P NATL ACAD SCI USA, V103, P2257, DOI 10.1073/pnas.0510565103; Wang YX, 2010, J DIGEST DIS, V11, P50, DOI 10.1111/j.1751-2980.2009.00413.x; Woods K, 2007, J BIOL CHEM, V282, P2130, DOI 10.1074/jbc.C600252200; Wu CW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057036; Wu LH, 2012, FEBS LETT, V586, P1038, DOI 10.1016/j.febslet.2012.02.050; Xu T, 2015, EXP THER MED, V10, P683, DOI 10.3892/etm.2015.2538; Zisman TL, 2008, WORLD J GASTROENTERO, V14, P2662, DOI 10.3748/wjg.14.2662	32	55	57	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 2	2016	11	5							e0154130	10.1371/journal.pone.0154130	http://dx.doi.org/10.1371/journal.pone.0154130			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DL5KB	27135244	Green Published, gold			2022-12-26	WOS:000375674800014
J	Hu, SR; Chen, MM; Wang, YL; Wang, ZT; Pei, YF; Fan, R; Liu, XQ; Wang, L; Zhou, J; Zheng, SC; Zhang, TY; Lin, Y; Zhang, MC; Tao, R; Zhong, J				Hu, Shurong; Chen, Mengmeng; Wang, Yilin; Wang, Zhengting; Pei, Yaofei; Fan, Rong; Liu, Xiqiang; Wang, Lei; Zhou, Jie; Zheng, Sichang; Zhang, Tianyu; Lin, Yun; Zhang, Maochen; Tao, Ran; Zhong, Jie			mTOR Inhibition Attenuates Dextran Sulfate Sodium-Induced Colitis by Suppressing T Cell Proliferation and Balancing TH1/TH17/Treg Profile	PLOS ONE			English	Article							INFLAMMATORY-BOWEL-DISEASE; GM-CSF; CROHNS-DISEASE; IN-VIVO; B-CELLS; DENDRITIC CELLS; TH17 CELLS; INTESTINAL INFLAMMATION; ANTITUMOR-ACTIVITY; KINASE INHIBITOR	It has been established that mammalian target of Rapamycin (mTOR) inhibitors have anti-inflammatory effects in models of experimental colitis. However, the underlying mechanism is largely unknown. In this research, we investigate the anti-inflammatory effects of AZD8055, a potent mTOR inhibitor, on T cell response in dextran sulfate sodium (DSS)induced colitis in mice, a commonly used animal model of inflammatory bowel diseases (IBD). Severity of colitis is evaluated by changing of body weight, bloody stool, fecal consistency, histology evaluation and cytokine expression. We find that AZD8055 treatment attenuates DSS-induced body weight loss, colon length shortening and pathological damage of the colon. And AZD8055 treatment decreases colonic expression of genes encoding the pro-inflammatory cytokines interferon-., interleukin (IL)-17A, IL-1 beta, IL-6 and tumor necrosis factor(TNF)-a and increases colonic expression of anti-inflammatory cytokines IL-10. We show that AZD8055 treatment decreases the percentages of CD4+ T cells and CD8+ T cells in spleen, lymph nodes and peripheral blood of mice. We also find that AZD8055 treatment significantly reduces the number of T helper 1(TH1) cells and TH17 cells and increases regulatory T (Treg) cells in the lamina propria and mesenteric lymph nodes. Furthermore, we demonstrates that AZD8055 suppresses the proliferation of CD4+ and CD8+ T cells and the differentiation of TH1/TH17 cells and expands Treg cells in vitro. The results suggest that, in experimental colitis, AZD8055 exerts anti-inflammatory effect by regulating T helper cell polarization and proliferation.	[Hu, Shurong; Chen, Mengmeng; Wang, Zhengting; Fan, Rong; Wang, Lei; Zhou, Jie; Zheng, Sichang; Zhang, Tianyu; Lin, Yun; Zhang, Maochen; Zhong, Jie] Shanghai Jiao Tong Univ, Sch Med, Ruijin Hosp, Dept Gastroenterol, Shanghai 200030, Peoples R China; [Wang, Yilin] Fudan Univ, Canc Hosp, Dept Surg, Shanghai 200433, Peoples R China; [Pei, Yaofei] Shanghai Jiao Tong Univ, Sch Med, Ruijin Hosp, Dept Surg, Shanghai 200030, Peoples R China; [Liu, Xiqiang; Tao, Ran] Zhejiang Prov Peoples Hosp, Dept Hepatobiliary Pancreat Surg, Hangzhou, Zhejiang, Peoples R China	Shanghai Jiao Tong University; Fudan University; Shanghai Jiao Tong University; Zhejiang Provincial People's Hospital	Zhong, J (corresponding author), Shanghai Jiao Tong Univ, Sch Med, Ruijin Hosp, Dept Gastroenterol, Shanghai 200030, Peoples R China.; Tao, R (corresponding author), Zhejiang Prov Peoples Hosp, Dept Hepatobiliary Pancreat Surg, Hangzhou, Zhejiang, Peoples R China.	taohdac9@yahoo.com; jimmyzj64@hotmail.com	zhang, tian/GZK-6001-2022		Shanghai Science and Technology Committee for the Promotion of Science in China [15ZR1426400, 14XJ10014]	Shanghai Science and Technology Committee for the Promotion of Science in China	This study was supported by a Grant-in-Aid for Scientific Research (15ZR1426400, 14XJ10014) from Shanghai Science and Technology Committee for the Promotion of Science in China.	Abraham C, 2009, NEW ENGL J MED, V361, P2066, DOI 10.1056/NEJMra0804647; Annunziato F, 2007, J EXP MED, V204, P1849, DOI 10.1084/jem.20070663; Ashour HM, 2007, INT ARCH ALLERGY IMM, V144, P343, DOI 10.1159/000106461; Ashour HM, 2007, J LEUKOCYTE BIOL, V82, P1033, DOI 10.1189/jlb.0507310; Atarashi K, 2008, NATURE, V455, P808, DOI 10.1038/nature07240; Bernasconi E, 2010, INFLAMM BOWEL DIS, V16, P428, DOI 10.1002/ibd.21072; Bhattacharya P, 2015, CYTOKINE, V75, P261, DOI 10.1016/j.cyto.2015.05.030; Bhattacharya P, 2015, J INTERF CYTOK RES, V35, P585, DOI 10.1089/jir.2014.0149; Bhattacharya P, 2014, CLIN IMMUNOL, V153, P187, DOI 10.1016/j.clim.2014.04.014; Bhattacharya P, 2011, J LEUKOCYTE BIOL, V89, P235, DOI 10.1189/jlb.0310154; Blair PA, 2010, IMMUNITY, V32, P129, DOI 10.1016/j.immuni.2009.11.009; Brown JB, 2012, INFLAMM BOWEL DIS, V18, P323, DOI 10.1002/ibd.21779; Brown SJ, 2007, AM J GASTROENTEROL, V102, P2058, DOI 10.1111/j.1572-0241.2007.01343.x; Chen Z, 2013, J IMMUNOL, V190, P5256, DOI 10.4049/jimmunol.1201675; Chresta CM, 2010, CANCER RES, V70, P288, DOI 10.1158/0008-5472.CAN-09-1751; COOPER HS, 1993, LAB INVEST, V69, P238; Delgoffe GM, 2009, IMMUNITY, V30, P832, DOI 10.1016/j.immuni.2009.04.014; Elson CO, 2005, IMMUNOL REV, V206, P260, DOI 10.1111/j.0105-2896.2005.00291.x; Farkas S, 2006, INT J COLORECTAL DIS, V21, P747, DOI 10.1007/s00384-005-0793-7; Flores-Borja F, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3005407; Gangi E, 2005, J IMMUNOL, V174, P7006, DOI 10.4049/jimmunol.174.11.7006; Gathungu G, 2013, INFLAMM BOWEL DIS, V19, P1671, DOI 10.1097/MIB.0b013e318281f506; Gaudreau S, 2007, J IMMUNOL, V179, P3638, DOI 10.4049/jimmunol.179.6.3638; Gopisetty A, 2013, J IMMUNOL, V190, P5516, DOI 10.4049/jimmunol.1202298; Guertin DA, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.267pe24; Heiseke AF, 2012, GASTROENTEROLOGY, V142, P335, DOI 10.1053/j.gastro.2011.10.027; Hua FL, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/571302; Ito H, 2005, J GASTROENTEROL, V40, P32, DOI 10.1007/BF02990576; Izcue A, 2006, IMMUNOL REV, V212, P256, DOI 10.1111/j.0105-2896.2006.00423.x; Kared H, 2008, BLOOD, V112, P2575, DOI 10.1182/blood-2008-02-140681; Karlsson F, 2011, METHODS MOL BIOL, V677, P47, DOI 10.1007/978-1-60761-869-0_4; Kaser A, 2010, ANNU REV IMMUNOL, V28, P573, DOI 10.1146/annurev-immunol-030409-101225; Kitani A, 2008, MUCOSAL IMMUNOL, V1, pS43, DOI 10.1038/mi.2008.51; Kleinewietfeld M, 2013, SEMIN IMMUNOL, V25, P305, DOI 10.1016/j.smim.2013.10.009; Li Q, 2013, BIOCHEM BIOPH RES CO, V440, P701, DOI 10.1016/j.bbrc.2013.09.130; Luckheeram RV, 2012, CLIN DEV IMMUNOL, DOI 10.1155/2012/925135; Lund FE, 2010, NAT REV IMMUNOL, V10, P236, DOI 10.1038/nri2729; Makita S, 2004, J IMMUNOL, V173, P3119, DOI 10.4049/jimmunol.173.5.3119; Martin B, 2004, J IMMUNOL, V172, P3391, DOI 10.4049/jimmunol.172.6.3391; Martin B, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3209; Maseda D, 2013, J IMMUNOL, V191, P2780, DOI 10.4049/jimmunol.1300649; Matsuda C, 2007, CLIN EXP IMMUNOL, V148, P348, DOI 10.1111/j.1365-2249.2007.03345.x; Mondino A, 2007, SEMIN IMMUNOL, V19, P162, DOI 10.1016/j.smim.2007.02.008; Morgan MAJ, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0071974, 10.1371/journal.pone.0056738, 10.1371/journal.pone.0069936]; Mudter J, 2011, INFLAMM BOWEL DIS, V17, P1343, DOI 10.1002/ibd.21476; O'Garra A, 2004, NAT MED, V10, P801, DOI 10.1038/nm0804-801; Ogino H, 2011, DIGEST DIS SCI, V56, P376, DOI 10.1007/s10620-010-1286-2; Powell JD, 2012, ANNU REV IMMUNOL, V30, P39, DOI 10.1146/annurev-immunol-020711-075024; Robb RJ, 2012, BLOOD, V119, P5898, DOI 10.1182/blood-2011-12-396119; Rosborough BR, 2014, AM J TRANSPLANT, V14, P2173, DOI 10.1111/ajt.12799; Rowin J, 2012, MUSCLE NERVE, V46, P449, DOI 10.1002/mus.23488; Sainathan SK, 2008, INFLAMM BOWEL DIS, V14, P88, DOI 10.1002/ibd.20279; Salinas GF, 2013, CLIN IMMUNOL, V146, P34, DOI 10.1016/j.clim.2012.10.005; Sandborn WJ, 2012, NEW ENGL J MED, V367, P1519, DOI 10.1056/NEJMoa1203572; Sartor RB, 2006, NAT CLIN PRACT GASTR, V3, P390, DOI 10.1038/ncpgasthep0528; Shin HJ, 2011, BLOOD, V118, P2342, DOI 10.1182/blood-2010-10-313684; Sini P, 2010, AUTOPHAGY, V6, P553, DOI 10.4161/auto.6.4.11671; Sokol H, 2013, GASTROENTEROLOGY, V145, P591, DOI 10.1053/j.gastro.2013.05.047; Takedatsu H, 2008, GASTROENTEROLOGY, V135, P552, DOI 10.1053/j.gastro.2008.04.037; ten Hove T, 2002, GUT, V50, P507, DOI 10.1136/gut.50.4.507; Thomson AW, 2009, NAT REV IMMUNOL, V9, P324, DOI 10.1038/nri2546; Thoreen CC, 2009, J BIOL CHEM, V284, P8023, DOI 10.1074/jbc.M900301200; Ustyugova IV, 2012, INFLAMM BOWEL DIS, V18, P333, DOI 10.1002/ibd.21772; Veltkamp C, 2006, INFLAMM BOWEL DIS, V12, P437, DOI 10.1097/00054725-200606000-00002; Willems L, 2012, LEUKEMIA, V26, P1195, DOI 10.1038/leu.2011.339; Wu X, 2015, BIOCHEM PHARMACOL, V96, P323, DOI 10.1016/j.bcp.2015.06.008; Wurbel MA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016442; Yen D, 2006, J CLIN INVEST, V116, P1310, DOI 10.1172/JCI21404; Yin H, 2013, IMMUNOLOGY, V139, P494, DOI 10.1111/imm.12096; Yurchenko E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035572; Zenewicz LA, 2009, TRENDS MOL MED, V15, P199, DOI 10.1016/j.molmed.2009.03.002	71	28	32	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 29	2016	11	4							e0154564	10.1371/journal.pone.0154564	http://dx.doi.org/10.1371/journal.pone.0154564			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DK8XM	27128484	gold, Green Submitted, Green Published			2022-12-26	WOS:000375212600040
J	Kohl, WT; McClure, TI; Miner, BG				Kohl, Warren T.; McClure, Timothy I.; Miner, Benjamin G.			Decreased Temperature Facilitates Short-Term Sea Star Wasting Disease Survival in the Keystone Intertidal Sea Star Pisaster ochraceus	PLOS ONE			English	Article							COMPLEXITY; SALINITY	An extensive 2013 mass mortality event along the West Coast of North America due to Sea Star Wasting Disease (SSWD) has affected at least 20 species of sea stars. Among environmental factors potentially contributing to the timing of the current outbreak, increased coastal water temperatures are hypothesized to have contributed to previous and current outbreaks of SSWD. With a laboratory experiment, we tested whether cooler temperatures, similar to average winter temperatures, compared to average summer temperatures could slow the progression of morbidity or prevent SSWD mortality entirely in Pisaster ochraceus. Sea stars housed in cooler water progressed through SSWD states more slowly than sea stars housed at summer temperatures. However, the cooler temperature did not prevent SSWD mortality, and all stars died of the disease. Our data are consistent with experimental studies and field observations during previous and current outbreaks, and support the hypothesis that changes in coastal water temperatures have influenced one of the largest disease related mass mortality events in our oceans.	[Kohl, Warren T.; McClure, Timothy I.; Miner, Benjamin G.] Western Washington Univ, 516 High St, Bellingham, WA USA	Western Washington University	Miner, BG (corresponding author), Western Washington Univ, 516 High St, Bellingham, WA USA.	benjamin.Miner@wwu.edu		Miner, Benjamin/0000-0002-0996-2252	Washington Sea Grant (National Oceanic and Atmospheric Administration) [NA10OAR4170057]; National Science Foundation [OCE-1401727]	Washington Sea Grant (National Oceanic and Atmospheric Administration); National Science Foundation(National Science Foundation (NSF))	This research was funded by a Washington Sea Grant (National Oceanic and Atmospheric Administration Award No. NA10OAR4170057) to B. Miner and C. Miner and a National Science Foundation grant OCE-1401727 to B. Miner and I. Hewson.	BAROSS J, 1970, APPL MICROBIOL, V20, P179, DOI 10.1128/AEM.20.2.179-186.1970; Bates AE, 2009, DIS AQUAT ORGAN, V86, P245, DOI 10.3354/dao02125; Becker P, 2004, AQUACULTURE, V242, P13, DOI 10.1016/j.aquaculture.2003.11.018; De Wolf H, 2004, AQUAT TOXICOL, V66, P241, DOI 10.1016/j.aquatox.2003.09.006; DUNGAN ML, 1982, SCIENCE, V216, P989, DOI 10.1126/science.216.4549.989; Eckert G.L., 2000, P 5 CAL ISL S US DEP, P390; Eisenlord ME, 2016, PHILOS T R SOC B, V371, DOI 10.1098/rstb.2015.0212; Gudenkauf BM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0128150; Hewson I, 2014, P NATL ACAD SCI USA, V111, P17278, DOI 10.1073/pnas.1416625111; KASPAR CW, 1993, APPL ENVIRON MICROB, V59, P2425, DOI 10.1128/AEM.59.8.2425-2429.1993; PAINE RT, 1969, AM NAT, V103, P91, DOI 10.1086/282586; PAINE RT, 1966, AM NAT, V100, P65, DOI 10.1086/282400; R Core Team, 2018, R LANG ENV STAT COMP; Rivera-Posada JA, 2011, DIS AQUAT ORGAN, V97, P85, DOI 10.3354/dao02401; Staehli Annette, 2009, Marine Biodiversity Records, V2, pe78, DOI 10.1017/S1755267209000633	15	34	34	3	73	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 29	2016	11	4							e0153670	10.1371/journal.pone.0153670	http://dx.doi.org/10.1371/journal.pone.0153670			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DK8XM	27128673	Green Published, Green Submitted, gold			2022-12-26	WOS:000375212600010
J	Neely, BA; Wilkins, CE; Marlow, LA; Malyarenko, D; Kim, Y; Ignatchenko, A; Sasinowska, H; Sasinowski, M; Nyalwidhe, JO; Kislinger, T; Copland, JA; Drake, RR				Neely, Benjamin A.; Wilkins, Christopher E.; Marlow, Laura A.; Malyarenko, Dariya; Kim, Yunee; Ignatchenko, Alexandr; Sasinowska, Heather; Sasinowski, Maciek; Nyalwidhe, Julius O.; Kislinger, Thomas; Copland, John A.; Drake, Richard R.			Proteotranscriptomic Analysis Reveals Stage Specific Changes in the Molecular Landscape of Clear-Cell Renal Cell Carcinoma	PLOS ONE			English	Article							QUANTITATIVE PROTEOMIC ANALYSIS; RECEPTOR-ALPHA; CANCER; BIOMARKERS; METASTASIS; HIF-2-ALPHA; PROTEIN; IDENTIFICATION; PROLIFERATION; PROGRESSION	Renal cell carcinoma comprises 2 to 3% of malignancies in adults with the most prevalent subtype being clear-cell RCC (ccRCC). This type of cancer is well characterized at the genomic and transcriptomic level and is associated with a loss of VHL that results in stabilization of HIF1. The current study focused on evaluating ccRCC stage dependent changes at the proteome level to provide insight into the molecular pathogenesis of ccRCC progression. To accomplish this, label-free proteomics was used to characterize matched tumor and normal-adjacent tissues from 84 patients with stage I to IV ccRCC. Using pooled samples 1551 proteins were identified, of which 290 were differentially abundant, while 783 proteins were identified using individual samples, with 344 being differentially abundant. These 344 differentially abundant proteins were enriched in metabolic pathways and further examination revealed metabolic dysfunction consistent with the Warburg effect. Additionally, the protein data indicated activation of ESRRA and ESRRG, and HIF1A, as well as inhibition of FOXA1, MAPK1 and WISP2. A subset analysis of complementary gene expression array data on 47 pairs of these same tissues indicated similar upstream changes, such as increased HIF1A activation with stage, though ESRRA and ESRRG activation and FOXA1 inhibition were not predicted from the transcriptomic data. The activation of ESRRA and ESRRG implied that HIF2A may also be activated during later stages of ccRCC, which was confirmed in the transcriptional analysis. This combined analysis highlights the importance of HIF1A and HIF2A in developing the ccRCC molecular phenotype as well as the potential involvement of ESRRA and ESRRG in driving these changes. In addition, cofilin-1, profilin1, nicotinamide N-methyltransferase, and fructose-bisphosphate aldolase A were identified as candidate markers of late stage ccRCC. Utilization of data collected from heterogeneous biological domains strengthened the findings from each domain, demonstrating the complementary nature of such an analysis. Together these results highlight the importance of the VHL/HIF1A/HIF2A axis and provide a foundation and therapeutic targets for future studies. (Data are available via ProteomeXchange with identifier PXD003271 and MassIVE with identifier MSV000079511.)	[Neely, Benjamin A.; Drake, Richard R.] Med Univ S Carolina, Dept Cell & Mol Pharmacol & Expt Therapeut, Charleston, SC 29425 USA; [Wilkins, Christopher E.; Nyalwidhe, Julius O.] Eastern Virginia Med Sch, Dept Microbiol & Mol Cell Biol, Norfolk, VA 23501 USA; [Marlow, Laura A.; Copland, John A.] Mayo Clin, Ctr Comprehens Canc, Dept Canc Biol, Jacksonville, FL 32224 USA; [Malyarenko, Dariya] Univ Michigan, Dept Radiol, Sch Med, Ann Arbor, MI 48109 USA; [Kim, Yunee; Kislinger, Thomas] Univ Toronto, Dept Med Biophys, Toronto, ON, Canada; [Ignatchenko, Alexandr; Kislinger, Thomas] Princess Margaret Canc Ctr, Toronto, ON, Canada; [Sasinowska, Heather; Sasinowski, Maciek] INCOGEN Inc, Williamsburg, VA USA; [Sasinowski, Maciek] Venebio Grp LLC, Richmond, VA USA; [Nyalwidhe, Julius O.] Eastern Virginia Med Sch, Leroy T Canoles Jr Canc Res Ctr, Norfolk, VA 23501 USA	Medical University of South Carolina; Eastern Virginia Medical School; Mayo Clinic; University of Michigan System; University of Michigan; University of Toronto; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Princess Margaret Cancer Centre; Eastern Virginia Medical School	Drake, RR (corresponding author), Med Univ S Carolina, Dept Cell & Mol Pharmacol & Expt Therapeut, Charleston, SC 29425 USA.	draker@musc.edu	Kislinger, Thomas/A-5934-2008; Neely, Benjamin/AGR-8303-2022	Sasinowska, Heather/0000-0001-8273-9105; Marlow, Laura/0000-0002-4726-9889; Kislinger, Thomas/0000-0003-3525-5540; Neely, Benjamin/0000-0001-6120-7695; Drake, Richard/0000-0002-6285-6440; Ignatchenko, Alexandr/0000-0002-6083-941X	South Carolina SmartState Center of Economic Excellence in Proteomics; MUSC Proteomics Center; Canadian Research Chair program; NIH/NCI [2R44CA125807-02, R01CA104505, R01CA136665, R01CA104505-05S1]; Mr. and Mrs. Ompal Chauhan Research Fund; Kidney Cancer Research at Mayo Clinic in Florida; Scheidel Foundation; INCOGEN, Inc; Venebio Group, LLC; NATIONAL CANCER INSTITUTE [R01CA104505, P30CA015083, R44CA125807, R01CA136665] Funding Source: NIH RePORTER	South Carolina SmartState Center of Economic Excellence in Proteomics; MUSC Proteomics Center; Canadian Research Chair program(Canada Research Chairs); NIH/NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Mr. and Mrs. Ompal Chauhan Research Fund; Kidney Cancer Research at Mayo Clinic in Florida; Scheidel Foundation; INCOGEN, Inc; Venebio Group, LLC; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This research was supported by the South Carolina SmartState Center of Economic Excellence in Proteomics and the MUSC Proteomics Center (BAN and RRD). TK is supported through the Canadian Research Chair program. This work was funded in part from NIH/NCI grants 2R44CA125807-02 (MS), R01CA104505 (JAC), R01CA136665 (JAC), and R01CA104505-05S1 (JAC); a generous gift from the David & Lois Stulberg Endowed Fund for Kidney Cancer Research (JAC); Mr. and Mrs. Ompal Chauhan Research Fund (JAC); Kidney Cancer Research at Mayo Clinic in Florida (JAC); Scheidel Foundation (JAC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. INCOGEN, Inc, & Venebio Group, LLC, provided support in the form of salaries for authors HS and MS, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Ariazi EA, 2002, CANCER RES, V62, P6510; Cooper S. J., 2012, J MOL BIOMARK DIAGN, DOI 10.4172/2155-9929.S2-005; Creighton CJ, 2013, NATURE, V499, P43, DOI 10.1038/nature12222; DeBerardinis RJ, 2007, P NATL ACAD SCI USA, V104, P19345, DOI 10.1073/pnas.0709747104; Dhar G, 2007, CANCER LETT, V254, P63, DOI 10.1016/j.canlet.2007.02.012; Du S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085804; Foss EJ, 2007, NAT GENET, V39, P1369, DOI 10.1038/ng.2007.22; Frew IJ, 2015, ANNU REV PATHOL-MECH, V10, P263, DOI 10.1146/annurev-pathol-012414-040306; Frewer KA, 2013, CANCER GENOM PROTEOM, V10, P187; Gerlinger M, 2014, NAT GENET, V46, P225, DOI 10.1038/ng.2891; Gordan JD, 2008, CANCER CELL, V14, P435, DOI 10.1016/j.ccr.2008.10.016; Gortzak-Uzan L, 2008, J PROTEOME RES, V7, P339, DOI 10.1021/pr0703223; Gossage L, 2015, NAT REV CANCER, V15, P55, DOI 10.1038/nrc3844; Gygi SP, 1999, MOL CELL BIOL, V19, P1720, DOI 10.1128/mcb.19.3.1720; Hakimi AA, 2016, CANCER CELL, V29, P104, DOI 10.1016/j.ccell.2015.12.004; Hamidian A, 2015, BIOCHEM BIOPH RES CO, V461, P560, DOI 10.1016/j.bbrc.2015.04.083; Haque I, 2015, ONCOGENE, V34, P3152, DOI 10.1038/onc.2014.250; Hu CJ, 2003, MOL CELL BIOL, V23, P9361, DOI 10.1128/MCB.23.24.9361-9374.2003; Iqbal MA, 2014, FEBS LETT, V588, P2685, DOI 10.1016/j.febslet.2014.04.011; Ji JF, 2015, BRIT J CANCER, V113, P921, DOI 10.1038/bjc.2015.285; Kandoth C, 2013, NATURE, V502, P333, DOI 10.1038/nature12634; Kim HL, 2004, CLIN CANCER RES, V10, P5464, DOI 10.1158/1078-0432.CCR-04-0488; King SC, 2014, J UROLOGY, V191, P1665, DOI 10.1016/j.juro.2013.12.046; Koppenol WH, 2011, NAT REV CANCER, V11, P325, DOI 10.1038/nrc3038; Lebdai S, 2015, UROLOGIC ONCOLOGY, V33; Long F, 2014, ONCOL REP, V32, P2031, DOI 10.3892/or.2014.3473; Lu JR, 2015, CANCER LETT, V356, P156, DOI 10.1016/j.canlet.2014.04.001; Masui O, 2013, MOL CELL PROTEOMICS, V12, P132, DOI 10.1074/mcp.M112.020701; Moch H, 2014, WORLD CANC REPORT 20, P436; Moch H, 2014, VIRCHOWS ARCH, V464, P359, DOI 10.1007/s00428-014-1546-1; Mole DR, 2009, J BIOL CHEM, V284, P16767, DOI 10.1074/jbc.M901790200; Morgan TM, 2013, J UROLOGY, V189, P1097, DOI 10.1016/j.juro.2012.09.074; Nickerson ML, 2008, CLIN CANCER RES, V14, P4726, DOI 10.1158/1078-0432.CCR-07-4921; Peng Y, 2012, MOL BIOSYST, V8, P3077, DOI 10.1039/c2mb25286d; Perroud B, 2009, MOL CELL PROTEOMICS, V8, P971, DOI 10.1074/mcp.M800252-MCP200; Raval RR, 2005, MOL CELL BIOL, V25, P5675, DOI 10.1128/MCB.25.13.5675-5686.2005; Rini BI, 2009, LANCET, V373, P1119, DOI 10.1016/S0140-6736(09)60229-4; Rose T, 2015, KIDNEY CANC, P59; Sato Y, 2013, NAT GENET, V45, P860, DOI 10.1038/ng.2699; Schodel J, 2011, BLOOD, V117, pE207, DOI 10.1182/blood-2010-10-314427; Seliger B, 2009, PROTEOMICS, V9, P1567, DOI 10.1002/pmic.200700288; Semenza GL, 2007, J BIOENERG BIOMEMBR, V39, P231, DOI 10.1007/s10863-007-9081-2; Sepiashvili L, 2014, MOL CELL PROTEOMICS, V13, P3572, DOI 10.1074/mcp.M114.041764; Smyth G.K., 2004, STAT APPL GENET MOL, V3, P3, DOI [DOI 10.2202/1544-6115.1027, 10.2202/1544-6115.1027]; Sun M, 2009, EUR UROL, V56, P775, DOI 10.1016/j.eururo.2009.06.008; Sun PM, 2005, J MOL MED, V83, P457, DOI 10.1007/s00109-005-0639-3; Tang SW, 2009, CANCER LETT, V273, P35, DOI 10.1016/j.canlet.2008.07.038; Taylor P, 2009, J PROTEOME RES, V8, P1610, DOI 10.1021/pr800986c; Tomaszewski Jeffrey J., 2014, Cancer Biology Medicine, V11, P162, DOI 10.7497/j.issn.2095-3941.2014.03.002; Tun HW, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010696; Unwin RD, 2003, PROTEOMICS, V3, P1620, DOI 10.1002/pmic.200300464; Vizcaino JA, 2014, NAT BIOTECHNOL, V32, P223, DOI 10.1038/nbt.2839; von Roemeling CA, 2014, ONCOTARGET, V5, P5320, DOI 10.18632/oncotarget.2097; Wang HX, 2005, J PROTEOME RES, V4, P2397, DOI 10.1021/pr050160f; Wang W, 2006, J CELL BIOL, V173, P395, DOI 10.1083/jcb.200510115; Wettersten HI, 2015, CANCER RES, V75, P2541, DOI 10.1158/0008-5472.CAN-14-1703; White NMA, 2014, ONCOTARGET, V5, P506, DOI 10.18632/oncotarget.1529; Yang ZL, 2013, CANCER INVEST, V31, P132, DOI 10.3109/07357907.2012.756113; Yokomizo A, 2011, CANCER BIOMARK, V10, P175, DOI 10.3233/CBM-2012-0243; Zaravinos Apostolos, 2014, Oncoscience, V1, P117; Zhang B, 2014, NATURE, V513, P382, DOI 10.1038/nature13438; Zhao ZH, 2015, TUMOR BIOL, V36, P939, DOI 10.1007/s13277-014-2694-2; Zhu BB, 2006, CANCER RES, V66, P8640, DOI 10.1158/0008-5472.CAN-06-1443; Zoidakis J, 2012, MOL CELL PROTEOMICS, V11, DOI 10.1074/mcp.M111.009449	64	34	36	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 29	2016	11	4							e0154074	10.1371/journal.pone.0154074	http://dx.doi.org/10.1371/journal.pone.0154074			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DK8XM	27128972	Green Submitted, Green Published, gold			2022-12-26	WOS:000375212600019
J	Nguyen, AT; Tsai, CL; Hwang, LY; Lai, DJ; Markham, C; Patel, B				Anh Tuan Nguyen; Tsai, Chu-lin; Hwang, Lu-yu; Lai, Dejian; Markham, Christine; Patel, Bela			Obesity and Mortality, Length of Stay and Hospital Cost among Patients with Sepsis: A Nationwide Inpatient Retrospective Cohort Study	PLOS ONE			English	Article							BODY-MASS INDEX; INTENSIVE-CARE-UNIT; LOGISTIC-REGRESSION; POOLED ANALYSIS; SEPTIC SHOCK; ALL-CAUSE; PARADOX; ASSOCIATION; OUTCOMES; DISEASE	Objectives The objective of this study was to examine the association between obesity and all-cause mortality, length of stay and hospital cost among patients with sepsis 20 years of age or older. Materials and Methods It was a retrospective cohort study. The dataset was the Nationwide Inpatient Sample 2011, the largest publicly available all-payer inpatient care database in the United States. Hospitalizations of sepsis patients 20 years of age or older were included. All 25 primary and secondary diagnosis fields were screened to identify patients with sepsis using International Classification of Diseases, Ninth Revision, Clinical Modification codes. Obesity was the exposure of interest. It was one of the 29 standardized Elixhauser comorbidity measures and readily available in the dataset as a dichotomized variable. The outcome measures were all-cause in-hospital death, length of stay and hospital cost. Results After weighting, our sample projected to a population size of 1,763,000, providing an approximation for the number of hospital discharges of all sepsis patients 20 years of age or older in the US in 2011. The overall all-cause mortality rate was 14.8%, the median hospital length of stay was 7 days and the median hospital cost was $15,917. After adjustment, the all-cause mortality was lower (adjusted OR = 0.84; 95% CI = 0.81 to 0.88); the average hospital length of stay was longer (adjusted difference = 0.65 day; 95% CI = 0.44 to 0.86) and the hospital cost per stay was higher (adjusted difference = $2,927; 95% CI = $1,606 to $4,247) for obese sepsis patients as compared to non-obese ones. Conclusion With this large and nationally representative sample of over 1,000 hospitals in the US, we found that obesity was significantly associated with a 16% decrease in the odds of dying among hospitalized sepsis patients; however it was also associated with greater duration and cost of hospitalization.	[Anh Tuan Nguyen] Vinmec Int Hosp, Dept Gen Planning, Hanoi, Vietnam; [Tsai, Chu-lin] Harvard Univ, Massachusetts Gen Hosp, Sch Med, Dept Emergency Med, Boston, MA USA; [Hwang, Lu-yu] Univ Texas Hlth Sci Ctr Houston, Dept Epidemiol Human Genet & Environm Sci, Sch Publ Hlth, Houston, TX 77030 USA; [Lai, Dejian] Univ Texas Hlth Sci Ctr Houston, Sch Publ Hlth, Dept Biostat, Houston, TX 77030 USA; [Markham, Christine] Univ Texas Hlth Sci Ctr Houston, Sch Publ Hlth, Dept Hlth Promot & Behav Sci, Houston, TX 77030 USA; [Patel, Bela] Univ Texas Hlth Sci Ctr Houston, Sch Med, Div Crit Care Med, Houston, TX 77030 USA	Harvard University; Harvard Medical School; Massachusetts General Hospital; University of Texas System; University of Texas Health Science Center Houston; University of Texas School Public Health; University of Texas System; University of Texas Health Science Center Houston; University of Texas School Public Health; University of Texas System; University of Texas Health Science Center Houston; University of Texas School Public Health; University of Texas System; University of Texas Health Science Center Houston	Nguyen, AT (corresponding author), Vinmec Int Hosp, Dept Gen Planning, Hanoi, Vietnam.	nguyentuananh.fsh@gmail.com		Nguyen, Anh/0000-0003-2608-0152; TSAI, CHU-LIN/0000-0003-4639-1513				Abdullah A, 2011, INT J EPIDEMIOL, V40, P985, DOI 10.1093/ije/dyr018; Akinnusi ME, 2008, CRIT CARE MED, V36, P151, DOI 10.1097/01.CCM.0000297885.60037.6E; Angus D C, 2001, Crit Care Med, V29, P1303, DOI 10.1097/00003246-200107000-00002; Angus DC, 2013, NEW ENGL J MED, V369, P840, DOI [10.1056/NEJMc1312359, 10.1056/NEJMra1208623]; [Anonymous], 2009, NCHS DATA BRIEF; Arabi YM, 2013, CRIT CARE, V17, DOI 10.1186/cc12680; Banack HR, 2013, EPIDEMIOLOGY, V24, P461, DOI 10.1097/EDE.0b013e31828c776c; Benson S, 2009, PSYCHONEUROENDOCRINO, V34, P181, DOI 10.1016/j.psyneuen.2008.08.019; Buck C, 2011, ICD9CM; Buck C, 2011, ICD9CM; Calle EE, 2003, NEW ENGL J MED, V348, P1625, DOI 10.1056/NEJMoa021423; Chalkias A, 2013, J CRIT CARE, V28, P964, DOI 10.1016/j.jcrc.2013.06.022; Chen Y, 2013, BMJ-BRIT MED J, V347, DOI 10.1136/bmj.f5446; Clark AL, 2012, AM J CARDIOL, V110, P77, DOI 10.1016/j.amjcard.2012.02.050; Elixhauser A, 1998, MED CARE, V36, P8, DOI 10.1097/00005650-199801000-00004; Gaulton TG, 2014, INTERN EMERG MED, V9, P213, DOI 10.1007/s11739-013-1002-2; Goldstein Brahm, 2005, Pediatr Crit Care Med, V6, P2; Gonzalez-Casanova I, 2013, REV PANAM SALUD PUBL, V33, P349, DOI 10.1590/S1020-49892013000500006; Hall Margaret Jean, 2011, NCHS Data Brief, P1; Hanses F, 2010, INFECTION, V38, P465, DOI 10.1007/s15010-010-0059-3; Huttunen R, 2007, BMC INFECT DIS, V7, DOI 10.1186/1471-2334-7-13; Kastorini CM, 2012, MATURITAS, V72, P220, DOI 10.1016/j.maturitas.2012.04.012; Koch A, 2011, J CRIT CARE, V26, P166, DOI 10.1016/j.jcrc.2010.07.015; Kumar G, 2011, CHEST, V140, P1223, DOI 10.1378/chest.11-0352; Kuperman EF, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-377; Lagu T, 2012, CRIT CARE MED, V40, P754, DOI 10.1097/CCM.0b013e318232db65; Levy MM, 2001, INTENS CARE MED, V29, P530, DOI DOI 10.1007/S00134-003-1662-X; Marti A, 2001, Obes Rev, V2, P131, DOI 10.1046/j.1467-789x.2001.00025.x; Martin-Ponce E, 2010, CLIN NUTR, V29, P501, DOI 10.1016/j.clnu.2009.12.009; McAuley PA, 2011, J SPORT SCI, V29, P773, DOI 10.1080/02640414.2011.553965; Peduzzi P, 1996, J CLIN EPIDEMIOL, V49, P1373, DOI 10.1016/S0895-4356(96)00236-3; Preston SH, 2014, EPIDEMIOLOGY, V25, P454, DOI 10.1097/EDE.0000000000000075; Romero-Corral A, 2006, LANCET, V368, P666, DOI 10.1016/S0140-6736(06)69251-9; Roytblat L, 2000, OBES RES, V8, P673, DOI 10.1038/oby.2000.86; Saito I, 2012, CIRC J, V76, P2867, DOI 10.1253/circj.CJ-11-1259; Sakr Y, 2008, INTENS CARE MED, V34, P1999, DOI 10.1007/s00134-008-1243-0; Stoltzfus JC, 2011, ACAD EMERG MED, V18, P1099, DOI 10.1111/j.1553-2712.2011.01185.x; Thompson SG, 2000, BRIT MED J, V320, P1197, DOI 10.1136/bmj.320.7243.1197; Vemmos K, 2011, STROKE, V42, P30, DOI 10.1161/STROKEAHA.110.593434; Wacharasint P, 2013, CRIT CARE, V17, DOI 10.1186/cc12794; who, WHO OB OV; Wisse BE, 2004, J AM SOC NEPHROL, V15, P2792, DOI 10.1097/01.ASN.0000141966.69934.21; Wurzinger B, 2010, WIEN KLIN WOCHENSCHR, V122, P31, DOI 10.1007/s00508-009-1241-4	43	39	40	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 28	2016	11	4							e0154599	10.1371/journal.pone.0154599	http://dx.doi.org/10.1371/journal.pone.0154599			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DK8XE	27124716	Green Submitted, Green Published, gold			2022-12-26	WOS:000375211700111
J	Izawa, T; Mori, H; Shinohara, T; Mino-Oka, A; Hutami, IR; Iwasa, A; Tanaka, E				Izawa, Takashi; Mori, Hiroki; Shinohara, Tekehiro; Mino-Oka, Akiko; Hutami, Islamy Rahma; Iwasa, Akihiko; Tanaka, Eiji			Rebamipide Attenuates Mandibular Condylar Degeneration in a Murine Model of TMJ-OA by Mediating a Chondroprotective Effect and by Downregulating RANKL-Mediated Osteoclastogenesis	PLOS ONE			English	Article							SUBCHONDRAL BONE LOSS; TEMPOROMANDIBULAR-JOINT; CHONDROCYTE APOPTOSIS; NITRIC-OXIDE; OXIDATIVE STRESS; II COLLAGEN; CARTILAGE; OSTEOARTHRITIS; EXPRESSION; ARTHRITIS	Temporomandibular joint osteoarthritis (TMJ-OA) is characterized by progressive degradation of cartilage and changes in subchondral bone. It is also one of the most serious subgroups of temporomandibular disorders. Rebamipide is a gastroprotective agent that is currently used for the treatment of gastritis and gastric ulcers. It scavenges reactive oxygen radicals and has exhibited anti-inflammatory potential. The aim of this study was to investigate the impact of rebamipide both in vivo and in vitro on the development of cartilage degeneration and osteoclast activity in an experimental murine model of TMJ-OA, and to explore its mode of action. Oral administration of rebamipide (0.6 mg/kg and 6 mg/kg) was initiated 24 h after TMJ-OA was induced, and was maintained daily for four weeks. Rebamipide treatment was found to attenuate cartilage degeneration, to reduce the number of apoptotic cells, and to decrease the expression levels of matrix metalloproteinase-13 (MMP-13) and inducible nitric oxide synthase (iNOS) in TMJ-OA cartilage in a dose-dependent manner. Rebamipide also suppressed the activation of transcription factors (e.g., NF-kappa B, NFATc1) and mitogen-activated protein kinases (MAPK) by receptor activator of nuclear factor kappa-B ligand (RANKL) to inhibit the differentiation of osteoclastic precursors, and disrupted the formation of actin rings in mature osteoclasts. Together, these results demonstrate the inhibitory effects of rebamipide on cartilage degradation in experimentally induced TMJ-OA. Furthermore, suppression of oxidative damage, restoration of extracellular matrix homeostasis of articular chondrocytes, and reduced subchondral bone loss as a result of blocked osteoclast activation suggest that rebamipide is a potential therapeutic strategy for TMJ-OA.	[Izawa, Takashi; Mori, Hiroki; Shinohara, Tekehiro; Mino-Oka, Akiko; Hutami, Islamy Rahma; Iwasa, Akihiko; Tanaka, Eiji] Univ Tokushima, Inst Biomed Sci, Dept Orthodont & Dentofacial Orthoped, Grad Sch, Tokushima, Japan	Tokushima University	Izawa, T (corresponding author), Univ Tokushima, Inst Biomed Sci, Dept Orthodont & Dentofacial Orthoped, Grad Sch, Tokushima, Japan.	tizawa@tokushima-u.ac.jp	Tanaka, Eiji/E-7105-2015; Hutami, Islamy Rahma/AAH-3664-2021	Tanaka, Eiji/0000-0002-2707-1613; Hutami, Islamy Rahma/0000-0003-3245-953X	Ministry of Education, Science, Sport, and Culture of Japan [25713063, 15K15757, 26293436]; Grants-in-Aid for Scientific Research [15K20597] Funding Source: KAKEN	Ministry of Education, Science, Sport, and Culture of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by the Ministry of Education, Science, Sport, and Culture of Japan (Grant-in-Aid for Young Scientists A Research No. 25713063, and Challenging Exploratory Research No. 15K15757 to T.I., Grant-in-Aid for Scientific Research B No. 26293436 to E.T.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aigner T, 2002, CELL MOL LIFE SCI, V59, P5, DOI 10.1007/s00018-002-8400-3; Aigner T, 2002, CURR OPIN RHEUMATOL, V14, P578, DOI 10.1097/00002281-200209000-00018; Arakaki R, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098390; BLANCO FJ, 1995, AM J PATHOL, V146, P75; Byun JK, 2014, CLIN EXP IMMUNOL, V178, P9, DOI 10.1111/cei.12355; Cao M, 1997, BIOCHEM J, V324, P305, DOI 10.1042/bj3240305; Chadjichristos C, 2003, J BIOL CHEM, V278, P39762, DOI 10.1074/jbc.M303541200; Embree M, 2011, J DENT RES, V90, P1331, DOI 10.1177/0022034511421930; Faccio R, 2003, J CELL BIOCHEM, V90, P871, DOI 10.1002/jcb.10694; Vitral RWF, 2007, AM J ORTHOD DENTOFAC, V132, P395, DOI 10.1016/j.ajodo.2005.12.033; Fujisawa T, 2003, J DENT RES, V82, P731, DOI 10.1177/154405910308200914; Hasegawa M, 2013, MOD RHEUMATOL, V23, P1172, DOI [10.1007/s10165-012-0819-2, 10.3109/s10165-012-0819-2]; Huser CAM, 2006, OSTEOARTHR CARTILAGE, V14, P1002, DOI 10.1016/j.joca.2006.03.012; Iijima K, 2009, DIGEST DIS SCI, V54, P1500, DOI 10.1007/s10620-008-0507-4; Izawa T, 2012, MOL CELL BIOL, V32, P2943, DOI 10.1128/MCB.00077-12; Jiao K, 2011, BONE, V48, P362, DOI 10.1016/j.bone.2010.09.010; Jiao K, 2010, AM J ORTHOD DENTOFAC, V137, P460, DOI 10.1016/j.ajodo.2009.12.018; Jiao K, 2010, AM J ORTHOD DENTOFAC, V137, DOI 10.1016/j.ajodo.2009.09.018; Jiao K, 2009, APOPTOSIS, V14, P22, DOI 10.1007/s10495-008-0279-5; Alcaraz MJ, 2010, BIOCHEM PHARMACOL, V80, P13, DOI 10.1016/j.bcp.2010.02.017; Kapoor M, 2011, NAT REV RHEUMATOL, V7, P33, DOI 10.1038/nrrheum.2010.196; Kawai N, 2008, J OROFAC PAIN, V22, P153; Kim HA, 2001, J RHEUMATOL, V28, P2038; Kishimoto S, 2000, DIGEST DIS SCI, V45, P1608, DOI 10.1023/A:1005525313856; Kobayashi T, 2000, HISTOL HISTOPATHOL, V15, P1067, DOI 10.14670/HH-15.1067; Kohashi M, 2008, ARTHRITIS RHEUM, V58, P389, DOI 10.1002/art.23163; Kurimoto C, 2007, J RHEUMATOL, V34, P2035; Kuroda S, 2009, OSTEOARTHR CARTILAGE, V17, P1408, DOI 10.1016/j.joca.2009.04.025; Lee SY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080873; Moon SJ, 2012, OSTEOARTHR CARTILAGE, V20, P1426, DOI 10.1016/j.joca.2012.08.002; Moon SJ, 2014, ARTHRITIS RHEUMATOL, V66, P874, DOI 10.1002/art.38310; NAITO Y, 1995, FREE RADICAL BIO MED, V18, P117, DOI 10.1016/0891-5849(94)00110-6; Naito Y, 2010, EXPERT REV GASTROENT, V4, P261, DOI [10.1586/egh.10.25, 10.1586/EGH.10.25]; Najim RA, 2007, J DERMATOL, V34, P308, DOI 10.1111/j.1346-8138.2007.00278.x; Pelletier JP, 2000, ARTHRITIS RHEUM-US, V43, P1290, DOI 10.1002/1529-0131(200006)43:6<1290::AID-ANR11>3.0.CO;2-R; Remans PHJ, 2006, ARTHRITIS RHEUM, V54, P3135, DOI 10.1002/art.22139; Sharif M, 2004, ARTHRITIS RHEUM-US, V50, P507, DOI 10.1002/art.20020; Sobue T, 2011, J DENT RES, V90, P512, DOI 10.1177/0022034510390810; STADLER J, 1991, J IMMUNOL, V147, P3915; Studer R, 1999, OSTEOARTHR CARTILAGE, V7, P377, DOI 10.1053/joca.1998.0216; Takayanagi H, 2007, NAT REV IMMUNOL, V7, P292, DOI 10.1038/nri2062; Tanaka E, 2008, J DENT RES, V87, P296, DOI 10.1177/154405910808700406; Tanaka E, 2005, HISTOCHEM CELL BIOL, V123, P275, DOI 10.1007/s00418-005-0773-6; Tanaka H, 2013, BRIT J OPHTHALMOL, V97, P912, DOI 10.1136/bjophthalmol-2012-302868; Teitelbaum SL, 2003, NAT REV GENET, V4, P638, DOI 10.1038/nrg1122; Thomas CM, 2007, OSTEOARTHR CARTILAGE, V15, P27, DOI 10.1016/j.joca.2006.06.012; Tsai HY, 2008, EUR J PHARMACOL, V588, P124, DOI 10.1016/j.ejphar.2008.04.024; Tung JT, 2002, AM J VET RES, V63, P987, DOI 10.2460/ajvr.2002.63.987; Urashima H, 2012, J OCUL PHARMACOL TH, V28, P264, DOI 10.1089/jop.2011.0147; van den Berg WB, 1999, OSTEOARTHR CARTILAGE, V7, P413, DOI 10.1053/joca.1999.0228; Wadhwa S, 2005, OSTEOARTHR CARTILAGE, V13, P817, DOI 10.1016/j.joca.2005.04.016; Wang XJ, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0040084, 10.1371/journal.pone.0040711, 10.1371/journal.pone.0038932, 10.1371/journal.pone.0052707, 10.1371/journal.pone.0036663, 10.1371/journal.pone.0045380, 10.1371/journal.pone.0052082, 10.1371/journal.pone.0040857, 10.1371/journal.pone.0047429, 10.1371/journal.pone.0045939, 10.1371/journal.pone.0045036]; Xu L, 2009, OSTEOARTHR CARTILAGE, V17, P917, DOI 10.1016/j.joca.2009.01.002; Yang T, 2014, ARCH ORAL BIOL, V59, P962, DOI 10.1016/j.archoralbio.2014.05.024; Zhang J, 2013, J DENT RES, V92, P253, DOI 10.1177/0022034512473482; Zou W, 2013, MOL CELL BIOL, V33, P830, DOI 10.1128/MCB.00790-12	56	13	14	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 28	2016	11	4							e0154107	10.1371/journal.pone.0154107	http://dx.doi.org/10.1371/journal.pone.0154107			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DK8XE	27123995	gold, Green Published			2022-12-26	WOS:000375211700045
J	Zhang, K; Song, JC; Ni, K; Li, S				Zhang Kai; Song Jinchun; Ni Ke; Li Song			Lagrange Interpolation Learning Particle Swarm Optimization	PLOS ONE			English	Article							ALGORITHM	In recent years, comprehensive learning particle swarm optimization (CLPSO) has attracted the attention of many scholars for using in solving multimodal problems, as it is excellent in preserving the particles' diversity and thus preventing premature convergence. However, CLPSO exhibits low solution accuracy. Aiming to address this issue, we proposed a novel algorithm called LILPSO. First, this algorithm introduced a Lagrange interpolation method to perform a local search for the global best point (gbest). Second, to gain a better exemplar, one gbest, another two particle's historical best points (pbest) are chosen to perform Lagrange interpolation, then to gain a new exemplar, which replaces the CLPSO's comparison method. The numerical experiments conducted on various functions demonstrate the superiority of this algorithm, and the two methods are proven to be efficient for accelerating the convergence without leading the particle to premature convergence.	[Zhang Kai; Song Jinchun; Ni Ke; Li Song] Northeast Univ, Mech Engn & Automat, Shenyang, Peoples R China; [Zhang Kai] Northeast Univ, Hydraul Pneumat Inst, Mailbox 319, Shenyang, Peoples R China	Northeastern University - China; Northeastern University - China	Zhang, K (corresponding author), Northeast Univ, Mech Engn & Automat, Shenyang, Peoples R China.; Zhang, K (corresponding author), Northeast Univ, Hydraul Pneumat Inst, Mailbox 319, Shenyang, Peoples R China.	zk1210071@stumail.neu.edu.cn	Song, Jin/HHS-8731-2022					Ali H, 2013, APPL SOFT COMPUT, V13, P3903, DOI 10.1016/j.asoc.2013.04.015; Ardizzon G, 2015, INFORM SCIENCES, V299, P337, DOI 10.1016/j.ins.2014.12.024; Arpso T, 2002, DIVERSITY GUIDED PAR; Boyd S., 2010, SUBGRADIENT METHODS; By Y, 1998, P 7 ANN C EV PROGR; Du WB, 2015, APPL MATH COMPUT, V268, P832, DOI 10.1016/j.amc.2015.06.062; Gao Y, 2015, SCI REP-UK, V5, DOI 10.1038/srep09295; Haddow BPC, 2010, PROCEEDINGS OF THE 2; Hu MQ, 2012, INFORM SCIENCES, V213, P68, DOI 10.1016/j.ins.2012.05.020; Huang VL, 2006, INT J INTELL SYST, V21, P209, DOI 10.1002/int.20128; Iwasaki N, 2006, IEEJ T ELECTR ELECTR, V1, P353, DOI 10.1002/tee.20078; Kennedy J, 2002, IEEE C EVOL COMPUTAT, P1671, DOI 10.1109/CEC.2002.1004493; Kennedy J, 1995, 1995 IEEE INTERNATIONAL CONFERENCE ON NEURAL NETWORKS PROCEEDINGS, VOLS 1-6, P1942, DOI 10.1109/icnn.1995.488968; Kennedy J, 2003, SOFT COMP IND APPL 2; Kennedy J, 1999, EV COMP 1999 CEC 99; KIRKPATRICK S, 1983, SCIENCE, V220, P671, DOI 10.1126/science.220.4598.671; Leu MS, 2012, APPL SOFT COMPUT, V12, P2985, DOI 10.1016/j.asoc.2012.04.030; Liang JJ, 2006, IEEE T EVOLUT COMPUT, V10, P281, DOI 10.1109/TEVC.2005.857610; Liang JJ, 2005, EV COMP 2005 2005 IE; Liang JJ, 2006, SIM EV LEARN INT C S; Liu B, 2005, CHAOS SOLITON FRACT, V25, P1261, DOI 10.1016/j.chaos.2004.11.095; Liu C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097822; Michalewicz Z., 1996, GENETIC ALGORITHMS D, V3rd; Nasir M, 2012, INFORM SCIENCES, V209, P16, DOI 10.1016/j.ins.2012.04.028; Ni J.C., 2012, IEEE C EVOLUTIONARY, P1, DOI DOI 10.1109/CEC.2012.6256632; Noel MM, 2012, APPL SOFT COMPUT, V12, P353, DOI 10.1016/j.asoc.2011.08.037; Parsopoulos KE, 2005, LECT NOTES COMPUT SC, V3449, P590; Plevris V, 2011, COMPUT-AIDED CIV INF, V26, P48, DOI 10.1111/j.1467-8667.2010.00664.x; Salomon R, 1996, BIOSYSTEMS, V39, P263, DOI 10.1016/0303-2647(96)01621-8; Shi YH, 1998, IEEE C EVOL COMPUTAT, P69, DOI 10.1109/ICEC.1998.699146; Shieh HL, 2011, APPL MATH COMPUT, V218, P4365, DOI 10.1016/j.amc.2011.10.012; Victoire TAA, 2007, IEEE C EV COMP CEC 2; Wang H, 2013, INFORM SCIENCES, V223, P119, DOI 10.1016/j.ins.2012.10.012; Wang Y, 2011, INFORM SCIENCES, V181, P4515, DOI 10.1016/j.ins.2010.07.013; Wolpert D. H., 1997, IEEE Transactions on Evolutionary Computation, V1, P67, DOI 10.1109/4235.585893; Xu WX, 2013, INFORM SCIENCES, V218, P85, DOI 10.1016/j.ins.2012.06.003; Yildiz AR, 2011, J MECH DESIGN, V133, DOI 10.1115/1.4003038; Yu X, 2014, APPL MATH COMPUT, V242, P265, DOI 10.1016/j.amc.2014.05.044; Zhan ZH, 2011, IEEE T EVOLUT COMPUT, V15, P832, DOI 10.1109/TEVC.2010.2052054; Zhan ZH, 2009, IEEE T SYST MAN CY B, V39, P1362, DOI 10.1109/TSMCB.2009.2015956; Zhao XC, 2011, APPL SOFT COMPUT, V11, P1827, DOI 10.1016/j.asoc.2010.05.029; Zheng YJ, 2012, MATH PROBL ENG, V2012, DOI [10.3389/fneur.2012.00020, 10.1155/2012/207318]	42	4	6	1	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 28	2016	11	4							e0154191	10.1371/journal.pone.0154191	http://dx.doi.org/10.1371/journal.pone.0154191			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DK8XE	27123982	Green Published, gold, Green Submitted			2022-12-26	WOS:000375211700054
J	Lin, LY; Du, LM; Cao, K; Huang, Y; Yu, PF; Zhang, LY; Li, FY; Wang, Y; Shi, YF				Lin, L. Y.; Du, L. M.; Cao, K.; Huang, Y.; Yu, P. F.; Zhang, L. Y.; Li, F. Y.; Wang, Y.; Shi, Y. F.			Tumour cell-derived exosomes endow mesenchymal stromal cells with tumour-promotion capabilities	ONCOGENE			English	Article							STEM-CELLS; ANGIOGENESIS; PROGRESSION; BIOGENESIS; MICRORNAS	Mesenchymal stromal cells (MSCs) are a major component of the tumour microenvironment. A plethora of elegant studies focusing on tumour-derived MSCs have shown that they, unlike normal MSCs in other tissue, exhibit a strong ability to promote tumour progression. However, the mechanisms underlying the conversion of normal MSCs into tumour-associated MSCs are unknown. We report here a critical role of tumour cell-derived exosomes in endowing bone marrow-derived MSCs (BM-MSCs) with a tumour-favourable phenotype. Tumour cell-derived exosomes affected neither the growth factor production nor the immunosuppressive property of MSCs; rather, they endowed MSCs with a strong ability to promote macrophage infiltration into B16-F0 melanoma or EL-4 lymphoma. Ablation of macrophages by clodronate liposome administration reversed the tumour-promoting effect of MSCs educated by tumour cell-derived exosomes (TE-MSCs) on the tumour growth. By comparing the chemokine profile of BM-MSCs with that of TE-MSCs, we found that TE-MSCs produced a large amount of CCR2 ligands, CCL2 and CCL7, which are responsible for macrophage recruitment. CCR2-specific inhibitor was found to block the tumour-promoting effect of TE-MSCs. Thus, our investigations demonstrated that tumour cell-derived exosomes confer BM-MSCs the ability to enhance tumour growth. Therefore, we uncovered a novel mechanism underlying the conversion of normal MSCs to tumour-associated MSCs.	[Lin, L. Y.; Du, L. M.; Cao, K.; Huang, Y.; Yu, P. F.; Li, F. Y.; Wang, Y.; Shi, Y. F.] Univ Chinese Acad Sci, Chinese Acad Sci, Shanghai Inst Biol Sci, Key Lab Stem Cell Biol,Inst Hlth Sci, 320 Yueyang Rd, Shanghai 200030, Peoples R China; [Lin, L. Y.; Du, L. M.; Cao, K.; Huang, Y.; Yu, P. F.; Li, F. Y.; Wang, Y.; Shi, Y. F.] Shanghai Jiao Tong Univ Med, 320 Yueyang Rd, Shanghai 200030, Peoples R China; [Zhang, L. Y.; Shi, Y. F.] Soochow Univ, Inst Translat Med, Affiliated Hosp 1, 199 Renai Rd, Suzhou, Peoples R China	Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; University of Chinese Academy of Sciences, CAS; Shanghai Jiao Tong University; Soochow University - China	Wang, Y; Shi, YF (corresponding author), Univ Chinese Acad Sci, Chinese Acad Sci, Shanghai Inst Biol Sci, Key Lab Stem Cell Biol,Inst Hlth Sci, 320 Yueyang Rd, Shanghai 200030, Peoples R China.; Wang, Y; Shi, YF (corresponding author), Shanghai Jiao Tong Univ Med, 320 Yueyang Rd, Shanghai 200030, Peoples R China.	yingwang@sibs.ac.cn; yfshi@suda.edu.cn	HUANG, YIN/AAH-6871-2020; Yu, Pengfei/AHC-3497-2022; Du, Liming/M-8227-2019; cao, kai/AAG-6833-2021; Shi, Yufang/AAE-4431-2020	HUANG, YIN/0000-0001-5602-9871; Yu, Pengfei/0000-0002-3894-5697; Shi, Yufang/0000-0001-8964-319X; cao, kai/0000-0002-7939-7279; Du, Liming/0000-0002-0527-3556; wang, ying/0000-0002-2571-9367	Scientific Innovation Project of the Chinese Academy of Science [XDA 01040107]; Ministry of Science and Technology of China [2015CB964400]; Programs of National Natural Science of China [81330046, 81273316, 81530043, 81571612]; External Cooperation Program of BIC, Chinese Academy of Sciences [GJHZ201307]; Shanghai Municipal Key Projects of Basic Research [12JC1409200]; Shanghai Rising-Star Program [14QA1404200]	Scientific Innovation Project of the Chinese Academy of Science; Ministry of Science and Technology of China(Ministry of Science and Technology, China); Programs of National Natural Science of China(National Natural Science Foundation of China (NSFC)); External Cooperation Program of BIC, Chinese Academy of Sciences; Shanghai Municipal Key Projects of Basic Research; Shanghai Rising-Star Program	This study was supported by grants from the Scientific Innovation Project of the Chinese Academy of Science (XDA 01040107), the Ministry of Science and Technology of China (2015CB964400), the Programs of National Natural Science of China (81330046, 81273316, 81530043 and 81571612), the External Cooperation Program of BIC, Chinese Academy of Sciences (GJHZ201307), Shanghai Municipal Key Projects of Basic Research (12JC1409200) and Shanghai Rising-Star Program (14QA1404200).	Arendt LM, 2013, CANCER RES, V73, P6080, DOI 10.1158/0008-5472.CAN-13-0926; Azmi AS, 2013, CANCER METAST REV, V32, P623, DOI 10.1007/s10555-013-9441-9; Beckermann BM, 2008, BRIT J CANCER, V99, P622, DOI 10.1038/sj.bjc.6604508; Christianson HC, 2013, P NATL ACAD SCI USA, V110, P17380, DOI 10.1073/pnas.1304266110; Colombo M, 2014, ANNU REV CELL DEV BI, V30, P255, DOI 10.1146/annurev-cellbio-101512-122326; Cuiffo BG, 2014, CELL STEM CELL, V15, P762, DOI 10.1016/j.stem.2014.10.001; De Boeck A, 2013, GUT, V62, P550, DOI 10.1136/gutjnl-2011-301393; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Huang WH, 2013, ONCOGENE, V32, P4343, DOI 10.1038/onc.2012.458; Huang Y, 2014, ONCOGENE, V33, P3830, DOI 10.1038/onc.2013.355; Kidd S, 2009, STEM CELLS, V27, P2614, DOI 10.1002/stem.187; Lin R, 2013, STEM CELLS DEV, V22, P2836, DOI 10.1089/scd.2013.0166; Luga V, 2012, CELL, V151, P1542, DOI 10.1016/j.cell.2012.11.024; McLean K, 2011, J CLIN INVEST, V121, P3206, DOI 10.1172/JCI45273; Ono M, 2014, SCI SIGNAL, V7, DOI 10.1126/scisignal.2005231; Peinado H, 2012, NAT MED, V18, P883, DOI 10.1038/nm.2753; Qian BZ, 2010, CELL, V141, P39, DOI 10.1016/j.cell.2010.03.014; Quail DF, 2013, NAT MED, V19, P1423, DOI 10.1038/nm.3394; Ren G, 2014, ONCOGENE, V33, P4016, DOI 10.1038/onc.2013.387; Ren GW, 2008, CELL STEM CELL, V2, P141, DOI 10.1016/j.stem.2007.11.014; Ren GW, 2012, CELL STEM CELL, V11, P812, DOI 10.1016/j.stem.2012.08.013; Roccaro AM, 2013, J CLIN INVEST, V123, P1542, DOI 10.1172/JCI66517; Thery C, 2002, NAT REV IMMUNOL, V2, P569, DOI 10.1038/nri855; Umezu T, 2013, ONCOGENE, V32, P2747, DOI 10.1038/onc.2012.295; Valadi H, 2007, NAT CELL BIOL, V9, P654, DOI 10.1038/ncb1596; Wang Y, 2014, NAT IMMUNOL, V15, P1009, DOI 10.1038/ni.3002; Webber JP, 2015, ONCOGENE, V34, P319, DOI 10.1038/onc.2013.560	27	54	61	0	17	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	NOV 17	2016	35	46					6038	6042		10.1038/onc.2016.131	http://dx.doi.org/10.1038/onc.2016.131			5	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	ED0CA	27132512	Green Published, hybrid			2022-12-26	WOS:000388509400010
J	Mast, FD; Jamakhandi, A; Saleem, RA; Dilworth, DJ; Rogers, RS; Rachubinski, RA; Aitchison, JD				Mast, Fred D.; Jamakhandi, Arvind; Saleem, Ramsey A.; Dilworth, David J.; Rogers, Richard S.; Rachubinski, Richard A.; Aitchison, John D.			Peroxins Pex30 and Pex29 Dynamically Associate with Reticulons to Regulate Peroxisome Biogenesis from the Endoplasmic Reticulum	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MEMBRANE-PROTEINS; FLUORESCENT PROTEINS; ACTIN ORGANIZATION; SECRETORY PROTEINS; ZELLWEGER-SYNDROME; ROUGH MICROSOMES; GENE-EXPRESSION; GLOBAL ANALYSIS; MONOMERIC RED; PEX11 FAMILY	Peroxisome proliferation occurs by at least two routes, division of existing peroxisomes and de novo biogenesis from the endoplasmic reticulum (ER). The proteins and molecular mechanisms governing peroxisome emergence from the ER are poorly characterized. In this study, we report that two integral membrane peroxins (proteins required for peroxisome biogenesis) in Saccharomyces cerevisiae, Pex29 and Pex30, reside in distinct regions of the ER and associate with Rtn1 and Yop1, reticulon family members that contribute to ER morphology, to govern peroxisome emergence from the ER. In vivo and in vitro analyses reveal that peroxisome proliferation is therefore not restricted to the peroxisome but begins at the level of the ER.	[Mast, Fred D.; Jamakhandi, Arvind; Saleem, Ramsey A.; Dilworth, David J.; Rogers, Richard S.; Aitchison, John D.] Ctr Infect Dis Res, 307 Westlake Ave N, Seattle, WA 98109 USA; [Mast, Fred D.; Jamakhandi, Arvind; Saleem, Ramsey A.; Dilworth, David J.; Rogers, Richard S.; Aitchison, John D.] Inst Syst Biol, Seattle, WA 98109 USA; [Rachubinski, Richard A.] Univ Alberta, Dept Cell Biol, Edmonton, AB T6G 2H7, Canada; [Mast, Fred D.] Canadian Inst Hlth Res, Ottawa, ON, Canada	Center for Infectious Disease Research; Walter Reed Army Institute of Research (WRAIR); Institute for Systems Biology (ISB); University of Alberta; Institute for Work & Health	Aitchison, JD (corresponding author), Ctr Infect Dis Res, 307 Westlake Ave N, Seattle, WA 98109 USA.	john.aitchison@CIDResearch.org	Mast, Fred/AAM-2426-2021; Mast, Fred/A-6507-2011	Mast, Fred/0000-0002-2177-6647; Mast, Fred/0000-0002-2177-6647	National Institutes of Health [P50 GM076547, P41 GM109824]; Canadian Institutes for Health Research Foundation [143289]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P41GM109824, P50GM076547] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Canadian Institutes for Health Research Foundation(Canadian Institutes of Health Research (CIHR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Grants P50 GM076547 and P41 GM109824 (to J. D. A.) and by Canadian Institutes for Health Research Foundation Grant 143289 (to R. A. R.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Adames NR, 2001, J CELL BIOL, V153, P159, DOI 10.1083/jcb.153.1.159; ADAMS AEM, 1991, NATURE, V354, P404, DOI 10.1038/354404a0; Agne B, 2003, MOL CELL, V11, P635, DOI 10.1016/S1097-2765(03)00062-5; Agrawal G, 2016, J CELL BIOL, V212, P335, DOI 10.1083/jcb.201506141; Agrawal G, 2011, P NATL ACAD SCI USA, V108, P9113, DOI 10.1073/pnas.1018749108; AITCHISON JD, 1995, J CELL BIOL, V131, P1133, DOI 10.1083/jcb.131.5.1133; BARLOWE C, 1994, CELL, V77, P895, DOI 10.1016/0092-8674(94)90138-4; BLOBEL G, 1980, P NATL ACAD SCI-BIOL, V77, P1496, DOI 10.1073/pnas.77.3.1496; BLOBEL G, 1975, J CELL BIOL, V67, P852, DOI 10.1083/jcb.67.3.852; Bolte S, 2006, J MICROSC-OXFORD, V224, P213, DOI 10.1111/j.1365-2818.2006.01706.x; Braakman I, 2011, ANNU REV BIOCHEM, V80, P71, DOI 10.1146/annurev-biochem-062209-093836; Brown TW, 2000, MOL BIOL CELL, V11, P141, DOI 10.1091/mbc.11.1.141; BRUL S, 1988, BIOCHEM BIOPH RES CO, V152, P1083, DOI 10.1016/S0006-291X(88)80395-4; Campbell RE, 2002, P NATL ACAD SCI USA, V99, P7877, DOI 10.1073/pnas.082243699; Chadrin A, 2010, J CELL BIOL, V189, P795, DOI 10.1083/jcb.200910043; Chang JL, 2015, J CELL SCI, V128, P1327, DOI 10.1242/jcs.157743; Cook JG, 1997, NATURE, V390, P85, DOI 10.1038/36355; Cristea I. M., 2011, COLD SPRING HARB PRO, V2011; David C, 2013, MOL CELL PROTEOMICS, V12, P2408, DOI 10.1074/mcp.M112.017830; De Craene JO, 2006, MOL BIOL CELL, V17, P3009, DOI 10.1091/mbc.e06-01-0080; Dilworth DJ, 2005, J CELL BIOL, V171, P955, DOI 10.1083/jcb.200509061; Dilworth DJ, 2001, J CELL BIOL, V153, P1465, DOI 10.1083/jcb.153.7.1465; Distel B, 1996, J CELL BIOL, V135, P1, DOI 10.1083/jcb.135.1.1; Dubois-Dalcq M, 1999, TRENDS NEUROSCI, V22, P4, DOI 10.1016/S0166-2236(98)01319-8; ERDMANN R, 1995, J CELL BIOL, V128, P509, DOI 10.1083/jcb.128.4.509; Fagarasanu A, 2009, J CELL BIOL, V186, P541, DOI 10.1083/jcb.200904050; Faulhammer F, 2005, J CELL BIOL, V168, P185, DOI 10.1083/jcb.200407118; Faulhammer F, 2007, TRAFFIC, V8, P1554, DOI 10.1111/j.1600-0854.2007.00632.x; Gari E, 1997, YEAST, V13, P837, DOI 10.1002/(SICI)1097-0061(199707)13:9<837::AID-YEA145>3.0.CO;2-T; Giaever G, 2002, NATURE, V418, P387, DOI 10.1038/nature00935; Graschopf A, 2001, J BIOL CHEM, V276, P16216, DOI 10.1074/jbc.M101504200; Hakhverdyan Z, 2015, NAT METHODS, V12, P553, DOI 10.1038/nmeth.3395; Hammond AT, 2000, TRAFFIC, V1, P935, DOI 10.1034/j.1600-0854.2000.011203.x; Hettema EH, 2014, CURR OPIN CELL BIOL, V29, P25, DOI 10.1016/j.ceb.2014.02.002; Hoepfner D, 2005, CELL, V122, P85, DOI 10.1016/j.cell.2005.04.025; Hu JJ, 2008, SCIENCE, V319, P1247, DOI 10.1126/science.1153634; Hu JJ, 2009, CELL, V138, P549, DOI 10.1016/j.cell.2009.05.025; Huber A, 2012, TRAFFIC, V13, P157, DOI 10.1111/j.1600-0854.2011.01290.x; Hughes TR, 2000, CELL, V102, P109, DOI 10.1016/S0092-8674(00)00015-5; Huh WK, 2003, NATURE, V425, P686, DOI 10.1038/nature02026; JACKSON RC, 1977, P NATL ACAD SCI USA, V74, P5598, DOI 10.1073/pnas.74.12.5598; Janke C, 2004, YEAST, V21, P947, DOI 10.1002/yea.1142; Keller A, 2002, ANAL CHEM, V74, P5383, DOI 10.1021/ac025747h; Keller A, 2005, MOL SYST BIOL, V1, DOI 10.1038/msb4100024; Knoblach B, 2013, EMBO J, V32, P2439, DOI 10.1038/emboj.2013.170; Knoblach B, 2010, J BIOL CHEM, V285, P6670, DOI 10.1074/jbc.M109.094805; Koch J, 2010, J CELL SCI, V123, P3389, DOI 10.1242/jcs.064907; Konrad G, 2002, J BIOL CHEM, V277, P10547, DOI 10.1074/jbc.M200090200; Kornmann B, 2009, SCIENCE, V325, P477, DOI 10.1126/science.1175088; Krogan NJ, 2006, NATURE, V440, P637, DOI 10.1038/nature04670; Lam SK, 2010, P NATL ACAD SCI USA, V107, P21523, DOI 10.1073/pnas.1013397107; Li Q, 2004, J NEUROSCI, V24, P4070, DOI 10.1523/JNEUROSCI.0346-04.2004; Lynes EM, 2011, BBA-MOL CELL RES, V1813, P1893, DOI 10.1016/j.bbamcr.2011.06.011; Ma CL, 2011, J CELL BIOL, V193, P7, DOI 10.1083/jcb.201010022; MANDERS EMM, 1992, J CELL SCI, V103, P857; Manford AG, 2012, DEV CELL, V23, P1129, DOI 10.1016/j.devcel.2012.11.004; Marelli M, 2004, J CELL BIOL, V167, P1099, DOI 10.1083/jcb.200404119; Mast FD, 2015, CURR OPIN CELL BIOL, V35, P131, DOI 10.1016/j.ceb.2015.05.002; Matsuzono Y, 1999, P NATL ACAD SCI USA, V96, P2116, DOI 10.1073/pnas.96.5.2116; Mnaimneh S, 2004, CELL, V118, P31, DOI 10.1016/j.cell.2004.06.013; Motley AM, 2007, J CELL BIOL, V178, P399, DOI 10.1083/jcb.200702167; Motley AM, 2015, J CELL BIOL, V211, P1041, DOI 10.1083/jcb.201412066; Oeffinger M, 2007, NAT METHODS, V4, P951, DOI 10.1038/NMETH1101; Opalinski L, 2011, EMBO J, V30, P5, DOI 10.1038/emboj.2010.299; Orso G, 2009, NATURE, V460, P978, DOI 10.1038/nature08280; Passreiter M, 1998, J CELL BIOL, V141, P373, DOI 10.1083/jcb.141.2.373; Pawley J.B., 2006, HDB BIOL CONFOCAL MI, DOI [10.1007/978-0-387-45524-2_23, 10.1007/978-0-387-45524-2, DOI 10.1007/978-0-387-45524-2]; Perry RJ, 2009, EUKARYOT CELL, V8, P830, DOI 10.1128/EC.00024-09; PREUSS D, 1991, YEAST, V7, P891, DOI 10.1002/yea.320070902; Prinz WA, 2000, J CELL BIOL, V150, P461, DOI 10.1083/jcb.150.3.461; Ptacek J, 2005, NATURE, V438, P679, DOI 10.1038/nature04187; Raychaudhuri S, 2008, P NATL ACAD SCI USA, V105, P15785, DOI 10.1073/pnas.0808321105; Roberg KJ, 1997, J CELL BIOL, V137, P1469, DOI 10.1083/jcb.137.7.1469; ROSE MD, 1989, CELL, V57, P1211, DOI 10.1016/0092-8674(89)90058-5; Rottensteiner H, 2003, MOL BIOL CELL, V14, P4316, DOI 10.1091/mbc.E03-03-0153; Rout MP, 1997, CELL, V89, P715, DOI 10.1016/S0092-8674(00)80254-8; Saleem RA, 2008, J CELL BIOL, V181, P281, DOI 10.1083/jcb.200710009; Shaner NC, 2004, NAT BIOTECHNOL, V22, P1567, DOI 10.1038/nbt1037; Shevchenko A, 2006, NAT PROTOC, V1, P2856, DOI 10.1038/nprot.2006.468; Siniossoglou S, 1996, CELL, V84, P265, DOI 10.1016/S0092-8674(00)80981-2; Smith JJ, 2013, NAT REV MOL CELL BIO, V14, P803, DOI 10.1038/nrm3700; Smith JJ, 2002, J CELL BIOL, V158, P259, DOI 10.1083/jcb.200204059; Stefan CJ, 2013, CURR OPIN CELL BIOL, V25, P434, DOI 10.1016/j.ceb.2013.02.020; Stefan CJ, 2011, CELL, V144, P389, DOI 10.1016/j.cell.2010.12.034; Tackett AJ, 2005, J PROTEOME RES, V4, P1752, DOI 10.1021/pr050225e; Tackett AJ, 2005, J CELL BIOL, V169, P35, DOI 10.1083/jcb.200502104; Tam YYC, 2005, J BIOL CHEM, V280, P34933, DOI 10.1074/jbc.M506208200; Tam YYC, 2003, MOL BIOL CELL, V14, P4089, DOI 10.1091/mbc.E03-03-0150; Tam YYC, 2002, MOL BIOL CELL, V13, P2681, DOI 10.1091/mbc.E02-02-0117; Titorenko VI, 2000, J CELL BIOL, V148, P29, DOI 10.1083/jcb.148.1.29; Titorenko VI, 1997, MOL CELL BIOL, V17, P5210, DOI 10.1128/MCB.17.9.5210; Titorenko VI, 1998, MOL CELL BIOL, V18, P2789, DOI 10.1128/MCB.18.5.2789; Titorenko VI, 2001, NAT REV MOL CELL BIO, V2, P357, DOI 10.1038/35073063; Titorenko VI, 2000, J CELL BIOL, V150, P881, DOI 10.1083/jcb.150.4.881; Titorenko VI, 2009, INT REV CEL MOL BIO, V272, P191, DOI 10.1016/S1937-6448(08)01605-5; Tower RJ, 2011, MOL BIOL CELL, V22, P1727, DOI 10.1091/mbc.E11-01-0084; van der Zand A, 2012, CELL, V149, P397, DOI 10.1016/j.cell.2012.01.054; vanSteensel B, 1996, J CELL SCI, V109, P787; Vizeacoumar FJ, 2004, MOL BIOL CELL, V15, P665, DOI 10.1091/mbc.E03-09-0681; Vizeacoumar FJ, 2003, J CELL BIOL, V161, P321, DOI 10.1083/jcb.200210130; Voeltz GK, 2006, CELL, V124, P573, DOI 10.1016/j.cell.2005.11.047; Voss C, 2012, J CELL SCI, V125, P4791, DOI 10.1242/jcs.105635; Wanders RJA, 2005, CLIN GENET, V67, P107, DOI 10.1111/j.1399-0004.2004.00329.x; Yan M, 2008, MOL BIOL CELL, V19, P885, DOI 10.1091/mbc.E07-10-1042	104	33	33	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 22	2016	291	30					15408	15427		10.1074/jbc.M116.728154	http://dx.doi.org/10.1074/jbc.M116.728154			20	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DS2HD	27129769	hybrid, Green Published			2022-12-26	WOS:000380584200001
J	Kumar, R; Hazan, A; Basu, A; Zalcman, N; Matzner, H; Priel, A				Kumar, Rakesh; Hazan, Adina; Basu, Arijit; Zalcman, Nomi; Matzner, Henry; Priel, Avi			Tyrosine Residue in the TRPV1 Vanilloid Binding Pocket Regulates Deactivation Kinetics	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						electrophysiology; gating; site-directed mutagenesis; structure-function; transient receptor potential channels (TRP channels)	CAPSAICIN RECEPTOR; ION-CHANNEL; PAIN PATHWAY; ACTIVATION; RESINIFERATOXIN; PHOSPHORYLATION; DESENSITIZATION; SENSITIVITY; MECHANISMS; LIGANDS	Vanilloids are pain evoking molecules that serve as ligands of the heat and capsaicin receptor TRPV1. Binding of either endogenous or exogenous vanilloids evokes channel and subsequent neuronal activation, leading to pain sensation. Despite its pivotal physiological role, the molecular basis of TRPV1 activation and deactivation is not fully understood. The highly conserved tyrosine in position 511 (Tyr(511)) of the rat TRPV1 (rTRPV1) was the first residue to be identified as a necessary participant in the vanilloid-mediated response. rTRPV1 cryo-EM structures implicated rotation of this residue in the vanilloids bound state. Therefore, we hypothesize that the rTRPV1 Tyr(511) residue entraps vanilloids in their binding site, prolonging channel activity. To test our hypothesis, we generated an array of rTRPV1 mutants, containing the whole spectrum of Tyr(511) substitutions, and tested their response to both exo- and endovanilloids. Our data show that only substitutions of Tyr(511) to aromatic amino acids were able to mimic, albeit partially, the vanilloid-evoked activation pattern of the wt receptor. Although these substitutions reduced the channel sensitivity to vanilloids, a maximal open-channel lifetime could be achieved. Moreover, whereas their current activation rate remains intact, receptors with Tyr(511) substitutions exhibited a faster current deactivation. Our findings therefore suggest that the duration of channel activity evoked by vanilloids is regulated by the interaction between Tyr(511) and the agonist. To conclude, we suggest that Tyr(511)-mediated anchoring of vanilloids in their binding pocket is pivotal for TRPV1 activation and subsequent pain sensation.	[Kumar, Rakesh; Hazan, Adina; Basu, Arijit; Zalcman, Nomi; Matzner, Henry; Priel, Avi] Hebrew Univ Jerusalem, Sch Pharm, Inst Drug Res, Fac Med, IL-91120 Jerusalem, Israel	Hebrew University of Jerusalem	Priel, A (corresponding author), Hebrew Univ Jerusalem, Sch Pharm, Inst Drug Res, Fac Med, IL-91120 Jerusalem, Israel.	avip@ekmd.huji.ac.il	kumar, rakesh/ABE-8708-2020; Priel, Avi/ABB-1721-2020	kumar, rakesh/0000-0001-9693-4374; Priel, Avi/0000-0002-6105-5035	Israel Science Foundation [1721/12, 1368/12]; Marie-Curie Career Integration Grant [FP7-CIG-321899]; Jerusalem Brain Committee (JBC) Postdoctoral Fellowship; Kaete Klausner fellowship; Fellowship Program for Outstanding Post-Doctoral Researchers of the Planning and Budget Commission of Israel	Israel Science Foundation(Israel Science Foundation); Marie-Curie Career Integration Grant; Jerusalem Brain Committee (JBC) Postdoctoral Fellowship; Kaete Klausner fellowship; Fellowship Program for Outstanding Post-Doctoral Researchers of the Planning and Budget Commission of Israel	This work was supported in part by the Israel Science Foundation Grants 1721/12 and 1368/12 (to A. P.), Marie-Curie Career Integration Grant FP7-CIG-321899 (to A. P.), a Jerusalem Brain Committee (JBC) Postdoctoral Fellowship (to R. K.), the Kaete Klausner fellowship (to A. H), and the Fellowship Program for Outstanding Post-Doctoral Researchers of the Planning and Budget Commission of Israel (to A. B.). The authors declare that they have no conflicts of interest with the contents of this article.	Basbaum AI, 2009, CELL, V139, P267, DOI 10.1016/j.cell.2009.09.028; Bevan S, 2014, HANDB EXP PHARMACOL, V222, P207, DOI 10.1007/978-3-642-54215-2_9; Bohlen CJ, 2010, CELL, V141, P834, DOI 10.1016/j.cell.2010.03.052; Boukalova S, 2010, J BIOL CHEM, V285, P41455, DOI 10.1074/jbc.M110.145466; Cao EH, 2013, NATURE, V504, P113, DOI 10.1038/nature12823; Caterina MJ, 2007, AM J PHYSIOL-REG I, V292, pR64, DOI 10.1152/ajpregu.00446.2006; Caterina MJ, 2001, ANNU REV NEUROSCI, V24, P487, DOI 10.1146/annurev.neuro.24.1.487; Caterina MJ, 1997, NATURE, V389, P816, DOI 10.1038/39807; Chou MZ, 2004, BIOCHEMISTRY-US, V43, P2501, DOI 10.1021/bi035981h; Colton C. K., 2007, V179, P173; Darre L, 2015, MOL PHARMACEUT, V12, P4454, DOI 10.1021/acs.molpharmaceut.5b00641; DELCASTILLO J, 1957, PROC R SOC SER B-BIO, V146, P369; Dubin AE, 2010, J CLIN INVEST, V120, P3760, DOI 10.1172/JCI42843; Elokely K, 2016, P NATL ACAD SCI USA, V113, pE137, DOI 10.1073/pnas.1517288113; Galzi JL, 1996, P NATL ACAD SCI USA, V93, P1853, DOI 10.1073/pnas.93.5.1853; Gavva NR, 2004, J BIOL CHEM, V279, P20283, DOI 10.1074/jbc.M312577200; Hanson SM, 2015, BIOPHYS J, V108, P1425, DOI 10.1016/j.bpj.2015.02.013; Hazan A, 2015, SCI REP-UK, V5, DOI 10.1038/srep12278; Jordt SE, 2000, P NATL ACAD SCI USA, V97, P8134, DOI 10.1073/pnas.100129497; Jordt SE, 2002, CELL, V108, P421, DOI 10.1016/S0092-8674(02)00637-2; Julius D, 2013, ANNU REV CELL DEV BI, V29, P355, DOI 10.1146/annurev-cellbio-101011-155833; Liao MF, 2013, NATURE, V504, P107, DOI 10.1038/nature12822; Meyer EA, 2003, ANGEW CHEM INT EDIT, V42, P1210, DOI 10.1002/anie.200390319; O'Neill J, 2012, PHARMACOL REV, V64, P939, DOI 10.1124/pr.112.006163; Piomelli D, 2014, NAT NEUROSCI, V17, P164, DOI 10.1038/nn.3612; Premkumar LS, 2004, J NEUROPHYSIOL, V91, P1442, DOI 10.1152/jn.00745.2003; Priel A, 2004, J GEN PHYSIOL, V123, P281, DOI 10.1085/jgp.200308986; Priel A, 2005, J NEUROSCI, V25, P2682, DOI 10.1523/JNEUROSCI.4834-04.2005; Ryu SJ, 2003, J GEN PHYSIOL, V122, P45, DOI 10.1085/jgp.200308847; Ryu SJ, 2007, J NEUROSCI, V27, P12797, DOI 10.1523/JNEUROSCI.2324-07.2007; Siemens J, 2006, NATURE, V444, P208, DOI 10.1038/nature05285; Studer M, 2010, J PHYSIOL-LONDON, V588, P3743, DOI 10.1113/jphysiol.2010.190611; Szallasi A, 2007, NAT REV DRUG DISCOV, V6, P357, DOI 10.1038/nrd2280; Tominaga M, 1998, NEURON, V21, P531, DOI 10.1016/S0896-6273(00)80564-4; Touska F, 2011, CURR PHARM BIOTECHNO, V12, P122, DOI 10.2174/138920111793937826; Trapani JG, 2003, BMC NEUROSCI, V4, DOI 10.1186/1471-2202-4-15; van der Stelt M, 2004, EUR J BIOCHEM, V271, P1827, DOI 10.1111/j.1432-1033.2004.04081.x; Vriens J, 2009, MOL PHARMACOL, V75, P1262, DOI 10.1124/mol.109.055624; Winter Z, 2013, MOL PAIN, V9, DOI 10.1186/1744-8069-9-30; Yang F, 2015, NAT CHEM BIOL, V11, P518, DOI [10.1038/NCHEMBIO.1835, 10.1038/nchembio.1835]; Zagotta WN, 2015, HDB ION CHANNELS, P41, DOI [10.1201/b18027, DOI 10.1201/B18027]; Zygmunt PM, 1999, NATURE, V400, P452, DOI 10.1038/22761	42	12	12	1	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 24	2016	291	26					13855	13863		10.1074/jbc.M116.726372	http://dx.doi.org/10.1074/jbc.M116.726372			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DR2YZ	27143360	hybrid, Green Published			2022-12-26	WOS:000379771100039
J	Young, SK; Shao, Y; Bidwell, JP; Wek, RC				Young, Sara K.; Shao, Yu; Bidwell, Joseph P.; Wek, Ronald C.			Nuclear Matrix Protein 4 Is a Novel Regulator of Ribosome Biogenesis and Controls the Unfolded Protein Response via Repression of Gadd34 Expression	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						endoplasmic reticulum stress (ER stress); eukaryotic initiation factor 2 (eIF2); protein synthesis; translation control; unfolded protein response (UPR); protein homeostasis	ENDOPLASMIC-RETICULUM STRESS; TRANSLATIONAL CONTROL; TRANSCRIPTION FACTORS; OSTEOBLAST DIFFERENTIATION; MAMMALIAN-CELLS; ER-STRESS; GENE; KINASE; BONE; DEPHOSPHORYLATION	The unfolded protein response (UPR) maintains protein homeostasis by governing the processing capacity of the endoplasmic reticulum (ER) to manage ER client loads; however, key regulators within the UPR remain to be identified. Activation of the UPR sensor PERK (EIFAK3/PEK) results in the phosphorylation of the subunit of eIF2 (eIF2-P), which represses translation initiation and reduces influx of newly synthesized proteins into the overloaded ER. As part of this adaptive response, eIF2-P also induces a feedback mechanism through enhanced transcriptional and translational expression of Gadd34 (Ppp1r15A),which targets type 1 protein phosphatase for dephosphorylation of eIF2-P to restore protein synthesis. Here we describe a novel mechanism by which Gadd34 expression is regulated through the activity of the zinc finger transcription factor NMP4 (ZNF384, CIZ). NMP4 functions to suppress bone anabolism, and we suggest that this occurs due to decreased protein synthesis of factors involved in bone formation through NMP4-mediated dampening of Gadd34 and c-Myc expression. Loss of Nmp4 resulted in an increase in c-Myc and Gadd34 expression that facilitated enhanced ribosome biogenesis and global protein synthesis. Importantly, protein synthesis was sustained during pharmacological induction of the UPR through a mechanism suggested to involve GADD34-mediated dephosphorylation of eIF2-P. Sustained protein synthesis sensitized cells to pharmacological induction of the UPR, and the observed decrease in cell viability was restored upon inhibition of GADD34 activity. We conclude that NMP4 is a key regulator of ribosome biogenesis and the UPR, which together play a central role in determining cell viability during endoplasmic reticulum stress.	[Young, Sara K.; Wek, Ronald C.] Indiana Univ Sch Med, Dept Biochem & Mol Biol, 635 Barnhill Dr, Indianapolis, IN 46202 USA; [Bidwell, Joseph P.] Indiana Univ Sch Med, Dept Anat & Cell Biol, 635 Barnhill Dr, Indianapolis, IN 46202 USA; [Shao, Yu] Indiana Univ Sch Med, Dept Med & Mol Genet, Indianapolis, IN 46202 USA	Indiana University System; Indiana University Bloomington; Indiana University System; Indiana University Bloomington; Indiana University System; Indiana University Bloomington	Wek, RC (corresponding author), Indiana Univ Sch Med, Dept Biochem & Mol Biol, 635 Barnhill Dr, Indianapolis, IN 46202 USA.; Bidwell, JP (corresponding author), Indiana Univ Sch Med, Dept Anat & Cell Biol, 635 Barnhill Dr, Indianapolis, IN 46202 USA.	jbidwell@iu.edu; rwek@iu.edu		Young-Baird, Sara/0000-0002-8915-3139	National Institutes of Health [GM049164]; Ralph W. and Grace M. Showalter Research Trust Fund; Department of Defense [PR120563]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM049164] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ralph W. and Grace M. Showalter Research Trust Fund; Department of Defense(United States Department of Defense); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM049164 (to R. C. W.). This work was also supported by the Ralph W. and Grace M. Showalter Research Trust Fund (to R. C. W.) and Department of Defense Grant PR120563 (to J. P. B.). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. The authors declare no conflicts of interest with the contents of this manuscript.	Alvarez M, 2005, GENE, V347, P43, DOI 10.1016/j.gene.2004.10.025; Baird TD, 2012, ADV NUTR, V3, P307, DOI 10.3945/an.112.002113; Bernales S, 2006, ANNU REV CELL DEV BI, V22, P487, DOI 10.1146/annurev.cellbio.21.122303.120200; Boyce M, 2005, SCIENCE, V307, P935, DOI 10.1126/science.1101902; Childress P, 2015, MOL ENDOCRINOL, V29, P1269, DOI 10.1210/me.2014-1406; Childress P, 2011, CALCIFIED TISSUE INT, V89, P74, DOI 10.1007/s00223-011-9496-y; Connor JH, 2001, MOL CELL BIOL, V21, P6841, DOI 10.1128/MCB.21.20.6841-6850.2001; Feister HA, 2000, J CELL BIOCHEM, V79, P506, DOI 10.1002/1097-4644(20001201)79:3<506::AID-JCB150>3.3.CO;2-1; Han J, 2013, NAT CELL BIOL, V15, P481, DOI 10.1038/ncb2738; Harding HP, 1999, NATURE, V397, P271, DOI 10.1038/16729; Harding HP, 2000, MOL CELL, V5, P897, DOI 10.1016/S1097-2765(00)80330-5; Harding HP, 2000, MOL CELL, V6, P1099, DOI 10.1016/S1097-2765(00)00108-8; Harding HP, 2003, MOL CELL, V11, P619, DOI 10.1016/S1097-2765(03)00105-9; Iadevaia V, 2014, SEMIN CELL DEV BIOL, V36, P113, DOI 10.1016/j.semcdb.2014.08.004; Jang WG, 2012, J BIOL CHEM, V287, P905, DOI 10.1074/jbc.M111.253187; Jousse C, 2003, J CELL BIOL, V163, P767, DOI 10.1083/jcb.200308075; Karsenty G, 2008, ANNU REV GENOM HUM G, V9, P183, DOI 10.1146/annurev.genom.9.081307.164437; Kondo S, 2011, IUBMB LIFE, V63, P233, DOI 10.1002/iub.433; Lee YY, 2009, J BIOL CHEM, V284, P6661, DOI 10.1074/jbc.M806735200; Ma YJ, 2003, J BIOL CHEM, V278, P34864, DOI 10.1074/jbc.M301107200; Marciniak SJ, 2004, GENE DEV, V18, P3066, DOI 10.1101/gad.1250704; Mertins P, 2014, MOL CELL PROTEOMICS, V13, P1690, DOI 10.1074/mcp.M113.036392; Murakami T, 2009, NAT CELL BIOL, V11, P1205, DOI 10.1038/ncb1963; Nakamoto T, 2000, MOL CELL BIOL, V20, P1649, DOI 10.1128/MCB.20.5.1649-1658.2000; Novoa I, 2001, J CELL BIOL, V153, P1011, DOI 10.1083/jcb.153.5.1011; Preston AM, 2013, J CELL SCI, V126, P4253, DOI 10.1242/jcs.130336; Robling AG, 2009, J CELL PHYSIOL, V219, P734, DOI 10.1002/jcp.21717; Saito A, 2011, J BIOL CHEM, V286, P4809, DOI 10.1074/jbc.M110.152900; Scheuner D, 2001, MOL CELL, V7, P1165, DOI 10.1016/S1097-2765(01)00265-9; Sharma K, 2014, CELL REP, V8, P1583, DOI 10.1016/j.celrep.2014.07.036; Shi YG, 1998, MOL CELL BIOL, V18, P7499, DOI 10.1128/MCB.18.12.7499; Thoreen CC, 2009, J BIOL CHEM, V284, P8023, DOI 10.1074/jbc.M900301200; Thunyakitpisal P, 2001, J BONE MINER RES, V16, P10, DOI 10.1359/jbmr.2001.16.1.10; Tohmonda T, 2011, EMBO REP, V12, P451, DOI 10.1038/embor.2011.34; van Riggelen J, 2010, NAT REV CANCER, V10, P301, DOI 10.1038/nrc2819; Vattem KM, 2004, P NATL ACAD SCI USA, V101, P11269, DOI 10.1073/pnas.0400541101; Walter P, 2011, SCIENCE, V334, P1081, DOI 10.1126/science.1209038; Wei JW, 2008, J CELL PHYSIOL, V217, P693, DOI 10.1002/jcp.21543; Wu XH, 2006, HUM MOL GENET, V15, P2837, DOI 10.1093/hmg/ddl208; Young SK, 2015, J BIOL CHEM, V290, P28257, DOI 10.1074/jbc.M115.693184	40	13	13	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 24	2016	291	26					13780	13788		10.1074/jbc.M116.729830	http://dx.doi.org/10.1074/jbc.M116.729830			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DR2YZ	27129771	Green Published, hybrid			2022-12-26	WOS:000379771100032
J	Broer, A; Rahimi, F; Broer, S				Broer, Angelika; Rahimi, Farid; Broer, Stefan			Deletion of Amino Acid Transporter ASCT2 (SLC1A5) Reveals an Essential Role for Transporters SNAT1 (SLC38A1) and SNAT2 (SLC38A2) to Sustain Glutaminolysis in Cancer Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN HEPATOMA-CELLS; GENE-EXPRESSION; SYSTEM-N; COPY-NUMBER; METABOLISM; CARCINOMA; GROWTH; PATHWAYS; PHOSPHORYLATION; INHIBITORS	Many cancer cells depend on glutamine as they use the glutaminolysis pathway to generate building blocks and energy for anabolic purposes. As a result, glutamine transporters are essential for cancer growth and are potential targets for cancer chemotherapy with ASCT2 (SLC1A5) being investigated most intensively. Here we show that HeLa epithelial cervical cancer cells and 143B osteosarcoma cells express a set of glutamine transporters including SNAT1 (SLC38A1), SNAT2 (SLC38A2), SNAT4 (SLC38A4), LAT1 (SLC7A5), and ASCT2 (SLC1A5). Net glutamine uptake did not depend on ASCT2 but required expression of SNAT1 and SNAT2. Deletion of ASCT2 did not reduce cell growth but caused an amino acid starvation response and up-regulation of SNAT1 to replace ASCT2 functionally. Silencing of GCN2 in the ASCT2(-/-) background reduced cell growth, showing that a combined targeted approach would inhibit growth of glutamine-dependent cancer cells.	[Broer, Angelika; Rahimi, Farid; Broer, Stefan] Australian Natl Univ, Res Sch Biol, Linnaeus Way 134, Canberra, ACT 2601, Australia	Australian National University	Broer, S (corresponding author), Australian Natl Univ, Res Sch Biol, Linnaeus Way 134, Canberra, ACT 2601, Australia.	Stefan.broeer@anu.edu.au	Broer, Stefan/A-1286-2008; Rahimi, Farid/E-6522-2018	Broer, Stefan/0000-0002-8040-1634; Rahimi, Farid/0000-0002-0920-8188				Baird FE, 2004, J PHYSIOL-LONDON, V559, P367, DOI 10.1113/jphysiol.2003.060293; Barretina J, 2012, NATURE, V483, P603, DOI 10.1038/nature11003; Bayley JP, 2012, CURR OPIN ONCOL, V24, P62, DOI 10.1097/CCO.0b013e32834deb9e; Beroukhim R, 2009, CANCER RES, V69, P4674, DOI 10.1158/0008-5472.CAN-09-0146; Bode BP, 2002, AM J PHYSIOL-GASTR L, V283, pG1062, DOI 10.1152/ajpgi.00031.2002; Boroughs LK, 2015, NAT CELL BIOL, V17, P351, DOI 10.1038/ncb3124; Broer A, 2000, BIOCHEM J, V346, P705, DOI 10.1042/0264-6021:3460705; Broer A, 1999, J NEUROCHEM, V73, P2184; Broer Stefan, 2003, Methods Mol Biol, V227, P245, DOI 10.1385/1-59259-387-9:245; Bror S, 2014, PFLUG ARCH EUR J PHY, V466, P155, DOI 10.1007/s00424-013-1393-y; Chandel NS., 2015, NAVIGATING METABOLIS; D'Aniello C, 2015, CELL DEATH DIFFER, V22, P1234, DOI 10.1038/cdd.2015.64; DeBerardinis RJ, 2007, P NATL ACAD SCI USA, V104, P19345, DOI 10.1073/pnas.0709747104; Deitmer JW, 2003, J NEUROCHEM, V87, P127, DOI 10.1046/j.1471-4159.2003.01981.x; Esslinger CS, 2005, BIOORGAN MED CHEM, V13, P1111, DOI 10.1016/j.bmc.2004.11.028; Frew IJ, 2015, ANNU REV PATHOL-MECH, V10, P263, DOI 10.1146/annurev-pathol-012414-040306; Fuchs BC, 2005, SEMIN CANCER BIOL, V15, P254, DOI 10.1016/j.semcancer.2005.04.005; Fuchs BC, 2004, AM J PHYSIOL-GASTR L, V286, pG467, DOI 10.1152/ajpgi.00344.2003; Fuchs BC, 2007, AM J PHYSIOL-CELL PH, V293, pC55, DOI 10.1152/ajpcell.00330.2006; Gaccioli F, 2006, J BIOL CHEM, V281, P17929, DOI 10.1074/jbc.M600341200; Gazzola RF, 2001, FEBS LETT, V490, P11; Grewer C, 2004, J PHYSIOL-LONDON, V557, P747, DOI 10.1113/jphysiol.2004.062521; Gumz ML, 2007, CLIN CANCER RES, V13, P4740, DOI 10.1158/1078-0432.CCR-07-0143; Heiden MGV, 2009, SCIENCE, V324, P1029, DOI 10.1126/science.1160809; Hellman NE, 2008, J BIOL CHEM, V283, P4272, DOI 10.1074/jbc.M708027200; Hitosugi T, 2011, MOL CELL, V44, P864, DOI 10.1016/j.molcel.2011.10.015; Hyde R, 2003, BIOCHEM J, V373, P1, DOI 10.1042/BJ20030405; Hyde R, 2007, J BIOL CHEM, V282, P19788, DOI 10.1074/jbc.M611520200; Jeon YJ, 2015, CANCER CELL, V27, P354, DOI 10.1016/j.ccell.2015.02.006; Kaira K, 2008, CANCER SCI, V99, P2380, DOI 10.1111/j.1349-7006.2008.00969.x; Kilberg MS, 2009, TRENDS ENDOCRIN MET, V20, P436, DOI 10.1016/j.tem.2009.05.008; Kim D, 2002, BBA-BIOMEMBRANES, V1565, P112, DOI 10.1016/S0005-2736(02)00516-3; Kung HN, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002229; Lenburg ME, 2003, BMC CANCER, V3, DOI 10.1186/1471-2407-3-31; Myers RM, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001046; Nakanishi T, 2001, BIOCHEM BIOPH RES CO, V281, P1343, DOI 10.1006/bbrc.2001.4504; NEWSHOLME EA, 1985, Q J EXP PHYSIOL CMS, V70, P473, DOI 10.1113/expphysiol.1985.sp002935; Nicklin P, 2009, CELL, V136, P521, DOI 10.1016/j.cell.2008.11.044; Oda K, 2010, CANCER SCI, V101, P173, DOI 10.1111/j.1349-7006.2009.01386.x; Phang JM, 2015, CURR OPIN CLIN NUTR, V18, P71, DOI 10.1097/MCO.0000000000000121; Rebsamen M, 2015, NATURE, V519, P477, DOI 10.1038/nature14107; TAMARAPPOO BK, 1992, J BIOL CHEM, V267, P2370; Wang Q, 2015, AM J CANCER RES, V5, P1281; Wang Q, 2015, J PATHOL, V236, P278, DOI 10.1002/path.4518; Wang Q, 2014, INT J CANCER, V135, P1060, DOI 10.1002/ijc.28749; Wang SY, 2015, SCIENCE, V347, P188, DOI 10.1126/science.1257132; Wise DR, 2010, TRENDS BIOCHEM SCI, V35, P427, DOI 10.1016/j.tibs.2010.05.003; Wise DR, 2008, P NATL ACAD SCI USA, V105, P18782, DOI 10.1073/pnas.0810199105; Yanagida O, 2001, BBA-BIOMEMBRANES, V1514, P291, DOI 10.1016/S0005-2736(01)00384-4; Yusenko MV, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-152; Zhang J, 2014, METHOD ENZYMOL, V542, P369, DOI 10.1016/B978-0-12-416618-9.00019-4	51	136	140	4	31	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 17	2016	291	25					13194	13205		10.1074/jbc.M115.700534	http://dx.doi.org/10.1074/jbc.M115.700534			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DR2YT	27129276	Green Published, hybrid			2022-12-26	WOS:000379770500025
J	Di Lascio, S; Belperio, D; Benfante, R; Fornasari, D				Di Lascio, Simona; Belperio, Debora; Benfante, Roberta; Fornasari, Diego			Alanine Expansions Associated with Congenital Central Hypoventilation Syndrome Impair PHOX2B Homeodomain-mediated Dimerization and Nuclear Import	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NICOTINIC RECEPTOR SUBUNIT; BETA-HYDROXYLASE GENE; AUTO-REGULATORY MECHANISM; TRANSCRIPTION FACTOR; POLYALANINE EXPANSIONS; FUNCTIONAL-CHARACTERIZATION; SUBCELLULAR-LOCALIZATION; TRINUCLEOTIDE REPEATS; FRAMESHIFT MUTATIONS; LOCUS-COERULEUS	Heterozygous mutations of the human PHOX2B gene, a key regulator of autonomic nervous system development, lead to congenital central hypoventilation syndrome (CCHS), a neuro-developmental disorder characterized by a failure in the autonomic control of breathing. Polyalanine expansions in the 20-residues region of the C terminus of PHOX2B are the major mutations responsible for CCHS. Elongation of the alanine stretch in PHOX2B leads to a protein with altered DNA binding, transcriptional activity, and nuclear localization and the possible formation of cytoplasmic aggregates; furthermore, the findings of various studies support the idea that CCHS is not due to a pure loss of function mechanism but also involves a dominant negative effect and/or toxic gain of function for PHOX2B mutations. Because PHOX2B forms homodimers and heterodimers with its paralogue PHOX2A in vitro, we tested the hypothesis that the dominant negative effects of the mutated proteins are due to non-functional interactions with the wild-type protein or PHOX2A using a co-immunoprecipitation assay and the mammalian two-hybrid system. Our findings show that PHOX2B forms homodimers and heterodimerizes weakly with mutated proteins, exclude the direct involvement of the polyalanine tract in dimer formation, and indicate that mutated proteins retain partial ability to form heterodimers with PHOX2A. Moreover, in this study, we investigated the effects of the longest polyalanine expansions on the homeodomain-mediated nuclear import, and our data clearly show that the expanded C terminus interferes with this process. These results provide novel insights into the effects of the alanine tract expansion on PHOX2B folding and activity.	[Di Lascio, Simona; Belperio, Debora; Benfante, Roberta; Fornasari, Diego] Univ Milan, Dept Med Biotechnol & Translat Med, Via Vanvitelli 32, I-20129 Milan, Italy; [Benfante, Roberta; Fornasari, Diego] Natl Res Council CNR, Neurosci Inst, I-20129 Milan, Italy	University of Milan	Fornasari, D (corresponding author), Univ Milan, Dept Med Biotechnol & Translat Med, Via Vanvitelli 32, I-20129 Milan, Italy.	diego.fornasari@unimi.it	Benfante, Roberta/C-1513-2015	Benfante, Roberta/0000-0001-5396-5429; Fornasari, Diego/0000-0002-9668-3103; DI LASCIO, SIMONA/0000-0002-5971-1515	Telethon Foundation [GGP13055]; Associazione Italiana per la Sindrome da Ipoventilazione Centrale Congenita (A.I.S.I.C.C.)	Telethon Foundation(Fondazione Telethon); Associazione Italiana per la Sindrome da Ipoventilazione Centrale Congenita (A.I.S.I.C.C.)(Fondazione AIRC per la ricerca sul cancro)	This work was supported by Telethon Foundation Grant GGP13055 (to D. F.) and the Associazione Italiana per la Sindrome da Ipoventilazione Centrale Congenita (A.I.S.I.C.C.). The authors declare that they have no conflicts of interest with the contents of this article.	Abu-Shaar M, 1999, GENE DEV, V13, P935, DOI 10.1101/gad.13.8.935; Adachi M, 2000, DNA CELL BIOL, V19, P539, DOI 10.1089/104454900439773; Amiel J, 2004, HUM MOL GENET, V13, pR235, DOI 10.1093/hmg/ddh251; Amiel J, 2003, NAT GENET, V33, P459, DOI 10.1038/ng1130; Bachetti T, 2005, HUM MOL GENET, V14, P1815, DOI 10.1093/hmg/ddi188; Battaglioli E, 1998, J NEUROCHEM, V71, P1261; Benfante R, 2007, J BIOL CHEM, V282, P13290, DOI 10.1074/jbc.M608616200; Berthelsen J, 1999, GENE DEV, V13, P946, DOI 10.1101/gad.13.8.946; Brown LY, 2004, TRENDS GENET, V20, P51, DOI 10.1016/j.tig.2003.11.002; Bruun JA, 2005, NUCLEIC ACIDS RES, V33, P2661, DOI 10.1093/nar/gki562; Bryan JT, 2000, J CELL SCI, V113, P4013; Cargnin F, 2005, J BIOL CHEM, V280, P37439, DOI 10.1074/jbc.M508368200; CHALEPAKIS G, 1994, P NATL ACAD SCI USA, V91, P12745, DOI 10.1073/pnas.91.26.12745; COLEMAN M, 1980, ARCH DIS CHILD, V55, P901, DOI 10.1136/adc.55.11.901; D'Elia AV, 2001, HUM MUTAT, V18, P361, DOI 10.1002/humu.1207; Di Lascio S, 2013, NEUROBIOL DIS, V50, P187, DOI 10.1016/j.nbd.2012.10.019; Di Zanni E, 2012, NEUROBIOL DIS, V45, P508, DOI 10.1016/j.nbd.2011.09.007; Fan XP, 2001, HUM MOL GENET, V10, P2341, DOI 10.1093/hmg/10.21.2341; Fei YJ, 2000, INVEST OPHTH VIS SCI, V41, P2849; Flora A, 2001, J NEUROSCI, V21, P7037, DOI 10.1523/JNEUROSCI.21-18-07037.2001; Furukawa K, 2002, GENES CELLS, V7, P1135, DOI 10.1046/j.1365-2443.2002.00587.x; Ge LM, 1997, BIOTECHNIQUES, V22, P28, DOI 10.2144/97221bm03; Goodman FR, 1997, P NATL ACAD SCI USA, V94, P7458, DOI 10.1073/pnas.94.14.7458; GREEN H, 1994, P NATL ACAD SCI USA, V91, P4298, DOI 10.1073/pnas.91.10.4298; Hong SJ, 2001, J NEUROCHEM, V79, P1225, DOI 10.1046/j.1471-4159.2001.00672.x; Jans DA, 2000, BIOESSAYS, V22, P532, DOI 10.1002/(SICI)1521-1878(200006)22:6<532::AID-BIES6>3.0.CO;2-O; Karlin S, 1996, P NATL ACAD SCI USA, V93, P1560, DOI 10.1073/pnas.93.4.1560; Kim HS, 1998, J NEUROSCI, V18, P8247; Lavoie H, 2003, HUM MOL GENET, V12, P2967, DOI 10.1093/hmg/ddg329; Matera I, 2004, J MED GENET, V41, P373, DOI 10.1136/jmg.2003.015412; Messaed C, 2009, NEUROBIOL DIS, V34, P397, DOI 10.1016/j.nbd.2009.02.013; Morin X, 1997, NEURON, V18, P411, DOI 10.1016/S0896-6273(00)81242-8; Nobuta H, 2015, ACTA NEUROPATHOL, V130, P171, DOI 10.1007/s00401-015-1441-0; Oma Y, 2007, PROTEIN SCI, V16, P2195, DOI 10.1110/ps.072955307; Parker GE, 2000, J BIOL CHEM, V275, P23891, DOI 10.1074/jbc.M000377200; Parodi S, 2012, J MOL MED, V90, P1025, DOI 10.1007/s00109-012-0868-1; Pattyn A, 1997, DEVELOPMENT, V124, P4065; Pattyn A, 1999, NATURE, V399, P366, DOI 10.1038/20700; Raabe EH, 2008, ONCOGENE, V27, P469, DOI 10.1038/sj.onc.1210659; Rychlik JL, 2003, J BIOL CHEM, V278, P49652, DOI 10.1074/jbc.M308577200; Seo H, 2002, J NEUROCHEM, V80, P905, DOI 10.1046/j.0022-3042.2002.00782.x; Shinchuk LM, 2005, PROTEINS, V61, P579, DOI 10.1002/prot.20536; Shoubridge Cheryl, 2010, Pathogenetics, V3, P1, DOI 10.1186/1755-8417-3-1; Stevens KE, 2007, GENETICS, V175, P1625, DOI 10.1534/genetics.106.066449; Tang HK, 1998, J BIOL CHEM, V273, P7210, DOI 10.1074/jbc.273.13.7210; Terzano S, 2000, J BIOL CHEM, V275, P41495, DOI 10.1074/jbc.M006197200; Trochet D, 2005, HUM MOL GENET, V14, P3697, DOI 10.1093/hmg/ddi401; Trochet D, 2005, AM J HUM GENET, V76, P421, DOI 10.1086/428366; Trochet D, 2009, HUM MUTAT, V30, pE421, DOI 10.1002/humu.20923; Vanderlaan M, 2004, PEDIATR PULM, V37, P217, DOI 10.1002/ppul.10438; Weese-Mayer DE, 2003, AM J MED GENET A, V123A, P267, DOI 10.1002/ajmg.a.20527; Wu HT, 2009, HUM MUTAT, V30, P655, DOI 10.1002/humu.20929; Yang CY, 1998, J NEUROCHEM, V71, P1813	53	16	16	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 17	2016	291	25					13375	13393		10.1074/jbc.M115.679027	http://dx.doi.org/10.1074/jbc.M115.679027			19	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DR2YT	27129232	Green Published, hybrid			2022-12-26	WOS:000379770500038
J	Jancso, Z; Sahin-Toth, M				Jancso, Zsanett; Sahin-Toth, Miklos			Tighter Control by Chymotrypsin C (CTRC) Explains Lack of Association between Human Anionic Trypsinogen and Hereditary Pancreatitis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN CATIONIC TRYPSINOGEN; ZYMOGEN ACTIVATION; BOVINE TRYPSIN; DEGRADATION; AUTOACTIVATION; VARIANTS; PROTEINS; PRSS2; PURIFICATION; EXPRESSION	The human pancreas expresses two major trypsinogen isoforms, cationic trypsinogen (PRSS1) and anionic trypsinogen (PRSS2). Mutations in PRSS1 cause hereditary pancreatitis by altering cleavage of regulatory nick sites by chymotrypsin C (CTRC) resulting in reduced trypsinogen degradation and increased autoactivation. Despite 90% identity with PRSS1 and a strong propensity for autoactivation, mutations in PRSS2 are not found in hereditary pancreatitis suggesting that activation of this isoform is more tightly regulated. Here, we demonstrated that CTRC promoted degradation and thereby markedly suppressed autoactivation of human anionic trypsinogen more effectively than previously observed with cationic trypsinogen. Increased sensitivity of anionic trypsinogen to CTRC-mediated degradation was due to an additional cleavage site at Leu-148 in the autolysis loop and the lack of the conserved Cys-139-Cys-206 disulfide bond. Significant stabilization of anionic trypsinogen against degradation was achieved by simultaneous mutations of CTRC cleavage sites Leu-81 and Leu-148, autolytic cleavage site Arg-122, and restoration of the missing disulfide bridge. This stands in stark contrast to cationic trypsinogen where single mutations of either Leu-81 or Arg-122 resulted in almost complete resistance to CTRC-mediated degradation. Finally, processing of the trypsinogen activation peptide at Phe-18 by CTRC inhibited autoactivation of anionic trypsinogen, although cationic trypsinogen was strongly stimulated. Taken together, the observations indicate that human anionic trypsinogen is controlled by CTRC in a manner that individual natural mutations are unlikely to increase stability enough to promote intra-pancreatic activation. This unique biochemical property of anionic trypsinogen explains the lack of association of PRSS2 mutations with hereditary pancreatitis.	[Jancso, Zsanett; Sahin-Toth, Miklos] Boston Univ, Henry M Goldman Sch Dent Med, Dept Mol & Cell Biol, Ctr Exocrine Disorders, Boston, MA 02118 USA	Boston University	Sahin-Toth, M (corresponding author), 72 East Concord St,Evans 433, Boston, MA 02118 USA.	miklos@bu.edu		Sahin-Toth, Miklos/0000-0003-4513-9922	National Institutes of Health [R01 DK058088, R01 DK082412, R01 DK095753]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK082412, R01DK095753, R01DK058088] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by National Institutes of Health Grants R01 DK058088, R01 DK082412, and R01 DK095753. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Biasini M, 2014, NUCLEIC ACIDS RES, V42, pW252, DOI 10.1093/nar/gku340; Borgstrom A, 1995, INT J PANCREATOL, V18, P221; Chen JM, 2000, PANCREAS, V21, P57, DOI 10.1097/00006676-200007000-00052; COLOMB E, 1979, BIOCHIM BIOPHYS ACTA, V570, P397, DOI 10.1016/0005-2744(79)90159-1; COLOMB E, 1979, BIOCHIM BIOPHYS ACTA, V571, P343, DOI 10.1016/0005-2744(79)90104-9; GUY O, 1978, BIOCHEMISTRY-US, V17, P1669, DOI 10.1021/bi00602a014; Kiraly O, 2006, PROTEIN EXPRES PURIF, V48, P104, DOI 10.1016/j.pep.2006.01.023; Kiraly O, 2011, METHODS MOL BIOL, V705, P175, DOI 10.1007/978-1-61737-967-3_10; KOSSIAKOFF AA, 1977, BIOCHEMISTRY-US, V16, P654, DOI 10.1021/bi00623a016; Kukor Z, 2003, EUR J BIOCHEM, V270, P2047, DOI 10.1046/j.1432-1033.2003.03581.x; Kukor Z, 2002, J BIOL CHEM, V277, P6111, DOI 10.1074/jbc.M110959200; Kume K, 2009, GUT, V58, P820, DOI 10.1136/gut.2008.151688; Lengyel Z, 1998, PROTEIN EXPRES PURIF, V12, P291, DOI 10.1006/prep.1997.0837; MAROUX S, 1969, BIOCHIM BIOPHYS ACTA, V181, P59, DOI 10.1016/0005-2795(69)90227-X; Nemeth BC, 2014, AM J PHYSIOL-GASTR L, V306, pG466, DOI 10.1152/ajpgi.00419.2013; Nemoda Z, 2006, J BIOL CHEM, V281, P11879, DOI 10.1074/jbc.M600124200; Nemoda Z, 2005, J BIOL CHEM, V280, P29645, DOI 10.1074/jbc.M505661200; RINDERKNECHT H, 1979, GUT, V20, P886, DOI 10.1136/gut.20.10.886; RINDERKNECHT H, 1985, DIGEST DIS SCI, V30, P65, DOI 10.1007/BF01318373; RINDERKNECHT H, 1986, DIGEST DIS SCI, V31, P314, DOI 10.1007/BF01318124; Ronai Z, 2009, BIOCHEM J, V418, P155, DOI 10.1042/BJ20081848; Rosendahl J, 2008, NAT GENET, V40, P78, DOI 10.1038/ng.2007.44; RU BG, 1980, SCI SINICA, V23, P1453; Sahin-Toth M, 2000, BIOCHEM BIOPH RES CO, V278, P286, DOI 10.1006/bbrc.2000.3797; Sahin-Toth M, 2000, J BIOL CHEM, V275, P22750, DOI 10.1074/jbc.M002943200; Sahin-Toth M, 1999, J BIOL CHEM, V274, P29699, DOI 10.1074/jbc.274.42.29699; Sahin-Toth M, 2006, FEBS J, V273, P5044, DOI 10.1111/j.1742-4658.2006.05501.x; Santhosh S, 2008, PANCREAS, V36, P317, DOI 10.1097/MPA.0b013e31815db4b3; SCHEELE G, 1981, GASTROENTEROLOGY, V80, P461; SMITH RL, 1969, J BIOL CHEM, V244, P4704; Szabo A, 2014, J BIOL CHEM, V289, P4753, DOI 10.1074/jbc.M113.538884; Szabo A, 2012, J BIOL CHEM, V287, P20701, DOI 10.1074/jbc.M112.360065; Szmola R, 2007, P NATL ACAD SCI USA, V104, P11227, DOI 10.1073/pnas.0703714104; Whitcomb DC, 1996, NAT GENET, V14, P141, DOI 10.1038/ng1096-141; Witt H, 2006, NAT GENET, V38, P668, DOI 10.1038/ng1797	35	8	9	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 17	2016	291	25					12897	12905		10.1074/jbc.M116.725374	http://dx.doi.org/10.1074/jbc.M116.725374			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DR2YT	27129265	Green Published, hybrid			2022-12-26	WOS:000379770500001
J	Bagdonaite, I; Norden, R; Joshi, HJ; King, SL; Vakhrushev, SY; Olofsson, S; Wandall, HH				Bagdonaite, Ieva; Norden, Rickard; Joshi, Hiren J.; King, Sarah L.; Vakhrushev, Sergey Y.; Olofsson, Sigvard; Wandall, Hans H.			Global Mapping of O-Glycosylation of Varicella Zoster Virus, Human Cytomegalovirus, and Epstein-Barr Virus	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HERPES-SIMPLEX-VIRUS; INSULIN-DEGRADING ENZYME; CELL-CELL FUSION; N-LINKED GLYCANS; GLYCOPROTEIN B; ENVELOPE PROTEIN; VIRAL REPLICATION; CRYSTAL-STRUCTURE; TERMINAL REGION; MEMBRANE-FUSION	Herpesviruses are among the most complex and widespread viruses, infection and propagation of which depend on envelope proteins. These proteins serve as mediators of cell entry as well as modulators of the immune response and are attractive vaccine targets. Although envelope proteins are known to carry glycans, little is known about the distribution, nature, and functions of these modifications. This is particularly true for O-glycans; thus we have recently developed a "bottom up" mass spectrometry-based technique for mapping O-glycosylation sites on herpes simplex virus type 1. We found wide distribution of O-glycans on herpes simplex virus type 1 glycoproteins and demonstrated that elongated O-glycans were essential for the propagation of the virus. Here, we applied our proteome-wide discovery platform for mapping O-glycosites on representative and clinically significant members of the herpesvirus family: varicella zoster virus, human cytomegalovirus, and Epstein-Barr virus. We identified a large number of O-glycosites distributed on most envelope proteins in all viruses and further demonstrated conserved patterns of O-glycans on distinct homologous proteins. Because glycosylation is highly dependent on the host cell, we tested varicella zoster virus-infected cell lysates and clinically isolated virus and found evidence of consistent O-glycosites. These results present a comprehensive view of herpesvirus O-glycosylation and point to the widespread occurrence of O-glycans in regions of envelope proteins important for virus entry, formation, and recognition by the host immune system. This knowledge enables dissection of specific functional roles of individual glycosites and, moreover, provides a framework for design of glycoprotein vaccines with representative glycosylation.	[Bagdonaite, Ieva; Joshi, Hiren J.; King, Sarah L.; Vakhrushev, Sergey Y.; Wandall, Hans H.] Univ Copenhagen, Dept Cellular & Mol Med, Copenhagen Ctr Glyc, Blegdamsvej 3B, DK-2200 Copenhagen, Denmark; [Norden, Rickard; Olofsson, Sigvard] Univ Gothenburg, Inst Biomed, Dept Infect Dis, S-41345 Gothenburg, Sweden	University of Copenhagen; University of Gothenburg	Wandall, HH (corresponding author), Univ Copenhagen, Dept Cellular & Mol Med, Copenhagen Ctr Glyc, Blegdamsvej 3B, DK-2200 Copenhagen, Denmark.	hhw@sund.ku.dk	Nordén, Rickard/AAQ-8843-2020; Vakhrushev, Sergey Y/A-7638-2014; Bagdonaite, Ieva/GLT-8773-2022; Joshi, Hiren/B-5739-2016	Vakhrushev, Sergey Y/0000-0002-0418-5765; Bagdonaite, Ieva/0000-0002-9383-8448; Norden, Rickard/0000-0002-3866-7228; Wandall, Hans H./0000-0003-0240-9232; Joshi, Hiren/0000-0002-8192-2829	Danish Research Council [1331-00133B]; University of Copenhagen [2016CDO04210, CDO2016]; Danish National Research Foundation [DNRF107]; Carl Emil Friis og hustru Olga Doris Friis Foundation; Lundbeck Foundation; A. P. Moller og Hustru Chastine Mc-Kinney Mollers Fond til Almene Formaal; Kirsten og Freddy Johansen Fonden; Mizutani Foundation; Novo Nordisk Foundation	Danish Research Council(Det Frie Forskningsrad (DFF)); University of Copenhagen; Danish National Research Foundation(Danmarks Grundforskningsfond); Carl Emil Friis og hustru Olga Doris Friis Foundation; Lundbeck Foundation(Lundbeckfonden); A. P. Moller og Hustru Chastine Mc-Kinney Mollers Fond til Almene Formaal; Kirsten og Freddy Johansen Fonden; Mizutani Foundation; Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited)	This work was supported in part by Danish Research Council Grant 1331-00133B; Program of Excellence 2016 Grant 2016CDO04210 ( Copenhagen as the next leader in precise genetic engineering, Program CDO2016) from the University of Copenhagen; Danish National Research Foundation Grant DNRF107; and by funds from the Carl Emil Friis og hustru Olga Doris Friis Foundation, the Lundbeck Foundation, the A. P. Moller og Hustru Chastine Mc-Kinney Mollers Fond til Almene Formaal, the Kirsten og Freddy Johansen Fonden, the Mizutani Foundation, and the Novo Nordisk Foundation. The authors declare that they have no conflicts of interest with the contents of this article.	Abaitua F, 2013, J VIROL, V87, P7921, DOI 10.1128/JVI.01172-13; Altgarde N, 2015, J BIOL CHEM, V290, P21473, DOI 10.1074/jbc.M115.637363; Astuto M, 2014, J CLIN VIROL, V59, P59, DOI 10.1016/j.jcv.2013.11.006; Backovic M, 2009, P NATL ACAD SCI USA, V106, P2880, DOI 10.1073/pnas.0810530106; Bagdonaite I, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1004784; Bennett EP, 2012, GLYCOBIOLOGY, V22, P736, DOI 10.1093/glycob/cwr182; Berarducci B, 2010, P NATL ACAD SCI USA, V107, P282, DOI 10.1073/pnas.0912373107; Berarducci B, 2009, J VIROL, V83, P228, DOI 10.1128/JVI.00913-08; Bergstrom T, 1996, SCAND J INFECT DIS, P41; Borza CM, 1998, J VIROL, V72, P7577, DOI 10.1128/JVI.72.9.7577-7582.1998; Borza CM, 2002, NAT MED, V8, P594, DOI 10.1038/nm0602-594; Bradel-Tretheway BG, 2015, J VIROL, V89, P7235, DOI 10.1128/JVI.00773-15; Brautigam J, 2013, GLYCOBIOLOGY, V23, P453, DOI 10.1093/glycob/cws171; Breuza L, 2002, EXP CELL RES, V273, P178, DOI 10.1006/excr.2001.5442; Bronzini M, 2012, J VIROL, V86, P6875, DOI 10.1128/JVI.06310-11; Casarosa P, 2005, J BIOL CHEM, V280, P3275, DOI 10.1074/jbc.M407536200; Cavaletto N, 2015, J VIROL, V89, P11092, DOI 10.1128/JVI.01141-15; CHIBA S, 1972, APPL MICROBIOL, V23, P780, DOI 10.1128/AEM.23.4.780-783.1972; Christensen J, 2013, J VIROL, V87, P13719, DOI 10.1128/JVI.02293-13; Chu FL, 2013, VIRUS RES, V174, P137, DOI 10.1016/j.virusres.2013.03.012; Ciferri C, 2015, P NATL ACAD SCI USA, V112, P1767, DOI 10.1073/pnas.1424818112; Clo E, 2012, J VIROL, V86, P6268, DOI 10.1128/JVI.00392-12; Corrales-Aguilar E, 2014, SEMIN IMMUNOPATHOL, V36, P627, DOI 10.1007/s00281-014-0448-2; Corrales-Aguilar E, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004131; Cortese M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050166; D'Arrigo I, 2013, GLYCOCONJUGATE J, V30, P633, DOI 10.1007/s10719-012-9465-3; Davis CW, 2006, J BIOL CHEM, V281, P37183, DOI 10.1074/jbc.M605429200; Davison AJ, 2002, VET MICROBIOL, V86, P69, DOI 10.1016/S0378-1135(01)00492-8; Davison AJ, 2007, HUMAN HERPESVIRUSES: BIOLOGY, THERAPY, AND IMMUNOPROPHYLAXIS, P3; Dunn W, 2003, P NATL ACAD SCI USA, V100, P14223, DOI 10.1073/pnas.2334032100; Engel P, 2011, IMMUNOL CELL BIOL, V89, P753, DOI 10.1038/icb.2011.55; Favoreel HW, 2006, VET MICROBIOL, V113, P257, DOI 10.1016/j.vetmic.2005.11.003; Fielding CA, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004058; Fishman JA, 2013, AM J TRANSPLANT, V13, P1, DOI 10.1111/ajt.12002; Fournillier A, 2001, J VIROL, V75, P12088, DOI 10.1128/JVI.75.24.12088-12097.2001; Fowler J, 1995, VIROLOGY, V214, P531; Gabaev I, 2014, J VIROL, V88, P14326, DOI 10.1128/JVI.01691-14; GarciaValcarcel M, 1997, VACCINE, V15, P709, DOI 10.1016/S0264-410X(96)00228-9; Geyer H, 2014, J VIROL, V88, P292, DOI 10.1128/JVI.02330-13; Go EP, 2014, J PROTEOME RES, V13, P4012, DOI 10.1021/pr5003643; Goth CK, 2015, P NATL ACAD SCI USA, V112, P14623, DOI 10.1073/pnas.1511175112; Gramolelli S, 2015, J PATHOL, V235, P368, DOI 10.1002/path.4441; Grinde B, 2013, J ORAL MICROBIOL, V5, DOI 10.3402/jom.v5i0.22766; Grose C, 2010, CURR TOP MICROBIOL, V342, P113, DOI 10.1007/82_2009_4; Gurevich VV, 2008, TRENDS PHARMACOL SCI, V29, P234, DOI 10.1016/j.tips.2008.02.004; Hakalahti AE, 2010, J BIOL CHEM, V285, P28850, DOI 10.1074/jbc.M110.149989; Halim A, 2014, J PROTEOME RES, V13, P6024, DOI 10.1021/pr500898r; Hannah BP, 2009, J VIROL, V83, P6825, DOI 10.1128/JVI.00301-09; Heldwein EE, 2006, SCIENCE, V313, P217, DOI 10.1126/science.1126548; Helle F, 2010, J VIROL, V84, P11905, DOI 10.1128/JVI.01548-10; Hobman T C, 1993, Trends Microbiol, V1, P124, DOI 10.1016/0966-842X(93)90126-C; Iversen MB, 2016, NAT IMMUNOL, V17, P150, DOI 10.1038/ni.3319; Janz A, 2000, J VIROL, V74, P10142, DOI 10.1128/JVI.74.21.10142-10152.2000; Johannsen E, 2004, P NATL ACAD SCI USA, V101, P16286, DOI 10.1073/pnas.0407320101; Kropff B, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002999; Krummenacher C, 2013, ADV EXP MED BIOL, V790, P178, DOI 10.1007/978-1-4614-7651-1_10; Lake CM, 2000, J VIROL, V74, P11162, DOI 10.1128/JVI.74.23.11162-11172.2000; Lennemann NJ, 2014, MBIO, V5, DOI 10.1128/mBio.00862-13; Lesniewski M, 2006, VIROLOGY, V354, P286, DOI 10.1016/j.virol.2006.06.035; Leuenberger B, 2003, BIOCHEM J, V369, P659, DOI 10.1042/BJ20021398; Levery SB, 2015, BBA-GEN SUBJECTS, V1850, P33, DOI 10.1016/j.bbagen.2014.09.026; Li G, 2015, P NATL ACAD SCI USA, V112, P4471, DOI 10.1073/pnas.1419875112; Li QX, 2007, J VIROL, V81, P8525, DOI 10.1128/JVI.00286-07; Li QX, 2006, CELL, V127, P305, DOI 10.1016/j.cell.2006.08.046; Liu FL, 2010, J VIROL, V84, P10375, DOI 10.1128/JVI.00381-10; LUNDSTROM M, 1987, VIROLOGY, V161, P395, DOI 10.1016/0042-6822(87)90132-2; Luo SK, 2015, VIROLOGY, V483, P72, DOI 10.1016/j.virol.2015.04.005; Luttichau HR, 2010, J BIOL CHEM, V285, P9137, DOI 10.1074/jbc.M109.002774; Mach M, 2005, J VIROL, V79, P2160, DOI 10.1128/JVI.79.4.2160-2170.2005; Machiels B, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002387; MacManiman JD, 2014, MBIO, V5, DOI 10.1128/mBio.02035-14; Madsen CB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050139; Magrane J, 1999, FEBS LETT, V451, P56, DOI 10.1016/S0014-5793(99)00494-9; Mallory S, 1997, J VIROL, V71, P8279, DOI 10.1128/JVI.71.11.8279-8288.1997; Maryon EB, 2009, J BIOL CHEM, V284, P28104, DOI 10.1074/jbc.M109.044925; Matsuura H, 2010, P NATL ACAD SCI USA, V107, P22641, DOI 10.1073/pnas.1011806108; McGeoch DJ, 2006, VIRUS RES, V117, P90, DOI 10.1016/j.virusres.2006.01.002; Mocarski ES, 2007, HUMAN HERPESVIRUSES: BIOLOGY, THERAPY, AND IMMUNOPROPHYLAXIS, P204; Moffat J, 2002, J VIROL, V76, P8468, DOI 10.1128/JVI.76.16.8468-8471.2002; Moffat JF, 1998, J VIROL, V72, P965, DOI 10.1128/JVI.72.2.965-974.1998; Muller S, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000723; Mullberg J, 1999, J GEN VIROL, V80, P437, DOI 10.1099/0022-1317-80-2-437; Nakamura S, 2016, J VIROL, V90, P1788, DOI 10.1128/JVI.02246-15; Nejatollahi F, 2002, FEMS IMMUNOL MED MIC, V34, P237, DOI 10.1016/S0928-8244(02)00400-5; NEMEROW GR, 1989, CELL, V56, P369, DOI 10.1016/0092-8674(89)90240-7; Norberg P, 2007, J GEN VIROL, V88, P1683, DOI 10.1099/vir.0.82500-0; Norberg P, 2010, INFECT GENET EVOL, V10, P14, DOI 10.1016/j.meegid.2009.09.004; Norden R, 2015, J BIOL CHEM, V290, P5078, DOI 10.1074/jbc.M114.616409; Noriega VM, 2014, VIRUSES-BASEL, V6, P1202, DOI 10.3390/v6031202; Noriega VM, 2012, MOL IMMUNOL, V51, P245, DOI 10.1016/j.molimm.2012.03.024; Oliver SL, 2013, P NATL ACAD SCI USA, V110, P1911, DOI 10.1073/pnas.1216985110; Oliver SL, 2011, J VIROL, V85, P4095, DOI 10.1128/JVI.02596-10; Oliver SL, 2009, J VIROL, V83, P7495, DOI 10.1128/JVI.00400-09; Olofsson S, 1998, SCAND J INFECT DIS, V30, P435, DOI 10.1080/00365549850161386; OLOFSSON S, 1983, J GEN VIROL, V64, P2735, DOI 10.1099/0022-1317-64-12-2735; Olofsson S, 2016, REV MED VIROL, V26, P34, DOI 10.1002/rmv.1859; Pedersen JW, 2011, J BIOL CHEM, V286, P32684, DOI 10.1074/jbc.M111.273722; Reimer JJ, 2009, J VIROL, V83, P734, DOI 10.1128/JVI.01817-08; Remacle AG, 2006, J BIOL CHEM, V281, P16897, DOI 10.1074/jbc.M600295200; Roizman B, 2007, HUMAN HERPESVIRUSES: BIOLOGY, THERAPY, AND IMMUNOPROPHYLAXIS, P70; Rowe AM, 2013, PROG RETIN EYE RES, V32, P88, DOI 10.1016/j.preteyeres.2012.08.002; Rowe CL, 2015, MBIO, V6, DOI 10.1128/mBio.02285-14; Sabugo F, 2014, JCR-J CLIN RHEUMATOL, V20, P42, DOI 10.1097/RHU.0000000000000060; Sadaoka T, 2010, J VIROL, V84, P3488, DOI 10.1128/JVI.01838-09; Sathiyamoorthy K, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004309; Schjoldager KT, 2015, EMBO REP, V16, P1713, DOI 10.15252/embr.201540796; Schjoldager KTBG, 2012, BBA-GEN SUBJECTS, V1820, P2079, DOI 10.1016/j.bbagen.2012.09.014; Schuman J, 2000, GLYCOCONJUGATE J, V17, P835, DOI 10.1023/A:1010909011496; Sekulin K, 2007, VIRUS GENES, V35, P577, DOI 10.1007/s11262-007-0158-0; SERAFINICESSI F, 1983, VIROLOGY, V131, P59, DOI 10.1016/0042-6822(83)90533-0; SERAFINICESSI F, 1989, VIROLOGY, V170, P1, DOI 10.1016/0042-6822(89)90345-0; Sharma S, 2013, VIROLOGY, V435, P239, DOI 10.1016/j.virol.2012.09.024; Shiley K, 2010, INFECT DIS CLIN N AM, V24, P373, DOI 10.1016/j.idc.2010.01.003; Sili U, 2014, J CLIN VIROL, V60, P112, DOI 10.1016/j.jcv.2014.03.010; Sorem J, 2009, J VIROL, V83, P6664, DOI 10.1128/JVI.00195-09; Steentoft C, 2013, EMBO J, V32, P1478, DOI 10.1038/emboj.2013.79; Steentoft C, 2011, NAT METHODS, V8, P977, DOI [10.1038/nmeth.1731, 10.1038/NMETH.1731]; Suenaga T, 2015, J BIOL CHEM, V290, P19833, DOI 10.1074/jbc.M114.635508; Suenaga T, 2010, P NATL ACAD SCI USA, V107, P866, DOI 10.1073/pnas.0913351107; Szakonyi G, 2006, NAT STRUCT MOL BIOL, V13, P996, DOI 10.1038/nsmb1161; Tadagaki K, 2012, BLOOD, V119, P4908, DOI 10.1182/blood-2011-08-372516; THORLEYLAWSON DA, 1982, J VIROL, V43, P730, DOI 10.1128/JVI.43.2.730-736.1982; Tirabassi RS, 2002, J VIROL, V76, P6832, DOI 10.1128/JVI.76.13.6832-6835.2002; Tsao SW, 2015, J PATHOL, V235, P323, DOI 10.1002/path.4448; Vanarsdall AL, 2008, J VIROL, V82, P11837, DOI 10.1128/JVI.01623-08; Varnum SM, 2004, J VIROL, V78, P10960, DOI 10.1128/JVI.78.20.10960-10966.2004; Vleck SE, 2011, P NATL ACAD SCI USA, V108, P18412, DOI 10.1073/pnas.1111333108; Vomaske Jennifer, 2009, Infectious Disorders - Drug Targets, V9, P548; Wandall HH, 2012, BLOOD, V120, P626, DOI 10.1182/blood-2012-02-409235; Wandall HH, 1997, J BIOL CHEM, V272, P23503, DOI 10.1074/jbc.272.38.23503; Wang J, 2009, J VIROL, V83, P13042, DOI 10.1128/JVI.00792-09; Wang WB, 2013, RETROVIROLOGY, V10, DOI 10.1186/1742-4690-10-14; Wang X, 1998, J VIROL, V72, P5552, DOI 10.1128/JVI.72.7.5552-5558.1998; Wille PT, 2013, MBIO, V4, DOI 10.1128/mBio.00332-13; Xing Y, 2015, P NATL ACAD SCI USA, V112, P6056, DOI 10.1073/pnas.1501176112; Yang Z, 2015, NAT BIOTECHNOL, V33, P842, DOI 10.1038/nbt.3280; Yang ZY, 2000, NAT MED, V6, P886, DOI 10.1038/78654; Zerboni L, 2014, NAT REV MICROBIOL, V12, P197, DOI 10.1038/nrmicro3215; Zhou MM, 2015, J VIROL, V89, P8999, DOI 10.1128/JVI.01325-15	139	38	39	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 3	2016	291	23					12014	12028		10.1074/jbc.M116.721746	http://dx.doi.org/10.1074/jbc.M116.721746			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DO9GJ	27129252	hybrid, Green Published			2022-12-26	WOS:000378092800006
J	Tsukamoto, T; Mizutani, K; Hasegawa, T; Takahashi, M; Honda, N; Hashimoto, N; Shimono, K; Yamashita, K; Yamamoto, M; Miyauchi, S; Takagi, S; Hayashi, S; Murata, T; Sudo, Y				Tsukamoto, Takashi; Mizutani, Kenji; Hasegawa, Taisuke; Takahashi, Megumi; Honda, Naoya; Hashimoto, Naoki; Shimono, Kazumi; Yamashita, Keitaro; Yamamoto, Masaki; Miyauchi, Seiji; Takagi, Shin; Hayashi, Shigehiko; Murata, Takeshi; Sudo, Yuki			X-ray Crystallographic Structure of Thermophilic Rhodopsin IMPLICATIONS FOR HIGH THERMAL STABILITY AND OPTOGENETIC FUNCTION	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTON-PUMPING RHODOPSIN; MOLECULAR-DYNAMICS; BACTERIORHODOPSIN; PROTEORHODOPSIN; XANTHORHODOPSIN; TRIMER	Thermophilic rhodopsin (TR) is a photoreceptor protein with an extremely high thermal stability and the first characterized light-driven electrogenic proton pump derived from the extreme thermophile Thermus thermophilus JL-18. In this study, we confirmed its high thermal stability compared with other microbial rhodopsins and also report the potential availability of TR for optogenetics as a light-induced neural silencer. The x-ray crystal structure of TR revealed that its overall structure is quite similar to that of xanthorhodopsin, including the presence of a putative binding site for a carotenoid antenna; but several distinct structural characteristics of TR, including a decreased surface charge and a larger number of hydrophobic residues and aromatic-aromatic interactions, were also clarified. Based on the crystal structure, the structural changes of TR upon thermal stimulation were investigated by molecular dynamics simulations. The simulations revealed the presence of a thermally induced structural substate in which an increase of hydrophobic interactions in the extracellular domain, the movement of extracellular domains, the formation of a hydrogen bond, and the tilting of transmembrane helices were observed. From the computational and mutational analysis, we propose that an extracellular LPGG motif between helices F and G plays an important role in the thermal stability, acting as a "thermal sensor." These findings will be valuable for understanding retinal proteins with regard to high protein stability and high optogenetic performance.	[Tsukamoto, Takashi; Honda, Naoya; Sudo, Yuki] Okayama Univ, Grad Sch Med Dent & Pharmaceut Sci, Div Pharmaceut Sci, Okayama 7008530, Japan; [Mizutani, Kenji; Hashimoto, Naoki; Murata, Takeshi] Chiba Univ, Grad Sch Sci, Dept Chem, Chiba 2638522, Japan; [Mizutani, Kenji; Murata, Takeshi] Chiba Univ, Mol Chiral Res Ctr, Chiba 2638522, Japan; [Hasegawa, Taisuke; Hayashi, Shigehiko] Kyoto Univ, Grad Sch Sci, Dept Chem, Kyoto 6068502, Japan; [Takahashi, Megumi; Takagi, Shin] Nagoya Univ, Grad Sch Sci, Div Biol Sci, Nagoya, Aichi 4648602, Japan; [Shimono, Kazumi; Miyauchi, Seiji] Toho Univ, Fac Pharmaceut Sci, Funabashi, Chiba 2748510, Japan; [Yamashita, Keitaro; Yamamoto, Masaki] RIKEN SPring 8 Ctr, Mikazuki, Hyogo 6795148, Japan	Okayama University; Chiba University; Chiba University; Kyoto University; Nagoya University; Toho University; RIKEN	Sudo, Y (corresponding author), Okayama Univ, Grad Sch Med Dent & Pharmaceut Sci, Div Pharmaceut Sci, Okayama 7008530, Japan.; Murata, T (corresponding author), Chiba Univ, Grad Sch Sci, Dept Chem, Chiba 2638522, Japan.; Murata, T (corresponding author), Chiba Univ, Mol Chiral Res Ctr, Chiba 2638522, Japan.	t.murata@faculty.chiba-u.jp; sudo@pharm.okayama-u.ac.jp	Hasegawa, Taisuke/I-6102-2012; Yamamoto, Masaki/B-7844-2015; Tsukamoto, Takashi/F-3993-2017; Murata, Takeshi/J-6181-2017; Miyauchi, Seiji/AAA-4036-2021; Sudo, Yuki/AGY-0493-2022	Yamamoto, Masaki/0000-0002-1311-1768; Tsukamoto, Takashi/0000-0002-6348-6664; Murata, Takeshi/0000-0002-5748-4670; Sudo, Yuki/0000-0001-8155-9356; Shimono, Kazumi/0000-0001-9752-5329; Mizutani, Kenji/0000-0002-7337-2134; Yamashita, Keitaro/0000-0002-5442-7582	Japanese Ministry of Education, Culture, Sports, Science, and Technology (MEXT) [15K18519, 25104004, 25291034, 15H04363, 15H00878]; Platform Project for Supporting in Drug Discovery and Life Science Research (Platform for Drug Discovery, Informatics, and Structural Life Science) from MEXT; Japan Agency for Medical Research and Development (AMED)	Japanese Ministry of Education, Culture, Sports, Science, and Technology (MEXT)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Platform Project for Supporting in Drug Discovery and Life Science Research (Platform for Drug Discovery, Informatics, and Structural Life Science) from MEXT; Japan Agency for Medical Research and Development (AMED)(Japan Agency for Medical Research and Development (AMED))	This work was supported by Grants 15K18519 ( to T. T.), 25104004 and 25291034 ( to S. H.), and 15H04363 and 15H00878 ( to Y. S.) from the Japanese Ministry of Education, Culture, Sports, Science, and Technology (MEXT). This work also was supported by the Platform Project for Supporting in Drug Discovery and Life Science Research (Platform for Drug Discovery, Informatics, and Structural Life Science) from MEXT and the Japan Agency for Medical Research and Development (AMED) ( to T. M.). The authors declare that they have no conflicts of interest with the contents of this article.r Supported by Grant-in-for Scientific Research on Innovative Areas 15H00878 (All Nippon Artificial Photosynthesis Project for Living Earth). To whom correspondence may be addressed. E-mail: sudo@pharm.okayamau.ac.jp.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Baker NA, 2001, P NATL ACAD SCI USA, V98, P10037, DOI 10.1073/pnas.181342398; Balashov SP, 2005, SCIENCE, V309, P2061, DOI 10.1126/science.1118046; Bergo VB, 2009, J BIOL CHEM, V284, P2836, DOI 10.1074/jbc.M803792200; Best RB, 2012, J CHEM THEORY COMPUT, V8, P3257, DOI 10.1021/ct300400x; Bricogne G., 2011, BUSTER VERSION 2 10; Cao PX, 2012, FASEB J, V26, P480, DOI 10.1096/fj.11-197798; Dolinsky TJ, 2007, NUCLEIC ACIDS RES, V35, pW522, DOI 10.1093/nar/gkm276; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Ernst OP, 2014, CHEM REV, V114, P126, DOI 10.1021/cr4003769; Grote M, 2014, BBA-BIOENERGETICS, V1837, P533, DOI 10.1016/j.bbabio.2013.08.006; Hayashi S, 2002, BIOPHYS J, V83, P1281, DOI 10.1016/S0006-3495(02)73900-3; Hempelmann F, 2011, J AM CHEM SOC, V133, P4645, DOI 10.1021/ja111116a; Hirata K, 2013, J PHYS CONF SER, V425, DOI 10.1088/1742-6596/425/1/012002; Hohenfeld IP, 1999, FEBS LETT, V442, P198, DOI 10.1016/S0014-5793(98)01659-7; Imasheva ES, 2009, BIOCHEMISTRY-US, V48, P10948, DOI 10.1021/bi901552x; Inoue K, 2014, BBA-BIOENERGETICS, V1837, P562, DOI 10.1016/j.bbabio.2013.05.005; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Li H, 2005, PROTEINS, V61, P704, DOI 10.1002/prot.20660; Lovell SC, 2003, PROTEINS, V50, P437, DOI 10.1002/prot.10286; Luecke H, 1999, J MOL BIOL, V291, P899, DOI 10.1006/jmbi.1999.3027; Luecke H, 2008, P NATL ACAD SCI USA, V105, P16561, DOI 10.1073/pnas.0807162105; Mackerell AD, 2004, J COMPUT CHEM, V25, P1400, DOI 10.1002/jcc.20065; Martinez A, 2007, P NATL ACAD SCI USA, V104, P5590, DOI 10.1073/pnas.0611470104; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Murshudov GN, 2011, ACTA CRYSTALLOGR D, V67, P355, DOI 10.1107/S0907444911001314; Murugapiran SK, 2013, GENOME ANNOUNCEMENTS, V1, DOI 10.1128/genomeA.00106-12; Okazaki A, 2014, METHODS, V68, P425, DOI 10.1016/j.ymeth.2014.02.030; Okazaki A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035370; Phillips JC, 2005, J COMPUT CHEM, V26, P1781, DOI 10.1002/jcc.20289; Sudo Y, 2003, PHOTOCHEM PHOTOBIOL, V78, P511, DOI 10.1562/0031-8655(2003)078<0511:IONPPS>2.0.CO;2; Sudo Y, 2013, J BIOL CHEM, V288, P20624, DOI 10.1074/jbc.M113.475533; Tian B, 2010, TRENDS MICROBIOL, V18, P512, DOI 10.1016/j.tim.2010.07.007; Tina KG, 2007, NUCLEIC ACIDS RES, V35, pW473, DOI 10.1093/nar/gkm423; Tsukamoto T, 2014, J PHYS CHEM B, V118, P12383, DOI 10.1021/jp507374q; Tsukamoto T, 2013, J BIOL CHEM, V288, P21581, DOI 10.1074/jbc.M113.479394; Tsukamoto T, 2013, FEBS LETT, V587, P322, DOI 10.1016/j.febslet.2012.12.022; Wada T, 2011, J MOL BIOL, V411, P986, DOI 10.1016/j.jmb.2011.06.028; Yoshizawa S, 2012, ENVIRON MICROBIOL, V14, P1240, DOI 10.1111/j.1462-2920.2012.02702.x; Zhang F, 2007, NATURE, V446, P633, DOI 10.1038/nature05744; Zhang L, 1996, PROTEINS, V24, P433, DOI 10.1002/(SICI)1097-0134(199604)24:4<433::AID-PROT3>3.0.CO;2-F	42	31	31	0	20	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 3	2016	291	23					12223	12232		10.1074/jbc.M116.719815	http://dx.doi.org/10.1074/jbc.M116.719815			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DO9GJ	27129243	Green Published, hybrid			2022-12-26	WOS:000378092800023
J	Boehme, SA; Franz-Bacon, K; DiTirro, DN; Ly, TW; Bacon, KB				Boehme, Stefen A.; Franz-Bacon, Karin; DiTirro, Danielle N.; Ly, Tai Wei; Bacon, Kevin B.			MAP3K19 Is a Novel Regulator of TGF-beta Signaling That Impacts Bleomycin-Induced Lung Injury and Pulmonary Fibrosis	PLOS ONE			English	Article							GROWTH-FACTOR-BETA; ALPHA-B-CRYSTALLIN; MECHANISMS; PATHOGENESIS; PIRFENIDONE; INHIBITION; PROTEINS; KINASES; TARGETS; EMT	Idiopathic pulmonary fibrosis (IPF) is a progressive, debilitating disease for which two medications, pirfenidone and nintedanib, have only recently been approved for treatment. The cytokine TGF-beta has been shown to be a central mediator in the disease process. We investigated the role of a novel kinase, MAP3K19, upregulated in IPF tissue, in TGF-beta-induced signal transduction and in bleomycin-induced pulmonary fibrosis. MAP3K19 has a very limited tissue expression, restricted primarily to the lungs and trachea. In pulmonary tissue, expression was predominantly localized to alveolar and interstitial macrophages, bronchial epithelial cells and type II pneumocytes of the epithelium. MAP3K19 was also found to be overexpressed in bronchoalveolar lavage macrophages from IPF patients compared to normal patients. Treatment of A549 or THP-1 cells with either MAP3K19 siRNA or a highly potent and specific inhibitor reduced phospho-Smad2 & 3 nuclear translocation following TGF-beta stimulation. TGF-beta-induced gene transcription was also strongly inhibited by both the MAP3K19 inhibitor and nintedanib, whereas pirfenidone had a much less pronounced effect. In combination, the MAP3K19 inhibitor appeared to act synergistically with either pirfenidone or nintedanib, at the level of target gene transcription or protein production. Finally, in an animal model of IPF, inhibition of MAP3K19 strongly attenuated bleomycin-induced pulmonary fibrosis when administered either prophylactically ortherapeutically. In summary, these results strongly suggest that inhibition of MAP3K19 may have a beneficial therapeutic effect in the treatment of IPF and represents a novel strategy to target this disease.	[Boehme, Stefen A.; DiTirro, Danielle N.; Ly, Tai Wei; Bacon, Kevin B.] AxikinPharmaceuticals Inc, San Diego, CA USA; [Franz-Bacon, Karin] DNA Consulting Inc, San Diego, CA USA; [DiTirro, Danielle N.] Brandeis Univ, Dept Biol, Waltham, MA 02254 USA	Brandeis University	Boehme, SA (corresponding author), AxikinPharmaceuticals Inc, San Diego, CA USA.	sboehme@axikin.com			Axikin Pharmaceuticals, Inc.; Genomics and Sequencing Core at the UC San Diego Center for AIDS Research [P30 AI036214]; VA San Diego Healthcare System; Veterans Medical Research Foundation; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI036214] Funding Source: NIH RePORTER	Axikin Pharmaceuticals, Inc.; Genomics and Sequencing Core at the UC San Diego Center for AIDS Research; VA San Diego Healthcare System(US Department of Veterans Affairs); Veterans Medical Research Foundation; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	The funder, Axikin Pharmaceuticals, Inc., provided support in the form of salaries for authors [SAB, DND, KFB, TWL, and KBB], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.; We acknowledge the original contributions to the cloning of MAP3K19 by Drs. S. Watanabe, S. Kondo and J. Encinas (WO 2005/001083 A1). We would also like to thank Dr. Gerrard Manning at the Salk Institute (presently at Genentech Inc.), Dr. Gary Hardiman at BIOGEM, UCSD (currently at the Medical College of South Carolina), Bettina Ernst at PreClin Biosystems AG and Pinyi Du at the Genomics and Sequencing Core, UCSD for their outstanding contributions. We would also like to thank Dr. Claire Weston, Casey Laris and Jeff Hodson at Reveal Biosciences for their histology work, and Dr. Cory Hogaboam, Cedars-Sinai Medical Center for materials, stimulating discussions and guidance. We would also like to thank Dr. Cesare Saltini (University of Rome and University of Florida) for his help in obtaining patient samples and many helpful discussions. This work was performed with the support of the Genomics and Sequencing Core at the UC San Diego Center for AIDS Research (P30 AI036214), the VA San Diego Healthcare System, and the Veterans Medical Research Foundation.	Ahluwalia N, 2014, AM J RESP CRIT CARE, V190, P867, DOI 10.1164/rccm.201403-0509PP; Arthur JSC, 2013, NAT REV IMMUNOL, V13, P679, DOI 10.1038/nri3495; ASHCROFT T, 1988, J CLIN PATHOL, V41, P467, DOI 10.1136/jcp.41.4.467; Bellaye PS, 2015, AM J RESP CELL MOL, V52, P244, DOI 10.1165/rcmb.2014-0011OC; Bellaye PS, 2014, J PATHOL, V232, P458, DOI 10.1002/path.4314; Boehme SA, 2009, INT IMMUNOL, V21, P621, DOI 10.1093/intimm/dxp031; Boehme SA, 2009, INT IMMUNOL, V21, P1, DOI 10.1093/intimm/dxn118; Boelens WC, 2014, PROG BIOPHYS MOL BIO, V115, P3, DOI 10.1016/j.pbiomolbio.2014.02.005; Bonniaud P, 2005, J IMMUNOL, V175, P5390, DOI 10.4049/jimmunol.175.8.5390; Bonniaud P, 2005, AM J RESP CRIT CARE, V171, P889, DOI 10.1164/rccm.200405-612OC; Bonniaud P, 2004, J IMMUNOL, V173, P2099, DOI 10.4049/jimmunol.173.3.2099; BORDER WA, 1994, NEW ENGL J MED, V331, P1286; Borensztajn K, 2013, RESPIRATION, V86, P441, DOI 10.1159/000357598; BREEN E, 1992, AM J RESP CELL MOL, V6, P146, DOI 10.1165/ajrcmb/6.2.146; Bruce DL, 2012, FEBS LETT, V586, P1897, DOI 10.1016/j.febslet.2012.02.001; Chilosi M, 2012, RESP RES, V13, DOI 10.1186/1465-9921-13-3; Choi K, 2012, MOL VIS, V18, P1010; Cottin V, 2013, RESP RES, V14, DOI 10.1186/1465-9921-14-S1-S5; Cutroneo KR, 2007, J CELL PHYSIOL, V211, P585, DOI 10.1002/jcp.20972; Derynck R, 2014, CURR OPIN CELL BIOL, V31, P56, DOI 10.1016/j.ceb.2014.09.001; Faress JA, 2007, J APPL PHYSIOL, V103, P2077, DOI 10.1152/japplphysiol.00239.2007; Feng XH, 2005, ANNU REV CELL DEV BI, V21, P659, DOI 10.1146/annurev.cellbio.21.022404.142018; Fulton BG, 2015, INT J GEN MED, V8, P309, DOI 10.2147/IJGM.S74880; Gao S, 2009, MOL CELL, V36, P457, DOI 10.1016/j.molcel.2009.09.043; Gauldie Jack, 2006, Proc Am Thorac Soc, V3, P696, DOI 10.1513/pats.200605-125SF; Gross TJ, 2001, NEW ENGL J MED, V345, P517, DOI 10.1056/NEJMra003200; Herbertz S, 2015, DRUG DES DEV THER, V9, P4479, DOI 10.2147/DDDT.S86621; Hunninghake Gary W, 2007, Proc Am Thorac Soc, V4, P449, DOI 10.1513/pats.200702-036MS; King CS, 2015, CURR OPIN PULM MED, V21, P479, DOI 10.1097/MCP.0000000000000190; King TE, 2011, LANCET, V378, P1949, DOI 10.1016/S0140-6736(11)60052-4; Lagna G, 1996, NATURE, V383, P832, DOI 10.1038/383832a0; Lin X, 2006, CELL, V125, P915, DOI 10.1016/j.cell.2006.03.044; Liu RM, 2008, ANTIOXID REDOX SIGN, V10, P303, DOI 10.1089/ars.2007.1903; Lopez-Otin C, 2013, CELL, V153, P1194, DOI 10.1016/j.cell.2013.05.039; Meister M, 2013, INT J MOL SCI, V14, P4854, DOI 10.3390/ijms14034854; Raghu G, 2015, EUR RESPIR J, V46, P1113, DOI 10.1183/13993003.02316-2014; Raghu G, 2011, AM J RESP CRIT CARE, V183, P788, DOI 10.1164/rccm.2009-040GL; Rangarajan S, 2015, ATS J; Selman M, 2001, ANN INTERN MED, V134, P136, DOI 10.7326/0003-4819-134-2-200101160-00015; Selman M, 2014, AM J RESP CRIT CARE, V189, P1161, DOI 10.1164/rccm.201312-2221PP; Shi YG, 2003, CELL, V113, P685, DOI 10.1016/S0092-8674(03)00432-X; Sime PJ, 1997, J CLIN INVEST, V100, P768, DOI 10.1172/JCI119590; Spagnolo P, 2015, PHARMACOL THERAPEUT, V152, P18, DOI 10.1016/j.pharmthera.2015.04.005; Symons A, 2006, TRENDS IMMUNOL, V27, P40, DOI 10.1016/j.it.2005.11.007; Tzouvelekis A, 2015, THER CLIN RISK MANAG, V11, P359, DOI 10.2147/TCRM.S69716; Wettstein G, 2013, FASEB J, V27, P1549, DOI 10.1096/fj.12-220053; Willis BC, 2007, AM J PHYSIOL-LUNG C, V293, pL525, DOI 10.1152/ajplung.00163.2007; Wollin L, 2015, EUR RESPIR J, V45, P1434, DOI 10.1183/09031936.00174914; Xu J, 2009, CELL RES, V19, P156, DOI 10.1038/cr.2009.5; Zhang Y, 1996, NATURE, V383, P168, DOI 10.1038/383168a0; Zhao JS, 2002, AM J PHYSIOL-LUNG C, V282, pL585, DOI 10.1152/ajplung.00151.2001	51	16	18	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 4	2016	11	5							e0154874	10.1371/journal.pone.0154874	http://dx.doi.org/10.1371/journal.pone.0154874			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DL5KR	27144281	gold, Green Published, Green Submitted			2022-12-26	WOS:000375676400089
J	Fleischmann, A; Rivadavia, F; Gonella, PM; Perez-Banon, C; Mengual, X; Rojo, S				Fleischmann, Andreas; Rivadavia, Fernando; Gonella, Paulo M.; Perez-Banon, Celeste; Mengual, Ximo; Rojo, Santos			Where Is My Food? Brazilian Flower Fly Steals Prey from Carnivorous Sundews in a Newly Discovered Plant-Animal Interaction	PLOS ONE			English	Article							FLIES DIPTERA; PITCHER PLANTS; SYRPHIDAE; PHYLOGENY; PREDATORS; CONFLICT; HABITS; LARVAE; KLEPTOPARASITISM; WIEDEMANN	A new interaction between insects and carnivorous plants is reported from Brazil. Larvae of the predatory flower fly Toxomerus basalis (Diptera: Syrphidae: Syrphinae) have been found scavenging on the sticky leaves of several carnivorous sundew species (Drosera, Droseraceae) in Minas Gerais and Sao Paulo states, SE Brazil. This syrphid apparently spends its whole larval stage feeding on prey trapped by Drosera leaves. The nature of this plant-animal relationship is discussed, as well as the Drosera species involved, and locations where T. basalis was observed. 180 years after the discovery of this flower fly species, its biology now has been revealed. This is (1) the first record of kleptoparasitism in the Syrphidae, (2) a new larval feeding mode for this family, and (3) the first report of a dipteran that shows a kleptoparasitic relationship with a carnivorous plant with adhesive flypaper traps. The first descriptions of the third instar larva and puparium of T. basalis based on Scanning Electron Microscope analysis are provided.	[Fleischmann, Andreas] Bot Staatssammlung Munchen, Munich, Germany; [Fleischmann, Andreas] Univ Munich, Ctr Geobiol & Biodivers Res, GeoBio Ctr LMU, Munich, Germany; [Rivadavia, Fernando] Illumina, San Francisco, CA USA; [Gonella, Paulo M.] Univ Sao Paulo, Inst Biociencias, Lab Sistemat Vegetal, Sao Paulo, Brazil; [Perez-Banon, Celeste; Rojo, Santos] Univ Alicante, Dept Ciencias Nat & Recursos Nat, Inst CIBIO, E-03080 Alicante, Spain; [Mengual, Ximo] Leibniz Inst Biodiversitat Tiere, Zool Forsch Museum Alexander Koenig, Bonn, Germany	University of Munich; Illumina; Universidade de Sao Paulo; Universitat d'Alacant; Zoologisches Forschungsmuseum Alexander Koenig (ZFMK)	Fleischmann, A (corresponding author), Bot Staatssammlung Munchen, Munich, Germany.; Fleischmann, A (corresponding author), Univ Munich, Ctr Geobiol & Biodivers Res, GeoBio Ctr LMU, Munich, Germany.	fleischmann@lrz.uni-muenchen.de	Pérez-Bañón, Celeste/M-1728-2014; Rojo, Santos/L-9717-2014; Gonella, Paulo Minatel/AAU-2393-2020	Pérez-Bañón, Celeste/0000-0002-2228-7773; Rojo, Santos/0000-0003-2160-9643; Gonella, Paulo Minatel/0000-0001-8332-5326; Mengual, Ximo/0000-0002-6185-9404	Illumina; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) [140135/2013-8]; Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES) [BEX 10612/14-9]	Illumina; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	The commercial funder Illumina provided support in the form of salaries for FR, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank Jose Mauricio Piliackas for help with initial attempts to identify the adult flies, Fabio Pinheiro, Adilson Peres, Nilber Silva, Carlos Rohrbacher, and Reginaldo Vasconcelos for help studying larvae in situ and for providing photographs; Matheus Cota and Juliana Rando (SPF) for the identification of the Chamaecrista species; Claudia Etzbauer for technical support, and three anonymous reviewers for valuable comments on the manuscript. The Instituto Chico Mendes de Conservacao da Biodiversidade (ICMBio) issued the permits for fieldwork; doctorate scholarship to PMG was provided by the Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq-Processo 140135/2013-8) and Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES-Processo BEX 10612/14-9).	Adamec L, 1997, BOT REV, V63, P273, DOI 10.1007/BF02857953; Adlassnig W, 2010, BIOLOGICAL ADHESIVE SYSTEMS: FROM NATURE TO TECHNICAL AND MEDICAL APPLICATION, P15, DOI 10.1007/978-3-7091-0286-2_2; Almohamad R, 2009, BIOTECHNOL AGRON SOC, V13, P467; Anderson B, 2005, ANN BOT-LONDON, V95, P757, DOI 10.1093/aob/mci082; Anderson B, 2003, OIKOS, V102, P221, DOI 10.1034/j.1600-0706.2003.12478.x; Anderson B, 2001, ECOL LETT, V4, P511, DOI 10.1046/j.1461-0248.2001.00258.x; Anderson B, 2006, BIOL J LINN SOC, V89, P541, DOI 10.1111/j.1095-8312.2006.00692.x; [Anonymous], COLOUR GUIDE HOVERFL; [Anonymous], SYSTEMA DIPTERORUM V; [Anonymous], 2009, STUDIA DIPTEROLOGICA; ANTOR RJ, 1995, OECOLOGIA, V101, P51, DOI 10.1007/BF00328899; Barrera R, 1989, ECOTROPICOS, V2, P31; Beaver R.A., 1983, P129; BLACKMAN R.L., 2006, APHIDS WORLDS HERBAC; Borges ZM, 2009, ZOOTAXA, P1; CHINA W. E., 1953, WEST AUSTRALIAN NAT, V4, P1; Chua TJL, 2012, J TROP ECOL, V28, P97, DOI 10.1017/S0266467411000629; CLARKE CM, 1993, ECOL ENTOMOL, V18, P7, DOI 10.1111/j.1365-2311.1993.tb01074.x; CLARKE CM, 1995, J TROP ECOL, V11, P589, DOI 10.1017/S0266467400009160; Costa J., 2014, ACTA BIOL PARAN, V43, P61, DOI 10.5380/abpr.v43i0.38097; Das I, 2010, ZOOTAXA, P37; Desoubeaux G, 2014, PATHOG GLOB HEALTH, V108, P158, DOI 10.1179/2047773214Y.0000000135; DIXON AFG, 1987, AM NAT, V129, P580, DOI 10.1086/284659; DOLLING WR, 1991, SYST ENTOMOL, V16, P319, DOI 10.1111/j.1365-3113.1991.tb00692.x; EISNER T, 1965, SCIENCE, V150, P1608, DOI 10.1126/science.150.3703.1608; Ellis AG, 1996, OECOLOGIA, V106, P478, DOI 10.1007/BF00329705; Ellison AM, 2009, J EXP BOT, V60, P19, DOI 10.1093/jxb/ern179; Erni P, 2011, SOFT MATTER, V7, P10889, DOI 10.1039/c1sm05815k; Fish D, 1978, P FLORIDA ANTIMOSQUI, V49, P11; Fleischmann A., 2010, CARNIVOROUS PLANTS T, P68123; Fletcher TB., 1908, SPOLIA ZEYLANICA, V5, P20; FLUKE C. L., 1929, Res. Bull. Wisconsin Agric. Expt. Stn.; Freitas L, 2006, ANN MO BOT GARD, V93, P465, DOI 10.3417/0026-6493(2007)93[465:PBIATH]2.0.CO;2; Gaume L, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001185; GIBSON TC, 1991, AM MIDL NAT, V125, P55, DOI 10.2307/2426369; Gilbert F, 2005, EUR J ENTOMOL, V102, P325, DOI 10.14411/eje.2005.050; Gonella PM, 2015, PHYTOTAXA, V220, P257, DOI 10.11646/phytotaxa.220.3.4; Hamilton IM, 2002, BEHAV ECOL, V13, P260, DOI 10.1093/beheco/13.2.260; HARTLEY J. C., 1963, PROC ZOOL SOC LONDON, V141, P261; Heiss E. M., 1938, ILLINOIS BIOL MONOGR, V16, P1, DOI [DOI 10.5962/BHL.TITLE.50277, 10.5962/bhl.title.50277]; HOLLOWAY BA, 1976, NEW ZEAL J ZOOL, V3, P339, DOI 10.1080/03014223.1976.9517924; JAFFE K, 1992, NEW PHYTOL, V122, P733; Jordaens K, 2015, ZOOTAXA, V4044, P567, DOI 10.11646/zootaxa.4044.4.6; Jurgens A, 2012, BIOL REV, V87, P602, DOI 10.1111/j.1469-185X.2011.00213.x; Juniper B. E., 1989, CARNIVOROUS PLANTS; Knutson LV, 2011, BIOL SNAIL KILLING S, P506; Koopman MM, 2010, APPL ENVIRON MICROB, V76, P1851, DOI 10.1128/AEM.02440-09; Larson BMH, 2001, CAN ENTOMOL, V133, P439, DOI 10.4039/Ent133439-4; Lopez R., 2012, Boletin de Sanidad Vegetal Plagas, V38, P3; Lowrie A., 1998, CARNIVOROUS PLANTS A; Marinoni Luciane, 2007, Biota Neotrop., V7, P0, DOI 10.1590/S1676-06032007000100019; Marshall SA, 2013, AFR INVERTEBR, V54, P427, DOI 10.5733/afin.054.0221; Mengual X, 2008, MOL PHYLOGENET EVOL, V49, P715, DOI 10.1016/j.ympev.2008.09.011; Mengual X, 2008, CLADISTICS, V24, P543, DOI 10.1111/j.1096-0031.2008.00200.x; Mengual X, 2012, MOL PHYLOGENET EVOL, V62, P191, DOI 10.1016/j.ympev.2011.09.014; Mengual X, 2011, ZOOKEYS, P1, DOI 10.3897/zookeys.140.1930; Metz Mark A., 2001, Studia Dipterologica, V8, P225; Mogi M, 1996, RAFFLES B ZOOL, V44, P233; Mogi M, 1997, ANN ENTOMOL SOC AM, V90, P177, DOI 10.1093/aesa/90.2.177; Monteiro SG, 2008, REV BRAS PARASITOL V, V17, P95; Morales MN, 2009, ZOOTAXA, P53, DOI 10.11646/zootaxa.2112.1.5; Moran JA., 1993, BRUNEI MUSEUM J, V8, P83; Murza GL, 2005, BOT J LINN SOC, V147, P417, DOI 10.1111/j.1095-8339.2005.00395.x; Nishida Kenji, 2003, Studia Dipterologica, V9, P421; Penney HD, 2014, AM NAT, V183, P281, DOI 10.1086/674612; Perez-Banon C, 2013, MICROSC RES TECHNIQ, V76, P853, DOI 10.1002/jemt.22239; Perez-Lachaud G, 2014, BIOL J LINN SOC, V111, P462, DOI 10.1111/bij.12220; Perez-Moreno S, 2006, MICRON, V37, P169, DOI 10.1016/j.micron.2005.07.013; Reemer M, 2009, J NAT HIST, V43, P939, DOI 10.1080/00222930802610576; Rojo S, 1996, ENTOMOL EXP APPL, V81, P53, DOI 10.1007/BF00187838; Rojo S., 2003, WORLD REV PREDATORY; Rotheray G, 1999, ZOOL J LINN SOC-LOND, V127, P1, DOI 10.1111/j.1096-3642.1999.tb01305.x; Rotheray G. E., 2011, NATURAL HIST HOVERFL; Rotheray Graham E., 2003, Studia Dipterologica, V10, P219; Rotheray Graham E., 2012, Entomologist's Monthly Magazine, V148, P15; Rotheray Graham E., 2000, Studia Dipterologica, V7, P385; Russell M. C., 1953, West Australian Naturalist, V4, P9; Sampson BJ, 2002, ENVIRON ENTOMOL, V31, P339, DOI 10.1603/0046-225X-31.2.339; Scharmann M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063556; Sivinski J, 1999, FLA ENTOMOL, V82, P179, DOI 10.2307/3496570; Sota T, 1998, BIOTROPICA, V30, P82, DOI 10.1111/j.1744-7429.1998.tb00371.x; Sturza VS, 2014, BRAZ J BIOL, V74, P656, DOI 10.1590/bjb.2014.0071; Thompson F.C., 1999, CONTRIBUTION ENTOMOL, V3, P321; Thompson F. Christian, 2010, P763; Thompson FC, 1976, MUS ZOOL UN SAO PAUL, V46, P1; THUM M, 1989, OECOLOGIA, V81, P397, DOI 10.1007/BF00377090; Torres LC, 2014, NEOTROP ENTOMOL, V43, P189, DOI 10.1007/s13744-013-0188-3; Urena O, 2010, REV BIOL TROP, V58, P1157; Vockeroth J. R., 1969, Mem ent Soc Canada Ottawa, VNo. 62, P1; Walker F, 1836, T LINNEAN SOC LONDON, V17, P331, DOI [DOI 10.1111/J.1095-8339.1834.TB00026.X, 10.1111/j.1095-8339.1834.tb00026.x]; WATSON AP, 1982, AUST J ECOL, V7, P13, DOI 10.1111/j.1442-9993.1982.tb01296.x; Wheeler Jr A. G., 2001, BIOL PLANT BUGS; Whitney HM, 2013, CURR OPIN PLANT BIOL, V16, P105, DOI 10.1016/j.pbi.2012.11.008; Wild AL, 2009, AFR INVERTEBR, V50, P205, DOI 10.5733/afin.050.0109; Wood-Baker C.S., 1972, Entomologist's Monthly Magazine, V108, P95; Woodcock Thomas S., 2014, Journal of Pollination Ecology, V12, P63; ZAMORA R, 1990, OIKOS, V59, P368, DOI 10.2307/3545148; Zamora R, 1996, J ANIM ECOL, V65, P154, DOI 10.2307/5718; ZAVORTINK T J, 1985, Wasmann Journal of Biology, V43, P46	99	11	11	0	61	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 4	2016	11	5							e0153900	10.1371/journal.pone.0153900	http://dx.doi.org/10.1371/journal.pone.0153900			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DL5KR	27144980	gold, Green Submitted, Green Published			2022-12-26	WOS:000375676400031
J	Liu, YX; Tian, XX; Li, Y; Liu, D; Liu, ML; Zhang, XL; Zhang, QY; Yan, CH; Han, YL				Liu, Yanxia; Tian, Xiaoxiang; Li, Yang; Liu, Dan; Liu, Meili; Zhang, Xiaolin; Zhang, Quanyu; Yan, Chenghui; Han, Yaling			Up-Regulation of CREG Expression by the Transcription Factor GATA1 Inhibits High Glucose- and High Palmitate-Induced Apoptosis in Human Umbilical Vein Endothelial Cells	PLOS ONE			English	Article							CELLULAR REPRESSOR; E1A-STIMULATED GENES; VASCULAR-DISEASE; VEGF/PI3K/AKT PATHWAY; SIGNALING PATHWAY; ACTIVATION; PROMOTES; DYSFUNCTION; OVEREXPRESSION; KINASE	Background Endothelial cell (EC) apoptosis plays a vital role in the pathogenesis of atherosclerosis in patients with diabetes mellitus (DM), but the underlying mechanism remains unclear. Cellular repressor of E1A-stimulated genes (CREG) is a novel gene reported to be involved in maintaining the homeostasis of ECs. Therefore, in the present study, we investigated the role of CREG in high glucose/high palmitate-induced EC apoptosis and to decipher the upstream regulatory mechanism underlying the transcriptional regulation of CREG. Methods The expression of CREG and the rate of apoptosis were assessed in lower-limb atherosclerotic lesions from patients with type 2 DM (T2DM). Primary human umbilical vein endothelial cells (HUVECs) were isolated and cultured in a high glucose/high palmitate medium (25 mmol/L D-glucose, 0.4 mmol/L palmitate), and the over-expression and knock-down of CREG were performed in HUVECs to determine the role of CREG in EC apoptosis. The upstream regulatory mechanism of CREG was identified using a promoter-binding transcription-factor profiling array, chromatin immunoprecipitation (ChIP) assay and a mutation analysis. Results Compared with normal arteries from non-diabetic patients, reduced CREG expression and increased apoptosis were found in the endothelium of atherosclerotic lesions from patients with T2DM. In vitro treatment of HUVECs with a high glucose/high palmitate medium also resulted in decreased CREG expression and increased apoptosis. Moreover, high glucose/high palmitate induced-HUVEC apoptosis was increased by the knock-down of CREG and rescued by the over-expression of CREG. We also demonstrated that GATA1 was able to bind to the promoter of the human CREG gene. A deletion mutation at -297/-292 in the CREG promoter disrupted GATA1 binding and reduced the activation of CREG transcription by approximately 83.3%. Finally, the overexpression of GATA1 abrogated the high glucose/high palmitate-induced apoptosis in HUVECs. Conclusions The over-expression of CREG inhibits high glucose/high palmitate-induced apoptosis in HUVECs. CREG is transcriptionally upregulated by GATA1. Thus, CREG might be a potential therapeutic target for intervention of vascular complications related to diabetes.	[Liu, Yanxia] Third Mil Med Univ, Grad Sch, Chongqing, Peoples R China; [Liu, Yanxia; Tian, Xiaoxiang; Li, Yang; Liu, Dan; Liu, Meili; Zhang, Xiaolin; Zhang, Quanyu; Yan, Chenghui; Han, Yaling] Gen Hosp Shenyang Mil Reg, Dept Cardiol, Shenyang, Peoples R China; [Liu, Yanxia; Tian, Xiaoxiang; Li, Yang; Liu, Dan; Liu, Meili; Zhang, Xiaolin; Zhang, Quanyu; Yan, Chenghui; Han, Yaling] Gen Hosp Shenyang Mil Reg, Cardiovasc Res Inst, Shenyang, Peoples R China	Army Medical University	Han, YL (corresponding author), Gen Hosp Shenyang Mil Reg, Dept Cardiol, Shenyang, Peoples R China.; Han, YL (corresponding author), Gen Hosp Shenyang Mil Reg, Cardiovasc Res Inst, Shenyang, Peoples R China.	yalinghan@gmail.com		Han, Yaling/0000-0003-4569-6737	National Nature Science Foundation of China [81130072, 81370243, 81570265, 81570767, 81400316, 81500329]	National Nature Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was supported by grants from the National Nature Science Foundation of China to YLH (No. 81130072 and No. 81370243), CHY (No. 81570265), XXT (No. 81570767), Y. Li (No. 81400316) and QYZ (No. 81500329). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altabas V, 2015, INT J ENDOCRINOL, V2015, DOI 10.1155/2015/848272; Asada S, 2008, AM J PHYSIOL-HEART C, V295, pH2512, DOI 10.1152/ajpheart.00233.2008; Borradaile NM, 2010, AM J PHYSIOL-CELL PH, V298, pC66, DOI 10.1152/ajpcell.00357.2009; Breton-Romero R, 2016, ARTERIOSCL THROM VAS, V36, P561, DOI 10.1161/ATVBAHA.115.306578; Caballero AE, 2003, OBES RES, V11, P1278, DOI 10.1038/oby.2003.174; Coultas L, 2005, NATURE, V438, P937, DOI 10.1038/nature04479; Deng J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060735; Duan Y, 2013, MOL BIOL REP, V40, P3891, DOI 10.1007/s11033-012-2373-6; Fan C, 2009, J BIOL CHEM, V284, P23331, DOI 10.1074/jbc.M109.036079; Han YL, 2008, CARDIOVASC RES, V78, P597, DOI 10.1093/cvr/cvn036; Han YL, 2010, J MOL CELL CARDIOL, V48, P1225, DOI 10.1016/j.yjmcc.2009.12.018; Han YL, 2009, EXP CELL RES, V315, P3301, DOI 10.1016/j.yexcr.2009.09.013; Li Y, 2012, ATHEROSCLEROSIS, V225, P304, DOI 10.1016/j.atherosclerosis.2012.08.015; Martin-Timon I, 2014, WORLD J DIABETES, V5, P444, DOI 10.4239/wjd.v5.i4.444; Paneni F, 2013, EUR HEART J, V34, P2436, DOI 10.1093/eurheartj/eht149; Peng F, 2011, BIOCHEM BIOPH RES CO, V406, P601, DOI 10.1016/j.bbrc.2011.02.100; Peng CF, 2015, INT J CARDIOL, V183, P232, DOI 10.1016/j.ijcard.2015.01.059; Sarwar N, 2010, LANCET, V375, P2215, DOI 10.1016/S0140-6736(10)60484-9; Sena CM, 2013, BBA-MOL BASIS DIS, V1832, P2216, DOI 10.1016/j.bbadis.2013.08.006; Tao J, 2013, INT J MOL SCI, V14, P18437, DOI 10.3390/ijms140918437; Tian XX, 2014, FRONT BIOSCI-LANDMRK, V19, P1215, DOI 10.2741/4277; Wang J, 2013, EXP CELL RES, V319, P1165, DOI 10.1016/j.yexcr.2013.03.010; Wang N, 2011, ATHEROSCLEROSIS, V218, P543, DOI 10.1016/j.atherosclerosis.2011.08.002; Weikel KA, 2015, AM J PHYSIOL-CELL PH, V308, pC249, DOI 10.1152/ajpcell.00265.2014; Wu Y, 2007, J BIOL CHEM, V282, P9777, DOI 10.1074/jbc.M608310200; Yan CH, 2014, FRONT BIOSCI-LANDMRK, V19, P1151, DOI 10.2741/4272; Yang GT, 2011, MOL BIOL REP, V38, P2133, DOI 10.1007/s11033-010-0340-7; Zhang HM, 2011, EXP CELL RES, V317, P2904, DOI 10.1016/j.yexcr.2011.08.012	28	8	8	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 3	2016	11	5							e0154861	10.1371/journal.pone.0154861	http://dx.doi.org/10.1371/journal.pone.0154861			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DL5KK	27139506	Green Published, gold			2022-12-26	WOS:000375675700074
J	Rasmussen, MK; Balaguer, P; Ekstrand, B; Daujat-Chavanieu, M; Gerbal-Chaloin, S				Rasmussen, Martin Kroyer; Balaguer, Patrick; Ekstrand, Bo; Daujat-Chavanieu, Martine; Gerbal-Chaloin, Sabine			Skatole (3-Methylindole) Is a Partial Aryl Hydrocarbon Receptor Agonist and Induces CYP1A1/2 and CYP1B1 Expression in Primary Human Hepatocytes	PLOS ONE			English	Article							ENTIRE MALE PIGS; TRYPTOPHAN-METABOLITES; CYTOCHROME-P450 ENZYMES; DIOXIN RECEPTOR; BOAR TAINT; ACTIVATION; ANTAGONIST; TOXICITY; INDOLE; URINE	Skatole (3-methylindole) is a product of bacterial fermentation of tryptophan in the intestine. A significant amount of skatole can also be inhaled during cigarette smoking. Skatole is a pulmonary toxin that induces the expression of aryl hydrocarbon receptor (AhR) regulated genes, such as cytochrome P450 1A1 (CYP1A1), in human bronchial cells. The liver has a high metabolic capacity for skatole and is the first organ encountered by the absorbed skatole; however, the effect of skatole in the liver is unknown. Therefore, we investigated the impact of skatole on hepatic AhR activity and AhR-regulated gene expression. Using reporter gene assays, we showed that skatole activates AhR and that this is accompanied by an increase of CYP1A1, CYP1A2 and CYP1B1 expression in HepG2-C3 and primary human hepatocytes. Specific AhR antagonists and siRNA-mediated AhR silencing demonstrated that skatole-induced CYP1A1 expression is dependent on AhR activation. The effect of skatole was reduced by blocking intrinsic cytochrome P450 activity and indole-3-carbinole, a known skatole metabolite, was a more potent inducer than skatole. Finally, skatole could reduce TCDD-induced CYP1A1 expression, suggesting that skatole is a partial AhR agonist. In conclusion, our findings suggest that skatole and its metabolites affect liver homeostasis by modulating the AhR pathway.	[Rasmussen, Martin Kroyer; Daujat-Chavanieu, Martine; Gerbal-Chaloin, Sabine] INSERM, U1183, Inst Regenerat Med & Biotherapy, F-34290 Montpellier, France; [Rasmussen, Martin Kroyer; Gerbal-Chaloin, Sabine] Univ Montpellier, UMR 1183, F-34203 Montpellier, France; [Rasmussen, Martin Kroyer; Ekstrand, Bo] Aarhus Univ, Dept Food Sci, Foulum, Denmark; [Balaguer, Patrick] Inst Rech Cancerol Montpellier, F-34298 Montpellier, France; [Daujat-Chavanieu, Martine] CHU Montpellier, Inst Regenerat Med & Biotherapy, F-34290 Montpellier, France	Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Montpellier; Universite de Montpellier; Aarhus University; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Montpellier; Universite de Montpellier; CHU de Montpellier	Rasmussen, MK (corresponding author), INSERM, U1183, Inst Regenerat Med & Biotherapy, F-34290 Montpellier, France.; Rasmussen, MK (corresponding author), Univ Montpellier, UMR 1183, F-34203 Montpellier, France.; Rasmussen, MK (corresponding author), Aarhus Univ, Dept Food Sci, Foulum, Denmark.	Martink.rasmussen@food.au.dk	Daujat-Chavanieu, Martine/AAU-2908-2020; GERBAL-CHALOIN, sabine/M-8783-2017; Rasmussen, Martin Krøyer/AAE-8454-2019; Balaguer, Patrick/I-2973-2016; Daujat-Chavanieu, Martine/T-5155-2018	Daujat-Chavanieu, Martine/0000-0001-5560-1610; GERBAL-CHALOIN, sabine/0000-0002-2549-7899; Rasmussen, Martin Krøyer/0000-0002-1889-2874; Daujat-Chavanieu, Martine/0000-0001-5560-1610	Willum Fonden; Lundbeckfonden; Norma of Frode S Jacobsens Fond	Willum Fonden; Lundbeckfonden(Lundbeckfonden); Norma of Frode S Jacobsens Fond	This work was supported by Willum Fonden (http://veluxfoundations.dk/en/forskning/teknisk-og-naturvidenskabelig-forskning), MKR; Lundbeckfonden (http://www.lundbeckfoundation.com/), MKR; and Norma of Frode S Jacobsens Fond (http://www.normaogfrodejacobsensfond.dk/menu.htm), MKR. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADAMS JD, 1987, BIOCHEM BIOPH RES CO, V149, P73, DOI 10.1016/0006-291X(87)91606-8; ALBRECHT CF, 1989, LIFE SCI, V45, P1119, DOI 10.1016/0024-3205(89)90169-0; BRAY TM, 1990, PHARMACOL THERAPEUT, V46, P105, DOI 10.1016/0163-7258(90)90038-4; Casper RF, 1999, MOL PHARMACOL, V56, P784; Cheng YT, 2015, DRUG METAB DISPOS, V43, P1536, DOI 10.1124/dmd.115.063677; Choi Y, 2013, J NUTR BIOCHEM, V24, P1393, DOI 10.1016/j.jnutbio.2012.11.007; Claus R, 2003, J ANIM SCI, V81, P239; Denison MS, 2003, ANNU REV PHARMACOL, V43, P309, DOI 10.1146/annurev.pharmtox.43.100901.135828; Dvorak Z, 2008, BIOCHEM PHARMACOL, V75, P580, DOI 10.1016/j.bcp.2007.09.013; Emoto Chie, 2005, Drug Metab Pharmacokinet, V20, P351, DOI 10.2133/dmpk.20.351; FORDTRAN JS, 1964, J LAB CLIN MED, V64, P125; Guengerich FP, 2008, CHEM RES TOXICOL, V21, P70, DOI 10.1021/tx700079z; Heath-Pagliuso S, 1998, BIOCHEMISTRY-US, V37, P11508, DOI 10.1021/bi980087p; HOFFMANN D, 1970, ANAL CHEM, V42, P366, DOI 10.1021/ac60285a023; Hubbard TD, 2015, SCI REP-UK, V5, DOI 10.1038/srep12689; HUIJZER JC, 1989, DRUG METAB DISPOS, V17, P37; ISOM HC, 1985, P NATL ACAD SCI USA, V82, P3252, DOI 10.1073/pnas.82.10.3252; Jin UH, 2014, MOL PHARMACOL, V85, P777, DOI 10.1124/mol.113.091165; KARLIN DA, 1985, J CANCER RES CLIN, V109, P135, DOI 10.1007/BF00391888; Kawajiri K, 2009, P NATL ACAD SCI USA, V106, P13481, DOI 10.1073/pnas.0902132106; Kim SH, 2006, MOL PHARMACOL, V69, P1871, DOI 10.1124/mol.105.021832; KOWALEWSKA J, 1985, J DAIRY SCI, V68, P2165, DOI 10.3168/jds.S0022-0302(85)81086-9; Kreuzer PE, 1997, ARCH TOXICOL, V71, P383, DOI 10.1007/s002040050402; Lanza DL, 2001, DRUG METAB DISPOS, V29, P950; Leong J, 2011, MEAT SCI, V88, P45, DOI 10.1016/j.meatsci.2010.12.001; LEYTON GB, 1958, BRIT MED J, V2, P1136, DOI 10.1136/bmj.2.5105.1136; Ma Q, 2007, DRUG METAB DISPOS, V35, P1009, DOI 10.1124/dmd.107.015826; Matal J, 2009, NEUROENDOCRINOL LETT, V30, P36; Miller CA, 1997, J BIOL CHEM, V272, P32824, DOI 10.1074/jbc.272.52.32824; Monostory K, 2009, DRUG METAB REV, V41, P547, DOI 10.1080/03602530903112284; NAKAO A, 1960, J NERV MENT DIS, V130, P417, DOI 10.1097/00005053-196005000-00005; Nichols WK, 2003, TOXICOL SCI, V71, P229, DOI 10.1093/toxsci/71.2.229; Pauly C, 2011, ANIMAL, V5, P378, DOI 10.1017/S1751731110001849; Pichard Lydiane, 2006, Methods Mol Biol, V320, P283; Rasmussen MK, 2014, COMPUT STRUCT BIOTEC, V11, P106, DOI 10.1016/j.csbj.2014.09.003; RUANGYUTTIKARN W, 1991, DRUG METAB DISPOS, V19, P977; Stejskalova L, 2011, CURR DRUG METAB, V12, P198, DOI 10.2174/138920011795016818; SUYAMA Y, 1988, CLIN CHIM ACTA, V176, P203, DOI 10.1016/0009-8981(88)90208-2; ThorntonManning J, 1996, J PHARMACOL EXP THER, V276, P21; THORNTONMANNING JR, 1991, BIOCHEM BIOPH RES CO, V181, P100, DOI 10.1016/S0006-291X(05)81387-7; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; VANG O, 1990, CARCINOGENESIS, V11, P1259, DOI 10.1093/carcin/11.8.1259; Weems JM, 2010, CHEM RES TOXICOL, V23, P696, DOI 10.1021/tx9004506; Weems JM, 2009, TOXICOL SCI, V112, P59, DOI 10.1093/toxsci/kfp201; WHITELAW ML, 1993, EMBO J, V12, P4169, DOI 10.1002/j.1460-2075.1993.tb06101.x; Wiercinska P, 2012, ANIMAL, V6, P834, DOI 10.1017/S1751731111002175; YOKOYAMA MT, 1979, AM J CLIN NUTR, V32, P173; YOST GS, 1989, CHEM RES TOXICOL, V2, P273, DOI 10.1021/tx00011a001; Zamaratskaia G, 2009, ANIMAL, V3, P1508, DOI 10.1017/S1751731108003674; Zhao B, 2010, TOXICOL SCI, V117, P393, DOI 10.1093/toxsci/kfq217; ZUCCATO E, 1993, DIGEST DIS SCI, V38, P514, DOI 10.1007/BF01316508	51	45	46	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 3	2016	11	5							e0154629	10.1371/journal.pone.0154629	http://dx.doi.org/10.1371/journal.pone.0154629			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DL5KK	27138278	gold, Green Published, Green Submitted			2022-12-26	WOS:000375675700046
J	Farkas, D; Denham, SL; Bendixen, A; Toth, D; Kondo, HM; Winkler, I				Farkas, David; Denham, Susan L.; Bendixen, Alexandra; Toth, Denes; Kondo, Hirohito M.; Winkler, Istvan			Auditory Multi-Stability: Idiosyncratic Perceptual Switching Patterns, Executive Functions and Personality Traits	PLOS ONE			English	Article							BINOCULAR-RIVALRY; PREFRONTAL CORTEX; WORKING-MEMORY; FRONTAL LOBES; CREATIVITY; MULTISTABILITY; INTERFERENCE; BISTABILITY; DIFFERENCE; COMPONENTS	Multi-stability refers to the phenomenon of perception stochastically switching between possible interpretations of an unchanging stimulus. Despite considerable variability, individuals show stable idiosyncratic patterns of switching between alternative perceptions in the auditory streaming paradigm. We explored correlates of the individual switching patterns with executive functions, personality traits, and creativity. The main dimensions on which individual switching patterns differed from each other were identified using multidimensional scaling. Individuals with high scores on the dimension explaining the largest portion of the inter-individual variance switched more often between the alternative perceptions than those with low scores. They also perceived the most unusual interpretation more often, and experienced all perceptual alternatives with a shorter delay from stimulus onset. The ego-resiliency personality trait, which reflects a tendency for adaptive flexibility and experience seeking, was significantly positively related to this dimension. Taking these results together we suggest that this dimension may reflect the individual's tendency for exploring the auditory environment. Executive functions were significantly related to some of the variables describing global properties of the switching patterns, such as the average number of switches. Thus individual patterns of perceptual switching in the auditory streaming paradigm are related to some personality traits and executive functions.	[Farkas, David; Toth, Denes; Winkler, Istvan] Hungarian Acad Sci, Res Ctr Nat Sci, Inst Cognit Neurosci & Psychol, Budapest, Hungary; [Farkas, David] Budapest Univ Technol & Econ, Fac Nat Sci, Dept Cognit Sci, Budapest, Hungary; [Denham, Susan L.] Univ Plymouth, Cognit Inst, Plymouth PL4 8AA, Devon, England; [Denham, Susan L.] Univ Plymouth, Sch Psychol, Plymouth PL4 8AA, Devon, England; [Bendixen, Alexandra] Tech Univ Chemnitz, Sch Nat Sci, Chemnitz, Germany; [Kondo, Hirohito M.] NTT Corp, NTT Commun Sci Labs, Human Informat Sci Lab, Atsugi, Kanagawa, Japan	Eotvos Lorand Research Network; Hungarian Academy of Sciences; Hungarian Research Centre for Natural Sciences; Budapest University of Technology & Economics; University of Plymouth; University of Plymouth; Technische Universitat Chemnitz; Nippon Telegraph & Telephone Corporation	Farkas, D (corresponding author), Hungarian Acad Sci, Res Ctr Nat Sci, Inst Cognit Neurosci & Psychol, Budapest, Hungary.; Farkas, D (corresponding author), Budapest Univ Technol & Econ, Fac Nat Sci, Dept Cognit Sci, Budapest, Hungary.	farkas.david@ttk.mta.hu	Kondo, Hirohito/H-3646-2011; Winkler, István/A-7659-2008	Kondo, Hirohito/0000-0002-7444-4996; Winkler, István/0000-0002-3344-6151; Bendixen, Alexandra/0000-0001-8211-9619; denham, susan/0000-0002-0988-5672	Hungarian Academy of Sciences [LP-36/2012]; NTT Corporation	Hungarian Academy of Sciences(Hungarian Academy of Sciences); NTT Corporation	This research was supported by the Hungarian Academy of Sciences (Lendulet Project LP-36/2012 to DF and IW). NTT Corporation provided support in the form of salary for author HK, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	AAFJES M, 1966, PSYCHOPHYSIOLOGY, V3, P18, DOI 10.1111/j.1469-8986.1966.tb02674.x; Alais D, 2012, WIRES COGN SCI, V3, P87, DOI 10.1002/wcs.151; Allen E, 2012, J VIS, V12, P678, DOI [10.1167/12.9.678, DOI 10.1167/12.9.678]; Allen E., 2011, J VIS, V11, P1257, DOI [10.1167/11.11.1257, DOI 10.1167/11.11.1257]; Alvarez JA, 2006, NEUROPSYCHOL REV, V16, P17, DOI 10.1007/s11065-006-9002-x; AMABILE TM, 1982, J PERS SOC PSYCHOL, V43, P997, DOI 10.1037/0022-3514.43.5.997; [Anonymous], 2005, SOCIAL MOTIVATION CO; ANSTIS S, 1985, J EXP PSYCHOL HUMAN, V11, P257, DOI 10.1037/0096-1523.11.3.257; Auguie B, 2017, GRIDEXTRA MISCELLANE; Baer John, 2009, HDB RES ASSESSMENT T, P65, DOI DOI 10.4018/978-1-60566-667-9.CH004; Barkley R.A, 1997, ADHD NATURE SELF CON; Beaton DE, 2000, SPINE, V25, P3186, DOI 10.1097/00007632-200012150-00014; Bendixen A, 2010, J ACOUST SOC AM, V128, P3658, DOI 10.1121/1.3500695; BLAIR RC, 1993, PSYCHOPHYSIOLOGY, V30, P518, DOI 10.1111/j.1469-8986.1993.tb02075.x; Block J, 1996, J PERS SOC PSYCHOL, V70, P349, DOI 10.1037/0022-3514.70.2.349; Block J., 2002, PERSONALITY AFFECT P; Block JH, 1980, DEV COGNITION AFFECT, P39; Bosten JM, 2015, VISION RES, V110, P34, DOI 10.1016/j.visres.2015.02.017; Bregman A.S., 1990, AUDITORY SCENE ANAL; CATTELL RB, 1966, MULTIVAR BEHAV RES, V1, P245, DOI 10.1207/s15327906mbr0102_10; Cogent 2000 team, 2011, COG 2000; Costa PT, 2007, REVISED NEO PERSONAL; Deike S, 2012, FRONT PSYCHOL, V3, DOI 10.3389/fpsyg.2012.00461; Denham SL, 2006, J PHYSIOL-PARIS, V100, P154, DOI 10.1016/j.jphysparis.2006.09.012; Denham S.L., 2013, LEARN PERCEPT, V5, P73, DOI [10.1556/LP.5.2013.Suppl2.6, DOI 10.1556/LP.5.2013.SUPPL2.6]; Denham S, 2014, FRONT NEUROSCI-SWITZ, V8, DOI 10.3389/fnins.2014.00025; Denham S, 2012, J NEUROSCI METH, V210, P79, DOI 10.1016/j.jneumeth.2012.04.004; DeYoung CG, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00762; Doherty MJ, 2012, PERCEPTION, V41, P1262, DOI 10.1068/p7350; Ecker UKH, 2010, J EXP PSYCHOL LEARN, V36, P170, DOI 10.1037/a0017891; Farkas D, 2016, J ACOUST SOC AM, V139, P1762, DOI 10.1121/1.4945720; Farkas D, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0120883; Fischer J.S., 2012, NEUROPSYCHOLOGICAL A, V5th; FRANKS CM, 1963, PERCEPT MOTOR SKILL, V16, P131, DOI 10.2466/pms.1963.16.1.131; Genc E, 2011, FRONT HUM NEUROSCI, V5, DOI 10.3389/fnhum.2011.00161; Guilford JP, 1950, AM PSYCHOL, V5, P444, DOI 10.1037/h0063487; Gutschalk A, 2005, J NEUROSCI, V25, P5382, DOI 10.1523/JNEUROSCI.0347-05.2005; Hill KT, 2011, BMC NEUROSCI, V12, DOI 10.1186/1471-2202-12-85; John O.P., 1999, HDB PERSONALITY THEO, VVolume 2, P102; Jung RE, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009818; Kanai R, 2010, CURR BIOL, V20, P1626, DOI 10.1016/j.cub.2010.07.027; Kashino M, 2012, PHILOS T R SOC B, V367, P977, DOI 10.1098/rstb.2011.0370; Kaufman JC, 2007, THINK SKILLS CREAT, V2, P96, DOI 10.1016/j.tsc.2007.04.002; KIRCHNER WK, 1958, J EXP PSYCHOL, V55, P352, DOI 10.1037/h0043688; Kleinschmidt A, 2012, PHILOS T R SOC B, V367, P988, DOI 10.1098/rstb.2011.0367; Kondo HM, 2012, CEREB CORTEX, V22, P1915, DOI 10.1093/cercor/bhr266; Kondo HM, 2009, J NEUROSCI, V29, P12695, DOI 10.1523/JNEUROSCI.1549-09.2009; Kondo HM, 2015, NEUROSCIENCE2015; Kozbelt A., 2010, CAMBRIDGE HDB CREATI, P20, DOI [10.1017/CBO9780511763205.004, DOI 10.1017/CBO9780511763205.004]; Kruskal J, 1978, MULTIDIMENSIONAL SCA; Kullback S., 1968, INFORM THEORY STAT; Lansbergen MM, 2007, NEUROPSYCHOLOGY, V21, P251, DOI 10.1037/0894-4105.21.2.251; Libedinsky C, 2011, J NEUROSCI, V31, P64, DOI 10.1523/JNEUROSCI.3620-10.2011; McNemar Q, 1947, PSYCHOMETRIKA, V12, P153, DOI 10.1007/BF02295996; Meszaros A, 2011, ALKALMAZOTT PSZICHOL, V14, P53; Mill RW, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1002925; Miller SM, 2010, P NATL ACAD SCI USA, V107, P2664, DOI 10.1073/pnas.0912149107; Miyake A, 2000, COGNITIVE PSYCHOL, V41, P49, DOI 10.1006/cogp.1999.0734; Moore BCJ, 2012, PHILOS T R SOC B, V367, P919, DOI 10.1098/rstb.2011.0355; Moreno-Bote R, 2010, J VISION, V10, DOI 10.1167/10.11.1; Nagamine M, 2007, PHYSIOL BEHAV, V91, P161, DOI 10.1016/j.physbeh.2007.02.016; Niendam TA, 2012, COGN AFFECT BEHAV NE, V12, P241, DOI 10.3758/s13415-011-0083-5; Noest AJ, 2007, J VISION, V7, DOI 10.1167/7.8.10; Paulhus D.L., 1991, MEASURES PERSONALITY, P17, DOI [DOI 10.1016/B978-0-12-590241-0.50006-X, 10.1016/B978-0-12-590241-0.50006-X]; PAULHUS DL, 1984, J PERS SOC PSYCHOL, V46, P598, DOI 10.1037/0022-3514.46.3.598; Peirce JW, 2009, FRONT NEUROINFORM, V2, DOI 10.3389/neuro.11.010.2008; Plucker J. A., 2010, CAMBRIDGE HDB CREATI, P48, DOI DOI 10.1017/CBO9780511763205.005; Pressnitzer D, 2006, CURR BIOL, V16, P1351, DOI 10.1016/j.cub.2006.05.054; Psychology Software Tools Inc., 2002, E PRIM 2 0; Schmiedek F, 2009, J EXP PSYCHOL LEARN, V35, P1089, DOI 10.1037/a0015730; Schwartz JL, 2012, PHILOS T R SOC B, V367, P896, DOI 10.1098/rstb.2011.0254; Sowell ER, 1999, NAT NEUROSCI, V2, P859, DOI 10.1038/13154; Stroop JR, 1935, J EXP PSYCHOL, V18, P643, DOI 10.1037/h0054651; Stuss DT, 2000, PSYCHOL RES-PSYCH FO, V63, P289, DOI 10.1007/s004269900007; The MathWorks Inc, 2014, MATLAB STAT TOOLB RE; Torrance E. P., 1988, NATURE CREATIVITY, P43; Troyer A. K., 2006, QUANTIFIED PROCESS A, P143, DOI [10.4324/9780203720899-20, DOI 10.4324/9780203720899-20, 10.4324/9780203720899, DOI 10.4324/9780203720899]; Troyer AK, 1997, NEUROPSYCHOLOGY, V11, P138, DOI 10.1037/0894-4105.11.1.138; Van Noorden L. P. A. S., 1975, THESIS TU EINDHOVEN; Weilnhammer VA, 2013, J NEUROSCI, V33, P16009, DOI 10.1523/JNEUROSCI.1418-13.2013; Whiteside SP, 2001, PERS INDIV DIFFER, V30, P669, DOI 10.1016/S0191-8869(00)00064-7; Wimmer M. C., 2011, MONOGRAPHS SOC RES C, V76, P1, DOI DOI 10.1111/J.1540-5834.2011.00589.X; Wimmer MC, 2007, THESIS U STIRLING; Windmann S, 2006, J COGNITIVE NEUROSCI, V18, P456, DOI 10.1162/089892906775990570; Winkler I, 2005, COGNITIVE BRAIN RES, V25, P291, DOI 10.1016/j.cogbrainres.2005.06.005; Winkler I, 2012, PHILOS T R SOC B, V367, P1001, DOI 10.1098/rstb.2011.0359; Wiseman R, 2011, BRIT J PSYCHOL, V102, P615, DOI 10.1111/j.2044-8295.2011.02031.x; Yerkes R., 1911, INTRO PSYCHOL; Yoder PJ, 2004, J CLIN EXP NEUROPSYC, V26, P320, DOI 10.1080/13803390490510040	89	8	8	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 2	2016	11	5							e0154810	10.1371/journal.pone.0154810	http://dx.doi.org/10.1371/journal.pone.0154810			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DL5KB	27135945	Green Published, Green Submitted, gold, Green Accepted			2022-12-26	WOS:000375674800049
J	Lau, Y; Htun, TP; Lim, PI; Ho-Lim, S; Klainin-Yobas, P				Lau, Ying; Htun, Tha Pyai; Lim, Peng Im; Ho-Lim, Sarah; Klainin-Yobas, Piyanee			Psychometric Evaluation of 5-and 4-Item Versions of the LATCH Breastfeeding Assessment Tool during the Initial Postpartum Period among a Multiethnic Population	PLOS ONE			English	Article							COEFFICIENT ALPHA; BIRTH; PREVALENCE; PATTERNS; DELIVERY; MOTHERS	Objectives The aim of this study was to evaluate the internal consistency, structural validity, sensitivity and specificity of the 5- and 4-item versions of the LATCH assessment tool among a multiethnic population in Singapore. Methods The study was a secondary analysis of a subset of data (n = 907) from our previous breastfeeding survey from 2013 to 2014. The internal consistency of the LATCH was examined using Cronbach's alpha. The structural validity was assessed using an exploratory factor analysis (EFA), and the proposed factors were confirmed by confirmatory factor analysis (CFA) using separate samples. Receiver operating characteristic analysis was used to evaluate the sensitivity and specificity of the LATCH score thresholds for predicting non-exclusive breastfeeding. Results The Cronbach's alpha values of the 5- and 4-item LATCH assessments were 0.70 and 0.74, respectively. The EFA demonstrated a one-factor structure for the 5-and 4-item LATCH assessments among a randomized split of 334 vaginally delivered women. Two CFA of the 4-item LATCH demonstrated better fit indices of the models compared to the two CFA of the 5-item LATCH among another randomized split of 335 vaginally delivered women and 238 cesarean delivered women. Using cutoffs of 5.5 and 3.5 were recommended when predicting non-exclusive breastfeeding for 5- and 4-item versions of the LATCH assessment among vaginally delivered women (n = 669), with satisfactory sensitivities (94% and 95%), low specificities (0% and 2%), low positive predictive values (25%) and negative predictive values (20% and 47%). A cutoff of 5.5 was recommended to predict non-exclusive breastfeeding for 5- and 4-item versions among cesarean delivered women (n = 238) with satisfactory sensitivities (93% and 98%), low specificities (4% and 9%), low positive predictive values (41%) and negative predictive values (65% and 75%). Therefore, the tool has good sensitivity but poor specificity, positive and negative predictive values. Conclusions We found that the 4-item version demonstrated sound psychometric properties compared to the 5-item version. Health professionals can use the 4-item LATCH as a clinical tool because it is a concise, easy-to-use and valid tool for assessing breastfeeding techniques among a multiethnic population.	[Lau, Ying; Htun, Tha Pyai; Klainin-Yobas, Piyanee] Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Alice Lee Ctr Nursing Studies, Singapore 117595, Singapore; [Lim, Peng Im] Natl Univ Singapore Hosp, Dept Nursing, Singapore 117548, Singapore; [Ho-Lim, Sarah] Natl Univ Singapore Hosp, Dept Obstet & Gynaecol, Lower Kent Ridge Rd, Singapore 117548, Singapore	National University of Singapore; National University of Singapore; National University of Singapore	Lau, Y (corresponding author), Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Alice Lee Ctr Nursing Studies, Singapore 117595, Singapore.	nurly@nus.edu.sg	YING, LAU/HHS-2619-2022		National University of Singapore [NUHSRO/2013/147/SU/01, R545000055133, R545000055750]	National University of Singapore(National University of Singapore)	The research was funded by a start-up grant (Ref: NUHSRO/2013/147/SU/01, WBS No: R545000055133 and R545000055750) from National University of Singapore.	Adams D, 1997, J Hum Lact, V13, P279, DOI 10.1177/089033449701300412; Altuntas N, 2014, BREASTFEED MED, V9, P191, DOI 10.1089/bfm.2014.0018; BARTLETT MS, 1954, J ROY STAT SOC B, V16, P296; Boyer CA, 2010, J HEALTH SOC BEHAV, V51, pS80, DOI 10.1177/0022146510383489; Browne M.W., 1992, SOCIOL METHOD RES, V21, P230, DOI 10.1177/0049124192021002005; Byrne BM, 2010, STUCTURAL EQUATION M; Cakmak H, 2007, INT J NURS STUD, V44, P1128, DOI 10.1016/j.ijnurstu.2006.04.018; Chang ZM, 2005, J HUM LACT, V21, P305, DOI 10.1177/0890334405277604; CORTINA JM, 1993, J APPL PSYCHOL, V78, P98, DOI 10.1037/0021-9010.78.1.98; da Costa SP, 2010, INFANT BEHAV DEV, V33, P61, DOI 10.1016/j.infbeh.2009.11.007; Department of Statistics, 2010, SING CENS POP 2010; Department of Statistics, 2014, SING IN FIG; Dodrill P., 2011, ICAN: Infant, Child & Adolescent Nutrition, V3, P324, DOI 10.1177/1941406411421003; Fabrigar LR, 1999, PSYCHOL METHODS, V4, P272, DOI 10.1037/1082-989X.4.3.272; Fletcher RH, 2014, CLIN EPIDEMIOLOGY ES, V5th; Hair J.F., 2010, MUTIVARIATE DATA ANA, V7th; Harmon G, 2006, CURR OPIN CARDIOL, V21, P310, DOI 10.1097/01.hco.0000231400.10104.e2; Hill PA, 2007, J MIDWIFERY WOM HEAL, V52, P571, DOI 10.1016/j.jmwh.2007.07.009; Hooper D., 2008, EJBRM, V6, P53, DOI DOI 10.21427/D7CF7R; Howe TH, 2008, JOGNN-J OBST GYN NEO, V37, P338, DOI 10.1111/j.1552-6909.2008.00240.x; Jensen D, 1994, J Obstet Gynecol Neonatal Nurs, V23, P27, DOI 10.1111/j.1552-6909.1994.tb01847.x; Kline P., 2000, HDB PSYCHOL TESTING; Kronborg H, 2009, BIRTH-ISS PERINAT C, V36, P34, DOI 10.1111/j.1523-536X.2008.00293.x; Kucukoglu S, 2014, IRAN J PEDIATR, V24, P49; Kumar SP, 2006, J HUM LACT, V22, P391, DOI 10.1177/0890334406293161; Lau Y, 2015, PLOS ONE IN PRESS; Lee CY, 2008, HONG KONG J GYNECOL, V8, P13; Lewallen LP, 2006, J PERINAT EDUC, V15, P26, DOI 10.1624/105812406X92967; Mauri PA, 2012, MIDWIFERY, V28, P816, DOI 10.1016/j.midw.2011.09.010; Nunnally JC, 1994, PSYCHMETRIC THEORY; Pai ALH, 2007, J PEDIATR PSYCHOL, V32, P288, DOI 10.1093/jpepsy/jsl021; Raghavan V, 2014, INDIAN J PEDIATR, V81, P743, DOI 10.1007/s12098-013-1200-y; Riordan J M, 1997, J Obstet Gynecol Neonatal Nurs, V26, P181, DOI 10.1111/j.1552-6909.1997.tb02131.x; Rollins NC, 2016, LANCET, V387, P491, DOI 10.1016/S0140-6736(15)01044-2; Schermelleh-Engel K, 2003, METHODS PSYCHOL RES, V8, P23, DOI DOI 10.1002/0470010940; Scurr JC, 2010, J SPORT SCI, V28, P1103, DOI 10.1080/02640414.2010.497542; Shah R, 2006, J OPER MANAG, V24, P148, DOI 10.1016/j.jom.2005.05.001; Singapore Department of Statistics, 2014, POP TRENDS 2014; Singapore Department of Statistics, 2013, POP TRENDS 2013; Streiner DL, 2003, J PERS ASSESS, V80, P217, DOI 10.1207/S15327752JPA8003_01; Streiner DL, 2008, HLTH MEASUREMENT SCA, V4th; Stuebe AM, 2014, J WOMENS HEALTH, V23, P404, DOI 10.1089/jwh.2013.4506; Tabachnick BG., 2013, USING MULTIVARIATE S, V6th; Terwee CB, 2007, J CLIN EPIDEMIOL, V60, P34, DOI 10.1016/j.jclinepi.2006.03.012; TETRAULT G, 1991, AM J CLIN PATHOL, V96, P556, DOI 10.1093/ajcp/96.4.556; Tornese G, 2012, BREASTFEED MED, V7, P423, DOI 10.1089/bfm.2011.0120; Victora CG, 2016, LANCET, V387, P475, DOI 10.1016/S0140-6736(15)01024-7; YOUDEN WJ, 1950, BIOMETRICS, V6, P172, DOI 10.1002/1097-0142(1950)3:1<32::AID-CNCR2820030106>3.0.CO;2-3	48	6	6	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 2	2016	11	5							e0154331	10.1371/journal.pone.0154331	http://dx.doi.org/10.1371/journal.pone.0154331			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DL5KB	27135746	Green Submitted, Green Published, gold			2022-12-26	WOS:000375674800017
J	Hsu, PY; Tsai, MT; Wang, SP; Chen, YJ; Wu, J; Hsu, JT				Hsu, Pei-Yu; Tsai, Ming-Tzu; Wang, Shun-Ping; Chen, Ying-Ju; Wu, Jay; Hsu, Jui-Ting			Cortical Bone Morphological and Trabecular Bone Microarchitectural Changes in the Mandible and Femoral Neck of Ovariectomized Rats	PLOS ONE			English	Article							MINERAL DENSITY; ALVEOLAR BONE; MICRO-CT; POSTMENOPAUSAL WOMEN; TOOTH LOSS; OSTEOPOROSIS; FRACTURES; PREVENTION; GUIDELINES; PARAMETERS	Objective This study used microcomputed tomography (micro-CT) to evaluate the effects of ovariectomy on the trabecular bone microarchitecture and cortical bone morphology in the femoral neck and mandible of female rats. Materials and Methods Twelve female Wister rats were divided into two groups: the control and ovariectomized groups. The rats in the ovariectomized group received ovariectomy at 8 weeks of age; all the rats were sacrificed at 20 weeks of age, and their mandibles and femurs were removed and scanned using micro-CT. Four microstructural trabecular bone parameters were measured for the region below the first mandibular molar and the femoral neck region: bone volume fraction (BV/TV), trabecular thickness (TbTh), trabecular separation (TbSp), and trabecular number (TbN). In addition, four cortical bone parameters weremeasured for the femoral neck region: total cross-sectional area (TtAr), cortical area (CtAr), cortical bone area fraction (CtAr/TtAr), and cortical thickness (CtTh). The CtTh at themasseteric ridge was used to assess the cortical bone morphology in the mandible. The trabecular bone microarchitecture and cortical bone morphology in the femoral necks and mandibles of the control group were compared with those of the ovariectomized group. Furthermore, Spearman's correlation (r(s)) was conducted to analyze the correlation between the osteoporosis conditions of the mandible and femoral neck. Results Regarding the trabecular bone microarchitectural parameters, the BV/TV of the trabecular bone microarchitecture in the femoral necks of the control group (61.199 +/- 11.288%, median +/- interquartile range) was significantly greater than that of the ovariectomized group (40.329 +/- 5.153%). Similarly, the BV/TV of the trabecular bonemicroarchitecture in the mandibles of the control group (51.704 +/- 6.253%) was significantly greater than that of the ovariectomized group (38.486 +/- 9.111%). Furthermore, the TbSp of the femoral necks in the ovariectomized group (0.185 +/- 0.066 mm) was significantly greater than that in the control group (0.130 +/- 0.026mm). Similarly, the TbSp of the mandibles in the ovariectomized group (0.322 +/- 0.047mm) was significantly greater than that in the control group (0.285 +/- 0.041mm). However, the TbTh and TbN trends for themandibles and femoral necks were inconsistent between the control and ovariectomized groups. Regarding the cortical bonemorphology parameters, the TtAr of the femoral necks in the ovariectomized group was significantly smaller than that in the control group. There was no significant difference in the TtAr, CtAr, or CtTh of the femoral necks between the control and ovariectomized groups, and no significant difference in the CtTh of the mandibles between the control and ovariectomized groups. Moreover, the BV/TV and TbSp of the mandibles were highly correlated with those of the femurs (r(s) = 0.874 and r(s) = 0.755 for BV/TV and TbSp, respectively). Nevertheless, the TbTh, TbN, and CtTh of the mandibles were not correlated with those of the femoral necks. Conclusion After the rats were ovariectomized, osteoporosis of the trabecular bone microarchitecture occurred in their femurs and mandibles; however, ovariectomy did not influence the cortical bone morphology. In addition, the parametric values of the trabecular bone microarchitecture in the femoral necks were highly correlated with those of the trabecular bone microarchitecture in the mandibles.	[Hsu, Pei-Yu] China Med Univ, Dept Biomed Imaging & Radiol Sci, Taichung 404, Taiwan; [Tsai, Ming-Tzu] Hungkuang Univ, Dept Biomed Engn, Taichung 433, Taiwan; [Wang, Shun-Ping] Taichung Vet Gen Hosp, Dept Orthopaed, Taichung 407, Taiwan; [Chen, Ying-Ju] Providence Univ, Dept Food & Nutr, Taichung 433, Taiwan; [Wu, Jay] Natl Yang Ming Univ, Dept Biomed Imaging Radiol Sci, Taipei 112, Taiwan; [Hsu, Jui-Ting] China Med Univ, Coll Med, Sch Dent, Taichung 404, Taiwan; [Hsu, Jui-Ting] Asia Univ Taichung, Dept Bioinformat & Med Engn, Taichung 413, Taiwan	China Medical University Taiwan; Hungkuang University; Taichung Veterans General Hospital; Providence University - Taiwan; National Yang Ming Chiao Tung University; China Medical University Taiwan	Hsu, JT (corresponding author), China Med Univ, Coll Med, Sch Dent, Taichung 404, Taiwan.; Hsu, JT (corresponding author), Asia Univ Taichung, Dept Bioinformat & Med Engn, Taichung 413, Taiwan.	jthsu@mail.cmu.edu.tw	Hsu, Jui-Ting/I-8224-2012; Tsai, Ming-Tzu/GSM-9284-2022		Ministry of Science and Technology, Taiwan [MOST 104-2815-C-039-038-B]	Ministry of Science and Technology, Taiwan(Ministry of Science and Technology, Taiwan)	This study was supported by the Ministry of Science and Technology, Taiwan (MOST 104-2815-C-039-038-B).	Ames MS, 2010, ARCH ORAL BIOL, V55, P599, DOI 10.1016/j.archoralbio.2010.05.011; Bagi CM, 2011, COMPARATIVE MED, V61, P76; Bellido M, 2010, J DENT RES, V89, P360, DOI 10.1177/0022034510363082; Bouxsein ML, 2010, J BONE MINER RES, V25, P1468, DOI 10.1002/jbmr.141; Branemark P I, 1977, Scand J Plast Reconstr Surg Suppl, V16, P1; Brouwers JEM, 2008, CALCIFIED TISSUE INT, V82, P202, DOI 10.1007/s00223-007-9084-3; Buckbinder L, 2007, P NATL ACAD SCI USA, V104, P10619, DOI 10.1073/pnas.0701421104; Butezloff MM, 2015, ACTA CIR BRAS, V30, P727, DOI 10.1590/S0102-865020150110000002; Compston JE, 1997, DRUGS, V53, P727, DOI 10.2165/00003495-199753050-00001; COOPER C, 1993, AM J EPIDEMIOL, V137, P1001, DOI 10.1093/oxfordjournals.aje.a116756; Elkomy M. M., 2015, Journal of Basic and Applied Zoology, V72, P81, DOI 10.1016/j.jobaz.2015.04.007; Fernandes DJ, 2015, MATERIALS, V8, P6558, DOI 10.3390/ma8095322; Francisco JI, 2011, J ORTHOP RES, V29, P189, DOI 10.1002/jor.21217; Giavaresi G, 2002, CLIN EXP RHEUMATOL, V20, P171; GILSANZ V, 1988, AM J PHYSIOL, V255, pE416, DOI 10.1152/ajpendo.1988.255.4.E416; Hsu JT, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107545; Hsu JT, 2013, J BIOMECH, V46, P2611, DOI 10.1016/j.jbiomech.2013.08.004; Hsu JT, 2013, CLIN IMPLANT DENT R, V15, P251, DOI 10.1111/j.1708-8208.2011.00349.x; Ip TP, 2010, OSTEOPOROSIS INT, V21, pS605, DOI 10.1007/s00198-010-1398-8; Irie K., 2004, J JPN SOC PERIODONTO, V46, P288; Iwasaki M, 2012, J BONE MINER METAB, V30, P447, DOI 10.1007/s00774-011-0337-x; JAFFIN RA, 1991, J PERIODONTOL, V62, P2, DOI 10.1902/jop.1991.62.1.2; Jee W. S. S., 2001, Journal of Musculoskeletal & Neuronal Interactions, V1, P193; Jiang Guizhen, 2004, J Oral Sci, V46, P75, DOI 10.2334/josnusd.46.75; Johnston BD, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/635023; Kanis JA, 2008, OSTEOPOROSIS INT, V19, P385, DOI 10.1007/s00198-007-0543-5; Kasabi Shivakumar HM, 2012, INT J DRUG DEV RES, V4, P163; Leitner MM, 2009, LAB ANIM-UK, V43, P266, DOI 10.1258/la.2008.008045; Lelovas PP, 2008, COMPARATIVE MED, V58, P424; Lips P, 1999, OSTEOPOROSIS INT, V10, P150, DOI 10.1007/s001980050210; Liu XC, 2014, AFR J TRADIT COMPLEM, V11, P91, DOI 10.4314/ajtcam.v11i5.15; Liu ZS, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0116194; Marks R, 2003, AGEING RES REV, V2, P57, DOI 10.1016/S1568-1637(02)00045-4; Matsukawa N, 2014, ANIMAL SCI LETTERS, V1, P11; Mavropoulos A, 2004, BONE, V35, P191, DOI 10.1016/j.bone.2004.03.020; Mavropoulos A, 2007, J BONE MINER RES, V22, P403, DOI 10.1359/JBMR.061208; Melton LJ, 2003, J BONE MINER RES, V18, P1139, DOI 10.1359/jbmr.2003.18.6.1139; NEWMAN E, 1995, BONE, V16, pS277, DOI 10.1016/S8756-3282(95)80121-9; Particelli F, 2012, J MICROSC-OXFORD, V245, P302, DOI 10.1111/j.1365-2818.2011.03573.x; PECK WA, 1993, AM J MED, V94, P646; Piscitelli P, 2008, CLIN CASES MINER BON, V5, P14; Reddy NP, 2003, J ETHNOPHARMACOL, V84, P259, DOI 10.1016/S0378-8741(02)00325-2; Reginster JY, 2006, BONE, V38, P4, DOI 10.1016/j.bone.2005.11.024; Riggs BL, 2002, ENDOCR REV, V23, P279, DOI 10.1210/er.23.3.279; RIGGS BL, 1983, AM J MED, V75, P899, DOI 10.1016/0002-9343(83)90860-4; Samelson Elizabeth J, 2006, Curr Rheumatol Rep, V8, P76, DOI 10.1007/s11926-006-0030-6; Schnell S, 2010, GERIATR ORTHOP SURG, V1, P6, DOI 10.1177/2151458510378105; Seeman E, 1998, J CLIN ENDOCR METAB, V83, P1414, DOI 10.1210/jc.83.5.1414; Sipos RS, 2015, OPEN LIFE SCI, V10, P379, DOI 10.1515/biol-2015-0039; Streckfus CF, 1997, J GERONTOL A-BIOL, V52, pM343, DOI 10.1093/gerona/52A.6.M343; Taguchi A, 1999, DENTOMAXILLOFAC RAD, V28, P219, DOI 10.1038/sj.dmfr.4600445; Tanaka M, 2002, J PERIODONTAL RES, V37, P161, DOI 10.1034/j.1600-0765.2002.01601.x; Tanaka M, 2003, ORAL SURG ORAL MED O, V95, P495, DOI 10.1067/moe.2003.135; THOMPSON DD, 1995, BONE, V17, pS125, DOI 10.1016/8756-3282(95)00285-L; Tsai CY, 2011, EUR J ORTHODONT, V33, P132, DOI 10.1093/ejo/cjq029; Uchiyama S, 2006, INT J MOL MED, V17, P15; Verdelis K, 2011, BONE, V49, P580, DOI 10.1016/j.bone.2011.05.013; Wang J, 2013, BONE RES, V1, P346, DOI 10.4248/BR201304005; Washimi Y, 2007, BONE, V41, P786, DOI 10.1016/j.bone.2007.06.019; Westerlind KC, 1997, P NATL ACAD SCI USA, V94, P4199, DOI 10.1073/pnas.94.8.4199; Xiang A, 2007, BONE, V40, P1231, DOI 10.1016/j.bone.2007.01.010; Sun XL, 2015, SCI REP-UK, V5, DOI 10.1038/srep13009; Yang J, 2003, DENTOMAXILLOFAC RAD, V32, P247, DOI 10.1259/dmfr/12560890	63	34	40	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 29	2016	11	4							e0154367	10.1371/journal.pone.0154367	http://dx.doi.org/10.1371/journal.pone.0154367			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DK8XM	27127909	Green Submitted, Green Published, gold			2022-12-26	WOS:000375212600029
J	Tupikina, L; Molkenthin, N; Lopez, C; Hernandez-Garcia, E; Marwan, N; Kurths, J				Tupikina, Liubov; Molkenthin, Nora; Lopez, Cristobal; Hernandez-Garcia, Emilio; Marwan, Norbert; Kurths, Jurgen			Correlation Networks from Flows. The Case of Forced and Time-Dependent Advection-Diffusion Dynamics	PLOS ONE			English	Article							CLIMATE; CONNECTIVITY; EVOLUTION	Complex network theory provides an elegant and powerful framework to statistically investigate different types of systems such as society, brain or the structure of local and long-range dynamical interrelationships in the climate system. Network links in climate networks typically imply information, mass or energy exchange. However, the specific connection between oceanic or atmospheric flows and the climate network's structure is still unclear. We propose a theoretical approach for verifying relations between the correlation matrix and the climate network measures, generalizing previous studies and overcoming the restriction to stationary flows. Our methods are developed for correlations of a scalar quantity (temperature, for example) which satisfies an advection-diffusion dynamics in the presence of forcing and dissipation. Our approach reveals that correlation networks are not sensitive to steady sources and sinks and the profound impact of the signal decay rate on the network topology. We illustrate our results with calculations of degree and clustering for a meandering flow resembling a geophysical ocean jet.	[Tupikina, Liubov; Marwan, Norbert; Kurths, Jurgen] Potsdam Inst Climate Impact Res, POB 601203, D-14412 Potsdam, Germany; [Tupikina, Liubov; Kurths, Jurgen] Humboldt Univ, D-10099 Berlin, Germany; [Molkenthin, Nora] Tech Univ Darmstadt, Dept Phys, D-64289 Darmstadt, Germany; UIB, CSIC, IFISC, Campus Univ Illes Balears, E-07122 Palma De Mallorca, Spain	Potsdam Institut fur Klimafolgenforschung; Humboldt University of Berlin; Technical University of Darmstadt; Consejo Superior de Investigaciones Cientificas (CSIC); Universitat de les Illes Balears; CSIC-UIB - Instituto de Fisica Interdisciplinar y Sistemas Complejos (IFISC)	Tupikina, L (corresponding author), Potsdam Inst Climate Impact Res, POB 601203, D-14412 Potsdam, Germany.; Tupikina, L (corresponding author), Humboldt Univ, D-10099 Berlin, Germany.	tupikina@pik-potsdam.de	Hernandez-Garcia, Emilio/B-1271-2008; Marwan, Norbert/D-9576-2011; López, Cristóbal/R-5410-2018	Hernandez-Garcia, Emilio/0000-0002-9568-8287; Marwan, Norbert/0000-0003-1437-7039; López, Cristóbal/0000-0002-3445-4284	EC through the Marie-Curie ITN LINC project [289447]; FEDER; MINECO (Spain) through project ESCOLA [TM2012-39025-C02-01]	EC through the Marie-Curie ITN LINC project; FEDER(European Commission); MINECO (Spain) through project ESCOLA	The authors would like to acknowledge EC-funding through the Marie-Curie ITN LINC project (P7-PEOPLE-2011-ITN, grant No. 289447, http://climatelinc.eu/home/), and FEDER and MINECO (Spain) through project ESCOLA (TM2012-39025-C02-01, http://ifisc.uib-csic.es/). Thanks to LINC and ESCOLA projects, the interaction between groups was possible; as the result, the collaborators developed methods together and analyzed the methods applications.	Arizmendi F, 2014, NONLINEAR PROC GEOPH, V21, P825, DOI 10.5194/npg-21-825-2014; Boccaletti S, 2006, PHYS REP, V424, P175, DOI 10.1016/j.physrep.2005.10.009; Cencini M, 1999, J PHYS OCEANOGR, V29, P2578, DOI 10.1175/1520-0485(1999)029<2578:MIAMJA>2.0.CO;2; Santos RPD, 2014, J APPL POLYM SCI, V131, DOI 10.1002/app.40386; Deser C, 2004, J CLIMATE, V17, P3109, DOI 10.1175/1520-0442(2004)017<3109:PICVLB>2.0.CO;2; Deza JI, 2015, CHAOS, V25, DOI 10.1063/1.4914101; Dorogovtsev SN, 2003, EVOLUTION NETWORKS B; Gao ZK, 2016, CHEM ENG J, V291, P74, DOI 10.1016/j.cej.2016.01.039; Gao ZK, 2015, SCI REP-UK, V5, DOI 10.1038/srep08222; Garaboa-Paz D, 2015, CHAOS, V25, DOI 10.1063/1.4919768; Ghil M, 2008, PHYSICA D, V237, P2967, DOI 10.1016/j.physd.2008.07.006; HASSELMANN K, 1976, TELLUS, V28, P473, DOI 10.1111/j.2153-3490.1976.tb00696.x; Holme P, 2012, PHYS REP, V519, P97, DOI 10.1016/j.physrep.2012.03.001; Deza JI, 2015, PROCEDIA COMPUT SCI, V51, P404, DOI 10.1016/j.procs.2015.05.260; Lopez C, 2001, PHYS CHEM EARTH PT B, V26, P313, DOI 10.1016/S1464-1909(01)00012-0; Malik N, 2012, CLIM DYNAM, V39, P971, DOI 10.1007/s00382-011-1156-4; Marwan N, 2015, CHAOS, V25, P1; Molkenthin N, 2014, SCI REP-UK, V4, DOI 10.1038/srep04119; Mugnolo D., 2008, SEMIGROUP METHODS EV; Neufeld Z, 2010, CHEM BIOL PROCESSES; Newman MEJ, 2003, SIAM REV, V45, P167, DOI 10.1137/S003614450342480; Palus M, 2011, NONLINEAR PROC GEOPH, V18, P751, DOI 10.5194/npg-18-751-2011; Rehfeld K, 2014, NONLINEAR PROC GEOPH, V21, P691, DOI 10.5194/npg-21-691-2014; Rossi V, 2014, GEOPHYS RES LETT, V41, P2883, DOI 10.1002/2014GL059540; Samelson R., 1991, AM METEOROLOGICAL SO, V22, P431; Ser-Giacomi E, 2015, CHAOS, V25, DOI 10.1063/1.4928704; Ser-Giacomi E, 2015, PHYS REV E, V92, DOI 10.1103/PhysRevE.92.012818; Ser-Giacomi E, 2015, CHAOS, V25, DOI 10.1063/1.4908231; Siedler G, 2013, OCEAN CIRCULATION CL; Timme M, 2014, J PHYS A-MATH THEOR, V47, DOI 10.1088/1751-8113/47/34/343001; Toral R, 2014, STOCHASTIC NUMERICAL; Tupikina L, 2014, NONLINEAR PROC GEOPH, V21, P705, DOI 10.5194/npg-21-705-2014; Uleysky MY, 2007, CHAOS, V17, DOI 10.1063/1.2783258; van der Mheen M, 2013, GEOPHYS RES LETT, V40, P2714, DOI 10.1002/grl.50515; Vetterling W.T., 1988, NUMERICAL RECIPES C; WANG Y, 2013, PHYS REV LETT, V111, DOI DOI 10.1103/PHYSREVLETT.111; WATTS DR, 1982, J GEOPHYS RES-OCEANS, V87, P9467, DOI 10.1029/JC087iC12p09467; Yamasaki K, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.228501; Zamora-Lopez G, 2011, PHILOS T R SOC A, V369, P3730, DOI 10.1098/rsta.2011.0121; Zhou D, 2015, PHYS REV LETT, V115, DOI 10.1103/PhysRevLett.115.268501	41	19	19	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 29	2016	11	4							e0153703	10.1371/journal.pone.0153703	http://dx.doi.org/10.1371/journal.pone.0153703			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DK8XM	27128846	Green Submitted, gold, Green Published			2022-12-26	WOS:000375212600012
J	Wang, H; Qin, F; Ruan, L; Wang, R; Liu, Q; Ma, ZH; Li, XL; Cheng, P; Wang, HG				Wang, Hui; Qin, Feng; Ruan, Liu; Wang, Rui; Liu, Qi; Ma, Zhanhong; Li, Xiaolong; Cheng, Pei; Wang, Haiguang			Identification and Severity Determination of Wheat Stripe Rust and Wheat Leaf Rust Based on Hyperspectral Data Acquired Using a Black-Paper-Based Measuring Method	PLOS ONE			English	Article							F-SP TRITICI; PUCCINIA-STRIIFORMIS; WINTER-WHEAT; YELLOW RUST; REFLECTANCE MEASUREMENTS; SPECTRAL REFLECTANCE; INDEXES; LEAVES; DIFFERENTIATION; STRESS	It is important to implement detection and assessment of plant diseases based on remotely sensed data for disease monitoring and control. Hyperspectral data of healthy leaves, leaves in incubation period and leaves in diseased period of wheat stripe rust and wheat leaf rust were collected under in-field conditions using a black-paper-based measuring method developed in this study. After data preprocessing, the models to identify the diseases were built using distinguished partial least squares (DPLS) and support vector machine (SVM), and the disease severity inversion models of stripe rust and the disease severity inversion models of leaf rust were built using quantitative partial least squares (QPLS) and support vector regression (SVR). All the models were validated by using leave-one-out cross validation and external validation. The diseases could be discriminated using both distinguished partial least squares and support vector machine with the accuracies of more than 99%. For each wheat rust, disease severity levels were accurately retrieved using both the optimal QPLS models and the optimal SVR models with the coefficients of determination (R-2) of more than 0.90 and the root mean square errors (RMSE) of less than 0.15. The results demonstrated that identification and severity evaluation of stripe rust and leaf rust at the leaf level could be implemented based on the hyperspectral data acquired using the developed method. A scientific basis was provided for implementing disease monitoring by using aerial and space remote sensing technologies.	[Wang, Hui; Qin, Feng; Ruan, Liu; Liu, Qi; Ma, Zhanhong; Li, Xiaolong; Cheng, Pei; Wang, Haiguang] China Agr Univ, Dept Plant Pathol, Beijing 100094, Peoples R China; [Wang, Rui] China Agr Univ, Kaifeng Expt Stn, Kaifeng, Henan Province, Peoples R China	China Agricultural University; China Agricultural University	Wang, HG (corresponding author), China Agr Univ, Dept Plant Pathol, Beijing 100094, Peoples R China.	wanghaiguang@cau.edu.cn	Ma, Zhanhong/AAY-4348-2021	Ma, Zhanhong/0000-0002-4910-5001	National Key Technologies Research and Development Program of China [2012BAD19BA04]; National Natural Science Foundation of China [31471726]; Chinese Universities Scientific Fund [2015NX005]	National Key Technologies Research and Development Program of China(National Key Technology R&D Program); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Chinese Universities Scientific Fund	This study was supported by National Key Technologies Research and Development Program of China (2012BAD19BA04), National Natural Science Foundation of China (31471726) and Chinese Universities Scientific Fund (2015NX005). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AN Hu, 2005, CHINA PLANT PROTECTI, V25, P8; Ashourloo D, 2014, REMOTE SENS-BASEL, V6, P5107, DOI 10.3390/rs6065107; Ashourloo D, 2014, REMOTE SENS-BASEL, V6, P4723, DOI 10.3390/rs6064723; Blackburn GA, 1999, REMOTE SENS ENVIRON, V70, P278, DOI 10.1016/S0034-4257(99)00044-9; Cai CJ, 2005, J NW SCI TECH U AGR, V33, P31; [陈万权 Chen Wanquan], 2013, [中国农业科学, Scientia Agricultura Sinica], V46, P4254; Cheng P, 2014, CROP PROT, V65, P6, DOI 10.1016/j.cropro.2014.07.002; Devadas R, 2009, PRECIS AGRIC, V10, P459, DOI 10.1007/s11119-008-9100-2; Dutta S, 2014, J INDIAN SOC REMOTE, V42, P335, DOI 10.1007/s12524-013-0329-5; Franke J, 2007, PRECIS AGRIC, V8, P161, DOI 10.1007/s11119-007-9036-y; Grossman YL, 1996, REMOTE SENS ENVIRON, V56, P182, DOI 10.1016/0034-4257(95)00235-9; Guo JieBin, 2009, Acta Phytophylacica Sinica, V36, P473; HATFIELD JL, 1990, PHYTOPATHOLOGY, V80, P37, DOI 10.1094/Phyto-80-37; [黄木易 Huang Muyi], 2004, [安徽农业科学, Journal of anhui agricultural sciences], V32, P132; Huang Muyi, 2003, Transactions of the Chinese Society of Agricultural Engineering, V19, P154; Huang Muyi, 2004, Transactions of the Chinese Society of Agricultural Engineering, V20, P176; Huang W, 2007, PRECIS AGRIC, V8, P187, DOI 10.1007/s11119-007-9038-9; Huang WJ, 2014, IEEE J-STARS, V7, P2516, DOI 10.1109/JSTARS.2013.2294961; Huerta-Espino J, 2011, EUPHYTICA, V179, P143, DOI 10.1007/s10681-011-0361-x; JACKSON RD, 1986, ANNU REV PHYTOPATHOL, V24, P265, DOI 10.1146/annurev.py.24.090186.001405; JACQUEMOUD S, 1990, REMOTE SENS ENVIRON, V34, P75, DOI 10.1016/0034-4257(90)90100-Z; [冷伟锋 Leng Weifeng], 2012, [植物病理学报, Acta Phytopathologica Sinica], V42, P202; Li G, 2012, SPECTROSC SPECT ANAL, V32, P2286, DOI 10.3964/j.issn.1000-0593(2012)08-2286-04; Li Z.Q., 2002, WHEAT RUST IN CHINA; Liu LiangYun, 2009, Transactions of the Chinese Society of Agricultural Engineering, V25, P137; [刘良云 Liu Liangyun], 2004, [遥感学报, Journal of Remote Sensing], V8, P275; Liu ZY, 2010, SPECTROSC SPECT ANAL, V30, P710, DOI 10.3964/j.issn.1000-0593(2010)03-0710-05; Luo JH, 2010, SPECTROSC SPECT ANAL, V30, P184, DOI 10.3964/j.issn.1000-0593(2010)01-0184-04; [马亚琴 Ma Yaqin], 2003, [干旱区地理, Arid Land Geography], V26, P408; Moshou D, 2004, COMPUT ELECTRON AGR, V44, P173, DOI 10.1016/j.compag.2004.04.003; NILSSON HE, 1995, ANNU REV PHYTOPATHOL, V33, P489, DOI 10.1146/annurev.py.33.090195.002421; Pu R. L., 2000, HYPERSPECTRAL REMOTE; Qiao HongBo, 2010, Journal of Triticeae Crops, V30, P770; [邱琳 Qiu Lin], 2012, [中南林业科技大学学报, Journal of Central South University of Forestry & Technology], V32, P28; Sankaran S, 2010, COMPUT ELECTRON AGR, V72, P1, DOI 10.1016/j.compag.2010.02.007; TONG Qingxi, 1997, J REMOTE SENSING, V1, P50; Wan AM, 2007, AUST J AGR RES, V58, P605, DOI 10.1071/AR06142; Wang HG, 2007, SPECTROSC SPECT ANAL, V27, P1811; Wang H, 2015, J SPECTROSC, V2015, DOI 10.1155/2015/651810; Wang HY, 2012, J MIANYANG NORMAL U, V31, P5; Wang JiHua, 2000, Acta Agriculturae Boreali-Sinica, V15, P68; Wang X., 2012, ENV SYST RES, V1, P1, DOI DOI 10.1186/2190-8532-1-2; Wang XJ, 2008, EUR J PLANT PATHOL, V120, P241, DOI 10.1007/s10658-007-9212-y; Wang XJ, 2009, J PHYTOPATHOL, V157, P490, DOI 10.1111/j.1439-0434.2008.01521.x; Wellings CR, 2011, EUPHYTICA, V179, P129, DOI 10.1007/s10681-011-0360-y; Winton LM, 2002, PHYTOPATHOLOGY, V92, P112, DOI 10.1094/PHYTO.2002.92.1.112; Yang Ke-ming, 2008, Acta Photonica Sinica, V37, P145; Yuan L, 2014, FIELD CROP RES, V156, P199, DOI 10.1016/j.fcr.2013.11.012; Yuan L, 2013, SPECTROSC SPECT ANAL, V33, P1608, DOI 10.3964/j.issn.1000-0593(2013)06-1608-07; Zhang JC, 2010, SPECTROSC SPECT ANAL, V30, P1579, DOI 10.3964/j.issn.1000-0593(2010)06-1579-07; Zhang JingCheng, 2012, Transactions of the Chinese Society of Agricultural Engineering, V28, P1; Zhang X. C., 2012, NEAR INFRARED SPECTR; Zhang XiJie, 2004, Transactions of the Chinese Society of Agricultural Engineering, V20, P11; Zhang YP, 2009, ACTA PHYTOPHYL SIN, V36, P19; Zhao J, 2007, PLANT DIS, V91, P1669, DOI 10.1094/PDIS-91-12-1669; Zhao JL, 2014, EUR J PLANT PATHOL, V139, P401, DOI 10.1007/s10658-014-0397-6	56	13	15	5	59	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 29	2016	11	4							e0154648	10.1371/journal.pone.0154648	http://dx.doi.org/10.1371/journal.pone.0154648			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DK8XM	27128464	Green Published, gold			2022-12-26	WOS:000375212600056
J	Edmonds, J; Lindquist, HDA; Sabol, J; Martinez, K; Shadomy, S; Cymet, T; Emanuel, P				Edmonds, Jason; Lindquist, H. D. Alan; Sabol, Jonathan; Martinez, Kenneth; Shadomy, Sean; Cymet, Tyler; Emanuel, Peter			Multigeneration Cross-Contamination of Mail with Bacillus anthracis Spores	PLOS ONE			English	Article							BIOTERRORISM-RELATED ANTHRAX; FATAL INHALATIONAL ANTHRAX; OUTBREAK; CONNECTICUT; WASHINGTON; DC	The release of biological agents, including those which could be used in biowarfare or bioterrorism in large urban areas, has been a concern for governments for nearly three decades. Previous incidents from Sverdlosk and the postal anthrax attack of 2001 have raised questions on the mechanism of spread of Bacillus anthracis spores as an aerosol or contaminant. Prior studies have demonstrated that Bacillus atrophaeus is easily transferred through simulated mail handing, but no reports have demonstrated this ability with Bacillus anthracis spores, which have morphological differences that may affect adhesion properties between spore and formite. In this study, equipment developed to simulate interactions across three generations of envelopes subjected to tumbling and mixing was used to evaluate the potential for cross-contamination of B. anthracis spores in simulated mail handling. In these experiments, we found that the potential for cross-contamination through letter tumbling from one generation to the next varied between generations while the presence of a fluidizer had no statistical impact on the transfer of material. Likewise, the presence or absence of a fluidizer had no statistically significant impact on cross-contamination levels or reaerosolization from letter opening.	[Edmonds, Jason; Sabol, Jonathan; Emanuel, Peter] US Army, Dept Def, Edgewood Chem Biol Ctr, 5183 Blackhawk Rd, Aberdeen Proving Ground, MD 21010 USA; [Lindquist, H. D. Alan] US EPA, Off Res & Dev, Natl Homeland Secur Res Ctr, 26 West Martin Luther King Dr, Cincinnati, OH 45268 USA; [Martinez, Kenneth] HWC Inc, 1100 New York Ave NW, Washington, DC 20005 USA; [Shadomy, Sean] Ctr Dis Control & Prevent, Natl Ctr Emerging & Zoonot Infect Dis, 1600 Clifton Rd,MS A-30, Atlanta, GA 30333 USA; [Cymet, Tyler] Amer Assoc Coll Osteopath Med, Med Educ, Chevy Chase, MD 20815 USA	United States Department of Defense; US Army Research, Development & Engineering Command (RDECOM); United States Environmental Protection Agency; Centers for Disease Control & Prevention - USA	Edmonds, J (corresponding author), US Army, Dept Def, Edgewood Chem Biol Ctr, 5183 Blackhawk Rd, Aberdeen Proving Ground, MD 21010 USA.	jason.m.edmonds2.civ@mail.mil	Lindquist, H D Alan/E-9081-2018; Shadomy, Sean/ABA-1234-2020	Lindquist, H D Alan/0000-0003-2555-2648; 	Combatting Terrorism Technical Support Working Group, Caution; Hassett Willis; Department of Defense; Edgewood Chemical Biological Center; Department of Health and Human Services Centers for Disease Control and Prevention; National Institutes for Occupational Safety and Health; Department of Justice; Federal Bureau of Investigations; U.S. Environmental Protection Agency through its Office of Research and Development	Combatting Terrorism Technical Support Working Group, Caution; Hassett Willis; Department of Defense(United States Department of Defense); Edgewood Chemical Biological Center(United States Department of Defense); Department of Health and Human Services Centers for Disease Control and Prevention(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); National Institutes for Occupational Safety and Health; Department of Justice; Federal Bureau of Investigations; U.S. Environmental Protection Agency through its Office of Research and Development(United States Environmental Protection Agency)	This program was partially funded by the Technical Support Working Group, now the Combatting Terrorism Technical Support Working Group, Caution (http://www.cttso.gov/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Hassett Willis provided support in the form of salaries for authors (KM), but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The Department of Defense, Edgewood Chemical Biological Center, Department of Health and Human Services Centers for Disease Control and Prevention, National Institutes for Occupational Safety and Health, Department of Justice, Federal Bureau of Investigations, and the U.S. Environmental Protection Agency through its Office of Research and Development partially funded and collaborated in the research described here. This manuscript has been subject to Agency review and but does not necessarily reflect the views of the Agencies listed above. The specific roles of these authors are articulated in the author contributions section.; The Department of Defense, Edgewood Chemical Biological Center, Department of Health and Human Services Centers for Disease Control and Prevention, National Institutes for Occupational Safety and Health, Department of Justice, Federal Bureau of Investigations, and the U.S. Environmental Protection Agency through its Office of Research and Development partially funded and collaborated in the research described here. This manuscript has been subject to Agency review and but does not necessarily reflect the views of the Agencies listed above. No official endorsement should be inferred. Mention or use of trade names does not constitute endorsement of recommendation for use.	[Anonymous], 2003, CDC ATSDR ACT SO CON; Baggett HC, 2005, CLIN INFECT DIS, V41, P991, DOI 10.1086/432937; Ball DA, 2008, MOL MICROBIOL, V68, P947, DOI 10.1111/j.1365-2958.2008.06206.x; Barakat LA, 2002, JAMA-J AM MED ASSOC, V287, P863, DOI 10.1001/jama.287.7.863; Beecher DJ, 2006, APPL ENVIRON MICROB, V72, P5304, DOI 10.1128/AEM.00940-06; Bozue J, 2007, INFECT IMMUN, V75, P4498, DOI 10.1128/IAI.00434-07; Bush LM, 2001, NEW ENGL J MED, V345, P1607, DOI 10.1056/NEJMoa012948; Centers for Disease Control and Prevention (CDC), 2003, MMWR Morb Mortal Wkly Rep, V52, P937; Clare Stroud KV, 2012, PREPOSITIONING ANTIB; Cymet T., 2005, J AM OSTEOPATH ASSOC, V105, P4; Cymet T, 2005, J AM OSTEOPATH ASSOC, V105, P533; Cymet Tyler C, 2004, J Am Osteopath Assoc, V104, P452; Dewan PK, 2002, EMERG INFECT DIS, V8, P1066, DOI 10.3201/eid0810.020330; Doolan DL, 2007, J INFECT DIS, V195, P174, DOI 10.1086/510312; Edmonds J, 2010, APPL ENVIRON MICROB, V76, P4797, DOI 10.1128/AEM.02978-09; Estill CF, 2009, APPL ENVIRON MICROB, V75, P4297, DOI 10.1128/AEM.02549-08; Herzog AB, 2009, APPL ENVIRON MICROB, V75, P6331, DOI 10.1128/AEM.00288-09; Holtz TH, 2003, EMERG INFECT DIS, V9, P689; Inglesby TV, 2002, JAMA-J AM MED ASSOC, V287, P2236, DOI 10.1001/jama.287.17.2236; Jernigan DB, 2002, EMERG INFECT DIS, V8, P1019, DOI 10.3201/eid0810.020353; MESELSON M, 1994, SCIENCE, V266, P1202, DOI 10.1126/science.7973702; Panzer LRG, 2003, PREPARING PSYCHOL CO; Visser J, 1995, PARTICUL SCI TECHNOL, V13, P169, DOI 10.1080/02726359508906677; Williams AA, 2002, EMERG INFECT DIS, V8, P1078, DOI 10.3201/eid0810.020399	25	2	2	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 28	2016	11	4							e0152225	10.1371/journal.pone.0152225	http://dx.doi.org/10.1371/journal.pone.0152225			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DK8XE	27123934	Green Published, gold			2022-12-26	WOS:000375211700004
J	Garcia-Alonso, V; Titos, E; Alcaraz-Quiles, J; Rius, B; Lopategi, A; Lopez-Vicario, C; Jakobsson, PJ; Delgado, S; Lozano, J; Claria, J				Garcia-Alonso, Veronica; Titos, Esther; Alcaraz-Quiles, Jose; Rius, Bibiana; Lopategi, Aritz; Lopez-Vicario, Cristina; Jakobsson, Per-Johan; Delgado, Salvadora; Lozano, Juanjo; Claria, Joan			Prostaglandin E-2 Exerts Multiple Regulatory Actions on Human Obese Adipose Tissue Remodeling, Inflammation, Adaptive Thermogenesis and Lipolysis	PLOS ONE			English	Article							FAT; FIBROSIS; BIOLOGY; SIGNALS; BROWN; AMP	Obesity induces white adipose tissue (WAT) dysfunction characterized by unremitting inflammation and fibrosis, impaired adaptive thermogenesis and increased lipolysis. Prostaglandins (PGs) are powerful lipid mediators that influence the homeostasis of several organs and tissues. The aim of the current study was to explore the regulatory actions of PGs in human omental WAT collected from obese patients undergoing laparoscopic bariatric surgery. In addition to adipocyte hypertrophy, obese WAT showed remarkable inflammation and total and pericellular fibrosis. In this tissue, a unique molecular signature characterized by altered expression of genes involved in inflammation, fibrosis and WAT browning was identified by microarray analysis. Targeted LC-MS/MS lipidomic analysis identified increased PGE(2) levels in obese fat in the context of a remarkable COX-2 induction and in the absence of changes in the expression of terminal prostaglandin E synthases (i.e. mPGES-1, mPGES-2 and cPGES). IPA analysis established PGE2 as a common top regulator of the fibrogenic/inflammatory process present in this tissue. Exogenous addition of PGE2 significantly reduced the expression of fibrogenic genes in human WAT explants and significantly down-regulated Col1 alpha 1, Col1 alpha 2 and alpha SMA in differentiated 3T3 adipocytes exposed to TGF-beta. In addition, PGE(2) inhibited the expression of inflammatory genes (i.e. IL-6 and MCP-1) in WAT explants as well as in adipocytes challenged with LPS. PGE(2) anti-inflammatory actions were confirmed by microarray analysis of human pre-adipocytes incubated with this prostanoid. Moreover, PGE(2) induced expression of brown markers (UCP1 and PRDM16) in WAT and adipocytes, but not in pre-adipocytes, suggesting that PGE(2) might induce the trans-differentiation of adipocytes towards beige/brite cells. Finally, PGE(2) inhibited isoproterenol-induced adipocyte lipolysis. Taken together, these findings identify PGE(2) as a regulator of the complex network of interactions driving uncontrolled inflammation and fibrosis and impaired adaptive thermogenesis and lipolysis in human obese visceral WAT.	[Garcia-Alonso, Veronica; Titos, Esther; Alcaraz-Quiles, Jose; Rius, Bibiana; Lopategi, Aritz; Lopez-Vicario, Cristina; Claria, Joan] Hosp Clin IDIBAPS, Dept Biochem & Mol Genet, Barcelona, Spain; [Titos, Esther; Lozano, Juanjo; Claria, Joan] Hosp Clin IDIBAPS, CIBERehd, Barcelona, Spain; [Jakobsson, Per-Johan] Karolinska Inst, Dept Med, Stockholm, Sweden; [Delgado, Salvadora] Hosp Clin IDIBAPS, Dept Gastrointestinal Surg, Barcelona, Spain; [Claria, Joan] Univ Barcelona, Dept Biomed, Barcelona, Spain	University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS; CIBER - Centro de Investigacion Biomedica en Red; CIBEREHD; University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS; Karolinska Institutet; University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS; University of Barcelona	Claria, J (corresponding author), Hosp Clin IDIBAPS, Dept Biochem & Mol Genet, Barcelona, Spain.; Claria, J (corresponding author), Hosp Clin IDIBAPS, CIBERehd, Barcelona, Spain.; Claria, J (corresponding author), Univ Barcelona, Dept Biomed, Barcelona, Spain.	jclaria@clinic.ub.es	Claria, Joan/M-7772-2019; Titos, Esther/AAA-5394-2019; Jakobsson, Per-Johan/ABC-5594-2021	Titos, Esther/0000-0002-2543-2243; Lopez-Vicario, Cristina/0000-0002-6609-8501; Claria, Joan/0000-0003-4333-7749	Spanish Ministerio de Economia y Competitividad (MEC) under European Regional Development Funds (ERDF) [SAF12/32789, PIE14/00045, SAF15/63674-R]; Instituto de Salud Carlos III; MEC; IDIBAPS/Fundacio Clinic; Marie Curie Action; Generalitat de Catalunya	Spanish Ministerio de Economia y Competitividad (MEC) under European Regional Development Funds (ERDF); Instituto de Salud Carlos III(Instituto de Salud Carlos IIIEuropean Commission); MEC(European Commission); IDIBAPS/Fundacio Clinic; Marie Curie Action(European Commission); Generalitat de Catalunya(Generalitat de Catalunya)	Supported by Spanish Ministerio de Economia y Competitividad (MEC) (SAF12/32789, PIE14/00045 and SAF15/63674-R) under European Regional Development Funds (ERDF). CIBERehd is funded by the Instituto de Salud Carlos III. This study was carried out at the Center Esther Koplowitz. V.G.-A. and B.R. had fellowships from MEC. C.L.-V. was supported by IDIBAPS/Fundacio Clinic. A.L. was funded by a Marie Curie Action and J.A.-Q. is a recipient of an Agaur/BFU fellowship (Generalitat de Catalunya).	Asterholm IW, 2014, CELL METAB, V20, P103, DOI 10.1016/j.cmet.2014.05.005; BJORNTORP P, 1991, DIABETES CARE, V14, P1132, DOI 10.2337/diacare.14.12.1132; CHATZIPANTELI K, 1992, DIABETES, V41, P927, DOI 10.2337/diabetes.41.8.927; Divoux A, 2010, DIABETES, V59, P2817, DOI 10.2337/db10-0585; Fujimori K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044698; Funk CD, 2001, SCIENCE, V294, P1871, DOI 10.1126/science.294.5548.1871; Garcia-Alonso V, 2013, J BIOL CHEM, V288, P28230, DOI 10.1074/jbc.M113.468603; Gomez I, 2013, PROSTAG LEUKOTR ESS, V89, P55, DOI 10.1016/j.plefa.2013.04.004; Haslam DW, 2005, LANCET, V366, P1197, DOI 10.1016/S0140-6736(05)67483-1; Hetu PO, 2007, OBESITY, V15, P60, DOI 10.1038/oby.2007.514; Hui AY, 2004, J HEPATOL, V41, P251, DOI 10.1016/j.jhep.2004.04.033; Kahn SE, 2006, NATURE, V444, P840, DOI 10.1038/nature05482; Kalinski P, 2012, J IMMUNOL, V188, P21, DOI 10.4049/jimmunol.1101029; Levy BD, 2001, NAT IMMUNOL, V2, P612, DOI 10.1038/89759; Lumeng CN, 2011, J CLIN INVEST, V121, P2111, DOI 10.1172/JCI57132; Mallat A, 1998, J BIOL CHEM, V273, P27300, DOI 10.1074/jbc.273.42.27300; Massague J, 2012, NAT REV MOL CELL BIO, V13, P616, DOI 10.1038/nrm3434; Na YR, 2015, EUR J IMMUNOL, V45, P2661, DOI 10.1002/eji.201545471; Rajan S, 2014, DIFFERENTIATION, V87, P183, DOI 10.1016/j.diff.2014.07.002; Ricciotti E, 2011, ARTERIOSCL THROM VAS, V31, P986, DOI 10.1161/ATVBAHA.110.207449; Ritchie ME, 2015, NUCLEIC ACIDS RES, V43, DOI 10.1093/nar/gkv007; Rouzer CA, 2009, J LIPID RES, V50, pS29, DOI 10.1194/jlr.R800042-JLR200; Rutkowski JM, 2015, J CELL BIOL, V208, P501, DOI 10.1083/jcb.201409063; Serezani CH, 2008, AM J RESP CELL MOL, V39, P127, DOI 10.1165/rcmb.2008-0091TR; Sidossis L, 2015, J CLIN INVEST, V125, P478, DOI 10.1172/JCI78362; Simmons DL, 2004, PHARMACOL REV, V56, P387, DOI 10.1124/pr.56.3.3; Smith WL, 2000, ANNU REV BIOCHEM, V69, P145, DOI 10.1146/annurev.biochem.69.1.145; Sun K, 2013, CELL METAB, V18, P470, DOI 10.1016/j.cmet.2013.06.016; Sun K, 2011, J CLIN INVEST, V121, P2094, DOI 10.1172/JCI45887; Titos E, 2011, J IMMUNOL, V187, P5408, DOI 10.4049/jimmunol.1100225; Wang D, 2006, GUT, V55, P115, DOI 10.1136/gut.2004.047100; Wood IS, 2009, P NUTR SOC, V68, P370, DOI 10.1017/S0029665109990206	32	79	83	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 28	2016	11	4							e0153751	10.1371/journal.pone.0153751	http://dx.doi.org/10.1371/journal.pone.0153751			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DK8XE	27124181	gold, Green Published, Green Submitted			2022-12-26	WOS:000375211700026
J	Ohrvik, H; Logeman, B; Turk, B; Reinheckel, T; Thiele, DJ				Ohrvik, Helena; Logeman, Brandon; Turk, Boris; Reinheckel, Thomas; Thiele, Dennis J.			Cathepsin Protease Controls Copper and Cisplatin Accumulation via Cleavage of the Ctr1 Metal-binding Ectodomain	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						copper transport; cysteine protease; intracellular processing; metal homeostasis; protein processing; anti-cancer drug; cathepsin; cisplatin	METHIONINE-RICH CLUSTERS; TRANSPORTER CTR1; CELLULAR ACCUMULATION; SACCHAROMYCES-CEREVISIAE; STIMULATED ENDOCYTOSIS; PROTEOLYTIC CLEAVAGE; CYSTEINE CATHEPSINS; LYSOSOMAL MEMBRANE; HCTR1; CANCER	Copper is an essential metal ion for embryonic development, iron acquisition, cardiac function, neuropeptide biogenesis, and other critical physiological processes. Ctr1 is a high affinity Cu+ transporter on the plasma membrane and endosomes that exists as a full-length protein and a truncated form of Ctr1 lacking the methionine- and histidine-rich metal-binding ectodomain, and it exhibits reduced Cu+ transport activity. Here, we identify the cathepsin L/B endolysosomal proteases functioning in a direct and rate-limiting step in the Ctr1 ectodomain cleavage. Cells and mice lacking cathepsin L accumulate full-length Ctr1 and hyper-accumulate copper. As Ctr1 also transports the chemotherapeutic drug cisplatin via direct binding to the ectodomain, we demonstrate that the combination of cisplatin with a cathepsin L/B inhibitor enhances cisplatin uptake and cell killing. These studies identify a new processing event and the key protease that cleaves the Ctr1 metal-binding ectodomain, which functions to regulate cellular Cu+ and cisplatin acquisition.	[Ohrvik, Helena; Logeman, Brandon; Thiele, Dennis J.] Duke Univ, Sch Med, Dept Pharmacol & Canc Biol, Box 3813,Res Dr,LSRC C134, Durham, NC 27710 USA; [Thiele, Dennis J.] Duke Univ, Sch Med, Dept Biochem, Box 3813,Res Dr,LSRC C134, Durham, NC 27710 USA; [Thiele, Dennis J.] Duke Univ, Sch Med, Dept Mol Genet & Microbiol, Box 3813,Res Dr,LSRC C134, Durham, NC 27710 USA; [Turk, Boris] Jozef Stefan Inst, Dept Biochem & Mol & Struct Biol, SI-1000 Ljubljana, Slovenia; [Turk, Boris] Univ Ljubljana, Fac Chem & Chem Technol, SI-1000 Ljubljana, Slovenia; [Reinheckel, Thomas] Univ Freiburg, Inst Mol Med & Cell Res, Fac Med, D-79104 Freiburg, Germany; [Reinheckel, Thomas] Univ Freiburg, BIOSS Ctr Biol Signalling Studies, D-79104 Freiburg, Germany	Duke University; Duke University; Duke University; Slovenian Academy of Sciences & Arts (SASA); Jozef Stefan Institute; University of Ljubljana; University of Freiburg; University of Freiburg	Thiele, DJ (corresponding author), Duke Univ, Sch Med, Dept Pharmacol & Canc Biol, Box 3813,Res Dr,LSRC C134, Durham, NC 27710 USA.; Thiele, DJ (corresponding author), Duke Univ, Sch Med, Dept Biochem, Box 3813,Res Dr,LSRC C134, Durham, NC 27710 USA.; Thiele, DJ (corresponding author), Duke Univ, Sch Med, Dept Mol Genet & Microbiol, Box 3813,Res Dr,LSRC C134, Durham, NC 27710 USA.; Ohrvik, H (corresponding author), Uppsala Univ, Dept Med Biochem & Microbiol, S-75123 Uppsala, Sweden.	helena.ohrvik@imbim.uu.se; dennis.thiele@duke.edu	Reinheckel, Thomas/AAL-9761-2021	Reinheckel, Thomas/0000-0001-9866-9105; Logeman, Brandon/0000-0002-9975-3541; Turk, Boris/0000-0002-9007-5764	National Institutes of Health [DK074192]; Alexander and Margaret Stewart Trust from Duke University Cancer Institute; Swedish Research Council [524-2014-1]; Ake Wiberg Foundation [M14-0080]; Magnus Bergvall Foundation [2014-00058]; Deutsche Forschungsgemeinschaft [Re1584/6-1, SFB850]; Excellence Initiative of the German Federal and State Governments [EXC 294]; Slovene Research Agency [P1-0140]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK074192] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Alexander and Margaret Stewart Trust from Duke University Cancer Institute; Swedish Research Council(Swedish Research CouncilEuropean Commission); Ake Wiberg Foundation; Magnus Bergvall Foundation; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Excellence Initiative of the German Federal and State Governments; Slovene Research Agency(Slovenian Research Agency - Slovenia); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by National Institutes of Health Grant DK074192 (to D. J. T.), the Alexander and Margaret Stewart Trust from Duke University Cancer Institute (to D. J. T.), Swedish Research Council Grant 524-2014-1 (to H. O.), Ake Wiberg Foundation Grant M14-0080 (to H. O.), Magnus Bergvall Foundation Grant 2014-00058 (to H. O.), Deutsche Forschungsgemeinschaft Grant Re1584/6-1 (to T. R.), SFB850 Project B7 (to T. R.), Excellence Initiative of the German Federal and State Governments Grant EXC 294, BIOSS, Project B10 (to T. R.). and by Grant P1-0140 from Slovene Research Agency (to B. T.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Blair BG, 2010, MOL PHARMACOL, V77, P912, DOI 10.1124/mol.109.062836; Blair BG, 2009, CLIN CANCER RES, V15, P4312, DOI 10.1158/1078-0432.CCR-09-0311; Collins JF, 2010, NUTR REV, V68, P133, DOI 10.1111/j.1753-4887.2010.00271.x; Crider SE, 2010, METALLOMICS, V2, P74, DOI 10.1039/b916899k; DANCIS A, 1994, CELL, V76, P393, DOI 10.1016/0092-8674(94)90345-X; De Feo CJ, 2009, P NATL ACAD SCI USA, V106, P4237, DOI 10.1073/pnas.0810286106; Du XB, 2013, CHEM COMMUN, V49, P9134, DOI 10.1039/c3cc45360j; Duncan EM, 2008, CELL, V135, P284, DOI 10.1016/j.cell.2008.09.055; Eisses JF, 2005, J BIOL CHEM, V280, P9635, DOI 10.1074/jbc.M500116200; Felbor U, 2002, P NATL ACAD SCI USA, V99, P7883, DOI 10.1073/pnas.112632299; Funkelstein L, 2008, J BIOL CHEM, V283, P35652, DOI 10.1074/jbc.M709010200; Garcia-Cattaneo A, 2012, P NATL ACAD SCI USA, V109, P9053, DOI 10.1073/pnas.1115091109; Guo Y, 2004, J BIOL CHEM, V279, P46393, DOI 10.1074/jbc.M407777200; Guo Y, 2004, J BIOL CHEM, V279, P17428, DOI 10.1074/jbc.M401493200; Haas KL, 2011, J AM CHEM SOC, V133, P4427, DOI 10.1021/ja108890c; Hardman B, 2006, PLACENTA, V27, P968, DOI 10.1016/j.placenta.2005.10.011; Holzer AK, 2006, MOL PHARMACOL, V70, P1390, DOI 10.1124/mol.106.022624; Ishida S, 2002, P NATL ACAD SCI USA, V99, P14298, DOI 10.1073/pnas.162491399; Jiang JF, 2005, INORG CHEM, V44, P9787, DOI 10.1021/ic051180m; Kambe T, 2009, MOL CELL BIOL, V29, P129, DOI 10.1128/MCB.00963-08; Kim BE, 2008, NAT CHEM BIOL, V4, P176, DOI 10.1038/nchembio.72; Klomp AEM, 2002, BIOCHEM J, V364, P497, DOI 10.1042/BJ20011803; Kuo MT, 2012, CANCER RES, V72, P4616, DOI 10.1158/0008-5472.CAN-12-0888; Kuo YM, 2006, J NUTR, V136, P21, DOI 10.1093/jn/136.1.21; Kuo YM, 2001, P NATL ACAD SCI USA, V98, P6836, DOI 10.1073/pnas.111057298; Larson CA, 2010, MOL PHARMACOL, V78, P333, DOI 10.1124/mol.110.064766; Larson CA, 2010, BIOCHEM PHARMACOL, V80, P448, DOI 10.1016/j.bcp.2010.04.030; Lee LW, 2001, P NATL ACAD SCI USA, V98, P6842, DOI 10.1073/pnas.111058698; Lee YY, 2011, GYNECOL ONCOL, V122, P361, DOI 10.1016/j.ygyno.2011.04.025; Liszewski MK, 2013, IMMUNITY, V39, P1143, DOI 10.1016/j.immuni.2013.10.018; LUKASEWYCZ OA, 1990, ANN NY ACAD SCI, V587, P147, DOI 10.1111/j.1749-6632.1990.tb00142.x; Madsen E, 2007, ANNU REV NEUROSCI, V30, P317, DOI 10.1146/annurev.neuro.30.051606.094232; Maryon EB, 2007, J BIOL CHEM, V282, P20376, DOI 10.1074/jbc.M701806200; Maryon EB, 2009, J BIOL CHEM, V284, P28104, DOI 10.1074/jbc.M109.044925; MCGOWAN EB, 1989, BIOCHEM BIOPH RES CO, V158, P432, DOI 10.1016/S0006-291X(89)80065-8; MEDEIROS DM, 1993, P SOC EXP BIOL MED, V203, P262, DOI 10.3181/00379727-203-43599; Mihelic M, 2008, J BIOL CHEM, V283, P14453, DOI 10.1074/jbc.M801283200; Molloy SA, 2009, J BIOL CHEM, V284, P29704, DOI 10.1074/jbc.M109.000166; Muller S, 2012, BBA-PROTEINS PROTEOM, V1824, P34, DOI 10.1016/j.bbapap.2011.07.003; Nakagawa T, 1998, SCIENCE, V280, P450, DOI 10.1126/science.280.5362.450; Nevitt T, 2012, BBA-MOL CELL RES, V1823, P1580, DOI 10.1016/j.bbamcr.2012.02.011; Nose Y, 2010, J BIOL CHEM, V285, P32385, DOI 10.1074/jbc.M110.143826; Ohrvika H, 2013, P NATL ACAD SCI USA, V110, pE4279, DOI 10.1073/pnas.1311749110; Olson OC, 2015, NAT REV CANCER, V15, P712, DOI 10.1038/nrc4027; Pena MMO, 2000, J BIOL CHEM, V275, P33244, DOI 10.1074/jbc.M005392200; Petris MJ, 2003, J BIOL CHEM, V278, P9639, DOI 10.1074/jbc.M209455200; Puig S, 2002, J BIOL CHEM, V277, P26021, DOI 10.1074/jbc.M202547200; Puzer L, 2004, ARCH BIOCHEM BIOPHYS, V430, P274, DOI 10.1016/j.abb.2004.07.006; Ralle M, 2010, J BIOL CHEM, V285, P30875, DOI 10.1074/jbc.M110.114447; Reddy VB, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8864; Riggio M, 2002, BBA-GENE STRUCT EXPR, V1576, P127, DOI 10.1016/S0167-4781(02)00337-8; Sancenon V, 2003, PLANT MOL BIOL, V51, P577, DOI 10.1023/A:1022345507112; Savalas LRT, 2011, BIOCHEM J, V439, P113, DOI 10.1042/BJ20110166; Sevenich L, 2006, BIOL CHEM, V387, P885, DOI 10.1515/BC.2006.112; Shree T, 2011, GENE DEV, V25, P2465, DOI 10.1101/gad.180331.111; Sinani D, 2007, J BIOL CHEM, V282, P26775, DOI 10.1074/jbc.M703973200; Sobotic B, 2015, MOL CELL PROTEOMICS, V14, P2213, DOI 10.1074/mcp.M114.044628; Song IS, 2004, MOL CANCER THER, V3, P1543; Steenhuis P, 2012, BBA-MOL BASIS DIS, V1822, P1617, DOI 10.1016/j.bbadis.2012.05.015; TOWATARI T, 1983, J BIOCHEM-TOKYO, V93, P1119, DOI 10.1093/oxfordjournals.jbchem.a134237; Turk V, 2012, BBA-PROTEINS PROTEOM, V1824, P68, DOI 10.1016/j.bbapap.2011.10.002; Turski ML, 2007, J BIOL CHEM, V282, P24017, DOI 10.1074/jbc.M703792200; Vasiljeva O, 2007, CURR PHARM DESIGN, V13, P387, DOI 10.2174/138161207780162962; Vizovisek M, 2015, PROTEOMICS, V15, P2479, DOI 10.1002/pmic.201400460; Wang D, 2005, NAT REV DRUG DISCOV, V4, P307, DOI 10.1038/nrd1691; Xu XJ, 2012, LUNG CANCER, V77, P438, DOI 10.1016/j.lungcan.2012.03.023; Yasothornsrikul S, 2003, P NATL ACAD SCI USA, V100, P9590, DOI 10.1073/pnas.1531542100; Yoshida H, 2013, ANTICANCER RES, V33, P1409	68	27	30	1	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 1	2016	291	27					13905	13916		10.1074/jbc.M116.731281	http://dx.doi.org/10.1074/jbc.M116.731281			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DR5XG	27143361	Green Published, hybrid			2022-12-26	WOS:000379975100001
J	Blazer, LL; Lima-Fernandes, E; Gibson, E; Eram, MS; Loppnau, P; Arrowsmith, CH; Schapira, M; Vedadi, M				Blazer, Levi L.; Lima-Fernandes, Evelyne; Gibson, Elisa; Eram, Mohammad S.; Loppnau, Peter; Arrowsmith, Cheryl H.; Schapira, Matthieu; Vedadi, Masoud			PR Domain-containing Protein 7 (PRDM7) Is a Histone 3 Lysine 4 Trimethyltransferase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						epigenetics; histone methylation; histone modification; substrate specificity; zinc finger	SINGLE-NUCLEOTIDE POLYMORPHISMS; MEIOTIC RECOMBINATION HOTSPOTS; ZINC-FINGER PROTEIN; MEISETZ GENE; METHYLTRANSFERASE; VARIANTS; LOCI; RIZ1; SET; DNA	PR domain-containing protein 7 (PRDM7) is a primate-specific histone methyltransferase that is the result of a recent gene duplication of PRDM9. The two proteins are highly homologous, especially in the catalytic PR/SET domain, where they differ by only three amino acid residues. Here we report that PRDM7 is an efficient methyltransferase that selectively catalyzes the trimethylation of H3 lysine 4 (H3K4) both in vitro and in cells. Through selective mutagenesis we have dissected the functional roles of each of the three divergent residues between the PR domains of PRDM7 and PRDM9. These studies indicate that after a single serine to tyrosine mutation at residue 357 (S357Y), PRDM7 regains the substrate specificities and catalytic activities similar to its evolutionary predecessor, including the ability to efficiently methylate H3K36.	[Blazer, Levi L.; Lima-Fernandes, Evelyne; Gibson, Elisa; Eram, Mohammad S.; Loppnau, Peter; Arrowsmith, Cheryl H.; Schapira, Matthieu; Vedadi, Masoud] Univ Toronto, Struct Genom Consortium, Toronto, ON M5G 1L7, Canada; [Arrowsmith, Cheryl H.] Univ Toronto, Princess Margaret Canc Ctr, Toronto, ON M5G 2M9, Canada; [Arrowsmith, Cheryl H.] Univ Toronto, Dept Med Biophys, Toronto, ON M5G 2M9, Canada; [Schapira, Matthieu; Vedadi, Masoud] Univ Toronto, Dept Pharmacol & Toxicol, Toronto, ON M5S 1A8, Canada	University of Toronto; Structural Genomics Consortium; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Princess Margaret Cancer Centre; University of Toronto; University of Toronto	Vedadi, M (corresponding author), Univ Toronto, Struct Genom Consortium, Toronto, ON M5G 1L7, Canada.; Vedadi, M (corresponding author), Univ Toronto, Dept Pharmacol & Toxicol, Toronto, ON M5S 1A8, Canada.	m.vedadi@utoronto.ca	Blazer, Levi/T-6267-2019	Blazer, Levi/0000-0001-9594-4642; Lima Fernandes, Evelyne/0000-0002-3628-9745; Arrowsmith, Cheryl/0000-0002-4971-3250; Gibson, Elisa/0000-0002-7112-337X	Structural Genomics Consortium [1097737]; AbbVie; Bayer Pharma AG; Boehringer Ingelheim; Canada Foundation for Innovation; Eshelman Institute for Innovation; Genome Canada; Innovative Medicines Initiative (EU/EFPIA); Janssen; Merck Co.; Novartis Pharma AG; Ontario Ministry of Economic Development and Innovation; Pfizer; Sao Paulo Research Foundation-FAPESP; Takeda; Wellcome Trust; National Research Fund Luxembourg; Marie Curie Actions of the European Commission (FP7-COFUND); Banting Postdoctoral Fellowship	Structural Genomics Consortium(University of Toronto); AbbVie(AbbVie); Bayer Pharma AG; Boehringer Ingelheim(Boehringer Ingelheim); Canada Foundation for Innovation(Canada Foundation for InnovationCGIAR); Eshelman Institute for Innovation; Genome Canada(Genome Canada); Innovative Medicines Initiative (EU/EFPIA); Janssen(Johnson & JohnsonJohnson & Johnson USAJanssen Biotech Inc); Merck Co.(Merck & Company); Novartis Pharma AG; Ontario Ministry of Economic Development and Innovation; Pfizer(Pfizer); Sao Paulo Research Foundation-FAPESP(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Takeda(Takeda Pharmaceutical Company Ltd); Wellcome Trust(Wellcome TrustEuropean Commission); National Research Fund Luxembourg(Luxembourg National Research Fund); Marie Curie Actions of the European Commission (FP7-COFUND); Banting Postdoctoral Fellowship	This work was supported in part by the Structural Genomics Consortium, a registered charity (number 1097737), that receives funds from AbbVie, Bayer Pharma AG, Boehringer Ingelheim, Canada Foundation for Innovation, Eshelman Institute for Innovation, Genome Canada, Innovative Medicines Initiative (EU/EFPIA), Janssen, Merck & Co., Novartis Pharma AG, Ontario Ministry of Economic Development and Innovation, Pfizer, Sao Paulo Research Foundation-FAPESP, Takeda, and Wellcome Trust. The authors declare that they have no conflicts of interest with the contents of this article.; Recipient of a postdoctoral fellowship by the National Research Fund Luxembourg and the Marie Curie Actions of the European Commission (FP7-COFUND) and subsequently of a Banting Postdoctoral Fellowship.	Baudat F, 2010, SCIENCE, V327, P836, DOI 10.1126/science.1183439; Baudat F, 2010, M S-MED SCI, V26, P468, DOI 10.1051/medsci/2010265468; Berg IL, 2011, P NATL ACAD SCI USA, V108, P12378, DOI 10.1073/pnas.1109531108; Bhattacharyya T, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004088; Brayer KJ, 2008, CELL BIOCHEM BIOPHYS, V50, P111, DOI 10.1007/s12013-008-9008-5; Buard J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085021; BUYSE IM, 1995, P NATL ACAD SCI USA, V92, P4467, DOI 10.1073/pnas.92.10.4467; CARDOZO T, 1995, PROTEINS, V23, P403, DOI 10.1002/prot.340230314; Caudill MA, 2001, J NUTR, V131, P2811, DOI 10.1093/jn/131.11.2811; Chasman DI, 2011, NAT GENET, V43, P695, DOI 10.1038/ng.856; Derunes C, 2005, BIOCHEM BIOPH RES CO, V333, P925, DOI 10.1016/j.bbrc.2005.05.190; Eom GH, 2009, BIOCHEM BIOPH RES CO, V388, P131, DOI 10.1016/j.bbrc.2009.07.134; Eram MS, 2015, BBA-GEN SUBJECTS, V1850, P1842, DOI 10.1016/j.bbagen.2015.05.013; Eram MS, 2014, J BIOL CHEM, V289, P12177, DOI 10.1074/jbc.M113.523183; Flachs P, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095806; Fog CK, 2012, BIOESSAYS, V34, P50, DOI 10.1002/bies.201100107; Fumasoni I, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-187; Gateva V, 2009, NAT GENET, V41, P1228, DOI 10.1038/ng.468; Groeneveld LF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039064; Gyory I, 2003, J IMMUNOL, V170, P3125, DOI 10.4049/jimmunol.170.6.3125; Hayashi K, 2005, NATURE, V438, P374, DOI 10.1038/nature04112; Hayashi K, 2006, CELL CYCLE, V5, P615, DOI 10.4161/cc.5.6.2572; Hohenauer T, 2012, DEVELOPMENT, V139, P2267, DOI 10.1242/dev.070110; Horowitz S, 2013, J AM CHEM SOC, V135, P15536, DOI 10.1021/ja407140k; Huang S, 1998, J BIOL CHEM, V273, P15933, DOI 10.1074/jbc.273.26.15933; Huang S, 2002, NAT REV CANCER, V2, P469, DOI 10.1038/nrc819; Irie S, 2009, J ANDROL, V30, P426, DOI 10.2164/jandrol.108.006262; Kaniskan HU, 2015, ANGEW CHEM INT EDIT, V54, P5166, DOI 10.1002/anie.201412154; Kim KC, 2003, CANCER RES, V63, P7619; Mihola O, 2009, SCIENCE, V323, P373, DOI 10.1126/science.1163601; Miyamoto T, 2008, J ASSIST REPROD GEN, V25, P553, DOI 10.1007/s10815-008-9270-x; Niesen FH, 2007, NAT PROTOC, V2, P2212, DOI 10.1038/nprot.2007.321; Nowick K, 2013, TRENDS GENET, V29, P130, DOI 10.1016/j.tig.2012.11.007; Pinheiro I, 2012, CELL, V150, P948, DOI 10.1016/j.cell.2012.06.048; Ponting CP, 2011, TRENDS GENET, V27, P165, DOI 10.1016/j.tig.2011.02.001; Raychaudhuri S, 2009, NAT GENET, V41, P1313, DOI 10.1038/ng.479; Sandovici I, 2010, F1000 BIOL REP, V2, P37; Schapira Matthieu, 2011, Curr Chem Genomics, V5, P85, DOI 10.2174/1875397301005010085; Segurel L, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001211; Soler Artigas M, 2011, NAT GENET, V43, P1082, DOI 10.1038/ng.941; Wu H, 2013, CELL REP, V5, P13, DOI 10.1016/j.celrep.2013.08.035; Wu H, 2010, PLOS ONE, V5, DOI [10.1371/journal.pone.0008570, 10.1371/journal.pone.0013316]; Wu YX, 2008, J MOL CELL CARDIOL, V44, P47, DOI 10.1016/j.yjmcc.2007.06.008	43	18	18	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 24	2016	291	26					13509	13519		10.1074/jbc.M116.721472	http://dx.doi.org/10.1074/jbc.M116.721472			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DR2YZ	27129774	hybrid, Green Published			2022-12-26	WOS:000379771100009
J	Lengyel, M; Czirjak, G; Enyedi, P				Lengyel, Miklos; Czirjak, Gabor; Enyedi, Peter			Formation of Functional Heterodimers by TREK-1 and TREK-2 Two-pore Domain Potassium Channel Subunits	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						electrophysiology; patch clamp; pharmacology; plasma membrane; potassium channel; Ion channel heteromerization; KCNK10; KCNK2; ruthenium red; spadin	BACKGROUND K+ CHANNEL; CONE DYSTROPHY; CONDUCTANCE; CELLS; TRAAK; ACID; TASK-1/TASK-3; K(2P)10.1; TASK-1; COMMON	Two-pore domain (K-2P) potassium channels are the major molecular correlates of the background (leak) K+ current in a wide variety of cell types. They generally play a key role in setting the resting membrane potential and regulate the response of excitable cells to various stimuli. K-2P channels usually function as homodimers, and only a few examples of heteromerization have been previously reported. Expression of the TREK (TWIK-related K+ channel) subfamily members of K-2P channels often overlaps in neurons and in other excitable cells. Here, we demonstrate that heterologous coexpression of TREK-1 and TREK-2 subunits results in the formation of functional heterodimers. Taking advantage of a tandem construct (in which the two different subunits were linked together to enforce heterodimerization), we characterized the biophysical and pharmacological properties of the TREK-1/TREK-2 current. The heteromer was inhibited by extracellular acidification and by spadin similarly to TREK-1, and its ruthenium red sensitivity was intermediate between TREK-1 and TREK-2 homodimers. The heterodimer has also been distinguished from the homodimers by its unique single channel conductance. Assembly of the two different subunits was confirmed by coimmunoprecipitation of epitope-tagged TREK-1 and TREK-2 subunits, coexpressed in Xenopus oocytes. Formation of TREK-1/TREK-2 channels was also demonstrated in native dorsal root ganglion neurons indicating that heterodimerization may provide greater diversity of leak K+ conductances also in native tissues.	[Lengyel, Miklos; Czirjak, Gabor; Enyedi, Peter] Semmelweis Univ, Dept Physiol, POB 2, H-1428 Budapest, Hungary	Semmelweis University	Enyedi, P (corresponding author), Semmelweis Univ, Dept Physiol, POB 2, H-1428 Budapest, Hungary.	enyedi.peter@med.semmelweis-univ.hu	Lengyel, Miklos/E-6697-2016	Lengyel, Miklos/0000-0001-6382-6369	Hungarian National Research Fund OTKA [K108496]	Hungarian National Research Fund OTKA(Orszagos Tudomanyos Kutatasi Alapprogramok (OTKA))	This work was supported by Hungarian National Research Fund OTKA K108496. The authors declare that they have no conflicts of interest with the contents of this article.	Bagriantsev SN, 2011, EMBO J, V30, P3594, DOI 10.1038/emboj.2011.230; Berg AP, 2004, J NEUROSCI, V24, P6693, DOI 10.1523/JNEUROSCI.1408-04.2004; Blin S, 2016, P NATL ACAD SCI USA, V113, P4200, DOI 10.1073/pnas.1522748113; Blin S, 2014, J BIOL CHEM, V289, P28202, DOI 10.1074/jbc.M114.600437; Braun G, 2015, BRIT J PHARMACOL, V172, P1728, DOI 10.1111/bph.13019; Cadaveira-Mosquera A, 2012, J MOL NEUROSCI, V48, P86, DOI 10.1007/s12031-012-9780-y; Coetzee WA, 1999, ANN NY ACAD SCI, V868, P233, DOI 10.1111/j.1749-6632.1999.tb11293.x; Czirjak B, 2004, J BIOL CHEM, V279, P18550, DOI 10.1074/jbc.M312229200; Czirjak G, 2002, J BIOL CHEM, V277, P5426, DOI 10.1074/jbc.M107138200; Czirjak G, 2006, MOL PHARMACOL, V69, P1024, DOI 10.1124/mol.105.018556; Enyeart JJ, 2002, J BIOL CHEM, V277, P49186, DOI 10.1074/jbc.M207233200; Enyedi P, 2010, PHYSIOL REV, V90, P559, DOI 10.1152/physrev.00029.2009; Gilling Mette, 2013, Frontiers in Genetics, V4, P54, DOI 10.3389/fgene.2013.00054; Han J, 2003, J PHYSIOL-LONDON, V546, P625, DOI 10.1113/jphysiol.2002.032094; Heurteaux C, 2006, NEUROSCIENCE, V137, P241, DOI 10.1016/j.neuroscience.2005.08.083; Heurteaux C, 2006, NAT NEUROSCI, V9, P1134, DOI 10.1038/nn1749; Hwang EM, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4227; Kang D, 2006, AM J PHYSIOL-CELL PH, V291, pC138, DOI 10.1152/ajpcell.00629.2005; Kang DW, 2004, J PHYSIOL-LONDON, V554, P64, DOI 10.1113/jphysiol.2003.054387; Kim D, 2009, J PHYSIOL-LONDON, V587, P2963, DOI 10.1113/jphysiol.2009.171181; Koh SD, 2001, J BIOL CHEM, V276, P44338, DOI 10.1074/jbc.M108125200; Larkman PM, 2005, EUR J NEUROSCI, V21, P679, DOI 10.1111/j.1460-9568.2005.03898.x; Levitz J, 2016, P NATL ACAD SCI USA, V113, P4194, DOI 10.1073/pnas.1522459113; Maati HMO, 2012, NEUROPHARMACOLOGY, V62, P278, DOI 10.1016/j.neuropharm.2011.07.019; Mazella J, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000355; Meuth SG, 2006, MOL PHARMACOL, V69, P1468, DOI 10.1124/mol.105.020594; Noel J, 2011, CHANNELS, V5, P400, DOI 10.4161/chan.5.5.16469; Noel J, 2009, EMBO J, V28, P1308, DOI 10.1038/emboj.2009.57; Plant LD, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2003431; Sandoz G, 2009, P NATL ACAD SCI USA, V106, P14628, DOI 10.1073/pnas.0906267106; Simkin D, 2008, J PHYSIOL-LONDON, V586, P5651, DOI 10.1113/jphysiol.2008.161927; Smith KE, 2012, J BIOL CHEM, V287, P43972, DOI 10.1074/jbc.M112.388033; Szymczak AL, 2004, NAT BIOTECHNOL, V22, P589, DOI 10.1038/nbt957; Talley EM, 2001, J NEUROSCI, V21, P7491, DOI 10.1523/JNEUROSCI.21-19-07491.2001; Thomas D, 2008, NEURON, V58, P859, DOI 10.1016/j.neuron.2008.04.016; Torborg CL, 2006, J NEUROSCI, V26, P7362, DOI 10.1523/JNEUROSCI.1257-06.2006; Toth JT, 2016, BBA-MOL CELL BIOL L, V1861, P177, DOI 10.1016/j.bbalip.2015.12.005; Usoskin D, 2015, NAT NEUROSCI, V18, P145, DOI 10.1038/nn.3881; Wissinger B, 2011, HUM MUTAT, V32, P1398, DOI 10.1002/humu.21580	39	32	32	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 24	2016	291	26					13649	13661		10.1074/jbc.M116.719039	http://dx.doi.org/10.1074/jbc.M116.719039			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DR2YZ	27129242	hybrid, Green Published			2022-12-26	WOS:000379771100021
J	Navarro, G; Aguinaga, D; Angelats, E; Medrano, M; Moreno, E; Mallol, J; Cortes, A; Canela, EI; Casado, V; McCormick, PJ; Lluis, C; Ferre, S				Navarro, Gemma; Aguinaga, David; Angelats, Edgar; Medrano, Mireia; Moreno, Estefania; Mallol, Josefa; Cortes, Antonio; Canela, Enric I.; Casado, Vicent; McCormick, Peter J.; Lluis, Carme; Ferre, Sergi			A Significant Role of the Truncated Ghrelin Receptor GHS-R1b in Ghrelin-induced Signaling in Neurons	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-COUPLED RECEPTORS; CELL-SURFACE EXPRESSION; ALLOSTERIC INTERACTIONS; POLYPEPTIDE GHS-R1B; INSULIN-RELEASE; HETEROTETRAMER; HETERODIMERS; ACTIVATION; ATTENUATE; PATHWAYS	The truncated non-signaling ghrelin receptor growth hormone secretagogue R1b (GHS-R1b) has been suggested to simply exert a dominant negative role in the trafficking and signaling of the full and functional ghrelin receptor GHS-R1a. Here we reveal a more complex modulatory role of GHS-R1b. Differential co-expression of GHS-R1a and GHS-R1b, both in HEK-293T cells and in striatal and hippocampal neurons in culture, demonstrates that GHS-R1b acts as a dual modulator of GHS-R1a function: low relative GHS-R1b expression potentiates and high relative GHS-R1b expression inhibits GHS-R1a function by facilitating GHS-R1a trafficking to the plasma membrane and by exerting a negative allosteric effect on GHS-R1a signaling, respectively. We found a preferential G(i/o) coupling of the GHS-R1a-GHS-R1b complex in HEK-293T cells and, unexpectedly, a preferential G(s/olf) coupling in both striatal and hippocampal neurons in culture. A dopamine D-1 receptor (D1R) antagonist blocked ghrelin-induced cAMP accumulation in striatal but not hippocampal neurons, indicating the involvement of D1R in the striatal GHS-R1a-G(s/olf) coupling. Experiments in HEK-293T cells demonstrated that D1R co-expression promotes a switch in GHS-R1a-G protein coupling from G(i/o) to G(s/olf), but only upon co-expression of GHS-R1b. Furthermore, resonance energy transfer experiments showed that D1R interacts with GHS-R1a, but only in the presence of GHS-R1b. Therefore, GHS-R1b not only determines the efficacy of ghrelin-induced GHS-R1a-mediated signaling but also determines the ability of GHS-R1a to form oligomeric complexes with other receptors, promoting profound qualitative changes in ghrelin-induced signaling.	[Navarro, Gemma; Aguinaga, David; Angelats, Edgar; Medrano, Mireia; Moreno, Estefania; Mallol, Josefa; Cortes, Antonio; Canela, Enric I.; Casado, Vicent; Lluis, Carme] Univ Barcelona, Fac Biol, Dept Biochem & Mol Biol, Diagonal 645, E-08028 Barcelona, Spain; [Navarro, Gemma; Aguinaga, David; Angelats, Edgar; Medrano, Mireia; Moreno, Estefania; Mallol, Josefa; Cortes, Antonio; Canela, Enric I.; Casado, Vicent; Lluis, Carme] Ctr Invest Biomed Red Enfermedades Neurodegenerat, Barcelona 08028, Spain; [McCormick, Peter J.] Univ East Anglia, Sch Pharm, Norwich Res Pk, Norwich NR4 7TJ, Norfolk, England; [Ferre, Sergi] NIDA, Integrat Neurobiol Sect, Intramural Res Program, Baltimore, MD 21224 USA	University of Barcelona; CIBERNED; University of East Anglia; National Institutes of Health (NIH) - USA; NIH National Institute on Drug Abuse (NIDA)	Navarro, G (corresponding author), Univ Barcelona, Fac Biol, Dept Biochem & Mol Biol, Diagonal 645, E-08028 Barcelona, Spain.; Ferre, S (corresponding author), NIDA, Integrat Neurobiol Sect, Intramural Res Program, NIH, Triad Technol Bldg,333 Cassell Dr, Baltimore, MD 21224 USA.	dimartts@hotmail.com; sferre@intra.nida.nih.gov	Ferre, Sergi/K-6115-2014; Mallol, Josefa/I-4194-2015; Casadó, Vicent/K-1660-2014; Medrano, Mireia/GVS-3226-2022; Canela, Enric I./M-8726-2013; Guillén, Estefanía Moreno/ABE-4371-2020; Navarro, Gemma/AAO-7866-2021; Medrano, Mireia/AFP-3427-2022	Ferre, Sergi/0000-0002-1747-1779; Mallol, Josefa/0000-0002-2479-4162; Casadó, Vicent/0000-0002-1764-3825; Canela, Enric I./0000-0003-4992-7440; Navarro, Gemma/0000-0003-4654-0873; Medrano, Mireia/0000-0002-8707-5501; Moreno, Estefania/0000-0002-2491-5753; Aguinaga Andres, David/0000-0003-2506-7204; Angelats Canals, Edgar/0000-0001-5405-7086	Spanish Ministerio de Ciencia y Tecnologia [SAF2011-23813]; government of Catalonia [2014-SGR-1236]; Centro de Investigacion Biomedica en Red sobre Enfermedades Neurodegenerativas Grant [CB06/05/0064]; National Institute on Drug Abuse; Ramon y Cajal fellowship; NATIONAL INSTITUTE ON DRUG ABUSE [ZIADA000493] Funding Source: NIH RePORTER	Spanish Ministerio de Ciencia y Tecnologia(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); government of Catalonia(Generalitat de Catalunya); Centro de Investigacion Biomedica en Red sobre Enfermedades Neurodegenerativas Grant; National Institute on Drug Abuse(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); Ramon y Cajal fellowship(Spanish Government); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported by Spanish Ministerio de Ciencia y Tecnologia Grant SAF2011-23813, government of Catalonia Grant 2014-SGR-1236, Centro de Investigacion Biomedica en Red sobre Enfermedades Neurodegenerativas Grant CB06/05/0064, and intramural funds of the National Institute on Drug Abuse. The authors declare that they have no conflicts of interest with the contents of this article.r Supported by a Ramon y Cajal fellowship.	Andrews ZB, 2011, TRENDS NEUROSCI, V34, P31, DOI 10.1016/j.tins.2010.10.001; Bennett KA, 2009, MOL PHARMACOL, V76, P802, DOI 10.1124/mol.109.056101; Bonaventura J, 2015, P NATL ACAD SCI USA, V112, pE3609, DOI 10.1073/pnas.1507704112; Carriba P, 2008, NAT METHODS, V5, P727, DOI 10.1038/nmeth.1229; Chen TW, 2013, NATURE, V499, P295, DOI 10.1038/nature12354; Chow KBS, 2012, MOL CELL ENDOCRINOL, V348, P247, DOI 10.1016/j.mce.2011.08.034; Ciruela F, 1999, FEBS LETT, V448, P91, DOI 10.1016/S0014-5793(99)00341-5; Cuellar JN, 2011, NEUROPHARMACOLOGY, V60, P842, DOI 10.1016/j.neuropharm.2010.12.024; Damian M, 2015, P NATL ACAD SCI USA, V112, P1601, DOI 10.1073/pnas.1414618112; DellaRocca GJ, 1997, J BIOL CHEM, V272, P19125, DOI 10.1074/jbc.272.31.19125; Dezaki K, 2007, DIABETES, V56, P2319, DOI 10.2337/db07-0345; Dezaki K, 2013, ENDOCR DEV, V25, P135, DOI 10.1159/000346064; Dorn GW, 1997, BIOCHEMISTRY-US, V36, P6415, DOI 10.1021/bi970080s; Ferre S, 2014, PHARMACOL REV, V66, P413, DOI 10.1124/pr.113.008052; Guitart X, 2014, MOL PHARMACOL, V86, P417, DOI 10.1124/mol.114.093096; Holst B, 2005, MOL ENDOCRINOL, V19, P2400, DOI 10.1210/me.2005-0059; Hradsky Johannes, 2013, Methods Mol Biol, V963, P147, DOI 10.1007/978-1-62703-230-8_10; Jang JK, 2013, BEHAV BRAIN RES, V248, P7, DOI 10.1016/j.bbr.2013.03.049; Jiang H, 2006, MOL ENDOCRINOL, V20, P1772, DOI 10.1210/me.2005-0084; Kern A, 2015, CELL, V163, P1176, DOI 10.1016/j.cell.2015.10.062; Kovacs JJ, 2009, DEV CELL, V17, P443, DOI 10.1016/j.devcel.2009.09.011; Leung PK, 2007, CELL SIGNAL, V19, P1011, DOI 10.1016/j.cellsig.2006.11.011; Malagon MM, 2003, ENDOCRINOLOGY, V144, P5372, DOI 10.1210/en.2003-0723; Mary S, 2013, J BIOL CHEM, V288, P24656, DOI 10.1074/jbc.M113.453423; Mason BL, 2014, ANNU REV PHYSIOL, V76, P519, DOI 10.1146/annurev-physiol-021113-170310; Schroder R, 2011, NAT PROTOC, V6, P1748, DOI 10.1038/nprot.2011.386; Silver R, 2010, SLEEP BIOL RHYTHMS, V8, P120, DOI 10.1111/j.1479-8425.2010.00438.x; Sun YM, 2014, CELL SIGNAL, V26, P2530, DOI 10.1016/j.cellsig.2014.07.014; Zimmermann T, 2002, FEBS LETT, V531, P245, DOI 10.1016/S0014-5793(02)03508-1	29	30	32	0	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 17	2016	291	25					13048	13062		10.1074/jbc.M116.715144	http://dx.doi.org/10.1074/jbc.M116.715144			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DR2YT	27129257	Green Accepted, Green Published, hybrid			2022-12-26	WOS:000379770500014
J	Horber, S; Hildebrand, DG; Lieb, WS; Lorscheid, S; Hailfinger, S; Schulze-Osthoff, K; Essmann, F				Hoerber, Sebastian; Hildebrand, Dominic G.; Lieb, Wolfgang S.; Lorscheid, Sebastian; Hailfinger, Stephan; Schulze-Osthoff, Klaus; Essmann, Frank			The Atypical Inhibitor of NF-kappa B, I kappa B zeta, Controls Macrophage Interleukin-10 Expression	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							IL-10 GENE; INFLAMMATORY GENES; P50 HOMODIMERS; PROTEIN; TRANSCRIPTION; POLARIZATION; ACTIVATION; PROMOTER; RECEPTOR; BCL-3	Macrophages constitute a first line of pathogen defense by triggering a number of inflammatory responses and the secretion of various pro-inflammatory cytokines. Recently, we and others found that I kappa B zeta, an atypical I kappa B family member and transcriptional coactivator of selected NF-kappa B target genes, is essential for macrophage expression of a subset of pro-inflammatory cytokines, such as IL-6, IL-12, and CCL2. Despite defective pro-inflammatory cytokine expression, however, I kappa B zeta-deficient mice develop symptoms of chronic inflammation. To elucidate this discrepancy, we analyzed a regulatory role of I kappa B zeta for the expression of anti-inflammatory cytokines and identified I kappa B zeta as an essential activator of IL-10 expression. LPS-challenged peritoneal and bone marrow-derived macrophages from I kappa B zeta-deficient mice revealed strongly decreased transcription and secretion of IL-10 compared with wild-type mice. Moreover, ectopic expression of I kappa B zeta was sufficient to stimulate Il10 transcription. On the molecular level, I kappa B zeta directly activated the Il10 promoter at a proximal kappa B site and was required for the transcription-enhancing trimethylation of histone 3 at lysine 4. Together, our findings show for the first time the I kappa B zeta-dependent expression of an anti-inflammatory cytokine that is crucial in controlling immune responses.	[Hoerber, Sebastian; Hildebrand, Dominic G.; Lieb, Wolfgang S.; Lorscheid, Sebastian; Hailfinger, Stephan; Schulze-Osthoff, Klaus; Essmann, Frank] Univ Tubingen, Dept Mol Med, Interfac Inst Biochem, D-72076 Tubingen, Germany; [Schulze-Osthoff, Klaus] German Canc Consortium DKTK, D-69120 Heidelberg, Germany; [Schulze-Osthoff, Klaus] German Canc Res Ctr, D-69120 Heidelberg, Germany	Eberhard Karls University of Tubingen; Helmholtz Association; German Cancer Research Center (DKFZ); Helmholtz Association; German Cancer Research Center (DKFZ)	Schulze-Osthoff, K; Essmann, F (corresponding author), Univ Tubingen, Interfac Inst Biochem, D-72076 Tubingen, Germany.	kso@uni-tuebingen.de; frank.essmann@uni-tuebingen.de	Schulze-Osthoff, Klaus/N-9025-2013; Hörber, Sebastian/AAO-2379-2021; Essmann, Frank/ABG-7409-2020	Schulze-Osthoff, Klaus/0000-0003-1443-2720; Essmann, Frank/0000-0003-4369-8456	Deutsche Forschungsgemeinschaft [SFB685, GRK1302]; Bundesminsterium fur Bildung und Forschung Grant AID-NET	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Bundesminsterium fur Bildung und Forschung Grant AID-NET	This work was supported by Deutsche Forschungsgemeinschaft Grants SFB685 and GRK1302 and Bundesminsterium fur Bildung und Forschung Grant AID-NET. The authors declare that they have no conflicts of interest with the contents of this article.	Alexander E, 2013, J CELL SCI, V126, P3738, DOI 10.1242/jcs.128835; Beguelin W, 2015, LEUKEMIA, V29, P1684, DOI 10.1038/leu.2015.57; Berg DJ, 1996, J CLIN INVEST, V98, P1010, DOI 10.1172/JCI118861; Brenner S, 2003, J BIOL CHEM, V278, P5597, DOI 10.1074/jbc.M207448200; Brightbill HD, 2000, J IMMUNOL, V164, P1940, DOI 10.4049/jimmunol.164.4.1940; Cao SJ, 2006, J BIOL CHEM, V281, P26041, DOI 10.1074/jbc.M602222200; Carmody RJ, 2007, SCIENCE, V317, P675, DOI 10.1126/science.1142953; Cowland JB, 2006, J IMMUNOL, V176, P5559, DOI 10.4049/jimmunol.176.9.5559; Ginhoux F, 2014, NAT REV IMMUNOL, V14, P392, DOI 10.1038/nri3671; Gordon S, 2005, NAT REV IMMUNOL, V5, P953, DOI 10.1038/nri1733; Graupner V, 2011, CELL DEATH DIFFER, V18, P1130, DOI 10.1038/cdd.2010.179; Hildebrand DG, 2013, J IMMUNOL, V190, P4812, DOI 10.4049/jimmunol.1300089; Hinz M, 2012, IMMUNOL REV, V246, P59, DOI 10.1111/j.1600-065X.2012.01102.x; Hirotani T, 2005, J IMMUNOL, V174, P3650, DOI 10.4049/jimmunol.174.6.3650; Johansen C, 2015, P NATL ACAD SCI USA, V112, pE5825, DOI 10.1073/pnas.1509971112; Kannan Y, 2011, BLOOD, V117, P2855, DOI 10.1182/blood-2010-07-294702; Kayama H, 2008, J BIOL CHEM, V283, P12468, DOI 10.1074/jbc.M709965200; KUHN R, 1993, CELL, V75, P263, DOI 10.1016/0092-8674(93)80068-P; Kuwata H, 2006, IMMUNITY, V24, P41, DOI 10.1016/j.immuni.2005.11.004; Kuwata H, 2003, BLOOD, V102, P4123, DOI 10.1182/blood-2003-04-1228; Lang R, 2002, J IMMUNOL, V168, P3402, DOI 10.4049/jimmunol.168.7.3402; Laskin DL, 2011, ANNU REV PHARMACOL, V51, P267, DOI 10.1146/annurev.pharmtox.010909.105812; Lucas M, 2005, J IMMUNOL, V175, P469, DOI 10.4049/jimmunol.175.1.469; Makita N, 2015, INT IMMUNOL, V27, P131, DOI 10.1093/intimm/dxu090; Moore KW, 2001, ANNU REV IMMUNOL, V19, P683, DOI 10.1146/annurev.immunol.19.1.683; Murray PJ, 2014, IMMUNITY, V41, P14, DOI 10.1016/j.immuni.2014.06.008; O'Garra A, 2004, J CLIN INVEST, V114, P1372, DOI 10.1172/JCI200423215; Oeckinghaus A, 2011, NAT IMMUNOL, V12, P695, DOI 10.1038/ni.2065; Okamoto K, 2010, NATURE, V464, P1381, DOI 10.1038/nature08922; Okuma A, 2013, IMMUNITY, V38, P450, DOI 10.1016/j.immuni.2012.11.016; Porta C, 2009, P NATL ACAD SCI USA, V106, P14978, DOI 10.1073/pnas.0809784106; Prasse A, 2007, J ALLERGY CLIN IMMUN, V119, P464, DOI 10.1016/j.jaci.2006.09.030; Riemann M, 2005, J IMMUNOL, V175, P3560, DOI 10.4049/jimmunol.175.6.3560; Ruffell B, 2014, CANCER CELL, V26, P623, DOI 10.1016/j.ccell.2014.09.006; Saraiva M, 2010, NAT REV IMMUNOL, V10, P170, DOI 10.1038/nri2711; Schuster M, 2013, CELL COMMUN SIGNAL, V11, DOI 10.1186/1478-811X-11-23; Shen F, 2005, J LEUKOCYTE BIOL, V77, P388, DOI 10.1189/jlb.0904490; Shiina T, 2004, J BIOL CHEM, V279, P55493, DOI 10.1074/jbc.M409770200; Sica A, 2012, J CLIN INVEST, V122, P787, DOI 10.1172/JCI59643; Smale ST, 2011, NAT IMMUNOL, V12, P689, DOI 10.1038/ni.2070; Smale ST, 2010, CELL, V140, P833, DOI 10.1016/j.cell.2010.01.037; Tartey S, 2014, EMBO J, V33, P2332, DOI 10.15252/embj.201488447; Tone M, 2000, J IMMUNOL, V165, P286, DOI 10.4049/jimmunol.165.1.286; Totzke G, 2006, J BIOL CHEM, V281, P12645, DOI 10.1074/jbc.M511956200; Trinh DV, 2008, J MOL BIOL, V379, P122, DOI 10.1016/j.jmb.2008.03.060; Villagra A, 2009, NAT IMMUNOL, V10, P92, DOI 10.1038/ni.1673; Wessells J, 2004, J BIOL CHEM, V279, P49995, DOI 10.1074/jbc.M404246200; Yamamoto M, 2004, NATURE, V430, P218, DOI 10.1038/nature02738; Zhang Q, 2015, NATURE, V525, P389, DOI 10.1038/nature15252; Ziegler-Heitbrock L, 2003, J IMMUNOL, V171, P285, DOI 10.4049/jimmunol.171.1.285	50	25	29	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 10	2016	291	24					12851	12861		10.1074/jbc.M116.718825	http://dx.doi.org/10.1074/jbc.M116.718825			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DO9PV	27129283	Green Published, hybrid			2022-12-26	WOS:000378119900035
J	Tiwari, S; Siddiqi, S; Zhelyabovska, O; Siddiqi, SA				Tiwari, Samata; Siddiqi, Shaila; Zhelyabovska, Olga; Siddiqi, Shadab A.			Silencing of Small Valosin-containing Protein-interacting Protein (SVIP) Reduces Very Low Density Lipoprotein (VLDL) Secretion from Rat Hepatocytes by Disrupting Its Endoplasmic Reticulum (ER)-to-Golgi Trafficking	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACID-BINDING PROTEIN; APOLIPOPROTEIN B100; TRANSPORT VESICLE; MULTIPROTEIN COMPLEX; HEPATIC STEATOSIS; COPII; ER; EXPORT; IDENTIFICATION; BIOGENESIS	The transport of nascent very low density lipoprotein (VLDL) particles from the endoplasmic reticulum (ER) to the Golgi determines their secretion by the liver and is mediated by a specialized ER-derived vesicle, the VLDL transport vesicle (VTV). Our previous studies have shown that the formation of ER-derived VTV requires proteins in addition to coat complex II proteins. The VTV proteome revealed that a 9-kDa protein, small valosin-containing protein-interacting protein (SVIP), is uniquely present in these specialized vesicles. Our biochemical and morphological data indicate that the VTV contains SVIP. Using confocal microscopy and co-immunoprecipitation assays, we show that SVIP co-localizes with apolipoprotein B-100 (apoB100) and specifically interacts with VLDL apoB100 and coat complex II proteins. Treatment of ER membranes with myristic acid in the presence of cytosol increases SVIP recruitment to the ER in a concentration-dependent manner. Furthermore, we show that myristic acid treatment of hepatocytes increases both VTV budding and VLDL secretion. To determine the role of SVIP in VTV formation, we either blocked the SVIP protein using specific antibodies or silenced SVIP by siRNA in hepatocytes. Our results show that both blocking and silencing of SVIP lead to significant reduction in VTV formation. Additionally, we show that silencing of SVIP reduces VLDL secretion, suggesting a physiological role of SVIP in intracellular VLDL trafficking and secretion. We conclude that SVIP acts as a novel regulator of VTV formation by interacting with its cargo and coat proteins and has significant implications in VLDL secretion by hepatocytes.	[Tiwari, Samata; Siddiqi, Shaila; Zhelyabovska, Olga; Siddiqi, Shadab A.] Univ Cent Florida, Burnett Sch Biomed Sci, Coll Med, 6900 Lake Nona Blvd,Rm 349, Orlando, FL 32827 USA	State University System of Florida; University of Central Florida	Siddiqi, SA (corresponding author), Univ Cent Florida, Burnett Sch Biomed Sci, Coll Med, 6900 Lake Nona Blvd,Rm 349, Orlando, FL 32827 USA.	shadab.siddiqi@ucf.edu			NIDDK, National Institutes of Health [RO1 DK-81413]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK081413] Funding Source: NIH RePORTER	NIDDK, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by NIDDK, National Institutes of Health Grant RO1 DK-81413 (to S. A. S.). The authors have no conflict of interest to report. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Angers S, 2006, NAT CELL BIOL, V8, P348, DOI 10.1038/ncb1381; Ballar P, 2007, J BIOL CHEM, V282, P33908, DOI 10.1074/jbc.M704446200; BARLOWE C, 1994, CELL, V77, P895, DOI 10.1016/0092-8674(94)90138-4; Barlowe C, 1998, BBA-MOL CELL RES, V1404, P67, DOI 10.1016/S0167-4889(98)00047-0; Butkinaree C, 2014, ARTERIOSCL THROM VAS, V34, P251, DOI 10.1161/ATVBAHA.113.302728; Choi SH, 2011, TRENDS ENDOCRIN MET, V22, P353, DOI 10.1016/j.tem.2011.04.007; D'Arcangelo JG, 2013, BBA-MOL CELL RES, V1833, P2464, DOI 10.1016/j.bbamcr.2013.02.003; Gillon AD, 2012, BBA-MOL CELL BIOL L, V1821, P1040, DOI 10.1016/j.bbalip.2012.01.005; Gusarova V, 2003, J BIOL CHEM, V278, P48051, DOI 10.1074/jbc.M306898200; Gusarova V, 2007, J BIOL CHEM, V282, P19453, DOI 10.1074/jbc.M700475200; Hossain T, 2014, BIOCHEM J, V459, P47, DOI 10.1042/BJ20131215; Jin LY, 2012, NATURE, V482, P495, DOI 10.1038/nature10822; Kummrow E, 2002, J LIPID RES, V43, P2155, DOI 10.1194/jlr.M200249-JLR200; Liang JS, 2003, J BIOL CHEM, V278, P23984, DOI 10.1074/jbc.M302683200; Mansbach CM, 2010, ANNU REV PHYSIOL, V72, P315, DOI 10.1146/annurev-physiol-021909-135801; Miller EA, 2013, CURR OPIN CELL BIOL, V25, P420, DOI 10.1016/j.ceb.2013.04.005; Miller EA, 2010, CURR OPIN CELL BIOL, V22, P447, DOI 10.1016/j.ceb.2010.04.003; Mirandola S, 2010, NUTR METAB, V7, DOI 10.1186/1743-7075-7-13; Nagahama M, 2003, MOL BIOL CELL, V14, P262, DOI 10.1091/mbc.02-07-0115; Neeli I, 2007, J BIOL CHEM, V282, P17974, DOI 10.1074/jbc.M610765200; Olofsson SO, 2005, J INTERN MED, V258, P395, DOI 10.1111/j.1365-2796.2005.01556.x; Pahuja KB, 2015, P NATL ACAD SCI USA, V112, pE3199, DOI 10.1073/pnas.1509119112; Perlemuter G, 2002, FASEB J, V16, P185, DOI 10.1096/fj.01-0396com; Powers J, 2002, MOL BIOL CELL, V13, P880, DOI 10.1091/mbc.01-10-0499; Rahim A, 2012, J PROTEOMICS, V75, P2225, DOI 10.1016/j.jprot.2012.01.026; Shrivastav A, 2003, CANCER RES, V63, P7975; Siddiqi SA, 2003, J CELL SCI, V116, P415, DOI 10.1242/jcs.00215; Siddiqi SA, 2008, BIOCHEM J, V413, P333, DOI 10.1042/BJ20071469; Siddiqi SA, 2006, J BIOL CHEM, V281, P20974, DOI 10.1074/jbc.M601401200; Siddiqi Shadab A, 2015, Curr Protoc Cell Biol, V67, DOI 10.1002/0471143030.cb1121s67; Siddiqi S, 2012, J BIOL CHEM, V287, P10178, DOI 10.1074/jbc.M111.327247; Siddiqi S, 2010, J LIPID RES, V51, P1918, DOI 10.1194/jlr.M005611; Siddiqi S, 2010, BIOCHEM J, V429, P391, DOI 10.1042/BJ20100336; Sparks JD, 2012, ARTERIOSCL THROM VAS, V32, P2104, DOI 10.1161/ATVBAHA.111.241463; Sundaram M, 2010, NUTR METAB, V7, DOI 10.1186/1743-7075-7-35; Syed GH, 2010, TRENDS ENDOCRIN MET, V21, P33, DOI 10.1016/j.tem.2009.07.005; Tiwari S, 2013, J BIOL CHEM, V288, P5157, DOI 10.1074/jbc.M112.434258; Tiwari S, 2012, ARTERIOSCL THROM VAS, V32, P1079, DOI 10.1161/ATVBAHA.111.241471; Tran K, 2002, J BIOL CHEM, V277, P31187, DOI 10.1074/jbc.M200249200; Ye J, 2009, CELL METAB, V9, P177, DOI 10.1016/j.cmet.2008.12.013	40	9	9	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 10	2016	291	24					12514	12526		10.1074/jbc.M115.705269	http://dx.doi.org/10.1074/jbc.M115.705269			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DO9PV	27129256	hybrid, Green Published			2022-12-26	WOS:000378119900006
J	Castanera, P; Farinos, GP; Ortego, F; Andow, DA				Castanera, Pedro; Farinos, Gema P.; Ortego, Felix; Andow, David A.			Sixteen Years of Bt Maize in the EU Hotspot: Why Has Resistance Not Evolved?	PLOS ONE			English	Article							SESAMIA-NONAGRIOIDES LEPIDOPTERA; MEDITERRANEAN CORN-BORER; BACILLUS-THURINGIENSIS; SPODOPTERA-FRUGIPERDA; OSTRINIA-NUBILALIS; INSECT RESISTANCE; FIELD-RESISTANCE; CRY1AB TOXIN; POPULATIONS; NOCTUIDAE	The majority of Bt maize production in the European Union (EU) is concentrated in northeast Spain, which is Europe's only hotspot where resistance might evolve, and the main target pest, Sesamia nonagrioides, has been exposed to Cry1Ab maize continuously since 1998. The cropping system in northeast Spain has some similar characteristics to those that probably led to rapid resistance failures in two other target noctuid maize pests. These include repeated cultivation of Bt maize in the same fields, low use of refuges, recurring exposure of larvae to non-high dose concentrations of Cry1Ab toxin during the first years of cultivation, low migratory potential, and production concentrated in an irrigated region with few alternative hosts. Available data reveal no evidence of resistance in S. nonagrioides after 16 years of use. We explore the possible reasons for this resistance management success using evolutionary models to consider factors expected to accelerate resistance, and those expected to delay resistance. Low initial adoption rates and the EU policy decision to replace Event 176 with MON 810 Bt maize were key to delaying resistance evolution. Model results suggest that if refuge compliance continues at the present 90%, Bt maize might be used sustainably in northeast Spain for at least 20 more years before resistance might occur. However, obtaining good estimates of the present R allele frequency and level of local assortative mating are crucial to reduce uncertainty about the future success of resistance management.	[Castanera, Pedro; Farinos, Gema P.; Ortego, Felix] CSIC, Dept Environm Biol, Ctr Invest Biol, Ramiro de Maeztu 9, E-28040 Madrid, Spain; [Andow, David A.] Univ Minnesota, Dept Entomol, 219 Hodson Hall,1980 Folwell Ave, St Paul, MN 55108 USA	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Investigaciones Biologicas (CIB); University of Minnesota System; University of Minnesota Twin Cities	Andow, DA (corresponding author), Univ Minnesota, Dept Entomol, 219 Hodson Hall,1980 Folwell Ave, St Paul, MN 55108 USA.	dandow@umn.edu	Ortego, Félix/F-9402-2011; FARINÓS, GEMA P./D-9849-2015	Ortego, Félix/0000-0002-7778-8508; FARINÓS, GEMA P./0000-0002-4952-5372	Ministerio de Agricultura, Alimentacion y Medio Ambiente; Ministerio de Economia y Competitividad [AGL2012-34289]; USDA Regional Research Fund [NC-205]	Ministerio de Agricultura, Alimentacion y Medio Ambiente(Spanish Government); Ministerio de Economia y Competitividad(Spanish Government); USDA Regional Research Fund	This work was supported by grants from the "Ministerio de Agricultura, Alimentacion y Medio Ambiente" (http://www.magrama.gob.es/es/), from the "Ministerio de Economia y Competitividad" (AGL2012-34289) (http://www.mineco.gob.es/), and from the USDA Regional Research Fund (NC-205) (http://nifa.usda.gov/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albajes Ramon, 2004, IOBC-WPRS Bulletin, V27, P15; ALSTAD DN, 1995, SCIENCE, V268, P1894, DOI 10.1126/science.268.5219.1894; Alyokhin A, 2011, NAT BIOTECHNOL, V29, P577, DOI 10.1038/nbt.1911; Andow DA, 1998, J ECON ENTOMOL, V91, P572, DOI 10.1093/jee/91.3.572; Andow DA, 2002, ECOL APPL, V12, P1378, DOI 10.2307/3099978; Andreadis SS, 2007, J ECON ENTOMOL, V100, P195, DOI 10.1603/0022-0493(2007)100[195:FORTBT]2.0.CO;2; Arpaia S, 2015, EFSA J, V13, DOI 10.2903/j.efsa.2015.4039; Carriere Y, 2015, NAT BIOTECHNOL, V33, P161, DOI 10.1038/nbt.3099; COMINS HN, 1977, J THEOR BIOL, V64, P177, DOI 10.1016/0022-5193(77)90119-9; Crespo ALB, 2011, J INVERTEBR PATHOL, V107, P185, DOI 10.1016/j.jip.2011.04.007; CURTIS CF, 1985, B ENTOMOL RES, V75, P259, DOI 10.1017/S0007485300014346; De La Poza M, 2008, ENVIRON ENTOMOL, V37, P1354, DOI 10.1603/0046-225X(2008)37[1354:GSOSNL]2.0.CO;2; Dutton A, 2002, ECOL ENTOMOL, V27, P441, DOI 10.1046/j.1365-2311.2002.00436.x; EFSA, 2012, EFSA J, V10, P2610; EIZAGUIRRE M, 1992, ENTOMOL GEN, V17, P277; Eizaguirre M, 2006, TRANSGENIC RES, V15, P1, DOI 10.1007/s11248-005-3998-1; Eizaguirre M, 2005, J ECON ENTOMOL, V98, P464, DOI 10.1603/0022-0493-98.2.464; Eizaguirre M, 2004, ENTOMOL EXP APPL, V113, P25, DOI 10.1111/j.0013-8703.2004.00201.x; Eizaguirre M, 2005, J ECON ENTOMOL, V98, P237; Fantinou AA, 2004, PHYSIOL ENTOMOL, V29, P169, DOI 10.1111/j.1365-3032.2004.00381.x; Farias JR, 2016, PEST MANAG SCI, V72, P974, DOI 10.1002/ps.4077; Farias JR, 2014, CROP PROT, V64, P150, DOI 10.1016/j.cropro.2014.06.019; Farinos GP, 2012, J ECON ENTOMOL, V105, P214, DOI 10.1603/EC11213; Farinos GP, 2004, ENTOMOL EXP APPL, V110, P23, DOI 10.1111/j.0013-8703.2004.00116.x; Fearing PL, 1997, MOL BREEDING, V3, P169, DOI 10.1023/A:1009611613475; FITT GP, 1990, J ECON ENTOMOL, V83, P1827, DOI 10.1093/jee/83.5.1827; Forrester NW, 1993, B ENTOMOL RES S1 SEP, V1, P1; Garcia M, 2015, PEST MANAG SCI, V71, P1631, DOI 10.1002/ps.3971; Gaspers C, 2011, J APPL ENTOMOL, V135, P7, DOI 10.1111/j.1439-0418.2010.01541.x; Gassmann AJ, 2009, ANNU REV ENTOMOL, V54, P147, DOI 10.1146/annurev.ento.54.110807.090518; GILLYBOEUF N, 1994, OECOLOGIA, V99, P366, DOI 10.1007/BF00627750; Gomez-Barbero M, 2008, NAT BIOTECHNOL, V26, P384, DOI 10.1038/nbt0408-384; Gonzalez-Cabrera J, 2006, APPL ENVIRON MICROB, V72, P2594, DOI 10.1128/AEM.72.4.2594-2600.2006; Gonzalez-Cabrera J, 2013, INSECT BIOCHEM MOLEC, V43, P635, DOI 10.1016/j.ibmb.2013.04.001; Gonzalez-Nunez M, 2000, J ECON ENTOMOL, V93, P459, DOI 10.1603/0022-0493-93.2.459; GREGG PC, 1995, INSECT MIGRATION: TRACKING RESOURCES THROUGH SPACE AND TIME, P151; Hua G, 2001, APPL ENVIRON MICROB, V67, P872, DOI 10.1128/AEM.67.2.872-879.2001; Hurley TM, 2001, J AGR RESOUR ECON, V26, P176; Ives AR, 2011, ECOL APPL, V21, P503, DOI 10.1890/09-1869.1; Ives AR, 2002, ECOL LETT, V5, P792, DOI 10.1046/j.1461-0248.2002.00392.x; Jakka SRK, 2016, APPL ENVIRON MICROB, V82, P1023, DOI 10.1128/AEM.02871-15; Larue P, 1984, DEFENSE VEGETAUX, V227, P163; Lopez C., 2003, Spanish Journal of Agricultural Research, V1, P43; Lopez C., 1999, Investigacion Agraria Produccion y Proteccion Vegetales, V14, P415; Obrist LB, 2006, ECOL ENTOMOL, V31, P143, DOI 10.1111/j.0307-6946.2006.00762.x; Omoto C, 2016, PEST MANAG SCI, V72, P1727, DOI 10.1002/ps.4201; Robertson JL, 2007, PESTICIDE BIOASSAYS; Roush RT, 1998, PHILOS T R SOC B, V353, P1777, DOI 10.1098/rstb.1998.0330; Storer NP, 2010, J ECON ENTOMOL, V103, P1031, DOI 10.1603/EC10040; Szekacs A, 2010, ENVIRON TOXICOL CHEM, V29, P182, DOI 10.1002/etc.5; TABASHNIK BE, 1982, ENVIRON ENTOMOL, V11, P1137, DOI 10.1093/ee/11.6.1137; Tabashnik BE, 2013, NAT BIOTECHNOL, V31, P510, DOI 10.1038/nbt.2597; Tellez-Rodriguez P, 2014, BMC BIOL, V12, DOI 10.1186/1741-7007-12-48; Van den Berg J, 2013, CROP PROT, V54, P154, DOI 10.1016/j.cropro.2013.08.010; van Rensburg J. B. J., 2007, South African Journal of Plant and Soil, V24, P147; Van Rensburg J.B.J., 1985, S AFR J PLANT SOIL, V2, P123, DOI DOI 10.1080/02571862.1985.10634151; Zoerb AC, 2003, CROP PROT, V22, P179, DOI 10.1016/S0261-2194(02)00143-6	57	22	25	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 4	2016	11	5							e0154200	10.1371/journal.pone.0154200	http://dx.doi.org/10.1371/journal.pone.0154200			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DL5KR	27144535	gold, Green Published, Green Submitted			2022-12-26	WOS:000375676400038
J	Collins, J; Zhang, T; Huston, S; Sun, FF; Zhang, YHP; Fu, JL				Collins, John; Zhang, Ting; Huston, Scott; Sun, Fangfang; Zhang, Y. -H. Percival; Fu, Jinglin			A Hidden Transhydrogen Activity of a FMN-Bound Diaphorase under Anaerobic Conditions	PLOS ONE			English	Article							PROTON-TRANSLOCATING TRANSHYDROGENASE; ESCHERICHIA-COLI; NUCLEOTIDE TRANSHYDROGENASE; ENZYMATIC PATHWAY; NADH OXIDASE; PURIFICATION; MECHANISM	Background Redox cofactors of NADH/NADPH participate in many cellular metabolic pathways for facilitating the electron transfer from one molecule to another in redox reactions. Transhydrogenase plays an important role in linking catabolism and anabolism, regulating the ratio of NADH/NADPH in cells. The cytoplasmic transhydrogenases could be useful to engineer synthetic biochemical pathways for the production of high-value chemicals and biofuels. Methodology/Principal Findings A transhydrogenase activity was discovered for a FMN-bound diaphorase (DI) from Geobacillus stearothermophilus under anaerobic conditions. The DI-catalyzed hydride exchange were monitored and characterized between a NAD(P)H and a thio-modified NAD(+) analogue. This new function of DI was demonstrated to transfer a hydride from NADPH to NAD(+) that was consumed by NAD-specific lactate dehydrogenase and malic dehydrogenase. Conclusions/Significance We discover a novel transhydrogenase activity of a FMN-DI by stabilizing the reduced state of FMNH2 under anaerobic conditions. FMN-DI was demonstrated to catalyze the hydride transfer between NADPH and NAD(+). In the future, it may be possible to incorporate this FMN-DI into synthetic enzymatic pathways for balancing NADH generation and NADPH consumption for anaerobic production of biofuels and biochemicals.	[Collins, John; Zhang, Ting; Huston, Scott; Fu, Jinglin] Rutgers State Univ, Dept Chem, Camden, NJ 08102 USA; [Fu, Jinglin] Rutgers State Univ, Ctr Computat & Integrat Biol, Camden, NJ 08102 USA; [Sun, Fangfang; Zhang, Y. -H. Percival] Cell Free Bioinnovat Inc, Blacksburg, VA 24060 USA; [Zhang, Y. -H. Percival] Virginia Tech, Dept Biol Syst Engn, Blacksburg, VA 24061 USA	Rutgers State University Camden; Rutgers State University New Brunswick; Rutgers State University Camden; Rutgers State University New Brunswick; Virginia Polytechnic Institute & State University	Fu, JL (corresponding author), Rutgers State Univ, Dept Chem, Camden, NJ 08102 USA.; Fu, JL (corresponding author), Rutgers State Univ, Ctr Computat & Integrat Biol, Camden, NJ 08102 USA.	jinglin.fu@rutgers.edu			Army Research Office [W911NF-14-1-0434]; MURI [W911NF-12-1-0420]; Cottrell College; Rutgers University-Camden; AEOP URAP program	Army Research Office; MURI(MURI); Cottrell College; Rutgers University-Camden; AEOP URAP program	This work is supported by an Army Research Office YIP award (W911NF-14-1-0434), a MURI subaward (parent award: W911NF-12-1-0420), the Cottrell College Science Award to J.F. and the start-up fund to J.F. from Rutgers University-Camden. J.C. is sponsored by the summer undergraduate research of the Cottrell College Science Award. S.H. is supported by the AEOP URAP program.	ANDERSON WM, 1981, J BIOL CHEM, V256, P1888; Bennett BD, 2009, NAT CHEM BIOL, V5, P593, DOI 10.1038/nchembio.186; BUTLER IB, 1994, TALANTA, V41, P211, DOI 10.1016/0039-9140(94)80110-X; Cao ZY, 2011, FEMS MICROBIOL LETT, V320, P9, DOI 10.1111/j.1574-6968.2011.02287.x; CARLBERG I, 1977, BIOCHIM BIOPHYS ACTA, V484, P268, DOI 10.1016/0005-2744(77)90083-3; CATOMERIS P, 1988, MICROCHEM J, V38, P390, DOI 10.1016/0026-265X(88)90051-3; Egorov MV, 2004, PROTEIN EXPRES PURIF, V36, P31, DOI 10.1016/j.pep.2004.03.002; FLORINI JR, 1989, ANAL BIOCHEM, V182, P399, DOI 10.1016/0003-2697(89)90614-3; HECHT HJ, 1995, NAT STRUCT BIOL, V2, P1109, DOI 10.1038/nsb1295-1109; Jackson JB, 2012, BBA-BIOENERGETICS, V1817, P1839, DOI 10.1016/j.bbabio.2012.04.006; Kruger NJ, 2003, CURR OPIN PLANT BIOL, V6, P236, DOI 10.1016/S1369-5266(03)00039-6; Lauterbach L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025939; Matsumoto K, 2010, APPL MICROBIOL BIOT, V86, P1431, DOI 10.1007/s00253-009-2351-7; Mukherjee A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064753; Pedersen A, 2008, J BIOENERG BIOMEMBR, V40, P463, DOI 10.1007/s10863-008-9170-x; Pessach I, 2002, ADV EXPT MED BIOL, P107; Poinas A, 2002, EUR J BIOCHEM, V269, P1243, DOI 10.1046/j.1432-1033.2002.02764.x; Reed DW, 2001, J BACTERIOL, V183, P7007, DOI 10.1128/JB.183.24.7007-7016.2001; Rice Lesley, 1998, Biochemical Society Transactions, V26, pS319; Sauer U, 2004, J BIOL CHEM, V279, P6613, DOI 10.1074/jbc.M311657200; Sazanov LA, 2015, NAT REV MOL CELL BIO, V16, P375, DOI 10.1038/nrm3997; Wang YR, 2011, CHEM BIOL, V18, P372, DOI 10.1016/j.chembiol.2010.12.019; You C, 2012, APPL ENVIRON MICROB, V78, P1593, DOI 10.1128/AEM.07105-11; Zhao C, 2010, ANAL CHEM, V82, P3856, DOI 10.1021/ac100378g; Zhao HJ, 2008, ANN MICROBIOL, V58, P275, DOI 10.1007/BF03175329; Zhu ZG, 2015, ENERGY SCI ENG, V3, P490, DOI 10.1002/ese3.91; Zhu ZG, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4026; Zhu ZG, 2012, BIOSENS BIOELECTRON, V36, P110, DOI 10.1016/j.bios.2012.04.001; Zhu ZG, 2011, J POWER SOURCES, V196, P7505, DOI 10.1016/j.jpowsour.2011.04.038	29	5	5	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 4	2016	11	5							e0154865	10.1371/journal.pone.0154865	http://dx.doi.org/10.1371/journal.pone.0154865			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DL5KR	27145082	Green Submitted, Green Published, gold			2022-12-26	WOS:000375676400087
J	Felfe, C; Lechner, M; Steinmayr, A				Felfe, Christina; Lechner, Michael; Steinmayr, Andreas			Sports and Child Development	PLOS ONE			English	Article							LABOR-MARKET OUTCOMES; DIFFICULTIES QUESTIONNAIRE; PHYSICAL-ACTIVITY; HEALTH; SENSITIVITY; STRENGTHS; PARTICIPATION; EDUCATION; VALIDITY; LEARN	The role of curricular activities for the formation of education, health and behavioural outcomes has been widely studied. Yet, the role of extra-curricular activities has received little attention. This study analyzes the effect of participation in sports clubs-one of the most popular extra-curricular activities among children. We use alternative datasets and flexible semi-parametric estimation methods with a specific way to use the panel dimension of the data to address selection into sports. We find positive and robust effects on children's school performance and peer relations. Crowding out of passive leisure activities can partially explain the effects.	[Felfe, Christina; Lechner, Michael] Univ St Gallen, Swiss Inst Empir Econ Res, St Gallen, Switzerland; [Felfe, Christina; Lechner, Michael] Ctr Econ Studies, Munich, Germany; [Felfe, Christina; Lechner, Michael] Ifo Inst, Munich, Germany; [Lechner, Michael] Ctr Econ Policy Res, London SW1Y 6LA, England; [Lechner, Michael] Policy Studies Inst, London NW1 3SR, England; [Lechner, Michael; Steinmayr, Andreas] Inst Study Labor, Bonn, Germany; [Lechner, Michael] Inst Employment Res, Nurnberg, Germany; [Steinmayr, Andreas] Univ Munich LMU, Dept Econ, Munich, Germany	University of St Gallen; Ifo Institut; Ifo Institut; Centre for Economic Policy Research - UK; IZA Institute Labor Economics; University of Munich	Steinmayr, A (corresponding author), Inst Study Labor, Bonn, Germany.; Steinmayr, A (corresponding author), Univ Munich LMU, Dept Econ, Munich, Germany.	andreas.steinmayr@econ.lmu.de	Steinmayr, Andreas/AAF-4741-2019	Steinmayr, Andreas/0000-0002-2491-5032; Felfe, Christina/0000-0002-4095-8112	St. Gallen Research Center in Aging, Welfare, and Labour Market Analysis (SCALA)	St. Gallen Research Center in Aging, Welfare, and Labour Market Analysis (SCALA)	Funding provided by St. Gallen Research Center in Aging, Welfare, and Labour Market Analysis (SCALA). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ahoney J L., 2000, CHILDHOOD SOCIAL DEV, P167; Almond D, 2011, HBK ECON, V4, P1315, DOI 10.1016/S0169-7218(11)02413-0; Altonji JG, 2005, J POLIT ECON, V113, P151, DOI 10.1086/426036; Barron JM, 2000, REV ECON STAT, V82, P409, DOI 10.1162/003465300558902; Black SE, 2005, AM ECON REV, V95, P437, DOI 10.1257/0002828053828635; Blau DM, 1999, REV ECON STAT, V81, P261, DOI 10.1162/003465399558067; BRONFENBRENNER U, 1986, DEV PSYCHOL, V22, P723, DOI 10.1037/0012-1649.22.6.723; Case A, 2005, J HEALTH ECON, V24, P365, DOI 10.1016/j.jhealeco.2004.09.008; Case A, 2002, AM ECON REV, V92, P1308, DOI 10.1257/000282802762024520; Cawley J., 2013, J HLTH EC, P18341; Cawley J., 2000, MERITOCRACY EC INEQU, P230; Cunha F., 2006, INTERPRETING EVIDENC, V1, P697, DOI [10.1016/S1574-0692(06)01012-9, DOI 10.1016/S1574-0692(06)01012-9]; Currie J, 1999, HDB LABOUR EC; Currie J, 2009, J ECON LIT, V47, P87, DOI 10.1257/jel.47.1.87; Dills AK, 2011, ECON EDUC REV, V30, P889, DOI 10.1016/j.econedurev.2011.04.011; Eccles JS, 2003, J SOC ISSUES, V59, P865, DOI 10.1046/j.0022-4537.2003.00095.x; Eide ER, 2001, ECON EDUC REV, V20, P431, DOI 10.1016/S0272-7757(00)00033-9; Felfe C., 2014, 8400 IZA DP; Felfe C., 2011, CESIFO WORKING PAPER, V3629; Gallagher D, 1996, AM J EPIDEMIOL, V143, P228, DOI 10.1093/oxfordjournals.aje.a008733; Gluckmann P., 2005, FETAL MATRIX EVOLUTI; Goodman R, 1998, EUR CHILD ADOLES PSY, V7, P125, DOI 10.1007/s007870050057; Goodman R, 1997, J CHILD PSYCHOL PSYC, V38, P581, DOI 10.1111/j.1469-7610.1997.tb01545.x; Grossman M, 2000, HDB HLTH EC; Hansen DM, 2003, J RES ADOLESCENCE, V13, P25, DOI 10.1111/1532-7795.1301006; Heckman JJ, 2007, P NATL ACAD SCI USA, V104, P13250, DOI 10.1073/pnas.0701362104; Heckman JJ, 2006, J LABOR ECON, V24, P411, DOI 10.1086/504455; Huber M., 2014, EMPIR ECON, V49, P1; Huber M, 2013, J ECONOMETRICS, V175, P1, DOI 10.1016/j.jeconom.2012.11.006; Ichino A, 2008, J APPL ECONOMET, V23, P305, DOI 10.1002/jae.998; Imbens GW, 2003, AM ECON REV, V93, P126, DOI 10.1257/000282803321946921; Kling JR, 2007, ECONOMETRICA, V75, P83, DOI 10.1111/j.1468-0262.2007.00733.x; Kurth BM, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-196; Kutteroff A., 2006, KIM STUDIE 2006 KIND; Larson RW, 2000, AM PSYCHOL, V55, P170, DOI 10.1037/0003-066X.55.1.170; Lechner M, 2013, LABOUR ECON, V21, P111, DOI 10.1016/j.labeco.2013.01.004; Lechner M, 2011, J EUR ECON ASSOC, V9, P742, DOI 10.1111/j.1542-4774.2011.01029.x; Lechner M, 2009, J HEALTH ECON, V28, P839, DOI 10.1016/j.jhealeco.2009.05.003; LEIBOWITZ A, 1974, J POLIT ECON, V82, pS111, DOI 10.1086/260295; Mahoney J.L., 2005, ORG ACTIVITIES CONTE, DOI [DOI 10.4324/9781410612748, 10.4324/9781410612748]; Meyer U, 2011, BONE, V48, P792, DOI 10.1016/j.bone.2010.11.018; Morrow JR, 2013, AM J PREV MED, V44, P439, DOI 10.1016/j.amepre.2013.01.008; Muris P, 2003, EUR CHILD ADOLES PSY, V12, P1, DOI 10.1007/s00787-003-0298-2; MURNANE RJ, 1995, REV ECON STAT, V77, P251, DOI 10.2307/2109863; Nannicini T., 2007, STATA J, V7, P334, DOI DOI 10.1177/1536867X0700700303; Persico N, 2004, J POLIT ECON, V112, P1019, DOI 10.1086/422566; Pfeifer C, 2010, ECON EDUC REV, V29, P94, DOI 10.1016/j.econedurev.2009.04.002; Rees DI, 2010, ECON EDUC REV, V29, P751, DOI 10.1016/j.econedurev.2010.04.008; ROSENBAUM PR, 1983, BIOMETRIKA, V70, P41, DOI 10.1093/biomet/70.1.41; ROSENBAUM PR, 1983, J ROY STAT SOC B MET, V45, P212; ROSENBAUM PR, 1987, BIOMETRIKA, V74, P13, DOI 10.2307/2336017; Smith JP, 1999, J ECON PERSPECT, V13, P145, DOI 10.1257/jep.13.2.145; Stattin H., 2009, HDB PEER RELATIONSHI, V23, P414; Steinmayr A, 2011, EUR REV AGING PHYS A, V8, P67, DOI 10.1007/s11556-011-0090-0; Stevenson B, 2010, REV ECON STAT, V92, P284, DOI 10.1162/rest.2010.11623; Strong WB, 2005, J PEDIATR-US, V146, P732, DOI 10.1016/j.jpeds.2005.01.055; Tietjens M., 2001, SPORTLICHES ENGAGEME; Williams W., 2002, HDB PARENTING, P169	58	52	53	1	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 4	2016	11	5							e0151729	10.1371/journal.pone.0151729	http://dx.doi.org/10.1371/journal.pone.0151729			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DL5KR	27144474	gold, Green Published, Green Submitted, Green Accepted			2022-12-26	WOS:000375676400004
J	Kaseke, KF; Wang, LX; Wanke, H; Turewicz, V; Koeniger, P				Kaseke, Kudzai Farai; Wang, Lixin; Wanke, Heike; Turewicz, Veronika; Koeniger, Paul			An Analysis of Precipitation Isotope Distributions across Namibia Using Historical Data	PLOS ONE			English	Article							SPATIAL-DISTRIBUTION; STABLE-ISOTOPES; CLIMATE-CHANGE; SOUTHERN AFRICA; AMAZON BASIN; WATER; DELTA-O-18; DEUTERIUM; VARIABILITY; GROUNDWATER	Global precipitation isoscapes based on the Global Network for Isotopes in Precipitation (GNIP) network are an important toolset that aid our understanding of global hydrologic cycles. Although the GNIP database is instrumental in developing global isoscapes, data coverage in some regions of hydrological interest (e.g., drylands) is low or non-existent thus the accuracy and relevance of global isoscapes to these regions is debatable. Capitalizing on existing literature isotope data, we generated rainfall isoscapes for Namibia (dryland) using the cokriging method and compared it to a globally fitted isoscape (GFI) downscaled to country level. Results showed weak correlation between observed and predicted isotope values in the GFI model (r(2) < 0.20) while the cokriging isoscape showed stronger correlation (r(2) = 0.67). The general trend of the local cokriging isoscape is consistent with synoptic weather systems (i.e., influences from Atlantic Ocean maritime vapour, Indian Ocean maritime vapour, Zaire Air Boundary, the Intertropical Convergence Zone and Tropical Temperate Troughs) and topography affecting the region. However, because we used the unweighted approach in this method, due to data scarcity, the absolute values could be improved in future studies. A comparison of local meteoric water lines (LMWL) constructed from the cokriging and GFI suggested that the GFI model still reflects the global average even when downscaled. The cokriging LMWL was however more consistent with expectations for an arid environment. The results indicate that although not ideal, for data deficient regions such as many drylands, the unweighted cokriging approach using historical local data can be an alternative approach to modelling rainfall isoscapes that are more relevant to the local conditions compared to using downscaled global isoscapes.	[Kaseke, Kudzai Farai; Wang, Lixin] Indiana Univ Purdue Univ, Dept Earth Sci, Indianapolis, IN 46202 USA; [Wanke, Heike] Univ Namibia, Dept Geol, Private Bag 13301, Windhoek, Namibia; [Turewicz, Veronika] Univ Vienna, Dept Environm Geosci, Vienna, Austria; [Koeniger, Paul] Fed Inst Geosci & Nat Resources BGR, Stilleweg 2, D-30655 Hannover, Germany	Indiana University System; Indiana University-Purdue University Indianapolis; University of Namibia; University of Vienna	Wang, LX (corresponding author), Indiana Univ Purdue Univ, Dept Earth Sci, Indianapolis, IN 46202 USA.	lxwang@iupui.edu	Kaseke, Kudzai Farai/AAH-3182-2019; Wang, Lixin/A-2572-2008	Kaseke, Kudzai Farai/0000-0002-3856-0711; Wang, Lixin/0000-0003-0968-1247; Koeniger, Paul/0000-0002-1197-6274; Wanke, Heike/0000-0002-7748-6921; Turewicz, Veronika/0000-0002-8936-7719	National Science Foundation CAREER [EAR-155489]; National Science Foundation [IIA-1427642]; Office Of The Director [1427642] Funding Source: National Science Foundation	National Science Foundation CAREER(National Science Foundation (NSF)); National Science Foundation(National Science Foundation (NSF)); Office Of The Director(National Science Foundation (NSF)NSF - Office of the Director (OD))	This work was supported by National Science Foundation CAREER award EAR-155489 (http://www.nsf.gov/pubs/2015/nsf15555/nsf15555.htm) and National Science Foundation IIA-1427642 (https://www.nsf.gov/funding/pgm_summ.jsp?pims_id=12815). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson S, 2010, NEW FRONT SOC POLICY, P199; Bowen GJ, 2010, ISOSCAPES: UNDERSTANDING MOVEMENT, PATTERN, AND PROCESS ON EARTH THROUGH ISOTOPE MAPPING, P139, DOI 10.1007/978-90-481-3354-3_7; Bowen GJ, 2008, TERR ECOL SER, V2, P79, DOI 10.1016/S1936-7961(07)00004-8; Bowen GJ, 2003, WATER RESOUR RES, V39, DOI 10.1029/2003WR002086; Bowen GJ, 2002, GEOLOGY, V30, P315, DOI 10.1130/0091-7613(2002)030<0315:SDOOIM>2.0.CO;2; Clark I., 1997, ENV ISOTOPES HYDROGE; CRAIG H, 1961, SCIENCE, V133, P1702, DOI 10.1126/science.133.3465.1702; DANSGAARD W, 1964, TELLUS, V16, P436; DOdorico P., 2006, DRYLAND ECOHYDROLOGY; Dutton A, 2005, HYDROL PROCESS, V19, P4121, DOI 10.1002/hyp.5876; Dyer T. G. J., 1978, South African Geographical Journal, V60, P144; Eckardt FD, 2013, J ARID ENVIRON, V93, P7, DOI 10.1016/j.jaridenv.2012.01.011; EHHALT D, 1963, J GEOPHYS RES, V68, P3775, DOI 10.1029/JZ068i013p03775; FRIEDMAN I, 1964, REV GEOPHYS, V2, P177, DOI 10.1029/RG002i001p00177; Gat J.R, 2001, PRINCIPLES APPL ATMO; Gat JR, 2003, TELLUS B, V55, P953, DOI 10.1034/j.1600-0889.2003.00081.x; Gat JR, 1996, ANNU REV EARTH PL SC, V24, P225, DOI 10.1146/annurev.earth.24.1.225; GAT JR, 1991, J GEOPHYS RES-ATMOS, V96, P13179, DOI 10.1029/91JD00054; Gilbert N, 2011, NATURE, V477, P262, DOI 10.1038/477262a; Goudie A, 2010, GEOMORPHOLOGICAL LANDSCAPES OF THE WORLD, P163, DOI 10.1007/978-90-481-3055-9_17; Grace J, 2006, J BIOGEOGR, V33, P387, DOI 10.1111/j.1365-2699.2005.01448.x; Hachfeld B, 1999, 42 S INT ASS VEG SCI; Harris C, 2010, S AFR J GEOL, V113, P33, DOI 10.2113/gssajg.113.1.33; Harrison M, 1984, S AFR GEOGR J, V66, P47; Henschel JR, 2008, ATMOS RES, V87, P362, DOI 10.1016/j.atmosres.2007.11.015; IAEA, 2015, RCWIP REG CLUST BAS; INGRAHAM NL, 1991, WATER RESOUR RES, V27, P77, DOI 10.1029/90WR01708; Kazmierz Rozanski LA-A, 1993, ISOTOPIC PATTERNS MO; Kendall C., 2012, ISOTOPE TRACERS CATC; Lai CT, 2011, OECOLOGIA, V165, P213, DOI 10.1007/s00442-010-1721-2; Liebminger A, 2006, J GEOPHYS RES-ATMOS, V111, DOI 10.1029/2005JD006258; Lindesay J., 1998, CLIAMTES SO CONTINEN, P297; Liu J, 2010, J GEOPHYS RES D, V115; Liu ZF, 2008, CHEM GEOL, V249, P203, DOI 10.1016/j.chemgeo.2007.12.011; Louw G. N., 1982, ECOLOGY DESERT ORG; Lovegrove B, 1993, LIVING DESERTS SO AF; Lykoudis SP, 2007, J GEOPHYS RES-ATMOS, V112, DOI 10.1029/2007JD008472; Martinelli LA, 1996, J HYDROL, V183, P191, DOI 10.1016/0022-1694(95)02974-5; Mason SJ, 1997, PROG PHYS GEOG, V21, P23, DOI 10.1177/030913339702100103; MERLIVAT L, 1979, J GEOPHYS RES-OCEANS, V84, P5029, DOI 10.1029/JC084iC08p05029; Millennium Ecosystem Assessment, 2005, MILLENNIUM ECOSYSTEM; MIYAKE Y, 1968, PAP METEOROL GEOPHYS, V19, P243, DOI 10.2467/mripapers1950.19.2_243; Morton J., 2008, WORKSH SOC DIM CLIM WORKSH SOC DIM CLIM; OJIMA DS, 1993, WATER AIR SOIL POLL, V70, P95, DOI 10.1007/BF01104990; OLIVIER J, 1995, J ARID ENVIRON, V29, P129, DOI 10.1016/S0140-1963(05)80084-9; Pfahl S, 2014, CLIM PAST, V10, P771, DOI 10.5194/cp-10-771-2014; Pietruszka R, 1985, S AFRICAN J SCI; Pineiro G, 2008, ECOL MODEL, V216, P316, DOI 10.1016/j.ecolmodel.2008.05.006; Reason CJC, 2006, B AM METEOROL SOC, V87, P941, DOI 10.1175/BAMS-87-7-941; Risi C, 2008, J GEOPHYS RES ATMOSP, V113; SALATI E, 1979, WATER RESOUR RES, V15, P1250, DOI 10.1029/WR015i005p01250; Sanchez-Murillo R, 2013, OPEN J MODERN HYDROL, V2013; Slaymaker O., 1998, PHYS GEOGRAPHY GLOBA; Soderberg K, 2013, ECOSPHERE, V4, DOI 10.1890/ES12-00160.1; Southgate RI, 1996, J ARID ENVIRON, V33, P267, DOI 10.1006/jare.1996.0064; STEWART MK, 1975, J GEOPHYS RES, V80, P1133, DOI 10.1029/JC080i009p01133; Stumpp C, 2014, J HYDROL, V517, P351, DOI 10.1016/j.jhydrol.2014.05.034; Talma A, 2013, TT57013 WAT RES COMM; Terzer S, 2013, HYDROL EARTH SYST SC, V17, P4713, DOI 10.5194/hess-17-4713-2013; Thomas DSG., 1991, KALAHARI ENV; Thuiller W, 2006, GLOBAL CHANGE BIOL, V12, P759, DOI 10.1111/j.1365-2486.2006.01140.x; Todd MC, 2004, INT J CLIMATOL, V24, P555, DOI 10.1002/joc.1023; Turewicz V., 2013, STABLE ISOTOPES WATE; Tyson P.D., 2000, WEATHER CLIMATE SO A; Tyson PD., 1986, CLIMATIC CHANGE VARI; Uemura R, 2008, J GEOPHYS RES-ATMOS, V113, DOI 10.1029/2008JD010209; Unep N. M., 1992, WORLD ATLAS DESERTIF, P15; van Wyk E, 2011, WATER SA, V37, P147; von Willert DJ, 1992, CUP ARCH; Vorosmarty CJ, 2000, SCIENCE, V289, P284, DOI 10.1126/science.289.5477.284; Wang L, 2012, HYDROL EARTH SYST SC, V16, P2585, DOI 10.5194/hess-16-2585-2012; Wang LX, 2009, RAPID COMMUN MASS SP, V23, P530, DOI 10.1002/rcm.3905; Wassenaar LI, 2009, J GEOCHEM EXPLOR, V102, P123, DOI 10.1016/j.gexplo.2009.01.001; Welp LR, 2012, GLOBAL BIOGEOCHEM CY, V26, DOI 10.1029/2011GB004246; West AG, 2014, J GEOCHEM EXPLOR, V145, P213, DOI 10.1016/j.gexplo.2014.06.009; Williams F, 1984, FORECASTERS HDB SO A; Zhao L, 2014, HYDROL EARTH SYST SC, V18, P4129, DOI 10.5194/hess-18-4129-2014; Zhao LJ, 2012, HYDROL PROCESS, V26, P143, DOI 10.1002/hyp.8118	78	21	21	1	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 4	2016	11	5							e0154598	10.1371/journal.pone.0154598	http://dx.doi.org/10.1371/journal.pone.0154598			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DL5KR	27144269	Green Published, Green Submitted, gold			2022-12-26	WOS:000375676400056
J	Yin, XQ; Wang, L; Qin, G; Luo, H; Liu, X; Zhang, F; Ye, Z; Zhang, JJ; Wang, E				Yin, Xiaoqing; Wang, Lu; Qin, Gang; Luo, Hui; Liu, Xiao; Zhang, Fan; Ye, Zhi; Zhang, Junjie; Wang, E.			Rats with Chronic, Stable Pulmonary Hypertension Tolerate Low Dose Sevoflurane Inhalation as Well as Normal Rats Do	PLOS ONE			English	Article							RIGHT-VENTRICULAR HYPERTROPHY; PRESSURE-VOLUME LOOPS; ARTERIAL-HYPERTENSION; SARCOPLASMIC-RETICULUM; SYSTOLIC FUNCTION; ISOFLURANE; OVERLOAD; PHOSPHOLAMBAN; PERFORMANCE; DESFLURANE	Background The effects of low concentration of sevoflurane on right ventricular (RV) function and intracellular calcium in the setting of pulmonary arterial hypertension (PAH) have not been investigated clearly. We aim to study these effects and associated signaling pathways in rats with PAH. Methods Hemodynamics were assessed with or without sevoflurane inhalation in established PAH rats. We analysis the classic RV function parameters and RV-PA coupling efficiency using steady-state PV loop recordings. The protein levels of SERCA2, PLB and p-PLB expression was analyzed by western blot to assess their relevance in PAH. Results Rats with PAH presented with RV hypertrophy and increased pulmonary arterial pressure. The values of Ea, R/L ratio, ESP, SW, PRSW, +dP/dt(max) and the slope of the dP/dtmax-EDV relationship increased significantly in PAH rats (P<0.05). Sevoflurane induced a concentration-dependent decrease of systemic and pulmonary blood pressure, HR, RV contractility, and increased the R/L ratio in both groups. Sevoflurane reduced the expression of SERCA2 and increased the expression of PLB in both groups. Interestingly, sevoflurane only reduced the p-PLB/PLB ratio in PAH rats, not in normal rats. Conclusions Rats with chronic, stable pulmonary hypertension tolerate low concentrations of sevoflurane inhalation as well as normal rats do. It may be related to the modulation of the SERCA2-PLB signaling pathway.	[Yin, Xiaoqing; Wang, Lu; Qin, Gang; Luo, Hui; Liu, Xiao; Zhang, Fan; Ye, Zhi; Zhang, Junjie; Wang, E.] Cent S Univ, Xiangya Hosp, Dept Anesthesiol, Changsha, Hunan, Peoples R China	Central South University	Wang, E (corresponding author), Cent S Univ, Xiangya Hosp, Dept Anesthesiol, Changsha, Hunan, Peoples R China.	ewang324@sina.com	Ye, zhi/HGD-4616-2022		National Natural Science Foundation of China [81370251]; Hunan Provincial Science and Technology Foundation, China [2013FJ4101]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Hunan Provincial Science and Technology Foundation, China	The project is sponsored by The National Natural Science Foundation of China ( Grant No. 81370251) and The Hunan Provincial Science and Technology Foundation, China ( Grant No. 2013FJ4101). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anwar A, 2008, PFLUG ARCH EUR J PHY, V457, P485, DOI 10.1007/s00424-008-0520-7; Archer S, 2000, CIRCULATION, V102, P2781, DOI 10.1161/01.CIR.102.22.2781; Bers DM, 2002, FRONT BIOSCI, V7, pD1697, DOI 10.2741/bers; Blaudszun G, 2012, ANESTHESIOLOGY, V117, P1051, DOI 10.1097/ALN.0b013e31826cb20b; Boissiere J, 2005, AM J PHYSIOL-HEART C, V289, pH2450, DOI 10.1152/ajpheart.00524.2005; Brimioulle S, 2003, AM J PHYSIOL-HEART C, V284, pH1625, DOI 10.1152/ajpheart.01023.2002; Carabello BA, 2002, CIRCULATION, V105, P2701, DOI 10.1161/01.CIR.0000021240.86593.9D; del Monte F, 2002, CIRCULATION, V105, P904, DOI 10.1161/hc0802.105564; DICKSTEIN ML, 1995, CARDIOVASC RES, V29, P820, DOI 10.1016/0008-6363(96)88618-4; Faber MJ, 2006, AM J PHYSIOL-HEART C, V291, pH1580, DOI 10.1152/ajpheart.00286.2006; Friesen RH, 2008, PEDIATR ANESTH, V18, P208, DOI 10.1111/j.1460-9592.2008.02419.x; Ghoreishi M, 2011, J THORAC CARDIOV SUR, V142, P1439, DOI 10.1016/j.jtcvs.2011.08.030; Hadri L, 2013, CIRCULATION, V128, P512, DOI 10.1161/CIRCULATIONAHA.113.001585; Handoko ML, 2009, CIRCULATION, V120, P42, DOI 10.1161/CIRCULATIONAHA.108.829713; Hannon JD, 2004, ANESTHESIOLOGY, V101, P675, DOI 10.1097/00000542-200409000-00016; Hardziyenka M, 2006, J AM SOC ECHOCARDIOG, V19, P1272, DOI 10.1016/j.echo.2006.04.036; Humbert M, 2004, NEW ENGL J MED, V351, P1425, DOI 10.1056/NEJMra040291; JAMES P, 1989, NATURE, V342, P90, DOI 10.1038/342090a0; KASS DA, 1992, ANN BIOMED ENG, V20, P41, DOI 10.1007/BF02368505; Kato Y, 2003, EXP ANIM TOKYO, V52, P285, DOI 10.1538/expanim.52.285; Kaw R, 2011, RESP MED, V105, P619, DOI 10.1016/j.rmed.2010.12.006; KELLY RP, 1992, CIRCULATION, V86, P513, DOI 10.1161/01.CIR.86.2.513; Kerbaul F, 2004, ANESTHESIOLOGY, V101, P1357; Kerbaul F, 2006, J CARDIOTHOR VASC AN, V20, P209, DOI 10.1053/j.jvca.2005.05.017; Kogler H, 2003, CIRC RES, V93, P230, DOI 10.1161/01.RES.0000085042.89656.C7; Lai HC, 2007, BRIT J ANAESTH, V99, P184, DOI 10.1093/bja/aem126; Lambermont B, 2003, CARDIOVASC RES, V59, P412, DOI 10.1016/S0008-6363(03)00368-7; Leeuwenburgh BPJ, 2001, AM J PHYSIOL-HEART C, V281, pH2697, DOI 10.1152/ajpheart.2001.281.6.H2697; McLaughlin VV, 2009, CIRCULATION, V119, P2250, DOI 10.1161/CIRCULATIONAHA.109.192230; Melby SJ, 2011, J THORAC CARDIOV SUR, V141, P1424, DOI 10.1016/j.jtcvs.2011.02.028; Menghraj SJ, 2012, INDIAN J ANAESTH, V56, P491, DOI 10.4103/0019-5049.103969; Perbet S, 2014, MINERVA ANESTESIOL, V80, P655; Riess ML, 2005, ANESTH ANALG, V100, P46, DOI 10.1213/01.ANE.0000139346.76784.72; Tabima DM, 2010, AM J PHYSIOL-HEART C, V299, pH2069, DOI 10.1152/ajpheart.00805.2010; Wang JK, 2010, BRAIN RES, V1357, P142, DOI 10.1016/j.brainres.2010.08.009; Wauthy P, 2004, AM J PHYSIOL-HEART C, V286, pH1441, DOI 10.1152/ajpheart.00640.2003	36	5	5	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 4	2016	11	5							e0154154	10.1371/journal.pone.0154154	http://dx.doi.org/10.1371/journal.pone.0154154			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DL5KR	27144451	Green Published, gold			2022-12-26	WOS:000375676400037
J	Zhou, Y; Zhang, MJ; Li, BH; Chen, L; Pi, Y; Yin, YW; Long, CY; Wang, X; Sun, MJ; Chen, X; Gao, CY; Li, JC; Zhang, LL				Zhou, Yi; Zhang, Ming-Jie; Li, Bing-Hu; Chen, Lei; Pi, Yan; Yin, Yan-Wei; Long, Chun-Yan; Wang, Xu; Sun, Meng-Jiao; Chen, Xue; Gao, Chang-Yue; Li, Jing-Cheng; Zhang, Li-Li			PPAR gamma Inhibits VSMC Proliferation and Migration via Attenuating Oxidative Stress through Upregulating UCP2	PLOS ONE			English	Article							SMOOTH-MUSCLE-CELL; UNCOUPLING PROTEIN-2 GENE; INTIMAL HYPERPLASIA; PHENOTYPE; ACTIVATION; EXPRESSION; PATHOLOGY; PROTECTS; DEATH	Increasing evidence showed that abnormal proliferation and migration of vascular smooth muscle cells (VSMCs) are common event in the pathophysiology of many vascular diseases, including atherosclerosis and restenosis after angioplasty. Among the underlying mechanisms, oxidative stress is one of the principal contributors to the proliferation and migration of VSMCs. Oxidative stress occurs as a result of persistent production of reactive oxygen species (ROS). Recently, the protective effects of peroxisome proliferator-activated receptor. (PPAR gamma) against oxidative stress/ROS in other cell types provide new insights to inhibit the suggests that PPAR gamma may regulate VSMCs function. However, it remains unclear whether activation of PPAR gamma can attenuate oxidative stress and further inhibit VSMC proliferation and migration. In this study, we therefore investigated the effect of PPAR gamma on inhibiting VSMC oxidative stress and the capability of proliferation and migration, and the potential role of mitochondrial uncoupling protein 2 (UCP2) in oxidative stress. It was found that platelet derived growth factor-BB (PDGF-BB) induced VSMC proliferation and migration as well as ROS production; PPAR gamma inhibited PDGF-BB-induced VSMC proliferation, migration and oxidative stress; PPAR gamma activation upregulated UCP2 expression in VSMCs; PPAR gamma inhibited PDGF-BB-induced ROS in VSMCs by upregulating UCP2 expression; PPAR gamma ameliorated injury-induced oxidative stress and intimal hyperplasia (IH) in UCP2-dependent manner. In conclusion, our study provides evidence that activation of PPAR gamma can attenuate ROS and VSMC proliferation and migration by upregulating UCP2 expression, and thus inhibit IH following carotid injury. These findings suggest PPAR gamma may represent a prospective target for the prevention and treatment of IH-associated vascular diseases.	[Zhou, Yi; Zhang, Ming-Jie; Li, Bing-Hu; Chen, Lei; Pi, Yan; Yin, Yan-Wei; Long, Chun-Yan; Wang, Xu; Sun, Meng-Jiao; Chen, Xue; Gao, Chang-Yue; Li, Jing-Cheng; Zhang, Li-Li] Third Mil Med Univ, Daping Hosp, Inst Surg Res, Dept Neurol, 10 Changjiang Branch Rd, Chongqing 400042, Peoples R China	Army Medical University	Li, JC; Zhang, LL (corresponding author), Third Mil Med Univ, Daping Hosp, Inst Surg Res, Dept Neurol, 10 Changjiang Branch Rd, Chongqing 400042, Peoples R China.	li_tmmudaping@sina.com; zhanglili333@hotmail.com		Zhang, Lili/0000-0002-1625-7877	National Natural Science Foundation of China [NSFC 81471193, NSFC 81271282, NSFC 81400967]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by National Natural Science Foundation of China (NSFC 81471193 to Li-Li Zhang, NSFC 81271282 to Jing-Cheng Li and NSFC 81400967 to Yan Pi).	Arsenijevic D, 2000, NAT GENET, V26, P435, DOI 10.1038/82565; Bugge A, 2010, J BIOL CHEM, V285, P17310, DOI 10.1074/jbc.M110.120584; Cardoso S, 2015, J BIOENERG BIOMEMBR, V47, P119, DOI 10.1007/s10863-014-9580-x; Chan SHH, 2009, CIRC RES, V105, P886, DOI 10.1161/CIRCRESAHA.109.199018; Chuang YC, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-184; Collins S, 2012, BEST PRACT RES CL EN, V26, P753, DOI 10.1016/j.beem.2012.08.002; Donadelli M, 2014, CELL MOL LIFE SCI, V71, P1171, DOI 10.1007/s00018-013-1407-0; Duval C, 2002, BIOCHEM CELL BIOL, V80, P757, DOI 10.1139/O02-158; Gross ER, 2003, AM J PHYSIOL-HEART C, V284, pH1552, DOI 10.1152/ajpheart.01013.2002; Gu WD, 2003, AM J PHYSIOL-HEART C, V285, pH1582, DOI 10.1152/ajpheart.00318.2003; Harrison D, 2003, AM J CARDIOL, V91, p7A; Kizaki T, 2002, P NATL ACAD SCI USA, V99, P9392, DOI 10.1073/pnas.142206299; Krauss S, 2005, NAT REV MOL CELL BIO, V6, P248, DOI 10.1038/nrm1592; Kunsch C, 1999, CIRC RES, V85, P753, DOI 10.1161/01.RES.85.8.753; Lacolley P, 2012, CARDIOVASC RES, V95, P194, DOI 10.1093/cvr/cvs135; LINDNER V, 1993, CIRC RES, V73, P792, DOI 10.1161/01.RES.73.5.792; Mailloux RJ, 2011, FREE RADICAL BIO MED, V51, P1106, DOI 10.1016/j.freeradbiomed.2011.06.022; Mattiasson G, 2003, NAT MED, V9, P1062, DOI 10.1038/nm903; MCMURRAY HF, 1991, ATHEROSCLEROSIS, V86, P227, DOI 10.1016/0021-9150(91)90219-S; Medvedev AV, 2001, J BIOL CHEM, V276, P10817, DOI 10.1074/jbc.M010587200; Mehta SL, 2009, J CEREBR BLOOD F MET, V29, P1069, DOI 10.1038/jcbfm.2009.4; Nadtochiy SM, 2006, BIOCHEM J, V395, P611, DOI 10.1042/BJ20051927; Nielsen R, 2006, MOL CELL BIOL, V26, P5698, DOI 10.1128/MCB.02266-05; Orr AW, 2010, J VASC RES, V47, P168, DOI 10.1159/000250095; Panchenko MP, 2009, CARDIOVASC PATHOL, V18, P167, DOI 10.1016/j.carpath.2008.03.008; Pi Y, 2013, LAB INVEST, V93, P880, DOI 10.1038/labinvest.2013.79; Satoh K, 2010, ANTIOXID REDOX SIGN, V12, P675, DOI 10.1089/ars.2009.2875; Song P, 2012, FREE RADICAL BIO MED, V52, P1607, DOI 10.1016/j.freeradbiomed.2012.01.025; Touyz RM, 2011, HYPERTENS RES, V34, P5, DOI 10.1038/hr.2010.201; Wan J, 2014, DIABETOL METAB SYNDR, V6, DOI 10.1186/1758-5996-6-101; Wang PJ, 2014, J CARDIOVASC PHARM, V64, P497, DOI 10.1097/FJC.0000000000000143; Wang ZY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055471; West NEJ, 2001, ARTERIOSCL THROM VAS, V21, P189, DOI 10.1161/01.ATV.21.2.189; Won KJ, 2013, CARDIOVASC RES, V97, P553, DOI 10.1093/cvr/cvs363; Wu L, 2009, J ETHNOPHARMACOL, V126, P197, DOI 10.1016/j.jep.2009.08.045; Yang HM, 2013, EXP MOL MED, V45, DOI 10.1038/emm.2013.112; Yu H, 2011, CHEM BIOL DRUG DES, V78, P527, DOI 10.1111/j.1747-0285.2011.01174.x; Zhang LL, 2011, CARDIOVASC RES, V92, P484, DOI 10.1093/cvr/cvr238	38	35	45	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 4	2016	11	5							e0154720	10.1371/journal.pone.0154720	http://dx.doi.org/10.1371/journal.pone.0154720			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DL5KR	27144886	Green Submitted, Green Published, gold			2022-12-26	WOS:000375676400063
J	Elie, AGIM; Jensen, PS; Nissen, KD; Geraets, IME; Xu, AM; Song, EF; Hansen, ML; Irmukhamedov, A; Rasmussen, LM; Wang, Y; De Mey, JGR				Elie, Atlanta G. I. M.; Jensen, Pia S.; Nissen, Katrine D.; Geraets, Ilvy M. E.; Xu, Aimin; Song, Erfei; Hansen, Maria L.; Irmukhamedov, Akhmadjon; Rasmussen, Lars M.; Wang, Yu; De Mey, Jo G. R.			Adipokine Imbalance in the Pericardial Cavity of Cardiac and Vascular Disease Patients	PLOS ONE			English	Article							EPICARDIAL ADIPOSE-TISSUE; CORONARY-ARTERY-DISEASE; ACID-BINDING PROTEIN; INDEPENDENT RISK-FACTOR; CARDIOVASCULAR-DISEASE; HEART-DISEASE; LEPTIN RATIO; ADIPONECTIN; FLUID; FAT	Aim Obesity and especially hypertrophy of epicardial adipose tissue accelerate coronary atherogenesis. We aimed at comparing levels of inflammatory and atherogenic hormones from adipose tissue in the pericardial fluid and circulation of cardiovascular disease patients. Methods and Results Venous plasma (P) and pericardial fluid (PF) were obtained from elective cardiothoracic surgery patients (n = 37). Concentrations of leptin, adipocyte fatty acid-binding protein (AFABP) and adiponectin (APN) were determined by enzyme-linked immunosorbent assays (ELISA). The median concentration of leptin in PF (4.3 (interquartile range: 2.8-9.1) mu g/L) was comparable to that in P (5.9 (2.2-11) mu g/L) and these were significantly correlated to most of the same patient characteristics. The concentration of A-FABP was markedly higher (73 (28-124) versus 8.4 (5.2-14) mu g/L) and that of APN was markedly lower (2.8 (1.7-4.2) versus 13 (7.2-19) mg/L) in PF compared to P. APN in PF was unlike in P not significantly related to age, body mass index, plasma triglycerides or coronary artery disease. PF levels of APN, but not A-FABP, were related to the size of paracardial adipocytes. PF levels of APN and A-FABP were not related to the immunoreactivity of paracardial adipocytes for these proteins. Conclusion In cardiac and vascular disease patients, PF is enriched in A-FABP and poor in APN. This adipokine microenvironment is more likely determined by the heart than by the circulation or paracardial adipose tissue.	[Elie, Atlanta G. I. M.; Nissen, Katrine D.; Geraets, Ilvy M. E.; De Mey, Jo G. R.] Univ Southern Denmark, Inst Mol Med, Dept Cardiovasc & Renal Res, Odense, Denmark; [Jensen, Pia S.; Rasmussen, Lars M.] Odense Univ Hosp, Dept Clin Biochem & Pharmacol, DK-5000 Odense, Denmark; [Geraets, Ilvy M. E.; De Mey, Jo G. R.] Cardiovasc Res Inst Maastricht, Maastricht, Netherlands; [Xu, Aimin; Song, Erfei; Wang, Yu] Univ Hong Kong, Li Ka Shing Fac Med, State Key Lab Pharmaceut Biotechnol, Hong Kong, Hong Kong, Peoples R China; [Xu, Aimin; Song, Erfei; Wang, Yu] Univ Hong Kong, Li Ka Shing Fac Med, Dept Pharmacol & Pharm, Hong Kong, Hong Kong, Peoples R China; [Hansen, Maria L.; Irmukhamedov, Akhmadjon; De Mey, Jo G. R.] Odense Univ Hosp, Dept Cardiothorac & Vasc Surg, DK-5000 Odense, Denmark; [Hansen, Maria L.; Irmukhamedov, Akhmadjon; Rasmussen, Lars M.; De Mey, Jo G. R.] Odense Univ Hosp, Ctr Individualized Med Arterial Dis CIMA, DK-5000 Odense, Denmark	University of Southern Denmark; University of Southern Denmark; Odense University Hospital; Maastricht University; University of Hong Kong; University of Hong Kong; University of Southern Denmark; Odense University Hospital; University of Southern Denmark; Odense University Hospital	De Mey, JGR (corresponding author), Univ Southern Denmark, Inst Mol Med, Dept Cardiovasc & Renal Res, Odense, Denmark.; De Mey, JGR (corresponding author), Cardiovasc Res Inst Maastricht, Maastricht, Netherlands.; De Mey, JGR (corresponding author), Odense Univ Hosp, Dept Cardiothorac & Vasc Surg, DK-5000 Odense, Denmark.; De Mey, JGR (corresponding author), Odense Univ Hosp, Ctr Individualized Med Arterial Dis CIMA, DK-5000 Odense, Denmark.	jdemey@health.sdu.dk	Geraets, Ilvy/HII-4771-2022	wang, yu/0000-0001-8697-2940; Elie, Atlanta/0000-0001-8805-4879; Rasmussen, Lars Melholt/0000-0001-5795-4794	Odense University Hospital; University of Southern Denmark; Danish Council for Independent Research [DFF-4092-00098]; Direktor Kurt Bonnelycke og hustru fru Grethe Bonnelyckes Fond; Hong Kong Research Grant Council [HKU780410M, HKU781311M, HKU763312M, HKU4/CRF/10]	Odense University Hospital; University of Southern Denmark; Danish Council for Independent Research(Det Frie Forskningsrad (DFF)); Direktor Kurt Bonnelycke og hustru fru Grethe Bonnelyckes Fond; Hong Kong Research Grant Council(Hong Kong Research Grants Council)	This work was supported by the Odense University Hospital, the University of Southern Denmark, the Danish Council for Independent Research [DFF-4092-00098], the Direktor Kurt Bonnelycke og hustru fru Grethe Bonnelyckes Fond and by grants from the Hong Kong Research Grant Council [HKU780410M, HKU781311M, HKU763312M] and [HKU4/CRF/10]. It was conducted within the frame of the elite research centre CIMA-Centre for Individualized Medicine in Arterial Diseases of the Odense University Hospital. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Mashhadi RH, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3004853; Bambace Clara, 2011, Cardiovasc Pathol, V20, pe153, DOI 10.1016/j.carpath.2010.07.005; Beleznai T, 2011, AM J PHYSIOL-HEART C, V300, pH777, DOI 10.1152/ajpheart.00831.2010; Beltowski J, 2006, ATHEROSCLEROSIS, V189, P47, DOI 10.1016/j.atherosclerosis.2006.03.003; Ben-Horin S, 2005, AM J MED, V118, P636, DOI 10.1016/j.amjmed.2005.01.066; Bloksgaard M, 2015, J VASC RES, V52, P1, DOI 10.1159/000376548; Bluher M, 2015, METABOLISM, V64, P131, DOI 10.1016/j.metabol.2014.10.016; Chen HC, 2002, J LIPID RES, V43, P986; Correia MLD, 2004, CURR OPIN NEPHROL HY, V13, P215, DOI 10.1097/01.mnh.0000119533.79618.b3; Fischer S, 2002, ACTA DIABETOL, V39, P105, DOI 10.1007/s005920200027; Fitzgibbons TP, 2014, J AM HEART ASSOC, V3, DOI 10.1161/JAHA.113.000582; Fujita M, 1996, CIRCULATION, V94, P610, DOI 10.1161/01.CIR.94.4.610; Fujita M, 2001, INT J CARDIOL, V77, P113, DOI 10.1016/S0167-5273(00)00462-9; Grosso AF, 2014, DIABETOL METAB SYNDR, V6, DOI 10.1186/1758-5996-6-47; Harada K, 2014, ATHEROSCLEROSIS, V237, P671, DOI 10.1016/j.atherosclerosis.2014.10.014; Hassan M, 2012, NAT REV CARDIOL, V9, P689, DOI 10.1038/nrcardio.2012.148; HUBERT HB, 1983, CIRCULATION, V67, P968, DOI 10.1161/01.CIR.67.5.968; Hui XY, 2012, BRIT J PHARMACOL, V165, P574, DOI 10.1111/j.1476-5381.2011.01395.x; Iacobellis G, 2005, NAT CLIN PRACT CARD, V2, P536, DOI 10.1038/ncpcardio0319; Iacobellis G, 2003, J CLIN ENDOCR METAB, V88, P5163, DOI 10.1210/jc.2003-030698; Iwayama T, 2014, J CARDIOL, V63, P344, DOI 10.1016/j.jjcc.2013.10.002; Jin J, 2010, CLIN CHIM ACTA, V411, P1761, DOI 10.1016/j.cca.2010.07.031; Karastergiou K, 2010, ARTERIOSCL THROM VAS, V30, P1340, DOI 10.1161/ATVBAHA.110.204719; Kotulak T, 2014, PHYSIOL RES, V63, P83, DOI 10.33549/physiolres.932574; Kremen J, 2006, J CLIN ENDOCR METAB, V91, P4620, DOI 10.1210/jc.2006-1044; Larsen BT, 2009, ARTERIOSCL THROM VAS, V29, P739, DOI 10.1161/ATVBAHA.108.169367; Liu MY, 2013, CLIN SCI, V124, P115, DOI 10.1042/CS20120004; Maeda N, 2001, DIABETES, V50, P2094, DOI 10.2337/diabetes.50.9.2094; Mahabadi AA, 2009, EUR HEART J, V30, P850, DOI 10.1093/eurheartj/ehn573; Mattu HS, 2013, J ENDOCRINOL, V216, pT17, DOI 10.1530/JOE-12-0232; Mazurek T, 2003, CIRCULATION, V108, P2460, DOI 10.1161/01.CIR.0000099542.57313.C5; Mostowik M, 2013, CARDIOVASC DRUG THER, V27, P289, DOI 10.1007/s10557-013-6457-x; Namiki A, 2003, JPN HEART J, V44, P633, DOI 10.1536/jhj.44.633; Garcia AN, 2015, WORLD J STEM CELLS, V7, P352, DOI 10.4252/wjsc.v7.i2.352; Payne GA, 2012, BRIT J PHARMACOL, V165, P659, DOI 10.1111/j.1476-5381.2011.01370.x; Pezeshkian M, 2013, BIOIMPACTS, V3, P83, DOI 10.5681/bi.2013.004; Rhee EJ, 2009, EUR J ENDOCRINOL, V160, P165, DOI 10.1530/EJE-08-0665; Rubanyi GM, 2013, MOL THER, V21, P725, DOI 10.1038/mt.2013.13; Sattar N, 2009, J AM COLL CARDIOL, V53, P167, DOI 10.1016/j.jacc.2008.09.035; Sattar N, 2006, CIRCULATION, V114, P623, DOI 10.1161/CIRCULATIONAHA.106.618918; Selmeci L, 2000, CORONARY ARTERY DIS, V11, P53, DOI 10.1097/00019501-200002000-00010; Shimabukuro M, 2013, ARTERIOSCL THROM VAS, V33, P1077, DOI 10.1161/ATVBAHA.112.300829; Talman AH, 2014, CARDIOVASC DIAGN THE, V4, P416, DOI 10.3978/j.issn.2223-3652.2014.11.05; Vogiatzidis K, 2015, FRONT PHYSIOL, V6, DOI [10.3389/fphs.2015.00062, 10.3389/fphys.2015.00062]; Wang Y, 2006, J BIOL CHEM, V281, P16391, DOI 10.1074/jbc.M513907200; Watanabe M, 2009, CLIN CARDIOL, V32, P159, DOI 10.1002/clc.20306; Wu GY, 2014, ARTERIOSCL THROM VAS, V34, P2457, DOI 10.1161/ATVBAHA.114.303718; Xiang F, 2013, PROTEOMICS, V13, P2692, DOI 10.1002/pmic.201200317; Xu AM, 2012, AM J PHYSIOL-HEART C, V302, pH1231, DOI 10.1152/ajpheart.00765.2011; Yerramasu A, 2012, ATHEROSCLEROSIS, V220, P223, DOI 10.1016/j.atherosclerosis.2011.09.041; Zaletel J, 2010, J ENDOCRINOL INVEST, V33, P514, DOI [10.1007/BF03346639, 10.3275/6811]	51	15	16	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 3	2016	11	5							e0154693	10.1371/journal.pone.0154693	http://dx.doi.org/10.1371/journal.pone.0154693			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DL5KK	27139713	Green Submitted, Green Published, gold			2022-12-26	WOS:000375675700055
J	Okamoto, M; Shirasu, M; Fujita, R; Hirasawa, Y; Touhara, K				Okamoto, Masako; Shirasu, Mika; Fujita, Rei; Hirasawa, Yukei; Touhara, Kazushige			Child Odors and Parenting: A Survey Examination of the Role of Odor in Child-Rearing	PLOS ONE			English	Article							HUMAN KIN RECOGNITION; FACTOR MIXTURE-MODELS; NEWBORN-INFANT ODORS; OLFACTORY CUES; BODY ODOR; MOTHERS; FATHERS; BRAIN; PERCEPTION; BEHAVIOR	Parental caregiving is critical for the survival of our young and continuation of our species. In humans, visual and auditory signals from offspring have been shown to be potent facilitators of parenting. However, whether odors emitted by our young also influence human parenting remains unclear. To explore this, we conducted a series of questionnaire surveys targeting parents with children under 6 years old. First, we collected episodes on experiencing odors/ sniffing various parts of a child's body (n = 507). The prevalence of experiencing events described in those episodes was examined in a separate survey (n = 384). Based on those results, the Child Odor in Parenting scale (COPs) was developed, and subsequently used in the main survey (n = 888). We found COPs to have adequate content validity, concurrent validity, and reliability. Responses to the COPs demonstrated that parents, especially mothers with infants, are aware of odors from their offspring, and actively seek them in daily child-rearing. The factor structure and content of the COPs items indicated that child odors have both affective and instrumental roles. Affective experiences induce loving feeling and affectionate sniffing, while instrumental experiences pertain to specific hygienic needs. The head was the most frequent source of affective experiences, and the child's bottom of instrumental. Each was experienced by more than 90% of the mothers with a child below 1 year of age. Affective experiences significantly declined as the child grew older, possibly associated with the decline of physical proximity between parents and child. This age-related decline was not prominent for instrumental experiences, except for the bottom, which significantly declined after 3 years of age. The present findings suggest that child odors play roles in human parenting, and that their nature and significance change during the course of a child's development.	[Okamoto, Masako; Shirasu, Mika; Fujita, Rei; Hirasawa, Yukei; Touhara, Kazushige] Univ Tokyo, Grad Sch Agr & Life Sci, Dept Appl Biol Chem, Tokyo 1138657, Japan; [Okamoto, Masako; Shirasu, Mika; Fujita, Rei; Hirasawa, Yukei; Touhara, Kazushige] Univ Tokyo, ERATO Touhara Chemosensory Signal Project, JST, Tokyo 1138657, Japan; [Fujita, Rei] T Hasegawa Co Ltd, Tech Res Inst, Ctr Res & Dev, Yokosuka, Kanagawa 2110022, Japan	University of Tokyo; Japan Science & Technology Agency (JST); University of Tokyo; T. Hasegawa Co., Ltd.	Okamoto, M (corresponding author), Univ Tokyo, Grad Sch Agr & Life Sci, Dept Appl Biol Chem, Tokyo 1138657, Japan.; Okamoto, M (corresponding author), Univ Tokyo, ERATO Touhara Chemosensory Signal Project, JST, Tokyo 1138657, Japan.	a-okmoto@mail.ecc.u-tokyo.ac.jp			Japan Science and Technology Agency through the ERATO Touhara Chemosensory Signal Project	Japan Science and Technology Agency through the ERATO Touhara Chemosensory Signal Project	This work was funded by the Japan Science and Technology Agency through the ERATO Touhara Chemosensory Signal Project to K.T., http://www.jst.go.jp/erato/en/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abraham E, 2014, P NATL ACAD SCI USA, V111, P9792, DOI 10.1073/pnas.1402569111; Ainsworth M., 1978, PATTERNS ATTACHMENT; Ainsworth MDS, 1974, INTEGRATION CHILD SO, P9; Amankwaa Linda, 2007, ABNF J, V18, P4; Bornstein, 2002, HDB PARENTING, V2; Bornstein MH, 2012, HDB PARENTING; Bowlby J, 1988, SECURE BASE CLIN APP; Bowlby J., 1969, ATTACHMENT ATTACHMEN, VI; Cassidy J, 2010, HANDBOOK OF ATTACHME; Clark SL, 2013, STRUCT EQU MODELING, V20, P681, DOI 10.1080/10705511.2013.824786; COHEN J, 1992, PSYCHOL BULL, V112, P155, DOI 10.1037/0033-2909.112.1.155; Cronbach LJ, 1951, PSYCHOMETRIKA, V16, P297; Crowne D, 1960, J CONSULT PSYCHOL; Cupchik GC, 2005, COGNITION EMOTION, V19, P121, DOI 10.1080/0269993044100011; DeVellis R., 2011, SCALE DEV THEORY APP, VXXVI; Doty RL, 2009, PHYSIOL BEHAV, V97, P213, DOI 10.1016/j.physbeh.2009.02.032; Dubas JS, 2009, HUM NATURE-INT BIOS, V20, P80, DOI 10.1007/s12110-009-9058-4; Feldman R, 2015, TRENDS NEUROSCI, V38, P387, DOI 10.1016/j.tins.2015.04.004; Ferdenzi C, 2008, INT J BEHAV DEV, V32, P422, DOI 10.1177/0165025408093661; Ferdenzi C, 2010, J CHEM ECOL, V36, P847, DOI 10.1007/s10886-010-9827-x; Fleming AS, 1997, HORM BEHAV, V32, P85, DOI 10.1006/hbeh.1997.1407; FLEMING AS, 1993, DEV PSYCHOBIOL, V26, P115, DOI 10.1002/dev.420260204; Goodman SH, 2014, INFANT MENT HEALTH J, V35, P495, DOI 10.1002/imhj.21469; Goto T., 2010, REPORT HLTH LABOUR W; GREEN JA, 1983, DEV PSYCHOBIOL, V16, P485, DOI 10.1002/dev.420160604; Gustafsson E, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2713; Heiman G. W., 2002, RES METHODS PSYCHOL; Herz R., 2008, SCENT DESIRE DISCOVE; Herz RS, 1997, HUM NATURE-INT BIOS, V8, P275, DOI 10.1007/BF02912495; Holmes WG, 1990, MAMMALIAN PARENTING; Japanese Ministry of Health Labour and Welfare, 2010, NAT GROWTH SURV PRES; Japanese Ministry of Internal Affairs and Communications, 2013, COMM US TREND SURV; KAITZ M, 1987, DEV PSYCHOBIOL, V20, P587, DOI 10.1002/dev.420200604; Kawauchi K, 2006, B RISSHO U, V8, P1; Keller A, 2007, NATURE, V449, P468, DOI 10.1038/nature06162; Keller A, 2011, FRONT PSYCHOL, V2, DOI 10.3389/fpsyg.2011.00380; Konner M., 1976, KALAHARI HUNTER GATH; Krippendorff KH, 2008, CONTENT ANAL READER; Lazarsfeld P.F., 1968, LATENT STRUCTURE ANA; Levy F, 2009, BEHAV BRAIN RES, V200, P336, DOI 10.1016/j.bbr.2008.12.017; Lorenz K., 1943, Zeitschrift fuer Tierpsychologie Berlin, V5, P235; Lubke GH, 2005, PSYCHOL METHODS, V10, P21, DOI 10.1037/1082-989X.10.1.21; Lubke G, 2008, MULTIVAR BEHAV RES, V43, P592, DOI 10.1080/00273170802490673; Lubke KT, 2015, HORM BEHAV, V68, P134, DOI 10.1016/j.yhbeh.2014.10.001; Lundstrom JN, 2013, FRONT PSYCHOL, V4, DOI 10.3389/fpsyg.2013.00597; Luo LZ, 2011, J EXP CHILD PSYCHOL, V110, P115, DOI 10.1016/j.jecp.2011.04.002; Luo LZ, 2015, FRONT PSYCHOL, V6, DOI 10.3389/fpsyg.2015.00970; MAIN M, 1988, DEV PSYCHOL, V24, P415, DOI 10.1037/0012-1649.24.3.415; Martin A, 2010, J INVEST DERMATOL, V130, P529, DOI 10.1038/jid.2009.254; Martin N., 2013, NEUROPSYCHOLOGY SMEL; Mascaro JS, 2013, P NATL ACAD SCI USA, V110, P15746, DOI 10.1073/pnas.1305579110; Mauss I, 2009, COGNITION EMOTION, V23, P209, DOI 10.1080/02699930802204677; McBride B. A., 1993, EARLY CHILD RES Q, V8, P457, DOI [10.1016/s0885-2006(05)80080-8, 10.1016/S0885-2006(05)80080-8, DOI 10.1016/S0885-2006(05)80080-8]; McBurney DH, 2006, J APPL SOC PSYCHOL, V36, P2325, DOI 10.1111/j.0021-9029.2006.00105.x; Montagna W., 1974, STRUCTURE FUNCTION S, V3rd, P28; Montague DPF, 2002, CHILD DEV, V73, P1339, DOI 10.1111/1467-8624.00475; Muthen L. K., 1998, MPLUS STAT ANAL LATE; NICHOLSON B, 1984, BRIT J DERMATOL, V111, P621, DOI 10.1111/j.1365-2133.1984.tb06635.x; Nishitani S, 2014, CHEM SENSES, V39, P195, DOI 10.1093/chemse/bjt068; Novakova L, 2014, CHEMOSENS PERCEPT, V7, P56, DOI 10.1007/s12078-014-9167-2; Numan M, 2006, KNOBIL AND NEILL'S PHYSIOLOGY OF REPRODUCTION, VOLS 1 AND 2, 3RD EDITON, P1921; Pandey SK, 2011, TRAC-TREND ANAL CHEM, V30, P784, DOI 10.1016/j.trac.2010.12.005; PORTER RH, 1981, PHYSIOL BEHAV, V27, P493, DOI 10.1016/0031-9384(81)90337-1; PORTER RH, 1986, CHEM SENSES, V11, P389, DOI 10.1093/chemse/11.3.389; PORTER RH, 1983, PHYSIOL BEHAV, V30, P151, DOI 10.1016/0031-9384(83)90051-3; Porter RH, 1998, GENETICA, V104, P259, DOI 10.1023/A:1026404319384; Rilling JK, 2013, NEUROPSYCHOLOGIA, V51, P731, DOI 10.1016/j.neuropsychologia.2012.12.017; RUSSELL MJ, 1983, ETHOL SOCIOBIOL, V4, P29, DOI 10.1016/0162-3095(83)90005-5; Sakai KL, 2005, SCIENCE, V310, P815, DOI 10.1126/science.1113530; SCHAAL B, 1980, REPROD NUTR DEV, V20, P843, DOI 10.1051/rnd:19800510; Schaal B, 1991, ADV STUD BEHAV, V20, P474; Schwarz N, 2001, AM J EVAL, V22, P127, DOI 10.1177/109821400102200202; Sela L, 2010, EXP BRAIN RES, V205, P13, DOI 10.1007/s00221-010-2348-6; Shoup ML, 2008, J APPL SOC PSYCHOL, V38, DOI 10.1111/j.1559-1816.2008.00420.x; Smeets MAM, 2008, CHEM SENSES, V33, P725, DOI 10.1093/chemse/bjn038; Solomon J, 1996, INFANT MENT HEALTH J, V17, P183, DOI 10.1002/(SICI)1097-0355(199623)17:3<183::AID-IMHJ1>3.0.CO;2-Q; Soo MLM, 2007, MANKIND QUART, V47, P25; Stevenson RJ, 2010, CHEM SENSES, V35, P3, DOI 10.1093/chemse/bjp083; Swain JE, 2014, BRAIN RES, V1580, P78, DOI 10.1016/j.brainres.2014.03.007; Swain JE, 2011, PROG NEURO-PSYCHOPH, V35, P1242, DOI 10.1016/j.pnpbp.2010.10.017; Takebayashi H, 2011, AURIS NASUS LARYNX, V38, P65, DOI 10.1016/j.anl.2010.05.013; The Japanese Society of Pedodontics, 1988, JPN J PED DENT, V26, P1; Viviers MZ, 2014, CHEM SENSES, V39, P249, DOI 10.1093/chemse/bjt075; Walker CD, 2004, J PSYCHIATR NEUROSCI, V29, P364; Weisfeld GE, 2003, J EXP CHILD PSYCHOL, V85, P279, DOI 10.1016/S0022-0965(03)00061-4; WIESENFELD AR, 1981, INFANT BEHAV DEV, V4, P281, DOI 10.1016/S0163-6383(81)80030-6; Wyatt TD, 2015, P ROY SOC B-BIOL SCI, V282, DOI 10.1098/rspb.2014.2994; Zeifman DM, 2001, DEV PSYCHOBIOL, V39, P265, DOI 10.1002/dev.1005	88	12	12	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 3	2016	11	5							e0154392	10.1371/journal.pone.0154392	http://dx.doi.org/10.1371/journal.pone.0154392			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DL5KK	27138751	Green Published, gold, Green Submitted			2022-12-26	WOS:000375675700030
J	Sasseville, LJ; Morin, M; Coady, MJ; Blunck, R; Lapointe, JY				Sasseville, Louis J.; Morin, Michael; Coady, Michael J.; Blunck, Rikard; Lapointe, Jean-Yves			The Human Sodium-Glucose Cotransporter (hSGLT1) Is a Disulfide-Bridged Homodimer with a Re-Entrant C-Terminal Loop	PLOS ONE			English	Article							NA+/GLUCOSE COTRANSPORTER; MEMBRANE TOPOLOGY; OLIGOMERIC STRUCTURE; SGLT1; BINDING; PHLORHIZIN; MECHANISM; SURFACE; IDENTIFICATION; RECOGNITION	Na-coupled cotransporters are proteins that use the trans-membrane electrochemical gradient of Na to activate the transport of a second solute. The sodium-glucose cotransporter 1 (SGLT1) constitutes a well-studied prototype of this transport mechanism but essential molecular characteristics, namely its quaternary structure and the exact arrangement of the C-terminal transmembrane segments, are still debated. After expression in Xenopus oocytes, human SGLT1 molecules (hSGLT1) were labelled on an externally accessible cysteine residue with a thiol-reactive fluorophore (tetramethylrhodamine-C5-maleimide, TMR). Addition of dipicrylamine (DPA, a negatively-charged amphiphatic fluorescence "quencher") to the fluorescently-labelled oocytes is used to quench the fluorescence originating from hSGLT1 in a voltage-dependent manner. Using this arrangement with a cysteine residue introduced at position 624 in the loop between transmembrane segments 12 and 13, the voltage-dependent fluorescence signal clearly indicated that this portion of the 12-13 loop is located on the external side of the membrane. As the 12-13 loop begins on the intracellular side of the membrane, this suggests that the 12-13 loop is re-entrant. Using fluorescence resonance energy transfer (FRET), we observed that different hSGLT1 molecules are within molecular distances from each other suggesting a multimeric complex arrangement. In agreement with this conclusion, a western blot analysis showed that hSGLT1 migrates as either a monomer or a dimer in reducing and non-reducing conditions, respectively. A systematic mutational study of endogenous cysteine residues in hSGLT1 showed that a disulfide bridge is formed between the C355 residues of two neighbouring hSGLT1 molecules. It is concluded that, 1) hSGLT1 is expressed as a disulfide bridged homodimer via C355 and that 2) a portion of the intracellular 12-13 loop is re-entrant and readily accessible from the extracellular milieu.	[Lapointe, Jean-Yves] Univ Montreal, Grp Etud Prot Membranaires GEPROM, Montreal, PQ, Canada; Univ Montreal, Dept Phys, Montreal, PQ, Canada	Universite de Montreal; Universite de Montreal	Lapointe, JY (corresponding author), Univ Montreal, Grp Etud Prot Membranaires GEPROM, Montreal, PQ, Canada.	jean-yves.lapointe@umontreal.ca	Blunck, Rikard/AAM-3078-2020	Blunck, Rikard/0000-0003-4484-2907	Natural Sciences and Engineering Research Council of Canada [380738-2010, 327201-2012]; Canadian Institutes of Health Research [MOP 324058]	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))	Funding was provided by grant #380738-2010, Natural Sciences and Engineering Research Council of Canada, http://www.nserc-crsng.gc.ca/ (JYL); grant #327201-2012, Natural Sciences and Engineering Research Council of Canada, http:// www.nserc-crsng.gc.ca/ (RB); and grant #MOP 324058 Canadian Institutes of Health Research, http://www.cihr-irsc.gc.ca/e/193.html, (RB).	Batulan Z, 2010, J BIOL CHEM, V285, P14005, DOI 10.1074/jbc.M109.097717; Bissonnette P, 1999, J PHYSIOL-LONDON, V520, P359, DOI 10.1111/j.1469-7793.1999.00359.x; Chanda B, 2005, NATURE, V436, P852, DOI 10.1038/nature03888; CHENU C, 1993, J MEMBRANE BIOL, V132, P95; Eskandari S, 1998, P NATL ACAD SCI USA, V95, P11235, DOI 10.1073/pnas.95.19.11235; Faham S, 2008, SCIENCE, V321, P810, DOI 10.1126/science.1160406; Farhan H, 2006, HANDB EXP PHARM, V175, P233; Forrest LR, 2010, BIOCH BIOPHYSICA ACT; Gagnon DG, 2006, J GEN PHYSIOL, V127, P145, DOI 10.1085/jgp.200509439; Gagnon DG, 2005, BBA-BIOMEMBRANES, V1712, P173, DOI 10.1016/j.bbamem.2005.04.007; Gagnon DG, 2007, BIOPHYS J, V92, P2403, DOI 10.1529/biophysj.106.097964; Gartner RM, 2011, J MOL BIOL; Groulx N, 2010, J GEN PHYSIOL, V136, P497, DOI 10.1085/jgp.200910347; Henry LK, 2006, NEURON, V49, P791, DOI 10.1016/j.neuron.2006.03.002; Herz K, 2009, J BIOL CHEM, V284, P6337, DOI 10.1074/jbc.M807720200; Jensen MO, 2012, SCIENCE, V336, P229, DOI 10.1126/science.1216533; Jette M, 1997, BBA-BIOMEMBRANES, V1327, P242, DOI 10.1016/S0005-2736(97)00069-2; Kanner BI, 2008, NATURE, V454, P593, DOI 10.1038/454593a; KOEPSELL H, 1994, J MEMBRANE BIOL, V138, P1; Leduc-Nadeau A, 2007, AM J PHYSIOL-CELL PH, V292, pC1132, DOI 10.1152/ajpcell.00136.2006; Lin JT, 1999, J MEMBRANE BIOL, V170, P243, DOI 10.1007/s002329900553; Liu T, 2009, BIOCHEM BIOPH RES CO, V378, P133, DOI 10.1016/j.bbrc.2008.11.015; Longpre JP, 2012, J GEN PHYSIOL, V140, P361, DOI 10.1085/jgp.201210822; Ma D, 2012, NATURE, V483, P632, DOI 10.1038/nature10917; Martin MG, 1997, GASTROENTEROLOGY, V112, P1206, DOI 10.1016/S0016-5085(97)70132-X; PARENT L, 1992, J MEMBRANE BIOL, V125, P49; Puntheeranurak T, 2007, J BIOL CHEM, V282, P25222, DOI 10.1074/jbc.M704190200; Raja M, CELL BIOCH BIOPHYSIC, P1; Raja MM, 2004, BIOCHEMISTRY-US, V43, P10944, DOI 10.1021/bi049106n; Raja MM, 2003, J BIOL CHEM, V278, P49154, DOI 10.1074/jbc.M306881200; Raja M, 2015, BIOCHIMIE, V115, P187, DOI 10.1016/j.biochi.2015.06.003; Turk E, 1996, J BIOL CHEM, V271, P1925, DOI 10.1074/jbc.271.4.1925; Turner JR, 1996, J BIOL CHEM, V271, P7738, DOI 10.1074/jbc.271.13.7738; Tyagi NK, 2007, BIOCHEMISTRY-US, V46, P13616, DOI 10.1021/bi701193x; Tyagi NK, 2011, BBA-BIOMEMBRANES, V1808, P1, DOI 10.1016/j.bbamem.2010.07.028; Tyagi NK, 2010, BIOCH BIOPHYSICA ACT; Vinothkumar KR, 2006, J BIOL CHEM, V281, P4795, DOI 10.1074/jbc.M508993200; Wang DS, 2010, BIOPHYS J, V99, P2355, DOI 10.1016/j.bpj.2010.07.037; Watanabe A, 2010, NATURE, V468, P988, DOI 10.1038/nature09580; Wimmer B, 2009, J BIOL CHEM, V284, P983, DOI 10.1074/jbc.M805082200; Wright EM, 2011, PHYSIOL REV, V91, P733, DOI 10.1152/physrev.00055.2009; Xia XB, 2005, ARCH BIOCHEM BIOPHYS, V438, P63, DOI 10.1016/j.abb.2005.04.010; Xia XB, 2003, BIOCHEMISTRY-US, V42, P6115, DOI 10.1021/bi020695b; Yagur-Kroll S, 2005, J BIOL CHEM, V280, P19306, DOI 10.1074/jbc.M410896200	44	3	3	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 3	2016	11	5							e0154589	10.1371/journal.pone.0154589	http://dx.doi.org/10.1371/journal.pone.0154589			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DL5KK	27137918	Green Published, Green Submitted, gold			2022-12-26	WOS:000375675700043
J	Staudacher, H; Kaltenpoth, M; Breeuwer, JAJ; Menken, SBJ; Heckel, DG; Groot, AT				Staudacher, Heike; Kaltenpoth, Martin; Breeuwer, Johannes A. J.; Menken, Steph B. J.; Heckel, David G.; Groot, Astrid T.			Variability of Bacterial Communities in the Moth Heliothis virescens Indicates Transient Association with the Host	PLOS ONE			English	Article							GUT BACTERIA; TETRACYCLINE RESISTANCE; MANDUCA-SEXTA; HOLOGENOME THEORY; ZEA LEPIDOPTERA; MIDGUT; DIVERSITY; NOCTUIDAE; PLANTS; LARVAE	Microbes associated with insects can confer a wide range of ecologically relevant benefits to their hosts. Since insect-associated bacteria often increase the nutritive value of their hosts' diets, the study of bacterial communities is especially interesting in species that are important agricultural pests. We investigated the composition of bacterial communities in the noctuid moth Heliothis virescens and its variability in relation to developmental stage, diet and population (field and laboratory), using bacterial tag-encoded FLX pyrosequencing of 16S rRNA amplicons. In larvae, bacterial communities differed depending on the food plant on which they had been reared, although the within-group variation between biological replicates was high as well. Moreover, larvae originating froma field or laboratory population did not share any OTUs. Interestingly, Enterococcus sp. was found to be the dominant taxon in laboratoryreared larvae, but was completely absent from field larvae, indicating dramatic shifts inmicrobial community profiles upon cultivation of the moths in the laboratory. Furthermore, microbiota composition varied strongly across developmental stages in individuals of the field population, and we found no evidence for vertical transmission of bacteria from mothers to offspring. Since sample sizes in our study were small due to pooling of samples for sequencing, we cautiously conclude that the high variability in bacterial communities suggests a loose and temporary association of the identified bacteria with H. virescens.	[Staudacher, Heike; Breeuwer, Johannes A. J.; Menken, Steph B. J.; Groot, Astrid T.] Univ Amsterdam, Sci Pk 904, NL-1098 XH Amsterdam, Netherlands; [Kaltenpoth, Martin; Heckel, David G.; Groot, Astrid T.] Max Planck Inst Chem Ecol, Hans Knoll Str 8, D-07745 Jena, Germany; [Kaltenpoth, Martin] Johannes Gutenberg Univ Mainz, Dept Evolutionary Ecol, Johann Joachim Becher Weg 13, D-55128 Mainz, Germany	University of Amsterdam; Max Planck Society; Johannes Gutenberg University of Mainz	Staudacher, H (corresponding author), Univ Amsterdam, Sci Pk 904, NL-1098 XH Amsterdam, Netherlands.	H.Staudacher@uva.nl	Heckel, David G/K-2138-2013; Kaltenpoth, Martin/M-8475-2014	Heckel, David G/0000-0001-8991-2150; Kaltenpoth, Martin/0000-0001-9450-0345	University of Amsterdam; Max Planck Gesellschaft; National Science Foundation [IOS-1052238, IOS-1456973]	University of Amsterdam; Max Planck Gesellschaft(Max Planck Society); National Science Foundation(National Science Foundation (NSF))	HS, JAJB, SBJM and ATG were supported by the University of Amsterdam. ATG, MK and DGH were supported by the Max Planck Gesellschaft. The National Science Foundation (www.nsf.gov) provided grants to ATG (IOS-1052238 and IOS-1456973). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams AS, 2010, ENVIRON ENTOMOL, V39, P406, DOI 10.1603/EN09221; Anand AAP, 2010, J INSECT SCI, V10, DOI 10.1673/031.010.10701; APPEL HM, 1995, J INSECT PHYSIOL, V41, P241, DOI 10.1016/0022-1910(94)00106-Q; Barber GW, 1937, J ECON ENTOMOL, V30, P150, DOI 10.1093/jee/30.1.150; Bates D, 2015, J STAT SOFTW, V67, P1, DOI 10.18637/jss.v067.i01; Belda E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021751; Benson DA, 2011, NUCL ACIDS RES; Blanco CA, 2007, FLA ENTOMOL, V90, P742, DOI 10.1653/0015-4040(2007)90[742:DOHVAH]2.0.CO;2; Bosch TCG, 2011, ZOOLOGY, V114, P185, DOI 10.1016/j.zool.2011.04.001; Brinkmann N, 2008, APPL ENVIRON MICROB, V74, P7189, DOI 10.1128/AEM.01464-08; Broderick NA, 2004, APPL ENVIRON MICROB, V70, P293, DOI 10.1128/AEM.70.1.293-300.2004; Broderick NA, 2006, P NATL ACAD SCI USA, V103, P15196, DOI 10.1073/pnas.0604865103; Broderick NA, 2009, BMC BIOL, V7, DOI 10.1186/1741-7007-7-11; BURTON R L, 1970, Journal of Economic Entomology, V63, P1969, DOI 10.1093/jee/63.6.1969; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Caporaso JG, 2010, BIOINFORMATICS, V26, P266, DOI 10.1093/bioinformatics/btp636; Cauwerts K, 2007, AVIAN PATHOL, V36, P395, DOI 10.1080/03079450701589167; Chandler DP, 1997, MOL ECOL, V6, P475, DOI 10.1046/j.1365-294X.1997.00205.x; Chandler JA, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002272; CHAPMAN R F, 1969, P819; Chu CC, 2013, P NATL ACAD SCI USA, V110, P11917, DOI 10.1073/pnas.1301886110; Colman DR, 2012, MOL ECOL, V21, P5124, DOI 10.1111/j.1365-294X.2012.05752.x; Dillon RJ, 2004, ANNU REV ENTOMOL, V49, P71, DOI 10.1146/annurev.ento.49.061802.123416; Douglas AE, 2009, FUNCT ECOL, V23, P38, DOI 10.1111/j.1365-2435.2008.01442.x; DOW JAT, 1992, J EXP BIOL, V172, P355; Edgar RC, 2010, BIOINFORMATICS, V26, P2460, DOI 10.1093/bioinformatics/btq461; Engel P, 2013, FEMS MICROBIOL REV, V37, P699, DOI 10.1111/1574-6976.12025; Feldhaar H, 2011, ECOL ENTOMOL, V36, P533, DOI 10.1111/j.1365-2311.2011.01318.x; FITT GP, 1989, ANNU REV ENTOMOL, V34, P17, DOI 10.1146/annurev.en.34.010189.000313; Freitak D, 2014, VIRULENCE, V5, P547, DOI 10.4161/viru.28367; GIES A, 1988, COMP BIOCHEM PHYS A, V91, P549, DOI 10.1016/0300-9629(88)90634-2; Haas BJ, 2011, GENOME RES, V21, P494, DOI 10.1101/gr.112730.110; Hammer TJ, 2015, PEERJ, V3, DOI 10.7717/peerj.1190; Hammer TJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086995; Hosokawa T, 2007, P ROY SOC B-BIOL SCI, V274, P1979, DOI 10.1098/rspb.2007.0620; Hothorn T, 2008, BIOMETRICAL J, V50, P346, DOI 10.1002/bimj.200810425; Hui XA, 2006, CAN J MICROBIOL, V52, P1085, DOI 10.1139/W06-064; Huys G, 2004, APPL ENVIRON MICROB, V70, P1555, DOI 10.1128/AEM.70.3.1555-1562.2004; Ishak HD, 2011, MICROB ECOL, V61, P821, DOI 10.1007/s00248-010-9793-4; JAROSZ J, 1975, J INVERTEBR PATHOL, V26, P275, DOI 10.1016/0022-2011(75)90222-0; Johnston PR, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1005246; Junker RR, 2011, PLANT BIOLOGY, V13, P918, DOI 10.1111/j.1438-8677.2011.00454.x; Kunin V, 2010, ENVIRON MICROBIOL, V12, P118, DOI 10.1111/j.1462-2920.2009.02051.x; Kuznetsova A, 2014, LMERTEST TESTS RANDO; Loman NJ, 2012, NAT BIOTECHNOL, V30, P434, DOI 10.1038/nbt.2198; Lozupone C, 2005, APPL ENVIRON MICROB, V71, P8228, DOI 10.1128/AEM.71.12.8228-8235.2005; Lozupone C, 2011, ISME J, V5, P169, DOI 10.1038/ismej.2010.133; Lv D, 2012, RES MICROBIOL, V163, P119, DOI 10.1016/j.resmic.2011.11.001; Ma AZ, 2013, INT J MOL SCI, V14, P14607, DOI 10.3390/ijms140714607; Madhaiyan M, 2012, INT J SYST EVOL MICR, V62, P162, DOI 10.1099/ijs.0.030148-0; Margulies M, 2005, NATURE, V437, P376, DOI 10.1038/nature03959; MCINROY JA, 1995, PLANT SOIL, V173, P337, DOI 10.1007/BF00011472; Neunzig HH, 1969, CAROLINA EXP STATION; NIJHOUT HF, 1974, J EXP BIOL, V61, P493; Oliver KM, 2010, ANNU REV ENTOMOL, V55, P247, DOI 10.1146/annurev-ento-112408-085305; Pinto-Tomas A, 2007, REV BIOL TROP, V55, P401; Pinto-Tomas AA, 2011, ENVIRON ENTOMOL, V40, P1111, DOI 10.1603/EN11083; Price MN, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009490; Prinja S, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0043093, 10.1371/journal.pone.0030362]; Priya NG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030768; R Core Team, 2021, R LANGUAGE ENV STAT; Rani A, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-96; Reeder J, 2010, NAT METHODS, V7, P668, DOI 10.1038/nmeth0910-668b; Robinson CJ, 2010, MICROB ECOL, V59, P199, DOI 10.1007/s00248-009-9595-8; Rosenberg E, 2009, ENVIRON MICROBIOL, V11, P2959, DOI 10.1111/j.1462-2920.2009.01995.x; Rothberg JM, 2008, NAT BIOTECHNOL, V26, P1117, DOI 10.1038/nbt1485; Russell V, 1996, J INSECT PHYSIOL, V42, P65, DOI 10.1016/0022-1910(95)00083-6; Salem H, 2015, P ROY SOC B-BIOL SCI, V282, DOI 10.1098/rspb.2014.2957; Schloss PD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027310; SCHULTZ JC, 1986, OECOLOGIA, V71, P133, DOI 10.1007/BF00377332; Shade A, 2012, ENVIRON MICROBIOL, V14, P4, DOI 10.1111/j.1462-2920.2011.02585.x; SHANNON CE, 1948, BELL SYST TECH J, V27, P379, DOI DOI 10.1002/J.1538-7305.1948.TB01338.X; SHECK AL, 1993, ENTOMOL EXP APPL, V69, P157, DOI 10.1007/BF02380642; Shimodaira H, 1999, MOL BIOL EVOL, V16, P1114, DOI 10.1093/oxfordjournals.molbev.a026201; SIEGERT KJ, 1987, ARCH INSECT BIOCHEM, V4, P151, DOI 10.1002/arch.940040208; Sikorowski PP, 1998, BIOL CONTROL, V12, P50, DOI 10.1006/bcon.1997.0609; STADELBACHER EA, 1981, ENVIRON ENTOMOL, V10, P766, DOI 10.1093/ee/10.5.766; Sudakaran S, 2012, MOL ECOL, V21, P6134, DOI 10.1111/mec.12027; Sullam KE, 2012, MOL ECOL, V21, P3363, DOI 10.1111/j.1365-294X.2012.05552.x; TAMURA K, 1993, MOL BIOL EVOL, V10, P512, DOI 10.1093/oxfordjournals.molbev.a040023; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Tang XS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036978; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Tsuchida T, 2011, BIOL LETTERS, V7, P245, DOI 10.1098/rsbl.2010.0699; Unbehend M, 2013, J CHEM ECOL, V39, P364, DOI 10.1007/s10886-013-0263-6; Vorholt JA, 2012, NAT REV MICROBIOL, V10, P828, DOI 10.1038/nrmicro2910; WALDVOGEL M, 1990, EVOLUTION, V44, P1326, DOI 10.2307/2409292; Wilcks A, 2005, FEMS MICROBIOL LETT, V243, P15, DOI 10.1016/j.femsle.2004.11.028; Xia XF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068852; Yang CH, 2001, P NATL ACAD SCI USA, V98, P3889, DOI 10.1073/pnas.051633898; Zhang Y, 2009, ARCH INSECT BIOCHEM, V70, P18, DOI 10.1002/arch.20258; Zilber-Rosenberg I, 2008, FEMS MICROBIOL REV, V32, P723, DOI 10.1111/j.1574-6976.2008.00123.x	92	59	61	1	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 3	2016	11	5							e0154514	10.1371/journal.pone.0154514	http://dx.doi.org/10.1371/journal.pone.0154514			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DL5KK	27139886	Green Published, Green Submitted, gold			2022-12-26	WOS:000375675700037
J	Wang, J; Yu, QB; Xiong, HB; Wang, J; Chen, SX; Yang, ZN; Dai, SJ				Wang, Jing; Yu, Qingbo; Xiong, Haibo; Wang, Jun; Chen, Sixue; Yang, Zhongnan; Dai, Shaojun			Proteomic Insight into the Response of Arabidopsis Chloroplasts to Darkness	PLOS ONE			English	Article							CYCLIC ELECTRON FLOW; PHOTOSYSTEM-II; THYLAKOID MEMBRANE; STATE TRANSITIONS; REDOX REGULATION; CIRCADIAN CLOCK; DIURNAL CHANGES; PROTEIN IMPORT; CHLOROPHYLL-A; PLANT-GROWTH	Chloroplast function in photosynthesis is essential for plant growth and development. It is well-known that chloroplasts respond to various light conditions. However, it remains poorly understood about how chloroplasts respond to darkness. In this study, we found 81 darkness-responsive proteins in Arabidopsis chloroplasts under 8 h darkness treatment. Most of the proteins are nucleus-encoded, indicating that chloroplast darkness response is closely regulated by the nucleus. Among them, 17 ribosome proteins were obviously reduced after darkness treatment. The protein expressional patterns and physiological changes revealed the mechanisms in chloroplasts in response to darkness, e.g., (1) inhibition of photosystem II resulted in preferential cyclic electron flow around PSI; (2) promotion of starch degradation; (3) inhibition of chloroplastic translation; and (4) regulation by redox and jasmonate signaling. The results have improved our understanding of molecular regulatory mechanisms in chloroplasts under darkness.	[Wang, Jing; Wang, Jun] Shanghai Normal Univ, Dept Math, Coll Math & Sci, Shanghai, Peoples R China; [Wang, Jing; Yu, Qingbo; Xiong, Haibo; Yang, Zhongnan] Shanghai Normal Univ, Inst Plant Gene Funct, Shanghai, Peoples R China; [Yu, Qingbo; Xiong, Haibo; Yang, Zhongnan; Dai, Shaojun] Shanghai Normal Univ, Dept Biol, Coll Life & Environm Sci, Shanghai, Peoples R China; [Chen, Sixue] Univ Florida, Dept Biol, Genet Inst, Plant Mol & Cellular Program,Interdisciplinary Ct, Gainesville, FL USA	Shanghai Normal University; Shanghai Normal University; Shanghai Normal University; State University System of Florida; University of Florida	Yang, ZN (corresponding author), Shanghai Normal Univ, Inst Plant Gene Funct, Shanghai, Peoples R China.; Yang, ZN; Dai, SJ (corresponding author), Shanghai Normal Univ, Dept Biol, Coll Life & Environm Sci, Shanghai, Peoples R China.	znyang@shnu.edu.cn; daishaojun@hotmail.com	yu, qing/HGC-4611-2022; Yang, Zhong-nan/O-2025-2019; CHEN, SI/GZL-4800-2022; Yang, Zhong-Nan/F-5570-2012	Yang, Zhong-nan/0000-0002-5918-2385; Yang, Zhong-Nan/0000-0002-5918-2385	Capacity Construction Project of Local Universities, Shanghai, China [14390502700]; Specially-Appointed Professors (Oriental Scholars) for Shanghai's Universities; National Science Foundation of China [N31370271]	Capacity Construction Project of Local Universities, Shanghai, China; Specially-Appointed Professors (Oriental Scholars) for Shanghai's Universities; National Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by grants from Capacity Construction Project of Local Universities, Shanghai, China (No. 14390502700) and Specially-Appointed Professors (Oriental Scholars) for Shanghai's Universities to S. Dai, and the National Science Foundation of China (N31370271) to ZN Yang. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albertsson PA, 2001, TRENDS PLANT SCI, V6, P349, DOI 10.1016/S1360-1385(01)02021-0; Allen JF, 2003, TRENDS PLANT SCI, V8, P15, DOI 10.1016/S1360-1385(02)00006-7; [Anonymous], 2002, PHOTOSYNTHETICA; Armbruster U, 2013, PLANT CELL, V25, P2661, DOI 10.1105/tpc.113.113118; Aronsson H, 2002, FEBS LETT, V529, P215, DOI 10.1016/S0014-5793(02)03342-2; Bellafiore S, 2005, NATURE, V433, P892, DOI 10.1038/nature03286; Blasing OE, 2005, PLANT CELL, V17, P3257, DOI 10.1105/tpc.105.035261; Breyton C, 2006, BIOCHEMISTRY-US, V45, P13465, DOI 10.1021/bi061439s; Buchanan BB, 2005, ANNU REV PLANT BIOL, V56, P187, DOI 10.1146/annurev.arplant.56.032604.144246; Chauton MS, 2013, PLANT PHYSIOL, V161, P1034, DOI 10.1104/pp.112.206177; CJ Xu, 1998, BIOTECHNOLOGY, V8, P41; Constan D, 2004, PLANT J, V38, P93, DOI 10.1111/j.1365-313X.2004.02024.x; Dalchau N, 2011, P NATL ACAD SCI USA, V108, P5104, DOI 10.1073/pnas.1015452108; Dekker JP, 2005, BBA-BIOENERGETICS, V1706, P12, DOI 10.1016/j.bbabio.2004.09.009; Dietz KJ, 2015, BIOL CHEM, V396, P483, DOI 10.1515/hsz-2014-0281; Dodd AN, 2005, SCIENCE, V309, P630, DOI 10.1126/science.1115581; Eberhard S, 2008, ANNU REV GENET, V42, P463, DOI 10.1146/annurev.genet.42.110807.091452; Eckardt NA, 2011, PLANT CELL, V23, P3870, DOI 10.1105/tpc.111.231113; Ferro M, 2010, MOL CELL PROTEOMICS, V9, P1063, DOI 10.1074/mcp.M900325-MCP200; Fincher V, 2003, EUR J BIOCHEM, V270, P4930, DOI 10.1046/j.1432-1033.2003.03894.x; Finster S, 2013, PLANT J, V76, P849, DOI 10.1111/tpj.12339; Friso G, 2011, METHODS MOL BIOL, V775, P265, DOI 10.1007/978-1-61779-237-3_14; Fristedt R, 2015, PLANT PHYSIOL, V167, P481, DOI 10.1104/pp.114.253336; Ghezzi P, 2005, BIOCHEM SOC T, V33, P1378, DOI 10.1042/BST0331378; Ghosh AK, 2013, J PHYS CHEM A, V117, P8710, DOI 10.1021/jp403178x; Gibon Y, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-8-r76; Graf A, 2011, TRENDS PLANT SCI, V16, P169, DOI 10.1016/j.tplants.2010.12.003; Grieco M, 2012, PLANT PHYSIOL, V160, P1896, DOI 10.1104/pp.112.206466; Hahn D, 1998, PLANT MOL BIOL, V36, P929, DOI 10.1023/A:1005911022601; Hausler RE, 1998, PLANTA, V204, P366, DOI 10.1007/s004250050268; Haydon MJ, 2013, NATURE, V502, P689, DOI 10.1038/nature12603; Heyes DJ, 2005, TRENDS BIOCHEM SCI, V30, P642, DOI 10.1016/j.tibs.2005.09.001; Hirashima M, 2006, J BIOL CHEM, V281, P15385, DOI 10.1074/jbc.M602903200; Ifuku K, 2014, PLANT PHYSIOL BIOCH, V81, P108, DOI 10.1016/j.plaphy.2014.01.001; Ifuku K, 2011, J PHOTOCH PHOTOBIO B, V104, P158, DOI 10.1016/j.jphotobiol.2011.02.006; Igamberdiev AU, 2001, J PLANT PHYSIOL, V158, P1325, DOI 10.1078/0176-1617-00551; Johnson X, 2012, J BIOL CHEM, V287, P26445, DOI 10.1074/jbc.M112.370205; Joliot P, 2002, P NATL ACAD SCI USA, V99, P10209, DOI 10.1073/pnas.102306999; Jung HS, 2010, PLANT PHYSIOL, V152, P453, DOI 10.1104/pp.109.149070; Juntawong P, 2012, FRONT PLANT SCI, V3, DOI 10.3389/fpls.2012.00066; Juric S, 2009, PLANT J, V60, P783, DOI 10.1111/j.1365-313X.2009.03999.x; Kato Y, 2012, PLANT PHYSIOL, V159, P1428, DOI 10.1104/pp.112.199042; KIM J, 1994, PLANT PHYSIOL, V104, P907, DOI 10.1104/pp.104.3.907; KLECZKOWSKI LA, 1993, J BIOL CHEM, V268, P6228; Kuchler M, 2002, EMBO J, V21, P6136, DOI 10.1093/emboj/cdf621; Kunz HH, 2014, P NATL ACAD SCI USA, V111, P7480, DOI 10.1073/pnas.1323899111; Lerbs-Mache S, 2011, PLANT MOL BIOL, V76, P235, DOI 10.1007/s11103-010-9714-4; Li H., 2000, PRINCIPLES TECHNIQUE, P134; Lidder P, PLANT PHYSL, V200, P2374; Lopez-Calcagno PE, 2014, FRONT PLANT SCI, V5, DOI 10.3389/fpls.2014.00009; Maslen S, 2006, ANAL CHEM, V78, P8491, DOI 10.1021/ac0614137; Masuda T, 2003, PLANT CELL PHYSIOL, V44, P963, DOI 10.1093/pcp/pcg128; Meldau S, 2012, BMC PLANT BIOL, V12, DOI 10.1186/1471-2229-12-213; Michelet L, 2013, FRONT PLANT SCI, V4, DOI 10.3389/fpls.2013.00470; Mintel R, 1996, J BIOL CHEM, V241, P3381; Mullineaux CW, 2005, TRENDS PLANT SCI, V10, P521, DOI 10.1016/j.tplants.2005.09.001; Muraki N, 2010, NATURE, V465, P110, DOI 10.1038/nature08950; NAGY F, 1988, GENE DEV, V2, P376, DOI 10.1101/gad.2.4.376; Nath K, 2013, FEBS LETT, V587, P3372, DOI 10.1016/j.febslet.2013.09.015; Nishimura K, 2015, BBA-BIOENERGETICS, V1847, P915, DOI 10.1016/j.bbabio.2014.11.012; Oelze ML, 2012, J EXP BOT, V63, P1297, DOI 10.1093/jxb/err356; Oosawa N, 2000, FEBS LETT, V474, P133, DOI 10.1016/S0014-5793(00)01568-4; Oster U, 2000, PLANT J, V21, P305, DOI 10.1046/j.1365-313x.2000.00672.x; Pal SK, 2013, PLANT PHYSIOL, V162, P1246, DOI 10.1104/pp.112.212258; Papenbrock J, 2011, AMINO ACIDS, V41, P43, DOI 10.1007/s00726-010-0478-6; Park SW, 2013, P NATL ACAD SCI USA, V110, P9559, DOI 10.1073/pnas.1218872110; Pattanayak GK, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026532; Peng LW, 2008, J BIOL CHEM, V283, P34873, DOI 10.1074/jbc.M803207200; Pfalz J, PLANT CELL; Pfalz J, 2013, TRENDS PLANT SCI, V18, P186, DOI 10.1016/j.tplants.2012.11.003; PONGRATZ P, 1978, PLANT PHYSIOL, V62, P687, DOI 10.1104/pp.62.5.687; PORRA RJ, 1989, BIOCHIM BIOPHYS ACTA, V975, P384, DOI 10.1016/S0005-2728(89)80347-0; PREISS J, 1982, ANNU REV PLANT PHYS, V33, P431, DOI 10.1146/annurev.pp.33.060182.002243; Reiland S, 2011, P NATL ACAD SCI USA, V108, P12955, DOI 10.1073/pnas.1104734108; Reinbothe S, 1996, CELL, V86, P703, DOI 10.1016/S0092-8674(00)80144-0; Rochaix JD, 2013, SCIENCE, V342, P50, DOI 10.1126/science.1244943; Roose JL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028624; Rumeau D, 2007, PLANT CELL ENVIRON, V30, P1041, DOI 10.1111/j.1365-3040.2007.01675.x; SCHAFER G, 1977, PLANT PHYSIOL, V60, P286, DOI 10.1104/pp.60.2.286; Schurmann P, 2003, ANTIOXID REDOX SIGN, V5, P69, DOI 10.1089/152308603321223559; Seok MS, 2014, PHYSIOL PLANTARUM, V150, P620, DOI 10.1111/ppl.12116; Shin J, 2012, PLANT CELL, V24, P2470, DOI 10.1105/tpc.111.095430; Smith SM, 2004, PLANT PHYSIOL, V136, P2687, DOI 10.1104/pp.104.044347; Sohrt K, 2000, J CELL BIOL, V148, P1213, DOI 10.1083/jcb.148.6.1213; STITT M, 1982, PLANT PHYSIOL, V70, P971, DOI 10.1104/pp.70.4.971; STITT M, 1985, PLANTA, V166, P354, DOI 10.1007/BF00401173; Sun Q, 2009, NUCLEIC ACIDS RES, V37, pD969, DOI 10.1093/nar/gkn654; TAKAHASHI N, 1989, NATURE, V337, P473, DOI 10.1038/337473a0; Tanaka R, 2005, PHOTOSYNTH RES, V85, P327, DOI 10.1007/s11120-005-6807-z; Tanaka R, 2001, PLANT J, V26, P365, DOI 10.1046/j.1365-313X.2001.2641034.x; Tanaka R, 2011, BBA-BIOENERGETICS, V1807, P968, DOI 10.1016/j.bbabio.2011.01.002; Tanaka R, 2010, ADV PHOTOSYNTH RESP, V31, P55; TANAKA Y, 1992, PLANT PHYSIOL BIOCH, V30, P365; Tikkanen M, 2008, BBA-BIOENERGETICS, V1777, P1432, DOI 10.1016/j.bbabio.2008.08.004; Usadel B, 2008, PLANT PHYSIOL, V146, P1834, DOI 10.1104/pp.107.115592; van der Fits L, 2000, SCIENCE, V289, P295, DOI 10.1126/science.289.5477.295; van Wijk KJ, 2004, PLANT PHYSIOL BIOCH, V42, P963, DOI 10.1016/j.plaphy.2004.10.015; Versaw WK, 2002, PLANT CELL, V14, P1751, DOI 10.1105/tpc.002220; Vizcaino JA, 2016, NUCLEIC ACIDS RES, V44, pD447, DOI 10.1093/nar/gkv1145; Walther TC, 2010, J CELL BIOL, V190, P491, DOI 10.1083/jcb.201004052; Wang LY, 2010, PLANT MOL BIOL, V74, P47, DOI 10.1007/s11103-010-9653-0; Weber A, 2000, PLANT CELL, V12, P787, DOI 10.1105/tpc.12.5.787; Wilhelm C, 2011, J PLANT PHYSIOL, V168, P79, DOI 10.1016/j.jplph.2010.07.012; Williams-Carrier R, 2010, PLANT J, V63, P167, DOI 10.1111/j.1365-313X.2010.04231.x; Wollman FA, 2001, EMBO J, V20, P3623, DOI 10.1093/emboj/20.14.3623; Wu QG, 1995, PLANT MOL BIOL, V29, P933, DOI 10.1007/BF00014967; Yamamoto H, 2006, PLANT CELL PHYSIOL, V47, P1355, DOI 10.1093/pcp/pcl005; Yamasato A, 2005, PLANT CELL, V17, P1585, DOI 10.1105/tpc.105.031518; Yamori W, 2011, PLANT J, V68, P966, DOI 10.1111/j.1365-313X.2011.04747.x; Yi XP, 2007, J BIOL CHEM, V282, P24833, DOI 10.1074/jbc.M705011200; Yoshida K, 2014, PLANT CELL PHYSIOL, V55, P1415, DOI 10.1093/pcp/pcu066; Yu QB, 2014, FRONT PLANT SCI, V5, DOI 10.3389/fpls.2014.00316; Zhang GX, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097322; Zhang N, 2002, P NATL ACAD SCI USA, V99, P3330, DOI 10.1073/pnas.042529999; Zhong LL, 2013, PLANT CELL, V25, P2925, DOI 10.1105/tpc.113.111229	115	16	16	1	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 3	2016	11	5							e0154235	10.1371/journal.pone.0154235	http://dx.doi.org/10.1371/journal.pone.0154235			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DL5KK	27137770	Green Submitted, Green Published, gold			2022-12-26	WOS:000375675700022
J	Li, SL; Huai, WX				Li, Shuolin; Huai, Wenxin			United Formula for the Friction Factor in the Turbulent Region of Pipe Flow	PLOS ONE			English	Article								Friction factor is an important element in both flow simulations and river engineering. In hydraulics, studies on the friction factor in turbulent regions have been based on the concept of three flow regimes, namely, the fully smooth regime, the fully rough regime, and the transitional regime, since the establishment of the Nikuradze's chart. However, this study further demonstrates that combining the friction factor with Reynolds number yields a united formula that can scale the entire turbulent region. This formula is derived by investigating the correlation between friction in turbulent pipe flow and its influencing factors, i.e., Reynolds number and relative roughness. In the present study, the formulae of Blasius and Stricklerare modified to rearrange the implicit model of Tao. In addition, we derive a united explicit formula that can compute the friction factor in the entire turbulent regimes based on the asymptotic behavior of the improved Tao's model. Compared with the reported formulae of Nikuradze, the present formula exhibits higher computational accuracy for the original pipe experiment data of Nikuradze.	[Li, Shuolin; Huai, Wenxin] Wuhan Univ, State Key Lab Water Resources & Hydropower Engn S, Wuhan 430072, Peoples R China	Wuhan University	Huai, WX (corresponding author), Wuhan Univ, State Key Lab Water Resources & Hydropower Engn S, Wuhan 430072, Peoples R China.	wxhuai@whu.edu.cn			Natural Science Foundation of China [51479007, 11172218, 11372232]; Specialized Research Fund for the Doctoral Program of Higher Education [20130141110016]	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Specialized Research Fund for the Doctoral Program of Higher Education(Specialized Research Fund for the Doctoral Program of Higher Education (SRFDP))	The authors, especially WENXIN HUAI, are grateful to the financial support of Natural Science Foundation of China (Grant Nos. 51479007, 11172218, and 11372232) and Specialized Research Fund for the Doctoral Program of Higher Education (Grant No. 20130141110016). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Batchelor G. K., 1973, SCENARIOS NARRATIVES, V10, P454; Blasius H.Z., 1913, ARB ING WES, V131; Brownlie W. R., 2014, J HYDRAULICS DIVISIO, V107, P115; Chanson H, 1996, HYDRAULICS OPEN CHAN; Cheng NS, 2008, J HYDRAUL ENG-ASCE, V134, P1357, DOI 10.1061/(ASCE)0733-9429(2008)134:9(1357); Cheng NS, 1998, J HYDRAUL ENG-ASCE, V124, P1235, DOI 10.1061/(ASCE)0733-9429(1998)124:12(1235); Colebrook C. F., 1939, J I CIVIL ENG, V12, P393, DOI [DOI 10.1680/IJOTI.1939.14509, 10.1680/ijoti.1939.14509]; Gioia G, 2005, PHYS REV LETT, V96; Goldenfeld N, 2006, PHYS REV LETT, V96, DOI 10.1103/PhysRevLett.96.044503; Griffiths D. V., 2010, NUMERICAL METHODS EN, V22, P59; Guo JK, 2002, J HYDRAUL RES, V40, P555, DOI 10.1080/00221680209499900; Li W., 2000, HYDRAULICS; LIGRANI PM, 1986, J FLUID MECH, V162, P69, DOI 10.1017/S0022112086001933; Mohammad M., 2008, PHYS REV E, V77, P463; Nikuradze J., 1950, LAWS FLOW ROUGH PIPE; Shames I. H., 1982, MECH FLUIDS; Strickler A., 1981, CONTRIBUTIONS QUESTI; Tao JJ, 2009, PHYS REV LETT, V103, DOI 10.1103/PhysRevLett.103.264502; Yalin M., 2001, IAHR MONOGRAPH; Zeng YH, 2009, COMMUN NONLINEAR SCI, V14, P2373, DOI 10.1016/j.cnsns.2008.06.020	20	7	7	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 2	2016	11	5							e0154408	10.1371/journal.pone.0154408	http://dx.doi.org/10.1371/journal.pone.0154408			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DL5KB	27136099	Green Submitted, Green Published, gold			2022-12-26	WOS:000375674800020
J	Si, S; Nakajima-Takagi, Y; Aoyama, K; Oshima, M; Saraya, A; Sugishita, H; Nakayama, M; Ishikura, T; Koseki, H; Iwama, A				Si, Sha; Nakajima-Takagi, Yaeko; Aoyama, Kazumasa; Oshima, Motohiko; Saraya, Atsunori; Sugishita, Hiroki; Nakayama, Manabu; Ishikura, Tomoyuki; Koseki, Haruhiko; Iwama, Atsushi			Loss of Pcgf5 Affects Global H2A Monoubiquitination but Not the Function of Hematopoietic Stem and Progenitor Cells	PLOS ONE			English	Article							METHYLTRANSFERASE GENE EZH2; SOMATIC MUTATIONS; POLYCOMB; COMPLEXES; UBIQUITYLATION; SPECIFICATION; MALIGNANCIES; MAINTENANCE; REGULATORS; PROTEINS	Polycomb-group RING finger proteins (Pcgf1-Pcgf6) are components of Polycomb repressive complex 1 (PRC1)-related complexes that catalyze monoubiquitination of histone H2A at lysine 119 (H2AK119ub1), an epigenetic mark associated with repression of genes. Pcgf5 has been characterized as a component of PRC1.5, one of the non-canonical PRC1, consisting of Ring1a/b, Rybp/Yaf2 and Auts2. However, the biological functions of Pcgf5 have not yet been identified. Here we analyzed the impact of the deletion of Pcgf5 specifically in hematopoietic stem and progenitor cells (HSPCs). Pcgf5 is expressed preferentially in hematopoietic stem cells (HSCs) and multipotent progenitors (MPPs) compared with committed myeloid progenitors and differentiated cells. We transplanted bone marrow (BM) cells from Rosa:: Cre-ERT control and Cre-ERT; Pcgf5(fl/fl) mice into lethally irradiated recipient mice. At 4 weeks post-transplantation, we deleted Pcgf5 by injecting tamoxifen, however, no obvious changes in hematopoiesis were detected including the number of HSPCs during a long-term observation period following the deletion. Competitive BM repopulating assays revealed normal repopulating capacity of Pcgf5-deficient HSCs. Nevertheless, Pcgf5-deficient HSPCs showed a significant reduction in H2AK119ub1 levels compared with the control. ChIP-sequence analysis confirmed the reduction in H2AK119ub1 levels, but revealed no significant association of changes in H2AK119ub1 levels with gene expression levels. Our findings demonstrate that Pcgf5-containing PRC1 functions as a histone modifier in vivo, but its role in HSPCs is limited and can be compensated by other PRC1-related complexes in HSPCs.	[Si, Sha; Nakajima-Takagi, Yaeko; Aoyama, Kazumasa; Oshima, Motohiko; Saraya, Atsunori; Iwama, Atsushi] Chiba Univ, Grad Sch Med, Dept Cellular & Mol Med, Chiba, Japan; [Nakayama, Manabu] Kazusa DNA Res Inst, Dev Technol Dept, Chromosome Engn Team, Kisarazu, Japan; [Sugishita, Hiroki; Ishikura, Tomoyuki; Koseki, Haruhiko] RIKEN Ctr Integrat Med Sci IMS, Lab Dev Genet, Yokohama, Kanagawa, Japan	Chiba University; Kazusa DNA Research Institute; RIKEN	Iwama, A (corresponding author), Chiba Univ, Grad Sch Med, Dept Cellular & Mol Med, Chiba, Japan.	aiwama@faculty.chiba-u.jp		Sugishita, Hiroki/0000-0002-6561-8261	MEXT, Japan [15H02544, 26115002]; Yasuda Memorial Medical Foundation; Naito Foundation; JSPS; MEXT, Japan; Grants-in-Aid for Scientific Research [16K20959, 16H02622] Funding Source: KAKEN	MEXT, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Yasuda Memorial Medical Foundation; Naito Foundation(Naito Memorial Foundation); JSPS(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); MEXT, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported in part by Grants-in-Aid for Scientific Research (#15H02544) and Scientific Research on Innovative Areas "Stem Cell Aging and Disease" (#26115002) from MEXT, Japan, and grants from the Yasuda Memorial Medical Foundation and the Naito Foundation. Yaeko Nakajima-Takagi is a research fellow supported by JSPS, MEXT, Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beerman I, 2015, CELL STEM CELL, V16, P613, DOI 10.1016/j.stem.2015.05.009; Blackledge NP, 2014, CELL, V157, P1445, DOI 10.1016/j.cell.2014.05.004; Comet I, 2014, NAT STRUCT MOL BIOL, V21, P573, DOI 10.1038/nsmb.2848; Ernst T, 2010, NAT GENET, V42, P722, DOI 10.1038/ng.621; Gao ZH, 2014, NATURE, V516, P349, DOI 10.1038/nature13921; Gao ZH, 2012, MOL CELL, V45, P344, DOI 10.1016/j.molcel.2012.01.002; Hidalgo I, 2012, CELL STEM CELL, V11, P649, DOI 10.1016/j.stem.2012.08.001; Laugesen A, 2014, CELL STEM CELL, V14, P735, DOI 10.1016/j.stem.2014.05.006; Mochizuki-Kashio M, 2015, BLOOD, V126, P1172, DOI 10.1182/blood-2015-03-634428; Morey L, 2015, CELL STEM CELL, V17, P300, DOI 10.1016/j.stem.2015.08.009; Morey L, 2013, CELL REP, V3, P60, DOI 10.1016/j.celrep.2012.11.026; Morin RD, 2010, NAT GENET, V42, P181, DOI 10.1038/ng.518; Nikoloski G, 2010, NAT GENET, V42, P665, DOI 10.1038/ng.620; Oguro H, 2006, J EXP MED, V203, P2247, DOI 10.1084/jem.20052477; Oguro H, 2010, CELL STEM CELL, V6, P279, DOI 10.1016/j.stem.2010.01.005; Oshima M, 2014, INT J HEMATOL, V100, P326, DOI 10.1007/s12185-014-1647-2; Park IK, 2003, NATURE, V423, P302, DOI 10.1038/nature01587; Sauvageau M, 2010, CELL STEM CELL, V7, P299, DOI 10.1016/j.stem.2010.08.002; Shih AH, 2012, NAT REV CANCER, V12, P599, DOI 10.1038/nrc3343; Wu XD, 2013, MOL CELL, V49, P1134, DOI 10.1016/j.molcel.2013.01.016; Xie HF, 2014, CELL STEM CELL, V14, P68, DOI 10.1016/j.stem.2013.10.001	21	14	15	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 2	2016	11	5							e0154561	10.1371/journal.pone.0154561	http://dx.doi.org/10.1371/journal.pone.0154561			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DL5KB	27136092	Green Published, gold, Green Submitted			2022-12-26	WOS:000375674800030
J	Boke-Olen, N; Lehsten, V; Ardo, J; Beringer, J; Eklundh, L; Holst, T; Veenendaal, E; Tagesson, T				Boke-Olen, Niklas; Lehsten, Veiko; Ardo, Jonas; Beringer, Jason; Eklundh, Lars; Holst, Thomas; Veenendaal, Elmar; Tagesson, Torbern			Estimating and Analyzing Savannah Phenology with a Lagged Time Series Model	PLOS ONE			English	Article							CARBON FLUXES; CLIMATE-CHANGE; ENERGY FLUXES; SOIL-MOISTURE; VEGETATION; WATER; PATTERNS; NDVI; PRECIPITATION; PRODUCTIVITY	Savannah regions are predicted to undergo changes in precipitation patterns according to current climate change projections. This change will affect leaf phenology, which controls net primary productivity. It is of importance to study this since savannahs play an important role in the global carbon cycle due to their areal coverage and can have an effect on the food security in regions that depend on subsistence farming. In this study we investigate how soil moisture, mean annual precipitation, and day length control savannah phenology by developing a lagged time series model. The model uses climate data for 15 flux tower sites across four continents, and normalized difference vegetation index from satellite to optimize a statistical phenological model. We show that all three variables can be used to estimate savannah phenology on a global scale. However, it was not possible to create a simplified savannah model that works equally well for all sites on the global scale without inclusion of more site specific parameters. The simplified model showed no bias towards tree cover or between continents and resulted in a cross-validated r(2) of 0.6 and root mean squared error of 0.1. We therefore expect similar average results when applying the model to other savannah areas and further expect that it could be used to estimate the productivity of savannah regions.	[Boke-Olen, Niklas; Lehsten, Veiko; Ardo, Jonas; Eklundh, Lars; Holst, Thomas] Lund Univ, Dept Phys Geog & Ecosyst Sci, Lund, Sweden; [Beringer, Jason] Univ Western Australia, SEE, Crawley, Australia; [Veenendaal, Elmar] Wageningen Univ, Ctr Ecosyst Studies, NL-6700 AP Wageningen, Netherlands; [Tagesson, Torbern] Univ Copenhagen, Dept Geosci & Nat Resource Management, Copenhagen, Denmark	Lund University; University of Western Australia; Wageningen University & Research; University of Copenhagen	Boke-Olen, N (corresponding author), Lund Univ, Dept Phys Geog & Ecosyst Sci, Lund, Sweden.	Niklas.Boke-Olen@nateko.lu.se	Beringer, Jason/B-8528-2008; Tagesson, Torbern/AGG-5627-2022; Eklundh, Lars R/G-4253-2010; Boke-Olen, Niklas/AAQ-8047-2020; Tagesson, Torbern/E-5429-2015	Beringer, Jason/0000-0002-4619-8361; Eklundh, Lars R/0000-0001-7644-6517; Boke-Olen, Niklas/0000-0003-2441-7153; Ardo, Jonas/0000-0002-9318-0973; Tagesson, Torbern/0000-0003-3011-1775; Holst, Thomas/0000-0002-3360-9395	Lund University Center for studies of Carbon Cycle and Climate Interactions (LUCCI); Lund University; University of Gothenburg Biodiversity and Ecosystem Services in a Changing Climate (BECC); ARC FT [FT1110602]; ERA-Net BiodivERsA; FORMAS part of the BiodivERsA call for research proposals via the EC21C project	Lund University Center for studies of Carbon Cycle and Climate Interactions (LUCCI); Lund University; University of Gothenburg Biodiversity and Ecosystem Services in a Changing Climate (BECC); ARC FT(Australian Research Council); ERA-Net BiodivERsA; FORMAS part of the BiodivERsA call for research proposals via the EC21C project	Boke-Olen is supported by Lund University Center for studies of Carbon Cycle and Climate Interactions (LUCCI) and Lund University and University of Gothenburg Biodiversity and Ecosystem Services in a Changing Climate (BECC). Beringer is funded under an ARC FT (FT1110602). Support for collection and archiving the data for the Australian sites were provided through the Australia Terrestrial Ecosystem Research Network (TERN) (http://www.tern.org.au). Lehsten is funded by the ERA-Net BiodivERsA, with the national funder FORMAS part of the 2012 BiodivERsA call for research proposals via the EC21C project. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2011, MODIS SUBS LAND PROD; Archibald S, 2007, J VEG SCI, V18, P583, DOI 10.1111/j.1654-1103.2007.tb02572.x; Ardo J., 2013, DATASET PAP GEOSCI, V2013, P297973, DOI [10.7167/2013/297973, DOI 10.7167/2013/297973]; Armah FA, 2011, MITIG ADAPT STRAT GL, V16, P291, DOI 10.1007/s11027-010-9263-9; Baldocchi DD, 2004, AGR FOREST METEOROL, V123, P13, DOI 10.1016/j.agrformet.2003.11.006; Beringer J, 2011, B AM METEOROL SOC, V92, P1467, DOI 10.1175/2011BAMS2948.1; Beringer J, 2011, AGR FOREST METEOROL, V151, P1409, DOI 10.1016/j.agrformet.2011.05.003; Blanco LJ, 2008, J ARID ENVIRON, V72, P764, DOI 10.1016/j.jaridenv.2007.10.003; Botta A, 2000, GLOBAL CHANGE BIOL, V6, P709, DOI 10.1046/j.1365-2486.2000.00362.x; Brovkin V, 2006, CLIM DYNAM, V26, P587, DOI 10.1007/s00382-005-0092-6; Cappelaere B, 2009, J HYDROL, V375, P34, DOI 10.1016/j.jhydrol.2009.06.021; Casals P, 2009, SOIL BIOL BIOCHEM, V41, P1915, DOI 10.1016/j.soilbio.2009.06.015; Chamaille-Jammes S, 2009, INT J REMOTE SENS, V30, P3409, DOI 10.1080/01431160802562206; Chidumayo EN, 2001, J VEG SCI, V12, P347, DOI 10.2307/3236848; Choler P, 2010, BIOGEOSCIENCES, V7, P907, DOI 10.5194/bg-7-907-2010; Churkina G, 1998, ECOSYSTEMS, V1, P206, DOI 10.1007/s100219900016; de Rosnay P, 2009, J HYDROL, V375, P241, DOI 10.1016/j.jhydrol.2009.01.015; Donohue RJ, 2014, REMOTE SENS ENVIRON, V155, P349, DOI 10.1016/j.rse.2014.09.007; Dorigo WA, 2011, HYDROL EARTH SYST SC, V15, P1675, DOI 10.5194/hess-15-1675-2011; DYE PJ, 1987, J APPL ECOL, V24, P633, DOI 10.2307/2403898; FARRAR TJ, 1994, REMOTE SENS ENVIRON, V50, P121, DOI 10.1016/0034-4257(94)90039-6; Fensholt R, 2010, IEEE J-STARS, V3, P271, DOI 10.1109/JSTARS.2010.2048744; Grace J, 2006, J BIOGEOGR, V33, P387, DOI 10.1111/j.1365-2699.2005.01448.x; Gromping U, 2006, J STAT SOFTW, V17, DOI 10.18637/jss.v017.i01; Grover SPP, 2012, BIOGEOSCIENCES, V9, P423, DOI 10.5194/bg-9-423-2012; HANNINEN H, 1995, CAN J BOT, V73, P183, DOI 10.1139/b95-022; Hansen M, 2003, MOD44B VEGETATION CO; Heumann BW, 2007, REMOTE SENS ENVIRON, V108, P385, DOI 10.1016/j.rse.2006.11.025; Higgins SI, 2011, J BIOGEOGR, V38, P2165, DOI 10.1111/j.1365-2699.2011.02549.x; Hutley LB, 2011, AGR FOREST METEOROL, V151, P1417, DOI 10.1016/j.agrformet.2011.03.002; Johnson LF, 2003, AUST J GRAPE WINE R, V9, P96, DOI 10.1111/j.1755-0238.2003.tb00258.x; Jolly WM, 2005, GLOBAL CHANGE BIOL, V11, P619, DOI 10.1111/j.1365-2486.2005.00930.x; Jonsson P, 2004, COMPUT GEOSCI-UK, V30, P833, DOI 10.1016/j.cageo.2004.05.006; Kanniah KD, 2010, PROG PHYS GEOG, V34, P459, DOI 10.1177/0309133310364933; Krinner G, 2005, GLOBAL BIOGEOCHEM CY, V19, DOI 10.1029/2003GB002199; Kucharik CJ, 2000, GLOBAL BIOGEOCHEM CY, V14, P795, DOI 10.1029/1999GB001138; KUTSCH WL, 2008, BIOGEOSCIENCES, V5, P1797; Lehmann CER, 2014, SCIENCE, V343, P548, DOI 10.1126/science.1247355; Lotsch A, 2003, GEOPHYS RES LETT, V30, DOI 10.1029/2003GL017506; Merbold L, 2009, BIOGEOSCIENCES, V6, P1027, DOI 10.5194/bg-6-1027-2009; Myneni RB, 1997, NATURE, V386, P698, DOI 10.1038/386698a0; Nickless A, 2012, MALOPENI DATASET; Pellarin T, 2009, J HYDROL, V375, P262, DOI 10.1016/j.jhydrol.2008.12.003; Penuelas J, 2009, SCIENCE, V324, P887, DOI 10.1126/science.1173004; PRINS HHT, 1988, J BIOGEOGR, V15, P465, DOI 10.2307/2845276; Rahmstorf S, 2012, ENVIRON RES LETT, V7, DOI [10.1088/1748-9326/7/4/044035, 10.1088/1748-9326/7/2/021001]; Redelsperger JL, 2006, B AM METEOROL SOC, V87, P1739, DOI 10.1175/BAMS-87-12-1739; REED BC, 1994, J VEG SCI, V5, P703, DOI 10.2307/3235884; Richardson AD, 2013, AGR FOREST METEOROL, V169, P156, DOI 10.1016/j.agrformet.2012.09.012; Sankaran M, 2005, NATURE, V438, P846, DOI 10.1038/nature04070; Scholes R. J., 2001, Koedoe, V44, P73; Scholes R.J., 1993, AFRICAN SAVANNA SYNT; SCHULTZ PA, 1993, ADV SPACE RES-SERIES, V13, P277, DOI 10.1016/0273-1177(93)90559-T; Schwartz MD, 2000, INT J CLIMATOL, V20, P929, DOI 10.1002/1097-0088(20000630)20:8&lt;929::AID-JOC557&gt;3.0.CO;2-5; SCHWARZ G, 1978, ANN STAT, V6, P461, DOI 10.1214/aos/1176344136; Seghieri J, 2012, PLANT ECOL, V213, P861, DOI 10.1007/s11258-012-0048-y; SELLERS PJ, 1985, INT J REMOTE SENS, V6, P1335, DOI 10.1080/01431168508948283; Sjostrom M, 2009, BIOGEOSCIENCES, V6, P129; Smith B, 2001, GLOBAL ECOL BIOGEOGR, V10, P621, DOI 10.1046/j.1466-822X.2001.00256.x; Tagesson T, 2009, INT J REMOTE SENS, V30, P5619, DOI 10.1080/01431160802695709; Trabucco A, 2009, CGIAR CONSORT SPATIA; Veenendaal EM, 2004, GLOBAL CHANGE BIOL, V10, P318, DOI 10.1111/j.1365-2486.2003.00699.x; Weedon GP, 2014, WATER RESOUR RES, V50, P7505, DOI 10.1002/2014WR015638; Williams CA, 2009, OECOLOGIA, V161, P469, DOI 10.1007/s00442-009-1405-y	64	10	10	2	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 29	2016	11	4							e0154615	10.1371/journal.pone.0154615	http://dx.doi.org/10.1371/journal.pone.0154615			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DK8XM	27128678	Green Published, Green Submitted, gold			2022-12-26	WOS:000375212600050
J	Gu, HF; Li, HZ; Tang, YL; Tang, XQ; Zheng, XL; Liao, DF				Gu, Hong-Feng; Li, Hai-Zhe; Tang, Ya-Ling; Tang, Xiao-Qing; Zheng, Xi-Long; Liao, Duan-Fang			Nicotinate-Curcumin Impedes Foam Cell Formation from THP-1 Cells through Restoring Autophagy Flux	PLOS ONE			English	Article								Our previous studies have indicated that a novel curcumin derivate nicotinate-curcumin (NC) has beneficial effects on the prevention of atherosclerosis, but the precise mechanisms are not fully understood. Given that autophagy regulates lipid metabolism, the present study was designed to investigate whether NC decreases foam cell formation through restoring autophagy flux in oxidized low-density lipoprotein (ox-LDL)-treated THP-1 cells. Our results showed that ox-LDL (100 mu g/ml) was accumulated in THP-1 cells and impaired autophagy flux. Ox-LDL-induced impairment of autophagy was enhanced by treatment with the autophagy inhibitor chloroquine (CQ) and rescued by the autophagy inducer rapamycin. The aggregation of ox-LDL was increased by CQ, but decreased by rapamycin. In addition, colocalization of lipid droplets with LC3-II was remarkably reduced in ox-LDL group. In contrast, NC (10 mu M) rescued the impaired autophagy flux by significantly increasing level of LC3-II, the number of autophagolysosomes, and the degradation of p62 in ox-LDL-treated THP-1 cells. Inhibition of the PI3K-Akt-mTOR signaling was required for NC-rescued autophagy flux. Notably, our results showed that NC remarkably promoted the colocalization of lipid droplets with autophagolysosomes, increased efflux of cholesterol, and reduced ox-LDL accumulation in THP-1 cells. However, treatment with 3-methyladenine (3-MA) or CQ reduced the protective effects of NC on lipid accumulation. Collectively, the findings suggest that NC decreases lipid accumulation in THP-1 cells through restoring autophagy flux, and further implicate that NC may be a potential therapeutic reagent to reverse atherosclerosis.	[Gu, Hong-Feng; Tang, Ya-Ling; Tang, Xiao-Qing] Univ South China, Dept Physiol, Hengyang, Peoples R China; [Gu, Hong-Feng; Tang, Ya-Ling; Tang, Xiao-Qing] Univ South China, Inst Neurosci, Hengyang, Peoples R China; [Li, Hai-Zhe] Univ South China, Affiliated Hosp 1, Dept Neurol, Hengyang, Peoples R China; [Zheng, Xi-Long] Univ Calgary, Fac Med, Libin Cardiovasc Inst Alberta, Smooth Muscle Res Grp,Dept Biochem & Mol Biol, Calgary, AB, Canada; [Zheng, Xi-Long; Liao, Duan-Fang] Hunan Univ Chinese Med, Div Stem Cell Regulat & Applicat, State Key Lab Chinese Med Powder & Med Innovat Hu, Changsha, Hunan, Peoples R China	University of South China; University of South China; University of South China; Libin Cardiovascular Institute Of Alberta; University of Calgary; Hunan University of Chinese Medicine	Liao, DF (corresponding author), Hunan Univ Chinese Med, Div Stem Cell Regulat & Applicat, State Key Lab Chinese Med Powder & Med Innovat Hu, Changsha, Hunan, Peoples R China.	dfliao66@aliyun.com		Zheng, Xi-Long/0000-0002-0889-1827	National Natural Science Foundation of China [31371161, 81500349]; construct program of the key discipline in Hunan province, China (Basic Medicine Sciences in University of South China); Postdoctoral Science Foundation of China [2012M521525]; Zhengxiang Scholar Program of University of South China [2014-004]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); construct program of the key discipline in Hunan province, China (Basic Medicine Sciences in University of South China); Postdoctoral Science Foundation of China(China Postdoctoral Science Foundation); Zhengxiang Scholar Program of University of South China	This work was supported by grants from the National Natural Science Foundation of China (grants no. 31371161, 81500349), the construct program of the key discipline in Hunan province, China (Basic Medicine Sciences in University of South China), Postdoctoral Science Foundation of China (2012M521525), and Zhengxiang Scholar Program of University of South China (2014-004). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barascuk N, 2010, BMC CARDIOVASC DISOR, V10, DOI 10.1186/1471-2261-10-19; Cheng LC, 2011, FREE RADICAL BIOL ME, V50; de Bem AF, 2008, ATHEROSCLEROSIS, V201, P92, DOI 10.1016/j.atherosclerosis.2008.02.030; Ding X, 2010, AUTOPHAGY, V6; Doonan RJ, 2014, ARTERIOSCLEROSIS THR, V34; Duarte JH., 2015, NATURE REV CARDIOLOG, V12; Gong YZ, 2014, CHINESE J ARTERIOSCL, V22; Gu HF, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112683; Gupta A., 2011, NEW ENGLAND J MED, V364; Han J, 2012, AUTOPHAGY, V8, P812, DOI 10.4161/auto.19471; Kim HS, 2013, J BIOL CHEM, V288; Klionsky DJ, 2012, AUTOPHAGY, V8, P445, DOI 10.4161/auto.19496; Li BH, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.146; Liao X, 2012, CELL METABOLISM, V15; Linder MD, 2009, ARTERIOSCLEROSIS THR, V29; Maiuri MC, 2013, MEDIAT INFLAMM, V2013, DOI 10.1155/2013/584715; Mei S, 2012, J BIOL CHEM, V287, P11761, DOI 10.1074/jbc.M111.333575; Mochida K, 2015, NATURE, V522, P359, DOI 10.1038/nature14506; Mourtas S, 2014, EUROPEAN J MED CHEM, V80; Nguyen SD, 2012, J LIPID RES, V53; Ouimet M, 2011, CELL METABOLISM, V13; Sarkar S, 2009, AUTOPHAGY, V5, P307, DOI 10.4161/auto.5.3.7664; Singh R, 2009, NATURE, V458, P1131, DOI 10.1038/nature07976; Suzuki H, 1997, NATURE, V386, P292, DOI 10.1038/386292a0; Tian GP, 2012, BIOCHIMIE, V94, P2749, DOI 10.1016/j.biochi.2012.08.018; Wang AL, 2009, AUTOPHAGY, V5; Wang X, 2014, DNA CELL BIOL, V33; Weibel GL, 2014, ARTERIOSCLEROSIS THR, V34; Xu X, 2014, GENE, V546; Zhang CP, 2015, PROGR BIOCH BIOPHYSI, V42; Zhang M, 2014, ATHEROSCLEROSIS, V234, P54, DOI 10.1016/j.atherosclerosis.2014.02.008; Zhang YL, 2010, BIOCH BIOPHYSICAL RE, V394; Zhao R, 2015, J CANC, V6; Zhao Z, 2015, MOL MED REPORTS, V12; Zhou GZ, 2015, J BIOCHEM MOL TOXIC, V29, P267, DOI 10.1002/jbt.21694	35	40	45	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 29	2016	11	4							e0154820	10.1371/journal.pone.0154820	http://dx.doi.org/10.1371/journal.pone.0154820			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DK8XM	27128486	Green Submitted, gold, Green Published			2022-12-26	WOS:000375212600072
J	Han, SY; Oh, SW; Hong, JW; Yi, SY; Noh, JH; Lee, HR; Kim, DJ				Han, Sang Youb; Oh, Se Won; Hong, Jae Won; Yi, Seong Yoon; Noh, Jung Hyun; Lee, Hye Ran; Kim, Dong-Jun			Association of Estimated Glomerular Filtration Rate with Hemoglobin Level in Korean Adults: The 2010-2012 Korea National Health and Nutrition Examination Survey	PLOS ONE			English	Article							ALL-CAUSE MORTALITY; KIDNEY-DISEASE; RENAL-FAILURE; RISK-FACTOR; ERYTHROPOIETIN; ANEMIA; CKD	Purpose Little is known about anemia in patients with early renal dysfunction. We aimed to investigate the association of hemoglobin level and anemia prevalence with estimated glomerular filtration rate (eGFR) decline using a nation-wide representative sample of the adult Korean population. Methods In total, 17,373 participants (7,296 men; weighted n = 18,330,187; mean age, 44.2 +/- 0.3 years; 9,886 women, weighted n = 18,317,454; mean age, 46.9 +/- 0.3 years) were included. eGFR was divided into 5 groups: Group 1,>= 105; Group 2, 90-104; 75-89; Group 4, 60-74; and Group 5, <60 mL/min/1.73m(2). Results The weighted anemia prevalence rates were 2.6% in men and 12.8% in women. In men, the weighted hemoglobin level increased with a decrease in eGFR; this value peaked at an eGFR of 60-89 mL/min/1.73m(2) and decreased thereafter at an eGFR of <60 mL/min/1.73m(2) (15.19 +/- 0.03, 15.35 +/- 0.03, 15.53 +/- 0.03, 15.52 +/- 0.06, and 14.90 +/- 0.12 g/dL from Groups 1 to 5) after adjustment for age, college graduation, cancer history, current smoking, waist circumference, serum cholesterol level, serum triglyceride level, and diastolic blood pressure. In women, the weighted hemoglobin level increased with a decrease in eGFR; this value peaked with an eGFR of 75-89 mL/min/1.73m(2) and decreased thereafter (12.90 +/- 0.03, 13.08 +/- 0.02, 13.20 +/- 0.04, 13.14 +/- 0.05, and 12.47 +/- 0.11 g/dL from Groups 1 to 5) after adjustment for menstruation, pregnancy, estrogen replacement, and the above-mentioned variables. In both sexes, the weighted prevalence of anemia with an eGFR of 60-104 mL/min/1.73m(2) was significantly lower than that with an eGFR of >= 105 mL/min/1.73m(2) (men, 3.2 +/- 0.4%, 1.9 +/- 0.3%, 1.8 +/- 0.3%, 2.0 +/- 0.9%, and 18.1 +/- 3.1%; women, 14.0 +/- 0.8%, 11.2 +/- 0.7%, 10.5 +/- 1.0%, 13.2 +/- 1.6%, and 32.3 +/- 3.2% from Groups 1 to 5). Conclusions We noted a compensatory increase in the hemoglobin level with a minor decline in kidney function (in the range of eGFR >= 60 mL/min/1.73m(2)) prior to a marked decrease in hemoglobin level with severe renal dysfunction.	[Han, Sang Youb; Oh, Se Won; Hong, Jae Won; Yi, Seong Yoon; Noh, Jung Hyun; Lee, Hye Ran; Kim, Dong-Jun] Inje Univ, Dept Internal Med, Ilsan Paik Hosp, Goyang, South Korea	Inje University	Kim, DJ (corresponding author), Inje Univ, Dept Internal Med, Ilsan Paik Hosp, Goyang, South Korea.	djkim@paik.ac.kr	Noh, Junghyun/AAU-8113-2020; Oh, Se Won/G-2632-2017	Oh, Se Won/0000-0003-3795-9322				Astor BC, 2004, AM J KIDNEY DIS, V43, P836, DOI 10.1053/j.ajkd.2003.12.047; Babitt JL, 2010, AM J KIDNEY DIS, V55, P726, DOI 10.1053/j.ajkd.2009.12.030; Blanc B., 1968, WHO TECH REP SER, V405, P1; Donnelly S, 2003, ADV EXP MED BIOL, V543, P73; Dunn A, 2007, AM J MED SCI, V334, P65, DOI 10.1097/MAJ.0b013e318095a4ae; ESCHBACH JW, 1967, NEW ENGL J MED, V276, P653, DOI 10.1056/NEJM196703232761202; Ferguson MA, 2012, CLIN CHEM, V58, P680, DOI 10.1373/clinchem.2011.167494; Go AS, 2006, CIRCULATION, V113, P2713, DOI 10.1161/CIRCULATIONAHA.105.577577; Group KAW, 2012, KIDNEY INT, V2, P279, DOI DOI 10.1038/kisup.2012.37; Gunaratnam L, 2009, J AM SOC NEPHROL, V20, P1877, DOI 10.1681/ASN.2008070804; Hayashi T, 2000, AM J KIDNEY DIS, V35, P250, DOI 10.1016/S0272-6386(00)70334-9; Kim YC, 2012, TOHOKU J EXP MED, V227, P149, DOI 10.1620/tjem.227.149; Levey AS, 2009, ANN INTERN MED, V150, P604, DOI 10.7326/0003-4819-150-9-200905050-00006; Levin A, 2006, AM J KIDNEY DIS, V47, pS9, DOI 10.1053/j.ajkd.2006.04.023; Manotham K, 2004, J AM SOC NEPHROL, V15, P1277, DOI 10.1097/01.ASN.0000125614.35046.10; Maxwell P, 2003, J AM SOC NEPHROL, V14, P2712, DOI 10.1097/01.ASN.0000092792.97122.E0; McFarlane SI, 2008, AM J KIDNEY DIS, V51, pS46, DOI 10.1053/j.ajkd.2007.12.019; Mercadal L, 2012, CLIN J AM SOC NEPHRO, V7, P35, DOI 10.2215/CJN.04690511; National Kidney Foundation, 2002, AM J KIDNEY DIS, V39, pS111; Nurko S, 2006, CLEV CLIN J MED, V73, P289, DOI 10.3949/ccjm.73.3.289; Oh SW, 2012, NEPHROL DIAL TRANSPL, V27, P267, DOI 10.1093/ndt/gfr296; Peti-Peterdi J, 2010, J AM SOC NEPHROL, V21, P1093, DOI 10.1681/ASN.2009070759; RADTKE HW, 1979, BLOOD, V54, P877; Tolonen H, 2013, MONITORING HLTH EURO; Vlagopoulos PT, 2005, J AM SOC NEPHROL, V16, P3403, DOI 10.1681/ASN.2005030226; Vlahakos DV, 2010, AM J KIDNEY DIS, V56, P558, DOI 10.1053/j.ajkd.2009.12.042; Vos FE, 2011, AM J KIDNEY DIS, V58, P591, DOI 10.1053/j.ajkd.2011.03.031; WHO/IASO/IOTF, 2000, ASIA PACIFIC PERSPEC; Won JC, 2012, PLOS ONE, V8	29	6	6	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 29	2016	11	4							e0150029	10.1371/journal.pone.0150029	http://dx.doi.org/10.1371/journal.pone.0150029			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DK8XM	27128634	Green Published, gold			2022-12-26	WOS:000375212600001
J	Ley, B; Alam, MS; Thriemer, K; Hossain, MS; Kibria, MG; Auburn, S; Poirot, E; Price, RN; Khan, WA				Ley, Benedikt; Alam, Mohammad Shafiul; Thriemer, Kamala; Hossain, Mohammad Sharif; Kibria, Mohammad Golam; Auburn, Sarah; Poirot, Eugenie; Price, Ric N.; Khan, Wasif Ali			G6PD Deficiency and Antimalarial Efficacy for Uncomplicated Malaria in Bangladesh: A Prospective Observational Study	PLOS ONE			English	Article							PLASMODIUM-FALCIPARUM MALARIA; ARTEMISININ-RESISTANT MALARIA; GLUCOSE-6-PHOSPHATE-DEHYDROGENASE DEFICIENCY; PARASITE CLEARANCE; INFECTION STATUS; VIVAX; PREVALENCE; ELIMINATION; CHITTAGONG; ADHERENCE	Background The Bangladeshi national treatment guidelines for uncomplicated malaria follow WHO recommendations but without G6PD testing prior to primaquine administration. A prospective observational study was conducted to assess the efficacy of the current antimalarial policy. Methods Patients with uncomplicated malaria, confirmed by microscopy, attending a health care facility in the Chittagong Hill Tracts, Bangladesh, were treated with artemether-lumefantrine (days 0-2) plus single dose primaquine (0.75mg/kg on day2) for P. falciparum infections, or with chloroquine (days 0-2) plus 14 days primaquine (3.5mg/kg total over 14 days) for P. vivax infections. Hb was measured on days 0, 2 and 9 in all patients and also on days 16 and 30 in patients with P. vivax infection. Participants were followed for 30 days. The study was registered with the clinical trials website (NCT02389374). Results Between September 2014 and February 2015 a total of 181 patients were enrolled (64% P. falciparum, 30% P. vivax and 6% mixed infections). Median parasite clearance times were 22.0 (Interquartile Range, IQR: 15.2-27.3) hours for P. falciparum, 20.0 (IQR: 9.5-22.7) hours for P. vivax and 16.6 (IQR: 10.0-46.0) hours for mixed infections. All participants were afebrile within 48 hours, two patients with P. falciparum infection remained parasitemic at 48 hours. No patient had recurrent parasitaemia within 30 days. Adjusted male median G6PD activity was 7.82U/gHb. One male participant (1/174) had severe G6PD deficiency (< 10% activity), five participants (5/174) had mild G6PD deficiency (10-60% activity). The Hb nadir occurred on day 2 prior to primaquine treatment in P. falciparum and P. vivax infected patients; mean fractional fall in Hb was -8.8% (95% CI -6.7% to -11.0%) and -7.4% (95% CI: -4.5 to -10.4%) respectively. Conclusion The current antimalarial policy remains effective. The prevalence of G6PD deficiency was low. Main contribution to haemolysis in G6PD normal individuals was attributable to acute malaria rather than primaquine administration.	[Ley, Benedikt; Thriemer, Kamala; Auburn, Sarah; Price, Ric N.] Menzies Sch Hlth Res, Global & Trop Hlth Div, Darwin, NT, Australia; [Ley, Benedikt; Thriemer, Kamala; Auburn, Sarah; Price, Ric N.] Charles Darwin Univ, Darwin, NT 0909, Australia; [Alam, Mohammad Shafiul; Hossain, Mohammad Sharif; Kibria, Mohammad Golam; Khan, Wasif Ali] Int Ctr Diarrheal Dis & Res, Dhaka, Bangladesh; [Poirot, Eugenie] Univ Calif San Francisco, Global Hlth Grp, San Francisco, CA 94143 USA; [Price, Ric N.] Univ Oxford, Nuffield Dept Clin Med, Ctr Trop Med & Global Hlth, Oxford, England	Charles Darwin University; Menzies School of Health Research; Charles Darwin University; International Centre for Diarrhoeal Disease Research (ICDDR); University of California System; University of California San Francisco; University of Oxford	Price, RN (corresponding author), Menzies Sch Hlth Res, Global & Trop Hlth Div, Darwin, NT, Australia.; Price, RN (corresponding author), Charles Darwin Univ, Darwin, NT 0909, Australia.; Price, RN (corresponding author), Univ Oxford, Nuffield Dept Clin Med, Ctr Trop Med & Global Hlth, Oxford, England.	rprice@menzies.edu.au	Alam, Mohammad Shafiul/C-2285-2011; Auburn, Sarah/N-2266-2013	Alam, Mohammad Shafiul/0000-0001-8330-5499; Ley, Benedikt/0000-0002-5734-0845; Price, Richard/0000-0003-2000-2874; Auburn, Sarah/0000-0002-4638-536X	Malaria Elimination Initiative at the Global Health Group of the University of California, San Francisco; Bill & Melinda Gates Foundation [OPP1089413]	Malaria Elimination Initiative at the Global Health Group of the University of California, San Francisco(University of California System); Bill & Melinda Gates Foundation(Bill & Melinda Gates Foundation)	This project was funded by the Malaria Elimination Initiative at the Global Health Group of the University of California, San Francisco. The work of the Malaria Elimination Initiative at the Global Health Group of the University of California, San Francisco is supported by the Bill & Melinda Gates Foundation (OPP1089413). RNP is a Wellcome Trust Senior Fellow in Clinical Science (091625). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abul Barakat SH, 2009, SOCIOECONOMIC BASELI; Alam MS, 2012, PARASITE VECTOR, V5, DOI 10.1186/1756-3305-5-150; Alam MS, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-15; Amaratunga C, 2016, LANCET INFECT DIS, V16, P357, DOI 10.1016/S1473-3099(15)00487-9; Amaratunga C, 2012, LANCET INFECT DIS, V12, P851, DOI 10.1016/S1473-3099(12)70181-0; [Anonymous], 1989, B WORLD HEALTH ORGAN, V67, P601; Ariey F, 2014, NATURE, V505, P50, DOI 10.1038/nature12876; Ashley EA, 2014, NEW ENGL J MED, V371, P411, DOI 10.1056/NEJMoa1314981; Baird JK, 2004, ANTIMICROB AGENTS CH, V48, P4075, DOI 10.1128/AAC.48.11.4075-4083.2004; Banek K, 2014, MALARIA J, V13, DOI 10.1186/1475-2875-13-7; Beales PF, 2000, T ROY SOC TROP MED H, V94, pS1; Domingo GJ, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-391; Dondorp AM, 2009, NEW ENGL J MED, V361, P455, DOI 10.1056/NEJMoa0808859; Flegg JA, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-339; Graves PM, 2015, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD008152.pub4; Haque R, 2007, AM J TROP MED HYG, V76, P39, DOI 10.4269/ajtmh.2007.76.39; Haque U, 2014, LANCET GLOB HEALTH, V2, pE98, DOI 10.1016/S2214-109X(13)70176-1; IMBRIANI M, 1987, Giornale Italiano di Medicina del Lavoro, V9, P11; KAPLAN EL, 1958, J AM STAT ASSOC, V53, P457, DOI 10.2307/2281868; Khim N, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-171; LaRue N, 2014, AM J TROP MED HYG, V91, P854, DOI 10.4269/ajtmh.14-0194; Leslie T, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-230; Maiga B, 2014, MALARIA J, V13, DOI 10.1186/1475-2875-13-270; Maude RJ, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-323; Mita T, 2016, EXPERT REV ANTI-INFE, V14, P125, DOI 10.1586/14787210.2016.1106938; Mohon A, 2014, MALARIA J, V13, DOI 10.1186/1475-2875-13-431; Noedl H, 2010, CLIN INFECT DIS, V51, pE82, DOI 10.1086/657120; Noedl H, 2008, NEW ENGL J MED, V359, P2619, DOI 10.1056/NEJMc0805011; Phyo AP, 2012, LANCET, V379, P1960, DOI 10.1016/S0140-6736(12)60484-X; Poirot E, 2013, 62 ANN M NOV 13 17 2; Price RN, 2014, LANCET INFECT DIS, V14, P982, DOI 10.1016/S1473-3099(14)70855-2; Price RN, 2014, AM J TROP MED HYG, V91, P3, DOI 10.4269/ajtmh.14-0118; Rahman MM, 2008, T ROY SOC TROP MED H, V102, P861, DOI 10.1016/j.trstmh.2008.05.022; Samad R, 2013, Bangladesh Med Res Counc Bull, V39, P109; Shannon KL, 2015, AM J TROP MED HYG, V93, P281, DOI 10.4269/ajtmh.14-0623; Starzengruber P, 2014, MALARIA J, V13, DOI 10.1186/1475-2875-13-16; Starzengruber P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052236; Sutanto I, 2013, ANTIMICROB AGENTS CH, V57, P1128, DOI 10.1128/AAC.01879-12; Thriemer K, 2014, ANTIMICROB AGENTS CH, V58, P7049, DOI 10.1128/AAC.02746-14; Tun KM, 2015, LANCET INFECT DIS, V15, P415, DOI 10.1016/S1473-3099(15)70032-0; van den Broek IV, 2005, T ROY SOC TROP MED H, V99, P727, DOI 10.1016/j.trstmh.2005.02.007; von Seidlein L, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-112; WHO, 2015, WORLD MAL REP 2015, P157; World Health Organization, 2009, METH SURV ANT DRUG E; World Health Organization, 2015, GUID TREATM MAL, Vthird; WWARN, 2012, PAR CLEAR EST	46	21	21	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 29	2016	11	4							e0154015	10.1371/journal.pone.0154015	http://dx.doi.org/10.1371/journal.pone.0154015			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DK8XM	27128675	Green Published, Green Submitted, gold			2022-12-26	WOS:000375212600017
J	Liess, M; Schmidt, J; Glaser, B				Liess, Mareike; Schmidt, Johannes; Glaser, Bruno			Improving the Spatial Prediction of Soil Organic Carbon Stocks in a Complex Tropical Mountain Landscape by Methodological Specifications in Machine Learning Approaches	PLOS ONE			English	Article							ARTIFICIAL NEURAL-NETWORKS; LAND-USE CHANGE; RANDOM FORESTS; TERRAIN; REGRESSION; VEGETATION; MATTER; TOPOGRAPHY; PARAMETERS; SELECTION	Tropical forests are significant carbon sinks and their soils' carbon storage potential is immense. However, little is known about the soil organic carbon (SOC) stocks of tropical mountain areas whose complex soil-landscape and difficult accessibility pose a challenge to spatial analysis. The choice of methodology for spatial prediction is of high importance to improve the expected poor model results in case of low predictor-response correlations. Four aspects were considered to improve model performance in predicting SOC stocks of the organic layer of a tropical mountain forest landscape: Different spatial predictor settings, predictor selection strategies, various machine learning algorithms and model tuning. Five machine learning algorithms: random forests, artificial neural networks, multivariate adaptive regression splines, boosted regression trees and support vector machines were trained and tuned to predict SOC stocks from predictors derived from a digital elevation model and satellite image. Topographical predictors were calculated with a GIS search radius of 45 to 615 m. Finally, three predictor selection strategies were applied to the total set of 236 predictors. All machine learning algorithms-including the model tuning and predictor selection-were compared via five repetitions of a tenfold cross-validation. The boosted regression tree algorithm resulted in the overall best model. SOC stocks ranged between 0.2 to 17.7 kg m(-2), displaying a huge variability with diffuse insolation and curvatures of different scale guiding the spatial pattern. Predictor selection and model tuning improved the models' predictive performance in all five machine learning algorithms. The rather low number of selected predictors favours forward compared to backward selection procedures. Choosing predictors due to their indiviual performance was vanquished by the two procedures which accounted for predictor interaction.	[Liess, Mareike] UFZ Helmholtz Ctr Environm Res, Dept Soil Phys, Halle, Saale, Germany; [Liess, Mareike] Univ Bayreuth, Dept Geosci, Soil Phys Div, Bayreuth, Germany; [Schmidt, Johannes] Univ Leipzig, Inst Geog, Dept Phys & Geosci, D-04109 Leipzig, Germany; [Glaser, Bruno] Univ Halle Wittenberg, Dept Soil Biochem, D-06108 Halle, Saale, Germany	Helmholtz Association; Helmholtz Center for Environmental Research (UFZ); University of Bayreuth; Leipzig University; Martin Luther University Halle Wittenberg	Liess, M (corresponding author), UFZ Helmholtz Ctr Environm Res, Dept Soil Phys, Halle, Saale, Germany.; Liess, M (corresponding author), Univ Bayreuth, Dept Geosci, Soil Phys Div, Bayreuth, Germany.	mareike.liess@ufz.de	Schmidt, Johannes/H-4542-2018; Ließ, Mareike/AAX-2803-2020; Schmidt, Johannes/AEM-1917-2022; Glaser, Bruno/ABC-1676-2021	Schmidt, Johannes/0000-0002-4584-7382; Ließ, Mareike/0000-0001-9325-199X; Schmidt, Johannes/0000-0002-4584-7382; Glaser, Bruno/0000-0002-3057-3868	German Research Foundation (DFG) [LI 2360/1-1]; German Research Foundation; University of Bayreuth; German Research Foundation (DFG) as part of the Platform for Biodiversity and Ecosystem Monitoring and Research in South Ecuador [LI 2360/1-1, PAK 825]	German Research Foundation (DFG)(German Research Foundation (DFG)); German Research Foundation(German Research Foundation (DFG)); University of Bayreuth; German Research Foundation (DFG) as part of the Platform for Biodiversity and Ecosystem Monitoring and Research in South Ecuador(German Research Foundation (DFG))	This work was funded by German Research Foundation (DFG) LI 2360/1-1 (to ML) http://www.dfg.de/, with additional funding from the German Research Foundation and University of Bayreuth, funding programme "Open Access Publishing" http://www.dfg.de/, http://www.uni-bayreuth.de/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This research was funded by the German Research Foundation (DFG) as part of the Platform for Biodiversity and Ecosystem Monitoring and Research in South Ecuador (PAK 825, LI 2360/1-1). Logistic support by the NGO Nature and Culture International (NCI) and the municipal public agency ETAPA is gratefully acknowledged.	Abrahams A.D., 1992, OVERLAND FLOW HYDRAU, P393; Anders N.S., 2009, P GEOM, VVol. 31, P61; [Anonymous], 2006, LYONIA; Bahr E, 2014, AGR ECOSYST ENVIRON, V188, P275, DOI 10.1016/j.agee.2014.03.005; Baret F., 1991, Remote Sensing of Environment, V35, P161, DOI 10.1016/0034-4257(91)90009-U; Baret F., 1989, P 12 CAN S REM SENS, V3, P1355; Basheer IA, 2000, J MICROBIOL METH, V43, P3, DOI 10.1016/S0167-7012(00)00201-3; Bauer FC, 2010, WATER FLOW PATHS SOI, P150; Beck E., 2008, V198, P371; Behrens T, 2010, GEODERMA, V155, P175, DOI 10.1016/j.geoderma.2009.07.010; Bennett KP., 2000, ACM SIGKDD EXPLOR NE, V2, P1, DOI [10.1145/380995.380999, DOI 10.1145/380995.380999]; Beven KJ., 1979, HYDROL SCI J, V24, P43, DOI [10.1080/ 02626667909491834, 10.1080/02626667909491834, DOI 10.1080/02626667909491834]; Bohner J, 2009, DEV SOIL SCI, V33, P195, DOI 10.1016/S0166-2481(08)00008-1; Bohner J., 2002, EUR SOIL BUR, V7, P213; Bohner J., 2006, SAGA ANAL MODELLING, P13; BREIMAN L, 1992, INT STAT REV, V60, P291, DOI 10.2307/1403680; Breiman L, 2012, BREIMAN CUTLERS RAND, P29; Breiman L., 2017, CLASSIFICATION REGRE; Brenning A, 2015, RSAGA SAGA GEOPROCES; Cavazzi S, 2013, GEODERMA, V195, P111, DOI 10.1016/j.geoderma.2012.11.020; Cerri CEP, 2007, AGR ECOSYST ENVIRON, V122, P58, DOI 10.1016/j.agee.2007.01.008; Cherkassky V, 2004, NEURAL NETWORKS, V17, P113, DOI 10.1016/S0893-6080(03)00169-2; Cherkassky V, 1997, IEEE Trans Neural Netw, V8, P1564, DOI 10.1109/TNN.1997.641482; Dai FQ, 2014, ECOL INDIC, V45, P184, DOI 10.1016/j.ecolind.2014.04.003; David L. O., 2008, ADV DATA MINING TECH; Desmet PJJ, 1996, J SOIL WATER CONSERV, V51, P427; Dieleman WIJ, 2013, GEODERMA, V204, P59, DOI 10.1016/j.geoderma.2013.04.005; Don A, 2011, GLOBAL CHANGE BIOL, V17, P1658, DOI 10.1111/j.1365-2486.2010.02336.x; Elith J, 2008, J ANIM ECOL, V77, P802, DOI 10.1111/j.1365-2656.2008.01390.x; Fao, 2014, STAT WORLDS FOR; Tapia-Armijos MF, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0133701; Foresee FD, 1930, GAUSS NEWTON APPROXI, P1930; Fox GA, 2004, SOIL SCI SOC AM J, V68, P1326, DOI 10.2136/sssaj2004.1326; Freund Y, 1997, J COMPUT SYST SCI, V55, P119, DOI 10.1006/jcss.1997.1504; Friedman J.H., 1993, FAST MARS; Friedman JH, 2002, COMPUT STAT DATA AN, V38, P367, DOI 10.1016/S0167-9473(01)00065-2; FRIEDMAN JH, 1991, ANN STAT, V19, P1, DOI 10.1214/aos/1176347963; Friedrich K., 1998, LAND INFORM SYSTEMS, P259; Friedrich K., 1996, DIGITALE RELIEFGLIED; Fries A, 2009, ERDKUNDE, V63, P321, DOI 10.3112/erdkunde.2009.04.03; Gasparini P, 2015, FOREST ECOL MANAG, V337, P186, DOI 10.1016/j.foreco.2014.11.012; Gessler PE, 2000, SOIL SCI SOC AM J, V64, P2046, DOI 10.2136/sssaj2000.6462046x; Grimm R, 2008, GEODERMA, V146, P102, DOI 10.1016/j.geoderma.2008.05.008; Guo PT, 2015, GEODERMA, V237, P49, DOI 10.1016/j.geoderma.2014.08.009; Hantzschel J, 2005, METEOROL APPL, V12, P33, DOI 10.1017/S1350482705001489; Hastie T, 2009, ELEMENTS STAT LEARNI, DOI [10.1007/978-0-387-98135-2, DOI 10.1007/978-0-387-98135-2]; Hitziger M., 2014, Applied and Environmental Soil Science, V2014, P809495; Hsu C., 2008, BJU INT, V101, P1396, DOI [http://dx.doi.org/10.1177/02632760022050997, DOI 10.1177/02632760022050997]; Iwahashi J, 2007, GEOMORPHOLOGY, V86, P409, DOI 10.1016/j.geomorph.2006.09.012; Jackson TJ, 2004, REMOTE SENS ENVIRON, V92, P475, DOI 10.1016/j.rse.2003.10.021; Jenny H., 1941, FACTORS SOIL FORMATI, DOI 10.1097/00010694-194111000-00009; Kheir RB, 2010, HYDROL EARTH SYST SC, V14, P847, DOI 10.5194/hess-14-847-2010; Kinnell PIA, 2005, SOIL SCI SOC AM J, V69, P674, DOI 10.2136/sssaj2004.0047; Kohavi J., 1994, P 11 INT C MACH LEAR, P121, DOI [DOI 10.1016/B978-1-55860-335-6.50023-4, 10.1016/B978-1-55860-335-6.50023-4]; Kohavi R, 1997, ARTIF INTELL, V97, P273, DOI 10.1016/S0004-3702(97)00043-X; Kohavi R., 1995, P INT JOINT C ARTIFI, P1137, DOI DOI 10.1067/MOD.2000.109031; Kothe R., 1996, USER MANUAL; Kuhn M., 2013, APPL PREDICTIVE MODE, P487, DOI 10.1007/978-1-4614-6849-3_19; Larose D.T., 2006, DATA MINING METHODS; Lawrence J., 1992, NEURONALE NETZE COMP; LIESS M, 2014, APPL ENVIRON SOIL SC, V2014, pNIL1, DOI DOI 10.1155/2014/603132; Liess M, 2015, SPAT STAT-NETH, V13, P106, DOI 10.1016/j.spasta.2015.06.002; Liess M, 2012, GEODERMA, V170, P70, DOI 10.1016/j.geoderma.2011.10.010; Liess M, 2009, ERDKUNDE, V63, P309, DOI 10.3112/erdkunde.2009.04.02; Litherland M., 1994, OVERSEAS MEM BRIT GE, V11, P147; Martin MP, 2014, GEODERMA, V223, P97, DOI 10.1016/j.geoderma.2014.01.005; Martin MP, 2011, BIOGEOSCIENCES, V8, P1053, DOI 10.5194/bg-8-1053-2011; Masters T., 1993, PRACTICAL NEURAL NET; Mattera D, 1999, ADVANCES IN KERNEL METHODS, P211; Maynard JJ, 2014, GEODERMA, V230, P29, DOI 10.1016/j.geoderma.2014.03.021; Meyer D., 2015, E1071 MISC FUNCTIONS, V6-7, pe1071; Milborrow S., 2015, MULTIVARIATE ADAPTIV; Moller M, 2008, J PLANT NUTR SOIL SC, V171, P419, DOI 10.1002/jpln.200625039; MOORE ID, 1991, HYDROL PROCESS, V5, P3, DOI 10.1002/hyp.3360050103; Moser G, 2011, GLOBAL CHANGE BIOL, V17, P2211, DOI 10.1111/j.1365-2486.2010.02367.x; Nauss T, 2007, E Z AGRAINFORMATIK E, V2; Oke T.R., 1987, BOUNDARY LAYER CLIMA; Pan YD, 2011, SCIENCE, V333, P988, DOI 10.1126/science.1201609; Pastick NJ, 2014, GEODERMA, V230, P79, DOI 10.1016/j.geoderma.2014.04.008; Perez Rodriguez P, 2015, PACKAGE BRNN; Post WM, 2000, GLOBAL CHANGE BIOL, V6, P317, DOI 10.1046/j.1365-2486.2000.00308.x; Prima ODA, 2006, GEOMORPHOLOGY, V78, P373, DOI 10.1016/j.geomorph.2006.02.005; RICHARDSON AJ, 1977, PHOTOGRAMM ENG REM S, V43, P1541; Ridgeway G., 2015, GEN BOOSTED REGRESSI; Riley S.J., 1999, INTERMOUNTAIN J SCI, V5, P23, DOI DOI 10.1016/j.geomorph.2010.11.003; Rodriguez F, 2002, GEOPHYS RES LETT, V29, DOI 10.1029/2001GL014412; Roman L, 2010, TROPICAL MONTANE CLO; Ryan PJ, 2000, FOREST ECOL MANAG, V138, P139, DOI 10.1016/S0378-1127(00)00393-5; Samuel-Rosa A, 2015, GEODERMA, V243, P214, DOI 10.1016/j.geoderma.2014.12.017; Scherer A., 1997, NEURONALE NETZE GRUN; Schmidt J, 2012, STAT MODELLIERUNG KO; Smola AJ, 2004, STAT COMPUT, V14, P199, DOI 10.1023/B:STCO.0000035301.49549.88; USGS, 2013, US USGS LANDS 8 PROD; Waring R.H., 2010, FOREST ECOSYSTEMS AN; Watson RT, 2000, LAND USE LAND USE CH, P392; Were K, 2015, ECOL INDIC, V52, P394, DOI 10.1016/j.ecolind.2014.12.028; Weston S., 2015, PACKAGE FOREACH PROV; Weston S., 2015, PACKAGE DOPARALLEL F; Wilcke W, 2010, TROPICAL MONTANE CLO; Wilson J.P., 2000, TERRAIN ANAL PRINCIP; Witten I. H., 2005, DATA MINING PRACTICA; Wood J, 2009, DEV SOIL SCI, V33, P333, DOI 10.1016/S0166-2481(08)00014-7; Wood J, 1996, GEOMORPHOLOGICAL CHR; Xu G, 2013, APPL DATA MINING; Yokoyama R, 2002, PHOTOGRAMM ENG REM S, V68, P257; ZEVENBERGEN LW, 1987, EARTH SURF PROCESSES, V12, P47, DOI 10.1002/esp.3290120107; Zhang SW, 2012, GEODERMA, V171, P35, DOI 10.1016/j.geoderma.2011.07.012	107	43	44	5	49	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 29	2016	11	4							e0153673	10.1371/journal.pone.0153673	http://dx.doi.org/10.1371/journal.pone.0153673			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DK8XM	27128736	Green Published, gold, Green Submitted			2022-12-26	WOS:000375212600011
J	Van Ombergen, A; Lubeck, AJ; Van Rompaey, V; Maes, LK; Stins, JF; Van de Heyning, PH; Wuyts, FL; Bos, JE				Van Ombergen, Angelique; Lubeck, Astrid J.; Van Rompaey, Vincent; Maes, Leen K.; Stins, John F.; Van de Heyning, Paul H.; Wuyts, Floris L.; Bos, Jelte E.			The Effect of Optokinetic Stimulation on Perceptual and Postural Symptoms in Visual Vestibular Mismatch Patients	PLOS ONE			English	Article							MOTION SICKNESS SYMPTOMS; VERTIGO; ORIENTATION; HUMANS; REHABILITATION; DEPENDENCE; DIZZINESS; SIMULATOR; CUES	Background Vestibular patients occasionally report aggravation or triggering of their symptoms by visual stimuli, which is called visual vestibular mismatch (VVM). These patients therefore experience discomfort, disorientation, dizziness and postural unsteadiness. Objective Firstly, we aimed to get a better insight in the underlying mechanism of VVM by examining perceptual and postural symptoms. Secondly, we wanted to investigate whether roll-motion is a necessary trait to evoke these symptoms or whether a complex but stationary visual pattern equally provokes them. Methods Nine VVM patients and healthy matched control group were examined by exposing both groups to a stationary stimulus as well as an optokinetic stimulus rotating around the nasooccipital axis for a prolonged period of time. Subjective visual vertical (SVV) measurements, posturography and relevant questionnaires were assessed. Results No significant differences between both groups were found for SVV measurements. Patients always swayed more and reported more symptoms than healthy controls. Prolonged exposure to roll-motion caused in patients and controls an increase in postural sway and symptoms. However, only VVM patients reported significantly more symptoms after prolonged exposure to the optokinetic stimulus compared to scores after exposure to a stationary stimulus. Conclusions VVM patients differ from healthy controls in postural and subjective symptoms and motion is a crucial factor in provoking these symptoms. A possible explanation could be a central visual-vestibular integration deficit, which has implications for diagnostics and clinical rehabilitation purposes. Future research should focus on the underlying central mechanism of VVM and the effectiveness of optokinetic stimulation in resolving it.	[Van Ombergen, Angelique; Maes, Leen K.; Van de Heyning, Paul H.; Wuyts, Floris L.] Univ Antwerp, Res Ctr Equilibrium & Aerosp AUREA, B-2020 Antwerp, Belgium; [Lubeck, Astrid J.; Stins, John F.; Bos, Jelte E.] Vrije Univ Amsterdam, Fac Behav & Movement Sci, Res Inst MOVE, Amsterdam, Netherlands; [Van Rompaey, Vincent; Van de Heyning, Paul H.] Univ Antwerp Hosp, Dept Otorhinolaryngol, Antwerp, Belgium; [Van Ombergen, Angelique; Van Rompaey, Vincent; Van de Heyning, Paul H.] Univ Antwerp, Fac Med & Hlth Sci, B-2020 Antwerp, Belgium; [Maes, Leen K.] Univ Ghent, Fac Med & Hlth Sci, Dept Speech Language & Hearing Sci, B-9000 Ghent, Belgium; [Bos, Jelte E.] TNO Perceptual & Cognit Syst, Soesterberg, Netherlands	University of Antwerp; Vrije Universiteit Amsterdam; University of Antwerp; University of Antwerp; Ghent University; Netherlands Organization Applied Science Research	Van Ombergen, A (corresponding author), Univ Antwerp, Res Ctr Equilibrium & Aerosp AUREA, B-2020 Antwerp, Belgium.; Van Ombergen, A (corresponding author), Univ Antwerp, Fac Med & Hlth Sci, B-2020 Antwerp, Belgium.	angelique.vanombergen@uantwerpen.be	Wuyts, Floris/AAE-3478-2020; Van Rompaey, Vincent/L-2450-2014; Heyning, Paul H Vande/I-8278-2017	Wuyts, Floris/0000-0002-4485-6412; Van Rompaey, Vincent/0000-0003-0912-7780; Heyning, Paul H Vande/0000-0002-8424-3717; Bos, Jelte/0000-0002-1494-6804; Maes, Leen/0000-0001-6090-5512; Stins, John/0000-0001-5251-5610	Netherlands Organization for Scientific Research (NWO) [406-11-020]; Research Foundation Flanders (FWO Vlaanderen) [11U6414N, 11U6416N]; Flemish Research Council [AUHA/09/006]	Netherlands Organization for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO)); Research Foundation Flanders (FWO Vlaanderen)(FWO); Flemish Research Council(FWO)	This work was supported by the Netherlands Organization for Scientific Research (NWO: grant 406-11-020). Angelique Van Ombergen is a research fellow for the Research Foundation Flanders (FWO Vlaanderen, grant 11U6414N and 11U6416N). This study was performed at the Multidisciplinary Motor Centre Antwerp (M2OCEAN) that was established by means of a Hercules Grant type 2 for medium-sized research infrastructure from the Flemish Research Council (AUHA/09/006).	Barra J, 2010, BRAIN, V133, P3552, DOI 10.1093/brain/awq311; Bisdorff A, 2009, J VESTIBUL RES-EQUIL, V19, P1, DOI 10.3233/VES-2009-0343; Bles W, 1998, BRAIN RES BULL, V47, P481, DOI 10.1016/S0361-9230(98)00115-4; Bos JE, 2002, BIOL CYBERN, V86, P191, DOI 10.1007/s00422-001-0289-7; Bos JE, 2005, AVIAT SPACE ENVIR MD, V76, P1111; Bos JE, 2008, DISPLAYS, V29, P47, DOI 10.1016/j.displa.2007.09.002; Brainard DH, 1997, SPATIAL VISION, V10, P433, DOI 10.1163/156856897X00357; BRANDT T, 1994, J NEUROL, V241, P191, DOI 10.1007/BF00863767; Brandt T, 1996, NEUROLOGY, V46, P1515, DOI 10.1212/WNL.46.6.1515; Brandt T, 2015, ANN NY ACAD SCI, V1343, P37, DOI 10.1111/nyas.12692; Bronstein AM, 2013, SEMIN NEUROL, V33, P219, DOI 10.1055/s-0033-1354602; BRONSTEIN AM, 1995, J NEUROL NEUROSUR PS, V59, P472, DOI 10.1136/jnnp.59.5.472; Bronstein AM, 2004, J NEUROL, V251, P381, DOI 10.1007/s00415-004-0410-7; BRONSTEIN AM, 1995, ACTA OTO-LARYNGOL, P45; Eckhardt-Henn A, 2008, J NEUROL, V255, P420, DOI 10.1007/s00415-008-0697-x; Guerraz M, 2001, BRAIN, V124, P1646, DOI 10.1093/brain/124.8.1646; Harm DL, 1998, BRAIN RES BULL, V47, P497, DOI 10.1016/S0361-9230(98)00096-3; Hettinger L J, 1990, Mil Psychol, V2, P171, DOI 10.1207/s15327876mp0203_4; Holle D, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0142468; Huppert D, 2005, J NEUROL, V252, P564, DOI 10.1007/s00415-005-0699-x; JACOB RG, 1988, PSYCHIAT CLIN N AM, V11, P361; Kennedy R. S., 1993, INT J AVIAT PSYCHOL, V3, P203; Longridge NS, 2002, J OTOLARYNGOL, V31, P5, DOI 10.2310/7070.2002.19125; Lubeck AJA, 2015, DISPLAYS, V38, P55, DOI 10.1016/j.displa.2015.03.001; Mach E., 1875, GRUNDLINIEN LEHRE BE; Mallinson A, 2011, VISUAL VESTIBULAR MI; Merfeld DM, 2002, J NEUROPHYSIOL, V87, P819, DOI 10.1152/jn.00485.2001; MITTELSTAEDT H, 1983, NATURWISSENSCHAFTEN, V70, P272, DOI 10.1007/BF00404833; Bittar RSM, 2015, BRAZ J OTORHINOLAR, V81, P276, DOI 10.1016/j.bjorl.2014.08.012; Oppenlander K, 2015, NEUROPSYCHOLOGIA, V74, P178, DOI 10.1016/j.neuropsychologia.2015.03.004; Pavlou M, 2004, J NEUROL, V251, P983, DOI 10.1007/s00415-004-0476-2; Pavlou M, 2013, NEUROREHAB NEURAL RE, V27, P208, DOI 10.1177/1545968312461715; Pavlou M, 2011, GAIT POSTURE, V33, P113, DOI 10.1016/j.gaitpost.2010.10.085; Pelli DG, 1997, SPATIAL VISION, V10, P437, DOI 10.1163/156856897X00366; Peterka RJ, 2002, J NEUROPHYSIOL, V88, P1097, DOI 10.1152/jn.2002.88.3.1097; Pollak L, 2003, ISR MED ASSOC J, V5, P720; Pollak L, 2015, BRAIN BEHAV, V5, DOI 10.1002/brb3.402; Pollock AS, 2000, CLIN REHABIL, V14, P402, DOI 10.1191/0269215500cr342oa; Schniepp R, 2014, FRONT HUM NEUROSCI, V8, DOI 10.3389/fnhum.2014.00963; Schniepp R, 2014, J NEUROL, V261, P738, DOI 10.1007/s00415-014-7259-1; Schniepp R, 2013, FRONT NEUROL, V4, DOI 10.3389/fneur.2013.00115; SHUMWAYCOOK A, 1990, NEUROL CLIN, V8, P441, DOI 10.1016/S0733-8619(18)30366-9; Staab JP, 2014, CURR OPIN NEUROL, V27, P118, DOI 10.1097/WCO.0000000000000055; Staab JP, 2014, J PSYCHOSOM RES, V76, P80, DOI 10.1016/j.jpsychores.2013.11.008; Staab Jeffrey P, 2012, Continuum (Minneap Minn), V18, P1118, DOI 10.1212/01.CON.0000421622.56525.58; Strupp M, 2003, NERVENARZT, V74, P911, DOI 10.1007/s00115-003-1567-5; Tanahashi S, 2007, J NEUROENG REHABIL, V4, DOI 10.1186/1743-0003-4-39; Thompson KJ, 2015, J VESTIBUL RES-EQUIL, V25, P97, DOI 10.3233/VES-150551; Van Ombergen A, 2015, 2 VERT AC INT M 22 2; Van Ombergen A, 2015, OTOL NEUROTOL, V36, P133, DOI 10.1097/MAO.0000000000000596; WITKIN HA, 1959, SCI AM, V200, P50, DOI 10.1038/scientificamerican0259-50; WITKIN HA, 1948, J EXP PSYCHOL, V38, P762, DOI 10.1037/h0053671; Wuehr M, 2013, J NEUROL, V260, P1314, DOI 10.1007/s00415-012-6797-7; Wuehr M, 2014, PHYSIOL REP, V2, DOI 10.1002/phy2.232; Wuyts F, 2008, 25 M BAR SOC 31 MARC; YARDLEY L, 1994, BRIT J CLIN PSYCHOL, V33, P101, DOI 10.1111/j.2044-8260.1994.tb01100.x; Yelnik AP, 2006, GAIT POSTURE, V24, P262, DOI 10.1016/j.gaitpost.2005.09.007; Zupan LH, 2003, J NEUROPHYSIOL, V89, P390, DOI 10.1152/jn.00513.2001; Zur O, 2015, DISABIL REHABIL, V37, P2197, DOI 10.3109/09638288.2014.1002577	59	27	27	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 29	2016	11	4							e0154528	10.1371/journal.pone.0154528	http://dx.doi.org/10.1371/journal.pone.0154528			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DK8XM	27128970	Green Published, gold			2022-12-26	WOS:000375212600036
J	Ana-Sosa-Batiz, F; Vanderven, H; Jegaskanda, S; Johnston, A; Rockman, S; Laurie, K; Barr, I; Reading, P; Lichtfuss, M; Kent, SJ				Ana-Sosa-Batiz, Fernanda; Vanderven, Hillary; Jegaskanda, Sinthujan; Johnston, Angus; Rockman, Steven; Laurie, Karen; Barr, Ian; Reading, Patrick; Lichtfuss, Marit; Kent, Stephen J.			Influenza-Specific Antibody-Dependent Phagocytosis	PLOS ONE			English	Article							CELLULAR CYTOTOXICITY; HEMAGGLUTININ-STEM; A VIRUS; PROTECTION; INFECTION; VACCINE; MACROPHAGES; MACAQUES; EFFICACY; IMMUNITY	Background Immunity to human influenza A virus (IAV) infection is only partially understood. Broadly non-neutralizing antibodies may assist in reducing disease but have not been well characterized. Methods We measured internalization of opsonized, influenza protein-coated fluorescent beads and live IAV into a monocytic cell line to study antibody-dependent phagocytosis (ADP) against multiple influenza hemagglutinin (HA) subtypes. We analyzed influenza HA-specific ADP in healthy human donors, in preparations of intravenous immunoglobulin (IVIG), and following IAV infection of humans and macaques. Results We found that both sera from healthy adults and IVIG preparations had broad ADP to multiple seasonal HA proteins and weak cross-reactive ADP to non-circulating HA proteins. The ADP in experimentally influenza-infected macaque plasma and naturally influenza-infected human sera mediated phagocytosis of both homologous and heterologous IAVs. Further, the IAV phagocytosed in an antibody-mediated manner had reduced infectivity in vitro. Conclusion We conclude that IAV infections in humans and macaques leads to the development of influenza-specific ADP that can clear IAV infection in vitro. Repeated exposure of humans to multiple IAV infections likely leads to the development of ADP that is cross-reactive to strains not previously encountered. Further analyses of the protective capacity of broadly reactive influenza-specific ADP is warranted.	[Ana-Sosa-Batiz, Fernanda; Vanderven, Hillary; Jegaskanda, Sinthujan; Rockman, Steven; Reading, Patrick; Lichtfuss, Marit; Kent, Stephen J.] Univ Melbourne, Dept Microbiol & Immunol, Peter Doherty Inst Infect & Immun, Melbourne, Vic, Australia; [Johnston, Angus] Monash Univ, Drug Delivery Disposit & Dynam Lab, Monash Inst Pharmaceut Sci, Melbourne, Vic 3004, Australia; [Johnston, Angus] Monash Univ, ARC Ctr Excellence Convergent Bionano Sci & Techn, Parkville, Vic, Australia; [Rockman, Steven] bioCSL Ltd, Parkville, Vic, Australia; [Laurie, Karen; Barr, Ian; Reading, Patrick] Peter Doherty Inst Infect & Immun, WHO Collaborating Ctr Reference & Res Influenza, Melbourne, Vic, Australia; [Kent, Stephen J.] Monash Univ, Melbourne Sexual Hlth Ctr, Cent Clin Sch, Melbourne, Vic 3004, Australia; [Kent, Stephen J.] Univ Melbourne, ARC Ctr Excellence Convergent Bionano Sci & Techn, Parkville, Vic 3052, Australia	University of Melbourne; Monash University; Monash University; World Health Organization; Monash University; University of Melbourne	Kent, SJ (corresponding author), Univ Melbourne, Dept Microbiol & Immunol, Peter Doherty Inst Infect & Immun, Melbourne, Vic, Australia.; Kent, SJ (corresponding author), Monash Univ, Melbourne Sexual Hlth Ctr, Cent Clin Sch, Melbourne, Vic 3004, Australia.; Kent, SJ (corresponding author), Univ Melbourne, ARC Ctr Excellence Convergent Bionano Sci & Techn, Parkville, Vic 3052, Australia.	skent@unimelb.edu.au	Kent, Stephen/AAL-5101-2020; rockman, steve/AAT-5105-2021; Johnston, Angus PR/A-9254-2011; Vanderven, Hillary A/Y-5768-2018	Kent, Stephen/0000-0002-8539-4891; Johnston, Angus PR/0000-0001-5611-4515; Barr, Ian/0000-0002-7351-418X; Vanderven, Hillary/0000-0001-8482-2308; Reading, Patrick/0000-0002-8860-5308	Australian National Health and Medical Research Council [628331, 1023294, 510488]; Australian Government Department of Health	Australian National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); Australian Government Department of Health(Australian GovernmentDepartment of Health & Ageing)	This work was supported by the Australian National Health and Medical Research Council [SJK 628331, 1023294, and 510488; https://www.nhmrc.gov.au/]. The Melbourne WHO Collaborating Centre for Reference and Research on Influenza is supported by the Australian Government Department of Health [http://www.health.gov.au/]. The funder provided support in the form of salaries for authors SJK, SJ, KL, IB, and PR, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Ana-Sosa-Batiz F, 2014, IMMUNOL CELL BIOL, V92, P679, DOI 10.1038/icb.2014.42; Andrews SF, 2015, J VIROL, V89, P3308, DOI 10.1128/JVI.02871-14; Chung AW, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3007736; Corti D, 2011, SCIENCE, V333, P850, DOI 10.1126/science.1205669; DAVIES JR, 1989, EPIDEMIOL INFECT, V102, P325, DOI 10.1017/S0950268800030004; DiLillo DJ, 2014, NAT MED, V20, P143, DOI 10.1038/nm.3443; DOWDLE WR, 1973, POSTGRAD MED J, V49, P159, DOI 10.1136/pgmj.49.569.159; HOBSON D, 1972, J HYG-CAMBRIDGE, V70, P767, DOI 10.1017/S0022172400022610; Huber VC, 2001, J IMMUNOL, V166, P7381, DOI 10.4049/jimmunol.166.12.7381; Impagliazzo A, 2015, SCIENCE, V349, P1301, DOI 10.1126/science.aac7263; Jegaskanda S, 2014, J INFECT DIS, V210, P1811, DOI 10.1093/infdis/jiu334; Jegaskanda S, 2013, J VIROL, V87, P13706, DOI 10.1128/JVI.01666-13; Jegaskanda S, 2013, J INFECT DIS, V208, P1051, DOI 10.1093/infdis/jit294; Jegaskanda S, 2013, J VIROL, V87, P5512, DOI 10.1128/JVI.03030-12; Jegaskanda S, 2013, J IMMUNOL, V190, P1837, DOI 10.4049/jimmunol.1201574; Kilbourne ED, 2002, P NATL ACAD SCI USA, V99, P10748, DOI 10.1073/pnas.162366899; Liu HY, 2013, ANGEW CHEM INT EDIT, V52, P5744, DOI 10.1002/anie.201301243; Manicassamy B, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000745; McVernon J, 2010, EURO SURVEILLANCE B, V15; MEIKLEJOHN G, 1952, AM J HYG, V55, P1; MEIKLEJOHN G, 1952, AM J HYG, V55, P12, DOI 10.1093/oxfordjournals.aje.a119500; MELLMAN I, 1988, J CELL SCI, P45; Osterholm MT, 2012, LANCET INFECT DIS, V12, P36, DOI 10.1016/S1473-3099(11)70295-X; POTTER CW, 1979, BRIT MED BULL, V35, P69, DOI 10.1093/oxfordjournals.bmb.a071545; Reece JC, 2013, J VIROL, V87, P4146, DOI 10.1128/JVI.02645-12; RODGERS B, 1981, INFECT IMMUN, V31, P751, DOI 10.1128/IAI.31.2.751-757.1981; Seidel UJE, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00076; Short KR, 2012, J GEN VIROL, V93, P2315, DOI 10.1099/vir.0.045021-0; Skountzou I, 2010, J IMMUNOL, V185, P1642, DOI 10.4049/jimmunol.1000091; Stratov I, 2008, J VIROL, V82, P5450, DOI 10.1128/JVI.01952-07; Talbot HK, 2013, CLIN INFECT DIS, V56, P1774, DOI 10.1093/cid/cit124; Tamm A, 1997, Int Rev Immunol, V16, P57, DOI 10.3109/08830189709045703; Tricco AC, 2013, BMC MED, V11, DOI 10.1186/1741-7015-11-153; WELLS MA, 1978, INFECT IMMUN, V22, P758, DOI 10.1128/IAI.22.3.758-762.1978; WHO, 2015, INFL SEAS; Yassine HM, 2015, NAT MED, V21, P1065, DOI 10.1038/nm.3927	37	44	44	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 28	2016	11	4							e0154461	10.1371/journal.pone.0154461	http://dx.doi.org/10.1371/journal.pone.0154461			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DK8XE	27124730	Green Published, gold, Green Accepted			2022-12-26	WOS:000375211700091
J	Rhodes, AC; Barney, T; Clair, SBS				Rhodes, Aaron C.; Barney, Trevor; Clair, Samuel B. St.			Stand Composition, Tree Proximity and Size Have Minimal Effects on Leaf Function of Coexisting Aspen and Subalpine Fir	PLOS ONE			English	Article							QUAKING ASPEN; SPATIAL-PATTERN; CLONAL GROWTH; COMPETITION; FACILITATION; SUCCESSION; MECHANISMS; MORTALITY; GRADIENT; DENSITY	Forest structural heterogeneity due to species composition, spatial relationships and tree size are widely studied patterns in forest systems, but their impacts on tree function are not as well documented. The objective of this study was to examine how stand composition, tree proximity relationships and tree size influence the leaf functional traits of aspen, an early successional species, and subalpine fir, a climax species. We measured foliar nutrients, nonstructural carbohydrates (aspen only), defense chemistry and xylem water potential of aspen and subalpine fir trees in three size classes growing in close proximity or independently from other trees under three stand conditions: aspen dominant, aspen-conifer mixed, and conifer dominant stands. Close proximity of subalpine fir to aspen reduced aspen's storage of starch in foliar tissue by 17% suggesting that competition between these species may have small effects on carbon metabolism in aspen leaves. Simple sugar (glucose + sucrose) concentrations in aspen leaves were slightly higher in larger aspen trees than smaller trees. However, no differences were found in stem water potential, foliar concentrations of nitrogen, phosphorus, or secondary defense chemicals of aspen or subalpine fir across the gradients of stand composition, tree proximity or tree size. These results suggest that mechanisms of coexistence allow both aspen and subalpine fir to maintain leaf function across a wide range of stand structural characteristics. For aspen, resource sharing through its clonal root system and high resource storage capacity may partially contribute to its functional stability in mixed aspen-conifer stands.	[Rhodes, Aaron C.; Barney, Trevor; Clair, Samuel B. St.] Brigham Young Univ, Plant & Wildlife Sci, Provo, UT 84602 USA	Brigham Young University	Clair, SBS (corresponding author), Brigham Young Univ, Plant & Wildlife Sci, Provo, UT 84602 USA.	samuel_stclair@byu.edu	St.Clair, Sam/GZA-4592-2022		Charles Redd Center of Western Studies at Brigham Young University	Charles Redd Center of Western Studies at Brigham Young University	The Charles Redd Center of Western Studies at Brigham Young University provided funding for this study.	ALPERT P, 1991, ECOLOGY, V72, P69, DOI 10.2307/1938903; ALPERT P, 1986, OECOLOGIA, V70, P227, DOI 10.1007/BF00379244; [Anonymous], 2014, R LANG ENV STAT COMP; Antos JA, 2010, CAN J FOREST RES, V40, P638, DOI 10.1139/X10-011; Bakker JD, 2003, ECOL APPL, V13, P137, DOI 10.1890/1051-0761(2003)013[0137:COGROY]2.0.CO;2; Bansal S, 2010, ENVIRON EXP BOT, V69, P313, DOI 10.1016/j.envexpbot.2010.05.002; Baribault TW, 2011, J ECOL, V99, P1358, DOI 10.1111/j.1365-2745.2011.01862.x; Barton K., 2015, MuMIn: multi-model inference. R package; BAZZAZ FA, 1987, BIOSCIENCE, V37, P58, DOI 10.2307/1310178; BRYANT JP, 1983, OIKOS, V40, P357, DOI 10.2307/3544308; Buck JR, 2014, PLANT SOIL, V381, P61, DOI 10.1007/s11104-014-2094-9; Calder WJ, 2012, ECOSPHERE, V3, DOI 10.1890/ES12-00119.1; Calder WJ, 2011, TREE PHYSIOL, V31, P582, DOI 10.1093/treephys/tpr041; Callaway RM, 1995, BOT REV, V61, P306, DOI 10.1007/BF02912621; Callaway RM, 1997, ECOLOGY, V78, P1958, DOI 10.1890/0012-9658(1997)078[1958:CAFASA]2.0.CO;2; Canham CD, 2004, CAN J FOREST RES, V34, P778, DOI [10.1139/x03-232, 10.1139/X03-232]; Casper BB, 1997, ANNU REV ECOL SYST, V28, P545, DOI 10.1146/annurev.ecolsys.28.1.545; Castanha C, 2013, PLANT ECOL DIVERS, V6, P307, DOI 10.1080/17550874.2012.716087; CASWELL H, 1991, BIOL J LINN SOC, V42, P193, DOI 10.1111/j.1095-8312.1991.tb00560.x; Cavard X, 2011, OIKOS, V120, P1683, DOI 10.1111/j.1600-0706.2011.19294.x; CHAPIN FS, 1994, ECOL MONOGR, V64, P149, DOI 10.2307/2937039; Chesson P, 2000, ANNU REV ECOL SYST, V31, P343, DOI 10.1146/annurev.ecolsys.31.1.343; Clark AL, 2011, FOREST ECOL MANAG, V262, P203, DOI 10.1016/j.foreco.2011.03.024; CONNELL JH, 1977, AM NAT, V111, P1119, DOI 10.1086/283241; Diggle P., 2002, ANAL LONGITUDINAL DA, DOI DOI 10.2307/2983303; Frey BR, 2004, CAN J FOREST RES, V34, P1379, DOI 10.1139/X04-062; Germino MJ, 2015, TREE PHYSIOL, V35, P1141, DOI 10.1093/treephys/tpv109; GRIME JP, 1977, AM NAT, V111, P1169, DOI 10.1086/283244; Grover JP, 2011, AM NAT, V178, pE124, DOI 10.1086/662163; HENDRIX DL, 1993, CROP SCI, V33, P1306, DOI 10.2135/cropsci1993.0011183X003300060037x; HilleRisLambers J, 2012, ANNU REV ECOL EVOL S, V43, P227, DOI 10.1146/annurev-ecolsys-110411-160411; Hothorn T, 2008, BIOMETRICAL J, V50, P346, DOI 10.1002/bimj.200810425; Jia X, 2011, OIKOS, V120, P472, DOI 10.1111/j.1600-0706.2010.18674.x; Kobe RK, 1997, CAN J FOREST RES, V27, P227, DOI 10.1139/cjfr-27-2-227; Kurzel BP, 2007, FOREST ECOL MANAG, V252, P176, DOI 10.1016/j.foreco.2007.06.027; Legner N, 2013, ANN FOREST SCI, V70, P557, DOI 10.1007/s13595-013-0298-4; Lindroth RL, 2013, FOREST ECOL MANAG, V299, P14, DOI 10.1016/j.foreco.2012.11.018; LINDROTH RL, 1993, ECOLOGY, V74, P763, DOI 10.2307/1940804; MacPherson DM, 2001, FOREST CHRON, V77, P351, DOI 10.5558/tfc77351-2; MCAULIFFE JR, 1984, OECOLOGIA, V64, P319, DOI 10.1007/BF00379128; MURPHY J, 1962, ANAL CHIM ACTA, V26, P31; NIHLGARD B, 1971, OIKOS, V22, P302, DOI 10.2307/3543854; Pennings SC, 2000, ECOLOGY, V81, P709; Peterson E.B., 1992, ECOLOGY MANAGEMENT U, V1, P1; Pinheiro J, R PACKAGE VERSION; Plank C.O., SO COOPERATIVE SERIE, V368, P21; POLLARD JH, 1971, BIOMETRICS, V27, P991, DOI 10.2307/2528833; PORTER L J, 1986, Phytochemistry (Oxford), V25, P223; Pugnaire FI, 2001, OIKOS, V93, P42, DOI 10.1034/j.1600-0706.2001.930104.x; RENAUD JP, 1991, CAN J FOREST RES, V21, P1111, DOI 10.1139/x91-153; Ruiz-Benito P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056843; Smith AE, 2005, FOREST ECOL MANAG, V213, P338, DOI 10.1016/j.foreco.2005.03.018; Smith EA, 2011, FOREST ECOL MANAG, V262, P325, DOI 10.1016/j.foreco.2011.03.038; Smith EA, 2011, TREE PHYSIOL, V31, P68, DOI 10.1093/treephys/tpq100; SMITH WK, 1994, AM NAT, V143, P528, DOI 10.1086/285618; Stadt KJ, 2000, AGR FOREST METEOROL, V102, P235, DOI 10.1016/S0168-1923(00)00128-3; STOLL P, 1994, ECOLOGY, V75, P660, DOI 10.2307/1941724; Stoll P, 2005, J ECOL, V93, P395, DOI 10.1111/j.0022-0477.2005.00989.x; STUEFER JF, 1994, OECOLOGIA, V100, P302, DOI 10.1007/BF00316958; Thorpe HC, 2010, FOREST ECOL MANAG, V259, P1586, DOI 10.1016/j.foreco.2010.01.035; Vacek S., 1996, Journal of Vegetation Science, V75, P789, DOI 10.2307/3236457; Waskiewicz J, 2013, FOREST ECOL MANAG, V298, P71, DOI 10.1016/j.foreco.2013.02.027; Weiner J, 2001, AM NAT, V158, P438, DOI 10.1086/321988; Zuur Alain F., 2009, P1	64	4	4	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 28	2016	11	4							e0154395	10.1371/journal.pone.0154395	http://dx.doi.org/10.1371/journal.pone.0154395			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DK8XE	27124496	Green Submitted, Green Published, gold			2022-12-26	WOS:000375211700079
J	Li, J; Gu, D; Lee, SSY; Song, B; Bandyopadhyay, S; Chen, S; Konieczny, SF; Ratliff, TL; Liu, X; Xie, J; Cheng, JX				Li, J.; Gu, D.; Lee, S. S-Y; Song, B.; Bandyopadhyay, S.; Chen, S.; Konieczny, S. F.; Ratliff, T. L.; Liu, X.; Xie, J.; Cheng, J-X			Abrogating cholesterol esterification suppresses growth and metastasis of pancreatic cancer	ONCOGENE			English	Article							ACYL-COENZYME; TUMOR PROGRESSION; INHIBITION; CAVEOLIN-1; MIGRATION; PATHWAY; CELLS; ACYLTRANSFERASE; ACCUMULATION; METABOLISM	Cancer cells are known to execute reprogramed metabolism of glucose, amino acids and lipids. Here, we report a significant role of cholesterol metabolism in cancer metastasis. By using label-free Raman spectromicroscopy, we found an aberrant accumulation of cholesteryl ester in human pancreatic cancer specimens and cell lines, mediated by acyl-CoA cholesterol acyltransferase-1 (ACAT-1) enzyme. Expression of ACAT-1 showed a correlation with poor patient survival. Abrogation of cholesterol esterification, either by an ACAT-1 inhibitor or by shRNA knockdown, significantly suppressed tumor growth and metastasis in an orthotopic mouse model of pancreatic cancer. Mechanically, ACAT-1 inhibition increased intracellular free cholesterol level, which was associated with elevated endoplasmic reticulum stress and caused apoptosis. Collectively, our results demonstrate a new strategy for treating metastatic pancreatic cancer by inhibiting cholesterol esterification.	[Li, J.; Lee, S. S-Y; Song, B.; Cheng, J-X] Purdue Univ, Weldon Sch Biomed Engn, 206 S Martin Jischke Dr, W Lafayette, IN 47907 USA; [Gu, D.; Xie, J.] Indiana Univ Sch Med, Dept Pediat, Wells Ctr Pediat Res, IU Simon Canc Ctr, 1044 W Walnut St, Indianapolis, IN 46202 USA; [Bandyopadhyay, S.; Konieczny, S. F.] Purdue Univ, Dept Biol Sci, W Lafayette, IN 47907 USA; [Chen, S.] Indiana Univ Sch Med, Dept Pathol & Lab Med, Indianapolis, IN 46202 USA; [Konieczny, S. F.; Ratliff, T. L.; Liu, X.; Cheng, J-X] Purdue Univ, Ctr Canc Res, W Lafayette, IN 47907 USA; [Ratliff, T. L.] Purdue Univ, Dept Comparat Pathobiol, W Lafayette, IN 47907 USA; [Liu, X.] Purdue Univ, Dept Biochem, W Lafayette, IN 47907 USA	Purdue University System; Purdue University; Purdue University West Lafayette Campus; Indiana University System; Indiana University Bloomington; Purdue University System; Purdue University; Purdue University West Lafayette Campus; Indiana University System; Indiana University Bloomington; Purdue University System; Purdue University; Purdue University West Lafayette Campus; Purdue University System; Purdue University; Purdue University West Lafayette Campus; Purdue University System; Purdue University; Purdue University West Lafayette Campus	Cheng, JX (corresponding author), Purdue Univ, Weldon Sch Biomed Engn, 206 S Martin Jischke Dr, W Lafayette, IN 47907 USA.; Xie, J (corresponding author), Indiana Univ Sch Med, Dept Pediat, Wells Ctr Pediat Res, IU Simon Canc Ctr, 1044 W Walnut St, Indianapolis, IN 46202 USA.	jinxie@iupui.edu; jcheng@purdue.edu	Xie, J/AAR-7259-2020; Li, Junjie/B-1424-2017; Liu, Bingya/GMW-5655-2022	Li, Junjie/0000-0003-4542-300X; Bandyopadhyay, Shovik/0000-0003-3919-3914	Indiana State CTSI grant [106564]; NIH [CA182608, CA124586, CA155086, P30CA023168]; NCI [R25CA128770]; NATIONAL CANCER INSTITUTE [P30CA023168, R21CA182608, R01CA124586, R01CA155086, R25CA128770, R01CA196835] Funding Source: NIH RePORTER	Indiana State CTSI grant; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We greatly appreciate the help from Dr Tian Shao, Dr Zhiguo Li for their technical support. This work was supported by Indiana State CTSI grant 106564 to JX and JXC, NIH CA182608 to JXC, NCI R25CA128770 CPIP fellowship to JL, NIH CA124586 to SFK, and CA155086 to JX, and NIH grant P30CA023168 to Purdue University Center for Cancer Research for publications.	Antalis CJ, 2010, BREAST CANCER RES TR, V122, P661, DOI 10.1007/s10549-009-0594-8; Bemlih S, 2010, CANCER BIOL THER, V9, P1025, DOI 10.4161/cbt.9.12.11875; Bonovas S, 2008, AM J GASTROENTEROL, V103, P2646, DOI 10.1111/j.1572-0241.2008.02051.x; Campbell L, 2008, BRIT J CANCER, V98, P931, DOI 10.1038/sj.bjc.6604243; Cao S, 2005, J BIOL CHEM, V280, P1901, DOI 10.1074/jbc.M407941200; Chaffer CL, 2011, SCIENCE, V331, P1559, DOI 10.1126/science.1203543; Chalhoub N, 2009, ANNU REV PATHOL-MECH, V4, P127, DOI 10.1146/annurev.pathol.4.110807.092311; Chambers AF, 2002, NAT REV CANCER, V2, P563, DOI 10.1038/nrc865; Chang TY, 2006, ANNU REV CELL DEV BI, V22, P129, DOI 10.1146/annurev.cellbio.22.010305.104656; Chang TY, 2009, AM J PHYSIOL-ENDOC M, V297, pE1, DOI 10.1152/ajpendo.90926.2008; Friedl P, 2003, NAT REV CANCER, V3, P362, DOI 10.1038/nrc1075; GOLDSTEIN JL, 1977, ANNU REV BIOCHEM, V46, P897, DOI 10.1146/annurev.bi.46.070177.004341; Gu DS, 2013, MOL CANCER THER, V12, P1038, DOI 10.1158/1535-7163.MCT-12-1030; Han TY, 2013, CELL ADHES MIGR, V7, P395, DOI 10.4161/cam.26345; Jakobisiak M, 2003, INT J ONCOL, V23, P1055; KRITCHEVSKY SB, 1992, ANNU REV NUTR, V12, P391, DOI 10.1146/annurev.nu.12.070192.002135; Lee SSY, 2015, ACS NANO, V9, P2420, DOI 10.1021/nn504025a; Li JJ, 2014, SCI REP-UK, V4, DOI 10.1038/srep06807; Li LK, 2003, MOL CELL BIOL, V23, P9389, DOI 10.1128/MCB.23.24.9389-9404.2003; Liu L., 2014, INT J PHOTOENERGY, V2014, P1, DOI DOI 10.1371/J0URNAL.P0NE.0094160; Llaverias G, 2003, CARDIOVASC DRUG REV, V21, P33; Massy ZA, 1996, LANCET, V347, P102, DOI 10.1016/S0140-6736(96)90217-2; Movasaghi Z, 2007, APPL SPECTROSC REV, V42, P493, DOI 10.1080/05704920701551530; Mulas MF, 2011, CELL PROLIFERAT, V44, P360, DOI 10.1111/j.1365-2184.2011.00758.x; Murai Toshiyuki, 2012, Int J Cell Biol, V2012, P763283, DOI 10.1155/2012/763283; Murai T, 2011, J BIOL CHEM, V286, P1999, DOI 10.1074/jbc.M110.184010; Nieman KM, 2011, NAT MED, V17, P1498, DOI 10.1038/nm.2492; Nomura DK, 2010, CELL, V140, P49, DOI 10.1016/j.cell.2009.11.027; Oslowski CM, 2011, METHOD ENZYMOL, V490, P71, DOI 10.1016/B978-0-12-385114-7.00004-0; Porstmann T, 2008, CELL METAB, V8, P224, DOI 10.1016/j.cmet.2008.07.007; Ramprasad OG, 2007, CELL MOTIL CYTOSKEL, V64, P199, DOI 10.1002/cm.20176; Reddy KB, 2003, CANCER METAST REV, V22, P395, DOI 10.1023/A:1023781114568; Santos CR, 2012, FEBS J, V279, P2610, DOI 10.1111/j.1742-4658.2012.08644.x; Silvente-Poirot S, 2014, SCIENCE, V343, P1445, DOI 10.1126/science.1252787; Son J, 2013, NATURE, V496, P101, DOI 10.1038/nature12040; Sounni NE, 2014, CELL METAB, V20, P280, DOI 10.1016/j.cmet.2014.05.022; Steeg PS, 2008, NAT CLIN PRACT ONCOL, V5, P206, DOI 10.1038/ncponc1066; Tanase CP, 2009, J MOL HISTOL, V40, P23, DOI 10.1007/s10735-008-9209-7; Thysell E, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014175; Valastyan S, 2011, CELL, V147, P275, DOI 10.1016/j.cell.2011.09.024; Ward PS, 2012, CANCER CELL, V21, P297, DOI 10.1016/j.ccr.2012.02.014; WARNER GJ, 1995, J BIOL CHEM, V270, P5772, DOI 10.1074/jbc.270.11.5772; Yue SH, 2014, CELL METAB, V19, P393, DOI 10.1016/j.cmet.2014.01.019	43	137	145	2	28	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	DEC 15	2016	35	50					6378	6388		10.1038/onc.2016.168	http://dx.doi.org/10.1038/onc.2016.168			11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	EF3TP	27132508	hybrid, Green Published, Green Accepted			2022-12-26	WOS:000390247600003
J	Brinkmann, EM; Mattes, B; Kumar, R; Hagemann, AIH; Gradl, D; Scholpp, S; Steinbeisser, H; Kaufmann, LT; Ozbek, S				Brinkmann, Eva-Maria; Mattes, Benjamin; Kumar, Rahul; Hagemann, Anja I. H.; Gradl, Dietmar; Scholpp, Steffen; Steinbeisser, Herbert; Kaufmann, Lilian T.; Oezbek, Suat			Secreted Frizzled-related Protein 2 (sFRP2) Redirects Non-canonical Wnt Signaling from Fz7 to Ror2 during Vertebrate Gastrulation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						development; embryo; Wnt signaling; Xenopus; zebrafish; Fz7; Ror2; papc; sFRP2	CONVERGENT EXTENSION MOVEMENTS; MORPHOGENETIC MOVEMENTS; PARAXIAL PROTOCADHERIN; WNT/BETA-CATENIN; XENOPUS; ENDOCYTOSIS; ANTAGONIST; EXPRESSION; COMPLEX; BINDS	Convergent extension movements during vertebrate gastrulation require a balanced activity of non-canonical Wnt signaling pathways, but the factors regulating this interplay on the molecular level are poorly characterized. Here we show that sFRP2, a member of the secreted frizzled-related protein (sFRP) family, is required for morphogenesis and papc expression during Xenopus gastrulation. We further provide evidence that sFRP2 redirects non-canonical Wnt signaling from Frizzled 7 (Fz7) to the receptor tyrosine kinase-like orphan receptor 2 (Ror2). During this process, sFRP2 promotes Ror2 signal transduction by stabilizing Wnt5a-Ror2 complexes at the membrane, whereas it inhibits Fz7 signaling, probably by blocking Fz7 receptor endocytosis. The cysteine-rich domain of sFRP2 is sufficient for Ror2 activation, and related sFRPs can substitute for this function. Notably, direct interaction of the two receptors via their cysteine-rich domains also promotes Ror2-mediated papc expression but inhibits Fz7 signaling. We propose that sFRPs can act as a molecular switch, channeling the signal input for different non-canonical Wnt pathways during vertebrate gastrulation.	[Brinkmann, Eva-Maria; Kumar, Rahul; Steinbeisser, Herbert; Kaufmann, Lilian T.] Univ Heidelberg Hosp, Dept Dev Genet, Inst Human Genet, D-69120 Heidelberg, Germany; [Mattes, Benjamin; Hagemann, Anja I. H.; Scholpp, Steffen] Karlsruhe Inst Technol, Inst Toxicol & Genet, D-76344 Karlsruhe, Germany; [Gradl, Dietmar] Karlsruhe Inst Technol, Dept Cell & Dev Biol, Inst Zool, D-76131 Karlsruhe, Germany; [Oezbek, Suat] Heidelberg Univ, Dept Mol Evolut & Genom, Ctr Organismal Studies, Neuenheimer Feld 329, D-69120 Heidelberg, Germany	Ruprecht Karls University Heidelberg; Helmholtz Association; Karlsruhe Institute of Technology; Helmholtz Association; Karlsruhe Institute of Technology; Ruprecht Karls University Heidelberg	Ozbek, S (corresponding author), Heidelberg Univ, Dept Mol Evolut & Genom, Ctr Organismal Studies, Neuenheimer Feld 329, D-69120 Heidelberg, Germany.; Kaufmann, LT (corresponding author), Univ Heidelberg Hosp, Inst Human Genet, Neuenheimer Feld 366, D-69120 Heidelberg, Germany.	lilian.kaufmann@med.uni-heidelberg.de; suat.oezbek@cos.uni-heidelberg.de	Scholpp, Steffen/E-4472-2018; Özbek, Suat/D-3701-2014; Heeren-Hagemann, Anja/AAC-8192-2020	Scholpp, Steffen/0000-0002-4903-9657; Heeren-Hagemann, Anja/0000-0001-5491-4607; Kumar, Rahul/0000-0002-0934-0859; Ozbek, Suat/0000-0003-2569-3942	Deutsche Forschungsgemeinschaft [STE 613/8-2, FOR1036, Oe 416/5-1, SCHO847/5]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by Deutsche Forschungsgemeinschaft research grants STE 613/8-2 and FOR1036 (to H. S., L. T. K., and E. M. B.), Oe 416/5-1 and FOR1036 (to S. O.), and SCHO847/5 (to S. S., B. M., and A. H.). The authors declare that they have no conflicts of interest with the contents of this article.	Bhat RA, 2007, J CELL BIOCHEM, V102, P1519, DOI 10.1002/jcb.21372; Brand Michael, 2002, P7; Chong JM, 2002, J BIOL CHEM, V277, P5134, DOI 10.1074/jbc.M108533200; Cruciat CM, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a015081; Dann CE, 2001, NATURE, V412, P86, DOI 10.1038/35083601; Djiane A, 2000, DEVELOPMENT, V127, P3091; DU SJ, 1995, MOL CELL BIOL, V15, P2625; Finch PW, 1997, P NATL ACAD SCI USA, V94, P6770, DOI 10.1073/pnas.94.13.6770; Gibb N, 2013, DEVELOPMENT, V140, P1537, DOI 10.1242/dev.088047; Habas R, 2003, GENE DEV, V17, P295, DOI 10.1101/gad.1022203; Hagemann AIH, 2014, J CELL SCI, V127, P3970, DOI 10.1242/jcs.148767; Hikasa H, 2002, DEVELOPMENT, V129, P5227; Ho HYH, 2012, P NATL ACAD SCI USA, V109, P4044, DOI 10.1073/pnas.1200421109; ISAACS HV, 1994, EMBO J, V13, P4469, DOI 10.1002/j.1460-2075.1994.tb06769.x; Itoh K, 1998, MECH DEVELOP, V74, P145, DOI 10.1016/S0925-4773(98)00076-8; Janda CY, 2012, SCIENCE, V337, P59, DOI 10.1126/science.1222879; Kawano Y, 2003, J CELL SCI, V116, P2627, DOI 10.1242/jcs.00623; Kim GH, 2008, J CELL BIOL, V182, P1073, DOI 10.1083/jcb.200710188; Kim SH, 1998, DEVELOPMENT, V125, P4681; Kim SH, 2000, CURR BIOL, V10, P821, DOI 10.1016/S0960-9822(00)00580-7; Kumar S, 2014, BMC BIOL, V12, DOI 10.1186/1741-7007-12-44; Leyns L, 1997, CELL, V88, P747, DOI 10.1016/S0092-8674(00)81921-2; Li Y, 2008, GENE DEV, V22, P3050, DOI 10.1101/gad.1687308; Lin KM, 1997, P NATL ACAD SCI USA, V94, P11196, DOI 10.1073/pnas.94.21.11196; Lopez-Rios J, 2008, NEURAL DEV, V3, DOI 10.1186/1749-8104-3-19; Malinauskas T, 2014, CURR OPIN STRUC BIOL, V29, P77, DOI 10.1016/j.sbi.2014.10.003; Medina A, 2000, DEV DYNAM, V218, P671, DOI 10.1002/1097-0177(2000)9999:9999<::AID-DVDY1017>3.0.CO;2-9; Medina A, 2004, EMBO J, V23, P3249, DOI 10.1038/sj.emboj.7600329; Medina A, 2000, MECH DEVELOP, V92, P227, DOI 10.1016/S0925-4773(00)00240-9; Minami Y, 2010, DEV DYNAM, V239, P1, DOI 10.1002/dvdy.21991; MOON RT, 1993, DEVELOPMENT, V119, P97; Niehrs C, 2012, NAT REV MOL CELL BIO, V13, P767, DOI 10.1038/nrm3470; Nishita M, 2010, MOL CELL BIOL, V30, P3610, DOI 10.1128/MCB.00177-10; Ohkawara B, 2011, DEV CELL, V20, P303, DOI 10.1016/j.devcel.2011.01.006; Ohkawara B, 2011, DEV DYNAM, V240, P188, DOI 10.1002/dvdy.22500; Oishi I, 2003, GENES CELLS, V8, P645, DOI 10.1046/j.1365-2443.2003.00662.x; Pera EM, 2000, MECH DEVELOP, V96, P183, DOI 10.1016/S0925-4773(00)00394-4; Perry SW, 1997, BIOTECHNIQUES, V22, P1020, DOI 10.2144/97226bm01; Rengarajan C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086373; Satoh W, 2006, DEVELOPMENT, V133, P989, DOI 10.1242/dev.02274; Satoh W, 2008, GENESIS, V46, P92, DOI 10.1002/dvg.20369; Schambony A, 2007, DEV CELL, V12, P779, DOI 10.1016/j.devcel.2007.02.016; Shibata M, 2005, MECH DEVELOP, V122, P1322, DOI 10.1016/j.mod.2005.06.002; Stanganello E, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms6846; Sugiyama Y, 2010, DEV BIOL, V338, P193, DOI 10.1016/j.ydbio.2009.11.033; Sumanas S, 2001, GENESIS, V30, P119, DOI 10.1002/gene.1044; Swain RK, 2001, INT J DEV BIOL, V45, P259; Uren A, 2000, J BIOL CHEM, V275, P4374, DOI 10.1074/jbc.275.6.4374; Wallkamm V, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109428; Wang YQ, 2009, CELL MOL LIFE SCI, V66, P2263, DOI 10.1007/s00018-009-0018-2; Wawrzak D, 2007, BIOCHEM BIOPH RES CO, V357, P1119, DOI 10.1016/j.bbrc.2007.04.069; Winklbauer R, 2001, NATURE, V413, P856, DOI 10.1038/35101621; Witzel S, 2006, J CELL BIOL, V175, P791, DOI 10.1083/jcb.200606017; Yu AA, 2010, STRUCTURE, V18, P1311, DOI 10.1016/j.str.2010.07.010; Yuan YA, 2011, INT J MOL MED, V27, P63, DOI 10.3892/ijmm.2010.560	55	18	18	1	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 24	2016	291	26					13730	13742		10.1074/jbc.M116.733766	http://dx.doi.org/10.1074/jbc.M116.733766			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DR2YZ	27129770	hybrid, Green Published, Green Submitted			2022-12-26	WOS:000379771100027
J	Higa, M; Zhang, X; Tanaka, K; Saijo, M				Higa, Mitsuru; Zhang, Xue; Tanaka, Kiyoji; Saijo, Masafumi			Stabilization of Ultraviolet (UV)-stimulated Scaffold Protein A by Interaction with Ubiquitin-specific Peptidase 7 Is Essential for Transcription-coupled Nucleotide Excision Repair	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						deubiquitylation (deubiquitination); genetic disease; nucleotide excision repair; protein degradation; protein stability; protein-protein interaction	UV-SENSITIVE SYNDROME; RNA-POLYMERASE-II; COCKAYNE-SYNDROME; COMPLEMENTATION GROUPS; XERODERMA-PIGMENTOSUM; DNA-DAMAGE; DEFECT; P53; CSA; DEUBIQUITINATION	UV-sensitive syndrome is an autosomal recessive disorder characterized by hypersensitivity to UV light and deficiency in transcription-coupled nucleotide excision repair (TC-NER), a subpathway of nucleotide excision repair that rapidly removes transcription-blocking DNA damage. UV-sensitive syndrome consists of three genetic complementation groups caused by mutations in the CSA, CSB, and UVSSA genes. UV-stimulated scaffold protein A (UVSSA), the product of UVSSA, which is required for stabilization of Cockayne syndrome group B (CSB) protein and reappearance of the hypophosphorylated form of RNA polymerase II after UV irradiation, forms a complex with ubiquitin-specific peptidase 7 (USP7). In this study, we demonstrated that the deubiquitination activity of USP7 is suppressed by its interaction with UVSSA. The interaction required the tumor necrosis factor receptor-associated factor domain of USP7 and the central region of UVSSA and was disrupted by an amino acid substitution in the tumor necrosis factor receptor-associated factor-binding motif of UVSSA. Cells expressing mutant UVSSA were highly sensitive to UV irradiation and defective in recovery of RNA synthesis after UV irradiation. These results indicate that the interaction between UVSSA and USP7 is important for TC-NER. Furthermore, the mutant UVSSA was rapidly degraded by the proteasome, and CSB was also degraded after UV irradiation as observed in UVSSA-deficient cells. Thus, stabilization of UVSSA by interaction with USP7 is essential for TC-NER.	[Higa, Mitsuru; Zhang, Xue; Tanaka, Kiyoji; Saijo, Masafumi] Osaka Univ, Grad Sch Frontier Biosci, Yamadaoka 1-3, Suita, Osaka 5650871, Japan	Osaka University	Tanaka, K; Saijo, M (corresponding author), Osaka Univ, Grad Sch Frontier Biosci, Yamadaoka 1-3, Suita, Osaka 5650871, Japan.	ktanaka@fbs.osaka-u.ac.jp; saijom@fbs.osaka-u.ac.jp			Japan Society for the Promotion of Science [22131009, 15H02820]	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work was supported by Grant-in-aid for Scientific Research on Innovative Areas 22131009 (to K. T.) and Grant-in-aid for Scientific Research (B) 15H02820 (to M. S.) from the Japan Society for the Promotion of Science. The authors declare that they have no conflicts of interest related to the contents of this article.	Bregman DB, 1996, P NATL ACAD SCI USA, V93, P11586, DOI 10.1073/pnas.93.21.11586; Cummins JM, 2004, NATURE, V428, DOI 10.1038/nature02501; Fei J, 2012, J BIOL CHEM, V287, P35118, DOI 10.1074/jbc.M112.398131; Fousteri M, 2008, CELL RES, V18, P73, DOI 10.1038/cr.2008.6; Friedberg E. C., 2005, DNA REPAIR MUTAGENES, P267; FUJIWARA Y, 1981, J INVEST DERMATOL, V77, P256, DOI 10.1111/1523-1747.ep12482447; Groisman R, 2006, GENE DEV, V20, P1429, DOI 10.1101/gad.378206; Hanawalt PC, 2008, NAT REV MOL CELL BIO, V9, P958, DOI 10.1038/nrm2549; Hassiepen U, 2007, ANAL BIOCHEM, V371, P201, DOI 10.1016/j.ab.2007.07.034; HENNING KA, 1995, CELL, V82, P555, DOI 10.1016/0092-8674(95)90028-4; Holowaty MN, 2003, J BIOL CHEM, V278, P47753, DOI 10.1074/jbc.M307200200; Horibata K, 2004, P NATL ACAD SCI USA, V101, P15410, DOI 10.1073/pnas.0404587101; Horibata K, 2011, GENES CELLS, V16, P101, DOI 10.1111/j.1365-2443.2010.01467.x; Hu M, 2002, CELL, V111, P1041, DOI 10.1016/S0092-8674(02)01199-6; Hu M, 2006, PLOS BIOL, V4, P228, DOI 10.1371/journal.pbio.0040027; ITOH T, 1995, AM J HUM GENET, V56, P1267; ITOH T, 1994, MUTAT RES, V314, P233, DOI 10.1016/0921-8777(94)90068-X; LEHMANN AR, 1985, LANCET, V1, P486; Li MY, 2002, NATURE, V416, P648, DOI 10.1038/nature737; Marteijn JA, 2014, NAT REV MOL CELL BIO, V15, P465, DOI 10.1038/nrm3822; MAYNE LV, 1982, CANCER RES, V42, P1473; Meulmeester E, 2005, MOL CELL, V18, P565, DOI 10.1016/j.molcel.2005.04.024; Nakazawa Y, 2012, NAT GENET, V44, P586, DOI 10.1038/ng.2229; NANCE MA, 1992, AM J MED GENET, V42, P68, DOI 10.1002/ajmg.1320420115; Nardo T, 2009, P NATL ACAD SCI USA, V106, P6209, DOI 10.1073/pnas.0902113106; Sarkari F, 2010, J MOL BIOL, V402, P825, DOI 10.1016/j.jmb.2010.08.017; Schwertman P, 2012, NAT GENET, V44, P598, DOI 10.1038/ng.2230; Sheng Y, 2006, NAT STRUCT MOL BIOL, V13, P285, DOI 10.1038/nsmb1067; Spivak G, 2005, MUTAT RES-FUND MOL M, V577, P162, DOI 10.1016/j.mrfmmm.2005.03.017; TANAKA K, 1981, SOMAT CELL GENET, V7, P445, DOI 10.1007/BF01542989; TROELSTRA C, 1992, CELL, V71, P939, DOI 10.1016/0092-8674(92)90390-X; VENEMA J, 1990, P NATL ACAD SCI USA, V87, P4707, DOI 10.1073/pnas.87.12.4707; Zhang X, 2012, NAT GENET, V44, P593, DOI 10.1038/ng.2228	33	22	22	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 24	2016	291	26					13771	13779		10.1074/jbc.M116.724658	http://dx.doi.org/10.1074/jbc.M116.724658			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DR2YZ	27129218	hybrid, Green Published			2022-12-26	WOS:000379771100031
J	Martin, J; Midgley, A; Meran, S; Woods, E; Bowen, T; Phillips, AO; Steadman, R				Martin, John; Midgley, Adam; Meran, Soma; Woods, Emma; Bowen, Timothy; Phillips, Aled O.; Steadman, Robert			Tumor Necrosis Factor-stimulated Gene 6 (TSG-6)-mediated Interactions with the Inter-alpha-inhibitor Heavy Chain 5 Facilitate Tumor Growth Factor beta 1 (TGF beta 1)-dependent Fibroblast to Myofibroblast Differentiation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						fibroblast; fibrosis; hyaluronan; myofibroblast; transforming growth factor beta (TGF-B); fibroblast; tumor necrosis factor gene 6	HYALURONAN; PROGRESSION; PROTEIN; ITIH5; TSG-6; INACTIVATION; INFLAMMATION; PREDICTORS; EXPRESSION; PROMOTES	Fibroblasts are central to wound healing and fibrosis through TGF1-triggered differentiation into contractile, -smooth muscle actin (-SMA)-positive myofibroblasts. This is mediated by accumulation of a pericellular matrix of hyaluronan (HA) and the HA-dependent co-localization of CD44 with the epidermal growth factor receptor (EGFR). Interactions of HA with hyaladherins, such as inter--inhibitor (II) and tumor necrosis factor-stimulated gene-6 (TSG-6), are also essential for differentiation. This study investigated the mechanisms involved. TSG-6 and -SMA had different kinetics of induction by TGF1, with TSG-6 peaking before -SMA. Si CD44 or EGFR inhibition prevented differentiation but had no effect on TSG-6 expression. TSG-6 was essential for differentiation, and mAb A38 (preventing II heavy chain (HC) transfer), HA-oligosaccharides, cobalt, or Si bikunin prevented TSG-6 activity, preventing differentiation. A38 also prevented the EGFR/CD44 association. This suggested that TSG-6/II HC interaction was necessary for the effect of TSG-6 and that HC stabilization of HA initiated the CD44/EGFR association. The newly described HC5 was shown to be the principal HC expressed, and its cell surface expression was prevented by siRNA inhibition of TSG-6 or bikunin. HC5 was released by hyaluronidase treatment, confirming its association with cell surface HA. Finally, HC5 knockdown by siRNA confirmed its role in myofibroblast differentiation. The current study describes a novel mechanism linking the TSG-6 transfer of the newly described HC5 to the HA-dependent control of cell phenotype. The interaction of HC5 with cell surface HA was essential for TGF1-dependent differentiation of fibroblasts to myofibroblasts, highlighting its importance as a novel potential therapeutic target.	[Steadman, Robert] Cardiff Univ, Sch Med, Inst Mol & Expt Med, Dept Nephrol, Heath Pk, Cardiff CF14 4XN, S Glam, Wales; [Steadman, Robert] Cardiff Inst Tissue Engn & Repair, Heath Pk, Cardiff CF14 4XN, S Glam, Wales	Cardiff University; Cardiff University	Steadman, R (corresponding author), Cardiff Univ, Sch Med, Inst Mol & Expt Med, Dept Nephrol, Heath Pk, Cardiff CF14 4XN, S Glam, Wales.; Steadman, R (corresponding author), Cardiff Inst Tissue Engn & Repair, Heath Pk, Cardiff CF14 4XN, S Glam, Wales.	steadmanr@cf.ac.uk	Midgley, Adam C./P-8108-2019; Steadman, Robert/O-1614-2016	Midgley, Adam C./0000-0002-7622-0275; Steadman, Robert/0000-0002-1303-2496; Phillips, Aled/0000-0001-9744-7113	Kidney Wales Foundation; Medical Research Council [MR/K010328/1] Funding Source: researchfish; MRC [MR/K010328/1] Funding Source: UKRI	Kidney Wales Foundation; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by Kidney Wales Foundation. The authors declare that they have no conflicts of interest with the contents of this article.	Banerji S, 2007, NAT STRUCT MOL BIOL, V14, P234, DOI 10.1038/nsmb1201; Baranova NS, 2011, J BIOL CHEM, V286, P25675, DOI 10.1074/jbc.M111.247395; Blom AM, 1999, J BIOL CHEM, V274, P298, DOI 10.1074/jbc.274.1.298; Bommaya G, 2011, INT J BIOCHEM CELL B, V43, P1739, DOI 10.1016/j.biocel.2011.08.009; Choi-Miura NH, 2000, INFLAMM RES, V49, P305, DOI 10.1007/PL00000211; Clark HF, 2003, GENOME RES, V13, P2265, DOI 10.1101/gr.1293003; Day AJ, 2005, TRENDS IMMUNOL, V26, P637, DOI 10.1016/j.it.2005.09.009; Desmouliere A, 2003, LAB INVEST, V83, P1689, DOI 10.1097/01.LAB.0000101911.53973.90; Eddy AA, 2005, ADV CHRONIC KIDNEY D, V12, P353, DOI 10.1053/j.ackd.2005.07.011; Essawy M, 1997, NEPHROL DIAL TRANSPL, V12, P43, DOI 10.1093/ndt/12.1.43; Evanko SP, 2007, ADV DRUG DELIVER REV, V59, P1351, DOI 10.1016/j.addr.2007.08.008; Evans RA, 2003, EXP CELL RES, V282, P90, DOI 10.1016/S0014-4827(02)00015-0; Fulop C, 2003, DEVELOPMENT, V130, P2253, DOI 10.1242/dev.00422; Gabbiani G, 2003, J PATHOL, V200, P500, DOI 10.1002/path.1427; Goumenos D, 1998, NEPHROL DIAL TRANSPL, V13, P1652, DOI 10.1093/ndt/13.7.1652; GOUMENOS DS, 1994, NEPHROL DIAL TRANSPL, V9, P1418; Hamm A, 2008, BMC CANCER, V8, DOI 10.1186/1471-2407-8-25; Himmelfarb M, 2004, CANCER LETT, V204, P69, DOI 10.1016/j.canlet.2003.09.011; Huth S, 2015, EXP DERMATOL, V24, P663, DOI 10.1111/exd.12704; Jiang DH, 2011, PHYSIOL REV, V91, P221, DOI 10.1152/physrev.00052.2009; Knudson W, 1996, EXP CELL RES, V228, P216, DOI 10.1006/excr.1996.0320; KUHN C, 1991, AM J PATHOL, V138, P1257; Lesley J, 2004, J BIOL CHEM, V279, P25745, DOI 10.1074/jbc.M313319200; Lesley J, 2002, J BIOL CHEM, V277, P26600, DOI 10.1074/jbc.M201068200; Lewis A, 2008, HISTOL HISTOPATHOL, V23, P731, DOI 10.14670/HH-23.731; Meran S, 2007, J BIOL CHEM, V282, P25687, DOI 10.1074/jbc.M700773200; Midgley AC, 2013, J BIOL CHEM, V288, P14824, DOI 10.1074/jbc.M113.451336; Ochsner SA, 2003, ENDOCRINOLOGY, V144, P4376, DOI 10.1210/en.2003-0487; Roberts ISD, 1997, J CLIN PATHOL, V50, P123, DOI 10.1136/jcp.50.2.123; Rose M, 2014, CARCINOGENESIS, V35, P727, DOI 10.1093/carcin/bgt375; Rugg MS, 2005, J BIOL CHEM, V280, P25674, DOI 10.1074/jbc.M501332200; Sanggaard KW, 2008, J BIOL CHEM, V283, P18530, DOI 10.1074/jbc.M800874200; Sato H, 2001, BIOCHEM BIOPH RES CO, V281, P1154, DOI 10.1006/bbrc.2001.4475; Selbi W, 2006, KIDNEY INT, V70, P1287, DOI 10.1038/sj.ki.5001760; Selbi W, 2004, J AM SOC NEPHROL, V15, P1199, DOI 10.1097/01.ASN.0000125619.27422.8E; Selbi W, 2006, J AM SOC NEPHROL, V17, P1553, DOI 10.1681/ASN.2005080879; Simpson RML, 2010, AM J PATHOL, V176, P1215, DOI 10.2353/ajpath.2010.090802; Simpson RML, 2009, AM J PATHOL, V175, P1915, DOI 10.2353/ajpath.2009.090045; Tomasek JJ, 2002, NAT REV MOL CELL BIO, V3, P349, DOI 10.1038/nrm809; Vaughan MB, 2000, EXP CELL RES, V257, P180, DOI 10.1006/excr.2000.4869; Veeck J, 2008, ONCOGENE, V27, P865, DOI 10.1038/sj.onc.1210669; Webber J, 2009, J BIOL CHEM, V284, P9083, DOI 10.1074/jbc.M806989200; Zhuo LS, 2001, J BIOL CHEM, V276, P7693, DOI 10.1074/jbc.C000899200	43	27	27	0	19	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 24	2016	291	26					13789	13801		10.1074/jbc.M115.670521	http://dx.doi.org/10.1074/jbc.M115.670521			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DR2YZ	27143355	Green Published, hybrid			2022-12-26	WOS:000379771100033
J	White, CL; Kessler, PM; Dickerman, BK; Ozato, K; Sen, GC				White, Christine L.; Kessler, Patricia M.; Dickerman, Benjamin K.; Ozato, Keiko; Sen, Ganes C.			Interferon Regulatory Factor 8 (IRF8) Impairs Induction of Interferon Induced with Tetratricopeptide Repeat Motif (IFIT) Gene Family Members	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						gene regulation; interferon; interferon regulatory factor (IRF); promoter; transcription regulation	SEQUENCE-BINDING-PROTEIN; INDUCIBLE HUMAN GENES; RIG-I; TRANSCRIPTION FACTOR; ALPHA; MOUSE; ACTIVATION; EXPRESSION; COMPLEX; RNA	The chromosomally clustered interferon-induced with tetratricopeptide repeat motif (IFIT) gene family members share structural features at the gene and protein levels. Despite these similarities, different IFIT genes have distinct inducer- and cell type-specific induction patterns. Here, we investigated the mechanism for the observed differential induction of the mouse Ifit1, Ifit2, and Ifit3 genes in B cells and demonstrated that the repressive effect of the transcription factor interferon regulatory factor 8 (IRF8), which is highly expressed in B cells, played an essential role in this regulation. Although IRF8 could impair induction of all three IFIT genes following stimulation of retinoic acid-inducible gene I (RIG-I), it could selectively impair the induction of the Ifit1 gene following IFN stimulation. The above properties could be imparted to IRF8-non-expressing cells by ectopic expression of the protein. Induction of reporter genes, driven by truncated Ifit1 promoters, identified the regions that mediate the repression, and a chromatin immunoprecipitation assay revealed that more IRF8 bound to the IFN-stimulated response element of the Ifit1 gene than to those of the Ifit2 and the Ifit3 genes. Mutational analyses of IRF8 showed that its ability to bind DNA, interact with other proteins, and undergo sumoylation were all necessary to selectively repress Ifit1 gene induction in response to IFN. Our study revealed a new role for IRFs in differentially regulating the induction patterns of closely related IFN-stimulated genes that are located adjacent to one another in the mouse genome.	[White, Christine L.; Kessler, Patricia M.; Dickerman, Benjamin K.; Sen, Ganes C.] Cleveland Clin, Lerner Res Inst, Dept Mol Genet, Cleveland, OH 44195 USA; [Dickerman, Benjamin K.; Sen, Ganes C.] Case Western Reserve Univ, Grad Program Mol Virol, Cleveland, OH 44106 USA; [Ozato, Keiko] NICHD, Program Genom Differentiat, NIH, Bethesda, MD 20892 USA; [Dickerman, Benjamin K.] Burnet Inst Med Res, Melbourne, Vic 3004, Australia	Cleveland Clinic Foundation; Case Western Reserve University; National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD); Burnet Institute	White, CL (corresponding author), Hudson Inst Med Res, Ctr Canc Res, 27-31 Wright St, Clayton, Vic 3168, Australia.; Sen, GC (corresponding author), Cleveland Clin, Dept Immunol NE20, 9500 Euclid Ave, Cleveland, OH 44195 USA.	christine.white@hudson.org.au; seng@ccf.org	White, Christine/AAQ-4546-2021	White, Christine/0000-0002-5920-0029	National Institutes of Health [CA068782, CA062220, AI073303]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [ZIAHD001310, ZIHHD001310] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [P01CA062220, R01CA068782] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R56AI073303, R01AI073303] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by National Institutes of Health Grants CA068782, CA062220, and AI073303 (to G. C. S.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	BLUYSSEN HAR, 1994, EUR J BIOCHEM, V220, P395, DOI 10.1111/j.1432-1033.1994.tb18636.x; BLUYSSEN HAR, 1994, GENOMICS, V24, P137, DOI 10.1006/geno.1994.1591; BOVOLENTA C, 1994, P NATL ACAD SCI USA, V91, P5046, DOI 10.1073/pnas.91.11.5046; Carey Michael F, 2009, Cold Spring Harb Protoc, V2009, DOI 10.1101/pdb.prot5277; Chang TH, 2012, J IMMUNOL, V189, P3548, DOI 10.4049/jimmunol.1201104; DARNELL JE, 1994, SCIENCE, V264, P1415, DOI 10.1126/science.8197455; Der SD, 1998, P NATL ACAD SCI USA, V95, P15623, DOI 10.1073/pnas.95.26.15623; DRIGGERS PH, 1990, P NATL ACAD SCI USA, V87, P3743, DOI 10.1073/pnas.87.10.3743; Edgar R, 2002, NUCLEIC ACIDS RES, V30, P207, DOI 10.1093/nar/30.1.207; Fensterl V, 2008, J VIROL, V82, P11045, DOI 10.1128/JVI.01593-08; Fensterl V, 2015, J VIROL, V89, P2462, DOI 10.1128/JVI.02744-14; Fensterl V, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002712; Fujii Y, 1999, EMBO J, V18, P5028, DOI 10.1093/emboj/18.18.5028; Huang WQ, 2007, J BIOL CHEM, V282, P6629, DOI 10.1074/jbc.M607760200; Hui DJ, 2005, J BIOL CHEM, V280, P3433, DOI 10.1074/jbc.M406700200; Kato H, 2006, NATURE, V441, P101, DOI 10.1038/nature04734; Kato H, 2005, IMMUNITY, V23, P19, DOI 10.1016/j.immuni.2005.04.010; Lai KC, 2008, MOL CANCER RES, V6, P1431, DOI 10.1158/1541-7786.MCR-08-0141; LEVY DE, 1989, GENE DEV, V3, P1362, DOI 10.1101/gad.3.9.1362; Li P, 2011, BLOOD, V117, P2847, DOI 10.1182/blood-2010-07-294272; Lin RT, 1998, MOL CELL BIOL, V18, P2986, DOI 10.1128/MCB.18.5.2986; Maniatis T., 1982, MOL CLONING; Marecki S, 1999, J IMMUNOL, V163, P2713; Meraro D, 1999, J IMMUNOL, V163, P6468; NELSON N, 1993, MOL CELL BIOL, V13, P588, DOI 10.1128/MCB.13.1.588; Ortiz MA, 1999, P NATL ACAD SCI USA, V96, P2740, DOI 10.1073/pnas.96.6.2740; Pichlmair A, 2011, NAT IMMUNOL, V12, P624, DOI 10.1038/ni.2048; SHARF R, 1995, J BIOL CHEM, V270, P13063, DOI 10.1074/jbc.270.22.13063; Stawowczyk M, 2011, J BIOL CHEM, V286, P7257, DOI 10.1074/jbc.M110.207068; Su AI, 2002, P NATL ACAD SCI USA, V99, P4465, DOI 10.1073/pnas.012025199; Su AI, 2004, P NATL ACAD SCI USA, V101, P6062, DOI 10.1073/pnas.0400782101; Tamura T, 2000, IMMUNITY, V13, P155, DOI 10.1016/S1074-7613(00)00016-9; Taniguchi T, 2001, ANNU REV IMMUNOL, V19, P623, DOI 10.1146/annurev.immunol.19.1.623; Terenzi F, 2007, J VIROL, V81, P8656, DOI 10.1128/JVI.00322-07; Terenzi F, 2006, J BIOL CHEM, V281, P34064, DOI 10.1074/jbc.M605771200; Tsujimura H, 2003, BLOOD, V101, P961, DOI 10.1182/blood-2002-05-1327; Unlu S, 2007, MOL IMMUNOL, V44, P3364, DOI 10.1016/j.molimm.2007.02.016; VEALS SA, 1992, MOL CELL BIOL, V12, P3315, DOI 10.1128/MCB.12.8.3315; WATHELET MG, 1988, EUR J BIOCHEM, V174, P323, DOI 10.1111/j.1432-1033.1988.tb14101.x; Yoneyama M, 2004, NAT IMMUNOL, V5, P730, DOI 10.1038/ni1087	40	8	8	1	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 24	2016	291	26					13535	13545		10.1074/jbc.M115.705467	http://dx.doi.org/10.1074/jbc.M115.705467			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DR2YZ	27137933	hybrid, Green Published			2022-12-26	WOS:000379771100012
J	Guo, JL; Buist, A; Soares, A; Callaerts, K; Calafate, S; Stevenaert, F; Daniels, JP; Zoll, BE; Crowe, A; Brunden, KR; Moechars, D; Lee, VMY				Guo, Jing L.; Buist, Arjan; Soares, Alberto; Callaerts, Kathleen; Calafate, Sara; Stevenaert, Frederik; Daniels, Joshua P.; Zoll, Bryan E.; Crowe, Alex; Brunden, Kurt R.; Moechars, Diederik; Lee, Virginia M. Y.			The Dynamics and Turnover of Tau Aggregates in Cultured Cells INSIGHTS INTO THERAPIES FOR TAUOPATHIES	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MICROTUBULE-ASSOCIATED PROTEIN; ALPHA-SYNUCLEIN FIBRILS; TRANSGENIC MOUSE MODEL; ALZHEIMERS-DISEASE; NEUROFIBRILLARY TANGLES; NEURODEGENERATIVE DISEASES; MAMMALIAN AUTOPHAGY; DEGRADATION; PROTEASOME; PHOSPHORYLATION	Filamentous tau aggregates, the hallmark lesions of Alzheimer disease (AD), play key roles in neurodegeneration. Activation of protein degradation systems has been proposed to be a potential strategy for removing pathological tau, but it remains unclear how effectively tau aggregates can be degraded by these systems. By applying our previously established cellular model system of AD-like tau aggregate induction using preformed tau fibrils, we demonstrate that tau aggregates induced in cells with regulated expression of full-length mutant tau can be gradually cleared when soluble tau expression is suppressed. This clearance is at least partially mediated by the autophagy-lysosome pathway, although both the ubiquitin-proteasome system and the autophagy-lysosome pathway are deficient in handling large tau aggregates. Importantly, residual tau aggregates left after the clearance phase leads to a rapid reinstatement of robust tau pathology once soluble tau expression is turned on again. Moreover, we succeeded in generating monoclonal cells persistently carrying tau aggregates without obvious cytotoxicity. Live imaging of GFP-tagged tau aggregates showed that tau inclusions are dynamic structures constantly undergoing "fission" and "fusion," which facilitate stable propagation of tau pathology in dividing cells. These findings provide a greater understanding of cell-to-cell transmission of tau aggregates in dividing cells and possibly neurons.	[Daniels, Joshua P.; Zoll, Bryan E.; Crowe, Alex; Brunden, Kurt R.; Lee, Virginia M. Y.] Univ Penn, Sch Med, Dept Pathol & Lab Med, Inst Aging, Philadelphia, PA 19104 USA; [Daniels, Joshua P.; Zoll, Bryan E.; Crowe, Alex; Brunden, Kurt R.; Lee, Virginia M. Y.] Univ Penn, Sch Med, Ctr Neurodegenerat Dis Res, Philadelphia, PA 19104 USA; [Buist, Arjan; Soares, Alberto; Callaerts, Kathleen; Calafate, Sara; Stevenaert, Frederik; Moechars, Diederik] Janssen Res & Dev, Neurosci Dept, B-2340 Beerse, Belgium	University of Pennsylvania; University of Pennsylvania; Pennsylvania Medicine; Johnson & Johnson; Janssen Pharmaceuticals	Guo, JL; Lee, VMY (corresponding author), Ctr Neurodegenerat Dis Res, Dept Pathol & Lab Med, 3rd Floor Maloney Bldg,3600 Spruce St, Philadelphia, PA 19104 USA.	guojing@mail.med.upenn.edu; vmylee@upenn.edu		calafate, sara/0000-0002-1276-3211	National Institutes of Health NIA [AG17586]; CurePSP Foundation; BrightFocus Foundation; NATIONAL INSTITUTE ON AGING [P01AG017586] Funding Source: NIH RePORTER	National Institutes of Health NIA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); CurePSP Foundation; BrightFocus Foundation(BrightFocus Foundation); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by National Institutes of Health NIA Grant AG17586, the CurePSP Foundation, and a postdoctoral fellowship award (to J. L. G.) from Sophie M. Moyer and other donors of the Alzheimer's disease research program of the BrightFocus Foundation. Some coauthors work for Janssen, Pharmaceutical Companies of Johnson & Johnson. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	ARRIAGADA PV, 1992, NEUROLOGY, V42, P631, DOI 10.1212/WNL.42.3.631; Ballatore C, 2007, NAT REV NEUROSCI, V8, P663, DOI 10.1038/nrn2194; Belitzky A, 2011, PHYS CHEM CHEM PHYS, V13, P13809, DOI 10.1039/c1cp20832b; Bi XN, 2000, J NEUROCHEM, V74, P1469, DOI 10.1046/j.1471-4159.2000.0741469.x; BRION JP, 1989, NEUROCHEM INT, V14, P121, DOI 10.1016/0197-0186(89)90111-3; Brunden KR, 2010, J NEUROSCI, V30, P13861, DOI 10.1523/JNEUROSCI.3059-10.2010; Caccamo A, 2013, AGING CELL, V12, P370, DOI 10.1111/acel.12057; Carulla N, 2005, NATURE, V436, P554, DOI 10.1038/nature03986; Caughey B, 2003, ANNU REV NEUROSCI, V26, P267, DOI 10.1146/annurev.neuro.26.010302.081142; Chesser AS, 2013, FRONT NEUROL, V4, DOI 10.3389/fneur.2013.00122; CLEVELAND DW, 1977, J MOL BIOL, V116, P207, DOI 10.1016/0022-2836(77)90213-3; COLE GM, 1987, NEUROSCI LETT, V79, P207, DOI 10.1016/0304-3940(87)90698-7; Cremades N, 2012, CELL, V149, P1048, DOI 10.1016/j.cell.2012.03.037; DRECHSEL DN, 1992, MOL BIOL CELL, V3, P1141, DOI 10.1091/mbc.3.10.1141; Glass CK, 2010, CELL, V140, P918, DOI 10.1016/j.cell.2010.02.016; Guo JL, 2014, NAT MED, V20, P130, DOI 10.1038/nm.3457; Guo JL, 2011, J BIOL CHEM, V286, P15317, DOI 10.1074/jbc.M110.209296; Haass C, 2007, NAT REV MOL CELL BIO, V8, P101, DOI 10.1038/nrm2101; Hamano T, 2008, EUR J NEUROSCI, V27, P1119, DOI 10.1111/j.1460-9568.2008.06084.x; Harper JD, 1999, BIOCHEMISTRY-US, V38, P8972, DOI 10.1021/bi9904149; Iba M, 2013, J NEUROSCI, V33, P1024, DOI 10.1523/JNEUROSCI.2642-12.2013; Ii K, 1997, J NEUROPATH EXP NEUR, V56, P125, DOI 10.1097/00005072-199702000-00002; Inoue K, 2012, MOL NEURODEGENER, V7, DOI 10.1186/1750-1326-7-48; Ishihara T, 1999, NEURON, V24, P751, DOI 10.1016/S0896-6273(00)81127-7; Keck S, 2003, J NEUROCHEM, V85, P115, DOI 10.1046/j.1471-4159.2003.01642.x; Keller JN, 2000, J NEUROCHEM, V75, P436, DOI 10.1046/j.1471-4159.2000.0750436.x; Knowles TPJ, 2009, SCIENCE, V326, P1533, DOI 10.1126/science.1178250; Kouri N, 2011, BRAIN, V134, P3264, DOI 10.1093/brain/awr234; Kruger U, 2012, NEUROBIOL AGING, V33, P2291, DOI 10.1016/j.neurobiolaging.2011.11.009; KWAK S, 1991, NEUROSCI LETT, V128, P21, DOI 10.1016/0304-3940(91)90751-E; Lee VMY, 2001, ANNU REV NEUROSCI, V24, P1121, DOI 10.1146/annurev.neuro.24.1.1121; Li WK, 2006, BIOCHEMISTRY-US, V45, P15692, DOI 10.1021/bi061422+; Ling H, 2014, NEUROPATH APPL NEURO, V40, P149, DOI 10.1111/nan.12037; Luk KC, 2009, P NATL ACAD SCI USA, V106, P20051, DOI 10.1073/pnas.0908005106; Meyer V, 2014, BIOCHEMISTRY-US, V53, P5804, DOI 10.1021/bi501050g; Mizushima N, 2010, CELL, V140, P313, DOI 10.1016/j.cell.2010.01.028; Nixon RA, 2005, J NEUROPATH EXP NEUR, V64, P113, DOI 10.1093/jnen/64.2.113; Polydoro M, 2013, J NEUROSCI, V33, P13300, DOI 10.1523/JNEUROSCI.0881-13.2013; Ravikumar B, 2010, PHYSIOL REV, V90, P1383, DOI 10.1152/physrev.00030.2009; Rubinsztein DC, 2006, NATURE, V443, P780, DOI 10.1038/nature05291; Rubinsztein DC, 2009, AUTOPHAGY, V5, P585, DOI 10.4161/auto.5.5.8823; Sampathu DM, 2006, AM J PATHOL, V169, P1343, DOI 10.2353/ajpath.2006.060438; SantaCruz K, 2005, SCIENCE, V309, P476, DOI 10.1126/science.1113694; Schaeffer V, 2012, BRAIN, V135, P2169, DOI 10.1093/brain/aws143; Shammas SL, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8025; Sydow A, 2010, NEURODEGENER DIS, V7, P28, DOI 10.1159/000283479; Tang L, 2006, MICRON, V37, P675, DOI 10.1016/j.micron.2006.02.004; Tanik SA, 2013, J BIOL CHEM, V288, P15194, DOI 10.1074/jbc.M113.457408; Waxman EA, 2008, J NEUROPATH EXP NEUR, V67, P402, DOI 10.1097/NEN.0b013e31816fc995; WEINGARTEN MD, 1975, P NATL ACAD SCI USA, V72, P1858, DOI 10.1073/pnas.72.5.1858; Wu JW, 2013, J BIOL CHEM, V288, P1856, DOI 10.1074/jbc.M112.394528; Yoshiyama Y, 2007, NEURON, V53, P337, DOI 10.1016/j.neuron.2007.01.010	52	46	46	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 17	2016	291	25					13175	13193		10.1074/jbc.M115.712083	http://dx.doi.org/10.1074/jbc.M115.712083			19	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DR2YT	27129267	Green Published, hybrid			2022-12-26	WOS:000379770500024
J	Vetterli, L; Carobbio, S; Frigerio, F; Karaca, M; Maechler, P				Vetterli, Laurene; Carobbio, Stefania; Frigerio, Francesca; Karaca, Melis; Maechler, Pierre			The Amplifying Pathway of the beta-Cell Contributes to Diet-induced Obesity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							STIMULATED INSULIN-SECRETION; GLUTAMATE-DEHYDROGENASE; WEIGHT-LOSS; GLUCOSE; DIAZOXIDE; HYPERINSULINEMIA; PROTECTS; MICE; EXPRESSION; CHANNELS	Efficient energy storage in adipose tissues requires optimal function of the insulin-producing beta-cell, whereas its dysfunction promotes diabetes. The associated paradox related to beta-cell efficiency is that excessive accumulation of fat in adipose tissue predisposes for type 2 diabetes. Insulin exocytosis is regulated by intracellular metabolic signal transduction, with glutamate dehydrogenase playing a key role in the amplification of the secretory response. Here, we used mice with beta-cell-selective glutamate dehydrogenase deletion (beta Glud1(-/-)), lacking an amplifying pathway of insulin secretion. As opposed to control mice, beta Glud1(-/-) animals fed a high calorie diet maintained glucose tolerance and did not develop diet-induced obesity. Islets of beta Glud1(-/-) mice did not increase their secretory response upon high calorie feeding, as did islets of control mice. Inhibited adipose tissue expansion observed in knock-out mice correlated with lower expression of genes responsible for adipogenesis. Rather than being efficiently stored, lipids were consumed at a higher rate in beta Glud1(-/-) mice compared with controls, in particular during food intake periods. These results show that reduced beta-cell function prior to high calorie feeding prevented diet-induced obesity.	Univ Geneva, Med Ctr, Dept Cell Physiol & Metab, CH-1211 Geneva 4, Switzerland; Univ Geneva, Med Ctr, Fac Diabet Ctr, CH-1211 Geneva 4, Switzerland	University of Geneva; University of Geneva	Maechler, P (corresponding author), Univ Med Ctr, Dept Cell Physiol & Metab, 1 Rue Michel Servet, CH-1211 Geneva 4, Switzerland.	Pierre.Maechler@unige.ch	carobbio, stefania/E-7095-2018	Karaca, Melis/0000-0001-6951-3507; Maechler, Pierre/0000-0002-2005-1433	State of Geneva; Swiss National Science Foundation	State of Geneva; Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	This work was supported by the State of Geneva and the Swiss National Science Foundation (to P. M.). The authors declare that they have no conflicts of interest with the contents of this article.	Alemzadeh R, 1998, J CLIN ENDOCR METAB, V83, P1911, DOI 10.1210/jc.83.6.1911; Amer Diabet Assoc, 2013, DIABETES CARE, V36, pS11, DOI 10.2337/dc13-S011; Ashcroft FM, 2006, BIOCHEM SOC T, V34, P243, DOI 10.1042/BST0340243; Bluher M, 2004, J BIOL CHEM, V279, P31902, DOI 10.1074/jbc.M404570200; Bluher M, 2002, DEV CELL, V3, P25, DOI 10.1016/S1534-5807(02)00199-5; Carobbio S, 2004, DIABETOLOGIA, V47, P266, DOI 10.1007/s00125-003-1306-2; Carobbio S, 2009, J BIOL CHEM, V284, P921, DOI 10.1074/jbc.M806295200; Casimir M, 2011, NUTR METAB, V8, DOI 10.1186/1743-7075-8-2; Casimir M, 2009, J BIOL CHEM, V284, P25004, DOI 10.1074/jbc.M109.015495; Dor Y, 2004, NATURE, V429, P41, DOI 10.1038/nature02520; Due A, 2007, DIABETES OBES METAB, V9, P566, DOI 10.1111/j.1463-1326.2006.00645.x; Ferdaoussi M, 2015, J CLIN INVEST, V125, P3847, DOI 10.1172/JCI82498; FOLCH J, 1957, J BIOL CHEM, V226, P497; GEMBAL M, 1992, J CLIN INVEST, V89, P1288, DOI 10.1172/JCI115714; Gheni G, 2014, CELL REP, V9, P661, DOI 10.1016/j.celrep.2014.09.030; GOTO Y, 1976, TOHOKU J EXP MED, V119, P85, DOI 10.1620/tjem.119.85; Hoy M, 2002, FEBS LETT, V531, P199, DOI 10.1016/S0014-5793(02)03500-7; Jones JR, 2005, P NATL ACAD SCI USA, V102, P6207, DOI 10.1073/pnas.0306743102; Karaca M, 2014, NEUROCHEM RES, V39, P456, DOI 10.1007/s11064-013-1041-0; Kasuga M, 2006, J CLIN INVEST, V116, P1756, DOI 10.1172/JCI29189; Lamberts SWJ, 1996, NEW ENGL J MED, V334, P246, DOI 10.1056/NEJM199601253340408; Li N, 2012, DIABETES, V61, P2842, DOI 10.2337/db12-0009; Lustig RH, 2006, INT J OBESITY, V30, P331, DOI 10.1038/sj.ijo.0803074; Maechler P, 1999, NATURE, V402, P685, DOI 10.1038/45280; Maechler P, 2013, MOL CELL ENDOCRINOL, V379, P12, DOI 10.1016/j.mce.2013.06.019; Matsumoto S, 2005, LANCET, V365, P1642, DOI 10.1016/S0140-6736(05)66383-0; Mehran AE, 2012, CELL METAB, V16, P723, DOI 10.1016/j.cmet.2012.10.019; MICHAELIDIS TM, 1993, GENOMICS, V16, P150, DOI 10.1006/geno.1993.1152; Movassat J, 2008, AM J PHYSIOL-ENDOC M, V294, pE168, DOI 10.1152/ajpendo.00501.2007; POLONSKY KS, 1988, J CLIN INVEST, V81, P435, DOI 10.1172/JCI113338; PORTHA B, 1991, DIABETES, V40, P486, DOI 10.2337/diabetes.40.4.486; Prentki M, 2006, J CLIN INVEST, V116, P1802, DOI 10.1172/JCI29103; Robertson RP, 2002, TRANSPLANTATION, V73, P736; Rubi B, 2001, J BIOL CHEM, V276, P36391, DOI 10.1074/jbc.M104999200; Shyng SL, 1997, J GEN PHYSIOL, V110, P643, DOI 10.1085/jgp.110.6.643; Steneberg R, 2005, CELL METAB, V1, P245, DOI 10.1016/j.cmet.2005.03.007; Stumvoll M, 2005, LANCET, V365, P1333, DOI 10.1016/S0140-6736(05)61032-X; Supale S, 2013, DIABETES, V62, P3488, DOI 10.2337/db13-0152; Templeman NM, 2015, DIABETOLOGIA, V58, P2392, DOI 10.1007/s00125-015-3676-7; Um SH, 2004, NATURE, V431, P200, DOI 10.1038/nature02866; van Boekel G, 2008, DIABETES OBES METAB, V10, P1195, DOI 10.1111/j.1463-1326.2008.00878.x; Vetterli L, 2012, MOL BIOL CELL, V23, P3851, DOI 10.1091/mbc.E11-08-0676; Virtue S, 2012, CELL METAB, V16, P665, DOI 10.1016/j.cmet.2012.10.008; Wicksteed B, 2010, DIABETES, V59, P3090, DOI 10.2337/db10-0624; Wu YJ, 2011, J CLIN INVEST, V121, P2422, DOI 10.1172/JCI45027; Yamauchi T, 2002, NAT MED, V8, P1288, DOI 10.1038/nm788	46	15	15	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 17	2016	291	25					13063	13075		10.1074/jbc.M115.707448	http://dx.doi.org/10.1074/jbc.M115.707448			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DR2YT	27137930	hybrid, Green Published			2022-12-26	WOS:000379770500015
J	Tando, T; Hirayama, A; Furukawa, M; Sato, Y; Kobayashi, T; Funayama, A; Kanaji, A; Hao, W; Watanabe, R; Morita, M; Oike, T; Miyamoto, K; Soga, T; Nomura, M; Yoshimura, A; Tomita, M; Matsumoto, M; Nakamura, M; Toyama, Y; Miyamoto, T				Tando, Toshimi; Hirayama, Akiyoshi; Furukawa, Mitsuru; Sato, Yuiko; Kobayashi, Tami; Funayama, Atsushi; Kanaji, Arihiko; Hao, Wu; Watanabe, Ryuichi; Morita, Mayu; Oike, Takatsugu; Miyamoto, Kana; Soga, Tomoyoshi; Nomura, Masatoshi; Yoshimura, Akihiko; Tomita, Masaru; Matsumoto, Morio; Nakamura, Masaya; Toyama, Yoshiaki; Miyamoto, Takeshi			Smad2/3 Proteins Are Required for Immobilization-induced Skeletal Muscle Atrophy	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GROWTH-FACTOR-I; FOXO TRANSCRIPTION FACTORS; SCF UBIQUITIN LIGASE; F-BOX PROTEIN; CAPILLARY-ELECTROPHORESIS; MYOSTATIN GENE; MASS-SPECTROMETRY; HYPERTROPHY; MICE; RECEPTOR	Skeletal muscle atrophy promotes muscle weakness, limiting activities of daily living. However, mechanisms underlying atrophy remain unclear. Here, we show that skeletal muscle immobilization elevates Smad2/3 protein but not mRNA levels in muscle, promoting atrophy. Furthermore, we demonstrate that myostatin, which negatively regulates muscle hypertrophy, is dispensable for denervation-induced muscle atrophy and Smad2/3 protein accumulation. Moreover, muscle-specific Smad2/3-deficient mice exhibited significant resistance to denervation-induced muscle atrophy. In addition, expression of the atrogenes Atrogin-1 and MuRF1, which underlie muscle atrophy, did not increase in muscles of Smad2/3-deficient mice following denervation. We also demonstrate that serum starvation promotes Smad2/3 protein accumulation in C2C12 myogenic cells, an in vitro muscle atrophy model, an effect inhibited by IGF1 treatment. In vivo, we observed IGF1 receptor deactivation in immobilized muscle, even in the presence of normal levels of circulating IGF1. Denervation-induced muscle atrophy was accompanied by reduced glucose intake and elevated levels of branched-chain amino acids, effects that were Smad2/3-dependent. Thus, muscle immobilization attenuates IGF1 signals at the receptor rather than the ligand level, leading to Smad2/3 protein accumulation, muscle atrophy, and accompanying metabolic changes.	[Tando, Toshimi; Furukawa, Mitsuru; Sato, Yuiko; Kobayashi, Tami; Funayama, Atsushi; Kanaji, Arihiko; Hao, Wu; Watanabe, Ryuichi; Oike, Takatsugu; Miyamoto, Kana; Matsumoto, Morio; Nakamura, Masaya; Toyama, Yoshiaki; Miyamoto, Takeshi] Keio Univ, Sch Med, Dept Orthoped Surg, Shinjuku Ku, 35 Shinano Machi, Tokyo 1608582, Japan; [Sato, Yuiko; Kobayashi, Tami] Keio Univ, Sch Med, Dept Musculoskeletal Reconstruct & Regenerat Surg, Shinjuku Ku, 35 Shinano Machi, Tokyo 1608582, Japan; [Yoshimura, Akihiko] Keio Univ, Sch Med, Dept Immunol, Shinjuku Ku, 35 Shinano Machi, Tokyo 1608582, Japan; [Morita, Mayu] Keio Univ, Sch Med, Dept Dent & Oral Surg, Shinjuku Ku, 35 Shinano Machi, Tokyo 1608582, Japan; [Hirayama, Akiyoshi; Soga, Tomoyoshi; Tomita, Masaru] Keio Univ, Inst Adv Biosci, 246-2 Mizukami, Tsuruoka, Yamagata 9970052, Japan; [Nomura, Masatoshi] Kyushu Univ, Grad Sch Med Sci, Dept Med & Bioregulatory Sci, Maidashi 3-1-1,Higashi Ward, Fukuoka 8128582, Japan	Keio University; Keio University; Keio University; Keio University; Keio University; Kyushu University	Miyamoto, T (corresponding author), Keio Univ, Sch Med, Dept Orthoped Surg, Shinjuku Ku, 35 Shinano Machi, Tokyo 1608582, Japan.	miyamoto@z5.keio.jp	hao, wu/HDM-1705-2022; Soga, Tomoyoshi/B-8105-2014; Nakamura, Masaya/K-4111-2013; Yoshimura, Akihiko/K-5515-2013	Soga, Tomoyoshi/0000-0001-9502-2509; 	Translational Research Network Program; Grants-in-Aid for Scientific Research [16K10917] Funding Source: KAKEN	Translational Research Network Program; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by a grant-in-aid for scientific research and in part by a grant from the Translational Research Network Program. The authors declare that they have no conflicts of interest with the contents of this article.	Alzghoul MB, 2004, FASEB J, V18, P221, DOI 10.1096/fj.03-0293fje; BILAN PJ, 1992, FEBS LETT, V298, P285, DOI 10.1016/0014-5793(92)80078-U; Bodine SC, 2001, NAT CELL BIOL, V3, P1014, DOI 10.1038/ncb1101-1014; Bodine SC, 2001, SCIENCE, V294, P1704, DOI 10.1126/science.1065874; Cai DS, 2004, CELL, V119, P285, DOI 10.1016/j.cell.2004.09.027; Clarke BA, 2007, CELL METAB, V6, P376, DOI 10.1016/j.cmet.2007.09.009; Clop A, 2006, NAT GENET, V38, P813, DOI 10.1038/ng1810; Cohen S, 2009, J CELL BIOL, V185, P1083, DOI 10.1083/jcb.200901052; Criswell DS, 1998, AM J PHYSIOL-ENDOC M, V275, pE373; Cruz-Jentoft AJ, 2010, AGE AGEING, V39, P412, DOI 10.1093/ageing/afq034; DIMITRIADIS G, 1992, BIOCHEM J, V285, P269, DOI 10.1042/bj2850269; DIMITRIADIS G, 1992, J ENDOCRINOL, V133, P37, DOI 10.1677/joe.0.1330037; Fielitz J, 2007, J CLIN INVEST, V117, P2486, DOI 10.1172/JCI32827; Foletta VC, 2011, PFLUG ARCH EUR J PHY, V461, P325, DOI 10.1007/s00424-010-0919-9; Gallot YS, 2014, CANCER RES, V74, P7344, DOI 10.1158/0008-5472.CAN-14-0057; Gomes MD, 2001, P NATL ACAD SCI USA, V98, P14440, DOI 10.1073/pnas.251541198; Hirayama A, 2009, CANCER RES, V69, P4918, DOI 10.1158/0008-5472.CAN-08-4806; Jackman RW, 2004, AM J PHYSIOL-CELL PH, V287, pC834, DOI 10.1152/ajpcell.00579.2003; Jogo M, 2009, FEBS LETT, V583, P2715, DOI 10.1016/j.febslet.2009.07.033; Katsuyama E, 2015, J BIOL CHEM, V290, P716, DOI 10.1074/jbc.M114.568360; Kedar V, 2004, P NATL ACAD SCI USA, V101, P18135, DOI 10.1073/pnas.0404341102; Klampfl CW, 2001, ELECTROPHORESIS, V22, P2737, DOI 10.1002/1522-2683(200108)22:13&lt;2737::AID-ELPS2737&gt;3.0.CO;2-Z; Lagirand-Cantaloube J, 2008, EMBO J, V27, P1266, DOI 10.1038/emboj.2008.52; Lee SW, 2004, J AM SOC NEPHROL, V15, P1537, DOI 10.1097/01.ASN.0000127211.86206.E1; Li HH, 2004, J CLIN INVEST, V114, P1058, DOI 10.1172/JCl200422220; Mavalli MD, 2010, J CLIN INVEST, V120, P4007, DOI 10.1172/JCI42447; McPherron AC, 1997, NATURE, V387, P83, DOI 10.1038/387083a0; McPherron AC, 1997, P NATL ACAD SCI USA, V94, P12457, DOI 10.1073/pnas.94.23.12457; Milan G, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7670; Miyamoto H, 2012, J BIOL CHEM, V287, P32479, DOI 10.1074/jbc.M112.358226; Miyauchi Y, 2013, P NATL ACAD SCI USA, V110, P16568, DOI 10.1073/pnas.1308755110; Musaro A, 2001, NAT GENET, V27, P195, DOI 10.1038/84839; Nakao R, 2009, MOL CELL BIOL, V29, P4798, DOI 10.1128/MCB.01347-08; Pallafacchina G, 2002, P NATL ACAD SCI USA, V99, P9213, DOI 10.1073/pnas.142166599; Paul PK, 2010, J CELL BIOL, V191, P1395, DOI 10.1083/jcb.201006098; Pistilli EE, 2011, AM J PATHOL, V178, P1287, DOI 10.1016/j.ajpath.2010.11.071; Powers SK, 2005, AM J PHYSIOL-REG I, V288, pR337, DOI 10.1152/ajpregu.00469.2004; Reid MB, 2001, RESP RES, V2, P269, DOI 10.1186/rr67; Sandri M, 2004, CELL, V117, P399, DOI 10.1016/S0092-8674(04)00400-3; Sandri M, 2008, PHYSIOLOGY, V23, P160, DOI 10.1152/physiol.00041.2007; Sartori R, 2013, NAT GENET, V45, P1309, DOI 10.1038/ng.2772; Sartori R, 2009, AM J PHYSIOL-CELL PH, V296, pC1248, DOI 10.1152/ajpcell.00104.2009; Schuelke M, 2004, NEW ENGL J MED, V350, P2682, DOI 10.1056/NEJMoa040933; Shi J, 2011, DEV CELL, V21, P835, DOI 10.1016/j.devcel.2011.09.011; Shimizu N, 2011, CELL METAB, V13, P170, DOI 10.1016/j.cmet.2011.01.001; Smith RC, 2013, CURR OPIN SUPPORT PA, V7, P352, DOI 10.1097/SPC.0000000000000013; Soga T, 2009, ANAL CHEM, V81, P6165, DOI 10.1021/ac900675k; Spate U, 2004, CURR OPIN CLIN NUTR, V7, P265, DOI 10.1097/01.mco.0000126344.88494.de; Stevenson EJ, 2005, J APPL PHYSIOL, V98, P1396, DOI 10.1152/japplphysiol.01055.2004; Stitt TN, 2004, MOL CELL, V14, P395, DOI 10.1016/S1097-2765(04)00211-4; Sugimoto M, 2010, METABOLOMICS, V6, P78, DOI 10.1007/s11306-009-0178-y; Tintignac LA, 2005, J BIOL CHEM, V280, P2847, DOI 10.1074/jbc.M411346200; Trendelenburg AU, 2009, AM J PHYSIOL-CELL PH, V296, pC1258, DOI 10.1152/ajpcell.00105.2009; Winbanks CE, 2013, J CELL BIOL, V203, P345, DOI 10.1083/jcb.201211134	54	38	39	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 3	2016	291	23					12184	12194		10.1074/jbc.M115.680579	http://dx.doi.org/10.1074/jbc.M115.680579			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DO9GJ	27129272	Green Published, hybrid			2022-12-26	WOS:000378092800020
J	Boron, V; Tzanopoulos, J; Gallo, J; Barragan, J; Jaimes-Rodriguez, L; Schaller, G; Payan, E				Boron, Valeria; Tzanopoulos, Joseph; Gallo, Jenny; Barragan, Jorge; Jaimes-Rodriguez, Laura; Schaller, George; Payan, Esteban			Jaguar Densities across Human-Dominated Landscapes in Colombia: The Contribution of Unprotected Areas to Long Term Conservation	PLOS ONE			English	Article							OIL-PALM EXPANSION; PUMA PUMA-CONCOLOR; PANTHERA-ONCA; CAMERA-TRAPS; SPATIAL ECOLOGY; POPULATION; PREY; PATTERNS; ABUNDANCE; PREDATOR	Large carnivores such as jaguars (Panthera onca) are species of conservation concern because they are suffering population declines and are keystone species in their ecosystems. Their large area requirements imply that unprotected and ever-increasing agricultural regions can be important habitats as they allow connectivity and dispersal among core protected areas. Yet information on jaguar densities across unprotected landscapes it is still scarce and crucially needed to assist management and range-wide conservation strategies. Our study provides the first jaguar density estimates of Colombia in agricultural regions which included cattle ranching, the main land use in the country, and oil palm cultivation, an increasing land use across the Neotropics. We used camera trapping across two agricultural landscapes located in the Magdalena River valley and in the Colombian llanos (47-53 stations respectively; >2000 trap nights at both sites) and classic and spatially explicit capture-recapture models with the sex of individuals as a covariate. Density estimates were 2.52 +/- 0.46-3.15 +/- 1.08 adults/100 km(2) in the Magdalena valley, whereas 1.12 +/- 0.13-2.19 +/- 0.99 adults/100 km(2) in the Colombian llanos, depending on analysis used. We suggest that jaguars are able to live across unprotected human-use areas and co-exist with agricultural landscapes including oil-palm plantations if natural areas and riparian habitats persist in the landscape and hunting of both jaguar and prey is limited. In the face of an expanding agriculture across the tropics we recommend land-use planning, adequate incentives, regulations, and good agricultural practices for range-wide jaguar connectivity and survival.	[Boron, Valeria; Tzanopoulos, Joseph] Univ Kent, Durrell Inst Conservat & Ecol, Canterbury, Kent, England; [Gallo, Jenny; Payan, Esteban] Panthera Colombia, Bogota, Colombia; [Barragan, Jorge] La Aurora Civil Soc Nat Reserve, Hato Corozal, Colombia; [Jaimes-Rodriguez, Laura] Univ Ind Santander, Escuela Biol, Bucaramanga, Colombia; [Schaller, George] Panthera, New York, NY USA; [Schaller, George] Wildlife Conservat Soc, Bronx, NY USA	University of Kent; Universidad Industrial de Santander; Wildlife Conservation Society	Boron, V (corresponding author), Univ Kent, Durrell Inst Conservat & Ecol, Canterbury, Kent, England.	vb210@kent.ac.uk		Jaimes Rodriguez, Laura Lizbeth/0000-0001-6878-484X	Panthera; Liz Claiborne and Art Orternberg Foundation (LCAOF); LCAOF Jaguar Research Grant; Rufford Foundation, Rufford Small Grant [14968-1]; Explorers Club, Exploration Fund grant; Idea Wild	Panthera; Liz Claiborne and Art Orternberg Foundation (LCAOF); LCAOF Jaguar Research Grant; Rufford Foundation, Rufford Small Grant; Explorers Club, Exploration Fund grant; Idea Wild	This study was supported by Panthera; Liz Claiborne and Art Orternberg Foundation (LCAOF) and LCAOF Jaguar Research Grant (http://www.panthera.org/node/785); The Rufford Foundation, Rufford Small Grant #14968-1 (http://www.rufford.org/projects/valeria_boron); The Explorers Club, Exploration Fund grant (https://explorers.org/expeditions/funding/expedition_grants); and Idea Wild. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Quiroga VA, 2014, ORYX, V48, P141, DOI 10.1017/S0030605312000944; Arispe R, 2007, CENSO DE JAGUARES PA; Athreya V, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057872; Azevedo FCC, 2012, J ZOOL, V286, P200, DOI 10.1111/j.1469-7998.2011.00867.x; Borchers DL, 2008, BIOMETRICS, V64, P377, DOI 10.1111/j.1541-0420.2007.00927.x; Boron V., 2012, ARE JAGUARS PAYING T; Brodie JF, 2009, BIODIVERS CONSERV, V18, P2927, DOI 10.1007/s10531-009-9617-3; Burnham K. P., 2002, MODEL SELECTION AND; Carbone C, 2001, ANIM CONSERV, V4, P75, DOI 10.1017/S1367943001001081; Carbone C, 2002, SCIENCE, V295, P2273, DOI 10.1126/science.1067994; Carbone Chris, 2011, Biol Lett, V7, P312, DOI 10.1098/rsbl.2010.0996; Cardillo M, 2005, MULTIPLE CAUSES OF H, V1067, P1239; Caso A, 2015, PANTHERA ONCA; Castiblanco C, 2013, ENVIRON SCI POLICY, V27, P172, DOI 10.1016/j.envsci.2013.01.003; Cavalcanti SMC, 2009, J MAMMAL, V90, P935, DOI 10.1644/08-MAMM-A-188.1; Ceballos G, 2002, EL JAGUAR EN EL NUEV, P403; Crawshaw Peter G. Jr, 2004, P271; CRAWSHAW PG, 1991, J ZOOL, V223, P357, DOI 10.1111/j.1469-7998.1991.tb04770.x; Crooks K. R., 2006, CONNECTIVITY CONSERV; Crooks KR, 2011, PHILOS T R SOC B, V366, P2642, DOI 10.1098/rstb.2011.0120; Cusack JJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126373; Danielsen F, 2009, CONSERV BIOL, V23, P348, DOI 10.1111/j.1523-1739.2008.01096.x; Efford M, 2004, OIKOS, V106, P598, DOI 10.1111/j.0030-1299.2004.13043.x; Efford M. G, 2015, SECR SPATIALLY EXPLI; Efford MG, 2009, ECOLOGY, V90, P2676, DOI 10.1890/08-1735.1; Estes JA, 2011, SCIENCE, V333, P301, DOI 10.1126/science.1205106; Etter A, 2006, AGR ECOSYST ENVIRON, V114, P369, DOI 10.1016/j.agee.2005.11.013; Etter A, 2000, AMBIO, V29, P432, DOI 10.1639/0044-7447(2000)029[0432:POLTIC]2.0.CO;2; Fahrig L, 2003, ANNU REV ECOL EVOL S, V34, P487, DOI 10.1146/annurev.ecolsys.34.011802.132419; Figueroa A., 2013, THE ECOLOGY AND CONS; Fitzherbert EB, 2008, TRENDS ECOL EVOL, V23, P538, DOI 10.1016/j.tree.2008.06.012; Foley JA, 2005, SCIENCE, V309, P570, DOI 10.1126/science.1111772; Foster RJ, 2010, J ZOOL, V280, P309, DOI 10.1111/j.1469-7998.2009.00663.x; Foster RJ, 2012, J WILDLIFE MANAGE, V76, P224, DOI 10.1002/jwmg.275; Garcia-Ulloa J, 2012, CONSERV LETT, V5, P366, DOI 10.1111/j.1755-263X.2012.00254.x; Garrote Germán, 2012, Mastozool. neotrop., V19, P139; Harmsen BJ, 2006, THE USE OF CAMERA TR; IDEAM IGAC IAVH INVEMAR SINCHI IIAP, 2007, ECOSISTEMAS CONTINEN; Inskip C, 2009, ORYX, V43, P18, DOI 10.1017/S003060530899030X; Jackson P., 1996, BIOL CONSERVATION; Karanth KU, 1998, ECOLOGY, V79, P2852; Lasso CA, 2011, BIODIVERSIDAD DE LA, P235; Linnell JDC, 2001, ANIM CONSERV, V4, P345, DOI 10.1017/S1367943001001408; Macdonald David W., 2010, P3; Maffei L, 2004, J ZOOL, V262, P295, DOI 10.1017/S0952836903004655; Maffei L, 2008, BIOTROPICA, V40, P71, DOI 10.1111/j.1744-7429.2007.00341.x; Maffei L, 2011, CAMERA TRAPS IN ANIMAL ECOLOGY: METHODS AND ANALYSES, P119, DOI 10.1007/978-4-431-99495-4_8; Marker LL, 2008, J ZOOL, V274, P226, DOI 10.1111/j.1469-7998.2007.00375.x; Mech LD, 2003, WOLVES BEHAVIOURAL E; Noss A, 2013, EVALUATING JAGUAR DE; Noss AJ, 2012, ANIM CONSERV, V15, P527, DOI 10.1111/j.1469-1795.2012.00545.x; Novack AJ, 2005, J ZOOL, V267, P167, DOI 10.1017/S0952836905007338; O'Brien TG, 2003, ANIM CONSERV, V6, P131, DOI 10.1017/S1367943003003172; Otis D.L., 1978, WILDLIFE MONOGR, P3, DOI DOI 10.2307/3830650; Pacheco P., 2012, WORKING PAPER 90, P1; Panthera, 2012, JAGUAR CORRIDOR; Parks SA, 2002, CONSERV BIOL, V16, P800, DOI 10.1046/j.1523-1739.2002.00288.x; Paviolo A, 2008, ORYX, V42, P554, DOI 10.1017/S0030605308000641; Payan E., 2009, JAGUARS OCELOTS AND; Payan E, 2009, INFORME SOBRE EL EST, P103; Payan E, 2013, MOLECULAR POPULATION, P603; Payan E., 2006, JAGUAR CONSERVATION; Payan Esteban, 2006, Cat News, V44, P25; Polisar J, 2003, BIOL CONSERV, V109, P297, DOI 10.1016/S0006-3207(02)00157-X; QUIGLEY HB, 1992, BIOL CONSERV, V61, P149, DOI 10.1016/0006-3207(92)91111-5; RABINOWITZ A, 2010, BIOL CONSERV, V143, P939, DOI DOI 10.1016/J.BI0C0N.2010.01.002; RABINOWITZ AR, 1986, J ZOOL, V210, P149, DOI 10.1111/j.1469-7998.1986.tb03627.x; Ripple WJ, 2014, SCIENCE, V343, P151, DOI 10.1126/science.1241484; Rodriiguez-Mahecha JV, 2006, BOGOTA CONSERVACIOON; Rovero F, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103300; Royle JA, 2008, ECOLOGY, V89, P2281, DOI 10.1890/07-0601.1; Royle JA, 2011, CAMERA TRAPS IN ANIMAL ECOLOGY: METHODS AND ANALYSES, P163, DOI 10.1007/978-4-431-99495-4_10; Royle JA, 2009, J APPL ECOL, V46, P118, DOI 10.1111/j.1365-2664.2008.01578.x; Sanderson EW, 2002, CONSERV BIOL, V16, P58, DOI 10.1046/j.1523-1739.2002.00352.x; Sanderson EW, 2002, LANDSCAPE URBAN PLAN, V58, P41, DOI 10.1016/S0169-2046(01)00231-6; SCHALLER G B, 1983, Arquivos de Zoologia (Sao Paulo), V31, P1; SCHALLER GB, 1980, BIOTROPICA, V12, P161, DOI 10.2307/2387967; Scognamillo D, 2003, J ZOOL, V259, P269, DOI 10.1017/S0952836902003230; Silver SC, 2004, ORYX, V38, P148, DOI 10.1017/S0030605304000286; Soisalo MK, 2006, BIOL CONSERV, V129, P487, DOI 10.1016/j.biocon.2005.11.023; Sollmann R, 2013, BIOL CONSERV, V159, P405, DOI 10.1016/j.biocon.2012.12.025; Sollmann R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034575; Sollmann R, 2011, BIOL CONSERV, V144, P1017, DOI 10.1016/j.biocon.2010.12.011; Thorbjarnarson J, 2006, BIOL CONSERV, V128, P25, DOI 10.1016/j.biocon.2005.09.013; Tobler MW, 2013, BIOL CONSERV, V159, P375, DOI 10.1016/j.biocon.2012.12.012; Tobler MW, 2013, BIOL CONSERV, V159, P109, DOI 10.1016/j.biocon.2012.12.009; Treves A, 2003, CONSERV BIOL, V17, P1491, DOI 10.1111/j.1523-1739.2003.00059.x; Weckel M, 2006, J ZOOL, V270, P25, DOI 10.1111/j.1469-7998.2006.00106.x; White GC, 1999, BIRD STUDY, V46, P120, DOI 10.1080/00063659909477239; White GC., 1982, CAPTURE RECAPTURE AN; Wikramanayake E, 2004, CONSERV BIOL, V18, P839, DOI 10.1111/j.1523-1739.2004.00145.x; Woodroffe R, 1998, SCIENCE, V280, P2126, DOI 10.1126/science.280.5372.2126; Zimmermann A, 2005, ORYX, V39, P406, DOI 10.1017/S0030605305000992	93	45	48	1	95	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 4	2016	11	5							e0153973	10.1371/journal.pone.0153973	http://dx.doi.org/10.1371/journal.pone.0153973			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DL5KR	27144280	Green Accepted, Green Published, Green Submitted, gold			2022-12-26	WOS:000375676400034
J	Yu, J; Tian, AJ; Yuan, X; Cheng, XX				Yu, Jing; Tian, Ai-Juan; Yuan, Xin; Cheng, Xiao-Xin			Subclinical Hypothyroidism after I-131-Treatment of Graves' Disease: A Risk Factor for Depression?	PLOS ONE			English	Article							SUBDINICAL HYPOTHYROIDISM; THYROID-FUNCTION; SYMPTOMS; HORMONE	Objectives Although it is well accepted that there is a close relationship between hypothyroidism and depression, previous studies provided inconsistent or even opposite results in whether subclinical hypothyroidism (SCH) increased the risk of depression. One possible reason is that the etiology of SCH in these studies was not clearly distinguished. We therefore investigated the relationship between SCH resulting from I-131 treatment of Graves' disease and depression. Design And Methods The incidence of depression among 95 patients with SCH and 121 euthyroid patients following I-131 treatment of Graves' disease was studied. The risk factors of depression were determined with multivariate logistic regression analysis. Thyroid hormone replacement therapy was performed in patients with thyroid-stimulating hormone (TSH) levels exceeding 10 mIU/L. Results Patients with SCH had significantly higher Hamilton Depression Scale scores, serum TSH and thyroid peroxidase antibody (TPOAb) levels compared with euthyroid patients. Multivariate logistic regression analysis revealed SCH, Graves' eye syndrome and high serum TPO antibody level as risk factors for depression. L-thyroxine treatment is beneficial for SCH patients with serum TSH levels exceeding 10 mIU/L. Conclusions The results of the present study demonstrated that SCH is prevalent among I-131 treated Graves' patients. SCH might increase the risk of developing depression. L-thyroxine replacement therapy helps to resolve depressive disorders in SCH patients with TSH > 10mIU/L. These data provide insight into the relationship between SCH and depression.	[Yu, Jing; Tian, Ai-Juan; Yuan, Xin] Dalian Med Univ, Affiliated Hosp 2, Div Nucl Med, Dalian 116023, Peoples R China; [Cheng, Xiao-Xin] Dalian Med Univ, Coll Basic Med Sci, Dept Cell Biol, Dalian 116044, Peoples R China; [Cheng, Xiao-Xin] Dalian Med Univ, Coll Basic Med Sci, Liaoning Prov Key Lab Canc Genom & Epigenet, Dalian 116044, Peoples R China	Dalian Medical University; Dalian Medical University; Dalian Medical University	Cheng, XX (corresponding author), Dalian Med Univ, Coll Basic Med Sci, Dept Cell Biol, Dalian 116044, Peoples R China.; Cheng, XX (corresponding author), Dalian Med Univ, Coll Basic Med Sci, Liaoning Prov Key Lab Canc Genom & Epigenet, Dalian 116044, Peoples R China.	xiaoxincheng@yahoo.com						Bono G, 2004, ACTA NEUROL SCAND, V110, P59, DOI 10.1111/j.1600-0404.2004.00262.x; Chinese Medical Association -Endocrinology Branch, 2007, CHINESE J INTERNAL M, V46, P5; Chu JW, 2001, J CLIN ENDOCR METAB, V86, P4591, DOI 10.1210/jc.86.10.4591; Chueire VB, 2007, ARCH GERONTOL GERIAT, V44, P21, DOI 10.1016/j.archger.2006.02.001; Correia N, 2009, J CLIN ENDOCR METAB, V94, P3789, DOI 10.1210/jc.2008-2702; Demartini B, 2014, J NERV MENT DIS, V202, P603, DOI 10.1097/NMD.0000000000000168; Engum A, 2002, ACTA PSYCHIAT SCAND, V106, P27, DOI 10.1034/j.1600-0447.2002.01250.x; Fatourechi V, 2001, MAYO CLIN PROC, V76, P413; FOWLER PBS, 1981, BRIT MED J, V282, P1072, DOI 10.1136/bmj.282.6269.1072-a; GOLD MS, 1981, JAMA-J AM MED ASSOC, V245, P1919, DOI 10.1001/jama.245.19.1919; Gussekloo J, 2004, JAMA-J AM MED ASSOC, V292, P2591, DOI 10.1001/jama.292.21.2591; HAGGERTY JJ, 1993, AM J PSYCHIAT, V150, P508; JOFFE RT, 1995, THYROID, V5, P235, DOI 10.1089/thy.1995.5.235; Jorde R, 2006, J CLIN ENDOCR METAB, V91, P145, DOI 10.1210/jc.2005-1775; Kong WM, 2002, AM J MED, V112, P348, DOI 10.1016/S0002-9343(02)01022-7; McDermott MT, 2001, J CLIN ENDOCR METAB, V86, P4585, DOI 10.1210/jc.86.10.4585; MONZANI F, 1993, CLIN INVESTIGATOR, V71, P367; Owen PJD, 2003, TRENDS ENDOCRIN MET, V14, P257, DOI 10.1016/S1043-2760(03)00108-5; Park YJ, 2010, ARCH GERONTOL GERIAT, V50, pE68, DOI 10.1016/j.archger.2009.05.015; Sawka AM, 2003, J CLIN ENDOCR METAB, V88, P4551, DOI 10.1210/jc.2003-030139; Surks MI, 2004, JAMA-J AM MED ASSOC, V291, P228, DOI 10.1001/jama.291.2.228; TARGUM SD, 1984, J CLIN PSYCHIAT, V45, P345; Vanderpump M, 2003, TRENDS ENDOCRIN MET, V14, P262, DOI 10.1016/S1043-2760(03)00103-6; VANDERPUMP MPJ, 1995, CLIN ENDOCRINOL, V43, P55, DOI 10.1111/j.1365-2265.1995.tb01894.x	24	12	12	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 2	2016	11	5							e0154846	10.1371/journal.pone.0154846	http://dx.doi.org/10.1371/journal.pone.0154846			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DL5KB	27135245	Green Published, Green Submitted, gold			2022-12-26	WOS:000375674800054
J	Guo, Y; Johnson, MA; Mehrabian, Z; Mishra, MK; Kannan, R; Miller, NR; Bernstein, SL				Guo, Yan; Johnson, Mary A.; Mehrabian, Zara; Mishra, Manoj K.; Kannan, Rangaramanujam; Miller, Neil R.; Bernstein, Steven L.			Dendrimers Target the Ischemic Lesion in Rodent and Primate Models of Nonarteritic Anterior Ischemic Optic Neuropathy	PLOS ONE			English	Article							SINGLE INTRAVITREAL INJECTION; SUSTAINED NEUROPROTECTION; INFLAMMATION; THERAPY; NEUROINFLAMMATION; INFARCT; PGJ(2); CELLS	Introduction Polyamidoamine dendrimer nanoparticles (similar to 4 nanometers) are inert polymers that can be linked to biologically active compounds. These dendrimers selectively target and accumulate in inflammatory cells upon systemic administration. Dendrimer-linked compounds enable sustained release of therapeutic compounds directly at the site of damage. The purpose of this study was to determine if dendrimers can be used to target the optic nerve (ON) ischemic lesion in our rodent and nonhuman primate models of nonarteritic anterior ischemic optic neuropathy (NAION), a disease affecting >10,000 individuals in the US annually, and for which there currently is no effective treatment. Methods NAION was induced in male Long-Evans rats (rNAION) and in one adult male rhesus monkey (pNAION) using previously described procedures. Dendrimers were covalently linked to near-infrared cyanine-5 fluorescent dye (D-Cy5) and injected both intravitreally and systemically (in the rats) or just systemically (in the monkey) to evaluate D-Cy5 tissue accumulation in the eye and optic nerve following induction of NAION. Results Following NAION induction, Cy-5 dendrimers selectively accumulated in astrocytes and circulating macrophages. Systemic dendrimer administration provided the best penetration of the ON lesion site when injected shortly after induction. Systemic administration 1 day post-induction in the pNAION model gave localization similar to that seen in the rats. Conclusions Dendrimers selectively target the ischemic ON lesion after induction of both rNAION and pNAION. Systemic nanoparticle-linked therapeutics thus may provide a powerful, targeted and safe approach to NAION treatment by providing sustained and focused treatment of the cells directly affected by ischemia.	[Guo, Yan; Johnson, Mary A.; Mehrabian, Zara; Bernstein, Steven L.] Univ Maryland, Sch Med, Dept Ophthalmol & Visual Sci, Baltimore, MD 21201 USA; [Mishra, Manoj K.; Kannan, Rangaramanujam] Johns Hopkins Sch Med, Ctr Nanomed, Dept Ophthalmol, Wilmer Eye Inst, Baltimore, MD 21287 USA; [Miller, Neil R.] Johns Hopkins Sch Med, Div Neuroophthalmol, Dept Ophthalmol, Baltimore, MD 21287 USA; [Bernstein, Steven L.] Univ Maryland, Sch Med, Dept Anat & Neurobiol, Baltimore, MD 21201 USA	University System of Maryland; University of Maryland Baltimore; Johns Hopkins University; Johns Hopkins Medicine; Johns Hopkins University; Johns Hopkins Medicine; University System of Maryland; University of Maryland Baltimore	Bernstein, SL (corresponding author), Univ Maryland, Sch Med, Dept Ophthalmol & Visual Sci, Baltimore, MD 21201 USA.; Bernstein, SL (corresponding author), Univ Maryland, Sch Med, Dept Anat & Neurobiol, Baltimore, MD 21201 USA.	sbernstein@som.umaryland.edu		Bernstein, Steven/0000-0001-7758-0136	NEI [RO1EY01530, RO1EY019529, RO1EY025304]; NIBIB [RO1 EB018306]; Johns Hopkins Optic Nerve Research Fund; NATIONAL EYE INSTITUTE [P30EY001765, R01EY019529, R01EY015304, R01EY028193] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R01EB018306] Funding Source: NIH RePORTER	NEI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NIBIB(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); Johns Hopkins Optic Nerve Research Fund; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB))	This work was funded by NEI RO1EY01530 and RO1EY019529 to SLB, RO1EY025304 to RK (https://nei.nih.gov), NIBIB RO1 EB018306 to RK (http://www.nibib.nih.gov), and Johns Hopkins Optic Nerve Research Fund to NRM.	Arnold AC, 2003, J NEURO-OPHTHALMOL, V23, P157, DOI 10.1097/00041327-200306000-00012; ARNOLD AC, 1994, J NEURO-OPHTHALMOL, V14, P66; Bernstein SL, 2003, INVEST OPHTH VIS SCI, V44, P4153, DOI 10.1167/iovs.03-0274; Chen CS, 2008, INVEST OPHTH VIS SCI, V49, P2985, DOI 10.1167/iovs.07-1651; Denes A, 2011, J NEUROINFLAMM, V8, DOI 10.1186/1742-2094-8-164; Hattenhauer MG, 1997, AM J OPHTHALMOL, V123, P103, DOI 10.1016/S0002-9394(14)70999-7; Hayreh SS, 2008, GRAEF ARCH CLIN EXP, V246, P1029, DOI 10.1007/s00417-008-0805-8; Iezzi R, 2012, BIOMATERIALS, V33, P979, DOI 10.1016/j.biomaterials.2011.10.010; JOHNSON LN, 1994, J NEURO-OPHTHALMOL, V14, P38; Kambhampati SP, 2015, EUR J PHARM BIOPHARM, V95, P239, DOI 10.1016/j.ejpb.2015.02.013; Kambhampati SP, 2013, J OCUL PHARMACOL TH, V29, P151, DOI 10.1089/jop.2012.0232; Kannan RM, 2014, J INTERN MED, V276, P579, DOI 10.1111/joim.12280; Kannan S, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003162; Lesniak WG, 2013, MOL PHARMACEUT, V10, P4560, DOI 10.1021/mp400371r; Miller NR, 2015, EYE, V29, P65, DOI 10.1038/eye.2014.144; Miller NR, 2014, INVEST OPHTH VIS SCI, V55, P7047, DOI 10.1167/iovs.14-14063; Mishra MK, 2014, ACS NANO, V8, P2134, DOI 10.1021/nn404872e; Nicholson JD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050021; Rutar M, 2015, J NEUROINFLAMM, V12, DOI 10.1186/s12974-014-0224-1; Salgado C, 2011, ARCH OPHTHALMOL-CHIC, V129, P1583, DOI 10.1001/archophthalmol.2011.351; Sofroniew MV, 2010, ACTA NEUROPATHOL, V119, P7, DOI 10.1007/s00401-009-0619-8; Tesser RA, 2003, OPHTHALMOLOGY, V110, P2031, DOI 10.1016/S0161-6420(03)00804-2; Touitou V, 2013, INVEST OPHTH VIS SCI, V54, P7402, DOI 10.1167/iovs.13-12055; Wang B, 2009, INT J PHARMACEUT, V377, P159, DOI 10.1016/j.ijpharm.2009.04.050; Zhang C, 2009, BRAIN RES, V1264, P67, DOI 10.1016/j.brainres.2008.12.075	25	26	27	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 29	2016	11	4							e0154437	10.1371/journal.pone.0154437	http://dx.doi.org/10.1371/journal.pone.0154437			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DK8XM	27128315	Green Submitted, Green Published, gold			2022-12-26	WOS:000375212600030
J	Gutsche, N; Zachgo, S				Gutsche, Nora; Zachgo, Sabine			The N-Terminus of the Floral Arabidopsis TGA Transcription Factor PERIANTHIA Mediates Redox-Sensitive DNA-Binding	PLOS ONE			English	Article							TRANSFER DISSOCIATION ETD; GENETIC INTERACTIONS; S-GLUTATHIONYLATION; DISEASE RESISTANCE; PROMOTER; EXPRESSION; PROTEIN; THALIANA; REGION; NPR1	The Arabidopsis TGA transcription factor (TF) PERIANTHIA (PAN) regulates the formation of the floral organ primordia as revealed by the pan mutant forming an abnormal pentamerous arrangement of the outer three floral whorls. The Arabidopsis TGA bZIP TF family comprises 10 members, of which PAN and TGA9/10 control flower developmental processes and TGA1/2/5/6 participate in stress-responses. For the TGA1 protein it was shown that several cysteines can be redox-dependently modified. TGA proteins interact in the nucleus with land plant-specific glutaredoxins, which may alter their activities posttranslationally. Here, we investigated the DNA-binding of PAN to the AAGAAT motif under different redoxconditions. The AAGAAT motif is localized in the second intron of the floral homeotic regulator AGAMOUS (AG), which controls stamen and carpel development as well as floral determinacy. Whereas PAN protein binds to this regulatory cis-element under reducing conditions, the interaction is strongly reduced under oxidizing conditions in EMSA studies. The redox-sensitive DNA-binding is mediated via a special PAN N-terminus, which is not present in other Arabidopsis TGA TFs and comprises five cysteines. Two N-terminal PAN cysteines, Cys68 and Cys87, were shown to form a disulfide bridge and Cys340, localized in a C-terminal putative transactivation domain, can be S-glutathionylated. Comparative land plant analyses revealed that the AAGAAT motif exists in asterid and rosid plant species. TGA TFs with N-terminal extensions of variable length were identified in all analyzed seed plants. However, a PAN-like N-terminus exists only in the rosids and exclusively Brassicaceae homologs comprise four to five of the PAN N-terminal cysteines. Redox-dependent modifications of TGA cysteines are known to regulate the activity of stress-related TGA TFs. Here, we show that the N-terminal PAN cysteines participate in a redox-dependent control of the PAN interaction with a highly conserved regulatory AG cis-element, emphasizing the importance of redox-modifications in the regulation of flower developmental processes.	[Gutsche, Nora; Zachgo, Sabine] Univ Osnabruck, Bot, Osnabruck, Germany	University Osnabruck	Zachgo, S (corresponding author), Univ Osnabruck, Bot, Osnabruck, Germany.	zachgo@biologie.uni-osnabrueck.de			Deutsche Forschungsgemeinschaft	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work has been supported by the Deutsche Forschungsgemeinschaft.	Cao X, 2005, J BIOL CHEM, V280, P25901, DOI 10.1074/jbc.M411443200; Causier B, 2009, PLANT J, V58, P41, DOI 10.1111/j.1365-313X.2008.03759.x; Chen WQ, 1999, PLANT J, V19, P667, DOI 10.1046/j.1365-313x.1999.00560.x; Chi YH, 2013, FRONT PLANT SCI, V4, DOI 10.3389/fpls.2013.00277; Choi J, 2010, DEV CELL, V19, P284, DOI 10.1016/j.devcel.2010.07.011; COEN ES, 1991, NATURE, V353, P31, DOI 10.1038/353031a0; Cole SR, 2012, J AM SOC MASS SPECTR, V23, P310, DOI 10.1007/s13361-011-0300-z; Couvreur TLP, 2010, MOL BIOL EVOL, V27, P55, DOI 10.1093/molbev/msp202; Das P, 2009, DEVELOPMENT, V136, P1605, DOI 10.1242/dev.035436; Delaunay A, 2002, CELL, V111, P471, DOI 10.1016/S0092-8674(02)01048-6; Despres C, 2003, PLANT CELL, V15, P2181, DOI 10.1105/tpc.012849; Vivancos PD, 2010, PLANT J, V64, P825, DOI 10.1111/j.1365-313X.2010.04371.x; Vivancos PD, 2010, BIOCHEM J, V431, P169, DOI 10.1042/BJ20100409; Durrant WE, 2004, ANNU REV PHYTOPATHOL, V42, P185, DOI 10.1146/annurev.phyto.42.040803.140421; Fan WH, 2002, PLANT CELL, V14, P1377, DOI 10.1105/tpc.001628; Fang Q, 2012, DIABETIC MED, V29, P1456, DOI 10.1111/j.1464-5491.2012.03626.x; Farinati S, 2010, NEW PHYTOL, V185, P964, DOI 10.1111/j.1469-8137.2009.03132.x; Foley RC, 2004, FEBS LETT, V563, P141, DOI 10.1016/S0014-5793(04)00288-1; Franzke A, 2009, TAXON, V58, P425, DOI 10.1002/tax.582009; Garreton V, 2002, PLANT PHYSIOL, V130, P1516, DOI 10.1104/pp.009886; Gatz C, 2013, MOL PLANT MICROBE IN, V26, P151, DOI 10.1094/MPMI-04-12-0078-IA; Goodstein DM, 2012, NUCLEIC ACIDS RES, V40, pD1178, DOI 10.1093/nar/gkr944; Gutsche N, 2015, BIOL CHEM, V396, P495, DOI 10.1515/hsz-2014-0300; Heine GF, 2004, J BIOL CHEM, V279, P37878, DOI 10.1074/jbc.M405166200; Hong RL, 2003, PLANT CELL, V15, P1296, DOI 10.1105/tpc.009548; Johnson C, 2001, J BIOL CHEM, V276, P172, DOI 10.1074/jbc.M005143200; Kesarwani M, 2007, PLANT PHYSIOL, V144, P336, DOI 10.1104/pp.106.095299; Klatt P, 1999, J BIOL CHEM, V274, P15857, DOI 10.1074/jbc.274.22.15857; Klatt P, 2000, EUR J BIOCHEM, V267, P4928, DOI 10.1046/j.1432-1327.2000.01601.x; LAM E, 1989, PLANT CELL, V1, P1147, DOI 10.1105/tpc.1.12.1147; Lebel E, 1998, PLANT J, V16, P223, DOI 10.1046/j.1365-313x.1998.00288.x; Li S, 2009, PLANT CELL, V21, P429, DOI 10.1105/tpc.108.064477; Liao BC, 2010, TOXICOL SCI, V116, P151, DOI 10.1093/toxsci/kfq098; Lindermayr C, 2010, PLANT CELL, V22, P2894, DOI 10.1105/tpc.109.066464; Lyons E, 2008, PLANT PHYSIOL, V148, P1772, DOI 10.1104/pp.108.124867; Maier AT, 2011, FRONT PLANT SCI, V2, DOI 10.3389/fpls.2011.00079; Maier AT, 2009, DEVELOPMENT, V136, P1613, DOI 10.1242/dev.033647; Markovic J, 2007, J BIOL CHEM, V282, P20416, DOI 10.1074/jbc.M609582200; Murmu J, 2010, PLANT PHYSIOL, V154, P1492, DOI 10.1104/pp.110.159111; Pape S, 2010, PLANT PHYSIOL, V154, P1805, DOI 10.1104/pp.110.165563; Perkins DN, 1999, ELECTROPHORESIS, V20, P3551, DOI 10.1002/(SICI)1522-2683(19991201)20:18<3551::AID-ELPS3551>3.0.CO;2-2; Pineda-Molina E, 2002, METHOD ENZYMOL, V359, P268; Proost S, 2015, NUCLEIC ACIDS RES, V43, pD974, DOI 10.1093/nar/gku986; Qanungo S, 2007, J BIOL CHEM, V282, P18427, DOI 10.1074/jbc.M610934200; Running MP, 1996, DEVELOPMENT, V122, P1261; Schranz ME, 2006, PLANT CELL, V18, P1152, DOI 10.1105/tpc.106.041111; Seldeen KL, 2009, BIOCHEMISTRY-US, V48, P1975, DOI 10.1021/bi802068s; Shaikhali J, 2008, BMC PLANT BIOL, V8, DOI 10.1186/1471-2229-8-48; Shaikhali J, 2012, J BIOL CHEM, V287, P27510, DOI 10.1074/jbc.M112.361394; Shearer HL, 2012, MOL PLANT MICROBE IN, V25, P1459, DOI 10.1094/MPMI-09-11-0256; SIEBURTH LE, 1995, PLANT CELL, V7, P1249, DOI 10.1105/tpc.7.8.1249; Soltis DE, 2003, AM J BOT, V90, P461, DOI 10.3732/ajb.90.3.461; Sundell D, 2015, NEW PHYTOL, V208, P1149, DOI 10.1111/nph.13557; Tron AE, 2002, J BIOL CHEM, V277, P34800, DOI 10.1074/jbc.M203297200; Verelst W, 2007, PLANT PHYSIOL, V143, P447, DOI 10.1104/pp.106.089805; Viola IL, 2016, PLANT PHYSIOL, V170, P74, DOI 10.1104/pp.15.01016; Viola IL, 2013, PLANT PHYSIOL, V162, P1434, DOI 10.1104/pp.113.216416; Wiesner J, 2008, PROTEOMICS, V8, P4466, DOI 10.1002/pmic.200800329; Wu SL, 2010, ANAL CHEM, V82, P5296, DOI 10.1021/ac100766r; Xiang CB, 1997, PLANT MOL BIOL, V34, P403, DOI 10.1023/A:1005873500238; Zander M, 2010, PLANT J, V61, P200, DOI 10.1111/j.1365-313X.2009.04044.x; Zeng LP, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5956; Zhang YL, 2003, PLANT CELL, V15, P2647, DOI 10.1105/tpc.014894	63	21	22	4	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 29	2016	11	4							e0153810	10.1371/journal.pone.0153810	http://dx.doi.org/10.1371/journal.pone.0153810			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DK8XM	27128442	Green Submitted, Green Published, gold			2022-12-26	WOS:000375212600015
J	Zhao, QS; Chang, C; Gonzalez, JP; Alzahrani, K; Button, JL; Fraidenraich, D				Zhao, Qingshi; Chang, Corey; Gonzalez, J. Patrick; Alzahrani, Kamal; Button, Jessica L.; Fraidenraich, Diego			Combined Id1 and Id3 Deletion Leads to Severe Erythropoietic Disturbances	PLOS ONE			English	Article							LOOP-HELIX PROTEIN; HEMATOPOIETIC PROGENITOR CELLS; ERYTHROID-DIFFERENTIATION; KNOCKOUT MICE; DNA-BINDING; STEM-CELLS; ERYTHROLEUKEMIA-CELLS; TRANSCRIPTION FACTORS; NEGATIVE REGULATOR; SJOGRENS-SYNDROME	The Inhibitor of DNA Binding (Id) proteins play a crucial role in regulating hematopoiesis and are known to interact with E proteins and the bHLH family of transcription factors. Current efforts seek to elucidate the individual roles of Id members in regulating hematopoietic development and specification. However, the nature of their functional redundancies remains elusive since ablation of multiple Id genes is embryonically lethal. We developed a model to test this compensation in the adult. We report that global Id3 ablation with Tie2Cre-mediated conditional ablation of Id1 in both hematopoietic and endothelial cells (Id cDKO) extends viability to 1 year but leads to multi-lineage hematopoietic defects including the emergence of anemia associated with defective erythroid development, a novel phenotype unreported in prior single Id knockout studies. We observe decreased cell counts in the bone marrow and splenomegaly to dimensions beyond what is seen in single Id knockout models. Transcriptional dysregulation of hematopoietic regulators observed in bone marrow cells is also magnified in the spleen. E47 protein levels were elevated in Id cDKO bone marrow cell isolates, but decreased in the erythroid lineage. Chromatin immunoprecipitation (ChIP) studies reveal increased occupancy of E47 and GATA1 at the promoter regions of beta-globin and E2A. Bone marrow transplantation studies highlight the importance of intrinsic Id signals in maintaining hematopoietic homeostasis while revealing a strong extrinsic influence in the development of anemia. Together, these findings demonstrate that loss of Id compensation leads to dysregulation of the hematopoietic transcriptional network and multiple defects in erythropoietic development in adult mice.	[Zhao, Qingshi; Chang, Corey; Gonzalez, J. Patrick; Alzahrani, Kamal; Button, Jessica L.; Fraidenraich, Diego] Univ Med & Dent New Jersey, New Jersey Med Sch, Rutgers Biomed & Hlth Sci, Dept Cell Biol & Mol Med, 185 S Orange Ave, Newark, NJ 07103 USA	Rutgers State University New Brunswick; Rutgers State University Medical Center	Fraidenraich, D (corresponding author), Univ Med & Dent New Jersey, New Jersey Med Sch, Rutgers Biomed & Hlth Sci, Dept Cell Biol & Mol Med, 185 S Orange Ave, Newark, NJ 07103 USA.	fraidedi@rutgers.edu			NIH-NHLBI [1R21HL09490501, 1F31HL117621]; American Heart Association [15GRNT25140001, 12PRE1207008]; New Jersey Health Foundation; Hispanic Center of Excellence; Department of Cell Biology and Molecular Medicine; NIH [NS046593]; Rutgers Neuroproteomics Core Facility; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [F31HL117621, R21HL094905] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P30NS046593] Funding Source: NIH RePORTER	NIH-NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); American Heart Association(American Heart Association); New Jersey Health Foundation; Hispanic Center of Excellence; Department of Cell Biology and Molecular Medicine; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Rutgers Neuroproteomics Core Facility; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by grants to DF from the NIH-NHLBI (1R21HL09490501), the American Heart Association (15GRNT25140001), the New Jersey Health Foundation, the Hispanic Center of Excellence, and through funds from the Department of Cell Biology and Molecular Medicine. CC was supported by a predoctoral fellowship from the American Heart Association (12PRE1207008). JPG is supported by a predoctoral fellowship from the NIH-NHLBI (1F31HL117621). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. In this resubmission, the mass spectrometry data were obtained from a Orbitrap instrument funded in part by an NIH grant NS046593, for the support of the Rutgers Neuroproteomics Core Facility.	Anguita E, 2004, EMBO J, V23, P2841, DOI 10.1038/sj.emboj.7600274; BENEZRA R, 1990, CELL, V61, P49, DOI 10.1016/0092-8674(90)90214-Y; CHRISTY BA, 1991, P NATL ACAD SCI USA, V88, P1815, DOI 10.1073/pnas.88.5.1815; Curtis DJ, 2012, STEM CELLS, V30, P1053, DOI 10.1002/stem.1093; Deed RW, 1998, J BIOL CHEM, V273, P8278, DOI 10.1074/jbc.273.14.8278; DEED RW, 1993, ONCOGENE, V8, P599; DESPREZ PY, 1995, MOL CELL BIOL, V15, P3398; ELLIS HM, 1990, CELL, V61, P27, DOI 10.1016/0092-8674(90)90212-W; Fraidenraich D, 2004, SCIENCE, V306, P247, DOI 10.1126/science.1102612; GARRELL J, 1990, CELL, V61, P39, DOI 10.1016/0092-8674(90)90213-X; Ghinassi B, 2007, EXP HEMATOL, V35, P735, DOI 10.1016/j.exphem.2007.02.007; Guo ZL, 2011, IMMUNOL LETT, V135, P34, DOI 10.1016/j.imlet.2010.09.009; Hata K, 2004, GENE, V325, P53, DOI 10.1016/j.gene.2003.09.040; Hayakawa I, 2007, IMMUNOLOGY, V122, P73, DOI 10.1111/j.1365-2567.2007.02614.x; Jen Y, 1996, DEV DYNAM, V207, P235; JEN Y, 1992, GENE DEV, V6, P1466, DOI 10.1101/gad.6.8.1466; Ji M, 2008, BLOOD, V112, P1068, DOI 10.1182/blood-2008-01-133504; KAWAGUCHI N, 1992, P NATL ACAD SCI USA, V89, P4569, DOI 10.1073/pnas.89.10.4569; Kim W, 2014, BLOOD, V124, P1586, DOI 10.1182/blood-2014-02-556522; Kisanuki YY, 2001, DEV BIOL, V230, P230, DOI 10.1006/dbio.2000.0106; KREIDER BL, 1992, SCIENCE, V255, P1700, DOI 10.1126/science.1372755; Lecuyer E, 2004, EXP HEMATOL, V32, P11, DOI 10.1016/j.exphem.2003.10.010; Lee J, 2006, BLOOD, V107, P2686, DOI 10.1182/blood-2005-07-2798; Leeanansaksiri W, 2005, J IMMUNOL, V174, P7014, DOI 10.4049/jimmunol.174.11.7014; Li J, 2010, BLOOD, V116, P5615, DOI 10.1182/blood-2010-03-274506; LISTER J, 1995, J BIOL CHEM, V270, P17939, DOI 10.1074/jbc.270.30.17939; Lyden D, 1999, NATURE, V401, P670, DOI 10.1038/44334; MACLEOD K, 1991, MOL CELL BIOL, V11, P4324, DOI 10.1128/MCB.11.9.4324; Moldes M, 1997, MOL CELL BIOL, V17, P1796, DOI 10.1128/MCB.17.4.1796; Nishiyama K, 2005, CIRCULATION, V112, P2840, DOI 10.1161/CIRCULATIONAHA.104.516898; Norton JD, 2000, J CELL SCI, V113, P3897; OGATA T, 1993, P NATL ACAD SCI USA, V90, P9219, DOI 10.1073/pnas.90.19.9219; Ohtani N, 2001, NATURE, V409, P1067, DOI 10.1038/35059131; Pan LH, 1999, MOL CELL BIOL, V19, P5969; Perry SS, 2007, BLOOD, V110, P2351, DOI 10.1182/blood-2007-01-069914; RIECHMANN V, 1994, NUCLEIC ACIDS RES, V22, P749, DOI 10.1093/nar/22.5.749; Rivera R, 2001, ONCOGENE, V20, P8308, DOI 10.1038/sj.onc.1205091; Ruzinova MB, 2003, TRENDS CELL BIOL, V13, P410, DOI 10.1016/S0962-8924(03)00147-8; SHOJI W, 1994, J BIOL CHEM, V269, P5078; Suh HC, 2008, ONCOGENE, V27, P5612, DOI 10.1038/onc.2008.175; Suh HC, 2009, BLOOD, V114, P1186, DOI 10.1182/blood-2008-09-179788; SUN XH, 1991, MOL CELL BIOL, V11, P5603, DOI 10.1128/MCB.11.11.5603; Takakura N, 1998, IMMUNITY, V9, P677, DOI 10.1016/S1074-7613(00)80665-2; Volpert OV, 2002, CANCER CELL, V2, P473, DOI 10.1016/S1535-6108(02)00209-X; Wan YH, 2007, NAT MED, V13, P1496, DOI 10.1038/nm1672; Wood AD, 2009, BLOOD, V114, P1820, DOI 10.1182/blood-2009-02-206573; Yan W, 1997, MOL CELL BIOL, V17, P7317, DOI 10.1128/MCB.17.12.7317; Yokota Y, 2002, J CELL PHYSIOL, V190, P21, DOI 10.1002/jcp.10042; Zhao QS, 2011, DEV BIOL, V349, P53, DOI 10.1016/j.ydbio.2010.10.004	49	5	5	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 29	2016	11	4							e0154480	10.1371/journal.pone.0154480	http://dx.doi.org/10.1371/journal.pone.0154480			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DK8XM	27128622	gold, Green Published			2022-12-26	WOS:000375212600033
J	Mondelaers, A; Sanchez-Canete, MP; Hendrickx, S; Eberhardt, E; Garcia-Hernandez, R; Lachaud, L; Cotton, J; Sanders, M; Cuypers, B; Imamura, H; Dujardin, JC; Delputte, P; Cos, P; Caljon, G; Gamarro, F; Castanys, S; Maes, L				Mondelaers, Annelies; Sanchez-Canete, Maria P.; Hendrickx, Sarah; Eberhardt, Eline; Garcia-Hernandez, Raquel; Lachaud, Laurence; Cotton, James; Sanders, Mandy; Cuypers, Bart; Imamura, Hideo; Dujardin, Jean-Claude; Delputte, Peter; Cos, Paul; Caljon, Guy; Gamarro, Francisco; Castanys, Santiago; Maes, Louis			Genomic and Molecular Characterization of Miltefosine Resistance in Leishmania infantum Strains with Either Natural or Acquired Resistance through Experimental Selection of Intracellular Amastigotes	PLOS ONE			English	Article							IN-VITRO SELECTION; VISCERAL LEISHMANIASIS; DRUG-RESISTANCE; L.-DONOVANI; TRANSPORTER; FAILURE; PAROMOMYCIN; SUSCEPTIBILITY; TRANSLOCATION; EXPRESSION	During the last decade miltefosine (MIL) has been used as first-line treatment for visceral leishmaniasis in endemic areas with antimonial resistance, but a decline in clinical effectiveness is now being reported. While only two MIL-resistant Leishmania infantum strains from HIV co-infected patients have been documented, phenotypic MIL-resistance for L. donovani has not yet been identified in the laboratory. Hence, a better understanding of the factors contributing to increased MIL-treatment failure is necessary. Given the paucity of defined MIL-resistant L. donovani clinical isolates, this study used an experimental amastigote-selected MIL-resistant L. infantum isolate (LEM3323). In-depth exploration of the MIL-resistant phenotype was performed by coupling genomic with phenotypic data to gain insight into gene function and the mutant phenotype. A naturally MIL-resistant L. infantum clinical isolate (LEM5159) was included to compare both datasets. Phenotypically, resistance was evaluated by determining intracellular amastigote susceptibility in vitro and actual MIL-uptake. Genomic analysis provided supportive evidence that the resistance selection model on intracellular amastigotes can be a good proxy for the in vivo field situation since both resistant strains showed mutations in the same inward transporter system responsible for the acquired MIL-resistant phenotype. In line with previous literature findings in promastigotes, our data confirm a defective import machinery through inactivation of the LiMT/LiRos3 protein complex as the main mechanism for MIL-resistance also in intracellular amastigotes. Whole genome sequencing analysis of LEM3323 revealed a 2 base pair deletion in the LiMT gene that led to the formation an early stop codon and a truncation of the LiMT protein. Interestingly, LEM5159 revealed mutations in both the LiMT and LiRos3 genes, resulting in an aberrant expression of the LiMT protein. To verify that these mutations were indeed accountable for the acquired resistance, transfection experiments were performed to re-establish MIL-susceptibility. In LEM3323, susceptibility was restored upon expression of a LiMT wild-type gene, whereas the MIL-susceptibility of LEM5159 could be reversed after expression of the LiRos3 wild-type gene. The aberrant expression profile of the LiMT protein could be restored upon rescue of the LiRos3 gene both in the LEM5159 clinical isolate and a Delta LiRos3 strain, showing that expression of LdMT is dependent on LdRos3 expression. The present findings clearly corroborate the pivotal role of the LiMT/LiRos3 complex in resistance towards MIL.	[Mondelaers, Annelies; Hendrickx, Sarah; Eberhardt, Eline; Dujardin, Jean-Claude; Delputte, Peter; Cos, Paul; Caljon, Guy; Maes, Louis] Univ Antwerp, Lab Microbiol Parasitol & Hyg, Univ Pl 1, B-2610 Antwerp, Belgium; [Sanchez-Canete, Maria P.; Garcia-Hernandez, Raquel; Gamarro, Francisco; Castanys, Santiago] Inst Parasitol & Biomed Lopez Neyra, Avda Conocimiento S-N, Granada 18016, Spain; [Lachaud, Laurence] CHU Montpellier, Lab Parasitol Mycol, 39 Ave Charles Flahault, F-34295 Montpellier, France; [Lachaud, Laurence] CHU Montpellier, Ctr Natl Reference Leishmanioses, 39 Ave Charles Flahault, F-34295 Montpellier, France; [Lachaud, Laurence] Univ Montpellier, 39 Ave Charles Flahault, F-34295 Montpellier, France; [Cuypers, Bart; Imamura, Hideo; Dujardin, Jean-Claude] Inst Trop Med, Mol Parasitol Unit, Natl Str 155, B-2000 Antwerp, Belgium; [Cuypers, Bart] Univ Antwerp, Adv Database Res & Modeling ADReM Res Grp, Middelheimlaan 1, B-2020 Antwerp, Belgium; [Cotton, James; Sanders, Mandy] Wellcome Trust Sanger Inst, Wellcome Trust Genome Campus, Cambridge CB10 1SA, England	University of Antwerp; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Parasitologia y Biomedicina Lopez-Neyra (IPBLN); Universite de Montpellier; CHU de Montpellier; Universite de Montpellier; CHU de Montpellier; Universite de Montpellier; Institute of Tropical Medicine (ITM); University of Antwerp; Wellcome Trust Sanger Institute	Maes, L (corresponding author), Univ Antwerp, Lab Microbiol Parasitol & Hyg, Univ Pl 1, B-2610 Antwerp, Belgium.; Castanys, S (corresponding author), Inst Parasitol & Biomed Lopez Neyra, Avda Conocimiento S-N, Granada 18016, Spain.	louis.maes@uantwerpen.be	cos, paul/AAU-3896-2020; Cos, Paul/L-9717-2015; Cotton, James A/B-8806-2008; Cuypers, Bart/B-4853-2014; Delputte, Peter/A-1062-2008; Castanys, Santiago/Y-3981-2019; Caljon, Guy/E-1310-2017; Dujardin, Jean-Claude/AAO-1783-2021; Mondelaers, Annelies/GLU-6555-2022; Maes, Louis JRM/A-2384-2017	cos, paul/0000-0003-4361-8911; Cos, Paul/0000-0003-4361-8911; Cotton, James A/0000-0001-5475-3583; Cuypers, Bart/0000-0002-7198-1470; Delputte, Peter/0000-0003-3972-616X; Castanys, Santiago/0000-0002-3460-844X; Caljon, Guy/0000-0002-4870-3202; Maes, Louis JRM/0000-0002-2324-9509; Imamura, Hideo/0000-0002-3282-1319; Hendrickx, Sarah/0000-0002-1571-7296; Sanchez-Canete, Maria P./0000-0002-9418-8942; Gamarro, Francisco/0000-0003-1347-3440	European Commission [222895]; Flanders Research Fund (FWO) [11V4315N]; Agency for Innovation by Science and Technology in Flanders (IWT) [121474, G051812N, G058916N]; Proyecto de Excelencia, Junta de Andalucia [CTS-7282]; Wellcome Trust via the Wellcome Trust Sanger Institute [098051];  [SAF2011-28102];  [SAF2012-34267]	European Commission(European CommissionEuropean Commission Joint Research Centre); Flanders Research Fund (FWO)(FWO); Agency for Innovation by Science and Technology in Flanders (IWT)(Institute for the Promotion of Innovation by Science and Technology in Flanders (IWT)); Proyecto de Excelencia, Junta de Andalucia(Junta de Andalucia); Wellcome Trust via the Wellcome Trust Sanger Institute; ; 	This work was supported by the European Commission's 7th Framework Programme (Kaladrug-R project, Grant 222895) (to LM and JCD), the Flanders Research Fund (FWO) (PhD grant 11V4315N) (to EE), the Agency for Innovation by Science and Technology in Flanders (IWT) (PhD grant 121474 (to AM) and project grants G051812N and G058916N) (to LM), the Spanish Grants SAF2011-28102 (to SC), SAF2012-34267 (to FG) and by the Proyecto de Excelencia, Junta de Andalucia, Ref. CTS-7282 (to FG). MJS and JAC are supported by the Wellcome Trust via core funding of the Wellcome Trust Sanger Institute (grant 098051). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aslett M, 2010, NUCLEIC ACIDS RES, V38, pD457, DOI 10.1093/nar/gkp851; Berg M, 2015, ANTIMICROB AGENTS CH, V59, P2242, DOI 10.1128/AAC.04231-14; Berg M, 2013, PARASITOLOGY, V140, P1492, DOI 10.1017/S0031182013000140; Bhandari V, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001657; Bourgeois N, 2008, JAIDS-J ACQ IMM DEF, V48, P13, DOI 10.1097/QAI.0b013e318166af5d; Canuto GAB, 2014, ANAL BIOANAL CHEM, V406, P3459, DOI 10.1007/s00216-014-7772-1; Carnielli JBT, 2014, J PROTEOMICS, V108, P198, DOI 10.1016/j.jprot.2014.05.010; Castanys-Munoz E, 2008, ANTIMICROB AGENTS CH, V52, P3573, DOI 10.1128/AAC.00587-08; Cojean S, 2012, EMERG INFECT DIS, V18, P704, DOI 10.3201/eid1804.110841; da Luz RI, 2009, ANTIMICROB AGENTS CH, V53, P5197, DOI 10.1128/AAC.00866-09; Das M, 2013, FEBS J, V280, P4807, DOI 10.1111/febs.12449; Dhillon G P S, 2008, J Indian Med Assoc, V106, P666; Dorlo TPC, 2014, J INFECT DIS, V210, P146, DOI 10.1093/infdis/jiu039; Dorlo TPC, 2012, J ANTIMICROB CHEMOTH, V67, P2576, DOI 10.1093/jac/dks275; Garcia-Sanchez S, 2014, BIOCHEM J, V459, P83, DOI 10.1042/BJ20131318; Hendrickx S, 2015, ANTIMICROB AGENTS CH, V59, P4714, DOI 10.1128/AAC.00707-15; Hendrickx S, 2015, PARASITOL RES, V114, P2561, DOI 10.1007/s00436-015-4460-9; Hendrickx S, 2014, PARASITOL RES, V113, P1875, DOI 10.1007/s00436-014-3835-7; Hendrickx S, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001664; Hornillos V, 2008, BIOORG MED CHEM LETT, V18, P6336, DOI 10.1016/j.bmcl.2008.10.089; Kulshrestha A, 2014, PARASITOL RES, V113, P1171, DOI 10.1007/s00436-014-3755-6; Lachaud L, 2009, CLIN INFECT DIS, V48, pE16, DOI 10.1086/595710; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Li H, 2009, BIOINFORMATICS, V25, P1094, DOI [10.1093/bioinformatics/btp100, 10.1093/bioinformatics/btp324]; Maes L, 2013, DRUG RESISTANCE LEIS, P407; Matlashewski G, 2011, LANCET INFECT DIS, V11, P322, DOI 10.1016/S1473-3099(10)70320-0; Mishra J, 2013, PARASITOL RES, V112, P1001, DOI 10.1007/s00436-012-3222-1; Peacock CS, 2007, NAT GENET, V39, P839, DOI 10.1038/ng2053; Perez-Victoria FJ, 2006, J BIOL CHEM, V281, P23766, DOI 10.1074/jbc.M605214200; Perez-Victoria FJ, 2006, DRUG RESIST UPDATE, V9, P26, DOI 10.1016/j.drup.2006.04.001; Perez-Victoria FJ, 2003, J BIOL CHEM, V278, P49965, DOI 10.1074/jbc.M308352200; Perez-Victoria FJ, 2003, ANTIMICROB AGENTS CH, V47, P2397, DOI 10.1128/AAC.47.8.2397-2403.2003; Prajapati VK, 2013, AM J TROP MED HYG, V89, P750, DOI 10.4269/ajtmh.13-0096; Rai K, 2013, MBIO, V4, DOI 10.1128/mBio.00611-13; Rijal S, 2013, CLIN INFECT DIS, V56, P1530, DOI 10.1093/cid/cit102; Robinson JT, 2011, NAT BIOTECHNOL, V29, P24, DOI 10.1038/nbt.1754; Rybczynska M, 2001, BRIT J CANCER, V84, P1405, DOI 10.1054/bjoc.2001.1776; Sanchez-Canete MP, 2009, ANTIMICROB AGENTS CH, V53, P1305, DOI 10.1128/AAC.01694-08; Seifert K, 2007, INT J ANTIMICROB AG, V30, P229, DOI 10.1016/j.ijantimicag.2007.05.007; Shaw CD, 2015, MOL MICROBI IN PRESS; Sundar S, 2002, NEW ENGL J MED, V347, P1739, DOI 10.1056/NEJMoa021556; Sundar S, 2015, EXPERT OPIN PHARMACO, V16, P237, DOI 10.1517/14656566.2015.973850; Sundar S, 2012, CLIN INFECT DIS, V55, P543, DOI 10.1093/cid/cis474; ter Horst R, 2008, CLIN INFECT DIS, V46, P1702, DOI 10.1086/587899; Troya J, 2008, SCAND J INFECT DIS, V40, P78, DOI 10.1080/00365540701466215; Vanaerschot M, 2014, EXPERT REV ANTI-INFE, V12, P937, DOI 10.1586/14787210.2014.916614; Vermeersch M, 2009, ANTIMICROB AGENTS CH, V53, P3855, DOI 10.1128/AAC.00548-09	47	57	58	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 28	2016	11	4							e0154101	10.1371/journal.pone.0154101	http://dx.doi.org/10.1371/journal.pone.0154101			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DK8XE	27123924	Green Published, gold			2022-12-26	WOS:000375211700044
J	Shang, HX; Sun, J; Chen, YQ				Shang, Haixiao; Sun, Jia; Chen, Yong Q.			Clostridium Butyricum CGMCC0313.1 Modulates Lipid Profile, Insulin Resistance and Colon Homeostasis in Obese Mice	PLOS ONE			English	Article							GUT MICROBIOTA; INDUCED COLITIS; RECEPTOR; ENDOTOXEMIA; BACTERIA; PERMEABILITY; INFLAMMATION; ADIPOSITY	Obesity is associated with a cluster of metabolic disorders and systemic low-grade inflammation involving multiple organs. Recent findings have suggested that intestine is a key organ altered in response to high fat diet (HFD) feeding. Probiotics mainly lactobacillus strains have earlier been implicated in alleviating metabolic disorders. Here we aimed to examine the effects of a naturally occurring butyrate-producing probiotic clostridium butyricum CGMCC0313.1 (CB0313.1) in limiting the development of HFD-induced obesity. Mice treated with CB0313.1 exhibited reduced lipid accumulation in liver and serum, lower circulating insulin levels and improved glucose tolerance and insulin sensitivity. Furthermore, CB0313.1 administration reversed the HFD-induced colonic inflammation as evidenced by reduced tumor necrosis factor (TNF)-alpha level and increases the interleukin (IL)-10 and IL-22 levels in colon tissue. Additionally to colonic inflammation, CB0313.1 also reduced the colon permeability by upregulating the tight junction (TJ) proteins (claudin-1 and occludin) and contributed to a decreased circulating endotoxin level. In colon content, CB0313.1 administration restored the reduced production of butyrate and other short chain fatty acids (SCFAs) caused by HFD feeding. In adipose tissue, lower transcriptional levels of pro-inflammatory TNF-alpha, IL-6, IL-1 beta and monocyte chemotactic protein (MCP)-1 in adipose tissue were observed in CB0313.1-treated mice. Collectively, our data demonstrated that CB0313.1, targeting colon inflammation and permeability, ameliorated HFD-induced obesity, insulin resistance as well as adipose inflammation.	[Sun, Jia; Chen, Yong Q.] Jiangnan Univ, State Key Lab Food Sci & Technol, Sch Food Sci & Technol, Wuxi, Peoples R China; Jiangnan Univ, Synerget Innovat Ctr Food Safety & Nutr, Wuxi, Peoples R China	Jiangnan University; Jiangnan University	Sun, J; Chen, YQ (corresponding author), Jiangnan Univ, State Key Lab Food Sci & Technol, Sch Food Sci & Technol, Wuxi, Peoples R China.	jiasun@jiangnan.edu.cn; yqchen@jiangnan.edu.cn	Chen, Yong Q/AAI-9864-2021	Chen, Yong Q/0000-0003-4747-4708	National Natural Science Foundation of China [31471128, 31400779, 31570915]; National Natural Science Foundation of China (National Young 1000 Talents Plan); Provincial Natural Science Foundation of Jiangsu [BK20130133]; Jiangsu Province Recruitment Plan for High-level, Innovative and Entrepreneurial Talents; Jiangsu Province 'Six Summit Talents' Program [2014-SWYY-035]; Key Program of Fundamental Research Funds for Central Universities [JUSRP51613A]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Natural Science Foundation of China (National Young 1000 Talents Plan); Provincial Natural Science Foundation of Jiangsu(Natural Science Foundation of Jiangsu Province); Jiangsu Province Recruitment Plan for High-level, Innovative and Entrepreneurial Talents; Jiangsu Province 'Six Summit Talents' Program; Key Program of Fundamental Research Funds for Central Universities	The present study was supported by funds from National Natural Science Foundation of China (grant NO. 31471128) to YC. The present study was also supported from the National Natural Science Foundation of China (grant nos. 31400779 and 31570915; National Young 1000 Talents Plan), the Provincial Natural Science Foundation of Jiangsu (grant NO. BK20130133), Jiangsu Province Recruitment Plan for High-level, Innovative and Entrepreneurial Talents, Jiangsu Province 'Six Summit Talents' Program (grant NO. 2014-SWYY-035) and Key Program of Fundamental Research Funds for the Central Universities (grant NO. JUSRP51613A) to JS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arpaia N, 2013, NATURE, V504, P451, DOI 10.1038/nature12726; Brun P, 2007, AM J PHYSIOL-GASTR L, V292, pG518, DOI 10.1152/ajpgi.00024.2006; Cani PD, 2008, DIABETES, V57, P1470, DOI 10.2337/db07-1403; Cani PD, 2007, DIABETES, V56, P1761, DOI 10.2337/db06-1491; Chambers ES, 2015, GUT, V64, P1744, DOI 10.1136/gutjnl-2014-307913; Colonna M, 2009, IMMUNITY, V31, P15, DOI 10.1016/j.immuni.2009.06.008; De Vadder F, 2014, CELL, V156, P84, DOI 10.1016/j.cell.2013.12.016; Donath MY, 2011, NAT REV IMMUNOL, V11, P98, DOI 10.1038/nri2925; Donohoe DR, 2011, CELL METAB, V13, P517, DOI 10.1016/j.cmet.2011.02.018; Farhadi A, 2008, LIVER INT, V28, P1026, DOI 10.1111/j.1478-3231.2008.01723.x; Furusawa Y, 2013, NATURE, V504, P446, DOI 10.1038/nature12721; Galisteo M, 2008, J NUTR BIOCHEM, V19, P71, DOI 10.1016/j.jnutbio.2007.02.009; Gao ZG, 2009, DIABETES, V58, P1509, DOI 10.2337/db08-1637; Gregor MF, 2011, ANNU REV IMMUNOL, V29, P415, DOI 10.1146/annurev-immunol-031210-101322; Hotamisligil GS, 1996, SCIENCE, V271, P665, DOI 10.1126/science.271.5249.665; Ichikawa H, 1999, DIGEST DIS SCI, V44, P2119, DOI 10.1023/A:1026647024077; Jager J, 2007, ENDOCRINOLOGY, V148, P241, DOI 10.1210/en.2006-0692; Jakobsdottir G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080476; Johnson AMF, 2013, CELL, V152, P673, DOI 10.1016/j.cell.2013.01.041; Kim KA, 2012, PLOS ONE, V7, P11; Kuo SM, 2014, J NUTR, V144, P245, DOI 10.3945/jn.113.185249; Larsen N, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009085; Luck H, 2015, CELL METAB, V21, P527, DOI 10.1016/j.cmet.2015.03.001; Okamoto T, 2000, J GASTROENTEROL, V35, P341, DOI 10.1007/s005350050358; Ouyang WJ, 2011, ANNU REV IMMUNOL, V29, P71, DOI 10.1146/annurev-immunol-031210-101312; Qin JJ, 2012, NATURE, V490, P55, DOI 10.1038/nature11450; Samuel BS, 2008, P NATL ACAD SCI USA, V105, P16767, DOI 10.1073/pnas.0808567105; Sartor RB, 2010, GASTROENTEROLOGY, V139, P1816, DOI 10.1053/j.gastro.2010.10.036; Ulluwishewa D, 2011, J NUTR, V141, P769, DOI 10.3945/jn.110.135657; van der Logt EMJ, 2013, J NUTR BIOCHEM, V24, P1159, DOI 10.1016/j.jnutbio.2012.09.001; Vijay-Kumar M, 2010, SCIENCE, V328, P228, DOI 10.1126/science.1179721; Wang XT, 2014, NATURE, V514, P237, DOI 10.1038/nature13564; Yin L, 2001, J BIOL CHEM, V276, P44641, DOI 10.1074/jbc.M105170200	33	44	48	0	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 28	2016	11	4							e0154373	10.1371/journal.pone.0154373	http://dx.doi.org/10.1371/journal.pone.0154373			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DK8XE	27123997	Green Submitted, Green Published, gold			2022-12-26	WOS:000375211700075
J	Stach, CS; Vu, BG; Merriman, JA; Herrera, A; Cahill, MP; Schlievert, PM; Salgado-Pabon, W				Stach, Christopher S.; Vu, Bao G.; Merriman, Joseph A.; Herrera, Alfa; Cahill, Michael P.; Schlievert, Patrick M.; Salgado-Pabon, Wilmara			Novel Tissue Level Effects of the Staphylococcus aureus Enterotoxin Gene Cluster Are Essential for Infective Endocarditis	PLOS ONE			English	Article							TOXIC-SHOCK-SYNDROME; RABBIT MODELS; SUPERANTIGENS; STRAINS; ENHANCE	Background Superantigens are indispensable virulence factors for Staphylococcus aureus in disease causation. Superantigens stimulate massive immune cell activation, leading to toxic shock syndrome (TSS) and contributing to other illnesses. However, superantigens differ in their capacities to induce body-wide effects. For many, their production, at least as tested in vitro, is not high enough to reach the circulation, or the proteins are not efficient in crossing epithelial and endothelial barriers, thus remaining within tissues or localized on mucosal surfaces where they exert only local effects. In this study, we address the role of TSS toxin-1 (TSST-1) and most importantly the enterotoxin gene cluster (egc) in infective endocarditis and sepsis, gaining insights into the body-wide versus local effects of superantigens. Methods We examined S. aureus TSST-1 gene (tstH) and egc deletion strains in the rabbit model of infective endocarditis and sepsis. Importantly, we also assessed the ability of commercial human intravenous immunoglobulin (IVIG) plus vancomycin to alter the course of infective endocarditis and sepsis. Results TSST-1 contributed to infective endocarditis vegetations and lethal sepsis, while superantigens of the egc, a cluster with uncharacterized functions in S. aureus infections, promoted vegetation formation in infective endocarditis. IVIG plus vancomycin prevented lethality and stroke development in infective endocarditis and sepsis. Conclusions Our studies support the local tissue effects of egc superantigens for establishment and progression of infective endocarditis providing evidence for their role in life-threatening illnesses. In contrast, TSST-1 contributes to both infective endocarditis and lethal sepsis. IVIG may be a useful adjunct therapy for infective endocarditis and sepsis.	[Stach, Christopher S.; Vu, Bao G.; Merriman, Joseph A.; Herrera, Alfa; Cahill, Michael P.; Schlievert, Patrick M.; Salgado-Pabon, Wilmara] Univ Iowa, Dept Microbiol, Carver Coll Med, Iowa City, IA 52242 USA	University of Iowa	Schlievert, PM (corresponding author), Univ Iowa, Dept Microbiol, Carver Coll Med, Iowa City, IA 52242 USA.	patrick-schlievert@uiowa.edu	Salgado-Pabon, Wilmara/N-9443-2018	Salgado-Pabon, Wilmara/0000-0003-0854-1568; Schlievert, Patrick/0000-0001-8314-9369	Department of Microbiology	Department of Microbiology	This work was supported by the Department of Microbiology startup funds to PMS and WSP.	Baek KT, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077122; Bor DH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060033; Bose JL, 2013, APPL ENVIRON MICROB, V79, P2218, DOI 10.1128/AEM.00136-13; Brosnahan AJ, 2011, FEBS J, V278, P4649, DOI 10.1111/j.1742-4658.2011.08151.x; Caes F, 2014, INTERACT CARDIOV TH, V18, P169, DOI 10.1093/icvts/ivt460; DeVries AS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022997; Ferro Jose M, 2014, Handb Clin Neurol, V119, P75, DOI 10.1016/B978-0-7020-4086-3.00007-2; Fowler VG, 2005, JAMA-J AM MED ASSOC, V293, P3012, DOI 10.1001/jama.293.24.3012; Fowler VG, 2003, ARCH INTERN MED, V163, P2066, DOI 10.1001/archinte.163.17.2066; Garcia-Cabrera E, 2013, CIRCULATION, V127, P2272, DOI 10.1161/CIRCULATIONAHA.112.000813; Giantonio BJ, 1997, J CLIN ONCOL, V15, P1994, DOI 10.1200/JCO.1997.15.5.1994; Grumann D, 2011, CLIN VACCINE IMMUNOL, V18, P487, DOI 10.1128/CVI.00329-10; Hoen B, 2013, NEW ENGL J MED, V368, P1425, DOI 10.1056/NEJMcp1206782; Holtfreter S, 2007, J CLIN MICROBIOL, V45, P2669, DOI 10.1128/JCM.00204-07; Jarraud S, 2002, INFECT IMMUN, V70, P631, DOI 10.1128/IAI.70.2.631-641.2002; Jarraud S, 2001, J IMMUNOL, V166, P669, DOI 10.4049/jimmunol.166.1.669; Klein E, 2007, EMERG INFECT DIS, V13, P1840, DOI 10.3201/eid1312.070629; Korol E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083743; KOTZIN BL, 1993, ADV IMMUNOL, V54, P99, DOI 10.1016/S0065-2776(08)60534-9; Kulhankova K, 2014, IMMUNOL RES, V59, P182, DOI 10.1007/s12026-014-8538-8; Kusch K, 2011, INT J MED MICROBIOL, V301, P488, DOI 10.1016/j.ijmm.2011.01.003; Lin YC, 2011, BIOCHEMISTRY-US, V50, P7157, DOI 10.1021/bi200435n; Malhotra A, 2014, CURR CARDIOL REP, V16, DOI 10.1007/s11886-014-0464-9; Mattis DM, 2013, PROTEIN ENG DES SEL, V26, P133, DOI 10.1093/protein/gzs094; McCormick JK, 2001, ANNU REV MICROBIOL, V55, P77, DOI 10.1146/annurev.micro.55.1.77; Merriman JA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095661; Murdoch DR, 2009, ARCH INTERN MED, V169, P463, DOI 10.1001/archinternmed.2008.603; Murray DL, 1996, INFECT IMMUN, V64, P371, DOI 10.1128/IAI.64.1.371-374.1996; Nienaber JJC, 2011, J INFECT DIS, V204, P704, DOI 10.1093/infdis/jir389; Norrby-Teglund A, 1998, CLIN INFECT DIS, V26, P631, DOI 10.1086/514588; Park KH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046389; Peterson ML, 2005, INFECT IMMUN, V73, P2164, DOI 10.1128/IAI.73.4.2164-2174.2005; Salgado-Pabon W, 2013, MBIO, V4, DOI [10.1128/mBio.00494-13, DOI 10.1128/MBI0.00494-13]; Salgado-Pabon W, 2014, J INFECT DIS, V210, P784, DOI 10.1093/infdis/jiu146; Salgado-Pabon W, 2014, NAT REV MICROBIOL, V12, P585, DOI 10.1038/nrmicro3308; Schlievert PM, 2007, BIOCHEMISTRY-US, V46, P14349, DOI 10.1021/bi701202w; Schlievert PM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040350; Schlievert PM, 2010, CLIN VACCINE IMMUNOL, V17, P722, DOI 10.1128/CVI.00483-09; Schlievert PM, 1998, INFECT IMMUN, V66, P218, DOI 10.1128/IAI.66.1.218-223.1998; Schlievert PM, 2004, J CLIN MICROBIOL, V42, P2875, DOI 10.1128/JCM.42.6.2875-2876.2004; Shorr AF, 2006, CRIT CARE MED, V34, P2588, DOI 10.1097/01.CCM.0000239121.09533.09; Spaulding AR, 2014, J INFECT DIS, V209, P1955, DOI 10.1093/infdis/jit823; Spaulding AR, 2013, CLIN MICROBIOL REV, V26, P422, DOI 10.1128/CMR.00104-12; Spaulding AR, 2012, FRONT CELL INFECT MI, V2, DOI 10.3389/fcimb.2012.00018; Spaulding AR, 2012, VACCINE, V30, P5099, DOI 10.1016/j.vaccine.2012.05.067; Strandberg KL, 2010, J INFECT DIS, V202, P1690, DOI 10.1086/657156; Traber KE, 2008, MICROBIOL-SGM, V154, P2265, DOI 10.1099/mic.0.2007/011874-0; Tristan A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051172; Ulrich A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0053360; Vu BG, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077988; Wilson GJ, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002271; Wisplinghoff H, 2004, CLIN INFECT DIS, V39, P309, DOI 10.1086/421946	52	29	29	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 28	2016	11	4							e0154762	10.1371/journal.pone.0154762	http://dx.doi.org/10.1371/journal.pone.0154762			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DK8XE	27124393	Green Published, gold			2022-12-26	WOS:000375211700127
J	Tonno, I; Agasild, H; Koiv, T; Freiberg, R; Noges, P; Noges, T				Tonno, Ilmar; Agasild, Helen; Koiv, Toomas; Freiberg, Rene; Noges, Peeter; Noges, Tiina			Algal Diet of Small-Bodied Crustacean Zooplankton in a Cyanobacteria-Dominated Eutrophic Lake	PLOS ONE			English	Article							CYCLOPOID COPEPODS; PHYTOPLANKTON; SHALLOW; CLADOCERANS; HPLC; REPRODUCTION; SELECTIVITY; COMMUNITY; RESPONSES; BACTERIA	Small-bodied cladocerans and cyclopoid copepods are becoming increasingly dominant over large crustacean zooplankton in eutrophic waters where they often coexist with cyanobacterial blooms. However, relatively little is known about their algal diet preferences. We studied grazing selectivity of small crustaceans (the cyclopoid copepods Mesocyclops leuckarti, Thermocyclops oithonoides, Cyclops kolensis, and the cladocerans Daphnia cucullata, Chydorus sphaericus, Bosmina spp.) by liquid chromatographic analyses of phytoplankton marker pigments in the shallow, highly eutrophic Lake Vortsjarv (Estonia) during a seasonal cycle. Copepods (mainly C. kolensis) preferably consumed cryptophytes (identified by the marker pigment alloxanthin in gut contents) during colder periods, while they preferred small non-filamentous diatoms and green algae (identified mainly by diatoxanthin and lutein, respectively) from May to September. All studied cladoceran species showed highest selectivity towards colonial cyanobacteria (identified by canthaxanthin). For small C. sphaericus, commonly occuring in the pelagic zone of eutrophic lakes, colonial cyanobacteria can be their major food source, supporting their coexistence with cyanobacterial blooms. Pigments characteristic of filamentous cyanobacteria and diatoms (zeaxanthin and fucoxanthin, respectively), algae dominating in Vortsjarv, were also found in the grazers' diet but were generally avoided by the crustaceans commonly dominating the zooplankton assemblage. Together these results suggest that the co-occurring small-bodied cyclopoid and cladoceran species have markedly different algal diets and that the cladocera represent the main trophic link transferring cyanobacterial carbon to the food web in a highly eutrophic lake.	[Tonno, Ilmar; Agasild, Helen; Koiv, Toomas; Freiberg, Rene; Noges, Peeter; Noges, Tiina] Estonian Univ Life Sci, Ctr Limnol, Inst Agr & Environm Sci, Tartu, Tartu County, Estonia	Estonian University of Life Sciences	Tonno, I (corresponding author), Estonian Univ Life Sci, Ctr Limnol, Inst Agr & Environm Sci, Tartu, Tartu County, Estonia.	ilmar.tenno@limnos.ee	Kõiv, Toomas/H-3466-2016; Tõnno, Ilmar/G-5043-2016; Noges, Tiina/AAL-5373-2020; Freiberg, Rene/O-2075-2019; Nõges, Peeter/AAL-5343-2020; Freiberg, Rene/A-6586-2013	Kõiv, Toomas/0000-0002-0051-3952; Tõnno, Ilmar/0000-0002-8864-0402; Noges, Tiina/0000-0002-4558-7373; Nõges, Peeter/0000-0003-2919-6038; Freiberg, Rene/0000-0002-8645-0031	Estonian Ministry of Education and Research [IUT21-2]; Estonian Science Foundation [8511, 9102]; Swiss Grant for Programme "Enhancing public environmental monitoring capacities"	Estonian Ministry of Education and Research(Ministry of Education and Research, Estonia); Estonian Science Foundation; Swiss Grant for Programme "Enhancing public environmental monitoring capacities"	Funding for this research was provided by the Estonian Ministry of Education and Research (IUT21-2), by Estonian Science Foundation grants 8511 and 9102 and by a Swiss Grant for Programme "Enhancing public environmental monitoring capacities." The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agasild H, 2007, HYDROBIOLOGIA, V584, P167, DOI 10.1007/s10750-007-0575-z; Agasild H, 2005, J PLANKTON RES, V27, P1155, DOI 10.1093/plankt/fbi080; Agasild H, 2012, HYDROBIOLOGIA, V684, P177, DOI 10.1007/s10750-011-0981-0; [Anonymous], 2002, TRACKING ENV CHANGE, DOI DOI 10.1007/0-306-47668-1_15; Balushkina E.V., 1979, GEN BASES RES WATER, P169; Bednarska A, 2014, J PLANKTON RES, V36, P838, DOI 10.1093/plankt/fbu009; Blumenshine SC, 2003, HYDROBIOLOGIA, V491, P347, DOI 10.1023/A:1024422121048; BOGDAN KG, 1982, LIMNOL OCEANOGR, V27, P918, DOI 10.4319/lo.1982.27.5.0918; Brierley B., 2007, GUIDANCE QUANTITATIV, P63; BURKILL PH, 1987, MAR BIOL, V93, P581, DOI 10.1007/BF00392796; Burns CW, 2011, FRESHWATER BIOL, V56, P889, DOI 10.1111/j.1365-2427.2010.02534.x; CHESSON J, 1983, ECOLOGY, V64, P1297, DOI 10.2307/1937838; Davis TW, 2012, HARMFUL ALGAE, V15, P26, DOI 10.1016/j.hal.2011.11.002; DEMOTT WR, 1995, HYDROBIOLOGIA, V307, P127, DOI 10.1007/BF00032004; DEMOTT WR, 1991, J PLANKTON RES, V13, P1203, DOI 10.1093/plankt/13.6.1203; Ghadouani A, 2003, FRESHWATER BIOL, V48, P363, DOI 10.1046/j.1365-2427.2003.01010.x; Guo NC, 2006, ENVIRON POLLUT, V143, P513, DOI 10.1016/j.envpol.2005.11.044; Haberman J., 2004, LAKE VORTSJARV, P233; Haberman J, 2007, HYDROBIOLOGIA, V584, P157, DOI 10.1007/s10750-007-0592-y; HANSEN AM, 1995, J PLANKTON RES, V17, P631, DOI 10.1093/plankt/17.3.631; HEAD EJH, 1994, MAR ECOL PROG SER, V110, P75, DOI 10.3354/meps110075; HEAD EJH, 1992, MAR ECOL PROG SER, V86, P229, DOI 10.3354/meps086229; Hopp U, 2005, FRESHWATER BIOL, V50, P742, DOI 10.1111/j.1365-2427.2005.01362.x; Hopp U, 1997, FRESHWATER BIOL, V38, P289, DOI 10.1046/j.1365-2427.1997.00214.x; JURGENS K, 1994, MARINE MICROBIAL FOOD WEBS, 1994, VOL 8, NO 1 AND 2, P295; Ka S, 2012, HYDROBIOLOGIA, V679, P119, DOI 10.1007/s10750-011-0860-8; KERFOOT WC, 1991, LIMNOL OCEANOGR, V36, P1107, DOI 10.4319/lo.1991.36.6.1107; Kozlowski WA, 2011, DEEP-SEA RES PT I, V58, P350, DOI 10.1016/j.dsr.2011.01.008; Lacerot G, 2013, FRESHWATER BIOL, V58, P494, DOI 10.1111/fwb.12075; Lampert W., 1987, Memorie dell'Istituto Italiano di Idrobiologia Dott Marco de Marchi, V45, P143; Lee DB, 2012, MAR ECOL-EVOL PERSP, V33, P88, DOI 10.1111/j.1439-0485.2011.00453.x; Lie AAY, 2010, J EXP MAR BIOL ECOL, V390, P149, DOI 10.1016/j.jembe.2010.05.001; Liu GM, 2014, HYDROBIOLOGIA, V736, P189, DOI 10.1007/s10750-014-1906-5; McGowan S, 2005, ECOLOGY, V86, P2200, DOI 10.1890/04-1029; Muller H, 1999, AQUAT MICROB ECOL, V17, P49, DOI 10.3354/ame017049; Noges P., 2012, ENCY LAKERESERVOIR, P850, DOI DOI 10.1007/978-1-4020-4410-6_228; NOGES P, 2004, LAKE VORTSJARV, P217; Obayashi Y, 2002, J EXP MAR BIOL ECOL, V280, P33, DOI 10.1016/S0022-0981(02)00365-9; Pandolfini E, 2000, J PLANKTON RES, V22, P305, DOI 10.1093/plankt/22.2.305; Patoine A, 2006, ECOLOGY, V87, P1710, DOI 10.1890/0012-9658(2006)87[1710:CSOFAI]2.0.CO;2; Perga ME, 2013, OECOLOGIA, V172, P551, DOI 10.1007/s00442-012-2519-1; Poister D, 1999, CAN J FISH AQUAT SCI, V56, P60, DOI 10.1139/cjfas-56-1-60; QuiblierLloberas C, 1996, J PLANKTON RES, V18, P305, DOI 10.1093/plankt/18.3.305; Reuss N, 2005, MAR CHEM, V95, P283, DOI 10.1016/j.marchem.2004.10.002; Roy S., 2011, PHYTOPLANKTON PIGMEN; Ruttner-Kolisko A., 1977, ARCH HYDROBIOL, V8, P71; Schluter L, 2006, FRESHWATER BIOL, V51, P1474, DOI 10.1111/j.1365-2427.2006.01582.x; Smirnov N.N., 1996, GUIDES IDENTIFICATIO; Soares MCS, 2009, ECOTOX ENVIRON SAFE, V72, P1183, DOI 10.1016/j.ecoenv.2008.09.004; Statsoft Inc, 2011, STATISTICA DAT AN SO; Studenikina E. I., 1969, Gidrobiologicheskii Zhurnal, V5, P89; Taipale SJ, 2012, FEMS MICROBIOL ECOL, V82, P50, DOI 10.1111/j.1574-6941.2012.01406.x; Tamm M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122526; Thys I, 2003, J PLANKTON RES, V25, P1471, DOI 10.1093/plankt/fbg103; Urrutia-Cordero P, 2015, FRESHWATER BIOL, V60, P960, DOI 10.1111/fwb.12555; Utermohl H., 1958, MITT INT VER THEOR, V9, P1, DOI DOI 10.1080/05384680.1958.11904091; Vakkilainen K, 2004, FRESHWATER BIOL, V49, P1619, DOI 10.1111/j.1365-2427.2004.01300.x; Van Nieuwerburgh L, 2005, J SEA RES, V53, P147, DOI 10.1016/j.seares.2004.07.003; Vijverberg J, 1997, HYDROBIOLOGIA, V360, P233, DOI 10.1023/A:1003148600983; Wong CK, 2006, J EXP MAR BIOL ECOL, V331, P21, DOI 10.1016/j.jembe.2005.09.019; Work KA, 2003, J PLANKTON RES, V25, P1301, DOI 10.1093/plankt/fbg092; Zhang J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076378; Zingel P, 2007, MICROB ECOL, V53, P134, DOI 10.1007/s00248-006-9155-4	63	45	48	3	59	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 28	2016	11	4							e0154526	10.1371/journal.pone.0154526	http://dx.doi.org/10.1371/journal.pone.0154526			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DK8XE	27124652	Green Published, gold, Green Submitted			2022-12-26	WOS:000375211700100
J	McDonald, S; Block, A; Beaucourt, S; Moratorio, G; Vignuzzi, M; Peersen, OB				McDonald, Seth; Block, Andrew; Beaucourt, Stephanie; Moratorio, Gonzalo; Vignuzzi, Marco; Peersen, Olve B.			Design of a Genetically Stable High Fidelity Coxsackievirus B3 Polymerase That Attenuates Virus Growth in Vivo	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						plus-stranded RNA virus; protein engineering; vaccine development; viral polymerase; virology; polymerase fidelity	DEPENDENT RNA-POLYMERASES; REPLICATION FIDELITY; MECHANISM; DYNAMICS; MUTATION; MODEL	Positive strand RNA viruses replicate via a virally encoded RNA-dependent RNA polymerase (RdRP) that uses a unique palm domain active site closure mechanism to establish the canonical two-metal geometry needed for catalysis. This mechanism allows these viruses to evolutionarily fine-tune their replication fidelity to create an appropriate distribution of genetic variants known as a quasispecies. Prior work has shown that mutations in conserved motif A drastically alter RdRP fidelity, which can be either increased or decreased depending on the viral polymerase background. In the work presented here, we extend these studies to motif D, a region that forms the outer edge of the NTP entry channel where it may act as a nucleotide sensor to trigger active site closure. Crystallography, stopped-flow kinetics, quench-flow reactions, and infectious virus studies were used to characterize 15 engineered mutations in coxsackievirus B3 polymerase. Mutations that interfere with the transport of the metal A Mg2+ ion into the active site had only minor effects on RdRP function, but the stacking interaction between Phe(364) and Pro(357), which is absolutely conserved in enteroviral polymerases, was found to be critical for processive elongation and virus growth. Mutating Phe(364) to tryptophan resulted in a genetically stable high fidelity virus variant with significantly reduced pathogenesis in mice. The data further illustrate the importance of the palm domain movement for RdRP active site closure and demonstrate that protein engineering can be used to alter viral polymerase function and attenuate virus growth and pathogenesis.	[McDonald, Seth; Block, Andrew; Peersen, Olve B.] Colorado State Univ, Dept Biochem & Mol Biol, Ft Collins, CO 80523 USA; [Beaucourt, Stephanie; Moratorio, Gonzalo; Vignuzzi, Marco] Inst Pasteur, CNRS, UMR 3569, 28 Rue Dr Roux, F-75724 Paris 15, France	Colorado State University; Centre National de la Recherche Scientifique (CNRS); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris	Peersen, OB (corresponding author), Colorado State Univ, Dept Biochem & Mol Biol, Ft Collins, CO 80523 USA.	Olve.Peersen@ColoState.edu	Peersen, Olve/P-5587-2016	Beaucourt, Stephanie/0000-0001-9394-6425; Vignuzzi, Marco/0000-0002-4400-771X	National Institutes of Health [R01 AI059130]; LabEx Integrative Biology of Emerging Infectious Diseases program grant; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI059130] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); LabEx Integrative Biology of Emerging Infectious Diseases program grant; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by National Institutes of Health Grant R01 AI059130 (to O. B. P.) and a LabEx Integrative Biology of Emerging Infectious Diseases program grant (to M. V.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Andino R, 2015, VIROLOGY, V479, P46, DOI 10.1016/j.virol.2015.03.022; Arnold JJ, 2004, BIOCHEMISTRY-US, V43, P5126, DOI 10.1021/bi035212y; Beaucourt S, 2011, JOVE-J VIS EXP, DOI 10.3791/2953; Campagnola G, 2015, J VIROL, V89, P275, DOI 10.1128/JVI.01574-14; Castro C, 2009, NAT STRUCT MOL BIOL, V16, P212, DOI 10.1038/nsmb.1540; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Ferrer-Orta C, 2015, VIRUSES-BASEL, V7, P4438, DOI 10.3390/v7082829; Gnadig NF, 2012, P NATL ACAD SCI USA, V109, pE2294, DOI 10.1073/pnas.1204022109; Gohara DW, 1999, PROTEIN EXPRES PURIF, V17, P128, DOI 10.1006/prep.1999.1100; Gong P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060272; Gong P, 2010, P NATL ACAD SCI USA, V107, P22505, DOI 10.1073/pnas.1007626107; Gong P, 2009, ANAL BIOCHEM, V391, P45, DOI 10.1016/j.ab.2009.04.035; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Karplus PA, 2012, SCIENCE, V336, P1030, DOI [10.1126/science.121823, 10.1126/science.1218231]; Kennedy EM, 2010, J BIOL CHEM, V285, P39380, DOI 10.1074/jbc.M110.178582; Korboukh VK, 2014, J BIOL CHEM, V289, P29531, DOI 10.1074/jbc.M114.592303; Kornberg RD, 2007, P NATL ACAD SCI USA, V104, P12955, DOI 10.1073/pnas.0704138104; Lauring AS, 2013, NAT REV MICROBIOL, V11, P327, DOI 10.1038/nrmicro3003; Morin A, 2013, ELIFE, V2, DOI 10.7554/eLife.01456; Moustafa IM, 2014, J BIOL CHEM, V289, P36229, DOI 10.1074/jbc.M114.616193; Moustafa IM, 2011, J MOL BIOL, V410, P159, DOI 10.1016/j.jmb.2011.04.078; Ng KKS, 2008, CURR TOP MICROBIOL, V320, P137; Pfeiffer JK, 2003, P NATL ACAD SCI USA, V100, P7289, DOI 10.1073/pnas.1232294100; Pfeiffer JK, 2005, PLOS PATHOG, V1, P102, DOI 10.1371/journal.ppat.0010011; REED L. J., 1938, AMER JOUR HYG, V27, P493; Shen HJ, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002851; Stapleford KA, 2015, J VIROL, V89, P11233, DOI 10.1128/JVI.01553-15; Steitz TA, 1998, NATURE, V391, P231, DOI 10.1038/34542; Steitz TA, 2009, CURR OPIN STRUC BIOL, V19, P683, DOI 10.1016/j.sbi.2009.09.001; Theobald DL, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.0040043; Theobald DL, 2006, BIOINFORMATICS, V22, P2171, DOI 10.1093/bioinformatics/btl332; Thompson AA, 2007, J MOL BIOL, V366, P1459, DOI 10.1016/j.jmb.2006.11.070; TRAUT TW, 1994, MOL CELL BIOCHEM, V140, P1, DOI 10.1007/BF00928361; Weeks SA, 2012, J BIOL CHEM, V287, P31618, DOI 10.1074/jbc.C112.401471; Yang XR, 2012, STRUCTURE, V20, P1519, DOI 10.1016/j.str.2012.06.012	37	37	37	1	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 1	2016	291	27					13999	14011		10.1074/jbc.M116.726596	http://dx.doi.org/10.1074/jbc.M116.726596			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DR5XG	27137934	Green Published, hybrid			2022-12-26	WOS:000379975100009
J	Groeme, R; Airouche, S; Kopecny, D; Jaekel, J; Savko, M; Berjont, N; Bussieres, L; Le Mignon, M; Jagic, F; Zieglmayer, P; Baron-Bodo, V; Bordas-Le Floch, V; Mascarell, L; Briozzo, P; Moingeon, P				Groeme, Rachel; Airouche, Sabi; Kopecny, David; Jaekel, Judith; Savko, Martin; Berjont, Nathalie; Bussieres, Laetitia; Le Mignon, Maxime; Jagic, Franck; Zieglmayer, Petra; Baron-Bodo, Veronique; Bordas-Le Floch, Veronique; Mascarell, Laurent; Briozzo, Pierre; Moingeon, Philippe			Structural and Functional Characterization of the Major Allergen Amb a 11 from Short Ragweed Pollen	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DUST-MITE ALLERGEN; DICHROISM SPECTROSCOPIC DATA; PROTEIN SECONDARY STRUCTURE; CRYSTAL-STRUCTURE; CYSTEINE PROTEASE; DERMATOPHAGOIDES-PTERONYSSINUS; ACTIVATION MECHANISM; PROTEOLYTIC ACTIVITY; PRO-SEQUENCE; DER-P-1	Allergy to the short ragweed (Ambrosia artemisiifolia) pollen is a major health problem. The ragweed allergen repertoire has been recently expanded with the identification of Amb a 11, a new major allergen belonging to the cysteine protease family. To better characterize Amb a 11, a recombinant proform of the molecule with a preserved active site was produced in Escherichia coli, refolded, and processed in vitro into a mature enzyme. The enzymatic activity is revealed by maturation following an autocatalytic processing resulting in the cleavage of both N- and C-terminal propeptides. The 2.05-angstrom resolution crystal structure of pro-Amb a 11 shows an overall typical C1A cysteine protease fold with a network of molecular interactions between the N-terminal propeptide and the catalytic triad of the enzyme. The allergenicity of Amb a 11 was confirmed in a murine sensitization model, resulting in airway inflammation, production of serum IgEs, and induction of Th2 immune responses. Of note, inflammatory responses were higher with the mature form, demonstrating that the cysteine protease activity critically contributes to the allergenicity of the molecule. Collectively, our results clearly demonstrate that Amb a 11 is a bona fide cysteine protease exhibiting a strong allergenicity. As such, it should be considered as an important molecule for diagnosis and immunotherapy of ragweed pollen allergy.	[Groeme, Rachel; Airouche, Sabi; Jaekel, Judith; Berjont, Nathalie; Bussieres, Laetitia; Le Mignon, Maxime; Baron-Bodo, Veronique; Bordas-Le Floch, Veronique; Mascarell, Laurent; Moingeon, Philippe] Stallergenes Greer, Res & Dev, F-92160 Antony, France; [Kopecny, David] Palacky Univ, Fac Sci, Dept Prot Biochem & Prote, Ctr Reg Hana Biotechnol & Agr Res, Slechtitelu 27, CZ-78371 Olomouc, Czech Republic; [Savko, Martin] SOLEIL Synchrotron, PROXIMA 2A, St Aubin BP 48, F-91192 Gif Sur Yvette, France; [Jagic, Franck; Briozzo, Pierre] AgroParisTech, INRA, Inst Jean Pierre Bourgin, F-78026 Versailles, France; [Zieglmayer, Petra] Allergy Ctr Vienna West, Vienna Challenge Chamber, A-1150 Vienna, Austria	Stallergenes Greer; Palacky University Olomouc; SOLEIL Synchrotron; AgroParisTech; INRAE; UDICE-French Research Universities; Universite Paris Saclay	Moingeon, P (corresponding author), Stallergenes Greer, Res & Dev, 6 Rue Alexis de Tocqueville, F-92183 Antony, France.	pmoingeon@stallergenes.com	Kopecny, David/ABH-4250-2020; Zieglmayer, Petra/AAG-1006-2020	Kopecny, David/0000-0002-4309-4284; 	Stallergenes; Convention Industrielles de Formation par la Recherche (CIFRE) fellowship from the Association Nationale de la Recherche et de la Technologie; National Program of Sustainability I Grant from the Czech Ministry of Education, Youth and Sports [LO1204]	Stallergenes; Convention Industrielles de Formation par la Recherche (CIFRE) fellowship from the Association Nationale de la Recherche et de la Technologie; National Program of Sustainability I Grant from the Czech Ministry of Education, Youth and Sports	This work was supported in part by Stallergenes. R. G., S. A., J. J., N. B., L. B., M. L. M., V. B.-B., V. B.-L. F., L. M., and P. M. are employees at Stallergenes SAS.r Supported by a Convention Industrielles de Formation par la Recherche (CIFRE) fellowship from the Association Nationale de la Recherche et de la Technologie.r Supported by National Program of Sustainability I Grant LO1204 from the Czech Ministry of Education, Youth and Sports.	Arbes SJ, 2005, J ALLERGY CLIN IMMUN, V116, P377, DOI 10.1016/j.jaci.2005.05.017; Asero R, 2006, CLIN EXP ALLERGY, V36, P658, DOI 10.1111/j.1365-2222.2006.02477.x; Bordas-Le Floch V, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0136258; Bouley J, 2015, J ALLERGY CLIN IMMUN, V136, P1055, DOI 10.1016/j.jaci.2015.03.001; Bricogne G., 2011, BUSTER VERSION 2 1 0; Bromme D, 2004, METHODS, V32, P199, DOI 10.1016/S1046-2023(03)00212-3; Burbach GJ, 2009, ALLERGY, V64, P664, DOI 10.1111/j.1398-9995.2009.01975.x; Burtin D, 2009, CLIN EXP ALLERGY, V39, P760, DOI 10.1111/j.1365-2222.2009.03201.x; Bussieres L, 2010, INT ARCH ALLERGY IMM, V153, P141, DOI 10.1159/000312631; Chapman MD, 2007, CURR ALLERGY ASTHM R, V7, P363, DOI 10.1007/s11882-007-0055-6; Chevigne A, 2007, J MOL BIOL, V374, P170, DOI 10.1016/j.jmb.2007.08.025; Choudhury D, 2009, PHYTOCHEMISTRY, V70, P465, DOI 10.1016/j.phytochem.2009.02.001; Comoy EE, 1998, J IMMUNOL, V160, P2456; Cunningham PT, 2012, INT ARCH ALLERGY IMM, V158, P347, DOI 10.1159/000334280; D'Amato G, 2007, ALLERGY, V62, P976, DOI 10.1111/j.1398-9995.2007.01393.x; de Halleux S, 2006, J ALLERGY CLIN IMMUN, V117, P571, DOI 10.1016/j.jaci.2005.11.032; Deb R, 2007, J BIOL CHEM, V282, P36808, DOI 10.1074/jbc.M702336200; Demidyuk Ilya V, 2010, Biomol Concepts, V1, P305, DOI 10.1515/bmc.2010.025; Dutta S, 2011, FEBS J, V278, P3012, DOI 10.1111/j.1742-4658.2011.08221.x; EDER J, 1995, MOL MICROBIOL, V16, P609, DOI 10.1111/j.1365-2958.1995.tb02423.x; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Floch VBL, 2015, CURR ALLERGY ASTHM R, V15, DOI 10.1007/s11882-015-0565-6; Gadermaier G, 2008, ALLERGY, V63, P1543, DOI 10.1111/j.1398-9995.2008.01780.x; Gadermaier G, 2014, METHODS, V66, P55, DOI 10.1016/j.ymeth.2013.06.014; Gough L, 2001, CLIN EXP ALLERGY, V31, P1594, DOI 10.1046/j.1365-2222.2001.01207.x; Groves MR, 1996, STRUCTURE, V4, P1193, DOI 10.1016/S0969-2126(96)00127-X; Gunawan Hendra, 2008, Allergol Int, V57, P83, DOI 10.2332/allergolint.O-07-507; Gunawan H, 2008, INT ARCH ALLERGY IMM, V147, P276, DOI 10.1159/000144035; Henriquez OA, 2013, INT FORUM ALLERGY RH, V3, P630, DOI 10.1002/alr.21168; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; KAMPHUIS IG, 1984, J MOL BIOL, V179, P233, DOI 10.1016/0022-2836(84)90467-4; Karplus PA, 2012, SCIENCE, V336, P1030, DOI [10.1126/science.121823, 10.1126/science.1218231]; Kaulmann G, 2006, PROTEIN SCI, V15, P2619, DOI 10.1110/ps.062401806; Lees JG, 2004, ANAL BIOCHEM, V332, P285, DOI 10.1016/j.ab.2004.06.002; Meno K, 2005, J IMMUNOL, V175, P3835, DOI 10.4049/jimmunol.175.6.3835; Nandana V, 2014, PROTEIN EXPRES PURIF, V103, P16, DOI 10.1016/j.pep.2014.08.003; Novinec Marko, 2013, Biomol Concepts, V4, P287, DOI 10.1515/bmc-2012-0054; Okomoto T, 1999, J BIOL CHEM, V274, P11390, DOI 10.1074/jbc.274.16.11390; Oswalt Matthew L, 2008, Allergy Asthma Clin Immunol, V4, P130, DOI 10.1186/1710-1492-4-3-130; PAUL W, 1995, PLANT PHYSIOL, V108, P261, DOI 10.1104/pp.108.1.261; Razafindratsita A, 2007, J ALLERGY CLIN IMMUN, V120, P278, DOI 10.1016/j.jaci.2007.04.009; Reubsaet L, 2013, J ALLERGY CLIN IMMUN, V132, P1440, DOI 10.1016/j.jaci.2013.06.028; Roy S, 2012, ACTA CRYSTALLOGR D, V68, P1591, DOI 10.1107/S0907444912038607; Schmid M, 1998, PLANTA, V206, P466, DOI 10.1007/s004250050423; Sivaraman J, 1999, PROTEIN SCI, V8, P283; Smith M, 2013, ENVIRON INT, V61, P115, DOI 10.1016/j.envint.2013.08.005; Stack CM, 2008, J BIOL CHEM, V283, P9896, DOI 10.1074/jbc.M708521200; Storoni LC, 2004, ACTA CRYSTALLOGR D, V60, P432, DOI 10.1107/S0907444903028956; Than ME, 2004, J MOL BIOL, V336, P1103, DOI 10.1016/j.jmb.2003.12.075; Turk V, 2012, BBA-PROTEINS PROTEOM, V1824, P68, DOI 10.1016/j.bbapap.2011.10.002; VANSTOKKUM IHM, 1990, ANAL BIOCHEM, V191, P110, DOI 10.1016/0003-2697(90)90396-Q; Whitmore L, 2004, NUCLEIC ACIDS RES, V32, pW668, DOI 10.1093/nar/gkh371; Wiederanders B, 2003, ACTA BIOCHIM POL, V50, P691; Wiederanders B, 2003, CURR PROTEIN PEPT SC, V4, P309, DOI 10.2174/1389203033487081; Yi MH, 2015, CYTOKINE, V75, P356, DOI 10.1016/j.cyto.2015.07.011	55	15	16	2	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 17	2016	291	25					13076	13087		10.1074/jbc.M115.702001	http://dx.doi.org/10.1074/jbc.M115.702001			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DR2YT	27129273	hybrid, Green Published			2022-12-26	WOS:000379770500016
J	Klein, RH; Stephens, DN; Ho, H; Chen, JK; Salmans, ML; Wang, WN; Yu, ZQ; Andersen, B				Klein, Rachel Herndon; Stephens, Denise N.; Ho, Hsiang; Chen, Jefferson K.; Salmans, Michael L.; Wang, Winnie; Yu, Zhengquan; Andersen, Bogi			Cofactors of LIM Domains Associate with Estrogen Receptor alpha to Regulate the Expression of Noncoding RNA H19 and Corneal Epithelial Progenitor Cell Function	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FOLLICLE STEM-CELLS; ERYTHROID-DIFFERENTIATION; HOMEODOMAIN PROTEINS; GENOME BROWSER; BREAST-CANCER; LDB1; BINDING; GENE; TRANSCRIPTION; LOCUS	Cofactors of LIM domain proteins, CLIM1 and CLIM2, are widely expressed transcriptional cofactors that are recruited to gene regulatory regions by DNA-binding proteins, including LIM domain transcription factors. In the cornea, epithelium-specific expression of a dominant negative (DN) CLIM under the keratin 14 (K14) promoter causes blistering, wounding, inflammation, epithelial hyperplasia, and neovascularization followed by epithelial thinning and subsequent epidermal-like differentiation of the corneal epithelium. The defects in corneal epithelial differentiation and cell fate determination suggest that CLIM may regulate corneal progenitor cells and the transition to differentiation. Consistent with this notion, the K14-DN-Clim corneal epithelium first exhibits increased proliferation followed by fewer progenitor cells with decreased proliferative potential. In vivo ChIP-sequencing experiments with corneal epithelium show that CLIM binds to and regulates numerous genes involved in cell adhesion and proliferation, including limbally enriched genes. Intriguingly, CLIM associates primarily with non-LIM homeodomain motifs in corneal epithelial cells, including that of estrogen receptor alpha. Among CLIM targets is the noncoding RNA H19 whose deregulation is associated with Silver-Russell and Beckwith-Wiedemann syndromes. We demonstrate here that H19 negatively regulates corneal epithelial proliferation. In addition to cell cycle regulators, H19 affects the expression of multiple cell adhesion genes. CLIM interacts with estrogen receptor alpha at the H19 locus, potentially explaining the higher expression of H19 in female than male corneas. Together, our results demonstrate an important role for CLIM in regulating the proliferative potential of corneal epithelial progenitors and identify CLIM downstream target H19 as a regulator of corneal epithelial proliferation and adhesion.	[Klein, Rachel Herndon; Stephens, Denise N.; Salmans, Michael L.; Wang, Winnie; Yu, Zhengquan; Andersen, Bogi] Univ Calif Irvine, Dept Biol Chem, Irvine, CA 92697 USA; [Ho, Hsiang; Chen, Jefferson K.; Andersen, Bogi] Univ Calif Irvine, Dept Med, 839 Hlth Sci Dr, Irvine, CA 92697 USA; [Klein, Rachel Herndon; Salmans, Michael L.; Andersen, Bogi] Univ Calif Irvine, Inst Genom & Bioinformat, Irvine, CA 92697 USA; [Yu, Zhengquan] China Agr Univ, State Key Labs AgroBiotechnol, Coll Biol Sci, Beijing 100193, Peoples R China	University of California System; University of California Irvine; University of California System; University of California Irvine; University of California System; University of California Irvine; China Agricultural University	Andersen, B (corresponding author), Univ Calif Irvine, Dept Med, 839 Hlth Sci Dr, Irvine, CA 92697 USA.	bogi@uci.edu	Wang, Winnie/GXN-4222-2022; tian, yuhua/AAK-1312-2020		National Institutes of Health [R01EY019413, R01AR44882, T15LM00744, F32AR065356, T32GM08620]; California Institute for Regenerative Medicine [TG2-01152]; NATIONAL CANCER INSTITUTE [P30CA062203] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [R01EY019413] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR044882, F32AR065356] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008620] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); California Institute for Regenerative Medicine(California Institute for Regenerative Medicine); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Grants R01EY019413 and R01AR44882 (to B. A.), T15LM00744 (to R. H. K. and M. L. S.), F32AR065356 (to H. H.), and T32GM08620 (to J. K. C.) and by California Institute for Regenerative Medicine Grant TG2-01152 (to D. S. and M. L. S.). The authors have no conflicts of interest to declare. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Agulnick AD, 1996, NATURE, V384, P270, DOI 10.1038/384270a0; Azzi S, 2014, CURR OPIN ENDOCRINOL, V21, P30, DOI 10.1097/MED.0000000000000037; Bach I, 1999, NAT GENET, V22, P394, DOI 10.1038/11970; Bach I, 1997, GENE DEV, V11, P1370, DOI 10.1101/gad.11.11.1370; Bailey TL, 2009, NUCLEIC ACIDS RES, V37, pW202, DOI 10.1093/nar/gkp335; Blankenberg Daniel, 2010, Curr Protoc Mol Biol, VChapter 19, DOI 10.1002/0471142727.mb1910s89; Deng WL, 2012, CELL, V149, P1233, DOI 10.1016/j.cell.2012.03.051; Dey-Guha I, 2009, INT J BIOL SCI, V5, P686; Drewell RA, 2002, DEVELOPMENT, V129, P1205; Folgueras AR, 2013, CELL STEM CELL, V13, P314, DOI 10.1016/j.stem.2013.06.018; Gabory A, 2010, BIOESSAYS, V32, P473, DOI 10.1002/bies.200900170; Giardine B, 2005, GENOME RES, V15, P1451, DOI 10.1101/gr.4086505; Goecks J, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-8-r86; Gordon WM, 2014, J CLIN INVEST, V124, P5205, DOI 10.1172/JCI77138; Gronlund MA, 2011, BRIT J OPHTHALMOL, V95, P637, DOI 10.1136/bjo.2010.184457; Hopkin AS, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002829; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; Johnsen SA, 2009, CANCER RES, V69, P128, DOI 10.1158/0008-5472.CAN-08-1630; Jurata LW, 1996, P NATL ACAD SCI USA, V93, P11693, DOI 10.1073/pnas.93.21.11693; Kaffer CR, 2001, MOL CELL BIOL, V21, P8189, DOI 10.1128/MCB.21.23.8189-8196.2001; Kawakita T, 2004, INVEST OPHTH VIS SCI, V45, P3507, DOI 10.1167/iovs.04-0266; Kayala MA, 2012, NUCLEIC ACIDS RES, V40, pW553, DOI 10.1093/nar/gks420; Kent WJ, 2002, GENOME RES, V12, P996, DOI 10.1101/gr.229102; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Lasek AW, 2011, J NEUROSCI, V31, P14134, DOI 10.1523/JNEUROSCI.3415-11.2011; Li LQ, 2011, NAT IMMUNOL, V12, P129, DOI 10.1038/ni.1978; Liu T, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-8-r83; Mardaryev AN, 2011, DEVELOPMENT, V138, P4843, DOI 10.1242/dev.070284; Meier N, 2006, DEVELOPMENT, V133, P4913, DOI 10.1242/dev.02656; Mukhopadhyay M, 2003, DEVELOPMENT, V130, P495, DOI 10.1242/dev.00225; Povinelli BJ, 2014, STEM CELLS, V32, P105, DOI 10.1002/stem.1513; Reinius B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056611; Rhee H, 2006, SCIENCE, V312, P1946, DOI 10.1126/science.1128004; Rosenbloom KR, 2013, NUCLEIC ACIDS RES, V41, pD56, DOI 10.1093/nar/gks1172; Ross-Innes CS, 2012, NATURE, V481, P389, DOI 10.1038/nature10730; Salmans ML, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004520; Schmidt D, 2009, METHODS, V48, P240, DOI 10.1016/j.ymeth.2009.03.001; Sherman BT, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-426; Singh Purnima, 2012, Frontiers in Genetics, V3, P214, DOI 10.3389/fgene.2012.00214; Singh RR, 2005, CANCER RES, V65, P10594, DOI 10.1158/0008-5472.CAN-05-2268; Soler E, 2010, GENE DEV, V24, P277, DOI 10.1101/gad.551810; Stephens DN, 2013, J BIOL CHEM, V288, P34304, DOI 10.1074/jbc.M113.504399; Storbeck CJ, 2009, MOL BIOL CELL, V20, P4174, DOI 10.1091/mbc.E08-07-0707; Visvader JE, 1997, P NATL ACAD SCI USA, V94, P13707, DOI 10.1073/pnas.94.25.13707; Wang SB, 2012, FASEB J, V26, P1506, DOI 10.1096/fj.11-198036; Xu XM, 2007, DEV BIOL, V312, P484, DOI 10.1016/j.ydbio.2007.09.052; Yu ZQ, 2009, EMBO J, V28, P1890, DOI 10.1038/emboj.2009.142; Zhang Y, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-r137; Zhou MY, 2006, J BIOL CHEM, V281, P19600, DOI 10.1074/jbc.M600777200	49	15	15	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 17	2016	291	25					13271	13285		10.1074/jbc.M115.709386	http://dx.doi.org/10.1074/jbc.M115.709386			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DR2YT	27129775	hybrid, Green Published			2022-12-26	WOS:000379770500031
J	Cheng, MZ; Xue, H; Cao, WP; Li, WX; Chen, H; Liu, BF; Ma, BY; Yan, XH; Chen, YG				Cheng, Minzhang; Xue, Hua; Cao, Weipeng; Li, Wenxia; Chen, Hua; Liu, Bofeng; Ma, Benyu; Yan, Xiaohua; Chen, Ye-Guang			Receptor for Activated C Kinase 1 (RACK1) Promotes Dishevelled Protein Degradation via Autophagy and Antagonizes Wnt Signaling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PLANAR CELL POLARITY; HEPATOCELLULAR-CARCINOMA; SELECTIVE AUTOPHAGY; COMPLEX-FORMATION; SRC ACTIVITY; PATHWAY; LIGASE; GROWTH; APOPTOSIS	Wnt signaling plays a critical role in embryonic development, tissue homeostasis, and cancer development. Dishevelled (Dvl) is an essential and central component in Wnt signaling, and its stability and activity is tightly regulated. It has been shown that Dvl can be degraded via both the proteasome and autophagy-lysosome pathways. Here we report that receptor for activated C kinase 1 (RACK1) negatively regulates Dishevelled stability and Wnt signaling. RACK1 interacts with Dvl proteins and promotes their lysosomal degradation, and this effect is enhanced by autophagy induction. RACK1 also interacts with LC3 and enhances the association of LC3 with Dvl2, thereby leading to degradation of Dvl proteins through autophagy. These findings reveal a novel regulatory function of RACK1 in Wnt signaling by modulating Dvl stability.	[Cheng, Minzhang; Xue, Hua; Cao, Weipeng; Li, Wenxia; Chen, Hua; Liu, Bofeng; Ma, Benyu; Yan, Xiaohua; Chen, Ye-Guang] Tsinghua Univ, Sch Life Sci, Tsinghua Peking Ctr Life Sci, State Key Lab Membrane Biol, Beijing 100084, Peoples R China; [Xue, Hua] Beijing Forestry Univ, Coll Biol Sci & Biotechnol, Beijing 100083, Peoples R China	Tsinghua University; Beijing Forestry University	Chen, YG (corresponding author), Tsinghua Univ, Sch Life Sci, Tsinghua Peking Ctr Life Sci, State Key Lab Membrane Biol, Beijing 100084, Peoples R China.	ygchen@tsinghua.edu.cn	Chen, Ye-Guang/L-6998-2019; Yan, Xiaohua/J-4922-2015	Yan, Xiaohua/0000-0002-7528-5771	973 Program [2013CB933700]; National Natural Science Foundation of China [31330049, 31501144]	973 Program(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by 973 Program Grant 2013CB933700 and National Natural Science Foundation of China Grants 31330049 (to Y. G. C.) and 31501144 (to H. X.). The authors declare that they have no conflicts of interest with the contents of this article.	Adams DR, 2011, CELL COMMUN SIGNAL, V9, DOI 10.1186/1478-811X-9-22; Angers S, 2006, NAT CELL BIOL, V8, P348, DOI 10.1038/ncb1381; Bilechele Travis L., 2008, V468, P99, DOI 10.1007/978-1-59745-249-6_8; Clevers H, 2012, CELL, V149, P1192, DOI 10.1016/j.cell.2012.05.012; De A, 2011, ACTA BIOCH BIOPH SIN, V43, P745, DOI 10.1093/abbs/gmr079; Deng YZ, 2012, GASTROENTEROLOGY, V142, P812, DOI 10.1053/j.gastro.2011.12.046; Devenport D, 2014, J CELL BIOL, V207, P171, DOI 10.1083/jcb.201408039; Ding Y, 2013, J BIOL CHEM, V288, P8289, DOI 10.1074/jbc.M112.433185; Erdi B, 2012, AUTOPHAGY, V8, P1124, DOI 10.4161/auto.20069; Gao C, 2010, NAT CELL BIOL, V12, P781, DOI 10.1038/ncb2082; Gao C, 2010, CELL SIGNAL, V22, P717, DOI 10.1016/j.cellsig.2009.11.021; Guo YY, 2013, HEPATOLOGY, V57, P140, DOI 10.1002/hep.25978; Harada M, 2008, EXP CELL RES, V314, P1753, DOI 10.1016/j.yexcr.2008.01.035; He X, 2011, ONCOGENE, V30, P535, DOI 10.1038/onc.2010.427; Johansen T, 2011, AUTOPHAGY, V7, P279, DOI 10.4161/auto.7.3.14487; Korinek V, 1997, SCIENCE, V275, P1784, DOI 10.1126/science.275.5307.1784; Li JJ, 2015, ONCOGENE, V34, P1890, DOI 10.1038/onc.2014.127; Li SD, 2011, P NATL ACAD SCI USA, V108, P2264, DOI 10.1073/pnas.1013170108; Ma BY, 2015, J BIOL CHEM, V290, P12346, DOI 10.1074/jbc.M115.654590; Ma BY, 2014, CELL RES, V24, P912, DOI 10.1038/cr.2014.84; MacDonald BT, 2009, DEV CELL, V17, P9, DOI 10.1016/j.devcel.2009.06.016; Mamidipudi V, 2007, ONCOGENE, V26, P2914, DOI 10.1038/sj.onc.1210091; Mamidipudi V, 2004, MOL CELL BIOL, V24, P6788, DOI 10.1128/MCB.24.15.6788-6798.2004; Mamidipudi V, 2009, ONCOGENE, V28, P4421, DOI 10.1038/onc.2009.293; Miyazaki K, 2004, J BIOL CHEM, V279, P11327, DOI 10.1074/jbc.M312389200; Mizushima N, 2011, ANNU REV CELL DEV BI, V27, P107, DOI 10.1146/annurev-cellbio-092910-154005; Nilsson J, 2004, EMBO REP, V5, P1137, DOI 10.1038/sj.embor.7400291; Noda NN, 2008, GENES CELLS, V13, P1211, DOI 10.1111/j.1365-2443.2008.01238.x; Ohsumi Y, 2014, CELL RES, V24, P9, DOI 10.1038/cr.2013.169; Peng RJ, 2013, ONCOL REP, V30, P2195, DOI 10.3892/or.2013.2723; Ruan YY, 2012, J CLIN INVEST, V122, P2554, DOI 10.1172/JCI58488; Russell RC, 2014, CELL RES, V24, P42, DOI 10.1038/cr.2013.166; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Sharma J, 2012, J BIOL CHEM, V287, P6830, DOI 10.1074/jbc.M111.315135; Shi S, 2012, J BIOL CHEM, V287, P7845, DOI 10.1074/jbc.M111.315416; Subauste MC, 2010, MOL CARCINOGEN, V49, P105, DOI 10.1002/mc.20594; Tumbarello DA, 2012, NAT CELL BIOL, V14, P1024, DOI 10.1038/ncb2589; Wehner P, 2011, DEVELOPMENT, V138, P1321, DOI 10.1242/dev.056291; Wei W, 2012, MOL CELL BIOL, V32, P3903, DOI 10.1128/MCB.00251-12; Yan XH, 2009, J BIOL CHEM, V284, P30097, DOI 10.1074/jbc.M109.049304; Zhang L, 2006, J BIOL CHEM, V281, P8607, DOI 10.1074/jbc.M600274200; Zhao YW, 2015, CELL REP, V13, P1407, DOI 10.1016/j.celrep.2015.10.011	42	19	21	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 10	2016	291	24					12871	12879		10.1074/jbc.M115.708818	http://dx.doi.org/10.1074/jbc.M115.708818			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DO9PV	27129200	hybrid, Green Published			2022-12-26	WOS:000378119900037
J	Zhang, XJ; Zhao, D; Xiong, XZ; He, ZM; Li, HT				Zhang, Xiaojie; Zhao, Dan; Xiong, Xiaozhe; He, Zhimin; Li, Haitao			Multifaceted Histone H3 Methylation and Phosphorylation Readout by the Plant Homeodomain Finger of Human Nuclear Antigen Sp100C	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PHD FINGER; OXIDATIVE STRESS; INNER CENTROMERE; INFECTION; BODIES; RECOGNITION; LYSINE-4; PROTEINS; ISOFORMS; FEATURES	The decoding of histone post-translational modifications by chromatin-binding modules ("readers") constitutes one major mechanism of epigenetic regulation. Nuclear antigen Sp100 (SPECKLED, 100 kDa), a constitutive component of the promyelocytic leukemia nuclear bodies, plays key roles in intrinsic immunity and transcriptional repression. Sp100C, a splicing isoform specifically up-regulated upon interferon stimulation, harbors a unique tandem plant homeodomain (PHD) finger and bromodomain at its C terminus. Combining structural, quantitative binding, and cellular co-localization studies, we characterized Sp100C PHD finger as an unmethylated histone H3 Lys(4) (H3K4me0) reader that tolerates histone H3 Thr(3) phosphorylation (H3T3ph), histone H3 Lys(9) trimethylation (H3K9me3), and histone H3 Ser(10) phosphorylation (H3S10ph), hallmarks associated with the mitotic chromosome. In contrast, whereas H3K4me0 reader activity is conserved in Sp140, an Sp100C paralog, the multivalent tolerance of H3T3ph, H3K9me3, and H3S10ph was lost for Sp140. The complex structure determined at 2.1 angstrom revealed a highly coordinated lysine epsilon-amine recognition sphere formed by an extended N-terminal motif for H3K4me0 readout. Interestingly, reader pocket rigidification by disulfide bond formation enhanced H3K4me0 binding by Sp100C. An additional complex structure solved at 2.7 angstrom revealed that H3T3ph is recognized by the arginine residue, Arg(713), that is unique to the PHD finger of Sp100C. Consistent with a restrictive cellular role of Sp100C, these results establish a direct chromatin targeting function of Sp100C that may regulate transcriptional gene silencing and promyelocytic leukemia nuclear body-mediated intrinsic immunity in response to interferon stimulation.	[Zhang, Xiaojie; Zhao, Dan; Xiong, Xiaozhe; He, Zhimin; Li, Haitao] Tsinghua Univ, Beijing Adv Innovat Ctr Struct Biol, Minist Educ,Key Lab Prot Sci, Dept Basic Med,Sci Sch Med, Beijing 100084, Peoples R China; [Li, Haitao] Sichuan Univ, West China Hosp, Collaborat Innovat Ctr Biotherapy, Chengdu 610041, Peoples R China	Tsinghua University; Sichuan University	Li, HT (corresponding author), Tsinghua Univ, Med Sci Bldg C228, Beijing 100084, Peoples R China.	lht@tsinghua.edu.cn	Li, Haitao/B-2668-2012	Li, Haitao/0000-0001-6741-293X	Major State Basic Research Development Program in China [2015CB910503]; Tsinghua University Initiative Scientific Research Program; National Natural Science Foundation of China [91519304]	Major State Basic Research Development Program in China(National Basic Research Program of China); Tsinghua University Initiative Scientific Research Program; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by Major State Basic Research Development Program in China Grant 2015CB910503, a grant from the Tsinghua University Initiative Scientific Research Program, and National Natural Science Foundation of China Grant 91519304 (to H. L.). The authors declare that they have no conflicts of interest with the contents of this article.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Berscheminski J, 2014, J VIROL, V88, P6076, DOI 10.1128/JVI.00469-14; Bloch DB, 1996, J BIOL CHEM, V271, P29198, DOI 10.1074/jbc.271.46.29198; Casas-Mollano JA, 2008, P NATL ACAD SCI USA, V105, P6486, DOI 10.1073/pnas.0711310105; Dai J, 2005, GENE DEV, V19, P472, DOI 10.1101/gad.1267105; DeLano W. L., 2012, PYMOL MOL GRAPHICS S; Dellaire G, 2004, BIOESSAYS, V26, P963, DOI 10.1002/bies.20089; Dent AL, 1996, BLOOD, V88, P1423, DOI 10.1182/blood.V88.4.1423.bloodjournal8841423; Di Bernardo MC, 2008, NAT GENET, V40, P1204, DOI 10.1038/ng.219; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Filippakopoulos P., 2015, HISTONE RECOGNITION, P173; Flynn EM, 2015, STRUCTURE, V23, P1801, DOI 10.1016/j.str.2015.08.004; Jaenisch R, 2003, NAT GENET, V33, P245, DOI 10.1038/ng1089; Jenuwein T, 2001, SCIENCE, V293, P1074, DOI 10.1126/science.1063127; Kavouras JH, 2007, J NEUROVIROL, V13, P416, DOI 10.1080/13550280701460573; Lan F, 2007, NATURE, V448, P718, DOI 10.1038/nature06034; Li H., 2015, HISTONE RECOGNITION, P149; Li HT, 2006, NATURE, V442, P91, DOI 10.1038/nature04802; Li YY, 2012, ACTA BIOCH BIOPH SIN, V44, P28, DOI 10.1093/abbs/gmr117; Maul GG, 1995, J CELL BIOCHEM, V59, P498, DOI 10.1002/jcb.240590410; Negorev DG, 2006, J VIROL, V80, P8019, DOI 10.1128/JVI.02164-05; Negorev DG, 2009, J VIROL, V83, P5168, DOI 10.1128/JVI.02083-08; Noh KM, 2015, MOL CELL, V59, P89, DOI 10.1016/j.molcel.2015.05.017; Noh KM, 2015, P NATL ACAD SCI USA, V112, P6820, DOI 10.1073/pnas.1411258112; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Ruthenburg AJ, 2007, MOL CELL, V25, P15, DOI 10.1016/j.molcel.2006.12.014; Saare M, 2015, J IMMUNOL RES, V2015, DOI 10.1155/2015/526518; Sanchez R, 2011, TRENDS BIOCHEM SCI, V36, P364, DOI 10.1016/j.tibs.2011.03.005; Schwarz KB, 1996, FREE RADICAL BIO MED, V21, P641, DOI 10.1016/0891-5849(96)00131-1; Seeler JS, 1998, P NATL ACAD SCI USA, V95, P7316, DOI 10.1073/pnas.95.13.7316; Sille FCM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029632; SZOSTECKI C, 1990, J IMMUNOL, V145, P4338; Tanno Y, 2015, SCIENCE, V349, P1237, DOI 10.1126/science.aaa2655; Tavalai N, 2009, VIRUSES-BASEL, V1, P1240, DOI 10.3390/v1031240; Tsai WW, 2010, NATURE, V468, P927, DOI 10.1038/nature09542; Vagin A, 1997, J APPL CRYSTALLOGR, V30, P1022, DOI 10.1107/S0021889897006766; VOLKIN DB, 1993, ARCH BIOCHEM BIOPHYS, V300, P30, DOI 10.1006/abbi.1993.1005; Xi QR, 2011, CELL, V147, P1511, DOI 10.1016/j.cell.2011.11.032; Xie J, 2015, CELL, V163, P920, DOI 10.1016/j.cell.2015.10.002; Yamagishi Y, 2010, SCIENCE, V330, P239, DOI 10.1126/science.1194498; Zucchelli C, 2014, FEBS J, V281, P216, DOI 10.1111/febs.12588	42	16	16	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 10	2016	291	24					12786	12798		10.1074/jbc.M116.721159	http://dx.doi.org/10.1074/jbc.M116.721159			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DO9PV	27129259	hybrid, Green Published			2022-12-26	WOS:000378119900030
J	Burton, CA; Hoefen, TM; Plumlee, GS; Baumberger, KL; Backlin, AR; Gallegos, E; Fisher, RN				Burton, Carmen A.; Hoefen, Todd M.; Plumlee, Geoffrey S.; Baumberger, Katherine L.; Backlin, Adam R.; Gallegos, Elizabeth; Fisher, Robert N.			Trace Elements in Stormflow, Ash, and Burned Soil following the 2009 Station Fire in Southern California	PLOS ONE			English	Article							WOOD-ASH; WILDFIRE; METALS; MODEL	Most research on the effects of wildfires on stream water quality has focused on suspended sediment and nutrients in streams and water bodies, and relatively little research has examined the effects of wildfires on trace elements. The purpose of this study was two-fold: 1) to determine the effect of the 2009 Station Fire in the Angeles National Forest northeast of Los Angeles, CA on trace element concentrations in streams, and 2) compare trace elements in post-fire stormflow water quality to criteria for aquatic life to determine if trace elements reached concentrations that can harm aquatic life. Pre-storm and stormflow water-quality samples were collected in streams located inside and outside of the burn area of the Station Fire. Ash and burned soil samples were collected from several locations within the perimeter of the Station Fire. Filtered concentrations of Fe, Mn, and Hg and total concentrations of most trace elements in storm samples were elevated as a result of the Station Fire. In contrast, filtered concentrations of Cu, Pb, Ni, and Se and total concentrations of Cu were elevated primarily due to storms and not the Station Fire. Total concentrations of Se and Zn were elevated as a result of both storms and the Station Fire. Suspended sediment in storm-flows following the Station Fire was an important transport mechanism for trace elements. Cu, Pb, and Zn primarily originate from ash in the suspended sediment. Fe primarily originates from burned soil in the suspended sediment. As, Mn, and Ni originate from both ash and burned soil. Filtered concentrations of trace elements in stormwater samples affected by the Station Fire did not reach levels that were greater than criteria established for aquatic life. Total concentrations for Fe, Pb, Ni, and Zn were detected at concentrations above criteria established for aquatic life.	[Burton, Carmen A.] US Geol Survey, Calif Water Sci Ctr, San Diego, CA USA; [Hoefen, Todd M.; Plumlee, Geoffrey S.] US Geol Survey, Denver Fed Ctr, Denver, CO USA; [Baumberger, Katherine L.; Backlin, Adam R.; Gallegos, Elizabeth] US Geol Survey, Western Ecol Res Ctr, Santa Ana, CA USA; [Fisher, Robert N.] US Geol Survey, Western Ecol Res Ctr, San Diego, CA USA	United States Department of the Interior; United States Geological Survey; United States Department of the Interior; United States Geological Survey; United States Department of the Interior; United States Geological Survey; United States Department of the Interior; United States Geological Survey	Burton, CA (corresponding author), US Geol Survey, Calif Water Sci Ctr, San Diego, CA USA.	caburton@usgs.gov	Fisher, Robert/AAA-7301-2022	Fisher, Robert/0000-0002-2956-3240; Plumlee, Geoffrey/0000-0002-9607-5626	Amphibian Research and Monitoring Initiative (ARMI) Program; Mineral Resources Program of the U.S. Geological Survey	Amphibian Research and Monitoring Initiative (ARMI) Program; Mineral Resources Program of the U.S. Geological Survey	This research was supported by Amphibian Research and Monitoring Initiative (ARMI) Program and the Mineral Resources Program of the U.S. Geological Survey.	Bitner K., 2001, REV WILDFIRE EFFECTS; Bladon KD, 2014, ENVIRON SCI TECHNOL, V48, P8936, DOI 10.1021/es500130g; Blaustein AR, 2003, DIVERS DISTRIB, V9, P123, DOI 10.1046/j.1472-4642.2003.00015.x; Bodi MB, 2014, EARTH-SCI REV, V130, P103, DOI 10.1016/j.earscirev.2013.12.007; Burke MP, 2013, ENVIRON MONIT ASSESS, V185, P10131, DOI 10.1007/s10661-013-3318-9; Cornelis R, 2005, HDB ELEMENTAL SPECIA; Demeyer A, 2001, BIORESOURCE TECHNOL, V77, P287, DOI 10.1016/S0960-8524(00)00043-2; Di Toro DM, 2001, ENVIRON TOXICOL CHEM, V20, P2383, DOI 10.1002/etc.5620201034; Earl SR, 2003, FRESHWATER BIOL, V48, P1015, DOI 10.1046/j.1365-2427.2003.01066.x; Gallaher B., LA13926 LOS AL NAT L; Goforth BR, 2005, INT J WILDLAND FIRE, V14, P343, DOI 10.1071/WF05038; Gomes HI, 2015, J CLEAN PROD, P1; Hageman P, 2007, 5D3 US GEOL SURV, P14; Harden D.R., 2004, CALIFORNIA GEOLOGY; Herndon V., 1998, MINTEQA2 PRODEFA2 GE, P1; Hoefen TM, 2009, 20091038 US GEOL SUR; Homer C, 2004, PHOTOGRAMM ENG REM S, V70, P829, DOI 10.14358/PERS.70.7.829; HydroQual Inc., 2007, BIOT LIG MOD WIND IN; Leak M., 2003, WATERWORKS, V6, P38; Lefcort H, 1998, ARCH ENVIRON CON TOX, V35, P447, DOI 10.1007/s002449900401; MacDonald DD, 2000, ARCH ENVIRON CON TOX, V39, P20, DOI 10.1007/s002440010075; Meyer JS, 2002, MAR ENVIRON RES, V53, P417, DOI 10.1016/S0141-1136(01)00121-0; Moody JA, 2013, EARTH-SCI REV, V122, P10, DOI 10.1016/j.earscirev.2013.03.004; Neary D.G., 2005, RMRSGTR42 USDA FOR S, V4, DOI DOI 10.2737/RMRS-GTR-42-V4; Parkhurst D.L., 1999, USERS GUIDE PHREEQC, V99, P312, DOI DOI 10.3133/WRI994259; Persaud D., 1993, GUIDELINES PROTECTIO; Pilliod DS, 2003, FOREST ECOL MANAG, V178, P163, DOI 10.1016/S0378-1127(03)00060-4; Plumlee G., 2014, TREATISE GEOCHEMISTR, P257, DOI [DOI 10.1016/B978-0-08-095975-7.00907-4, 10.1016/B978-0-08-095975-7.00907-4]; Plumlee G.S., 2007, 20071407 US GEOL SUR; Reimann C, 1998, CHEM ELEMENTS ENV FA, DOI DOI 10.1017/S0016756800264613; Roesijadi G., 1994, P387; Rowe CL, 2001, ARCH ENVIRON CON TOX, V40, P399; Russell KR, 1999, WILDLIFE SOC B, V27, P374; Santin C, 2015, ENVIRON RES, V142, P297, DOI 10.1016/j.envres.2015.06.041; Shacklette H. T., 1984, 1270 US GEOL SURV; Smith HG, 2011, J HYDROL, V396, P170, DOI 10.1016/j.jhydrol.2010.10.043; Someshwar AV, 1996, J ENVIRON QUAL, V25, P962, DOI 10.2134/jeq1996.00472425002500050006x; Stein ED, 2009, 598 SO CAL COAST WAT; Stein ED, 2012, ENVIRON TOXICOL CHEM, V31, P2625, DOI 10.1002/etc.1994; Stumm W., 2012, AQUATIC CHEM CHEM EQ; Syphard AD, 2007, ECOL APPL, V17, P1388, DOI 10.1890/06-1128.1; TIPPING E, 1992, GEOCHIM COSMOCHIM AC, V56, P3627, DOI 10.1016/0016-7037(92)90158-F; Townsend SA, 2000, J HYDROL, V229, P118, DOI 10.1016/S0022-1694(00)00165-7; U.S. Geological Survey, TECHN WAT RES INV 9; ULERY AL, 1993, SOIL SCI, V156, P358, DOI 10.1097/00010694-199311000-00008; Unrine JM, 2007, ENVIRON POLLUT, V149, P182, DOI 10.1016/j.envpol.2007.01.039; US Environmental Protection Agency, 2007, 822R07001 US EPA; US EPA, 1996, 823896007 US EPA; US EPA US Environmental Protection Agency, 2013, NAT REC WAT QUAL CRI; USDA Forest Service, 2009, STAT FIR BURN AR EM; Verkaik I, 2013, HYDROBIOLOGIA, V719, P353, DOI 10.1007/s10750-013-1463-3; Wagner S, 2015, BIOGEOCHEMISTRY, V124, P145, DOI 10.1007/s10533-015-0088-1; Westerling AL, 2006, SCIENCE, V313, P940, DOI 10.1126/science.1128834; Yoon VK, 2008, J ENVIRON ENG, V134, P961, DOI 10.1061/(ASCE)0733-9372(2008)134:12(961)	54	47	48	4	45	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 4	2016	11	5							e0153372	10.1371/journal.pone.0153372	http://dx.doi.org/10.1371/journal.pone.0153372			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DL5KR	27144270	Green Published, gold			2022-12-26	WOS:000375676400012
J	You, XF; Wang, L; Tan, H; He, XG; Qu, XM; Shi, HJ; Zhu, JF; Zou, HD				You, Xiaofang; Wang, Ling; Tan, Hui; He, Xiangui; Qu, Xiaomei; Shi, Huijing; Zhu, Jianfeng; Zou, Haidong			Near Work Related Behaviors Associated with Myopic Shifts among Primary School Students in the Jiading District of Shanghai: A School-Based One-Year Cohort Study	PLOS ONE			English	Article							TIME SPENT OUTDOORS; REFRACTIVE ERROR; RISK-FACTORS; CHILDREN; CHINA; SCHOOLCHILDREN; DEPRIVATION; AGONIST	Purpose To investigate the characteristics of various near work related behaviors among primary students and their associations with changes in myopia related ocular biometric parameters during one-year of follow up. Methods A school-based sample of 4,814 primary 1st to 4th grade students aged 6-10 years old were selected by cluster randomization based on probability proportion to size in 2013. At baseline, students together with their parents filled in a self-administered questionnaire on 9 aspects of near work related behaviors and some important covariants of myopia. A comprehensive set of eye examinations including axial length (AL) and cycloplegic refraction was conducted both at baseline and one year later. Results With the grade level increase, students did increasingly better at finding various ways to have an eye break, but they were increasingly likely to continuously do long-time near work without an eye break. Keeping a reasonable eye distance and correct hand posture for reading, writing, or watching TV became worse for the first time before grade 2, but then became better at grade 3. In contrast, selecting appropriate lighting environments or situations and keeping a balanced diet became better for the first time before grade 2, but then became worse at grade 3. At one-year follow up, the mean AL increased by 0.32 +/- 0.35 mm, the ratio of AL divided by the mean corneal radius of curvature (AL/CR ratio) increased by 0.032 +/- 0.054, the myopic spherical equivalent (SE) increased by -0.51 +/- 0.51 diopters and the incidence of myopia was 16.0% (237/1,477). After controlling for the confounding effects of parental myopia, student's age, gender, height, daily near work time, daily outdoor activity time and all of the other near work related behaviors, keeping a reasonable distance when reading, writing and watching TV was associated with elongation of the AL [standard coefficient beta = -0.062, P = 0.004], a change in SE [beta = -0.072, P = 0.020] and incident myopia [adjusted odds ratio (aOR) = 0.90, 95% confidence interval (CI): 0.84-0.96]. Selecting an environment with adequate light for visual comfort to read and write was related to elongation of the AL [beta = -0.039, P = 0.034] and increase of AL/CR ratio [beta = -0.030, P = 0.048]. Also, not continuing to do near work for more than 30-40 minutes without an eye break was related to increase of the AL/CR ratio [beta = -0.028, P = 0.044] and a change in SE [beta = -0.064, P = 0.023]. Conclusion Various near work related behaviors changed according to grade level in primary school students. Independent of hereditary factors, daily near work load and outdoor activity, near work related behaviors such as keeping an inappropriate eye distance for near work, selecting inadequate lighting environments, and continuing to do near work without an eye break were risk factors for myopic shifts.	[You, Xiaofang; Wang, Ling; Tan, Hui; He, Xiangui; Shi, Huijing] Fudan Univ, Sch Publ Hlth, Dept Maternal & Child Hlth, Key Lab Publ Hlth Safety,Minist Educ, Shanghai 200433, Peoples R China; [He, Xiangui; Zhu, Jianfeng; Zou, Haidong] Shanghai Eye Dis Prevent & Treatment Ctr, Dept Eye Dis Prevent, Shanghai, Peoples R China; [Qu, Xiaomei] Fudan Univ, Eye & ENT Hosp, Shanghai 200433, Peoples R China	Fudan University; Fudan University	Shi, HJ (corresponding author), Fudan Univ, Sch Publ Hlth, Dept Maternal & Child Hlth, Key Lab Publ Hlth Safety,Minist Educ, Shanghai 200433, Peoples R China.	hjshi@fudan.edu.cn	Shi, Huijing/GRR-8564-2022	Zou, Haidong/0000-0002-6831-7560	Three-year Action Program of Shanghai Municipality for Strengthening the Construction of the Public Health System [2011-15]; National Natural Science Foundation of China for Young Staff [81402695]; Shanghai Municipal Health Bureau Research Projects [20134263]; Key Laboratory of the Ministry of Health in Myopia Shanghai Scientific Research Plan Project [14411969500]; Shanghai Municipal Health Bureau [12GWZX0301]	Three-year Action Program of Shanghai Municipality for Strengthening the Construction of the Public Health System; National Natural Science Foundation of China for Young Staff; Shanghai Municipal Health Bureau Research Projects; Key Laboratory of the Ministry of Health in Myopia Shanghai Scientific Research Plan Project; Shanghai Municipal Health Bureau	This study was supported by the Three-year Action Program of Shanghai Municipality for Strengthening the Construction of the Public Health System (2011-2013; Grant No. 2011-15), National Natural Science Foundation of China for Young Staff (Grant NO. 81402695), Shanghai Municipal Health Bureau Research Projects (Grant NO. 20134263), Key Laboratory of the Ministry of Health in Myopia Shanghai Scientific Research Plan Project (Grant NO. 14411969500) and the Shanghai Municipal Health Bureau (12GWZX0301).	Ashby R, 2009, INVEST OPHTH VIS SCI, V50, P5348, DOI 10.1167/iovs.09-3419; Breslin KMM, 2013, INVEST OPHTH VIS SCI, V54, P4843, DOI 10.1167/iovs.13-11813; Dolgin E, 2015, NATURE, V519, P276, DOI 10.1038/519276a; Dong F, 2011, MOL VIS, V17, P2824; Donovan L, 2012, OPTOMETRY VISION SCI, V89, P1196, DOI 10.1097/OPX.0b013e3182640996; French AN, 2013, OPHTHALMOLOGY, V120, P2100, DOI 10.1016/j.ophtha.2013.02.035; French AN, 2013, EXP EYE RES, V114, P58, DOI 10.1016/j.exer.2013.04.018; Goldschmidt E, 2014, EYE, V28, P126, DOI 10.1038/eye.2013.254; Guo Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075260; Guo Y, 2013, OPHTHALMOLOGY, V120, P277, DOI 10.1016/j.ophtha.2012.07.086; He MG, 2004, INVEST OPHTH VIS SCI, V45, P793, DOI 10.1167/iovs.03-1051; He MG, 2015, JAMA-J AM MED ASSOC, V314, P1142, DOI 10.1001/jama.2015.10803; Holden B, 2014, EYE, V28, P142, DOI 10.1038/eye.2013.256; Hua WJ, 2015, OPHTHAL PHYSL OPT, V35, P252, DOI 10.1111/opo.12207; Ip JM, 2008, INVEST OPHTH VIS SCI, V49, P2903, DOI 10.1167/iovs.07-0804; IUVONE PM, 1991, INVEST OPHTH VIS SCI, V32, P1674; Li SM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0134514; Li SM, 2013, OPHTHAL EPIDEMIOL, V20, P348, DOI 10.3109/09286586.2013.842596; Lim MCC, 2009, EYE, V23, P1086, DOI 10.1038/eye.2008.225; Lin Z, 2014, OPTOMETRY VISION SCI, V91, P376, DOI 10.1097/OPX.0000000000000219; Lu B, 2009, ARCH OPHTHALMOL-CHIC, V127, P769, DOI 10.1001/archophthalmol.2009.105; Molloy LE, 2011, DEV PSYCHOL, V47, P1589, DOI 10.1037/a0025413; Mutti DO, 2002, INVEST OPHTH VIS SCI, V43, P3633; Mutti DO, 2002, ARV ANN M ABSTR SEAR, P1512; Negrel AD, 2000, AM J OPHTHALMOL, V129, P421, DOI 10.1016/S0002-9394(99)00455-9; Pan CW, 2012, OPHTHAL PHYSL OPT, V32, P3, DOI 10.1111/j.1475-1313.2011.00884.x; Sherwin JC, 2012, OPHTHALMOLOGY, V119, P2141, DOI 10.1016/j.ophtha.2012.04.020; Tan H, 2009, CHIN J SCH HLTH, V11, P1007; Tan H., 2010, THESIS FUDAN U; Unterrainer JM, 2015, BRIT J PSYCHOL, V106, P46, DOI 10.1111/bjop.12065; Williams C, 2008, BRIT J OPHTHALMOL, V92, P723, DOI 10.1136/bjo.2007.136051; Wu LJ, 2015, INT J MED SCI, V12, P633, DOI 10.7150/ijms.12133; [杨晓 YANG Xiao], 2006, [中国实用眼科杂志, Chinese Journal of Practical Ophtahalmology], V24, P138; You QS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052668; Zhou ZQ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0121796	35	33	38	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 3	2016	11	5							e0154671	10.1371/journal.pone.0154671	http://dx.doi.org/10.1371/journal.pone.0154671			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DL5KK	27139017	Green Published, Green Submitted, gold			2022-12-26	WOS:000375675700052
J	Brighenti-Zogg, S; Mundwiler, J; Schupbach, U; Dieterle, T; Wolfer, DP; Leuppi, JD; Miedinger, D				Brighenti-Zogg, Stefanie; Mundwiler, Jonas; Schupbach, Ulla; Dieterle, Thomas; Wolfer, David Paul; Leuppi, Jorg Daniel; Miedinger, David			Physical Workload and Work Capacity across Occupational Groups	PLOS ONE			English	Article							ENERGY-EXPENDITURE; EARLY RETIREMENT; POPULATION; ADULTS; QUESTIONNAIRE; VALIDITY; OFFICE; RISK; COPD; TIME	This study aimed to determine physical performance criteria of different occupational groups by investigating physical activity and energy expenditure in healthy Swiss employees in real-life workplaces on workdays and non-working days in relation to their aerobic capacity (VO2max). In this cross-sectional study, 337 healthy and full-time employed adults were recruited. Participants were classified (nine categories) according to the International Standard Classification of Occupations 1988 and merged into three groups with low-, moderate- and high-intensity occupational activity. Daily steps, energy expenditure, metabolic equivalents and activity at different intensities were measured using the SenseWear Mini armband on seven consecutive days (23 hours/day). VO2max was determined by the 20-meter shuttle run test. Data of 303 subjects were considered for analysis (63% male, mean age: 33 yrs, SD 12), 101 from the low-, 102 from the moderate-and 100 from the high-intensity group. At work, the high-intensity group showed higher energy expenditure, metabolic equivalents, steps and activity at all intensities than the other groups (p<0.001). There were no significant differences in physical activity between the occupational groups on non-working days. VO2max did not differ across groups when stratified for gender. The upper workload limit was 21%, 29% and 44% of VO2max in the low-, moderate-and high-intensity group, respectively. Men had a lower limit than women due to their higher VO2max (26% vs. 37%), when all groups were combined. While this study did confirm that the average workload limit is one third of VO2max, it showed that the average is misrepresenting the actual physical work demands of specific occupational groups, and that it does not account for gender-related differences in relative workload. Therefore, clinical practice needs to consider these differences with regard to a safe return to work, particularly for the high-intensity group.	[Brighenti-Zogg, Stefanie; Mundwiler, Jonas; Schupbach, Ulla; Dieterle, Thomas; Leuppi, Jorg Daniel] Cantonal Hosp Baselland, Univ Clin Internal Med, Liestal, Switzerland; [Brighenti-Zogg, Stefanie; Wolfer, David Paul] ETH, Dept Hlth Sci & Technol, Zurich, Switzerland; [Mundwiler, Jonas] Univ Basel, Dept Sport Exercise & Hlth, Basel, Switzerland; [Dieterle, Thomas; Leuppi, Jorg Daniel; Miedinger, David] Univ Basel, Fac Med, Basel, Switzerland; [Wolfer, David Paul] Univ Zurich, Inst Anat, Zurich, Switzerland; [Miedinger, David] Swiss Natl Accid Insurance Fund, Dept Occupat Med, Luzern, Switzerland	Kantonsspital Baselland; ETH Zurich; University of Basel; University of Basel; University of Geneva; University of Zurich	Brighenti-Zogg, S (corresponding author), Cantonal Hosp Baselland, Univ Clin Internal Med, Liestal, Switzerland.; Brighenti-Zogg, S (corresponding author), ETH, Dept Hlth Sci & Technol, Zurich, Switzerland.	stefanie.brighenti@ksbl.ch	Leuppi, Jörg/W-6798-2019; Dieterle, Thomas/CAA-2532-2022; Dieterle, Thomas/AAG-3619-2019; Wolfer, David P/B-3293-2016	Wolfer, David P/0000-0002-5957-1401; Dieterle, Thomas/0000-0002-3740-1903	Swiss National Accident Insurance Fund (Suva); Suva	Swiss National Accident Insurance Fund (Suva)(Swiss National Science Foundation (SNSF)); Suva	This study was financially supported by an unrestricted grant of the Swiss National Accident Insurance Fund (Suva). Grant number: not applicable. URL: http://www.suva.ch. Recipient: JDL. The funder (Suva) provided support in the form of a project grant that covered salaries for the involved personnel at the Cantonal Hospital Baselland Liestal as well as expenses for infrastructure and conducting the study, but did not have any role in the study design, data collection and analysis, decision to publish, or preparation of this manuscript. The participation of DM in the study was independent from the project grant and is covered by the contractual agreement between Suva and DM that permits active participation in independently conducted research projects. The specific role of each author is articulated in the 'author contributions' section.	Ainsworth BE, 2011, MED SCI SPORT EXER, V43, P1575, DOI 10.1249/MSS.0b013e31821ece12; Bassett DR, 2012, PHYSIOL MEAS, V33, P1769, DOI 10.1088/0967-3334/33/11/1769; Bauman A, 2009, INT J BEHAV NUTR PHY, V6, DOI 10.1186/1479-5868-6-21; Bos J, 2002, OCCUP ENVIRON MED, V59, P800, DOI 10.1136/oem.59.12.800; Bradshaw DI, 2005, RES Q EXERCISE SPORT, V76, P426; Cooper CB, 2001, EXERCISE TESTING INT, P57; Craig CL, 2003, MED SCI SPORT EXER, V35, P1381, DOI 10.1249/01.MSS.0000078924.61453.FB; Duncan MJ, 2010, J PHYS ACT HEALTH, V7, P718, DOI 10.1123/jpah.7.6.718; Federal Office of Social Insurances, STAT SOC SEC 4 STAT; Field A., 2009, DISCOVERING STAT USI, P26; Hagstromer M, 2010, J PHYS ACT HEALTH, V7, P541, DOI 10.1123/jpah.7.4.541; ILMARINEN J, 1992, SCAND J WORK ENV HEA, V18, P8; International Labour Organization, 1988, INT STAND CLASS OCC; International Physical Activity Questionnaire, GUID DAT PROC AN INT; Jang TW, 2012, TOHOKU J EXP MED, V227, P313, DOI 10.1620/tjem.227.313; Janssen I, 2000, J APPL PHYSIOL, V89, P81; Johannsen DL, 2010, MED SCI SPORT EXER, V42, P2134, DOI 10.1249/MSS.0b013e3181e0b3ff; JORGENSEN K, 1985, ERGONOMICS, V28, P365, DOI 10.1080/00140138508963145; Karpansalo M, 2002, J OCCUP ENVIRON MED, V44, P930, DOI 10.1097/00043764-200210000-00012; Kelloway E K, 1998, Womens Health, V4, P1; Leger L, 1989, CANJ SPORT SCI, V14, P21; Leger LA, 1988, J SPORT SCI, V6, P93, DOI 10.1080/02640418808729800; Miller R, 2004, INT J BEHAV MED, V11, P219, DOI 10.1207/s15327558ijbm1104_5; Parry S, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-296; Pitta F, 2008, RESP MED, V102, P1203, DOI 10.1016/j.rmed.2008.03.004; Scheers T, 2012, EUR J APPL PHYSIOL, V112, P1653, DOI 10.1007/s00421-011-2131-9; SEQUEIRA MM, 1995, AM J EPIDEMIOL, V142, P989, DOI 10.1093/oxfordjournals.aje.a117748; Soer R, 2008, J OCCUP REHABIL, V18, P389, DOI 10.1007/s10926-008-9155-y; Soer R, 2009, ARCH PHYS MED REHAB, V90, P1785, DOI 10.1016/j.apmr.2009.05.008; Steele R, 2003, J SCI MED SPORT, V6, P398, DOI 10.1016/S1440-2440(03)80266-9; Swiss Federal Statistical Office, SWISS HLTH SURV 2012; Swiss Federal Statistical Office, SWISS LAB FORC SURV; Thorp AA, 2012, INT J BEHAV NUTR PHY, V9, DOI 10.1186/1479-5868-9-128; Tigbe WW, 2011, PREV MED, V53, P48, DOI 10.1016/j.ypmed.2011.04.018; Tudor-Locke C, 2013, APPL PHYSIOL NUTR ME, V38, P100, DOI 10.1139/apnm-2012-0235; US Department of Labour, 1991, DICT OCC TITL, P95; Watz H, 2009, EUR RESPIR J, V33, P262, DOI 10.1183/09031936.00024608; Wetten AA, 2014, J PHYS ACT HEALTH, V11, P638, DOI 10.1123/jpah.2011-0167; Wu HC, 2002, ERGONOMICS, V45, P280, DOI 10.1080/00140130210123499; Wultsch G, 2012, SCAND J WORK ENV HEA, V38, P370, DOI 10.5271/sjweh.3195	40	21	21	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 2	2016	11	5							e0154073	10.1371/journal.pone.0154073	http://dx.doi.org/10.1371/journal.pone.0154073			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DL5KB	27136206	gold, Green Published, Green Submitted, Green Accepted			2022-12-26	WOS:000375674800011
J	Chater-Diehl, EJ; Laufer, BI; Castellani, CA; Alberry, BL; Singh, SM				Chater-Diehl, Eric J.; Laufer, Benjamin I.; Castellani, Christina A.; Alberry, Bonnie L.; Singh, Shiva M.			Alteration of Gene Expression, DNA Methylation, and Histone Methylation in Free Radical Scavenging Networks in Adult Mouse Hippocampus following Fetal Alcohol Exposure	PLOS ONE			English	Article							HEPATIC METHIONINE METABOLISM; OXIDATIVE STRESS; CHOLINE SUPPLEMENTATION; ETHANOL EXPOSURE; BRAIN; MICE; DISORDERS; PROTEIN; MODEL; NEURODEGENERATION	The molecular basis of Fetal Alcohol Spectrum Disorders (FASD) is poorly understood; however, epigenetic and gene expression changes have been implicated. We have developed a mouse model of FASD characterized by learning and memory impairment and persistent gene expression changes. Epigenetic marks may maintain expression changes over a mouse's lifetime, an area few have explored. Here, mice were injected with saline or ethanol on postnatal days four and seven. At 70 days of age gene expression microarray, methylated DNA immunoprecipitation microarray, H3K4me3 and H3K27me3 chromatin immunoprecipitation microarray were performed. Following extensive pathway analysis of the affected genes, we identified the top affected gene expression pathway as "Free radical scavenging". We confirmed six of these changes by droplet digital PCR including the caspase Casp3 and Wnt transcription factor Tcf7l2. The top pathway for all methylation-affected genes was "Peroxisome biogenesis"; we confirmed differential DNA methylation in the Acca1 thiolase promoter. Altered methylation and gene expression in oxidative stress pathways in the adult hippocampus suggests a novel interface between epigenetic and oxidative stress mechanisms in FASD.	[Chater-Diehl, Eric J.; Laufer, Benjamin I.; Castellani, Christina A.; Alberry, Bonnie L.; Singh, Shiva M.] Univ Western Ontario, Dept Biol, Mol Genet Unit, London, ON, Canada	Western University (University of Western Ontario)	Singh, SM (corresponding author), Univ Western Ontario, Dept Biol, Mol Genet Unit, London, ON, Canada.	ssingh@uwo.ca	Alberry, Bonnie/H-6135-2019; Laufer, Ben/N-3553-2013	Alberry, Bonnie/0000-0003-1713-821X; Laufer, Ben/0000-0002-7558-1335; Castellani, Christina/0000-0003-2737-0549; Chater-Diehl, Eric/0000-0003-2587-5893	Natural Science and Engineering Research Council of Canada [R2258A01]	Natural Science and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC))	Support was provided by the Natural Science and Engineering Research Council of Canada grant number R2258A01 [http://www.nserc-crsng.gc.ca/index_eng.asp].	Bannister AJ, 2011, CELL RES, V21, P381, DOI 10.1038/cr.2011.22; Barak AJ, 1996, ALCOHOL, V13, P483, DOI 10.1016/0741-8329(96)00040-7; Barski A, 2007, CELL, V129, P823, DOI 10.1016/j.cell.2007.05.009; Bekdash RA, 2013, ALCOHOL CLIN EXP RES, V37, P1133, DOI 10.1111/acer.12082; Berman RE, 2000, HIPPOCAMPUS, V10, P94, DOI 10.1002/(SICI)1098-1063(2000)10:1<94::AID-HIPO11>3.3.CO;2-K; Brocardo PS, 2011, BRAIN RES REV, V67, P209, DOI 10.1016/j.brainresrev.2011.02.001; Butcher LM, 2010, METHODS, V52, P223, DOI 10.1016/j.ymeth.2010.04.003; Cedar H, 2012, ANNU REV BIOCHEM, V81, P97, DOI 10.1146/annurev-biochem-052610-091920; Chen EY, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-128; Chen YY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060503; Chudley AE, 2005, CAN MED ASSOC J, V172, pS1, DOI 10.1503/cmaj.1040302; Deller T, 2003, P NATL ACAD SCI USA, V100, P10494, DOI 10.1073/pnas.1832384100; Dembele K, 2006, AM J PHYSIOL-REG I, V291, pR796, DOI 10.1152/ajpregu.00633.2005; DOBBING J, 1979, EARLY HUM DEV, V3, P79, DOI 10.1016/0378-3782(79)90022-7; Fortin M, 2016, ALCOHOL ALCOHOLISM, V51, P339, DOI 10.1093/alcalc/agv112; Fowler AK, 2012, J BIOL CHEM, V287, P43533, DOI 10.1074/jbc.M112.401497; Goodlett CR, 2005, EXP BIOL MED, V230, P394, DOI 10.1177/15353702-0323006-07; Guo JU, 2014, NAT NEUROSCI, V17, P215, DOI 10.1038/nn.3607; Halsted CH, 2002, P NATL ACAD SCI USA, V99, P10072, DOI 10.1073/pnas.112336399; Haorah J, 2008, GLIA, V56, P78, DOI 10.1002/glia.20596; Hellemans KGC, 2010, NEUROSCI BIOBEHAV R, V34, P791, DOI 10.1016/j.neubiorev.2009.06.004; Hellemans KGC, 2008, ANN NY ACAD SCI, V1144, P154, DOI 10.1196/annals.1418.016; Ikonomidou C, 2000, SCIENCE, V287, P1056, DOI 10.1126/science.287.5455.1056; Irizarry RA, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng015; Johnson WE, 2006, P NATL ACAD SCI USA, V103, P12457, DOI 10.1073/pnas.0601180103; Kaminen-Ahola N, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000811; Kleiber ML, 2014, DEV NEUROSCI-BASEL, V36, P499, DOI 10.1159/000365549; Kleiber ML, 2013, J NEURODEV DISORD, V5, DOI 10.1186/1866-1955-5-6; Kleiber ML, 2012, BRAIN RES, V1458, P18, DOI 10.1016/j.brainres.2012.04.016; Knezovich Jaysen Gregory, 2012, Frontiers in Genetics, V3, P10, DOI 10.3389/fgene.2012.00010; Laufer BI, 2015, EPIGENOMICS-UK, V7, P1259, DOI 10.2217/epi.15.60; Laufer BI, 2013, DIS MODEL MECH, V6, P977, DOI 10.1242/dmm.010975; Lefebvre JL, 2012, NATURE, V488, P517, DOI 10.1038/nature11305; Lim AM, 2014, CLIN EPIGENETICS, V6, DOI 10.1186/1868-7083-6-22; Liu YL, 2009, EPIGENETICS-US, V4, P500, DOI 10.4161/epi.4.7.9925; Logan-Garbisch T, 2015, G3-GENES GENOM GENET, V5, P49, DOI 10.1534/g3.114.015040; Lynch MA, 2004, PHYSIOL REV, V84, P87, DOI 10.1152/physrev.00014.2003; Mansouri A, 2001, J PHARMACOL EXP THER, V298, P737; Mantha K., 2013, J BEHAV BRAIN SCI, V03, P85, DOI [10.4236/jbbs.2013.31009., DOI 10.4236/JBBS.2013.31009]; Mundel P, 1997, J CELL BIOL, V139, P193, DOI 10.1083/jcb.139.1.193; Ngai YF, 2015, AM J PHYSIOL-REG I, V309, pR613, DOI 10.1152/ajpregu.00075.2015; Nguyen T, 2009, J BIOL CHEM, V284, P13291, DOI 10.1074/jbc.R900010200; Oliva CA, 2013, FRONT CELL NEUROSCI, V7, DOI 10.3389/fncel.2013.00224; Otero NKH, 2012, ALCOHOL CLIN EXP RES, V36, P1701, DOI 10.1111/j.1530-0277.2012.01784.x; Samudio-Ruiz SL, 2010, ALCOHOL CLIN EXP RES, V34, P342, DOI 10.1111/j.1530-0277.2009.01096.x; SHAW S, 1989, FREE RADICAL BIO MED, V7, P541, DOI 10.1016/0891-5849(89)90030-0; Shioda Seiji, 2000, Acta Anatomica Nipponica, V75, P487; Spijker S, 2011, NEUROMETHODS, V57, P13, DOI 10.1007/978-1-61779-111-6_2; Tamura S, 2014, J BIOL CHEM, V289, P24336, DOI 10.1074/jbc.M114.588038; Thu CA, 2014, CELL, V158, P1045, DOI 10.1016/j.cell.2014.07.012; Trompier D, 2014, BIOCHIMIE, V98, P102, DOI 10.1016/j.biochi.2013.09.009; Ueda S, 1998, J IMMUNOL, V161, P6689; Veazey KJ, 2013, ALCOHOL CLIN EXP RES, V37, P1111, DOI 10.1111/acer.12080; Vincent SR, 2010, PROG NEUROBIOL, V90, P246, DOI 10.1016/j.pneurobio.2009.10.007; Wallace DC, 2010, MITOCHONDRION, V10, P12, DOI 10.1016/j.mito.2009.09.006; Wilmot B, 2016, J CHILD PSYCHOL PSYC, V57, P152, DOI 10.1111/jcpp.12457; Wozniak DF, 2004, NEUROBIOL DIS, V17, P403, DOI 10.1016/j.nbd.2004.08.006; Wu DF, 2003, ALCOHOL RES HEALTH, V27, P277; Zmienko A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118226	59	35	38	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 2	2016	11	5							e0154836	10.1371/journal.pone.0154836	http://dx.doi.org/10.1371/journal.pone.0154836			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DL5KB	27136348	gold, Green Submitted, Green Published			2022-12-26	WOS:000375674800052
J	Bakhlanova, IV; Dudkina, AV; Wood, EA; Lanzov, VA; Cox, MM; Baitin, DM				Bakhlanova, Irina V.; Dudkina, Alexandra V.; Wood, Elizabeth A.; Lanzov, Vladislav A.; Cox, Michael M.; Baitin, Dmitry M.			DNA Metabolism in Balance: Rapid Loss of a RecA-Based Hyperrec Phenotype	PLOS ONE			English	Article							SINGLE-STRANDED-DNA; PLASMID COPY NUMBER; ESCHERICHIA-COLI; IONIZING-RADIATION; HOMOLOGOUS RECOMBINATION; MEIOTIC RECOMBINATION; SOS RESPONSE; IN-VITRO; PROTEIN; REPLICATION	The RecA recombinase of Escherichia coli has not evolved to optimally promote DNA pairing and strand exchange, the key processes of recombinational DNA repair. Instead, the recombinase function of RecA protein represents an evolutionary compromise between necessary levels of recombinational DNA repair and the potentially deleterious consequences of RecA functionality. A RecA variant, RecA D112R, promotes conjugational recombination at substantially enhanced levels. However, expression of the D112R RecA protein in E. coli results in a reduction in cell growth rates. This report documents the consequences of the substantial selective pressure associated with the RecA-mediated hyperrec phenotype. With continuous growth, the deleterious effects of RecA D112R, along with the observed enhancements in conjugational recombination, are lost over the course of 70 cell generations. The suppression reflects a decline in RecA D112R expression, associated primarily with a deletion in the gene promoter or chromosomal mutations that decrease plasmid copy number. The deleterious effects of RecA D112R on cell growth can also be negated by over-expression of the RecX protein from Neisseria gonorrhoeae. The effects of the RecX proteins in vivo parallel the effects of the same proteins on RecA D112R filaments in vitro. The results indicate that the toxicity of RecA D112R is due to its persistent binding to duplex genomic DNA, creating barriers for other processes in DNA metabolism. A substantial selective pressure is generated to suppress the resulting barrier to growth.	[Bakhlanova, Irina V.; Dudkina, Alexandra V.; Lanzov, Vladislav A.; Baitin, Dmitry M.] NRC Kurchatov Inst, Petersburg Nucl Phys Inst, Gatchina 188300, Russia; [Bakhlanova, Irina V.; Baitin, Dmitry M.] Peter Great St Petersburg Polytech Univ, St Petersburg 195251, Russia; [Wood, Elizabeth A.; Cox, Michael M.] Univ Wisconsin, Dept Biochem, Madison, WI 53706 USA	National Research Centre - Kurchatov Institute; Petersburg Nuclear Physics Institute; Peter the Great St. Petersburg Polytechnic University; University of Wisconsin System; University of Wisconsin Madison	Baitin, DM (corresponding author), NRC Kurchatov Inst, Petersburg Nucl Phys Inst, Gatchina 188300, Russia.; Baitin, DM (corresponding author), Peter Great St Petersburg Polytech Univ, St Petersburg 195251, Russia.; Cox, MM (corresponding author), Univ Wisconsin, Dept Biochem, Madison, WI 53706 USA.	cox@biochem.wisc.edu; dimabaytin@yahoo.com	Baitin, Dmitry/G-1900-2014	Baitin, Dmitry/0000-0003-0022-1084	Russian Science Foundation [14-34-00023]; Russian Foundation for Basic Research [14-04-00817 A]; National Institutes of General Medical Sciences (USA) [GM32335]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U01GM032335, R01GM032335] Funding Source: NIH RePORTER	Russian Science Foundation(Russian Science Foundation (RSF)); Russian Foundation for Basic Research(Russian Foundation for Basic Research (RFBR)); National Institutes of General Medical Sciences (USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The work was carried out with financial support from the Russian Science Foundation (grant no. 14-34-00023 to Dmitry Baitin and Irina Bakhlanova, partly RecA biochemistry; http://rscf.ru/en/proposals-en), the Russian Foundation for Basic Research (grant 14-04-00817 A to Irina Bakhlanova, FRE data; http://www.rfbr.ru/rffi/eng), and the National Institutes of General Medical Sciences (USA) grant GM32335 (to MMC; https://www.nigms.nih.gov/Pages/default.aspx). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anand SP, 2007, J BACTERIOL, V189, P4502, DOI 10.1128/JB.00376-07; Arnold DA, 2000, J BIOL CHEM, V275, P12261, DOI 10.1074/jbc.275.16.12261; BAILONE A, 1995, J CELL BIOCHEM, P346; Baitin DM, 2006, J BACTERIOL, V188, P5812, DOI 10.1128/JB.00358-06; Bakhlanova IV, 2010, MOL MICROBIOL, V78, P1523, DOI 10.1111/j.1365-2958.2010.07424.x; Bakhlanova IV, 2001, GENETICS, V159, P7; Baudat F, 2013, NAT REV GENET, V14, P794, DOI 10.1038/nrg3573; Bierne H, 1997, MOL MICROBIOL, V26, P557, DOI 10.1046/j.1365-2958.1997.6011973.x; Blattner FR, 1997, SCIENCE, V277, P1453, DOI 10.1126/science.277.5331.1453; Bork JM, 2001, EMBO J, V20, P7313, DOI 10.1093/emboj/20.24.7313; Breed RS, 1916, J BACTERIOL, V1, P321, DOI 10.1128/JB.1.3.321-331.1916; Byrne RT, 2014, ELIFE, V3, DOI 10.7554/eLife.01322; Centore RC, 2007, J BACTERIOL, V189, P2915, DOI 10.1128/JB.01777-06; Centore RC, 2009, J BACTERIOL, V191, P1429, DOI 10.1128/JB.01415-08; Churchill JJ, 2000, J MOL BIOL, V297, P537, DOI 10.1006/jmbi.2000.3590; Cox JM, 2008, J BIOL CHEM, V283, P24909, DOI 10.1074/jbc.M803934200; Cox Michael M., 2005, P369; Cox MM, 2007, CRIT REV BIOCHEM MOL, V42, P41, DOI 10.1080/10409230701260258; Cox MM, 2007, NAT REV MOL CELL BIO, V8, P127, DOI 10.1038/nrm2099; Cox MM, 2001, ANNU REV GENET, V35, P53, DOI 10.1146/annurev.genet.35.102401.090016; Cox MM, 2000, NATURE, V404, P37, DOI 10.1038/35003501; Cox MM, 2000, PROG NUCLEIC ACID RE, V63, P311, DOI 10.1016/S0079-6603(08)60726-6; Cox MM, 2001, P NATL ACAD SCI USA, V98, P8173, DOI 10.1073/pnas.131004998; CRAIG NL, 1981, J BIOL CHEM, V256, P8039; Daley JM, ADV EXPT MED BIOL, V9732013, P185; Drees JC, 2004, MOL CELL, V15, P789, DOI 10.1016/j.molcel.2004.08.026; Eggler AL, 2003, J BIOL CHEM, V278, P16389, DOI 10.1074/jbc.M212920200; Eldin S, 2000, J MOL BIOL, V299, P91, DOI 10.1006/jmbi.2000.3721; Flores MJ, 2005, MOL MICROBIOL, V57, P1664, DOI 10.1111/j.1365-2958.2005.04753.x; Galkin VE, 2011, J MOL BIOL, V408, P815, DOI 10.1016/j.jmb.2011.03.046; Galletto R, 2007, CURR BIOL, V17, pR395, DOI 10.1016/j.cub.2007.03.009; Gruenig MC, 2010, J BIOL CHEM, V285, P37188, DOI 10.1074/jbc.M110.171967; Hager JE, 2014, GENOME STABILITY: DNA REPAIR AND RECOMBINATION, P1; Handa N, 2009, GENE DEV, V23, P1234, DOI 10.1101/gad.1780709; Harris DR, 2009, J BACTERIOL, V191, P5240, DOI 10.1128/JB.00502-09; Heyer WD, ANN REV GENET, V44, P113; Hobbs MD, 2007, J BIOL CHEM, V282, P11058, DOI 10.1074/jbc.M611007200; Holthausen JT, 2010, DNA REPAIR, V9, P1264, DOI 10.1016/j.dnarep.2010.09.014; ILIAKIS G, 1991, BIOESSAYS, V13, P641; Kim T, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005278; KOWALCZYKOWSKI SC, 1994, ANNU REV BIOCHEM, V63, P991, DOI 10.1146/annurev.biochem.63.1.991; Kowalczykowski SC, 2000, TRENDS BIOCHEM SCI, V25, P156, DOI 10.1016/S0968-0004(00)01569-3; Krejci L, 2012, NUCLEIC ACIDS RES, V40, P5795, DOI 10.1093/nar/gks270; KUZMINOV A, 1995, J THEOR BIOL, V177, P29, DOI 10.1006/jtbi.1995.0222; Kuzminov A, 2001, P NATL ACAD SCI USA, V98, P8241, DOI 10.1073/pnas.131009198; Kuzminov A, 2001, P NATL ACAD SCI USA, V98, P8461, DOI 10.1073/pnas.151260698; Lanzov VA, 2003, GENETICS, V163, P1243; LENSKI RE, 1991, AM NAT, V138, P1315, DOI 10.1086/285289; Lestini R, 2007, EMBO J, V26, P3804, DOI 10.1038/sj.emboj.7601804; LINDSLEY JE, 1990, J BIOL CHEM, V265, P9043; LINN S, 1987, J CELL SCI, P289; Logan KM, 2001, BIOCHEMISTRY-US, V40, P11382, DOI 10.1021/bi011081u; LOHMAN TM, 1986, BIOCHEMISTRY-US, V25, P21, DOI 10.1021/bi00349a004; LOPILATO J, 1986, MOL GEN GENET, V205, P285, DOI 10.1007/BF00430440; Lusetti SL, 2004, J BIOL CHEM, V279, P55073, DOI 10.1074/jbc.M410371200; Lusetti SL, 2004, J BIOL CHEM, V279, P30037, DOI 10.1074/jbc.M403064200; Lusetti SL, 2003, J BIOL CHEM, V278, P16381, DOI 10.1074/jbc.M212916200; Lusetti SL, 2003, J BIOL CHEM, V278, P16372, DOI 10.1074/jbc.M212917200; MARCH JB, 1989, MOL MICROBIOL, V3, P903, DOI 10.1111/j.1365-2958.1989.tb00239.x; Marsin S, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000146; MASTERS M, 1993, J BACTERIOL, V175, P4405, DOI 10.1128/JB.175.14.4405-4413.1993; Michel B, 2000, TRENDS BIOCHEM SCI, V25, P173, DOI 10.1016/S0968-0004(00)01560-7; Michel B, 2007, DNA REPAIR, V6, P967, DOI 10.1016/j.dnarep.2007.02.016; Miller J.H., 1992, SHORT COURSE BACTERI, P150; Morimatsu K, 2012, J BIOL CHEM, V287, P35621, DOI 10.1074/jbc.M112.397034; MORRICAL SW, 1986, BIOCHEMISTRY-US, V25, P1482, DOI 10.1021/bi00355a003; Mortier-Barriere I, 2007, CELL, V130, P824, DOI 10.1016/j.cell.2007.07.038; Pages V, 2003, DNA REPAIR, V2, P273, DOI 10.1016/S1568-7864(02)00217-3; PARK EM, 1992, P NATL ACAD SCI USA, V89, P3375, DOI 10.1073/pnas.89.8.3375; Park J, 2010, CELL, V142, P544, DOI 10.1016/j.cell.2010.07.016; Patel M, 2010, CRIT REV BIOCHEM MOL, V45, P171, DOI 10.3109/10409238.2010.480968; Petranovic M, 2001, BIOCHIMIE, V83, P1041, DOI 10.1016/S0300-9084(01)01346-3; Petrova V, 2015, NUCLEIC ACIDS RES, V43, P4133, DOI 10.1093/nar/gkv186; Petrova V, 2010, J BIOL CHEM, V285, P30615, DOI 10.1074/jbc.M110.152298; Petrova V, 2009, MOL CELL, V36, P121, DOI 10.1016/j.molcel.2009.07.026; Piechura JR, 2015, DNA REPAIR, V26, P30, DOI 10.1016/j.dnarep.2014.12.001; PUGH BF, 1988, J MOL BIOL, V203, P479, DOI 10.1016/0022-2836(88)90014-9; PUGH BF, 1987, J BIOL CHEM, V262, P1326; Ragone S, 2008, EMBO J, V27, P2259, DOI 10.1038/emboj.2008.145; RESNICK MA, 1978, J THEOR BIOL, V71, P339, DOI 10.1016/0022-5193(78)90164-9; RICHTER C, 1988, P NATL ACAD SCI USA, V85, P6465, DOI 10.1073/pnas.85.17.6465; Sakai A, 2009, J BIOL CHEM, V284, P3264, DOI 10.1074/jbc.M807220200; Sarkar N, 2002, MOL GENET GENOMICS, V268, P62, DOI 10.1007/s00438-002-0723-0; Sehorn MG, 2004, CELL CYCLE, V3, P1375, DOI 10.4161/cc.3.11.1364; Shan Q, 1996, J BIOL CHEM, V271, P5712, DOI 10.1074/jbc.271.10.5712; Shvetsov AV, 2014, FEBS LETT, V588, P948, DOI 10.1016/j.febslet.2014.01.053; Smeets LC, 2006, FEMS MICROBIOL LETT, V263, P223, DOI 10.1111/j.1574-6968.2006.00423.x; Sommer S, 1998, MOL MICROBIOL, V28, P281, DOI 10.1046/j.1365-2958.1998.00803.x; Spies M, 2006, MOL CELL, V21, P573, DOI 10.1016/j.molcel.2006.01.007; Stohl EA, 2003, J BIOL CHEM, V278, P2278, DOI 10.1074/jbc.M210496200; Tadesse S, 2007, BMC MICROBIOL, V7, DOI 10.1186/1471-2180-7-105; UMEZU K, 1993, P NATL ACAD SCI USA, V90, P3875, DOI 10.1073/pnas.90.9.3875; Uranga LA, 2011, J BIOL CHEM, V286, P29480, DOI 10.1074/jbc.M111.245373; Veaute X, 2005, EMBO J, V24, P180, DOI 10.1038/sj.emboj.7600485; WALEH NS, 1979, J BACTERIOL, V137, P830, DOI 10.1128/JB.137.2.830-838.1979; Webb BL, 1997, CELL, V91, P347, DOI 10.1016/S0092-8674(00)80418-3	96	4	4	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 28	2016	11	4							e0154137	10.1371/journal.pone.0154137	http://dx.doi.org/10.1371/journal.pone.0154137			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DK8XE	27124470	gold, Green Submitted, Green Published			2022-12-26	WOS:000375211700049
J	Fujita, G; Azuma, A; Nonaka, J; Sakai, Y; Sakai, H; Iseki, F; Itaya, H; Fukasawa, K; Miyashita, T				Fujita, Go; Azuma, Atsuki; Nonaka, Jun; Sakai, Yoshiaki; Sakai, Hatsumi; Iseki, Fumitaka; Itaya, Hiroo; Fukasawa, Keita; Miyashita, Tadashi			Context Dependent Effect of Landscape on the Occurrence of an Apex Predator across Different Climate Regions	PLOS ONE			English	Article							SPECIES DISTRIBUTION; HABITAT SUITABILITY; DISTRIBUTION MODELS; BUTASTUR-INDICUS; TRANSFERABILITY; CONSERVATION; JAPAN; MANAGEMENT; DENSITIES; BUZZARDS	In studies of habitat suitability at landscape scales, transferability of species-landscape associations among sites are likely to be critical because it is often impractical to collect datasets across various regions. However, limiting factors, such as prey availability, are not likely to be constant across scales because of the differences in species pools. This is particularly true for top predators that are often the target for conservation concern. Here we focus on gray-faced buzzards, apex predators of farmland-dominated landscapes in East Asia. We investigated context dependency of "buzzard-landscape relationship", using nest location datasets from five sites, each differing in landscape composition. Based on the similarities of prey items and landscape compositions across the sites, we determined several alternative ways of grouping the sites, and then examined whether buzzard-landscape relationship change among groups, which was conducted separately for each way of grouping. As a result, the model of study-sites grouping based on similarities in prey items showed the smallest Delta AICc. Because the terms of interaction between group IDs and areas of broad-leaved forests and grasslands were selected, buzzard-landscape relationship showed a context dependency, i. e., these two landscape elements strengthen the relationship in southern region. The difference in prey fauna, which is associated with the difference in climate, might generate regional differences in the buzzard-landscape associations.	[Fujita, Go; Miyashita, Tadashi] Univ Tokyo, Sch Agr & Life Sci, Lab Biodivers Sci, Bunkyo Ku, Yayoi 1-1-1, Tokyo 1138656, Japan; [Azuma, Atsuki] Iwate Univ, Fac Agr Environm Sci Sustainabil, Ueda 3-18-8, Morioka, Iwate 0208550, Japan; [Nonaka, Jun] Goshawk Protect Fund, Hanawada 2-5-1, Utsunomiya, Tochigi 3200027, Japan; [Sakai, Yoshiaki; Sakai, Hatsumi] Assoc Gray Faced Buzzards Inzai, Kigari 3-9-1, Inzai City, Chiba 2701359, Japan; [Iseki, Fumitaka] Inst Endangered Species, Sadanomi 750-2, Oita 8790122, Japan; [Itaya, Hiroo] Ryokusei Kenkyujo, Kojimacho 2-40-10, Chofu, Tokyo 1820026, Japan; [Fukasawa, Keita] Natl Inst Environm Studies, Onogawa 16-2, Tsukuba, Ibaraki 3050053, Japan	University of Tokyo; Iwate University; National Institute for Environmental Studies - Japan	Fujita, G (corresponding author), Univ Tokyo, Sch Agr & Life Sci, Lab Biodivers Sci, Bunkyo Ku, Yayoi 1-1-1, Tokyo 1138656, Japan.	go@es.a.u-tokyo.ac.jp	Fukasawa, Keita/AAH-1395-2019		Japan Society for the Promotion of Science (JSPS) KAKENHI [23241077]; Ryokusei Kenkyujo Inc.; JSPS KAKENHI [23241077]; Ryokusei Kenkyujo Inc	Japan Society for the Promotion of Science (JSPS) KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Ryokusei Kenkyujo Inc.; JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Ryokusei Kenkyujo Inc	Funded by Japan Society for the Promotion of Science (JSPS) KAKENHI (grant number 23241077). Ryokusei Kenkyujo Inc. provided support in the form of salaries for author HI, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.; Aichi Public Enterprise Bureau of Aichi Prefectural Government permitted to use nest location data of gray-faced buzzards in Aichi. Koji Ohata and Mutsuyuki Ueta helped us to use the datasets. The study was financially supported by JSPS KAKENHI (grant number 23241077). Though an author of the present paper, HI, is employed by a commercial company, Ryokusei Kenkyujo Inc, we confirmed that this does not alter our adherence to PLOS ONE policies on sharing data and materials. The funder provided support in the form of salaries for author HI, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Araujo MB, 2012, ECOLOGY, V93, P1527, DOI 10.1890/11-1930.1; Azuma A., 1998, ENV INF SCI, V12, P239; Azuma A., 1999, J RURAL PLAN ASS, V18, P253; Boyce MS, 1999, TRENDS ECOL EVOL, V14, P268, DOI 10.1016/S0169-5347(99)01593-1; Burnham K.P., 1998, MODEL SELECTION INFE, DOI [10.1007/978-1-4757-2917-7, DOI 10.1007/978-1-4757-2917-7]; Davis NE, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0120975; ESRI, ARCGIS FOR DESKT; Fujita G, 2015, LANDSC ECOL ENG, V11, P189, DOI 10.1007/s11355-014-0263-x; Godsoe W, 2015, AM NAT, V185, P281, DOI 10.1086/679440; Goshawk Protection Fund, 2012, GRAY FAC BUZZ ICH; Guthlin D, 2011, BIOL CONSERV, V144, P1733, DOI 10.1016/j.biocon.2011.03.010; Hakkarainen H, 2004, OECOLOGIA, V141, P420, DOI 10.1007/s00442-004-1656-6; Hirano Toshiaki, 2004, Strix, V22, P45; Japan Meteorological Agency, TABL MONTHL CLIM STA; Japan Meteorological Agency, MET DAT; Japanese Society of Orthoptera, 2006, ENC ORTH JAP; Kadowaki Seishi, 2007, Journal of the Yamashina Institute for Ornithology, V39, P19; Katoh K, 2009, BIOL CONSERV, V142, P1930, DOI 10.1016/j.biocon.2009.02.030; Kojima Yukihiko, 1999, Japanese Journal of Ornithology, V48, P151, DOI 10.3838/jjo.48.151; Linnell JDC, 2001, ANIM CONSERV, V4, P345, DOI 10.1017/S1367943001001408; Lourenco R, 2014, BIOL REV, V89, P270, DOI 10.1111/brv.12054; Martin J, 2012, J APPL ECOL, V49, P621, DOI 10.1111/j.1365-2664.2012.02139.x; Matsui M, 1999, PICTORIAL BOOK FROGS; Matsuzawa Tlnoue M, 2013, STRIX, V29, P105; McAlpine CA, 2008, J APPL ECOL, V45, P558, DOI 10.1111/j.1365-2664.2007.01431.x; Ministry of Agriculture Forestry and Fisheries, CENS AGR FOR; Ministry of Environment Japan, NAT SURV NAT ENV; Ministry of Environment Japan, NAT BIOD STRAT; Momose H., 2005, J JPN I LANDSC ARCHI, V68, P555; Mueller AK, 2016, J ANIM ECOL, V85, P774, DOI 10.1111/1365-2656.12493; Naito R, 2012, ZOOL SCI, V29, P577, DOI 10.2108/zsj.29.577; Newton I., 1990, BIRDS OF PREY; Newton I, 1986, THE SPARROWHAWK; Noss RF, 1996, CONSERV BIOL, V10, P949, DOI 10.1046/j.1523-1739.1996.10040949.x; Randin CF, 2006, J BIOGEOGR, V33, P1689, DOI 10.1111/j.1365-2699.2006.01466.x; Reif V, 2001, ECOGRAPHY, V24, P267, DOI 10.1034/j.1600-0587.2001.240304.x; Sakai S, 2011, ORNITHOL SCI, V10, P51, DOI 10.2326/osj.10.51; Sutherland WJ, 2004, TRENDS ECOL EVOL, V19, P305, DOI 10.1016/j.tree.2004.03.018; THOMAS JA, 1993, REGUL RIVER, V8, P285, DOI 10.1002/rrr.3450080307; Tuanmu MN, 2011, J BIOGEOGR, V38, P1510, DOI 10.1111/j.1365-2699.2011.02479.x; Wenger SJ, 2012, METHODS ECOL EVOL, V3, P260, DOI 10.1111/j.2041-210X.2011.00170.x; Whittingham MJ, 2007, ECOL LETT, V10, P25, DOI 10.1111/j.1461-0248.2006.00992.x; Yang LH, 2010, ECOL LETT, V13, P1, DOI 10.1111/j.1461-0248.2009.01402.x	43	3	3	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 28	2016	11	4							e0153722	10.1371/journal.pone.0153722	http://dx.doi.org/10.1371/journal.pone.0153722			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DK8XE	27123930	Green Published, Green Submitted, gold			2022-12-26	WOS:000375211700024
J	Mann, ML; Batllori, E; Moritz, MA; Waller, EK; Berck, P; Flint, AL; Flint, LE; Dolfi, E				Mann, Michael L.; Batllori, Enric; Moritz, Max A.; Waller, Eric K.; Berck, Peter; Flint, Alan L.; Flint, Lorraine E.; Dolfi, Emmalee			Incorporating Anthropogenic Influences into Fire Probability Models: Effects of Human Activity and Climate Change on Fire Activity in California	PLOS ONE			English	Article							WILDLAND-URBAN INTERFACE; VEGETATION DISTRIBUTION; WILDFIRE; IMPACT; PRECIPITATION; PATTERNS; DRIVERS; ECOLOGY; GROWTH	The costly interactions between humans and wildfires throughout California demonstrate the need to understand the relationships between them, especially in the face of a changing climate and expanding human communities. Although a number of statistical and process-based wildfire models exist for California, there is enormous uncertainty about the location and number of future fires, with previously published estimates of increases ranging from nine to fifty-three percent by the end of the century. Our goal is to assess the role of climate and anthropogenic influences on the state's fire regimes from 1975 to 2050. We develop an empirical model that integrates estimates of biophysical indicators relevant to plant communities and anthropogenic influences at each forecast time step. Historically, we find that anthropogenic influences account for up to fifty percent of explanatory power in the model. We also find that the total area burned is likely to increase, with burned area expected to increase by 2.2 and 5.0 percent by 2050 under climatic bookends (PCM and GFDL climate models, respectively). Our two climate models show considerable agreement, but due to potential shifts in rainfall patterns, substantial uncertainty remains for the semiarid inland deserts and coastal areas of the south. Given the strength of human-related variables in some regions, however, it is clear that comprehensive projections of future fire activity should include both anthropogenic and biophysical influences. Previous findings of substantially increased numbers of fires and burned area for California may be tied to omitted variable bias from the exclusion of human influences. The omission of anthropogenic variables in our model would overstate the importance of climatic ones by at least 24%. As such, the failure to include anthropogenic effects in many models likely overstates the response of wildfire to climatic change.	[Mann, Michael L.; Dolfi, Emmalee] George Washington Univ, Dept Geog, Washington, DC USA; [Mann, Michael L.; Moritz, Max A.] Univ Calif Berkeley, Dept Environm Sci Policy & Management, Berkeley, CA 94720 USA; [Batllori, Enric] CSIC CTFC CREAF, InForest Joint Res Unit, CEMFOR CTFC, E-25280 Solsona, Spain; [Batllori, Enric] CREAF, E-08193 Cerdanyola Del Valles, Spain; [Waller, Eric K.] US Geol Survey, Western Geog Sci Ctr, 345 Middlefield Rd, Menlo Pk, CA 94025 USA; [Berck, Peter] Univ Calif Berkeley, Dept Agr & Resource Econ, Berkeley, CA 94720 USA; [Flint, Alan L.; Flint, Lorraine E.] US Geol Survey, Calif Water Sci Ctr, Sacramento, CA USA	George Washington University; University of California System; University of California Berkeley; Centre Tecnologic Forestal de Catalunya (CTFC); Centro de Investigacion Ecologica y Aplicaciones Forestales (CREAF); Consejo Superior de Investigaciones Cientificas (CSIC); Centro de Investigacion Ecologica y Aplicaciones Forestales (CREAF); United States Department of the Interior; United States Geological Survey; University of California System; University of California Berkeley; United States Department of the Interior; United States Geological Survey	Mann, ML (corresponding author), George Washington Univ, Dept Geog, Washington, DC USA.; Mann, ML (corresponding author), Univ Calif Berkeley, Dept Environm Sci Policy & Management, Berkeley, CA 94720 USA.	mmann1123@gwu.edu	Batllori, Enric/A-5695-2018	Batllori, Enric/0000-0002-2130-0489; Mann, Michael/0000-0002-6268-6867	Nature Conservancy; Marie Curie International Incoming Fellowship	Nature Conservancy; Marie Curie International Incoming Fellowship(European Commission)	This work was supported by The Nature Conservancy (http://www.nature.org/ourinitiatives/regions/northamerica/unitedstates/california/) to MAM, and a Marie Curie International Incoming Fellowship to EB. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We are grateful to The Nature Conservancy for their generous support. E.B. also thanks the support of a Marie Curie International Incoming Fellowship.	Abatzoglou JT, 2013, INT J WILDLAND FIRE, V22, P1003, DOI 10.1071/WF13019; Ackerly DD, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0130629; Aldersley A, 2011, SCI TOTAL ENVIRON, V409, P3472, DOI 10.1016/j.scitotenv.2011.05.032; America R, 2013, RES AM CAMPS RES SYS; Batllori E, 2013, GLOBAL ECOL BIOGEOGR, V22, P1118, DOI 10.1111/geb.12065; Bistinas I, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081188; Bond WJ, 2005, TRENDS ECOL EVOL, V20, P387, DOI 10.1016/j.tree.2005.04.025; Bowman DMJS, 2011, J BIOGEOGR, V38, P2223, DOI 10.1111/j.1365-2699.2011.02595.x; Brooks ML, 2006, J ARID ENVIRON, V67, P148, DOI 10.1016/j.jaridenv.2006.09.027; Butsic V, 2015, LAND-BASEL, V4, P140, DOI 10.3390/land4010140; Cal-Adapt, 2011, WHAT AR DIFF CLIM MO; [CALFIRE CDF], 2011, CAL FIRE WILDL FIR S; Carroll C, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0140486; Cayan DR, 2008, CLIMATIC CHANGE, V87, pS21, DOI 10.1007/s10584-007-9377-6; Fire C, 2011, MULTISOURCE LAND OWN; FRANK DA, 1994, J BIOGEOGR, V21, P401, DOI 10.2307/2845758; FRAP, 2012, FRAP VEG FVEG 12; FRAP, 2015, FIR PER PROJ INTR; FRAP, 2013, FIR PER 2013; Fried JS, 2004, CLIMATIC CHANGE, V64, P169, DOI 10.1023/B:CLIM.0000024667.89579.ed; Garner KL, 2015, PEERJ, V3, DOI 10.7717/peerj.958; Gujarati D. N., 2009, BASIC ECONOMETRICS; Hammer RB, 2007, INT J WILDLAND FIRE, V16, P255, DOI 10.1071/WF05077; Hessl AE, 2011, PROG PHYS GEOG, V35, P393, DOI 10.1177/0309133311407654; Jarvis A., 2008, CGIAR CSI SRTM 90 M, DOI DOI 10.1111/ecog.00774; Keeley JE, 2001, CONSERV BIOL, V15, P1536, DOI 10.1046/j.1523-1739.2001.00097.x; Keeley JE, 2011, TRENDS PLANT SCI, V16, P406, DOI 10.1016/j.tplants.2011.04.002; Knorr W, 2014, BIOGEOSCIENCES, V11, P1085, DOI 10.5194/bg-11-1085-2014; Knutti R, 2013, GEOPHYS RES LETT, V40, P1194, DOI 10.1002/grl.50256; Knutti R, 2013, NAT CLIM CHANGE, V3, P369, DOI [10.1038/nclimate1716, 10.1038/NCLIMATE1716]; Krawchuk MA, 2014, ENVIRONMETRICS, V25, P472, DOI 10.1002/env.2287; Krawchuk MA., 2012, FIRE CLIMATE CHANGE; Krawchuk MA, 2011, ECOLOGY, V92, P121, DOI 10.1890/09-1843.1; Krawchuk MA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005102; Laris P, 2013, LAND-BASEL, V2, P609, DOI 10.3390/land2040609; Leathwick JR, 2001, ECOLOGY, V82, P2560, DOI 10.1890/0012-9658(2001)082[2560:CIBTSI]2.0.CO;2; Lenihan JM, 2008, CLIMATIC CHANGE, V87, pS215, DOI 10.1007/s10584-007-9362-0; Lenihan JM, 2003, ECOL APPL, V13, P1667, DOI 10.1890/025295; Liang XZ, 2008, J CLIMATE, V21, P4424, DOI 10.1175/2008JCLI2174.1; Littell JS, 2011, ECOSPHERE, V2, DOI 10.1890/ES11-00114.1; Lutz JA, 2009, INT J WILDLAND FIRE, V18, P765, DOI 10.1071/WF08117; Major J., 1967, AM ASS ADV SCI PUBL, P86; Mann ML, 2014, LAND USE POLICY, V41, P438, DOI 10.1016/j.landusepol.2014.06.020; Martin TG, 2005, ECOL LETT, V8, P1235, DOI 10.1111/j.1461-0248.2005.00826.x; Metz MR, 2011, ECOL APPL, V21, P313, DOI 10.1890/10-0419.1; Meyn A, 2007, PROG PHYS GEOG, V31, P287, DOI 10.1177/0309133307079365; Moritz MA, 2014, NATURE, V515, P58, DOI 10.1038/nature13946; Moritz MA, 2012, ECOSPHERE, V3, DOI 10.1890/ES11-00345.1; Parisien MA, 2014, ECOL APPL, V24, P1341, DOI 10.1890/13-1477.1; Parisien MA, 2009, ECOL MONOGR, V79, P127, DOI 10.1890/07-1289.1; Parks SA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099699; PRICE C, 1994, J CLIMATE, V7, P1484, DOI 10.1175/1520-0442(1994)007<1484:TIOACC>2.0.CO;2; Protection CD of F and F, 2015, EM FUND FIR SUPPR EX; Radeloff VC, 2005, ECOL APPL, V15, P799, DOI 10.1890/04-1413; ROGERS GF, 1987, J ARID ENVIRON, V13, P47; Stephenson NL, 1998, J BIOGEOGR, V25, P855, DOI 10.1046/j.1365-2699.1998.00233.x; STEPHENSON NL, 1990, AM NAT, V135, P649, DOI 10.1086/285067; Syphard AD, 2008, INT J WILDLAND FIRE, V17, P602, DOI 10.1071/WF07087; Syphard AD, 2007, ECOL APPL, V17, P1388, DOI 10.1890/06-1128.1; Thorne JH, 2015, ECOSPHERE, V6, DOI 10.1890/ES14-00300.1; [USFS Service UF FS], 2013, WILDF SUPR COSTS FS; USPLN, 2012, LIGHTN STRIK INT DAT; van Mantgem PJ, 2013, ECOL LETT, V16, P1151, DOI 10.1111/ele.12151; VUONG QH, 1989, ECONOMETRICA, V57, P307, DOI 10.2307/1912557; WESTERLING A, 2006, CLIMATE CHANGE WILDF; Westerling AL, 2008, CLIMATIC CHANGE, V87, pS231, DOI 10.1007/s10584-007-9363-z; Westerling AL, 2006, SCIENCE, V313, P940, DOI 10.1126/science.1128834	67	69	70	4	57	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 28	2016	11	4							e0153589	10.1371/journal.pone.0153589	http://dx.doi.org/10.1371/journal.pone.0153589			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DK8XE	27124597	gold, Green Published, Green Submitted			2022-12-26	WOS:000375211700019
J	Radisauskas, R; Malinauskiene, V; Milinaviciene, E; Kranciukaite-Butylkiniene, D; Tamosiunas, A; Bernotiene, G; Luksiene, D; Milasauskiene, Z; Sopagiene, D; Rastenyte, D				Radisauskas, Ricardas; Malinauskiene, Vilija; Milinaviciene, Egle; Kranciukaite-Butylkiniene, Daina; Tamosiunas, Abdonas; Bernotiene, Gailute; Luksiene, Dalia; Milasauskiene, Zemyna; Sopagiene, Diana; Rastenyte, Daiva			Trends in the Attack Rates, Incidence, and Mortality of Stroke during 1986-2012: Data of Kaunas (Lithuania) Stroke Registry	PLOS ONE			English	Article							RISK-FACTORS; CASE-FATALITY; GLOBAL BURDEN; UNITED-STATES; SURVIVAL; POPULATION; PREVENTION; DECLINE; DIJON; UK	Background There is a lack of reliable epidemiological data on longitudinal trends in stroke attack rates, incidence, and mortality in the countries of the Baltic region. Aims The aim of the present study was to explore the longitudinal trends of stroke in middle-aged urban population of Lithuania during the period of 1986 through 2012. Methods All stroke events in the studied population were ascertained and validated according to the standardized criteria outlined by the WHO MONICA Project. The study included all patients in Kaunas (Lithuania) city aged 25 to 64 years who experienced a stroke between 1986 and 2012. Estimates of time-trends of the annual percentage change in stroke attack rates, incidence of stroke, and mortality from this condition were made by applying the Joinpoint regression analysis. Results During the study period, 9,992 stroke events were registered. The overall proportion of recurrent events was 25.7%. Overall, 18.9% of the events (20.0% in men, and 17.4% in women) were fatal within 28 days. During the period of 1986 to 2012, a flat trend in the incidence of stroke was observed among both male and female middle-aged inhabitants of Kaunas city, while attack rates were increasing due to the increase in recurrent strokes. Both mortality and 28-day case fatality of stroke declined significantly over the study period in both sexes. Conclusions An increase both in the incidence and recurrence of stroke among middle-aged men residing in Kaunas city and in the recurrence of stroke among women denotes the inefficiency of measures applied both for primary and secondary prevention of stroke in Lithuania. The revision of current prevention strategies and the introduction of new ones are of paramount importance in order to fight the epidemic of stroke.	[Radisauskas, Ricardas; Malinauskiene, Vilija; Milinaviciene, Egle; Kranciukaite-Butylkiniene, Daina; Tamosiunas, Abdonas; Bernotiene, Gailute; Luksiene, Dalia] Lithuanian Univ Hlth Sci, Inst Cardiol, Kaunas, Lithuania; [Radisauskas, Ricardas; Malinauskiene, Vilija; Luksiene, Dalia] Lithuanian Univ Hlth Sci, Dept Environm & Occupat Med, Kaunas, Lithuania; [Milinaviciene, Egle] Lithuanian Univ Hlth Sci, Dept Rehabil, Kaunas, Lithuania; [Kranciukaite-Butylkiniene, Daina] Lithuanian Univ Hlth Sci, Dept Family Med, Kaunas, Lithuania; [Tamosiunas, Abdonas; Milasauskiene, Zemyna] Lithuanian Univ Hlth Sci, Dept Prevent Med, Kaunas, Lithuania; [Sopagiene, Diana] Klaipeda Univ, Dept Publ Hlth, Klaipeda, Lithuania; [Rastenyte, Daiva] Lithuanian Univ Hlth Sci, Dept Neurol, Kaunas, Lithuania	Lithuanian University of Health Sciences; Lithuanian University of Health Sciences; Lithuanian University of Health Sciences; Lithuanian University of Health Sciences; Lithuanian University of Health Sciences; Klaipeda University; Lithuanian University of Health Sciences	Radisauskas, R (corresponding author), Lithuanian Univ Hlth Sci, Inst Cardiol, Kaunas, Lithuania.; Radisauskas, R (corresponding author), Lithuanian Univ Hlth Sci, Dept Environm & Occupat Med, Kaunas, Lithuania.	ricardas.radisauskas@lsmuni.lt	Tamosiunas, Abdonas/AAD-4274-2021; Radišauskas, Ričardas/AAT-8920-2021	Radišauskas, Ričardas/0000-0002-1227-2674				Aiyagari V, 2015, J STROKE CEREBROVASC, V24, P290, DOI 10.1016/j.jstrokecerebrovasdis.2014.08.002; Amarenco P, 2004, STROKE, V35, P2902, DOI 10.1161/01.STR.0000147965.52712.fa; Arboix A, 2008, CEREBROVASC DIS, V26, P509, DOI 10.1159/000155989; Ayis SA, 2013, J NEUROL NEUROSUR PS, V84, P604, DOI 10.1136/jnnp-2012-303525; Bejot Y, 2008, REV NEUROL-FRANCE, V164, P138, DOI 10.1016/j.neurol.2007.06.003; Fang MC, 2014, AM J MED, V127, P608, DOI 10.1016/j.amjmed.2014.03.017; Feigin VL, 2009, LANCET NEUROL, V8, P355, DOI 10.1016/S1474-4422(09)70025-0; Feigin VL, 2014, LANCET, V383, P345; Go AS, 2014, CIRCULATION, V129, pE28, DOI 10.1161/01.cir.0000441139.02102.80; Goldacre MJ, 2008, STROKE, V39, P2197, DOI 10.1161/STROKEAHA.107.509695; Goldstein LB, 2011, STROKE, V42, P517, DOI 10.1161/STR.0b013e3181fcb238; Hallstrom B, 2008, STROKE, V39, P10, DOI 10.1161/STROKEAHA.107.491779; Harmsen P, 2009, STROKE, V40, P2691, DOI 10.1161/STROKEAHA.109.550814; Johnston SC, 2009, LANCET NEUROL, V8, P345, DOI 10.1016/S1474-4422(09)70023-7; Khellaf M, 2010, STROKE, V41, P2762, DOI 10.1161/STROKEAHA.110.592147; Krishnamurthi RV, 2013, LANCET GLOB HEALTH, V1, pE259, DOI 10.1016/S2214-109X(13)70089-5; Kunst AE, 2011, STROKE, V42, P2126, DOI 10.1161/STROKEAHA.110.599712; Lakshminarayan K, 2014, STROKE, V45, P2575, DOI 10.1161/STROKEAHA.114.005512; Lakshminarayan K, 2009, AM J EPIDEMIOL, V169, P1070, DOI 10.1093/aje/kwp029; Lee S, 2011, BMJ OPEN, V1, DOI 10.1136/bmjopen-2011-000269; Lewsey JD, 2009, CIRC-CARDIOVASC QUAL, V2, P475, DOI 10.1161/CIRCOUTCOMES.108.825968; Lim SS, 2012, LANCET, V380, P2224, DOI 10.1016/S0140-6736(12)61766-8; Luger S, 2014, INT J STROKE, V9, P569, DOI 10.1111/ijs.12289; Modig K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064928; Norrving B, 2013, NEUROLOGY, V80, pS5, DOI 10.1212/WNL.0b013e3182762397; O'Donnell MJ, 2010, LANCET, V376, P112, DOI 10.1016/S0140-6736(10)60834-3; Ovbiagele B, 2010, STROKE, V41, P1748, DOI 10.1161/STROKEAHA.110.585455; Peeters A, 2011, EUR J EPIDEMIOL, V26, P369, DOI 10.1007/s10654-011-9546-9; Putaala J, 2012, STROKE, V43, P2624, DOI 10.1161/STROKEAHA.112.662866; Radisauskas R, 2014, MEDICINA-LITHUANIA, V50, P182, DOI 10.1016/j.medici.2014.08.003; Rastenyte D, 2006, SCAND J PUBLIC HEALT, V34, P488, DOI 10.1080/14034940600551640; Reklaitiene R, 2012, BMC CARDIOVASC DISOR, V12, DOI 10.1186/1471-2261-12-68; Rothwell PM, 2004, LANCET, V363, P1925, DOI 10.1016/S0140-6736(04)16405-2; Sutton CJ, 2010, J EPIDEMIOL COMMUN H, V64, P523, DOI 10.1136/jech.2008.086785; Tamosiunas A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0114283; Tolonen H, 2000, RUOKOKOSKI E WHO MON; Tunstall-Pedoe H., 2003, MONICA MONOGRAPH MUL; Vibo R, 2005, STROKE, V36, P2544, DOI 10.1161/01.STR.0000189633.33623.69; Waterhouse J., 1976, IARC SCI PUBLICATION, V15; WHO MONICA Project, 1990, WHO MONICA PROJECT 5; Wieberdink RG, 2012, EUR J EPIDEMIOL, V27, P287, DOI 10.1007/s10654-012-9673-y; Yang QH, 2006, CIRCULATION, V113, P1335, DOI 10.1161/CIRCULATIONAHA.105.570846	42	7	8	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 28	2016	11	4							e0153942	10.1371/journal.pone.0153942	http://dx.doi.org/10.1371/journal.pone.0153942			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DK8XE	27124412	Green Published, gold, Green Submitted			2022-12-26	WOS:000375211700038
J	Shearn, CT; Orlicky, DJ; McCullough, RL; Jiang, H; Maclean, KN; Mercer, KE; Stiles, BL; Saba, LM; Ronis, MJ; Petersen, DR				Shearn, Colin T.; Orlicky, David J.; McCullough, Rebecca L.; Jiang, Hua; Maclean, Kenneth N.; Mercer, Kelly E.; Stiles, Bangyan L.; Saba, Laura M.; Ronis, Martin J.; Petersen, Dennis R.			Liver-Specific Deletion of Phosphatase and Tensin Homolog Deleted on Chromosome 10 Significantly Ameliorates Chronic EtOH-Induced Increases in Hepatocellular Damage	PLOS ONE			English	Article							GLUTATHIONE-S-TRANSFERASE; PTEN-DEFICIENT MICE; FATTY LIVER; INSULIN-RESISTANCE; HEPATIC STEATOSIS; OXIDATIVE-STRESS; TUMOR-SUPPRESSOR; MURINE MODEL; MOUSE MODEL; STEATOHEPATITIS	Alcoholic liver disease is a significant contributor to global liver failure. In murine models, chronic ethanol consumption dysregulates PTEN/Akt signaling. Hepatospecific deletion of phosphatase and tensin homolog deleted on chromosome 10 (PTENLKO) mice possess constitutive activation of Akt(s) and increased de novo lipogenesis resulting in increased hepatocellular steatosis. This makes PTENLKO a viable model to examine the effects of ethanol in an environment of preexisting steatosis. The aim of this study was to determine the impact of chronic ethanol consumption and the absence of PTEN (PTENLKO) compared to Alb-Cre control mice (PTENf/f) on hepatocellular damage as evidenced by changes in lipid accumulation, protein carbonylation and alanine amino transferase (ALT). In the control PTENf/f animals, ethanol significantly increased ALT, liver triglycerides and steatosis. In contrast, chronic ethanol consumption in PTENLKO mice decreased hepatocellular damage when compared to PTENLKO pair-fed controls. Consumption of ethanol elevated protein carbonylation in PTENf/f animals but had no effect in PTENLKO animals. In PTENLKO mice, overall hepatic mRNA expression of genes that contribute to GSH homeostasis as well as reduced glutathione (GSH) and oxidized glutathione (GSSG) concentrations were significantly elevated compared to respective PTENf/f counterparts. These data indicate that during conditions of constitutive Akt activation and steatosis, increased GSH homeostasis assists in mitigation of ethanol-dependent induction of oxidative stress and hepatocellular damage. Furthermore, data herein suggest a divergence in EtOH-induced hepatocellular damage and increases in steatosis due to polyunsaturated fatty acids downstream of PTEN.	[Shearn, Colin T.; McCullough, Rebecca L.; Saba, Laura M.; Petersen, Dennis R.] Univ Colorado Anschutz Med Campus, Skaggs Sch Pharmaceut Sci & Pharm, Aurora, CO USA; [Orlicky, David J.] Univ Colorado Anschutz Med Campus, Dept Pathol, Dept Pathol, Aurora, CO USA; [Jiang, Hua; Maclean, Kenneth N.] Univ Colorado Anschutz Med Campus, Dept Pediat, Sch Med, Aurora, CO USA; [Mercer, Kelly E.; Ronis, Martin J.] Univ Arkansas Med Sci, Arkansas Childrens Nutr Ctr, Little Rock, AR 72205 USA; [Stiles, Bangyan L.] Univ So Calif, Sch Pharm, Dept Pharmacol & Pharmaceut Sci, Los Angeles, CA USA	University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Arkansas System; University of Arkansas Medical Sciences; University of Southern California	Shearn, CT; Petersen, DR (corresponding author), Univ Colorado Anschutz Med Campus, Skaggs Sch Pharmaceut Sci & Pharm, Aurora, CO USA.	Colin.Shearn@ucdenver.edu; Dennis.Petersen@ucdenver.edu	Saba, Laura/R-9533-2018	Saba, Laura/0000-0001-9649-1294; Shearn, Colin/0000-0002-9618-9885	National Institutes of Health (NIH) Division of Alcohol Abuse and Alcoholism [F32 AA018613-03, R37AA009300-18]; National Institutes of Health [F32 AA018613-03, R37AA009300-18]; NIH/NCRR Colorado CTSI [UL1 RR025780]; University of Colorado Cancer Center [P30 CA046934]; NATIONAL CANCER INSTITUTE [P30CA046934] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR025780] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK048522, P30DK048520] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [R37AA009300, F32AA018613] Funding Source: NIH RePORTER	National Institutes of Health (NIH) Division of Alcohol Abuse and Alcoholism; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH/NCRR Colorado CTSI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Colorado Cancer Center; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	Funding was provided by National Institutes of Health (NIH) Division of Alcohol Abuse and Alcoholism, www.niaaa.nih.gov: F32 AA018613-03 CTS, R37AA009300-18 DRP. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This research was supported by the following grants from the National Institutes of Health; F32 AA018613-03 CTS, R37AA009300-18 DRP. The authors also wish to thank E. Erin Smith, HTL(ASCP)CMQIHC of the University of Colorado Denver Cancer Center Research Histology Core for assistance in preparing histology slides. The UCDCCRHC is supported in part by NIH/NCRR Colorado CTSI Grant Number UL1 RR025780 and the University of Colorado Cancer Center Grant (P30 CA046934).	Alatalo PI, 2008, AM J CLIN NUTR, V88, P1097, DOI 10.1093/ajcn/88.4.1097; Albano E, 1996, HEPATOLOGY, V23, P155, DOI 10.1002/hep.510230121; Codreanu SG, 2009, MOL CELL PROTEOMICS, V8, P670, DOI 10.1074/mcp.M800070-MCP200; de la Monte SM, 2008, J GASTROEN HEPATOL, V23, pE477, DOI 10.1111/j.1440-1746.2008.05339.x; De Minicis S, 2008, J GASTROEN HEPATOL, V23, pS98, DOI 10.1111/j.1440-1746.2007.05277.x; DeNucci SM, 2010, GASTROENT RES PRACT, V2010, DOI 10.1155/2010/312790; Engle MR, 2004, TOXICOL APPL PHARM, V194, P296, DOI 10.1016/j.taap.2003.10.001; Fitzpatrick AM, 2011, PEDIATR RES, V69, P154, DOI 10.1203/PDR.0b013e3182026370; Galligan JJ, 2012, J TOXICOL-US, V2012, DOI 10.1155/2012/207594; Galligan JJ, 2012, CHEM RES TOXICOL, V25, P1012, DOI 10.1021/tx300002q; Galligan JJ, 2011, J PROTEOME RES, V10, P1837, DOI 10.1021/pr101101s; Go Young-Mi, 2008, V464, P303; Guenzl PM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067013; HARTLEY DP, 1995, ARCH BIOCHEM BIOPHYS, V316, P197, DOI 10.1006/abbi.1995.1028; He LN, 2010, AM J PATHOL, V176, P2302, DOI 10.2353/ajpath.2010.090931; Horie Y, 2004, J CLIN INVEST, V113, P1774, DOI 10.1172/JCI200420513; Jones DP, 2008, AM J PHYSIOL-CELL PH, V295, pC849, DOI 10.1152/ajpcell.00283.2008; JUNQUEIRA LCU, 1979, HISTOCHEM J, V11, P447, DOI 10.1007/BF01002772; Kleiner DE, 2012, SEMIN LIVER DIS, V32, P3, DOI 10.1055/s-0032-1306421; Leavens KF, 2009, CELL METAB, V10, P405, DOI 10.1016/j.cmet.2009.10.004; Li Y, 2013, J BIOL CHEM, V288, P25007, DOI 10.1074/jbc.M113.450353; Liu JZ, 2015, INT J BIOL SCI, V11, P569, DOI 10.7150/ijbs.11039; Maehama T, 1999, TRENDS CELL BIOL, V9, P125, DOI 10.1016/S0962-8924(99)01519-6; Matsuda Satoru, 2013, ISRN Endocrinol, V2013, P472432, DOI 10.1155/2013/472432; Nanduri B, 1996, ARCH BIOCHEM BIOPHYS, V335, P305, DOI 10.1006/abbi.1996.0511; Nobili V, 2005, CLIN CHIM ACTA, V355, P105, DOI 10.1016/j.cccn.2004.12.022; Peyrou M, 2010, DIGEST DIS, V28, P236, DOI 10.1159/000282095; Roede JR, 2009, J PHARMACOL EXP THER, V330, P79, DOI 10.1124/jpet.109.152983; Ronis MJJ, 2015, AM J PHYSIOL-GASTR L, V308, pG403, DOI 10.1152/ajpgi.00154.2014; Ronis MJJ, 2011, AM J PHYSIOL-GASTR L, V300, pG109, DOI 10.1152/ajpgi.00145.2010; Ross SH, 2007, CELL SIGNAL; Sato W, 2006, HEPATOL RES, V34, P256, DOI 10.1016/j.hepres.2006.01.003; Setshedi M, 2011, ALCOHOL CLIN EXP RES, V35, P2139, DOI 10.1111/j.1530-0277.2011.01569.x; Shearn CT, 2013, FREE RADICAL BIO MED, V65, P680, DOI 10.1016/j.freeradbiomed.2013.07.011; Shearn CT, 2016, REDOX BIOL, V7, P68, DOI 10.1016/j.redox.2015.11.013; Shearn CT, 2015, ADV EXP MED BIOL, V815, P173, DOI 10.1007/978-3-319-09614-8_10; Shearn CT, 2014, J BIOL CHEM, V289, P15449, DOI 10.1074/jbc.M113.543942; Shearn CT, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096553; Shearn CT, 2013, J NUTR BIOCHEM, V24, P1436, DOI 10.1016/j.jnutbio.2012.12.002; Shearn CT, 2011, MOL PHARMACOL, V79, P941, DOI 10.1124/mol.110.069534; Stiles B, 2004, P NATL ACAD SCI USA, V101, P2082, DOI 10.1073/pnas.0308617100; Vaillancourt F, 2008, ARTHRITIS RES THER, V10, DOI 10.1186/ar2503; Watanabe S, 2005, HEPATOL RES, V33, P161, DOI 10.1016/j.hepres.2005.09.026; Yang YS, 2003, ACTA BIOCHIM POL, V50, P319; Ye ZW, 2017, ANTIOXID REDOX SIGN, V26, P248, DOI 10.1089/ars.2015.6486; Yeon JE, 2003, HEPATOLOGY, V38, P703, DOI 10.1053/jhep.2003.50368; You M, 2004, ALCOHOL, V34, P39, DOI 10.1016/j.alcohol.2004.07.004; You M, 2002, J BIOL CHEM, V277, P29342, DOI 10.1074/jbc.M202411200; Zeng N, 2011, MOL CANCER RES, V9, P1708, DOI 10.1158/1541-7786.MCR-11-0299; Zhang Z, 2010, MOL GENET METAB, V99, P309, DOI 10.1016/j.ymgme.2009.10.179	50	9	9	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 28	2016	11	4							e0154152	10.1371/journal.pone.0154152	http://dx.doi.org/10.1371/journal.pone.0154152			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DK8XE	27124661	Green Published, gold, Green Submitted			2022-12-26	WOS:000375211700051
J	Tjernberg, AR; Bonnedahl, J; Ludvigsson, JF				Tjernberg, Anna Rockert; Bonnedahl, Jonas; Ludvigsson, Jonas F.			Does Celiac Disease Influence Survival in Sepsis? A Nationwide Longitudinal Study	PLOS ONE			English	Article							VILLOUS ATROPHY; MORTALITY; RISK; GLUTEN; PEOPLE; IMPACT; COHORT; DEATH; HOMOCYSTEINE; VALIDATION	Background Individuals with celiac disease (CD) are at increased risk of sepsis. The aim of this study was to examine whether CD influences survival in sepsis of bacterial origin. Methods Nationwide longitudinal registry-based study. Through data on small intestinal biopsies from Sweden's 28 pathology departments, we identified 29,096 individuals with CD (villous atrophy, Marsh stage III). Each individual with CD was matched with five population-based controls. Among these, 5,470 had a record of sepsis according to the Swedish Patient Register (1,432 celiac individuals and 4,038 controls). Finally we retrieved data on mortality in sepsis patients through the Swedish Cause of Death Registry. Results CD was associated with a 19% increase in overall mortality after sepsis (95% confidence interval (CI) = 1.09-1.29), with the highest relative risk occurring in children (adjusted hazard ratio (aHR) = 1.62; 95% CI = 0.67-3.91). However, aHR for death from sepsis was lower (aHR = 1.10) and failed to reach statistical significance (95% CI = 0.72-1.69). CD did not influence survival within 28 days after sepsis (aHR = 0.98; 95% CI = 0.80-1.19). Conclusions Although individuals with CD seem to be at an increased risk of overall death after sepsis, that excess risk does not differ from the general excess mortality previously seen in celiac patients in Sweden. CD as such does not seem to influence short-term or sepsis-specific survival in individuals with sepsis and therefore is not an independent risk factor for poor prognosis in sepsis.	[Tjernberg, Anna Rockert] Kalmar Cty Hosp, Dept Pediat, Kalmar, Sweden; [Tjernberg, Anna Rockert] Univ Orebro, Sch Hlth & Med Sci, SE-70182 Orebro, Sweden; [Bonnedahl, Jonas] Kalmar Cty Hosp, Dept Infect Dis, Kalmar, Sweden; [Bonnedahl, Jonas] Linnaeus Univ, Zoonot Ecol & Epidemiol, Fac Hlth & Life Sci, Kalmar, Sweden; [Ludvigsson, Jonas F.] Karolinska Inst, Dept Med Epidemiol & Biostat, Stockholm, Sweden; [Ludvigsson, Jonas F.] Orebro Univ Hosp, Dept Pediat, Orebro, Sweden	Orebro University; Linnaeus University; Karolinska Institutet; Orebro University	Tjernberg, AR (corresponding author), Kalmar Cty Hosp, Dept Pediat, Kalmar, Sweden.; Tjernberg, AR (corresponding author), Univ Orebro, Sch Hlth & Med Sci, SE-70182 Orebro, Sweden.	annart@ltkalmar.se	Ludvigsson, Jonas F/A-8560-2012; Bonnedahl, Jonas/GZG-8435-2022	Ludvigsson, Jonas F/0000-0003-1024-5602; Rockert Tjernberg, Anna/0000-0001-8126-9738	Swedish Research Council; Kalmar County Council	Swedish Research Council(Swedish Research CouncilEuropean Commission); Kalmar County Council	This work was supported by the Swedish Research Council to JFL. ART and JB were funded by Kalmar County Council. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ayala-Ramirez OH, 2014, EUR J CLIN MICROBIOL, V33, P411, DOI 10.1007/s10096-013-1971-0; Christensen JS, 2012, EUR J CLIN MICROBIOL, V31, P2719, DOI 10.1007/s10096-012-1619-5; Cohn A, 2014, CURR DIABETES REP, V14, DOI 10.1007/s11892-014-0517-x; Corrao G, 2001, LANCET, V358, P356, DOI 10.1016/S0140-6736(01)05554-4; Dellinger RP, 2013, INTENS CARE MED, V41, P580, DOI [DOI 10.1007/s00134-012-2769-8, 10.1007/s00134-012-2769-8]; Dhainaut JF, 2005, CLIN INFECT DIS, V41, pS481, DOI 10.1086/432001; Di Sabatino A, 2006, CLIN GASTROENTEROL H, V4, P179, DOI 10.1016/S1542-3565(05)00982-1; Di Sabatino A, 2011, LANCET, V378, P86, DOI 10.1016/S0140-6736(10)61493-6; Gedeborg R, 2007, J CLIN EPIDEMIOL, V60, P155, DOI 10.1016/j.jclinepi.2006.05.013; Grainge MJ, 2011, AM J GASTROENTEROL, V106, P933, DOI 10.1038/ajg.2010.506; Iqbal T, 2013, J GASTROEN HEPATOL, V28, P99, DOI 10.1111/j.1440-1746.2012.07272.x; Jawad Issrah, 2012, J Glob Health, V2, P010404, DOI 10.7189/jogh.02.010404; Johansson LA, 2009, J CLIN EPIDEMIOL, V62, P1202, DOI 10.1016/j.jclinepi.2009.01.010; Ludvigsson JF, 2008, GUT, V57, P1074, DOI 10.1136/gut.2007.133868; Ludvigsson JF, 2011, J INTERN MED, V269, P560, DOI 10.1111/j.1365-2796.2011.02379.x; Ludvigsson JF, 2011, ALIMENT PHARM THER, V33, P689, DOI 10.1111/j.1365-2036.2010.04572.x; Ludvigsson JF, 2013, AM J GASTROENTEROL, V108, P818, DOI 10.1038/ajg.2013.60; Ludvigsson JF, 2013, GUT, V62, P43, DOI 10.1136/gutjnl-2011-301346; Ludvigsson JF, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-450; Ludvigsson JF, 2009, EUR J EPIDEMIOL, V24, P659, DOI 10.1007/s10654-009-9350-y; Ludvigsson JF, 2009, JAMA-J AM MED ASSOC, V302, P1171, DOI 10.1001/jama.2009.1320; Ludvigsson JF, 2009, BMC GASTROENTEROL, V9, DOI 10.1186/1471-230X-9-19; Marild K, 2015, MAYO CLIN PROC, V90, P730, DOI 10.1016/j.mayocp.2015.04.002; Marild K, 2010, AM J GASTROENTEROL, V105, P2465, DOI 10.1038/ajg.2010.352; Martin GS, 2012, EXPERT REV ANTI-INFE, V10, P701, DOI [10.1586/ERI.12.50, 10.1586/eri.12.50]; Olen O, 2012, DIGEST LIVER DIS, V44, P471, DOI 10.1016/j.dld.2012.01.006; Oltean S, 2012, J CRIT CARE, V27, P370, DOI 10.1016/j.jcrc.2011.08.021; Peters U, 2003, ARCH INTERN MED, V163, P1566, DOI 10.1001/archinte.163.13.1566; Ploder M, 2010, MOL MED, V16, P498, DOI 10.2119/molmed.2010.00008; Rampertab SD, 2006, AM J MED, V119, DOI 10.1016/j.amjmed.2005.08.044; Sapone A, 2011, BMC MED, V9, DOI 10.1186/1741-7015-9-23; Schottker B, 2014, BMJ-BRIT MED J, V348, DOI 10.1136/bmj.g3656; Solaymani-Dodaran M, 2007, AM J GASTROENTEROL, V102, P864, DOI 10.1111/j.1572-0241.2007.01111.x; Theethira TG, 2014, EXPERT REV GASTROENT, V8, P123, DOI 10.1586/17474124.2014.876360; Thomas HJ, 2008, EUR J GASTROEN HEPAT, V20, P624, DOI 10.1097/MEG.0b013e3282f45764; Thomsen RW, 2011, J INFECTION, V63, P8, DOI 10.1016/j.jinf.2011.05.013; Tsai CL, 2007, J INFECTION, V55, P27, DOI 10.1016/j.jinf.2007.01.004; Tsantes A, 2010, MINERVA ANESTESIOL, V76, P787; Ventura A, 1999, GASTROENTEROLOGY, V117, P297, DOI 10.1053/gast.1999.0029900297; Walters JRF, 2008, GUT, V57, P1034, DOI 10.1136/gut.2008.151571; Welfare TSNBoHa, 2013, CAUS OF DEATH 2013, P8; West J, 2004, BRIT MED J, V329, P716, DOI 10.1136/bmj.38169.486701.7C; Zanchi C, 2008, J PEDIATR-US, V153, P262, DOI 10.1016/j.jpeds.2008.03.003	43	1	1	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 28	2016	11	4							e0154663	10.1371/journal.pone.0154663	http://dx.doi.org/10.1371/journal.pone.0154663			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DK8XE	27124735	Green Published, gold, Green Submitted			2022-12-26	WOS:000375211700121
J	van de Beek, MC; Dijkstra, IME; van Lenthe, H; Ofman, R; Goldhaber-Pasillas, D; Schauer, N; Schackmann, M; Engelen-Lee, JY; Vaz, FM; Kulik, W; Wanders, RJA; Engelen, M; Kemp, S				van de Beek, Malu-Clair; Dijkstra, Inge M. E.; van Lenthe, Henk; Ofman, Rob; Goldhaber-Pasillas, Dalia; Schauer, Nicolas; Schackmann, Martin; Engelen-Lee, Joo-Yeon; Vaz, Frederic M.; Kulik, Wim; Wanders, Ronald J. A.; Engelen, Marc; Kemp, Stephan			C26:0-Carnitine Is a New Biomarker for X-Linked Adrenoleukodystrophy in Mice and Man	PLOS ONE			English	Article							CHAIN FATTY-ACIDS; DRIED BLOOD SPOTS; MASS-SPECTROMETRY; SKIN FIBROBLASTS; ABC TRANSPORTERS; OXIDATIVE DAMAGE; MOUSE MODEL; ESI-MS/MS; DIAGNOSIS; ALD	X-linked adrenoleukodystrophy (ALD), a progressive neurodegenerative disease, is caused by mutations in ABCD1 and characterized by very-long-chain fatty acids (VLCFA) accumulation. Virtually all males develop progressive myelopathy (AMN). A subset of patients, however, develops a fatal cerebral demyelinating disease (cerebral ALD). Hematopoietic stem cell transplantation is curative for cerebral ALD provided the procedure is performed in an early stage of the disease. Unfortunately, this narrow therapeutic window is often missed. Therefore, an increasing number of newborn screening programs are including ALD. To identify new biomarkers for ALD, we developed an Abcd1 knockout mouse with enhanced VLCFA synthesis either ubiquitous or restricted to oligodendrocytes. Biochemical analysis revealed VLCFA accumulation in different lipid classes and acylcarnitines. Both C26:0-lysoPC and C26:0-carnitine were highly elevated in brain, spinal cord, but also in bloodspots. We extended the analysis to patients and confirmed that C26:0-carnitine is also elevated in bloodspots from ALD patients. We anticipate that validation of C26:0-carnitine for the diagnosis of ALD in newborn bloodspots may lead to a faster inclusion of ALD in newborn screening programs in countries that already screen for other inborn errors of metabolism.	[van de Beek, Malu-Clair; Dijkstra, Inge M. E.; van Lenthe, Henk; Ofman, Rob; Schackmann, Martin; Vaz, Frederic M.; Kulik, Wim; Wanders, Ronald J. A.; Kemp, Stephan] Univ Amsterdam, Acad Med Ctr, Dept Pediat, Lab Genet Metab Dis, NL-1105 AZ Amsterdam, Netherlands; [van de Beek, Malu-Clair; Dijkstra, Inge M. E.; van Lenthe, Henk; Ofman, Rob; Schackmann, Martin; Vaz, Frederic M.; Kulik, Wim; Wanders, Ronald J. A.; Kemp, Stephan] Univ Amsterdam, Acad Med Ctr, Dept Clin Chem, Lab Genet Metab Dis, NL-1105 AZ Amsterdam, Netherlands; [Engelen, Marc; Kemp, Stephan] Univ Amsterdam, Acad Med Ctr, Dept Pediat, Emma Childrens Hosp, NL-1105 AZ Amsterdam, Netherlands; [Engelen, Marc; Kemp, Stephan] Univ Amsterdam, Acad Med Ctr, Emma Childrens Hosp, Dept Pediat Neurol, Meibergdreef 9, NL-1105 AZ Amsterdam, Netherlands; [Goldhaber-Pasillas, Dalia; Schauer, Nicolas] Metabol Discoveries GmbH, Potsdam, Germany; [Engelen, Marc] Univ Amsterdam, Acad Med Ctr, Dept Neurol, NL-1105 AZ Amsterdam, Netherlands	University of Amsterdam; Academic Medical Center Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam; Emma Children's Hospital; University of Amsterdam; Academic Medical Center Amsterdam; Vrije Universiteit Amsterdam; Emma Children's Hospital; University of Amsterdam; Academic Medical Center Amsterdam; Vrije Universiteit Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam	Kemp, S (corresponding author), Univ Amsterdam, Acad Med Ctr, Dept Pediat, Lab Genet Metab Dis, NL-1105 AZ Amsterdam, Netherlands.; Kemp, S (corresponding author), Univ Amsterdam, Acad Med Ctr, Dept Clin Chem, Lab Genet Metab Dis, NL-1105 AZ Amsterdam, Netherlands.; Kemp, S (corresponding author), Univ Amsterdam, Acad Med Ctr, Dept Pediat, Emma Childrens Hosp, NL-1105 AZ Amsterdam, Netherlands.; Kemp, S (corresponding author), Univ Amsterdam, Acad Med Ctr, Emma Childrens Hosp, Dept Pediat Neurol, Meibergdreef 9, NL-1105 AZ Amsterdam, Netherlands.	s.kemp@amc.uva.nl	Kemp, Stephan/A-3935-2008	Kemp, Stephan/0000-0003-2023-064X; Vaz, Frederic/0000-0002-9048-1041; Engelen, Marc/0000-0002-5346-8497	European Leukodystrophy Association [ELA:2006-031I4, ELA:2007-026I4, ELA:2011-024I1, ELA:2014-014I1]; European Union [241622]; Marie Curie International Training Network [316723]; Netherlands Organization for Scientific Research [91786328]; Metabolomic Discoveries GmbH	European Leukodystrophy Association; European Union(European Commission); Marie Curie International Training Network; Netherlands Organization for Scientific Research(Netherlands Organization for Scientific Research (NWO)); Metabolomic Discoveries GmbH	Funded by European Leukodystrophy Association (http://ela-asso.com) ELA:2006-031I4 (SK); ELA:2007-026I4 (SK); ELA:2011-024I1 (SK) and ELA:2014-014I1 (SK); European Union Framework Programme 7 (https://ec.europa.eu/research/fp7/) (LeukoTreat (241622) RW, SK); Marie Curie International Training Network (http://www.mediasres-itn.eu/) (PerFuMe (316723) DG, NS); and Netherlands Organization for Scientific Research (http://www.nwo.nl/) (VIDI-grant (91786328) SK). Metabolomic Discoveries GmbH provided support in the form of salary for author NS, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific role of the author is articulated in the 'author contributions' section." The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asheuer M, 2005, HUM MOL GENET, V14, P1293, DOI 10.1093/hmg/ddi140; Bezman L, 2001, ANN NEUROL, V49, P512, DOI 10.1002/ana.101; Brand B, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0125044; CHRISTOPHERSEN BO, 1972, BIOCHIM BIOPHYS ACTA, V260, P515, DOI 10.1016/0005-2760(72)90001-X; de Beer M, 2014, NEUROLOGY, V83, P2227, DOI 10.1212/WNL.0000000000001074; Dubey P, 2005, J PEDIATR-US, V146, P528, DOI 10.1016/j.jpeds.2004.10.067; Duranti G, 2008, CLIN CHIM ACTA, V398, P86, DOI 10.1016/j.cca.2008.08.018; Eichler FS, 2008, ANN NEUROL, V63, P729, DOI 10.1002/ana.21391; Engelen M, 2014, BRAIN, V137, P693, DOI 10.1093/brain/awt361; Engelen M, 2012, ORPHANET J RARE DIS, V7, DOI 10.1186/1750-1172-7-51; Engelen M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041013; ForssPetter S, 1997, J NEUROSCI RES, V50, P829, DOI 10.1002/(SICI)1097-4547(19971201)50:5<829::AID-JNR19>3.0.CO;2-W; Fourcade S, 2008, HUM MOL GENET, V17, P1762, DOI 10.1093/hmg/ddn085; Haynes CA, 2016, CLIN BIOCHEM, V49, P161, DOI 10.1016/j.clinbiochem.2015.09.011; Hein S, 2008, HUM MOL GENET, V17, P1750, DOI 10.1093/hmg/ddn066; Hubbard WC, 2009, MOL GENET METAB, V97, P212, DOI 10.1016/j.ymgme.2009.03.010; Kassmann CM, 2007, NAT GENET, V39, P969, DOI 10.1038/ng2070; Kemp S, 2004, CLIN CHEM, V50, P1824, DOI 10.1373/clinchem.2004.038539; Kemp S, 2001, HUM MUTAT, V18, P499, DOI 10.1002/humu.1227; Kemp S, 2012, BBA-MOL BASIS DIS, V1822, P1465, DOI 10.1016/j.bbadis.2012.03.012; Lappe-Siefke C, 2003, NAT GENET, V33, P366, DOI 10.1038/ng1095; Lu JF, 1997, P NATL ACAD SCI USA, V94, P9366, DOI 10.1073/pnas.94.17.9366; Lu JF, 2007, LAB INVEST, V87, P261, DOI 10.1038/labinvest.3700512; Miller WP, 2011, BLOOD, V118, P1971, DOI 10.1182/blood-2011-01-329235; Moon YA, 2001, J BIOL CHEM, V276, P45358, DOI 10.1074/jbc.M108413200; Moser H., 2001, METABOLIC MOL BASES, VII, P3257; MOSER HW, 1981, NEUROLOGY, V31, P1241, DOI 10.1212/WNL.31.10.1241; MOSSER J, 1993, NATURE, V361, P726, DOI 10.1038/361726a0; Ofman R, 2010, EMBO MOL MED, V2, P90, DOI 10.1002/emmm.201000061; Ohno Y, 2010, P NATL ACAD SCI USA, V107, P18439, DOI 10.1073/pnas.1005572107; OSEI P, 1989, J BIOL CHEM, V264, P6844; Pujol A, 2002, HUM MOL GENET, V11, P499, DOI 10.1093/hmg/11.5.499; Rizzo C, 2003, PEDIATR RES, V53, P1013, DOI 10.1203/01.PDR.0000064902.59052.0F; Sandlers Y, 2012, MOL GENET METAB, V105, P416, DOI 10.1016/j.ymgme.2011.11.195; Schackmann MJA, 2015, BBA-MOL CELL BIOL L, V1851, P231, DOI 10.1016/j.bbalip.2014.12.005; SINGH I, 1984, PEDIATR RES, V18, P286, DOI 10.1203/00006450-198403000-00016; Turgeon CT, 2015, MOL GENET METAB, V114, P46, DOI 10.1016/j.ymgme.2014.11.013; Valianpour F, 2003, MOL GENET METAB, V79, P189, DOI 10.1016/S1096-7192(03)00098-2; Wanders RJA, 2010, BBA-MOL CELL BIOL L, V1801, P272, DOI 10.1016/j.bbalip.2010.01.001	39	35	35	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 28	2016	11	4							e0154597	10.1371/journal.pone.0154597	http://dx.doi.org/10.1371/journal.pone.0154597			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DK8XE	27124591	Green Published, gold			2022-12-26	WOS:000375211700110
J	Yin, GK; Whelan, J; Wu, SH; Zhou, J; Chen, BY; Chen, XL; Zhang, JM; He, JJ; Xin, X; Lu, XX				Yin, Guangkun; Whelan, James; Wu, Shuhua; Zhou, Jing; Chen, Baoyin; Chen, Xiaoling; Zhang, Jinmei; He, Juanjuan; Xin, Xia; Lu, Xinxiong			Comprehensive Mitochondrial Metabolic Shift during the Critical Node of Seed Ageing in Rice	PLOS ONE			English	Article							ELECTRON-TRANSPORT CHAIN; OXIDATIVE STRESS; GENE-EXPRESSION; RESPIRATORY COMPONENTS; L. SEEDS; ARABIDOPSIS; GERMINATION; GROWTH; DEHYDROGENASE; BIOGENESIS	The critical node (CN) in seed aging in rice (Oryza sativa) is the transformation from Phase I (P-I) to Phase II (P-II) of the reverse S-shaped curve (RS-SC). Although mitochondrial dysfunction plays a key role in seed ageing, the metabolic shift in the CN remains poorly understood. Here, we investigated the mitochondrial regulatory mechanisms during the CN of rice seed ageing. We showed that during the CN of seed ageing, the mitochondrial ultrastructure was impaired, causing oxygen consumption to decrease, along with cytochrome c (cyt c) oxidase and malate dehydrogenase (MDH) activity. In addition, the transcript levels for the alternative pathway of the electron transport chain (ETC) were significantly induced, whereas the transcripts of the cytochrome oxidase (COX) pathway were inhibited. These changes were concomitant with the down-regulation of mitochondrial protein levels related to carbon and nitrogen metabolism, ATP synthase (ATPase) complex, tricarboxylic acid cycle (TCA) cycle, mitochondrial oxidative enzymes, and a variety of other proteins. Therefore, while these responses inhibit the production of ATP and its intermediates, signals from mitochondria (such as the decrease of cyt c and accumulation of reactive oxygen species (ROS)) may also induce oxidative damage. These events provide considerable information about the mitochondrial metabolic shifts involved in the progression of seed ageing in the CN.	[Yin, Guangkun; Wu, Shuhua; Zhou, Jing; Chen, Baoyin; Chen, Xiaoling; Zhang, Jinmei; He, Juanjuan; Xin, Xia; Lu, Xinxiong] Chinese Acad Agr Sci, Natl Genebank Inst Crop Sci, Beijing 100081, Peoples R China; [Whelan, James] La Trobe Univ, Sch Life Sci, Australian Res Council Ctr Excellence Plant Energ, Bundoora, Vic 3083, Australia; [Chen, Baoyin] Fujian Agr & Forestry Univ, Breeding & Multiple Utilizat Crops, Key Lab Minist Educ Genet, Fuzhou 350002, Fujian, Peoples R China	Chinese Academy of Agricultural Sciences; Institute of Crop Sciences, CAAS; La Trobe University; Fujian Agriculture & Forestry University	Xin, X; Lu, XX (corresponding author), Chinese Acad Agr Sci, Natl Genebank Inst Crop Sci, Beijing 100081, Peoples R China.	xinxia@caas.cn; luxinxiong@caas.cn	Whelan, James/F-6402-2011	Whelan, James/0000-0001-5754-025X	National Natural Science Foundation of China [31371713, 31401470]; National Key Technology RD Program [2013BAD01B01]; Agricultural Science and Technology Innovation Program/Crop Germplasm Resources Preservation and Sharing Innovation Team	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Key Technology RD Program(National Key Technology R&D Program); Agricultural Science and Technology Innovation Program/Crop Germplasm Resources Preservation and Sharing Innovation Team	This work was supported as follows: 1. the National Natural Science Foundation of China, grant number: 31371713, Recipient: Xinxiong Lu. 2. the National Natural Science Foundation of China, grant number: 31401470, Recipient: Guangkun Yin. 3. the National Key Technology R&D Program grant number: 2013BAD01B01, Recipient: Xinxiong Lu. 4. the Agricultural Science and Technology Innovation Program/Crop Germplasm Resources Preservation and Sharing Innovation Team, Recipient: Xinxiong Lu. The funders played extremely key roles in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al Bitar F, 2003, BBA-GENE STRUCT EXPR, V1625, P43, DOI 10.1016/S0167-4781(02)00590-0; [Anonymous], 2011, INT RUL SEED TEST; Armstrong AF, 2008, PLANT CELL ENVIRON, V31, P1156, DOI 10.1111/j.1365-3040.2008.01830.x; Bailly C, 2011, METHODS MOL BIOL, V773, P343, DOI 10.1007/978-1-61779-231-1_20; Balaban RS, 2005, CELL, V120, P483, DOI 10.1016/j.cell.2005.02.001; Bellani LM, 2012, ACTA PHYSIOL PLANT, V34, P1789, DOI 10.1007/s11738-012-0976-0; Bewley JD, 1997, PLANT CELL, V9, P1055, DOI 10.1105/tpc.9.7.1055; Boex-Fontvieille ERA, 2013, NEW PHYTOL, V199, P673, DOI 10.1111/nph.12319; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Carrie C, 2013, PLANTA, V237, P429, DOI 10.1007/s00425-012-1762-3; Cheng ZY, 2013, ANTIOXID REDOX SIGN, V19, P240, DOI 10.1089/ars.2013.5255; Chivasa S, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M110.003905; Clifton R, 2005, PLANT MOL BIOL, V58, P193, DOI 10.1007/s11103-005-5514-7; Desai MK, 2006, PLANT PHYSIOL BIOCH, V44, P483, DOI 10.1016/j.plaphy.2006.08.008; FAO, 2010, 2 FAO UN COMM GEN RE, P47; Giege P, 2005, PLANT CELL, V17, P1497, DOI 10.1105/tpc.104.030254; Giraud E, 2009, PLANT PHYSIOL, V150, P1286, DOI 10.1104/pp.109.139782; GLATTHAAR BE, 1974, ANAL BIOCHEM, V57, P432, DOI 10.1016/0003-2697(74)90099-2; Grabelnych OI, 2014, BIOCHEMISTRY-MOSCOW+, V79, P506, DOI 10.1134/S0006297914060030; HAMASUR B, 1992, EUR J BIOCHEM, V205, P409, DOI 10.1111/j.1432-1033.1992.tb16794.x; Ho LHM, 2008, PLANT PHYSIOL, V147, P1858, DOI 10.1104/pp.108.121384; Howell KA, 2006, PLANT MOL BIOL, V60, P201, DOI 10.1007/s11103-005-3688-7; Howell KA, 2009, PLANT PHYSIOL, V149, P961, DOI 10.1104/pp.108.129874; Hu D, 2012, PLANT CELL ENVIRON, V35, P2045, DOI 10.1111/j.1365-3040.2012.02535.x; Huang S, 2013, FRONT PLANT SCI, V4, DOI 10.3389/fpls.2013.00016; Kaewnaree P., 2011, Biotechnology, V10, P175; Kerchev PI, 2014, MOL PLANT, V7, P1138, DOI 10.1093/mp/ssu071; Kuhn K, 2015, PLANT PHYSIOL, V167, P228, DOI 10.1104/pp.114.249946; Kujoth GC, 2005, SCIENCE, V309, P481, DOI 10.1126/science.1112125; Law SR, 2012, PLANT PHYSIOL, V158, P1610, DOI 10.1104/pp.111.192351; Lee SM, 2009, MOL CELLS, V27, P321, DOI 10.1007/s10059-009-0041-z; Li P, 1997, CELL, V91, P479, DOI 10.1016/S0092-8674(00)80434-1; Liochev SI, 2013, FREE RADIC BIOL MED, V16, P29; Logan DC, 2001, PLANT PHYSIOL, V125, P662, DOI 10.1104/pp.125.2.662; Lu XinXiong, 2005, Agricultural Sciences in China, V4, P408; Millar AH, 2011, ANNU REV PLANT BIOL, V62, P79, DOI 10.1146/annurev-arplant-042110-103857; Moller IM, 2001, ANNU REV PLANT PHYS, V52, P561, DOI 10.1146/annurev.arplant.52.1.561; NEUBERGER M, 1985, HIGHER PLANT CELL RE, P7; Ng S, 2013, J BIOL CHEM, V288, P3449, DOI 10.1074/jbc.M112.416727; Qin GZ, 2009, J PROTEOME RES, V8, P2449, DOI 10.1021/pr801046m; Rajjou L, 2008, PLANT PHYSIOL, V148, P620, DOI 10.1104/pp.108.123141; Rasmusson AG, 2008, MITOCHONDRION, V8, P47, DOI 10.1016/j.mito.2007.10.004; Shoshan-Barmatz V, 2012, MITOCHONDRION, V12, P24, DOI 10.1016/j.mito.2011.04.001; Shoshan-Barmatz V, 2010, MOL ASPECTS MED, V31, P227, DOI 10.1016/j.mam.2010.03.002; Sveinsdottira H, 2009, J PLANT PHYSIOL, V166, P128, DOI 10.1016/j.jplph.2008.01.012; Sweetlove LJ, 2002, PLANT J, V32, P891, DOI 10.1046/j.1365-313X.2002.01474.x; Taylor NL, 2010, PLANT PHYSIOL, V154, P691, DOI 10.1104/pp.110.162214; Van Aken O, 2012, FRONT PLANT SCI, V3, DOI 10.3389/fpls.2012.00281; Van Aken O, 2009, MOL PLANT, V2, P1310, DOI 10.1093/mp/ssp053; Wallstrom SV, 2014, PLANT CELL PHYSIOL, V55, P881, DOI 10.1093/pcp/pcu021; Walters C, 2004, CRYOBIOLOGY, V48, P229, DOI 10.1016/j.cryobiol.2004.01.007; Watanabe CK, 2010, PLANT CELL PHYSIOL, V51, P810, DOI 10.1093/pcp/pcq033; Xin X, 2011, J PLANT GENET RESOUR, V12, P936; Xin X, 2014, J PLANT PHYSIOL, V171, P140, DOI 10.1016/j.jplph.2013.09.016; Xin X, 2011, PHYSIOL PLANTARUM, V143, P126, DOI 10.1111/j.1399-3054.2011.01497.x; Yin GK, 2014, PLANT PHYSIOL BIOCH, V80, P1, DOI 10.1016/j.plaphy.2014.03.006; Yin GK, 2009, PLANT CELL PHYSIOL, V50, P1305, DOI 10.1093/pcp/pcp074; Yoshida K, 2009, PLANT CELL PHYSIOL, V50, P1449, DOI 10.1093/pcp/pcp090	58	22	25	4	45	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 28	2016	11	4							e0148013	10.1371/journal.pone.0148013	http://dx.doi.org/10.1371/journal.pone.0148013			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DK8XE	27124767	gold, Green Published, Green Submitted			2022-12-26	WOS:000375211700001
J	Matsumoto, K; Ayukawa, T; Ishio, A; Sasamura, T; Yamakawa, T; Matsuno, K				Matsumoto, Kenjiroo; Ayukawa, Tomonori; Ishio, Akira; Sasamura, Takeshi; Yamakawa, Tomoko; Matsuno, Kenji			Dual Roles of O-Glucose Glycans Redundant with Monosaccharide O-Fucose on Notch in Notch Trafficking	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						cell signaling; Drosophila; fucosyltransferase; intracellular trafficking; Notch pathway; O-fucosetransferase; O-glucose; O-glycan; UDP-xylose synthase; xylosyltransferase	HEPARAN-SULFATE PROTEOGLYCANS; PROTEIN O-FUCOSYL-TRANSFERASE-1; LIGAND BINDING; MODIFIES NOTCH; DROSOPHILA; GLYCOSYLATION; RECEPTOR; GLYCOSYLTRANSFERASE; GENE; XYLOSYLTRANSFERASE	Notch is a transmembrane receptor that mediates cell-cell interactions and controls various cell-fate specifications in metazoans. The extracellular domain of Notch contains multiple epidermal growth factor (EGF)-like repeats. At least five different glycans are found in distinct sites within these EGF-like repeats. The function of these individual glycans in Notch signaling has been investigated, primarily by disrupting their individual glycosyltransferases. However, we are just beginning to understand the potential functional interactions between these glycans. Monosaccharide O-fucose and O-glucose trisaccharide (O-glucose-xylose-xylose) are added to many of the Notch EGF-like repeats. In Drosophila, Shams adds a xylose specifically to the monosaccharide O-glucose. We found that loss of the terminal dixylose of O-glucose-linked saccharides had little effect on Notch signaling. However, our analyses of double mutants of shams and other genes required for glycan modifications revealed that both the monosaccharide O-glucose and the terminal dixylose of O-glucose-linked saccharides function redundantly with the monosaccharide O-fucose in Notch activation and trafficking. The terminal dixylose of O-glucose-linked saccharides and the monosaccharide O-glucose were required in distinct Notch trafficking processes: Notch transport from the apical plasma membrane to adherens junctions, and Notch export from the endoplasmic reticulum, respectively. Therefore, the monosaccharide O-glucose and terminal dixylose of O-glucose-linked saccharides have distinct activities in Notch trafficking, although a loss of these activities is compensated for by the presence of monosaccharide O-fucose. Given that various glycans attached to a protein motif may have redundant functions, our results suggest that these potential redundancies may lead to a serious underestimation of glycan functions.	[Matsumoto, Kenjiroo; Sasamura, Takeshi; Yamakawa, Tomoko; Matsuno, Kenji] Osaka Univ, Dept Biol Sci, 1-1 Machikaneyama, Toyonaka, Osaka 5600043, Japan; [Ayukawa, Tomonori; Ishio, Akira] Tokyo Univ Sci, Dept Biol Sci & Technol, Katsushika Ku, 6-3-1 Niijuku, Tokyo 1251500, Japan	Osaka University; Tokyo University of Science	Matsuno, K (corresponding author), Osaka Univ, Dept Biol Sci, 1-1 Machikaneyama, Toyonaka, Osaka 5600043, Japan.	kmatsuno@bio.sci.osaka-u.ac.jp	Tomoko, Yamakawa/GXG-9619-2022	Tomoko, Yamakawa/0000-0002-6590-6183	Japanese Ministry of Education, Culture, Sports, and Science; PRESTO, the Japan Science and Technology Agency; Japan Society for the Promotion of Science; Naito Foundation; Mizutani Foundation for Glycoscience	Japanese Ministry of Education, Culture, Sports, and Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); PRESTO, the Japan Science and Technology Agency(Japan Science & Technology Agency (JST)); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Naito Foundation(Naito Memorial Foundation); Mizutani Foundation for Glycoscience	This work was supported by grants-in-aid from the Japanese Ministry of Education, Culture, Sports, and Science (to K. Matsuno), grants from PRESTO, the Japan Science and Technology Agency (to K. Matsuno), the Japan Society for the Promotion of Science (to K. Matsumoto), the Naito Foundation (to K. Matsumoto), and a research grant (2015) from the Mizutani Foundation for Glycoscience (to K. Matsuno). The authors declare no that they have no conflict of interest with the contents of this article.	Abad-Rodriguez J, 2015, TRENDS BIOCHEM SCI, V40, P385, DOI 10.1016/j.tibs.2015.03.015; Acar M, 2008, CELL, V132, P247, DOI 10.1016/j.cell.2007.12.016; Ayukawa T, 2012, P NATL ACAD SCI USA, V109, P15318, DOI 10.1073/pnas.1202369109; Bakker H, 2009, J BIOL CHEM, V284, P2576, DOI 10.1074/jbc.M804394200; Bar-Peled M, 2001, P NATL ACAD SCI USA, V98, P12003, DOI 10.1073/pnas.211229198; Boskovski MT, 2013, NATURE, V504, P456, DOI 10.1038/nature12723; Chillakuri CR, 2012, SEMIN CELL DEV BIOL, V23, P421, DOI 10.1016/j.semcdb.2012.01.009; COUSO JP, 1994, CELL, V79, P259, DOI 10.1016/0092-8674(94)90195-3; DANG DT, 1992, DEV GENET, V13, P367, DOI 10.1002/dvg.1020130507; Eames BF, 2010, DEV BIOL, V341, P400, DOI 10.1016/j.ydbio.2010.02.035; Eixelsberger T, 2012, J BIOL CHEM, V287, P31349, DOI 10.1074/jbc.M112.386706; Forsten-Williams K, 2005, J THEOR BIOL, V233, P483, DOI 10.1016/j.jtbi.2004.10.020; Franch-Marro X, 2008, NAT CELL BIOL, V10, P170, DOI 10.1038/ncb1678; Frise E, 1996, P NATL ACAD SCI USA, V93, P11925, DOI 10.1073/pnas.93.21.11925; Goto S, 2001, NAT CELL BIOL, V3, P816, DOI 10.1038/ncb0901-816; Gotting C, 2000, J MOL BIOL, V304, P517, DOI 10.1006/jmbi.2000.4261; Guo M, 1996, NEURON, V17, P27, DOI 10.1016/S0896-6273(00)80278-0; Guruharsha KG, 2012, NAT REV GENET, V13, P654, DOI 10.1038/nrg3272; Han C, 2004, DEVELOPMENT, V131, P1563, DOI 10.1242/dev.01051; Hoskins RA, 2011, GENOME RES, V21, P182, DOI 10.1101/gr.112466.110; Hummel Thomas, 2008, V420, P97, DOI 10.1007/978-1-59745-583-1_6; Ishikawa HO, 2010, J BIOL CHEM, V285, P4122, DOI 10.1074/jbc.M109.016964; Ishio A, 2015, J BIOL CHEM, V290, P505, DOI 10.1074/jbc.M114.616847; Kamimura K, 2006, J CELL BIOL, V174, P773, DOI 10.1083/jcb.200603129; Kuroda J, 2012, MECH DEVELOP, V128, P625, DOI 10.1016/j.mod.2011.12.002; Lacroix C, 2011, NAT PROTOC, V6, P1412, DOI 10.1038/nprot.2011.363; Lee TV, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003547; Luca VC, 2015, SCIENCE, V347, P847, DOI 10.1126/science.1261093; Micchelli CA, 2002, DEVELOPMENT, V129, P843; Moloney DJ, 2000, NATURE, V406, P369, DOI 10.1038/35019000; Moremen KW, 2012, NAT REV MOL CELL BIO, V13, P448, DOI 10.1038/nrm3383; Mummery-Widmer JL, 2009, NATURE, V458, P987, DOI 10.1038/nature07936; Okajima T, 2003, J BIOL CHEM, V278, P42340, DOI 10.1074/jbc.M308687200; Okajima T, 2005, SCIENCE, V307, P1599, DOI 10.1126/science.1108995; Okajima T, 2002, CELL, V111, P893, DOI 10.1016/S0092-8674(02)01114-5; Okajima T, 2008, BMC BIOL, V6, DOI 10.1186/1741-7007-6-1; Pan Y, 2006, DEVELOPMENT, V133, P4933, DOI 10.1242/dev.02679; Pinho SS, 2015, NAT REV CANCER, V15, P540, DOI 10.1038/nrc3982; Port F, 2008, NAT CELL BIOL, V10, P178, DOI 10.1038/ncb1687; Ray M, 2015, J GENET, V94, P407, DOI 10.1007/s12041-015-0535-8; Rincon-Limas DE, 1999, P NATL ACAD SCI USA, V96, P2165, DOI 10.1073/pnas.96.5.2165; Ryder E, 2007, GENETICS, V177, P615, DOI 10.1534/genetics.107.076216; Sakaidani Y, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1591; Sasaki N, 2007, GENES CELLS, V12, P89, DOI 10.1111/j.1365-2443.2007.01037.x; Sasamura T, 2003, DEVELOPMENT, V130, P4785, DOI 10.1242/dev.00679; Sasamura T, 2007, DEVELOPMENT, V134, P1347, DOI 10.1242/dev.02811; Stanley P, 2010, CURR TOP DEV BIOL, V92, P131, DOI 10.1016/S0070-2153(10)92004-8; Takei Y, 2004, DEVELOPMENT, V131, P73, DOI 10.1242/dev.00913; Takeuchi H, 2011, P NATL ACAD SCI USA, V108, P16600, DOI 10.1073/pnas.1109696108; The I, 2000, NAT CELL BIOL, V2, pE79, DOI 10.1038/35010511; Ueyama M, 2008, J BIOL CHEM, V283, P6076, DOI 10.1074/jbc.M709189200; Watson FL, 1999, J NEUROBIOL, V39, P323, DOI 10.1002/(SICI)1097-4695(199905)39:2<323::AID-NEU15>3.0.CO;2-4; Yamamoto S, 2012, SCIENCE, V338, P1229, DOI 10.1126/science.1228745	53	16	17	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 24	2016	291	26					13743	13752		10.1074/jbc.M115.710483	http://dx.doi.org/10.1074/jbc.M115.710483			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DR2YZ	27129198	hybrid, Green Published			2022-12-26	WOS:000379771100028
J	Fishburn, J; Galburt, E; Hahn, S				Fishburn, James; Galburt, Eric; Hahn, Steven			Transcription Start Site Scanning and the Requirement for ATP during Transcription Initiation by RNA Polymerase II	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							OPEN COMPLEX-FORMATION; SACCHAROMYCES-CEREVISIAE; PREINITIATION COMPLEX; PROMOTER CLEARANCE; FACTOR TFIIH; IN-VITRO; MECHANISM; DNA; ARCHITECTURE; ACTIVATION	Saccharomyces cerevisiae RNA polymerase (Pol) II locates transcription start sites (TSS) at TATA-containing promoters by scanning sequences downstream from the site of preinitiation complex formation, a process that involves the translocation of downstream promoter DNA toward Pol II. To investigate a potential role of yeast Pol II transcription in TSS scanning, HIS4 promoter derivatives were generated that limited transcripts in the 30-bp scanned region to two nucleotides in length. Although we found that TSS scanning does not require RNA synthesis, our results revealed that transcription in the purified yeast basal system is largely ATP-independent despite a requirement for the TFIIH DNA translocase subunit Ssl2. This result is rationalized by our finding that, although they are poorer substrates, UTP and GTP can also be utilized by Ssl2. ATP gamma S is a strong inhibitor of rNTP-fueled translocation, and high concentrations of ATP gamma S make transcription completely dependent on added dATP. Limiting Pol II function with low ATP concentrations shifted the TSS position downstream. Combined with prior work, our results show that Pol II transcription plays an important role in TSS selection but is not required for the scanning reaction.	[Fishburn, James; Hahn, Steven] Fred Hutchinson Canc Res Ctr, 1100 Fairview Ave N,Mailstop A1-162, Seattle, WA 98109 USA; [Galburt, Eric] Washington Univ, Sch Med, Dept Biochem & Mol Biophys, St Louis, MO 63110 USA	Fred Hutchinson Cancer Center; Washington University (WUSTL)	Hahn, S (corresponding author), Fred Hutchinson Canc Res Ctr, 1100 Fairview Ave N,Mailstop A1-162, Seattle, WA 98109 USA.	shahn@fredhutch.org		Galburt, Eric/0000-0003-4314-3215; Hahn, Steven/0000-0001-7240-2533	National Institute of General Medical Sciences, National Institutes of Health [2RO1GM053451]; National Science Foundation Molecular and Cellular Biosciences Grant [1243918]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM053451] Funding Source: NIH RePORTER; Direct For Biological Sciences [1243918] Funding Source: National Science Foundation	National Institute of General Medical Sciences, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); National Science Foundation Molecular and Cellular Biosciences Grant; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This work was supported by National Institute of General Medical Sciences, National Institutes of Health Grant 2RO1GM053451 (to S. H.) and National Science Foundation Molecular and Cellular Biosciences Grant 1243918 (to E. G.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	BUNICK D, 1982, CELL, V29, P877, DOI 10.1016/0092-8674(82)90449-4; CHEN W, 1985, EMBO J, V4, P3273, DOI 10.1002/j.1460-2075.1985.tb04077.x; Coin F, 1998, COLD SPRING HARB SYM, V63, P105, DOI 10.1101/sqb.1998.63.105; Dvir A, 1997, P NATL ACAD SCI USA, V94, P9006, DOI 10.1073/pnas.94.17.9006; Dvir A, 1996, J BIOL CHEM, V271, P7245, DOI 10.1074/jbc.271.13.7245; Fazal FM, 2015, NATURE, V525, P274, DOI 10.1038/nature14882; Fishburn J, 2015, P NATL ACAD SCI USA, V112, P3961, DOI 10.1073/pnas.1417709112; Fishburn J, 2012, MOL CELL BIOL, V32, P12, DOI 10.1128/MCB.06242-11; Goel S, 2012, J BIOL CHEM, V287, P557, DOI 10.1074/jbc.M111.281576; GOODRICH JA, 1994, CELL, V77, P145, DOI 10.1016/0092-8674(94)90242-9; Grunberg S, 2013, TRENDS BIOCHEM SCI, V38, P603, DOI 10.1016/j.tibs.2013.09.002; Grunberg S, 2012, NAT STRUCT MOL BIOL, V19, P788, DOI 10.1038/nsmb.2334; HAHN S, 1985, P NATL ACAD SCI USA, V82, P8562, DOI 10.1073/pnas.82.24.8562; Hahn S, 2011, GENETICS, V189, P705, DOI 10.1534/genetics.111.127019; Hampsey M, 1998, MICROBIOL MOL BIOL R, V62, P465, DOI 10.1128/MMBR.62.2.465-503.1998; He Y, 2013, NATURE, V495, P481, DOI 10.1038/nature11991; Holstege FCP, 1997, EMBO J, V16, P7468, DOI 10.1093/emboj/16.24.7468; Jeronimo C, 2014, NAT STRUCT MOL BIOL, V21, P449, DOI 10.1038/nsmb.2810; JIANG Y, 1995, J BIOL CHEM, V270, P1277, DOI 10.1074/jbc.270.3.1277; Jiang Y, 1996, MOL CELL BIOL, V16, P1614; Kaplan CD, 2012, PLOS GENET, V8, P172, DOI 10.1371/journal.pgen.1002627; Khaperskyy DA, 2008, MOL CELL BIOL, V28, P3757, DOI 10.1128/MCB.02272-07; Kim TK, 2000, SCIENCE, V288, P1418, DOI 10.1126/science.288.5470.1418; Kostrewa D, 2009, NATURE, V462, P323, DOI 10.1038/nature08548; Kuehner JN, 2006, J BIOL CHEM, V281, P14119, DOI 10.1074/jbc.M601937200; Kugel JF, 1998, P NATL ACAD SCI USA, V95, P9232, DOI 10.1073/pnas.95.16.9232; Luse DS, 2013, BBA-GENE REGUL MECH, V1829, P63, DOI 10.1016/j.bbagrm.2012.08.010; LUSE DS, 1987, J BIOL CHEM, V262, P14990; Murakami K, 2015, MOL CELL, V59, P133, DOI 10.1016/j.molcel.2015.05.021; NAGAWA F, 1985, P NATL ACAD SCI USA, V82, P8557, DOI 10.1073/pnas.82.24.8557; Pal M, 2005, MOL CELL, V19, P101, DOI 10.1016/j.molcel.2005.05.024; Sainsbury S, 2015, NAT REV MOL CELL BIO, V16, P129, DOI 10.1038/nrm3952; SAWADOGO M, 1984, J BIOL CHEM, V259, P5321; Tirode F, 1999, MOL CELL, V3, P87, DOI 10.1016/S1097-2765(00)80177-X; Tuteja N, 2004, EUR J BIOCHEM, V271, P1835, DOI 10.1111/j.1432-1033.2004.04093.x; WANG WD, 1992, SCIENCE, V255, P450, DOI 10.1126/science.1310361; Wong KH, 2014, MOL CELL, V54, P601, DOI 10.1016/j.molcel.2014.03.024; Yan M, 1997, EMBO J, V16, P7457, DOI 10.1093/emboj/16.24.7457; Zhang ZH, 2005, NUCLEIC ACIDS RES, V33, P2838, DOI 10.1093/nar/gki583; Zhou XH, 1999, J VIROL, V73, P1580, DOI 10.1128/JVI.73.2.1580-1590.1999	40	15	15	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 17	2016	291	25					13040	13047		10.1074/jbc.M116.724583	http://dx.doi.org/10.1074/jbc.M116.724583			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DR2YT	27129284	Green Published, hybrid			2022-12-26	WOS:000379770500013
J	Han, XZ; Tang, JS; Wang, JN; Ren, F; Zheng, JH; Gragg, M; Kiser, P; Park, PSH; Palczewski, K; Yao, XS; Zhang, YW				Han, Xiangzi; Tang, Jinshan; Wang, Jingna; Ren, Feng; Zheng, Jinhua; Gragg, Megan; Kiser, Philip; Park, Paul S. H.; Palczewski, Krzysztof; Yao, Xinsheng; Zhang, Youwei			Conformational Change of Human Checkpoint Kinase 1 (Chk1) Induced by DNA Damage	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PHOSPHORYLATION-INDEPENDENT ACTIVATION; CELL-CYCLE; REPLICATION CHECKPOINT; PROTEIN INTERACTIONS; FISSION YEAST; IN-VIVO; ATR; GENE; CANCER; DOMAIN	Phosphorylation of Chk1 by ataxia telangiectasia-mutated and Rad3-related (ATR) is critical for checkpoint activation upon DNA damage. However, how phosphorylation activates Chk1 remains unclear. Many studies suggest a conformational change model of Chk1 activation in which phosphorylation shifts Chk1 from a closed inactive conformation to an open active conformation during the DNA damage response. However, no structural study has been reported to support this Chk1 activation model. Here we used FRET and bimolecular fluorescence complementary techniques to show that Chk1 indeed maintains a closed conformation in the absence of DNA damage through an intramolecular interaction between a region (residues 31-87) at the N-terminal kinase domain and the distal C terminus. A highly conserved Leu-449 at the C terminus is important for this intramolecular interaction. We further showed that abolishing the intramolecular interaction by a Leu-449 to Arg mutation or inducing ATR-dependent Chk1 phosphorylation by DNA damage disrupts the closed conformation, leading to an open and activated conformation of Chk1. These data provide significant insight into the mechanisms of Chk1 activation during the DNA damage response.	[Han, Xiangzi; Wang, Jingna; Ren, Feng; Zheng, Jinhua; Kiser, Philip; Palczewski, Krzysztof; Zhang, Youwei] Case Western Reserve Univ, Dept Pharmacol, Case Comprehens Canc Ctr, 2109 Adelbert Rd,Wood Bldg W343A, Cleveland, OH 44106 USA; [Gragg, Megan; Park, Paul S. H.] Case Western Reserve Univ, Dept Ophthalmol & Visual Sci, Cleveland, OH 44106 USA; [Tang, Jinshan; Yao, Xinsheng] Jinan Univ, Coll Pharm, Inst Tradit Chinese Med & Nat Prod, Guangzhou 510632, Guangdong, Peoples R China	Case Western Reserve University; Case Western Reserve University; Jinan University	Zhang, YW (corresponding author), Case Western Reserve Univ, Dept Pharmacol, Case Comprehens Canc Ctr, 2109 Adelbert Rd,Wood Bldg W343A, Cleveland, OH 44106 USA.	yxz169@case.edu	金华, 郑/GWM-7529-2022	, Megan/0000-0003-3722-9493	National Institutes of Health [R01EY021731]; Arnold and Mabel Beckman Foundation; NCI, National Institutes of Health [R01 163214]; American Cancer Society [ACS RSG-15-042 DMC]; NATIONAL EYE INSTITUTE [R01EY021731, T32EY024236] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Arnold and Mabel Beckman Foundation; NCI, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); American Cancer Society(American Cancer Society); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	Supported by National Institutes of Health Grant R01EY021731.r John H. Hord Professor of Pharmacology and supported by the Arnold and Mabel Beckman Foundation.r Supported by NCI, National Institutes of Health Grant R01 163214 and American Cancer Society Grant ACS RSG-15-042 DMC.	Capasso H, 2002, J CELL SCI, V115, P4555, DOI 10.1242/jcs.00133; Chen P, 2000, CELL, V100, P681, DOI 10.1016/S0092-8674(00)80704-7; Chen YH, 2009, J BIOL CHEM, V284, P182, DOI 10.1074/jbc.M806530200; Cho SH, 2005, CELL CYCLE, V4, P131, DOI 10.4161/cc.4.1.1299; Cliby WA, 2002, J BIOL CHEM, V277, P1599, DOI 10.1074/jbc.M106287200; Goedhart J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027321; Gong EY, 2015, SCI REP-UK, V5, DOI 10.1038/srep10856; Guo C, 2015, MOL CELL, V57, P492, DOI 10.1016/j.molcel.2014.12.003; Guo ZJ, 2000, GENE DEV, V14, P2745, DOI 10.1101/gad.842500; Han XZ, 2015, J BIOL CHEM, V290, P12370, DOI 10.1074/jbc.M114.621532; Han XZ, 2014, P NATL ACAD SCI USA, V111, P17456, DOI 10.1073/pnas.1408538111; Han XZ, 2014, J BIOL CHEM, V289, P24716, DOI 10.1074/jbc.M114.575035; Hong J, 2012, J CLIN INVEST, V122, P2165, DOI 10.1172/JCI61380; Hovan SC, 2010, J BIOMED OPT, V15, DOI 10.1117/1.3505023; Jackson SP, 2009, NATURE, V461, P1071, DOI 10.1038/nature08467; Katsuragi Y, 2004, MOL BIOL CELL, V15, P1680, DOI 10.1091/mbc.E03-12-0874; Kerppola TK, 2008, ANNU REV BIOPHYS, V37, P465, DOI 10.1146/annurev.biophys.37.032807.125842; Kosoy A, 2008, MOL BIOL CELL, V19, P4546, DOI 10.1091/mbc.E08-04-0444; Kosoy A, 2007, J BIOL CHEM, V282, P20388, DOI 10.1074/jbc.M702652200; Liu QH, 2000, GENE DEV, V14, P1448; Lundgren K, 2008, BREAST CANCER RES, V10, DOI 10.1186/bcr2150; Madoz-Gurpide J, 2007, MOL CELL PROTEOMICS, V6, P2150, DOI 10.1074/mcp.M700006-MCP200; Miyawaki A, 2000, METHOD ENZYMOL, V327, P472, DOI 10.1016/S0076-6879(00)27297-2; Ng CP, 2004, J BIOL CHEM, V279, P8808, DOI 10.1074/jbc.M312215200; Niida H, 2007, MOL CELL BIOL, V27, P2572, DOI 10.1128/MCB.01611-06; Oe T, 2001, DEV BIOL, V229, P250, DOI 10.1006/dbio.2000.9968; Pabla N, 2012, P NATL ACAD SCI USA, V109, P197, DOI 10.1073/pnas.1104767109; Pereira E, 2009, CELL CYCLE, V8, P1788, DOI 10.4161/cc.8.11.8737; Shann YJ, 2001, J BIOL CHEM, V276, P48863, DOI 10.1074/jbc.M108253200; Sriuranpong V, 2004, CLIN CANCER RES, V10, P4944, DOI 10.1158/1078-0432.CCR-03-0757; Truong K, 2001, CURR OPIN STRUC BIOL, V11, P573, DOI 10.1016/S0959-440X(00)00249-9; Verlinden L, 2007, CANCER RES, V67, P6574, DOI 10.1158/0008-5472.CAN-06-3545; Walker M, 2009, ONCOGENE, V28, P2314, DOI 10.1038/onc.2009.102; Walworth NC, 1996, SCIENCE, V271, P353, DOI 10.1126/science.271.5247.353; Wan SH, 1999, YEAST, V15, P821, DOI 10.1002/(SICI)1097-0061(199907)15:10A<821::AID-YEA422>3.3.CO;2-R; Wang JN, 2012, CANCER RES, V72, P3786, DOI 10.1158/0008-5472.CAN-12-0523; Wang JN, 2012, J BIOL CHEM, V287, P25501, DOI 10.1074/jbc.M112.350397; Wang SX, 2000, FEBS LETT, V487, P277, DOI 10.1016/S0014-5793(00)02370-X; Wilsker D, 2008, P NATL ACAD SCI USA, V105, P20752, DOI 10.1073/pnas.0806917106; Xu J, 2012, INT J PHOTOENERGY, V2012, DOI 10.1155/2012/425735; Yao Hongliang, 2010, Zhong Nan Da Xue Xue Bao Yi Xue Ban, V35, P1080, DOI 10.3969/j.issn.1672-7347.2010.10.008; Zhang YW, 2009, MOL CELL, V35, P442, DOI 10.1016/j.molcel.2009.06.030; Zhang YW, 2014, INT J CANCER, V134, P1013, DOI 10.1002/ijc.28226; Zhang YW, 2006, CELL CYCLE, V5, P125, DOI 10.4161/cc.5.2.2308; Zhang YW, 2005, MOL CELL, V19, P607, DOI 10.1016/j.molcel.2005.07.019; Zhao H, 2001, MOL CELL BIOL, V21, P4129, DOI 10.1128/MCB.21.13.4129-4139.2001	46	12	12	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 17	2016	291	25					12951	12959		10.1074/jbc.M115.713248	http://dx.doi.org/10.1074/jbc.M115.713248			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DR2YT	27129240	Green Published, hybrid			2022-12-26	WOS:000379770500006
J	Park, J; Yu, YP; Zhou, CY; Li, KW; Wang, DQ; Chang, E; Kim, DS; Vo, B; Zhang, X; Gong, NA; Sharp, K; Steward, O; Vitko, I; Perez-Reyes, E; Eroglu, C; Barres, B; Zaucke, F; Feng, GP; Luo, ZD				Park, John; Yu, Yanhui Peter; Zhou, Chun-Yi; Li, Kang-Wu; Wang, Dongqing; Chang, Eric; Kim, Doo-Sik; Vo, Benjamin; Zhang, Xia; Gong, Nian; Sharp, Kelli; Steward, Oswald; Vitko, Iuliia; Perez-Reyes, Edward; Eroglu, Cagla; Barres, Ben; Zaucke, Frank; Feng, Guoping; Luo, Z. David			Central Mechanisms Mediating Thrombospondin-4-induced Pain States	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BIOSPECIFIC INTERACTION ANALYSIS; CHANNEL ALPHA(2)DELTA SUBUNITS; SURFACE-PLASMON RESONANCE; GATED CALCIUM-CHANNELS; NEUROPATHIC PAIN; SPINAL-CORD; UP-REGULATION; PERIPHERAL NEUROPATHY; GABAPENTIN NEURONTIN; DOUBLE-BLIND	Peripheral nerve injury induces increased expression of thrombospondin-4 (TSP4) in spinal cord and dorsal root ganglia that contributes to neuropathic pain states through unknown mechanisms. Here, we test the hypothesis that TSP4 activates its receptor, the voltage-gated calcium channel Ca-v alpha(2)delta(1) subunit (Ca-v alpha(2)delta(1)), on sensory afferent terminals in dorsal spinal cord to promote excitatory synaptogenesis and central sensitization that contribute to neuropathic pain states. We show that there is a direct molecular interaction between TSP4 and Ca-v alpha(2)delta(1) in the spinal cord in vivo and that TSP4/Ca-v alpha(2)delta(1)-dependent processes lead to increased behavioral sensitivities to stimuli. In dorsal spinal cord, TSP4/Ca-v alpha(2)delta(1)-dependent processes lead to increased frequency of miniature and amplitude of evoked excitatory post-synaptic currents in second-order neurons as well as increased VGlut(2)- and PSD95-positive puncta, indicative of increased excitatory synapses. Blockade of TSP4/Ca-v alpha(2)delta(1)-dependent processes with Ca-v alpha(2)delta(1) ligand gabapentin or genetic Ca-v alpha(2)delta(1) knockdown blocks TSP4 induced nociception and its pathological correlates. Conversely, TSP4 antibodies or genetic ablation blocks nociception and changes in synaptic transmission in mice overexpressing Ca-v alpha(2)delta(1). Importantly, TSP4/Ca-v alpha(2)delta(1)-dependent processes also lead to similar behavioral and pathological changes in a neuropathic pain model of peripheral nerve injury. Thus, a TSP4/Ca-v alpha(2)delta(1)-dependent pathway activated by TSP4 or peripheral nerve injury promotes exaggerated presynaptic excitatory input and evoked sensory neuron hyperexcitability and excitatory synaptogenesis, which together lead to central sensitization and pain state development.	[Park, John; Yu, Yanhui Peter; Zhou, Chun-Yi; Luo, Z. David] Univ Calif Irvine, Dept Pharmacol, Irvine, CA 92697 USA; [Li, Kang-Wu; Chang, Eric; Kim, Doo-Sik; Vo, Benjamin; Zhang, Xia; Gong, Nian; Luo, Z. David] Univ Calif Irvine, Dept Anesthesiol & Perioperat Care, Gillespie Bldg,Rm 3113,837 Hlth Sci Rd, Irvine, CA 92697 USA; [Wang, Dongqing; Feng, Guoping] MIT, Dept Brain & Cognit Sci, E25-618, Cambridge, MA 02139 USA; [Sharp, Kelli; Steward, Oswald; Luo, Z. David] Univ Calif Irvine, Sch Med, Reeve Irvine Res Ctr, Irvine, CA 92697 USA; [Vitko, Iuliia; Perez-Reyes, Edward] Univ Virginia, Dept Pharmacol, Sch Med, Charlottesville, VA 22908 USA; [Eroglu, Cagla] Duke Univ, Med Ctr, Cell Biol, Durham, NC 27710 USA; [Barres, Ben] Stanford Univ, Dept Neurobiol, Stanford, CA 94305 USA; [Zaucke, Frank] Univ Cologne, Fac Med, Ctr Biochem, D-50931 Cologne, Germany; [Zaucke, Frank] Univ Cologne, Fac Med, Cologne Ctr Musculoskeletal Biomech, D-50931 Cologne, Germany	University of California System; University of California Irvine; University of California System; University of California Irvine; Massachusetts Institute of Technology (MIT); University of California System; University of California Irvine; University of Virginia; Duke University; Stanford University; University of Cologne; University of Cologne	Luo, ZD (corresponding author), Univ Calif Irvine, Dept Anesthesiol & Perioperat Care, Gillespie Bldg,Rm 3113,837 Hlth Sci Rd, Irvine, CA 92697 USA.	zluo@uci.edu	Core, Vector/CAF-4832-2022; Zaucke, Frank/AAT-2688-2021; Feng, Guoping/Y-2827-2019; Zaucke, Frank/E-2077-2012; Eroglu, Cagla/P-5315-2014	Eroglu, Cagla/0000-0002-7204-0218	University of California Irvine [CA-62203]; National Institutes of Health [NS069524, NS40135, DE014545, NS064341, DE021847]; Pharmaceutical Research and Manufacturers of America Foundation [PRMAF-52427]; National Institutes of Health Rehabilitation Medicine Scientist Training Program fellowship [K-12]; Institute for Clinical and Translational Science; NATIONAL CANCER INSTITUTE [P30CA062203] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE021847] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [R21DE014545] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R21NS069524, R01NS096352, R01NS040135, R01NS064341] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA031833] Funding Source: NIH RePORTER	University of California Irvine(University of California System); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Pharmaceutical Research and Manufacturers of America Foundation; National Institutes of Health Rehabilitation Medicine Scientist Training Program fellowship(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Institute for Clinical and Translational Science; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported, in part, through access to the confocal facility of the Optical Biology Shared Resource of the Cancer Center, Support Grant CA-62203, at the University of California Irvine and by National Institutes of Health Grants NS069524 (to E. P.-R.), NS40135, DE014545, and NS064341 (to Z. D. L.), and DE021847 (to O. S. and Z. D. L). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.r Recipient of a Pre-Doctoral Fellowship in Pharmacology/Toxicology from the Pharmaceutical Research and Manufacturers of America Foundation (PRMAF-52427).r Recipient of National Institutes of Health Rehabilitation Medicine Scientist Training Program fellowship (K-12) and faculty career development (KL-2) fellowship from the Institute for Clinical and Translational Science.	Abdi S, 1998, ANESTH ANALG, V87, P1360, DOI 10.1097/00000539-199812000-00027; Adams JC, 2001, ANNU REV CELL DEV BI, V17, P25, DOI 10.1146/annurev.cellbio.17.1.25; Adams JC, 2011, CSH PERSPECT BIOL, V3, DOI [10.1101/cshperspect.a009712, 10.1016/j.biocel.2004.01.004]; Ahn SH, 2003, SPINE, V28, P341, DOI 10.1097/00007632-200302150-00005; ARBER S, 1995, J CELL BIOL, V131, P1083, DOI 10.1083/jcb.131.4.1083; Backonja M, 1998, JAMA-J AM MED ASSOC, V280, P1831, DOI 10.1001/jama.280.21.1831; Backonja M, 2003, CLIN THER, V25, P81, DOI 10.1016/S0149-2918(03)90011-7; Basso DM, 2006, J NEUROTRAUM, V23, P635, DOI 10.1089/neu.2006.23.635; Bauer CS, 2009, J NEUROSCI, V29, P4076, DOI 10.1523/JNEUROSCI.0356-09.2009; BENMENACHEM E, 1995, EPILEPSY RES, V21, P231; Bernstein GM, 2007, CELL CALCIUM, V41, P27, DOI 10.1016/j.ceca.2006.04.010; Bornstein P, 2001, J CLIN INVEST, V107, P929, DOI 10.1172/JCI12749; Boroujerdi A, 2011, PAIN, V152, P649, DOI 10.1016/j.pain.2010.12.014; Braz J, 2014, NEURON, V82, P522, DOI 10.1016/j.neuron.2014.01.018; Chang EY, 2013, EUR J PAIN, V17, P505, DOI 10.1002/j.1532-2149.2012.00221.x; Chang K, 2006, NAT METHODS, V3, P707, DOI 10.1038/NMETH923; Chung KH, 2006, NUCLEIC ACIDS RES, V34, DOI 10.1093/nar/gkl143; Davies A, 2007, TRENDS PHARMACOL SCI, V28, P220, DOI 10.1016/j.tips.2007.03.005; Davies A, 2010, P NATL ACAD SCI USA, V107, P1654, DOI 10.1073/pnas.0908735107; DIXON WJ, 1980, ANNU REV PHARMACOL, V20, P441, DOI 10.1146/annurev.pa.20.040180.002301; Dunkle ET, 2007, EXP EYE RES, V84, P707, DOI 10.1016/j.exer.2006.12.014; Dworkin RH, 2005, NAT REV DRUG DISCOV, V4, P455, DOI 10.1038/nrd1756; Dworkin RH, 2007, PAIN, V132, P237, DOI 10.1016/j.pain.2007.08.033; ELLIS SB, 1988, SCIENCE, V241, P1661, DOI 10.1126/science.2458626; Eroglu C, 2009, CELL, V139, P380, DOI 10.1016/j.cell.2009.09.025; Faralli A, 2016, BRAIN STRUCT FUNCT, V221, P3193, DOI 10.1007/s00429-015-1095-7; Field MJ, 2006, P NATL ACAD SCI USA, V103, P17537, DOI 10.1073/pnas.0409066103; Field MJ, 1997, BRIT J PHARMACOL, V121, P1513, DOI 10.1038/sj.bjp.0701320; Gee NS, 1996, J BIOL CHEM, V271, P5768, DOI 10.1074/jbc.271.10.5768; Gordh TE, 2008, PAIN, V138, P255, DOI 10.1016/j.pain.2007.12.011; Graham BA, 2007, J NEUROPHYSIOL, V98, P1057, DOI 10.1152/jn.00581.2007; Guay David R P, 2005, Am J Geriatr Pharmacother, V3, P274, DOI 10.1016/j.amjopharm.2005.12.008; Gustorff G, 2004, ANESTH ANALG, V98, P401, DOI [10.1213/01/ANE.0000095150.76735.5D, 10.1213/01.ANE.0000095150.76735.5D]; HARGREAVES K, 1988, PAIN, V32, P77, DOI 10.1016/0304-3959(88)90026-7; Hasegawa H, 2007, J NEUROSCI, V27, P14404, DOI 10.1523/JNEUROSCI.4908-07.2007; Hioki H, 2007, GENE THER, V14, P872, DOI 10.1038/sj.gt.3302924; Hoppa MB, 2012, NATURE, V486, P122, DOI 10.1038/nature11033; Hunter JC, 1997, EUR J PHARMACOL, V324, P153, DOI 10.1016/S0014-2999(97)00070-8; Hwang JH, 1997, REGION ANESTH, V22, P249, DOI 10.1016/S1098-7339(06)80010-6; JAY SD, 1991, J BIOL CHEM, V266, P3287; JOHNSSON B, 1991, ANAL BIOCHEM, V198, P268, DOI 10.1016/0003-2697(91)90424-R; JONSSON U, 1991, BIOTECHNIQUES, V11, P620; Kim DS, 2012, J NEUROSCI, V32, P8977, DOI 10.1523/JNEUROSCI.6494-11.2012; Kim DS, 2009, PAIN, V143, P114, DOI 10.1016/j.pain.2009.02.006; KIM SH, 1992, PAIN, V50, P355, DOI 10.1016/0304-3959(92)90041-9; Klugbauer N, 1999, J NEUROSCI, V19, P684; Klugbauer N, 2003, J BIOENERG BIOMEMBR, V35, P639, DOI 10.1023/B:JOBB.0000008028.41056.58; Levendoglu F, 2004, SPINE, V29, P743, DOI 10.1097/01.BRS.0000112068.16108.3A; Li CY, 2006, PAIN, V125, P20, DOI 10.1016/j.pain.2006.04.022; Li CY, 2004, J NEUROSCI, V24, P8494, DOI 10.1523/JNEUROSCI.2982-04.2004; Li KW, 2014, J BIOL CHEM, V289, P7025, DOI 10.1074/jbc.M114.548990; Lin YX, 2004, J NEUROPHYSIOL, V92, P2820, DOI 10.1152/jn.00048.2004; Luo ZD, 2002, J PHARMACOL EXP THER, V303, P1199, DOI 10.1124/jpet.102.041574; Luo ZD, 2001, J NEUROSCI, V21, P1868, DOI 10.1523/JNEUROSCI.21-06-01868.2001; Ma DK, 2001, SCIENCE, V291, P316, DOI 10.1126/science.291.5502.316; Marais E, 2001, MOL PHARMACOL, V59, P1243, DOI 10.1124/mol.59.5.1243; McCarty DM, 2001, GENE THER, V8, P1248, DOI 10.1038/sj.gt.3301514; Michalski D, 2013, NEUROSCIENCE, V231, P328, DOI 10.1016/j.neuroscience.2012.11.046; Newton RA, 2001, MOL BRAIN RES, V95, P1, DOI 10.1016/S0169-328X(01)00188-7; Nguyen D, 2009, MOL PAIN, V5, DOI 10.1186/1744-8069-5-6; Nikitczuk JS, 2014, HIPPOCAMPUS, V24, P943, DOI 10.1002/hipo.22282; Pan B, 2015, J NEUROSCI RES, V93, P443, DOI 10.1002/jnr.23498; Pan JQ, 2000, J NEUROSCI, V20, P4769; Park J, 2016, J COMP NEUROL, V524, P309, DOI 10.1002/cne.23844; Patel MK, 2000, BRIT J PHARMACOL, V130, P1731, DOI 10.1038/sj.bjp.0703530; Perederiy JV, 2013, J NEUROSCI, V33, P4754, DOI 10.1523/JNEUROSCI.4785-12.2013; Qin N, 2002, MOL PHARMACOL, V62, P485, DOI 10.1124/mol.62.3.485; RANDALL LO, 1957, ARCH INT PHARMACOD T, V111, P409; Rigaud M, 2008, PAIN, V136, P188, DOI 10.1016/j.pain.2008.01.016; Rose MA, 2002, ANAESTHESIA, V57, P451, DOI 10.1046/j.0003-2409.2001.02399.x; Rosenberg JM, 1997, CLIN J PAIN, V13, P251, DOI 10.1097/00002508-199709000-00011; Rosner H, 1996, CLIN J PAIN, V12, P56, DOI 10.1097/00002508-199603000-00010; Shepard AR, 2005, ANAL BIOCHEM, V344, P287, DOI 10.1016/j.ab.2005.06.005; Shimoyama M, 2000, PAIN, V85, P405, DOI 10.1016/S0304-3959(99)00283-3; Sodersten F, 2006, CONNECT TISSUE RES, V47, P85, DOI 10.1080/03008200600584124; Stacey BR, 2008, PAIN MED, V9, P1202, DOI 10.1111/j.1526-4637.2008.00423.x; Stanfa LC, 1997, NEUROREPORT, V8, P587, DOI 10.1097/00001756-199702100-00002; To TP, 2002, SPINAL CORD, V40, P282, DOI 10.1038/sj.sc.3101300; Underhill SM, 2015, J NEUROSCI, V35, P5260, DOI 10.1523/JNEUROSCI.4365-14.2015; Werner MU, 2001, REGION ANESTH PAIN M, V26, P322, DOI 10.1053/rapm.2001.25070; Xiao W, 2007, NEUROSCIENCE, V144, P714, DOI 10.1016/j.neuroscience.2006.09.044; Xu JY, 2010, NAT NEUROSCI, V13, P22, DOI 10.1038/nn.2459; Zareba G, 2005, DRUG TODAY, V41, P509, DOI 10.1358/dot.2005.41.8.910482; Zhou C, 2015, EUR J PAIN, V19, P1267, DOI 10.1002/ejp.656; Zhou C, 2014, EUR J PAIN, V18, P649, DOI 10.1002/j.1532-2149.2013.00416.x	85	34	34	0	5	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 17	2016	291	25					13335	13348		10.1074/jbc.M116.723478	http://dx.doi.org/10.1074/jbc.M116.723478			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DR2YT	27129212	Green Published, hybrid			2022-12-26	WOS:000379770500035
J	Schnicker, NJ; Dey, M				Schnicker, Nicholas J.; Dey, Mishtu			Bacillus anthracis Prolyl 4-Hydroxylase Modifies Collagen-like Substrates in Asymmetric Patterns	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TAURINE/ALPHA-KETOGLUTARATE DIOXYGENASE; 2-HIS-1-CARBOXYLATE FACIAL TRIAD; SPIN FE(IV) COMPLEX; BINDING DOMAIN; NITRIC-OXIDE; ACTIVE-SITE; ZALERION-ARBORICOLA; STRUCTURAL MOTIFS; CRYSTAL-STRUCTURE; IRON ENZYMES	Proline hydroxylation is the most prevalent post-translational modification in collagen. The resulting product trans-4-hydroxyproline (Hyp) is of critical importance for the stability and thus function of collagen, with defects leading to several diseases. Prolyl 4-hydroxylases (P4Hs) are mononuclear non-heme iron alpha-ketoglutarate (alpha KG)-dependent dioxygenases that catalyze Hyp formation. Although animal and plant P4Hs target peptidyl proline, prokaryotes have been known to use free L-proline as a precursor to form Hyp. The P4H from Bacillus anthracis (BaP4H) has been postulated to act on peptidyl proline in collagen peptides, making it unusual within the bacterial clade, but its true physiological substrate remains enigmatic. Here we use mass spectrometry, fluorescence binding, x-ray crystallography, and docking experiments to confirm that BaP4H recognizes and acts on peptidyl substrates but not free L-proline, using elements characteristic of an Fe(II)/alpha KG-dependent dioxygenases. We further show that BaP4H can hydroxylate unique peptidyl proline sites in collagen-derived peptides with asymmetric hydroxylation patterns. The cofactor-bound crystal structures of BaP4H reveal active site conformational changes that define open and closed forms and mimic "ready" and "product-released" states of the enzyme in the catalytic cycle. These results help to clarify the role of BaP4H as well as provide broader insights into human collagen P4H and proteins with poly-L-proline type II helices.	[Schnicker, Nicholas J.; Dey, Mishtu] Univ Iowa, Dept Chem, Iowa City, IA 52242 USA	University of Iowa	Dey, M (corresponding author), Univ Iowa, Dept Chem, Iowa City, IA 52242 USA.	mishtu-dey@uiowa.edu		Schnicker, Nicholas/0000-0002-5189-4943	University of Iowa College of Liberal Arts and Sciences	University of Iowa College of Liberal Arts and Sciences	This work was supported by the University of Iowa College of Liberal Arts and Sciences. The authors declare that they have no conflicts of interest with the contents of this article.	ADEFARATI AA, 1992, J ANTIBIOT, V45, P1953, DOI 10.7164/antibiotics.45.1953; ADEFARATI AA, 1991, J AM CHEM SOC, V113, P3542, DOI 10.1021/ja00009a048; Afonine PV, 2012, ACTA CRYSTALLOGR D, V68, P352, DOI 10.1107/S0907444912001308; Aik W, 2012, CURR OPIN STRUC BIOL, V22, P691, DOI 10.1016/j.sbi.2012.10.001; Anantharajan J, 2013, STRUCTURE, V21, P2107, DOI 10.1016/j.str.2013.09.005; Aprelikova O, 2004, J CELL BIOCHEM, V92, P491, DOI 10.1002/jcb.20067; BERG RA, 1973, BIOCHEMISTRY-US, V12, P3395, DOI 10.1021/bi00742a005; BERG RA, 1977, BIOCHEMISTRY-US, V16, P1615, DOI 10.1021/bi00627a014; Berisio R, 2012, CURR PROTEIN PEPT SC, V13, P855, DOI 10.2174/138920312804871157; Bollinger JM, 2009, CURR OPIN CHEM BIOL, V13, P51, DOI 10.1016/j.cbpa.2009.03.018; Bollinger JM, 2006, J INORG BIOCHEM, V100, P586, DOI 10.1016/j.jinorgbio.2006.01.022; Bruijnincx PCA, 2008, CHEM SOC REV, V37, P2716, DOI 10.1039/b707179p; Brummett AE, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0127288; Cerveny L, 2013, INFECT IMMUN, V81, P629, DOI 10.1128/IAI.01035-12; Clifton IJ, 2006, J INORG BIOCHEM, V100, P644, DOI 10.1016/j.jinorgbio.2006.01.024; Costas M, 2004, CHEM REV, V104, P939, DOI 10.1021/cr020628n; Coufal DE, 1999, BIOCHEMISTRY-US, V38, P4504, DOI 10.1021/bi9823378; Culpepper MA, 2010, BIOCHEMISTRY-US, V49, P124, DOI 10.1021/bi901771z; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Eriksson M, 1999, J BIOL CHEM, V274, P22131, DOI 10.1074/jbc.274.32.22131; Evans PR, 2011, ACTA CRYSTALLOGR D, V67, P282, DOI 10.1107/S090744491003982X; Gaffney BJ, 2009, BIOL MAGN RESON, V28, P233, DOI 10.1007/978-0-387-84856-3_6; Gorres KL, 2010, CRIT REV BIOCHEM MOL, V45, P106, DOI 10.3109/10409231003627991; Grzyska PK, 2005, BIOCHEMISTRY-US, V44, P3845, DOI 10.1021/bi048746n; Hausinger RP, 2004, CRIT REV BIOCHEM MOL, V39, P21, DOI 10.1080/10409230490440541; Hieta R, 2003, J BIOL CHEM, V278, P34966, DOI 10.1074/jbc.M303624200; Hieta R, 2002, J BIOL CHEM, V277, P23965, DOI 10.1074/jbc.M201865200; Hoffart LM, 2006, P NATL ACAD SCI USA, V103, P14738, DOI 10.1073/pnas.0604005103; Horita S, 2015, STRUCTURE, V23, P639, DOI 10.1016/j.str.2015.01.014; Huttlin EL, 2010, CELL, V143, P1174, DOI 10.1016/j.cell.2010.12.001; HUTTON JJ, 1967, ARCH BIOCHEM BIOPHYS, V121, P384, DOI 10.1016/0003-9861(67)90091-4; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Kaelin WG, 2008, MOL CELL, V30, P393, DOI 10.1016/j.molcel.2008.04.009; Keskiaho K, 2007, PLANT CELL, V19, P256, DOI 10.1105/tpc.106.042739; KIVIRIKKO KI, 1971, BIOCHEM BIOPH RES CO, V45, P1591, DOI 10.1016/0006-291X(71)90203-8; Knauer SH, 2012, FEBS J, V279, P816, DOI 10.1111/j.1742-4658.2012.08473.x; Koehntop KD, 2005, J BIOL INORG CHEM, V10, P87, DOI 10.1007/s00775-005-0624-x; Koski MK, 2007, J BIOL CHEM, V282, P37112, DOI 10.1074/jbc.M706554200; Koski MK, 2009, J BIOL CHEM, V284, P25290, DOI 10.1074/jbc.M109.014050; Kukkola L, 2004, J BIOL CHEM, V279, P18656, DOI 10.1074/jbc.M401514200; LANCASTER JR, 1992, J BIOL CHEM, V267, P10994; Lange SJ, 1998, CURR OPIN CHEM BIOL, V2, P159, DOI 10.1016/S1367-5931(98)80057-4; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Loenarz C, 2008, NAT CHEM BIOL, V4, P152, DOI 10.1038/nchembio0308-152; Loenarz C, 2011, TRENDS BIOCHEM SCI, V36, P7, DOI 10.1016/j.tibs.2010.07.002; London N, 2011, NUCLEIC ACIDS RES, V39, pW249, DOI 10.1093/nar/gkr431; Longbotham JE, 2015, BIOCHEMISTRY-US, V54, P6093, DOI 10.1021/acs.biochem.5b00789; MAJAMAA K, 1984, EUR J BIOCHEM, V138, P239, DOI 10.1111/j.1432-1033.1984.tb07907.x; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; McDonough MA, 2006, P NATL ACAD SCI USA, V103, P9814, DOI 10.1073/pnas.0601283103; McNeill LA, 2005, MOL BIOSYST, V1, P321, DOI 10.1039/b511249b; Miller MA, 2008, ACTA CRYSTALLOGR F, V64, P788, DOI 10.1107/S1744309108023439; Myllyharju J, 1999, EMBO J, V18, P306, DOI 10.1093/emboj/18.2.306; Myllyharju J, 2013, ACTA PHYSIOL, V208, P148, DOI 10.1111/apha.12096; Myllyharju J, 2004, TRENDS GENET, V20, P33, DOI 10.1016/j.tig.2003.11.004; Myllyharju J, 2008, ANN MED, V40, P402, DOI 10.1080/07853890801986594; ORVILLE AM, 1993, J BIOL CHEM, V268, P8596; Pappalardi MB, 2011, BIOCHEM J, V436, P363, DOI 10.1042/BJ20101201; Pekkala M, 2004, J BIOL CHEM, V279, P52255, DOI 10.1074/jbc.M410007200; Pierce BG, 2014, BIOINFORMATICS, V30, P1771, DOI 10.1093/bioinformatics/btu097; Ploumakis A, 2015, MOL CELL, V58, P729, DOI 10.1016/j.molcel.2015.05.026; Price JC, 2003, BIOCHEMISTRY-US, V42, P7497, DOI 10.1021/bi030011f; RAMACHANDRAN GN, 1963, J MOL BIOL, V7, P95, DOI 10.1016/S0022-2836(63)80023-6; Rasmussen M, 2003, J BIOL CHEM, V278, P32313, DOI 10.1074/jbc.M304709200; Raveh B, 2010, PROTEINS, V78, P2029, DOI 10.1002/prot.22716; Robert X, 2014, NUCLEIC ACIDS RES, V42, pW320, DOI 10.1093/nar/gku316; Ryle MJ, 2003, P NATL ACAD SCI USA, V100, P3790, DOI 10.1073/pnas.0636740100; Ryle MJ, 2003, BIOCHEMISTRY-US, V42, P1854, DOI 10.1021/bi026832m; Schnicker NJ, 2016, ACTA CRYSTALLOGR D, V72, P675, DOI 10.1107/S2059798316004198; Schofield CJ, 2004, NAT REV MOL CELL BIO, V5, P343, DOI 10.1038/nrm1366; Scotti JS, 2014, P NATL ACAD SCI USA, V111, P13331, DOI 10.1073/pnas.1409916111; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Yuan HX, 2013, MOL CELL, V49, P379, DOI 10.1016/j.molcel.2013.01.019; Zarrinpar A, 2000, NAT STRUCT BIOL, V7, P611, DOI 10.1038/77891	74	11	11	1	25	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 17	2016	291	25					13360	13374		10.1074/jbc.M116.725432	http://dx.doi.org/10.1074/jbc.M116.725432			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DR2YT	27129244	hybrid, Green Published, Green Submitted			2022-12-26	WOS:000379770500037
J	Rosiak, K; Smolarz, M; Stec, WJ; Peciak, J; Grzela, D; Winiecka-Klimek, M; Stoczynska-Fidelus, E; Krynska, B; Piaskowski, S; Rieske, P				Rosiak, Kamila; Smolarz, Maciej; Stec, Wojciech J.; Peciak, Joanna; Grzela, Dawid; Winiecka-Klimek, Marta; Stoczynska-Fidelus, Ewelina; Krynska, Barbara; Piaskowski, Sylwester; Rieske, Piotr			IDH1(R132H) in Neural Stem Cells: Differentiation Impaired by Increased Apoptosis	PLOS ONE			English	Article							GLIOMA-CELLS; IDH2 MUTATIONS; IN-VITRO; INHIBITOR; GROWTH; 2-HYDROXYGLUTARATE; HYPERMETHYLATION; PROLIFERATION; HISTONE; CULTURE	Background The high frequency of mutations in the isocitrate dehydrogenase 1 (IDH1) gene in diffuse gliomas indicates its importance in the process of gliomagenesis. These mutations result in loss of the normal function and acquisition of the neomorphic activity converting a-ketoglutarate to 2-hydroxyglutarate. This potential oncometabolite may induce the epigenetic changes, resulting in the deregulated expression of numerous genes, including those related to the differentiation process or cell survivability. Methods Neural stem cells were derived from human induced pluripotent stem cells following embryoid body formation. Neural stem cells transduced with mutant IDH1(R132H), empty vector, non-transduced and overexpressing IDH1(WT) controls were differentiated into astrocytes and neurons in culture. The neuronal and astrocytic differentiation was determined by morphology and expression of lineage specific markers (MAP2, Synapsin I and GFAP) as determined by real-time PCR and immunocytochemical staining. Apoptosis was evaluated by real-time observation of Caspase-3 activation and measurement of PARP cleavage by Western Blot. Results Compared with control groups, cells expressing IDH1(R132H) retained an undifferentiated state and lacked morphological changes following stimulated differentiation. The significant inhibitory effect of IDH1(R132H) on neuronal and astrocytic differentiation was confirmed by immunocytochemical staining for markers of neural stem cells. Additionally, real-time PCR indicated suppressed expression of lineage markers. High percentage of apoptotic cells was detected within IDH1(R132H)-positive neural stem cells population and their derivatives, if compared to normal neural stem cells and their derivatives. The analysis of PARP and Caspase-3 activity confirmed apoptosis sensitivity in mutant protein-expressing neural cells. Conclusions Our study demonstrates that expression of IDH1(R132H) increases apoptosis susceptibility of neural stem cells and their derivatives. Robust apoptosis causes differentiation deficiency of IDH1(R132H)-expressing cells.	[Rosiak, Kamila; Peciak, Joanna; Winiecka-Klimek, Marta; Stoczynska-Fidelus, Ewelina; Piaskowski, Sylwester; Rieske, Piotr] Med Univ Lodz, Dept Tumor Biol, Zeligowskiego 7-9, PL-90752 Lodz, Poland; [Smolarz, Maciej; Stec, Wojciech J.; Grzela, Dawid] Celther Polska, Dept Res & Dev, Milionowa 23, PL-93193 Lodz, Poland; [Krynska, Barbara] Temple Univ, Shriners Hosp Pediat Res Ctr, Ctr Neural Repair & Rehabil, Sch Med, 3500 N Broad St, Philadelphia, PA 19140 USA	Medical University Lodz; Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University; Shriners Hospitals Children Philadelphia	Rieske, P (corresponding author), Med Univ Lodz, Dept Tumor Biol, Zeligowskiego 7-9, PL-90752 Lodz, Poland.	piotr.rieske@umed.lodz.pl	Pęciak, Joanna/W-3441-2018; Rieske, Piotr/M-4821-2015; Stoczynska-Fidelus, Ewelina/S-9948-2016; Grzela, Dawid P/G-6395-2015; Stoczynska-Fidelus, Ewelina/M-4871-2015	Pęciak, Joanna/0000-0003-0911-4795; Rieske, Piotr/0000-0002-2970-0970; Grzela, Dawid P/0000-0002-0667-6488; Rosiak, Kamila/0000-0002-7711-3519; Stoczynska-Fidelus, Ewelina/0000-0002-7779-3075	National Science Center [2012/05/B/NZ4/02623]	National Science Center(National Science Centre, Poland)	This study was financially supported by the National Science Center, grant no. 2012/05/B/NZ4/02623 (to SP). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Balss J, 2008, ACTA NEUROPATHOL, V116, P597, DOI 10.1007/s00401-008-0455-2; Brat DJ, 2015, NEW ENGL J MED, V372, P2481, DOI 10.1056/NEJMoa1402121; Campos B, 2012, INT J CANCER, V131, P1963, DOI 10.1002/ijc.27446; Cui DM, 2016, INT J BIOCHEM CELL B, V73, P72, DOI 10.1016/j.biocel.2016.02.007; Dang L, 2009, NATURE, V462, P739, DOI 10.1038/nature08617; Eckel-Passow JE, 2015, NEW ENGL J MED, V372, P2499, DOI 10.1056/NEJMoa1407279; Figueroa ME, 2010, CANCER CELL, V18, P553, DOI 10.1016/j.ccr.2010.11.015; Hartmann C, 2009, ACTA NEUROPATHOL, V118, P469, DOI 10.1007/s00401-009-0561-9; Jaeger A, 2015, CELL MOL NEUROBIOL, V35, P1203, DOI 10.1007/s10571-015-0213-7; Jin YH, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0131998; Kernytsky A, 2015, BLOOD, V125, P296, DOI 10.1182/blood-2013-10-533604; Kim YH, 2011, J CLIN PATHOL, V64, P850, DOI 10.1136/jclinpath-2011-200133; Kivell BM, 2001, BRAIN RES PROTOC, V6, P91, DOI 10.1016/S1385-299X(00)00037-4; Koivunen P, 2012, NATURE, V483, P485, DOI 10.1038/nature10898; Kraus TFJ, 2012, INT J CANCER, V131, P1577, DOI 10.1002/ijc.27429; Lee SM, 2002, FREE RADICAL BIO MED, V32, P1185, DOI 10.1016/S0891-5849(02)00815-8; Li SC, 2013, NEURO-ONCOLOGY, V15, P57, DOI 10.1093/neuonc/nos261; Llaguno SA, 2009, CANCER CELL, V15, P45, DOI 10.1016/j.ccr.2008.12.006; Lu C, 2012, NATURE, V483, P474, DOI 10.1038/nature10860; Ohgaki H, 2013, CLIN CANCER RES, V19, P764, DOI 10.1158/1078-0432.CCR-12-3002; Ohgaki H, 2011, BRAIN TUMOR PATHOL, V28, P177, DOI 10.1007/s10014-011-0029-1; Orr BA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041036; Pfaffl MW, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.9.e36; Piaskowski S, 2011, BRIT J CANCER, V104, P968, DOI 10.1038/bjc.2011.27; Rieske P, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-54; Rohle D, 2013, SCIENCE, V340, P626, DOI 10.1126/science.1236062; Saha SK, 2014, NATURE, V513, P110, DOI 10.1038/nature13441; Sasaki M, 2012, GENE DEV, V26, P2038, DOI 10.1101/gad.198200.112; SCOTT RE, 1993, INT J DEV BIOL, V37, P67; Shi JL, 2014, NEUROL SCI, V35, P839, DOI 10.1007/s10072-013-1607-2; Soffietti R, 2010, EUR J NEUROL, V17, P1124, DOI 10.1111/j.1468-1331.2010.03151.x; Stoczynsica-Fidelus E, 2014, ANTICANCER RES, V34, P2859; Suijker J, 2015, ONCOTARGET, V6, P14832, DOI 10.18632/oncotarget.4024; The WHO, 2020, CLASSIFICATION TUMOU; Turcan S, 2013, ONCOTARGET, V4, P1729, DOI 10.18632/oncotarget.1412; Wang F, 2013, SCIENCE, V340, P622, DOI 10.1126/science.1234769; Ward PS, 2010, CANCER CELL, V17, P225, DOI 10.1016/j.ccr.2010.01.020; Weller M, 2014, LANCET ONCOL, V15, pE395, DOI 10.1016/S1470-2045(14)70011-7; Winiecka-Klimek M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0141688; Xu W, 2011, CANCER CELL, V19, P17, DOI 10.1016/j.ccr.2010.12.014	40	15	15	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 4	2016	11	5							e0154726	10.1371/journal.pone.0154726	http://dx.doi.org/10.1371/journal.pone.0154726			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DL5KR	27145078	gold, Green Submitted, Green Published			2022-12-26	WOS:000375676400065
J	Xiang, N; Lawrence, KS				Xiang, Ni; Lawrence, Kathy S.			Optimization of In Vitro Techniques for Distinguishing between Live and Dead Second Stage Juveniles of Heterodera glycines and Meloidogyne incognita	PLOS ONE			English	Article							PLANT-PARASITIC NEMATODES; ROTYLENCHULUS-RENIFORMIS; CAENORHABDITIS-ELEGANS; LIVING NEMATODES	Heterodera glycines (Soybean Cyst nematode, or SCN) and Meloidogyne incognita (Root-Knot nematode, or RKN) are two damaging plant-parasitic nematodes on important field crops. Developing a quick method to distinguish between live and dead SCN and RKN second stage juveniles (J2) is vital for high throughput screening of pesticides or biological compounds against SCN and RKN. The in vitro assays were conducted in 96-well plates to determine the optimum chemical stimulus to distinguish between live and dead SCN and RKN J2. Sodium carbonate (Na2CO3), sodium bicarbonate (NaHCO3), and sodium hydroxide (NaOH) were evaluated for the nematode response to see if these compounds can help distinguish between viable from the dead J2. Results indicated that live SCN J2 responded equally (P <= 0.05) to 1 mu l Na2CO3 and 10 mu l NaHCO3 in 100 mu l of water at pH = 10. Live SCN J2 responded by twisting their bodies in a curling shape and increasing rate of movements within 2 minutes of exposure. The twisting activity continued for up to 30 minutes. Live RKN J2 responded by increasing activity with the application of 1 mu l NaOH in 100 mu l of water at pH = 10 also in the 2 minutes to 30 minutes time frame. Furthermore, in growth chamber tests to confirm the infectivity of live SCN. The live SCN as determined by exposure to 1 mu l of Na2CO3 indicated 60.5% of the SCN J2 were alive and of those, 29.5% were infective and entered the soybean roots. The 1 mu l of NaOH stimulus revealed that 75.2% RKN J2 were alive and of those, 14.9% were infective and entered soybean roots. These results confirmed that 1 mu l of Na2CO3 added to 100 mu l suspension of SCN J2 and 1 mu l of NaOH added to 100 mu l suspension of RKN J2 are the effective stimuli for rapidly distinguishing between live and dead SCN and RKN J2 in vitro. SCN and RKN J2 responded differently to different compounds.	[Xiang, Ni; Lawrence, Kathy S.] Auburn Univ, Dept Entomol & Plant Pathol, Auburn, AL 36849 USA	Auburn University System; Auburn University	Xiang, N (corresponding author), Auburn Univ, Dept Entomol & Plant Pathol, Auburn, AL 36849 USA.	nzx0001@auburn.edu	Lawrence, Kathy/AAA-3808-2020; Xiang, Ni/I-3176-2019	Lawrence, Kathy/0000-0002-5358-2011; Xiang, Ni/0000-0003-0805-7901	Auburn University; BASF; Cotton Inc.	Auburn University; BASF(BASF); Cotton Inc.(Cotton R&D Corp)	This work was supported in part by Auburn University, BASF, and Cotton Inc. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BALDWIN JG, 1973, J NEMATOL, V5, P285; Bird AF, 1979, J NEMATOL, V11, P103; Byrd D.W., 1983, J NEMATOL, V15, P142; CHAUDHURI N, 1966, NEMATOLOGICA, V12, P337, DOI 10.1163/187529266X00761; Chen SY, 2000, J NEMATOL, V32, P190; Chen SY, 2000, J NEMATOL, V32, P117; DROPKIN VH, 1966, ANN NY ACAD SCI, V139, P39, DOI 10.1111/j.1749-6632.1966.tb41183.x; Faske TR, 2006, J NEMATOL, V38, P240; Grego M, 2013, BIOGEOSCIENCES, V10, P4565, DOI 10.5194/bg-10-4565-2013; HUSSEY RS, 1973, PLANT DIS REP, V57, P1025; JENKINS W. R., 1964, PLANT DIS REP, V48, P692; Lee DL, 1976, PHYS NEMATODES; MEYER SLF, 1988, P HELM SOC WASH, V55, P132; Micnroy, 2014, P 2014 BELTW COTT C, V1, P258; Nehrke K, 2002, J BIOL CHEM, V277, P29036, DOI 10.1074/jbc.M203200200; OGIGA IR, 1974, NEMATOLOGICA, V20, P271, DOI 10.1163/187529274X00302; Perry RN, 1996, ANNU REV PHYTOPATHOL, V34, P181, DOI 10.1146/annurev.phyto.34.1.181; RIDDLE DL, 1985, PARASITOLOGY, V91, P185, DOI 10.1017/S0031182000056626; RIGGS RD, 1988, J NEMATOL, V20, P392; Sambongi Y, 2000, NEUROREPORT, V11, P2229, DOI 10.1097/00001756-200007140-00033; Schroeder NE, 2007, J NEMATOL, V39, P43; SHEPHERD AUDREY M., 1962, NEMATOLOGICA, V8, P201; WERGIN WP, 1976, J ULTRA MOL STRUCT R, V56, P258, DOI 10.1016/S0022-5320(76)90002-2	23	15	17	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 4	2016	11	5							e0154818	10.1371/journal.pone.0154818	http://dx.doi.org/10.1371/journal.pone.0154818			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DL5KR	27144277	Green Published, gold, Green Submitted			2022-12-26	WOS:000375676400078
J	Bischof, HJ; Eckmeier, D; Keary, N; Lowel, S; Mayer, U; Michael, N				Bischof, Hans-Joachim; Eckmeier, Dennis; Keary, Nina; Loewel, Siegrid; Mayer, Uwe; Michael, Neethu			Multiple Visual Field Representations in the Visual Wulst of a Laterally Eyed Bird, the Zebra Finch (Taeniopygia guttata)	PLOS ONE			English	Article							GENICULATE-NUCLEUS; OCULAR DOMINANCE; PROJECTION AREA; DOMESTIC CHICK; STRIATE CORTEX; ORIENTATION; LESIONS; CAT; ORGANIZATION; ECTOSTRIATUM	The visual wulst is the telencephalic target of the avian thalamofugal visual system. It contains several retinotopically organised representations of the contralateral visual field. We used optical imaging of intrinsic signals, electrophysiological recordings, and retrograde tracing with two fluorescent tracers to evaluate properties of these representations in the zebra finch, a songbird with laterally placed eyes. Our experiments revealed that there is some variability of the neuronal maps between individuals and also concerning the number of detectable maps. It was nonetheless possible to identify three different maps, a posterolateral, a posteromedial, and an anterior one, which were quite constant in their relation to each other. The posterolateral map was in contrast to the two others constantly visible in each successful experiment. The topography of the two other maps was mirrored against that map. Electrophysiological recordings in the anterior and the posterolateral map revealed that all units responded to flashes and to moving bars. Mean directional preferences as well as latencies were different between neurons of the two maps. Tracing experiments confirmed previous reports on the thalamo-wulst connections and showed that the anterior and the posterolateral map receive projections from separate clusters within the thalamic nuclei. Maps are connected to each other by wulst intrinsic projections. Our experiments confirm that the avian visual wulst contains several separate retinotopic maps with both different physiological properties and different thalamo-wulst afferents. This confirms that the functional organization of the visual wulst is very similar to its mammalian equivalent, the visual cortex.	[Bischof, Hans-Joachim; Keary, Nina] Univ Bielefeld, Verhaltensforsch, D-33615 Bielefeld, Germany; [Eckmeier, Dennis] Ctr Unknown, Champalimaud Neurosci Programme, Lisbon, Portugal; [Loewel, Siegrid; Michael, Neethu] Univ Gottingen, Johann Friedrich Blumenbach Inst Zool & Anthropol, Dept Syst Neurosci, D-37073 Gottingen, Germany; [Mayer, Uwe] Univ Trento, Ctr Mind Brain Sci, Rovereto, Italy; [Michael, Neethu] Gottingen Grad Sch Neurosci Biophys & Mol Biosci, Gottingen, Germany	University of Bielefeld; Fundacao Champalimaud; University of Gottingen; University of Trento	Bischof, HJ (corresponding author), Univ Bielefeld, Verhaltensforsch, D-33615 Bielefeld, Germany.	bischof@uni-bielefeld.de	Mayer, Uwe/AFV-7974-2022; Eckmeier, Dennis/AAE-7886-2020	Mayer, Uwe/0000-0001-6841-0282; Eckmeier, Dennis/0000-0002-7818-8993	Federal Ministry of Education and Research (Bundesministerium fur Bildung und Forschung, BMBF) [01GQ0810]; DeutscheForschungsgemeinschaft (DFG) [BI 245/21-1, LO 442/8-1, LO 442/8-2, GSC 226/2]; Bielefeld University	Federal Ministry of Education and Research (Bundesministerium fur Bildung und Forschung, BMBF)(Federal Ministry of Education & Research (BMBF)); DeutscheForschungsgemeinschaft (DFG)(German Research Foundation (DFG)); Bielefeld University	This study was funded by grants from a Federal Ministry of Education and Research (Bundesministerium fur Bildung und Forschung, BMBF, http://www.bmbf.de/)-grant number 01GQ0810 (S.L.), DeutscheForschungsgemeinschaft (DFG) (http://www.dfg.de/index.jsp) Grant numbers: BI 245/21-1 (HJB), LO 442/8-1 and LO 442/8-2 (SL), GSC 226/2, (Gottingen Graduate School for Neurosciences, Biophysics and Molecular Biosciences Grant to NM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; Our thanks are due to Edda Geissler and Anja Wildberg who helped managing the administrative side of the research project. We acknowledge support for the Article Processing Charge by the Deutsche Forschungsgemeinschaft and the Open Access Publication Fund of Bielefeld University.	ALBUS K, 1975, EXP BRAIN RES, V24, P181, DOI 10.1007/BF00234062; [Anonymous], 1941, AM J OPHTHALMOL, DOI [10.1016/S0002-9394(41)91363-6, DOI 10.1016/S0002-9394(41)91363-6]; BAGNOLI P, 1990, BRAIN BEHAV EVOLUT, V35, P31, DOI 10.1159/000115854; Berens P, 2009, J STAT SOFTW, V31, P1, DOI 10.18637/jss.v031.i10; BISCHOF HJ, 1981, BRAIN RES BULL, V7, P435, DOI 10.1016/0361-9230(81)90042-3; Blake R, 2011, VISION RES, V51, P754, DOI 10.1016/j.visres.2010.10.009; BONHOEFFER T, 1991, NATURE, V353, P429, DOI 10.1038/353429a0; BREDENKOTTER M, 1990, BRAIN RES, V515, P343, DOI 10.1016/0006-8993(90)90620-Q; Bredenkotter M, 1996, BRAIN BEHAV EVOLUT, V47, P23, DOI 10.1159/000113226; Budzynski CA, 2002, EUR J NEUROSCI, V15, P197, DOI 10.1046/j.0953-816x.2001.01833.x; Chapman B, 1998, P NATL ACAD SCI USA, V95, P2609, DOI 10.1073/pnas.95.5.2609; CHAVES LM, 1993, VISUAL NEUROSCI, V10, P1099, DOI 10.1017/S0952523800010208; Coppola DM, 1998, P NATL ACAD SCI USA, V95, P2621, DOI 10.1073/pnas.95.5.2621; DENTON CJ, 1981, EXP NEUROL, V74, P482, DOI 10.1016/0014-4886(81)90186-2; Dugas-Ford J, 2012, P NATL ACAD SCI USA, V109, P16974, DOI 10.1073/pnas.1204773109; DULAC S, 1990, J NEUROPHYSIOL, V63, P131, DOI 10.1152/jn.1990.63.1.131; GANDAL CHARLES P., 1956, JOUR AMER VET MED ASSOC, V128, P332; GEISERT EE, 1980, J COMP NEUROL, V190, P793, DOI 10.1002/cne.901900410; GOODALE MA, 1992, TRENDS NEUROSCI, V15, P20, DOI 10.1016/0166-2236(92)90344-8; GUILLERY RW, 1980, J COMP NEUROL, V194, P117, DOI 10.1002/cne.901940107; Gunturkun Onur, 1993, P115; GUSEL'NIKOV V I, 1977, Neuroscience and Behavioral Physiology, V8, P210, DOI 10.1007/BF01184060; HALLETT PE, 1987, BIOL CYBERN, V57, P275, DOI 10.1007/BF00338820; Henke H, 1983, PROGR NONMAMMALIAN B, P113; Heyers D, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000937; HODOS W, 1984, BEHAV BRAIN RES, V13, P15, DOI 10.1016/0166-4328(84)90026-3; HODOS W, 1988, BEHAV BRAIN RES, V30, P43, DOI 10.1016/0166-4328(88)90007-1; HOLLANDER H, 1977, J COMP NEUROL, V173, P519, DOI 10.1002/cne.901730308; Horton JC, 1996, J NEUROSCI, V16, P7228; HUBEL DH, 1962, J PHYSIOL-LONDON, V160, P106, DOI 10.1113/jphysiol.1962.sp006837; HUNT SP, 1972, BRAIN RES, V44, P647, DOI 10.1016/0006-8993(72)90328-9; Iwaniuk AN, 2008, J COMP PHYSIOL A, V194, P267, DOI 10.1007/s00359-007-0304-0; Kalatsky VA, 2003, NEURON, V38, P529, DOI 10.1016/S0896-6273(03)00286-1; Keary N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038697; Keary N, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011912; Leminski S, 1996, NEUROREPORT, V7, P557, DOI 10.1097/00001756-199601310-00043; Liu GB, 2003, BRAIN RES, V961, P153, DOI 10.1016/S0006-8993(02)03747-2; Martin GR, 2014, PHILOS T R SOC B, V369, DOI 10.1098/rstb.2013.0040; Mayer U, 2013, J PHYSIOL-PARIS, V107, P2, DOI 10.1016/j.jphysparis.2012.05.002; Medina L, 2000, TRENDS NEUROSCI, V23, P1, DOI 10.1016/S0166-2236(99)01486-1; MICELI D, 1987, J HIRNFORSCH, V28, P45; MICELI D, 1975, BRAIN RES, V100, P125, DOI 10.1016/0006-8993(75)90247-4; Michael N, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0124917; Michael N, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085225; MISHKIN M, 1982, BEHAV BRAIN RES, V6, P57, DOI 10.1016/0166-4328(82)90081-X; MONTERO VM, 1981, BRAIN BEHAV EVOLUT, V18, P194, DOI 10.1159/000121787; Ng BSW, 2010, J NEUROSCI, V30, P6713, DOI 10.1523/JNEUROSCI.4078-09.2010; Nieder A, 2000, J NEUROPHYSIOL, V83, P2967, DOI 10.1152/jn.2000.83.5.2967; NIXDORF BE, 1982, BRAIN RES, V248, P9, DOI 10.1016/0006-8993(82)91142-8; Nixdorf-Bergweiler BE., 2007, STEREOTAXIC ATLAS BR; Orban GA, 1984, STUDIES BRAIN FUNCTI; PARKER DM, 1972, EXP BRAIN RES, V14, P198; PERISIC M, 1971, International Journal of Neuroscience, V2, P7, DOI 10.3109/00207457109146988; PETTIGREW JD, 1976, SCIENCE, V193, P675, DOI 10.1126/science.948741; Reiner A, 2004, J COMP NEUROL, V473, P377, DOI 10.1002/cne.20118; SCHNEIDER GE, 1969, SCIENCE, V163, P895, DOI 10.1126/science.163.3870.895; Schuett S, 2002, J NEUROSCI, V22, P6549; Serre T, 2007, PROG BRAIN RES, V165, P33, DOI 10.1016/S0079-6123(06)65004-8; Shibuki K, 2003, J PHYSIOL-LONDON, V549, P919, DOI 10.1113/jphysiol.2003.040709; SHIMIZU T, 1995, J COMP NEUROL, V359, P551, DOI 10.1002/cne.903590404; SHIMIZU T, 1989, BEHAV NEUROSCI, V103, P262, DOI 10.1037/0735-7044.103.2.262; Shimizu Toru, 2012, P473; Straw Andrew D, 2008, Front Neuroinform, V2, P4, DOI 10.3389/neuro.11.004.2008; THINUSBLANC C, 1991, PHYSIOL BEHAV, V49, P1, DOI 10.1016/0031-9384(91)90221-9; Tohmi M, 2006, J NEUROSCI, V26, P11775, DOI 10.1523/JNEUROSCI.1643-06.2006; TOOTELL RBH, 1988, J NEUROSCI, V8, P1500; WASSLE H, 1989, NATURE, V341, P643, DOI 10.1038/341643a0; Watanabe S, 2004, BEHAV BRAIN RES, V155, P147, DOI 10.1016/j.bbr.2004.04.007; WATANABE S, 1991, VISUAL NEUROSCI, V6, P497, DOI 10.1017/S0952523800001346; WATANABE S, 1992, BEHAV BRAIN RES, V49, P197, DOI 10.1016/S0166-4328(05)80165-2; WATANABE S, 2001, CURR PSYCHOL LETT, V6, P71; Watanabe S, 2011, BEHAV BRAIN RES, V222, P51, DOI 10.1016/j.bbr.2011.03.035; WILSON P, 1980, BRAIN RES, V188, P333, DOI 10.1016/0006-8993(80)90035-9; WILSON P, 1980, BRAIN RES, V188, P319, DOI 10.1016/0006-8993(80)90034-7	74	10	11	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 3	2016	11	5							e0154927	10.1371/journal.pone.0154927	http://dx.doi.org/10.1371/journal.pone.0154927			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DL5KK	27139912	Green Published, gold, Green Submitted			2022-12-26	WOS:000375675700076
J	Chen, WM; Sheu, WHH; Tseng, PC; Lee, TS; Lee, WJ; Chang, PJ; Chiang, AN				Chen, Wei-Ming; Sheu, Wayne H-H; Tseng, Pei-Chi; Lee, Tzong-Shyuan; Lee, Wen-Jane; Chang, Pey-Jium; Chiang, An-Na			Modulation of microRNA Expression in Subjects with Metabolic Syndrome and Decrease of Cholesterol Efflux from Macrophages via microRNA-33-Mediated Attenuation of ATP-Binding Cassette Transporter A1 Expression by Statins	PLOS ONE			English	Article							DENSITY-LIPOPROTEIN CHOLESTEROL; ATORVASTATIN; ABCA1; HDL; PATHWAY; RISK; PITAVASTATIN; METAANALYSIS; FLUVASTATIN; PRAVASTATIN	Metabolic syndrome (MetS) is a complicated health problem that encompasses a variety of metabolic disorders. In this study, we analyzed the relationship between the major biochemical parameters associated with MetS and circulating levels of microRNA (miR)-33, miR-103, and miR-155. We found that miRNA-33 levels were positively correlated with levels of fasting blood glucose, glycosylated hemoglobin A1c, total cholesterol, LDL-cholesterol, and triacylglycerol, but negatively correlated with HDL-cholesterol levels. In the cellular study, miR-33 levels were increased in macrophages treated with high glucose and cholesterol-lowering drugs atorvastatin and pitavastatin. miR-33 has been reported to play an essential role in cholesterol homeostasis through ATP-binding cassette transporter A1 (ABCA1) regulation and reverse cholesterol transport. However, the molecular mechanism underlying the linkage between miR-33 and statin treatment remains unclear. In the present study, we investigated whether atorvastatin and pitavastatin exert their functions through the modulation of miR-33 and ABCA1-mediated cholesterol efflux from macrophages. The results showed that treatment of the statins up-regulated miR-33 expression, but down-regulated ABCA1 mRNA levels in RAW264.7 cells and bone marrow-derived macrophages. Statin-mediated ABCA1 regulation occurs at the post-transcriptional level through targeting of the 3'-UTR of the ABCA1 transcript by miR-33. Additionally, we found significant down-regulation of ABCA1 protein expression in macrophages treated with statins. Finally, we showed that high glucose and statin treatment significantly suppressed cholesterol efflux from macrophages. These findings have highlighted the complexity of statins, which may exert detrimental effects on metabolic abnormalities through regulation of miR-33 target genes.	[Chen, Wei-Ming; Tseng, Pei-Chi; Chiang, An-Na] Natl Yang Ming Univ, Inst Biochem & Mol Biol, Taipei 112, Taiwan; [Chen, Wei-Ming; Chang, Pey-Jium] Chang Gung Mem Hosp, Dept Internal Med, Div Gastroenterol & Hepatol, Chiayi, Taiwan; [Chen, Wei-Ming; Chang, Pey-Jium] Chang Gung Univ, Grad Inst Clin Med Sci, Coll Med, Taoyuan, Taiwan; [Sheu, Wayne H-H; Lee, Wen-Jane] Taichung Vet Gen Hosp, Div Endocrinol & Metab, Dept Internal Med, Taichung, Taiwan; [Sheu, Wayne H-H] Natl Yang Ming Univ, Sch Med, Taipei 112, Taiwan; [Sheu, Wayne H-H] Natl Def Med Ctr, Sch Med, Taipei, Taiwan; [Sheu, Wayne H-H] Natl Chung Hsing Univ, Inst Med Technol, Taichung 40227, Taiwan; [Lee, Tzong-Shyuan] Natl Yang Ming Univ, Inst Physiol, Taipei 112, Taiwan	National Yang Ming Chiao Tung University; Chang Gung Memorial Hospital; Chang Gung University; Taichung Veterans General Hospital; National Yang Ming Chiao Tung University; National Defense Medical Center; National Chung Hsing University; National Yang Ming Chiao Tung University	Chiang, AN (corresponding author), Natl Yang Ming Univ, Inst Biochem & Mol Biol, Taipei 112, Taiwan.	anchia@ym.edu.tw	Lee, Tzong-Shyuan/AAE-5803-2020	Lee, Tzong-Shyuan/0000-0002-9593-4062; Chen, Wei-Ming/0000-0002-4949-393X; Chang, Pey-Jium/0000-0002-6492-0346	Ministry of Education, Aim for the Top University Plan, Taiwan, R.O.C. [103AC-P504]; TCVGH-NYMU Joint Research Program [TCVGH-YM1030202]; Ministry of Science and Technology, R.O.C. [MOST 104-3011-B-010-001-1-4-2]; Ministry of Education; Ministry of Science and Technology, Taiwan	Ministry of Education, Aim for the Top University Plan, Taiwan, R.O.C.(Ministry of Education, Taiwan); TCVGH-NYMU Joint Research Program; Ministry of Science and Technology, R.O.C.; Ministry of Education; Ministry of Science and Technology, Taiwan(Ministry of Science and Technology, Taiwan)	This study was supported by grants from the Ministry of Education, Aim for the Top University Plan (103AC-P504), Taiwan, R.O.C., the TCVGH-NYMU Joint Research Program (TCVGH-YM1030202), and the Ministry of Science and Technology (MOST 104-3011-B-010-001-1-4-2), R.O.C. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We wish to particularly acknowledge the subjects enrolled in this study for their participation and the financial support from the Ministry of Education and the Ministry of Science and Technology, Taiwan.	Abel ED, 2001, NATURE, V409, P729, DOI 10.1038/35055575; Alberti KGMM, 2005, LANCET, V366, P1059, DOI 10.1016/S0140-6736(05)67402-8; Baigent C, 2010, LANCET, V376, P1670, DOI 10.1016/S0140-6736(10)61350-5; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Brault M, 2014, METABOLISM, V63, P735, DOI 10.1016/j.metabol.2014.02.014; Brown AS, 1998, J AM COLL CARDIOL, V32, P665, DOI 10.1016/S0735-1097(98)00300-3; Brunham LR, 2008, J CLIN INVEST, V118, P403, DOI 10.1172/JCI33296; Buechler C, 2012, CURR PHARM BIOTECHNO, V13, P319, DOI 10.2174/138920112799095365; Canfran-Duque A, 2014, CARDIOVASC RES, V103, P414, DOI 10.1093/cvr/cvu140; Cederberg H, 2015, DIABETOLOGIA, V58, P1109, DOI 10.1007/s00125-015-3528-5; Chang YC, 2013, J CELL BIOCHEM, V114, P1364, DOI 10.1002/jcb.24478; Chang YC, 2012, J LIPID RES, V53, P1840, DOI 10.1194/jlr.M024471; Corral-Fernandez NE, 2013, EXP CLIN ENDOCR DIAB, V121, P347, DOI 10.1055/s-0033-1341516; Costet P, 2000, J BIOL CHEM, V275, P28240; Guay C, 2013, NAT REV ENDOCRINOL, V9, P513, DOI 10.1038/nrendo.2013.86; Heinecke JW, 2015, CIRC RES, V116, P1101, DOI 10.1161/CIRCRESAHA.115.306052; Ho PC, 2011, FASEB J, V25, P1758, DOI 10.1096/fj.10-179267; Horie T, 2010, P NATL ACAD SCI USA, V107, P17321, DOI 10.1073/pnas.1008499107; Kardassis D, 2014, CURR MED CHEM, V21, P2864, DOI 10.2174/0929867321666140303153430; Kim HS, 2010, CELL METAB, V12, P224, DOI 10.1016/j.cmet.2010.06.009; Kim VN, 2005, MOL CELLS, V19, P1; Libby P, 2011, NATURE, V473, P317, DOI 10.1038/nature10146; Lujambio A, 2012, NATURE, V482, P347, DOI 10.1038/nature10888; Marim FM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015263; Masana L, 2013, CARDIOVASC DIABETOL, V12, DOI 10.1186/1475-2840-12-S1-S2; Moore KJ, 2011, CELL, V145, P341, DOI 10.1016/j.cell.2011.04.005; Najafi-Shoushtari SH, 2010, SCIENCE, V328, P1566, DOI 10.1126/science.1189123; Navarese EP, 2013, AM J CARDIOL, V111, P1123, DOI 10.1016/j.amjcard.2012.12.037; O'Connell RM, 2010, NAT REV IMMUNOL, V10, P111, DOI 10.1038/nri2708; Oikonomou E, 2015, ATHEROSCLEROSIS, V238, P159, DOI 10.1016/j.atherosclerosis.2014.12.014; Park JY, 2015, INT J CARDIOL, V184, P502, DOI 10.1016/j.ijcard.2015.03.047; Patel DC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022142; Petersen CP, 2006, MOL CELL, V21, P533, DOI 10.1016/j.molcel.2006.01.031; Pincus J, 1998, AM J CARDIOL, V82, P406; Preiss D, 2011, JAMA-J AM MED ASSOC, V305, P2556, DOI 10.1001/jama.2011.860; Raitoharju E, 2013, CLIN CHEM, V59, P1708, DOI 10.1373/clinchem.2013.204917; Rajpathak SN, 2009, DIABETES CARE, V32, P1924, DOI 10.2337/dc09-0738; Ramirez CM, 2013, MOL CELL BIOL, V33, P2891, DOI 10.1128/MCB.00016-13; Rayner KJ, 2011, NATURE, V478, P404, DOI 10.1038/nature10486; Rayner KJ, 2011, J CLIN INVEST, V121, P2921, DOI 10.1172/JCI57275; Rayner KJ, 2010, SCIENCE, V328, P1570, DOI 10.1126/science.1189862; Rottiers V, 2011, COLD SH Q B, V76, P225, DOI 10.1101/sqb.2011.76.011049; Sasaki J, 2008, CLIN THER, V30, P1089, DOI 10.1016/j.clinthera.2008.05.017; Satoh M, 2015, CLIN SCI, V129, P93, DOI 10.1042/CS20150027; Sattar N, 2010, LANCET, V375, P735, DOI 10.1016/S0140-6736(09)61965-6; Takaguri A, 2008, J PHARMACOL SCI, V107, P80, DOI 10.1254/jphs.FP0072403; Tang CR, 2009, BBA-MOL CELL BIOL L, V1791, P563, DOI 10.1016/j.bbalip.2009.03.011; Thum T, 2012, EMBO MOL MED, V4, P3, DOI 10.1002/emmm.201100191; Vickers Kasey C, 2010, Curr Opin Endocrinol Diabetes Obes, V17, P150, DOI 10.1097/MED.0b013e32833727a1; Wong J, 2006, BIOCHEM J, V400, P485, DOI 10.1042/BJ20060914; Xu Q, 2015, WORLD J GASTROENTERO, V21, P511, DOI 10.3748/wjg.v21.i2.511; Yildirir Aylin, 2004, Current Vascular Pharmacology, V2, P309, DOI 10.2174/1570161043385475; Yin K, 2010, MOL MED, V16, P438, DOI 10.2119/molmed.2010.00004	53	25	25	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 3	2016	11	5							e0154672	10.1371/journal.pone.0154672	http://dx.doi.org/10.1371/journal.pone.0154672			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DL5KK	27139226	Green Published, gold, Green Submitted			2022-12-26	WOS:000375675700053
J	Louw, JS; Mabaso, M; Peltzer, K				Louw, Julia S.; Mabaso, Musawenkosi; Peltzer, Karl			Change in Health-Related Quality of Life among Pulmonary Tuberculosis Patients at Primary Health Care Settings in South Africa: A Prospective Cohort Study	PLOS ONE			English	Article							RISK-FACTORS; ALCOHOL-USE; PSYCHOLOGICAL DISTRESS; POPULATION; CLINICS; PREVALENCE; DISORDERS; OUTCOMES; SMOKING; TB	Introduction Pulmonary tuberculosis (TB) remains a major public health challenge in South Africa. However, little attention is paid to the impact of health related quality of life (HRQL) among TB patients at the beginning and at the end of TB treatment. This study assesses factors associated with HRQL among tuberculosis patients in three high risk provinces in South Africa. Methods A prospective cohort study was conducted at primary health care settings. Patients completed the HRQL social functioning (SF)-12 health survey. Comparison of Physical Health Summary Score (PCS) and Mental Health Summary Score (MCS) was assessed at 6 months after treatment. Generalized estimating equations (GEEs) were used to examine the factors associated with changes in HRQL. Results In all patients, after 6 months of treatment there was a significant improvement in HRQL with the biggest increase in the PCS. A higher educational qualification had a strong significant positive effect on the mental HRQL. Psychological distress showed a significant negative association with physical and mental HRQL after six months. Permanent residence showed a significant positive association with mental HRQL among TB patients compared to those living in shack/traditional dwellings. Rating ones health as being good and fair/poor was significantly associated with poor physical HRQL. Twenty drinks or more in the past month had a significant negative effect on the physical HRQL. Conclusion The findings suggest that programmes targeted at improving TB treatment success should have specific interventions for patients with low educational background, impoverished households/communities and those with hazardous or harmful alcohol use.	[Louw, Julia S.; Mabaso, Musawenkosi; Peltzer, Karl] Human Sci Res Council, HIV STI & TB HAST Res Programme, Pretoria, South Africa; [Peltzer, Karl] Univ Limpopo, Dept Res & Innovat, Sovenga, South Africa; [Peltzer, Karl] Madidol Univ, ASEAN Inst Hlth Dev, Phutthamonthon, Nakhonpathom, Thailand	Human Sciences Research Council-South Africa; University of Limpopo	Peltzer, K (corresponding author), Human Sci Res Council, HIV STI & TB HAST Res Programme, Pretoria, South Africa.; Peltzer, K (corresponding author), Univ Limpopo, Dept Res & Innovat, Sovenga, South Africa.; Peltzer, K (corresponding author), Madidol Univ, ASEAN Inst Hlth Dev, Phutthamonthon, Nakhonpathom, Thailand.	jslouw@hsrc.ac.za	Peltzer, Karl/D-1518-2019; Peltzer, Karl/Q-7334-2019	Peltzer, Karl/0000-0002-5980-0876; Peltzer, Karl/0000-0002-5980-0876	Department of Health in South Africa [NDOH: 21/2010-2011]	Department of Health in South Africa	The Department of Health in South Africa funded this study through a tender "NDOH: 21/2010-2011 Implementation and monitoring of Screening and Brief Intervention for alcohol use disorders among Tuberculosis patients" that was awarded the HSRC. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrews G, 2001, AUST NZ J PUBL HEAL, V25, P494, DOI 10.1111/j.1467-842X.2001.tb00310.x; Atif M, 2014, HEALTH QUAL LIFE OUT, V12, DOI 10.1186/1477-7525-12-19; Babikako HM, 2010, HEALTH QUAL LIFE OUT, V8, P1, DOI 10.1186/1477-7525-8-93; Babor TF., 2001, AUDIT ALCOHOL USE DI; Bauer M, 2012, QUAL LIFE RES, V21, P9; Brown J, 2015, INT J INFECT DIS, V32, P68, DOI 10.1016/j.ijid.2014.12.045; Chamla D, 2004, INT J TUBERC LUNG D, V8, P1100; COETZEE N, 1988, S AFR MED J, V74, P352; Creswell J, 2011, EUR RESPIR J, V37, P1269, DOI 10.1183/09031936.00084310; Deribew A, 2009, HEALTH QUAL LIFE OUT, V7, DOI 10.1186/1477-7525-7-105; Deribew A, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-408; Dhingra V K, 2005, J Commun Dis, V37, P261; Diel R, 2014, EUR RESPIR J, V43, P554, DOI 10.1183/09031936.00079413; Dujaili JA, 2015, INT J INFECT DIS, V31, P4, DOI 10.1016/j.ijid.2014.12.004; Dujaili JA, 2011, J PUBLIC HEALTH-HEID, V19, P183, DOI 10.1007/s10389-010-0365-3; Guo N, 2009, HEALTH QUAL LIFE OUT, V7, DOI 10.1186/1477-7525-7-14; Hansel NN, 2004, QUAL LIFE RES, V13, P639, DOI 10.1023/B:QURE.0000021317.12945.f0; Harling G, 2008, SOC SCI MED, V66, P492, DOI 10.1016/j.socscimed.2007.08.026; Jeon CY, 2008, PLOS MED, V5; Kessler RC, 2002, PSYCHOL MED, V32, P959, DOI 10.1017/S0033291702006074; Kibrisli E, 2015, MEDICINE, V94, DOI 10.1097/MD.0000000000000413; Kirenga BJ, 2015, BMC PUBLIC HEALTH, V15, DOI 10.1186/s12889-015-1376-3; Kruijshaar ME, 2010, INT J TUBERC LUNG D, V14, P296; Kuznetsov VN, 2013, J ENVIRON PUBLIC HEA, DOI DOI 10.1155/2013/693963; Lienhardt C, 2005, INT J EPIDEMIOL, V34, P914, DOI 10.1093/ije/dyi100; Lonnroth K, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-289; Louw J, 2012, HEALTH QUAL LIFE OUT, V10, DOI 10.1186/1477-7525-10-77; Marra CA, 2008, CHEST, V133, P396, DOI 10.1378/chest.07-1494; Mertens JR, 2009, J DRUG ISSUES, V39, P989, DOI 10.1177/002204260903900411; Miller TL, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005080; Naidoo P, 2010, SOC BEHAV PERSONAL, V38, P1323, DOI 10.2224/sbp.2010.38.10.1323; Pachi A, 2013, TUBERC RES TREAT, V2013, P37; Peltzer K, 2012, ALCOH ALCOHOL, P1; Peltzer K, 2012, BMC PSYCHIATRY, V12, DOI 10.1186/1471-244X-12-89; Peltzer KK, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-394; Rajeswari R, 2005, SOC SCI MED, V60, P1845, DOI 10.1016/j.socscimed.2004.08.024; Rehm J, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-450; Rodriguez FAH, 2015, S AFR FAM PRACT, V57, P106, DOI 10.1080/20786190.2014.978105; Statistics South Africa, 2011, MORT CAUS DEATH S AF; Statistics SouthAfrica, 2014, MORT CAUS DEATH S AF; Unalan Demet, 2008, Indian J Tuberc, V55, P127; Vogl M, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-203; Ware JE, 1995, SCORE SF 12 PHYS MEN; Wig Naveet, 2006, Indian J Med Sci, V60, P3; Williams DR, 2008, PSYCHOL MED, V38, P211, DOI 10.1017/S0033291707001420; Wood R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025098; World Health Organization, GLOB TUB REP 2015 GL; ZEGER SL, 1986, BIOMETRICS, V42, P121, DOI 10.2307/2531248	48	18	21	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 3	2016	11	5							e0151892	10.1371/journal.pone.0151892	http://dx.doi.org/10.1371/journal.pone.0151892			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DL5KK	27137914	Green Published, gold, Green Submitted			2022-12-26	WOS:000375675700003
J	Harlow, BE; Lawrence, LM; Hayes, SH; Crum, A; Flythe, MD				Harlow, Brittany E.; Lawrence, Laurie M.; Hayes, Susan H.; Crum, Andrea; Flythe, Michael D.			Effect of Dietary Starch Source and Concentration on Equine Fecal Microbiota	PLOS ONE			English	Article							HAY-GRAIN RATIOS; SACCHAROMYCES-CEREVISIAE; CELLULOLYTIC BACTERIA; STREPTOCOCCUS-BOVIS; RUMEN BACTERIA; BAG TECHNIQUE; DIGESTION; HORSES; LACTOBACILLI; FERMENTATION	Starch from corn is less susceptible to equine small intestinal digestion than starch from oats, and starch that reaches the hindgut can be utilized by the microbiota. The objective of the current study was to examine the effects of starch source on equine fecal microbiota. Thirty horses were assigned to treatments: control (hay only), HC (high corn), HO (high oats), LC (low corn), LO (low oats), and LW (low pelleted wheat middlings). Horses received an all-forage diet (2 wk; d -14 to d -1) before the treatment diets (2 wk; d 1 to 14). Starch was introduced gradually so that horses received 50% of the assigned starch amount (high = 2 g starch/kg BW; low = 1 g starch/kg BW) by d 4 and 100% by d 11. Fecal samples were obtained at the end of the forage-only period (S0; d -2), and on d 6 (S1) and d 13 (S2) of the treatment period. Cellulolytics, lactobacilli, Group D Gram-positive cocci (GPC), lactate-utilizers and amylolytics were enumerated. Enumeration data were log transformed and analyzed by repeated measures ANOVA. There were sample day x treatment interactions (P < 0.0001) for all bacteria enumerated. Enumerations from control horses did not change during the sampling period (P > 0.05). All treatments except LO resulted in increased amylolytics and decreased cellulolytics, but the changes were larger in horses fed corn and wheat middlings (P < 0.05). Feeding oats resulted in increased lactobacilli and decreased GPC (P < 0.05), while corn had the opposite effects. LW had increased lactobacilli and GPC (P < 0.05). The predominant amylolytic isolates from HC, LC and LW on S2 were identified by 16S RNA gene sequencing as Enterococcus faecalis, but other species were found in oat fed horses. These results demonstrate that starch source can have a differential effect on the equine fecal microbiota.	[Harlow, Brittany E.; Lawrence, Laurie M.; Hayes, Susan H.; Crum, Andrea; Flythe, Michael D.] Univ Kentucky, Dept Anim & Food Sci, Lexington, KY 40546 USA; [Flythe, Michael D.] ARS, Forage Anim Prod Res Unit, USDA, Lexington, KY 40546 USA	University of Kentucky; United States Department of Agriculture (USDA)	Flythe, MD (corresponding author), Univ Kentucky, Dept Anim & Food Sci, Lexington, KY 40546 USA.; Flythe, MD (corresponding author), ARS, Forage Anim Prod Res Unit, USDA, Lexington, KY 40546 USA.	michael.flythe@ars.usda.gov	Flythe, Michael/F-2500-2010	Flythe, Michael/0000-0002-8868-9169; Harlow, Brittany/0000-0002-2269-351X	Prairie Oat Growers Association; USDA-ARS, National Program [215]; National Institutes of Food and Agriculture (Hatch); Prairie Oat Growers	Prairie Oat Growers Association; USDA-ARS, National Program; National Institutes of Food and Agriculture (Hatch); Prairie Oat Growers	This work is supported by: a competitive grant from the Prairie Oat Growers Association. Principle investigator: LML, Co-investigator: MDF. The National Institutes of Food and Agriculture via Hatch: Principle investigator: LML. Salary for MDF was provided by USDA-ARS, National Program 215. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The information reported in this article (No. 15-07-084) is part of a project of the Kentucky Agricultural Experiment Station and is published with the approval of the Director. This work is supported by the National Institutes of Food and Agriculture (Hatch) and the Prairie Oat Growers. MDF was supported by USDA-ARS, National Program 215. The authors acknowledge the technical assistance of Gloria Gellin, and animal husbandry assistance of Laura Strasinger, Ashley Fowler and Tayler Hansen.	Aguilar G, 2000, ENZYME MICROB TECH, V27, P406, DOI 10.1016/S0141-0229(00)00230-1; ALLISON MJ, 1975, AM J VET RES, V36, P181; Bailey SR, 2004, EQUINE VET J, V36, P267, DOI 10.2746/0425164044877297; Bailey SR, 2003, APPL ENVIRON MICROB, V69, P2087, DOI 10.1128/AEM.69.4.2087-2093.2003; Benson DA, 2011, NUCLEIC ACIDS RES, V39, pD32, DOI [10.1093/nar/gkw1070, 10.1093/nar/gks1195, 10.1093/nar/gkq1079, 10.1093/nar/gkt1030, 10.1093/nar/gkx1094, 10.1093/nar/gkn723, 10.1093/nar/gkp1024, 10.1093/nar/gkr1202]; Bochnia M., 2015, INT J SCI RES SCI TE, V1, P110; Bochnia M, 2015, INT J SCI RES SCI TE, V2, P81; Crittenden R, 2002, J SCI FOOD AGR, V82, P781, DOI 10.1002/jsfa.1095; de Fombelle A, 2004, J ANIM SCI, V82, P3625; de Fombelle A, 2001, J EQUINE VET SCI, V21, P439, DOI 10.1016/S0737-0806(01)70018-4; Dougal K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087424; Drogoul C, 2001, J EQUINE VET SCI, V21, P487, DOI 10.1016/S0737-0806(01)70211-0; DRUMMOND AJ, 2006, GENEIOUS V 2 5; Durham AE, 2009, VET CLIN N AM-EQUINE, V25, P67, DOI 10.1016/j.cveq.2008.11.003; FASS, 2010, GUID CAR US AGR AN R, V3rd; Faubladier C, 2013, J ANIM SCI, V91, P1736, DOI 10.2527/jas.2012-5720; Fisher K, 2009, MICROBIOL-SGM, V155, P1749, DOI 10.1099/mic.0.026385-0; Gardini F, 2001, INT J FOOD MICROBIOL, V64, P105, DOI 10.1016/S0168-1605(00)00445-1; GARNER HE, 1975, AM J VET RES, V36, P441; GOODSON J, 1988, APPL ENVIRON MICROB, V54, P1946, DOI 10.1128/AEM.54.8.1946-1950.1988; Harlow BE, 2015, J APPL MICROBIOL, V119, P1234, DOI 10.1111/jam.12927; Harlow BE, 2014, J APPL MICROBIOL, V117, P329, DOI 10.1111/jam.12532; Harlow BE, 2015, J EQUINE VET SCI, V35, P744, DOI 10.1016/j.jevs.2015.07.011; Harlow BE, 2013, VET MICROBIOL, V166, P225, DOI 10.1016/j.vetmic.2013.05.003; HUNGATE RE, 1952, CORNELL VET, V42, P423; IVERSON WG, 1976, CAN J MICROBIOL, V22, P1040, DOI 10.1139/m76-151; Julliand V., 2005, Applied equine nutrition. 1st Equine NUtrition COnference (ENUCO), Hannover, Germany, 1-2 October, 2005, P85; Julliand V, 2001, J EQUINE VET SCI, V21, P543, DOI 10.1016/S0737-0806(01)70159-1; KERN DL, 1973, J ANIM SCI, V37, P463, DOI 10.2527/jas1973.372463x; Kienzle E, 1998, J ANIM PHYSIOL AN N, V80, P213, DOI 10.1111/j.1439-0396.1998.tb00529.x; Kienzle E, 1997, J VET MED A, V44, P207, DOI 10.1111/j.1439-0442.1997.tb01103.x; Kienzle E., 1992, Pferdeheilkunde, P103; Klare I, 2001, Contrib Microbiol, V8, P108; Kong BW, 2003, BIOTECHNOL PROGR, V19, P1162, DOI 10.1021/bp034005m; KOTARSKI SF, 1992, J NUTR, V122, P178, DOI 10.1093/jn/122.1.178; KROGH NILS, 1961, ACTA VET SCAND, V2, P357; KROGH NILS, 1963, ACTA VET SCAND, V4, P41; MacGregor EA, 2001, BBA-PROTEIN STRUCT M, V1546, P1, DOI 10.1016/S0167-4838(00)00302-2; MACGREGOR EA, 1988, J PROTEIN CHEM, V7, P399, DOI 10.1007/BF01024888; MACKIE RI, 1979, APPL ENVIRON MICROB, V38, P416, DOI 10.1128/AEM.38.3.416-421.1979; MANN SO, 1970, J APPL BACTERIOL, V33, P403, DOI 10.1111/j.1365-2672.1970.tb02213.x; MCALLISTER TA, 1990, APPL ENVIRON MICROB, V56, P3146, DOI 10.1128/AEM.56.10.3146-3153.1990; Medina B, 2002, J ANIM SCI, V80, P2600; MEYER H, 1995, J VET MED A, V42, P371, DOI 10.1111/j.1439-0442.1995.tb00389.x; Milinovich GJ, 2006, ENVIRON MICROBIOL, V8, P885, DOI 10.1111/j.1462-2920.2005.00975.x; Moreno MRF, 2006, INT J FOOD MICROBIOL, V106, P1, DOI 10.1016/j.ijfoodmicro.2005.06.026; Nagaraja TG, 2007, J DAIRY SCI, V90, pE17, DOI 10.3168/jds.2006-478; Nagaraja TG, 1998, J ANIM SCI, V76, P287; NRC, 2007, NUTR REQ HORS; Potter G. D., 1992, Pferdeheilkunde, P107; Radicke S, 1991, P 12 EQUINE NUTR PHY, P43; Rosenfeld I, 2009, ANIM FEED SCI TECH, V150, P249, DOI 10.1016/j.anifeedsci.2008.09.002; RUSSELL JB, 1979, APPL ENVIRON MICROB, V37, P531, DOI 10.1128/AEM.37.3.531-536.1979; RUSSELL JB, 1984, J DAIRY SCI, V67, P1525, DOI 10.3168/jds.S0022-0302(84)81471-X; Russell JB, 2002, J MOL MICROB BIOTECH, V4, P347; RUSSELL JB, 1980, APPL ENVIRON MICROB, V39, P604, DOI 10.1128/AEM.39.3.604-610.1980; SCHLEIFER KH, 1984, INT J SYST BACTERIOL, V34, P31, DOI 10.1099/00207713-34-1-31; Sherman JM, 1937, BACTERIOL REV, V1, P3, DOI 10.1128/MMBR.1.1.3-97.1937; Snart J, 2006, APPL ENVIRON MICROB, V72, P1925, DOI 10.1128/AEM.72.3.1925-1931.2006; Svihus B, 2005, ANIM FEED SCI TECH, V122, P303, DOI 10.1016/j.anifeedsci.2005.02.025; Tester RF, 2006, ANIM FEED SCI TECH, V130, P39, DOI 10.1016/j.anifeedsci.2006.01.016; THOMPSON KN, 1984, NUTR REP INT, V30, P189; Whitford MF, 2001, APPL ENVIRON MICROB, V67, P569, DOI 10.1128/AEM.67.2.569-574.2001; Willing B, 2009, EQUINE VET J, V41, P908, DOI 10.2746/042516409X447806; Xiao HJ, 2004, MICROBIOL-SGM, V150, P103, DOI 10.1099/mic.0.26437-0	65	34	35	1	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 29	2016	11	4							e0154037	10.1371/journal.pone.0154037	http://dx.doi.org/10.1371/journal.pone.0154037			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DK8XM	27128793	gold, Green Published, Green Submitted			2022-12-26	WOS:000375212600018
J	Bechill, J; Zhong, R; Zhang, C; Solomaha, E; Spiotto, MT				Bechill, John; Zhong, Rong; Zhang, Chen; Solomaha, Elena; Spiotto, Michael T.			A High-Throughput Cell-Based Screen Identified a 2-[(E)-2-Phenylvinyl]-8-Quinolinol Core Structure That Activates p53	PLOS ONE			English	Article							HUMAN-PAPILLOMAVIRUS TYPE-16; SMALL-MOLECULE RITA; PROTEIN-PROTEIN INTERACTIONS; MUTANT P53; CANCER; INHIBITORS; CHEMOTHERAPY; MDM2; RADIOTHERAPY; DEGRADATION	p53 function is frequently inhibited in cancer either through mutations or by increased degradation via MDM2 and/or E6AP E3-ubiquitin ligases. Most agents that restore p53 expression act by binding MDM2 or E6AP to prevent p53 degradation. However, fewer compounds directly bind to and activate p53. Here, we identified compounds that shared a core structure that bound p53, caused nuclear localization of p53 and caused cell death. To identify these compounds, we developed a novel cell-based screen to redirect p53 degradation to the Skip-Cullin-F-box (SCF) ubiquitin ligase complex in cells expressing high levels of p53. In a multiplexed assay, we coupled p53 targeted degradation with Rb1 targeted degradation in order to identify compounds that prevented p53 degradation while not inhibiting degradation through the SCF complex or other proteolytic machinery. High-throughput screening identified several leads that shared a common 2-[(E)-2-phenylvinyl]-8-quinolinol core structure that stabilized p53. Surface plasmon resonance analysis indicated that these compounds bound p53 with a K-D of 200 +/- 52 nM. Furthermore, these compounds increased p53 nuclear localization and transcription of the p53 target genes PUMA, BAX, p21 and FAS in cancer cells. Although p53-null cells had a 2.5 +/- 0.5-fold greater viability compared to p53 wild type cells after treatment with core compounds, loss of p53 did not completely rescue cell viability suggesting that compounds may target both p53-dependent and p53-independent pathways to inhibit cell proliferation. Thus, we present a novel, cell-based high-throughput screen to identify a 2-[(E)-2-phenylvinyl]-8-quinolinol core structure that bound to p53 and increased p53 activity in cancer cells. These compounds may serve as anti-neoplastic agents in part by targeting p53 as well as other potential pathways.	[Bechill, John; Zhong, Rong; Spiotto, Michael T.] Univ Chicago, Dept Radiat & Cellular Oncol, Chicago, IL 60637 USA; [Zhang, Chen] Univ Illinois Champaign Urbana, High Throughput Screening Facil, Champaign, IL USA; [Solomaha, Elena] Univ Chicago, Biophys Core Facil, Chicago, IL 60637 USA	University of Chicago; University of Illinois System; University of Illinois Urbana-Champaign; University of Chicago	Spiotto, MT (corresponding author), Univ Chicago, Dept Radiat & Cellular Oncol, Chicago, IL 60637 USA.	mspiotto@radonc.uchicago.edu	Spiotto, Michael/AAC-8331-2021		Burroughs Wellcome Fund [1010964]; Fanconi Anemia Research Fund	Burroughs Wellcome Fund(Burroughs Wellcome Fund); Fanconi Anemia Research Fund	This work was supported by Burroughs Wellcome Fund Grant 1010964 and Fanconi Anemia Research Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arkin MR, 2004, NAT REV DRUG DISCOV, V3, P301, DOI 10.1038/nrd1343; Bartelink H, 1997, J CLIN ONCOL, V15, P2040, DOI 10.1200/JCO.1997.15.5.2040; Beerheide W, 1999, J NATL CANCER I, V91, P1211, DOI 10.1093/jnci/91.14.1211; Bernard X, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025981; Boyd SD, 2000, NAT CELL BIOL, V2, P563, DOI 10.1038/35023500; Bykov VJN, 2002, NAT MED, V8, P282, DOI 10.1038/nm0302-282; Cencic R, 2011, P NATL ACAD SCI USA, V108, P1046, DOI 10.1073/pnas.1011477108; Cheok CF, 2011, NAT REV CLIN ONCOL, V8, P25, DOI 10.1038/nrclinonc.2010.174; Cherry JJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0084506; Cinatl J, 2014, BIOCHEM SOC T, V42, P752, DOI 10.1042/BST20140035; Deane CM, 2002, MOL CELL PROTEOMICS, V1, P349, DOI 10.1074/mcp.M100037-MCP200; Feng BY, 2005, NAT CHEM BIOL, V1, P146, DOI 10.1038/nchembio718; Fu L, 2002, J BIOL CHEM, V277, P4255, DOI 10.1074/jbc.M110027200; Hiraki M, 2015, CHEM BIOL, V22, P1206, DOI 10.1016/j.chembiol.2015.07.016; Issaeva N, 2004, NAT MED, V10, P1321, DOI 10.1038/nm1146; Jin LY, 2014, ANNU REV PHARMACOL, V54, P435, DOI 10.1146/annurev-pharmtox-011613-140028; Keys HM, 1999, NEW ENGL J MED, V340, P1154, DOI 10.1056/NEJM199904153401503; Khan MZ, 2008, CELL DEATH DIFFER, V15, P1663, DOI 10.1038/cdd.2008.95; Kostecka A, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.408; Krajewski M, 2005, NAT MED, V11, P1135, DOI 10.1038/nm1105-1135; Kravchenko JE, 2008, P NATL ACAD SCI USA, V105, P6302, DOI 10.1073/pnas.0802091105; Lambert JMR, 2009, CANCER CELL, V15, P376, DOI 10.1016/j.ccr.2009.03.003; Lavelin I, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008503; Liu J, 2004, BIOCHEM BIOPH RES CO, V313, P1023, DOI 10.1016/j.bbrc.2003.12.035; Lu YP, 2006, J MED CHEM, V49, P3759, DOI 10.1021/jm060023+; Mo ZH, 2009, J BIOTECHNOL, V139, P6, DOI 10.1016/j.jbiotec.2008.09.004; Morris M, 1999, NEW ENGL J MED, V340, P1137, DOI 10.1056/NEJM199904153401501; MUNGER K, 1989, J VIROL, V63, P4417; Omura G A, 1996, J Natl Cancer Inst Monogr, P123; Pearcey R, 2002, J CLIN ONCOL, V20, P966, DOI 10.1200/JCO.20.4.966; PHELPS WC, 1988, CELL, V53, P539, DOI 10.1016/0092-8674(88)90570-3; Saddler C, 2008, BLOOD, V111, P1584, DOI 10.1182/blood-2007-09-112698; Schorpp K, 2014, J BIOMOL SCREEN, V19, P715, DOI 10.1177/1087057113516861; Sehr P, 2007, J BIOMOL SCREEN, V12, P560, DOI 10.1177/1087057107301246; Shangary S, 2008, P NATL ACAD SCI USA, V105, P3933, DOI 10.1073/pnas.0708917105; Shangary S, 2009, ANNU REV PHARMACOL, V49, P223, DOI 10.1146/annurev.pharmtox.48.113006.094723; Strack RL, 2008, NAT METHODS, V5, P955, DOI 10.1038/nmeth.1264; Thigpen T, 2003, CANCER J, V9, P425, DOI 10.1097/00130404-200309000-00013; Vassilev LT, 2004, SCIENCE, V303, P844, DOI 10.1126/science.1092472; Wade M, 2013, NAT REV CANCER, V13, P83, DOI 10.1038/nrc3430; WEICHSELBAUM RR, 1986, P NATL ACAD SCI USA, V83, P2684, DOI 10.1073/pnas.83.8.2684; WERNESS BA, 1990, SCIENCE, V248, P76, DOI 10.1126/science.2157286; Wright JD, 2007, J BIOSCIENCES, V32, P827, DOI 10.1007/s12038-007-0083-3; Yakubov B, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089285; Young K, 1998, NAT BIOTECHNOL, V16, P946, DOI 10.1038/nbt1098-946; Yu X, 2012, CANCER CELL, V21, P614, DOI 10.1016/j.ccr.2012.03.042; Zhao CY, 2010, CANCER RES, V70, P3372, DOI 10.1158/0008-5472.CAN-09-2787; Zhou PB, 2000, MOL CELL, V6, P751, DOI 10.1016/S1097-2765(00)00074-5	48	4	4	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 28	2016	11	4							e0154125	10.1371/journal.pone.0154125	http://dx.doi.org/10.1371/journal.pone.0154125			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DK8XE	27124407	Green Submitted, gold, Green Published			2022-12-26	WOS:000375211700048
J	Chang, WX; Xu, N; Kumagai, T; Shiraishi, T; Kikuyama, T; Omizo, H; Sakai, K; Arai, S; Tamura, Y; Ota, T; Shibata, S; Fujigaki, Y; Shen, ZY; Uchida, S				Chang, Wen Xiu; Xu, Ning; Kumagai, Takanori; Shiraishi, Takeshi; Kikuyama, Takahiro; Omizo, Hiroki; Sakai, Kazuhiro; Arai, Shigeyuki; Tamura, Yoshifuru; Ota, Tatsuru; Shibata, Shigeru; Fujigaki, Yoshihide; Shen, Zhong Yang; Uchida, Shunya			The Impact of Normal Range of Serum Phosphorus on the Incidence of End-Stage Renal Disease by A Propensity Score Analysis	PLOS ONE			English	Article							PLASMA PHOSPHATE; KIDNEY-DISEASE; TIME; PROGRESSION; RISK; CKD; ASSOCIATION; PROTEINURIA; PROGNOSIS; MORTALITY	Background Although hyperphosphatemia is deemed a risk factor of the progression of chronic kidney disease (CKD), it remains unclear whether the normal range of serum phosphorus likewise deteriorates CKD. A propensity score analysis was applied to examine the causal effect of the normal range of serum phosphorus on the incidence of end-stage renal disease (ESRD). Methods A retrospective CKD cohort of 803 participants in a single institution was analyzed. Propensity score was estimated using 22 baseline covariates by multivariate binary logistic regression for the different thresholds of time-averaged phosphorus (TA-P) in the normal range of serum phosphorus incremented by 0.1 mg/dL from 3.3 to 4.5 mg/dL. Results The incidence rate of ESRD was 33.9 per 1,000 person-years over median follow-up of 4.3 years. Total patients showed the mean baseline phosphorus of 3.37 mg/dL and were divided to quartile. The higher quartile was associated with the parameters consistent with the advancement of CKD. A stratified Cox regression showed the highest hazard ratio (HR) at TA-P 3.4 mg/dL (HR 17.60, 95% CI 3.92-78.98) adjusted for baseline covariates such as sex, age, diabetic nephropathy, estimated GFR, serum albumin, Na-Cl, phosphorus, LDL-C and proteinuria. Adjusted HRs remained high up to TA-P 4.2 mg/dL (HR 2.22, 95% CI 1.33-3.71). After propensity score matching conducted at the thresholds of TA-P 3.4, 3.6, 3.8 and 4.0 mg/dL, the higher levels of TA-P showed the higher HRs by Kaplan-Meier analysis (p < 0.05 by stratified log-rank test). The numbers needed to treat were calculated as 3.9 to 5.3 over 5 years. Conclusions The propensity score analysis shows that even the normal range of serum phosphorus clearly accelerates CKD progression to ESRD. Our results encourage clinicians to target serum phosphorus to inhibit CKD progression in the manner of 'the lower the better.'	[Chang, Wen Xiu; Xu, Ning] Tianjin First Cent Hosp, Dept Nephrol, Tianjin, Peoples R China; [Kumagai, Takanori; Shiraishi, Takeshi] Teikyo Univ, Sch Med, Support Community Med Endowed Chair, Tokyo 173, Japan; [Kumagai, Takanori; Shiraishi, Takeshi; Kikuyama, Takahiro; Omizo, Hiroki; Sakai, Kazuhiro; Arai, Shigeyuki; Tamura, Yoshifuru; Ota, Tatsuru; Shibata, Shigeru; Fujigaki, Yoshihide; Uchida, Shunya] Teikyo Univ, Sch Med, Dept Internal Med, Tokyo 173, Japan; [Shen, Zhong Yang] Tianjin First Cent Hosp, Dept Organ Transplantat, Tianjin, Peoples R China	Tianjin Medical University; Teikyo University; Teikyo University; Tianjin Medical University	Uchida, S (corresponding author), Teikyo Univ, Sch Med, Dept Internal Med, Tokyo 173, Japan.	s_uchida@netjoy.ne.jp		Shibata, Shigeru/0000-0002-6868-0626; , wen xiu/0000-0001-6269-5694	Ministry of Health, Labour and Welfare of Japan; Gout Research Foundation	Ministry of Health, Labour and Welfare of Japan(Ministry of Health, Labour and Welfare, Japan); Gout Research Foundation	This study was supported in part by a Grant-in-Aid for Progressive Renal Diseases Research, Research on Rare and Intractable Disease, from the Ministry of Health, Labour and Welfare of Japan (to SU) and Gout Research Foundation (to SU). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allison PD, 2013, MEASURES FIT LOGISTI; Altman DG, 1999, BRIT MED J, V319, P1492, DOI 10.1136/bmj.319.7223.1492; Altman DG, 1998, BRIT MED J, V317, P1309, DOI 10.1136/bmj.317.7168.1309; Austin PC, 2008, STAT MED, V27, P2037, DOI 10.1002/sim.3150; Austin PC, 2014, STAT MED, V33, P1242, DOI 10.1002/sim.5984; Austin PC, 2009, STAT MED, V28, P3083, DOI 10.1002/sim.3697; Barbour SJ, 2015, KIDNEY INT, V88, P1392, DOI 10.1038/ki.2015.241; Bouma-de Krijger A, 2014, NEPHROL DIAL TRANSPL, V29, P88, DOI 10.1093/ndt/gft456; Chang WX, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0132927; Chang WX, 2016, CLIN EXP NEPHROL, V20, P58, DOI 10.1007/s10157-015-1132-0; COOK RJ, 1995, BRIT MED J, V310, P452, DOI 10.1136/bmj.310.6977.452; Coresh J, 2014, JAMA-J AM MED ASSOC, V311, P2518, DOI 10.1001/jama.2014.6634; D'Agostino RB, 1998, STAT MED, V17, P2265, DOI 10.1002/(SICI)1097-0258(19981015)17:19<2265::AID-SIM918>3.0.CO;2-B; Da JJ, 2015, AM J KIDNEY DIS, V66, P258, DOI 10.1053/j.ajkd.2015.01.009; de Borst MH, 2011, J AM SOC NEPHROL, V22, P1603, DOI 10.1681/ASN.2010121251; HAKIM RM, 1988, AM J KIDNEY DIS, V11, P238, DOI 10.1016/S0272-6386(88)80156-2; Inker LA, 2014, AM J KIDNEY DIS, V63, P713, DOI 10.1053/j.ajkd.2014.01.416; Johnson ES, 2011, BMC NEPHROL, V12, DOI 10.1186/1471-2369-12-17; Kuro-o M, 2013, NAT REV NEPHROL, V9, P650, DOI 10.1038/nrneph.2013.111; Martin KJ, 2011, CLIN J AM SOC NEPHRO, V6, P440, DOI 10.2215/CJN.05130610; Matsuo S, 2009, AM J KIDNEY DIS, V53, P982, DOI 10.1053/j.ajkd.2008.12.034; Mehrotra R, 2013, KIDNEY INT, V84, P989, DOI 10.1038/ki.2013.145; Ni ZH, 2014, J TRANSL MED, V12, DOI 10.1186/1479-5876-12-194; Normand SLT, 2001, J CLIN EPIDEMIOL, V54, P387, DOI 10.1016/S0895-4356(00)00321-8; Petersen ML, 2012, STAT METHODS MED RES, V21, P31, DOI 10.1177/0962280210386207; Reich HN, 2007, J AM SOC NEPHROL, V18, P3177, DOI 10.1681/ASN.2007050526; ROSENBAUM PR, 1983, BIOMETRIKA, V70, P41, DOI 10.1093/biomet/70.1.41; Seiler S, 2013, CLIN J AM SOC NEPHRO, V8, P1764, DOI 10.2215/CJN.13021212; Sekiguchi S, 2011, AM J PHYSIOL-RENAL, V300, pF848, DOI 10.1152/ajprenal.00334.2010; Tangri N, 2011, JAMA-J AM MED ASSOC, V305, P1553, DOI 10.1001/jama.2011.451; Tierney JF, 2007, TRIALS, V8, DOI 10.1186/1745-6215-8-16; Uchida S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0145506; Uno H, 2011, STAT MED, V30, P1105, DOI 10.1002/sim.4154; Vansteelandt S, 2014, STAT MED, V33, P4053, DOI 10.1002/sim.6207; Voormolen N, 2007, NEPHROL DIAL TRANSPL, V22, P2909, DOI 10.1093/ndt/gfm286; Weitzen S, 2005, PHARMACOEPIDEM DR S, V14, P227, DOI 10.1002/pds.986; Wolkewitz M, 2016, J CLIN EPIDEMIOL, V74, P187, DOI 10.1016/j.jclinepi.2015.11.011; Yang W, 2014, AM J KIDNEY DIS, V63, P236, DOI 10.1053/j.ajkd.2013.08.028; Zoccali C, 2011, J AM SOC NEPHROL, V22, P1923, DOI 10.1681/ASN.2011020175	39	17	17	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 28	2016	11	4							e0154469	10.1371/journal.pone.0154469	http://dx.doi.org/10.1371/journal.pone.0154469			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DK8XE	27123981	Green Published, Green Submitted, gold			2022-12-26	WOS:000375211700094
J	Kolahi, K; Louey, S; Varlamov, O; Thornburg, K				Kolahi, Kevin; Louey, Samantha; Varlamov, Oleg; Thornburg, Kent			Real-Time Tracking of BODIPY-C12 Long-Chain Fatty Acid in Human Term Placenta Reveals Unique Lipid Dynamics in Cytotrophoblast Cells	PLOS ONE			English	Article							COA SYNTHETASE 5; TROPHOBLAST CELLS; TRANSPORT; METABOLISM; FUSION; DIFFERENTIATION; IDENTIFICATION; INVOLVEMENT; PROTEINS; MODEL	While the human placenta must provide selected long-chain fatty acids to support the developing fetal brain, little is known about the mechanisms underlying the transport process. We tracked the movement of the fluorescently labeled long-chain fatty acid analogue, BODIPY-C-12, across the cell layers of living explants of human term placenta. Although all layers took up the fatty acid, rapid esterification of long-chain fatty acids and incorporation into lipid droplets was exclusive to the inner layer cytotrophoblast cells rather than the expected outer syncytiotrophoblast layer. Cytotrophoblast is a progenitor cell layer previously relegated to a repair role. As isolated cytotrophoblasts differentiated into syncytialized cells in culture, they weakened their lipid processing capacity. Syncytializing cells suppress previously active genes that regulate fatty-acid uptake (SLC27A2/FATP2, FABP4, ACSL5) and lipid metabolism (GPAT3, LPCAT3). We speculate that cytotrophoblast performs a previously unrecognized role in regulating placental fatty acid uptake and metabolism.	[Kolahi, Kevin; Louey, Samantha; Thornburg, Kent] Oregon Hlth & Sci Univ, Dept Biomed Engn, Portland, OR 97201 USA; [Kolahi, Kevin; Thornburg, Kent] Oregon Hlth & Sci Univ, Ctr Dev Hlth, Portland, OR 97201 USA; [Thornburg, Kent] Oregon Hlth & Sci Univ, Knight Cardiovasc Inst, Portland, OR 97201 USA; [Thornburg, Kent] Oregon Hlth & Sci Univ, Dept Med, Portland, OR 97201 USA; [Varlamov, Oleg] Oregon Natl Primate Res Ctr, Div Diabet Obes & Metab, Beaverton, OR USA	Oregon Health & Science University; Oregon Health & Science University; Oregon Health & Science University; Oregon Health & Science University; Oregon Health & Science University; Oregon National Primate Research Center	Thornburg, K (corresponding author), Oregon Hlth & Sci Univ, Dept Biomed Engn, Portland, OR 97201 USA.; Thornburg, K (corresponding author), Oregon Hlth & Sci Univ, Ctr Dev Hlth, Portland, OR 97201 USA.; Thornburg, K (corresponding author), Oregon Hlth & Sci Univ, Knight Cardiovasc Inst, Portland, OR 97201 USA.; Thornburg, K (corresponding author), Oregon Hlth & Sci Univ, Dept Med, Portland, OR 97201 USA.	thornbur@ohsu.edu	Varlamov, Oleg/AAK-6980-2020; Louey, Samantha/A-1381-2009	Varlamov, Oleg/0000-0003-0294-215X; Louey, Samantha/0000-0002-2628-0085; Kolahi, Kevin/0000-0002-6190-5597	M. Lowell Edwards Endowment; NICHD [P01HD034430]; Oregon Health and Science University School of Medicine Faculty Innovation Program; Tartar Trust Fellowship; Charles Patrick Memorial Fund; Ruth L. Kirchstein National Research Service Award [F30 HD084095-01]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P01HD034430, F30HD084095] Funding Source: NIH RePORTER	M. Lowell Edwards Endowment; NICHD(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); Oregon Health and Science University School of Medicine Faculty Innovation Program; Tartar Trust Fellowship; Charles Patrick Memorial Fund; Ruth L. Kirchstein National Research Service Award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This research was supported by the M. Lowell Edwards Endowment and NICHD P01HD034430 (KT). Additional funding was provided by the Oregon Health and Science University School of Medicine Faculty Innovation Program (KLT), the Tartar Trust Fellowship (KK). KK was funded by the Charles Patrick Memorial Fund and a Ruth L. Kirchstein National Research Service Award F30 HD084095-01. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This research was supported by the M. Lowell Edwards Endowment and NICHD P01HD034430 (KT). Additional funding provided by Oregon Health and Science University School of Medicine Faculty Innovation Program (KT), the Tartar Trust Fellowship (KK). KK was funded by the Charles Patrick Memorial Fund and a Ruth L. Kirchstein National Research Service Award F30 HD084095-01. The authors thank Amy Valent for proofreading the manuscript.	Afzal I, 2002, BIOCHEM J, V365, P707, DOI 10.1042/BJ20011624; Araujo JR, 2013, J NUTR BIOCHEM, V24, P1741, DOI 10.1016/j.jnutbio.2013.03.003; Benirschke K, 2012, PATHOLOGY OF THE HUM, DOI [10.1007/b138589, DOI 10.1007/B138589]; Brass E, 2013, PLACENTA, V34, P503, DOI 10.1016/j.placenta.2013.03.009; Bu SY, 2010, J LIPID RES, V51, P3270, DOI 10.1194/jlr.M009407; BUDOWSKI P, 1987, BRIT J NUTR, V58, P511, DOI 10.1079/BJN19870119; Campbell FM, 1998, PLACENTA, V19, P409, DOI 10.1016/S0143-4004(98)90081-9; CARLSON SE, 1993, AM J CLIN NUTR, V58, P35, DOI 10.1093/ajcn/58.1.35; COLEMAN RA, 1987, J LIPID RES, V28, P1335; Coleman RA, 2004, PROG LIPID RES, V43, P134, DOI 10.1016/S0163-7827(03)00051-1; Costes SV, 2004, BIOPHYS J, V86, P3993, DOI [10.1529/biophysj.103.038422, 10.1529/biophysi.103.038422]; Crawford MA, 1997, AM J CLIN NUTR, V66, P1032, DOI 10.1093/ajcn/66.4.1032S; CRAWFORD MA, 1976, LANCET, V1, P452; DESOYE G, 1994, MOL ASPECTS MED, V15, P505, DOI 10.1016/0098-2997(94)90004-3; Duttaroy AK, 2009, PROG LIPID RES, V48, P52, DOI 10.1016/j.plipres.2008.11.001; Frendo JL, 2003, J CELL SCI, V116, P3413, DOI 10.1242/jcs.00648; Gauster M, 2007, J CLIN ENDOCR METAB, V92, P2256, DOI 10.1210/jc.2006-2403; Gil-Sanchez A, 2012, CURR OPIN CLIN NUTR, V15, P265, DOI 10.1097/MCO.0b013e3283523b6e; Gil-Sanchez A, 2010, AM J CLIN NUTR, V92, P115, DOI 10.3945/ajcn.2010.29589; Glatz JFC, 2010, PHYSIOL REV, V90, P367, DOI 10.1152/physrev.00003.2009; Greenwood SL, 1996, J PHYSIOL-LONDON, V492, P629, DOI 10.1113/jphysiol.1996.sp021333; Guo W, 2006, AM J PHYSIOL-GASTR L, V290, pG528, DOI 10.1152/ajpgi.00386.2005; Haggarty P, 1997, PLACENTA, V18, P635, DOI 10.1016/S0143-4004(97)90004-7; Hashidate-Yoshida T, 2015, ELIFE, V4, DOI 10.7554/eLife.06328; Hernandez-Albaladejo I, 2014, ACTA OBSTET GYN SCAN, V93, P1198, DOI 10.1111/aogs.12461; Jansson T, 2001, PEDIATR RES, V49, P141, DOI 10.1203/00006450-200102000-00003; Kaemmerer E, 2011, WORLD J GASTROENTERO, V17, P4883, DOI 10.3748/wjg.v17.i44.4883; Kassan A, 2013, J CELL BIOL, V203, P985, DOI 10.1083/jcb.201305142; Kim JH, 2001, J BIOL CHEM, V276, P24667, DOI 10.1074/jbc.M010793200; KLIMAN HJ, 1986, ENDOCRINOLOGY, V118, P1567, DOI 10.1210/endo-118-4-1567; Klingler M, 2003, LIPIDS, V38, P561, DOI 10.1007/s11745-003-1496-8; Krammer J, 2011, INT J MED SCI, V8, P599, DOI 10.7150/ijms.8.599; Kulkarni AV, 2011, PROSTAG LEUKOTR ESS, V84, P51, DOI 10.1016/j.plefa.2010.09.005; Lafond J, 2000, PLACENTA, V21, P661, DOI 10.1053/plac.2000.0561; Lager S, 2012, J PREGNANCY, V2012, DOI 10.1155/2012/179827; Langbein M, 2008, MOL REPROD DEV, V75, P175, DOI 10.1002/mrd.20729; Larque E, 2003, J LIPID RES, V44, P49, DOI 10.1194/jlr.M200067-JLR200; Lindegaard MLS, 2005, J LIPID RES, V46, P2339, DOI 10.1194/jlr.M500277-JLR200; Listenberger LL, 2003, P NATL ACAD SCI USA, V100, P3077, DOI 10.1073/pnas.0630588100; Madsen EM, 2004, J BIOL CHEM, V279, P55271, DOI 10.1074/jbc.M411404200; Melton EM, 2011, J BIOL CHEM, V286, P30670, DOI 10.1074/jbc.M111.226316; Mishima T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025865; Mori M, 2007, BIOL REPROD, V76, P164, DOI 10.1095/biolreprod.106.056127; Morrish DW, 1997, PLACENTA, V18, P577, DOI 10.1016/0143-4004(77)90013-3; O'Tierney PF, 2012, REPROD SCI, V19, P1041, DOI 10.1177/1933719112440051; Pagan A, 2013, AM J PHYSIOL-ENDOC M, V305, pE826, DOI 10.1152/ajpendo.00291.2013; Perazzolo S, 2015, IEEE ENG MED BIO, P8054, DOI 10.1109/EMBC.2015.7320262; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Rambold AS, 2015, DEV CELL, V32, P678, DOI 10.1016/j.devcel.2015.01.029; RIZZO T, 1991, NEW ENGL J MED, V325, P911, DOI 10.1056/NEJM199109263251303; RYBAKOWSKI C, 1995, EUR J OBSTET GYN R B, V62, P107, DOI 10.1016/0301-2115(95)02117-P; Sandoval A, 2010, BIOCHEM PHARMACOL, V79, P990, DOI 10.1016/j.bcp.2009.11.008; Schaiff WT, 2005, J CLIN ENDOCR METAB, V90, P4267, DOI 10.1210/jc.2004-2265; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/nmeth.2019, 10.1038/NMETH.2019]; SIMPSON RA, 1992, PLACENTA, V13, P501, DOI 10.1016/0143-4004(92)90055-X; Sooranna SR, 1999, HUM REPROD, V14, P536, DOI 10.1093/humrep/14.2.536; Stahl A, 1999, MOL CELL, V4, P299, DOI 10.1016/S1097-2765(00)80332-9; Stahl A, 2001, TRENDS ENDOCRIN MET, V12, P266, DOI 10.1016/S1043-2760(01)00427-1; THORNBURG KL, 1976, J CLIN INVEST, V58, P912, DOI 10.1172/JCI108544; Tobin KAR, 2009, PLACENTA, V30, P41, DOI 10.1016/j.placenta.2008.10.007; Van Horn CG, 2005, BIOCHEMISTRY-US, V44, P1635, DOI 10.1021/bi047721l; Varlamov O, 2013, ENDOCRINOLOGY, V154, P4126, DOI 10.1210/en.2013-1428; Wang HJ, 2010, MOL BIOL CELL, V21, P1991, DOI 10.1091/mbc.E09-05-0364; Waterman IJ, 1998, BBA-LIPID LIPID MET, V1394, P169, DOI 10.1016/S0005-2760(98)00105-2; Weedon-Fekjaer MS, 2010, J LIPID RES, V51, P1886, DOI 10.1194/jlr.M004978; Wendel AA, 2009, BBA-MOL CELL BIOL L, V1791, P501, DOI 10.1016/j.bbalip.2008.10.010; Ye J, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-134	67	43	43	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 28	2016	11	4							e0153522	10.1371/journal.pone.0153522	http://dx.doi.org/10.1371/journal.pone.0153522			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DK8XE	27124483	Green Published, gold, Green Submitted			2022-12-26	WOS:000375211700018
J	Toppi, J; Borghini, G; Petti, M; He, EJ; De Giusti, V; He, B; Astolfi, L; Babiloni, F				Toppi, Jlenia; Borghini, Gianluca; Petti, Manuela; He, Eric J.; De Giusti, Vittorio; He, Bin; Astolfi, Laura; Babiloni, Fabio			Investigating Cooperative Behavior in Ecological Settings: An EEG Hyperscanning Study	PLOS ONE			English	Article							PARTIAL DIRECTED COHERENCE; ANTERIOR CINGULATE CORTEX; MENTAL WORKLOAD; INFORMATION-FLOW; BRAIN; CONNECTIVITY; PILOTS; SYNCHRONIZATION; FLIGHT; IDENTIFICATION	The coordinated interactions between individuals are fundamental for the success of the activities in some professional categories. We reported on brain-to-brain cooperative interactions between civil pilots during a simulated flight. We demonstrated for the first time how the combination of neuroelectrical hyperscanning and intersubject connectivity could provide indicators sensitive to the humans' degree of synchronization under a highly demanding task performed in an ecological environment. Our results showed how intersubject connectivity was able to i) characterize the degree of cooperation between pilots in different phases of the flight, and ii) to highlight the role of specific brain macro areas in cooperative behavior. During the most cooperative flight phases pilots showed, in fact, dense patterns of interbrain connectivity, mainly linking frontal and parietal brain areas. On the contrary, the amount of interbrain connections went close to zero in the non-cooperative phase. The reliability of the interbrain connectivity patterns was verified by means of a baseline condition represented by formal couples, i. e. pilots paired offline for the connectivity analysis but not simultaneously recorded during the flight. Interbrain density was, in fact, significantly higher in real couples with respect to formal couples in the cooperative flight phases. All the achieved results demonstrated how the description of brain networks at the basis of cooperation could effectively benefit from a hyperscanning approach. Interbrain connectivity was, in fact, more informative in the investigation of cooperative behavior with respect to established EEG signal processing methodologies applied at a single subject level.	[Toppi, Jlenia; Astolfi, Laura] Univ Roma La Sapienza, Dept Comp Control & Management Engn, Via Ariosto 25, I-00185 Rome, Italy; [Toppi, Jlenia; Borghini, Gianluca; Petti, Manuela; Astolfi, Laura; Babiloni, Fabio] IRCCS Fdn Santa Lucia, Neuroelect Imaging & BCI Lab, Via Ardeatina 306, I-00179 Rome, Italy; [Borghini, Gianluca; De Giusti, Vittorio; Babiloni, Fabio] Univ Roma La Sapienza, Dept Mol Med, Viale Regina Elena 291, I-00185 Rome, Italy; [He, Bin] Univ Minnesota, Dept Biomed Engn, 7-105 Hasselmo Hall 312 Church St SE, Minneapolis, MN USA; [He, Eric J.] Carnegie Mellon Univ, Pittsburgh, PA 15213 USA	Sapienza University Rome; IRCCS Santa Lucia; Sapienza University Rome; University of Minnesota System; University of Minnesota Twin Cities; Carnegie Mellon University	Toppi, J (corresponding author), Univ Roma La Sapienza, Dept Comp Control & Management Engn, Via Ariosto 25, I-00185 Rome, Italy.; Toppi, J (corresponding author), IRCCS Fdn Santa Lucia, Neuroelect Imaging & BCI Lab, Via Ardeatina 306, I-00179 Rome, Italy.	jlenia.toppi@uniroma1.it	Borghini, Gianluca/AAA-4687-2019; Toppi, Jlenia/J-9134-2016; Babiloni, Fabio/E-5169-2015; Petti, Manuela/K-1950-2016	Borghini, Gianluca/0000-0001-8560-5671; Toppi, Jlenia/0000-0002-8279-1699; Babiloni, Fabio/0000-0002-4962-176X; Petti, Manuela/0000-0002-0149-161X	EUROCONTROL on behalf of the SESAR Joint Undertaking in the context of SESAR Work Package E - NINA research project; Project FIRB (Fondo per gli Investimenti della Ricerca di Base-Futuro in Ricerca) [RBFR136E24]; University of Rome Sapienza "Progetti di Ateneo per la Ricerca Scientifica anno"; MIUR under the grant PRIN	EUROCONTROL on behalf of the SESAR Joint Undertaking in the context of SESAR Work Package E - NINA research project; Project FIRB (Fondo per gli Investimenti della Ricerca di Base-Futuro in Ricerca)(Ministry of Education, Universities and Research (MIUR)); University of Rome Sapienza "Progetti di Ateneo per la Ricerca Scientifica anno"; MIUR under the grant PRIN(Ministry of Education, Universities and Research (MIUR))	This work is co-financed by EUROCONTROL on behalf of the SESAR Joint Undertaking in the context of SESAR Work Package E - NINA research project, by Project FIRB 2013 (Fondo per gli Investimenti della Ricerca di Base-Futuro in Ricerca) - RBFR136E24, by the University of Rome Sapienza "Progetti di Ateneo per la Ricerca Scientifica anno 2014" and by the Italian Minister of University (MIUR) under the grant PRIN2012.	Andriy Cherkas OY, 2014, OA MED HYPOTHESIS, V2, P8; Apps MAJ, 2012, SOC NEUROSCI-UK, V7, P424, DOI 10.1080/17470919.2011.638799; Astolfi L, 2012, IEEE ENG MED BIO, P4752, DOI 10.1109/EMBC.2012.6347029; Astolfi L, 2011, IEEE ENG MED BIO, P2338, DOI 10.1109/IEMBS.2011.6090654; Astolfi L, 2007, HUM BRAIN MAPP, V28, P143, DOI 10.1002/hbm.20263; Astolfi L, 2006, IEEE T BIO-MED ENG, V53, P1802, DOI 10.1109/TBME.2006.873692; Astolfi L, 2011, IEEE INTELL SYST, V26, P38, DOI 10.1109/MIS.2011.61; Astolfi L, 2010, BRAIN TOPOGR, V23, P243, DOI 10.1007/s10548-010-0147-9; Babiloni C, 2012, NEUROIMAGE, V60, P105, DOI 10.1016/j.neuroimage.2011.12.008; Babiloni C, 2011, CORTEX, V47, P1082, DOI 10.1016/j.cortex.2011.05.006; Babiloni F, 2014, NEUROSCI BIOBEHAV R, V44, P76, DOI 10.1016/j.neubiorev.2012.07.006; Baccala LA, 2001, BIOL CYBERN, V84, P463, DOI 10.1007/PL00007990; Benjamini Y, 2001, ANN STAT, V29, P1165; Bilek E, 2015, P NATL ACAD SCI USA, V112, P5207, DOI 10.1073/pnas.1421831112; Borghini G., 2012, NEUROSCI BIOBEHAV R, DOI [DOI 10.1016/J.NEUBIOREV.2012.10.003, 10.1016/j.neubiorev.2012.10.003]; Borghini G., 2015, BRAIN TOPOGR, DOI [10.1007/s10548-015-0425-7, DOI 10.1007/S10548-015-0425-7]; Botvinick MM, 2004, TRENDS COGN SCI, V8, P539, DOI 10.1016/j.tics.2004.10.003; Burgess AP, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00881; Burgess PW, 2000, NEUROPSYCHOLOGIA, V38, P848, DOI 10.1016/S0028-3932(99)00134-7; Caldwell JA, 2002, INT J AVIAT PSYCHOL, V12, P19, DOI 10.1207/S15327108IJAP1201_3; Caldwell John A, 2005, Travel Med Infect Dis, V3, P85, DOI 10.1016/j.tmaid.2004.07.008; Carron L, 1991, MORSE CODE THE ESSEN; Cui X, 2012, NEUROIMAGE, V59, P2430, DOI 10.1016/j.neuroimage.2011.09.003; D'Ausilio A, 2015, TRENDS COGN SCI, V19, P111, DOI 10.1016/j.tics.2015.01.005; Dahlstrom N, 2009, INT J AVIAT PSYCHOL, V19, P309, DOI 10.1080/10508410903187547; Dumas G, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012166; Dussault C, 2005, AVIAT SPACE ENVIR MD, V76, P344; Fallani FD, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014187; Forstmann BU, 2006, J COGNITIVE NEUROSCI, V18, P388, DOI 10.1162/089892906775990589; Friston Karl J., 1994, Human Brain Mapping, V2, P56, DOI 10.1002/hbm.460020107; Friston KJ, 2003, NEUROIMAGE, V19, P1273, DOI 10.1016/S1053-8119(03)00202-7; GRANGER CWJ, 1969, ECONOMETRICA, V37, P424, DOI 10.2307/1912791; GUNDEL A, 1995, BIOL PSYCHOL, V40, P131, DOI 10.1016/0301-0511(95)05107-4; Hari R, 2015, NEURON, V88, P181, DOI 10.1016/j.neuron.2015.09.022; Hari R, 2013, TRENDS COGN SCI, V17, P105, DOI 10.1016/j.tics.2013.01.003; Hasson U, 2004, SCIENCE, V303, P1634, DOI 10.1126/science.1089506; Hasson U, 2008, NEURON, V57, P452, DOI 10.1016/j.neuron.2007.12.009; Hasson U, 2012, TRENDS COGN SCI, V16, P114, DOI 10.1016/j.tics.2011.12.007; Helmreich RL, 2000, AVIAT SPACE ENVIR MD, V71, pA133; Hoffmann S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003004; Jiang J, 2012, J NEUROSCI, V32, P16064, DOI 10.1523/JNEUROSCI.2926-12.2012; Jokisch D, 2007, J NEUROSCI, V27, P3244, DOI 10.1523/JNEUROSCI.5399-06.2007; KAMINSKI MJ, 1991, BIOL CYBERN, V65, P203, DOI 10.1007/BF00198091; Kawasaki M, 2013, SCI REP-UK, V3, DOI 10.1038/srep01692; King-Casas B, 2005, SCIENCE, V308, P78, DOI 10.1126/science.1108062; Kitzbichler MG, 2011, J NEUROSCI, V31, P8259, DOI 10.1523/JNEUROSCI.0440-11.2011; Klimesch W, 2012, TRENDS COGN SCI, V16, P606, DOI 10.1016/j.tics.2012.10.007; Knobe J, 2005, TRENDS COGN SCI, V9, P357, DOI 10.1016/j.tics.2005.06.011; Konvalinka I, 2014, NEUROIMAGE, V94, P79, DOI 10.1016/j.neuroimage.2014.03.003; Lal SKL, 2002, PSYCHOPHYSIOLOGY, V39, P313, DOI 10.1017/S0048577201393095; Latora V, 2001, PHYS REV LETT, V87, DOI 10.1103/PhysRevLett.87.198701; Lindenberger U, 2009, BMC NEUROSCI, V10, DOI 10.1186/1471-2202-10-22; McConaughey E, 2008, J PERINAT NEONAT NUR, V22, P96, DOI 10.1097/01.JPN.0000319095.59673.6c; McIntosh AR, 1998, ANN NY ACAD SCI, V855, P556, DOI 10.1111/j.1749-6632.1998.tb10625.x; Montague PR, 2002, NEUROIMAGE, V16, P1159, DOI 10.1006/nimg.2002.1150; Naeem M, 2012, CLIN NEUROPHYSIOL, V123, P1789, DOI 10.1016/j.clinph.2012.02.065; Rubinov M, 2010, NEUROIMAGE, V52, P1059, DOI 10.1016/j.neuroimage.2009.10.003; Sakai K, 2006, J NEUROSCI, V26, P1211, DOI 10.1523/JNEUROSCI.3887-05.2006; Sato JR, 2009, HUM BRAIN MAPP, V30, P452, DOI 10.1002/hbm.20513; Scerbo M, 2001, TP2001211018 NASA LA; STERMAN MB, 1995, BIOL PSYCHOL, V40, P115, DOI 10.1016/0301-0511(95)05101-5; Takahashi DY, 2007, J APPL STAT, V34, P1259, DOI 10.1080/02664760701593065; Tang HH, 2016, SOC COGN AFFECT NEUR, V11, P23, DOI 10.1093/scan/nsv092; Toppi J, 2014, J NEURAL ENG, V11, DOI 10.1088/1741-2560/11/3/035010; Toppi J, 2012, COMPUT MATH METHOD M, V2012, DOI 10.1155/2012/130985; Toppi J, 2011, IEEE ENG MED BIO, P5016, DOI 10.1109/IEMBS.2011.6091243; Wilson GF, 2003, HUM FACTORS, V45, P635, DOI 10.1518/hfes.45.4.635.27088; Wilson GF, 2002, INT J AVIAT PSYCHOL, V12, P3, DOI 10.1207/S15327108IJAP1201_2	68	103	105	1	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 28	2016	11	4							e0154236	10.1371/journal.pone.0154236	http://dx.doi.org/10.1371/journal.pone.0154236			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DK8XE	27124558	gold, Green Submitted, Green Published			2022-12-26	WOS:000375211700059
J	Tang, W; Wang, H; Ha, HL; Tassi, I; Bhardwaj, R; Claudio, E; Siebenlist, U				Tang, W.; Wang, H.; Ha, H. L.; Tassi, I.; Bhardwaj, R.; Claudio, E.; Siebenlist, U.			The B-cell tumor promoter Bcl-3 suppresses inflammation associated colon tumorigenesis in epithelial cells	ONCOGENE			English	Article							NF-KAPPA-B; NECROSIS-FACTOR-ALPHA; MICE DEFICIENT; COLITIS; ONCOPROTEIN; EXPRESSION; SURVIVAL; SODIUM; STAT3	Bcl-3 is an atypical member of the inhibitor of kappa light polypeptide gene enhancer in B-cells (I.B) family. It associates with p50/nuclear factor-kappa B1 (NF-kappa B1) and p52/NF-kappa B2 homodimers in nuclei where it modulates transcription in a context-dependent manner. A subset of B-cell tumors exhibits recurrent translocations of Bcl-3, resulting in overexpression. Elevated expression without translocations is also observed in various B-cell lymphomas and even some solid tumors. Here we investigated the role of Bcl-3 in azoxymethane/dextran sulfate sodium (AOM/DSS)-induced colon tumors, a mouse model for colitis-associated colorectal cancers in humans. Contrary to expectations, Bcl-3 suppressed colorectal tumor formation: Bcl-3-deficient mice were relatively protected from DSS-induced epithelial damage and developed more polyps after AOM/DSS treatment, although polyp size was unaffected. DSSchallenged mutant mice exhibited increased recruitment of myeloid-derived suppressor cells, consistent with protection of the epithelium. Loss of Bcl-3 in intestinal epithelial cells was sufficient to increase tumorigenesis. The added tumor burden in mutant mice was dependent on tumor necrosis factor-a (TNF alpha), a tumorigenic, NF-kappa B-mediated signaling pathway that was dampened by Bcl-3. These findings reveal a tumor-suppressive role for Bcl-3 in this inflammation-associated cancer model. Bcl-3 thus functions as a tumor promoter or suppressor, depending on the cellular and environmental context.	[Tang, W.; Wang, H.; Ha, H. L.; Tassi, I.; Bhardwaj, R.; Claudio, E.; Siebenlist, U.] NIAID, Lab Mol Immunol, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Siebenlist, U (corresponding author), NIH, Bldg 10,Room 11N210, Bethesda, MD 20892 USA.	usiebenlist@niaid.nih.gov		tassi, ilaria/0000-0002-5803-9499	Intramural Research Program of NIAID, NIH; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI000722] Funding Source: NIH RePORTER	Intramural Research Program of NIAID, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We greatly appreciate the constructive inputs provided by all members of the Siebenlist laboratory. This research was supported by the Intramural Research Program of NIAID, NIH.	Bollrath J, 2009, CANCER CELL, V15, P91, DOI 10.1016/j.ccr.2009.01.002; Burkitt MD, 2015, J PATHOL, V236, P326, DOI 10.1002/path.4527; De Robertis Mariangela, 2011, J Carcinog, V10, P9, DOI 10.4103/1477-3163.78279; Diaz-Montero CM, 2014, SEMIN ONCOL, V41, P174, DOI 10.1053/j.seminoncol.2014.02.003; Eigenbrod T, 2013, J IMMUNOL, V190, P6533, DOI 10.4049/jimmunol.1300324; Franzoso G, 1998, J EXP MED, V187, P147, DOI 10.1084/jem.187.2.147; Franzoso G, 1997, IMMUNITY, V6, P479, DOI 10.1016/S1074-7613(00)80291-5; Greten FR, 2004, CELL, V118, P285, DOI 10.1016/j.cell.2004.07.013; Grivennikov S, 2009, CANCER CELL, V15, P103, DOI 10.1016/j.ccr.2009.01.001; Grivennikov SI, 2013, SEMIN IMMUNOPATHOL, V35, P229, DOI 10.1007/s00281-012-0352-6; Hayden MS, 2012, GENE DEV, V26, P203, DOI 10.1101/gad.183434.111; Hinz M, 2012, IMMUNOL REV, V246, P59, DOI 10.1111/j.1600-065X.2012.01102.x; Kashatus D, 2006, GENE DEV, V20, P225, DOI 10.1101/gad.1352206; Katoh H, 2013, CANCER CELL, V24, P631, DOI 10.1016/j.ccr.2013.10.009; Liu ZJ, 2013, J MOL CELL BIOL, V5, P280, DOI 10.1093/jmcb/mjt020; Maldonado V, 2011, MOL CANCER, V10, DOI 10.1186/1476-4598-10-152; Manjili MH, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00303; Massoumi R, 2006, CELL, V125, P665, DOI 10.1016/j.cell.2006.03.041; Moore RJ, 1999, NAT MED, V5, P828, DOI 10.1038/10552; Naito Y, 2003, J GASTROEN HEPATOL, V18, P560, DOI 10.1046/j.1440-1746.2003.03034.x; Nielsen OH, 2014, FRONT MED-LAUSANNE, V1, DOI 10.3389/fmed.2014.00003; Onizawa M, 2009, AM J PHYSIOL-GASTR L, V296, pG850, DOI 10.1152/ajpgi.00071.2008; Palmer S, 2008, IMMUNOL RES, V42, P210, DOI 10.1007/s12026-008-8075-4; Pasparakis M, 2012, IMMUNOL REV, V246, P346, DOI 10.1111/j.1600-065X.2012.01109.x; Pene F, 2011, J IMMUNOL, V186, P2412, DOI 10.4049/jimmunol.1001331; Popivanova BK, 2008, J CLIN INVEST, V118, P560, DOI [10.1172/JC132453, 10.1172/JCI32453]; Schuster M, 2013, CELL COMMUN SIGNAL, V11, DOI 10.1186/1478-811X-11-23; Siebenlist U, 2005, NAT REV IMMUNOL, V5, P435, DOI 10.1038/nri1629; Tang WH, 2014, IMMUNITY, V41, P555, DOI 10.1016/j.immuni.2014.09.017; Tassi I, 2015, EUR J IMMUNOL, V45, P1059, DOI 10.1002/eji.201444994; Tassi I, 2014, J IMMUNOL, V193, P4303, DOI 10.4049/jimmunol.1401505; Wakefield A, 2013, CANCER RES, V73, P745, DOI 10.1158/0008-5472.CAN-12-1321; Zaki MH, 2010, IMMUNITY, V32, P379, DOI 10.1016/j.immuni.2010.03.003	34	6	7	0	6	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	DEC 1	2016	35	48					6203	6211		10.1038/onc.2016.152	http://dx.doi.org/10.1038/onc.2016.152			9	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	ED4YH	27132515	Green Accepted			2022-12-26	WOS:000388857700005
J	Montenegro, MF; Sanchez-del-Campo, L; Gonzalez-Guerrero, R; Martinez-Barba, E; Pinero-Madrona, A; Cabezas-Herrera, J; Rodriguez-Lopez, JN				Montenegro, M. F.; Sanchez-del-Campo, L.; Gonzalez-Guerrero, R.; Martinez-Barba, E.; Pinero-Madrona, A.; Cabezas-Herrera, J.; Rodriguez-Lopez, J. N.			Tumor suppressor SET9 guides the epigenetic plasticity of breast cancer cells and serves as an early-stage biomarker for predicting metastasis	ONCOGENE			English	Article							EPITHELIAL-MESENCHYMAL TRANSITION; STEM-CELLS; LYSINE METHYLATION; ESTROGEN-RECEPTOR; DNA METHYLATION; E2F1; METHYLTRANSFERASE; EXPRESSION; LSD1; REPRESSION	During the course of cancer progression, neoplastic cells undergo dynamic and reversible transitions between multiple phenotypic states, and this plasticity is enabled by underlying shifts in epigenetic regulation. Our results identified a negative feedback loop in which SET9 controls DNA methyltransferase-1 protein stability, which represses the transcriptional activity of the SET9 promoter in coordination with Snail. The modulation of SET9 expression in breast cancer cells revealed a connection with E2F1 and the silencing of SET9 was sufficient to complete an epigenetic program that favored epithelial-mesenchymal transition and the generation of cancer stem cells, indicating that SET9 plays a role in modulating breast cancer metastasis. SET9 expression levels were significantly higher in samples from patients with pathological complete remission than in samples from patients with disease recurrence, which indicates that SET9 acts as a tumor suppressor in breast cancer and that its expression may serve as a prognostic marker for malignancy.	[Montenegro, M. F.; Gonzalez-Guerrero, R.; Rodriguez-Lopez, J. N.] Univ Murcia, IMIB, Sch Biol, Dept Biochem & Mol Biol A, Murcia 30100, Spain; [Sanchez-del-Campo, L.] Univ Oxford, Nuffield Dept Clin Med, Ludwig Inst Canc Res, Oxford, England; [Martinez-Barba, E.] Univ Hosp Virgen Arrixaca, IMIB, Dept Pathol, Murcia, Spain; [Pinero-Madrona, A.] Univ Hosp Virgen Arrixaca, IMIB, Dept Surg, Murcia, Spain; [Cabezas-Herrera, J.] Univ Hosp Virgen Arrixaca, IMIB, Mol Therapy & Biomarkers Res Grp, Murcia 30120, Spain	University of Murcia; Ludwig Institute for Cancer Research; University of Oxford; Hospital Clinico Universitario Virgen de la Arrixaca; Hospital Clinico Universitario Virgen de la Arrixaca; Hospital Clinico Universitario Virgen de la Arrixaca	Rodriguez-Lopez, JN (corresponding author), Univ Murcia, IMIB, Sch Biol, Dept Biochem & Mol Biol A, Murcia 30100, Spain.; Cabezas-Herrera, J (corresponding author), Univ Hosp Virgen Arrixaca, IMIB, Mol Therapy & Biomarkers Res Grp, Murcia 30120, Spain.	juan.cabezas@carm.es; neptuno@um.es	del Campo, Luis Sanchez/R-1308-2018; CABEZAS-HERRERA, JUAN/J-9434-2015; Piñero-Madrona, Antonio/AAB-5138-2022; Montenegro, Maria Fernanda/AAF-2695-2021	CABEZAS-HERRERA, JUAN/0000-0001-9053-5380; Sanchez del Campo, Luis/0000-0002-9537-7761; Montenegro, Maria Fernanda/0000-0002-0064-0484; Gonzalez Guerrero, Rebeca/0000-0003-1006-7658; Rodriguez-Lopez, Jose Neptuno/0000-0001-6863-1173	Ministerio de Economia y Competitividad (MINECO); Fondos (FEDER) [SAF2013-48375-C2-1-R]; Fundacion Seneca, Region de Murcia (FS-RM) [15230/PI/10, 19304/PI/14]; Ludwig Institute for Cancer Research; FAECC	Ministerio de Economia y Competitividad (MINECO); Fondos (FEDER); Fundacion Seneca, Region de Murcia (FS-RM)(Fundacion Seneca); Ludwig Institute for Cancer Research; FAECC	This work was supported by grants from Ministerio de Economia y Competitividad (MINECO; Co-financing with Fondos FEDER) (SAF2013-48375-C2-1-R) to JNR-L and Fundacion Seneca, Region de Murcia (FS-RM) (15230/PI/10 and 19304/PI/14) to JNR-L, JC-H, and AP-M. JC-H is contracted by the FFIS. MFM is contracted by Fundacion de la Asociacion Espanola contra el Cancer (FAECC). LS-d-C is supported by the Ludwig Institute for Cancer Research and FAECC.	Alla V, 2010, JNCI-J NATL CANCER I, V102, P127, DOI 10.1093/jnci/djp458; Barsyte-Lovejoy D, 2014, P NATL ACAD SCI USA, V111, P12853, DOI 10.1073/pnas.1407358111; Biswas AK, 2012, CANCER RES, V72, P13, DOI 10.1158/0008-5472.CAN-11-2196; Cavallaro U, 2001, BBA-REV CANCER, V1552, P39, DOI 10.1016/S0304-419X(01)00038-5; Chaffer CL, 2011, SCIENCE, V331, P1559, DOI 10.1126/science.1203543; Chang HW, 2014, MOLECULES, V19, P3149, DOI 10.3390/molecules19033149; Christofori G, 2006, NATURE, V441, P444, DOI 10.1038/nature04872; Chuikov S, 2004, NATURE, V432, P353, DOI 10.1038/nature03117; Dong C, 2013, ONCOGENE, V32, P1351, DOI 10.1038/onc.2012.169; Dong CF, 2012, J CLIN INVEST, V122, P1469, DOI 10.1172/JCI57349; Edge SB, 2010, ANN SURG ONCOL, V17, P1471, DOI 10.1245/s10434-010-0985-4; Engelmann D, 2012, CANCER RES, V72, P571, DOI 10.1158/0008-5472.CAN-11-2575; Engelmann D, 2010, CELL MOL LIFE SCI, V67, P931, DOI 10.1007/s00018-009-0222-0; Esteller M, 2005, ANNU REV PHARMACOL, V45, P629, DOI 10.1146/annurev.pharmtox.45.120403.095832; Esteller M, 2002, J PATHOL, V196, P1, DOI 10.1002/path.1024; Esteve PO, 2009, P NATL ACAD SCI USA, V106, P5076, DOI 10.1073/pnas.0810362106; Geng Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054959; Gupta A, 2003, CANCER, V97, P2341, DOI 10.1002/cncr.11332; Guttilla IK, 2012, BREAST CANCER RES TR, V132, P75, DOI 10.1007/s10549-011-1534-y; Hanada N, 2006, MOL CARCINOGEN, V45, P10, DOI 10.1002/mc.20147; Harris WJ, 2012, CANCER CELL, V21, P473, DOI 10.1016/j.ccr.2012.03.014; Hirohashi S, 1998, AM J PATHOL, V153, P333, DOI 10.1016/S0002-9440(10)65575-7; Jaggupilli A, 2012, CLIN DEV IMMUNOL, DOI 10.1155/2012/708036; Kalluri R, 2009, J CLIN INVEST, V119, P1420, DOI 10.1172/JCI39104; Kontaki H, 2010, MOL CELL, V39, P152, DOI 10.1016/j.molcel.2010.06.006; Laine A, 2014, CLIN CANCER RES, V20, P3644, DOI 10.1158/1078-0432.CCR-13-1942; Laine A, 2013, CANCER DISCOV, V3, P182, DOI 10.1158/2159-8290.CD-12-0292; Leis O, 2012, ONCOGENE, V31, P1354, DOI 10.1038/onc.2011.338; Lim S, 2010, CARCINOGENESIS, V31, P512, DOI 10.1093/carcin/bgp324; Liu Z, 2013, ONCOGENE, V32, P4203, DOI 10.1038/onc.2012.441; Mani SA, 2008, CELL, V133, P704, DOI 10.1016/j.cell.2008.03.027; Iglesias JM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077281; Montenegro MF, 2015, ONCOGENE, V34, P135, DOI 10.1038/onc.2013.605; Montenegro MF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052231; Morel AP, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002888; Mukherjee D, 2013, AM J CANCER RES, V3, P46; Munoz P, 2012, MOL ONCOL, V6, P620, DOI 10.1016/j.molonc.2012.10.006; Nakshatri H, 2010, BREAST CANCER RES, V12, DOI 10.1186/bcr2559; Nishioka K, 2002, GENE DEV, V16, P479, DOI 10.1101/gad.967202; Putzer BM, 2013, TRENDS MOL MED, V19, P89, DOI 10.1016/j.molmed.2012.10.009; Pyle AD, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-8-235; Rhim AD, 2012, CELL, V148, P349, DOI 10.1016/j.cell.2011.11.025; Saez-Ayala M, 2013, CANCER CELL, V24, P105, DOI 10.1016/j.ccr.2013.05.009; Scheel C, 2011, INT J CANCER, V129, P2310, DOI 10.1002/ijc.26311; Schenk T, 2012, NAT MED, V18, P605, DOI 10.1038/nm.2661; SCHMIEGEL W, 1993, P NATL ACAD SCI USA, V90, P863, DOI 10.1073/pnas.90.3.863; Singh JK, 2013, CLIN CANCER RES, V19, P643, DOI 10.1158/1078-0432.CCR-12-1063; Subramanian K, 2008, MOL CELL, V30, P336, DOI 10.1016/j.molcel.2008.03.022; Tam WL, 2013, NAT MED, V19, P1438, DOI 10.1038/nm.3336; Tao DY, 2015, MED ONCOL, V32, DOI 10.1007/s12032-014-0412-y; Veronesi U, 2003, NEW ENGL J MED, V349, P546, DOI 10.1056/NEJMoa012782; Wang LF, 2007, WORLD J GASTROENTERO, V13, P5692, DOI 10.3748/wjg.v13.i43.5692; Wu YD, 2013, CELL REP, V5, P224, DOI 10.1016/j.celrep.2013.08.030; Xie Q, 2011, J RECEPT SIG TRANSD, V31, P139, DOI 10.3109/10799893.2011.552914; Yui S, 2005, CANCER SCI, V96, P560, DOI 10.1111/j.1349-7006.2005.00097.x	55	22	23	1	7	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	NOV 24	2016	35	47					6143	6152		10.1038/onc.2016.154	http://dx.doi.org/10.1038/onc.2016.154			10	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	ED0CE	27132511				2022-12-26	WOS:000388509800010
J	Almeida, AS; Soares, NL; Vieira, M; Gramsbergen, JB; Vieira, HLA				Almeida, Ana S.; Soares, Nuno L.; Vieira, Melissa; Gramsbergen, Jan Bert; Vieira, Helena L. A.			Carbon Monoxide Releasing Molecule-A1 (CORM-A1) Improves Neurogenesis: Increase of Neuronal Differentiation Yield by Preventing Cell Death	PLOS ONE			English	Article							HIPPOCAMPAL SLICE CULTURES; HEME OXYGENASE-1; MITOCHONDRIAL BIOGENESIS; RETINOID RECEPTORS; NTERA-2 CELLS; STEM-CELLS; EXPRESSION; PROLIFERATION; SYSTEM; ACID	Cerebral ischemia and neurodegenerative diseases lead to impairment or death of neurons in the central nervous system. Stem cell based therapies are promising strategies currently under investigation. Carbon monoxide (CO) is an endogenous product of heme degradation by heme oxygenase (HO) activity. Administration of CO at low concentrations produces several beneficial effects in distinct tissues, namely anti-apoptotic and anti-inflammatory. Herein the CO role on modulation of neuronal differentiation was assessed. Three different models with increasing complexity were used: human neuroblastoma SH-S5Y5 cell line, human teratocarcinoma NT2 cell line and organotypic hippocampal slice cultures (OHSC). Cell lines were differentiated into post-mitotic neurons by treatment with retinoic acid (RA) supplemented with CO-releasing molecule A1 (CORM-A1). CORM-A1 positively modulated neuronal differentiation, since it increased final neuronal production and enhanced the expression of specific neuronal genes: Nestin, Tuj1 and MAP2. Furthermore, during neuronal differentiation process, there was an increase in proliferative cell number (ki67 mRNA expressing cells) and a decrease in cell death (lower propidium iodide (PI) uptake, limitation of caspase-3 activation and higher Bcl-2 expressing cells). CO supplementation did not increase the expression of RA receptors. In the case of SH-S5Y5 model, small amounts of reactive oxygen species (ROS) generation emerges as important signaling molecules during CO-promoted neuronal differentiation. CO's improvement of neuronal differentiation yield was validated using OHSC as ex vivo model. CORM-A1 treatment of OHSC promoted higher levels of cells expressing the neuronal marker Tuj1. Still, CORM-A1 increased cell proliferation assessed by ki67 expression and also prevented cell death, which was followed by increased Bcl-2 expression, decreased levels of active caspase-3 and PI uptake. Likewise, ROS signaling emerged as key factors in CO's increasing number of differentiated neurons in OHSC. In conclusion, CO's increasing number of differentiated neurons is a novel biological role disclosed herein. CO improves neuronal yield due to its capacity to reduce cell death, promoting an increase in proliferative population. However, one cannot disregard a direct CO's effect on specific cellular processes of neuronal differentiation. Further studies are needed to evaluate how CO can potentially modulate cell mechanisms involved in neuronal differentiation. In summary, CO appears as a promising therapeutic molecule to stimulate endogenous neurogenesis or to improve in vitro neuronal production for cell therapy strategies.	[Almeida, Ana S.; Soares, Nuno L.; Vieira, Melissa; Vieira, Helena L. A.] Univ Nova Lisboa, Fac Ciencia Med, CEDOC, P-1169056 Lisbon, Portugal; [Almeida, Ana S.] Univ Nova Lisboa, Inst Tecnol Quim & Biol, Apartado 127, P-2781901 Oeiras, Portugal; [Almeida, Ana S.; Vieira, Helena L. A.] Inst Biol Expt & Tecnol, Apartado 12, P-2781901 Oeiras, Portugal; [Gramsbergen, Jan Bert] Univ Southern Denmark, Inst Mol Med, Winslowpk 21, DK-5000 Odense C, Denmark	Universidade Nova de Lisboa; Universidade Nova de Lisboa; University of Southern Denmark	Vieira, HLA (corresponding author), Univ Nova Lisboa, Fac Ciencia Med, CEDOC, P-1169056 Lisbon, Portugal.; Vieira, HLA (corresponding author), Inst Biol Expt & Tecnol, Apartado 12, P-2781901 Oeiras, Portugal.	helena.vieira@fcm.unl.pt	Vieira, Helena/AAZ-9562-2021	Vieira, Helena/0000-0001-9415-3742; Soares, Nuno/0000-0002-4972-5737; Almeida, Ana Sofia/0000-0001-7654-9049	Grant "Translational and mechanistic approaches on carbon monoxide as a modulator of neuroinflammation and neuroprotection in glial cells" [ANR/NEU-NMC/0022/2012]; Fellowship "Translational and mechanistic approaches on carbon monoxide/heme-oxygenase for cytoprotection following cerebral ischemia: integrative role of apoptosis, autophagy, metabolism and neurogenesis" [IF/00185/2012]; Fellowship "Carbon Monoxide modulation of neuronal differentiation - novel cell therapy strategies for neurological disorders" [SFRH/BD/78440/2011]; COST Action [BM1005]	Grant "Translational and mechanistic approaches on carbon monoxide as a modulator of neuroinflammation and neuroprotection in glial cells"; Fellowship "Translational and mechanistic approaches on carbon monoxide/heme-oxygenase for cytoprotection following cerebral ischemia: integrative role of apoptosis, autophagy, metabolism and neurogenesis"; Fellowship "Carbon Monoxide modulation of neuronal differentiation - novel cell therapy strategies for neurological disorders"; COST Action(European Cooperation in Science and Technology (COST))	This work was supported by: Grant 1 "Translational and mechanistic approaches on carbon monoxide as a modulator of neuroinflammation and neuroprotection in glial cells", ANR/NEU-NMC/0022/2012 (http://www.fct.pt); Fellowship 1 - salary for HLAV, "Translational and mechanistic approaches on carbon monoxide/heme-oxygenase for cytoprotection following cerebral ischemia: integrative role of apoptosis, autophagy, metabolism and neurogenesis", IF/00185/2012 (http://www.fct.pt); Fellowship 2 - salary for ASA, "Carbon Monoxide modulation of neuronal differentiation - novel cell therapy strategies for neurological disorders", SFRH/BD/78440/2011 (http://www.fct.pt); and COST Action BM1005, European Network on Gasotransmitters (http://gasotransmitters.eu).	Ahlenius H, 2009, J NEUROSCI, V29, P4408, DOI 10.1523/JNEUROSCI.6003-08.2009; Ahmad S, 2015, THROMB HAEMOSTASIS, V113, P329, DOI 10.1160/TH14-01-0002; Almeida AS, 2012, J BIOL CHEM, V287, P10761, DOI 10.1074/jbc.M111.306738; Amaral A. I., 2015, GLIA; Balu DT, 2009, NEUROSCI BIOBEHAV R, V33, P232, DOI 10.1016/j.neubiorev.2008.08.007; Barbagallo I, 2008, J NEUROSCI RES, V86, P1927, DOI 10.1002/jnr.21660; Biemann K., 1962, ANGEW CHEM INT EDIT, V1, P98, DOI [10.1002/anie.196200981, DOI 10.1002/ANIE.196200981]; Bilban M, 2008, J MOL MED, V86, P267, DOI 10.1007/s00109-007-0276-0; Borghi R, 2003, J NEUROCHEM, V84, P94, DOI 10.1046/j.1471-4159.2003.01501.x; Boya Patricia, 2005, Birth Defects Research, V75, P281, DOI 10.1002/bdrc.20054; Burns TC, 2009, J COMP NEUROL, V515, P125, DOI 10.1002/cne.22038; Buss Robert R., 2004, Anatomical Science International, V79, P191, DOI 10.1111/j.1447-073x.2004.00088.x; CAMERON HA, 1993, NEUROSCIENCE, V56, P337, DOI 10.1016/0306-4522(93)90335-D; Chen C. T., 2009, BIOCH BIOPHYS ACTA B, V1800, P1; Chen J, 2003, J NEUROCHEM, V85, P1247, DOI 10.1046/j.1471-4159.2003.01776.x; Cheung WMW, 2000, J NEUROCHEM, V75, P34, DOI 10.1046/j.1471-4159.2000.0750034.x; Cho YM, 2006, BIOCHEM BIOPH RES CO, V348, P1472, DOI 10.1016/j.bbrc.2006.08.020; Constantinescu R, 2007, J NEURAL TRANSM-SUPP, P17; de la Rosa EJ, 2000, TRENDS NEUROSCI, V23, P454, DOI 10.1016/S0166-2236(00)01628-3; Dekkers MPJ, 2013, SCIENCE, V340, P39, DOI 10.1126/science.1236152; Ferrari A, 2000, FEBS LETT, V486, P121, DOI 10.1016/S0014-5793(00)02251-1; Grochot-Przeczek A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005803; Guillemain I, 2000, NEUROREPORT, V11, P1421, DOI 10.1097/00001756-200005150-00014; Haile Y, 2014, J NEUROSCI RES, V92, P1187, DOI 10.1002/jnr.23399; Hartley RS, 1999, J COMP NEUROL, V415, P404, DOI 10.1002/(SICI)1096-9861(19991220)415:3<404::AID-CNE6>3.0.CO;2-R; Holopainen IE, 2005, NEUROCHEM RES, V30, P1521, DOI 10.1007/s11064-005-8829-5; Jazwa A., 2015, VASCUL PHARM, P1; Jazwa A, 2013, CARDIOVASC RES, V97, P115, DOI 10.1093/cvr/cvs284; Joshi S, 2006, ONCOGENE, V25, P240, DOI 10.1038/sj.onc.1209027; Kim HS, 2008, AM J PHYSIOL-GASTR L, V295, pG146, DOI 10.1152/ajpgi.00105.2007; Kondziolka D, 2000, NEUROLOGY, V55, P565, DOI 10.1212/WNL.55.4.565; Kovalevich J, 2013, METHODS MOL BIOL, V1078, P9, DOI 10.1007/978-1-62703-640-5_2; Kozakowska M, 2015, STEM CELL RES THER, V6, DOI 10.1186/s13287-015-0063-8; Kozakowska M, 2014, ANTIOXID REDOX SIGN, V20, P1827, DOI 10.1089/ars.2013.5341; Kozakowska M, 2012, ANTIOXID REDOX SIGN, V16, P113, DOI 10.1089/ars.2011.3964; Lancel S, 2009, J PHARMACOL EXP THER, V329, P641, DOI 10.1124/jpet.108.148049; Lee WY, 2014, TOXICOL APPL PHARM, V274, P55, DOI 10.1016/j.taap.2013.10.027; MAWHINNEY TP, 1986, J CHROMATOGR, V361, P117, DOI 10.1016/S0021-9673(01)86899-0; Morita T, 1997, J BIOL CHEM, V272, P32804, DOI 10.1074/jbc.272.52.32804; Motterlini R, 2004, FASEB J, V18, P284, DOI 10.1096/fj.04-2169fje; Motterlini R, 2002, CIRC RES, V90, pE17, DOI 10.1161/hh0202.104530; Motterlini R, 2010, NAT REV DRUG DISCOV, V9, P728, DOI 10.1038/nrd3228; Namba T, 2007, J NEUROSCI RES, V85, P1704, DOI 10.1002/jnr.21295; Nikolic I, 2014, SCAND J IMMUNOL, V80, P95, DOI 10.1111/sji.12189; Noraberg J., 1999, MARKERS NEURONAL DEG, P278; Noraberg J, 2005, CNS NEUROL DISORD-DR, V4, P435, DOI 10.2174/1568007054546108; PAHLMAN S, 1990, ACTA PHYSIOL SCAND, V140, P25; Petrik D, 2012, NEUROPHARMACOLOGY, V62, P21, DOI 10.1016/j.neuropharm.2011.09.003; PLEASURE SJ, 1992, J NEUROSCI, V12, P1802; PLEASURE SJ, 1993, J NEUROSCI RES, V35, P585, DOI 10.1002/jnr.490350603; Poulsen RC, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.52; Queiroga C. S. F., 2014, BR J PHARM; Queiroga CSF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042632; Queiroga CSF, 2011, BMC CELL BIOL, V12, DOI 10.1186/1471-2121-12-10; Queiroga CSF, 2010, J BIOL CHEM, V285, P17077, DOI 10.1074/jbc.M109.065052; Raineteau O, 2004, MOL CELL NEUROSCI, V26, P241, DOI 10.1016/j.mcn.2004.01.003; Ryter SW, 2006, PHYSIOL REV, V86, P583, DOI 10.1152/physrev.00011.2005; Schallner N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060672; Scholzen T, 2000, J CELL PHYSIOL, V182, P311, DOI 10.1002/(SICI)1097-4652(200003)182:3<311::AID-JCP1>3.0.CO;2-9; Southwell DG, 2012, NATURE, V491, P109, DOI 10.1038/nature11523; Stein AB, 2012, J MOL CELL CARDIOL, V52, P228, DOI 10.1016/j.yjmcc.2011.11.005; Suliman HB, 2007, J CLIN INVEST, V117, P3730, DOI 10.1172/JCI32967; Suliman HB, 2007, J CELL SCI, V120, P299, DOI 10.1242/jcs.03318; Sun BW, 2008, INT J BIOL SCI, V4, P270; Sundstrom L, 2005, DRUG DISCOV TODAY, V10, P993, DOI 10.1016/S1359-6446(05)03502-6; Taille C, 2005, J BIOL CHEM, V280, P25350, DOI 10.1074/jbc.M503512200; Vanella L, 2012, INT J HYPERTENS, V2012, DOI 10.1155/2012/890671; Vanella L, 2010, BONE, V46, P236, DOI 10.1016/j.bone.2009.10.012; Vieira HLA, 2008, J NEUROCHEM, V107, P375, DOI 10.1111/j.1471-4159.2008.05610.x; Vieira HLA, 2011, PROG NEUROBIOL, V93, P444, DOI 10.1016/j.pneurobio.2011.01.007; Vitek L, 2014, DIGEST LIVER DIS, V46, P369, DOI 10.1016/j.dld.2013.12.007; Wang B, 2011, STROKE, V42, P2605, DOI 10.1161/STROKEAHA.110.607101; Wang S, 1998, NEUROREPORT, V9, P3207, DOI 10.1097/00001756-199810050-00014; Watson DJ, 2003, J NEUROPATH EXP NEUR, V62, P368, DOI 10.1093/jnen/62.4.368; Wegiel B, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.97; Wegiel B, 2013, CANCER RES, V73, P7009, DOI 10.1158/0008-5472.CAN-13-1075; Yeo W, 2004, DEV BIOL, V274, P233, DOI 10.1016/j.ydbio.2004.07.026; Yoshioka A, 1997, BRAIN RES, V767, P333, DOI 10.1016/S0006-8993(97)00627-6; Zuckerbraun BS, 2007, FASEB J, V21, P1099, DOI 10.1096/fj.06-6644com	79	19	20	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 4	2016	11	5							e0154781	10.1371/journal.pone.0154781	http://dx.doi.org/10.1371/journal.pone.0154781			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DL5KR	27144388	Green Submitted, Green Published, gold			2022-12-26	WOS:000375676400069
J	Dams-Kozlowska, H; Kwiatkowska-Borowczyk, E; Gryska, K; Lewandowska, A; Marszalek, A; Adamczyk, S; Kowalik, A; Leporowska, E; Mackiewicz, A				Dams-Kozlowska, Hanna; Kwiatkowska-Borowczyk, Eliza; Gryska, Katarzyna; Lewandowska, Anna; Marszalek, Andrzej; Adamczyk, Sebastian; Kowalik, Anna; Leporowska, Ewa; Mackiewicz, Andrzej			Effects of Designer Hyper-Interleukin 11 (H11) on Hematopoiesis in Myelosuppressed Mice	PLOS ONE			English	Article							RECOMBINANT HUMAN INTERLEUKIN-11; CHEMOTHERAPY-INDUCED THROMBOCYTOPENIA; CANCER-PATIENTS; IN-VIVO; PLATELET PRODUCTION; MYELOID-LEUKEMIA; CYTOKINE; RECEPTOR; THROMBOPOIETIN; GP130	The incidence of cancer is constantly increasing. Chemo/radiotherapy is one of major methods of treating cancer. Although adverse chemo/radiotherapy events, such as anemia and neutropenia, can be successfully cured, thrombocytopenia is still problematic. We constructed the Hyper-IL11 (H11) cytokine by linking soluble interleukin 11 receptor alpha (sIL-11Ralpha) with IL-11. In vivo H11 activity was examined in myelosuppressed mice. Myelosuppression was induced by either i) sublethal irradiation and carboplatin administration or ii) sublethal irradiation. A dose of 100 mu g/kg of H11 or IL-11 was administered subcutaneously for 7 days. IL-11 and H11 accelerated leukocyte, hematocrit and platelet recovery. The effect on the attenuation of thrombocytopenia was significant. Moreover, both cytokines increased the cellularity and numbers of megakaryocyte, erythroid, and granulocyte/macrophage progenitors in the bone morrow and spleen compared with the control. Although H11 was administered at a molar concentration that was three times lower, its effects were comparable with or better than those of IL-11; thus, the activity of H11 was superior to that of IL-11. Because no toxicity was observed after the intravenous administration of H11, this hyper-cytokine may be potentially useful for treatment of thrombocytopenia and other IL-11-dependent disorders.	[Dams-Kozlowska, Hanna; Kwiatkowska-Borowczyk, Eliza; Mackiewicz, Andrzej] Poznan Univ Med Sci, Chair Med Biotechnol, Poznan, Poland; [Dams-Kozlowska, Hanna; Kwiatkowska-Borowczyk, Eliza; Gryska, Katarzyna; Mackiewicz, Andrzej] Greater Poland Canc Ctr, Dept Diagnost & Canc Immunol, Poznan, Poland; [Lewandowska, Anna; Marszalek, Andrzej] Poznan Univ Med Sci, Dept Oncol Pathol & Prophylact, Poznan, Poland; [Lewandowska, Anna; Marszalek, Andrzej] Greater Poland Canc Ctr, Dept Oncol Pathol, Poznan, Poland; [Adamczyk, Sebastian; Kowalik, Anna] Greater Poland Canc Ctr, Dept Med Phys, Poznan, Poland; [Leporowska, Ewa] Greater Poland Canc Ctr, Dept Lab Diagnost, Poznan, Poland	Poznan University of Medical Sciences; Wielkopolskie Centrum Onkologii; Poznan University of Medical Sciences; Wielkopolskie Centrum Onkologii; Wielkopolskie Centrum Onkologii; Wielkopolskie Centrum Onkologii	Dams-Kozlowska, H (corresponding author), Poznan Univ Med Sci, Chair Med Biotechnol, Poznan, Poland.; Dams-Kozlowska, H (corresponding author), Greater Poland Canc Ctr, Dept Diagnost & Canc Immunol, Poznan, Poland.	hanna.dams-kozlowska@wco.pl		Dams-Kozlowska, Hanna/0000-0003-2349-419X	National Science Centre, Poland [2011/01/B/ NZ4/05796]	National Science Centre, Poland(National Science Centre, Poland)	The study was supported by a grant from The National Science Centre, Poland (2011/01/B/ NZ4/05796). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barton VA, 2000, J BIOL CHEM, V275, P36197, DOI 10.1074/jbc.M004648200; Basser RL, 2002, BLOOD, V99, P2599, DOI 10.1182/blood.V99.7.2599; Baumann H, 1996, J IMMUNOL, V157, P284; Bhatia M, 2007, LEUKEMIA LYMPHOMA, V48, P9, DOI 10.1080/10428190600909115; Birkmann J, 1999, HYPER IL 6 H IL 6 FU; Chawla SP, 2013, BMC CANCER, V13, DOI 10.1186/1471-2407-13-121; Ciurea SO, 2007, SEMIN HEMATOL, V44, P166, DOI 10.1053/j.seminhematol.2007.04.005; Dams-Kozlowska H, 2013, INT J MED SCI, V10, P1157, DOI 10.7150/ijms.5638; Dams-Kozlowska H, 2012, BMC BIOTECHNOL, V12, DOI 10.1186/1472-6750-12-8; Dorner AJ, 1997, BIODRUGS, V8, P418, DOI 10.2165/00063030-199708060-00002; DU XX, 1993, BLOOD, V81, P27; Du XX, 1997, BLOOD, V89, P3897, DOI 10.1182/blood.V89.11.3897; Fischer M, 1997, NAT BIOTECHNOL, V15, P142, DOI 10.1038/nbt0297-142; Galun E, 2000, FASEB J, V14, P1979, DOI 10.1096/fj.99-0913com; Garbers C, 2013, BIOL CHEM, V394, P1145, DOI 10.1515/hsz-2013-0166; Gurfein BT, 2009, J IMMUNOL, V183, P4229, DOI 10.4049/jimmunol.0900622; HANGOC G, 1993, BLOOD, V81, P965; Hao J, 2004, RADIAT RES, V162, P157, DOI 10.1667/RR3202; HAWLEY RG, 1993, J EXP MED, V178, P1175, DOI 10.1084/jem.178.4.1175; Heinrich PC, 2003, BIOCHEM J, V374, P1, DOI 10.1042/BJ20030407; Kimura T, 2000, STEM CELLS, V18, P444, DOI 10.1634/stemcells.18-6-444; Kuter DJ, 2015, ONCOLOGY-NY, V29, P282; Kuter DJ, 2014, BRIT J HAEMATOL, V165, P248, DOI 10.1111/bjh.12781; Kuter DJ, 2002, BLOOD, V100, P3457, DOI 10.1182/blood.V100.10.3457; LEONARD JP, 1994, BLOOD, V83, P1499; Li JZ, 2001, BLOOD, V98, P3241, DOI 10.1182/blood.V98.12.3241; Liebman HA, 2014, THROMB RES, V133, pS63, DOI 10.1016/S0049-3848(14)50011-4; Liou SY, 2007, CLIN DRUG INVEST, V27, P381, DOI 10.2165/00044011-200727060-00002; Mackiewicz J, 2015, ANTICANCER RES, V35, P3275; MAZE R, 1994, CANCER RES, V54, P4947; Morita Y, 2011, EXP HEMATOL, V39, P351, DOI 10.1016/j.exphem.2010.12.008; Obana M, 2010, CIRCULATION, V121, P684, DOI 10.1161/CIRCULATIONAHA.109.893677; PAUL SR, 1994, EXP HEMATOL, V22, P295; Peeters K, 2008, DRUG DISCOV TODAY, V13, P798, DOI 10.1016/j.drudis.2008.06.002; Peters M, 1998, J IMMUNOL, V161, P3575; Piatek C, 2015, ONCOLOGY-NY, V29, P297; Putoczki TL, 2014, ACTA CRYSTALLOGR D, V70, P2277, DOI 10.1107/S1399004714012267; Rakemann T, 1999, J BIOL CHEM, V274, P1257, DOI 10.1074/jbc.274.3.1257; Robb L, 1998, NAT MED, V4, P303, DOI 10.1038/nm0398-303; Schlerman FJ, 1996, STEM CELLS, V14, P517, DOI 10.1002/stem.140517; Sims NA, 2010, BMB REP, V43, P513, DOI 10.5483/BMBRep.2010.43.8.513; Suchorska WM, 2011, EXPERT OPIN BIOL TH, V11, P1555, DOI 10.1517/14712598.2011.627852; Trepicchio WL, 2001, TOXICOL PATHOL, V29, P242, DOI 10.1080/019262301317052521; Vadhan-Raj S, 2009, SEMIN HEMATOL, V46, pS26, DOI 10.1053/j.seminhematol.2008.12.007; Van der Meeren A, 2002, RADIAT RES, V157, P642, DOI 10.1667/0033-7587(2002)157[0642:AORHIA]2.0.CO;2; Wang ES, 2012, J HEMATOL ONCOL, V5, DOI 10.1186/1756-8722-5-71	46	0	0	2	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 4	2016	11	5							e0154520	10.1371/journal.pone.0154520	http://dx.doi.org/10.1371/journal.pone.0154520			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DL5KR	27144685	Green Published, Green Submitted, gold			2022-12-26	WOS:000375676400050
J	Gonzalez, N; Moresco, JJ; Cabezas, F; de la Vega, E; Bustos, F; Yates, JR; Olguin, HC				Gonzalez, Natalia; Moresco, James J.; Cabezas, Felipe; de la Vega, Eduardo; Bustos, Francisco; Yates, John R., III; Olguin, Hugo C.			Ck2-Dependent Phosphorylation Is Required to Maintain Pax7 Protein Levels in Proliferating Muscle Progenitors	PLOS ONE			English	Article							SATELLITE CELLS; KINASE CK2; IDENTIFICATION; REGENERATION; SELECTIVITY; MYOGENESIS; INHIBITORS; QUIESCENT; SITE	Skeletal muscle regeneration and long term maintenance is directly link to the balance between self-renewal and differentiation of resident adult stem cells known as satellite cells. In turn, satellite cell fate is influenced by a functional interaction between the transcription factor Pax7 and members of the MyoD family of muscle regulatory factors. Thus, changes in the Pax7-to-MyoD protein ratio may act as a molecular rheostat fine-tuning acquisition of lineage identity while preventing precocious terminal differentiation. Pax7 is expressed in quiescent and proliferating satellite cells, while its levels decrease sharply in differentiating progenitors Pax7 is maintained in cells (re) acquiring quiescence. While the mechanisms regulating Pax7 levels based on differentiation status are not well understood, we have recently described that Pax7 levels are directly regulated by the ubiquitin-ligase Nedd4, thus promoting proteasome-dependent Pax7 degradation in differentiating satellite cells. Here we show that Pax7 levels are maintained in proliferating muscle progenitors by a mechanism involving casein kinase 2-dependent Pax7 phosphorylation at S201. Point mutations preventing S201 phosphorylation or casein kinase 2 inhibition result in decreased Pax7 protein in proliferating muscle progenitors. Accordingly, this correlates directly with increased Pax7 ubiquitination. Finally, Pax7 down regulation induced by casein kinase 2 inhibition results in precocious myogenic induction, indicating early commitment to terminal differentiation. These observations highlight the critical role of post translational regulation of Pax7 as a molecular switch controlling muscle progenitor fate.	[Gonzalez, Natalia; Cabezas, Felipe; de la Vega, Eduardo; Bustos, Francisco; Olguin, Hugo C.] Pontificia Univ Catolica Chile, Fac Ciencias Biol, Dept Biol Celular & Mol, Santiago 8331150, Chile; [Moresco, James J.; Yates, John R., III] Scripps Res Inst, Dept Physiol Chem, La Jolla, CA 92037 USA; [Bustos, Francisco] Univ Dundee, MRC, Prot Phosphorylat & Ubiquitylat Unit, Sir James Black Ctr,Sch Life Sci, Dundee DD1 5EH, Scotland	Pontificia Universidad Catolica de Chile; Scripps Research Institute; University of Dundee	Olguin, HC (corresponding author), Pontificia Univ Catolica Chile, Fac Ciencias Biol, Dept Biol Celular & Mol, Santiago 8331150, Chile.	holguin@bio.puc.cl		de la Vega, Eduardo/0000-0003-0309-2783; BUSTOS, FRANCISCO/0000-0001-5457-4956; Moresco, James/0000-0003-1178-1642	National Fund for Scientific and Technological Development (FONDECYT) [1130631]; CONICYT [AT-24121135]; Institutional Fellowship for graduate students (VRI-PUC); National Doctoral Fellowship, CONICYT; National Institute of General Medical Sciences [8 P41 GM103533]	National Fund for Scientific and Technological Development (FONDECYT)(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT FONDECYT); CONICYT(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)); Institutional Fellowship for graduate students (VRI-PUC); National Doctoral Fellowship, CONICYT; National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the National Fund for Scientific and Technological Development (FONDECYT) (Grant 1130631) (to HO); National Doctoral Fellowship and Doctoral Thesis Support Fellowship AT-24121135 from CONICYT (to FB); Institutional Fellowship for graduate students (VRI-PUC) (to EdV); from National Doctoral Fellowship, CONICYT (to EdV. and FC); from the National Institute of General Medical Sciences (8 P41 GM103533) (to JY). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bustos F, 2015, STEM CELLS, V33, P3138, DOI 10.1002/stem.2125; Canton DA, 2005, MOL CELL BIOL, V25, P3519, DOI 10.1128/MCB.25.9.3519-3534.2005; Charge SBP, 2004, PHYSIOL REV, V84, P209, DOI 10.1152/physrev.00019.2003; Chen Y, 2006, DEVELOPMENT, V133, P2303, DOI 10.1242/dev.02397; Ciciliot S, 2010, CURR PHARM DESIGN, V16, P906, DOI 10.2174/138161210790883453; Cornelison DDW, 2004, GENE DEV, V18, P2231, DOI 10.1101/gad.1214204; Dick SA, 2015, P NATL ACAD SCI USA, V112, pE5246, DOI 10.1073/pnas.1512869112; Dietz KN, 2011, INT J BIOCHEM CELL B, V43, P936, DOI 10.1016/j.biocel.2011.03.010; Dietz KN, 2009, BIOCHEMISTRY-US, V48, P11786, DOI 10.1021/bi9012947; Duncan JS, 2008, MOL CELL PROTEOMICS, V7, P1077, DOI 10.1074/mcp.M700559-MCP200; Gros J, 2005, NATURE, V435, P954, DOI 10.1038/nature03572; Gunther S, 2013, CELL STEM CELL, V13, P590, DOI 10.1016/j.stem.2013.07.016; Hawke TJ, 2001, J APPL PHYSIOL, V91, P534, DOI 10.1152/jappl.2001.91.2.534; Iyengar AS, 2012, BIOCHEM BIOPH RES CO, V428, P24, DOI 10.1016/j.bbrc.2012.09.141; Kassar-Duchossoy L, 2005, GENE DEV, V19, P1426, DOI 10.1101/gad.345505; Kumar D, 2009, MOL BIOL CELL, V20, P3170, DOI 10.1091/mbc.E08-12-1185; Lepper C, 2011, DEVELOPMENT, V138, P3639, DOI 10.1242/dev.067595; MAURO A, 1961, J BIOPHYS BIOCHEM CY, V9, P493, DOI 10.1083/jcb.9.2.493; McDonald WH, 2004, RAPID COMMUN MASS SP, V18, P2162, DOI 10.1002/rcm.1603; McKinnell IW, 2008, NAT CELL BIOL, V10, P77, DOI 10.1038/ncb1671; Miller PJ, 2008, PROTEIN SCI, V17, P1979, DOI 10.1110/ps.035956.108; Murphy MM, 2011, DEVELOPMENT, V138, P3625, DOI 10.1242/dev.064162; Olguin HC, 2004, DEV BIOL, V275, P375, DOI 10.1016/j.ydbio.2004.08.015; Olguin HC, 2007, J CELL BIOL, V177, P769, DOI 10.1083/jcb.200608122; Olguin HC, 2012, J CELL MOL MED, V16, P1013, DOI 10.1111/j.1582-4934.2011.01348.x; Olguin HC, 2011, BIOL RES, V44, P323, DOI /S0716-97602011000400002; Pagano MA, 2008, BIOCHEM J, V415, P353, DOI 10.1042/BJ20080309; Peng JM, 2003, J PROTEOME RES, V2, P43, DOI 10.1021/pr025556v; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Relaix F, 2006, J CELL BIOL, V172, P91, DOI 10.1083/jcb.200508044; Sambasivan R, 2011, DEVELOPMENT, V138, P3647, DOI 10.1242/dev.067587; Sarno S, 2001, FEBS LETT, V496, P44, DOI 10.1016/S0014-5793(01)02404-8; SCHULTZ E, 1978, J EXP ZOOL, V206, P451, DOI 10.1002/jez.1402060314; Seale P, 2000, CELL, V102, P777, DOI 10.1016/S0092-8674(00)00066-0; Tabb DL, 2002, J PROTEOME RES, V1, P21, DOI 10.1021/pr015504q; von Maltzahn J, 2013, P NATL ACAD SCI USA, V110, P16474, DOI 10.1073/pnas.1307680110; Wolters DA, 2001, ANAL CHEM, V73, P5683, DOI 10.1021/ac010617e; Xu T, 2015, J PROTEOMICS, V129, P16, DOI 10.1016/j.jprot.2015.07.001	38	15	15	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 4	2016	11	5							e0154919	10.1371/journal.pone.0154919	http://dx.doi.org/10.1371/journal.pone.0154919			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DL5KR	27144531	Green Published, gold, Green Submitted			2022-12-26	WOS:000375676400093
J	Yang, G; Wu, L; Xian, QM; Shen, F; Wu, J; Zhang, YZ				Yang, Gang; Wu, Lin; Xian, Qiming; Shen, Fei; Wu, Jun; Zhang, Yanzong			Removal of Congo Red and Methylene Blue from Aqueous Solutions by Vermicompost-Derived Biochars	PLOS ONE			English	Article							PYROLYSIS TEMPERATURE; ACTIVATED CARBON; SEWAGE-SLUDGE; CATIONIC DYE; ADSORPTION; COMPOSITE; ADSORBENT; KINETICS; ISOTHERM; MANURE	Biochars, produced by pyrolyzing vermicompost at 300, 500, and 700 degrees C were characterized and their ability to adsorb the dyes Congo red (CR) and Methylene blue (MB) in an aqueous solution was investigated. The physical and chemical properties of biochars varied significantly based on the pyrolysis temperatures. Analysis of the data revealed that the aromaticity, polarity, specific surface area, pH, and ash content of the biochars increased gradually with the increase in pyrolysis temperature, while the cation exchange capacity, and carbon, hydrogen, nitrogen and oxygen contents decreased. The adsorption kinetics of CR and MB were described by pseudo-second-order kinetic models. Both of Langmuir and Temkin model could be employed to describe the adsorption behaviors of CR and MB by these biochars. The biochars generated at higher pyrolysis temperature displayed higher CR adsorption capacities and lower MB adsorption capacities than those compared with the biochars generated at lower pyrolysis temperatures. The biochar generated at the higher pyrolytic temperature displayed the higher ability to adsorb CR owing to its promoted aromaticity, and the cation exchange is the key factor that positively affects adsorption of MB.	[Yang, Gang; Xian, Qiming] Nanjing Univ, State Key Lab Pollut Control & Resource Reuse, Sch Environm, Nanjing 210008, Jiangsu, Peoples R China; [Yang, Gang; Wu, Lin; Shen, Fei; Wu, Jun; Zhang, Yanzong] Sichuan Agr Univ, Inst Ecol & Environm Sci, Chengdu, Peoples R China	Nanjing University; Sichuan Agricultural University	Xian, QM (corresponding author), Nanjing Univ, State Key Lab Pollut Control & Resource Reuse, Sch Environm, Nanjing 210008, Jiangsu, Peoples R China.; Shen, F (corresponding author), Sichuan Agr Univ, Inst Ecol & Environm Sci, Chengdu, Peoples R China.	xianqm@nju.edu.cn; fishen@sicau.edu.cn			Jiangsu province Natural Science Foundation [BK20131271]; National Hightech R&D Program of China [2013AA06A309]; Department of Science and Technology of Sichuan Province [2014JQ0037, 2015NZ0100]; Department of Education of Sichuan Province [16ZA0043]; Ministry and Education of China [IRT13083]	Jiangsu province Natural Science Foundation(Natural Science Foundation of Jiangsu Province); National Hightech R&D Program of China; Department of Science and Technology of Sichuan Province; Department of Education of Sichuan Province; Ministry and Education of China(Ministry of Education, China)	This work was supported by the following sources of funding: Jiangsu province Natural Science Foundation (BK20131271); National Hightech R&D Program of China (2013AA06A309); Department of Science and Technology of Sichuan Province (2014JQ0037, 2015NZ0100); Department of Education of Sichuan Province (16ZA0043); and "Program for Changjiang Scholars and Innovative Research Team in University'' from the Ministry and Education of China (IRT13083). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adhikary S., 2012, AGR SCI, V3, P905, DOI DOI 10.4236/AS.2012.37110; Ahmad R, 2010, APPL SURF SCI, V257, P1628, DOI 10.1016/j.apsusc.2010.08.111; Al-Wabel MI, 2013, BIORESOURCE TECHNOL, V131, P374, DOI 10.1016/j.biortech.2012.12.165; Auta M, 2014, CHEM ENG J, V237, P352, DOI 10.1016/j.cej.2013.09.066; Chen T, 2014, BIORESOURCE TECHNOL, V164, P47, DOI 10.1016/j.biortech.2014.04.048; Chen ZH, 2014, APPL SURF SCI, V289, P495, DOI 10.1016/j.apsusc.2013.11.022; Cherifi H, 2013, APPL SURF SCI, V282, P52, DOI 10.1016/j.apsusc.2013.05.031; Demirel B, 2013, J MATER CYCLES WASTE, V15, P242, DOI 10.1007/s10163-012-0107-4; Deng H, 2011, CHEM ENG J, V172, P326, DOI 10.1016/j.cej.2011.06.013; El Saliby I, 2013, WATER RES, V47, P4115, DOI 10.1016/j.watres.2012.12.045; Ertugay N, 2014, POL J ENVIRON STUD, V23, P1995; Fan HW, 2014, APPL CLAY SCI, V95, P150, DOI 10.1016/j.clay.2014.04.001; Ferlian O, 2014, SOIL BIOL BIOCHEM, V77, P22, DOI 10.1016/j.soilbio.2014.06.002; Fu JW, 2015, CHEM ENG J, V259, P53, DOI 10.1016/j.cej.2014.07.101; Gao Y, 2012, J COLLOID INTERF SCI, V368, P540, DOI 10.1016/j.jcis.2011.11.015; Hassan AF, 2014, CARBOHYD POLYM, V102, P192, DOI 10.1016/j.carbpol.2013.10.104; Hmid A, 2014, BIOMASS BIOENERG, V71, P330, DOI 10.1016/j.biombioe.2014.09.024; Keiluweit M, 2010, ENVIRON SCI TECHNOL, V44, P1247, DOI 10.1021/es9031419; Laird DA, 2009, BIOFUEL BIOPROD BIOR, V3, P547, DOI 10.1002/bbb.169; Liang B, 2006, SOIL SCI SOC AM J, V70, P1719, DOI 10.2136/sssaj2005.0383; Liao P, 2012, CHEM ENG J, V195, P339, DOI 10.1016/j.cej.2012.04.092; Lima I, 2005, WASTE MANAGE, V25, P726, DOI 10.1016/j.wasman.2004.12.019; Liu HH, 2011, WATER RES, V45, P3499, DOI 10.1016/j.watres.2011.04.004; Liu SG, 2014, CHEM ENG J, V248, P135, DOI 10.1016/j.cej.2014.03.026; Madrakian T, 2011, J HAZARD MATER, V196, P109, DOI 10.1016/j.jhazmat.2011.08.078; Malash GF, 2010, J COLLOID INTERF SCI, V348, P537, DOI 10.1016/j.jcis.2010.05.005; Mendez A, 2013, CHEMOSPHERE, V93, P668, DOI 10.1016/j.chemosphere.2013.06.004; Meng J, 2014, ENVIRON SCI POLLUT R, V21, P7035, DOI 10.1007/s11356-014-2627-z; Peng X, 2011, SOIL TILL RES, V112, P159, DOI 10.1016/j.still.2011.01.002; PEREIRA MG, 2014, SCI WORLD J, V2014, P1; Peydayesh M, 2015, J IND ENG CHEM, V21, P1014, DOI 10.1016/j.jiec.2014.05.010; Shaaban A, 2014, J ANAL APPL PYROL, V107, P31, DOI 10.1016/j.jaap.2014.01.021; Sharma YC, 2009, ENERG FUEL, V23, P2983, DOI 10.1021/ef9001132; Singh A, 2013, WASTE MANAGE, V33, P1113, DOI 10.1016/j.wasman.2013.01.022; Sun K, 2011, BIORESOURCE TECHNOL, V102, P5757, DOI 10.1016/j.biortech.2011.03.038; Vimonses V, 2009, APPL CLAY SCI, V43, P465, DOI 10.1016/j.clay.2008.11.008; Xiong L, 2010, CHEM ENG J, V156, P313, DOI 10.1016/j.cej.2009.10.023; Yang G, 2015, RSC ADV, V5, P40117, DOI 10.1039/c5ra02836a; Yao YJ, 2010, BIORESOURCE TECHNOL, V101, P3040, DOI 10.1016/j.biortech.2009.12.042; Yuan HR, 2013, J MATER CYCLES WASTE, V15, P357, DOI 10.1007/s10163-013-0126-9; Yuan JH, 2011, BIORESOURCE TECHNOL, V102, P3488, DOI 10.1016/j.biortech.2010.11.018; Zhai YB, 2012, J THERM ANAL CALORIM, V107, P1015, DOI 10.1007/s10973-011-1644-0; Zhang P, 2013, J HAZARD MATER, V244, P217, DOI 10.1016/j.jhazmat.2012.11.046	43	64	64	2	69	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 4	2016	11	5							e0154562	10.1371/journal.pone.0154562	http://dx.doi.org/10.1371/journal.pone.0154562			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DL5KR	27144922	gold, Green Submitted, Green Published			2022-12-26	WOS:000375676400052
J	Fenner, K; Yoon, S; White, P; Starling, M; McGreevy, P				Fenner, Kate; Yoon, Samuel; White, Peter; Starling, Melissa; McGreevy, Paul			The Effect of Noseband Tightening on Horses' Behavior, Eye Temperature, and Cardiac Responses	PLOS ONE			English	Article							HEART-RATE-VARIABILITY; STRESS; WELFARE; BRIDLES	Restrictive nosebands are common in equestrian sport. This is concerning, as recent evidence suggests that very tight nosebands can cause a physiological stress response, and may compromise welfare. The objective of the current study was to investigate relationships that noseband tightness has with oral behavior and with physiological changes that indicate a stress response, such as increases in eye temperature (measured with infrared thermography) and heart rate and decreases in heart rate variability (HRV). Horses (n = 12) wearing a double bridle and crank noseband, as is common in dressage at elite levels, were randomly assigned to four treatments: unfastened noseband (UN), conventional area under noseband (CAUN) with two fingers of space available under the noseband, half conventional area under noseband (HCAUN) with one finger of space under the noseband, and no area under the noseband (NAUN). During the tightest treatment (NAUN), horse heart rate increased (P = 0.003), HRV decreased (P < 0.001), and eye temperature increased (P = 0.011) compared with baseline readings, indicating a physiological stress response. The behavioral results suggest some effects from bits alone but the chief findings are the physiological readings that reflect responses to the nosebands at their tightest. Chewing decreased during the HCAUN (P < 0.001) and NAUN (P < 0.001) treatments. Yawning rates were negligible in all treatments. Similarly, licking was eliminated by the NAUN treatment. Following the removal of the noseband and double bridle during the recovery session, yawning (P = 0.015), swallowing (P = 0.003), and licking (P < 0.001) significantly increased compared with baseline, indicating a post- inhibitory rebound response. This suggests a rise in motivation to perform these behaviors and implies that their inhibition may place horses in a state of deprivation. It is evident that a very tight noseband can cause physiological stress responses and inhibit the expression of oral behaviors.	[Fenner, Kate] Kandoo Equine, Towrang, NSW, Australia; [Yoon, Samuel; White, Peter; Starling, Melissa; McGreevy, Paul] Univ Sydney, Fac Vet Sci, Sydney, NSW 2006, Australia	University of Sydney	Fenner, K (corresponding author), Kandoo Equine, Towrang, NSW, Australia.	kate@kandooequine.com.au	White, Peter J/B-5208-2013	McGreevy, Paul/0000-0001-7220-8378; Fenner, Kate/0000-0002-0649-3278				Ashley FH, 2005, EQUINE VET J, V37, P565, DOI 10.2746/042516405775314826; Casey V, 2013, J VET BEHAV, V8, P479, DOI 10.1016/j.jveb.2013.06.003; Dai F, 2015, J VET BEHAV, V10, P128, DOI 10.1016/j.jveb.2014.12.001; Federation Equestre Internationale, 2015, DRESS RUL; Freire R, 2009, EQUINE VET J, V41, P487, DOI 10.2746/095777309X383883; Fureix C., 2011, ISRN Zoology, V2011, P271209, DOI 10.5402/2011/271209; Gallup AC, 2008, PHYSIOL BEHAV, V95, P10, DOI 10.1016/j.physbeh.2008.05.003; GRECO M, 1993, PSYCHOL REC, V43, P175; Manfredi J., 2005, Equine and Comparative Exercise Physiology, V2, P241, DOI 10.1079/ECP200569; McGreevy P., 2010, EQUITATION SCI, V1st ed.; McGreevy PD, 2015, EQUINE VET EDUC, V27, P503, DOI 10.1111/eve.12445; McGreevy P, 2012, J VET BEHAV, V7, P142, DOI 10.1016/j.jveb.2011.08.001; McLean AN, 2010, J VET BEHAV, V5, P187, DOI 10.1016/j.jveb.2010.04.002; Miller ML, 2010, ANIM BEHAV, V80, P615, DOI 10.1016/j.anbehav.2010.05.018; NICOL CJ, 1987, ANIM BEHAV, V35, P1709, DOI 10.1016/S0003-3472(87)80063-5; Pierard M, 2015, J VET BEHAV, V10, P255, DOI 10.1016/j.jveb.2015.01.006; Quick JS, 2009, J VET BEHAV, V4, P169, DOI 10.1016/j.jveb.2008.12.001; Rietmann TR, 2004, APPL ANIM BEHAV SCI, V88, P121, DOI 10.1016/j.applanim.2004.02.016; Stewart M, 2008, PHYSIOL BEHAV, V93, P789, DOI 10.1016/j.physbeh.2007.11.044; Stewart M, 2007, PHYSIOL BEHAV, V92, P520, DOI 10.1016/j.physbeh.2007.04.034; Valera M, 2012, J EQUINE VET SCI, V32, P827, DOI 10.1016/j.jevs.2012.03.005; Visser EK, 2002, PHYSIOL BEHAV, V76, P289, DOI 10.1016/S0031-9384(02)00698-4; von Borell E, 2007, PHYSIOL BEHAV, V92, P293, DOI 10.1016/j.physbeh.2007.01.007; Webster A.J.F, 1994, ANIMAL WELFARE COOL; Yarnell K, 2015, PHYSIOL BEHAV, V143, P51, DOI 10.1016/j.physbeh.2015.02.040	25	65	66	5	60	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 3	2016	11	5							e0154179	10.1371/journal.pone.0154179	http://dx.doi.org/10.1371/journal.pone.0154179			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DL5KK	27140187	Green Published, Green Submitted, gold			2022-12-26	WOS:000375675700019
J	Han, E; Yun, Y; Kim, G; Lee, YH; Wang, HJ; Lee, BW; Cha, BS; Kim, BS; Kang, ES				Han, Eugene; Yun, Yujung; Kim, Gyuri; Lee, Yong-Ho; Wang, Hye Jin; Lee, Byung-Wan; Cha, Bong Soo; Kim, Beom Seok; Kang, Eun Seok			Effects of Omega-3 Fatty Acid Supplementation on Diabetic Nephropathy Progression in Patients with Diabetes and Hypertriglyceridemia	PLOS ONE			English	Article							POLYUNSATURATED FATTY-ACIDS; CORONARY-HEART-DISEASE; FAMILIAL COMBINED HYPERLIPIDEMIA; BLOOD-PRESSURE; RENAL-FUNCTION; FISH-OIL; CONTROLLED-TRIALS; IGA NEPHROPATHY; KIDNEY; MICROALBUMINURIA	Beneficial effects of omega-3 fatty acid (O3FA) supplementation in a wide range of disease condition have been well studied. However, there is limited information regarding the effects of O3FAs on chronic kidney disease (CKD), especially in diabetic nephropathy (DN) with hypertriglyceridemia. We investigate whether O3FA supplementation could help maintain renal function in patients with diabetes and hypertriglyceridemia. Total 344 type 2 diabetic patients with a history of O3FA supplementation for managing hypertriglyceridemia were included. Reduction in urine albumin to creatinine ratio (ACR) and glomerular filtrate rate (GFR) were examined. Subgroup analyses were stratified according to the daily O3FA doses. Serum total cholesterol, triglyceride, and urine ACR significantly reduced after O3FA supplementation. Overall, 172 (50.0%) patients did not experience renal function loss, and 125 (36.3%) patients had a GFR with a positive slope. The patients treated with O3FAs at 4g/day showed greater maintenance in renal function than those treated with lower dosages (p < 0.001). This dose dependent effect remains significant after adjustment for multiple variables. O3FA supplementation in diabetic patients with hypertriglyceridemia shows benefits of reducing albuminuria and maintaining renal function. The effects are dependent on the dose of daily O3FA supplementation.	[Han, Eugene; Yun, Yujung; Kim, Gyuri; Lee, Yong-Ho; Lee, Byung-Wan; Cha, Bong Soo; Kang, Eun Seok] Yonsei Univ, Coll Med, Dept Internal Med, Div Endocrinol & Metab, Seoul, South Korea; [Wang, Hye Jin] Yonsei Univ, Coll Med, Brain Korea Project Med Sci 21, Seoul, South Korea; [Lee, Byung-Wan; Cha, Bong Soo; Kang, Eun Seok] Yonsei Univ, Coll Med, Inst Endocrine Res, Seoul, South Korea; [Kim, Beom Seok] Yonsei Univ, Coll Med, Dept Internal Med, Div Nephrol, Seoul, South Korea; [Han, Eugene; Kim, Gyuri; Lee, Byung-Wan; Cha, Bong Soo; Kang, Eun Seok] Yonsei Univ, Coll Med, Grad Sch, Seoul, South Korea	Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University Health System	Kang, ES (corresponding author), Yonsei Univ, Coll Med, Dept Internal Med, Div Endocrinol & Metab, Seoul, South Korea.; Kang, ES (corresponding author), Yonsei Univ, Coll Med, Inst Endocrine Res, Seoul, South Korea.; Kang, ES (corresponding author), Yonsei Univ, Coll Med, Grad Sch, Seoul, South Korea.	edgo@yuhs.ac	Lee, Yong-ho/AAT-4106-2020; Kim, Gyuri/E-8992-2018	Lee, Yong-ho/0000-0002-6219-4942; Kim, Gyuri/0000-0002-2242-2816; Kang, Eun Seok/0000-0002-0364-4675; Lee, Byung-Wan/0000-0002-9899-4992; Cha, Bong-Soo/0000-0003-0542-2854; Kim, Beom Seok/0000-0002-5732-2583				Athyros VG, 2004, J CLIN PATHOL, V57, P728, DOI 10.1136/jcp.2003.012989; Baggio B, 2005, J NEPHROL, V18, P362; Bucher HC, 2002, AM J MED, V112, P298, DOI 10.1016/S0002-9343(01)01114-7; Calabresi L, 2004, METABOLISM, V53, P153, DOI 10.1016/j.metabol.2003.09.007; Calabresi L, 2000, ATHEROSCLEROSIS, V148, P387, DOI 10.1016/S0021-9150(99)00267-1; Chin HJ, 2010, NEPHROL DIAL TRANSPL, V25, P1450, DOI 10.1093/ndt/gfp695; Cicero AFG, 2009, CURR VASC PHARMACOL, V7, P330, DOI 10.2174/157016109788340659; Davidson MH, 2007, CLIN THER, V29, P1354, DOI 10.1016/j.clinthera.2007.07.018; Davis TME, 2011, DIABETOLOGIA, V54, P280, DOI 10.1007/s00125-010-1951-1; DECATERINA R, 1994, AM J KIDNEY DIS, V24, P397, DOI 10.1016/S0272-6386(12)80896-1; DONADIO JV, 1994, NEW ENGL J MED, V331, P1194, DOI 10.1056/NEJM199411033311804; Donadio JV, 2001, J AM SOC NEPHROL, V12, P791, DOI 10.1681/ASN.V124791; Forsblom C, 2010, DIABETES CARE, V33, P215, DOI 10.2337/dc09-0621; Garman JH, 2009, AM J PHYSIOL-RENAL, V296, pF306, DOI 10.1152/ajprenal.90326.2008; Gopinath B, 2011, BRIT J NUTR, V105, P1361, DOI 10.1017/S0007114510005040; Gross JL, 2005, DIABETES CARE, V28, P164, DOI 10.2337/diacare.28.1.164; GRUNDT H, 1995, J INTERN MED, V237, P249, DOI 10.1111/j.1365-2796.1995.tb01173.x; Hagiwara S, 2006, NEPHROL DIAL TRANSPL, V21, P605, DOI 10.1093/ndt/gfi208; HAMAZAKI T, 1990, LIPIDS, V25, P541, DOI 10.1007/BF02537161; Han SH, 2005, HYPERTENSION, V46, P1086, DOI 10.1161/01.HYP.0000187900.36455.4c; Harris WS, 1997, AM J CLIN NUTR, V65, P1645, DOI 10.1093/ajcn/65.5.1645S; Inker LA, 2014, AM J KIDNEY DIS, V63, P713, DOI 10.1053/j.ajkd.2014.01.416; Keech A, 2005, LANCET, V366, P1849, DOI 10.1016/S0140-6736(05)67667-2; Kim SY, 2003, NEPHROLOGY, V8, pS2, DOI 10.1046/j.1440-1797.8.s.5.x; Kris-Etherton PM, 2003, ARTERIOSCL THROM VAS, V23, P151, DOI 10.1161/01.ATV.0000057393.97337.AE; Lee MW, 2013, DIABETES METAB J, V37, P207, DOI 10.4093/dmj.2013.37.3.207; Levey AS, 2009, ANN INTERN MED, V150, P604, DOI 10.7326/0003-4819-150-9-200905050-00006; Lichtenstein AH, 2006, CIRCULATION, V114, P82, DOI 10.1161/CIRCULATIONAHA.106.176158; Lungershausen YK, 1997, ANN NY ACAD SCI, V827, P369, DOI 10.1111/j.1749-6632.1997.tb51848.x; MACKNESS MI, 1994, EUR J CLIN NUTR, V48, P859; MANTTARI M, 1995, HYPERTENSION, V26, P670, DOI 10.1161/01.HYP.26.4.670; Miller ER, 2013, DIABETES CARE, V36, P1462, DOI 10.2337/dc12-1940; Miller ER, 2009, AM J CLIN NUTR, V89, P1937, DOI 10.3945/ajcn.2008.26867; Mollsten AV, 2001, DIABETES CARE, V24, P805, DOI 10.2337/diacare.24.5.805; Mori TA, 1999, HYPERTENSION, V34, P253, DOI 10.1161/01.HYP.34.2.253; MORRIS MC, 1993, CIRCULATION, V88, P523, DOI 10.1161/01.CIR.88.2.523; Reddy MA, 2013, SEMIN NEPHROL, V33, P341, DOI 10.1016/j.semnephrol.2013.05.006; Rossing K, 2004, KIDNEY INT, V66, P1596, DOI 10.1111/j.1523-1755.2004.00925.x; Sanders TAB, 1997, ARTERIOSCL THROM VAS, V17, P3449, DOI 10.1161/01.ATV.17.12.3449; Shepherd J, 2008, J AM COLL CARDIOL, V51, P1448, DOI 10.1016/j.jacc.2007.11.072; Shlipak MG, 2009, AM J NEPHROL, V30, P171, DOI 10.1159/000212381; Skulas-Ray AC, 2008, EXPERT OPIN PHARMACO, V9, P1237, DOI 10.1517/14656560802025496; Skulas-Ray AC, 2011, AM J CLIN NUTR, V93, P243, DOI 10.3945/ajcn.110.003871; Stirban A, 2010, AM J CLIN NUTR, V91, P808, DOI 10.3945/ajcn.2009.28374; Wall R, 2010, NUTR REV, V68, P280, DOI 10.1111/j.1753-4887.2010.00287.x	45	31	33	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 2	2016	11	5							e0154683	10.1371/journal.pone.0154683	http://dx.doi.org/10.1371/journal.pone.0154683			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DL5KB	27135947	Green Published, Green Submitted, gold			2022-12-26	WOS:000375674800039
J	Nagata, T; Sobajima, H; Ohashi, N; Hirakawa, A; Katsuno, T; Yasuda, Y; Matsuo, S; Tsuboi, N; Maruyama, S				Nagata, Takanobu; Sobajima, Hiroshi; Ohashi, Norimi; Hirakawa, Akihiro; Katsuno, Takayuki; Yasuda, Yoshinari; Matsuo, Seiichi; Tsuboi, Naotake; Maruyama, Shoichi			Association between 24h Urinary Sodium and Potassium Excretion and Estimated Glomerular Filtration Rate (eGFR) Decline or Death in Patients with Diabetes Mellitus and eGFR More than 30 ml/min/1.73m(2)	PLOS ONE			English	Article							KIDNEY-DISEASE; INDIVIDUALS	Background Data regarding the association between 24h urinary sodium and potassium excretion with kidney outcomes in patients with diabetes mellitus is currently scarce. Methods We conducted a single-center, retrospective cohort study in which 1230 patients with diabetes who had undergone a 24h urinary sodium and potassium excretion test were analyzed. Patients with incomplete urine collection were excluded based on 24h urinary creatinine excretion. Outcomes were the composite of a 30% decline in eGFR or death. Multivariate cox regression analysis was used to investigate the association between urinary sodium and potassium excretion and outcomes. Results With a mean follow up period of 5.47 years, 130 patients reached the outcomes (30% decline in eGFR: 124, death: 6). Mean (SD) eGFR and 24h urinary sodium and potassium excretion at baseline were 78.6 (19.5) ml/min/1.73m(2), 4.50 (1.64) g/day, and 2.14 (0.77) g/day. Compared with sodium excretion <3.0 g/day, no significant change in risk of outcomes was observed with increased increments of 1.0 g/day. Compared with potassium excretion of <1.5 g/day, 2.0-2.5 g/day, and 2.5-3.0 g/day were significantly associated with a lower risk of outcomes (hazard ratio [HR], 0.49 and 0.44; 95% confidence interval [CI], 0.28 to 0.84 and 0.22 to 0.87). Conclusions 24h urinary sodium excretion was not significantly associated with a risk of 30% decline in eGFR or death in patients with diabetes. However, an increased risk of 30% decline in eGFR or death was significantly associated with 24h urinary potassium excretion <1.5 g/day than with 2.0-2.5 g/day and 2.5-3.0 g/day.	[Nagata, Takanobu; Katsuno, Takayuki; Yasuda, Yoshinari; Matsuo, Seiichi; Tsuboi, Naotake; Maruyama, Shoichi] Nagoya Univ, Grad Sch Med, Dept Nephrol, Nagoya, Aichi 4648601, Japan; [Nagata, Takanobu; Sobajima, Hiroshi; Ohashi, Norimi] Ogaki Municipal Hosp, Dept Diabetol & Nephrol, Ogaki, Japan; [Hirakawa, Akihiro] Nagoya Univ Hosp, Ctr Adv Med & Clin Res, Nagoya, Aichi, Japan	Nagoya University; Ogaki Municipal Hospital; Nagoya University	Maruyama, S (corresponding author), Nagoya Univ, Grad Sch Med, Dept Nephrol, Nagoya, Aichi 4648601, Japan.	marus@med.nagoya-u.ac.jp	Hirakawa, Akihiro/AAE-5936-2019; Tsuboi, Naotake/L-5960-2019	Tsuboi, Naotake/0000-0003-0760-845X	Ministry of Health, Labor, and Welfare of Japan [H26-Nanchi-Ippan-042]	Ministry of Health, Labor, and Welfare of Japan(Ministry of Health, Labour and Welfare, Japan)	This study was supported by a Grant-in-Aid for Progressive Renal Diseases Research, Research on Rare and Intractable Disease, from the Ministry of Health, Labor, and Welfare of Japan (http://jin-shogai.jp/mt/public/hp/). The grant number is H26-Nanchi-Ippan-042. TN, TK, YY, SMatsu, NT, and SMaru received the funding. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aburto NJ, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f1326; Aburto NJ, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f1378; Ahmed J, 2001, SEMIN DIALYSIS, V14, P348, DOI 10.1046/j.1525-139X.2001.00087.x; [Anonymous], 2015, J CLIN APPL RES ED S, V38, ps1, DOI [10.2337/dc13-S011, DOI 10.2337/DC13-S011]; Araki S, 2015, CLIN J AM SOC NEPHRO, V10, P2152, DOI 10.2215/CJN.00980115; Cook NR, 2009, ARCH INTERN MED, V169, P32, DOI 10.1001/archinternmed.2008.523; Donnell MJO, 2011, CLIN CORNER URINARY, V306, P2229; Dunkler D, 2015, NEPHROL DIAL TRANSPL, V30, P76, DOI 10.1093/ndt/gfv086; Dunkler D, 2013, JAMA INTERN MED, V173, P1682, DOI 10.1001/jamainternmed.2013.9051; Ekinci EI, 2011, DIABETES CARE, V34, P703, DOI 10.2337/dc10-1723; Fan L, 2014, KIDNEY INT, V86, P582, DOI 10.1038/ki.2014.59; Harrell FE, 2001, REGRESSION MODELING; He J, 2015, J ENG-JOE, P1, DOI [10.1681/ASN.2015010022, 10.1049/joe.2015.0102]; Houston MC, 2011, CURR HYPERTENS REP, V13, P309, DOI 10.1007/s11906-011-0197-8; KAWASAKI T, 1993, CLIN EXP PHARMACOL P, V20, P7, DOI 10.1111/j.1440-1681.1993.tb01496.x; Levin A, 2013, KIDNEY INT SUPPL, V3, P5, DOI 10.1038/kisup.2012.77; Liamis G, 2014, WORLD J CLIN CASES, V2, P488, DOI 10.12998/wjcc.v2.i10.488; LUFT FC, 1982, HYPERTENSION, V4, P805, DOI 10.1161/01.HYP.4.6.805; Luo J, 2015, CLIN J AM SOC NEPHRO, V11, P1; Luther JM, 2012, J AM SOC NEPHROL, V23, P10, DOI 10.1681/ASN.2011111107; Matavelli LC, 2007, AM J PHYSIOL-HEART C, V292, pH814, DOI 10.1152/ajpheart.00671.2006; Matsuo S, 2009, AM J KIDNEY DIS, V53, P982, DOI 10.1053/j.ajkd.2008.12.034; McMahon EJ, 2013, J AM SOC NEPHROL, V24, P2096, DOI 10.1681/ASN.2013030285; Mente A, 2014, J HYPERTENS, V32, P1005, DOI 10.1097/HJH.0000000000000122; Mente A, 2009, J NUTR, V139, P743, DOI 10.3945/jn.108.098319; O'Donnell M, 2015, CIRC RES, V116, P1046, DOI 10.1161/CIRCRESAHA.116.303771; O'Donnell M, 2014, NEW ENGL J MED, V371, P612, DOI 10.1056/NEJMoa1311889; Rocco MV, 2012, AM J KIDNEY DIS, V60, P857, DOI 10.1053/j.ajkd.2012.07.005; Smyth A, 2014, KIDNEY INT, V86, P1205, DOI 10.1038/ki.2014.214; Stolarz-Skrzypek K, 2013, CURR HYPERTENS REP, V15, P122, DOI 10.1007/s11906-013-0331-x; Thomas MC, 2011, DIABETES CARE, V34, P861, DOI 10.2337/dc10-1722; Wang W, 2007, AM J PHYSIOL-RENAL, V293, pF1123, DOI 10.1152/ajprenal.00104.2007; Weir MR, 2010, CLIN J AM SOC NEPHRO, V5, P531, DOI 10.2215/CJN.07821109; Well ITIS, 1991, STIMULATION RENIN RE; World Health Organization, 2011, GUID INT TUB CAS FIN, P52	35	16	16	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 2	2016	11	5							e0152306	10.1371/journal.pone.0152306	http://dx.doi.org/10.1371/journal.pone.0152306			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DL5KB	27136292	Green Published, gold			2022-12-26	WOS:000375674800002
J	Tan, TXZ; Quek, NXE; Koh, ZX; Nadkarni, N; Singaram, K; Ho, AFW; Ong, MEH; Wong, TH				Tan, Timothy Xin Zhong; Quek, Nathaniel Xin Ern; Koh, Zhi Xiong; Nadkarni, Nivedita; Singaram, Kanageswari; Ho, Andrew Fu Wah; Ong, Marcus Eng Hock; Wong, Ting Hway			The Effect of Availability of Manpower on Trauma Resuscitation Times in a Tertiary Academic Hospital	PLOS ONE			English	Article							EMERGENCY-DEPARTMENT; TEAM; MORTALITY; PERFORMANCE; CARE	Background For trauma patients, delays to assessment, resuscitation, and definitive care affect outcomes. We studied the effects of resuscitation area occupancy and trauma team size on trauma team resuscitation speed in an observational study at a tertiary academic institution in Singapore. Methods From January 2014 to January 2015, resuscitation videos of trauma team activated patients with an Injury Severity Score of 9 or more were extracted for review within 14 days by independent reviewers. Exclusion criteria were patients dead on arrival, inter-hospital transfers, and up-triaged patients. Data captured included manpower availability (trauma team size and resuscitation area occupancy), assessment (airway, breathing, circulation, logroll), interventions (vascular access, imaging), and process-of-care time intervals (time to assessment/intervention/adjuncts, time to imaging, and total time in the emergency department). Clinical data were obtained by chart review and from the trauma registry. Results Videos of 70 patients were reviewed over a 13-month period. The median time spent in the emergency department was 154.9 minutes (IQR 130.7-207.5) and the median resuscitation team size was 7, with larger team sizes correlating with faster process-of-care time intervals: time to airway assessment (p = 0.08) and time to disposition (p = 0.04). The mean resuscitation area occupancy rate (RAOR) was 1.89 +/- 2.49, and the RAOR was positively correlated with time spent in the emergency department (p = 0.009). Conclusion Our results suggest that adequate staffing for trauma teams and resuscitation room occupancy are correlated with faster trauma resuscitation and reduced time spent in the emergency department.	[Tan, Timothy Xin Zhong; Quek, Nathaniel Xin Ern] Natl Univ Singapore, Yong Loo Lin Sch Med, Singapore 117595, Singapore; [Koh, Zhi Xiong; Ho, Andrew Fu Wah; Ong, Marcus Eng Hock] Singapore Gen Hosp, Dept Emergency Med, Singapore, Singapore; [Nadkarni, Nivedita] Duke NUS Grad Med Sch, Ctr Quantitat Med, Singapore, Singapore; [Singaram, Kanageswari; Wong, Ting Hway] Singapore Gen Hosp, Trauma Serv, Dept Gen Surg, Singapore, Singapore; [Ong, Marcus Eng Hock] Duke NUS Grad Med Sch, Hlth Serv & Syst Res, Singapore, Singapore	National University of Singapore; Singapore General Hospital; National University of Singapore; Singapore General Hospital; National University of Singapore	Wong, TH (corresponding author), Singapore Gen Hosp, Trauma Serv, Dept Gen Surg, Singapore, Singapore.	wong.ting.hway@sgh.com.sg	Ho, Andrew Fu Wah/F-6213-2016	Ho, Andrew Fu Wah/0000-0003-4338-3876; Wong, Ting Hway/0000-0001-9234-4529; Tan, Timothy Xin Zhong/0000-0001-5938-2304; KOH, ZHI XIONG/0000-0001-6440-1709				Adedeji OA, 1996, POSTGRAD MED J, V72, P587, DOI 10.1136/pgmj.72.852.587; Alavi-Moghaddam M, 2012, ARCH TRAUMA RES, V1, P101, DOI 10.5812/atr.7177; American College of Surgeons Committee on Trauma, 2014, RESOURCES OPTIMAL CA; Cassera MA, 2009, AM J SURG, V198, P216, DOI 10.1016/j.amjsurg.2008.10.016; Cole E, 2006, J CLIN NURS, V15, P1257, DOI 10.1111/j.1365-2702.2006.01566.x; DRISCOLL PA, 1992, INJURY, V23, P111, DOI 10.1016/0020-1383(92)90044-S; DRISCOLL PA, 1992, INJURY, V23, P107, DOI 10.1016/0020-1383(92)90043-R; DRISCOLL PA, 1992, INJURY, V23, P151, DOI 10.1016/S0020-1383(05)80033-6; Georgiou A, 2010, SCAND J TRAUMA RESUS, V18, DOI 10.1186/1757-7241-18-66; Gjeraa K, 2014, ACTA ANAESTH SCAND, V58, P775, DOI 10.1111/aas.12336; Groenestege-Kreb DT, 2014, BRIT J ANAESTH, V113, P258, DOI 10.1093/bja/aeu236; Guttmann A, 2011, BMJ-BRIT MED J, V342, DOI 10.1136/bmj.d2983; Ho AFW, 2015, PREHOSP EMERG CARE, V19, P409, DOI 10.3109/10903127.2014.980477; HOYT DB, 1988, J TRAUMA, V28, P435, DOI 10.1097/00005373-198804000-00003; Kelleher DC, 2014, PEDIATR EMERG CARE, V30, P248, DOI 10.1097/PEC.0000000000000106; Mowery NT, 2011, J TRAUMA, V70, P1317, DOI 10.1097/TA.0b013e3182175199; Ong MEH, 2013, RESUSCITATION, V84, P508, DOI 10.1016/j.resuscitation.2012.07.033; Scottish Trauma Audit Group, 2012, STAG TRAUM AUD; Wong TH, 2013, EUR J TRAUMA EMERG S, V39, P495, DOI 10.1007/s00068-013-0292-4; Wong TH, 2012, EUR J TRAUMA, P467; Wong TH, 2013, J TRAUMA ACUTE CARE, V74, P780, DOI 10.1097/TA.0b013e3182826d5f	21	2	2	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 2	2016	11	5							e0154595	10.1371/journal.pone.0154595	http://dx.doi.org/10.1371/journal.pone.0154595			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DL5KB	27136299	Green Published, Green Submitted, gold			2022-12-26	WOS:000375674800032
J	Westphal, MF; Stewart, JAE; Tennant, EN; Butterfield, HS; Sinervo, B				Westphal, Michael F.; Stewart, Joseph A. E.; Tennant, Erin N.; Butterfield, H. Scott; Sinervo, Barry			Contemporary Drought and Future Effects of Climate Change on the Endangered Blunt-Nosed Leopard Lizard, Gambelia sila	PLOS ONE			English	Article							DESERT; REPRODUCTION; DIVERSITY; ECOLOGY; MODELS; WATER; US	Extreme weather events can provide unique opportunities for testing models that predict the effect of climate change. Droughts of increasing severity have been predicted under numerous models, thus contemporary droughts may allow us to test these models prior to the onset of the more extreme effects predicted with a changing climate. In the third year of an ongoing severe drought, surveys failed to detect neonate endangered blunt-nosed leopard lizards in a subset of previously surveyed populations where we expected to see them. By conducting surveys at a large number of sites across the range of the species over a short time span, we were able to establish a strong positive correlation between winter precipitation and the presence of neonate leopard lizards over geographic space. Our results are consistent with those of numerous longitudinal studies and are in accordance with predictive climate change models. We suggest that scientists can take immediate advantage of droughts while they are still in progress to test patterns of occurrence in other drought-sensitive species and thus provide for more robust models of climate change effects on biodiversity.	[Westphal, Michael F.] US Bur Land Management, Hollister Field Off, Hollister, CA USA; [Stewart, Joseph A. E.; Sinervo, Barry] Univ Calif Santa Cruz, Dept Ecol & Evolutionary Biol, Santa Cruz, CA 95064 USA; [Tennant, Erin N.] Calif Dept Fish & Wildlife, Lands Unit, Fresno, CA USA; [Butterfield, H. Scott] Nature Conservancy, San Francisco, CA USA	University of California System; University of California Santa Cruz; Nature Conservancy	Westphal, MF (corresponding author), US Bur Land Management, Hollister Field Off, Hollister, CA USA.	mwestpha@blm.gov	Stewart, Joseph/AAA-4647-2020	Stewart, Joseph/0000-0001-5915-6892	US BLM [L12AC20104]; Nature Conservancy [12112012-1361]; California Department of Fish and Wildlife; NSF [EF-1241848]; Bureau of Land Management; Nature Conservancy; Emerging Frontiers [1241848] Funding Source: National Science Foundation	US BLM; Nature Conservancy; California Department of Fish and Wildlife; NSF(National Science Foundation (NSF)); Bureau of Land Management; Nature Conservancy; Emerging Frontiers(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This work was supported by a Grant from US BLM to Regents of University of California Santa Cruz Award #L12AC20104 www.grants.gov. The funders had a role in study design, data collection and analysis, decision to publish, and preparation of the manuscript. This work also received support from a Grant from The Nature Conservancy to Regents of the University of California Santa Cruz #12112012-1361 www.nature.org. The funder had a role in decision to publish, and preparation of the manuscript. California Department of Fish and Wildlife sopported this project and had a role in decision to publish, and preparation of the manuscript. An NSF grant EF-1241848 to B. Sinervo supported this work. The funder had a role in decision to publish, and preparation of the manuscript.; We would like to thank M. Powers, J. Richmond, D. Wood, R. O'Dell, J. McLeod, P. Prather, K. Sharum, M. White, L. Saslaw, D. Germano, G. Hill, R. Cooper, J. Eade, L. Peppel, and R. McCormick. Funding was provided by Bureau of Land Management, The Nature Conservancy, and California Department of Fish and Wildlife. B. Sinervo was also supported by NSF grant EF-1241848.	ABTS ML, 1987, ECOL MONOGR, V57, P215, DOI 10.2307/2937081; Algar AC, 2009, ECOGRAPHY, V32, P22, DOI 10.1111/j.1600-0587.2009.05832.x; Araujo MB, 2005, GLOBAL CHANGE BIOL, V11, P1504, DOI 10.1111/j.1365-2486.2005.01000.x; Archer Steven R., 2008, Rangelands, V30, P23, DOI 10.2111/1551-501X(2008)30[23:CCAEOT]2.0.CO;2; Bailey CV, 2015, W WILD, V2, P23; BALLINGER RE, 1977, ECOLOGY, V58, P628, DOI 10.2307/1939012; Barrows CW, 2010, BIOL CONSERV, V143, P731, DOI 10.1016/j.biocon.2009.12.013; Bucklin DN, 2013, REG ENVIRON CHANGE, V13, pS57, DOI 10.1007/s10113-012-0389-z; Cayan DR, 2010, P NATL ACAD SCI USA, V107, P21271, DOI 10.1073/pnas.0912391107; Cliff A. D., 1981, SPATIAL PROCESSES MO; Cook BI, 2015, SCI ADV, V1, DOI 10.1126/sciadv.1400082; Cook ER, 2004, SCIENCE, V306, P1015, DOI 10.1126/science.1102586; DALY C, 1994, J APPL METEOROL, V33, P140, DOI 10.1175/1520-0450(1994)033&lt;0140:ASTMFM&gt;2.0.CO;2; Dunham A. E., 1981, MISC PUBL MUS ZOOL, V158, P1; Falcone C, 2010, THESIS U NEBRASKA; Germano DJ, 2011, NAT AREA J, V31, P138, DOI 10.3375/043.031.0206; Germano DJ, 2009, CALIF FISH GAME, V95, P106; Germano David J., 1994, Northwestern Naturalist, V75, P11, DOI 10.2307/3536555; Germano DJ, 2005, J HERPETOL, V39, P1, DOI 10.1670/0022-1511(2005)039[0001:PEOBLL]2.0.CO;2; Griffin D, 2014, GEOPHYS RES LETT, V41, P9017, DOI 10.1002/2014GL062433; Hijmans RJ, 2006, GLOBAL CHANGE BIOL, V12, P2272, DOI 10.1111/j.1365-2486.2006.01256.x; Knight C. G., 2004, DROUGHT BULGARIA CON; Lovich JE, 2014, BIOL CONSERV, V169, P214, DOI 10.1016/j.biocon.2013.09.027; MAYHEW WW, 1966, COPEIA, P114; MAYHEW WW, 1966, ECOLOGY, V47, P9, DOI 10.2307/1935740; MUTH A, 1980, ECOLOGY, V61, P1335, DOI 10.2307/1939042; PIANKA ER, 1970, AM NAT, V104, P592, DOI 10.1086/282697; Porter W.P., 1983, P55; Povilitis A, 2010, CONSERV BIOL, V24, P372, DOI 10.1111/j.1523-1739.2010.01447.x; Preston K, 2008, GLOBAL CHANGE BIOL, V14, P2501, DOI 10.1111/j.1365-2486.2008.01671.x; R Development Core Team, 2007, R LANG ENV STAT COMP; Robinson M.D., 1990, Transvaal Museum Monograph, P163; Rowland EL, 2011, ENVIRON MANAGE, V47, P322, DOI 10.1007/s00267-010-9608-x; Sewall JO, 2004, GEOPHYS RES LETT, V31, DOI 10.1029/2003GL019133; Sinervo B, 2010, SCIENCE, V328, P894, DOI 10.1126/science.1184695; STEWART JAE, 2015, CALIF J BIOGEOG, V42, P880, DOI DOI 10.1111/JBI.12466; Thomas CD, 2004, NATURE, V427, P145, DOI 10.1038/nature02121; TOLLESTRUP K, 1982, AM MIDL NAT, V108, P1, DOI 10.2307/2425287; U.S. Environmental Protection Agency, 2009, FRAM CAT REL VULN TH; WHITFORD W G, 1977, Herpetologica, V33, P54	40	18	18	0	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 2	2016	11	5							e0154838	10.1371/journal.pone.0154838	http://dx.doi.org/10.1371/journal.pone.0154838			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DL5KB	27136458	Green Submitted, Green Published, gold			2022-12-26	WOS:000375674800053
J	Derryberry, EP; Danner, RM; Danner, JE; Derryberry, GE; Phillips, JN; Lipshutz, SE; Gentry, K; Luther, DA				Derryberry, Elizabeth P.; Danner, Raymond M.; Danner, Julie E.; Derryberry, Graham E.; Phillips, Jennifer N.; Lipshutz, Sara E.; Gentry, Katherine; Luther, David A.			Patterns of Song across Natural and Anthropogenic Soundscapes Suggest That White-Crowned Sparrows Minimize Acoustic Masking and Maximize Signal Content	PLOS ONE			English	Article							URBAN NOISE; HIGHER PITCH; BIRD SONG; COMMUNICATION; PLASTICITY; EVOLUTION; CONSEQUENCES; POPULATIONS; BEHAVIOR; ECOLOGY	Soundscapes pose both evolutionarily recent and long-standing sources of selection on acoustic communication. We currently know more about the impact of evolutionarily recent human-generated noise on communication than we do about how natural sounds such as pounding surf have shaped communication signals over evolutionary time. Based on signal detection theory, we hypothesized that acoustic phenotypes will vary with both anthropogenic and natural background noise levels and that similar mechanisms of cultural evolution and/or behavioral flexibility may underlie this variation. We studied song characteristics of white-crowned sparrows (Zonotrichia leucophrys nuttalli) across a noise gradient that includes both anthropogenic and natural sources of noise in San Francisco and Marin counties, California, USA. Both anthropogenic and natural soundscapes contain high amplitude low frequency noise (traffic or surf, respectively), so we predicted that birds would produce songs with higher minimum frequencies in areas with higher amplitude background noise to avoid auditory masking. We also anticipated that song minimum frequencies would be higher than the projected lower frequency limit of hearing based on site-specific masking profiles. Background noise was a strong predictor of song minimum frequency, both within a local noise gradient of three urban sites with the same song dialect and cultural evolutionary history, and across the regional noise gradient, which encompasses 11 urban and rural sites, several dialects, and several anthropogenic and natural sources of noise. Among rural sites alone, background noise tended to predict song minimum frequency, indicating that urban sites were not solely responsible for driving the regional pattern. These findings support the hypothesis that songs vary with local and regional soundscapes regardless of the source of noise. Song minimum frequency from five core study sites was also higher than the lower frequency limit of hearing at each site, further supporting the hypothesis that songs vary to transmit through noise in local soundscapes. Minimum frequencies leveled off at noisier sites, suggesting that minimum frequencies are constrained to an upper limit, possibly to retain the information content of wider bandwidths. We found evidence that site noise was a better predictor of song minimum frequency than territory noise in both anthropogenic and natural soundscapes, suggesting that cultural evolution rather than immediate behavioral flexibility is responsible for local song variation. Taken together, these results indicate that soundscapes shape song phenotype across both evolutionarily recent and long-standing soundscapes.	[Derryberry, Elizabeth P.; Danner, Julie E.; Phillips, Jennifer N.; Lipshutz, Sara E.] Tulane Univ, Dept Ecol & Evolutionary Biol, New Orleans, LA 70118 USA; [Danner, Raymond M.; Gentry, Katherine; Luther, David A.] George Mason Univ, Dept Biol, Fairfax, VA 22030 USA; [Derryberry, Graham E.] Louisiana State Univ, Museum Nat Sci, Baton Rouge, LA 70803 USA; [Luther, David A.] Natl Zoo, Smithsonian Inst, Smithsonian Migratory Bird Ctr, Washington, DC USA; [Danner, Raymond M.] Univ N Carolina, Dept Biol & Marine Biol, Wilmington, NC 28401 USA	Tulane University; George Mason University; Louisiana State University System; Louisiana State University; Smithsonian Institution; Smithsonian National Zoological Park & Conservation Biology Institute; University of North Carolina; University of North Carolina Wilmington	Derryberry, EP (corresponding author), Tulane Univ, Dept Ecol & Evolutionary Biol, New Orleans, LA 70118 USA.	ederrybe@tulane.edu		Derryberry, Elizabeth/0000-0002-8248-9748; Gentry, Katherine/0000-0002-0006-7403	National Science Foundation [1354763]; National Science Foundation Integrative Organismal Systems [1354756]	National Science Foundation(National Science Foundation (NSF)); National Science Foundation Integrative Organismal Systems	This study was supported by the National Science Foundation, award #1354763 (DAL) and the National Science Foundation Integrative Organismal Systems, award #1354756 (EDP), www.nsf.gov. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akaike H., 1973, P 2 INT S INF THEOR, P267, DOI 10.1007/978-1-4612-1694-0; BAKER MC, 1985, CONDOR, V87, P127, DOI 10.2307/1367144; Ballentine B, 2004, BEHAV ECOL, V15, P163, DOI 10.1093/beheco/arg090; Baptista LF, 1975, U CALIF PUBL ZOOL, V105, P1; Beeman K., 1998, ANIMAL ACOUSTIC COMM; Bermudez-Cuamatzin E, 2011, BIOL LETTERS, V7, P36, DOI 10.1098/rsbl.2010.0437; Bermudez-Cuamatzin E, 2009, BEHAVIOUR, V146, P1269, DOI 10.1163/156853909X423104; Blickley Jessica L., 2012, Ornithological Monographs, V74, P23; Bradbury J. W., 2011, PRINCIPLES ANIMAL CO; Brumm H, 2004, J ANIM ECOL, V73, P434, DOI 10.1111/j.0021-8790.2004.00814.x; Brumm H, ADV STUDY BEHAV, V35, P151; Brumm H, 2006, BEHAV ECOL SOCIOBIOL, V60, P475, DOI 10.1007/s00265-006-0188-y; Bunkley JP, 2015, GLOB ECOL CONSERV, V3, P62, DOI 10.1016/j.gecco.2014.11.002; Burnham K. P., 2002, MODEL SELECTION MULT, V2nd; Catchpole CK, 2008, BIRD SONG: BIOLOGICAL THEMES AND VARIATIONS, 2ND EDITION, P1, DOI 10.1017/CBO9780511754791; Cavalli-Sforza LL., 1981, CULTURAL TRANSMISSIO; Dooling RJ, 2002, GOLDEN; Dooling RJ., 2007, ENV BIOACOUSTICS, V27, P1, DOI DOI 10.1121/2.0000244; Draganoiu TI, 2002, P ROY SOC B-BIOL SCI, V269, P2525, DOI 10.1098/rspb.2002.2192; DUBOIS A, 1984, J ORNITHOL, V125, P455, DOI 10.1007/BF01640137; ENDLER JA, 1992, AM NAT, V139, pS125, DOI 10.1086/285308; Fernandez-Juricic E, 2005, URBAN HABITATS, V3, P1541; Francis CD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027052; Gross K, 2010, AM NAT, V176, P456, DOI 10.1086/655428; Halfwerk W, 2009, ANIM BEHAV, V78, P1301, DOI 10.1016/j.anbehav.2009.09.015; HANSEN P, 1979, ANIM BEHAV, V27, P1270, DOI 10.1016/0003-3472(79)90073-3; Haven Wiley R., 1982, P131; Hu Y, 2010, ANIM BEHAV, V79, P863, DOI 10.1016/j.anbehav.2009.12.036; Hu Y, 2009, BEHAV ECOL, V20, P1268, DOI 10.1093/beheco/arp131; Kight CR, 2015, INTEGR COMP BIOL, V55, P418, DOI 10.1093/icb/icv070; Lee C, 2011, BASELINE AMBIENT SOU; Lee C., 2013, GOLDEN GATE NATL REC; Lengagne T, 2002, P ROY SOC B-BIOL SCI, V269, P2121, DOI 10.1098/rspb.2002.2115; Lengagne T, 1999, P ROY SOC B-BIOL SCI, V266, P1623, DOI 10.1098/rspb.1999.0824; Lohr B, 2003, ANIM BEHAV, V65, P763, DOI 10.1006/anbe.2003.2093; Luther D, 2010, P R SOC B, V277, P469, DOI 10.1098/rspb.2009.1571; Luther DA, 2016, BEHAV ECOL, V27, P332, DOI 10.1093/beheco/arv162; Luther DA, 2012, ANIM BEHAV, V83, P1059, DOI 10.1016/j.anbehav.2012.01.034; Lynch Alejandro, 1996, P181; MARLER P., 1962, CONDOR, V64, P368, DOI 10.2307/1365545; MARLER P, 1964, SCIENCE, V146, P1483, DOI 10.1126/science.146.3650.1483; MARLER P, 1970, J COMP PHYSIOL PSYCH, V71, P1, DOI 10.1037/h0029144; Mazerolle MJ, 2015, AICCMODAVG MODEL SEL; Morley EL, 2014, P ROY SOC B-BIOL SCI, V281, DOI 10.1098/rspb.2013.2683; MORTON ES, 1986, ANIM BEHAV, V34, P815, DOI 10.1016/S0003-3472(86)80066-5; Nelson DA, 1996, ANIM BEHAV, V52, P379, DOI 10.1006/anbe.1996.0182; Nemeth E, 2010, AM NAT, V176, P465, DOI 10.1086/656275; Nemeth E, 2009, ANIM BEHAV, V78, P637, DOI 10.1016/j.anbehav.2009.06.016; Parris KM, 2009, ECOL SOC, V14; Patricelli GL, 2006, AUK, V123, P639, DOI 10.1642/0004-8038(2006)123[639:ACIUNC]2.0.CO;2; Peters S, 2012, BIOL LETTERS, V8, P736, DOI 10.1098/rsbl.2012.0446; Pijanowski BC, 2011, BIOSCIENCE, V61, P203, DOI 10.1525/bio.2011.61.3.6; Pinheiro J, R PACKAGE VERSION; Podos J, 2004, ANNU REV ECOL EVOL S, V35, P55, DOI 10.1146/annurev.ecolsys.35.021103.105719; R Core Team, 2013, R LANG ENV STAT COMP; Rabin LA., 2003, INT J COMP PSYCHOL, V16, P172; Ripmeester EAP, 2010, BEHAV ECOL, V21, P876, DOI 10.1093/beheco/arq075; Ripmeester EAP, 2010, BEHAV ECOL SOCIOBIOL, V64, P409, DOI 10.1007/s00265-009-0857-8; Risch D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029741; Rossing T., 2007, SPRINGER HDB ACOUSTI; Shannon G, 2014, ANIM BEHAV, V94, P135, DOI 10.1016/j.anbehav.2014.06.004; Slabbekoorn H, 2003, NATURE, V424, P267, DOI 10.1038/424267a; Slabbekoorn H, 2006, CURR BIOL, V16, P2326, DOI 10.1016/j.cub.2006.10.008; Slabbekoorn H, 2013, ANIM BEHAV, V85, P1089, DOI 10.1016/j.anbehav.2013.01.021; Snell-Rood EC, 2013, ANIM BEHAV, V85, P1004, DOI 10.1016/j.anbehav.2012.12.031; Swaddle JP, 2015, TRENDS ECOL EVOL, V30, P550, DOI 10.1016/j.tree.2015.06.009; Velez A, 2014, DRYAD DIGITAL REPOSI; Velez A, 2015, FUNCT ECOL, V29, P487, DOI 10.1111/1365-2435.12352; Verzijden MN, 2010, J EXP BIOL, V213, P2575, DOI 10.1242/jeb.038299; Wiley RH, 2006, ADV STUD BEHAV, V36, P217, DOI 10.1016/S0065-3454(06)36005-6; Wiley RH, 2013, ANIMAL COMMUNICATION THEORY: INFORMATION AND INFLUENCE, P113; Wiley RH, 2013, BEHAVIOUR, V150, P957, DOI 10.1163/1568539X-00003063; Wood WE, 2006, AUK, V123, P650, DOI 10.1642/0004-8038(2006)123[650:SSMMSV]2.0.CO;2; Zollinger SA, 2012, ANIM BEHAV, V84, pE1, DOI 10.1016/j.anbehav.2012.04.026	74	41	42	7	74	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 29	2016	11	4							e0154456	10.1371/journal.pone.0154456	http://dx.doi.org/10.1371/journal.pone.0154456			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DK8XM	27128443	gold, Green Published, Green Submitted			2022-12-26	WOS:000375212600031
J	Richardson, TG; Shihab, HA; Rivas, MA; McCarthy, MI; Campbell, C; Timpson, NJ; Gaunt, TR				Richardson, Tom G.; Shihab, Hashem A.; Rivas, Manuel A.; McCarthy, Mark I.; Campbell, Colin; Timpson, Nicholas J.; Gaunt, Tom R.			A Protein Domain and Family Based Approach to Rare Variant Association Analysis	PLOS ONE			English	Article							DISEASE; MUTATIONS; DATABASE; IMPACT	Background It has become common practice to analyse large scale sequencing data with statistical approaches based around the aggregation of rare variants within the same gene. We applied a novel approach to rare variant analysis by collapsing variants together using protein domain and family coordinates, regarded to be a more discrete definition of a biologically functional unit. Methods Using Pfam definitions, we collapsed rare variants (Minor Allele Frequency <= 1%) together in three different ways 1) variants within single genomic regions which map to individual protein domains 2) variants within two individual protein domain regions which are predicted to be responsible for a protein-protein interaction 3) all variants within combined regions from multiple genes responsible for coding the same protein domain (i.e. protein families). A conventional collapsing analysis using gene coordinates was also undertaken for comparison. We used UK10K sequence data and investigated associations between regions of variants and lipid traits using the sequence kernel association test (SKAT). Results We observed no strong evidence of association between regions of variants based on Pfam domain definitions and lipid traits. Quantile-Quantile plots illustrated that the overall distributions of p-values from the protein domain analyses were comparable to that of a conventional gene-based approach. Deviations from this distribution suggested that collapsing by either protein domain or gene definitions may be favourable depending on the trait analysed. Conclusion We have collapsed rare variants together using protein domain and family coordinates to present an alternative approach over collapsing across conventionally used gene-based regions. Although no strong evidence of association was detected in these analyses, future studies may still find value in adopting these approaches to detect previously unidentified association signals.	[Richardson, Tom G.; Shihab, Hashem A.; Timpson, Nicholas J.; Gaunt, Tom R.] Univ Bristol, Sch Social & Community Med, MRC Integrat Epidemiol Unit, Bristol, Avon, England; [Rivas, Manuel A.; McCarthy, Mark I.] Univ Oxford, Nuffield Dept Clin Med, Wellcome Trust Ctr Human Genet, Oxford, England; [McCarthy, Mark I.] Univ Oxford, Oxford Ctr Diabet Endocrinol & Metab, Oxford, England; [Campbell, Colin] Univ Bristol, Intelligent Syst Lab, Bristol, Avon, England	University of Bristol; University of Oxford; Wellcome Centre for Human Genetics; University of Oxford; University of Bristol	Gaunt, TR (corresponding author), Univ Bristol, Sch Social & Community Med, MRC Integrat Epidemiol Unit, Bristol, Avon, England.	Tom.Gaunt@bristol.ac.uk	Gaunt, Tom R/O-3918-2014; Attrill, Lauren/V-1688-2018; Fox, Laura J/C-6249-2016; Rivas, Manuel/ABE-8173-2020; Timpson, Nicholas John/O-7548-2015; McCarthy, Mark/M-3763-2015	Gaunt, Tom R/0000-0003-0924-3247; Rivas, Manuel/0000-0003-1457-9925; Timpson, Nicholas John/0000-0002-7141-9189; McCarthy, Mark/0000-0002-4393-0510; Richardson, Tom/0000-0002-7918-2040	Wellcome Trust [WT091310]; UK Medical Research Council (MRC) [IEU MC_UU_12013/8]; EPSRC [EP/M01715X/1] Funding Source: UKRI; MRC [MC_UU_12013/3, MC_UU_12013/2, MC_UU_12013/8] Funding Source: UKRI; Engineering and Physical Sciences Research Council [EP/M01715X/1] Funding Source: researchfish; Medical Research Council [MC_UU_12013/8, 1170461, MC_UU_12013/3, G9815508, MC_UU_12013/2, MC_PC_15018] Funding Source: researchfish	Wellcome Trust(Wellcome TrustEuropean Commission); UK Medical Research Council (MRC)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	Funding for UK10K was provided by the Wellcome Trust under award WT091310. This work was supported by the UK Medical Research Council (MRC IEU MC_UU_12013/8). TR is a UK MRC PhD Student.	Altshuler DM, 2010, NATURE, V467, P52, DOI 10.1038/nature09298; Boyd A, 2013, INT J EPIDEMIOL, V42, P111, DOI 10.1093/ije/dys064; Browning SR, 2007, AM J HUM GENET, V81, P1084, DOI 10.1086/521987; Castello A, 2013, TRENDS GENET, V29, P318, DOI 10.1016/j.tig.2013.01.004; Chang CC, 2015, GIGASCIENCE, V4, DOI 10.1186/s13742-015-0047-8; Cirulli ET, 2010, NAT REV GENET, V11, P415, DOI 10.1038/nrg2779; Demirkan A, 2011, EUR J HUM GENET, V19, P813, DOI 10.1038/ejhg.2011.21; Feng S, 2014, BIOINFORMATICS, V30, P2828, DOI 10.1093/bioinformatics/btu367; Fong Jessica H, 2008, BMC Res Notes, V1, P114, DOI 10.1186/1756-0500-1-114; Franceschini A, 2013, NUCLEIC ACIDS RES, V41, pD808, DOI 10.1093/nar/gks1094; Frohne IH, 2009, R J SAMPLE QUANTILES; Gibson G, 2012, NAT REV GENET, V13, P135, DOI 10.1038/nrg3118; Golding J, 2001, PAEDIATR PERINAT EP, V15, P74; Gonzalez MW, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002819; Gough J, 2002, ACTA CRYSTALLOGR D, V58, P1897, DOI 10.1107/S0907444902015160; Ladouceur M, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002496; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; Lee S, 2012, AM J HUM GENET, V91, P224, DOI 10.1016/j.ajhg.2012.06.007; Li H, 2010, BIOINFORMATICS, V26, P589, DOI 10.1093/bioinformatics/btp698; Liu DJJ, 2014, NAT GENET, V46, P200, DOI 10.1038/ng.2852; Mata IF, 2006, TRENDS NEUROSCI, V29, P286, DOI 10.1016/j.tins.2006.03.006; Mi HY, 2005, NUCLEIC ACIDS RES, V33, pD284, DOI 10.1093/nar/gki078; Miller MP, 2001, HUM MOL GENET, V10, P2319, DOI 10.1093/hmg/10.21.2319; Moayyeri A, 2013, TWIN RES HUM GENET, V16, P144, DOI 10.1017/thg.2012.89; Mooney SD, 2002, BMC BIOINFORMATICS, V3, DOI 10.1186/1471-2105-3-24; Moutsianas L, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005165; Myers GL, 2000, CLIN CHEM, V46, P1762; Neale BM, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001322; Orchard S, 2014, NUCLEIC ACIDS RES, V42, pD358, DOI 10.1093/nar/gkt1115; Peterson TA, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-S3-S5; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; Quang D, 2015, BIOINFORMATICS, V31, P761, DOI 10.1093/bioinformatics/btu703; R Core Development Team, 2013, R LANG ENV STAT COMP; Rader DJ, 2003, J CLIN INVEST, V111, P1795, DOI 10.1172/JCI200318925; Reva B, 2011, NUCLEIC ACIDS RES, V39, pE118, DOI 10.1093/nar/gkr407; Shihab HA, 2015, BIOINFORMATICS, V31, P1536, DOI 10.1093/bioinformatics/btv009; Soutar AK, 2007, NAT CLIN PRACT CARD, V4, P214, DOI 10.1038/ncpcardio0836; Surakka I, 2015, NAT GENET, V47, P589, DOI 10.1038/ng.3300; Timpson NJ, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5871; Torkamani A, 2008, CANCER RES, V68, P1675, DOI 10.1158/0008-5472.CAN-07-5283; Turner S.D., 2014, QQMAN R PACKAGE VISU, V7, pe1002043, DOI [DOI 10.21105/JOSS.00731, 10.1101/005165, DOI 10.1101/005165]; WARNICK GR, 1990, SCAND J CLIN LAB INV, V50, P9, DOI 10.3109/00365519009091079; Wu MC, 2011, AM J HUM GENET, V89, P82, DOI 10.1016/j.ajhg.2011.05.029; Zhai G, 2010, ANN RHEUM DIS, V69, P1227, DOI 10.1136/ard.2009.120857; Zuk O, 2014, P NATL ACAD SCI USA, V111, pE455, DOI 10.1073/pnas.1322563111	45	3	3	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 29	2016	11	4							e0153803	10.1371/journal.pone.0153803	http://dx.doi.org/10.1371/journal.pone.0153803			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DK8XM	27128313	Green Published, gold, Green Submitted			2022-12-26	WOS:000375212600014
J	Lu, J; Cowperthwaite, MC; Burnett, MG; Shpak, M				Lu, Jie; Cowperthwaite, Matthew C.; Burnett, Mark G.; Shpak, Max			Molecular Predictors of Long-Term Survival in Glioblastoma Multiforme Patients	PLOS ONE			English	Article							GRADE GLIOMA; GENOME; CANCER; PROGNOSIS; EXPRESSION; MUTATIONS; LEVEL	Glioblastoma multiforme (GBM) is the most common and aggressive adult primary brain cancer, with <10% of patients surviving for more than 3 years. Demographic and clinical factors (e.g. age) and individual molecular biomarkers have been associated with prolonged survival in GBM patients. However, comprehensive systems-level analyses of molecular profiles associated with long-term survival (LTS) in GBM patients are still lacking. We present an integrative study of molecular data and clinical variables in these long-term survivors (LTSs, patients surviving >3 years) to identify biomarkers associated with prolonged survival, and to assess the possible similarity of molecular characteristics between LGG and LTS GBM. We analyzed the relationship between multivariable molecular data and LTS in GBM patients from the Cancer Genome Atlas (TCGA), including germline and somatic point mutation, gene expression, DNA methylation, copy number variation (CNV) and microRNA (miRNA) expression using logistic regression models. The molecular relationship between GBM LTS and LGG tumors was examined through cluster analysis. We identified 13, 94, 43, 29, and 1 significant predictors of LTS using Lasso logistic regression from the somatic point mutation, gene expression, DNA methylation, CNV, and miRNA expression data sets, respectively. Individually, DNA methylation provided the best prediction performance (AUC = 0.84). Combining multiple classes of molecular data into joint regression models did not improve prediction accuracy, but did identify additional genes that were not significantly predictive in individual models. PCA and clustering analyses showed that GBM LTS typically had gene expression profiles similar to non-LTS GBM. Furthermore, cluster analysis did not identify a close affinity between LTS GBM and LGG, nor did we find a significant association between LTS and secondary GBM. The absence of unique LTS profiles and the lack of similarity between LTS GBM and LGG, indicates that there are multiple genetic and epigenetic pathways to LTS in GBM patients.	[Lu, Jie; Cowperthwaite, Matthew C.; Burnett, Mark G.; Shpak, Max] NeuroTexas Inst Res Fdn, St Davids Healthcare, Austin, TX USA; [Cowperthwaite, Matthew C.; Shpak, Max] Univ Texas Austin, Ctr Syst & Synthet Biol, Austin, TX 78712 USA; [Shpak, Max] Fresh Pond Res Inst, Cambridge, MA USA	University of Texas System; University of Texas Austin	Lu, J (corresponding author), NeuroTexas Inst Res Fdn, St Davids Healthcare, Austin, TX USA.	lujie0823@gmail.com			St. David's Foundation Impact Fund	St. David's Foundation Impact Fund	Support was provided by St. David's Foundation Impact Fund.; The authors wish to thank Anurekha Ramakrishnan for bringing Moran's I and several other statistical techniques to our attention. The authors were supported from a grant from the St. David's Foundation Impact Fund.	Adeberg S, 2014, RADIAT ONCOL, V9, DOI 10.1186/1748-717X-9-95; Amelot A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0130596; Babu R, 2013, J CLIN NEUROSCI, V20, P1117, DOI 10.1016/j.jocn.2012.12.006; Brennan CW, 2013, CELL, V155, P462, DOI 10.1016/j.cell.2013.09.034; Burton EC, 2002, CANCER RES, V62, P6205; Burton EC, 2002, CLIN CANCER RES, V8, P180; Chambless LB, 2015, J NEURO-ONCOL, V121, P359, DOI 10.1007/s11060-014-1640-x; Chawla NV, 2010, DATA MINING AND KNOWLEDGE DISCOVERY HANDBOOK, SECOND EDITION, P875, DOI 10.1007/978-0-387-09823-4_45; Cingolani P, 2012, FLY, V6, P80, DOI 10.4161/fly.19695; Das P, 2011, J CLIN NEUROSCI, V18, P66, DOI 10.1016/j.jocn.2010.04.050; Dixit R, 2014, J NEUROSCI, V34, P539, DOI 10.1523/JNEUROSCI.0614-13.2014; Efron B, 2004, ANN STAT, V32, P407, DOI 10.1214/009053604000000067; Erson-Omay EZ, 2015, NEURO-ONCOLOGY, V17, P1356, DOI 10.1093/neuonc/nov027; Gerber NK, 2014, NEURO-ONCOLOGY, V16, P1186, DOI 10.1093/neuonc/nou043; GETIS A, 1992, GEOGR ANAL, V24, P189, DOI 10.1111/j.1538-4632.1992.tb00261.x; HARTIGAN JA, 1985, ANN STAT, V13, P70, DOI 10.1214/aos/1176346577; Huse JT, 2011, GLIA, V59, P1190, DOI 10.1002/glia.21165; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Kleihues P, 1999, Neuro Oncol, V1, P44, DOI 10.1093/neuonc/1.1.44; Kleihues P., 1997, PATHOLOGY GENETICS T; Kraus JA, 2000, J NEUROL, V247, P455, DOI 10.1007/s004150070175; Kraus JA, 2000, J NEURO-ONCOL, V48, P89, DOI 10.1023/A:1006402614838; Krex D, 2007, BRAIN, V130, P2596, DOI 10.1093/brain/awm204; KUHAJDA FP, 1989, NEW ENGL J MED, V321, P636, DOI 10.1056/NEJM198909073211003; Lai RK, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089376; Larson DE, 2012, BIOINFORMATICS, V28, P311, DOI 10.1093/bioinformatics/btr665; Leu S, 2013, NEURO-ONCOLOGY, V15, P469, DOI 10.1093/neuonc/nos317; Lin Q, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005334; Martin S, 2009, BBA-MOL CELL RES, V1793, P354, DOI 10.1016/j.bbamcr.2008.09.019; Niyazi M, 2011, RADIAT ONCOL, V6, DOI 10.1186/1748-717X-6-153; Ohgaki H, 2005, ACTA NEUROPATHOL, V109, P93, DOI 10.1007/s00401-005-0991-y; Parker NR, 2015, FRONT ONCOL, V5, DOI 10.3389/fonc.2015.00055; Patel VN, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1003237; Phillips HS, 2006, CANCER CELL, V9, P157, DOI 10.1016/j.ccr.2006.02.019; Reifenberger G, 2014, INT J CANCER, V135, P1822, DOI 10.1002/ijc.28836; Senger D, 2003, CANCER J, V9, P214, DOI 10.1097/00130404-200305000-00009; Shete S, 2009, NAT GENET, V41, P899, DOI 10.1038/ng.407; Shpak M, 2015, GENOMICS, V105, P159, DOI 10.1016/j.ygeno.2014.12.010; Shpak M, 2014, GENOMICS, V103, P252, DOI 10.1016/j.ygeno.2014.02.005; Smith AA, 2014, EPIGENETICS, V9, P37; Sonoda Y, 2009, ACTA NEUROCHIR, V151, P1349, DOI 10.1007/s00701-009-0387-1; Stuehr DJ, 1999, BBA-BIOENERGETICS, V1411, P217, DOI 10.1016/S0005-2728(99)00016-X; ULLEN H, 1990, ACTA ONCOL, V29, P875, DOI 10.3109/02841869009096382; Verhaak RGW, 2010, CANCER CELL, V17, P98, DOI 10.1016/j.ccr.2009.12.020; Wang D, 2014, INT J ONCOL, V45, P2596, DOI 10.3892/ijo.2014.2653; Wrensch M, 2009, NAT GENET, V41, P905, DOI 10.1038/ng.408; Yuan Y, 2014, NAT BIOTECHNOL, V32, P644, DOI 10.1038/nbt.2940; Zhang CZ, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-229; Zhang CZ, 2012, J TRANSL MED, V10, DOI 10.1186/1479-5876-10-119; Zhao Q, 2015, BRIEF BIOINFORM, V16, P291, DOI 10.1093/bib/bbu003	50	35	36	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 28	2016	11	4							e0154313	10.1371/journal.pone.0154313	http://dx.doi.org/10.1371/journal.pone.0154313			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DK8XE	27124395	Green Submitted, Green Published, gold			2022-12-26	WOS:000375211700067
J	Brown, LE; Nicholson, MW; Arama, JE; Mercer, A; Thomson, AM; Jovanovic, JN				Brown, Laura E.; Nicholson, Martin W.; Arama, Jessica E.; Mercer, Audrey; Thomson, Alex M.; Jovanovic, Jasmina N.			gamma-Aminobutyric Acid Type A (GABA(A)) Receptor Subunits Play a Direct Structural Role in Synaptic Contact Formation via Their N-terminal Extracellular Domains	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						cell culture; -aminobutyric acid (GABA); inhibition mechanism; protein domain; synapse	INFECTED INSECT CELLS; BASAL GANGLIA; GLOBUS-PALLIDUS; PYRAMIDAL CELLS; RAT-BRAIN; SYNAPSES; EXPRESSION; SUBTYPES; BETA; GLYCOSYLATION	The establishment of cell-cell contacts between presynaptic GABAergic neurons and their postsynaptic targets initiates the process of GABAergic synapse formation. GABA(A) receptors (GABA(A)Rs), the main postsynaptic receptors for GABA, have been recently demonstrated to act as synaptogenic proteins that can single-handedly induce the formation and functional maturation of inhibitory synapses. To establish how the subunit composition of GABA(A)Rs influences their ability to induce synaptogenesis, a co-culture model system incorporating GABAergic medium spiny neurons and the HEK293 cells, stably expressing different combinations of receptor subunits, was developed. Analyses of HEK293 cell innervation by medium spiny neuron axons using immunocytochemistry, activity-dependent labeling, and electrophysiology have indicated that the 2 subunit is required for the formation of active synapses and that its effects are influenced by the type of / subunits incorporated into the functional receptor. To further characterize this process, the large N-terminal extracellular domains (ECDs) of 1, 2, 2, and 2 subunits were purified using the baculovirus/Sf9 cell system. When these proteins were applied to the co-cultures of MSNs and 1/2/2-expressing HEK293 cells, the 1, 2, or 2 ECD each caused a significant reduction in contact formation, in contrast to the 2 ECD, which had no effect. Together, our experiments indicate that the structural role of GABA(A)Rs in synaptic contact formation is determined by their subunit composition, with the N-terminal ECDs of each of the subunits directly participating in interactions between the presynaptic and postsynaptic elements, suggesting the these interactions are multivalent and specific.	[Brown, Laura E.; Nicholson, Martin W.; Arama, Jessica E.; Mercer, Audrey; Thomson, Alex M.; Jovanovic, Jasmina N.] UCL, UCL Sch Pharm, Res Dept Pharmacol, London WC1N 1AX, England	University of London; University College London	Jovanovic, JN (corresponding author), UCL, UCL Sch Pharm, 29-39 Brunswick Sq, London WC1N 1AX, England.	j.jovanovic@ucl.ac.uk		Mercer, Audrey/0000-0002-5086-2560	Medical Research Council United Kingdom Project Grant [G0800498]; Wellcome Trust; Medical Research Council; Medical Research Council [G0800498] Funding Source: researchfish; MRC [G0800498] Funding Source: UKRI	Medical Research Council United Kingdom Project Grant(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome Trust); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported in part by Medical Research Council United Kingdom Project Grant G0800498 and The Wellcome Trust. The authors declare that they have no conflicts of interest with the contents of this article.; Supported by a Medical Research Council studentship.	Ali AB, 2008, CEREB CORTEX, V18, P1260, DOI 10.1093/cercor/bhm160; BANKER G, 1988, NATURE, V336, P185, DOI 10.1038/336185a0; Braat S, 2015, NEURON, V86, P1119, DOI 10.1016/j.neuron.2015.03.042; Brown LE, 2014, JOVE-J VIS EXP, DOI 10.3791/52115; CHAI H, 1993, BIOTECHNOL APPL BIOC, V18, P259; Chiou TT, 2011, J BIOL CHEM, V286, P22456, DOI 10.1074/jbc.M111.236190; Connolly CN, 1996, J BIOL CHEM, V271, P89, DOI 10.1074/jbc.271.1.89; Connolly CN, 1996, P NATL ACAD SCI USA, V93, P9899, DOI 10.1073/pnas.93.18.9899; Crestani F, 2015, ADV PHARMACOL, V72, P37, DOI 10.1016/bs.apha.2014.10.001; Deidda G, 2014, FRONT CELL NEUROSCI, V8, DOI 10.3389/fncel.2014.00119; Dong N, 2007, MOL CELL NEUROSCI, V35, P14, DOI 10.1016/j.mcn.2007.01.013; DUGGAN MJ, 1990, J BIOL CHEM, V265, P3831; Essrich C, 1998, NAT NEUROSCI, V1, P563, DOI 10.1038/2798; Fritschy JM, 2012, CELL MOL LIFE SCI, V69, P2485, DOI 10.1007/s00018-012-0926-4; FRITSCHY JM, 1995, J COMP NEUROL, V359, P154, DOI 10.1002/cne.903590111; Fu ZY, 2009, MOL CELL NEUROSCI, V42, P45, DOI 10.1016/j.mcn.2009.05.004; Fuchs Celine, 2013, Eur J Neurosci, V38, P3146, DOI 10.1111/ejn.12331; Fujiyama F, 2000, J COMP NEUROL, V416, P158; Goffin D, 2010, J NEUROSCI, V30, P2935, DOI 10.1523/JNEUROSCI.4411-09.2010; Graf ER, 2004, CELL, V119, P1013, DOI 10.1016/j.cell.2004.11.035; Gross A, 2011, EUR J NEUROSCI, V33, P868, DOI 10.1111/j.1460-9568.2010.07552.x; GUNTHER U, 1995, P NATL ACAD SCI USA, V92, P7749, DOI 10.1073/pnas.92.17.7749; Homanics GE, 1997, P NATL ACAD SCI USA, V94, P4143, DOI 10.1073/pnas.94.8.4143; JARVIS DL, 1989, MOL CELL BIOL, V9, P214, DOI 10.1128/MCB.9.1.214; JARVIS DL, 1990, J CELL BIOCHEM, V42, P181, DOI 10.1002/jcb.240420402; Jovanovic JN, 2004, J NEUROSCI, V24, P522, DOI 10.1523/JNEUROSCI.3606-03.2004; Kins S, 2000, NAT NEUROSCI, V3, P22, DOI 10.1038/71096; Klausberger T, 2002, J NEUROSCI, V22, P2513, DOI 10.1523/JNEUROSCI.22-07-02513.2002; Klausberger T, 2008, SCIENCE, V321, P53, DOI 10.1126/science.1149381; Krueger DD, 2012, CURR OPIN NEUROBIOL, V22, P412, DOI 10.1016/j.conb.2012.02.012; Kubota Y, 2014, CURR OPIN NEUROBIOL, V26, P7, DOI 10.1016/j.conb.2013.10.003; Low K, 2000, SCIENCE, V290, P131, DOI 10.1126/science.290.5489.131; Mallet N, 2005, J NEUROSCI, V25, P3857, DOI 10.1523/JNEUROSCI.5027-04.2005; MHATRE MC, 1993, J NEUROCHEM, V61, P1620, DOI 10.1111/j.1471-4159.1993.tb09795.x; Miller PS, 2014, NATURE, V512, P270, DOI 10.1038/nature13293; Mohler H, 2006, CELL TISSUE RES, V326, P505, DOI 10.1007/s00441-006-0284-3; Nelson AB, 2014, ANNU REV NEUROSCI, V37, P117, DOI 10.1146/annurev-neuro-071013-013916; Nuss P, 2015, NEUROPSYCH DIS TREAT, V11, P165, DOI 10.2147/NDT.S58841; Nyiri G, 2001, EUR J NEUROSCI, V13, P428, DOI 10.1046/j.1460-9568.2001.01407.x; Obeso JA, 2014, LANCET, V384, P523, DOI 10.1016/S0140-6736(13)62418-6; Panzanelli P, 2011, J PHYSIOL-LONDON, V589, P4959, DOI 10.1113/jphysiol.2011.216028; Porcher C, 2011, J BIOL CHEM, V286, P21667, DOI 10.1074/jbc.M110.201582; Possee RD, 1997, CURR OPIN BIOTECH, V8, P569, DOI 10.1016/S0958-1669(97)80030-4; Rudolph U, 1999, NATURE, V401, P796, DOI 10.1038/44579; Scheiffele P, 2000, CELL, V101, P657, DOI 10.1016/S0092-8674(00)80877-6; SCHOFIELD PR, 1987, NATURE, V328, P221, DOI 10.1038/328221a0; Schweizer C, 2003, MOL CELL NEUROSCI, V24, P442, DOI 10.1016/S1044-7431(03)00202-1; Shen K, 2010, ANNU REV NEUROSCI, V33, P473, DOI 10.1146/annurev.neuro.051508.135302; Siddiqui TJ, 2011, CURR OPIN NEUROBIOL, V21, P132, DOI 10.1016/j.conb.2010.08.016; Sieghart W, 2006, ADV PHARMACOL, V54, P231, DOI 10.1016/S1054-3589(06)54010-4; Silberberg G, 2015, CURR OPIN NEUROBIOL, V33, P182, DOI 10.1016/j.conb.2015.05.002; Sims RE, 2008, EUR J NEUROSCI, V28, P2401, DOI 10.1111/j.1460-9568.2008.06546.x; Somogyi P, 1996, NEUROPHARMACOLOGY, V35, P1425, DOI 10.1016/S0028-3908(96)00086-X; Tanaka H, 2012, CELL REPORTS, V2, P101, DOI 10.1016/j.celrep.2012.06.009; Tepper JM, 2007, PROG BRAIN RES, V160, P3, DOI 10.1016/S0079-6123(06)60001-0; Tepper JM, 2004, CURR OPIN NEUROBIOL, V14, P685, DOI 10.1016/j.conb.2004.10.003; Thomson AM, 2010, EUR J NEUROSCI, V31, P2193, DOI 10.1111/j.1460-9568.2010.07252.x; Thomson AM, 2000, EUR J NEUROSCI, V12, P425, DOI 10.1046/j.1460-9568.2000.00915.x; Tretter V, 1997, J NEUROSCI, V17, P2728; UNWIN N, 1993, CELL, V72, P31, DOI 10.1016/S0092-8674(05)80026-1; Zhang B, 2015, NEURON, V87, P781, DOI 10.1016/j.neuron.2015.07.020; Zhang C, 2010, NEURON, V66, P403, DOI 10.1016/j.neuron.2010.04.008	62	13	13	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 1	2016	291	27					13926	13942		10.1074/jbc.M116.714790	http://dx.doi.org/10.1074/jbc.M116.714790			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DR5XG	27129275	Green Published, hybrid			2022-12-26	WOS:000379975100003
J	Zhang, WB; Yao, LL; Li, XD				Zhang, Wen-Bo; Yao, Lin-Lin; Li, Xiang-dong			The Globular Tail Domain of Myosin-5a Functions as a Dimer in Regulating the Motor Activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						allosteric regulation; cytoskeleton; intracellular trafficking; molecular motor; myosin; myosin-5a	CLASS-V MYOSIN; UNCONVENTIONAL MYOSIN; STRUCTURAL BASIS; IDENTIFICATION; BINDING; SLAC2-A/MELANOPHILIN; MELANOPHILIN; CALMODULIN; ACTIVATION; SEQUENCES	Myosin-5a contains two heavy chains, which are dimerized via the coiled-coil regions. Thus, myosin-5a comprises two heads and two globular tail domains (GTDs). The GTD is the inhibitory domain that binds to the head and inhibits its motor function. Although the two-headed structure is essential for the processive movement of myosin-5a along actin filaments, little is known about the role of GTD dimerization. Here, we investigated the effect of GTD dimerization on its inhibitory activity. We found that the potent inhibitory activity of the GTD is dependent on its dimerization by the preceding coiled-coil regions, indicating synergistic interactions between the two GTDs and the two heads of myosin-5a. Moreover, we found that alanine mutations of the two conserved basic residues at N-terminal extension of the GTD not only weaken the inhibitory activity of the GTD but also enhance the activation of myosin-5a by its cargo-binding protein melanophilin (Mlph). These results are consistent with the GTD forming a head to head dimer, in which the N-terminal extension of the GTD interacts with the Mlph-binding site in the counterpart GTD. The Mlph-binding site at the GTD-GTD interface must be exposed prior to the binding of Mlph. We therefore propose that the inhibited Myo5a is equilibrated between the folded state, in which the Mlph-binding site is buried, and the preactivated state, in which the Mlph-binding site is exposed, and that Mlph is able to bind to the Myo5a in preactivated state and activates its motor function.	[Zhang, Wen-Bo; Yao, Lin-Lin; Li, Xiang-dong] Chinese Acad Sci, Inst Zool, Grp Cell Motil & Muscle Contract, State Key Lab Integrated Management Pest Insects, Beijing 100101, Peoples R China; [Zhang, Wen-Bo] Univ Chinese Acad Sci, Beijing 100049, Peoples R China	Chinese Academy of Sciences; Institute of Zoology, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS	Li, XD (corresponding author), Chinese Acad Sci, Inst Zool, Beijing 100101, Peoples R China.	lixd@ioz.ac.cn			National Basic Research Program of China [2013CB932802, 2012CB114102]; National Natural Science Foundation of China [31171367, 31470791]	National Basic Research Program of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by National Basic Research Program of China Grants 2013CB932802 and 2012CB114102 and the National Natural Science Foundation of China Grants 31171367 and 31470791. The authors declare that they have no conflicts of interest with the contents of this article.	CHENEY RE, 1993, CELL, V75, P13, DOI 10.1016/0092-8674(93)90675-G; Donovan KW, 2015, J CELL BIOL, V209, P359, DOI 10.1083/jcb.201411010; Fukuda M, 2004, J BIOL CHEM, V279, P22314, DOI 10.1074/jbc.401791200; Fukuda M, 2004, J CELL SCI, V117, P583, DOI 10.1242/jcs.00891; Geething NC, 2007, J BIOL CHEM, V282, P21518, DOI 10.1074/jbc.M701932200; Krementsov DN, 2004, J CELL BIOL, V164, P877, DOI 10.1083/jcb.200310065; Li XD, 2005, J BIOL CHEM, V280, P17815, DOI 10.1074/jbc.M413295200; Li XD, 2004, BIOCHEM BIOPH RES CO, V315, P538, DOI 10.1016/j.bbrc.2004.01.084; Li XD, 2008, P NATL ACAD SCI USA, V105, P1140, DOI 10.1073/pnas.0709741105; Li XD, 2006, J BIOL CHEM, V281, P21789, DOI 10.1074/jbc.M602957200; Liu J, 2006, NATURE, V442, P208, DOI 10.1038/nature04719; Lu ZK, 2012, J BIOL CHEM, V287, P16530, DOI 10.1074/jbc.M112.343079; Nascimento AFZ, 2013, J BIOL CHEM, V288, P34131, DOI 10.1074/jbc.M113.507202; Pylypenko O, 2013, P NATL ACAD SCI USA, V110, P20443, DOI 10.1073/pnas.1314329110; Rodriguez OC, 2002, J CELL SCI, V115, P991; SEPERACK PK, 1995, EMBO J, V14, P2326, DOI 10.1002/j.1460-2075.1995.tb07227.x; SPUDICH JA, 1971, J BIOL CHEM, V246, P4866; Thirumurugan K, 2006, NATURE, V442, P212, DOI 10.1038/nature04865; Velvarska H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082065; Wang F, 2004, J BIOL CHEM, V279, P2333, DOI 10.1074/jbc.C300488200; Wang ZP, 2008, CELL, V135, P535, DOI 10.1016/j.cell.2008.09.057; Wei ZY, 2013, P NATL ACAD SCI USA, V110, P11314, DOI 10.1073/pnas.1306768110; Wu XFS, 2002, NAT CELL BIOL, V4, P271, DOI 10.1038/ncb760; Yao LL, 2016, J BIOL CHEM, V291, P8241, DOI 10.1074/jbc.M115.693762; Yao LL, 2015, SCI REP-UK, V5, DOI 10.1038/srep10874; Zhao LP, 1996, P NATL ACAD SCI USA, V93, P10826, DOI 10.1073/pnas.93.20.10826	26	9	9	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 24	2016	291	26					13571	13579		10.1074/jbc.M116.724328	http://dx.doi.org/10.1074/jbc.M116.724328			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DR2YZ	27129208	hybrid, Green Published			2022-12-26	WOS:000379771100015
J	Shen, WJ; Wang, Y; Liu, Y; Liu, HC; Zhao, HS; Zhang, GZ; Snead, ML; Han, D; Feng, H				Shen, Wenjing; Wang, Yue; Liu, Yang; Liu, Haochen; Zhao, Hongshan; Zhang, Guozhong; Snead, Malcolm L.; Han, Dong; Feng, Hailan			Functional Study of Ectodysplasin-A Mutations Causing Non-Syndromic Tooth Agenesis	PLOS ONE			English	Article							HYPOHIDROTIC ECTODERMAL DYSPLASIA; NF-KAPPA-B; SIGNALING PATHWAYS; GENE-EXPRESSION; MISSENSE MUTATION; EDA GENE; HYPODONTIA; WNT10A; MORPHOGENESIS; PAX9	Recent studies have demonstrated that ectodysplasin-A (EDA) mutations are associated with non-syndromic tooth agenesis. Indeed, we were the first to report three novel EDA mutations (A259E, R289C and R334H) in sporadic non-syndromic tooth agenesis. We studied the mechanism linking EDA mutations and non-syndromic tooth agenesis in human embryonic kidney 293T cells and mouse ameloblast-derived LS8 cells transfected with mutant isoforms of EDA. The receptor binding capability of the mutant EDA1 protein was impaired in comparison to wild-type EDA1. Although the non-syndromic tooth agenesis-causing EDA1 mutants possessed residual binding capability, the transcriptional activation of the receptor's downstream target, nuclear factor kappa B (NF-kappa B), was compromised. We also analyzed the changes of selected genes in other signaling pathways, such as WNT and BMP, after EDA mutation. We found that non-syndromic tooth agenesis-causing EDA1 mutant proteins upregulate BMP4 (bone morphogenetic protein 4) mRNA expression and downregulate WNT10A and WNT10B (wingless-type MMTV integration site family member 10A and 10B) mRNA expression. Our results indicated that non-syndromic tooth agenesis causing EDA mutations (A259E, R289C and R334H) were loss-of-function, and suggested that EDA may regulate the expression of WNT10A, WNT10B and BMP4 via NF-kappa B during tooth development. The results from our study may help to understand the molecular mechanism linking specific EDA mutations with non-syndromic tooth agenesis.	[Shen, Wenjing; Wang, Yue; Liu, Yang; Liu, Haochen; Han, Dong; Feng, Hailan] Peking Univ, Sch & Hosp Stomatol, Dept Prosthodont, Beijing 100081, Peoples R China; [Zhao, Hongshan] Peking Univ, Dept Med Genet, Sch Basic Med Sci, Beijing 100191, Peoples R China; [Zhao, Hongshan] Peking Univ, Human Dis Genom Ctr, Beijing 100191, Peoples R China; [Shen, Wenjing; Zhang, Guozhong] Hebei Med Univ, Dept Forens Med, Shijiazhuang 050017, Hebei, Peoples R China; [Shen, Wenjing] Hebei Med Univ, Sch & Hosp Stomatol, Dept Prosthodont, Shijiazhuang 050017, Hebei, Peoples R China; [Snead, Malcolm L.] Univ So Calif, Ctr Craniofacial Mol Biol, 2250 Alcazar St, Los Angeles, CA 90033 USA	Peking University; Peking University; Peking University; Hebei Medical University; Hebei Medical University; University of Southern California	Han, D (corresponding author), Peking Univ, Sch & Hosp Stomatol, Dept Prosthodont, Beijing 100081, Peoples R China.	donghan@bjmu.edu.cn	Han, Dong/V-2128-2018	Han, Dong/0000-0001-9625-3384	National Natural Science Foundation of China [81100725, 81070814]; Capital Medical Developing Foundation [2007-1005]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Capital Medical Developing Foundation	This work was supported by grants from the National Natural Science Foundation of China (No.81100725 and No.81070814), and the Capital Medical Developing Foundation (No.2007-1005).	Abdalla EM, 2014, ARCH ORAL BIOL, V59, P722, DOI 10.1016/j.archoralbio.2014.04.004; Arte S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073705; Bayes M, 1998, HUM MOL GENET, V7, P1661, DOI 10.1093/hmg/7.11.1661; Bergendal B, 2011, AM J MED GENET A, V155A, P1616, DOI 10.1002/ajmg.a.34045; Casal ML, 2007, AM J HUM GENET, V81, P1050, DOI 10.1086/521988; Chen YP, 2000, P NATL ACAD SCI USA, V97, P10044, DOI 10.1073/pnas.160245097; Chen YW, 2001, P NATL ACAD SCI USA, V98, P7218, DOI 10.1073/pnas.131076098; Dassule HR, 1998, DEV BIOL, V202, P215, DOI 10.1006/dbio.1998.8992; Doffinger R, 2001, NAT GENET, V27, P277, DOI 10.1038/85837; Elomaa O, 2001, HUM MOL GENET, V10, P953, DOI 10.1093/hmg/10.9.953; Fliniaux I, 2008, DEV BIOL, V320, P60, DOI 10.1016/j.ydbio.2008.04.023; Han D, 2012, DEVELOPMENT, V139, P1640, DOI 10.1242/dev.076653; Han D, 2008, EUR J MED GENET, V51, P536, DOI 10.1016/j.ejmg.2008.06.002; Harris MP, 2006, CURR BIOL, V16, P371, DOI 10.1016/j.cub.2005.12.047; Kere J, 1996, NAT GENET, V13, P409, DOI 10.1038/ng0895-409; Klein OD, 2013, AM J MED GENET C, V163, P318, DOI 10.1002/ajmg.c.31382; Lainoff AJ, 2015, J EXP ZOOL PART B, V324, P255, DOI 10.1002/jez.b.22594; Lammi L, 2004, AM J HUM GENET, V74, P1043, DOI 10.1086/386293; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Monreal AW, 1998, AM J HUM GENET, V63, P380, DOI 10.1086/301984; Mou C, 2006, P NATL ACAD SCI USA, V103, P9075, DOI 10.1073/pnas.0600825103; Mues G, 2014, AM J MED GENET A, V164, P2455, DOI 10.1002/ajmg.a.36520; Mues G, 2010, EUR J HUM GENET, V18, P19, DOI 10.1038/ejhg.2009.127; Mustonen T, 2004, DEVELOPMENT, V131, P4907, DOI 10.1242/dev.01377; Neubuser A, 1997, CELL, V90, P247, DOI 10.1016/S0092-8674(00)80333-5; Nieminen P, 2009, J EXP ZOOL PART B, V312B, P320, DOI 10.1002/jez.b.21277; Paakkonen K, 2001, Hum Mutat, V17, P349, DOI 10.1002/humu.33; Pan YC, 2008, EUR J ORAL SCI, V116, P98, DOI 10.1111/j.1600-0722.2007.00517.x; Puel A, 2004, CURR OPIN IMMUNOL, V16, P34, DOI 10.1016/j.coi.2003.11.013; Pummila M, 2007, DEVELOPMENT, V134, P117, DOI 10.1242/dev.02708; Schmidt-Ullrich R, 2001, DEVELOPMENT, V128, P3843; Schneider P, 2001, J BIOL CHEM, V276, P18819, DOI 10.1074/jbc.M101280200; Silva Elisangela R, 2009, J Oral Sci, V51, P341; Sinha SK, 2002, J BIOL CHEM, V277, P44953, DOI 10.1074/jbc.M207923200; Song S, 2009, J DENT RES, V88, P126, DOI 10.1177/0022034508328627; Song SJ, 2014, HUM GENET, V133, P117, DOI 10.1007/s00439-013-1360-x; Stockton DW, 2000, NAT GENET, V24, P18, DOI 10.1038/71634; Tao R, 2006, J HUM GENET, V51, P498, DOI 10.1007/s10038-006-0389-2; Tarpey P, 2007, AM J MED GENET A, V143A, P390, DOI 10.1002/ajmg.a.31567; Tatematsu T, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0128227; Tucker AS, 2000, DEVELOPMENT, V127, P4691; van den Boogaard MJ, 2012, J MED GENET, V49, P327, DOI 10.1136/jmedgenet-2012-100750; Vastardis H, 1996, NAT GENET, V13, P417, DOI 10.1038/ng0896-417; Wang XW, 2012, NUCLEIC ACIDS RES, V40, pD1144, DOI 10.1093/nar/gkr1013; Wang Y, 2009, CELLS TISSUES ORGANS, V189, P80, DOI 10.1159/000151448; Yamashiro T, 2007, DIFFERENTIATION, V75, P452, DOI 10.1111/j.1432-0436.2006.00150.x; Yan MH, 2000, SCIENCE, V290, P523, DOI 10.1126/science.290.5491.523; Zhang J, 2011, EUR J MED GENET, V54, pE377, DOI 10.1016/j.ejmg.2011.03.005; Zhang YH, 2009, DEV CELL, V17, P49, DOI 10.1016/j.devcel.2009.05.011	49	16	20	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 4	2016	11	5							e0154884	10.1371/journal.pone.0154884	http://dx.doi.org/10.1371/journal.pone.0154884			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DL5KR	27144394	Green Submitted, gold, Green Published			2022-12-26	WOS:000375676400091
J	Aoki, S; Hosomi, N; Hirayama, J; Nakamori, M; Yoshikawa, M; Nezu, T; Kubo, S; Nagano, Y; Nagao, A; Yamane, N; Nishikawa, Y; Takamoto, M; Ueno, H; Ochi, K; Maruyama, H; Yamamoto, H; Matsumoto, M				Aoki, Shiro; Hosomi, Naohisa; Hirayama, Junko; Nakamori, Masahiro; Yoshikawa, Mineka; Nezu, Tomohisa; Kubo, Satoshi; Nagano, Yuka; Nagao, Akiko; Yamane, Naoya; Nishikawa, Yuichi; Takamoto, Megumi; Ueno, Hiroki; Ochi, Kazuhide; Maruyama, Hirofumi; Yamamoto, Hiromi; Matsumoto, Masayasu		Hiroshima Univ Hosp Stroke Swallow	The Multidisciplinary Swallowing Team Approach Decreases Pneumonia Onset in Acute Stroke Patients	PLOS ONE			English	Article							ACUTE ISCHEMIC-STROKE; CLINICAL-TRIAL; ORAL CARE; DYSPHAGIA; COMPLICATIONS; MULTICENTER; PREDICTORS; PROTOCOLS	Dysphagia occurs in acute stroke patients at high rates, and many of them develop aspiration pneumonia. Team approaches with the cooperation of various professionals have the power to improve the quality of medical care, utilizing the specialized knowledge and skills of each professional. In our hospital, a multidisciplinary participatory swallowing team was organized. The aim of this study was to clarify the influence of a team approach on dysphagia by comparing the rates of pneumonia in acute stroke patients prior to and post team organization. All consecutive acute stroke patients who were admitted to our hospital between April 2009 and March 2014 were registered. We analyzed the difference in the rate of pneumonia onset between the periods before team organization (prior period) and after team organization (post period). Univariate and multivariate analyses were performed using a Cox proportional hazards model to determine the predictors of pneumonia. We recruited 132 acute stroke patients from the prior period and 173 patients from the post period. Pneumonia onset was less frequent in the post period compared with the prior period (6.9% vs. 15.9%, respectively; p = 0.01). Based on a multivariate analysis using a Cox proportional hazards model, it was determined that a swallowing team approach was related to pneumonia onset independent from the National Institutes of Health Stroke Scale score on admission (adjusted hazard ratio 0.41, 95% confidence interval 0.19-0.84, p = 0.02). The multidisciplinary participatory swallowing team effectively decreased the pneumonia onset in acute stroke patients.	[Aoki, Shiro; Hosomi, Naohisa; Nakamori, Masahiro; Nezu, Tomohisa; Kubo, Satoshi; Ueno, Hiroki; Ochi, Kazuhide; Maruyama, Hirofumi; Matsumoto, Masayasu] Hiroshima Univ, Grad Sch Biomed & Hlth Sci, Dept Clin Neurosci & Therapeut, Hiroshima, Japan; [Hirayama, Junko; Yamamoto, Hiromi] Hiroshima Univ Hosp, Div Nursing, Hiroshima, Japan; [Yoshikawa, Mineka] Hiroshima Univ, Grad Sch Biomed & Hlth Sci, Dept Adv Prosthodont, Hiroshima, Japan; [Nagano, Yuka; Yamane, Naoya; Nishikawa, Yuichi] Hiroshima Univ Hosp, Dept Clin Practice & Support, Div Rehabil, Hiroshima, Japan; [Nagao, Akiko] Hiroshima Univ Hosp, Div Nutr Management, Hiroshima, Japan; [Takamoto, Megumi] Hiroshima Univ Hosp, Dept Clin Practice & Support, Div Dent Hyg, Hiroshima, Japan	Hiroshima University; Hiroshima University; Hiroshima University; Hiroshima University; Hiroshima University; Hiroshima University	Hosomi, N (corresponding author), Hiroshima Univ, Grad Sch Biomed & Hlth Sci, Dept Clin Neurosci & Therapeut, Hiroshima, Japan.	nhosomi@hiroshima-u.ac.jp	OCHI, Kazuhide/Q-7830-2016; Nishikawa, Yuichi/R-4042-2019; Maruyama, Hirofumi/B-9333-2011; Hosomi, Naohisa/H-8660-2019	OCHI, Kazuhide/0000-0003-1921-9603; Nishikawa, Yuichi/0000-0002-0088-8447; Maruyama, Hirofumi/0000-0001-7613-8717; Aoki, Shiro/0000-0001-5348-5783; Nezu, Tomohisa/0000-0003-4877-2336	JSPS [23590598, 15K08615]; Japan Science and Technology Agency [AS242Z02592P]; Smoking Research Foundation; Tsuchiya Foundation; Japan Heart Foundation; Grants-in-Aid for Scientific Research [26293211] Funding Source: KAKEN	JSPS(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Japan Science and Technology Agency(Japan Science & Technology Agency (JST)); Smoking Research Foundation; Tsuchiya Foundation(Tsuchiya Foundation); Japan Heart Foundation; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This study was supported in part by research grants from JSPS KAKENHI Grant Number (23590598, 15K08615), the Japan Science and Technology Agency (AS242Z02592P), the Smoking Research Foundation, the Tsuchiya Foundation, and the Japan Heart Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADAMS HP, 1993, STROKE, V24, P35, DOI 10.1161/01.STR.24.1.35; Broadley S, 2003, J CLIN NEUROSCI, V10, P300, DOI 10.1016/S0967-5868(03)00022-5; BROTT T, 1989, STROKE, V20, P864, DOI 10.1161/01.STR.20.7.864; GORDON C, 1987, BRIT MED J, V295, P411, DOI 10.1136/bmj.295.6595.411; Harms H, 2012, J NEUROL NEUROSUR PS, V83, P1225, DOI 10.1136/jnnp-2012-302194; Hilker R, 2003, STROKE, V34, P975, DOI 10.1161/01.STR.0000063373.70993.CD; Hinchey JA, 2005, STROKE, V36, P1972, DOI 10.1161/01.STR.0000177529.86868.8d; Kalra L, 2015, LANCET, V386, P1835, DOI 10.1016/S0140-6736(15)00126-9; Katzan IL, 2007, NEUROLOGY, V68, P1938, DOI 10.1212/01.wnl.0000263187.08969.45; Katzan IL, 2003, NEUROLOGY, V60, P620, DOI 10.1212/01.WNL.0000046586.38284.60; Lakshminarayan K, 2010, STROKE, V41, P2849, DOI 10.1161/STROKEAHA.110.597039; Langhorne P, 2000, STROKE, V31, P1223, DOI 10.1161/01.STR.31.6.1223; Middleton S, 2011, LANCET, V378, P1699, DOI 10.1016/S0140-6736(11)61485-2; Sekizawa K, 1998, LANCET, V352, P1069, DOI 10.1016/S0140-6736(05)60114-6; Shinohara Y, 2006, CEREBROVASC DIS, V22, P57, DOI 10.1159/000092922; Smithard DG, 1997, DYSPHAGIA, V12, P188, DOI 10.1007/PL00009535; US Centers for Disease Control and Prevention, 2010, VITAL HLTH STAT, V245, P80; Walter U, 2007, J NEUROL, V254, P1323, DOI 10.1007/s00415-007-0520-0; Weimar C, 2002, EUR NEUROL, V48, P133, DOI 10.1159/000065512; Westendorp WF, 2015, LANCET, V385, P1519, DOI 10.1016/S0140-6736(14)62456-9; Yoneyama T, 2002, J AM GERIATR SOC, V50, P430, DOI 10.1046/j.1532-5415.2002.50106.x; Yoo SH, 2008, ARCH NEUROL-CHICAGO, V65, P39, DOI 10.1001/archneurol.2007.12; Yoshino A, 2001, JAMA-J AM MED ASSOC, V286, P2235, DOI 10.1001/jama.286.18.2235	23	24	26	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 3	2016	11	5							e0154608	10.1371/journal.pone.0154608	http://dx.doi.org/10.1371/journal.pone.0154608			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DL5KK	27138162	gold, Green Published, Green Submitted			2022-12-26	WOS:000375675700045
J	Carissimo, G; Eiglmeier, K; Reveillaud, J; Holm, I; Diallo, M; Diallo, D; Vantaux, A; Kim, S; Menard, D; Siv, S; Belda, E; Bischoff, E; Antoniewski, C; Vernick, KD				Carissimo, Guillaume; Eiglmeier, Karin; Reveillaud, Julie; Holm, Inge; Diallo, Mawlouth; Diallo, Diawo; Vantaux, Amelie; Kim, Saorin; Menard, Didier; Siv, Sovannaroth; Belda, Eugeni; Bischoff, Emmanuel; Antoniewski, Christophe; Vernick, Kenneth D.			Identification and Characterization of Two Novel RNA Viruses from Anopheles gambiae Species Complex Mosquitoes	PLOS ONE			English	Article							ONYONG-NYONG VIRUS; ANTIVIRAL RESPONSE; ADULT DROSOPHILA; IMMUNE-RESPONSE; INTERFERENCE; ALPHAVIRUS; INFECTION; CULICIDAE; DIPTERA; HOST	Mosquitoes of the Anopheles gambiae complex display strong preference for human blood-meals and are major malaria vectors in Africa. However, their interaction with viruses or role in arbovirus transmission during epidemics has been little examined, with the exception of O'nyong-nyong virus, closely related to Chikungunya virus. Deep-sequencing has revealed different RNA viruses in natural insect viromes, but none have been previously described in the Anopheles gambiae species complex. Here, we describe two novel insect RNA viruses, a Dicistrovirus and a Cypovirus, found in laboratory colonies of An. gambiae taxa using small-RNA deep sequencing. Sequence analysis was done with Metavisitor, an open-source bioinformatic pipeline for virus discovery and de novo genome assembly. Wild-collected Anopheles from Senegal and Cambodia were positive for the Dicistrovirus and Cypovirus, displaying high sequence identity to the laboratory-derived virus. Thus, the Dicistrovirus (Anopheles C virus, AnCV) and Cypovirus (Anopheles Cypovirus, AnCPV) are components of the natural virome of at least some anopheline species. Their possible influence on mosquito immunity or transmission of other pathogens is unknown. These natural viruses could be developed as models for the study of Anopheles-RNA virus interactions in low security laboratory settings, in an analogous manner to the use of rodent malaria parasites for studies of mosquito anti-parasite immunity.	[Carissimo, Guillaume; Eiglmeier, Karin; Holm, Inge; Belda, Eugeni; Bischoff, Emmanuel; Vernick, Kenneth D.] Inst Pasteur, Unit Insect Vector Genet & Genom, Dept Parasites & Insect Vectors, 28 Rue Docteur Roux, F-75015 Paris, France; [Carissimo, Guillaume; Eiglmeier, Karin; Holm, Inge; Belda, Eugeni; Bischoff, Emmanuel; Vernick, Kenneth D.] CNRS, Unit Hosts Vectors & Pathogens URA3012, 28 Rue Docteur Roux, F-75015 Paris, France; [Carissimo, Guillaume] ASTAR, Singapore Immunol Network, Lab Microbial Immun, Singapore, Singapore; [Reveillaud, Julie] INRA, UMR CMAEE 1309, F-34060 Montpellier, France; [Diallo, Mawlouth; Diallo, Diawo] Inst Pasteur, Dakar, Senegal; [Vantaux, Amelie; Kim, Saorin; Menard, Didier] Inst Pasteur Cambodia, Phnom Penh, Cambodia; [Siv, Sovannaroth] Natl Ctr Parasitol Entomol & Malaria Control, Phnom Penh, Cambodia; [Antoniewski, Christophe] Univ Paris 06, Sorbonne Univ, CNRS UMR 7622, Inst Biol Paris Seine,Drosophila Genet & Epigenet, F-75005 Paris, France; [Antoniewski, Christophe] Univ Paris 06, Sorbonne Univ, Inst Biol Paris Seine, ARTbio Bioinformat Anal Facil,CNRS FR3631, F-75005 Paris, France; [Vernick, Kenneth D.] Univ Minnesota, Dept Microbiol, Minneapolis, MN 55108 USA	Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); Agency for Science Technology & Research (A*STAR); A*STAR - Singapore Immunology Network (SIgN); INRAE; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Dakar; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Cambodia; National Center Parasitology, Entomology & Malaria Control; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Sorbonne Universite; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Sorbonne Universite; University of Minnesota System; University of Minnesota Twin Cities	Vernick, KD (corresponding author), Inst Pasteur, Unit Insect Vector Genet & Genom, Dept Parasites & Insect Vectors, 28 Rue Docteur Roux, F-75015 Paris, France.; Vernick, KD (corresponding author), CNRS, Unit Hosts Vectors & Pathogens URA3012, 28 Rue Docteur Roux, F-75015 Paris, France.; Vernick, KD (corresponding author), Univ Minnesota, Dept Microbiol, Minneapolis, MN 55108 USA.	kvernick@pasteur.fr	Vantaux, Amelie/G-6689-2016; Menard, Didier/O-3294-2013; Antoniewski, Christophe/G-4519-2011; Bischoff, Emmanuel/F-1197-2011; Belda, Eugeni/ABI-1349-2020	Vantaux, Amelie/0000-0002-7945-961X; Menard, Didier/0000-0003-1357-4495; Antoniewski, Christophe/0000-0001-7709-2116; Bischoff, Emmanuel/0000-0003-4655-4247; Belda, Eugeni/0000-0003-4307-5072; Carissimo, Guillaume/0000-0002-9703-9096; DIALLO, Diawo/0000-0002-7478-5248	European Research Council; European Commission [228421 Infravec]; French Laboratoire d'Excellence; Integrative Biology of Emerging Infectious Diseases [ANR-10-LABX-62-IBEID]; Agence Nationale de la Recherche grant [ANR-13-BSV2-0007];  [323173 AnoPath]; BBSRC [BBS/E/D/20310000] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BBS/E/D/20310000] Funding Source: researchfish	European Research Council(European Research Council (ERC)European Commission); European Commission(European CommissionEuropean Commission Joint Research Centre); French Laboratoire d'Excellence; Integrative Biology of Emerging Infectious Diseases; Agence Nationale de la Recherche grant(French National Research Agency (ANR)); ; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work received financial support to KDV from the European Research Council (http://erc.europa.eu/funding-and-grants), Support for frontier research, Advanced Grant #323173 AnoPath; European Commission (http://ec.europa.eu/research/fp7/index_en.cfm), FP7 Infrastructures #228421 Infravec; and French Laboratoire d'Excellence (http://www.enseignementsuprecherche.gouv.fr/cid55551/investissements-avenir-projets-labex-parregiondomaine.html), and "Integrative Biology of Emerging Infectious Diseases" #ANR-10-LABX-62-IBEID. This work received financial support to CA from the Agence Nationale de la Recherche grant ANR-13-BSV2-0007 "Plastisipi". The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2015, ARTBIO BIOINF AN FAC; Bell-Sakyi L, 2012, VECTOR-BORNE ZOONOT, V12, P769, DOI 10.1089/vbz.2011.0766; Blankenberg Daniel, 2010, Curr Protoc Mol Biol, VChapter 19, DOI 10.1002/0471142727.mb1910s89; Bonning BC, 2010, ANNU REV ENTOMOL, V55, P129, DOI 10.1146/annurev-ento-112408-085457; Bonning Bryony C., 2009, Virologica Sinica, V24, P415, DOI 10.1007/s12250-009-3044-1; Carissimo G, 2015, P NATL ACAD SCI USA, V112, pE176, DOI 10.1073/pnas.1412984112; Ciota AT, 2014, J GEN VIROL, V95, P1281, DOI 10.1099/vir.0.063545-0; Coffey LL, 2014, VIRUSES-BASEL, V6, P4628, DOI 10.3390/v6114628; Cook S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080720; Dostert C, 2005, NAT IMMUNOL, V6, P946, DOI 10.1038/ni1237; Fansiri T, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003621; Giardine B, 2005, GENOME RES, V15, P1451, DOI 10.1101/gr.4086505; Goecks J, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-8-r86; Green TB, 2006, J INVERTEBR PATHOL, V91, P27, DOI 10.1016/j.jip.2005.10.007; Harris C, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001112; Hess AM, 2011, BMC MICROBIOL, V11, DOI 10.1186/1471-2180-11-45; Huhtamo E, 2014, VIROLOGY, V464, P320, DOI 10.1016/j.virol.2014.07.015; JOUSSET FX, 1972, ANN I PASTEUR PARIS, V123, P275; Keene KM, 2004, P NATL ACAD SCI USA, V101, P17240, DOI 10.1073/pnas.0406983101; Kerr CH, 2015, J VIROL, V89, P5919, DOI 10.1128/JVI.00463-15; Kreuze JF, 2009, VIROLOGY, V388, P1, DOI 10.1016/j.virol.2009.03.024; Lai D, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gks241; Li CX, 2015, ELIFE, V4, DOI 10.7554/eLife.05378; Morazzani EM, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002470; Myles KM, 2009, RNA BIOL, V6, P387, DOI 10.4161/rna.6.4.8946; Myles KM, 2008, P NATL ACAD SCI USA, V105, P19938, DOI 10.1073/pnas.0803408105; Nasar F, 2012, P NATL ACAD SCI USA, V109, P14622, DOI 10.1073/pnas.1204787109; Nawrocki EP, 2015, NUCLEIC ACIDS RES, V43, pD130, DOI 10.1093/nar/gku1063; Posey DL, 2005, AM J TROP MED HYG, V73, P32, DOI 10.4269/ajtmh.2005.73.1.0730032; Powers AM, 2001, J VIROL, V75, P10118, DOI 10.1128/JVI.75.21.10118-10131.2001; Rider MA, 2013, J MED ENTOMOL, V50, P1077, DOI 10.1603/ME12155; Roxstrom-Lindquist K, 2004, EMBO REP, V5, P207, DOI 10.1038/sj.embor.7400073; Schulz MH, 2012, BIOINFORMATICS, V28, P1086, DOI 10.1093/bioinformatics/bts094; Scott JC, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000848; Shapiro A, 2005, J VIROL, V79, P9430, DOI 10.1128/JVI.79.15.9430-9438.2005; Sievers F, 2014, METHODS MOL BIOL, V1079, P105, DOI 10.1007/978-1-62703-646-7_6; Sim C, 2005, INSECT MOL BIOL, V14, P475, DOI 10.1111/j.1365-2583.2005.00578.x; Sim C, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-231; Siu RWC, 2011, J VIROL, V85, P2907, DOI 10.1128/JVI.02052-10; Stevanovic AL, 2015, J GEN VIROL, V96, P1490, DOI 10.1099/vir.0.000068; Sudeep AB, 2009, IN VITRO CELL DEV-AN, V45, P491, DOI 10.1007/s11626-009-9218-1; Vasilakis N, 2013, J VIROL, V87, P2475, DOI 10.1128/JVI.00776-12; Waldock J, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001565; Wang XH, 2006, SCIENCE, V312, P452, DOI 10.1126/science.1125694; Webster CL, 2015, PLOS BIOL, V13, DOI 10.1371/journal.pbio.1002210; Wiebe NJP, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000823; Wu QF, 2010, P NATL ACAD SCI USA, V107, P1606, DOI 10.1073/pnas.0911353107; Zerbino DR, 2008, GENOME RES, V18, P821, DOI 10.1101/gr.074492.107; Zhou Y, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113201; Zuo SQ, 2014, VIRUS RES, V180, P31, DOI 10.1016/j.virusres.2013.12.005	50	27	27	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 3	2016	11	5							e0153881	10.1371/journal.pone.0153881	http://dx.doi.org/10.1371/journal.pone.0153881			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DL5KK	27138938	Green Published, Green Submitted, gold			2022-12-26	WOS:000375675700013
J	Ren, GX; Li, L; Hu, HJ; Li, YP; Liu, CS; Wei, SL				Ren, Guangxi; Li, Li; Hu, Huijuan; Li, Yanpeng; Liu, Chunsheng; Wei, Shengli			Influence of the Environmental Factors on the Accumulation of the Bioactive Ingredients in Chinese Rhubarb Products	PLOS ONE			English	Article							NITROGEN; CONSTITUENTS; ACTIVATION; EMODIN	To provide a basis for controlling the quality of rhubarb under artificial cultivation, the present work was designed to evaluate the contents of 14 active pharmaceutical ingredients (API) of rhubarb in major rhubarb production areas in China and analyze the correlations between the contents of API and such factors as species, geographic distribution and soil. The levels of fourteen API in rhubarb were measured using HPLC. The geographic distributions were collected using GPS and the nutrients in the soil were measured using the methods in the literature. The results showed that the levels of major API vary significantly among plants of different locations according to variance analysis. The species factor has few obvious effect on the overall properties of the rhubarb by the cluster analysis because of the two source species occurring in all divided three groups. However, Rheum tanguticum Maxim. ex Balf. is less effective at synthesizing and accumulating 9 API out of 14 than Rheum palmatum L. The correlation analysis and regression analysis also indicated that a lower latitude should be considered in the accumulation of API and a lower longitude should be considered to produce more compound anthraquinones. Lower levels of total P, rapidly available P and available molybdenum (Mo) and higher available K and available Zn in the soil were significantly correlated to accumulation of API in rhubarb. These results provide a basis for the clinical application and controlling the levels of the major API of rhubarb during artificial cultivation.	[Ren, Guangxi; Hu, Huijuan; Li, Yanpeng; Liu, Chunsheng; Wei, Shengli] Beijing Univ Chinese Med, Sch Chinese Mat Med, Beijing, Peoples R China; [Li, Li] Capital Med Univ Beijing, Beijing Hosp Tradit Chinese Med, Beijing, Peoples R China; [Li, Li] Beijing Inst Chinese Med, 13 Shuiche Hutong, Beijing, Peoples R China; [Wei, Shengli] Minist Educ, Engn Res Ctr Good Agr Practice Chinese Crude Drug, Beijing, Peoples R China	Beijing University of Chinese Medicine; Capital Medical University	Liu, CS; Wei, SL (corresponding author), Beijing Univ Chinese Med, Sch Chinese Mat Med, Beijing, Peoples R China.; Wei, SL (corresponding author), Minist Educ, Engn Res Ctr Good Agr Practice Chinese Crude Drug, Beijing, Peoples R China.	max_liucs@263.net; wsl7491@126.com		wei, shengli/0000-0003-1442-7120	National Natural Science Foundation of China [31170307, 31570331]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was funded by the National Natural Science Foundation of China (No. 31170307; 31570331). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2005, MINERAL NUTR PLANTS; Buckingham SE, 2010, BIOGEOCHEMISTRY, V100, P105, DOI 10.1007/s10533-010-9408-7; Cakmak I, 2000, NEW PHYTOL, V146, P185, DOI 10.1046/j.1469-8137.2000.00630.x; Chen W, 2011, CHIN TRADIT HERB DRU, V32, P39; He ZH, 2011, PHYTOMEDICINE, V18, P470, DOI 10.1016/j.phymed.2010.10.006; Jones DL, 2002, SOIL BIOL BIOCHEM, V34, P209, DOI 10.1016/S0038-0717(01)00175-4; Kemen AC, 2014, P NATL ACAD SCI USA, V111, P8679, DOI 10.1073/pnas.1401553111; Komatsu K, 2006, CHEM PHARM BULL, V54, P941, DOI 10.1248/cpb.54.941; Kon R, 2014, J ETHNOPHARMACOL, V152, P190, DOI 10.1016/j.jep.2013.12.055; Koyama J, 2007, J CHROMATOGR A, V1145, P183, DOI 10.1016/j.chroma.2007.01.076; Lee MS, 2008, BIOL PHARM BULL, V31, P2154, DOI 10.1248/bpb.31.2154; Li HuChen, 2003, World Forestry Research, V16, P17; Lin CC, 2006, J SEP SCI, V29, P2584, DOI 10.1002/jssc.200500307; Liu L, 2009, INT IMMUNOPHARMACOL, V9, P1568, DOI 10.1016/j.intimp.2009.09.013; Liu LingDi, 2007, Cotton Science, V19, P129; Miller AE, 2007, ECOLOGY, V88, P1832, DOI 10.1890/06-0946.1; Mishra SK, 2014, J NAT MED-TOKYO, V68, P363, DOI 10.1007/s11418-013-0810-z; Shi XY, 2004, THESIS CHINESE ACAD; Soil Survey Staff. Kf, 1990, SMSS TECHN MON, V19; State Pharmacopoeia Committee, 2015, PHARMACOPOEIA PEOPLE, P22; Wang J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024498; Wang SJ, 2008, PHYTOTHER RES, V22, P247, DOI 10.1002/ptr.2301; Wang WM, 2012, PHARMACOL REP, V64, P1216, DOI 10.1016/S1734-1140(12)70917-9; Wang XY, 2012, PHYTOCHEM ANALYSIS, V23, P684, DOI 10.1002/pca.2373; Wang Z, 2013, CHEM CENT J, V7, DOI 10.1186/1752-153X-7-170; Weigelt A, 2005, OECOLOGIA, V142, P627, DOI 10.1007/s00442-004-1765-2; Xie Z., 1998, P 3 CHIN NAT S BIOD, V12, P230; Xiong HR, 2011, J ETHNOPHARMACOL, V133, P718, DOI 10.1016/j.jep.2010.10.059	28	14	16	3	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 3	2016	11	5							e0154649	10.1371/journal.pone.0154649	http://dx.doi.org/10.1371/journal.pone.0154649			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DL5KK	27138597	Green Published, gold, Green Submitted			2022-12-26	WOS:000375675700049
J	Stumpf, M; Blokzijl-Franke, S; den Hertog, J				Stumpf, Miriam; Blokzijl-Franke, Sasja; den Hertog, Jeroen			Fine-Tuning of Pten Localization and Phosphatase Activity Is Essential for Zebrafish Angiogenesis	PLOS ONE			English	Article							TUMOR-SUPPRESSOR PTEN; NUCLEAR PTEN; EMBRYONIC-DEVELOPMENT; MEMBRANE ASSOCIATION; PROTEIN STABILITY; DISTINCT ROLES; GASTRIC-CANCER; PHOSPHORYLATION; EXPRESSION; CELLS	The lipid-and protein phosphatase PTEN is an essential tumor suppressor that is highly conserved among all higher eukaryotes. As an antagonist of the PI3K/Akt cell survival and proliferation pathway, it exerts its most prominent function at the cell membrane, but (PIP3-independent) functions of nuclear PTEN have been discovered as well. PTEN subcellular localization is tightly controlled by its protein conformation. In the closed conformation, PTEN localizes predominantly to the cytoplasm. Opening up of the conformation of PTEN exposes N-terminal and C-terminal regions of the protein that are required for both interaction with the cell membrane and translocation to the nucleus. Lack of Pten leads to hyperbranching of the intersegmental vessels during zebrafish embryogenesis, which is rescued by expression of exogenous Pten. Here, we observed that expression of mutant PTEN with an open conformation rescued the hyperbranching phenotype in pten double homozygous embryos and suppressed the increased p-Akt levels that are characteristic for embryos lacking Pten. In addition, in pten mutant and wild type embryos alike, open conformation PTEN induced stalled intersegmental vessels, which fail to connect with the dorsal longitudinal anastomotic vessel. Functional hyperactivity of open conformation PTEN in comparison to wild type PTEN seems to result predominantly from its enhanced recruitment to the cell membrane. Enhanced recruitment of phosphatase inactive mutants to the membrane did not induce the stalled vessel phenotype nor did it rescue the hyperbranching phenotype in pten double homozygous embryos, indicating that PTEN phosphatase activity is indispensable for its regulatory function during angiogenesis. Taken together, our data suggest that PTEN phosphatase activity needs to be carefully fine-tuned for normal embryogenesis and that the control of its subcellular localization is a key mechanism in this process.	[Stumpf, Miriam; Blokzijl-Franke, Sasja; den Hertog, Jeroen] KNAW, Hubrecht Inst, Utrecht, Netherlands; [Stumpf, Miriam; Blokzijl-Franke, Sasja; den Hertog, Jeroen] Univ Med Ctr Utrecht, Utrecht, Netherlands; [den Hertog, Jeroen] Leiden Univ, Inst Biol Leiden, Leiden, Netherlands	Royal Netherlands Academy of Arts & Sciences; Hubrecht Institute (KNAW); Utrecht University; Utrecht University Medical Center; Leiden University; Leiden University - Excl LUMC	den Hertog, J (corresponding author), KNAW, Hubrecht Inst, Utrecht, Netherlands.; den Hertog, J (corresponding author), Univ Med Ctr Utrecht, Utrecht, Netherlands.; den Hertog, J (corresponding author), Leiden Univ, Inst Biol Leiden, Leiden, Netherlands.	j.denhertog@hubrecht.eu						Andres-Pons A, 2012, CELL SIGNAL, V24, P577, DOI 10.1016/j.cellsig.2011.10.012; Bassi C, 2013, SCIENCE, V341, P395, DOI 10.1126/science.1236188; Chang HN, 2015, J ETHNOPHARMACOL, V174, P474, DOI 10.1016/j.jep.2015.08.050; Chen JH, 2015, AUTOPHAGY, V11, P239, DOI 10.1080/15548627.2015.1009767; Choorapoikayil S, 2013, DIS MODEL MECH, V6, P1159, DOI 10.1242/dmm.012377; Cleaver O, 1999, METH MOL B, V127, P133, DOI 10.1385/1-59259-678-9:133; Covassin LD, 2009, DEV BIOL, V329, P212, DOI 10.1016/j.ydbio.2009.02.031; Croushore JA, 2005, DEV DYNAM, V234, P911, DOI 10.1002/dvdy.20576; Denning G, 2007, ONCOGENE, V26, P3930, DOI 10.1038/sj.onc.1210175; Faucherre A, 2008, ONCOGENE, V27, P1079, DOI 10.1038/sj.onc.1210730; Garcia-Cao I, 2012, CELL, V149, P49, DOI 10.1016/j.cell.2012.02.030; Gil A, 2007, CELL DEATH DIFFER, V14, P395, DOI 10.1038/sj.cdd.4402073; Gil A, 2006, MOL BIOL CELL, V17, P4002, DOI 10.1091/mbc.E06-05-0380; Gil A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0119287; Gu JG, 1999, J CELL BIOL, V146, P389, DOI 10.1083/jcb.146.2.389; Harada K, 2016, BIOCHEM BIOPH RES CO, V469, P993, DOI 10.1016/j.bbrc.2015.12.073; Nguyen HN, 2015, SCI REP-UK, V5, DOI 10.1038/srep12600; Nguyen HN, 2014, P NATL ACAD SCI USA, V111, pE2684, DOI 10.1073/pnas.1409433111; Izaguirre-Carbonell J, 2015, SCI REP-UK, V5, DOI 10.1038/srep15136; Kim S. J., 2015, ONCOGENE; KIMMEL CB, 1995, DEV DYNAM, V203, P253, DOI 10.1002/aja.1002030302; Lee JO, 1999, CELL, V99, P323, DOI 10.1016/S0092-8674(00)81663-3; Li J, 1997, SCIENCE, V275, P1943, DOI 10.1126/science.275.5308.1943; Maccario H, 2007, BIOCHEM J, V405, P439, DOI 10.1042/BJ20061837; Maehama T, 1998, J BIOL CHEM, V273, P13375, DOI 10.1074/jbc.273.22.13375; Masson GR, 2016, BIOCHEM J, V473, P135, DOI 10.1042/BJ20150931; Misra S, 2014, MUTAT RES-FUND MOL M, V770, P112, DOI 10.1016/j.mrfmmm.2014.08.008; Nguyen HN, 2014, ONCOGENE, V33, P5688, DOI 10.1038/onc.2013.507; Pauls S, 2001, DEV GENES EVOL, V211, P603, DOI 10.1007/s00427-001-0196-x; Planchon SM, 2008, J CELL SCI, V121, P249, DOI 10.1242/jcs.022459; Rahdar M, 2009, P NATL ACAD SCI USA, V106, P480, DOI 10.1073/pnas.0811212106; Ross AH, 2009, P NATL ACAD SCI USA, V106, P1297, DOI 10.1073/pnas.0812473106; Semenza GL, 2003, ANNU REV MED, V54, P17, DOI 10.1146/annurev.med.54.101601.152418; Serra H, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8935; Shen WH, 2007, CELL, V128, P157, DOI 10.1016/j.cell.2006.11.042; Song MS, 2011, CELL, V144, P187, DOI 10.1016/j.cell.2010.12.020; Steck PA, 1997, NAT GENET, V15, P356, DOI 10.1038/ng0497-356; Stumpf M, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0148508; Stumpf M, 2015, METHODS, V77-78, P191, DOI 10.1016/j.ymeth.2014.11.002; Tamura M, 1998, SCIENCE, V280, P1614, DOI 10.1126/science.280.5369.1614; Torres J, 2003, J BIOL CHEM, V278, P30652, DOI 10.1074/jbc.M212610200; Torres J, 2001, J BIOL CHEM, V276, P993, DOI 10.1074/jbc.M009134200; Trotman LC, 2007, CELL, V128, P141, DOI 10.1016/j.cell.2006.11.040; Vazquez F, 2000, MOL CELL BIOL, V20, P5010, DOI 10.1128/MCB.20.14.5010-5018.2000; Vazquez F, 2001, J BIOL CHEM, V276, P48627, DOI 10.1074/jbc.C100556200; Weinstein BM, 2002, COLD SPRING HARB SYM, V67, P155, DOI 10.1101/sqb.2002.67.155; Wen SH, 2001, P NATL ACAD SCI USA, V98, P4622, DOI 10.1073/pnas.081063798; You DW, 2015, CELL REP, V10, P2055, DOI 10.1016/j.celrep.2015.02.056; Zhang LL, 2014, CELL SIGNAL, V26, P1011, DOI 10.1016/j.cellsig.2014.01.025; Zhou YJ, 2004, WORLD J GASTROENTERO, V10, P3225	50	6	6	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 3	2016	11	5							e0154771	10.1371/journal.pone.0154771	http://dx.doi.org/10.1371/journal.pone.0154771			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DL5KK	27138341	Green Published, Green Submitted, gold			2022-12-26	WOS:000375675700067
J	Lee, SM; Park, JS; Norwitz, ER; Panyavatthanasinh, S; Kim, SM; Lee, J; Park, CW; Kim, BJ; Jun, JK				Lee, Seung Mi; Park, Joong Shin; Norwitz, Errol R.; Panyavatthanasinh, Sitthysack; Kim, Sun Min; Lee, JoonHo; Park, Chan-Wook; Kim, Byoung Jae; Jun, Jong Kwan			Levels of Adipokines in Amniotic Fluid and Cord Blood Collected from Dichorionic-Diamniotic Twins Discordant for Fetal Growth	PLOS ONE			English	Article							LEPTIN LEVELS; ADIPONECTIN CONCENTRATIONS; INSULIN-RESISTANCE; DIABETES-MELLITUS; BIRTH-WEIGHT; PLASMA; PREECLAMPSIA; ADIPOSITY; SERUM; RISK	Objective To compare the concentrations of adipokines in amniotic fluid (AF) and cord blood collected from discordant dichorionic-diamniotic (DCDA) twin fetuses. Study Design The study population included DCDA twins discordant for fetal growth (birth weight difference >10%) who either underwent mid-trimester amniocentesis for routine clinical indication (Cohort 1) or whose amniotic fluid was collected at the time of delivery (Cohort 2). In both cohorts, cord blood was collected at delivery. Results A total of 92 twin pairs were enrolled (n = 49 in Cohort 1; n = 43 in Cohort 2). In Cohort 1, the concentrations of adiponectin (median, 68.5 ng/mL vs 61.4 ng/mL; p<0.05) and leptin (median, 13.9 ng/mL vs 11.2 ng/mL; p<0.1) in mid-trimester AF were significantly higher in smaller compared with larger twins. In Cohort 2, the concentration of serpin E1 (median, 246.0 ng/mL vs 182.8 ng/mL; p<0.01) in AF at delivery was significantly higher in smaller twins, but no difference was noted in adiponectin and leptin concentrations. Levels of adiponectin (median, 10425.5 ng/mL vs 11552.0 ng/mL; p<0.005) and leptin (median, 2.1 ng/mL vs 2.6 ng/mL; p<0.005) were significantly lower in the cord blood of smaller twins whereas cord blood concentrations of serpin E1 (median, 15.5 ng/mL vs 13.3 ng/mL; p<0.05) was higher in the smaller twins. Conclusion In discordant DCDA twin pairs, concentrations of adiponectin, leptin, and serpin E1 in midtrimester AF, AF at delivery, and cord blood at birth vary significantly but predictably between the smaller and larger twins.	[Lee, Seung Mi; Park, Joong Shin; Kim, Sun Min; Lee, JoonHo; Park, Chan-Wook; Kim, Byoung Jae; Jun, Jong Kwan] Seoul Natl Univ, Coll Med, Dept Obstet & Gynecol, Seoul, South Korea; [Norwitz, Errol R.] Tufts Univ, Sch Med, Dept Obstet & Gynecol, Boston, MA 02111 USA; [Panyavatthanasinh, Sitthysack] Univ Hlth Sci, Dept Obstet & Gynecol, Viangchan, Laos; [Kim, Sun Min; Kim, Byoung Jae] Seoul Natl Univ, Dept Obstet & Gynecol, Seoul Metropolitan Govt, Boramae Med Ctr, Seoul, South Korea	Seoul National University (SNU); Tufts University; Seoul National University (SNU); Seoul National University Hospital	Park, JS (corresponding author), Seoul Natl Univ, Coll Med, Dept Obstet & Gynecol, Seoul, South Korea.	jsparkmd@snu.ac.kr	Park, Joong Shin/D-5741-2012; PARK, Chan-Wook/G-3663-2013	Park, Joong Shin/0000-0002-5246-0477; PARK, Chan-Wook/0000-0002-1290-6438; Lee, Seung Mi/0000-0002-2543-0408	Korea Health R&D Project through the Korea Health Industry Development Institute (KHIDI); Ministry of Health & Welfare, Republic of Korea [HI12C00240300]	Korea Health R&D Project through the Korea Health Industry Development Institute (KHIDI)(Korea Health Industry Development Institute (KHIDI)); Ministry of Health & Welfare, Republic of Korea(Ministry of Health & Welfare (MOHW), Republic of Korea)	This study was supported by a grant of the Korea Health R&D Project through the Korea Health Industry Development Institute (KHIDI), funded by the Ministry of Health & Welfare, Republic of Korea (HI12C00240300).	Ahima RS, 2000, ANNU REV PHYSIOL, V62, P413, DOI 10.1146/annurev.physiol.62.1.413; Alexe DM, 2006, CLIN MED RES, V4, P326, DOI 10.3121/cmr.4.4.326; Arita Y, 1999, BIOCHEM BIOPH RES CO, V257, P79, DOI 10.1006/bbrc.1999.0255; Barker DJP, 2006, CLIN OBSTET GYNECOL, V49, P270, DOI 10.1097/00003081-200606000-00009; Bastard JP, 2000, DIABETES-METAB RES, V16, P192, DOI 10.1002/1520-7560(200005/06)16:3<192::AID-DMRR114>3.3.CO;2-7; Boutsikou T, 2010, MEDIAT INFLAMM, V2010, DOI 10.1155/2010/790605; Chan TF, 2006, ACTA OBSTET GYN SCAN, V85, P171, DOI 10.1080/00016340500460615; CLEVELAND MG, 1991, J IMMUNOL, V147, P181; DORNER G, 1994, HORM METAB RES, V26, P213, DOI 10.1055/s-2007-1001668; Fowden AL, 2004, REPRODUCTION, V127, P515, DOI 10.1530/rep.1.00033; HALES CN, 1992, DIABETOLOGIA, V35, P595, DOI 10.1007/BF00400248; Haugen F, 2006, AM J PHYSIOL-ENDOC M, V290, pE326, DOI 10.1152/ajpendo.00020.2005; Ibanez L, 2008, J CLIN ENDOCR METAB, V93, P2079, DOI 10.1210/jc.2007-2850; Jaquet D, 2005, DIABETOLOGIA, V48, P849, DOI 10.1007/s00125-005-1724-4; Jaquet D, 1998, J CLIN ENDOCR METAB, V83, P1243, DOI 10.1210/jc.83.4.1243; Jaquet D, 2000, J CLIN ENDOCR METAB, V85, P1401, DOI 10.1210/jc.85.4.1401; Kajantie E, 2004, J CLIN ENDOCR METAB, V89, P4031, DOI 10.1210/jc.2004-0018; Kamoda T, 2004, PEDIATR RES, V56, P690, DOI 10.1203/01.PDR.0000142711.24999.8A; Khairy P, 2006, CIRCULATION, V113, P517, DOI 10.1161/CIRCULATIONAHA.105.589655; Krechowec SO, 2006, J ENDOCRINOL, V189, P355, DOI 10.1677/joe.1.06679; Kyriakakou M, 2008, EUR J ENDOCRINOL, V158, P343, DOI 10.1530/EJE-07-0692; Lepercq J, 2001, J CLIN ENDOCR METAB, V86, P2409, DOI 10.1210/jc.86.6.2409; Lindsay RS, 2003, DIABETES CARE, V26, P2244, DOI 10.2337/diacare.26.8.2244; Meier U, 2004, CLIN CHEM, V50, P1511, DOI 10.1373/clinchem.2004.032482; Mise H, 1998, J CLIN ENDOCR METAB, V83, P3225, DOI 10.1210/jc.83.9.3225; Pardo IMCG, 2004, OBES RES, V12, P521, DOI 10.1038/oby.2004.59; Pighetti M, 2003, OBSTET GYNECOL, V102, P535, DOI 10.1016/S0029-7844(03)00668-9; Schondorf T, 2005, CLIN LAB, V51, P489; Shekhawat PS, 1998, PEDIATR RES, V43, P338, DOI 10.1203/00006450-199803000-00005; Sheppard BL, 1999, SEMIN THROMB HEMOST, V25, P443, DOI 10.1055/s-2007-994947; Takaya J, 2007, PEDIATR RES, V62, P700, DOI 10.1203/PDR.0b013e318157d219; Touboul C, 2008, AM J OBSTET GYNECOL, V199, DOI 10.1016/j.ajog.2008.04.003; Tsai PJ, 2004, CLIN ENDOCRINOL, V61, P88, DOI 10.1111/j.1365-2265.2004.02057.x; van Nimwegen FA, 2011, J ALLERGY CLIN IMMUN, V128, P948, DOI 10.1016/j.jaci.2011.07.027; Wallace AM, 2001, CIRCULATION, V104, P3052, DOI 10.1161/hc5001.101061; Wang CN, 2010, J CLIN ENDOCR METAB, V95, P1431, DOI 10.1210/jc.2009-1954; Xu WL, 2011, NEUROLOGY, V76, P1568, DOI 10.1212/WNL.0b013e3182190d09; Yajnik CS, 2002, J CLIN ENDOCR METAB, V87, P5575, DOI 10.1210/jc.2002-020434; Yildiz L, 2002, CLIN CHEM LAB MED, V40, P612, DOI 10.1515/CCLM.2002.106	39	6	6	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 2	2016	11	5							e0154537	10.1371/journal.pone.0154537	http://dx.doi.org/10.1371/journal.pone.0154537			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DL5KB	27135745	Green Published, gold, Green Submitted			2022-12-26	WOS:000375674800027
J	Wegayehu, T; Karim, MR; Anberber, M; Adamu, H; Erko, B; Zhang, LX; Tilahun, G				Wegayehu, Teklu; Karim, Md. Robiul; Anberber, Manyazewal; Adamu, Haileeyesus; Erko, Berhanu; Zhang, Longxian; Tilahun, Getachew			Prevalence and Genetic Characterization of Cryptosporidium Species in Dairy Calves in Central Ethiopia	PLOS ONE			English	Article							MOLECULAR CHARACTERIZATION; CATTLE; SPP.; INFECTION; GENOTYPES; PARVUM; AGE; IDENTIFICATION; ANDERSONI; DIARRHEA	The burden of cryptosporidiosis due to Cryptosporidium parvum is well documented in HIV-positive patients in Ethiopia. However, the role of animals in zoonotic transmission of the disease is poorly understood. The aim of this study was to determine the prevalence and genotypes of Cryptosporidium species in dairy calves; to assess the role of cattle in zoonotic transmission in central Ethiopia. A total of 449 fecal samples were collected and screened using modified Ziehl-Neelson staining method and PCR targeting the small-subunit (SSU) rRNA gene. The prevalence of Cryptosporidium was 9.4% (42/449) and 15.8% (71/449) as detected by microscopy and nested PCR, respectively. The prevalence of infection varied significantly across the study areas with the higher prevalence being observed in Chancho 25.4%(30/118). Crossbred calves had significantly higher prevalence of Cryptosporidium than indigenous zebu. Genotyping results revealed the presence of C. andersoni (76.1%), C. bovis (19.7%) and C. ryanae (4.2%). The occurrence of these Cryptosporidium species appeared to be age-related. C. andersoni constituted 92.1% of the Cryptosporidium infection in calves older than 3 months. Sequence analysis also showed the existence of intra-species variation at SSU rRNA gene. Findings of the current study indicate that cattle may not be an important source of zoonotic cryptosporidiosis in central Ethiopia. Further molecular studies are needed to support this observation from other part of the country.	[Wegayehu, Teklu; Erko, Berhanu; Tilahun, Getachew] Univ Addis Ababa, Aklilu Lemma Inst Pathobiol, Addis Ababa, Ethiopia; [Wegayehu, Teklu] Arba Minch Univ, Coll Nat Sci, Arba Minch, Ethiopia; [Anberber, Manyazewal] Univ Addis Ababa, Coll Vet Med, Debre Zeit, Ethiopia; [Adamu, Haileeyesus] Univ Addis Ababa, Inst Biotechnol, Addis Ababa, Ethiopia; [Karim, Md. Robiul] Sun Yat Sen Univ, Zhongshan Sch Med, Guangzhou 510275, Guangdong, Peoples R China; [Karim, Md. Robiul; Zhang, Longxian] Henan Agr Univ, Coll Anim Sci & Vet Med, Zhengzhou, Henan, Peoples R China	Addis Ababa University; Arba Minch University; Addis Ababa University; Addis Ababa University; Sun Yat Sen University; Henan Agricultural University	Wegayehu, T (corresponding author), Univ Addis Ababa, Aklilu Lemma Inst Pathobiol, Addis Ababa, Ethiopia.; Wegayehu, T (corresponding author), Arba Minch Univ, Coll Nat Sci, Arba Minch, Ethiopia.; Zhang, LX (corresponding author), Henan Agr Univ, Coll Anim Sci & Vet Med, Zhengzhou, Henan, Peoples R China.	tekluweg2007@yahoo.com; zhanglx8999@gmail.com	Zhang, Longxian/R-7799-2019; Zhang, Longxian/HGE-1918-2022; Zhang, Longxian/I-9223-2019	Zhang, Longxian/0000-0002-5706-131X; Karim, Md Robiul/0000-0002-0712-5573; Adamu, Haileeyesus/0000-0003-2998-5977	Office of Graduate Studies, Addis Ababa University [0106072700]; Office of the Vice President for Research and Technology Transfer, Addis Ababa University [0106072700]; State Key Program of National Natural Science Foundation of China [31330079]; Innovation Scientists and Technicians Troop Construction Projects of Henan Province [134200510012]; Arba Minch University, office of research and publications [GOV/AMU/THS/CNS/BIO/08/07]	Office of Graduate Studies, Addis Ababa University; Office of the Vice President for Research and Technology Transfer, Addis Ababa University; State Key Program of National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Innovation Scientists and Technicians Troop Construction Projects of Henan Province; Arba Minch University, office of research and publications	Support was provided by: 1) The Office of Graduate Studies and the Office of the Vice President for Research and Technology Transfer, Thematic Research Fund, Addis Ababa University. (Grant No: 0106072700); 2) The State Key Program of National Natural Science Foundation of China (Grant No: 31330079), and Innovation Scientists and Technicians Troop Construction Projects of Henan Province (Grant No: 134200510012); 3) Arba Minch University, office of research and publications (Grant No: GOV/AMU/THS/CNS/BIO/08/07).	Abebe R, 2008, REV MED VET-TOULOUSE, V159, P107; ABRAHAM G, 1992, TROP ANIM HEALTH PRO, V24, P74, DOI 10.1007/BF02356948; Adamu H, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002831; Adamu H, 2010, ACTA TROP, V115, P77, DOI 10.1016/j.actatropica.2010.02.003; Amer S, 2010, VET PARASITOL, V169, P382, DOI 10.1016/j.vetpar.2010.01.017; Ayinmode AB, 2010, PARASITOL RES, V107, P1019, DOI 10.1007/s00436-010-1972-1; Bornay-Llinares FJ, 1999, APPL ENVIRON MICROB, V65, P1455; Brook EJ, 2009, VET J, V179, P378, DOI 10.1016/j.tvjl.2007.10.023; Caccio S. M., 2005, Parassitologia (Rome), V47, P185; Caccio SM, 2005, TRENDS PARASITOL, V21, P430, DOI 10.1016/j.pt.2005.06.013; Enemark HL, 2002, VET PARASITOL, V107, P37, DOI 10.1016/S0304-4017(02)00083-3; Fayer R, 2006, VET PARASITOL, V135, P105, DOI 10.1016/j.vetpar.2005.08.003; Fayer R, 2004, VET PARASITOL, V126, P37, DOI 10.1016/j.vetpar.2004.09.004; Fayer R, 2008, VET PARASITOL, V156, P191, DOI 10.1016/j.vetpar.2008.05.024; Fayer R, 2007, VET PARASITOL, V145, P260, DOI 10.1016/j.vetpar.2006.12.009; Fayer R, 2010, EXP PARASITOL, V124, P90, DOI 10.1016/j.exppara.2009.03.005; Feltus DC, 2006, J CLIN MICROBIOL, V44, P4303, DOI 10.1128/JCM.01067-06; Feng YY, 2007, VET PARASITOL, V144, P1, DOI 10.1016/j.vetpar.2006.10.001; GARBER LP, 1994, J AM VET MED ASSOC, V205, P87; Geurden T, 2006, VET PARASITOL, V138, P217, DOI 10.1016/j.vetpar.2006.02.009; HENRIKSEN SA, 1981, ACTA VET SCAND, V22, P594; Jex AR, 2008, BIOTECHNOL ADV, V26, P304, DOI 10.1016/j.biotechadv.2008.02.003; Jex AR, 2010, BIOTECHNOL ADV, V28, P17, DOI 10.1016/j.biotechadv.2009.08.003; Kvac M, 2006, VET PARASITOL, V137, P202, DOI 10.1016/j.vetpar.2006.01.027; Maikai BV, 2011, VET PARASITOL, V178, P241, DOI 10.1016/j.vetpar.2010.12.048; Mohammed HO, 1999, VET PARASITOL, V83, P1, DOI 10.1016/S0304-4017(99)00032-1; Morgan UM, 1998, J CLIN MICROBIOL, V36, P995, DOI 10.1128/JCM.36.4.995-998.1998; Murakoshi F, 2012, VET PARASITOL, V187, P123, DOI 10.1016/j.vetpar.2011.12.011; Nagano S, 2007, VET PARASITOL, V149, P213, DOI 10.1016/j.vetpar.2007.07.016; Nguyen ST, 2007, VET PARASITOL, V150, P357, DOI 10.1016/j.vetpar.2007.09.010; Omoruyi BE, 2014, MOLECULES, V19, P2674, DOI 10.3390/molecules19022674; Ondrackova Z, 2009, VET PARASITOL, V165, P141, DOI 10.1016/j.vetpar.2009.06.035; Paul S, 2009, VET PARASITOL, V161, P31, DOI 10.1016/j.vetpar.2008.12.013; Santin M, 2004, VET PARASITOL, V122, P103, DOI 10.1016/j.vetpar.2004.03.020; Santin Monica, 2007, P451, DOI 10.1201/9781420052275.ch18; Silverlas C, 2010, VET PARASITOL, V169, P289, DOI 10.1016/j.vetpar.2010.01.003; Smith HV, 2005, VET REC, V156, P710, DOI 10.1136/vr.156.22.710; Starkey SR, 2006, JAVMA-J AM VET MED A, V229, P1623, DOI 10.2460/javma.229.10.1623; Thompson HP, 2007, PARASITOL RES, V100, P619, DOI 10.1007/s00436-006-0305-x; UPPAL B, 2014, J PARASITOL RES, V2014, DOI DOI 10.1155/2014/706105; Venu R, 2012, VET PARASITOL, V188, P19, DOI 10.1016/j.vetpar.2012.02.025; Wang RJ, 2011, J CLIN MICROBIOL, V49, P1077, DOI 10.1128/JCM.02194-10; Wegayehu T, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-419; Xiao LH, 2001, APPL ENVIRON MICROB, V67, P1097, DOI 10.1128/AEM.67.3.1097-1101.2001; Xiao LH, 2004, CURR OPIN INFECT DIS, V17, P483, DOI 10.1097/00001432-200410000-00014; Xiao LH, 2008, FEMS IMMUNOL MED MIC, V52, P309, DOI 10.1111/j.1574-695X.2008.00377.x; Xiao LH, 2010, EXP PARASITOL, V124, P80, DOI 10.1016/j.exppara.2009.03.018; Zhang WZ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054857	48	22	25	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 2	2016	11	5							e0154647	10.1371/journal.pone.0154647	http://dx.doi.org/10.1371/journal.pone.0154647			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DL5KB	27135243	Green Published, gold, Green Submitted			2022-12-26	WOS:000375674800034
J	Merilahti, P; Tauriainen, S; Susi, P				Merilahti, Pirjo; Tauriainen, Sisko; Susi, Petri			Human Parechovirus 1 Infection Occurs via alpha V beta 1 Integrin	PLOS ONE			English	Article							SARCOMA-ASSOCIATED HERPESVIRUS; COXSACKIEVIRUS A9; HUMAN CYTOMEGALOVIRUS; CELLULAR ENTRY; GENE DELIVERY; ECHOVIRUS 22; RECEPTOR; CELLS; EXPRESSION; IDENTIFICATION	Human parechovirus 1 (HPeV-1) (family Picornaviridae) is a global cause of pediatric respiratory and CNS infections for which there is no treatment. Although biochemical and in vitro studies have suggested that HPeV-1 binds to alpha V beta 1, alpha V beta 3 and alpha V beta 6 integrin receptor(s), the actual cellular receptors required for infectious entry of HPeV-1 remain unknown. In this paper we analyzed the expression profiles of alpha V beta 1, alpha V beta 3, alpha V beta 6 and alpha 5 beta 1 in susceptible cell lines (A549, HeLa and SW480) to identify which integrin receptors support HPeV-1 internalization and/or replication cycle. We demonstrate by antibody blocking assay, immunofluorescence microscopy and RT-qPCR that HPeV-1 internalizes and replicates in cell lines that express alpha V beta 1 integrin but not alpha V beta 3 or alpha V beta 6 integrins. To further study the role of beta 1 integrin, we used a mouse cell line, GE11-KO, which is deficient in beta 1 expression, and its derivate GE11-beta 1 in which human integrin beta 1 subunit is overexpressed. HPeV-1 (Harris strain) and three clinical HPeV-1 isolates did not internalize into GE11-KO whereas GE11-beta 1 supported the internalization process. An integrin beta 1-activating antibody, TS2/16, enhanced HPeV-1 infectivity, but infection occurred in the absence of visible receptor clustering. HPeV-1 also co-localized with beta 1 integrin on the cell surface, and HPeV-1 and beta 1 integrin co-endocytosed into the cells. In conclusion, our results demonstrate that in some cell lines the cellular entry of HPeV-1 is primarily mediated by the active form of alpha V beta 1 integrin without visible receptor clustering.	[Merilahti, Pirjo; Tauriainen, Sisko; Susi, Petri] Univ Turku, Dept Virol, Turku, Finland	University of Turku	Susi, P (corresponding author), Univ Turku, Dept Virol, Turku, Finland.	pesusi@utu.fi	Susi, Petri/AAL-8194-2020	Susi, Petri/0000-0002-9245-3271	Turku Doctoral Programme of Molecular Medicine; Finnish Cultural Foundation; European Union [612308]; Academy of Finland [128539]; Jane and Aatos Erkko Foundation	Turku Doctoral Programme of Molecular Medicine; Finnish Cultural Foundation(Finnish Cultural FoundationFinnish IT center for science); European Union(European Commission); Academy of Finland(Academy of Finland); Jane and Aatos Erkko Foundation	This work was supported by Turku Doctoral Programme of Molecular Medicine, The Finnish Cultural Foundation, European Union (AIROPico, FP7-PEOPLE-2013-IAPP Grant no. 612308)(http://airopico.eu), Academy of Finland (grant no. 128539 to P.S.)(www.aka.fi/en-GB/A/) and Jane and Aatos Erkko Foundation (to S.T.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abed Y, 2005, J MED VIROL, V77, P566, DOI 10.1002/jmv.20493; Adams MJ, 2013, ARCH VIROL, V158, P2023, DOI 10.1007/s00705-013-1688-5; Al-Sunaidi M, 2007, J VIROL, V81, P1013, DOI 10.1128/JVI.00584-06; Bazzoni G, 1998, J BIOL CHEM, V273, P6670, DOI 10.1074/jbc.273.12.6670; Benschop K, 2008, J CLIN MICROBIOL, V46, P3965, DOI 10.1128/JCM.01379-08; Benschop KSM, 2006, EMERG INFECT DIS, V12, P1572, DOI 10.3201/eid1210.051647; Boonyakiat Y, 2001, J VIROL, V75, P10000, DOI 10.1128/JVI.75.20.10000-10004.2001; CHANG KH, 1989, J GEN VIROL, V70, P3269, DOI 10.1099/0022-1317-70-12-3269; Croyle MA, 1998, HUM GENE THER, V9, P561, DOI 10.1089/hum.1998.9.4-561; Cseke G, 2009, P NATL ACAD SCI USA, V106, P1566, DOI 10.1073/pnas.0801433106; Danen EHJ, 2002, J CELL BIOL, V159, P1071, DOI 10.1083/jcb.200205014; Davison E, 1997, J VIROL, V71, P6204, DOI 10.1128/JVI.71.8.6204-6207.1997; DEDHAR S, 1990, J CELL BIOL, V110, P2185, DOI 10.1083/jcb.110.6.2185; Dibya D, 2010, BIOPHYS J, V99, P853, DOI 10.1016/j.bpj.2010.05.027; Drexler JF, 2009, EMERG INFECT DIS, V15, P310, DOI 10.3201/eid1502.081028; EHRNST A, 1993, SCAND J INFECT DIS, V25, P275, DOI 10.3109/00365549309008499; Esposito S, 2014, J CLIN VIROL, V60, P84, DOI 10.1016/j.jcv.2014.03.003; Feire AL, 2004, P NATL ACAD SCI USA, V101, P15470, DOI 10.1073/pnas.0406821101; Friedlander DR, 1996, CANCER RES, V56, P1939; Gavrilovskaya IN, 1999, J VIROL, V73, P3951, DOI 10.1128/JVI.73.5.3951-3959.1999; Gavrilovskaya IN, 1998, P NATL ACAD SCI USA, V95, P7074, DOI 10.1073/pnas.95.12.7074; Ghazi F, 1998, J GEN VIROL, V79, P2641, DOI 10.1099/0022-1317-79-11-2641; Gimond C, 1999, J CELL BIOL, V147, P1325, DOI 10.1083/jcb.147.6.1325; Grist N R, 1978, Prog Med Virol, V24, P114; Harvala H, 2009, J CLIN VIROL, V45, P1, DOI 10.1016/j.jcv.2009.03.009; Heikkila O, 2010, J VIROL, V84, P3666, DOI 10.1128/JVI.01340-09; Heikkila O, 2009, J GEN VIROL, V90, P197, DOI 10.1099/vir.0.004838-0; Hendry E, 1999, STRUCT FOLD DES, V7, P1527, DOI 10.1016/S0969-2126(00)88343-4; HUGHES PJ, 1995, J VIROL, V69, P8035, DOI 10.1128/JVI.69.12.8035-8040.1995; Humphries JD, 2006, J CELL SCI, V119, P3901, DOI 10.1242/jcs.03098; Huttunen M, 2014, J VIROL, V88, P5138, DOI 10.1128/JVI.03275-13; Hynes RO, 2002, CELL, V110, P673, DOI 10.1016/S0092-8674(02)00971-6; HYYPIA T, 1992, P NATL ACAD SCI USA, V89, P8847, DOI 10.1073/pnas.89.18.8847; Ito M, 2004, J GEN VIROL, V85, P391, DOI 10.1099/vir.0.19456-0; Izmailyan R, 2012, J VIROL, V86, P6677, DOI 10.1128/JVI.06860-11; Jackson T, 2002, J VIROL, V76, P935, DOI 10.1128/JVI.76.3.935-941.2002; Joki-Korpela P, 1998, CLIN INFECT DIS, V27, P129, DOI 10.1086/514615; Joki-Korpela P, 2001, J VIROL, V75, P1958, DOI 10.1128/JVI.75.4.1958-1967.2001; Joki-Korpela P, 2000, J GEN VIROL, V81, P1709, DOI 10.1099/0022-1317-81-7-1709; Jokinen J, 2010, EMBO J, V29, P196, DOI 10.1038/emboj.2009.326; Kankaanpaa P, 2012, NAT METHODS, V9, P683, DOI [10.1038/NMETH.2047, 10.1038/nmeth.2047]; Kasono K, 1999, CLIN CANCER RES, V5, P2571; Knowles NJ, 2012, VIRUS TAXONOMY CLASS, P855, DOI DOI 10.1016/B978-0-12-384684-6.00074-4; Koistinen P, 2002, J BIOL CHEM, V277, P24835, DOI 10.1074/jbc.M203149200; KOSKINIEMI M, 1989, SCAND J INFECT DIS, V21, P463, DOI 10.3109/00365548909167453; KOWALIK TF, 1993, P NATL ACAD SCI USA, V90, P1107, DOI 10.1073/pnas.90.3.1107; Krishnan HH, 2006, J VIROL, V80, P1167, DOI 10.1128/JVI.80.3.1167-1180.2006; Li E, 2001, J VIROL, V75, P5405, DOI 10.1128/JVI.75.11.5405-5409.2001; Li EG, 1998, J VIROL, V72, P2055, DOI 10.1128/JVI.72.3.2055-2061.1998; Li LL, 2009, EMERG INFECT DIS, V15, P288, DOI 10.3201/eid1502.080341; Lord R, 2006, J GEN VIROL, V87, P2497, DOI 10.1099/vir.0.81620-0; Mackow ER, 2001, CURR TOP MICROBIOL, V256, P91; MANDERS EMM, 1993, J MICROSC-OXFORD, V169, P375, DOI 10.1111/j.1365-2818.1993.tb03313.x; Merilahti P, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0147168; Merilahti P, 2012, ADV VIROL, V2012, DOI 10.1155/2012/547530; Meyer T, 1998, BRIT J CANCER, V77, P530, DOI 10.1038/bjc.1998.86; Oberste MS, 1998, VIRUS RES, V56, P217, DOI 10.1016/S0168-1702(98)00080-X; Philpott NJ, 2004, P NATL ACAD SCI USA, V101, P6200, DOI 10.1073/pnas.0308368101; Pulli T, 1997, J BIOL CHEM, V272, P21176, DOI 10.1074/jbc.272.34.21176; Pulli T, 1998, J GEN VIROL, V79, P2249, DOI 10.1099/0022-1317-79-9-2249; Rajala MS, 2005, J VIROL, V79, P12332, DOI 10.1128/JVI.79.19.12332-12341.2005; Raymond T, 2005, P NATL ACAD SCI USA, V102, P1163, DOI 10.1073/pnas.0406743102; Seitsonen J, 2010, J VIROL, V84, P8509, DOI 10.1128/JVI.02176-09; Stanway G, 1999, J VIROL, V73, P5249, DOI 10.1128/JVI.73.7.5249-5254.1999; STANWAY G, 1994, J VIROL, V68, P8232, DOI 10.1128/JVI.68.12.8232-8238.1994; Stewart PL, 2007, TRENDS MICROBIOL, V15, P500, DOI 10.1016/j.tim.2007.10.001; Tauriainen S, 2007, J MED VIROL, V79, P457, DOI 10.1002/jmv.20831; Triantafilou K, 2001, J CELL BIOCHEM, V80, P373, DOI 10.1002/1097-4644(20010301)80:3<373::AID-JCB110>3.0.CO;2-C; Triantafilou K, 2000, J VIROL, V74, P5856, DOI 10.1128/JVI.74.13.5856-5862.2000; Upla P, 2004, MOL BIOL CELL, V15, P625, DOI 10.1091/mbc.E03-08-0588; Veettil MV, 2006, J VIROL, V80, P11432, DOI 10.1128/JVI.01342-06; Wang X, 2005, NAT MED, V11, P515, DOI 10.1038/nm1236; Watanabe K, 2007, EMERG INFECT DIS, V13, P889, DOI 10.3201/eid1306.060896; WIGAND REINHARD, 1961, ARCH GES VIRUSFORSCH, V11, P224, DOI 10.1007/BF01241688; Williams CH, 2004, J VIROL, V78, P6967, DOI 10.1128/JVI.78.13.6967-6973.2004; ZHANG ZH, 1993, J CELL BIOL, V122, P235, DOI 10.1083/jcb.122.1.235	76	0	0	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 29	2016	11	4							e0154769	10.1371/journal.pone.0154769	http://dx.doi.org/10.1371/journal.pone.0154769			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DK8XM	27128974	Green Published, Green Submitted, gold			2022-12-26	WOS:000375212600068
J	Kasparovska, J; Pecinkova, M; Dadakova, K; Krizova, L; Hadrova, S; Lexa, M; Lochman, J; Kasparovsky, T				Kasparovska, Jitka; Pecinkova, Martina; Dadakova, Katerina; Krizova, Ludmila; Hadrova, Sylvie; Lexa, Matej; Lochman, Jan; Kasparovsky, Tomas			Effects of Isoflavone-Enriched Feed on the Rumen Microbiota in Dairy Cows	PLOS ONE			English	Article							ESTROGEN-RECEPTOR-ALPHA; RIBOSOMAL-RNA; PHYTO-ESTROGENS; GRASS SILAGES; RUMINAL PH; RED-CLOVER; C-RING; PHYTOESTROGENS; EQUOL; MILK	In this study, we compared the effects of two diets containing different isoflavone concentrations on the isoflavone transfer from feed into milk and on the rumen microbiota in lactating dairy cows. The on-farm experiment was conducted on twelve lactating Czech Fleckvieh x Holstein cows divided into two groups, each with similar mean milk yield. Twice daily, cows were individually fed a diet based on maize silage, meadow hay and supplemental mixture. Control group (CTRL) received the basal diet while the experimental group (EXP) received the basal diet supplemented with 40% soybean isoflavone extract. The average daily isoflavone intake in the EXP group (16 g/day) was twice as high as that in the CTRL group (8.4 g/day, P<0.001). Total isoflavone concentrations in milk from the CTRL and EXP groups were 96.89 and 276.07 mu g/L, respectively (P<0.001). Equol concentrations in milk increased from 77.78 mu g/L in the CTRL group to 186.30 mu g/L in the EXP group (P<0.001). The V3-4 region of bacterial 16S rRNA genes was used for metagenomic analysis of the rumen microbiome. The experimental cows exhibited fewer OTUs at a distance level of 0.03 compared to control cows (P<0.05) and reduced microbial richness compared to control cows based on the calculated Inverse Simpson and Shannon indices. Non-metric multidimensional scaling analysis showed that the major contributor to separation between the experimental and control groups were changes in the representation of bacteria belonging to the phyla Bacteroidetes, Proteobacteria, Firmicutes, and Planctomycetes. Surprisingly, a statistically significant positive correlation was found only between isoflavones and the phyla Burkholderiales (r = 0.65, P<0.05) and unclassified Betaproteobacteria (r = 0.58, P<0.05). Previous mouse and human studies of isoflavone effects on the composition of gastrointestinal microbial populations generally report similar findings.	[Kasparovska, Jitka; Pecinkova, Martina; Dadakova, Katerina; Krizova, Ludmila; Hadrova, Sylvie; Lochman, Jan; Kasparovsky, Tomas] Masaryk Univ, Fac Sci, Dept Biochem, CS-61137 Brno, Czech Republic; [Lexa, Matej] Masaryk Univ, Fac Informat, Dept Informat Technol, Brno, Czech Republic	Masaryk University Brno; Masaryk University Brno	Kasparovsky, T (corresponding author), Masaryk Univ, Fac Sci, Dept Biochem, CS-61137 Brno, Czech Republic.	tkasp@sci.muni.cz	Kasparovsky, Tomas/ABJ-8990-2022; Křížová, Ludmila/ABE-7683-2020; Zapletalova, Martina/AAO-3092-2021; Lexa, Matej/S-7256-2019; Dadakova, Katerina/AAB-5237-2022; Hadrová, Sylvie/AAK-9229-2020; Dadakova, Katerina/AAC-6554-2019; Lexa, Matej/A-1772-2011	Kasparovsky, Tomas/0000-0001-8194-2320; Zapletalova, Martina/0000-0003-3118-2647; Dadakova, Katerina/0000-0003-0252-5110; Lexa, Matej/0000-0002-4213-5259; Kasparovska, Jitka/0000-0002-5589-1846; Krizova, Ludmila/0000-0003-1616-1207; Lochman, Jan/0000-0003-4420-8842	Czech Science Foundation (GACR) [13-34134S]	Czech Science Foundation (GACR)(Grant Agency of the Czech Republic)	This work was supported by the Czech Science Foundation (GACR) project No. 13-34134S. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adler SA, 2014, LIVEST SCI, V163, P62, DOI 10.1016/j.livsci.2014.02.006; Andersen C, 2009, ANIMAL, V3, P1189, DOI 10.1017/S1751731109004613; [Anonymous], 1997, RUMEN MICROBIAL ECOS; Antignac JP, 2004, FOOD CHEM, V87, P275, DOI 10.1016/j.foodchem.2003.12.013; Bhathena SJ, 2002, AM J CLIN NUTR, V76, P1191, DOI 10.1093/ajcn/76.6.1191; Blaut M, 2003, INT J VITAM NUTR RES, V73, P79, DOI 10.1024/0300-9831.73.2.79; Chen J, 1999, JIANGSU AGR RES, P17; Clavel T, 2005, J NUTR, V135, P2786, DOI 10.1093/jn/135.12.2786; Conway E, 1984, MICRODIFFUSION ANAL; COWARD L, 1993, J AGR FOOD CHEM, V41, P1961, DOI 10.1021/jf00035a027; De Boever P, 2000, J NUTR, V130, P2599; Decroos K, 2005, ARCH MICROBIOL, V183, P45, DOI 10.1007/s00203-004-0747-4; Deng WD, 2008, MOL BIOL REP, V35, P265, DOI 10.1007/s11033-007-9079-1; Duffy C, 2007, CA-CANCER J CLIN, V57, P260, DOI 10.3322/CA.57.5.260; Edgar RC, 2011, BIOINFORMATICS, V27, P2194, DOI 10.1093/bioinformatics/btr381; Edwards JE, 2004, ANTON LEEUW INT J G, V86, P263, DOI 10.1023/B:ANTO.0000047942.69033.24; Flachowsky G, 2011, J VERBRAUCH LEBENSM, V6, P449, DOI 10.1007/s00003-011-0702-7; Goering H.K., 1970, AGR HDB USDA; Han Zhengkang, 2006, Current Issues in Intestinal Microbiology, V7, P53; Hoikkala A, 2007, MOL NUTR FOOD RES, V51, P782, DOI 10.1002/mnfr.200600222; Hojer A, 2012, J DAIRY SCI, V95, P4526, DOI 10.3168/jds.2011-5226; Hur HG, 2000, ARCH MICROBIOL, V174, P422, DOI 10.1007/s002030000222; Hur HG, 2002, ARCH MICROBIOL, V178, P8, DOI 10.1007/s00203-002-0414-6; Ishler V., 1996, 422 PENNS STAT U; Jami E, 2013, ISME J, V7, P1069, DOI 10.1038/ismej.2013.2; Kalac P, 2013, CZECH J ANIM SCI, V58, P296, DOI 10.17221/6859-CJAS; Kamra DN, 2005, INDIAN J ANIM SCI, V75, P128; Kasparovska J, 2016, J CHROMATOG IN PRESS, DOI [10.1093/chromsci/bmw033, DOI 10.1093/CHR0MSCI/BMW033]; Kim M, 2011, FOLIA MICROBIOL, V56, P453, DOI 10.1007/s12223-011-0066-5; Kiova L., 2011, SOYBEAN APPL TECHNOL, P95; Klejdus B, 2001, ANAL CHIM ACTA, V450, P81, DOI 10.1016/S0003-2670(01)01370-8; Klindworth A, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gks808; Kong YH, 2010, FEMS MICROBIOL ECOL, V74, P612, DOI 10.1111/j.1574-6941.2010.00977.x; Kostelac D, 2003, J AGR FOOD CHEM, V51, P7632, DOI 10.1021/jf034427b; Kozich JJ, 2013, APPL ENVIRON MICROB, V79, P5112, DOI 10.1128/AEM.01043-13; Krizova L, 2011, CZECH J ANIM SCI, V56, P37, DOI 10.17221/39/2010-CJAS; Kurzer MS, 1997, ANNU REV NUTR, V17, P353, DOI 10.1146/annurev.nutr.17.1.353; Lozupone C, 2005, APPL ENVIRON MICROB, V71, P8228, DOI 10.1128/AEM.71.12.8228-8235.2005; Lund TD, 2004, BIOL REPROD, V70, P1188, DOI 10.1095/biolreprod.103.023713; LUNDH T, 1995, P SOC EXP BIOL MED, V208, P33; Marden JP, 2005, J DAIRY SCI, V88, P277, DOI 10.3168/jds.S0022-0302(05)72685-0; McMurdie PJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061217; Menon R, 2013, APPL ENVIRON MICROB, V79, P5763, DOI 10.1128/AEM.01182-13; Morito K, 2001, BIOL PHARM BULL, V24, P351, DOI 10.1248/bpb.24.351; Mustonen EA, 2009, BRIT J NUTR, V102, P1552, DOI 10.1017/S0007114509990857; Nakamura Y, 2000, J AOAC INT, V83, P635; Noziere P, 2011, ANIMAL, V5, P403, DOI 10.1017/S1751731110002016; Quast C, 2013, NUCLEIC ACIDS RES, V41, pD590, DOI 10.1093/nar/gks1219; Schoefer L, 2002, FEMS MICROBIOL LETT, V208, P197, DOI 10.1111/j.1574-6968.2002.tb11081.x; Setchell KDR, 2002, J NUTR, V132, P3577, DOI 10.1093/jn/132.12.3577; SETCHELL KDR, 1984, AM J CLIN NUTR, V40, P569, DOI 10.1093/ajcn/40.3.569; Seymour WM, 2005, ANIM FEED SCI TECH, V119, P155, DOI 10.1016/j.anifeedsci.2004.10.001; Singh KM, 2015, MOL BIOL REP, V42, P95, DOI 10.1007/s11033-014-3746-9; STAHL DA, 1988, APPL ENVIRON MICROB, V54, P1079, DOI 10.1128/AEM.54.5.1079-1084.1988; Stark A, 2002, J PEDIATR ENDOCR MET, V15, P561; Steinshamn H, 2008, J DAIRY SCI, V91, P2715, DOI 10.3168/jds.2007-0857; Tajima K, 2001, APPL ENVIRON MICROB, V67, P2766, DOI 10.1128/AEM.67.6.2766-2774.2001; Trinacty J, 2009, ARCH ANIM NUTR, V63, P219, DOI 10.1080/17450390902859739; Tsangalis D, 2002, J FOOD SCI, V67, P3104, DOI 10.1111/j.1365-2621.2002.tb08866.x; Turner R, 2004, FREE RADICAL RES, V38, P209, DOI 10.1080/10715760310001641854; Vanhoutte T, 2004, FEMS MICROBIOL ECOL, V48, P437, DOI 10.1016/j.femsec.2004.03.001; VANSOEST PJ, 1991, J DAIRY SCI, V74, P3583, DOI 10.3168/jds.S0022-0302(91)78551-2; Vetrovsky T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057923; Wang XL, 2005, J BIOTECHNOL, V115, P261, DOI 10.1016/j.jbiotec.2004.08.014; Wang XL, 2005, APPL ENVIRON MICROB, V71, P214, DOI 10.1128/AEM.71.1.214-219.2005; Welkie DG, 2010, ANAEROBE, V16, P94, DOI 10.1016/j.anaerobe.2009.07.002; William H., 1984, OFF METH AN, P1141; Woclawek-Potocka I, 2013, INT J ENDOCRINOL, V2013, DOI 10.1155/2013/650984; Yang G, 1998, J NANJING AGR U, P82; Yao Wen, 2004, Scientia Agricultura Sinica, V37, P1374; Zhao H, 2011, APPL MICROBIOL BIOT, V92, P803, DOI 10.1007/s00253-011-3278-3	71	34	36	2	59	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 28	2016	11	4							e0154642	10.1371/journal.pone.0154642	http://dx.doi.org/10.1371/journal.pone.0154642			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DK8XE	27124615	Green Published, gold, Green Submitted			2022-12-26	WOS:000375211700120
J	Xiao, Y; Lu, Y; Hsieh, M; Liao, J; Wong, PK				Xiao, Yuan; Lu, Yi; Hsieh, Michael; Liao, Joseph; Wong, Pak Kin			A Microfiltration Device for Urogenital Schistosomiasis Diagnostics	PLOS ONE			English	Article							INFECTION; HAEMATOBIUM; MANSONI; BIOSENSORS	Schistosomiasis is a parasitic disease affecting over 200 million people worldwide. This study reports the design and development of a microfiltration device for isolating schistosome eggs in urine for rapid diagnostics of urogenital schistosomiasis. The design of the device comprises a linear array of microfluidic traps to immobilize and separate schistosome eggs. Sequential loading of individual eggs is achieved autonomously by flow resistance, which facilitates observation and enumeration of samples with low-abundance targets. Computational fluid dynamics modeling and experimental characterization are performed to optimize the trapping performance. By optimizing the capture strategy, the trapping efficiency could be achieved at 100% with 300 mu l/min and 83% with 3000 mu l/min, and the filtration procedure could be finished within 10 min. The trapped eggs can be either recovered for downstream analysis or preserved in situ for whole-mount staining. On-chip phenotyping using confocal laser fluorescence microscopy identifies the microstructure of the trapped schistosome eggs. The device provides a novel microfluidic approach for trapping, counting and on-chip fluorescence characterization of urinal Schistosoma haematobium eggs for clinical and investigative application.	[Xiao, Yuan; Lu, Yi; Wong, Pak Kin] Penn State Univ, Dept Biomed Engn, University Pk, PA 16802 USA; [Xiao, Yuan; Lu, Yi; Wong, Pak Kin] Univ Arizona, Dept Aerosp & Mech Engn, Tucson, AZ 85721 USA; [Hsieh, Michael] Stanford Univ, Sch Med, Dept Urol, Stanford, CA 94305 USA; [Liao, Joseph] Vet Affairs Palo Alto Hlth Care Syst, Palo Alto, CA USA; [Liao, Joseph; Wong, Pak Kin] Penn State Univ, Dept Mech & Nucl Engn, University Pk, PA 16802 USA; [Liao, Joseph; Wong, Pak Kin] Penn State Univ, Dept Surg, University Pk, PA 16802 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; University of Arizona; Stanford University; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Palo Alto Health Care System; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park	Wong, PK (corresponding author), Penn State Univ, Dept Biomed Engn, University Pk, PA 16802 USA.; Wong, PK (corresponding author), Univ Arizona, Dept Aerosp & Mech Engn, Tucson, AZ 85721 USA.; Wong, PK (corresponding author), Penn State Univ, Dept Mech & Nucl Engn, University Pk, PA 16802 USA.; Wong, PK (corresponding author), Penn State Univ, Dept Surg, University Pk, PA 16802 USA.	pak@engr.psu.edu	Wong, Pak Kin/A-7974-2012	Wong, Pak Kin/0000-0001-7388-2110; Liao, Joseph/0000-0003-2448-5463	National Institutes of Health, Health Director's New Innovator Award [DP2OD007161]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K08DK087895] Funding Source: NIH RePORTER	National Institutes of Health, Health Director's New Innovator Award; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work is supported by National Institutes of Health, Health Director's New Innovator Award (DP2OD007161).	Breslauer DN, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006320; CANCADO JR, 1965, B WORLD HEALTH ORGAN, V33, P557; Chiu ML, 2010, JALA-J LAB AUTOM, V15, P233, DOI 10.1016/j.jala.2010.02.001; Colley DG, 2014, LANCET, V383, P2253, DOI 10.1016/S0140-6736(13)61949-2; Crane MM, 2010, LAB CHIP, V10, P1509, DOI 10.1039/b927258e; Gryseels B, 2006, LANCET, V368, P1106, DOI 10.1016/S0140-6736(06)69440-3; Jurberg AD, 2009, DEV GENES EVOL, V219, P219, DOI 10.1007/s00427-009-0285-9; Kadlec MW, 2014, JALA-J LAB AUTOM, V19, P258, DOI 10.1177/2211068213491095; Khoshmanesh K, 2012, BIOMICROFLUIDICS, V6, DOI 10.1063/1.3699971; Levario TJ, 2013, NAT PROTOC, V8, P721, DOI 10.1038/nprot.2013.034; Liu TT, 2014, ANN BIOMED ENG, V42, P2314, DOI 10.1007/s10439-014-1040-6; Liu TT, 2014, NANOMED-NANOTECHNOL, V10, P159, DOI 10.1016/j.nano.2013.07.006; Mach KE, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003845; Mach KE, 2011, TRENDS PHARMACOL SCI, V32, P330, DOI 10.1016/j.tips.2011.03.001; Rane TD, 2015, LAB CHIP, V15, P776, DOI 10.1039/c4lc01158a; Riahi R, 2014, ACS NANO, V8, P3597, DOI 10.1021/nn500107g; SAVIOLI L, 1990, AM J TROP MED HYG, V43, P289, DOI 10.4269/ajtmh.1990.43.289; Stete K, 2012, PARASITE VECTOR, V5, DOI 10.1186/1756-3305-5-298; Taguchi T, 2007, BIOTECHNOL BIOENG, V96, P272, DOI 10.1002/bit.21104; ten Hove RJ, 2008, T ROY SOC TROP MED H, V102, P179, DOI 10.1016/j.trstmh.2007.10.011; Vashist SK, 2015, TRENDS BIOTECHNOL, V33, P692, DOI 10.1016/j.tibtech.2015.09.001; World Health Organization, 2002, WHO TRADITIONAL MED, P1	22	5	5	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 28	2016	11	4							e0154640	10.1371/journal.pone.0154640	http://dx.doi.org/10.1371/journal.pone.0154640			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DK8XE	27124499	Green Published, gold, Green Submitted			2022-12-26	WOS:000375211700119
J	Bajaj, S; Alam, SK; Roy, KS; Datta, A; Nath, S; Roychoudhury, S				Bajaj, Swati; Alam, Sk. Kayum; Roy, Kumar Singha; Datta, Arindam; Nath, Somsubhra; Roychoudhury, Susanta			E2 Ubiquitin-conjugating Enzyme, UBE2C Gene, Is Reciprocally Regulated by Wild-type and Gain-of-Function Mutant p53	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						E2F transcription factor; mitosis; mitotic spindle; p53; ubiquitin-conjugating enzyme (E2 enzyme)	SPINDLE ASSEMBLY CHECKPOINT; CELL-CYCLE GENES; SUPPRESSOR PROTEIN P53; TRANSCRIPTIONAL REPRESSION; DNA-DAMAGE; PROMOTER ELEMENTS; CANCER; EXPRESSION; UBCH10; COMPLEX	Spindle assembly checkpoint governs proper chromosomal segregation during mitosis to ensure genomic stability. At the cellular level, this event is tightly regulated by UBE2C, an E2 ubiquitin-conjugating enzyme that donates ubiquitin to the anaphase-promoting complex/cyclosome. This, in turn, facilitates anaphase-onset by ubiquitin-mediated degradation of mitotic substrates. UBE2C is an important marker of chromosomal instability and has been associated with malignant growth. However, the mechanism of its regulation is largely unexplored. In this study, we report that UBE2C is transcriptionally activated by the gain-of-function (GOF) mutant p53, although it is transcriptionally repressed by wild-type p53. We showed that wild-type p53-mediated inhibition of UBE2C is p21-E2F4-dependent and GOF mutant p53-mediated transactivation of UBE2C is NF-Y-dependent. We further explored that DNA damage-induced wild-type p53 leads to spindle assembly checkpoint arrest by repressing UBE2C, whereas mutant p53 causes premature anaphase exit by increasing UBE2C expression in the presence of 5-fluorouracil. Identification of UBE2C as a target of wild-type and GOF mutant p53 further highlights the contribution of p53 in regulation of spindle assembly checkpoint.	[Bajaj, Swati; Alam, Sk. Kayum; Roy, Kumar Singha; Datta, Arindam; Nath, Somsubhra; Roychoudhury, Susanta] CSIR Indian Inst Chem Biol, Canc Biol & Inflammatory Disorder Div, 4 Raja SC Mullick Rd, Kolkata 700032, India; [Bajaj, Swati] Univ Hlth Network, Princess Margaret Canc Ctr, Dept Pathol, Adv Mol Diagnost Lab, Toronto, ON M5G 2M9, Canada; [Nath, Somsubhra] Saroj Gupta Canc Ctr & Res Inst, Mol Biol Res & Diagnost Lab, Mahatma Gandhi Rd, Kolkata 700063, India	Council of Scientific & Industrial Research (CSIR) - India; CSIR - Indian Institute of Chemical Biology (IICB); University of Toronto; University Toronto Affiliates; University Health Network Toronto; Princess Margaret Cancer Centre	Roychoudhury, S (corresponding author), CSIR Indian Inst Chem Biol, Canc Biol & Inflammatory Disorder Div, 4 Raja SC Mullick Rd, Kolkata 700032, India.	susantarc@gmail.com	Nath, Somsubhra/AAL-6377-2020; Datta, Arindam/ADR-8763-2022; ALAM, SK KAYUM/ABA-3659-2020; Roychoudhury, Susanta/AAD-7946-2021	Datta, Arindam/0000-0002-0617-9908; ALAM, SK KAYUM/0000-0001-5342-4542; Nath, Somsubhra/0000-0001-8214-1218	Department of Biotechnology [BT/PR/5524/Med/14/649/2004, BT/01/COE/05/04]; Council of Scientific and Industrial Research [IAP-001]; CSIR-Mayo Clinic Collaboration for Innovation and Translational Research Grant [CMPP-08]; Council of Scientific and Industrial Research (New Delhi, India); University Grants Commission (New Delhi, India)	Department of Biotechnology; Council of Scientific and Industrial Research(Council of Scientific & Industrial Research (CSIR) - India); CSIR-Mayo Clinic Collaboration for Innovation and Translational Research Grant; Council of Scientific and Industrial Research (New Delhi, India)(Council of Scientific & Industrial Research (CSIR) - India); University Grants Commission (New Delhi, India)(University Grants Commission, India)	This work was supported in part by Department of Biotechnology Grants BT/PR/5524/Med/14/649/2004 and BT/01/COE/05/04, Council of Scientific and Industrial Research Grant IAP-001, and CSIR-Mayo Clinic Collaboration for Innovation and Translational Research Grant CMPP-08 (to S.R.). The authors declare that they have no conflicts of interest with the contents of this article.; Recipients of predoctoral fellowships from Council of Scientific and Industrial Research (New Delhi, India).; Supported by a predoctoral fellowship from University Grants Commission (New Delhi, India).	Aas T, 1996, NAT MED, V2, P811, DOI 10.1038/nm0796-811; Alam SK, 2016, CELL DEATH DIFFER, V23, P707, DOI 10.1038/cdd.2015.133; Arvand A, 1998, ONCOGENE, V17, P2039, DOI 10.1038/sj.onc.1202129; Banerjee T, 2009, NUCLEIC ACIDS RES, V37, P2688, DOI 10.1093/nar/gkp110; Berlingieri MT, 2007, ONCOGENE, V26, P2136, DOI 10.1038/sj.onc.1210010; Blandino G, 1999, ONCOGENE, V18, P477, DOI 10.1038/sj.onc.1202314; Bunz F, 1998, SCIENCE, V282, P1497, DOI 10.1126/science.282.5393.1497; Carter SL, 2006, NAT GENET, V38, P1043, DOI 10.1038/ng1861; Chae HD, 2004, ONCOGENE, V23, P4084, DOI 10.1038/sj.onc.1207482; Chen HZ, 2009, NAT REV CANCER, V9, P785, DOI 10.1038/nrc2696; Chun ACS, 2003, J BIOL CHEM, V278, P37439, DOI 10.1074/jbc.M307185200; Ciliberto A, 2009, EMBO J, V28, P2162, DOI 10.1038/emboj.2009.186; Collins K, 1997, P NATL ACAD SCI USA, V94, P2776, DOI 10.1073/pnas.94.7.2776; Di Agostino S, 2006, CANCER CELL, V10, P191, DOI 10.1016/j.ccr.2006.08.013; Dohna CLZ, 2000, FEBS LETT, V484, P77, DOI 10.1016/S0014-5793(00)02133-5; Fajas L, 2000, FEBS LETT, V471, P29, DOI 10.1016/S0014-5793(00)01363-6; Fujita T, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-87; Haugwitz U, 2002, NUCLEIC ACIDS RES, V30, P1967, DOI 10.1093/nar/30.9.1967; Ho JSL, 2005, MOL CELL BIOL, V25, P7423, DOI 10.1128/MCB.25.17.7423-7431.2005; Hoffman WH, 2002, J BIOL CHEM, V277, P3247, DOI 10.1074/jbc.M106643200; Imbriano C, 2005, MOL CELL BIOL, V25, P3737, DOI 10.1128/MCB.25.9.3737-3751.2005; Incassati A, 2006, ONCOGENE, V25, P2444, DOI 10.1038/sj.onc.1209276; Kannan K, 2001, ONCOGENE, V20, P2225, DOI 10.1038/sj.onc.1204319; Krause K, 2001, BIOCHEM BIOPH RES CO, V284, P743, DOI 10.1006/bbrc.2001.5040; Krause K, 2000, NUCLEIC ACIDS RES, V28, P4410, DOI 10.1093/nar/28.22.4410; Levine AJ, 2009, NAT REV CANCER, V9, P749, DOI 10.1038/nrc2723; Lohr K, 2003, J BIOL CHEM, V278, P32507, DOI 10.1074/jbc.M212517200; Mannefeld M, 2009, CANCER RES, V69, P4073, DOI 10.1158/0008-5472.CAN-08-4156; Mantovani R, 1998, NUCLEIC ACIDS RES, V26, P1135, DOI 10.1093/nar/26.5.1135; Mondal G, 2007, CARCINOGENESIS, V28, P81, DOI 10.1093/carcin/bgl100; Muller GA, 2010, FEBS J, V277, P877, DOI 10.1111/j.1742-4658.2009.07508.x; Nath S, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M110.160671; Nevins JR, 2001, HUM MOL GENET, V10, P699, DOI 10.1093/hmg/10.7.699; Okamoto Y, 2003, CANCER RES, V63, P4167; Pallante P, 2005, BRIT J CANCER, V93, P464, DOI 10.1038/sj.bjc.6602721; Polager S, 2009, NAT REV CANCER, V9, P738, DOI 10.1038/nrc2718; Quaas M, 2012, CELL CYCLE, V11, P4661, DOI 10.4161/cc.22917; Reddy SK, 2007, NATURE, V446, P921, DOI 10.1038/nature05734; Rhodes DR, 2004, NEOPLASIA, V6, P1, DOI 10.1016/S1476-5586(04)80047-2; RIEDER CL, 1994, J CELL BIOL, V127, P1301, DOI 10.1083/jcb.127.5.1301; Rudner AD, 1996, CURR OPIN CELL BIOL, V8, P773, DOI 10.1016/S0955-0674(96)80077-9; Salvatore G, 2007, CANCER RES, V67, P10148, DOI 10.1158/0008-5472.CAN-07-1887; Spurgers KB, 2006, J BIOL CHEM, V281, P25134, DOI 10.1074/jbc.M513901200; Stegmeier F, 2007, NATURE, V446, P876, DOI 10.1038/nature05694; Tabach Y, 2005, MOL SYST BIOL, V1, DOI 10.1038/msb4100030; Taylor WR, 2001, J BIOL CHEM, V276, P1998, DOI 10.1074/jbc.M005101200; Vogel C, 2004, ONCOGENE, V23, P6845, DOI 10.1038/sj.onc.1207860; Vousden KH, 2007, NAT REV MOL CELL BIO, V8, P275, DOI 10.1038/nrm2147; Vousden KH, 2009, CELL, V137, P413, DOI 10.1016/j.cell.2009.04.037; Weisz L, 2007, ONCOGENE, V26, P2202, DOI 10.1038/sj.onc.1210294; Yu HT, 1996, CURR BIOL, V6, P455, DOI 10.1016/S0960-9822(02)00513-4; Zwicker J, 1997, NUCLEIC ACIDS RES, V25, P4926, DOI 10.1093/nar/25.24.4926	52	18	18	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 1	2016	291	27					14231	14247		10.1074/jbc.M116.731398	http://dx.doi.org/10.1074/jbc.M116.731398			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DR5XG	27129209	hybrid, Green Published			2022-12-26	WOS:000379975100028
J	Jadhav, S; Ajay, AK; Trivedi, P; Seematti, J; Pellegrini, K; Craciun, F; Vaidya, VS				Jadhav, Shreyas; Ajay, Amrendra K.; Trivedi, Priyanka; Seematti, Jenifer; Pellegrini, Kathryn; Craciun, Florin; Vaidya, Vishal S.			RNA-binding Protein Musashi Homologue 1 Regulates Kidney Fibrosis by Translational Inhibition of p21 and Numb mRNA	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						apoptosis; cell cycle; fatty acid; fibrosis; kidney; RNA binding protein	CELL-CYCLE ARREST; TRANSITION; INJURY; NOTCH; EXPRESSION; PATHWAY; SCREEN; MICE	RNA-binding proteins (RBPs) are recognized as key posttranscriptional regulators that not only modulate the spatiotemporal expression of genes during organism development but also regulate disease pathogenesis. Very limited information exists on the potential role of RBPs in modulating kidney fibrosis, which is a major hallmark of chronic kidney disease. Here, we report a novel mechanism in kidney fibrosis involving a RBP, Musashi homologue 1 (Msi1), which is expressed in tubular epithelial cells. Using two mechanistically distinct mouse models of kidney fibrosis, we show that Msi1 protein levels are significantly down-regulated in the kidneys following fibrosis. We found that Msi1 functions by negatively regulating the translation of its target mRNAs, p21 and Numb, whose protein levels are markedly increased in kidney fibrosis. Also, Msi1 overexpression and knockdown in kidney epithelial cells cause p21- and Numb-mediated cell cycle arrest. Furthermore, we observed that Numb looses its characteristic membrane localization in fibrotic kidneys and therefore is likely unable to inhibit Notch resulting in tubular cell death. Oleic acid is a known inhibitor of Msi1 and injecting oleic acid followed by unilateral ureteral obstruction surgery in mice resulted in enhanced fibrosis compared with the control group, indicating that inhibiting Msi1 activity renders the mice more susceptible to fibrosis. Given that deregulated fatty acid metabolism plays a key role in kidney fibrosis, these results demonstrate a novel connection between fatty acid and Msi1, an RNA-binding protein, in kidney fibrosis.	[Jadhav, Shreyas; Ajay, Amrendra K.; Trivedi, Priyanka; Seematti, Jenifer; Pellegrini, Kathryn; Craciun, Florin; Vaidya, Vishal S.] Brigham & Womens Hosp, Dept Med, Div Renal, Boston, MA 02115 USA; [Vaidya, Vishal S.] Harvard Med Sch, Harvard Program Therapeut Sci, Boston, MA 02115 USA; [Vaidya, Vishal S.] Harvard TH Chan Sch Publ Hlth, Dept Environm Hlth, Boston, MA 02115 USA	Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Harvard University; Harvard T.H. Chan School of Public Health	Vaidya, VS (corresponding author), Harvard Inst Med, Rm 562,77 Ave Louis Pasteur, Boston, MA 02115 USA.	vvaidya@bwh.harvard.edu	Ajay, Amrendra K/D-7431-2016	Ajay, Amrendra K/0000-0003-2790-5726; Pellegrini, Kathryn/0000-0002-5089-5477	National Institutes of Health NIEHS Outstanding New Environmental Sciences (ONES) Award [ES017543]; Innovation in Regulatory Science Award from Burroughs Wellcome Fund [BWF-1012518]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R56ES017543, R01ES017543] Funding Source: NIH RePORTER	National Institutes of Health NIEHS Outstanding New Environmental Sciences (ONES) Award; Innovation in Regulatory Science Award from Burroughs Wellcome Fund; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported by National Institutes of Health NIEHS Outstanding New Environmental Sciences (ONES) Award ES017543 (to V. S. V.) and Innovation in Regulatory Science Award from Burroughs Wellcome Fund Grant BWF-1012518 (to V. S. V.). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. The authors declare that they have no conflicts of interest with the contents of this article.	Abreu RD, 2009, J BIOL CHEM, V284, P12125, DOI 10.1074/jbc.M809605200; Adler M, 2016, J AM SOC NEPHROL, V27, P1015, DOI 10.1681/ASN.2015010060; Ajay AK, 2014, J AM SOC NEPHROL, V25, P105, DOI 10.1681/ASN.2013020161; Battelli C, 2006, MOL CELL NEUROSCI, V31, P85, DOI 10.1016/j.mcn.2005.09.003; Bielesz B, 2010, J CLIN INVEST, V120, P4040, DOI 10.1172/JCI43025; Bonventre JV, 2014, KIDNEY INT SUPPL, V4, P39, DOI 10.1038/kisup.2014.8; Busa R, 2007, ONCOGENE, V26, P4372, DOI 10.1038/sj.onc.1210224; Cartegni L, 2002, NAT GENET, V30, P377, DOI 10.1038/ng854; Cheng HT, 2003, DEVELOPMENT, V130, P5031, DOI 10.1242/dev.00697; Clingman CC, 2014, ELIFE, V3, DOI 10.7554/eLife.02848; Craciun F. L., 2015, J AM SOC NEPHROL; Craciun FL, 2014, AM J PHYSIOL-RENAL, V307, pF471, DOI 10.1152/ajprenal.00189.2014; Darnell RB, 2003, NEW ENGL J MED, V349, P1543, DOI 10.1056/NEJMra023009; DEBOULLE K, 1993, NAT GENET, V3, P31, DOI 10.1038/ng0193-31; Duffield JS, 2014, J CLIN INVEST, V124, P2299, DOI 10.1172/JCI72267; Glisovic T, 2008, FEBS LETT, V582, P1977, DOI 10.1016/j.febslet.2008.03.004; Heraud-Farlow JE, 2013, CELL REP, V5, P1511, DOI 10.1016/j.celrep.2013.11.039; Imai T, 2001, MOL CELL BIOL, V21, P3888, DOI 10.1128/MCB.21.12.3888-3900.2001; Jadhav S, 2008, DEVELOPMENT, V135, P1803, DOI 10.1242/dev.013656; Kang HM, 2015, NAT MED, V21, P37, DOI 10.1038/nm.3762; Kawahara H, 2008, J CELL BIOL, V181, P639, DOI 10.1083/jcb.200708004; Kramann R, 2013, J PATHOL, V231, P273, DOI 10.1002/path.4253; Lasko P, 2000, J CELL BIOL, V150, pF51, DOI 10.1083/jcb.150.2.F51; Lee Min-Ho, 2006, WormBook, P1; Lovisa S, 2015, NAT MED, V21, P998, DOI 10.1038/nm.3902; Martinez-Gimeno M, 2003, INVEST OPHTH VIS SCI, V44, P2171, DOI 10.1167/iovs.02-0871; Megyesi J, 2015, AM J PHYSIOL-RENAL, V308, pF122, DOI 10.1152/ajprenal.00489.2014; Minuesa G, 2014, COMB CHEM HIGH T SCR, V17, P596, DOI 10.2174/1386207317666140609122714; Nakagawa Naoki, 2013, Curr Pathobiol Rep, V1, DOI 10.1007/s40139-013-0025-8; NAKAMURA M, 1994, NEURON, V13, P67, DOI 10.1016/0896-6273(94)90460-X; Nikpour P, 2011, J CELL MOL MED, V15, P1210, DOI 10.1111/j.1582-4934.2010.01090.x; Riggi N, 2007, J PATHOL, V213, P4, DOI 10.1002/path.2209; Rockey DC, 2015, NEW ENGL J MED, V372, P1138, DOI 10.1056/NEJMra1300575; Saunders PTK, 2002, BIOL REPROD, V66, P500, DOI 10.1095/biolreprod66.2.500; Sirin Y, 2012, J PATHOL, V226, P394, DOI 10.1002/path.2967; Song Y, 2012, J BIOL CHEM, V287, P17716, DOI 10.1074/jbc.M112.360719; Takahashi T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053540; Grande MT, 2015, NAT MED, V21, P989, DOI 10.1038/nm.3901; Wang ZZ, 2009, EMBO J, V28, P2360, DOI 10.1038/emboj.2009.190; Yang L, 2010, NAT MED, V16, P535, DOI 10.1038/nm.2144; Zeisberg M, 2015, CLIN J AM SOC NEPHRO, V10, P1831, DOI 10.2215/CJN.00640114	41	21	21	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 1	2016	291	27					14085	14094		10.1074/jbc.M115.713289	http://dx.doi.org/10.1074/jbc.M115.713289			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DR5XG	27129280	hybrid, Green Published			2022-12-26	WOS:000379975100017
J	Tobias, IS; Newton, AC				Tobias, Irene S.; Newton, Alexandra C.			Protein Scaffolds Control Localized Protein Kinase C Activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						insulin; insulin receptor substrate 1 (IRS-1); p62 (sequestosome 1(SQSTM1)); protein kinase C (PKC); scaffold protein; MARK2; Par6; autoinhibition	INSULIN-RECEPTOR SUBSTRATE-1; STIMULATED GLUCOSE-TRANSPORT; ENCODED FLUORESCENT REPORTER; PKC-ZETA; CELL-POLARITY; PHOSPHATASE TYPE-1; ACTIVATION LOOP; IN-VIVO; PHOSPHORYLATION; APKC	Atypical protein kinase C (aPKC) isozymes modulate insulin signaling and cell polarity, but how their activity is controlled in cells is not well understood. These enzymes are constitutively phosphorylated, insensitive to second messengers, and have relatively low activity. Here we show that protein scaffolds not only localize but also differentially control the catalytic activity of the aPKC PKC, thus promoting activity toward localized substrates and restricting activity toward global substrates. Using cellular substrate readouts and scaffolded activity reporters in live cell imaging, we show that PKC has highly localized and differentially controlled activity on the scaffolds p62 and Par6. Both scaffolds tether aPKC in an active conformation as assessed through pharmacological inhibition of basal activity, monitored using a genetically encoded reporter for PKC activity. However, binding to Par6 is of higher affinity and is more effective in locking PKC in an active conformation. FRET-based translocation assays reveal that insulin promotes the association of both p62 and aPKC with the insulin-regulated scaffold IRS-1. Using the aPKC substrate MARK2 as another readout for activity, we show that overexpression of IRS-1 reduces the phosphorylation of MARK2 and enhances its plasma membrane localization, indicating sequestration of aPKC by IRS-1 away from MARK2. These results are consistent with scaffolds serving as allosteric activators of aPKCs, tethering them in an active conformation near specific substrates. Thus, signaling of these intrinsically low activity kinases is kept at a minimum in the absence of scaffolding interactions, which position the enzymes for stoichiometric phosphorylation of substrates co-localized on the same protein scaffold.	[Tobias, Irene S.; Newton, Alexandra C.] Univ Calif San Diego, Dept Pharmacol, La Jolla, CA 92093 USA; [Tobias, Irene S.] Univ Calif San Diego, Biomed Sci Grad Program, La Jolla, CA 92093 USA	University of California System; University of California San Diego; University of California System; University of California San Diego	Newton, AC (corresponding author), Univ Calif San Diego, Dept Pharmacol, La Jolla, CA 92093 USA.; Newton, AC (corresponding author), 9500 Gilman Dr, La Jolla, CA 92093 USA.	anewton@ucsd.edu			National Institutes of Health [P01DK054441]; University of California San Diego Graduate Training Program in Cellular and Molecular Pharmacology through National Institutes of Health Institutional Training Grant from NIGMS [T32 GM007752]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of California San Diego Graduate Training Program in Cellular and Molecular Pharmacology through National Institutes of Health Institutional Training Grant from NIGMS	This work was supported in part by National Institutes of Health Grants P01DK054441 (to A. C. N.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.; Supported in part by the University of California San Diego Graduate Training Program in Cellular and Molecular Pharmacology through National Institutes of Health Institutional Training Grant T32 GM007752 from the NIGMS.	Alessi DR, 1997, CURR BIOL, V7, P261, DOI 10.1016/S0960-9822(06)00122-9; Alessi DR, 1996, EMBO J, V15, P6541, DOI 10.1002/j.1460-2075.1996.tb01045.x; Allen PB, 1998, J BIOL CHEM, V273, P4089, DOI 10.1074/jbc.273.7.4089; Antal CE, 2014, CHEM BIOL, V21, P459, DOI 10.1016/j.chembiol.2014.02.008; Armstrong CG, 1997, FEBS LETT, V418, P210, DOI 10.1016/S0014-5793(97)01385-9; Bandyopadhyay G, 2000, ENDOCRINOLOGY, V141, P4120, DOI 10.1210/en.141.11.4120; Bandyopadhyay G, 1997, J BIOL CHEM, V272, P2551; Bandyopadhyay G, 1999, MOL ENDOCRINOL, V13, P1766, DOI 10.1210/me.13.10.1766; Bandyopadhyay G, 2002, J CLIN ENDOCR METAB, V87, P716, DOI 10.1210/jc.87.2.716; Betschinger J, 2003, NATURE, V422, P326, DOI 10.1038/nature01486; Christian F, 2014, BBA-MOL CELL RES, V1843, P2765, DOI 10.1016/j.bbamcr.2014.07.021; Cohen PTW, 2002, J CELL SCI, V115, P241; Copps KD, 2012, DIABETOLOGIA, V55, P2565, DOI 10.1007/s00125-012-2644-8; DUTIL EM, 1994, J BIOL CHEM, V269, P29359; Farese RV, 2007, J CLIN INVEST, V117, P2289, DOI 10.1172/JCI31408; Geetha T, 2012, J BIOL CHEM, V287, P29672, DOI 10.1074/jbc.M111.322404; Graybill C, 2012, J BIOL CHEM, V287, P21003, DOI 10.1074/jbc.M112.360495; HERBERT JM, 1990, BIOCHEM BIOPH RES CO, V172, P993, DOI 10.1016/0006-291X(90)91544-3; Hirai T, 2003, J BIOCHEM, V133, P1, DOI 10.1093/jb/mvg017; Hirano K, 1996, FEBS LETT, V389, P191, DOI 10.1016/0014-5793(96)00577-7; Hirose T, 2002, J CELL SCI, V115, P2485; Hoshi N, 2010, MOL CELL, V37, P541, DOI 10.1016/j.molcel.2010.01.014; HUBBARD MJ, 1993, TRENDS BIOCHEM SCI, V18, P172, DOI 10.1016/0968-0004(93)90109-Z; Hurov JB, 2004, CURR BIOL, V14, P736, DOI 10.1016/j.cub.2004.04.007; Hurov J, 2007, CELL CYCLE, V6, P1966, DOI 10.4161/cc.6.16.4576; Hurov JB, 2007, P NATL ACAD SCI USA, V104, P5680, DOI 10.1073/pnas.0701179104; Joberty G, 2000, NAT CELL BIOL, V2, P531, DOI 10.1038/35019573; Johnson JE, 1997, J BIOL CHEM, V272, P30787, DOI 10.1074/jbc.272.49.30787; KAZANIETZ MG, 1994, J BIOL CHEM, V269, P11590; Komatsu M, 2012, PHARMACOL RES, V66, P457, DOI 10.1016/j.phrs.2012.07.004; Kotani K, 1998, MOL CELL BIOL, V18, P6971, DOI 10.1128/MCB.18.12.6971; Kunkel MT, 2005, J BIOL CHEM, V280, P5581, DOI 10.1074/jbc.M411534200; Kusne Y, 2014, SCI SIGNAL, V7, DOI 10.1126/scisignal.2005196; Langeberg LK, 2015, NAT REV MOL CELL BIO, V16, P232, DOI 10.1038/nrm3966; Lee S, 2008, ENDOCRINOLOGY, V149, P2451, DOI 10.1210/en.2007-1595; Lin D, 2000, NAT CELL BIOL, V2, P540, DOI 10.1038/35019582; Ling DSF, 2002, NAT NEUROSCI, V5, P295, DOI 10.1038/nn829; Macara IG, 2004, NAT REV MOL CELL BIO, V5, P220, DOI 10.1038/nrm1332; Moeschel K, 2004, J BIOL CHEM, V279, P25157, DOI 10.1074/jbc.M402477200; Moscat J, 2009, CELL, V137, P1001, DOI 10.1016/j.cell.2009.05.023; Nagai-Tamai Y, 2002, GENES CELLS, V7, P1161, DOI 10.1046/j.1365-2443.2002.00590.x; Newton AC, 2001, CHEM REV, V101, P2353, DOI 10.1021/cr0002801; Newton AC, 2010, AM J PHYSIOL-ENDOC M, V298, pE395, DOI 10.1152/ajpendo.00477.2009; Okada K, 2009, HEPATOL RES, V39, P490, DOI 10.1111/j.1872-034X.2008.00478.x; Parker PJ, 2004, J CELL SCI, V117, P131, DOI 10.1242/jcs.00982; Plant PJ, 2003, NAT CELL BIOL, V5, P301, DOI 10.1038/ncb948; Pu YM, 2006, J BIOL CHEM, V281, P33773, DOI 10.1074/jbc.M606560200; Puls A, 1997, P NATL ACAD SCI USA, V94, P6191, DOI 10.1073/pnas.94.12.6191; Ravichandran LV, 2001, J BIOL CHEM, V276, P3543, DOI 10.1074/jbc.M007231200; Rodriguez A, 2006, CELL METAB, V3, P211, DOI 10.1016/j.cmet.2006.01.011; Sajan MP, 2006, J BIOL CHEM, V281, P17466, DOI 10.1074/jbc.M510803200; Schillace RV, 1999, CURR BIOL, V9, P321, DOI 10.1016/S0960-9822(99)80141-9; Scott JD, 2012, BMC BIOL, V10, DOI 10.1186/1741-7007-10-61; Sommerfeld MR, 2004, BIOCHEMISTRY-US, V43, P5888, DOI 10.1021/bi049640v; Standaert ML, 2001, BIOCHEMISTRY-US, V40, P249, DOI 10.1021/bi0018234; Sumimoto Hideki, 2007, Sci STKE, V2007, pre6, DOI 10.1126/stke.4012007re6; Suzuki A, 2004, CURR BIOL, V14, P1425, DOI 10.1016/j.cub.2004.08.021; Tobias IS, 2016, BIOCHEM J, V473, P509, DOI 10.1042/BJ20151013; Trujillo JI, 2009, BIOORG MED CHEM LETT, V19, P908, DOI 10.1016/j.bmcl.2008.11.105; Tsai LCL, 2015, J BIOL CHEM, V290, P21845, DOI 10.1074/jbc.M115.676221; Violin JD, 2003, J CELL BIOL, V161, P899, DOI 10.1083/jcb.200302125; Wu J, 1996, BIOCHEMISTRY-US, V35, P13858, DOI 10.1021/bi961669e; Wu-Zhang AX, 2013, BIOCHEM J, V452, P195, DOI 10.1042/BJ20130220; Wu-Zhang AX, 2012, J BIOL CHEM, V287, DOI 10.1074/jbc.M112.412635; Wu-Zhang AX, 2012, J BIOL CHEM, V287, P12879, DOI 10.1074/jbc.M112.357244; Xi G, 2016, J BONE MINER RES, V31, P1300, DOI 10.1002/jbmr.2791; Xi G, 2015, FASEB J, V29, P4772, DOI 10.1096/fj.15-275453; Yamanaka T, 2003, CURR BIOL, V13, P734, DOI 10.1016/S0960-9822(03)00244-6	68	24	26	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 24	2016	291	26					13809	13822		10.1074/jbc.M116.729483	http://dx.doi.org/10.1074/jbc.M116.729483			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DR2YZ	27143478	Green Published, hybrid			2022-12-26	WOS:000379771100035
J	Fancy, RM; Wang, LY; Zeng, QH; Wang, H; Zhou, T; Buchsbaum, DJ; Song, YH				Fancy, Romone M.; Wang, Lingyun; Zeng, Qinghua; Wang, Hong; Zhou, Tong; Buchsbaum, Donald J.; Song, Yuhua			Characterization of the Interactions between Calmodulin and Death Receptor 5 in Triple-negative and Estrogen Receptor-positive Breast Cancer Cells AN INTEGRATED EXPERIMENTAL AND COMPUTATIONAL STUDY	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							APOPTOSIS-INDUCING LIGAND; FADD-DEPENDENT APOPTOSIS; NF-KAPPA-B; TAMOXIFEN RESISTANCE; TUMORICIDAL ACTIVITY; MONOCLONAL-ANTIBODY; MOLECULAR-DYNAMICS; SIGNALING COMPLEX; EF-HANDS; PROTEIN	Activation of death receptor-5 (DR5) leads to the formation of death inducing signaling complex (DISC) for apoptotic signaling. Targeting DR5 to induce breast cancer apoptosis is a promising strategy to circumvent drug resistance and present a target for breast cancer treatment. Calmodulin (CaM) has been shown to regulate DR5-mediated apoptotic signaling, however, its mechanism remains unknown. In this study, we characterized CaM and DR5 interactions in breast cancer cells with integrated experimental and computational approaches. Results show that CaM directly binds to DR5 in a calcium dependent manner in breast cancer cells. The direct interaction of CaM with DR5 is localized at DR5 death domain. We have predicted and verified the CaM-binding site in DR5 being (354)WEPLMRKLGL(363) that is located at the alpha 2 helix and the loop between alpha 2 helix and alpha 3 helix of DR5 DD. The residues of Trp-354, Arg-359, Glu-355, Leu-363, and Glu-367 in DR5 death domain that are important for DR5 recruitment of FADD and caspase-8 for DISC formation to signal apoptosis also play an important role for CaM-DR5 binding. The changed electrostatic potential distribution in the CaM-binding site in DR5 DD by the point mutations of W354A, E355K, R359A, L363N, or E367K in DR5 DD could directly contribute to the experimentally observed decreased CaM-DR5 binding by the point mutations of the key residues in DR5 DD. Results from this study provide a key step for the further investigation of the role of CaM-DR5 binding in DR5-mediated DISC formation for apoptosis in breast cancer cells.	[Fancy, Romone M.; Wang, Lingyun; Zeng, Qinghua; Song, Yuhua] Univ Alabama Birmingham, Dept Biomed Engn, 803 Shelby Interdisciplinary Biomed Res Bldg, Birmingham, AL 35294 USA; [Wang, Hong; Zhou, Tong] Univ Alabama Birmingham, Dept Med, Birmingham, AL 35294 USA; [Buchsbaum, Donald J.] Univ Alabama Birmingham, Dept Radiat Oncol, Birmingham, AL 35294 USA	University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham	Song, YH (corresponding author), Univ Alabama Birmingham, Dept Biomed Engn, 803 Shelby Interdisciplinary Biomed Res Bldg, Birmingham, AL 35294 USA.	yhsong@uab.edu		Buchsbaum, Donald/0000-0003-2797-5847	National Institutes of Health [5K25 CA140791]; Comprehensive Minority Faculty and Student Development Program fellowship from the University of Alabama VP Office for Equity and Diversity; NATIONAL CANCER INSTITUTE [K25CA140791] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Comprehensive Minority Faculty and Student Development Program fellowship from the University of Alabama VP Office for Equity and Diversity; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported in part by an National Institutes of Health K25 award (5K25 CA140791) (to Y. S.). The authors declare that they have no conflicts of interest with the contents of this article except that Dr. Tong Zhou and Dr. Donald J. Buchsbaum have intellectual property right in TRA-8. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.r Supported by Comprehensive Minority Faculty and Student Development Program fellowship from the University of Alabama VP Office for Equity and Diversity.	Ahn EY, 2004, J BIOL CHEM, V279, P5661, DOI 10.1074/jbc.M311040200; Amm HM, 2011, MOL CANCER RES, V9, P403, DOI 10.1158/1541-7786.MCR-10-0133; Ashkenazi A, 1999, J CLIN INVEST, V104, P155, DOI 10.1172/JCI6926; BABU YS, 1985, NATURE, V315, P37, DOI 10.1038/315037a0; Baker NA, 2001, P NATL ACAD SCI USA, V98, P10037, DOI 10.1073/pnas.181342398; Bin L, 2007, J BIOL CHEM, V282, P28189, DOI 10.1074/jbc.M704210200; BLALOCK JE, 1995, NAT MED, V1, P876, DOI 10.1038/nm0995-876; Buchsbaum DJ, 2003, CLIN CANCER RES, V9, P3731; Chang JM, 2014, MOL BIOL EVOL, V31, P1625, DOI 10.1093/molbev/msu117; Chaudhary PM, 1997, IMMUNITY, V7, P821, DOI 10.1016/S1074-7613(00)80400-8; Chen YB, 2008, J CELL BIOCHEM, V103, P788, DOI 10.1002/jcb.21447; Chinnaiyan AM, 2000, P NATL ACAD SCI USA, V97, P1754, DOI 10.1073/pnas.030545097; Cohen P, 1988, CALMODULIN; COLOVOS C, 1993, PROTEIN SCI, V2, P1511, DOI 10.1002/pro.5560020916; Daniel PT, 2001, LEUKEMIA, V15, P1022, DOI 10.1038/sj.leu.2402169; DeSantis C, 2011, CA-CANCER J CLIN, V61, P409, DOI 10.3322/caac.20134; DILLON J, 1991, P NATL ACAD SCI USA, V88, P9726, DOI 10.1073/pnas.88.21.9726; Dong HP, 2008, CANCER-AM CANCER SOC, V112, P84, DOI 10.1002/cncr.23140; Eisenberg D, 1997, METHOD ENZYMOL, V277, P396, DOI 10.1016/S0076-6879(97)77022-8; Eldik L., 1998, CALMODULIN CALCIUM S; Eldik L. V., 1988, CALMODULIN SIGNAL TR; Fancy RM, 2014, BIOCHEMISTRY-US, V53, P2680, DOI 10.1021/bi500228h; Friedl J. E. F., 1997, MASTERING REGULAR EX; Ganoth A, 2006, BIOPHYS J, V91, P2436, DOI 10.1529/biophysj.106.085399; Goicoechea S, 2002, J BIOL CHEM, V277, P37219, DOI 10.1074/jbc.M202200200; Guarneri V, 2004, EUR J NUCL MED MOL I, V31, pS149, DOI 10.1007/s00259-004-1538-5; HAIT WN, 1986, J CLIN ONCOL, V4, P994, DOI 10.1200/JCO.1986.4.6.994; Houtman R, 2001, J IMMUNOL, V166, P861, DOI 10.4049/jimmunol.166.2.861; Huang BH, 1996, NATURE, V384, P638, DOI 10.1038/384638a0; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Hwang MK, 2009, BIOCHEM CELL BIOL, V87, P919, DOI [10.1139/O09-058, 10.1139/o09-058]; Hymowitz SG, 1999, MOL CELL, V4, P563, DOI 10.1016/S1097-2765(00)80207-5; Ichikawa K, 2001, NAT MED, V7, P954, DOI 10.1038/91000; Jacchieri SG, 2003, J BACTERIOL, V185, P4243, DOI 10.1128/JB.185.14.4243-4247.2003; Jo M, 2000, NAT MED, V6, P564, DOI 10.1038/75045; KISCHKEL FC, 1995, EMBO J, V14, P5579, DOI 10.1002/j.1460-2075.1995.tb00245.x; Kischkel FC, 2000, IMMUNITY, V12, P611, DOI 10.1016/S1074-7613(00)80212-5; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Lee SH, 1999, CANCER RES, V59, P5683; Maier C C, 1994, Immunomethods, V5, P107, DOI 10.1006/immu.1994.1044; Manion MK, 2000, BIOCHEM BIOPH RES CO, V277, P462, DOI 10.1006/bbrc.2000.3691; Marti-Renom MA, 2000, ANNU REV BIOPH BIOM, V29, P291, DOI 10.1146/annurev.biophys.29.1.291; McCarthy MM, 2005, CLIN CANCER RES, V11, P5188, DOI 10.1158/1078-0432.CCR-05-0158; McDonald ER, 2001, J BIOL CHEM, V276, P14939, DOI 10.1074/jbc.M100399200; MOSER MJ, 1995, J BIOL CHEM, V270, P20643, DOI 10.1074/jbc.270.35.20643; Oliver PG, 2012, BREAST CANCER RES TR, V133, P417, DOI 10.1007/s10549-011-1755-0; Osborne CK, 2003, J NATL CANCER I, V95, P353, DOI 10.1093/jnci/95.5.353; Ozoren N, 2003, SEMIN CANCER BIOL, V13, P135, DOI 10.1016/S1044-579X(02)00131-1; Park WS, 2001, GASTROENTEROLOGY, V121, P1219, DOI 10.1053/gast.2001.28663; Patterson RE, 2011, BREAST CANCER RES TR, V127, P541, DOI 10.1007/s10549-010-1236-x; Pitt RM, 1996, J BIOL CHEM, V271, P12687, DOI 10.1074/jbc.271.22.12687; Plasschaert SLA, 2004, LEUKEMIA LYMPHOMA, V45, P649, DOI 10.1080/10428190310001597928; Rhoads AR, 1997, FASEB J, V11, P331, DOI 10.1096/fasebj.11.5.9141499; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Schneider P, 1997, IMMUNITY, V7, P831, DOI 10.1016/S1074-7613(00)80401-X; Shin MS, 2001, CANCER RES, V61, P4942; Shou J, 2004, JNCI-J NATL CANCER I, V96, P926, DOI 10.1093/jnci/djh166; Siegel R, 2012, CA-CANCER J CLIN, V62, P10, DOI 10.3322/caac.20138; Sorlie T, 2009, J CLIN ONCOL, V27, P1153, DOI 10.1200/JCO.2008.20.6276; Sprick MR, 2000, IMMUNITY, V12, P599, DOI 10.1016/S1074-7613(00)80211-3; Suever JD, 2008, BIOPHYS J, V95, P5913, DOI 10.1529/biophysj.108.130542; Sukits SF, 2001, J MOL BIOL, V310, P895, DOI 10.1006/jmbi.2001.4790; Sun M, 2008, CELL DEATH DIFFER, V15, P1887, DOI 10.1038/cdd.2008.124; Villain M, 2000, J BIOL CHEM, V275, P2676, DOI 10.1074/jbc.275.4.2676; VRIEND G, 1990, J MOL GRAPHICS, V8, P52, DOI 10.1016/0263-7855(90)80070-V; Walczak H, 1999, NAT MED, V5, P157, DOI 10.1038/5517; Wang C, 2009, J BIOL CHEM, V284, P3804, DOI 10.1074/jbc.M807191200; WEI JW, 1982, CANCER RES, V42, P2571; Weigent D A, 1994, Immunomethods, V5, P91, DOI 10.1006/immu.1994.1042; Wiederstein M, 2007, NUCLEIC ACIDS RES, V35, pW407, DOI 10.1093/nar/gkm290; Wu XJ, 2005, J BIOL CHEM, V280, P29964, DOI 10.1074/jbc.M500710200	71	13	13	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 10	2016	291	24					12862	12870		10.1074/jbc.M116.727727	http://dx.doi.org/10.1074/jbc.M116.727727			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DO9PV	27129269	Green Published, hybrid			2022-12-26	WOS:000378119900036
J	Wei, DH; Li, NL; Zeng, YL; Liu, BM; Kumthip, K; Wang, TT; Huo, DZ; Ingels, JF; Lu, L; Shang, J; Li, K				Wei, Dahai; Li, Nan L.; Zeng, Yanli; Liu, Baoming; Kumthip, Kattareeya; Wang, Tony T.; Huo, Dezheng; Ingels, Jesse F.; Lu, Lu; Shang, Jia; Li, Kui			The Molecular Chaperone GRP78 Contributes to Toll-like Receptor 3-mediated Innate Immune Response to Hepatitis C Virus in Hepatocytes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							UNFOLDED PROTEIN RESPONSE; ENDOPLASMIC-RETICULUM STRESS; SIGNALING PATHWAY; GENETIC-VARIATION; HEPATOMA-CELLS; ER STRESS; INFECTION; ACTIVATION; IL28B; REPLICATION	Toll-like receptor-3 (TLR3) senses double-stranded RNA intermediates produced during hepatitis C virus (HCV) replication, leading to activation of interferon regulatory factor-3 (IRF3) and NF-kappa B and subsequent antiviral and proinflammatory responses. Yet, how this TLR3-dependent pathway operates in hepatocytes is unclear. Upon fractionating cultured hepatocytes into various cellular organelles, we observed that TLR3 predominantly resides in endolysosomes of hepatocytes. To determine the critical regulators of TLR3 signaling in response to HCV infection in human hepatocytes, we isolated endolysosome fractions from mock-infected and HCV-infected hepatoma Huh7.5 cells that had been reconstituted for TLR3 expression, separated these fractions on two-dimensional gels, and identified up-regulated/down-regulated proteins by mass spectrometry. Approximately a dozen of cellular proteins were found to be differentially expressed in endolysosome fractions following HCV infection. Of these, expression of several molecular chaperone proteins was elevated. Knock down of one of these chaperones, glucose-regulated protein 78 kDa (GRP78), compromised TLR3-dependent induction of interferon-stimulated genes and chemokines following HCV infection or poly(I: C) stimulation in cultured hepatocytes. Consistent with this finding, GRP78 depletion impaired TLR3-mediated establishment of an antiviral state. Mechanistically, although TLR3 trafficking to endolysosomes was not affected, phosphorylated IRF3 diminished faster following GRP78 knockdown. Remarkably, GRP78 transcript was significantly up-regulated in liver biopsies of chronic hepatitis C patients as compared with normal liver tissues. Moreover, the GRP78 expression level correlated with that of RANTES (regulated upon activation, normal T-cell expressed and secreted) and CXCL10, two inflammatory chemokines most frequently elevated in HCV-infected liver. Altogether, our data suggest that GRP78 contributes to TLR3-mediated, IRF3-dependent innate immune response to HCV in hepatocytes.	[Wei, Dahai; Li, Nan L.; Liu, Baoming; Kumthip, Kattareeya; Li, Kui] Univ Tennessee, Hlth Sci Ctr, Dept Microbiol Immunol & Biochem, 858 Madison Ave, Memphis, TN 38163 USA; [Ingels, Jesse F.; Lu, Lu] Univ Tennessee, Hlth Sci Ctr, Dept Genet Genom & Informat, Memphis, TN 38163 USA; [Zeng, Yanli; Shang, Jia] Henan Prov Peoples Hosp, Dept Infect Dis, Zhengzhou 450003, Henan, Peoples R China; [Wang, Tony T.] SRI Int, Harrisonburg, VA 22802 USA; [Huo, Dezheng] Univ Chicago, Dept Publ Hlth Sci, Chicago, IL 60637 USA	University of Tennessee System; University of Tennessee Health Science Center; University of Tennessee System; University of Tennessee Health Science Center; Zhengzhou University; SRI International; University of Chicago	Li, K (corresponding author), Univ Tennessee, Hlth Sci Ctr, Dept Microbiol Immunol & Biochem, 858 Madison Ave, Memphis, TN 38163 USA.	kli1@uthsc.edu		Kumthip, Kattareeya/0000-0001-7028-7607	National Institutes of Health [AI069285, DK088787]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R56AI069285, R01AI069285] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK088787, R56DK088787] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was support by National Institutes of Health Grants AI069285 ( to K. L.) and DK088787 ( to T. T. W.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Bigger CB, 2001, J VIROL, V75, P7059, DOI 10.1128/JVI.75.15.7059-7066.2001; Chan SW, 2014, FRONT MICROBIOL, V5, DOI 10.3389/fmicb.2014.00233; Chan SW, 2005, FASEB J, V19, P1510, DOI 10.1096/fj.04-3455fje; Chang CH, 2011, J BIOL CHEM, V286, P7043, DOI 10.1074/jbc.M110.164632; Chen LM, 2010, GASTROENTEROLOGY, V138, P1123, DOI 10.1053/j.gastro.2009.10.046; Ciccaglione AR, 2005, ARCH VIROL, V150, P1339, DOI 10.1007/s00705-004-0487-4; Cureton DK, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000394; Deng L, 2008, J VIROL, V82, P10375, DOI 10.1128/JVI.00395-08; Dixit E, 2010, CELL, V141, P668, DOI 10.1016/j.cell.2010.04.018; Garg AD, 2012, TRENDS MOL MED, V18, P589, DOI 10.1016/j.molmed.2012.06.010; Ge DL, 2009, NATURE, V461, P399, DOI 10.1038/nature08309; Hetz C, 2012, NAT REV MOL CELL BIO, V13, P89, DOI 10.1038/nrm3270; Horner SM, 2013, NAT MED, V19, P879, DOI 10.1038/nm.3253; Johnsen IB, 2006, EMBO J, V25, P3335, DOI 10.1038/sj.emboj.7601222; Joyce MA, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000291; Ke PY, 2011, J CLIN INVEST, V121, P37, DOI 10.1172/JCI41474; Keskinen P, 1999, VIROLOGY, V263, P364, DOI 10.1006/viro.1999.9983; Kim YM, 2008, NATURE, V452, P234, DOI 10.1038/nature06726; Lee SH, 2008, HEPATOLOGY, V47, P854, DOI 10.1002/hep.22107; Li K, 2005, J BIOL CHEM, V280, P16739, DOI 10.1074/jbc.M414139200; Li K, 2013, SEMIN IMMUNOPATHOL, V35, P53, DOI 10.1007/s00281-012-0332-x; Li K, 2012, HEPATOLOGY, V55, P666, DOI 10.1002/hep.24763; Li WC, 2010, METHODS MOL BIOL, V633, P185, DOI 10.1007/978-1-59745-019-5_13; Lin L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0114874; Lindenbach BD, 2005, SCIENCE, V309, P623, DOI 10.1126/science.1114016; Liu B, 2010, NAT COMMUN, V1, DOI 10.1038/ncomms1070; MACEJAK DG, 1990, ENZYME, V44, P310, DOI 10.1159/000468767; McGilvray I, 2012, GASTROENTEROLOGY, V142, P1122, DOI 10.1053/j.gastro.2012.01.028; McPherson S, 2011, J GASTROEN HEPATOL, V26, P319, DOI 10.1111/j.1440-1746.2010.06368.x; Ni M, 2011, BIOCHEM J, V434, P181, DOI 10.1042/BJ20101569; Park SH, 2014, IMMUNITY, V40, P13, DOI 10.1016/j.immuni.2013.12.010; Pfeffer LM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104202; Prokunina-Olsson L, 2013, NAT GENET, V45, P164, DOI 10.1038/ng.2521; Sekine-Osajima Y, 2008, VIROLOGY, V371, P71, DOI 10.1016/j.virol.2007.09.019; Shen Y, 2012, J BIOL CHEM, V287, P36404, DOI 10.1074/jbc.M112.397075; Sir D, 2008, HEPATOLOGY, V48, P1054, DOI 10.1002/hep.22464; Su AI, 2002, P NATL ACAD SCI USA, V99, P15669, DOI 10.1073/pnas.202608199; Suppiah V, 2009, NAT GENET, V41, P1100, DOI 10.1038/ng.447; Tanaka Y, 2009, NAT GENET, V41, P1105, DOI 10.1038/ng.449; Tardif KD, 2002, J VIROL, V76, P7453, DOI 10.1128/JVI.76.15.7453-7459.2002; Thomas DL, 2009, NATURE, V461, P798, DOI 10.1038/nature08463; Chau TL, 2015, J IMMUNOL, V194, P3970, DOI 10.4049/jimmunol.1401614; Tsutsumi S, 2006, ONCOGENE, V25, P1018, DOI 10.1038/sj.onc.1209139; Ueno T, 1999, J BIOL CHEM, V274, P15222, DOI 10.1074/jbc.274.21.15222; von dem Bussche A, 2010, J HEPATOL, V53, P797, DOI 10.1016/j.jhep.2010.05.022; Wakita T, 2005, NAT MED, V11, P791, DOI 10.1038/nm1268; Wang N, 2010, J BIOL CHEM, V285, P6080, DOI 10.1074/jbc.M109.054486; Wang N, 2009, J VIROL, V83, P9824, DOI 10.1128/JVI.01125-09; Yang K, 2006, MOL BIOL CELL, V17, P1461, DOI 10.1091/mbc.E05-09-0853; Zheng Y, 2005, J MICROBIOL, V43, P529	50	18	18	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 3	2016	291	23					12294	12309		10.1074/jbc.M115.711598	http://dx.doi.org/10.1074/jbc.M115.711598			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DO9GJ	27129228	Green Published, hybrid			2022-12-26	WOS:000378092800029
J	Dong, XW; Tian, HY; He, J; Wang, C; Qiu, R; Chen, YM				Dong, Xiao-wei; Tian, Hui-Yuan; He, Juan; Wang, Chen; Qiu, Rui; Chen, Yu-ming			Elevated Serum Uric Acid Is Associated with Greater Bone Mineral Density and Skeletal Muscle Mass in Middle-Aged and Older Adults	PLOS ONE			English	Article							INCIDENT OSTEOPOROTIC FRACTURES; X-RAY ABSORPTIOMETRY; GENERAL-POPULATION; OXIDATIVE STRESS; TRANSCRIPTION FACTORS; POSTMENOPAUSAL WOMEN; BODY-COMPOSITION; SARCOPENIA; RISK; PREVALENCE	Background and objective Previous studies have suggested a positive link between serum uric acid (UA) and bone mineral density (BMD). In this study, we re-examined the association between UA and BMD and further explored whether this was mediated by skeletal muscle mass in a general Chinese population. Method This community-based cross-sectional study was conducted among 3079 (963 men and 2116 women) Chinese adults aged 40-75 years. Face-to-face interviews and laboratory analyses were performed to determine serum UA and various covariates. Dual-energy Xray absorptiometry was used to assess the BMD and appendicular skeletal muscle mass. The skeletal muscle mass index (SMI = ASM/Height(2), kg/m(2)) for the total limbs, arms, and legs was then calculated. Results The serum UA was graded and, in general, was significantly and positively associated with the BMD and muscle mass, after adjustment for multiple covariates in the total sample. Compared with participants in lowest quartile of UA, those participants in highest quartile showed a 2.3%(whole body), 4.1%(lumbar spine), 2.4%(total hip), and 2.0% (femoral neck) greater BMDs. The mean SMIs in the highest (vs. lowest) quartile increased by 2.7% (total), 2.5% (arm), 2.7% (leg) respectively. In addition, path analysis suggested that the favorable association between UA and BMD might be mediated by increasing SMI. Conclusion The elevated serum UA was associated with a higher BMD and a greater muscle mass in a middle-aged and elderly Chinese population and the UA-BMD association was partly mediated by muscle mass.	[Dong, Xiao-wei; Tian, Hui-Yuan; He, Juan; Wang, Chen; Qiu, Rui; Chen, Yu-ming] Sun Yat Sen Univ, Sch Publ Hlth, Guangdong Prov Key Lab Food Nutr & Hlth, Guangzhou 510080, Guangdong, Peoples R China	Sun Yat Sen University	Chen, YM (corresponding author), Sun Yat Sen Univ, Sch Publ Hlth, Guangdong Prov Key Lab Food Nutr & Hlth, Guangzhou 510080, Guangdong, Peoples R China.	chenyum@mail.sysu.edu.cn	Chen, Yu/Y-3292-2019; Chen, Yi/HIR-2608-2022	chen, Yu-ming/0000-0003-1658-5528	National Natural Science Foundation of China [81273049, 81072299]; 5010 Program for Clinical Researches by the Sun Yat-sen University	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); 5010 Program for Clinical Researches by the Sun Yat-sen University	The study was jointly supported by the National Natural Science Foundation of China (No. 81273049, 81072299) and the 5010 Program for Clinical Researches by the Sun Yat-sen University.	Abraham A, 2014, J NEUROL, V261, P1133, DOI 10.1007/s00415-014-7331-x; Ahn SH, 2013, OSTEOPOROSIS INT, V24, P2961, DOI 10.1007/s00198-013-2377-7; Almeida M, 2013, J GERONTOL A-BIOL, V68, P1197, DOI 10.1093/gerona/glt079; Andreoli A, 2011, RADIOL MED, V116, P1115, DOI 10.1007/s11547-011-0689-2; [Anonymous], FACTS AND STAT, VInternational Osteoporosis Foundation; Avin KG, 2015, CURR OSTEOPOROS REP, V13, P1, DOI 10.1007/s11914-014-0244-x; Beaudart C, 2015, EXP GERONTOL, V61, P31, DOI 10.1016/j.exger.2014.11.014; Beavers KM, 2009, J NUTR HEALTH AGING, V13, P177, DOI 10.1007/s12603-009-0054-5; Beberashvili I, 2015, NUTRITION, V31, P138, DOI 10.1016/j.nut.2014.06.012; Binkley N, 2009, J CLIN DENSITOM, V12, P413, DOI 10.1016/j.jocd.2009.06.004; Bonewald LF, 2013, J BONE MINER RES, V28, P1857, DOI 10.1002/jbmr.1980; Cheng Q, 2012, MENOPAUSE, V19, P448, DOI 10.1097/gme.0b013e31823a40ba; Cianferotti L, 2014, ENDOCRINE, V45, P165, DOI 10.1007/s12020-013-0026-8; Cooper C, 2012, OSTEOPOROSIS INT, V23, P1839, DOI 10.1007/s00198-012-1913-1; Dawson J, 2006, BRIT J CLIN PHARMACO, V62, P633, DOI 10.1111/j.1365-2125.2006.02785.x; Deng MY, 2011, INT ORTHOP, V35, P1099, DOI 10.1007/s00264-010-1141-2; Feig DI, 2008, NEW ENGL J MED, V359, P1811, DOI 10.1056/NEJMra0800885; Feig DI, 2006, J AM SOC NEPHROL, V17, pS69, DOI 10.1681/ASN.2005121331; Genaro PS, 2010, ARCH GERONTOL GERIAT, V51, P295, DOI 10.1016/j.archger.2009.12.006; Glantzounis GK, 2005, CURR PHARM DESIGN, V11, P4145, DOI 10.2174/138161205774913255; Hida T, 2013, GERIATR GERONTOL INT, V13, P413, DOI 10.1111/j.1447-0594.2012.00918.x; Hill PA, 1997, ENDOCRINOLOGY, V138, P3849, DOI 10.1210/en.138.9.3849; Ishii S, 2014, OSTEOPOROSIS INT, V25, P1099, DOI 10.1007/s00198-013-2571-7; Jalal DI, 2013, AM J KIDNEY DIS, V61, P134, DOI 10.1053/j.ajkd.2012.07.021; Jaspers RT, 2014, CLIN REV BONE MINER, V12, P27, DOI 10.1007/s12018-014-9156-7; Karasik D, 2012, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.00303; Kim BJ, 2014, OSTEOPOROSIS INT, V25, P1837, DOI 10.1007/s00198-014-2697-2; Kim J, 2002, AM J CLIN NUTR, V76, P378, DOI 10.1093/ajcn/76.2.378; Kousteni Stavroula, 2011, Curr Osteoporos Rep, V9, P60, DOI 10.1007/s11914-011-0054-3; Lane NE, 2014, J BONE MINER RES, V29, P1701, DOI 10.1002/jbmr.2164; Lauretani F, 2008, J GERONTOL A-BIOL, V63, P376, DOI 10.1093/gerona/63.4.376; Lin XF, 2015, ONCOTARGET, V6, P35395, DOI 10.18632/oncotarget.6173; Liu YH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063339; Macchi C, 2008, MECH AGEING DEV, V129, P522, DOI 10.1016/j.mad.2008.04.008; Mainini G, 2012, CLIN EXP OBSTET GYN, V39, P489; Makovey J, 2013, BONE, V52, P400, DOI 10.1016/j.bone.2012.10.025; Manolagas SC, 2014, MATURITAS, V78, P233, DOI 10.1016/j.maturitas.2014.04.013; Mehta T, 2015, METABOLISM, V64, P438, DOI 10.1016/j.metabol.2014.11.006; Meng SJ, 2010, INT J MOL SCI, V11, P1509, DOI 10.3390/ijms11041509; Mlakar SJ, 2010, DIS MARKERS, V29, P71, DOI [10.1155/2010/354189, 10.3233/DMA-2010-0728]; Muka T, 2016, J CLIN ENDOCR METAB, V101, P1113, DOI 10.1210/jc.2015-2446; Nabipour I, 2011, J BONE MINER RES, V26, P955, DOI 10.1002/jbmr.286; Nader GA, 2005, INT J BIOCHEM CELL B, V37, P1985, DOI 10.1016/j.biocel.2005.02.026; Sahni S, 2009, OSTEOPOROSIS INT, V20, P1853, DOI 10.1007/s00198-009-0897-y; Sanchez AMJ, 2014, CELL MOL LIFE SCI, V71, P1657, DOI 10.1007/s00018-013-1513-z; Schoenau E., 2005, Journal of Musculoskeletal & Neuronal Interactions, V5, P232; Sendur OF, 2009, JOINT BONE SPINE, V76, P514, DOI 10.1016/j.jbspin.2009.02.005; Shen L, 2013, BMJ OPEN, V3, DOI 10.1136/bmjopen-2013-003620; Storz P, 2011, ANTIOXID REDOX SIGN, V14, P593, DOI 10.1089/ars.2010.3405; Taghizadeh N, 2014, CANCER CAUSE CONTROL, V25, P1075, DOI 10.1007/s10552-014-0408-0; Terkeltaub RA, 2003, NEW ENGL J MED, V349, P1647, DOI 10.1056/NEJMcp030733; Veronese N, 2015, BONE, V79, P183, DOI 10.1016/j.bone.2015.06.005; Visser M, 1999, J APPL PHYSIOL, V87, P1513, DOI 10.1152/jappl.1999.87.4.1513; Wu YL, 2013, GERIATR GERONTOL INT, V13, P672, DOI 10.1111/j.1447-0594.2012.00962.x; Zeng FF, 2014, J NUTR, V144, P1240, DOI 10.3945/jn.114.192286; Zhang DH, 2015, J BONE MINER RES, V30, P992, DOI 10.1002/jbmr.2430; Zhang S, 2013, CHIN J OSTEOPOROS, V19, P363; Zhang S, 2013, CHIN J OSTEOPOROS, V19, P44; Zhao G, 2000, ENDOCRINOLOGY, V141, P2674, DOI 10.1210/en.141.7.2674	59	37	43	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 4	2016	11	5							e0154692	10.1371/journal.pone.0154692	http://dx.doi.org/10.1371/journal.pone.0154692			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DL5KR	27144737	gold, Green Submitted, Green Published			2022-12-26	WOS:000375676400062
J	Berggren, H; Nordahl, O; Tibblin, P; Larsson, P; Forsman, A				Berggren, Hanna; Nordahl, Oscar; Tibblin, Petter; Larsson, Per; Forsman, Anders			Testing for Local Adaptation to Spawning Habitat in Sympatric Subpopulations of Pike by Reciprocal Translocation of Embryos	PLOS ONE			English	Article							LIFE-HISTORY EVOLUTION; ESOX-LUCIUS; NORTHERN PIKE; GENE FLOW; EGG SIZE; REPRODUCTIVE ISOLATION; PHENOTYPIC PLASTICITY; POPULATION-STRUCTURE; ADAPTIVE DIVERGENCE; JUVENILE GROWTH	We tested for local adaption in early life-history traits by performing a reciprocal translocation experiment with approximately 2,500 embryos of pike (Esox lucius) divided in paired split-family batches. The experiment indicated local adaptation in one of the two subpopulations manifested as enhanced hatching success of eggs in the native habitat, both when compared to siblings transferred to a non-native habitat, and when compared to immigrant genotypes from the other subpopulation. Gene-by-environment effects on viability of eggs and larvae were evident in both subpopulations, showing that there existed genetic variation allowing for evolutionary responses to divergent selection, and indicating a capacity for plastic responses to environmental change. Next, we tested for differences in female life-history traits. Results uncovered that females from one population invested more resources into reproduction and also produced more (but smaller) eggs in relation to their body size compared to females from the other population. We suggest that these females have adjusted their reproductive strategies as a counter-adaptation because a high amount of sedimentation on the eggs in that subpopulations spawning habitat might benefit smaller eggs. Collectively, our findings point to adaptive divergence among sympatric subpopulations that are physically separated only for a short period during reproduction and early development-which is rare. These results illustrate how combinations of translocation experiments and field studies of life-history traits might infer about local adaptation and evolutionary divergence among populations. Local adaptations in subdivided populations are important to consider in management and conservation of biodiversity, because they may otherwise be negatively affected by harvesting, supplementation, and reintroduction efforts targeted at endangered populations.	[Berggren, Hanna; Nordahl, Oscar; Tibblin, Petter; Larsson, Per; Forsman, Anders] Linnaeus Univ, Dept Biol & Environm Sci, Ctr Ecol & Evolut Microbial Model Syst, EEMiS, SE-39182 Kalmar, Sweden	Linnaeus University	Forsman, A (corresponding author), Linnaeus Univ, Dept Biol & Environm Sci, Ctr Ecol & Evolut Microbial Model Syst, EEMiS, SE-39182 Kalmar, Sweden.	anders.forsman@lnu.se	Forsman, Anders/G-8778-2012	Forsman, Anders/0000-0001-9598-7618; Tibblin, Petter/0000-0001-6804-5342	Linnaeus University; Swedish Research Council [A0532701]	Linnaeus University; Swedish Research Council(Swedish Research CouncilEuropean Commission)	Funding was provided by Linnaeus University, www.lnu.se (to AF and PL) and The Swedish Research Council, www.vr.se (grant A0532701 to AF). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arendt JD, 2005, P ROY SOC B-BIOL SCI, V272, P333, DOI 10.1098/rspb.2004.2899; AULD AH, 1978, ESTUAR COAST MAR SCI, V6, P153, DOI 10.1016/0302-3524(78)90097-X; BALON EK, 1975, J FISH RES BOARD CAN, V32, P821, DOI 10.1139/f75-110; Berggren H, 2012, J EVOLUTION BIOL, V25, P2126, DOI 10.1111/j.1420-9101.2012.02592.x; Bolker BM, 2009, TRENDS ECOL EVOL, V24, P127, DOI 10.1016/j.tree.2008.10.008; BRADSHAW A. D., 1965, ADVANCE GENET, V13, P115, DOI 10.1016/S0065-2660(08)60048-6; Brooks S, 1997, REV FISH BIOL FISHER, V7, P387, DOI 10.1023/A:1018400130692; Craig JF, 2008, HYDROBIOLOGIA, V601, P5, DOI 10.1007/s10750-007-9262-3; Craig J.F., 1996, PIKE BIOL EXPLOITATI; Edelaar P, 2008, EVOLUTION, V62, P2462, DOI 10.1111/j.1558-5646.2008.00459.x; Eizaguirre C, 2012, ECOL LETT, V15, P723, DOI 10.1111/j.1461-0248.2012.01791.x; Endler J.A., 1977, Monographs in Population Biology, pi; Engstedt O, 2014, ECOL FRESHW FISH, V23, P313, DOI 10.1111/eff.12082; Engstedt O, 2010, ENVIRON BIOL FISH, V89, P547, DOI 10.1007/s10641-010-9686-x; Evans ML, 2010, CONSERV GENET, V11, P2333, DOI 10.1007/s10592-010-0119-3; Forsman A, 2015, HEREDITY, V115, P276, DOI 10.1038/hdy.2014.92; Forsman A, 2015, J FISH BIOL, V87, P472, DOI 10.1111/jfb.12712; Forsman A, 1995, FUNCT ECOL, V9, P818, DOI 10.2307/2389979; Forsman A, 2016, ECOGRAPHY, V39, P630, DOI 10.1111/ecog.01357; Forsman A, 2014, P NATL ACAD SCI USA, V111, P302, DOI 10.1073/pnas.1317745111; Fraser DJ, 2005, EVOLUTION, V59, P611; Garcia de Leaniz C, 2007, BIOL REV, V82, P173, DOI 10.1111/j.1469-185X.2006.00004.x; Gregersen F, 2006, ECOL FRESHW FISH, V15, P237, DOI 10.1111/j.1600-0633.2006.00129.x; HASSLER TJ, 1970, T AM FISH SOC, V99, P369, DOI 10.1577/1548-8659(1970)99<369:EIOEDA>2.0.CO;2; Heath DD, 1999, EVOLUTION, V53, P1605, DOI 10.1111/j.1558-5646.1999.tb05424.x; Hendry AP, 2001, GENETICA, V112, P515, DOI 10.1023/A:1013367100865; Hereford J, 2009, AM NAT, V173, P579, DOI 10.1086/597611; Hughes AR, 2008, ECOL LETT, V11, P609, DOI 10.1111/j.1461-0248.2008.01179.x; Jensen LF, 2008, P ROY SOC B-BIOL SCI, V275, P2859, DOI 10.1098/rspb.2008.0870; Johnston TA, 2002, ECOLOGY, V83, P1777, DOI 10.2307/3071764; Jonsson N, 1999, J FISH BIOL, V55, P767, DOI 10.1111/j.1095-8649.1999.tb00716.x; Junge C, 2011, HEREDITY, V106, P460, DOI 10.1038/hdy.2010.160; Kalbe M, 2002, J FISH BIOL, V60, P1529, DOI [10.1111/j.1095-8649.2002.tb02445.x, 10.1006/jfbi.2002.2013]; Kawecki TJ, 2004, ECOL LETT, V7, P1225, DOI 10.1111/j.1461-0248.2004.00684.x; Laikre L, 2005, AMBIO, V34, P111, DOI 10.1639/0044-7447(2005)034[0111:GPSOFI]2.0.CO;2; Larsson P, 2015, AMBIO, V44, pS451, DOI 10.1007/s13280-015-0664-6; LEGGETT WC, 1978, J FISH RES BOARD CAN, V35, P1469, DOI 10.1139/f78-230; LEGGETT WC, 1977, ANNU REV ECOL SYST, V8, P285, DOI 10.1146/annurev.es.08.110177.001441; Leimar O, 2009, EVOL ECOL, V23, P125, DOI 10.1007/s10682-007-9194-4; Lucek K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049377; Matthews B, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010948; Merila J, 2014, EVOL APPL, V7, P1, DOI 10.1111/eva.12137; Murry BA, 2008, HYDROBIOLOGIA, V601, P71, DOI 10.1007/s10750-007-9267-y; Nilsson J, 2014, HYDROBIOLOGIA, V721, P145, DOI 10.1007/s10750-013-1656-9; PALUMBI SR, 1994, ANNU REV ECOL SYST, V25, P547, DOI 10.1146/annurev.es.25.110194.002555; Pigliucci M., 2001, SYN ECO EVO; Raat AJP, 1988, SYNOPSIS OF BIOLOGIC; Reznick D, 2000, TRENDS ECOL EVOL, V15, P421, DOI 10.1016/S0169-5347(00)01941-8; REZNICK D, 1982, EVOLUTION, V36, P160, DOI 10.1111/j.1558-5646.1982.tb05021.x; Richter-Boix A, 2013, MOL ECOL, V22, P1322, DOI 10.1111/mec.12181; Roff D.A., 1997, EVOLUTIONARY QUANTIT; ROFF DA, 1984, CAN J FISH AQUAT SCI, V41, P989, DOI 10.1139/f84-114; Roff Derek A., 1992; Rossiter MC, 1996, ANNU REV ECOL SYST, V27, P451, DOI 10.1146/annurev.ecolsys.27.1.451; SCHEINER SM, 1993, ANNU REV ECOL SYST, V24, P35, DOI 10.1146/annurev.es.24.110193.000343; SMITH CC, 1974, AM NAT, V108, P499, DOI 10.1086/282929; STEARNS SC, 1986, EVOLUTION, V40, P893, DOI 10.1111/j.1558-5646.1986.tb00560.x; Stearns SC, 2000, NATURWISSENSCHAFTEN, V87, P476, DOI 10.1007/s001140050763; Taborsky B, 2006, P ROY SOC B-BIOL SCI, V273, P741, DOI 10.1098/rspb.2005.3347; Tibblin P, SCIENTIFIC REPORTS U; Tibblin P, 2016, J ANIM ECOL, V85, P136, DOI 10.1111/1365-2656.12439; Tibblin P, 2015, AM NAT, V186, P98, DOI 10.1086/681597; VAN NOORDWIJK AJ, 1986, AM NAT, V128, P137, DOI 10.1086/284547; VANDENBERGHE EP, 1989, EVOLUTION, V43, P125, DOI 10.1111/j.1558-5646.1989.tb04212.x; VIA S, 1985, EVOLUTION, V39, P505, DOI [10.2307/2408649, 10.1111/j.1558-5646.1985.tb00391.x]; Wennersten L, 2012, BIOL REV, V87, P756, DOI 10.1111/j.1469-185X.2012.00231.x; West-Eberhard Mary Jane, 2003, pi; Williams G. C., 1966, P307	68	16	16	0	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 3	2016	11	5							e0154488	10.1371/journal.pone.0154488	http://dx.doi.org/10.1371/journal.pone.0154488			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DL5KK	27139695	Green Published, Green Submitted, gold			2022-12-26	WOS:000375675700036
J	Okamoto, K; Koda, M; Okamoto, T; Onoyama, T; Miyoshi, K; Kishina, M; Kato, J; Tokunaga, S; Sugihara, T; Hara, Y; Hino, K; Murawaki, Y				Okamoto, Kinya; Koda, Masahiko; Okamoto, Toshiaki; Onoyama, Takumi; Miyoshi, Kenichi; Kishina, Manabu; Kato, Jun; Tokunaga, Shiho; Sugihara, Takaaki; Hara, Yuichi; Hino, Keisuke; Murawaki, Yoshikazu			A Series of microRNA in the Chromosome 14q32.2 Maternally Imprinted Region Related to Progression of Non-Alcoholic Fatty Liver Disease in a Mouse Model	PLOS ONE			English	Article							ELEVATED MICRORNA-34A; EXPRESSION PROFILES; OVER-EXPRESSION; MIRNA CLUSTER; STEATOHEPATITIS; OBESITY; PATHOGENESIS; ADIPONECTIN; INVOLVEMENT; BIOGENESIS	Background & Aims Simple steatosis (SS) and non-alcoholic steatohepatitis (NASH) are subtypes of non-alcoholic fatty liver disease (NAFLD), and the pathogenic differences between SS and NASH remain unclear. MicroRNAs (miRNAs) are endogenous, non-coding, short RNAs that regulate gene expression. The aim of this study was to use animal models and human samples to examine the relationship between miRNA expression profiles and each type of NAFLD (SS and NASH). Methods DD Shionogi, Fatty Liver Shionogi (FLS) and FLS ob/ob mice were used as models for normal control, SS and NASH, respectively. Microarray analysis and real-time PCR were used to identify candidate NAFLD-related miRNAs. Human serum samples were used to examine the expression profiles of these candidate miRNAs in control subjects and patients with SS or NASH. Results Fourteen miRNAs showed clear expression differences among liver tissues from SS, NASH, and control mice with good reproducibility. Among these NAFLD candidate miRNAs, seven showed similar expression patterns and were upregulated in both SS and NASH tissues; these seven candidate miRNAs mapped to an miRNA cluster in the 14q32.2 maternally imprinted region delineated by delta-like homolog 1 and type III iodothyronine deiodinase (Dlk1-Dio3 mat). Software-based predictions indicated that the transforming growth factor-beta pathway, insulin like growth factor-1 and 5' adenosine monophosphate activated protein kinase were potential targets of theses Dlk1-Dio3 mat NAFLD candidate miRNAs. In addition, serum samples from patients with SS or NASH differed markedly with regard to expression of the putative Dlk1-Dio3 mat miRNAs, and these differences accurately corresponded with NAFLD diagnosis. Conclusion The expression profiles of seven miRNAs in 14q32.2 mat have high potential as biomarkers for NAFLD and for improving future research on the pathogenesis and treatment of NASH.	[Okamoto, Kinya; Koda, Masahiko; Okamoto, Toshiaki; Onoyama, Takumi; Miyoshi, Kenichi; Kishina, Manabu; Kato, Jun; Tokunaga, Shiho; Sugihara, Takaaki; Murawaki, Yoshikazu] Tottori Univ, Sch Med, Dept Internal Med 2, Yonago, Tottori 683, Japan; [Hara, Yuichi; Hino, Keisuke] Kawasaki Med Sch, Dept Hepatol & Pancreatol, Kurashiki, Okayama, Japan	Tottori University; Kawasaki Medical School	Okamoto, K (corresponding author), Tottori Univ, Sch Med, Dept Internal Med 2, Yonago, Tottori 683, Japan.	okamotka@grape.med.tottori-u.ac.jp		Okamoto, Kinya/0000-0001-9087-8965	Japan Society for the Promotion of Science [26461005]; Grants-in-Aid for Scientific Research [26293179] Funding Source: KAKEN	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by a grant-in-aid for scientific research category C from the Japan Society for the Promotion of Science (http://www.jsps.go.jp/english/e-grants/index.html) Grant number: 26461005 (Receiver: MK). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams LA, 2005, GASTROENTEROLOGY, V129, P113, DOI 10.1053/j.gastro.2005.04.014; Alisi A, 2011, LAB INVEST, V91, P283, DOI 10.1038/labinvest.2010.166; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Basaranoglu M, 2013, WORLD J GASTROENTERO, V19, P1166, DOI 10.3748/wjg.v19.i8.1166; Begriche K, 2013, HEPATOLOGY, V58, P1497, DOI 10.1002/hep.26226; Benetatos L, 2013, CELL MOL LIFE SCI, V70, P795, DOI 10.1007/s00018-012-1080-8; Bolmeson C, 2011, BIOCHEM BIOPH RES CO, V404, P16, DOI 10.1016/j.bbrc.2010.11.024; Bracken CP, 2008, CANCER RES, V68, P7846, DOI 10.1158/0008-5472.CAN-08-1942; Brunt EM, 1999, AM J GASTROENTEROL, V94, P2467, DOI 10.1111/j.1572-0241.1999.01377.x; Chan WC, 2012, GENOMICS, V100, P141, DOI 10.1016/j.ygeno.2012.06.007; Chartoumpekis DV, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034872; Cheung O, 2008, HEPATOLOGY, V48, P1810, DOI 10.1002/hep.22569; Choi SE, 2013, AGING CELL, V12, P1062, DOI 10.1111/acel.12135; Cittelly DM, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-317; Day CP, 1998, GASTROENTEROLOGY, V114, P842, DOI 10.1016/S0016-5085(98)70599-2; Du HC, 2015, MOL MED REP, V11, P4701, DOI 10.3892/mmr.2015.3282; Feng XL, 2014, CANCER LETT, V344, P166, DOI 10.1016/j.canlet.2013.11.004; Fu T, 2012, P NATL ACAD SCI USA, V109, P16137, DOI 10.1073/pnas.1205951109; Garcia-Galiano D, 2007, OBES SURG, V17, P493, DOI 10.1007/s11695-007-9087-1; Gardiner E, 2012, MOL PSYCHIATR, V17, P827, DOI 10.1038/mp.2011.78; Gregory RI, 2005, CELL, V123, P631, DOI 10.1016/j.cell.2005.10.022; Hauff P, 2015, EXPERT OPIN INV DRUG, V24, P309, DOI 10.1517/13543784.2015.997874; Heneghan HM, 2010, OBES REV, V11, P354, DOI 10.1111/j.1467-789X.2009.00659.x; Hribal ML, 2013, J CLIN ENDOCR METAB, V98, pE304, DOI 10.1210/jc.2012-3290; Ichikawa T, 2007, HEPATOL INT, V1, P287, DOI 10.1007/s12072-007-9007-4; Inagaki Y, 2007, GUT, V56, P284, DOI 10.1136/gut.2005.088690; Inoue Y, 2008, CANCER SCI, V99, P2107, DOI 10.1111/j.1349-7006.2008.00925.x; Jordan SD, 2011, NAT CELL BIOL, V13, P434, DOI 10.1038/ncb2211; Kaser S, 2005, GUT, V54, P117, DOI 10.1136/gut.2003.037010; Kircher M, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-346; Labialle S, 2014, EMBO J, V33, P2216, DOI 10.15252/embj.201387038; Lagos-Quintana M, 2001, SCIENCE, V294, P853, DOI 10.1126/science.1064921; Leclercq IA, 2000, J CLIN INVEST, V105, P1067, DOI 10.1172/JCI8814; Liang Y, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-166; Lu YF, 2015, EXP CELL RES, V334, P173, DOI 10.1016/j.yexcr.2015.03.027; Manzardo AM, 2013, GENE, V526, P356, DOI 10.1016/j.gene.2013.05.052; Mitter D, 2006, AM J MED GENET A, V140A, P2039, DOI 10.1002/ajmg.a.31414; Miura K, 2014, WORLD J GASTROENTERO, V20, P7381, DOI 10.3748/wjg.v20.i23.7381; Neuschwander-Tetri BA, 2003, HEPATOLOGY, V37, P1202, DOI 10.1053/jhep.2003.50193; Pirola CJ, 2015, GUT, V64, P800, DOI 10.1136/gutjnl-2014-306996; Pogribny IP, 2010, LAB INVEST, V90, P1437, DOI 10.1038/labinvest.2010.113; Sanyal Arun J, 2011, Hepatology, V54, P344, DOI 10.1002/hep.24376; Seitz H, 2004, GENOME RES, V14, P1741, DOI 10.1101/gr.2743304; Soga M, 1999, LAB ANIM SCI, V49, P269; Song Z, 2007, AM J PHYSIOL-GASTR L, V293, pG894, DOI 10.1152/ajpgi.00133.2007; Stojsavljevic S, 2014, WORLD J GASTROENTERO, V20, P18070, DOI 10.3748/wjg.v20.i48.18070; Sugihara T, 2013, HEPATOL RES, V43, P547, DOI 10.1111/j.1872-034X.2012.01101.x; Szabo G, 2013, NAT REV GASTRO HEPAT, V10, P542, DOI 10.1038/nrgastro.2013.87; Tilg H, 2010, HEPATOLOGY, V52, P1836, DOI 10.1002/hep.24001; Um MY, 2013, BASIC CLIN PHARMACOL, V113, P152, DOI 10.1111/bcpt.12076; Wei YR, 2006, AM J PHYSIOL-ENDOC M, V291, pE275, DOI 10.1152/ajpendo.00644.2005; Zehavi L, 2012, MOL CANCER, V11, DOI 10.1186/1476-4598-11-44; Zhang J, 2015, GENOM PROTEOM BIOINF, V13, P17, DOI 10.1016/j.gpb.2015.02.001; Zhu J, 2014, FRONT GENET, V5, DOI [10.3389/fgene.2014.00149, 10.3389/fgene.2014.00187]	54	10	10	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 2	2016	11	5							e0154676	10.1371/journal.pone.0154676	http://dx.doi.org/10.1371/journal.pone.0154676			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DL5KB	27135827	Green Submitted, Green Published, gold			2022-12-26	WOS:000375674800038
J	Rajh, M; Dolinar, K; Mis, K; Pavlin, M; Pirkmajer, S				Rajh, Marusa; Dolinar, Klemen; Mis, Katarina; Pavlin, Mojca; Pirkmajer, Sergej			Medium Renewal Blocks Anti-Proliferative Effects of Metformin in Cultured MDA-MB-231 Breast Cancer Cells	PLOS ONE			English	Article							ACTIVATED PROTEIN-KINASE; DIABETES-MELLITUS; RESPIRATORY-CHAIN; CELLULAR-ENERGY; PROSTATE-CANCER; GLUCOSE; SUPPRESSES; METABOLISM; INHIBITION; PATHWAY	Epidemiological studies indicate that metformin, a widely used type 2 diabetes drug, might reduce breast cancer risk and mortality in patients with type 2 diabetes. Metformin might protect against breast cancer indirectly by ameliorating systemic glucose homeostasis. Alternatively, it might target breast cancer cells directly. However, experiments using MDA-MB-231 cells, a standard in vitro breast cancer model, produced inconsistent results regarding effectiveness of metformin as a direct anti-cancer agent. Metformin treatments in cultured MDA-MB-231 cells are usually performed for 48-96 hours, but protocols describing renewal of cell culture medium during these prolonged treatments are rarely reported. We determined whether medium renewal protocol might alter sensitivity of MDA-MB-231 cells treated with metformin. Using the MTS assay, BrdU incorporation and Hoechst staining we found that treatment with metformin for 48-72 hours failed to suppress viability and proliferation of MDA-MB-231 cells if low-glucose (1 g/L) medium was renewed every 24 hours. Conversely, metformin suppressed their viability and proliferation if medium was not renewed. Without renewal glucose concentration in the medium was reduced to 0.1 g/L in 72 hours, which likely explains increased sensitivity to metformin under these conditions. We also examined whether 2-deoxy-D-glucose (2-DG) reduces resistance to metformin. In the presence of 2-DG metformin reduced viability and proliferation of MDA-MB-231 cells with or without medium renewal, thus demonstrating that 2-DG reduces their resistance to metformin. In sum, we show that medium renewal blocks anti-proliferative effects of metformin during prolonged treatments in low-glucose medium. Differences in medium renewal protocols during prolonged treatments might therefore lead to apparently inconsistent results as regards effectiveness of metformin as a direct anti-cancer agent. Finally, our results indicate that co-therapy with 2-DG and metformin might provide an effective strategy to overcome metformin resistance of breast cancer cells.	[Rajh, Marusa; Dolinar, Klemen; Pavlin, Mojca] Univ Ljubljana, Fac Elect Engn, Ljubljana, Slovenia; [Dolinar, Klemen; Mis, Katarina; Pirkmajer, Sergej] Univ Ljubljana, Fac Med, Inst Pathophysiol, Ljubljana, Slovenia	University of Ljubljana; University of Ljubljana	Pirkmajer, S (corresponding author), Univ Ljubljana, Fac Med, Inst Pathophysiol, Ljubljana, Slovenia.	sergej.pirkmajer@mf.uni-lj.si	Pavlin, Mojca/AAD-4738-2022	Pavlin, Mojca/0000-0001-5477-7833; Pirkmajer, Sergej/0000-0003-1459-6936	Slovenian Research Agency (ARRS) [J3-6794, P3-0043]; MRIC UL [IP-0510]; ARRS	Slovenian Research Agency (ARRS)(Slovenian Research Agency - Slovenia); MRIC UL; ARRS(Slovenian Research Agency - Slovenia)	This study was supported by the Slovenian Research Agency (ARRS) research grants #J3-6794 and #P3-0043 and MRIC UL IP-0510 Infrastructure Program. M.R. was also supported by the ARRS young researcher programme.	Beckers A, 2006, MOL CANCER THER, V5, P2211, DOI 10.1158/1535-7163.MCT-06-0001; Ben Sahra I, 2010, CANCER RES, V70, P2465, DOI 10.1158/0008-5472.CAN-09-2782; Birsoy K, 2014, NATURE, V508, P108, DOI 10.1038/nature13110; Bodmer M, 2010, DIABETES CARE, V33, P1304, DOI 10.2337/dc09-1791; Cheong JH, 2011, MOL CANCER THER, V10, P2350, DOI 10.1158/1535-7163.MCT-11-0497; Corominas-Faja B, 2012, AGING-US, V4, P480, DOI 10.18632/aging.100472; Cryer P, 2009, DIABETOLOGIA, V52, P35, DOI 10.1007/s00125-008-1205-7; El-Mir MY, 2000, J BIOL CHEM, V275, P223, DOI 10.1074/jbc.275.1.223; Fan C, 2015, INT J MOL MED, V36, P204, DOI 10.3892/ijmm.2015.2217; Faubert B, 2013, CELL METAB, V17, P113, DOI 10.1016/j.cmet.2012.12.001; Fendt SM, 2013, CANCER RES, V73, P4429, DOI 10.1158/0008-5472.CAN-13-0080; Foretz M, 2014, CELL METAB, V20, P953, DOI 10.1016/j.cmet.2014.09.018; Griss T, 2015, PLOS BIOL, V13, DOI 10.1371/journal.pbio.1002309; Hadad SM, 2014, CLIN TRANSL ONCOL, V16, P746, DOI 10.1007/s12094-013-1144-8; Hardie DG, 2007, NAT REV MOL CELL BIO, V8, P774, DOI 10.1038/nrm2249; Hirayama A, 2009, CANCER RES, V69, P4918, DOI 10.1158/0008-5472.CAN-08-4806; Jeon SM, 2012, NATURE, V485, P661, DOI 10.1038/nature11066; Kato K, 2002, ONCOGENE, V21, P6082, DOI 10.1038/sj.onc.1205737; Kim HJ, 2015, BREAST CANCER RES, V17, DOI 10.1186/s13058-015-0574-3; Lalau JD, 1999, DRUG SAFETY, V20, P377, DOI 10.2165/00002018-199920040-00006; Larsson SC, 2007, INT J CANCER, V121, P856, DOI 10.1002/ijc.22717; Levesley J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064051; Liu BL, 2009, CELL CYCLE, V8, P2031, DOI 10.4161/cc.8.13.8814; Madiraju AK, 2014, NATURE, V510, P542, DOI 10.1038/nature13270; Marinello PC, 2016, TUMOR BIOL, V37, P5337, DOI 10.1007/s13277-015-4395-x; Masters JR, 2007, NAT PROTOC, V2, P2276, DOI 10.1038/nprot.2007.319; Menendez JA, 2012, CELL CYCLE, V11, P2782, DOI 10.4161/cc.20948; Meng SM, 2015, J BIOL CHEM, V290, P3793, DOI 10.1074/jbc.M114.604421; Mohanti BK, 1996, INT J RADIAT ONCOL, V35, P103, DOI 10.1016/S0360-3016(96)85017-6; Monnier L, 2006, JAMA-J AM MED ASSOC, V295, P1681, DOI 10.1001/jama.295.14.1681; Mullen AR, 2012, NATURE, V481, P385, DOI 10.1038/nature10642; Nathan DM, 2009, DIABETES CARE, V32, P193, DOI 10.2337/dc08-9025; Ouyang JY, 2011, J BIOL CHEM, V286, P1, DOI 10.1074/jbc.M110.121806; Owen MR, 2000, BIOCHEM J, V348, P607, DOI 10.1042/0264-6021:3480607; Peairs KS, 2011, J CLIN ONCOL, V29, P40, DOI 10.1200/JCO.2009.27.3011; Raez LE, 2013, CANCER CHEMOTH PHARM, V71, P523, DOI 10.1007/s00280-012-2045-1; Sadighi S, 2014, ASIAN PAC J CANCER P, V15, P2287, DOI 10.7314/APJCP.2014.15.5.2287; Saito S, 2009, CANCER RES, V69, P4225, DOI 10.1158/0008-5472.CAN-08-2689; Scott JW, 2004, J CLIN INVEST, V113, P274, DOI 10.1172/JCI200419874; Seshasai SRK, 2011, NEW ENGL J MED, V364, P829, DOI 10.1056/NEJMoa1008862; Silvestri A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0136250; Stein M, 2010, PROSTATE, V70, P1388, DOI 10.1002/pros.21172; Stephenne X, 2011, DIABETOLOGIA, V54, P3101, DOI 10.1007/s00125-011-2311-5; Suter M, 2006, J BIOL CHEM, V281, P32207, DOI 10.1074/jbc.M606357200; Swinnen JV, 2005, CANCER RES, V65, P2441, DOI 10.1158/0008-5472.CAN-04-3025; Wahdan-Alaswad R, 2013, CELL CYCLE, V12, P3759, DOI 10.4161/cc.26641; Wang DS, 2002, J PHARMACOL EXP THER, V302, P510, DOI 10.1124/jpet.102.034140; Wheaton WW, 2014, ELIFE, V3, DOI 10.7554/eLife.02242; WILCOCK C, 1994, XENOBIOTICA, V24, P49, DOI 10.3109/00498259409043220; Xiao B, 2007, NATURE, V449, P496, DOI 10.1038/nature06161; Zakikhani M, 2006, CANCER RES, V66, P10269, DOI 10.1158/0008-5472.CAN-06-1500; Zhou GC, 2001, J CLIN INVEST, V108, P1167, DOI 10.1172/JCI200113505; Zhuang Yongxian, 2008, J Mol Signal, V3, P18, DOI 10.1186/1750-2187-3-18; Zhuang YX, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108444; Zhuang YX, 2011, MOL CANCER RES, V9, P603, DOI 10.1158/1541-7786.MCR-10-0343; Zordoky BNM, 2014, BBA-GEN SUBJECTS, V1840, P1943, DOI 10.1016/j.bbagen.2014.01.023	56	13	14	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 2	2016	11	5							e0154747	10.1371/journal.pone.0154747	http://dx.doi.org/10.1371/journal.pone.0154747			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DL5KB	27135408	Green Published, gold, Green Submitted			2022-12-26	WOS:000375674800045
J	Mori, S; Hidaka, M; Kawakita, T; Hidaka, T; Tsuda, H; Yoshitama, T; Migita, K; Ueki, Y				Mori, Shunsuke; Hidaka, Michihiro; Kawakita, Toshiro; Hidaka, Toshihiko; Tsuda, Hiroyuki; Yoshitama, Tamami; Migita, Kiyoshi; Ueki, Yukitaka			Factors Associated with Myelosuppression Related to Low-Dose Methotrexate Therapy for Inflammatory Rheumatic Diseases	PLOS ONE			English	Article							MODIFYING ANTIRHEUMATIC DRUGS; LONG-TERM SAFETY; INDUCED PANCYTOPENIA; CLINICAL CHARACTERISTICS; PULSE METHOTREXATE; RISK-FACTORS; ARTHRITIS; TOXICITY; PHARMACOKINETICS; EFFICACY	Objective Severe myelosuppression is a serious concern in the management of rheumatic disease patients receiving methotrexate (MTX) therapy. This study was intended to explore factors associated with the development of MTX-related myelosuppression and its disease severity. Methods We retrospectively examined a total of 40 cases of MTX-related myelosuppression that had been filed in the registries of participating rheumatology and hematology divisions. Data before onset were compared with those of 120 controls matched for age and sex. Cytopenia was graded according to the National Cancer Institute criteria for adverse events. Data before and at onset were compared between the severe and non-severe groups. Results Non-use of folic acid supplements, concurrent medications, and low renal function were significantly associated with the development of myelosuppression (p < 0.001, p < 0.001, and p = 0.002, respectively). In addition, significantly lower MTX dosages, higher blood cell counts, and lower hemoglobin levels were seen in the myelosuppression group (p < 0.001). No patients exhibited leukocytopenia, neutropenia, or thrombocytopenia in routine blood monitoring taken within the past month. One-fourth developed myelosuppression within the first two months (an early-onset period). Myelosuppression was severe in approximately 40% of patients. Hypoalbuminemia and non-use of folic acid supplements were significantly associated with the severity of pancytopenia (p = 0.001 and 0.008, respectively). Besides these two factors, early onset and the use of lower doses of MTX were significantly associated with the severity of neutropenia (p = 0.003, 0.007, 0.003, and 0.002, respectively). Conclusions Myelosuppression can occur abruptly at any time during low-dose MTX therapy, but severe neutropenia is more likely to occur in the early-onset period of this therapy. Contrary to our expectations, disease severity was not dependent on MTX doses. Serum albumin levels and folic acid supplementation are the important factors affecting the severity of MTXrelated pancytopenia and neutropenia.	[Mori, Shunsuke] NHO Kumamoto Saishunsou Natl Hosp, Dept Rheumatol, Clin Res Ctr Rheumat Dis, Kumamoto 8611196, Japan; [Hidaka, Michihiro; Kawakita, Toshiro] NHO Natl Kumamoto Med Ctr, Dept Hematol, Kumamoto 8600008, Japan; [Hidaka, Toshihiko] Zenjinkai Shimin No Mori Hosp, Inst Rheumatol, Miyazaki 8800122, Japan; [Tsuda, Hiroyuki] Kumamoto City Hosp, Dept Hematol & Oncol, Kumamoto 8628505, Japan; [Yoshitama, Tamami] Yoshitama Clin Rheumat Dis, Kagoshima 8995117, Japan; [Migita, Kiyoshi] NHO Natl Nagasaki Med Ctr, Clin Res Ctr, Omura, Nagasaki 8568652, Japan; [Ueki, Yukitaka] Sasebo Chuo Hosp, Rheumat & Collagen Dis Ctr, Sasebo, Nagasaki 8571195, Japan		Mori, S (corresponding author), NHO Kumamoto Saishunsou Natl Hosp, Dept Rheumatol, Clin Res Ctr Rheumat Dis, Kumamoto 8611196, Japan.	moris@saisyunsou1.hosp.go.jp		Mori, Shunsuke/0000-0001-7972-4252	National Hospital Organization (NHO), Japan	National Hospital Organization (NHO), Japan	This study was supported by research funds from the National Hospital Organization (NHO), Japan. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALAWADHI A, 1993, J RHEUMATOL, V20, P1121; Andersohn F, 2007, ANN INTERN MED, V146, P657, DOI 10.7326/0003-4819-146-9-200705010-00009; BERTHELOT JM, 1995, REV RHUM, V62, P477; Bourre-Tessier J, 2010, J RHEUMATOL, V37, P1416, DOI 10.3899/jrheum.090153; BUCHBINDER R, 1993, J RHEUMATOL, V20, P639; Colebatch AN, 2012, J RHEUMATOL, V39, P62, DOI 10.3899/jrheum.120345; Crofford LJ, 2013, ARTHRITIS RES THER, V15, DOI 10.1186/ar4174; Dalrymple JM, 2008, ARTHRITIS RHEUM-US, V58, P3299, DOI 10.1002/art.24034; Elsby R, 2011, EUR J PHARM SCI, V43, P41, DOI 10.1016/j.ejps.2011.03.006; Franck H, 1996, CLIN RHEUMATOL, V15, P266, DOI 10.1007/BF02229705; Gilani STA, 2012, JCPSP-J COLL PHYSICI, V22, P101, DOI 02.2012/JCPSP.101104; Grove ML, 2001, QJM-MON J ASSOC PHYS, V94, P309, DOI 10.1093/qjmed/94.6.309; GutierrezUrena S, 1996, ARTHRITIS RHEUM, V39, P272, DOI 10.1002/art.1780390214; HANRAHAN PS, 1989, BRIT J RHEUMATOL, V28, P147; Hillson JL, 1997, RHEUM DIS CLIN N AM, V23, P757, DOI 10.1016/S0889-857X(05)70359-8; Hocaoglu N, 2008, HUM EXP TOXICOL, V27, P585, DOI 10.1177/0960327108094507; Inoue K, 2014, DRUG METAB PHARMACOK, V29, P12, DOI 10.2133/dmpk.DMPK-13-RV-119; Jacobs JWG, 2012, RHEUMATOLOGY, V51, piv3, DOI 10.1093/rheumatology/kes083; Jurgens MS, 2011, BEST PRACT RES CL RH, V25, P523, DOI 10.1016/j.berh.2011.10.006; Kanik KS, 1997, RHEUM DIS CLIN N AM, V23, P955, DOI 10.1016/S0889-857X(05)70368-9; Katchamart W, 2009, ANN RHEUM DIS, V68, P1105, DOI 10.1136/ard.2008.099861; Kent PD, 2004, J RHEUMATOL, V31, P1727; Kinder AJ, 2005, RHEUMATOLOGY, V44, P61, DOI 10.1093/rheumatology/keh512; Kivity S, 2014, AUTOIMMUN REV, V13, P1109, DOI 10.1016/j.autrev.2014.08.027; Knowles SR, 2000, LANCET, V356, P1587, DOI 10.1016/S0140-6736(00)03137-8; Kuitunen T, 2005, SCAND J RHEUMATOL, V34, P238, DOI 10.1080/03009740510018570; Lateef Omar, 2005, Expert Opin Drug Saf, V4, P723, DOI 10.1517/14740338.4.4.723; Lim AYN, 2005, RHEUMATOLOGY, V44, P1051, DOI 10.1093/rheumatology/keh685; MACKINNON SK, 1985, SEMIN ARTHRITIS RHEU, V15, P119, DOI 10.1016/0049-0172(85)90029-0; Matsuo S, 2009, AM J KIDNEY DIS, V53, P982, DOI 10.1053/j.ajkd.2008.12.034; McEwen J, 2007, PHARMACOEPIDEM DR S, V16, P65, DOI 10.1002/pds.1236; Mori S, 2015, WORLD J GASTROENTERO, V21, P10274, DOI 10.3748/wjg.v21.i36.10274; Mori S, 2015, ANN RHEUM DIS, V74, P628, DOI 10.1136/annrheumdis-2014-206695; Mori S, 2012, RHEUMATOLOGY, V51, P2120, DOI 10.1093/rheumatology/kes244; Ohosone Y, 1997, CLIN RHEUMATOL, V16, P321, DOI 10.1007/BF02238974; Patane M, 2013, ADV PHARMACOL SCI, V2013, DOI 10.1155/2013/313858; Pincus T, 2003, CLIN EXP RHEUMATOL, V21, pS179; Salliot C, 2009, ANN RHEUM DIS, V68, P1100, DOI 10.1136/ard.2008.093690; Smolen JS, 2014, ANN RHEUM DIS, V73, P492, DOI 10.1136/annrheumdis-2013-204573; Varatharajan N, 2009, INTERN MED J, V39, P228, DOI 10.1111/j.1445-5994.2009.01800.x; Visser K, 2009, ANN RHEUM DIS, V68, P1086, DOI 10.1136/ard.2008.094474; WEINBLATT ME, 1985, J RHEUMATOL, V12, P35; WILLIAMS HJ, 1985, ARTHRITIS RHEUM-US, V28, P721, DOI 10.1002/art.1780280702; Wolfe F, 2006, J RHEUMATOL, V33, P1516; Yazici Y, 2006, RHEUMATOLOGY, V45, P361, DOI 10.1093/rheumatology/kei199; Yoon KH, 2001, JCR-J CLIN RHEUMATOL, V7, P17, DOI 10.1097/00124743-200102000-00005	46	35	37	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 29	2016	11	4							e0154744	10.1371/journal.pone.0154744	http://dx.doi.org/10.1371/journal.pone.0154744			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DK8XM	27128679	Green Submitted, Green Published, gold			2022-12-26	WOS:000375212600066
J	Vargas-Prada, S; Coggon, D; Ntani, G; Walker-Bone, K; Palmer, KT; Felli, VE; Harari, R; Barrero, LH; Felknor, SA; Gimeno, D; Cattrell, A; Bonzini, M; Solidaki, E; Merisalu, E; Habib, RR; Sadeghian, F; Kadir, MM; Wamakulasuriya, SSP; Matsudaira, K; Nyantumbu, B; Sim, MR; Harcombe, H; Cox, K; Sarquis, LMM; Marziale, MH; Harari, F; Freire, R; Harari, N; Monroy, MV; Quintana, LA; Rojas, M; Harris, EC; Serra, C; Martinez, JM; Delclos, G; Benavides, FG; Carugno, M; Ferrario, MM; Pesatori, AC; Chatzi, L; Bitsios, P; Kogevinas, M; Oha, K; Freimann, T; Sadeghian, A; Peiris-John, RJ; Sathiakumar, N; Wickremasinghe, AR; Yoshimura, N; Kelsall, HL; Hoe, VCW; Urquhart, DM; Derrett, S; McBride, D; Herbison, P; Gray, A; Vega, EJS				Vargas-Prada, Sergio; Coggon, David; Ntani, Georgia; Walker-Bone, Karen; Palmer, Keith T.; Felli, Vanda E.; Harari, Raul; Barrero, Lope H.; Felknor, Sarah A.; Gimeno, David; Cattrell, Anna; Bonzini, Matteo; Solidaki, Eleni; Merisalu, Eda; Habib, Rima R.; Sadeghian, Farideh; Kadir, M. Masood; Wamakulasuriya, Sudath S. P.; Matsudaira, Ko; Nyantumbu, Busisiwe; Sim, Malcolm R.; Harcombe, Helen; Cox, Ken; Sarquis, Leila M. M.; Marziale, Maria H.; Harari, Florencia; Freire, Rocio; Harari, Natalia; Monroy, Magda V.; Quintana, Leonardo A.; Rojas, Marianela; Harris, E. Clare; Serra, Consol; Martinez, J. Miguel; Delclos, George; Benavides, Fernando G.; Carugno, Michele; Ferrario, Marco M.; Pesatori, Angela C.; Chatzi, Leda; Bitsios, Panos; Kogevinas, Manolis; Oha, Kristel; Freimann, Tiina; Sadeghian, Ali; Peiris-John, Roshini J.; Sathiakumar, Nalini; Wickremasinghe, A. Rajitha; Yoshimura, Noriko; Kelsall, Helen L.; Hoe, Victor C. W.; Urquhart, Donna M.; Derrett, Sarah; McBride, David; Herbison, Peter; Gray, Andrew; Vega, Eduardo J. Salazar			Descriptive Epidemiology of Somatising Tendency: Findings from the CUPID Study	PLOS ONE			English	Article							CHRONIC WIDESPREAD PAIN; MUSCULOSKELETAL PAIN; RISK-FACTORS; PSYCHOSOCIAL FACTORS; GENDER-DIFFERENCES; HEALTH BELIEFS; ONSET; SOMATIZATION; DETERMINANTS; PERSISTENCE	Somatising tendency, defined as a predisposition to worry about common somatic symptoms, is importantly associated with various aspects of health and health-related behaviour, including musculoskeletal pain and associated disability. To explore its epidemiological characteristics, and how it can be specified most efficiently, we analysed data from an international longitudinal study. A baseline questionnaire, which included questions from the Brief Symptom Inventory about seven common symptoms, was completed by 12,072 participants aged 20-59 from 46 occupational groups in 18 countries (response rate 70%). The seven symptoms were all mutually associated (odds ratios for pairwise associations 3.4 to 9.3), and each contributed to a measure of somatising tendency that exhibited an exposureresponse relationship both with multi-site pain (prevalence rate ratios up to six), and also with sickness absence for non-musculoskeletal reasons. In most participants, the level of somatising tendency was little changed when reassessed after a mean interval of 14 months (75% having a change of 0 or 1 in their symptom count), although the specific symptoms reported at follow-up often differed from those at baseline. Somatising tendency was more common in women than men, especially at older ages, and varied markedly across the 46 occupational groups studied, with higher rates in South and Central America. It was weakly associated with smoking, but not with level of education. Our study supports the use of questions from the Brief Symptom Inventory as a method for measuring somatising tendency, and suggests that in adults of working age, it is a fairly stable trait.	[Vargas-Prada, Sergio; Serra, Consol; Delclos, George; Benavides, Fernando G.] Univ Pompeu Fabra, Ctr Res Occupat Hlth CiSAL, Barcelona, Spain; [Vargas-Prada, Sergio; Coggon, David; Serra, Consol; Delclos, George; Benavides, Fernando G.; Kogevinas, Manolis] CIBER Epidemiol & Publ Hlth, Barcelona, Spain; [Vargas-Prada, Sergio; Serra, Consol; Delclos, George; Benavides, Fernando G.; Kogevinas, Manolis] IMIM Hosp Mar Res Inst, Barcelona, Spain; [Coggon, David; Ntani, Georgia; Walker-Bone, Karen; Palmer, Keith T.; Cox, Ken; Harris, E. Clare; Wickremasinghe, A. Rajitha] Univ Southampton, MRC, Lifecourse Epidemiol Unit, Southampton, Hants, England; [Coggon, David; Ntani, Georgia; Walker-Bone, Karen; Palmer, Keith T.; Harris, E. Clare] Univ Southampton, Arthrit Res UK, MRC Ctr Musculoskeletal Hlth & Work, Southampton, Hants, England; [Felli, Vanda E.] Univ Sao Paulo, Sch Nursing, Sao Paulo, Brazil; [Harari, Raul; Harari, Florencia; Freire, Rocio; Harari, Natalia] IFA Inst Dev Prod & Work Environm, Corporac Desarrollo Prod & Medio Ambiente Laboral, Quito, Ecuador; [Barrero, Lope H.; Monroy, Magda V.; Quintana, Leonardo A.] Pontificia Univ Javeriana, Sch Engn, Dept Ind Engn, Bogota, Colombia; [Felknor, Sarah A.; Gimeno, David; Delclos, George] Univ Texas Hlth Sci Ctr Houston, Southwest Ctr Occupat & Environm Hlth, Sch Publ Hlth, Houston, TX 77030 USA; [Felknor, Sarah A.] NIOSH, Ctr Dis Control & Prevent, Atlanta, GA USA; [Cattrell, Anna] Goodmayes Hosp, North East London NHS Fdn Trust, Ilford, England; [Bonzini, Matteo; Ferrario, Marco M.] Univ Insubria, Epidemiol & Prevent Med Res Ctr, Varese, Italy; [Solidaki, Eleni; Chatzi, Leda] Univ Crete, Sch Med, Dept Social Med, Iraklion, Greece; [Merisalu, Eda] Estonian Univ Life Sci, Inst Technol, Tartu, Estonia; [Habib, Rima R.] Amer Univ Beirut, Dept Environm Hlth, Fac Hlth Sci, Beirut, Lebanon; [Sadeghian, Farideh] Shahroud Univ Med Sci, Sch Publ Hlth, Dept Occupat Hlth, Shahroud, Iran; [Kadir, M. Masood] Aga Khan Univ, Dept Community Hlth Sci, Karachi, Pakistan; [Wamakulasuriya, Sudath S. P.] Univ Sri Jayewardenepura, Dept Med Educ & Hlth Sci, Fac Med Sci, Nugegoda, Sri Lanka; [Matsudaira, Ko] Tokyo Univ Hosp, Dept Med Res & Management Musculoskeletal Pain, 22nd Century Med & Res Ctr, Fac Med, Tokyo 113, Japan; [Nyantumbu, Busisiwe] Natl Inst Occupat Hlth, Natl Hlth Lab Serv, Johannesburg, South Africa; [Nyantumbu, Busisiwe] Univ Witwatersrand, Fac Hlth Sci, Johannesburg, South Africa; [Sim, Malcolm R.; Kelsall, Helen L.; Urquhart, Donna M.] Monash Univ, Sch Publ Hlth & Prevent Med, Dept Epidemiol & Prevent Med, Melbourne, Vic 3004, Australia; [Harcombe, Helen; McBride, David; Herbison, Peter; Gray, Andrew] Univ Otago, Dept Prevent & Social Med, Dunedin, New Zealand; [Sarquis, Leila M. M.] Univ Fed Parana, BR-80060000 Curitiba, Parana, Brazil; [Marziale, Maria H.] Univ Sao Paulo, Sch Nursing Ribeirao Preto, Sao Paulo, Brazil; [Rojas, Marianela] Natl Univ Costa Rica, Inst Studies Toxic Subst IRET, Program Hlth Work & Environm Cent Amer, Heredia, Costa Rica; [Serra, Consol] Parc Salut MAR, Occupat Hlth Serv, Barcelona, Spain; [Martinez, J. Miguel] MC Mutual, Serv Invest & Anal IT EP, Dept Invest & Anal Prestac, Barcelona, Spain; [Carugno, Michele; Pesatori, Angela C.] Univ Milan, Dept Clin Sci & Community Hlth, Milan, Italy; [Pesatori, Angela C.] Osped Maggiore Policlin, Fdn Ca Granda, Milan, Italy; [Bitsios, Panos] Univ Crete, Sch Med, Dept Psychiat, Iraklion, Greece; [Kogevinas, Manolis] Ctr Res Environm Epidemiol CREAL, Barcelona, Spain; [Oha, Kristel] North Estonia Med Ctr, Tallinn, Estonia; [Freimann, Tiina] Tartu Univ Hosp, Tartu, Estonia; [Sadeghian, Ali] Klinikum Leverkusen, Leverkusen, Germany; [Peiris-John, Roshini J.] Univ Sri Jayewardenepura, Dept Physiol, Fac Med Sci, Nugegoda, Sri Lanka; [Peiris-John, Roshini J.] Univ Auckland, Sch Populat Hlth, Sect Epidemiol & Biostat, Fac Med & Hlth Sci, Auckland 1, New Zealand; [Sathiakumar, Nalini] Univ Alabama Birmingham, Sch Publ Hlth, Dept Epidemiol, Birmingham, AL 35294 USA; [Wickremasinghe, A. Rajitha] Univ Kelaniya, Fac Med, Kelaniya, Sri Lanka; [Yoshimura, Noriko] Univ Tokyo, 22nd Century Med & Res Ctr, Dept Joint Dis Res, Tokyo, Japan; [Hoe, Victor C. W.] Univ Malaya, Fac Med, Dept Social & Prevent Med, Ctr Occupat & Environm Hlth, Kuala Lumpur, Malaysia; [Derrett, Sarah] Univ Otago, Injury Prevent Res Unit, Dept Prevent & Social Med, Dunedin, New Zealand; [Vega, Eduardo J. Salazar] AkzoNobel, Hlth Safety & Environm Dept, Houston, TX USA	Pompeu Fabra University; CIBER - Centro de Investigacion Biomedica en Red; CIBERESP; Institut Hospital del Mar d'Investigacions Mediques (IMIM); University of Southampton; University of Southampton; Universidade de Sao Paulo; Pontificia Universidad Javeriana; University of Texas System; University of Texas Health Science Center Houston; University of Texas School Public Health; Centers for Disease Control & Prevention - USA; National Institute for Occupational Safety & Health (NIOSH); University of Insubria; University of Crete; Estonian University of Life Sciences; American University of Beirut; Shahroud University Medical Sciences; Aga Khan University; University Sri Jayewardenepura; University of Tokyo; National Health Laboratory Service; University of Witwatersrand; Monash University; University of Otago; Universidade Federal do Parana; Universidade de Sao Paulo; Universidad Nacional Costa Rica; University of Milan; IRCCS Ca Granda Ospedale Maggiore Policlinico; University of Crete; Pompeu Fabra University; University Sri Jayewardenepura; University of Auckland; University of Alabama System; University of Alabama Birmingham; University Kelaniya; University of Tokyo; Universiti Malaya; University of Otago	Coggon, D (corresponding author), Univ Southampton, MRC, Lifecourse Epidemiol Unit, Southampton, Hants, England.; Coggon, D (corresponding author), Univ Southampton, Arthrit Res UK, MRC Ctr Musculoskeletal Hlth & Work, Southampton, Hants, England.	dnc@mrc.soton.ac.uk	Harari, Florencia/AAQ-2003-2020; Freimann, Tiina/GOH-1303-2022; sadeghian, farideh/N-2607-2019; Felli, Vanda Elisa Andres/H-5942-2012; Carugno, Michele/AAA-6958-2019; Walker-Bone, Karen/AAE-5255-2019; Kogevinas, Manolis/C-3918-2017; Gray, Andrew Robert/L-9161-2015; Sim, Malcolm/I-2761-2014; Ferrario, Marco M./ABH-2115-2021; Hoe, VICTOR CW/B-5190-2010; Martínez, José Miguel/AAU-3228-2021; McBride, David I/F-9664-2010; harari, florencia/O-3786-2014; Vargas-Prada, Sergio/I-3065-2014; pesatori, angela/K-5742-2016	Felli, Vanda Elisa Andres/0000-0001-7250-4353; Kogevinas, Manolis/0000-0002-9605-0461; Gray, Andrew Robert/0000-0003-4299-2194; Hoe, VICTOR CW/0000-0002-8073-157X; Martínez, José Miguel/0000-0002-9633-1204; McBride, David I/0000-0001-5531-7687; harari, florencia/0000-0002-0362-579X; Peiris-John, Roshini/0000-0001-7812-2268; Sadeghian, Farideh/0000-0001-7173-6451; Herbison, Graham Peter/0000-0002-5684-024X; Ferrario, Marco M/0000-0003-2741-7124; Walker-Bone, Karen/0000-0002-5992-1459; Vargas-Prada, Sergio/0000-0002-0713-5392; Gimeno, David/0000-0003-2502-0465; Quintana, Leonardo/0000-0001-5625-0111; Merisalu, Eda/0000-0001-7940-9586; Monroy Silva, Magda Viviana/0000-0002-6185-5999; Derrett, Sarah/0000-0003-2867-0498; Carugno, Michele/0000-0001-5212-2489; Marziale, Maria Helena Palucci/0000-0003-2790-3333; pesatori, angela/0000-0002-0261-3252; Barrero, Lope/0000-0003-1503-0264	Monash University; National Health and Medical Research Council (Australia); Ministry of Higher Education in Malaysia; Health Research Council of New Zealand; Southwest Center for Occupational and Environmental Health at the University of Texas Health Science Center from the NIH Fogarty International Center; MRC [MC_UU_12011/5, MC_UP_A620_1018, G0400490, MC_PC_15015] Funding Source: UKRI; Medical Research Council [G0400490, MC_UU_12011/5, MC_UP_A620_1018, MC_PC_15015] Funding Source: researchfish	Monash University(Monash University); National Health and Medical Research Council (Australia)(National Health and Medical Research Council (NHMRC) of Australia); Ministry of Higher Education in Malaysia(Ministry of Education, Malaysia); Health Research Council of New Zealand(Health Research Council of New Zealand); Southwest Center for Occupational and Environmental Health at the University of Texas Health Science Center from the NIH Fogarty International Center; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	Monash University funded data collection in Australia through its grant schemes; National Health and Medical Research Council (Australia) supported HLK and DMU through fellowships; the Ministry of Higher Education in Malaysia supported VCWH in Australia; and the Health Research Council of New Zealand funded data collection in New Zealand. Data collection in Central America and Colombia was supported by the Southwest Center for Occupational and Environmental Health at the University of Texas Health Science Center research training grant from the NIH Fogarty International Center.	Barsky AJ, 2001, J GEN INTERN MED, V16, P266, DOI 10.1046/j.1525-1497.2001.016004266.x; Boss MW, 1991, PSYCHOL ASSESSMENT J, V3, P433, DOI [10.1037/1040-3590.3.3.433, DOI 10.1037/1040-3590.3.3.433]; Carugno M, 2012, CAD SAUDE PUBLICA, V28, P1632, DOI 10.1590/S0102-311X2012000900003; Coggon D, 2013, PAIN, V154, P1769, DOI 10.1016/j.pain.2013.05.039; Coggon D, 2013, OCCUP ENVIRON MED, V70, P575, DOI 10.1136/oemed-2012-101316; Coggon D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039820; Craig TKJ, 2002, PSYCHOL MED, V32, P805, DOI 10.1017/S0033291702005846; CROFT P, 1993, J RHEUMATOL, V20, P710; DEROGATIS LR, 1983, PSYCHOL MED, V13, P595, DOI 10.1017/S0033291700048017; Gierk B, 2014, JAMA INTERN MED, V174, P399, DOI 10.1001/jamainternmed.2013.12179; Gupta A, 2007, RHEUMATOLOGY, V46, P666, DOI 10.1093/rheumatology/kel363; Gureje O, 1997, AM J PSYCHIAT, V154, P989; Hunt IM, 1999, RHEUMATOLOGY, V38, P275, DOI 10.1093/rheumatology/38.3.275; Kroenke K, 1998, PSYCHOSOM MED, V60, P150, DOI 10.1097/00006842-199803000-00006; Macfarlane GJ, 2000, BRIT MED J, V321, P676, DOI 10.1136/bmj.321.7262.676; MAIN CJ, 1983, J PSYCHOSOM RES, V27, P503, DOI 10.1016/0022-3999(83)90040-5; McBeth J, 2003, RHEUMATOLOGY, V42, P1486, DOI 10.1093/rheumatology/keg399; McBeth J, 2001, RHEUMATOLOGY, V40, P95, DOI 10.1093/rheumatology/40.1.95; Palmer KT, 2008, PAIN, V136, P30, DOI 10.1016/j.pain.2007.06.011; Palmer KT, 2007, ANN RHEUM DIS, V66, P1190, DOI 10.1136/ard.2006.061481; Palmer KT, 2006, FAM PRACT, V23, P609, DOI 10.1093/fampra/cml047; Palmer KT, 2005, OCCUP MED-OXFORD, V55, P612, DOI 10.1093/occmed/kqi142; Poikolainen K, 2000, ARCH DIS CHILD, V83, P388, DOI 10.1136/adc.83.5.388; Rief W, 2007, PSYCHOSOM MED, V69, P864, DOI 10.1097/PSY.0b013e31815b006e; Solidaki E, 2013, OCCUP ENVIRON MED, V70, P29, DOI 10.1136/oemed-2012-100689; Solidaki E, 2010, SCAND J WORK ENV HEA, V36, P54, DOI 10.5271/sjweh.2884; Vargas-Prada S, 2015, BEST PRACT RES CL RH, V29, P374, DOI 10.1016/j.berh.2015.03.003; Vargas-Prada S, 2013, SCAND J WORK ENV HEA, V39, P589, DOI 10.5271/sjweh.3377; WOOL CA, 1994, PSYCHOSOMATICS, V35, P445, DOI 10.1016/S0033-3182(94)71738-2	29	8	8	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 29	2016	11	4							e0153748	10.1371/journal.pone.0153748	http://dx.doi.org/10.1371/journal.pone.0153748			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DK8XM	27128094	Green Published, Green Submitted, gold			2022-12-26	WOS:000375212600013
J	Ma, Y; Yu, C; Mohamed, EM; Shao, H; Wang, L; Sundaresan, G; Zweit, J; Idowu, M; Fang, X				Ma, Y.; Yu, C.; Mohamed, E. M.; Shao, H.; Wang, L.; Sundaresan, G.; Zweit, J.; Idowu, M.; Fang, X.			A causal link from ALK to hexokinase II overexpression and hyperactive glycolysis in EML4-ALK-positive lung cancer	ONCOGENE			English	Article							ANAPLASTIC LYMPHOMA KINASE; ENDOTHELIAL GROWTH-FACTOR; INDUCIBLE FACTOR 1-ALPHA; EML4-ALK FUSION GENE; GLUCOSE CATABOLISM; RESPONSE ELEMENTS; EXPRESSION; METABOLISM; TARGET; IDENTIFICATION	A high rate of aerobic glycolysis is a hallmark of malignant transformation. Accumulating evidence suggests that diverse regulatory mechanisms mediate this cancer-associated metabolic change seen in a wide spectrum of cancer. The echinoderm microtubule-associated protein-like 4-anaplastic lymphoma kinase (EML4-ALK) fusion protein is found in approximately 3-7% of non-small cell lung carcinomas (NSCLC). Molecular evidence and therapeutic effectiveness of FDA-approved ALK inhibitors indicated that EML4-ALK is a driving factor of lung tumorigenesis. A recent clinical study showed that NSCLC harboring EML4-ALK rearrangements displayed higher glucose metabolism compared with EML4-ALK-negative NSCLC. In the current work, we presented evidence that EML4-ALK is coupled to overexpression of hexokinase II (HK2), one of the rate-limiting enzymes of the glycolytic pathway. The link from EML4-ALK to HK2 upregulation is essential for a high rate of glycolysis and proliferation of EML4-ALK-rearranged NSCLC cells. We identified hypoxia-inducible factor 1a (HIF1a) as a key transcription factor to drive HK2 gene expression in normoxia in these cells. EML4-ALK induced hypoxia-independent but glucose-dependent accumulation of HIF1a protein via both transcriptional activation of HIF1a mRNA and the phosphatidylinositol 3 kinase-AKT pathway to enhance HIF1a protein synthesis. The EML4ALK- mediated upregulation of HIF1a, HK2 and glycolytic metabolism was also highly active in vivo as demonstrated by fluorodeoxyglucose-positron emission tomography imaging of xenografts grown from EML4-ALK-positive NSCLC cells. Our data reveal a novel EML4-ALK-HIF1a-HK2 cascade to enhance glucose metabolism in EML4-ALK-positive NSCLC.	[Ma, Y.; Mohamed, E. M.; Shao, H.; Fang, X.] Virginia Commonwealth Univ, Sch Med, Dept Biochem & Mol Biol, Sanger Hall 2-016,1101 East Marshall St, Richmond, VA 23298 USA; [Yu, C.] Wuhan Univ, Coll Life Sci, Wuhan, Hunan, Peoples R China; [Wang, L.; Sundaresan, G.; Zweit, J.] Virginia Commonwealth Univ, Sch Med, Dept Radiol, Richmond, VA USA; [Idowu, M.] Virginia Commonwealth Univ, Sch Med, Dept Pathol, Richmond, VA USA	Virginia Commonwealth University; Wuhan University; Virginia Commonwealth University; Virginia Commonwealth University	Fang, X (corresponding author), Virginia Commonwealth Univ, Sch Med, Dept Biochem & Mol Biol, Sanger Hall 2-016,1101 East Marshall St, Richmond, VA 23298 USA.	xfang@vcu.edu	Ma, Yibao/H-3849-2016	Ma, Yibao/0000-0002-3270-8893	Astar Biotech research award; Jeffress Memorial Fund award; NIH [P30 CA16059]; NATIONAL CANCER INSTITUTE [P30CA016059] Funding Source: NIH RePORTER	Astar Biotech research award; Jeffress Memorial Fund award; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	The work was supported in part by Astar Biotech research award (XF), the Jeffress Memorial Fund award (XF) and the NIH grant P30 CA16059 to Massey Cancer Center of VCU School of Medicine.	Cairns RA, 2011, NAT REV CANCER, V11, P85, DOI 10.1038/nrc2981; Choi H, 2013, LUNG CANCER, V79, P242, DOI 10.1016/j.lungcan.2012.11.021; Choi YL, 2008, CANCER RES, V68, P4971, DOI 10.1158/0008-5472.CAN-07-6158; Dang CV, 2012, GENE DEV, V26, P877, DOI 10.1101/gad.189365.112; Dang CV, 1999, TRENDS BIOCHEM SCI, V24, P68, DOI 10.1016/S0968-0004(98)01344-9; Fang R, 2012, J BIOL CHEM, V287, P23227, DOI 10.1074/jbc.M112.373084; Ferreira JV, 2013, AUTOPHAGY, V9, P1349, DOI 10.4161/auto.25190; Friboulet L, 2014, CANCER DISCOV, V4, P662, DOI 10.1158/2159-8290.CD-13-0846; Ganapathy-Kanniappan S, 2010, CURR PHARM BIOTECHNO, V11, P510, DOI 10.2174/138920110791591427; Gershon TR, 2013, CANCER METAB, V1, DOI 10.1186/2049-3002-1-2; Goel A, 2003, J BIOL CHEM, V278, P15333, DOI 10.1074/jbc.M300608200; Hallberg B, 2013, NAT REV CANCER, V13, P685, DOI 10.1038/nrc3580; Heiden MGV, 2009, SCIENCE, V324, P1029, DOI 10.1126/science.1160809; Horn L, 2009, J CLIN ONCOL, V27, P4232, DOI 10.1200/JCO.2009.23.6661; Huang LE, 1998, P NATL ACAD SCI USA, V95, P7987, DOI 10.1073/pnas.95.14.7987; Hubbi ME, 2013, J BIOL CHEM, V288, P10703, DOI 10.1074/jbc.M112.414771; Jones RG, 2009, GENE DEV, V23, P537, DOI 10.1101/gad.1756509; Kim JW, 2007, MOL CELL BIOL, V27, P7381, DOI 10.1128/MCB.00440-07; Koivunen JP, 2008, CLIN CANCER RES, V14, P4275, DOI 10.1158/1078-0432.CCR-08-0168; Kuo AH, 2007, ONCOGENE, V26, P859, DOI 10.1038/sj.onc.1209840; Kwak EL, 2010, NEW ENGL J MED, V363, P1693, DOI 10.1056/NEJMoa1006448; Laughner E, 2001, MOL CELL BIOL, V21, P3995, DOI 10.1128/MCB.21.12.3995-4004.2001; Levine AJ, 2010, SCIENCE, V330, P1340, DOI 10.1126/science.1193494; Mano H, 2015, P JPN ACAD B-PHYS, V91, P193, DOI 10.2183/pjab.91.193; Martinengo C, 2014, CANCER RES, V74, P6094, DOI 10.1158/0008-5472.CAN-14-0268; Marzec M, 2011, ONCOGENE, V30, P1372, DOI 10.1038/onc.2010.505; Mathupala SP, 2006, ONCOGENE, V25, P4777, DOI 10.1038/sj.onc.1209603; Mathupala SP, 1997, J BIOL CHEM, V272, P22776, DOI 10.1074/jbc.272.36.22776; Mathupala SP, 1997, J BIOENERG BIOMEMBR, V29, P339, DOI 10.1023/A:1022494613613; McDonnell SRP, 2013, BLOOD, V122, P958, DOI 10.1182/blood-2013-01-482026; Messeguer X, 2002, BIOINFORMATICS, V18, P333, DOI 10.1093/bioinformatics/18.2.333; Miyamoto S, 2008, CELL DEATH DIFFER, V15, P521, DOI 10.1038/sj.cdd.4402285; Mukherjee A, 2015, NEOPLASIA, V17, P723, DOI 10.1016/j.neo.2015.09.003; Nishino M, 2012, MODERN PATHOL, V25, P1462, DOI 10.1038/modpathol.2012.109; Osthus RC, 2000, J BIOL CHEM, V275, P21797, DOI 10.1074/jbc.C000023200; Ota K, 2015, CLIN CANCER RES, V21, P4014, DOI 10.1158/1078-0432.CCR-15-0016; Patra KC, 2013, CANCER CELL, V24, P213, DOI 10.1016/j.ccr.2013.06.014; Pore N, 2006, MOL CANCER RES, V4, P471, DOI 10.1158/1541-7786.MCR-05-0234; Rempel A, 1996, CANCER RES, V56, P2468; Ren H, 2012, CANCER RES, V72, P3312, DOI 10.1158/0008-5472.CAN-11-3931; Riddle SR, 2000, AM J PHYSIOL-LUNG C, V278, pL407, DOI 10.1152/ajplung.2000.278.2.L407; Rikova K, 2007, CELL, V131, P1190, DOI 10.1016/j.cell.2007.11.025; Sasaki T, 2010, EUR J CANCER, V46, P1773, DOI 10.1016/j.ejca.2010.04.002; SATO S, 1969, CANCER RES, V29, P1437; Schonherr C, 2011, TRANSL ONCOL, V4, P248, DOI 10.1593/tlo.11139; Semenza GL, 1996, J BIOL CHEM, V271, P32529, DOI 10.1074/jbc.271.51.32529; Semenza GL, 2003, NAT REV CANCER, V3, P721, DOI 10.1038/nrc1187; Shaw AT, 2014, NEW ENGL J MED, V370, P2537, DOI 10.1056/NEJMc1404894; Shaw AT, 2009, J CLIN ONCOL, V27, P4247, DOI 10.1200/JCO.2009.22.6993; Soda M, 2007, NATURE, V448, P561, DOI 10.1038/nature05945; Soda M, 2012, CLIN CANCER RES, V18, P5682, DOI 10.1158/1078-0432.CCR-11-2947; Wang L, 2014, CELL REP, V8, P1461, DOI 10.1016/j.celrep.2014.07.053; WARBURG O, 1956, SCIENCE, V123, P309, DOI 10.1126/science.123.3191.309; Wilson JE, 2003, J EXP BIOL, V206, P2049, DOI 10.1242/jeb.00241; Wolf A, 2011, J EXP MED, V208, P313, DOI 10.1084/jem.20101470; Wu J, 2013, ONCOGENE, V32, P3198, DOI 10.1038/onc.2012.325; Ying HQ, 2012, CELL, V149, P656, DOI 10.1016/j.cell.2012.01.058; Yoshida A, 2011, AM J SURG PATHOL, V35, P1226, DOI 10.1097/PAS.0b013e3182233e06; Younes M, 1997, CANCER-AM CANCER SOC, V80, P1046, DOI 10.1002/(SICI)1097-0142(19970915)80:6<1046::AID-CNCR6>3.0.CO;2-7	59	30	30	1	15	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	NOV 24	2016	35	47					6132	6142		10.1038/onc.2016.150	http://dx.doi.org/10.1038/onc.2016.150			11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	ED0CE	27132509	Green Accepted			2022-12-26	WOS:000388509800009
J	Belinsky, GS; Sreekumar, B; Andrejecsk, JW; Saltzman, WM; Gong, JJ; Herzog, RI; Lin, S; Horsley, V; Carpenter, TO; Chung, CH				Belinsky, Glenn S.; Sreekumar, Bharath; Andrejecsk, Jillian W.; Saltzman, W. Mark; Gong, Jingjing; Herzog, Raimund I.; Lin, Samantha; Horsley, Valerie; Carpenter, Thomas O.; Chung, Chuhan			Pigment epithelium-derived factor restoration increases bone mass and improves bone plasticity in a model of osteogenesis imperfecta type VI via Wnt3a blockade	FASEB JOURNAL			English	Article						PEDF; Wnt signaling; mesenchymal stem cell	MESENCHYMAL STEM-CELLS; FACTOR PEDF; PROMOTES PROLIFERATION; SUPPRESSES; DIFFERENTIATION; EXPRESSION; SERPINF1; MUTATION; GENES; MINERALIZATION	Null mutations in for pigment epithelium-derived factor (PEDF), the protein product of the SERPINF1 gene, are the cause of osteogenesis imperfecta (OI) type VI. The PEDF-knockout (KO) mouse captures crucial elements of the human disease, including diminished bone mineralization and propensity to fracture. Our group and others have demonstrated that PEDF directs human mesenchymal stem cell (hMSC) commitment to the osteoblast lineage and modulates Wnt/beta-catenin signaling, a major regulator of bone development; however, the ability of PEDF to restore bone mass in a mouse model of OI type VI has not been determined. In this study, PEDF delivery increased trabecular bone volume/total volume by 52% in 6-mo-old PEDF-KO mice but not in wild-type mice. In young (19-d-old) PEDF-KO mice, PEDF restoration increased bone volume fraction by 35% and enhanced biomechanical parameters of bone plasticity. A Wnt-green fluorescent protein reporter demonstrated dynamic changes in Wnt/beta-catenin signaling characterized by early activation and marked suppression during terminal differentiation of hMSCs. Continuous Wnt3a exposure impeded mineralization of hMSCs, whereas the combination of Wnt3a and PEDF potentiated mineralization. Interrogation of the PEDF sequence identified a conserved motif found in other Wnt modulators, such as the dickkopf proteins. Mutation of a single amino acid on a 34-mer PEDF peptide increased mineralization of hMSC cultures compared with the native peptide sequence. These results indicate that PEDF counters Wnt signaling to allow for osteoblast differentiation and provides a mechanistic insight into how the PEDF null state results in OI type VI.	[Belinsky, Glenn S.; Sreekumar, Bharath; Gong, Jingjing; Herzog, Raimund I.; Chung, Chuhan] Yale Univ, Sch Med, Dept Med, New Haven, CT 06510 USA; [Carpenter, Thomas O.] Yale Univ, Sch Med, Dept Pediat, New Haven, CT 06510 USA; [Andrejecsk, Jillian W.; Saltzman, W. Mark] Yale Univ, Dept Biomed Engn, New Haven, CT USA; [Lin, Samantha; Horsley, Valerie] Yale Univ, Dept Mol Cellular & Dev Biol, New Haven, CT USA; [Chung, Chuhan] Vet Affairs Connecticut Healthcare Syst, West Haven, CT USA	Yale University; Yale University; Yale University; Yale University; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Connecticut Healthcare System	Chung, CH (corresponding author), Yale Univ, Sch Med, Dept Med, Sect Digest Dis, 1080 LMP, New Haven, CT 06520 USA.	chuhan.chung@yale.edu			Yale Core Center for Musculoskeletal Disorders/NIH National Institute of Arthritis and Musculoskeletal and Skin Diseases Grant [P30-AR46032]; NIH Liver Center Core Grant [DK34989]; Veterans Affairs Merit Grant; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [KL2TR001862, UL1TR000142, TL1TR001864, UL1TR001863] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [P30AR046032] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK101984, R37DK020495, P30DK034989, P30DK045735, R03DK100709] Funding Source: NIH RePORTER	Yale Core Center for Musculoskeletal Disorders/NIH National Institute of Arthritis and Musculoskeletal and Skin Diseases Grant; NIH Liver Center Core Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Veterans Affairs Merit Grant(US Department of Veterans Affairs); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	The authors thank Drs. Joan Marini [U.S. National Institutes of Health (NIH)] and Caren Gundberg (Yale University School of Medicine) for a thorough reading of the manuscript and helpful suggestions. The authors also thank Drs. Ben-hua Sun and Steven Tommasini (Yale University School of Medicine) for technical support. This work was supported by the Yale Core Center for Musculoskeletal Disorders/NIH National Institute of Arthritis and Musculoskeletal and Skin Diseases Grant P30-AR46032 (to C.C. and T.O.C.), NIH Liver Center Core Grant DK34989 (to C.C.), and Veterans Affairs Merit Grant (to C.C.).	Akiyama T, 2010, BIOCHEM BIOPH RES CO, V391, P789, DOI 10.1016/j.bbrc.2009.11.139; Apte RS, 2004, INVEST OPHTH VIS SCI, V45, P4491, DOI 10.1167/iovs.04-0172; Becker J, 2011, AM J HUM GENET, V88, P362, DOI 10.1016/j.ajhg.2011.01.015; Bogan R, 2013, J BONE MINER RES, V28, P1531, DOI 10.1002/jbmr.1892; Boland GM, 2004, J CELL BIOCHEM, V93, P1210, DOI 10.1002/jcb.20284; Bourhis E, 2011, STRUCTURE, V19, P1433, DOI 10.1016/j.str.2011.07.005; Bouxsein ML, 2010, J BONE MINER RES, V25, P1468, DOI 10.1002/jbmr.141; Caparros-Martin JA, 2013, AM J MED GENET A, V161A, P1354, DOI 10.1002/ajmg.a.35938; Cho HH, 2006, TISSUE ENG, V12, P111, DOI 10.1089/ten.2006.12.111; Chung CH, 2009, GASTROENTEROLOGY, V136, P331, DOI 10.1053/j.gastro.2008.09.065; Crowe S, 2009, CELL METAB, V10, P40, DOI 10.1016/j.cmet.2009.06.001; Cruciat CM, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a015081; Doll JA, 2003, NAT MED, V9, P774, DOI 10.1038/nm870; Farber CR, 2014, J BONE MINER RES, V29, P1402, DOI 10.1002/jbmr.2173; Forlino A, 2016, LANCET, V387, P1657, DOI 10.1016/S0140-6736(15)00728-X; Gattu AK, 2014, ENDOCRINOLOGY, V155, P1373, DOI 10.1210/en.2013-1785; Gattu AK, 2013, FASEB J, V27, P4384, DOI 10.1096/fj.13-232900; Glorieux FH, 2002, J BONE MINER RES, V17, P30, DOI 10.1359/jbmr.2002.17.1.30; Homan EP, 2011, J BONE MINER RES, V26, P2798, DOI 10.1002/jbmr.487; Jay SM, 2010, BIOMATERIALS, V31, P3054, DOI 10.1016/j.biomaterials.2010.01.014; Krishnan V, 2006, J CLIN INVEST, V116, P1202, DOI 10.1172/JCI28551; Land C, 2007, BONE, V40, P638, DOI 10.1016/j.bone.2006.10.010; Li F, 2015, J CELL PHYSIOL, V230, P1243, DOI 10.1002/jcp.24859; Li F, 2013, STEM CELLS, V31, P2714, DOI 10.1002/stem.1505; Ling L, 2009, GENE, V433, P1, DOI 10.1016/j.gene.2008.12.008; Liu GZ, 2009, J CELL BIOL, V185, P67, DOI 10.1083/jcb.200810137; Mao BY, 2003, GENE, V302, P179, DOI 10.1016/S0378-1119(02)01106-X; Marini JC, 2013, J CLIN ENDOCR METAB, V98, P3095, DOI 10.1210/jc.2013-1505; Minillo RM, 2014, MOL SYNDROMOL, V5, P268, DOI 10.1159/000369108; Park K, 2011, MOL CELL BIOL, V31, P3038, DOI 10.1128/MCB.01211-10; Petersen SV, 2003, BIOCHEM J, V374, P199, DOI 10.1042/BJ20030313; Protiva P, 2015, CELL MOL GASTROENTER, V1, P535, DOI 10.1016/j.jcmgh.2015.06.006; Rajagopal A, 2016, MOL GENET METAB, V117, P378, DOI 10.1016/j.ymgme.2015.11.015; Rauch F, 2012, J CLIN ENDOCR METAB, V97, pE1550, DOI 10.1210/jc.2012-1827; Schmitz JC, 2011, AM J PATHOL, V179, P2990, DOI 10.1016/j.ajpath.2011.08.009; Shaheen R, 2012, J MED GENET, V49, P630, DOI 10.1136/jmedgenet-2012-101142; Stephen J, 2014, AM J MED GENET A, V164, P1482, DOI 10.1002/ajmg.a.36481; Tombran-Tink J, 1996, Mol Vis, V2, P11; Tucker T, 2012, AM J MED GENET A, V158A, P1422, DOI 10.1002/ajmg.a.35319; Uhlen M, 2015, SCIENCE, V347, DOI 10.1126/science.1260419; van der Horst G, 2005, J BONE MINER RES, V20, P1867, DOI 10.1359/JBMR.050614; Venturi G, 2012, J BONE MINER RES, V27, P723, DOI 10.1002/jbmr.1480; Wang M, 2009, AM J PHYSIOL-ENDOC M, V297, pE1378, DOI 10.1152/ajpendo.00252.2009; Yamagishi S, 2006, J CLIN ENDOCR METAB, V91, P2447, DOI 10.1210/jc.2005-2654; Zheng CH, 2004, BIOCHEM BIOPH RES CO, V323, P1321, DOI 10.1016/j.bbrc.2004.09.007	45	27	28	0	10	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	AUG	2016	30	8					2837	2848		10.1096/fj.201500027R	http://dx.doi.org/10.1096/fj.201500027R			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	DS7WP	27127101	Green Published			2022-12-26	WOS:000380994000019
J	Godoi, PHC; Wilkie-Grantham, RP; Hishiki, A; Sano, R; Matsuzawa, Y; Yanagi, H; Munte, CE; Chen, Y; Yao, Y; Marassi, FM; Kalbitzer, HR; Matsuzawa, SI; Reed, JC				Godoi, Paulo H. C.; Wilkie-Grantham, Rachel P.; Hishiki, Asami; Sano, Renata; Matsuzawa, Yasuko; Yanagi, Hiroko; Munte, Claudia E.; Chen, Ya; Yao, Yong; Marassi, Francesca M.; Kalbitzer, Hans R.; Matsuzawa, Shu-ichi; Reed, John C.			Orphan Nuclear Receptor NR4A1 Binds a Novel Protein Interaction Site on Anti-apoptotic B Cell Lymphoma Gene 2 Family Proteins	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						apoptosis; autophagy; B cell lymphoma 2 (Bcl-2) family; NMR; protein-protein interaction; Bcl-b; Bfl-1; NR4A1; Nur77	BH3 MIMETIC ABT-737; BCL-B; NMR-SPECTROSCOPY; RESISTANCE; AUTOPHAGY; NUR77; BFL-1; CONFORMATION; INHIBITORS; CONVERSION	B cell lymphoma gene 2 (Bcl-2) family proteins are key regulators of programmed cell death and important targets for drug discovery. Pro-apoptotic and anti-apoptotic Bcl-2 family proteins reciprocally modulate their activities in large part through protein interactions involving a motif known as BH3 (Bcl-2 homology 3). Nur77 is an orphan member of the nuclear receptor family that lacks a BH3 domain but nevertheless binds certain anti-apoptotic Bcl-2 family proteins (Bcl-2, Bfl-1, and Bcl-B), modulating their effects on apoptosis and autophagy. We used a combination of NMR spectroscopy-based methods, mutagenesis, and functional studies to define the interaction site of a Nur77 peptide on anti-apoptotic Bcl-2 family proteins and reveal a novel interaction surface. Nur77 binds adjacent to the BH3 peptide-binding crevice, suggesting the possibility of cross-talk between these discrete binding sites. Mutagenesis of residues lining the identified interaction site on Bcl-B negated the interaction with Nur77 protein in cells and prevented Nur77-mediated modulation of apoptosis and autophagy. The findings establish a new protein interaction site with the potential to modulate the apoptosis and autophagy mechanisms governed by Bcl-2 family proteins.	[Godoi, Paulo H. C.; Wilkie-Grantham, Rachel P.; Hishiki, Asami; Sano, Renata; Matsuzawa, Yasuko; Yanagi, Hiroko; Chen, Ya; Yao, Yong; Marassi, Francesca M.; Matsuzawa, Shu-ichi; Reed, John C.] Sanford Burnham Prebys Med Discovery Inst, La Jolla, CA 92037 USA; [Munte, Claudia E.; Kalbitzer, Hans R.] Univ Regensburg, Inst Biophys & Phys Biochem, Univ Str 31, D-93040 Regensburg, Germany; [Reed, John C.] Roche, Pharma Res & Early Dev, CH-4070 Basel, Switzerland	Sanford Burnham Prebys Medical Discovery Institute; University of Regensburg; Roche Holding	Matsuzawa, SI (corresponding author), Sanford Burnham Prebys Med Discovery Inst, La Jolla, CA 92037 USA.; Reed, JC (corresponding author), Roche, Pharma Res & Early Dev, CH-4070 Basel, Switzerland.	smatsuzawa@sbpdiscovery.org; John_C.Reed@roche.com	Godoi, Paulo HC/B-9847-2012	Godoi, Paulo HC/0000-0003-1859-3513; Kalbitzer, Hans Robert/0000-0002-6514-2355	California Tobacco-related Disease Research Program Fellowship [16FT-0056]; National Institutes of Health [AI-091967, CA-179087, CA-55164, CA-81543]; NATIONAL CANCER INSTITUTE [R01CA179087, P01CA055164, P30CA030199] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI091967] Funding Source: NIH RePORTER	California Tobacco-related Disease Research Program Fellowship; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by California Tobacco-related Disease Research Program Fellowship 16FT-0056 (to P. H. C. G.) and National Institutes of Health Grants AI-091967 (to S. M.), CA-179087 (to F. M. M.), CA-55164 (to J. C. R.), and CA-81543 (to J. C. R.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Bouzas-Rodriguez J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046422; Brien G, 2007, ONCOGENE, V26, P5828, DOI 10.1038/sj.onc.1210363; Chipuk JE, 2010, MOL CELL, V37, P299, DOI 10.1016/j.molcel.2010.01.025; Ferlini C, 2009, CANCER RES, V69, P6906, DOI 10.1158/0008-5472.CAN-09-0540; Goddard T. D., SPARKY 3; Gronwald W, 2004, PROG NUCL MAG RES SP, V44, P33, DOI 10.1016/j.pnmrs.2003.12.002; Hagn F, 2010, J BIOL CHEM, V285, P3439, DOI 10.1074/jbc.M109.065391; Herman MD, 2008, FEBS LETT, V582, P3590, DOI 10.1016/j.febslet.2008.09.028; Huang J, 2015, EXPERT REV HEMATOL, V8, P283, DOI 10.1586/17474086.2015.1026321; Ichimura Y, 2008, AUTOPHAGY, V4, P1063, DOI 10.4161/auto.6826; Jung YS, 2004, J BIOMOL NMR, V30, P11, DOI 10.1023/B:JNMR.0000042954.99056.ad; Kabeya Y, 2000, EMBO J, V19, P5720, DOI 10.1093/emboj/19.21.5720; Kang R, 2011, CELL DEATH DIFFER, V18, P571, DOI 10.1038/cdd.2010.191; Khaw SL, 2014, LEUKEMIA, V28, P1207, DOI 10.1038/leu.2014.1; Kolluri SK, 2008, CANCER CELL, V14, P285, DOI 10.1016/j.ccr.2008.09.002; Konopleva M, 2006, CANCER CELL, V10, P375, DOI 10.1016/j.ccr.2006.10.006; Kumar M, 2014, CANCER RES, V74, P3271, DOI 10.1158/0008-5472.CAN-13-2015; Li H, 2000, SCIENCE, V289, P1159, DOI 10.1126/science.289.5482.1159; Lin BZ, 2004, CELL, V116, P527, DOI 10.1016/S0092-8674(04)00162-X; Luciano F, 2007, BLOOD, V109, P3849, DOI 10.1182/blood-2006-11-056879; Markley JL, 1998, J BIOMOL NMR, V12, P1, DOI 10.1023/A:1008290618449; MILLER S, 1987, J MOL BIOL, V196, P641, DOI 10.1016/0022-2836(87)90038-6; Moldoveanu T, 2014, TRENDS BIOCHEM SCI, V39, P101, DOI 10.1016/j.tibs.2013.12.006; Pattingre S, 2005, CELL, V122, P927, DOI 10.1016/j.cell.2005.07.002; Petros AM, 2001, P NATL ACAD SCI USA, V98, P3012, DOI 10.1073/pnas.041619798; Rautureau GJP, 2012, CELL DEATH DIS, V3, DOI 10.1038/cddis.2012.178; Robert G, 2012, AUTOPHAGY, V8, P637, DOI 10.4161/auto.19084; Souers AJ, 2013, NAT MED, V19, P202, DOI 10.1038/nm.3048; Tamir S, 2014, P NATL ACAD SCI USA, V111, P5177, DOI 10.1073/pnas.1403770111; Thompson J, 2008, J EXP MED, V205, P1029, DOI 10.1084/jem.20080101; van Delft MF, 2006, CANCER CELL, V10, P389, DOI 10.1016/j.ccr.2006.08.027; Vogler M, 2009, CELL DEATH DIFFER, V16, P360, DOI 10.1038/cdd.2008.137; Vogler M, 2009, BLOOD, V113, P4403, DOI 10.1182/blood-2008-08-173310; Volkmann N, 2014, CELL DEATH DIFFER, V21, P206, DOI 10.1038/cdd.2013.153; Wang WJ, 2014, NAT CHEM BIOL, V10, P133, DOI [10.1038/nchembio.1406, 10.1038/NCHEMBIO.1406]; Wendt MD, 2008, EXPERT OPIN DRUG DIS, V3, P1123, DOI 10.1517/17460441.3.9.1123; Williamson MP, 2013, PROG NUCL MAG RES SP, V73, P1, DOI 10.1016/j.pnmrs.2013.02.001; Yao Y, 2015, J MOL BIOL, V427, P2262, DOI 10.1016/j.jmb.2015.02.019; Yecies D, 2010, BLOOD, V115, P3304, DOI 10.1182/blood-2009-07-233304; Yip KW, 2008, J BIOMOL SCREEN, V13, P665, DOI 10.1177/1087057108320918; Ziarek JJ, 2011, METHOD ENZYMOL, V493, P241, DOI 10.1016/B978-0-12-381274-2.00010-8	41	14	14	2	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 1	2016	291	27					14072	14084		10.1074/jbc.M116.715235	http://dx.doi.org/10.1074/jbc.M116.715235			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DR5XG	27129202	hybrid, Green Published			2022-12-26	WOS:000379975100016
J	Lee, SG; Nwumeh, R; Jez, JM				Lee, Soon Goo; Nwumeh, Ronald; Jez, Joseph M.			Structure and Mechanism of Isopropylmalate Dehydrogenase from Arabidopsis thaliana: INSIGHTS ON LEUCINE AND ALIPHATIC GLUCOSINOLATE BIOSYNTHESIS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						enzyme; plant biochemistry; protein evolution; protein structure; x-ray crystallography; reaction mechanism	THERMOPHILUS 3-ISOPROPYLMALATE DEHYDROGENASE; ACID-BASE CHEMISTRY; THERMUS-THERMOPHILUS; CLONING; EXPRESSION; COMPLEX; ENZYME	Isopropylmalate dehydrogenase (IPMDH) and 3-(2-methylthio)ethylmalate dehydrogenase catalyze the oxidative decarboxylation of different -hydroxyacids in the leucine- and methionine-derived glucosinolate biosynthesis pathways, respectively, in plants. Evolution of the glucosinolate biosynthetic enzyme from IPMDH results from a single amino acid substitution that alters substrate specificity. Here, we present the x-ray crystal structures of Arabidopsis thaliana IPMDH2 (AtIPMDH2) in complex with either isopropylmalate and Mg2+ or NAD(+). These structures reveal conformational changes that occur upon ligand binding and provide insight on the active site of the enzyme. The x-ray structures and kinetic analysis of site-directed mutants are consistent with a chemical mechanism in which Lys-232 activates a water molecule for catalysis. Structural analysis of the AtIPMDH2 K232M mutant and isothermal titration calorimetry supports a key role of Lys-232 in the reaction mechanism. This study suggests that IPMDH-like enzymes in both leucine and glucosinolate biosynthesis pathways use a common mechanism and that members of the -hydroxyacid reductive decarboxylase family employ different active site features for similar reactions.	[Lee, Soon Goo; Nwumeh, Ronald; Jez, Joseph M.] Washington Univ, Dept Biol, Campus Box 1137, St Louis, MO 63130 USA	Washington University (WUSTL)	Jez, JM (corresponding author), Washington Univ, Dept Biol, Campus Box 1137, St Louis, MO 63130 USA.	jjez@wustl.edu		Lee, Soon Goo/0000-0002-1541-8587	National Science Foundation [MCB-0904215]; Department of Energy Office of Biological and Environmental Research [DE-AC02-06CH11357]; Washington University Summer Scholars Program in Biology and Biomedicine; Washington University uSTAR Summer Scholars Program	National Science Foundation(National Science Foundation (NSF)); Department of Energy Office of Biological and Environmental Research(United States Department of Energy (DOE)); Washington University Summer Scholars Program in Biology and Biomedicine; Washington University uSTAR Summer Scholars Program	This work was supported in part by National Science Foundation Grant MCB-0904215. Portions of this research were carried out at the Argonne National Laboratory Structural Biology Center of the Advanced Photon Source, a national user facility operated by the University of Chicago for the Department of Energy Office of Biological and Environmental Research Grant DE-AC02-06CH11357. The authors declare that they have no conflicts of interest with the contents of this article.; Supported in part by the Washington University Summer Scholars Program in Biology and Biomedicine and the Washington University uSTAR Summer Scholars Program.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Agerbirk N, 2012, PHYTOCHEMISTRY, V77, P16, DOI 10.1016/j.phytochem.2012.02.005; Aktas DF, 2009, BIOCHEMISTRY-US, V48, P3565, DOI 10.1021/bi8022976; ELLERSTROM M, 1992, PLANT MOL BIOL, V18, P557, DOI 10.1007/BF00040671; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Graczer E, 2016, BIOCHEMISTRY-US, V55, P560, DOI 10.1021/acs.biochem.5b00839; Halkier BA, 2006, ANNU REV PLANT BIOL, V57, P303, DOI 10.1146/annurev.arplant.57.032905.105228; He Y, 2011, J BIOL CHEM, V286, P28794, DOI 10.1074/jbc.M111.262519; He Y, 2011, NEW PHYTOL, V189, P160, DOI 10.1111/j.1469-8137.2010.03460.x; He Y, 2009, PLANT J, V60, P679, DOI 10.1111/j.1365-313X.2009.03990.x; HURLEY JH, 1994, STRUCTURE, V2, P1007, DOI 10.1016/S0969-2126(94)00104-9; IMADA K, 1991, J MOL BIOL, V222, P725, DOI 10.1016/0022-2836(91)90508-4; Imada K, 1998, STRUCTURE, V6, P971, DOI 10.1016/S0969-2126(98)00099-9; JACKSON SD, 1993, MOL GEN GENET, V236, P309, DOI 10.1007/BF00277127; KADONO S, 1995, J BIOCHEM-TOKYO, V118, P745, DOI 10.1093/oxfordjournals.jbchem.a124975; Karsten WE, 2005, BIOCHEMISTRY-US, V44, P3626, DOI 10.1021/bi047826o; Karsten WE, 1998, BIOCHEMISTRY-US, V37, P15691, DOI 10.1021/bi9812827; Knill T, 2008, PLANT PHYSIOL, V146, P1028, DOI 10.1104/pp.107.111609; Kroymann J, 2011, CURR OPIN PLANT BIOL, V14, P246, DOI 10.1016/j.pbi.2011.03.021; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Miyazaki J, 2005, J BACTERIOL, V187, P6779, DOI 10.1128/JB.187.19.6779-6788.2005; MIYAZAKI K, 1993, FEBS LETT, V332, P37, DOI 10.1016/0014-5793(93)80478-D; Nozawa A, 2005, BIOSCI BIOTECH BIOCH, V69, P806, DOI 10.1271/bbb.69.806; Ober D, 2005, TRENDS PLANT SCI, V10, P444, DOI 10.1016/j.tplants.2005.07.007; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Schuster J, 2006, PLANT CELL, V18, P2664, DOI 10.1105/tpc.105.039339; Taylor AB, 2008, J BIOL CHEM, V283, P10872, DOI 10.1074/jbc.M708719200; Textor S, 2004, PLANTA, V218, P1026, DOI 10.1007/s00425-003-1184-3; Textor S, 2007, PLANT PHYSIOL, V144, P60, DOI 10.1104/pp.106.091579; Wallon G, 1997, J MOL BIOL, V266, P1016, DOI 10.1006/jmbi.1996.0797	30	10	10	0	31	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 24	2016	291	26					13421	13430		10.1074/jbc.M116.730358	http://dx.doi.org/10.1074/jbc.M116.730358			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DR2YZ	27137927	hybrid, Green Submitted, Green Published			2022-12-26	WOS:000379771100002
J	Chen, SM; Feng, T; Spasic, MV; Altamura, S; Breitkopf-Heinlein, K; Altenoder, J; Weiss, TS; Dooley, S; Muckenthaler, MU				Chen, Simeng; Feng, Teng; Spasic, Maja Vujic; Altamura, Sandro; Breitkopf-Heinlein, Katja; Altenoeder, Jutta; Weiss, Thomas S.; Dooley, Steven; Muckenthaler, Martina U.			Transforming Growth Factor beta 1 (TGF-beta 1) Activates Hepcidin mRNA Expression in Hepatocytes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HEREDITARY HEMOCHROMATOSIS PROTEIN; TRANSFERRIN RECEPTOR; IRON OVERLOAD; SMAD1/5 PHOSPHORYLATION; HUMAN CHONDROCYTES; I RECEPTORS; HFE; CELLS; LIVER; GENE	The hepatic hormone hepcidin is the master regulator of systemic iron homeostasis. Its expression level is adjusted to alterations in iron levels, inflammatory cues, and iron requirements for erythropoiesis. Bone morphogenetic protein 6 (BMP6) contributes to the iron-dependent control of hepcidin. In addition, TGF-beta 1 may stimulate hepcidin mRNA expression in murine hepatocytes and human leukocytes. However, receptors and downstream signaling proteins involved in TGF-beta 1-induced hepcidin expression are still unclear. Here we show that TGF-beta 1 treatment of mouse and human hepatocytes, as well as ectopic expression of TGF-beta 1 in mice, increases hepcidin mRNA levels. The hepcidin response to TGF-beta 1 depends on functional TGF-beta 1 type I receptor (ALK5) and TGF-beta 1 type II receptor (T beta RII) and is mediated by a noncanonical mechanism that involves Smad1/5/8 phosphorylation. Interestingly, increasing availability of canonical Smad2/3 decreases TGF-beta 1-induced hepcidin regulation, whereas the BMP6-hepcidin signal was enhanced, indicating a signaling component stoichiometry-dependent cross-talk between the two pathways. Although ALK2/3-dependent hepcidin activation by BMP6 can be modulated by each of the three hemochromatosis-associated proteins: HJV (hemojuvelin), HFE (hemochromatosis protein), and TfR2 (transferrin receptor 2), these proteins do not control the ALK5-mediated hepcidin response to TGF-beta 1. TGF-beta 1 mRNA levels are increased in mouse models of iron overload, indicating that TGF-beta 1 may contribute to hepcidin synthesis under these conditions. In conclusion, these data demonstrate that a complex regulatory network involving TGF-beta 1 and BMP6 may control the sensing of systemic and/or hepatic iron levels.	[Chen, Simeng; Spasic, Maja Vujic; Altamura, Sandro; Muckenthaler, Martina U.] Heidelberg Univ, Dept Pediat Hematol Oncol & Immunol, D-69117 Heidelberg, Germany; [Chen, Simeng; Feng, Teng; Breitkopf-Heinlein, Katja; Altenoeder, Jutta; Dooley, Steven] Heidelberg Univ, Med Fac Mannheim, Mol Hepatol, Dept Med 2, D-68167 Mannheim, Germany; [Chen, Simeng; Spasic, Maja Vujic; Altamura, Sandro; Muckenthaler, Martina U.] Mol Med Partnership Unit, D-69120 Heidelberg, Germany; [Weiss, Thomas S.] Univ Regensburg Hosp, Dept Pediat & Juvenile Med, Ctr Liver Cell Res, D-93053 Regensburg, Germany	Ruprecht Karls University Heidelberg; Ruprecht Karls University Heidelberg; University of Regensburg	Muckenthaler, MU (corresponding author), Heidelberg Univ, Dept Pediat Hematol Oncol & Immunol, D-69117 Heidelberg, Germany.; Dooley, S (corresponding author), Heidelberg Univ, Med Fac Mannheim, Mol Hepatol, Dept Med 2, D-68167 Mannheim, Germany.; Muckenthaler, MU (corresponding author), Mol Med Partnership Unit, D-69120 Heidelberg, Germany.	Steven.Dooley@medma.uni-heidelberg.de; Martina.Muckenthaler@med.uni-heidelberg.de	Dooley, Steven/T-6491-2018; Weiss, Thomas S./G-3989-2012; Altamura, Sandro/R-1195-2016	Dooley, Steven/0000-0002-4840-6240; Weiss, Thomas S./0000-0003-0336-0581; Muckenthaler, Martina/0000-0002-3778-510X; Altamura, Sandro/0000-0002-6781-1073	Federal Ministry of Education and Research (Germany) in Virtual Liver Network Projects [0315755, 0315761]; European Union; CellNetworks of Heidelberg University; Deutsche Forschungsgemeinschaft [SFB 1036]	Federal Ministry of Education and Research (Germany) in Virtual Liver Network Projects; European Union(European Commission); CellNetworks of Heidelberg University; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by the Federal Ministry of Education and Research (Germany) in Virtual Liver Network Projects 0315755 and 0315761. This work was also supported by a grant from the European Union FP7 Marie Curie International Training Network IT-Liver (to T. F.). The authors declare that they have no conflicts of interest with the contents of this article.r Supported by the Postdoc Program of CellNetworks of Heidelberg University.r Supported by Deutsche Forschungsgemeinschaft Grant SFB 1036.	Ahmad KA, 2002, BLOOD CELL MOL DIS, V29, P361, DOI 10.1006/bcmd.2002.0575; Altamura S, 2014, CELL METAB, V20, P359, DOI 10.1016/j.cmet.2014.07.007; Armitage AE, 2011, BLOOD, V118, P4129, DOI 10.1182/blood-2011-04-351957; Babitt JL, 2007, J CLIN INVEST, V117, P1933, DOI 10.1172/JCI31342; Bennett MJ, 2000, NATURE, V403, P46, DOI 10.1038/47417; Bharathy S, 2008, CANCER RES, V68, P1656, DOI 10.1158/0008-5472.CAN-07-5089; Bridle KR, 2003, LANCET, V361, P669, DOI 10.1016/S0140-6736(03)12602-5; Butz H, 2012, TRENDS PHARMACOL SCI, V33, P382, DOI 10.1016/j.tips.2012.04.003; Casanovas G, 2009, J MOL MED, V87, P471, DOI 10.1007/s00109-009-0447-2; Castoldi M, 2011, J CLIN INVEST, V121, P1386, DOI 10.1172/JCI44883; Chen JX, 2007, J BIOL CHEM, V282, P36862, DOI 10.1074/jbc.M706720200; Corradini E, 2011, GASTROENTEROLOGY, V141, P1907, DOI 10.1053/j.gastro.2011.06.077; Corradini E, 2009, GASTROENTEROLOGY, V137, P1489, DOI 10.1053/j.gastro.2009.06.057; D'Alessio F, 2012, J HEPATOL, V57, P1052, DOI 10.1016/j.jhep.2012.06.015; Daly AC, 2008, MOL CELL BIOL, V28, P6889, DOI 10.1128/MCB.01192-08; Dong J, 2005, ARTERIOSCL THROM VAS, V25, P1078, DOI 10.1161/01.ATV.0000159701.24372.49; Dooley S, 2012, CELL TISSUE RES, V347, P245, DOI 10.1007/s00441-011-1246-y; Falzacappa MVV, 2008, J MOL MED, V86, P531, DOI 10.1007/s00109-008-0313-7; Falzacappa MVV, 2007, BLOOD, V109, P353, DOI 10.1182/blood-2006-07-033969; Fechner H, 1999, GENE THER, V6, P1520, DOI 10.1038/sj.gt.3301030; Finnson KW, 2010, OSTEOARTHR CARTILAGE, V18, P1518, DOI 10.1016/j.joca.2010.09.002; Finnson KW, 2008, J BONE MINER RES, V23, P896, DOI 10.1359/JBMR.080209; Fujii M, 1999, MOL BIOL CELL, V10, P3801, DOI 10.1091/mbc.10.11.3801; Ganz T, 2013, PHYSIOL REV, V93, P1721, DOI 10.1152/physrev.00008.2013; Goswami T, 2006, J BIOL CHEM, V281, P28494, DOI 10.1074/jbc.C600197200; Goumans MJ, 2002, EMBO J, V21, P1743, DOI 10.1093/emboj/21.7.1743; Goumans MJ, 2003, MOL CELL, V12, P817, DOI 10.1016/S1097-2765(03)00386-1; Gronroos E, 2012, MOL CELL BIOL, V32, P2904, DOI 10.1128/MCB.00231-12; Hentze MW, 2010, CELL, V142, P24, DOI 10.1016/j.cell.2010.06.028; Houglum K, 1997, HEPATOLOGY, V26, P605, DOI 10.1002/hep.510260311; Inman GJ, 2002, MOL PHARMACOL, V62, P65, DOI 10.1124/mol.62.1.65; Kato M, 2009, NAT CELL BIOL, V11, P881, DOI 10.1038/ncb1897; Lee P, 2005, P NATL ACAD SCI USA, V102, P1906, DOI 10.1073/pnas.0409808102; Lee PL, 2004, BLOOD, V103, P4669, DOI 10.1182/blood-2004-01-0072; Liu IM, 2009, EMBO J, V28, P88, DOI 10.1038/emboj.2008.266; Massague J, 2012, NAT REV MOL CELL BIO, V13, P616, DOI 10.1038/nrm3434; Muckenthaler M, 2003, NAT GENET, V34, P102, DOI 10.1038/ng1152; Nemeth E, 2005, BLOOD, V105, P1803, DOI 10.1182/blood-2004-08-3042; Nemeth E, 2004, J CLIN INVEST, V113, P1271, DOI 10.1172/JCI200420945; Nurgazieva D, 2015, J IMMUNOL, V194, P709, DOI 10.4049/jimmunol.1300272; Ramos E, 2011, HEPATOLOGY, V53, P1333, DOI 10.1002/hep.24178; Ryan JD, 2010, HEPATOLOGY, V52, P1266, DOI 10.1002/hep.23814; Sanvitale CE, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062721; Shayakhmetov DM, 2004, J VIROL, V78, P5368, DOI 10.1128/JVI.78.10.5368-5381.2004; Sime PJ, 1997, J CLIN INVEST, V100, P768, DOI 10.1172/JCI119590; Spasic MV, 2013, BBA-MOL BASIS DIS, V1832, P76, DOI 10.1016/j.bbadis.2012.08.013; Steinbicker AU, 2011, BLOOD, V118, P4224, DOI 10.1182/blood-2011-03-339952; Thompson MD, 2011, HEPATOLOGY, V54, P1333, DOI 10.1002/hep.24506; Wallace DF, 2007, GASTROENTEROLOGY, V132, P301, DOI 10.1053/j.gastro.2006.11.028; Warburton D, 2013, AM J PHYSIOL-LUNG C, V304, pL83, DOI 10.1152/ajplung.00258.2012; Weng HL, 2007, HEPATOLOGY, V46, P1257, DOI 10.1002/hep.21806; Wiercinska E, 2006, HEPATOLOGY, V43, P1032, DOI 10.1002/hep.21135; Wrighting DM, 2006, BLOOD, V108, P3204, DOI 10.1182/blood-2006-06-027631; Wrighton KH, 2009, J BIOL CHEM, V284, P9755, DOI 10.1074/jbc.M809223200; Wu XG, 2014, BLOOD, V124, P1335, DOI 10.1182/blood-2014-01-552281; Xia Y, 2008, BLOOD, V111, P5195, DOI 10.1182/blood-2007-09-111567; Xia Y, 2007, J BIOL CHEM, V282, P18129, DOI 10.1074/jbc.M701679200	57	22	24	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 17	2016	291	25					13160	13174		10.1074/jbc.M115.691543	http://dx.doi.org/10.1074/jbc.M115.691543			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DR2YT	27129231	hybrid, Green Published			2022-12-26	WOS:000379770500023
J	Ren, YJ; Zhao, Y; Lin, DD; Xu, XM; Zhu, QY; Yao, J; Shu, HB; Zhong, B				Ren, Yujie; Zhao, Yin; Lin, Dandan; Xu, Ximing; Zhu, Qiyun; Yao, Jing; Shu, Hong-Bing; Zhong, Bo			The Type I Interferon-IRF7 Axis Mediates Transcriptional Expression of Usp25 Gene	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NF-KAPPA-B; VIRAL-INFECTION; POSITIVE FEEDBACK; IMMUNE-RESPONSES; IKK-EPSILON; ACTIVATION; INDUCTION; PATHWAY; BINDING; ROLES	Viral infection or lipopolysaccharide (LPS) treatment induces expression of a large array of genes, the products of which play a critical role in host antipathogen immunity and inflammation. We have previously reported that the expression of ubiquitin-specific protease 25 (USP25) is significantly up-regulated after viral infection or LPS treatment, and this is essential for innate immune signaling. However, the mechanism behind this phenomenon is unclear. In this study, we found that viral infection-induced up-regulation of Usp25 is diminished in cells lacking interferon regulatory factor 7 (IRF7) or interferon alpha receptor 1 (IFNAR1) but not p65. Sendai virus- or type I interferon-induced up-regulation of Usp25 requires de novo protein synthesis of IRF7. Furthermore, IRF7 directly binds to the two conserved IRF binding sites on the USP25 promoter to drive transcription of Usp25, and mutation of these two sites abolished Sendai virus-induced IRF7-mediated activation of the USP25 promoter. Our study has uncovered a previously unknown mechanism by which viral infection or LPS induces up-regulation of USP25.	[Ren, Yujie; Zhao, Yin; Yao, Jing; Zhong, Bo] Wuhan Univ, Coll Life Sci, State Key Lab Virol, Wuhan 430072, Peoples R China; [Shu, Hong-Bing; Zhong, Bo] Wuhan Univ, Sch Med, Med Res Inst, Wuhan 430071, Peoples R China; [Lin, Dandan; Xu, Ximing] Wuhan Univ, Renmin Hosp, Ctr Canc, Wuhan 430060, Peoples R China; [Zhu, Qiyun] Chinese Acad Agr Sci, Lanzhou Vet Res Inst, State Key Lab Vet Etiol Biol, Lanzhou 730046, Peoples R China	Wuhan University; Wuhan University; Wuhan University; Chinese Academy of Agricultural Sciences; Lanzhou Veterinary Research Institute, CAAS	Zhong, B (corresponding author), Wuhan Univ, Coll Life Sci, State Key Lab Virol, Wuhan 430072, Peoples R China.; Zhong, B (corresponding author), Wuhan Univ, Sch Med, Med Res Inst, Wuhan 430071, Peoples R China.	zhongbo@whu.edu.cn	Lin, Dandan/GRJ-2233-2022	Zhao, Yin/0000-0001-7007-2999; Yao, Jing/0000-0003-1844-3988	Ministry of Science and Technology of China [2014CB542601, 2012CB910201]; National Natural Science Foundation of China [31371427, 31271209]; Ministry of Education of China [201427]; State Key Laboratory of Veterinary Etiological Biology [SKLVEB2015KFKT001]; Natural Science Foundation of Hubei Province [2015CFA095]; Large-scale Instrument and Equipment Sharing Foundation of Wuhan University	Ministry of Science and Technology of China(Ministry of Science and Technology, China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Ministry of Education of China(Ministry of Education, China); State Key Laboratory of Veterinary Etiological Biology; Natural Science Foundation of Hubei Province(Natural Science Foundation of Hubei Province); Large-scale Instrument and Equipment Sharing Foundation of Wuhan University	This work was supported by Ministry of Science and Technology of China Grants 2014CB542601 and 2012CB910201, National Natural Science Foundation of China Grants 31371427 and 31271209, Ministry of Education of China Grant 201427, State Key Laboratory of Veterinary Etiological Biology Grant SKLVEB2015KFKT001, Natural Science Foundation of Hubei Province Grant 2015CFA095, and the Large-scale Instrument and Equipment Sharing Foundation of Wuhan University. The authors declare that they have no conflicts of interest with the contents of this article.	Akira S, 2006, CELL, V124, P783, DOI 10.1016/j.cell.2006.02.015; BAEUERLE PA, 1994, ANNU REV IMMUNOL, V12, P141, DOI 10.1146/annurev.immunol.12.1.141; Bonnard M, 2000, EMBO J, V19, P4976, DOI 10.1093/emboj/19.18.4976; Bosch-Comas A, 2006, CELL MOL LIFE SCI, V63, P723, DOI 10.1007/s00018-005-5533-1; Crouse J, 2015, NAT REV IMMUNOL, V15, P231, DOI 10.1038/nri3806; Fitzgerald KA, 2003, NAT IMMUNOL, V4, P491, DOI 10.1038/ni921; Gajewski TF, 2015, CYTOKINE GROWTH F R, V26, P175, DOI 10.1016/j.cytogfr.2015.01.001; Hemmi H, 2004, J EXP MED, V199, P1641, DOI 10.1084/jem.20040520; Hoffmann HH, 2015, TRENDS IMMUNOL, V36, P124, DOI 10.1016/j.it.2015.01.004; Honda K, 2005, NATURE, V434, P772, DOI 10.1038/nature03464; Honda K, 2006, IMMUNITY, V25, P349, DOI 10.1016/j.immuni.2006.08.009; Ivashkiv LB, 2014, NAT REV IMMUNOL, V14, P36, DOI 10.1038/nri3581; Levy DE, 2012, IMMUNITY, V36, P553, DOI 10.1016/j.immuni.2012.04.003; Lin DD, 2015, P NATL ACAD SCI USA, V112, P11324, DOI 10.1073/pnas.1509968112; Lin RT, 2000, MOL CELL BIOL, V20, P6342, DOI 10.1128/MCB.20.17.6342-6353.2000; Lochte S, 2014, J CELL BIOL, V207, P407, DOI 10.1083/jcb.201406032; Marie I, 1998, EMBO J, V17, P6660, DOI 10.1093/emboj/17.22.6660; McWhirter SM, 2004, P NATL ACAD SCI USA, V101, P233, DOI 10.1073/pnas.2237236100; Nguyen VP, 2002, J BIOL CHEM, V277, P9713, DOI 10.1074/jbc.m111161200; Perry AK, 2004, J EXP MED, V199, P1651, DOI 10.1084/jem.20040528; Platanias LC, 2005, NAT REV IMMUNOL, V5, P375, DOI 10.1038/nri1604; Prakash A, 2006, BIOCHEM BIOPH RES CO, V342, P50, DOI 10.1016/j.bbrc.2006.01.122; Sato M, 2000, IMMUNITY, V13, P539, DOI 10.1016/S1074-7613(00)00053-4; Sato M, 1998, FEBS LETT, V441, P106, DOI 10.1016/S0014-5793(98)01514-2; Schreiber G, 2015, TRENDS IMMUNOL, V36, P139, DOI 10.1016/j.it.2015.01.002; Sharma S, 2003, SCIENCE, V300, P1148, DOI 10.1126/science.1081315; Stark GR, 2012, IMMUNITY, V36, P503, DOI 10.1016/j.immuni.2012.03.013; Stifter SA, 2015, J IMMUNOL, V194, P2455, DOI 10.4049/jimmunol.1402794; Takeda Kiyoshi, 2015, Curr Protoc Immunol, V109, DOI 10.1002/0471142735.im1412s109; Takeuchi O, 2010, CELL, V140, P805, DOI 10.1016/j.cell.2010.01.022; Taniguchi T, 2001, ANNU REV IMMUNOL, V19, P623, DOI 10.1146/annurev.immunol.19.1.623; Tenoever BR, 2007, SCIENCE, V315, P1274, DOI 10.1126/science.1136567; Wu JX, 2014, ANNU REV IMMUNOL, V32, P461, DOI 10.1146/annurev-immunol-032713-120156; Yang JB, 2008, CELL RES, V18, P443, DOI 10.1038/cr.2008.41; Zhong B, 2008, IMMUNITY, V29, P538, DOI 10.1016/j.immuni.2008.09.003; Zhong B, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2003708	36	21	22	2	27	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 17	2016	291	25					13206	13215		10.1074/jbc.M116.718080	http://dx.doi.org/10.1074/jbc.M116.718080			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DR2YT	27129230	hybrid, Green Published			2022-12-26	WOS:000379770500026
J	Velasquez, SY; Killian, D; Schulte, J; Sticht, C; Thiel, M; Lindner, HA				Velasquez, Sonia Y.; Killian, Doreen; Schulte, Jutta; Sticht, Carsten; Thiel, Manfred; Lindner, Holger A.			Short Term Hypoxia Synergizes with Interleukin 15 Priming in Driving Glycolytic Gene Transcription and Supports Human Natural Killer Cell Activities	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MIGRATION INHIBITORY FACTOR; TUMOR MICROENVIRONMENT; INDUCIBLE FACTOR-1; IMMUNE CELLS; GRANZYME-B; EXPRESSION; CANCER; ACTIVATION; CYTOTOXICITY; METABOLISM	Natural killer (NK) cells induce apoptosis in infected and transformed cells and are important producers of immunoregulatory cytokines. Therefore, they operate under low oxygen conditions (hypoxia) in inflammatory and tumor environments. In vitro studies of NK cells are, however, commonly performed in ambient air (normoxia). We used global gene expression profiling to evaluate changes in transcriptional pathways in primary human NK cells following short term culture under hypoxia compared with normoxia and in response to interleukin 15 (IL-15) priming using a 2 x 2 factorial design. The largest contrasts observed were priming dependences for associations between hypoxia and the hypoxia-inducible factor (Hif) 1 signaling and glycolysis pathways. RT-PCR confirmed positive synergistic hypoxia/IL-15 interactions for genes of key regulatory and metabolic enzymes. IL-15 primes NK cells for effector functions, which were recently demonstrated to depend on glycolytic switching. We did not, however, observe important increases in glycolytic flux through hypoxia and priming alone. Chemical Hif-1 alpha inhibition suggested equal importance of this transcription factor for glycolysis and energy production under normoxia and hypoxia. Hypoxia promoted secretion of CC chemokines Ccl3/4/5 and macrophage migration inhibitory factor. Unexpectedly, hypoxia also stimulated migration of NK cells through the extracellular matrix and shifted amounts of susceptible leukemia target cells toward late apoptosis in a cell killing assay. We conclude that short term hypoxia supports these activities by positively interacting with NK cell priming at the level of glycolytic gene transcription. Hypoxic conditioning of NK cells may thus benefit their use in cell-based immunotherapy of cancer.	[Velasquez, Sonia Y.; Killian, Doreen; Schulte, Jutta; Thiel, Manfred; Lindner, Holger A.] Heidelberg Univ, Dept Anesthesiol & Surg Intens Care Med, Med Fac Mannheim, Theodor Kutzer Ufer 1-3, D-68167 Mannheim, Germany; [Sticht, Carsten] Heidelberg Univ, Univ Med Ctr Mannheim, Med Fac Mannheim, Med Res Ctr, D-68167 Mannheim, Germany	Ruprecht Karls University Heidelberg; Ruprecht Karls University Heidelberg	Lindner, HA (corresponding author), Heidelberg Univ, Dept Anesthesiol & Surg Intens Care Med, Med Fac Mannheim, Theodor Kutzer Ufer 1-3, D-68167 Mannheim, Germany.	holger.lindner@medma.uni-heidelberg.de	Lindner, Holger A/C-5106-2014	Lindner, Holger A/0000-0002-6679-4355				Allavena P, 1997, J LEUKOCYTE BIOL, V61, P729, DOI 10.1002/jlb.61.6.729; Arnaud C, 2011, AM J RESP CRIT CARE, V184, P724, DOI 10.1164/rccm.201012-2033OC; Bacher M, 2003, AM J PATHOL, V162, P11, DOI 10.1016/S0002-9440(10)63793-5; Baginska J, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00490; Balsamo M, 2013, EUR J IMMUNOL, V43, P2756, DOI 10.1002/eji.201343448; Bentz S, 2013, DIGESTION, V88, P182, DOI 10.1159/000355015; Berthou C, 2000, BLOOD, V95, P2329, DOI 10.1182/blood.V95.7.2329.007k34_2329_2336; Bezu L, 2015, FRONT IMMUNOL, V6, DOI 10.3389/fimmu.2015.00187; Bosco MC, 2008, IMMUNOBIOLOGY, V213, P733, DOI 10.1016/j.imbio.2008.07.031; Buck MD, 2015, J EXP MED, V212, P1345, DOI 10.1084/jem.20151159; Carreau A, 2011, J CELL MOL MED, V15, P1239, DOI 10.1111/j.1582-4934.2011.01258.x; Casazza A, 2014, ONCOGENE, V33, P1743, DOI 10.1038/onc.2013.121; Childs RW, 2015, NAT REV DRUG DISCOV, V14, P487, DOI 10.1038/nrd4506; Cowell RM, 2002, STROKE, V33, P795, DOI 10.1161/hs0302.103740; Dai MH, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni179; Domogala A, 2015, FRONT IMMUNOL, V6, DOI 10.3389/fimmu.2015.00264; Donnelly RP, 2014, J IMMUNOL, V193, P4477, DOI 10.4049/jimmunol.1401558; Edsparr K, 2011, CANCER MICROENVIRON, V4, P351, DOI 10.1007/s12307-010-0057-0; Edsparr K, 2009, IMMUNOL CELL BIOL, V87, P489, DOI 10.1038/icb.2009.35; Eltzschig HK, 2011, NEW ENGL J MED, V364, P656, DOI 10.1056/NEJMra0910283; Fink T, 2003, SCAND J IMMUNOL, V58, P607, DOI 10.1111/j.1365-3083.2003.01347.x; Finlay DK, 2012, J EXP MED, V209, P2441, DOI 10.1084/jem.20112607; Ganeshan K, 2014, ANNU REV IMMUNOL, V32, P609, DOI 10.1146/annurev-immunol-032713-120236; Ghesquiere B, 2014, NATURE, V511, P167, DOI 10.1038/nature13312; Gonsalves C, 2010, J IMMUNOL, V185, P6253, DOI 10.4049/jimmunol.1000660; Grayson MH, 2006, AM J RESP CELL MOL, V35, P143, DOI 10.1165/rcmb.f318; Grieb G, 2010, DRUG NEWS PERSPECT, V23, P257, DOI 10.1358/dnp.2010.23.4.1453629; Grimm M, 2013, BMC CANCER, V13, DOI 10.1186/1471-2407-13-569; Hatfield SM, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aaa1260; Hira E, 2005, CANCER, V103, P588, DOI 10.1002/cncr.20818; Horng T, 2015, TRENDS IMMUNOL, V36, P1, DOI [10.1016/Lit.2014.11.004, 10.1016/j.it.2014.11.004]; Kepp O, 2011, CANCER METAST REV, V30, P61, DOI 10.1007/s10555-011-9273-4; Keppel MP, 2015, J IMMUNOL, V194, P1954, DOI 10.4049/jimmunol.1402099; Kim JW, 2006, CELL METAB, V3, P177, DOI 10.1016/j.cmet.2006.02.002; Kim TD, 2011, BLOOD, V118, P5476, DOI 10.1182/blood-2011-04-347526; Knorr DA, 2014, SEMIN IMMUNOL, V26, P161, DOI 10.1016/j.smim.2014.02.002; Krockenberger M, 2008, J IMMUNOL, V180, P7338, DOI 10.4049/jimmunol.180.11.7338; Kung AL, 2004, CANCER CELL, V6, P33, DOI 10.1016/j.ccr.2004.06.009; Kurschus FC, 2005, BLOOD, V105, P2049, DOI 10.1182/blood-2004-06-2180; Lin SS, 2012, CANCER SCI, V103, P904, DOI 10.1111/j.1349-7006.2012.02259.x; Long EO, 2013, ANNU REV IMMUNOL, V31, P227, DOI 10.1146/annurev-immunol-020711-075005; Maghazachi AA, 2010, CURR TOP MICROBIOL, V341, P37, DOI 10.1007/82_2010_20; Marais A, 2014, NAT IMMUNOL, V15, P749, DOI 10.1038/ni.2936; Martinvalet D, 2005, IMMUNITY, V22, P355, DOI 10.1016/j.immuni.2005.02.004; Maurer M, 2004, INT J BIOCHEM CELL B, V36, P1882, DOI 10.1016/j.biocel.2003.10.019; Mishra A, 2014, CLIN CANCER RES, V20, P2044, DOI 10.1158/1078-0432.CCR-12-3603; Nandagopal N, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00187; Ohta A, 2011, FRONT IMMUNOL, V2, DOI 10.3389/fimmu.2011.00027; Palazon A, 2014, IMMUNITY, V41, P518, DOI 10.1016/j.immuni.2014.09.008; Papandreou I, 2006, CELL METAB, V3, P187, DOI 10.1016/j.cmet.2006.01.012; Pearce EJ, 2015, NAT REV IMMUNOL, V15, P18, DOI 10.1038/nri3771; Pearce EL, 2013, IMMUNITY, V38, P633, DOI 10.1016/j.immuni.2013.04.005; Peter C, 2010, APOPTOSIS, V15, P1007, DOI 10.1007/s10495-010-0472-1; Prakash MD, 2014, IMMUNITY, V41, P960, DOI 10.1016/j.immuni.2014.11.012; Roiniotis J, 2009, J IMMUNOL, V182, P7974, DOI 10.4049/jimmunol.0804216; Sarkar S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064835; Semenza GL, 2009, PHYSIOLOGY, V24, P97, DOI 10.1152/physiol.00045.2008; Simons D, 2011, J CELL MOL MED, V15, P668, DOI 10.1111/j.1582-4934.2010.01041.x; Sitkovsky M, 2005, NAT REV IMMUNOL, V5, P712, DOI 10.1038/nri1685; Skurk T, 2009, HORM METAB RES, V41, P183, DOI 10.1055/s-0028-1093345; Smyth MJ, 2005, MOL IMMUNOL, V42, P501, DOI 10.1016/j.molimm.2004.07.034; Spencer JA, 2014, NATURE, V508, P269, DOI 10.1038/nature13034; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; TAUB DD, 1995, J IMMUNOL, V155, P3877; Telang S, 2012, J TRANSL MED, V10, DOI 10.1186/1479-5876-10-95; Van den Bergh JMJ, 2015, CYTOKINE GROWTH F R, V26, P15, DOI 10.1016/j.cytogfr.2014.09.001; Vivier E, 2011, SCIENCE, V331, DOI 10.1126/science.1198687; Walmsley SR, 2005, J EXP MED, V201, P105, DOI 10.1084/jem.20040624; Yalcin A, 2009, EXP MOL PATHOL, V86, P174, DOI 10.1016/j.yexmp.2009.01.003; Yeligar SM, 2009, J IMMUNOL, V183, P5964, DOI 10.4049/jimmunol.0901564; Yoon SR, 2015, EXP MOL MED, V47, DOI 10.1038/emm.2014.114; Yoshida S, 2003, J LEUKOCYTE BIOL, V73, P137, DOI 10.1189/jlb.0302117	72	52	54	1	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 17	2016	291	25					12960	12977		10.1074/jbc.M116.721753	http://dx.doi.org/10.1074/jbc.M116.721753			18	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DR2YT	27129235	Green Published, hybrid			2022-12-26	WOS:000379770500007
J	Herbin, M; Simonis, C; Reveret, L; Hackert, R; Libourel, PA; Eugene, D; Diaz, J; de Waele, C; Vidal, PP				Herbin, Marc; Simonis, Caroline; Reveret, Lionel; Hackert, Remi; Libourel, Paul-Antoine; Eugene, Daniel; Diaz, Jorge; de Waele, Catherine; Vidal, Pierre-Paul			Dopamine Modulates Motor Control in a Specific Plane Related to Support	PLOS ONE			English	Article							MEMBRANE-PROPERTIES; PARKINSONS-DISEASE; VESTIBULAR NEURONS; CIRCLING BEHAVIOR; RATS; MICE; MODEL; DEGENERATION; IMPAIRMENT; MUTANTS	At the acute stage following unilateral labyrinthectomy (UL), rats, mice or guinea pigs exhibit a complex motor syndrome combining circling (HSCC lesion) and rolling (utricular lesion). At the chronic stage, they only display circling, because proprioceptive information related to the plane of support substitutes the missing utricular information to control posture in the frontal plane. Circling is also observed following unilateral lesion of the mesencephalic dopaminergic neurons by 6-hydroxydopamine hydrobromide (6-OHDA rats) and systemic injection of apomorphine (APO rats). The resemblance of behavior induced by unilateral vestibular and dopaminergic lesions at the chronic stage can be interpreted in two ways. One hypothesis is that the dopaminergic system exerts three-dimensional control over motricity, as the vestibular system does. If this hypothesis is correct, then a unilateral lesion of the nigro-striatal pathway should induce three-dimensional motor deficits, i.e., circling and at least some sort of barrel rolling at the acute stage of the lesion. Then, compensation could also take place very rapidly based on proprioception, which would explain the prevalence of circling. In addition, barrel rolling should reappear when the rodent is placed in water, as it occurs in UL vertebrates. Alternatively, the dopaminergic network, together with neurons processing the horizontal canal information, could control the homeostasis of posture and locomotion specifically in one and only one plane of space, i.e. the plane related to the basis of support. In that case, barrel rolling should never occur, whether at the acute or chronic stage on firm ground or in water. Moreover, circling should have the same characteristics following both types of lesions. Clearly, 6-OHDA and APO-rats never exhibited barrel rolling at the acute stage. They circled at the acute stage of the lesion and continued to do so three weeks later, including in water. In contrast, UL-rats, exhibited both circling and barrel rolling at the acute stage, and then only circled on the ground. Furthermore, barrel rolling instantaneously reappeared in water in UL rats, which was not the case in 6-OHDA and APO-rats. That is, the lesion of the dopaminergic system on one side did not compromise trim in the pitch and roll planes, even when proprioceptive information related to the basis of support was lacking as in water. Altogether, these results strongly suggest that dopamine does not exert three-dimensional control of the motor system but regulates postural control in one particular plane of space, the one related to the basis of support. In contrast, as previously shown, the vestibular system exerts three-dimensional control on posture. That is, we show here for the first time a relationship between a given neuromodulator and the spatial organization of motor control.	[Herbin, Marc; Simonis, Caroline; Hackert, Remi; Libourel, Paul-Antoine] Museum Natl Hist Nat, Dept EGB, UMR MNHN CNRS 7179, CP 55,57 Rue Cuvier, F-75231 Paris 05, France; [Simonis, Caroline] MENESR, DEPP, 61-65 Rue Dudot, F-75015 Paris, France; [Reveret, Lionel] CNRS UMR 5224 INRIA UJF, INRIA Rhone Alpes, LJK, 655 Av Europe, F-38330 Montbonnot St Martin, France; [Libourel, Paul-Antoine] Ctr Rech Neurosci Lyon, CNRS, INSERM,U1028,UMR5292,Fac Med Laennec, SLEEP Physiopathol Reseaux Neuronaux Cycle Sommei, 7 Rue Guillaume Paradin, F-69372 Lyon, France; [Eugene, Daniel] Univ Paris 05, CNRS, Ctr Neurophys, UMR 8119,Physiol,Pathol, 45 Rue St Peres, F-75270 Paris 06, France; [Diaz, Jorge] Univ Paris 05, INSERM, UMR 894, Ctr Psychiat & Neurosci, 2ter,Rue Alesia, F-78014 Paris, France; [de Waele, Catherine; Vidal, Pierre-Paul] COGNAC G Univ Paris Descartes, CNRS UMR MD SSA, 45 Rue St Peres, F-75270 Paris 06, France	Museum National d'Histoire Naturelle (MNHN); Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Mathematical Sciences (INSMI); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite	Herbin, M (corresponding author), Museum Natl Hist Nat, Dept EGB, UMR MNHN CNRS 7179, CP 55,57 Rue Cuvier, F-75231 Paris 05, France.	herbin@mnhn.fr		Hackert, Remi/0000-0002-8752-9999; Diaz, Jorge/0000-0001-9894-0444	CNRS; Paris Descartes University; Museum National d'Histoire Naturelle de Paris; ANR Kameleon [ANR-05MMSA-00002]	CNRS(Centre National de la Recherche Scientifique (CNRS)); Paris Descartes University; Museum National d'Histoire Naturelle de Paris; ANR Kameleon(French National Research Agency (ANR))	This study was funded by grants from the CNRS, Paris Descartes University, the Museum National d'Histoire Naturelle de Paris and the ANR Kameleon (ANR-05MMSA-00002).; The authors would like to thank S. Deforges, Laboratoire de Neurobiologie des Reseaux Sensorimoteurs for her help in characterizing the lesion of the dopaminergic system. They are also indebted to the members of UMR7179, E. Pelle, who provided attentive care for the animals, T. Decamps and L. Botton-Divet who helped us in making some figures, and K. Boyle who improved the English of the manuscript. This study was funded by grants from the CNRS, Paris Descartes University, the Museum National d'Histoire Naturelle de Paris and the ANR Kameleon (ANR-05MMSA-00002).	ARCHER T, 1988, PHARMACOL BIOCHEM BE, V31, P357, DOI 10.1016/0091-3057(88)90358-9; Armstrong PA, 2015, EXP BRAIN RES, V233, P1825, DOI 10.1007/s00221-015-4254-4; Bellissimo MI, 2004, NEUROBIOL LEARN MEM, V82, P150, DOI 10.1016/j.nlm.2004.06.006; Brach Jennifer S, 2005, J Neuroeng Rehabil, V2, P21, DOI 10.1186/1743-0003-2-21; DEWAELE C, 1989, EXP BRAIN RES, V77, P166, DOI 10.1007/BF00250579; Eugene D, 2007, J PHYSIOL-LONDON, V583, P923, DOI 10.1113/jphysiol.2007.133710; Ferro MM, 2005, J NEUROSCI METH, V148, P78, DOI 10.1016/j.jneumeth.2005.04.005; GLICK SD, 1976, LIFE SCI, V18, P889, DOI 10.1016/0024-3205(76)90405-7; Goode CT, 2001, J NEUROPHYSIOL, V85, P1119, DOI 10.1152/jn.2001.85.3.1119; Haobam R, 2005, BEHAV BRAIN RES, V163, P159, DOI 10.1016/j.bbr.2005.04.011; Ishiguro A, 2007, INT J NEUROSCI, V117, P1049, DOI 10.1080/00207450600936874; Jones SM, 2004, HEARING RES, V191, P34, DOI 10.1016/j.heares.2004.01.008; KEEFE KA, 1989, ARCH NEUROL-CHICAGO, V46, P1070, DOI 10.1001/archneur.1989.00520460046012; Loscher W, 2010, NEUROSCI BIOBEHAV R, V34, P31, DOI 10.1016/j.neubiorev.2009.07.001; Mura A, 2003, MOVEMENT DISORD, V18, P860, DOI 10.1002/mds.10472; Ornitz DM, 1998, HEARING RES, V122, P60, DOI 10.1016/S0378-5955(98)00080-X; Paxinos G., 1998, RAT BRAIN STEROTAXIC; Straka H, 2005, PROG NEUROBIOL, V76, P349, DOI 10.1016/j.pneurobio.2005.10.002; Stuchlik A, 2007, NEUROSCI LETT, V422, P169, DOI 10.1016/j.neulet.2007.06.012; Torres AC, 1999, NEUROSCIENCE, V92, P1475, DOI 10.1016/S0306-4522(99)00078-0; UNGERSTEDT U, 1971, ACTA PHYSIOL SCAND, P69; UNGERSTEDT U, 1971, ACTA PHYSIOL SCAND, P49; UNGERSTEDT U, 1968, EUR J PHARMACOL, V5, P107, DOI 10.1016/0014-2999(68)90164-7; UNGERSTEDT U, 1969, BRAIN RES, V14, P461, DOI 10.1016/0006-8993(69)90122-X; VIDAL PP, 1993, PROG BRAIN RES, V97, P229; WHISHAW IQ, 1987, BEHAV BRAIN RES, V24, P125, DOI 10.1016/0166-4328(87)90250-6; Zhao X, 2008, NEUROSCIENCE, V153, P289, DOI 10.1016/j.neuroscience.2008.01.055	27	8	8	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 4	2016	11	5							e0155058	10.1371/journal.pone.0155058	http://dx.doi.org/10.1371/journal.pone.0155058			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DL5KR	27145032	Green Published, gold, Green Submitted			2022-12-26	WOS:000375676400098
J	Horst, K; Eschbach, D; Pfeifer, R; Relja, B; Sassen, M; Steinfeldt, T; Wulf, H; Vogt, N; Frink, M; Ruchholtz, S; Pape, HC; Hildebrand, F				Horst, K.; Eschbach, D.; Pfeifer, R.; Relja, B.; Sassen, M.; Steinfeldt, T.; Wulf, H.; Vogt, N.; Frink, M.; Ruchholtz, S.; Pape, H. C.; Hildebrand, F.			Long-Term Effects of Induced Hypothermia on Local and Systemic Inflammation - Results from a Porcine Long-Term Trauma Model	PLOS ONE			English	Article							MILD HYPOTHERMIA; THERAPEUTIC HYPOTHERMIA; GENE-EXPRESSION; CARDIAC-ARREST; PROFOUND HYPOTHERMIA; ENDOTHELIAL-CELLS; LETHAL HEMORRHAGE; CLINICAL-PRACTICE; IMMUNE-SYSTEM; BRAIN-INJURY	Background Hypothermia has been discussed as playing a role in improving the early phase of systemic inflammation. However, information on the impact of hypothermia on the local inflammatory response is sparse. We therefore investigated the kinetics of local and systemic inflammation in the late posttraumatic phase after induction of hypothermia in an established porcine long-term model of combined trauma. Materials & Methods Male pigs (35 +/- 5kg) were mechanically ventilated and monitored over the study period of 48 h. Combined trauma included tibia fracture, lung contusion, liver laceration and pressure-controlled hemorrhagic shock (MAP < 30 +/- 5 mmHg for 90 min). After resuscitation, hypothermia (33 degrees C) was induced for a period of 12 h (HT-T group) with subsequent rewarming over a period of 10 h. The NT-T group was kept normothermic. Systemic and local (fracture hematoma) cytokine levels (IL-6, -8, -10) and alarmins (HMGB1, HSP70) were measured via ELISA. Results Severe signs of shock as well as systemic and local increases of pro-inflammatory mediators were observed in both trauma groups. In general the local increase of pro-and anti-inflammatory mediator levels was significantly higher and prolonged compared to systemic concentrations. Induction of hypothermia resulted in a significantly prolonged elevation of both systemic and local HMGB1 levels at 48 h compared to the NT-T group. Correspondingly, local IL-6 levels demonstrated a significantly prolonged increase in the HT-T group at 48 h. Conclusion A prolonged inflammatory response might reduce the well-described protective effects on organ and immune function observed in the early phase after hypothermia induction. Furthermore, local immune response also seems to be affected. Future studies should aim to investigate the use of therapeutic hypothermia at different degrees and duration of application.	[Horst, K.; Pfeifer, R.; Pape, H. C.; Hildebrand, F.] Univ Hosp Aachen, Dept Orthoped Trauma, Pauwelsstr 30, D-52074 Aachen, Germany; [Horst, K.; Pape, H. C.; Hildebrand, F.] Univ Hosp Aachen, Harald Tscherne Res Lab, Pauwelsstr 30, D-52074 Aachen, Germany; [Eschbach, D.; Frink, M.; Ruchholtz, S.] Univ Hosp Marburg, Dept Hand Traumatol & Reconstruct Surg, Marburg, Germany; [Relja, B.] Goethe Univ Frankfurt, Dept Trauma Hand & Reconstruct Surg, D-60054 Frankfurt, Germany; [Sassen, M.; Steinfeldt, T.; Wulf, H.] Univ Hosp Marburg, Dept Anesthesiol, Marburg, Germany; [Vogt, N.] Univ Hosp Giessen, Dept Neurosurg, Giessen, Germany	RWTH Aachen University; RWTH Aachen University Hospital; RWTH Aachen University; RWTH Aachen University Hospital; University Hospital of Giessen & Marburg; Goethe University Frankfurt; University Hospital of Giessen & Marburg; University Hospital of Giessen & Marburg	Horst, K (corresponding author), Univ Hosp Aachen, Dept Orthoped Trauma, Pauwelsstr 30, D-52074 Aachen, Germany.; Horst, K (corresponding author), Univ Hosp Aachen, Harald Tscherne Res Lab, Pauwelsstr 30, D-52074 Aachen, Germany.	khorst@ukaachen.de	Relja, Borna/B-6642-2016; Hildebrand, Frank/J-3176-2017	Relja, Borna/0000-0002-5625-8823; Pape, Hans-Christoph/0000-0002-2059-4980	AO-Trauma, Germany	AO-Trauma, Germany	The article was proofread by Proof-Reading-Service.com, Devonshire Business Centre, Works Road, Letchworth Garden City, SG6 1GJ, United Kingdom. We would like to thank Jan Goloup, Nick Lippitz, Christin Buttner, and Johanna Miller for their support in conducting the experiments. We also thank Katharina Eisoldt, Andreas Gockel, and Petra Ewers for their substantial commitment during the entire investigation. This research project is supported by AO-Trauma, Germany.	Alam HB, 2010, J TRAUMA, V68, P1084, DOI 10.1097/TA.0b013e3181d76bd1; Andersson U, 2000, J EXP MED, V192, P565, DOI 10.1084/jem.192.4.565; Bastian O, 2011, J LEUKOCYTE BIOL, V89, P669, DOI 10.1189/jlb.0810446; Bisschops LLA, 2014, CRIT CARE, V18, DOI 10.1186/s13054-014-0546-5; Bisschops LLA, 2012, CRIT CARE MED, V40, P1136, DOI 10.1097/CCM.0b013e3182377050; Chen CW, 2014, NEUROL RES, V36, P897, DOI 10.1179/1743132814Y.0000000374; Chen Z, 2005, RESUSCITATION, V66, P209, DOI 10.1016/j.resuscitation.2005.01.021; Claes L, 2012, NAT REV RHEUMATOL, V8, P133, DOI 10.1038/nrrheum.2012.1; Cohen MJ, 2009, CRIT CARE, V13, DOI 10.1186/cc8152; Crossley S, 2014, CRIT CARE, V18, DOI 10.1186/cc13835; Currie HN, 2014, CYTOKINE, V66, P112, DOI 10.1016/j.cyto.2014.01.001; De Benedetti F, 2006, ARTHRITIS RHEUM, V54, P3551, DOI 10.1002/art.22175; Delavary BM, 2011, IMMUNOBIOLOGY, V216, P753, DOI 10.1016/j.imbio.2011.01.001; Diestel A, 2008, CRYOBIOLOGY, V57, P216, DOI 10.1016/j.cryobiol.2008.08.005; Drapalova J, 2014, CRYOBIOLOGY, V68, P269, DOI 10.1016/j.cryobiol.2014.02.007; Dresner-Pollak R, 2004, GASTROENTEROLOGY, V127, P792, DOI 10.1053/j.gastro.2004.06.013; Eschbach D, 2015, EUR J MED RES, V20, DOI 10.1186/s40001-015-0162-0; Fantus Richard J, 2015, Bull Am Coll Surg, V100, P61; Flohe SB, 2008, INNATE IMMUN-LONDON, V14, P333, DOI 10.1177/1753425908100016; Frohlich M, 2014, J TRAUMA ACUTE CARE, V76, P1425, DOI 10.1097/TA.0000000000000224; George ME, 2010, J TRAUMA, V68, P662, DOI 10.1097/TA.0b013e3181d3cbc0; Haider AH, 2009, J SURG RES, V153, P138, DOI 10.1016/j.jss.2008.04.011; Hashiguchi N, 2003, J TRAUMA, V55, P1054, DOI 10.1097/01.TA.0000033252.43742.8B; Hauser CJ, 1997, J TRAUMA, V42, P895, DOI 10.1097/00005373-199705000-00021; Hayashi S, 2005, ACT NEUR S, V95, P269; Heiner DE, 2006, J ORTHOP TRAUMA, V20, P27, DOI 10.1097/01.bot.0000184143.90448.aa; Hildebrand F, 2005, CYTOKINE, V31, P382, DOI 10.1016/j.cyto.2005.06.008; Hildebrand F, 2004, AM J SURG, V187, P363, DOI 10.1016/j.amjsurg.2003.12.016; Hildebrand F, 2014, INTENS CARE MED EXP, V2, DOI 10.1186/2197-425X-2-16; Hoff P, 2013, CELL MOL IMMUNOL, V10, P151, DOI 10.1038/cmi.2012.56; Horst K, 2015, MEDIAT INFLAMM, V2015, DOI 10.1155/2015/126060; Huet O, 2007, ACTA ANAESTH SCAND, V51, P1211, DOI 10.1111/j.1399-6576.2007.01419.x; Kolar P, 2011, CLIN ORTHOP RELAT R, V469, P3118, DOI 10.1007/s11999-011-1865-3; Kortbeek JB, 2008, J TRAUMA, V64, P1638, DOI 10.1097/TA.0b013e3181744b03; Liu DW, 2006, EUR J ORAL SCI, V114, P42, DOI 10.1111/j.1600-0722.2006.00283.x; Lotze MT, 2005, NAT REV IMMUNOL, V5, P331, DOI 10.1038/nri1594; Luchette F, 2010, J TRAUMA, V69, P530; Manganelli V, 2010, CRIT CARE, V14, DOI 10.1186/cc9316; Mantovani A, 2002, TRENDS IMMUNOL, V23, P549, DOI 10.1016/S1471-4906(02)02302-5; Metsemakers WJ, 2015, INJURY, V46, P740, DOI 10.1016/j.injury.2014.12.018; Moffatt SE, 2013, EMERG MED J, V30, P989, DOI 10.1136/emermed-2012-201883; Mohr J, 2013, J TRAUMA ACUTE CARE, V74, P1014, DOI 10.1097/TA.0b013e3182826edd; Mommsen P, 2013, INJURY, V44, P86, DOI 10.1016/j.injury.2011.10.013; Morita Y, 2009, CYTOKINE, V47, P48, DOI 10.1016/j.cyto.2009.04.004; Mosser DM, 2008, NAT REV IMMUNOL, V8, P958, DOI 10.1038/nri2448; Oddo M, 2006, CRIT CARE MED, V34, P1865, DOI 10.1097/01.CCM.0000221922.08878.49; Recknagel S, 2011, J ORTHOP RES, V29, P734, DOI 10.1002/jor.21299; Ruchholtz S, 2013, CHIRURG, V84, P730, DOI 10.1007/s00104-013-2474-3; Sasaki H, 2000, J IMMUNOL, V165, P3626, DOI 10.4049/jimmunol.165.7.3626; Schmidt-Bleek K, 2014, J TISSUE ENG REGEN M, V8, P120, DOI 10.1002/term.1505; Schmidt-Bleek K, 2012, CELL TISSUE RES, V347, P567, DOI 10.1007/s00441-011-1205-7; Schmidt-Bleek K, 2009, J ORTHOP RES, V27, P1147, DOI 10.1002/jor.20901; Shin HI, 2004, ENDOCRINOLOGY, V145, P1376, DOI 10.1210/en.2003-0839; Sims NA, 2004, J CLIN INVEST, V113, P379, DOI 10.1172/JCI200419872; So HY, 2010, KOREAN J ANESTHESIOL, V59, P299, DOI 10.4097/kjae.2010.59.5.299; Song H, 2008, CLIN EXP IMMUNOL, V152, P311, DOI 10.1111/j.1365-2249.2008.03643.x; Soreide K, 2014, INJURY, V45, P647, DOI 10.1016/j.injury.2012.12.027; Steel J, 2010, J TRAUMA, V69, P523, DOI 10.1097/TA.0b013e3181e90c24; Street J, 2000, CLIN ORTHOP RELAT R, P224, DOI 10.1097/00003086-200009000-00033; Taniguchi N, 2007, MOL CELL BIOL, V27, P5650, DOI 10.1128/MCB.00130-07; Tisherman SA, 2004, J TRAUMA, V57, P898, DOI 10.1097/01.TA.0000133577.25793.E5; Toben D, 2011, J BONE MINER RES, V26, P113, DOI 10.1002/jbmr.185; Vaagenes P, 2003, RESUSCITATION, V58, P103, DOI 10.1016/S0300-9572(03)00102-3; vanderPoll T, 1997, J INFECT DIS, V176, P439, DOI 10.1086/514062; Venjakob AJ, 2013, J ORTHOP RES, V31, P1820, DOI 10.1002/jor.22417; Weuster M, 2015, MEDIAT INFLAMM, V2015, DOI 10.1155/2015/829195; Wu XR, 2003, CRIT CARE MED, V31, P195, DOI 10.1097/00003246-200301000-00030	67	16	16	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 4	2016	11	5							e0154788	10.1371/journal.pone.0154788	http://dx.doi.org/10.1371/journal.pone.0154788			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DL5KR	27144532	Green Published, gold			2022-12-26	WOS:000375676400071
J	Hughes, SJ; Antoshchenko, T; Chen, Y; Lu, H; Pizarro, JC; Park, HW				Hughes, Scott J.; Antoshchenko, Tetyana; Chen, Yun; Lu, Hua; Pizarro, Juan C.; Park, Hee-Won			Probing the ATP Site of GRP78 with Nucleotide Triphosphate Analogs	PLOS ONE			English	Article							MACROMOLECULAR STRUCTURES; BINDING-SITE; HEAVY-CHAIN; CANCER; NUCLEOSIDE; LIGAND; CRYSTALLOGRAPHY; REFINEMENT; TUBERCIDIN; ACTIVATION	GRP78, a member of the ER stress protein family, can relocate to the surface of cancer cells, playing key roles in promoting cell proliferation and metastasis. GRP78 consists of two major functional domains: the ATPase and protein/peptide-binding domains. The protein/peptide-binding domain of cell-surface GRP78 has served as a novel functional receptor for delivering cytotoxic agents (e.g., a apoptosis-inducing peptide or taxol) across the cell membrane. Here, we report our study on the ATPase domain of GRP78 (GRP78(ATPase)), whose potential as a transmembrane delivery system of cytotoxic agents (e.g., ATP-based nucleotide triphosphate analogs) remains unexploited. As the binding of ligands (ATP analogs) to a receptor (GRP78(ATPase)) is a pre-requisite for internalization, we determined the binding affinities and modes of GRP78(ATPase) for ADP, ATP and several ATP analogs using surface plasmon resonance and x-ray crystallography. The tested ATP analogs contain one of the following modifications: the nitrogen at the adenine ring 7-position to a carbon atom (7-deazaATP), the oxygen at the beta-gamma bridge position to a carbon atom (AMPPCP), or the removal of the 2'-OH group (2'-deoxyATP). We found that 7-deazaATP displays an affinity and a binding mode that resemble those of ATP regardless of magnesium ion (Mg++) concentration, suggesting that GRP78 is tolerant to modifications at the 7-position. By comparison, AMPPCP's binding affinity was lower than ATP and Mg++-dependent, as the removal of Mg++ nearly abolished binding to GRP78(ATPase). The AMPPCP-Mg++ structure showed evidence for the critical role of Mg++ in AMPPCP binding affinity, suggesting that while GRP78 is sensitive to modifications at the beta-gamma bridge position, these can be tolerated in the presence of Mg++. Furthermore, 2'-deoxyATP's binding affinity was significantly lower than those for all other nucleotides tested, even in the presence of Mg++. The 2'-deoxyATP structure showed the conformation of the bound nucleotide flipped out of the active site, explaining the low affinity binding to GRP78 and suggesting that the 2'-OH group is essential for the high affinity binding to GRP78. Together, our results demonstrate that GRP78(ATPase) possesses nucleotide specificity more relaxed than previously anticipated and can tolerate certain modifications to the nucleobase 7-position and, to a lesser extent, the beta-gamma bridging atom, thereby providing a possible atomic mechanism underlying the transmembrane transport of the ATP analogs.	[Hughes, Scott J.] Univ Toronto, Dept Pharmacol & Toxicol, Toronto, ON M5G 1L7, Canada; [Antoshchenko, Tetyana; Chen, Yun; Lu, Hua; Park, Hee-Won] Tulane Sch Med, Dept Biochem & Mol Biol, New Orleans, LA 70112 USA; [Pizarro, Juan C.] Tulane Univ, Dept Trop Med, Sch Publ Hlth & Trop Med, New Orleans, LA 70112 USA	University of Toronto; Tulane University; Tulane University	Park, HW (corresponding author), Tulane Sch Med, Dept Biochem & Mol Biol, New Orleans, LA 70112 USA.	hpark1@tulane.edu		Hughes, Scott/0000-0001-8360-929X; Chen, Yun/0000-0003-0547-9463	Canada Foundation for Innovation; Natural Sciences and Engineering Research Council of Canada; University of Saskatchewan; Government of Saskatchewan; Western Economic Diversification Canada; National Research Council Canada; Canadian Institutes of Health Research; National Cancer Institute [ACB-12002]; National Institute of General Medical Sciences [AGM-12006]; U.S. Department of Energy, Office of Biological and Environmental Research [DE-AC02-06CH11357]; NIH-NCI [R01CA095441, R01CA172468, R01CA127724, R21 CA190775]; Louisiana board of Regents [LEQSF(2015-18)-RD-A-27, LEQSF-EPS(2015)-PFUND-417]; NATIONAL CANCER INSTITUTE [R01CA127724, R21CA190775, R01CA095441, R01CA172468] Funding Source: NIH RePORTER	Canada Foundation for Innovation(Canada Foundation for InnovationCGIAR); Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); University of Saskatchewan; Government of Saskatchewan; Western Economic Diversification Canada; National Research Council Canada; Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); U.S. Department of Energy, Office of Biological and Environmental Research(United States Department of Energy (DOE)); NIH-NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Louisiana board of Regents; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Research described in this paper was in part performed at three different synchrotron beamlines: Beamline 08ID-1 at the Canadian Light Source, the GM/CA AND SBC beamlines of Advanced Photon Source at Argonne National Laboratory. The 08ID-1 is supported by the Canada Foundation for Innovation, Natural Sciences and Engineering Research Council of Canada, the University of Saskatchewan, the Government of Saskatchewan, Western Economic Diversification Canada, the National Research Council Canada, and the Canadian Institutes of Health Research. The GM/CA has been funded in whole or in part with Federal funds from the National Cancer Institute (ACB-12002) and the National Institute of General Medical Sciences (AGM-12006). Argonne is operated by UChicago Argonne, LLC, for the U.S. Department of Energy, Office of Biological and Environmental Research under contract DE-AC02-06CH11357. H.L. was supported in part by NIH-NCI grants, R01CA095441, R01CA172468, R01CA127724, and R21 CA190775. H.W.P. was supported in part by Louisiana board of Regents grants, LEQSF(2015-18)-RD-A-27 and LEQSF-EPS(2015)-PFUND-417. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arap MA, 2004, CANCER CELL, V6, P275, DOI 10.1016/j.ccr.2004.08.018; Berdis AJ, 2008, BIOCHEMISTRY-US, V47, P8253, DOI 10.1021/bi801179f; BERGSTROM DE, 1984, J MED CHEM, V27, P285, DOI 10.1021/jm00369a010; Bourderioux A, 2011, J MED CHEM, V54, P5498, DOI 10.1021/jm2005173; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Evans P, 2006, ACTA CRYSTALLOGR D, V62, P72, DOI 10.1107/S0907444905036693; Galmarini CM, 2008, CURR MED CHEM, V15, P1072, DOI 10.2174/092986708784221449; GAUT JR, 1993, J BIOL CHEM, V268, P7248; Hattori M, 2012, NATURE, V485, P207, DOI 10.1038/nature11010; HEATON FW, 1990, MET IONS BIOL SYST, V26, P119; HOWLIN B, 1993, J APPL CRYSTALLOGR, V26, P622, DOI 10.1107/S0021889893002729; Idzko M, 2014, NATURE, V509, P310, DOI 10.1038/nature13085; Jordheim LP, 2013, NAT REV DRUG DISCOV, V12, P447, DOI 10.1038/nrd4010; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; KASSENBROCK CK, 1989, EMBO J, V8, P1461, DOI 10.1002/j.1460-2075.1989.tb03529.x; Kim Y, 2006, BIOCHEMISTRY-US, V45, P9434, DOI 10.1021/bi060264j; Lee AS, 2007, CANCER RES, V67, P3496, DOI 10.1158/0008-5472.CAN-07-0325; Lee SA, 2007, J BIOL CHEM, V282, P15271, DOI 10.1074/jbc.M701362200; Levesque SA, 2007, BRIT J PHARMACOL, V152, P141, DOI 10.1038/sj.bjp.0707361; Liu Y, 2007, MOL PHARMACEUT, V4, P435, DOI 10.1021/mp060122j; Macias AT, 2011, J MED CHEM, V54, P4034, DOI 10.1021/jm101625x; Moriarty NW, 2009, ACTA CRYSTALLOGR D, V65, P1074, DOI 10.1107/S0907444909029436; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Ni M, 2011, BIOCHEM J, V434, P181, DOI 10.1042/BJ20101569; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Schuttelkopf AW, 2004, ACTA CRYSTALLOGR D, V60, P1355, DOI 10.1107/S0907444904011679; TOLMAN RL, 1969, J AM CHEM SOC, V91, P2102, DOI 10.1021/ja01036a040; Vagin A, 2010, ACTA CRYSTALLOGR D, V66, P22, DOI 10.1107/S0907444909042589; Wang XJ, 2004, NUCLEOS NUCLEOT NUCL, V23, P161, DOI 10.1081/NCN-120027825; WEI JY, 1995, J BIOL CHEM, V270, P26670, DOI 10.1074/jbc.270.44.26670; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Wisniewska M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008625; Yan M, 2011, BIOCHEM J, V438, P447, DOI 10.1042/BJ20110500; Yang J, 2015, STRUCTURE, V23, P2191, DOI 10.1016/j.str.2015.10.012; Zhang J, 2014, NATURE, V509, P119, DOI 10.1038/nature13288; Zhang J, 2007, CANCER METAST REV, V26, P85, DOI 10.1007/s10555-007-9044-4; Zimmermann H, 2012, PURINERG SIGNAL, V8, P437, DOI 10.1007/s11302-012-9309-4	39	13	13	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 4	2016	11	5							e0154862	10.1371/journal.pone.0154862	http://dx.doi.org/10.1371/journal.pone.0154862			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DL5KR	27144892	gold, Green Published, Green Submitted			2022-12-26	WOS:000375676400085
J	Siegelmann-Danieli, N; Farkash, A; Katzir, I; Landes, JV; Rabinovich, HR; Lomnicky, Y; Carmeli, B; Parush-Shear-Yashuv, N				Siegelmann-Danieli, Nava; Farkash, Ariel; Katzir, Itzhak; Landes, Janet Vesterman; Rabinovich, Hadas Rotem; Lomnicky, Yossef; Carmeli, Boaz; Parush-Shear-Yashuv, Naama			A Novel Computational Tool for Mining Real-Life Data: Application in the Metastatic Colorectal Cancer Care Setting	PLOS ONE			English	Article							CLINICAL-TRIALS; OBSERVATIONAL COHORT; ELDERLY-PATIENTS; PHASE-3 TRIAL; LUNG-CANCER; BEVACIZUMAB; CHEMOTHERAPY; FOLFIRI; EFFICACY; FLUOROURACIL	Background Randomized clinical trials constitute the gold-standard for evaluating new anti-cancer therapies; however, real-life data are key in complementing clinically useful information. We developed a computational tool for real-life data analysis and applied it to the metastatic colorectal cancer (mCRC) setting. This tool addressed the impact of oncology/non-oncology parameters on treatment patterns and clinical outcomes. Methods The developed tool enables extraction of any computerized information including comorbidities and use of drugs (oncological/non-oncological) per individual HMO member. The study in which we evaluated this tool was a retrospective cohort study that included Maccabi Healthcare Services members with mCRC receiving bevacizumab with fluoropyrimidines (FP), FP plus oxaliplatin (FP-O), or FP plus irinotecan (FP-I) in the first-line between 9/2006 and 12/2013. Results The analysis included 753 patients of whom 15.4% underwent subsequent metastasectomy (the Surgery group). For the entire cohort, median overall survival (OS) was 20.5 months; in the Surgery group, median duration of bevacizumab-containing therapy (DOT) pre-surgery was 6.1 months; median OS was not reached. In the Non-surgery group, median OS and DOT were 18.7 and 11.4 months, respectively; no significant OS differences were noted between FP-O and FP-I, whereas FP use was associated with shorter OS (12.3 month; p < 0.002; notably, these patients were older). Patients who received both FP-O- and FP-Ibased regimens achieved numerically longer OS vs. those who received only one of these regimens (22.1 [19.9-24.0] vs. 18.9 [15.5-21.9] months). Among patients assessed for wild-type KRAS and treated with subsequent anti-EGFR agent, OS was 25.4 months and 18.7 months for 124 treated vs. 37 non-treated patients (non-significant). Cox analysis (controlling for age and gender) identified several non-oncology parameters associated with poorer clinical outcomes including concurrent use of diuretics and proton-pump inhibitors. Conclusions Our tool provided insights that confirmed/complemented information gained from randomized-clinical trials. Prospective tool implementation is warranted.	[Siegelmann-Danieli, Nava] Maccabi Healthcare Serv, Dept Profess Med, Tel Aviv, Israel; [Farkash, Ariel; Carmeli, Boaz; Parush-Shear-Yashuv, Naama] IBM Res Haifa, Dept Biomed Informat, Haifa Univ Campus, Haifa, Israel; [Katzir, Itzhak; Landes, Janet Vesterman; Rabinovich, Hadas Rotem; Lomnicky, Yossef] Maccabi Healthcare Serv, Dept Pharmacol, Tel Aviv, Israel	International Business Machines (IBM)	Siegelmann-Danieli, N (corresponding author), Maccabi Healthcare Serv, Dept Profess Med, Tel Aviv, Israel.	danieli_na@mac.org.il			IBM Research-Haifa; Roche Pharmaceuticals (Israel) Ltd (a subsidiary of F. Hoffmann-La Roche Ltd); Roche Pharmaceuticals (Israel) Ltd	IBM Research-Haifa; Roche Pharmaceuticals (Israel) Ltd (a subsidiary of F. Hoffmann-La Roche Ltd); Roche Pharmaceuticals (Israel) Ltd(Roche Holding)	The study was supported by IBM Research-Haifa, and Roche Pharmaceuticals (Israel) Ltd (a subsidiary of F. Hoffmann-La Roche Ltd). IBM Research-Haifa had a role in the study design, data analysis, decision to publish, and preparation of the manuscript. Roche Pharmaceuticals (Israel) Ltd provided the financial support for medical writing assistance. Roche Pharmaceuticals (Israel) Ltd had no role in study design, data collection and analysis, decision to publish, and preparation of the manuscript.	Bendell JC, 2012, ONCOLOGIST, V17, P1486, DOI 10.1634/theoncologist.2012-0190; Carmeli B, 2012, STUD HEALTH TECHNOL, V180, P604, DOI 10.3233/978-1-61499-101-4-604; Chu MP, 2015, CLIN LUNG CANCER, V16, P33, DOI 10.1016/j.cllc.2014.07.005; Chu MP, 2014, ANN ONCOL, V25, piv210; Cunningham D, 2013, LANCET ONCOL, V14, P1077, DOI 10.1016/S1470-2045(13)70154-2; Ferlay J, GLOBOCAN 2012 V1 0; Ferrucci D., 2004, Natural Language Engineering, V10, P327, DOI 10.1017/S1351324904003523; Goldbraich E, 2015, STUD HEALTH TECHNOL, V216, P280, DOI 10.3233/978-1-61499-564-7-280; Guan Zhong-Zhen, 2011, Chin J Cancer, V30, P682, DOI 10.5732/cjc.011.10188; Hammerman A, 2014, ACTA ONCOL, P1; Hecht JR, 2009, J CLIN ONCOL, V27, P672, DOI 10.1200/JCO.2008.19.8135; Holmes S, 2013, CANCER EPIDEMIOL, V37, P881, DOI 10.1016/j.canep.2013.09.001; Horn L, 2013, CLIN LUNG CANCER, V14, P14, DOI 10.1016/j.cllc.2012.03.008; Hurwitz H, 2004, NEW ENGL J MED, V350, P2335, DOI 10.1056/NEJMoa032691; Hurwitz HI, 2013, ONCOLOGIST, V18, P1004, DOI 10.1634/theoncologist.2013-0107; IBM website, 2016, IBM CAR MAN DESCR; Jagsi R, 2009, CANCER-AM CANCER SOC, V115, P3293, DOI 10.1002/cncr.24366; Kozloff M, 2009, ONCOLOGIST, V14, P862, DOI 10.1634/theoncologist.2009-0071; Murthy VH, 2004, JAMA-J AM MED ASSOC, V291, P2720, DOI 10.1001/jama.291.22.2720; Nordlinger B, 2013, LANCET ONCOL, V14, P1208, DOI 10.1016/S1470-2045(13)70447-9; Saltz LB, 2008, J CLIN ONCOL, V26, P2013, DOI 10.1200/JCO.2007.14.9930; Sobrero A, 2009, ONCOLOGY-BASEL, V77, P113, DOI 10.1159/000229787; Stein A, 2015, ACTA ONCOL, V54, P171, DOI 10.3109/0284186X.2014.961649; Talarico L, 2004, J CLIN ONCOL, V22, P4626, DOI 10.1200/JCO.2004.02.175; Tol J, 2009, NEW ENGL J MED, V360, P563, DOI 10.1056/NEJMoa0808268; Tournigand C, 2004, J CLIN ONCOL, V22, P229, DOI 10.1200/JCO.2004.05.113; Van Cutsem E, 2009, ANN ONCOL, V20, P1842, DOI 10.1093/annonc/mdp233; Vauthey JN, 2006, J CLIN ONCOL, V24, P2065, DOI 10.1200/JCO.2005.05.3074	28	0	0	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 4	2016	11	5							e0154689	10.1371/journal.pone.0154689	http://dx.doi.org/10.1371/journal.pone.0154689			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DL5KR	27144545	Green Published, gold			2022-12-26	WOS:000375676400060
J	Hsieh, YH; Huang, HM; Lan, YC				Hsieh, Ying-Hen; Huang, Hsiang-Min; Lan, Yu-Ching			On Temporal Patterns and Circulation of Influenza Virus Strains in Taiwan, 2008-2014: Implications of 2009 pH1N1 Pandemic	PLOS ONE			English	Article							SEASONAL INFLUENZA; REPRODUCTION NUMBER; GLOBAL CIRCULATION; EXCESS MORTALITY; A H1N1; EPIDEMIOLOGY; SURVEILLANCE; EVOLUTION; IMPACT	Background It has been observed that, historically, strains of pandemic influenza led to succeeding seasonal waves, albeit with decidedly different patterns. Recent studies suggest that the 2009 A(H1N1)pdm09 pandemic has had an impact on the circulation patterns of seasonal influenza strains in the post-pandemic years. In this work we aim to investigate this issue and also to compare the relative transmissibility of these waves of differing strains using Taiwan influenza surveillance data before, during and after the pandemic. Methods We make use of the Taiwan Center for Disease Control and Prevention influenza surveillance data on laboratory-confirmed subtyping of samples and a mathematical model to determine the waves of circulating (and co-circulating) H1, H3 and B virus strains in Taiwan during 2008-2014; or namely, short before, during and after the 2009 pandemic. We further pinpoint the turning points and relative transmissibility of each wave, in order to ascertain whether any temporal pattern exists. Results/Findings For two consecutive years following the 2009 pandemic, A(H1N1)pdm09 circulated in Taiwan (as in most of Northern Hemisphere), sometimes co-circulating with AH3. From the evolution point of view, A(H1N1)pdm09 and AH3 were able to sustain their circulation patterns to the end of 2010. In fact, A(H1N1)pdm09 virus circulated in six separate waves in Taiwan between summer of 2009 and spring of 2014. Since 2009, a wave of A(H1N1) pmd09 occurred every fall/winter influenza season during our study period except 20112012 season, when mainly influenza strain B circulated. In comparing transmissibility, while the estimated per capita weekly growth rates for cumulative case numbers (and the reproduction number) seem to be lower for most of the influenza B waves (0.06 similar to 0.26; range of 95% CIs: 0.05 similar to 0.32) when compared to those of influenza A, the wave of influenza B from week 8 to week 38 of 2010 immediately following the fall/winter wave of 2009 A(H1N1)pdm09 was substantially higher at r = 0.89 (95% CI: 0.49, 1.28), in fact highest among all the waves detected in this study. Moreover, when AH3 or A(H1N1)pdm09 exhibit high incidence, reported cases of subtype B decreases and vice versa. Further modeling analysis indicated that during the study period, Taiwan nearly experienced at least one wave of influenza epidemic of some strain every summer except in 2012. Discussion Estimates of R for seasonal influenza are consistent with that of temperate and tropical-subtropical regions, while estimate of R for A(H1N1)pdm09 is comparatively less than countries in Europe and North America, but similar to that of tropical-subtropical regions. This offers indication of regional differences in transmissibility of influenza virus that exists only for pandemic influenza. Despite obvious limitations in the data used, this study, designed to qualitatively compare the temporal patterns and transmissibility of the waves of different strains, illustrates how influenza subtyping data can be utilized to explore the mechanism for various influenza strains to compete or to circulate, to possibly provide predictors of future trends in the evolution of influenza viruses of various subtypes, and perhaps more importantly, to be of use to future annual seasonal influenza vaccine design.	[Hsieh, Ying-Hen; Huang, Hsiang-Min] China Med Univ, Dept Publ Hlth, Taichung 40402, Taiwan; [Hsieh, Ying-Hen] China Med Univ, Ctr Infect Dis Educ & Res, Taichung 40402, Taiwan; [Lan, Yu-Ching] China Med Univ, Dept Hlth Risk Management, Taichung 40402, Taiwan	China Medical University Taiwan; China Medical University Taiwan; China Medical University Taiwan	Hsieh, YH (corresponding author), China Med Univ, Dept Publ Hlth, Taichung 40402, Taiwan.; Hsieh, YH (corresponding author), China Med Univ, Ctr Infect Dis Educ & Res, Taichung 40402, Taiwan.	hsieh@mail.cmu.edu.tw	Lan, Yu-Ching/F-2449-2017; Hsieh, Ying-Hen/E-9685-2010	Lan, Yu-Ching/0000-0003-4781-6405; 	Taiwan Ministry of Science and Technology [103-2314-B-039-010-MY3, 103-2115-M-039-002-MY2, 103-2815-C-039-067-B, 99-2314-B-039-022-MY3]	Taiwan Ministry of Science and Technology	The work was supported by the following: YHH: Taiwan Ministry of Science and Technology (https://www.most.gov.tw/), grants (103-2314-B-039-010-MY3, 103-2115-M-039-002-MY2); HMH: Taiwan Ministry of Science and Technology (https://www.most.gov.tw/), grant (103-2815-C-039-067-B); and YCL: Taiwan Ministry of Science and Technology (https://www.most.gov.tw/), grant (99-2314-B-039-022-MY3). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ann J, 2012, J CLIN VIROL, V53, P88, DOI 10.1016/j.jcv.2011.09.016; [Anonymous], 2009, Wkly Epidemiol Rec, V84, P481; Bedford T, 2015, NATURE, V523, P217, DOI 10.1038/nature14460; Chan CH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072498; Chowell G, 2008, EPIDEMIOL INFECT, V136, P852, DOI 10.1017/S0950268807009144; Cowling BJ, 2010, EPIDEMIOLOGY, V21, P842, DOI 10.1097/EDE.0b013e3181f20977; Cowling BJ, 2009, EPIDEMIOLOGY, V20, P344, DOI 10.1097/EDE.0b013e31819d1092; DAUER CC, 1961, AM REV RESPIR DIS, V83, P15; Eshaghi A, 2014, INFLUENZA OTHER RESP, V8, P250, DOI 10.1111/irv.12219; Fraser C, 2009, SCIENCE, V324, P1557, DOI 10.1126/science.1176062; Hernandez Caceres JL, 2011, ELECT J BIOMED, V1, P87; HOUSWORTH WJ, 1971, AM J EPIDEMIOL, V94, P348, DOI 10.1093/oxfordjournals.aje.a121329; Hsieh YH, 2009, TROP MED INT HEALTH, V14, P628, DOI 10.1111/j.1365-3156.2009.02277.x; Hsieh YH, 2006, EMERG INFECT DIS, V12, P122, DOI 10.3201/eid1201.050396; Hsieh YH, 2013, INT J INFECT DIS, V17, pE838, DOI 10.1016/j.ijid.2013.01.002; Hsieh YH, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-332; Hsieh Ying-Hen, 2010, BMC Res Notes, V3, P283, DOI 10.1186/1756-0500-3-283; Hsieh YH, 2010, INFLUENZA OTHER RESP, V4, P187, DOI 10.1111/j.1750-2659.2010.00147.x; Hsieh YH, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-106; Hsieh YH, 2009, EMERG INFECT DIS, V15, P1617, DOI 10.3201/eid1510.080811; Huang WT, 2010, VACCINE, V28, P7161, DOI 10.1016/j.vaccine.2010.08.069; King AA, 2015, P ROY SOC B-BIOL SCI, V282, DOI 10.1098/rspb.2015.0347; Liu WD, 2015, COMPUT MATH METHOD M, V2015, DOI 10.1155/2015/207105; Morens DM, 2007, J INFECT DIS, V195, P1018, DOI 10.1086/511989; Mostaco-Guidolin LC, 2012, BMJ OPEN, V2, DOI 10.1136/bmjopen-2012-001614; Opatowski L, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002225; PALESE P., 2007, FIELDS VIROLOGY, V2, P1647, DOI DOI 10.1371/JOURNAL.PPAT.1003019; Razum O, 2003, LANCET, V361, P1739, DOI 10.1016/S0140-6736(03)13335-1; RETAILLIAU HF, 1978, INT J EPIDEMIOL, V7, P223, DOI 10.1093/ije/7.3.223; RICHARDS FJ, 1959, J EXP BOT, V10, P290, DOI 10.1093/jxb/10.2.290; Russell CA, 2008, SCIENCE, V320, P340, DOI 10.1126/science.1154137; Shih SR, 2005, J CLIN MICROBIOL, V43, P1651, DOI 10.1128/JCM.43.4.1651-1661.2005; Simonsen L, 1999, VACCINE, V17, pS3, DOI 10.1016/S0264-410X(99)00099-7; Taiwan Center for Disease Control and Prevention (TCDC), TAIW NAT INF DIS STA; Taiwan Center for Disease Control and Prevention (TCDC), INFL EXPR WEEKL INFL; Taiwan Center for Disease Control and Prevention (TCDC), 2016, INFLUENZA EXPRESS WE; Taiwan Centers for Disease Control, SUMM 2009 MON H1N1 V; Taubenberger JK, 2007, JAMA-J AM MED ASSOC, V297, P2025, DOI 10.1001/jama.297.18.2025; Taubenberger JK, 2010, PUBLIC HEALTH REP, V125, P16, DOI 10.1177/00333549101250S305; Wallinga J, 2007, P ROY SOC B-BIOL SCI, V274, P599, DOI 10.1098/rspb.2006.3754; Wang XS, 2012, J THEOR BIOL, V313, P12, DOI 10.1016/j.jtbi.2012.07.024; WEBSTER RG, 1992, MICROBIOL REV, V56, P152, DOI 10.1128/MMBR.56.1.152-179.1992; WHO, 2014, WHO MED CTR INFL SEA; Zhou GF, 2003, EMERG INFECT DIS, V9, P1608	44	9	9	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 3	2016	11	5							e0154695	10.1371/journal.pone.0154695	http://dx.doi.org/10.1371/journal.pone.0154695			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DL5KK	27139905	gold, Green Submitted, Green Published			2022-12-26	WOS:000375675700056
J	Tan, S; Soulez, G; Martinez, PD; Larrivee, S; Stevens, LM; Goussard, Y; Mansour, S; Chartrand-Lefebvre, C				Tan, Stephanie; Soulez, Gilles; Martinez, Patricia Diez; Larrivee, Sandra; Stevens, Louis-Mathieu; Goussard, Yves; Mansour, Samer; Chartrand-Lefebvre, Carl			Coronary Stent Artifact Reduction with an Edge-Enhancing Reconstruction Kernel - A Prospective Cross-Sectional Study with 256-Slice CT	PLOS ONE			English	Article							IN-VITRO EVALUATION; DUAL-SOURCE CT; COMPUTED-TOMOGRAPHY ANGIOGRAPHY; HIGH-RESOLUTION KERNEL; ARTERY STENTS; ITERATIVE RECONSTRUCTION; RESTENOSIS; KAPPA; VISUALIZATION; EXPERIENCE	Purpose Metallic artifacts can result in an artificial thickening of the coronary stent wall which can significantly impair computed tomography (CT) imaging in patients with coronary stents. The objective of this study is to assess in vivo visualization of coronary stent wall and lumen with an edge-enhancing CT reconstruction kernel, as compared to a standard kernel. Methods This is a prospective cross-sectional study involving the assessment of 71 coronary stents (24 patients), with blinded observers. After 256-slice CT angiography, image reconstruction was done with medium-smooth and edge-enhancing kernels. Stent wall thickness was measured with both orthogonal and circumference methods, averaging thickness from diameter and circumference measurements, respectively. Image quality was assessed quantitatively using objective parameters (noise, signal to noise (SNR) and contrast to noise (CNR) ratios), as well as visually using a 5-point Likert scale. Results Stent wall thickness was decreased with the edge-enhancing kernel in comparison to the standard kernel, either with the orthogonal (0.97 +/- 0.02 versus 1.09 +/- 0.03 mm, respectively; p< 0.001) or the circumference method (1.13 +/- 0.02 versus 1.21 +/- 0.02 mm, respectively; p = 0.001). The edge-enhancing kernel generated less overestimation from nominal thickness compared to the standard kernel, both with the orthogonal (0.89 +/- 0.19 versus 1.00 +/- 0.26 mm, respectively; p< 0.001) and the circumference (1.06 +/- 0.26 versus 1.13 +/- 0.31 mm, respectively; p = 0.005) methods. The edge-enhancing kernel was associated with lower SNR and CNR, as well as higher background noise (all p < 0.001), in comparison to the medium-smooth kernel. Stent visual scores were higher with the edge-enhancing kernel (p< 0.001). Conclusion In vivo 256-slice CT assessment of coronary stents shows that the edge-enhancing CT reconstruction kernel generates thinner stent walls, less overestimation from nominal thickness, and better image quality scores than the standard kernel.	[Tan, Stephanie; Soulez, Gilles; Chartrand-Lefebvre, Carl] Univ Montreal, Med Ctr CHUM, Radiol, Montreal, PQ, Canada; [Soulez, Gilles; Larrivee, Sandra; Stevens, Louis-Mathieu; Mansour, Samer; Chartrand-Lefebvre, Carl] Univ Montreal, Med Ctr, Res Ctr, Montreal, PQ, Canada; [Martinez, Patricia Diez] CHU Sherbrooke, Radiol, Sherbrooke, PQ J1H 5N4, Canada; [Larrivee, Sandra] Pennington Biomed Res Ctr, Biostat, 6400 Perkins Rd, Baton Rouge, LA 70808 USA; [Stevens, Louis-Mathieu] Univ Montreal, Med Ctr CHUM, Cardiac Surg, Montreal, PQ, Canada; [Goussard, Yves] Ecole Polytech, Elect Engn, Montreal, PQ H3C 3A7, Canada; [Mansour, Samer] Univ Montreal, Med Ctr CHUM, Cardiol, Montreal, PQ, Canada	Universite de Montreal; Universite de Montreal; University of Sherbrooke; Louisiana State University System; Louisiana State University; Pennington Biomedical Research Center; Universite de Montreal; Universite de Montreal; Polytechnique Montreal; Universite de Montreal	Chartrand-Lefebvre, C (corresponding author), Univ Montreal, Med Ctr CHUM, Radiol, Montreal, PQ, Canada.; Chartrand-Lefebvre, C (corresponding author), Univ Montreal, Med Ctr, Res Ctr, Montreal, PQ, Canada.	chartrandlef@videotron.ca	Soulez, Gilles/F-2834-2013; Tan, Stephanie/GRR-6503-2022; Chartrand-Lefebvre, Carl/G-1260-2015	Chartrand-Lefebvre, Carl/0000-0002-2299-7855	Fonds de recherche du Quebec - Sante (FRQS) [14261]; Faculty Support Program of the Radiology Department of the University of Montreal	Fonds de recherche du Quebec - Sante (FRQS)(Fonds de la Recherche en Sante du Quebec); Faculty Support Program of the Radiology Department of the University of Montreal	This study was funded by the Fonds de recherche du Quebec - Sante (FRQS) (grant no 14261) (CCL); and by the Faculty Support Program of the Radiology Department of the University of Montreal (3rd grant cycle) (CCL). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andre Florian, 2014, BMC Res Notes, V7, P38, DOI 10.1186/1756-0500-7-38; Andreini D, 2012, RADIOLOGY, V265, P410, DOI 10.1148/radiol.12112363; [Anonymous], 2014, R LANG ENV STAT COMP; Cademartiri F, 2007, J AM COLL CARDIOL, V49, P2204, DOI 10.1016/j.jacc.2007.02.045; Carrabba N, 2010, J NUCL CARDIOL, V17, P470, DOI 10.1007/s12350-010-9218-2; Cicchetti D.V., 1994, PSYCHOL ASSESS, V6, P284, DOI [10.1037/1040-3590.6.4.284, DOI 10.1037/1040-3590.6.4.284]; COHEN J, 1968, PSYCHOL BULL, V70, P213, DOI 10.1037/h0026256; Cui X, 2015, EUR J RADIO IN PRESS; Eisentopf J, 2013, JACC-CARDIOVASC IMAG, V6, P458, DOI 10.1016/j.jcmg.2012.10.023; Fuchs TA, 2013, INT J CARDIOVAS IMAG, V29, P1409, DOI 10.1007/s10554-013-0225-7; Funama Y, 2012, ACAD RADIOL, V19, P1324, DOI 10.1016/j.acra.2012.06.013; Gassenmaier T, 2014, EUR RADIOL, V24, P2953, DOI 10.1007/s00330-014-3323-6; Hong C, 2004, RADIOLOGY, V233, P286, DOI 10.1148/radiol.2331031564; Jang JH, 2012, ACTA RADIOL, V53, P456, DOI 10.1258/ar.2012.110659; Joseph L., 2003, STAT METHODS RATES P, VThird; Jung JI, 2007, KOREAN CIRC J, V37, P521; Kruger S, 2003, INT J CARDIOL, V89, P167, DOI 10.1016/S0167-5273(02)00471-0; Leipsic J, 2012, INT J CARDIOVAS IMAG, V28, P613, DOI 10.1007/s10554-011-9832-3; Mahnken AH, 2004, INVEST RADIOL, V39, P27, DOI 10.1097/01.rli.0000095471.91575.18; Mahnken AH, 2012, ISRN CARDIOL, V2012; Maintz D, 2003, INVEST RADIOL, V38, P790, DOI 10.1097/01.rli.0000086495.96457.54; Maintz D, 2006, EUR RADIOL, V16, P818, DOI 10.1007/s00330-005-0062-8; Maintz D, 2009, EUR RADIOL, V19, P42, DOI 10.1007/s00330-008-1132-5; Oda S, 2013, EUR J RADIOL, V82, P288, DOI 10.1016/j.ejrad.2012.11.003; Pugliese F, 2008, HEART, V94, P848, DOI 10.1136/hrt.2007.126474; Scanlon PJ, 1999, J AM COLL CARDIOL, V33, P1756, DOI 10.1016/S0735-1097(99)00126-6; Seifarth H, 2005, EUR RADIOL, V15, P721, DOI 10.1007/s00330-004-2594-8; Seifarth H, 2006, INVEST RADIOL, V41, P22, DOI 10.1097/01.rli.0000191365.88345.e1; Sirineni GKR, 2007, INT J CARDIOVAS IMAG, V23, P253, DOI 10.1007/s10554-006-9107-6; Steen H, 2011, EUR J RADIOL, V80, P143, DOI 10.1016/j.ejrad.2010.08.007; Suzuki S, 2005, CIRC J, V69, P1124, DOI 10.1253/circj.69.1124; Ulrich A, 2015, ACTA RADIOL, V56, P42, DOI 10.1177/0284185113517229; VALIQUETTE CAM, 1994, BEHAV RES METH INSTR, V26, P60, DOI 10.3758/BF03204566; Viera AJ, 2005, FAM MED, V37, P360; Zhou QJ, 2014, J COMPUT ASSIST TOMO, V38, P604, DOI 10.1097/RCT.0000000000000080	35	8	10	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 29	2016	11	4							e0154292	10.1371/journal.pone.0154292	http://dx.doi.org/10.1371/journal.pone.0154292			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DK8XM	27128507	Green Published, gold, Green Accepted			2022-12-26	WOS:000375212600025
J	Williams, FP; Milbradt, AG; Embrey, KJ; Bobby, R				Williams, Felix P.; Milbradt, Alexander G.; Embrey, Kevin J.; Bobby, Romel			Segmental Isotope Labelling of an Individual Bromodomain of a Tandem Domain BRD4 Using Sortase A	PLOS ONE			English	Article							STAPHYLOCOCCUS-AUREUS SORTASE; 2-DIMENSIONAL NMR-SPECTROSCOPY; NF-KAPPA-B; SURFACE-PROTEINS; SMALL-MOLECULE; MULTIDIMENSIONAL NMR; CELL-WALL; INHIBITOR; CHROMATIN; BINDING	Bromodomain and extra-terminal (BET) family of proteins are one of the major readers of epigenetic marks and an important target class in oncology and other disease areas. The importance of the BET family of proteins is manifested by the explosion in the number of inhibitors against these targets that have successfully entered clinical trials. One important BET family member is bromodomain containing protein 4 (BRD4). Structural and biophysical studies of BRD4 are complicated by its tertiary-structure consisting of two bromodomains connected by a flexible inter-domain linker of approximately 180 amino acids. A detailed understanding of the interplay of these bromodomains will be key to rational drug design in BRD4, yet there are no reported three-dimensional structures of the multi-domain BRD4 and NMR studies of the tandem domain are hampered by the size of the protein. Here, we present a method for rapid Sortase A-mediated segmental labelling of the individual bromodomains of BRD4 that provides a powerful strategy that will enable NMR studies of ligand-bromodomain interactions with atomic detail. In our labelling strategy, we have used U-[H-2, N-15]-isotope labelling on the C-terminal bromodomain with selective introduction of (CH3)-C-13 methyl groups on Ile (delta 1), Val and Leu, whereas the N-terminal bromodomain remained unlabelled. This labelling scheme resulted in significantly simplified NMR spectra and will allow for high-resolution interaction, structure and dynamics studies in the presence of ligands.	[Williams, Felix P.; Milbradt, Alexander G.; Embrey, Kevin J.; Bobby, Romel] AstraZeneca, Innovat Med & Early Dev Biotech Unit, Discovery Sci, Alderley Pk, Macclesfield SK10 4TF, Cheshire, England	AstraZeneca	Embrey, KJ; Bobby, R (corresponding author), AstraZeneca, Innovat Med & Early Dev Biotech Unit, Discovery Sci, Alderley Pk, Macclesfield SK10 4TF, Cheshire, England.	Kevin.Embrey@astrazeneca.com; Romel.Bobby@astrazeneca.com		Williams, Felix Preston/0000-0003-4144-1411	AstraZeneca	AstraZeneca(AstraZeneca)	All authors were employees of Astrazeneca at the time of writing. AstraZeneca provided support in the form of salaries for all authors, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of the authors are articulated in the "author contributions" section.	Amero C, 2009, J AM CHEM SOC, V131, P3448, DOI 10.1021/ja809880p; Bailey D, 2010, J AM COLL CARDIOL, V55, P2580, DOI 10.1016/j.jacc.2010.02.035; Baud MGJ, 2014, SCIENCE, V346, P638, DOI 10.1126/science.1249830; Bentley ML, 2007, J BIOL CHEM, V282, P6571, DOI 10.1074/jbc.M610519200; Camarero JA, 2002, P NATL ACAD SCI USA, V99, P8536, DOI 10.1073/pnas.132033899; Cavanagh J, 1995, PROTEIN NMR SPECTROS, V28; Chavan TS, 2014, METHOD MOL BIOL, P1120; Chen I, 2011, P NATL ACAD SCI USA, V108, P11399, DOI 10.1073/pnas.1101046108; Chung CW, 2011, J MED CHEM, V54, P3827, DOI 10.1021/jm200108t; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Dey A, 2003, P NATL ACAD SCI USA, V100, P8758, DOI 10.1073/pnas.1433065100; Dhalluin C, 1999, NATURE, V399, P491, DOI 10.1038/20974; Filippakopoulos P, 2014, NAT REV DRUG DISCOV, V13, P339, DOI 10.1038/nrd4286; Filippakopoulos P, 2012, CELL, V149, P214, DOI 10.1016/j.cell.2012.02.013; Filippakopoulos P, 2010, NATURE, V468, P1067, DOI 10.1038/nature09504; Fitzpatrick PF, 2015, BBA-PROTEINS PROTEOM, V1854, P1746, DOI 10.1016/j.bbapap.2014.10.020; Freiburger L, 2015, J BIOMOL NMR, V63, P1, DOI 10.1007/s10858-015-9981-0; Gardner KH, 1997, J AM CHEM SOC, V119, P7599, DOI 10.1021/ja9706514; Gardner KH, 1998, ANNU REV BIOPH BIOM, V27, P357, DOI 10.1146/annurev.biophys.27.1.357; Helmus JJ, 2013, J BIOMOL NMR, V55, P355, DOI 10.1007/s10858-013-9718-x; Hirakawa H, 2012, BIOTECHNOL BIOENG, V109, P2955, DOI 10.1002/bit.24585; Huang XY, 2003, BIOCHEMISTRY-US, V42, P11307, DOI 10.1021/bi034391g; Jang MK, 2005, MOL CELL, V19, P523, DOI 10.1016/j.molcel.2005.06.027; Jung M, 2014, J BIOL CHEM, V289, P9304, DOI 10.1074/jbc.M113.523019; Kobashigawa Y, 2009, J BIOMOL NMR, V43, P145, DOI 10.1007/s10858-008-9296-5; Levary DA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018342; Liu Y, 2008, BIOCHEMISTRY-US, V47, P6403, DOI 10.1021/bi8001659; Mao HY, 2004, J AM CHEM SOC, V126, P2670, DOI 10.1021/ja039915e; Markley JL, 1998, J MOL BIOL, V280, P933, DOI 10.1006/jmbi.1998.1852; Mazmanian SK, 1999, SCIENCE, V285, P760, DOI 10.1126/science.285.5428.760; Mazmanian SK, 2001, MOL MICROBIOL, V40, P1049, DOI 10.1046/j.1365-2958.2001.02411.x; McLure KG, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083190; Mele DA, 2013, J EXP MED, V210, P2181, DOI 10.1084/jem.20130376; Michel E, 2015, METHOD ENZYMOL, V565, P389, DOI 10.1016/bs.mie.2015.05.028; Mirguet O, 2013, J MED CHEM, V56, P7501, DOI 10.1021/jm401088k; Nguyen UTT, 2014, NAT METHODS, V11, P834, DOI [10.1038/NMETH.3022, 10.1038/nmeth.3022]; Nicodeme E, 2010, NATURE, V468, P1119, DOI 10.1038/nature09589; Odore E, 2015, CANCER RES, V75, DOI 10.1158/1538-7445.AM2015-4511; Parthasarathy R, 2007, BIOCONJUGATE CHEM, V18, P469, DOI 10.1021/bc060339w; Pervushin KV, 1998, J BIOMOL NMR, V12, P345, DOI 10.1023/A:1008268930690; Refaei MA, 2011, J BIOMOL NMR, V49, P3, DOI 10.1007/s10858-010-9464-2; Schanda P, 2005, J AM CHEM SOC, V127, P8014, DOI 10.1021/ja051306e; SCHNEEWIND O, 1992, CELL, V70, P267, DOI 10.1016/0092-8674(92)90101-H; Shi J, 2014, CANCER CELL, V25, P210, DOI 10.1016/j.ccr.2014.01.028; Skrisovska L, 2010, J BIOMOL NMR, V46, P51, DOI 10.1007/s10858-009-9362-7; Stathis A, 2014, EUR J CANCER, V50, P196, DOI 10.1016/S0959-8049(14)70726-9; TAL M, 1985, J BIOL CHEM, V260, P9976; Ton-That H, 2002, J BIOL CHEM, V277, P7447, DOI 10.1074/jbc.M109945200; Tsai WW, 2010, NATURE, V468, P927, DOI 10.1038/nature09542; Vollmuth F, 2009, J BIOL CHEM, V284, P36547, DOI 10.1074/jbc.M109.033712; Vranken WF, 2005, PROTEINS, V59, P687, DOI 10.1002/prot.20449; Wu SY, 2013, MOL CELL, V49, P843, DOI 10.1016/j.molcel.2012.12.006; Yagi H, 2004, J AM CHEM SOC, V126, P16632, DOI 10.1021/ja045279o; Zhang GT, 2012, J BIOL CHEM, V287, P28840, DOI 10.1074/jbc.M112.359505; Zou Z, 2014, ONCOGENE, V33, P2395, DOI 10.1038/onc.2013.179	55	15	15	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 29	2016	11	4							e0154607	10.1371/journal.pone.0154607	http://dx.doi.org/10.1371/journal.pone.0154607			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DK8XM	27128490	gold, Green Published			2022-12-26	WOS:000375212600048
J	Dekhil, N; Meftahi, N; Mhenni, B; Ben Fraj, S; Haltiti, R; Belhaj, S; Mardassi, H				Dekhil, Naira; Meftahi, Nedra; Mhenni, Besma; Ben Fraj, Saloua; Haltiti, Raja; Belhaj, Sameh; Mardassi, Helmi			MDR-TB Outbreak among HIV-Negative Tunisian Patients followed during 11 Years	PLOS ONE			English	Article							MULTIDRUG-RESISTANT TUBERCULOSIS; MYCOBACTERIUM-TUBERCULOSIS; DRUG-RESISTANCE; BUENOS-AIRES; STRAIN; TRANSMISSION; EVOLUTION; FITNESS; MUTATION; COST	Background Multidrug-resistant tuberculosis (MDR-TB) outbreaks that evolve, from the outset, in a context strictly negative for HIV infection deserve special consideration since they reflect the true intrinsic epidemic potential of the causative strain. To our knowledge, the long-term evolution of such exceptional outbreaks and the treatment outcomes for the involved patients has never been reported hitherto. Here we provide a thorough description, over an 11-year period, of an MDR-TB outbreak that emerged and expanded in an HIV-negative context, Northern Tunisia. Methodology/Principal Findings From October 2001 to June 2011, the MDR-TB outbreak involved 48 HIV-negative individuals that are mainly young (mean age 31.09 yrs; 89.6% male) and noninstitutionalized. Drug susceptibility testing coupled to mutational analysis revealed that initial transmission involved an isolate that was simultaneously resistant to isoniazid, rifampicin, ethambutol, and streptomycin. The causative Haarlem3-ST50 outbreak strain expanded mainly as an 11-banded IS6110 RFLP profile (77.1%), from which a 12-banded subclone evolved. After undergoing a 2-year treatment with second-line drugs, 22 (45.8%) patients were cured and 3 (6.2%) completed treatment, thus yielding an overall treatment success rate of 52.1%. Among the patients that experienced unfavorable treatment outcomes, 10 (20.8%) failed treatment, 3 (6.2%) were lost to follow-up, 5 (10.4%) died, and 5 (10.4%) could not be evaluated. Poor adherence to treatment was found to be the main independent predictor of unfavorable outcomes (HR: 9.15; 95% CI 1.72-48.73; P = 0.014). Intriguingly, the evolved 12-banded subclone proved significantly associated with unfavorable outcomes (HR: 4.90; 95% CI 1.04-23.04, P = 0.044). High rate of fatality and relapse was further demonstrated at the long-term, since 70% of those whose treatment failed have died, and 24% among those deemed successfully treated have relapsed. Conclusions/Significance Taken together, the data obtained in this study indicate that MDR-TB clinical isolates could become fit enough to cause large and severe outbreaks in an HIV-negative context. Such MDR-TB outbreaks are characterized by low treatment success rates and could evolve towards increased severity, thus calling for early detection of cases and the necessity to raise the bar of surveillance throughout and beyond the treatment period.	[Dekhil, Naira; Meftahi, Nedra; Mhenni, Besma; Ben Fraj, Saloua; Mardassi, Helmi] Univ Tunis El Manar, Unit Typing & Genet Mycobacteria, Lab Mol Microbiol Vaccinol & Biotechnol Dev, Tunis, Tunisia; [Haltiti, Raja; Belhaj, Sameh] Hop Reg Menzel Bourguiba, Menzel Bourguiba, Tunisia	Universite de Tunis-El-Manar	Mardassi, H (corresponding author), Univ Tunis El Manar, Unit Typing & Genet Mycobacteria, Lab Mol Microbiol Vaccinol & Biotechnol Dev, Tunis, Tunisia.	helmi.merdassi@pasteur.rns.tn		ben fraj, salwa/0000-0002-0435-9999; mhenni, besma/0000-0001-6476-768X; dekhil, naira/0000-0001-7881-9348; MEFTAHI, NEDRA/0000-0002-8505-2058	Tunisian Ministry of Higher Education and Scientific Research [LR11IPT01]; EU [245 872]	Tunisian Ministry of Higher Education and Scientific Research; EU(European Commission)	HM received financial support from the Tunisian Ministry of Higher Education and Scientific Research (www.mes.tn). Grant: LR11IPT01. This work was also supported by the EU's 7th Framework Program (EUMEDNETvsTB, project no 245 872).	Alito A, 1999, J CLIN MICROBIOL, V37, P788, DOI 10.1128/JCM.37.3.788-791.1999; Billington OJ, 1999, ANTIMICROB AGENTS CH, V43, P1866, DOI 10.1128/AAC.43.8.1866; Bottger EC, 2008, EUR J PEDIATR, V167, P141, DOI 10.1007/s00431-007-0606-9; Borrell S, 2011, CLIN MICROBIOL INFEC, V17, P815, DOI 10.1111/j.1469-0691.2011.03556.x; Borrell S, 2009, INT J TUBERC LUNG D, V13, P1456; Casali N, 2014, NAT GENET, V46, P279, DOI 10.1038/ng.2878; Comas I, 2012, NAT GENET, V44, P106, DOI 10.1038/ng.1038; Dahle UR, 2003, J CLIN MICROBIOL, V41, P67, DOI 10.1128/JCM.41.1.67-72.2003; den Hertog AL, 2015, PATHOG DIS, V73, DOI 10.1093/femspd/ftv037; Dye C, 2001, P ROY SOC B-BIOL SCI, V268, P45, DOI 10.1098/rspb.2000.1328; Eldholm V, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8119; Farnia P, 2007, EPIDEMIOL INFECT, V135, P346, DOI 10.1017/S0950268806006790; Ford CB, 2013, NAT GENET, V45, P784, DOI 10.1038/ng.2656; Gagneux S, 2006, P NATL ACAD SCI USA, V103, P2869, DOI 10.1073/pnas.0511240103; Gandhi NR, 2010, LANCET, V375, P1830, DOI 10.1016/S0140-6736(10)60410-2; Johnston JC, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006914; Kamerbeek J, 1997, J CLIN MICROBIOL, V35, P907, DOI 10.1128/JCM.35.4.907-914.1997; Mardassi H, 2005, EMERG INFECT DIS, V11, P957; Meftahi N, 2016, J ANTIMICROB CHEMOTH, V71, P324, DOI 10.1093/jac/dkv345; Meressa D, 2015, THORAX, V70, P1181, DOI 10.1136/thoraxjnl-2015-207374; Miotto P, 2014, MBIO, V5, DOI 10.1128/mBio.01819-14; Mokdad AH, 2014, LANCET, V383, P309, DOI 10.1016/S0140-6736(13)62189-3; Namouchi A, 2008, J MED MICROBIOL, V57, P864, DOI 10.1099/jmm.0.47483-0; Namouchi A, 2010, J INFECT DIS, V201, P390, DOI 10.1086/649900; Palmero D, 2003, EMERG INFECT DIS, V9, P965; Palmero DJ, 2004, INT J TUBERC LUNG D, V8, P778; Ritacco V, 1997, J INFECT DIS, V176, P637, DOI 10.1086/514084; Sander P, 2002, ANTIMICROB AGENTS CH, V46, P1204, DOI 10.1128/AAC.46.5.1204-1211.2002; Sandgren A, 2009, PLOS MED, V6, P132, DOI 10.1371/journal.pmed.1000002; Stoffels K, 2012, ANTIMICROB AGENTS CH, V56, P5186, DOI 10.1128/AAC.05385-11; Suchindran S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005561; Supply P, 2006, J CLIN MICROBIOL, V44, P4498, DOI 10.1128/JCM.01392-06; van Rie A, 1999, J INFECT DIS, V180, P1608, DOI 10.1086/315054; Weiss P, 2014, BMC INFECT DIS, V14, DOI 10.1186/1471-2334-14-333; World Health Organization, 2013, DEFINITIONS REPORTIN; World Health Organization, 2015, WHOHTMTB201522	36	8	8	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 28	2016	11	4							e0153983	10.1371/journal.pone.0153983	http://dx.doi.org/10.1371/journal.pone.0153983			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DK8XE	27124599	Green Published, Green Submitted, gold			2022-12-26	WOS:000375211700040
J	Mary, N; Barasc, H; Ferchaud, S; Priet, A; Calgaro, A; Loustau-Dudez, AM; Bonnet, N; Yerle, M; Ducos, A; Pinton, A				Mary, Nicolas; Barasc, Harmonie; Ferchaud, Stephane; Priet, Aurelia; Calgaro, Anne; Loustau-Dudez, Anne-Marie; Bonnet, Nathalie; Yerle, Martine; Ducos, Alain; Pinton, Alain			Meiotic Recombination Analyses in Pigs Carrying Different Balanced Structural Chromosomal Rearrangements	PLOS ONE			English	Article							SYNAPTONEMAL COMPLEX-ANALYSIS; CROSSOVER INTERFERENCE; CROSSING-OVER; HOUSE MOUSE; INVERSION; SYNAPSIS; PATTERNS; SINGLE; HETEROZYGOTES; LOCALIZATION	Correct pairing, synapsis and recombination between homologous chromosomes are essential for normal meiosis. All these events are strongly regulated, and our knowledge of the mechanisms involved in this regulation is increasing rapidly. Chromosomal rearrangements are known to disturb these processes. In the present paper, synapsis and recombination (number and distribution of MLH1 foci) were studied in three boars (Sus scrofa domestica) carrying different chromosomal rearrangements. One (T34he) was heterozygote for the t(3;4)(p1.3;q1.5) reciprocal translocation, one (T34ho) was homozygote for that translocation, while the third (T34Inv) was heterozygote for both the translocation and a pericentric inversion inv(4)(p1.4;q2.3). All three boars were normal for synapsis and sperm production. This particular situation allowed us to rigorously study the impact of rearrangements on recombination. Overall, the rearrangements induced only minor modifications of the number of MLH1 foci (per spermatocyte or per chromosome) and of the length of synaptonemal complexes for chromosomes 3 and 4. The distribution of MLH1 foci in T34he was comparable to that of the controls. Conversely, the distributions of MLH1 foci on chromosome 4 were strongly modified in boar T34Inv (lack of crossover in the heterosynaptic region of the quadrivalent, and crossover displaced to the chromosome extremities), and also in boar T34ho (two recombination peaks on the q-arms compared with one of higher magnitude in the controls). Analyses of boars T34he and T34Inv showed that the interference was propagated through the breakpoints. A different result was obtained for boar T34ho, in which the breakpoints (transition between SSC3 and SSC4 chromatin on the bivalents) seemed to alter the transmission of the interference signal. Our results suggest that the number of crossovers and crossover interference could be regulated by partially different mechanisms.	[Mary, Nicolas; Barasc, Harmonie; Calgaro, Anne; Loustau-Dudez, Anne-Marie; Bonnet, Nathalie; Yerle, Martine; Ducos, Alain; Pinton, Alain] INRA, Genet Physiol & Syst Elevage UMR1388, F-31326 Castanet Tolosan, France; [Mary, Nicolas; Barasc, Harmonie; Calgaro, Anne; Loustau-Dudez, Anne-Marie; Bonnet, Nathalie; Yerle, Martine; Ducos, Alain; Pinton, Alain] Univ Toulouse INPT ENSAT, Genet Physiol & Syst Elevage UMR1388, Castanet Tolosan, France; [Mary, Nicolas; Barasc, Harmonie; Calgaro, Anne; Loustau-Dudez, Anne-Marie; Bonnet, Nathalie; Yerle, Martine; Ducos, Alain; Pinton, Alain] Univ Toulouse INPT ENVT, Genet Physiol & Syst Elevage UMR1388, Toulouse, France; [Ferchaud, Stephane; Priet, Aurelia] UE1372 GenESI Genet Expt & Syst Innovants, Surgeres, France	INRAE; Universite de Toulouse; Ecole Nationale Veterinaire de Toulouse	Mary, N (corresponding author), INRA, Genet Physiol & Syst Elevage UMR1388, F-31326 Castanet Tolosan, France.; Mary, N (corresponding author), Univ Toulouse INPT ENSAT, Genet Physiol & Syst Elevage UMR1388, Castanet Tolosan, France.; Mary, N (corresponding author), Univ Toulouse INPT ENVT, Genet Physiol & Syst Elevage UMR1388, Toulouse, France.	n.mary@envt.fr	Pinton, Alain/AAQ-1648-2020; Barasc, Harmonie/AAS-9519-2020; Ducos, Alain/AAQ-3673-2020; MARY, Nicolas/AAT-9071-2020	Pinton, Alain/0000-0002-0809-7180; Barasc, Harmonie/0000-0002-1644-4701; Ducos, Alain/0000-0002-2741-9579; MARY, Nicolas/0000-0002-7304-5555				Alpi A, 2003, CHROMOSOMA, V112, P6, DOI 10.1007/s00412-003-0237-5; Barasc H, 2014, THERIOGENOLOGY, V81, P368, DOI 10.1016/j.theriogenology.2013.10.006; Basheva EA, 2014, CHROMOSOME RES, V22, P351, DOI 10.1007/s10577-014-9429-5; Baudat F, 2013, NAT REV GENET, V14, P794, DOI 10.1038/nrg3573; Berchowitz LE, 2010, CURR GENOMICS, V11, P91, DOI 10.2174/138920210790886835; Broman KW, 2000, AM J HUM GENET, V66, P1911, DOI 10.1086/302923; Cheng EY, 1999, HUM GENET, V105, P191, DOI 10.1007/s004399900120; Colombo PC, 1997, HEREDITY, V79, P214, DOI 10.1038/sj.hdy.6881930; DEBOER P, 1979, ENVIRON HEALTH PERSP, V31, P137, DOI 10.2307/3429151; Ducos A, 2008, CYTOGENET GENOME RES, V120, P26, DOI 10.1159/000118738; Dumas D, 2015, HEREDITY, V114, P56, DOI 10.1038/hdy.2014.69; Ederveen A, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-1276-z; Ferguson KA, 2008, HUM REPROD, V23, P988, DOI 10.1093/humrep/den013; Fung JC, 2004, CELL, V116, P795, DOI 10.1016/S0092-8674(04)00249-1; GABRIELROBEZ O, 1988, CYTOGENET CELL GENET, V48, P84, DOI 10.1159/000132595; GORLOV IP, 1991, HEREDITY, V66, P453, DOI 10.1038/hdy.1991.55; GORLOV IP, 1995, HEREDITY, V75, P113, DOI 10.1038/hdy.1995.114; Hillers KJ, 2003, CURR BIOL, V13, P1641, DOI 10.1016/j.cub.2003.08.026; Hou Y, 2013, CELL, V155, P1492, DOI 10.1016/j.cell.2013.11.040; Hulten MA, 2011, MOL CYTOGENET, V4, DOI 10.1186/1755-8166-4-10; Jiang HW, 2014, J GENET GENOMICS, V41, P177, DOI 10.1016/j.jgg.2014.01.005; Jones GH, 2006, CELL, V126, P246, DOI 10.1016/j.cell.2006.07.010; Kirkpatrick G, 2012, REPROD BIOMED ONLINE, V24, P91, DOI 10.1016/j.rbmo.2011.09.013; Libuda DE, 2013, NATURE, V502, P703, DOI 10.1038/nature12577; Lynn A, 2002, SCIENCE, V296, P2222, DOI 10.1126/science.1071220; Martini E, 2006, CELL, V126, P285, DOI 10.1016/j.cell.2006.05.044; Mary N, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099123; Massip K, 2010, CHROMOSOME RES, V18, P925, DOI 10.1007/s10577-010-9162-7; MCKIM KS, 1988, GENETICS, V120, P987; Mercier R, 2015, ANNU REV PLANT BIOL, V66, P297, DOI 10.1146/annurev-arplant-050213-035923; Mompart F, 2013, BMC CELL BIOL, V14, DOI 10.1186/1471-2121-14-30; MOSES MJ, 1982, CHROMOSOMA, V84, P457, DOI 10.1007/BF00292848; Naranjo T, 2015, CYTOGENET GENOME RES, V147, P55, DOI 10.1159/000442219; Oliver-Bonet M, 2005, CYTOGENET GENOME RES, V111, P343, DOI 10.1159/000086908; Petes TD, 2001, NAT REV GENET, V2, P360, DOI 10.1038/35072078; Reeves A, 2001, GENOME, V44, P439, DOI 10.1139/gen-44-3-439; Rogel-Gaillard C, 1999, CYTOGENET CELL GENET, V85, P205, DOI 10.1159/000015294; Sun F, 2005, CYTOGENET GENOME RES, V111, P366, DOI 10.1159/000086913; Sun F, 2004, AM J HUM GENET, V74, P521, DOI 10.1086/382138; Tease C, 2004, CYTOGENET GENOME RES, V107, P208, DOI 10.1159/000080599; Tease C, 1998, CHROMOSOMA, V107, P549, DOI 10.1007/s004120050341; Torgasheva AA, 2013, CHROMOSOME RES, V21, P37, DOI 10.1007/s10577-012-9336-6; Tortereau F, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-586; Turner JMA, 2005, NAT GENET, V37, P41, DOI 10.1038/ng1484; Wang SX, 2015, CELL CYCLE, V14, P305, DOI 10.4161/15384101.2014.991185; Wessa P., 2013, FREE STAT SOFTWARE; Yelina NE, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002844; ZETKA MC, 1992, GENETICS, V131, P321; Zickler D, 2015, CSH PERSPECT BIOL, V7, DOI 10.1101/cshperspect.a016626	49	7	7	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 28	2016	11	4							e0154635	10.1371/journal.pone.0154635	http://dx.doi.org/10.1371/journal.pone.0154635			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DK8XE	27124413	Green Submitted, Green Published, gold			2022-12-26	WOS:000375211700118
J	Willegger, M; Holinka, J; Nemecek, E; Bock, P; Wanivenhaus, AH; Windhager, R; Schuh, R				Willegger, Madeleine; Holinka, Johannes; Nemecek, Elena; Bock, Peter; Wanivenhaus, Axel Hugo; Windhager, Reinhard; Schuh, Reinhard			Reliability of the Radiographic Sagittal and Frontal Tibiotalar Alignment after Ankle Arthrodesis	PLOS ONE			English	Article							GAIT ANALYSIS; LATERAL RADIOGRAPHS; FOLLOW-UP; ARTHROPLASTY; REPLACEMENT; ARTHRITIS; FUSION; REPRODUCIBILITY; MALALIGNMENT; POSITION	Background Accurate measurement of the tibiotalar alignment is important in radiographic outcome assessment of ankle arthrodesis (AA). In studies, various radiological methods have been used to measure the tibiotalar alignment leading to facultative misinterpretation of results. However, to our knowledge, no previous study has investigated the reliability of tibiotalar alignment measurement in AA. We aimed to investigate the reliability of four different methods of measurement of the frontal and sagittal tibiotalar alignment after AA, and to further clarify the most reliable method for determining the longitudinal axis of the tibia. Methods Thirty-eight weight bearing anterior to posterior and lateral ankle radiographs of thirty-seven patients who had undergone AA with a two screw fixation technique were selected. Three observers measured the frontal tibiotalar angle (FTTA) and the sagittal tibiotalar angle (STTA) using four different methods. The methods differed by the definition of the longitudinal tibial axis. Method A was defined by a line drawn along the lateral tibial border in anterior to posterior radiographs and along the posterior tibial border in lateral radiographs. Method B was defined by a line connecting two points in the middle of the proximal and the distal tibial shaft. Method C was drawn "freestyle" along the longitudinal axis of the tibia, and method D was defined by a line connecting the center of the tibial articular surface and a point in the middle of the proximal tibial shaft. Intra-and interobserver correlation coefficients(ICC) and repeated measurement ANOVA were calculated to assess measurement reliability and accuracy. Results All four methods showed excellent inter-and intraobserver reliability for the FTTA and the STTA. When the longitudinal tibial axis is defined by connecting two points in the middle of the proximal and the distal tibial shaft, the highest interobserver reliability for the FTTA (ICC: 0.980; CI 95%: 0.966-0.989) and for the STTA (ICC: 0.997; CI 95%: 0.996-0.999) is provided. Intergroup analysis for FTTA measurements revealed a statistically significant difference between the method in which the lateral border of the tibia was used to determine the longitudinal axis of the tibia, and the other methods in which the longitudinal axis was defined by bisecting the tibia. Conclusions When the longitudinal axis of the tibia is defined by connecting two points in the middle of the proximal and the distal tibial shaft for measuring the FTTA and STTA, the most favorable interobserver reliability is provided. Therefore, this method can be recommended for evaluating the frontal and the sagittal alignment on anterior to posterior and lateral radiographs after ankle arthrodesis.	[Willegger, Madeleine; Holinka, Johannes; Nemecek, Elena; Wanivenhaus, Axel Hugo; Windhager, Reinhard; Schuh, Reinhard] Med Univ Vienna, Vienna Gen Hosp, Dept Orthopaed, Vienna, Austria; [Bock, Peter] Orthopaed Hosp Vienna Speising, Foot & Ankle Unit, Vienna, Austria	Medical University of Vienna	Schuh, R (corresponding author), Med Univ Vienna, Vienna Gen Hosp, Dept Orthopaed, Vienna, Austria.	reinhard.schuh@meduniwien.ac.at	Willegger, Madeleine/AAJ-7093-2020	Willegger, Madeleine/0000-0003-4400-0136; Windhager, Reinhard/0000-0002-6321-1804				Adams SB, 2013, FOOT ANKLE INT, V34, P1624, DOI 10.1177/1071100713505534; Barg A, 2015, FOOT ANKLE INT, V36, P1352, DOI 10.1177/1071100715591091; Barg A, 2012, FOOT ANKLE INT, V33, P655, DOI 10.3113/FAI.2012.0655; Barg A, 2011, J BONE JOINT SURG AM, V93A, P1969, DOI 10.2106/JBJS.J.01415; BLAND JM, 1986, LANCET, V1, P307, DOI 10.1016/s0140-6736(86)90837-8; Bonett DG, 2002, STAT MED, V21, P1331, DOI 10.1002/sim.1108; Braito M, 2015, FOOT ANKLE INT, V36, P1029, DOI 10.1177/1071100715583383; Braito M, 2015, J ORTHOP SURG RES, V10, DOI 10.1186/s13018-015-0220-x; BUCK P, 1987, J BONE JOINT SURG AM, V69A, P1052, DOI 10.2106/00004623-198769070-00014; Cerrato RA, 2014, FOOT ANKLE INT, V35, P1176, DOI 10.1177/1071100714544521; Coester LM, 2001, J BONE JOINT SURG AM, V83A, P219, DOI 10.2106/00004623-200102000-00009; Datir A, 2013, SKELETAL RADIOL, V42, P1693, DOI 10.1007/s00256-013-1718-0; Hastings MK, 2011, FOOT ANKLE INT, V32, P867, DOI 10.3113/FAI.2011.0867; HEFTI FL, 1980, ARCH ORTHOP TRAUM SU, V96, P187, DOI 10.1007/BF00457782; Hintermann B, 2004, CLIN ORTHOP RELAT R, P57, DOI 10.1097/01.blo.0000132462.72843.e8; Kleiber BD, 2011, FOOT ANKLE INT, V32, P380, DOI 10.3113/FAI.2011.0380; Krause FG, 2011, J BONE JOINT SURG AM, V93A, P830, DOI 10.2106/JBJS.J.00103; Lee KM, 2010, J BONE JOINT SURG AM, V92A, P2319, DOI 10.2106/JBJS.I.01150; Magerkurth O, 2006, FOOT ANKLE INT, V27, P612, DOI 10.1177/107110070602700808; MANN RA, 1991, CLIN ORTHOP RELAT R, P49; MAZUR JM, 1979, J BONE JOINT SURG AM, V61, P964, DOI 10.2106/00004623-197961070-00002; MORREY BF, 1980, J BONE JOINT SURG AM, V62, P777, DOI 10.2106/00004623-198062050-00012; Munro BH, 2005, STAT METHODS HLTH CA, P248; O'Brien TS, 1999, FOOT ANKLE INT, V20, P368, DOI 10.1177/107110079902000605; Pellegrini MJ, 2015, J BONE JOINT SURG AM, V97A, P2004, DOI 10.2106/JBJS.O.00396; Perlman MH, 1999, FOOT ANKLE INT, V20, P491, DOI 10.1177/107110079902000805; Pyevich MT, 1998, J BONE JOINT SURG AM, V80A, P1410, DOI 10.2106/00004623-199810000-00002; Rungprai C, 2014, FOOT ANKLE INT, V35, P1166, DOI 10.1177/1071100714545514; SALTZMAN CL, 1995, FOOT ANKLE INT, V16, P572, DOI 10.1177/107110079501600911; Schneider W, 2003, J BONE JOINT SURG AM, V85A, P494, DOI 10.2106/00004623-200303000-00015; Schuh R, 2011, CLIN BIOMECH, V26, P620, DOI 10.1016/j.clinbiomech.2011.02.001; Sensiba PR, 2010, FOOT ANKLE INT, V31, P141, DOI 10.3113/FAI.2010.0141; Steel M W 3rd, 1980, Foot Ankle, V1, P151; Thomas R, 2006, J BONE JOINT SURG AM, V88A, P526, DOI 10.2106/JBJS.E.00521; Thomas RH, 2003, J BONE JOINT SURG AM, V85A, P923, DOI 10.2106/00004623-200305000-00026; Tochigi Y, 2006, FOOT ANKLE INT, V27, P82, DOI 10.1177/107110070602700202; Tochigi YI, 2006, FOOT ANKLE INT, V27, P88, DOI 10.1177/107110070602700203; Wang BB, 2015, CLIN ORTHOP RELAT R, V473, P318, DOI 10.1007/s11999-014-3960-8; Winson IG, 2005, J BONE JOINT SURG BR, V87B, P343, DOI 10.1302/0301-620X.87B3.15756; Wood PLR, 2003, J BONE JOINT SURG BR, V85B, P334, DOI 10.1302/0301-620X.85B3.13849	40	9	9	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 28	2016	11	4							e0154224	10.1371/journal.pone.0154224	http://dx.doi.org/10.1371/journal.pone.0154224			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DK8XE	27124403	Green Published, Green Submitted, gold			2022-12-26	WOS:000375211700057
J	Liu, YD; Zhang, B; Kuang, H; Korakavi, G; Lu, LY; Yu, XC				Liu, Yidan; Zhang, Bin; Kuang, Henry; Korakavi, Gautam; Lu, Lin-Yu; Yu, Xiaochun			Zinc Finger Protein 618 Regulates the Function of UHRF2 (Ubiquitin-like with PHD and Ring Finger Domains 2) as a Specific 5-Hydroxymethylcytosine Reader	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						5-hydroxymethylcytosine (5-hmC); chromatin; DNA demethylation; molecular biology; molecular cell biology	EMBRYONIC STEM-CELLS; DNA METHYLATION; METHYLTRANSFERASE DNMT1; MAMMALIAN DNA; SRA DOMAIN; GENOME; MAINTENANCE; 5-CARBOXYLCYTOSINE; 5-METHYLCYTOSINE; CHROMATIN	5-Hydroxymethylcytosine (5hmC) is an epigenetic modification that is generated by ten-eleven translocation (TET) protein-mediated oxidation of 5-methylcytosine (5mC). 5hmC is associated with transcription regulation and is decreased in many cancers including melanoma. Accumulating evidence has suggested that 5hmC is functionally distinct from 5mC. Ubiquitin-like with PHD and ring finger domains 2 (UHRF2) is the first known specific 5hmC reader that has higher affinity to 5hmC than 5mC, suggesting that UHRF2 might mediate 5hmC's function. Structural analysis has revealed the molecular mechanism of UHRF2-5hmC binding in vitro, but it is not clear how UHRF2 recognizes 5hmC in vivo. In this study, we have identified zinc figure protein 618 (ZNF618) as a novel binding partner of UHRF2. ZNF618 specifically interacts with UHRF2 but not its paralog UHRF1. Importantly, ZNF618 co-localizes with UHRF2 at genomic loci that are enriched for 5hmC. The ZNF618 chromatin localization is independent of its interaction with UHRF2 and is through its first two zinc fingers. Instead, ZNF618 regulates UHRF2 chromatin localization. Collectively, our study suggests that ZNF618 is a key protein that regulates UHRF2 function as a specific 5hmC reader in vivo.	[Liu, Yidan; Zhang, Bin; Lu, Lin-Yu] Zhejiang Univ, Sch Med, Womens Hosp, Key Lab Reprod Genet,Minist Educ, Hangzhou 310006, Zhejiang, Peoples R China; [Liu, Yidan; Zhang, Bin; Lu, Lin-Yu] Zhejiang Univ, Sch Med, Womens Hosp, Womens Reprod Hlth Lab Zhejiang Prov, Hangzhou 310006, Zhejiang, Peoples R China; [Liu, Yidan; Zhang, Bin; Lu, Lin-Yu] Zhejiang Univ, Inst Translat Med, Hangzhou 310029, Zhejiang, Peoples R China; [Kuang, Henry; Korakavi, Gautam; Yu, Xiaochun] City Hope Natl Med Ctr, Beckman Res Inst, Dept Canc Genet & Epigenet, Duarte, CA 91010 USA	Zhejiang University; Zhejiang University; Zhejiang University; City of Hope; Beckman Research Institute of City of Hope	Lu, LY (corresponding author), Zhejiang Univ, Sch Med, Womens Hosp, Key Lab Reprod Genet,Minist Educ, Hangzhou 310006, Zhejiang, Peoples R China.; Lu, LY (corresponding author), Zhejiang Univ, Sch Med, Womens Hosp, Womens Reprod Hlth Lab Zhejiang Prov, Hangzhou 310006, Zhejiang, Peoples R China.; Lu, LY (corresponding author), Zhejiang Univ, Inst Translat Med, Hangzhou 310029, Zhejiang, Peoples R China.; Yu, XC (corresponding author), City Hope Natl Med Ctr, Beckman Res Inst, Dept Canc Genet & Epigenet, Duarte, CA 91010 USA.	lulinyu@zju.edu.cn; xyu@coh.org			Zhejiang Provincial Natural Science Foundation of China [LR15H040001]; National Natural Science Foundation of China [81471494]; National Institutes of Health [CA130899, CA132755, CA187209, GM108647]; Department of Defense; NATIONAL CANCER INSTITUTE [R01CA187209, R01CA132755, R01CA130899] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM108647] Funding Source: NIH RePORTER	Zhejiang Provincial Natural Science Foundation of China(Natural Science Foundation of Zhejiang Province); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Defense(United States Department of Defense); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was funded by Zhejiang Provincial Natural Science Foundation of China (LR15H040001, to L. Y.), National Natural Science Foundation of China (81471494, to L. Y.), and National Institutes of Health (CA130899, CA132755, CA187209, and GM108647, to X. Y.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.; Recipient of Era of Hope Scholar Award from the Department of Defense and a research scholar of Leukemia and Lymphoma Society. To whom correspondence may be addressed. E-mail: xyu@coh.org.	Bashtrykov P, 2014, J BIOL CHEM, V289, P4106, DOI 10.1074/jbc.M113.528893; Berkyurek AC, 2014, J BIOL CHEM, V289, P379, DOI 10.1074/jbc.M113.523209; Bostick M, 2007, SCIENCE, V317, P1760, DOI 10.1126/science.1147939; Ficz G, 2011, NATURE, V473, P398, DOI 10.1038/nature10008; Frauer C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021306; Globisch D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015367; Grosser C, 2015, EPIGENETICS-US, V10, P819, DOI 10.1080/15592294.2015.1073879; Hashimoto H, 2014, NATURE, V506, P391, DOI 10.1038/nature12905; He YF, 2011, SCIENCE, V333, P1303, DOI 10.1126/science.1210944; Heinz S, 2010, MOL CELL, V38, P576, DOI 10.1016/j.molcel.2010.05.004; Hu LL, 2015, NATURE, V527, P118, DOI 10.1038/nature15713; Ito S, 2011, SCIENCE, V333, P1300, DOI 10.1126/science.1210597; Kohli RM, 2013, NATURE, V502, P472, DOI 10.1038/nature12750; Kriaucionis S, 2009, SCIENCE, V324, P929, DOI 10.1126/science.1169786; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; LI E, 1992, CELL, V69, P915, DOI 10.1016/0092-8674(92)90611-F; Lian CG, 2012, CELL, V150, P1135, DOI 10.1016/j.cell.2012.07.033; Lu LY, 2015, J BIOL CHEM, V290, P851, DOI 10.1074/jbc.M114.611509; Mellen M, 2012, CELL, V151, P1417, DOI 10.1016/j.cell.2012.11.022; Nishiyama A, 2013, NATURE, V502, P249, DOI 10.1038/nature12488; Pastor WA, 2011, NATURE, V473, P394, DOI 10.1038/nature10102; Pichler G, 2011, J CELL BIOCHEM, V112, P2585, DOI 10.1002/jcb.23185; Qin WH, 2015, CELL RES, V25, P911, DOI 10.1038/cr.2015.72; Quinlan AR, 2010, BIOINFORMATICS, V26, P841, DOI 10.1093/bioinformatics/btq033; Sharif J, 2007, NATURE, V450, P908, DOI 10.1038/nature06397; Song CX, 2012, NAT BIOTECHNOL, V30, P1107, DOI 10.1038/nbt.2398; Song CX, 2011, NAT BIOTECHNOL, V29, P68, DOI 10.1038/nbt.1732; Spruijt CG, 2013, CELL, V152, P1146, DOI 10.1016/j.cell.2013.02.004; Stroud H, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-6-r54; Tahiliani M, 2009, SCIENCE, V324, P930, DOI 10.1126/science.1170116; Wu H, 2011, GENE DEV, V25, P679, DOI 10.1101/gad.2036011; Xu YF, 2011, MOL CELL, V42, P451, DOI 10.1016/j.molcel.2011.04.005; Zhang JQ, 2011, CELL RES, V21, P1723, DOI 10.1038/cr.2011.176; Zhang Y, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-r137; Zhang ZM, 2015, CELL REP, V12, P1400, DOI 10.1016/j.celrep.2015.07.046; Zhou T, 2014, MOL CELL, V54, P879, DOI 10.1016/j.molcel.2014.04.003	36	11	11	1	19	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 24	2016	291	26					13679	13688		10.1074/jbc.M116.717314	http://dx.doi.org/10.1074/jbc.M116.717314			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DR2YZ	27129234	Green Published, hybrid			2022-12-26	WOS:000379771100023
J	Kirkby, CA; Richardson, AE; Wade, LJ; Conyers, M; Kirkegaard, JA				Kirkby, Clive A.; Richardson, Alan E.; Wade, Len J.; Conyers, Mark; Kirkegaard, John A.			Inorganic Nutrients Increase Humification Efficiency and C-Sequestration in an Annually Cropped Soil	PLOS ONE			English	Article							ORGANIC-MATTER; CARBON SEQUESTRATION; NITROGEN; FOREST; DEEP; STOICHIOMETRY; PRODUCTIVITY; SYSTEMS; GROWTH; POOLS	Removing carbon dioxide (CO2) from the atmosphere and storing the carbon (C) in resistant soil organic matter (SOM) is a global priority to restore soil fertility and help mitigate climate change. Although it is widely assumed that retaining rather than removing or burning crop residues will increase SOM levels, many studies have failed to demonstrate this. We hypothesised that the microbial nature of resistant SOM provides a predictable nutrient stoichiometry (C:nitrogen, C:phosphorus and C:sulphur-C:N:P:S) to target using supplementary nutrients when incorporating C-rich crop residues into soil. An improvement in the humification efficiency of the soil microbiome as a whole, and thereby C-sequestration, was predicted. In a field study over 5 years, soil organic-C (SOC) stocks to 1.6 m soil depth were increased by 5.5 t C ha(-1) where supplementary nutrients were applied with incorporated crop residues, but were reduced by 3.2 t C ha(-1) without nutrient addition, with 2.9 t C ha(-1) being lost from the 0-10 cm layer. A net difference of 8.7 t C ha(-1) was thus achieved in a cropping soil over a 5 year period, despite the same level of C addition. Despite shallow incorporation (0.15 m), more than 50% of the SOC increase occurred below 0.3 m, and as predicted by the stoichiometry, increases in resistant SOC were accompanied by increases in soil NPS at all depths. Interestingly the C:N, C:P and C:S ratios decreased significantly with depth possibly as a consequence of differences in fungi to bacteria ratio. Our results demonstrate that irrespective of the C-input, it is essential to balance the nutrient stoichiometry of added C to better match that of resistant SOM to increase SOC sequestration. This has implications for global practices and policies aimed at increasing SOC sequestration and specifically highlight the need to consider the hidden cost and availability of associated nutrients in building soil-C.	[Kirkby, Clive A.; Richardson, Alan E.; Kirkegaard, John A.] Commonwealth Sci & Ind Res Org CSIRO Agr, GPO Box 1600, Canberra, ACT, Australia; [Kirkby, Clive A.; Wade, Len J.] Charles Sturt Univ, EH Graham Ctr Agr Innovat, Wagga Wagga, NSW, Australia; [Conyers, Mark] New South Wales Dept Primary Ind, PMB Pine Gully Rd, Wagga Wagga, NSW, Australia	Commonwealth Scientific & Industrial Research Organisation (CSIRO); Charles Sturt University; NSW Department of Primary Industries	Kirkby, CA (corresponding author), Commonwealth Sci & Ind Res Org CSIRO Agr, GPO Box 1600, Canberra, ACT, Australia.; Kirkby, CA (corresponding author), Charles Sturt Univ, EH Graham Ctr Agr Innovat, Wagga Wagga, NSW, Australia.	Clive.Kirkby@csiro.au	Kirkegaard, John/A-1449-2010; Wade, Len J/A-8872-2008; Richardson, Alan/I-1903-2012	Kirkegaard, John/0000-0001-5982-9508; Wade, Len J/0000-0002-1321-4310; Richardson, Alan/0000-0003-0708-1299				Ajwa HA, 1998, SOIL SCI SOC AM J, V62, P942, DOI 10.2136/sssaj1998.03615995006200040014x; Baisden WT, 2002, GLOBAL BIOGEOCHEM CY, V16, DOI 10.1029/2001GB001823; Chapin F.S., 2002, PRINCIPLES TERRESTRI, P197; Corvasce M, 2006, CHEMOSPHERE, V62, P1583, DOI 10.1016/j.chemosphere.2005.07.065; Cotrufo MF, 2013, GLOBAL CHANGE BIOL, V19, P988, DOI 10.1111/gcb.12113; Cross WF, 2005, FRESHWATER BIOL, V50, P1895, DOI 10.1111/j.1365-2427.2005.01458.x; Dighton J, 2003, FUNGI ECOSYSTEM PROC, P1; Eswaran H, 2000, GLOBAL CLIMATE CHANGE AND PEDOGENIC CARBONATES, P15; Fierer N, 2003, SOIL BIOL BIOCHEM, V35, P167, DOI 10.1016/S0038-0717(02)00251-1; Fontaine S, 2004, ECOL LETT, V7, P314, DOI 10.1111/j.1461-0248.2004.00579.x; Gregory PJ, 1996, PLANT SOIL, V187, P221, DOI 10.1007/BF00017089; Harper RJ, 2013, PLANT SOIL, V368, P641, DOI 10.1007/s11104-013-1600-9; Heldal M, 1996, MAR POLLUT BULL, V33, P3, DOI 10.1016/S0025-326X(97)00007-6; Isbell R.F., 2002, AUSTR SOIL CLASSIFIC; Johnson DW, 2011, FOREST SCI, V57, P3; Kirkby CA, 2011, GEODERMA, V163, P197, DOI 10.1016/j.geoderma.2011.04.010; Kirkby CA, 2014, SOIL BIOL BIOCHEM, V68, P402, DOI 10.1016/j.soilbio.2013.09.032; Kirkby CA, 2013, SOIL BIOL BIOCHEM, V60, P77, DOI 10.1016/j.soilbio.2013.01.011; KIRKEGAARD JA, 1994, AUST J AGR RES, V45, P511, DOI 10.1071/AR9940511; Kirkegaard JA, 2014, AGR ECOSYST ENVIRON, V187, P133, DOI 10.1016/j.agee.2013.08.011; Lal R, 2006, LAND DEGRAD DEV, V17, P197, DOI 10.1002/ldr.696; Lal R, 2004, SCIENCE, V304, P1623, DOI 10.1126/science.1097396; Lal R, 2004, GEODERMA, V123, P1, DOI 10.1016/j.geoderma.2004.01.032; Leckie SE, 2005, FOREST ECOL MANAG, V220, P88, DOI 10.1016/j.foreco.2005.08.007; Liang Chao, 2011, Nat Rev Microbiol, V9, P75, DOI 10.1038/nrmicro2386-c1; Lilley JM, 2004, NEW DIRECTIONS DIVER, P1; Lorenz K, 2011, FOREST SCI, V57, P19; Lou YL, 2012, CATENA, V95, P124, DOI 10.1016/j.catena.2012.02.009; MCGILL WB, 1975, SOIL BIOL BIOCHEM, V7, P57, DOI 10.1016/0038-0717(75)90032-2; Neff JC, 2003, FRONT ECOL ENVIRON, V1, P205, DOI 10.1890/1540-9295(2003)001[0205:BITCDO]2.0.CO;2; Olsson PA, 2008, APPL ENVIRON MICROB, V74, P4144, DOI 10.1128/AEM.00376-08; Paul EA, 1997, SOIL SCI SOC AM J, V61, P1058, DOI 10.2136/sssaj1997.03615995006100040011x; Pinck LA, 1944, SOIL SCI, V57, P155, DOI 10.1097/00010694-194402000-00006; POST WM, 1982, NATURE, V298, P156, DOI 10.1038/298156a0; Richardson AE, 2014, CARBON MANAG, V5, P265, DOI 10.1080/17583004.2014.923226; RICHTER DD, 1995, BIOSCIENCE, V45, P600, DOI 10.2307/1312764; Riedel, 2011, ENCY GEOBIOLOGY, P355; Rumpel C, 2011, PLANT SOIL, V338, P143, DOI 10.1007/s11104-010-0391-5; SCHARPENSEEL HW, 1989, RADIOCARBON, V31, P627; Schlesinger WH., 1984, ROLE TERRESTRIAL VEG, P111; Schlesinger WH, 1995, ADV SOIL SCI SOILS G, P9; Smith P, 2007, CLIMATE CHANGE 2007, P497; Smith P, 2014, CLIMATE CHANGE 2014: MITIGATION OF CLIMATE CHANGE, P811; Soil Science Society of America, 2008, GLOSS SOIL SCI TERMS, P59; Veldkamp E, 2003, GLOBAL CHANGE BIOL, V9, P1171, DOI 10.1046/j.1365-2486.2003.00656.x	45	65	66	8	72	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 4	2016	11	5							e0153698	10.1371/journal.pone.0153698	http://dx.doi.org/10.1371/journal.pone.0153698			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DL5KR	27144282	Green Published, Green Submitted, gold			2022-12-26	WOS:000375676400023
J	Motamedinia, P; Scott, AN; Bate, KL; Sadeghi, N; Salazar, G; Shapiro, E; Ahn, J; Lipsky, M; Lin, J; Hruby, GW; Badani, KK; Petrylak, DP; Benson, MC; Donovan, MJ; Comper, WD; McKiernan, JM; Russo, LM				Motamedinia, Piruz; Scott, Anna N.; Bate, Kendall L.; Sadeghi, Neda; Salazar, Guillermo; Shapiro, Edan; Ahn, Jennifer; Lipsky, Michael; Lin, James; Hruby, Greg W.; Badani, Ketan K.; Petrylak, Daniel P.; Benson, Mitchell C.; Donovan, Michael J.; Comper, Wayne D.; McKiernan, James M.; Russo, Leileata M.			Urine Exosomes for Non-Invasive Assessment of Gene Expression and Mutations of Prostate Cancer	PLOS ONE			English	Article							TMPRSS2-ERG FUSION TRANSCRIPTS; MESSENGER-RNA; BIOPSY; BIOMARKERS; MORTALITY; DIAGNOSIS; PCA3	Purpose The analysis of exosome/microvesicle (extracellular vesicles (EVs)) and the RNA packaged within them (exoRNA) has the potential to provide a non-invasive platform to detect and monitor disease related gene expression potentially in lieu of more invasive procedures such as biopsy. However, few studies have tested the diagnostic potential of EV analysis in humans. Experimental Design The ability of EV analysis to accurately reflect prostate tissue mRNA expression was examined by comparing urinary EV TMPRSS2:ERG exoRNA from pre-radical prostatectomy (RP) patients versus corresponding RP tissue in 21 patients. To examine the differential expression of TMPRSS2: ERG across patient groups a random urine sample was taken without prostate massage from a cohort of 207 men including prostate biopsy negative (Bx Neg, n = 39), prostate biopsy positive (Bx Pos, n = 47), post-radical prostatectomy (post-RP, n = 37), un-biopsied healthy age-matched men (No Bx, n = 44), and young male controls (Cont, n = 40). The use of EVs was also examined as a potential platform to non-invasively differentiate Bx Pos versus Bx Neg patients via the detection of known prostate cancer genes TMPRSS2: ERG, BIRC5, ERG, PCA3 and TMPRSS2. Results In this technical pilot study urinary EVs had a sensitivity: 81% (13/16), specificity: 80%(4/5) and an overall accuracy: 81%(17/21) for non-invasive detection of TMPRSS2: ERG versus RP tissue. The rate of TMPRSS2: ERG exoRNA detection was found to increase with age and the expression level correlated with Bx Pos status. Receiver operator characteristic analyses demonstrated that various cancer-related genes could differentiate Bx Pos from Bx Neg patients using exoRNA isolated from urinary EVs: BIRC5 (AUC 0.674 (CI: 0.560-0.788), ERG (AUC 0.785 (CI: 0.680-0.890), PCA3 (AUC 0.681 (CI: 0.567-0.795), TMPRSS2: ERG (AUC 0.744 (CI: 0.600-0.888), and TMPRSS2 (AUC 0.637 (CI: 0.519-0.754). Conclusion This pilot study suggests that urinary EVs have the potential to be used as a platform to non-invasively differentiate patients with prostate cancer with very good accuracy. Larger studies are needed to confirm the potential for clinical utility.	[Motamedinia, Piruz; Sadeghi, Neda; Shapiro, Edan; Ahn, Jennifer; Lipsky, Michael; Lin, James; Hruby, Greg W.; Badani, Ketan K.; Petrylak, Daniel P.; Benson, Mitchell C.; McKiernan, James M.] Columbia Univ, Dept Urol, Med Ctr, New York, NY USA; [Scott, Anna N.; Bate, Kendall L.; Salazar, Guillermo; Donovan, Michael J.; Comper, Wayne D.; Russo, Leileata M.] Exosome Diagnost Inc, New York, NY USA; [Donovan, Michael J.] Icahn Sch Med Mt Sinai, Dept Pathol, New York, NY 10029 USA; [Badani, Ketan K.] Icahn Sch Med Mt Sinai, Dept Urol, New York, NY 10029 USA; [Petrylak, Daniel P.] Yale Univ, Smilow Canc Ctr, New Haven, CT USA; [Russo, Leileata M.] Harvard Univ, Massachusetts Gen Hosp, Sch Med, Progam Membrane Biol,Div Nephrol, Boston, MA USA	Columbia University; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Yale University; Harvard University; Harvard Medical School; Massachusetts General Hospital	Russo, LM (corresponding author), Exosome Diagnost Inc, New York, NY USA.; Russo, LM (corresponding author), Harvard Univ, Massachusetts Gen Hosp, Sch Med, Progam Membrane Biol,Div Nephrol, Boston, MA USA.	Lrusso@mgh.harvard.edu			Doris Duke Charitable Foundation; Exosome Diagnostics, Inc.	Doris Duke Charitable Foundation(Doris Duke Charitable Foundation (DDCF)); Exosome Diagnostics, Inc.	J Lin received a Doris Duke Charitable Foundation Award. This study was supported by Exosome Diagnostics, Inc. The funder provided support in the form of salaries for authors ANS, KLB, GS, MJD, WDC, LMR, and had an additional role in the study design, data collection and analysis, and preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Ambrosini G, 1997, NAT MED, V3, P917, DOI 10.1038/nm0897-917; Andriole GL, 2009, NEW ENGL J MED, V360, P1310, DOI 10.1056/NEJMoa0810696; Bussemakers MJG, 1999, CANCER RES, V59, P5975; Chou R, 2011, ANN INTERN MED, V155, P762, DOI 10.7326/0003-4819-155-11-201112060-00375; Deras IL, 2008, J UROLOGY, V179, P1587, DOI 10.1016/j.juro.2007.11.038; Hessels D, 2007, CLIN CANCER RES, V13, P5103, DOI 10.1158/1078-0432.CCR-07-0700; Hugosson J, 2010, LANCET ONCOL, V11, P725, DOI 10.1016/S1470-2045(10)70146-7; Jemal A, 2011, CA-CANCER J CLIN, V61, P133, DOI [10.3322/caac.20105, 10.3322/caac.20073]; Laxman B, 2008, CANCER RES, V68, P645, DOI 10.1158/0008-5472.CAN-07-3224; Laxman B, 2006, NEOPLASIA, V8, P885, DOI 10.1593/neo.06625; Leitzmann Michael F, 2012, Clin Epidemiol, V4, P1, DOI 10.2147/CLEP.S16747; Leyten GHJM, 2014, EUR UROL, V65, P534, DOI 10.1016/j.eururo.2012.11.014; Miranda KC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096094; Miranda KC, 2010, KIDNEY INT, V78, P191, DOI 10.1038/ki.2010.106; Nilsson J, 2009, BRIT J CANCER, V100, P1603, DOI 10.1038/sj.bjc.6605058; Perner S, 2007, AM J SURG PATHOL, V31, P882, DOI 10.1097/01.pas.0000213424.38503.aa; Petrovics G, 2005, ONCOGENE, V24, P3847, DOI 10.1038/sj.onc.1208518; Bories PN, 2013, CLIN CHEM, V59, P245, DOI 10.1373/clinchem.2012.192260; Pisitkun T, 2004, P NATL ACAD SCI USA, V101, P13368, DOI 10.1073/pnas.0403453101; Rice KR, 2010, CLIN CANCER RES, V16, P1572, DOI 10.1158/1078-0432.CCR-09-2191; Rostad K, 2009, APMIS, V117, P575, DOI 10.1111/j.1600-0463.2009.02517.x; Salami SS, 2013, UROL ONCOL-SEMIN ORI, V31, P566, DOI 10.1016/j.urolonc.2011.04.001; Schroder FH, 2012, NEW ENGL J MED, V366, P981, DOI 10.1056/NEJMoa1113135; Skog J, 2008, NAT CELL BIOL, V10, P1470, DOI 10.1038/ncb1800; Soller MJ, 2006, GENE CHROMOSOME CANC, V45, P717, DOI 10.1002/gcc.20329; Svensson MA, 2014, APPL IMMUNOHISTO M M, V22, P136, DOI 10.1097/PDM.0b013e31829e0484; Tomlins SA, 2005, SCIENCE, V310, P644, DOI 10.1126/science.1117679; Tomlins SA, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3001970; Valadi H, 2007, NAT CELL BIOL, V9, P654, DOI 10.1038/ncb1596; WANG MC, 1981, PROSTATE, V2, P89, DOI 10.1002/pros.2990020109; Winnes M, 2007, ONCOL REP, V17, P1033	31	34	36	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 4	2016	11	5							e0154507	10.1371/journal.pone.0154507	http://dx.doi.org/10.1371/journal.pone.0154507			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DL5KR	27144529	Green Submitted, gold, Green Published			2022-12-26	WOS:000375676400048
J	Rubin, MR; Paschalis, EP; Poundarik, A; Sroga, GE; McMahon, DJ; Gamsjaeger, S; Klaushofer, K; Vashishth, D				Rubin, Mishaela R.; Paschalis, Eleftherios P.; Poundarik, Atharva; Sroga, Gyna E.; McMahon, Donald J.; Gamsjaeger, Sonja; Klaushofer, Klaus; Vashishth, Deepak			Advanced Glycation Endproducts and Bone Material Properties in Type 1 Diabetic Mice	PLOS ONE			English	Article							GLYCOSYLATION END-PRODUCTS; TISSUE MATERIAL PROPERTIES; IN-VIVO MEASUREMENT; POSTMENOPAUSAL WOMEN; NONENZYMATIC GLYCATION; MECHANICAL-PROPERTIES; SPECTROSCOPIC CHARACTERIZATION; RAMAN-SPECTROSCOPY; AGE-MODIFICATIONS; FRACTURE RISK	Fractures, particularly at the lower extremities and hip, are a complication of diabetes. In both type 1 (T1D) and type 2 diabetes (T2D), fracture risk is disproportionately worse than that predicted from the measurement of bone mineral density. Although an explanation for this discrepancy is the presence of organic matrix abnormalities, it has not been fully elucidated how advanced glycation endproducts (AGEs) relate to bone deterioration at both the macroscopic and microscopic levels. We hypothesized that there would be a relationship between skeletal AGE levels (determined by Raman microspectroscopy at specific anatomical locations) and bone macroscopic and microscopic properties, as demonstrated by the biomechanical measures of crack growth and microindentation respectively. We found that in OVE26 mice, a transgenic model of severe early onset T1D, AGEs were increased by Raman (carboxymethyl-lysine [CML] wildtype (WT): 0.0143 +/- 0.0005 vs T1D: 0.0175 +/- 0.0002, p = 0.003) at the periosteal surface. These differences were associated with less tough bone in T1D by fracture mechanics (propagation toughness WT: 4.73 +/- 0.32 vs T1D: 3.39 +/- 0.24 NM/m(1/2), p = 0.010) and by reference point indentation (indentation distance increase WT: 6.85 +/- 0.44 vs T1D: 9.04 +/- 0.77 mu m; p = 0.043). Within T1D, higher AGEs by Raman correlated inversely with macroscopic bone toughness. These data add to the existing body of knowledge regarding AGEs and the relationship between skeletal AGEs with biomechanical indices.	[Rubin, Mishaela R.; McMahon, Donald J.] Columbia Univ Coll Phys & Surg, Dept Med, Metab Bone Dis Unit, New York, NY USA; [Paschalis, Eleftherios P.; Gamsjaeger, Sonja; Klaushofer, Klaus] Hanusch Hosp WGKK, Ludwig Boltzmann Inst Osteol, Vienna, Austria; [Paschalis, Eleftherios P.; Gamsjaeger, Sonja; Klaushofer, Klaus] Hanusch Hosp, AUVA Trauma Ctr Meidling, Dept Med 1, Vienna, Austria; [Poundarik, Atharva; Sroga, Gyna E.; Vashishth, Deepak] Rensselaer Polytech Inst, Dept Biomed Engn, Ctr Biotechnol & Interdisciplinary Studies, Troy, NY 12180 USA	Columbia University; Ludwig Boltzmann Institute; WGKK - Hanusch Hospital; WGKK - Hanusch Hospital; Rensselaer Polytechnic Institute	Rubin, MR (corresponding author), Columbia Univ Coll Phys & Surg, Dept Med, Metab Bone Dis Unit, New York, NY USA.	mrr6@columbia.edu	Gamsjaeger, Sonja/AAB-6636-2021; /AAC-1939-2021; Gamsjaeger, Sonja/AAD-3956-2019	Gamsjaeger, Sonja/0000-0002-9543-6530; Gamsjaeger, Sonja/0000-0002-9543-6530; Vashishth, Deepak/0000-0001-5712-0167	Columbia University Irving Institute for Clinical and Translational Research CTSA/CTO pilot award; NIH [AR 49635, AG20618]; AUVA (Austrian Workers' Compensation Board); WGKK (Vienna Health Insurance Fund)	Columbia University Irving Institute for Clinical and Translational Research CTSA/CTO pilot award; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); AUVA (Austrian Workers' Compensation Board); WGKK (Vienna Health Insurance Fund)	This work was supported by Columbia University Irving Institute for Clinical and Translational Research CTSA/CTO pilot award; NIH AR 49635; NIH AG20618; the AUVA (Austrian Workers' Compensation Board); and the WGKK (Vienna Health Insurance Fund).	Abraham AC, 2015, J BONE MINER RES, V30, P2207, DOI 10.1002/jbmr.2568; [Anonymous], 2011, GUIDE CARE USE LAB A; Aref M, 2013, BONE, V56, P449, DOI 10.1016/j.bone.2013.07.009; Barzilay JI, 2014, J BONE MINER RES, V29, P1061, DOI 10.1002/jbmr.2123; Beattie JR, 2011, INVEST OPHTH VIS SCI, V52, P1593, DOI 10.1167/iovs.10-6554; Botolin S, 2005, ENDOCRINOLOGY, V146, P3622, DOI 10.1210/en.2004-1677; BROWNLEE M, 1988, NEW ENGL J MED, V318, P1315; Czamara K, 2015, J RAMAN SPECTROSC, V46, P4, DOI 10.1002/jrs.4607; De Gelder J, 2007, J RAMAN SPECTROSC, V38, P1133, DOI 10.1002/jrs.1734; Devlin MJ, 2014, ENDOCRINOLOGY, V155, P3806, DOI 10.1210/en.2014-1041; Diez-Perez A, 2010, J BONE MINER RES, V25, P1877, DOI 10.1002/jbmr.73; Donnelly E, 2010, CALCIFIED TISSUE INT, V87, P450, DOI 10.1007/s00223-010-9404-x; Ellis R, 2009, CONNECT TISSUE RES, V50, P29, DOI 10.1080/03008200802398422; EPSTEIN PN, 1989, CELL, V58, P1067, DOI 10.1016/0092-8674(89)90505-9; Farr JN, 2014, J BONE MINER RES, V29, P787, DOI 10.1002/jbmr.2106; FRUSHOUR BG, 1975, BIOPOLYMERS, V14, P379, DOI 10.1002/bip.1975.360140211; Frye EB, 1998, J BIOL CHEM, V273, P18714, DOI 10.1074/jbc.273.30.18714; Gamsjaeger S, 2014, BONE, V69, P89, DOI 10.1016/j.bone.2014.09.012; Gamsjaeger S, 2014, J BONE MINER RES, V29, P2382, DOI 10.1002/jbmr.2268; Gamsjaeger S, 2014, J RAMAN SPECTROSC, V45, P794, DOI 10.1002/jrs.4552; Gamsjaeger S, 2011, J BONE MINER RES, V26, P12, DOI 10.1002/jbmr.180; Gamsjaeger S, 2010, BONE, V47, P392, DOI 10.1016/j.bone.2010.04.608; Genuth S, 2005, DIABETES, V54, P3103, DOI 10.2337/diabetes.54.11.3103; Glenn JV, 2007, FASEB J, V21, P3542, DOI 10.1096/fj.06-7896com; Guerri-Fernandez RC, 2013, J BONE MINER RES, V28, P162, DOI 10.1002/jbmr.1731; Hammond MA, 2014, BONE, V60, P26, DOI 10.1016/j.bone.2013.11.015; KOENIG JL, 1970, BIOPOLYMERS, V9, P1229, DOI 10.1002/bip.1970.360091003; MAKITA Z, 1991, NEW ENGL J MED, V325, P836, DOI 10.1056/NEJM199109193251202; McNerny EMB, 2015, J BONE MINER RES, V30, P446, DOI 10.1002/jbmr.2356; Mieczkowska A, 2015, BONE, V76, P31, DOI 10.1016/j.bone.2015.03.010; Monnier VM, 2005, ANN NY ACAD SCI, V1043, P567, DOI 10.1196/annals.1333.065; MONNIER VM, 1984, P NATL ACAD SCI-BIOL, V81, P583, DOI 10.1073/pnas.81.2.583; Morris MD, 2011, CLIN ORTHOP RELAT R, V469, P2160, DOI 10.1007/s11999-010-1692-y; Oren TW, 2011, J REHABIL RES DEV, V48, P1195, DOI 10.1682/JRRD.2010.09.0186; Paschalis EP, 2015, CALCIFIED TISSUE INT, V96, P18, DOI 10.1007/s00223-014-9933-9; Paschalis EP, 2016, J BONE MINER RES, V31, P347, DOI 10.1002/jbmr.2696; Paschalis EP, 2001, J BONE MINER RES, V16, P1821, DOI 10.1359/jbmr.2001.16.10.1821; Patsch JM, 2013, J BONE MINER RES, V28, P313, DOI 10.1002/jbmr.1763; Penel G, 2005, BONE, V36, P893, DOI 10.1016/j.bone.2005.02.012; Poundarik AA, 2015, J MECH BEHAV BIOMED, V52, P120, DOI 10.1016/j.jmbbm.2015.08.012; Ramasamy R, 2005, GLYCOBIOLOGY, V15, p16R, DOI 10.1093/glycob/cwi053; REDDY S, 1995, BIOCHEMISTRY-US, V34, P10872, DOI 10.1021/bi00034a021; Reiniger N, 2010, DIABETES, V59, P2043, DOI 10.2337/db09-1766; Ritchie RO, 2008, BONE, V43, P798, DOI 10.1016/j.bone.2008.04.027; Ritchie RO, 2010, ANN NY ACAD SCI, V1192, P72, DOI 10.1111/j.1749-6632.2009.05232.x; Shanbhogue VV, 2015, J BONE MINER RES, V30, P2188, DOI 10.1002/jbmr.2573; Tang SY, 2009, OSTEOPOROSIS INT, V20, P887, DOI 10.1007/s00198-008-0754-4; Thornalley PJ, 1999, BIOCHEM J, V344, P109, DOI 10.1042/0264-6021:3440109; Thrailkill KM, 2005, DIABETES, V54, P2875, DOI 10.2337/diabetes.54.10.2875; Valcourt U, 2007, J BIOL CHEM, V282, P5691, DOI 10.1074/jbc.M610536200; Vashishth D, 2001, BONE, V28, P195, DOI 10.1016/S8756-3282(00)00434-8; Vashishth D, 2008, BONE, V43, P794, DOI 10.1016/j.bone.2008.06.013; Vashishth Deepak, 2007, Curr Osteoporos Rep, V5, P62; Vestergaard P, 2007, OSTEOPOROSIS INT, V18, P427, DOI 10.1007/s00198-006-0253-4; Yamamoto M, 2012, J CLIN ENDOCR METAB, V97, P1277, DOI 10.1210/jc.2011-2537; Zhang LW, 2012, DIABETES RES CLIN PR, V96, P286, DOI 10.1016/j.diabres.2011.12.006	56	59	60	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 3	2016	11	5							e0154700	10.1371/journal.pone.0154700	http://dx.doi.org/10.1371/journal.pone.0154700			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DL5KK	27140650	Green Published, gold			2022-12-26	WOS:000375675700059
J	Borup, R; Thuesen, LL; Andersen, CY; Nyboe-Andersen, A; Ziebe, S; Winther, O; Grondahl, ML				Borup, Rehannah; Thuesen, Lea Langhoff; Andersen, Claus Yding; Nyboe-Andersen, Anders; Ziebe, Soren; Winther, Ole; Grondahl, Marie Louise			Competence Classification of Cumulus and Granulosa Cell Transcriptome in Embryos Matched by Morphology and Female Age	PLOS ONE			English	Article							CONTROLLED OVARIAN STIMULATION; GENE-EXPRESSION PROFILES; BOVINE FOLLICULAR CELLS; APOPTOSIS; QUALITY; IDENTIFICATION; OOCYTES; MARKERS; SET	Objective By focussing on differences in the mural granulosa cell (MGC) and cumulus cell (CC) transcriptomes from follicles resulting in competent (live birth) and non-competent (no pregnancy) oocytes the study aims on defining a competence classifier expression profile in the two cellular compartments. Design: A case-control study. Setting: University based facilities for clinical services and research. Patients: MGC and CC samples from 60 women undergoing IVF treatment following the long GnRH-agonist protocol were collected. Samples from 16 oocytes where live birth was achieved and 16 age-and embryo morphology matched incompetent oocytes were included in the study. Methods MGC and CC were isolated immediately after oocyte retrieval. From the 16 competent and non-competent follicles, mRNA was extracted and expression profile generated on the Human Gene 1.0 ST Affymetrix array. Live birth prediction analysis using machine learning algorithms (support vector machines) with performance estimation by leave-one-out cross validation and independent validation on an external data set. Results We defined a signature of 30 genes expressed in CC predictive of live birth. This live birth prediction model had an accuracy of 81%, a sensitivity of 0.83, a specificity of 0.80, a positive predictive value of 0.77, and a negative predictive value of 0.86. Receiver operating characteristic analysis found an area under the curve of 0.86, significantly greater than random chance. When applied on 3 external data sets with the end-point outcome measure of blastocyst formation, the signature resulted in 62%, 75% and 88% accuracy, respectively. The genes in the classifier are primarily connected to apoptosis and involvement in formation of extracellular matrix. We were not able to define a robust MGC classifier signature that could classify live birth with accuracy above random chance level. Conclusion We have developed a cumulus cell classifier, which showed a promising performance on external data. This suggests that the gene signature at least partly include genes that relates to competence in the developing blastocyst.	[Borup, Rehannah] Rigshosp, Univ Copenhagen Hosp, Ctr Genom Med, DK-2100 Copenhagen, Denmark; [Thuesen, Lea Langhoff; Nyboe-Andersen, Anders; Ziebe, Soren] Rigshosp, Univ Copenhagen Hosp, Fertil Clin, DK-2100 Copenhagen, Denmark; [Andersen, Claus Yding] Rigshosp, Univ Copenhagen Hosp, Reprod Biol Lab, DK-2100 Copenhagen, Denmark; [Winther, Ole] Univ Copenhagen, Bioinformat Ctr, Dept Biol, Copenhagen, Denmark; [Winther, Ole] Univ Copenhagen, Biotech Res & Innovat Ctr, Copenhagen, Denmark; [Grondahl, Marie Louise] Herlev Hosp, Univ Copenhagen Hosp, Fertil Clin, Copenhagen, Denmark	Rigshospitalet; University of Copenhagen; Rigshospitalet; University of Copenhagen; Rigshospitalet; University of Copenhagen; University of Copenhagen; University of Copenhagen; University of Copenhagen; Herlev & Gentofte Hospital	Borup, R (corresponding author), Rigshosp, Univ Copenhagen Hosp, Ctr Genom Med, DK-2100 Copenhagen, Denmark.	Rehannah.borup@regionh.dk		Andersen, Claus Yding/0000-0001-7681-253X	ph.d. school, The Medical Faculty, Copenhagen University; Ferring Medical, Copenhagen; ph.d. of Lea Langhoff Thuesen; Novo Nordisk Fonden [NNF10SA1016550] Funding Source: researchfish	ph.d. school, The Medical Faculty, Copenhagen University; Ferring Medical, Copenhagen; ph.d. of Lea Langhoff Thuesen; Novo Nordisk Fonden(Novo Nordisk Foundation)	The study was funded from the ph.d. school, The Medical Faculty, Copenhagen University and through an educational grant from Ferring Medical, Copenhagen. Funding was supporting the ph.d. of Lea Langhoff Thuesen. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adriaenssens T, 2010, HUM REPROD, V25, P1259, DOI 10.1093/humrep/deq049; Adriaenssens T, 2009, BIOL REPROD, V80, P1015, DOI 10.1095/biolreprod.107.067462; Affymetrix I, 2005, AFFYMETRIX TECHNICAL; Alisch A, 2003, Zentralbl Gynakol, V125, P452; Alpha Scientists in Reproductive Medicine and ESHRE Special Interest Group of Embryology, 2011, Hum Reprod, V26, P1270, DOI 10.1093/humrep/der037; Assidi M, 2011, J ASSIST REPROD GEN, V28, P173, DOI 10.1007/s10815-010-9491-7; Assou S, 2008, MOL HUM REPROD, V14, P711, DOI 10.1093/molehr/gan067; Assou S, 2010, MOL HUM REPROD, V16, P531, DOI 10.1093/molehr/gaq032; Bar-Ami S, 2000, J ASSIST REPROD GEN, V17, P437, DOI 10.1023/A:1009465218688; Bolstad BM, 2003, BIOINFORMATICS, V19, P185, DOI 10.1093/bioinformatics/19.2.185; Bourgon R, 2010, P NATL ACAD SCI USA, V107, P9546, DOI 10.1073/pnas.0914005107; Corn CM, 2005, FERTIL STERIL, V84, P627, DOI 10.1016/j.fertnstert.2005.03.061; de Wit AAC, 2000, J ANIM SCI, V78, P1277; Devjak R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047106; Dudoit S, 2002, J AM STAT ASSOC, V97, P77, DOI 10.1198/016214502753479248; Ebner T, 2014, EUR J OBSTET GYN R B, V183, P59, DOI 10.1016/j.ejogrb.2014.10.015; Eppig JJ, 2002, P NATL ACAD SCI USA, V99, P2890, DOI 10.1073/pnas.052658699; Falgreen Steffen, 2015, HEMACLASS ONLINE CLA; Fan X, 2010, PHARMACOGENOMICS J, V10, P247, DOI 10.1038/tpj.2010.34; Feuerstein P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040449; Filali M, 2009, Reprod Biomed Online, V19 Suppl 4, P4309; Fragouli E, 2012, HUM REPROD, V27, P2559, DOI 10.1093/humrep/des170; Gebhardt KM, 2011, FERTIL STERIL, V96, P47, DOI 10.1016/j.fertnstert.2011.04.033; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Gilbert I, 2011, REPRODUCTION, V141, P193, DOI 10.1530/REP-10-0381; Grondahl ML, 2012, MOL HUM REPROD, V18, P572, DOI 10.1093/molehr/gas035; Hamel M, 2008, HUM REPROD, V23, P1118, DOI 10.1093/humrep/den048; Hamel M, 2010, MOL HUM REPROD, V16, P87, DOI 10.1093/molehr/gap079; Iager AE, 2013, FERTIL STERIL, V99, P745, DOI 10.1016/j.fertnstert.2012.10.041; Irizarry RA, 2006, BIOINFORMATICS, V22, P789, DOI 10.1093/bioinformatics/btk046; Janowski D, 2012, THERIOGENOLOGY, V78, P656, DOI 10.1016/j.theriogenology.2012.03.012; Lorincz AT, 2014, EXPERT REV MOL DIAGN, V14, P293, DOI 10.1586/14737159.2014.897610; Lourenco Barbara, 2014, J Reprod Infertil, V15, P15; Lu TP, 2015, BMC MED RES METHODOL, V15, DOI 10.1186/s12874-015-0098-7; Novianti PW, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096063; Oksjoki S, 1999, MOL HUM REPROD, V5, P803, DOI 10.1093/molehr/5.9.803; Ouandaogo ZG, 2012, HUM REPROD, V27, P2438, DOI 10.1093/humrep/des172; Papler TB, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0115865; Platt JC, 2000, ADV NEUR IN, P61; Quackenbush J, 2006, NEW ENGL J MED, V354, P2463, DOI 10.1056/NEJMra042342; Quirk S M, 2004, J Anim Sci, V82 E-Suppl, pE40; Ruvolo G, 2013, J ASSIST REPROD GEN, V30, P207, DOI 10.1007/s10815-013-9943-y; Shi LM, 2010, NAT BIOTECHNOL, V28, P827, DOI 10.1038/nbt.1665; Simon R, 2003, BRIT J CANCER, V89, P1599, DOI 10.1038/sj.bjc.6601326; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Thuesen LL, 2012, HUM REPROD, V27, P3074, DOI 10.1093/humrep/des256; Thys M, 2009, REPRODUCTION, V138, P471, DOI 10.1530/REP-09-0094; Vapnik VN, 1999, IEEE T NEURAL NETWOR, V10, P988, DOI 10.1109/72.788640; Wathlet S, 2012, FERTIL STERIL, V98, P432, DOI 10.1016/j.fertnstert.2012.05.007; Wissing ML, 2014, HUM REPROD, V29, P997, DOI 10.1093/humrep/deu008; Wu ZJ, 2009, STAT METHODS MED RES, V18, P533, DOI 10.1177/0962280209351924; Xu FH, 2011, MOL HUM REPROD, V17, P152, DOI 10.1093/molehr/gaq089; Yamada S, 1999, MOL HUM REPROD, V5, P607, DOI 10.1093/molehr/5.7.607; Yerushalmi GM, 2014, MOL HUM REPROD, V20, P719, DOI 10.1093/molehr/gau031; Yuan YQ, 2005, THERIOGENOLOGY, V63, P2147, DOI 10.1016/j.theriogenology.2004.09.054; Zeuner A, 2003, THERIOGENOLOGY, V59, P1421, DOI 10.1016/S0093-691X(02)01190-1; Zhang LF, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-143; Zuo YC, 2015, MOL BIOSYST, V11, P950, DOI 10.1039/c4mb00681j; Zuo YC, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0145541	60	21	21	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 29	2016	11	4							e0153562	10.1371/journal.pone.0153562	http://dx.doi.org/10.1371/journal.pone.0153562			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DK8XM	27128483	Green Submitted, gold, Green Published			2022-12-26	WOS:000375212600008
J	Kartha, VK; Stawski, L; Han, R; Haines, P; Gallagher, G; Noonan, V; Kukuruzinska, M; Monti, S; Trojanowska, M				Kartha, Vinay K.; Stawski, Lukasz; Han, Rong; Haines, Paul; Gallagher, George; Noonan, Vikki; Kukuruzinska, Maria; Monti, Stefano; Trojanowska, Maria			PDGFR beta Is a Novel Marker of Stromal Activation in Oral Squamous Cell Carcinomas	PLOS ONE			English	Article							CANCER-ASSOCIATED FIBROBLASTS; GROWTH-FACTOR; TGF-BETA; EXPRESSION; PROGRESSION; METASTASIS; MICROENVIRONMENT; DISINTEGRIN; INVASION; DISEASE	Carcinoma associated fibroblasts (CAFs) form the main constituents of tumor stroma and play an important role in tumor growth and invasion. The presence of CAFs is a strong predictor of poor prognosis of head and neck squamous cell carcinoma. Despite significant progress in determining the role of CAFs in tumor progression, the mechanisms contributing to their activation remain poorly characterized, in part due to fibroblast heterogeneity and the scarcity of reliable fibroblast surface markers. To search for such markers in oral squamous cell carcinoma (OSCC), we applied a novel approach that uses RNA-sequencing data derived from the cancer genome atlas (TCGA). Specifically, our strategy allowed for an unbiased identification of genes whose expression was closely associated with a set of bona fide stroma-specific transcripts, namely the interstitial collagens COL1A1, COL1A2, and COL3A1. Among the top hits were genes involved in cellular matrix remodeling and tumor invasion and migration, including platelet-derived growth factor receptor beta (PDGFR beta), which was found to be the highest-ranking receptor protein genome-wide. Similar analyses performed on ten additional TCGA cancer datasets revealed that other tumor types shared CAF markers with OSCC, including PDGFR beta, which was found to significantly correlate with the reference collagen expression in ten of the 11 cancer types tested. Subsequent immunostaining of OSCC specimens demonstrated that PDGFR beta was abundantly expressed in stromal fibroblasts of all tested cases (12/12), while it was absent in tumor cells, with greater specificity than other known markers such as alpha smooth muscle actin or podoplanin (3/11). Overall, this study identified PDGFR beta as a novel marker of stromal activation in OSCC, and further characterized a list of promising candidate CAF markers that may be relevant to other carcinomas. Our novel approach provides for a fast and accurate method to identify CAF markers without the need for large-scale immunostaining experiments.	[Kartha, Vinay K.] Boston Univ, Bioinformat Program, Boston, MA 02215 USA; [Kartha, Vinay K.; Monti, Stefano] Boston Univ, Sch Med, Div Computat Biomed, Boston, MA 02118 USA; [Stawski, Lukasz; Han, Rong; Haines, Paul; Trojanowska, Maria] Boston Univ, Sch Med, Arthrit Ctr, Boston, MA 02118 USA; [Gallagher, George; Noonan, Vikki] Boston Univ, Sch Dent Med, Div Oral Pathol, Boston, MA 02215 USA; [Kukuruzinska, Maria] Boston Univ, Sch Dent Med, Dept Mol & Cell Biol, Boston, MA 02215 USA	Boston University; Boston University; Boston University; Boston University; Boston University	Monti, S (corresponding author), Boston Univ, Sch Med, Div Computat Biomed, Boston, MA 02118 USA.; Trojanowska, M (corresponding author), Boston Univ, Sch Med, Arthrit Ctr, Boston, MA 02118 USA.	smonti@bu.edu; trojanme@bu.edu		Noonan, Vikki/0000-0003-4005-0275; Kukukruzinska, Maria/0000-0001-5314-1454; KARTHA, VINAY/0000-0002-2160-2196; Monti, Stefano/0000-0002-9376-0660	NIH [R01 AR 44883]; Evans Center for Interdisciplinary Biomedical Research ARC on "Etiology and Pathogenesis of Oral Cancer (EPOC)" at Boston University; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR044883] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Evans Center for Interdisciplinary Biomedical Research ARC on "Etiology and Pathogenesis of Oral Cancer (EPOC)" at Boston University; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was in part supported by NIH grant R01 AR 44883, and by the Evans Center for Interdisciplinary Biomedical Research ARC on "Etiology and Pathogenesis of Oral Cancer (EPOC)" at Boston University (http://www.bumc.bu.edu/evanscenteribr/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aquino G, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/736438; Barron DA, 2012, ENDOCR-RELAT CANCER, V19, pR187, DOI 10.1530/ERC-12-0085; Brown GT, 2015, J PATHOL, V237, P273, DOI 10.1002/path.4586; Calon A, 2014, SEMIN CANCER BIOL, V25, P15, DOI 10.1016/j.semcancer.2013.12.008; Carter SL, 2012, NAT BIOTECHNOL, V30, P413, DOI 10.1038/nbt.2203; Cheon DJ, 2014, CLIN CANCER RES, V20, P711, DOI 10.1158/1078-0432.CCR-13-1256; Choi P, 2008, ARCH OTOLARYNGOL, V134, P539, DOI 10.1001/archotol.134.5.539; Curry JM, 2014, SEMIN ONCOL, V41, P217, DOI 10.1053/j.seminoncol.2014.03.003; De Wever O, 2014, SEMIN CANCER BIOL, V25, P33, DOI 10.1016/j.semcancer.2013.12.009; DVORAK HF, 1986, NEW ENGL J MED, V315, P1650; Franz M, 2010, J ORAL PATHOL MED, V39, P290, DOI 10.1111/j.1600-0714.2009.00840.x; Guerrero-Preston R, 2011, CANCER PREV RES, V4, P1061, DOI 10.1158/1940-6207.CAPR-11-0006; Heldin CH, 2013, CELL COMMUN SIGNAL, V11, DOI 10.1186/1478-811X-11-97; Inoue H, 2014, TUMOR BIOL, V35, P11345, DOI 10.1007/s13277-014-2450-7; Jafarian AH, 2015, IRAN J OTORHINOLARYN, V27; Jechlinger M, 2006, J CLIN INVEST, V116, P1561, DOI 10.1172/JCI24652; Kalluri R, 2006, NAT REV CANCER, V6, P392, DOI 10.1038/nrc1877; Karagiannis GS, 2012, MOL CANCER RES, V10, P1403, DOI 10.1158/1541-7786.MCR-12-0307; Kelwick R, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-015-0676-3; KOEBNICK C, 2013, DECREASED LYMPHANGIO, V55, P328, DOI DOI 10.1097/MPG.0B013E31824D256F.PEDIATRIC; Li C, 2005, INT J ORAL MAX SURG, V34, P559, DOI 10.1016/j.ijom.2004.10.016; Marsh D, 2011, J PATHOL, V223, P470, DOI 10.1002/path.2830; Mochizuki S, 2007, CANCER SCI, V98, P621, DOI 10.1111/j.1349-7006.2007.00434.x; Nyren-Erickson EK, 2013, BBA-GEN SUBJECTS, V1830, P4445, DOI 10.1016/j.bbagen.2013.05.011; Paulsson J, 2009, AM J PATHOL, V175, P334, DOI 10.2353/ajpath.2009.081030; Rodrigues PC, 2015, ONCOL LETT, V9, P667, DOI 10.3892/ol.2014.2763; Routray S, 2014, ORAL DIS, V20, P246, DOI 10.1111/odi.12107; Sasahira T, 2014, EUR J CANCER, V50, P2142, DOI 10.1016/j.ejca.2014.05.006; Siriwardena BSMS, 2006, BRIT J CANCER, V95, P1396, DOI 10.1038/sj.bjc.6603431; Sweeney SM, 2008, J BIOL CHEM, V283, P21187, DOI 10.1074/jbc.M709319200; Tandefelt DG, 2013, EUR UROL, V64, P941, DOI 10.1016/j.eururo.2013.02.039; Tommelein J, 2015, FRONT ONCOL, V5, DOI 10.3389/fonc.2015.00063; Torres S, 2013, CLIN CANCER RES, V19, P6006, DOI 10.1158/1078-0432.CCR-13-1130; Uehara E, 2012, INT J ONCOL, V40, P1414, DOI 10.3892/ijo.2012.1339; Vered M, 2010, CANCER SCI, V101, P274, DOI 10.1111/j.1349-7006.2009.01357.x; Yoshihara K, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3612	36	29	29	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 29	2016	11	4							e0154645	10.1371/journal.pone.0154645	http://dx.doi.org/10.1371/journal.pone.0154645			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DK8XM	27128408	Green Published, Green Submitted, gold			2022-12-26	WOS:000375212600055
J	Kronborg, TM; Hansen, JF; Nielsen, CH; Ramhoj, L; Frederiksen, M; Vorkamp, K; Feldt-Rasmussen, U				Kronborg, Thit Mynster; Hansen, Juliana Frohnert; Nielsen, Claus Henrik; Ramhoj, Louise; Frederiksen, Marie; Vorkamp, Katrin; Feldt-Rasmussen, Ulla			Effects of the Commercial Flame Retardant Mixture DE-71 on Cytokine Production by Human Immune Cells	PLOS ONE			English	Article							POLYBROMINATED DIPHENYL ETHERS; EXPOSURE; MACROPHAGES; PBDE; ASSOCIATIONS	Introduction Although production of polybrominated diphenyl ethers (PBDEs) is now banned, release from existing products will continue for many years. The PBDEs are assumed to be neurotoxic and toxic to endocrine organs at low concentrations. Their effect on the immune system has not been investigated thoroughly. We aimed to investigate the influence of DE-71 on cytokine production by peripheral blood mononuclear cells (PBMCs) stimulated with Escherichia Coli lipopolysaccharide (LPS) or phytohaemagglutinin-L (PHA-L). Material and Methods PBMCs isolated from healthy donors were pre-incubated with DE-71 at various concentrations and subsequently incubated with the monocyte stimulator LPS, or the T-cell activator PHA-L. Interferon (IFN)-gamma, interleukin (IL)-1 beta, IL-2, IL-4, IL-6, IL-8, IL-10, tumor necrosis factor (TNF)-alpha, IL-17A, and IL-17F were quantified in the supernatants by Luminex kits. Results At non-cytotoxic concentrations (0.01-10 mu g/mL), DE-71 significantly enhanced secretion of IL-1 beta, IL-6, CXCL8, IL-10 and TNF-alpha, (p = <0.001-0.043; n = 6) from LPS-stimulated PBMCs. IFN-gamma, TNF-alpha, IL-17A, and IL-17F (p = < 0.001-0.043; n = 6) secretion were enhanced from PHA-L-stimulated PBMCs as well. Secretion of IL-1 beta, IL-2, IL-10, IL-8 and IL-6 was not significantly affected by DE-71. Conclusions We demonstrate an enhancing effect of DE-71 on cytokine production by normal human PBMCs stimulated with LPS or PHA-L ex vivo.	[Kronborg, Thit Mynster; Hansen, Juliana Frohnert; Feldt-Rasmussen, Ulla] Univ Copenhagen, Rigshosp, Dept Med Endocrinol, PE 2132, DK-2100 Copenhagen, Denmark; [Nielsen, Claus Henrik] Univ Copenhagen, Rigshosp, Inst Inflammat Res, Sect 7521, DK-2100 Copenhagen, Denmark; [Ramhoj, Louise] Tech Univ Denmark, Natl Food Inst, Div Diet Dis Prevent & Toxicol, Soborg, Denmark; [Frederiksen, Marie] Aalborg Univ, Danish Bldg Res Inst, Dept Energy Environm & Indoor Climate, AC Meyers Vaenge 15, DK-2450 Copenhagen SV, Denmark; [Vorkamp, Katrin] Aarhus Univ, Dept Environm Sci, Frederiksborgvej 399, DK-4000 Roskilde, Denmark	Rigshospitalet; University of Copenhagen; Rigshospitalet; University of Copenhagen; Technical University of Denmark; Aalborg University; Aarhus University	Feldt-Rasmussen, U (corresponding author), Univ Copenhagen, Rigshosp, Dept Med Endocrinol, PE 2132, DK-2100 Copenhagen, Denmark.	ufeldt@rh.dk	Feldt-Rasmussen, Ulla/AAB-9218-2021; Frederiksen, Marie/AAW-9783-2021; Ramhøj, Louise/HGC-4949-2022	Feldt-Rasmussen, Ulla/0000-0002-5903-3355; Frederiksen, Marie/0000-0003-1553-5414; Ramhøj, Louise/0000-0002-0298-8003; Nielsen, Claus Henrik/0000-0001-7543-9016; Vorkamp, Katrin/0000-0002-1131-5687	Novo Nordisk foundation [13495, F-22222-1, 8005, 14266]; Arvid Nilsson's Fund; Danish Council for Independent Research [0602-01959B]; Danish Foundation "Musikforlaeggernes Agnes og Knut Morks fond";  [R129-A4222]; Novo Nordisk Fonden [NNF15OC0014622, NNF14OC0013495] Funding Source: researchfish	Novo Nordisk foundation(Novo Nordisk FoundationNovocure Limited); Arvid Nilsson's Fund; Danish Council for Independent Research(Det Frie Forskningsrad (DFF)); Danish Foundation "Musikforlaeggernes Agnes og Knut Morks fond"; ; Novo Nordisk Fonden(Novo Nordisk Foundation)	Ulla Feldt-Rasmussen received funding as main supervisor on the scholarship project "Interaction between thyroid autoimmunity and endocrine disrupting chemicals" by the Novo Nordisk foundation (application number: 13495), reference number: F-22222-1 for Thit Mynster Kronborg's salary. Ulla Feldt-Rasmussen further received funding for research salary, equipment and material from the local region's (RegionH, R129-A4222) research fund, from Arvid Nilsson's Fund, Novo Nordisk Foundation (application number 8005 and 14266) and Danish Council for Independent Research (0602-01959B). Thit Mynster Kronborg received funding from the Danish Foundation "Musikforlaeggernes Agnes og Knut Morks fond", which sponsored equipment and materials. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ali N, 2011, CHEMOSPHERE, V83, P1360, DOI 10.1016/j.chemosphere.2011.02.078; Birnbaum LS, 2004, ENVIRON HEALTH PERSP, V112, P9, DOI 10.1289/ehp.6559; Bondy GS, 2013, ENVIRON TOXICOL, V28, P215, DOI 10.1002/tox.20713; Cope A, 2011, TRENDS IMMUNOL, V32, P278, DOI 10.1016/j.it.2011.03.010; Darnerud PO, 2001, ENVIRON HEALTH PERSP, V109, P49, DOI 10.2307/3434846; de Wit CA, 2002, CHEMOSPHERE, V46, P583, DOI 10.1016/S0045-6535(01)00225-9; de Wit CA, 2010, SCI TOTAL ENVIRON, V408, P2885, DOI 10.1016/j.scitotenv.2009.08.037; Dodson RE, 2012, ENVIRON SCI TECHNOL, V46, P13056, DOI 10.1021/es303879n; Fair PA, 2012, J IMMUNOTOXICOL, V9, P96, DOI 10.3109/1547691X.2011.643418; Fernlof G, 1997, TOXICOL LETT, V90, P189, DOI 10.1016/S0378-4274(96)03848-9; Frederiksen M, 2014, ORGANOHALOGEN COMPOU, V76, P1344; Frederiksen M, 2010, INT J HYG ENVIR HEAL, V213, P233, DOI 10.1016/j.ijheh.2010.04.008; Frederiksen M, 2009, INT J HYG ENVIR HEAL, V212, P109, DOI 10.1016/j.ijheh.2008.04.005; Galbiati V, 2010, J IMMUNOTOXICOL, V7, P255, DOI 10.3109/1547691X.2010.509848; Geyer H.J., 2004, ORGANOHALOGEN COMP, V66, P3820; Groothuis FA, 2015, TOXICOLOGY, V332, P30, DOI 10.1016/j.tox.2013.08.012; Hansen JF, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0131168; Harrington LE, 2005, NAT IMMUNOL, V6, P1123, DOI 10.1038/ni1254; Hennigar SR, 2012, EXP BIOL MED, V237, P429, DOI 10.1258/ebm.2011.011202; Huang WT, 2004, J INFECT DIS, V190, P624, DOI 10.1086/422329; Kim YR, 2014, CHEMOSPHERE, V106, P1, DOI 10.1016/j.chemosphere.2013.12.064; Koike E, 2014, TOXICOL IN VITRO, V28, P327, DOI 10.1016/j.tiv.2013.10.014; Koike E, 2013, J APPL TOXICOL, V33, P1451, DOI 10.1002/jat.2809; La Guardia MJ, 2006, ENVIRON SCI TECHNOL, V40, P6247, DOI 10.1021/es060630m; Lundgren M, 2009, TOXICOL LETT, V184, P107, DOI 10.1016/j.toxlet.2008.10.021; Lv QY, 2015, CHEMOSPHERE, V120, P621, DOI 10.1016/j.chemosphere.2014.08.029; MALEFYT RD, 1991, J EXP MED, V174, P1209; Martin PA, 2007, ENVIRON TOXICOL CHEM, V26, P988, DOI 10.1897/06-246R.1; Ouyang WJ, 2008, IMMUNITY, V28, P454, DOI 10.1016/j.immuni.2008.03.004; Peltier MR, 2012, PLACENTA, V33, P745, DOI 10.1016/j.placenta.2012.06.005; Siddiqi Muhammad Akmal, 2003, Clin Med Res, V1, P281; Siewe L, 2006, EUR J IMMUNOL, V36, P3248, DOI 10.1002/eji.200636012; Stapleton HM, 2011, ENVIRON HEALTH PERSP, V119, P1454, DOI 10.1289/ehp.1003235; Vorkamp K, 2014, ARCH ENVIRON CON TOX, V67, P9, DOI 10.1007/s00244-013-9988-z; Vorkamp K, 2011, ENVIRON INT, V37, P1, DOI 10.1016/j.envint.2010.06.001; Wirth JR, 2014, J APPL TOXICOL; Zhang ZL, 2014, SCI TOTAL ENVIRON, V468, P158, DOI 10.1016/j.scitotenv.2013.08.029	37	10	10	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 29	2016	11	4							e0154621	10.1371/journal.pone.0154621	http://dx.doi.org/10.1371/journal.pone.0154621			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DK8XM	27128973	Green Published, Green Submitted, gold			2022-12-26	WOS:000375212600052
J	Schutz, E; Wehrhahn, C; Wanjek, M; Bortfeld, R; Wemheuer, WE; Beck, J; Brenig, B				Schuetz, Ekkehard; Wehrhahn, Christin; Wanjek, Marius; Bortfeld, Ralf; Wemheuer, Wilhelm E.; Beck, Julia; Brenig, Bertram			The Holstein Friesian Lethal Haplotype 5 (HH5) Results from a Complete Deletion of TBF1M and Cholesterol Deficiency (CDH) from an ERV-(LTR) Insertion into the Coding Region of APOB	PLOS ONE			English	Article							HOMOZYGOUS FAMILIAL HYPOBETALIPOPROTEINEMIA; RNA DIMETHYLASE DIM1P; APOLIPOPROTEIN-B; RIBOSOMAL-RNA; DAIRY-CATTLE; REPRODUCTIVE-PERFORMANCE; SEQUENCING DATA; SELECTION; GENOME; DISEASE	Background With the availability of massive SNP data for several economically important cattle breeds, haplotype tests have been performed to identify unknown recessive disorders. A number of so-called lethal haplotypes, have been uncovered in Holstein Friesian cattle and, for at least seven of these, the causative mutations have been identified in candidate genes. However, several lethal haplotypes still remain elusive. Here we report the molecular genetic causes of lethal haplotype 5 (HH5) and cholesterol deficiency (CDH). A targeted enrichment for the known genomic regions, followed by massive parallel sequencing was used to interrogate for causative mutations in a case/control approach. Methods Targeted enrichment for the known genomic regions, followed by massive parallel sequencing was used in a case/control approach. PCRs for the causing mutations were developed and compared to routine imputing in 2,100 (HH5) and 3,100 (CDH) cattle. Results HH5 is caused by a deletion of 138kbp, spanning position 93,233kb to 93,371kb on chromosome 9 (BTA9), harboring only dimethyl-adenosine transferase 1 (TFB1M). The deletion breakpoints are flanked by bovine long interspersed nuclear elements Bov-B (upstream) and L1ME3 (downstream), suggesting a homologous recombination/deletion event. TFB1M di-methylates adenine residues in the hairpin loop at the 3'-end of mitochondrial 12S rRNA, being essential for synthesis and function of the small ribosomal subunit of mitochondria. Homozygous TFB1M(-/-) mice reportedly exhibit embryonal lethality with developmental defects. A 2.8% allelic frequency was determined for the German HF population. CDH results from a 1.3kbp insertion of an endogenous retrovirus (ERV2-1-LTR_BT) into exon 5 of the APOB gene at BTA11: 77,959kb. The insertion is flanked by 6bp target site duplications as described for insertions mediated by retroviral integrases. A premature stop codon in the open reading frame of APOB is generated, resulting in a truncation of the protein to a length of only < 140 amino acids. Such early truncations have been shown to cause an inability of chylomicron excretion from intestinal cells, resulting in malabsorption of cholesterol. The allelic frequency of this mutation in the German HF population was 6.7%, which is substantially higher than reported so far. Compared to PCR assays inferring the genetic variants directly, the routine imputing used so far showed a diagnostic sensitivity of as low as 91% (HH5) and 88% (CDH), with a high specificity for both (>= 99.7%). Conclusion With the availability of direct genetic tests it will now be possible to more effectively reduce the carrier frequency and ultimately eliminate the disorders from the HF populations. Beside this, the fact that repetitive genomic elements (RE) are involved in both diseases, underline the evolutionary importance of RE, which can be detrimental as here, but also advantageous over generations.	[Schuetz, Ekkehard; Wehrhahn, Christin; Wemheuer, Wilhelm E.; Brenig, Bertram] Univ Gottingen, Inst Vet Med, D-37073 Gottingen, Germany; [Wanjek, Marius; Bortfeld, Ralf] Inst Livestock Reprod GmbH, Schonow, Germany; [Schuetz, Ekkehard; Beck, Julia] Chronix Biomed GmbH, Gottingen, Germany	University of Gottingen	Schutz, E (corresponding author), Univ Gottingen, Inst Vet Med, D-37073 Gottingen, Germany.; Schutz, E (corresponding author), Chronix Biomed GmbH, Gottingen, Germany.	eschuet@gwdg.de		Brenig, Bertram/0000-0002-7635-9656	Institute for Livestock Reproduction GmbH; Livestock Reproduction GmbH; Chronix Biomedical GmbH	Institute for Livestock Reproduction GmbH; Livestock Reproduction GmbH; Chronix Biomedical GmbH	Institute for Livestock Reproduction GmbH provided only support in the form of salaries for authors MW and RB. In the frame of and for her work linked to the study JB did not receive salary from Chronix Biomedical GmbH. Neither Livestock Reproduction GmbH nor Chronix Biomedical GmbH were funders of the study or had any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adelson DL, 2009, P NATL ACAD SCI USA, V106, P12855, DOI 10.1073/pnas.0901282106; ALTMAN DG, 1994, BRIT MED J, V308, P1552, DOI 10.1136/bmj.308.6943.1552; Andersen SL, 2010, BIOESSAYS, V32, P1058, DOI 10.1002/bies.201000087; Bashiardes S, 2005, NAT METHODS, V2, P63, DOI 10.1038/nmeth0105-63; Berry DP, 2014, ANIMAL, V8, P105, DOI 10.1017/S1751731114000743; Bowley FE, 2015, J DAIRY SCI, V98, P2005, DOI 10.3168/jds.2014-8266; Browning SR, 2007, AM J HUM GENET, V81, P1084, DOI 10.1086/521987; Butler ST, 2014, REPROD FERT DEVELOP, V26, P1, DOI 10.1071/RD13304; Cefalu AB, 2015, ATHEROSCLEROSIS, V239, P209, DOI 10.1016/j.atherosclerosis.2015.01.014; Cole J., 2015, 0913 USDA; Cole JB, 2015, GENET SEL EVOL, V47, DOI 10.1186/s12711-015-0174-9; Creighton HB, 1931, P NATL ACAD SCI USA, V17, P492, DOI 10.1073/pnas.17.8.492; Egger-Danner C, 2015, ANIMAL, V9, P191, DOI 10.1017/S1751731114002614; Floren C, 2015, FOOD CHEM, V173, P1054, DOI 10.1016/j.foodchem.2014.10.138; Fritz S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065550; Glusman G, 2014, GENOME MED, V6, DOI 10.1186/s13073-014-0073-7; Kasinathan P, 2015, SCI REP-UK, V5, DOI 10.1038/srep08674; Kipp S, 2015, INT M 2015 JUL 9 12; Kohany O, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-474; LAFONTAINE D, 1995, GENE DEV, V9, P2470, DOI 10.1101/gad.9.20.2470; Lafontaine DLJ, 1998, MOL CELL BIOL, V18, P2360, DOI 10.1128/MCB.18.4.2360; LEPPERT M, 1988, J CLIN INVEST, V82, P847, DOI 10.1172/JCI113688; Levic D, 2015, J MOL MED, V93, P165, DOI 10.1007/s00109-014-1247-x; Levy E, 2015, J LIPID RES, V56, P945, DOI 10.1194/jlr.R052415; Mager DL, 2015, MICROBIOL SPECTR, V3, DOI 10.1128/microbiolspec.MDNA3-0009-2014; Markham NR, 2005, NUCLEIC ACIDS RES, V33, pW577, DOI 10.1093/nar/gki591; McClure MC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092769; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; Menzi F, 2016, ANIM GENET, V47, P253, DOI 10.1111/age.12410; Metodiev MD, 2009, CELL METAB, V9, P386, DOI 10.1016/j.cmet.2009.03.001; Miglior F, 2005, J DAIRY SCI, V88, P1255, DOI 10.3168/jds.S0022-0302(05)72792-2; Morgan T. H, 1915, MECH MENDELIAN HERED; Ramasamy I, 2016, CLIN CHIM ACTA, V454, P143, DOI 10.1016/j.cca.2015.10.033; Schutz E, 2008, J DAIRY SCI, V91, P4854, DOI 10.3168/jds.2008-1154; Schutz E, 2015, GENET SEL EVOL, V47, DOI 10.1186/s12711-014-0085-1; Segelke D, 2016, J DAIRY SCI, V99, P458, DOI 10.3168/jds.2015-9764; Seidel-Rogol BL, 2003, NAT GENET, V33, P23, DOI 10.1038/ng1064; Skinner LM, 2001, J BIOL CHEM, V276, P114, DOI 10.1074/jbc.M007032200; STEINBERG D, 1979, J CLIN INVEST, V64, P292, DOI 10.1172/JCI109451; Urnovitz HB, 1996, CLIN MICROBIOL REV, V9, P72, DOI 10.1128/CMR.9.1.72; VanRaden PM, 2011, J DAIRY SCI, V94, P6153, DOI 10.3168/jds.2011-4624; Weigel KA, 2006, ANIM REPROD SCI, V96, P323, DOI 10.1016/j.anireprosci.2006.08.010; Xu LY, 2015, MOL BIOL EVOL, V32, P711, DOI 10.1093/molbev/msu333; Yilmaz BS, 2016, CLIN CHIM ACTA, V452, P185, DOI 10.1016/j.cca.2015.11.017; YOUNG SG, 1987, J CLIN INVEST, V79, P1831, DOI 10.1172/JCI113025; Zeitouni B, 2010, BIOINFORMATICS, V26, P1895, DOI 10.1093/bioinformatics/btq293	46	24	32	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 29	2016	11	4							e0154602	10.1371/journal.pone.0154602	http://dx.doi.org/10.1371/journal.pone.0154602			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DK8XM	27128314	gold, Green Published			2022-12-26	WOS:000375212600046
J	Borg, BL; Arthur, SM; Bromen, NA; Cassidy, KA; McIntyre, R; Smith, DW; Prugh, LR				Borg, Bridget L.; Arthur, Stephen M.; Bromen, Nicholas A.; Cassidy, Kira A.; McIntyre, Rick; Smith, Douglas W.; Prugh, Laura R.			Implications of Harvest on the Boundaries of Protected Areas for Large Carnivore Viewing Opportunities	PLOS ONE			English	Article							POPULATION-DYNAMICS; BEHAVIORAL TRAITS; BREEDER LOSS; GRAY WOLF; WOLVES; SELECTION; CONSERVATION; IMPACT; COMPLEX; ROADS	The desire to see free ranging large carnivores in their natural habitat is a driver of tourism in protected areas around the globe. However, large carnivores are wide-ranging and subject to human-caused mortality outside protected area boundaries. The impact of harvest (trapping or hunting) on wildlife viewing opportunities has been the subject of intense debate and speculation, but quantitative analyses have been lacking. We examined the effect of legal harvest of wolves (Canis lupus) along the boundaries of two North American National Parks, Denali (DNPP) and Yellowstone (YNP), on wolf viewing opportunities within the parks during peak tourist season. We used data on wolf sightings, pack sizes, den site locations, and harvest adjacent to DNPP from 1997-2013 and YNP from 2008-2013 to evaluate the relationship between harvest and wolf viewing opportunities. Although sightings were largely driven by wolf population size and proximity of den sites to roads, sightings in both parks were significantly reduced by harvest. Sightings in YNP increased by 45% following years with no harvest of a wolf from a pack, and sightings in DNPP were more than twice as likely during a period with a harvest buffer zone than in years without the buffer. These findings show that harvest of wolves adjacent to protected areas can reduce sightings within those areas despite minimal impacts on the size of protected wolf populations. Consumptive use of carnivores adjacent to protected areas may therefore reduce their potential for non-consumptive use, and these tradeoffs should be considered when developing regional wildlife management policies.	[Borg, Bridget L.; Prugh, Laura R.] Univ Alaska Fairbanks, Inst Arctic Biol, 323 Murie Bldg, Fairbanks, AK 99775 USA; [Borg, Bridget L.; Arthur, Stephen M.; Bromen, Nicholas A.] Natl Pk Serv, Denali Natl Pk & Preserve, POB 9, Denali Natl Pk, AK 99755 USA; [Cassidy, Kira A.; McIntyre, Rick; Smith, Douglas W.] Natl Pk Serv, Yellowstone Ctr Resources, Wolf Project, POB 168, Yellowstone Natl Pk, WY 82190 USA; [Prugh, Laura R.] Univ Washington, Sch Environm & Forest Sci, Box 352100, Seattle, WA 98195 USA	University of Alaska System; University of Alaska Fairbanks; United States Department of the Interior; United States Department of the Interior; University of Washington; University of Washington Seattle	Borg, BL (corresponding author), Univ Alaska Fairbanks, Inst Arctic Biol, 323 Murie Bldg, Fairbanks, AK 99775 USA.; Borg, BL (corresponding author), Natl Pk Serv, Denali Natl Pk & Preserve, POB 9, Denali Natl Pk, AK 99755 USA.	bridget_borg@nps.gov	Arthur, Stephen/GPX-2624-2022; Arthur, Stephen/AAP-1708-2021		National Park Service; US Geological Survey; National Science Foundation [DEB-1245373]; Yellowstone Park Foundation	National Park Service; US Geological Survey(United States Geological Survey); National Science Foundation(National Science Foundation (NSF)); Yellowstone Park Foundation	Funding was provided by the National Park Service and the US Geological Survey, National Science Foundation grant DEB-1245373, the Yellowstone Park Foundation, V. Gates, B. Graham, A. Graham, F. Yeager, and K. Yeager. National Park Service supported data collection, analysis, and preparation of the manuscript. Other funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ackerman A, 2010, IMPACTS VISITOR SPEN; Adams L.G., 2009, DYNAMICS DENALI CARI; Adams LG, 2008, WILDLIFE MONOGR, P1, DOI 10.2193/2008-012; Alaska Department of Fish and Game, 2006, WILDL ACT PLAN, P824; [Anonymous], MUMLN MULTIMODEL INF; [Anonymous], 2014, WOLF VIEWING PROJECT; BALLARD WB, 1987, WILDLIFE MONOGR, P1; Balme GA, 2010, ANIM CONSERV, V13, P315, DOI 10.1111/j.1469-1795.2009.00342.x; Bangs EE, 1996, WILDLIFE SOC B, V24, P402; Borg BL, 2015, THESIS U FAIRBANKS F; Borg BL, 2015, J ANIM ECOL, V84, P177, DOI 10.1111/1365-2656.12256; Brainerd SM, 2008, J WILDLIFE MANAGE, V72, P89, DOI 10.2193/2006-305; Brashares JS, 2001, P R SOC B, V268; Burnham K. P., 2002, MODEL SELECTION MULT, V2nd; Ciucci P, 2003, ECOGRAPHY, V26, P223, DOI 10.1034/j.1600-0587.2003.03353.x; Ciuti S, 2012, P ROY SOC B-BIOL SCI, V279, P4407, DOI 10.1098/rspb.2012.1483; Croes BM, 2011, BIOL CONSERV, V144, P3064, DOI 10.1016/j.biocon.2011.09.013; Darimont CT, 2009, P NATL ACAD SCI USA, V106, P952, DOI 10.1073/pnas.0809235106; Dickman AJ, 2011, P NATL ACAD SCI USA, V108, P13937, DOI 10.1073/pnas.1012972108; Duffield J.W., 2008, YELLOWSTONE SCI, V16, P20; ECONorthwest, 2012, IHP12052 ECONORTHWES; Frank LG, 2005, CONSERV BIOL SER, V9, P286; Fuller Todd K., 2003, P161; Hebblewhite M, 2008, J APPL ECOL, V45, P834, DOI 10.1111/j.1365-2664.2008.01466.x; Houston D.B., 1982, NO YELLOWSTONE ELK E; James ARC, 2000, J WILDLIFE MANAGE, V64, P154, DOI 10.2307/3802985; LEGENDRE P, 1993, ECOLOGY, V74, P1659, DOI 10.2307/1939924; Legendre P., 2012, NUMERICAL ECOLOGY; Loveridge AJ, 2007, BIOL CONSERV, V134, P548, DOI 10.1016/j.biocon.2006.09.010; Madden JR, 2014, ANIM BEHAV, V87, P129, DOI 10.1016/j.anbehav.2013.10.021; Manning R., 2010, PARK SCI, V27, P33; Mech LD, 2010, J WILDLIFE MANAGE, V74, P1421, DOI 10.2193/2009-540; Mech LD., 1998, WOLVES DENALI; Meier TJ, 2009, WOLF MONITORING PROT; Montana Fish Wildlife and Parks, 2011, 2011 MONT WOLF HUNT; Munoz AR, 2005, DIVERS DISTRIB, V11, P477, DOI 10.1111/j.1366-9516.2005.00188.x; Murray DL, 2010, BIOL CONSERV, V143, P2514, DOI 10.1016/j.biocon.2010.06.018; National Park Service, 2016, NAT PARK SERV VIS US; National Park Service, 2007, WOLF HUM CONFL MAN P, P85; National Park Service, 1986, D96A NPS DENV SERV C; National Research Council, 1997, WOLV BEARS THEIR PRE; Owen P.A., 2009, 2008 AERIAL MOOSE SU; Packer C, 2011, CONSERV BIOL, V25, P142, DOI 10.1111/j.1523-1739.2010.01576.x; Peterson RO, 1984, WILDLIFE MONOGR, P3; Ray J.C., 2005, 24 WILDL CONS SOC; Ruth TK, 2003, WILDLIFE SOC B, V31, P1150; Schmidt JH, 2013, J WILDLIFE MANAGE, V77, P1048, DOI 10.1002/jwmg.557; Schweber N., 2012, NY TIMES; Sikes RS, 2011, J MAMMAL, V92, P235, DOI 10.1644/10-MAMM-F-355.1; Smith DW, 2012, YELLOWSTONE WOLF PRO; Stander PE, 2008, RES REPORT; Tankersley N, 1991, ALASKAS WILDLIFE, V23, P6; Theuerkauf J, 2003, J WILDLIFE MANAGE, V67, P706, DOI 10.2307/3802677; THURBER JM, 1994, WILDLIFE SOC B, V22, P61; Treves A, 2009, J APPL ECOL, V46, P1350, DOI 10.1111/j.1365-2664.2009.01729.x; US Department of the Interior US Fish and Wildlife Service and US Department of Commerce US Census Bureau, 2011, NAT SURV FISH HUNT W; Walpole MJ, 2005, CONSERV BIOL SER, V9, P122; Western Regional Climate Center, 2015, COOP CLIM DAT SUMM; Whittington J, 2005, ECOL APPL, V15, P543, DOI 10.1890/03-5317; Woodroffe R, 1998, SCIENCE, V280, P2126, DOI 10.1126/science.280.5372.2126	60	16	16	0	50	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 28	2016	11	4							e0153808	10.1371/journal.pone.0153808	http://dx.doi.org/10.1371/journal.pone.0153808			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DK8XE	27124729	Green Published, gold, Green Submitted			2022-12-26	WOS:000375211700031
J	Lin, TL; Chen, TH; Hsu, YY; Cheng, YH; Juang, BT; Jong, YJ				Lin, Te-Lin; Chen, Tai-Heng; Hsu, Ya-Yun; Cheng, Yu-Hua; Juang, Bi-Tzen; Jong, Yuh-Jyh			Selective Neuromuscular Denervation in Taiwanese Severe SMA Mouse Can Be Reversed by Morpholino Antisense Oligonucleotides	PLOS ONE			English	Article							SPINAL MUSCULAR-ATROPHY; AMYOTROPHIC-LATERAL-SCLEROSIS; MOTOR-NEURONS; NERVE-TERMINALS; MODEL; MICE; PROTEIN; SMN2; SURVIVAL; MUSCLES	Spinal muscular atrophy (SMA) is an autosomal recessive motor neuron disease caused by deficiency of the survival of motor neuron (SMN) protein, which leads to synaptic defects and spinal motor neuron death. Neuromuscular junction (NMJ) abnormalities have been found to be involved in SMA pathogenesis in the SMN Delta 7 SMA mouse model. However, whether similar NMJ pathological findings present in another commonly used mouse model, the Taiwanese SMA mouse, has not been fully investigated. To examine the NMJs of the Taiwanese severe SMA mouse model (Smn(-/-); SMN2(tg/0)), which is characterized by severe phenotype and death before postnatal day (P) 9, we investigated 25 axial and appendicular muscles from P1 to P9. We labelled the muscles with anti-neurofilament and anti-synaptophysin antibodies for nerve terminals and a-bungarotoxin for acetylcholine receptors (AChRs). We found that severe NMJ denervation (<50% fully innervated endplates) selectively occurred in the flexor digitorum brevis 2 and 3 (FDB-2/3) muscles from P5, and an increased percentage of fully denervated endplates correlated with SMA progression. Furthermore, synaptophysin signals were absent at the endplate compared to control littermate mice, suggesting that vesicle transport might only be affected at the end stage. Subsequently, we treated the Taiwanese severe SMA mice with morpholino (MO) antisense oligonucleotides (80 mu g/g) via subcutaneous injection at P0. We found that MO significantly reversed the NMJ denervation in FDB-2/3 muscles and extended the survival of Taiwanese severe SMA mice. We conclude that early NMJ denervation in the FDB-2/3 muscles of Taiwanese severe SMA mice can be reversed by MO treatment. The FDB-2/3 muscles of Taiwanese severe SMA mice provide a very sensitive platform for assessing the effectiveness of drug treatments in SMA preclinical studies.	[Lin, Te-Lin; Hsu, Ya-Yun; Cheng, Yu-Hua] Kaohsiung Med Univ, Coll Med, Grad Inst Med, Kaohsiung, Taiwan; [Chen, Tai-Heng] Kaohsiung Med Univ, Dept Emergency, Div Pediat Emergency, Kaohsiung, Taiwan; [Chen, Tai-Heng] Kaohsiung Med Univ Hosp, Kaohsiung, Taiwan; [Juang, Bi-Tzen; Jong, Yuh-Jyh] Natl Chiao Tung Univ, Dept Biol Sci & Technol, Coll Biol Sci & Technol, Hsinchu, Taiwan; [Jong, Yuh-Jyh] Kaohsiung Med Univ, Coll Med, Grad Inst Clin Med, Kaohsiung, Taiwan; [Jong, Yuh-Jyh] Natl Chiao Tung Univ, Inst Mol Med & Bioengn, Coll Biol Sci & Technol, Hsinchu, Taiwan; [Jong, Yuh-Jyh] Kaohsiung Med Univ, Dept Pediat, Kaohsiung Med Univ Hosp, Kaohsiung, Taiwan; [Jong, Yuh-Jyh] Kaohsiung Med Univ, Dept Lab Med, Kaohsiung Med Univ Hosp, Kaohsiung, Taiwan	Kaohsiung Medical University; Kaohsiung Medical University; Kaohsiung Medical University; Kaohsiung Medical University Hospital; National Yang Ming Chiao Tung University; Kaohsiung Medical University; National Yang Ming Chiao Tung University; Kaohsiung Medical University; Kaohsiung Medical University Hospital; Kaohsiung Medical University; Kaohsiung Medical University Hospital	Jong, YJ (corresponding author), Natl Chiao Tung Univ, Dept Biol Sci & Technol, Coll Biol Sci & Technol, Hsinchu, Taiwan.; Jong, YJ (corresponding author), Kaohsiung Med Univ, Coll Med, Grad Inst Clin Med, Kaohsiung, Taiwan.; Jong, YJ (corresponding author), Natl Chiao Tung Univ, Inst Mol Med & Bioengn, Coll Biol Sci & Technol, Hsinchu, Taiwan.; Jong, YJ (corresponding author), Kaohsiung Med Univ, Dept Pediat, Kaohsiung Med Univ Hosp, Kaohsiung, Taiwan.; Jong, YJ (corresponding author), Kaohsiung Med Univ, Dept Lab Med, Kaohsiung Med Univ Hosp, Kaohsiung, Taiwan.	yjjong@gap.kmu.edu.tw	Chen, Tai-Heng/G-9900-2012	Chen, Tai-Heng/0000-0001-7713-3627; Jong, Yuh-Jyh/0000-0002-1735-1101	Ministry of Science and Technology, Taiwan, Republic of China [99-2628-B-037-001-MY3, 102-2628-B-009-003-MY3]	Ministry of Science and Technology, Taiwan, Republic of China	This study was supported by grants 99-2628-B-037-001-MY3 and 102-2628-B-009-003-MY3 from the Ministry of Science and Technology, Taiwan, Republic of China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BETZ WJ, 1980, J PHYSIOL-LONDON, V303, P281, DOI 10.1113/jphysiol.1980.sp013285; Biondi O, 2008, J NEUROSCI, V28, P953, DOI 10.1523/JNEUROSCI.3237-07.2008; Chang JG, 2001, P NATL ACAD SCI USA, V98, P9808, DOI 10.1073/pnas.171105098; Cifuentes-Diaz C, 2002, HUM MOL GENET, V11, P1439, DOI 10.1093/hmg/11.12.1439; Comley LH, 2016, J COMP NEUROL, V524, P1424, DOI 10.1002/cne.23917; Crawford TO, 1996, NEUROBIOL DIS, V3, P97, DOI 10.1006/nbdi.1996.0010; d'Ydewalle C, 2015, NEUROTHERAPEUTICS, V12, P303, DOI 10.1007/s13311-015-0337-y; Araujo APDC, 2009, J PEDIATR-US, V155, P292, DOI 10.1016/j.jpeds.2009.01.071; Fischer LR, 2004, EXP NEUROL, V185, P232, DOI 10.1016/j.expneurol.2003.10.004; Hastings ML, 2009, SCI TRANSL MED, V1, DOI 10.1126/scitranslmed.3000208; Hsieh-Li HM, 2000, NAT GENET, V24, P66, DOI 10.1038/71709; Hsu YY, 2012, BRIT J PHARMACOL, V166, P1114, DOI 10.1111/j.1476-5381.2012.01829.x; Hua YM, 2015, GENE DEV, V29, P288, DOI 10.1101/gad.256644.114; Hua YM, 2011, NATURE, V478, P123, DOI 10.1038/nature10485; Hua YM, 2010, GENE DEV, V24, P1634, DOI 10.1101/gad.1941310; Kariya S, 2008, HUM MOL GENET, V17, P2552, DOI 10.1093/hmg/ddn156; Kariya S, 2012, HUM MOL GENET, V21, P3421, DOI 10.1093/hmg/dds174; Keil JM, 2014, MOL THER-NUCL ACIDS, V3, DOI 10.1038/mtna.2014.23; Kong LL, 2009, J NEUROSCI, V29, P842, DOI 10.1523/JNEUROSCI.4434-08.2009; Lee YI, 2011, DEV BIOL, V356, P432, DOI 10.1016/j.ydbio.2011.05.667; LEFEBVRE S, 1995, CELL, V80, P155, DOI 10.1016/0092-8674(95)90460-3; Ling KKY, 2012, HUM MOL GENET, V21, P185, DOI 10.1093/hmg/ddr453; Ling KKY, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015457; Martinez-Hernandez R, 2013, J PATHOL, V229, P49, DOI 10.1002/path.4080; McGovern VL, 2008, HUM MOL GENET, V17, P2900, DOI 10.1093/hmg/ddn189; Mentis GZ, 2011, NEURON, V69, P453, DOI 10.1016/j.neuron.2010.12.032; Monani UR, 1999, HUM MOL GENET, V8, P1177, DOI 10.1093/hmg/8.7.1177; Monani UR, 2005, NEURON, V48, P885, DOI 10.1016/j.neuron.2005.12.001; Murray LM, 2008, HUM MOL GENET, V17, P949, DOI 10.1093/hmg/ddm367; Murray LM, 2010, HUM MOL GENET, V19, P420, DOI 10.1093/hmg/ddp506; MUSCH BC, 1975, J NEUROL SCI, V26, P221, DOI 10.1016/0022-510X(75)90034-9; Narver HL, 2008, ANN NEUROL, V64, P465, DOI 10.1002/ana.21449; Naryshkin NA, 2014, SCIENCE, V345, P688, DOI 10.1126/science.1250127; Paez-Colasante X, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075866; Passini MA, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3001777; Porensky PN, 2012, HUM MOL GENET, V21, P1625, DOI 10.1093/hmg/ddr600; Riessland M, 2010, HUM MOL GENET, V19, P1492, DOI 10.1093/hmg/ddq023; Rindt H, 2015, HUM MOL GENET, V24, P4094, DOI 10.1093/hmg/ddv148; Robbins KL, 2014, HUM MOL GENET, V23, P4559, DOI 10.1093/hmg/ddu169; ROBERTS DF, 1970, ARCH DIS CHILD, V45, P33, DOI 10.1136/adc.45.239.33; Rudnik-Schoneborn S, 2010, MUSCLE NERVE, V42, P144, DOI 10.1002/mus.21654; Ruggiu M, 2012, MOL CELL BIOL, V32, P126, DOI 10.1128/MCB.06077-11; Ruiz R, 2014, J ANAT, V224, P74, DOI 10.1111/joa.12038; Ruiz R, 2010, J NEUROSCI, V30, P849, DOI 10.1523/JNEUROSCI.4496-09.2010; Schreml J, 2013, EUR J HUM GENET, V21, P643, DOI 10.1038/ejhg.2012.222; Shababi M, 2014, J ANAT, V224, P15, DOI 10.1111/joa.12083; Sumner CJ, 2007, J CHILD NEUROL, V22, P979, DOI 10.1177/0883073807305787; Thomson SR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052605; Tsai LK, 2006, NEUROBIOL DIS, V24, P286, DOI 10.1016/j.nbd.2006.07.004; Turner BJ, 2009, NEUROBIOL DIS, V34, P511, DOI 10.1016/j.nbd.2009.03.005; Valdez G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034640; Wang CC, 2008, ELECTROPHORESIS, V29, P2904, DOI 10.1002/elps.200700799; Wertz MH, 2016, ANN NY ACAD SCI, V1366, P5, DOI 10.1111/nyas.12813; Yamazaki T, 2012, CELL REP, V2, P799, DOI 10.1016/j.celrep.2012.08.025; Zhou HY, 2013, HUM GENE THER, V24, P331, DOI 10.1089/hum.2012.211	55	17	17	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 28	2016	11	4							e0154723	10.1371/journal.pone.0154723	http://dx.doi.org/10.1371/journal.pone.0154723			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DK8XE	27124114	Green Published, gold, Green Submitted			2022-12-26	WOS:000375211700125
J	Shcherbatko, A; Rossi, A; Foletti, D; Zhu, GY; Bogin, O; Casas, MG; Rickert, M; Hasa-Moreno, A; Bartsevich, V; Crameri, A; Steiner, AR; Henningsen, R; Gill, A; Pons, J; Shelton, DL; Rajpal, A; Strop, P				Shcherbatko, Anatoly; Rossi, Andrea; Foletti, Davide; Zhu, Guoyun; Bogin, Oren; Casas, Meritxell Galindo; Rickert, Mathias; Hasa-Moreno, Adela; Bartsevich, Victor; Crameri, Andreas; Steiner, Alexander R.; Henningsen, Robert; Gill, Avinash; Pons, Jaume; Shelton, David L.; Rajpal, Arvind; Strop, Pavel			Engineering Highly Potent and Selective Microproteins against Nav1.7 Sodium Channel for Treatment of Pain	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						directed evolution; pain; sodium channel; structure-function; toxin; ceratotoxin; Nav1; 7; engineering	SPIDER-VENOM PEPTIDES; II VOLTAGE SENSOR; HUWENTOXIN-IV; DOMAIN-II; ANALGESIC TARGET; GATING MODIFIER; HAINANTOXIN-IV; NA(V)1.7; ANTAGONIST; MODULATORS	The prominent role of voltage-gated sodium channel 1.7 (Nav1.7) in nociception was revealed by remarkable human clinical and genetic evidence. Development of potent and subtype-selective inhibitors of this ion channel is crucial for obtaining therapeutically useful analgesic compounds. Microproteins isolated from animal venoms have been identified as promising therapeutic leads for ion channels, because they naturally evolved to be potent ion channel blockers. Here, we report the engineering of highly potent and selective inhibitors of the Nav1.7 channel based on tarantula ceratotoxin-1 (CcoTx1). We utilized a combination of directed evolution, saturation mutagenesis, chemical modification, and rational drug design to obtain higher potency and selectivity to the Nav1.7 channel. The resulting microproteins are highly potent (IC50 to Nav1.7 of 2.5 nm) and selective. We achieved 80- and 20-fold selectivity over the closely related Nav1.2 and Nav1.6 channels, respectively, and the IC50 on skeletal (Nav1.4) and cardiac (Nav1.5) sodium channels is above 3000 nm. The lead molecules have the potential for future clinical development as novel therapeutics in the treatment of pain.	[Shcherbatko, Anatoly; Rossi, Andrea; Foletti, Davide; Zhu, Guoyun; Casas, Meritxell Galindo; Rickert, Mathias; Hasa-Moreno, Adela; Pons, Jaume; Shelton, David L.; Rajpal, Arvind; Strop, Pavel] Pfizer Inc, Rinat Labs, San Francisco, CA 94080 USA; [Steiner, Alexander R.; Henningsen, Robert; Gill, Avinash] Sutro Biopharma, San Francisco, CA 94080 USA; [Bogin, Oren; Bartsevich, Victor; Crameri, Andreas] Amunix, Mountain View, CA 94043 USA; [Foletti, Davide] 23andme, 899 W Evelyn Ave, Mountain View, CA 94041 USA; [Bogin, Oren] Chan Bio Ltd, IL-69416 Tel Aviv, Israel; [Rickert, Mathias] Delinia Biosci, 953 Indiana St, San Francisco, CA USA; [Bartsevich, Victor] Precis BioSci, 302 E Pettigrew St, Durham, NC 27701 USA; [Crameri, Andreas] GlaxoSmithKline, Stevenage SG1 2NY, Herts, England; [Gill, Avinash] Genentech Inc, 1DNA Way, San Francisco, CA 94080 USA; [Pons, Jaume] Alexo Therapeut, San Francisco, CA 94080 USA; [Rajpal, Arvind; Strop, Pavel] Bristol Myers Squibb, 700 Bay Rd, Redwood City, CA 94063 USA	Pfizer; GlaxoSmithKline; Roche Holding; Genentech; Bristol-Myers Squibb	Strop, P (corresponding author), Bristol Myers Squibb, 700 Bay Rd, Redwood City, CA 94063 USA.	pavel.strop@bms.com		Galindo Casas, Meritxell/0000-0002-5034-1722				BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Billen B, 2008, CURR PHARM DESIGN, V14, P2492, DOI 10.2174/138161208785777423; Bosmans F, 2006, MOL PHARMACOL, V69, P419, DOI 10.1124/mol.105.015941; Bosmans F, 2010, TRENDS PHARMACOL SCI, V31, P175, DOI 10.1016/j.tips.2009.12.007; Cai TF, 2015, PEPTIDES, V68, P148, DOI 10.1016/j.peptides.2014.09.005; Chessell IP, 2012, DRUG DISCOV TODAY, V17, P875, DOI 10.1016/j.drudis.2012.03.005; Chow CY, 2015, TOXINS, V7, P2494, DOI 10.3390/toxins7072494; Cox JJ, 2006, NATURE, V444, P894, DOI 10.1038/nature05413; Craik DJ, 2013, CHEM BIOL DRUG DES, V81, P136, DOI 10.1111/cbdd.12055; Crameri A, 1998, NATURE, V391, P288, DOI 10.1038/34663; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Estacion M, 2011, MOL PAIN, V7, DOI 10.1186/1744-8069-7-92; Faber CG, 2012, ANN NEUROL, V71, P26, DOI 10.1002/ana.22485; Fertleman CR, 2006, NEURON, V52, P767, DOI 10.1016/j.neuron.2006.10.006; Gilchrist John, 2014, Handb Exp Pharmacol, V221, P203, DOI 10.1007/978-3-642-41588-3_10; Goldberg DS, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-770; Goldberg YP, 2007, CLIN GENET, V71, P311, DOI 10.1111/j.1399-0004.2007.00790.x; Harvey AL, 2014, TOXICON, V92, P193, DOI 10.1016/j.toxicon.2014.10.020; King GF, 2014, ACS CHEM NEUROSCI, V5, P749, DOI 10.1021/cn500171p; Klint JK, 2015, BRIT J PHARMACOL, V172, P2445, DOI 10.1111/bph.13081; Klint JK, 2012, TOXICON, V60, P478, DOI 10.1016/j.toxicon.2012.04.337; KOHLER G, 1975, NATURE, V256, P495, DOI 10.1038/256495a0; Lee CW, 2004, BIOCHEMISTRY-US, V43, P890, DOI 10.1021/bi0353373; Lee JH, 2014, CELL, V157, P1393, DOI 10.1016/j.cell.2014.03.064; Li DL, 2004, J BIOL CHEM, V279, P37734, DOI 10.1074/jbc.M405765200; Malakhov Michael P., 2004, Journal of Structural and Functional Genomics, V5, P75, DOI 10.1023/B:JSFG.0000029237.70316.52; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Minassian NA, 2013, J BIOL CHEM, V288, P22707, DOI 10.1074/jbc.M113.461392; Minett MS, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9967; Murray JK, 2015, J MED CHEM, V58, P2299, DOI 10.1021/jm501765v; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Nicholson GM, 2007, TOXICON, V49, P490, DOI 10.1016/j.toxicon.2006.11.027; Ogata N, 2002, JPN J PHARMACOL, V88, P365, DOI 10.1254/jjp.88.365; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Packer MS, 2015, NAT REV GENET, V16, P379, DOI 10.1038/nrg3927; PALLAGHY PK, 1994, PROTEIN SCI, V3, P1833, DOI 10.1002/pro.5560031022; Park JH, 2014, J MED CHEM, V57, P6623, DOI 10.1021/jm500687u; Peng K, 2002, J BIOL CHEM, V277, P47564, DOI 10.1074/jbc.M204063200; Pineda SS, 2014, FUTURE MED CHEM, V6, P1699, DOI [10.4155/FMC.14.103, 10.4155/fmc.14.103]; Revell JD, 2013, PEPTIDES, V44, P40, DOI 10.1016/j.peptides.2013.03.011; Rong MQ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065984; Saez NJ, 2010, TOXINS, V2, P2851, DOI 10.3390/toxins2122851; Sokolov S, 2008, MOL PHARMACOL, V73, P1020, DOI 10.1124/mol.107.041046; Takahashi H, 2000, J MOL BIOL, V297, P771, DOI 10.1006/jmbi.2000.3609; Takeuchi K, 2002, J MOL BIOL, V321, P517, DOI 10.1016/S0022-2836(02)00595-8; Tripathi A, 2014, CURR OPIN STRUC BIOL, V24, P63, DOI 10.1016/j.sbi.2013.12.001; Wood DLA, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-375; Xiao YC, 2008, J BIOL CHEM, V283, P27300, DOI 10.1074/jbc.M708447200; Yang SL, 2013, P NATL ACAD SCI USA, V110, P17534, DOI 10.1073/pnas.1306285110; Yang Y, 2004, J MED GENET, V41, P171, DOI 10.1136/jmg.2003.012153; Zawada JF, 2011, BIOTECHNOL BIOENG, V108, P1570, DOI 10.1002/bit.23103	51	44	45	1	22	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 1	2016	291	27					13974	13986		10.1074/jbc.M116.725978	http://dx.doi.org/10.1074/jbc.M116.725978			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DR5XG	27129258	hybrid, Green Published			2022-12-26	WOS:000379975100007
J	Qvit, N; Joshi, AU; Cunningham, AD; Ferreira, JCB; Mochly-Rosen, D				Qvit, Nir; Joshi, Amit U.; Cunningham, Anna D.; Ferreira, Julio C. B.; Mochly-Rosen, Daria			Glyceraldehyde-3-Phosphate Dehydrogenase (GAPDH) Protein-Protein Interaction Inhibitor Reveals a Non-catalytic Role for GAPDH Oligomerization in Cell Death	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						docking; oligomerization; oxidative stress; peptides; protein kinase; protein kinase C (PKC); protein structure; Pseudosubstrate; glyceraldehyde-3-phosphate dehydrogenase (GAPDH); mitochondria elimination	KINASE-C; DOCKING-SITE; NUCLEAR TRANSLOCATION; DELTA-PKC; REGULATORY DOMAIN; CARDIAC ISCHEMIA; MAP KINASES; EPSILON-PKC; CYCLIN-A; IDENTIFICATION	Glyceraldehyde-3-phosphate dehydrogenase (GAPDH), an important glycolytic enzyme, has a non-catalytic (thus a non-canonical) role in inducing mitochondrial elimination under oxidative stress. We recently demonstrated that phosphorylation of GAPDH by protein kinase C (PKC) inhibits this GAPDH-dependent mitochondrial elimination. PKC phosphorylation of GAPDH correlates with increased cell injury following oxidative stress, suggesting that inhibiting GAPDH phosphorylation should decrease cell injury. Using rational design, we identified pseudo-GAPDH (GAPDH) peptide, an inhibitor of PKC-mediated GAPDH phosphorylation that does not inhibit the phosphorylation of other PKC substrates. Unexpectedly, GAPDH decreased mitochondrial elimination and increased cardiac damage in an animal model of heart attack. Either treatment with GAPDH or direct phosphorylation of GAPDH by PKC decreased GAPDH tetramerization, which corresponded to reduced GAPDH glycolytic activity in vitro and ex vivo. Taken together, our study identified the potential mechanism by which oxidative stress inhibits the protective GAPDH-mediated elimination of damaged mitochondria. Our study also identified a pharmacological tool, GAPDH peptide, with interesting properties. GAPDH peptide is an inhibitor of the interaction between PKC and GAPDH and of the resulting phosphorylation of GAPDH by PKC. GAPDH peptide is also an inhibitor of GAPDH oligomerization and thus an inhibitor of GAPDH glycolytic activity. Finally, we found that GAPDH peptide is an inhibitor of the elimination of damaged mitochondria. We discuss how this unique property of increasing cell damage following oxidative stress suggests a potential use for GAPDH peptide-based therapy.	[Qvit, Nir; Joshi, Amit U.; Cunningham, Anna D.; Mochly-Rosen, Daria] Stanford Univ, Sch Med, Dept Chem & Syst Biol, Stanford, CA 94305 USA; [Ferreira, Julio C. B.] Univ Sao Paulo, Inst Biomed Sci, Dept Anat, BR-05508000 Sao Paulo, Brazil	Stanford University; Universidade de Sao Paulo	Qvit, N; Mochly-Rosen, D (corresponding author), Stanford Univ, Sch Med, Stanford, CA 94305 USA.	nirqvit@stanford.edu; mochly@stanford.edu	Ferreira, Julio Cesar Batista/AEU-0494-2022; Joshi, Amit/U-3832-2018; Ferreira, Julio/L-4687-2019; Ferreira, Julio Cesar Batista/I-3177-2012	Ferreira, Julio Cesar Batista/0000-0003-2694-239X; Joshi, Amit/0000-0002-2472-7672; Ferreira, Julio Cesar Batista/0000-0003-2694-239X; Mochly-Rosen, Daria/0000-0002-6691-8733	National Institutes of Health [HL52141]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL052141] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by National Institutes of Health Grant HL52141 (to D. M.-R.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Abramoff M.D., 2004, BIOPHOT INT, V11, P36, DOI DOI 10.1117/1.3589100; Adams PD, 1999, MOL CELL BIOL, V19, P1068; Adams PD, 1996, MOL CELL BIOL, V16, P6623; BAIER G, 1993, J BIOL CHEM, V268, P4997; Begley R, 2004, BIOCHEM BIOPH RES CO, V318, P949, DOI 10.1016/j.bbrc.2004.04.121; Biondi RM, 2003, BIOCHEM J, V372, P1, DOI 10.1042/BJ20021641; Caffrey DR, 2004, PROTEIN SCI, V13, P190, DOI 10.1110/ps.03323604; Chang CI, 2002, MOL CELL, V9, P1241, DOI 10.1016/S1097-2765(02)00525-7; Chen L, 2001, CHEM BIOL, V8, P1123, DOI 10.1016/S1074-5521(01)00076-X; Chen L, 2001, P NATL ACAD SCI USA, V98, P11114, DOI 10.1073/pnas.191369098; Churchill EN, 2005, CIRC RES, V97, P78, DOI 10.1161/01.RES.0000173896.32522.6e; Dastoor Z, 2001, J CELL SCI, V114, P1643; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; Eaton P, 2002, J MOL CELL CARDIOL, V34, P1549, DOI 10.1006/jmcc.2002.2108; El Kadmiri N, 2014, PATHOL BIOL, V62, P333, DOI 10.1016/j.patbio.2014.08.002; Eltzschig HK, 2011, NAT MED, V17, P1391, DOI 10.1038/nm.2507; Guharoy M, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-286; Guo CM, 2013, CLIN TRANSL ONCOL, V15, P167, DOI 10.1007/s12094-012-0924-x; Hara MR, 2005, NAT CELL BIOL, V7, P665, DOI 10.1038/ncb1268; HOAGLAND VD, 1969, BIOCHEMISTRY-US, V8, P594, DOI 10.1021/bi00830a020; Holland PM, 1999, CURR BIOL, V9, pR329, DOI 10.1016/S0960-9822(99)80205-X; Hoshino A, 2012, J MOL CELL CARDIOL, V52, P175, DOI 10.1016/j.yjmcc.2011.10.008; HOUSE C, 1987, SCIENCE, V238, P1726, DOI 10.1126/science.3686012; HUANG XQ, 1991, ADV APPL MATH, V12, P337, DOI 10.1016/0196-8858(91)90017-D; Hwang S, 2015, EMBO MOL MED, V7, P1307, DOI 10.15252/emmm.201505256; Inagaki K, 2003, CIRCULATION, V108, P2304, DOI 10.1161/01.CIR.0000101682.24138.36; Inagaki K, 2003, CIRCULATION, V108, P869, DOI 10.1161/01.CIR.0000081943.93653.73; KAISER E, 1970, ANAL BIOCHEM, V34, P595, DOI 10.1016/0003-2697(70)90146-6; Kallunki T, 1996, CELL, V87, P929, DOI 10.1016/S0092-8674(00)81999-6; Kim EH, 2007, CANCER RES, V67, P6333, DOI 10.1158/0008-5472.CAN-06-4344; KUMAGAI H, 1983, J BIOCHEM-TOKYO, V93, P1259, DOI 10.1093/oxfordjournals.jbchem.a134260; Lee S, 2003, P NATL ACAD SCI USA, V100, P14707, DOI 10.1073/pnas.2534493100; Lee T, 2004, MOL CELL, V14, P43, DOI 10.1016/S1097-2765(04)00161-3; Li J, 2005, J BIOL CHEM, V280, P8351, DOI 10.1074/jbc.M409431200; Lonn P, 2015, EXPERT OPIN DRUG DEL, V12, P1627, DOI 10.1517/17425247.2015.1046431; Luciani MG, 2000, J MOL BIOL, V300, P503, DOI 10.1006/jmbi.2000.3830; Ma S, 2015, BBA-MOL BASIS DIS, V1852, P271, DOI 10.1016/j.bbadis.2014.05.010; Mazzola JL, 2003, BBA-GEN SUBJECTS, V1622, P50, DOI 10.1016/S0304-4165(03)00117-X; MERRIFIELD RB, 1963, J AM CHEM SOC, V85, P2149, DOI 10.1021/ja00897a025; MEYERSIEGLER K, 1991, P NATL ACAD SCI USA, V88, P8460, DOI 10.1073/pnas.88.19.8460; Murriel CL, 2004, J BIOL CHEM, V279, P47985, DOI 10.1074/jbc.M405071200; NOLAND TA, 1989, J BIOL CHEM, V264, P20778; Novotny-Diermayr V, 2002, J BIOL CHEM, V277, P49134, DOI 10.1074/jbc.M206727200; Pawson T, 1997, SCIENCE, V278, P2075, DOI 10.1126/science.278.5346.2075; PEARSON WR, 1988, P NATL ACAD SCI USA, V85, P2444, DOI 10.1073/pnas.85.8.2444; Quinsay MN, 2010, AUTOPHAGY, V6, P855, DOI 10.4161/auto.6.7.13005; Qvit Nir, 2010, Drug Discov Today Dis Mech, V7, pe87, DOI 10.1016/j.ddmec.2010.07.001; Remenyi A, 2006, CURR OPIN STRUC BIOL, V16, P676, DOI 10.1016/j.sbi.2006.10.008; Rizzuti M, 2015, DRUG DISCOV TODAY, V20, P76, DOI 10.1016/j.drudis.2014.09.017; Roitel O, 2003, J MOL BIOL, V326, P1513, DOI 10.1016/S0022-2836(03)00049-4; Saunders PA, 1997, J NEUROCHEM, V69, P1820; Sawa A, 1997, P NATL ACAD SCI USA, V94, P11669, DOI 10.1073/pnas.94.21.11669; Schulman BA, 1998, P NATL ACAD SCI USA, V95, P10453, DOI 10.1073/pnas.95.18.10453; Seidler N. W., 2012, GAPDH BIOL PROPERTIE, P207; SINGH R, 1993, SCIENCE, V259, P365, DOI 10.1126/science.8420004; SODERLING TR, 1990, J BIOL CHEM, V265, P1823; Steinberg SF, 2008, PHYSIOL REV, V88, P1341, DOI 10.1152/physrev.00034.2007; Tanoue T, 2001, EMBO J, V20, P466, DOI 10.1093/emboj/20.3.466; Tatton NA, 2000, EXP NEUROL, V166, P29, DOI 10.1006/exnr.2000.7489; Thomas PD, 2003, GENOME RES, V13, P2129, DOI 10.1101/gr.772403; Tisdale EJ, 2001, J BIOL CHEM, V276, P2480, DOI 10.1074/jbc.M007567200; Ubersax JA, 2007, NAT REV MOL CELL BIO, V8, P530, DOI 10.1038/nrm2203; van der Bliek AM, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a011072; Werbovetz KA, 2000, CURR MED CHEM, V7, P835, DOI 10.2174/0929867003374615; White MR, 2015, J BIOL CHEM, V290, P1770, DOI 10.1074/jbc.M114.618165; Yogalingam G, 2013, J BIOL CHEM, V288, P18947, DOI 10.1074/jbc.M113.466870; Zheng L, 2003, CELL, V114, P255, DOI 10.1016/S0092-8674(03)00552-X	67	17	20	4	29	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 24	2016	291	26					13608	13621		10.1074/jbc.M115.711630	http://dx.doi.org/10.1074/jbc.M115.711630			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DR2YZ	27129213	Green Published, hybrid			2022-12-26	WOS:000379771100018
J	Chen, YF; Pan, KW; Wang, PZ; Cao, ZY; Wang, WB; Wang, SY; Hu, NG; Xue, JH; Li, H; Jiang, W; Li, G; Zhang, XW				Chen, Yifan; Pan, Kewu; Wang, Pingzhang; Cao, Zhengyi; Wang, Weibin; Wang, Shuya; Hu, Ningguang; Xue, Junhui; Li, Hui; Jiang, Wei; Li, Gang; Zhang, Xiaowei			HBP1-mediated Regulation of p21 Protein through the Mdm2/p53 and TCF4/EZH2 Pathways and Its Impact on Cell Senescence and Tumorigenesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSCRIPTIONAL REPRESSOR HBP1; INDUCED PREMATURE SENESCENCE; HUMAN FIBROBLASTS; GENE-EXPRESSION; IMMUNE CELLS; CANCER CELLS; DNA-DAMAGE; P53; ACTIVATION; P16	The activity of the CDK inhibitor p21 is associated with diverse biological activities, including cell proliferation, senescence, and tumorigenesis. However, the mechanisms governing transcription of p21 need to be extensively studied. In this study, we demonstrate that the high-mobility group box-containing protein 1 (HBP1) transcription factor is a novel activator of p21 that works as part of a complex mechanism during senescence and tumorigenesis. We found that HBP1 activates the p21 gene through enhancing p53 stability by inhibiting Mdm2-mediated ubiquitination of p53, a well known positive regulator of p21. HBP1 was also found to enhance p21 transcription by inhibiting Wnt/beta-catenin signaling. We identified histone methyltransferase EZH2, the catalytic subunit of polycomb repressive complex 2, as a target of Wnt/beta-catenin signaling. HBP1-mediated repression of EZH2 through Wnt/beta-catenin signaling decreased the level of trimethylation of histone H3 at lysine 27 of overall and specific histone on the p21 promoter, resulting in p21 transactivation. Although intricate, the reciprocal partnership of HBP1 and p21 has exceptional importance. HBP1-mediated elevation of p21 through the Mdm2/p53 and TCF4/EZH2 pathways contributes to both cellular senescence and tumor inhibition. Together, our results suggest that the HBP1 transcription factor orchestrates a complex regulation of key genes during cellular senescence and tumorigenesis with an impact on protein ubiquitination and overall histone methylation state.	[Chen, Yifan; Pan, Kewu; Cao, Zhengyi; Wang, Weibin; Wang, Shuya; Hu, Ningguang; Xue, Junhui; Li, Hui; Jiang, Wei; Li, Gang; Zhang, Xiaowei] Peking Univ, Beijing Key Lab Prot Posttranslat Modificat & Cel, Dept Biochem & Mol Biol, Sch Basic Med Sci,Hlth Sci Ctr, Beijing 100191, Peoples R China; [Wang, Pingzhang] Peking Univ, Hlth Sci Ctr, Sch Basic Med Sci, Dept Immunol, Beijing 100191, Peoples R China	Peking University; Peking University	Zhang, XW (corresponding author), Peking Univ, Hlth Sci Ctr, Dept Biochem & Mol Biol, Beijing 100191, Peoples R China.	xiaoweizhang@bjmu.edu.cn			National Natural Science Foundation of China [81170320, 31471292, 81572705]; Beijing Natural Science Foundation [5162013]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Beijing Natural Science Foundation(Beijing Natural Science Foundation)	This work was supported by National Natural Science Foundation of China Grants 81170320, 31471292, and 81572705 and Beijing Natural Science Foundation Grant 5162013. The authors declare that they have no conflicts of interest with the contents of this article.	Bai J, 2014, DNA CELL BIOL, V33, P337, DOI 10.1089/dna.2014.2340; Baygi ME, 2010, CELL BIOL TOXICOL, V26, P553, DOI 10.1007/s10565-010-9163-5; Becker TM, 2009, MOL CANCER, V8, DOI 10.1186/1476-4598-8-4; Bellei B, 2008, CELL SIGNAL, V20, P1750, DOI 10.1016/j.cellsig.2008.06.001; Berasi SP, 2004, MOL CELL BIOL, V24, P3011, DOI 10.1128/MCB.24.7.3011-3024.2004; Cao LL, 2016, ONCOGENE, V35, P301, DOI 10.1038/onc.2015.81; Cao R, 2002, SCIENCE, V298, P1039, DOI 10.1126/science.1076997; CHEN JD, 1993, MOL CELL BIOL, V13, P4107, DOI 10.1128/MCB.13.7.4107; Chen YC, 2010, ONCOGENE, V29, P3067, DOI 10.1038/onc.2010.97; Childs BG, 2014, EMBO REP, V15, P1139, DOI 10.15252/embr.201439245; Cipriano R, 2011, P NATL ACAD SCI USA, V108, P8668, DOI 10.1073/pnas.1015022108; Escamilla-Powers JR, 2010, J BIOL CHEM, V285, P4847, DOI 10.1074/jbc.M109.074856; Gartel AL, 1998, ONCOGENE, V17, P3463, DOI 10.1038/sj.onc.1202240; Gu ZF, 2014, MOL CELL BIOCHEM, V387, P27, DOI 10.1007/s11010-013-1866-5; Hornsby PJ, 2007, J CLIN ONCOL, V25, P1852, DOI 10.1200/JCO.2006.10.3101; Jackson DP, 2014, MOL PHARMACOL, V85, P533, DOI 10.1124/mol.113.089730; Jackson JG, 2006, CANCER RES, V66, P8356, DOI 10.1158/0008-5472.CAN-06-1752; Kruse JP, 2009, CELL, V137, P609, DOI 10.1016/j.cell.2009.04.050; Lee KW, 2015, CANCER RES, V75, P73, DOI 10.1158/0008-5472.CAN-14-0350; Lemercier C, 2000, MOL CELL BIOL, V20, P6627, DOI 10.1128/MCB.20.18.6627-6637.2000; Li H, 2010, ONCOGENE, V29, P5083, DOI 10.1038/onc.2010.252; Li J, 2015, STEM CELLS, V33, P951, DOI 10.1002/stem.1908; Li MY, 2002, NATURE, V416, P648, DOI 10.1038/nature737; Li MY, 2004, MOL CELL, V13, P879, DOI 10.1016/S1097-2765(04)00157-1; Lin KM, 2001, LEUKEMIA, V15, P601, DOI 10.1038/sj.leu.2402071; Liu YQ, 2013, J BIOL CHEM, V288, P11572, DOI 10.1074/jbc.M112.434951; Mattia M, 2007, MOL CELL BIOL, V27, P1309, DOI 10.1128/MCB.01520-06; Meng X, 2014, CANCER RES, V74, P7161, DOI 10.1158/0008-5472.CAN-14-1446; MOMAND J, 1992, CELL, V69, P1237, DOI 10.1016/0092-8674(92)90644-R; Negishi M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095216; Nejman D, 2014, CANCER RES, V74, P1475, DOI 10.1158/0008-5472.CAN-13-3042; Onder TT, 2012, NATURE, V483, P598, DOI 10.1038/nature10953; Pan KW, 2013, MOL CELL BIOL, V33, P887, DOI 10.1128/MCB.00637-12; Paulson KE, 2007, CANCER RES, V67, P6136, DOI 10.1158/0008-5472.CAN-07-0567; Pu MT, 2015, GENE DEV, V29, P718, DOI 10.1101/gad.254144.114; Sampson EM, 2001, EMBO J, V20, P4500, DOI 10.1093/emboj/20.16.4500; Sashida G, 2009, MOL CELL BIOL, V29, P3687, DOI 10.1128/MCB.01551-08; Shih HH, 2001, MOL CELL BIOL, V21, P5723, DOI 10.1128/MCB.21.17.5723-5732.2001; Tevosian SG, 1997, GENE DEV, V11, P383, DOI 10.1101/gad.11.3.383; Tiwari N, 2013, CANCER CELL, V23, P768, DOI 10.1016/j.ccr.2013.04.020; Vigneron AM, 2012, EMBO J, V31, P471, DOI 10.1038/emboj.2011.402; Wan Q, 2015, DATABASE-OXFORD, DOI 10.1093/database/bav019; Wang CH, 2014, FEBS LETT, V588, P4654, DOI 10.1016/j.febslet.2014.10.037; Wang PZ, 2015, SCI REP-UK, V5, DOI 10.1038/srep10370; Wang PZ, 2015, NUCLEIC ACIDS RES, V43, pD1133, DOI 10.1093/nar/gku980; Wang WB, 2014, J BIOL CHEM, V289, P3217, DOI 10.1074/jbc.M113.508515; Wei WY, 2001, MOL CELL BIOL, V21, P6748, DOI 10.1128/MCB.21.20.6748-6757.2001; Xu HR, 2015, BBA-MOL CELL RES, V1853, P65, DOI 10.1016/j.bbamcr.2014.10.002; Yao CJ, 2005, LEUKEMIA, V19, P1958, DOI 10.1038/sj.leu.2403918; Zhang XW, 2006, MOL CELL BIOL, V26, P8252, DOI 10.1128/MCB.00604-06; Zhuma T, 1999, EMBO J, V18, P6396, DOI 10.1093/emboj/18.22.6396	51	21	26	0	21	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 10	2016	291	24					12688	12705		10.1074/jbc.M116.714147	http://dx.doi.org/10.1074/jbc.M116.714147			18	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DO9PV	27129219	Green Published, hybrid			2022-12-26	WOS:000378119900023
J	Moreno-Azanza, M; Bauluz, B; Canudo, JI; Gasca, JM; Fernandez-Baldor, FT				Moreno-Azanza, Miguel; Bauluz, Blanca; Ignacio Canudo, Jose; Manuel Gasca, Jose; Torcida Fernandez-Baldor, Fidel			Combined Use of Electron and Light Microscopy Techniques Reveals False Secondary Shell Units in Megaloolithidae Eggshells	PLOS ONE			English	Article							BACKSCATTER DIFFRACTION; DINOSAUR EGGSHELLS; ZHEJIANG PROVINCE; BASIN; CLUTCHES; SPAIN; EGGS; EVOLUTION; PYRENEES; LLEIDA	Abnormalities in the histo- and ultrastructure of the amniote eggshell are often related to diverse factors, such as ambient stress during egg formation, pathologies altering the physiology of the egg-laying females, or evolutionarily selected modifications of the eggshell structure that vary the physical properties of the egg, for example increasing its strength so as to avoid fracture during incubation. When dealing with fossil materials, all the above hypotheses are plausible, but a detailed taphonomical study has to be performed to rule out the possibility that secondary processes of recrystallization have occurred during fossilization. Traditional analyses, such as optical microscopy inspection and cathodoluminescence, have proven not to be enough to understand the taphonomic story of some eggshells. Recently, electron backscatter diffraction has been used, in combination with other techniques, to better understand the alteration of fossil eggshells. Here we present a combined study using scanning electron microscopy, optical microscopy, cathodoluminescence and electron backscatter diffraction of eggshell fragments assigned to Megaloolithus cf. siruguei from the Upper Cretaceous outcrops of the Cameros Basin. We focus our study on the presence of secondary shell units that mimic most aspects of the ultrastructure of the eggshell mammillae, but grow far from the inner surface of the eggshell. We call these structures extra-spherulites, describe their crystal structure and demonstrate their secondary origin. Our study has important implications for the interpretation of secondary shell units as biological or pathological structures. Thus, electron backscatter diffraction complements other microscope techniques as a useful tool for understanding taphonomical alterations in fossil eggshells.	[Moreno-Azanza, Miguel] Univ Nova Lisboa, Fac Ciencias & Tecnol, Dept Ciencias Terra, Geobiotec, Caparica, Portugal; [Moreno-Azanza, Miguel] Museu Lourinha, Lourinha, Portugal; [Moreno-Azanza, Miguel; Ignacio Canudo, Jose; Manuel Gasca, Jose] Univ Zaragoza, Fac Ciencias, Grp Aragosaurus IUCA, Area Paleontol, E-50009 Zaragoza, Spain; [Bauluz, Blanca] Univ Zaragoza, Fac Ciencias, Area Mineral, E-50009 Zaragoza, Spain; [Manuel Gasca, Jose] CONICET Museo Olsacher, Zapala, Neuquen, Argentina; [Torcida Fernandez-Baldor, Fidel] Museo Dinosaurios, Fidel Torcida Fernandez Baldor Colect Arqueol Pal, Burgos, Spain	Universidade Nova de Lisboa; University of Zaragoza; University of Zaragoza	Moreno-Azanza, M (corresponding author), Univ Nova Lisboa, Fac Ciencias & Tecnol, Dept Ciencias Terra, Geobiotec, Caparica, Portugal.; Moreno-Azanza, M (corresponding author), Museu Lourinha, Lourinha, Portugal.; Moreno-Azanza, M (corresponding author), Univ Zaragoza, Fac Ciencias, Grp Aragosaurus IUCA, Area Paleontol, E-50009 Zaragoza, Spain.	mmazanza@fct.unl.pt	Moreno-Azanza, Miguel/G-9165-2017; Bauluz, Blanca/N-9802-2018; Gasca, José M./F-1201-2018	Moreno-Azanza, Miguel/0000-0002-7210-1033; Bauluz, Blanca/0000-0002-4970-6333; Gasca, Jose Manuel/0000-0002-8427-6199; Torcida, Fidel/0000-0003-4616-1777	Spanish Ministerio de Economia y Competitividad; European Regional Development Fund; Government of Aragon ("Grupos Consolidados"); Fundacao para a Ciencia e a Tecnologia [SFRH/BPD/113130/2015];  [CGL2013-46169-C2-1-P];  [CGL2014-53548-P]	Spanish Ministerio de Economia y Competitividad(Spanish Government); European Regional Development Fund(European Commission); Government of Aragon ("Grupos Consolidados")(Gobierno de Aragon); Fundacao para a Ciencia e a Tecnologia(Portuguese Foundation for Science and TechnologyEuropean Commission); ; 	This paper was partially funded by projects CGL2013-46169-C2-1-P and CGL2014-53548-P, subsidized by the Spanish Ministerio de Economia y Competitividad, the European Regional Development Fund, and the Government of Aragon ("Grupos Consolidados"). MMA is supported by the Fundacao para a Ciencia e a Tecnologia, grant number SFRH/BPD/113130/2015.	Alonso A., 1991, ACTA GEOL HISP, V26, P35; Barta DE, 2014, HIST BIOL, V26, P183, DOI 10.1080/08912963.2013.792811; Bauluz B, 2014, LETHAIA, V47, P556, DOI 10.1111/let.12081; Bravo A, 2006, NUEVO YACIMIENTO CAS, P223; Cojan I, 2003, PALAEOGEOGR PALAEOCL, V191, P111, DOI 10.1016/S0031-0182(02)00655-7; Cusack M, 2008, CORAL REEFS, V27, P905, DOI 10.1007/s00338-008-0414-3; Eagle RA, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9296; England J, 2006, J GEOPHYS RES-BIOGEO, V111, DOI 10.1029/2005JG000144; Floquet M., 1991, THESIS DIJON; Grellet-Tinner G, 2010, J IBER GEOL, V36, P181, DOI 10.5209/rev_JIGE.2010.v36.n2.6; Haq BU, 1988, MESOZOIC CENOZOIC CH, P7; Hirsch Karl F., 2001, P378; Izquierdo L, 2001, MACROESTRUCTURA HUEV, P389; Jackson FD, 2004, J VERTEBR PALEONTOL, V24, P913, DOI 10.1671/0272-4634(2004)024[0913:AMTDSE]2.0.CO;2; Jackson FD, 2008, CRETACEOUS RES, V29, P27, DOI 10.1016/j.cretres.2007.02.004; Jin XS, 2010, J VERTEBR PALEONTOL, V30, P188, DOI 10.1080/02724630903409279; Leduc T., 2012, BERNISSART DINOSAURS; Mas R., 1993, REV SOC GEOLOGICA ES, V6, P129; MIKHAILOV K E, 1991, Acta Palaeontologica Polonica, V36, P193; Mikhailov K.E., 1997, FOSSIL RECENT EGGSHE; Miller GH, 2000, PERSPECTIVES AMINO A, P161; Mohabey DM, CURR SCI, V53, P701; Moratalla JJ, 1993, RESTOS INDIRECTOS DI; Moreno-Azanza M, 2014, CRETACEOUS RES, V51, P75, DOI 10.1016/j.cretres.2014.05.017; Moreno-Azanza M, 2013, J VERTEBR PALEONTOL, V33, P121, DOI 10.1080/02724634.2012.710284; Nys Y, 2004, CR PALEVOL, V3, P549, DOI 10.1016/j.crpv.2004.08.002; Perez-Huerta A, 2009, MICROSC MICROANAL, V15, P197, DOI 10.1017/S1431927609090370; Prior D. J., 2009, ELECT BACKSCATTER DI, P345, DOI [10.1007/978-0-387-88136-2_26, DOI 10.1007/978-0-387-88136-2_26]; Quintero Amador I, SANTO DOMINGO SILOS; Riera Rubio VL, 2010, THESIS U AUTONOMA BA; Salas R, 2001, MEM MUS NAT HIST NAT, V186, P145; Selles AG, 2013, CRETACEOUS RES, V40, P10, DOI 10.1016/j.cretres.2012.05.004; Seward GGE, 2002, SCANNING, V24, P232, DOI 10.1002/sca.4950240503; Sochava A, 1971, PALEONTOLOGY J, V4, P517; Fernandez MS, 2011, AMEGHINIANA, V48, P43, DOI 10.5710/AMGH.v48i1(272); Tyler C, 1964, WILHELM NATHUSIUS 18; Vianey-Liaud Monique, 1994, P151; VianeyLiaud M, 1997, J PALEONTOL, V71, P1157, DOI 10.1017/S002233600003609X; Wang Qiang, 2011, Vertebrata Palasiatica, V49, P446; Zelenitsky DK, 1997, J VERTEBR PALEONTOL, V17, P167, DOI 10.1080/02724634.1997.10010960; Zhao ZK, 1979, MESOZOIC CENOZOIC RE, P330	41	16	16	2	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 4	2016	11	5							e0153026	10.1371/journal.pone.0153026	http://dx.doi.org/10.1371/journal.pone.0153026			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DL5KR	27144767	Green Submitted, Green Published, gold			2022-12-26	WOS:000375676400007
J	Ponce-Guevara, E; Davidson, A; Sierra-Corona, R; Ceballos, G				Ponce-Guevara, Eduardo; Davidson, Ana; Sierra-Corona, Rodrigo; Ceballos, Gerardo			Interactive Effects of Black-Tailed Prairie Dogs and Cattle on Shrub Encroachment in a Desert Grassland Ecosystem	PLOS ONE			English	Article							CONSEQUENCES; POPULATIONS; CHALLENGES; DYNAMICS; DENSITY; AFRICAN; RODENT; BISON; FIRE	The widespread encroachment of woody plants throughout the semi-arid grasslands in North America has largely resulted from overgrazing by domestic livestock, fire suppression, and loss of native large and small mammalian herbivores. Burrowing-herbivorous mammals, such as prairie dogs (Cynomys spp.), help control shrub encroachment through clipping of shrubs and consumption of their seedlings, but little is known about how this important ecological role interacts with and may be influenced by co-existing large herbivores, especially domestic livestock. Here, we established a long-term manipulative experiment using a 2 x 2 factorial design to assess the independent and interactive effects of black-tailed prairie dogs (Cynomys ludovicianus) and cattle (Bos taurus) on honey mesquite (Prosopis glandulosa) abundance and structure. We found that, after five years, mesquite abundance was three to five times greater in plots where prairie dogs were removed compared to plots where they occurred together or alone, respectively. While both prairie dogs and cattle reduced mesquite cover, the effect of prairie dogs on reducing mesquite abundance, cover, and height was significantly greater than that by cattle. Surprisingly, cattle grazing enhanced prairie dog abundance, which, in turn, magnified the effects of prairie dogs on mesquite shrubs. Mesquite canopy cover per hectare was three to five times greater where prairie dogs and cattle were absent compared to where they occurred together or by themselves; whereas, cumulative mesquite height was two times lower on sites where prairie dog and cattle occurred together compared to where they occurred alone or where neither occurred. Data from our experimental study demonstrate that prairie dogs and moderate grazing by cattle can suppress mesquite growth, and, when their populations are properly managed, they may interact synergistically to significantly limit mesquite encroachment in desert grasslands.	[Ponce-Guevara, Eduardo; Sierra-Corona, Rodrigo; Ceballos, Gerardo] Univ Nacl Autonoma Mexico, Inst Ecol, Mexico City 04510, DF, Mexico; [Davidson, Ana] SUNY Stony Brook, Dept Ecol & Evolut, Stony Brook, NY 11794 USA; [Davidson, Ana] Univ New Mexico, Dept Biol, Albuquerque, NM 87131 USA	Universidad Nacional Autonoma de Mexico; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; University of New Mexico	Ponce-Guevara, E (corresponding author), Univ Nacl Autonoma Mexico, Inst Ecol, Mexico City 04510, DF, Mexico.	eponce@ecologia.unam.mx	Ponce, Eduardo/L-2649-2013	Ponce, Eduardo/0000-0002-9590-2132	NSF [OISE-0653296]; Consejo Nacional de Ciencia y Tecnologia (CONACyT); National University of Mexico (UNAM); J. M. Kaplan Fund; Whitley Fund for Nature; World Wildlife Fund; Carlos Slim Fund Alliance	NSF(National Science Foundation (NSF)); Consejo Nacional de Ciencia y Tecnologia (CONACyT)(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); National University of Mexico (UNAM)(Universidad Nacional Autonoma de Mexico); J. M. Kaplan Fund; Whitley Fund for Nature; World Wildlife Fund; Carlos Slim Fund Alliance	This research was partially funded by NSF (Grant OISE-0653296), Consejo Nacional de Ciencia y Tecnologia (CONACyT), National University of Mexico (UNAM), the J. M. Kaplan Fund, the Whitley Fund for Nature and the World Wildlife Fund and Carlos Slim Fund Alliance. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allred BW, 2011, ECOSPHERE, V2, DOI 10.1890/ES10-00152.1; Anderson RC, 2006, J TORREY BOT SOC, V133, P626, DOI 10.3159/1095-5674(2006)133[626:EAOOTC]2.0.CO;2; Archer S, 2012, AUTOGENIC SUCCESSION, V58, P111; Augustine DJ, 2013, ECOL APPL, V23, P850, DOI 10.1890/12-0890.1; Branch LC, 1999, PATTERNS PLANT SPECI, P173; Briggs JM, 2005, BIOSCIENCE, V55, P243, DOI 10.1641/0006-3568(2005)055[0243:AEITCA]2.0.CO;2; Brown JH, 2002, BIOSCIENCE, V52, P979, DOI 10.1641/0006-3568(2002)052[0979:RARCDO]2.0.CO;2; Burns CE, 2009, BIODIVERS CONSERV, V18, P2327, DOI 10.1007/s10531-009-9590-x; Ceballos G, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008562; COPPOCK DL, 1983, OECOLOGIA, V56, P10, DOI 10.1007/BF00378211; Davidson AD, 2012, FRONT ECOL ENVIRON, V10, P477, DOI 10.1890/110054; Davidson AD, 2010, ECOLOGY, V91, P3189, DOI 10.1890/09-1277.1; Delibes-Mateos M, 2011, BIOL CONSERV, V144, P1335, DOI 10.1016/j.biocon.2011.02.012; Derner JD, 2006, FRONT ECOL ENVIRON, V4, P459, DOI 10.1890/1540-9295(2006)4[459:ALWGAB]2.0.CO;2; Facka AN, 2010, J WILDLIFE MANAGE, V74, P1752, DOI 10.2193/2009-208; Freilich JE, 2003, BIOSCIENCE, V53, P759, DOI 10.1641/0006-3568(2003)053[0759:EEORAS]2.0.CO;2; Fuhlendorf SD, 2001, BIOSCIENCE, V51, P625, DOI 10.1641/0006-3568(2001)051[0625:RHOREM]2.0.CO;2; Geist HJ, 2004, BIOSCIENCE, V54, P817, DOI 10.1641/0006-3568(2004)054[0817:DCPOD]2.0.CO;2; Guenther DA, 2003, J RANGE MANAGE, V56, P410, DOI 10.2307/4003830; Holechek JL, 2006, RANGELANDS, V28, P7, DOI [10.2111/1551-501X(2006)28.1[7:GIORVW]2.0.CO;2, DOI 10.2111/1551-501X(2006)28.1[7:GIORVW]2.0.CO;2]; Knapp A.K., 1998, GRASSLAND DYNAMICS L; Knapp AK, 2008, GLOBAL CHANGE BIOL, V14, P615, DOI 10.1111/j.1365-2486.2007.01512.x; KRUEGER K, 1986, ECOLOGY, V67, P760, DOI 10.2307/1937699; Lightfoot DC, 2012, J MAMMAL, V93, P1017, DOI 10.1644/11-MAMM-A-391.1; List R, 2010, INT J WILDERNESS, V16, P35; List R, 2007, CONSERV BIOL, V21, P1487, DOI 10.1111/j.1523-1739.2007.00810.x; Lloyd N, 2013, BIOL CONSERV, V161, P110, DOI 10.1016/j.biocon.2013.03.008; MILLER B, 1994, CONSERV BIOL, V8, P677, DOI 10.1046/j.1523-1739.1994.08030677.x; Miller BJ, 2007, J WILDLIFE MANAGE, V71, P2801, DOI 10.2193/2007-041; Pringle RM, 2008, ECOLOGY, V89, P26, DOI 10.1890/07-0776.1; Reviews A, 2011, SHRUB INVASIONS N A, V31, P197; Roques KG, 2001, J APPL ECOL, V38, P268, DOI 10.1046/j.1365-2664.2001.00567.x; SCHLESINGER WH, 1990, SCIENCE, V247, P1043, DOI 10.1126/science.247.4946.1043; Sierra-Corona R, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118602; Smith AT, 1999, PLATEAU PIKA OCHOTON, P235; Suttie J. M., 2006, P1; Van Auken OW, 2009, J ENVIRON MANAGE, V90, P2931, DOI 10.1016/j.jenvman.2009.04.023; Weltzin JF, 1997, ECOLOGY, V78, P751, DOI 10.1890/0012-9658(1997)078[0751:SMROVS]2.0.CO;2	38	13	13	2	55	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 4	2016	11	5							e0154748	10.1371/journal.pone.0154748	http://dx.doi.org/10.1371/journal.pone.0154748			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DL5KR	27144274	Green Submitted, gold, Green Published			2022-12-26	WOS:000375676400067
J	de Rooij, BH; van der Berg, JD; van der Kallen, CJH; Schram, MT; Savelberg, HHCM; Schaper, NC; Dagnelie, PC; Henry, RMA; Kroon, AA; Stehouwer, CDA; Koster, A				de Rooij, Belle H.; van der Berg, Julianne D.; van der Kallen, Carla J. H.; Schram, Miranda T.; Savelberg, Hans H. C. M.; Schaper, Nicolaas C.; Dagnelie, Pieter C.; Henry, Ronald M. A.; Kroon, Abraham A.; Stehouwer, Coen D. A.; Koster, Annemarie			Physical Activity and Sedentary Behavior in Metabolically Healthy versus Unhealthy Obese and Non-Obese Individuals - The Maastricht Study	PLOS ONE			English	Article							NORMAL-WEIGHT; LIFE-STYLE; PHENOTYPES; RISK; ASSOCIATION; TIME; DETERMINANTS; ADULTS; TOO; FAT	Background Both obesity and the metabolic syndrome are associated with increased risk of cardiovascular diseases and type 2 diabetes. Although both frequently occur together in the same individual, obesity and the metabolic syndrome can also develop independently from each other. The (patho) physiology of "metabolically healthy obese" (i.e. obese without metabolic syndrome) and "metabolically unhealthy non-obese" phenotypes (i.e. non-obese with metabolic syndrome) is not fully understood, but physical activity and sedentary behavior may play a role. Objective To examine objectively measured physical activity and sedentary behavior across four groups: I) "metabolically healthy obese" (MHO); II) "metabolically unhealthy obese" (MUO); III) "metabolically healthy non-obese" (MHNO); and IV) "metabolically unhealthy non-obese" (MUNO). Methods Data were available from 2,449 men and women aged 40-75 years who participated in The Maastricht Study from 2010 to 2013. Participants were classified into the four groups according to obesity (BMI >= 30 kg/m(2)) and metabolic syndrome (ATPIII definition). Daily activity was measured for 7 days with the activPAL physical activity monitor and classified as time spent sitting, standing, and stepping. Results In our study population, 562 individuals were obese. 19.4% of the obese individuals and 72.7% of the non-obese individuals was metabolically healthy. After adjustments for age, sex, educational level, smoking, alcohol use, waking time, T2DM, history of CVD and mobility limitation, MHO (n = 107) spent, per day, more time stepping (118.2 versus 105.2 min; p < 0.01) and less time sedentary (563.5 versus 593.0 min., p = 0.02) than MUO (n = 440). In parallel, MHNO (n = 1384) spent more time stepping (125.0 versus 115.4 min; p < 0.01) and less time sedentary (553.3 versus 576.6 min., p < 0.01) than MUNO (n = 518). Conclusion Overall, the metabolically healthy groups were less sedentary and more physically active than the metabolically unhealthy groups. Therefore, physical activity and sedentary time may partly explain the presence of the metabolic syndrome in obese as well as non-obese individuals.	[de Rooij, Belle H.; van der Berg, Julianne D.; Koster, Annemarie] Maastricht Univ, Dept Social Med, NL-6200 MD Maastricht, Netherlands; [de Rooij, Belle H.; van der Berg, Julianne D.; Schaper, Nicolaas C.; Dagnelie, Pieter C.; Koster, Annemarie] Maastricht Univ, CAPHRI Sch Publ Hlth & Primary Care, NL-6200 MD Maastricht, Netherlands; [van der Kallen, Carla J. H.; Schram, Miranda T.; Schaper, Nicolaas C.; Henry, Ronald M. A.; Kroon, Abraham A.; Stehouwer, Coen D. A.] Maastricht Univ Med Ctr, Dept Internal Med, Maastricht, Netherlands; [van der Kallen, Carla J. H.; Schram, Miranda T.; Schaper, Nicolaas C.; Dagnelie, Pieter C.; Henry, Ronald M. A.; Kroon, Abraham A.; Stehouwer, Coen D. A.] Maastricht Univ, Cardiovasc Res Inst Maastricht CARIM, Med Ctr, NL-6200 MD Maastricht, Netherlands; [Savelberg, Hans H. C. M.] Maastricht Univ, Dept Human Movement Sci, NL-6200 MD Maastricht, Netherlands; [Savelberg, Hans H. C. M.] Maastricht Univ, Sch Nutr & Translat Res Metab NUTRIM, NL-6200 MD Maastricht, Netherlands; [Dagnelie, Pieter C.] Maastricht Univ, Dept Epidemiol, NL-6200 MD Maastricht, Netherlands	Maastricht University; Maastricht University; Maastricht University; Maastricht University Medical Centre (MUMC); Maastricht University; Maastricht University; Maastricht University; Maastricht University	Koster, A (corresponding author), Maastricht Univ, Dept Social Med, NL-6200 MD Maastricht, Netherlands.; Koster, A (corresponding author), Maastricht Univ, CAPHRI Sch Publ Hlth & Primary Care, NL-6200 MD Maastricht, Netherlands.	a.koster@maastrichtuniversity.nl	Schaper, Nicolaas C/E-7112-2014; Savelberg, Hans/ABC-8946-2020; Stehouwer, Coen/AAB-3435-2021; Koster, Annemarie/E-7438-2010; van der Berg, Julianne/M-7172-2016	Savelberg, Hans/0000-0002-8864-2109; Koster, Annemarie/0000-0003-1583-7391; van der Berg, Julianne/0000-0001-9513-683X; Stehouwer, Coen/0000-0001-8752-3223; Schram, Miranda/0000-0001-8113-7604; de Rooij, Belle/0000-0002-0172-0857; schaper, nicolaas/0000-0002-2128-8029; van der Kallen, Carla/0000-0003-1468-8793; Kroon, Abraham/0000-0001-7750-8249	European Regional Development Fund via OP-Zuid; Province of Limburg; Dutch Ministry of Economic Affairs [31O.041]; Stichting De Weijerhorst (Maastricht, the Netherlands); Pearl String Initiative Diabetes (Amsterdam, the Netherlands); Cardiovascular Center (CVC, Maastricht, the Netherlands); Cardiovascular Research Institute Maastricht (CARIM, Maastricht, the Netherlands); School for Public Health and Primary Care (CAPHRI, Maastricht, the Netherlands); School for Nutrition, Toxicology and Metabolism (NUTRIM, Maastricht, the Netherlands); Stichting Annadal (Maastricht, the Netherlands); Health Foundation Limburg (Maastricht, the Netherlands); Janssen-Cilag B.V. (Tilburg, the Netherlands); Novo Nordisk Farma B.V. (Alphen aan den Rijn, the Netherlands); Sanofi-Aventis Netherlands B.V. (Gouda, the Netherlands); European Union [PCIG09-GA-2011-293621]	European Regional Development Fund via OP-Zuid; Province of Limburg; Dutch Ministry of Economic Affairs(Ministry of Economic Affairs, Netherlands); Stichting De Weijerhorst (Maastricht, the Netherlands)(Netherlands Government); Pearl String Initiative Diabetes (Amsterdam, the Netherlands)(Netherlands Government); Cardiovascular Center (CVC, Maastricht, the Netherlands); Cardiovascular Research Institute Maastricht (CARIM, Maastricht, the Netherlands); School for Public Health and Primary Care (CAPHRI, Maastricht, the Netherlands)(Netherlands Government); School for Nutrition, Toxicology and Metabolism (NUTRIM, Maastricht, the Netherlands); Stichting Annadal (Maastricht, the Netherlands); Health Foundation Limburg (Maastricht, the Netherlands); Janssen-Cilag B.V. (Tilburg, the Netherlands); Novo Nordisk Farma B.V. (Alphen aan den Rijn, the Netherlands); Sanofi-Aventis Netherlands B.V. (Gouda, the Netherlands)(Netherlands Government); European Union(European Commission)	This study was supported by the European Regional Development Fund via OP-Zuid, the Province of Limburg, the Dutch Ministry of Economic Affairs (grant 31O.041), Stichting De Weijerhorst (Maastricht, the Netherlands), the Pearl String Initiative Diabetes (Amsterdam, the Netherlands), the Cardiovascular Center (CVC, Maastricht, the Netherlands), Cardiovascular Research Institute Maastricht (CARIM, Maastricht, the Netherlands), School for Public Health and Primary Care (CAPHRI, Maastricht, the Netherlands), School for Nutrition, Toxicology and Metabolism (NUTRIM, Maastricht, the Netherlands), Stichting Annadal (Maastricht, the Netherlands), Health Foundation Limburg (Maastricht, the Netherlands) and by unrestricted grants from Janssen-Cilag B.V. (Tilburg, the Netherlands), Novo Nordisk Farma B.V. (Alphen aan den Rijn, the Netherlands) and Sanofi-Aventis Netherlands B.V. (Gouda, the Netherlands). A Koster has received funding from the European Union Seventh Framework Programme (FP7-PEOPLE-2011-CIG) under grant agreement PCIG09-GA-2011-293621. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bankoski A, 2011, DIABETES CARE, V34, P497, DOI 10.2337/dc10-0987; Bell JA, 2015, AM J CLIN NUTR, V102, P268, DOI 10.3945/ajcn.115.110924; Bell JA, 2014, PREV MED, V62, P35, DOI 10.1016/j.ypmed.2014.01.028; Bouchard DR, 2011, METAB SYNDR RELAT D, V9, P225, DOI 10.1089/met.2010.0101; Brown RE, 2015, OBES REV, V16, P77, DOI 10.1111/obr.12232; Camhi SM, 2013, J OBES, V2013, DOI 10.1155/2013/984613; Conus F, 2004, J CLIN ENDOCR METAB, V89, P5013, DOI 10.1210/jc.2004-0265; Dunstan DW, 2012, DIABETES CARE, V35, P976, DOI 10.2337/dc11-1931; Ford ES, 2005, OBES RES, V13, P608, DOI 10.1038/oby.2005.65; Grundy SM, 2004, ARTERIOSCL THROM VAS, V24, pE13, DOI 10.1161/01.ATV.0000111245.75752.C6; Gutierrez-Repiso C, 2014, SLEEP MED, V15, P1398, DOI 10.1016/j.sleep.2014.06.014; Gutierrez-Repiso C, 2014, NUTR METAB CARDIOVAS, V24, P947, DOI 10.1016/j.numecd.2014.04.019; Hamilton MT, 2007, DIABETES, V56, P2655, DOI 10.2337/db07-0882; Hankinson AL, 2013, OBESITY, V21, P637, DOI 10.1002/oby.20257; Hayes L, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-723; Healy GN, 2008, DIABETES CARE, V31, P369, DOI 10.2337/dc07-1795; Healy GN, 2008, DIABETES CARE, V31, P661, DOI 10.2337/dc07-2046; Hoffstedt J, 1997, J LIPID RES, V38, P795; Kim LJ, 2011, OBESITY, V19, P1265, DOI 10.1038/oby.2010.291; Kopelman PG, 2000, NATURE, V404, P635, DOI 10.1038/35007508; Koster A, 2010, OBESITY, V18, P2354, DOI 10.1038/oby.2010.86; Lee K, 2009, ASIA PAC J CLIN NUTR, V18, P280; Maury E, 2010, MOL CELL ENDOCRINOL, V314, P1, DOI 10.1016/j.mce.2009.07.031; Owen N, 2009, BRIT J SPORT MED, V43, P81, DOI 10.1136/bjsm.2008.055269; Owen N, 2010, EXERC SPORT SCI REV, V38, P105, DOI 10.1097/JES.0b013e3181e373a2; Park S, 2008, J GERONTOL A-BIOL, V63, P1119, DOI 10.1093/gerona/63.10.1119; Phillips CM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076188; Phillips CM, 2013, REV ENDOCR METAB DIS, V14, P219, DOI 10.1007/s11154-013-9252-x; Poelkens F, 2014, EXP CLIN ENDOCR DIAB, V122, P87, DOI 10.1055/s-0033-1363686; Schram MT, 2014, EUR J EPIDEMIOL, V29, P439, DOI 10.1007/s10654-014-9889-0; Stenholm S, 2010, CLIN ENDOCRINOL, V73, P55, DOI 10.1111/j.1365-2265.2009.03742.x; Van der Berg JD, 2016, J SPORTS SC IN PRESS; van der Berg JD, 2016, DIABETOLOGIA, V59, P709, DOI 10.1007/s00125-015-3861-8; Velho S, 2010, EUR J CLIN NUTR, V64, P1043, DOI 10.1038/ejcn.2010.114; Wajchenberg BL, 2000, ENDOCR REV, V21, P697, DOI 10.1210/er.21.6.697; Warren JM, 2010, EUR J CARDIOV PREV R, V17, P127, DOI 10.1097/HJR.0b013e32832ed875; WHO, 2014, OB OV; Wijndaele K, 2009, EUR J CLIN NUTR, V63, P421, DOI 10.1038/sj.ejcn.1602944; Wildman RP, 2008, ARCH INTERN MED, V168, P1617, DOI 10.1001/archinte.168.15.1617; Wildman RP, 2009, CURR OPIN CLIN NUTR, V12, P438, DOI 10.1097/MCO.0b013e32832c6db7	40	40	40	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 3	2016	11	5							e0154358	10.1371/journal.pone.0154358	http://dx.doi.org/10.1371/journal.pone.0154358			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DL5KK	27138596	Green Published, gold			2022-12-26	WOS:000375675700029
J	Li, ZJ; Zhang, PP; Lv, JY; Cheng, YF; Cui, JM; Zhao, HX; Hu, SW				Li, Zhanjie; Zhang, Peipei; Lv, Jinyang; Cheng, Yufeng; Cui, Jianmin; Zhao, Huixian; Hu, Shengwu			Global Dynamic Transcriptome Programming of Rapeseed (Brassica napus L.) Anther at Different Development Stages	PLOS ONE			English	Article							MALE REPRODUCTIVE DEVELOPMENT; LATHYRUS-ODORATUS L; GENE-EXPRESSION; MALE GAMETOPHYTE; MALE-STERILITY; ARABIDOPSIS POLLEN; NEUTRAL LIPIDS; TAPETAL CELLS; MADS-BOX; PROFILES	Rapeseed (Brassica napus L.) is an important oil crop worldwide and exhibits significant heterosis. Effective pollination control systems, which are closely linked to anther development, are a prerequisite for utilizing heterosis. The anther, which is the male organ in flowering plants, undergoes many metabolic processes during development. Although the gene expression patterns underlying pollen development are well studied in model plant Arabidopsis, the regulatory networks of genome-wide gene expression during rapeseed anther development is poorly understood, especially regarding metabolic regulations. In this study, we systematically analyzed metabolic processes occurring during anther development in rapeseed using ultrastructural observation and global transcriptome analysis. Anther ultrastructure exhibited that numerous cellular organelles abundant with metabolic materials, such as elaioplast, tapetosomes, plastids (containing starch deposits) etc. appeared, accompanied with anther structural alterations during anther development, suggesting many metabolic processes occurring. Global transcriptome analysis revealed dynamic changes in gene expression during anther development that corresponded to dynamic functional alterations between early and late anther developmental stages. The early stage anthers preferentially expressed genes involved in lipid metabolism that are related to pollen extine formation as well as elaioplast and tapetosome biosynthesis, whereas the late stage anthers expressed genes associated with carbohydrate metabolism to form pollen intine and to accumulate starch in mature pollen grains. Finally, a predictive gene regulatory module responsible for early pollen extine formation was generated. Taken together, this analysis provides a comprehensive understanding of dynamic gene expression programming of metabolic processes in the rapeseed anther, especially with respect to lipid and carbohydrate metabolism during pollen development.	[Li, Zhanjie; Zhang, Peipei; Lv, Jinyang; Cheng, Yufeng; Cui, Jianmin; Zhao, Huixian; Hu, Shengwu] Northwest A&F Univ, State Key Lab Crop Stress Biol Arid Areas, Yangling 712100, Shaanxi, Peoples R China; [Li, Zhanjie; Zhang, Peipei; Lv, Jinyang; Cheng, Yufeng; Zhao, Huixian] Northwest A&F Univ, Coll Life Sci, Yangling 712100, Shaanxi, Peoples R China; [Cui, Jianmin; Hu, Shengwu] Northwest A&F Univ, Coll Agron, Yangling 712100, Shaanxi, Peoples R China	Northwest A&F University - China; Northwest A&F University - China; Northwest A&F University - China	Zhao, HX; Hu, SW (corresponding author), Northwest A&F Univ, State Key Lab Crop Stress Biol Arid Areas, Yangling 712100, Shaanxi, Peoples R China.; Zhao, HX (corresponding author), Northwest A&F Univ, Coll Life Sci, Yangling 712100, Shaanxi, Peoples R China.; Hu, SW (corresponding author), Northwest A&F Univ, Coll Agron, Yangling 712100, Shaanxi, Peoples R China.	hxzhao212@nwsuaf.edu.cn; swhu83251@nwsuaf.edu.cn	Hu, Shengwu/ABD-5969-2021; Hu, shengwu/A-1053-2010	Hu, shengwu/0000-0001-6859-6873	earmarked fund for China Agriculture Research System [CARS-13]; National Key Technology RD Program [2010BAD01B02]; Northwest AF University	earmarked fund for China Agriculture Research System; National Key Technology RD Program(National Key Technology R&D Program); Northwest AF University	This work was supported by the earmarked fund for China Agriculture Research System [CARS-13], the National Key Technology R&D Program [2010BAD01B02] and a grant of Northwest A&F University to SH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baud S, 2009, PLANT PHYSIOL BIOCH, V47, P448, DOI 10.1016/j.plaphy.2008.12.006; Becker JD, 2003, PLANT PHYSIOL, V133, P713, DOI 10.1104/pp.103.028241; Belmonte MF, 2013, P NATL ACAD SCI USA, V110, pE435, DOI 10.1073/pnas.1222061110; Bolstad BM, 2003, BIOINFORMATICS, V19, P185, DOI 10.1093/bioinformatics/19.2.185; Cavell AC, 1998, GENOME, V41, P62, DOI 10.1139/gen-41-1-62; Datta R, 2002, PLANT PHYSIOL, V130, P1645, DOI 10.1104/pp.006908; Focks N, 1998, PLANT PHYSIOL, V118, P91, DOI 10.1104/pp.118.1.91; Fu TD, 1995, BREEDING UTILIZATION; Gibalova A, 2009, PLANT MOL BIOL, V70, P581, DOI 10.1007/s11103-009-9493-y; GOLDBERG RB, 1993, PLANT CELL, V5, P1217, DOI 10.1105/tpc.5.10.1217; Gonzalez-Melendi P, 2008, J EXP BOT, V59, P827, DOI 10.1093/jxb/erm365; Hernandez-Pinzon I, 1999, PLANTA, V208, P588, DOI 10.1007/s004250050597; HIRD DL, 1993, PLANT J, V4, P1023, DOI 10.1046/j.1365-313X.1993.04061023.x; Hobo T, 2008, PLANT CELL PHYSIOL, V49, P1417, DOI 10.1093/pcp/pcn128; Honys D, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-11-r85; Honys D, 2003, PLANT PHYSIOL, V132, P640, DOI 10.1104/pp.103.020925; Hsieh K, 2005, PLANT J, V43, P889, DOI 10.1111/j.1365-313X.2005.02502.x; Hsieh K, 2007, PLANT CELL, V19, P582, DOI 10.1105/tpc.106.049049; Ito T, 2002, PLANT CELL PHYSIOL, V43, P1285, DOI 10.1093/pcp/pcf154; Ito T, 2007, PLANT CELL, V19, P3549, DOI 10.1105/tpc.107.054536; JACK T, 1992, CELL, V68, P683, DOI 10.1016/0092-8674(92)90144-2; Kang JG, 2008, PLANT MOL BIOL, V66, P177, DOI 10.1007/s11103-007-9261-9; Kim HU, 2001, PLANT PHYSIOL, V126, P330, DOI 10.1104/pp.126.1.330; Konyar ST, 2013, PLANT SYST EVOL, V299, P743, DOI 10.1007/s00606-013-0758-1; Li H, 2010, PLANT SIGNAL BEHAV, V5, P1121, DOI 10.4161/psb.5.9.12562; Li ZJ, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-1388-5; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Ma Hong, 2005, Annu Rev Plant Biol, V56, P393, DOI 10.1146/annurev.arplant.55.031903.141717; Ma J, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-12-r181; McCormick S, 2004, PLANT CELL, V16, pS142, DOI 10.1105/tpc.016659; Nakamura Y, 2014, BIOCHEM BIOPH RES CO, V450, P1272, DOI 10.1016/j.bbrc.2014.06.115; NEELAM A, 1995, J PLANT PHYSIOL, V146, P622, DOI 10.1016/S0176-1617(11)81924-3; Pacini E, 2006, PROTOPLASMA, V228, P73, DOI 10.1007/s00709-006-0169-z; Pelaz S, 2000, NATURE, V405, P200, DOI 10.1038/35012103; Piffanelli P, 1998, SEX PLANT REPROD, V11, P65, DOI 10.1007/s004970050122; Platt KA, 1998, INT J PLANT SCI, V159, P724, DOI 10.1086/297590; Rhee SY, 2003, PLANT PHYSIOL, V133, P1170, DOI 10.1104/pp.103.028266; Rondanini DP, 2012, EUR J AGRON, V37, P56, DOI 10.1016/j.eja.2011.10.005; Saeed AI, 2006, METHOD ENZYMOL, V411, P134, DOI 10.1016/S0076-6879(06)11009-5; Sanders PM, 1999, SEX PLANT REPROD, V11, P297, DOI 10.1007/s004970050158; Scott RJ, 2004, PLANT CELL, V16, pS46, DOI 10.1105/tpc.017012; SEXTON R, 1990, PLANT SCI, V67, P169, DOI 10.1016/0168-9452(90)90240-O; SHULL GH, 1948, GENETICS, V33, P439; Sorensen AM, 2003, PLANT J, V33, P413, DOI 10.1046/j.1365-313X.2003.01644.x; Sturn A, 2002, BIOINFORMATICS, V18, P207, DOI 10.1093/bioinformatics/18.1.207; Suwabe K, 2008, PLANT CELL PHYSIOL, V49, P1407, DOI 10.1093/pcp/pcn124; Ting JTL, 1998, PLANT J, V16, P541, DOI 10.1046/j.1365-313x.1998.00325.x; Wei LQ, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-338; Wilson ZA, 2001, PLANT J, V28, P27, DOI 10.1046/j.1365-313X.2001.01125.x; Wilson ZA, 2009, J EXP BOT, V60, P1479, DOI 10.1093/jxb/erp095; WORRALL D, 1992, PLANT CELL, V4, P759, DOI 10.1105/tpc.4.7.759; Wu SSH, 1999, LIPIDS, V34, P517, DOI 10.1007/s11745-999-0393-5; Xu J, 2010, PLANT CELL, V22, P91, DOI 10.1105/tpc.109.071803; Yang SL, 2005, PLANT PHYSIOL, V139, P186, DOI 10.1104/pp.105.063529; Zhang DB, 2011, J GENET GENOMICS, V38, P379, DOI 10.1016/j.jgg.2011.08.001	55	12	13	1	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 3	2016	11	5							e0154039	10.1371/journal.pone.0154039	http://dx.doi.org/10.1371/journal.pone.0154039			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DL5KK	27139433	Green Published, gold, Green Submitted			2022-12-26	WOS:000375675700016
J	Ibrahim, MK; Salum, GM; El Din, NGB; Dawood, RM; Barakat, A; Khairy, A; El Awady, MK				Ibrahim, Marwa K.; Salum, Ghada Maher; El Din, Noha G. Bader; Dawood, Reham M.; Barakat, Ahmed; Khairy, Ahmed; El Awady, Mostafa K.			Transcriptional Dysregulation of Upstream Signaling of IFN Pathway in Chronic HCV Type 4 Induced Liver Fibrosis	PLOS ONE			English	Article							HEPATITIS-C-VIRUS; GENE-EXPRESSION; ANTIVIRAL RESPONSES; INTERFERON; PROGRESSION; GENOTYPE; CELLS; IL28B; POLYMORPHISM; ALPHA	IFN orchestrates the expression of various genes to halt hepatitis C virus (HCV) replication with the possibility of either reduced or increased liver fibrosis; due to controlled viral replication or overproduction of inflammatory mediators, repectively. In this study, we examined the transcriptional profiling of type I IFN related genes in HCV-chronically infected patients with varying degrees of liver fibrosis. PCR array was used to examine the expression of 84 type I IFN related genes in peripheral blood mononuclear cells (PBMCs) RNA from 12 treatment-naive chronic HCV patients (5 F0-F1 and 7 F2-F4) and 5 healthy subjects. We further validated our results by quantitative real time PCR (qRT-PCR) in 103 treatment-naive chronic HCV patients (43 F0-F1 and 60 F2-F4) and 15 controls. PCR array data revealed dysregulation in TLR7 pathway. The expression of TLR7 was decreased by 4 folds and MyD88 was increased by 3 folds in PBMCs of F2-F4 patients when compared to the healthy volunteers (p = 0.03 and 0.002, respectively). In addition, IRF7 and TLR7 showed dramatic downregulation (6 and 8 folds, respectively) in F2-F4 patients when compared to F0-F1 ones. qRT-PCR confirmed the altered expression patterns of TLR7 and MyD88 in F2-F4 patients when compared to either controls or F0-F1 patients. However, by qRT-PCR, IRF7 and NF-.B1 (TLR7 pathway transcription factors) exhibited similar mRNA abundance among F2-F4 and F0-F1 patients. These results suggest that TLR7 and MyD88 are possible candidates as biomarkers for the progression of HCV-induced liver fibrosis and/or targets for therapeutic intervention.	[Ibrahim, Marwa K.; Salum, Ghada Maher; El Din, Noha G. Bader; Dawood, Reham M.; El Awady, Mostafa K.] Natl Res Ctr, Dept Microbial Biotechnol, Genet Engn Div, Giza, Egypt; [Barakat, Ahmed] Ain Shams Univ, Fac Sci, Dept Microbiol, Cairo, Egypt; [Khairy, Ahmed] Cairo Univ, Fac Med, Endem Med Dept, Giza, Egypt	Egyptian Knowledge Bank (EKB); National Research Centre (NRC); Egyptian Knowledge Bank (EKB); Ain Shams University; Egyptian Knowledge Bank (EKB); Cairo University	Ibrahim, MK (corresponding author), Natl Res Ctr, Dept Microbial Biotechnol, Genet Engn Div, Giza, Egypt.	khalilm@livemail.uthscsa.edu	Issa, Randa @M.T/E-7144-2019; salum, Ghada/AAW-1428-2020	Issa, Randa @M.T/0000-0003-0619-1234; salum, Ghada/0000-0002-8837-2065; Bader El Din, Noha/0000-0001-8524-1046; Khairy, Ahmed/0000-0003-2848-6885; El Awady, Mostafa/0000-0002-1453-763X; Dawood, Reham/0000-0003-3255-6129; Ibrahim, Marwa/0000-0002-2603-8280	Science and Technology Development Fund in Egypt (STDF) [3365]	Science and Technology Development Fund in Egypt (STDF)(Science and Technology Development Fund (STDF))	Support was provided by Science and Technology Development Fund in Egypt (STDF) project number 3365. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Boghdadi Ghada, 2014, Egypt J Immunol, V21, P67; Bolen CR, 2013, J INTERF CYTOK RES, V33, P15, DOI 10.1089/jir.2012.0037; Boone DR, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0127287; Bourke NM, 2014, J TRANSL MED, V12, DOI 10.1186/1479-5876-12-206; Chang S, 2010, HEPATOLOGY, V51, P35, DOI 10.1002/hep.23256; Chen LM, 2005, GASTROENTEROLOGY, V128, P1437, DOI 10.1053/j.gastro.2005.01.059; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1016/0003-2697(87)90021-2; Dolganiuc A, 2006, WORLD J GASTROENTERO, V12, P1198, DOI 10.3748/wjg.v12.i8.1198; Doyle SE, 2006, HEPATOLOGY, V44, P896, DOI 10.1002/hep.21312; Duong FHT, 2014, J EXP MED, V211, P857, DOI 10.1084/jem.20131557; El Awady MK, 2013, WORLD J GASTROENTERO, V19, P290, DOI 10.3748/wjg.v19.i2.290; El Din NGB, 2015, J INTERF CYTOK RES, V35, P641, DOI 10.1089/jir.2014.0137; El-Awady MK, 2012, HEPAT MON, V12, P271, DOI 10.5812/hepatmon.835; Firdaus R, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/491064; Fischer J, 2012, HEPATOLOGY, V55, P1700, DOI 10.1002/hep.25582; Friedman SL, 2008, GASTROENTEROLOGY, V134, P1655, DOI 10.1053/j.gastro.2008.03.003; Horsmans Y, 2005, HEPATOLOGY, V42, P724, DOI 10.1002/hep.20839; Jorgensen TN, 2002, SCAND J IMMUNOL, V56, P492, DOI 10.1046/j.1365-3083.2002.01166.x; Lee J, 2006, P NATL ACAD SCI USA, V103, P1828, DOI 10.1073/pnas.0510801103; Li K, 2013, SEMIN IMMUNOPATHOL, V35, P53, DOI 10.1007/s00281-012-0332-x; Lin CJ, 2015, J MED FOOD, V18, P1291, DOI 10.1089/jmf.2014.3408; Marcello T, 2006, GASTROENTEROLOGY, V131, P1887, DOI 10.1053/j.gastro.2006.09.052; Mohammed Kawthar I, 2013, Egypt J Immunol, V20, P13; Mostoller K, 2004, J NEUROVIROL, V10, P358, DOI 10.1080/13550280490521104; Motavaf M, 2014, HEPAT MON, V14, DOI 10.5812/hepatmon.16421; Mozer-Lisewska I, 2010, ARCH IMMUNOL THER EX, V58, P295, DOI 10.1007/s00005-010-0087-9; Noha G., 2016, J VIRAL IMM IN PRESS; Pham TNQ, 2009, J VIRAL HEPATITIS, V16, P547, DOI 10.1111/j.1365-2893.2009.01092.x; Prinz M, 2003, EMBO REP, V4, P195, DOI 10.1038/sj.embor.embor731; Randall RE, 2008, J GEN VIROL, V89, P1, DOI 10.1099/vir.0.83391-0; Rio A, 2008, EUR J CLIN INVEST, V38, P306, DOI 10.1111/j.1365-2362.2008.01939.x; Sadler AJ, 2008, NAT REV IMMUNOL, V8, P559, DOI 10.1038/nri2314; Schwabe RF, 2006, GASTROENTEROLOGY, V130, P1886, DOI 10.1053/j.gastro.2006.01.038; Shaker O, 2015, CELL BIOCHEM BIOPHYS, V71, P307, DOI 10.1007/s12013-014-0199-7; Shimozono R, 2015, J INTERF CYTOK RES, V35, P464, DOI 10.1089/jir.2014.0096; Smith MW, 2006, GASTROENTEROLOGY, V130, P179, DOI 10.1053/j.gastro.2005.08.015; Smith MW, 2003, HEPATOLOGY, V38, P1458, DOI [10.1016/jhep.2003.09.024, 10.1053/jhep.2003.09024]; Stetson DB, 2006, IMMUNITY, V25, P373, DOI 10.1016/j.immuni.2006.08.007; Sun R, 2004, J IMMUNOL, V172, P5648, DOI 10.4049/jimmunol.172.9.5648; Tache DE, 2014, ROM J MORPHOL EMBRYO, V55, P539; Takahara Y, 2008, WORLD J GASTROENTERO, V14, P2010, DOI 10.3748/wjg.14.2010; Takahashi K, 2010, P NATL ACAD SCI USA, V107, P7431, DOI 10.1073/pnas.1002301107; Taylor MW, 2007, J VIROL, V81, P3391, DOI 10.1128/JVI.02640-06; Thomas A, 2007, ANTIMICROB AGENTS CH, V51, P2969, DOI 10.1128/AAC.00268-07; Urban TJ, 2010, HEPATOLOGY, V52, P1888, DOI 10.1002/hep.23912; Yilmaz H, 2015, ANN CLIN LAB SCI, V45, P278; Zeuzem S, 2009, J VIRAL HEPATITIS, V16, P75, DOI 10.1111/j.1365-2893.2008.01012.x; Zhang B, 2005, NUCLEIC ACIDS RES, V33, pW741, DOI 10.1093/nar/gki475; Zhang RN, 2015, HEPAT MON, V15, DOI 10.5812/hepatmon.15(5)2015.27909	49	8	10	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 2	2016	11	5							e0154512	10.1371/journal.pone.0154512	http://dx.doi.org/10.1371/journal.pone.0154512			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DL5KB	27135246	Green Published, gold, Green Submitted			2022-12-26	WOS:000375674800024
J	Spadafora, D; Kozhukhar, N; Chouljenko, VN; Kousoulas, KG; Alexeyev, MF				Spadafora, Domenico; Kozhukhar, Nataliya; Chouljenko, Vladimir N.; Kousoulas, Konstantin G.; Alexeyev, Mikhail F.			Methods for Efficient Elimination of Mitochondrial DNA from Cultured Cells	PLOS ONE			English	Article							HEREDITARY OPTIC NEUROPATHY; XENOMITOCHONDRIAL CYBRIDS; GENE-EXPRESSION; SEQUENCE; MTDNA; ORGANIZATION; DEGRADATION; INHERITANCE; BIOGENESIS; TERMINUS	Here, we document that persistent mitochondria DNA (mtDNA) damage due to mitochondrial overexpression of the Y147A mutant uracil-N-glycosylase as well as mitochondrial overexpression of bacterial Exonuclease III or Herpes Simplex Virus protein UL12.5M185 can induce a complete loss of mtDNA (rho(0) phenotype) without compromising the viability of cells cultured in media supplemented with uridine and pyruvate. Furthermore, we use these observations to develop rapid, sequence-independent methods for the elimination of mtDNA, and demonstrate utility of these methods for generating rho(0) cells of human, mouse and rat origin. We also demonstrate that rho(0) cells generated by each of these three methods can serve as recipients of mtDNA in fusions with enucleated cells.	[Spadafora, Domenico] Univ S Alabama, Dept Pharmacol, Mobile, AL 36688 USA; [Kozhukhar, Nataliya; Alexeyev, Mikhail F.] Univ S Alabama, Dept Physiol & Cell Biol, Mobile, AL 36688 USA; [Chouljenko, Vladimir N.; Kousoulas, Konstantin G.] Louisiana State Univ, Sch Vet Med, Div Biotechnol & Mol Med, Baton Rouge, LA 70803 USA; [Chouljenko, Vladimir N.; Kousoulas, Konstantin G.] Louisiana State Univ, Sch Vet Med, Dept Pathobiol Sci, Baton Rouge, LA 70803 USA; [Alexeyev, Mikhail F.] Univ S Alabama, Ctr Lung Biol, Mobile, AL 36688 USA	University of South Alabama; University of South Alabama; Louisiana State University School of Veterinary Medicine; Louisiana State University System; Louisiana State University; Louisiana State University School of Veterinary Medicine; Louisiana State University System; Louisiana State University; University of South Alabama	Alexeyev, MF (corresponding author), Univ S Alabama, Dept Physiol & Cell Biol, Mobile, AL 36688 USA.; Alexeyev, MF (corresponding author), Univ S Alabama, Ctr Lung Biol, Mobile, AL 36688 USA.	malexeye@southalabama.edu		KOUSOULAS, KONSTANTIN/0000-0001-7077-9003	National Institutes of Health [HL66299, OD010944]; US Department of Defence [PR150220]; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [R01OD010944] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); US Department of Defence(United States Department of Defense); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This study was supported by the National Institutes of Health grants HL66299 and OD010944, and by US Department of Defence award PR150220. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexeyev MF, 2010, MOL BIOL REP, V37, P1987, DOI 10.1007/s11033-009-9647-7; ANDERSON S, 1981, NATURE, V290, P457, DOI 10.1038/290457a0; Barrientos A, 1998, J BIOL CHEM, V273, P14210, DOI 10.1074/jbc.273.23.14210; Bayona-Bafaluy MP, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng100; Bendich AJ, 2013, CHROMOSOME RES, V21, P287, DOI 10.1007/s10577-013-9349-9; BIBB MJ, 1981, CELL, V26, P167, DOI 10.1016/0092-8674(81)90300-7; Blackstone NW, 2015, CELL CALCIUM, V57, P133, DOI 10.1016/j.ceca.2014.11.006; Brand MD, 2010, EXP GERONTOL, V45, P466, DOI 10.1016/j.exger.2010.01.003; Bratic A, 2013, J CLIN INVEST, V123, P951, DOI 10.1172/JCI64125; Cha MY, 2015, EXP MOL MED, V47, DOI 10.1038/emm.2014.122; Chowdhury S, 2013, J VIROL, V87, P3305, DOI 10.1128/JVI.02982-12; Corcoran JA, 2009, J VIROL, V83, P2601, DOI 10.1128/JVI.02087-08; Crider DG, 2012, J CELL BIOL, V198, P793, DOI 10.1083/jcb.201205193; Duguay BA, 2013, J VIROL, V87, P11787, DOI 10.1128/JVI.02306-13; Elkholi R, 2014, CANCER METAB, V2, DOI 10.1186/2049-3002-2-16; Fayzulin RZ, 2015, NUCLEIC ACIDS RES, V43, DOI 10.1093/nar/gkv140; Furda AM, 2012, DNA REPAIR, V11, P684, DOI 10.1016/j.dnarep.2012.06.002; Giordano C, 2014, BRAIN, V137, P335, DOI 10.1093/brain/awt343; HOLT IJ, 1988, NATURE, V331, P717, DOI 10.1038/331717a0; Kenyon L, 1997, P NATL ACAD SCI USA, V94, P9131, DOI 10.1073/pnas.94.17.9131; King M P, 1996, Methods Enzymol, V264, P304, DOI 10.1016/S0076-6879(96)64029-4; KING MP, 1989, SCIENCE, V246, P500, DOI 10.1126/science.2814477; Kukat A, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkn124; Li HZ, 2014, FRONT BIOSCI-LANDMRK, V19, P777, DOI 10.2741/4244; Lill R, 2014, CURR OPIN MICROBIOL, V22, P111, DOI 10.1016/j.mib.2014.09.015; PASTUKH V, 2007, MOL BIOL REP; Pastukh V, 2008, MOL BIOL REP, V35, P215, DOI 10.1007/s11033-007-9073-7; Sambrook J., 2001, MOL CLONING LAB MANU; Shah DI, 2012, NATURE, V491, P608, DOI 10.1038/nature11536; Shokolenko I, 2009, NUCLEIC ACIDS RES, V37, P2539, DOI 10.1093/nar/gkp100; Shokolenko IN, 2016, MITOCHONDRIAL DNA A, V27, P490, DOI 10.3109/19401736.2014.905829; Shokolenko IN, 2015, BBA-MOL BASIS DIS, V1852, P1805, DOI 10.1016/j.bbadis.2015.05.016; Shokolenko IN, 2013, J BIOL CHEM, V288, P26594, DOI 10.1074/jbc.M113.472977; Shokolenko IN, 2013, DNA REPAIR, V12, P488, DOI 10.1016/j.dnarep.2013.04.023; VAILLANT F, 1995, HUM MOL GENET, V4, P903, DOI 10.1093/hmg/4.5.903; WALLACE DC, 1988, CELL, V55, P601, DOI 10.1016/0092-8674(88)90218-8; WALLACE DC, 1988, SCIENCE, V242, P1427, DOI 10.1126/science.3201231; Wallace DC, 2012, NAT REV CANCER, V12, P685, DOI 10.1038/nrc3365; Yin DX, 1996, ANAL BIOCHEM, V235, P195, DOI 10.1006/abio.1996.0112; Zorov DB, 2014, PHYSIOL REV, V94, P909, DOI 10.1152/physrev.00026.2013; Zufferey R, 1997, NAT BIOTECHNOL, V15, P871, DOI 10.1038/nbt0997-871	41	15	16	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 2	2016	11	5							e0154684	10.1371/journal.pone.0154684	http://dx.doi.org/10.1371/journal.pone.0154684			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DL5KB	27136098	Green Published, Green Submitted, gold			2022-12-26	WOS:000375674800040
J	Hsiao, HY; Liu, JW; Brey, EM; Cheng, MH				Hsiao, Hui-Yi; Liu, Jia-Wei; Brey, Eric M.; Cheng, Ming-Huei			The Effects of Negative Pressure by External Tissue Expansion Device on Epithelial Cell Proliferation, Neo-Vascularization and Hair Growth in a Porcine Model	PLOS ONE			English	Article							AUTOLOGOUS FAT TRANSPLANTATION; VACUUM-ASSISTED CLOSURE; BREAST AUGMENTATION; MURINE MODEL; ANGIOGENESIS; INFLAMMATION; LIPOSUCTION; MECHANISMS	While pre-treating a fat transplant recipient site with negative pressure has shown promise for increasing the fat survival rate, the underlying mechanisms have not been investigated, partly due to challenges related to immobilization of vacuum domes on large animal subjects. The aim of this study was to examine the effect of negative pressure treatment by External Tissue Expansion Device (ETED) on fat grating recipient sites in a porcine model. The ETED was designed to provide negative pressure on the dorsum of swine. Pressure treatment (-70 mmHg) was applied for 1 or 3 hours every other day for 10 and 20 treatments. The treated areas (3.5 cm in diameter) were harvested and examined for histological changes, vessel density, cell proliferation (Ki67) and growth factor expression (FGF-1, VEGF and PDGB-bb). The application of the ETED increased epidermis thickness even after 1-hour treatments repeated 10 times. The results of Ki67 analysis suggested that the increasing thickness was due to cell proliferation in the epidermis. There was a more than two-fold increase in the vessel density, indicating that the ETED promotes vascularization. Unexpectedly, the treatment also increased the number of hair follicles. Negative pressure provided by the ETED increases the thickness of epidermis section of tissue, cell proliferation and vessel density. The porcine model provides a better representation of the effect of the ETED on skin tissue compared to small animal models and provides an environment for studying the mechanisms underlying the clinical benefits of negative pressure treatment.	[Hsiao, Hui-Yi; Liu, Jia-Wei; Cheng, Ming-Huei] Chang Gung Mem Hosp, Dept Plast & Reconstruct Surg, Taoyuan, Taiwan; [Hsiao, Hui-Yi; Liu, Jia-Wei; Cheng, Ming-Huei] Chang Gung Mem Hosp, Ctr Tissue Engn, Taoyuan, Taiwan; [Brey, Eric M.] IIT, Dept Biomed Engn, Chicago, IL 60616 USA; [Brey, Eric M.] Edward Hines Vet Adm Med Ctr, Res Serv, Hines, IL USA	Chang Gung Memorial Hospital; Chang Gung Memorial Hospital; Illinois Institute of Technology; US Department of Veterans Affairs; Veterans Health Administration (VHA); Edward Hines Jr. VA Hospital	Cheng, MH (corresponding author), Chang Gung Mem Hosp, Dept Plast & Reconstruct Surg, Taoyuan, Taiwan.	minghueicheng@gmail.com	Hsiao, Ivy/K-5428-2017; Cheng, Ming-Huei/AAD-8579-2019	Hsiao, Ivy/0000-0003-3170-2112; 	Ministry of Science and Technology;  [NMRPG3C6193]	Ministry of Science and Technology(Ministry of Science, ICT & Future Planning, Republic of Korea); 	The study is supported by Ministry of Science and Technology (www.most.gov.tw). The financial support is founded with the grant number NMRPG3C6193. MHC was the PI on this funding support. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Argenta LC, 2006, PLAST RECONSTR SURG, V117, p127S, DOI 10.1097/01.prs.0000222551.10793.51; Arnould T, 2001, AM J PATHOL, V159, P345, DOI 10.1016/S0002-9440(10)61701-4; Bernot KM, 2002, J INVEST DERMATOL, V119, P1137, DOI 10.1046/j.1523-1747.2002.19518.x; Cao L, 2015, GENET MOL RES, V14, P6146, DOI 10.4238/2015.June.8.12; Castello JR, 1999, PLAST RECONSTR SURG, V103, P291, DOI 10.1097/00006534-199901000-00046; De Caridi G, 2016, INT WOUND J, V13, P336, DOI 10.1111/iwj.12301; Del Vecchio D, 2009, ANN PLAS SURG, V62, P523, DOI 10.1097/SAP.0b013e3181a23f08; Del Vecchio DA, 2011, PLAST RECONSTR SURG, V127, P2441, DOI 10.1097/PRS.0b013e3182050a64; Heit YI, 2012, PLAST RECONSTR SURG, V130, P541, DOI 10.1097/PRS.0b013e31825dc04d; HORL HW, 1991, ANN PLAS SURG, V26, P248; Ingber DE, 2006, FASEB J, V20, P811, DOI 10.1096/fj.05-5424rev; Johnstone MA, 2002, SURV OPHTHALMOL, V47, pS185, DOI 10.1016/S0039-6257(02)00307-7; Kato H, 2014, PLAST RECONSTR SURG, V133, p303E, DOI 10.1097/PRS.0000000000000066; Lancerotto L, 2013, PLAST RECONSTR SURG, V132, P569, DOI 10.1097/PRS.0b013e31829ace30; Lee MS, 2011, J ACUPUNCT MERIDIAN, V4, P1, DOI 10.1016/S2005-2901(11)60001-0; MAILLARD GF, 1994, AESTHET PLAST SURG, V18, P405, DOI 10.1007/BF00451348; Mecklenburg L, 2000, J INVEST DERMATOL, V114, P909, DOI 10.1046/j.1523-1747.2000.00954.x; Meyer W, 1978, Curr Probl Dermatol, V7, P39; MOSCONA R, 1994, ANN PLAS SURG, V33, P500, DOI 10.1097/00000637-199411000-00007; Pasparakis M, 2014, NAT REV IMMUNOL, V14, P289, DOI 10.1038/nri3646; PINSKI KS, 1992, J DERMATOL SURG ONC, V18, P179, DOI 10.1111/j.1524-4725.1992.tb02795.x; Ricciotti E, 2011, ARTERIOSCL THROM VAS, V31, P986, DOI 10.1161/ATVBAHA.110.207449; Sasaki S, 2005, EXP DERMATOL, V14, P323, DOI 10.1111/j.0906-6705.2005.00270.x; Stefanova P, 2014, Khirurgiia (Sofiia), P11; Sullivan TP, 2001, WOUND REPAIR REGEN, V9, P66, DOI 10.1046/j.1524-475x.2001.00066.x; Vardaxis NJ, 1997, J ANAT, V190, P601, DOI 10.1046/j.1469-7580.1997.19040601.x; VIZCAINO JM, 1990, PLAST RECONSTR SURG, V85, P638, DOI 10.1097/00006534-199004000-00037; Yano K, 2001, J CLIN INVEST, V107, P409, DOI 10.1172/JCI11317	28	8	8	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 29	2016	11	4							e0154328	10.1371/journal.pone.0154328	http://dx.doi.org/10.1371/journal.pone.0154328			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DK8XM	27128731	Green Published, Green Submitted, gold			2022-12-26	WOS:000375212600027
J	Lin, Q; Luo, W; Wan, SM; Gao, ZX				Lin, Qiang; Luo, Wei; Wan, Shiming; Gao, Zexia			De Novo Transcriptome Analysis of Two Seahorse Species (Hippocampus erectus and H. mohnikei) and the Development of Molecular Markers for Population Genetics	PLOS ONE			English	Article							BREAM MEGALOBRAMA-AMBLYCEPHALA; ENDANGERED KNYSNA SEAHORSE; SSR-MARKERS; MICROSATELLITE MARKERS; GENOME; CONSERVATION; SYNGNATHIDAE; ANNOTATION; TELEOSTEI; GROWTH	Seahorse conservation has been performed utilizing various strategies for many decades, and the deeper understanding of genomic information is necessary to more efficiently protect the germplasm resources of seahorse species. However, little genetic information about seahorses currently exists in the public databases. In this study, high-throughput RNA sequencing for two seahorse species, Hippocampus erectus and H. mohnikei, was carried out, and de novo assembly generated 37,506 unigenes for H. erectus and 36,113 unigenes for H. mohnikei. Among them, 17,338 (46.23%) unigenes for H. erectus and 17,900 (49.57%) for H. mohnikei were successfully annotated based on the information available from the public databases. Through comparing the unigenes of two seahorse species, 7,802 candidate orthologous genes were identified and 5,268 genes among them could be annotated. In addition, gene ontology analysis of two species was similarly performed on biological processes, cellular components, and molecular functions. Twenty-four and twenty-one unigenes in H. erectus and H. mohnikei were annotated in the biosynthesis of unsaturated fatty acids pathways, and both seahorses lacked the Delta 12 and Delta 15 desaturases. Total of 8,992 and 9,116 SSR loci were obtained from H. erectus and H. mohnikei unigenes, respectively. Dozens of SSR were developed and then applied to assess the population genetic diversity, as well as cross-amplified in a related species, H. trimaculatus. The H-O and H-E values of the tested populations for H. erectus, H. mohnikei, and H. trimaculatus were medium. These resources would facilitate the conservation of the species through a better understanding of the genomics and comparative genome analysis within the Hippocampus genus.	[Lin, Qiang; Luo, Wei] Chinese Acad Sci, South China Sea Inst Oceanol, Key Lab Trop Marine Bioresources & Ecol, Guangzhou 510275, Guangdong, Peoples R China; [Wan, Shiming; Gao, Zexia] Huazhong Agr Univ, Freshwater Aquaculture Collaborat Innovat Ctr Hub, Key Lab Agr Anim Genet Breeding & Reprod,Coll Fis, Minist Educ,Key Lab Freshwater Anim Breeding,Mini, Wuhan 430070, Peoples R China	Chinese Academy of Sciences; South China Sea Institute of Oceanology, CAS; Huazhong Agricultural University	Lin, Q (corresponding author), Chinese Acad Sci, South China Sea Inst Oceanol, Key Lab Trop Marine Bioresources & Ecol, Guangzhou 510275, Guangdong, Peoples R China.	linqiangzsu@163.com			Outstanding Youth Foundation in Guangdong Province [S2013050014802]; National Science Fund for Excellent Young Scholars [41322038]; National Natural Science Foundation of China [41576145, 41306148]	Outstanding Youth Foundation in Guangdong Province; National Science Fund for Excellent Young Scholars; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was funded by the Outstanding Youth Foundation in Guangdong Province (S2013050014802), the National Science Fund for Excellent Young Scholars (41322038), and the National Natural Science Foundation of China (41576145, 41306148). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bell MV, 2009, LIPIDS IN AQUATIC ECOSYSTEMS, P211, DOI 10.1007/978-0-387-89366-2_9; Bouck A, 2007, MOL ECOL, V16, P907, DOI 10.1111/j.1365-294X.2006.03195.x; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; Edwards YJK, 1998, J MOL BIOL, V278, P843, DOI 10.1006/jmbi.1998.1752; Fu BD, 2012, DNA RES, V19, P131, DOI 10.1093/dnares/dsr046; Galbusera PHA, 2007, MOL ECOL NOTES, V7, P638, DOI 10.1111/j.1471-8286.2007.01688.x; Gao XG, 2012, COMP BIOCHEM PHYS D, V7, P277, DOI 10.1016/j.cbd.2012.05.001; Gao ZX, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042637; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; Haas BJ, 2014, NAT PROTOC, V123, pe783; Hellsten U, 2010, SCIENCE, V328, P633, DOI 10.1126/science.1183670; Huang W, 2013, MOL BIOL REP, V40, P751, DOI 10.1007/s11033-012-1958-4; Iseli C, 1999, Proc Int Conf Intell Syst Mol Biol, P138; Jones AG, 1998, MOL ECOL, V7, P1497, DOI 10.1046/j.1365-294x.1998.00481.x; Koldewey HJ, 2010, AQUACULTURE, V302, P131, DOI 10.1016/j.aquaculture.2009.11.010; Li DJ, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-192; Lin Q, 2012, BIOL OPEN, V1, P391, DOI 10.1242/bio.2012398; Lin Q, 2009, AQUACULTURE, V291, P224, DOI 10.1016/j.aquaculture.2009.03.031; Long Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056998; Lourie S.A., 2004, GUIDE IDENTIFICATION; Lourie SA, 1999, BIOL J LINN SOC, V66, P231, DOI 10.1111/j.1095-8312.1999.tb01886.x; Lourie SA, 2004, THESIS MCGILL U MONT; Luo W, 2014, CHINESE SCI BULL, V59, P857, DOI 10.1007/s11434-014-0115-y; Luo W, 2012, INT J MOL SCI, V13, P14946, DOI 10.3390/ijms131114946; Martin-Smith KM, 2005, BIOL CONSERV, V123, P533, DOI 10.1016/j.biocon.2005.01.003; Muthusamy Thangaraj, 2012, Notulae Scientia Biologicae, V4, P7; Near TJ, 2012, MOL PHYLOGENET EVOL, V63, P388, DOI 10.1016/j.ympev.2012.01.011; Tran NT, 2015, FISH SHELLFISH IMMUN, V45, P72, DOI 10.1016/j.fsi.2015.01.034; O'Neil ST, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-465; Panithanarak T, 2010, ZOOL STUD, V49, P564; Parchman TL, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-180; Qin G, 2014, J EXP MAR BIOL ECOL, V461, P337, DOI 10.1016/j.jembe.2014.09.001; Reid DP, 2005, HEREDITY, V94, P166, DOI 10.1038/sj.hdy.6800590; Rivera M., 2021, IUCN RED LIST THREAT, DOI DOI 10.2305/IUCN.UK.2020-3.RLTS.T22678711A183481909.EN; Robinson N, 2012, MAR BIOTECHNOL, V14, P620, DOI 10.1007/s10126-012-9433-8; Saarinen EV, 2010, J HERED, V101, P784, DOI 10.1093/jhered/esq080; Salem M, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-564; Sargent John R., 2002, P181; Singh KV, 2012, MAR BIODIVERS, V42, P481, DOI 10.1007/s12526-012-0122-7; Somridhivej B, 2008, AQUACULTURE, V275, P76, DOI 10.1016/j.aquaculture.2008.01.013; Teske PR, 2003, MOL ECOL, V12, P1703, DOI 10.1046/j.1365-294X.2003.01852.x; Thiel T, 2003, THEOR APPL GENET, V106, P411, DOI 10.1007/s00122-002-1031-0; Tocher DR, 2003, REV FISH SCI, V11, P107, DOI 10.1080/713610925; Vincent ACJ, 2011, J FISH BIOL, V78, P1681, DOI 10.1111/j.1095-8649.2011.03003.x; Vincent ACJ, 1995, ANIM BEHAV, V50, P1557, DOI 10.1016/0003-3472(95)80011-5; Vincent ACJ, 1996, INT TRADE SEAHORSES; Vitturi R, 1998, J FISH BIOL, V52, P677, DOI 10.1111/j.1095-8649.1998.tb00812.x; Wang WJ, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-470; Woods CMC, 2000, NEW ZEAL J MAR FRESH, V34, P475, DOI 10.1080/00288330.2000.9516950; Ye J, 2006, NUCLEIC ACIDS RES, V34, pW293, DOI 10.1093/nar/gkl031; Zhang LL, 2014, MAR BIOTECHNOL, V16, P17, DOI 10.1007/s10126-013-9526-z; Zhang L, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-329; Zhang R, 2013, MOL BIOL REP, V40, P5657, DOI 10.1007/s11033-013-2667-3; Zhang YH, 2015, J WORLD AQUACULT SOC, V46, P292, DOI 10.1111/jwas.12193; Zhang YH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105494; Zhao F, 2014, DNA RES, V21, P1, DOI 10.1093/dnares/dst035	56	6	6	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 29	2016	11	4							e0154096	10.1371/journal.pone.0154096	http://dx.doi.org/10.1371/journal.pone.0154096			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DK8XM	27128031	gold, Green Published, Green Submitted			2022-12-26	WOS:000375212600021
J	Soskic, M; Porobic, I				Soskic, Milan; Porobic, Ivana			Interactions of Indole Derivatives with beta-Cyclodextrin: A Quantitative Structure-Property Relationship Study	PLOS ONE			English	Article							AUXIN-BINDING PROTEIN-1; INDOLE-3-ACETIC ACIDS; BIOLOGICAL-ACTIVITY; RECEPTOR; TIR1; CLASSIFICATION; SPECIFICITY; VALIDATION; COMPLEX; SITE	Retention factors for 31 indole derivatives, most of them with auxin activity, were determined by high-performance liquid chromatography, using bonded beta-cyclodextrin as a stationary phase. A three-parameter QSPR (quantitative structure-property relationship) model, based on physico-chemical and structural descriptors was derived, which accounted for about 98% variations in the retention factors. The model suggests that the indole nucleus occupies the relatively apolar cavity of beta-cyclodextrin while the carboxyl group of the indole-3-carboxylic acids makes hydrogen bonds with the hydroxyl groups of beta-cyclodextrin. The length and flexibility of the side chain containing carboxyl group strongly affect the binding of these compounds to beta-cyclodextrin. Non-acidic derivatives, unlike the indole-3-carboxylic acids, are poorly retained on the column. A reasonably well correlation was found between the retention factors of the indole-3-acetic acids and their relative binding affinities for human serum albumin, a carrier protein in the blood plasma. A less satisfactory correlation was obtained when the retention factors of the indole derivatives were compared with their affinities for auxin-binding protein 1, a plant auxin receptor.	[Soskic, Milan; Porobic, Ivana] Univ Zagreb, Dept Chem, Fac Agr, Svetosimunska 25, Zagreb 10000, Croatia	University of Zagreb	Soskic, M (corresponding author), Univ Zagreb, Dept Chem, Fac Agr, Svetosimunska 25, Zagreb 10000, Croatia.	msoskic@agr.hr	Soskic, Milan/AAQ-8182-2020		Croatian Ministry of Science, Education and Sports [178-0982929-2259]	Croatian Ministry of Science, Education and Sports(Ministry of Science, Education and Sports, Republic of Croatia)	Grant No. 178-0982929-2259 Croatian Ministry of Science, Education and Sports (MS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Sou'od KA, 2006, J SOLUTION CHEM, V35, P1377, DOI 10.1007/s10953-006-9067-4; [Anonymous], 1995, BIOL VERS 1 5; Antolic S, 2003, PLANT GROWTH REGUL, V39, P235, DOI 10.1023/A:1022894914226; Breslow R, 1998, CHEM REV, V98, P1997, DOI 10.1021/cr970011j; Del Valle EMM, 2004, PROCESS BIOCHEM, V39, P1033, DOI 10.1016/S0032-9592(03)00258-9; Dharmasiri N, 2005, NATURE, V435, P441, DOI 10.1038/nature03543; Draper N.R, 1998, WILEY SERIES PROBABI, Vthird; EDGERTON MD, 1994, PHYTOCHEMISTRY, V35, P1111, DOI 10.1016/S0031-9422(00)94807-6; Eriksson L, 2003, ENVIRON HEALTH PERSP, V111, P1361, DOI 10.1289/ehp.5758; Ferro N, 2006, J CHEM INF MODEL, V46, P1751, DOI 10.1021/ci050491c; Folkes LK, 2001, BIOCHEM PHARMACOL, V61, P129, DOI 10.1016/S0006-2952(00)00498-6; Ghuman J, 2005, J MOL BIOL, V353, P38, DOI 10.1016/j.jmb.2005.07.075; Gramatica P, 2007, QSAR COMB SCI, V26, P694, DOI 10.1002/qsar.200610151; Grandits M, 2014, PROTEINS, V82, P2744, DOI 10.1002/prot.24639; Greco O, 2001, MOL CANCER THER, V1, P151; HANSCH C, 1962, NATURE, V194, P178, DOI 10.1038/194178b0; Hansch C., 1995, EXPLORING QSAR HYDRO; HE XM, 1992, NATURE, V358, P209, DOI 10.1038/358209a0; KAETHNER TM, 1977, NATURE, V267, P19, DOI 10.1038/267019a0; KATEKAR GF, 1979, PHYTOCHEMISTRY, V18, P223, DOI 10.1016/0031-9422(79)80059-X; Kepinski S, 2005, NATURE, V435, P446, DOI 10.1038/nature03542; MUIR RM, 1967, PLANT PHYSIOL, V42, P1519, DOI 10.1104/pp.42.11.1519; Nah TH, 1996, J CHROMATOGR A, V722, P41; Napier RM, 2002, PLANT MOL BIOL, V49, P339, DOI 10.1023/A:1015259130955; ORSTAN A, 1987, J PHYS CHEM-US, V91, P2739, DOI 10.1021/j100295a019; Porobic I, 2013, BIOORGAN MED CHEM, V21, P653, DOI 10.1016/j.bmc.2012.11.048; RAY PM, 1977, PLANT PHYSIOL, V60, P585, DOI 10.1104/pp.60.4.585; Rescher U, 1996, J PLANT GROWTH REGUL, V15, P1, DOI 10.1007/BF00213127; Sanrame CN, 1996, J PHYS CHEM-US, V100, P8151, DOI 10.1021/jp953369x; Scherer GFE, 2011, J EXP BOT, V62, P3339, DOI 10.1093/jxb/err033; Simon S, 2011, PLANT SCI, V180, P454, DOI 10.1016/j.plantsci.2010.12.007; Soskic M, 2007, BIOORGAN MED CHEM, V15, P4595, DOI 10.1016/j.bmc.2007.04.005; Soskic M, 2009, QSAR COMB SCI, V28, P1276, DOI 10.1002/qsar.200960056; Szejtli J, 1998, CHEM REV, V98, P1743, DOI 10.1021/cr970022c; Tan X, 2007, NATURE, V446, P640, DOI 10.1038/nature05731; TODESCHINI R, 2004, MOBYDIGS VERSION 1 0; Tomic S, 1998, J COMPUT AID MOL DES, V12, P63, DOI 10.1023/A:1007973008558; Tropsha A, 2003, QSAR COMB SCI, V22, P69, DOI 10.1002/qsar.200390007; VELDSTRA H, 1953, ANNU REV PLANT PHYS, V4, P151, DOI 10.1146/annurev.pp.04.060153.001055; Wold S, 1995, CHEMOMETRIC METHODS, P309; Woo EJ, 2002, EMBO J, V21, P2877, DOI 10.1093/emboj/cdf291; Woodward AW, 2005, ANN BOT-LONDON, V95, P707, DOI 10.1093/aob/mci083	42	1	1	2	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 28	2016	11	4							e0154339	10.1371/journal.pone.0154339	http://dx.doi.org/10.1371/journal.pone.0154339			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DK8XE	27124734	gold, Green Published			2022-12-26	WOS:000375211700070
J	Shen, J; Tsoi, H; Liang, Q; Chu, ESH; Liu, D; Yu, ACS; Chan, TF; Li, X; Sung, JJY; Wong, VWS; Yu, J				Shen, J.; Tsoi, H.; Liang, Q.; Chu, E. S. H.; Liu, D.; Yu, A. C-S; Chan, T. F.; Li, X.; Sung, J. J. Y.; Wong, V. W. S.; Yu, J.			Oncogenic mutations and dysregulated pathways in obesity-associated hepatocellular carcinoma	ONCOGENE			English	Article							CARBOXYL ESTER LIPASE; FATTY LIVER-DISEASE; CELL-PROLIFERATION; CHOLESTERYL ESTERS; SEQUENCING DATA; DOWN-REGULATION; INHIBITORY ROLE; BILIARY-TRACT; IN-VITRO; CANCER	Epidemiological studies showed that obesity and its related non-alcoholic fatty liver disease (NAFLD) promote hepatocellular carcinoma (HCC) development. We aimed to uncover the genetic alterations of NAFLD-HCC using whole-exome sequencing. We compared HCC development in genetically obese mice and dietary obese mice with wild-type lean mice fed a normal chow after treatment with diethylnitrosamine. HCC tumor and adjacent normal samples from obese and lean mice were then subjected to whole-exome sequencing. Functional and mechanistic importance of the identified mutations in Carboxyl ester lipase (Cel) gene and Harvey rat sarcoma virus oncogene 1 (Hras) was further elucidated. We demonstrated significantly higher incidences of HCC in both genetic and dietary obese mice with NAFLD development as compared with lean mice without NAFLD. The mutational signatures of NAFLD-HCC and lean HCC were distinct, with o3% overlapped. Eight metabolic or oncogenic pathways were found to be significantly enriched by mutated genes in NAFLD-HCC, but only two of these pathways were dysregulated by mutations in lean HCC. In particular, Cel was mutated significantly more frequently in NAFLD-HCC than in lean HCC. The multiple-site mutations in Cel are loss-of-function mutations, with effects similar to Cel knock-down. Mutant Cel caused accumulation of cholesteryl ester in liver cells, which led to induction of endoplasmic reticulum stress and consequently activated the IRE1a/c-Jun N-terminal kinase (JNK)/cJun/ activating protein-1 (AP-1) signaling cascade to promote liver cell growth. In addition, single-site mutations in Hras at codon 61 were found in NAFLD-HCC but none in lean HCC. The gain-of-function mutations in Hras (Q61R and Q61K) significantly promoted liver cell growth through activating the mitogen-activated protein kinase (MAPK) and phosphatidylinositol-4,5-bisphosphate 3-kinase (PI3K)/3-phosphoinositide-dependent protein kinase-1 (PDK1)/Akt pathways. In conclusion, we have identified mutation signature and pathways in NAFLD-associated HCC. Mutations in Cel and Hras have important roles in NAFLD-associated hepatocellular carcinogenesis.	[Shen, J.; Tsoi, H.; Liang, Q.; Chu, E. S. H.; Liu, D.; Li, X.; Sung, J. J. Y.; Wong, V. W. S.; Yu, J.] Chinese Univ Hong Kong, Inst Digest Dis, Hong Kong, Hong Kong, Peoples R China; [Shen, J.; Tsoi, H.; Liang, Q.; Chu, E. S. H.; Liu, D.; Li, X.; Sung, J. J. Y.; Wong, V. W. S.; Yu, J.] Chinese Univ Hong Kong, CUHK Shenzhen Res Inst, Li Ka Shing Inst Hlth Sci, Dept Med & Therapeut,State Key Lab Digest Dis, Hong Kong, Hong Kong, Peoples R China; [Yu, A. C-S; Chan, T. F.] Chinese Univ Hong Kong, Sch Life Sci, Hong Kong, Hong Kong, Peoples R China; [Yu, A. C-S; Chan, T. F.] Chinese Univ Hong Kong, State Key Lab Agrobiotechnol, Hong Kong, Hong Kong, Peoples R China	Chinese University of Hong Kong; Chinese University of Hong Kong; Chinese University of Hong Kong; Chinese University of Hong Kong	Wong, VWS; Yu, J (corresponding author), Chinese Univ Hong Kong, Prince Wales Hosp, Dept Med & Therapeut, Room 707A,7-F,Li Ka Shing Med Sci Bldg, Shatin, Hong Kong, Peoples R China.	wongv@cuhk.edu.hk; junyu@cuhk.edu.hk	Sung, Joseph J. Y./R-3203-2018; Chan, TingFung/A-6161-2013; Li, Xiao-xing/B-9114-2008; Wong, Vincent WS/K-3864-2014; Liu, Dabin/GNH-2648-2022; Liang, Qiaoyi Jessie/G-9612-2019; Wong, Grace LH/L-8586-2014; Jun, Yu/D-8569-2015	Sung, Joseph J. Y./0000-0003-3125-5199; Chan, TingFung/0000-0002-0489-3884; Li, Xiao-xing/0000-0001-8791-7505; Wong, Vincent WS/0000-0003-2215-9410; Liang, Qiaoyi Jessie/0000-0001-8496-3442; Wong, Grace LH/0000-0002-2863-9389; Yu, Allen Chi-Shing/0000-0002-9568-8316; Jun, Yu/0000-0001-5008-2153; Liu, Dabin/0000-0002-3811-8317; tsoi, ho/0000-0003-2037-9575	RGC-GRF Hong Kong [14106415]; RGC-CRF Hong Kong [CUHK3/CRF/12R, HKU3/CRF11R]; National Basic Research Program of China (973 Program) [2013CB531401]; RGC-Theme-based Research Scheme Hong Kong [T12-403-11]; Shenzhen Virtual University Park Support Scheme	RGC-GRF Hong Kong(Hong Kong Research Grants Council); RGC-CRF Hong Kong; National Basic Research Program of China (973 Program)(National Basic Research Program of China); RGC-Theme-based Research Scheme Hong Kong; Shenzhen Virtual University Park Support Scheme	The project was supported by the RGC-GRF Hong Kong (14106415); RGC-CRF Hong Kong (CUHK3/CRF/12R; HKU3/CRF11R); National Basic Research Program of China (973 Program, 2013CB531401); RGC-Theme-based Research Scheme Hong Kong (T12-403-11); Shenzhen Virtual University Park Support Scheme to CUHK Shenzhen Research Institute. The results shown here are in part based upon data generated by the TCGA Research Network: http://cancergenome.nih.gov/.	Agrawal N, 2011, SCIENCE, V333, P1154, DOI 10.1126/science.1206923; Borena W, 2012, INT J CANCER, V131, P193, DOI 10.1002/ijc.26338; Camarota LM, 2004, J BIOL CHEM, V279, P27599, DOI 10.1074/jbc.M402946200; Castellano Esther, 2011, Genes Cancer, V2, P261, DOI 10.1177/1947601911408079; Castellano E, 2010, CURR TOP MICROBIOL, V346, P143, DOI 10.1007/82_2010_56; Chang TY, 2009, AM J PHYSIOL-ENDOC M, V297, pE1, DOI 10.1152/ajpendo.90926.2008; Chang WC, 2006, ACTA PHARMACOL SIN, V27, P813, DOI 10.1111/j.1745-7254.2006.00395.x; Chanson M, 2005, BBA-BIOMEMBRANES, V1711, P197, DOI 10.1016/j.bbamem.2004.10.005; Chen HF, 2010, HEPATOLOGY, V52, P155, DOI 10.1002/hep.23641; Cianciola NL, 2013, MOL BIOL CELL, V24, P3309, DOI 10.1091/mbc.E12-10-0760; El-Serag HB, 2007, GASTROENTEROLOGY, V132, P2557, DOI 10.1053/j.gastro.2007.04.061; Guo GW, 2013, NAT GENET, V45, P1459, DOI 10.1038/ng.2798; Hui DY, 2002, J LIPID RES, V43, P2017, DOI 10.1194/jlr.R200013-JLR200; Hui LJ, 2008, J CLIN INVEST, V118, P3943, DOI 10.1172/JCI37156; Keane MP, 2000, CRIT CARE MED, V28, pN13, DOI 10.1097/00003246-200004001-00003; Larsson SC, 2007, BRIT J CANCER, V97, P1005, DOI 10.1038/sj.bjc.6603932; Leithe Edward, 2006, Critical Reviews in Oncogenesis, V12, P225; Li H, 2009, BIOINFORMATICS, V25, P2078, DOI 10.1093/bioinformatics/btp352; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Limonta P, 2012, ENDOCR REV, V33, P784, DOI 10.1210/er.2012-1014; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; Mohit E, 2012, IMMUNOTHERAPY-UK, V4, P807, DOI [10.2217/IMT.12.72, 10.2217/imt.12.72]; Nakagawa H, 2014, CANCER CELL, V26, P331, DOI 10.1016/j.ccr.2014.07.001; Osaki LH, 2013, INT J MOL SCI, V14, P10143, DOI 10.3390/ijms140510143; Otoda T, 2013, DIABETES, V62, P811, DOI 10.2337/db11-1652; Park EJ, 2010, CELL, V140, P197, DOI 10.1016/j.cell.2009.12.052; Petit V, 2000, BIOL CELL, V92, P477, DOI 10.1016/S0248-4900(00)01101-1; Prior IA, 2012, CANCER RES, V72, P2457, DOI 10.1158/0008-5472.CAN-11-2612; Raeder H, 2006, NAT GENET, V38, P54, DOI 10.1038/ng1708; Renauld JC, 2003, NAT REV IMMUNOL, V3, P667, DOI 10.1038/nri1153; Schlesinger S, 2013, INT J CANCER, V132, P645, DOI 10.1002/ijc.27645; Shaulian E, 2001, ONCOGENE, V20, P2390, DOI 10.1038/sj.onc.1204383; Shields JM, 2000, TRENDS CELL BIOL, V10, P147, DOI 10.1016/S0962-8924(00)01740-2; Swami M, 2010, NAT REV CANCER, V10, P738, DOI 10.1038/nrc2956; Turati F, 2013, BRIT J CANCER, V108, P222, DOI 10.1038/bjc.2012.492; VOGEL MJ, 1971, IBM J RES DEV, V15, P52, DOI 10.1147/rd.151.0052; Wang J, 2013, J PATHOL, V230, P441, DOI 10.1002/path.4206; Wang K, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq603; White DL, 2012, CLIN GASTROENTEROL H, V10, P1342, DOI 10.1016/j.cgh.2012.10.001; Wong VWS, 2013, J GASTROEN HEPATOL, V28, P18, DOI 10.1111/jgh.12011; Ximing DU, 2011, [Frontiers in Biology, 生物学前沿], V6, P190; Yu J, 2010, HEPATOLOGY, V51, P2008, DOI 10.1002/hep.23550; Yue SH, 2014, CELL METAB, V19, P393, DOI 10.1016/j.cmet.2014.01.019	43	23	23	0	11	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	DEC 8	2016	35	49					6271	6280		10.1038/onc.2016.162	http://dx.doi.org/10.1038/onc.2016.162			10	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	EF3TJ	27132506	Green Published, hybrid			2022-12-26	WOS:000390247000001
J	Shi, SS; Liu, K; Chen, YH; Zhang, SJ; Lin, JY; Gong, CF; Jin, QW; Yang, XJ; Chen, RC; Ji, ZL; Han, AD				Shi, Shasha; Liu, Ke; Chen, Yanheng; Zhang, Shijun; Lin, Juanyu; Gong, Chenfang; Jin, Quanwen; Yang, Xiang-Jiao; Chen, Ruichuan; Ji, Zhiliang; Han, Aidong			Competitive Inhibition of Lysine Acetyltransferase 2B by a Small Motif of the Adenoviral Oncoprotein E1A	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						acetyl coenzyme A (acetyl-CoA); acetyltransferase; adenovirus; enzyme inhibitor; structural model	HISTONE ACETYLTRANSFERASE; P300/CBP-ASSOCIATED FACTOR; KINETIC MECHANISM; STRUCTURAL BASIS; GENE-EXPRESSION; COENZYME-A; CELL-CYCLE; PROTEIN; BINDING; GCN5	The adenovirus early region 1A (E1A) oncoprotein hijacks host cells via direct interactions with many key cellular proteins, such as KAT2B, also known as PCAF (p300/CBP associated factor). E1A binds the histone acetyltransferase (HAT) domain of KAT2B to repress its transcriptional activation. However, the molecular mechanism by which E1A inhibits the HAT activity is not known. Here we demonstrate that a short and relatively conserved N-terminal motif (cNM) in the intrinsically disordered E1A protein is crucial for KAT2B interaction, and inhibits its HAT activity through a direct competition with acetyl-CoA, but not its substrate histone H3. Molecular modeling together with a series of mutagenesis experiments suggests that the major helix of E1A cNM binds to a surface of the acetyl-CoA pocket of the KAT2B HAT domain. Moreover, transient expression of the cNM peptide is sufficient to inhibit KAT2B-specific H3 acetylation H3K14ac in vivo. Together, our data define an essential motif cNM in N-terminal E1A as an acetyl-CoA entry blocker that directly associates with the entrance of acetyl-CoA binding pocket to block the HAT domain access to its cofactor.	[Shi, Shasha; Liu, Ke; Chen, Yanheng; Zhang, Shijun; Lin, Juanyu; Gong, Chenfang; Jin, Quanwen; Chen, Ruichuan; Ji, Zhiliang; Han, Aidong] Xiamen Univ, Sch Life Sci, State Key Lab Cellular Stress Biol, Xiamen 361102, Peoples R China; [Yang, Xiang-Jiao] McGill Univ, Goodman Canc Ctr, Montreal, PQ H3A 1A3, Canada; [Yang, Xiang-Jiao] McGill Univ, Ctr Hlth, Dept Med, Montreal, PQ H3A 1A3, Canada	Xiamen University; McGill University; McGill University	Chen, RC; Ji, ZL (corresponding author), Xiamen Univ, Sch Life Sci, State Key Lab Cellular Stress Biol, Xiamen 361102, Peoples R China.; Han, AD (corresponding author), Xiamen Univ, Sch Life Sci, Dept Biochem Sci, Xiamen 361102, Peoples R China.	chenrc@xmu.edu.cn; appo@xmu.edu.cn; ahan@xmu.edu.cn			National Science Foundation of China [31170685, 90919036, 81361120386, 31570751, 31270809];  [0660ZK1022]	National Science Foundation of China(National Natural Science Foundation of China (NSFC)); 	This work was supported by the National Science Foundation of China Grants 31170685 and 90919036 (to A. H.), 81361120386, 31570751, and 31270809 (to R. C.) and Project 985 (0660ZK1022). The authors declare that they have no conflicts of interest with the contents of this article.	Ablack JNG, 2012, J VIROL, V86, P8198, DOI 10.1128/JVI.00289-12; Ai NP, 2011, NUCLEIC ACIDS RES, V39, P9592, DOI 10.1093/nar/gkr698; Avvakumov N, 2002, J VIROL, V76, P7968, DOI 10.1128/JVI.76.16.7968-7975.2002; BAYLEY ST, 1994, INT J ONCOL, V5, P425; Berk AJ, 2005, ONCOGENE, V24, P7673, DOI 10.1038/sj.onc.1209040; Chakravarti D, 1999, CELL, V96, P393, DOI 10.1016/S0092-8674(00)80552-8; Chen RC, 2008, GENE DEV, V22, P1356, DOI 10.1101/gad.1636008; Clements A, 2003, MOL CELL, V12, P461, DOI 10.1016/S1097-2765(03)00288-0; Clements A, 1999, EMBO J, V18, P3521, DOI 10.1093/emboj/18.13.3521; DYSON N, 1992, CANCER SURV, V12, P161; ELLMAN GL, 1959, ARCH BIOCHEM BIOPHYS, V82, P70, DOI 10.1016/0003-9861(59)90090-6; Ferrari R, 2008, SCIENCE, V321, P1086, DOI 10.1126/science.1155546; Ferrari R, 2014, CELL HOST MICROBE, V16, P663, DOI 10.1016/j.chom.2014.10.004; Ferreon ACM, 2013, NATURE, V498, P390, DOI 10.1038/nature12294; Ferreon JC, 2009, P NATL ACAD SCI USA, V106, P13260, DOI 10.1073/pnas.0906770106; FLINT J, 1989, ANNU REV GENET, V23, P141, DOI 10.1146/annurev.genet.23.1.141; Flint J, 1997, ANNU REV GENET, V31, P177, DOI 10.1146/annurev.genet.31.1.177; Freyer MW, 2008, METHOD CELL BIOL, V84, P79, DOI 10.1016/S0091-679X(07)84004-0; Frisch SM, 2002, NAT REV MOL CELL BIO, V3, P441, DOI 10.1038/nrm827; Gallimore PH, 2001, ONCOGENE, V20, P7824, DOI 10.1038/sj.onc.1204913; GREEN M, 1970, ANNU REV BIOCHEM, V39, P701, DOI 10.1146/annurev.bi.39.070170.003413; Hamamori Y, 1999, CELL, V96, P405, DOI 10.1016/S0092-8674(00)80553-X; Horwitz GA, 2008, SCIENCE, V321, P1084, DOI 10.1126/science.1155544; Hu XM, 2014, J BIOL CHEM, V289, P23154, DOI 10.1074/jbc.M114.570812; KIMELMAN D, 1985, J VIROL, V53, P399, DOI 10.1128/JVI.53.2.399-409.1985; Lang SE, 2003, ONCOGENE, V22, P2836, DOI 10.1038/sj.onc.1206376; Lill NL, 1997, NATURE, V387, P823, DOI 10.1038/42981; London N, 2011, NUCLEIC ACIDS RES, V39, pW249, DOI 10.1093/nar/gkr431; Mao YJ, 2011, ANAL BIOCHEM, V415, P21, DOI 10.1016/j.ab.2011.04.004; MORAN E, 1993, CURR OPIN GENET DEV, V3, P63, DOI 10.1016/S0959-437X(05)80342-9; Nagy Z, 2007, ONCOGENE, V26, P5341, DOI 10.1038/sj.onc.1210604; NEVINS JR, 1979, J VIROL, V32, P727, DOI 10.1128/JVI.32.3.727-733.1979; O'Connor MJ, 1999, J VIROL, V73, P3574; Pelka P, 2008, J VIROL, V82, P7252, DOI 10.1128/JVI.00104-08; Pelka P, 2009, VIROLOGY, V391, P90, DOI 10.1016/j.virol.2009.05.024; Pierce BG, 2014, BIOINFORMATICS, V30, P1771, DOI 10.1093/bioinformatics/btu097; Rasti M, 2005, J VIROL, V79, P5594, DOI 10.1128/JVI.79.9.5594-5605.2005; Reid JL, 1998, EMBO J, V17, P4469, DOI 10.1093/emboj/17.15.4469; Rojas JR, 1999, NATURE, V401, P93, DOI 10.1038/43487; Shi SS, 2014, BMC STRUCT BIOL, V14, DOI 10.1186/1472-6807-14-2; Shuen M, 2002, J BIOL CHEM, V277, P30844, DOI 10.1074/jbc.M201877200; Simossis VA, 2005, NUCLEIC ACIDS RES, V33, pW289, DOI 10.1093/nar/gki390; Spedale G, 2012, GENE DEV, V26, P527, DOI 10.1101/gad.184705.111; SPRENGEL J, 1994, J VIROL, V68, P379, DOI 10.1128/JVI.68.1.379-389.1994; Tanner KG, 2000, J BIOL CHEM, V275, P22048, DOI 10.1074/jbc.M002893200; Tanner KG, 2000, BIOCHEMISTRY-US, V39, P11961, DOI 10.1021/bi001272h; TRENTIN JJ, 1968, P SOC EXP BIOL MED, V127, P683, DOI 10.3181/00379727-127-32773; Trievel RC, 2000, ANAL BIOCHEM, V287, P319, DOI 10.1006/abio.2000.4855; WANG HGH, 1993, J VIROL, V67, P476, DOI 10.1128/JVI.67.1.476-488.1993; Yang JY, 2015, NAT METHODS, V12, P7, DOI 10.1038/nmeth.3213; Yang XJ, 2004, NUCLEIC ACIDS RES, V32, P959, DOI 10.1093/nar/gkh252; Yang XJ, 1996, NATURE, V382, P319, DOI 10.1038/382319a0	52	3	3	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 1	2016	291	27					14363	14372		10.1074/jbc.M115.697300	http://dx.doi.org/10.1074/jbc.M115.697300			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DR5XG	27143356	Green Published, hybrid			2022-12-26	WOS:000379975100038
J	LaRocca, TJ; Sosunov, SA; Shakerley, NL; Ten, VS; Ratner, AJ				LaRocca, Timothy J.; Sosunov, Sergey A.; Shakerley, Nicole L.; Ten, Vadim S.; Ratner, Adam J.			Hyperglycemic Conditions Prime Cells for RIP1-dependent Necroptosis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						apoptosis; diabetes; glucose; ischemia; necrosis (necrotic death); tumor necrosis factor (TNF); Fas ligand; hyperglycemia; necroptosis; programmed cell death	HYPOXIA-ISCHEMIA; GLUCOSE; APOPTOSIS; DEATH; DEPRIVATION; METABOLISM; HEMOLYSIS; SYSTEM	Necroptosis is a RIP1-dependent programmed cell death (PCD) pathway that is distinct from apoptosis. Downstream effector pathways of necroptosis include formation of advanced glycation end products (AGEs) and reactive oxygen species (ROS), both of which depend on glycolysis. This suggests that increased cellular glucose may prime necroptosis. Here we show that exposure to hyperglycemic levels of glucose enhances necroptosis in primary red blood cells (RBCs), Jurkat T cells, and U937 monocytes. Pharmacologic or siRNA inhibition of RIP1 prevented the enhanced death, confirming it as RIP1-dependent necroptosis. Hyperglycemic enhancement of necroptosis depends upon glycolysis with AGEs and ROS playing a role. Total levels of RIP1, RIP3, and mixed lineage kinase domain-like (MLKL) proteins were increased following treatment with high levels of glucose in Jurkat and U937 cells and was not due to transcriptional regulation. The observed increase in RIP1, RIP3, and MLKL protein levels suggests a potential positive feedback mechanism in nucleated cell types. Enhanced PCD due to hyperglycemia was specific to necroptosis as extrinsic apoptosis was inhibited by exposure to high levels of glucose. Hyperglycemia resulted in increased infarct size in a mouse model of brain hypoxia-ischemia injury. The increased infarct size was prevented by treatment with nec-1s, strongly suggesting that increased necroptosis accounts for exacerbation of this injury in conditions of hyperglycemia. This work reveals that hyperglycemia represents a condition in which cells are extraordinarily susceptible to necroptosis, that local glucose levels alter the balance of PCD pathways, and that clinically relevant outcomes may depend on glucose-mediated effects on PCD.	[LaRocca, Timothy J.; Shakerley, Nicole L.] Albany Coll Pharm & Hlth Sci, Dept Basic & Social Sci, Albany, NY 12208 USA; [Sosunov, Sergey A.; Ten, Vadim S.; Ratner, Adam J.] Columbia Univ, Dept Pediat, New York, NY 10032 USA; [Ratner, Adam J.] NYU, Dept Pediat, New York, NY 10016 USA; [Ratner, Adam J.] NYU, Dept Microbiol, New York, NY 10016 USA	Albany College of Pharmacy & Health Sciences; Columbia University; New York University; New York University	Ratner, AJ (corresponding author), NYU, Depts Pediat, Div Pediat Infect Dis, Sch Med, 550 First Ave,MSB 223, New York, NY 10016 USA.; Ratner, AJ (corresponding author), NYU, Depts Microbiol, Div Pediat Infect Dis, Sch Med, 550 First Ave,MSB 223, New York, NY 10016 USA.	Adam.Ratner@nyumc.org	Shakerley, Nicole L/C-1245-2015	Shakerley, Nicole L/0000-0002-7880-3343; Ratner, Adam/0000-0003-1761-794X	Albany College of Pharmacy and Health Sciences; National Institutes of Health [R01-AI092743, R21-AI111020, R01-NS088197]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI092743, R21AI111020] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS088197] Funding Source: NIH RePORTER	Albany College of Pharmacy and Health Sciences; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by startup funds from the Albany College of Pharmacy and Health Sciences (to T. J. L.) and National Institutes of Health Grants R01-AI092743 and R21-AI111020 (to A. J. R.), and R01-NS088197 (to V. S. T.). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. The authors declare that they have no conflicts of interest with the contents of this article.	Basu SK, 2016, ARCH DIS CHILD-FETAL, V101, pF149, DOI 10.1136/archdischild-2015-308733; Bernassola F, 2010, CELL DEATH DIFFER, V17, P1, DOI 10.1038/cdd.2009.189; Borutaite V, 2001, FEBS LETT, V500, P114, DOI 10.1016/S0014-5793(01)02593-5; Brown DI, 2009, FREE RADICAL BIO MED, V47, P1239, DOI 10.1016/j.freeradbiomed.2009.07.023; Brownlee M, 2001, NATURE, V414, P813, DOI 10.1038/414813a; Caro-Maldonado A, 2010, CELL DEATH DIFFER, V17, P1335, DOI 10.1038/cdd.2010.21; Chang YS, 1998, BRAIN RES, V798, P271, DOI 10.1016/S0006-8993(98)00470-3; Chauvier D, 2007, CELL DEATH DIFFER, V14, P387, DOI 10.1038/sj.cdd.4402044; Darwazeh R, 2013, NEURAL REGEN RES, V8, P2677, DOI 10.3969/j.issn.1673-5374.2013.28.010; Degterev A, 2005, NAT CHEM BIOL, V1, P112, DOI 10.1038/nchembio711; Fulda S., 2013, INT J CELL BIOL; Gelber SE, 2008, J BACTERIOL, V190, P3896, DOI 10.1128/JB.01965-07; Klarl BA, 2006, AM J PHYSIOL-CELL PH, V290, pC244, DOI 10.1152/ajpcell.00283.2005; Lang E, 2012, INT J BIOCHEM CELL B, V44, P1236, DOI 10.1016/j.biocel.2012.04.019; LaRocca TJ, 2015, CELL DEATH DIS, V6, DOI 10.1038/cddis.2015.135; LaRocca TJ, 2014, MBIO, V5, DOI 10.1128/mBio.01251-14; Li HK, 2005, DIABETES, V54, P540, DOI 10.2337/diabetes.54.2.540; Li JX, 2012, CELL, V150, P339, DOI 10.1016/j.cell.2012.06.019; Linkermann A, 2013, AM J TRANSPLANT, V13, P2797, DOI 10.1111/ajt.12448; Linkermann A, 2014, NEW ENGL J MED, V370, P455, DOI 10.1056/NEJMra1310050; Munoz-Pinedo C, 2003, J BIOL CHEM, V278, P12759, DOI 10.1074/jbc.M212392200; Nam SY, 2002, ONCOGENE, V21, P337, DOI 10.1038/sj.onc.1205068; Niatsetskaya ZV, 2012, J NEUROSCI, V32, P3235, DOI 10.1523/JNEUROSCI.6303-11.2012; O'Donnell MA, 2011, NAT CELL BIOL, V13, P1437, DOI 10.1038/ncb2362; ROTRUCK JT, 1971, NATURE-NEW BIOL, V231, P223, DOI 10.1038/newbio231223a0; SHELDON RA, 1992, PEDIATR RES, V32, P489, DOI 10.1203/00006450-199210000-00022; Shrikhande GV, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014240; Singh R, 2001, DIABETOLOGIA, V44, P129, DOI 10.1007/s001250051591; Sonksen PH, 2001, J ENDOCRINOL, V170, P13, DOI 10.1677/joe.0.1700013; Sosunov SA, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0120456; Spies EE, 2014, PEDIATR NEUROL, V50, P586, DOI 10.1016/j.pediatrneurol.2014.01.043; TATO L, 1973, CLIN CHIM ACTA, V49, P349, DOI 10.1016/0009-8981(73)90232-5; Vandenabeele P, 2010, NAT REV MOL CELL BIO, V11, P700, DOI 10.1038/nrm2970; Vesely ED, 2009, AM J PHYSIOL-CELL PH, V297, pC759, DOI 10.1152/ajpcell.00213.2009; Wallace DC, 1999, SCIENCE, V283, P1482, DOI 10.1126/science.283.5407.1482	35	29	32	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 24	2016	291	26					13753	13761		10.1074/jbc.M116.716027	http://dx.doi.org/10.1074/jbc.M116.716027			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DR2YZ	27129772	Green Published, hybrid			2022-12-26	WOS:000379771100029
J	Datta, A; Bhattacharyya, D; Singh, S; Ghosh, A; Schmidtchen, A; Malmsten, M; Bhunia, A				Datta, Aritreyee; Bhattacharyya, Dipita; Singh, Shalini; Ghosh, Anirban; Schmidtchen, Artur; Malmsten, Martin; Bhunia, Anirban			Role of Aromatic Amino Acids in Lipopolysaccharide and Membrane Interactions of Antimicrobial Peptides for Use in Plant Disease Control	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSFER DIFFERENCE NMR; HEPARIN-COFACTOR II; BACTERIAL SPOT; MECHANISM; MSI-594; MICELLES; STRAINS; BINDING; TOMATO; LIGAND	KYE28 (KYEITTIHNLFRKLTHRLFRRNFGYT-LR), the representative sequence of helix D of heparin co-factor II, was demonstrated to be potent against agronomically important Gram-negative plant pathogens Xanthomonas vesicatoria and Xanthomonas oryzae, capable of inhibiting disease symptoms in detached tomato leaves. NMR studies in the presence of lipopolysaccharide provided structural insights into the mechanisms underlying this, notably in relationship to outer membrane permeabilization. The three-dimensional solution structure of KYE28 in LPS is characterized by an N-terminal helical segment, an intermediate loop followed by another short helical stretch, and an extended C terminus. The two termini are in close proximity to each other via aromatic packing interactions, whereas the positively charged residues form an exterior polar shell. To further demonstrate the importance of the aromatic residues for this, a mutant peptide KYE28A, with Ala substitutions at Phe(11), Phe(19), Phe(23), and Tyr(25) was designed, which showed attenuated antimicrobial activity at high salt concentrations, as well as lower membrane disruption and LPS binding abilities compared with KYE28. In contrast to KYE28, KYE28A adopted an extended helical structure in LPS with extended N and C termini. Aromatic packing interactions were completely lost, although hydrophobic interaction between the side chains of hydrophobic residues were still partly retained, imparting an amphipathic character and explaining its residual antimicrobial activity and LPS binding as observed from ellipsometry and isothermal titration calorimetry. We thus present key structural aspects of KYE28, constituting an aromatic zipper, of potential importance for the development of novel plant protection agents and therapeutic agents.	[Datta, Aritreyee; Bhattacharyya, Dipita; Ghosh, Anirban; Bhunia, Anirban] Bose Inst, Dept Biophys, P-1-12 CIT Scheme 7 M, Kolkata 700054, India; [Singh, Shalini; Malmsten, Martin] Uppsala Univ, Dept Pharm, SE-75232 Uppsala, Sweden; [Schmidtchen, Artur] Lund Univ, Div Dermatol & Venereol, Dept Clin Sci, SE-22184 Lund, Sweden; [Schmidtchen, Artur] Nanyang Technol Univ, Lee Kong Chian Sch Med, 11 Mandalay Rd, Singapore 308232, Singapore	Department of Science & Technology (India); Bose Institute; Uppsala University; Lund University; Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University	Malmsten, M (corresponding author), Uppsala Univ, Dept Pharm, SE-75232 Uppsala, Sweden.; Bhunia, A (corresponding author), Bose Inst, P-1-12 CIT Scheme 7 M, Kolkata 700054, India.	martin.malmsten@farmaci.uu.se; anirbanbhunia@gmail.com	Ghosh, Anirban/S-9315-2017	Ghosh, Anirban/0000-0001-9837-3339; Malmsten, Martin/0000-0003-0046-5599; Datta, Aritreyee/0000-0001-7757-8415; Bhunia, Anirban/0000-0002-8752-2842	DBT, Government of India [BT/PR3106/INF/22/138/2011]	DBT, Government of India(Department of Biotechnology (DBT) India)	We acknowledge DBT, Government of India, for infrastructure development funding (BT/PR3106/INF/22/138/2011) to Bose Institute for purchasing 700 MHz NMR spectrometer with cryoprobe. Ann-Charlotte Stromdahl and Lise-Britt Walberg are gratefully acknowledged for skillful technical assistance. We thank Prof. Pallob Kundu, Bose Institute, India, for stimulating discussions on plant experiments. We are grateful to Dr. Christian Lindermayer (Helmholtz-Munich, Germany) and Prof. Sampa Das (Bose Institute, India) for providing Xanthomonas bacterial strains. Dr. Kaustuv Sanyal (JNCASR, India) is thanked for providing Candida and Cryptococcus strains. The Central Instrument Facility (CIF) as well as the Madhyamgram Experimental Farm (MEF) of the Bose Institute are greatly acknowledged.	Abbasi PA, 2015, CAN J MICROBIOL, V61, P753, DOI 10.1139/cjm-2015-0228; Bera S, 2015, J COLLOID INTERF SCI, V452, P148, DOI 10.1016/j.jcis.2015.04.031; Bhunia A, 2012, DRUG DISCOV TODAY, V17, P505, DOI 10.1016/j.drudis.2011.12.016; Bhunia A, 2011, BIOPOLYMERS, V96, P273, DOI 10.1002/bip.21530; Bhunia A, 2010, J BIOL CHEM, V285, P3883, DOI 10.1074/jbc.M109.065672; Bhunia A, 2009, CHEM-EUR J, V15, P2036, DOI 10.1002/chem.200802635; Bhunia A, 2009, J BIOL CHEM, V284, P21991, DOI 10.1074/jbc.M109.013573; Brogden KA, 2005, NAT REV MICROBIOL, V3, P238, DOI 10.1038/nrmicro1098; Cohen J, 2002, NATURE, V420, P885, DOI 10.1038/nature01326; Datta A, 2015, SCI REP-UK, V5, DOI 10.1038/srep11951; Domadia PN, 2010, J AM CHEM SOC, V132, P18417, DOI 10.1021/ja1083255; Epand RM, 1999, BBA-BIOMEMBRANES, V1462, P11, DOI 10.1016/S0005-2736(99)00198-4; Hancock REW, 2000, P NATL ACAD SCI USA, V97, P8856, DOI 10.1073/pnas.97.16.8856; Hancock REW, 1999, ANTIMICROB AGENTS CH, V43, P1317, DOI 10.1128/AAC.43.6.1317; HANCOCK REW, 1984, ANNU REV MICROBIOL, V38, P237, DOI 10.1146/annurev.mi.38.100184.001321; Hancock REW, 2006, NAT BIOTECHNOL, V24, P1551, DOI 10.1038/nbt1267; Jeremy B. M., 2002, BIOCHEMISTRY; Junkes C, 2011, EUR BIOPHYS J BIOPHY, V40, P515, DOI 10.1007/s00249-011-0671-x; Kalle M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102577; Kalle M, 2013, J IMMUNOL, V190, P6303, DOI 10.4049/jimmunol.1203030; Kuligowska K, 2015, BMC PLANT BIOL, V15, DOI 10.1186/s12870-014-0394-0; Laskowski RA, 1996, J BIOMOL NMR, V8, P477, DOI 10.1007/BF00228148; Lee DK, 2015, BIOCHEMISTRY-US, V54, P1897, DOI 10.1021/bi501418m; Levy SB, 2004, NAT MED, V10, pS122, DOI 10.1038/nm1145; Makovitzki A, 2007, APPL ENVIRON MICROB, V73, P6629, DOI 10.1128/AEM.01334-07; MALMSTEN M, 1994, J COLLOID INTERF SCI, V166, P333, DOI 10.1006/jcis.1994.1303; Malmsten M, 1998, J COLLOID INTERF SCI, V204, P104, DOI 10.1006/jcis.1998.5568; MALMSTEN M, 1994, LANGMUIR, V10, P1274, DOI 10.1021/la00016a048; Mangoni ML, 2008, J BIOL CHEM, V283, P22907, DOI 10.1074/jbc.M800495200; MARCO GM, 1983, PLANT DIS, V67, P779, DOI 10.1094/PD-67-779; MARION D, 1989, J MAGN RESON, V85, P393, DOI 10.1016/0022-2364(89)90152-2; Matsuzaki K, 1998, BBA-REV BIOMEMBRANES, V1376, P391, DOI 10.1016/S0304-4157(98)00014-8; Mayer M, 1999, ANGEW CHEM INT EDIT, V38, P1784, DOI 10.1002/(SICI)1521-3773(19990614)38:12<1784::AID-ANIE1784>3.0.CO;2-Q; Mayer M, 2001, J AM CHEM SOC, V123, P6108, DOI 10.1021/ja0100120; Manzur JP, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0144142; Papo N, 2005, J BIOL CHEM, V280, P10378, DOI 10.1074/jbc.M412865200; Porcelli F, 2006, BIOCHEMISTRY-US, V45, P5793, DOI 10.1021/bi0601813; Post CB, 2003, CURR OPIN STRUC BIOL, V13, P581, DOI 10.1016/j.sbi.2003.09.012; Potnis N, 2015, MOL PLANT PATHOL, V16, P907, DOI 10.1111/mpp.12244; Ramamoorthy A, 2006, BIOPHYS J, V91, P206, DOI 10.1529/biophysj.105.073890; Ringstad L, 2006, LANGMUIR, V22, P5042, DOI 10.1021/la060317y; Salnikov ES, 2011, BIOCHEMISTRY-US, V50, P3784, DOI 10.1021/bi1018732; Saravanan R, 2011, BBA-BIOMEMBRANES, V1808, P369, DOI 10.1016/j.bbamem.2010.10.001; Schmidtchen A, 2011, BBA-BIOMEMBRANES, V1808, P1081, DOI 10.1016/j.bbamem.2010.12.020; Schmidtchen A, 2009, J BIOL CHEM, V284, P17584, DOI 10.1074/jbc.M109.011650; Scorciapino MA, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00171; Scorciapino MA, 2012, BIOPHYS J, V102, P1039, DOI 10.1016/j.bpj.2012.01.048; Shai Y, 2002, BIOPOLYMERS, V66, P236, DOI 10.1002/bip.10260; Singh S, 2013, BBA-BIOMEMBRANES, V1828, P2709, DOI 10.1016/j.bbamem.2013.06.015; SKLENAR V, 1993, J MAGN RESON SER A, V102, P241, DOI 10.1006/jmra.1993.1098; Strange RN, 2005, ANNU REV PHYTOPATHOL, V43, P83, DOI 10.1146/annurev.phyto.43.113004.133839; Timilsina S, 2015, APPL ENVIRON MICROB, V81, P1520, DOI 10.1128/AEM.03000-14; Wang GS, 2009, NUCLEIC ACIDS RES, V37, pD933, DOI 10.1093/nar/gkn823; Wang JJ, 2015, SCI REP-UK, V5, DOI 10.1038/srep15963; Yu LL, 2006, ANAL CHIM ACTA, V556, P216, DOI 10.1016/j.aca.2005.09.008; Zasloff M, 2002, NATURE, V415, P389, DOI 10.1038/415389a; Zweytick D, 2011, J BIOL CHEM, V286, P21266, DOI 10.1074/jbc.M110.195412	58	36	36	2	14	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 17	2016	291	25					13301	13317		10.1074/jbc.M116.719575	http://dx.doi.org/10.1074/jbc.M116.719575			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DR2YT	27137928	Green Published, hybrid			2022-12-26	WOS:000379770500033
J	Karner, CM; Esen, E; Chen, JK; Hsu, FF; Turk, J; Long, FX				Karner, Courtney M.; Esen, Emel; Chen, Jiakun; Hsu, Fong-Fu; Turk, John; Long, Fanxin			Wnt Protein Signaling Reduces Nuclear Acetyl-CoA Levels to Suppress Gene Expression during Osteoblast Differentiation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RECEPTOR-RELATED PROTEIN-5; HISTONE ACETYLATION; BETA-CATENIN; VERTEBRATE GASTRULATION; BONE ANABOLISM; STEM-CELLS; PKC-DELTA; ACTIVATION; METABOLISM; GLYCOLYSIS	Developmental signals in metazoans play critical roles in inducing cell differentiation from multipotent progenitors. The existing paradigm posits that the signals operate directly through their downstream transcription factors to activate expression of cell type-specific genes, which are the hallmark of cell identity. We have investigated the mechanism through which Wnt signaling induces osteoblast differentiation in an osteoblast-adipocyte bipotent progenitor cell line. Unexpectedly, Wnt3a acutely suppresses the expression of a large number of genes while inducing osteoblast differentiation. The suppressed genes include Pparg and Cebpa, which encode adipocyte-specifying transcription factors and suppression of which is sufficient to induce osteoblast differentiation. The large scale gene suppression induced by Wnt3a corresponds to a global decrease in histone acetylation, an epigenetic modification that is associated with gene activation. Mechanistically, Wnt3a does not alter histone acetyltransferase or deacetylase activities but, rather, decreases the level of acetyl-CoA in the nucleus. The Wnt-induced decrease in histone acetylation is independent of beta-catenin signaling but, rather, correlates with suppression of glucose metabolism in the tricarboxylic acid cycle. Functionally, preventing histone deacetylation by increasing nucleocytoplasmic acetyl-CoA levels impairs Wnt3a-induced osteoblast differentiation. Thus, Wnt signaling induces osteoblast differentiation in part through histone deacetylation and epigenetic suppression of an alternative cell fate.	[Karner, Courtney M.; Esen, Emel; Long, Fanxin] Washington Univ, Sch Med, Dept Orthopaed Surg, St Louis, MO 63131 USA; [Esen, Emel; Chen, Jiakun; Long, Fanxin] Washington Univ, Sch Med, Div Biol & Biomed Sci, St Louis, MO 63131 USA; [Long, Fanxin] Washington Univ, Sch Med, Dept Dev Biol, St Louis, MO 63131 USA; [Hsu, Fong-Fu; Turk, John; Long, Fanxin] Washington Univ, Sch Med, Dept Med, St Louis, MO 63131 USA; [Karner, Courtney M.] Duke Univ, Sch Med, Dept Orthopaed Surg, Durham, NC 27710 USA	Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); Duke University	Long, FX (corresponding author), Washington Univ, Sch Med, Dept Orthopaed Surg, St Louis, MO 63131 USA.; Long, FX (corresponding author), Washington Univ, Sch Med, Div Biol & Biomed Sci, St Louis, MO 63131 USA.; Long, FX (corresponding author), Washington Univ, Sch Med, Dept Dev Biol, St Louis, MO 63131 USA.; Long, FX (corresponding author), Washington Univ, Sch Med, Dept Med, St Louis, MO 63131 USA.	flong@wustl.edu	Chen, Jiakun/J-2063-2019; Chen, Jiakun/AAP-9621-2021	Chen, Jiakun/0000-0003-1806-2421; Karner, Courtney/0000-0003-0387-4486; Hsu, Fong-Fu/0000-0001-5368-0183	National Institutes of Health [AR060456, 5F32AR060674, P41-RR00954, P60-DK20579, P30-DK56341]; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR000954] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR060456, F32AR060674, R01AR055923] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK020579, P30DK056341] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P41GM103422] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Grants AR060456 (to F. L.), 5F32AR060674 (to C. M. K.), P41-RR00954 (to J. T.), P60-DK20579 (to J. T.), and P30-DK56341 (to J. T.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Balemans W, 2002, J MED GENET, V39, P91, DOI 10.1136/jmg.39.2.91; Balemans W, 2001, HUM MOL GENET, V10, P537, DOI 10.1093/hmg/10.5.537; Boyden LM, 2002, NEW ENGL J MED, V346, P1513, DOI 10.1056/NEJMoa013444; Bracha AL, 2010, NAT CHEM BIOL, V6, P202, DOI 10.1038/NCHEMBIO.301; Cui YJ, 2011, NAT MED, V17, P684, DOI 10.1038/nm.2388; Day TF, 2005, DEV CELL, V8, P739, DOI 10.1016/j.devcel.2005.03.016; Eden E, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-48; Esen E, 2015, J BONE MINER RES, V30, P1959, DOI 10.1002/jbmr.2556; Esen E, 2013, CELL METAB, V17, P745, DOI 10.1016/j.cmet.2013.03.017; Frey JL, 2015, MOL CELL BIOL, V35, P1979, DOI 10.1128/MCB.01343-14; Goldberg AD, 2007, CELL, V128, P635, DOI 10.1016/j.cell.2007.02.006; Gong YQ, 2001, CELL, V107, P513, DOI 10.1016/S0092-8674(01)00571-2; Guarente L, 2000, GENE DEV, V14, P1021; Habas R, 2003, GENE DEV, V17, P295, DOI 10.1101/gad.1022203; Habas R, 2001, CELL, V107, P843, DOI 10.1016/S0092-8674(01)00614-6; Hecht A, 2000, EMBO J, V19, P1839, DOI 10.1093/emboj/19.8.1839; Hill TP, 2005, DEV CELL, V8, P727, DOI 10.1016/j.devcel.2005.02.013; Hu HL, 2005, DEVELOPMENT, V132, P49, DOI 10.1242/dev.01564; Inoki K, 2006, CELL, V126, P955, DOI 10.1016/j.cell.2006.06.055; Jenuwein T, 2001, SCIENCE, V293, P1074, DOI 10.1126/science.1063127; Joeng KS, 2011, DEV BIOL, V359, P222, DOI 10.1016/j.ydbio.2011.08.020; Kang S, 2007, J BIOL CHEM, V282, P14515, DOI 10.1074/jbc.M700030200; Karner CM, 2015, J CLIN INVEST, V125, P551, DOI 10.1172/JCI78470; Kato M, 2002, J CELL BIOL, V157, P303, DOI 10.1083/jcb.200201089; Kinoshita N, 2003, GENE DEV, V17, P1663, DOI 10.1101/gad.1101303; Kouzarides T, 2007, CELL, V128, P693, DOI 10.1016/j.cell.2007.02.005; Kuhl M, 2000, TRENDS GENET, V16, P279, DOI 10.1016/s0168-9525(00)02028-x; Li XD, 2008, J BONE MINER RES, V23, P860, DOI 10.1359/JBMR.080216; Little RD, 2002, AM J HUM GENET, V70, P11, DOI 10.1086/338450; Long FX, 2012, NAT REV MOL CELL BIO, V13, P27, DOI 10.1038/nrm3254; Mahmoudi T, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000539; McBrian MA, 2013, MOL CELL, V49, P310, DOI 10.1016/j.molcel.2012.10.025; Meshorer E, 2006, DEV CELL, V10, P105, DOI 10.1016/j.devcel.2005.10.017; Mohan M, 2010, GENE DEV, V24, P574, DOI 10.1101/gad.1898410; Moussaieff A, 2015, CELL METAB, V21, P392, DOI 10.1016/j.cmet.2015.02.002; OGAWA M, 1988, EMBO J, V7, P1337, DOI 10.1002/j.1460-2075.1988.tb02949.x; Pate KT, 2014, EMBO J, V33, P1454, DOI 10.15252/embj.201488598; Rodda SJ, 2006, DEVELOPMENT, V133, P3231, DOI 10.1242/dev.02480; Shechter D, 2007, NAT PROTOC, V2, P1445, DOI 10.1038/nprot.2007.202; Sierra J, 2006, GENE DEV, V20, P586, DOI 10.1101/gad.1385806; Tsukada Y, 2006, NATURE, V439, P811, DOI 10.1038/nature04433; Tu XL, 2007, DEV CELL, V12, P113, DOI 10.1016/j.devcel.2006.11.003; Wellen KE, 2009, SCIENCE, V324, P1076, DOI 10.1126/science.1164097; Wu XM, 2008, CELL, V133, P340, DOI 10.1016/j.cell.2008.01.052; Yoon JC, 2010, GENE DEV, V24, P1507, DOI 10.1101/gad.1924910	45	34	38	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 17	2016	291	25					13028	13039		10.1074/jbc.M115.708578	http://dx.doi.org/10.1074/jbc.M115.708578			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DR2YT	27129247	Green Published, hybrid			2022-12-26	WOS:000379770500012
J	Konuma, T; Tsukamoto, Y; Nagasawa, H; Nagata, S				Konuma, Takahiro; Tsukamoto, Yusuke; Nagasawa, Hiromichi; Nagata, Shinji			Imbalanced Hemolymph Lipid Levels Affect Feeding Motivation in the Two-Spotted Cricket, Gryllus bimaculatus	PLOS ONE			English	Article							LOCUSTA-MIGRATORIA NYMPHS; ADIPOKINETIC HORMONE; INSECTS; APOLIPOPROTEINS; MECHANISMS; DROSOPHILA	Insect feeding behavior is regulated by many intrinsic factors, including hemolymph nutrient levels. Adipokinetic hormone (AKH) is a peptide factor that modulates hemolymph nutrient levels and regulates the nutritional state of insects by triggering the transfer of lipids into the hemolymph. We recently demonstrated that RNA interference (RNAi)-mediated knockdown of the AKH receptor (AKHR) reduces hemolymph lipid levels, causing an increase in the feeding frequency of the two-spotted cricket, Gryllus bimaculatus. This result indicated that reduced hemolymph lipid levels might motivate crickets to feed. In the present study, to elucidate whether hemolymph lipid levels contribute to insect feeding behavior, we attempted to manipulate hemolymph lipid levels via the lipophorin (Lp)-mediated lipid transferring system in G. bimaculatus. Of the constituent proteins in Lp, we focused on apolipophorin-III (GrybiApoLp-III) because of its possible role in facilitating lipid mobilization. First, we used RNAi to reduce the expression of GrybiApoLp-III. RNAi-mediated knockdown of GrybiApoLp-III had little effect on basal hemolymph lipid levels and the amount of food intake. In addition, hemolymph lipid levels remained static even after injecting AKH into GrybiApoLp-IIIRNAi crickets. These observations indicated that ApoLp-III does not maintain basal hemolymph lipid levels in crickets fed ad libitum, but is necessary for mobilizing lipid transfer into the hemolymph following AKH stimulation. Second, Lp (containing lipids) was injected into the hemolymph to induce a temporary increase in hemolymph lipid levels. Consequently, the initiation of feeding was delayed in a dose-dependent manner, indicating that increased hemolymph lipid levels reduced the motivation to feed. Taken together, these data validate the importance of basal hemolymph lipid levels in the control of energy homeostasis and for regulating feeding behavior in crickets.	[Konuma, Takahiro; Nagasawa, Hiromichi; Nagata, Shinji] Univ Tokyo, Grad Sch Agr & Life Sci, Dept Appl Biol Chem, Tokyo, Japan; [Tsukamoto, Yusuke; Nagata, Shinji] Univ Tokyo, Grad Sch Frontier Sci, Dept Integrated Biosci, Chiba, Japan	University of Tokyo; University of Tokyo	Nagata, S (corresponding author), Univ Tokyo, Grad Sch Agr & Life Sci, Dept Appl Biol Chem, Tokyo, Japan.; Nagata, S (corresponding author), Univ Tokyo, Grad Sch Frontier Sci, Dept Integrated Biosci, Chiba, Japan.	shinjin@edu.k.u-tokyo.ac.jp			Ministry of Education, Science, Sports, and Culture of Japan [24580157]; NAITO Foundation; Grants-in-Aid for Scientific Research [15H04609] Funding Source: KAKEN	Ministry of Education, Science, Sports, and Culture of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); NAITO Foundation(Naito Memorial Foundation); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was partly supported by a Grant-in-Aid for Scientific Research #24580157 from the Ministry of Education, Science, Sports, and Culture of Japan, and the NAITO Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BERNAYS EA, 1973, ENTOMOL EXP APPL, V16, P329, DOI 10.1007/BF00334244; Bharucha KN, 2008, J EXP BIOL, V211, P3103, DOI 10.1242/jeb.016451; Canavoso LE, 2001, ANNU REV NUTR, V21, P23, DOI 10.1146/annurev.nutr.21.1.23; Candy DJ, 2002, INSECT BIOCHEM MOLEC, V32, P1361, DOI 10.1016/S0965-1748(02)00056-5; CHINO H, 1985, COMPREHENSIVE INSECT, V10, P115; Gade G, 1997, PHYSIOL REV, V77, P963, DOI 10.1152/physrev.1997.77.4.963; Gade G, 2009, ANN NY ACAD SCI, V1163, P125, DOI 10.1111/j.1749-6632.2008.03625.x; Isabel G, 2005, AM J PHYSIOL-REG I, V288, pR531, DOI 10.1152/ajpregu.00158.2004; KANOST MR, 1988, J BIOL CHEM, V263, P10568; Kilby B. A., 1963, P111; Konuma T, 2012, ENDOCRINOLOGY, V153, P3111, DOI 10.1210/en.2011-1533; Lorenz MW, 2003, COMP BIOCHEM PHYS B, V136, P197, DOI 10.1016/S1096-4959(03)00227-6; Mullen L, 2003, INSECT BIOCHEM MOLEC, V33, P661, DOI 10.1016/S0965-1748(03)00045-6; Mullens DE, 1985, COMPREHENSIVE INSECT, V3, P356; Nagata S, 2011, GEN COMP ENDOCR, V172, P90, DOI 10.1016/j.ygcen.2011.03.004; Ryan RO, 2000, ANNU REV ENTOMOL, V45, P233, DOI 10.1146/annurev.ento.45.1.233; Simpson S.J., 1995, P137; SIMPSON SJ, 1981, PHYSIOL ENTOMOL, V6, P315, DOI 10.1111/j.1365-3032.1981.tb00276.x; SIMPSON SJ, 1986, ANIM BEHAV, V34, P480, DOI 10.1016/S0003-3472(86)80117-8; SIMPSON SJ, 1982, PHYSIOL ENTOMOL, V7, P325, DOI 10.1111/j.1365-3032.1982.tb00305.x; SIMPSON SJ, 1983, PHYSIOL ENTOMOL, V8, P451, DOI 10.1111/j.1365-3032.1983.tb00380.x; SIMPSON SJ, 1985, PHYSIOL ENTOMOL, V10, P443, DOI 10.1111/j.1365-3032.1985.tb00066.x; SIMPSON SJ, 1993, PHYSIOL ENTOMOL, V18, P395, DOI 10.1111/j.1365-3032.1993.tb00613.x; SMITH AF, 1994, J LIPID RES, V35, P1976; STONE JV, 1976, NATURE, V263, P207, DOI 10.1038/263207a0; STOREY KB, 1978, INSECT BIOCHEM, V8, P73, DOI 10.1016/0020-1790(78)90013-6; Sundermeyer K, 1996, INSECT BIOCHEM MOLEC, V26, P735, DOI 10.1016/S0965-1748(96)00060-4; Tsuchida K, 2010, COMP BIOCHEM PHYS B, V155, P363, DOI 10.1016/j.cbpb.2009.12.006; van der Horst DJ, 2002, MOL CELL BIOCHEM, V239, P113, DOI 10.1023/A:1020541010547; van der Horst DJ, 1988, J INSECT PHYSL, V56, P844; VANDERHORST DJ, 1993, INSECT LIPIDS: CHEMISTRY, BIOCHEMISTRY AND BIOLOGY, P1; ZOLLNER N., 1962, ZEIT GES EXPTL MED, V135, P545, DOI 10.1007/BF02045455	32	8	8	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 4	2016	11	5							e0154841	10.1371/journal.pone.0154841	http://dx.doi.org/10.1371/journal.pone.0154841			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DL5KR	27144650	Green Submitted, Green Published, gold			2022-12-26	WOS:000375676400083
J	Ravensbergen, SJ; Lokate, M; Cornish, D; Kloeze, E; Ott, A; Friedrich, AW; van Hest, R; Akkerman, OW; de Lange, WC; van der Werf, TS; Bathoorn, E; Stienstra, Y				Ravensbergen, Sofanne J.; Lokate, Mariette; Cornish, Darren; Kloeze, Eveline; Ott, Alewijn; Friedrich, Alex W.; van Hest, Rob; Akkerman, Onno W.; de lange, Wiel C.; van der Werf, Tjip S.; Bathoorn, Erik; Stienstra, Ymkje			High Prevalence of Infectious Diseases and Drug-Resistant Microorganisms in Asylum Seekers Admitted to Hospital; No Carbapenemase Producing Enterobacteriaceae until September 2015	PLOS ONE			English	Article							LACTAMASE-PRODUCING ENTEROBACTERIACEAE; FEVER BORRELIA-RECURRENTIS; REFUGEES	Introduction The current refugee crisis emphasizes the need for information on infectious diseases and resistant microorganisms in asylum seekers with possible consequences for public health and infection control. Methods We collected data from asylum seekers admitted to our university hospital or who presented at the Emergency Department (n = 273). We collected general and demographic characteristics including country of origin, the reason of presentation, and the screening results of multi-drug resistant organisms. Results 67% of the patients were male with a median age of the study group of 24 years (IQR 15-33); 48% of the patients had an infectious disease-predominantly malaria with P. vivax or tuberculosis. Patients also reported with diseases which are less common-e. g. leishmaniasis, or even conditions rarely diagnosed in Europe-e. g. louse borne relapsing fever. A carriage rate of 31% for multi-drug resistant microorganisms (MDRO) was observed, with ESBL-expressing E. coli (n = 20) being the most common MDRO. No carriage of Carbapenemase Producing Enterobacteriaceae was found. Conclusion The current refugee crisis in Europe challenges hospitals to quickly identify and respond to communicable diseases and the carriage of MDRO. A rapid response is necessary to optimize the treatment of infectious diseases amongst asylum seekers to maximize infection control.	[Ravensbergen, Sofanne J.; Kloeze, Eveline; van der Werf, Tjip S.; Stienstra, Ymkje] Univ Groningen, Univ Med Ctr Groningen, Dept Internal Med Infect Dis, Groningen, Netherlands; [Lokate, Mariette; Ott, Alewijn; Friedrich, Alex W.; Bathoorn, Erik] Univ Groningen, Univ Med Ctr Groningen, Dept Med Microbiol, Groningen, Netherlands; [Cornish, Darren] Primary Hlth Care Ctr Asylum Seekers Gezondheidsc, Ter Apel, Netherlands; [Ott, Alewijn] Certe, Dept Med Microbiol, Groningen, Netherlands; [van Hest, Rob] Reg Publ Hlth Serv Groningen, Dept TB Control, Groningen, Netherlands; [Akkerman, Onno W.; de lange, Wiel C.; van der Werf, Tjip S.] Univ Groningen, Univ Med Ctr Groningen, Dept Pulm Dis & TB, Groningen, Netherlands	University of Groningen; University of Groningen; University of Groningen	Stienstra, Y (corresponding author), Univ Groningen, Univ Med Ctr Groningen, Dept Internal Med Infect Dis, Groningen, Netherlands.	y.stienstra@umcg.nl	Friedrich, Alex/ABG-9823-2020	Akkerman, Onno/0000-0001-5638-9260; van der Werf, Tjip/0000-0002-4824-1642; Bathoorn, Erik/0000-0003-2319-8147				de Sande-Bruinsma NV, 2008, EMERG INFECT DIS, V14, P1722, DOI 10.3201/eid1411.070467; Djahmi N, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/305784; Gerritsen AAM, 2006, SOC PSYCH PSYCH EPID, V41, P18, DOI 10.1007/s00127-005-0003-5; Glasner C., 2013, EURP SURVEILL, P18, DOI DOI 10.2807/1560-7917.ES2013.18.28.20525; Goldenberger D, 2015, EUROSURVEILLANCE, V20, P2, DOI 10.2807/1560-7917.ES2015.20.32.21204; Greenaway C, 2011, CAN MED ASSOC J, V183, pE939, DOI 10.1503/cmaj.090302; Huijbers PMC, 2013, CLIN MICROBIOL INFEC, V19, pE256, DOI 10.1111/1469-0691.12150; Lee D P R, 2009, MMWR REP, V62, P1; Norredam M, 2006, EUR J PUBLIC HEALTH, V16, P285, DOI 10.1093/eurpub/cki191; Paltansing S, 2013, EMERG INFECT DIS, V19, P1206, DOI [10.3201/eid1908.130257, 10.3201/eid.1908.130257]; Pfortmueller CA, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0148196; Pottie K, 2011, CAN MED ASSOC J, V183, pE824, DOI 10.1503/cmaj.090313; Reinheimer C, 2016, EUROSURVEILLANCE, V21, P9, DOI 10.2807/1560-7917.ES.2016.21.2.30110; Sonden K, 2014, EUROSURVEILLANCE, V19, P2, DOI 10.2807/1560-7917.ES2014.19.35.20890; Teicher CL, 2014, EMERG INFECT DIS, V20, P1949, DOI 10.3201/eid2011.140835; van der Bij AK, 2012, J ANTIMICROB CHEMOTH, V67, P2090, DOI 10.1093/jac/dks214; Wilting KR, 2015, EUROSURVEILLANCE, V20, P2, DOI 10.2807/1560-7917.ES2015.20.30.21196; Zhou X, 2014, J CLIN MICROBIOL, V52, P4293, DOI 10.1128/JCM.01125-14	18	26	26	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 4	2016	11	5							e0154791	10.1371/journal.pone.0154791	http://dx.doi.org/10.1371/journal.pone.0154791			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DL5KR	27144599	gold, Green Submitted, Green Published			2022-12-26	WOS:000375676400072
J	Guo, T; Wang, HC; Xue, WQ; Zhao, J; Yang, ZL				Guo, Ting; Wang, Han Chen; Xue, Wan Qiu; Zhao, Jun; Yang, Zhu L.			Phylogenetic Analyses of Armillaria Reveal at Least 15 Phylogenetic Lineages in China, Seven of Which Are Associated with Cultivated Gastrodia elata	PLOS ONE			English	Article							DNA-BASED IDENTIFICATION; SPECIES RECOGNITION; FUNGI; ALPHA; RECOMBINATION; HYBRIDIZATION; NEUROSPORA; SPECIATION; SEQUENCES; PATHOGEN	Fungal species of Armillaria, which can act as plant pathogens and/or symbionts of the Chinese traditional medicinal herb Gastrodia elata ("Tianma"), are ecologically and economically important and have consequently attracted the attention of mycologists. However, their taxonomy has been highly dependent on morphological characterization and mating tests. In this study, we phylogenetically analyzed Chinese Armillaria samples using the sequences of the internal transcribed spacer region, translation elongation factor-1 alpha gene and beta-tubulin gene. Our data revealed at least 15 phylogenetic lineages of Armillaria from China, of which seven were newly discovered and two were recorded from China for the first time. Fourteen Chinese biological species of Armillaria, which were previously defined based on mating tests, could be assigned to the 15 phylogenetic lineages identified herein. Seven of the 15 phylogenetic lineages were found to be disjunctively distributed in different continents of the Northern Hemisphere, while eight were revealed to be endemic to certain continents. In addition, we found that seven phylogenetic lineages of Armillaria were used for the cultivation of Tianma, only two of which had been recorded to be associated with Tianma previously. We also illustrated that G. elata f. glauca ("Brown Tianma") and G. elata f. elata ("Red Tianma"), two cultivars of Tianma grown in different regions of China, form symbiotic relationships with different phylogenetic lineages of Armillaria. These findings should aid the development of Tianma cultivation in China.	[Guo, Ting; Yang, Zhu L.] Chinese Acad Sci, Kunming Inst Bot, Key Lab Plant Div & Biogeog East Asia, Heilongtan 650201, Kunming, Peoples R China; [Wang, Han Chen; Xue, Wan Qiu] Chongqing Normal Univ, Coll Life Sci, Chongqing 401331, Peoples R China; [Guo, Ting] Univ Chinese Acad Sci, 19A Yuquan Rd, Beijing 100049, Peoples R China; [Zhao, Jun] State Forestry Adm, Gen Stn Forest Pest Control, Shenyang 110034, Peoples R China	Chinese Academy of Sciences; Kunming Institute of Botany, CAS; Chongqing Normal University; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS	Yang, ZL (corresponding author), Chinese Acad Sci, Kunming Inst Bot, Key Lab Plant Div & Biogeog East Asia, Heilongtan 650201, Kunming, Peoples R China.; Wang, HC (corresponding author), Chongqing Normal Univ, Coll Life Sci, Chongqing 401331, Peoples R China.	higherfungi2005@aliyun.com; fungi@mail.kib.ac.cn			National Natural Science Foundation of China [30800006, 31170024]; Chongqing Natural Science Foundation [CSTC, 2009BA5030]; Key Laboratory for Plant Diversity and Biogeography of East Asia, KIB, Chinese Academy of Sciences [KLBB 201207]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Chongqing Natural Science Foundation(Natural Science Foundation of Chongqing); Key Laboratory for Plant Diversity and Biogeography of East Asia, KIB, Chinese Academy of Sciences	This study was financed by the National Natural Science Foundation of China (Nos. 30800006 and 31170024), the Chongqing Natural Science Foundation (No. CSTC, 2009BA5030), and the Key Laboratory for Plant Diversity and Biogeography of East Asia, KIB, Chinese Academy of Sciences (KLBB 201207). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aagesen L, 2004, ORG DIVERS EVOL, V4, P35, DOI 10.1016/j.ode.2003.11.003; Antonin V, 2009, MYCOL PROG, V8, P259, DOI 10.1007/s11557-009-0597-1; Baumgartner K, 2012, FUNGAL BIOL-UK, V116, P677, DOI 10.1016/j.funbio.2012.03.006; Brasier CM, 1999, P NATL ACAD SCI USA, V96, P5878, DOI 10.1073/pnas.96.10.5878; Bursdall Jr H.H., 2008, N AM FUNGI, V3, P261, DOI [10.2509/naf2008.003.00717, DOI 10.2509/NAF2008.003.00717]; Cai L, 2011, FUNGAL DIVERS, V50, P121, DOI 10.1007/s13225-011-0127-8; Cha JY, 1995, EUR J FOREST PATHOL, V25, P319; Coetzee MPA, 2015, MYCOSCIENCE, V56, P530, DOI 10.1016/j.myc.2015.05.001; Dettman JR, 2006, MYCOLOGIA, V98, P436, DOI 10.3852/mycologia.98.3.436; Dettman JR, 2003, EVOLUTION, V57, P2721; Doyle J. J., 1987, PHYTOCHEM B, P11; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.1111/j.1558-5646.1985.tb00420.x; GARDES M, 1993, MOL ECOL, V2, P113, DOI 10.1111/j.1365-294X.1993.tb00005.x; Geiser DM, 1998, P NATL ACAD SCI USA, V95, P388, DOI 10.1073/pnas.95.1.388; GRIFFITH GW, 1994, HEREDITY, V72, P278, DOI 10.1038/hdy.1994.38; Guillaumin J. J., 1991, USDA HDB, P10; Hall T.A., 1999, NUCL ACIDS S SER, V41, P95; Hasegawa E, 2010, MYCOLOGIA, V102, P898, DOI 10.3852/09-238; Hughes KW, 2001, MOL BIOL EVOL, V18, P94, DOI 10.1093/oxfordjournals.molbev.a003724; Inderbitzin P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028341; Jargeat P, 2010, MOL ECOL, V19, P5216, DOI 10.1111/j.1365-294X.2010.04863.x; Johnston PR, 2006, NEW ZEAL J BOT, V44, P65, DOI 10.1080/0028825X.2006.9513007; Katoh K, 2002, NUCLEIC ACIDS RES, V30, P3059, DOI 10.1093/nar/gkf436; Kauserud H, 2004, MOL ECOL, V13, P3137, DOI 10.1111/j.1365-294X.2004.02307.x; Kauserud H, 2007, MOL ECOL, V16, P389, DOI 10.1111/j.1365-294X.2006.03129.x; Kikuchi G, 2010, MYCOSCIENCE, V51, P366, DOI 10.1007/s10267-010-0053-8; Klopfenstein NB, 2012, P 60 ANN W INT FOR D; KORHONEN K, 1978, Karstenia, V18, P31; Kusano S., 1911, J COLL AGR IMPERIAL, V9, P1; Lee MSY, 2001, TRENDS ECOL EVOL, V16, P681, DOI 10.1016/S0169-5347(01)02313-8; Maphosa L, 2006, AUSTRALAS PLANT PATH, V35, P513, DOI 10.1071/AP06056; MOHAMMED C, 1994, MYCOL RES, V98, P607, DOI 10.1016/S0953-7562(09)80406-1; Moon CD, 2004, MOL ECOL, V13, P1455, DOI 10.1111/j.1365-294X.2004.02138.x; Morrison DJ, 2004, FOREST PATHOL, V34, P15, DOI 10.1046/j.1439-0329.2003.00345.x; Mulholland V, 2012, FOREST PATHOL, V42, P229, DOI 10.1111/j.1439-0329.2011.00747.x; Myllys L, 2001, MYCOLOGIA, V93, P335, DOI 10.2307/3761655; Newcombe G, 2000, MYCOL RES, V104, P261, DOI 10.1017/S0953756299001665; Nylander JAA., 2004, BIOINFORMATICS; Ota Y, 2000, MYCOL RES, V104, P1046, DOI 10.1017/S0953756200002550; Ota Y, 1998, PLANT DIS, V82, P537, DOI 10.1094/PDIS.1998.82.5.537; Qin GF, 2007, MYCOLOGIA, V99, P430, DOI 10.3852/mycologia.99.3.430; Qin GF, 2001, MYCOSYSTEMA, V21, P346; Qin GuoFu, 2000, Mycosystema, V19, P509; Qin GuoFu, 1999, Mycosystema, V18, P243; Ranjitkar S, 2016, ENVIRON MODELL SOFTW, V75, P263, DOI 10.1016/j.envsoft.2015.10.027; Redhead S. A., 2011, Taxon, V60, P1770; Rehner S., 2001, PRIMERS ELONGATION F; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Ross-Davis AL, 2012, MYCOSCIENCE, V53, P161, DOI 10.1007/s10267-011-0148-x; Sekizaki H, 2008, BIOL PHARM BULL, V31, P1410, DOI 10.1248/bpb.31.1410; Shaw CG, 1991, ARMILLARIA ROOT DIS; Smith SA, 2008, BIOINFORMATICS, V24, P715, DOI 10.1093/bioinformatics/btm619; Stamatakis A, 2008, SYST BIOL, V57, P758, DOI 10.1080/10635150802429642; Stephens M, 2003, AM J HUM GENET, V73, P1162, DOI 10.1086/379378; SUN LF, 2003, FOREST PEST DIS, V22, P35; Sun Lifu, 2007, Journal of Northeast Forestry University, V35, P48; [孙立夫 SUN LiFu], 2007, [菌物学报, Mygosystema], V26, P306; Sun LiFu, 2007, Mycosystema, V26, P59; Sun SQ, 2003, SHANDONG SCI, V16, P7; Sung GH, 2007, MOL PHYLOGENET EVOL, V44, P1204, DOI 10.1016/j.ympev.2007.03.011; Swofford D, 2002, PAUP PHYLOGENETIC AN, DOI 10.1111/J.0014-3820.2002.TB00191.X; Taylor JW, 2000, FUNGAL GENET BIOL, V31, P21, DOI 10.1006/fgbi.2000.1228; Tsykun T, 2013, MYCOLOGIA, V105, P1059, DOI 10.3852/12-209; Wang HC, 2007, SYSTEMATIC STUDIES A; Wang QY, 2001, CHINESE TRADITIONAL, V32, P839; WARGO PM, 1985, PLANT DIS, V69, P826, DOI 10.1094/PD-69-826; Wendland J, 1997, MYCOL RES, V101, P798, DOI 10.1017/S0953756296003450; XU J-T, 1990, Acta Botanica Sinica, V32, P26; Zervakis GI, 2004, MICROBIOL-SGM, V150, P715, DOI 10.1099/mic.0.26673-0; Zhao J, 2000, J JILIN FORESTRY U, V16, P5; Zhao Jun, 2008, Mycosystema, V27, P156; [赵俊 Zhao Jun], 2005, [菌物学报, Mygosystema], V24, P164; ZHOU X., 1987, MORPHOLOGY GASTRODIA	73	27	35	3	52	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 3	2016	11	5							e0154794	10.1371/journal.pone.0154794	http://dx.doi.org/10.1371/journal.pone.0154794			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DL5KK	27138686	gold, Green Published, Green Submitted			2022-12-26	WOS:000375675700070
J	Jumbe, T; Comstock, SS; Hahn, SL; Harris, WS; Kinabo, J; Fenton, JI				Jumbe, Theresia; Comstock, Sarah S.; Hahn, Samantha L.; Harris, William S.; Kinabo, Joyce; Fenton, Jenifer I.			Whole Blood Levels of the n-6 Essential Fatty Acid Linoleic Acid Are Inversely Associated with Stunting in 2-to-6 Year Old Tanzanian Children: A Cross-Sectional Study	PLOS ONE			English	Article							RANDOMIZED CONTROLLED-TRIAL; LOW-INCOME COUNTRIES; DOCOSAHEXAENOIC ACID; ARACHIDONIC-ACID; PRETERM INFANTS; YOUNG-CHILDREN; 5,8,11-EICOSATRIENOIC ACID; OMEGA-3-FATTY-ACID LEVELS; PLASMA PHOSPHOLIPIDS; COMPLEMENTARY FOODS	Background In Tanzania, 35% of all children below five years of age are stunted. Dietary fatty acids (FA) are critical for growth and development. However, whole blood FA levels in Tanzanian children are poorly described. Objective The objectives of this cross-sectional study were to assess 1) whole blood levels of essential fatty acids and 2) the association between whole blood FA levels and growth parameters in Tanzanian children 2-6 years of age. Methods A drop of blood was collected on an antioxidant treated card and analyzed for FA composition. Weight and height were measured and z-scores calculated. Relationships between FAs and growth parameters were analyzed by linear regression. Results Of the 334 children that participated, 30.3% were stunted. The average whole blood level of Mead acid was 0.15%. The anthropometric z-score height-for-age (HAZ) was inversely associated with Mead acid, the Mead acid to arachidonic acid (T/T) ratio, and total n-9 FA. Additionally, HAZ was positively associated with linoleic acid and total n-6 FA. BMI-for-age was positively associated with oleic acid, total n-9 FA and T/T ratio but inversely associated with arachidonic acid and total n-6 FA. Weight-for-height was inversely associated with arachidonic acid and total n-6 FAs and positively associated with oleic acid and total n-9 FA. Weight-for-age was not associated with any FA tested. Total n-3 FAs were not associated with any growth parameters measured. Conclusions The EFA linoleic acid and the markers of FA deficiency were associated with HAZ, an indicator for stunting in 2-6 year old Tanzanian children. Total n-6, total n-9, and a number of individual FAs were associated with growth. Increasing dietary intake of EFA and n-6 FAs may be a strategy to combat stunting in this population.	[Jumbe, Theresia; Comstock, Sarah S.; Hahn, Samantha L.; Fenton, Jenifer I.] Michigan State Univ, Dept Food Sci & Human Nutr, E Lansing, MI 48824 USA; [Harris, William S.] Univ S Dakota, Sanford Sch Med, Sioux Falls, SD USA; [Harris, William S.] OmegaQuant Analyt LLC, Sioux Falls, SD USA; [Jumbe, Theresia; Kinabo, Joyce] Sokoine Univ Agr, Morogoro, Tanzania	Michigan State University; University of South Dakota; Sokoine University of Agriculture	Fenton, JI (corresponding author), Michigan State Univ, Dept Food Sci & Human Nutr, E Lansing, MI 48824 USA.	imigjeni@msu.edu	Harris, William Stephen/T-1674-2019; Hahn, Samantha L./N-3027-2017	Harris, William Stephen/0000-0003-3042-9353; Hahn, Samantha L./0000-0002-9553-0383	United States Agency for International Development (USAID) [CA-621-A-00-11-00009-00]	United States Agency for International Development (USAID)(United States Agency for International Development (USAID)CGIAR)	This work was made possible by the generous support of the American people through the United States Agency for International Development (USAID)-funded Innovative Agricultural Research Initiative project (iAGRI) (Award No. CA-621-A-00-11-00009-00). The opinions expressed herein are those of the authors and do not necessarily reflect the views of the U.S. Agency for International Development or the United States Government. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aarsetoey H, 2011, LIPIDS, V46, P151, DOI 10.1007/s11745-010-3511-3; Aarsetoey H, 2009, J NUTR, V139, P507, DOI 10.3945/jn.108.096446; Aarsetoy H, 2008, RESUSCITATION, V78, P258, DOI 10.1016/j.resuscitation.2008.04.007; Ackatia-Armah RS, 2015, AM J CLIN NUTR, V101, P632, DOI 10.3945/ajcn.113.069807; Adu-Afarwuah S, 2007, FASEB J, V21, pA99; Adu-Afarwuah S, 2007, AM J CLIN NUTR, V86, P412, DOI 10.1093/ajcn/86.2.412; Adu-Afarwuah S, 2015, AM J CLIN NUTR, V101, P835, DOI 10.3945/ajcn.114.091546; Agostoni C, 2007, J PEDIATR GASTR NUTR, V44, P136, DOI 10.1097/01.mpg.0000243429.24463.2f; [Anonymous], 2015, NAT NUTR DAT STAND R; [Anonymous], 2011, TANZ DEM HLTH SURV 2; Araujo P, 2008, J CHROMATOGR A, V1212, P106, DOI 10.1016/j.chroma.2008.10.006; Arimond M, 2015, MATERN CHILD NUTR, V11, P31, DOI 10.1111/mcn.12049; Tinoco SMB, 2009, LIPIDS HEALTH DIS, V8, DOI 10.1186/1476-511X-8-23; Baylin A, 2005, AM J EPIDEMIOL, V162, P373, DOI 10.1093/aje/kwi213; Bell JG, 2011, BRIT J NUTR, V106, P1408, DOI 10.1017/S0007114511001978; Briend A, 2011, MATERN CHILD NUTR, V7, P141, DOI 10.1111/j.1740-8709.2011.00305.x; CARLSON SE, 1992, LIPIDS, V27, P901, DOI 10.1007/BF02535870; Carlson SE, 1996, AM J CLIN NUTR, V63, P687, DOI 10.1093/ajcn/63.5.687; Chen BC, 2013, ANNU REV FOOD SCI T, V4, P35, DOI 10.1146/annurev-food-032112-135808; Damsgaard CT, 2012, PEDIATR RES, V71, P713, DOI 10.1038/pr.2012.28; Dewey KG, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001314; Farina EK, 2011, J NUTR, V141, P1146, DOI 10.3945/jn.110.133728; Feingold KR, 2014, BBA-MOL CELL BIOL L, V1841, P280, DOI 10.1016/j.bbalip.2013.11.007; Fokkema MR, 2002, PROSTAG LEUKOTR ESS, V67, P345, DOI 10.1054/plef.2002.0440; Food and Agriculture Organization (FAO), 2010, FATS FATT AC HUM NUT, V91; Freedman DS, 2013, AM J CLIN NUTR, V98, P1417, DOI 10.3945/ajcn.113.065961; FULCO AJ, 1959, J BIOL CHEM, V234, P1411; Fumagalli M, 2015, SCIENCE, V349, P1343, DOI 10.1126/science.aab2319; Gajjar R, 2015, HARRIET LANE HDB; GARROW JS, 1985, INT J OBESITY, V9, P147; Georgiadi A, 2012, ADV NUTR, V3, P127, DOI 10.3945/an.111.001602; Glew R. H., 2013, Journal of Medicine in the Tropics, V15, P69; Guerra A, 2007, ANN NUTR METAB, V51, P433, DOI 10.1159/000111163; Guillou H, 2010, PROG LIPID RES, V49, P186, DOI 10.1016/j.plipres.2009.12.002; Gurzell EA, 2014, PROSTAG LEUKOTR ESS, V91, P87, DOI 10.1016/j.plefa.2014.04.001; HANSEN A. E., 1963, Pediatrics, V31, P171; HANSEN AE, 1958, J NUTR, V66, P565, DOI 10.1093/jn/66.4.565; Harada S I, 1995, Connect Tissue Res, V31, P279, DOI 10.3109/03008209509010823; Harris WS, 2013, J CLIN LIPIDOL, V7, P433, DOI 10.1016/j.jacl.2013.05.001; Hess SY, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122242; Hibbeln JR, 2006, AM J CLIN NUTR, V83, p1483S, DOI 10.1093/ajcn/83.6.1483S; Hoile SP, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109896; Holman RT, 1960, J NUTR, V70; Hsieh JC, 2015, J PEDIATR GASTR NUTR, V61, P138, DOI 10.1097/MPG.0000000000000741; Huffman SL, 2011, MATERN CHILD NUTR, V7, P44, DOI 10.1111/j.1740-8709.2011.00356.x; Hussein A, 2005, E AFRICAN J PUBLIC H, V2, P27; Iannotti LL, 2014, AM J CLIN NUTR, V99, P198, DOI 10.3945/ajcn.113.063883; Ichi I, 2014, BBA-MOL CELL BIOL L, V1841, P204, DOI 10.1016/j.bbalip.2013.10.013; Innis SM, 2007, P NUTR SOC, V66, P397, DOI 10.1017/S0029665107005666; Innis SM, 2008, BRAIN RES, V1237, P35, DOI 10.1016/j.brainres.2008.08.078; Innis SM, 2003, J PEDIATR-US, V143, pS1, DOI 10.1067/S0022-3476(03)00396-2; INNIS SM, 1991, PROG LIPID RES, V30, P39, DOI 10.1016/0163-7827(91)90006-Q; Innis SM, 2002, J PEDIATR-US, V140, P547, DOI 10.1067/mpd.2002.123282; Jensen CL, 2010, J PEDIATR-US, V157, P900, DOI 10.1016/j.jpeds.2010.06.006; Johnston DT, 2013, NUTR NEUROSCI, V16, P30, DOI 10.1179/1476830512Y.0000000025; Jones KDJ, 2015, BMC MED, V13, DOI 10.1186/s12916-015-0315-6; Kasonga AE, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0125145; Kidd PM, 2007, ALTERN MED REV, V12, P207; KOLETZKO B, 1991, ANN NUTR METAB, V35, P128, DOI 10.1159/000177636; KOLETZKO B, 1986, EUR J PEDIATR, V145, P109, DOI 10.1007/BF00441868; Kuipers RS, 2007, PROSTAG LEUKOTR ESS, V76, P221, DOI 10.1016/j.plefa.2007.01.004; Kuipers RS, 2011, PROSTAG LEUKOTR ESS, V85, P387, DOI 10.1016/j.plefa.2011.06.004; Lands B, 2009, WORLD REV NUTR DIET, V100, P22, DOI 10.1159/000235708; Lartey A, 1999, AM J CLIN NUTR, V70, P391; Lim JH, 2013, J BIOL CHEM, V288, P7117, DOI 10.1074/jbc.M112.415729; Ling PR, 2002, DIGEST DIS SCI, V47, P1679, DOI 10.1023/A:1016415805637; Malcher-Lopes R, 2008, EUR J PHARMACOL, V583, P322, DOI 10.1016/j.ejphar.2007.12.033; Marangoni F, 2007, PROSTAG LEUKOTR ESS, V76, P87, DOI 10.1016/j.plefa.2006.11.004; Mathias RA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044926; Mazengo MC, 1997, ACTA TROP, V68, P313, DOI 10.1016/S0001-706X(97)00113-7; McLaughlin V, 2013, NUTR REV, V71, P600, DOI 10.1111/nure.12043; MEAD JF, 1956, J BIOL CHEM, V219, P705; Michaelsen KF, 2011, MATERN CHILD NUTR, V7, P124, DOI 10.1111/j.1740-8709.2011.00302.x; Min YJ, 2011, PROSTAG LEUKOTR ESS, V84, P13, DOI 10.1016/j.plefa.2010.10.002; MORRISON WR, 1964, J LIPID RES, V5, P600; Nakamura MT, 2014, PROG LIPID RES, V53, P124, DOI 10.1016/j.plipres.2013.12.001; Ntwenya JE, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126038; PEIFER JJ, 1959, J NUTR, V68, P155; PHINNEY SD, 1993, METABOLISM, V42, P1022, DOI 10.1016/0026-0495(93)90017-I; Pickens CA, 2015, PROSTAG LEUKOTR ESS, V95, P31, DOI 10.1016/j.plefa.2014.12.001; Picklo MJ, 2016, LIPIDS, V51, P537, DOI 10.1007/s11745-015-4106-9; References Tanzania Food and Nutrition Centre, 2014, GOV REP; Rocquelin G, 2003, PUBLIC HEALTH NUTR, V6, P241, DOI 10.1079/PHN2002420; RODEMANN HP, 1982, J BIOL CHEM, V257, P1632; Sarter B, 2015, CLIN NUTR, V34, P212, DOI 10.1016/j.clnu.2014.03.003; Siguel E, 1998, CIRCULATION, V97, P2580, DOI 10.1161/01.CIR.97.25.2580; SIGUEL EN, 1987, CLIN CHEM, V33, P1869; Simopoulos AP, 2016, NUTRIENTS, V8, DOI 10.3390/nu8030128; Smit EN, 2004, PROSTAG LEUKOTR ESS, V71, P241, DOI 10.1016/j.plefa.2004.03.019; Smit EN, 2000, ARCH DIS CHILD, V82, P493, DOI 10.1136/adc.82.6.493; van der Merwe LF, 2013, AM J CLIN NUTR, V97, P45, DOI 10.3945/ajcn.112.042267; Vanderhoof J, 1999, J PEDIATR GASTR NUTR, V29, P318, DOI 10.1097/00005176-199909000-00015; Victor R, 2014, MATERN CHILD NUTR, V10, P545, DOI 10.1111/j.1740-8709.2012.00435.x; WENE JD, 1975, J CLIN INVEST, V56, P127, DOI 10.1172/JCI108061; Wohlfahrt-Veje C, 2014, EUR J CLIN NUTR, V68, P664, DOI 10.1038/ejcn.2013.282; Wolters M, 2014, INT J OBESITY, V38, pS86, DOI 10.1038/ijo.2014.139; World Health Organization, 2011, WHO ANTHR PERS COMP; World Health Organization, 2013, GUID UPD MAN SEV AC; World Health Organization (WHO), 2009, WHO ANTHROPLUS PERS	99	18	18	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 3	2016	11	5							e0154715	10.1371/journal.pone.0154715	http://dx.doi.org/10.1371/journal.pone.0154715			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DL5KK	27137223	Green Submitted, Green Published, gold			2022-12-26	WOS:000375675700061
J	Lee, IK; Liu, JW; Chen, YH; Chen, YC; Tsai, CY; Huang, SY; Lin, CY; Huang, CH				Lee, Ing-Kit; Liu, Jien-Wei; Chen, Yen-Hsu; Chen, Yi-Chun; Tsai, Ching-Yen; Huang, Shi-Yu; Lin, Chun-Yu; Huang, Chung-Hao			Development of a Simple Clinical Risk Score for Early Prediction of Severe Dengue in Adult Patients	PLOS ONE			English	Article							HEMORRHAGIC-FEVER; INFECTION; FEATURES; RHABDOMYOLYSIS; CLASSIFICATION; CHALLENGES; EPIDEMIC; CHILDREN; SHOCK; TIME	We aimed to develop and validate a risk score to aid in the early identification of laboratory-confirmed dengue patients at high risk of severe dengue (SD) (i.e. severe plasma leakage with shock or respiratory distress, or severe bleeding or organ impairment). We retrospectively analyzed data of 1184 non-SD patients at hospital presentation and 69 SD patients before SD onset. We fit a logistic regression model using 85% of the population and converted the model coefficients to a numeric risk score. Subsequently, we validated the score using the remaining 15% of patients. Using the derivation cohort, two scoring algorithms for predicting SD were developed: models 1 (dengue illness <= 4 days) and 2 (dengue illness >4 days). In model 1, we identified four variables: age >= 65 years, minor gastrointestinal bleeding, leukocytosis, and platelet count >= 100x10(9) cells/L. Model 1 (ranging from -2 to +6 points) showed good discrimination between SD and non-SD, with an area under the receiver operating characteristic curve (AUC) of 0.848 (95% confidence interval [CI], 0.771-0.924). The optimal cutoff value for model 1 was 1 point, with a sensitivity and specificity for predicting SD of 70.3% and 90.6%, respectively. In model 2 (ranging from 0 to +3 points), significant predictors were age >= 65 years and leukocytosis. Model 2 showed an AUC of 0.859 (95% CI, 0.756-0.963), with an optimal cutoff value of 1 point (sensitivity, 80.3%; specificity, 85.8%). The median interval from hospital presentation to SD was 1 day. This finding underscores the importance of close monitoring, timely resuscitation of shock including intravenous fluid adjustment and early correction of dengue-related complications to prevent the progressive dengue severity. In the validation data, AUCs of 0.904 (95% CI, 0.825-0.983) and 0.917 (95% CI, 0.833-1.0) in models 1 and 2, respectively, were achieved. The observed SD rates (in both cohorts) were <3% for patients with a score <1 point, but >50% for those with a score of >= 2 points, irrespective of the day of illness onset, suggesting that our simple risk score can be easily implemented in resource-limited countries for early prediction of dengue patients at risk of SD provided that they have rapid dengue confirmed tests. For patients with other acute febrile illnesses or bacterial infections usually have SD risk score of >1. Thus, these scoring algorithms cannot totally replace good clinical judgement of the physician, and most importantly, early differentiating dengue from other febrile illnesses is critical for appropriate monitoring and management.	[Lee, Ing-Kit; Liu, Jien-Wei; Chen, Yi-Chun; Tsai, Ching-Yen] Kaohsiung Chang Gung Mem Hosp, Dept Internal Med, Div Infect Dis, Kaohsiung 833, Taiwan; [Lee, Ing-Kit; Liu, Jien-Wei] Chang Gung Univ, Coll Med, Taoyuan 333, Taiwan; [Chen, Yen-Hsu; Lin, Chun-Yu; Huang, Chung-Hao] Kaohsiung Med Univ Hosp, Div Infect Dis, Dept Internal Med, Kaohsiung 833, Taiwan; [Chen, Yen-Hsu] Kaohsiung Med Univ, Kaohsiung 833, Taiwan; [Huang, Shi-Yu] Kaohsiung Chang Gung Mem Hosp, Dept Emergency Med, Kaohsiung 833, Taiwan	Chang Gung Memorial Hospital; Chang Gung University; Kaohsiung Medical University; Kaohsiung Medical University Hospital; Kaohsiung Medical University; Chang Gung Memorial Hospital	Lee, IK (corresponding author), Kaohsiung Chang Gung Mem Hosp, Dept Internal Med, Div Infect Dis, Kaohsiung 833, Taiwan.; Lee, IK (corresponding author), Chang Gung Univ, Coll Med, Taoyuan 333, Taiwan.	leee@cgmh.org.tw		Chen, Yen-hsu/0000-0002-8667-4844	Kaohsiung Chang Gung Memorial Hospital, Kaohsiung, Taiwan [CMRPG-8D-1091]; Center for Disease Control, Taiwan [MOHW104-CDC-C-114-114901]	Kaohsiung Chang Gung Memorial Hospital, Kaohsiung, Taiwan; Center for Disease Control, Taiwan	This study was supported by a grant from the Kaohsiung Chang Gung Memorial Hospital (CMRPG-8D-1091), Kaohsiung, Taiwan. It was also partially supported by grant from Center for Disease Control, Taiwan (MOHW104-CDC-C-114-114901). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], DEF OLD ELD PERS; Azin Francisca Raimunda F. Guerreiro, 2012, Rev. Bras. Hematol. Hemoter., V34, P36, DOI 10.5581/1516-8484.20120012; Bagley WH, 2007, INTERN EMERG MED, V2, P210, DOI 10.1007/s11739-007-0060-8; Bandyopadhyay S, 2006, TROP MED INT HEALTH, V11, P1238, DOI 10.1111/j.1365-3156.2006.01678.x; Basílio-de-Oliveira C.A., 2005, Braz J Infect Dis, V9, P341, DOI 10.1590/S1413-86702005000400012; Chalasani N, 1998, AM J MED SCI, V315, P233, DOI 10.1097/00000441-199804000-00003; Deen JL, 2006, LANCET, V368, P170, DOI 10.1016/S0140-6736(06)69006-5; GOLDSTEIN S, 1971, NEW ENGL J MED, V285, P1120, DOI 10.1056/NEJM197111112852005; Guzman M G, 1999, Int J Infect Dis, V3, P130, DOI 10.1016/S1201-9712(99)90033-4; Hamilton H, OVERVIEW DECISION TR; Htun NSN, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003741; Huang SY, 2015, AM J TROP MED HYG, V92, P75, DOI 10.4269/ajtmh.14-0343; Lane R, 2003, BMJ-BRIT MED J, V327, P115, DOI 10.1136/bmj.327.7407.115; Lee IK, 2005, AM J TROP MED HYG, V72, P221, DOI 10.4269/ajtmh.2005.72.221; Lee IK, 2008, AM J TROP MED HYG, V79, P149, DOI 10.4269/ajtmh.2008.79.149; Lee IK, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001532; Lee IK, 2009, AM J TROP MED HYG, V80, P651, DOI 10.4269/ajtmh.2009.80.651; Lee LK, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001676; Lee VJ, 2009, TROP MED INT HEALTH, V14, P1154, DOI 10.1111/j.1365-3156.2009.02337.x; Lichtman M.A., 2010, WILLIAMS HEMATOLOGY; Liu JienWei, 2003, Dengue Bulletin, V27, P19; Low JGH, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001191; Mehta RL, 2007, CRIT CARE, V11, DOI 10.1186/cc5713; MITRAKUL C, 1977, AM J TROP MED HYG, V26, P975, DOI 10.4269/ajtmh.1977.26.975; MORENS DM, 1994, CLIN INFECT DIS, V19, P500, DOI 10.1093/clinids/19.3.500; NELSON ER, 1965, J PEDIATR-US, V67, P463, DOI 10.1016/S0022-3476(65)80408-5; Huy NT, 2013, CRIT CARE, V17, DOI 10.1186/cc13135; Ong A, 2007, INT J INFECT DIS, V11, P263, DOI 10.1016/j.ijid.2006.02.012; Pancharoen C, 1998, PEDIATR INFECT DIS J, V17, P81, DOI 10.1097/00006454-199801000-00019; Pang JX, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001641; Lam PK, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126134; Pongpan Surangrat, 2013, ISRN Pediatr, V2013, P845876, DOI 10.1155/2013/845876; Potts JA, 2008, TROP MED INT HEALTH, V13, P1328, DOI 10.1111/j.1365-3156.2008.02151.x; Potts JA, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000769; Rockey DC, 2005, GASTROENTEROL CLIN N, V34, P581, DOI 10.1016/j.gtc.2005.08.002; Rowe EK, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002777; See KC, 2013, AM J TROP MED HYG, V89, P804, DOI 10.4269/ajtmh.13-0197; SHAPIRO MF, 1987, ANN INTERN MED, V106, P65, DOI 10.7326/0003-4819-106-1-65; Shu PY, 2009, CLIN VACCINE IMMUNOL, V16, P589, DOI 10.1128/CVI.00475-08; Shu PY, 2003, J CLIN MICROBIOL, V41, P2408, DOI 10.1128/JCM.41.6.2408-2416.2003; Simmons CP, 2012, NEW ENGL J MED, V366, P1423, DOI 10.1056/NEJMra1110265; Sirivichayakul C, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001520; Srichaikul T, 2000, BEST PRACT RES CL HA, V13, P261, DOI 10.1053/beha.2000.0073; Sullivan LM, 2004, STAT MED, V23, P1631, DOI 10.1002/sim.1742; SUMARMO, 1983, B WORLD HEALTH ORGAN, V61, P693; Tan LH, 2012, J CLIN VIROL, V55, P79, DOI 10.1016/j.jcv.2012.06.005; Tanner L, 2008, PLOS NEGLECT TROP D, V2, DOI 10.1371/journal.pntd.0000196; Thein TL, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002023; Tomashek KM, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001614; The TD, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001679; TSAI CJ, 1991, AM J GASTROENTEROL, V86, P33; WHO, 1997, DENG HAEM FEV DIAGN; Wiwanitkit V, 2004, CLIN APPL THROMB-HEM, V10, P65, DOI 10.1177/107602960401000111; World Health Organization, 2009, DENGUE GUIDELINES DI; ZWEIG MH, 1993, CLIN CHEM, V39, P561	55	25	25	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 3	2016	11	5							e0154772	10.1371/journal.pone.0154772	http://dx.doi.org/10.1371/journal.pone.0154772			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DL5KK	27138448	gold, Green Submitted, Green Published			2022-12-26	WOS:000375675700068
J	Li, W; Graham, AD; Lin, MC				Li, Wing; Graham, Andrew D.; Lin, Meng C.			Understanding Ocular Discomfort and Dryness Using the Pain Sensitivity Questionnaire	PLOS ONE			English	Article							TFOS INTERNATIONAL WORKSHOP; GLAND DYSFUNCTION REPORT; DRY EYE SYMPTOMS; ETHNIC-DIFFERENCES; CLINICAL-TESTS; CORNEAL PAIN; RISK-FACTORS; CONTACT; PREVALENCE; MODULATION	Purpose To utilize the Pain Sensitivity Questionnaire (PSQ) to assess the influence of pain sensitivity on perceptions of ocular discomfort and dryness. Methods Subjects completed a battery of questionnaires, including history of ocular and general health, contact lens wear history, the Ocular Surface Disease Index (OSDI) questionnaire, visual analog scale (VAS) 100-point rating scales to assess severity and frequency of average and end of day (EOD) discomfort and dryness, and the PSQ to assess pain sensitivity level. Masked subjects were then instructed to wear one inverted and one normally oriented soft contact lens contralaterally for 30 minutes to induce an inter-eye difference in comfort and dryness sensations. Subjects rated comfort and dryness in each eye on VAS every 5 minutes during contact lens wear. A slit lamp examination was performed to evaluate ocular surface health and to assess contact lens fit. Results One hundred and fifty-three subjects (111 females, 42 males) completed the study. In separate models, a higher PSQ score was significantly associated with higher OSDI score (p = 0.002), lower average and EOD comfort (p = 0.005 and 0.001, respectively), and greater EOD dryness (p = 0.04). The minimum (0.14) and maximum (7.14) PSQ scores observed in our subject cohort (i.e., from the subjects who were the least and most sensitive to pain, respectively) corresponded to an estimated difference of 11 points on the OSDI, 20 points on the VAS scale for average comfort, 31 points for EOD comfort and 17 points for EOD dryness. In a mixed effects model, a higher PSQ score was significantly associated with a greater inter-eye difference in comfort (p = 0.013) and dryness (p = 0.010) during CL wear. Conclusions Pain sensitivity influences perceptions of ocular discomfort and dryness, and should be taken into account when evaluating subjective assessments of these symptoms.	[Li, Wing; Lin, Meng C.] Univ Calif Berkeley, Vis Sci Program, Berkeley, CA 94720 USA; [Li, Wing; Graham, Andrew D.; Lin, Meng C.] Univ Calif Berkeley, Sch Optometry, Clin Res Ctr, Berkeley, CA 94720 USA	University of California System; University of California Berkeley; University of California System; University of California Berkeley	Lin, MC (corresponding author), Univ Calif Berkeley, Vis Sci Program, Berkeley, CA 94720 USA.; Lin, MC (corresponding author), Univ Calif Berkeley, Sch Optometry, Clin Res Ctr, Berkeley, CA 94720 USA.	mlin@berkeley.edu			Ruth L. Kirschstein Institutional National Research Service Award (T32 grant) [T32EY007043]; Michael G. Harris Ezell Fellowship; Roberta Smith Research Fund; Clinical Research Center Unrestricted Fund	Ruth L. Kirschstein Institutional National Research Service Award (T32 grant)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Michael G. Harris Ezell Fellowship; Roberta Smith Research Fund; Clinical Research Center Unrestricted Fund	WL: Ruth L. Kirschstein Institutional National Research Service Award (T32 grant) https://researchtraining.nih.gov/programs/training-grants/T32, Grant number: T32EY007043. WL: Michael G. Harris Ezell Fellowship http://www.aaopt.org/AOF/Programs/Graduates. MCL: Roberta Smith Research Fund. MCL: Clinical Research Center Unrestricted Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baudouin C, 2014, BRIT J OPHTHALMOL, V98, P1168, DOI 10.1136/bjophthalmol-2013-304619; Belmonte C, 1996, PROG RETIN EYE RES, V9462, P118; Bushnell MC, 2013, NAT REV NEUROSCI, V14, P502, DOI 10.1038/nrn3516; Chan MYP, 2013, PAIN, V154, P119, DOI 10.1016/j.pain.2012.09.015; Chapman CR, 2011, J PAIN, V12, P257, DOI 10.1016/j.jpain.2010.08.005; Craig JP, 2013, INVEST OPHTH VIS SCI, V54, P123, DOI 10.1167/iovs.13-13235; Cuevas M, 2012, CURR EYE RES, V37, P855, DOI 10.3109/02713683.2012.683508; Edwards RR, 2005, NEUROLOGY, V65, P437, DOI 10.1212/01.wnl.0000171862.17301.84; Fillingim Roger B, 2005, Curr Rheumatol Rep, V7, P342, DOI 10.1007/s11926-005-0018-7; Flor H, 2003, J REHABIL MED, V35, P66, DOI 10.1080/16501960310010179; Galor A, 2011, AM J OPHTHALMOL, V152, P377, DOI 10.1016/j.ajo.2011.02.026; Gatchel RJ, 2007, PSYCHOL BULL, V133, P581, DOI 10.1037/0033-2909.133.4.581; Granot M, 2009, CURR OPIN ANESTHESIO, V22, P425, DOI 10.1097/ACO.0b013e32832a40e1; Green CR, 2003, PAIN MED, V4, P277, DOI 10.1046/j.1526-4637.2003.03034.x; Greenspan JD, 2007, PAIN, V132, pS26, DOI 10.1016/j.pain.2007.10.014; GREENWALD HP, 1991, PAIN, V44, P157, DOI 10.1016/0304-3959(91)90130-P; Hart Robert P, 2003, Curr Pain Headache Rep, V7, P116, DOI 10.1007/s11916-003-0021-5; Hsieh AY, 2010, J PAIN, V11, P1187, DOI 10.1016/j.jpain.2010.02.015; Jie Y, 2009, EYE, V23, P688, DOI 10.1038/sj.eye.6703101; Jones L, 2013, INVEST OPHTH VIS SCI, V54, P37, DOI 10.1167/iovs.13-13215; Karpecki PM., 2013, REV OPTOMETRY    JAN, P50; Kil HK, 2012, BRIT J ANAESTH, V108, P119, DOI 10.1093/bja/aer305; Kim H, 2013, EVID-BASED COMPL ALT, V2013, P1, DOI DOI 10.1111/CHS0.12019; Kim HJ, 2014, PAIN PRACT, V14, P405, DOI 10.1111/papr.12084; Kim HJ, 2013, PAIN PHYSICIAN, V16, pE715; Kim HJ, 2013, PAIN PHYSICIAN, V16, P135; Kim HS, 2004, PAIN, V109, P488, DOI 10.1016/j.pain.2004.02.027; Labbe A, 2013, BRIT J OPHTHALMOL, V97, P1399, DOI 10.1136/bjophthalmol-2013-303838; Lin MC, 2003, EYE CONTACT LENS, V29; Lin MC, 2014, EYE CONTACT LENS, V40, P191, DOI 10.1097/ICL.0000000000000034; Lin MC, 2014, INVEST OPHTH VIS SCI, V55, P776, DOI 10.1167/iovs.13-13508; Lin MC, 2011, INVEST OPHTH VIS SCI, V52, P3530, DOI 10.1167/iovs.10-6025; Lin Meng C, 2003, Eye Contact Lens, V29, pS33; Linton SJ, 2011, PHYS THER, V91, P700, DOI 10.2522/ptj.20100330; Lu Q, 2013, HEALTH PSYCHOL, V32, P905, DOI 10.1037/a0032428; Maissa C, 2010, CONTACT LENS ANTERIO, V33, P176, DOI 10.1016/j.clae.2010.02.003; Miller KL, 2014, MINIMAL CLIN IMPORTA, V128, P94; Mizuno Y, 2010, JPN J OPHTHALMOL, V54, P259, DOI 10.1007/s10384-010-0812-2; Mobilio N, 2011, J ORAL MAXIL SURG, V69, P2731, DOI 10.1016/j.joms.2011.05.023; Moriarty O, 2011, PROG NEUROBIOL, V93, P385, DOI 10.1016/j.pneurobio.2011.01.002; Nichols JJ, 2013, INVEST OPHTH VIS SCI, V54, P7, DOI 10.1167/iovs.13-13212; Nichols KK, 2004, CORNEA, V23, P762, DOI 10.1097/01.ico.0000133997.07144.9e; Niederer RL, 2010, PROG RETIN EYE RES, V29, P30, DOI 10.1016/j.preteyeres.2009.11.001; Nielsen CS, 2009, J PAIN, V10, P231, DOI 10.1016/j.jpain.2008.09.010; Nien CJ, 2011, ARCH OPHTHALMOL-CHIC, V129, P462, DOI 10.1001/archophthalmol.2011.69; Tran N, 2013, CONTACT LENS ANTERIO, V36, P281, DOI 10.1016/j.clae.2013.06.001; Peters ML, 2015, MOD TR PHARMACOPSYCH, V30, P138, DOI 10.1159/000435938; Pult H, 2008, OPTOMETRY VISION SCI, V85, P924, DOI 10.1097/OPX.0b013e3181888909; Rahim-Williams B, 2012, PAIN MED, V13, P522, DOI 10.1111/j.1526-4637.2012.01336.x; Rosenthal P, 2012, OCUL SURF, V10, P2, DOI 10.1016/j.jtos.2012.01.002; Rosenthal P, 2009, OCUL SURF, V7, P28, DOI 10.1016/S1542-0124(12)70290-2; Rowell LN, 2011, EUR J PAIN, V15, P764, DOI 10.1016/j.ejpain.2010.11.016; Ruscheweyh R, 2012, PAIN, V153, P1210, DOI 10.1016/j.pain.2012.02.025; Ruscheweyh R, 2009, PAIN, V146, P65, DOI 10.1016/j.pain.2009.06.020; Schaumberg DA, 2011, INVEST OPHTH VIS SCI, V52, P1994, DOI 10.1167/iovs.10-6997e; Schulz KF, 2011, INT J SURG, V9, P672, DOI 10.1016/j.ijsu.2011.09.004; Shiraishi A, 2014, EYE CONTACT LENS, V40, P220, DOI 10.1097/ICL.0000000000000040; Svitova TF, 2013, OPTOMETRY VISION SCI, V90, P1361, DOI 10.1097/OPX.0000000000000098; Tan EC, 2008, J PAIN, V9, P849, DOI 10.1016/j.jpain.2008.04.004; Tomlinson A, 2011, INVEST OPHTH VIS SCI, V52, P2006, DOI 10.1167/iovs.10-6997f; Tracey I, 2007, NEURON, V55, P377, DOI 10.1016/j.neuron.2007.07.012; Truong TN, 2014, OPTOMETRY VISION SCI, V91, P133, DOI 10.1097/OPX.0000000000000138; Vehof J, 2013, JAMA OPHTHALMOL, P1; Villemure C, 2002, PAIN, V95, P195, DOI 10.1016/S0304-3959(02)00007-6; Wise RJ, 2012, SAUDI J OPHTHALMOL, V26, P349, DOI 10.1016/j.sjopt.2012.08.007; Young G, 2012, OPTOMETRY VISION SCI, V89, P1125, DOI 10.1097/OPX.0b013e3182640af8	66	16	16	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 3	2016	11	5							e0154753	10.1371/journal.pone.0154753	http://dx.doi.org/10.1371/journal.pone.0154753			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DL5KK	27137908	Green Published, gold			2022-12-26	WOS:000375675700063
J	Murcia, RY; Vargas, A; Lavoie, JP				Murcia, Ruby Yoana; Vargas, Amandine; Lavoie, Jean-Pierre			The Interleukin-17 Induced Activation and Increased Survival of Equine Neutrophils Is Insensitive to Glucocorticoids	PLOS ONE			English	Article							EPITHELIAL-CELLS; INHALED CORTICOSTEROIDS; MONONUCLEAR-CELLS; ASTHMATIC AIRWAYS; IL-17; EXPRESSION; INFLAMMATION; CYTOKINES; APOPTOSIS; RESISTANCE	Background Glucocorticoids (GCs) are the most effective drugs for the treatment of human asthma. However, a subgroup of asthmatic patients with neutrophilic airway inflammation is insensitive to GCs. Interleukin-17 (IL-17), a cytokine upregulated in the airways of a subset of human asthmatic patients, contributes to the recruitment of neutrophils and induces a glucocorticoid resistance in human airway epithelial cells. We hypothesized that IL-17 similarly activates neutrophils and contributes to their persistence in the asthmatic airways in spite of glucocorticoid therapy. Objective To determine whether IL-17 directly activates neutrophils and whether this response is attenuated by GCs. Methods Neutrophils were isolated from the blood of horses and incubated in the presence of recombinant equine IL-17, LPS and dexamethasone. mRNA and protein expression of IL-17 receptors (IL-17RA/IL-17RC) were assessed by qPCR and immunoblot, respectively. Proinflammatory cytokine expression, cell viability and apoptosis were determined by qPCR, Trypan Blue exclusion test, and flow cytometry, respectively. Results Equine neutrophils express both IL-17RA and IL-17RC at the mRNA and protein levels. Neutrophil stimulation with IL-17 increases the mRNA expression of IL-8, which is not attenuated by dexamethasone (p = 0.409). Also, neutrophil viability is significantly increased (p<0.0001) by IL-17 in the presence of LPS when compared to LPS alone. Flow cytometry and light microscopy revealed that LPS-induced apoptosis is decreased by IL-17 (p = 0.02 and p = 0.006 respectively). Conclusion These results indicate that IL-17 directly activates equine neutrophils at 24 hours, and that the expression of IL-8 thus induced is not attenuated by GCs. Additionally, IL-17 increases neutrophil viability and decreases apoptosis. These findings suggest an important role of IL-17 in pulmonary persistence of neutrophils in the asthmatic airways.	[Murcia, Ruby Yoana; Vargas, Amandine; Lavoie, Jean-Pierre] Univ Montreal, Fac Vet Med, Dept Clin Sci, St Hyacinthe, PQ J2S 7C6, Canada	Universite de Montreal	Lavoie, JP (corresponding author), Univ Montreal, Fac Vet Med, Dept Clin Sci, St Hyacinthe, PQ J2S 7C6, Canada.	jean-pierre.lavoie@umontreal.ca			Natural Sciences and Engineering Research Council of Canada [RGPIN-2014-06-198]	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR)	This work was funded by Natural Sciences and Engineering Research Council of Canada RGPIN-2014-06-198, www.nserc-crsng.gc.ca. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ainsworth DM, 2007, AM J VET RES, V68, P1361, DOI 10.2460/ajvr.68.12.1361; Al-Ramli W, 2009, J ALLERGY CLIN IMMUN, V123, P1185, DOI 10.1016/j.jaci.2009.02.024; [Anonymous], 2000, Am J Respir Crit Care Med, V162, P2341; Barczyk A, 2003, RESP MED, V97, P726, DOI 10.1053/rmed.2003.1507; Barnes PJ, 2009, LANCET, V373, P1905, DOI 10.1016/S0140-6736(09)60326-3; Barnes PJ, 1998, CLIN SCI, V94, P557, DOI 10.1042/cs0940557; Boivin R, 2014, THORAX, V69, P1113, DOI 10.1136/thoraxjnl-2014-205572; Bullone M, 2015, MOL IMMUNOL, V66, P97, DOI 10.1016/j.molimm.2014.12.005; Ciepiela O, 2015, RESP PHYSIOL NEUROBI, V209, P13, DOI 10.1016/j.resp.2014.12.004; Debrue M, 2005, VET IMMUNOL IMMUNOP, V105, P25, DOI 10.1016/j.vetimm.2004.12.013; Dragon S, 2008, MOL IMMUNOL, V45, P160, DOI 10.1016/j.molimm.2007.04.027; Ferretti S, 2003, J IMMUNOL, V170, P2106, DOI 10.4049/jimmunol.170.4.2106; Fialkow L, 2006, CRIT CARE, V10, DOI 10.1186/cc5090; Francois S, 2005, J IMMUNOL, V174, P3633, DOI 10.4049/jimmunol.174.6.3633; Gaffen SL, 2009, NAT REV IMMUNOL, V9, P556, DOI 10.1038/nri2586; Green RH, 2002, THORAX, V57, P875, DOI 10.1136/thorax.57.10.875; Gu CF, 2013, CYTOKINE, V64, P477, DOI 10.1016/j.cyto.2013.07.022; Halwani R, 2011, J IMMUNOL, V186, P4156, DOI 10.4049/jimmunol.1001210; Hirsch G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044606; Jatakanon A, 1999, AM J RESP CRIT CARE, V160, P1532, DOI 10.1164/ajrccm.160.5.9806170; Jiang L.-L., 2014, SHOCK VIB, V2014, P8, DOI [10.1155/2014/418178, DOI 10.1155/2014/418178]; Jones CE, 2002, AM J RESP CELL MOL, V26, P748, DOI 10.1165/ajrcmb.26.6.4757; Lavoie JP, 2002, AM J VET RES, V63, P579, DOI 10.2460/ajvr.2002.63.579; Lavoie-Lamoureux A, 2010, AM J PHYSIOL-LUNG C, V299, pL472, DOI 10.1152/ajplung.00135.2009; Leclere M, 2012, AM J RESP CELL MOL, V47, P589, DOI 10.1165/rcmb.2011-0363OC; Miyamoto M, 2003, J IMMUNOL, V170, P4665, DOI 10.4049/jimmunol.170.9.4665; Nanzer AM, 2013, J ALLERGY CLIN IMMUN, V132, P297, DOI 10.1016/j.jaci.2013.03.037; Ouyang WJ, 2008, IMMUNITY, V28, P454, DOI 10.1016/j.immuni.2008.03.004; Pelletier M, 2010, BLOOD, V115, P335, DOI 10.1182/blood-2009-04-216085; Ramirez-Velazquez C, 2013, ALLERGY ASTHMA CL IM, V9, DOI 10.1186/1710-1492-9-23; Saadoun D, 2015, ARTHRITIS RHEUMATOL, V67, P1353, DOI 10.1002/art.39037; Silverpil E, 2011, INFLAMMATION, V34, P1, DOI 10.1007/s10753-010-9201-8; Taylor PR, 2014, NAT IMMUNOL, V15, P143, DOI 10.1038/ni.2797; Toy D, 2006, J IMMUNOL, V177, P36, DOI 10.4049/jimmunol.177.1.36; Vazquez-Tello A, 2010, CLIN EXP ALLERGY, V40, P1312, DOI 10.1111/j.1365-2222.2010.03544.x; Vazquez-Tello A, 2013, J CLIN IMMUNOL, V33, P466, DOI 10.1007/s10875-012-9828-3; Wang W, 2014, INFECT IMMUN, V82, P2368, DOI 10.1128/IAI.00006-14; Wenzel SE, 1997, AM J RESP CRIT CARE, V156, P737, DOI 10.1164/ajrccm.156.3.9610046; YUE TL, 1994, CIRC RES, V75, P1, DOI 10.1161/01.RES.75.1.1; Zijlstra GJ, 2012, EUR RESPIR J, V39, P439, DOI 10.1183/09031936.00017911	40	24	29	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 3	2016	11	5							e0154755	10.1371/journal.pone.0154755	http://dx.doi.org/10.1371/journal.pone.0154755			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DL5KK	27138006	Green Published, Green Submitted, gold			2022-12-26	WOS:000375675700064
J	Zhong, Y; Anderl, F; Kruse, T; Schindele, F; Jagusztyn-Krynicka, EK; Fischer, W; Gerhard, M; Mejias-Luque, R				Zhong, Yu; Anderl, Florian; Kruse, Tobias; Schindele, Franziska; Jagusztyn-Krynicka, Elzbieta Katarzyna; Fischer, Wolfgang; Gerhard, Markus; Mejias-Luque, Raquel			Helicobacter pylori HP0231 Influences Bacterial Virulence and Is Essential for Gastric Colonization	PLOS ONE			English	Article							CAG PATHOGENICITY ISLAND; VACUOLATING CYTOTOXIN; EPITHELIAL-CELLS; IV SECRETION; PROTEIN; INFECTION; REVEALS; VACA; DSBA; TRANSLOCATION	The Dsb protein family is responsible for introducing disulfide bonds into nascent proteins in prokaryotes, stabilizing the structure of many proteins. Helicobacter pylori HP0231 is a Dsb-like protein, shown to catalyze disulfide bond formation and to participate in redox homeostasis. Notably, many H. pylori virulence factors are stabilized by the formation of disulfide bonds. By employing H. pylori HP0231 deficient strains we analyzed the effect of lack of this bacterial protein on the functionality of virulence factors containing putative disulfide bonds. The lack of H. pylori HP0231 impaired CagA translocation into gastric epithelial cells and reduced VacA-induced cellular vacuolation. Moreover, H. pylori HP0231 deficient bacteria were not able to colonize the gastric mucosa of mice, probably due to compromised motility. Together, our data demonstrate an essential function for H. pylori HP0231 in gastric colonization and proper function of bacterial virulence factors related to gastric pathology.	[Zhong, Yu; Anderl, Florian; Kruse, Tobias; Gerhard, Markus; Mejias-Luque, Raquel] Tech Univ Munich, Inst Med Mikrobiol Immunol & Hyg, D-80290 Munich, Germany; [Schindele, Franziska; Fischer, Wolfgang] Univ Munich, Max Von Pettenkofer Inst Hyg & Med Microbiol, Munich, Germany; [Schindele, Franziska; Gerhard, Markus; Mejias-Luque, Raquel] German Ctr Infect Res DZIF, Partner Site Munich, Munich, Germany; [Jagusztyn-Krynicka, Elzbieta Katarzyna] Univ Warsaw, Fac Biol, Inst Microbiol, Dept Bacterial Genet, Warsaw, Poland	Technical University of Munich; University of Munich; German Center for Infection Research; University of Warsaw	Mejias-Luque, R (corresponding author), Tech Univ Munich, Inst Med Mikrobiol Immunol & Hyg, D-80290 Munich, Germany.; Mejias-Luque, R (corresponding author), German Ctr Infect Res DZIF, Partner Site Munich, Munich, Germany.	raquel.mejias-luque@tum.de	Gerhard, Markus/N-3387-2014; Gerhard, Markus/P-8996-2019	Gerhard, Markus/0000-0001-9110-3950; Gerhard, Markus/0000-0001-9110-3950; Jagusztyn-Krynicka, Elzbieta/0000-0003-0484-9290; Mejias-Luque, Raquel/0000-0002-4602-4927	Polish National Science Centre [2012/05/B/NZ1/00039]; China Scholarship Council [2011630085]	Polish National Science Centre; China Scholarship Council(China Scholarship Council)	This work was supported by the Polish National Science Centre, 2012/05/B/NZ1/00039, https://www.ncn.gov.pl (to EKJK), and the China Scholarship Council, 2011630085, http://en.csc.edu.cn/ (to YZ). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arnold IC, 2011, GASTROENTEROLOGY, V140, P199, DOI 10.1053/j.gastro.2010.06.047; Backert S, 2001, PROTEOMICS, V1, P608, DOI 10.1002/1615-9861(200104)1:4<608::AID-PROT608>3.3.CO;2-7; Barden S, 2013, STRUCTURE, V21, P1931, DOI 10.1016/j.str.2013.08.018; CORREA P, 1992, CANCER RES, V52, P6735; Gangwer KA, 2007, P NATL ACAD SCI USA, V104, P16293, DOI 10.1073/pnas.0707447104; Gebert B, 2003, SCIENCE, V301, P1099, DOI 10.1126/science.1086871; Godlewska R, 2006, INT J MED MICROBIOL, V296, P321, DOI 10.1016/j.ijmm.2005.11.010; Guillemin K, 2002, P NATL ACAD SCI USA, V99, P15136, DOI 10.1073/pnas.182558799; Kaakoush NO, 2007, FEMS IMMUNOL MED MIC, V50, P177, DOI 10.1111/j.1574-695X.2007.00259.x; Pham KT, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035341; Lee A, 1997, GASTROENTEROLOGY, V112, P1386, DOI 10.1016/S0016-5085(97)70155-0; Lester J, 2015, MOL MICROBIOL, V96, P110, DOI 10.1111/mmi.12923; Letley DP, 2006, MICROBIOL-SGM, V152, P1319, DOI 10.1099/mic.0.28548-0; Martinez LE, 2015, MOL MICROBIOL; Morrow AL, 2007, BIOCHEMISTRY-US, V46, P13407, DOI 10.1021/bi701599e; MOTOYAMA T, 1986, ACTA PATHOL JAPON, V36, P65; Oertli M, 2013, P NATL ACAD SCI USA, V110, P3047, DOI 10.1073/pnas.1211248110; Ohnishi N, 2008, P NATL ACAD SCI USA, V105, P1003, DOI 10.1073/pnas.0711183105; Pachathundikandi SK, 2013, GUT MICROBES, V4, P454, DOI 10.4161/gmic.27001; PEEK JA, 1992, P NATL ACAD SCI USA, V89, P6210, DOI 10.1073/pnas.89.13.6210; Raczko AM, 2005, MICROBIOL-SGM, V151, P219, DOI 10.1099/mic.0.27483-0; Raju D, 2012, GASTROENTEROLOGY, V142, P1160, DOI 10.1053/j.gastro.2012.01.043; Rassow J, 2012, MICROBES INFECT, V14, P1026, DOI 10.1016/j.micinf.2012.07.002; Roszczenko P, 2015, BMC MICROBIOL, V15, DOI 10.1186/s12866-015-0471-z; Roszczenko P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046563; Sanders L, 2013, MICROBIOL-SGM, V159, P46, DOI 10.1099/mic.0.062877-0; Schindele F, 2016, MOL MICROBIOL, V100, P188, DOI 10.1111/mmi.13309; SCHMITT W, 1994, MOL MICROBIOL, V12, P307, DOI 10.1111/j.1365-2958.1994.tb01019.x; Schreiber S, 2004, P NATL ACAD SCI USA, V101, P5024, DOI 10.1073/pnas.0308386101; Semper RP, 2014, J IMMUNOL, V193, P3566, DOI 10.4049/jimmunol.1400362; Sgouras DN, 2015, HELICOBACTER, V20, P8, DOI 10.1111/hel.12251; Stenson TH, 2002, INFECT IMMUN, V70, P2297, DOI 10.1128/IAI.70.5.2297-2303.2002; XIANG ZY, 1995, INFECT IMMUN, V63, P94, DOI 10.1128/IAI.63.1.94-98.1995; Yoon JY, 2011, FEBS LETT, V585, P3862, DOI 10.1016/j.febslet.2011.10.042; Yu J, 1998, INFECT IMMUN, V66, P3909, DOI 10.1128/IAI.66.8.3909-3917.1998; Yu J, 1999, MICROBES INFECT, V1, P1221, DOI 10.1016/S1286-4579(99)00239-7	36	15	18	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 3	2016	11	5							e0154643	10.1371/journal.pone.0154643	http://dx.doi.org/10.1371/journal.pone.0154643			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DL5KK	27138472	Green Published, gold, Green Submitted			2022-12-26	WOS:000375675700048
J	Ballhorn, DJ; Schadler, M; Elias, JD; Millar, JA; Kautz, S				Ballhorn, Daniel J.; Schaedler, Martin; Elias, Jacob D.; Millar, Jess A.; Kautz, Stefanie			Friend or Foe-Light Availability Determines the Relationship between Mycorrhizal Fungi, Rhizobia and Lima Bean (Phaseolus lunatus L.)	PLOS ONE			English	Article							TRIPARTITE SYMBIOSIS; PLANT-GROWTH; GLOMUS; COLONIZATION; REPRODUCTION; PHOSPHORUS; CARBON; PRODUCTIVITY; ALLOCATION; RESPONSES	Plant associations with root microbes represent some of the most important symbioses on earth. While often critically promoting plant fitness, nitrogen-fixing rhizobia and arbuscular mycorrhizal fungi (AMF) also demand significant carbohydrate allocation in exchange for key nutrients. Though plants may often compensate for carbon loss, constraints may arise under light limitation when plants cannot extensively increase photosynthesis. Under such conditions, costs for maintaining symbioses may outweigh benefits, turning mutualist microbes into parasites, resulting in reduced plant growth and reproduction. In natural systems plants commonly grow with different symbionts simultaneously which again may interact with each other. This might add complexity to the responses of such multipartite relationships. We experimented with lima bean (Phaseolus lunatus), which efficiently forms associations with both types of root symbionts. We applied full light and low-light to each of four treatments of microbial inoculation. After an incubation period of 14 weeks, we quantified vegetative aboveground and belowground biomass and number and viability of seeds to determine effects of combined inoculant and light treatment on plant fitness. Under light-limited conditions, vegetative and reproductive traits were inhibited in AMF and rhizobia inoculated lima bean plants relative to controls (un-colonized plants). Strikingly, reductions in seed production were most critical in combined treatments with rhizobia x AMF. Our findings suggest microbial root symbionts create additive costs resulting in decreased plant fitness under light-limited conditions.	[Ballhorn, Daniel J.; Elias, Jacob D.; Millar, Jess A.; Kautz, Stefanie] Portland State Univ, Dept Biol, Portland, OR 97201 USA; [Schaedler, Martin] Helmholtz Ctr Environm Res, Dept Community Ecol, D-06120 Halle, Germany; [Schaedler, Martin] German Ctr Integrat Biodivers Res Halle Jena Leip, Deutsch Pl 5e, D-04103 Leipzig, Germany	Portland State University; Helmholtz Association; Helmholtz Center for Environmental Research (UFZ)	Ballhorn, DJ (corresponding author), Portland State Univ, Dept Biol, Portland, OR 97201 USA.	ballhorn@pdx.edu	Millar, Jess/J-6736-2014; Schädler, Martin/H-3176-2011	Millar, Jess/0000-0001-8945-3396; Schädler, Martin/0000-0001-9700-0311	National Science Foundation (NSF) [1457369]	National Science Foundation (NSF)(National Science Foundation (NSF))	This work was supported by the National Science Foundation (NSF) (grant 1457369) to DJB. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AMES RN, 1987, NEW PHYTOL, V106, P207, DOI 10.1111/j.1469-8137.1987.tb00136.x; Ballhorn DJ, 2008, J ECOL, V96, P971, DOI 10.1111/j.1365-2745.2008.01404.x; Ballhorn DJ, 2014, BMC PLANT BIOL, V14, DOI 10.1186/s12870-014-0321-4; Ballhorn DJ, 2014, J CHEM ECOL, V40, P294, DOI 10.1007/s10886-014-0392-6; Ballhorn DJ, 2013, OECOLOGIA, V172, P833, DOI 10.1007/s00442-012-2539-x; Ballhorn DJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055602; Ballhorn DJ, 2011, ECOL ENTOMOL, V36, P1, DOI 10.1111/j.1365-2311.2010.01240.x; BAREA JM, 1992, METHOD MICROBIOL, V24, P391, DOI 10.1016/S0580-9517(08)70104-1; BETHLENFALVAY GJ, 1983, PLANT PHYSIOL, V73, P969, DOI 10.1104/pp.73.4.969; Biro B, 2000, APPL SOIL ECOL, V15, P159, DOI 10.1016/S0929-1393(00)00092-5; Blue E, 2015, PLANT BIOLOGY, V17, P712, DOI 10.1111/plb.12285; Carney KM, 2005, ECOSYSTEMS, V8, P928, DOI 10.1007/s10021-005-0047-0; Chirko CP, 1996, FOREST ECOL MANAG, V83, P171, DOI 10.1016/0378-1127(96)03721-8; DAFT MJ, 1978, NEW PHYTOL, V80, P365, DOI 10.1111/j.1469-8137.1978.tb01570.x; Denison RF, 2011, CURR BIOL, V21, pR775, DOI 10.1016/j.cub.2011.06.018; Fellbaum CR, 2014, NEW PHYTOL, V203, P646, DOI 10.1111/nph.12827; GianinazziPearson V, 1996, PLANT CELL, V8, P1871, DOI 10.1105/tpc.8.10.1871; Godschalx AL, 2015, ECOLOGY, V96, P348, DOI 10.1890/14-1178.1; Goverde M, 2000, OECOLOGIA, V125, P362, DOI 10.1007/s004420000465; Graham PH, 2003, PLANT PHYSIOL, V131, P872, DOI 10.1104/pp.017004; Franzini VI, 2010, J PLANT PHYSIOL, V167, P614, DOI 10.1016/j.jplph.2009.11.010; Jamshidi S, 2015, ECOL MODEL, V311, P11, DOI 10.1016/j.ecolmodel.2015.04.021; Kaschuk G, 2009, SOIL BIOL BIOCHEM, V41, P1233, DOI 10.1016/j.soilbio.2009.03.005; Kautz S, 2014, J CHEM ECOL, V40, P1186, DOI 10.1007/s10886-014-0524-z; Kiers ET, 2008, ANNU REV ECOL EVOL S, V39, P215, DOI 10.1146/annurev.ecolsys.39.110707.173423; Konvalinkova T, 2015, FRONT PLANT SCI, V6, DOI 10.3389/fpls.2015.00065; Koo Chang-Duck, 1996, Journal of Korean Forestry Society, V85, P96; Larimer AL, 2010, SYMBIOSIS, V51, P139, DOI 10.1007/s13199-010-0083-1; Lau JA, 2012, ACTA OECOL, V39, P80, DOI 10.1016/j.actao.2012.01.004; MCGONIGLE TP, 1990, NEW PHYTOL, V115, P495, DOI 10.1111/j.1469-8137.1990.tb00476.x; Millar JA, 2013, J APPL BOT FOOD QUAL, V86, P172, DOI 10.5073/JABFQ.2013.086.023; Mortimer PE, 2008, SOIL BIOL BIOCHEM, V40, P1019, DOI 10.1016/j.soilbio.2007.11.014; REINHARD S, 1994, EXPERIENTIA, V50, P890, DOI 10.1007/BF01923475; REINHARD S, 1993, J PLANT PHYSIOL, V141, P7, DOI 10.1016/S0176-1617(11)80844-8; Ronsheim ML, 2012, AM MIDL NAT, V167, P28, DOI 10.1674/0003-0031-167.1.28; Safapour M., 2011, American-Eurasian Journal of Agricultural & Environmental Sciences, V11, P398; SAITO M, 1994, BIOL FERT SOILS, V17, P206, DOI 10.1007/BF00336324; Smith S., 1997, MYCORRHIZAL SYMBIOSI, V2nd Edn; Sprent J.I., 2001, NODULATION LEGUMES; Stonor RN, 2014, MYCORRHIZA, V24, P465, DOI 10.1007/s00572-014-0556-9; Thamer S, 2011, PLANT SOIL, V341, P209, DOI 10.1007/s11104-010-0635-4; Thornley JHM, 2014, J THEOR BIOL, V342, P1, DOI 10.1016/j.jtbi.2013.10.003; van der Heijden MGA, 2008, ECOL LETT, V11, P296, DOI 10.1111/j.1461-0248.2007.01139.x; van der Heijden MGA, 2006, FEMS MICROBIOL ECOL, V56, P178, DOI 10.1111/j.1574-6941.2006.00086.x; VEJSADOVA H, 1993, J PLANT NUTR, V16, P619, DOI 10.1080/01904169309364561; Wardle D., 2002, COMMUNITIES ECOSYSTE	46	25	27	3	68	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 2	2016	11	5							e0154116	10.1371/journal.pone.0154116	http://dx.doi.org/10.1371/journal.pone.0154116			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DL5KB	27136455	Green Submitted, Green Published, gold			2022-12-26	WOS:000375674800013
J	Kaczmarczyk, L; Mende, Y; Zevnik, B; Jackson, WS				Kaczmarczyk, Lech; Mende, Ylva; Zevnik, Branko; Jackson, Walker S.			Manipulating the Prion Protein Gene Sequence and Expression Levels with CRISPR/Cas9	PLOS ONE			English	Article							TRANSMISSIBLE SPONGIFORM ENCEPHALOPATHY; ONE-STEP GENERATION; SYNAPTIC PLASTICITY; TRANSGENIC MICE; HOMOLOGOUS RECOMBINATION; ALZHEIMERS-DISEASE; PRP; SCRAPIE; CRISPR-CAS9; CELLS	The mammalian prion protein (PrP, encoded by Prnp) is most infamous for its central role in prion diseases, invariably fatal neurodegenerative diseases affecting humans, food animals, and animals in the wild. However, PrP is also hypothesized to be an important receptor for toxic protein conformers in Alzheimer's disease, and is associated with other clinically relevant processes such as cancer and stroke. Thus, key insights into important clinical areas, as well as into understanding PrP functions in normal physiology, can be obtained from studying transgenic mouse models and cell culture systems. However, the Prnp locus is difficult to manipulate by homologous recombination, making modifications of the endogenous locus rarely attempted. Fortunately in recent years genome engineering technologies, like TALENs or CRISPR/Cas9 (CC9), have brought exceptional new possibilities for manipulating Prnp. Herein, we present our observations made during systematic experiments with the CC9 system targeting the endogenous mouse Prnp locus, to either modify sequences or to boost PrP expression using CC9-based synergistic activation mediators (SAMs). It is our hope that this information will aid and encourage researchers to implement gene-targeting techniques into their research program.	[Kaczmarczyk, Lech; Jackson, Walker S.] German Ctr Neurodegenerat Dis DZNE, Bonn, Germany; [Mende, Ylva; Zevnik, Branko] Univ Cologne, Cologne Excellence Cluster Cellular Stress Respon, Fac Med, D-50931 Cologne, Germany	Helmholtz Association; German Center for Neurodegenerative Diseases (DZNE); University of Cologne	Jackson, WS (corresponding author), German Ctr Neurodegenerat Dis DZNE, Bonn, Germany.	walker.jackson@dzne.de	Kaczmarczyk, Lech/AAK-2892-2020; Zevnik, Branko/AAB-7853-2020	Kaczmarczyk, Lech/0000-0003-2747-3134; Zevnik, Branko/0000-0001-7845-9522; Jackson, Walker/0000-0002-3003-5509	DZNE	DZNE(Helmholtz Association)	This work was supported by internal funding from the DZNE.	Aguzzi A, 2009, NEURON, V64, P783, DOI 10.1016/j.neuron.2009.12.016; Aymard F, 2014, NAT STRUCT MOL BIOL, V21, P366, DOI 10.1038/nsmb.2796; Baybutt H, 1997, GENE, V184, P125, DOI 10.1016/S0378-1119(96)00600-2; Biasini E, 2012, TRENDS NEUROSCI, V35, P92, DOI 10.1016/j.tins.2011.10.002; Borchelt DR, 1996, GENET ANAL-BIOMOL E, V13, P159, DOI 10.1016/S1050-3862(96)00167-2; Bouybayoune I, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1004796; Bremer J, 2010, NAT NEUROSCI, V13, P310, DOI 10.1038/nn.2483; BUELER H, 1993, CELL, V73, P1339, DOI 10.1016/0092-8674(93)90360-3; BUELER H, 1992, NATURE, V356, P577, DOI 10.1038/356577a0; BUTLER DA, 1988, J VIROL, V62, P1558, DOI 10.1128/JVI.62.5.1558-1564.1988; Caiati MD, 2013, J NEUROSCI, V33, P2973, DOI 10.1523/JNEUROSCI.4149-12.2013; Castellani RJ, 2004, ACTA NEUROBIOL EXP, V64, P11; CAUGHEY B, 1989, J VIROL, V63, P175, DOI 10.1128/JVI.63.1.175-181.1989; Checler F, 2013, NAT MED, V19, P1088, DOI 10.1038/nm.3332; Chiarini LB, 2002, EMBO J, V21, P3317, DOI 10.1093/emboj/cdf324; Cho SW, 2014, GENOME RES, V24, P132, DOI 10.1101/gr.162339.113; Cushman M, 2010, J CELL SCI, V123, P1191, DOI 10.1242/jcs.051672; Dametto P, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117412; DIEDRICH J, 1987, MICROB PATHOGENESIS, V2, P435, DOI 10.1016/0882-4010(87)90050-7; Doench JG, 2014, NAT BIOTECHNOL, V32, P1262, DOI 10.1038/nbt.3026; Doudna JA, 2014, SCIENCE, V346, P1077, DOI 10.1126/science.1258096; Eggan K, 2002, NAT BIOTECHNOL, V20, P455, DOI 10.1038/nbt0502-455; Falsig J, 2008, NAT PROTOC, V3, P555, DOI 10.1038/nprot.2008.13; Falsig J, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002985; Fischer M, 1996, EMBO J, V15, P1255, DOI 10.1002/j.1460-2075.1996.tb00467.x; Friedman-Levi Y, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002350; Fritsch O, 2004, MOL CELL, V16, P479, DOI 10.1016/j.molcel.2004.09.034; Gilbert LA, 2013, CELL, V154, P442, DOI 10.1016/j.cell.2013.06.044; Harris DA, 2003, BRIT MED BULL, V66, P71, DOI 10.1093/bmb/66.1.71; Heigwer F, 2014, NAT METHODS, V11, P122, DOI 10.1038/nmeth.2812; Heintze Jacob, 2013, Frontiers in Genetics, V4, P193, DOI 10.3389/fgene.2013.00193; Herrmann US, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1004662; HSIAO KK, 1990, SCIENCE, V250, P1587, DOI 10.1126/science.1980379; Hsu PD, 2014, CELL, V157, P1262, DOI 10.1016/j.cell.2014.05.010; Jackson WS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095958; Jackson WS, 2014, DIS MODEL MECH, V7, P21, DOI 10.1242/dmm.012146; Jackson WS, 2013, P NATL ACAD SCI USA, V110, P14759, DOI 10.1073/pnas.1312006110; Jackson WS, 2009, NEURON, V63, P438, DOI 10.1016/j.neuron.2009.07.026; Kaczmarczyk L, 2015, SWISS MED WKLY, V145, DOI 10.4414/smw.2015.14186; Kleinstiver BP, 2016, NATURE, V529, P490, DOI 10.1038/nature16526; Kocisko DA, 2003, J VIROL, V77, P10288, DOI 10.1128/JVI.77.19.10288-10294.2003; Konermann S, 2015, NATURE, V517, P583, DOI 10.1038/nature14136; Kovacs GG, 2002, J NEUROL, V249, P1567, DOI 10.1007/s00415-002-0896-9; Kurt TD, 2014, J NEUROSCI, V34, P1022, DOI 10.1523/JNEUROSCI.4636-13.2014; Lauren J, 2009, NATURE, V457, P1128, DOI 10.1038/nature07761; Linden R, 2008, PHYSIOL REV, V88, P673, DOI 10.1152/physrev.00007.2007; Maglio LE, 2004, MOL BRAIN RES, V131, P58, DOI 10.1016/j.molbrainres.2004.08.004; Manson JC, 1999, EMBO J, V18, P6855, DOI 10.1093/emboj/18.23.6855; MANSON JC, 1994, MOL NEUROBIOL, V8, P121, DOI 10.1007/BF02780662; Maruyama T, 2015, NAT BIOTECHNOL, V33, P538, DOI 10.1038/nbt.3190; Mehrabian M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0114594; MOORE RC, 1995, BIO-TECHNOL, V13, P999, DOI 10.1038/nbt0995-999; Moore RC, 1998, NAT GENET, V18, P118, DOI 10.1038/ng0298-118; Nagy A., 2003, MANIPULATING MOUSE E, Vx; Nishida N, 1999, LAB INVEST, V79, P689; Nygaard HB, 2009, ARCH NEUROL-CHICAGO, V66, P1325, DOI 10.1001/archneurol.2009.223; Priola SA, 2009, PRION, V3, P134, DOI 10.4161/pri.3.3.9771; PRUSINER SB, 1982, SCIENCE, V216, P136, DOI 10.1126/science.6801762; Prusiner SB, 1998, P NATL ACAD SCI USA, V95, P13363, DOI 10.1073/pnas.95.23.13363; Qin W., 2015, GENETICS; Ran FA, 2013, NAT PROTOC, V8, P2281, DOI 10.1038/nprot.2013.143; Ran FA, 2013, CELL, V154, P1380, DOI 10.1016/j.cell.2013.08.021; Remy S, 2014, GENOME RES, V24, P1371, DOI 10.1101/gr.171538.113; Roucou X, 2004, J NEUROSCI RES, V75, P153, DOI 10.1002/jnr.10864; Salmena L, 2011, CELL, V146, P353, DOI 10.1016/j.cell.2011.07.014; Saxena S, 2011, NEURON, V71, P35, DOI 10.1016/j.neuron.2011.06.031; SCOTT M, 1993, CELL, V73, P979, DOI 10.1016/0092-8674(93)90275-U; Shaked H, 2006, GENETICS, V173, P985, DOI 10.1534/genetics.105.051664; Shorter J, 2005, NAT REV GENET, V6, P435, DOI 10.1038/nrg1616; Sigurdson CJ, 2009, P NATL ACAD SCI USA, V106, P304, DOI 10.1073/pnas.0810680105; Sonati T, 2013, NATURE, V501, P102, DOI 10.1038/nature12402; STACEY A, 1994, MOL CELL BIOL, V14, P1009, DOI 10.1128/MCB.14.2.1009; Steele AD, 2009, PRION, V3, P240, DOI 10.4161/pri.3.4.10135; Tay Y, 2014, NATURE, V505, P344, DOI 10.1038/nature12986; Tuzi NL, 2004, GENESIS, V40, P1, DOI 10.1002/gene.20046; van Rheede T, 2003, MOL BIOL EVOL, V20, P111, DOI 10.1093/molbev/msg014; Wang HY, 2013, CELL, V153, P910, DOI 10.1016/j.cell.2013.04.025; Weise J, 2006, STROKE, V37, P1296, DOI 10.1161/01.STR.0000217262.03192.d4; WEISSMANN C, 1994, ANN NY ACAD SCI, V724, P235, DOI 10.1111/j.1749-6632.1994.tb38913.x; Weissmann Charles, 2004, Cell, VS116, pS111, DOI 10.1016/S0092-8674(04)00032-7; Westergard L, 2007, BBA-MOL BASIS DIS, V1772, P629, DOI 10.1016/j.bbadis.2007.02.011; Yang H, 2013, CELL, V154, P1370, DOI 10.1016/j.cell.2013.08.022; Yang WB, 2009, J NEUROSCI, V29, P10072, DOI 10.1523/JNEUROSCI.2542-09.2009; Yewdell JW, 2001, TRENDS CELL BIOL, V11, P294, DOI 10.1016/S0962-8924(01)02030-X; Zhou JY, 2013, INTRACTABLE RARE DIS, V2, P35, DOI 10.5582/irdr.2013.v2.2.35	85	15	15	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 29	2016	11	4							e0154604	10.1371/journal.pone.0154604	http://dx.doi.org/10.1371/journal.pone.0154604			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DK8XM	27128441	Green Submitted, gold, Green Published			2022-12-26	WOS:000375212600047
J	Hirano, A; Nakagawa, T; Yoshitane, H; Oyama, M; Kozuka-Hata, H; Lanjakornsiripan, D; Fukada, Y				Hirano, Arisa; Nakagawa, Tomoki; Yoshitane, Hikari; Oyama, Masaaki; Kozuka-Hata, Hiroko; Lanjakornsiripan, Darin; Fukada, Yoshitaka			USP7 and TDP-43: Pleiotropic Regulation of Cryptochrome Protein Stability Paces the Oscillation of the Mammalian Circadian Clock	PLOS ONE			English	Article							DEUBIQUITINATING ENZYME; DEGRADATION; PHOSPHORYLATION; FBXL3; UBIQUITINATION; MECHANISMS; REVEALS; RHYTHMS; SLEEP; MCRY2	Mammalian Cryptochromes, CRY1 and CRY2, function as principal regulators of a transcription-translation-based negative feedback loop underlying the mammalian circadian clockwork. An F-box protein, FBXL3, promotes ubiquitination and degradation of CRYs, while FBXL21, the closest paralog of FBXL3, ubiquitinates CRYs but leads to stabilization of CRYs. Fbxl3 knockout extremely lengthened the circadian period, and deletion of Fbxl21 gene in Fbxl3-deficient mice partially rescued the period-lengthening phenotype, suggesting a key role of CRY protein stability for maintenance of the circadian periodicity. Here, we employed a proteomics strategy to explore regulators for the protein stability of CRYs. We found that ubiquitin-specific protease 7 (USP7 also known as HAUSP) associates with CRY1 and CRY2 and stabilizes CRYs through deubiquitination. Treatment with USP7-specific inhibitor or Usp7 knockdown shortened the circadian period of the cellular rhythm. We identified another CRYs-interacting protein, TAR DNA binding protein 43 (TDP-43), an RNA-binding protein. TDP-43 stabilized CRY1 and CRY2, and its knockdown also shortened the circadian period in cultured cells. The present study identified USP7 and TDP-43 as the regulators of CRY1 and CRY2, underscoring the significance of the stability control process of CRY proteins for period determination in the mammalian circadian clockwork.	[Hirano, Arisa; Nakagawa, Tomoki; Yoshitane, Hikari; Lanjakornsiripan, Darin; Fukada, Yoshitaka] Univ Tokyo, Dept Biol Sci, Sch Sci, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1130033, Japan; [Oyama, Masaaki; Kozuka-Hata, Hiroko] Univ Tokyo, Med Prote Lab, Inst Med Sci, Minato Ku, 4-6-1 Shirokanedai, Tokyo 1088639, Japan	University of Tokyo; University of Tokyo	Fukada, Y (corresponding author), Univ Tokyo, Dept Biol Sci, Sch Sci, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1130033, Japan.	sfukada@mail.ecc.u-tokyo.ac.jp	吉孝, 深田/G-5090-2014	Kozuka-Hata, Hiroko/0000-0002-9286-6594; Yoshitane, Hikari/0000-0001-6319-3354	Ministry of Education, Culture, Sports, Science and Technology, MEXT (Japan); Japan Society of the Promotion of Science [24227001, 15H01173]; Grants-in-Aid for Scientific Research [16H06578] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science and Technology, MEXT (Japan)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Society of the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by Ministry of Education, Culture, Sports, Science and Technology, MEXT (Japan), Japan Society of the Promotion of Science, Grants-in-Aid for Scientific Research, https://www.jsps.go.jp/english/e-grants/, grant numbers 24227001 and 15H01173, Recipient Y.F.; Ministry of Education, Culture, Sports, Science and Technology, MEXT (Japan), Japan Society of the Promotion of Science, Research Fellowships for Young Researchers, http://www.jsps.go.jp/english/epd/index.html, Recipient A.H.	Baralle M, 2013, BIOCHEM SOC T, V41, P1536, DOI 10.1042/BST20130186; Barthlen GM, 2000, EUR J NEUROL, V7, P299, DOI 10.1046/j.1468-1331.2000.00044.x; Bunger MK, 2000, CELL, V103, P1009, DOI 10.1016/S0092-8674(00)00205-1; Busino L, 2007, SCIENCE, V316, P900, DOI 10.1126/science.1141194; Colland F, 2009, MOL CANCER THER, V8, P2286, DOI 10.1158/1535-7163.MCT-09-0097; Fang LK, 2015, MOL CANCER THER, V14, P1476, DOI 10.1158/1535-7163.MCT-15-0030; Gallego M, 2007, NAT REV MOL CELL BIO, V8, P139, DOI 10.1038/nrm2106; Gao P, 2013, J BIOL CHEM, V288, P35277, DOI 10.1074/jbc.M113.509604; Gekakis N, 1998, SCIENCE, V280, P1564, DOI 10.1126/science.280.5369.1564; Godinho SIH, 2007, SCIENCE, V316, P897, DOI 10.1126/science.1141138; Hanson KA, 2012, WIRES RNA, V3, P265, DOI 10.1002/wrna.111; Harada Y, 2005, J BIOL CHEM, V280, P31714, DOI 10.1074/jbc.M506225200; Heintzen C, 2007, ADV GENET, V58, P25, DOI 10.1016/S0065-2660(06)58002-2; Hirano A, 2014, MOL CELL BIOL, V34, P4464, DOI 10.1128/MCB.00711-14; Hirano A, 2013, CELL, V152, P1106, DOI 10.1016/j.cell.2013.01.054; Hirota T, 2012, SCIENCE, V337, P1094, DOI 10.1126/science.1223710; Hu M, 2002, CELL, V111, P1041, DOI 10.1016/S0092-8674(02)01199-6; Hurley JM, 2013, MOL CELL, V52, P832, DOI 10.1016/j.molcel.2013.11.005; Kim J, 2014, MOL CELL BIOL, V34, P4177, DOI 10.1128/MCB.00530-14; King DP, 1997, CELL, V89, P641, DOI 10.1016/S0092-8674(00)80245-7; Komander D, 2012, ANNU REV BIOCHEM, V81, P203, DOI 10.1146/annurev-biochem-060310-170328; Kon N, 2008, NAT CELL BIOL, V10, P1463, DOI 10.1038/ncb1806; Kume K, 1999, CELL, V98, P193, DOI 10.1016/S0092-8674(00)81014-4; Kurabayashi N, 2010, MOL CELL BIOL, V30, P1757, DOI 10.1128/MCB.01047-09; Lamia KA, 2011, NATURE, V480, P552, DOI 10.1038/nature10700; Lamia KA, 2009, SCIENCE, V326, P437, DOI 10.1126/science.1172156; Lee C, 2001, CELL, V107, P855, DOI 10.1016/S0092-8674(01)00610-9; Lee MH, 2006, SEMIN CANCER BIOL, V16, P225, DOI 10.1016/j.semcancer.2006.03.009; Liscic RM, 2008, EUR J NEUROL, V15, P772, DOI 10.1111/j.1468-1331.2008.02195.x; Nicholson B, 2011, CELL BIOCHEM BIOPHYS, V60, P61, DOI 10.1007/s12013-011-9185-5; Papp SJ, 2015, ELIFE, V4, DOI 10.7554/eLife.04883; Reppert SM, 2001, ANNU REV PHYSIOL, V63, P647, DOI 10.1146/annurev.physiol.63.1.647; Sato Y, 2015, NAT STRUCT MOL BIOL, V22, P222, DOI 10.1038/nsmb.2970; Scoma HD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025382; Shi GS, 2013, P NATL ACAD SCI USA, V110, P4750, DOI 10.1073/pnas.1302560110; Siepka SM, 2007, CELL, V129, P1011, DOI 10.1016/j.cell.2007.04.030; Soekadar SR, 2013, J CLIN SLEEP MED, V9, P951, DOI 10.5664/jcsm.3002; St John PC, 2014, P NATL ACAD SCI USA, V111, P2040, DOI 10.1073/pnas.1323618111; Stojkovic K, 2014, FRONT MOL NEUROSCI, V7, DOI 10.3389/fnmol.2014.00069; TAKAHASHI JS, 1995, ANNU REV NEUROSCI, V18, P531, DOI 10.1146/annurev.neuro.18.1.531; Tong X, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0139725; Tong X, 2012, J BIOL CHEM, V287, P25280, DOI 10.1074/jbc.M112.340786; Ventii KH, 2008, BIOCHEM J, V414, P161, DOI 10.1042/BJ20080798; Verma A, 2013, MUSCLE NERVE, V47, P330, DOI 10.1002/mus.23673; Yang YM, 2012, BIOL OPEN, V1, P789, DOI 10.1242/bio.20121990; Yoo SH, 2013, CELL, V152, P1091, DOI 10.1016/j.cell.2013.01.055	46	16	16	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 28	2016	11	4							e0154263	10.1371/journal.pone.0154263	http://dx.doi.org/10.1371/journal.pone.0154263			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DK8XE	27123980	Green Submitted, Green Published, gold			2022-12-26	WOS:000375211700064
J	Mamun, AA; Aseltine, R; Rajasekaran, S				Mamun, Abdullah-Al; Aseltine, Robert; Rajasekaran, Sanguthevar			Efficient Record Linkage Algorithms Using Complete Linkage Clustering	PLOS ONE			English	Article							PARALLEL ALGORITHMS; INTEGRATION; IDENTIFICATION	Data from different agencies share data of the same individuals. Linking these datasets to identify all the records belonging to the same individuals is a crucial and challenging problem, especially given the large volumes of data. A large number of available algorithms for record linkage are prone to either time inefficiency or low-accuracy in finding matches and non-matches among the records. In this paper we propose efficient as well as reliable sequential and parallel algorithms for the record linkage problem employing hierarchical clustering methods. We employ complete linkage hierarchical clustering algorithms to address this problem. In addition to hierarchical clustering, we also use two other techniques: elimination of duplicate records and blocking. Our algorithms use sorting as a subroutine to identify identical copies of records. We have tested our algorithms on datasets with millions of synthetic records. Experimental results show that our algorithms achieve nearly 100% accuracy. Parallel implementations achieve almost linear speedups. Time complexities of these algorithms do not exceed those of previous best-known algorithms. Our proposed algorithms outperform previous best-known algorithms in terms of accuracy consuming reasonable run times.	[Mamun, Abdullah-Al; Rajasekaran, Sanguthevar] Univ Connecticut, Dept Comp Sci & Engn, Storrs, CT USA; [Aseltine, Robert] Univ Connecticut, Publ Hlth Res Inst, E Hartford, CT USA	University of Connecticut; University of Connecticut	Rajasekaran, S (corresponding author), Univ Connecticut, Dept Comp Sci & Engn, Storrs, CT USA.	rajasek@engr.uconn.edu	Mamun, Abdullah/HHM-9898-2022		National Library of Medicine, NIH [R01-LM010101]; National Science Foundation [1447711]; NATIONAL LIBRARY OF MEDICINE [R01LM010101] Funding Source: NIH RePORTER; Div Of Information & Intelligent Systems [1447711] Funding Source: National Science Foundation	National Library of Medicine, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM)); National Science Foundation(National Science Foundation (NSF)); NATIONAL LIBRARY OF MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM)); Div Of Information & Intelligent Systems(National Science Foundation (NSF)NSF - Directorate for Computer & Information Science & Engineering (CISE))	This work was supported by National Library of Medicine, NIH, R01-LM010101 (SR, https://www.nlm.nih.gov/), and National Science Foundation, 1447711 (SR, http://www.nsf.gov/div/index.jsp?div=iis). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdullah-Al Mamun, 2014, J AM MED INFORM ASSN, V21, P252, DOI 10.1136/amiajnl-2013-002034; [Anonymous], [No title captured]; [Anonymous], 2001, CONDITIONAL RANDOM F; Bachteler T, 2013, WPGRLC201302; Bhattacharya I., 2007, ACM T KNOWL DISCOV D, V1, P5, DOI [DOI 10.1145/1217299.1217304, 10.1145/1217299.1217304]; Brin S., 1995, SIGMOD Record, V24, P398, DOI 10.1145/568271.223855; Christen P, 2004, LECT NOTES ARTIF INT, V3056, P638; Christen P, 2007, QUALITY MEASURES DAT, P127, DOI DOI 10.1007/978-3-540-44918-8_6; Christen P., 2012, DATA MATCHING CONCEP, DOI 10.1007/978-3-642-31164-2; Christen P., 2008, P 2 AUSTR WORKSH HLT, P17; Christen P, 2006, ICDM 2006: SIXTH IEEE INTERNATIONAL CONFERENCE ON DATA MINING, WORKSHOPS, P290; Christen P, 2012, IEEE T KNOWL DATA EN, V24, P1537, DOI 10.1109/TKDE.2011.127; Clark DE, 2004, INJURY PREV, V10, P186, DOI 10.1136/ip.2003.004580; Clatworthy J, 2005, BRIT J HEALTH PSYCH, V10, P329, DOI 10.1348/135910705X25697; Cox S, 2013, AUST HEALTH REV, V37, P54, DOI 10.1071/AH11161; Culotta A., 2005, CIKM, P257, DOI DOI 10.1145/1099554; Dal Bianco G, 2011, ACM S APPL COMP, P1027; Dennis G, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r60; Domingos P, 2004, P KDD 2004 WORKSHOP; Elmagarmid AK, 2007, IEEE T KNOWL DATA EN, V19, P1, DOI 10.1109/TKDE.2007.250581; Fayyad U, 1996, AI MAG, V17, P37; FELLEGI IP, 1969, J AM STAT ASSOC, V64, P1183, DOI 10.2307/2286061; FRIEDMAN C, 1992, COMPUT BIOMED RES, V25, P486, DOI 10.1016/0010-4809(92)90005-U; Gomatam S, 2002, STAT MED, V21, P1485, DOI 10.1002/sim.1147; Gu L, 2003, RECORD LINKAGE CURRE; Hawse J, 2003, MOL VIS, V9, P515; Heyer LJ, 1999, GENOME RES, V9, P1106, DOI 10.1101/gr.9.11.1106; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Jain AK, 1999, ACM COMPUT SURV, V31, P264, DOI 10.1145/331499.331504; JARO MA, 1989, J AM STAT ASSOC, V84, P414, DOI 10.2307/2289924; JOHNSON SC, 1967, PSYCHOMETRIKA, V32, P241, DOI 10.1007/BF02289588; Jurczyk Pawel, 2008, AMIA Annu Symp Proc, P440; Jurczyk P, 2008, BIRTH DEFECTS RES A, V82, P822, DOI 10.1002/bdra.20521; Kawai H., 2006, P SWOOSH PARALLEL AL; Kim Hs, 2007, ACM CIKM, P283; Kirsten T., 2010, ARXIV10065309; KOUDAS N., 2006, SIGMOD, P802, DOI DOI 10.1145/1142473.1142599; KUKICH K, 1992, COMPUT SURV, V24, P377; Levenshtein VI, 1966, SOV PHYS DOKL, V10, P707; Li X, 1990, PATTERN ANAL MACHINE, V12, P1088, DOI [10.1109/34.61708, DOI 10.1109/34.61708]; Li XC, 2013, STAT METHODS MED RES, V22, P31, DOI 10.1177/0962280211403600; Maizlish NA, 2005, J AM MED INFORM ASSN, V12, P331, DOI 10.1197/jamia.M1696; McCallum A., 2000, Proceedings. KDD-2000. Sixth ACM SIGKDD International Conference on Knowledge Discovery and Data Mining, P169, DOI 10.1145/347090.347123; Mi T, 2012, BMC MED INFORM DECIS, V12, DOI 10.1186/1472-6947-12-59; Mi T, 2008, IEEE INT C BIOINFORM, P443, DOI 10.1109/BIBM.2008.48; Mong Li Loo, 2000, Proceedings. KDD-2000. Sixth ACM SIGKDD International Conference on Knowledge Discovery and Data Mining, P290; Ng R. T., 1994, P VLDB, P144; OLSON CF, 1995, PARALLEL COMPUT, V21, P1313, DOI 10.1016/0167-8191(95)00017-I; Pasula H, 2002, ADV NEURAL INFORM PR, P1401; Rajasekaran S, 2005, IEEE T PARALL DISTR, V16, P497, DOI 10.1109/TPDS.2005.72; Reuter T, 2011, ICWSM; Shivakumar N., 1996, Proceedings of the 1st ACM International Conference on Digital Libraries, P160, DOI 10.1145/226931.226961; Steorts RC, 2016, J AM STAT ASSOC, V111, P1660, DOI 10.1080/01621459.2015.1105807; Steorts RC, 2014, LECT NOTES COMPUT SC, V8744, P253, DOI 10.1007/978-3-319-11257-2_20; Victor TW, 2001, J AM MED INFORM ASSN, V8, P281, DOI 10.1136/jamia.2001.0080281; Vinh N.X., 2009, P 26 ANN INT C MACH, P1073, DOI [10.1145/1553374.1553511, DOI 10.1145/1553374.1553511]; Wellner B, 2004, ADV NEURAL INFORM PR; Winkler W. E., 1993, IMPROVED DECISION RU; WINKLER WE, 1995, WILEY S PRO, P355; Winkler WE, 1991, APPL FELLEGI SUNTER, P1; Winkler WE, 2006, OVERVIEW RECORD LINK; Winkler William E, 1999, STATE RECORD LINKAGE; Wong W, 2007, DATA MIN KNOWL DISC, V15, P349, DOI 10.1007/s10618-007-0073-y; Wu CH, 2000, J PARALLEL DISTR COM, V60, P1137, DOI 10.1006/jpdc.2000.1644; Zhao Y., 2002, Proceedings of the Eleventh International Conference on Information and Knowledge Management. CIKM 2002, P515, DOI 10.1145/584792.584877	65	10	10	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 28	2016	11	4							e0154446	10.1371/journal.pone.0154446	http://dx.doi.org/10.1371/journal.pone.0154446			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DK8XE	27124604	Green Published, gold, Green Submitted			2022-12-26	WOS:000375211700090
J	Strasser, B; Geiger, D; Schauer, M; Gatterer, H; Burtscher, M; Fuchs, D				Strasser, Barbara; Geiger, Daniela; Schauer, Markus; Gatterer, Hannes; Burtscher, Martin; Fuchs, Dietmar			Effects of Exhaustive Aerobic Exercise on Tryptophan-Kynurenine Metabolism in Trained Athletes	PLOS ONE			English	Article							QUINOLINIC ACID; MITOCHONDRIAL-FUNCTION; SERUM TRYPTOPHAN; IMMUNE-SYSTEM; NEOPTERIN; PHENYLALANINE; PERFORMANCE; DEPRESSION; RESPONSES; LIVER	Exhaustive exercise can cause a transient depression of immune function. Data indicate significant effects of immune activation cascades on the biochemistry of monoamines and amino acids such as tryptophan. Tryptophan can be metabolized through different pathways, a major route being the kynurenine pathway, which is often systemically up-regulated when the immune response is activated. The present study was undertaken to examine the effect of exhaustive aerobic exercise on biomarkers of immune activation and tryptophan metabolism in trained athletes. After a standardized breakfast 2 h prior to exercise, 33 trained athletes (17 women, 16 men) performed an incremental cycle ergometer exercise test at 60 rpm until exhaustion. After a 20 min rest phase, the participants performed a 20 min maximal time-trial on a cycle ergometer (RBM Cyclus 2, Germany). During the test, cyclists were strongly encouraged to choose a maximal pedalling rate that could be maintained for the respective test duration. Serum concentrations of amino acids tryptophan, kynurenine, phenylalanine, and tyrosine were determined by HPLC and immune system biomarker neopterin by ELISA at rest and immediately post exercise. Intense exercise was associated with a strong increase in neopterin concentrations (p<0.001), indicating increased immune activation following intense exercise. Exhaustive exercise significantly reduced tryptophan concentrations by 12% (p<0.001) and increased kynurenine levels by 6% (p = 0.022). Also phenylalanine to tyrosine ratios were lower after exercise as compared with baseline (p<0.001). The kynurenine to tryptophan ratio correlated with neopterin (r = 0.560, p<0.01). Thus, increased tryptophan catabolism by indoleamine 2,3-dioxygenase appears likely. Peak oxygen uptake correlated with baseline tryptophan and kynurenine concentrations (r = 0.562 and r = 0.511, respectively, both p<0.01). Findings demonstrate that exhaustive aerobic exercise is associated with increased immune activation and alterations in monoamine metabolism in trained athletes which may play a role in the regulation of mood and cognitive processes.	[Strasser, Barbara] Med Univ Innsbruck, Bioctr, Div Med Biochem, A-6020 Innsbruck, Austria; [Geiger, Daniela; Schauer, Markus; Fuchs, Dietmar] Med Univ Innsbruck, Bioctr, Div Biol Chem, A-6020 Innsbruck, Austria; [Gatterer, Hannes; Burtscher, Martin] Univ Innsbruck, Med Sect, Dept Sport Sci, A-6020 Innsbruck, Austria	Medical University of Innsbruck; Medical University of Innsbruck; University of Innsbruck	Fuchs, D (corresponding author), Med Univ Innsbruck, Bioctr, Div Biol Chem, A-6020 Innsbruck, Austria.	dietmar.fuchs@i-med.ac.at	Gatterer, Hannes/S-7848-2017; Fuchs, Dietmar/AAL-8011-2021; Strasser, Barbara/ABG-3013-2020; Burtscher, Martin/M-7015-2019	Gatterer, Hannes/0000-0002-5084-2930; Fuchs, Dietmar/0000-0003-1627-9563; Strasser, Barbara/0000-0002-4318-5629; Burtscher, Martin/0000-0002-5232-3632				Areces F, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0138376; Badawy AA, 2015, NEUROPHARMACOLOGY; Braidy N, 2011, FEBS J, V278, P4425, DOI 10.1111/j.1742-4658.2011.08366.x; Braidy N, 2009, NEUROTOX RES, V16, P77, DOI 10.1007/s12640-009-9051-z; Capuron L, 2014, CURR PHARM DESIGN, V20, P6048, DOI 10.2174/1381612820666140317110217; Capuron L, 2011, BIOL PSYCHIAT, V70, P175, DOI 10.1016/j.biopsych.2010.12.006; Chen YQ, 2009, INT J TRYPTOPHAN RES, V2, P1; Edvardsen E, 2013, CHEST, V144, P241, DOI 10.1378/chest.12-1458; Fallarino F, 2003, NAT IMMUNOL, V4, P1206, DOI 10.1038/ni1003; Faulhaber M, 2010, J SPORT SCI, V28, P513, DOI 10.1080/02640410903581588; FUCHS D, 1990, J ACQ IMMUN DEF SYND, V3, P873; Gerhart-Hines Z, 2007, EMBO J, V26, P1913, DOI 10.1038/sj.emboj.7601633; Gleeson M, 2013, SCAND J MED SCI SPOR, V23, P451, DOI 10.1111/j.1600-0838.2011.01422.x; Gleeson M, 2013, EXERC SPORT SCI REV, V41, P148, DOI 10.1097/JES.0b013e3182956ead; Halson SL, 2014, SPORTS MED, V44, P13, DOI 10.1007/s40279-014-0147-0; Haroon E, 2012, NEUROPSYCHOPHARMACOL, V37, P137, DOI 10.1038/npp.2011.205; Ito Y, 2003, ADV EXP MED BIOL, V527, P531; Ito Y, 2007, INT C SER, V1304, P167; Lagouge M, 2006, CELL, V127, P1109, DOI 10.1016/j.cell.2006.11.013; Meeusen R, 2014, SPORTS MED, V44, P47, DOI 10.1007/s40279-014-0150-5; Mrakic-Sposta S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0141780; Munn DH, 2013, TRENDS IMMUNOL, V34, P137, DOI 10.1016/j.it.2012.10.001; Murr C, 2002, CURR DRUG METAB, V3, P175, DOI 10.2174/1389200024605082; Neurauter G, 2008, CURR DRUG METAB, V9, P622, DOI 10.2174/138920008785821738; Neurauter G, 2013, CLIN BIOCHEM, V46, P1848, DOI 10.1016/j.clinbiochem.2013.10.015; OCONNOR PJ, 1987, MED SCI SPORT EXER, V19, P224; Rahman A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006344; Saanijoki T, 2015, MED SCI SPORT EXER, V47, P2604, DOI 10.1249/MSS.0000000000000721; Schrocksnadel K, 2006, CLIN CHIM ACTA, V364, P82, DOI 10.1016/j.cca.2005.06.013; SPRENGER H, 1992, CLIN IMMUNOL IMMUNOP, V63, P188, DOI 10.1016/0090-1229(92)90012-D; STONE TW, 1981, EUR J PHARMACOL, V72, P411, DOI 10.1016/0014-2999(81)90587-2; TILZ GP, 1993, IMMUNOBIOLOGY, V188, P194, DOI 10.1016/S0171-2985(11)80497-3; Viru A, 2005, BIOL SPORT, V22, P29; Walsh NP, 2011, EXERC IMMUNOL REV, V17, P64; Werner ER, 2011, BIOCHEM J, V438, P397, DOI 10.1042/BJ20110293; Widner B, 1997, CLIN CHEM, V43, P2424; Widner B, 2002, BRAIN BEHAV IMMUN, V16, P590, DOI 10.1016/S0889-1591(02)00006-5; Widner B, 2001, J NEUROL NEUROSUR PS, V70, P419, DOI 10.1136/jnnp.70.3.419	38	63	64	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 28	2016	11	4							e0153617	10.1371/journal.pone.0153617	http://dx.doi.org/10.1371/journal.pone.0153617			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DK8XE	27124720	gold, Green Submitted, Green Published			2022-12-26	WOS:000375211700020
J	Almuzzaini, B; Sarshad, AA; Rahmanto, AS; Hansson, ML; Von Euler, A; Sangfelt, O; Visa, N; Farrants, AKO; Percipalle, P				Almuzzaini, Bader; Sarshad, Aishe A.; Rahmanto, Aldwin S.; Hansson, Magnus L.; Von Euler, Anne; Sangfelt, Olle; Visa, Neus; Farrants, Ann-Kristin Ostlund; Percipalle, Piergiorgio			In beta-actin knockouts, epigenetic reprogramming and rDNA transcription inactivation lead to growth and proliferation defects	FASEB JOURNAL			English	Article						genome-wide analysis; NM1; nuclear actin; rRNA synthesis	POLYMERASE-I TRANSCRIPTION; NUCLEOLAR TRANSCRIPTION; NUCLEAR ACTIN; CELL-GROWTH; FACTOR UBF; FACTOR SL1; MYOSIN-I; RNA; COMPLEX; CONFORMATION	Actin and nuclear myosin 1 (NM1) are regulators of transcription and chromatin organization. Using a genome-wide approach, we report here that beta-actin binds intergenic and genic regions across the mammalian genome, associated with both protein-coding and rRNA genes. Within the rDNA, the distribution of beta-actin correlated with NM1 and the other subunits of the B-WICH complex, WSTF and SNF2h. In beta-actin(-/-) mouse embryonic fibroblasts (MEFs), we found that rRNA synthesis levels decreased concomitantly with drops in RNA polymerase I (Pol I) and NM1 occupancies across the rRNA gene. Reintroduction of wild-type beta-actin, in contrast to mutated forms with polymerization defects, efficiently rescued rRNA synthesis underscoring the direct role for a polymerization-competent form of beta-actin in Pol I transcription. The rRNA synthesis defects in the beta-actin(-/-) MEFs are a consequence of epigenetic reprogramming with up-regulation of the repressive mark H3K4me1 (mono-methylation of lys4 on histone H3) and enhanced chromatin compaction at promoter-proximal enhancer (T0 sequence), which disturb binding of the transcription factor TTF1. We propose a novel genome-wide mechanism where the polymerase-associated beta-actin synergizes with NM1 to coordinate permissive chromatin with Pol I transcription, cell growth, and proliferation.	[Almuzzaini, Bader; Sarshad, Aishe A.; Rahmanto, Aldwin S.; Hansson, Magnus L.; Sangfelt, Olle; Percipalle, Piergiorgio] Karolinska Inst, Dept Cell & Mol Biol, Stockholm, Sweden; [Almuzzaini, Bader] King Abdullah Int Med Res Ctr, Natl Guard Hlth Affairs, Riyadh, Saudi Arabia; [Von Euler, Anne; Visa, Neus; Farrants, Ann-Kristin Ostlund; Percipalle, Piergiorgio] Stockholm Univ, Wenner Gren Inst, Dept Mol Biosci, Stockholm, Sweden; [Percipalle, Piergiorgio] New York Univ Abu Dhabi, Dept Biol, Div Sci, Abu Dhabi, U Arab Emirates; [Sarshad, Aishe A.] NIAMSD, NIH, Bethesda, MD USA	Karolinska Institutet; King Saud Bin Abdulaziz University for Health Sciences; King Abdulaziz Medical City - Riyadh; King Abdullah International Medical Research Center (KAIMRC); Ministry of National Guard - Health Affairs; National Guard Health Affairs - Saudi Arabia; Stockholm University; National Institutes of Health (NIH) - USA; NIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)	Percipalle, P (corresponding author), New York Univ Abu Dhabi, Saadyiat Campus, Abu Dhabi 129188, U Arab Emirates.	pp69@nyu.edu	Visa, Neus/C-9459-2016; Visa, Neus/R-8037-2019	Visa, Neus/0000-0003-3145-3953; Visa, Neus/0000-0003-3145-3953; Almuzzaini, Bader/0000-0003-1176-9037; Sarshad, Aishe/0000-0001-7153-5959	Swedish Research Council; Swedish Cancer Society; National Guard Health Affairs-King Abdullah International Medical Research Center; Karolinska Institute doctoral fellowship; Swedish Society for Medical Research; Radiumhemmets Forskningsfonder	Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Cancer Society(Swedish Cancer Society); National Guard Health Affairs-King Abdullah International Medical Research Center; Karolinska Institute doctoral fellowship; Swedish Society for Medical Research; Radiumhemmets Forskningsfonder	The authors thank C. Ampe (University of Ghent, Ghent, Belgium) and R. Treissman (London Research Institute, London, United Kingdom) for kindly providing the beta-actin<SUP>+/+</SUP> MEFs, beta-actin<SUP>-/-</SUP> MEFs, and beta-actin constructs. The authors also thank M. Corcoran and M. Rahman (both from the Karolinska Institute) for technical help. This work was supported by grants from the Swedish Research Council and the Swedish Cancer Society to P.P., O.S., and N.V. B.A.M. was cofunded by National Guard Health Affairs-King Abdullah International Medical Research Center, and A.A.S. was cofunded by a Karolinska Institute doctoral fellowship. M.H. was supported by a postdoctoral fellowship from the Swedish Society for Medical Research. A.S.R. was supported by funds from Radiumhemmets Forskningsfonder.	Almuzzaini B, 2015, BMC BIOL, V13, DOI 10.1186/s12915-015-0147-z; Belmont LD, 1999, P NATL ACAD SCI USA, V96, P29, DOI 10.1073/pnas.96.1.29; Belmont LD, 1998, J CELL BIOL, V142, P1289, DOI 10.1083/jcb.142.5.1289; Bunnell TM, 2011, MOL BIOL CELL, V22, P4047, DOI 10.1091/mbc.E11-06-0582; Cavellan E, 2006, J BIOL CHEM, V281, P16264, DOI 10.1074/jbc.M600233200; Chen TW, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-539; CHEN X, 1995, J BIOL CHEM, V270, P11415, DOI 10.1074/jbc.270.19.11415; CHEN X, 1995, J BIOL CHEM, V270, P11406, DOI 10.1074/jbc.270.19.11406; Cheng J, 2014, MOL CELL, V53, P979, DOI 10.1016/j.molcel.2014.02.032; Cheung TH, 2013, NAT REV MOL CELL BIO, V14, P329, DOI 10.1038/nrm3591; Diermeier SD, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003786; Drygin D, 2010, ANNU REV PHARMACOL, V50, P131, DOI 10.1146/annurev.pharmtox.010909.105844; Fomproix N, 2004, EXP CELL RES, V294, P140, DOI 10.1016/j.yexcr.2003.10.028; Ford E, 2006, GENE DEV, V20, P1075, DOI 10.1101/gad.1399706; Grummt I, 2006, CURR OPIN GENET DEV, V16, P191, DOI 10.1016/j.gde.2006.02.001; Grummt I, 2003, GENE DEV, V17, P1691, DOI 10.1101/gad.1098503R; Grummt I, 2007, HUM MOL GENET, V16, pR21, DOI 10.1093/hmg/ddm020; Hanada K, 1996, EMBO J, V15, P2217, DOI 10.1002/j.1460-2075.1996.tb00575.x; Heix J, 1998, EMBO J, V17, P7373, DOI 10.1093/emboj/17.24.7373; Klein J, 1999, P NATL ACAD SCI USA, V96, P6096, DOI 10.1073/pnas.96.11.6096; Kuhn A, 1998, J MOL BIOL, V284, P1, DOI 10.1006/jmbi.1998.2164; Langst G, 1998, EMBO J, V17, P3135, DOI 10.1093/emboj/17.11.3135; Mayer C, 2006, ONCOGENE, V25, P6384, DOI 10.1038/sj.onc.1209883; McStay B, 2008, ANNU REV CELL DEV BI, V24, P131, DOI 10.1146/annurev.cellbio.24.110707.175259; Nemeth A, 2008, EMBO J, V27, P1255, DOI 10.1038/emboj.2008.57; Panov KI, 2006, EMBO J, V25, P3310, DOI 10.1038/sj.emboj.7601221; Percipalle P, 2006, EMBO REP, V7, P525, DOI 10.1038/sj.embor.7400657; Petesch SJ, 2008, CELL, V134, P74, DOI 10.1016/j.cell.2008.05.029; Philimonenko VV, 2004, NAT CELL BIOL, V6, P1165, DOI 10.1038/ncb1190; Posern G, 2002, MOL BIOL CELL, V13, P4167, DOI 10.1091/mbc.02-05-0068; Prieto JL, 2005, BIOCHEM SOC T, V33, P1441, DOI 10.1042/BST0331441; Rosner M, 2013, NAT PROTOC, V8, P602, DOI 10.1038/nprot.2013.011; Russell J, 2006, BIOCHEM SOC SYMP, V73, P203; Sarshad A, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003397; Sarshad AA, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004390; Sarshad AA, 2014, INT REV CEL MOL BIO, V311, P183, DOI 10.1016/B978-0-12-800179-0.00004-0; Schneider A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052007; Sirri V, 2008, HISTOCHEM CELL BIOL, V129, P13, DOI 10.1007/s00418-007-0359-6; Spencer VA, 2011, J CELL SCI, V124, P123, DOI 10.1242/jcs.073197; Tondeleir D, 2012, MOL CELL PROTEOMICS, V11, P255, DOI 10.1074/mcp.M111.015099; Vintermist A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019184; Visa N, 2005, EMBO REP, V6, P218, DOI 10.1038/sj.embor.7400362; Visa N, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a000620; Xu YZ, 2010, MOL BIOL CELL, V21, P811, DOI 10.1091/mbc.E09-06-0534; Ye J, 2008, GENE DEV, V22, P322, DOI 10.1101/gad.455908; Zentner GE, 2011, NUCLEIC ACIDS RES, V39, P4949, DOI 10.1093/nar/gkq1326; ZETTERBERG A, 1985, P NATL ACAD SCI USA, V82, P5365, DOI 10.1073/pnas.82.16.5365; Zhang Q, 2014, SCIENCE, V343, P298, DOI 10.1126/science.1246384	48	22	22	0	4	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	AUG	2016	30	8					2860	2873		10.1096/fj.201600280R	http://dx.doi.org/10.1096/fj.201600280R			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	DS7WP	27127100				2022-12-26	WOS:000380994000021
J	Lei, DS; Rames, M; Zhang, X; Zhang, L; Zhang, SL; Ren, G				Lei, Dongsheng; Rames, Matthew; Zhang, Xing; Zhang, Lei; Zhang, Shengli; Ren, Gang			Insights into the Tunnel Mechanism of Cholesteryl Ester Transfer Protein through All-atom Molecular Dynamics Simulations	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						cholesterol; cholesterol metabolism; cholesterol regulation; cholesterol-binding protein; lipid metabolism; lipid transport; lipid-protein interaction; lipoprotein metabolism; molecular dynamics	LOW-DENSITY-LIPOPROTEIN; LIPID-TRANSFER; SURFACE-LIPIDS; HEART-DISEASE; CETP; IMPLICIT; BINDING; MODEL; HDL; PHOSPHATIDYLCHOLINE	Cholesteryl ester transfer protein (CETP) mediates cholesteryl ester (CE) transfer from the atheroprotective high density lipoprotein (HDL) cholesterol to the atherogenic low density lipoprotein cholesterol. In the past decade, this property has driven the development of CETP inhibitors, which have been evaluated in large scale clinical trials for treating cardiovascular diseases. Despite the pharmacological interest, little is known about the fundamental mechanism of CETP in CE transfer. Recent electron microscopy (EM) experiments have suggested a tunnel mechanism, and molecular dynamics simulations have shown that the flexible N-terminal distal end of CETP penetrates into the HDL surface and takes up a CE molecule through an open pore. However, it is not known whether a CE molecule can completely transfer through an entire CETP molecule. Here, we used all-atom molecular dynamics simulations to evaluate this possibility. The results showed that a hydrophobic tunnel inside CETP is sufficient to allow a CE molecule to completely transfer through the entire CETP within a predicted transfer time and at a rate comparable with those obtained through physiological measurements. Analyses of the detailed interactions revealed several residues that might be critical for CETP function, which may provide important clues for the effective development of CETP inhibitors and treatment of cardiovascular diseases.	[Lei, Dongsheng; Rames, Matthew; Zhang, Xing; Ren, Gang] Lawrence Berkeley Natl Lab, Mol Foundry, Lawrence, CA 94720 USA; [Lei, Dongsheng; Zhang, Xing; Zhang, Lei; Zhang, Shengli] Xi An Jiao Tong Univ, Dept Appl Phys, Xian 710049, Shaanxi, Peoples R China	United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; Xi'an Jiaotong University	Ren, G (corresponding author), Lawrence Berkeley Natl Lab, Mol Foundry, Lawrence, CA 94720 USA.; Zhang, SL (corresponding author), Xi An Jiao Tong Univ, Dept Appl Phys, Xian 710049, Shaanxi, Peoples R China.	zhangsl@xjtu.edu.cn; gren@lbl.gov	Lei, Dongsheng/AAH-4177-2020; Lei, Dongsheng/K-3485-2012; Zhang, Lei/G-6427-2012; Ren, Gang/B-1567-2012	Lei, Dongsheng/0000-0003-1640-0693; Zhang, Lei/0000-0002-4880-824X; Ren, Gang/0000-0002-8036-2321	National Institutes of Health from the NHLBI [1R01HL115153]; National Natural Science Foundation of China [11074196, 11374237]; Office of Science, Office of Basic Energy Sciences, of the United States Department of Energy [DE-AC02-05CH11231]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL115153] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM104427] Funding Source: NIH RePORTER	National Institutes of Health from the NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Office of Science, Office of Basic Energy Sciences, of the United States Department of Energy(United States Department of Energy (DOE)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Grant 1R01HL115153 from the NHLBI (to G. R.) and National Natural Science Foundation of China Grants 11074196 and 11374237 (to S. Z.). The work performed at the Molecular Foundry was supported by the Office of Science, Office of Basic Energy Sciences, of the United States Department of Energy under Contract DE-AC02-05CH11231. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Armen RS, 1998, BIOPHYS J, V75, P734, DOI 10.1016/S0006-3495(98)77563-0; Barter PJ, 2007, NEW ENGL J MED, V357, P2109, DOI 10.1056/NEJMoa0706628; BARTER PJ, 1980, J LIPID RES, V21, P238; Berka K, 2012, NUCLEIC ACIDS RES, V40, pW222, DOI 10.1093/nar/gks363; BROWN ML, 1989, NATURE, V342, P448, DOI 10.1038/342448a0; CAMEJO G, 1976, ATHEROSCLEROSIS, V24, P341, DOI 10.1016/0021-9150(76)90126-X; Cilpa-Karhu G, 2015, J LIPID RES, V56, P98, DOI 10.1194/jlr.M054288; Cournia Z, 2005, J COMPUT CHEM, V26, P1383, DOI 10.1002/jcc.20277; DARDEN T, 1993, J CHEM PHYS, V98, P10089, DOI 10.1063/1.464397; Elder RM, 2012, BIOPHYS J, V102, P2331, DOI 10.1016/j.bpj.2012.04.013; Feller SE, 2000, J PHYS CHEM B, V104, P7510, DOI 10.1021/jp0007843; FELLER SE, 1995, J CHEM PHYS, V103, P4613, DOI 10.1063/1.470648; Feller SE, 1997, BIOPHYS J, V73, P2269, DOI 10.1016/S0006-3495(97)78259-6; Garcia-Gonzalez V, 2014, J STRUCT BIOL, V186, P19, DOI 10.1016/j.jsb.2014.02.002; GORDON T, 1977, AM J MED, V62, P707, DOI 10.1016/0002-9343(77)90874-9; Gotto AM, 2012, EXPERT REV CARDIOVAS, V10, P955, DOI [10.1586/ERC.12.82, 10.1586/erc.12.82]; GREST GS, 1986, PHYS REV A, V33, P3628, DOI 10.1103/PhysRevA.33.3628; Nguyen H, 2015, J CHEM THEORY COMPUT, V11, P3714, DOI 10.1021/acs.jctc.5b00271; Hall A, 2008, J PHYS CHEM B, V112, P13772, DOI 10.1021/jp803950w; HANNUKSELA M, 1992, J LIPID RES, V33, P737; Heikela M, 2006, BIOPHYS J, V90, P2247, DOI 10.1529/biophysj.105.069849; Hevonoja T, 2000, BBA-MOL CELL BIOL L, V1488, P189, DOI 10.1016/S1388-1981(00)00123-2; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; IBDAH JA, 1989, BIOCHEMISTRY-US, V28, P1126, DOI 10.1021/bi00429a029; IHM J, 1982, J LIPID RES, V23, P1328; Jarvis L, 2015, CHEM ENG NEWS, V93, P9; Kale L, 1999, J COMPUT PHYS, V151, P283, DOI 10.1006/jcph.1999.6201; Kleinjung J, 2014, CURR OPIN STRUC BIOL, V25, P126, DOI 10.1016/j.sbi.2014.04.003; KYTE J, 1982, J MOL BIOL, V157, P105, DOI 10.1016/0022-2836(82)90515-0; Lassel TS, 1998, ARTERIOSCL THROM VAS, V18, P65, DOI 10.1161/01.ATV.18.1.65; Lauer ME, 2016, J STRUCT BIOL, V194, P191, DOI 10.1016/j.jsb.2016.02.016; Lei DS, 2013, PROTEINS, V81, P415, DOI 10.1002/prot.24200; Lund-Katz S, 2003, FRONT BIOSCI-LANDMRK, V8, pD1044, DOI 10.2741/1077; MCLEAN LR, 1984, BIOCHEMISTRY-US, V23, P4624, DOI 10.1021/bi00315a017; Mozaffarian D, 2015, CIRCULATION, V131, pE29, DOI 10.1161/CIR.0000000000000152; Nicholls SJ, 2011, JAMA-J AM MED ASSOC, V306, P2099, DOI 10.1001/jama.2011.1649; Qiu XY, 2007, NAT STRUCT MOL BIOL, V14, P106, DOI 10.1038/nsmb1197; Ren G, 2010, P NATL ACAD SCI USA, V107, P1059, DOI 10.1073/pnas.0908004107; SAKAI N, 1991, ARTERIOSCLER THROMB, V11, P71, DOI 10.1161/01.ATV.11.1.71; Schlenkrich Michael, 1996, P31; Schmidtke P, 2010, NUCLEIC ACIDS RES, V38, pW582, DOI 10.1093/nar/gkq383; Schwartz GG, 2012, NEW ENGL J MED, V367, P2089, DOI 10.1056/NEJMoa1206797; SLOTTE JP, 1990, J LIPID RES, V31, P2235; TALL AR, 1986, J LIPID RES, V27, P361; TALL AR, 1993, J LIPID RES, V34, P1255; WANG SK, 1993, J BIOL CHEM, V268, P1955; WEINBERG RB, 1992, J BIOL CHEM, V267, P8977; Zhang L, 2012, NAT CHEM BIOL, V8, P342, DOI [10.1038/NCHEMBIO.796, 10.1038/nchembio.796]; Zhang L, 2011, J LIPID RES, V52, P175, DOI 10.1194/jlr.D010959; Zhang LQ, 2013, PROTEINS, V81, P365, DOI 10.1002/prot.24192; Zhang M, 2015, SCI REP-UK, V5, DOI 10.1038/srep08741	51	13	13	0	10	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 1	2016	291	27					14034	14044		10.1074/jbc.M116.715565	http://dx.doi.org/10.1074/jbc.M116.715565			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DR5XG	27143480	Green Submitted, Green Published, hybrid			2022-12-26	WOS:000379975100012
J	Hinz, C; Aldrovandi, M; Uhlson, C; Marnett, LJ; Longhurst, HJ; Warner, TD; Alam, S; Slatter, DA; Lauder, SN; Allen-Redpath, K; Collins, PW; Murphy, RC; Thomas, CP; O'Donnell, VB				Hinz, Christine; Aldrovandi, Maceler; Uhlson, Charis; Marnett, Lawrence J.; Longhurst, Hilary J.; Warner, Timothy D.; Alam, Saydul; Slatter, David A.; Lauder, Sarah N.; Allen-Redpath, Keith; Collins, Peter W.; Murphy, Robert C.; Thomas, Christopher P.; O'Donnell, Valerie B.			Human Platelets Utilize Cycloxygenase-1 to Generate Dioxolane A(3), a Neutrophil-activating Eicosanoid	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						cyclooxygenase (COX); eicosanoid; eicosanoid biosynthesis; lipid; platelet; lipidomics	CYCLOOXYGENASE ACTIVE-SITE; ENDOPEROXIDE-H SYNTHASE-1; ARACHIDONIC-ACID; FATTY-ACIDS; IN-VIVO; AUTOXIDATION; LIPOXYGENASE; OXYGENATION; PRODUCTS; IDENTIFICATION	Eicosanoids are important mediators of fever, pain, and inflammation that modulate cell signaling during acute and chronic disease. We show by using lipidomics that thrombin-activated human platelets generate a new type of eicosanoid that both stimulates and primes human neutrophil integrin (Mac-1) expression, in response to formylmethionylleucylphenylalanine. Detailed characterization proposes a dioxolane structure, 8-hydroxy-9,11-dioxolane eicosatetraenoic acid (dioxolane A(3), DXA(3)). The lipid is generated in nanogram amounts by platelets from endogenous arachidonate during physiological activation, with inhibition by aspirin in vitro or in vivo, implicating cyclooxygenase-1 (COX). Pharmacological and genetic studies on human/murine platelets revealed that DXA(3) formation requires protease-activated receptors 1 and 4, cytosolic phospholipase A(2) (cPLA(2)), Src tyrosine kinases, p38 MAPK, phospholipase C, and intracellular calcium. From data generated by purified COX isoforms and chemical oxidation, we propose that DXA(3) is generated by release of an intermediate from the active site followed by oxygenation at C8. In summary, a new neutrophil-activating platelet-derived lipid generated by COX-1 is presented that can activate or prime human neutrophils, suggesting a role in innate immunity and acute inflammation.	[Hinz, Christine; Aldrovandi, Maceler; Alam, Saydul; Slatter, David A.; Lauder, Sarah N.; Allen-Redpath, Keith; Collins, Peter W.; Thomas, Christopher P.; O'Donnell, Valerie B.] Cardiff Univ, Sch Med, Syst Immun Res Inst, Cardiff CF14 4XN, S Glam, Wales; [Hinz, Christine; Aldrovandi, Maceler; Alam, Saydul; Slatter, David A.; Lauder, Sarah N.; Allen-Redpath, Keith; Collins, Peter W.; Thomas, Christopher P.; O'Donnell, Valerie B.] Cardiff Univ, Sch Med, Div Infect & Immun, Cardiff CF14 4XN, S Glam, Wales; [Uhlson, Charis; Murphy, Robert C.] Univ Colorado Denver, Dept Pharmacol, Aurora, CO 80045 USA; [Marnett, Lawrence J.] Vanderbilt Ingram Canc Ctr, Ctr Mol Toxicol, Vanderbilt Inst Chem Biol, Nashville, TN 37232 USA; [Longhurst, Hilary J.; Warner, Timothy D.] Queen Mary Univ London, William Harvey Res Inst, Charterhouse Sq, London EC1M 6BQ, England	Cardiff University; Cardiff University; Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus; Vanderbilt University; University of London; Queen Mary University London	O'Donnell, VB (corresponding author), Cardiff Univ, Sch Med, Syst Immun Res Inst, Cardiff CF14 4XN, S Glam, Wales.	O-DonnellVB@cardiff.ac.uk	Thomas, Christopher P/R-5243-2016; Slatter, David/AAV-5771-2020; Slatter, David/AAW-6938-2021	Thomas, Christopher P/0000-0001-5840-8613; /0000-0003-4089-8460	Wellcome Trust [94143/Z/10/Z]; British Heart Foundation [RG/12/11/29815]; National Institutes of Health [U54HL117798]; Wellcome Trust/NISCHR ISSF Fellowship; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [U54HL117798] Funding Source: NIH RePORTER; Medical Research Council [MR/M011445/1] Funding Source: researchfish; MRC [MR/M011445/1] Funding Source: UKRI	Wellcome Trust(Wellcome TrustEuropean Commission); British Heart Foundation(British Heart Foundation); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Wellcome Trust/NISCHR ISSF Fellowship; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported in part by Wellcome Trust 94143/Z/10/Z, British Heart Foundation Grant RG/12/11/29815 (to V. B. O. and P. W. C.), and National Institutes of Health Grant U54HL117798 (to R. C. M.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.; Supported by a Wellcome Trust/NISCHR ISSF Fellowship.	Aldrovandi M, 2013, J LIPID RES, V54, P3085, DOI 10.1194/jlr.M041533; ANDERSON DC, 1987, ANNU REV MED, V38, P175, DOI 10.1146/annurev.med.38.1.175; ARNAOUT MA, 1990, BLOOD, V75, P1037; Brooke MA, 2014, GUT, V63, P96, DOI 10.1136/gutjnl-2012-303581; Coffey MJ, 2004, CIRC RES, V94, P1598, DOI 10.1161/01.RES.0000132281.78948.65; Cyrus T, 1999, J CLIN INVEST, V103, P1597, DOI 10.1172/JCI5897; Dovizio M, 2014, BASIC CLIN PHARMACOL, V114, P118, DOI 10.1111/bcpt.12156; Duggan KC, 2010, J BIOL CHEM, V285, P34950, DOI 10.1074/jbc.M110.162982; HAMBERG M, 1967, J BIOL CHEM, V242, P5344; Harman CA, 2004, J BIOL CHEM, V279, P42929, DOI 10.1074/jbc.M403013200; Havrilla CM, 2000, J AM CHEM SOC, V122, P8042, DOI 10.1021/ja001180f; Hermanson DJ, 2014, TRENDS PHARMACOL SCI, V35, P358, DOI 10.1016/j.tips.2014.04.006; MARNETT LJ, 1984, MOL PHARMACOL, V26, P328; Martinod K, 2014, BLOOD, V123, P2768, DOI 10.1182/blood-2013-10-463646; Maskrey BH, 2007, J BIOL CHEM, V282, P20151, DOI 10.1074/jbc.M611776200; Maugeri N, 2014, J THROMB HAEMOST, V12, P2074, DOI 10.1111/jth.12710; ODENWALLER R, 1990, METHOD ENZYMOL, V187, P479; OLIW EH, 1993, ARCH BIOCHEM BIOPHYS, V305, P288, DOI 10.1006/abbi.1993.1425; Ostermann AI, 2015, ANAL BIOANAL CHEM, V407, P1403, DOI 10.1007/s00216-014-8377-4; PORTER NA, 1980, BIOCHEM BIOPH RES CO, V92, P349, DOI 10.1016/0006-291X(80)90340-X; Powell WS, 1997, J IMMUNOL, V159, P2952; Rowlinson SW, 1999, J BIOL CHEM, V274, P23305, DOI 10.1074/jbc.274.33.23305; ROZA M, 1978, BIOCHIM BIOPHYS ACTA, V528, P119, DOI 10.1016/0005-2760(78)90057-7; Sahin IH, 2014, CANCER LETT, V345, P249, DOI 10.1016/j.canlet.2013.09.001; Shen X, 2013, CURR MED CHEM, V20, P4153; Smith W L, 1990, Methods Enzymol, V187, P1; Teder T, 2014, J LIPID RES, V55, P2587, DOI 10.1194/jlr.M054072; Thomas CP, 2010, J BIOL CHEM, V285, P6891, DOI 10.1074/jbc.M109.078428; Thuresson ED, 2000, J BIOL CHEM, V275, P8501, DOI 10.1074/jbc.275.12.8501; TONNESEN MG, 1989, J CLIN INVEST, V83, P637, DOI 10.1172/JCI113928; von Bruhl ML, 2012, J EXP MED, V209, P819, DOI 10.1084/jem.20112322; Wang ZN, 2011, NATURE, V472, P57, DOI 10.1038/nature09922; Yin HY, 2007, J BIOL CHEM, V282, P29890, DOI 10.1074/jbc.M703108200; Yin HY, 2004, J BIOL CHEM, V279, P3766, DOI 10.1074/jbc.M307137200; Yin HY, 2003, J BIOL CHEM, V278, P16720, DOI 10.1074/jbc.M300604200; Yin HY, 2002, J AM CHEM SOC, V124, P7745, DOI 10.1021/ja0201092; Yore MM, 2014, CELL, V159, P318, DOI 10.1016/j.cell.2014.09.035	37	13	13	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 24	2016	291	26					13448	13464		10.1074/jbc.M115.700609	http://dx.doi.org/10.1074/jbc.M115.700609			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DR2YZ	27129261	Green Accepted, Green Published, hybrid			2022-12-26	WOS:000379771100005
J	Kumar, V; Ero, R; Ahmed, T; Goh, KJ; Zhan, Y; Bhushan, S; Gao, YG				Kumar, Veerendra; Ero, Rya; Ahmed, Tofayel; Goh, Kwok Jian; Zhan, Yin; Bhushan, Shashi; Gao, Yong-Gui			Structure of the GTP Form of Elongation Factor 4 (EF4) Bound to the Ribosome	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-SYNTHESIS; ESCHERICHIA-COLI; LEPA CONTRIBUTES; RNA; GENE	Elongation factor 4 (EF4) is a member of the family of ribosome-dependent translational GTPase factors, along with elongation factor G and BPI-inducible protein A. Although EF4 is highly conserved in bacterial, mitochondrial, and chloroplast genomes, its exact biological function remains controversial. Here we present the cryo-EM reconstitution of the GTP form of EF4 bound to the ribosome with P and E site tRNAs at 3.8-angstrom resolution. Interestingly, our structure reveals an unrotated ribosome rather than a clockwise-rotated ribosome, as observed in the presence of EF4-GDP and P site tRNA. In addition, we also observed a counterclockwise-rotated form of the above complex at 5.7-angstrom resolution. Taken together, our results shed light on the interactions formed between EF4, the ribosome, and the P site tRNA and illuminate the GTPase activation mechanism at previously unresolved detail.	[Kumar, Veerendra; Gao, Yong-Gui] ASTAR, Inst Mol & Cell Biol, 61 Biopolis Dr, Singapore 138673, Singapore; [Kumar, Veerendra; Ero, Rya; Ahmed, Tofayel; Goh, Kwok Jian; Zhan, Yin; Bhushan, Shashi; Gao, Yong-Gui] Nanyang Technol Univ, Sch Biol Sci, 60 Nanyang Dr, Singapore 637551, Singapore; [Bhushan, Shashi; Gao, Yong-Gui] Nanyang Technol Univ, Inst Biol Struct, Singapore 636921, Singapore	Agency for Science Technology & Research (A*STAR); A*STAR - Institute of Molecular & Cell Biology (IMCB); Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University; Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University	Gao, YG (corresponding author), ASTAR, Inst Mol & Cell Biol, 61 Biopolis Dr, Singapore 138673, Singapore.; Gao, YG (corresponding author), Nanyang Technol Univ, Sch Biol Sci, 60 Nanyang Dr, Singapore 637551, Singapore.; Gao, YG (corresponding author), Nanyang Technol Univ, Inst Biol Struct, Singapore 636921, Singapore.	ygao@ntu.edu.sg	Gao, Yonggui/A-9473-2015; Ahmed, Tofayel/AAV-7091-2021; Ahmed, Tofayel/R-4346-2019; Gao, Yong Gui/A-2187-2011	Gao, Yonggui/0000-0001-7298-0835; Ahmed, Tofayel/0000-0002-2305-7750; Ahmed, Tofayel/0000-0002-7214-1000; YIN, ZHAN/0000-0002-3846-0147; Bhushan, Shashi/0000-0002-8514-5959; Kumar, Veerendra/0000-0002-9241-1303; Goh, Kwok Jian/0000-0002-9825-8071	Singapore National Research Foundation [NRF-RF2009-RF001-267]; Ministry of Education of Singapore; Nanyang Technological University Startup Grant; Ministry of Education Singapore	Singapore National Research Foundation(National Research Foundation, Singapore); Ministry of Education of Singapore(Ministry of Education, Singapore); Nanyang Technological University Startup Grant(Nanyang Technological University); Ministry of Education Singapore(Ministry of Education, Singapore)	This work was supported by Singapore National Research Foundation Grant NRF-RF2009-RF001-267 (to Y. G. G.), a Tier II grant from the Ministry of Education of Singapore (to Y. G. G.), a Nanyang Technological University Startup Grant (to S. B.), and a Tier I grant from the Ministry of Education Singapore (to S. B). The authors declare that they have no conflicts of interest with the contents of this article.	Badu-Nkansah A, 2010, FEMS MICROBIOL LETT, V311, P147, DOI 10.1111/j.1574-6968.2010.02083.x; Balakrishnan R, 2014, NUCLEIC ACIDS RES, V42, P13370, DOI 10.1093/nar/gku1098; Chen Y, 2013, NAT STRUCT MOL BIOL, V20, P1077, DOI 10.1038/nsmb.2645; Colca JR, 2003, J BIOL CHEM, V278, P21972, DOI 10.1074/jbc.M302109200; Connell SR, 2008, NAT STRUCT MOL BIOL, V15, P910, DOI 10.1038/nsmb.1469; Cunha CE, 2013, TRANSLATION, V1, DOI 10.4161/trla.24315; De Laurentiis EI, 2015, SCI REP-UK, V5, DOI 10.1038/srep08573; DIBB NJ, 1986, J BACTERIOL, V166, P83, DOI 10.1128/jb.166.1.83-87.1986; Evans RN, 2008, P NATL ACAD SCI USA, V105, P4673, DOI 10.1073/pnas.0801308105; Feng S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058829; Frank J, 2000, NATURE, V406, P318, DOI 10.1038/35018597; Gagnon MG, 2016, P NATL ACAD SCI USA, V113, P4994, DOI 10.1073/pnas.1522932113; Gagnon MG, 2014, SCIENCE, V345, P684, DOI 10.1126/science.1253525; Gao YG, 2009, SCIENCE, V326, P694, DOI 10.1126/science.1179709; Koch M, 2015, P NATL ACAD SCI USA, V112, pE2561, DOI 10.1073/pnas.1505231112; Kumar V, 2015, P NATL ACAD SCI USA, V112, P10944, DOI 10.1073/pnas.1513216112; Li LP, 2014, MBIO, V5, DOI 10.1128/mBio.01708-14; Liu HQ, 2011, P NATL ACAD SCI USA, V108, P16223, DOI 10.1073/pnas.1103820108; Liu HQ, 2010, J MOL BIOL, V396, P1043, DOI 10.1016/j.jmb.2009.12.043; Margus T, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-15; Mindell JA, 2003, J STRUCT BIOL, V142, P334, DOI 10.1016/S1047-8477(03)00069-8; Pech M, 2011, P NATL ACAD SCI USA, V108, P3199, DOI 10.1073/pnas.1012994108; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Pulk A, 2013, SCIENCE, V340, P1544, DOI 10.1126/science.1235970; Qin Y, 2006, CELL, V127, P721, DOI 10.1016/j.cell.2006.09.037; Scheres SHW, 2012, J STRUCT BIOL, V180, P519, DOI 10.1016/j.jsb.2012.09.006; Selmer M, 2006, SCIENCE, V313, P1935, DOI 10.1126/science.1131127; Selmer M, 2012, ACTA CRYSTALLOGR D, V68, P578, DOI 10.1107/S0907444912006348; Shoji S, 2010, BIOCHIMIE, V92, P157, DOI 10.1016/j.biochi.2009.11.002; Tang G, 2007, J STRUCT BIOL, V157, P38, DOI 10.1016/j.jsb.2006.05.009; Tourigny DS, 2013, SCIENCE, V340, P1542, DOI 10.1126/science.1235490; Voorhees RM, 2010, SCIENCE, V330, P835, DOI 10.1126/science.1194460; Yamamoto H, 2014, NAT REV MICROBIOL, V12, P89, DOI 10.1038/nrmicro3176; Yang F, 2014, PROTEIN CELL, V5, P563, DOI 10.1007/s13238-014-0050-3; Zhang DJ, 2016, NAT STRUCT MOL BIOL, V23, P125, DOI 10.1038/nsmb.3160; Zhang G, 2009, NAT STRUCT MOL BIOL, V16, P274, DOI 10.1038/nsmb.1554; Zhou J, 2013, SCIENCE, V340, P1543, DOI 10.1126/science.1236086	37	11	11	1	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 17	2016	291	25					12943	12950		10.1074/jbc.M116.725945	http://dx.doi.org/10.1074/jbc.M116.725945			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DR2YT	27137929	Green Accepted, hybrid, Green Published			2022-12-26	WOS:000379770500005
J	Ma, QG; Hu, LF; Li, JJ; Hu, Y; Xia, L; Chen, XJ; Hu, WD				Ma, Qingguo; Hu, Linfeng; Li, Jiaojie; Hu, Yue; Xia, Ling; Chen, Xiaojian; Hu, Wendong			Different Effects of Hypoxia on Mental Rotation of Normal and Mirrored Letters: Evidence from the Rotation-Related Negativity	PLOS ONE			English	Article							HIGH-ALTITUDE; BRAIN-POTENTIALS; LETTER DISCRIMINATIONS; HYPOBARIC HYPOXIA; RIGHT-HEMISPHERE; SPATIAL ABILITY; SEX-DIFFERENCES; WORKING-MEMORY; OBJECTS; DIMENSIONALITY	The present study explored the neural mechanism underlying the effect of moderate and transient hypoxic exposure on mental rotation of two-dimensional letters in both normal and mirror versions. Event-related potential data and behavioral data were acquired in the task of discrimination between normal and mirrored versions separately in conditions of normoxia (simulated sea level) and hypoxia conditions (simulated 5000 meter altitude). The behavioral results revealed no significant difference between the normoxia and hypoxia conditions both in response time and error rate. However, obvious differences between these two conditions in ERP were found. First, enlarged P300 and Rotation-related Negativity (RRN) were observed in the hypoxia condition compared to the normoxia condition only with normal letters. Second, the angle effect on the amplitude of RRN was more evident with normal letters in the hypoxia condition than that in the normoxia condition. However, this angle effect nearly disappeared with the mirrored letters in the hypoxia condition. Third, more bilateral parietal activation was observed in the hypoxia condition than the normoxia condition. These results suggested that the compensation mechanism existed in the hypoxia condition and was effective with normal letters but had little effect on the mirrored letters. This study extends the research about the hypoxic effect on spatial ability of humans by employing a mental rotation task and further provides neural evidence for this effect.	[Ma, Qingguo] Zhejiang Univ Technol, Inst Neural Management Sci, Hangzhou, Zhejiang, Peoples R China; [Hu, Linfeng; Hu, Yue] Zhejiang Univ, Sch Management, Hangzhou 310003, Zhejiang, Peoples R China; [Ma, Qingguo; Hu, Linfeng; Hu, Yue] Zhejiang Univ, Neuromanagement Lab, Hangzhou 310003, Zhejiang, Peoples R China; [Li, Jiaojie; Xia, Ling; Chen, Xiaojian] Hangzhou Aviat Med Assessment & Training Ctr Air, Hangzhou, Zhejiang, Peoples R China; [Hu, Wendong] Fourth Mil Med Univ, Fac Aerosp Med, Xian 710032, Peoples R China	Zhejiang University of Technology; Zhejiang University; Zhejiang University; Air Force Military Medical University	Ma, QG (corresponding author), Zhejiang Univ Technol, Inst Neural Management Sci, Hangzhou, Zhejiang, Peoples R China.; Ma, QG (corresponding author), Zhejiang Univ, Neuromanagement Lab, Hangzhou 310003, Zhejiang, Peoples R China.	maqingguo3669@zju.edu.cn			National Natural Science Foundation [71371167]; National Project [AWS12J003]	National Natural Science Foundation(National Natural Science Foundation of China (NSFC)); National Project	This work was supported by grant no. 71371167 from the National Natural Science Foundation and no. AWS12J003 from the National Project to QGM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alivisatos B, 1997, NEUROPSYCHOLOGIA, V35, P111, DOI 10.1016/S0028-3932(96)00083-8; Bartholomew CJ, 1999, INT J AVIAT PSYCHOL, V9, P351, DOI 10.1207/s15327108ijap0904_3; Bauer B, 1996, J EXP PSYCHOL HUMAN, V22, P82, DOI 10.1037/0096-1523.22.1.82; Burykh E A, 2005, Ross Fiziol Zh Im I M Sechenova, V91, P1260; Carroll J. B., 1993, HUMAN COGNITIVE ABIL, DOI DOI 1017/CBO9780511571312; Chen J, 2014, J NERV MENT DIS, V202, P594, DOI 10.1097/NMD.0000000000000167; Cohen MS, 1996, BRAIN, V119, P89, DOI 10.1093/brain/119.1.89; Cooper L. A., 1973, VISUAL INFORM PROCES, Vxiv, P555; Cooper L. A, 1986, MENTAL IMAGES THEIR; COOPER LA, 1975, J EXP PSYCHOL HUMAN, V104, P48, DOI 10.1037/0096-1523.1.1.48; COOPER LA, 1975, COGNITIVE PSYCHOL, V7, P20, DOI 10.1016/0010-0285(75)90003-1; COOPER LA, 1976, PERCEPT PSYCHOPHYS, V19, P296, DOI 10.3758/BF03204234; Corballis MC, 1997, BRAIN LANG, V57, P100, DOI 10.1006/brln.1997.1835; Dalecki M, 2012, HUM MOVEMENT SCI, V31, P1151, DOI 10.1016/j.humov.2011.12.001; DITUNNO PL, 1990, CORTEX, V26, P177, DOI 10.1016/S0010-9452(13)80349-8; DONCHIN E, 1988, BEHAV BRAIN SCI, V11, P357, DOI 10.1017/S0140525X00058027; Frick A, 2014, TRENDS COGN SCI, V18, P536, DOI 10.1016/j.tics.2014.05.011; Gogos A, 2010, NEUROPSYCHOLOGIA, V48, P529, DOI 10.1016/j.neuropsychologia.2009.10.013; Hamm JP, 2004, NEUROPSYCHOLOGIA, V42, P810, DOI 10.1016/j.neuropsychologia.2003.11.009; Harris IM, 2000, BRAIN, V123, P65, DOI 10.1093/brain/123.1.65; Hayashi R, 2005, CLIN NEUROPHYSIOL, V116, P1471, DOI 10.1016/j.clinph.2005.02.020; Heil M, 2002, PSYCHOPHYSIOLOGY, V39, P535, DOI 10.1017/S0048577202020449; Heil M, 1997, J EXP PSYCHOL HUMAN, V23, P681, DOI 10.1037/0096-1523.23.3.681; Heil M, 1998, ACTA PSYCHOL, V99, P217, DOI 10.1016/S0001-6918(98)00012-2; Heil M, 1996, J PSYCHOPHYSIOLOGY; HOCHACHKA PW, 1994, J CEREBR BLOOD F MET, V14, P671, DOI 10.1038/jcbfm.1994.84; Hoffler TN, 2010, EDUC PSYCHOL REV, V22, P245, DOI 10.1007/s10648-010-9126-7; Horst AC, 2012, PSYCHOPHYSIOLOGY, V49, P566, DOI [10.1111/j.1469-8986.2011.01322.x, DOI 10.1111/J.1469-8986.2011.01322.X]; JOLICOEUR P, 1985, CAN J PSYCHOL, V39, P100, DOI 10.1037/h0080118; Jordan K, 2001, NEUROIMAGE, V13, P143, DOI 10.1006/nimg.2000.0677; Klimesch W, 1999, BRAIN RES REV, V29, P169, DOI 10.1016/S0165-0173(98)00056-3; Kok A, 2001, PSYCHOPHYSIOLOGY, V38, P557, DOI 10.1017/S0048577201990559; Kung E, 2010, MEM COGNITION, V38, P206, DOI 10.3758/MC.38.2.206; Legg S, 2014, INT J AVIAT PSYCHOL, V24, P126, DOI 10.1080/10508414.2014.892751; Lemos VD, 2012, PSYCHOPHYSIOLOGY, V49, P1298, DOI 10.1111/j.1469-8986.2012.01411.x; LINN MC, 1985, CHILD DEV, V56, P1479, DOI 10.1111/j.1467-8624.1985.tb00213.x; Lutz P.L., 2003, BRAIN OXYGEN CAUSES; MEHTA Z, 1991, CORTEX, V27, P153, DOI 10.1016/S0010-9452(13)80121-9; Milivojevic B, 2003, NEUROPSYCHOLOGIA, V41, P1345, DOI 10.1016/S0028-3932(03)00060-5; Milivojevic B, 2009, J COGNITIVE NEUROSCI, V21, P945, DOI 10.1162/jocn.2009.21085; Nunez-Pena MI, 2009, BRAIN COGNITION, V69, P180, DOI 10.1016/j.bandc.2008.07.003; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Papadelis C, 2007, CLIN NEUROPHYSIOL, V118, P31, DOI 10.1016/j.clinph.2006.09.008; Paschke K, 2012, NEUROPSYCHOLOGIA, V50, P1844, DOI 10.1016/j.neuropsychologia.2012.04.010; Roberts JE, 2003, INT J PSYCHOPHYSIOL, V50, P235, DOI 10.1016/S0167-8760(03)00195-8; Sharma VK, 2014, DOMAIN SPECIFIC CHAN; Shepard R. N., 1971, MENTAL ROTATION 3 DI; SHEPARD S, 1988, J EXP PSYCHOL HUMAN, V14, P3, DOI 10.1037/0096-1523.14.1.3; Tsarouchas N, 2008, CLIN NEUROPHYSIOL, V119, P1475, DOI 10.1016/j.clinph.2008.02.021; Virues-Ortega J, 2006, DEVELOPMENTAL SCI, V9, P400, DOI 10.1111/j.1467-7687.2006.00505.x; Virues-Ortega Javier, 2004, Neuropsychology Review, V14, P197; VOYER D, 1995, PSYCHOL BULL, V117, P250, DOI 10.1037/0033-2909.117.2.250; Wang Y, 2014, SCI REP; WIJERS AA, 1989, PSYCHOPHYSIOLOGY, V26, P452, DOI 10.1111/j.1469-8986.1989.tb01951.x; Wilson MH, 2009, LANCET NEUROL, V8, P175, DOI 10.1016/S1474-4422(09)70014-6; Yan XD, 2011, BRAIN COGNITION, V77, P53, DOI 10.1016/j.bandc.2011.06.002; Yan XA, 2011, EXP BRAIN RES, V208, P437, DOI 10.1007/s00221-010-2494-x; Zhang JX, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068621	58	7	7	3	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 4	2016	11	5							e0154479	10.1371/journal.pone.0154479	http://dx.doi.org/10.1371/journal.pone.0154479			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DL5KR	27144444	gold, Green Published, Green Submitted			2022-12-26	WOS:000375676400047
J	Paresque, K; Fukuda, MV; Nogueira, JMD				Paresque, Karla; Fukuda, Marcelo Veronesi; de Matos Nogueira, Joao Miguel			Branchiosyllis, Haplosyllis, Opisthosyllis and Trypanosyllis (Annelida: Syllidae) from Brazil, with the Description of Two New Species	PLOS ONE			English	Article							POLYCHAETA SYLLIDAE; ROCAS ATOLL; SYLLINAE; ISLANDS; EHLERS	Brazilian specimens of Branchiosyllis cf. exilis, B. tamandarensis sp. n., Haplosyllis lattigae sp. n., H. loboi, Opisthosyllis brunnea and O. viridis are described and illustrated herein, from recently collected material; also, the distributions of Haplosyllis amphimedonicola and H. rosenalessoae are expanded to other localities in the states of Paraiba and Pernambuco. Branchiosyllis tamandarensis sp. n. was found associated with sponges and is characterized by having a flattened, ribbon-like body, with longitudinal line of mid-dorsal papillae, peristomium dorsally inconspicuous, branchiae with up to six lobes, branchiae and ungulae on all parapodia, and falcigers absent. Haplosyllis lattigae sp. n. is characterized by having two kinds of chaetae with different sizes and shapes per parapodium, papillate dorsum from midbody, and midbody dorsal cirri alternating in length. Additionally, we provide keys to the Brazilian species of Branchiosyllis, Haplosyllis and Opisthosyllis, comparative tables of the new species described herein and selected similar congeners, and the first record for Trypanosyllis zebra in the states of Espirito Santo and Paraiba.	[Paresque, Karla; de Matos Nogueira, Joao Miguel] Univ Sao Paulo, Inst Biociencias, Dept Zool, Sao Paulo, SP, Brazil; [Fukuda, Marcelo Veronesi] Univ Fed Juiz de Fora, Inst Ciencias Biol, Dept Zool, Juiz De Fora, MG, Brazil	Universidade de Sao Paulo; Universidade Federal de Juiz de Fora	Paresque, K (corresponding author), Univ Sao Paulo, Inst Biociencias, Dept Zool, Sao Paulo, SP, Brazil.	kparesque@gmail.com	Fapesp, Biota/F-8655-2017; Fukuda, Marcelo Veronesi/H-1736-2016; Paresque, Karla/R-7056-2019; nogueira, Joao/K-4660-2016; Paresque, Karla/L-8588-2016	Fapesp, Biota/0000-0002-9887-8449; Fukuda, Marcelo Veronesi/0000-0002-7849-5563; Paresque, Karla/0000-0001-9150-3786; nogueira, Joao/0000-0002-8450-4294; Paresque, Karla/0000-0001-9150-3786	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico - CNPq [481510/2008-7]; JAMSTEC (Japan Agency for Marine Earth Science and Technology); Sao Paulo Research Foundation - FAPESP (Fundacao de Amparo a Pesquisa do Estado de Sao Paulo) [2010/52116-4]; FAPESP [2014/01285-1, 2010/19424-7]; FAPESP (Fundacao de Amparo a Pesquisa do Estado de Sao Paulo)	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico - CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); JAMSTEC (Japan Agency for Marine Earth Science and Technology); Sao Paulo Research Foundation - FAPESP (Fundacao de Amparo a Pesquisa do Estado de Sao Paulo)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); FAPESP(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); FAPESP (Fundacao de Amparo a Pesquisa do Estado de Sao Paulo)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP))	The Project 'Diversity of Polychaeta (Annelida) on sandstone reefs off northeastern Brazil, states of Paraiba and Pernambuco' was funded by the Conselho Nacional de Desenvolvimento Cientifico e Tecnologico - CNPq (proc. 481510/2008-7), in 2008-2010, JAMSTEC (Japan Agency for Marine Earth Science and Technology), and by the Sao Paulo Research Foundation - FAPESP (Fundacao de Amparo a Pesquisa do Estado de Sao Paulo) (proc. 2010/52116-4), from 2011-2014. In addition, KP and MVF received post-doc fellowships from FAPESP ( procs. 2014/01285-1 and 2010/19424-7). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We are thankful to Orlemir Carrerette (IB-USP), Ruda Amorin, Rafael Brito, Carmem Alonso Samiguel, and other students of Laboratorio de Invertebrados Paulo Young ( Universidade Federal da Paraiba/UFPB) for the help with the collections; to Enio Mattos and Phillip Lenktaitis for preparing the specimens and photographing them under the SEM; to Filipe Gudin for drawing the chaetae of Branchiosyllis tamandarensis sp. n., and Branchiosyllis cf. exilis; to Dr. Paulo Y. G. Sumida and Dr. Hiroshi Kitazato, organizers of the Workshop "Biodiversity and Conservation of Continental Margin Ecosystems: from observation to management", FAPESP (Fundacao de Amparo a Pesquisa do Estado de Sao Paulo) and JAMSTEC (Japan Agency for Marine Earth Science and Technology) for the grant to KP, that allowed the visit to NSMT. We are also grateful to Drs Stephen Keable (AM), Javier Sanchez Almazan (MNCN), Aline Benetti (MZUSP), Geoff Keel and Karen Osborn (USNM), Hironori Komatsu (NSMT) and Angelika Brandt (ZMH), and to the staff of all these institutions, for providing access to the comparative material used for the present study.	Alvarez-Campos P, 2012, ZOOTAXA, P49; Amaral A. C. Z., 2004, BIODIVERSIDADE BENTO, P11; Amaral A. C. Z., 2013, CATALOGO ESPECIES AN; Amaral ACZ, 2001, BIODIVERSIDADE ECOSS; Amaral ACZ., 2012, CATALOGO ESPECIES AN; [Anonymous], 1967, MONOGRAPH POLYCHAETA; Attolini Fabiano Da Silva, 1997, Revista Brasileira de Oceanografia, V45, P25; Augener H., 1913, ERGEBNISSE HAMBURGER, V4, P65, DOI 10.1038/077051b0; Augener H., 1918, BEITRAGE KENNTNIS ME, V2, P67, DOI DOI 10.5962/BHL.TITLE.7400; Cantone C., 1976, ITAL J ZOOL, V9, P223; Capa M, 2001, REV BIOL TROP, V49, P103; Capa M, 2003, ESTUDIO CRIPTOFAUNA; Claparede E., 1864, Mem. de la Soc. de Phys. et d'Hist. Nat. de Geneve, Vtome xvii, P463; DAY J H, 1979, Records of the Australian Museum, V32, P80, DOI 10.3853/j.0067-1975.32.1979.203; Nogueira JMD, 2008, J MAR BIOL ASSOC UK, V88, P913, DOI 10.1017/S0025315408001707; De Matos Nogueira JM, 2008, J MAR BIOL ASSOC UK, V88, P1391, DOI 10.1017/S0025315408002099; Duarte LFL, 1996, ESTUAR COAST SHELF S, V42, P139, DOI 10.1006/ecss.1996.0011; Ehlers E., 1887, MEMOIRS MUSEUM COMP, V15, P1, DOI DOI 10.5962/BHL.TITLE.65639; Fauvel P, 1923, POLYCHETES ERRANTES, P486; Fauvel P., 1953, ANNELIDA POLYCHAETA, P507; Fukuda MV, 2010, CONTRIBUICAO CONHECI; Glasby Christopher J., 2001, Beagle, V17, P43; Gongora-Garza G, 2011, P BIOL SOC WASH, V124, P378; Gravier C., 1900, NOUVELLES ARCH MUSEU, V2, P137; Grube E., 1860, ARCH NATURGESCH, V26, P71; Hartmann-Schroder G., 1960, Kieler Meeresforschungen, V16, P69; Hartmann-Schroder G., 1965, Abhandlungen und Verhandlungen des Naturwissenschaftlichen Vereins in Hamburg NF, V9, P81; Hartmann-Schroder G., 1989, Mitteilungen aus dem Hamburgischen Zoologischen Museum und Institut, V86, P11; Hartmann-Schroeder G., 1981, Mitteilungen aus dem Hamburgischen Zoologischen Museum und Institut, V78, P19; HARTMANN G, 1980, Mitteilungen aus dem Hamburgischen Zoologischen Museum und Institut, V77, P111; HARTMANN-SCHROEDER G, 1979, Mitteilungen aus dem Hamburgischen Zoologischen Museum und Institut, V76, P75; HARTMANN-SCHROEDER G, 1982, Mitteilungen aus dem Hamburgischen Zoologischen Museum und Institut, V79, P51; HARTMANN-SCHROEDER G, 1991, Mitteilungen aus dem Hamburgischen Zoologischen Museum und Institut, V88, P17; Haswell W. A., 1920, P LINN SOC N S W, V45, P90; Haswell WA, 1886, P LINNEAN SOC NEW S, V10, P733, DOI DOI 10.5962/BHL.PART.17962; Imajima M., 1964, Occasional Papers of the Allan Hancock Foundation, V26, P1; Imajima M., 1966, Publications of the Seto Marine Biological Laboratory, V14, P253; Langerhans P., 1879, Z WISS ZOOL, V32, P513; Lattig P, 2011, ITAL J ZOOL, V78, P112, DOI 10.1080/11250003.2011.569373; Lattig P, 2010, ZOOTAXA, P1; Lattig P, 2009, ZOOTAXA, P1; Lee Jong Wui, 1994, Korean Journal of Systematic Zoology, V10, P55; LOPEZ E, 1994, REV BIOL TROP, V42, P129; Martin D, 2003, HYDROBIOLOGIA, V496, P145, DOI 10.1023/A:1026184529208; Martin D, 1998, SYMBIOTIC POLYCHAETE, P1; Martin GS, 2008, ZOOTAXA, P1; Monro C. C. A., 1939, Novitates Zoologicae Tring, V41, P383; Monro CCA, 1933, ANN MAGAZINE NATURAL, V10, P244, DOI DOI 10.1080/00222933308655413; MORGADO E H, 1985, Revista Brasileira de Zoologia, V3, P219; Neves G, 2003, CORAL REEFS, V22, P123, DOI 10.1007/s00338-003-0295-4; Nogueira J. M. M., 2006, MANUAL IDENTIFICACAO, P134; Nogueira J.M.M., 2002, BEAUFORTIA, V52, P57; Nogueira JMM, 2000, ANELIDEOS POLIQUETAS; Nunez J, 1993, REV ACAD CANARIA CIE, V4, P109; Paiva Paulo Cesar, 2007, Arquivos do Museu Nacional Rio de Janeiro, V65, P241; Paola A, 2006, P BIOL SOC WASH, V119, P346, DOI 10.2988/0006-324X(2006)119[346:ANSOHL]2.0.CO;2; Paresque K, 2008, INFLUENCIA CARACTERI; Paresque K, 2014, MAR BIOL RES, V10, P554, DOI 10.1080/17451000.2013.841941; PAWLIK J R, 1983, Marine Ecology, V4, P65, DOI 10.1111/j.1439-0485.1983.tb00288.x; Pillai T. G., 1965, Ceylon Journal of Science Biol Sci, V5, P110; RIOJA ENRIQUE, 1958, AN INST BIOL [MEXICO], V29, P219; Ruiz-Ramirez J. D., 2008, Animal Biodiversity and Conservation, V31, P1; RULLIER F, 1979, Annales de l'Institut Oceanographique, V55, P145; San Martin G., 2003, FAUNA IBERICA, V21, P554; San Martin G., 1991, B MAR SCI, V48, P236; San Martin G., 2014, PHYLLODOCIDA NEREIDI, P52; San Martin G., 1984, ESTUDIO BIOGEOGRAFIC; Martin GS, 2008, REC AUST MUS, V60, P119, DOI 10.3853/j.0067-1975.60.2008.1494; San Martin Guillermo, 2013, Pan-American Journal of Aquatic Sciences, V8, P166; Santa-Isabel LM, 1998, REV BIOL TROP, V46, P111; Santi L, 2009, BRAZ J OCEANOGR, V57, P287, DOI 10.1590/S1679-87592009000400004; Spalding MD, 2007, BIOSCIENCE, V57, P573, DOI 10.1641/B570707; Aguado MT, 2012, CLADISTICS, V28, P234, DOI 10.1111/j.1096-0031.2011.00377.x; Aguado MT, 2009, ZOOL SCR, V38, P379, DOI 10.1111/j.1463-6409.2008.00380.x; Aguado MT, 2008, SYST BIODIVERS, V6, P521, DOI 10.1017/S1477200008002831; Uebelacker JM, 1850, TAXONOMIC GUIDE POLY, VIV, P1; Verrill A. E., 1900, T CONN ACAD ARTS SCI, V10, P595; Westheide W., 1974, Mikrofauna Meeresbodens, VNo. 44, P1	78	8	9	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 4	2016	11	5							e0153442	10.1371/journal.pone.0153442	http://dx.doi.org/10.1371/journal.pone.0153442			50	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DL5KR	27144528	Green Published, gold, Green Submitted			2022-12-26	WOS:000375676400015
J	Sahoo, S; Meijles, DN; Al Ghouleh, I; Tandon, M; Cifuentes-Pagano, E; Sembrat, J; Rojas, M; Goncharova, E; Pagano, PJ				Sahoo, Sanghamitra; Meijles, Daniel N.; Al Ghouleh, Imad; Tandon, Manuj; Cifuentes-Pagano, Eugenia; Sembrat, John; Rojas, Mauricio; Goncharova, Elena; Pagano, Patrick J.			MEF2C-MYOCD and Leiomodin1 Suppression by miRNA-214 Promotes Smooth Muscle Cell Phenotype Switching in Pulmonary Arterial Hypertension	PLOS ONE			English	Article							SERUM RESPONSE FACTOR; TRANSCRIPTION FACTOR MEF2C; CARDIAC-HYPERTROPHY; MOLECULAR-MECHANISMS; GENE-EXPRESSION; HEART-FAILURE; MYOCARDIN; MICRORNA-214; HYPOXIA; GROWTH	Background Vascular hyperproliferative disorders are characterized by excessive smooth muscle cell (SMC) proliferation leading to vessel remodeling and occlusion. In pulmonary arterial hypertension (PAH), SMC phenotype switching from a terminally differentiated contractile to synthetic state is gaining traction as our understanding of the disease progression improves. While maintenance of SMC contractile phenotype is reportedly orchestrated by a MEF2C-myocardin (MYOCD) interplay, little is known regarding molecular control at this nexus. Moreover, the burgeoning interest in microRNAs (miRs) provides the basis for exploring their modulation of MEF2C-MYOCD signaling, and in turn, a pro-proliferative, synthetic SMC phenotype. We hypothesized that suppression of SMC contractile phenotype in pulmonary hypertension is mediated by miR-214 via repression of the MEF2C-MYOCD-leiomodin1 (LMOD1) signaling axis. Methods and Results In SMCs isolated from a PAH patient cohort and commercially obtained hPASMCs exposed to hypoxia, miR-214 expression was monitored by qRT-PCR. miR-214 was upregulated in PAH-vs. control subject hPASMCs as well as in commercially obtained hPASMCs exposed to hypoxia. These increases in miR-214 were paralleled by MEF2C, MYOCD and SMC contractile protein downregulation. Of these, LMOD1 and MEF2C were directly targeted by the miR. Mir-214 overexpression mimicked the PAH profile, downregulating MEF2C and LMOD1. AntagomiR-214 abrogated hypoxia-induced suppression of the contractile phenotype and its attendant proliferation. Anti-miR-214 also restored PAH-PASMCs to a contractile phenotype seen during vascular homeostasis. Conclusions Our findings illustrate a key role for miR-214 in modulation of MEF2C-MYOCD-LMOD1 signaling and suggest that an antagonist of miR-214 could mitigate SMC phenotype changes and proliferation in vascular hyperproliferative disorders including PAH.	[Sahoo, Sanghamitra; Meijles, Daniel N.; Al Ghouleh, Imad; Tandon, Manuj; Cifuentes-Pagano, Eugenia; Pagano, Patrick J.] Univ Pittsburgh, Dept Pharmacol & Chem Biol, Pittsburgh, PA 15261 USA; [Sahoo, Sanghamitra; Meijles, Daniel N.; Al Ghouleh, Imad; Cifuentes-Pagano, Eugenia; Sembrat, John; Rojas, Mauricio; Goncharova, Elena; Pagano, Patrick J.] Univ Pittsburgh, Vasc Med Inst, Pittsburgh, PA 15261 USA; [Sembrat, John; Rojas, Mauricio; Goncharova, Elena] Univ Pittsburgh, Div Pulm Allergy & Crit Care Med, Pittsburgh, PA 15261 USA; [Meijles, Daniel N.] Univ Reading, Inst Cardiovasc & Metab Res, Reading RG6 6AS, Berks, England	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; University of Reading	Pagano, PJ (corresponding author), Univ Pittsburgh, Dept Pharmacol & Chem Biol, Pittsburgh, PA 15261 USA.; Pagano, PJ (corresponding author), Univ Pittsburgh, Vasc Med Inst, Pittsburgh, PA 15261 USA.	pagano@pitt.edu	Pagano, Patrick/GYO-2619-2022; Meijles, Daniel/J-6457-2014	Cifuentes-Pagano, Eugenia/0000-0002-2482-080X; Meijles, Daniel/0000-0002-5557-3549	National Institutes of Health [R01 HL079207, HL112914, P01HL103455, R42-AA024003, R01-CA162306, R01HL113178]; Institute for Transfusion Medicine; Hemophilia Center of Western Pennsylvania; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL079207, R01HL112914, R01HL123766, R01HL113178] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Institute for Transfusion Medicine; Hemophilia Center of Western Pennsylvania; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by National Institutes of Health grants, R01 HL079207, HL112914, and P01HL103455 ( PJP); R42-AA024003 and R01-CA162306 ( MR); and R01HL113178 ( EG). The study was supported by the Institute for Transfusion Medicine and the Hemophilia Center of Western Pennsylvania. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbas T, 2009, NAT REV CANCER, V9, P400, DOI 10.1038/nrc2657; Aurora AB, 2012, J CLIN INVEST, V122, P1222, DOI 10.1172/JCI59327; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Caruso P, 2012, CIRC RES, V111, P290, DOI 10.1161/CIRCRESAHA.112.267591; Caruso P, 2010, ARTERIOSCL THROM VAS, V30, P716, DOI 10.1161/ATVBAHA.109.202028; Cordes KR, 2009, NATURE, V460, P705, DOI 10.1038/nature08195; Courboulin A, 2011, J EXP MED, V208, P535, DOI 10.1084/jem.20101812; Di Giorgio E, 2015, MOL CELL BIOL, V35, P1633, DOI 10.1128/MCB.01461-14; Duan QL, 2015, J CELL PHYSIOL, V230, P1964, DOI 10.1002/jcp.24942; el Azzouzi H, 2013, CELL METAB, V18, P341, DOI 10.1016/j.cmet.2013.08.009; Flynt AS, 2007, NAT GENET, V39, P259, DOI 10.1038/ng1953; Goncharov DA, 2014, CIRCULATION, V129, P864, DOI 10.1161/CIRCULATIONAHA.113.004581; Gregoire S, 2006, J BIOL CHEM, V281, P4423, DOI 10.1074/jbc.M509471200; Han J, 1997, NATURE, V386, P296, DOI 10.1038/386296a0; Imamura M, 2010, GENE, V464, P1, DOI 10.1016/j.gene.2010.03.012; Jie W, 2010, CARDIOVASC RES, V87, P740, DOI 10.1093/cvr/cvq147; Jonigk D, 2011, AM J PATHOL, V179, P167, DOI 10.1016/j.ajpath.2011.03.040; Juan AH, 2009, MOL CELL, V36, P61, DOI 10.1016/j.molcel.2009.08.008; Kim J, 2015, CIRCULATION, V131, P190, DOI 10.1161/CIRCULATIONAHA.114.013339; Lanner MC, 2005, AM J RESP CELL MOL, V33, P412, DOI 10.1165/rcmb.2005-0004OC; Li K, 2015, J BIOL CHEM, V290, P8185, DOI 10.1074/jbc.M114.633990; Lin Q, 1998, DEVELOPMENT, V125, P4565; Lin Q, 1997, SCIENCE, V276, P1404, DOI 10.1126/science.276.5317.1404; Lu JR, 2000, P NATL ACAD SCI USA, V97, P4070, DOI 10.1073/pnas.080064097; Mandegar M, 2004, MICROVASC RES, V68, P75, DOI 10.1016/j.mvr.2004.06.001; Miano JM, 2007, AM J PHYSIOL-CELL PH, V292, pC70, DOI 10.1152/ajpcell.00386.2006; Miano JM, 2015, J BIOMED RES, V29, P3, DOI 10.7555/JBR.29.20140151; Nanda V, 2012, J BIOL CHEM, V287, P2459, DOI 10.1074/jbc.M111.302224; Owens GK, 2004, PHYSIOL REV, V84, P767, DOI 10.1152/physrev.00041.2003; Passier R, 2000, J CLIN INVEST, V105, P1395, DOI 10.1172/JCI8551; Penna E, 2015, J INVEST DERMATOL, V135, P960, DOI 10.1038/jid.2014.479; Pipes GCT, 2006, GENE DEV, V20, P1545, DOI 10.1101/gad.1428006; Posern G, 2006, TRENDS CELL BIOL, V16, P588, DOI 10.1016/j.tcb.2006.09.008; Rabinovitch M, 2007, ANNU REV PATHOL-MECH, V2, P369, DOI 10.1146/annurev.pathol.2.010506.092033; Ranayhossaini DJ, 2013, J BIOL CHEM, V288, P36437, DOI 10.1074/jbc.M113.521344; Rensen SSM, 2006, CARDIOVASC RES, V70, P136, DOI 10.1016/j.cardiores.2005.12.018; Schultz K, 2006, AM J PHYSIOL-HEART C, V290, pH2528, DOI 10.1152/ajpheart.01077.2005; Small EM, 2011, NATURE, V469, P336, DOI 10.1038/nature09783; Stenmark KR, 2006, CIRC RES, V99, P675, DOI 10.1161/01.RES.0000243584.45145.3f; van Mil A, 2012, CARDIOVASC RES, V93, P655, DOI 10.1093/cvr/cvs003; van Rooij E, 2006, P NATL ACAD SCI USA, V103, P18255, DOI 10.1073/pnas.0608791103; Wang DZ, 2001, CELL, V105, P851, DOI 10.1016/S0092-8674(01)00404-4; Wang ZG, 2004, NATURE, V428, P185, DOI 10.1038/nature02382; Watanabe T, 2008, DEV DYNAM, V237, P3738, DOI 10.1002/dvdy.21787; Yang T, 2013, BIOCHEM BIOPH RES CO, V436, P578, DOI 10.1016/j.bbrc.2013.05.079; Yoshida T, 2004, ARTERIOSCL THROM VAS, V24, P1596, DOI 10.1161/01.ATV.0000137190.63214.c5; Yoshida T, 2003, CIRC RES, V92, P856, DOI 10.1161/01.RES.0000068405.49081.09; Zhou WL, 2009, AM J PHYSIOL-LUNG C, V296, pL780, DOI 10.1152/ajplung.90295.2008	48	41	45	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 4	2016	11	5							e0153780	10.1371/journal.pone.0153780	http://dx.doi.org/10.1371/journal.pone.0153780			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DL5KR	27144530	Green Accepted, Green Published, gold, Green Submitted			2022-12-26	WOS:000375676400027
J	Zhu, B; Zhu, M; Jiang, JC; Niu, H; Wang, YH; Wu, Y; Xu, LY; Chen, Y; Zhang, LP; Gao, X; Gao, HJ; Liu, JF; Li, JY				Zhu, Bo; Zhu, Miao; Jiang, Jicai; Niu, Hong; Wang, Yanhui; Wu, Yang; Xu, Lingyang; Chen, Yan; Zhang, Lupei; Gao, Xue; Gao, Huijiang; Liu, Jianfeng; Li, Junya			The Impact of Variable Degrees of Freedom and Scale Parameters in Bayesian Methods for Genomic Prediction in Chinese Simmental Beef Cattle	PLOS ONE			English	Article							BREEDING VALUES; SELECTION; TRAITS; REGRESSION; ACCURACY; ALPHABET; PRIORS; PLANT	Three conventional Bayesian approaches (BayesA, BayesB and BayesC(TT)) have been demonstrated to be powerful in predicting genomic merit for complex traits in livestock. A priori, these Bayesian models assume that the non-zero SNP effects (marginally) follow a t-distribution depending on two fixed hyperparameters, degrees of freedom and scale parameters. In this study, we performed genomic prediction in Chinese Simmental beef cattle and treated degrees of freedom and scale parameters as unknown with inappropriate priors. Furthermore, we compared the modified methods (BayesFA, BayesFB and BayesFC(TT)) with their corresponding counterparts using simulation datasets. We found that the modified methods with distribution assumed to the two hyperparameters were beneficial for improving the predictive accuracy. Our results showed that the predictive accuracies of the modified methods were slightly higher than those of their counterparts especially for traits with low heritability and a small number of QTLs. Moreover, cross-validation analysis for three traits, namely carcass weight, live weight and tenderloin weight, in 1136 Simmental beef cattle suggested that predictive accuracy of BayesFC(TT) noticeably outperformed BayesC(TT) with the highest increase (3.8%) for live weight using the cohort masking cross-validation.	[Zhu, Bo; Zhu, Miao; Niu, Hong; Wang, Yanhui; Wu, Yang; Xu, Lingyang; Chen, Yan; Zhang, Lupei; Gao, Xue; Gao, Huijiang; Li, Junya] Chinese Acad Agr Sci, Inst Anim Sci, Lab Mol Biol & Bovine Breeding, Beijing 100193, Peoples R China; [Jiang, Jicai; Liu, Jianfeng] China Agr Univ, Dept Anim Genet Breeding & Reprod, Beijing 100094, Peoples R China	Chinese Academy of Agricultural Sciences; Institute of Animal Science, CAAS; China Agricultural University	Li, JY (corresponding author), Chinese Acad Agr Sci, Inst Anim Sci, Lab Mol Biol & Bovine Breeding, Beijing 100193, Peoples R China.	jl1@iascaas.net.cn	Wu, Yang/D-6754-2017; Xu, Lingyang/W-8664-2019	Wu, Yang/0000-0002-0128-7280; Jiang, Jicai/0000-0001-6890-7539	Cattle Breeding Innovative Research Team [cxgc-ias-03]; 12th "Five-Year" National Science and Technology Support Project Basic Research Fund Program [2011BAD28B04]; National High Technology Research and Development Program of China (863 Program) [2013AA102505-4]; Chinese Academy of Agricultural Sciences Fundamental Research Budget Increment Projects [2013ZL031, 2014ZL006]; Chinese Academy of Agricultural Sciences Foundation [2014ywf-yb-4]; Beijing Natural Science Foundation [6154032]; National Natural Science Foundations of China [31472079, 31372294, 31402039]	Cattle Breeding Innovative Research Team; 12th "Five-Year" National Science and Technology Support Project Basic Research Fund Program; National High Technology Research and Development Program of China (863 Program)(National High Technology Research and Development Program of China); Chinese Academy of Agricultural Sciences Fundamental Research Budget Increment Projects; Chinese Academy of Agricultural Sciences Foundation(Chinese Academy of Sciences); Beijing Natural Science Foundation(Beijing Natural Science Foundation); National Natural Science Foundations of China(National Natural Science Foundation of China (NSFC))	This study was supported by Cattle Breeding Innovative Research Team (cxgc-ias-03), the 12th "Five-Year" National Science and Technology Support Project (2011BAD28B04) Basic Research Fund Program, the National High Technology Research and Development Program of China (863 Program 2013AA102505-4), Chinese Academy of Agricultural Sciences Fundamental Research Budget Increment Projects (2013ZL031 and 2014ZL006), Chinese Academy of Agricultural Sciences Foundation (2014ywf-yb-4), Beijing Natural Science Foundation (6154032), and the National Natural Science Foundations of China (31472079, 31372294, and 31402039).	Brondum RF, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-543; Crews DH, 2004, J ANIM SCI, V82, P661; de los Campos G, 2009, J ANIM SCI, V87, P1883, DOI 10.2527/jas.2008-1259; de los Campos G, 2013, GENETICS, V193, P327, DOI 10.1534/genetics.112.143313; de los Campos G, 2009, GENETICS, V182, P375, DOI 10.1534/genetics.109.101501; Fernando RL, 2007, ACTA AGR SCAND A-AN, V57, P192, DOI 10.1080/09064700801959395; GEWEKE J, 1993, J APPL ECONOM, V8, pS19, DOI 10.1002/jae.3950080504; Geweke J., INSTITUTE FOR EMPIRI; Gianola D, 2013, GENETICS, V194, P573, DOI 10.1534/genetics.113.151753; Gianola D, 2009, GENETICS, V183, P347, DOI 10.1534/genetics.109.103952; Habier D, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-186; Hayes BJ, 2009, J DAIRY SCI, V92, P433, DOI 10.3168/jds.2008-1646; Heffner EL, 2009, CROP SCI, V49, P1, DOI 10.2135/cropsci2008.08.0512; Jia Y, 2012, GENETICS, V192, P1513, DOI 10.1534/genetics.112.144246; Latushkin Y., 1998, J DYNAM DIFFERENTIAL, V10, P489, DOI 10.1023/A:1022609414870; Lorenz AJ, 2011, ADV AGRON, V110, P77, DOI 10.1016/B978-0-12-385531-2.00002-5; Luan T, 2009, GENETICS, V183, P1119, DOI 10.1534/genetics.109.107391; Meuwissen THE, 2001, GENETICS, V157, P1819; Meuwissen T, 2010, GENETICS, V185, P623, DOI 10.1534/genetics.110.116590; Park T, 2008, J AM STAT ASSOC, V103, P681, DOI 10.1198/016214508000000337; Pintus MA, 2012, J DAIRY SCI, V95, P3390, DOI 10.3168/jds.2011-4274; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Saatchi M, 2012, GENET SEL EVOL, V44, DOI 10.1186/1297-9686-44-38; Saatchi M, 2011, GENET SEL EVOL, V43, DOI 10.1186/1297-9686-43-40; Spelman RJ, 2013, ANIM PROD SCI, V53, P869, DOI 10.1071/AN12304; VanRaden PM, 2008, J DAIRY SCI, V91, P4414, DOI 10.3168/jds.2007-0980; Verbyla KL, 2009, GENET RES, V91, P307, DOI 10.1017/S0016672309990243; Wang CL, 2013, HEREDITY, V110, P213, DOI 10.1038/hdy.2012.65; Yang WZ, 2015, GENET SEL EVOL, V47, DOI 10.1186/s12711-015-0092-x; Yang WZ, 2012, GENETICS, V190, P1491, DOI 10.1534/genetics.111.131540; Yi NJ, 2008, GENETICS, V179, P1045, DOI 10.1534/genetics.107.085589	31	14	17	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 3	2016	11	5							e0154118	10.1371/journal.pone.0154118	http://dx.doi.org/10.1371/journal.pone.0154118			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DL5KK	27139889	Green Published, Green Submitted, gold			2022-12-26	WOS:000375675700018
J	Jiang, J; Yu, JQ; Li, J; Li, P; Fan, ZX; Niu, LL; Deng, JB; Yue, BS; Li, J				Jiang, Juan; Yu, Jianqiu; Li, Jing; Li, Peng; Fan, Zhenxin; Niu, Lili; Deng, Jiabo; Yue, Bisong; Li, Jing			Mitochondrial Genome and Nuclear Markers Provide New Insight into the Evolutionary History of Macaques	PLOS ONE			English	Article							POLYMORPHIC ALU INSERTIONS; PHYLOGENETIC-RELATIONSHIPS; POPULATION-STRUCTURE; GENETIC DIVERSITY; MOLECULAR PHYLOGENY; MACACA; DNA; INFERENCES; SSR; CERCOPITHECIDAE	The evolutionary history of macaques, genus Macaca, has been under debate due to the short times of divergence. In this study, maternal, paternal, and biparental genetic systems were applied to infer phylogenetic relationships among macaques and to trace ancient hybridization events in their evolutionary history. Using a PCR display method, 17 newly phylogenetically informative Alu insertions were identified from M. assamensis. We combined presence/absence analysis of 84 Alu elements with mitochondrial genomes as well as nuclear sequences (five autosomal genes, two Y chromosomal genes, and one X chromosomal fragment) to reconstruct a robust macaque phylogeny. Topologies generated from different inherited markers were similar supporting six well defined species groups and a close relationship of M. assamensis and M. thibetana, but differed in the placing of M. arctoides. Both Alu elements and nuclear genes supported that M. arctoides was close to the sinica group, whereas the mitochondrial data clustered it into the fascicularis/mulatta lineage. Our results reveal that a sex-biased hybridization most likely occurred in the evolutionary history of M. arctoides, and suggest an introgressive pattern of male-mediated gene flow from the ancestors of M. arctoides to the M. mulatta population followed by nuclear swamping. According to the estimation of divergence dates, the hybridization occurred around 0.88 +/- 1.77 mya (nuclear data) or 1.38 +/- 2.56 mya (mitochondrial data). In general, our study indicates that a combination of various molecular markers could help explain complicated evolutionary relationships. Our results have provided new insights into the evolutionary history of macaques and emphasize that hybridization might play an important role in macaque evolution.	[Jiang, Juan; Li, Peng; Fan, Zhenxin; Li, Jing] Sichuan Univ, Coll Life Sci, Minist Educ, Key Lab Bioresources & Ecoenvironm, Chengdu 610064, Sichuan, Peoples R China; [Yu, Jianqiu; Niu, Lili; Deng, Jiabo] Inst Chengdu Wildlife, Chengdu Zoo, Chengdu 610081, Peoples R China; [Li, Jing; Yue, Bisong] Sichuan Univ, Coll Life Sci, Sichuan Key Lab Conservat Biol Endangered Wildlif, Chengdu 610064, Sichuan, Peoples R China	Sichuan University; Sichuan University	Li, J (corresponding author), Sichuan Univ, Coll Life Sci, Minist Educ, Key Lab Bioresources & Ecoenvironm, Chengdu 610064, Sichuan, Peoples R China.	ljtjf@126.com	Li, Jingyu/GSD-1924-2022		National Natural Science Foundation of China [31270431, 31530068]; Sichuan Application Foundation Project [2015JY0268]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Sichuan Application Foundation Project	The research was funded by the National Natural Science Foundation of China (No. 31270431 and 31530068), and partly supported by the Sichuan Application Foundation Project (2015JY0268). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Batzer MA, 2002, NAT REV GENET, V3, P370, DOI 10.1038/nrg798; BROWN WM, 1982, J MOL EVOL, V18, P225, DOI 10.1007/BF01734101; Chen D, 2015, ZOOL J LINN SOC-LOND, V175, P429, DOI 10.1111/zoj.12273; Corbet GB, 1992, MAMMALS INDO MALAYAN; Cordaux R, 2007, GENOMICS, V90, P154, DOI 10.1016/j.ygeno.2007.03.010; Cordaux R, 2006, GENE, V373, P138, DOI 10.1016/j.gene.2006.01.020; Cronin J.E., 1980, P31; Deinard A, 2001, J HUM EVOL, V41, P45, DOI 10.1006/jhev.2001.0480; Delson E., 1980, P10; Delson E., 1996, INT S EVOL AS PRIM P, P40; Delson E., 2000, ENCY HUMAN EVOLUTION, P166; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Emanuelli F, 2013, BMC PLANT BIOL, V13, DOI 10.1186/1471-2229-13-39; Eudey A.A., 1980, P52; FA JE, 1989, MAMMAL REV, V19, P45, DOI 10.1111/j.1365-2907.1989.tb00401.x; Fan ZX, 2014, MOL BIOL EVOL, V31, P1475, DOI 10.1093/molbev/msu104; FARRIS JS, 1970, SYST ZOOL, V19, P172, DOI 10.2307/2412452; Filippi CV, 2015, BMC PLANT BIOL, V15, DOI 10.1186/s12870-014-0360-x; FOODEN J, 1990, J HUM EVOL, V19, P607, DOI 10.1016/0047-2484(90)90002-S; FOODEN J, 1989, AM J PRIMATOL, V17, P209, DOI 10.1002/ajp.1350170304; FOODEN J, 1976, FOLIA PRIMATOL, V25, P225, DOI 10.1159/000155715; Groves C.P., 2001, PRIMATE TAXONOMY; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Guo HW, 2015, EUR J WILDLIFE RES, V61, P143, DOI 10.1007/s10344-014-0887-z; Haddrath O, 2012, P ROY SOC B-BIOL SCI, V279, P4617, DOI 10.1098/rspb.2012.1630; Han K, 2007, SCIENCE, V316, P238, DOI 10.1126/science.1139462; Hayasaka K, 1996, MOL BIOL EVOL, V13, P1044, DOI 10.1093/oxfordjournals.molbev.a025655; Inagaki H, 1996, VARIATIONS ASIAN MAC, P89; Jia XD, 2011, RUSS J GENET+, V47, P884, DOI 10.1134/S1022795411070088; Kawamoto Y, 2007, PRIMATES, V48, P27, DOI 10.1007/s10329-006-0013-2; Kent WJ, 2002, GENOME RES, V12, P656, DOI [10.1101/gr.229202, 10.1101/gr.229202. Article published online before March 2002]; Koblmuller S, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-7; Li J, 2009, GENE, V448, P242, DOI 10.1016/j.gene.2009.05.013; Li Qing-qing, 2004, Zoological Research, V25, P385; Li QQ, 2005, BIOCHEM GENET, V43, P375, DOI 10.1007/s10528-005-6777-z; Liedigk R, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-1437-0; Liedigk R, 2014, BMC EVOL BIOL, V14, DOI 10.1186/s12862-014-0176-1; Liedigk R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037418; Liedigk Rasmus, 2009, Vietnamese Journal of Primatology, V1, P1; Lin BZ, 2010, ANIM SCI J, V81, P281, DOI 10.1111/j.1740-0929.2010.00744.x; Matthee CA, 2007, MOL PHYLOGENET EVOL, V42, P827, DOI 10.1016/j.ympev.2006.10.002; McCracken KG, 2005, SYST BIOL, V54, P35, DOI 10.1080/10635150590910249; MOORE WS, 1995, EVOLUTION, V49, P718, DOI 10.1111/j.1558-5646.1995.tb02308.x; Morales JC, 1998, J HUM EVOL, V34, P1, DOI 10.1006/jhev.1997.0171; Nichols R, 2001, TRENDS ECOL EVOL, V16, P358, DOI 10.1016/S0169-5347(01)02203-0; Pollard DA, 2006, PLOS GENET, V2, P1634, DOI 10.1371/journal.pgen.0020173; Posada D, 2009, METHODS MOL BIOL, V537, P93, DOI 10.1007/978-1-59745-251-9_5; Raaum RL, 2005, J HUM EVOL, V48, P237, DOI 10.1016/j.jhevol.2004.11.007; Rahim NAA, 2014, FACULTY REOURCE SCI, V4, P42; Rambaut A., 2014, TRACER V1 6; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Roos C, 2004, P NATL ACAD SCI USA, V101, P10650, DOI 10.1073/pnas.0403852101; Roos C, 2014, ASIAN PRIMATES J, V4, P2; Roos C, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-77; Roy AM, 1999, GENETICA, V107, P149, DOI 10.1023/A:1003941704138; Rozen S, 1998, PRIMER3; Ruvolo M, 1997, MOL BIOL EVOL, V14, P248, DOI 10.1093/oxfordjournals.molbev.a025761; Sambrook J., 2002, MOL CLONING LAB MANU; Schmitz J, 2005, CYTOGENET GENOME RES, V108, P26, DOI 10.1159/000080799; Shen YY, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-132; Stewart C, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002236; Swofford D.L, 1998, PAUP 4 0 PHYLOGENETI; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Ting N, 2008, MOL PHYLOGENET EVOL, V46, P466, DOI 10.1016/j.ympev.2007.11.008; Tosi AJ, 2000, MOL PHYLOGENET EVOL, V17, P133, DOI 10.1006/mpev.2000.0834; Tosi AJ, 2004, J HUM EVOL, V46, P223, DOI 10.1016/j.jhevol.2003.11.006; Tosi AJ, 2003, EVOLUTION, V57, P1419; Van Inghelandt D, 2010, THEOR APPL GENET, V120, P1289, DOI 10.1007/s00122-009-1256-2; Watkins WS, 2003, GENOME RES, V13, P1607, DOI 10.1101/gr.894603; Xing J, 2005, MOL PHYLOGENET EVOL, V37, P872, DOI 10.1016/j.ympev.2005.04.015; Yan GM, 2011, NAT BIOTECHNOL, V29, P1019, DOI 10.1038/nbt.1992; Yu L, 2011, SYST BIOL, V60, P175, DOI 10.1093/sysbio/syq090; ZHANG YP, 1993, FOLIA PRIMATOL, V60, P7; Zinner D., 2013, P550; Zinner D, 2011, EVOL ANTHROPOL, V20, P96, DOI 10.1002/evan.20301	75	19	20	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 2	2016	11	5							e0154665	10.1371/journal.pone.0154665	http://dx.doi.org/10.1371/journal.pone.0154665			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DL5KB	27135608	Green Published, Green Submitted, gold			2022-12-26	WOS:000375674800036
J	Summers, JC; Kurek, J; Kirk, JL; Muir, DCG; Wang, XW; Wiklund, JA; Cooke, CA; Evans, MS; Smol, JP				Summers, Jamie C.; Kurek, Joshua; Kirk, Jane L.; Muir, Derek C. G.; Wang, Xiaowa; Wiklund, Johan A.; Cooke, Colin A.; Evans, Marlene S.; Smol, John P.			Recent Warming, Rather than Industrial Emissions of Bioavailable Nutrients, Is the Dominant Driver of Lake Primary Production Shifts across the Athabasca Oil Sands Region	PLOS ONE			English	Article							POLYCYCLIC AROMATIC-HYDROCARBONS; SHALLOW LAKES; PHYTOPLANKTON BIOMASS; ACIDIFICATION; DEPOSITION; MORPHOMETRY; SEDIMENT; ALBERTA; RIVER	Freshwaters in the Athabasca Oil Sands Region (AOSR) are vulnerable to the atmospheric emissions and land disturbances caused by the local oil sands industry; however, they are also affected by climate change. Recent observations of increases in aquatic primary production near the main development area have prompted questions about the principal drivers of these limnological changes. Is the enhanced primary production due to deposition of nutrients (nitrogen and phosphorus) from local industry or from recent climatic changes? Here, we use downcore, spectrally-inferred chlorophyll-a (VRS-chla) profiles (including diagenetic products) from 23 limnologically-diverse lakes with undisturbed catchments to characterize the pattern of primary production increases in the AOSR. Our aim is to better understand the relative roles of the local oil sands industry versus climate change in driving aquatic primary production trends. Nutrient deposition maps, generated using geostatistical interpolations of spring-time snowpack measurements from a grid pattern across the AOSR, demonstrate patterns of elevated total phosphorus, total nitrogen, and bioavailable nitrogen deposition around the main area of industrial activity. However, this pattern is not observed for bioavailable phosphorus. Our paleolimnological findings demonstrate consistently greater VRS-chla concentrations compared to pre-oil sands development levels, regardless of morphological and limnological characteristics, landscape position, bioavailable nutrient deposition, and dibenzothiophene (DBT)-inferred industrial impacts. Furthermore, breakpoint analyses on VRS-chla concentrations across a gradient of DBT-inferred industrial impact show limited evidence of a contemporaneous change among lakes. Despite the contribution of bioavailable nitrogen to the landscape from industrial activities, we find no consistency in the spatial pattern and timing of VRS-chla shifts with an industrial fertilizing signal. Instead, significant positive correlations were observed between VRS-chla and annual and seasonal temperatures. Our findings suggest warmer air temperatures and likely decreased ice covers are important drivers of enhanced aquatic primary production across the AOSR.	[Summers, Jamie C.; Smol, John P.] Queens Univ, Dept Biol, Paleoecol Environm Assessment & Res Lab, Kingston, ON K7L 3N6, Canada; [Kurek, Joshua] Mt Allison Univ, Dept Geog & Environm, Sackville, NB E0A 3C0, Canada; [Kirk, Jane L.; Muir, Derek C. G.; Wang, Xiaowa; Wiklund, Johan A.] Environm Canada, Aquat Contaminants Res Div, Burlington, ON L7R 4A6, Canada; [Cooke, Colin A.] Alberta Environm Monitoring Evaluat & Reporting A, Edmonton, AB, Canada; [Cooke, Colin A.] Univ Alberta, Dept Earth & Atmospher Sci, Edmonton, AB, Canada; [Evans, Marlene S.] Environm Canada, Water Hydrol Ecol Res Div, Saskatoon, SK, Canada	Queens University - Canada; Mount Allison University; Environment & Climate Change Canada; University of Alberta; Environment & Climate Change Canada	Smol, JP (corresponding author), Queens Univ, Dept Biol, Paleoecol Environm Assessment & Res Lab, Kingston, ON K7L 3N6, Canada.	smolj@queensu.ca	Muir, Derek/AAD-7526-2021	Wiklund, Johan/0000-0002-2327-5651; Smol, John/0000-0002-2499-6696; Evans, Marlene/0000-0002-8869-1162; Cooke, Colin/0000-0002-7417-5263	Environment Canada; Canada-Alberta Joint Oil Sands Monitoring Program; Alberta Environmental, Monitoring Evaluation and Reporting Agency; Natural Sciences and Engineering Research Council of Canada [2360-2009]	Environment Canada(CGIAR); Canada-Alberta Joint Oil Sands Monitoring Program; Alberta Environmental, Monitoring Evaluation and Reporting Agency; Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR)	This study was funded by Environment Canada (www.ec.gc.ca) (2011), the Canada-Alberta Joint Oil Sands Monitoring Program (www.jointoilsandsmonitoring.ca) (2012-2014), the Alberta Environmental, Monitoring Evaluation and Reporting Agency (www.aemera.org) (2015), and the Natural Sciences and Engineering Research Council of Canada (www.nserc-crsng.gc.ca) (grant number: 2360-2009 to JPS). The funders had no role in study design, data collection, and analyses, decision to publish, or preparation of the manuscript.	ADDISON PA, 1980, CAN J BOT, V58, P2323, DOI 10.1139/b80-269; Adrian R, 2009, LIMNOL OCEANOGR, V54, P2283, DOI 10.4319/lo.2009.54.6_part_2.2283; Akre CJ, 2004, J ENVIRON SCI HEAL A, V39, P1163, DOI 10.1081/ESE-120030301; Alberta Energy, 2013, ALB LEAS OIL SANDS A; [Anonymous], 2015, ALB EN RES 2015 SUPP; Appleby PG, 2002, DEV PALEOENVIRON RES, V1, P171; Barrie L.A., 1980, WINTERTIME INVESTIGA; Bayley SE, 2007, LIMNOL OCEANOGR, V52, P2002, DOI 10.4319/lo.2007.52.5.2002; Beklioglu M, 2006, ARCH HYDROBIOL, V166, P535, DOI 10.1127/0003-9136/2006/0166-0535; CAPP (Canadian Association of Petroleum Producers), 2015, CAN OIL SANDS HIST; CAPP ( Canadian Association of Petroleum Producers), 2015, CAN OIL SANDS QUICK; CAPP (Canadian Association of Petroleum Producers), 2014, FACTS OIL SANDS; CARRICK HJ, 1993, LIMNOL OCEANOGR, V38, P1179, DOI 10.4319/lo.1993.38.6.1179; CCME, 1999, CAN SED QUAL GUID PR; Cobbaert D, 2015, FRESHWATER BIOL, V60, P2084, DOI 10.1111/fwb.12633; COTNER JB, 1992, LIMNOL OCEANOGR, V37, P232, DOI 10.4319/lo.1992.37.2.0232; Curtis CJ, 2010, J LIMNOL, V69, P92, DOI 10.4081/jlimnol.2010.s1.92; Environment Canada, 2011, INT OIL SANDS ENV MO; Harrell Jr FE, 2015, HMISC HARRELL MISCEL; Hazewinkel RRO, 2008, CAN J FISH AQUAT SCI, V65, P1554, DOI 10.1139/F08-074; Kelly EN, 2010, P NATL ACAD SCI USA, V107, P16178, DOI 10.1073/pnas.1008754107; Kelly EN, 2009, P NATL ACAD SCI USA, V106, P22346, DOI 10.1073/pnas.0912050106; Kirk JL, 2014, ENVIRON SCI TECHNOL, V48, P7374, DOI 10.1021/es500986r; Korosi JB, 2012, AQUAT SCI, V74, P781, DOI 10.1007/s00027-012-0261-8; Kraemer BM, 2015, GEOPHYS RES LETT, V42, P4981, DOI 10.1002/2015GL064097; Kurek J, 2013, P NATL ACAD SCI USA, V110, pE2749, DOI 10.1073/pnas.1307696110; Kurek J, 2013, P NATL ACAD SCI USA, V110, P1761, DOI 10.1073/pnas.1217675110; Labaj AL, 2014, WATER AIR SOIL POLL, V225, DOI 10.1007/s11270-014-1868-2; Laird KR, 2013, HYDROBIOLOGIA, V720, P55, DOI 10.1007/s10750-013-1623-5; Landis MS, 2012, DEV ENVIRONM SCI, V11, P427, DOI 10.1016/B978-0-08-097760-7.00018-4; Markensten H, 2006, HYDROBIOLOGIA, V559, P319, DOI 10.1007/s10750-005-1526-1; Michelutti N, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0115338; Michelutti N, 2010, J PALEOLIMNOL, V43, P205, DOI 10.1007/s10933-009-9325-8; Oksanen J, 2012, HMISC HARRELL MISCEL; R Core Team, 2012, R LANG ENV STAT COMP; Rooney RC, 2012, P NATL ACAD SCI USA, V109, P4933, DOI 10.1073/pnas.1117693108; Ruhland KM, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2013.1887; Sass GZ, 2008, WATER RESOUR RES, V44, DOI 10.1029/2007WR006310; Schindler DW, 2006, P NATL ACAD SCI USA, V103, P7210, DOI 10.1073/pnas.0601568103; Schindler D, 2010, NATURE, V468, P499, DOI 10.1038/468499a; Schindler DW, 1996, LIMNOL OCEANOGR, V41, P1004, DOI 10.4319/lo.1996.41.5.1004; Schindler DW, 1998, BIOSCIENCE, V48, P157, DOI 10.2307/1313261; Simpson G.L., 2015, ANALOGUE ANALOGUE MA; Smol J.P., 2009, POLLUTION LAKES RIVE; Smol JP, 2007, FRONT ECOL ENVIRON, V5, P466, DOI 10.1890/060162; Smol JP, 2007, P NATL ACAD SCI USA, V104, P12395, DOI 10.1073/pnas.0702777104; Smol JP, 2015, HYDROBIOLOGIA, P1; Wang ZD, 2014, J HAZARD MATER, V271, P166, DOI 10.1016/j.jhazmat.2014.02.021; Watmough SA, 2014, SCI TOTAL ENVIRON, V493, P1, DOI 10.1016/j.scitotenv.2014.05.110; Weyhenmeyer GA, 2001, AMBIO, V30, P565, DOI 10.1639/0044-7447(2001)030[0565:WWAPAP]2.0.CO;2; Wolfe AP, 2006, J PALEOLIMNOL, V36, P91, DOI 10.1007/s10933-006-0006-6; Zhang YF, 2016, ENVIRON SCI TECHNOL, V50, P1711, DOI 10.1021/acs.est.5b05092	52	36	38	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 2	2016	11	5							e0153987	10.1371/journal.pone.0153987	http://dx.doi.org/10.1371/journal.pone.0153987			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DL5KB	27135946	Green Published, gold			2022-12-26	WOS:000375674800009
J	Liu, ZF; He, CY; Wu, JG				Liu, Zhifeng; He, Chunyang; Wu, Jianguo			The Relationship between Habitat Loss and Fragmentation during Urbanization: An Empirical Evaluation from 16 World Cities	PLOS ONE			English	Article							LANDSCAPE SPATIAL-PATTERN; URBAN EXPANSION; BIODIVERSITY CONSERVATION; SPATIOTEMPORAL PATTERNS; CHANGING SCALE; METRICS; CONNECTIVITY; FORECASTS; DYNAMICS; BEHAVIOR	Urbanization results in habitat loss and habitat fragmentation concurrently, both influencing biodiversity and ecological processes. To evaluate these impacts, it is important to understand the relationships between habitat loss and habitat fragmentation per se (HLHF) during urbanization. The objectives of this study were two-fold: 1) to quantify the different forms of the HLHF relationship during urbanization using multiple landscape metrics, and 2) to test the validity of the HLHF relations reported in the literature. Our analysis was based on a long-term urbanization dataset (1800-2000) of 16 large cities from around the world. Habitat area was represented as the percentage of non-built-up area in the landscape, while habitat fragmentation was measured using several landscape metrics. Our results show that the relationship between habitat loss and habitat fragmentation during urbanization is commonly monotonic-linear, exponential, or logarithmic, indicating that the degree of habitat fragmentation per se increases with habitat loss in general. We compared our results with 14 hypothesized HLHF relationships based on simulated landscapes found in the literature, and found that four of them were consistent with those of urbanization, whereas the other ten were not. Also, we identified six new HLHF relationships when fragmentation was measured by total core area, normalized total core area, patch density, edge density and landscape shape index, respectively. In addition, our study demonstrated that the "space-for-time" approach, frequently used in ecology and geography, generated specious HLHF relationships, suggesting that this approach is largely inappropriate for analyses of urban landscapes that are highly heterogeneous in space and unusually contingent in dynamics. Our results show both generalities and idiosyncrasies of the HLHF relationship, providing new insights for assessing ecological effects of urbanization.	[Liu, Zhifeng; He, Chunyang; Wu, Jianguo] Beijing Normal Univ, CHESS, State Key Lab Earth Surface Proc & Resource Ecol, Beijing 100875, Peoples R China; [Wu, Jianguo] Arizona State Univ, Sch Life Sci, Tempe, AZ USA; [Wu, Jianguo] Arizona State Univ, Sch Sustainabil, Tempe, AZ USA	Beijing Normal University; Arizona State University; Arizona State University-Tempe; Arizona State University; Arizona State University-Tempe	He, CY (corresponding author), Beijing Normal Univ, CHESS, State Key Lab Earth Surface Proc & Resource Ecol, Beijing 100875, Peoples R China.	hcy@bnu.edu.cn	Wu, Jianguo/G-6267-2010	Wu, Jianguo/0000-0002-1182-3024	National Basic Research Programs of China [2014CB954303, 2014CB954302]; National Natural Science Foundation of China [41222003, 41321001, 41501195]; 111 project of "Hazard and Risk Science Base at Beijing Normal University" [B08008]; State Key Laboratory of Earth Surface Processes and Resource Ecology [2015-RC-01]; Youth Scholars Program of Beijing Normal University [2014NT02]	National Basic Research Programs of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); 111 project of "Hazard and Risk Science Base at Beijing Normal University"; State Key Laboratory of Earth Surface Processes and Resource Ecology; Youth Scholars Program of Beijing Normal University	This research was supported in part by the National Basic Research Programs of China (Grant No. 2014CB954303 & 2014CB954302), National Natural Science Foundation of China (Grant No. 41222003 & No. 41321001 & 41501195), the 111 project of "Hazard and Risk Science Base at Beijing Normal University" (Grant No. B08008), the State Key Laboratory of Earth Surface Processes and Resource Ecology (2015-RC-01), and the Youth Scholars Program of Beijing Normal University (2014NT02).	ANDREN H, 1994, OIKOS, V71, P355, DOI 10.2307/3545823; Angel S., 2010, PERSISTENT DECLINE U; Angel S, 2011, PROG PLANN, V75, P53, DOI 10.1016/j.progress.2011.04.001; Angold PG, 2006, SCI TOTAL ENVIRON, V360, P196, DOI 10.1016/j.scitotenv.2005.08.035; [Anonymous], LONG TERM STUDIES EC; Didham RK, 2012, OIKOS, V121, P161, DOI 10.1111/j.1600-0706.2011.20273.x; Fahrig L, 1997, J WILDLIFE MANAGE, V61, P603, DOI 10.2307/3802168; Fahrig L, 2003, ANNU REV ECOL EVOL S, V34, P487, DOI 10.1146/annurev.ecolsys.34.011802.132419; Fortin MJ, 2003, OIKOS, V102, P203, DOI 10.1034/j.1600-0706.2003.12447.x; Frohn RC, 2006, REMOTE SENS ENVIRON, V100, P237, DOI 10.1016/j.rse.2005.10.026; Guneralp B, 2013, ENVIRON RES LETT, V8, DOI 10.1088/1748-9326/8/1/014025; GUSTAFSON EJ, 1992, LANDSCAPE ECOL, V7, P101, DOI 10.1007/BF02418941; Gustafson EJ, 1998, ECOSYSTEMS, V1, P143, DOI 10.1007/s100219900011; Haddad NM, 2015, SCI ADV, V1, DOI 10.1126/sciadv.1500052; Hargis CD, 1998, LANDSCAPE ECOL, V13, P167, DOI 10.1023/A:1007965018633; He CY, 2014, GLOBAL CHANGE BIOL, V20, P2886, DOI 10.1111/gcb.12553; IUCN, HAB CLASS SCHEM VERS; [匡文慧 KUANG Wenhui], 2009, [地球信息科学, Geo-information Science], V11, P428; Laurance WF, 2011, BIOL CONSERV, V144, P56, DOI 10.1016/j.biocon.2010.09.021; Li TA, 2010, LANDSCAPE ECOL, V25, P839, DOI 10.1007/s10980-010-9461-6; Liu ZF, 2016, SUSTAINABILITY-BASEL, V8, DOI 10.3390/su8010041; Liu ZF, 2014, LANDSCAPE ECOL, V29, P763, DOI 10.1007/s10980-014-0034-y; Mcdonald RI, 2008, BIOL CONSERV, V141, P1695, DOI 10.1016/j.biocon.2008.04.025; McGarigal K., 2002, FRAGSTATS SPATIAL PA; Neel MC, 2004, LANDSCAPE ECOL, V19, P435, DOI 10.1023/B:LAND.0000030521.19856.cb; Pe'er G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064968; Pearson SM, 1997, WILDLIFE AND LANDSCAPE ECOLOGY, P215; Qian YG, 2015, LANDSCAPE ECOL, V30, P1165, DOI 10.1007/s10980-015-0195-3; ROBINSON SK, 1995, SCIENCE, V267, P1987, DOI 10.1126/science.267.5206.1987; Rudd H, 2002, RESTOR ECOL, V10, P368, DOI 10.1046/j.1526-100X.2002.02041.x; Savard JPL, 2000, LANDSCAPE URBAN PLAN, V48, P131, DOI 10.1016/S0169-2046(00)00037-2; Scolozzi R, 2012, ENVIRON IMPACT ASSES, V36, P9, DOI 10.1016/j.eiar.2012.03.001; Seto KC, 2012, P NATL ACAD SCI USA, V109, P16083, DOI 10.1073/pnas.1211658109; Smith AC, 2009, LANDSCAPE ECOL, V24, P1271, DOI 10.1007/s10980-009-9383-3; Sushinsky JR, 2013, GLOBAL CHANGE BIOL, V19, P401, DOI 10.1111/gcb.12055; Swenson JJ, 2000, LANDSCAPE ECOL, V15, P713, DOI 10.1023/A:1008153522122; Syphard AD, 2011, J ENVIRON MANAGE, V92, P1882, DOI 10.1016/j.jenvman.2011.03.014; Tratalos J, 2007, LANDSCAPE URBAN PLAN, V83, P308, DOI 10.1016/j.landurbplan.2007.05.003; United Nations, 2012, WORLD URB PROSP 2011; Wang XL, 2011, LANDSCAPE ECOL, V26, P723, DOI 10.1007/s10980-011-9601-7; Wiegand T, 2005, CONSERV BIOL, V19, P108, DOI 10.1111/j.1523-1739.2005.00208.x; Wilson MC, 2016, LANDSCAPE ECOL, V31, P219, DOI 10.1007/s10980-015-0312-3; Wissink B, 2013, GEOFORUM, V47, P1, DOI 10.1016/j.geoforum.2013.02.009; Wu J., 2013, LANDSCAPE ECOLOGY SU, P37; Wu JG, 2004, LANDSCAPE ECOL, V19, P125, DOI 10.1023/B:LAND.0000021711.40074.ae; Wu JG, 2002, LANDSCAPE ECOL, V17, P761, DOI 10.1023/A:1022995922992; Wu JG, 2014, LANDSCAPE URBAN PLAN, V125, P209, DOI 10.1016/j.landurbplan.2014.01.018; Wu JG, 2011, ECOL COMPLEX, V8, P1, DOI 10.1016/j.ecocom.2010.03.002	48	66	72	7	115	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 28	2016	11	4							e0154613	10.1371/journal.pone.0154613	http://dx.doi.org/10.1371/journal.pone.0154613			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DK8XE	27124180	Green Published, Green Submitted, gold			2022-12-26	WOS:000375211700116
J	Stevenson, EGJ; Ambelu, A; Caruso, BA; Tesfaye, Y; Freeman, MC				Stevenson, E. G. J.; Ambelu, A.; Caruso, B. A.; Tesfaye, Y.; Freeman, M. C.			Community Water Improvement, Household Water Insecurity, and Women's Psychological Distress: An Intervention and Control Study in Ethiopia	PLOS ONE			English	Article							PSYCHIATRIC SCREENING INSTRUMENT; FOOD INSECURITY; EMOTIONAL DISTRESS; COUNTRIES; VALIDITY; ACCESS; CRISIS; WEALTH; HEALTH; URBAN	Background Over 650 million people worldwide lack access to safe water supplies, and even among those who have gained access to 'improved' sources, water may be seasonally unreliable, far from homes, expensive, and provide insufficient quantity. Measurement of water access at the level of communities and households remains crude, and better measures of household water insecurity are urgently needed to inform needs assessments and monitoring and evaluation. We set out to assess the validity of a quantitative scale of household water insecurity, and to investigate (1) whether improvements to community water supply reduce water insecurity, (2) whether water interventions affect women's psychological distress, and (3) the impacts of water insecurity on psychological distress, independent of socio-economic status, food security, and harvest quality. Methods and Findings Measures were taken before and one to six months after a community water supply improvement in three villages in rural northern Ethiopia. Villages similar in size and access to water sources and other amenities did not receive interventions, and served as controls. Household water insecurity was assessed using a 21-item scale based on prior qualitative work in Ethiopia. Women's psychological distress was assessed using the WHO Self-Reporting Questionnaire (SRQ-20). Respondents were either female heads of household or wives of the heads of household (n = 247 at baseline, n = 223 at endline); 123 households provided data at both rounds. The intervention was associated with a decline of approximately 2 points on the water insecurity scale between baseline and endline compared to the control (beta -1.99; 95% CI's -3.15, -0.84). We did not find evidence of impact of the intervention on women's psychological distress. Water insecurity was, however, predictive of psychological distress (p < 0.01), independent of household food security and the quality of the previous year's harvest. Conclusion These results contribute to the construct validity of our water insecurity scale, and establish our approach to measuring water insecurity as a plausible means of evaluating water interventions. Improvements to community water supplies were effective in reducing household water insecurity, but not psychological distress, in this population. Water insecurity was an important predictor of psychological distress. This study contributes to an emerging literature on quantitative assessment of household water insecurity, and draws attention to the potential impact of improved access to water on women's mental well-being.	[Stevenson, E. G. J.] UCL, Dept Anthropol, London, England; [Stevenson, E. G. J.] Emory Univ, Hubert Dept Global Hlth, Atlanta, GA 30322 USA; [Ambelu, A.] Jimma Univ, Dept Environm Hlth Sci, Jimma, Ethiopia; [Caruso, B. A.] Emory Univ, Dept Behav Sci & Hlth Educ, Atlanta, GA 30322 USA; [Tesfaye, Y.] Oregon State Univ, Dept Anthropol, Corvallis, OR 97331 USA; [Freeman, M. C.] Emory Univ, Dept Environm Hlth, Atlanta, GA 30322 USA	University of London; University College London; Emory University; Jimma University; Emory University; Oregon State University; Emory University	Stevenson, EGJ (corresponding author), UCL, Dept Anthropol, London, England.; Stevenson, EGJ (corresponding author), Emory Univ, Hubert Dept Global Hlth, Atlanta, GA 30322 USA.	jed.stevenson@gmail.com	Freeman, Matthew/ABE-6245-2020; Ambelu, Argaw/V-8317-2018; Ambelu, Argaw/GQA-6114-2022	Freeman, Matthew/0000-0002-1517-2572; Ambelu, Argaw/0000-0003-1898-4100; Ambelu, Argaw/0000-0003-1898-4100; Stevenson, Edward/0000-0003-2018-8920	Millennium Water Alliance through Conrad N. Hilton Foundation	Millennium Water Alliance through Conrad N. Hilton Foundation	Funding for this study was provided by the Millennium Water Alliance (http://www.mwawater.org) through a grant from the Conrad N. Hilton Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; Funding for this study was provided by the Millennium Water Alliance through a grant from the Conrad N. Hilton Foundation. At CRS we would like to thank Art Kirby, Solomon Bezabeh, and Dejene Mideksa; we are also grateful for the help of partners at WaterAction in Kombolcha and Team Today & Tomorrow in Dessie. Leslie Greene provided important input at the early stages of the project. For advice on analysis we thank Craig Hadley, Kenny Maes, Alexander Tsai, and two anonymous reviewers.	Aaronson N, 2002, QUAL LIFE RES, V11, P193; [Anonymous], 2009, WORLDS WATER 2008 20; [Anonymous], 2013, WAT SEC GLOB WAT AG; Beusenberg M, 1994, USERS GUIDE SELF REP; Calow RC, 2012, ACHIEVING WATER SECU; Coates J., 2007, FOOD NUTR TECHNICAL, DOI 10.1007/s13398-014-0173-7.2; Dangour AD, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD009382.pub2; Dessalegn M, 2013, VOICES SOURCE STRUGG; Dufaut A, 1988, WATERLINES, V6, P26; Ennis-McMillan M, 2005, PRECIOUS LIQUID DRIN; Ennis-McMillan MC, 2001, MED ANTHROPOL Q, V15, P368, DOI 10.1525/maq.2001.15.3.368; FAO, 2004, STAT FOOD INS WORLD; Filmer D, 1999, POPUL DEV REV, V25, P85, DOI 10.1111/j.1728-4457.1999.00085.x; Filmer D, 2001, DEMOGRAPHY, V38, P115, DOI 10.2307/3088292; Frongillo EA, 2001, FOOD NUTR B, V22; Hadley C, 2011, SOC SCI MED, V73, P1534, DOI 10.1016/j.socscimed.2011.09.004; Hadley C, 2009, HUM ORGAN, V68, P451, DOI 10.17730/humo.68.4.932w421317680w5x; Hanlon C, 2008, SOC PSYCH PSYCH EPID, V43, P653, DOI 10.1007/s00127-008-0342-0; Kloos H, 1992, ECOLOGY HLTH DIS ETH; KORTMANN F, 1988, BRIT J PSYCHIAT, V153, P95, DOI 10.1192/bjp.153.1.95; Maes KC, 2011, HEALTH POLICY PLANN, V26, P43, DOI 10.1093/heapol/czq017; Maes KC, 2010, SOC SCI MED, V70, P1450, DOI 10.1016/j.socscimed.2010.01.018; MEHRETU A, 1992, SOC SCI MED, V34, P17, DOI 10.1016/0277-9536(92)90062-U; Mekonnen MM, 2016, SCI ADV, V2, DOI 10.1126/sciadv.1500323; Prasad V, 2013, JAMA-J AM MED ASSOC, V309, P241, DOI 10.1001/jama.2012.96867; Pruss-Ustun A, 2014, TROP MED INT HEALTH, V19, P894, DOI 10.1111/tmi.12329; Rasmussen A, 2014, BMC PSYCHIATRY, V14, DOI 10.1186/1471-244X-14-206; Ray I, 2007, ANNU REV ENV RESOUR, V32, P421, DOI 10.1146/annurev.energy.32.041806.143704; Remigios MV, 2011, AGENDA-EMPOWER WOMEN, V25, P113, DOI 10.1080/10130950.2011.576004; Senturk V, 2012, J AFFECT DISORDERS, V136, P340, DOI 10.1016/j.jad.2011.11.028; Sorenson SB, 2011, SOC SCI MED, V72, P1522, DOI 10.1016/j.socscimed.2011.03.010; Stevenson EGJ, 2012, SOC SCI MED, V75, P392, DOI 10.1016/j.socscimed.2012.03.022; Stocks ME, 2014, PLOS MED, V11, DOI 10.1371/journal.pmed.1001605; Swindale A, 2006, J NUTR, V136, P1449, DOI 10.1093/jn/136.5.1449S; Tadesse D, 2010, ASSESSMENT DRINKING; Tsai AC, 2015, J WATER HLTH; Tucker J., 2014, WATER RESOURCES RURA, V3, P27, DOI [DOI 10.1016/J.WRR.2014.04.001, 10.1016/j.wrr.2014.04.001]; WHO UNICEF, 2015, PROGR DRINK WAT SAN; World Health Organization, 2012, PROGR DRINK WAT SAN; Wutich A, 2014, CURR ANTHROPOL, V55, P444, DOI 10.1086/677311; Wutich A, 2009, MED ANTHROPOL Q, V23, P436, DOI 10.1111/j.1548-1387.2009.01072.x; Wutich A, 2008, SOC SCI MED, V67, P2116, DOI 10.1016/j.socscimed.2008.09.042; Youngmann R, 2008, TRANSCULT PSYCHIATRY, V45, P566, DOI 10.1177/1363461508100783	43	56	56	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 28	2016	11	4							e0153432	10.1371/journal.pone.0153432	http://dx.doi.org/10.1371/journal.pone.0153432			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DK8XE	27124391	Green Submitted, Green Published, gold			2022-12-26	WOS:000375211700017
J	Irie, K; Tsujimura, K; Nakashima, H; Nakashima, K				Irie, Koichiro; Tsujimura, Keita; Nakashima, Hideyuki; Nakashima, Kinichi			MicroRNA-214 Promotes Dendritic Development by Targeting the Schizophrenia-associated Gene Quaking (Qki)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						dendrite; microRNA (miRNA); neurite outgrowth; neurodevelopment; RNA binding protein; schizophrenia	RNA-BINDING PROTEIN; MESSENGER-RNA; OLIGODENDROCYTE DIFFERENTIATION; HIPPOCAMPAL-NEURONS; STAR PROTEIN; MYELINATION; EXPRESSION; MATURATION; MICE; METAANALYSIS	Proper dendritic elaboration of neurons is critical for the formation of functional circuits during brain development. Defects in dendrite morphogenesis are associated with neuropsychiatric disorders, and microRNAs are emerging as regulators of aspects of neuronal maturation such as axonal and dendritic growth, spine formation, and synaptogenesis. Here, we show that miR-214 plays a pivotal role in the regulation of dendritic development. Overexpression of miR-214 increased dendrite size and complexity, whereas blocking of endogenous miR-214-3p, a mature form of miR-214, inhibited dendritic morphogenesis. We also found that miR-214-3p targets quaking (Qki), which is implicated in psychiatric diseases such as schizophrenia, through conserved target sites located in the 3-untranslated region of Qki mRNA, thereby down-regulating Qki protein levels. Overexpression and knockdown of Qki impaired and enhanced dendritic formation, respectively. Moreover, overexpression of Qki abolished the dendritic growth induced by miR-214 overexpression. Taken together, our findings reveal a crucial role for the miR-214-Qki pathway in the regulation of neuronal dendritic development.	[Irie, Koichiro; Tsujimura, Keita; Nakashima, Hideyuki; Nakashima, Kinichi] Kyushu Univ, Grad Sch Med Sci, Dept Stem Cell Biol & Med, Higashi Ku, 3-1-1 Maidashi, Fukuoka, Fukuoka 8128582, Japan	Kyushu University	Nakashima, K (corresponding author), Kyushu Univ, Grad Sch Med Sci, Dept Stem Cell Biol & Med, Higashi Ku, 3-1-1 Maidashi, Fukuoka, Fukuoka 8128582, Japan.; Tsujimura, K (corresponding author), Nagoya Univ, Grad Sch Med, Dept Cell Pharmacol, Showa Ku, 65 Tsurumai, Nagoya, Aichi 4668550, Japan.	tsujimura@med.nagoya-u.ac.jp; kin1@scb.med.kyushu-u.ac.jp		Tsujimura, Keita/0000-0002-7464-6133	 [24240051];  [27-7]	; 	This work was supported in part by a Grant-in-aid for Scientific Research (A) 24240051, a grant-in-aid for scientific research on innovative areas: Foundation of Synapse and Neurocircuit Pathology, and Intramural Research Grant 27-7 for Neurological and Psychiatric Disorders of the National Center of Neurology and Psychiatry. The authors declare that they have no conflicts of interest with the contents of this article.	Aberg K, 2006, AM J MED GENET B, V141B, P84, DOI 10.1002/ajmg.b.30243; Aberg K, 2006, P NATL ACAD SCI USA, V103, P7482, DOI 10.1073/pnas.0601213103; Aurora AB, 2012, J CLIN INVEST, V122, P1222, DOI 10.1172/JCI59327; Chen HL, 2010, BIOCHEM BIOPH RES CO, V394, P921, DOI 10.1016/j.bbrc.2010.03.076; Chenard CA, 2008, J NEUROSCI RES, V86, P233, DOI 10.1002/jnr.21485; CRAIG AM, 1994, ANNU REV NEUROSCI, V17, P267, DOI 10.1146/annurev.ne.17.030194.001411; Dajas-Bailador F, 2012, NAT NEUROSCI, V15, P697, DOI 10.1038/nn.3082; Doukhanine E, 2010, MOL BIOL CELL, V21, P3029, DOI 10.1091/mbc.E10-04-0305; Ebersole TA, 1996, NAT GENET, V12, P260, DOI 10.1038/ng0396-260; Fanous AH, 2007, AM J MED GENET B, V144B, P589, DOI 10.1002/ajmg.b.30442; Galarneau A, 2005, NAT STRUCT MOL BIOL, V12, P691, DOI 10.1038/nsmb963; Hall MP, 2013, RNA, V19, P627, DOI 10.1261/rna.038422.113; Haroutunian V, 2006, AM J PSYCHIAT, V163, P1834, DOI 10.1176/appi.ajp.163.10.1834; HUME RI, 1981, NATURE, V293, P469, DOI 10.1038/293469a0; Jan YN, 2010, NAT REV NEUROSCI, V11, P316, DOI 10.1038/nrn2836; JUSTICE MJ, 1988, GENET RES, V51, P95, DOI 10.1017/S0016672300024101; Kaech S, 2006, NAT PROTOC, V1, P2406, DOI 10.1038/nprot.2006.356; Kawauchi T, 2010, NEURON, V67, P588, DOI 10.1016/j.neuron.2010.07.007; Klempan TA, 2009, BIOL PSYCHIAT, V66, P824, DOI 10.1016/j.biopsych.2009.05.010; Kulkarni VA, 2012, MOL CELL NEUROSCI, V50, P10, DOI 10.1016/j.mcn.2012.03.005; Larocque D, 2005, NAT NEUROSCI, V8, P27, DOI 10.1038/nn1359; Larocque D, 2002, NEURON, V36, P815, DOI 10.1016/S0896-6273(02)01055-3; Larocque Daniel, 2005, RNA Biol, V2, P37, DOI 10.4161/rna.2.2.1603; Lewis CM, 2003, AM J HUM GENET, V73, P34, DOI 10.1086/376549; Li XK, 2010, NAT REV NEUROSCI, V11, P329, DOI 10.1038/nrn2739; Li ZH, 2003, DEV GROWTH DIFFER, V45, P449; Lindholm E, 2001, AM J HUM GENET, V69, P96, DOI 10.1086/321288; Liu J, 2010, J BIOL CHEM, V285, P26599, DOI 10.1074/jbc.M110.115824; Lois C, 2002, SCIENCE, V295, P868, DOI 10.1126/science.1067081; London M, 2005, ANNU REV NEUROSCI, V28, P503, DOI 10.1146/annurev.neuro.28.061604.135703; Makeyev EV, 2007, MOL CELL, V27, P435, DOI 10.1016/j.molcel.2007.07.015; McCullumsmith RE, 2007, SCHIZOPHR RES, V90, P15, DOI 10.1016/j.schres.2006.11.017; Motti D, 2012, SEMIN FETAL NEONAT M, V17, P347, DOI 10.1016/j.siny.2012.07.008; Mumm JS, 2006, NEURON, V52, P609, DOI 10.1016/j.neuron.2006.10.004; Ng MYM, 2009, MOL PSYCHIATR, V14, P774, DOI 10.1038/mp.2008.135; Parrish JZ, 2007, GENE DEV, V21, P956, DOI 10.1101/gad.1514507; Pilotte J, 2001, GENE DEV, V15, P845, DOI 10.1101/gad.860301; Qurashi A, 2010, CURR PSYCHIAT REP, V12, P154, DOI 10.1007/s11920-010-0102-1; Rosoklija G, 2000, ARCH GEN PSYCHIAT, V57, P349, DOI 10.1001/archpsyc.57.4.349; Saccomanno L, 1999, P NATL ACAD SCI USA, V96, P12605, DOI 10.1073/pnas.96.22.12605; Schratt GM, 2006, NATURE, V439, P283, DOI 10.1038/nature04367; SIDMAN RL, 1964, SCIENCE, V144, P309, DOI 10.1126/science.144.3616.309; Siegel G, 2009, NAT CELL BIOL, V11, P705, DOI 10.1038/ncb1876; Siomi H, 2010, MOL CELL, V38, P323, DOI 10.1016/j.molcel.2010.03.013; Smrt RD, 2010, STEM CELLS, V28, P1060, DOI 10.1002/stem.431; SNIDER WD, 1987, J NEUROSCI, V7, P1760; Soetanto A, 2010, ARCH GEN PSYCHIAT, V67, P448, DOI 10.1001/archgenpsychiatry.2010.48; Spruston N, 2008, NAT REV NEUROSCI, V9, P206, DOI 10.1038/nrn2286; Suzuki HI, 2009, NATURE, V460, P529, DOI 10.1038/nature08199; Tsujimura K, 2015, CELL REP, V12, P1887, DOI 10.1016/j.celrep.2015.08.028; Winter J, 2009, NAT CELL BIOL, V11, P228, DOI 10.1038/ncb0309-228; Wu JI, 2002, P NATL ACAD SCI USA, V99, P4233, DOI 10.1073/pnas.072090399; Xu CX, 2012, J BIOL CHEM, V287, P34970, DOI 10.1074/jbc.M112.374611; Zagrebelsky M, 2005, J NEUROSCI, V25, P9989, DOI 10.1523/JNEUROSCI.2492-05.2005; Zhao LX, 2006, MOL BIOL CELL, V17, P4179, DOI 10.1091/mbc.E06-04-0355; Zhou ZL, 2006, NEURON, V52, P255, DOI 10.1016/j.neuron.2006.09.037	56	23	25	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 24	2016	291	26					13891	13904		10.1074/jbc.M115.705749	http://dx.doi.org/10.1074/jbc.M115.705749			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DR2YZ	27129236	Green Published, hybrid			2022-12-26	WOS:000379771100042
J	Mahalingam, M; Perez, CF; Fessenden, JD				Mahalingam, Mohana; Perez, Claudio F.; Fessenden, James D.			Fluorescence Resonance Energy Transfer-based Structural Analysis of the Dihydropyridine Receptor (1S) Subunit Reveals Conformational Differences Induced by Binding of the beta(1a) Subunit	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						calcium channel; dihydropyridine receptor (DHPR); excitation-contraction coupling (E-C coupling); fluorescence resonance energy transfer (FRET); skeletal muscle	II-III LOOP; TYPE-1 RYANODINE RECEPTOR; SLOW CALCIUM CURRENT; SKELETAL-MUSCLE; ALPHA(1S) SUBUNIT; MUSCULAR DYSGENESIS; IN-VITRO; IV LOOP; CHANNEL; PROTEIN	The skeletal muscle dihydropyridine receptor (1S) subunit plays a key role in skeletal muscle excitation-contraction coupling by sensing membrane voltage changes and then triggering intracellular calcium release. The cytoplasmic loops connecting four homologous (1S) structural domains have diverse functions, but their structural arrangement is poorly understood. Here, we used a novel FRET-based method to characterize the relative proximity of these intracellular loops in (1S) subunits expressed in intact cells. In dysgenic myotubes, energy transfer was observed from an N-terminal-fused YFP to a FRET acceptor, ReAsH (resorufin arsenical hairpin binder), targeted to each (1S) intracellular loop, with the highest FRET efficiencies measured to the (1S) II-III loop and C-terminal tail. However, in HEK-293T cells, FRET efficiencies from the (1S) N terminus to the II-III and III-IV loops and the C-terminal tail were significantly lower, thus suggesting that these loop structures are influenced by the cellular microenvironment. The addition of the (1a) dihydropyridine receptor subunit enhanced FRET to the II-III loop, thus indicating that (1a) binding directly affects II-III loop conformation. This specific structural change required the C-terminal 36 amino acids of (1a), which are essential to support EC coupling. Direct FRET measurements between (1S) and (1a) confirmed that both wild type and truncated (1a) bind similarly to (1S). These results provide new insights into the role of muscle-specific proteins on the structural arrangement of (1S) intracellular loops and point to a new conformational effect of the (1a) subunit in supporting skeletal muscle excitation-contraction coupling.	[Mahalingam, Mohana; Perez, Claudio F.; Fessenden, James D.] Brigham & Womens Hosp, Dept Anesthesia Perioperat & Pain Med, 75 Francis St, Boston, MA 02115 USA	Harvard University; Brigham & Women's Hospital	Perez, CF; Fessenden, JD (corresponding author), Brigham & Womens Hosp, 75 Francis St, Boston, MA 02115 USA.	cperez@zeus.bwh.harvard.edu; jfessenden@zeus.bwh.harvard.edu			National Institutes of Health [R03AR066359, R01AR059124, R01AR067738]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR059124, R03AR066359, R01AR067738] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported by National Institutes of Health Grants R03AR066359 (to C. F. P.), R01AR059124 (to J. D. F.), and R01AR067738 (to C. F. P. and J. D. F.). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. The authors declare that they have no conflicts of interest with the contents of this article.	Adams SR, 2002, J AM CHEM SOC, V124, P6063, DOI 10.1021/ja017687n; Bannister RA, 2008, J BIOL CHEM, V283, P23217, DOI 10.1074/jbc.M804312200; Bannister RA, 2009, J GEN PHYSIOL, V134, P35, DOI 10.1085/jgp.200910241; BEAM KG, 1986, NATURE, V320, P168, DOI 10.1038/320168a0; Beurg M, 1997, BIOPHYS J, V73, P807, DOI 10.1016/S0006-3495(97)78113-X; CATTERALL WA, 1988, SCIENCE, V242, P50, DOI 10.1126/science.2459775; CHAUDHARI N, 1989, DEV BIOL, V133, P456, DOI 10.1016/0012-1606(89)90049-3; Chen YY, 2014, BIOCHEM J, V460, P261, DOI 10.1042/BJ20131553; Coronado R, 2004, BIOL RES, V37, P565; Dayal A, 2013, P NATL ACAD SCI USA, V110, P7488, DOI 10.1073/pnas.1301087110; Eltit JM, 2014, J BIOL CHEM, V289, P36116, DOI 10.1074/jbc.M114.615526; Fessenden JD, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064686; Fessenden JD, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007338; Flucher BE, 2000, J CELL BIOL, V151, P467, DOI 10.1083/jcb.151.2.467; Flucher BE, 2005, J MUSCLE RES CELL M, V26, P1, DOI 10.1007/s10974-005-9000-2; Flucher BE, 2000, FEBS LETT, V474, P93, DOI 10.1016/S0014-5793(00)01583-0; FLUCHER BE, 1994, MOL BIOL CELL, V5, P1105, DOI 10.1091/mbc.5.10.1105; Girgenrath T, 2013, J BIOL CHEM, V288, P16073, DOI 10.1074/jbc.M113.463299; Grabner M, 1999, J BIOL CHEM, V274, P21913, DOI 10.1074/jbc.274.31.21913; Gregg RG, 1996, P NATL ACAD SCI USA, V93, P13961, DOI 10.1073/pnas.93.24.13961; Griesbeck O, 2001, J BIOL CHEM, V276, P29188, DOI 10.1074/jbc.M102815200; Griffin BA, 2000, METHOD ENZYMOL, V327, P565; Hulme JT, 2005, P NATL ACAD SCI USA, V102, P5274, DOI 10.1073/pnas.0409885102; Karunasekara Y, 2009, EUR BIOPHYS J BIOPHY, V39, P75, DOI 10.1007/s00249-009-0467-4; KNUDSON CM, 1989, J BIOL CHEM, V264, P1345; Lee DY, 2008, BLOOD, V111, P2280, DOI 10.1182/blood-2007-07-100032; Mahalingam M, 2015, METHOD ENZYMOL, V556, P455, DOI 10.1016/bs.mie.2014.11.049; Nakai J, 1998, J BIOL CHEM, V273, P24983, DOI 10.1074/jbc.273.39.24983; Papadopoulos S, 2004, J BIOL CHEM, V279, P44046, DOI 10.1074/jbc.M405317200; Peterson BZ, 1999, NEURON, V22, P549, DOI 10.1016/S0896-6273(00)80709-6; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Polster A, 2012, J BIOL CHEM, V287, P41560, DOI 10.1074/jbc.M112.404194; PRAGNELL M, 1994, NATURE, V368, P67, DOI 10.1038/368067a0; Proenza C, 2000, J BIOL CHEM, V275, P29935, DOI 10.1074/jbc.C000464200; Raina SA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038594; Schredelseker J, 2005, P NATL ACAD SCI USA, V102, P17219, DOI 10.1073/pnas.0508710102; Schredelseker J, 2009, J BIOL CHEM, V284, P1242, DOI 10.1074/jbc.M807767200; Sheridan DC, 2003, BIOPHYS J, V84, P220, DOI 10.1016/S0006-3495(03)74844-9; Stroffekova K, 2001, PFLUG ARCH EUR J PHY, V442, P859, DOI 10.1007/s004240100619; TANABE T, 1987, NATURE, V328, P313, DOI 10.1038/328313a0; TANABE T, 1988, NATURE, V336, P134, DOI 10.1038/336134a0; Weiss RG, 2004, AM J PHYSIOL-CELL PH, V287, pC1094, DOI 10.1152/ajpcell.00173.2004; WITCHER DR, 1995, J BIOL CHEM, V270, P18088, DOI 10.1074/jbc.270.30.18088; Wu JP, 2015, SCIENCE, V350, DOI 10.1126/science.aad2395	44	4	4	1	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 24	2016	291	26					13762	13770		10.1074/jbc.M115.704049	http://dx.doi.org/10.1074/jbc.M115.704049			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DR2YZ	27129199	Green Published, hybrid			2022-12-26	WOS:000379771100030
J	Acevedo, J; Yan, S; Michael, WM				Acevedo, Julyana; Yan, Shan; Michael, W. Matthew			Direct Binding to Replication Protein A (RPA)-coated Single-stranded DNA Allows Recruitment of the ATR Activator TopBP1 to Sites of DNA Damage	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DEPENDENT CHECKPOINT; POLYMERASE-ALPHA; DISTINCT MODES; MRN COMPLEX; PHOSPHORYLATION; CHK1; RAD9-HUS1-RAD1; KINASE; SSDNA; RPA	A critical event for the ability of cells to tolerate DNA damage and replication stress is activation of the ATR kinase. ATR activation is dependent on the BRCT (BRCA1 C terminus) repeat-containing protein TopBP1. Previous work has shown that recruitment of TopBP1 to sites of DNA damage and stalled replication forks is necessary for downstream events in ATR activation; however, the mechanism for this recruitment was not known. Here, we use protein binding assays and functional studies in Xenopus egg extracts to show that TopBP1 makes a direct interaction, via its BRCT2 domain, with RPA-coated single-stranded DNA. We identify a point mutant that abrogates this interaction and show that this mutant fails to accumulate at sites of DNA damage and that the mutant cannot activate ATR. These data thus supply a mechanism for how the critical ATR activator, TopBP1, senses DNA damage and stalled replication forks to initiate assembly of checkpoint signaling complexes.	[Acevedo, Julyana; Michael, W. Matthew] Univ Southern Calif, Dept Biol Sci, Mol & Computat Biol Sect, Rm 104B RRI,1050 Childs Way, Los Angeles, CA 90089 USA; [Yan, Shan] Univ N Carolina, Dept Biol Sci, Charlotte, NC 28223 USA	University of Southern California; University of North Carolina; University of North Carolina Charlotte	Michael, WM (corresponding author), Univ Southern Calif, Dept Biol Sci, Mol & Computat Biol Sect, Rm 104B RRI,1050 Childs Way, Los Angeles, CA 90089 USA.	mattm@usc.edu	Yan, Shan/I-2298-2013; McDermott, Michael Francis/GZM-5330-2022	Yan, Shan/0000-0001-8106-6295; 	National Institutes of Health [R01GM099825]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM099825, R15GM101571, R15GM114713] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Grant R01GM099825 (to W. M. M.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Ball HL, 2007, MOL CELL BIOL, V27, P3367, DOI 10.1128/MCB.02238-06; Ball HL, 2005, MOL BIOL CELL, V16, P2372, DOI 10.1091/mbc.e04-11-1006; Ball HL, 2005, J BIOL CHEM, V280, P31390, DOI 10.1074/jbc.M504961200; Burdova K, 2015, MOL CELL, V59, P603, DOI 10.1016/j.molcel.2015.06.026; Byun TS, 2005, GENE DEV, V19, P1040, DOI 10.1101/gad.1301205; Cliby WA, 1998, EMBO J, V17, P159, DOI 10.1093/emboj/17.1.159; Cooper TJ, 2014, EXP CELL RES, V329, P124, DOI 10.1016/j.yexcr.2014.07.016; Cortez D, 2001, SCIENCE, V294, P1713, DOI 10.1126/science.1065521; Delacroix S, 2007, GENE DEV, V21, P1472, DOI 10.1101/gad.1547007; Duursma AM, 2013, MOL CELL, V50, P116, DOI 10.1016/j.molcel.2013.03.006; Fan J, 2012, GENE DEV, V26, P2337, DOI 10.1101/gad.194787.112; Garcia-Muse T, 2005, EMBO J, V24, P4345, DOI 10.1038/sj.emboj.7600896; Gerloff DL, 2012, FEBS LETT, V586, P2711, DOI 10.1016/j.febslet.2012.05.005; Gong ZH, 2010, MOL CELL, V37, P438, DOI 10.1016/j.molcel.2010.01.002; Guo ZJ, 2000, GENE DEV, V14, P2745, DOI 10.1101/gad.842500; Hashimoto Y, 2003, EMBO J, V22, P2526, DOI 10.1093/emboj/cdg238; Kondo S, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2001350; Kumagai A, 2006, CELL, V124, P943, DOI 10.1016/j.cell.2005.12.041; LaRocque JR, 2007, GENETICS, V175, P1023, DOI 10.1534/genetics.106.067330; Lee J, 2007, J BIOL CHEM, V282, P28036, DOI 10.1074/jbc.M704635200; Lee J, 2013, MOL BIOL CELL, V24, P1343, DOI 10.1091/mbc.E13-01-0025; Lee J, 2010, MOL BIOL CELL, V21, P926, DOI 10.1091/mbc.E09-11-0958; Liu QH, 2000, GENE DEV, V14, P1448; Lyndaker AM, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003320; Marechal A, 2015, CELL RES, V25, P9, DOI 10.1038/cr.2014.147; Mordes DA, 2008, GENE DEV, V22, P1478, DOI 10.1101/gad.1666208; Nam EA, 2011, BIOCHEM J, V436, P527, DOI 10.1042/BJ20102162; Namiki Y, 2006, P NATL ACAD SCI USA, V103, P580, DOI 10.1073/pnas.0510223103; Ohashi E, 2014, DNA REPAIR, V21, P1, DOI 10.1016/j.dnarep.2014.05.001; Petersen P, 2006, MOL CELL BIOL, V26, P1997, DOI 10.1128/MCB.26.5.1997-2011.2006; Rappas M, 2011, NUCLEIC ACIDS RES, V39, P313, DOI 10.1093/nar/gkq743; Shiotani B, 2013, CELL REP, V3, P1651, DOI 10.1016/j.celrep.2013.04.018; Sirbu BM, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a012724; Takeishi Y, 2010, GENES CELLS, V15, P761, DOI 10.1111/j.1365-2443.2010.01418.x; Van Hatten RA, 2002, J CELL BIOL, V159, P541, DOI 10.1083/jcb.200207090; Waiter J, 1997, SCIENCE, V275, P993, DOI 10.1126/science.275.5302.993; Walter J, 2000, MOL CELL, V5, P617, DOI 10.1016/S1097-2765(00)80241-5; Wang HY, 2004, CANCER RES, V64, P7139, DOI 10.1158/0008-5472.CAN-04-1289; Wanrooij PH, 2015, DNA REPAIR, V32, P17, DOI 10.1016/j.dnarep.2015.04.009; Wardlaw CP, 2014, DNA REPAIR, V22, P165, DOI 10.1016/j.dnarep.2014.06.004; Yan S, 2006, J CELL BIOL, V173, P181, DOI 10.1083/jcb.200601076; Yan S, 2009, J CELL BIOL, V184, P793, DOI 10.1083/jcb.200810185; Yoo HY, 2007, J BIOL CHEM, V282, P17501, DOI 10.1074/jbc.M701770200; Yoo HY, 2009, MOL BIOL CELL, V20, P2351, DOI 10.1091/mbc.E08-12-1190; Yoo HY, 2006, GENE DEV, V20, P772, DOI 10.1101/gad.1398806; Zou L, 2002, GENE DEV, V16, P198, DOI 10.1101/gad.950302; Zou L, 2003, SCIENCE, V300, P1542, DOI 10.1126/science.1083430	47	25	25	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 17	2016	291	25					13124	13131		10.1074/jbc.M116.729194	http://dx.doi.org/10.1074/jbc.M116.729194			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DR2YT	27129245	Green Published, Green Submitted, hybrid			2022-12-26	WOS:000379770500020
J	Chen, YTS; Wu, JH; Modrich, P; Hsieh, TS				Chen, Yu-tsung Shane; Wu, Jianhong; Modrich, Paul; Hsieh, Tao-shih			The C-terminal 20 Amino Acids of Drosophila Topoisomerase 2 Are Required for Binding to a BRCA1 C Terminus (BRCT) Domain-containing Protein, Mus101, and Fidelity of DNA Segregation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							REPLICATION CHECKPOINT CONTROL; CASEIN KINASE-II; ANAPHASE BRIDGES; IN-VITRO; PHOSPHORYLATION; ALPHA; TOPBP1; CLEAVAGE; COMPLEX; YEAST	Eukaryotic topoisomerase 2 (Top2) and one of its interacting partners, topoisomerase II beta binding protein 1 (TopBP1) are two proteins performing essential cellular functions. We mapped the interacting domains of these two proteins using co-immunoprecipitation and pulldown experiments with truncated or mutant Drosophila Top2 with various Ser-to-Ala substitutions. We discovered that the last 20 amino acids of Top2 represent the key region for binding with Mus101 (the Drosophila homolog of TopBP1) and that phosphorylation of Ser-1428 and Ser-1443 is important for Top2 to interact with the N terminus of Mus101, which contains the BRCT1/2 domains. The interaction between Mus101 and the Top2 C-terminal regulatory domain is phosphorylation-dependent because treatment with phosphatase abolishes their association in pulldown assays. The binding affinity of N-terminal Mus101 with a synthetic phosphorylated peptide spanning the last 25 amino acids of Top2 (with Ser(P)-1428 and Ser(P)-1443) was determined by surface plasmon resonance with a K-d of 0.57 mu M. In an in vitro decatenation assay, Mus101 can specifically reduce the decatenation activity of Top2, and dephosphorylation of Top2 attenuates this response. Next, we endeavored to establish a cellular system for testing the biological function of Top2-Mus101 interaction. Top2-silenced S2 cells rescued by Top2 Delta 20, Top2 with 20 amino acids truncated from the C terminus, developed abnormally high chromosome numbers, which implies that Top2-Mus101 interaction is important for maintaining the fidelity of chromosome segregation during mitosis.	[Chen, Yu-tsung Shane; Wu, Jianhong; Modrich, Paul; Hsieh, Tao-shih] Duke Univ, Med Ctr, Dept Biochem, Durham, NC 27710 USA; [Hsieh, Tao-shih] Duke Univ, Med Ctr, Howard Hughes Med Inst, Durham, NC 27710 USA; [Hsieh, Tao-shih] Acad Sinica, Inst Cellular & Organism Biol, Taipei 115, Taiwan; [Modrich, Paul] Howard Hughes Med Inst, Chevy Chase, MD USA	Duke University; Duke University; Howard Hughes Medical Institute; Academia Sinica - Taiwan; Howard Hughes Medical Institute	Hsieh, TS (corresponding author), 128 Sec 2,Acad Rd, Taipei 115, Taiwan.	hsieh002@gate.sinica.edu.tw	Wu, Jian/AAU-5221-2020; Wu, Jian/AAU-5221-2020	Wu, Jian/0000-0001-9933-7364; Modrich, Paul/0000-0001-8708-9885; Wu, Jian/0000-0002-3394-1507	National Institute of Health [GM29006, GM45190]; Taiwan's Ministry of Science and Technology [334122]; Howard Hughes Medical Institute; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM045190, R01GM029006] Funding Source: NIH RePORTER	National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Taiwan's Ministry of Science and Technology; Howard Hughes Medical Institute(Howard Hughes Medical Institute); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institute of Health Grants GM29006 (to T. S. H.) and GM45190 (to P. M.), Taiwan's Ministry of Science and Technology Grant 334122 (to T. S. H.), and the Howard Hughes Medical Institute (to P. M.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	ACKERMAN P, 1985, P NATL ACAD SCI USA, V82, P3164, DOI 10.1073/pnas.82.10.3164; Agostinho M, 2008, CANCER RES, V68, P2409, DOI 10.1158/0008-5472.CAN-07-2092; Azuma Y, 2005, EMBO J, V24, P2172, DOI 10.1038/sj.emboj.7600700; Bai LP, 2014, CELL SIGNAL, V26, P857, DOI 10.1016/j.cellsig.2014.01.006; Baird CL, 1999, P NATL ACAD SCI USA, V96, P13685, DOI 10.1073/pnas.96.24.13685; Bloom KS, 2014, ANNU REV GENET, V48, P457, DOI 10.1146/annurev-genet-120213-092033; Boos D, 2011, CURR BIOL, V21, P1152, DOI 10.1016/j.cub.2011.05.057; Broderick R, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7572; Chen SH, 2013, ANNU REV BIOCHEM, V82, P139, DOI 10.1146/annurev-biochem-061809-100002; Chikamori K, 2003, J BIOL CHEM, V278, P12696, DOI 10.1074/jbc.M300837200; CRENSHAW DG, 1993, J BIOL CHEM, V268, P21328; DARZYNKIEWICZ Z, 1992, CYTOMETRY, V13, P795, DOI 10.1002/cyto.990130802; DEVORE RF, 1992, CANCER RES, V52, P2156; Germann SM, 2014, J CELL BIOL, V204, P45, DOI 10.1083/jcb.201305157; Haley B, 2010, P NATL ACAD SCI USA, V107, P11435, DOI 10.1073/pnas.1006689107; Harkins TT, 1998, BIOCHEMISTRY-US, V37, P7299, DOI 10.1021/bi9729108; Kumagai A, 2011, J CELL BIOL, V193, P995, DOI 10.1083/jcb.201102003; Kurz EU, 2000, J BIOL CHEM, V275, P13948, DOI 10.1074/jbc.275.18.13948; Li H, 2008, J BIOL CHEM, V283, P6209, DOI 10.1074/jbc.M709007200; LIU LF, 1983, J BIOL CHEM, V258, P5365; Liu SZ, 2011, MOL CELL, V43, P192, DOI 10.1016/j.molcel.2011.06.019; Losada A, 2002, GENE DEV, V16, P3004, DOI 10.1101/gad.249202; MORRISON A, 1979, CELL, V17, P175, DOI 10.1016/0092-8674(79)90305-2; Morrison C, 2002, NUCLEIC ACIDS RES, V30, P5318, DOI 10.1093/nar/gkf665; Moyer SE, 2006, P NATL ACAD SCI USA, V103, P10236, DOI 10.1073/pnas.0602400103; Nitiss JL, 2009, NAT REV CANCER, V9, P327, DOI 10.1038/nrc2608; Onn I, 2008, ANNU REV CELL DEV BI, V24, P105, DOI 10.1146/annurev.cellbio.24.110707.175350; Qi XM, 2011, J BIOL CHEM, V286, P35883, DOI 10.1074/jbc.M111.229260; Rappas M, 2011, NUCLEIC ACIDS RES, V39, P313, DOI 10.1093/nar/gkq743; Ryu H, 2010, J CELL BIOL, V191, P783, DOI 10.1083/jcb.201004033; SAKA Y, 1994, EMBO J, V13, P5319, DOI 10.1002/j.1460-2075.1994.tb06866.x; SANDER M, 1983, J BIOL CHEM, V258, P8421; SANDER M, 1984, P NATL ACAD SCI-BIOL, V81, P6938, DOI 10.1073/pnas.81.22.6938; Schmidt BH, 2012, NAT STRUCT MOL BIOL, V19, P1147, DOI 10.1038/nsmb.2388; Stros M, 2007, NUCLEIC ACIDS RES, V35, P5001, DOI 10.1093/nar/gkm525; Takeishi Y, 2010, GENES CELLS, V15, P761, DOI 10.1111/j.1365-2443.2010.01418.x; Vert JP, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-520; Wang JD, 2011, J CELL BIOL, V193, P267, DOI 10.1083/jcb.201010026; Yamane K, 1997, EUR J BIOCHEM, V250, P794, DOI 10.1111/j.1432-1033.1997.00794.x; Zegerman P, 2007, NATURE, V445, P281, DOI 10.1038/nature05432	40	1	1	1	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 17	2016	291	25					13216	13228		10.1074/jbc.M116.721357	http://dx.doi.org/10.1074/jbc.M116.721357			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DR2YT	27129233	hybrid, Green Published			2022-12-26	WOS:000379770500027
J	Welk, V; Coux, O; Kleene, V; Abeza, C; Trumbach, D; Eickelberg, O; Meiners, S				Welk, Vanessa; Coux, Olivier; Kleene, Vera; Abeza, Claire; Truembach, Dietrich; Eickelberg, Oliver; Meiners, Silke			Inhibition of Proteasome Activity Induces Formation of Alternative Proteasome Complexes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							REG-GAMMA-PROTEASOME; ACTIVATOR PA200; IONIZING-RADIATION; MULTIPLE-MYELOMA; LUNG FIBROBLASTS; CORE PARTICLE; DNA-REPAIR; DEGRADATION; EXPRESSION; PROTEIN	The proteasome is an intracellular protease complex consisting of the 20S catalytic core and its associated regulators, including the 19S complex, PA28 alpha beta, PA28 gamma, PA200, and PI31. Inhibition of the proteasome induces autoregulatory de novo formation of 20S and 26S proteasome complexes. Formation of alternative proteasome complexes, however, has not been investigated so far. We here show that catalytic proteasome inhibition results in fast recruitment of PA28 gamma and PA200 to 20S and 26S proteasomes within 2-6 h. Rapid formation of alternative proteasome complexes did not involve transcriptional activation of PA28 gamma and PA200 but rather recruitment of preexisting activators to 20S and 26S proteasome complexes. Recruitment of proteasomal activators depended on the extent of active site inhibition of the proteasome with inhibition of beta 5 active sites being sufficient for inducing recruitment. Moreover, specific inhibition of 26S proteasome activity via siRNA-mediated knockdown of the 19S subunit RPN6 induced recruitment of only PA200 to 20S proteasomes, whereas PA28 gamma was not mobilized. Here, formation of alternative PA200 complexes involved transcriptional activation of the activator. Alternative proteasome complexes persisted when cells had regained proteasome activity after pulse exposure to proteasome inhibitors. Knockdown of PA28 gamma sensitized cells to proteasome inhibitor-mediated growth arrest. Thus, formation of alternative proteasome complexes appears to be a formerly unrecognized but integral part of the cellular response to impaired proteasome function and altered proteostasis.	[Welk, Vanessa; Kleene, Vera; Eickelberg, Oliver; Meiners, Silke] Univ Munich, Univ Hosp, CPC, Helmholtz Zentrum Munchen, D-81377 Munich, Germany; [Welk, Vanessa; Kleene, Vera; Eickelberg, Oliver; Meiners, Silke] German Ctr Lung Res DZL, D-81377 Munich, Germany; [Coux, Olivier; Abeza, Claire] Univ Montpellier, CNRS, UMR 5237, CRBM, F-34293 Montpellier, France; [Truembach, Dietrich] Helmholtz Zentrum Munchen, Inst Dev Genet, D-85764 Neuherberg, Germany	Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; University of Munich; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Montpellier; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health	Meiners, S (corresponding author), Max Lebsche Pl 31, D-81377 Munich, Germany.	silke.meiners@helmholtz-muenchen.de	Coux, Olivier/B-3406-2010; Meiners, S/M-9822-2014; Coux, Olivier/P-6847-2019	Coux, Olivier/0000-0001-8455-3849; Meiners, S/0000-0003-3678-7995; Coux, Olivier/0000-0001-8455-3849	COST Action PROTEOSTASIS [BM1307]; European ITN program "UPSTREAM"; Helmholtz Alliance ICEMED, Imaging and Curing Environmental Metabolic Diseases through the Initiative and Network Fund of the Helmholtz Association; Helmholtz Graduate School, Lung Biology and Disease	COST Action PROTEOSTASIS(European Cooperation in Science and Technology (COST)); European ITN program "UPSTREAM"; Helmholtz Alliance ICEMED, Imaging and Curing Environmental Metabolic Diseases through the Initiative and Network Fund of the Helmholtz Association; Helmholtz Graduate School, Lung Biology and Disease	This work was supported in part by the COST Action BM1307 PROTEOSTASIS, the European ITN program "UPSTREAM," and the Helmholtz Alliance ICEMED, Imaging and Curing Environmental Metabolic Diseases, through the Initiative and Network Fund of the Helmholtz Association. The authors declare that they have no conflicts of interest with the contents of this article.r Supported by the Helmholtz Graduate School, Lung Biology and Disease.	Acosta-Alvear D, 2015, ELIFE, V4, DOI 10.7554/eLife.08153; Arciniega M, 2014, P NATL ACAD SCI USA, V111, P9479, DOI 10.1073/pnas.1408018111; Baldin V, 2008, MOL BIOL CELL, V19, P1706, DOI 10.1091/mbc.E07-07-0637; Blickwedehl J, 2008, P NATL ACAD SCI USA, V105, P16165, DOI 10.1073/pnas.0803145105; Blickwedehl J, 2007, RADIAT RES, V167, P663, DOI 10.1667/RR0690.1; Blickwedehl J, 2012, MOL CANCER RES, V10, P937, DOI 10.1158/1541-7786.MCR-11-0493-T; Cartharius K, 2005, BIOINFORMATICS, V21, P2933, DOI 10.1093/bioinformatics/bti473; Chen XY, 2007, MOL CELL, V26, P843, DOI 10.1016/j.molcel.2007.05.022; Dahlmann B, 2016, ARCH BIOCHEM BIOPHYS, V591, P132, DOI 10.1016/j.abb.2015.12.012; Di Napoli Mario, 2005, Curr Opin Investig Drugs, V6, P686; Dick LR, 2010, DRUG DISCOV TODAY, V15, P243, DOI 10.1016/j.drudis.2010.01.008; Dick TP, 1996, CELL, V86, P253, DOI 10.1016/S0092-8674(00)80097-5; Dong SX, 2013, CELL METAB, V18, P380, DOI 10.1016/j.cmet.2013.08.012; Fabre B, 2015, MOL SYST BIOL, V11, DOI 10.15252/msb.20145497; Fabre B, 2014, J PROTEOME RES, V13, P3027, DOI 10.1021/pr500193k; Finley D, 2009, ANNU REV BIOCHEM, V78, P477, DOI 10.1146/annurev.biochem.78.081507.101607; Fort P, 2015, GENOME BIOL EVOL, V7, P1363, DOI 10.1093/gbe/evv068; Glickman MH, 2001, CURR PROTOC PROTEIN; Groettrup M, 1996, NATURE, V381, P166, DOI 10.1038/381166a0; Groll M, 2000, NAT STRUCT BIOL, V7, P1062, DOI 10.1038/80992; Herndon TM, 2013, CLIN CANCER RES, V19, P4559, DOI 10.1158/1078-0432.CCR-13-0755; JORDANA M, 1988, THORAX, V43, P552, DOI 10.1136/thx.43.7.552; JORDANA M, 1987, J LEUKOCYTE BIOL, V42, P51, DOI 10.1002/jlb.42.1.51; Kane RC, 2006, CLIN CANCER RES, V12, P2955, DOI 10.1158/1078-0432.CCR-06-0170; Keller IE, 2015, SCI REP-UK, V5, DOI 10.1038/srep10230; Khor B, 2006, MOL CELL BIOL, V26, P2999, DOI 10.1128/MCB.26.8.2999-3007.2006; Kish-Trier E, 2013, ANNU REV BIOPHYS, V42, P29, DOI 10.1146/annurev-biophys-083012-130417; Kleijnen MF, 2007, NAT STRUCT MOL BIOL, V14, P1180, DOI 10.1038/nsmb1335; Le Feuvre AY, 2009, PROTEIN EXPRES PURIF, V64, P219, DOI 10.1016/j.pep.2008.10.014; Li J, 2001, BIOCHIMIE, V83, P373, DOI 10.1016/S0300-9084(01)01236-6; Li XH, 2014, J BIOL CHEM, V289, P17392, DOI 10.1074/jbc.M114.561183; Li XT, 2007, MOL CELL, V26, P831, DOI 10.1016/j.molcel.2007.05.028; Li XT, 2006, CELL, V124, P381, DOI 10.1016/j.cell.2005.11.037; Liu JA, 2010, J CELL SCI, V123, P4076, DOI 10.1242/jcs.067405; Livnat-Levanon N, 2014, CELL REP, V7, P1371, DOI 10.1016/j.celrep.2014.04.030; Lokireddy S, 2015, P NATL ACAD SCI USA, V112, pE7176, DOI 10.1073/pnas.1522332112; Meiners S, 2003, J BIOL CHEM, V278, P21517, DOI 10.1074/jbc.M301032200; Meiners S, 2006, FREE RADICAL BIO MED, V40, P2232, DOI 10.1016/j.freeradbiomed.2006.03.003; Meiners S, 2014, ANTIOXID REDOX SIGN, V21, P2364, DOI 10.1089/ars.2013.5798; Murata S, 1999, J BIOL CHEM, V274, P38211, DOI 10.1074/jbc.274.53.38211; Myeku N, 2016, NAT MED, V22, P46, DOI 10.1038/nm.4011; Ortega J, 2005, J MOL BIOL, V346, P1221, DOI 10.1016/j.jmb.2004.12.049; Ossendorp F, 2005, J IMMUNOL, V174, P7815, DOI 10.4049/jimmunol.174.12.7815; Qian MX, 2013, CELL, V153, P1012, DOI 10.1016/j.cell.2013.04.032; Radhakrishnan SK, 2010, MOL CELL, V38, P17, DOI 10.1016/j.molcel.2010.02.029; Realini C, 1997, J BIOL CHEM, V272, P25483, DOI 10.1074/jbc.272.41.25483; Rechsteiner M, 2005, TRENDS CELL BIOL, V15, P27, DOI 10.1016/j.tcb.2004.11.003; Ron D, 2007, NAT REV MOL CELL BIO, V8, P519, DOI 10.1038/nrm2199; Ruschak AM, 2012, P NATL ACAD SCI USA, V109, pE3454, DOI 10.1073/pnas.1213640109; Santamaria PG, 2003, J BIOL CHEM, V278, P6687, DOI 10.1074/jbc.M209420200; Savulescu AF, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.R110.006890; Schmidt M, 2014, BBA-MOL CELL RES, V1843, P13, DOI 10.1016/j.bbamcr.2013.08.012; Schwanhausser B, 2011, NATURE, V473, P337, DOI 10.1038/nature10098; Semren N, 2015, AM J RESP CRIT CARE, V192, P1089, DOI 10.1164/rccm.201412-2270OC; Sha Z, 2014, CURR BIOL, V24, P1573, DOI 10.1016/j.cub.2014.06.004; Shibatani T, 2006, MOL BIOL CELL, V17, P4962, DOI 10.1091/mbc.E06-04-0311; Smulski PA, 2009, STRUCTURE, V17, P1137, DOI 10.1016/j.str.2009.06.011; Stadtmueller BM, 2011, MOL CELL, V41, P8, DOI 10.1016/j.molcel.2010.12.020; Steffen J, 2010, MOL CELL, V40, P147, DOI 10.1016/j.molcel.2010.09.012; Tanahashi N, 2000, J BIOL CHEM, V275, P14336, DOI 10.1074/jbc.275.19.14336; Tonoki A, 2009, MOL CELL BIOL, V29, P1095, DOI 10.1128/MCB.01227-08; Tsvetkov P, 2015, ELIFE, V4, DOI 10.7554/eLife.08467; Ustrell V, 2002, EMBO J, V21, P3516, DOI 10.1093/emboj/cdf333; van Rijt SH, 2012, AM J PHYSIOL-LUNG C, V303, pL814, DOI 10.1152/ajplung.00128.2012; Vernace VA, 2007, FASEB J, V21, P2672, DOI 10.1096/fj.06-6751com; Vilchez D, 2012, NATURE, V489, P304, DOI 10.1038/nature11468; Wojcik C, 2002, J BIOL CHEM, V277, P6188, DOI 10.1074/jbc.M109996200; Wojcik C, 1999, CELL MOL LIFE SCI, V56, P908, DOI 10.1007/s000180050483; Yu GW, 2010, J MOL CELL BIOL, V2, P192, DOI 10.1093/jmcb/mjq009; Zhang Z, 2008, EMBO J, V27, P852, DOI 10.1038/emboj.2008.25	70	32	33	1	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 17	2016	291	25					13147	13159		10.1074/jbc.M116.717652	http://dx.doi.org/10.1074/jbc.M116.717652			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DR2YT	27129254	hybrid, Green Published			2022-12-26	WOS:000379770500022
J	Bancu, I; Diaz, MN; Serra, A; Granada, M; Lopez, D; Romero, R; Bonet, J				Bancu, Ioana; Navarro Diaz, Maruja; Serra, Assumpta; Granada, Marisa; Lopez, Dolores; Romero, Ramon; Bonet, Josep			Low Insulin-Like Growth Factor-1 Level in Obesity Nephropathy: A New Risk Factor?	PLOS ONE			English	Article							FACTOR BINDING PROTEIN-3; KIDNEY-DISEASE; RENAL-FUNCTION; CHILDREN; INCREASES; SECRETION; CLEARANCE; ADULTS; STAGE; MICE	Introduction IGF-1 (insulin-like growth factor-1) is a hormone involved in cell growth and other important processes. In the kidney, IGF-1 has a stimulating effect, increasing the blood flow and glomerular filtration rate. Although many experimental animal studies regarding the role of IGF-1 in the kidney have been conducted, few human studies are available in the literature. Obesity is a cause of renal failure, and several glomerular lesions associated with obesity have been described. However, no studies regarding the levels of IGF-1 in morbidly obese patients with renal injury associated with obesity have been conducted. Aim To determine the serum IGF-1 concentrations in morbidly obese patients with normal renal function but with different types of early obesity-related glomerular lesions and to evaluate the possible relationship between IGF-1 and the presence of renal lesions. Methods Eighty morbidly obese patients with renal biopsy, including 11 patients with no evidence of renal lesion, 17 patients with single glomerulomegaly, 21 patients with single podocyte hypertrophy, 10 patients with glomerulomegaly and podocyte hypertrophy, 5 patients with focal segmental hyalinosis, and 16 patients with increased mesangial matrix and/or mesangial proliferation, participated in this study. Biological parameters, including serum IGF-1 concentrations with the standard deviation score for age (SDS-IGF-1), were determined for all patients. Results Eighty patients (50 women and 30 men) with a mean BMI of 52.63 +/- 8.71 and a mean age of 42.40 +/- 9.45 years were included in this study. IGF-1, IGF-1 SDS and IGF-1BP3 levels according to the renal injury were compared (normal glomeruli: IGF-1 = 190.17 +/- 72.46; glomerulomegaly: IGF-1 = 122.3 +/- 50.05; podocyte hypertrophy: IGF-1 = 119.81 +/- 60.34; focal segmental hyalinosis: IGF-1 170.98 +/- 100.83, increased mesangial matrix and/ or mesangial proliferation: IGF-1 117.73 +/- 63.87). Statistically significant differences were observed between serum levels of IGF-1 and between the levels of SDS-IGF-1 by comparing the group without glomerular lesion with the group formed by patients with any type of glomerular injury. Logistic regression analysis was performed, with the dependent variable defined as the glomerular injury. In the multivariate analysis, only SDS-IGF-1 was associated with glomerular injury, and low levels of IGF-1 SDS were a risk factor for kidney injury. Conclusions Our study demonstrates that low IGF-1 serum levels are associated with renal lesions in morbidly obese patients without overt clinical renal manifestations.	[Bancu, Ioana; Navarro Diaz, Maruja; Serra, Assumpta; Romero, Ramon; Bonet, Josep] Hosp Badalona Germans Trias & Pujol, Dept Nephrol, Barcelona, Spain; [Bancu, Ioana; Romero, Ramon] Univ Autonoma Barcelona, E-08193 Barcelona, Spain; [Navarro Diaz, Maruja; Serra, Assumpta; Bonet, Josep] REDinREN, Madrid, Spain; [Granada, Marisa] Hosp Badalona Germans Trias & Pujol, Dept Biochem, Barcelona, Spain; [Lopez, Dolores] Hosp Badalona Germans Trias & Pujol, Dept Pathol, Barcelona, Spain	Hospital Germans Trias i Pujol; Autonomous University of Barcelona; Hospital Germans Trias i Pujol; Hospital Germans Trias i Pujol	Bancu, I (corresponding author), Hosp Badalona Germans Trias & Pujol, Dept Nephrol, Barcelona, Spain.; Bancu, I (corresponding author), Univ Autonoma Barcelona, E-08193 Barcelona, Spain.	ioana_bancu@yahoo.com		romero, ramon/0000-0001-9053-2649				Atamer A, 2008, J INT MED RES, V36, P522, DOI 10.1177/147323000803600317; Bach LA, 2015, AM J KIDNEY DIS, V65, P327, DOI 10.1053/j.ajkd.2014.05.024; Chernausek SD, 2007, J CLIN ENDOCR METAB, V92, P902, DOI 10.1210/jc.2006-1610; Derakhshan A, 2007, SAUDI J KIDNEY DIS T, V18, P173; FELD SM, 1995, KIDNEY INT, V48, P45, DOI 10.1038/ki.1995.265; Frystyk J, 1999, KIDNEY INT, V56, P2076, DOI 10.1046/j.1523-1755.1999.00798.x; Gooch JL, 2001, J BIOL CHEM, V276, P42492, DOI 10.1074/jbc.M102994200; GULER HP, 1988, P NATL ACAD SCI USA, V85, P4889, DOI 10.1073/pnas.85.13.4889; GULER HP, 1989, ACTA ENDOCRINOL-COP, V121, P101, DOI 10.1530/acta.0.1210101; GULER HP, 1989, P NATL ACAD SCI USA, V86, P2868, DOI 10.1073/pnas.86.8.2868; HAMMERMAN MR, 1993, AM J PHYSIOL, V265, pF1, DOI 10.1152/ajprenal.1993.265.1.F1; Heald AH, 2003, ATHEROSCLEROSIS, V170, P79, DOI 10.1016/S0021-9150(03)00235-1; Imberti B, 2007, J AM SOC NEPHROL, V18, P2921, DOI 10.1681/ASN.2006121318; Iversen P, 2010, GROWTH HORM IGF RES, V20, P156, DOI 10.1016/j.ghir.2009.12.001; JORGENSEN JOL, 1989, LANCET, V1, P1221; Juul A, 2002, CIRCULATION, V106, P939, DOI 10.1161/01.CIR.0000027563.44593.CC; JUUL A, 1994, J CLIN ENDOCR METAB, V78, P744, DOI 10.1210/jc.78.3.744; KLINGER B, 1994, PEDIATR NEPHROL, V8, P684, DOI 10.1007/BF00869089; LIU JP, 1993, CELL, V75, P59, DOI 10.1016/S0092-8674(05)80084-4; Liu PF, 2016, SCI REP-UK, V6, DOI 10.1038/srep20287; Navarro-Diaz M, 2008, KIDNEY INT, V74, pS15, DOI 10.1038/ki.2008.518; Nordstrom SM, 2011, MOL ENDOCRINOL, V25, P1223, DOI 10.1210/me.2011-0047; Ohlsson C, 2009, ENDOCR REV, V30, P494, DOI 10.1210/er.2009-0010; Pellitero S, 2013, EUR J ENDOCRINOL, V169, P695, DOI 10.1530/EJE-13-0209; Rasmussen MH, 2010, MOL CELL ENDOCRINOL, V316, P147, DOI 10.1016/j.mce.2009.08.017; Reddy GR, 2007, ENDOCRINOLOGY, V148, P2045, DOI 10.1210/en.2006-1285; Serra A, 2008, KIDNEY INT, V73, P947, DOI 10.1038/sj.ki.5002796; Sesti G, 2011, NUTR METAB CARDIOVAS, V21, P933, DOI 10.1016/j.numecd.2010.02.008; Sesti G, 2005, DIABETES CARE, V28, P120, DOI 10.2337/diacare.28.1.120; Tang JH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099186; TATTERSALL RB, 1973, LANCET, V2, P1105; THISSEN JP, 1994, ENDOCR REV, V15, P80, DOI 10.1210/er.15.1.80; Tiryakioglu O, 2003, Indian J Med Sci, V57, P543; Tonshoff B, 1996, PEDIATR NEPHROL, V10, P269; Tonshoff B, 1997, KIDNEY INT, pS106; Vasylyeva TL, 2005, GROWTH HORM IGF RES, V15, P207, DOI 10.1016/j.ghir.2005.02.008; VELDHUIS JD, 1991, J CLIN ENDOCR METAB, V72, P51, DOI 10.1210/jcem-72-1-51	37	8	9	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 3	2016	11	5							e0154451	10.1371/journal.pone.0154451	http://dx.doi.org/10.1371/journal.pone.0154451			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DL5KK	27138941	gold, Green Submitted, Green Published			2022-12-26	WOS:000375675700032
J	Casellini, CM; Parson, HK; Hodges, K; Edwards, JF; Lieb, DC; Wohlgemuth, SD; Vinik, AI				Casellini, Carolina M.; Parson, Henri K.; Hodges, Kim; Edwards, Joshua F.; Lieb, David C.; Wohlgemuth, Stephen D.; Vinik, Aaron I.			Bariatric Surgery Restores Cardiac and Sudomotor Autonomic C-Fiber Dysfunction towards Normal in Obese Subjects with Type 2 Diabetes	PLOS ONE			English	Article							HEART-RATE-VARIABILITY; NERVOUS-SYSTEM ACTIVITY; ELECTROCHEMICAL SKIN-CONDUCTANCE; INTENSIVE MEDICAL THERAPY; DIETARY WEIGHT-LOSS; ALPHA-LIPOIC ACID; Y GASTRIC BYPASS; SLEEVE GASTRECTOMY; INSULIN-RESISTANCE; LIFE-STYLE	Objective The aim was to evaluate the impact of bariatric surgery on cardiac and sudomotor autonomic C-fiber function in obese subjects with and without Type 2 diabetes mellitus (T2DM), using sudorimetry and heart rate variability (HRV) analysis. Method Patients were evaluated at baseline, 4, 12 and 24 weeks after vertical sleeve gastrectomy or Roux-en-Y gastric bypass. All subjects were assessed using Sudoscan (TM) to measure electrochemical skin conductance (ESC) of hands and feet, time and frequency domain analysis of HRV, Neurologic Impairment Scores of lower legs (NIS-LL), quantitative sensory tests (QST) and sural nerve conduction studies. Results Seventy subjects completed up to 24-weeks of follow-up (24 non-T2DM, 29 pre-DM and 17 T2DM). ESC of feet improved significantly towards normal in T2DM subjects (Baseline = 56.71 +/- 3.98 vs 12-weeks = 62.69 +/- 3.71 vs 24-weeks = 70.13 +/- 2.88, p < 0.005). HRV improved significantly in T2DM subjects (Baseline sdNN (sample difference of the beat to beat (NN) variability) = 32.53 +/- 4.28 vs 12-weeks = 44.94 +/- 4.18 vs 24-weeks = 49.71 +/- 5.19, p < 0,001 and baseline rmsSD (root mean square of the difference of successive R-R intervals) = 23.88 +/- 4.67 vs 12-weeks = 38.06 +/- 5.39 vs 24-weeks = 43.0 +/- 6.25, p < 0.0005). Basal heart rate (HR) improved significantly in all groups, as did weight, body mass index (BMI), percent body fat, waist circumference and high-density lipoprotein (HDL). Glycated hemoglobin (HbA1C), insulin and HOMA2-IR (homeostatic model assessment) levels improved significantly in pre-DM and T2DM subjects. On multiple linear regression analysis, feet ESC improvement was independently associated with A1C, insulin and HOMA2-IR levels at baseline, and improvement in A1C at 24 weeks, after adjusting for age, gender and ethnicity. Sudomotor function improvement was not associated with baseline weight, BMI,% body fat or lipid levels. Improvement in basal HR was also independently associated with A1C, insulin and HOMA2-IR levels at baseline. Conclusion This study shows that bariatric surgery can restore both cardiac and sudomotor autonomic C-fiber dysfunction in subjects with diabetes, potentially impacting morbidity and mortality.	[Casellini, Carolina M.; Parson, Henri K.; Hodges, Kim; Edwards, Joshua F.; Lieb, David C.; Vinik, Aaron I.] Eastern Virginia Med Sch, Strelitz Diabet Ctr Endocrine & Metab Disorders, Norfolk, VA 23501 USA; [Casellini, Carolina M.; Parson, Henri K.; Hodges, Kim; Edwards, Joshua F.; Lieb, David C.; Vinik, Aaron I.] Eastern Virginia Med Sch, Neuroendocrine Unit, Dept Med, Norfolk, VA 23501 USA; [Wohlgemuth, Stephen D.] Sentara Med Grp, Sentara Comprehens Weight Loss Solut, Norfolk, VA USA	Eastern Virginia Medical School; Eastern Virginia Medical School; Sentara Healthcare	Casellini, CM (corresponding author), Eastern Virginia Med Sch, Strelitz Diabet Ctr Endocrine & Metab Disorders, Norfolk, VA 23501 USA.; Casellini, CM (corresponding author), Eastern Virginia Med Sch, Neuroendocrine Unit, Dept Med, Norfolk, VA 23501 USA.	casellcm@evms.edu			Impeto Medical	Impeto Medical	This study was performed with a grant from Impeto Medical. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams TD, 2012, JAMA-J AM MED ASSOC, V308, P1122, DOI 10.1001/2012.jama.11164; Amer Diabet Assoc, 2013, DIABETES CARE, V36, pS11, DOI 10.2337/dc13-S011; Bobbioni-Harsch E, 2009, OBESITY, V17, P247, DOI 10.1038/oby.2008.532; Bril V, 1999, EUR NEUROL, V41, P8, DOI 10.1159/000052074; Buchwald H, 2009, AM J MED, V122, P248, DOI 10.1016/j.amjmed.2008.09.041; CALVET JH, 2012, EXP CLIN ENDOCRINOL, V120, P1; Carlsson LMS, 2012, NEW ENGL J MED, V367, P695, DOI 10.1056/NEJMoa1112082; Casellini CM, 2013, DIABETES TECHNOL THE, V15, P948, DOI 10.1089/dia.2013.0129; Courcoulas AP, 2015, JAMA SURG, V150, P931, DOI 10.1001/jamasurg.2015.1534; Courcoulas AP, 2014, JAMA SURG, V149, P1323, DOI 10.1001/jamasurg.2014.2440; Courcoulas AP, 2014, JAMA SURG, V149, P707, DOI 10.1001/jamasurg.2014.467; de Jonge L, 2010, OBESITY, V18, P414, DOI 10.1038/oby.2009.408; Dixon JB, 2012, LANCET, V379, P2300, DOI 10.1016/S0140-6736(12)60401-2; Dyck PJ, 1997, NEUROLOGY, V49, P229, DOI 10.1212/WNL.49.1.229; Freedman BI, 2015, AM J NEPHROL, V41, P438, DOI 10.1159/000437342; Freedman BI, 2014, J DIABETES COMPLICAT, V28, P56, DOI 10.1016/j.jdiacomp.2013.09.006; Gibbons CH, 2009, NEUROLOGY, V72, P1479, DOI 10.1212/WNL.0b013e3181a2e8b8; Gin H, 2011, DIABETES METAB, V37, P527, DOI 10.1016/j.diabet.2011.05.003; Gloy VL, 2013, BMJ-BRIT MED J, V347, DOI 10.1136/bmj.f5934; Golomb I, 2015, JAMA SURG       0805; Ikramuddin S, 2013, JAMA-J AM MED ASSOC, V309, P2240, DOI 10.1001/jama.2013.5835; Ito H, 2001, JPN HEART J, V42, P459, DOI 10.1536/jhj.42.459; Karason K, 1999, AM J CARDIOL, V83, P1242, DOI 10.1016/S0002-9149(99)00066-1; Kassir R, 2015, INT J SURG, V18, P55, DOI 10.1016/j.ijsu.2015.04.033; Kokkinos A, 2013, OBES SURG, V23, P31, DOI 10.1007/s11695-012-0743-8; Lambert E, 2010, HYPERTENSION, V56, P351, DOI 10.1161/HYPERTENSIONAHA.110.155663; Lambert GW, 2010, PHARMACOL THERAPEUT, V126, P159, DOI 10.1016/j.pharmthera.2010.02.002; Lee JA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086515; Levy JC, 1998, DIABETES CARE, V21, P2191, DOI 10.2337/diacare.21.12.2191; Lieb DC, 2012, EXP DIABETES RES, DOI 10.1155/2012/878760; Lips MA, 2013, EUR J ENDOCRINOL, V169, P383, DOI 10.1530/EJE-13-0506; Lonn EM, 2014, CLIN RES CARDIOL, V103, P149, DOI 10.1007/s00392-013-0644-4; Luk AOY, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0134981; Machado MB, 2009, OBES SURG, V19, P332, DOI 10.1007/s11695-008-9665-x; Madsbad S, 2014, LANCET DIABETES ENDO, V2, P152, DOI 10.1016/S2213-8587(13)70218-3; Maser RE, 2007, OBESITY, V15, P364, DOI 10.1038/oby.2007.554; Maser RE, 2013, SURG OBES RELAT DIS, V9, P221, DOI 10.1016/j.soard.2011.11.014; Mayaudon H, 2010, DIABETES METAB, V36, P450, DOI 10.1016/j.diabet.2010.05.004; Mehrabyan AC, 2004, DIABETES, V53, pA510; Mingrone G, 2012, NEW ENGL J MED, V366, P1577, DOI 10.1056/NEJMoa1200111; Nault I, 2007, METABOLISM, V56, P1425, DOI 10.1016/j.metabol.2007.06.006; Perugini RA, 2010, SURG OBES RELAT DIS, V6, P237, DOI 10.1016/j.soard.2009.09.012; Peterli R, 2012, OBES SURG, V22, P740, DOI 10.1007/s11695-012-0622-3; Piestrzeniewicz Katarzyna, 2008, Cardiol J, V15, P43; Quilliot D, 2008, METABOLISM, V57, P555, DOI 10.1016/j.metabol.2007.11.020; Raisanen A, 2014, INT J ENV RES PUB HE, V11, P5839, DOI 10.3390/ijerph110605839; Schauer PR, 2014, NEW ENGL J MED, V370, P2002, DOI [10.1056/NEJMoa1401329, 10.1056/NEJMc1407393]; Schauer PR, 2012, NEW ENGL J MED, V366, P1567, DOI 10.1056/NEJMoa1200225; Selvarajah D, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0138224; Sjoholm K, 2015, DIABETES CARE; Sjostrom L, 2004, NEW ENGL J MED, V351, P2683, DOI 10.1056/NEJMoa035622; Sjostrom L, 2014, JAMA-J AM MED ASSOC, V311, P2297, DOI 10.1001/jama.2014.5988; Sjostrom L, 2012, JAMA-J AM MED ASSOC, V307, P56, DOI 10.1001/jama.2011.1914; Skrapari I, 2006, CURR DIABETES REV, V2, P329, DOI 10.2174/157339906777950589; Smith AG, 2014, J DIABETES COMPLICAT, V28, P511, DOI 10.1016/j.jdiacomp.2014.02.013; Straznicky NE, 2005, J CLIN ENDOCR METAB, V90, P5998, DOI 10.1210/jc.2005-0961; Straznicky NE, 2012, J CLIN ENDOCR METAB, V97, P605, DOI 10.1210/jc.2011-2320; Straznicky NE, 2009, DIABETES, V58, P1126, DOI 10.2337/db08-1595; Vinik A I, 2001, Diabetes Technol Ther, V3, P29, DOI 10.1089/152091501750220000; Vinik AI, 2007, CIRCULATION, V115, P387, DOI 10.1161/CIRCULATIONAHA.106.634949; Vinik AI, 2013, CURR DIABETES REP, V13, P517, DOI 10.1007/s11892-013-0392-x; Wallace TM, 2004, DIABETES CARE, V27, P1487, DOI 10.2337/diacare.27.6.1487; Wu JM, 2015, SURG OBES RELAT DIS, V11, P557, DOI 10.1016/j.soard.2014.09.011; Wulsin LR, 2015, J CLIN ENDOCR METAB, DOI DOI 10.1519/JSC.000000000001202; Ziegler D, 2016, J DIABETES COMPLICAT, V30, P350, DOI 10.1016/j.jdiacomp.2015.10.018; Ziegler D, 2015, DIABETES CARE, V38, P1750, DOI 10.2337/dc15-0466; Ziegler D, 2011, DIABETES CARE, V34, P2054, DOI 10.2337/dc11-0503	67	36	36	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 3	2016	11	5							e0154211	10.1371/journal.pone.0154211	http://dx.doi.org/10.1371/journal.pone.0154211			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DL5KK	27137224	Green Published, gold, Green Submitted			2022-12-26	WOS:000375675700021
J	Salloum-Asfar, S; Arroyo, AB; Teruel-Montoya, R; Garcia-Barbera, N; Roldan, V; Vicente, V; Martinez, C; Gonzalez-Conejero, R				Salloum-Asfar, Salam; Arroyo, Ana B.; Teruel-Montoya, Raul; Garcia-Barbera, Nuria; Roldan, Vanessa; Vicente, Vicente; Martinez, Constantino; Gonzalez-Conejero, Rocio			MiRNA-Based Regulation of Hemostatic Factors through Hepatic Nuclear Factor-4 Alpha	PLOS ONE			English	Article							FACTOR 4-ALPHA; TRANSCRIPTION FACTORS; GENE PROMOTER; BINDING-SITE; EXPRESSION; LIVER; HNF-4-ALPHA; MICRORNAS; HNF-4; SP1	MiRNAs have been reported as CIS-acting elements of several hemostatic factors, however, their mechanism as TRANS-acting elements mediated by a transcription factor is little known and could have important effects. HNF4 alpha has a direct and important role in the regulation of multiple hepatic coagulation genes. Previous in vitro studies have demonstrated that miR-24-3p and miR-34a-5p regulate HNF4A expression. Here we aimed to investigate the molecular mechanisms of miR-24 and miR-34a on coagulation through HNF4A. Transfections with miR-24 and miR-34a in HepG2 cells decreased not only HNF4A but also F10, F12, SERPINC1, PROS1, PROC, and PROZ transcripts levels. Positive and significant correlations were observed between levels of HNF4A and several hemostatic factors (F5, F8, F9, F11, F12, SERPINC1, PROC, and PROS1) in human liver samples (N = 104). However, miR-24 and miR-34a levels of the low (10th) and high (90th) percentiles of those liver samples were inversely correlated with HNF4A and almost all hemostatic factors expression levels. These outcomes suggest that miR-24 and miR-34a might be two indirect elements of regulation of several hemostatic factors. Additionally, variations in miRNA expression profiles could justify, at least in part, changes in HNF4A expression levels and its downstream targets of coagulation.	[Salloum-Asfar, Salam; Arroyo, Ana B.; Teruel-Montoya, Raul; Garcia-Barbera, Nuria; Roldan, Vanessa; Vicente, Vicente; Martinez, Constantino; Gonzalez-Conejero, Rocio] Univ Murcia, IMIB Arrixaca, Ctr Reg Hemodonac, Murcia, Spain	Hospital Clinico Universitario Virgen de la Arrixaca; University of Murcia	Martinez, C; Gonzalez-Conejero, R (corresponding author), Univ Murcia, IMIB Arrixaca, Ctr Reg Hemodonac, Murcia, Spain.	constant@um.es; rocio.gonzalez@carm.es	Teruel-Montoya, Raúl/H-9012-2017; Rodríguez, Ana Belén Arroyo/AAF-4759-2021; Vicente, Vicente/L-6185-2019; Martinez, Constantino/R-8972-2019; Roldan, Vanessa/I-5858-2019; Salloum-Asfar, Salam/AAQ-4772-2021; Gonzalez-Conejero, Rocio/H-9254-2017	Teruel-Montoya, Raúl/0000-0002-6741-9725; Rodríguez, Ana Belén Arroyo/0000-0002-0150-2331; Vicente, Vicente/0000-0002-4278-3264; Roldan, Vanessa/0000-0002-4945-6602; Salloum-Asfar, Salam/0000-0002-8357-2180; Martinez, Constantino/0000-0002-2976-2354; Gonzalez-Conejero, Rocio/0000-0002-4772-9822	Instituto de Salud Carlos III; Fondo Europeo de Desarrollo Regional (FEDER) [PI14/00253]; Instituto de Salud Carlos III, Red RIC [RD12/0042/0050]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM094418] Funding Source: NIH RePORTER	Instituto de Salud Carlos III(Instituto de Salud Carlos IIIEuropean Commission); Fondo Europeo de Desarrollo Regional (FEDER)(European Commission); Instituto de Salud Carlos III, Red RIC; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by Instituto de Salud Carlos III and Fondo Europeo de Desarrollo Regional (FEDER) [PI14/00253]: CM and VR. Instituto de Salud Carlos III, Red RIC (RD12/0042/0050): VV. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Babeu JP, 2014, WORLD J GASTROENTERO, V20, P22, DOI 10.3748/wjg.v20.i1.22; Carew JA, 1998, BLOOD, V92, P1639, DOI 10.1182/blood.V92.5.1639.417k10_1639_1645; Ceelie H, 2003, J THROMB HAEMOST, V1, P1688, DOI 10.1046/j.1538-7836.2003.00393.x; ERDMANN D, 1995, J BIOL CHEM, V270, P22988, DOI 10.1074/jbc.270.39.22988; Farsetti A, 1998, ENDOCRINOLOGY, V139, P4581, DOI 10.1210/en.139.11.4581; FernandezRachubinski FA, 1996, J BIOL CHEM, V271, P29502, DOI 10.1074/jbc.271.46.29502; FIGUEIREDO MS, 1995, J BIOL CHEM, V270, P11828, DOI 10.1074/jbc.270.20.11828; Hall AJ, 2006, BRIT J HAEMATOL, V135, P538, DOI 10.1111/j.1365-2141.2006.06327.x; Hatziapostolou M, 2011, CELL, V147, P1233, DOI 10.1016/j.cell.2011.10.043; Hatzis P, 2002, MOL CELL, V10, P1467, DOI 10.1016/S1097-2765(02)00786-4; Hatzis P, 2001, MOL CELL BIOL, V21, P7320, DOI 10.1128/MCB.21.21.7320-7330.2001; He L, 2004, NAT REV GENET, V5, P522, DOI 10.1038/nrg1379; Hellgren M, 2003, SEMIN THROMB HEMOST, V29, P125, DOI 10.1055/s-2003-38897; Inoue Y, 2006, J MOL MED, V84, P334, DOI 10.1007/s00109-005-0013-5; Lamba V, 2014, BIOCHEM BIOPH RES CO, V445, P404, DOI 10.1016/j.bbrc.2014.02.024; Lamba V, 2010, J PHARMACOL EXP THER, V332, P1088, DOI 10.1124/jpet.109.160804; MARI D, 1995, BLOOD, V85, P3144, DOI 10.1182/blood.V85.11.3144.bloodjournal85113144; MIAO CH, 1992, J BIOL CHEM, V267, P7395; Naka H, 1996, BRIT J HAEMATOL, V92, P231, DOI 10.1046/j.1365-2141.1995.269804.x; REIJNEN MJ, 1992, P NATL ACAD SCI USA, V89, P6300, DOI 10.1073/pnas.89.14.6300; Rosendaal FR, 1999, LANCET, V353, P1167, DOI 10.1016/S0140-6736(98)10266-0; Rosendaal Frits R, 2005, Hematology Am Soc Hematol Educ Program, P1; Safdar H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074637; Safdar H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038104; Salloum-Asfar S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111713; SLADEK FM, 1990, GENE DEV, V4, P2353, DOI 10.1101/gad.4.12b.2353; Sugawara H, 2007, J THROMB HAEMOST, V5, P2250, DOI 10.1111/j.1538-7836.2007.02738.x; Takagi S, 2010, J BIOL CHEM, V285, P4415, DOI 10.1074/jbc.M109.085431; Tarumi T, 2002, J BIOL CHEM, V277, P18510, DOI 10.1074/jbc.M201886200; Teruel-Montoya R, 2014, J THROMB HAEMOST, P1; TREMP GL, 1995, GENE, V156, P199, DOI 10.1016/0378-1119(95)00010-4; Vlieg AV, 2003, J THROMB HAEMOST, V1, P516, DOI 10.1046/j.1538-7836.2003.00080.x; Walesky C, 2015, GENE EXPRESSION, V16, P101, DOI 10.3727/105221615X14181438356292; Wang ZY, 2013, BBA-GENE REGUL MECH, V1829, P436, DOI 10.1016/j.bbagrm.2012.12.009; Wirsing A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027438	35	16	16	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 2	2016	11	5							e0154751	10.1371/journal.pone.0154751	http://dx.doi.org/10.1371/journal.pone.0154751			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DL5KB	27135744	Green Published, gold, Green Submitted			2022-12-26	WOS:000375674800047
J	Fonseca, JA; Cabrera-Mora, M; Kashentseva, EA; Villegas, JP; Fernandez, A; Van Pelt, A; Dmitriev, IP; Curiel, DT; Moreno, A				Fonseca, Jairo Andres; Cabrera-Mora, Monica; Kashentseva, Elena A.; Villegas, John Paul; Fernandez, Alejandra; Van Pelt, Amelia; Dmitriev, Igor P.; Curiel, David T.; Moreno, Alberto			A Plasmodium Promiscuous T Cell Epitope Delivered within the Ad5 Hexon Protein Enhances the Protective Efficacy of a Protein Based Malaria Vaccine	PLOS ONE			English	Article							FALCIPARUM CIRCUMSPOROZOITE PROTEIN; ADENOVIRUS TYPE 5; PHASE 2A TRIAL; IMMUNE-RESPONSES; PREEXISTING IMMUNITY; NEUTRALIZING ANTIBODIES; DENDRITIC CELLS; CAPSID DISPLAY; GENE-TRANSFER; NAIVE ADULTS	A malaria vaccine is a public health priority. In order to produce an effective vaccine, a multi-stage approach targeting both the blood and the liver stage infection is desirable. The vaccine candidates also need to induce balanced immune responses including antibodies, CD4+ and CD8+ T cells. Protein-based subunit vaccines like RTS, S are able to induce strong antibody response but poor cellular reactivity. Adenoviral vectors have been effective inducing protective CD8+ T cell responses in several models including malaria; nonetheless this vaccine platform exhibits a limited induction of humoral immune responses. Two approaches have been used to improve the humoral immunogenicity of recombinant adenovirus vectors, the use of heterologous prime-boost regimens with recombinant proteins or the genetic modification of the hypervariable regions (HVR) of the capsid protein hexon to express B cell epitopes of interest. In this study, we describe the development of capsid modified Ad5 vectors that express a promiscuous Plasmodium yoelii T helper epitope denominated PyT53 within the hexon HVR2 region. Several regimens were tested in mice to determine the relevance of the hexon modification in enhancing protective immune responses induced by the previously described protein-based multi-stage experimental vaccine PyCMP. A heterologous prime-boost immunization regime that combines a hexon modified vector with transgenic expression of PyCMP followed by protein immunizations resulted in the induction of robust antibody and cellular immune responses in comparison to a similar regimen that includes a vector with unmodified hexon. These differences in immunogenicity translated into a better protective efficacy against both the hepatic and red blood cell stages of P. yoelii. To our knowledge, this is the first time that a hexon modification is used to deliver a promiscuous T cell epitope. Our data support the use of such modification to enhance the immunogenicity and protective efficacy of adenoviral based malaria vaccines.	[Fonseca, Jairo Andres; Cabrera-Mora, Monica; Villegas, John Paul; Fernandez, Alejandra; Van Pelt, Amelia; Moreno, Alberto] Emory Univ, Emory Vaccine Ctr, Yerkes Natl Primate Res Ctr, Atlanta, GA 30322 USA; [Fonseca, Jairo Andres; Moreno, Alberto] Emory Univ, Sch Med, Dept Med, Div Infect Dis, Atlanta, GA USA; [Kashentseva, Elena A.; Dmitriev, Igor P.; Curiel, David T.] Washington Univ, Sch Med, Div Canc Biol, Dept Radiat Oncol, St Louis, MO USA; [Fernandez, Alejandra] Inst Tecnol Santo Domingo, Area Ciencias Salud, Santo Domingo, Dominican Rep; [Van Pelt, Amelia] Emory Univ, Rollins Sch Publ Hlth, Atlanta, GA 30322 USA	Emory University; Emory University; Washington University (WUSTL); Instituto Tecnologico de Santo Domingo (INTEC); Emory University; Rollins School Public Health	Moreno, A (corresponding author), Emory Univ, Emory Vaccine Ctr, Yerkes Natl Primate Res Ctr, Atlanta, GA 30322 USA.; Moreno, A (corresponding author), Emory Univ, Sch Med, Dept Med, Div Infect Dis, Atlanta, GA USA.	alberto.moreno@emory.edu	fernandez, Alejandra/GQZ-7186-2022	Van Pelt, Amelia/0000-0002-5671-7479; Moreno, Alberto/0000-0002-3031-7194	National Institute of Allergy and Infectious Diseases [R56-AI103382-01A1, R21-AI094402-01, R21-AI095718-01]; National Center for Research Resources: Yerkes National Primate Research Center Base Grant [RR00165]; NATIONAL CENTER FOR RESEARCH RESOURCES [P51RR000165] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI117459, P30AI050409, R56AI103382, R21AI095718, R21AI094402] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); National Center for Research Resources: Yerkes National Primate Research Center Base Grant; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by the National Institute of Allergy and Infectious Diseases: R56-AI103382-01A1, R21-AI094402-01 and R21-AI095718-01. It was also supported by the National Center for Research Resources: Yerkes National Primate Research Center Base Grant No RR00165. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbink P, 2007, J VIROL, V81, P4654, DOI 10.1128/JVI.02696-06; Abe S, 2009, J GENE MED, V11, P570, DOI 10.1002/jgm.1332; Barbosa A, 2009, INFECT IMMUN, V77, P4502, DOI 10.1128/IAI.00442-09; Barouch DH, 2011, VACCINE, V29, P5203, DOI 10.1016/j.vaccine.2011.05.025; Bart PA, 2014, J CLIN INVEST, V124, P4843, DOI 10.1172/JCI75894; Bejon P, 2005, J INFECT DIS, V191, P619, DOI 10.1086/427243; Bertolino P, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.00041; Bessis N, 2004, GENE THER, V11, pS10, DOI 10.1038/sj.gt.3302364; Bollard CM, 2014, J CLIN ONCOL, V32, P798, DOI 10.1200/JCO.2013.51.5304; Boyle MJ, 2015, IMMUNITY, V42, P580, DOI 10.1016/j.immuni.2015.02.012; Bradley RR, 2012, J VIROL, V86, P1267, DOI 10.1128/JVI.06165-11; Bruder JT, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033920; Butler NS, 2012, NAT IMMUNOL, V13, P188, DOI 10.1038/ni.2180; Cabrera-Mora M, 2015, INFECT IMMUN, V83, P3749, DOI 10.1128/IAI.00480-15; Caro-Aguilar I, 2005, MICROBES INFECT, V7, P1324, DOI 10.1016/j.micinf.2005.04.020; Caro-Aguilar I, 2002, INFECT IMMUN, V70, P3479, DOI 10.1128/IAI.70.7.3479-3492.2002; Chen L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102225; Chirmule N, 1999, GENE THER, V6, P1574, DOI 10.1038/sj.gt.3300994; Chuang I, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055571; Creech CB, 2013, HUM VACC IMMUNOTHER, V9, P2548, DOI 10.4161/hv.26038; de Souza JB, 2014, PARASITE IMMUNOL, V36, P131, DOI 10.1111/pim.12086; Dhiman S, 2014, J INFECT PUBLIC HEAL, V7, P457, DOI 10.1016/j.jiph.2014.06.002; Di Nicola M, 1998, CANCER GENE THER, V5, P350; DiLiberto DD, 2015, GLOBAL HEALTH ACTION, V8, DOI 10.3402/gha.v8.29067; Doll KL, 2014, VACCINE, V32, P483, DOI 10.1016/j.vaccine.2013.11.058; Douglas AD, 2010, VACCINE, V28, P7167, DOI 10.1016/j.vaccine.2010.08.068; Druilhe P, 2005, PLOS MED, V2, P1135, DOI 10.1371/journal.pmed.0020344; Egan A, 1997, INFECT IMMUN, V65, P3024, DOI 10.1128/IAI.65.8.3024-3031.1997; Elias SC, 2014, IMMUNOLOGY, V141, P628, DOI 10.1111/imm.12226; Ersching J, 2010, VIROLOGY, V407, P1, DOI 10.1016/j.virol.2010.07.043; Ewer KJ, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3836; Farrow AL, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003089; Ferreira AR, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105828; FINKELMAN FD, 1990, ANNU REV IMMUNOL, V8, P303, DOI 10.1146/annurev.iy.08.040190.001511; Flatt JW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049607; Gu LL, 2016, VIROLOGY, V487, P75, DOI 10.1016/j.virol.2015.10.010; Gu LL, 2014, VIROL J, V11, DOI 10.1186/1743-422X-11-112; Hangalapura BN, 2011, VACCINE, V29, P2313, DOI 10.1016/j.vaccine.2011.01.022; Hodgson SH, 2015, J INFECT DIS, V211, P1076, DOI 10.1093/infdis/jiu579; Karen KA, 2015, INFECT IMMUN, V83, P268, DOI 10.1128/IAI.02626-14; Kester KE, 2008, VACCINE, V26, P2191, DOI 10.1016/j.vaccine.2008.02.048; Kester KE, 2009, J INFECT DIS, V200, P337, DOI 10.1086/600120; Krasnykh VN, 1996, J VIROL, V70, P6839, DOI 10.1128/JVI.70.10.6839-6846.1996; Krzych U, 2014, IMMUNOL LETT, V161, P189, DOI 10.1016/j.imlet.2014.03.011; Lanzi A, 2011, VACCINE, V29, P1463, DOI 10.1016/j.vaccine.2010.12.025; Lewis MD, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088117; Li J, 2015, CANCER RES, V75, P508, DOI 10.1158/0008-5472.CAN-14-1215; Lundie RJ, 2008, P NATL ACAD SCI USA, V105, P14509, DOI 10.1073/pnas.0806727105; MAIZEL JV, 1968, VIROLOGY, V36, P115, DOI 10.1016/0042-6822(68)90121-9; Matthews QL, 2011, MOL PHARMACEUT, V8, P3, DOI 10.1021/mp100214b; Matthews QL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011815; Matthews QL, 2008, VIROL J, V5, DOI 10.1186/1743-422X-5-98; McCoy K, 2007, J VIROL, V81, P6594, DOI 10.1128/JVI.02497-06; Menard S, 2015, EMERG INFECT DIS, V21, P1733, DOI 10.3201/eid2110.150682; Mittereder N, 1996, J VIROL, V70, P7498, DOI 10.1128/JVI.70.11.7498-7509.1996; Moreno A, 2015, CURR OPIN IMMUNOL, V35, P98, DOI 10.1016/j.coi.2015.06.008; Na-Bangchang K, 2013, EXPERT REV CLIN PHAR, V6, P307, DOI [10.1586/ecp.13.17, 10.1586/ECP.13.17]; Ockenhouse CF, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0131571; Palma C, 2011, VACCINE, V29, P1683, DOI 10.1016/j.vaccine.2010.12.040; Penaloza-MacMaster P, 2013, J VIROL, V87, P1373, DOI 10.1128/JVI.02058-12; Perciani CT, 2007, J CLIN LAB ANAL, V21, P201, DOI 10.1002/jcla.20172; Pereboev AV, 2004, MOL THER, V9, P712, DOI 10.1016/j.ymthe.2004.02.006; Perreau M, 2007, J VIROL, V81, P3272, DOI 10.1128/JVI.01530-06; Porter MD, 2013, CLIN VACCINE IMMUNOL, V20, P803, DOI 10.1128/CVI.00066-13; Price RN, 2014, LANCET INFECT DIS, V14, P982, DOI 10.1016/S1473-3099(14)70855-2; Qiu HL, 2012, J VIROL, V86, P7964, DOI 10.1128/JVI.07076-11; Radosevic K, 2010, CLIN VACCINE IMMUNOL, V17, P1687, DOI 10.1128/CVI.00311-10; Sarwar UN, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106240; Sedegah M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106241; Sheehy SH, 2012, MOL THER, V20, P2355, DOI 10.1038/mt.2012.223; Shiratsuchi T, 2010, J CLIN INVEST, V120, P3688, DOI 10.1172/JCI39812; Singh B, 2012, INFECT IMMUN, V80, P1491, DOI 10.1128/IAI.05980-11; Singh B, 2010, VACCINE, V28, P2580, DOI 10.1016/j.vaccine.2010.01.019; Ferreira ACS, 2011, REV LAT-AM ENFERM, V19, P1281, DOI 10.1590/S0104-11692011000600002; Strode C, 2014, PLOS MED, V11, DOI 10.1371/journal.pmed.1001619; Tamminga C, 2013, HUM VACC IMMUNOTHER, V9, P2165, DOI 10.4161/hv.24941; Tamminga C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025868; Tatsis N, 2007, BLOOD, V110, P1916, DOI 10.1182/blood-2007-02-062117; Teigler JE, 2014, CLIN VACCINE IMMUNOL, V21, P1137, DOI 10.1128/CVI.00207-14; Teigler JE, 2012, J VIROL, V86, P9590, DOI 10.1128/JVI.00740-12; Tinto H, 2015, LANCET, V386, P31, DOI 10.1016/S0140-6736(15)60721-8; VANOOSTRUM J, 1985, J VIROL, V56, P439, DOI 10.1128/JVI.56.2.439-448.1985; Wei F, 2013, P NATL ACAD SCI USA, V110, pE2480, DOI 10.1073/pnas.1305394110; White MT, 2015, LANCET INFECT DIS, V15, P1450, DOI 10.1016/S1473-3099(15)00239-X; White MT, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061395; WHO, 2013, WORLD MALARIA REPORT 2013, P1; Worgall S, 2005, J CLIN INVEST, V115, P1281, DOI 10.1172/JCI200523135; WorldWide Antimalarial Resistance, 2015, BMC MED, V13, DOI 10.1186/s12916-015-0456-7; Wu HJ, 2005, J VIROL, V79, P3382, DOI 10.1128/JVI.79.6.3382-3390.2005; Wu WH, 2015, VIROL J, V12, DOI 10.1186/s12985-015-0364-7; Zhu FC, 2015, LANCET, V385, P2272, DOI 10.1016/S0140-6736(15)60553-0; Zinselmeyer BH, 2013, J EXP MED, V210, P757, DOI 10.1084/jem.20121416	92	10	10	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 29	2016	11	4							e0154819	10.1371/journal.pone.0154819	http://dx.doi.org/10.1371/journal.pone.0154819			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DK8XM	27128437	Green Submitted, Green Published, gold			2022-12-26	WOS:000375212600071
J	Lin, YP; Hsu, HH; Ko, KH; Chu, CM; Chou, YC; Chang, WC; Chang, TH				Lin, Yu-Pang; Hsu, Hsian-He; Ko, Kai-Hsiung; Chu, Chi-Ming; Chou, Yu-Ching; Chang, Wei-Chou; Chang, Tsun-Hou			Differentiation of Malignant and Benign Incidental Breast Lesions Detected by Chest Multidetector-Row Computed Tomography: Added Value of Quantitative Enhancement Analysis	PLOS ONE			English	Article							INITIAL CLINICAL-EXPERIENCE; CT; MAMMOGRAPHY; CANCER; TUMORS	To retrospectively determine the association between breast lesion morphology and malignancy and to determine the optimal value of lesion enhancement (HU, Hounsfield units) to improve the diagnostic accuracy of breast cancer in patients with incidental breast lesions (IBLs). A total of 97 patients with 102 IBLs detected from July 2009 to December 2012 were enrolled in this study. Two radiologists analyzed CT images for the presence of malignancy based on the morphology of the lesions alone and in combination with an enhancement value (HU) analysis. There were 36 malignant and 66 benign IBLs. When the morphology and enhancement values were combined, the sensitivity, specificity, and accuracy were 92%, 97%, and 95%, respectively, for reader 1 and 89%, 94%, and 92%, respectively, for reader 2. The addition of HU values led to correct changes in the diagnosis; specifically, the accuracy of the diagnosis of reader 1 and reader 2 improved by 6.9% and 11.8%, respectively. The addition of the enhancement value (HU) to the CT morphology improved the diagnostic accuracy in the differentiation of malignant from benign IBLs by using the region of interest (ROI) to measure the HU within the most suspicious part of the lesion.	[Lin, Yu-Pang; Hsu, Hsian-He; Ko, Kai-Hsiung; Chang, Wei-Chou; Chang, Tsun-Hou] Natl Def Med Ctr, Dept Radiol, Taipei, Taiwan; [Lin, Yu-Pang; Hsu, Hsian-He; Ko, Kai-Hsiung; Chang, Wei-Chou; Chang, Tsun-Hou] Triserv Gen Hosp, Dept Radiol, Taipei, Taiwan; [Chu, Chi-Ming; Chou, Yu-Ching] Natl Def Med Ctr, Sch Publ Hlth, Taipei, Taiwan	National Defense Medical Center; Tri-Service General Hospital; National Defense Medical Center	Hsu, HH (corresponding author), Natl Def Med Ctr, Dept Radiol, Taipei, Taiwan.; Hsu, HH (corresponding author), Triserv Gen Hosp, Dept Radiol, Taipei, Taiwan.	hsianhe@yahoo.com.tw		Chu, Cordia/0000-0002-3683-5638	Tri-Service General Hospital [TSGH-C105-044]; Tri-Service General Hospital (TSGHIRB) [1-103-05-036]; Ministry of Science and Technology, R. O. C. [MOST 104-2314-B-016-025]	Tri-Service General Hospital; Tri-Service General Hospital (TSGHIRB); Ministry of Science and Technology, R. O. C.	HHH received the funding partly from Tri-Service General Hospital (TSGH-C105-044 and TSGHIRB No. 1-103-05-036) and Ministry of Science and Technology, R. O. C. (MOST 104-2314-B-016-025). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baltzer PAT, 2010, AM J ROENTGENOL, V194, P1658, DOI 10.2214/AJR.09.3486; Boone JM, 2006, J MAMMARY GLAND BIOL, V11, P103, DOI 10.1007/s10911-006-9017-1; CHANG CHJ, 1980, CANCER, V46, P939, DOI 10.1002/1097-0142(19800815)46:4+<939::AID-CNCR2820461315>3.0.CO;2-L; HANLEY JA, 1982, RADIOLOGY, V143, P29, DOI 10.1148/radiology.143.1.7063747; Harish MG, 2007, RADIOGRAPHICS, V27, pS37, DOI 10.1148/rg.27si075510; Hussain A, 2010, ANN ROY COLL SURG, V92, P124, DOI 10.1308/003588410X12518836439083; Inoue M, 2003, AM J ROENTGENOL, V181, P679, DOI 10.2214/ajr.181.3.1810679; LANDIS JR, 1977, BIOMETRICS, V33, P363, DOI 10.2307/2529786; Lin WC, 2011, KOREAN J RADIOL, V12, P44, DOI 10.3348/kjr.2011.12.1.44; Lindfors KK, 2008, RADIOLOGY, V246, P725, DOI 10.1148/radiol.2463070410; Miyake K, 2005, J COMPUT ASSIST TOMO, V29, P772, DOI 10.1097/01.rct.0000178712.32547.53; Morris E.A., 2013, ACR BI RADS ATLAS BR; Moyle P, 2010, BRIT J RADIOL, V83, P233, DOI 10.1259/bjr/58729988; Nishino M, 2003, J COMPUT ASSIST TOMO, V27, P771, DOI 10.1097/00004728-200309000-00015; Perrone A, 2008, AM J ROENTGENOL, V190, P1644, DOI 10.2214/AJR.07.3145; Porter G, 2009, CLIN RADIOL, V64, P529, DOI 10.1016/j.crad.2009.01.005; Prionas ND, 2010, RADIOLOGY, V256, P714, DOI 10.1148/radiol.10092311; Shojaku H, 2008, RADIAT MED, V26, P362, DOI 10.1007/s11604-008-0241-z; Uematsu T, 2008, BREAST CANCER RES TR, V112, P461, DOI 10.1007/s10549-008-9890-y; Yi JG, 2008, J THORAC IMAG, V23, P148, DOI 10.1097/RTI.0b013e318156eb52	20	10	10	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 29	2016	11	4							e0154569	10.1371/journal.pone.0154569	http://dx.doi.org/10.1371/journal.pone.0154569			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DK8XM	27128524	Green Published, gold			2022-12-26	WOS:000375212600041
J	Oelmann, S; Nauck, M; Volzke, H; Bahls, M; Friedrich, N				Oelmann, Simon; Nauck, Matthias; Voelzke, Henry; Bahls, Martin; Friedrich, Nele			Circulating Irisin Concentrations Are Associated with a Favourable Lipid Profile in the General Population	PLOS ONE			English	Article							BODY-COMPOSITION; SERUM IRISIN; OBESE; FAT; MYOKINE; HUMANS; ADULTS; HEALTH; FNDC5	Background/aims Irisin is a myokine, which is mainly inversely associated with the risk for non-communicable diseases. Irisin improves cellular energy metabolism by uncoupling the mitochondrial respiratory chain resulting in increased energy expenditure using lipids. To date potential associations between irisin concentration and lipid profile are poorly understood. Therefore, this investigation aimed to evaluate potential associations between irisin and lipid levels in the general population. Methods Data of 430 men and 537 women from the population-based Study of Health in Pomerania (SHIP-TREND) with available irisin and lipid concentrations were used. Analyses of variance, linear and logistic regression models adjusted for age, HBA1c, waist circumference, physical activity, smoking, alcohol consumption, systolic blood pressure, ALAT were calculated. Results We detected significantly inverse associations between irisin and circulating levels of total [beta coefficient 0.21 (standard error 0.08), p = 0.01], low-density cholesterol [-0.16 (0.07), p = 0.03] and triglycerides [-0.17 (0.08), p = 0.02] for men. Females without lipid lowering medication had an inverse association between irisin and total cholesterol [-0.12 (0.06), p = 0.05]. Further, male subjects with irisin concentrations in the third tertile had an increased odds for elevated low-density cholesterol [odds ratio 1.96 (95% confidence interval 1.07-3.48), p = 0.03) and triglyceride [1.95 (1.09-3.47), p = 0.02] levels, even after exclusion of subjects with lipid lowering medication. In addition, our data revealed an annual rhythm of serum irisin levels with peak levels arise in winter and summer months. Conclusion This is the first investigation to report a significant association between circulating irisin and a favourable lipid profile in the general population. This may infer that higher irisin concentrations are associated with a reduced risk for non-communicable diseases.	[Oelmann, Simon; Nauck, Matthias; Friedrich, Nele] Univ Med Greifswald, Inst Clin Chem & Lab Med, Greifswald, Germany; [Voelzke, Henry] Univ Med Greifswald, Inst Community Med, Greifswald, Germany; [Bahls, Martin] Univ Med Greifswald, Dept Cardiol, Greifswald, Germany; [Nauck, Matthias; Voelzke, Henry; Bahls, Martin; Friedrich, Nele] German Ctr Cardiovasc Res DZHK, Partner Site Greifswald, Greifswald, Germany	Greifswald Medical School; Greifswald Medical School; Greifswald Medical School; German Centre for Cardiovascular Research	Friedrich, N (corresponding author), Univ Med Greifswald, Inst Clin Chem & Lab Med, Greifswald, Germany.; Friedrich, N (corresponding author), German Ctr Cardiovasc Res DZHK, Partner Site Greifswald, Greifswald, Germany.	nele.friedrich@uni-greifswald.de	Bahls, Martin/Q-6639-2018	Bahls, Martin/0000-0002-2016-5852	German Federal Ministry of Education and Research (BMBF) [01ZZ0403, 01ZZ0103, 01GI0883]; Ministry for Education, Research and Cultural Affairs; Ministry of Social Affairs of the Federal State of Mecklenburg-West Pomerania; Federal Ministry of Education and Research; Ministry of Cultural Affairs of the Federal State of Mecklenburg - West Pomerania [03IS2061A]	German Federal Ministry of Education and Research (BMBF)(Federal Ministry of Education & Research (BMBF)); Ministry for Education, Research and Cultural Affairs; Ministry of Social Affairs of the Federal State of Mecklenburg-West Pomerania; Federal Ministry of Education and Research(Federal Ministry of Education & Research (BMBF)); Ministry of Cultural Affairs of the Federal State of Mecklenburg - West Pomerania	This work was funded by grants from the German Federal Ministry of Education and Research (BMBF, Grants 01ZZ0403, 01ZZ0103, 01GI0883), the Ministry for Education, Research and Cultural Affairs, as well as the Ministry of Social Affairs of the Federal State of Mecklenburg-West Pomerania. This work is also part of the research project Greifswald Approach to Individualized Medicine (GANI_MED). The GANI_MED consortium is funded by the Federal Ministry of Education and Research and the Ministry of Cultural Affairs of the Federal State of Mecklenburg - West Pomerania (03IS2061A).	Albrecht E, 2015, SCI REP-UK, V5, DOI 10.1038/srep08889; Anderson TJ, 2015, CAN J CARDIOL, V31, P605, DOI 10.1016/j.cjca.2014.11.007; Aydin S, 2014, PEPTIDES, V61, P130, DOI 10.1016/j.peptides.2014.09.014; Aydin S, 2013, PEPTIDES, V50, P13, DOI 10.1016/j.peptides.2013.09.011; Bostrom P, 2012, NATURE, V481, P463, DOI 10.1038/nature10777; Choi ES, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110680; Consultation W, 1999, DEF DIAGN CLASS DIAB; Ebert T, 2014, EUR J ENDOCRINOL, V170, P501, DOI 10.1530/EJE-13-1053; Gouni-Berthold I, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072858; Grundy SM, 2002, CIRCULATION, V106, P3143, DOI 10.1161/circ.106.25.3143; Hecksteden A, 2013, BMC MED, V11, DOI 10.1186/1741-7015-11-235; Hofmann T, 2014, PEPTIDES, V54, P89, DOI 10.1016/j.peptides.2014.01.016; Huh JY, 2012, METABOLISM, V61, P1725, DOI 10.1016/j.metabol.2012.09.002; Jameel F., 2015, J NUTR INTERMEDIARY, V2, P86, DOI [10.1016/j.jnim.2015.10.001, DOI 10.1016/j.jnim.2015.10.001, DOI 10.1016/J.JNIM.2015.10.001]; Jedrychowski MP, 2015, CELL METAB, V22, P734, DOI 10.1016/j.cmet.2015.08.001; Kerstholt N, 2015, BMC PULM MED, V15, DOI 10.1186/s12890-015-0035-x; Lee P, 2014, CELL METAB, V19, P302, DOI 10.1016/j.cmet.2013.12.017; Liu JJ, 2014, J DIABETES COMPLICAT, V28, P208, DOI 10.1016/j.jdiacomp.2013.09.011; Liu JJ, 2013, J DIABETES COMPLICAT, V27, P365, DOI 10.1016/j.jdiacomp.2013.03.002; Panagiotou G, 2014, METABOLISM, V63, P1265, DOI 10.1016/j.metabol.2014.06.001; Park KH, 2013, J CLIN ENDOCR METAB, V98, P4899, DOI 10.1210/jc.2013-2373; Polyzos SA, 2015, METABOLISM, V64, P937, DOI 10.1016/j.metabol.2015.06.005; Sanchis-Gomar F, 2014, ENDOCRINE, V46, P674, DOI 10.1007/s12020-014-0170-9; Scalzo RL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090696; Spiegelman BM, 2013, DIABETES, V62, P1774, DOI 10.2337/db12-1665; STONE CJ, 1985, ADDITIVE SPLINES STA, P45; Tanisawa K, 2014, METABOLISM, V63, P574, DOI 10.1016/j.metabol.2014.01.005; Volzke H, 2011, INT J EPIDEMIOL, V40, P294, DOI 10.1093/ije/dyp394; Wen MS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064025; Yan B, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094235; Yang SY, 2015, BMC NEPHROL, V16, DOI 10.1186/s12882-015-0009-5; Zhang C, 2016, J DIABETES, V8, P56, DOI 10.1111/1753-0407.12256; Zhang HJ, 2013, J HEPATOL, V59, P557, DOI 10.1016/j.jhep.2013.04.030	33	46	47	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 29	2016	11	4							e0154319	10.1371/journal.pone.0154319	http://dx.doi.org/10.1371/journal.pone.0154319			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DK8XM	27128661	Green Submitted, gold, Green Published			2022-12-26	WOS:000375212600026
J	[Anonymous]				[Anonymous]			Revealing the Impact of Oxygen on Molecular Biology: The Work of Howard Mason	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Editorial Material																			0	1	1	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 29	2016	291	18					9851	+		10.1074/jbc.O116.000002	http://dx.doi.org/10.1074/jbc.O116.000002			2	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DL4JY	27129197	hybrid, Green Published			2022-12-26	WOS:000375602300041
J	MacParland, SA; Fadel, SM; Mihajlovic, V; Fawaz, A; Kim, C; Rahman, AKMNU; Liu, J; Kaul, R; Kovacs, C; Grebely, J; Dore, GJ; Wong, DK; Ostrowski, MA				MacParland, Sonya A.; Fadel, Saleh M.; Mihajlovic, Vesna; Fawaz, Ali; Kim, Connie; Rahman, A. K. M. Nur-ur; Liu, Jun; Kaul, Rupert; Kovacs, Colin; Grebely, Jason; Dore, Gregory J.; Wong, David K.; Ostrowski, Mario A.			HCV Specific IL-21 Producing T Cells but Not IL-17A Producing T Cells Are Associated with HCV Viral Control in HIV/HCV Coinfection	PLOS ONE			English	Article							CHRONIC HEPATITIS-C; INFECTED PATIENTS; HIV-INFECTION; TH17 CELLS; HCV/HIV COINFECTION; VIRUS-INFECTION; TGF-BETA; RESPONSES; LIVER; EXPRESSION	Background Decreased hepatitis C virus (HCV) clearance, faster cirrhosis progression and higher HCV RNA levels are associated with Human Immunodeficiency virus (HIV) coinfection. The CD4(+) T helper cytokines interleukin (IL)-21 and IL-17A are associated with virus control and inflammation, respectively, both important in HCV and HIV disease progression. Here, we examined how antigen-specific production of these cytokines during HCV mono and HIV/HCV coinfection was associated with HCV virus control. Methods We measured HCV-specific IL-21 and IL-17A production by transwell cytokine secretion assay in PBMCs from monoinfected and coinfected individuals. Viral control was determined by plasma HCV RNA levels. Results In acutely infected individuals, those able to establish transient/complete HCV viral control tended to have stronger HCV-specific IL-21-production than non-controllers. HCV-specific IL-21 production also correlated with HCV viral decline in acute infection. Significantly stronger HCV-specific IL-21 production was detected in HAART-treated coinfected individuals. HCV-specific IL-17A production was not associated with lower plasma HCV RNA levels in acute or chronic HCV infection and responses were stronger in HIV coinfection. HCV-specific IL-21/IL-17A responses did not correlate with microbial translocation or fibrosis. Exogenous IL-21 treatment of HCV-specific CD8(+) T cells from monoinfected individuals enhanced their function although CD8(+) T cells from coinfected individuals were somewhat refractory to the effects of IL-21. Conclusions These data show that HCV-specific IL-21 and IL-17A-producing T cells are induced in HIV/HCV coinfection. In early HIV/HCV coinfection, IL-21 may contribute to viral control, and may represent a novel tool to enhance acute HCV clearance in HIV/HCV coinfected individuals.	[MacParland, Sonya A.; Fadel, Saleh M.; Mihajlovic, Vesna; Fawaz, Ali; Kim, Connie; Rahman, A. K. M. Nur-ur; Liu, Jun; Kaul, Rupert; Ostrowski, Mario A.] Univ Toronto, Dept Immunol, Toronto, ON, Canada; [MacParland, Sonya A.; Fadel, Saleh M.; Mihajlovic, Vesna; Fawaz, Ali; Kim, Connie; Rahman, A. K. M. Nur-ur; Liu, Jun; Kaul, Rupert; Ostrowski, Mario A.] Univ Toronto, Dept Med, Toronto, ON, Canada; [Kim, Connie; Kaul, Rupert; Wong, David K.] Toronto Gen Hosp, Toronto, ON, Canada; [Kovacs, Colin] Maple Leaf Clin, Toronto, ON, Canada; [Grebely, Jason; Dore, Gregory J.] UNSW Australia, Kirby Inst, Sydney, NSW, Australia; [Ostrowski, Mario A.] St Michaels Hosp, Keenan Res Ctr Biomed Sci, 30 Bond St, Toronto, ON M5B 1W8, Canada	University of Toronto; University of Toronto; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Toronto General Hospital; University of New South Wales Sydney; Kirby Institute; University of Toronto; University Toronto Affiliates; Saint Michaels Hospital Toronto	MacParland, SA (corresponding author), Univ Toronto, Dept Immunol, Toronto, ON, Canada.; MacParland, SA (corresponding author), Univ Toronto, Dept Med, Toronto, ON, Canada.	Sonya.macparland@gmail.com	Dore, Gregory John/ABD-5665-2021	Dore, Gregory John/0000-0002-4741-2622; Kaul, Rupert/0000-0002-1586-4093; Wong, David/0000-0002-3310-3538; MacParland, Sonya/0000-0002-8036-1425	CASL/CIHR Hepatology Fellowship Program; National CIHR Research Training Program in Hepatitis C; Canfar [021-012]	CASL/CIHR Hepatology Fellowship Program; National CIHR Research Training Program in Hepatitis C(Canadian Institutes of Health Research (CIHR)); Canfar	Research conducted by the authors is supported by Canfar grant #021-012 to M.A.O. S.A. M. thanks the CASL/CIHR Hepatology Fellowship Program and the National CIHR Research Training Program in Hepatitis C for financial support. S.M.F. and A.F. thank the National CIHR Research Training Program in Hepatitis C for financial support. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; HIV/HCV research conducted by the authors is supported by Canfar grant #021-012. S.A.M. thanks the CASL/CIHR Hepatology Fellowship Program and the National CIHR Research Training Program in Hepatitis C for financial support. S.M.F. and A.F. thank the National CIHR Research Training Program in Hepatitis C for financial support.	Alvarez Y, 2013, J VIROL, V87, P10843, DOI 10.1128/JVI.01838-13; Balagopal A, 2008, GASTROENTEROLOGY, V135, P226, DOI 10.1053/j.gastro.2008.03.022; Bani-Sadr F, 2007, AIDS, V21, P1645, DOI 10.1097/QAD.0b013e32826fb710; Brenchley JM, 2008, BLOOD, V112, P2826, DOI 10.1182/blood-2008-05-159301; Chevalier MF, 2011, J VIROL, V85, P733, DOI 10.1128/JVI.02030-10; Elsaesser H, 2009, SCIENCE, V324, P1569, DOI 10.1126/science.1174182; Fabre T, 2014, J IMMUNOL, V193, P3925, DOI 10.4049/jimmunol.1400861; Feng GH, 2013, MOL CELLS, V36, P362, DOI 10.1007/s10059-013-0181-z; Foster RG, 2012, DIGEST DIS SCI, V57, P381, DOI 10.1007/s10620-011-1997-z; Ghany MG, 2009, HEPATOLOGY, V49, P1335, DOI 10.1002/hep.22759; Grafmueller S, 2012, J INFECT DIS, V205, P1142, DOI 10.1093/infdis/jis018; Grakoui A, 2003, SCIENCE, V302, P659, DOI 10.1126/science.1088774; Hajarizadeh B, 2015, J VIRAL HEPATITIS, V22, P708, DOI 10.1111/jvh.12384; Harrington LE, 2005, NAT IMMUNOL, V6, P1123, DOI 10.1038/ni1254; Iannello A, 2008, VIRAL IMMUNOL, V21, P385, DOI 10.1089/vim.2008.0025; Kared H, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101441; Kared H, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003422; Korn T, 2007, NATURE, V448, P484, DOI 10.1038/nature05970; Korn T, 2009, ANNU REV IMMUNOL, V27, P485, DOI 10.1146/annurev.immunol.021908.132710; Li J, 2015, J INTERF CYTOK RES, V35, P134, DOI 10.1089/jir.2013.0119; Lin WY, 2011, J BIOL CHEM, V286, P2665, DOI 10.1074/jbc.M110.168286; Lo Re V, 2014, ANN INTERN MED, V160, P369, DOI 10.7326/M13-1829; MacParland SA, 2011, FUTURE VIROL, V6, P1115, DOI 10.2217/FVL.11.80; Martin-Carbonero L, 2004, CLIN INFECT DIS, V38, P128, DOI 10.1086/380130; Rockstroh JK, 2013, BMC MED, V11, DOI 10.1186/1741-7015-11-234; Rowan AG, 2008, J IMMUNOL, V181, P4485, DOI 10.4049/jimmunol.181.7.4485; Shoukry NH, 2003, J EXP MED, V197, P1645, DOI 10.1084/jem.20030239; Soriano V, 2008, J INFECT DIS, V198, P1337, DOI 10.1086/592171; Spaan M, 2015, J HEPATOL, V62, P303, DOI 10.1016/j.jhep.2014.09.024; Thein HH, 2008, AIDS, V22, P1979, DOI 10.1097/QAD.0b013e32830e6d51; Trimoulet P, 2002, J MED VIROL, V67, P143, DOI 10.1002/jmv.2203; Vali B, 2010, EUR J IMMUNOL, V40, P2493, DOI 10.1002/eji.201040340; Vali B, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003454; Yue FY, 2008, J VIROL, V82, P6767, DOI 10.1128/JVI.02550-07; Yue FY, 2010, J IMMUNOL, V185, P498, DOI 10.4049/jimmunol.0903915	35	7	7	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 28	2016	11	4							e0154433	10.1371/journal.pone.0154433	http://dx.doi.org/10.1371/journal.pone.0154433			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DK8XE	27124305	Green Published, gold, Green Submitted			2022-12-26	WOS:000375211700087
J	Sawicka, M; Wanrooij, PH; Darbari, VC; Tannous, E; Hailemariam, S; Bose, D; Makarova, AV; Burgers, PM; Zhang, XD				Sawicka, Marta; Wanrooij, Paulina H.; Darbari, Vidya C.; Tannous, Elias; Hailemariam, Sarem; Bose, Daniel; Makarova, Alena V.; Burgers, Peter M.; Zhang, Xiaodong			The Dimeric Architecture of Checkpoint Kinases Mec1(ATR) and Tel1(ATM) Reveal a Common Structural Organization	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						checkpoint control; DNA damage response; nucleic acid enzymology; phosphatidylinositol kinase (PI Kinase); protein structure; serine; threonine protein kinase	CRYO-EM STRUCTURE; DNA-DAMAGE CHECKPOINT; REPLICATION PROTEIN-A; DOUBLE-STRAND BREAKS; SACCHAROMYCES-CEREVISIAE; ELECTRON-MICROSCOPY; CATALYTIC SUBUNIT; MEC1 KINASE; ATM KINASE; 3-DIMENSIONAL STRUCTURE	The phosphatidylinositol 3-kinase-related protein kinases are key regulators controlling a wide range of cellular events. The yeast Tel1 and Mec1Ddc2 complex (ATM and ATR-ATRIP in humans) play pivotal roles in DNA replication, DNA damage signaling, and repair. Here, we present the first structural insight for dimers of Mec1Ddc2 and Tel1 using single-particle electron microscopy. Both kinases reveal a head to head dimer with one major dimeric interface through the N-terminal HEAT (named after Huntingtin, elongation factor 3, protein phosphatase 2A, and yeast kinase TOR1) repeat. Their dimeric interface is significantly distinct from the interface of mTOR complex 1 dimer, which oligomerizes through two spatially separate interfaces. We also observe different structural organizations of kinase domains of Mec1 and Tel1. The kinase domains in the Mec1Ddc2 dimer are located in close proximity to each other. However, in the Tel1 dimer they are fully separated, providing potential access of substrates to this kinase, even in its dimeric form.	[Sawicka, Marta; Darbari, Vidya C.; Bose, Daniel; Zhang, Xiaodong] Imperial Coll London, Sect Struct Biol, Dept Med, London SW7 2AZ, England; [Wanrooij, Paulina H.; Tannous, Elias; Hailemariam, Sarem; Makarova, Alena V.; Burgers, Peter M.] Washington Univ, Sch Med, Dept Biochem & Mol Biophys, St Louis, MO 63110 USA; [Wanrooij, Paulina H.] Umea Univ, Dept Med Biochem & Biophys, SE-90187 Umea, Sweden; [Bose, Daniel] Univ Penn, Perelman Sch Med, Philadelphia, PA 19104 USA	Imperial College London; Washington University (WUSTL); Umea University; University of Pennsylvania; Pennsylvania Medicine	Zhang, XD (corresponding author), Imperial Coll London, Sect Struct Biol, Dept Med, London SW7 2AZ, England.; Burgers, PM (corresponding author), Washington Univ, Sch Med, Dept Biochem & Mol Biophys, St Louis, MO 63110 USA.	burgers@biochem.wustl.edu; xiaodong.zhang@imperial.ac.uk	Makarova, Alena Vladimirovna/I-1338-2014; Wanrooij, Paulina/R-1509-2019; Burgers, Peter M/AAW-6621-2021; Bose, Daniel/AAI-2775-2020	Wanrooij, Paulina/0000-0002-8607-7564; Bose, Daniel/0000-0002-0276-6486; Darbari, Vidya/0000-0002-3387-5108; Sawicka, Marta/0000-0003-4589-4290; Tannous, Elias/0000-0001-8073-1599	Wellcome Trust [WT/098412/Z/12/Z]; National Institutes of Health [GM083970]; Biotechnology and Biological Sciences Research Council; Emil Aaltonen Foundation; Swedish Cultural Foundation in Finland; BBSRC [BB/H012249/1] Funding Source: UKRI; MRC [MR/J001201/1, MR/N006828/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [1235357, BB/H012249/1] Funding Source: researchfish; Medical Research Council [MR/N006828/1, MR/J001201/1] Funding Source: researchfish; Wellcome Trust [098412/Z/12/Z] Funding Source: researchfish; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM083970, R35GM118129] Funding Source: NIH RePORTER	Wellcome Trust(Wellcome TrustEuropean Commission); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Emil Aaltonen Foundation; Swedish Cultural Foundation in Finland; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); Wellcome Trust(Wellcome TrustEuropean Commission); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by Wellcome Trust Senior Investigator Award WT/098412/Z/12/Z (to X. Z.) and National Institutes of Health Grant GM083970 (to P. M. B.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.; Supported by a Biotechnology and Biological Sciences Research Council doctoral studentship.; Supported by the Emil Aaltonen Foundation and the Swedish Cultural Foundation in Finland. Present address: Dept. of Medical Biochemistry and Biophysics, Umea University, SE-901 87 Umea, Sweden.	Abraham RT, 2004, DNA REPAIR, V3, P883, DOI 10.1016/j.dnarep.2004.04.002; Arias-Palomo E, 2011, GENE DEV, V25, P153, DOI 10.1101/gad.606911; Aylett CHS, 2016, SCIENCE, V351, P48, DOI 10.1126/science.aaa3870; Bakkenist CJ, 2003, NATURE, V421, P499, DOI 10.1038/nature01368; Ball HL, 2007, MOL CELL BIOL, V27, P3367, DOI 10.1128/MCB.02238-06; Ball HL, 2005, MOL BIOL CELL, V16, P2372, DOI 10.1091/mbc.e04-11-1006; Ball HL, 2005, J BIOL CHEM, V280, P31390, DOI 10.1074/jbc.M504961200; Boskovic J, 2003, EMBO J, V22, P5875, DOI 10.1093/emboj/cdg555; Brush GS, 1996, P NATL ACAD SCI USA, V93, P15075, DOI 10.1073/pnas.93.26.15075; Chan DW, 2002, GENE DEV, V16, P2333, DOI 10.1101/gad.1015202; Deniaud A, 2015, NUCLEIC ACIDS RES, V43, P7600, DOI 10.1093/nar/gkv668; Flott S, 2011, EMBO REP, V12, P833, DOI 10.1038/embor.2011.127; Gaubitz C, 2015, MOL CELL, V58, P977, DOI 10.1016/j.molcel.2015.04.031; Guo Z, 2010, SCIENCE, V330, P517, DOI 10.1126/science.1192912; Itakura E, 2005, MOL BIOL CELL, V16, P5551, DOI 10.1091/mbc.E05-05-0427; Kumar S, 2013, GENE DEV, V27, P313, DOI 10.1101/gad.204750.112; Lau WCY, 2016, CELL CYCLE, V15, P1117, DOI 10.1080/15384101.2016.1158362; Lee JH, 2004, SCIENCE, V304, P93, DOI 10.1126/science.1091496; Lempiainen H, 2009, EMBO J, V28, P3067, DOI 10.1038/emboj.2009.281; Liu SZ, 2011, MOL CELL, V43, P192, DOI 10.1016/j.molcel.2011.06.019; Llorca O, 2003, ONCOGENE, V22, P3867, DOI 10.1038/sj.onc.1206649; Ludtke SJ, 1999, J STRUCT BIOL, V128, P82, DOI 10.1006/jsbi.1999.4174; Lydall D, 1996, NATURE, V383, P840, DOI 10.1038/383840a0; Majka J, 2006, MOL CELL, V24, P891, DOI 10.1016/j.molcel.2006.11.027; Melero R, 2014, STRUCTURE, V22, P1105, DOI 10.1016/j.str.2014.05.015; Mills KD, 1999, CELL, V97, P609, DOI 10.1016/S0092-8674(00)80772-2; Mindell JA, 2003, J STRUCT BIOL, V142, P334, DOI 10.1016/S1047-8477(03)00069-8; Mordes DA, 2008, GENE DEV, V22, P1478, DOI 10.1101/gad.1666208; Mordes DA, 2008, P NATL ACAD SCI USA, V105, P18730, DOI 10.1073/pnas.0806621105; MORROW DM, 1995, CELL, V82, P831, DOI 10.1016/0092-8674(95)90480-8; Moser BA, 2011, NAT STRUCT MOL BIOL, V18, P1408, DOI 10.1038/nsmb.2187; Nakada D, 2005, MOL BIOL CELL, V16, P5227, DOI 10.1091/mbc.E05-05-0405; Navadgi-Patil VM, 2011, J BIOL CHEM, V286, P40999, DOI 10.1074/jbc.M111.283994; Navadgi-Patil VM, 2009, DNA REPAIR, V8, P996, DOI 10.1016/j.dnarep.2009.03.011; Navadgi-Patil VM, 2008, J BIOL CHEM, V283, P35853, DOI 10.1074/jbc.M807435200; Paciotti V, 2000, GENE DEV, V14, P2046; Paciotti V, 1998, EMBO J, V17, P4199, DOI 10.1093/emboj/17.14.4199; Paciotti V, 2001, MOL CELL BIOL, V21, P3913, DOI 10.1128/MCB.21.12.3913-3925.2001; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Pfander B, 2011, EMBO J, V30, P4897, DOI 10.1038/emboj.2011.345; Rivera-Calzada A, 2005, STRUCTURE, V13, P243, DOI 10.1016/j.str.2004.12.006; Rivera-Calzada A, 2015, AIMS BIOPHYS, V2, P36, DOI 10.3934/biophy.2015.2.36; Rouse J, 2000, EMBO J, V19, P5801, DOI 10.1093/emboj/19.21.5801; Sanchez Y, 1996, SCIENCE, V271, P357, DOI 10.1126/science.271.5247.357; Sanchez Y, 1999, SCIENCE, V286, P1166, DOI 10.1126/science.286.5442.1166; Santocanale C, 1998, NATURE, V395, P615, DOI 10.1038/27001; Scheres SHW, 2012, J STRUCT BIOL, V180, P519, DOI 10.1016/j.jsb.2012.09.006; Scheres SHW, 2012, NAT METHODS, V9, P853, DOI 10.1038/nmeth.2115; Scheres SHW, 2012, J MOL BIOL, V415, P406, DOI 10.1016/j.jmb.2011.11.010; Seidel JJ, 2008, MOL CELL BIOL, V28, P5736, DOI 10.1128/MCB.00326-08; Shaikh TR, 2008, NAT PROTOC, V3, P1941, DOI 10.1038/nprot.2008.156; Sibanda BL, 2010, NATURE, V463, P118, DOI 10.1038/nature08648; Soliman GA, 2010, J BIOL CHEM, V285, P7866, DOI 10.1074/jbc.M109.096222; Spagnolo L, 2006, MOL CELL, V22, P511, DOI 10.1016/j.molcel.2006.04.013; Sun YL, 2007, MOL CELL BIOL, V27, P8502, DOI 10.1128/MCB.01382-07; Sun ZX, 1996, GENE DEV, V10, P395, DOI 10.1101/gad.10.4.395; Tang G, 2007, J STRUCT BIOL, V157, P38, DOI 10.1016/j.jsb.2006.05.009; vanHeel M, 1996, J STRUCT BIOL, V116, P17, DOI 10.1006/jsbi.1996.0004; Wakayama T, 2001, MOL CELL BIOL, V21, P755, DOI 10.1128/MCB.21.3.755-764.2001; Williams DR, 2008, STRUCTURE, V16, P468, DOI 10.1016/j.str.2007.12.014; Yang HJ, 2013, NATURE, V497, P217, DOI 10.1038/nature12122; Yip CK, 2010, MOL CELL, V38, P768, DOI 10.1016/j.molcel.2010.05.017; Zou L, 2003, SCIENCE, V300, P1542, DOI 10.1126/science.1083430	63	28	28	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 24	2016	291	26					13436	13447		10.1074/jbc.M115.708263	http://dx.doi.org/10.1074/jbc.M115.708263			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DR2YZ	27129217	Green Published, Green Accepted, Green Submitted, hybrid			2022-12-26	WOS:000379771100004
J	Schmid-Siegert, E; Stepushenko, O; Glauser, G; Farmer, EE				Schmid-Siegert, Emanuel; Stepushenko, Olga; Glauser, Gaetan; Farmer, Edward E.			Membranes as Structural Antioxidants RECYCLING OF MALONDIALDEHYDE TO ITS SOURCE IN OXIDATION-SENSITIVE CHLOROPLAST FATTY ACIDS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LIPID-PEROXIDATION; SINGLET OXYGEN; MALONIC SEMIALDEHYDE; GENE-EXPRESSION; ACETYL-COENZYME; PHOTOSYSTEM-II; LINOLENIC ACID; FATTY-ACIDS; ARABIDOPSIS; METABOLISM	Genetic evidence suggests that membranes rich in polyunsaturated fatty acids (PUFAs) act as supramolecular antioxidants that capture reactive oxygen species, thereby limiting damage to proteins. This process generates lipid fragmentation products including malondialdehyde (MDA), an archetypal marker of PUFA oxidation. We observed transient increases in levels of endogenous MDA in wounded Arabidopsis thaliana leaves, raising the possibility that MDA is metabolized. We developed a rigorous ion exchange method to purify enzymatically generated C-13- and C-14-MDA. Delivered as a volatile to intact plants, MDA was efficiently incorporated into lipids. Mass spectral and genetic analyses identified the major chloroplast galactolipid: alpha-linolenic acid (18:3)-7Z,10Z,13Z-hexadecatrienoic acid (16:3)-monogalactosyldiacylglycerol (18:3-16:3-MGDG) as an end-product of MDA incorporation. Consistent with this, the fad3-2 fad7-2 fad8 mutant that lacks tri-unsaturated fatty acids incorporated C-14-MDA into 18:2-16:2-MGDG. Saponification of C-14-labeled 18:3-16:3-MGDG revealed 84% of C-14-label in the acyl groups with the remaining 16% in the head group. 18:3-16:3-MGDG is enriched proximal to photosystem II and is likely a major in vivo source of MDA in photosynthetic tissues. We propose that nonenzymatically generated lipid fragments such as MDA are recycled back into plastidic galactolipids that, in their role as cell protectants, can again be fragmented into MDA.	[Schmid-Siegert, Emanuel; Stepushenko, Olga; Farmer, Edward E.] Univ Lausanne, Dept Plant Mol Biol, Biophore, CH-1015 Lausanne, Switzerland; [Glauser, Gaetan] Univ Neuchatel, Neuchatel Platform Analyt Chem, CH-2009 Neuchatel, Switzerland; [Schmid-Siegert, Emanuel] Swiss Inst Bioinformat, Vital IT Grp, Batiment Genopode, CH-1015 Lausanne, Switzerland	University of Lausanne; University of Neuchatel; Swiss Institute of Bioinformatics	Farmer, EE (corresponding author), Univ Lausanne, Dept Plant Mol Biol, Biophore, CH-1015 Lausanne, Switzerland.	edward.farmer@unil.ch	Glauser, Gaetan/K-7574-2017; Schmid-Siegert, Emanuel/N-8657-2019	Glauser, Gaetan/0000-0002-0983-8614; Schmid-Siegert, Emanuel/0000-0003-1339-5120	National Center of Competence in Research "Plant Survival" grant; Swiss National Science Foundation [3100A0-122441, 31003A-138235]	National Center of Competence in Research "Plant Survival" grant; Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	This work was supported with a National Center of Competence in Research "Plant Survival" grant and Swiss National Science Foundation Grants 3100A0-122441 and 31003A-138235. The authors declare that they have no conflicts of interest with the contents of this article.	Aronsson H, 2008, PLANT PHYSIOL, V148, P580, DOI 10.1104/pp.108.123372; Behal RH, 2002, ARCH BIOCHEM BIOPHYS, V402, P259, DOI 10.1016/S0003-9861(02)00086-3; Biswas MS, 2015, PLANT PHYSIOL, V168, P885, DOI 10.1104/pp.115.256834; BLOCK MA, 1983, J BIOL CHEM, V258, P3281; Blokhina O, 2010, PHYSIOL PLANTARUM, V138, P447, DOI 10.1111/j.1399-3054.2009.01340.x; Botte CY, 2011, NAT CHEM BIOL, V7, P834, DOI 10.1038/nchembio.658; Brooks C., 1971, J CHROMATOGR, V9, P193; Devaiah SP, 2006, PHYTOCHEMISTRY, V67, P1907, DOI 10.1016/j.phytochem.2006.06.005; DRAPER HH, 1986, LIPIDS, V21, P305, DOI 10.1007/BF02536418; ESTERBAUER H, 1991, FREE RADICAL BIO MED, V11, P81, DOI 10.1016/0891-5849(91)90192-6; Farmer EE, 2013, ANNU REV PLANT BIOL, V64, P429, DOI 10.1146/annurev-arplant-050312-120132; Flors C, 2006, J EXP BOT, V57, P1725, DOI 10.1093/jxb/erj181; FRANKEL EN, 2012, LIPID OXIDATION; Guskov A, 2009, NAT STRUCT MOL BIOL, V16, P334, DOI 10.1038/nsmb.1559; HOLTE LL, 1990, ANAL BIOCHEM, V188, P136, DOI 10.1016/0003-2697(90)90541-G; JANERO DR, 1990, FREE RADICAL BIO MED, V9, P515, DOI 10.1016/0891-5849(90)90131-2; Kariola T, 2005, PLANT CELL, V17, P282, DOI 10.1105/tpc.104.025817; Kobayashi K, 2013, PLANT J, V73, P250, DOI 10.1111/tpj.12028; Krieger-Liszkay A, 2005, J EXP BOT, V56, P337, DOI 10.1093/jxb/erh237; Li-Beisson Y., 2010, ARABIDOPSIS BOOK, V8, DOI [10.1199/tab.0161, DOI 10.1199/TAB.0133, 10.1199/tab.0133]; Lin M, 2008, PLANT PHYSIOL, V147, P1822, DOI 10.1104/pp.108.121269; Liu JK, 1997, ANAL BIOCHEM, V245, P161, DOI 10.1006/abio.1996.9990; LLOYD D, 1965, BIOCHEM J, V96, P766, DOI 10.1042/bj0960766; Loll B, 2005, NATURE, V438, P1040, DOI 10.1038/nature04224; Maeda H, 2007, CURR OPIN PLANT BIOL, V10, P260, DOI 10.1016/j.pbi.2007.04.006; Mano J, 2012, PLANT PHYSIOL BIOCH, V59, P90, DOI 10.1016/j.plaphy.2012.03.010; Marnett LJ, 2002, TOXICOLOGY, V181, P219, DOI 10.1016/S0300-483X(02)00448-1; MARNETT LJ, 1980, CANCER RES, V40, P276; MARNETT LJ, 1985, PROSTAGLANDINS, V30, P241, DOI 10.1016/0090-6980(85)90188-1; McConn M, 1996, PLANT CELL, V8, P403, DOI 10.1105/tpc.8.3.403; Mene-Saffrane L, 2009, J BIOL CHEM, V284, P1702, DOI 10.1074/jbc.M807114200; Pospisil P, 2014, J PHOTOCH PHOTOBIO B, V137, P39, DOI 10.1016/j.jphotobiol.2014.04.025; Ramel F, 2012, PLANT PHYSIOL, V158, P1267, DOI 10.1104/pp.111.182394; Rastogi A, 2014, PLANT CELL ENVIRON, V37, P392, DOI 10.1111/pce.12161; Refsgaard HHF, 2000, P NATL ACAD SCI USA, V97, P611, DOI 10.1073/pnas.97.2.611; Robinson T., 1963, ORGANIC CONSTITUENTS, V40, P36; Roessner U, 2001, PLANT CELL, V13, P11, DOI 10.1105/tpc.13.1.11; ROUGHAN PG, 1970, BIOCHEM J, V117, P1; Russell NJ, 1999, MICROBIOL-UK, V145, P767, DOI 10.1099/13500872-145-4-767; Sattler SE, 2006, PLANT CELL, V18, P3706, DOI 10.1105/tpc.106.044065; Schmid-Siegert E, 2012, J BIOL CHEM, V287, P8954, DOI 10.1074/jbc.M111.322842; SCHOLEM RD, 1983, BIOCHEM J, V216, P81, DOI 10.1042/bj2160081; SIU GM, 1982, LIPIDS, V17, P349, DOI 10.1007/BF02535193; SLACK CR, 1975, BIOCHEM J, V152, P217, DOI 10.1042/bj1520217; SUMMERFIELD FW, 1978, BIOCHEM BIOPH RES CO, V82, P547, DOI 10.1016/0006-291X(78)90909-9; Triantaphylides C, 2008, PLANT PHYSIOL, V148, P960, DOI 10.1104/pp.108.125690; Vijayan P, 2002, PLANT PHYSIOL, V129, P876, DOI 10.1104/pp.004341; Wada H., 2010, LIPIDS PHOTOSYNTHESI, P265; Wang SW, 2014, PLANT PHYSIOL, V165, P1144, DOI 10.1104/pp.114.238899; Weber H, 2004, PLANT J, V37, P877, DOI 10.1111/j.1365-313X.2003.02013.x; Yamauchi Y, 2008, PLANT PHYSIOL BIOCH, V46, P786, DOI 10.1016/j.plaphy.2008.04.018; Yamauchi Y, 2011, J BIOL CHEM, V286, P6999, DOI 10.1074/jbc.M110.202226; YEO HC, 1994, ANAL BIOCHEM, V220, P391, DOI 10.1006/abio.1994.1355; Zoeller M, 2012, PLANT PHYSIOL, V160, P365, DOI 10.1104/pp.112.202846	54	41	41	1	25	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 17	2016	291	25					13005	13013		10.1074/jbc.M116.729921	http://dx.doi.org/10.1074/jbc.M116.729921			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DR2YT	27143359	Green Published, hybrid			2022-12-26	WOS:000379770500010
J	Oecal, S; Socher, E; Uthoff, M; Ernst, C; Zaucke, F; Sticht, H; Baumann, U; Gebauer, JM				Oecal, Sinan; Socher, Eileen; Uthoff, Matthias; Ernst, Corvin; Zaucke, Frank; Sticht, Heinrich; Baumann, Ulrich; Gebauer, Jan M.			The pH-dependent Client Release from the Collagen-specific Chaperone HSP47 Is Triggered by a Tandem Histidine Pair	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN SECONDARY STRUCTURE; HEAT-SHOCK-PROTEIN; MOLECULAR CHAPERONE; CIRCULAR-DICHROISM; I COLLAGEN; BINDING; RECOGNITION; STABILITY; EVOLUTION; PROTOCOL	Heat shock protein 47 (HSP47) is an endoplasmic reticulum (ER)-resident collagen-specific chaperone and essential for proper formation of the characteristic collagen triple helix. It preferentially binds to the folded conformation of its clients and accompanies them from the ER to the Golgi compartment, where it releases them and is recycled back to the ER. Unlike other chaperones, the binding and release cycles are not governed by nucleotide exchange and hydrolysis, but presumably the dissociation of the HSP47-procollagen complex is triggered by the lower pH in the Golgi (pH 6.3) compared with the ER (pH 7.4). Histidine residues have been suggested as triggers due to their approximate textbook pK(a) value of 6.1 for their side chains. We present here an extensive theoretical and experimental study of the 14 histidine residues present in canine HSP47, where we have mutated all histidine residues in the collagen binding interface and additionally all of those that were predicted to undergo a significant change in protonation state between pH 7 and 6. These mutants were characterized by bio-layer interferometry for their pH-dependent binding to a collagen model. One mutant (H238N) loses binding, which can be explained by a rearrangement of the Arg(222) and Asp(385) residues, which are crucial for specific collagen recognition. Most of the other mutants were remarkably silent, but a double mutant with His(273) and His(274) exchanged for asparagines exhibits a much less pronounced pH dependence of collagen binding. This effect is mainly caused by a lower k(off) at the low pH values.	[Oecal, Sinan; Uthoff, Matthias; Ernst, Corvin; Baumann, Ulrich; Gebauer, Jan M.] Univ Cologne, Inst Biochem, Otto Fischer Str 12-14, D-50674 Cologne, Germany; [Socher, Eileen; Sticht, Heinrich] Univ Erlangen Nurnberg, Inst Biochem, Div Bioinformat, Fahrstr 17, D-91054 Erlangen, Germany; [Zaucke, Frank] Univ Cologne, Fac Med, Ctr Biochem, Joseph Stelzmann Str 52, D-50931 Cologne, Germany	University of Cologne; University of Erlangen Nuremberg; University of Cologne	Baumann, U; Gebauer, JM (corresponding author), Univ Cologne, Inst Biochem, Otto Fischer Str 12-14, D-50674 Cologne, Germany.	ubaumann@uni-koeln.de; jan.gebauer@uni-koeln.de	Baumann, Ulrich/B-1220-2013; Zaucke, Frank/AAT-2688-2021; Gebauer, Jan M/C-3085-2009; Zaucke, Frank/E-2077-2012	Gebauer, Jan M/0000-0002-3989-4748; Sticht, Heinrich/0000-0001-5644-045X; Socher, Eileen/0000-0002-6239-3749; Uthoff, Matthias/0000-0002-6477-5505	German Research Council [SFB829/B11, SFB796/A2, BA 1264/2-1]; University of Cologne	German Research Council(German Research Foundation (DFG)); University of Cologne	This work was supported by German Research Council Grants SFB829/B11, SFB796/A2, and BA 1264/2-1 and by the University of Cologne. The authors declare that they have no conflicts of interest with the contents of this article.	Abdul-Wahab MF, 2013, J BIOL CHEM, V288, P4452, DOI 10.1074/jbc.M112.409029; Case D. A., 2012, AMBER; Christiansen HE, 2010, AM J HUM GENET, V86, P389, DOI 10.1016/j.ajhg.2010.01.034; Drogemuller C, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000579; Du CL, 2008, APPL MICROBIOL BIOT, V79, P195, DOI 10.1007/s00253-008-1427-0; Edgcomb SP, 2002, PROTEINS, V49, P1, DOI 10.1002/prot.10177; ElThaher TSH, 1996, PROTEIN PEPTIDE LETT, V3, P1; Findlay JWA, 2007, AAPS J, V9, pE260, DOI 10.1208/aapsj0902029; Fiser A, 2000, PROTEIN SCI, V9, P1753, DOI 10.1110/ps.9.9.1753; Fiser A, 2003, BIOINFORMATICS, V19, P2500, DOI 10.1093/bioinformatics/btg362; Gebauer JM, 2016, MATRIX BIOL, V49, P106, DOI 10.1016/j.matbio.2015.07.001; HIRAYOSHI K, 1991, MOL CELL BIOL, V11, P4036, DOI 10.1128/MCB.11.8.4036; Ishida Y, 2006, MOL BIOL CELL, V17, P2346, DOI 10.1091/mbc.E05-11-1065; Ishida Y, 2011, METHOD ENZYMOL, V499, P167, DOI 10.1016/B978-0-12-386471-0.00009-2; Kadler KE, 2007, J CELL SCI, V120, P1955, DOI 10.1242/jcs.03453; Koide T, 2005, TOP CURR CHEM, V247, P85, DOI 10.1007/b103820; Macdonald JR, 2001, J BIOL CHEM, V276, P25399, DOI 10.1074/jbc.M102471200; McIlvaine TC, 1921, J BIOL CHEM, V49, P183; Meyer A, 1999, CURR OPIN CELL BIOL, V11, P699, DOI 10.1016/S0955-0674(99)00039-3; Mongan J, 2004, J COMPUT CHEM, V25, P2038, DOI 10.1002/jcc.20139; Nagai N, 2000, J CELL BIOL, V150, P1499, DOI 10.1083/jcb.150.6.1499; Ono T, 2012, J BIOL CHEM, V287, P6810, DOI 10.1074/jbc.M111.280248; Onufriev A, 2004, PROTEINS, V55, P383, DOI 10.1002/prot.20033; Paroutis P, 2004, PHYSIOLOGY, V19, P207, DOI 10.1152/physiol.00005.2004; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; PROVENCHER SW, 1981, BIOCHEMISTRY-US, V20, P33, DOI 10.1021/bi00504a006; Ricard-Blum S, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a004978; Shoulders MD, 2009, ANNU REV BIOCHEM, V78, P929, DOI 10.1146/annurev.biochem.77.032207.120833; Socher E, 2016, SCI REP-UK, V6, DOI 10.1038/srep22523; Sreerama N, 2000, ANAL BIOCHEM, V287, P252, DOI 10.1006/abio.2000.4880; Thomson CA, 2000, BIOCHEM J, V349, P877, DOI 10.1042/bj3490877; Wang JM, 2000, J COMPUT CHEM, V21, P1049, DOI 10.1002/1096-987X(200009)21:12<1049::AID-JCC3>3.0.CO;2-F; Whisstock JC, 2010, J BIOL CHEM, V285, P24307, DOI 10.1074/jbc.R110.141408; Widmer C, 2012, P NATL ACAD SCI USA, V109, P13243, DOI 10.1073/pnas.1208072109; Wu MM, 2000, CHEM BIOL, V7, P197, DOI 10.1016/S1074-5521(00)00088-0; Zheng L, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh110	36	24	24	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 10	2016	291	24					12612	12626		10.1074/jbc.M115.706069	http://dx.doi.org/10.1074/jbc.M115.706069			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DO9PV	27129216	Green Published, hybrid			2022-12-26	WOS:000378119900018
J	Patane, I; Iachini, T; Farne, A; Frassinetti, F				Patane, Ivan; Iachini, Tina; Farne, Alessandro; Frassinetti, Francesca			Disentangling Action from Social Space: Tool-Use Differently Shapes the Space around Us	PLOS ONE			English	Article							PERIPERSONAL SPACE; MULTISENSORY REPRESENTATION; PERSONAL-SPACE; BODY; PERCEPTION; MACAQUE; PLASTICITY; AREA; HAND	Converging evidence suggests close relationships between the action and social space representations. The concepts of peripersonal space, as defined by cognitive neuroscience, and interpersonal space, as defined by social psychology, refer to approximately the same spatial area surrounding our bodies. The aim of this study was thus to assess experimentally whether the peripersonal (PPS) and interpersonal space (IPS) represent a similar psychological entity. Were this true, they should share some functional features. Here we tested tool-use dependent plasticity, known to modulate PPS, but still unexplored in the IPS. Results from two experiments converge in showing that tool-use remapped the action-related PPS, measured by a Reaching-distance toward a confederate, but did not affect the social-related IPS, measured by a Comfort-distance task. These findings indicate that PPS and IPS rely on dissociable plastic mechanisms and suggest that, at least in the present experimental conditions, there is no full functional overlap between these two spatial representations.	[Patane, Ivan; Frassinetti, Francesca] Univ Bologna, Dept Psychol, Bologna, Italy; [Patane, Ivan; Farne, Alessandro] Lyon Neurosci Res Ctr, CNRS UMR5292, INSERM U1028, ImpAct Team, Lyon, France; [Patane, Ivan; Farne, Alessandro] Univ Lyon 1, UCBL, F-69365 Lyon, France; [Iachini, Tina] Univ Naples 2, Dept Psychol, Lab Cognit Sci & Immers Virtual Real, Caserta, Italy; [Farne, Alessandro] Hosp Civiles Lyon, Neuroimmers & Mouvement & Handicap, Lyon, France; [Frassinetti, Francesca] IRCCS Ist Sci Castel Goffredo, Fdn Salvatore Maugeri, Clin Lavoro & Riabilitaz, Mantua, Italy	University of Bologna; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); CHU Lyon; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Claude Bernard Lyon 1; Universita della Campania Vanvitelli; CHU Lyon; Istituti Clinici Scientifici Maugeri IRCCS	Patane, I (corresponding author), Univ Bologna, Dept Psychol, Bologna, Italy.; Patane, I (corresponding author), Lyon Neurosci Res Ctr, CNRS UMR5292, INSERM U1028, ImpAct Team, Lyon, France.; Patane, I (corresponding author), Univ Lyon 1, UCBL, F-69365 Lyon, France.	ivan.patane2@unibo.it	Iachini, Tina/E-1268-2014; FARNE, ALESSANDRO/G-1238-2015; Patané, Ivan/GSI-5656-2022; FRASSINETTI, FRANCESCA/ABI-1533-2020	Iachini, Tina/0000-0001-8405-8768; FARNE, ALESSANDRO/0000-0001-5769-3491; Patané, Ivan/0000-0002-3351-3502; FRASSINETTI, FRANCESCA/0000-0001-6810-2861	RFO (Ministry of University and Research); IHU CeSaMe [ANR-10-IBHU-0003]; FRC (Federation pour la Recherche sur le Cerveau, Neurodon); James S. McDonnell Scholar Award	RFO (Ministry of University and Research)(Ministry of Education, Universities and Research (MIUR)); IHU CeSaMe; FRC (Federation pour la Recherche sur le Cerveau, Neurodon); James S. McDonnell Scholar Award	This work was supported by grants from RFO (Ministry of University and Research) to FF and from IHU CeSaMe ANR-10-IBHU-0003, FRC (Federation pour la Recherche sur le Cerveau, Neurodon) and the James S. McDonnell Scholar Award to AF, and was performed within the framework of the LABEX CORTEX (ANR-11-LABX-0042) of Universite de Lyon. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aiello J. R., 1987, HDB ENV PSYCHOL; Bartolo A, 2014, FRONT HUM NEUROSCI, V8, DOI 10.3389/fnhum.2014.00003; Berti A, 2000, J COGNITIVE NEUROSCI, V12, P415, DOI 10.1162/089892900562237; Bourgeois J, 2014, ACTA PSYCHOL, V148, P91, DOI 10.1016/j.actpsy.2014.01.008; Brozzoli C, 2014, NEUROSCIENTIST, V20, P122, DOI 10.1177/1073858413511153; Brozzoli C, 2013, CURR BIOL, V23, P1764, DOI 10.1016/j.cub.2013.07.004; Brozzoli C, 2011, J NEUROSCI, V31, P9023, DOI 10.1523/JNEUROSCI.1172-11.2011; Canzoneri E, 2013, EXP BRAIN RES, V228, P25, DOI 10.1007/s00221-013-3532-2; Cardinali L, 2009, CURR BIOL, V19, pR478, DOI 10.1016/j.cub.2009.05.009; Clery J, 2015, NEUROPSYCHOLOGIA, V70, P313, DOI 10.1016/j.neuropsychologia.2014.10.022; COLBY CL, 1993, J NEUROPHYSIOL, V69, P902, DOI 10.1152/jn.1993.69.3.902; Costantini M, 2011, NEUROPSYCHOLOGIA, V49, P2658, DOI 10.1016/j.neuropsychologia.2011.05.013; de Vignemont F, 2015, NEUROPSYCHOLOGIA, V70, P327, DOI 10.1016/j.neuropsychologia.2014.11.018; Dijkerman HC, 2015, NEUROPSYCHOLOGIA, V70, P309, DOI 10.1016/j.neuropsychologia.2015.03.005; Farne A, 2005, NEUROPSYCHOLOGIA, V43, P238, DOI 10.1016/j.neuropsychologia.2004.11.010; Fini C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0114719; Gallese V, 2010, NEUROPSYCHOLOGIA, V48, P746, DOI 10.1016/j.neuropsychologia.2009.09.038; Graziano M, 1993, EXPT BRAIN RES, V97; Hall E.T., 1966, HIDDEN DIMENSION, V609; HAYDUK LA, 1983, PSYCHOL BULL, V94, P293, DOI 10.1037/0033-2909.94.2.293; Heed T, 2010, CURR BIOL, V20, P1345, DOI 10.1016/j.cub.2010.05.068; Holt DJ, 2014, J NEUROSCI, V34, P4123, DOI 10.1523/JNEUROSCI.0686-13.2014; Iachini T, 2015, ACTA PSYCHOL, V161, P131, DOI 10.1016/j.actpsy.2015.09.003; Iachini T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111511; Iriki A, 1996, NEUROREPORT, V7, P2325; Lloyd DM, 2009, NEUROSCI BIOBEHAV R, V33, P297, DOI 10.1016/j.neubiorev.2008.09.007; Longo MR, 2007, EXP BRAIN RES, V177, P285, DOI 10.1007/s00221-007-0855-x; Maister L, 2015, NEUROPSYCHOLOGIA, V70, P455, DOI 10.1016/j.neuropsychologia.2014.10.027; Makin TR, 2007, J NEUROSCI, V27, P731, DOI 10.1523/JNEUROSCI.3653-06.2007; Maravita A, 2004, TRENDS COGN SCI, V8, P79, DOI 10.1016/j.tics.2003.12.008; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; PEDERSEN DM, 1974, J PERS SOC PSYCHOL, V30, P838, DOI 10.1037/h0037533; Rizzolatti G, 1997, SCIENCE, V277, P190, DOI 10.1126/science.277.5323.190; RIZZOLATTI G, 1981, BEHAV BRAIN RES, V2, P147, DOI 10.1016/0166-4328(81)90053-X; Sereno MI, 2006, NAT NEUROSCI, V9, P1337, DOI 10.1038/nn1777; Serino A, 2007, PSYCHOL SCI, V18, P642, DOI 10.1111/j.1467-9280.2007.01952.x; Sommer R, 2002, HDB ENV PSYCHOL, V1937, P647; Sposito A, 2012, NEUROPSYCHOLOGIA, V50, P2187, DOI 10.1016/j.neuropsychologia.2012.05.022; Tajadura-Jimenez A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026083; TEDESCO JF, 1974, SOCIOMETRY, V37, P116, DOI 10.2307/2786471; Teneggi C, 2013, CURR BIOL, V23, P406, DOI 10.1016/j.cub.2013.01.043	41	31	31	2	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 4	2016	11	5							e0154247	10.1371/journal.pone.0154247	http://dx.doi.org/10.1371/journal.pone.0154247			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DL5KR	27144720	gold, Green Published			2022-12-26	WOS:000375676400040
J	Grudzinska, M; Czerko, Z; Zarzynska, K; Borowska-Komenda, M				Grudzinska, Magdalena; Czerko, Zbigniew; Zarzynska, Krystyna; Borowska-Komenda, Monika			Bioactive Compounds in Potato Tubers: Effects of Farming System, Cooking Method, and Flesh Color	PLOS ONE			English	Article							ANTIOXIDANT ACTIVITY; PHENOLIC-ACIDS; VITAMIN-C; NUTRITIONAL-VALUE; QUALITY; CULTIVARS; CAPACITY; ANTHOCYANINS; FLAVONOIDS; FRUITS	We investigated the effect of cultivation system (conventional or organic), cooking method, and flesh color on the contents of ascorbic acid (AA) and total phenolics (TPs), and on total antioxidant activity (Trolox equivalents, TE) in Solanum tuberosum (potato) tubers. The research material, consisting of 4 potato cultivars, was grown in experimental fields, using organic and conventional systems, at the experimental station in 2012 and 2013. The analysis showed that organically grown potatoes with creamy, light yellow, and yellow flesh had significantly higher TPs than did potatoes grown conventionally. Flesh color and cooking method also affected AA. The greatest losses of AA occurred in yellow-fleshed potatoes grown conventionally and cooked in the microwave; such losses were not observed in potatoes grown organically. A dry cooking method (baking in a microwave) increased the TP contents in potatoes by about 30%, regardless of the flesh color and the production system. TE was significantly higher in organically grown potatoes (raw and cooked in a steamer) than in conventionally grown potatoes. TE and AA contents showed a significant positive correlation, but only in potatoes from the organic system [R-2 = 0.686]. By contrast, the positive correlation between TE and TPs was observed regardless of the production system. Therefore, we have identified the effects of farming system, cooking method, and flesh color on the contents of bioactive compounds in potato tubers.	[Grudzinska, Magdalena; Czerko, Zbigniew; Zarzynska, Krystyna] Plant Breeding & Acclimatizat Inst, Natl Res Inst, Div Jadwisin, Jadwisin, Poland; [Borowska-Komenda, Monika] Warsaw Univ Life Sci SGGW, Sect Agr Chem, Dept Soil Environm Sci, Fac Agr & Biol, Warsaw, Poland	Institute of Plant Breeding & Acclimatization; Warsaw University of Life Sciences	Grudzinska, M (corresponding author), Plant Breeding & Acclimatizat Inst, Natl Res Inst, Div Jadwisin, Jadwisin, Poland.	m.grudzinska@ihar.edu.pl		Grudzinska, Magdalena/0000-0003-2979-1187				Abong G. O., 2011, American Journal of Food Technology, V6, P772, DOI 10.3923/ajft.2011.772.780; [Anonymous], PNA040191998; Baranski M, 2014, BRIT J NUTR, V112, P794, DOI 10.1017/S0007114514001366; Blessington T, 2010, AM J POTATO RES, V87, P479, DOI 10.1007/s12230-010-9150-7; Bourn D, 2002, CRIT REV FOOD SCI, V42, P1, DOI 10.1080/10408690290825439; Brand K., 2003, DENMARK FOCUS SCANDI, P16; Brandt K, 2001, J SCI FOOD AGR, V81, P924, DOI 10.1002/jsfa.903; Brandt K, 2011, CRIT REV PLANT SCI, V30, P177, DOI 10.1080/07352689.2011.554417; Brazinskiene V, 2014, FOOD CHEM, V145, P903, DOI 10.1016/j.foodchem.2013.09.011; Brown CR, 2008, POTATO RES, V51, P259, DOI 10.1007/s11540-008-9115-0; Brown CR, 2005, AM J POTATO RES, V82, P163, DOI 10.1007/BF02853654; Bunea A, 2008, FOOD CHEM, V108, P649, DOI 10.1016/j.foodchem.2007.11.056; BURG P, 1995, FOOD SCI TECHNOL-LEB, V28, P506; Burgos G, 2009, J FOOD COMPOS ANAL, V22, P533, DOI 10.1016/j.jfca.2008.05.013; Cheynier V, 2005, AM J CLIN NUTR, V81, p223S, DOI 10.1093/ajcn/81.1.223S; Golaszewska B., 2001, POLISH J FOOD NUTR S, V10/51, P59; Hacisevki A., 2009, J FAC PHARM ANK, V38, P233, DOI DOI 10.1501/ECZFAK_0000000528; Hajslova J, 2005, FOOD ADDIT CONTAM A, V22, P514, DOI 10.1080/02652030500137827; Hamouzi K, 2009, PLANT SOIL ENVIRON, V55, P281, DOI 10.17221/82/2009-PSE; Hejtmankova K, 2009, CZECH J FOOD SCI, V27, pS310, DOI 10.17221/605-CJFS; Kalt W, 2005, J FOOD SCI, V70, pR11, DOI 10.1111/j.1365-2621.2005.tb09053.x; Kaur C, 2002, INT J FOOD SCI TECH, V37, P153, DOI 10.1046/j.1365-2621.2002.00552.x; Lachman J, 2005, PLANT SOIL ENVIRON, V51, P477, DOI 10.17221/3620-PSE; Lachman J, 2008, SCI HORTIC-AMSTERDAM, V117, P109, DOI 10.1016/j.scienta.2008.03.030; Lachman J, 2013, FOOD CHEM, V138, P1189, DOI 10.1016/j.foodchem.2012.11.114; Lee SK, 2000, POSTHARVEST BIOL TEC, V20, P207, DOI 10.1016/S0925-5214(00)00133-2; Lewis CE, 1998, J SCI FOOD AGR, V77, P45, DOI [10.1002/(SICI)1097-0010(199805)77:1&lt;45::AID-JSFA1&gt;3.0.CO;2-S, 10.1002/(SICI)1097-0010(199805)77:1<45::AID-JSFA1>3.0.CO;2-S]; Lombardo S, 2013, J FOOD COMPOS ANAL, V32, P28, DOI 10.1016/j.jfca.2013.08.003; Lombardo S, 2012, FOOD CHEM, V133, P1249, DOI 10.1016/j.foodchem.2011.10.005; Mattila P, 2007, J FOOD COMPOS ANAL, V20, P152, DOI 10.1016/j.jfca.2006.05.007; Merkl R, 2010, CZECH J FOOD SCI, V28, P275, DOI 10.17221/132/2010-CJFS; Navarre DA, 2010, AM J POTATO RES, V87, P350, DOI 10.1007/s12230-010-9141-8; Nebesny E, 2003, EUR FOOD RES TECHNOL, V217, P157, DOI 10.1007/s00217-003-0705-4; Nzaramba MN, 2013, AM J POTATO RES, V90, P541, DOI 10.1007/s12230-013-9326-z; Perla V, 2012, LWT-FOOD SCI TECHNOL, V45, P161, DOI 10.1016/j.lwt.2011.08.005; Ranalli, 2005, AGROINDUSTRIA, V4, P325; Ranilla LG, 2009, J AGR FOOD CHEM, V57, P5734, DOI 10.1021/jf900527v; Re R, 1999, FREE RADICAL BIO MED, V26, P1231, DOI 10.1016/S0891-5849(98)00315-3; Rembialkowska E, 2007, J SCI FOOD AGR, V87, P2757, DOI 10.1002/jsfa.3000; Reyes LF, 2005, AM J POTATO RES, V82, P271, DOI 10.1007/BF02871956; RiceEvans CA, 1997, TRENDS PLANT SCI, V2, P152, DOI 10.1016/S1360-1385(97)01018-2; Rumbaoa RGO, 2009, J FOOD COMPOS ANAL, V22, P546, DOI 10.1016/j.jfca.2008.11.004; Rytel E, 2007, ZYWN-NAUK TECHNOL JA, V6, P186; Singleton VL, 1999, METHOD ENZYMOL, V299, P152; Smith-Spangler C, 2012, ANN INTERN MED, V157, P348, DOI 10.7326/0003-4819-157-5-201209040-00007; Soltoft M, 2010, J AGR FOOD CHEM, V58, P10323, DOI 10.1021/jf101091c; Teow CC, 2007, FOOD CHEM, V103, P829, DOI 10.1016/j.foodchem.2006.09.033; Tierno R, 2015, J FOOD COMPOS ANAL, V41, P58, DOI 10.1016/j.jfca.2015.01.013; Velioglu YS, 1998, J AGR FOOD CHEM, V46, P4113, DOI 10.1021/jf9801973; Wang SY, 2008, J AGR FOOD CHEM, V56, P5788, DOI 10.1021/jf703775r; Winter CK, 2006, J FOOD SCI, V71, pR117, DOI 10.1111/j.1750-3841.2006.00196.x; Xu XY, 2009, J AGR FOOD CHEM, V57, P10231, DOI 10.1021/jf902532q; Zhang DL, 2004, FOOD CHEM, V88, P503, DOI 10.1016/j.foodchem.2004.01.065	53	21	22	2	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 3	2016	11	5							e0153980	10.1371/journal.pone.0153980	http://dx.doi.org/10.1371/journal.pone.0153980			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DL5KK	27139188	gold, Green Published, Green Submitted			2022-12-26	WOS:000375675700015
J	Holler, M; Grottke, A; Mueck, K; Manes, J; Jucker, M; Rodemann, P; Toulany, M				Holler, Marina; Grottke, Astrid; Mueck, Katharina; Manes, Julia; Juecker, Manfred; Rodemann, Peter; Toulany, Mahmoud			Dual Targeting of Akt and mTORC1 Impairs Repair of DNA Double-Strand Breaks and Increases Radiation Sensitivity of Human Tumor Cells	PLOS ONE			English	Article							LUNG-CANCER CELLS; MAMMALIAN TARGET; SIGNALING PATHWAYS; ANTITUMOR-ACTIVITY; RAPAMYCIN PATHWAY; INHIBITION; SURVIVAL; AUTOPHAGY; RADIOSENSITIZATION; RECEPTOR	Inhibition of mammalian target of rapamycin-complex 1 (mTORC1) induces activation of Akt. Because Akt activity mediates the repair of ionizing radiation-induced DNA double-strand breaks (DNA-DSBs) and consequently the radioresistance of solid tumors, we investigated whether dual targeting of mTORC1 and Akt impairs DNA-DSB repair and induces radiosensitization. Combining mTORC1 inhibitor rapamycin with ionizing radiation in human non-small cell lung cancer (NSCLC) cells (H661, H460, SK-MES-1, HTB-182, A549) and in the breast cancer cell line MDA-MB-231 resulted in radiosensitization of H661 and H460 cells (responders), whereas only a very slight effect was observed in A549 cells, and no effect was observed in SK-MES-1, HTB-182 or MDA-MB-231 cells (non-responders). In responder cells, rapamycin treatment did not activate Akt1 phosphorylation, whereas in non-responders, rapamycin mediated PI3K-dependent Akt activity. Molecular targeting of Akt by Akt inhibitor MK2206 or knockdown of Akt1 led to a rapamycin-induced radiosensitization of non-responder cells. Compared to the single targeting of Akt, the dual targeting of mTORC1 and Akt1 markedly enhanced the frequency of residual DNA-DSBs by inhibiting the non-homologous end joining repair pathway and increased radiation sensitivity. Together, lack of radiosensitization induced by rapamycin was associated with rapamycin-mediated Akt1 activation. Thus, dual targeting of mTORC1 and Akt1 inhibits repair of DNA-DSB leading to radiosensitization of solid tumor cells.	[Holler, Marina; Mueck, Katharina; Manes, Julia; Rodemann, Peter; Toulany, Mahmoud] Univ Tubingen, Dept Radiat Oncol, Div Radiobiol & Mol Environm Res, Rontgenweg 11, D-72076 Tubingen, Germany; [Grottke, Astrid; Juecker, Manfred] Univ Med Ctr Hamburg Eppendorf, Inst Biochem & Signal Transduct, Martinistr 52, D-20246 Hamburg, Germany	Eberhard Karls University of Tubingen; University of Hamburg; University Medical Center Hamburg-Eppendorf	Toulany, M (corresponding author), Univ Tubingen, Dept Radiat Oncol, Div Radiobiol & Mol Environm Res, Rontgenweg 11, D-72076 Tubingen, Germany.	mahmoud.toulany@uni-tuebingen.de			Deutsche Forschungsgemeinschaft [Ro527/5-1, SFB-773-TP B02, DFG-RO 527/7-1, GRK 1302/2 (T11)]; University of Tubingen	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); University of Tubingen	This work was supported by grants from the Deutsche Forschungsgemeinschaft [Ro527/5-1 and SFB-773-TP B02] awarded to HPR, DFG-RO 527/7-1 awarded to HPR/MT and GRK 1302/2 (T11) awarded to MT/HPR. We acknowledge support by Deutsche Forschungsgemeinschaft and Open Access Publishing Fund of University of Tubingen.	Albert JM, 2006, MOL CANCER THER, V5, P1183, DOI 10.1158/1535-7163.MCT-05-0400; Apel A, 2008, CANCER RES, V68, P1485, DOI 10.1158/0008-5472.CAN-07-0562; Bjornsti MA, 2004, NAT REV CANCER, V4, P335, DOI 10.1038/nrc1362; Boura-Halfon S, 2009, AM J PHYSIOL-ENDOC M, V296, pE581, DOI 10.1152/ajpendo.90437.2008; Bozulic L, 2008, MOL CELL, V30, P203, DOI 10.1016/j.molcel.2008.02.024; Cao C, 2006, CANCER RES, V66, P10040, DOI 10.1158/0008-5472.CAN-06-0802; Cerniglia GJ, 2012, MOL PHARMACOL, V82, P1230, DOI 10.1124/mol.112.080408; Chaachouay H, 2011, RADIOTHER ONCOL, V99, P287, DOI 10.1016/j.radonc.2011.06.002; Chen HH, 2011, RADIAT RES, V175, P214, DOI 10.1667/RR2323.1; Choi EJ, 2010, MOL CANCER RES, V8, P1027, DOI 10.1158/1541-7786.MCR-09-0507; Cloughesy TF, 2008, PLOS MED, V5, P139, DOI 10.1371/journal.pmed.0050008; Edwards E, 2002, CANCER RES, V62, P4671; Fraser M, 2011, CELL CYCLE, V10, P2218, DOI 10.4161/cc.10.13.16305; Fujiwara K, 2007, INT J ONCOL, V31, P753; Golding SE, 2009, CANCER BIOL THER, V8, P730, DOI 10.4161/cbt.8.8.7927; Grabinski N, 2011, CELL SIGNAL, V23, P1952, DOI 10.1016/j.cellsig.2011.07.003; Gulhati P, 2009, CLIN CANCER RES, V15, P7207, DOI 10.1158/1078-0432.CCR-09-1249; Harrington LS, 2004, J CELL BIOL, V166, P213, DOI 10.1083/jcb.200403069; Hay N, 2004, GENE DEV, V18, P1926, DOI 10.1101/gad.1212704; Hein AL, 2014, INT J ONCOL, V45, P1813, DOI 10.3892/ijo.2014.2614; Hudes G, 2007, NEW ENGL J MED, V356, P2271, DOI 10.1056/NEJMoa066838; Kao GD, 2007, J BIOL CHEM, V282, P21206, DOI 10.1074/jbc.M703042200; Klokov D, 2006, RADIOTHER ONCOL, V80, P223, DOI 10.1016/j.radonc.2006.07.026; Kriegs M, 2010, DNA REPAIR, V9, P889, DOI 10.1016/j.dnarep.2010.05.005; Li YK, 2013, J BIOL CHEM, V288, P13215, DOI 10.1074/jbc.M113.463679; Liu PX, 2009, NAT REV DRUG DISCOV, V8, P627, DOI 10.1038/nrd2926; Lo Nigro C, 2007, ANTI-CANCER DRUG, V18, P659; Motzer RJ, 2008, LANCET, V372, P449, DOI 10.1016/S0140-6736(08)61039-9; Mukherjee B, 2009, CANCER RES, V69, P4252, DOI 10.1158/0008-5472.CAN-08-4853; Murphy JD, 2009, CLIN CANCER RES, V15, P589, DOI 10.1158/1078-0432.CCR-08-1019; Myllynen L, 2011, RADIOTHER ONCOL, V101, P147, DOI 10.1016/j.radonc.2011.05.046; Nagata Y, 2010, INT J ONCOL, V37, P1001, DOI 10.3892/ijo_00000751; Nam HY, 2013, AUTOPHAGY, V9, P1631, DOI 10.4161/auto.25879; No M, 2009, CANCER BIOL THER, V8, P2351, DOI 10.4161/cbt.8.24.10131; Noh WC, 2004, CLIN CANCER RES, V10, P1013, DOI 10.1158/1078-0432.CCR-03-0043; O'Reilly KE, 2006, CANCER RES, V66, P1500, DOI 10.1158/0008-5472.CAN-05-2925; Rivera VM, 2011, MOL CANCER THER, V10, P1059, DOI 10.1158/1535-7163.MCT-10-0792; Schuurbiers OCJ, 2009, J THORAC ONCOL, V4, P761, DOI 10.1097/JTO.0b013e3181a1084f; Shinohara ET, 2005, ONCOGENE, V24, P5414, DOI 10.1038/sj.onc.1208715; Sun SY, 2005, CANCER RES, V65, P7052, DOI 10.1158/0008-5472.CAN-05-0917; Tabernero J, 2008, J CLIN ONCOL, V26, P1603, DOI 10.1200/JCO.2007.14.5482; Thoreen CC, 2009, J BIOL CHEM, V284, P8023, DOI 10.1074/jbc.M900301200; Toulany M, 2008, MOL CANCER THER, V7, P1772, DOI 10.1158/1535-7163.MCT-07-2200; Toulany M, 2006, CLIN CANCER RES, V12, P4119, DOI 10.1158/1078-0432.CCR-05-2454; Toulany M, 2015, SEMIN CANCER BIOL, V35, P180, DOI 10.1016/j.semcancer.2015.07.003; Toulany M, 2013, TRANSL CANCER RES, V2, P190, DOI 10.3978/j.issn.2218-676X.2013.04.09; Toulany M, 2014, RADIOTHER ONCOL, V111, P228, DOI 10.1016/j.radonc.2014.04.001; Toulany M, 2014, CANCER BIOL THER, V15, P317, DOI 10.4161/cbt.27311; Toulany M, 2012, MOL CANCER RES, V10, P945, DOI 10.1158/1541-7786.MCR-11-0592; Wan X, 2007, ONCOGENE, V26, P1932, DOI 10.1038/sj.onc.1209990; Wee KB, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004407; Wullschleger S, 2006, CELL, V124, P471, DOI 10.1016/j.cell.2006.01.016; Yu K, 2001, ENDOCR-RELAT CANCER, V8, P249, DOI 10.1677/erc.0.0080249	53	36	36	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 3	2016	11	5							e0154745	10.1371/journal.pone.0154745	http://dx.doi.org/10.1371/journal.pone.0154745			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DL5KK	27137757	Green Published, gold			2022-12-26	WOS:000375675700062
J	Yu, XD; Lu, L; Wang, FY; Luo, TH; Zou, SS; Wang, CB; Song, TT; Zhou, HZ				Yu, Xiao-Dong; Lu, Liang; Wang, Feng-Yan; Luo, Tian-Hong; Zou, Si-Si; Wang, Cheng-Bin; Song, Ting-Ting; Zhou, Hong-Zhang			The Relative Importance of Spatial and Local Environmental Factors in Determining Beetle Assemblages in the Inner Mongolia Grassland	PLOS ONE			English	Article							SCALE GEOGRAPHIC PATTERNS; SPECIES-RICHNESS; BETA-DIVERSITY; PITFALL TRAPS; BIODIVERSITY; GRADIENTS; ENERGY; COMMUNITIES; COLEOPTERA; ABUNDANCE	The aim of this paper is to increase understanding of the relative importance of the input of geographic and local environmental factors on richness and composition of epigaeic steppe beetles (Coleoptera: Carabidae and Tenebrionidae) along a geographic (longitudinal/precipitation) gradient in the Inner Mongolia grassland. Specifically, we evaluate the associations of environmental variables representing climate and environmental heterogeneity with beetle assemblages. Beetles were sampled using pitfall traps at 25 sites scattered across the full geographic extent of the study biome in 2011-2012. We used variance partitioning techniques and multi-model selection based on the Akaike information criterion to assess the relative importance of the spatial and environmental variables on beetle assemblages. Species richness and abundance showed unimodal patterns along the geographic gradient. Together with space, climate variables associated with precipitation, water-energy balance and harshness of climate had strong explanatory power in richness pattern. Abundance pattern showed strongest association with variation in temperature and environmental heterogeneity. Climatic factors associated with temperature and precipitation variables and the interaction between climate with space were able to explain a substantial amount of variation in community structure. In addition, the turnover of species increased significantly as geographic distances increased. We confirmed that spatial and local environmental factors worked together to shape epigaeic beetle communities along the geographic gradient in the Inner Mongolia grassland. Moreover, the climate features, especially precipitation, water-energy balance and temperature, and the interaction between climate with space and environmental heterogeneity appeared to play important roles on controlling richness and abundance, and species compositions of epigaeic beetles.	[Yu, Xiao-Dong; Lu, Liang; Wang, Feng-Yan; Luo, Tian-Hong; Zou, Si-Si; Wang, Cheng-Bin; Song, Ting-Ting; Zhou, Hong-Zhang] Chinese Acad Sci, Inst Zool, Key Lab Zool Systemat & Evolut, Beijing 100101, Peoples R China	Chinese Academy of Sciences; Institute of Zoology, CAS	Yu, XD; Zhou, HZ (corresponding author), Chinese Acad Sci, Inst Zool, Key Lab Zool Systemat & Evolut, Beijing 100101, Peoples R China.	yuxd@ioz.ac.cn; zhouhz@ioz.ac.cn		Lu, Liang/0000-0001-7533-6244	CAS Innovation Program [KSCX2-EW-Z-5]; National Natural Science Foundation of China [NSFC-31570424, 31472036]; Key Laboratory of Zoological Systematics and Evolution of CAS [Y229YX5105]	CAS Innovation Program(Knowledge Innovation Program of the Chinese Academy of Sciences); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Key Laboratory of Zoological Systematics and Evolution of CAS	This study was supported in part by CAS Innovation Program (KSCX2-EW-Z-5), National Natural Science Foundation of China (NSFC-31570424, 31472036), a grant from the Key Laboratory of Zoological Systematics and Evolution of CAS (No. Y229YX5105).	Allen AP, 2002, SCIENCE, V297, P1545, DOI 10.1126/science.1072380; Bai YF, 2008, ECOLOGY, V89, P2140, DOI 10.1890/07-0992.1; BORCARD D, 1992, ECOLOGY, V73, P1045, DOI 10.2307/1940179; Brehm G, 2007, GLOBAL ECOL BIOGEOGR, V16, P205, DOI 10.1111/j.1466-8238.2006.00281.x; Chao A, 2005, ECOL LETT, V8, P148, DOI 10.1111/j.1461-0248.2004.00707.x; Chase J.M., 2009, ECOLOGICAL NICHES LI; Chesson P, 2000, ANNU REV ECOL SYST, V31, P343, DOI 10.1146/annurev.ecolsys.31.1.343; COLWELL RK, 1994, PHILOS T R SOC B, V345, P101, DOI 10.1098/rstb.1994.0091; Colwell RK, 2013, ESTIMATES STAT ESTIM; den Boer P. J., 1970, Oecologia, V4, P1, DOI 10.1007/BF00390612; Digweed SC, 1995, PEDOBIOLOGIA, V39, P561; Diniz JAF, 2003, GLOBAL ECOL BIOGEOGR, V12, P53, DOI 10.1046/j.1466-822X.2003.00322.x; DUTILLEUL P, 1993, BIOMETRICS, V49, P305, DOI 10.2307/2532625; Elek Z, 2014, EUR J ENTOMOL, V111, P663, DOI 10.14411/eje.2014.080; Evans KL, 2005, BIOL REV, V80, P1, DOI 10.1017/S1464793104006517; Field R, 2009, J BIOGEOGR, V36, P132, DOI 10.1111/j.1365-2699.2008.01963.x; Flombaum P, 2007, J ARID ENVIRON, V69, P352, DOI 10.1016/j.jaridenv.2006.09.008; Gotelli NJ, 2001, ECOL LETT, V4, P379, DOI 10.1046/j.1461-0248.2001.00230.x; Guisan A, 2011, J BIOGEOGR, V38, P1433, DOI 10.1111/j.1365-2699.2011.02550.x; Hammer Oyvind, 2001, Palaeontologia Electronica, V4, pUnpaginated; Han XG, 2009, RANGELAND ECOL MANAG, V62, P303, DOI 10.2111/09-002.1; Hawkins BA, 2003, ECOLOGY, V84, P3105, DOI 10.1890/03-8006; Hijmans RJ, 2005, INT J CLIMATOL, V25, P1965, DOI 10.1002/joc.1276; Homburg K, 2013, ECOGRAPHY, V36, P166, DOI 10.1111/j.1600-0587.2012.07488.x; Hortal J, 2008, J BIOGEOGR, V35, P1202, DOI 10.1111/j.1365-2699.2007.01850.x; Hortal J, 2010, ECOGRAPHY, V33, P51, DOI 10.1111/j.1600-0587.2009.06428.x; Hubbell S.P., 2001, MG POP BIOL, V32; Kaspari M, 2000, AM NAT, V155, P280, DOI 10.1086/303313; Kaspari M, 2000, P ROY SOC B-BIOL SCI, V267, P485, DOI 10.1098/rspb.2000.1026; Kaspari M, 2012, ECOGRAPHY, V35, P65, DOI 10.1111/j.1600-0587.2011.06971.x; Koleff P, 2003, J ANIM ECOL, V72, P367, DOI 10.1046/j.1365-2656.2003.00710.x; Legendre P., 2012, NUMERICAL ECOLOGY; Legendre P, 2009, ECOLOGY, V90, P663, DOI 10.1890/07-1880.1; Li B., 1962, J INNER MONGOL U, V2, P42; Lindroth C. H., 1961, Opuscula Entomologica Suppl, V20, P1; Lindroth C. H., 1969, Opusc. ent., V34, P945; Lindroth CH, 1961, OPUSCULA ENTOMOLOG S, V33, P649; Lindroth CH, 1961, OPUSCULA ENTOMOLOG S, V24, P201; Lindroth CH, 1961, OPUSC ENT S, V29, P409; Lomolino M.V., 2010, BIOGEOGRAPHY, Vfourth; Lomolino MV, 2001, GLOBAL ECOL BIOGEOGR, V10, P3, DOI 10.1046/j.1466-822x.2001.00229.x; Lovei GL, 1996, ANNU REV ENTOMOL, V41, P231, DOI 10.1146/annurev.en.41.010196.001311; Niemela J, 1996, ECOGRAPHY, V19, P352, DOI 10.1111/j.1600-0587.1996.tb01264.x; Nogues-Bravo D, 2011, SCIENCE, V334, P1070, DOI 10.1126/science.1214833; Paknia O, 2011, INSECT CONSERV DIVER, V4, P297, DOI 10.1111/j.1752-4598.2011.00136.x; Pellissier L, 2013, ECOGRAPHY, V36, P541, DOI 10.1111/j.1600-0587.2012.07716.x; Pellissier L, 2013, GLOBAL ECOL BIOGEOGR, V22, P577, DOI 10.1111/geb.12026; Pfeiffer M, 2003, J BIOGEOGR, V30, P1921, DOI 10.1046/j.0305-0270.2003.00977.x; Quinn GP, 2003, EXPT DESIGN DATA ANA; R Development Core Team, 2014, R LANG ENV STAT COMP; Rahbek C, 2005, ECOL LETT, V8, P224, DOI 10.1111/j.1461-0248.2004.00701.x; Rangel TF, 2010, ECOGRAPHY, V33, P46, DOI 10.1111/j.1600-0587.2009.06299.x; Ren G. D., 1999, DARKLING BEETLES DES; ROSENBERG MS, 2001, PATTERN ANAL SPATIAL; Ruggiero A, 2009, INSECT CONSERV DIVER, V2, P81, DOI 10.1111/j.1752-4598.2009.00045.x; Sanders NJ, 2007, GLOBAL ECOL BIOGEOGR, V16, P640, DOI 10.1111/j.1466-8238.2007.00316.x; Sklodowski J, 2008, PENSOFT SER FAUNIST, P451; Soberon JM, 2010, ECOGRAPHY, V33, P159, DOI 10.1111/j.1600-0587.2009.06074.x; Soininen J, 2007, ECOGRAPHY, V30, P3, DOI 10.1111/j.2006.0906-7590.04817.x; SPENCE JR, 1994, CAN ENTOMOL, V126, P881, DOI 10.4039/Ent126881-3; Tang ZY, 2012, ECOGRAPHY, V35, P1103, DOI 10.1111/j.1600-0587.2012.07713.x; ter Braak C.J.F., 2003, CANOCO WINDOWS VERSI; Thiele H. -U., 1977, CARABID BEETLES THEI, DOI 10.1007/978-3-642-81154-8; Vanbergen AJ, 2005, ECOGRAPHY, V28, P3, DOI 10.1111/j.0906-7590.2005.03991.x; Vasconcelos HL, 2010, J BIOGEOGR, V37, P432, DOI 10.1111/j.1365-2699.2009.02230.x; Werenkraut V, 2014, J BIOGEOGR, V41, P561, DOI 10.1111/jbi.12210; Werenkraut V, 2011, ECOLOGY, V92, P253, DOI 10.1890/09-2405.1; Wiens JJ, 2010, ECOL LETT, V13, P1310, DOI 10.1111/j.1461-0248.2010.01515.x; Willig MR, 2003, ANNU REV ECOL EVOL S, V34, P273, DOI 10.1146/annurev.ecolsys.34.012103.144032; Yu XD, 2006, FOREST ECOL MANAG, V231, P169, DOI 10.1016/j.foreco.2006.05.043; Yu XD, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069177; Yu XD, 2010, J INSECT CONSERV, V14, P617, DOI 10.1007/s10841-010-9290-6; Ziesche TM, 2008, FOREST ECOL MANAG, V255, P738, DOI 10.1016/j.foreco.2007.09.060	73	5	7	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 3	2016	11	5							e0154659	10.1371/journal.pone.0154659	http://dx.doi.org/10.1371/journal.pone.0154659			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DL5KK	27138752	Green Published, gold, Green Submitted			2022-12-26	WOS:000375675700050
J	Zheng, WN; Tan, TK; Paterson, IC; Mutha, NVR; Siow, CC; Tan, SY; Old, LA; Jakubovics, NS; Choo, SW				Zheng, Wenning; Tan, Tze King; Paterson, Ian C.; Mutha, Naresh V. R.; Siow, Cheuk Chuen; Tan, Shi Yang; Old, Lesley A.; Jakubovics, Nicholas S.; Choo, Siew Woh			StreptoBase: An Oral Streptococcus mitis Group Genomic Resource and Analysis Platform	PLOS ONE			English	Article							HYALURONIC-ACID CAPSULE; PLATELET-AGGREGATION; VIRULENCE; PROTEIN; POLYSACCHARIDE; EXPRESSION; RESISTANCE; GORDONII; LMB; PYOGENES	The oral streptococci are spherical Gram-positive bacteria categorized under the phylum Firmicutes which are among the most common causative agents of bacterial infective endocarditis (IE) and are also important agents in septicaemia in neutropenic patients. The Streptococcus mitis group is comprised of 13 species including some of the most common human oral colonizers such as S. mitis, S. oralis, S. sanguinis and S. gordonii as well as species such as S. tigurinus, S. oligofermentans and S. australis that have only recently been classified and are poorly understood at present. We present StreptoBase, which provides a specialized free resource focusing on the genomic analyses of oral species from the mitis group. It currently hosts 104 S. mitis group genomes including 27 novel mitis group strains that we sequenced using the high throughput Illumina HiSeq technology platform, and provides a comprehensive set of genome sequences for analyses, particularly comparative analyses and visualization of both cross-species and cross-strain characteristics of S. mitis group bacteria. StreptoBase incorporates sophisticated in-house designed bioinformatics web tools such as Pairwise Genome Comparison (PGC) tool and Pathogenomic Profiling Tool (PathoProT), which facilitate comparative pathogenomics analysis of Streptococcus strains. Examples are provided to demonstrate how StreptoBase can be employed to compare genome structure of different S. mitis group bacteria and putative virulence genes profile across multiple streptococcal strains. In conclusion, StreptoBase offers access to a range of streptococci genomic resources as well as analysis tools and will be an invaluable platform to accelerate research in streptococci.	[Zheng, Wenning; Tan, Tze King; Mutha, Naresh V. R.; Siow, Cheuk Chuen; Tan, Shi Yang; Choo, Siew Woh] Univ Malaya, Genome Informat Res Lab, High Impact Res Bldg HIR Bldg, Kuala Lumpur 50603, Malaysia; [Zheng, Wenning; Tan, Tze King; Paterson, Ian C.; Mutha, Naresh V. R.; Tan, Shi Yang; Choo, Siew Woh] Univ Malaya, Fac Dent, Dept Oral Biol & Biomed Sci, Kuala Lumpur 50603, Malaysia; [Paterson, Ian C.] Univ Malaya, Oral Canc Res & Coordinating Ctr, Fac Dent, Kuala Lumpur 50603, Malaysia; [Old, Lesley A.; Jakubovics, Nicholas S.] Newcastle Univ, Sch Dent Sci, Ctr Oral Hlth Res, Framlington Pl, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England; [Jakubovics, Nicholas S.] Univ Malaya, Genome Solut Sdn Bhd, Innovat Incubator UM, Suite 8,Level 5,Res Management & Innovat Complex, Kuala Lumpur 50603, Malaysia	Universiti Malaya; Universiti Malaya; Universiti Malaya; Newcastle University - UK; Universiti Malaya	Choo, SW (corresponding author), Univ Malaya, Genome Informat Res Lab, High Impact Res Bldg HIR Bldg, Kuala Lumpur 50603, Malaysia.; Choo, SW (corresponding author), Univ Malaya, Fac Dent, Dept Oral Biol & Biomed Sci, Kuala Lumpur 50603, Malaysia.; Jakubovics, NS (corresponding author), Newcastle Univ, Sch Dent Sci, Ctr Oral Hlth Res, Framlington Pl, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England.; Jakubovics, NS (corresponding author), Univ Malaya, Genome Solut Sdn Bhd, Innovat Incubator UM, Suite 8,Level 5,Res Management & Innovat Complex, Kuala Lumpur 50603, Malaysia.	nick.jakubovics@ncl.ac.uk; lchoo@um.edu.my	Jakubovics, Nicholas S/B-1938-2010; Paterson, Ian/G-8688-2011	Jakubovics, Nicholas S/0000-0001-6667-0515; Paterson, Ian/0000-0001-9156-401X; Tze King, Tan/0000-0003-1623-615X; Zheng, Wenning/0000-0002-4528-3038	University of Malaya and Ministry of Education (MOHE), Malaysia under the High Impact Research (HIR) Grant [UM.C/HIR/MOHE/08]; UM Research Grant (UMRG) [UMRG: RG541-13HTM]	University of Malaya and Ministry of Education (MOHE), Malaysia under the High Impact Research (HIR) Grant; UM Research Grant (UMRG)	This project was funded by University of Malaya and Ministry of Education (MOHE), Malaysia under the High Impact Research (HIR) Grant UM.C/HIR/MOHE/08 and UM Research Grant (UMRG) [Account No. UMRG: RG541-13HTM]. The funder provided support in the form of salaries for a few authors but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aziz RK, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-75; Bancescu G, 2004, INDIAN J MED RES, V119, P257; Barnard JP, 1996, INFECT IMMUN, V64, P3853, DOI 10.1128/IAI.64.9.3853-3857.1996; BENTLEY RW, 1991, INT J SYST BACTERIOL, V41, P487, DOI 10.1099/00207713-41-4-487; Carver TJ, 2005, BIOINFORMATICS, V21, P3422, DOI 10.1093/bioinformatics/bti553; Chen LH, 2005, NUCLEIC ACIDS RES, V33, pD325, DOI 10.1093/nar/gki008; Chen WY, 2009, J BIOL CHEM, V284, P18007, DOI 10.1074/jbc.M109.011999; Chia JS, 2004, INFECT IMMUN, V72, P2605, DOI 10.1128/IAI.72.5.2605-2617.2004; CLEARY PP, 1979, J BACTERIOL, V140, P1090, DOI 10.1128/JB.140.3.1090-1097.1979; CRATER DL, 1995, J BIOL CHEM, V270, P18452, DOI 10.1074/jbc.270.31.18452; Dmitriev A, 2004, ACTA VET BRNO, V73, P215, DOI 10.2754/avb200473020215; Elsner A, 2002, INFECT IMMUN, V70, P4859, DOI 10.1128/IAI.70.9.4859-4869.2002; Facklam R, 2002, CLIN MICROBIOL REV, V15, P613, DOI 10.1128/CMR.15.4.613-630.2002; Frazer KA, 2004, NUCLEIC ACIDS RES, V32, pW273, DOI 10.1093/nar/gkh458; Hermans PWM, 2006, J BIOL CHEM, V281, P968, DOI 10.1074/jbc.M510014200; Holden MTG, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006072; Huttenhower C, 2012, NATURE, V486, P207, DOI 10.1038/nature11234; Jakubovics NS, 2014, ADV APPL MICROBIOL, V87, P43, DOI 10.1016/B978-0-12-800261-2.00002-5; Johnson M, 2008, NUCLEIC ACIDS RES, V36, pW5, DOI 10.1093/nar/gkn201; Kamio N, 2015, CELL MOL LIFE SCI, V72, P357, DOI 10.1007/s00018-014-1669-1; KAWAMURA Y, 1995, INT J SYST BACTERIOL, V45, P406, DOI 10.1099/00207713-45-2-406; KELLY T, 1994, INFECT IMMUN, V62, P1813, DOI 10.1128/IAI.62.5.1813-1819.1994; KILIAN M, 1989, INT J SYST BACTERIOL, V39, P471, DOI 10.1099/00207713-39-4-471; Kim SJ, 2006, J MICROBIOL BIOTECHN, V16, P1849; Lemos JAC, 2005, CURR ISSUES MOL BIOL, V7, P95; Martin V, 1997, INFECT IMMUN, V65, P2074, DOI 10.1128/IAI.65.6.2074-2079.1997; MCANALLY JR, 1993, ORAL MICROBIOL IMMUN, V8, P69, DOI 10.1111/j.1399-302X.1993.tb00547.x; Moscoso M, 2006, J BACTERIOL, V188, P7785, DOI 10.1128/JB.00673-06; Sanchez CJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028738; Schmidt KH, 1996, MED MICROBIOL IMMUN, V184, P169, DOI 10.1007/PL00008248; Shelburne SA, 2014, EMERG INFECT DIS, V20, P762, DOI 10.3201/eid2005.130953; Shibata Y, 2002, INFECT IMMUN, V70, P2891, DOI 10.1128/IAI.70.6.2891-2898.2002; Silvia A, 2014, INFECT GENET EVOL, V21, P269, DOI 10.1016/j.meegid.2013.11.003; Skinner ME, 2009, GENOME RES, V19, P1630, DOI 10.1101/gr.094607.109; Spellerberg B, 1999, INFECT IMMUN, V67, P871, DOI 10.1128/IAI.67.2.871-878.1999; SULLAM PM, 1987, INFECT IMMUN, V55, P1743, DOI 10.1128/IAI.55.8.1743-1750.1987; Terao Y, 2002, INFECT IMMUN, V70, P993; Tsuda H, 2000, INFECT IMMUN, V68, P644, DOI 10.1128/IAI.68.2.644-650.2000; WESSELS MR, 1991, P NATL ACAD SCI USA, V88, P8317, DOI 10.1073/pnas.88.19.8317; Westling K., 2005, VIRIDANS GROUP STREP; Wibawan IWT, 1999, RES VET SCI, V67, P131, DOI 10.1053/rvsc.1998.0287; Yamashita Y, 1999, J BACTERIOL, V181, P6556, DOI 10.1128/JB.181.20.6556-6559.1999; Yu NY, 2010, BIOINFORMATICS, V26, P1608, DOI 10.1093/bioinformatics/btq249; Zhang YM, 2014, MICROBIOL RES, V169, P395, DOI 10.1016/j.micres.2013.09.007	44	13	15	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 3	2016	11	5							e0151908	10.1371/journal.pone.0151908	http://dx.doi.org/10.1371/journal.pone.0151908			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DL5KK	27138013	Green Published, gold			2022-12-26	WOS:000375675700004
J	Prebensen, C; Lind, A; Dyrhol-Riise, AM; Kvale, D				Prebensen, Christian; Lind, Andreas; Dyrhol-Riise, Anne-Ma; Kvale, Dag			Regulation of Gag- and Env-Specific CD8(+) T Cell Responses in ART-Naive HIV-Infected Patients: Potential Implications for Individualized Immunotherapy	PLOS ONE			English	Article							ANTIRETROVIRAL THERAPY; LYMPHOCYTE ACTIVITY; VIRAL LOAD; TGF-BETA; PROLIFERATION; VIREMIA; PD-1; ASSOCIATION; ACTIVATION; EXPRESSION	Strategies to develop a functional cure for HIV infection will likely require boosting of effector T cell responses to eliminate reactivated, latently infected cells. We have recently explored an assay for assessing antigen-specific regulation of T cell proliferation, which was related to clinical progression in untreated patients and to vaccine efficacy in two trials of therapeutic Gag-based vaccines. We here expand the same assay to further investigate regulation mediated by various inhibitory pathways. Peripheral blood mononuclear cells from 26 asymptomatic HIV-infected, antiretroviral therapy-naive patients were stimulated with Gag and Env overlapping peptide panels for 5 days. Monoclonal antibodies (mAbs) blocking inhibitory mediators interleukin (IL) 10, transforming growth factor (TGF) beta, programmed death ligand (PD-L) 1 and herpes virus entry mediator (HVEM) were added to parallel cultures. Functional T cell regulation (FTR) was defined as the difference in proliferation between stimulated cultures with and without blocking mAbs. FTR was detected in 54% of patients. Blockade of IL-10/PD-L1 and IL10/TGF-beta detected all cases with Gag-and Env-associated FTR, respectively. In accordance with previous findings, isolated Env FTR was associated with higher plasma HIV RNA and lower CD4 counts, while patients with both Gag and Env FTR also had higher Gag-and Env-specific proliferative CD8(+) T cell responses. There was no association between FTR and frequencies of activated regulatory T cells. In conclusion, we observed substantial heterogeneity in FTR between patients, inhibitory pathways and HIV antigens. FTR may help to individualize immunomodulation and warrants further assessment in clinical immunotherapy trials.	[Prebensen, Christian; Lind, Andreas; Dyrhol-Riise, Anne-Ma; Kvale, Dag] Oslo Univ Hosp, Dept Infect Dis, Oslo, Norway; [Prebensen, Christian; Dyrhol-Riise, Anne-Ma; Kvale, Dag] Univ Oslo, Inst Clin Med, Oslo, Norway; [Prebensen, Christian; Dyrhol-Riise, Anne-Ma; Kvale, Dag] Univ Oslo, KG Jebsen Inflammat Ctr, Oslo, Norway	University of Oslo; University of Oslo; University of Oslo	Kvale, D (corresponding author), Oslo Univ Hosp, Dept Infect Dis, Oslo, Norway.; Kvale, D (corresponding author), Univ Oslo, Inst Clin Med, Oslo, Norway.; Kvale, D (corresponding author), Univ Oslo, KG Jebsen Inflammat Ctr, Oslo, Norway.	dag.kvale@medisin.uio.no	Lind, Andreas/AAN-3730-2021	Lind, Andreas/0000-0002-8289-8410; Kvale, Dag/0000-0001-6410-2530	Norwegian Health Region South-East [2013033]; Research Council of Norway (GLOBVAC) [192514]	Norwegian Health Region South-East; Research Council of Norway (GLOBVAC)	This work was supported by the Norwegian Health Region South-East (Grant #2013033) and The Research Council of Norway (GLOBVAC grant #192514), both recieved by DK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amarnath S, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3003130; Betts MR, 2006, BLOOD, V107, P4781, DOI 10.1182/blood-2005-12-4818; Betts MR, 1999, AIDS RES HUM RETROV, V15, P1219, DOI 10.1089/088922299310313; Blackburn SD, 2009, NAT IMMUNOL, V10, P29, DOI 10.1038/ni.1679; Boehm U, 1997, ANNU REV IMMUNOL, V15, P749, DOI 10.1146/annurev.immunol.15.1.749; BORROW P, 1994, J VIROL, V68, P6103, DOI 10.1128/JVI.68.9.6103-6110.1994; Boyman O, 2012, NAT REV IMMUNOL, V12, P180, DOI 10.1038/nri3156; Brandt L, 2013, JAIDS-J ACQ IMM DEF, V63, P418, DOI 10.1097/QAI.0b013e31828fa22b; Brekke K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112556; Brockman MA, 2009, BLOOD, V114, P346, DOI 10.1182/blood-2008-12-191296; Chun TW, 2010, AIDS, V24, P2803, DOI 10.1097/QAD.0b013e328340a239; Corinti S, 2001, J IMMUNOL, V166, P4312, DOI 10.4049/jimmunol.166.7.4312; Deeks SG, 2013, LANCET, V382, P1525, DOI 10.1016/S0140-6736(13)61809-7; Deeks SG, 2012, NAT REV IMMUNOL, V12, P607, DOI 10.1038/nri3262; Edwards BH, 2002, J VIROL, V76, P2298, DOI 10.1128/JVI.76.5.2298-2305.2002; Fantini MC, 2004, J IMMUNOL, V172, P5149, DOI 10.4049/jimmunol.172.9.5149; Francisco LM, 2009, J EXP MED, V206, P3015, DOI 10.1084/jem.20090847; Garba ML, 2002, J IMMUNOL, V168, P2247, DOI 10.4049/jimmunol.168.5.2247; Goulder PJR, 2001, J VIROL, V75, P1339, DOI 10.1128/JVI.75.3.1339-1347.2001; Horton H, 2006, J IMMUNOL, V177, P7406, DOI 10.4049/jimmunol.177.10.7406; Hryniewicz A, 2006, BLOOD, V108, P3834, DOI 10.1182/blood-2006-04-010637; Kalams SA, 1999, J VIROL, V73, P6715, DOI 10.1128/JVI.73.8.6715-6720.1999; Kaufmann DE, 2009, J IMMUNOL, V182, P5891, DOI 10.4049/jimmunol.0803771; Kiepiela P, 2007, NAT MED, V13, P46, DOI 10.1038/nm1520; KOUP RA, 1994, J VIROL, V68, P4650, DOI 10.1128/JVI.68.7.4650-4655.1994; Kretschmer K, 2005, NAT IMMUNOL, V6, P1219, DOI 10.1038/ni1265; Lind A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085604; Lind A, 2013, VACCINE, V31, P4611, DOI 10.1016/j.vaccine.2013.07.037; Lozano JM, 2007, AIDS RES HUM RETROV, V23, P1279, DOI 10.1089/aid.2007.0082; McKinnon LR, 2012, IMMUNOL CELL BIOL, V90, P346, DOI 10.1038/icb.2011.44; Migueles SA, 2002, NAT IMMUNOL, V3, P1061, DOI 10.1038/ni845; Migueles SA, 2009, J VIROL, V83, P11876, DOI 10.1128/JVI.01153-09; Miyara M, 2009, IMMUNITY, V30, P899, DOI 10.1016/j.immuni.2009.03.019; Pantaleo G, 1997, P NATL ACAD SCI USA, V94, P9848, DOI 10.1073/pnas.94.18.9848; Peretz Y, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002840; Porichis F, 2014, J VIROL, V88, P2508, DOI 10.1128/JVI.02034-13; Saez-Cirion A, 2007, P NATL ACAD SCI USA, V104, P6776, DOI 10.1073/pnas.0611244104; Shan L, 2012, IMMUNITY, V36, P491, DOI 10.1016/j.immuni.2012.01.014; Shanker P, 2000, BLOOD, V96, P3094, DOI 10.1182/blood.V96.9.3094.h8003094_3094_3101; Trautmann L, 2006, NAT MED, V12, P1198, DOI 10.1038/nm1482; Velu V, 2015, RETROVIROLOGY, V12, DOI 10.1186/s12977-015-0144-x; Wang L, 2008, P NATL ACAD SCI USA, V105, P9331, DOI 10.1073/pnas.0710441105	42	2	2	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 29	2016	11	4							e0153849	10.1371/journal.pone.0153849	http://dx.doi.org/10.1371/journal.pone.0153849			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DK8XM	27128502	Green Published, Green Submitted, gold			2022-12-26	WOS:000375212600016
J	Kayamori, K; Katsube, K; Sakamoto, K; Ohyama, Y; Hirai, H; Yukimori, A; Ohata, Y; Akashi, T; Saitoh, M; Harada, K; Harada, H; Yamaguchi, A				Kayamori, Kou; Katsube, Ken-ichi; Sakamoto, Kei; Ohyama, Yoshio; Hirai, Hideaki; Yukimori, Akane; Ohata, Yae; Akashi, Takumi; Saitoh, Masao; Harada, Kiyoshi; Harada, Hiroyuki; Yamaguchi, Akira			NOTCH3 Is Induced in Cancer-Associated Fibroblasts and Promotes Angiogenesis in Oral Squamous Cell Carcinoma	PLOS ONE			English	Article							TUMOR MICROENVIRONMENT; COLORECTAL-CANCER; OVARIAN-CANCER; EXPRESSION; ACTIVATION; PERICYTES; GENE; MODULATION; RECURRENCE; THERAPIES	Recent studies have shown that Notch signaling is involved in many types of cancers, including oral squamous cell carcinomas (OSCCs). However, the role of Notch signaling in the tumor microenvironment is not yet fully understood. In this study, we investigated the roles of NOTCH3 signaling in cancer associated fibroblasts (CAFs) in OSCCs. Immunohistochemical study of 93 human tongue OSCC cases indicated that about one third of OSCCs showed NOTCH3 expression in CAFs, and that this expression significantly correlated with tumor-size. In vitro study showed that OSCC cell lines, especially HO1-N-1 cells stimulated NOTCH3 expression in normal human dermal fibroblasts (NHDFs) through direct cell-to-cell contact. Immunohistochemical and morphometric analysis using human OSCC samples demonstrated that NOTCH3 expression in CAFs significantly correlated with micro-vessel density in cancer stroma. In vitro angiogenesis assays involving coculture of NHDFs with HO1-N-1 and human umbilical endothelial cells (HUVECs), and NOTCH3 knockdown in NHDFs using siRNA, demonstrated that HO1-N-1 cells significantly promoted tube formation dependent on NOTCH3-expression in NHDFs. Moreover, NOTCH3 expression in CAFs was related to poor prognosis of the OSCC patients. This work provides a new insight into the role of Notch signaling in CAFs associated with tumor angiogenesis and the possibility of NOTCH3-targeted molecular therapy in OSCCs.	[Kayamori, Kou; Katsube, Ken-ichi; Sakamoto, Kei; Yukimori, Akane; Ohata, Yae; Yamaguchi, Akira] Tokyo Med & Dent Univ, Grad Sch Med & Dent Sci, Dept Oral Pathol, Tokyo, Japan; [Ohyama, Yoshio; Harada, Kiyoshi] Tokyo Med & Dent Univ, Grad Sch Med & Dent Sci, Dept Maxillofacial Surg, Tokyo, Japan; [Hirai, Hideaki; Harada, Hiroyuki] Tokyo Med & Dent Univ, Grad Sch Med & Dent Sci, Dept Oral & Maxillofacial Surg, Tokyo, Japan; [Akashi, Takumi] Tokyo Med & Dent Univ, Grad Sch Med & Dent Sci, Dept Surg Pathol, Tokyo, Japan; [Katsube, Ken-ichi] Tohto Coll Hlth Sci, Dept Human Care, Saitama, Japan; [Saitoh, Masao] Univ Yamanashi, Dept Biochem, Interdisciplinary Grad Sch Med & Engn, Yamanashi, Japan; [Yamaguchi, Akira] Tokyo Dent Coll, Dept Oral Hlth Sci Ctr, Tokyo, Japan	Tokyo Medical & Dental University (TMDU); Tokyo Medical & Dental University (TMDU); Tokyo Medical & Dental University (TMDU); Tokyo Medical & Dental University (TMDU); University of Yamanashi; Tokyo Dental College	Kayamori, K (corresponding author), Tokyo Med & Dent Univ, Grad Sch Med & Dent Sci, Dept Oral Pathol, Tokyo, Japan.	kayamori.mpa@tmd.ac.jp	Yamaguchi, Akira/AAX-9286-2020		Japan Society for the Promotion of Science [KAKENHI 26861543, 20233760, KAKENHI 25253098]; Grants-in-Aid for Scientific Research [25253098, 25462915] Funding Source: KAKEN	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by the Japan Society for the Promotion of Science: Grant-in-aid for Young Scientists (B) (KAKENHI 26861543 to Kou Kayamori) and Scientific Research (C) (20233760 to Ken-ichi Katsube). This work was also supported by the Japan Society for the Promotion of Science: Grant-in-Aid for Scientific Research (A) (KAKENHI 25253098 to Akira Yamaguchi).	Agrawal N, 2011, SCIENCE, V333, P1154, DOI 10.1126/science.1206923; Artavanis-Tsakonas S, 1999, SCIENCE, V284, P770, DOI 10.1126/science.284.5415.770; Bello IO, 2011, ORAL ONCOL, V47, P33, DOI 10.1016/j.oraloncology.2010.10.013; Bergers G, 2005, NEURO-ONCOLOGY, V7, P452, DOI 10.1215/S1152851705000232; Brakenhoff RH, 2011, SCIENCE, V333, P1102, DOI 10.1126/science.1210986; Castells M, 2012, INT J MOL SCI, V13, P9545, DOI 10.3390/ijms13089545; Chi AC, 2015, CA CANC J CLIN; Daly AJ, 2008, ORAL ONCOL, V44, P646, DOI 10.1016/j.oraloncology.2007.08.012; Fujii N, 2012, J ORAL PATHOL MED, V41, P444, DOI 10.1111/j.1600-0714.2012.01127.x; Fullar A, 2012, EXP CELL RES, V318, P1517, DOI 10.1016/j.yexcr.2012.03.023; Gerhardt H, 2003, CELL TISSUE RES, V314, P15, DOI 10.1007/s00441-003-0745-x; Gokcinar-Yagci B, 2015, STEM CELL REV REP, V11, P549, DOI 10.1007/s12015-015-9590-z; Gorsky M, 2004, ORAL SURG ORAL MED O, V98, P546, DOI 10.1016/j.tripleo.2003.12.041; Hellstrom M, 2007, NATURE, V445, P776, DOI 10.1038/nature05571; Hetheridge C, 2011, BIOCHEM SOC T, V39, P1597, DOI 10.1042/BST20110738; Jemal A, 2009, CA-CANCER J CLIN, V59, P225, DOI 10.3322/caac.20006; Joutel A, 2011, BIOESSAYS, V33, P73, DOI 10.1002/bies.201000093; Kalluri R, 2006, NAT REV CANCER, V6, P392, DOI 10.1038/nrc1877; Kangsamaksin T, 2014, BIOCHEM SOC T, V42, P1563, DOI 10.1042/BST20140233; Kayamori K, 2010, AM J PATHOL, V176, P968, DOI 10.2353/ajpath.2010.090299; Kellermann MG, 2008, ORAL ONCOL, V44, P509, DOI 10.1016/j.oraloncology.2007.07.001; Kopan R, 2009, CELL, V137, P216, DOI 10.1016/j.cell.2009.03.045; Lau TS, 2014, J PATHOL, V232, P43, DOI 10.1002/path.4258; Lilly B, 2009, PHYSIOL GENOMICS, V36, P69, DOI 10.1152/physiolgenomics.90318.2008; Liu H, 2010, CIRC RES, V107, P860, DOI 10.1161/CIRCRESAHA.110.218271; Liu H, 2009, CIRC RES, V104, P466, DOI 10.1161/CIRCRESAHA.108.184846; Madar S, 2013, TRENDS MOL MED, V19, P447, DOI 10.1016/j.molmed.2013.05.004; Manderfield LJ, 2012, CIRCULATION, V125, P314, DOI 10.1161/CIRCULATIONAHA.111.047159; Mann CD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051119; MOMOSE F, 1989, J ORAL PATHOL MED, V18, P391, DOI 10.1111/j.1600-0714.1989.tb01570.x; Neves J, 2013, DEV GROWTH DIFFER, V55, P96, DOI 10.1111/dgd.12016; Ntziachristos P, 2014, CANCER CELL, V25, P318, DOI 10.1016/j.ccr.2014.02.018; Ozawa T, 2014, ANN SURG ONCOL, V21, P2650, DOI 10.1245/s10434-014-3659-9; Pannequin J, 2009, CANCER RES, V69, P6065, DOI 10.1158/0008-5472.CAN-08-2409; Park JT, 2010, AM J PATHOL, V177, P1087, DOI 10.2353/ajpath.2010.100316; Penton AL, 2012, SEMIN CELL DEV BIOL, V23, P450, DOI 10.1016/j.semcdb.2012.01.010; Pickering CR, 2013, CANCER DISCOV, V3, P770, DOI 10.1158/2159-8290.CD-12-0537; Ranganathan P, 2011, NAT REV CANCER, V11, P338, DOI 10.1038/nrc3035; Sainson RCA, 2008, ANGIOGENESIS, V11, P41, DOI 10.1007/s10456-008-9098-0; Sakamoto K, 2012, LAB INVEST, V92, P688, DOI 10.1038/labinvest.2012.9; Shi CL, 2014, CELL PHYSIOL BIOCHEM, V34, P743, DOI 10.1159/000363039; Sobral LM, 2011, ORAL ONCOL, V47, P840, DOI 10.1016/j.oraloncology.2011.06.011; Sun Y, 2015, MED RES REV, V35, P408, DOI 10.1002/med.21338; Terrinoni A, 2013, P NATL ACAD SCI USA, V110, P7300, DOI 10.1073/pnas.1214498110; van Dijk CGM, 2015, INT J CARDIOL, V190, P75, DOI 10.1016/j.ijcard.2015.03.258; Yen WC, 2015, CLIN CANCER RES, V21, P2084, DOI 10.1158/1078-0432.CCR-14-2808; Zhang P, 2014, SCI CHINA LIFE SCI, V57, P774, DOI 10.1007/s11427-014-4716-0; Zhang TH, 2011, J ORAL PATHOL MED, V40, P37, DOI 10.1111/j.1600-0714.2010.00931.x	48	31	34	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 28	2016	11	4							e0154112	10.1371/journal.pone.0154112	http://dx.doi.org/10.1371/journal.pone.0154112			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DK8XE	27124156	Green Published, gold			2022-12-26	WOS:000375211700046
J	Wang, K; Peng, X; Zuo, YY; Li, YT; Chen, MH				Wang, Kang; Peng, Xiong; Zuo, Yayun; Li, Yuting; Chen, Maohua			Molecular Cloning, Expression Pattern and Polymorphisms of NADPH-Cytochrome P450 Reductase in the Bird Cherry-Oat Aphid Rhopalosiphum padi (L.)	PLOS ONE			English	Article							3-DIMENSIONAL STRUCTURE; FUNCTIONAL EXPRESSION; METABOLIC RESISTANCE; ANOPHELES-MINIMUS; ELECTRON-TRANSFER; STRUCTURAL BASIS; OXIDOREDUCTASE; BINDING; GENE; BIOSYNTHESIS	NADPH-cytochrome P450 reductase (CPR) plays an important role in the cytochrome P450 (CYP)-mediated metabolism of endogenous and exogenous substrates. CPR has been found to be associated with insecticide metabolism and resistance in many insects. However, information regarding CPR in the bird cherry-oat aphid, Rhopalosiphum padi, is unavailable. In the current study, a full-length cDNA (2,476 bp) of CPR (RpCPR) encoding 681 amino acids was cloned from R. padi. Nucleotide sequence and deduced amino acid sequence analysis showed that RpCPR exhibits characteristics of classical CPRs and shares high identities with those of other insects, especially with the pea aphid, Acyrthosiphon pisum. The mRNA of RpCPR was expressed at all developmental stages, with the highest expression level found in the second instar and the lowest in adult. Expression levels of RpCPR in isoprocarb-resistant and imidacloprid-resistant strains were 3.74- and 3.53-fold higher, respectively, than that of a susceptible strain. RpCPR expression could also be induced by low concentrations (LC30) of isoprocarb and imidacloprid. Moreover, we sequenced the open reading frame (ORF) of RpCPR from 167 field samples collected in 11 geographical populations. Three hundred and thirty-four SNPs were detected, of which, 65 were found in more than two individuals. One hundred and ninety-four missense mutations were present in the amino acid sequence, of which, the P484S mutant had an allele frequency of 35.1%. The present results suggest that RpCPR may play an important role in the P450-mediated insecticide resistance of R. padi to isoprocarb and imidacloprid and possibly other insecticides. Meanwhile, RpCPRmaintains high genetic diversity in natural individuals, which provides the possibility of studying potential correlations between variants and certain special physiological characters.	[Wang, Kang; Peng, Xiong; Zuo, Yayun; Li, Yuting; Chen, Maohua] Northwest A&F Univ, Coll Plant Protect, Yangling, Peoples R China; [Chen, Maohua] Minist Agr, Key Lab Crop Pest Integrated Pest Management Loes, Yangling, Peoples R China	Northwest A&F University - China; Ministry of Agriculture & Rural Affairs	Chen, MH (corresponding author), Northwest A&F Univ, Coll Plant Protect, Yangling, Peoples R China.; Chen, MH (corresponding author), Minist Agr, Key Lab Crop Pest Integrated Pest Management Loes, Yangling, Peoples R China.	maohua.chen@nwsuaf.edu.cn			National Natural Science Foundation of China [31471766, 31272036]; Doctoral Program Foundation of Institutions of Higher Education of China [20110204110001]; National Key Technology R&D Program of the Ministry of Science and Technology [2012BAK11B03]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Doctoral Program Foundation of Institutions of Higher Education of China(Specialized Research Fund for the Doctoral Program of Higher Education (SRFDP)); National Key Technology R&D Program of the Ministry of Science and Technology(National Key Technology R&D Program)	This work was funded by the National Natural Science Foundation of China (grant nos. 31471766 and 31272036), the Doctoral Program Foundation of Institutions of Higher Education of China (grant no. 20110204110001) and the National Key Technology R&D Program of the Ministry of Science and Technology (grant no. 2012BAK11B03). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aigrain L, 2012, INT J MOL SCI, V13, P15012, DOI 10.3390/ijms131115012; Aliferis KA, 2011, PESTIC BIOCHEM PHYS, V100, P105, DOI 10.1016/j.pestbp.2011.03.004; Backes WL, 2003, PHARMACOL THERAPEUT, V98, P221, DOI 10.1016/S0163-7258(03)00031-7; Bass C, 2011, BMC NEUROSCI, V12, DOI 10.1186/1471-2202-12-51; BLACKMAN R.L., 1984, ORIENT INSECTS; BRATTSTEN LB, 1986, SCIENCE, V231, P1255, DOI 10.1126/science.231.4743.1255; CARINO FA, 1994, INSECT BIOCHEM MOLEC, V24, P411, DOI 10.1016/0965-1748(94)90034-5; Chen MH, 2007, GENOME, V50, P172, DOI 10.1139/G07-021; Chen XE, 2015, GENE, V558, P208, DOI 10.1016/j.gene.2014.12.053; Du ZQ, 2007, J PLANT PATHOL, V89, P251; Feyereisen R., 2005, P1; Fluck CE, 2004, NAT GENET, V36, P228, DOI 10.1038/ng1300; Foster SP, 2007, APHIDS AS CROP PESTS, P261, DOI 10.1079/9780851998190.0261; Gilbert LI, 2005, VITAM HORM, V73, P31, DOI 10.1016/S0083-6729(05)73002-8; Helvig C, 2004, P NATL ACAD SCI USA, V101, P4024, DOI 10.1073/pnas.0306980101; Henderson CJ, 2003, J BIOL CHEM, V278, P13480, DOI 10.1074/jbc.M212087200; Horike N, 2000, EUR J BIOCHEM, V267, P6914, DOI 10.1046/j.1432-1033.2000.01796.x; Hovemann BT, 1997, GENE, V189, P213, DOI 10.1016/S0378-1119(96)00851-7; Huang N, 2008, P NATL ACAD SCI USA, V105, P1733, DOI 10.1073/pnas.0711621105; Hubbard PA, 2001, J BIOL CHEM, V276, P29163, DOI 10.1074/jbc.M101731200; Ingelman M, 1997, J MOL BIOL, V268, P147, DOI 10.1006/jmbi.1997.0957; Iyanagi T, 2012, ARCH BIOCHEM BIOPHYS, V528, P72, DOI 10.1016/j.abb.2012.09.002; Kaewpa D, 2007, J ECON ENTOMOL, V100, P946, DOI 10.1603/0022-0493(2007)100[946:FEOMNP]2.0.CO;2; Kang XL, 2016, ARCH INSECT BIOCH; KOENER JF, 1993, INSECT BIOCHEM MOLEC, V23, P439, DOI 10.1016/0965-1748(93)90051-S; Lamb DC, 2006, STRUCTURE, V14, P51, DOI 10.1016/j.str.2005.09.015; Li XC, 2007, ANNU REV ENTOMOL, V52, P231, DOI 10.1146/annurev.ento.51.110104.151104; Li ZQ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083180; Lian LY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020574; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; Liu NN, 2015, PESTIC BIOCHEM PHYS, V120, P77, DOI 10.1016/j.pestbp.2015.01.006; Liu NN, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023403; Liu S, 2015, PEST MANAG SCI, V71, P32, DOI 10.1002/ps.3760; Lycett GJ, 2006, INSECT MOL BIOL, V15, P321, DOI 10.1111/j.1365-2583.2006.00647.x; Maibeche-Coisne M, 2005, GENE, V346, P195, DOI 10.1016/j.gene.2004.11.010; Marohnic CC, 2006, J BIOL CHEM, V281, P35975, DOI 10.1074/jbc.M607095200; Marohnic CC, 2010, DRUG METAB DISPOS, V38, P332, DOI 10.1124/dmd.109.030445; Medina-Ortega KJ, 2009, ENVIRON ENTOMOL, V38, P836, DOI 10.1603/022.038.0337; Muller P, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000286; Murataliev MB, 2004, BBA-PROTEINS PROTEOM, V1698, P1, DOI 10.1016/j.bbapap.2003.10.003; Pandey AV, 2007, MOL ENDOCRINOL, V21, P2579, DOI 10.1210/me.2007-0245; Pandey AV, 2013, PHARMACOL THERAPEUT, V138, P229, DOI 10.1016/j.pharmthera.2013.01.010; Petryk A, 2003, P NATL ACAD SCI USA, V100, P13773, DOI 10.1073/pnas.2336088100; Pompon D, 1996, METHOD ENZYMOL, V272, P51, DOI 10.1016/S0076-6879(96)72008-6; Porter TD, 2002, J BIOCHEM MOL TOXIC, V16, P311, DOI 10.1002/jbt.10052; Puinean AM, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000999; Qiu Y, 2012, P NATL ACAD SCI USA, V109, P14858, DOI 10.1073/pnas.1208650109; Ramsey JS, 2010, INSECT MOL BIOL, V19, P155, DOI 10.1111/j.1365-2583.2009.00973.x; ROCHOW WF, 1969, PHYTOPATHOLOGY, V59, P1580; Sandstrom P, 2006, INSECT BIOCHEM MOLEC, V36, P835, DOI 10.1016/j.ibmb.2006.08.004; Sarapuist S, 2008, ARCH BIOCHEM BIOPHYS, V477, P53, DOI 10.1016/j.abb.2008.05.012; Sarapusit S, 2013, INT J MOL SCI, V14, P1788, DOI 10.3390/ijms14011788; Sekun N. P., 1990, Zashchita Rastenii (Kiev), V37, P49; Shen AL, 1999, J BIOL CHEM, V274, P5391, DOI 10.1074/jbc.274.9.5391; Silva AX, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036366; Silva AX, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036810; Sukhoruchenko G. I., 2008, Bulletin OEPP, V38, P119, DOI 10.1111/j.1365-2338.2008.01194.x; SZCZESNASKORUPA E, 1995, J BIOL CHEM, V270, P24327, DOI 10.1074/jbc.270.41.24327; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Wang M, 1997, P NATL ACAD SCI USA, V94, P8411, DOI 10.1073/pnas.94.16.8411; Waskell L., 2015, CYTOCHROME P450 STRU, P33, DOI [DOI 10.1007/978-3-319-12108-6, DOI 10.1007/978-3-319-12108-6_9]; Xia CW, 2011, P NATL ACAD SCI USA, V108, P13486, DOI 10.1073/pnas.1106632108; Yang T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029418; Zhang M, 2016, PESTIC BIOCHEM PHYS, V132, P89, DOI 10.1016/j.pestbp.2016.02.008; Zhao CQ, 2014, PEST MANAG SCI, V70, P130, DOI 10.1002/ps.3538; Zhu F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031037; Zuo YY, 2016, FLA ENTOMOL	67	21	22	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 28	2016	11	4							e0154633	10.1371/journal.pone.0154633	http://dx.doi.org/10.1371/journal.pone.0154633			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DK8XE	27124302	Green Published, gold			2022-12-26	WOS:000375211700117
J	Zhang, PS; Yang, XW; Yin, Q; Yi, JL; Shen, WZ; Zhao, L; Zhu, Z; Liu, JW				Zhang, Panshi; Yang, Xiaowei; Yin, Qian; Yi, Jilin; Shen, Wenzhuang; Zhao, Lu; Zhu, Zhi; Liu, Jinwen			Inhibition of SK4 Potassium Channels Suppresses Cell Proliferation, Migration and the Epithelial-Mesenchymal Transition in Triple-Negative Breast Cancer Cells	PLOS ONE			English	Article							CA2+-ACTIVATED K+ CHANNELS; FIBROBLASTS DERIVE; INTERMEDIATE; BLOCKAGE; IDENTIFICATION; HEPATOCYTES; EXPRESSION; FIBROSIS; GENE; IK	Treatments for triple-negative breast cancer (TNBC) are limited; intermediate-conductance calcium-activated potassium (SK4) channels are closely involved in tumor progression, but little is known about these channels in TNBC. We aimed to investigate whether SK4 channels affect TNBC. First, by immunohistochemistry (IHC) and western blotting (WB), increased SK4 protein expression in breast tumor tissues was detected relative to that in non-tumor breast tissues, but there was no apparent expression difference between various subtypes of breast cancer (p>0.05). Next, functional SK4 channels were detected in the TNBC cell line MDA-MB-231 using WB, real-time PCR, immunofluorescence and patch-clamp recording. By employing SK4 specific siRNAs and blockers, including TRAM-34 and clotrimazole, in combination with an MTT assay, a colony-formation assay, flow cytometry and a cell motility assay, we found that the suppression of SK4 channels significantly inhibited cell proliferation and migration and promoted apoptosis in MDA-MB-231 cells (p<0.05). Further investigation revealed that treatment with epidermal growth factor (EGF)/basic fibroblast growth factor (bFGF) caused MDA-MB-231 cells to undergo the epithelial-mesenchymal transition (EMT) and to show increased SK4 mRNA expression. In addition, the downregulation of SK4 expression inhibited the EMT markers Vimentin and Snail1. Collectively, our findings suggest that SK4 channels are expressed in TNBC and are involved in the proliferation, apoptosis, migration and EMT processes of TNBC cells.	[Zhang, Panshi; Yin, Qian; Yi, Jilin; Shen, Wenzhuang; Zhao, Lu; Zhu, Zhi; Liu, Jinwen] Huazhong Univ Sci & Technol, Dept Thyroid & Breast Surg, Tongji Hosp, Tongji Med Coll, Wuhan 430074, Peoples R China; [Yang, Xiaowei] Anhui Med Univ, Affiliated Hosp 1, Dept Gen Surg, Hefei, Peoples R China	Huazhong University of Science & Technology; Anhui Medical University	Liu, JW (corresponding author), Huazhong Univ Sci & Technol, Dept Thyroid & Breast Surg, Tongji Hosp, Tongji Med Coll, Wuhan 430074, Peoples R China.	liujinwen@tjh.tjmu.edu.cn			National Natural Science Foundation of China [81372204]; Natural Science Foundation of Hubei Province, China [2011CDB556]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Hubei Province, China(Natural Science Foundation of Hubei Province)	This work was funded by the National Natural Science Foundation of China (No. 81372204) (website: http://www.nsfc.gov.cn/publish/portal1/), and by the Natural Science Foundation of Hubei Province, China (No. 2011CDB556) (website: http://www.hbstd.gov.cn/). Jinwen Liu received the funding. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Nieto MA, 2013, SCIENCE, V342, P708, DOI 10.1126/science.1234850; Nieto MA, 2011, ANNU REV CELL DEV BI, V27, P347, DOI 10.1146/annurev-cellbio-092910-154036; AYUB M, 1990, BIOCHEM PHARMACOL, V40, P1569, DOI 10.1016/0006-2952(90)90456-U; Brewster AM, 2014, LANCET ONCOL, V15, pE625, DOI 10.1016/S1470-2045(14)70364-X; Brown KA, 2004, BREAST CANCER RES, V6, pR215, DOI 10.1186/bcr778; Chen MX, 2004, N-S ARCH PHARMACOL, V369, P602, DOI 10.1007/s00210-004-0934-5; Fioretti B, 2006, CELL PHYSIOL BIOCHEM, V18, P47, DOI 10.1159/000095135; Foulkes WD, 2010, NEW ENGL J MED, V363, P1938, DOI 10.1056/NEJMra1001389; Fowler SM, 2000, BIOCHEMISTRY-US, V39, P4406, DOI 10.1021/bi992372u; Fu RG, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087410; Ghanshani S, 1998, GENOMICS, V51, P160, DOI 10.1006/geno.1998.5333; Ishii TM, 1997, P NATL ACAD SCI USA, V94, P11651, DOI 10.1073/pnas.94.21.11651; Iwano M, 2002, J CLIN INVEST, V110, P341, DOI 10.1172/JCI200215518; Jager H, 2004, MOL PHARMACOL, V65, P630, DOI 10.1124/mol.65.3.630; Joiner WJ, 1997, P NATL ACAD SCI USA, V94, P11013, DOI 10.1073/pnas.94.20.11013; Kohler R, 2003, CIRCULATION, V108, P1119, DOI 10.1161/01.CIR.0000086464.04719.DD; Lai W, 2013, MED ONCOL, V30, DOI 10.1007/s12032-013-0566-z; Logsdon NJ, 1997, J BIOL CHEM, V272, P32723, DOI 10.1074/jbc.272.52.32723; MAURICE M, 1992, FASEB J, V6, P752, DOI 10.1096/fasebj.6.2.1371482; McFerrin MB, 2012, AM J PHYSIOL-CELL PH, V303, pC1070, DOI 10.1152/ajpcell.00040.2012; Metzger O, 2012, J CLIN ONCOL, V30, P1879, DOI 10.1200/JCO.2011.38.2010; Neve RM, 2006, CANCER CELL, V10, P515, DOI 10.1016/j.ccr.2006.10.008; Neylon CB, 1999, CIRC RES, V85, pE33, DOI 10.1161/01.RES.85.9.e33; Ouadid-Ahidouch H, 2004, AM J PHYSIOL-CELL PH, V287, pC125, DOI 10.1152/ajpcell.00488.2003; Pardo LA, 2014, NAT REV CANCER, V14, P39, DOI 10.1038/nrc3635; Parihar AS, 2003, EUR J PHARMACOL, V471, P157, DOI 10.1016/S0014-2999(03)01825-9; Pena TL, 1999, J MEMBRANE BIOL, V172, P249, DOI 10.1007/s002329900601; Potier M, 2006, MOL CANCER THER, V5, P2946, DOI 10.1158/1535-7163.MCT-06-0194; Roach KM, 2014, RESP RES, V15, DOI 10.1186/s12931-014-0155-5; Roy JW, 2010, BRIT J PHARMACOL, V159, P650, DOI 10.1111/j.1476-5381.2009.00557.x; Ruggieri P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047825; Sarrio D, 2008, CANCER RES, V68, P989, DOI 10.1158/0008-5472.CAN-07-2017; Schmidt J, 2010, CELL RES, V20, P1224, DOI 10.1038/cr.2010.121; Sleeman JP, 2011, CELL, V145, DOI 10.1016/j.cell.2011.03.029; Tajima N, 2006, J PHYSIOL-LONDON, V571, P349, DOI 10.1113/jphysiol.2005.096818; Thiery JP, 2009, CELL, V139, P871, DOI 10.1016/j.cell.2009.11.007; Torre LA, 2015, CA-CANCER J CLIN, V65, P87, DOI 10.3322/caac.21262; Wang ZH, 2007, ONCOGENE, V26, P5107, DOI 10.1038/sj.onc.1210308; Wei AD, 2005, PHARMACOL REV, V57, P463, DOI 10.1124/pr.57.4.9; Wulff H, 2000, P NATL ACAD SCI USA, V97, P8151, DOI 10.1073/pnas.97.14.8151; Wulff Heike, 2010, Expert Rev Clin Pharmacol, V3, P385, DOI 10.1586/ecp.10.11; Yang XW, 2013, J HUAZHONG U SCI-MED, V33, P86, DOI 10.1007/s11596-013-1076-0; Zeisberg M, 2007, J BIOL CHEM, V282, P23337, DOI 10.1074/jbc.M700194200	43	34	36	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 28	2016	11	4							e0154471	10.1371/journal.pone.0154471	http://dx.doi.org/10.1371/journal.pone.0154471			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DK8XE	27124117	Green Published, gold			2022-12-26	WOS:000375211700095
J	Wilson, M; Tsakraklides, V; Tran, M; Xiao, YY; Zhang, Y; Perkins, AS				Wilson, Michael; Tsakraklides, Vasiliki; Minh Tran; Xiao, Ying-Yi; Zhang, Yi; Perkins, Archibald S.			EVI1 Interferes with Myeloid Maturation via Transcriptional Repression of Cebpa, via Binding to Two Far Downstream Regulatory Elements	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						CCAAT-enhancer-binding protein (CEBP); leukemia; myeloid cell; transcription regulation; transcription target gene	POINT MUTATIONS; GENE-TRANSFER; ZINC FINGERS; EXPRESSION; DIFFERENTIATION; PROTEIN; CELLS; DNA; IDENTIFICATION; ENHANCERS	One mechanism by which oncoproteins work is through perturbation of cellular maturation; understanding the mechanisms by which this occurs can lead to the development of targeted therapies. EVI1 is a zinc finger oncoprotein involved in the development of acute myeloid leukemia; previous work has shown it to interfere with the maturation of granulocytes from immature precursors. Here we investigate the mechanism by which that occurs, using an immortalized hematopoietic progenitor cell line, EML-C1, as a model system. We document that overexpression of EVI1 abrogates retinoic acid-induced maturation of EML cells into committed myeloid cells, a process that can be documented by the down-regulation of stem cell antigen-1 and acquisition of responsiveness to granulocyte-macrophage colony-stimulating factor. We show that this requires DNA binding capacity of EVI1, suggesting that downstream target genes are involved. We identify the myeloid regulator Cebpa as a target gene and identify two EVI1 binding regions within evolutionarily conserved enhancer elements at +35 and +37 kb relative to the gene. EVI1 can strongly suppress Cebpa transcription, and add-back of Cebpa into EVI1-expressing EML cells partially corrects the block in maturation. We identify the DNA sequences to which EVI1 binds at +35 and +37 kb and show that mutation of one of these releases Cebpa from EVI1-induced suppression. We observe a more complex picture in primary bone marrow cells, where EVI1 suppresses Cebpa in stem cells but not in more committed progenitors. Our data thus identify a regulatory node by which EVI1 contributes to leukemia, and this represents a possible therapeutic target for treatment of EVI1-expressing leukemia.	[Wilson, Michael; Zhang, Yi; Perkins, Archibald S.] Univ Rochester, Med Ctr, Dept Pathol & Lab Med, Rochester, NY 14642 USA; [Tsakraklides, Vasiliki; Minh Tran; Xiao, Ying-Yi] Yale Univ, Dept Pathol, New Haven, CT 06520 USA	University of Rochester; Yale University	Zhang, Y; Perkins, AS (corresponding author), 601 Elmwood Ave, Rochester, NY 14642 USA.	yi_zhang@urmc.rochester.edu; archibald_perkins@urmc.rochester.edu		Zhang, Yi/0000-0003-2785-1780; Tsakraklides, Vasiliki/0000-0003-1998-1075	National Institutes of Health [R01-CA081216, P01HL63357, 5 U24 DK58776, NYSTEM C029547, NYSTEM C026423]; NATIONAL CANCER INSTITUTE [R01CA081216] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL063357] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by National Institutes of Health Grants R01-CA081216 (to A. S. P.), P01HL63357 (to A. S. P.), 5 U24 DK58776 (to Y. Z.), NYSTEM C029547 (to Y. Z.), and NYSTEM C026423 (to Y. Z.). The authors declare that they have no conflicts of interest with the contents of this article.	Alvarez-Errico D, 2015, NAT REV IMMUNOL, V15, P7, DOI 10.1038/nri3777; Bindels EMJ, 2012, BLOOD, V119, P5838, DOI 10.1182/blood-2011-11-393827; BRUNELLE A, 1987, P NATL ACAD SCI USA, V84, P6673, DOI 10.1073/pnas.84.19.6673; Cabezas-Wallscheid N, 2014, CELL STEM CELL, V15, P507, DOI 10.1016/j.stem.2014.07.005; Chang HH, 2008, NATURE, V453, P544, DOI 10.1038/nature06965; Chen L, 2014, SCIENCE, V345, P1580, DOI 10.1126/science.1251033; Chi YQ, 2003, J BIOL CHEM, V278, P49806, DOI 10.1074/jbc.M309645200; Chim CS, 2002, BRIT J HAEMATOL, V119, P988, DOI 10.1046/j.1365-2141.2002.03952.x; Cooper S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126385; Dostie J, 2007, NAT PROTOC, V2, P988, DOI 10.1038/nprot.2007.116; FUNABIKI T, 1994, ONCOGENE, V9, P1575; Glass C, 2014, BLOOD CELL MOL DIS, V53, P67, DOI 10.1016/j.bcmd.2014.01.002; Glass C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067134; Goyama S, 2008, CELL STEM CELL, V3, P207, DOI 10.1016/j.stem.2008.06.002; GRAHAM FL, 1973, VIROLOGY, V52, P456, DOI 10.1016/0042-6822(73)90341-3; Grimwade D, 1998, BLOOD, V92, P2322, DOI 10.1182/blood.V92.7.2322; Guo H, 2012, BLOOD, V119, P4408, DOI 10.1182/blood-2011-12-397091; Hasemann MS, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004079; Heath V, 2004, BLOOD, V104, P1639, DOI 10.1182/blood-2003-11-3963; Helbling D, 2004, P NATL ACAD SCI USA, V101, P13312, DOI 10.1073/pnas.0404731101; Hochedlinger K, 2005, CELL, V121, P465, DOI 10.1016/j.cell.2005.02.018; Hoyt PR, 1997, MECH DEVELOP, V65, P55, DOI 10.1016/S0925-4773(97)00057-9; IHLE JN, 1985, CONTEMP TOP MOLEC IM, V10, P93; Kilbey A, 1999, CELL GROWTH DIFFER, V10, P601; Kitamura T, 2003, EXP HEMATOL, V31, P1007, DOI 10.1016/j.exphem.2003.07.005; Konrad TA, 2009, J LEUKOCYTE BIOL, V86, P813, DOI 10.1189/jlb.0109042; KREIDER BL, 1993, P NATL ACAD SCI USA, V90, P6454, DOI 10.1073/pnas.90.14.6454; Laricchia-Robbio L, 2006, MOL CELL BIOL, V26, P7658, DOI 10.1128/MCB.00363-06; Laricchia-Robbio L, 2009, CANCER RES, V69, P1633, DOI 10.1158/0008-5472.CAN-08-2562; Leroy H, 2005, LEUKEMIA, V19, P329, DOI 10.1038/sj.leu.2403614; Louz D, 2000, LEUKEMIA, V14, P1876, DOI 10.1038/sj.leu.2401887; MIZUSHIMA S, 1990, NUCLEIC ACIDS RES, V18, P5322, DOI 10.1093/nar/18.17.5322; MORGENSTERN JP, 1990, NUCLEIC ACIDS RES, V18, P3587, DOI 10.1093/nar/18.12.3587; MORISHITA K, 1992, MOL CELL BIOL, V12, P183, DOI 10.1128/MCB.12.1.183; MORISHITA K, 1988, CELL, V54, P831, DOI 10.1016/S0092-8674(88)91175-0; MUCENSKI ML, 1988, MOL CELL BIOL, V8, P301, DOI 10.1128/MCB.8.1.301; PEAR WS, 1993, P NATL ACAD SCI USA, V90, P8392, DOI 10.1073/pnas.90.18.8392; PERKINS AS, 1991, MOL CELL BIOL, V11, P2665, DOI 10.1128/MCB.11.5.2665; Perkins AS, 1996, J BIOL CHEM, V271, P1104, DOI 10.1074/jbc.271.2.1104; Perrotti D, 2002, NAT GENET, V30, P48, DOI 10.1038/ng791; Rada-Iglesias A, 2011, NATURE, V470, P279, DOI 10.1038/nature09692; Shalem O, 2014, SCIENCE, V343, P84, DOI 10.1126/science.1247005; Su MY, 2013, J BIOL CHEM, V288, P8433, DOI 10.1074/jbc.M112.413260; Tanaka KF, 2010, BIOL PSYCHIAT, V67, P770, DOI 10.1016/j.biopsych.2009.12.020; Tokita K, 2007, CANCER SCI, V98, P1752, DOI 10.1111/j.1349-7006.2007.00597.x; TSAI S, 1994, GENE DEV, V8, P2831, DOI 10.1101/gad.8.23.2831; van Doorn-Khosrovani SBV, 2003, BLOOD, V101, P837, DOI 10.1182/blood-2002-05-1459; Wilson NK, 2010, CELL STEM CELL, V7, P532, DOI 10.1016/j.stem.2010.07.016; Wouters BJ, 2007, BLOOD, V110, P3706, DOI 10.1182/blood-2007-02-073486; Yatsula B, 2005, J BIOL CHEM, V280, P30712, DOI 10.1074/jbc.M504293200; Zentner GE, 2011, GENOME RES, V21, P1273, DOI 10.1101/gr.122382.111; Zhang B, 2013, GENOME RES, V23, P917, DOI 10.1101/gr.149674.112; Zhang DE, 1997, P NATL ACAD SCI USA, V94, P569, DOI 10.1073/pnas.94.2.569; Zhang P, 2004, IMMUNITY, V21, P853, DOI 10.1016/j.immuni.2004.11.006; Zhang Y, 2011, BIOCHEMISTRY-US, V50, P10431, DOI 10.1021/bi200962u; Zhang Y, 2011, BLOOD, V118, P3853, DOI 10.1182/blood-2011-02-334680	56	10	11	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 24	2016	291	26					13591	13607		10.1074/jbc.M115.708156	http://dx.doi.org/10.1074/jbc.M115.708156			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DR2YZ	27129260	Green Published, hybrid			2022-12-26	WOS:000379771100017
J	Chaubal, A; Todi, SV; Pile, LA				Chaubal, Ashlesha; Todi, Sokol V.; Pile, Lori A.			Inter-isoform-dependent Regulation of the Drosophila Master Transcriptional Regulator SIN3	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GENE-EXPRESSION; CHROMATIN; COMPLEX; COREPRESSOR; PROTEINS; PATHWAY; LIFE	SIN3 is a transcriptional corepressor that acts as a scaffold for a histone deacetylase (HDAC) complex. The SIN3 complex regulates various biological processes, including organ development, cell proliferation, and energy metabolism. Little is known, however, about the regulation of SIN3 itself. There are two major isoforms of Drosophila SIN3, 187 and 220, which are differentially expressed. Intrigued by the developmentally timed exchange of SIN3 isoforms, we examined whether SIN3 187 controls the fate of the 220 counterpart. Here, we show that in developing tissue, there is interplay between SIN3 isoforms: when SIN3 187 protein levels increase, SIN3 220 protein decreases concomitantly. SIN3 187 has a dual effect on SIN3 220. Expression of 187 leads to reduced 220 transcript, while also increasing the turnover of SIN3 220 protein by the proteasome. These data support the presence of a novel, inter-isoform-dependent mechanism that regulates the amount of SIN3 protein, and potentially the level of specific SIN3 complexes, during distinct developmental stages.	[Chaubal, Ashlesha; Pile, Lori A.] Wayne State Univ, Dept Biol Sci, 5047 Gullen Mall,Biol Sci Bldg, Detroit, MI 48202 USA; [Todi, Sokol V.] Wayne State Univ, Dept Pharmacol, Detroit, MI 48201 USA	Wayne State University; Wayne State University	Pile, LA (corresponding author), Wayne State Univ, Dept Biol Sci, 5047 Gullen Mall,Biol Sci Bldg, Detroit, MI 48202 USA.	loripile@wayne.edu		Chaubal, Ashlesha/0000-0002-7276-8946; TODI, SOKOL/0000-0003-4399-5549	National Institutes of Health [1R01GM088886-01A2]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM088886] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Grant 1R01GM088886-01A2 (to L. A. P.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Bannister AJ, 2011, CELL RES, V21, P381, DOI 10.1038/cr.2011.22; Barnes VL, 2014, AGING-US, V6, P645, DOI 10.18632/aging.100684; Blount JR, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5638; BRAND AH, 1993, DEVELOPMENT, V118, P401; Ciechanover A, 1998, EMBO J, V17, P7151, DOI 10.1093/emboj/17.24.7151; Cogoni C, 2000, CURR OPIN GENET DEV, V10, P638, DOI 10.1016/S0959-437X(00)00134-9; Cowley SM, 2005, MOL CELL BIOL, V25, P6990, DOI 10.1128/MCB.25.16.6990-7004.2005; Dannenberg JH, 2005, GENE DEV, V19, P1581, DOI 10.1101/gad.1286905; Gajan A, 2016, EPIGENET CHROMATIN, V9, DOI 10.1186/s13072-016-0053-9; Grzenda A, 2009, BBA-GENE REGUL MECH, V1789, P443, DOI 10.1016/j.bbagrm.2009.05.007; Kadamb R, 2013, EUR J CELL BIOL, V92, P237, DOI 10.1016/j.ejcb.2013.09.001; Kim W, 2011, MOL CELL, V44, P325, DOI 10.1016/j.molcel.2011.08.025; Komander D, 2012, ANNU REV BIOCHEM, V81, P203, DOI 10.1146/annurev-biochem-060310-170328; Kong QH, 2010, BIOCHEM BIOPH RES CO, V393, P708, DOI 10.1016/j.bbrc.2010.02.066; Mertins P, 2013, NAT METHODS, V10, P634, DOI 10.1038/nmeth.2518; Neufeld TP, 1998, GENETICS, V148, P277; Pennetta G, 1998, DEV GENES EVOL, V208, P531, DOI 10.1007/s004270050212; Pile LA, 2000, EMBO J, V19, P6131, DOI 10.1093/emboj/19.22.6131; Pungaliya P, 2007, J PROTEOME RES, V6, P3918, DOI 10.1021/pr0703674; Saha N, 2016, BMC GENOMICS, V17, DOI 10.1186/s12864-016-2428-5; Sambrook J, 2001, MOL CLONING LAB MANU; Sharma V, 2008, DEV DYNAM, V237, P3040, DOI 10.1002/dvdy.21706; Silverstein RA, 2005, CURR GENET, V47, P1, DOI 10.1007/s00294-004-0541-5; Spain MM, 2010, J BIOL CHEM, V285, P27457, DOI 10.1074/jbc.M110.130245; Swaminathan A, 2010, MECH DEVELOP, V127, P96, DOI 10.1016/j.mod.2009.10.003	25	2	2	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 27	2016	291	22					11566	11571		10.1074/jbc.C116.724799	http://dx.doi.org/10.1074/jbc.C116.724799			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DN7NZ	27129248	Green Published, hybrid			2022-12-26	WOS:000377264800009
J	Wongkidakarn, S; McHenry, AM; Sattabongkot, J; Adams, JH; Chootong, P				Wongkidakarn, Sudarat; McHenry, Amy M.; Sattabongkot, Jetsumon; Adams, John H.; Chootong, Patchanee			Strain-Transcending Inhibitory Antibodies against Homologous and Heterologous Strains of Duffy Binding Protein region II	PLOS ONE			English	Article							PLASMODIUM-VIVAX; LIGAND DOMAIN; GENETIC DIVERSITY; NATURAL-SELECTION; BRAZILIAN AMAZON; SRI-LANKA; POLYMORPHISM; MALARIA; ANTIGEN; IMMUNOGENICITY	Duffy binding protein region II (DBPII) is a promising vaccine candidate against vivax malaria. However, polymorphisms of DBPII are the major obstacle to designing a successful vaccine. Here, we examined whether anti-DBPII antibodies from individual P. vivax exposures provide strain-transcending immunity and whether their presence is associated with DBPII haplotypes found in patients with acute P. vivax. The ability of antibodies to inhibit DBL-TH-erythrocyte binding was tested by COS7 erythrocyte binding inhibition assay. Seven samples of high responders (HR) were identified from screening anti-DBPII levels. HR no. 3 and HR no. 6 highly inhibited all DBL-TH binding to erythrocytes, by >80%. Antibodies from these two patients' plasma had the potential to be broadly inhibitory against DBL-TH1, -TH2, -TH6, -TH7, -TH8 and -TH9 haplotypes when plasma was serially diluted from 1: 500 to 1: 2000. To further examine the association of DBPII haplotypes and the ability of antibodies to broadly inhibit DBL-TH variants, the individual samples underwent sequencing analysis and the inhibitory function of the anti-DBPII antibodies was tested. The patterns of DBPII polymorphisms in acute patients were classified into two groups, DBPII Sal I (55%) and DBL-TH variants (45%). Plasma from Sal I and DBPII-TH patients who had the highest inhibition against Sal I or DBL-TH4 and -TH5 was serially diluted from 1: 500 to 1: 2000 and their inhibitory capacity was tested against a panel of DBL-TH haplotypes. Results provided evidence of both strain-transcending inhibition as well as strain-specific inhibition by antibodies that blocked erythrocyte binding against some DBL-TH variants and against homologous alleles. This study demonstrated broad inhibition by anti-DBPII antibodies against DBL-TH haplotypes in natural P. vivax exposed individuals. The identification of conserved epitopes among DBL-TH may have implications for vaccine development of a DBPII-based vaccine against diverse P. vivax infections.	[Wongkidakarn, Sudarat; Chootong, Patchanee] Mahidol Univ, Dept Clin Microbiol & Appl Technol, Fac Med Technol, Bangkok 10700, Thailand; [McHenry, Amy M.] Southwestern Adventist Univ, Dept Biol, Keene, TX USA; [Sattabongkot, Jetsumon] Mahidol Univ, Fac Trop Med, Mahidol Vivax Res Unit, Bangkok, Thailand; [Adams, John H.] Univ S Florida, Dept Global Hlth, Tampa, FL USA	Mahidol University; Mahidol University; State University System of Florida; University of South Florida	Chootong, P (corresponding author), Mahidol Univ, Dept Clin Microbiol & Appl Technol, Fac Med Technol, Bangkok 10700, Thailand.	pchooton@gmail.com	Prachumsri, Jetsumon/AAZ-7732-2021; Adams, John/G-1800-2015; Adams, John H./ABB-8458-2020	Adams, John/0000-0003-3707-7979; Adams, John H./0000-0003-3707-7979; Sattabongkot, Jetsumon/0000-0002-3938-4588	Thailand Research Fund [TRG5880217]; NIH [R01 AI064478]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI064478] Funding Source: NIH RePORTER	Thailand Research Fund(Thailand Research Fund (TRF)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This study was supported in part by Thailand Research Fund (TRG5880217) (to PC) and NIH (R01 AI064478) (to JHA).	Ampudia E, 1996, MOL BIOCHEM PARASIT, V78, P269, DOI 10.1016/S0166-6851(96)02611-4; Babaeekho L, 2009, AM J TROP MED HYG, V80, P112, DOI 10.4269/ajtmh.2009.80.112; Chitnis CE, 1996, J EXP MED, V184, P1531, DOI 10.1084/jem.184.4.1531; Chootong P, 2014, PARASITOL INT, V63, P858, DOI 10.1016/j.parint.2014.07.014; Chootong P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035769; Chootong P, 2010, INFECT IMMUN, V78, P1089, DOI 10.1128/IAI.01036-09; Cole-Tobian J, 2003, MOL BIOCHEM PARASIT, V127, P121, DOI 10.1016/S0166-6851(02)00327-4; Cole-Tobian JL, 2007, AM J TROP MED HYG, V77, P955, DOI 10.4269/ajtmh.2007.77.955; Dias S, 2011, VACCINE, V29, P7491, DOI 10.1016/j.vaccine.2011.07.029; Dutta S, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003840; Fraser T, 1997, INFECT IMMUN, V65, P2772, DOI 10.1128/IAI.65.7.2772-2777.1997; Gosi P, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-112; Grimberg BT, 2007, PLOS MED, V4, P1940, DOI 10.1371/journal.pmed.0040337; Jia XL, 2000, MOL BIOCHEM PARASIT, V111, P253, DOI 10.1016/S0166-6851(00)00315-7; Ju HL, 2013, ACTA TROP, V125, P67, DOI 10.1016/j.actatropica.2012.09.016; Ju HL, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-60; Kho Weon-Gyu, 2001, Korean Journal of Parasitology, V39, P143, DOI 10.3347/kjp.2001.39.2.143; King CL, 2008, P NATL ACAD SCI USA, V105, P8363, DOI 10.1073/pnas.0800371105; McHenry AM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020192; Michon P, 2000, INFECT IMMUN, V68, P3164, DOI 10.1128/IAI.68.6.3164-3171.2000; Michon P, 2001, FEBS LETT, V495, P111, DOI 10.1016/S0014-5793(01)02370-5; Miller LH, 2002, NATURE, V415, P673, DOI 10.1038/415673a; Ntumngia FB, 2013, VACCINE, V31, P4382, DOI 10.1016/j.vaccine.2013.07.002; Ntumngia FB, 2012, INFECT IMMUN, V80, P1203, DOI 10.1128/IAI.05924-11; Ntumngia FB, 2012, CLIN VACCINE IMMUNOL, V19, P30, DOI 10.1128/CVI.05466-11; Premaratne PH, 2011, INFECT GENET EVOL, V11, P1327, DOI 10.1016/j.meegid.2011.04.023; Ranjan A, 1999, P NATL ACAD SCI USA, V96, P14067, DOI 10.1073/pnas.96.24.14067; Sousa TN, 2006, MOL BIOCHEM PARASIT, V146, P251, DOI 10.1016/j.molbiopara.2005.11.006; Souza-Silva FA, 2010, AM J TROP MED HYG, V82, P185, DOI 10.4269/ajtmh.2010.08-0580; TSUBOI T, 1994, INFECT IMMUN, V62, P5581, DOI 10.1128/IAI.62.12.5581-5586.1994; Valizadeh V, 2014, ACTA TROP, V136, P89, DOI 10.1016/j.actatropica.2014.03.019; VanBuskirk KM, 2004, J INFECT DIS, V190, P1556, DOI 10.1086/424852; Xainli J, 2003, INFECT IMMUN, V71, P2508, DOI 10.1128/IAI.71.5.2508-2515.2003; Zakeri S, 2013, ACTA TROP, V126, P269, DOI 10.1016/j.actatropica.2013.02.017	34	4	4	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 4	2016	11	5							e0154577	10.1371/journal.pone.0154577	http://dx.doi.org/10.1371/journal.pone.0154577			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DL5KR	27145131	Green Submitted, Green Published, gold			2022-12-26	WOS:000375676400054
J	Ishak, NSM; Kato, Y; Matsuura, T; Watanabe, H				Ishak, Nur Syafiqah Mohamad; Kato, Yasuhiko; Matsuura, Tomoaki; Watanabe, Hajime			Sequence Conservation and Sexually Dimorphic Expression of the Ftz-F1 Gene in the Crustacean Daphnia magna	PLOS ONE			English	Article							ENVIRONMENTAL SEX DETERMINATION; STEROIDOGENIC FACTOR-I; HORMONE RECEPTOR; KEY REGULATOR; WATER FLEA; PROTEIN; ACTIVATION; CLADOCERA; DOMAIN; GONAD	Identifying the genes required for environmental sex determination is important for understanding the evolution of diverse sex determination mechanisms in animals. Orthologs of Drosophila orphan receptor Fushi tarazu factor-1 (Ftz-F1) are known to function in genetic sex determination. In contrast, their roles in environmental sex determination remain unknown. In this study, we have cloned and characterized the Ftz-F1 ortholog in the branchiopod crustacean Daphnia magna, which produces males in response to environmental stimuli. Similar to that observed in Drosophila, D. magna Ftz-F1 (DapmaFtz-F1) produces two splicing variants, alpha Ftz-F1 and beta Ftz-F1, which encode 699 and 777 amino acids, respectively. Both isoforms share a DNA-binding domain, a ligand-binding domain, and an AF-2 activation domain and differ only at the A/B domain. The phylogenetic position and genomic structure of DapmaFtz-F1 suggested that this gene has diverged from an ancestral gene common to branchiopod crustacean and insect Ftz-F1 genes. qRT-PCR showed that at the one cell and gastrulation stages, both DapmaFtz-F1 isoforms are two-fold more abundant in males than in females. In addition, in later stages, their sexual dimorphic expressions were maintained in spite of reduced expression. Time-lapse imaging of DapmaFtz-F1 RNAi embryos was performed in H2B-GFP expressing transgenic Daphnia, demonstrating that development of the RNAi embryos slowed down after the gastrulation stage and stopped at 30-48 h after ovulation. DapmaFtz-F1 shows high homology to insect Ftz-F1 orthologs based on its amino acid sequence and exon-intron organization. The sexually dimorphic expression of DapmaFtz-F1 suggests that it plays a role in environmental sex determination of D. magna.	[Ishak, Nur Syafiqah Mohamad; Kato, Yasuhiko; Matsuura, Tomoaki; Watanabe, Hajime] Osaka Univ, Grad Sch Engn, Dept Biotechnol, Suita, Osaka, Japan; [Kato, Yasuhiko] Osaka Univ, Grad Sch Engn, Frontier Res Base Global Young Researchers, Suita, Osaka, Japan	Osaka University; Osaka University	Kato, Y (corresponding author), Osaka Univ, Grad Sch Engn, Dept Biotechnol, Suita, Osaka, Japan.; Kato, Y (corresponding author), Osaka Univ, Grad Sch Engn, Frontier Res Base Global Young Researchers, Suita, Osaka, Japan.	kato_yasuhiko@bio.eng.osaka-u.ac.jp	matsuura, tomoaki/O-7368-2018; Kato, Yasuhiko/AES-3929-2022; Watanabe, Hajime/S-8957-2019; Matsuura, Tomoaki/W-6086-2019; WATANABE, Hajime/AAJ-8904-2021	matsuura, tomoaki/0000-0003-1015-6781; Kato, Yasuhiko/0000-0002-1041-1044; Matsuura, Tomoaki/0000-0003-1015-6781; Watanabe, Hajime/0000-0001-9657-6554	JSPS [26840105]	JSPS(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work was supported by JSPS KAKENHI Grant Number 26840105 (to YK). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asada M, 2014, J INSECT SCI, V14, DOI 10.1093/jisesa/ieu043; Barton NH, 1998, SCIENCE, V281, P1986, DOI 10.1126/science.281.5385.1986; Bernardo TJ, 2012, J BIOL CHEM, V287, P7821, DOI 10.1074/jbc.M111.327254; BULL JJ, 1985, EXPERIENTIA, V41, P1285, DOI 10.1007/BF01952071; Chan SM, 1999, FEBS LETT, V454, P109, DOI 10.1016/S0014-5793(99)00787-5; Crews D, 2009, SEMIN CELL DEV BIOL, V20, P251, DOI 10.1016/j.semcdb.2009.02.004; Dubrovsky EB, 2011, J BIOL CHEM, V286, P33689, DOI 10.1074/jbc.M111.273458; Gissendanner CR, 2000, DEV BIOL, V221, P259, DOI 10.1006/dbio.2000.9679; Glenner H, 2006, SCIENCE, V314, P1883, DOI 10.1126/science.1129844; HEBERT PDN, 1978, BIOL REV, V53, P387, DOI 10.1111/j.1469-185X.1978.tb00860.x; HOBAEK A, 1990, ECOLOGY, V71, P2255, DOI 10.2307/1938637; HONDA S, 1993, J BIOL CHEM, V268, P7494; IKEDA Y, 1994, MOL ENDOCRINOL, V8, P654, DOI 10.1210/me.8.5.654; IKEDA Y, 1993, MOL ENDOCRINOL, V7, P852, DOI 10.1210/me.7.7.852; Kato Y, 2008, GENOMICS, V91, P94, DOI 10.1016/j.ygeno.2007.09.002; Kato Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045318; Kato Y, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001345; Kato Y, 2011, DEV GENES EVOL, V220, P337, DOI 10.1007/s00427-011-0353-9; Kato Y, 2010, GENOMICS, V95, P160, DOI 10.1016/j.ygeno.2009.12.005; KLEIVEN OT, 1992, OIKOS, V65, P197, DOI 10.2307/3545010; KLUTTGEN B, 1994, WATER RES, V28, P743, DOI 10.1016/0043-1354(94)90157-0; KORPELAINEN H, 1990, BIOL REV, V65, P147, DOI 10.1111/j.1469-185X.1990.tb01187.x; LALA DS, 1992, MOL ENDOCRINOL, V6, P1249, DOI 10.1210/me.6.8.1249; LAVORGNA G, 1991, SCIENCE, V252, P848, DOI 10.1126/science.1709303; Marin I, 1998, SCIENCE, V281, P1990, DOI 10.1126/science.281.5385.1990; Mittmann B, 2014, EVODEVO, V5, DOI 10.1186/2041-9139-5-12; Oda S, 2005, CHEMOSPHERE, V61, P1168, DOI 10.1016/j.chemosphere.2005.02.075; Olmstead AW, 2002, J EXP ZOOL, V293, P736, DOI 10.1002/jez.10162; Sagawa K, 2005, GENE EXPR PATTERNS, V5, P669, DOI 10.1016/j.modgep.2005.02.007; Takase M, 2000, BBA-GENE STRUCT EXPR, V1494, P195, DOI 10.1016/S0167-4781(00)00201-3; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Tatarazako N, 2003, CHEMOSPHERE, V53, P827, DOI 10.1016/S0045-6535(03)00761-6; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; UEDA H, 1990, GENE DEV, V4, P624, DOI 10.1101/gad.4.4.624; Wurtz JM, 1996, NAT STRUCT BIOL, V3, P87, DOI 10.1038/nsb0196-87; Yamada M, 2000, DEVELOPMENT, V127, P5083; Yussa M, 2001, MECH DEVELOP, V107, P39, DOI 10.1016/S0925-4773(01)00448-8; Zarkower D, 2001, NAT REV GENET, V2, P175, DOI 10.1038/35056032	38	11	11	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 3	2016	11	5							e0154636	10.1371/journal.pone.0154636	http://dx.doi.org/10.1371/journal.pone.0154636			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DL5KK	27138373	Green Submitted, Green Published, gold			2022-12-26	WOS:000375675700047
J	Maldonado, A; Lavado, R; Knuston, S; Slattery, M; Ankisetty, S; Goldstone, JV; Watanabe, K; Hoh, E; Gadepalli, RS; Rimoldi, JM; Ostrander, GK; Schlenk, D				Maldonado, Aileen; Lavado, Ramon; Knuston, Sean; Slattery, Marc; Ankisetty, Sridevi; Goldstone, Jared V.; Watanabe, Kayo; Hoh, Eunha; Gadepalli, Rama S.; Rimoldi, John M.; Ostrander, Gary K.; Schlenk, Daniel			Biochemical Mechanisms for Geographical Adaptations to Novel Toxin Exposures in Butterflyfish	PLOS ONE			English	Article							GENERALIST FISH PREDATORS; PLANT SECONDARY COMPOUNDS; CORAL-FEEDING FISHES; CHEMICAL DEFENSES; DIETARY SPECIALIZATION; MOLECULAR-CLONING; CYTOCHROME-P450; CHAETODON; REEF; EXPRESSION	Some species of butterflyfish have had preyed upon corals for millions of years, yet the mechanism of butterflyfish specialized coral feeding strategy remains poorly understood. Certain butterflyfish have the ability to feed on allelochemically rich soft corals, e.g. Sinularia maxima. Cytochrome P450 (CYP) is the predominant enzyme system responsible for the detoxification of dietary allelochemicals. CYP2-like and CYP3A-like content have been associated with butterflyfish that preferentially consumes allelochemically rich soft corals. To investigate the role of butterflyfish CYP2 and CYP3A enzymes in dietary preference, we conducted oral feeding experiments using homogenates of S. maxima and a toxin isolated from the coral in four species of butterflyfish with different feeding strategies. After oral exposure to the S. maxima toxin 5-episinulaptolide (5ESL), which is not normally encountered in the Hawaiian butterflyfish diet, an endemic specialist, Chaetodon multicinctus experienced 100% mortality compared to a generalist, Chaetodon auriga, which had significantly more (3-6 fold higher) CYP3A-like basal content and catalytic activity. The specialist, Chaetodon unimaculatus, which preferentially feed on S. maxima in Guam, but not in Hawaii, had 100% survival, a significant induction of 8-12 fold CYP3A-like content, and an increased ability (2-fold) to metabolize 5ESL over other species. Computer modeling data of CYP3A4 with 5ESL were consistent with microsomal transformation of 5ESL to a C15-16 epoxide from livers of C. unimaculatus. Epoxide formation correlated with CYP3A-like content, catalytic activity, induction, and NADPH-dependent metabolism of 5ESL. These results suggest a potentially important role for the CYP3A family in butterflyfish-coral diet selection through allelochemical detoxification.	[Maldonado, Aileen; Lavado, Ramon; Schlenk, Daniel] Univ Calif Riverside, Dept Environm Sci, Riverside, CA 92521 USA; [Knuston, Sean; Ostrander, Gary K.] Univ Hawaii Manoa, Honolulu, HI 96822 USA; [Slattery, Marc; Ankisetty, Sridevi; Gadepalli, Rama S.; Rimoldi, John M.] Univ Mississippi, Dept Biomol Sci, University, MS 38677 USA; [Slattery, Marc; Ankisetty, Sridevi; Gadepalli, Rama S.; Rimoldi, John M.] Univ Mississippi, Natl Ctr Nat Prod Res, University, MS 38677 USA; [Goldstone, Jared V.] Woods Hole Oceanog Inst, Woods Hole, MA 02543 USA; [Watanabe, Kayo; Hoh, Eunha] San Diego State Univ, Grad Sch Publ Hlth, San Diego, CA 92182 USA; [Maldonado, Aileen] Sch Field Studies, Trop Coastal Ecol, Bocas Del Toro, Panama; [Lavado, Ramon] Iowa State Univ, Vet Diagnost Lab, Ames, IA USA; [Knuston, Sean] Agr Pesticide Div, Hawaii Dept, Honolulu, HI USA; [Ostrander, Gary K.] Florida State Univ, Dept Biomed Sci, Coll Med, Tallahassee, FL 32306 USA	University of California System; University of California Riverside; University of Hawaii System; University of Hawaii Manoa; University of Mississippi; University of Mississippi; Woods Hole Oceanographic Institution; California State University System; San Diego State University; Iowa State University; State University System of Florida; Florida State University	Maldonado, A (corresponding author), Univ Calif Riverside, Dept Environm Sci, Riverside, CA 92521 USA.	amald008@ucr.edu	Lavado, Ramon/D-3544-2011	Lavado, Ramon/0000-0002-2774-5104; Goldstone, Jared/0000-0002-9618-4961; Hoh, Eunha/0000-0002-4075-040X; Rimoldi, John/0000-0002-7355-6902	Resource Allocation Program of the Agricultural Research Station; Hilda and George Liebig Environmental Sciences Summer Fellowship; Albert March Environmental Sciences Scholarship from the University of California, Riverside; National Institute of General Medical Sciences (NIGMS), a component of the National Institutes of Health (NIH) [P20GM104932]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM104932] Funding Source: NIH RePORTER	Resource Allocation Program of the Agricultural Research Station; Hilda and George Liebig Environmental Sciences Summer Fellowship; Albert March Environmental Sciences Scholarship from the University of California, Riverside; National Institute of General Medical Sciences (NIGMS), a component of the National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work received support from the following sources: Resource Allocation Program of the Agricultural Research Station for UCR to DS; Summer funding by Hilda and George Liebig Environmental Sciences Summer Fellowship and travel grant Albert March Environmental Sciences Scholarship from the University of California, Riverside; and the Chemistry and DMPK CORE of COBRE, P20GM104932 from the National Institute of General Medical Sciences (NIGMS), a component of the National Institutes of Health (NIH) supported the chemistry studies. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Becerro MA, 1998, MAR ECOL PROG SER, V168, P187, DOI 10.3354/meps168187; Bellwood DR, 2010, J EVOLUTION BIOL, V23, P335, DOI 10.1111/j.1420-9101.2009.01904.x; BERENBAUM MR, 1986, EVOLUTION, V40, P1215, DOI 10.1111/j.1558-5646.1986.tb05746.x; Berenbaum MR, 1989, ACS S SERIES; Bernays Elizabeth A., 1993, P1; Berumen ML, 2008, BEHAV ECOL SOCIOBIOL, V62, P989, DOI 10.1007/s00265-007-0526-8; COHEN MB, 1989, J CHEM ECOL, V15, P2347, DOI 10.1007/BF01012086; COHEN MB, 1992, P NATL ACAD SCI USA, V89, P10920, DOI 10.1073/pnas.89.22.10920; Cole AJ, 2008, FISH FISH, V9, P286, DOI 10.1111/j.1467-2979.2008.00290.x; Cowman PF, 2013, J BIOGEOGR, V40, P209, DOI 10.1111/jbi.12003; Cox EF, THESIS U HAWAII MANO; Craig MT, 2007, MAR ECOL PROG SER, V334, P245, DOI 10.3354/meps334245; Crawford IP, 1980, J CLIN INVEST, V66, P473; Dearing MD, 1999, J CHEM ECOL, V25, P1205, DOI 10.1023/A:1020958221803; DeBusk BC, 2008, FISH PHYSIOL BIOCHEM, V34, P483, DOI 10.1007/s10695-008-9225-2; FRITZ RS, 1992, PLANT RESISTANCE HER; Gaither MR, 2013, J BIOGEOGR, V40, P1638, DOI 10.1111/jbi.12126; Kamel HN, 2007, CHEM PHARM BULL, V55, P537, DOI 10.1248/cpb.55.537; Khan KK, 2000, ARCH BIOCHEM BIOPHYS, V373, P335, DOI 10.1006/abbi.1999.1578; Krebs J.R., 2009, BEHAV ECOLOGY EVOLUT; Kullak-Ublick GA, 2003, DRUG METAB REV, V35, P305, DOI 10.1081/DMR-120026398; Labandeira C, 2007, INSECT SCI, V14, P259, DOI 10.1111/j.1744-7917.2007.00152.x; Lages BG, 2010, MAR ECOL-EVOL PERSP, V31, P473, DOI 10.1111/j.1439-0485.2010.00376.x; LaJeunesse TC, 2004, CORAL REEFS, V23, P596, DOI 10.1007/s00338-004-0428-4; Lawton RJ, 2011, MOL ECOL, V20, P3584, DOI 10.1111/j.1365-294X.2011.05207.x; Li XC, 2004, P NATL ACAD SCI USA, V101, P2939, DOI 10.1073/pnas.0308691101; Li XC, 2000, INSECT BIOCHEM MOLEC, V30, P75, DOI 10.1016/S0965-1748(99)00102-2; Li XC, 2007, ANNU REV ENTOMOL, V52, P231, DOI 10.1146/annurev.ento.51.110104.151104; Long JD, 2006, MAR ECOL PROG SER, V307, P199, DOI 10.3354/meps307199; Maldonado A, 2016, COMP BIOCHEM PHYS C, V179, P57, DOI 10.1016/j.cbpc.2015.08.005; Moore LB, 2000, P NATL ACAD SCI USA, V97, P7500, DOI 10.1073/pnas.130155097; Morris GM, 2009, J COMPUT CHEM, V30, P2785, DOI 10.1002/jcc.21256; Pratchett MS, 2005, MAR BIOL, V148, P373, DOI 10.1007/s00227-005-0084-4; Pratchett MS, 2014, Biology of Butterflyfishes, P1; Roslin T, 2008, OIKOS, V117, P1560, DOI 10.1111/j.0030-1299.2008.16725.x; Rotjan RD, 2008, MAR ECOL PROG SER, V367, P73, DOI 10.3354/meps07531; Schoener T. W., 1971, A Rev Ecol Syst, V2, P369, DOI 10.1146/annurev.es.02.110171.002101; Slattery M, 2008, MAR ECOL PROG SER, V354, P169, DOI 10.3354/meps07200; Sorensen JS, 2005, ECOLOGY, V86, P140, DOI 10.1890/03-0669; Sorensen JS, 2003, OECOLOGIA, V134, P88, DOI 10.1007/s00442-002-1085-3; Sotka E. E., 2008, P203, DOI 10.1007/978-3-540-74181-7_10; Sotka EE, 2009, INTEGR COMP BIOL, V49, P291, DOI 10.1093/icb/icp049; Stewart JJP, 2008, J MOL MODEL, V14, P499, DOI 10.1007/s00894-008-0299-7; Torregrossa AM, 2012, OECOLOGIA, V168, P711, DOI 10.1007/s00442-011-2121-y; TRICAS TC, 1989, ANIM BEHAV, V37, P830, DOI 10.1016/0003-3472(89)90067-5; Trott O, 2010, J COMPUT CHEM, V31, P455, DOI 10.1002/jcc.21334; VROLIJK NH, 1995, MAR ENVIRON RES, V39, P11, DOI 10.1016/0141-1136(94)00076-2; WYLIE CR, 1989, J EXP MAR BIOL ECOL, V129, P141, DOI 10.1016/0022-0981(89)90053-1	48	5	5	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 3	2016	11	5							e0154208	10.1371/journal.pone.0154208	http://dx.doi.org/10.1371/journal.pone.0154208			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DL5KK	27136924	Green Published, Green Submitted, gold			2022-12-26	WOS:000375675700020
J	Neuwirth, C; Burkhardt, C; Alix, J; Castro, J; de Carvalho, M; Gawel, M; Goedee, S; Grosskreutz, J; Lenglet, T; Moglia, C; Omer, T; Schrooten, M; Weber, M				Neuwirth, Christoph; Burkhardt, Christian; Alix, James; Castro, Jose; de Carvalho, Mamede; Gawel, Malgorzata; Goedee, Stephan; Grosskreutz, Julian; Lenglet, Timothee; Moglia, Cristina; Omer, Taha; Schrooten, Maarten; Weber, Markus			Quality Control of Motor Unit Number Index (MUNIX) Measurements in 6 Muscles in a Single-Subject "Round-Robin" Setup	PLOS ONE			English	Article							AMYOTROPHIC-LATERAL-SCLEROSIS; DISEASE PROGRESSION; OUTCOME MEASURE; REPRODUCIBILITY; ALS	Background Motor Unit Number Index (MUNIX) is a neurophysiological measure that provides an index of the number of lower motor neurons in a muscle. Its performance across centres in healthy subjects and patients with Amyotrophic Lateral Sclerosis (ALS) has been established, but inter-rater variability between multiple raters in one single subject has not been investigated. Objective To assess reliability in a set of 6 muscles in a single subject among 12 examiners (6 experienced with MUNIX, 6 less experienced) and to determine variables associated with variability of measurements. Methods Twelve raters applied MUNIX in six different muscles (abductor pollicis brevis (APB), abductor digiti minimi (ADM), biceps brachii (BB), tibialis anterior (TA), extensor dig. brevis (EDB), abductor hallucis (AH)) twice in one single volunteer on consecutive days. All raters visited at least one training course prior to measurements. Intra-and inter-rater variability as determined by the coefficient of variation (COV) between different raters and their levels of experience with MUNIX were compared. Results Mean intra-rater COV of MUNIX was 14.0% (+/- 6.4) ranging from 5.8 (APB) to 30.3% (EDB). Mean inter-rater COV was 18.1 (+/- 5.4) ranging from 8.0 (BB) to 31.7 (AH). No significant differences of variability between experienced and less experienced raters were detected. Conclusion We provide evidence that quality control for neurophysiological methods can be performed with similar standards as in laboratory medicine. Intra-and inter-rater variability of MUNIX is muscle-dependent and mainly below 20%. Experienced neurophysiologists can easily adopt MUNIX and adequate teaching ensures reliable utilization of this method.	[Neuwirth, Christoph; Burkhardt, Christian; Weber, Markus] Kantonsspital St Gallen, ALS Clin, Neuromuscular Dis Unit, St Gallen, Switzerland; [Alix, James] Univ Sheffield, Sheffield Inst Translat Neurosci, Sheffield, S Yorkshire, England; [Castro, Jose; de Carvalho, Mamede] Univ Lisbon, Fac Med, Dept Neurosci, Hosp Santa Maria,Inst Med Mol, P-1699 Lisbon, Portugal; [Gawel, Malgorzata] Med Univ Warsaw, Dept Neurol, Warsaw, Poland; [Goedee, Stephan] UMC Utrecht, Dept Neurol & Neurosurg, Brain Ctr Rudolf Magnus, Utrecht, Netherlands; [Grosskreutz, Julian] Univ Hosp Jena, Hans Berger Dept Neurol, Jena, Germany; [Lenglet, Timothee] Grp Hosp Pitie Salpetriere, AP HP, Dept Neurophysiol, F-75634 Paris, France; [Moglia, Cristina] Univ Turin, Dept Neurosci Rita Levi Montalcini, ALS Ctr Torino, Turin, Italy; [Omer, Taha] Trinity Coll Biomed Sci Inst TBSI, Dublin, Ireland; [Omer, Taha] Beaumont Hosp, Dublin 9, Ireland; [Schrooten, Maarten] Univ Hosp Leuven, Dept Neurol, Leuven, Belgium; [Weber, Markus] Univ Basel Hosp, Dept Neurol, CH-4031 Basel, Switzerland	Kantonsspital St. Gallen; University of Sheffield; Universidade de Lisboa; Hospital Santa Maria; Medical University of Warsaw; Utrecht University; Utrecht University Medical Center; Friedrich Schiller University of Jena; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite; University of Turin; KU Leuven; University Hospital Leuven; University of Basel	Neuwirth, C (corresponding author), Kantonsspital St Gallen, ALS Clin, Neuromuscular Dis Unit, St Gallen, Switzerland.	christoph.neuwirth@kssg.ch	de Carvalho, Mamede/I-6295-2019; Castro, José/C-1930-2009; Grosskreutz, Julian/G-2293-2010; Weber, Markus/AAI-7138-2020; Schrooten, Maarten/A-4042-2011; Neuwirth, Christoph/AAE-2211-2020; moglia, cristina/K-4142-2016; Moglia, Cristina/AAB-9643-2019	de Carvalho, Mamede/0000-0001-7556-0158; Grosskreutz, Julian/0000-0001-9525-1424; Schrooten, Maarten/0000-0002-9360-342X; moglia, cristina/0000-0001-7377-7222; Moglia, Cristina/0000-0001-7377-7222; Castro, Jose/0000-0001-8984-475X	Swiss ALS Foundation; Swiss NeRAB Foundation; "SOPHIA" consortium through the Swiss National Foundation under EU [31ND30_141622]; National Institute for Health Research [CL-2014-04-002] Funding Source: researchfish	Swiss ALS Foundation; Swiss NeRAB Foundation; "SOPHIA" consortium through the Swiss National Foundation under EU; National Institute for Health Research(National Institute for Health Research (NIHR))	Study funded by: CN, CB, and MW were supported by the Swiss ALS Foundation and the Swiss NeRAB Foundation. CB and CN were supported by the "SOPHIA" consortium through the Swiss National Foundation (31ND30_141622) under the aegis of the EU Joint Programme - Neurodegenerative Disease Research (JPND): http://www.jpnd.eu.	Ahn SW, 2010, MUSCLE NERVE, V42, P808, DOI 10.1002/mus.21765; Boekestein W.A., 2012, CLIN NEUROPHYSIOL; Bundesarztekammer, 2015, GMS Z FORDERUNG QUAL, V6, P1; Cudkowicz ME, 2010, AMYOTROPH LATERAL SC, V11, P259, DOI 10.3109/17482960903358865; Fathi D, 2016, CLIN NEUROPHYSIOL, V127, P1984, DOI 10.1016/j.clinph.2015.12.023; Furtula J, 2013, CLIN NEUROPHYSIOL, V124, P610, DOI 10.1016/j.clinph.2012.08.023; Gunter EW, 1996, CLIN CHEM, V42, P1689; Manolis E, 2011, PROTEOM CLIN APPL, V5, P248, DOI 10.1002/prca.201000130; Nandedkar SD, 2007, MUSCLE NERVE, V36, P87, DOI 10.1002/mus.20798; Nandedkar SD, 2011, MUSCLE NERVE, V44, P919, DOI 10.1002/mus.22204; Nandedkar SD, 2010, MUSCLE NERVE, V42, P798, DOI 10.1002/mus.21824; Nandedkar SD, 2004, IEEE T BIO-MED ENG, V51, P2209, DOI 10.1109/TBME.2004.834281; Neuwirth C, 2015, J NEUROLNEUROSURGPSY; Neuwirth C, 2011, CLIN NEUROPHYSIOL, V122, P1867, DOI 10.1016/j.clinph.2011.02.017; Neuwirth C, 2010, MUSCLE NERVE, V42, P379, DOI 10.1002/mus.21707; Petzold A, 2010, J IMMUNOL METHODS, V352, P23, DOI 10.1016/j.jim.2009.09.014; Sanjak M, 2010, AMYOTROPH LATERAL SC, V11, P383, DOI 10.3109/17482960903486083; Shefner JM, 2011, NEUROLOGY, V77, P235, DOI 10.1212/WNL.0b013e318225aabf; Shefner JM, 2014, AMYOTROPH LAT SCL FR, V15, P337, DOI 10.3109/21678421.2014.918150; Woodcock Janet, 2011, Expert Opin Med Diagn, V5, P369, DOI 10.1517/17530059.2011.588947; Zhou P, 2014, IEEE T NEUR SYS REH, V22, P992, DOI 10.1109/TNSRE.2014.2314391; Zhou P, 2012, MED ENG PHYS, V34, P1209, DOI 10.1016/j.medengphy.2012.06.011	22	32	32	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 2	2016	11	5							e0153948	10.1371/journal.pone.0153948	http://dx.doi.org/10.1371/journal.pone.0153948			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DL5KB	27135747	Green Published, Green Submitted, Green Accepted, gold			2022-12-26	WOS:000375674800007
J	Zhou, SM; Fernandez-Gutierrez, F; Kennedy, J; Cooksey, R; Atkinson, M; Denaxas, S; Siebert, S; Dixon, WG; O'Neill, TW; Choy, E; Sudlow, C; Brophy, S				Zhou, Shang-Ming; Fernandez-Gutierrez, Fabiola; Kennedy, Jonathan; Cooksey, Roxanne; Atkinson, Mark; Denaxas, Spiros; Siebert, Stefan; Dixon, William G.; O'Neill, Terence W.; Choy, Ernest; Sudlow, Cathie; Brophy, Sinead		UK Biobank Follow-Up Outcomes Grp	Defining Disease Phenotypes in Primary Care Electronic Health Records by a Machine Learning Approach: A Case Study in Identifying Rheumatoid Arthritis	PLOS ONE			English	Article							PATIENT RECRUITMENT; SYSTEM; PREVALENCE; DIAGNOSES; ACCURACY; SUPPORT	Objectives 1) To use data-driven method to examine clinical codes (risk factors) of a medical condition in primary care electronic health records (EHRs) that can accurately predict a diagnosis of the condition in secondary care EHRs. 2) To develop and validate a disease phenotyping algorithm for rheumatoid arthritis using primary care EHRs. Methods This study linked routine primary and secondary care EHRs in Wales, UK. A machine learning based scheme was used to identify patients with rheumatoid arthritis from primary care EHRs via the following steps: i) selection of variables by comparing relative frequencies of Read codes in the primary care dataset associated with disease case compared to non-disease control (disease/non-disease based on the secondary care diagnosis); ii) reduction of predictors/associated variables using a Random Forest method, iii) induction of decision rules from decision tree model. The proposed method was then extensively validated on an independent dataset, and compared for performance with two existing deterministic algorithms for RA which had been developed using expert clinical knowledge. Results Primary care EHRs were available for 2,238,360 patients over the age of 16 and of these 20,667 were also linked in the secondary care rheumatology clinical system. In the linked dataset, 900 predictors (out of a total of 43,100 variables) in the primary care record were discovered more frequently in those with versus those without RA. These variables were reduced to 37 groups of related clinical codes, which were used to develop a decision tree model. The final algorithm identified 8 predictors related to diagnostic codes for RA, medication codes, such as those for disease modifying anti-rheumatic drugs, and absence of alternative diagnoses such as psoriatic arthritis. The proposed data-driven method performed as well as the expert clinical knowledge based methods. Conclusion Data-driven scheme, such as ensemble machine learning methods, has the potential of identifying the most informative predictors in a cost-effective and rapid way to accurately and reliably classify rheumatoid arthritis or other complex medical conditions in primary care EHRs.	[Zhou, Shang-Ming; Fernandez-Gutierrez, Fabiola; Kennedy, Jonathan; Cooksey, Roxanne; Atkinson, Mark; Brophy, Sinead] Swansea Univ, Coll Med, Inst Life Sci, Swansea, W Glam, Wales; [Denaxas, Spiros] UCL Inst Hlth Informat, London, England; [Denaxas, Spiros] Farr Inst Hlth Informat Res, London, England; [Siebert, Stefan] Univ Glasgow, Inst Infect Immun & Inflammat, Glasgow, Lanark, Scotland; [Dixon, William G.; O'Neill, Terence W.] Univ Manchester, Arthrit Res UK Ctr Epidemiol, Inst Inflammat & Repair, Fac Med & Human Sci,Manchester Acad Hlth Sci Ctr, Manchester, Lancs, England; [Choy, Ernest] Cardiff Univ, Arthrit Res UK CREATE Ctr, Cardiff CF10 3AX, S Glam, Wales; [Choy, Ernest] Cardiff Univ, Sch Med, Welsh Arthrit Res Network, Cardiff CF10 3AX, S Glam, Wales; [Sudlow, Cathie] Univ Edinburgh, Ctr Clin Brain Sci, Edinburgh, Midlothian, Scotland; [UK Biobank Follow-Up Outcomes Grp] UK Biobank, Stockport, Lancs, England	Swansea University; University of London; University College London; University of Glasgow; University of Manchester; Cardiff University; Cardiff University; University of Edinburgh	Zhou, SM (corresponding author), Swansea Univ, Coll Med, Inst Life Sci, Swansea, W Glam, Wales.	s.zhou@swansea.ac.uk	Atkinson, Mark D/K-1813-2013; Sullivan, Frank/L-8286-2019; Dixon, William/L-8408-2019; Hemingway, Harry/C-1219-2009; Zhou, Shang-Ming/A-8443-2008	Atkinson, Mark D/0000-0003-4237-3588; Sullivan, Frank/0000-0002-6623-4964; Dixon, William/0000-0001-5881-4857; Brophy, Sinead/0000-0001-7417-2858; Hotopf, Matthew/0000-0002-3980-4466; Hemingway, Harry/0000-0003-2279-0624; Denaxas, Spiros/0000-0001-9612-7791; Moller, Henrik/0000-0001-8200-5929; Eastwood, Sophie/0000-0002-1883-8771; Zhou, Shang-Ming/0000-0002-0719-9353; Siebert, Stefan/0000-0002-1802-7311; Sudlow, Cathie/0000-0002-7725-7520	UK Biobank; National Centre for Population Health and Wellbeing Research (NCPHWR); Farr Institute of Health Informatics Research; Health and Care Research Wales [CA02]; Arthritis Research UK [MR/K006525/1]; British Heart Foundation [MR/K006525/1]; Cancer Research UK [MR/K006525/1]; Economic and Social Research Council [MR/K006525/1]; Engineering and Physical Sciences Research Council [MR/K006525/1]; Medical Research Council [MR/K006525/1]; National Institute of Health Research [MR/K006525/1]; National Institute for Social Care and Health Research (Welsh Government) [MR/K006525/1]; Chief Scientist Office (Scottish Government Health Directorates) [MR/K006525/1]; MRC Clinician Scientist Fellowship [G0902272]; ESRC [ES/L007444/1, ES/L007517/1] Funding Source: UKRI; MRC [MR/K006665/1, MR/K023233/1, MC_U137686860, G0902272, MR/K006525/1] Funding Source: UKRI; Economic and Social Research Council [ES/L007444/1, ES/L007517/1] Funding Source: researchfish; Medical Research Council [MR/K006584/1, MR/K023233/1, MC_PC_13042, MC_qA137853, MC_PC_13043, MC_U137686860, G0902272, MR/K006665/1] Funding Source: researchfish; National Institute for Health Research [NF-SI-0611-10084, NF-SI-0515-10102] Funding Source: researchfish	UK Biobank; National Centre for Population Health and Wellbeing Research (NCPHWR); Farr Institute of Health Informatics Research; Health and Care Research Wales; Arthritis Research UK(Versus Arthritis); British Heart Foundation(British Heart Foundation); Cancer Research UK(Cancer Research UK); Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); National Institute of Health Research(National Institute for Health Research (NIHR)); National Institute for Social Care and Health Research (Welsh Government); Chief Scientist Office (Scottish Government Health Directorates); MRC Clinician Scientist Fellowship(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); ESRC(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR))	The work was supported by the UK Biobank, and undertaken with the support of the National Centre for Population Health and Wellbeing Research (NCPHWR) and the Farr Institute of Health Informatics Research. The NCPHWR is funded by Health and Care Research Wales (grant ref. : CA02). The Farr Institute is funded by a consortium of ten UK research organisations (grant ref. : MR/K006525/1): Arthritis Research UK, the British Heart Foundation, Cancer Research UK, the Economic and Social Research Council, the Engineering and Physical Sciences Research Council, the Medical Research Council, the National Institute of Health Research, the National Institute for Social Care and Health Research (Welsh Government) and the Chief Scientist Office (Scottish Government Health Directorates). WGD was supported by an MRC Clinician Scientist Fellowship (G0902272). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ng B, 2012, ARTHRIT CARE RES, V64, P1490, DOI 10.1002/acr.21736; Bishop Christopher M., 2006, PATTERN RECOGNITION; Breiman L., 2001, Machine Learning, V45, P5, DOI 10.1023/A:1010933404324; Breiman T, 2014, CLASSIFICATION D PAC; Chung CP, 2013, VACCINE, V31, pK41, DOI 10.1016/j.vaccine.2013.03.075; Dugas M, 2010, CLIN TRIALS, V7, P183, DOI 10.1177/1740774510363013; Gottesman O, 2013, GENET MED, V15, P761, DOI 10.1038/gim.2013.72; Gray J, 2003, BRIT MED J, V326, P1130, DOI 10.1136/bmj.326.7399.1130; Holt TA, 2008, BRIT J GEN PRACT, V58, P192, DOI 10.3399/bjgp08X277302; Ishwaran H, 2010, J AM STAT ASSOC, V105, P205, DOI 10.1198/jasa.2009.tm08622; Jensen PB, 2012, NAT REV GENET, V13, P395, DOI 10.1038/nrg3208; Jones KH, 2014, J BIOMED INFORM, V50, P196, DOI 10.1016/j.jbi.2014.01.003; Kim SY, 2011, ARTHRITIS RES THER, V13, DOI 10.1186/ar3260; Kuhn M, 2014, PACKAGE C50 C5 0 DEC; Lyons RA, 2009, BMC MED INFORM DECIS, V9, DOI 10.1186/1472-6947-9-3; MacGillivray TJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0127914; Majeed A, 2008, FAM PRACT, V25, P213, DOI 10.1093/fampra/cmn047; Majeed Azeem, 2004, Health Stat Q, P5; Malinowski JR, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111301; Meeraus WH, 2013, ARCH DIS CHILD, V98, P195, DOI 10.1136/archdischild-2012-302237; Namjou B, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0138677; Nicholson A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054878; Quinlan J.R., 1993, C4 5 PROGRAMS MACHIN; Racine JS, 2012, J APPL ECONOMET, V27, P167, DOI 10.1002/jae.1278; Richesson RL, 2013, J AM MED INFORM ASSN, V20, pE226, DOI 10.1136/amiajnl-2013-001926; Schreiweis B, 2014, INT J MED INFORM, V83, P860, DOI 10.1016/j.ijmedinf.2014.08.005; Seidu S, 2014, POSTGRAD MED J, V90, P13, DOI 10.1136/postgradmedj-2013-132068; Seroussi B, 2003, ARTIF INTELL MED, V29, P153, DOI 10.1016/S0933-3657(03)00040-X; Shivade C, 2014, J AM MED INFORM ASSN, V21, P221, DOI 10.1136/amiajnl-2013-001935; Singh JA, 2004, ARTHRIT RHEUM-ARTHR, V51, P952, DOI 10.1002/art.20827; Sudlow C, 2015, PLOS MED, V12, DOI 10.1371/journal.pmed.1001779; Symmons D, 2002, RHEUMATOLOGY, V41, P793, DOI 10.1093/rheumatology/41.7.793; Team/MSDi H-QOFBR, NEW GMS CONTR QOF IM; Thomas SL, 2008, ARTHRIT RHEUM-ARTHR, V59, P1314, DOI 10.1002/art.24015; Wang MH, 2010, BIOINFORMATICS, V26, P831, DOI 10.1093/bioinformatics/btq038; Zhou SM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113592; Zhou SM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051468	37	34	35	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 2	2016	11	5							e0154515	10.1371/journal.pone.0154515	http://dx.doi.org/10.1371/journal.pone.0154515			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DL5KB	27135409	Green Published, Green Submitted, gold, Green Accepted			2022-12-26	WOS:000375674800025
J	Ansari, M; Rainger, J; Hanson, IM; Williamson, KA; Sharkey, F; Harewood, L; Sandilands, A; Clayton-Smith, J; Dollfus, H; Bitoun, P; Meire, F; Fantes, J; Franco, B; Lorenz, B; Taylor, DS; Stewart, F; Willoughby, CE; McEntagart, M; Khaw, PT; Clericuzio, C; Van Maldergem, L; Williams, D; Newbury-Ecob, R; Traboulsi, EI; Silva, ED; Madlom, MM; Goudie, DR; Fleck, BW; Wieczorek, D; Kohlhase, J; McTrusty, AD; Gardiner, C; Yale, C; Moore, AT; Russell-Eggitt, I; Islam, L; Lees, M; Beales, PL; Tuft, SJ; Solano, JB; Splitt, M; Hertz, JM; Prescott, TE; Shears, DJ; Nischal, KK; Doco-Fenzy, M; Prieur, F; Temple, IK; Lachlan, KL; Damante, G; Morrison, DA; van Heyningen, V; FitzPatrick, DR				Ansari, Morad; Rainger, Jacqueline; Hanson, Isabel M.; Williamson, Kathleen A.; Sharkey, Freddie; Harewood, Louise; Sandilands, Angela; Clayton-Smith, Jill; Dollfus, Helene; Bitoun, Pierre; Meire, Francoise; Fantes, Judy; Franco, Brunella; Lorenz, Birgit; Taylor, David S.; Stewart, Fiona; Willoughby, Colin E.; McEntagart, Meriel; Khaw, Peng Tee; Clericuzio, Carol; Van Maldergem, Lionel; Williams, Denise; Newbury-Ecob, Ruth; Traboulsi, Elias I.; Silva, Eduardo D.; Madlom, Mukhlis M.; Goudie, David R.; Fleck, Brian W.; Wieczorek, Dagmar; Kohlhase, Juergen; McTrusty, Alice D.; Gardiner, Carol; Yale, Christopher; Moore, Anthony T.; Russell-Eggitt, Isabelle; Islam, Lily; Lees, Melissa; Beales, Philip L.; Tuft, Stephen J.; Solano, Juan B.; Splitt, Miranda; Hertz, Jens Michael; Prescott, Trine E.; Shears, Deborah J.; Nischal, Ken K.; Doco-Fenzy, Martine; Prieur, Fabienne; Temple, I. Karen; Lachlan, Katherine L.; Damante, Giuseppe; Morrison, Danny A.; van Heyningen, Veronica; FitzPatrick, David R.			Genetic Analysis of 'PAX6-Negative' Individuals with Aniridia or Gillespie Syndrome	PLOS ONE			English	Article							AXENFELD-RIEGER SYNDROME; GTPASE-ACTIVATING PROTEIN; LINEAR SKIN DEFECTS; CEREBELLAR-ATAXIA; MENTAL-RETARDATION; PAX6 GENE; MISSENSE MUTATIONS; IMPAIRED ACCOMMODATION; PITX2 MUTATIONS; PHENOTYPE	We report molecular genetic analysis of 42 affected individuals referred with a diagnosis of aniridia who previously screened as negative for intragenic PAX6 mutations. Of these 42, the diagnoses were 31 individuals with aniridia and 11 individuals referred with a diagnosis of Gillespie syndrome (iris hypoplasia, ataxia and mild to moderate developmental delay). Array-based comparative genomic hybridization identified six whole gene deletions: four encompassing PAX6 and two encompassing FOXC1. Six deletions with plausible cis-regulatory effects were identified: five that were 3' (telomeric) to PAX6 and one within a gene desert 5' (telomeric) to PITX2. Sequence analysis of the FOXC1 and PITX2 coding regions identified two plausibly pathogenic de novo FOXC1 missense mutations (p.Pro79Thr and p.Leu101Pro). No intragenic mutations were detected in PITX2. FISH mapping in an individual with Gillespie-like syndrome with an apparently balanced X;11 reciprocal translocation revealed disruption of a gene at each breakpoint: ARHGAP6 on the X chromosome and PHF21A on chromosome 11. In the other individuals with Gillespie syndrome no mutations were identified in either of these genes, or in HCCS which lies close to the Xp breakpoint. Disruption of PHF21A has previously been implicated in the causation of intellectual disability (but not aniridia). Plausibly causative mutations were identified in 15 out of 42 individuals (12/32 aniridia; 3/11 Gillespie syndrome). Fourteen of these mutations presented in the known aniridia genes; PAX6, FOXC1 and PITX2. The large number of individuals in the cohort with no mutation identified suggests greater locus heterogeneity may exist in both isolated and syndromic aniridia than was previously appreciated.	[Ansari, Morad; Rainger, Jacqueline; Hanson, Isabel M.; Williamson, Kathleen A.; Sharkey, Freddie; Harewood, Louise; Sandilands, Angela; Fantes, Judy; van Heyningen, Veronica; FitzPatrick, David R.] Univ Edinburgh, Western Gen Hosp, Inst Genet & Mol Med, MRC Human Genet Unit, Edinburgh, Midlothian, Scotland; [Clayton-Smith, Jill] Univ Manchester, Inst Human Dev, Manchester Acad Hlth Sci Ctr, Fac Med & Human Sci,Manchester Ctr Genom Med, Manchester, Lancs, England; [Dollfus, Helene] Hop Haute Pierre, Serv Genet Med, Strasbourg, France; [Bitoun, Pierre] Univ Hosp Jean Verdier, Dept Med Genet, Bondy, France; [Meire, Francoise] Hop Univ Enfants Reine Fabiola, Dept Ophthalmopediat, Brussels, Belgium; [Franco, Brunella] Univ Naples Federico II, Dept Med Translat Sci, Med Genet, Naples, Italy; [Franco, Brunella] Telethon Inst Genet & Med TIGEM, Pozzuoli, Italy; [Lorenz, Birgit] Univ Giessen, Univ Klinikum Giessen & Marburg UKGM, Dept Ophthalmol, D-35390 Giessen, Germany; [Taylor, David S.; Russell-Eggitt, Isabelle; Islam, Lily; Beales, Philip L.] UCL, Inst Child Hlth, London WC1E 6BT, England; [Taylor, David S.; Russell-Eggitt, Isabelle; Islam, Lily; Beales, Philip L.] Great Ormond St Hosp Sick Children, Great Ormond St, London WC1N 3JH, England; [Stewart, Fiona] Belfast City Hosp, Northern Ireland Reg Genet Serv, Belfast BT9 7AD, Antrim, North Ireland; [Willoughby, Colin E.] Univ Liverpool, Inst Ageing & Chron Dis, Dept Eye & Vis Sci, Liverpool L69 3BX, Merseyside, England; [McEntagart, Meriel] St Georges Univ London, Med Genet Unit, London, England; [Khaw, Peng Tee; Moore, Anthony T.; Tuft, Stephen J.] Moorfields Eye Hosp, London, England; [Khaw, Peng Tee; Moore, Anthony T.; Tuft, Stephen J.] UCL, Inst Ophthalmol, London, England; [Clericuzio, Carol] Univ New Mexico, Hlth Sci Ctr, Dept Pediat Genet, Albuquerque, NM 87131 USA; [Van Maldergem, Lionel] Univ Franche Comte, Ctr Genet Humaine, F-25030 Besancon, France; [Williams, Denise] Birmingham Womens Hosp, Clin Genet Unit, Birmingham, W Midlands, England; [Newbury-Ecob, Ruth] Univ Hosp, Dept Clin Genet, Bristol, Avon, England; [Traboulsi, Elias I.] Cleveland Clin Fdn, Cole Eye Inst, Ctr Genet Eye Dis, 9500 Euclid Ave, Cleveland, OH 44195 USA; [Silva, Eduardo D.] Univ Hosp Coimbra, Dept Ophthalmol, Coimbra, Portugal; [Madlom, Mukhlis M.] Doncaster Royal Infirm, Childrens Hosp, Doncaster DN2 5LT, England; [Goudie, David R.] Univ Dundee, Ninewells Hosp, Coll Med Dent & Nursing, Human Genet Unit, Dundee DD1 9SY, Scotland; [Fleck, Brian W.] Princess Alexandra Eye Pavil, Dept Ophthalmol, Chalmers St, Edinburgh, Midlothian, Scotland; [Wieczorek, Dagmar] Univ Duisburg Essen, Univ Klinikum Essen, Inst Humangenet, Essen, Germany; [Wieczorek, Dagmar] Univ Dusseldorf, Univ Klinikum Dusseldorf, Inst Humangenet, Dusseldorf, Germany; [Kohlhase, Juergen] Ctr Human Genet, Freiburg, Germany; [McTrusty, Alice D.] Glasgow Caledonian Univ, Dept Life Sci, Glasgow G4 0BA, Lanark, Scotland; [Gardiner, Carol] So Gen Hosp, Clin Genet, Glasgow G51 4TF, Lanark, Scotland; [Yale, Christopher] Ipswich Hosp, Dept Paediat & Child Hlth, Ipswich, Suffolk, England; [Lees, Melissa] Great Ormond St Hosp Children NHS Fdn Trust, Great Ormond St Hosp, North East Thames Reg Genet Serv, London, England; [Solano, Juan B.] Ruber Int Hosp, Med Genet Unit, Ruber Int Hosp, Madrid, Spain; [Splitt, Miranda] Newcastle Tyne Hosp NHS Fdn Trust, Inst Med Genet, Northern Genet Serv, Newcastle Upon Tyne, Tyne & Wear, England; [Hertz, Jens Michael] Odense Univ Hosp, Dept Clin Genet, Odense C, Denmark; [Prescott, Trine E.] Oslo Univ Hosp, Dept Med Genet, N-0450 Oslo, Norway; [Shears, Deborah J.] Oxford Univ Hosp NHS Trust, Churchill Hosp, Dept Clin Genet, Oxford, England; [Nischal, Ken K.] Univ Pittsburgh, Sch Med, Childrens Hosp Pittsburgh UPMC, UPMC Eye Ctr, Pittsburgh, PA USA; [Doco-Fenzy, Martine] SFR Cap Sante, HMB CHU Reims, Serv Genet, EA 3801, Reims, France; [Prieur, Fabienne] CHU St Etienne, Serv Genet Med, St Etienne, France; [Temple, I. Karen] Univ Southampton, Div Human Genet, Acad Unit Genet Med, Southampton, Hants, England; [Lachlan, Katherine L.] Univ Hosp Southampton NHS Fdn Trust, Wessex Clin Genet Serv, Southampton, Hants, England; [Damante, Giuseppe] Univ Udine, Dept Med & Biol Sci, Udine, Italy; [Morrison, Danny A.] St Thomas Hosp, Westminster Bridge Rd, London, England	University of Edinburgh; University of Manchester; CHU Strasbourg; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Jean-Verdier - APHP; University of Naples Federico II; Fondazione Telethon; Telethon Institute of Genetics & Medicine (TIGEM); Justus Liebig University Giessen; University Hospital of Giessen & Marburg; University of London; University College London; University of London; University College London; Great Ormond Street Hospital for Children NHS Foundation Trust; Belfast City Hospital; University of Liverpool; St Georges University London; University of London; University College London; Moorfields Eye Hospital NHS Foundation Trust; University of London; University College London; University of New Mexico; University of New Mexico's Health Sciences Center; Universite de Franche-Comte; Birmingham Women's Hospital; Cleveland Clinic Foundation; Universidade de Coimbra; Centro Hospitalar e Universitario de Coimbra (CHUC); University of Dundee; University of Duisburg Essen; Heinrich Heine University Dusseldorf; Heinrich Heine University Dusseldorf Hospital; Glasgow Caledonian University; University of Glasgow; Ipswich Hospital NHS Trust; Ipswich Hospital; University of London; University College London; Great Ormond Street Hospital for Children NHS Foundation Trust; Newcastle University - UK; Newcastle Upon Tyne Hospitals NHS Foundation Trust; University of Southern Denmark; Odense University Hospital; University of Oslo; Oxford University Hospitals NHS Foundation Trust; University of Oxford; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; CHU de Reims; Universite de Reims Champagne-Ardenne; CHU de St Etienne; University of Southampton; University of Southampton; University Hospital Southampton NHS Foundation Trust; University of Udine; Guy's & St Thomas' NHS Foundation Trust	FitzPatrick, DR (corresponding author), Univ Edinburgh, Western Gen Hosp, Inst Genet & Mol Med, MRC Human Genet Unit, Edinburgh, Midlothian, Scotland.	david.fitzpatrick@igmm.ed.ac.uk	Wieczorek, Dagmar/AAU-6008-2021; Damante, Giuseppe/AAC-5200-2022; VAN HEYNINGEN, Veronica/GYE-0531-2022; Van Maldergem, Lionel/O-3242-2019; Traboulsi, Elias/AAY-7443-2020; Beales, Philip L/C-7367-2009; Van Maldergem, Lionel/G-9849-2017; LACHLAN, KATHERINE/ABH-6991-2020; Hertz, Jens Michael/H-6269-2014; FRANCO, Brunella/S-2882-2018	Wieczorek, Dagmar/0000-0003-2812-6492; Van Maldergem, Lionel/0000-0001-8880-5214; Van Maldergem, Lionel/0000-0001-8880-5214; LACHLAN, KATHERINE/0000-0002-3816-7346; Hertz, Jens Michael/0000-0003-0087-4739; Dollfus, Helene/0000-0002-2249-895X; Ansari, Morad/0000-0002-8905-5379; van Heyningen, Veronica/0000-0003-0359-0141; Harewood, Louise/0000-0002-6398-6714; Hanson, Isabel/0000-0002-1878-0530; Damante, Giuseppe/0000-0003-2312-4009; FitzPatrick, David R./0000-0003-4861-969X; Bitoun, Pierre/0000-0001-6557-6826; Willoughby, Colin/0000-0002-1246-4166; Temple, Isabel Karen/0000-0002-6045-1781; Khaw, Sir Peng Tee/0000-0002-8087-2268; FRANCO, Brunella/0000-0001-5588-4569	Medical Research Council [MC_PC_U127527199, MC_PC_U127561093, MC_U127527199, MC_U127561093] Funding Source: Medline; MRC [MC_PC_U127561093, MC_U127527199, MC_PC_U127527199, MC_U127561093] Funding Source: UKRI; National Institute for Health Research [NF-SI-0512-10101] Funding Source: researchfish	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); National Institute for Health Research(National Institute for Health Research (NIHR))		Acharya M, 2011, HUM MOL GENET, V20, P1610, DOI 10.1093/hmg/ddr038; Agarwal PK, 2009, J PEDIAT OPHTH STRAB, V46, P317, DOI 10.3928/01913913-20090903-12; Agarwal PK, 2009, J PEDIAT OPHTH STRAB, V46, P60, DOI 10.3928/01913913-20090101-10; Aijaz S, 2004, INVEST OPHTH VIS SCI, V45, P3871, DOI 10.1167/iovs.04-0641; Ansari M, 2014, EUR J MED GENET, V57, P587, DOI 10.1016/j.ejmg.2014.08.007; Azuma N, 2003, AM J HUM GENET, V72, P1565, DOI 10.1086/375555; Bayrakli F, 2009, J CLIN NEUROSCI, V16, P1610, DOI 10.1016/j.jocn.2009.03.022; Bhatia S, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005193; Bhatia S, 2013, AM J HUM GENET, V93, P1126, DOI 10.1016/j.ajhg.2013.10.028; Boonstra N, 2012, ACTA OPHTHALMOL, V90, P277, DOI 10.1111/j.1755-3768.2011.02205.x; Boughamoura L, 2006, ARCH PEDIATRIE, V13, P1323, DOI 10.1016/j.arcped.2006.06.028; Cassao BD, 2013, J NEUROGASTROENTEROL, V19, P538, DOI 10.5056/jnm.2013.19.4.538; Chang TC, 2012, BRIT J OPHTHALMOL, V96, P318, DOI 10.1136/bjophthalmol-2011-300801; Chong SS, 1997, HUM MOL GENET, V6, P147, DOI 10.1093/hmg/6.2.147; CRAWFURD MDA, 1979, J MED GENET, V16, P373, DOI 10.1136/jmg.16.5.373; D'haene B, 2011, INVEST OPHTH VIS SCI, V52, P324, DOI 10.1167/iovs.10-5309; Davis LK, 2008, HUM GENET, V123, P371, DOI 10.1007/s00439-008-0484-x; Defreyn A, 2007, J Fr Ophtalmol, V30, pe1; Dilling-Ostrowska E, 1973, Neurol Neurochir Pol, V7, P97; Dollfus H, 1998, AM J OPHTHALMOL, V125, P397, DOI 10.1016/S0002-9394(99)80157-3; Donald KA, 2006, J CHILD NEUROL, V21, P337, DOI 10.1177/08830738060210040201; Dubey SK, 2015, MOL VIS, V21, P88; Eden U, 2008, ACTA OPHTHALMOL, V86, P730, DOI 10.1111/j.1755-3768.2008.01310.x; FANTES J, 1995, HUM MOL GENET, V4, P415, DOI 10.1093/hmg/4.3.415; Fantes JA, 2008, AM J HUM GENET, V82, P916, DOI 10.1016/j.ajhg.2008.02.007; Fischbach BV, 2005, PEDIATRICS, V116, P984, DOI 10.1542/peds.2004-0467; FRANCOIS J, 1984, OPHTHALMIC PAED GEN, V4, P29, DOI 10.3109/13816818409009891; FRANCOIS J, 1984, KLIN MONATSBL AUGENH, V184, P313, DOI 10.1055/s-2008-1054475; Gerth-Kahlert C, 2013, MOL GENET GENOM MED, V1, P15, DOI 10.1002/mgg3.2; GILLESPIE FD, 1965, ARCH OPHTHALMOL-CHIC, V73, P338; GLASER T, 1994, GENOMICS, V19, P145, DOI 10.1006/geno.1994.1024; Graziano C, 2007, AM J MED GENET A, V143A, P1802, DOI 10.1002/ajmg.a.31808; Gronskov K, 1999, EUR J HUM GENET, V7, P274, DOI 10.1038/sj.ejhg.5200308; Hanson I, 1999, HUM MOL GENET, V8, P165, DOI 10.1093/hmg/8.2.165; Hever AM, 2006, CLIN GENET, V69, P459, DOI 10.1111/j.1399-0004.2006.00619.x; Hingorani M, 2012, EUR J HUM GENET, V20, P1011, DOI 10.1038/ejhg.2012.100; Ito YA, 2009, INVEST OPHTH VIS SCI, V50, P3573, DOI 10.1167/iovs.08-3032; Iwase S, 2006, FEBS LETT, V580, P3129, DOI 10.1016/j.febslet.2006.04.065; Kelberman D, 2011, HUM MUTAT, V32, P1144, DOI 10.1002/humu.21550; Khan AO, 2008, OPHTHALMIC GENET, V29, P67, DOI 10.1080/13816810801908152; Khan AO, 2011, MOL VIS, V17, P708; Kieslich M, 2001, KLIN PADIATR, V213, P47, DOI 10.1055/s-2001-12875; Kim HG, 2012, AM J HUM GENET, V91, P56, DOI 10.1016/j.ajhg.2012.05.005; Klajn A, 2009, J NEUROSCI, V29, P6296, DOI 10.1523/JNEUROSCI.5943-08.2009; Kleinjan DA, 2001, HUM MOL GENET, V10, P2049, DOI 10.1093/hmg/10.19.2049; Kleinjan DA, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.0040029; Lauderdale J, 2000, P NATL ACAD SCI USA, V97, P13755, DOI 10.1073/pnas.240398797; Law SK, 2011, MOL VIS, V17, P1231; Marien P, 2008, CORTEX, V44, P54, DOI 10.1016/j.cortex.2005.12.001; Nelson J, 1997, AM J MED GENET, V71, P134, DOI 10.1002/(SICI)1096-8628(19970808)71:2<134::AID-AJMG3>3.3.CO;2-K; NEVIN NC, 1990, AM J MED GENET, V35, P468, DOI 10.1002/ajmg.1320350404; Perveen R, 2000, INVEST OPHTH VIS SCI, V41, P2456; Prakash SK, 2000, HUM MOL GENET, V9, P477, DOI 10.1093/hmg/9.4.477; QUARRELL O, 1993, BRIT J OPHTHALMOL, V77, P827, DOI 10.1136/bjo.77.12.827-c; Ravi V, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003177; Reis LM, 2011, CURR OPIN OPHTHALMOL, V22, P314, DOI 10.1097/ICU.0b013e328349412b; Rowan S, 2010, GENE DEV, V24, P980, DOI 10.1101/gad.1890410; Sadagopan KA, 2015, AM J MED GENET A, V167, P524, DOI 10.1002/ajmg.a.36890; Saleem RA, 2003, HUM MOL GENET, V12, P2993, DOI 10.1093/hmg/ddg324; Schaefer L, 1997, GENOMICS, V46, P268, DOI 10.1006/geno.1997.5040; Ticho BH, 2006, OPHTHALMIC GENET, V27, P145, DOI 10.1080/13816810600976897; Tumer Z, 2009, EUR J HUM GENET, V17, P1527, DOI 10.1038/ejhg.2009.93; Luquetti DV, 2007, OPHTHALMIC GENET, V28, P89, DOI 10.1080/13816810701209495; Verhulst S, 1993, Bull Soc Belge Ophtalmol, V250, P37; Volkmann BA, 2011, INVEST OPHTH VIS SCI, V52, P1450, DOI 10.1167/iovs.10-6060; WEIER HU, 1991, BIOTECHNIQUES, V10, P498; Wimplinger I, 2006, AM J HUM GENET, V79, P878, DOI 10.1086/508474; WITTIG EO, 1988, AM J MED GENET, V30, P703, DOI 10.1002/ajmg.1320300302	68	39	40	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 28	2016	11	4							e0153757	10.1371/journal.pone.0153757	http://dx.doi.org/10.1371/journal.pone.0153757			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DK8XE	27124303	Green Accepted, Green Published, gold			2022-12-26	WOS:000375211700027
J	Bryan, L; Kaye, W; Antao, V; Mehta, P; Muravov, O; Horton, DK				Bryan, Leah; Kaye, Wendy; Antao, Vinicius; Mehta, Paul; Muravov, Oleg; Horton, D. Kevin			Preliminary Results of National Amyotrophic Lateral Sclerosis (ALS) Registry Risk Factor Survey Data	PLOS ONE			English	Article							PILOT CASE-CONTROL; BODY-MASS INDEX; OCCUPATIONAL-EXPOSURE; CIGARETTE-SMOKING; NEURODEGENERATIVE DISEASES; ELECTROMAGNETIC-FIELDS; ALCOHOL-CONSUMPTION; MAGNETIC-FIELDS; MORTALITY; AGGREGATION	Background The National ALS Registry is made up of two components to capture amyotrophic lateral sclerosis (ALS) cases: national administrative databases (Medicare, Medicaid, Veterans Health Administration and Veterans Benefits Administration) and self-identified cases captured by the Registry's web portal. This study describes self-reported characteristics of U.S. adults with ALS using the data collected by the National ALS Registry web portal risk factor surveys only from October 19, 2010 through December 31, 2013. Objective To describe findings from the National ALS Registry's web portal risk factor surveys. Measurements The prevalence of select risk factors among adults with ALS was determined by calculating the frequencies of select risk factors-smoking and alcohol (non, current and former) histories, military service and occupational history, and family history of neurodegenerative diseases such as ALS, Alzheimer's and/or Parkinson's. Results Nearly half of survey respondents were ever smokers compared with nearly 41% of adults nationally. Most respondents were ever drinkers which is comparable to national estimates. The majority were light drinkers. Nearly one-quarter of survey respondents were veterans compared with roughly 9% of US adults nationally. Most respondents were retired or disabled. The industries in which respondents were employed for the longest time were Professional and Scientific and Technical Services. When family history of neurodegenerative diseases in first degree relatives was evaluated against our comparison group, the rates of ALS were similar, but were higher for Parkinson's disease, Alzheimer's disease and any neurodegenerative diseases. Conclusions The National ALS Registry web portal, to our knowledge, is the largest, most geographically diverse collection of risk factor data about adults living with ALS. Various characteristics were consistent with other published studies on ALS risk factors and will allow researchers to generate hypotheses for future research.	[Bryan, Leah] Carter Consulting Inc, Atlanta, GA USA; [Kaye, Wendy] McKing Consulting Corp, Atlanta, GA USA; [Antao, Vinicius; Mehta, Paul; Muravov, Oleg; Horton, D. Kevin] Agcy Tox Subst & Dis Registry, Div Toxicol & Human Hlth Sci, Atlanta, GA USA	Centers for Disease Control & Prevention - USA	Bryan, L (corresponding author), Carter Consulting Inc, Atlanta, GA USA.	LBN4@cdc.gov	Mehta, Paul/ABH-6582-2020	Mehta, Paul/0000-0002-0796-8861; Horton, D. Kevin/0000-0001-6214-6687	federal government of the United States; Carter Consulting Incorporated; McKing Consulting Corporation	federal government of the United States; Carter Consulting Incorporated; McKing Consulting Corporation	This project was designed, implemented, and funded by the federal government of the United States. The funder provided support in the form of salaries for authors LB, WK, VCA, PM, OM, and DKH and had a role in the study design, data collection and analysis, decision to publish, and preparation of the manuscript. Carter Consulting Incorporated and McKing Consulting Corporation provided support in the form of salaries for authors LB and WK, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abel EL, 1998, ALCOHOL CLIN EXP RES, V22, P979, DOI 10.1111/j.1530-0277.1998.tb03692.x; Allen KD, 2008, NEUROEPIDEMIOLOGY, V30, P180, DOI 10.1159/000126910; Alonso A, 2010, J NEUROL NEUROSUR PS, V81, P1249, DOI 10.1136/jnnp.2009.180232; ALS Consortium of Epidemiologic Studies (ACES), ALS CONS EP STUD ACE; Andersen PM, 2011, NAT REV NEUROL, V7, P603, DOI 10.1038/nrneurol.2011.150; Antao VC, 2012, J ENVIRON HEALTH, V75, P28; Armon C, 2009, NEUROLOGY, V73, P1693, DOI 10.1212/WNL.0b013e3181c1df48; Barber SC, 2010, FREE RADICAL BIO MED, V48, P629, DOI 10.1016/j.freeradbiomed.2009.11.018; Beghi E, 2010, AMYOTROPH LATERAL SC, V11, P289, DOI 10.3109/17482960903384283; Behavioral Risk Factor Surveillance System, 2012, BEHAV RISK FACTOR SU; Bonvicini F, 2010, ANN I SUPER SANITA, V46, P284, DOI 10.4415/ANN_10_03_10; Cawley JC, 2003, J SAFETY RES, V34, P241, DOI 10.1016/S0022-4375(03)00028-8; Chio A, 2013, NEUROEPIDEMIOLOGY, V41, P118, DOI 10.1159/000351153; Coffman CJ, 2005, NEUROEPIDEMIOLOGY, V24, P141, DOI 10.1159/000083297; Cronin S, 2007, NEUROLOGY, V68, P1002, DOI 10.1212/01.wnl.0000258551.96893.6f; Das K, 2012, N AM J MED SCI, V4, P350, DOI 10.4103/1947-2714.99517; Davanipour Z, 1997, BIOELECTROMAGNETICS, V18, P28, DOI 10.1002/(SICI)1521-186X(1997)18:1<28::AID-BEM6>3.0.CO;2-7; de Jong SW, 2012, AM J EPIDEMIOL, V176, P233, DOI 10.1093/aje/kws015; DEAPEN DM, 1986, AM J EPIDEMIOL, V123, P790, DOI 10.1093/oxfordjournals.aje.a114308; Fallis BA, 2009, AMYOTROPH LATERAL SC, V10, P95, DOI 10.1080/17482960802209664; Fang F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029749; Fang F, 2009, ENVIRON HEALTH PERSP, V117, P1387, DOI 10.1289/ehp.0900580; Furby A, 2010, J NEUROL, V257, P792, DOI 10.1007/s00415-009-5419-5; Gallo V, 2009, ANN NEUROL, V65, P378, DOI 10.1002/ana.21653; Govoni V, 2005, J NEUROL, V252, P1322, DOI 10.1007/s00415-005-0859-z; Gundogdu B, 2014, AMYOTROPH LAT SCL FR, V15, P114, DOI 10.3109/21678421.2013.837930; GUNNARSSON LG, 1991, ACTA NEUROL SCAND, V83, P394, DOI 10.1111/j.1600-0404.1991.tb03970.x; Hakansson N, 2003, EPIDEMIOLOGY, V14, P420, DOI 10.1097/01.EDE.0000078446.76859.c9; Haley RW, 2003, NEUROLOGY, V61, P750, DOI 10.1212/WNL.61.6.750; Horner RD, 2003, NEUROLOGY, V61, P742, DOI 10.1212/01.WNL.0000069922.32557.CA; Irving SA, 2009, VACCINE, V27, P6546, DOI 10.1016/j.vaccine.2009.08.050; Jawaid A, 2010, AMYOTROPH LATERAL SC, V11, P542, DOI 10.3109/17482968.2010.482592; Johansen C, 1998, AM J EPIDEMIOL, V148, P362; Johnson FO, 2009, NEUROTOXICOLOGY, V30, P761, DOI 10.1016/j.neuro.2009.07.010; Kamel F, 2005, NEURODEGENER DIS, V2, P195, DOI 10.1159/000089625; Kamel F, 1999, NEUROEPIDEMIOLOGY, V18, P194, DOI 10.1159/000026211; Li CY, 2003, AM J IND MED, V43, P212, DOI 10.1002/ajim.10148; Mac Donald R, 1999, AM J PREV MED, V16, P173, DOI 10.1016/S0749-3797(98)00159-7; MAJOORKRAKAUER D, 1994, NEUROLOGY, V44, P1872, DOI 10.1212/WNL.44.10.1872; Malek AM, 2013, NEUROGENERATIVE DIS; McGuire V, 1997, AM J EPIDEMIOL, V145, P1076, DOI 10.1093/oxfordjournals.aje.a009070; Mehta P, 2014, MMWR SURVEILL SUMM, V63, P1; Mitsumoto H., 1998, AMYOTROPHIC LATERAL; Nelson LM, 2000, AM J EPIDEMIOL, V151, P156, DOI 10.1093/oxfordjournals.aje.a010183; Noonan CW, 2002, SCAND J WORK ENV HEA, V28, P42, DOI 10.5271/sjweh.645; Peregoy J.A., 2012, SUMMARY HLTH STAT US; Plato CC, 2002, NEUROLOGY, V58, P765, DOI 10.1212/WNL.58.5.765; Rikard-Bell A, 2013, PLOS ONE, V8; Ritchie GD, 2001, J TOXICOL ENV HEAL B, V4, P223, DOI 10.1080/109374001301419728; ROELOFSIVERSON RA, 1984, NEUROLOGY, V34, P393, DOI 10.1212/WNL.34.3.393; Savitz DA, 1998, ARCH ENVIRON HEALTH, V53, P71, DOI 10.1080/00039899809605691; Schiller JS., 2012, SUMMARY HLTH STAT US; Shimizu T, 2012, AMYOTROPH LATERAL SC, V13, P363, DOI 10.3109/17482968.2012.678366; Strickland D, 1996, ARCH NEUROL-CHICAGO, V53, P730, DOI 10.1001/archneur.1996.00550080044011; Sutedja NA, 2009, AMYOTROPH LATERAL SC, V10, P302, DOI 10.3109/17482960802455416; Sutedja NA, 2009, AMYOTROPH LATERAL SC, V10, P295, DOI 10.3109/17482960802430799; U.S. Census Bureau, 2013, P20569 US CENS BUR; Wang H, 2011, AM J EPIDEMIOL, V173, P595, DOI 10.1093/aje/kwq416; Weisskopf MG, 2009, J NEUROL NEUROSUR PS, V80, P558, DOI 10.1136/jnnp.2008.156976; Weisskopf MG, 2004, AM J EPIDEMIOL, V160, P26, DOI 10.1093/aje/kwh179; Weisskopf MG, 2005, NEUROLOGY, V64, P32, DOI 10.1212/01.WNL.0000148649.17706.D9; Zhou H, 2012, PLOS ONE, V7	62	15	15	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 28	2016	11	4							e0153683	10.1371/journal.pone.0153683	http://dx.doi.org/10.1371/journal.pone.0153683			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DK8XE	27124833	Green Submitted, gold, Green Published			2022-12-26	WOS:000375211700021
J	Chin, K; Wieslander, C; Shi, H; Balgobin, S; Montoya, TI; Yanagisawa, H; Word, RA				Chin, Kathleen; Wieslander, Cecilia; Shi, Haolin; Balgobin, Sunil; Montoya, T. Ignacio; Yanagisawa, Hiromi; Word, R. Ann			Pelvic Organ Support in Animals with Partial Loss of Fibulin-5 in the Vaginal Wall	PLOS ONE			English	Article							ABDOMINAL AORTIC-ANEURYSMS; ELASTIC FIBER HOMEOSTASIS; EXTRACELLULAR-SUPEROXIDE DISMUTASE; KNOCKOUT MICE; FLOOR DYSFUNCTION; URINARY-INCONTINENCE; PULMONARY-EMPHYSEMA; BINDING-PROTEIN; MOUSE VAGINA; RAT UTERUS	Compromise of elastic fiber integrity in connective tissues of the pelvic floor is most likely acquired through aging, childbirth-associated injury, and genetic susceptibility. Mouse models of pelvic organ prolapse demonstrate systemic deficiencies in proteins that affect elastogenesis. Prolapse, however, does not occur until several months after birth and is thereby acquired with age or after parturition. To determine the impact of compromised levels of fibulin-5 (Fbln5) during adulthood on pelvic organ support after parturition and elastase-induced injury, tissue-specific conditional knockout (cKO) mice were generated in which doxycycline (dox) treatment results in deletion of Fbln5 in cells that utilize the smooth muscle a actin promoter-driven reverse tetracycline transactivator and tetracycline responsive element-Cre recombinase (i.e., Fbln5(f/f)/SMA(++)-rtTA/Cre(+), cKO). Fbln5 was decreased significantly in the vagina of cKO mice compared with dox-treated wild type or controls (Fbln5(f/f)/SMA(++)-rtTA/Cre(-/-)). In controls, perineal body length (PBL) and bulge increased significantly after delivery but declined to baseline values within 6-8 weeks. Although overt prolapse did not occur in cKO animals, these transient increases in PBL postpartum were amplified and, unlike controls, parturition-induced increases in PBL (and bulge) did not recover to baseline but remained significantly increased for 12 wks. This lack of recovery from parturition was associated with increased MMP-(and nondetectable levels of Fbln5 in the postpartum vagina. This predisposition to prolapse was accentuated by injection of elastase into the vaginal wall in which overt prolapse occurred in cKO animals, but rarely in controls. Taken together, our model system in which Fbln5 is conditionally knock-downed in stromal cells of the pelvic floor results in animals that undergo normal elastogenesis during development but lose Fbln5 as adults. The results indicate that vaginal fibulin-5 during development is crucial for baseline pelvic organ support and is also important for protection and recovery from parturition-and elastase-induced prolapse.	[Chin, Kathleen; Wieslander, Cecilia; Shi, Haolin; Balgobin, Sunil; Montoya, T. Ignacio; Word, R. Ann] Univ Texas SW Med Ctr Dallas, Dept Obstet & Gynecol, Div Female Pelv Med & Reconstruct Surg, Dallas, TX 75390 USA; [Yanagisawa, Hiromi] Univ Texas SW Med Ctr Dallas, Dept Mol Biol, Dallas, TX 75390 USA; [Yanagisawa, Hiromi] Univ Tsukuba, Life Sci Ctr, Tsukuba Adv Res Alliance, Tsukuba, Ibaraki, Japan	University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Tsukuba	Word, RA (corresponding author), Univ Texas SW Med Ctr Dallas, Dept Obstet & Gynecol, Div Female Pelv Med & Reconstruct Surg, Dallas, TX 75390 USA.	ruth.word@UTSouthwestern.edu	Yanagisawa, Hiromi/Y-2843-2019	Yanagisawa, Hiromi/0000-0002-7576-9186	NIH [AG028048, HD064824]; National Institutes of Health [AG028048, HD064824]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD064824] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG028048] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by the National Institutes of Health AG028048 and HD064824. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors wish to thank Dr. Mike Shipley (Washington University, St. Louis, MO) for transgenic mice harboring rtTA under the control of the smooth muscle alpha actin promoter and Mr. Greg Urquhart for technical assistance. This work was supported by NIH AG028048 and HD064824. Presented at the 33nd Annual Scientific Meeting of the American Urogynecologic Society, 2012.	Ailawadi G, 2009, J THORAC CARDIOV SUR, V138, P1392, DOI 10.1016/j.jtcvs.2009.07.075; Azuma Junya, 2009, J Vis Exp, DOI 10.3791/1280; Buckley C, 2004, J AM COLL SURGEONS, V199, P896, DOI 10.1016/j.jamcollsurg.2004.08.010; Budatha M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056376; Budatha M, 2011, J CLIN INVEST, V121, P2048, DOI 10.1172/JCI45636; Bump RC, 1998, OBSTET GYN CLIN N AM, V25, P723, DOI 10.1016/S0889-8545(05)70039-5; Chapman SL, 2010, ARTERIOSCL THROM VAS, V30, P68, DOI 10.1161/ATVBAHA.109.196725; Chou YT, 2006, ONCOGENE, V25, P5547, DOI 10.1038/sj.onc.1209552; Daugherty A, 2004, ARTERIOSCL THROM VAS, V24, P429, DOI 10.1161/01.ATV.0000118013.72016.ea; DeLancey JOL, 2005, AM J OBSTET GYNECOL, V192, P1488, DOI 10.1016/j.ajog.2005.02.028; Drewes PG, 2007, AM J PATHOL, V170, P578, DOI 10.2353/ajpath.2007.060662; Dviri M, 2011, EUR J OBSTET GYN R B, V156, P113, DOI 10.1016/j.ejogrb.2010.12.043; Eskandari MK, 2005, J SURG RES, V123, P289, DOI 10.1016/j.jss.2004.07.247; Fata JE, 2000, CELL MOL LIFE SCI, V57, P77, DOI 10.1007/s000180050500; Gonzalez JM, 2006, AM J PHYSIOL-HEART C, V291, pH804, DOI 10.1152/ajpheart.01262.2005; Hannawa KK, 2006, ANN NY ACAD SCI, V1085, P353, DOI 10.1196/annals.1383.014; Hirai M, 2007, J CELL BIOL, V176, P1061, DOI 10.1083/jcb.200611026; Houghton AM, 2006, J CLIN INVEST, V116, P753, DOI 10.1172/JCI25617; HSUWONG S, 1994, J BIOL CHEM, V269, P18072; Koo HP, 1998, CONNECT TISSUE RES, V37, P1, DOI 10.3109/03008209809028896; Kuang PP, 2003, AM J PHYSIOL-LUNG C, V285, pL1147, DOI 10.1152/ajplung.00098.2003; Lee UJ, 2008, AM J PHYSIOL-RENAL, V295, pF545, DOI 10.1152/ajprenal.00063.2008; Liu XQ, 2006, AM J PATHOL, V168, P519, DOI 10.2353/ajpath.2006.050399; Liu XQ, 2004, NAT GENET, V36, P178, DOI 10.1038/ng1297; Matt P, 2010, J THORAC CARDIOV SUR, V139, P1041, DOI 10.1016/j.jtcvs.2009.08.039; Moalli PA, 2005, OBSTET GYNECOL, V106, P953, DOI 10.1097/01.AOG.0000182584.15087.dd; Moalli PA, 2002, AM J OBSTET GYNECOL, V187, P72, DOI 10.1067/mob.2002.124845; Morimoto K, 2012, J VASC SURG, V55, P1749, DOI 10.1016/j.jvs.2011.11.059; Murakami S, 2005, AM J RESP CRIT CARE, V172, P581, DOI 10.1164/rccm.200409-1280OC; Nakasaki M, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9574; Nguyen AD, 2004, CIRC RES, V95, P1067, DOI 10.1161/01.RES.0000149568.85071.FB; Olsen AL, 1997, OBSTET GYNECOL, V89, P501, DOI 10.1016/S0029-7844(97)00058-6; OSMAN M, 1985, J LAB CLIN MED, V105, P254; Otto LN, 2002, AM J OBSTET GYNECOL, V186, P416, DOI 10.1067/mob.2002.121723; OTTOVERBERNE CJM, 1992, EUR RESPIR J, V5, P1223; Rahn DD, 2008, AM J PHYSIOL-REG I, V295, pR1351, DOI 10.1152/ajpregu.90447.2008; Rahn DD, 2008, AM J OBSTET GYNECOL, V198, DOI 10.1016/j.ajog.2008.02.022; Rahn DD, 2009, AM J PATHOL, V174, P206, DOI 10.2353/ajpath.2009.080212; Schiemann WP, 2002, J BIOL CHEM, V277, P27367, DOI 10.1074/jbc.M200148200; Sharma AK, 2012, CIRCULATION, V126, pS38, DOI 10.1161/CIRCULATIONAHA.111.083451; SHARROW L, 1989, P SOC EXP BIOL MED, V192, P121; STARCHER B, 1985, CONNECT TISSUE RES, V13, P207, DOI 10.3109/03008208509152400; Thompson RW, 2006, ANN NY ACAD SCI, V1085, P59, DOI 10.1196/annals.1383.029; Wieslander CK, 2008, BIOL REPROD, V78, P521, DOI 10.1095/biolreprod.107.063024; Wieslander CK, 2009, BIOL REPROD, V80, P407, DOI 10.1095/biolreprod.108.072900; Wu JM, 2014, OBSTET GYNECOL, V123, P1201, DOI 10.1097/AOG.0000000000000286; Wu JM, 2012, OBSTET GYNECOL, V120, P587, DOI 10.1097/AOG.0b013e318262234b; Yamaguchi T, 2000, SURG TODAY, V30, P1093, DOI 10.1007/s005950070007; Yanagisawa H, 1998, J CLIN INVEST, V102, P22, DOI 10.1172/JCI2698; Yanagisawa H, 2002, NATURE, V415, P168, DOI 10.1038/415168a; Yao HW, 2010, P NATL ACAD SCI USA, V107, P15571, DOI 10.1073/pnas.1007625107; Zhang X, 2007, MOL REPROD DEV, V74, P321, DOI 10.1002/mrd.20582	52	13	14	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 28	2016	11	4							e0152793	10.1371/journal.pone.0152793	http://dx.doi.org/10.1371/journal.pone.0152793			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DK8XE	27124299	Green Published, gold, Green Submitted			2022-12-26	WOS:000375211700007
J	Hyvarinen, P; Makitie, A; Aarnisalo, AA				Hyvarinen, Petteri; Makitie, Antti; Aarnisalo, Antti A.			Self-Administered Domiciliary tDCS Treatment for Tinnitus: A Double-Blind Sham-Controlled Study	PLOS ONE			English	Article							DIRECT-CURRENT STIMULATION; HUMAN MOTOR CORTEX; HANDICAP INVENTORY; CLINICAL-TRIALS; DEPRESSION; INTENSITY; NEUROSCIENCE; SUPPRESSION; MODULATION; GUIDELINES	Transcranial direct current stimulation (tDCS) has shown potential for providing tinnitus relief, although positive effects have usually been observed only during a short time period after treatment. In recent studies the focus has turned from one-session experiments towards multi-session treatment studies investigating long-term outcomes with double-blinded and sham-controlled study designs. Traditionally, tDCS has been administered in a clinical setting by a healthcare professional but in studies involving multiple treatment sessions, often a trade-off has to be made between sample size and the amount of labor needed to run the trial. Also, as the number of required visits to the clinic increases, the dropout rate is likely to rise proportionally. The aim of the current study was to find out if tDCS treatment for tinnitus could be patient-administered in a domiciliary setting and whether the results would be comparable to those from in-hospital treatment studies. Forty-three patients with chronic (> 6 months) tinnitus were involved in the study, and data on 35 out of these patients were included in final analysis. Patients received 20 minutes of left temporal area anodal (LTA) or bifrontal tDCS stimulation (2 mA) or sham stimulation (0.3 mA) for ten consecutive days. An overall reduction in the main outcome measure, Tinnitus Handicap Inventory (THI), was found (mean change -5.0 points, p < 0.05), but there was no significant difference between active and sham treatment outcomes. Patients found the tDCS treatment easy to administer and they all tolerated it well. In conclusion, self-administered domiciliary tDCS treatment for tinnitus was found safe and feasible and gave outcome results similar to recent randomized controlled long-term treatment trials. The results suggest better overall treatment response-as measured by THI-with domiciliary treatment than with in-hospital treatment, but this advantage is not related to the tDCS variant. The study protocol demonstrated in the current study is not restricted to tinnitus only.	[Hyvarinen, Petteri; Makitie, Antti; Aarnisalo, Antti A.] Univ Helsinki, Dept Otorhinolaryngol Head & Neck Surg, POB 220, FI-00029 Helsinki, Finland; [Hyvarinen, Petteri; Makitie, Antti; Aarnisalo, Antti A.] Helsinki Univ Hosp, Biomed Helsinki 1, POB 220, FI-00029 Helsinki, Finland; [Hyvarinen, Petteri] Aalto Univ, Dept Neurosci & Biomed Engn, Sch Sci, POB 12200, FI-00076 Espoo, Finland	University of Helsinki; University of Helsinki; Helsinki University Central Hospital; Aalto University	Hyvarinen, P (corresponding author), Univ Helsinki, Dept Otorhinolaryngol Head & Neck Surg, POB 220, FI-00029 Helsinki, Finland.; Hyvarinen, P (corresponding author), Helsinki Univ Hosp, Biomed Helsinki 1, POB 220, FI-00029 Helsinki, Finland.; Hyvarinen, P (corresponding author), Aalto Univ, Dept Neurosci & Biomed Engn, Sch Sci, POB 12200, FI-00076 Espoo, Finland.	petteri.hyvarinen@aalto.fi		Hyvarinen, Petteri/0000-0002-6922-4331	Paulo Foundation; Jenny and Antti Wihuri Foundation; Avohoidon tutkimussaatio	Paulo Foundation; Jenny and Antti Wihuri Foundation; Avohoidon tutkimussaatio	PH has received personal grants from the Paulo Foundation (www.paulo.fi) and the Jenny and Antti Wihuri Foundation (www.wihurinrahasto.fi). PH, AM and AAA have received a research group grant from the Avohoidon tutkimussaatio (Research fund for outpatient care: http://www.aurora-tietokanta.fi/foundation/details/id/276/refc/lang). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This study was supported by Avohoidon tutkimussaatio (Research Fund for Outpatient Care). PH would also like to thank the Jenny and Antti Wihuri Foundation and the Paulo Foundation for their financial support. The authors wish to thank Tuomas Neuvonen, Mika Nikander and Jani Virtanen from Sooma Oy for their valuable technical support and advice.	Baguley D, 2013, LANCET, V382, P1600, DOI 10.1016/S0140-6736(13)60142-7; BECK AT, 1988, J CONSULT CLIN PSYCH, V56, P893, DOI 10.1037/0022-006X.56.6.893; Beck AT, 1996, J PERS ASSESS, V67, P588, DOI 10.1207/s15327752jpa6703_13; Bikson M, 2009, CLIN NEUROPHYSIOL, V120, P1033, DOI 10.1016/j.clinph.2009.03.018; Cavalcanti K, 2015, BRAIN STIMUL, V8, P978, DOI 10.1016/j.brs.2015.06.019; Charvet LE, 2015, FRONT SYST NEUROSCI, V9, DOI 10.3389/fnsys.2015.00026; Coffman BA, 2012, BMC NEUROSCI, V13, DOI 10.1186/1471-2202-13-108; De Ridder D, 2015, FRONT NEUROL, V6, DOI 10.3389/fneur.2015.00124; Eggermont JJ, 2004, TRENDS NEUROSCI, V27, P676, DOI 10.1016/j.tins.2004.08.010; Epp B, 2012, J ACOUST SOC AM, V132, pEL196, DOI 10.1121/1.4740462; Forogh B, 2016, NEUROL SCI, V37, P253, DOI 10.1007/s10072-015-2393-9; Frank E, 2012, J NEUROL, V259, P327, DOI 10.1007/s00415-011-6189-4; Fregni F, 2006, EUR J NEUROL, V13, P996, DOI 10.1111/j.1468-1331.2006.01414.x; Goebel G, INT J AUDIOL, V43, P600; Hagenacker T, 2014, J HEADACHE PAIN, V15, DOI 10.1186/1129-2377-15-78; Heimrath K, 2015, EUR J NEUROSCI, V41, P1580, DOI 10.1111/ejn.12908; Koehler SD, 2013, J NEUROSCI, V33, P19647, DOI 10.1523/JNEUROSCI.2788-13.2013; Landgrebe M, 2012, J PSYCHOSOM RES, V73, P112, DOI 10.1016/j.jpsychores.2012.05.002; Langguth B, 2013, LANCET NEUROL, V12, P920, DOI 10.1016/S1474-4422(13)70160-1; Leaver AM, 2011, NEURON, V69, P33, DOI 10.1016/j.neuron.2010.12.002; McCombe A, 2001, CLIN OTOLARYNGOL, V26, P388, DOI 10.1046/j.1365-2273.2001.00490.x; Newman CW, 1996, ARCH OTOLARYNGOL, V122, P143; Nitsche MA, 2000, J PHYSIOL-LONDON, V527, P633, DOI 10.1111/j.1469-7793.2000.t01-1-00633.x; Pal N, 2015, BRAIN STIMUL, V8, P1101, DOI 10.1016/j.brs.2015.06.014; Priori A, 1998, NEUROREPORT, V9, P2257, DOI 10.1097/00001756-199807130-00020; Rauschecker JP, 2010, NEURON, V66, P819, DOI 10.1016/j.neuron.2010.04.032; Roberts LE, 2012, FRONT SYST NEUROSCI, V6, DOI 10.3389/fnsys.2012.00040; Roberts LE, 2010, J NEUROSCI, V30, P14972, DOI 10.1523/JNEUROSCI.4028-10.2010; Schlee W, 2009, BMC BIOL, V7, DOI 10.1186/1741-7007-7-80; Schlee W, 2009, BMC NEUROSCI, V10, DOI 10.1186/1471-2202-10-11; Shekhawat GS, 2015, NEUROREHAB NEURAL RE, V29, P837, DOI 10.1177/1545968314567152; Shekhawat GS, 2013, NEUROREHAB NEURAL RE, V27, P164, DOI 10.1177/1545968312459908; Smarr KL, 2011, ARTHRIT CARE RES, V63, pS454, DOI 10.1002/acr.20556; Valiengo L, 2013, DEPRESS ANXIETY, V30, P646, DOI 10.1002/da.22079; van der Loo E, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007396; Vanneste S, 2011, EXP BRAIN RES, V210, P217, DOI 10.1007/s00221-011-2617-z; Weisz N, 2005, PLOS MED, V2, P546, DOI 10.1371/journal.pmed.0020153; Weisz N, 2006, HEARING RES, V222, P108, DOI 10.1016/j.heares.2006.09.003; Zeman F, 2011, OTOLARYNG HEAD NECK, V145, P282, DOI 10.1177/0194599811403882; Zobay O, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0120123	40	23	23	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 28	2016	11	4							e0154286	10.1371/journal.pone.0154286	http://dx.doi.org/10.1371/journal.pone.0154286			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DK8XE	27124116	Green Published, Green Submitted, gold			2022-12-26	WOS:000375211700065
J	Lightfoot, E; O'Connell, TC				Lightfoot, Emma; O'Connell, Tamsin C.			On the Use of Biomineral Oxygen Isotope Data to Identify Human Migrants in the Archaeological Record: Intra-Sample Variation, Statistical Methods and Geographical Considerations	PLOS ONE			English	Article							LABELED WATER METHOD; HUMAN TOOTH ENAMEL; HYDROGEN ISOTOPES; BONE PHOSPHATE; CARBONATE; RATIOS; TEOTIHUACAN; DELTA-O-18; STRONTIUM; ROMAN	Oxygen isotope analysis of archaeological skeletal remains is an increasingly popular tool to study past human migrations. It is based on the assumption that human body chemistry preserves the delta O-18 of precipitation in such a way as to be a useful technique for identifying migrants and, potentially, their homelands. In this study, the first such global survey, we draw on published human tooth enamel and bone bioapatite data to explore the validity of using oxygen isotope analyses to identify migrants in the archaeological record. We use human delta O-18 results to show that there are large variations in human oxygen isotope values within a population sample. This may relate to physiological factors influencing the preservation of the primary isotope signal, or due to human activities (such as brewing, boiling, stewing, differential access to water sources and so on) causing variation in ingested water and food isotope values. We compare the number of outliers identified using various statistical methods. We determine that the most appropriate method for identifying migrants is dependent on the data but is likely to be the IQR or median absolute deviation from the median under most archaeological circumstances. Finally, through a spatial assessment of the dataset, we show that the degree of overlap in human isotope values from different locations across Europe is such that identifying individuals' homelands on the basis of oxygen isotope analysis alone is not possible for the regions analysed to date. Oxygen isotope analysis is a valid method for identifying first-generation migrants from an archaeological site when used appropriately, however it is difficult to identify migrants using statistical methods for a sample size of less than c. 25 individuals. In the absence of local previous analyses, each sample should be treated as an individual dataset and statistical techniques can be used to identify migrants, but in most cases pinpointing a specific homeland should not be attempted.	[Lightfoot, Emma] Univ Cambridge, McDonald Inst Archaeol Res, Cambridge, England; [O'Connell, Tamsin C.] Univ Cambridge, Dept Archaeol & Anthropol, Cambridge, England	University of Cambridge; University of Cambridge	O'Connell, TC (corresponding author), Univ Cambridge, Dept Archaeol & Anthropol, Cambridge, England.	tco21@cam.ac.uk	Lightfoot, Emma/O-3793-2019	O'Connell, Tamsin/0000-0002-4744-0332				Aggarwal C. C., 2013, OUTLIER ANALYSIS; [Anonymous], 2015, GRIDDED MAPS ISOTOPI; Balasse M, 2006, J ZOOL, V270, P170, DOI 10.1111/j.1469-7998.2006.00104.x; Balasse M, 2003, J ARCHAEOL SCI, V30, P205, DOI 10.1006/jasc.2002.0833; Barnett V., 1994, OUTLIERS STAT DATA; Bentley RA, 2007, CURR ANTHROPOL, V48, P301, DOI 10.1086/512987; Bowen GJ, 2003, WATER RESOUR RES, V39, DOI 10.1029/2003WR002086; Bowen GJ, 2002, GEOLOGY, V30, P315, DOI 10.1130/0091-7613(2002)030<0315:SDOOIM>2.0.CO;2; Brettell R, 2012, J ANAL ATOM SPECTROM, V27, P778, DOI 10.1039/c2ja10335d; BRYANT JD, 1994, PALAEOGEOGR PALAEOCL, V107, P303; Bryant JD, 1996, GEOCHIM COSMOCHIM AC, V60, P5145; Buckberry J, 2014, OXFORD J ARCHAEOL, V33, P413, DOI 10.1111/ojoa.12045; Chenery C, 2003, TRAC-TREND ANAL CHEM, V22, pIII, DOI 10.1016/S0165-9936(03)00309-1; Chenery C, 2010, J ARCHAEOL SCI, V37, P150, DOI 10.1016/j.jas.2009.09.025; Chenery CA, 2012, RAPID COMMUN MASS SP, V26, P309, DOI 10.1002/rcm.5331; COPLEN TB, 1983, NATURE, V302, P236, DOI 10.1038/302236a0; DANGELA D, 1990, CHEM GEOL, V86, P75, DOI 10.1016/0168-9622(90)90007-Y; DANSGAARD W, 1964, TELLUS, V16, P436; Darling WG, 2003, HYDROL EARTH SYST SC, V7, P183, DOI 10.5194/hess-7-183-2003; Daux V, 2005, CLIMATIC CHANGE, V70, P445, DOI 10.1007/s10584-005-5385-6; Daux V, 2008, J HUM EVOL, V55, P1138, DOI 10.1016/j.jhevol.2008.06.006; Dupras TL, 2001, J ARCHAEOL SCI, V28, P1199, DOI 10.1006/jasc.2001.0640; Eckardt H, 2009, J ARCHAEOL SCI, V36, P2816, DOI 10.1016/j.jas.2009.09.010; Ehleringer JR, 2008, P NATL ACAD SCI USA, V105, P2788, DOI 10.1073/pnas.0712228105; EPSTEIN S, 1988, P NATL ACAD SCI USA, V85, P1727, DOI 10.1073/pnas.85.6.1727; Evans JA, 2012, J ANAL ATOM SPECTROM, V27, P754, DOI 10.1039/c2ja10362a; GAT J R, 1972, Journal of Hydrology (Amsterdam), V16, P177, DOI 10.1016/0022-1694(72)90052-2; GAT JR, 1971, WATER RESOUR RES, V7, P980, DOI 10.1029/WR007i004p00980; Global Network of Isotopes in Precipitation, 2015, THE GNIP DAT; Grimes V, 2013, RAPID COMMUN MASS SP, V27, P375, DOI 10.1002/rcm.6463; Hawkins D. M, 1980, IDENTIFICATION OUTLI; Hubert M, 2008, COMPUT STAT DATA AN, V52, P5186, DOI 10.1016/j.csda.2007.11.008; Johnson RA., 2007, APPL MULTIVARIATE ST; King CL, 2013, J ARCHAEOL SCI, V40, P1681, DOI 10.1016/j.jas.2012.11.013; Koch PL, 1997, J ARCHAEOL SCI, V24, P417, DOI 10.1006/jasc.1996.0126; Lawrence JR, 1991, STABLE ISOTOPE GEOCH; Leach S, 2010, ANTIQUITY, V84, P131, DOI 10.1017/S0003598X00099816; LEETHORP JA, 1991, J ARCHAEOL SCI, V18, P343, DOI 10.1016/0305-4403(91)90070-6; Levinson A.A., 1987, APPL GEOCHEM, V2, P367, DOI DOI 10.1016/0883-2927(87)90021-7; Leys C, 2013, J EXP SOC PSYCHOL, V49, P764, DOI 10.1016/j.jesp.2013.03.013; Lightfoot E, 2014, AM J PHYS ANTHROPOL, V154, P535, DOI 10.1002/ajpa.22544; Lin GP, 2003, J FOOD SCI, V68, P2192, DOI 10.1111/j.1365-2621.2003.tb05745.x; LONGINELLI A, 1984, GEOCHIM COSMOCHIM AC, V48, P385, DOI 10.1016/0016-7037(84)90259-X; LUZ B, 1985, EARTH PLANET SC LETT, V75, P29, DOI 10.1016/0012-821X(85)90047-0; McGlynn GC, 2007, USING 13C 15N 180 ST; Muldner G, 2011, J ARCHAEOL SCI, V38, P280, DOI 10.1016/j.jas.2010.09.003; O'Connell TC, 2001, J ARCHAEOL SCI, V28, P1247, DOI 10.1006/jasc.2001.0698; O'Grady SP, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011699; Pearson J, 2013, WORLD ARCHAEOL, V45, P373, DOI 10.1080/00438243.2013.820646; Pellegrini M, 2016, CHEM GEOL, V420, P88, DOI 10.1016/j.chemgeo.2015.10.038; Pestle WJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102844; Podlesak DW, 2008, GEOCHIM COSMOCHIM AC, V72, P19, DOI 10.1016/j.gca.2007.10.003; Pollard AM, 2011, AM J PHYS ANTHROPOL, V145, P499, DOI 10.1002/ajpa.21524; Pryor AJE, 2014, PALAEOGEOGR PALAEOCL, V412, P99, DOI 10.1016/j.palaeo.2014.07.003; Reade H, 2015, CHEM GEOL, V404, P126, DOI 10.1016/j.chemgeo.2015.03.026; Reitsema LJ, 2011, AM J PHYS ANTHROPOL, V145, P495, DOI 10.1002/ajpa.21513; ROBERTS SB, 1988, AM J PHYSIOL, V254, pR622, DOI 10.1152/ajpregu.1988.254.4.R622; Rousseeuw PJ, 2011, WIRES DATA MIN KNOWL, V1, P73, DOI 10.1002/widm.2; Rousseeuw PJ, 1999, AM STAT, V53, P382, DOI 10.2307/2686061; ROUSSEEUW PJ, 1993, J AM STAT ASSOC, V88, P1273, DOI 10.2307/2291267; Rozanski K., 1993, CLIMATE CHANGE CONTI, V78, P1, DOI DOI 10.1029/GM078P0001; Salesse K, 2013, AM J PHYS ANTHROPOL, V151, P202, DOI 10.1002/ajpa.22267; Santana-Sagredo F, 2015, AM J PHYS ANTHROPOL, V156, P374, DOI 10.1002/ajpa.22663; Scheeres M, 2014, AM J PHYS ANTHROPOL, V155, P496, DOI 10.1002/ajpa.22597; SCHOELLER DA, 1986, AM J PHYSIOL, V251, pR1137, DOI 10.1152/ajpregu.1986.251.6.R1137; Schwarcz H. P., 1991, SNAKE HILL INVESTIGA, P263; Seo S, REV COMP METHODS DET; Sharp Z., 2007, PRINCIPLES STABLE IS; Turner BL, 2009, J ARCHAEOL SCI, V36, P317, DOI 10.1016/j.jas.2008.09.018; Tuross N, 2008, RAPID COMMUN MASS SP, V22, P1741, DOI 10.1002/rcm.3556; van Dam JA, 2009, PALAEOGEOGR PALAEOCL, V274, P64, DOI 10.1016/j.palaeo.2008.12.022; Warinner C, 2009, J ARCHAEOL SCI, V36, P1690, DOI 10.1016/j.jas.2009.03.034; White CD, 2004, J ANTHROPOL ARCHAEOL, V23, P385, DOI 10.1016/j.jaa.2004.08.002; White CD, 2002, LAT AM ANTIQ, V13, P217, DOI 10.2307/971915; White CD, 2000, J ANTHROPOL RES, V56, P535, DOI 10.1086/jar.56.4.3630930; Widory D, 2004, CR BIOL, V327, P729, DOI 10.1016/j.crvi.2004.07.001; WONG WW, 1987, AM J CLIN NUTR, V45, P905, DOI 10.1093/ajcn/45.5.905; Wright LE, 1998, AM J PHYS ANTHROPOL, V106, P1; Wright LE, 2010, J ANTHROPOL ARCHAEOL, V29, P155, DOI 10.1016/j.jaa.2010.01.002; ZANCONATO S, 1992, RESP PHYSIOL, V89, P319, DOI 10.1016/0034-5687(92)90090-J	80	104	104	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 28	2016	11	4							e0153850	10.1371/journal.pone.0153850	http://dx.doi.org/10.1371/journal.pone.0153850			29	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Arts &amp; Humanities Citation Index (A&amp;HCI)	Science & Technology - Other Topics	DK8XE	27124001	Green Published, Green Submitted, gold			2022-12-26	WOS:000375211700035
J	Golan, Y; Itsumura, N; Glaser, F; Berman, B; Kambe, T; Assaraf, YG				Golan, Yarden; Itsumura, Naoya; Glaser, Fabian; Berman, Bluma; Kambe, Taiho; Assaraf, Yehuda G.			Molecular Basis of Transient Neonatal Zinc Deficiency: NOVEL ZnT2 MUTATIONS DISRUPTING ZINC BINDING AND PERMEATION	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						dimerization; metal homeostasis; mutant; transport; zinc; bimolecular fluorescence complementation; neonatal zinc deficiency; transport metals; zinc transport	MAMMARY-GLAND DEVELOPMENT; TRANSPORTERS; SLC30A2; FAMILY; GENE; HAPLOINSUFFICIENCY; SERVER	A gradually increasing number of transient neonatal zinc deficiency (TNZD) cases was recently reported, all of which were associated with inactivating ZnT2 mutations. Here we characterized the impact of three novel heterozygous ZnT2 mutations G280R, T312M, and E355Q, which cause TNZD in exclusively breastfed infants of Japanese mothers. We used the bimolecular fluorescence complementation (BiFC) assay to provide direct visual evidence for the in situ dimerization of these ZnT2 mutants, and to explore their subcellular localization. Moreover, using three complementary functional assays, zinc accumulation using BiFC-Zinquin and Zinpyr-1 fluorescence as well as zinc toxicity assay, we determined the impact of these ZnT2 mutations on vesicular zinc accumulation. Although all three mutants formed homodimers with the wild type (WT) ZnT2 and retained substantial vesicular localization, as well as vesicular zinc accumulation, they had no dominant-negative effect over the WT ZnT2. Furthermore, using advanced bioinformatics, structural modeling, and site-directed mutagenesis we found that these mutations localized at key residues, which play an important physiological role in zinc coordination (G280R and E355Q) and zinc permeation (T312M). Collectively, our findings establish that some heterozygous loss of function ZnT2 mutations disrupt zinc binding and zinc permeation, thereby suggesting a haploinsufficiency state for the unaffected WT ZnT2 allele in TNZD pathogenesis. These results highlight the burning need for the development of a suitable genetic screen for the early diagnosis of TNZD to prevent morbidity.	[Golan, Yarden; Berman, Bluma; Assaraf, Yehuda G.] Technion, Fred Wyszkowski Canc Res Lab, Dept Biol, IL-32000 Haifa, Israel; [Glaser, Fabian] Technion, Lorry I Lokey Interdisciplinary Ctr Life Sci & En, Bioinformat Knowledge Unit, IL-32000 Haifa, Israel; [Itsumura, Naoya; Kambe, Taiho] Kyoto Univ, Grad Sch Biostudies, Div Integrated Life Sci, Sakyo Ku, Kitashirakawa Oiwake Cho, Kyoto 6068502, Japan	Technion Israel Institute of Technology; Technion Israel Institute of Technology; Kyoto University	Assaraf, YG (corresponding author), Technion, Fred Wyszkowski Canc Res Lab, Dept Biol, IL-32000 Haifa, Israel.; Kambe, T (corresponding author), Kyoto Univ, Grad Sch Biostudies, Div Integrated Life Sci, Sakyo Ku, Kitashirakawa Oiwake Cho, Kyoto 6068502, Japan.	kambe1@kais.kyoto-u.ac.jp; assaraf@tx.technion.ac.il		Assaraf, Yehuda G./0000-0001-6692-8221; Golan, Yarden/0000-0002-3043-3638	Grants-in-Aid for Scientific Research [15J08478] Funding Source: KAKEN	Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))		Alam S, 2015, J MAMMARY GLAND BIOL, V20, P159, DOI 10.1007/s10911-015-9338-z; Chowanadisai W, 2006, J BIOL CHEM, V281, P39699, DOI 10.1074/jbc.M605821200; Coromilas A, 2011, PEDIATR DERMATOL, V28, P697, DOI 10.1111/j.1525-1470.2011.01637.x; Coudray N, 2013, P NATL ACAD SCI USA, V110, P2140, DOI 10.1073/pnas.1215455110; Fujimoto S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077445; Golan Y, 2015, J BIOL CHEM, V290, P9050, DOI 10.1074/jbc.M114.617332; Hennigar SR, 2015, J CELL PHYSIOL, V230, P2345, DOI 10.1002/jcp.24992; Ho G, 2011, HUM MUTAT, V32, pE1976, DOI 10.1002/humu.21399; Huang LP, 2013, MOL ASPECTS MED, V34, P548, DOI 10.1016/j.mam.2012.05.008; Huo J, 2010, ARCH DERMATOL RES, V302, P769, DOI 10.1007/s00403-010-1081-0; Itsumura N., 2016, PEDIAT RES IN PRESS; Itsumura N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064045; Kambe T, 2015, PHYSIOL REV, V95, P749, DOI 10.1152/physrev.00035.2014; Kambe T, 2011, BIOSCI BIOTECH BIOCH, V75, P1036, DOI 10.1271/bbb.110056; Kasana S, 2015, J TRACE ELEM MED BIO, V29, P47, DOI 10.1016/j.jtemb.2014.10.003; Kerppola TK, 2009, CHEM SOC REV, V38, P2876, DOI 10.1039/b909638h; Lasry I, 2014, J BIOL CHEM, V289, P7275, DOI 10.1074/jbc.M113.533786; Lasry I, 2012, J BIOL CHEM, V287, P29348, DOI 10.1074/jbc.M112.368159; Lee S, 2015, J BIOL CHEM, V290, P13064, DOI 10.1074/jbc.M115.637439; Lessen R, 2015, J ACAD NUTR DIET, V115, P444, DOI 10.1016/j.jand.2014.12.014; Navarro ML, 2014, PEDIATR DERMATOL, V31, P251, DOI 10.1111/pde.12257; Lu M, 2009, NAT STRUCT MOL BIOL, V16, P1063, DOI 10.1038/nsmb.1662; McCormick NH, 2014, J MAMMARY GLAND BIOL, V19, P59, DOI 10.1007/s10911-013-9314-4; Meng EC, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-339; Miletta MC, 2013, INT J ENDOCRINOL, V2013, DOI 10.1155/2013/259189; Murthy Sambasiviah C, 2010, Dermatol Online J, V16, P3; Page DT, 2009, P NATL ACAD SCI USA, V106, P1989, DOI 10.1073/pnas.0804428106; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Pires DEV, 2014, NUCLEIC ACIDS RES, V42, pW314, DOI 10.1093/nar/gku411; Prasad AS, 2003, BMJ-BRIT MED J, V326, P409, DOI 10.1136/bmj.326.7386.409; Savignac M, 2011, BBA-MOL CELL RES, V1813, P1111, DOI 10.1016/j.bbamcr.2010.12.006; Schymkowitz J, 2005, NUCLEIC ACIDS RES, V33, pW382, DOI 10.1093/nar/gki387; Sedic M, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8505; Sharma M, 2014, DNA RES, V21, P267, DOI 10.1093/dnares/dst056; Webb B., 2014, CURR PROTOC BIOINFOR, V5.6, P32, DOI [10.1002/0471250953.bi0506s47, DOI 10.1002/0471250953.BI0506S47]	35	13	13	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 24	2016	291	26					13546	13559		10.1074/jbc.M116.732693	http://dx.doi.org/10.1074/jbc.M116.732693			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DR2YZ	27137936	Green Published, hybrid			2022-12-26	WOS:000379771100013
J	Ozmeral, EJ; Buss, E; Hall, JW				Ozmeral, Erol J.; Buss, Emily; Hall, Joseph W., III			The Effects of Sensorineural Hearing Impairment on Asynchronous Glimpsing of Speech	PLOS ONE			English	Article							TEMPORAL FINE-STRUCTURE; MASKING RELEASE; SPECTRAL INTEGRATION; NORMALLY-HEARING; WORD RECOGNITION; OLDER-ADULTS; NOISE; INTELLIGIBILITY; LISTENERS; PERCEPTION	In a previous study with normal-hearing listeners, we evaluated consonant identification masked by two or more spectrally contiguous bands of noise, with asynchronous square-wave modulation applied to neighboring bands. Speech recognition thresholds were 5.1-8.5 dB better when neighboring bands were presented to different ears (dichotic) than when all bands were presented to one ear (monaural), depending on the spectral width of the frequency bands. This dichotic advantage was interpreted as reflecting masking release from peripheral spread of masking from neighboring frequency bands. The present study evaluated this effect in listeners with sensorineural hearing loss, a population more susceptible to spread of masking. Speech perception (vowel-consonant-vowel stimuli, as in /aBa/) was measured in the presence of fluctuating noise that was either modulated synchronously across frequency or asynchronously. Hearing-impaired listeners (n = 9) and normal-hearing controls were tested at either the same intensity (n = 7) or same sensation level (n = 8). Hearing-impaired listeners had mild-to-moderate hearing loss and symmetrical, flat audiometric thresholds. While all groups of listeners performed better in the dichotic than monaural condition, this effect was smaller for the hearing-impaired (3.5 dB) and equivalent-sensation-level controls (3.3 dB) than controls tested at the same intensity (11.0 dB). The present study is consistent with the idea that dichotic presentation can improve speech-in-noise listening for hearing-impaired listeners, and may be enhanced when combined with amplification.	[Ozmeral, Erol J.] Univ S Florida, Dept Commun Sci & Disorders, Tampa, FL USA; [Buss, Emily; Hall, Joseph W., III] Univ N Carolina, Sch Med, Div Otolaryngol Head & Neck Surg, Chapel Hill, NC 27599 USA	State University System of Florida; University of South Florida; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine	Ozmeral, EJ (corresponding author), Univ S Florida, Dept Commun Sci & Disorders, Tampa, FL USA.	eozmeral@usf.edu		Ozmeral, Erol/0000-0001-9529-001X; Buss, Emily/0000-0001-8244-3013	National Institutes of Health-National Institute on Deafness and Other Communication Disorders grants [R01 DC000418, F31 DC012694]; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [F31DC012694, R01DC000418] Funding Source: NIH RePORTER	National Institutes of Health-National Institute on Deafness and Other Communication Disorders grants; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	This work was supported by National Institutes of Health-National Institute on Deafness and Other Communication Disorders grants R01 DC000418 awarded to JWH and F31 DC012694 awarded to EJO. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANSI, 2010, S362010 ANSI; Aronoff JM, 2014, EAR HEARING, V35, P708, DOI 10.1097/AUD.0000000000000060; Assmann P. F., 2004, SPR HDB AUD, V14, P231; BAER T, 1994, J ACOUST SOC AM, V95, P2277, DOI 10.1121/1.408640; BAER T, 1993, J ACOUST SOC AM, V94, P1229, DOI 10.1121/1.408176; Bernstein JGW, 2009, J ACOUST SOC AM, V125, P3358, DOI 10.1121/1.3110132; BRONKHORST AW, 1992, J ACOUST SOC AM, V92, P3132, DOI 10.1121/1.404209; Buss E, 2004, J ACOUST SOC AM, V115, P2278, DOI 10.1121/1.1691035; BUUS S, 1985, J ACOUST SOC AM, V78, P1958, DOI 10.1121/1.392652; BYRNE D, 1994, J ACOUST SOC AM, V96, P2108, DOI 10.1121/1.410152; Cooke M, 2006, J ACOUST SOC AM, V119, P1562, DOI 10.1121/1.2166600; DUBNO JR, 1989, J ACOUST SOC AM, V85, P1666, DOI 10.1121/1.397955; Dubno JR, 2003, J ACOUST SOC AM, V113, P2084, DOI 10.1121/1.1555611; Dubno JR, 2002, J ACOUST SOC AM, V111, P2897, DOI 10.1121/1.1480421; DUBNO JR, 1982, J SPEECH HEAR RES, V25, P141, DOI 10.1044/jshr.2501.141; FESTEN JM, 1990, J ACOUST SOC AM, V88, P1725, DOI 10.1121/1.400247; FLORENTINE M, 1980, J SPEECH HEAR RES, V23, P646, DOI 10.1044/jshr.2303.646; Fullgrabe C, 2006, HEARING RES, V211, P74, DOI 10.1016/j.heares.2005.09.001; GAGNE JP, 1988, J ACOUST SOC AM, V83, P2311, DOI 10.1121/1.396362; George ELJ, 2006, J ACOUST SOC AM, V120, P2295, DOI 10.1121/1.2266530; Gnansia D, 2009, J ACOUST SOC AM, V125, P4023, DOI 10.1121/1.3126344; GORDONSALANT S, 1985, J SPEECH HEAR RES, V28, P87, DOI 10.1044/jshr.2801.87; GUSTAFSSON HA, 1994, J ACOUST SOC AM, V95, P518, DOI 10.1121/1.408346; Hall JW, 2008, J ACOUST SOC AM, V124, P1105, DOI 10.1121/1.2940582; HALL JW, 1984, J SPEECH HEAR RES, V27, P145, DOI 10.1044/jshr.2701.145; Healy EW, 2010, J SPEECH LANG HEAR R, V53, P1087, DOI 10.1044/1092-4388(2010/09-0185); Healy EW, 2002, J SPEECH LANG HEAR R, V45, P1262, DOI 10.1044/1092-4388(2002/101); Hopkins K, 2009, J ACOUST SOC AM, V125, P442, DOI 10.1121/1.3037233; HOWARDJONES PA, 1993, J ACOUST SOC AM, V93, P2915, DOI 10.1121/1.405811; Hu Y, 2007, J ACOUST SOC AM, V122, P1777, DOI 10.1121/1.2766778; Jin SH, 2006, J ACOUST SOC AM, V119, P3097, DOI 10.1121/1.2188688; Kulkarni PN, 2012, INT J AUDIOL, V51, P334, DOI 10.3109/14992027.2011.642012; LEEK MR, 1993, J ACOUST SOC AM, V94, P3127, DOI 10.1121/1.407218; LESHOWITZ B, 1977, J ACOUST SOC AM, V62, pS93, DOI 10.1121/1.2016459; LEVITT H, 1971, J ACOUST SOC AM, V49, P467, DOI 10.1121/1.1912375; Loizou PC, 2003, J ACOUST SOC AM, V114, P475, DOI 10.1121/1.1582861; LUNNER T, 1993, SCAND AUDIOL, V22, P75; LYREGAARD PE, 1982, SCAND AUDIOL, P113; MARTIN ES, 1970, J SPEECH HEAR RES, V13, P426, DOI 10.1044/jshr.1302.426; MILLER GA, 1950, J ACOUST SOC AM, V22, P167, DOI 10.1121/1.1906584; Nasreddine ZS, 2005, J AM GERIATR SOC, V53, P695, DOI 10.1111/j.1532-5415.2005.53221.x; Oxenham AJ, 2009, J ACOUST SOC AM, V125, P457, DOI 10.1121/1.3021299; Ozmeral EJ, 2012, J ACOUST SOC AM, V132, P1152, DOI 10.1121/1.4730976; PEKKARINEN E, 1990, SCAND AUDIOL, V19, P31, DOI 10.3109/01050399009070749; Peters RW, 1998, J ACOUST SOC AM, V103, P577, DOI 10.1121/1.421128; Qin MK, 2006, J ACOUST SOC AM, V119, P2417, DOI 10.1121/1.2178719; Rosen SM, 1986, FREQUENCY SELECTIVIT, P373; SMOORENBURG GF, 1992, J ACOUST SOC AM, V91, P421, DOI 10.1121/1.402729; Snell KB, 2002, J ACOUST SOC AM, V112, P720, DOI 10.1121/1.1487841; Stone MA, 2014, J ACOUST SOC AM, V135, P1967, DOI 10.1121/1.4868392; Studebaker GA, 1999, J ACOUST SOC AM, V105, P2431, DOI 10.1121/1.426848; TERKEURS M, 1993, J ACOUST SOC AM, V93, P1547, DOI 10.1121/1.406813; Tyler RS, 1986, FREQUENCY SELECTIVIT, P309; Zhou N, 2012, J ACOUST SOC AM, V132, P994, DOI 10.1121/1.4730907; ZWICKER E, 1978, AUDIOLOGY, V17, P120	55	1	1	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 4	2016	11	5							e0154920	10.1371/journal.pone.0154920	http://dx.doi.org/10.1371/journal.pone.0154920			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DL5KR	27144601	Green Submitted, Green Published, gold			2022-12-26	WOS:000375676400094
J	Wallensten, J; Asberg, M; Nygren, A; Szulkin, R; Wallen, H; Mobarrez, F; Nager, A				Wallensten, Johanna; Asberg, Marie; Nygren, Ake; Szulkin, Robert; Wallen, Hakan; Mobarrez, Fariborz; Nager, Anna			Possible Biomarkers of Chronic Stress Induced Exhaustion - A Longitudinal Study	PLOS ONE			English	Article							GROWTH-FACTOR; VEGF; PROLIFERATION; CYTOKINES; SYMPTOMS; MARKERS; WOMEN; MCP-1; AXIS; SEX	Background Vascular endothelial growth factor (VEGF), epidermal growth factor (EGF) and monocyte chemotactic protein-1 (MCP-1) have previously been suggested to be potential biomarkers for chronic stress induced exhaustion. The knowledge about VEGF has increased during the last decades and supports the contention that VEGF plays an important role in stress and depression. There is scarce knowledge on the possible relationship of EGF and MCP-1 in chronic stress and depression. This study further examines the role of VEGF, EGF and MCP-1 in women with chronic stress induced exhaustion and healthy women during a follow-up period of two years. Methods and Findings Blood samples were collected from 105 women with chronic stress induced exhaustion on at least 50% sick leave for at least three months, at inclusion (T0), after 12 months (T12) and after 24 months (T24). Blood samples were collected at inclusion (T0) in 116 physically and psychiatrically healthy women. The plasma levels of VEGF, EGF and MCP-1 were analyzed using Biochip Array Technology. Women with chronic stress induced exhaustion had significantly higher plasma levels of VEGF and EGF compared to healthy women at baseline, T12 and at T24. There was no significant difference in plasma levels of MCP-1. Plasma levels of VEGF and EGF decreased significantly in women with chronic stress induced exhaustion during the two years follow-up. Conclusions The replicated findings of elevated levels of VEGF and EGF in women with chronic stress induced exhaustion and decreasing plasma levels of VEGF and EGF during the two years follow-up add important knowledge to the pathophysiology of chronic stress induced exhaustion.	[Wallensten, Johanna] Danderyd Hosp, Div Rehabil Med, Stockholm, Sweden; [Wallensten, Johanna; Asberg, Marie; Nygren, Ake; Wallen, Hakan; Mobarrez, Fariborz; Nager, Anna] Karolinska Inst, Danderyd Hosp, Dept Clin Sci, Stockholm, Sweden; [Szulkin, Robert] Karolinska Inst, Dept Med Epidemiol & Biostat, Stockholm, Sweden; [Szulkin, Robert] Karolinska Inst, Stockholms Lans Landsting, Acad Primary Healthcare Ctr, Stockholm, Sweden; [Wallen, Hakan] Danderyd Hosp, Div Cardiovasc Med, Stockholm, Sweden; [Mobarrez, Fariborz] Karolinska Univ Hosp, Dept Med, Rheumatol Unit, S-17176 Stockholm, Sweden; [Nager, Anna] Karolinska Inst, Dept Neurobiol Care Sci & Soc, Div Family Med, Stockholm, Sweden	Danderyds Hospital; Danderyds Hospital; Karolinska Institutet; Karolinska Institutet; Karolinska Institutet; Danderyds Hospital; Karolinska Institutet; Karolinska University Hospital; Karolinska Institutet	Wallensten, J (corresponding author), Danderyd Hosp, Div Rehabil Med, Stockholm, Sweden.; Wallensten, J (corresponding author), Karolinska Inst, Danderyd Hosp, Dept Clin Sci, Stockholm, Sweden.	johanna.wallensten@ki.se	Nager, Anna/K-4135-2019; Mobarrez, Fariborz/AAK-8929-2020	Mobarrez, Fariborz/0000-0002-7106-6248	Swedish Research Council [5454]	Swedish Research Council(Swedish Research CouncilEuropean Commission)	AFA Insurance https://www.afaforsakring.se/forskning/. The Swedish Research Council. Grant number 5454 http://www.vr.se/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arakelyan A, 2005, MEDIAT INFLAMM, P175, DOI 10.1155/MI.2005.175; Asberg M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0003590; Blix E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064065; Bryngelson A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067887; Chen QS, 2013, MEDIAT INFLAMM, V2013, DOI [10.1155/2013/928315, 10.1155/2013/434010]; DSM IV: American Psychiatric Association, 2000, DIAGN STAT MAN MENT; Ekstedt M, 2009, BIOL PSYCHOL, V82, P267, DOI 10.1016/j.biopsycho.2009.08.006; Elfving B, 2014, INT J NEUROPSYCHOPH, V17, P1409, DOI 10.1017/S1461145714000273; First M. B., 1997, STRUCTURED CLIN INTE; Glise K, 2015, EUR PSYCHIAT, V30, DOI 10.1016/S0924-9338(15)30776-8; Glise K, 2012, BMC PSYCHIATRY, V12, DOI 10.1186/1471-244X-12-18; Harvey SB, 2009, J PSYCHOSOM RES, V66, P445, DOI 10.1016/j.jpsychores.2008.12.007; Heine VM, 2005, EUR J NEUROSCI, V21, P1304, DOI 10.1111/j.1460-9568.2005.03951.x; Hetland ML, 2008, DIS MARKERS, V24, P1; Holmes DIR, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-2-209; Isung J, 2012, WORLD J BIOL PSYCHIA, V13, P468, DOI 10.3109/15622975.2011.624549; Jonsdottir IH, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007659; Kahl KG, 2009, PSYCHONEUROENDOCRINO, V34, P353, DOI 10.1016/j.psyneuen.2008.09.016; Lee BH, 2012, J AFFECT DISORDERS, V136, P181, DOI 10.1016/j.jad.2011.07.021; Lu SJ, 2013, COMPR PSYCHIAT, V54, P953, DOI 10.1016/j.comppsych.2013.03.026; Lu XT, 2013, STRESS, V16, P87, DOI 10.3109/10253890.2012.676696; LUGER A, 1988, J CLIN ENDOCR METAB, V66, P334, DOI 10.1210/jcem-66-2-334; Mirhafez SR, 2014, J AM SOC HYPERTENS, V8, P614, DOI 10.1016/j.jash.2014.05.007; Rydrnark I, 2006, BIOL PSYCHIAT, V60, P867, DOI 10.1016/j.biopsych.2006.04.029; Sandstrom A, 2005, BIOL PSYCHOL, V69, P271, DOI 10.1016/j.biopsycho.2004.08.003; Sandstrom A, 2011, SCAND J PSYCHOL, V52, P71, DOI 10.1111/j.1467-9450.2010.00844.x; Savic I, 2013, STRUCTURAL CHANGES B; Schmidt HD, 2007, BEHAV PHARMACOL, V18, P391, DOI 10.1097/FBP.0b013e3282ee2aa8; Segi-Nishida E, 2008, P NATL ACAD SCI USA, V105, P11352, DOI 10.1073/pnas.0710858105; Shibuya M, 2006, EXP CELL RES, V312, P549, DOI 10.1016/j.yexcr.2005.11.012; Swedish National Board of Health and Welfare, 2003, UTM STRESSR PSYK OH; Swedish Social Insurance Agency, 2014, 20144 SWED SOC INS A; Takebayashi M, 2010, J NEURAL TRANSM, V117, P1119, DOI 10.1007/s00702-010-0452-1; Wahlberg K, 2009, BIOL PSYCHIAT, V65, P742, DOI 10.1016/j.biopsych.2008.10.035	34	9	9	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 4	2016	11	5							e0153924	10.1371/journal.pone.0153924	http://dx.doi.org/10.1371/journal.pone.0153924			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DL5KR	27145079	Green Published, Green Submitted, gold			2022-12-26	WOS:000375676400032
J	Zhuang, MNV; Higham, TE				Zhuang, Mingna V.; Higham, Timothy E.			Arboreal Day Geckos (Phelsuma madagascariensis) Differentially Modulate Fore- and Hind Limb Kinematics in Response to Changes in Habitat Structure	PLOS ONE			English	Article							LIZARD CALLISAURUS-DRACONOIDES; DIPSOSAURUS-DORSALIS; FUNCTIONAL-ANALYSIS; ADHESIVE SYSTEM; UMA-SCOPARIA; TOE FRINGES; LOCOMOTION; INCLINE; SPEED; FOOT	By using adhesion, geckos can move through incredibly challenging habitats. However, continually changing terrain may necessitate modulation of the adhesive apparatus in order to maximize its effectiveness over a range of challenges. Behaviorally modulating how the adhesive system is applied can occur by altering the alignment of the foot relative to the long axis of the body and/or the angles between the digits (interdigital angle). Given the directionality of the adhesive system, geckos likely vary the application of the system via these mechanisms as they run. We quantified 3D movements (using high-speed video) of the day gecko, Phelsuma madagascariensis, running on a range of ecologically relevant inclines (0 degrees, 45 degrees, 90 degrees) and perch diameters (1.5 cm, 10 cm and broad). We measured the instantaneous sum of interdigital angles and foot alignment relative to the body, as well as other kinematic variables, throughout each stride and across treatments. Modulation of foot alignment at 45 degrees and 90 degrees was similar between the forelimb and hind limb, but differed at 0 degrees, suggesting that P. madagascariensis is able to exert an adhesive force using multiple strategies. Both the sum of interdigital angles and alignment in the fore-and hind foot were modulated. Differences in modulation between the limbs are likely related to the underlying morphology. The modulation of interdigital angle and foot alignment suggests that aspects other than the mechanism of adhesion, such as joint morphology, are important for arboreal movement in geckos. Our study of foot usage in arboreal locomotion reveals patterns that may be widespread across pad-bearing lizards. In addition to understanding the constraints exerted by the adhesive apparatus, we highlight how biomechanical traits may respond to the evolution of novel adaptations and morphologies.	[Zhuang, Mingna V.; Higham, Timothy E.] Univ Calif Riverside, Dept Biol, Riverside, CA 92521 USA	University of California System; University of California Riverside	Zhuang, MNV (corresponding author), Univ Calif Riverside, Dept Biol, Riverside, CA 92521 USA.	mzhua001@ucr.edu			National Science Foundation [IOS 1147043]; Division Of Integrative Organismal Systems [1147043] Funding Source: National Science Foundation	National Science Foundation(National Science Foundation (NSF)); Division Of Integrative Organismal Systems(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This work was funded by the National Science Foundation (IOS 1147043) to TEH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdala V, 2009, ANAT REC, V292, P842, DOI 10.1002/ar.20909; Alexander RM., 2003, PRINCIPLES ANIMAL LO; Autumn K, 2006, J EXP BIOL, V209, P260, DOI 10.1242/jeb.01980; Autumn K, 2002, INTEGR COMP BIOL, V42, P1081, DOI 10.1093/icb/42.6.1081; Autumn K, 2002, P NATL ACAD SCI USA, V99, P12252, DOI 10.1073/pnas.192252799; Autumn K, 2000, NATURE, V405, P681, DOI 10.1038/35015073; Birn-Jeffery AV, 2016, FRONT ZOOL, V13, DOI 10.1186/s12983-016-0144-2; Birn-Jeffery AV, 2014, BIOL LETTERS, V10, DOI 10.1098/rsbl.2014.0456; CAROTHERS JH, 1986, EVOLUTION, V40, P871, DOI 10.1111/j.1558-5646.1986.tb00550.x; Cartmill M., 1974, P45; CARTMILL M, 1979, AM J PHYS ANTHROPOL, V50, P497, DOI 10.1002/ajpa.1330500402; Fieler CL, 1998, J EXP BIOL, V201, P609; Foster KL, 2014, P ROY SOC B-BIOL SCI, V281, DOI 10.1098/rspb.2013.3331; Foster KL, 2012, J EXP BIOL, V215, P2288, DOI 10.1242/jeb.069856; Franz TM, 2005, J HUM EVOL, V48, P199, DOI 10.1016/j.jhevol.2004.11.004; Gilman CA, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0134604; Hedrick TL, 2008, BIOINSPIR BIOMIM, V3, DOI 10.1088/1748-3182/3/3/034001; Higham T.E., 2015, ALL ANIMALS ARE INTE, P279; Higham TE, 2004, J EXP BIOL, V207, P233, DOI 10.1242/jeb.00763; Higham TE, 2015, BIOL J LINN SOC, V116, P27, DOI 10.1111/bij.12566; Higham TE, 2015, P NATL ACAD SCI USA, V112, P809, DOI 10.1073/pnas.1418979112; Hill GC, 2011, J R SOC INTERFACE, V8, P926, DOI 10.1098/rsif.2010.0720; Hsieh ST, 2003, J EXP BIOL, V206, P4363, DOI 10.1242/jeb.00679; Humphrey LR, 2010, J BIOMECH, V43, P3199, DOI 10.1016/j.jbiomech.2010.07.021; Ikeuchi I, 2005, AMPHIBIA-REPTILIA, V26, P475, DOI 10.1163/156853805774806142; Irschick DJ, 1998, J EXP BIOL, V201, P273; Irschick DJ, 1999, J EXP BIOL, V202, P1047; Irschick DJ, 2006, J COMP PHYSIOL A, V192, P1169, DOI 10.1007/s00359-006-0145-2; Jayne BC, 1999, J EXP BIOL, V202, P143; Krause C, 2013, J EXP BIOL, V216, P1448, DOI 10.1242/jeb.082586; LAERM J, 1974, ECOLOGY, V55, P404, DOI 10.2307/1935228; Lammers AR, 2004, J EXP BIOL, V207, P4325, DOI 10.1242/jeb.01231; Lepore E, 2012, J ADHESION, V88, P820, DOI 10.1080/00218464.2012.705639; Li C, 2012, J EXP BIOL, V215, P3293, DOI 10.1242/jeb.061937; LUKE C, 1986, BIOL J LINN SOC, V27, P1, DOI 10.1111/j.1095-8312.1986.tb01723.x; MELDRUM DJ, 1991, AM J PHYS ANTHROPOL, V84, P273, DOI 10.1002/ajpa.1330840305; PETERSON JA, 1984, J ZOOL, V202, P1; Reilly SM, 1997, J ZOOL, V243, P417, DOI 10.1111/j.1469-7998.1997.tb02791.x; REWCASTLE SC, 1983, COPEIA, P476, DOI 10.2307/1444393; Russell AP, 2009, P R SOC B, V276, P3705, DOI 10.1098/rspb.2009.0946; RUSSELL AP, 1975, J ZOOL, V176, P437, DOI 10.1111/j.1469-7998.1975.tb03215.x; Russell AP, 2002, INTEGR COMP BIOL, V42, P1154, DOI 10.1093/icb/42.6.1154; Russell AP, 1997, J ZOOL, V241, P767, DOI 10.1111/j.1469-7998.1997.tb05747.x; Russell AP, 2001, COMP BIOCHEM PHYS A, V131, P89, DOI 10.1016/S1095-6433(01)00469-X; Russell AP, 2015, ACTA ZOOLOGICA; Santos D, 2007, J ADHES SCI TECHNOL, V21, P1317, DOI 10.1163/156856107782328399; Schmidt A, 2010, J EXP BIOL, V213, P3615, DOI 10.1242/jeb.045278; SCHMITT D, 1994, J HUM EVOL, V26, P441, DOI 10.1006/jhev.1994.1027; SCOTT SH, 1993, J BIOMECH, V26, P1091, DOI 10.1016/S0021-9290(05)80008-9; Spezzano LC, 2004, J EXP BIOL, V207, P2115, DOI 10.1242/jeb.00995; Wang ZY, 2015, BIOINSPIR BIOMIM, V10, DOI 10.1088/1748-3190/10/1/016019; Wang ZY, 2010, SCI CHINA TECHNOL SC, V53, P1688, DOI 10.1007/s11431-010-3188-0; Wanger TC, 2009, ECOL RES, V24, P345, DOI 10.1007/s11284-008-0511-3; Zaaf A, 2001, BELG J ZOOL, V131, P173; Zaaf A, 2001, J EXP BIOL, V204, P1233	55	13	13	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 4	2016	11	5							e0153520	10.1371/journal.pone.0153520	http://dx.doi.org/10.1371/journal.pone.0153520			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DL5KR	27145027	Green Published, Green Submitted, gold			2022-12-26	WOS:000375676400020
J	Zimmerman, ME; Ezzati, A; Katz, MJ; Lipton, ML; Brickman, AM; Sliwinski, MJ; Lipton, RB				Zimmerman, Molly E.; Ezzati, Ali; Katz, Mindy J.; Lipton, Michael L.; Brickman, Adam M.; Sliwinski, Martin J.; Lipton, Richard B.			Perceived Stress Is Differentially Related to Hippocampal Subfield Volumes among Older Adults	PLOS ONE			English	Article							MILD COGNITIVE IMPAIRMENT; PITUITARY-ADRENAL AXIS; ALZHEIMERS-DISEASE; PSYCHOLOGICAL DISTRESS; CORTISOL-LEVELS; MENTAL-HEALTH; SEXUAL-ABUSE; SELF-ESTEEM; DEPRESSION; ATROPHY	Introduction Chronic exposure to stress has been shown to impact a wide range of health-related outcomes in older adults. Despite extensive animal literature revealing deleterious effects of biological markers of stress on the dentate gyrus subfield of the hippocampus, links between hippocampal subfields and psychological stress have not been studied in humans. This study examined the relationship between perceived stress and hippocampal subfield volumes among racially/ethnically diverse older adults. Methods and Materials Between July 2011 and March 2014, 116 nondemented participants were consecutively drawn from the Einstein Aging Study, an ongoing community-based sample of individuals over the age of 70 residing in Bronx, New York. All participants completed the Perceived Stress Scale, Geriatric Depression Scale, and underwent 3.0 T MRI. FreeSurfer was used to derive total hippocampal volume, hippocampal subfield volumes (CA1, CA2/CA3, CA4/Dentate Gyrus (CA4/DG), and subiculum), entorhinal cortex volume, whole brain volume, and total intracranial volume. Results Linear regression analyses revealed that higher levels of perceived stress were associated with smaller total hippocampal volume (beta = -0.20, t = -2.40, p = 0.02), smaller CA2/CA3 volumes (beta = -0.18, t = -2.24, p = 0.03) and smaller CA4/DG volumes (beta = -0.19, t = -2.28, p = 0.03) after controlling for total intracranial volume, age, gender, and race. These findings remained unchanged after removal of individuals with clinically significant symptoms of depression. Discussion Our findings provide evidence of a relationship between a direct indicator of psychological stress and specific hippocampal subfield volumes in elderly individuals. These results highlight the importance of clinical screening for chronic stress in otherwise healthy older adults.	[Zimmerman, Molly E.] Fordham Univ, Dept Psychol, Bronx, NY 10458 USA; [Zimmerman, Molly E.; Ezzati, Ali; Katz, Mindy J.; Lipton, Richard B.] Albert Einstein Coll Med, Dept Neurol, Bronx, NY 10467 USA; [Lipton, Michael L.] Albert Einstein Coll Med, Dept Radiol, Bronx, NY 10467 USA; [Lipton, Michael L.] Albert Einstein Coll Med, Dept Neurosci, Bronx, NY 10467 USA; [Lipton, Michael L.] Albert Einstein Coll Med, Gruss Magnet Resonance Res Ctr, Bronx, NY 10467 USA; [Brickman, Adam M.] Columbia Univ Coll Phys & Surg, Taub Inst Res Alzheimers Dis & Aging Brain, 630 W 168th St, New York, NY 10032 USA; [Sliwinski, Martin J.] Penn State Univ, Dept Human Dev & Family Studies, University Pk, PA 16802 USA; [Lipton, Richard B.] Albert Einstein Coll Med, Dept Epidemiol & Populat Hlth, Bronx, NY 10467 USA; [Lipton, Richard B.] Albert Einstein Coll Med, Dept Psychiat & Behav Sci, Bronx, NY 10467 USA	Fordham University; Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine; Columbia University; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine	Zimmerman, ME (corresponding author), Fordham Univ, Dept Psychol, Bronx, NY 10458 USA.; Zimmerman, ME (corresponding author), Albert Einstein Coll Med, Dept Neurol, Bronx, NY 10467 USA.	mzimmerman7@fordham.edu	Lipton, Richard Bruce/AAY-2818-2021; Sliwinski, Martin/HGC-5907-2022; Lipton, Richard B/B-5060-2011; Ezzati, Ali/H-7600-2019	Ezzati, Ali/0000-0003-1307-4589	National Institutes of Health [P01 AG003949]; Fordham University; NATIONAL INSTITUTE ON AGING [R01AG034119, R01AG037212, P01AG027734, R01AG025119, R01AG022374] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Fordham University; NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	The work in this manuscript was supported by a research grant from the National Institutes of Health (P01 AG003949) awarded to RBL and a faculty research grant from Fordham University awarded to MEZ. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	*AM PSYCH ASS, 1994, DIAGN STAT MAN MENT, P133; BLESSED G, 1968, BRIT J PSYCHIAT, V114, P797, DOI 10.1192/bjp.114.512.797; Bremner JD, 1997, BIOL PSYCHIAT, V41, P23, DOI 10.1016/S0006-3223(96)00162-X; Bremner JD, 2000, AM J PSYCHIAT, V157, P115, DOI 10.1176/ajp.157.1.115; Buckner RL, 2004, NEUROIMAGE, V23, P724, DOI 10.1016/j.neuroimage.2004.06.018; Cameron HA, 2015, ANNU REV PSYCHOL, V66, P53, DOI 10.1146/annurev-psych-010814-015006; COHEN S, 1983, J HEALTH SOC BEHAV, V24, P385, DOI 10.2307/2136404; Dale AM, 1999, NEUROIMAGE, V9, P179, DOI 10.1006/nimg.1998.0395; deLeon MJ, 1997, NEUROBIOL AGING, V18, P1, DOI 10.1016/S0197-4580(96)00213-8; DELEON MJ, 1988, LANCET, V2, P391; Elbejjani M, 2015, PSYCHOL MED, V45, P1931, DOI 10.1017/S0033291714003055; Epp JR, 2013, FRONT NEUROSCI-SWITZ, V7, DOI 10.3389/fnins.2013.00057; Ezzati A, 2014, INT J GERIATR PSYCH, V29, P645, DOI 10.1002/gps.4049; Ezzati A, 2013, HIPPOCAMPUS, V23, P1137, DOI 10.1002/hipo.22185; Fa MX, 2014, NEUROBIOL LEARN MEM, V112, P53, DOI 10.1016/j.nlm.2014.04.008; Fanselow MS, 2010, NEURON, V65, P7, DOI 10.1016/j.neuron.2009.11.031; Fischl B, 2002, NEURON, V33, P341, DOI 10.1016/S0896-6273(02)00569-X; Gurvits TV, 1996, BIOL PSYCHIAT, V40, P1091, DOI 10.1016/S0006-3223(96)00229-6; Hanson ND, 2011, NEUROPSYCHOPHARMACOL, V36, P2589, DOI 10.1038/npp.2011.220; Johansson L, 2010, BRAIN, V133, P2217, DOI 10.1093/brain/awq116; Julian LJ, 2009, COPD, V6, P452, DOI 10.3109/15412550903341463; Katz MJ, 2012, ALZ DIS ASSOC DIS, V26, P335, DOI 10.1097/WAD.0b013e31823dbcfc; Lupien SJ, 2007, NEUROIMAGE, V34, P479, DOI 10.1016/j.neuroimage.2006.09.041; Lupien SJ, 1998, NAT NEUROSCI, V1, P69, DOI 10.1038/271; Lupien SJ, 2009, NAT REV NEUROSCI, V10, P434, DOI 10.1038/nrn2639; Marin MF, 2011, NEUROBIOL LEARN MEM, V96, P583, DOI 10.1016/j.nlm.2011.02.016; MCEWEN BS, 1993, ARCH INTERN MED, V153, P2093, DOI 10.1001/archinte.153.18.2093; McEwen BS, 2002, NEUROBIOL AGING, V23, P921, DOI 10.1016/S0197-4580(02)00027-1; Munoz E, 2015, PSYCHOL AGING, V30, P487, DOI 10.1037/pag0000036; OBrien JT, 1996, BRIT J PSYCHIAT, V168, P679, DOI 10.1192/bjp.168.6.679; Payne C, 2014, J GERONTOL B-PSYCHOL, V69, pS99, DOI 10.1093/geronb/gbu100; Petrik D, 2012, NEUROPHARMACOLOGY, V62, P21, DOI 10.1016/j.neuropharm.2011.09.003; Pruessner JC, 2005, NEUROIMAGE, V28, P815, DOI 10.1016/j.neuroimage.2005.06.014; Pruessner JC, 2004, ANN NY ACAD SCI, V1032, P186, DOI 10.1196/annals.1314.017; Schoenfeld TJ, 2012, EXP NEUROL, V233, P12, DOI 10.1016/j.expneurol.2011.01.008; Schroeter ML, 2009, NEUROIMAGE, V47, P1196, DOI 10.1016/j.neuroimage.2009.05.037; Segonne F, 2004, NEUROIMAGE, V22, P1060, DOI 10.1016/j.neuroimage.2004.03.032; Simard M, 2009, CURR PSYCHIAT REP, V11, P41, DOI 10.1007/s11920-009-0007-z; Small SA, 2011, NAT REV NEUROSCI, V12, P585, DOI 10.1038/nrn3085; STARKMAN MN, 1992, BIOL PSYCHIAT, V32, P756, DOI 10.1016/0006-3223(92)90079-F; Stein MB, 1997, PSYCHOL MED, V27, P951, DOI 10.1017/S0033291797005242; Van Leemput K, 2009, HIPPOCAMPUS, V19, P549, DOI 10.1002/hipo.20615; VanGuilder HD, 2011, NEUROBIOL DIS, V43, P201, DOI 10.1016/j.nbd.2011.03.012; Wang Z, 2010, ARCH GEN PSYCHIAT, V67, P296, DOI 10.1001/archgenpsychiatry.2009.205; Wilson RS, 2005, NEUROLOGY, V64, P380, DOI 10.1212/01.WNL.0000149525.53525.E7; Yang J, 2012, J NEUROL SCI, V316, P21, DOI 10.1016/j.jns.2012.02.010	47	39	40	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 4	2016	11	5							e0154530	10.1371/journal.pone.0154530	http://dx.doi.org/10.1371/journal.pone.0154530			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DL5KR	27144832	Green Submitted, Green Published, gold			2022-12-26	WOS:000375676400051
J	Blomquist, N; Engstrom, AC; Hummelgard, M; Andres, B; Forsberg, S; Olin, H				Blomquist, Nicklas; Engstrom, Ann-Christine; Hummelgard, Magnus; Andres, Britta; Forsberg, Sven; Olin, Hakan			Large-Scale Production of Nanographite by Tube-Shear Exfoliation in Water	PLOS ONE			English	Article							GRAPHENE DISPERSIONS; NANOCOMPOSITES; CONDUCTIVITY; CELLULOSE	The number of applications based on graphene, few-layer graphene, and nanographite is rapidly increasing. A large-scale process for production of these materials is critically needed to achieve cost-effective commercial products. Here, we present a novel process to mechanically exfoliate industrial quantities of nanographite from graphite in an aqueous environment with low energy consumption and at controlled shear conditions. This process, based on hydrodynamic tube shearing, produced nanometer-thick and micrometer-wide flakes of nanographite with a production rate exceeding 500 gh(-1) with an energy consumption about 10 Whg(-1). In addition, to facilitate large-area coating, we show that the nanographite can be mixed with nanofibrillated cellulose in the process to form highly conductive, robust and environmentally friendly composites. This composite has a sheet resistance below 1.75 Omega/sq and an electrical resistivity of 1.39x10(-4) Omega m and may find use in several applications, from supercapacitors and batteries to printed electronics and solar cells. A batch of 100 liter was processed in less than 4 hours. The design of the process allow scaling to even larger volumes and the low energy consumption indicates a low-cost process.	[Blomquist, Nicklas; Engstrom, Ann-Christine; Hummelgard, Magnus; Andres, Britta; Forsberg, Sven; Olin, Hakan] Mid Sweden Univ, Dept Nat Sci, SE-85170 Sundsvall, Sweden; [Blomquist, Nicklas] STT Emtec AB, SE-85229 Sundsvall, Sweden	Mid-Sweden University	Blomquist, N (corresponding author), Mid Sweden Univ, Dept Nat Sci, SE-85170 Sundsvall, Sweden.; Blomquist, N (corresponding author), STT Emtec AB, SE-85229 Sundsvall, Sweden.	nicklas.blomquist@miun.se	Blomquist, Nicklas/AGZ-9611-2022; Olin, Håkan/A-8175-2008	Blomquist, Nicklas/0000-0002-4303-2585; Olin, Håkan/0000-0001-7329-3359; Andres, Britta/0000-0002-2393-3378	Swedish Energy Agency [2012-008971, 37193-1]; County Administrative Board of Vasternorrland; Bo Rydin Foundation; STT Emtec AB; Superior Graphite; Nordic Paper; SCA R/D; project KEPS	Swedish Energy Agency(Swedish Energy AgencyMaterials & Energy Research Center (MERC)); County Administrative Board of Vasternorrland; Bo Rydin Foundation; STT Emtec AB; Superior Graphite; Nordic Paper; SCA R/D; project KEPS	This work is included in project KEPS (kinetic Energy-storage in Paper-based Supercapacitors, mainly funded by the Swedish Energy Agency (grant number 2012-008971, project number 37193-1, http://www.energimyndigheten.se). The project is co-funded by the County Administrative Board of Vasternorrland (http://www.lansstyrelsen.se/vasternorrland), Bo Rydin Foundation (http://www.sca.com/sv/Karriar/Forskare/Bo-Rydins-stiftelse), STT Emtec AB (http://www.sttemtec.com), Superior Graphite (http://www.superiorgraphite.com), Nordic Paper (http://www.nordic-paper.com), and SCA R/D (http://www.sca.com). All authors are funded in project KEPS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andres B, 2014, PHYS STATUS SOLIDI B, V251, P2581, DOI 10.1002/pssb.201451168; Backes C, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5576; Bianco A, 2013, CARBON, V65, P1, DOI 10.1016/j.carbon.2013.08.038; Chang HX, 2013, ENERG ENVIRON SCI, V6, P3483, DOI 10.1039/c3ee42518e; Ciesielski A, 2014, CHEM SOC REV, V43, P381, DOI 10.1039/c3cs60217f; Cravotto G, 2010, CHEM-EUR J, V16, P5246, DOI 10.1002/chem.200903259; Huang X, 2012, CHEM SOC REV, V41, P666, DOI 10.1039/c1cs15078b; Jeong SY, 2011, ACS NANO, V5, P870, DOI 10.1021/nn102017f; Knieke C, 2010, CARBON, V48, P3196, DOI 10.1016/j.carbon.2010.05.003; Li D, 2008, NAT NANOTECHNOL, V3, P101, DOI 10.1038/nnano.2007.451; Malho JM, 2012, BIOMACROMOLECULES, V13, P1093, DOI 10.1021/bm2018189; McCabe W. L., 1993, UNIT OPERATIONS CHEM, V5; Nacken TJ, 2015, RSC ADV, V5, P57328, DOI 10.1039/c5ra08643d; Niu LY, 2016, SMALL, V12, P272, DOI 10.1002/smll.201502207; Pantea D, 2001, CARBON, V39, P1147, DOI 10.1016/S0008-6223(00)00239-6; Paton KR, 2014, NAT MATER, V13, P624, DOI [10.1038/nmat3944, 10.1038/NMAT3944]; Saito T, 2009, BIOMACROMOLECULES, V10, P1992, DOI 10.1021/bm900414t; Shen ZG, 2011, NANOTECHNOLOGY, V22, DOI 10.1088/0957-4484/22/36/365306; Shi JN, 2013, CARBON, V51, P365, DOI 10.1016/j.carbon.2012.08.068; Texter J, 2014, CURR OPIN COLLOID IN, V19, P163, DOI 10.1016/j.cocis.2014.04.004; Tolle FJ, 2012, ADV FUNCT MATER, V22, P1136, DOI 10.1002/adfm.201102888; Zhao W., 2010, J NANOMATER, V2010, P6, DOI DOI 10.1155/2010/528235	22	33	33	0	45	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 29	2016	11	4							e0154686	10.1371/journal.pone.0154686	http://dx.doi.org/10.1371/journal.pone.0154686			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DK8XM	27128841	Green Submitted, Green Published, gold			2022-12-26	WOS:000375212600060
J	Chen, Y; Liu, TJ; Wang, K; Hou, CC; Cai, SQ; Huang, YY; Du, ZY; Huang, H; Kong, JL; Chen, YQ				Chen, Yan; Liu, Tangjuan; Wang, Ke; Hou, Changchun; Cai, Shuangqi; Huang, Yingying; Du, Zhongye; Huang, Hong; Kong, Jinliang; Chen, Yiqiang			Baicalein Inhibits Staphylococcus aureus Biofilm Formation and the Quorum Sensing System In Vitro	PLOS ONE			English	Article							GENE-EXPRESSION; VIRULENCE; BACTERIA; AGR; ENTEROTOXIN; ADHESION; TARGET	Biofilm formed by Staphylococcus aureus significantly enhances antibiotic resistance by inhibiting the penetration of antibiotics, resulting in an increasingly serious situation. This study aimed to assess whether baicalein can prevent Staphylococcus aureus biofilm formation and whether it may have synergistic bactericidal effects with antibiotics in vitro. To do this, we used a clinically isolated strain of Staphylococcus aureus 17546 (t037) for biofilm formation. Virulence factors were detected following treatment with baicalein, and the molecular mechanism of its antibiofilm activity was studied. Plate counting, crystal violet staining, and fluorescence microscopy revealed that 32 mu g/mL and 64 mu g/mL baicalein clearly inhibited 3- and 7-day biofilm formation in vitro. Moreover, colony forming unit count, confocal laser scanning microscopy, and scanning electron microscopy showed that vancomycin (VCM) and baicalein generally enhanced destruction of biofilms, while VCM alone did not. Western blotting and real-time quantitative polymerase chain reaction analyses (RTQ-PCR) confirmed that baicalein treatment reduced staphylococcal enterotoxin A (SEA) and a-hemolysin (hla) levels. Most strikingly, real-time qualitative polymerase chain reaction data demonstrated that 32 mu g/mL and 64 mu g/mL baicalein downregulated the quorum-sensing system regulators agrA, RNAIII, and sarA, and gene expression of ica, but 16 mu g/mL baicalein had no effect. In summary, baicalein inhibited Staphylococcus aureus biofilm formation, destroyed biofilms, increased the permeability of vancomycin, reduced the production of staphylococcal enterotoxin A and a-hemolysin, and inhibited the quorum sensing system. These results support baicalein as a novel drug candidate and an effective treatment strategy for Staphylococcus aureus biofilm-associated infections.	[Chen, Yan; Liu, Tangjuan; Wang, Ke; Hou, Changchun; Cai, Shuangqi; Huang, Yingying; Du, Zhongye; Huang, Hong; Kong, Jinliang; Chen, Yiqiang] Guangxi Med Univ, Inst Resp Dis, Affiliated Hosp 1, Nanning, Peoples R China	Guangxi Medical University	Kong, JL; Chen, YQ (corresponding author), Guangxi Med Univ, Inst Resp Dis, Affiliated Hosp 1, Nanning, Peoples R China.	kjl071@126.com; chenyiq0708@163.com			National Natural Science Foundation of China [81060002]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	All sources of funding are from the National Natural Science Foundation of China (Grant Number: 81060002; website: http://www.nsfc.gov.cn/). The author Yiqiang Chen received the funding. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Balaban N, 1998, SCIENCE, V280, P438, DOI 10.1126/science.280.5362.438; Balaban N, 2001, J BIOL CHEM, V276, P2658, DOI 10.1074/jbc.M005446200; Beenken KE, 2004, J BACTERIOL, V186, P4665, DOI 10.1128/JB.186.14.4665-4684.2004; Coelho LR, 2008, MICROBIOL-SGM, V154, P3480, DOI 10.1099/mic.0.2007/016014-0; Cramton SE, 1999, INFECT IMMUN, V67, P5427, DOI 10.1128/IAI.67.10.5427-5433.1999; Deschamps JD, 2006, BIOORGAN MED CHEM, V14, P4295, DOI 10.1016/j.bmc.2006.01.057; Donlan RM, 2002, CLIN MICROBIOL REV, V15, P167, DOI 10.1128/CMR.15.2.167-193.2002; Dunne WM, 2002, CLIN MICROBIOL REV, V15, P155, DOI 10.1128/CMR.15.2.155-166.2002; Federle MJ, 2003, J CLIN INVEST, V112, P1291, DOI 10.1172/JCI200320195; Fujimura S, 2008, INT J ANTIMICROB AG, V32, P481, DOI 10.1016/j.ijantimicag.2008.06.030; Gustafsson E, 2004, J MOL MICROB BIOTECH, V8, P232, DOI 10.1159/000086704; Hsieh Chia-Jung, 2007, Clin Mol Allergy, V5, P5, DOI 10.1186/1476-7961-5-5; Kiran MD, 2008, MOL PHARMACOL, V73, P1578, DOI 10.1124/mol.107.044164; Kleerebezem M, 1997, MOL MICROBIOL, V24, P895, DOI 10.1046/j.1365-2958.1997.4251782.x; Lin YL, 2011, J ETHNOPHARMACOL, V138, P373, DOI 10.1016/j.jep.2011.09.014; Nadell CD, 2008, PLOS BIOL, V6, P171, DOI 10.1371/journal.pbio.0060014; Parsek MR, 2005, TRENDS MICROBIOL, V13, P27, DOI 10.1016/j.tim.2004.11.007; Pepe O, 2006, APPL ENVIRON MICROB, V72, P7057, DOI 10.1128/AEM.00198-06; Quave CL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0028737; Rasooly A, 1998, INT J FOOD MICROBIOL, V41, P205, DOI 10.1016/S0168-1605(98)00050-6; Reading NC, 2006, FEMS MICROBIOL LETT, V254, P1, DOI 10.1111/j.1574-6968.2005.00001.x; RECSEI P, 1986, MOL GEN GENET, V202, P58, DOI 10.1007/BF00330517; Sabersheikh SS, 2004, MOL CELL PROBE, V18, P23, DOI 10.1016/j.mcp.2003.07.009; Shiner EK, 2005, FEMS MICROBIOL REV, V29, P935, DOI 10.1016/j.femsre.2005.03.001; Si DY, 2009, DRUG METAB DISPOS, V37, P629, DOI 10.1124/dmd.108.023416; Tamber S, 2009, INFECT IMMUN, V77, P419, DOI 10.1128/IAI.00859-08; Tarrago T, 2008, BIOORGAN MED CHEM, V16, P7516, DOI 10.1016/j.bmc.2008.04.067; Vuong C, 2004, CELL MICROBIOL, V6, P753, DOI 10.1111/j.1462-5822.2004.00401.x; Xiong Z, 2011, BIOL PHARM BULL, V34, P253, DOI 10.1248/bpb.34.253; Zeng Z, 2008, APPL MICROBIOL BIOT, V79, P119, DOI 10.1007/s00253-008-1406-5; 孔晋亮, 2007, [中华微生物学和免疫学杂志, Chinese Journal of Microbiology and Immunology], V27, P241	31	71	81	7	52	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 29	2016	11	4							e0153468	10.1371/journal.pone.0153468	http://dx.doi.org/10.1371/journal.pone.0153468			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DK8XM	27128436	Green Published, gold, Green Submitted			2022-12-26	WOS:000375212600007
J	Gero, D; Szabo, C				Geroe, Domokos; Szabo, Csaba			Glucocorticoids Suppress Mitochondrial Oxidant Production via Upregulation of Uncoupling Protein 2 in Hyperglycemic Endothelial Cells	PLOS ONE			English	Article							MIDDLE-T-ONCOGENE; OXIDATIVE STRESS; DIABETIC COMPLICATIONS; DOWN-REGULATION; CARDIOVASCULAR-DISEASE; DENSITY-LIPOPROTEIN; MICRORNA EXPRESSION; GENE-TRANSCRIPTION; INDUCED APOPTOSIS; SKELETAL-MUSCLE	Diabetic complications are the leading cause of morbidity and mortality in diabetic patients. Elevated blood glucose contributes to the development of endothelial and vascular dysfunction, and, consequently, to diabetic micro-and macrovascular complications, because it increases the mitochondrial proton gradient and mitochondrial oxidant production. Therapeutic approaches designed to counteract glucose-induced mitochondrial reactive oxygen species (ROS) production in the vasculature are expected to show efficacy against all diabetic complications, but direct pharmacological targeting (scavenging) of mitochondrial oxidants remains challenging due to the high reactivity of some of these oxidant species. In a recent study, we have conducted a medium-throughput cell-based screening of a focused library of well-annotated pharmacologically active compounds and identified glucocorticoids as inhibitors of mitochondrial superoxide production in microvascular endothelial cells exposed to elevated extracellular glucose. The goal of the current study was to investigate the mechanism of glucocorticoids' action. Our findings show that glucocorticoids induce the expression of the mitochondrial UCP2 protein and decrease the mitochondrial potential. UCP2 silencing prevents the protective effect of the glucocorticoids on ROS production. UCP2 induction also increases the oxygen consumption and the "proton leak" in microvascular endothelial cells. Furthermore, glutamine supplementation augments the effect of glucocorticoids via further enhancing the expression of UCP2 at the translational level. We conclude that UCP2 induction represents a novel experimental therapeutic intervention in diabetic vascular complications. While direct repurposing of glucocorticoids may not be possible for the therapy of diabetic complications due to their significant side effects that develop during chronic administration, the UCP2 pathway may be therapeutically targetable by other, glucocorticoid-independent pharmacological means.	[Geroe, Domokos; Szabo, Csaba] Univ Texas Med Branch, Dept Anesthesiol, Galveston, TX 77555 USA; [Geroe, Domokos] Univ Exeter, Sch Med, Exeter, Devon, England	University of Texas System; University of Texas Medical Branch Galveston; University of Exeter	Gero, D (corresponding author), Univ Texas Med Branch, Dept Anesthesiol, Galveston, TX 77555 USA.; Gero, D (corresponding author), Univ Exeter, Sch Med, Exeter, Devon, England.	d.m.gero@exeter.ac.uk	Szabo, Csaba/ABG-2644-2021; Gero, Domokos/F-7853-2017	Gero, Domokos/0000-0002-3132-3465	Juvenile Diabetes Foundation [17-2010-542]; European Union [628100]	Juvenile Diabetes Foundation(Juvenile Diabetes Research Foundation); European Union(European Commission)	The current work was supported by a grant from the Juvenile Diabetes Foundation (Award# 17-2010-542) to C.S. D.G. received funding from the People Programme (Marie Curie Actions) of the European Union's Seventh Framework Programme under the grant agreement number 628100.	Alberti KG, 1998, DEFINITION DIAGNOS 1; Amat R, 2007, J BIOL CHEM, V282, P34066, DOI 10.1074/jbc.M707114200; [Anonymous], 2015, DIABETES CARE, V38, pS4, DOI 10.2337/dc15-S003; [Anonymous], MEDICOGRAPHIA; Berraondo B, 2000, INT J OBESITY, V24, P156, DOI 10.1038/sj.ijo.0801097; BOWRY VW, 1992, BIOCHEM J, V288, P341, DOI 10.1042/bj2880341; Brand MD, 2005, BIOCHEM SOC T, V33, P897, DOI 10.1042/BST0330897; Brown SHM, 2009, POSTGRAD MED, V121, P31, DOI 10.3810/pgm.2009.09.2050; Brownlee M, 2005, DIABETES, V54, P1615, DOI 10.2337/diabetes.54.6.1615; Calcutt NA, 2009, NAT REV DRUG DISCOV, V8, P417, DOI 10.1038/nrd2476; Celik VK, 2012, EXP DIABETES RES, DOI 10.1155/2012/386831; Ceriello A, 2003, DIABETES CARE, V26, P1589, DOI 10.2337/diacare.26.5.1589; Ceriello A, 2009, DIABETES CARE, V32, pS232, DOI 10.2337/dc09-S316; Chan CB, 2004, DIABETES, V53, pS136, DOI 10.2337/diabetes.53.2007.S136; Chan SHH, 2009, CIRC RES, V105, P886, DOI 10.1161/CIRCRESAHA.109.199018; Chen X, 2009, J BIOL CHEM, V284, P5362, DOI 10.1074/jbc.M807523200; Chen XL, 2014, RENAL FAILURE, V36, P1298, DOI 10.3109/0886022X.2014.930650; Cheng AYY, 2010, EUR J CARDIOV PREV R, V17, pS25, DOI 10.1097/01.hjr.0000368194.32356.5f; Christ M, 2002, DIABETES, V51, P2648, DOI 10.2337/diabetes.51.8.2648; de Souza BM, 2011, ARQ BRAS ENDOCRINOL, V55, P239, DOI 10.1590/S0004-27302011000400001; Dorenkamp M, 2005, EUR J PHARMACOL, V520, P179, DOI 10.1016/j.ejphar.2005.07.020; Ferreira FM, 2003, J BIOCHEM MOL TOXIC, V17, P214, DOI 10.1002/jbt.10081; Fowler MJ, 2008, CLIN DIABETES, V26, P77, DOI [DOI 10.2337/DIACLIN.26.2.77, 10.2337/diaclin.26.2.77]; Gero D, 2015, BRIT J PHARM; Gero D, 2007, INT J MOL MED, V20, P749; Gero D, 2014, MOL MED, V20, P313, DOI 10.2119/molmed.2014.00102; Gero D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065994; Gero D, 2013, DIABETES, V62, P953, DOI 10.2337/db12-0789; Gerstein HC, 2008, NEW ENGL J MED, V358, P2545, DOI 10.1056/NEJMoa0802743; Giacco F, 2010, CIRC RES, V107, P1058, DOI 10.1161/CIRCRESAHA.110.223545; Giugliano D, 1996, DIABETES CARE, V19, P257, DOI 10.2337/diacare.19.3.257; Hu ZG, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078040; Huerta MG, 2003, DIABETES MELLITUS FU, P1485; HUNT JV, 1992, FEBS LETT, V311, P161, DOI 10.1016/0014-5793(92)81389-4; Hurtaud C, 2007, CELL MOL LIFE SCI, V64, P1853, DOI 10.1007/s00018-007-7039-5; Hwang J, 2007, VASC PHARMACOL, V46, P456, DOI 10.1016/j.vph.2007.01.007; Johansen JS, 2005, CARDIOVASC DIABETOL, V4, DOI 10.1186/1475-2840-4-5; KAMMA H, 1995, EXP CELL RES, V221, P187, DOI 10.1006/excr.1995.1366; Keij JF, 2000, CYTOMETRY, V39, P203, DOI 10.1002/(SICI)1097-0320(20000301)39:3<203::AID-CYTO5>3.0.CO;2-Z; Korshunov SS, 1997, FEBS LETT, V416, P15, DOI 10.1016/S0014-5793(97)01159-9; Koziel A, 2012, PFLUG ARCH EUR J PHY, V464, P657, DOI 10.1007/s00424-012-1156-1; Kuhad A, 2008, EXP BRAIN RES, V185, P411, DOI 10.1007/s00221-007-1166-y; Lee S., 2013, INT J DISTRIB SENS N, V2013, P1, DOI DOI 10.1371/J0URNAL.P0NE.0055979; Lenaz G, 2001, IUBMB LIFE, V52, P159, DOI 10.1080/15216540152845957; Lenaz G, 2010, BBA-BIOENERGETICS, V1797, P633, DOI 10.1016/j.bbabio.2010.01.025; Li GY, 2011, MOL VIS, V17, P3156; Li K, 2000, CELL, V101, P389, DOI 10.1016/S0092-8674(00)80849-1; Li T, 2014, J CELL BIOCHEM, V115, P1683, DOI 10.1002/jcb.24831; Lu JY, 2013, FRONT MED-PRC, V7, P4, DOI 10.1007/s11684-013-0248-4; Mailloux RJ, 2011, FREE RADICAL BIO MED, V51, P1106, DOI 10.1016/j.freeradbiomed.2011.06.022; Mailloux RJ, 2011, J BIOL CHEM, V286, P21865, DOI 10.1074/jbc.M111.240242; Mannucci E, 2013, DIABETES CARE, V36, pS259, DOI 10.2337/dcS13-2018; MARONE JR, 1994, J APPL PHYSIOL, V77, P1685; Martin-Oliva D, 2006, CANCER RES, V66, P5744, DOI 10.1158/0008-5472.CAN-05-3050; McAlpine RR, 2005, DIABETIC MED, V22, P348, DOI 10.1111/j.1464-5491.2004.01391.x; McCall MN, 2011, BMC MED GENOMICS, V4, DOI 10.1186/1755-8794-4-78; Meng B, 2013, CURR PHARM DESIGN, V19, P2101; MINCHENKO A G, 1979, Problemy Endokria, V25, P52; Modis K, 2012, BIOCHEM PHARMACOL, V83, P633, DOI 10.1016/j.bcp.2011.12.014; MONTESANO R, 1990, CELL, V62, P435, DOI 10.1016/0092-8674(90)90009-4; Munusamy S, 2009, BMC ENDOCR DISORD, V9, DOI 10.1186/1472-6823-9-2; Nau PN, 2002, PEDIATR RES, V52, DOI 10.1023/01.PDR.00000231740.89966.D7; Nishikawa T, 2000, NATURE, V404, P787, DOI 10.1038/35008121; Ohkouchi S, 2012, MOL THER, V20, P417, DOI 10.1038/mt.2011.259; Pecqueur C, 2001, J BIOL CHEM, V276, P8705, DOI 10.1074/jbc.M006938200; Piconi L, 2008, J DIABETES COMPLICAT, V22, P38, DOI 10.1016/j.jdiacomp.2007.03.004; Psarra AMG, 2011, BBA-MOL CELL RES, V1813, P1814, DOI 10.1016/j.bbamcr.2011.05.014; Quijano C, 2007, AM J PHYSIOL-HEART C, V293, pH3404, DOI 10.1152/ajpheart.00761.2007; Rabilloud T, 2001, PROTEOMICS, V1, P1105, DOI 10.1002/1615-9861(200109)1:9<1105::AID-PROT1105>3.0.CO;2-M; RACHAMIM N, 1995, AM J PHYSIOL-CELL PH, V269, pC1305, DOI 10.1152/ajpcell.1995.269.5.C1305; Reinecke F, 2009, BBA-MOL BASIS DIS, V1792, P1113, DOI 10.1016/j.bbadis.2009.04.003; Rousset S, 2004, DIABETES, V53, pS130, DOI 10.2337/diabetes.53.2007.S130; Scheller K, 2003, EXP PHYSIOL, V88, P129, DOI 10.1113/eph8802507; Sharma K, 2015, DIABETES, V64, P663, DOI 10.2337/db14-0874; Shenouda SM, 2011, CIRCULATION, V124, P444, DOI 10.1161/CIRCULATIONAHA.110.014506; SIKORSKI EE, 1993, J IMMUNOL, V151, P5239; Singh PP, 2009, INDIAN J CLIN BIOCHE, V24, P324, DOI 10.1007/s12291-009-0062-6; Skyler J.S., 2004, CLIN DIABETES, V22, P162, DOI [10.2337/diaclin.22.4.162, DOI 10.2337/DIACLIN.22.4.162]; Smith LK, 2010, J BIOL CHEM, V285, P36698, DOI 10.1074/jbc.M110.162123; Stankov MV, 2010, ANTIMICROB AGENTS CH, V54, P280, DOI 10.1128/AAC.00914-09; Supino Rosa, 1995, V43, P137; Suski JM, 2012, METHODS MOL BIOL, V810, P183, DOI 10.1007/978-1-61779-382-0_12; Szabo C, 2006, DIABETES, V55, P3004, DOI 10.2337/db06-0147; Szoleczky P, 2012, ARCH BIOCHEM BIOPHYS, V517, P53, DOI 10.1016/j.abb.2011.11.005; Tahir TA, 2014, CELL SIGNAL, V26, P1379, DOI 10.1016/j.cellsig.2014.03.005; Tawfik HE, 2006, J PHARMACOL EXP THER, V319, P386, DOI 10.1124/jpet.106.106823; Tucker Stephanie, 2005, Current Alzheimer Research, V2, P249, DOI 10.2174/1567205053585855; Turner RC, 1998, LANCET, V352, P837, DOI 10.1016/s0140-6736(98)07019-6; Turrens JF, 2003, J PHYSIOL-LONDON, V552, P335, DOI 10.1113/jphysiol.2003.049478; Van Linthout S, 2009, HYPERTENSION, V53, P682, DOI 10.1161/HYPERTENSIONAHA.108.118919; Vecchione C, 2006, CIRC RES, V98, P218, DOI 10.1161/01.RES.0000200440.18768.30; Vempati UD, 2009, J BIOL CHEM, V284, P4383, DOI 10.1074/jbc.M805972200; Vincent AM, 2004, DIABETES, V53, P726, DOI 10.2337/diabetes.53.3.726; W.H. Organization, 1999, DEFINITION DIAGNOSIS; Weber K, 2002, ENDOCRINOLOGY, V143, P177, DOI 10.1210/en.143.1.177; WILLIAMS RL, 1989, CELL, V57, P1053, DOI 10.1016/0092-8674(89)90343-7; World Health Organization, DEF DIAGN DIAB MELL; Wu Y, 2014, OXID MED CELL LONGEV, V2014, DOI 10.1155/2014/752387; Yamagishi S, 2012, BBA-GEN SUBJECTS, V1820, P663, DOI 10.1016/j.bbagen.2011.03.014; Yang SL, 2013, J BIOL CHEM, V288, P23725, DOI 10.1074/jbc.M113.470146; YOUNG IS, 1995, FREE RADICAL BIO MED, V18, P833, DOI 10.1016/0891-5849(94)00202-U; Zhang J, 2011, EMBO J, V30, P4860, DOI 10.1038/emboj.2011.401	102	23	24	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 29	2016	11	4							e0154813	10.1371/journal.pone.0154813	http://dx.doi.org/10.1371/journal.pone.0154813			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DK8XM	27128320	gold, Green Published, Green Submitted			2022-12-26	WOS:000375212600070
J	Kini, S; Kamath, VG; Kulkarni, MM; Kamath, A; Shivalli, S				Kini, Sanjay; Kamath, Veena G.; Kulkarni, Muralidhar M.; Kamath, Asha; Shivalli, Siddharudha			Pre-Hypertension among Young Adults (20-30 Years) in Coastal Villages of Udupi District in Southern India: An Alarming Scenario	PLOS ONE			English	Article							BLOOD-PRESSURE; RISK-FACTORS; HYPERTENSION; PREVALENCE; AWARENESS; POPULATION	Introduction According to Joint National Committee-7 (JNC-7) guidelines, a systolic blood pressure (SBP) of 120 to 139 mm Hg and/or diastolic blood pressure (DBP) of 80 to 89 mm Hg is considered as pre-hypertension. Existing evidence suggest that the cardiovascular morbidities are increasing among pre-hypertensive individuals compared to normal. Objective To assess the magnitude and factors associated with pre-hypertension among young adults (20-30 years) in coastal villages of Udupi Taluk (an area of land with a city or town that serves as its administrative centre and usually a number of villages), Udupi District, Karnataka state, India. Design Community based cross sectional study Setting 6 (out of total 14) coastal villages of Udupi Taluk, Karnataka state, India. Sample 1,152 young adults (age group: 20-30 years) selected by stratified random sampling in 6 coastal villages of Udupi Taluk, Karnataka state, India Method A semi structured pre-tested questionnaire was used to elicit the details on socio-demographic variables, dietary habits, tobacco use, alcohol consumption, physical activity, family history of hypertension and stress levels. Anthropometric measurements and blood pressure were recorded according to standard protocols. Serum cholesterol was measured in a sub sample of the study population. Multivariate logistic regression was applied to identify the independent correlates of pre-hypertension among young adults (20-30 years). Main Outcome Measures Prevalence, Odds ratio (OR) and adjusted (adj) OR for pre-hypertension among young adults (20-30 years). Results The prevalence of pre-hypertension in the study population was 45.2% (95% CI: 42.4-48). Multivariate logistic regression analysis revealed that age group of 25-30 years (adj OR: 4.25, 95% CI: 2.99-6.05), white collared (adj OR: 2.29, 95% CI: 1.08-4.85) and skilled occupation (adj OR: 3.24, 95% CI: 1.64-6.42), students (adj OR: 2.46, 95% CI: 1.22-4.95), using refined cooking oil (adj OR: 0.53, 95% CI: 0.29-0.95), extra salt in meals (adj OR: 2.46, 95% CI: 1.52-3.99), salty food items (adj OR: 6.99, 95% CI: 3.63-13.48), pre-obese (adj OR: 1.66, 95% CI: 1.03-2.67) and obese (adj OR: 9.16, 95% CI: 2.54, 36.4) were the significant correlates of pre-hypertension. Conclusion In the study population, prevalence of pre-hypertension among young adults (20-30 years) was high (45.2%). Biological (age 25-30 years, pre-obesity and obesity) and behavioral (sedentary occupation, intake of extra salt in meals/salty food and not using refined cooking oil) factors were associated with pre-hypertension. Study emphasizes the need of community based screening of pre-hypertension under National Rural Health Mission. It also provides apt information for the evidence based designing of interventions for lifestyle modifications among high risk young adults in the study area.	[Kini, Sanjay] NITTE Univ, Dept Community Med, KS Hegde Med Acad KSHEMA, Mangalore 575108, Karnataka, India; [Kamath, Veena G.; Kulkarni, Muralidhar M.; Kamath, Asha] Manipal Univ, Kasturba Med Coll, Dept Community Med, Manipal 576102, Karnataka, India; [Shivalli, Siddharudha] Yenepoya Univ, Yenepoya Med Coll, Dept Community Med, Mangalore 575018, Karnataka, India	NITTE (Deemed to be University); K.S. Hegde Medical Academy; Manipal Academy of Higher Education (MAHE); Kasturba Medical College, Manipal; Yenepoya (Deemed to be University)	Kini, S (corresponding author), NITTE Univ, Dept Community Med, KS Hegde Med Acad KSHEMA, Mangalore 575108, Karnataka, India.	sanjaykini2010@gmail.com	Shivalli, Siddharudha/AAU-3907-2020	Kamath, Asha/0000-0003-0727-8067; Kini, Sanjay/0000-0002-3571-2337				Al-Majed HT, 2012, J FAM COMMUNITY MED, V19, P105, DOI 10.4103/2230-8229.98296; [Anonymous], 2012, CENS IND 2011; Bhardwaj Rajeev, 2010, J Assoc Physicians India, V58, P423; Chobanian AV., 2003, HYPERTENSION, V42, P1206, DOI [10.1161/01.HYP.0000107251, DOI 10.1161/01.HYP.9.2_PT_2.II36, DOI 10.1161/01.HYP.0000107251.49515.C2]; COHEN S, 1983, J HEALTH SOC BEHAV, V24, P385, DOI 10.2307/2136404; Das Shyamal Kumar, 2005, Int J Med Sci, V2, P70; Dawson DA, NIH PUB; Ferguson TS, 2010, W INDIAN MED J, V59, P486; Gupta R, 2013, AM J HYPERTENS, V26, P83, DOI 10.1093/ajh/hps013; James PA, 2014, JAMA-J AM MED ASSOC, V311, P1809, DOI 10.1001/jama.2013.284427; Mungreiphy N K, 2012, J Nat Sci Biol Med, V3, P52, DOI 10.4103/0976-9668.95955; Pareekh U., 1981, MANNUAL SOCIOECONOMI; Park K, 2013, MED SOCIAL SCI PARKS, P620; Pletcher MJ, 2008, ANN INTERN MED, V149, P91, DOI 10.7326/0003-4819-149-2-200807150-00005; Prabhakaran D, 2005, NATL MED J INDIA, V18, P59; Ramachandran A, 2004, DIABETOLOGIA, V47, P860, DOI 10.1007/s00125-004-1387-6; Rasheed S, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-584; Ray S, 2011, INDIAN J MED RES, V134, P162; SANDERS TAB, 1987, BRIT HEART J, V57, P214, DOI 10.1136/hrt.57.3.214; Singh RB, 2011, ACTA CARDIOL, V66, P29, DOI 10.1080/AC.66.1.2064964; Smith L, 2005, AM FAM PHYSICIAN, V72, P1391; Srinivas S., 2013, Asian Journal of Biomedical and Pharmaceutical Sciences, V3, P45; Vimala A, 2009, SAUDI J KIDNEY DIS T, V20, P685; World Health Organization, 1998, GUID CONTR MON TOB E	24	12	12	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 29	2016	11	4							e0154538	10.1371/journal.pone.0154538	http://dx.doi.org/10.1371/journal.pone.0154538			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DK8XM	27128029	Green Published, gold, Green Submitted, Green Accepted			2022-12-26	WOS:000375212600037
J	Yang, GD; Zhou, BL; Zhang, XY; Zhang, ZJ; Wu, YY; Zhang, YM; Lu, SW; Zou, QD; Gao, Y; Teng, L				Yang, Guodong; Zhou, Baoli; Zhang, Xinyu; Zhang, Zijun; Wu, Yuanyuan; Zhang, Yiming; Lu, Shuwen; Zou, Qingdao; Gao, Yuan; Teng, Long			Effects of Tomato Root Exudates on Meloidogyne incognita	PLOS ONE			English	Article							KNOT NEMATODE; PRATYLENCHUS-PENETRANS; HOST ROOTS; BEHAVIOR; PLANTS	Plant root exudates affect root-knot nematodes egg hatch. Chemicals in root exudates can attract nematodes to the roots or result in repellence, motility inhibition or even death. However, until recently little was known about the relationship between tomato root exudates chemicals and root-knot nematodes. In this study, root exudates were extracted from three tomato rootstocks with varying levels of nematode resistance: Baliya (highly resistant, HR), RS2 (moderately resistant, MR) and L-402 (highly susceptible, T). The effects of the root exudates on Meloidogyne incognita (M. incognita) egg hatch, survival and chemotaxis of second-stage juveniles (J2) were explored. The composition of the root exudates was analysed by gas chromatography/mass spectrometry (GC/MS) prior to and following M. incognita inoculation. Four compounds in root exudates were selected for further analysis and their allopathic effect on M. incognita were investigated. Root exudates from each tomato rootstocks (HR, MR and T strains) suppressed M. incognita egg hatch and increased J2 mortality, with the highest rate being observed in the exudates from the HR plants. Exudate from HR variety also repelled M. incognita J2 while that of the susceptible plant, T, was demonstrated to be attractive. The relative amount of esters and phenol compounds in root exudates from HR and MR tomato rootstocks increased notably after inoculation. Four compounds, 2,6-Di-tert-butyl-p-cresol, L-ascorbyl 2,6-dipalmitate, dibutyl phthalate and dimethyl phthalate increased significantly after inoculation. The egg hatch of M. incognita was suppressed by each of the compound. L-ascorbyl 2,6-dipalmitate showed the most notable effect in a concentration-dependent manner. All four compounds were associated with increased J2 mortality. The greatest effect was observed with dimethyl phthalate at 2 mmol.L-1. Dibutyl phthalate was the only compound observed to repel M. incognita J2 with no effect being detected in the other compounds. Each of the four compounds were correlated with a reduction in disease index in the susceptible cultivar, T, and tomato seedlings irrigated with L-ascorbyl 2,6-dipalmitate at 2 mmol.L-1 showed the best resistance to M. incognita. Taken together, this study provided a valuable contribution to understanding the underlying mechanism of nematode resistance in tomato cultivars.	[Yang, Guodong; Zhou, Baoli] Shenyang Agr Univ, Coll Hort, Shenyang 110161, Peoples R China; [Yang, Guodong; Zhang, Xinyu; Zhang, Zijun; Wu, Yuanyuan; Zhang, Yiming; Lu, Shuwen; Zou, Qingdao; Gao, Yuan; Teng, Long] Liaoning Acad Agr Sci, Vegetable Res Inst, Shenyang, Peoples R China	Shenyang Agricultural University	Zhou, BL (corresponding author), Shenyang Agr Univ, Coll Hort, Shenyang 110161, Peoples R China.	zblaaa@163.com	Zhang, Yiming/HGB-7344-2022		Liaoning Province Natural Science Foundation of China [2013020076]	Liaoning Province Natural Science Foundation of China(Natural Science Foundation of Liaoning Province)	Financial support was from the Liaoning Province Natural Science Foundation of China (No. 2013020076). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ali JG, 2011, J ECOL, V99, P26, DOI 10.1111/j.1365-2745.2010.01758.x; Badri DV, 2009, PLANT CELL ENVIRON, V32, P666, DOI [10.1111/j.1365-3040.2009.01926.x, 10.1111/j.1365-3040.2008.01926.x]; Bai ChunMing, 2010, China Vegetables, P33; Bais HP, 2006, ANNU REV PLANT BIOL, V57, P233, DOI 10.1146/annurev.arplant.57.032905.105159; Bie ZL, 2012, CHINA VEGETABLES, P1; Chitwood DJ, 2002, ANNU REV PHYTOPATHOL, V40, P221, DOI 10.1146/annurev.phyto.40.032602.130045; Cortada L, 2009, EUR J PLANT PATHOL, V124, P337, DOI 10.1007/s10658-008-9413-z; Curtis RHC, 2008, PARASITE, V15, P310, DOI 10.1051/parasite/2008153310; Curtis RH, 2009, 6 HATCH HOST LOCATIO, P139; Duan Yuxi, 2009, Acta Phytophylacica Sinica, V36, P537; Duarte A, 2015, PHYTOPATHOL MEDITERR, V54, P104; DUSENBERY DB, 1987, J CHEM ECOL, V13, P1617, DOI 10.1007/BF00980204; Dutta TK, 2012, NEMATOLOGY, V14, P309, DOI 10.1163/156854111X612306; Evans A, 1976, SURVIVAL STRATEGIES; Fudali SL, 2013, MOL PLANT MICROBE IN, V26, P75, DOI 10.1094/MPMI-05-12-0107-R; Gaur HS, 2000, NEMATOLOGY, V2, P191, DOI 10.1163/156854100509088; Hubbard JE, 2005, NEMATOLOGY, V7, P321, DOI 10.1163/156854105774355527; Hussey R. S., 2002, P43, DOI 10.1079/9780851994666.0043; Jacquet M, 2005, PLANT PATHOL, V54, P93, DOI 10.1111/j.1365-3059.2005.01143.x; Jia SS, 2012, THESIS SHANDONG AGR; Lin T, 2014, NAT GENET, V46, P1220, DOI 10.1038/ng.3117; Narula N, 2009, J APPL BOT FOOD QUAL, V82, P122; Oka Y, 2009, NEMATOLOGY, V11, P51, DOI 10.1163/156854108X398417; PERRY RN, 1981, PARASITOLOGY, V83, P435, DOI 10.1017/S0031182000085413; PLINE M, 1987, J CHEM ECOL, V13, P873, DOI 10.1007/BF01020167; Pudasaini MP, 2008, NEMATOLOGY, V10, P47, DOI 10.1163/156854108783360078; Rasmann S, 2012, ROLE ROOT PRODUCED V; Rasmann S, 2012, J CHEM ECOL, V38, P615, DOI 10.1007/s10886-012-0118-6; RICK CM, 1951, P NATL ACAD SCI USA, V37, P741, DOI 10.1073/pnas.37.11.741; Rocha RO, 2015, J AGR FOOD CHEM, V63, P5335, DOI 10.1021/acs.jafc.5b01109; SASSER JN, 1980, PLANT DIS, V64, P36, DOI 10.1094/PD-64-36; Seid A, 2015, NEMATOLOGY, V17, P995, DOI 10.1163/15685411-00002935; Sikora EJ, 1996, J NEMATOL, V28, P501; Wang RH, 2005, ALLELOPATHY J, V15, P75; Wesemael WML, 2011, NEMATOLOGY, V13, P3, DOI 10.1163/138855410X526831; Wuyts N, 2006, NEMATOLOGY, V8, P89, DOI 10.1163/156854106776179953; Xu X, 2008, THESIS SHANDONG AGR; Yang GD, 2015, J SHENYANG AGR U, V46, P11; Zhao XW, 2000, PHYTOPATHOLOGY, V90, P1239, DOI 10.1094/PHYTO.2000.90.11.1239	39	36	39	4	62	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 29	2016	11	4							e0154675	10.1371/journal.pone.0154675	http://dx.doi.org/10.1371/journal.pone.0154675			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DK8XM	27128659	Green Published, Green Submitted, gold			2022-12-26	WOS:000375212600058
J	Bugueno, IM; Khelif, Y; Seelam, N; Morand, DN; Tenenbaum, H; Davideau, JL; Huck, O				Bugueno, Isaac Maximiliano; Khelif, Yacine; Seelam, Narendra; Morand, David-Nicolas; Tenenbaum, Henri; Davideau, Jean-Luc; Huck, Olivier			Porphyromonas gingivalis Differentially Modulates Cell Death Profile in Ox-LDL and TNF-alpha Pre-Treated Endothelial Cells	PLOS ONE			English	Article							LOW-DENSITY-LIPOPROTEIN; PERIODONTAL PATHOGENS; EPITHELIAL-CELLS; IMMUNE-RESPONSE; CATHEPSIN-B; ATHEROSCLEROSIS; APOPTOSIS; EXPRESSION; DISEASE; ACTIVATION	Objective Clinical studies demonstrated a potential link between atherosclerosis and periodontitis. Porphyromonas gingivalis (Pg), one of the main periodontal pathogen, has been associated to atheromatous plaque worsening. However, synergism between infection and other endothelial stressors such as oxidized-LDL or TNF-alpha especially on endothelial cell (EC) death has not been investigated. This study aims to assess the role of Pg on EC death in an inflammatory context and to determine potential molecular pathways involved. Methods Human umbilical vein ECs (HUVECs) were infected with Pg (MOI 100) or stimulated by its lipopolysaccharide (Pg-LPS) (1 mu g/ml) for 24 to 48 hours. Cell viability was measured with AlamarBlue test, type of cell death induced was assessed using Annexin V/propidium iodide staining. mRNA expression regarding caspase-1, -3, -9, Bcl-2, Bax-1 and Apaf-1 has been evaluated with RT-qPCR. Caspases enzymatic activity and concentration of APAF-1 protein were evaluated to confirm mRNA results. Results Pg infection and Pg-LPS stimulation induced EC death. A cumulative effect has been observed in Ox-LDL pre-treated ECs infected or stimulated. This effect was not observed in TNF-alpha pre-treated cells. Pg infection promotes EC necrosis, however, in infected Ox-LDL pre-treated ECs, apoptosis was promoted. This effect was not observed in TNF-alpha pre-treated cells highlighting specificity of molecular pathways activated. Regarding mRNA expression, Pg increased expression of pro-apoptotic genes including caspases-1,-3,-9, Bax-1 and decreased expression of anti-apoptotic Bcl-2. In Ox-LDL pre-treated ECs, Pg increased significantly the expression of Apaf-1. These results were confirmed at the protein level. Conclusion This study contributes to demonstrate that Pg and its Pg-LPS could exacerbate Ox-LDL and TNF-alpha induced endothelial injury through increase of EC death. Interestingly, molecular pathways are differentially modulated by the infection in function of the pre-stimulation.	[Bugueno, Isaac Maximiliano; Khelif, Yacine; Seelam, Narendra; Morand, David-Nicolas; Tenenbaum, Henri; Davideau, Jean-Luc; Huck, Olivier] FMTS, INSERM Osteoarticular & Dent Regenerat Nanomed 11, Strasbourg, France; [Seelam, Narendra; Morand, David-Nicolas; Tenenbaum, Henri; Davideau, Jean-Luc; Huck, Olivier] Univ Strasbourg, Fac Chirurg Dent, Dept Periodontol, Strasbourg, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg	Huck, O (corresponding author), FMTS, INSERM Osteoarticular & Dent Regenerat Nanomed 11, Strasbourg, France.; Huck, O (corresponding author), Univ Strasbourg, Fac Chirurg Dent, Dept Periodontol, Strasbourg, France.	huck.olivier@gmail.com	huck, olivier/AFH-8285-2022	huck, olivier/0000-0002-7988-2290; Bugueno, Isaac Maximiliano/0000-0002-6994-6262	INSERM	INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission)	This study was supported by INSERM.	Ao M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110519; Bach LA, 2015, J MOL ENDOCRINOL, V54, pR1, DOI 10.1530/JME-14-0215; Birck MM, 2013, J CARDIOVASC TRANSL, V6, P579, DOI 10.1007/s12265-013-9463-2; Brennan MA, 2000, MOL MICROBIOL, V38, P31, DOI 10.1046/j.1365-2958.2000.02103.x; Choy JC, 2001, J MOL CELL CARDIOL, V33, P1673, DOI 10.1006/jmcc.2001.1419; Czabotar PE, 2014, NAT REV MOL CELL BIO, V15, P49, DOI 10.1038/nrm3722; Duprez L, 2009, MICROBES INFECT, V11, P1050, DOI 10.1016/j.micinf.2009.08.013; Elkaim R, 2008, J DENT RES, V87, P932, DOI 10.1177/154405910808701010; Elkaim R, 2008, J PERIODONTAL RES, V43, P224, DOI 10.1111/j.1600-0765.2007.01018.x; Gortat A, 2015, PROTEIN CELL, V6, P833, DOI 10.1007/s13238-015-0200-2; Gupta S, 2009, J CELL MOL MED, V13, P1004, DOI 10.1111/j.1582-4934.2009.00697.x; Hajishengallis G, 2015, NAT REV IMMUNOL, V15, P30, DOI 10.1038/nri3785; Hajishengallis G, 2014, EUR J IMMUNOL, V44, P328, DOI 10.1002/eji.201344202; Hasegawa J, 1996, CANCER RES, V56, P1713; Hayashi C, 2011, ATHEROSCLEROSIS, V215, P52, DOI 10.1016/j.atherosclerosis.2010.12.009; Hendrani AD, 2016, WORLD J CARDIOL, V8, P201, DOI 10.4330/wjc.v8.i2.201; Hopkins PN, 2013, PHYSIOL REV, V93, P1317, DOI 10.1152/physrev.00004.2012; Huck O, 2012, MOL ORAL MICROBIOL, V27, P137, DOI 10.1111/j.2041-1014.2012.00638.x; Huck O, 2015, INNATE IMMUN-LONDON, V21, P65, DOI 10.1177/1753425914523459; Huck O, 2011, ARCH CARDIOVASC DIS, V104, P352, DOI 10.1016/j.acvd.2011.02.002; Kocgozlu L, 2009, J DENT RES, V88, P741, DOI 10.1177/0022034509341166; Lei L, 2011, J PERIODONTAL RES, V46, P427, DOI 10.1111/j.1600-0765.2011.01356.x; Leist M, 2001, NAT REV MOL CELL BIO, V2, P589, DOI 10.1038/35085008; Li L, 2002, CIRCULATION, V105, P861, DOI 10.1161/hc0702.104178; Lockhart PB, 2012, CIRCULATION, V125, P2520, DOI 10.1161/CIR.0b013e31825719f3; Maiolino G, 2013, MEDIAT INFLAMM, V2013, DOI 10.1155/2013/714653; Mao S, 2007, CELL MICROBIOL, V9, P1997, DOI 10.1111/j.1462-5822.2007.00931.x; Napoli C, 2003, ANN NY ACAD SCI, V1010, P698, DOI 10.1196/annals.1299.127; Nazzal D, 2006, J INFECT DIS, V193, P136, DOI 10.1086/498617; Park E, 2014, INFECT IMMUN, V82, P112, DOI 10.1128/IAI.00862-13; Petrache I, 2003, FASEB J, V17, P407, DOI 10.1096/fj.02-0672com; Pirillo A, 2013, MEDIAT INFLAMM, V2013, DOI 10.1155/2013/152786; Pussinen PJ, 2007, ARTERIOSCL THROM VAS, V27, P1433, DOI 10.1161/ATVBAHA.106.138743; Qin B, 2015, MOL CELL BIOCHEM, V405, P115, DOI 10.1007/s11010-015-2403-5; Rahman MA, 2015, APOPTOSIS, V20, P1271, DOI 10.1007/s10495-015-1161-x; Rastogi S, 2012, CELL DEATH DIFFER, V19, P274, DOI 10.1038/cdd.2011.93; Rodrigues PH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052606; Rosado JA, 2006, J CELL PHYSIOL, V209, P142, DOI 10.1002/jcp.20715; Rosenfeld ME, 2011, THROMB HAEMOSTASIS, V106, P858, DOI 10.1160/TH11-06-0392; ROSS R, 1993, NATURE, V362, P801, DOI 10.1038/362801a0; Roth GA, 2007, FEMS MICROBIOL LETT, V272, P106, DOI 10.1111/j.1574-6968.2007.00736.x; Soto C, 2016, J PERIODONTAL RES, V51, P518, DOI 10.1111/jre.12331; Stathopoulou PG, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-107; Tang Y, 2015, SCI REP-UK, V5, DOI 10.1038/srep15132; Velsko IM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097811; Wilson PWF, 2008, AM J MED, V121, P15, DOI 10.1016/j.amjmed.2008.06.012; Yilmaz Ozlem, 2008, Microbiology (Reading), V154, P2897, DOI 10.1099/mic.0.2008/021220-0; Yuan SJ, 2013, STRUCTURE, V21, P501, DOI 10.1016/j.str.2013.02.024; Zelkha SA, 2010, PERIODONTOL 2000, V54, P207, DOI 10.1111/j.1600-0757.2010.00358.x; Zhang YL, 2015, CARDIOLOGY, V132, P27, DOI 10.1159/000381332	50	18	19	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 28	2016	11	4							e0154590	10.1371/journal.pone.0154590	http://dx.doi.org/10.1371/journal.pone.0154590			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DK8XE	27124409	Green Published, Green Submitted, gold			2022-12-26	WOS:000375211700108
J	Grau-Moya, J; Ortega, PA; Braun, DA				Grau-Moya, Jordi; Ortega, Pedro A.; Braun, Daniel A.			Decision-Making under Ambiguity Is Modulated by Visual Framing, but Not by Motor vs. Non-Motor Context. Experiments and an Information-Theoretic Ambiguity Model	PLOS ONE			English	Article							SENSORIMOTOR CONTROL; BAYESIAN-INFERENCE; RISK-SENSITIVITY; UNCERTAINTY; REPRESENTATION; VISUALIZATION; PREFERENCES; ROBUSTNESS; AVERSION; CHOICE	A number of recent studies have investigated differences in human choice behavior depending on task framing, especially comparing economic decision-making to choice behavior in equivalent sensorimotor tasks. Here we test whether decision-making under ambiguity exhibits effects of task framing in motor vs. non-motor context. In a first experiment, we designed an experience-based urn task with varying degrees of ambiguity and an equivalent motor task where subjects chose between hitting partially occluded targets. In a second experiment, we controlled for the different stimulus design in the two tasks by introducing an urn task with bar stimuli matching those in the motor task. We found ambiguity attitudes to be mainly influenced by stimulus design. In particular, we found that the same subjects tended to be ambiguity-preferring when choosing between ambiguous bar stimuli, but ambiguity-avoiding when choosing between ambiguous urn sample stimuli. In contrast, subjects' choice pattern was not affected by changing from a target hitting task to a non-motor context when keeping the stimulus design unchanged. In both tasks subjects' choice behavior was continuously modulated by the degree of ambiguity. We show that this modulation of behavior can be explained by an information-theoretic model of ambiguity that generalizes Bayes-optimal decision-making by combining Bayesian inference with robust decision-making under model uncertainty. Our results demonstrate the benefits of information-theoretic models of decision-making under varying degrees of ambiguity for a given context, but also demonstrate the sensitivity of ambiguity attitudes across contexts that theoretical models struggle to explain.	[Grau-Moya, Jordi; Braun, Daniel A.] Max Planck Inst Biol Cybernet, Spemannstr 38, D-72076 Tubingen, Germany; [Grau-Moya, Jordi; Braun, Daniel A.] Max Planck Inst Intelligent Syst, Tubingen, Germany; [Grau-Moya, Jordi] Grad Training Ctr Neurosci, Tubingen, Germany; [Ortega, Pedro A.] Univ Penn, Sch Engn & Appl Sci, Philadelphia, PA 19104 USA	Max Planck Society; Max Planck Society; University of Pennsylvania	Grau-Moya, J (corresponding author), Max Planck Inst Biol Cybernet, Spemannstr 38, D-72076 Tubingen, Germany.; Grau-Moya, J (corresponding author), Max Planck Inst Intelligent Syst, Tubingen, Germany.; Grau-Moya, J (corresponding author), Grad Training Ctr Neurosci, Tubingen, Germany.	jordi.grau@tuebingen.mpg.de			DFG [BR4164/1-1]; U.S. National Science Foundation, Office of Naval Research and Department of Transportation	DFG(German Research Foundation (DFG)); U.S. National Science Foundation, Office of Naval Research and Department of Transportation	This work was supported by DFG Emmy Noether grant BR4164/1-1 and by grants from the U.S. National Science Foundation, Office of Naval Research and Department of Transportation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This study was supported by the DFG, Emmy Noether grant BR4164/1-1 and by Grants from the U.S. National Science Foundation, Office of Naval Research and Department of Transportation.	Arrow K., 1972, UNCERTAINTY EXPECTAT, P1; Arrow K., 1965, ASPECTS THEORY RISK; Braun DA, 2011, AD DYN PROGR REINF L, P202; Braun DA, 2011, FRONT HUM NEUROSCI, V5, DOI 10.3389/fnhum.2011.00001; Braun DA, 2009, J NEUROSCI, V29, P6472, DOI 10.1523/JNEUROSCI.3075-08.2009; Brodlie K., 2012, EXPANDING FRONTIERS, P81; CAMERER C, 1992, J RISK UNCERTAINTY, V5, P325, DOI 10.1007/BF00122575; Chumbley JR, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002346; Diedrichsen J, 2010, TRENDS COGN SCI, V14, P31, DOI 10.1016/j.tics.2009.11.004; ELLSBERG D, 1961, Q J ECON, V75, P643, DOI 10.2307/1884324; Etner J, 2012, J ECON SURV, V26, P234, DOI 10.1111/j.1467-6419.2010.00641.x; Friston KJ, 2010, NAT REV NEUROSCI, V11, P127, DOI 10.1038/nrn2787; Friston KJ, 2009, TRENDS COGN SCI, V13, P293, DOI 10.1016/j.tics.2009.04.005; Ghirardato P, 2004, J ECON THEORY, V118, P133, DOI 10.1016/j.jet.2003.12.004; GILBOA I, 1989, J MATH ECON, V18, P141, DOI 10.1016/0304-4068(89)90018-9; Gilboa I, 2011, AMBIGUITY BAYESIAN P; Gino F, 2011, ORGAN BEHAV HUM DEC, V114, P104, DOI 10.1016/j.obhdp.2010.10.002; Grau-Moya J, 2013, J R SOC INTERFACE, V10, DOI 10.1098/rsif.2013.0554; Grau-Moya J, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002698; Hanany E, THE BE JOURNAL OF TH, V9; HANSEN L. P., 2008, ROBUSTNESS; Howard IS, 2009, J NEUROSCI METH, V181, P199, DOI 10.1016/j.jneumeth.2009.05.005; Hsu M, 2005, SCIENCE, V310, P1680, DOI 10.1126/science.1115327; Huettel SA, 2006, NEURON, V49, P765, DOI 10.1016/j.neuron.2006.01.024; Inukai K, 2009, INT J NEUROSCI, V119, P1170, DOI 10.1080/00207450802174472; Johnson C, 2004, IEEE COMPUT GRAPH, V24, P13, DOI 10.1109/MCG.2004.20; Keren G, 1999, ACTA PSYCHOL, V103, P149, DOI 10.1016/S0001-6918(99)00034-7; Kitano H, 2004, NAT REV GENET, V5, P826, DOI 10.1038/nrg1471; Klibanoff P, 2005, ECONOMETRICA, V73, P1849, DOI 10.1111/j.1468-0262.2005.00640.x; Knight, 1933, RISK UNCERTAINTY PRO; Kording K, 2007, SCIENCE, V318, P606, DOI 10.1126/science.1142998; Kording KP, 2004, NATURE, V427, P244, DOI 10.1038/nature02169; Krain AL, 2006, NEUROIMAGE, V32, P477, DOI 10.1016/j.neuroimage.2006.02.047; LANGER EJ, 1975, J PERS SOC PSYCHOL, V32, P311, DOI 10.1037/0022-3514.32.2.311; Levy I, 2010, J NEUROPHYSIOL, V103, P1036, DOI 10.1152/jn.00853.2009; Ma WJ, 2008, CURR OPIN NEUROBIOL, V18, P217, DOI 10.1016/j.conb.2008.07.004; Ma WJ, 2006, NAT NEUROSCI, V9, P1432, DOI 10.1038/nn1790; Maccheroni F, 2006, ECONOMETRICA, V74, P1447, DOI 10.1111/j.1468-0262.2006.00716.x; Marx V, 2013, NAT METHODS, V10, P613, DOI 10.1038/nmeth.2530; Nagengast AJ, 2011, P ROY SOC B-BIOL SCI, V278, P2325, DOI 10.1098/rspb.2010.2518; Nagengast AJ, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000857; Ortega DA, 2011, ARTIFICIAL GEN INTEL, P269; Ortega P. A., 2013, P ROYAL SOC A, V469, P2153, DOI 1098/rspa.2012.0683; Pang AT, 1997, VISUAL COMPUT, V13, P370, DOI 10.1007/s003710050111; PRATT JW, 1964, ECONOMETRICA, V32, P122, DOI 10.2307/1913738; Pulford BD, 2008, EXP PSYCHOL, V55, P31, DOI 10.1027/1618-3169.55.1.31; Schmeidler D, 1989, ECONOMETRICA J ECONO, P571, DOI [10.2307/1911053, DOI 10.2307/1911053]; Smith K, 2002, MANAGE SCI, V48, P711, DOI 10.1287/mnsc.48.6.711.194; Stevenson IH, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000629; Todorov E, 2004, NAT NEUROSCI, V7, P907, DOI 10.1038/nn1309; Trommershauser J, 2008, TRENDS COGN SCI, V12, P291, DOI 10.1016/j.tics.2008.04.010; Trommershauser J, 2003, SPATIAL VISION, V16, P255, DOI 10.1163/156856803322467527; TVERSKY A, 1981, SCIENCE, V211, P453, DOI 10.1126/science.7455683; TVERSKY A, 1992, J RISK UNCERTAINTY, V5, P297, DOI 10.1007/BF00122574; van Beers RJ, 2004, J NEUROPHYSIOL, V91, P1050, DOI 10.1152/jn.00652.2003; Wolpert DM, 2012, CURR OPIN NEUROBIOL, V22, P996, DOI 10.1016/j.conb.2012.05.003; Wu SW, 2009, P NATL ACAD SCI USA, V106, P6088, DOI 10.1073/pnas.0900102106	58	1	1	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 28	2016	11	4							e0153179	10.1371/journal.pone.0153179	http://dx.doi.org/10.1371/journal.pone.0153179			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DK8XE	27124723	gold, Green Submitted, Green Published			2022-12-26	WOS:000375211700011
J	Mora-Zamorano, FX; Svoboda, KR; Carvan, MJ				Mora-Zamorano, Francisco X.; Svoboda, Kurt R.; Carvan, Michael J., III			The Nicotine-Evoked Locomotor Response: A Behavioral Paradigm for Toxicity Screening in Zebrafish (Danio rerio) Embryos and Eleutheroembryos Exposed to Methylmercury	PLOS ONE			English	Article							LARVAL ZEBRAFISH; ACETYLCHOLINE-RECEPTORS; EXPRESSION; CLONING	This study is an adaptation of the nicotine-evoked locomotor response (NLR) assay, which was originally utilized for phenotype-based neurotoxicity screening in zebrafish embryos. Zebrafish embryos do not exhibit spontaneous swimming until roughly 4 days post-fertilization (dpf), however, a robust swimming response can be induced as early as 36 hours postfertilization (hpf) by means of acute nicotine exposure (30-240 mu M). Here, the NLR was tested as a tool for early detection of locomotor phenotypes in 36, 48 and 72 hpf mutant zebrafish embryos of the non-touch-responsive maco strain; this assay successfully discriminated mutant embryos from their non-mutant siblings. Then, methylmercury (MeHg) was used as a proof-of-concept neurotoxicant to test the effectiveness of the NLR assay as a screening tool in toxicology. The locomotor effects of MeHg were evaluated in 6 dpf wild type eleutheroembryos exposed to waterborne MeHg (0, 0.01, 0.03 and 0.1 mu M). Afterwards, the NLR assay was tested in 48 hpf embryos subjected to the same MeHg exposure regimes. Embryos exposed to 0.01 and 0.03 mu M of MeHg exhibited significant increases in locomotion in both scenarios. These findings suggest that similar locomotor phenotypes observed in free swimming fish can be detected as early as 48 hpf, when locomotion is induced with nicotine.	[Mora-Zamorano, Francisco X.; Carvan, Michael J., III] Univ Wisconsin, Sch Freshwater Sci, Milwaukee, WI 53201 USA; [Svoboda, Kurt R.] Univ Wisconsin, Joseph J Zilber Sch Publ Hlth, Milwaukee, WI 53201 USA	University of Wisconsin System; University of Wisconsin Milwaukee; University of Wisconsin System; University of Wisconsin Milwaukee	Carvan, MJ (corresponding author), Univ Wisconsin, Sch Freshwater Sci, Milwaukee, WI 53201 USA.	carvanmj@uwm.edu	svoboda, kurt/AAH-4940-2019	Mora, Francisco/0000-0003-3530-9203; Carvan, Michael/0000-0002-9190-9417	National Institutes of Health [2P30ES004184, R21ES019104]; United States Environmental Protection Agency [GL00E00496-1]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R21ES019104] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); United States Environmental Protection Agency(United States Environmental Protection Agency); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	Funding provided by National Institutes of Health, 2P30ES004184, National Institutes of Health, R21ES019104, to MJC and United States Environmental Protection Agency, GL00E00496-1, to MJC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ackerman KM, 2009, DEV DYNAM, V238, P980, DOI 10.1002/dvdy.21912; Ali S, 2011, BIRTH DEFECTS RES C, V93, P115, DOI 10.1002/bdrc.20206; Best JD, 2008, NEUROPSYCHOPHARMACOL, V33, P1206, DOI 10.1038/sj.npp.1301489; Boucher O, 2012, ENVIRON HEALTH PERSP, V120, P1456, DOI 10.1289/ehp.1204976; Branson K, 2009, NAT METHODS, V6, P451, DOI [10.1038/nmeth.1328, 10.1038/NMETH.1328]; Budick SA, 2000, J EXP BIOL, V203, P2565; Burgess HA, 2007, J EXP BIOL, V210, P2526, DOI 10.1242/jeb.003939; Burgess HA, 2010, CURR BIOL, V20, P381, DOI 10.1016/j.cub.2010.01.022; Carvan MJ, 2004, NEUROTOXICOL TERATOL, V26, P757, DOI 10.1016/j.ntt.2004.06.016; Downes GB, 2006, J NEUROBIOL, V66, P437, DOI 10.1002/neu.20226; Eldefrawi M, 1977, MEMBRANE TOXICITY, P449; Gimenez-Llort L, 2001, ENVIRON TOXICOL PHAR, V9, P61, DOI 10.1016/S1382-6689(00)00060-0; Grunwald DJ, 2002, NAT REV GENET, V3, P717, DOI 10.1038/nrg892; Ho NY, 2013, ENVIRON SCI TECHNOL, V47, P3316, DOI 10.1021/es3050967; Kanungo J, 2009, NEUROCHEM RES, V34, P1129, DOI 10.1007/s11064-008-9885-4; LITTLE EE, 1990, ENVIRON TOXICOL CHEM, V9, P13, DOI 10.1002/etc.5620090103; Menelaou E, 2014, EUR J NEUROSCI, V40, P2225, DOI 10.1111/ejn.12591; Mora-Zamorano FX, 2016, ENV SCI TECHNOL; Petzold AM, 2009, P NATL ACAD SCI USA, V106, P18662, DOI 10.1073/pnas.0908247106; Ribera AB, 1998, J NEUROSCI, V18, P9181; Saint-Amant L, 1998, J NEUROBIOL, V37, P622, DOI 10.1002/(SICI)1097-4695(199812)37:4<622::AID-NEU10>3.0.CO;2-S; Sandheinrich MB, 2006, ENVIRON TOXICOL CHEM, V25, P3053, DOI 10.1897/05-641R.1; Schneider H, 2012, ZEBRAFISH DRUG DEV B, P53; Stringari J, 2006, NEUROCHEM RES, V31, P563, DOI 10.1007/s11064-006-9051-9; Thomas LT, 2009, TOXICOL APPL PHARM, V239, P1, DOI 10.1016/j.taap.2008.08.023; Welsh L, 2009, TOXICOL APPL PHARM, V237, P29, DOI 10.1016/j.taap.2008.06.025; Whitlock KE, 2006, ZEBRAFISH, V3, P203, DOI 10.1089/zeb.2006.3.203; Zirger JM, 2003, GENE EXPR PATTERNS, V3, P747, DOI 10.1016/S1567-133X(03)00126-1; Zon LI, 2005, NAT REV DRUG DISCOV, V4, P35, DOI 10.1038/nrd1606	29	16	16	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 28	2016	11	4							e0154570	10.1371/journal.pone.0154570	http://dx.doi.org/10.1371/journal.pone.0154570			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DK8XE	27123921	Green Published, gold, Green Submitted			2022-12-26	WOS:000375211700104
J	Rampone, G; Sullivan, NO; Bertamini, M				Rampone, Giulia; Sullivan, Noreen O'; Bertamini, Marco			The Role of Visual Eccentricity on Preference for Abstract Symmetry	PLOS ONE			English	Article							BILATERAL SYMMETRY; MIRROR SYMMETRY; FACIAL ATTRACTIVENESS; FEMALE PREFERENCE; PERCEPTION; RESPONSES; SELECTION; LOOKING; INNATE; BEAUTY	This study tested preference for abstract patterns, comparing random patterns to a two-fold bilateral symmetry. Stimuli were presented at random locations in the periphery. Preference for bilateral symmetry has been extensively studied in central vision, but evaluation at different locations had not been systematically investigated. Patterns were presented for 200 ms within a large circular region. On each trial participant changed fixation and were instructed to select any location. Eccentricity values were calculated a posteriori as the distance between ocular coordinates at pattern onset and coordinates for the centre of the pattern. Experiment 1 consisted of two Tasks. In Task 1, participants detected pattern regularity as fast as possible. In Task 2 they evaluated their liking for the pattern on a Likert-scale. Results from Task 1 revealed that with our parameters eccentricity did not affect symmetry detection. However, in Task 2, eccentricity predicted more negative evaluation of symmetry, but not random patterns. In Experiment 2 participants were either presented with symmetry or random patterns. Regularity was task-irrelevant in this task. Participants discriminated the proportion of black/white dots within the pattern and then evaluated their liking for the pattern. Even when only one type of regularity was presented and regularity was task-irrelevant, preference evaluation for symmetry decreased with increasing eccentricity, whereas eccentricity did not affect the evaluation of random patterns. We conclude that symmetry appreciation is higher for foveal presentation in a way not fully accounted for by sensitivity.	[Rampone, Giulia; Bertamini, Marco] Univ Liverpool, Dept Psychol Sci, Eleanor Rathbone Bldg, Liverpool L69 7ZA, Merseyside, England; [Sullivan, Noreen O'] Liverpool John Moores Univ, Inst Nat Sci & Psychol, Sch Nat Sci & Psychol, Byrom St, Liverpool L3 3AF, Merseyside, England	University of Liverpool; Liverpool John Moores University	Rampone, G (corresponding author), Univ Liverpool, Dept Psychol Sci, Eleanor Rathbone Bldg, Liverpool L69 7ZA, Merseyside, England.	giulia@liverpool.ac.uk		Rampone, Giulia/0000-0002-2710-688X	Economic and Social Research Council (ESRC) [ES/K000187/1]; ESRC [ES/K000187/1] Funding Source: UKRI; Economic and Social Research Council [ES/K000187/1] Funding Source: researchfish	Economic and Social Research Council (ESRC)(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); ESRC(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC))	The Economic and Social Research Council (ESRC, Ref. ES/K000187/1) (www.esrc.ac.uk) supported this work. MB received the funding. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The Economic and Social Research Council (ESRC, Ref. ES/K000187/1) supported this work.	Apthorp D, 2015, CURR BIOL, V25, pR267, DOI 10.1016/j.cub.2015.02.017; BARLOW HB, 1979, VISION RES, V19, P783, DOI 10.1016/0042-6989(79)90154-8; Barrett BT, 1999, VISION RES, V39, P3737, DOI 10.1016/S0042-6989(99)00083-8; Bertamini M, 2014, SYMMETRY-BASEL, V6, P975, DOI 10.3390/sym6040975; Bertamini M, 2013, I-PERCEPTION, V4, P317, DOI 10.1068/i0601JW; Cardenas RA, 2006, EVOL HUM BEHAV, V27, P1, DOI 10.1016/j.evolhumbehav.2005.05.002; DELIUS JD, 1982, PSYCHOL RES-PSYCH FO, V44, P199, DOI 10.1007/BF00308420; Guo K, 2011, PERCEPTION, V40, P191, DOI 10.1068/p6849; Gurnsey R, 1998, VISION RES, V38, P3795, DOI 10.1016/S0042-6989(98)00106-0; Herbert AM, 1996, PERCEPTION, V25, P463, DOI 10.1068/p250463; Jacobsen T, 2003, COGN AFFECT BEHAV NE, V3, P289, DOI 10.3758/CABN.3.4.289; JENKINS B, 1983, PERCEPT PSYCHOPHYS, V34, P433, DOI 10.3758/BF03203058; JOHNSTONE RA, 1994, NATURE, V372, P172, DOI 10.1038/372172a0; Julesz B, 1971, FOUNDATIONS OF CYCLO; Julesz B., 1981, PERCEPTUAL ORG, P27; Kuraguchi K, 2015, FRONT PSYCHOL, V6, DOI 10.3389/fpsyg.2015.00566; Little AC, 2011, PHILOS T R SOC B, V366, P1638, DOI 10.1098/rstb.2010.0404; Machilsen B, 2009, J VISION, V9, DOI 10.1167/9.12.11; Makin ADJ, 2013, PSYCHOPHYSIOLOGY, V50, P1045, DOI 10.1111/psyp.12082; Makin ADJ, 2012, NEUROPSYCHOLOGIA, V50, P3250, DOI 10.1016/j.neuropsychologia.2012.10.003; Makin ADJ, 2012, EMOTION, V12, P1021, DOI 10.1037/a0026924; Masame K, 1983, TOHOKU PSYCHOL FOLIA; Moller AP, 1998, AM NAT, V151, P174, DOI 10.1086/286110; Palmer SE., 1990, MIND LANG, V5, P289, DOI [10.1111/j.1468-0017.1990.tb00166.x, DOI 10.1111/J.1468-0017.1990.TB00166.X]; Pecchinenda A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092685; Peirce JW, 2007, J NEUROSCI METH, V162, P8, DOI 10.1016/j.jneumeth.2006.11.017; Pomeranz J, 1986, HDB PERCEPTION HUMAN, V2, P1; Ramachandran VS, 2000, J CONSCIOUSNESS STUD, V7, P17; Rampone G, 2014, NEUROPSYCHOLOGIA, V58, P107, DOI 10.1016/j.neuropsychologia.2014.04.005; Rasbash J., 2009, MLWIN VERSION 2 11; Rentschler I, 1999, CURR BIOL, V9, P665, DOI 10.1016/S0960-9822(99)80306-6; Rodriguez I, 2004, NATURWISSENSCHAFTEN, V91, P374, DOI 10.1007/s00114-004-0537-5; SAARINEN J, 1988, VISION RES, V28, P755, DOI 10.1016/0042-6989(88)90054-5; SAARINEN J, 1989, INVEST OPHTH VIS SCI, V30, P293; Sally S, 2001, SPATIAL VISION, V14, P217, DOI 10.1163/156856801300202940; Sasaki Y, 2005, P NATL ACAD SCI USA, V102, P3159, DOI 10.1073/pnas.0500319102; SNODGRASS JG, 1985, AM J PSYCHOL, V98, P480, DOI 10.2307/1422636; Sui J, 2009, PSYCHON B REV, V16, P276, DOI 10.3758/PBR.16.2.276; SWADDLE JP, 1994, NATURE, V367, P165, DOI 10.1038/367165a0; Swaddle JP, 2001, AM NAT, V158, P300, DOI 10.1086/321323; Thornhill R, 1999, TRENDS COGN SCI, V3, P452, DOI 10.1016/S1364-6613(99)01403-5; Townsend JT, 1978, COGNITIVE THEORY, P199; Treder MS, 2010, SYMMETRY-BASEL, V2, P1510, DOI 10.3390/sym2031510; Tudor MS, 2009, ETHOLOGY, V115, P812, DOI 10.1111/j.1439-0310.2009.01676.x; Tyler CW, 2005, NEUROIMAGE, V24, P306, DOI 10.1016/j.neuroimage.2004.09.018; Tyler CW, 1996, HUMAN SYMMETRY PERCE, P157; van der Helm PA, 2011, SYMMETRY-BASEL, V3, P54, DOI 10.3390/sym3010054; WENDEROTH P, 1994, PERCEPTION, V23, P221, DOI 10.1068/p230221; Wignall AE, 2006, ETHOLOGY, V112, P510, DOI 10.1111/j.1439-0310.2006.01199.x; Winkielman P, 2003, PSYCHOLOGY OF EVALUATION, P189; ZAJONC RB, 1968, J PERS SOC PSYCHOL, V9, P1, DOI 10.1037/h0025848	51	4	4	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 28	2016	11	4							e0154428	10.1371/journal.pone.0154428	http://dx.doi.org/10.1371/journal.pone.0154428			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DK8XE	27124081	Green Published, Green Submitted, gold			2022-12-26	WOS:000375211700085
J	Thompson, VD; Marquardt, WH; Cherkinsky, A; Thompson, ADR; Walker, KJ; Newsom, LA; Savarese, M				Thompson, Victor D.; Marquardt, William H.; Cherkinsky, Alexander; Thompson, Amanda D. Roberts; Walker, Karen J.; Newsom, Lee A.; Savarese, Michael			From Shell Midden to Midden-Mound: The Geoarchaeology of Mound Key, an Anthropogenic Island in Southwest Florida, USA	PLOS ONE			English	Article							CRYSTAL RIVER; AGE-DETERMINATIONS; RADIOCARBON; CONSTRUCTION; HISTORY	Mound Key was once the capital of the Calusa Kingdom, a large Pre-Hispanic polity that controlled much of southern Florida. Mound Key, like other archaeological sites along the southwest Gulf Coast, is a large expanse of shell and other anthropogenic sediments. The challenges that these sites pose are largely due to the size and areal extent of the deposits, some of which begin up to a meter below and exceed nine meters above modern sea levels. Additionally, the complex depositional sequences at these sites present difficulties in determining their chronology. Here, we examine the development of Mound Key as an anthropogenic island through systematic coring of the deposits, excavations, and intensive radiocarbon dating. The resulting data, which include the reversals of radiocarbon dates from cores and dates from mound-top features, lend insight into the temporality of site formation. We use these insights to discuss the nature and scale of human activities that worked to form this large island in the context of its dynamic, environmental setting. We present the case that deposits within Mound Key's central area accumulated through complex processes that represent a diversity of human action including midden accumulation and the redeposition of older sediments as mound fill.	[Thompson, Victor D.] Univ Georgia, Ctr Archaeol Sci, Athens, GA 30602 USA; [Thompson, Victor D.] Univ Georgia, Dept Anthropol, Athens, GA 30602 USA; [Marquardt, William H.; Walker, Karen J.] Univ Florida, Florida Museum Nat Hist, Gainesville, FL 32611 USA; [Cherkinsky, Alexander] Univ Georgia, Ctr Appl Isotope Studies, Athens, GA 30602 USA; [Thompson, Amanda D. Roberts] Univ Georgia, Lab Archaeol, Athens, GA 30602 USA; [Newsom, Lee A.] Penn State Univ, Dept Anthropol, State Coll, PA USA; [Savarese, Michael] Florida Gulf Coast Univ, Dept Marine & Ecol Sci, Ft Myers, FL USA	University System of Georgia; University of Georgia; University System of Georgia; University of Georgia; State University System of Florida; University of Florida; University System of Georgia; University of Georgia; University System of Georgia; University of Georgia; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; State University System of Florida; Florida Gulf Coast University	Thompson, VD (corresponding author), Univ Georgia, Ctr Archaeol Sci, Athens, GA 30602 USA.; Thompson, VD (corresponding author), Univ Georgia, Dept Anthropol, Athens, GA 30602 USA.	vdthom@uga.edu			Committee of Research at Exploration; National Geographic Society [9258-13]; University of Georgia Office of the Vice President for Research; John S. and James L. Knight Endowment for South Florida Archaeology; Direct For Social, Behav & Economic Scie [1550910] Funding Source: National Science Foundation	Committee of Research at Exploration; National Geographic Society(National Geographic Society); University of Georgia Office of the Vice President for Research; John S. and James L. Knight Endowment for South Florida Archaeology; Direct For Social, Behav & Economic Scie(National Science Foundation (NSF)NSF - Directorate for Social, Behavioral & Economic Sciences (SBE))	Research at Mound Key is supported in part by a grant from the Committee of Research at Exploration, National Geographic Society (#9258-13), and a Faculty Research Grant from the University of Georgia Office of the Vice President for Research, and the John S. and James L. Knight Endowment for South Florida Archaeology.	[Anonymous], 2013, SE ARCHAEOL, V32, P14, DOI [10.1179/sea.2013.32.1.002, DOI 10.1179/sea.2013.32.1.002]; Bayliss A, 2007, CAMB ARCHAEOL J, V17, P1, DOI 10.1017/S0959774307000145; Bayliss A, 2007, CAMB ARCHAEOL J, V17, P85, DOI 10.1017/S0959774307000182; Cherkinsky A, 2014, RADIOCARBON, V56, P801, DOI 10.2458/56.16960; Cherkinsky A, 2010, NUCL INSTRUM METH B, V268, P867, DOI 10.1016/j.nimb.2009.10.051; Cushing F. H., 1897, EXPLORATION ANCIENT; deFrance S. D., 2013, ARCHAEOLOGY PINELAND, P53; Feinman G., 1995, FDN SOCIAL INEQUALIT, P15, DOI DOI 10.1007/978-1-4899-1289-3_2; Hadden CS, 2015, RADIOCARBON, V57, P469, DOI 10.2458/azu_rc.57.18353; Hann John H., 1991, MISSIONS CALUSA; Hill CL, 2006, GEOARCHAEOLOGY EARTH; Kennett Douglas J., 2012, Anthropological Papers of the American Museum of Natural History, V97, P37; Krus AM, 2013, MIDCONT J ARCHAEOL, V38, P171, DOI 10.1179/mca.2013.006; Larsen B. P., 2015, SHAPE OUTCOME FORMAT; Luer GM, 2014, BIG MOUND KEY NEAR C, V17, P97; Luer GM, 2014, BIG MOUND KEY NEAR C, V17, P39; Luer GM, 2014, BIG MOUND KEY NEAR C, V17, P57; Luer GM, 2014, BIG MOUND KEY NEAR C, V17, P87; Marquardt W.H., 1988, HUNTERS GATHERERS, P161; Marquardt W. H., 2013, ARCHAEOLOGY PINELAND, P793; Marquardt W.H., 1987, POWER RELATIONS STAT, P98; Marquardt W. H., 2014, SE ARCHAEOLOGY, V33, P1, DOI DOI 10.1179/sea.2014.33.1.001; Marquardt W.H., 2010, TREND TRADITION TURM, V93, P253; Marquardt W. H., 2012, LATE PREHISTORIC FLO, P29; Marquardt WH, 2010, AM ANTIQUITY, V75, P551, DOI 10.7183/0002-7316.75.3.551; McNiven IJ, 2013, J ARCHAEOL METHOD TH, V20, P552, DOI 10.1007/s10816-012-9130-y; Meehan B., 1982, SHELL BED SHELL MIDD; Moore C. B., 1999, W CENTRAL FLORIDA EX; Myers RL, 2000, FLORA OF FLORIDA, V1, P10; Newsom L. A., 2004, LAND SEA NATIVE AM U; Newsom L. A., 2013, ARCHAEOLOGY PINELAND, P253; Pluckhahn TJ, 2015, GEOARCHAEOLOGY, V30, P238, DOI 10.1002/gea.21511; Pluckhahn TJ, 2015, J ANTHROPOL ARCHAEOL, V37, P19, DOI 10.1016/j.jaa.2014.10.004; Price T. D., 1985, PREHISTORIC HUNTERS, P3, DOI DOI 10.1016/B978-0-12-564750-2.50006-8; Ramsey CB, 2009, RADIOCARBON, V51, P337, DOI 10.1017/S0033822200033865; Reimer PJ, 2013, RADIOCARBON, V55, P1869, DOI 10.2458/azu_js_rc.55.16947; Rowley-Conwy P, 2013, SHELL ENERGY MOLLUSC, P137; Russo M, 2004, EARLY POTTERY TECHNO, P105; Sassaman KE, 2004, J ARCHAEOL RES, V12, P227, DOI 10.1023/B:JARE.0000040231.67149.a8; Saunders Rebecca, 2004, EARLY POTTERY TECHNO; SCHIFFER MB, 1986, J ARCHAEOL SCI, V13, P13, DOI 10.1016/0305-4403(86)90024-5; Schwadron M., 2013, SHELL ENERGY MOLLUSC, P43; Shiner J.S., 2013, QUEENSLAND ARCHAEOLO, V16, P65; STAPOR FW, 1991, J COASTAL RES, V7, P815; Steier P, 2000, RADIOCARBON, V42, P183, DOI 10.1017/S0033822200058999; Stein JK, 2003, J ARCHAEOL SCI, V30, P297, DOI 10.1006/jasc.2002.0838; Tanner W.F., 2000, YEARS SUMMER TRACING, P89; Tanner WF, 1992, HOLOCENE, V2, P249, DOI DOI 10.1306/A1ADDD3F-0DFE-11D7-8641000102C1865D; Thomas David Hurst, 2011, ANTHR PAPERS AM MUSE, V94, P25; Thompson VD, 2016, NEW APPROACHES ANTHR; Thompson VD, 2015, J ARCHAEOL SCI-REP, V4, P111, DOI 10.1016/j.jasrep.2015.08.020; Thompson VD, 2014, ARCHAEOL PROSPECT, V21, P59, DOI 10.1002/arp.1470; Thompson VD, 2013, AM ANTIQUITY, V78, P181, DOI 10.7183/0002-7316.78.1.181; Thompson VD, 2011, AM ANTIQUITY, V76, P315, DOI 10.7183/0002-7316.76.2.315; Thompson VD, 2011, J ARCHAEOL RES, V19, P51, DOI 10.1007/s10814-010-9043-9; Thompson Victor D., 2010, TREND TRADITION TURM, V93, P217; Thompson Victor D., 2007, SE ARCHAEOLOGY, V26, P91; Torrence C.M., 1994, TOPOGRAPHIC MAPPING; van der Plicht J., 2011, GATHERING TIME DATIN, P17; Walker K.J., 1992, CULTURE ENV DOMAIN C, P265; Walker K. J., 2013, ARCHAEOLOGY PINELAND, P23; Walker K.J., 2000, BRIT ARCHAEOLOGICAL, P119; Widmer R., 2014, CULTURAL DYNAMICS SH, P11; Widmer R. J., 1988, EVOLUTION CALUSA NON; Williams AN, 2012, J ARCHAEOL SCI, V39, P578, DOI 10.1016/j.jas.2011.07.014	65	37	37	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 28	2016	11	4							e0154611	10.1371/journal.pone.0154611	http://dx.doi.org/10.1371/journal.pone.0154611			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Arts &amp; Humanities Citation Index (A&amp;HCI)	Science & Technology - Other Topics	DK8XE	27123928	Green Published, Green Submitted, gold			2022-12-26	WOS:000375211700114
J	Gangalum, RK; Bhat, AM; Kohan, SA; Bhat, SP				Gangalum, Rajendra K.; Bhat, Ankur M.; Kohan, Sirus A.; Bhat, Suraj P.			Inhibition of the Expression of the Small Heat Shock Protein alpha B-Crystallin Inhibits Exosome Secretion in Human Retinal Pigment Epithelial Cells in Culture	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DEVELOPING OCULAR LENS; PLASMA-MEMBRANE; BIOGENESIS; COMPARTMENTS; TRAFFICKING; DISEASE; ALIX	Exosomes carry cell type-specific molecular cargo to extracellular destinations and therefore act as lateral vectors of intercellular communication and transfer of genetic information from one cell to the other. We have shown previously that the small heat shock protein alpha B-crystallin (alpha B) is exported out of the adult human retinal pigment epithelial cells (ARPE19) packaged in exosomes. Here, we demonstrate that inhibition of the expression of alpha B via shRNA inhibits exosome secretion from ARPE19 cells indicating that exosomal cargo may have a role in exosome biogenesis (synthesis and/or secretion). Sucrose density gradient fractionation of the culture medium and cellular extracts suggests continued synthesis of exosomes but an inhibition of exosome secretion. In cells where alpha B expression was inhibited, the distribution of CD63 (LAMP3), an exosome marker, is markedly altered from the normal dispersed pattern to a stacked perinuclear presence. Interestingly, the total anti-CD63(LAMP3) immunofluorescence in the native and alpha B-inhibited cells remains unchanged suggesting continued exosome synthesis under conditions of impaired exosome secretion. Importantly, inhibition of the expression of alpha B results in a phenotype of the RPE cell that contains an increased number of vacuoles and enlarged (fused) vesicles that show increased presence of CD63(LAMP3) and LAMP1 indicating enhancement of the endolysosomal compartment. This is further corroborated by increased Rab7 labeling of this compartment (Rab-GTPase 7 is known to be associated with late endosome maturation). These data collectively point to a regulatory role for alpha B in exosome biogenesis possibly via its involvement at a branch point in the endocytic pathway that facilitates secretion of exosomes.	[Gangalum, Rajendra K.; Bhat, Ankur M.; Bhat, Suraj P.] UCLA, Geffen Sch Med, Jules Stein Eye Inst, Los Angeles, CA 90095 USA; [Bhat, Suraj P.] UCLA, Inst Mol Biol, Los Angeles, CA 90095 USA; [Kohan, Sirus A.; Bhat, Suraj P.] UCLA, Brain Res Inst, Los Angeles, CA 90095 USA	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles	Bhat, SP (corresponding author), UCLA, Geffen Sch Med, 100 Stein Plaza, Los Angeles, CA 90095 USA.	bhat@jsei.ucla.edu	; Gangalum, Rajendra K/H-1369-2013	Bhat, Suraj P/0000-0003-4707-5870; Gangalum, Rajendra K/0000-0002-8746-0266	NEI, National Institutes of Health [1R01EY024929]; Gerald Oppenheimer Family Foundation for the Prevention of Eye Disease Endowment Fund; NATIONAL EYE INSTITUTE [P30EY000331, R01EY024929] Funding Source: NIH RePORTER	NEI, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); Gerald Oppenheimer Family Foundation for the Prevention of Eye Disease Endowment Fund; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported by NEI, National Institutes of Health grant 1R01EY024929 (to S. P. B.) and the Gerald Oppenheimer Family Foundation for the Prevention of Eye Disease Endowment Fund. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Alge CS, 2002, INVEST OPHTH VIS SCI, V43, P3575; An EY, 2008, MOL VIS, V14, P2292; Andley UP, 2007, PROG RETIN EYE RES, V26, P78, DOI 10.1016/j.preteyeres.2006.10.003; Baietti MF, 2012, NAT CELL BIOL, V14, P677, DOI 10.1038/ncb2502; Bhat SP, 2003, PROG DRUG RES, V60, P205; BHAT SP, 1989, BIOCHEM BIOPH RES CO, V158, P319, DOI 10.1016/S0006-291X(89)80215-3; Bhat Suraj P, 2011, Commun Integr Biol, V4, P739; BOK D, 1985, INVEST OPHTH VIS SCI, V26, P1659; Brady JP, 2001, INVEST OPHTH VIS SCI, V42, P2924; Brinton LT, 2015, CELL MOL LIFE SCI, V72, P659, DOI 10.1007/s00018-014-1764-3; Bsibsi M, 2014, ACTA NEUROPATHOL, V128, P215, DOI 10.1007/s00401-014-1317-8; Bucci C, 2000, MOL BIOL CELL, V11, P467, DOI 10.1091/mbc.11.2.467; Cobb BA, 2000, J BIOL CHEM, V275, P6664, DOI 10.1074/jbc.275.9.6664; D'Antonio M, 2006, GLIA, V53, P501, DOI 10.1002/glia.20309; De S, 2007, ARCH OPHTHALMOL-CHIC, V125, P641, DOI 10.1001/archopht.125.5.641; Duran JM, 2012, EMBO J, V31, P4535, DOI 10.1038/emboj.2012.317; FENG Y, 1995, J CELL BIOL, V131, P1435, DOI 10.1083/jcb.131.6.1435; Fuhrmann S, 2014, EXP EYE RES, V123, P141, DOI 10.1016/j.exer.2013.09.003; Gangalum RK, 2012, J BIOL CHEM, V287, P42407, DOI 10.1074/jbc.M112.414854; Gangalum RK, 2011, J BIOL CHEM, V286, P3261, DOI 10.1074/jbc.M110.160135; Gangalum RK, 2009, INVEST OPHTH VIS SCI, V50, P3283, DOI 10.1167/iovs.08-3052; Gangalum RK, 2004, J BIOL CHEM, V279, P43374, DOI 10.1074/jbc.C400371200; Hanson PI, 2012, ANNU REV CELL DEV BI, V28, P337, DOI 10.1146/annurev-cellbio-092910-154152; Horwitz J, 2000, SEMIN CELL DEV BIOL, V11, P53, DOI 10.1006/scdb.1999.0351; Hurley JH, 2012, NAT CELL BIOL, V14, P654, DOI 10.1038/ncb2530; Jing Z, 2013, CELL STRESS CHAPERON, V18, P377, DOI 10.1007/s12192-012-0386-7; Keller P, 1997, J CELL SCI, V110, P3001; KIBBELAAR MA, 1979, EXP EYE RES, V29, P679, DOI 10.1016/0014-4835(79)90024-1; Kobayashi T, 2000, MOL BIOL CELL, V11, P1829, DOI 10.1091/mbc.11.5.1829; KOK JW, 1990, EUR J CELL BIOL, V53, P173; Lobert VH, 2011, PHYSIOLOGY, V26, P171, DOI 10.1152/physiol.00054.2010; Manjithaya R, 2011, TRENDS CELL BIOL, V21, P67, DOI 10.1016/j.tcb.2010.09.009; Mathivanan S, 2009, PROTEOMICS, V9, P4997, DOI 10.1002/pmic.200900351; NAGINENI CN, 1989, FEBS LETT, V249, P89, DOI 10.1016/0014-5793(89)80022-5; Nickel W, 2005, TRAFFIC, V6, P607, DOI 10.1111/j.1600-0854.2005.00302.x; Perrett RM, 2015, MOL CELL NEUROSCI, V66, P21, DOI 10.1016/j.mcn.2015.02.009; Persson S, 2009, J NEUROSCI METH, V184, P42, DOI 10.1016/j.jneumeth.2009.07.017; Robinson DG, 2014, TRENDS PLANT SCI, V19, P134, DOI 10.1016/j.tplants.2013.10.008; Savina A, 2003, J BIOL CHEM, V278, P20083, DOI 10.1074/jbc.M301642200; Segev N, 2011, SEMIN CELL DEV BIOL, V22, P33, DOI 10.1016/j.semcdb.2010.11.005; Simons M, 2009, CURR OPIN CELL BIOL, V21, P575, DOI 10.1016/j.ceb.2009.03.007; Tagliaferro P, 2015, NEUROBIOL DIS, V82, P359, DOI 10.1016/j.nbd.2015.07.009; Villarroya-Beltri C, 2014, SEMIN CANCER BIOL, V28, P3, DOI 10.1016/j.semcancer.2014.04.009; Yang JM, 2013, BIOCHEM SOC T, V41, P277, DOI 10.1042/BST20120275; Zerial M, 2001, NAT REV MOL CELL BIO, V2, P107, DOI 10.1038/35052055; Zhang M, 2013, SCIENCE, V340, P559, DOI 10.1126/science.1234740; Zhu H, 2013, MOL BIOL CELL, V24, P1619, DOI 10.1091/mbc.E12-07-0544	47	26	31	0	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 17	2016	291	25					12930	12942		10.1074/jbc.M115.698530	http://dx.doi.org/10.1074/jbc.M115.698530			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DR2YT	27129211	Green Published, hybrid			2022-12-26	WOS:000379770500004
J	Zhao, D; Ma, G; Zhang, XL; He, Y; Li, M; Han, XY; Fu, LY; Dong, XY; Nagy, T; Zhao, Q; Fu, L; Dong, JT				Zhao, Dan; Ma, Gui; Zhang, Xiaolin; He, Yuan; Li, Mei; Han, Xueying; Fu, Liya; Dong, Xue-Yuan; Nagy, Tamas; Zhao, Qiang; Fu, Li; Dong, Jin-Tang			Zinc Finger Homeodomain Factor Zfhx3 Is Essential for Mammary Lactogenic Differentiation by Maintaining Prolactin Signaling Activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CASEIN GENE PROMOTER; BREAST-CANCER; GLAND DEVELOPMENT; EPITHELIAL-CELLS; HOMEOBOX GENES; RECEPTOR GENE; GROWTH-HORMONE; MESSENGER-RNA; UP-REGULATION; FACTOR ATBF1	The zinc finger homeobox 3 (ZFHX3, also named ATBF1 for AT motif binding factor 1) is a transcription factor that suppresses prostatic carcinogenesis and induces neuronal differentiation. It also interacts with estrogen receptor alpha to inhibit cell proliferation and regulate pubertal mammary gland development in mice. In the present study, we examined whether and how Zfhx3 regulates lactogenic differentiation in mouse mammary glands. At different stages of mammary gland development, Zfhx3 protein was expressed at varying levels, with the highest level at lactation. In the HC11 mouse mammary epithelial cell line, an in vitro model of lactogenesis, knockdown of Zfhx3 attenuated prolactin-induced beta-casein expression and morphological changes, indicators of lactogenic differentiation. In mouse mammary tissue, knock-out of Zfhx3 interrupted lactogenesis, resulting in underdeveloped glands with much smaller and fewer alveoli, reduced beta-casein expression, accumulation of large cytoplasmic lipid droplets in luminal cells after parturition, and failure in lactation. Mechanistically, Zfhx3 maintained the expression of Prlr (prolactin receptor) and Prlr-Jak2-Stat5 signaling activity, whereas knockdown and knock-out of Zfhx3 in HC11 cells and mammary tissues, respectively, decreased Prlr expression, Stat5 phosphorylation, and the expression of Prlr-Jak2-Stat5 target genes. These findings indicate that Zfhx3 plays an essential role in proper lactogenic development in mammary glands, at least in part by maintaining Prlr expression and Prlr-Jak2-Stat5 signaling activity.	[Zhao, Dan; Ma, Gui; Zhang, Xiaolin; He, Yuan; Han, Xueying; Fu, Liya; Zhao, Qiang; Dong, Jin-Tang] Nankai Univ, Dept Genet & Cell Biol, Coll Life Sci, Tianjin 300071, Peoples R China; [Li, Mei] Ningbo Inst Med Sci, Ningbo 315020, Zhejiang, Peoples R China; [Dong, Xue-Yuan; Dong, Jin-Tang] Emory Univ, Winship Canc Inst, Sch Med, Dept Hematol & Med Oncol, Atlanta, GA 30322 USA; [Nagy, Tamas] Univ Georgia, Coll Vet Med, Dept Pathol, Athens, GA 30602 USA; [Fu, Li] Tianjin Med Univ, Canc Hosp, Tianjin 300060, Peoples R China	Nankai University; Emory University; University System of Georgia; University of Georgia; Tianjin Medical University	Dong, JT (corresponding author), Nankai Univ, Dept Genet & Cell Biol, Coll Life Sci, Tianjin 300071, Peoples R China.; Dong, JT (corresponding author), Emory Univ, Winship Canc Inst, Sch Med, Dept Hematol & Med Oncol, Atlanta, GA 30322 USA.	j.dong@emory.edu	Zhao, Dan/Y-8065-2019	Zhao, Dan/0000-0002-5120-6725; Dong, Jin-Tang/0000-0003-2349-5782	National Natural Science Foundation of China [81472464]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by Grant 81472464 from the National Natural Science Foundation of China. The authors declare that they have no conflicts of interest with the contents of this article.	Abate-Shen C, 2002, NAT REV CANCER, V2, P777, DOI 10.1038/nrc907; Anderson SM, 2007, BREAST CANCER RES, V9, DOI 10.1186/bcr1653; BALL RK, 1988, EMBO J, V7, P2089, DOI 10.1002/j.1460-2075.1988.tb03048.x; Ben-Jonathan N, 2008, ENDOCR REV, V29, P1, DOI 10.1210/er.2007-0017; Berry FB, 2001, J BIOL CHEM, V276, P25057, DOI 10.1074/jbc.M010378200; Brisken C, 2002, J MAMMARY GLAND BIOL, V7, P39, DOI 10.1023/A:1015718406329; Brisken C, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a003178; Brisken C, 2006, J MAMMARY GLAND BIOL, V11, P239, DOI 10.1007/s10911-006-9026-0; Brooks CL, 2012, ENDOCR REV, V33, P504, DOI 10.1210/er.2011-1040; Casey TM, 2014, BIOL REPROD, V90, DOI 10.1095/biolreprod.113.116137; Cerami E, 2012, CANCER DISCOV, V2, P401, DOI 10.1158/2159-8290.CD-12-0095; Chakrabarti R, 2012, STEM CELLS, V30, P1496, DOI 10.1002/stem.1112; Chen HX, 2003, J MAMMARY GLAND BIOL, V8, P159, DOI 10.1023/A:1025996707117; Choi YS, 2009, DEV BIOL, V329, P227, DOI 10.1016/j.ydbio.2009.02.032; Dammeier J, 1998, J BIOL CHEM, V273, P18185, DOI 10.1074/jbc.273.29.18185; DANIELSON KG, 1984, P NATL ACAD SCI-BIOL, V81, P3756, DOI 10.1073/pnas.81.12.3756; Dong XY, 2011, J BIOL CHEM, V286, P13879, DOI 10.1074/jbc.M110.187849; Dong XY, 2010, J BIOL CHEM, V285, P32801, DOI 10.1074/jbc.M110.128330; DOPPLER W, 1989, P NATL ACAD SCI USA, V86, P104, DOI 10.1073/pnas.86.1.104; Duverger O, 2008, J CELL PHYSIOL, V216, P337, DOI 10.1002/jcp.21491; Feng F.-Y., 2011, ACTA AGR BOREALI SIN, V5; Galsgaard ED, 1999, J BIOL CHEM, V274, P18686, DOI 10.1074/jbc.274.26.18686; Gao JJ, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2004088; Grasso CS, 2012, NATURE, V487, P239, DOI 10.1038/nature11125; Hachim IY, 2016, APPL IMMUNOHISTO M M, V24, P238, DOI 10.1097/PAI.0000000000000178; Harris J, 2006, MOL ENDOCRINOL, V20, P1177, DOI 10.1210/me.2005-0473; Hennighausen L, 2001, DEV CELL, V1, P467, DOI 10.1016/S1534-5807(01)00064-8; Hennighausen L, 2005, NAT REV MOL CELL BIO, V6, P715, DOI 10.1038/nrm1714; Hesling C, 2013, DEVELOPMENT, V140, P167, DOI 10.1242/dev.085068; Holland PWH, 2007, BMC BIOL, V5, DOI 10.1186/1741-7007-5-47; Horseman ND, 1999, J MAMMARY GLAND BIOL, V4, P79, DOI 10.1023/A:1018708704335; Hu ZZ, 2002, ENDOCRINOLOGY, V143, P2139, DOI 10.1210/en.143.6.2139; Hynes NE, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a003186; Hynes NE, 1997, J MAMMARY GLAND BIOL, V2, P19, DOI 10.1023/A:1026317428542; Jung CG, 2005, DEVELOPMENT, V132, P5137, DOI 10.1242/dev.02098; Kataoka H, 2000, BIOCHEM BIOPH RES CO, V267, P91, DOI 10.1006/bbrc.1999.1911; Kavarthapu R, 2014, ONCOTARGET, V5, P9079, DOI 10.18632/oncotarget.2376; Kelly PA, 2002, MOL CELL ENDOCRINOL, V197, P127, DOI 10.1016/S0303-7207(02)00286-1; Kim NS, 2011, MOL CELL BIOL, V31, P4775, DOI 10.1128/MCB.05646-11; Kim NS, 2006, MOL CELL BIOL, V26, P1002, DOI 10.1128/MCB.26.3.1002-1013.2006; Kmiec M, 2006, J APPL GENET, V47, P139, DOI 10.1007/BF03194613; Lewis MT, 2000, BREAST CANCER RES, V2, P158, DOI 10.1186/bcr49; Li M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051283; Li M, 2013, BIOCHEM BIOPH RES CO, V430, P358, DOI 10.1016/j.bbrc.2012.11.009; Liu XW, 1997, GENE DEV, V11, P179, DOI 10.1101/gad.11.2.179; May M, 2016, EXP MOL PATHOL, V100, P39, DOI 10.1016/j.yexmp.2015.11.003; MEIER VS, 1994, MOL CELL BIOL, V14, P128, DOI 10.1128/MCB.14.1.128; Metz RP, 2006, DEV DYNAM, V235, P263, DOI 10.1002/dvdy.20605; MIURA Y, 1995, J BIOL CHEM, V270, P26840, DOI 10.1074/jbc.270.45.26840; Miyoshi K, 2001, J CELL BIOL, V155, P531, DOI 10.1083/jcb.200107065; Mori S, 2000, EMBO J, V19, P5772, DOI 10.1093/emboj/19.21.5772; MORINAGA T, 1991, MOL CELL BIOL, V11, P6041, DOI 10.1128/MCB.11.12.6041; Morrison B., 2009, JOVE-J VIS EXP, pe1265; Morrison BL, 2010, BMC CELL BIOL, V11, DOI 10.1186/1471-2121-11-35; Nevalainen MT, 2004, J CLIN ONCOL, V22, P2053, DOI 10.1200/JCO.2004.11.046; Nouhi Z, 2006, CANCER RES, V66, P1824, DOI 10.1158/0008-5472.CAN-05-2292; Oakes SR, 2008, GENE DEV, V22, P581, DOI 10.1101/gad.1614608; Pal R, 2009, BLOOD, V114, P3890, DOI 10.1182/blood-2009-01-201111; Parsons MJ, 2015, CELL, V162, P607, DOI 10.1016/j.cell.2015.06.060; Paten AM, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-1947-9; Peck AR, 2012, BREAST CANCER RES, V14, DOI 10.1186/bcr3328; Peck AR, 2011, J CLIN ONCOL, V29, P2448, DOI 10.1200/JCO.2010.30.3552; Peirce SK, 2001, J ENDOCRINOL, V171, pR1, DOI 10.1677/joe.0.171R001; Roylance R, 2006, ONCOGENE, V25, P6544, DOI 10.1038/sj.onc.1209659; Schennink A, 2015, J MOL ENDOCRINOL, V54, P1, DOI 10.1530/JME-14-0212; Silva CM, 2007, MOL ENDOCRINOL, V21, P1499, DOI 10.1210/me.2007-0109; Spandidos A, 2010, NUCLEIC ACIDS RES, V38, pD792, DOI 10.1093/nar/gkp1005; Stute P, 2012, BREAST CANCER RES TR, V133, P617, DOI 10.1007/s10549-011-1811-9; Sun XD, 2005, NAT GENET, V37, P407, DOI 10.1038/ng1528; Sun XD, 2015, J GENET GENOMICS, V42, P373, DOI 10.1016/j.jgg.2015.06.004; Sun XD, 2014, NEOPLASIA, V16, P377, DOI 10.1016/j.neo.2014.05.001; Sun XD, 2012, GENESIS, V50, P819, DOI 10.1002/dvg.22041; Tabata H, 2012, J MOL ENDOCRINOL, V48, P169, DOI 10.1530/JME-11-0122; Tempfli K, 2011, ACTA VET HUNG, V59, P269, DOI 10.1556/AVet.2011.012; Wang XingPing, 2008, Agricultural Sciences in China, V7, P1374, DOI 10.1016/S1671-2927(08)60187-X; Watson C J, 1996, Rev Reprod, V1, P1; Welch RP, 2014, NUCLEIC ACIDS RES, V42, DOI 10.1093/nar/gku463; Yamashita H, 2006, ENDOCR-RELAT CANCER, V13, P885, DOI 10.1677/erc.1.01095; Yan J, 2013, CELL, V154, P801, DOI 10.1016/j.cell.2013.07.034; YASUDA H, 1994, MOL CELL BIOL, V14, P1395, DOI 10.1128/MCB.14.2.1395; Zhang ZH, 2005, CLIN CANCER RES, V11, P193; Zhou J, 2005, EMBO J, V24, P635, DOI 10.1038/sj.emboj.7600538	82	17	19	2	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 10	2016	291	24					12809	12820		10.1074/jbc.M116.719377	http://dx.doi.org/10.1074/jbc.M116.719377			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DO9PV	27129249	Green Published, hybrid			2022-12-26	WOS:000378119900032
J	Shcherbatko, A; Foletti, D; Poulsen, K; Strop, P; Zhu, GY; Hasa-Moreno, A; Witt, JM; Loo, C; Krimm, S; Pios, A; Yu, J; Brown, C; Lee, JK; Stroud, R; Rajpal, A; Shelton, D				Shcherbatko, Anatoly; Foletti, Davide; Poulsen, Kris; Strop, Pavel; Zhu, Guoyun; Hasa-Moreno, Adela; Witt, Jody Melton; Loo, Carole; Krimm, Stellanie; Pios, Ariel; Yu, Jessica; Brown, Colleen; Lee, John K.; Stroud, Robert; Rajpal, Arvind; Shelton, David			Modulation of P2X3 and P2X2/3 Receptors by Monoclonal Antibodies	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ROOT GANGLION NEURONS; IONOTROPIC ATP RECEPTORS; RAT SENSORY NEURONS; P2X(3) RECEPTOR; PHARMACOLOGICAL-PROPERTIES; RHEUMATOID-ARTHRITIS; INFLAMMATORY PAIN; ION CHANNELS; ANTAGONIST; SUBUNIT	Purinergic homomeric P2X3 and heteromeric P2X2/3 receptors are ligand-gated cation channels activated by ATP. Both receptors are predominantly expressed in nociceptive sensory neurons, and an increase in extracellular ATP concentration under pathological conditions, such as tissue damage or visceral distension, induces channel opening, membrane depolarization, and initiation of pain signaling. Hence, these receptors are considered important therapeutic targets for pain management, and development of selective antagonists is currently progressing. To advance the search for novel analgesics, we have generated a panel of monoclonal antibodies directed against human P2X3 (hP2X3). We have found that these antibodies produce distinct functional effects, depending on the homomeric or heteromeric composition of the target, its kinetic state, and the duration of antibody exposure. The most potent antibody, 12D4, showed an estimated IC50 of 16 nM on hP2X3 after short term exposure (up to 18 min), binding to the inactivated state of the channel to inhibit activity. By contrast, with the same short term application, 12D4 potentiated the slow inactivating current mediated by the heteromeric hP2X2/3 channel. Extending the duration of exposure to similar to 20 h resulted in a profound inhibition of both homomeric hP2X3 and heteromeric hP2X2/3 receptors, an effect mediated by efficient antibody-induced internalization of the channel from the plasma membrane. The therapeutic potential of mAb12D4 was assessed in the formalin, complete Freund's adjuvant, and visceral pain models. The efficacy of 12D4 in the visceral hypersensitivity model indicates that antibodies against P2X3 may have therapeutic potential in visceral pain indications.	[Shcherbatko, Anatoly; Foletti, Davide; Poulsen, Kris; Strop, Pavel; Zhu, Guoyun; Hasa-Moreno, Adela; Witt, Jody Melton; Loo, Carole; Krimm, Stellanie; Pios, Ariel; Yu, Jessica; Brown, Colleen; Rajpal, Arvind; Shelton, David] Pfizer Inc, Rinat Labs, 230 E Grand Ave, San Francisco, CA 94080 USA; [Lee, John K.] Univ Minnesota, Dept Biochem Mol Biol & Biophys, Minneapolis, MN 55455 USA; [Stroud, Robert] Univ Calif San Francisco, Dept Biochem & Biophys, San Francisco, CA 94158 USA	Pfizer; University of Minnesota System; University of Minnesota Twin Cities; University of California System; University of California San Francisco	Shcherbatko, A (corresponding author), Pfizer Inc, Rinat Labs, 230 E Grand Ave, San Francisco, CA 94080 USA.	anatoly.shcherbatko@pfizer.com						Abdulqawi R, 2015, LANCET, V385, P1198, DOI 10.1016/S0140-6736(14)61255-1; Baqi Y, 2011, J MED CHEM, V54, P817, DOI 10.1021/jm1012193; Barclay J, 2002, J NEUROSCI, V22, P8139; Brass D, 2012, PURINERG SIGNAL, V8, pS61, DOI 10.1007/s11302-011-9278-z; Buell G, 1998, BLOOD, V92, P3521, DOI 10.1182/blood.V92.10.3521.422k50_3521_3528; Burgard EC, 1999, J NEUROPHYSIOL, V82, P1590, DOI 10.1152/jn.1999.82.3.1590; Burnstock G, 2011, ADV PHARMACOL, V61, P333, DOI 10.1016/B978-0-12-385526-8.00011-4; Burnstock G, 2004, INT REV CYTOL, V240, P31, DOI 10.1016/S0074-7696(04)40002-3; Burnstock G, 2014, EXP PHYSIOL, V99, P16, DOI 10.1113/expphysiol.2013.071951; Burnstock G, 2013, EUR J PHARMACOL, V716, P24, DOI 10.1016/j.ejphar.2013.01.078; CHEN CC, 1995, NATURE, V377, P428, DOI 10.1038/377428a0; Chen XQ, 2014, J MOL CELL BIOL, V6, P140, DOI 10.1093/jmcb/mju011; Collo G, 1996, J NEUROSCI, V16, P2495; De Roo M, 2003, J PHYSIOL-LONDON, V552, P59, DOI 10.1113/jphysiol.2003.046078; De Roo M, 2010, NEUROPHARMACOLOGY, V58, P569, DOI 10.1016/j.neuropharm.2009.12.002; Evans RJ, 1996, SEMIN NEUROSCI, V8, P217, DOI 10.1006/smns.1996.0028; Fabbretti E, 2006, J NEUROSCI, V26, P6163, DOI 10.1523/JNEUROSCI.0647-06.2006; Ford AP, 2013, FRONT CELL NEUROSCI, V7, DOI 10.3389/fncel.2013.00267; Ford AP, 2012, PURINERG SIGNAL, V8, pS3, DOI 10.1007/s11302-011-9271-6; GarciaGuzman M, 1997, MOL BRAIN RES, V47, P59, DOI 10.1016/S0169-328X(97)00036-3; Gever JR, 2010, BRIT J PHARMACOL, V160, P1387, DOI 10.1111/j.1476-5381.2010.00796.x; Golay J, 2012, ARCH BIOCHEM BIOPHYS, V526, P146, DOI 10.1016/j.abb.2012.02.011; Gonzales EB, 2009, NATURE, V460, P599, DOI 10.1038/nature08218; Goswami S, 2013, ANTIBODIES, V2, P452, DOI 10.3390/antib2030452; Grishin EV, 2010, ANN NEUROL, V67, P680, DOI 10.1002/ana.21949; Grubb BD, 1999, EUR J NEUROSCI, V11, P149, DOI 10.1046/j.1460-9568.1999.00426.x; Gum RJ, 2012, PURINERG SIGNAL, V8, pS41, DOI 10.1007/s11302-011-9272-5; Gunosewoyo H, 2010, EXPERT OPIN THER PAT, V20, P625, DOI 10.1517/13543771003702424; HARGREAVES K, 1988, PAIN, V32, P77, DOI 10.1016/0304-3959(88)90026-7; Hattori M, 2012, NATURE, V485, P207, DOI 10.1038/nature11010; Jarvis MF, 2002, P NATL ACAD SCI USA, V99, P17179, DOI 10.1073/pnas.252537299; Jarvis MF, 2009, NEUROPHARMACOLOGY, V56, P208, DOI 10.1016/j.neuropharm.2008.06.067; Jiang LH, 2003, J NEUROSCI, V23, P8903; Kaan TKY, 2010, BRAIN, V133, P2549, DOI 10.1093/brain/awq194; Kawate T, 2009, NATURE, V460, P592, DOI 10.1038/nature08198; Keystone EC, 2012, ANN RHEUM DIS, V71, P1630, DOI 10.1136/annrheumdis-2011-143578; Kobayashi K, 2005, J COMP NEUROL, V481, P377, DOI 10.1002/cne.20393; LEWIS C, 1995, NATURE, V377, P432, DOI 10.1038/377432a0; Lu Shing-Hwa, 2007, J Chin Med Assoc, V70, P439, DOI 10.1016/S1726-4901(08)70035-2; McGaraughty S, 2003, BRIT J PHARMACOL, V140, P1381, DOI 10.1038/sj.bjp.0705574; North RA, 1996, SEMIN NEUROSCI, V8, P187; Ohashi K, 2008, PHARMACOLOGY, V81, P144, DOI 10.1159/000110737; Paukert M, 2001, J BIOL CHEM, V276, P21077, DOI 10.1074/jbc.M101465200; Petruska JC, 2000, NEUROREPORT, V11, P3589, DOI 10.1097/00001756-200011090-00037; PONTEN J, 1968, ACTA PATHOL MIC SC, V74, P465; Pratt EB, 2005, J NEUROSCI, V25, P7359, DOI 10.1523/JNEUROSCI.5189-04.2005; Rae MG, 1998, BRIT J PHARMACOL, V124, P176, DOI 10.1038/sj.bjp.0701803; Reeves PJ, 2002, P NATL ACAD SCI USA, V99, P13419, DOI 10.1073/pnas.212519299; Robinson LE, 2013, FRONT CELL NEUROSCI, V7, DOI 10.3389/fncel.2013.00233; Shields SD, 2010, PAIN, V151, P422, DOI 10.1016/j.pain.2010.08.001; Stock TC, 2012, J RHEUMATOL, V39, P720, DOI 10.3899/jrheum.110874; Ueno S, 1999, BRIT J PHARMACOL, V126, P429, DOI 10.1038/sj.bjp.0702319; Vacca F, 2009, J NEUROCHEM, V109, P1031, DOI 10.1111/j.1471-4159.2009.06029.x; Wesselmann U, 1998, NEUROSCI LETT, V246, P73, DOI 10.1016/S0304-3940(98)00234-1; Wirkner K, 2007, MOL NEUROBIOL, V36, P165, DOI 10.1007/s12035-007-0033-y; Ye Y, 2014, ACTA NEUROPATHOL COM, V2, DOI 10.1186/2051-5960-2-62	56	18	18	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 3	2016	291	23					12254	12270		10.1074/jbc.M116.722330	http://dx.doi.org/10.1074/jbc.M116.722330			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DO9GJ	27129281	Green Published, hybrid			2022-12-26	WOS:000378092800026
J	Wu, Y; Lan, C; Ren, DR; Chen, GY				Wu, Yin; Lan, Chao; Ren, Dongren; Chen, Guo-Yun			Induction of Siglec-1 by Endotoxin Tolerance Suppresses the Innate Immune Response by Promoting TGF-beta 1 Production	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PHOSPHOTYROSINE-BINDING DOMAIN; SYK TYROSINE KINASE; REGULATORY T-CELLS; DENDRITIC CELLS; ADAPTIVE IMMUNITY; UBIQUITIN LIGASES; MARGINAL ZONE; UP-REGULATION; HUMAN SEPSIS; CBL-FAMILY	Sepsis is one of the leading causes of death worldwide. Although the prevailing theory for the sepsis syndrome is a condition of uncontrolled inflammation in response to infection, sepsis is increasingly being recognized as an immunosuppressive state known as endotoxin tolerance. We found sialylation of cell surface was significantly increased on LPS-induced tolerant cells; knockdown of Neu1 in macrophage cell line RAW 264.7 cells resulted in enhanced LPS-induced tolerance, whereas overexpression of Neu1 or treatment with sialidase abrogated LPS-induced tolerance, as defined by measuring TNF-alpha levels in the culture supernatants. Wealso found that the expression of Siglec-1 (a member of sialic acid-binding Ig (I)like lectin family members, the predominant sialic acid-binding proteins on cell surface) was specifically up-regulated in endotoxin tolerant cells and the induction of Siglec-1 suppresses the innate immune response by promoting TGF-beta 1 production. The enhanced TGF-beta 1 production by Siglec-1 was significantly attenuated by spleen tyrosine kinase (Syk) inhibitor. Knockdown of siglec-1 inRAW264.7 cells resulted in inhibiting the production of TGF-beta 1 by ubiquitin-dependent degradation of Syk. Mechanistically, Siglec-1 associates with adaptor protein DNAX-activation protein of 12k Da(DAP12) and transduces a signal to Syk to control the production of TGF-beta 1 in endotoxin tolerance. Thus, Siglec-1 plays an important role in the development of endotoxin tolerance and targeted manipulation of this process could lead to a new therapeutic opportunity for patients with sepsis.	[Wu, Yin; Lan, Chao; Ren, Dongren; Chen, Guo-Yun] Univ Tennessee, Hlth Sci Ctr, Dept Pediat, Childrens Fdn Res Inst, Memphis, TN 38103 USA	University of Tennessee System; University of Tennessee Health Science Center	Chen, GY (corresponding author), Univ Tennessee, Hlth Sci Ctr, Dept Pediat, Childrens Fdn Res Inst, Memphis, TN 38103 USA.	Gchen14@uthsc.edu			National Institutes of Health [AI105727]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI105727] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This study was supported by Grant AI105727 from the National Institutes of Health. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Beutler B, 2004, IMMUNITY, V21, P134, DOI 10.1016/j.immuni.2004.07.014; Bokers S, 2014, J IMMUNOL, V192, P2994, DOI 10.4049/jimmunol.1303367; Brennan PJ, 2006, INT IMMUNOL, V18, P627, DOI 10.1093/intimm/dxh344; Changsirivathanathamrong D, 2011, CRIT CARE MED, V39, P2678, DOI 10.1097/CCM.0b013e31822827f2; Chen GY, 2014, ELIFE, V3, DOI 10.7554/eLife.04066; Chen GY, 2014, GLYCOBIOLOGY, V24, P800, DOI 10.1093/glycob/cwu068; Chen GY, 2011, NAT BIOTECHNOL, V29, P428, DOI 10.1038/nbt.1846; Chen GY, 2009, SCIENCE, V323, P1722, DOI 10.1126/science.1168988; Crocker PR, 2002, CURR OPIN STRUC BIOL, V12, P609, DOI 10.1016/S0959-440X(02)00375-5; Crocker PR, 2001, IMMUNOLOGY, V103, P137, DOI 10.1046/j.0019-2805.2001.01241.x; Crocker PR, 2001, TRENDS IMMUNOL, V22, P337, DOI 10.1016/S1471-4906(01)01930-5; Draisma A, 2009, CRIT CARE MED, V37, P1261, DOI 10.1097/CCM.0b013e31819c3c67; Fan HK, 2004, J ENDOTOXIN RES, V10, P71, DOI 10.1179/096805104225003997; FINK MP, 1990, J SURG RES, V49, P186, DOI 10.1016/0022-4804(90)90260-9; Geahlen RL, 2014, TRENDS PHARMACOL SCI, V35, P414, DOI 10.1016/j.tips.2014.05.007; Glavey SV, 2014, BLOOD, V124, P1765, DOI 10.1182/blood-2014-03-560862; Hall Margaret Jean, 2011, NCHS Data Brief, P1; Heikema AP, 2010, INFECT IMMUN, V78, P3237, DOI 10.1128/IAI.01273-09; Humphrey MB, 2005, IMMUNOL REV, V208, P50, DOI 10.1111/j.0105-2896.2005.00325.x; Jenner J, 2006, EXP HEMATOL, V34, P1212, DOI 10.1016/j.exphem.2006.04.016; Jia Y, 2015, J ALLERGY CLIN IMMUN, V135, P799, DOI 10.1016/j.jaci.2015.01.004; Jones C, 2003, MOL MICROBIOL, V49, P1213, DOI 10.1046/j.1365-2958.2003.03634.x; Lanier LL, 2009, IMMUNOL REV, V227, P150, DOI 10.1111/j.1600-065X.2008.00720.x; Lupher ML, 1998, J BIOL CHEM, V273, P35273, DOI 10.1074/jbc.273.52.35273; Macauley MS, 2014, NAT REV IMMUNOL, V14, P653, DOI 10.1038/nri3737; Martinez-Pomares L, 2012, TRENDS IMMUNOL, V33, P66, DOI 10.1016/j.it.2011.11.001; McGaha TL, 2011, BLOOD, V117, P5403, DOI 10.1182/blood-2010-11-320028; Meesmann HM, 2010, J CELL SCI, V123, P3347, DOI 10.1242/jcs.066696; Miyagi T, 2012, GLYCOBIOLOGY, V22, P880, DOI 10.1093/glycob/cws057; Miyake Y, 2007, J CLIN INVEST, V117, P2268, DOI 10.1172/JCI31990; Mocsai A, 2010, NAT REV IMMUNOL, V10, P387, DOI 10.1038/nri2765; Mohapatra B, 2013, BBA-MOL CELL RES, V1833, P122, DOI 10.1016/j.bbamcr.2012.10.010; Monteiro VG, 2005, PARASITOL RES, V97, P380, DOI 10.1007/s00436-005-1460-1; Morelli AE, 2007, NAT REV IMMUNOL, V7, P610, DOI 10.1038/nri2132; Nahid MA, 2011, CELL MOL IMMUNOL, V8, P388, DOI 10.1038/cmi.2011.26; Otto GP, 2011, CRIT CARE, V15, DOI 10.1186/cc10332; PILATTE Y, 1990, AM J MED, V88, P486, DOI 10.1016/0002-9343(90)90427-F; Pillai S, 2012, ANNU REV IMMUNOL, V30, P357, DOI 10.1146/annurev-immunol-020711-075018; RANDOW F, 1995, J EXP MED, V181, P1887, DOI 10.1084/jem.181.5.1887; Rao N, 2002, J LEUKOCYTE BIOL, V71, P753; Rittirsch D, 2007, J LEUKOCYTE BIOL, V81, P137, DOI 10.1189/jlb.0806542; ROGENTINE GN, 1974, J IMMUNOL, V113, P848; Sly LM, 2004, IMMUNITY, V21, P227, DOI 10.1016/j.immuni.2004.07.010; SPRINGER GF, 1984, SCIENCE, V224, P1198, DOI 10.1126/science.6729450; Sundar KM, 2013, INDIAN J CRIT CARE M, V17, P162, DOI 10.4103/0972-5229.117054; Takamiya R, 2013, GLYCOBIOLOGY, V23, P178, DOI 10.1093/glycob/cws139; Tateno H, 2007, MOL CELL BIOL, V27, P5699, DOI 10.1128/MCB.00383-07; VAITH P, 1978, Z IMMUNITATSFORSCH, V154, P1; Vanderheijden N, 2003, J VIROL, V77, P8207, DOI 10.1128/JVI.77.15.8207-8215.2003; Volk HD, 1996, INTENS CARE MED, V22, pS474, DOI 10.1007/BF01743727; von Gunten S, 2007, J ALLERGY CLIN IMMUN, V119, P1005, DOI 10.1016/j.jaci.2007.01.023; Wang TS, 2008, J MOL MED, V86, P495, DOI 10.1007/s00109-007-0300-4; West MA, 2008, J TRAUMA, V65, P893, DOI 10.1097/TA.0b013e3181877fde; Wood KA, 2004, PHARMACOECONOMICS, V22, P895, DOI 10.2165/00019053-200422140-00001; Wu C, 2009, J IMMUNOL, V182, P6508, DOI 10.4049/jimmunol.0804247; Yang WS, 2012, EXP CELL RES, V318, P1867, DOI 10.1016/j.yexcr.2012.05.016; Yankee TM, 1999, J IMMUNOL, V163, P5827; Yu XW, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5136; Zheng QL, 2015, CELL RES, V25, P1121, DOI 10.1038/cr.2015.108	59	27	29	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 3	2016	291	23					12370	12382		10.1074/jbc.M116.721258	http://dx.doi.org/10.1074/jbc.M116.721258			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DO9GJ	27129263	Green Published, hybrid			2022-12-26	WOS:000378092800035
J	Oh, CS; Sippy, J; Charbonneau, B; Hutchinson, JC; Mejia-Romero, OE; Barton, M; Patel, P; Sippy, R; Feiss, M				Oh, Choon Seok; Sippy, Jean; Charbonneau, Bridget; Hutchinson, Jennifer Crow; Mejia-Romero, Olga Esther; Barton, Michael; Patel, Priyal; Sippy, Rachel; Feiss, Michael			DNA Topology and the Initiation of Virus DNA Packaging	PLOS ONE			English	Article							BACTERIOPHAGE-LAMBDA DNA; INTEGRATION HOST FACTOR; COHESIVE END SITE; BINDING-SITE; VIRAL-DNA; CRYSTAL-STRUCTURE; TERMINASE ENZYME; GENETIC-ANALYSIS; PROHEAD BINDING; SMALL-SUBUNIT	During progeny assembly, viruses selectively package virion genomes from a nucleic acid pool that includes host nucleic acids. For large dsDNA viruses, including tailed bacteriophages and herpesviruses, immature viral DNA is recognized and translocated into a preformed icosahedral shell, the prohead. Recognition involves specific interactions between the viral packaging enzyme, terminase, and viral DNA recognition sites. Generally, viral DNA is recognized by terminase's small subunit (TerS). The large terminase subunit (TerL) contains translocation ATPase and endonuclease domains. In phage lambda, TerS binds a sequence repeated three times in cosB, the recognition site. TerS binding to cosB positions TerL to cut the concatemeric DNA at the adjacent nicking site, cosN. TerL introduces staggered nicks in cosN, generating twelve bp cohesive ends. Terminase separates the cohesive ends and remains bound to the cosB-containing end, in a nucleoprotein structure called Complex I. Complex I docks on the prohead's portal vertex and translocation ensues. DNA topology plays a role in the TerS(lambda)-cosB(lambda) interaction. Here we show that a site, I2, located between cosN and cosB, is critically important for an early DNA packaging step. I2 contains a complex static bend. I2 mutations block DNA packaging. I2 mutant DNA is cut by terminase at cosN in vitro, but in vivo, no cos cleavage is detected, nor is there evidence for Complex I. Models for what packaging step might be blocked by I2 mutations are presented.	[Oh, Choon Seok; Sippy, Jean; Charbonneau, Bridget; Hutchinson, Jennifer Crow; Mejia-Romero, Olga Esther; Barton, Michael; Patel, Priyal; Sippy, Rachel; Feiss, Michael] Univ Iowa, Dept Microbiol, Iowa City, IA 52242 USA; [Patel, Priyal] Univ Iowa Hosp & Clin, Dept Pathol, Iowa City, IA 52242 USA; [Sippy, Rachel] Univ Wisconsin, Dept Populat Hlth Sci, Madison, WI USA	University of Iowa; University of Iowa; University of Wisconsin System; University of Wisconsin Madison	Sippy, J (corresponding author), Univ Iowa, Dept Microbiol, Iowa City, IA 52242 USA.	jean-sippy@uiowa.edu		Sippy, Rachel/0000-0003-3617-2093	National Science Foundation [MCB-0717620, MCB-1158495]; National Institutes of Health, United States [5R01GM088186, 5R01GM051611]; University of Iowa Department of Microbiology; National Center for Complementary & Integrative Health [T32AT006956] Funding Source: NIH RePORTER	National Science Foundation(National Science Foundation (NSF)); National Institutes of Health, United States(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Iowa Department of Microbiology; National Center for Complementary & Integrative Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by funding from National Science Foundation, awards MCB-0717620 and MCB-1158495; the National Institutes of Health, United States, awards 5R01GM088186 and 5R01GM051611 (www.nih.gov); and the University of Iowa Department of Microbiology. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arber W., 1983, LAMBDA, P433; BEAR SE, 1984, J VIROL, V52, P966, DOI 10.1128/JVI.52.3.966-972.1984; Black LW, 2015, VIROLOGY; Buttner CR, 2012, P NATL ACAD SCI USA, V109, P811, DOI 10.1073/pnas.1110270109; Cao S, 2014, J VIROL, V88, P3986, DOI 10.1128/JVI.03203-13; CASJENS S, 1988, J MOL BIOL, V199, P467, DOI 10.1016/0022-2836(88)90618-3; Casjens SR, 2011, NAT REV MICROBIOL, V9, P647, DOI 10.1038/nrmicro2632; Catalano C.E., 2005, VIRAL GENOME PACKAGI; CATALANO CE, 1995, MOL MICROBIOL, V16, P1075, DOI 10.1111/j.1365-2958.1995.tb02333.x; CHAI SH, 1995, J MOL BIOL, V252, P386, DOI 10.1006/jmbi.1995.0505; CUE D, 1993, P NATL ACAD SCI USA, V90, P9290, DOI 10.1073/pnas.90.20.9290; Cue D, 2001, J MOL BIOL, V311, P233, DOI 10.1006/jmbi.2001.4840; Cue D, 1998, J MOL BIOL, V280, P11, DOI 10.1006/jmbi.1998.1841; CUE D, 1992, J MOL BIOL, V228, P58, DOI 10.1016/0022-2836(92)90491-2; CUE D, 1993, J MOL BIOL, V234, P594, DOI 10.1006/jmbi.1993.1614; DAVIDSON A, 1987, VIROLOGY, V161, P305, DOI 10.1016/0042-6822(87)90122-X; de Beer T, 2002, MOL CELL, V9, P981, DOI 10.1016/S1097-2765(02)00537-3; DOKLAND T, 1993, J MOL BIOL, V233, P682, DOI 10.1006/jmbi.1993.1545; FEISS M, 1983, P NATL ACAD SCI-BIOL, V80, P955, DOI 10.1073/pnas.80.4.955; Feiss M, 2015, VIROLOGY, V482, P260, DOI 10.1016/j.virol.2015.03.027; Feiss Michael, 2005, P5; FRACKMAN S, 1984, J MOL BIOL, V180, P283, DOI 10.1016/S0022-2836(84)80005-4; FRACKMAN S, 1985, J MOL BIOL, V183, P225, DOI 10.1016/0022-2836(85)90215-3; FRIEDMAN DI, 1988, CELL, V55, P545, DOI 10.1016/0092-8674(88)90213-9; Fuller DN, 2007, J MOL BIOL, V373, P1113, DOI 10.1016/j.jmb.2007.09.011; Furth M., 1983, LAMBDA 2, P145; Georgopoulos C., 1983, LAMBDA 2, P279; Goldberg A R, 1969, Virology, V38, P200, DOI 10.1016/0042-6822(69)90148-2; Greive SJ, 2016, NUCLEIC ACIDS RES, V44, P776, DOI 10.1093/nar/gkv1467; HAGERMAN PJ, 1986, NATURE, V321, P449, DOI 10.1038/321449a0; Hang JQ, 2000, J MOL BIOL, V302, P777, DOI 10.1006/jmbi.2000.4086; Hang JQ, 2001, BIOCHEMISTRY-US, V40, P13370, DOI 10.1021/bi011126r; HIGGINS RR, 1994, EMBO J, V13, P6162, DOI 10.1002/j.1460-2075.1994.tb06963.x; KIM J, 1989, GENE, V85, P15, DOI 10.1016/0378-1119(89)90459-9; KOO HS, 1990, BIOCHEMISTRY-US, V29, P4227, DOI 10.1021/bi00469a027; KOSTURKO LD, 1989, NUCLEIC ACIDS RES, V17, P317, DOI 10.1093/nar/17.1.317; Leavitt JC, 2013, VIROLOGY, V440, P117, DOI 10.1016/j.virol.2013.02.023; Lee KK, 2008, STRUCTURE, V16, P1491, DOI 10.1016/j.str.2008.06.014; Maluf NK, 2006, BIOCHEMISTRY-US, V45, P15259, DOI 10.1021/bi0615036; Maluf NK, 2005, J MOL BIOL, V347, P523, DOI 10.1016/j.jmb.2005.01.016; Maniatis T., 1982, MOL CLONING; MILLER G, 1988, MOL GEN GENET, V212, P157, DOI 10.1007/BF00322459; Morais MC, 2008, STRUCTURE, V16, P1267, DOI 10.1016/j.str.2008.05.010; MURIALDO H, 1987, GENETICS, V115, P3; Murialdo H, 1997, MOL MICROBIOL, V24, P341, DOI 10.1046/j.1365-2958.1997.3321698.x; MURIALDO H, 1981, J MOL BIOL, V145, P375, DOI 10.1016/0022-2836(81)90211-4; Murialdo H, 1997, MOL MICROBIOL, V24, P937, DOI 10.1046/j.1365-2958.1997.4011769.x; Oliveira L, 2013, VIRUS RES, V173, P247, DOI 10.1016/j.virusres.2013.01.021; Ortega ME, 2006, BIOCHEMISTRY-US, V45, P5180, DOI 10.1021/bi052284b; PAL SK, 1988, J BACTERIOL, V172, P2819; PEDEN KWC, 1982, P NATL ACAD SCI-BIOL, V79, P7214, DOI 10.1073/pnas.79.23.7214; Peters JP, 2010, Q REV BIOPHYS, V43, P23, DOI 10.1017/S0033583510000077; Popovic A, 2012, J BIOL CHEM, V287, P32085, DOI 10.1074/jbc.M112.378349; Rao VB, 2015, ANNU REV VIROL, V2, P351, DOI 10.1146/annurev-virology-100114-055212; Rice PA, 1996, CELL, V87, P1295, DOI 10.1016/S0092-8674(00)81824-3; Roy A, 2012, STRUCTURE, V20, P1403, DOI 10.1016/j.str.2012.05.014; SHINDER G, 1988, J VIROL, V62, P387, DOI 10.1128/JVI.62.2.387-392.1988; SIPPY J, 1992, J BACTERIOL, V174, P850, DOI 10.1128/jb.174.3.850-856.1992; SIX EW, 1973, VIROLOGY, V51, P327, DOI 10.1016/0042-6822(73)90432-7; STERNBERG N, 1983, J BACTERIOL, V153, P800, DOI 10.1128/JB.153.2.800-812.1983; Sun S, 2012, P NATL ACAD SCI USA, V109, P817, DOI 10.1073/pnas.1110224109; Sun S, 2008, CELL, V135, P1251, DOI 10.1016/j.cell.2008.11.015; Tavares P, 1996, J MOL BIOL, V264, P954, DOI 10.1006/jmbi.1996.0689; TOMKA MA, 1993, J BIOL CHEM, V268, P3056; XIN W, 1993, J MOL BIOL, V230, P505, DOI 10.1006/jmbi.1993.1167; XIN W, 1993, J MOL BIOL, V230, P492, DOI 10.1006/jmbi.1993.1166; XU SY, 1991, J MOL BIOL, V220, P281, DOI 10.1016/0022-2836(91)90013-V; Yang TC, 2015, BIOPHYS J, V109, P1663, DOI 10.1016/j.bpj.2015.08.037; YEO A, 1995, J MOL BIOL, V245, P126; YEO A, 1990, VIROLOGY, V174, P329, DOI 10.1016/0042-6822(90)90085-6; YEO A, 1995, J MOL BIOL, V245, P141, DOI 10.1006/jmbi.1994.0013; Zhao HY, 2012, J MOL BIOL, V423, P413, DOI 10.1016/j.jmb.2012.07.016; Zhao HY, 2010, P NATL ACAD SCI USA, V107, P1971, DOI 10.1073/pnas.0908569107; Zwieb C, 1994, Methods Mol Biol, V30, P281	74	1	1	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 4	2016	11	5							e0154785	10.1371/journal.pone.0154785	http://dx.doi.org/10.1371/journal.pone.0154785			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DL5KR	27144448	gold, Green Published			2022-12-26	WOS:000375676400070
J	Yperzeele, L; van Hooff, RJ; De Smedt, A; Nagels, G; Hubloue, I; De Keyser, J; Brouns, R				Yperzeele, Laetitia; van Hooff, Robbert-Jan; De Smedt, Ann; Nagels, Guy; Hubloue, Ives; De Keyser, Jacques; Brouns, Raf			Feasibility, Reliability and Predictive Value Of In-Ambulance Heart Rate Variability Registration	PLOS ONE			English	Article							CARDIAC AUTONOMIC DERANGEMENT; LIFESAVING INTERVENTIONS; PERIOD VARIABILITY; TRAUMA PATIENTS; STROKE; COMPLEXITY; MORTALITY; ARRHYTHMIAS	Background Heart rate variability (HRV) is a parameter of autonomic nervous system function. A decrease of HRV has been associated with disease severity, risk of complications and prognosis in several conditions. Objective We aim to investigate the feasibility and the reliability of in-ambulance HRV registration during emergency interventions, and to evaluate the association between prehospital HRV parameters, patient characteristics, vital parameters and short-term outcome. Methods We conducted a prospective study using a non-invasive 2-lead ECG registration device in 55 patients transported by the paramedic intervention team of the Universitair Ziekenhuis Brussel. HRV assessment included time domain parameters, frequency domain parameters, nonlinear analysis, and time-frequency analysis. The correlation between HRV parameters and patient and outcome characteristics was analyzed and compared to controls. Results Artifact and ectopic detection rates were higher in patients during ambulance transportation compared to controls in resting conditions, yet technical reasons precluding in-ambulance HRV analysis occurred in only 9.6% of cases. HRV acquisition was possible without safety issues or interference with routine emergency care. Reliability of the results was considered sufficient for Sample entropy (SampEn), good for the ratio of low frequency and high frequency components (LF/HF ratio) in the frequency and the time frequency domain, and excellent for the triangular interpolation of the NN interval histogram (TINN), and for the short-term scaling exponent of the detrended fluctuation analysis (DFA alpha 1). HRV indices were significantly reduced inpatients with unfavorable outcome compared to patients with favorable outcome and controls. Multivariate analysis identified lower DFA alpha 1 as an independent predictor of unfavorable outcome (OR, 0.155; 95% CI 0.024-0.966; p = 0.049). Conclusion In-ambulance HRV registration is technically and operationally feasible and produces reliable results for parameters in the time, frequency, nonlinear and time frequency domain. Especially non-linear HRV analysis during emergency ambulance transportation may be a promising approach to predict patient outcome.	[Yperzeele, Laetitia] Univ Ziekenhuis Antwerpen, Dept Neurol, Edegem, Belgium; [Yperzeele, Laetitia; van Hooff, Robbert-Jan; De Smedt, Ann; Nagels, Guy; De Keyser, Jacques; Brouns, Raf] Vrije Univ Brussel, Ctr Neurosci C4N, Brussels, Belgium; [van Hooff, Robbert-Jan; De Smedt, Ann; Nagels, Guy; De Keyser, Jacques; Brouns, Raf] Univ Ziekenhuis Brussel, Dept Neurol, Brussels, Belgium; [Nagels, Guy] Natl MS Ctr, Melsbroek, Belgium; [Hubloue, Ives] Univ Ziekenhuis Brussel, Dept Emergency Med, Brussels, Belgium; [Hubloue, Ives] Vrije Univ Brussel, Res Grp Emergency & Disaster Med Brussels, Brussels, Belgium; [De Keyser, Jacques] Univ Groningen, Univ Med Ctr Groningen, Dept Neurol, Groningen, Netherlands	University of Antwerp; Vrije Universiteit Brussel; University Hospital Brussels; Vrije Universiteit Brussel; University Hospital Brussels; Vrije Universiteit Brussel; Vrije Universiteit Brussel; University of Groningen	Yperzeele, L (corresponding author), Univ Ziekenhuis Antwerpen, Dept Neurol, Edegem, Belgium.; Yperzeele, L (corresponding author), Vrije Univ Brussel, Ctr Neurosci C4N, Brussels, Belgium.	laetitia.yperzeele@uza.be	Hubloue, Ives/GYR-0901-2022; De Keyser, Jacques/AAA-8721-2021; De Keyser, Jacques/D-3725-2013; Van+Hooff, Robbert-Jan/AAG-5136-2019; Yperzeele, Laetitia/AAQ-7742-2020; Brouns, Raf/E-1044-2013	De Keyser, Jacques/0000-0002-3394-7757; De Keyser, Jacques/0000-0002-3394-7757; Van+Hooff, Robbert-Jan/0000-0003-2712-2772; Yperzeele, Laetitia/0000-0002-5503-5724; Brouns, Raf/0000-0001-6540-5699; De Smedt, Ann/0000-0003-0252-0600; Nagels, Guy/0000-0002-2597-0383				Acharya UR, 2004, BIOMED ENG ONLINE, V3, DOI 10.1186/1475-925X-3-24; Albentosa Marina, 1994, Aquaculture, V126, P315; Batchinsky AL, 2007, J TRAUMA, V63, P512, DOI 10.1097/TA.0b013e318142d2f0; Batchinsky AI, 2007, CRIT CARE MED, V35, P519, DOI 10.1097/01.CCM.0000254065.44990.77; BLAND JM, 1986, LANCET, V1, P307, DOI 10.1016/s0140-6736(86)90837-8; Cancio LC, 2008, J TRAUMA, V65, P813, DOI 10.1097/TA.0b013e3181848241; Chen PL, 2012, J NEUROL SCI, V314, P57, DOI 10.1016/j.jns.2011.10.034; Chen WL, 2009, RESUSCITATION, V80, P1114, DOI 10.1016/j.resuscitation.2009.06.020; Colivicchi F, 2005, STROKE, V36, P1710, DOI 10.1161/01.STR.0000173400.19346.bd; Colivicchi F, 2004, STROKE, V35, P2094, DOI 10.1161/01.STR.0000138452.81003.4c; Cooke WH, 2006, J TRAUMA, V60, P363, DOI 10.1097/01.ta.0000196623.48952.0e; Cooke WH, 2006, AVIAT SPACE ENVIR MD, V77, P1107; Graff B, 2013, J HYPERTENS, V31, P1629, DOI 10.1097/HJH.0b013e328361e48b; Gujjar AR, 2004, NEUROCRIT CARE, V1, P347, DOI 10.1385/NCC:1:3:347; Heikkinen O, DEV VALIDATION UNPUB; Hilz MJ, 2011, STROKE, V42, P1528, DOI 10.1161/STROKEAHA.110.607721; King DR, 2009, J TRAUMA, V67, P436, DOI 10.1097/TA.0b013e3181ad67de; Ong MEH, 2008, RESUSCITATION, V78, P289, DOI 10.1016/j.resuscitation.2008.03.224; Park SB, 2007, INT J NEUROSCI, V117, P1707, DOI 10.1080/00207450601050097; Ramshur J, DESIGN EVALUATION AP; Rickards CA, 2010, CRIT CARE MED, V38, P1666, DOI 10.1097/CCM.0b013e3181e74cab; Sandercock GRH, 2005, INT J CARDIOL, V103, P238, DOI 10.1016/j.ijcard.2004.09.013; Su IC, 2009, ACTA NEUROCHIR, V151, P1631, DOI 10.1007/s00701-009-0517-9; Tokgozoglu SL, 1999, STROKE, V30, P1307, DOI 10.1161/01.STR.30.7.1307; Yperzeele L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110043; Yperzeele L, 2014, CEREBROVASC DIS, V38, P1, DOI 10.1159/000363617	26	9	9	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 4	2016	11	5							e0154834	10.1371/journal.pone.0154834	http://dx.doi.org/10.1371/journal.pone.0154834			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DL5KR	27144492	Green Published, Green Submitted, gold			2022-12-26	WOS:000375676400081
J	Delil, RK; Dileba, TK; Habtu, YA; Gone, TF; Leta, TJ				Delil, Romedan Kedir; Dileba, Temesgen Kale; Habtu, Yitagesu Aweke; Gone, Terefe Fuge; Leta, Taye Janfa			Magnitude of Malaria and Factors among Febrile Cases in Low Transmission Areas of Hadiya Zone, Ethiopia: A Facility Based Cross Sectional Study	PLOS ONE			English	Article							HEALTH FACILITIES; PREVALENCE	Background Despite a remarkable decline in morbidity and mortality since the era of malaria roll back strategy, it still poses a huge challenge in Ethiopia in general and in Hadiya Zone in particular. Although, there are data from routine health management information on few indicators, there is scarcity of data showing magnitude of malaria and associated factors including knowledge and practice in the study area. Therefore, the aim of this study was to assess magnitude and factors affecting malaria in low transmission areas among febrile cases attending public health facilities in Hadiya Zone, Ethiopia. Methods A facility based cross-sectional study was conducted in Hadiya Zone from May 15 to June 15, 2014. Simple random sampling was used to select the health facility while systematic random sampling technique was used to reach febrile patients attending public health facilities. Data were collected by a pre-tested structured questionnaire containing sections of socio demographic risk factors and knowledge and prevention practices of malaria. Data were entered to Epi-Info software version 3.5.4 and exported to SPSS version 16 for descriptive and logistic regression analysis. Results One hundred six (25.8%) of participating febrile patients attending at sampled health facilities were found to have malaria by microscopy. Of which, P. vivax, P. falciparum and mixed infection accounted for 76(71. 7%), 27 (25.5%) and 3 (2.8%), respectively. History of travel to malaria endemic area, [AOR: 2.59, 95% CI: (1.24, 5.38)], not using bed net, [AOR: 4.67, 95% CI:, (2.11, 10.37)], poor practice related to malaria prevention and control, [AOR: 2.28, (95% CI: (1.10, 4.74)], poor knowledge about malaria, [AOR: 5.09,95% CI: (2.26,11.50)] and estimated distance of stagnant water near to the residence, [AOR: 3.32, (95% CI: (1.13, 9.76)] were significantly associated factors of malaria positivity in the study. Conclusion The present study revealed that malaria is still a major source of morbidity in the study area among febrile illnesses. Poor level of knowledge, poor prevention practices, not using bed net, travel history to endemic areas and residing near stagnant water were associated factors with malaria positivity in the study area. Therefore, implementers, policy makers and stakeholders should strengthen the services provided by the community health development army, health extension service and health facilities services focusing on increasing malaria intervention coverage and mobilization of information, education and communication to increase knowledge about malaria transmission, prevention and control practices.	[Delil, Romedan Kedir] Hossana Coll Hlth Sci, Dept Clin Nursing, Hossana, Ethiopia; [Dileba, Temesgen Kale; Habtu, Yitagesu Aweke; Gone, Terefe Fuge; Leta, Taye Janfa] Hossana Coll Hlth Sci, Dept Hlth Informat, Hossana, Ethiopia; [Gone, Terefe Fuge] Hossana Coll Hlth Sci, Dept Med Lab Sci, Hossana, Ethiopia; [Leta, Taye Janfa] Hossana Coll Hlth Sci, Dept Publ Hlth, Hossana, Ethiopia		Habtu, YA (corresponding author), Hossana Coll Hlth Sci, Dept Hlth Informat, Hossana, Ethiopia.	yitagesuh@yahoo.com		Fuge, Dr Terefe G/0000-0001-6229-4436	Hossana College of Health and Science [6223]	Hossana College of Health and Science	Funding was provided by the Hossana College of Health and Science, under grant number 6223. This funder played a role in obtaining ethical clearance, obtaining approval of the manuscript proposal, evaluating study design, supervising data collection, as well as deciding to publish the manuscript.	Abate A, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-312; Abreha T, 2014, MALARIA J, V13, DOI 10.1186/1475-2875-13-292; Adugna A., 2007, MALARIA IN ETHIOPIA; Adugna Woyessa, 2004, Ethiopian Journal of Health Development, V18, P2; Afrane YA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054305; Alemu A, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-173; Alemu G., 2006, PREVALENCE MALARIA I; [Anonymous], 2013, ETHIOPIA J TROP DIS, DOI DOI 10.4172/2329-891X.1000118; Ayele DG, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-195; Cheesbrough M., 2008, DISTRICT LAB PRACTIC, P239; Daniel Wane W., 2005, SAMPLE SIZE ESTIMATI, P189; de Oliveira AM, 2011, AM J TROP MED HYG, V85, P1002, DOI 10.4269/ajtmh.2011.11-0365; Deressa W, 2007, MALARIA J, V6, DOI 10.1186/1475-2875-6-49; Federal Democratic Republic of Ethiopia Ministry of Health, 2012, NAT MAL GUID; Federal Democratic Republic of Ethiopia Ministry of Health, 2014, POL PRACT INF ACT, V6; Federal Ministry of Health, 2004, GUID MAL EP PREV CON, V2nd; Federal Ministry of Health, 2014, EP PROF MAL ETH REP; Federal Ministry of Health, 2014, NAT MAL PROGR MON EV; Graves PM, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-354; Hay SI, 2005, NAT REV MICROBIOL, V3, P81, DOI 10.1038/nrmicro1069; Howes R.E., 2014, PLASMODIUM VIVAX THE, P103; Hwang J, 2010, KNOWLEDGE MALARIA IT, DOI [10.1371/journal.pone.0011692, DOI 10.1371/JOURNAL.PONE.0011692]; Kinung'hi SM, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-395; Legesse Y., 2007, ETHIOP J HEALTH DEV, V21, DOI 10.4314/ejhd.v21i2.10044; Tabachnick B. G., 2001, USING MULTIVARIATE S, P136; Tamirat G, 2012, PLASMODIUM VIVAX MAL; Tesfaye S, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-153; Wakgari Deressa, 2005, Ethiopian Journal of Health Development, V19, P3; WHO, 2013, WORLD MALARIA REPORT 2013, P1; Woyessa A, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-99; Woyessa A, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-84; Yukich JO, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-33	32	28	28	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 3	2016	11	5							e0154277	10.1371/journal.pone.0154277	http://dx.doi.org/10.1371/journal.pone.0154277			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DL5KK	27137913	Green Submitted, Green Published, gold			2022-12-26	WOS:000375675700023
J	Gladstone-Gallagher, RV; Lohrer, AM; Lundquist, CJ; Pilditch, CA				Gladstone-Gallagher, Rebecca V.; Lohrer, Andrew M.; Lundquist, Carolyn J.; Pilditch, Conrad A.			Effects of Detrital Subsidies on Soft-Sediment Ecosystem Function Are Transient and Source-Dependent	PLOS ONE			English	Article							MACROFAUNAL ASSEMBLAGES; MACROALGAL DETRITUS; LITTER PRODUCTION; MARINE-SEDIMENTS; DECOMPOSITION; ENRICHMENT; ESTUARIES; MANGROVE; COMMUNITY; IMPACTS	Detrital subsidies from marine macrophytes are prevalent in temperate estuaries, and their role in structuring benthic macrofaunal communities is well documented, but the resulting impact on ecosystem function is not understood. We conducted a field experiment to test the effects of detrital decay on soft-sediment primary production, community metabolism and nutrient regeneration (measures of ecosystem function). Twenty four (2 m(2)) plots were established on an intertidal sandflat, to which we added 0 or 220 g DW m(-2) of detritus from either mangroves (Avicennia marina), seagrass (Zostera muelleri), or kelp (Ecklonia radiata) (n = 6 plots per treatment). Then, after 4, 17 and 46 d we measured ecosystem function, macrofaunal community structure and sediment properties. We hypothesized that (1) detrital decay would stimulate benthic primary production either by supplying nutrients to the benthic macrophytes, or by altering the macrofaunal community; and (2) ecosystem responses would depend on the stage and rate of macrophyte decay (a function of source). Avicennia detritus decayed the slowest with a half-life (t(50)) of 46 d, while Zostera and Ecklonia had t50 values of 28 and 2.6 d, respectively. However, ecosystem responses were not related to these differences. Instead, we found transient effects (up to 17 d) of Avicennia and Ecklonia detritus on benthic primary production, where initially (4 d) these detrital sources suppressed primary production, but after 17 d, primary production was stimulated in Avicennia plots relative to controls. Other ecosystem function response variables and the macrofaunal community composition were not altered by the addition of detritus, but did vary with time. By sampling ecosystem function temporally, we were able to capture the in situ transient effects of detrital subsidies on important benthic ecosystem functions.	[Gladstone-Gallagher, Rebecca V.; Pilditch, Conrad A.] Univ Waikato, Sch Sci, Hamilton, New Zealand; [Lohrer, Andrew M.; Lundquist, Carolyn J.] Natl Inst Water & Atmospher Res Ltd NIWA, Hamilton, New Zealand; [Lundquist, Carolyn J.] Univ Auckland, Inst Marine Sci, Auckland 1, New Zealand	University of Waikato; National Institute of Water & Atmospheric Research (NIWA) - New Zealand; University of Auckland	Gladstone-Gallagher, RV (corresponding author), Univ Waikato, Sch Sci, Hamilton, New Zealand.	rgladstonegallagher@gmail.com	Gladstone-Gallagher, Rebecca/ABA-6627-2021	Lundquist, Carolyn/0000-0002-2101-7237; Gladstone-Gallagher, Rebecca/0000-0002-1745-2084	University of Waikato Doctoral Scholarship; Shirtcliffe Fellowship; Waikato Graduate Women Charitable Trust; New Zealand Coastal Society; New Zealand Ministry of Business, Innovation and Employment [CO1X1002, COME1601]; Walter and Andree de Nottbeck Foundation	University of Waikato Doctoral Scholarship; Shirtcliffe Fellowship; Waikato Graduate Women Charitable Trust; New Zealand Coastal Society; New Zealand Ministry of Business, Innovation and Employment(New Zealand Ministry of Business, Innovation and Employment (MBIE)); Walter and Andree de Nottbeck Foundation	This project was supported by a University of Waikato Doctoral Scholarship, Shirtcliffe Fellowship, Waikato Graduate Women Charitable Trust Merit Award for Doctoral Study, and New Zealand Coastal Society PhD scholarship to RVGG; in addition, funding was provided by the New Zealand Ministry of Business, Innovation and Employment (Contract # CO1X1002: Aquatic Rehabilitation, and NIWA Coasts & Oceans Research Programme, Project COME1601). RVGG and CAP gratefully acknowledge the Walter and Andree de Nottbeck Foundation, A Norkko and the staff at Tvarminne Zoological Station, University of Helsinki, Finland, for support during the manuscript preparation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ainley LB, 2015, ESTUAR COAST SHELF S, V164, P244, DOI 10.1016/j.ecss.2015.07.027; Albright L. J., 1980, NAT CAN, V107, P3; ALONGI DM, 1987, OECOLOGIA, V71, P537, DOI 10.1007/BF00379293; Anderson MJ, 2008, PERMANOVA A PRIMER G; ANDERSON RO, 1959, LIMNOL OCEANOGR, V4, P223, DOI 10.4319/lo.1959.4.2.0223; Arar E.J., 1997, 4450 USEPA; Arnold TM, 2002, J CHEM ECOL, V28, P1919, DOI 10.1023/A:1020737609151; Bishop MJ, 2008, OIKOS, V117, P531, DOI 10.1111/j.0030-1299.2008.16418.x; Bishop MJ, 2007, MAR ECOL PROG SER, V341, P25, DOI 10.3354/meps341025; Bishop MJ, 2007, OIKOS, V116, P427, DOI 10.1111/j.2006.0030-1299.15557.x; Bishop MJ, 2013, ECOL EVOL, V3, P3986, DOI 10.1002/ece3.775; Bishop MJ, 2013, BIOL INVASIONS, V15, P45, DOI 10.1007/s10530-012-0267-0; Bishop MJ, 2010, OECOLOGIA, V163, P517, DOI 10.1007/s00442-009-1555-y; BLACKBURN TH, 1993, PHILOS T ROY SOC A, V344, P49, DOI 10.1098/rsta.1993.0074; Braeckman U, 2014, ECOSYSTEMS, V17, P720, DOI 10.1007/s10021-014-9755-7; Garcia-Robledo E, 2008, MAR ECOL PROG SER, V356, P139, DOI 10.3354/meps07287; Garcia-Robledo E, 2013, AQUAT MICROB ECOL, V69, P113, DOI 10.3354/ame01626; Gladstone-Gallagher RV, 2014, NEW ZEAL J MAR FRESH, V48, P24, DOI 10.1080/00288330.2013.827124; Gladstone-Gallagher RV, 2014, J EXP MAR BIOL ECOL, V460, P80, DOI 10.1016/j.jembe.2014.06.006; Gorley C.K., 2006, GETTING STARTED PRIM; Hewitt J, 2006, J EXP MAR BIOL ECOL, V330, P261, DOI 10.1016/j.jembe.2005.12.032; Hewitt J, 2010, BIODIVERS CONSERV, V19, P1315, DOI 10.1007/s10531-009-9763-7; Hyndes GA, 2012, MAR ECOL PROG SER, V445, P97, DOI 10.3354/meps09367; Kelaher BP, 2003, MAR ECOL PROG SER, V261, P85, DOI 10.3354/meps261085; Kelaher BP, 2013, GLOBAL CHANGE BIOL, V19, P1909, DOI 10.1111/gcb.12162; Lohrer AM, 2010, J EXP MAR BIOL ECOL, V390, P6, DOI 10.1016/j.jembe.2010.04.035; Lohrer AM, 2004, NATURE, V431, P1092, DOI 10.1038/nature03042; Lohrer AM, 2015, SCI REP-UK, V5, DOI 10.1038/srep10349; Lohrer AM, 2011, AUSTRAL ECOL, V36, P378, DOI 10.1111/j.1442-9993.2010.02148.x; Miller DC, 1996, ESTUARIES, V19, P202, DOI 10.2307/1352225; Moore JC, 2004, ECOL LETT, V7, P584, DOI 10.1111/j.1461-0248.2004.00606.x; MORRISEY DJ, 1992, J EXP MAR BIOL ECOL, V164, P233, DOI 10.1016/0022-0981(92)90177-C; Needham H, 2013, INTERTIDAL HABITAT M, P1; O'Brien AL, 2010, MAR FRESHWATER RES, V61, P1388, DOI 10.1071/MF10085; Oakes JM, 2010, LIMNOL OCEANOGR, V55, P393, DOI 10.4319/lo.2010.55.1.0393; Olabarria C, 2010, J EXP MAR BIOL ECOL, V396, P18, DOI 10.1016/j.jembe.2010.10.003; Pratt DR, 2014, ECOSYSTEMS, V17, P182, DOI 10.1007/s10021-013-9716-6; Rodil IF, 2008, J EXP MAR BIOL ECOL, V358, P1, DOI 10.1016/j.jembe.2007.12.030; Rodil IF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081646; Rossi F, 2006, J EXP MAR BIOL ECOL, V332, P84, DOI 10.1016/j.jembe.2005.11.003; Rossi F, 2002, MAR ECOL PROG SER, V241, P29, DOI 10.3354/meps241029; Rossi F, 2007, MAR BIOL, V150, P1073, DOI 10.1007/s00227-006-0438-6; Rossi F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066650; Rossi F, 2011, MAR BIOL, V158, P2705, DOI 10.1007/s00227-011-1768-6; Singleton P., 2007, DRAFT WHANGAMATA HAR, P1; Taylor SL, 2010, MAR ECOL PROG SER, V420, P73, DOI 10.3354/meps08903; THRUSH SF, 1994, ECOL APPL, V4, P31, DOI 10.2307/1942112; Thrush SF, 2008, ECOL APPL, V18, P12, DOI 10.1890/07-0436.1; Thrush SF, 2006, ECOSYSTEMS, V9, P1029, DOI 10.1007/s10021-005-0068-8; Turner SJ, 2007, NEW ZEAL J MAR FRESH, V41, P77, DOI 10.1080/00288330709509897; Underwood GJC, 1999, ADV ECOL RES, V29, P93; WIEDER RK, 1982, ECOLOGY, V63, P1636, DOI 10.2307/1940104; WOODROFFE CD, 1982, NEW ZEAL J MAR FRESH, V16, P179, DOI 10.1080/00288330.1982.9515961	53	17	17	1	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 3	2016	11	5							e0154790	10.1371/journal.pone.0154790	http://dx.doi.org/10.1371/journal.pone.0154790			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DL5KK	27138563	Green Published, Green Submitted, gold			2022-12-26	WOS:000375675700069
J	Li, X; Zhou, ZY; Zhang, YY; Yang, HL				Li, Xiang; Zhou, Zong-yu; Zhang, Yuan-yuan; Yang, Hui-lin			IL-6 Contributes to the Defective Osteogenesis of Bone Marrow Stromal Cells from the Vertebral Body of the Glucocorticoid-Induced Osteoporotic Mouse	PLOS ONE			English	Article							MESENCHYMAL STEM-CELLS; RHEUMATOID-ARTHRITIS; INFLAMMATORY MARKERS; RECEPTOR INHIBITION; CIRCULATING LEVELS; SIGNALING PATHWAY; MINERAL DENSITY; INTERLEUKIN-6; MICE; ADIPOGENESIS	Osteoporosis is one of the most prevalent skeletal system diseases. It is characterized by a decrease in bone mass and microarchitectural changes in bone tissue that lead to an attenuation of bone resistance and susceptibility to fracture. Vertebral fracture is by far the most prevalent osteoporotic fracture. In the musculoskeletal system, osteoblasts, originated from bone marrow stromal cells (BMSC), are responsible for osteoid synthesis and mineralization. In osteoporosis, BMSC osteogenic differentiation is defective. However, to date, what leads to the defective BMSC osteogenesis in osteoporosis remains an open question. In the current study, we made attempts to answer this question. A mouse model of glucocorticoid-induced osteoporosis (GIO) was established and BMSC were isolated from vertebral body. The impairment of osteogenesis was observed in BMSC of osteoporotic vertebral body. The expression profiles of thirty-six factors, which play important roles in bone metabolisms, were compared through antibody array between normal and osteoporotic BMSC. Significantly higher secretion level of IL-6 was observed in osteoporotic BMSCs compared with normal control. We provided evidences that IL-6 over-secretion impaired osteogenesis of osteoporotic BMSC. Further, it was observed that beta-catenin activity was inhibited in response to IL-6 over-secretion. More importantly, in vivo administration of IL-6 neutralizing antibody was found to be helpful to rescue the osteoporotic phenotype of mouse vertebral body. Our study provides a deeper insight into the pathophysiology of osteoporosis and identifies IL-6 as a promising target for osteoporosis therapy.	[Li, Xiang; Yang, Hui-lin] Soochow Univ, Dept Orthoped, Affiliated Hosp 1, Suzhou 215006, Peoples R China; [Li, Xiang] Huaian First Peoples Hosp, Dept Orthoped, Huaian 223300, Peoples R China; [Zhou, Zong-yu] Huaiyin Hosp Huaian City, Dept Orthoped, Huaian 223300, Peoples R China; [Zhang, Yuan-yuan] Huaian First Peoples Hosp, Dept Pediat, Huaian 223300, Peoples R China	Soochow University - China	Yang, HL (corresponding author), Soochow Univ, Dept Orthoped, Affiliated Hosp 1, Suzhou 215006, Peoples R China.; Zhang, YY (corresponding author), Huaian First Peoples Hosp, Dept Pediat, Huaian 223300, Peoples R China.	hazhangyuanyuan@163.com; hlyang@suda.edu.cn			Jiangsu Provincial Special Program of Medical Science [BL2012004]; Jiangsu Provincial Clinical Orthopedic Center; Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD)	Jiangsu Provincial Special Program of Medical Science; Jiangsu Provincial Clinical Orthopedic Center; Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD)	This study was supported by grants from the Jiangsu Provincial Special Program of Medical Science (BL2012004), the Jiangsu Provincial Clinical Orthopedic Center, and the Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD).	Astudillo P, 2008, J CELL BIOCHEM, V103, P1054, DOI 10.1002/jcb.21516; Barbour KE, 2012, J BONE MINER RES, V27, P1167, DOI 10.1002/jbmr.1559; Bellido T, 1997, ENDOCRINOLOGY, V138, P3666, DOI 10.1210/en.138.9.3666; Bian ZY, 2010, CANCER SCI, V101, P2554, DOI 10.1111/j.1349-7006.2010.01731.x; Blanchard F, 2009, CYTOKINE GROWTH F R, V20, P19, DOI 10.1016/j.cytogfr.2008.11.004; Cushing H, 1994, Obes Res, V2, P486; De Benedetti F, 2001, J IMMUNOL, V166, P4334, DOI 10.4049/jimmunol.166.7.4334; De Benedetti F, 2006, ARTHRITIS RHEUM, V54, P3551, DOI 10.1002/art.22175; De Vos J, 2000, BRIT J HAEMATOL, V109, P823, DOI 10.1046/j.1365-2141.2000.02127.x; DEMPSTER DW, 1989, J BONE MINER RES, V4, P137; Ding C, 2008, J CLIN ENDOCR METAB, V93, P1952, DOI 10.1210/jc.2007-2325; FALLA N, 1993, BLOOD, V82, P3580; Ferrari SL, 2003, J CLIN ENDOCR METAB, V88, P255, DOI 10.1210/jc.2002-020092; Fukuyo S, 2014, RHEUMATOLOGY, V53, P1282, DOI 10.1093/rheumatology/ket496; Hallek M, 1998, BLOOD, V91, P3, DOI 10.1182/blood.V91.1.3.3_3_21; Hattori T, 2010, PHYTOMEDICINE, V17, P170, DOI 10.1016/j.phymed.2009.12.004; Heymann D, 2000, CYTOKINE, V12, P1455, DOI 10.1006/cyto.2000.0747; HILBERT DM, 1995, J EXP MED, V182, P243, DOI 10.1084/jem.182.1.243; HOUSSIAU FA, 1988, ARTHRITIS RHEUM, V31, P784, DOI 10.1002/art.1780310614; Huh JE, 2013, BBA-MOL CELL RES, V1833, P2608, DOI 10.1016/j.bbamcr.2013.06.025; Kaneshiro S, 2014, J BONE MINER METAB, V32, P378, DOI 10.1007/s00774-013-0514-1; Karsdal MA, 2012, SEMIN ARTHRITIS RHEU, V42, P131, DOI 10.1016/j.semarthrit.2012.01.004; Kendler DL, 2016, AM J MED, V129, DOI 10.1016/j.amjmed.2015.09.020; Khosla S, 2002, J CLIN ENDOCR METAB, V87, P1550, DOI 10.1210/jc.87.4.1550; KOPF M, 1994, NATURE, V368, P339, DOI 10.1038/368339a0; Koshihara Y, 2002, MECH AGEING DEV, V123, P1321, DOI 10.1016/S0047-6374(02)00071-4; Lattanzio G, 1997, AM J PATHOL, V151, P689; Liu XH, 2006, VITAM HORM, V74, P341, DOI 10.1016/S0083-6729(06)74014-6; Nuttall ME, 2004, CURR OPIN PHARMACOL, V4, P290, DOI 10.1016/j.coph.2004.03.002; Olmos JM, 1999, METHOD FIND EXP CLIN, V21, P519, DOI 10.1358/mf.1999.21.8.794832; PARFITT AM, 1987, J BONE MINER RES, V2, P595, DOI 10.1002/jbmr.5650020617; Park JH, 2013, MENOPAUSE, V20, P747, DOI [10.1097/GME.0b013e31827cabca, 10.1097/gme.0b013e31827cabca]; POLI V, 1994, EMBO J, V13, P1189, DOI 10.1002/j.1460-2075.1994.tb06368.x; Raisz LG, 2005, J CLIN INVEST, V115, P3318, DOI 10.1172/JCI27071; REID IR, 1989, CLIN ENDOCRINOL, V30, P83, DOI 10.1111/j.1365-2265.1989.tb03730.x; Rodriguez JP, 2000, J CELL BIOCHEM, V79, P557, DOI 10.1002/1097-4644(20001215)79:4<557::AID-JCB40>3.0.CO;2-H; Rodriguez JP, 2004, J CELL BIOCHEM, V92, P745, DOI 10.1002/jcb.20119; Rodriguez JP, 1999, J CELL BIOCHEM, V75, P414, DOI 10.1002/(SICI)1097-4644(19991201)75:3<414::AID-JCB7>3.0.CO;2-C; Romer P, 2012, ANN ANAT, V194, P208, DOI 10.1016/j.aanat.2011.09.008; Sambrook P, 2006, LANCET, V367, P2010, DOI 10.1016/S0140-6736(06)68891-0; Scheidt-Nave C, 2001, J CLIN ENDOCR METAB, V86, P2032, DOI 10.1210/jc.86.5.2032; Sims NA, 2005, J BONE MINER RES, V20, P1093, DOI 10.1359/JBMR.050209; TAMURA T, 1993, P NATL ACAD SCI USA, V90, P11924, DOI 10.1073/pnas.90.24.11924; Terpos E, 2011, CLIN EXP RHEUMATOL, V29, P921; TONTONOZ P, 1994, GENE DEV, V8, P1224, DOI 10.1101/gad.8.10.1224; Weinstein RS, 1998, J CLIN INVEST, V102, P274, DOI 10.1172/JCI2799; Wong PKK, 2003, ARTHRITIS RHEUM-US, V48, P1177, DOI 10.1002/art.10943; Yadav VK, 2010, ANN NY ACAD SCI, V1192, P103, DOI 10.1111/j.1749-6632.2009.05312.x; Yamaguchi K, 1999, BIOORG MED CHEM LETT, V9, P957, DOI 10.1016/S0960-894X(99)00122-5; Yang X, 2007, BONE, V41, P928, DOI 10.1016/j.bone.2007.07.022; Zhang YX, 2015, J BIOCHEM, V158, P445, DOI 10.1093/jb/mvv059; Zhang YX, 2015, BBA-MOL BASIS DIS, V1852, P2504, DOI 10.1016/j.bbadis.2015.08.020	52	32	33	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 29	2016	11	4							e0154677	10.1371/journal.pone.0154677	http://dx.doi.org/10.1371/journal.pone.0154677			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DK8XM	27128729	Green Submitted, Green Published, gold			2022-12-26	WOS:000375212600059
J	Ono, M; Yamada, K; Bensaddek, D; Afzal, V; Biddlestone, J; Ortmann, B; Mudie, S; Boivin, V; Scott, MS; Rocha, S; Lamond, AI				Ono, Motoharu; Yamada, Kayo; Bensaddek, Dalila; Afzal, Vackar; Biddlestone, John; Ortmann, Brian; Mudie, Sharon; Boivin, Vincent; Scott, Michelle S.; Rocha, Sonia; Lamond, Angus I.			Enhanced snoMEN Vectors Facilitate Establishment of GFP-HIF-1 alpha Protein Replacement Human Cell Lines	PLOS ONE			English	Article							SMALL NUCLEOLAR RNAS; NONCODING RNAS; SNORNA; IDENTIFICATION; C/D; GENE; PROTEOMICS; MOUSE	The snoMEN (snoRNA Modulator of gene ExpressioN) vector technology was developed from a human box C/D snoRNA, HBII-180C, which contains an internal sequence that can be manipulated to make it complementary to RNA targets, allowing knock-down of targeted genes. Here we have screened additional human nucleolar snoRNAs and assessed their application for gene specific knock-downs to improve the efficiency of snoMEN vectors. We identify and characterise a new snoMEN vector, termed 47snoMEN, that is derived from box C/D snoRNA U47, demonstrating its use for knock-down of both endogenous cellular proteins and G/YFP-fusion proteins. Using multiplex 47snoMEM vectors that co-express multiple 47snoMEN in a single transcript, each of which can target different sites in the same mRNA, we document > 3-fold increase in knock-down efficiency when compared with the original HBII-180C based snoMEN. The multiplex 47snoMEM vector allowed the construction of human protein replacement cell lines with improved efficiency, including the establishment of novel GFP-HIF-1 alpha replacement cells. Quantitative mass spectrometry analysis confirmed the enhanced efficiency and specificity of protein replacement using the 47snoMEN-PR vectors. The 47snoMEN vectors expand the potential applications for snoMEN technology in gene expression studies, target validation and gene therapy.	[Ono, Motoharu; Yamada, Kayo; Bensaddek, Dalila; Afzal, Vackar; Biddlestone, John; Ortmann, Brian; Mudie, Sharon; Rocha, Sonia; Lamond, Angus I.] Univ Dundee, Ctr Gene Regulat & Express, Sch Life Sci, Dundee, Scotland; [Boivin, Vincent; Scott, Michelle S.] Univ Sherbrooke, Dept Biochem, Sherbrooke, PQ J1K 2R1, Canada; [Boivin, Vincent; Scott, Michelle S.] Univ Sherbrooke, Fac Med & Hlth Sci, RNA Grp, Sherbrooke, PQ J1K 2R1, Canada	University of Dundee; University of Sherbrooke; University of Sherbrooke	Lamond, AI (corresponding author), Univ Dundee, Ctr Gene Regulat & Express, Sch Life Sci, Dundee, Scotland.	a.i.lamond@dundee.ac.uk		Boivin, Vincent/0000-0001-6434-2737; Ortmann, Brian/0000-0002-3639-0691	Wellcome Trust [073980/Z/03/Z, 105024/Z/14/Z]; MRC [G0801738]; Cancer Research UK [C99667/A12918]; Fonds de Recherche du Quebec - Sante Research Scholar Junior 1 Career Award; Cancer Research UK [12918] Funding Source: researchfish; Medical Research Council [G0801738] Funding Source: researchfish	Wellcome Trust(Wellcome TrustEuropean Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Cancer Research UK(Cancer Research UK); Fonds de Recherche du Quebec - Sante Research Scholar Junior 1 Career Award; Cancer Research UK(Cancer Research UK); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	Funding for this research was provided by a Wellcome Trust Programme Grant to A. I. L (Ref: 073980/Z/03/Z) and by an MRC Milstein Award to AIL (Ref: G0801738) and by a Cancer Research UK programme grant and senior fellowship to SR (Ref: C99667/A12918). This project was also supported in part from a Wellcome Trust Strategic Award (Ref: 105024/Z/14/Z). MSS is a recipient of a Fonds de Recherche du Quebec - Sante Research Scholar Junior 1 Career Award and a member of the Centre de Recherche du Centre Hospitalier Universitaire de Sherbrooke (CRCHUS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almeida F, 1998, J CELL BIOL, V142, P899, DOI 10.1083/jcb.142.4.899; Andersen JS, 2005, NATURE, V433, P77, DOI 10.1038/nature03207; Biddlestone J, 2015, INT J MOL MED, V35, P859, DOI 10.3892/ijmm.2015.2079; Boulon S, 2010, MOL CELL, V39, P912, DOI 10.1016/j.molcel.2010.08.023; Boulon S, 2010, MOL CELL PROTEOMICS, V9, P861, DOI 10.1074/mcp.M900517-MCP200; Brameier M, 2011, NUCLEIC ACIDS RES, V39, P675, DOI 10.1093/nar/gkq776; Cummins JM, 2006, P NATL ACAD SCI USA, V103, P3687, DOI 10.1073/pnas.0511155103; de Godoy LMF, 2008, NATURE, V455, P1251, DOI 10.1038/nature07341; Ender C, 2008, MOL CELL, V32, P519, DOI 10.1016/j.molcel.2008.10.017; Filipowicz W, 2002, CURR OPIN CELL BIOL, V14, P319, DOI 10.1016/S0955-0674(02)00334-4; Henras AK, 2004, CURR OPIN STRUC BIOL, V14, P335, DOI 10.1016/j.sbi.2004.05.006; Hirose T, 2003, MOL CELL, V12, P113, DOI 10.1016/S1097-2765(03)00267-3; Huttenhofer A, 2001, EMBO J, V20, P2943, DOI 10.1093/emboj/20.11.2943; Isken O, 2008, NAT REV GENET, V9, P699, DOI 10.1038/nrg2402; Kawaji H, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-157; Kent WJ, 2002, GENOME RES, V12, P996, DOI 10.1101/gr.229102; Kiss AM, 2004, MOL CELL BIOL, V24, P5797, DOI 10.1128/MCB.24.13.5797-5807.2004; Kiss T, 2001, EMBO J, V20, P3617, DOI 10.1093/emboj/20.14.3617; KissLaszlo Z, 1996, CELL, V85, P1077, DOI 10.1016/S0092-8674(00)81308-2; Larance M, 2013, MOL CELL PROTEOMICS, V12, P638, DOI 10.1074/mcp.M112.024547; Ly T, 2014, ELIFE, V3, DOI 10.7554/eLife.01630; Matera AG, 2007, NAT REV MOL CELL BIO, V8, P209, DOI 10.1038/nrm2124; Ofengand J, 1997, J MOL BIOL, V266, P246, DOI 10.1006/jmbi.1996.0737; Ono M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0138668; Ono M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062305; Ono M, 2011, NUCLEIC ACIDS RES, V39, P3879, DOI 10.1093/nar/gkq1355; Ono M, 2010, MOL BIOL CELL, V21, P1569, DOI 10.1091/mbc.E10-01-0078; Rebbapragada I, 2009, CURR OPIN CELL BIOL, V21, P394, DOI 10.1016/j.ceb.2009.02.007; REIMER G, 1987, ARTHRITIS RHEUM, V30, P793, DOI 10.1002/art.1780300709; Ritorto MS, 2013, J PROTEOME RES, V12, P2449, DOI 10.1021/pr301011r; Scott MS, 2012, NUCLEIC ACIDS RES, V40, P3676, DOI 10.1093/nar/gkr1233; Scott MS, 2011, BIOCHIMIE, V93, P1987, DOI 10.1016/j.biochi.2011.05.026; Scott MS, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000507; Sleeman JE, 2003, J CELL SCI, V116, P2039, DOI 10.1242/jcs.00400; Smith CM, 1998, MOL CELL BIOL, V18, P6897, DOI 10.1128/MCB.18.12.6897; Taft RJ, 2009, RNA, V15, P1233, DOI 10.1261/rna.1528909; Trinkle-Mulcahy L, 2006, J CELL BIOL, V172, P679, DOI 10.1083/jcb.200508154; Vermeulen M, 2010, CELL, V142, P967, DOI 10.1016/j.cell.2010.08.020; Vitali P, 2003, NUCLEIC ACIDS RES, V31, P6543, DOI 10.1093/nar/gkg849; Vizcaino JA, 2016, NUCLEIC ACIDS RES, V44, pD447, DOI 10.1093/nar/gkv1145; Weinstein LB, 1999, CURR OPIN CELL BIOL, V11, P378, DOI 10.1016/S0955-0674(99)80053-2; Weischenfeldt J, 2005, CURR BIOL, V15, pR559, DOI 10.1016/j.cub.2005.07.002; Westman BJ, 2010, MOL CELL, V39, P618, DOI 10.1016/j.molcel.2010.07.025; Yamada K, 2013, MOL CELL, V49, P922, DOI 10.1016/j.molcel.2012.12.023	44	1	1	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 29	2016	11	4							e0154759	10.1371/journal.pone.0154759	http://dx.doi.org/10.1371/journal.pone.0154759			28	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DK8XM	27128805	Green Published, gold, Green Accepted			2022-12-26	WOS:000375212600067
J	Richardson, TG; Campbell, C; Timpson, NJ; Gaunt, TR				Richardson, Tom G.; Campbell, Colin; Timpson, Nicholas J.; Gaunt, Tom R.			Incorporating Non-Coding Annotations into Rare Variant Analysis	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; DISEASE; COMMON; PATHOGENICITY; FREQUENCY; FRAMEWORK; MODEL; POWER	Background The success of collapsing methods which investigate the combined effect of rare variants on complex traits has so far been limited. The manner in which variants within a gene are selected prior to analysis has a crucial impact on this success, which has resulted in analyses conventionally filtering variants according to their consequence. This study investigates whether an alternative approach to filtering, using annotations from recently developed bioinformatics tools, can aid these types of analyses in comparison to conventional approaches. Methods & Results We conducted a candidate gene analysis using the UK10K sequence and lipids data, filtering according to functional annotations using the resource CADD (Combined Annotation-Dependent Depletion) and contrasting results with 'nonsynonymous' and 'loss of function' consequence analyses. Using CADD allowed the inclusion of potentially deleterious intronic variants, which was not possible when filtering by consequence. Overall, different filtering approaches provided similar evidence of association, although filtering according to CADD identified evidence of association between ANGPTL4 and High Density Lipoproteins (P = 0.02, N = 3,210) which was not observed in the other analyses. We also undertook genome-wide analyses to determine how filtering in this manner compared to conventional approaches for gene regions. Results suggested that filtering by annotations according to CADD, as well as other tools known as FATHMM-MKL and DANN, identified association signals not detected when filtering by variant consequence and vice versa. Conclusion Incorporating variant annotations from non-coding bioinformatics tools should prove to be a valuable asset for rare variant analyses in the future. Filtering by variant consequence is only possible in coding regions of the genome, whereas utilising non-coding bioinformatics annotations provides an opportunity to discover unknown causal variants in non-coding regions as well. This should allow studies to uncover a greater number of causal variants for complex traits and help elucidate their functional role in disease.	[Richardson, Tom G.; Timpson, Nicholas J.; Gaunt, Tom R.] Univ Bristol, MRC Integrat Epidemiol Unit, Sch Social & Community Med, Bristol, Avon, England; [Campbell, Colin] Univ Bristol, Intelligent Syst Lab, Bristol, Avon, England	University of Bristol; University of Bristol	Gaunt, TR (corresponding author), Univ Bristol, MRC Integrat Epidemiol Unit, Sch Social & Community Med, Bristol, Avon, England.	Tom.Gaunt@bristol.ac.uk	Timpson, Nicholas John/O-7548-2015; Gaunt, Tom R/O-3918-2014; Attrill, Lauren/V-1688-2018; Fox, Laura J/C-6249-2016	Timpson, Nicholas John/0000-0002-7141-9189; Gaunt, Tom R/0000-0003-0924-3247; Richardson, Tom/0000-0002-7918-2040	Wellcome Trust [WT091310]; UK Medical Research Council (MRC) [IEU MC_UU_12013/8]; EPSRC [EP/M01715X/1] Funding Source: UKRI; MRC [MC_UU_12013/3, MC_UU_12013/8, MC_UU_12013/2] Funding Source: UKRI; Engineering and Physical Sciences Research Council [EP/M01715X/1] Funding Source: researchfish; Medical Research Council [G9815508, MC_UU_12013/2, MC_PC_15018, 1170461, MC_UU_12013/3, MC_UU_12013/8] Funding Source: researchfish	Wellcome Trust(Wellcome TrustEuropean Commission); UK Medical Research Council (MRC)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	Funding for UK10K was provided by the Wellcome Trust under award WT091310. This work was supported by the UK Medical Research Council (MRC IEU MC_UU_12013/8). TGR is a UK MRC PhD Student.	Adzhubei IA, 2010, NAT METHODS, V7, P248, DOI 10.1038/nmeth0410-248; Altshuler D, 2008, SCIENCE, V322, P881, DOI 10.1126/science.1156409; Altshuler DM, 2012, NATURE, V491, P56, DOI 10.1038/nature11632; Altshuler DM, 2010, NATURE, V467, P52, DOI 10.1038/nature09298; Asimit J, 2010, ANNU REV GENET, V44, P293, DOI 10.1146/annurev-genet-102209-163421; Bodmer W, 2008, NAT GENET, V40, P695, DOI 10.1038/ng.f.136; Boyd A, 2013, INT J EPIDEMIOL, V42, P111, DOI 10.1093/ije/dys064; Browning SR, 2007, AM J HUM GENET, V81, P1084, DOI 10.1086/521987; Cirulli ET, 2010, NAT REV GENET, V11, P415, DOI 10.1038/nrg2779; CROW J F, 1970, P591, DOI 10.1093/bioinformatics/btr330; Fu WQ, 2013, NATURE, V493, P216, DOI 10.1038/nature11690; Golding J, 2001, PAEDIATR PERINAT EP, V15, P74; Guerreiro R, 2013, NEW ENGL J MED, V368, P117, DOI 10.1056/NEJMoa1211851; Hindorff LA, 2009, P NATL ACAD SCI USA, V106, P9362, DOI 10.1073/pnas.0903103106; Hunt KA, 2013, NATURE, V498, P232, DOI 10.1038/nature12170; Kellis M, 2014, P NATL ACAD SCI USA, V111, P6131, DOI 10.1073/pnas.1318948111; Kircher M, 2014, NAT GENET, V46, P310, DOI 10.1038/ng.2892; Ladouceur M, 2013, EUR J HUM GENET, V21, P1027, DOI 10.1038/ejhg.2012.284; Lee S, 2012, AM J HUM GENET, V91, P224, DOI 10.1016/j.ajhg.2012.06.007; Lee S, 2014, AM J HUM GENET, V95, P5, DOI 10.1016/j.ajhg.2014.06.009; Lewin-Koh N., 2011, TECHNICAL REPORT; Li H, 2010, BIOINFORMATICS, V26, P589, DOI 10.1093/bioinformatics/btp698; Liu DJJ, 2014, NAT GENET, V46, P200, DOI 10.1038/ng.2852; Liu XM, 2016, HUM MUTAT, V37, P235, DOI 10.1002/humu.22932; Maher B, 2008, NATURE, V456, P18, DOI 10.1038/456018a; Manolio TA, 2010, NEW ENGL J MED, V363, P166, DOI 10.1056/NEJMra0905980; McLaren W, 2010, BIOINFORMATICS, V26, P2069, DOI 10.1093/bioinformatics/btq330; Moayyeri A, 2013, TWIN RES HUM GENET, V16, P144, DOI 10.1017/thg.2012.89; Moutsianas L, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005165; Muddyman D, 2013, GENOME MED, V5, DOI 10.1186/gm504; Myers GL, 2000, CLIN CHEM, V46, P1762; Neale BM, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001322; Ng PC, 2003, NUCLEIC ACIDS RES, V31, P3812, DOI 10.1093/nar/gkg509; Peloso GM, 2014, AM J HUM GENET, V94, P223, DOI 10.1016/j.ajhg.2014.01.009; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; Quang D, 2015, BIOINFORMATICS, V31, P761, DOI 10.1093/bioinformatics/btu703; Schaid DJ, 2013, GENET EPIDEMIOL, V37, P409, DOI 10.1002/gepi.21727; Shihab HA, 2015, BIOINFORMATICS, V31, P1536, DOI 10.1093/bioinformatics/btv009; Smemo S, 2014, NATURE, V507, P371, DOI 10.1038/nature13138; Stenson PD, 2014, HUM GENET, V133, P1, DOI 10.1007/s00439-013-1358-4; Sul JH, 2011, J COMPUT BIOL, V18, P1611, DOI 10.1089/cmb.2011.0161; Sun JP, 2013, GENET EPIDEMIOL, V37, P334, DOI 10.1002/gepi.21717; Tachmazidou I, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3872; Team RDC, 2019, R LANG ENV STAT COMP; Timpson NJ, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5871; Wagner MJ, 2013, PHARMACOGENOMICS, V14, P413, DOI [10.2217/PGS.13.36, 10.2217/pgs.13.36]; WARNICK GR, 1990, SCAND J CLIN LAB INV, V50, P9, DOI 10.3109/00365519009091079; Wickham H, 2009, USE R, P1, DOI 10.1007/978-0-387-98141-3_1; Wu MC, 2011, AM J HUM GENET, V89, P82, DOI 10.1016/j.ajhg.2011.05.029; Zhai G, 2010, ANN RHEUM DIS, V69, P1227, DOI 10.1136/ard.2009.120857	50	7	7	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 29	2016	11	4							e0154181	10.1371/journal.pone.0154181	http://dx.doi.org/10.1371/journal.pone.0154181			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DK8XM	27128317	Green Published, gold			2022-12-26	WOS:000375212600022
J	Yun, KJ; Han, K; Kim, MK; Park, YM; Baek, KH; Song, KH; Kwon, HS				Yun, Kyung-Jin; Han, Kyungdo; Kim, Mee Kyoung; Park, Yong-Moon; Baek, Ki-Hyun; Song, Ki-Ho; Kwon, Hyuk-Sang			Insulin Resistance Distribution and Cut-Off Value in Koreans from the 2008-2010 Korean National Health and Nutrition Examination Survey	PLOS ONE			English	Article							HOMEOSTASIS MODEL ASSESSMENT; METABOLIC SYNDROME; CARDIOVASCULAR-DISEASE; POPULATION; INDEX; SENSITIVITY; SECRETION; MENOPAUSE; NONOBESE; GLUCOSE	Background We sought to identify the distribution and cut-off value of the 'homeostasis model assessment of insulin resistance' (HOMA-IR) according to gender and menopausal status for metabolic syndrome in Koreans. Methods Data were from the Korean National Health and Nutrition Examination Survey in 20082010. The subjects included adults aged 20 years or older. We excluded participants who had diabetes or fasting serum glucose >= 7 mmol/L. Finally, 11,121 subjects (4,911 men, 3,597 premenopausal women, 2,613 postmenopausal women) were enrolled. The modified Adult Treatment Panel III criteria were used to define metabolic syndrome. Results The mean HOMA-IR was 2.11 (2.07-2.15) for men, 2.0 (1.97-2.04) for premenopausal women, and 2.14 (2.2-2.19) for postmenopausal women. The first cut-off values in men, premenopausal women, and postmenopausal women were 2.23 (sensitivity 70.6%, specificity 66.9%), 2.39 (sensitivity 72.3%, specificity 76.4%), and 2.48 (sensitivity 51.9%, specificity 80.2%), respectively. Based on the first HOMA-IR cut-off value, the prevalence of metabolic syndrome was 22.9% in men, 13.7% in premenopausal women, and 51.6% in postmenopausal women. The second cut-off value was around 3.2 in all three groups. Based on the second HOMA-IR cut-off value, the prevalence of metabolic syndrome was 50.8% in men, 42.5% in premenopausal women, and 71.6% in postmenopausal women. Conclusion In conclusion, the first cut-off values for HOMA-IR were 2.2-2.5 and the second cut-off value was 3.2 in Korea. The distribution of HOMA-IR showed differences according to gender and menopausal status. When we apply HOMA-IR, we should consider gender, menopausal status, and the prevalence of metabolic syndrome.	[Yun, Kyung-Jin; Kim, Mee Kyoung; Baek, Ki-Hyun; Song, Ki-Ho; Kwon, Hyuk-Sang] Yeouido St Marys Hosp, Div Endocrinol & Metab, Dept Internal Med, Seoul, South Korea; [Han, Kyungdo] Catholic Univ Korea, Dept Med Stat, Coll Med, Seoul, South Korea; [Park, Yong-Moon] NIEHS, Dept Epidemiol Branch, NIH, POB 12233, Res Triangle Pk, NC 27709 USA	Catholic University of Korea; National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS)	Kwon, HS (corresponding author), Yeouido St Marys Hosp, Div Endocrinol & Metab, Dept Internal Med, Seoul, South Korea.	drkwon@catholic.ac.kr	PARK, YONG-MOON ("MARK")/ABA-2765-2021	PARK, YONG-MOON ("MARK")/0000-0002-5879-6879				Antuna-Puente B, 2011, DIABETES METAB, V37, P179, DOI 10.1016/j.diabet.2011.01.002; DEFRONZO RA, 1991, DIABETES CARE, V14, P173, DOI 10.2337/diacare.14.3.173; DEFRONZO RA, 1979, AM J PHYSIOL, V237, pE214; Esteghamati A, 2010, NUTR METAB, V7, DOI 10.1186/1743-7075-7-26; Esteghamati A, 2009, DIABETES RES CLIN PR, V84, P279, DOI 10.1016/j.diabres.2009.03.005; Gayoso-Diz P, 2013, BMC ENDOCR DISORD, V13, DOI 10.1186/1472-6823-13-47; Gayoso-Diz P, 2011, DIABETES RES CLIN PR, V94, P146, DOI 10.1016/j.diabres.2011.07.015; Geloneze B, 2009, ARQ BRAS ENDOCRINOL, V53, P281, DOI 10.1590/S0004-27302009000200020; Ginsberg HN, 2000, J CLIN INVEST, V106, P453, DOI 10.1172/JCI10762; Grundy SM, 2005, CIRCULATION, V112, P2735, DOI 10.1161/CIRCULATIONAHA.105.169404; Katz A, 2000, J CLIN ENDOCR METAB, V85, P2402, DOI 10.1210/jc.85.7.2402; KCDC, KOR NAT HLTH NUTR EX; Lee JG, 2009, CLIN CHIM ACTA, V408, P50, DOI 10.1016/j.cca.2009.07.006; Lee S, 2006, J KOREAN MED SCI, V21, P695; LEY CJ, 1992, AM J CLIN NUTR, V55, P950, DOI 10.1093/ajcn/55.5.950; Lim S, 2011, DIABETES CARE, V34, P1323, DOI 10.2337/dc10-2109; Livingstone C, 2002, CLIN SCI, V102, P151, DOI 10.1042/cs1020151; Louet Jean-Francois, 2004, Curr Atheroscler Rep, V6, P180, DOI 10.1007/s11883-004-0030-9; MATTHEWS DR, 1985, DIABETOLOGIA, V28, P412, DOI 10.1007/BF00280883; McFarlane SI, 2001, J CLIN ENDOCR METAB, V86, P713, DOI 10.1210/jc.86.2.713; Park SH, 2005, CLIN SCI, V108, P553, DOI 10.1042/CS20040331; PROUDLER AJ, 1992, CLIN SCI, V83, P489, DOI 10.1042/cs0830489; Qu HQ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021041; Region WWP., 2000, ASIA PACIFIC PERSPEC; Sumner AE, 2008, ATHEROSCLEROSIS, V196, P696, DOI 10.1016/j.atherosclerosis.2006.12.018; Sun Y, 2014, CHINESE MED J-PEKING, V127, P1858, DOI 10.3760/cma.j.issn.0366-6999.20140030; Timoteo AT, 2014, ACTA MEDICA PORT, V27, P473, DOI 10.20344/amp.5180; WALTON C, 1993, EUR J CLIN INVEST, V23, P466, DOI 10.1111/j.1365-2362.1993.tb00792.x; Yamada C, 2012, J DIABETES INVEST, V3, P384, DOI 10.1111/j.2040-1124.2012.00194.x	29	29	32	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 29	2016	11	4							e0154593	10.1371/journal.pone.0154593	http://dx.doi.org/10.1371/journal.pone.0154593			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DK8XM	27128847	Green Published, gold, Green Submitted			2022-12-26	WOS:000375212600044
J	Tandon, D; Haque, MM; Mande, SS				Tandon, Disha; Haque, Mohammed Monzoorul; Mande, Sharmila S.			Inferring Intra-Community Microbial Interaction Patterns from Metagenomic Datasets Using Associative Rule Mining Techniques	PLOS ONE			English	Article							ACCURATE TAXONOMIC CLASSIFICATION; PHYLOGENETIC CLASSIFICATION; ALGORITHM; BUTYRATE	The nature of inter-microbial metabolic interactions defines the stability of microbial communities residing in any ecological niche. Deciphering these interaction patterns is crucial for understanding the mode/mechanism(s) through which an individual microbial community transitions from one state to another (e.g. from a healthy to a diseased state). Statistical correlation techniques have been traditionally employed for mining microbial interaction patterns from taxonomic abundance data corresponding to a given microbial community. In spite of their efficiency, these correlation techniques can capture only 'pair-wise interactions'. Moreover, their emphasis on statistical significance can potentially result in missing out on several interactions that are relevant from a biological standpoint. This study explores the applicability of one of the earliest association rule mining algorithm i.e. the 'Apriori algorithm' for deriving 'microbial association rules' from the taxonomic profile of given microbial community. The classical Apriori approach derives association rules by analysing patterns of co-occurrence/co-exclusion between various '(subsets of) features/items' across various samples. Using real-world microbiome data, the efficiency/utility of this rule mining approach in deciphering multiple (biologically meaningful) association patterns between 'subsets/subgroups' of microbes (constituting microbiome samples) is demonstrated. As an example, association rules derived from publicly available gut microbiome datasets indicate an association between a group of microbes (Faecalibacterium, Dorea, and Blautia) that are known to have mutualistic metabolic associations among themselves. Application of the rule mining approach on gut microbiomes (sourced from the Human Microbiome Project) further indicated similar microbial association patterns in gut microbiomes irrespective of the gender of the subjects. A Linux implementation of the Association Rule Mining (ARM) software (customised for deriving 'microbial association rules' from microbiome data) is freely available for download from the following link: http://metagenomics.atc.tcs.com/arm.	[Tandon, Disha; Haque, Mohammed Monzoorul; Mande, Sharmila S.] Tata Consultancy Serv Ltd, TCS Res, Biosci R&D Div, 54-B,Hadapsar Ind Estate, Pune 411013, Maharashtra, India	Tata Sons; Tata Consultancy Services Limited (TCS)	Mande, SS (corresponding author), Tata Consultancy Serv Ltd, TCS Res, Biosci R&D Div, 54-B,Hadapsar Ind Estate, Pune 411013, Maharashtra, India.	sharmila.mande@tcs.com						Agrawal R, 1997, P 20 VLDB C, P487; Arndt D, 2012, NUCLEIC ACIDS RES, V40, pW88, DOI 10.1093/nar/gks497; Bernalier A, 1996, ARCH MICROBIOL, V166, P176, DOI 10.1007/s002030050373; Bose T, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0142102; Brady A, 2009, NAT METHODS, V6, P673, DOI [10.1038/NMETH.1358, 10.1038/nmeth.1358]; Canani RB, 2011, WORLD J GASTROENTERO, V17, P1519, DOI [10.3748/wjg.v17.i12. 1519, 10.3748/wjg.v17.i12.1519]; Crost EH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076341; Dutta A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0114814; Faust K, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002606; Ghosh TS, 2011, BIOINFORMATION, V6, P91, DOI 10.6026/97320630006091; Ghosh TS, 2012, GENOMICS, V99, P195, DOI 10.1016/j.ygeno.2012.01.008; Ghosh TS, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-S13-S9; Ghosh TS, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-S7-S14; Hague MM, 2015, GENOMICS, V106, P116, DOI 10.1016/j.ygeno.2015.04.005; Huson DH, 2007, GENOME RES, V17, P377, DOI 10.1101/gr.5969107; Huson DH, 2013, METHOD ENZYMOL, V531, P465, DOI 10.1016/B978-0-12-407863-5.00021-6; Kato T, 2014, DNA RES, V21, P469, DOI 10.1093/dnares/dsu013; Kuntal BK, 2013, GENOMICS, V102, P409, DOI 10.1016/j.ygeno.2013.08.004; MILLER TL, 1978, ARCH MICROBIOL, V117, P145, DOI 10.1007/BF00402302; Mohammed MH, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-S3-S4; Mohammed MH, 2011, J BIOSCIENCES, V36, P709, DOI 10.1007/s12038-011-9105-2; Mohammed MH, 2011, BIOINFORMATICS, V27, P22, DOI 10.1093/bioinformatics/btq608; Monzoorul HM, 2009, BIOINFORMATICS, V25, P1722; Nagpal S, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0148347; Naulaerts S, 2015, BRIEF BIOINFORM, V16, P216, DOI 10.1093/bib/bbt074; Peng Y, 2011, BIOINFORMATICS, V27, pI94, DOI 10.1093/bioinformatics/btr216; Pokusaeva K, 2011, GENES NUTR, V6, P285, DOI 10.1007/s12263-010-0206-6; Pryde SE, 2002, FEMS MICROBIOL LETT, V217, P133, DOI 10.1016/S0378-1097(02)01106-0; Reddy RM, 2014, GENOMICS, V103, P161, DOI 10.1016/j.ygeno.2014.02.007; Reddy RM, 2012, GENE, V505, P259, DOI 10.1016/j.gene.2012.06.014; Sanli K, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-38; Schmieder R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017288; Shichao Z, 2002, ASS RULES MINING MOD, P25; Treangen TJ, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-1-r2; Turnbaugh PJ, 2007, NATURE, V449, P804, DOI 10.1038/nature06244; Xiao SM, 2014, FEMS MICROBIOL ECOL, V87, P357, DOI 10.1111/1574-6941.12228	36	12	12	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 28	2016	11	4							e0154493	10.1371/journal.pone.0154493	http://dx.doi.org/10.1371/journal.pone.0154493			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DK8XE	27124399	Green Published, gold			2022-12-26	WOS:000375211700097
J	Tenorio, MJ; Ross, BH; Luchsinger, C; Rivera-Dictter, A; Arriagada, C; Acuna, D; Aguilar, M; Cavieres, V; Burgos, PV; Ehrenfeld, P; Mardones, GA				Tenorio, Maria J.; Ross, Breyan H.; Luchsinger, Charlotte; Rivera-Dictter, Andres; Arriagada, Cecilia; Acuna, Diego; Aguilar, Marcelo; Cavieres, Viviana; Burgos, Patricia V.; Ehrenfeld, Pamela; Mardones, Gonzalo A.			Distinct Biochemical Pools of Golgi Phosphoprotein 3 in the Human Breast Cancer Cell Lines MCF7 and MDA-MB-231	PLOS ONE			English	Article							POTENTIAL THERAPEUTIC TARGET; HEPATOCELLULAR-CARCINOMA; PHOSPHATIDYLINOSITOL 4-PHOSPHATE; MEMBRANE-PROTEIN; WORSE PROGNOSIS; HIGH EXPRESSION; BREFELDIN-A; GOLPH3; OVEREXPRESSION; MIGRATION	Golgi phosphoprotein 3 (GOLPH3) has been implicated in the development of carcinomas in many human tissues, and is currently considered a bona fide oncoprotein. Importantly, several tumor types show overexpression of GOLPH3, which is associated with tumor progress and poor prognosis. However, the underlying molecular mechanisms that connect GOLPH3 function with tumorigenicity are poorly understood. Experimental evidence shows that depletion of GOLPH3 abolishes transformation and proliferation of tumor cells in GOLPH3-overexpressing cell lines. Conversely, GOLPH3 overexpression drives transformation of primary cell lines and enhances mouse xenograft tumor growth in vivo. This evidence suggests that overexpression of GOLPH3 could result in distinct features of GOLPH3 in tumor cells compared to that of non-tumorigenic cells. GOLPH3 is a peripheral membrane protein mostly localized at the trans-Golgi network, and its association with Golgi membranes depends on binding to phosphatidylinositol-4-phosphate. GOLPH3 is also contained in a large cytosolic pool that rapidly exchanges with Golgi-associated pools. GOLPH3 has also been observed associated with vesicles and tubules arising from the Golgi, as well as other cellular compartments, and hence it has been implicated in several membrane trafficking events. Whether these and other features are typical to all different types of cells is unknown. Moreover, it remains undetermined how GOLPH3 acts as an oncoprotein at the Golgi. Therefore, to better understand the roles of GOLPH3 in cancer cells, we sought to compare some of its biochemical and cellular properties in the human breast cancer cell lines MCF7 and MDA-MB-231 with that of the non-tumorigenic breast human cell line MCF 10A. We found unexpected differences that support the notion that in different cancer cells, overexpression of GOLPH3 functions in diverse fashions, which may influence specific tumorigenic phenotypes.	[Tenorio, Maria J.; Ross, Breyan H.; Luchsinger, Charlotte; Rivera-Dictter, Andres; Arriagada, Cecilia; Acuna, Diego; Aguilar, Marcelo; Cavieres, Viviana; Burgos, Patricia V.; Mardones, Gonzalo A.] Univ Austral Chile, Dept Physiol, Sch Med, Valdivia, Chile; [Tenorio, Maria J.; Ross, Breyan H.; Luchsinger, Charlotte; Rivera-Dictter, Andres; Arriagada, Cecilia; Acuna, Diego; Aguilar, Marcelo; Cavieres, Viviana; Burgos, Patricia V.; Ehrenfeld, Pamela; Mardones, Gonzalo A.] Univ Austral Chile, Ctr Interdisciplinario Estudios Sistema Nervioso, Valdivia, Chile; [Ehrenfeld, Pamela] Univ Austral Chile, Dept Anat Histol & Pathol, Sch Med, Valdivia, Chile; [Ross, Breyan H.] Max Planck Inst Biochem, Klopferspitz 18A, D-82152 Martinsried, Germany	Universidad Austral de Chile; Universidad Austral de Chile; Universidad Austral de Chile; Max Planck Society	Mardones, GA (corresponding author), Univ Austral Chile, Dept Physiol, Sch Med, Valdivia, Chile.; Mardones, GA (corresponding author), Univ Austral Chile, Ctr Interdisciplinario Estudios Sistema Nervioso, Valdivia, Chile.	gonzalo.mardones@uach.cl	Luchsinger, Charlotte/AAZ-6028-2021	EHRENFELD, INGRID/0000-0002-2519-7570; Arriagada, Cecilia/0000-0002-5351-2240	Fondo Nacional de Desarrollo Cientifico y Tecnologico of Chile (FONDECYT) [1130710, 1130929]; Direccion de Investigacion y Desarrollo de la Universidad Austral de Chile (DID-UACh); Comision Nacional de Investigacion Cientifica y Tecnologica of Chile (CONICYT)	Fondo Nacional de Desarrollo Cientifico y Tecnologico of Chile (FONDECYT)(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT FONDECYT); Direccion de Investigacion y Desarrollo de la Universidad Austral de Chile (DID-UACh); Comision Nacional de Investigacion Cientifica y Tecnologica of Chile (CONICYT)	This work was funded by grants 1130710 (G.A.M.) and 1130929 (P.V.B.) from Fondo Nacional de Desarrollo Cientifico y Tecnologico of Chile (FONDECYT; http://www.conicyt.cl/fondecyt), and from Direccion de Investigacion y Desarrollo de la Universidad Austral de Chile (DID-UACh; http://investigacion.uach.cl) (G.A.M. and P.V.B.). C.L., C. A., and V.C. are supported by fellowships from Comision Nacional de Investigacion Cientifica y Tecnologica of Chile (CONICYT; http://www.conicyt.cl). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ali MF, 2012, J BIOL CHEM, V287, DOI 10.1074/jbc.M112.346528; Bell AW, 2001, J BIOL CHEM, V276, P5152, DOI 10.1074/jbc.M006143200; Bishe B, 2012, J BIOL CHEM, V287, P27637, DOI 10.1074/jbc.M112.346569; Bonangelino CJ, 2002, MOL BIOL CELL, V13, P2486, DOI 10.1091/mbc.02-01-0005; Bugarcic A, 2011, TRAFFIC, V12, P1759, DOI 10.1111/j.1600-0854.2011.01284.x; Cavieres VA, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0136313; Dai T, 2015, J PATHOL, V235, P490, DOI 10.1002/path.4479; Diao A, 2003, J CELL BIOL, V160, P201, DOI 10.1083/jcb.200207045; Dippold HC, 2009, CELL, V139, P337, DOI 10.1016/j.cell.2009.07.052; DONALDSON JG, 1990, J CELL BIOL, V111, P2295, DOI 10.1083/jcb.111.6.2295; Eckert ESP, 2014, J BIOL CHEM, V289, P31319, DOI 10.1074/jbc.M114.608182; Farber-Katz SE, 2014, CELL, V156, P413, DOI 10.1016/j.cell.2013.12.023; Ho JR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039469; HOWELL KE, 1982, J CELL BIOL, V92, P822, DOI 10.1083/jcb.92.3.822; Hsu JW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074715; Hu BS, 2013, TUMOR BIOL, V34, P515, DOI 10.1007/s13277-012-0576-z; Hu GS, 2014, TUMOR BIOL, V35, P8625, DOI 10.1007/s13277-014-2105-8; Hua X, 2012, DIAGN PATHOL, V7, DOI 10.1186/1746-1596-7-127; Isaji T, 2014, J BIOL CHEM, V289, P20694, DOI 10.1074/jbc.M113.542688; Jackson CL, 2000, TRENDS CELL BIOL, V10, P60, DOI 10.1016/S0962-8924(99)01699-2; Jiang JX, 2014, CLIN INVEST MED, V37, pE233; Kunigou O, 2011, ONCOL REP, V26, P1337, DOI 10.3892/or.2011.1413; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LEELAVATHI DE, 1970, BIOCHIM BIOPHYS ACTA, V211, P124, DOI 10.1016/0005-2736(70)90087-8; Li H, 2012, J TRANSL MED, V10, DOI 10.1186/1479-5876-10-168; Li XY, 2011, J NEURO-ONCOL, V105, P159, DOI 10.1007/s11060-011-0573-x; LIPPINCOTTSCHWARTZ J, 1991, CELL, V67, P601, DOI 10.1016/0092-8674(91)90534-6; LIPPINCOTTSCHWARTZ J, 1989, CELL, V56, P801, DOI 10.1016/0092-8674(89)90685-5; Ma YC, 2014, TUMOR BIOL, V35, P11845, DOI 10.1007/s13277-014-2411-1; Ma YC, 2014, VIRCHOWS ARCH, V464, P443, DOI 10.1007/s00428-014-1536-3; MANDERS EMM, 1992, J CELL SCI, V103, P857; Mardones GA, 2006, MOL BIOL CELL, V17, P525, DOI 10.1091/mbc.E05-05-0447; Mardones GA, 2007, MOL BIOL CELL, V18, P3486, DOI 10.1091/mbc.E07-02-0190; Mellman I, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a016949; Nakashima-Kamimura N, 2005, J CELL SCI, V118, P5357, DOI 10.1242/jcs.02645; Ng MM, 2013, MOL BIOL CELL, V24, P796, DOI 10.1091/mbc.E12-07-0525; Peng JZ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107362; Pereira NA, 2014, J BIOL CHEM, V289, P14762, DOI 10.1074/jbc.M114.548305; Popoff V, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a005231; Presley JF, 2002, NATURE, V417, P187, DOI 10.1038/417187a; Puertollano R, 2003, MOL BIOL CELL, V14, P1545, DOI 10.1091/mbc.02-07-0109; Ross BH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088147; Salem AF, 2012, CELL CYCLE, V11, P2545, DOI 10.4161/cc.20920; Sangwung P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031564; Schmitz KR, 2008, DEV CELL, V14, P523, DOI 10.1016/j.devcel.2008.02.016; Scott KL, 2009, NATURE, V459, P1085, DOI 10.1038/nature08109; Sechi S, 2015, ONCOTARGET, V6, P3493, DOI 10.18632/oncotarget.3051; Sechi S, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004305; Sheffield P, 1999, PROTEIN EXPRES PURIF, V15, P34, DOI 10.1006/prep.1998.1003; Shorter J, 1999, EMBO J, V18, P4949, DOI 10.1093/emboj/18.18.4949; Snyder CM, 2006, MOL BIOL CELL, V17, P511, DOI 10.1091/mbc.E05-07-0682; Sotgia F, 2012, CELL CYCLE, V11, P4390, DOI 10.4161/cc.22777; Tenorio MJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0135260; Tokuda E, 2014, CANCER RES, V74, P3054, DOI 10.1158/0008-5472.CAN-13-2441; Tu L, 2008, SCIENCE, V321, P404, DOI 10.1126/science.1159411; Tu LN, 2012, TRAFFIC, V13, P1496, DOI 10.1111/j.1600-0854.2012.01403.x; Wang JH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045622; Wang ZZ, 2014, J TRANSL MED, V12, DOI 10.1186/1479-5876-12-15; WATERS MG, 1991, NATURE, V349, P248, DOI 10.1038/349248a0; White J, 1999, J CELL BIOL, V147, P743, DOI 10.1083/jcb.147.4.743; Wood CS, 2009, J CELL BIOL, V187, P967, DOI 10.1083/jcb.200909063; Wu CC, 2004, MOL BIOL CELL, V15, P2907, DOI 10.1091/mbc.E04-02-0101; Wu CC, 2000, TRAFFIC, V1, P963, DOI 10.1034/j.1600-0854.2000.011206.x; Xue Y, 2014, BRIT J CANCER, V110, P2250, DOI 10.1038/bjc.2014.124; Zeng ZL, 2012, CLIN CANCER RES, V18, P4059, DOI 10.1158/1078-0432.CCR-11-3156; Zhang LJ, 2014, BMC CANCER, V14, DOI 10.1186/1471-2407-14-571; Zhang Q, 2015, ONCOTARGET, V6, P32177, DOI 10.18632/oncotarget.4867; Zhang X, 2015, MOL CARCINOGEN, V54, P1252, DOI 10.1002/mc.22197; Zhang Y, 2014, TUMOR BIOL, V35, P10833, DOI 10.1007/s13277-014-2357-3; Zhou JX, 2012, J NEURO-ONCOL, V110, P195, DOI 10.1007/s11060-012-0970-9; Zhou XP, 2013, BIOCHEM BIOPH RES CO, V433, P338, DOI 10.1016/j.bbrc.2013.03.003	71	13	14	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 28	2016	11	4							e0154719	10.1371/journal.pone.0154719	http://dx.doi.org/10.1371/journal.pone.0154719			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DK8XE	27123979	Green Published, gold, Green Submitted			2022-12-26	WOS:000375211700124
J	Kunishima, M; Yamauchi, Y; Mizutani, M; Kuse, M; Takikawa, H; Sugimoto, Y				Kunishima, Mikiko; Yamauchi, Yasuo; Mizutani, Masaharu; Kuse, Masaki; Takikawa, Hirosato; Sugimoto, Yukihiro			Identification of (Z)-3:(E)-2-Hexenal Isomerases Essential to the Production of the Leaf Aldehyde in Plants	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						enzyme mechanism; enzyme purification; lipid peroxidation; plant biochemistry; polyunsaturated fatty acid (PUFA)	SWISS-MODEL; LIPOXYGENASE PATHWAY; BIOSYNTHETIC-PATHWAY; TOMATO; VOLATILES; ACID; ALCOHOL; AROMA; ENVIRONMENT; COMPONENTS	The green odor of plants is characterized by green leaf volatiles (GLVs) composed of C6 compounds. GLVs are biosynthesized from polyunsaturated fatty acids in thylakoid membranes by a series of enzymes. A representative member of GLVs (E)-2-hexenal, known as the leaf aldehyde, has been assumed to be produced by isomerization from (Z)-3-hexenal in the biosynthesis pathway; however, the enzyme has not yet been identified. In this study, we purified the (Z)-3:(E)-2-hexenal isomerase (HI) from paprika fruits and showed that various plant species have homologous HIs. Purified HI is a homotrimeric protein of 110 kDa composed of 35-kDa subunits and shows high activity at acidic and neutral pH values. Phylogenetic analysis showed that HIs belong to the cupin superfamily, and at least three catalytic amino acids (His, Lys, Tyr) are conserved in HIs of various plant species. Enzymatic isomerization of (Z)-3-hexenal in the presence of deuterium oxide resulted in the introduction of deuterium at the C4 position of (E)-2-hexenal, and a suicide substrate 3-hexyn-1-al inhibited HI irreversibly, suggesting that the catalytic mode of HI is a keto-enol tautomerism reaction mode mediated by a catalytic His residue. The gene expression of HIs in Solanaceae plants was enhanced in specific developmental stages and by wounding treatment. Transgenic tomato plants overexpressing paprika HI accumulated (E)-2-hexenal in contrast to wild-type tomato plants mainly accumulating (Z)-3-hexenal, suggesting that HI plays a key role in the production of (E)-2-hexenal in planta.	[Kunishima, Mikiko; Yamauchi, Yasuo; Mizutani, Masaharu; Kuse, Masaki; Takikawa, Hirosato; Sugimoto, Yukihiro] Kobe Univ, Grad Sch Agr Sci, Nada Ku, 1-1 Rokkodai, Kobe, Hyogo 6578501, Japan	Kobe University	Yamauchi, Y (corresponding author), Kobe Univ, Grad Sch Agr Sci, Nada Ku, 1-1 Rokkodai, Kobe, Hyogo 6578501, Japan.	yamauchi@kobe-u.ac.jp		Mizutani, Masaharu/0000-0002-4321-0644	University of Tsukuba, Gene Research Center, through the National Bio-Resource Project (NBRP) of the Japan Agency for Research and Development (AMED), Japan [TOMJPF00001]	University of Tsukuba, Gene Research Center, through the National Bio-Resource Project (NBRP) of the Japan Agency for Research and Development (AMED), Japan(Japan Agency for Medical Research and Development (AMED))	Tomato seeds (Micro-Tom, TOMJPF00001) were provided by University of Tsukuba, Gene Research Center, through the National Bio-Resource Project (NBRP) of the Japan Agency for Research and Development (AMED), Japan.	Alonso A, 2009, FOOD SCI TECHNOL INT, V15, P47, DOI 10.1177/1082013208102385; Arnold K, 2006, BIOINFORMATICS, V22, P195, DOI 10.1093/bioinformatics/bti770; Bate NJ, 1998, PHYSIOL PLANTARUM, V104, P97, DOI 10.1034/j.1399-3054.1998.1040113.x; Benkert P, 2009, NUCLEIC ACIDS RES, V37, pW510, DOI 10.1093/nar/gkp322; Biasini M, 2014, NUCLEIC ACIDS RES, V42, pW252, DOI 10.1093/nar/gku340; Bloch K., 1971, ENZYMES, V5, P441; Bordoli L, 2009, NAT PROTOC, V4, P1, DOI 10.1038/nprot.2008.197; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Chen GP, 2004, PLANT PHYSIOL, V136, P2641, DOI 10.1104/pp.104.041608; CROFT KPC, 1993, PLANT PHYSIOL, V101, P13, DOI 10.1104/pp.101.1.13; Curtins T, 1912, LIEBIGS ANN CHEM, V390, P89; D'Auria JC, 2007, PLANT J, V49, P194, DOI 10.1111/j.1365-313X.2006.02946.x; De Moraes CM, 2001, NATURE, V410, P577, DOI 10.1038/35069058; Dunwell JM, 2004, PHYTOCHEMISTRY, V65, P7, DOI 10.1016/j.phytochem.2003.08.016; ENDO K, 1970, J BIOL CHEM, V245, P4293; Fall R, 1999, J GEOPHYS RES-ATMOS, V104, P15963, DOI 10.1029/1999JD900144; GALLIARD T, 1976, BIOCHIM BIOPHYS ACTA, V441, P181, DOI 10.1016/0005-2760(76)90161-2; Guex N, 1997, ELECTROPHORESIS, V18, P2714, DOI 10.1002/elps.1150181505; HATANAKA A, 1987, CHEM PHYS LIPIDS, V44, P341, DOI 10.1016/0009-3084(87)90057-0; HATANAKA A, 1975, PHYTOCHEMISTRY, V14, P2589, DOI 10.1016/0031-9422(75)85230-7; Howe GA, 2000, PLANT PHYSIOL, V123, P711, DOI 10.1104/pp.123.2.711; Kishimoto K, 2006, PLANT SCI, V170, P715, DOI 10.1016/j.plantsci.2005.11.002; Kishimoto K, 2005, PLANT CELL PHYSIOL, V46, P1093, DOI 10.1093/pcp/pci122; Leesong M, 1996, STRUCTURE, V4, P253, DOI 10.1016/S0969-2126(96)00030-5; Lewinsohn E, 2001, PLANT PHYSIOL, V127, P1256, DOI 10.1104/pp.127.3.1256; LUNING PA, 1995, J AGR FOOD CHEM, V43, P1493, DOI 10.1021/jf00054a015; Mano J, 2002, PLANT CELL PHYSIOL, V43, P1445, DOI 10.1093/pcp/pcf187; Mathieu S, 2009, J EXP BOT, V60, P325, DOI 10.1093/jxb/ern294; Matsui K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036433; Myung K, 2006, J AGR FOOD CHEM, V54, P1442, DOI 10.1021/jf052068+; Niinemets U, 2010, TRENDS PLANT SCI, V15, P145, DOI 10.1016/j.tplants.2009.11.008; Noordermeer MA, 1999, FEBS LETT, V443, P201, DOI 10.1016/S0014-5793(98)01706-2; PHILLIPS DR, 1979, PHYTOCHEMISTRY, V18, P401, DOI 10.1016/S0031-9422(00)81874-9; RYAN CA, 1990, ANNU REV PHYTOPATHOL, V28, P425, DOI 10.1146/annurev.py.28.090190.002233; Scala A, 2013, INT J MOL SCI, V14, P17781, DOI 10.3390/ijms140917781; Speirs J, 1998, PLANT PHYSIOL, V117, P1047, DOI 10.1104/pp.117.3.1047; Sun HJ, 2006, PLANT CELL PHYSIOL, V47, P426, DOI 10.1093/pcp/pci251; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Tandon KS, 2000, POSTHARVEST BIOL TEC, V20, P261, DOI 10.1016/S0925-5214(00)00143-5; Vancanneyt G, 2001, P NATL ACAD SCI USA, V98, P8139, DOI 10.1073/pnas.141079498; Wang CL, 2001, PHYTOCHEMISTRY, V58, P227, DOI 10.1016/S0031-9422(01)00233-3; Wavrin L, 2002, SYNTHESIS-STUTTGART, P326; Yamauchi Y, 2015, SCI REP-UK, V5, DOI 10.1038/srep08030; Yamauchi Y, 2012, FEBS LETT, V586, P1208, DOI 10.1016/j.febslet.2012.03.013; Yamauchi Y, 2011, J BIOL CHEM, V286, P6999, DOI 10.1074/jbc.M110.202226	45	40	41	1	34	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 1	2016	291	27					14023	14033		10.1074/jbc.M116.726687	http://dx.doi.org/10.1074/jbc.M116.726687			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DR5XG	27129773	hybrid, Green Published			2022-12-26	WOS:000379975100011
J	Lewis, BA; Burlingame, AL; Myers, SA				Lewis, Brian A.; Burlingame, Alma L.; Myers, Samuel A.			Human RNA Polymerase II Promoter Recruitment in Vitro Is Regulated by O-Linked N-Acetylglucosaminyltransferase (OGT)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						gene regulation; O-GlcNAcylation; O-linked N-acetylglucosamine (O-GlcNAc) transferase (OGT); RNA polymerase II; transcription	TERMINAL DOMAIN; GLCNAC; TRANSCRIPTION; PHOSPHORYLATION; METABOLISM; PROTEIN	Although the O-linked N-acetylglucosamine (O-GlcNAc) modification of the RNA polymerase II C-terminal domain was described 20 years ago, the function of this RNA polymerase II (pol II) species is not known. We show here that an O-GlcNAcylated pol II species (pol II) exists on promoters in vitro. Inhibition of O-GlcNAc-transferase activity and O-GlcNAcylation prevents pol II entry into the promoter, and O-GlcNAc removal from pol II is an ATP-dependent step during initiation. These data indicate that O-GlcNAc-transferase activity is essential for RNA pol II promoter recruitment and that pol II goes through a cycling of O-GlcNAcylation at the promoter. Mass spectrometry shows that serine residues 2 and 5 of the pol II C-terminal domain are O-GlcNAcylated, suggesting an overlap with the transcription factor IIH (TFIIH)-dependent serine 5 phosphorylation events during initiation and P-TEFb (positive transcriptional elongation factor b) events during elongation. These data provide unexpected and important insights into the role of a previously ill-defined species of RNA polymerase II in regulating transcription.	[Lewis, Brian A.] NCI, Transcript Regulat & Biochem Unit, Metab Branch, Ctr Canc Res,NIH, Bethesda, MD 20892 USA; [Burlingame, Alma L.; Myers, Samuel A.] Univ Calif San Francisco, Dept Pharmaceut Chem, San Francisco, CA 94158 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); University of California System; University of California San Francisco	Lewis, BA (corresponding author), NCI, Transcript Regulat & Biochem Unit, Metab Branch, Ctr Canc Res,NIH, Bethesda, MD 20892 USA.	lewisbri@mail.nih.gov		Lewis, Brian/0000-0002-8321-0665	NCI Intramural Program; Biomedical Technology Research Centers Program of the National Institutes of Health NIGMS; National Institutes of Health NIGMS [8P41GM103481]; NATIONAL CANCER INSTITUTE [ZIABC011223] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P41GM103481] Funding Source: NIH RePORTER	NCI Intramural Program(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Biomedical Technology Research Centers Program of the National Institutes of Health NIGMS; National Institutes of Health NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the NCI Intramural Program (to B. A. L.) and by the Biomedical Technology Research Centers Program of the National Institutes of Health NIGMS, National Institutes of Health NIGMS Grant 8P41GM103481, and Howard Hughes Medical Institute (to S. A. M. and A. L. B.). The authors have no conflicts of interest to declare. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Adamson TE, 2003, METHOD ENZYMOL, V371, P264; Bond MR, 2013, ANNU REV NUTR, V33, P205, DOI 10.1146/annurev-nutr-071812-161240; Cheng B, 2009, METHODS, V48, P346, DOI 10.1016/j.ymeth.2009.02.026; CHESNUT JD, 1992, J BIOL CHEM, V267, P10500; Comer FI, 2001, BIOCHEMISTRY-US, V40, P7845, DOI 10.1021/bi0027480; DIGNAM JD, 1983, NUCLEIC ACIDS RES, V11, P1475, DOI 10.1093/nar/11.5.1475; GOODRICH JA, 1994, CELL, V77, P145, DOI 10.1016/0092-8674(94)90242-9; Gross BJ, 2005, J AM CHEM SOC, V127, P14588, DOI 10.1021/ja0555217; Hart GW, 2007, NATURE, V446, P1017, DOI 10.1038/nature05815; Hsu JY, 2008, GENE DEV, V22, P2353, DOI 10.1101/gad.1681808; JONES KA, 1987, CELL, V48, P79, DOI 10.1016/0092-8674(87)90358-8; KELLY WG, 1993, J BIOL CHEM, V268, P10416; Lewis BA, 2013, BBA-GENE REGUL MECH, V1829, P1202, DOI 10.1016/j.bbagrm.2013.09.003; LU H, 1991, P NATL ACAD SCI USA, V88, P10004, DOI 10.1073/pnas.88.22.10004; Ma ZY, 2013, AMINO ACIDS, V45, P719, DOI 10.1007/s00726-013-1543-8; Macauley MS, 2010, BBA-GEN SUBJECTS, V1800, P107, DOI 10.1016/j.bbagen.2009.07.028; Myers SA, 2013, PROTEOMICS, V13, P982, DOI 10.1002/pmic.201200332; Qian H, 2007, ANNU REV PHYS CHEM, V58, P113, DOI 10.1146/annurev.physchem.58.032806.104550; Ranuncolo SM, 2012, J BIOL CHEM, V287, P23549, DOI 10.1074/jbc.M111.330910; REASON A J, 1991, Glycobiology, V1, P387, DOI 10.1093/glycob/1.4.387; Ruan HB, 2013, TRENDS ENDOCRIN MET, V24, P301, DOI 10.1016/j.tem.2013.02.002; Sim RJ, 2004, GENE DEV, V18, P2437, DOI 10.1101/gad.1235904; Thomas MC, 2006, CRIT REV BIOCHEM MOL, V41, P105, DOI 10.1080/10409230600648736	23	30	32	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 1	2016	291	27					14056	14061		10.1074/jbc.M115.684365	http://dx.doi.org/10.1074/jbc.M115.684365			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DR5XG	27129214	Green Published, hybrid			2022-12-26	WOS:000379975100014
J	Bedard, LG; Dronamraju, R; Kerschner, JL; Hunter, GO; Axley, ED; Boyd, AK; Strahl, BD; Mosley, AL				Bedard, Lynn Glowczewski; Dronamraju, Raghuvar; Kerschner, Jenny L.; Hunter, Gerald O.; Axley, Elizabeth DeVlieger; Boyd, Asha K.; Strahl, Brian D.; Mosley, Amber L.			Quantitative Analysis of Dynamic Protein Interactions during Transcription Reveals a Role for Casein Kinase II in Polymerase-associated Factor (PAF) Complex Phosphorylation and Regulation of Histone H2B Monoubiquitylation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						chromatin; histone modification; phosphorylation; transcription; ubiquitylation (ubiquitination); FACT; PAF-C; SILAC; casein kinase II; quantitative proteomics	MASS SPECTROMETRY DATA; SACCHAROMYCES-CEREVISIAE; AFFINITY PURIFICATION; ELONGATION-FACTORS; IN-VIVO; YEAST; CK2; CHROMATIN; UBIQUITINATION; H3	Using affinity purification MS approaches, we have identified a novel role for casein kinase II (CKII) in the modification of the polymerase associated factor complex (PAF-C). Our data indicate that the facilitates chromatin transcription complex (FACT) interacts with CKII and may facilitate PAF complex phosphorylation. Posttranslational modification analysis of affinity-isolated PAF-C shows extensive CKII phosphorylation of all five subunits of PAF-C, although CKII subunits were not detected as interacting partners. Consistent with this, recombinant CKII or FACT-associated CKII isolated from cells can phosphorylate PAF-C in vitro, whereas no intrinsic kinase activity was detected in PAF-C samples. Significantly, PAF-C purifications combined with stable isotope labeling in cells (SILAC) quantitation for PAF-C phosphorylation from wild-type and CKII temperature-sensitive strains (cka1 cka2-8) showed that PAF-C phosphorylation at consensus CKII sites is significantly reduced in cka1 cka2-8 strains. Consistent with a role of CKII in FACT and PAF-C function, we show that decreased CKII function in vivo results in decreased levels of histone H2B lysine 123 monoubiquitylation, a modification dependent on FACT and PAF-C. Taken together, our results define a coordinated role of CKII and FACT in the regulation of RNA polymerase II transcription through chromatin via phosphorylation of PAF-C.	[Bedard, Lynn Glowczewski; Boyd, Asha K.] Depauw Univ, Dept Biol, Greencastle, IN 46135 USA; [Bedard, Lynn Glowczewski; Hunter, Gerald O.; Axley, Elizabeth DeVlieger; Boyd, Asha K.; Mosley, Amber L.] Indiana Univ Sch Med, Dept Biochem & Mol Biol, 635 Barnhill Dr, Indianapolis, IN 46202 USA; [Mosley, Amber L.] Indiana Univ Sch Med, Ctr Computat Biol & Bioinformat, Indianapolis, IN 46202 USA; [Dronamraju, Raghuvar; Kerschner, Jenny L.; Strahl, Brian D.] Univ N Carolina, Sch Med, Dept Biochem & Biophys, Chapel Hill, NC 27599 USA; [Kerschner, Jenny L.; Strahl, Brian D.] Univ N Carolina, Sch Med, Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27599 USA; [Strahl, Brian D.] Univ N Carolina, Sch Med, Curriculum Genet & Mol Biol, Chapel Hill, NC 27599 USA	DePauw University; Indiana University System; Indiana University Bloomington; Indiana University System; Indiana University Bloomington; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine	Mosley, AL (corresponding author), Indiana Univ Sch Med, Dept Biochem & Mol Biol, 635 Barnhill Dr, Indianapolis, IN 46202 USA.	almosley@iu.edu	, PEP-MX Core/AGV-4051-2022; Strahl, Brian D/C-7601-2012	Strahl, Brian D/0000-0002-4947-6259	National Institutes of Health [R01 GM099714, R01 GM110058]; Indiana University School of Medicine; DePauw University; University of North Carolina Lineberger Comprehensive Cancer Center Basic Mechanisms of Viral and Chemical Carcinogenesis Training Grant [5 T32 CA009156]; summer undergraduate program for prospective physician scientists at the Indiana University School of Medicine; NATIONAL CANCER INSTITUTE [T32CA009156] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [F32GM116352, R01GM110058, R01GM099714] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Indiana University School of Medicine; DePauw University; University of North Carolina Lineberger Comprehensive Cancer Center Basic Mechanisms of Viral and Chemical Carcinogenesis Training Grant; summer undergraduate program for prospective physician scientists at the Indiana University School of Medicine; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Grants R01 GM099714 (to A.L.M.) and R01 GM110058 (to B.D.S.) and a biomedical research grant from the Indiana University School of Medicine. Summer support for part of the work on this project was provided by the DePauw University Student Faculty Summer Research Fund and Professional Development Fund (to L. G. B. and A. K. B.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.; Supported by a postdoctoral fellowship awarded by University of North Carolina Lineberger Comprehensive Cancer Center Basic Mechanisms of Viral and Chemical Carcinogenesis Training Grant 5 T32 CA009156.; Supported by the summer undergraduate program for prospective physician scientists at the Indiana University School of Medicine.	Adelman K, 2006, MOL CELL BIOL, V26, P250, DOI 10.1128/MCB.26.1.250-260.2006; Amanchy R, 2007, NAT BIOTECHNOL, V25, P285, DOI 10.1038/nbt0307-285; Betz JL, 2002, MOL GENET GENOMICS, V268, P272, DOI 10.1007/s00438-002-0752-8; Blatch GL, 1997, GENE, V194, P277, DOI 10.1016/S0378-1119(97)00206-0; Breitkreutz A, 2010, SCIENCE, V328, P1043, DOI 10.1126/science.1176495; Briggs SD, 2002, NATURE, V418, P498, DOI 10.1038/nature00970; Choi H., 2012, CURR PROTOC BIOINFOR; Choi H, 2011, NAT METHODS, V8, P70, DOI 10.1038/NMETH.1541; Costa PJ, 2000, GENETICS, V156, P535; Cucinotta CE, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005420; Daniels DL, 2012, J PROTEOME RES, V11, P564, DOI 10.1021/pr200459c; Dover J, 2002, J BIOL CHEM, V277, P28368, DOI 10.1074/jbc.C200348200; Dronamraju R, 2014, NUCLEIC ACIDS RES, V42, P870, DOI 10.1093/nar/gkt1003; Filhol O, 2015, CELL MOL LIFE SCI, V72, P3305, DOI 10.1007/s00018-015-1929-8; Formosa T, 2001, EMBO J, V20, P3506, DOI 10.1093/emboj/20.13.3506; Gelbart ME, 2001, MOL CELL BIOL, V21, P2098, DOI 10.1128/MCB.21.6.2098-2106.2001; Gietz RD, 2007, NAT PROTOC, V2, P31, DOI 10.1038/nprot.2007.13; HANNA DE, 1995, J BIOL CHEM, V270, P25905, DOI 10.1074/jbc.270.43.25905; Hockman DJ, 1996, MOL CELL BIOL, V16, P892; Janke C, 2004, YEAST, V21, P947, DOI 10.1002/yea.1142; Keller DM, 2001, MOL CELL, V7, P283, DOI 10.1016/S1097-2765(01)00176-9; Kemble DJ, 2013, J BIOL CHEM, V288, P10188, DOI 10.1074/jbc.C113.451369; Kim J, 2010, CELL, V140, P491, DOI 10.1016/j.cell.2009.12.050; Krogan NJ, 2002, MOL CELL BIOL, V22, P6979, DOI 10.1128/MCB.22.20.6979-6992.2002; Kwon Y, 2013, SCIENCE, V342, P737, DOI 10.1126/science.1243971; Laribee RN, 2005, CURR BIOL, V15, P1487, DOI 10.1016/j.cub.2005.07.028; McCullough L, 2013, GENETICS, V195, P101, DOI 10.1534/genetics.113.153080; Meggio F, 2003, FASEB J, V17, P349, DOI 10.1096/fj.02-0473rev; Mellacheruvu D, 2013, NAT METHODS, V10, P730, DOI 10.1038/nmeth.2557; Miteva YV, 2013, ANAL CHEM, V85, P749, DOI 10.1021/ac3033257; Mosley AL, 2013, MOL CELL PROTEOMICS, V12, P1530, DOI 10.1074/mcp.M112.024034; Mosley AL, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M110.000687; Mosley AL, 2009, MOL CELL, V34, P168, DOI 10.1016/j.molcel.2009.02.025; Mueller CL, 2002, MOL CELL BIOL, V22, P1971, DOI 10.1128/MCB.22.7.1971-1980.2002; Ng HH, 2002, J BIOL CHEM, V277, P34655, DOI 10.1074/jbc.C200433200; Orphanides G, 1999, NATURE, V400, P284, DOI 10.1038/22350; Pavri R, 2006, CELL, V125, P703, DOI 10.1016/j.cell.2006.04.029; Peng YT, 2011, MOL BIOL CELL, V22, P2680, DOI 10.1091/mbc.E10-11-0915; Piazza F, 2012, LEUKEMIA, V26, P1174, DOI 10.1038/leu.2011.385; Piazza F, 2013, LEUKEMIA RES, V37, P221, DOI 10.1016/j.leukres.2012.10.016; Puig O, 2001, METHODS, V24, P218, DOI 10.1006/meth.2001.1183; Riles L, 2004, YEAST, V21, P241, DOI 10.1002/yea.1068; Robzyk K, 2000, SCIENCE, V287, P501, DOI 10.1126/science.287.5452.501; Ruan WJ, 2011, J BIOL CHEM, V286, P18701, DOI 10.1074/jbc.M111.222273; Schwartz D, 2005, NAT BIOTECHNOL, V23, P1391, DOI 10.1038/nbt1146; Shi XM, 1997, MOL CELL BIOL, V17, P1160, DOI 10.1128/MCB.17.3.1160; Smith-Kinnaman WR, 2014, MOL BIOSYST, V10, P1730, DOI 10.1039/c4mb00109e; Squazzo SL, 2002, EMBO J, V21, P1764, DOI 10.1093/emboj/21.7.1764; Stuwe T, 2008, P NATL ACAD SCI USA, V105, P8884, DOI 10.1073/pnas.0712293105; Sun ZW, 2002, NATURE, V418, P104, DOI 10.1038/nature00883; Thomsen MCF, 2012, NUCLEIC ACIDS RES, V40, pW281, DOI 10.1093/nar/gks469; Thornton JL, 2014, GENE DEV, V28, P115, DOI 10.1101/gad.232215.113; Tomson BN, 2013, BBA-GENE REGUL MECH, V1829, P116, DOI 10.1016/j.bbagrm.2012.08.011; Trembley JH, 2003, J BIOL CHEM, V278, P2265, DOI 10.1074/jbc.M207518200; Tripodi F, 2013, EUKARYOT CELL, V12, P1271, DOI 10.1128/EC.00117-13; Venerando A, 2014, BIOCHEM J, V460, P141, DOI 10.1042/BJ20140178; Wozniak GG, 2014, BBA-GENE REGUL MECH, V1839, P1353, DOI 10.1016/j.bbagrm.2014.03.002; Xiao TJ, 2005, MOL CELL BIOL, V25, P637, DOI 10.1128/MCB.25.2.637-651.2005; Zhu B, 2005, GENE DEV, V19, P1668, DOI 10.1101/gad.1292105; Zybailov B, 2006, J PROTEOME RES, V5, P2339, DOI 10.1021/pr060161n	60	11	11	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 24	2016	291	26					13410	13420		10.1074/jbc.M116.727735	http://dx.doi.org/10.1074/jbc.M116.727735			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DR2YZ	27143358	Green Published, hybrid			2022-12-26	WOS:000379771100001
J	Stolle, P; Hou, B; Bruser, T				Stolle, Patrick; Hou, Bo; Brueser, Thomas			The Tat Substrate CueO Is Transported in an Incomplete Folding State	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						copper; metalloprotein; protein folding; protein translocation; stress response; Tat system	MULTICOPPER OXIDASE CUEO; ESCHERICHIA-COLI K-12; NITRITE REDUCTASE; ALCALIGENES-XYLOSOXIDANS; COPPER HOMEOSTASIS; CUPROUS OXIDASE; PROTEIN EXPORT; EXPRESSION; CLONING; PATHWAY	In Escherichia coli, cytoplasmic copper ions are toxic to cells even at the lowest concentrations. As a defense strategy, the cuprous oxidase CueO is secreted into the periplasm to oxidize the more membrane-permeable and toxic Cu(I) before it can enter the cytoplasm. CueO itself is a multicopper oxidase that requires copper for activity. Because it is transported by the twin-arginine translocation (Tat) pathway, which transports folded proteins, a requirement for cofactor assembly before translocation has been discussed. Here we show that CueO is transported as an apo-protein. Periplasmic CueO was readily activated by the addition of copper ions in vitro or under copper stress conditions in vivo. Cytoplasmic CueO did not contain copper, even under copper stress conditions. In vitro Tat transport proved that the cofactor assembly was not required for functional Tat transport of CueO. Due to the post-translocational activation of CueO, this enzyme contributes to copper resistance not only by its cuprous oxidase activity but also by chelation of copper ions before they can enter the cytoplasm. Apo-CueO was indistinguishable from holo-CueO in terms of secondary structural elements. Importantly, the binding of copper to apo-CueO greatly stabilized the protein, indicating a transformation from an open or flexible domain arrangement with accessible copper sites to a closed structure with deeply buried copper ions. CueO is thus the first example for a natural Tat substrate of such incomplete folding state. The Tat system may need to transport flexibly folded proteins in any case when cofactor assembly or quaternary structure formation occurs after transport.	[Stolle, Patrick; Hou, Bo; Brueser, Thomas] Leibniz Univ Hannover, Inst Microbiol, Herrenhauser Str 2, D-30419 Hannover, Germany	Leibniz University Hannover	Bruser, T (corresponding author), Leibniz Univ Hannover, Inst Microbiol, Herrenhauser Str 2, D-30419 Hannover, Germany.	brueser@ifmb.uni-hannover.de		Stolle, Patrick/0000-0001-5825-4079; Bruser, Thomas/0000-0002-5889-8306				Berks BC, 2005, CURR OPIN MICROBIOL, V8, P174, DOI 10.1016/j.mib.2005.02.010; Berks BC, 2000, MOL MICROBIOL, V35, P260, DOI 10.1046/j.1365-2958.2000.01719.x; Berthelmann F, 2008, J BIOL CHEM, V283, P25281, DOI 10.1074/jbc.M707757200; Bruser T, 2003, EUR J BIOCHEM, V270, P1211, DOI 10.1046/j.1432-1033.2003.03481.x; Calloni G, 2012, CELL REP, V1, P251, DOI 10.1016/j.celrep.2011.12.007; CASADABAN MJ, 1976, J MOL BIOL, V104, P541, DOI 10.1016/0022-2836(76)90119-4; Changela A, 2003, SCIENCE, V301, P1383, DOI 10.1126/science.1085950; Chen JY, 1996, BIOCHEM BIOPH RES CO, V219, P423, DOI 10.1006/bbrc.1996.0249; Cline K, 2007, EMBO J, V26, P3039, DOI 10.1038/sj.emboj.7601759; Djoko KY, 2010, J AM CHEM SOC, V132, P2005, DOI 10.1021/ja9091903; Eser M, 2003, P NATL ACAD SCI USA, V100, P13231, DOI 10.1073/pnas.2234410100; Fan EG, 2010, BIOCHEM BIOPH RES CO, V398, P438, DOI 10.1016/j.bbrc.2010.06.095; Galli I, 2004, J BIOL INORG CHEM, V9, P90, DOI 10.1007/s00775-003-0501-4; Genest O, 2008, J BIOL CHEM, V283, P21433, DOI 10.1074/jbc.M802954200; Gort AS, 1999, MOL MICROBIOL, V32, P179, DOI 10.1046/j.1365-2958.1999.01343.x; Grass G, 2001, BIOCHEM BIOPH RES CO, V286, P902, DOI 10.1006/bbrc.2001.5474; Graubner W, 2007, J BIOL CHEM, V282, P7116, DOI 10.1074/jbc.M608235200; GREENFIE.N, 1969, BIOCHEMISTRY-US, V8, P4108, DOI 10.1021/bi00838a031; Guex N, 1997, ELECTROPHORESIS, V18, P2714, DOI 10.1002/elps.1150181505; HANLON SP, 1995, FEMS MICROBIOL LETT, V133, P271, DOI 10.1111/j.1574-6968.1995.tb07896.x; Hou Bo, 2011, Biomol Concepts, V2, P507, DOI 10.1515/BMC.2011.040; HOWES BD, 1994, BIOCHEMISTRY-US, V33, P3171, DOI 10.1021/bi00177a005; Kaluarachchi H, 2010, NAT PROD REP, V27, P681, DOI 10.1039/b906688h; Kittleson JT, 2006, BIOCHEMISTRY-US, V45, P11096, DOI 10.1021/bi0612622; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Li X, 2007, BIOCHEM BIOPH RES CO, V354, P21, DOI 10.1016/j.bbrc.2006.12.116; Lindenstrauss U, 2009, FEMS MICROBIOL LETT, V295, P135, DOI 10.1111/j.1574-6968.2009.01600.x; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Macomber L, 2009, P NATL ACAD SCI USA, V106, P8344, DOI 10.1073/pnas.0812808106; Moser Michael, 2007, V390, P63; MULLER M, 1984, P NATL ACAD SCI-BIOL, V81, P7421, DOI 10.1073/pnas.81.23.7421; NISHIYAMA M, 1993, J GEN MICROBIOL, V139, P725, DOI 10.1099/00221287-139-4-725; Prudencio M, 1999, J BACTERIOL, V181, P2323; Py B, 2010, NAT REV MICROBIOL, V8, P436, DOI 10.1038/nrmicro2356; Rapisarda VA, 2002, ARCH BIOCHEM BIOPHYS, V405, P87, DOI 10.1016/S0003-9861(02)00277-1; Rensing C, 2003, FEMS MICROBIOL REV, V27, P197, DOI 10.1016/S0168-6445(03)00049-4; Richter S, 2007, J BIOL CHEM, V282, P33257, DOI 10.1074/jbc.M703303200; Roberts SA, 2003, J BIOL CHEM, V278, P31958, DOI 10.1074/jbc.M302963200; Roberts SA, 2002, P NATL ACAD SCI USA, V99, P2766, DOI 10.1073/pnas.052710499; Sakurai T, 2007, CHEM REC, V7, P220, DOI 10.1002/tcr.20125; Sedlak E, 2008, P NATL ACAD SCI USA, V105, P19258, DOI 10.1073/pnas.0806431105; Sevcenco AM, 2009, J BIOL INORG CHEM, V14, P631, DOI 10.1007/s00775-009-0477-9; Singh SK, 2004, J BACTERIOL, V186, P7815, DOI 10.1128/JB.186.22.7815-7817.2004; Stoyanov JV, 2001, MOL MICROBIOL, V39, P502, DOI 10.1046/j.1365-2958.2001.02264.x; Tree JJ, 2005, BIOCHEM BIOPH RES CO, V328, P1205, DOI 10.1016/j.bbrc.2005.01.084; Tsai TY, 1998, J BIOL CHEM, V273, P19243, DOI 10.1074/jbc.273.30.19243; Watmough NJ, 1998, J BIOENERG BIOMEMBR, V30, P55, DOI 10.1023/A:1020507511285; Wilms B, 2001, BIOTECHNOL BIOENG, V73, P95, DOI 10.1002/bit.1041; Yamamoto K, 2005, MOL MICROBIOL, V56, P215, DOI 10.1111/j.1365-2958.2005.04532.x; Zumft WG, 2005, J MOL MICROB BIOTECH, V10, P154, DOI 10.1159/000091562	50	20	20	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 24	2016	291	26					13520	13528		10.1074/jbc.M116.729103	http://dx.doi.org/10.1074/jbc.M116.729103			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DR2YZ	27129241	Green Published, hybrid			2022-12-26	WOS:000379771100010
J	Celik, H; Bulut, G; Han, J; Graham, GT; Minas, TZ; Conn, EJ; Hong, SH; Pauly, GT; Hayran, M; Li, X; Ozdemirli, M; Ayhan, A; Rudek, MA; Toretsky, JA; Uren, A				Celik, Haydar; Bulut, Gulay; Han, Jenny; Graham, Garrett T.; Minas, Tsion Z.; Conn, Erin J.; Hong, Sung-Hyeok; Pauly, Gary T.; Hayran, Mutlu; Li, Xin; Ozdemirli, Metin; Ayhan, Ayse; Rudek, Michelle A.; Toretsky, Jeffrey A.; Uren, Aykut			Ezrin Inhibition Up-regulates Stress Response Gene Expression	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							METASTATIC PHENOTYPE; ERM PROTEINS; MURINE MODEL; LINKER EZRIN; OSTEOSARCOMA; GROWTH; MTOR; PHOSPHORYLATION; METABOLISM; INITIATION	Ezrin is a member of the ERM (ezrin/radixin/moesin) family of proteins that links cortical cytoskeleton to the plasma membrane. High expression of ezrin correlates with poor prognosis and metastasis in osteosarcoma. In this study, to uncover specific cellular responses evoked by ezrin inhibition that can be used as a specific pharmacodynamic marker(s), we profiled global gene expression in osteosarcoma cells after treatment with small molecule ezrin inhibitors, NSC305787 and NSC668394. We identified and validated several up-regulated integrated stress response genes including PTGS2, ATF3, DDIT3, DDIT4, TRIB3, and ATF4 as novel ezrin-regulated transcripts. Analysis of transcriptional response in skin and peripheral blood mononuclear cells from NSC305787-treated mice compared with a control group revealed that, among those genes, the stress gene DDIT4/REDD1 may be used as a surrogate pharmacodynamic marker of ezrin inhibitor compound activity. In addition, we validated the anti-metastatic effects of NSC305787 in reducing the incidence of lung metastasis in a genetically engineered mouse model of osteosarcoma and evaluated the pharmacokinetics of NSC305787 and NSC668394 in mice. In conclusion, our findings suggest that cytoplasmic ezrin, previously considered a dormant and inactive protein, has important functions in regulating gene expression that may result in down-regulation of stress response genes.	[Celik, Haydar; Bulut, Gulay; Han, Jenny; Graham, Garrett T.; Minas, Tsion Z.; Conn, Erin J.; Hong, Sung-Hyeok; Toretsky, Jeffrey A.; Uren, Aykut] Georgetown Univ, Med Ctr, Dept Oncol, Washington, DC 20007 USA; [Ozdemirli, Metin] Georgetown Univ, Med Ctr, Dept Pathol, Washington, DC 20007 USA; [Bulut, Gulay] Bahcesehir Univ, Fac Engn & Nat Sci, Dept Mol Biol & Genet, TR-34349 Istanbul, Turkey; [Pauly, Gary T.] NCI, Biol Chem Lab, Ctr Canc Res, NIH, Frederick, MD 21702 USA; [Hayran, Mutlu] Hacettepe Univ, Inst Canc, Dept Prevent Oncol, TR-06800 Ankara, Turkey; [Li, Xin] Georgetown Univ, Dept Biostat Bioinformat & Biomath, Washington, DC 20057 USA; [Ayhan, Ayse] Seirei Mikatahara Hosp, Dept Pathol, Hamamatsu, Shizuoka, Japan; [Ayhan, Ayse] Hamamatsu Univ Sch Med, Hamamatsu, Shizuoka, Japan; [Ayhan, Ayse] Johns Hopkins Univ, Sch Med, Dept Pathol, Baltimore, MD 21218 USA; [Rudek, Michelle A.] Johns Hopkins Univ, Sch Med, Div Clin Pharmacol, Dept Oncol, Baltimore, MD 21218 USA; [Rudek, Michelle A.] Johns Hopkins Univ, Sch Med, Div Clin Pharmacol, Dept Med, Baltimore, MD 21218 USA; Johns Hopkins Univ, Sidney Kimmel Comprehens Canc Ctr, Baltimore, MD 21218 USA	Georgetown University; Georgetown University; Bahcesehir University; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Hacettepe University; Georgetown University; Hamamatsu University School of Medicine; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins Medicine	Uren, A (corresponding author), Georgetown Univ, Med Ctr, Dept Oncol, Dept Biochem & Mol & Cellular Biol,NRB, 3970 Reservoir Rd NW,Rm E312, Washington, DC 20057 USA.	au26@georgetown.edu	AYHAN, Ayse/H-3331-2012; AYHAN, Ayse/AAP-2948-2021	AYHAN, Ayse/0000-0003-0136-4271; AYHAN, Ayse/0000-0003-0136-4271; Pauly, Gary/0000-0002-3481-7129; Celik, Haydar/0000-0003-4314-8438; Graham, Garrett/0000-0002-1097-0962	National Cancer Institute [P30CA51008]; NATIONAL CANCER INSTITUTE [P30CA006973, P30CA051008] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR001079] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR026824] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	We thank the Animal Models Shared Resource, Histopathology & Tissue Shared Resource and the Genomics & Epigenomics Shared Resource at the Lombardi Comprehensive Cancer Center (Georgetown University), which are supported by a grant P30CA51008 from the National Cancer Institute. We thank Dr. Chand Khanna from National Cancer Institute (NCI/NIH, Bethesda, MD) for providing human MG63.3 osteosarcoma and mouse K7M2 osteosarcoma cell lines. We thank Dr. Douglas H. Thamm (Colorado State University, Fort Collins, CO) for providing MCKOS, SKKOS and CSKOS canine osteosarcoma cell lines. We thank Dr. Stuart H. Orkin and Dr. Katherine A. Janeway (Harvard Medical School, Boston, MA) for providing mice to generate the Osx-Cre <SUP>+</SUP> p53<SUP>fl/f</SUP>lpRB<SUP>fl/fl</SUP> transgenic mouse model of osteosarcoma and helpful discussion. We thank the Brandon Carrington Lee Foundation and Children's Cancer Foundation for continuous support of our research program.	Anderson P, 2008, TRENDS BIOCHEM SCI, V33, P141, DOI 10.1016/j.tibs.2007.12.003; Baird TD, 2012, ADV NUTR, V3, P307, DOI 10.3945/an.112.002113; Brambilla D, 2009, INT J CANCER, V125, P2239, DOI 10.1002/ijc.24734; Bretscher A, 2002, NAT REV MOL CELL BIO, V3, P586, DOI 10.1038/nrm882; Briggs JW, 2012, NEOPLASIA, V14, P297, DOI 10.1593/neo.11518; Bruce B, 2007, CLIN EXP METASTAS, V24, P69, DOI 10.1007/s10585-006-9050-x; Brugarolas J, 2004, GENE DEV, V18, P2893, DOI 10.1101/gad.1256804; Bulut G, 2012, ONCOGENE, V31, P269, DOI 10.1038/onc.2011.245; Celik H, 2015, MOL CANCER THER, V14, P2497, DOI 10.1158/1535-7163.MCT-15-0511; Celik H, 2015, MOL CELL BIOL, V35, P3145, DOI 10.1128/MCB.00332-15; Chen QY, 2013, MOL CELL BIOCHEM, V377, P207, DOI 10.1007/s11010-013-1586-x; Daw NC, 2015, BRIT J CANCER, V112, P278, DOI 10.1038/bjc.2014.585; Elliott BE, 2005, BREAST CANCER RES, V7, pR365, DOI 10.1186/bcr1006; Ellisen LW, 2005, CELL CYCLE, V4, P1500, DOI 10.4161/cc.4.11.2139; Federici C, 2009, INT J CANCER, V124, P2804, DOI 10.1002/ijc.24255; Fehon RG, 2010, NAT REV MOL CELL BIO, V11, P276, DOI 10.1038/nrm2866; Fletcher C., 2013, IARC WHO CLASSIFICAT, V5; Geiger KD, 2000, AM J PATHOL, V157, P1785, DOI 10.1016/S0002-9440(10)64816-X; Gill J, 2013, PHARMACOL THERAPEUT, V137, P89, DOI 10.1016/j.pharmthera.2012.09.003; Harding HP, 2003, MOL CELL, V11, P619, DOI 10.1016/S1097-2765(03)00105-9; Iiizumi M, 2008, BBA-REV CANCER, V1786, P87, DOI 10.1016/j.bbcan.2008.07.002; Isakoff MS, 2015, J CLIN ONCOL, V33, P3029, DOI 10.1200/JCO.2014.59.4895; Kansara M, 2014, NAT REV CANCER, V14, P722, DOI 10.1038/nrc3838; Khanna C, 2000, CLIN EXP METASTAS, V18, P261, DOI 10.1023/A:1006767007547; Khanna C, 2004, NAT MED, V10, P182, DOI 10.1038/nm982; Khanna C, 2001, CANCER RES, V61, P3750; Kimball SR, 2008, J BIOL CHEM, V283, P3465, DOI 10.1074/jbc.M706643200; Kobel M, 2006, MODERN PATHOL, V19, P581, DOI 10.1038/modpathol.3800567; Leiphrakpam PD, 2014, CELL SIGNAL, V26, P868, DOI 10.1016/j.cellsig.2014.01.014; Li JW, 2015, SCI REP-UK, V5, DOI 10.1038/srep17903; Li QC, 2012, TUMOR BIOL, V33, P1493, DOI 10.1007/s13277-012-0400-9; Marciniak SJ, 2004, GENE DEV, V18, P3066, DOI 10.1101/gad.1250704; Marciniak SJ, 2006, PHYSIOL REV, V86, P1133, DOI 10.1152/physrev.00015.2006; McClatchey AI, 2014, J CELL SCI, V127, P3199, DOI 10.1242/jcs.098343; Mehlen P, 2006, NAT REV CANCER, V6, P449, DOI 10.1038/nrc1886; Nguyen DX, 2007, NAT REV GENET, V8, P341, DOI 10.1038/nrg2101; Ohoka N, 2005, EMBO J, V24, P1243, DOI 10.1038/sj.emboj.7600596; Ren L, 2015, ONCOTARGET, V6, P29469, DOI 10.18632/oncotarget.5177; Ren L, 2014, ADV EXP MED BIOL, V804, P181, DOI 10.1007/978-3-319-04843-7_10; Ren L, 2012, CANCER RES, V72, P1001, DOI 10.1158/0008-5472.CAN-11-0210; Sofer A, 2005, MOL CELL BIOL, V25, P5834, DOI 10.1128/MCB.25.14.5834-5845.2005; Walkley CR, 2008, GENE DEV, V22, P1662, DOI 10.1101/gad.1656808; Wan LL, 2013, NAT MED, V19, P1450, DOI 10.1038/nm.3391; Wan XL, 2005, CANCER RES, V65, P2406, DOI 10.1158/0008-5472.CAN-04-3135; Weng WH, 2005, CLIN CANCER RES, V11, P6198, DOI 10.1158/1078-0432.CCR-05-0548; Wu BL, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/651954; Xie JJ, 2009, INT J CANCER, V124, P2549, DOI 10.1002/ijc.24216; Yu YL, 2004, NAT MED, V10, P175, DOI 10.1038/nm966	48	31	32	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 17	2016	291	25					13257	13270		10.1074/jbc.M116.718189	http://dx.doi.org/10.1074/jbc.M116.718189			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DR2YT	27137931	Green Published, hybrid			2022-12-26	WOS:000379770500030
J	Lucena, MC; Carvalho-Cruz, P; Donadio, JL; Oliveira, IA; de Queiroz, RM; Marinho-Carvalho, MM; Sola-Penna, M; de Paula, IF; Gondim, KC; McComb, ME; Costello, CE; Whelan, SA; Todeschini, AR; Dias, WB				Lucena, Miguel C.; Carvalho-Cruz, Patricia; Donadio, Joana L.; Oliveira, Isadora A.; de Queiroz, Rafaela M.; Marinho-Carvalho, Monica M.; Sola-Penna, Mauro; de Paula, Iron F.; Gondim, Katia C.; McComb, Mark E.; Costello, Catherine E.; Whelan, Stephen A.; Todeschini, Adriane R.; Dias, Wagner B.			Epithelial Mesenchymal Transition Induces Aberrant Glycosylation through Hexosamine Biosynthetic Pathway Activation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BETA-N-ACETYLGLUCOSAMINE; O-GLCNAC TRANSFERASE; PROSTATE-CANCER CELLS; TUMOR PROGRESSION; BREAST-CANCER; CROSS-TALK; METABOLISM; GLYCANS; GLCNACYLATION; METASTASIS	Deregulated cellular metabolism is a hallmark of tumors. Cancer cells increase glucose and glutamine flux to provide energy needs and macromolecular synthesis demands. Several studies have been focused on the importance of glycolysis and pentose phosphate pathway. However, a neglected but very important branch of glucose metabolism is the hexosamine biosynthesis pathway (HBP). The HBP is a branch of the glucose metabolic pathway that consumes similar to 2-5% of the total glucose, generating UDP-GlcNAc as the end product. UDP-GlcNAc is the donor substrate used in multiple glycosylation reactions. Thus, HBP links the altered metabolism with aberrant glycosylation providing a mechanism for cancer cells to sense and respond to microenvironment changes. Here, we investigate the changes of glucose metabolism during epithelial mesenchymal transition (EMT) and the role of O-GlcNAcylation in this process. We show that A549 cells increase glucose uptake during EMT, but instead of increasing the glycolysis and pentose phosphate pathway, the glucose is shunted through the HBP. The activation of HBP induces an aberrant cell surface glycosylation and O-GlcNAcylation. The cell surface glycans display an increase of sialylation alpha 2-6, poly-LacNAc, and fucosylation, all known epitopes found in different tumor models. In addition, modulation of O-GlcNAc levels was demonstrated to be important during the EMT process. Taken together, our results indicate that EMT is an applicable model to study metabolic and glycophenotype changes during carcinogenesis, suggesting that cell glycosylation senses metabolic changes and modulates cell plasticity.	[Lucena, Miguel C.; Carvalho-Cruz, Patricia; Donadio, Joana L.; Oliveira, Isadora A.; de Queiroz, Rafaela M.; Todeschini, Adriane R.; Dias, Wagner B.] Univ Fed Rio de Janeiro, Inst Biofis Carlos Chagas Filho, BR-21949900 Rio De Janeiro, Brazil; [Marinho-Carvalho, Monica M.; Sola-Penna, Mauro] Univ Fed Rio de Janeiro, Fac Farm, BR-21949900 Rio De Janeiro, Brazil; [de Paula, Iron F.; Gondim, Katia C.] Univ Fed Rio de Janeiro, Inst Bioquim Med Leopoldo de Meis, BR-21949900 Rio De Janeiro, Brazil; [McComb, Mark E.; Costello, Catherine E.; Whelan, Stephen A.] Boston Univ, Sch Med, Cardiovasc Prote Ctr, Dept Biochem, Boston, MA 02118 USA	Universidade Federal do Rio de Janeiro; Universidade Federal do Rio de Janeiro; Universidade Federal do Rio de Janeiro; Boston University	Dias, WB (corresponding author), Univ Fed Rio de Janeiro, Ilha Fundao, Inst Biofis Carlos Chagas Filho, Bloco D Sala 03 CCS, BR-21949900 Rio de Janeiro, Brazil.	diaswb@biof.ufrj.br	Dias, Wagner/B-1401-2016; de Carvalho, Mônica Mesquita Marinho/ABC-7373-2020; Sola-Penna, Mauro/E-8221-2011; Gondim, Katia C./AAN-4059-2020; Todeschini, Adriane Regina/ABC-9165-2020; Todeschini, Adriane/AAG-8128-2020	Sola-Penna, Mauro/0000-0001-9796-6829; Todeschini, Adriane Regina/0000-0002-6049-2751; Oliveira, Isadora/0000-0003-0269-1450; Costello, Catherine/0000-0003-1594-5122; /0000-0002-4249-485X; Dias, Wagner/0000-0002-8378-8846; Whelan, Stephen A/0000-0002-5439-6501; Muniz de Queiroz, Rafaela/0000-0001-5962-9071	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico; Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio de Janeiro; Fundacao de Amparo a Ciencia e Tecnologia de Pernambuco; Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio de Janeiro(Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio De Janeiro (FAPERJ)); Fundacao de Amparo a Ciencia e Tecnologia de Pernambuco(Fundacao de Amparo a Ciencia e Tecnologia do Estado de Pernambuco (FACEPE)); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	This work was supported by grants from Conselho Nacional de Desenvolvimento Cientifico e Tecnologico, Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio de Janeiro, Fundacao de Amparo a Ciencia e Tecnologia de Pernambuco, and Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior. The authors declare that they have no conflicts of interest with the contents of this article.	Alisson-Silva F, 2014, GLYCOBIOLOGY, V24, P458, DOI 10.1093/glycob/cwu012; Alisson-Silva F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060471; Amoedo ND, 2013, BIOSCIENCE REP, V33, P865, DOI 10.1042/BSR20130066; BAUMANN H, 1979, CANCER RES, V39, P2637; Cairns RA, 2011, NAT REV CANCER, V11, P85, DOI 10.1038/nrc2981; Caldwell SA, 2010, ONCOGENE, V29, P2831, DOI 10.1038/onc.2010.41; Cazet A, 2010, CARBOHYD RES, V345, P1377, DOI 10.1016/j.carres.2010.01.024; De Craene B, 2013, NAT REV CANCER, V13, P97, DOI 10.1038/nrc3447; de Queirozl RM, 2014, FRONT ONCOL, V4, DOI 10.3389/fonc.2014.00132; Dennis JW, 2009, CELL, V139, P1229, DOI 10.1016/j.cell.2009.12.008; Ding MX, 2012, ASIAN PAC J CANCER P, V13, P5653, DOI 10.7314/APJCP.2012.13.11.5653; Fardini Y, 2013, FRONT ENDOCRINOL, V4, DOI 10.3389/fendo.2013.00099; Ferrer CM, 2014, MOL CELL, V54, P820, DOI 10.1016/j.molcel.2014.04.026; Freire-De-Lima L, 2011, P NATL ACAD SCI USA, V108, P17690, DOI 10.1073/pnas.1115191108; Fuster MM, 2005, NAT REV CANCER, V5, P526, DOI 10.1038/nrc1649; Garcia AD, 2013, RAPID COMMUN MASS SP, V27, P1794, DOI 10.1002/rcm.6631; Guan F, 2009, P NATL ACAD SCI USA, V106, P7461, DOI 10.1073/pnas.0902368106; Guo JM, 2004, ONCOLOGY-BASEL, V67, P271, DOI 10.1159/000081328; Hakomori S, 2002, P NATL ACAD SCI USA, V99, P10231, DOI 10.1073/pnas.172380699; HAMILTON SD, 1984, CLIN CHEM, V30, P226; Hart GW, 2007, NATURE, V446, P1017, DOI 10.1038/nature05815; Hart GW, 2011, ANNU REV BIOCHEM, V80, P825, DOI 10.1146/annurev-biochem-060608-102511; Hauselmann I, 2014, FRONT ONCOL, V4, DOI 10.3389/fonc.2014.00028; Hedou J, 2009, PROTEOMICS, V9, P2139, DOI 10.1002/pmic.200800617; Heiden MGV, 2009, SCIENCE, V324, P1029, DOI 10.1126/science.1160809; Itkonen HM, 2013, CANCER RES, V73, P5277, DOI 10.1158/0008-5472.CAN-13-0549; Ito N, 1996, HISTOL HISTOPATHOL, V11, P203; Jin FZ, 2013, EXP CELL RES, V319, P1482, DOI 10.1016/j.yexcr.2013.03.013; Kang JG, 2009, J BIOL CHEM, V284, P34777, DOI 10.1074/jbc.M109.026351; Kee HJ, 2014, BMB REP, V47, P158, DOI 10.5483/BMBRep.2014.47.3.273; Krishnan V, 2005, CLIN EXP METASTAS, V22, P11, DOI 10.1007/s10585-005-2036-2; Lau KS, 2008, GLYCOBIOLOGY, V18, P750, DOI 10.1093/glycob/cwn071; Lau KS, 2007, CELL, V129, P123, DOI 10.1016/j.cell.2007.01.049; Liu J, 2011, MOL MED REP, V4, P1299, DOI 10.3892/mmr.2011.569; Lynch TP, 2012, J BIOL CHEM, V287, P11070, DOI 10.1074/jbc.M111.302547; Lynch TP, 2011, CELL CYCLE, V10, P1712, DOI 10.4161/cc.10.11.15561; Ma ZY, 2014, J BIOL CHEM, V289, P34457, DOI 10.1074/jbc.R114.577718; Ma ZY, 2013, J BIOL CHEM, V288, P15121, DOI 10.1074/jbc.M113.470047; MARSHALL S, 1991, J BIOL CHEM, V266, P4706; Masoudi-Nejad A, 2015, SEMIN CANCER BIOL, V30, P21, DOI 10.1016/j.semcancer.2014.01.007; Micalizzi DS, 2010, J MAMMARY GLAND BIOL, V15, P117, DOI 10.1007/s10911-010-9178-9; Okamoto T, 2013, MOL MED REP, V7, P359, DOI 10.3892/mmr.2012.1189; Onitsuka K, 2003, CANCER SCI, V94, P32, DOI 10.1111/j.1349-7006.2003.tb01348.x; Park SY, 2010, EMBO J, V29, P3787, DOI 10.1038/emboj.2010.254; Parrou JL, 1997, ANAL BIOCHEM, V248, P186, DOI 10.1006/abio.1997.2138; Patra KC, 2014, TRENDS BIOCHEM SCI, V39, P347, DOI 10.1016/j.tibs.2014.06.005; Pousset D, 1997, CANCER RES, V57, P4249; Ramirez-Correa GA, 2008, CIRC RES, V103, P1354, DOI 10.1161/CIRCRESAHA.108.184978; Schultz MJ, 2012, CANCER METAST REV, V31, P501, DOI 10.1007/s10555-012-9359-7; Shan CL, 2014, MOL CELL, V55, P552, DOI 10.1016/j.molcel.2014.06.020; Slawson C, 2011, NAT REV CANCER, V11, P678, DOI 10.1038/nrc3114; Sola-Penna M, 2002, J BIOCHEM BIOPH METH, V50, P129, DOI 10.1016/S0165-022X(01)00180-4; Thiery JP, 2009, CELL, V139, P871, DOI 10.1016/j.cell.2009.11.007; Thiery JP, 2002, NAT REV CANCER, V2, P442, DOI 10.1038/nrc822; Todeschini AR, 2007, J BIOL CHEM, V282, P8123, DOI 10.1074/jbc.M611407200; Vasconcelos-dos-Santos A, 2015, FRONT ONCOL, V5, DOI 10.3389/fonc.2015.00138; WARBURG O, 1956, SCIENCE, V123, P309, DOI 10.1126/science.123.3191.309; Wise DR, 2010, TRENDS BIOCHEM SCI, V35, P427, DOI 10.1016/j.tibs.2010.05.003; Ye F, 2004, J BIOCHEM BIOPH METH, V59, P201, DOI 10.1016/j.jbbm.2003.02.001; Yi W, 2012, SCIENCE, V337, P975, DOI 10.1126/science.1222278; Yilmaz M, 2009, CANCER METAST REV, V28, P15, DOI 10.1007/s10555-008-9169-0; Yoshioka K, 1996, APPL MICROBIOL BIOT, V46, P400; Zaman MH, 2006, P NATL ACAD SCI USA, V103, P10889, DOI 10.1073/pnas.0604460103; Zancan P, 2005, MOL GENET METAB, V86, P401, DOI 10.1016/j.ymgme.2005.06.011; Zhu AP, 2010, ANAL BIOCHEM, V396, P146, DOI 10.1016/j.ab.2009.09.017	65	68	71	1	22	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 17	2016	291	25					12917	12929		10.1074/jbc.M116.729236	http://dx.doi.org/10.1074/jbc.M116.729236			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DR2YT	27129262	hybrid, Green Published			2022-12-26	WOS:000379770500003
J	Diehl, C; Akke, M; Bekker-Jensen, S; Mailand, N; Streicher, W; Wikstrom, M				Diehl, Carl; Akke, Mikael; Bekker-Jensen, Simon; Mailand, Niels; Streicher, Werner; Wikstrom, Mats			Structural Analysis of a Complex between Small Ubiquitin-like Modifier 1 (SUMO1) and the ZZ Domain of CREB-binding Protein (CBP/p300) Reveals a New Interaction Surface on SUMO	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CHEMICAL-EXCHANGE; DIPOLAR COUPLINGS; NMR; RESONANCES; SEQUENCE; PHOSPHORYLATION; CONJUGATION; SUMOYLATION; RESTRAINTS; DYNAMICS	We have recently discovered that the ZZ zinc finger domain represents a novel small ubiquitin-like modifier (SUMO) binding motif. In this study we identify the binding epitopes in the ZZ domain of CBP (CREB-binding protein) and SUMO1 using NMR spectroscopy. The binding site on SUMO1 represents a unique epitope for SUMO interaction spatially opposite to that observed for canonical SUMO interaction motifs (SIMs). HADDOCK docking simulations using chemical shift perturbations and residual dipolar couplings was employed to obtain a structural model for the ZZ domain-SUMO1 complex. Isothermal titration calorimetry experiments support this model by showing that the mutation of key residues in the binding site abolishes binding and that SUMO1 can simultaneously and noncooperatively bind both the ZZ domain and a canonical SIM motif. The binding dynamics of SUMO1 was further characterized using N-15 Carr-Purcell-Meiboom-Gill (CPMG) relaxation dispersions, which define the off rates for the ZZ domain and SIM motif and show that the dynamic binding process has different characteristics for the two cases. Furthermore, in the absence of bound ligands SUMO1 transiently samples a high energy conformation, which might be involved in ligand binding.	[Diehl, Carl; Bekker-Jensen, Simon; Mailand, Niels; Streicher, Werner; Wikstrom, Mats] Univ Copenhagen, Fac Hlth & Med Sci, Novo Nordisk Fdn Ctr Prot Res, DK-2200 Copenhagen, Denmark; [Diehl, Carl] SAR Biostruct, SE-22363 Lund, Sweden; [Akke, Mikael] Lund Univ, Ctr Mol Prot Sci, Dept Biophys Chem, SE-22100 Lund, Sweden; [Streicher, Werner] Novozymes AS, DK-2880 Bagsvaerd, Denmark; [Wikstrom, Mats] Amgen Inc, One Amgen Ctr Dr, Thousand Oaks, CA 91320 USA	University of Copenhagen; Lund University; Novozymes; Amgen	Wikstrom, M (corresponding author), Amgen Inc, One Amgen Ctr Dr, Thousand Oaks, CA 91320 USA.	mats.wikstrom@amgen.com		Akke, Mikael/0000-0002-2395-825X; Streicher, Werner/0000-0002-2425-5839	Novo Nordisk Foundation [NNF14CC0001]; European Commission [Bio-NMR 261863]; MAX laboratory, Lund, Sweden [20130289]; Novo Nordisk Foundation Center for Protein Research [PI Niels Mailand] Funding Source: researchfish	Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited); European Commission(European CommissionEuropean Commission Joint Research Centre); MAX laboratory, Lund, Sweden; Novo Nordisk Foundation Center for Protein Research	This work was supported by Novo Nordisk Foundation Grant NNF14CC0001, the European Commission under the Seventh Framework Program (FP7) contract Bio-NMR 261863 providing access to the Swedish NMR Centre, Gothenburg, Sweden, and the MAX laboratory, Lund, Sweden, enabling access to the MAX laboratory (ID 20130289). The authors declare that they have no conflicts of interest with the contents of this article.	ASLANIDIS C, 1990, NUCLEIC ACIDS RES, V18, P6069, DOI 10.1093/nar/18.20.6069; BAX A, 1991, Journal of Biomolecular NMR, V1, P99, DOI 10.1007/BF01874573; Bayer P, 1998, J MOL BIOL, V280, P275, DOI 10.1006/jmbi.1998.1839; Becker J, 2013, NAT STRUCT MOL BIOL, V20, P525, DOI 10.1038/nsmb.2526; Bernier-Villamor V, 2002, CELL, V108, P345, DOI 10.1016/S0092-8674(02)00630-X; Bhattacharya A, 2007, PROTEINS, V66, P778, DOI 10.1002/prot.21165; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Cappadocia L, 2015, STRUCTURE, V23, P126, DOI 10.1016/j.str.2014.10.015; CARVER JP, 1972, J MAGN RESON, V6, P89, DOI 10.1016/0022-2364(72)90090-X; Case DA, 2005, J COMPUT CHEM, V26, P1668, DOI 10.1002/jcc.20290; Chang CC, 2011, MOL CELL, V42, P62, DOI 10.1016/j.molcel.2011.02.022; CLORE GM, 1990, BIOCHEMISTRY-US, V29, P8172, DOI 10.1021/bi00487a027; Cornilescu G, 1999, J BIOMOL NMR, V13, P289, DOI 10.1023/A:1008392405740; Danielsen JR, 2012, J CELL BIOL, V197, P179, DOI 10.1083/jcb.201106152; DAVIS DG, 1994, J MAGN RESON SER B, V104, P266, DOI 10.1006/jmrb.1994.1084; De Vries SJ, 2010, NAT PROTOC, V5, P883, DOI 10.1038/nprot.2010.32; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; Dominguez C, 2003, J AM CHEM SOC, V125, P1731, DOI 10.1021/ja026939x; Dosset P, 2001, J BIOMOL NMR, V20, P223, DOI 10.1023/A:1011206132740; Gareau JR, 2010, NAT REV MOL CELL BIO, V11, P861, DOI 10.1038/nrm3011; Geiss-Friedlander R, 2007, NAT REV MOL CELL BIO, V8, P947, DOI 10.1038/nrm2293; Gileadi Opher, 2008, V426, P221, DOI 10.1007/978-1-60327-058-8_14; GRZESIEK S, 1992, J AM CHEM SOC, V114, P6291, DOI 10.1021/ja00042a003; Hecker CM, 2006, J BIOL CHEM, V281, P16117, DOI 10.1074/jbc.M512757200; Koradi R, 1996, J MOL GRAPHICS, V14, P51, DOI 10.1016/0263-7855(96)00009-4; Legge GB, 2004, J MOL BIOL, V343, P1081, DOI 10.1016/j.jmb.2004.08.087; Loria JP, 1999, J AM CHEM SOC, V121, P2331, DOI 10.1021/ja983961a; MANDEL AM, 1995, J MOL BIOL, V246, P144, DOI 10.1006/jmbi.1994.0073; Meiler J, 2000, J BIOMOL NMR, V16, P245, DOI 10.1023/A:1008378624590; Mulder FAA, 2001, NAT STRUCT BIOL, V8, P932, DOI 10.1038/nsb1101-932; NEIDHARDT FC, 1974, J BACTERIOL, V119, P736, DOI 10.1128/JB.119.3.736-747.1974; Ottiger M, 1998, J MAGN RESON, V131, P373, DOI 10.1006/jmre.1998.1361; Ponting CP, 1996, TRENDS BIOCHEM SCI, V21, P11, DOI 10.1016/0968-0004(96)80878-4; PRESS WH, 1986, NUMERICAL RECIPES AR; Reverter D, 2006, NAT STRUCT MOL BIOL, V13, P1060, DOI 10.1038/nsmb1168; Rodriguez MS, 2001, J BIOL CHEM, V276, P12654, DOI 10.1074/jbc.M009476200; Sampson DA, 2001, J BIOL CHEM, V276, P21664, DOI 10.1074/jbc.M100006200; Schwieters CD, 2003, J MAGN RESON, V160, P65, DOI 10.1016/S1090-7807(02)00014-9; Song J, 2005, J BIOL CHEM, V280, P40122, DOI 10.1074/jbc.M507059200; Vranken WF, 2005, PROTEINS, V59, P687, DOI 10.1002/prot.20449; Wang WY, 1999, BIOTECHNIQUES, V26, P680, DOI 10.2144/99264st03; Weininger U, 2014, BIOCHEMISTRY-US, V53, P4519, DOI 10.1021/bi500462k; WISEMAN T, 1989, ANAL BIOCHEM, V179, P131, DOI 10.1016/0003-2697(89)90213-3; WITTEKIND M, 1993, J MAGN RESON SER B, V101, P201, DOI 10.1006/jmrb.1993.1033; Yip GNB, 2004, J MAGN RESON, V171, P25, DOI 10.1016/j.jmr.2004.06.021; Zweckstetter M, 2000, J AM CHEM SOC, V122, P3791, DOI 10.1021/ja0000908	47	17	18	0	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 10	2016	291	24					12658	12672		10.1074/jbc.M115.711325	http://dx.doi.org/10.1074/jbc.M115.711325			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DO9PV	27129204	Green Published, hybrid			2022-12-26	WOS:000378119900021
J	Ding, Y; Li, Q; Xu, Y; Chen, YN; Deng, Y; Zhi, F; Qian, K				Ding, Yi; Li, Qing; Xu, Yuan; Chen, Yuning; Deng, Yue; Zhi, Feng; Qian, Ke			Attenuating Oxidative Stress by Paeonol Protected against Acetaminophen-Induced Hepatotoxicity in Mice	PLOS ONE			English	Article							INDUCED LIVER-INJURY; N-ACETYLCYSTEINE; C-JUN; INDUCED APOPTOSIS; INFLAMMATION; ACTIVATION; EXPRESSION; FAILURE; RAT; JNK	Acetaminophen (APAP) overdose is the most frequent cause of drug-induced acute liver failure. The purpose of this study was to investigate whether paeonol protected against APAP-induced hepatotoxicity. Mice treated with paeonol (25, 50, 100 mg/kg) received 400 mg/kg acetaminophen intraperitoneally (i.p.) and hepatotoxicity was assessed. Pretreatment with paeonol for 6 and 24 h ameliorated APAP-induced hepatic necrosis and significantly reduced the serum alanine aminotransferase (ALT) and aspartate transaminase (AST) levels in a dose-dependent manner. Post-treatment with 100 mg/kg paeonol ameliorated APAP-induced hepatic necrosis and reduced AST and ALT levels in the serum after APAP administration for 24 h. Western blot revealed that paeonol inhibited APAP-induced phosphorylated JNK protein expression but not p38 and Erk1/2. Moreover, paeonol showed anti-oxidant activities with reducing hepatic MDA contents and increasing hepatic SOD, GSH-PX and GSH levels. Paeonol dose-dependently prevented against H2O2 or APAP-induced LDH releasing and ROS production in primary mouse hepatocytes. In addition, the mRNA levels of pro-inflammatory genes such as TNF-alpha, MCP-1, IL-1 beta and IL-6 in the liver were dose-dependently reduced by paeonol pre-treatment. Pre-treatment with paeonol significantly inhibited IKK alpha/beta, I kappa B alpha and p65 phosphorylation which contributed to ameliorating APAP-induced hepatic inflammation. Collectively, the present study demonstrates paeonol has a protective ability against APAP-induced hepatotoxicity and might be an effective candidate compound against drug-induced acute liver failure.	[Ding, Yi; Chen, Yuning; Deng, Yue; Qian, Ke] Soochow Univ, Affiliated Hosp 3, Dept Geriatr, Changzhou, Peoples R China; [Li, Qing] Soochow Univ, Affiliated Hosp 3, Dept Pathol, Changzhou, Peoples R China; [Xu, Yuan; Zhi, Feng] Soochow Univ, Affiliated Hosp 3, Modern Med Res Ctr, Changzhou, Peoples R China	Soochow University - China; Soochow University - China; Soochow University - China	Qian, K (corresponding author), Soochow Univ, Affiliated Hosp 3, Dept Geriatr, Changzhou, Peoples R China.; Zhi, F (corresponding author), Soochow Univ, Affiliated Hosp 3, Modern Med Res Ctr, Changzhou, Peoples R China.	danielzhif@163.com; keqiandr@163.com			National Natural Science Foundation of China [81302197]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Natural Science Foundation of China Projects ( No. 81302197).	Asai T, 2002, NATURE, V415, P977, DOI 10.1038/415977a; Bourdi M, 2002, HEPATOLOGY, V35, P289, DOI 10.1053/jhep.2002.30956; De Nicola GM, 2011, NATURE, V475, P106, DOI 10.1038/nature10189; Deng YB, 2003, CELL, V115, P61, DOI 10.1016/S0092-8674(03)00757-8; Du QA, 2010, CAN J PHYSIOL PHARM, V88, P1010, DOI [10.1139/Y10-077, 10.1139/y10-077]; Holubek WJ, 2006, HEPATOLOGY, V43, P880, DOI 10.1002/hep.21106; Hsieh CL, 2006, J ETHNOPHARMACOL, V106, P208, DOI 10.1016/j.jep.2005.12.027; Jaeschke H, 2014, J CLIN TRANSL HEPATO, V2, P153, DOI 10.14218/JCTH.2014.00014; Jaeschke H, 2011, LIFE SCI, V88, P737, DOI 10.1016/j.lfs.2011.01.025; Jin X, 2016, INFLAMMATION, V39, P434, DOI 10.1007/s10753-015-0265-3; Kubes P, 2012, GASTROENTEROLOGY, V143, P1158, DOI 10.1053/j.gastro.2012.09.008; Lee KK, 2015, HEPATOLOGY, V61, P326, DOI 10.1002/hep.27385; Lee WM, 2008, HEPATOLOGY, V47, P1401, DOI 10.1002/hep.22177; Liu HL, 2002, HEPATOLOGY, V35, P772, DOI 10.1053/jhep.2002.32534; Liu JP, 2013, NEUROSCI LETT, V549, P63, DOI 10.1016/j.neulet.2013.06.002; Liu MH, 2014, MEDIAT INFLAMM, V2014, DOI 10.1155/2014/651890; Liu YR, 2014, ACTA PHARMACOL SIN, V35, P483, DOI 10.1038/aps.2013.190; McGill MR, 2012, TOXICOL APPL PHARM, V264, P387, DOI 10.1016/j.taap.2012.08.015; Michael SL, 1999, HEPATOLOGY, V30, P186, DOI 10.1002/hep.510300104; Nakagawa H, 2008, GASTROENTEROLOGY, V135, P1311, DOI 10.1053/j.gastro.2008.07.006; Nemoto S, 2000, MOL CELL BIOL, V20, P7311, DOI 10.1128/MCB.20.19.7311-7318.2000; Oeckinghaus A, 2011, NAT IMMUNOL, V12, P695, DOI 10.1038/ni.2065; Ping M, 2014, PHARMACOLOGY, V93, P286, DOI 10.1159/000363577; Polson J, 2005, HEPATOLOGY, V41, P1179, DOI 10.1002/hep.20703; PRESCOTT LF, 1977, LANCET, V2, P432; Saito C, 2010, HEPATOLOGY, V51, P246, DOI 10.1002/hep.23267; Salminen WF, 1998, J PHARMACOL EXP THER, V286, P519; Schroeter H, 2003, BIOCHEM J, V372, P359, DOI 10.1042/BJ20030201; Shen H, 2014, HEPATOLOGY, V60, P2065, DOI 10.1002/hep.27348; SMILKSTEIN MJ, 1988, NEW ENGL J MED, V319, P1557, DOI 10.1056/NEJM198812153192401; Tseng YT, 2012, SHOCK, V37, P312, DOI 10.1097/SHK.0b013e31823fe939; West AP, 2011, NATURE, V472, P476, DOI 10.1038/nature09973; Win S, 2011, J BIOL CHEM, V286, P35071, DOI 10.1074/jbc.M111.276089; Yazdanpanah B, 2009, NATURE, V460, P1159, DOI 10.1038/nature08206; Zhao Y, 2014, BRAIN RES BULL, V109, P61, DOI 10.1016/j.brainresbull.2014.09.008; Zhou J, 2011, BRAIN RES, V1388, P141, DOI 10.1016/j.brainres.2011.02.064	36	57	58	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 4	2016	11	5							e0154375	10.1371/journal.pone.0154375	http://dx.doi.org/10.1371/journal.pone.0154375			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DL5KR	27144271	gold, Green Submitted, Green Published			2022-12-26	WOS:000375676400045
J	Menge, BA; Cerny-Chipman, EB; Johnson, A; Sullivan, J; Gravem, S; Chan, F				Menge, Bruce A.; Cerny-Chipman, Elizabeth B.; Johnson, Angela; Sullivan, Jenna; Gravem, Sarah; Chan, Francis			Sea Star Wasting Disease in the Keystone Predator Pisaster ochraceus in Oregon: Insights into Differential Population Impacts, Recovery, Predation Rate, and Temperature Effects from Long-Term Research	PLOS ONE			English	Article							INTERACTION STRENGTH; OCEAN ACIDIFICATION; CLIMATE-CHANGE; REPRODUCTIVE-CYCLES; PREY RECRUITMENT; BODY-TEMPERATURE; ASTERIAS-FORBESI; COMMUNITY; ECOLOGY; COMPETITION	Sea star wasting disease (SSWD) first appeared in Oregon in April 2014, and by June had spread to most of the coast. Although delayed compared to areas to the north and south, SSWD was initially most intense in north and central Oregon and spread southward. Up to 90% of individuals showed signs of disease from June-August 2014. In rocky intertidal habitats, populations of the dominant sea star Pisaster ochraceus were rapidly depleted, with magnitudes of decline in density among sites ranging from -2x to -9x (59 to 84%) and of biomass from -2.6x to -15.8x (60 to 90%) by September 2014. The frequency of symptomatic individuals declined over winter and persisted at a low rate through the spring and summer 2015 (similar to 5-15%, at most sites) and into fall 2015. Disease expression included six symptoms: initially with twisting arms, then deflation and/or lesions, lost arms, losing grip on substrate, and final disintegration. SSWD was disproportionally higher in orange individuals, and higher in tidepools. Although historically P. ochraceus recruitment has been low, from fall 2014 to spring 2015 an unprecedented surge of sea star recruitment occurred at all sites, ranging from similar to 7x to 300x greater than in 2014. The loss of adult and juvenile individuals in 2014 led to a dramatic decline in predation rate on mussels compared to the previous two decades. A proximate cause of wasting was likely the "Sea Star associated Densovirus" (SSaDV), but the ultimate factors triggering the epidemic, if any, remain unclear. Although warm temperature has been proposed as a possible trigger, SSWD in Oregon populations increased with cool temperatures. Since P. ochraceus is a keystone predator that can strongly influence the biodiversity and community structure of the intertidal community, major community-level responses to the disease are expected. However, predicting the specific impacts and time course of change across west coast meta-communities is difficult, suggesting the need for detailed coast-wide investigation of the effects of this outbreak.	[Menge, Bruce A.; Cerny-Chipman, Elizabeth B.; Johnson, Angela; Sullivan, Jenna; Gravem, Sarah; Chan, Francis] Oregon State Univ, Dept Integrat Biol, Corvallis, OR 97331 USA; [Johnson, Angela] Quantaphy, 440 Encinal St, Santa Cruz, CA USA	Oregon State University	Menge, BA (corresponding author), Oregon State Univ, Dept Integrat Biol, Corvallis, OR 97331 USA.	mengeb@oregonstate.edu	Menge, Bruce/I-6571-2012	Gravem, Sarah/0000-0002-3857-9930	David and Lucile Packard Foundation; Kingfisher Foundation; NSF [OCE14-48913]; Wayne and Gladys Valley Foundation; Division Of Ocean Sciences [1448913] Funding Source: National Science Foundation	David and Lucile Packard Foundation(The David & Lucile Packard Foundation); Kingfisher Foundation; NSF(National Science Foundation (NSF)); Wayne and Gladys Valley Foundation; Division Of Ocean Sciences(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO))	This research was funded by grants from the David and Lucile Packard Foundation (https://www.packard.org), the Kingfisher Foundation (www.kingfisherfoundation.org), NSF (http://www.nsf.gov; OCE14-48913), and endowments from the Wayne and Gladys Valley Foundation (http://fdnweb.org/wgvalley). This is publication 453 from PISCO, the Partnership for Interdisciplinary Studies of Coastal Oceans, funded in part by the David and Lucile Packard Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BARBER RT, 1983, SCIENCE, V222, P1203, DOI 10.1126/science.222.4629.1203; Barner AK, 2015, J ECOLOGY IN PRESS; Barth JA, 2007, P NATL ACAD SCI USA, V104, P3719, DOI 10.1073/pnas.0700462104; Bates AE, 2009, DIS AQUAT ORGAN, V86, P245, DOI 10.3354/dao02125; Berlow EL, 1999, NATURE, V398, P330, DOI 10.1038/18672; Berlow EL, 1997, ECOL MONOGR, V67, P435, DOI 10.1890/0012-9615(1997)067[0435:FCTCHE]2.0.CO;2; Blanchette CA, 2005, P CAL CHANN ISL S; Burge CA, 2016, PHILOS T R SOC B, V371, DOI 10.1098/rstb.2015.0207; Chavez FP, 1999, SCIENCE, V286, P2126, DOI 10.1126/science.286.5447.2126; Crawford AJ, 2010, P NATL ACAD SCI USA, V107, P13777, DOI 10.1073/pnas.0914115107; DANTONIO CM, 1986, MAR ECOL PROG SER, V27, P263, DOI 10.3354/meps027263; DAYTON PK, 1975, ECOL MONOGR, V45, P137, DOI 10.2307/1942404; DAYTON PK, 1971, ECOL MONOGR, V41, P351, DOI 10.2307/1948498; DUNGAN ML, 1982, SCIENCE, V216, P989, DOI 10.1126/science.216.4549.989; EBERT TA, 1988, LIMNOL OCEANOGR, V33, P286, DOI 10.4319/lo.1988.33.2.0286; Eckert G.L., 2000, P 5 CAL ISL S US DEP, P390; Eisenlord ME, 2016, PHILOS T R SOC B, V371, DOI 10.1098/rstb.2015.0212; ESTES JA, 1974, SCIENCE, V185, P1058, DOI 10.1126/science.185.4156.1058; Evans TG, 2015, COMP BIOCHEM PHYS A, V185, P33, DOI 10.1016/j.cbpa.2015.03.007; FARMANFARMAIAN A, 1958, J EXP ZOOL, V138, P355, DOI 10.1002/jez.1401380209; Feely RA, 2008, SCIENCE, V320, P1490, DOI 10.1126/science.1155676; Feely RA, 2009, OCEANOGRAPHY, V22, P36, DOI 10.5670/oceanog.2009.95; Fisher MC, 2009, ANNU REV MICROBIOL, V63, P291, DOI 10.1146/annurev.micro.091208.073435; Fuess LE, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0133053; Gruber N, 2012, SCIENCE, V337, P220, DOI 10.1126/science.1216773; Harvell CD, 1999, SCIENCE, V285, P1505, DOI 10.1126/science.285.5433.1505; Harvell CD, 2002, SCIENCE, V296, P2158, DOI 10.1126/science.1063699; Hauri C, 2013, GEOPHYS RES LETT, V40, P3424, DOI 10.1002/grl.50618; Hauri C, 2009, OCEANOGRAPHY, V22, P60, DOI 10.5670/oceanog.2009.97; Hewson I, 2014, P NATL ACAD SCI USA, V111, P17278, DOI 10.1073/pnas.1416625111; Hixon M. A., 2010, OREGON CLIMATE ASSES, P268; Hoegh-Guldberg O, 2010, SCIENCE, V328, P1523, DOI 10.1126/science.1189930; Huyer A, 2010, OCEANOGRAPHIC CONTEX; Hyman LH, 1955, ECHINODERMATA; Kavanaugh MT, 2009, LIMNOL OCEANOGR, V54, P276, DOI 10.4319/lo.2009.54.1.0276; Lafferty KD, 2009, ECOLOGY, V90, P888, DOI 10.1890/08-0079.1; Lawrence J.M., 2013, STARFISH BIOL ECOLOG; LESSIOS HA, 1988, ANNU REV ECOL SYST, V19, P371, DOI 10.1146/annurev.es.19.110188.002103; LOOSANOFF VL, 1964, BIOL BULL, V126, P423, DOI 10.2307/1539311; MAUZEY KP, 1966, BIOL BULL-US, V131, P127, DOI 10.2307/1539653; MENGE BA, 1972, ECOLOGY, V53, P635, DOI 10.2307/1934777; Menge BA, 2004, ECOL MONOGR, V74, P663, DOI 10.1890/03-4060; MENGE BA, 1974, ECOLOGY, V55, P84, DOI 10.2307/1934620; MENGE BA, 1975, MAR BIOL, V31, P87, DOI 10.1007/BF00390651; MENGE BA, 1972, ECOL MONOGR, V42, P25, DOI 10.2307/1942229; MENGE BA, 1994, ECOL MONOGR, V64, P249, DOI 10.2307/2937163; MENGE BA, 1979, OECOLOGIA, V41, P245, DOI 10.1007/BF00377430; Menge BA, 2015, ECOL MONOGR, V85, P213, DOI 10.1890/14-0113.1; Menge BA, 2011, ECOL MONOGR, V81, P493, DOI 10.1890/10-1508.1; Menge BA, 2011, J EXP MAR BIOL ECOL, V400, P236, DOI 10.1016/j.jembe.2011.02.003; Menge BA, 2009, ECOL MONOGR, V79, P379, DOI 10.1890/08-2086.1; Miller BA, 1997, MAR ECOL PROG SER, V148, P83, DOI 10.3354/meps148083; Monaco CJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104658; Navarrete SA, 2000, ECOLOGY, V81, P2264, DOI 10.1890/0012-9658(2000)081[2264:SIIIFW]2.0.CO;2; Navarrete SA, 1996, ECOL MONOGR, V66, P409, DOI 10.2307/2963488; PAINE RT, 1969, AM NAT, V103, P91, DOI 10.1086/282586; PAINE RT, 1966, AM NAT, V100, P65, DOI 10.1086/282400; PAINE RT, 1976, ECOLOGY, V57, P858, DOI 10.2307/1941053; PAINE RT, 1974, OECOLOGIA, V15, P93, DOI 10.1007/BF00345739; Paine RT, 2004, ECOL LETT, V7, P441, DOI 10.1111/j.1461-0248.2004.00601.x; Petes LE, 2008, OECOLOGIA, V156, P671, DOI 10.1007/s00442-008-1018-x; Pincebourde S, 2008, LIMNOL OCEANOGR, V53, P1562, DOI 10.4319/lo.2008.53.4.1562; Pincebourde S, 2013, J EXP BIOL, V216, P2183, DOI 10.1242/jeb.083881; Pincebourde S, 2009, AM NAT, V174, P890, DOI 10.1086/648065; Sanford E, 1999, SCIENCE, V283, P2095, DOI 10.1126/science.283.5410.2095; Sanford E, 2002, WILDLIFE RESPONSES TO CLIMATE CHANGE: NORTH AMERICAN CASE STUDIES, P165; Sanford E, 2002, J EXP MAR BIOL ECOL, V273, P199, DOI 10.1016/S0022-0981(02)00164-8; Sanford E, 2007, MAR ECOL PROG SER, V349, P1, DOI 10.3354/meps07166; Sanford E, 2010, ECOLOGY, V91, P891, DOI 10.1890/09-0536.1; Sanford E, 2009, INVERTEBR BIOL, V128, P372, DOI 10.1111/j.1744-7410.2009.00182.x; Sanford E, 2009, ECOLOGY, V90, P3108, DOI 10.1890/08-2055.1; Smith JR, 2006, ECOLOGY, V87, P1153, DOI 10.1890/0012-9658(2006)87[1153:DDIMBC]2.0.CO;2; Strathmann MF, 1987, REPROD DEV MARINE IN; SUCHANEK TH, 1992, NORTHWEST ENVIRON J, V8, P150; Szathmary PL, 2009, MAR ECOL PROG SER, V374, P43, DOI 10.3354/meps07682; Vredenburg VT, 2010, P NATL ACAD SCI USA, V107, P9689, DOI 10.1073/pnas.0914111107; Wares J, 2015, PEERJ IN PRESS, P1; Wieters EA, 2008, AM NAT, V171, P405, DOI 10.1086/527492; Witman JD, 2003, ECOL MONOGR, V73, P441, DOI 10.1890/01-4073; Wootton JT, 2002, ECOL RES, V17, P249, DOI 10.1046/j.1440-1703.2002.00484.x; WOOTTON JT, 1994, ECOLOGY, V75, P151, DOI 10.2307/1939391	81	69	69	2	162	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 4	2016	11	5							e0153994	10.1371/journal.pone.0153994	http://dx.doi.org/10.1371/journal.pone.0153994			28	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DL5KR	27144391	Green Published, gold, Green Submitted			2022-12-26	WOS:000375676400036
J	Ericsson, AC; Personett, AR; Grobman, ME; Rindt, H; Reinero, CR				Ericsson, Aaron C.; Personett, Alexa R.; Grobman, Megan E.; Rindt, Hansjorg; Reinero, Carol R.			Composition and Predicted Metabolic Capacity of Upper and Lower Airway Microbiota of Healthy Dogs in Relation to the Fecal Microbiota	PLOS ONE			English	Article							GRAM-NEGATIVE BACTERIA; SURFACTANT PROTEIN-A; BRONCHOALVEOLAR LAVAGE; PSEUDOMONAS-AERUGINOSA; CYSTIC-FIBROSIS; COMMUNITIES; INFECTIONS; DIVERSITY; DATABASE; GENES	The upper and lower airways of healthy humans are reported to harbor stable and consistent bacterial populations, and the composition of these communities is altered in individuals affected with several respiratory diseases. Data regarding the presence of airway microbiota in other animals are scant and a better understanding of the composition and metabolic function of such bacterial populations is essential for the development of novel therapeutic and diagnostic modalities for use in both veterinary and human medicine. Based on targeted next-generation sequencing of feces and samples collected at multiple levels of the airways from 16 healthy female dogs, we demonstrate that canine airways harbor a topographically continuous microbiota with increasing relative abundance of proteobacterial species from the upper to lower airways. The lung-associated microbiota, as assessed via bronchoalveolar lavage fluid (BALF), was the most consistent between dogs and was dominated by three distinct taxa, two of which were resolved to the species level and one to the level of family. The gene content of the nasal, oropharyngeal, and lung-associated microbiota, predicted using the Phylogenetic Investigations into Communities by Reconstruction of Unobserved States (PICRUSt) software, provided information regarding the glyoxylate and citrate cycle metabolic pathways utilized by these bacterial populations to colonize such nutrient-poor, low-throughput environments. These data generated in healthy subjects provide context for future analysis of diseased canine airways. Moreover, as dogs have similar respiratory anatomy, physiology, and immune systems as humans, are exposed to many of the same environmental stimuli, and spontaneously develop similar respiratory diseases, these data support the use of dogs as a model species for prospective studies of the airway microbiota, with findings translatable to the human condition.	[Ericsson, Aaron C.] Univ Missouri, Metagen Ctr, Columbia, MO USA; [Ericsson, Aaron C.; Personett, Alexa R.; Grobman, Megan E.; Rindt, Hansjorg; Reinero, Carol R.] Univ Missouri, Coll Vet Med, Columbia, MO USA; [Ericsson, Aaron C.] Univ Missouri, Coll Vet Med, Dept Vet Pathobiol, Columbia, MO USA; [Grobman, Megan E.; Reinero, Carol R.] Univ Missouri, Coll Vet Med, Dept Vet Med & Surg, Columbia, MO 65211 USA; [Grobman, Megan E.; Rindt, Hansjorg; Reinero, Carol R.] Univ Missouri, Comparat Internal Med Lab, Columbia, MO USA	University of Missouri System; University of Missouri Columbia; University of Missouri System; University of Missouri Columbia; University of Missouri System; University of Missouri Columbia; University of Missouri System; University of Missouri Columbia; University of Missouri System; University of Missouri Columbia	Ericsson, AC (corresponding author), Univ Missouri, Metagen Ctr, Columbia, MO USA.; Ericsson, AC; Reinero, CR (corresponding author), Univ Missouri, Coll Vet Med, Columbia, MO USA.; Ericsson, AC (corresponding author), Univ Missouri, Coll Vet Med, Dept Vet Pathobiol, Columbia, MO USA.; Reinero, CR (corresponding author), Univ Missouri, Coll Vet Med, Dept Vet Med & Surg, Columbia, MO 65211 USA.; Reinero, CR (corresponding author), Univ Missouri, Comparat Internal Med Lab, Columbia, MO USA.	ericssona@missouri.edu; reineroc@missouri.edu	Ericsson, Aaron C./AAJ-1406-2021	Ericsson, Aaron C./0000-0002-3053-7269	Mizzou Advantage Program-One Health initiative; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [K01OD019924] Funding Source: NIH RePORTER	Mizzou Advantage Program-One Health initiative; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	The authors wish to acknowledge funding for the University of Missouri Metagenomics Center provided by the Mizzou Advantage Program-One Health initiative. The authors would also like to acknowledge Dr. Joan Coates for allowing the sample collection on the beagles in this study, and Karen Clifford for assistance formatting figures.	Abubucker S, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002358; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Antunes LCS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022674; Bassis CM, 2015, MBIO, V6, DOI 10.1128/mBio.00037-15; Charlson ES, 2011, AM J RESP CRIT CARE, V184, P957, DOI 10.1164/rccm.201104-0655OC; DeSantis TZ, 2006, APPL ENVIRON MICROB, V72, P5069, DOI 10.1128/AEM.03006-05; Dickson RP, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1004923; Erb-Downward JR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016384; Ericsson AC, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0116704; Han XY, 2005, J ANTIMICROB CHEMOTH, V55, P853, DOI 10.1093/jac/dki139; Handelsman J, 2004, MICROBIOL MOL BIOL R, V68, P669, DOI 10.1128/MMBR.68.4.669-685.2004; Harris JK, 2007, P NATL ACAD SCI USA, V104, P20529, DOI 10.1073/pnas.0709804104; Hart ML, 2015, PLOS ONE IN PRESS; Hilty M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008578; Huang YJ, 2011, J ALLERGY CLIN IMMUN, V127, P372, DOI 10.1016/j.jaci.2010.10.048; KAHN FW, 1987, J INFECT DIS, V155, P862, DOI 10.1093/infdis/155.5.862; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; Kanehisa M, 2014, NUCLEIC ACIDS RES, V42, pD199, DOI 10.1093/nar/gkt1076; Kuczynski J, 2011, USING QIIME TO ANALY, DOI [10.1002/0471250953.bi0801s36, DOI 10.1002/0471250953.BI0801S36]; Langille MGI, 2013, NAT BIOTECHNOL, V31, P814, DOI 10.1038/nbt.2676; LAURENZI GA, 1961, NEW ENGL J MED, V265, P1273, DOI 10.1056/NEJM196112282652601; Lozupone CA, 2007, APPL ENVIRON MICROB, V73, P1576, DOI 10.1128/AEM.01996-06; Magoc T, 2011, BIOINFORMATICS, V27, P2957, DOI 10.1093/bioinformatics/btr507; Martens M, 2008, INT J SYST EVOL MICR, V58, P200, DOI 10.1099/ijs.0.65392-0; Mentula S, 2005, APPL ENVIRON MICROB, V71, P4169, DOI 10.1128/AEM.71.8.4169-4175.2005; Obritsch MD, 2005, PHARMACOTHERAPY, V25, P1353, DOI 10.1592/phco.2005.25.10.1353; PIKAAR JC, 1995, J INFECT DIS, V172, P481, DOI 10.1093/infdis/172.2.481; Reinero CR, 2009, ENVIRON RES, V109, P634, DOI 10.1016/j.envres.2009.02.001; Rogers GB, 2004, J CLIN MICROBIOL, V42, P5176, DOI 10.1128/JCM.42.11.5176-5183.2004; Song SH, 2009, APPL MICROBIOL BIOT, V84, P55, DOI 10.1007/s00253-009-2086-5; Stoveken N, 2011, J BACTERIOL, V193, P4456, DOI 10.1128/JB.00345-11; Stressmann FA, 2011, J CLIN MICROBIOL, V49, P281, DOI 10.1128/JCM.01650-10; Sukdeo N, 2004, BIOCHEM J, V384, P111, DOI 10.1042/BJ20041006; THORPE JE, 1987, J INFECT DIS, V155, P855, DOI 10.1093/infdis/155.5.855; Turnbaugh PJ, 2007, NATURE, V449, P804, DOI 10.1038/nature06244; Widderich N, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093809; Wu HX, 2003, J CLIN INVEST, V111, P1589, DOI 10.1172/JCI200316889; Yu ZT, 2004, BIOTECHNIQUES, V36, P808, DOI 10.2144/04365ST04; Zakharkina T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068302	39	38	38	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 2	2016	11	5							e0154646	10.1371/journal.pone.0154646	http://dx.doi.org/10.1371/journal.pone.0154646			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DL5KB	27136381	Green Published, gold, Green Submitted			2022-12-26	WOS:000375674800033
J	Kusumoto, Y; Nitta, O; Matsuo, A; Takaki, K; Matsuda, T				Kusumoto, Yasuaki; Nitta, Osamu; Matsuo, Atsushi; Takaki, Kenji; Matsuda, Tadamitsu			Factors Contributing to Satisfaction with Changes in Physical Function after Orthopedic Surgery for Musculoskeletal Dysfunction in Patients with Cerebral Palsy	PLOS ONE			English	Article							EVENT MULTILEVEL SURGERY; CHILDREN; RELEASE	Background The recognition of required treatments for cerebral palsy (CP) patients, including orthopedic surgery, differs according to region. This study was performed to identify factors associated with satisfactory changes in physical function after orthopedic surgery. Methods 358 patients were selected for the questionnaire survey. The following information was collected: gender, primary disease, age of initial surgery, total procedural count, operated sites, satisfaction of postoperative rehabilitation frequency, ideal amount of postoperative rehabilitation sessions per week, frequency of voluntary home training per week, satisfaction of the timing of surgery and the current satisfaction with the changes in physical function after the orthopedic surgery. We classified the patients into the satisfied and dissatisfied group according to satisfactory changes in physical function after the surgery. We performed unpaired t-tests and chi-square tests to determine the variables that differed significantly between the groups. Variables with a p value of <0.2 were included in the multivariate logistic regression analysis. Results The logistic model was revised and summed up to two potential predictors of postsurgical satisfaction with physical function: satisfaction with the frequency of postoperative rehabilitation sessions and the orthopedic surgery of the hip (distinction hit ratio, 75.4%). Conclusions This study demonstrated that the frequency of postoperative rehabilitation and history of hip surgery seemed to be related to the satisfaction with the changes in physical function after orthopedic surgery.	[Kusumoto, Yasuaki] Tokyo Univ Technol, Fac Hlth Sci, Dept Phys Therapy, Ota Ku, Tokyo, Japan; [Nitta, Osamu] Tokyo Metropolitan Univ, Fac Hlth Sci, Dept Phys Therapy, Arakawa Ku, Tokyo 158, Japan; [Matsuo, Atsushi] Minamitama Orthoped Hosp, Dept Orthoped, Machida, Tokyo, Japan; [Takaki, Kenji] Minamitama Orthoped Hosp, Dept Rehabil, Machida, Tokyo, Japan; [Matsuda, Tadamitsu] Uekusa Gakuen Univ, Fac Hlth Sci, Dept Phys Therapy, Chiba, Chiba, Japan	Tokyo University of Technology	Kusumoto, Y (corresponding author), Tokyo Univ Technol, Fac Hlth Sci, Dept Phys Therapy, Ota Ku, Tokyo, Japan.	kusumotoys@stf.teu.ac.jp		Takaki, Kenji/0000-0003-3401-6644	Japanese Physical Therapy Association	Japanese Physical Therapy Association	This study was financially supported by the Japanese Physical Therapy Association. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Borowski Andrzej, 2010, Ortop Traumatol Rehabil, V12, P347; Capjon H, 2010, DEV NEUROREHABIL, V13, P182, DOI 10.3109/17518421003606151; Kondo I, 2004, DEV MED CHILD NEUROL, V46, P540, DOI 10.1017/S0012162204000908; Kusumoto Y, 2013, J JPN HLTH SCI, V16, P38; Kusumoto Y, 2014, J INTERPROF CARE, V7, P118; Lee KM, 2010, J PEDIATR ORTHOPED, V30, P396, DOI 10.1097/BPO.0b013e3181da855f; MATSUO T, 1990, CLIN ORTHOP RELAT R, P185; Matsuo T, 2001, CLIN ORTHOP RELAT R, P162; MATSUO T, 1986, J PEDIATR ORTHOPED, V6, P686, DOI 10.1097/01241398-198611000-00008; Matsuo T., 2002, CEREBRAL PALSY SPAST; Palisano RJ, 2010, CHILD CARE HLTH DEV, V36, P85, DOI 10.1111/j.1365-2214.2009.01030.x; Park MS, 2009, J PEDIATR ORTHOPED, V29, P765, DOI 10.1097/BPO.0b013e3181b529e8	12	1	1	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 2	2016	11	5							e0154749	10.1371/journal.pone.0154749	http://dx.doi.org/10.1371/journal.pone.0154749			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DL5KB	27135609	Green Published, gold			2022-12-26	WOS:000375674800046
J	Wang, LZ; Xu, Q; Kong, FL; Yang, YD; Wu, D; Mishra, S; Li, Y				Wang, Lizhi; Xu, Qin; Kong, Fanli; Yang, Yindong; Wu, De; Mishra, Sudhanshu; Li, Ying			Exploring the Goat Rumen Microbiome from Seven Days to Two Years	PLOS ONE			English	Article							COMMUNITY STRUCTURE; DAIRY CALVES; ESTABLISHMENT; SIMILARITY; DIVERSITY; BACTERIA; DIET; QUANTIFICATION; MICROORGANISMS; PREVOTELLA	Rumen microbial communities play important roles in feed conversion and the physiological development of the ruminants. Despite its significance, little is known about the rumen microbial communities at different life stages after birth. In this study, we characterized the rumen bacterial and the archaeal communities in 11 different age groups (7, 15, 30, 60, 90, 120, 150, 180, 360, 540 and 720 days old) of a crossbred F1 goats (n = 5 for each group) by using an Illumina MiSeq platform targeting the V3-V4 region of the 16S rRNA gene. We found that the bacterial communities were mainly composed of Bacteroidetes, Firmicutes, and Proteobacteria across all age groups. The relative abundance of Firmicutes was stable across all age groups. While changes in relative abundance were observed in Bacteroidetes and Proteobacteria, these two phyla reached a stable stage after weaning (day 90). Euryarchaeota (82%) and Thaumarchaeota (15%) were the dominant phyla of Archaea. Crenarchaeota was also observed, although at a very low relative abundance (0.68% at most). A clear age-related pattern was observed in the diversity of bacterial community with 59 OTUs associated with age. In contrast, no age-related OTU was observed in archaea. In conclusion, our results suggested that from 7 days to 2 years, the ruminal microbial community of our experimental goats underwent significant changes in response to the shift in age and diet.	[Wang, Lizhi; Xu, Qin; Wu, De] Sichuan Agr Univ, Inst Anim Nutr, Yaan, Sichuan, Peoples R China; [Yang, Yindong] Inst Agr & Technol, Panzhihua, Sichuan, Peoples R China; [Kong, Fanli; Mishra, Sudhanshu; Li, Ying] Sichuan Agr Univ, Farm Anim Genet Resources Explorat & Innovat Key, Chengdu, Sichuan, Peoples R China	Sichuan Agricultural University; Sichuan Agricultural University	Li, Y (corresponding author), Sichuan Agr Univ, Farm Anim Genet Resources Explorat & Innovat Key, Chengdu, Sichuan, Peoples R China.	yingli@sicau.edu.cn	MISHRA, SUDHANSHU/E-6732-2011		International Cooperation Project of Chinese Ministry of Sciences and Technology [2014DFA32860]; "1000-Talent Program" in Sichuan; Innovative Research Team in University of Sichuan Bureau of Education	International Cooperation Project of Chinese Ministry of Sciences and Technology; "1000-Talent Program" in Sichuan; Innovative Research Team in University of Sichuan Bureau of Education	This work was funded by the International Cooperation Project of Chinese Ministry of Sciences and Technology (grant number: 2014DFA32860), LZW received this funding. This work was funded also by the "1000-Talent Program" in Sichuan, and the Innovative Research Team in University of Sichuan Bureau of Education, YL received this funding. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALGERS B, 1990, APPL ANIM BEHAV SCI, V26, P143, DOI 10.1016/0168-1591(90)90094-T; [Anonymous], 1997, RUMEN MICROBIAL ECOS; Baldwin R L, 2004, J DAIRY SCI, V87, pE55, DOI [10.3168/jds.2012-5970, DOI 10.3168/JDS.S0022-0302(04)70061-2]; Beharka AA, 1998, J DAIRY SCI, V81, P1946, DOI 10.3168/jds.S0022-0302(98)75768-6; Bekele AZ, 2010, FEMS MICROBIOL LETT, V305, P49, DOI 10.1111/j.1574-6968.2010.01911.x; Belanche A, 2014, FEMS MICROBIOL ECOL, V90, P663, DOI 10.1111/1574-6941.12423; BRAY JR, 1957, ECOL MONOGR, V27, P326, DOI 10.2307/1942268; BRYANT MP, 1958, J DAIRY SCI, V41, P1747, DOI 10.3168/jds.S0022-0302(58)91160-3; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Chao A, 2005, ECOL LETT, V8, P148, DOI 10.1111/j.1461-0248.2004.00707.x; Conlon MA, 2015, NUTRIENTS, V7, P17, DOI 10.3390/nu7010017; Cunha IS, 2011, ANAEROBE, V17, P118, DOI 10.1016/j.anaerobe.2011.04.018; Edgar RC, 2011, BIOINFORMATICS, V27, P2194, DOI 10.1093/bioinformatics/btr381; FONTY G, 1987, J GEN MICROBIOL, V133, P1835; Fonty G, 2007, APPL ENVIRON MICROB, V73, P6391, DOI 10.1128/AEM.00181-07; Guzman CE, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0133048; Han XF, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117811; Huo WJ, 2014, WORLD J MICROB BIOT, V30, P669, DOI 10.1007/s11274-013-1489-8; Huse SM, 2010, ENVIRON MICROBIOL, V12, P1889, DOI 10.1111/j.1462-2920.2010.02193.x; Jami E, 2013, ISME J, V7, P1069, DOI 10.1038/ismej.2013.2; Jami E, 2012, ANAEROBE, V18, P338, DOI 10.1016/j.anaerobe.2012.04.003; Jeyanathan J, 2011, FEMS MICROBIOL ECOL, V76, P311, DOI 10.1111/j.1574-6941.2011.01056.x; Khan MA, 2011, J DAIRY SCI, V94, P1071, DOI 10.3168/jds.2010-3733; KLEIN RD, 1987, J DAIRY SCI, V70, P2095, DOI 10.3168/jds.S0022-0302(87)80259-X; Kumar S, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.00781; Lay DC, 1998, APPL ANIM BEHAV SCI, V56, P109, DOI 10.1016/S0168-1591(97)00103-2; Ley RE, 2008, SCIENCE, V320, P1647, DOI 10.1126/science.1155725; Loberg JM, 2008, APPL ANIM BEHAV SCI, V111, P222, DOI 10.1016/j.applanim.2007.06.011; Mao SY, 2016, ENVIRON MICROBIOL, V18, P525, DOI 10.1111/1462-2920.12724; MINATO H, 1992, J GEN APPL MICROBIOL, V38, P447, DOI 10.2323/jgam.38.447; Pitta DW, 2014, ANAEROBE, V30, P11, DOI 10.1016/j.anaerobe.2014.07.008; Rey M, 2014, J APPL MICROBIOL, V116, P245, DOI 10.1111/jam.12405; Rey M, 2012, J DAIRY SCI, V95, P1500, DOI 10.3168/jds.2011-4902; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; Shannon C. E., 1949, MATH THEORY COMMUNIC; SIMPSON EH, 1949, NATURE, V163, P688, DOI 10.1038/163688a0; Skillman LC, 2004, ANAEROBE, V10, P277, DOI 10.1016/j.anaerobe.2004.05.003; Stevenson DM, 2007, APPL MICROBIOL BIOT, V75, P165, DOI 10.1007/s00253-006-0802-y; Subramanian A, MULTIVARIAT IN PRESS; Takai K, 2000, APPL ENVIRON MICROB, V66, P5066, DOI 10.1128/AEM.66.11.5066-5072.2000; Van Soest P.J., 1994, NUTR ECOLOGY RUMINAN; Yue JC, 2005, COMMUN STAT-THEOR M, V34, P2123, DOI 10.1080/STA-200066418; Zilber-Rosenberg I, 2008, FEMS MICROBIOL REV, V32, P723, DOI 10.1111/j.1574-6976.2008.00123.x	43	63	68	0	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 2	2016	11	5							e0154354	10.1371/journal.pone.0154354	http://dx.doi.org/10.1371/journal.pone.0154354			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DL5KB	27135948	Green Published, Green Submitted, gold			2022-12-26	WOS:000375674800019
J	Kivisto, J; Lehto, SM; Halonen, K; Georgiadis, L; Heinonen, S				Kivisto, Julia; Lehto, Soili M.; Halonen, Katja; Georgiadis, Leena; Heinonen, Seppo			Maternal Use of Selective Serotonin Reuptake Inhibitors and Lengthening of the Umbilical Cord: Indirect Evidence of Increased Foetal Activity-A Retrospective Cohort Study	PLOS ONE			English	Article							IN-UTERO EXPOSURE; PREGNANCY; DEPRESSION; OUTCOMES; ANTIDEPRESSANTS; PREVALENCE; IMPACT; RISK; TERM	Background Antenatal depression affects up to 19% of pregnant women. Some of these women are also in need of antidepressant treatment. Nevertheless, the impact of maternal antidepressant treatment and prenatal depression on the course of pregnancy, foetal development and delivery outcomes is not fully understood. Methods We analysed data from 24 818 women who gave birth at Kuopio University Hospital between 2002-2012. Logistic regression analysis was used to estimate associations between the use of selective serotonin reuptake inhibitors (SSRIs) during pregnancy and the progression of pregnancy, development of the foetus and delivery outcomes. Results Altogether, 369 (1.5%) women used SSRIs. A regression model adjusted for age, overweight, nulliparity, prior termination, miscarriages, smoking, maternal alcohol consumption, chronic illness and polyhydramnion showed that pregnant women exposed to SSRI medication had significantly lower Apgar scores at 1 minute (p < 0.0001) and 5 minutes (p < 0.0001) and more admissions to the neonatal intensive care unit (p < 0.0001) than unexposed pregnant women. In addition, exposed newborns had longer umbilical cords (p < 0.0001) than non-exposed newborns. Conclusion In addition to the previously known associates with maternal SSRI exposure, such as lowered Apgar scores, SSRI exposure appeared to be associated with increased umbilical cord length. The observation related to increased umbilical cord length may be explained by an SSRI-induced increase in the movements of the developing foetus.	[Kivisto, Julia; Lehto, Soili M.] Univ Eastern Finland, Inst Clin Med, Dept Psychiat, Kuopio, Finland; [Lehto, Soili M.] Kuopio Univ Hosp, Dept Psychiat, SF-70210 Kuopio, Finland; [Halonen, Katja] Univ Eastern Finland, Dept Pharmacol & Toxicol, Kuopio, Finland; [Georgiadis, Leena] Univ Eastern Finland, Inst Clin Med, Dept Obstet & Gynaecol, Kuopio, Finland; [Heinonen, Seppo] Helsinki Univ Hosp, Dept Obstet & Gynaecol, Helsinki, Finland; [Heinonen, Seppo] Univ Helsinki, Dept Obstet & Gynaecol, Helsinki, Finland	University of Eastern Finland; Kuopio University Hospital; University of Eastern Finland; University of Eastern Finland; University of Eastern Finland; University of Helsinki; Helsinki University Central Hospital; University of Helsinki	Kivisto, J (corresponding author), Univ Eastern Finland, Inst Clin Med, Dept Psychiat, Kuopio, Finland.	julia.kivisto@gmail.com		Lehto, Soili/0000-0003-4324-6679	Finnish Cultural Foundation	Finnish Cultural Foundation(Finnish Cultural FoundationFinnish IT center for science)	SML was supported by the Finnish Cultural Foundation (no grant numbers). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ACOG Committee on Practice Bulletins--Obstetrics, 2002, Obstet Gynecol, V99, P159; Baergen RN, 2001, PEDIATR DEVEL PATHOL, V4, P144, DOI 10.1007/s100240010135; Bennett HA, 2004, OBSTET GYNECOL, V103, P698, DOI 10.1097/01.AOG.0000116689.75396.5f; Cooper WO, 2007, AM J OBSTET GYNECOL, V196, P544, DOI 10.1016/j.ajog.2007.01.033; Davis RL, 2007, PHARMACOEPIDEM DR S, V16, P1086, DOI 10.1002/pds.1462; Einarson A, 2009, J OBSTET GYNAECOL CA, V31, P452, DOI 10.1016/S1701-2163(16)34177-9; Gavin NI, 2005, OBSTET GYNECOL, V106, P1071, DOI 10.1097/01.AOG.0000183597.31630.db; Georgiadis L, 2014, PLACENTA, V35, P275, DOI 10.1016/j.placenta.2014.02.001; Grigoriadis S, 2013, J CLIN PSYCHIAT, V74, pE321, DOI 10.4088/JCP.12r07968; Heinonen S, 2001, PLACENTA, V22, P399, DOI 10.1053/plac.2001.0630; Huopio H, 2014, BMC PREGNANCY CHILDB, V14, DOI 10.1186/1471-2393-14-296; Klieger-Grossmann C, 2012, J CLIN PHARMACOL, V52, P766, DOI 10.1177/0091270011405524; Krakowiak P, 2004, OBSTET GYNECOL, V103, P119, DOI 10.1097/01.AOG.0000102706.84063.C7; Lennestal R, 2007, J CLIN PSYCHOPHARM, V27, P607, DOI 10.1097/jcp.0b013e31815ac4d2; Lewis AJ, 2010, AUST NZ J PSYCHIAT, V44, P482, DOI 10.3109/00048670903559593; Lund N, 2009, ARCH PEDIAT ADOL MED, V163, P949, DOI 10.1001/archpediatrics.2009.164; Maschi S, 2008, BJOG-INT J OBSTET GY, V115, P283, DOI 10.1111/j.1471-0528.2007.01518.x; McDonagh MS, 2014, OBSTET GYNECOL, V124, P526, DOI 10.1097/AOG.0000000000000410; MILLER ME, 1982, J PEDIATR-US, V101, P844, DOI 10.1016/S0022-3476(82)80344-2; Misra DP, 2009, PLACENTA, V30, P1052, DOI 10.1016/j.placenta.2009.09.008; Mitchell AA, 2011, AM J OBSTET GYNECOL, V205, DOI 10.1016/j.ajog.2011.02.029; NAEYE RL, 1985, J PEDIATR-US, V107, P278, DOI 10.1016/S0022-3476(85)80149-9; Nakhai-Pour HR, 2010, CAN MED ASSOC J, V182, P1031, DOI 10.1503/cmaj.091208; Oberlander TF, 2006, ARCH GEN PSYCHIAT, V63, P898, DOI 10.1001/archpsyc.63.8.898; Reis M, 2010, PSYCHOL MED, V40, P1723, DOI 10.1017/S0033291709992194; Smith MV, 2013, EARLY HUM DEV, V89, P81, DOI 10.1016/j.earlhumdev.2012.08.001; SORNES T, 1989, ACTA OBSTET GYN SCAN, V68, P439, DOI 10.3109/00016348909021017; Stefos T, 2003, EUR J OBSTET GYN R B, V107, P41, DOI 10.1016/S0301-2115(02)00307-X; Wisner KL, 2009, AM J PSYCHIAT, V166, P557, DOI 10.1176/appi.ajp.2008.08081170; Zeskind PS, 2004, PEDIATRICS, V113, P368, DOI 10.1542/peds.113.2.368	30	7	7	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 29	2016	11	4							e0154628	10.1371/journal.pone.0154628	http://dx.doi.org/10.1371/journal.pone.0154628			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DK8XM	27128030	Green Published, gold, Green Submitted			2022-12-26	WOS:000375212600053
J	Mizuno, M; Tomizawa, A; Ohno, K; Jakubowski, JA; Sugidachi, A				Mizuno, Makoto; Tomizawa, Atsuyuki; Ohno, Kousaku; Jakubowski, Joseph A.; Sugidachi, Atsuhiro			A Novel Model of Intravital Platelet Imaging Using CD41-ZsGreen1 Transgenic Rats	PLOS ONE			English	Article							ARTERIAL THROMBUS FORMATION; IN-VIVO; ANTITHROMBOTIC ACTIVITY; FLUORESCENT PROTEINS; RECEPTOR ANTAGONIST; SPECIES-DIFFERENCES; AGGREGATION; EXPRESSION; CORONARY; DISEASE	Platelets play pivotal roles in both hemostasis and thrombosis. Although models of intravital platelet imaging are available for thrombosis studies in mice, few are available for rat studies. The present effort aimed to generate fluorescent platelets in rats and assess their dynamics in a rat model of arterial injury. We generated CD41-ZsGreen1 transgenic rats, in which green fluorescence protein ZsGreen1 was expressed specifically in megakaryocytes and thus platelets. The transgenic rats exhibited normal hematological and biochemical values with the exception of body weight and erythroid parameters, which were slightly lower than those of wild-type rats. Platelet aggregation, induced by 20 mu M ADP and 10 mu g/ml collagen, and blood clotting times were not significantly different between transgenic and wildtype rats. Saphenous arteries of transgenic rats were injured with 10% FeCl3, and the formation of fluorescent thrombi was evaluated using confocal microscopy. FeCl3 caused time-dependent increases in the mean fluorescence intensity of injured arteries of vehicle-treated rats. Prasugrel (3 mg/kg, p.o.), administered 2 h before FeCl3, significantly inhibited fluorescence compared with vehicle-treated rats (4.5 +/- 0.4 vs. 14.9 +/- 2.4 arbitrary fluorescence units at 30 min, respectively, n = 8, P = 0.0037). These data indicate that CD41-ZsGreen1 transgenic rats represent a useful model for intravital imaging of platelet-mediated thrombus formation and the evaluation of antithrombotic agents.	[Mizuno, Makoto; Tomizawa, Atsuyuki; Ohno, Kousaku; Sugidachi, Atsuhiro] Daiichi Sankyo Co Ltd, Biol Res Labs, Tokyo, Japan; [Jakubowski, Joseph A.] Eli Lilly & Co, Lilly Res Labs, Indianapolis, IN 46285 USA	Daiichi Sankyo Company Limited; Eli Lilly	Sugidachi, A (corresponding author), Daiichi Sankyo Co Ltd, Biol Res Labs, Tokyo, Japan.	sugidachi.atsuhiro.r7@daiichisankyo.co.jp			Eli Lilly and Company; Daiichi Sankyo Co., Ltd.	Eli Lilly and Company(Eli Lilly); Daiichi Sankyo Co., Ltd.(Daiichi Sankyo Company Limited)	The funders provided support in the form of salaries for authors (JAJ: Eli Lilly and Company; other authors: Daiichi Sankyo Co., Ltd.), but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section. The authors received no other specific funding for this work.	Alonso-Martin S, 2010, THROMB RES, V125, pE300, DOI 10.1016/j.thromres.2010.02.008; Bell P, 2007, J HISTOCHEM CYTOCHEM, V55, P931, DOI 10.1369/jhc.7A7180.2007; BLOCK KL, 1995, STEM CELLS, V13, P135, DOI 10.1002/stem.5530130205; BORN GVR, 1962, NATURE, V194, P927, DOI 10.1038/194927b0; Coller BS, 1997, J CLIN INVEST, V99, P1467, DOI 10.1172/JCI119307; Du X, 1997, THROMB HAEMOSTASIS, V78, P96; Dubois C, 2006, BLOOD, V107, P3902, DOI 10.1182/blood-2005-09-3687; Falati S, 2002, NAT MED, V8, P1175, DOI 10.1038/nm782; FRENETTE PS, 1995, P NATL ACAD SCI USA, V92, P7450, DOI 10.1073/pnas.92.16.7450; FUSTER V, 1992, NEW ENGL J MED, V326, P242, DOI 10.1056/NEJM199201233260406; FUSTER V, 1992, NEW ENGL J MED, V326, P310; Goto S., 2004, Current Medicinal Chemistry - Cardiovascular & Hematological Agents, V2, P149, DOI 10.2174/1568016043477233; Harazono Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062757; Hayashi T, 2008, PFLUG ARCH EUR J PHY, V456, P1239, DOI 10.1007/s00424-008-0466-9; Herbert JM, 1996, THROMB HAEMOSTASIS, V76, P94; Jahan MR, 2015, NEUROSCIENCE, V284, P943, DOI 10.1016/j.neuroscience.2014.11.003; Kihara H, 2001, EUR J PHARMACOL, V433, P157, DOI 10.1016/S0014-2999(01)01432-7; Krumholz HM, 2006, CIRCULATION, V113, P732, DOI 10.1161/CIRCULATIONAHA.106.172860; Massberg S, 1999, BLOOD, V94, P3829, DOI 10.1182/blood.V94.11.3829.423k35_3829_3838; Maxwell MJ, 2007, BLOOD, V109, P566, DOI 10.1182/blood-2006-07-028282; Nylander S, 2006, THROMB RES, V117, P543, DOI 10.1016/j.thromres.2005.04.026; Ogawa T, 2009, EUR J PHARMACOL, V612, P29, DOI 10.1016/j.ejphar.2009.03.073; Poujol C, 1998, BLOOD, V92, P2012, DOI 10.1182/blood.V92.6.2012.418k28_2012_2023; Richards B, 2002, CYTOMETRY, V48, P106, DOI 10.1002/cyto.10117; Rosamond W, 2007, CIRCULATION, V115, pE69, DOI 10.1161/CIRCULATIONAHA.106.179918; Ruggeri ZM, 2002, NAT MED, V8, P1227, DOI 10.1038/nm1102-1227; Sekine S, 2013, BIOCHEM PHARMACOL, V86, P1507, DOI 10.1016/j.bcp.2013.08.027; Sim DS, 2004, BLOOD, V103, P2127, DOI 10.1182/blood-2003-04-1133; Smith SC, 2006, CIRCULATION, V113, P2363, DOI 10.1161/CIRCULATIONAHA.106.174516; Sugidachi A, 2000, BRIT J PHARMACOL, V129, P1439, DOI 10.1038/sj.bjp.0703237; Sugidachi A, 2011, J CARDIOVASC PHARM, V58, P329, DOI 10.1097/FJC.0b013e3182244a6f; Surin WR, 2010, J PHARMACOL TOX MET, V61, P287, DOI 10.1016/j.vascn.2009.11.002; WEISS HJ, 1975, NEW ENGL J MED, V293, P531, DOI 10.1056/NEJM197509112931105; WEISS HJ, 1975, NEW ENGL J MED, V293, P580, DOI 10.1056/NEJM197509182931204; Zhang JH, 2007, EXP HEMATOL, V35, P490, DOI 10.1016/j.exphem.2006.11.011; Zhang YM, 1998, NAT GENET, V20, P123, DOI 10.1038/2417	36	3	3	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 29	2016	11	4							e0154661	10.1371/journal.pone.0154661	http://dx.doi.org/10.1371/journal.pone.0154661			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DK8XM	27128503	Green Submitted, Green Published, gold			2022-12-26	WOS:000375212600057
J	Endo, H; Sugie, K; Yoshimura, T; Suzuki, K				Endo, Hisashi; Sugie, Koji; Yoshimura, Takeshi; Suzuki, Koji			Response of Spring Diatoms to CO2 Availability in the Western North Pacific as Determined by Next-Generation Sequencing	PLOS ONE			English	Article							INORGANIC CARBON ACQUISITION; SUB-ARCTIC PACIFIC; COMMUNITY STRUCTURE; OCEAN ACIDIFICATION; IRON AVAILABILITY; INCREASED PCO(2); ORGANIC-MATTER; OYASHIO REGION; PHYTOPLANKTON COMMUNITY; MICROCOSM EXPERIMENTS	Next-generation sequencing (NGS) technologies have enabled us to determine phytoplankton community compositions at high resolution. However, few studies have adopted this approach to assess the responses of natural phytoplankton communities to environmental change. Here, we report the impact of different CO2 levels on spring diatoms in the Oyashio region of the western North Pacific as estimated by NGS of the diatom-specific rbcL gene (DNA), which encodes the large subunit of RubisCO. We also examined the abundance and composition of rbcL transcripts (cDNA) in diatoms to assess their physiological responses to changing CO2 levels. A short-term (3-day) incubation experiment was carried out on-deck using surface Oyashio waters under different pCO(2) levels (180, 350, 750, and 1000 mu atm) in May 2011. During the incubation, the transcript abundance of the diatom-specific rbcL gene decreased with an increase in seawater pCO(2) levels. These results suggest that CO2 fixation capacity of diatoms decreased rapidly under elevated CO2 levels. In the high CO2 treatments (750 and 1000 mu atm), diversity of diatom-specific rbcL gene and its transcripts decreased relative to the control treatment (350 mu atm), as well as contributions of Chaetocerataceae, Thalassiosiraceae, and Fragilariaceae to the total population, but the contributions of Bacillariaceae increased. In the low CO2 treatment, contributions of Bacillariaceae also increased together with other eukaryotes. These suggest that changes in CO2 levels can alter the community composition of spring diatoms in the Oyashio region. Overall, the NGS technology provided us a deeper understanding of the response of diatoms to changes in CO2 levels in terms of their community composition, diversity, and photosynthetic physiology.	[Endo, Hisashi; Suzuki, Koji] Hokkaido Univ, Fac Environm Earth Sci, Grad Sch Environm Sci, Sapporo, Hokkaido, Japan; [Endo, Hisashi; Suzuki, Koji] Japan Sci & Technol, CREST, Sapporo, Hokkaido, Japan; [Sugie, Koji; Yoshimura, Takeshi] Cent Res Inst Elect Power Ind, Abiko, Chiba, Japan; [Sugie, Koji] Japan Agcy Marine Earth Sci & Technol JAMSTEC, Res & Dev Ctr Global Change, Yokosuka, Kanagawa, Japan	Hokkaido University; Japan Science & Technology Agency (JST); Central Research Institute of Electric Power Industry - Japan; Japan Agency for Marine-Earth Science & Technology (JAMSTEC)	Endo, H (corresponding author), Hokkaido Univ, Fac Environm Earth Sci, Grad Sch Environm Sci, Sapporo, Hokkaido, Japan.; Endo, H (corresponding author), Japan Sci & Technol, CREST, Sapporo, Hokkaido, Japan.	endo@ees.hokudai.ac.jp	Suzuki, Koji/GVS-9807-2022; Sugie, Koji/AAG-1639-2020; Endo, Hisashi/C-3318-2019; 毅, 芳村/M-1778-2017; Suzuki, Koji/AAD-2630-2022; Suzuki, Koji/A-4349-2013	Suzuki, Koji/0000-0001-5354-1044; Sugie, Koji/0000-0003-3316-504X; Endo, Hisashi/0000-0003-0016-1624; 毅, 芳村/0000-0001-5700-2590; Suzuki, Koji/0000-0001-5354-1044	Central Research Institute of Electric Power Industry [090313];  [18067008];  [22681004];  [24121004]; Grants-in-Aid for Scientific Research [15K21683] Funding Source: KAKEN	Central Research Institute of Electric Power Industry; ; ; ; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by grants from the Central Research Institute of Electric Power Industry (No. 090313; URL: http://criepi.denken.or.jp/en/) and Grants-in-Aid for Scientific Research (No. 18067008, 22681004, and 24121004; URL: https://www.jsps.go.jp/english/e-grants/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bent SJ, 2008, ISME J, V2, P689, DOI 10.1038/ismej.2008.44; Bhadury P, 2009, J PHYCOL, V45, P1335, DOI 10.1111/j.1529-8817.2009.00766.x; Bittner L, 2013, MOL ECOL, V22, P87, DOI 10.1111/mec.12108; Burkhardt S, 2001, LIMNOL OCEANOGR, V46, P1378, DOI 10.4319/lo.2001.46.6.1378; Caldeira K, 2003, NATURE, V425, P365, DOI 10.1038/425365a; Chiba S, 2004, J OCEANOGR, V60, P149, DOI 10.1023/B:JOCE.0000038324.14054.cf; Chiba S, 2012, GEOPHYS RES LETT, V39, DOI 10.1029/2012GL052912; Corredor JE, 2004, APPL ENVIRON MICROB, V70, P5459, DOI 10.1128/AEM.70.9.5459-5468.2004; Doney SC, 2009, ANNU REV MAR SCI, V1, P169, DOI 10.1146/annurev.marine.010908.163834; EDMOND JM, 1970, DEEP-SEA RES, V17, P737, DOI 10.1016/0011-7471(70)90038-0; Endo H, 2015, BIOGEOSCIENCES, V12, P2247, DOI 10.5194/bg-12-2247-2015; Endo H, 2013, J EXP MAR BIOL ECOL, V439, P160, DOI 10.1016/j.jembe.2012.11.003; Engel A, 2008, BIOGEOSCIENCES, V5, P509, DOI 10.5194/bg-5-509-2008; Feng YY, 2009, MAR ECOL PROG SER, V388, P13, DOI 10.3354/meps08133; Fielding AS, 1998, CAN J BOT, V76, P1098, DOI 10.1139/b98-069; Gao KS, 2012, NAT CLIM CHANGE, V2, P519, DOI 10.1038/NCLIMATE1507; GIESKES WWC, 1983, MAR BIOL, V75, P179, DOI 10.1007/BF00406000; Granum E, 2009, J PHYCOL, V45, P1083, DOI 10.1111/j.1529-8817.2009.00728.x; Hare CE, 2007, MAR ECOL PROG SER, V352, P9, DOI 10.3354/meps07182; Hattori-Saito A, 2010, J OCEANOGR, V66, P105, DOI 10.1007/s10872-010-0009-9; Hirai J, 2015, MOL ECOL RESOUR, V15, P68, DOI 10.1111/1755-0998.12294; Hopkinson BM, 2010, LIMNOL OCEANOGR, V55, P2011, DOI 10.4319/lo.2010.55.5.2011; Hoppe CJM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079890; Hutchins DA, 2007, LIMNOL OCEANOGR, V52, P1293, DOI 10.4319/lo.2007.52.4.1293; Isada T, 2009, J PLANKTON RES, V31, P1009, DOI 10.1093/plankt/fbp050; Jing HM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079423; John DE, 2007, MAR BIOTECHNOL, V9, P747, DOI 10.1007/s10126-007-9027-z; John DE, 2007, ISME J, V1, P517, DOI 10.1038/ismej.2007.70; John DE, 2012, HYDROBIOLOGIA, V679, P155, DOI 10.1007/s10750-011-0862-6; Kirkham AR, 2013, ISME J, V7, P922, DOI 10.1038/ismej.2012.166; Kroeker KJ, 2013, GLOBAL CHANGE BIOL, V19, P1884, DOI 10.1111/gcb.12179; Lewis E., 1998, PROGRAM DEV CO2 SYST; Li G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055562; Liu HB, 2004, J OCEANOGR, V60, P119, DOI 10.1023/B:JOCE.0000038322.79644.36; Liu L, 2012, J BIOMED BIOTECHNOL, DOI 10.1155/2012/251364; Losh JL, 2013, NEW PHYTOL, V198, P52, DOI 10.1111/nph.12143; Losh JL, 2012, MAR ECOL PROG SER, V468, P31, DOI 10.3354/meps09981; Mackey MD, 1996, MAR ECOL PROG SER, V144, P265, DOI 10.3354/meps144265; Meakin NG, 2011, ISME J, V5, P1397, DOI 10.1038/ismej.2011.18; Midorikawa T, 2003, J OCEANOGR, V59, P871, DOI 10.1023/B:JOCE.0000009577.40878.d4; NELSON DM, 1995, GLOBAL BIOGEOCHEM CY, V9, P359, DOI 10.1029/95GB01070; Newbold LK, 2012, ENVIRON MICROBIOL, V14, P2293, DOI 10.1111/j.1462-2920.2012.02762.x; Nogueira P, 2014, J EXP MAR BIOL ECOL, V461, P323, DOI 10.1016/j.jembe.2014.09.006; Raven JA, 2010, PHOTOSYNTH RES, V106, P123, DOI 10.1007/s11120-010-9563-7; Riebesell U, 2000, NATURE, V407, P364, DOI 10.1038/35030078; Riebesell U., 2011, OCEAN ACIDIFICATION, P99, DOI [10.1093/oso/9780199591091.003.0011, DOI 10.1093/OSO/9780199591091.003.0011]; Rose JM, 2009, MAR ECOL PROG SER, V388, P27, DOI 10.3354/meps08134; Rost B, 2003, LIMNOL OCEANOGR, V48, P55, DOI 10.4319/lo.2003.48.1.0055; Sakurai Y, 2007, DEEP-SEA RES PT II, V54, P2526, DOI 10.1016/j.dsr2.2007.02.007; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; Schulz KG, 2008, BIOGEOSCIENCES, V5, P707, DOI 10.5194/bg-5-707-2008; SHANNON CE, 1948, BELL SYST TECH J, V27, P379, DOI 10.1002/j.1538-7305.1948.tb01338.x; Shokralla S, 2012, MOL ECOL, V21, P1794, DOI 10.1111/j.1365-294X.2012.05538.x; SIMPSON EH, 1949, NATURE, V163, P688, DOI 10.1038/163688a0; Sugie K, 2013, BIOGEOSCIENCES, V10, P6309, DOI 10.5194/bg-10-6309-2013; Sugie K, 2013, J PHYCOL, V49, P475, DOI 10.1111/jpy.12054; Sugie K, 2010, J EXP MAR BIOL ECOL, V382, P108, DOI 10.1016/j.jembe.2009.11.001; Sun J, 2011, LIMNOL OCEANOGR, V56, P829, DOI 10.4319/lo.2011.56.3.0829; Suzuki K, 2011, DEEP-SEA RES PT I, V58, P575, DOI 10.1016/j.dsr.2011.03.003; SUZUKI R, 1990, Journal of the Oceanographical Society of Japan, V46, P190, DOI 10.1007/BF02125580; Tai V, 2009, ISME J, V3, P903, DOI 10.1038/ismej.2009.35; Takahashi T, 2002, DEEP-SEA RES PT II, V49, P1601, DOI 10.1016/S0967-0645(02)00003-6; Taniguchi A, 1999, PROG OCEANOGR, V43, P289, DOI 10.1016/S0079-6611(99)00011-7; Tortell PD, 2002, MAR ECOL PROG SER, V236, P37, DOI 10.3354/meps236037; Tortell PD, 2008, GEOPHYS RES LETT, P35; Trimborn S, 2008, PHYSIOL PLANTARUM, V133, P92, DOI 10.1111/j.1399-3054.2007.01038.x; Trimborn S, 2009, J EXP MAR BIOL ECOL, V376, P26, DOI 10.1016/j.jembe.2009.05.017; VENRICK EL, 1977, J EXP MAR BIOL ECOL, V26, P55, DOI 10.1016/0022-0981(77)90080-6; WELSCHMEYER NA, 1994, LIMNOL OCEANOGR, V39, P1985, DOI 10.4319/lo.1994.39.8.1985; Wu Y, 2014, LIMNOL OCEANOGR, V59, P1027, DOI 10.4319/lo.2014.59.3.1027; Yang GY, 2012, MAR ENVIRON RES, V79, P142, DOI 10.1016/j.marenvres.2012.06.002; Yoshie N, 2010, MAR ECOL PROG SER, V399, P39, DOI 10.3354/meps08329; Yoshimura T, 2014, DEEP-SEA RES PT I, V94, P1, DOI 10.1016/j.dsr.2014.08.004; Yoshimura T, 2013, J OCEANOGR, V69, P601, DOI 10.1007/s10872-013-0196-2	75	9	9	2	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 28	2016	11	4							e0154291	10.1371/journal.pone.0154291	http://dx.doi.org/10.1371/journal.pone.0154291			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DK8XE	27124280	Green Published, Green Submitted, gold			2022-12-26	WOS:000375211700066
J	Lemoyne, J; Valois, P; Wittman, W				Lemoyne, Jean; Valois, Pierre; Wittman, Werner			Analyzing Exercise Behaviors during the College Years: Results from Latent Growth Curve Analysis	PLOS ONE			English	Article							COVARIANCE STRUCTURE-ANALYSIS; PHYSICAL-ACTIVITY; PLANNED BEHAVIOR; SELF-EFFICACY; GENDER-DIFFERENCES; REASONED ACTION; INTENTIONS; EDUCATION; INTERVENTION; METAANALYSIS	The objective of this study is to analyze changes in the predictors of physical activity behavior among college students. The Theory of Planned Behavior served as its theoretical framework. Methods: Among an initial sample of 417 college students, 195 participants completed a validated questionnaire measuring attitudes, subjective norms, perceived control, intentions and self-reported physical activity, at the beginning and end of each of 3 college semesters. Latent growth curve modeling analyses were conducted to examine the relationships between the trajectories of changes in PA, intentions, attitudes, subjective norms, and perceived control. Results: Good fit indices supported the validity of the proposed longitudinal model (CFI > .97, RMSEA < .05). Changes in perceived control (Upsilon = 0.57) were significantly linked with changes in intentions (p < .05). Perceived control (Upsilon = 0.28) and intention growth (Upsilon = 0.36) predicted behavior changes (p < .05). No gender differences were observed on attitudes, subjective norms and perceived control (p > .10). However, girls tend to have higher growth parameters on intentions and physical activity (p < .05). In summary, intentions and physical activity has significantly increased over 3 college semesters (growth parameters significant at p < .05). Conclusions: This study demonstrated that attitudes and perceived control are key determinants regarding the intentions of being active. On a longer term perspective, future physical activity interventions should focus on the enhancement of students' perceived control. Such educational context should help in promoting the adoption of an active lifestyle during college.	[Lemoyne, Jean] Univ Quebec Trois Rivieres, Dept Human Kinet, Trois Rivieres, PQ GA9 5H7, Canada; [Valois, Pierre] Univ Laval, Fac Educ, Quebec City, PQ, Canada; [Wittman, Werner] Univ Mannheim, Dept Psychol, D-68131 Mannheim, Germany	University of Quebec; University of Quebec Trois Rivieres; Laval University; University of Mannheim	Lemoyne, J (corresponding author), Univ Quebec Trois Rivieres, Dept Human Kinet, Trois Rivieres, PQ GA9 5H7, Canada.	jean.lemoyne@uqtr.ca	Lemoyne, Jean/AAK-8501-2020		Quebec's Ministere de l'Education, du Loisir et du Sport (MELS) [ministry of education, recreation and sport] under its Research Program for Teaching and Learning	Quebec's Ministere de l'Education, du Loisir et du Sport (MELS) [ministry of education, recreation and sport] under its Research Program for Teaching and Learning	This study was funded by Quebec's Ministere de l'Education, du Loisir et du Sport (MELS) [ministry of education, recreation and sport] under its Research Program for Teaching and Learning. No funding was received from other organizations. The authors would like to thank the Shawinigan College Department of Physical Education for its contribution during data collection.; This study was funded by Quebec's Ministere de l'Education, du Loisir et du Sport (MELS) [ministry of education, recreation and sport] under its Research Program for Teaching and Learning. No funding was received from other organizations. The authors would like to thank the Shawinigan College Department of Physical Education for its contribution during data collection. The authors declare no conflict of interest.	Ajzen I, 2002, J APPL SOC PSYCHOL, V32, P665, DOI 10.1111/j.1559-1816.2002.tb00236.x; Ajzen I., 2012, HDB THEORIES SOCIAL, VVolume 1, P438, DOI DOI 10.4135/9781446249215.N22; Ajzen I, 2012, ANN AM ACAD POLIT SS, V640, P11, DOI 10.1177/0002716211423363; Ajzen I, 2011, PSYCHOL HEALTH, V26, P1113, DOI 10.1080/08870446.2011.613995; Avery L, 2012, DIABETES CARE, V35, P2681, DOI 10.2337/dc11-2452; Barfield JP, 2012, PHYS EDUC-US, V69, P171; Berube B, 2008, RECUEIL STATISTIQUE, P4; Beville JM, 2014, J AM COLL HEALTH, V62, P173, DOI 10.1080/07448481.2013.872648; BRYNTESON P, 1993, RES Q EXERCISE SPORT, V64, P208, DOI 10.1080/02701367.1993.10608798; Byrne B. M., 2006, STRUCTURAL EQUATION, V2nd; Canadian Society for Exercise Physiology, 1998, CAN GUID PHYS ACT; Digelidis N, 2003, PSYCHOL SPORT EXERC, V4, P195, DOI 10.1016/S1469-0292(02)00002-X; Druckman James N., 2009, STUDENTS EXPT PARTIC; Duncan SC, 2007, ANN BEHAV MED, V33, P80, DOI 10.1207/s15324796abm3301_9; Duncan T, 2006, INTRO LATENT VARIABL; Fishbein M, 2011, PREDICTING AND CHANGING BEHAVIOR: THE REASONED ACTION APPROACH, P397; Hagger MS, 2002, J SPORT EXERCISE PSY, V24, P3, DOI 10.1123/jsep.24.1.3; Hox J.J., 1998, FAMILY SCI REV; Hu LT, 1999, STRUCT EQU MODELING, V6, P1, DOI 10.1080/10705519909540118; Keating XFD, 2005, J AM COLL HEALTH, V54, P116, DOI 10.3200/JACH.54.2.116-126; Kilpatrick M, 2005, J AM COLL HEALTH, V54, P87, DOI 10.3200/JACH.54.2.87-94; Kline R.B., 2010, PRINCIPLES PRACTICE; Lippke S, 2008, APPL PSYCHOL-INT REV, V57, P698, DOI 10.1111/j.1464-0597.2008.00339.x; Little T. D., 2013, LONGITUDINAL STRUCTU; Nelson MC, 2006, PEDIATRICS, V118, pE1627, DOI 10.1542/peds.2006-0926; Nigg CR, 2009, PSYCHOL SPORT EXERC, V10, P219, DOI 10.1016/j.psychsport.2008.09.005; Povey R, 1999, PSYCHOL HEALTH, V14, P991, DOI 10.1080/08870440008407363; Reuter T, 2010, J HEALTH PSYCHOL, V15, P935, DOI 10.1177/1359105309360071; Rhodes RE, 2008, J SPORT EXERCISE PSY, V30, P412, DOI 10.1123/jsep.30.3.412; Shevlin M, 2006, BRIT J EDUC PSYCHOL, V76, P141, DOI 10.1348/000709904x22386; SICONOLFI SF, 1985, AM J EPIDEMIOL, V122, P101, DOI 10.1093/oxfordjournals.aje.a114068; Skinner EA, 1998, MONOGR SOC RES CHILD, V63, P1; Sniehotta FF, 2006, BRIT J SOC PSYCHOL, V45, P87, DOI 10.1348/014466605X62460; Sniehotta FF, 2005, PSYCHOL HEALTH, V20, P143, DOI 10.1080/08870440512331317670; Telama R, 2005, AM J PREV MED, V28, P267, DOI 10.1016/j.amepre.2004.12.003; Trinh L, 2008, SOC BEHAV PERSONAL, V36, P77, DOI 10.2224/sbp.2008.36.1.77; Webb TL, 2006, PSYCHOL BULL, V132, P249, DOI 10.1037/0033-2909.132.2.249; Welk GJ, 2000, RES Q EXERCISE SPORT, V71, pS59, DOI 10.1080/02701367.2000.11082788; Yuan KH, 2000, SOCIOL METHODOL, V30, P165, DOI 10.1111/0081-1750.00078	39	6	6	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 28	2016	11	4							e0154377	10.1371/journal.pone.0154377	http://dx.doi.org/10.1371/journal.pone.0154377			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DK8XE	27124179	Green Published, Green Submitted, gold			2022-12-26	WOS:000375211700076
J	Minamimoto, R; Barkhodari, A; Harshman, L; Srinivas, S; Quon, A				Minamimoto, Ryogo; Barkhodari, Amir; Harshman, Lauren; Srinivas, Sandy; Quon, Andrew			Prognostic Value of Quantitative Metabolic Metrics on Baseline Pre-Sunitinib FDG PET/CT in Advanced Renal Cell Carcinoma	PLOS ONE			English	Article							POSITRON-EMISSION-TOMOGRAPHY; KINASE INHIBITORS; INTERFERON-ALPHA; EVEROLIMUS; BIOMARKER; SURVIVAL	Purpose The objective of this study was to prospectively evaluate various quantitative metrics on FDG PET/CT for monitoring sunitinib therapy and predicting prognosis in patients with metastatic renal cell cancer (mRCC). Methods Seventeen patients (mean age: 59.0 +/- 11.6) prospectively underwent a baseline FDG PET/CT and interim PET/CT after 2 cycles (12 weeks) of sunitinib therapy. We measured the highest maximum standardized uptake value (SUVmax) of all identified lesions (highest SUVmax), sum of SUVmax with maximum six lesions (sum of SUVmax), total lesion glycolysis (TLG) and metabolic tumor volume (MTV) from baseline PET/CT and interim PET/CT, and the % decrease in highest SUVmax of lesion (%Delta highest SUVmax), the% decrease in sum of SUVmax, the% decrease in TLG (%Delta TLG) and the% decrease in MTV (%Delta MTV) between baseline and interim PET/CT, and the imaging results were validated by clinical follow-up at 12 months after completion of therapy for progression free survival (PFS). Results At 12 month follow-up, 6/17 (35.3%) patients achieved PFS, while 11/17 (64.7%) patients were deemed to have progression of disease or recurrence within the previous 12 months. At baseline, PET/CT demonstrated metabolically active cancer in all cases. Using baseline PET/CT alone, all of the quantitative imaging metrics were predictive of PFS. Using interim PET/CT, the%. highest SUVmax, %. sum of SUVmax, and %Delta TLG were also predictive of PFS. Otherwise, interim PET/CT showed no significant difference between the two survival groups regardless of the quantitative metric utilized including MTV and TLG. Conclusions Quantitative metabolic measurements on baseline PET/CT appears to be predictive of PFS at 12 months post-therapy in patients scheduled to undergo sunitinib therapy for mRCC. Change between baseline and interim PET/CT also appeared to have prognostic value but otherwise interim PET/CT after 12 weeks of sunitinib did not appear to be predictive of PFS.	[Minamimoto, Ryogo; Barkhodari, Amir; Quon, Andrew] Stanford Univ, Dept Radiol, Sch Med, Div Nucl Med, Stanford, CA 94305 USA; [Minamimoto, Ryogo] Stanford Univ, Dept Radiol, Mol Imaging Program, Stanford, CA 94305 USA; [Harshman, Lauren] Harvard Univ, Sch Med, Dept Internal Med, Div Med Oncol, Boston, MA USA; [Srinivas, Sandy] Stanford Univ, Sch Med, Dept Internal Med, Div Oncol, Stanford, CA 94305 USA	Stanford University; Stanford University; Harvard University; Harvard Medical School; Stanford University	Quon, A (corresponding author), Stanford Univ, Dept Radiol, Sch Med, Div Nucl Med, Stanford, CA 94305 USA.	aquon@stanford.edu	Minamimoto, Ryogo/HCH-7365-2022	Minamimoto, Ryogo/0000-0003-1026-255X	National Comprehensive Cancer Network (NCCN); Pfizer, Inc.	National Comprehensive Cancer Network (NCCN); Pfizer, Inc.(Pfizer)	The research was funded by a grant from the National Comprehensive Cancer Network (NCCN), which in turn was funded by general research support provided by Pfizer, Inc. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmad T, 2004, CLIN CANCER RES, V10, p6388S, DOI 10.1158/1078-0432.CCR-040028; Bellmunt J, 2009, CRIT REV ONCOL HEMAT, V69, P64, DOI 10.1016/j.critrevonc.2008.08.002; Chen JL, 2013, CANCER MED-US, V2, P545, DOI 10.1002/cam4.102; DELONG ER, 1988, BIOMETRICS, V44, P837, DOI 10.2307/2531595; Escudier B, 2007, NEW ENGL J MED, V356, P125, DOI 10.1056/NEJMoa060655; Kayani I, 2011, CLIN CANCER RES, V17, P6021, DOI 10.1158/1078-0432.CCR-10-3309; Larkin JMG, 2006, CRIT REV ONCOL HEMAT, V60, P216, DOI 10.1016/j.critrevonc.2006.06.008; Lyrdal D, 2009, NUCL MED COMMUN, V30, P519, DOI 10.1097/MNM.0b013e32832cc220; Majhail NS, 2003, J CLIN ONCOL, V21, P3995, DOI 10.1200/JCO.2003.04.073; Minamimoto R, 2010, CLIN NUCL MED, V35, P918, DOI 10.1097/RLU.0b013e3181f9ddd9; Motzer RJ, 2006, J CLIN ONCOL, V24, P16, DOI 10.1200/JCO.2005.02.2574; Motzer RJ, 2008, LANCET, V372, P449, DOI 10.1016/S0140-6736(08)61039-9; Motzer RJ, 2007, NEW ENGL J MED, V356, P115, DOI 10.1056/NEJMoa065044; Motzer RJ, 2009, J CLIN ONCOL, V27, P3584, DOI 10.1200/JCO.2008.20.1293; Namura K, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-667; Park JW, 2009, BJU INT, V103, P615, DOI 10.1111/j.1464-410X.2008.08150.x; Revheim ME, 2011, CLIN ONCOL-UK, V23, P339, DOI 10.1016/j.clon.2010.11.006; Saranathan M, 2014, J MAGN RESON IMAGING, V40, P1392, DOI 10.1002/jmri.24490; Sternberg CN, 2010, J CLIN ONCOL, V28, P1061, DOI 10.1200/JCO.2009.23.9764; Therasse P, 2006, EUR J CANCER, V42, P1031, DOI 10.1016/j.ejca.2006.01.026; Ueno D, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-162; Vercellino L, 2009, CANCER BIOTHER RADIO, V24, P137, DOI 10.1089/cbr.2008.0527; Young H, 1999, EUR J CANCER, V35, P1773, DOI 10.1016/S0959-8049(99)00229-4	23	6	6	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 28	2016	11	4							e0153321	10.1371/journal.pone.0153321	http://dx.doi.org/10.1371/journal.pone.0153321			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DK8XE	27123976	Green Published, Green Submitted, gold			2022-12-26	WOS:000375211700014
J	New, S; Hadi, M; Pickering, S; Robertson, E; Morgan, L; Griffin, D; Collins, G; Rivero-Arias, O; Catchpole, K; McCulloch, P				New, Steve; Hadi, Mohammed; Pickering, Sharon; Robertson, Eleanor; Morgan, Lauren; Griffin, Damian; Collins, Gary; Rivero-Arias, Oliver; Catchpole, Ken; McCulloch, Peter			Lean Participative Process Improvement: Outcomes and Obstacles in Trauma Orthopaedics	PLOS ONE			English	Article							QUALITY IMPROVEMENT; HEALTH-CARE; SYSTEM	Objectives To examine the effectiveness of a "systems" approach using Lean methodology to improve surgical care, as part of a programme of studies investigating possible synergy between improvement approaches. Setting A controlled before-after study using the orthopaedic trauma theatre of a UK Trust hospital as the active site and an elective orthopaedic theatre in the same Trust as control. Participants All staff involved in surgical procedures in both theatres. Interventions A one-day "lean" training course delivered by an experienced specialist team was followed by support and assistance in developing a 6 month improvement project. Clinical staff selected the subjects for improvement and designed the improvements. Outcome Measures We compared technical and non-technical team performance in theatre using WHO checklist compliance evaluation, "glitch count" and Oxford NOTECHS II in a sample of directly observed operations, and patient outcome (length of stay, complications and readmissions) for all patients. We collected observational data for 3 months and clinical data for 6 months before and after the intervention period. We compared changes in measures using 2-way analysis of variance. Results We studied 576 cases before and 465 after intervention, observing the operation in 38 and 41 cases respectively. We found no significant changes in team performance or patient outcome measures. The intervention theatre staff focused their efforts on improving first patient arrival time, which improved by 20 minutes after intervention. Conclusions This version of "lean" system improvement did not improve measured safety processes or outcomes. The study highlighted an important tension between promoting staff ownership and providing direction, which needs to be managed in "lean" projects. Space and time for staff to conduct improvement activities are important for success.	[New, Steve] Univ Oxford, Said Business Sch, Oxford, England; [Hadi, Mohammed; Pickering, Sharon; Griffin, Damian] Univ Coventry & Warwick, Warwick Med Sch, Warwick, England; [Robertson, Eleanor; Morgan, Lauren; McCulloch, Peter] Univ Oxford, Nuffield Dept Surg Sci, Oxford, England; [Collins, Gary] Univ Oxford, Ctr Stat Med, Oxford, England; [Rivero-Arias, Oliver] Univ Oxford, Nuffield Dept Populat Hlth, Oxford, England; [Catchpole, Ken] Cedars Sinai Med Ctr, Los Angeles, CA 90048 USA	University of Oxford; University of Warwick; University of Oxford; University of Oxford; University of Oxford; Cedars Sinai Medical Center	McCulloch, P (corresponding author), Univ Oxford, Nuffield Dept Surg Sci, Oxford, England.	peter.mcculloch@nds.ox.ac.uk	Collins, Gary Stephen/A-2258-2014; Catchpole, Ken/A-6149-2008	Collins, Gary Stephen/0000-0002-2772-2316; Catchpole, Ken/0000-0003-4073-3025; McCulloch, Peter/0000-0002-3210-8273; Morgan, Lauren/0000-0001-8395-9492; Rivero-Arias, Oliver/0000-0003-2233-6544	National Institute for Health Research (NIHR) under its Programme Grants for Applied Research programme [RP-PG-0108-10020]; National Institute for Health Research [RP-PG-0108-10020] Funding Source: researchfish	National Institute for Health Research (NIHR) under its Programme Grants for Applied Research programme(National Institute for Health Research (NIHR)); National Institute for Health Research(National Institute for Health Research (NIHR))	This paper presents independent research funded by the National Institute for Health Research (NIHR) under its Programme Grants for Applied Research programme (Reference Number RP-PG-0108-10020). The views expressed are those of the authors and not necessarily those of the NHS, the NIHR or the Department of Health.	Aherne J., 2010, APPL LEAN HEALTHCARE; Bercaw R.G., 2013, LEAN LEADERSHIP HEAL; Black JR, 2008, TOYOTA WAY HEALTHCAR; Blumenthal D, 1998, MILBANK Q, V76, P625, DOI 10.1111/1468-0009.00108; Boaden R, 2008, QUALITY IMPROVEMENT; Boaden R., 2005, CONTRIBUTION QUALITY, P41; Burgess N, 2013, INT J HEALTH CARE Q, V26, P220, DOI 10.1108/09526861311311418; Graban M., 2011, LEAN HOSP IMPROVING; Joosten T, 2009, INT J QUAL HEALTH C, V21, P341, DOI 10.1093/intqhc/mzp036; Kreckler S, 2013, BMJ QUAL SAF, V22, P916, DOI 10.1136/bmjqs-2013-001855; Liker J., 2011, TOYOTA WAY CONTINUOU; Liker J.K., 2004, TOYOTA WAY; Mazzocato P, 2012, BMC HEALTH SERV RES, V12, DOI 10.1186/1472-6963-12-28; McCulloch P, 2010, BMJ BRIT MED J, V341; Mishra A, 2009, QUAL SAF HEALTH CARE, V18, P104, DOI 10.1136/qshc.2007.024760; Morgan L, 2013, BMJ OPEN, V3, DOI 10.1136/bmjopen-2013-003519; Ovretveit J, 2002, QUAL SAF HEALTH CARE, V11, P270, DOI 10.1136/qhc.11.3.270; Pickering SP, 2013, BRIT J SURG, V100, P1664, DOI 10.1002/bjs.9305; Radnor ZJ, 2012, SOC SCI MED, V74, P364, DOI 10.1016/j.socscimed.2011.02.011; Robertson ER, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090320; Smith ML, 2012, AM J CLIN PATHOL, V138, P367, DOI 10.1309/AJCP3YXID2UHZPHT; Spear S, 1999, HARVARD BUS REV, V77, P96; Waring JJ, 2010, SOC SCI MED, V71, P1332, DOI 10.1016/j.socscimed.2010.06.028	23	8	8	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 28	2016	11	4							e0152360	10.1371/journal.pone.0152360	http://dx.doi.org/10.1371/journal.pone.0152360			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DK8XE	27124012	gold, Green Published, Green Submitted			2022-12-26	WOS:000375211700005
J	Hildebrandt, ER; Arachea, BT; Wiener, MC; Schmidt, WK				Hildebrandt, Emily R.; Arachea, Buenafe T.; Wiener, Michael C.; Schmidt, Walter K.			Ste24p Mediates Proteolysis of Both Isoprenylated and Non-prenylated Oligopeptides	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						enzyme kinetics; membrane enzyme; metalloprotease; peptidase; protein isoprenylation	INSULIN-DEGRADING ENZYME; RAS-CONVERTING-ENZYME; BETA-STRAND MIMETICS; A-FACTOR PRECURSOR; SACCHAROMYCES-CEREVISIAE; CAAX PROTEASES; IN-VITRO; YEAST; PROTEIN; MEMBRANE	Rce1p and Ste24p are integral membrane proteins involved in the proteolytic maturation of isoprenylated proteins. Extensive published evidence indicates that Rce1p requires the isoprenyl moiety as an important substrate determinant. By contrast, we report that Ste24p can cleave both isoprenylated and non-prenylated substrates in vitro, indicating that the isoprenyl moiety is not required for substrate recognition. Steady-state enzyme kinetics are significantly different for prenylated versus non-prenylated substrates, strongly suggestive of a role for substrate-membrane interaction in protease function. Mass spectroscopy analyses identify a cleavage preference at bonds where P1 is aliphatic in both isoprenylated and non-prenylated substrates, although this is not necessarily predictive. The identified cleavage sites are not at a fixed distance position relative to the C terminus. In this study, the substrates cleaved by Ste24p are based on known isoprenylated proteins (i.e. K-Ras4b and the yeast a-factor mating pheromone) and non-prenylated biological peptides (A and insulin chains) that are known substrates of the M16A family of soluble zinc-dependent metalloproteases. These results establish that the substrate profile of Ste24p is broader than anticipated, being more similar to that of the M16A protease family than that of the Rce1p CAAX protease with which it has been functionally associated.	[Hildebrandt, Emily R.; Schmidt, Walter K.] Univ Georgia, Dept Biochem & Mol Biol, Athens, GA 30602 USA; [Arachea, Buenafe T.; Wiener, Michael C.] Univ Virginia, Dept Mol Physiol & Biol Phys, Charlottesville, VA 22908 USA	University System of Georgia; University of Georgia; University of Virginia	Schmidt, WK (corresponding author), A416 Life Sci Bldg,120 Green St, Athens, GA 30602 USA.	wschmidt@bmb.uga.edu			National Institutes of Health [GM108612]; University of Georgia; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM108612, R01GM117148] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Georgia; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Grant GM108612 (to M. C. W.) and University of Georgia institutional funds (to W. K. S.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	ADAMES N, 1995, SCIENCE, V270, P464, DOI 10.1126/science.270.5235.464; Adolphsen K, 2012, G3-GENES GENOM GENET, V2, P629, DOI 10.1534/g3.112.002188; Akiyama Y, 2009, J BIOCHEM, V146, P449, DOI 10.1093/jb/mvp071; Alper BJ, 2009, YEAST, V26, P595, DOI 10.1002/yea.1709; Alper BJ, 2009, J NEUROSCI METH, V178, P40, DOI 10.1016/j.jneumeth.2008.11.010; ANDEREGG RJ, 1988, J BIOL CHEM, V263, P18236; Ast T, 2016, CELL, V164, P103, DOI 10.1016/j.cell.2015.11.053; Barrowman J, 2012, HUM MOL GENET, V21, P4084, DOI 10.1093/hmg/dds233; Barrowman J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032120; Bergo MO, 2002, MOL CELL BIOL, V22, P171, DOI 10.1128/MCB.22.1.171-181.2002; Boyartchuk VL, 1997, SCIENCE, V275, P1796, DOI 10.1126/science.275.5307.1796; Boyartchuk VL, 1998, GENETICS, V150, P95; Chen P, 1997, MOL BIOL CELL, V8, P1273, DOI 10.1091/mbc.8.7.1273; Chen P, 1997, J CELL BIOL, V136, P251, DOI 10.1083/jcb.136.2.251; Corrigan DP, 2005, BIOCHEM J, V387, P129, DOI 10.1042/BJ20041359; Costanzo M, 2010, SCIENCE, V327, P425, DOI 10.1126/science.1180823; Erez E, 2009, NATURE, V459, P371, DOI 10.1038/nature08146; Farris W, 2003, P NATL ACAD SCI USA, V100, P4162, DOI 10.1073/pnas.0230450100; FujimuraKamada K, 1997, J CELL BIOL, V136, P271, DOI 10.1083/jcb.136.2.271; Ghaemmaghami S, 2003, NATURE, V425, P737, DOI 10.1038/nature02046; Guo Q, 2010, J MOL BIOL, V395, P430, DOI 10.1016/j.jmb.2009.10.072; Hanker AB, 2010, ONCOGENE, V29, P380, DOI 10.1038/onc.2009.336; Hildebrandt ER, 2013, BIOCHEMISTRY-US, V52, P6601, DOI 10.1021/bi400647c; Hollander I, 2000, ANAL BIOCHEM, V286, P129, DOI 10.1006/abio.2000.4795; Hoppe T, 2000, CELL, V102, P577, DOI 10.1016/S0092-8674(00)00080-5; Hoppins S, 2011, J CELL BIOL, V195, P323, DOI 10.1083/jcb.201107053; Im H, 2007, J BIOL CHEM, V282, P25453, DOI 10.1074/jbc.M701590200; Keil B., 1905, SPECIFICITY PROTEOLY, V40, P155; Krishnankutty RK, 2009, YEAST, V26, P451, DOI 10.1002/yea.1678; Kukday SS, 2012, J BIOMOL SCREEN, V17, P1348, DOI 10.1177/1087057112451921; Kurochkin IV, 1998, FEBS LETT, V427, P153, DOI 10.1016/S0014-5793(98)00422-0; Kurochkin IV, 2001, TRENDS BIOCHEM SCI, V26, P421, DOI 10.1016/S0968-0004(01)01876-X; Lazure C, 1998, J BIOL CHEM, V273, P8572, DOI 10.1074/jbc.273.15.8572; Leissring MA, 2003, NEURON, V40, P1087, DOI 10.1016/S0896-6273(03)00787-6; Leung GK, 2001, J BIOL CHEM, V276, P29051, DOI 10.1074/jbc.M102908200; Loughlin WA, 2004, CHEM REV, V104, P6085, DOI 10.1021/cr040648k; Loughlin WA, 2010, CHEM REV, V110, pPR32, DOI 10.1021/cr900395y; Manandhar SP, 2007, J BIOMOL SCREEN, V12, P983, DOI 10.1177/1087057107307226; Manolaridis I, 2013, NATURE, V504, P301, DOI 10.1038/nature12754; McLure JA, 2000, BRIT J CLIN PHARMACO, V49, P453, DOI 10.1046/j.1365-2125.2000.00193.x; Mokry DZ, 2009, EUKARYOT CELL, V8, P1891, DOI 10.1128/EC.00169-09; Mukherjee A, 2000, J NEUROSCI, V20, P8745; Oldenburg KR, 1997, NUCLEIC ACIDS RES, V25, P451, DOI 10.1093/nar/25.2.451; Otto JC, 1999, J BIOL CHEM, V274, P8379, DOI 10.1074/jbc.274.13.8379; Plummer LJ, 2006, J BIOL CHEM, V281, P4596, DOI 10.1074/jbc.M506284200; Porter SB, 2007, BBA-MOL CELL RES, V1773, P853, DOI 10.1016/j.bbamcr.2007.03.004; Pryor EE, 2013, SCIENCE, V339, P1600, DOI 10.1126/science.1232048; Quigley A, 2013, SCIENCE, V339, P1604, DOI 10.1126/science.1231513; Rape M, 2002, NAT CELL BIOL, V4, pE113, DOI 10.1038/ncb0502-e113; Remaut H, 2006, TRENDS BIOCHEM SCI, V31, P436, DOI 10.1016/j.tibs.2006.06.007; Ricardo S, 2009, SCIENCE, V323, P943, DOI 10.1126/science.1166239; Roberts PJ, 2008, J BIOL CHEM, V283, P25150, DOI 10.1074/jbc.M800882200; Sakoh M, 2005, J BIOL CHEM, V280, P33305, DOI 10.1074/jbc.M506180200; Schmidt WK, 1998, P NATL ACAD SCI USA, V95, P11175, DOI 10.1073/pnas.95.19.11175; Schmidt WK, 2000, J BIOL CHEM, V275, P6227, DOI 10.1074/jbc.275.9.6227; Schuldiner M, 2005, CELL, V123, P507, DOI 10.1016/j.cell.2005.08.031; Selkoe DJ, 2001, NEURON, V32, P177, DOI 10.1016/S0896-6273(01)00475-5; Shen YQ, 2006, NATURE, V443, P870, DOI 10.1038/nature05143; SIKORSKI RS, 1989, GENETICS, V122, P19; Silvius JR, 2002, J MEMBRANE BIOL, V190, P83, DOI 10.1007/s00232-002-1026-4; Skaug B, 2009, ANNU REV BIOCHEM, V78, P769, DOI 10.1146/annurev.biochem.78.070907.102750; Tam A, 2001, J BIOL CHEM, V276, P46798, DOI 10.1074/jbc.M106150200; Tam A, 1998, J CELL BIOL, V142, P635, DOI 10.1083/jcb.142.3.635; Tipper DJ, 2002, MOL BIOL CELL, V13, P1158, DOI 10.1091/mbc.01-10-0488; Trueblood CE, 2000, MOL CELL BIOL, V20, P4381, DOI 10.1128/MCB.20.12.4381-4392.2000; WEBER K, 1989, FEBS LETT, V257, P411, DOI 10.1016/0014-5793(89)81584-4; Wolfe MS, 2009, J BIOL CHEM, V284, P13969, DOI 10.1074/jbc.R800039200	67	14	14	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 1	2016	291	27					14185	14198		10.1074/jbc.M116.718197	http://dx.doi.org/10.1074/jbc.M116.718197			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DR5XG	27129777	Green Published, hybrid			2022-12-26	WOS:000379975100025
J	Wang, WJ; Yan, RY; Nocek, BP; Vuong, TV; Di Leo, R; Xu, XH; Cui, H; Gatenholm, P; Toriz, G; Tenkanen, M; Savchenko, A; Master, ER				Wang, Weijun; Yan, Ruoyu; Nocek, Boguslaw P.; Vuong, Thu V.; Di Leo, Rosa; Xu, Xiaohui; Cui, Hong; Gatenholm, Paul; Toriz, Guillermo; Tenkanen, Maija; Savchenko, Alexei; Master, Emma R.			Biochemical and Structural Characterization of a Five-domain GH115-Glucuronidase from the Marine Bacterium Saccharophagus degradans 2-40(T)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						carbohydrate; crystal structure; enzyme catalysis; enzyme structure; protein domain; GH115-glucuronidase; carbohydrate degradation; catalytic apparatus; enzyme domain composition	PLANT-CELL WALL; THERMOTOGA-MARITIMA MSB8; ALPHA-GLUCURONIDASE; DENSITY MODIFICATION; FAMILY GH115; SCHIZOPHYLLUM-COMMUNE; INVERTING CHARACTER; CRYSTAL-STRUCTURES; XYLAN; POLYSACCHARIDES	Glucuronic acid (GlcAp) and/or methylglucuronic acid (MeGlcAp) decorate the major forms of xylan in hardwood and coniferous softwoods as well as many cereal grains. Accordingly, the complete utilization of glucuronoxylans or conversion to sugar precursors requires the action of main chain xylanases as well as -glucuronidases that release the - (12)-linked (Me)GlcAp side groups. Herein, a family GH115 enzymefrom the marine bacterium Saccharophagus degradans 2-40(T), SdeAgu115A, demonstrated activity toward glucuronoxylan and oligomers thereof with preference toward MeGlcAp linked to internal xylopyranosyl residues. Unique biochemical characteristics of NaCl activation were also observed. The crystal structure of SdeAgu115A revealed a five-domain architecture, with an additional insertion C+ domain that had significant impact on the domain arrangement of SdeAgu115A monomer and its dimerization. The participation of domain C+ in substrate binding was supported by reduced substrate inhibition upon introducing W773A, W689A, and F696A substitutions within this domain. In addition to Asp-335, the catalytic essentiality of Glu-216 was revealed by site-specific mutagenesis. A primary sequence analysis suggested that the SdeAgu115A architecture is shared by more than half of GH115 members, thus defining a distinct archetype for GH115 enzymes.	[Wang, Weijun; Yan, Ruoyu; Vuong, Thu V.; Di Leo, Rosa; Xu, Xiaohui; Cui, Hong; Savchenko, Alexei; Master, Emma R.] Univ Toronto, Dept Chem Engn & Appl Chem, 200 Coll St, Toronto, ON M5S 3E5, Canada; [Nocek, Boguslaw P.] Argonne Natl Lab, Struct Biol Ctr, Biosci Div, 9700 S Cass Ave, Argonne, IL 60439 USA; [Gatenholm, Paul; Toriz, Guillermo] Chalmers, Dept Chem & Chem Engn, Wallenberg Wood Sci Ctr, Kemivagen 4, S-41296 Gothenburg, Sweden; [Gatenholm, Paul; Toriz, Guillermo] Chalmers, Biopolymer Technol, Kemivagen 4, S-41296 Gothenburg, Sweden; [Toriz, Guillermo] Univ Guadalajara, Dept Wood Cellulose & Paper Res, Guadalajara 44100, Mexico; [Tenkanen, Maija] Univ Helsinki, Dept Food & Environm Sci, POB 27, FIN-00014 Helsinki, Finland	University of Toronto; United States Department of Energy (DOE); Argonne National Laboratory; Chalmers University of Technology; Chalmers University of Technology; Universidad de Guadalajara; University of Helsinki	Savchenko, A; Master, ER (corresponding author), Univ Toronto, Dept Chem Engn & Appl Chem, 200 Coll St, Toronto, ON M5S 3E5, Canada.	alexei.savchenko@utoronto.ca; emma.master@utoronto.ca	Master, Emma/O-3554-2014; Toriz, Guillermo/Q-6876-2019; Toriz, Guillermo/GRE-6547-2022	Toriz, Guillermo/0000-0002-8154-8590; Tenkanen, Maija/0000-0003-2883-2717; wang, weijun/0000-0001-9283-5619	United States Department of Energy, Office of Biological and Environmental Research [DE-AC02-06CH11357]	United States Department of Energy, Office of Biological and Environmental Research(United States Department of Energy (DOE))	We thank G. Brown and Professor A. Yakunin (University of Toronto) for technical support and Dr. Masoud Vedadi and Dr. Guillermo Senisterra (Structural Genomics Consortium, Toronto, Canada) for circular dichroism spectra acquisition. We also thank K. Parikka for preparing figures of xylan structures. Structural results shown in this report are derived from work performed at Argonne National Laboratory, Structural Biology Center at the Advanced Photon Source. Argonne National Laboratory is operated by UChicago Argonne, LLC, for the United States Department of Energy, Office of Biological and Environmental Research, under contract DE-AC02-06CH11357.	Aalbers F, 2015, J MOL BIOL, V427, P3935, DOI 10.1016/j.jmb.2015.07.006; ANDRYKOVITCH G, 1988, APPL ENVIRON MICROB, V54, P1061, DOI 10.1128/AEM.54.4.1061-1062.1988; Biely P, 2000, BBA-GEN SUBJECTS, V1474, P360, DOI 10.1016/S0304-4165(00)00029-5; Bosmans TJ, 2014, BIOMACROMOLECULES, V15, P924, DOI 10.1021/bm4017868; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BRONNENMEIER K, 1995, MICROBIOL-SGM, V141, P2033, DOI 10.1099/13500872-141-9-2033; Busse-Wicher M, 2014, PLANT J, V79, P492, DOI 10.1111/tpj.12575; Chong SL, 2011, APPL MICROBIOL BIOT, V90, P1323, DOI 10.1007/s00253-011-3157-y; Collaborative Computational Project, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI DOI 10.1107/S0907444994003112; Copeland RA, 2000, ENZYMES PRACTICAL IN, P109; COUGHLAN MP, 1993, BIOTECHNOL APPL BIOC, V17, P259; Cowtan K, 1998, ACTA CRYSTALLOGR D, V54, P487, DOI 10.1107/S0907444997011980; Cowtan K, 2001, ACTA CRYSTALLOGR D, V57, P1435, DOI 10.1107/S0907444901010812; Cowtan KD, 1999, PROG BIOPHYS MOL BIO, V72, P245, DOI 10.1016/S0079-6107(99)00008-5; de Beer TAP, 2014, NUCLEIC ACIDS RES, V42, pD292, DOI 10.1093/nar/gkt940; de Vries RP, 2000, CARBOHYD RES, V327, P401, DOI 10.1016/S0008-6215(00)00066-5; DERUITER GA, 1992, ANAL BIOCHEM, V207, P176, DOI 10.1016/0003-2697(92)90520-H; DUBOIS M, 1956, ANAL CHEM, V28, P350, DOI 10.1021/ac60111a017; Eidam O, 2008, FEBS LETT, V582, P651, DOI 10.1016/j.febslet.2008.01.030; Ekborg NA, 2006, APPL ENVIRON MICROB, V72, P3396, DOI 10.1128/AEM.72.5.3396-3405.2006; Escalante A, 2012, CARBOHYD POLYM, V87, P2381, DOI 10.1016/j.carbpol.2011.11.003; Freelove Alexander C. J., 2001, Journal of Biological Chemistry, V276, P43010, DOI 10.1074/jbc.M107143200; Fujimoto Z, 2011, ACTA CRYSTALLOGR F, V67, P68, DOI 10.1107/S1744309110043721; Gilbert HJ, 2008, CURR OPIN PLANT BIOL, V11, P338, DOI 10.1016/j.pbi.2008.03.004; Golan G, 2004, J BIOL CHEM, V279, P3014, DOI 10.1074/jbc.M310098200; HENRISSAT B, 1991, BIOCHEM J, V280, P309, DOI 10.1042/bj2800309; Holm L, 2010, NUCLEIC ACIDS RES, V38, pW545, DOI 10.1093/nar/gkq366; Hutcheson SW, 2011, MAR DRUGS, V9, P645, DOI 10.3390/md9040645; Ito T, 2013, J BIOL CHEM, V288, P11795, DOI 10.1074/jbc.M112.420109; Knight SD, 2002, ACTA CRYSTALLOGR D, V58, P1016, DOI 10.1107/S0907444902005954; Kolenova K, 2010, FEBS LETT, V584, P4063, DOI 10.1016/j.febslet.2010.08.031; KORMELINK FJM, 1993, APPL MICROBIOL BIOT, V38, P688, DOI 10.1007/BF00182811; Koutaniemi S, 2012, PLANTA, V236, P739, DOI 10.1007/s00425-012-1653-7; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Larsbrink J, 2014, NATURE, V506, P498, DOI 10.1038/nature12907; Laue T.M., 1992, ANAL ULTRACENTRIFUGA, P90; Lemak S, 2012, BIOCHEM J, V445, P193, DOI 10.1042/BJ20112113; Liu HT, 2008, BMC BIOTECHNOL, V8, DOI 10.1186/1472-6750-8-91; Mello LV, 2010, FEBS LETT, V584, P2421, DOI 10.1016/j.febslet.2010.04.045; Mikkonen KS, 2012, TRENDS FOOD SCI TECH, V28, P90, DOI 10.1016/j.tifs.2012.06.012; Minor W, 2006, ACTA CRYSTALLOGR D, V62, P859, DOI 10.1107/S0907444906019949; Nocek B, 2008, PROTEINS, V70, P273, DOI 10.1002/prot.21276; Nurizzo D, 2002, STRUCTURE, V10, P547, DOI 10.1016/S0969-2126(02)00742-6; Pathak S, 2008, CHEM BIOL, V15, P799, DOI 10.1016/j.chembiol.2008.06.010; Rogowski A, 2014, J BIOL CHEM, V289, P53, DOI 10.1074/jbc.M113.525295; Rosa L, 2013, FUNGAL BIOL-UK, V117, P380, DOI 10.1016/j.funbio.2013.04.002; Rosenbaum G, 2006, J SYNCHROTRON RADIAT, V13, P30, DOI 10.1107/S0909049505036721; Ryabova O, 2009, FEBS LETT, V583, P1457, DOI 10.1016/j.febslet.2009.03.057; Rye CS, 2000, CURR OPIN CHEM BIOL, V4, P573, DOI 10.1016/S1367-5931(00)00135-6; Scheller HV, 2010, ANNU REV PLANT BIOL, V61, P263, DOI 10.1146/annurev-arplant-042809-112315; Sedlmeyer FB, 2011, FOOD HYDROCOLLOID, V25, P1891, DOI 10.1016/j.foodhyd.2011.04.005; Shallom D, 2003, CURR OPIN MICROBIOL, V6, P219, DOI 10.1016/S1369-5274(03)00056-0; Sheldrick GM, 2002, Z KRISTALLOGR, V217, P644, DOI 10.1524/zkri.217.12.644.20662; SOMOGYI M, 1952, J BIOL CHEM, V195, P19; Suresh C, 2003, BIOSCI BIOTECH BIOCH, V67, P2359, DOI 10.1271/bbb.67.2359; Suresh C, 2002, FEBS LETT, V517, P159, DOI 10.1016/S0014-5793(02)02611-X; Taylor LE, 2006, J BACTERIOL, V188, P3849, DOI 10.1128/JB.01348-05; Teleman A, 2000, CARBOHYD RES, V329, P807, DOI 10.1016/S0008-6215(00)00249-4; Tenkanen M, 2000, J BIOTECHNOL, V78, P149, DOI 10.1016/S0168-1656(99)00240-0; Terwilliger T, 2004, J SYNCHROTRON RADIAT, V11, P49, DOI 10.1107/S0909049503023938; Terwilliger TC, 1999, ACTA CRYSTALLOGR D, V55, P849, DOI 10.1107/S0907444999000839; Timell T. E., 1967, Wood Science and Technology, V1, P45, DOI 10.1007/BF00592255; Uchimura K, 2010, MAR BIOTECHNOL, V12, P526, DOI 10.1007/s10126-009-9237-7; Vuong TV, 2013, BIOTECHNOL BIOFUELS, V6, DOI 10.1186/1754-6834-6-148; Weiner RM, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000087	65	11	11	1	21	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 1	2016	291	27					14120	14133		10.1074/jbc.M115.702944	http://dx.doi.org/10.1074/jbc.M115.702944			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DR5XG	27129264	Green Published, hybrid			2022-12-26	WOS:000379975100020
J	Watson, JR; Fox, HM; Nietlispach, D; Gallop, JL; Owen, D; Mott, HR				Watson, Joanna R.; Fox, Helen M.; Nietlispach, Daniel; Gallop, Jennifer L.; Owen, Darerca; Mott, Helen R.			Investigation of the Interaction between Cdc42 and Its Effector TOCA1: HANDOVER OF Cdc42 TO THE ACTIN REGULATOR N-WASP IS FACILITATED BY DIFFERENTIAL BINDING AFFINITIES	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						actin; CDC42; endocytosis; nuclear magnetic resonance (NMR); protein-protein interaction; BAR domain; CIP4; FBP17; TOCA1; WASP	ALDRICH-SYNDROME PROTEIN; GTPASE-BINDING; SIGNAL INTEGRATION; STRUCTURAL BASIS; STRESS FIBERS; BAR-DOMAIN; WEB SERVER; COMPLEX; RHO; POLYMERIZATION	Transducer of Cdc42-dependent actin assembly protein 1 (TOCA1) is an effector of the Rho family small G protein Cdc42. It contains a membrane-deforming F-BAR domain as well as a Src homology 3 (SH3) domain and a G protein-binding homology region 1 (HR1) domain. TOCA1 binding to Cdc42 leads to actin rearrangements, which are thought to be involved in processes such as endocytosis, filopodia formation, and cell migration. We have solved the structure of the HR1 domain of TOCA1, providing the first structural data for this protein. We have found that the TOCA1 HR1, like the closely related CIP4 HR1, has interesting structural features that are not observed in other HR1 domains. We have also investigated the binding of the TOCA HR1 domain to Cdc42 and the potential ternary complex between Cdc42 and the G protein-binding regions of TOCA1 and a member of the Wiskott-Aldrich syndrome protein family, N-WASP. TOCA1 binds Cdc42 with micromolar affinity, in contrast to the nanomolar affinity of the N-WASP G protein-binding region for Cdc42. NMR experiments show that the Cdc42-binding domain from N-WASP is able to displace TOCA1 HR1 from Cdc42, whereas the N-WASP domain but not the TOCA1 HR1 domain inhibits actin polymerization. This suggests that TOCA1 binding to Cdc42 is an early step in the Cdc42-dependent pathways that govern actin dynamics, and the differential binding affinities of the effectors facilitate a handover from TOCA1 to N-WASP, which can then drive recruitment of the actin-modifying machinery.	[Watson, Joanna R.; Fox, Helen M.; Nietlispach, Daniel; Gallop, Jennifer L.; Owen, Darerca; Mott, Helen R.] Univ Cambridge, Dept Biochem, 80 Tennis Court Rd, Cambridge CB2 1GA, England; [Fox, Helen M.; Gallop, Jennifer L.] Univ Cambridge, Wellcome Trust Canc Res UK Gurdon Inst, Cambridge CB2 1QN, England	University of Cambridge; University of Cambridge	Owen, D; Mott, HR (corresponding author), Univ Cambridge, Dept Biochem, 80 Tennis Court Rd, Cambridge CB2 1GA, England.	do202@cam.ac.uk; hrm28@cam.ac.uk	Mott, Helen/AAV-3873-2020	Mott, Helen/0000-0002-7890-7097; Watson, Joanna/0000-0002-0606-3200; Nietlispach, Daniel/0000-0003-4364-9291; Fox, Helen Mary/0000-0002-6907-2278; Gallop, Jennifer Louise/0000-0002-9978-1382	Herchel Smith studentship; Wellcome Trust Ph.D. Studentship [WT099740Z12Z]; Wellcome Trust Research Career Development Fellowship [WT095829AIA]; European Research Council Starting Grant [281971]; Gurdon Institute by Wellcome Trust [092096]; CRUK [C6946/A14492]	Herchel Smith studentship; Wellcome Trust Ph.D. Studentship(Wellcome Trust); Wellcome Trust Research Career Development Fellowship(Wellcome Trust); European Research Council Starting Grant(European Research Council (ERC)); Gurdon Institute by Wellcome Trust; CRUK(Cancer Research UK)	Supported by a Herchel Smith studentship.; Supported by Wellcome Trust Ph.D. Studentship WT099740Z12Z.; Supported by Wellcome Trust Research Career Development Fellowship WT095829AIA, European Research Council Starting Grant 281971, and Gurdon Institute funding provided by Wellcome Trust Grant 092096 and CRUK Grant C6946/A14492.	Abdul-Manan N, 1999, NATURE, V399, P379, DOI 10.1038/20726; Aspenstrom P, 1997, CURR BIOL, V7, P479, DOI 10.1016/S0960-9822(06)00219-3; Bai ZY, 2015, P NATL ACAD SCI USA, V112, pE1443, DOI 10.1073/pnas.1418651112; Bailey LK, 2009, J BIOL CHEM, V284, P992, DOI 10.1074/jbc.M806167200; BOURNE HR, 1991, NATURE, V349, P117, DOI 10.1038/349117a0; Bu WY, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012153; Bu WY, 2009, J BIOL CHEM, V284, P11622, DOI 10.1074/jbc.M805940200; Buck M, 2004, J MOL BIOL, V338, P271, DOI 10.1016/j.jmb.2004.02.036; BURBELO PD, 1995, J BIOL CHEM, V270, P29071, DOI 10.1074/jbc.270.49.29071; Chander H, 2013, ONCOGENE, V32, P3080, DOI 10.1038/onc.2012.317; Cherfils J, 2013, PHYSIOL REV, V93, P269, DOI 10.1152/physrev.00003.2012; De Vries SJ, 2010, NAT PROTOC, V5, P883, DOI 10.1038/nprot.2010.32; Elliot-Smith AE, 2005, BIOCHEMISTRY-US, V44, P12373, DOI 10.1021/bi0506021; Elliot-Smith AE, 2007, BIOCHEMISTRY-US, V46, P14087, DOI 10.1021/bi701539x; Fenwick RB, 2010, STRUCTURE, V18, P985, DOI 10.1016/j.str.2010.05.013; Fricke R, 2009, CURR BIOL, V19, P1429, DOI 10.1016/j.cub.2009.07.058; Gallop JL, 2013, P NATL ACAD SCI USA, V110, P7193, DOI 10.1073/pnas.1305286110; Giuliani C, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000675; Hall A, 1998, SCIENCE, V279, P509, DOI 10.1126/science.279.5350.509; Heinig M, 2004, NUCLEIC ACIDS RES, V32, pW500, DOI 10.1093/nar/gkh429; Hemsath L, 2005, MOL CELL, V20, P313, DOI 10.1016/j.molcel.2005.08.036; Henne WM, 2007, STRUCTURE, V15, P839, DOI 10.1016/j.str.2007.05.002; Ho HYH, 2004, CELL, V118, P203, DOI 10.1016/j.cell.2004.06.027; Honing S, 2005, MOL CELL, V18, P519, DOI 10.1016/j.molcel.2005.04.019; Hu JH, 2011, J BIOL CHEM, V286, P2261, DOI 10.1074/jbc.M110.157974; Hubbard S. J., 1993, NACCESS; Hutchinson CL, 2013, BIOCHEMISTRY-US, V52, P7999, DOI 10.1021/bi401216w; Hutchinson CL, 2011, BIOCHEMISTRY-US, V50, P2860, DOI 10.1021/bi200039u; Itoh T, 2005, DEV CELL, V9, P791, DOI 10.1016/j.devcel.2005.11.005; Kakimoto T, 2006, J BIOL CHEM, V281, P29042, DOI 10.1074/jbc.M604025200; Kim AS, 2000, NATURE, V404, P151, DOI 10.1038/35004513; Kobashigawa Y, 2009, J BIOMOL NMR, V44, P113, DOI 10.1007/s10858-009-9317-z; KOZMA R, 1995, MOL CELL BIOL, V15, P1942; Kuhn Sonja, 2014, Small GTPases, V5, pe29513, DOI 10.4161/sgtp.29513; Lebensohn AM, 2009, MOL CELL, V36, P512, DOI 10.1016/j.molcel.2009.10.024; Lee K, 2010, SCIENCE, V329, P1341, DOI 10.1126/science.1191710; Leung DW, 2005, P NATL ACAD SCI USA, V102, P5685, DOI 10.1073/pnas.0406472102; Ma L, 1998, J CELL BIOL, V140, P1125; Ma L, 1998, P NATL ACAD SCI USA, V95, P15362, DOI 10.1073/pnas.95.26.15362; Machesky LM, 1999, J CELL BIOL, V146, P267, DOI 10.1083/jcb.146.2.267; Machesky LM, 1996, TRENDS CELL BIOL, V6, P304, DOI 10.1016/0962-8924(96)10026-X; Maesaki R, 1999, MOL CELL, V4, P793, DOI 10.1016/S1097-2765(00)80389-5; Miki H, 1998, BIOCHEM BIOPH RES CO, V243, P73, DOI 10.1006/bbrc.1997.8064; Miki H, 1998, EMBO J, V17, P6932, DOI 10.1093/emboj/17.23.6932; Miyamoto K, 2011, GENE DEV, V25, P946, DOI 10.1101/gad.615211; Modha R, 2008, J BIOL CHEM, V283, P1492, DOI 10.1074/jbc.M706760200; Mott HR, 2015, CRIT REV BIOCHEM MOL, V50, P85, DOI 10.3109/10409238.2014.999191; Mott HR, 1999, NATURE, V399, P384, DOI 10.1038/20732; Nakamura K, 2012, J BIOL CHEM, V287, P25478, DOI 10.1074/jbc.M112.365783; NOBES CD, 1995, CELL, V81, P53, DOI 10.1016/0092-8674(95)90370-4; Owen D, 2003, J BIOL CHEM, V278, P50578, DOI 10.1074/jbc.M304313200; Owen D, 2000, BIOCHEMISTRY-US, V39, P1243, DOI 10.1021/bi991567z; Owen D, 2008, J BIOL CHEM, V283, P1692, DOI 10.1074/jbc.M707257200; Ozbabacan SEA, 2011, PROTEIN ENG DES SEL, V24, P635, DOI 10.1093/protein/gzr025; Padrick SB, 2010, ANNU REV BIOCHEM, V79, P707, DOI 10.1146/annurev.biochem.77.060407.135452; Perkins JR, 2010, STRUCTURE, V18, P1233, DOI 10.1016/j.str.2010.08.007; Praefcke GJK, 2004, EMBO J, V23, P4371, DOI 10.1038/sj.emboj.7600445; RIDLEY AJ, 1992, CELL, V70, P401, DOI 10.1016/0092-8674(92)90164-8; RIDLEY AJ, 1992, CELL, V70, P389, DOI 10.1016/0092-8674(92)90163-7; Ridley AJ, 1996, CURR BIOL, V6, P1256, DOI 10.1016/S0960-9822(02)70711-2; Rieping W, 2007, BIOINFORMATICS, V23, P381, DOI 10.1093/bioinformatics/btl589; Rohatgi R, 2000, J CELL BIOL, V150, P1299, DOI 10.1083/jcb.150.6.1299; Rohatgi R, 1999, CELL, V97, P221, DOI 10.1016/S0092-8674(00)80732-1; Rudolph MG, 1998, J BIOL CHEM, V273, P18067, DOI 10.1074/jbc.273.29.18067; Schanda P, 2005, J BIOMOL NMR, V33, P199, DOI 10.1007/s10858-005-4425-x; Schmid EM, 2007, NATURE, V448, P883, DOI 10.1038/nature06031; Shen Y, 2013, J BIOMOL NMR, V56, P227, DOI 10.1007/s10858-013-9741-y; Symons M, 1996, CELL, V84, P723, DOI 10.1016/S0092-8674(00)81050-8; Takano K, 2008, EMBO J, V27, P2817, DOI 10.1038/emboj.2008.216; ten Klooster JP, 2006, J CELL BIOL, V172, P759, DOI 10.1083/jcb.200509096; Thompson G, 1998, BIOCHEMISTRY-US, V37, P7885, DOI 10.1021/bi980140+; Tsujita K, 2006, J CELL BIOL, V172, P269, DOI 10.1083/jcb.200508091; Van Itallie CM, 2015, MOL BIOL CELL, V26, P2769, DOI 10.1091/mbc.E15-04-0232; Vetter IR, 2001, SCIENCE, V294, P1299, DOI 10.1126/science.1062023; Vranken WF, 2005, PROTEINS, V59, P687, DOI 10.1002/prot.20449; Walrant A, 2015, METHOD CELL BIOL, V128, P125, DOI 10.1016/bs.mcb.2015.01.020; Wang J, 2006, PLOS COMPUT BIOL, V2, P842, DOI 10.1371/journal.pcbi.0020078; Watanabe G, 1996, SCIENCE, V271, P645, DOI 10.1126/science.271.5249.645; Watson JR, 2016, BIOMOL NMR ASSIGN, V10, P407, DOI 10.1007/s12104-016-9677-8; Wu M, 2013, P NATL ACAD SCI USA, V110, P1339, DOI 10.1073/pnas.1221538110	80	15	15	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 24	2016	291	26					13875	13890		10.1074/jbc.M116.724294	http://dx.doi.org/10.1074/jbc.M116.724294			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DR2YZ	27129201	Green Published, hybrid			2022-12-26	WOS:000379771100041
J	Wynn, ML; Yates, JA; Evans, CR; Van Wassenhove, LD; Wu, ZF; Bridges, S; Bao, LW; Fournier, C; Ashrafzadeh, S; Merrins, MJ; Satin, LS; Schnell, S; Burant, CF; Merajver, SD				Wynn, Michelle L.; Yates, Joel A.; Evans, Charles R.; Van Wassenhove, Lauren D.; Wu, Zhi Fen; Bridges, Sydney; Bao, Liwei; Fournier, Chelsea; Ashrafzadeh, Sepideh; Merrins, Matthew J.; Satin, Leslie S.; Schnell, Santiago; Burant, Charles F.; Merajver, Sofia D.			RhoC GTPase Is a Potent Regulator of Glutamine Metabolism and N-Acetylaspartate Production in Inflammatory Breast Cancer Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						breast cancer; glutamine; hypoxia-inducible factor (HIF); Rho (Rho GTPase); tumor metabolism; N-acetylaspartate	KINASE TYPE M2; PYRUVATE-KINASE; LUNG-CANCER; E-CADHERIN; IN-VIVO; GROWTH; OVEREXPRESSION; HYPOXIA; PROTEIN; CARBOXYLATION	Inflammatory breast cancer (IBC) is an extremely lethal cancer that rapidly metastasizes. Although the molecular attributes of IBC have been described, little is known about the underlying metabolic features of the disease. Using a variety of metabolic assays, including C-13 tracer experiments, we found that SUM149 cells, the primary in vitro model of IBC, exhibit metabolic abnormalities that distinguish them from other breast cancer cells, including elevated levels of N-acetylaspartate, a metabolite primarily associated with neuronal disorders and gliomas. Here we provide the first evidence of N-acetylaspartate in breast cancer. We also report that the oncogene RhoC, a driver of metastatic potential, modulates glutamine and N-acetylaspartate metabolism in IBC cells in vitro, revealing a novel role for RhoC as a regulator of tumor cell metabolism that extends beyond its well known role in cytoskeletal rearrangement.	[Wynn, Michelle L.; Yates, Joel A.; Evans, Charles R.; Wu, Zhi Fen; Bridges, Sydney; Bao, Liwei; Fournier, Chelsea; Ashrafzadeh, Sepideh; Burant, Charles F.; Merajver, Sofia D.] Univ Michigan, Dept Internal Med, Ann Arbor, MI 48109 USA; [Wynn, Michelle L.; Schnell, Santiago] Univ Michigan, Dept Mol & Integrat Physiol, Ann Arbor, MI 48109 USA; [Satin, Leslie S.] Univ Michigan, Dept Pharmacol, Ann Arbor, MI 48109 USA; [Van Wassenhove, Lauren D.] Stanford Univ, Dept Chem & Syst Biol, Stanford, CA 94305 USA; [Merrins, Matthew J.] Univ Wisconsin, Dept Med, Madison, WI 53705 USA; [Merrins, Matthew J.] William S Middleton Mem Vet Adm Med Ctr, Madison, WI 53705 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; Stanford University; University of Wisconsin System; University of Wisconsin Madison; US Department of Veterans Affairs; Veterans Health Administration (VHA); William S Middleton Memorial Veterans Hospital	Merajver, SD (corresponding author), Univ Michigan, Dept Internal Med, Ctr Canc 7217, 1500 E Med Ctr Dr, Ann Arbor, MI 48109 USA.	smerajve@umich.edu	Burant, Charles/GPC-5690-2022; Schnell, Santiago/B-8682-2008	Burant, Charles/0000-0001-9189-5003; Schnell, Santiago/0000-0002-9477-3914; Merrins, Matthew J./0000-0003-1599-9227; Van Wassenhove, Lauren/0000-0002-6130-4580; Yates, Joel/0000-0002-1462-8494; Evans, Charles/0000-0001-6698-5330	National Institutes of Health [U24 DK097153]; NATIONAL CANCER INSTITUTE [T32CA140044, P30CA046592] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK020572, R01DK046409, U24DK097153, K25DK092558] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008353] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work utilized core services of the Michigan Regional Comprehensive Metabolomics Resource Core, supported by National Institutes of Health Grant U24 DK097153. We thank Firas Midani for help with natural abundance correction algorithms and Mariana Rodriguez Ortiz for help with figure preparation.	Chen YC, 2015, SCI REP-UK, V5, DOI 10.1038/srep09980; Christofk HR, 2008, NATURE, V452, P230, DOI 10.1038/nature06734; Chu K, 2013, ONCOTARGET, V4, P446, DOI 10.18632/oncotarget.872; Clark EA, 2000, NATURE, V406, P532, DOI 10.1038/35020106; Clark JB, 1998, DEV NEUROSCI-BASEL, V20, P271, DOI 10.1159/000017321; EAGLE H, 1955, SCIENCE, V122, P501, DOI 10.1126/science.122.3168.501; Evans CR, 2014, J PROTEOME RES, V13, P640, DOI 10.1021/pr4007624; Fernandez CA, 1996, J MASS SPECTROM, V31, P255, DOI 10.1002/(SICI)1096-9888(199603)31:3<255::AID-JMS290>3.0.CO;2-3; Ferreira LMR, 2010, EXP MOL PATHOL, V89, P372, DOI 10.1016/j.yexmp.2010.08.006; Fong MY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019963; Gao XL, 2012, MOL CELL, V45, P598, DOI 10.1016/j.molcel.2012.01.001; Gillies RJ, 2008, J NUCL MED, V49, p24S, DOI 10.2967/jnumed.107.047258; Griner EM, 2015, MOL CANCER RES, V13, P483, DOI 10.1158/1541-7786.MCR-14-0420; Hascalik S, 2006, INT J GYNECOL CANCER, V16, P423, DOI 10.1111/j.1525-1438.2006.00200.x; Hitosugi T, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000431; Holleran AL, 1995, MOL CELL BIOCHEM, V152, P95, DOI 10.1007/BF01076071; Howlader N, 2015, SEER CANC STAT REV 1; Ikoma T, 2004, CLIN CANCER RES, V10, P1192, DOI 10.1158/1078-0432.CCR-03-0275; Kleer CG, 2005, BREAST CANCER RES TR, V93, P101, DOI 10.1007/s10549-005-4170-6; Kolwijck E, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010293; Levine PH, 2012, CLIN BREAST CANCER, V12, P232, DOI 10.1016/j.clbc.2012.04.005; Lorenz MA, 2011, ANAL CHEM, V83, P3406, DOI 10.1021/ac103313x; Lou TF, 2016, CANCER PREV RES, V9, P43, DOI 10.1158/1940-6207.CAPR-14-0287; Mazurek S, 2005, SEMIN CANCER BIOL, V15, P300, DOI 10.1016/j.semcancer.2005.04.009; Mazurek S, 2011, INT J BIOCHEM CELL B, V43, P969, DOI 10.1016/j.biocel.2010.02.005; MEHTA V, 1995, MOL BRAIN RES, V31, P151, DOI 10.1016/0169-328X(95)00044-S; Merrins MJ, 2013, J BIOL CHEM, V288, P33312, DOI 10.1074/jbc.M113.508127; Metallo CM, 2012, NATURE, V481, P380, DOI 10.1038/nature10602; Mullen AR, 2012, NATURE, V481, P385, DOI 10.1038/nature10642; Noguchi Y, 2009, J BIOL CHEM, V284, P33425, DOI 10.1074/jbc.M109.049478; Poore B, 2015, GLUTAMINE CLIN NUTR, P77; Rocheleau JV, 2004, J BIOL CHEM, V279, P31780, DOI 10.1074/jbc.M314005200; Rosenthal DT, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040979; Satrustegui J, 2007, PHYSIOL REV, V87, P29, DOI 10.1152/physrev.00005.2006; SAUER LA, 1983, CANCER RES, V43, P3497; Silvera D, 2009, CELL CYCLE, V8, P3091, DOI 10.4161/cc.8.19.9637; Suwa H, 1998, BRIT J CANCER, V77, P147, DOI 10.1038/bjc.1998.23; Tong ZY, 2004, MAGN RESON IMAGING, V22, P1017, DOI 10.1016/j.mri.2004.02.007; van Golen KL, 1999, CLIN CANCER RES, V5, P2511; van Golen KL, 2000, CANCER RES, V60, P5832; van Golen KL, 2000, NEOPLASIA, V2, P418, DOI 10.1038/sj.neo.7900115; Vander Heiden MG, 2011, NAT REV DRUG DISCOV, V10, P671, DOI 10.1038/nrd3504; Vaupel P, 2012, INT J BIOCHEM CELL B, V44, P1477, DOI 10.1016/j.biocel.2012.05.019; Wang JB, 2010, CANCER CELL, V18, P207, DOI 10.1016/j.ccr.2010.08.009; Wecsler JS, 2015, BREAST CANCER RES TR, V151, P113, DOI 10.1007/s10549-015-3367-6; Wise DR, 2011, P NATL ACAD SCI USA, V108, P19611, DOI 10.1073/pnas.1117773108; Woodward WA, 2009, SEMIN RADIAT ONCOL, V19, P256, DOI 10.1016/j.semradonc.2009.05.008; Yalcinkaya C, 2005, NEUROPEDIATRICS, V36, P336, DOI 10.1055/s-2005-872878; Young JD, 2014, BIOINFORMATICS, V30, P1333, DOI 10.1093/bioinformatics/btu015; Yuan Y, 2003, J BIOL CHEM, V278, P15911, DOI 10.1074/jbc.M300463200; Zand B, 2016, JNCI-J NATL CANCER I, V108, DOI 10.1093/jnci/djv426	51	22	22	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 24	2016	291	26					13715	13729		10.1074/jbc.M115.703959	http://dx.doi.org/10.1074/jbc.M115.703959			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DR2YZ	27129239	Green Published, hybrid			2022-12-26	WOS:000379771100026
J	Kim, Y; Joachimiak, G; Bigelow, L; Babnigg, G; Joachimiak, A				Kim, Youngchang; Joachimiak, Grazyna; Bigelow, Lance; Babnigg, Gyorgy; Joachimiak, Andrzej			How Aromatic Compounds Block DNA Binding of HcaR Catabolite Regulator	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							3-HYDROXYBENZOATE HYDROXYLASE GENE; CRYSTAL-STRUCTURE REVEALS; TRANSCRIPTIONAL REGULATOR; MARR FAMILY; HIGH-THROUGHPUT; ESCHERICHIA-COLI; NUCLEIC-ACIDS; PROTEIN; MECHANISM; REPRESSOR	Bacterial catabolism of aromatic compounds from various sources including phenylpropanoids and flavonoids that are abundant in soil plays an important role in the recycling of carbon in the ecosystem. We have determined the crystal structures of apo-HcaR from Acinetobacter sp. ADP1, a MarR/SlyA transcription factor, in complexes with hydroxycinnamates and a specific DNA operator. The protein regulates the expression of the hca catabolic operon in Acinetobacter and related bacterial strains, allowing utilization of hydroxycinnamates as sole sources of carbon. HcaR binds multiple ligands, and as a result the transcription of genes encoding several catabolic enzymes is increased. The 1.9-2.4 angstrom resolution structures presented here explain how HcaR recognizes four ligands (ferulate, 3,4-dihydroxybenzoate, p-coumarate, and vanillin) using the same binding site. The ligand promiscuity appears to be an adaptation to match a broad specificity of hydroxycinnamate catabolic enzymes while responding to toxic thioester intermediates. Structures of apo-HcaR and in complex with a specific DNA hca operator when combined with binding studies of hydroxycinnamates show how aromatic ligands render HcaR unproductive in recognizing a specific DNA target. The current study contributes to a better understanding of the hca catabolic operon regulation mechanism by the transcription factor HcaR.	[Kim, Youngchang; Joachimiak, Grazyna; Bigelow, Lance; Babnigg, Gyorgy; Joachimiak, Andrzej] Argonne Natl Lab, Midwest Ctr Struct Genom, 9700 S Cass Ave, Argonne, IL 60439 USA; [Kim, Youngchang; Babnigg, Gyorgy; Joachimiak, Andrzej] Argonne Natl Lab, Struct Biol Ctr, Biosci, 9700 S Cass Ave, Argonne, IL 60439 USA	United States Department of Energy (DOE); Argonne National Laboratory; United States Department of Energy (DOE); Argonne National Laboratory	Joachimiak, A (corresponding author), Argonne Natl Lab, Struct Biol Ctr, Biosci, 9700 S Cass Ave, Argonne, IL 60439 USA.	andrzejj@anl.gov		Kim, Youngchang/0000-0002-1610-4889; Joachimiak, Andrzej/0000-0003-2535-6209	National Institute of Health [GM115586, GM094585]; United States Department of Energy, Office of Biological and Environmental Research [DE-AC02-06CH11357]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U54GM094585, R24GM115586] Funding Source: NIH RePORTER	National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); United States Department of Energy, Office of Biological and Environmental Research(United States Department of Energy (DOE)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institute of Health Grants GM115586 and GM094585 and by United States Department of Energy, Office of Biological and Environmental Research, Contract DE-AC02-06CH11357. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Alekshun MN, 2001, NAT STRUCT BIOL, V8, P710, DOI 10.1038/90429; Alekshun MN, 1999, TRENDS MICROBIOL, V7, P410, DOI 10.1016/S0966-842X(99)01589-9; Bordelon T, 2006, J MOL BIOL, V360, P168, DOI 10.1016/j.jmb.2006.05.005; Brugarolas P, 2012, J BIOL CHEM, V287, DOI 10.1074/jbc.M112.388611; Carmona M, 2009, MICROBIOL MOL BIOL R, V73, P71, DOI 10.1128/MMBR.00021-08; Chang YM, 2014, NUCLEIC ACIDS RES, V42, P5314, DOI 10.1093/nar/gku128; Chang YM, 2010, P NATL ACAD SCI USA, V107, P8617, DOI 10.1073/pnas.0913302107; Copley SD, 2015, TRENDS BIOCHEM SCI, V40, P72, DOI 10.1016/j.tibs.2014.12.004; Cowtan K., 1994, JOINT CCP4 ESF EACBM, V31, P34; COWTAN KD, 1993, ACTA CRYSTALLOGR D, V49, P148, DOI 10.1107/S0907444992007698; Cowtan K, 2006, ACTA CRYSTALLOGR D, V62, P1002, DOI 10.1107/S0907444906022116; Dal S, 2005, APPL ENVIRON MICROB, V71, P1025, DOI 10.1128/AEM.71.2.1025-1034.2005; Davis IW, 2004, NUCLEIC ACIDS RES, V32, pW615, DOI 10.1093/nar/gkh398; Davis JR, 2010, APPL MICROBIOL BIOT, V86, P921, DOI 10.1007/s00253-009-2358-0; Di Fiore A, 2009, J MOL BIOL, V388, P559, DOI 10.1016/j.jmb.2009.03.030; Dolan KT, 2011, J BIOL CHEM, V286, P22178, DOI 10.1074/jbc.M111.245258; Donnelly MI, 2006, PROTEIN EXPRES PURIF, V47, P446, DOI 10.1016/j.pep.2005.12.011; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Enemark EJ, 2006, NATURE, V442, P270, DOI 10.1038/nature04943; Fiorentino G, 2007, J BACTERIOL, V189, P7351, DOI 10.1128/JB.00885-07; Fischer R, 2008, MICROBIOL-SGM, V154, P3095, DOI 10.1099/mic.0.2008/016907-0; Guerra AJ, 2011, J AM CHEM SOC, V133, P19614, DOI 10.1021/ja2080532; Hertz R, 1998, NATURE, V392, P512, DOI 10.1038/33185; Hirakawa H, 2012, J BACTERIOL, V194, P1960, DOI 10.1128/JB.06817-11; Hiromoto T, 2006, J MOL BIOL, V364, P863, DOI 10.1016/j.jmb.2006.08.098; Hong M, 2005, MOL CELL, V20, P131, DOI 10.1016/j.molcel.2005.09.013; JOACHIMIAK A, 1991, METHOD ENZYMOL, V208, P82; Kim Youngchang, 2004, Journal of Structural and Functional Genomics, V5, P111, DOI 10.1023/B:JSFG.0000029206.07778.fc; Kim Y, 2011, METHODS, V55, P12, DOI 10.1016/j.ymeth.2011.07.010; Kumaraswami M, 2009, NUCLEIC ACIDS RES, V37, P1211, DOI 10.1093/nar/gkn1046; Kumarevel T, 2009, NUCLEIC ACIDS RES, V37, P4723, DOI 10.1093/nar/gkp496; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Lavery R, 2009, NUCLEIC ACIDS RES, V37, P5917, DOI 10.1093/nar/gkp608; Lintner NG, 2011, J MOL BIOL, V405, P939, DOI 10.1016/j.jmb.2010.11.019; Manso I, 2009, J BIOL CHEM, V284, P21218, DOI 10.1074/jbc.M109.008243; Michalska K, 2012, J MOL BIOL, V423, P555, DOI 10.1016/j.jmb.2012.08.017; Minor W, 2006, ACTA CRYSTALLOGR D, V62, P859, DOI 10.1107/S0907444906019949; Oh SY, 2007, J BACTERIOL, V189, P6284, DOI 10.1128/JB.00632-07; OTWINOWSKI Z, 1991, DARESBURY STUDY WEEK, P80; Parke D, 2003, APPL ENVIRON MICROB, V69, P5398, DOI 10.1128/AEM.69.9.5398-5409.2003; Perera IC, 2011, PROTEIN SCI, V20, P621, DOI 10.1002/pro.588; Providenti MA, 2001, APPL ENVIRON MICROB, V67, P3530, DOI 10.1128/AEM.67.8.3530-3541.2001; Reyes-Caballero H, 2010, J MOL BIOL, V403, P197, DOI 10.1016/j.jmb.2010.08.030; Rosenbaum G, 2006, J SYNCHROTRON RADIAT, V13, P30, DOI 10.1107/S0909049505036721; Saridakis V, 2008, J MOL BIOL, V377, P655, DOI 10.1016/j.jmb.2008.01.001; Schneider TR, 2002, ACTA CRYSTALLOGR D, V58, P1772, DOI 10.1107/S0907444902011678; Schumacher MA, 2002, MOL MICROBIOL, V45, P885, DOI 10.1046/j.1365-2958.2002.03039.x; Sheldrick GM, 2010, ACTA CRYSTALLOGR D, V66, P479, DOI 10.1107/S0907444909038360; Spory A, 2002, J BACTERIOL, V184, P3549, DOI 10.1128/JB.184.13.3549-3559.2002; Stols L, 2002, PROTEIN EXPRES PURIF, V25, P8, DOI 10.1006/prep.2001.1603; Tatusov RL, 1997, SCIENCE, V278, P631, DOI 10.1126/science.278.5338.631; Terwilliger TC, 2003, ACTA CRYSTALLOGR D, V59, P1174, DOI 10.1107/S0907444903009922; Turlin E, 2005, RES MICROBIOL, V156, P312, DOI 10.1016/j.resmic.2004.10.012; Wilkinson SP, 2006, CURR ISSUES MOL BIOL, V8, P51; Wilkinson SP, 2005, J MOL BIOL, V350, P617, DOI 10.1016/j.jmb.2005.05.027; Yoshida M, 2007, BIOCHEM BIOPH RES CO, V362, P275, DOI 10.1016/j.bbrc.2007.07.190	57	14	15	2	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 17	2016	291	25					13243	13256		10.1074/jbc.M115.712067	http://dx.doi.org/10.1074/jbc.M115.712067			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DR2YT	27129205	hybrid, Green Published			2022-12-26	WOS:000379770500029
J	Bansal, R; Mittapelly, P; Chen, YT; Mamidala, P; Zhao, CY; Michel, A				Bansal, Raman; Mittapelly, Priyanka; Chen, Yuting; Mamidala, Praveen; Zhao, Chaoyang; Michel, Andy			Quantitative RT-PCR Gene Evaluation and RNA Interference in the Brown Marmorated Stink Bug	PLOS ONE			English	Article							REAL-TIME PCR; RHODNIUS-PROLIXUS HEMIPTERA; POLYMERASE-CHAIN-REACTION; EXPRESSION ANALYSIS; HOUSEKEEPING GENES; SALIVARY-GLAND; VALIDATION; QUANTIFICATION; PENTATOMIDAE; HETEROPTERA	The brown marmorated stink bug (Halyomorpha halys) has emerged as one of the most important invasive insect pests in the United States. Functional genomics in H. halys remains unexplored as molecular resources in this insect have recently been developed. To facilitate functional genomics research, we evaluated ten common insect housekeeping genes (RPS26, EF1A, FAU, UBE4A, ARL2, ARP8, GUS, TBP, TIF6 and RPL9) for their stability across various treatments in H. halys. Our treatments included two biotic factors (tissues and developmental stages) and two stress treatments (RNAi injection and starvation). Reference gene stability was determined using three software algorithms (geNorm, NormFinder, BestKeeper) and a web-based tool (RefFinder). The qRT-PCR results indicated ARP8 and UBE4A exhibit the most stable expression across tissues and developmental stages, ARL2 and FAU for dsRNA treatment and TBP and UBE4A for starvation treatment. Following the dsRNA treatment, all genes except GUS showed relatively stable expression. To demonstrate the utility of validated reference genes in accurate gene expression analysis and to explore gene silencing in H. halys, we performed RNAi by administering dsRNA of target gene (catalase) through microinjection. A successful RNAi response with over 90% reduction in expression of target gene was observed.	[Bansal, Raman; Mittapelly, Priyanka; Chen, Yuting; Zhao, Chaoyang; Michel, Andy] Ohio State Univ, Ohio Agr Res & Dev Ctr, Dept Entomol, Wooster, OH 44691 USA; [Mamidala, Praveen] Telangana Univ, Univ Coll Sci, Dept Biotechnol, Nizamabad 503322, Telangana, India; [Chen, Yuting] Iowa State Univ, Dept Entomol, Ames, IA USA; [Zhao, Chaoyang] Washington State Univ, Dept Entomol, Pullman, WA 99164 USA	University System of Ohio; Ohio State University; Telangana University; Iowa State University; Washington State University	Bansal, R (corresponding author), Ohio State Univ, Ohio Agr Res & Dev Ctr, Dept Entomol, Wooster, OH 44691 USA.	bansal.67@osu.edu	Mittapelly, Priyanka/Q-2940-2019	Mamidala, Praveen/0000-0001-8587-0635; Mittapelly, Priyanka/0000-0002-1021-8789	Ohio Soybean Council; Ohio State University, Ohio Agricultural Research and Development Center	Ohio Soybean Council; Ohio State University, Ohio Agricultural Research and Development Center(Ohio State University)	Funding for this work was provided by the Ohio Soybean Council, and by state and federal funds appropriated to The Ohio State University, Ohio Agricultural Research and Development Center. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AHMAD S, 1992, BIOCHEM SYST ECOL, V20, P269, DOI 10.1016/0305-1978(92)90040-K; Andersen CL, 2004, CANCER RES, V64, P5245, DOI 10.1158/0008-5472.CAN-04-0496; Araujo RN, 2006, INSECT BIOCHEM MOLEC, V36, P683, DOI 10.1016/j.ibmb.2006.05.012; Bansal R, 2012, J ECON ENTOMOL, V105, P1432, DOI 10.1603/EC12095; Bewick V, 2004, CRIT CARE, V8, P389, DOI 10.1186/cc2955; Bustin SA, 2002, J MOL ENDOCRINOL, V29, DOI 10.1677/jme.0.0290023; Bustin Stephen A, 2010, Expert Rev Mol Diagn, V10, P713, DOI 10.1586/erm.10.65; Bustin SA, 2009, CLIN CHEM, V55, P611, DOI 10.1373/clinchem.2008.112797; Butte AJ, 2001, PHYSIOL GENOMICS, V7, P95, DOI 10.1152/physiolgenomics.2001.7.2.95; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; Conesa Ana, 2008, Int J Plant Genomics, V2008, P619832, DOI 10.1155/2008/619832; Deng F, 2014, ARCH INSECT BIOCHEM, V86, P46, DOI 10.1002/arch.21161; Diaz-Albiter H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017486; Espy MJ, 2006, CLIN MICROBIOL REV, V19, P165, DOI 10.1128/CMR.19.1.165-256.2006; Ginzinger DG, 2002, EXP HEMATOL, V30, P503, DOI 10.1016/S0301-472X(02)00806-8; Gotz S, 2008, NUCLEIC ACIDS RES, V36, P3420, DOI 10.1093/nar/gkn176; Hannon GJ, 2002, NATURE, V418, P244, DOI 10.1038/418244a; Hoebeke ER, 2003, P ENTOMOL SOC WASH, V105, P225; Hornakova D, 2010, ANAL BIOCHEM, V397, P118, DOI 10.1016/j.ab.2009.09.019; Ioannidis P, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-738; Koci J, 2013, J MED ENTOMOL, V50, P79, DOI 10.1603/ME12034; Lee DH, 2013, ENVIRON ENTOMOL, V42, P627, DOI 10.1603/EN13006; Leskey T. C., 2012, Outlooks on Pest Management, V23, P218, DOI 10.1564/23oct07; Leskey TC, 2012, PSYCHE J ENTOMOLOGY, V2012; Lord JC, 2010, J MICROBIOL METH, V80, P219, DOI 10.1016/j.mimet.2009.12.007; Lu YH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068059; Medal J, 2012, FLA ENTOMOL, V95, P800, DOI 10.1653/024.095.0339; Paim Rafaela M., 2012, BMC Research Notes, V5, DOI 10.1186/1756-0500-5-128; Pfaffl MW, 2004, BIOTECHNOL LETT, V26, P509, DOI 10.1023/B:BILE.0000019559.84305.47; Ponton F, 2011, J INSECT PHYSIOL, V57, P840, DOI 10.1016/j.jinsphys.2011.03.014; Scharlaken B, 2008, J INSECT SCI, V8, DOI 10.1673/031.008.3301; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Silver N, 2006, BMC MOL BIOL, V7, DOI 10.1186/1471-2199-7-33; Sparks ME, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111646; Teng XL, 2012, J INSECT SCI, V12, DOI 10.1673/031.012.6001; Van Hiel MB, 2009, BMC MOL BIOL, V10, DOI 10.1186/1471-2199-10-56; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Wong ML, 2005, BIOTECHNIQUES, V39, P75, DOI 10.2144/05391RV01; Zhao HM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059527	39	32	34	1	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 4	2016	11	5							e0152730	10.1371/journal.pone.0152730	http://dx.doi.org/10.1371/journal.pone.0152730			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DL5KR	27144586	Green Published, gold			2022-12-26	WOS:000375676400005
J	Coelho, MS; de Lima, CL; Royer, C; Silva, JB; Oliveira, FCB; Christ, CG; Pereira, SA; Bao, SN; Lima, MCA; Pitta, MGR; Pitta, IR; Neves, FAR; Amato, AA				Coelho, Michella S.; de Lima, Caroline L.; Royer, Carine; Silva, Janaina B.; Oliveira, Fernanda C. B.; Christ, Camila G.; Pereira, Sidney A.; Bao, Sonia N.; Lima, Maria C. A.; Pitta, Marina G. R.; Pitta, Ivan R.; Neves, Francisco A. R.; Amato, Angelica A.			GQ-16, a TZD-Derived Partial PPAR gamma Agonist, Induces the Expression of Thermogenesis-Related Genes in Brown Fat and Visceral White Fat and Decreases Visceral Adiposity in Obese and Hyperglycemic Mice	PLOS ONE			English	Article							ACTIVATED-RECEPTOR-GAMMA; ENERGY-BALANCE; TISSUE; ROSIGLITAZONE; ADIPOCYTES; LIGAND; DISTINCT; PRDM16; THIAZOLIDINEDIONE; WEIGHT	Background Beige adipocytes comprise a unique thermogenic cell type in the white adipose tissue (WAT) of rodents and humans, and play a critical role in energy homeostasis. In this scenario, recruitment of beige cells has been an important focus of interest for the development of novel therapeutic strategies to treat obesity. PPAR gamma activation by full agonists (thiazolidinediones, TZDs) drives the appearance of beige cells, a process so-called browning of WAT. However, this does not translate into increased energy expenditure, and TZDs are associated with weight gain. Partial PPAR gamma agonists, on the other hand, do not induce weight gain, but have not been shown to drive WAT browning. The present study was designed to investigate the effects of GQ-16 on BAT and on browning of WAT in obese mice. Methods Male Swiss mice with obesity and hyperglycemia induced by high fat diet were treated with vehicle, rosiglitazone (4 mg/kg/d) or the TZD-derived partial PPAR gamma agonist GQ-16 (40 mg/kg/d) for 14 days. Fasting blood glucose, aspartate aminotransferase, alanine aminotransferase and lipid profile were measured. WAT and brown adipose tissue (BAT) depots were excised for determination of adiposity, relative expression of Ucp-1, Cidea, Prdm16, Cd40 and Tmem26 by RT-qPCR, histological analysis, and UCP-1 protein expression analysis by immunohistochemistry. Liver samples were also removed for histological analysis and determination of hepatic triglyceride content. Result GQ-16 treatment reduced high fat diet-induced weight gain in mice despite increasing energy intake. This was accompanied by reduced epididymal fat mass, reduced liver triglyceride content, morphological signs of increased BAT activity, increased expression of thermogenesis- related genes in interscapular BAT and epididymal WAT, and increased UCP-1 protein expression in interscapular BAT and in epididymal and inguinal WAT. Conclusion This study suggests for the first time that a partial PPAR gamma agonist may increase BAT activity and induce the expression of thermogenesis-related genes in visceral WAT. General Significance These findings suggest that PPAR gamma activity might be modulated by partial agonists to induce WAT browning and treat obesity.	[Coelho, Michella S.; de Lima, Caroline L.; Royer, Carine; Silva, Janaina B.; Oliveira, Fernanda C. B.; Christ, Camila G.; Pereira, Sidney A.; Neves, Francisco A. R.; Amato, Angelica A.] Univ Brasilia, Lab Farmacol Mol, Fac Ciencias Saude, Brasilia, DF, Brazil; [Bao, Sonia N.] Univ Brasilia, Dept Biol Celular, Inst Ciencias Biol, Brasilia, DF, Brazil; [Lima, Maria C. A.; Pitta, Marina G. R.; Pitta, Ivan R.] Univ Fed Pernambuco, Nucleo Pesquisa Inovacao Terapeut, Recife, PE, Brazil	Universidade de Brasilia; Universidade de Brasilia; Universidade Federal de Pernambuco	Coelho, MS; Neves, FAR; Amato, AA (corresponding author), Univ Brasilia, Lab Farmacol Mol, Fac Ciencias Saude, Brasilia, DF, Brazil.	coelhoms@usp.br; chico@unb.br; angelicaamato@unb.br	Báo, Sônia/V-1214-2019; Royer, Carine/GQR-0414-2022	Pereira, Sidney/0000-0002-7937-2952; Bao, Sonia/0000-0002-9873-3098; Silva, Janaina/0000-0001-5581-5416	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) [478889/2012-7]; Instituto Nacional de Ciencias e Tecnologia para Inovacao Farmaceutica (INCT-IF) [573663/2008-4]; CNPq [485811/2011-1]; CNPq/MCT/FAPDF/CAPES [564666/2010-6]	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Instituto Nacional de Ciencias e Tecnologia para Inovacao Farmaceutica (INCT-IF); CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); CNPq/MCT/FAPDF/CAPES	This work was supported by the Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq), grants 478889/2012-7 from AAA, Instituto Nacional de Ciencias e Tecnologia para Inovacao Farmaceutica (INCT-IF) 573663/2008-4, from IRP; 485811/2011-1 (CNPq), from FARN, and 564666/2010-6 (CNPq/MCT/FAPDF/CAPES) from AAA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmadian M, 2013, NAT MED, V19, P557, DOI 10.1038/nm.3159; Amato AA, 2012, J BIOL CHEM, V287, P28169, DOI 10.1074/jbc.M111.332106; Baba S, 2007, J NUCL MED, V48, P1715, DOI 10.2967/jnumed.107.041715; Berger JP, 2003, MOL ENDOCRINOL, V17, P662, DOI 10.1210/me.2002-0217; Bruning JB, 2007, STRUCTURE, V15, P1258, DOI 10.1016/j.str.2007.07.014; Cannon B, 2004, PHYSIOL REV, V84, P277, DOI 10.1152/physrev.00015.2003; Choi JH, 2011, NATURE, V477, P477, DOI 10.1038/nature10383; Choi SS, 2014, J BIOL CHEM, V289, P26618, DOI 10.1074/jbc.M114.566794; Cohen P, 2014, CELL, V156, P304, DOI 10.1016/j.cell.2013.12.021; Cypess AM, 2013, NAT MED, V19, P635, DOI 10.1038/nm.3112; Cypess AM, 2009, NEW ENGL J MED, V360, P1509, DOI 10.1056/NEJMoa0810780; Leite LFCD, 2007, EUR J MED CHEM, V42, P1263, DOI 10.1016/j.ejmech.2007.02.015; Edvardsson U, 1999, J LIPID RES, V40, P1177; Festuccia WT, 2008, ENDOCRINOLOGY, V149, P2121, DOI 10.1210/en.2007-1553; Festuccia WT, 2009, J LIPID RES, V50, P1185, DOI 10.1194/jlr.M800620-JLR200; Festuccia WT, 2008, AM J PHYSIOL-REG I, V296, pE1327; FOLCH J, 1957, J BIOL CHEM, V226, P497; Fukui Y, 2000, DIABETES, V49, P759, DOI 10.2337/diabetes.49.5.759; Garcia-Ruiz I, 2007, HEPATOLOGY, V46, P414, DOI 10.1002/hep.21687; Guerra C, 1998, J CLIN INVEST, V102, P412, DOI 10.1172/JCI3155; Imai T, 2004, P NATL ACAD SCI USA, V101, P4543, DOI 10.1073/pnas.0400356101; Jespersen NZ, 2013, CELL METAB, V17, P798, DOI 10.1016/j.cmet.2013.04.011; Joosen AMCP, 2006, DIABETES-METAB RES, V22, P204, DOI 10.1002/dmrr.592; Kim KR, 2006, BIOCHEM PHARMACOL, V72, P446, DOI 10.1016/j.bcp.2006.05.005; Lichtenbelt WDV, 2009, NEW ENGL J MED, V360, P1500, DOI 10.1056/NEJMoa0808718; Lidell ME, 2013, NAT MED, V19, P631, DOI 10.1038/nm.3017; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Long JZ, 2014, CELL METAB, V19, P810, DOI 10.1016/j.cmet.2014.03.025; Misra P, 2003, J PHARMACOL EXP THER, V306, P763, DOI 10.1124/jpet.103.049791; Nolte RT, 1998, NATURE, V395, P137, DOI 10.1038/25931; Ohno H, 2012, CELL METAB, V15, P395, DOI 10.1016/j.cmet.2012.01.019; Petrovic N, 2010, J BIOL CHEM, V285, P7153, DOI 10.1074/jbc.M109.053942; Rong JX, 2007, DIABETES, V56, P1751, DOI 10.2337/db06-1135; Rull A, 2014, J PROTEOME RES, V13, P1731, DOI 10.1021/pr401230s; Seale P, 2008, NATURE, V454, P961, DOI 10.1038/nature07182; Seale P, 2011, J CLIN INVEST, V121, P96, DOI 10.1172/JCI44271; Sell H, 2004, ENDOCRINOLOGY, V145, P3925, DOI 10.1210/en.2004-0321; Sharp LZ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049452; Tiikkainen M, 2004, DIABETES, V53, P2169, DOI 10.2337/diabetes.53.8.2169; Virtanen KA, 2009, NEW ENGL J MED, V360, P1518, DOI 10.1056/NEJMoa0808949; Wilson-Fritch L, 2004, J CLIN INVEST, V114, P1281, DOI 10.1172/JCI200421752; Wu J, 2012, CELL, V150, P366, DOI 10.1016/j.cell.2012.05.016; Xue BZ, 2007, J LIPID RES, V48, P41, DOI 10.1194/jlr.M600287-JLR200	43	19	20	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 3	2016	11	5							e0154310	10.1371/journal.pone.0154310	http://dx.doi.org/10.1371/journal.pone.0154310			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DL5KK	27138164	gold, Green Published, Green Submitted			2022-12-26	WOS:000375675700025
J	Li, XX; Gao, LH; Fang, WH				Li, Xiaoxu; Gao, Lianghui; Fang, Weihai			Dissipative Particle Dynamics Simulations for Phospholipid Membranes Based on a Four-To-One Coarse-Grained Mapping Scheme	PLOS ONE			English	Article							CRITICAL MICELLE CONCENTRATION; NONIONIC SURFACTANTS; LIPID-BILAYERS; INTERACTION POTENTIALS; MESOSCOPIC SIMULATION; PHASE-BEHAVIOR; FORCE-FIELD; MODEL; WATER; EQUILIBRIUM	In this article, a new set of parameters compatible with the dissipative particle dynamics (DPD) force field is developed for phospholipids. The coarse-grained (CG) models of these molecules are constructed by mapping four heavy atoms and their attached hydrogen atoms to one bead. The beads are divided into types distinguished by charge type, polarizability, and hydrogen-bonding capacity. First, we derive the relationship between the DPD repulsive force and Flory-Huggins.-parameters based on this four-to-one CG mapping scheme. Then, we optimize the DPD force parameters for phospholipids. The feasibility of this model is demonstrated by simulating the structural and thermodynamic properties of lipid bilayer membranes, including the membrane thickness, the area per lipid, the lipid tail orientation, the bending rigidity, the rupture behavior, and the potential of mean force for lipid flip-flop.	[Li, Xiaoxu; Gao, Lianghui; Fang, Weihai] Beijing Normal Univ, Coll Chem, Minist Educ, Key Lab Theoret & Computat Photochem, Beijing 100875, Peoples R China	Beijing Normal University	Gao, LH (corresponding author), Beijing Normal Univ, Coll Chem, Minist Educ, Key Lab Theoret & Computat Photochem, Beijing 100875, Peoples R China.	lhgao@bnu.edu.cn		Gao, Lianghui/0000-0003-4414-3671	National Natural Science Foundation of China [91127016, 21373031, 21421003]; National Basic Research Program of China [2011CB808503]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Basic Research Program of China(National Basic Research Program of China)	This work was supported by National Natural Science Foundation of China, Grant Nos. 91127016, 21373031 (LG); National Natural Science Foundation of China, Grant No. 21421003 (WF); and National Basic Research Program of China, Grant No. 2011CB808503 (WF).	BARNEVELD PA, 1992, LANGMUIR, V8, P3122, DOI 10.1021/la00048a044; Benjamini A, 2013, SOFT MATTER, V9, P2673, DOI 10.1039/c2sm27165f; Bennett WFD, 2011, J CHEM THEORY COMPUT, V7, P2981, DOI 10.1021/ct200291v; Borrell B, 2008, NATURE, V451, P240, DOI 10.1038/451240a; Chen LC, 2015, J PHYS CHEM B, V119, P850, DOI 10.1021/jp505497k; Cheng JL, 2014, LANGMUIR, V30, P12932, DOI 10.1021/la503520e; de Jong DH, 2013, FARADAY DISCUSS, V161, P347, DOI 10.1039/c2fd20086d; Delgado-Buscalioni R, 2008, J CHEM PHYS, V128, DOI 10.1063/1.2890729; ESPANOL P, 1995, EUROPHYS LETT, V30, P191, DOI 10.1209/0295-5075/30/4/001; FINE RA, 1973, J CHEM PHYS, V59, P5529, DOI 10.1063/1.1679903; Gao LH, 2007, J CHEM PHYS, V126, DOI 10.1063/1.2424698; Gao LH, 2008, SOFT MATTER, V4, P1208, DOI 10.1039/b801407h; Gao LH, 2011, J CHEM PHYS, V135, DOI 10.1063/1.3658500; Gao LH, 2010, J PHYS CHEM B, V114, P7261, DOI 10.1021/jp102115m; Gao LH, 2010, J CHEM PHYS, V132, DOI 10.1063/1.3297889; Gao LH, 2009, SOFT MATTER, V5, P3312, DOI 10.1039/b902971k; Goetz R, 1999, PHYS REV LETT, V82, P221, DOI 10.1103/PhysRevLett.82.221; Groot RD, 2001, BIOPHYS J, V81, P725, DOI 10.1016/S0006-3495(01)75737-2; Groot RD, 2003, J CHEM PHYS, V118, P11265, DOI 10.1063/1.1574800; Groot RD, 1997, J CHEM PHYS, V107, P4423, DOI 10.1063/1.474784; Izvekov S, 2005, J PHYS CHEM B, V109, P2469, DOI 10.1021/jp044629q; Jakobsen AF, 2005, J CHEM PHYS, V122, DOI [10.1063/1.1900725, 10.1063/1.1867374]; Klein ML, 2008, SCIENCE, V321, P798, DOI 10.1126/science.1157834; Kranenburg M, 2005, J PHYS CHEM B, V109, P6553, DOI 10.1021/jp0457646; Kranenburg M, 2004, PHYS CHEM CHEM PHYS, V6, P4142, DOI 10.1039/b406433j; KUMAR S, 1992, J COMPUT CHEM, V13, P1011, DOI 10.1002/jcc.540130812; Lee MT, 2013, J PHYS CHEM B, V117, P10304, DOI 10.1021/jp4042028; LEERMAKERS FAM, 1988, J CHEM PHYS, V89, P3264, DOI 10.1063/1.454931; Li XX, 2016, SCI REP-UK, V6, DOI 10.1038/srep21614; Li Z, 2014, J COMPUT PHYS, V265, P113, DOI 10.1016/j.jcp.2014.02.003; Lopez CA, 2013, J CHEM THEORY COMPUT, V9, P1694, DOI 10.1021/ct3009655; LYUBARTSEV AP, 1995, PHYS REV E, V52, P3730, DOI 10.1103/PhysRevE.52.3730; Mao RF, 2015, J PHYS CHEM B, V119, P11673, DOI 10.1021/acs.jpcb.5b05630; Marrink SJ, 2004, J PHYS CHEM B, V108, P750, DOI 10.1021/jp036508g; Milano G, 2005, J PHYS CHEM B, V109, P18609, DOI 10.1021/jp0523571; Monticelli L, 2008, J CHEM THEORY COMPUT, V4, P819, DOI 10.1021/ct700324x; Nagle JF, 2000, BBA-REV BIOMEMBRANES, V1469, P159, DOI 10.1016/S0304-4157(00)00016-2; Ortiz V, 2005, J PHYS CHEM B, V109, P17708, DOI 10.1021/jp0512762; Ruhle V, 2009, J CHEM THEORY COMPUT, V5, P3211, DOI 10.1021/ct900369w; Shaw DG., 1989, SOLUBILITY DATA SERI, V37, P317; Shelley JC, 2001, J PHYS CHEM B, V105, P4464, DOI 10.1021/jp010238p; Shillcock JC, 2005, NAT MATER, V4, P225, DOI 10.1038/nmat1333; Shillcock JC, 2002, J CHEM PHYS, V117, P5048, DOI 10.1063/1.1498463; SMIT B, 1990, NATURE, V348, P624, DOI 10.1038/348624a0; Soddemann T, 2003, PHYS REV E, V68, DOI 10.1103/PhysRevE.68.046702; Steltenkamp S, 2006, BIOPHYS J, V91, P217, DOI 10.1529/biophysj.106.081398; Sun HJ, 2015, LANGMUIR, V31, P9105, DOI 10.1021/acs.langmuir.5b01866; Tieleman DP, 2006, J AM CHEM SOC, V128, P12462, DOI 10.1021/ja0624321; Vishnyakov A, 2013, J PHYS CHEM LETT, V4, P797, DOI 10.1021/jz400066k; Vishnyakov A, 2012, J PHYS CHEM LETT, V3, P3081, DOI 10.1021/jz301277b; Wijmans CM, 2001, J CHEM PHYS, V114, P7644, DOI 10.1063/1.1362298; Wu J, 2011, J CHEM PHYS, V135, DOI 10.1063/1.3651626	52	9	9	1	55	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 3	2016	11	5							e0154568	10.1371/journal.pone.0154568	http://dx.doi.org/10.1371/journal.pone.0154568			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DL5KK	27137463	Green Published, gold			2022-12-26	WOS:000375675700041
J	Lee, SY; Ng, WL; Mahat, MN; Nazre, M; Mohamed, R				Lee, Shiou Yih; Ng, Wei Lun; Mahat, Mohd Noor; Nazre, Mohd; Mohamed, Rozi			DNA Barcoding of the Endangered Aquilaria (Thymelaeaceae) and Its Application in Species Authentication of Agarwood Products Traded in the Market	PLOS ONE			English	Article							INTERNAL TRANSCRIBED SPACER; IDENTIFICATION; MORPHOLOGY; PRIMERS; PLANTS	The identification of Aquilaria species from their resinous non-wood product, the agarwood, is challenging as conventional techniques alone are unable to ascertain the species origin. Aquilaria is a highly protected species due to the excessive exploitation of its precious agarwood. Here, we applied the DNA barcoding technique to generate barcode sequences for Aquilaria species and later applied the barcodes to identify the source species of agarwood found in the market. We developed a reference DNA barcode library using eight candidate barcode loci (matK, rbcL, rpoB, rpoC1, psbA-trnH, trnL-trnF, ITS, and ITS2) amplified from 24 leaf accessions of seven Aquilaria species obtained from living trees. Our results indicated that all single barcodes can be easily amplified and sequenced with the selected primers. The combination of trnL-trnF+ITS and trnL-trnF+ITS2 yielded the greatest species resolution using the least number of loci combination, while matK+trnL-trnF+ ITS showed potential in detecting the geographical origins of Aquilaria species. We propose trnL-trnF+ITS2 as the best candidate barcode for Aquilaria as ITS2 has a shorter sequence length compared to ITS, which eases PCR amplification especially when using degraded DNA samples such as those extracted from processed agarwood products. A blind test conducted on eight agarwood samples in different forms using the proposed barcode combination proved successful in their identification up to the species level. Such potential of DNA barcoding in identifying the source species of agarwood will contribute to the international timber trade control, by providing an effective method for species identification and product authentication.	[Lee, Shiou Yih; Mohamed, Rozi] Univ Putra Malaysia, Dept Forest Management, Forest Biotech Lab, Upm Serdang 43400, Selangor, Malaysia; [Ng, Wei Lun] Univ Putra Malaysia, Inst Biosci, Upm Serdang 43400, Selangor, Malaysia; [Mahat, Mohd Noor] Forest Res Inst Malaysia, Kepong 52109, Selangor, Malaysia; [Nazre, Mohd] Univ Putra Malaysia, Dept Forest Management, Upm Serdang 43400, Selangor, Malaysia	Universiti Putra Malaysia; Universiti Putra Malaysia; Institute Penyelidikan Perhutanan Malaysia; Universiti Putra Malaysia	Mohamed, R (corresponding author), Univ Putra Malaysia, Dept Forest Management, Forest Biotech Lab, Upm Serdang 43400, Selangor, Malaysia.	rozimohd@upm.edu.my	Ng, Wei Lun/AAJ-2898-2021; Nazre, M./G-1631-2013	Nazre, M./0000-0001-7685-1184; Ng, Wei Lun/0000-0002-6056-7549; Mohamed, Rozi/0000-0003-1088-4252	Ministry of Higher Education of Malaysia [FRGS/1/2012/STWN02/UPM/02/1, 07-01-13-1183FR]; Universiti Putra Malaysia [GP-IPS/2015/9454000]	Ministry of Higher Education of Malaysia(Ministry of Education, Malaysia); Universiti Putra Malaysia	This work was supported by the Ministry of Higher Education of Malaysia (FRGS/1/2012/STWN02/UPM/02/1, Project No. 07-01-13-1183FR), to RM and the Universiti Putra Malaysia (GP-IPS/2015/9454000), to RM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Antonopoulou M, 2010, TRADE USE AGARWOOD O; Ashfaq M, 2013, MOL ECOL RESOUR, V13, P573, DOI 10.1111/1755-0998.12089; Awano T, 2009, P NATL ACAD SCI USA, V106, P2794, DOI [10.1073/pnas.0905845106, 10.1073/pnas.0812297106]; Baldwin BG, 1992, MOL PHYLOGENET EVOL, V1, P3, DOI 10.1016/1055-7903(92)90030-K; Ball SL, 2006, CAN J FOREST RES, V36, P337, DOI 10.1139/X05-276; Barden A, 2000, HEART MATTER AGARWOO; Borisenko AV, 2008, MOL ECOL RESOUR, V8, P471, DOI 10.1111/j.1471-8286.2007.01998.x; Che J, 2012, MOL ECOL RESOUR, V12, P247, DOI 10.1111/j.1755-0998.2011.03090.x; Chen SL, 2014, BIOTECHNOL ADV, V32, P1237, DOI 10.1016/j.biotechadv.2014.07.004; Chen SL, 2010, PLOS ONE, V5, DOI [10.1371/journal.pone.0008613, 10.1371/journal.pone.0015633]; Chinese Pharmacopoeia Commission, 2010, PHARM PEOPL REP CHIN, V1; Compton J, 2004, USE TRADE AGARWOOD J; Eurlings MCM, 2005, PLANT SYST EVOL, V254, P1, DOI 10.1007/s00606-005-0312-x; Gasson P, 2011, IAWA J, V32, P137, DOI 10.1163/22941932-90000049; Hebert PDN, 2004, PLOS BIOL, V2, P1657, DOI 10.1371/journal.pbio.0020312; Hebert PDN, 2003, P ROY SOC B-BIOL SCI, V270, pS96, DOI 10.1098/rsbl.2003.0025; Herber BE, 2003, FA GE VAS P, V5, P373; Herber BE, 2002, PLANT SYST EVOL, V232, P107, DOI 10.1007/s006060200030; HOU DING, 1964, BLUMEA, V12, P285; Ito Michiho, 2005, Natural Medicines, V59, P104; Jiao LC, 2014, HOLZFORSCHUNG, V68, P487, DOI 10.1515/hf-2013-0129; Kiebala M, 2010, PLOS ONE, V5, DOI [10.1371/journal.pone.0011875, 10.1371/journal.pone.0013102]; Kiet L, 2005, BLUMEA, V50, P135, DOI 10.3767/000651905X623319; KIMURA M, 1980, J MOL EVOL, V16, P111, DOI 10.1007/BF01731581; Kress WJ, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000508; Lee SY, 2016, BLUMEA, V61, P13, DOI 10.3767/000651916X691196; Lee Shiou Yih, 2011, Asian Journal of Plant Sciences, V10, P202, DOI 10.3923/ajps.2011.202.211; Li DZ, 2011, P NATL ACAD SCI USA, V108, P19641, DOI 10.1073/pnas.1104551108; Li XW, 2015, BIOL REV, V90, P157, DOI 10.1111/brv.12104; Lim TW, 2010, WOOD TREES REV AGARW; Lok EngHai, 1996, Journal of Tropical Forest Science, V8, P573; Mabberley D. J., 2008, MABBERLEYS PLANT BOO; Meier R, 2006, SYST BIOL, V55, P715, DOI 10.1080/10635150600969864; Mohamed R, 2012, CONSERV GENET RESOUR, V4, P803, DOI 10.1007/s12686-012-9648-z; Nakashima E. M. N., 2005, Journal of Traditional Medicines, V22, P296; Nithaniyal S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107669; [牛宪立 NIU Xian-li], 2010, [广东农业科学, Guangdong Agricultural Sciences], V37, P167; Nobuchi T., 1991, KYOTO U FOR, V63, P226; Pojanagaroon S, 2005, ACTA HORTIC, P161, DOI 10.17660/ActaHortic.2005.676.20; Rautenbach M., 2008, THESIS U JOHANNESBUR; Sang T, 1997, AM J BOT, V84, P1120, DOI 10.2307/2446155; Sass C, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001154; Shen YJ, 2009, CHINA J TRADITIONAL, V4, P46; Soehartono T, 2001, FOREST ECOL MANAG, V152, P59, DOI 10.1016/S0378-1127(00)00610-1; Song JY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043971; TABERLET P, 1991, PLANT MOL BIOL, V17, P1105, DOI 10.1007/BF00037152; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Tate JA, 2003, SYST BOT, V28, P723; Techen N, 2014, CURR OPIN BIOTECH, V25, P103, DOI 10.1016/j.copbio.2013.09.010; Valentini A, 2009, TRENDS ECOL EVOL, V24, P110, DOI 10.1016/j.tree.2008.09.011; Van der Bank M, 2002, TAXON, V51, P329, DOI 10.2307/1554901; Ward RD, 2009, J FISH BIOL, V74, P329, DOI 10.1111/j.1095-8649.2008.02080.x; Xin TY, 2015, SCI REP-UK, V5, DOI 10.1038/srep08337; Xin TY, 2013, FOOD RES INT, V54, P1699, DOI 10.1016/j.foodres.2013.10.007; Yang DJ, 2007, GUANGXI FORESTRY SCI, V4	55	42	48	2	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 29	2016	11	4							e0154631	10.1371/journal.pone.0154631	http://dx.doi.org/10.1371/journal.pone.0154631			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DK8XM	27128309	Green Published, gold, Green Accepted, Green Submitted			2022-12-26	WOS:000375212600054
J	Jalloul, AH; Rogasevskaia, TP; Szerencsei, RT; Schnetkamp, PPM				Jalloul, Ali H.; Rogasevskaia, Tatiana P.; Szerencsei, Robert T.; Schnetkamp, Paul P. M.			A Functional Study of Mutations in K+-dependent Na+-Ca2+ Exchangers Associated with Amelogenesis Imperfecta and Non-syndromic Oculocutaneous Albinism	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NCKX2 NA+/CA2+-K+ EXCHANGER; SKIN PIGMENTATION; SODIUM/CALCIUM EXCHANGER; GENE FAMILY; RETINAL ROD; AMELOBLASTS; TRANSPORT; SLC24A5; IDENTIFICATION; STOICHIOMETRY	K+-dependent Na+/Ca2+ exchangers belong to the solute carrier 24 (SLC24A1-5) gene family of membrane transporters. Five different gene products (NCKX1-5) have been identified in humans, which play key roles in biological processes including vision, olfaction, and skin pigmentation. NCKXs are bi-directional membrane transporters that transport 1 Ca2+ + K+ ions in exchange for 4 Na+ ions. Recent studies have linked mutations in the SLC24A4 (NCKX4) and SLC24A5 (NCKX5) genes to amylogenesis imperfecta (AI) and non-syndromic oculocutaneous albinism (OCA6), respectively. Here, we introduced mutations found in patients with AI and OCA6 into human SLC24A4 (NCKX4) cDNA leading to single residue substitutions in the mutant NCKX4 proteins. We measured NCKX-mediated Ca2+ transport activity of WT and mutant NCKX4 proteins expressed in HEK293 cells. Three mutant NCKX4 cDNAs represent mutations found in the SCL24A4 gene and three represent mutations found in the SCL24A5 gene involving residues conserved between NCKX4 and NCKX5. Five mutant proteins had no observable NCKX activity, whereas one mutation resulted in a 78% reduction in transport activity. Total protein expression and trafficking to the plasma membrane (the latter with one exception) were not affected in the HEK293 cell expression system. We also analyzed two mutations in a Drosophila NCKX gene that have been reported to result in an increased susceptibility for seizures, and found that both resulted in mutant proteins with significantly reduced but observable NCKX activity. The data presented here support the genetic analyses that mutations in SLC24A4 and SLC24A5 are responsible for the phenotypic defects observed in human patients.	[Jalloul, Ali H.; Rogasevskaia, Tatiana P.; Szerencsei, Robert T.; Schnetkamp, Paul P. M.] Univ Calgary, Dept Physiol & Pharmacol, Cumming Sch Med, Hotchkiss Brain Inst, Calgary, AB T2N 4N1, Canada	University of Calgary	Schnetkamp, PPM (corresponding author), 3230 Hosp Dr NW, Calgary, AB T2N 4N1, Canada.	pschnetk@ucalgary.ca			Canadian Institutes for Health Research [MOP-81327]	Canadian Institutes for Health Research(Canadian Institutes of Health Research (CIHR))	This work was supported by Canadian Institutes for Health Research operating Grant MOP-81327. The authors declare that they have no competing financial interests.	Altimimi HF, 2007, J BIOL CHEM, V282, P3720, DOI 10.1074/jbc.M609285200; Altimimi HF, 2010, J BIOL CHEM, V285, P15245, DOI 10.1074/jbc.M109.090738; Bertolotti A, 2016, PIGM CELL MELANOMA R, V29, P104, DOI 10.1111/pcmr.12425; Chi A, 2006, J PROTEOME RES, V5, P3135, DOI 10.1021/pr060363j; Dong H, 2001, J BIOL CHEM, V276, P25919, DOI 10.1074/jbc.M103401200; Ginger RS, 2008, J BIOL CHEM, V283, P5486, DOI 10.1074/jbc.M707521200; Herzog CR, 2015, OR SURG OR MED OR PA, V119, pE77, DOI 10.1016/j.oooo.2014.09.003; Hu P, 2012, CELLS TISSUES ORGANS, V196, P501, DOI 10.1159/000337493; HUBBARD MJ, 1995, EUR J BIOCHEM, V230, P68, DOI 10.1111/j.1432-1033.1995.0068i.x; Hubbard MJ, 2000, CRIT REV ORAL BIOL M, V11, P437, DOI 10.1177/10454411000110040401; Jalloul AH, 2016, CELL CALCIUM, V59, P1, DOI 10.1016/j.ceca.2015.11.001; Kang K, 2003, BIOCHEMISTRY-US, V42, P9438, DOI 10.1021/bi0342261; Kang K, 2003, BIOCHEMISTRY-US, V42, P4593, DOI 10.1021/bi027276z; Kang KJ, 2005, J BIOL CHEM, V280, P6823, DOI 10.1074/jbc.M407933200; Kinjo TG, 2003, BIOCHEMISTRY-US, V42, P2485, DOI 10.1021/bi0270788; Lacruz RS, 2013, J DENT RES, V92, P122, DOI 10.1177/0022034512470954; Lamason RL, 2005, SCIENCE, V310, P1782, DOI 10.1126/science.1116238; Li XF, 2002, J BIOL CHEM, V277, P48410, DOI 10.1074/jbc.M210011200; Li XF, 2014, J BIOL CHEM, V289, P25445, DOI 10.1074/jbc.M114.564450; Liao J, 2012, SCIENCE, V335, P686, DOI 10.1126/science.1215759; Lytton J, 2007, BIOCHEM J, V406, P365, DOI 10.1042/BJ20070619; Melom JE, 2013, J NEUROSCI, V33, P1169, DOI 10.1523/JNEUROSCI.3920-12.2013; Morice-Picard F, 2014, J INVEST DERMATOL, V134, P568, DOI 10.1038/jid.2013.360; Okumura R, 2010, J PHARMACOL SCI, V112, P223, DOI 10.1254/jphs.09267FP; Parry DA, 2013, AM J HUM GENET, V92, P307, DOI 10.1016/j.ajhg.2013.01.003; Picard C, 2009, NEW ENGL J MED, V360, P1971, DOI 10.1056/NEJMoa0900082; Pospiech E, 2011, J HUM GENET, V56, P447, DOI 10.1038/jhg.2011.38; Schnetkamp PPM, 2014, CURR TOP MEMBR, V73, P263, DOI 10.1016/B978-0-12-800223-0.00007-4; Schnetkamp PPM, 2013, MOL ASPECTS MED, V34, P455, DOI 10.1016/j.mam.2012.07.008; SCHNETKAMP PPM, 1989, AM J PHYSIOL, V257, pC153, DOI 10.1152/ajpcell.1989.257.1.C153; Seymen F, 2014, J DENT RES, V93, P366, DOI 10.1177/0022034514523786; Splawski I, 2004, CELL, V119, P19, DOI 10.1016/j.cell.2004.09.011; Stephan AB, 2012, NAT NEUROSCI, V15, P131, DOI 10.1038/nn.2943; Stokowski RP, 2007, AM J HUM GENET, V81, P1119, DOI 10.1086/522235; Sulem P, 2007, NAT GENET, V39, P1443, DOI 10.1038/ng.2007.13; Szerencsei RT, 2013, CHANNELS, V7, P109, DOI 10.4161/chan.23898; Szerencsei RT, 2001, BIOCHEMISTRY-US, V40, P6009, DOI 10.1021/bi0102353; Wang S, 2014, J DENT RES, V93, P94, DOI 10.1177/0022034514527971; Winkfein RJ, 2004, CELL CALCIUM, V36, P147, DOI 10.1016/j.ceca.2004.01.021; Winkfein RJ, 2003, BIOCHEMISTRY-US, V42, P543, DOI 10.1021/bi026982x	40	17	17	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 17	2016	291	25					13113	13123		10.1074/jbc.M116.728824	http://dx.doi.org/10.1074/jbc.M116.728824			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DR2YT	27129268	Green Published, hybrid			2022-12-26	WOS:000379770500019
J	Bhootada, Y; Kotla, P; Zolotukhin, S; Gorbatyuk, O; Bebok, Z; Athar, M; Gorbatyuk, M				Bhootada, Yogesh; Kotla, Pravallika; Zolotukhin, Sergei; Gorbatyuk, Oleg; Bebok, Zsuzsanna; Athar, Mohammad; Gorbatyuk, Marina			Limited ATF4 Expression in Degenerating Retinas with Ongoing ER Stress Promotes Photoreceptor Survival in a Mouse Model of Autosomal Dominant Retinitis Pigmentosa	PLOS ONE			English	Article							ENDOPLASMIC-RETICULUM STRESS; TRANSCRIPTION FACTOR; OXIDATIVE STRESS; PARKINSONS-DISEASE; RHODOPSIN MUTANTS; GENE-EXPRESSION; CELL-SURVIVAL; MTOR PATHWAY; AUTOPHAGY; ACTIVATION	T17M rhodopsin expression in rod photoreceptors leads to severe retinal degeneration and is associated with the activation of ER stress related Unfolded Protein Response (UPR) signaling. Here, we show a novel role of a UPR transcription factor, ATF4, in photoreceptor cellular pathology. We demonstrated a pro-death role for ATF4 overexpression during autosomal dominant retinitis pigmentosa (ADRP). Based on our results in ATF4 knockout mice and adeno-associated viral (AAV) delivery of ATF4 to the retina, we validated a novel therapeutic approach targeting ATF4 over the course of retinal degeneration. In T17M rhodopsin retinas, we observed ATF4 overexpression concomitantly with reduction of p62 and elevation of p53 levels. These molecular alterations, together with increased CHOP and caspase-3/7 activity, possibly contributed to the mechanism of photoreceptor cell loss. Conversely, ATF4 knockdown retarded retinal degeneration in 1-month-old T17M Rhodopsin mice and promoted photoreceptor survival, as measured by scotopic and photopic ERGs and photoreceptor nuclei row counts. Similarly, ATF4 knockdown also markedly delayed retinal degeneration in 3-month-old ADRP animals. This delay was accompanied by a dramatic decrease in UPR signaling, the launching of anti-oxidant defense, initiation of autophagy, and improvement of rhodopsin biosynthesis which together perhaps combat the cellular stress associated with T17M rhodopsin. Our data indicate that augmented ATF4 signals during retinal degeneration plays a cytotoxic role by triggering photoreceptor cell death. Future ADRP therapy regulating ATF4 expression can be developed to treat retinal degenerative disorders associated with activated UPR.	[Bhootada, Yogesh; Kotla, Pravallika; Gorbatyuk, Oleg; Bebok, Zsuzsanna; Athar, Mohammad; Gorbatyuk, Marina] Univ Alabama Birmingham, Dept Optometry & Vis Sci, Birmingham, AL USA; [Bhootada, Yogesh; Kotla, Pravallika; Gorbatyuk, Oleg; Gorbatyuk, Marina] Univ Alabama Birmingham, Vis Sci Res Ctr, Birmingham, AL USA; [Zolotukhin, Sergei] Univ Florida, Dept Pediat, Gainesville, FL USA; [Gorbatyuk, Oleg] Univ Alabama Birmingham, Ctr Neurodegenerat & Expt Therapy, Birmingham, AL USA; [Bebok, Zsuzsanna] Univ Alabama Birmingham, Dept Cell Dev & Integrat Biol, Birmingham, AL USA; [Athar, Mohammad] Univ Alabama Birmingham, Dept Dermatol, Birmingham, AL USA	University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; State University System of Florida; University of Florida; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham	Gorbatyuk, M (corresponding author), Univ Alabama Birmingham, Dept Optometry & Vis Sci, Birmingham, AL USA.; Gorbatyuk, M (corresponding author), Univ Alabama Birmingham, Vis Sci Res Ctr, Birmingham, AL USA.	mgortk@uab.edu	Bhootada, Yogesh/AAD-3539-2020	Bhootada, Yogesh/0000-0002-4656-7868; Gorbatyuk, Marina/0000-0001-9060-856X	 [R01EY020905];  [P30 EY003039]; NATIONAL EYE INSTITUTE [R01EY020905, P30EY003039] Funding Source: NIH RePORTER	; ; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was funded by R01EY020905, P30 EY003039.	Abedin MJ, 2007, CELL DEATH DIFFER, V14, P500, DOI 10.1038/sj.cdd.4402039; Aguila M, 2014, HUM MOL GENET, V23, P2164, DOI 10.1093/hmg/ddt613; Amaral JD, 2010, DISCOV MED, V9, P145; B'chir W, 2013, NUCLEIC ACIDS RES, V41, P7683, DOI 10.1093/nar/gkt563; Bhootada Y, 2015, INVEST OPHTH VIS SCI, V56, P4725, DOI 10.1167/iovs.15-16924; Bouman L, 2011, CELL DEATH DIFFER, V18, P769, DOI 10.1038/cdd.2010.142; Chen Y, 2013, J BIOL CHEM, V288, P7506, DOI 10.1074/jbc.M112.439935; Choudhury S, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.34; Cullinan SB, 2003, MOL CELL BIOL, V23, P7198, DOI 10.1128/MCB.23.20.7198-7209.2003; Cullinan SB, 2004, J BIOL CHEM, V279, P20108, DOI 10.1074/jbc.M314219200; Deng Q, 2013, JPN J CLIN ONCOL, V43, P1261, DOI 10.1093/jjco/hyt160; Fawcett TW, 1999, BIOCHEM J, V339, P135, DOI 10.1042/0264-6021:3390135; Frost LS, 2014, EXP EYE RES, V124, P56, DOI 10.1016/j.exer.2014.04.010; Galluzzi L, 2012, CELL DEATH DIFFER, V19, P107, DOI 10.1038/cdd.2011.96; Gorbatyuk M, 2013, MOL VIS, V19, P1985; Gorbatyuk MS, 2010, P NATL ACAD SCI USA, V107, P5961, DOI 10.1073/pnas.0911991107; Harding HP, 2003, MOL CELL, V11, P619, DOI 10.1016/S1097-2765(03)00105-9; Hyrskyluoto A, 2012, EXP CELL RES, V318, P33, DOI 10.1016/j.yexcr.2011.08.020; Ichimura Y, 2013, MOL CELL, V51, P618, DOI 10.1016/j.molcel.2013.08.003; Ito S, 2015, SCI REP-UK, V5, DOI 10.1038/srep08327; Iwawaki T, 2004, NAT MED, V10, P98, DOI 10.1038/nm970; Janssen A, 2008, MOL THER, V16, P1010, DOI 10.1038/mt.2008.57; Jiang Q, 2013, FEBS LETT, V587, P2420, DOI 10.1016/j.febslet.2013.06.011; Komaromy AM, 2008, GENE THER, V15, P1049, DOI 10.1038/gt.2008.32; Krebs MP, 2010, J MOL BIOL, V395, P1063, DOI 10.1016/j.jmb.2009.11.015; Kroemer G, 2009, CELL DEATH DIFFER, V16, P3, DOI 10.1038/cdd.2008.150; Krokowski D, 2015, J BIOL CHEM, V290, P17822, DOI 10.1074/jbc.M114.636217; Kunte MM, 2012, INVEST OPHTH VIS SCI, V53, P3792, DOI 10.1167/iovs.11-9235; Kwak MK, 2002, MOL CELL BIOL, V22, P2883, DOI 10.1128/MCB.22.9.2883-2892.2002; Lange PS, 2008, J EXP MED, V205, P1227, DOI 10.1084/jem.20071460; Li JM, 2009, FEBS LETT, V583, P1521, DOI 10.1016/j.febslet.2009.04.007; Li TS, 1998, P NATL ACAD SCI USA, V95, P11933, DOI 10.1073/pnas.95.20.11933; Malabanan KP, 2010, J MOL MED, V88, P545, DOI 10.1007/s00109-010-0615-4; Meixner A, 2010, CELL DEATH DIFFER, V17, P1409, DOI 10.1038/cdd.2010.22; Mendes HF, 2005, TRENDS MOL MED, V11, P177, DOI 10.1016/j.molmed.2005.02.007; Midorikawa R, 2010, J NEUROSCI, V30, P10703, DOI 10.1523/JNEUROSCI.2061-10.2010; Miyamoto N, 2011, INVEST OPHTH VIS SCI, V52, P1226, DOI 10.1167/iovs.10-5775; Nashine S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063205; Pankiv S, 2007, J BIOL CHEM, V282, P24131, DOI 10.1074/jbc.M702824200; Regan PL, 2011, INT J ONCOL, V38, P105, DOI 10.3892/ijo_00000829; Rutkowski DT, 2006, PLOS BIOL, V4, P2024, DOI 10.1371/journal.pbio.0040374; Ryoo IG, 2015, ONCOTARGET, V6, P8167, DOI 10.18632/oncotarget.3047; Shinde VM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033266; Song PP, 2016, PROTEIN CELL, V7, P114, DOI 10.1007/s13238-015-0230-9; Sun XT, 2013, J NEUROSCI, V33, P2398, DOI 10.1523/JNEUROSCI.2292-12.2013; Suzuki T, 2013, MOL CELL BIOL, V33, P2402, DOI 10.1128/MCB.00065-13; Tam BM, 2014, J NEUROSCI, V34, P13336, DOI 10.1523/JNEUROSCI.1655-14.2014; Tam LCS, 2010, HUM MOL GENET, V19, P4421, DOI 10.1093/hmg/ddq369; Teske BF, 2013, MOL BIOL CELL, V24, P2477, DOI 10.1091/mbc.E13-01-0067; Timmers A, 2001, MOL VIS, V7, P131; Uddin MN, 2011, BIOCHEM BIOPH RES CO, V407, P692, DOI 10.1016/j.bbrc.2011.03.077; Wang CX, 2012, IUBMB LIFE, V64, P226, DOI 10.1002/iub.605; Wang L, 2014, BBA-MOL CELL RES, V1843, P1248, DOI 10.1016/j.bbamcr.2014.03.016; Wang XQ, 2013, INVEST OPHTH VIS SCI, V54, P5995, DOI 10.1167/iovs.13-12117; Zhong YM, 2012, DIABETES, V61, P492, DOI 10.2337/db11-0315; Zhou Z, 2015, CELL DEATH DIFFER, V22, P488, DOI 10.1038/cdd.2014.229	56	26	26	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 4	2016	11	5							e0154779	10.1371/journal.pone.0154779	http://dx.doi.org/10.1371/journal.pone.0154779			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DL5KR	27144303	gold, Green Submitted, Green Published			2022-12-26	WOS:000375676400068
J	Chen, R; Zhu, MH; Sahn, DJ; Ashraf, M				Chen, Ran; Zhu, Meihua; Sahn, David J.; Ashraf, Muhammad			Non-Invasive Evaluation of Heart Function with Four-Dimensional Echocardiography	PLOS ONE			English	Article							SPECKLE-TRACKING ECHOCARDIOGRAPHY; GLOBAL LONGITUDINAL STRAIN; LEFT-VENTRICULAR FUNCTION; TIME 3-DIMENSIONAL ECHOCARDIOGRAPHY; REGIONAL MYOCARDIAL-FUNCTION; DOPPLER-ECHOCARDIOGRAPHY; FAILURE; DEFORMATION; INFARCTION; REPERFUSION	Background The aim of this study is to assess the accuracy and feasibility of left ventricular systolic function determined by four-dimensional echocardiography (4DE). Methods Latex balloons were sewn into the left ventricle (LV) of 20 freshly harvested pig hearts which were then passively driven by a pulsatile pump apparatus. Global longitudinal strain (GLS), global circumferential strain (GCS), global area strain (GAS) and left ventricular ejection fraction (LVEF) derived from 4DE and two-dimensional echocardiography (2DE)derived LVEF were quantified at different stroke volumes (SV) 30-70 ml and correlated with sonomicrometry data. Results In all comparisons, GLS, GCS, GAS, 2DE-LVEF, and 4DE-LVEF demonstrated strong correlations with sonomicrometry data (r = 0.77, r = 0.89, r = 0.79, r = 0.93, r = 0.96, all P < 0.001). Bland-Altman analyses showed slight overestimations of echo-derived GLS, GCS, 2DE-LVEF and 3DE-LVEF over sonomicrometry values (bias = 2.88, bias = 3.99, bias = 3.37, bias = 2.78, respectively). Furthermore, there is better agreement between GCS, 4D LVEF and sonomicrometry values compared with GLS and 2D LVEF. Conclusion Four-dimensional echocardiography accurately assesses LV function. GCS derived by 4DE is a potential alternative parameter to quantify LV systolic function.	[Chen, Ran] Zhejiang Univ, Coll Med, Sir Run Run Shaw Hosp, Dept Diagnost Ultrasound & Echocardiog, Hangzhou 310003, Zhejiang, Peoples R China; [Chen, Ran; Zhu, Meihua; Sahn, David J.; Ashraf, Muhammad] Oregon Hlth & Sci Univ, Div Pediat Cardiol, Portland, OR 97201 USA	Zhejiang University; Oregon Health & Science University	Ashraf, M (corresponding author), Oregon Hlth & Sci Univ, Div Pediat Cardiol, Portland, OR 97201 USA.	ashrafm@ohsu.edu	Zhu, Meihua/AAO-2377-2020	Zhu, Meihua/0000-0003-3106-806X				Adamu U, 2009, EUR J ECHOCARDIOGR, V10, P303, DOI 10.1093/ejechocard/jen238; Bertini M, 2012, CIRC-CARDIOVASC IMAG, V5, P383, DOI 10.1161/CIRCIMAGING.111.970434; Bogaert J, 2001, AM J PHYSIOL-HEART C, V280, pH610; Brown J, 2009, AM HEART J, V157, P102, DOI 10.1016/j.ahj.2008.08.032; Chen R, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100265; Chen X, 2005, ULTRASONIC IMAGING, V27, P21, DOI 10.1177/016173460502700102; Cho GY, 2009, J AM COLL CARDIOL, V54, P618, DOI 10.1016/j.jacc.2009.04.061; Dahl JS, 2012, CIRC-CARDIOVASC IMAG, V5, P613, DOI 10.1161/CIRCIMAGING.112.973834; Gaynor JW, AM J PHYSL 2, V266, pH329; Hoit BD, 2011, CIRC-CARDIOVASC IMAG, V4, P179, DOI 10.1161/CIRCIMAGING.110.959817; Jenkins C, 2004, J AM COLL CARDIOL, V44, P878, DOI 10.1016/j.jacc.2004.05.050; Jenkins C, 2007, J AM SOC ECHOCARDIOG, V20, P862, DOI 10.1016/j.echo.2006.12.010; Kang Y, 2012, ACTA CARDIOL, V67, P423, DOI 10.1080/AC.67.4.2170683; Kearney LG, 2012, EUR HEART J-CARD IMG, V13, P827, DOI 10.1093/ehjci/jes115; Kleijn SA, 2011, J AM SOC ECHOCARDIOG, V24, P314, DOI 10.1016/j.echo.2011.01.014; Kocabay G, 2014, REV ESP CARDIOL, V67, P651, DOI 10.1016/j.rec.2013.12.009; Lainchbury JG, 2000, AM J PHYSIOL-HEART C, V279, pH1000, DOI 10.1152/ajpheart.2000.279.3.H1000; Luis SA, 2014, J AM SOC ECHOCARDIOG, V27, P285, DOI 10.1016/j.echo.2013.11.002; Mignot A, 2010, J AM SOC ECHOCARDIOG, V23, P1019, DOI 10.1016/j.echo.2010.07.019; Mor-Avi V, 2011, J AM SOC ECHOCARDIOG, V24, P277, DOI 10.1016/j.echo.2011.01.015; Nahum J, 2010, CIRC-CARDIOVASC IMAG, V3, P249, DOI 10.1161/CIRCIMAGING.109.910893; Nakatani Satoshi, 2011, J Cardiovasc Ultrasound, V19, P1, DOI 10.4250/jcu.2011.19.1.1; Pedrizzetti G, 2014, J BIOMECH, V47, P746, DOI 10.1016/j.jbiomech.2013.12.016; Pirat B, 2008, J AM COLL CARDIOL, V51, P651, DOI 10.1016/j.jacc.2007.10.029; Poveda F, 2013, REV ESP CARDIOL, V66, P782, DOI 10.1016/j.rec.2013.04.021; Quinones MA, 2000, J AM COLL CARDIOL, V35, P1237, DOI 10.1016/S0735-1097(00)00511-8; Quinones MA, 2003, J AM SOC ECHOCARDIOG, V16, P379, DOI 10.1016/S0894-7317(03)00113-5; RANKIN JS, 1976, CIRC RES, V39, P304, DOI 10.1161/01.RES.39.3.304; Sagawa K., 1988, CARDIAC CONTRACTION; Seo Y, 2011, JACC-CARDIOVASC IMAG, V4, P358, DOI 10.1016/j.jcmg.2010.12.007; Seo Y, 2009, CIRC-CARDIOVASC IMAG, V2, P451, DOI 10.1161/CIRCIMAGING.109.858480; Thune JJ, 2006, J AM SOC ECHOCARDIOG, V19, P1462, DOI 10.1016/j.echo.2006.05.028; Urheim S, 2000, CIRCULATION, V102, P1158, DOI 10.1161/01.CIR.102.10.1158; Vartdal T, 2007, J AM COLL CARDIOL, V49, P1715, DOI 10.1016/j.jacc.2006.12.047; Wen HL, 2011, EUR J ECHOCARDIOGR, V12, P910, DOI 10.1093/ejechocard/jer162; Woo JS, 2011, AM J CARDIOL, V108, P340, DOI 10.1016/j.amjcard.2011.03.052; Zhu MH, 2015, ECHOCARDIOGR-J CARD, V32, P339, DOI 10.1111/echo.12632; Zhu MH, 2014, ECHOCARDIOGR-J CARD, V31, P1138, DOI 10.1111/echo.12520	38	7	7	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 4	2016	11	5							e0154996	10.1371/journal.pone.0154996	http://dx.doi.org/10.1371/journal.pone.0154996			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DL5KR	27144844	Green Submitted, Green Published, gold			2022-12-26	WOS:000375676400096
J	Simpson, TS; Wernberg, T; McDonald, JI				Simpson, Tiffany Schenk; Wernberg, Thomas; McDonald, Justin I.			Distribution and Localised Effects of the Invasive Ascidian Didemnum perlucidum (Monniot 1983) in an Urban Estuary	PLOS ONE			English	Article							COASTAL MARINE COMMUNITIES; WESTERN-AUSTRALIA; HALOPHILA-OVALIS; ECOLOGICAL PERFORMANCE; BIOLOGICAL INVASIONS; SEAGRASS ECOSYSTEMS; NORTH-AMERICA; SURVIVAL; VEXILLUM; HABITAT	Didemnid ascidians are notorious marine invaders, fouling infrastructure in many ecosystems globally. However, there have been few reports of direct interactions with native species in their natural environment. The invasive colonial ascidian Didemnum perlucidum was discovered in the Swan River estuary (Western Australia) growing on the native seagrass Halophila ovalis. Given the known effects of other related Didemnum species it was expected that D. perlucidum could adversely affect the seagrass, with possible flow on effects to the rest of the ecosystem. This study aimed to document the distribution and abundance of D. perlucidum in the estuary, and to determine whether this species had a negative impact on H. ovalis or associated flora and fauna. D. perlucidum was largely present near areas of infrastructure, particularly mooring buoys, suggesting these were the source of D. perlucidum recruits on the seagrasses. It showed a clear seasonal pattern in abundance, with highly variable cover and colony size. D. perlucidum had a measurable effect on H. ovalis, with colonies enveloping all plant tissue, likely restricting the photosynthetic ability of individual leaves and total plant biomass. There were also significantly less seagrass-associated mud snails (Batillaria australis) where D. perlucidum cover was high. These results demonstrate the ability of invasive ascidians to colonise and affect native seagrasses and associated biota. Seagrasses are pivotal to the ecological function of many urban estuaries world-wide. Biodiversity in these systems is already vulnerable to multiple stressors from human activities but the potential stress of fouling ascidians may pose an additional and increasing threat in the future.	[Simpson, Tiffany Schenk; Wernberg, Thomas] Univ Western Australia, Sch Plant Biol, Perth, WA 6009, Australia; [Simpson, Tiffany Schenk; Wernberg, Thomas] Univ Western Australia, UWA Oceans Inst, Perth, WA 6009, Australia; [Simpson, Tiffany Schenk; McDonald, Justin I.] Western Australia Fisheries & Marine Res Labs, Biodivers & Biosecur, Perth, WA, Australia	University of Western Australia; University of Western Australia	Simpson, TS (corresponding author), Univ Western Australia, Sch Plant Biol, Perth, WA 6009, Australia.; Simpson, TS (corresponding author), Univ Western Australia, UWA Oceans Inst, Perth, WA 6009, Australia.; Simpson, TS (corresponding author), Western Australia Fisheries & Marine Res Labs, Biodivers & Biosecur, Perth, WA, Australia.	tiffanysimpson2010@gmail.com	Wernberg, Thomas/B-4172-2010; Simpson, Tiffany/F-2454-2013	Wernberg, Thomas/0000-0003-1185-9745; Simpson, Tiffany/0000-0002-0071-464X	Australian Research Council [FT110100174]; WA Department of Fisheries	Australian Research Council(Australian Research Council); WA Department of Fisheries	This work was supported by the Australian Research Council, grant number FT110100174 to TW, the WA Department of Fisheries to JIM and TSS has been supported as a PhD student at the University of Western Australia with additional financial support from the WA Department of Fisheries. The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Anderson M.J., 2008, PERMANOVA PRIMER GUI; Baardseth EA., 1970, NORW I SEAWEED RES R, V33, P1; Barbier EB, 2011, ECOL MONOGR, V81, P169, DOI 10.1890/10-1510.1; Bite JS, 2007, MAR BIOL, V152, P405, DOI 10.1007/s00227-007-0700-6; Botting GC, 2009, SOUNDING OUT; Bridgwood SD, 2014, BIOINVASIONS REC, V3, P217, DOI 10.3391/bir.2014.3.4.02; Bullard SG, 2007, J EXP MAR BIOL ECOL, V342, P99, DOI 10.1016/j.jembe.2006.10.020; CARLTON JT, 1989, CONSERV BIOL, V3, P265, DOI 10.1111/j.1523-1739.1989.tb00086.x; Carlton JT, 1982, MALACOL REV, V15, P143; Carman MR, 2010, AQUAT INVASIONS, V5, P23, DOI 10.3391/ai.2010.5.1.4; Clarke K.R., 2014, CHANGE MARINE COMMUN, V3; Farnham W.F., 1980, SYSTEMATICS ASS SPEC, V17B, P875; Fofonoff PW, 2003, NATL EXOTIC MARINE E; HILLMAN K, 1995, AQUAT BOT, V51, P1, DOI 10.1016/0304-3770(95)00466-D; Hoffle H, 2012, MAR ECOL PROG SER, V450, P67, DOI 10.3354/meps09552; Kendrick GA, 2002, AQUAT BOT, V73, P75, DOI 10.1016/S0304-3770(02)00005-0; Kennish MJ, 2002, ENVIRON CONSERV, V29, P78, DOI 10.1017/S0376892902000061; Kilminster K, 2013, WATER SCI TECHNICAL; Kremer LP, 2011, AQUAT INVASIONS, V6, P441, DOI 10.3391/ai.2011.6.4.09; Kremer LP, 2010, BIOL INVASIONS, V12, P1581, DOI 10.1007/s10530-009-9571-8; Kurup GR, 1998, ESTUAR COAST SHELF S, V47, P191, DOI 10.1006/ecss.1998.0346; Lambert G, 2007, J EXP MAR BIOL ECOL, V342, P3, DOI 10.1016/j.jembe.2006.10.009; Lambert Gretchen, 2002, Pacific Science, V56, P291, DOI 10.1353/psc.2002.0026; Longstaff BJ, 1999, AQUAT BOT, V65, P105, DOI 10.1016/S0304-3770(99)00035-2; Lotze HK, 2006, SCIENCE, V312, P1806, DOI 10.1126/science.1128035; Morris JA, 2012, BIOL INVASIONS, V14, P2133, DOI 10.1007/s10530-012-0219-8; Munoz J, 2014, 252 DEP FISH; Munoz J, 2015, AQUAT INVASIONS, V10, P265, DOI 10.3391/ai.2015.10.3.02; Orth RJ, 2006, BIOSCIENCE, V56, P987, DOI 10.1641/0006-3568(2006)56[987:AGCFSE]2.0.CO;2; Pisut DP, 2002, J EXP MAR BIOL ECOL, V270, P203, DOI 10.1016/S0022-0981(02)00023-0; Pritchard D.W., 1967, ESTUARIES, VVolume 83, P3; RACE MS, 1982, OECOLOGIA, V54, P337, DOI 10.1007/BF00380002; Ruiz GM, 2000, ANNU REV ECOL SYST, V31, P481, DOI 10.1146/annurev.ecolsys.31.1.481; Sand-Jensen J, 1977, AQUAT BOT, V3, P55; Simberloff D, 2014, ECOL ENG, V65, P112, DOI 10.1016/j.ecoleng.2013.08.004; Simberloff D, 2013, TRENDS ECOL EVOL, V28, P58, DOI 10.1016/j.tree.2012.07.013; Smale DA, 2012, BIOL INVASIONS, V14, P1325, DOI 10.1007/s10530-011-0167-8; Smale DA, 2012, MAR ECOL PROG SER, V453, P129, DOI 10.3354/meps09680; Smale DA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016050; Stephens R, 1996, MAR FRESHWATER RES, V47, P517, DOI 10.1071/MF9960517; SUCHANEK TH, 1994, AM ZOOL, V34, P100; Thiel M, 2005, OCEANOGR MAR BIOL, V43, P279; Thomsen MS, 2010, ESTUAR COAST SHELF S, V87, P501, DOI 10.1016/j.ecss.2010.02.014; Thomsen MS, 2012, HARMFUL ALGAE, V16, P74, DOI 10.1016/j.hal.2012.01.005; Thomsen MS, 2012, PLOS ONE, V7, P21, DOI 10.1371/journal.pone.0028595; Thyrring J, 2013, HELGOLAND MAR RES, V67, P789, DOI 10.1007/s10152-013-0363-2; Valentine PC, 2007, J EXP MAR BIOL ECOL, V342, P109, DOI 10.1016/j.jembe.2006.10.021; Wernberg T, 2005, AQUAT BOT, V83, P61, DOI 10.1016/j.aquabot.2005.05.007; Western Australian Prevention List for Introduced Marine Pests, 2014, W AUSTR PREV LIST IN; WHEELER WN, 1980, MAR BIOL, V56, P97, DOI 10.1007/BF00397127; Williams SL, 2007, J EXP MAR BIOL ECOL, V350, P89, DOI 10.1016/j.jembe.2007.05.032; Wong MC, 2012, AQUAT INVASIONS, V7, P315, DOI 10.3391/ai.2012.7.3.003	52	10	10	1	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 4	2016	11	5							e0154201	10.1371/journal.pone.0154201	http://dx.doi.org/10.1371/journal.pone.0154201			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DL5KR	27144600	gold, Green Published			2022-12-26	WOS:000375676400039
J	Filgueiras, CC; Willett, DS; Moino, A; Pareja, M; El Borai, F; Dickson, DW; Stelinski, LL; Duncan, LW				Filgueiras, Camila Cramer; Willett, Denis S.; Moino Junior, Alcides; Pareja, Martin; El Borai, Fahiem; Dickson, Donald W.; Stelinski, Lukasz L.; Duncan, Larry W.			Stimulation of the Salicylic Acid Pathway Aboveground Recruits Entomopathogenic Nematodes Belowground	PLOS ONE			English	Article							DIAPREPES-ABBREVIATUS COLEOPTERA; MULTITROPHIC INTERACTIONS; INSECT HERBIVORES; PLANTS; CURCULIONIDAE; JASMONATE; WEEVIL; ROOTS; RESISTANCE; EVOLUTION	Plant defense pathways play a critical role in mediating tritrophic interactions between plants, herbivores, and natural enemies. While the impact of plant defense pathway stimulation on natural enemies has been extensively explored aboveground, belowground ramifications of plant defense pathway stimulation are equally important in regulating subterranean pests and still require more attention. Here we investigate the effect of aboveground stimulation of the salicylic acid pathway through foliar application of the elicitor methyl salicylate on belowground recruitment of the entomopathogenic nematode, Steinernema diaprepesi. Also, we implicate a specific root-derived volatile that attracts S. diaprepesi belowground following aboveground plant stimulation by an elicitor. In four-choice olfactometer assays, citrus plants treated with foliar applications of methyl salicylate recruited S. diaprepesi in the absence of weevil feeding as compared with negative controls. Additionally, analysis of root volatile profiles of citrus plants receiving foliar application of methyl salicylate revealed production of d-limonene, which was absent in negative controls. The entomopathogenic nematode S. diaprepesi was recruited to d-limonene in two-choice olfactometer trials. These results reinforce the critical role of plant defense pathways in mediating tritrophic interactions, suggest a broad role for plant defense pathway signaling belowground, and hint at sophisticated plant responses to pest complexes.	[Filgueiras, Camila Cramer; Moino Junior, Alcides] Univ Fed Lavras, Dept Entomol, Lavras, MG, Brazil; [Willett, Denis S.; El Borai, Fahiem; Stelinski, Lukasz L.; Duncan, Larry W.] Univ Florida, Ctr Citrus Res & Educ, Dept Entomol & Nematol, Lake Alfred, FL USA; [El Borai, Fahiem] Zagazig Univ, Dept Plant Protect, Fac Agr, Sharkia, Egypt; [Pareja, Martin] Univ Estadual Campinas, UNICAMP, Inst Biol, Dept Biol Anim, Campinas, SP, Brazil; [Dickson, Donald W.] Univ Florida, Dept Entomol & Nematol, Gainesville, FL 32611 USA	Universidade Federal de Lavras; State University System of Florida; University of Florida; Egyptian Knowledge Bank (EKB); Zagazig University; Universidade de Sao Paulo; Universidade Estadual de Campinas; State University System of Florida; University of Florida	Filgueiras, CC (corresponding author), Univ Fed Lavras, Dept Entomol, Lavras, MG, Brazil.	camilacramer@gmail.com	Moino Junior, Alcides/GPX-7909-2022; Pareja, Martin/A-9982-2012	Moino Junior, Alcides/0000-0002-8566-0694	Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES) program; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq); FAEPEX-PAPDIC grant from UNICAMP; CNPq [474449/2012-2]	Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES) program(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); FAEPEX-PAPDIC grant from UNICAMP; CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	The Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES) program and the Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) provided financial support for the project through studentships and grants to CCF. MP was supported by a FAEPEX-PAPDIC grant from UNICAMP, and CNPq project 474449/2012-2.	Ali JG, 2013, J CHEM ECOL, V39, P1140, DOI 10.1007/s10886-013-0332-x; Ali JG, 2011, J ECOL, V99, P26, DOI 10.1111/j.1365-2745.2010.01758.x; Ali JG, 2010, J CHEM ECOL, V36, P361, DOI 10.1007/s10886-010-9773-7; Bari R, 2009, PLANT MOL BIOL, V69, P473, DOI 10.1007/s11103-008-9435-0; Bezemer TM, 2005, TRENDS ECOL EVOL, V20, P617, DOI 10.1016/j.tree.2005.08.006; Bezemer TM, 2003, OIKOS, V101, P555, DOI 10.1034/j.1600-0706.2003.12424.x; Bi HH, 2007, J CHEM ECOL, V33, P1089, DOI 10.1007/s10886-007-9286-1; De Moraes CM, 1998, NATURE, V393, P570, DOI 10.1038/31219; Graham JH, 2003, PLANT DIS, V87, P85, DOI 10.1094/PDIS.2003.87.1.85; Heil M, 2010, TRENDS ECOL EVOL, V25, P137, DOI 10.1016/j.tree.2009.09.010; Howe GA, 2008, ANNU REV PLANT BIOL, V59, P41, DOI 10.1146/annurev.arplant.59.032607.092825; Jenkins W., 1964, PLANT DIS REPORTER, V48; Kaplan I, 2008, ECOLOGY, V89, P392, DOI 10.1890/07-0471.1; Kaya H. K., 1997, MANUAL TECHNIQUES IN, V1, P281; Lapointe SL, 1999, FLA ENTOMOL, V82, P291, DOI 10.2307/3496582; Lapointe SL, 2008, J INSECT PHYSIOL, V54, P1157, DOI 10.1016/j.jinsphys.2008.04.020; Nguyen KB, 2002, J NEMATOL, V34, P159; R Core Team, 2013, R LANG ENV STAT COMP; RASKIN I, 1992, ANNU REV PLANT PHYS, V43, P439, DOI 10.1146/annurev.pp.43.060192.002255; Rasmann S, 2005, NATURE, V434, P732, DOI 10.1038/nature03451; Rodriguez-Saona C, 2005, OECOLOGIA, V143, P566, DOI 10.1007/s00442-005-0006-7; Rogers S, 1996, SCIENCE, V5, P472; RStudio Team, 2015, RSTUDIO INT DEV ENV; Simpson SE, 1996, ENVIRON ENTOMOL, V25, P333, DOI 10.1093/ee/25.2.333; Thaler JS, 2012, TRENDS PLANT SCI, V17, P260, DOI 10.1016/j.tplants.2012.02.010; Thaler JS, 2010, ECOLOGY, V91, P1075, DOI 10.1890/08-2347.1; Thaler JS, 2002, J CHEM ECOL, V28, P1131, DOI 10.1023/A:1016225515936; TURLINGS TCJ, 1990, SCIENCE, V250, P1251, DOI 10.1126/science.250.4985.1251; van Dam NM, 2011, J ECOL, V99, P77, DOI 10.1111/j.1365-2745.2010.01761.x; van Dam NM, 2009, ANNU REV ECOL EVOL S, V40, P373, DOI 10.1146/annurev.ecolsys.110308.120314; Van der Putten WH, 2001, TRENDS ECOL EVOL, V16, P547, DOI 10.1016/S0169-5347(01)02265-0; van Poecke RMP, 2002, J EXP BOT, V53, P1793, DOI 10.1093/jxb/erf022; van Tol RWHM, 2001, ECOL LETT, V4, P292, DOI 10.1046/j.1461-0248.2001.00227.x; VIGLIERCHIO DR, 1983, J NEMATOL, V15, P438; Viswanathan DV, 2007, OIKOS, V116, P1389, DOI [10.1111/j.2007.0030-1299.15882.x, 10.1111/j.0030-1299.2007.15882.x]; WHITE G. F., 1927, SCIENCE, V66, P302, DOI 10.1126/science.66.1709.302-a; Wickham H., 2015, SCALES SCALE FUNCTIO; Wickham H, 2015, TIDYR EASILY TIDY DA; Wickham H., 2015, R PACKAGE VERSION, V0.4, P156; Wickham H, 2009, USE R, P1, DOI 10.1007/978-0-387-98141-3_1	40	18	20	2	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 3	2016	11	5							e0154712	10.1371/journal.pone.0154712	http://dx.doi.org/10.1371/journal.pone.0154712			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DL5KK	27136916	Green Published, gold, Green Submitted			2022-12-26	WOS:000375675700060
J	Kotb, AM; Simon, O; Blumenthal, A; Vogelgesang, S; Dombrowski, F; Amann, K; Zimmermann, U; Endlich, K; Endlich, N				Kotb, Ahmed M.; Simon, Ole; Blumenthal, Antje; Vogelgesang, Silke; Dombrowski, Frank; Amann, Kerstin; Zimmermann, Uwe; Endlich, Karlhans; Endlich, Nicole			Knockdown of ApoL1 in Zebrafish Larvae Affects the Glomerular Filtration Barrier and the Expression of Nephrin	PLOS ONE			English	Article							KIDNEY-DISEASE; TRYPANOLYTIC FACTOR; AFRICAN-AMERICANS; HUMAN SERUM; PRONEPHROS; VARIANTS; GENE; LOCALIZATION; PODOCIN; PROTEIN	APOL1, a secreted high-density lipoprotein, is expressed in different human tissues. Genetic variants of APOL1 are described to be associated with the development of end stage renal diseases in African Americans. In human kidney, APOL1 is mainly expressed in podocytes that are responsible for proper blood filtration. Since mice do not express ApoL1, the zebrafish is an ideal model to study the role of ApoL1. Injection of morpholinos against zApoL1 into zebrafish eggs and larvae, respectively, induces severe edema indicating a leakage of the filtration barrier. This was demonstrated in zApoL1 knockdown larvae by intravascular injection of fluorescently-labeled 10- and 500-kDa dextrans and by clearance of the vitamin D-binding protein from the circulation. Immunohistochemistry and RT-PCR revealed the reduction of nephrin, a podocyte-specific protein essential for blood filtration. Coinjection of human nephrin mRNA rescued the zApoL1 knockdown induced phenotype. Reduced APOL1 and nephrin levels were also found in biopsies of patients suffering from end stage renal diseases. Our results demonstrate that zApoL1 is essential for proper blood filtration in the zebrafish glomerulus and that zApoL1 affects the expression of nephrin.	[Kotb, Ahmed M.; Simon, Ole; Blumenthal, Antje; Endlich, Karlhans; Endlich, Nicole] Univ Med Greifswald, Inst Anat & Cell Biol, Greifswald, Germany; [Vogelgesang, Silke; Dombrowski, Frank] Univ Med Greifswald, Inst Pathol, Greifswald, Germany; [Amann, Kerstin] Univ Hosp Erlangen, Inst Pathol, Dept Nephropathol, Erlangen, Germany; [Kotb, Ahmed M.] Assiut Univ, Fac Vet Med, Dept Anat & Histol, Assiut, Egypt; [Zimmermann, Uwe] Univ Med Greifswald, Dept Urol, Greifswald, Germany	Greifswald Medical School; Greifswald Medical School; University of Erlangen Nuremberg; Egyptian Knowledge Bank (EKB); Assiut University; Greifswald Medical School	Endlich, N (corresponding author), Univ Med Greifswald, Inst Anat & Cell Biol, Greifswald, Germany.	nicole.endlich@uni-greifswald.de		Endlich, Karlhans/0000-0001-6052-6061; M Kotb, Ahmed/0000-0002-0426-4922	European Union [FP7-REGPOT-2010-1, 264143]; German Federal Ministry of Education and Research (BMBF, GANI_MED) [03IS2061A]; Forschungsverbund Molekulare Medizin	European Union(European Commission); German Federal Ministry of Education and Research (BMBF, GANI_MED)(Federal Ministry of Education & Research (BMBF)); Forschungsverbund Molekulare Medizin	This study was supported by grants of the European Union (FP7-REGPOT-2010-1, EnVision, grant No. 264143) and of the German Federal Ministry of Education and Research (BMBF, GANI_MED, grant No. 03IS2061A) and the Forschungsverbund Molekulare Medizin to N.E. and K.E.	Anderson BR, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005349; Behar DM, 2010, HUM MOL GENET, V19, P1816, DOI 10.1093/hmg/ddq040; Bollig F, 2009, DEVELOPMENT, V136, P2883, DOI 10.1242/dev.031773; Drummond IA, 1998, DEVELOPMENT, V125, P4655; Drummond IA, 2000, PEDIATR NEPHROL, V14, P428, DOI 10.1007/s004670050788; Endlich N, 2013, J AM SOC NEPHROL; Freedman BI, 2010, J AM SOC NEPHROL, V21, P1422, DOI 10.1681/ASN.2010070730; Fukuyo Y, 2014, MOL MED REP, V9, P457, DOI 10.3892/mmr.2013.1844; Genovese G, 2010, SCIENCE, V329, P841, DOI 10.1126/science.1193032; Johnstone DB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051546; Kotb AM, 2014, AM J PHYSIOL-RENAL, V307, pF1427, DOI 10.1152/ajprenal.00029.2014; Kramer-Zucker AG, 2005, DEV BIOL, V285, P316, DOI 10.1016/j.ydbio.2005.06.038; Lan XQ, 2014, AM J PHYSIOL-RENAL, V307, pF326, DOI 10.1152/ajprenal.00647.2013; Larsen CP, 2013, J AM SOC NEPHROL, V24, P722, DOI 10.1681/ASN.2012121180; Ma LJ, 2015, J AM SOC NEPHROL, V26, P339, DOI 10.1681/ASN.2013091017; Madhavan SM, 2011, J AM SOC NEPHROL, V22, P2119, DOI 10.1681/ASN.2011010069; Muller T, 2011, KIDNEY INT, V80, P1055, DOI 10.1038/ki.2011.256; Pays E, 2006, NAT REV MICROBIOL, V4, P477, DOI 10.1038/nrmicro1428; Price AL, 2007, AM J HUM GENET, V80, P1024, DOI 10.1086/518313; Putaala H, 2001, HUM MOL GENET, V10, P1, DOI 10.1093/hmg/10.1.1; Sato T, 1968, J Electron Microsc (Tokyo), V17, P158; Smith EE, 2009, GENOME RES, V19, P850, DOI 10.1101/gr.085647.108; Thomson R, 2014, P NATL ACAD SCI USA, V111, pE2130, DOI 10.1073/pnas.1400699111; Vanhamme L, 2003, NATURE, V422, P83, DOI 10.1038/nature01461; Vanhollebeke B, 2006, CELL MOL LIFE SCI, V63, P1937, DOI 10.1007/s00018-006-6091-x; Zhaorigetu S, 2011, J BIOL CHEM, V286, P27389, DOI 10.1074/jbc.M110.210245	26	34	34	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 3	2016	11	5							e0153768	10.1371/journal.pone.0153768	http://dx.doi.org/10.1371/journal.pone.0153768			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DL5KK	27138898	Green Published, gold, Green Submitted			2022-12-26	WOS:000375675700012
J	Bin Shahid, AMS; Ahmed, T; Shahunja, KM; Kabir, S; Chowdhury, F; Faruque, AG; Das, SK; Sarker, MHR; Bardhan, PK; Chisti, MJ				Bin Shahid, Abu Sadat Mohammad Sayeem; Ahmed, Tahmeed; Shahunja, K. M.; Kabir, Senjuti; Chowdhury, Fahmida; Faruque, Abu Syeed Golam; Das, Sumon Kumar; Sarker, Mohammad Habibur Rahman; Bardhan, Pradip Kumar; Chisti, Mohammod Jobayer			Factors Associated with Streptococcal Bacteremia in Diarrheal Children under Five Years of Age and Their Outcome in an Urban Hospital in Bangladesh	PLOS ONE			English	Article							SEVERELY MALNOURISHED CHILDREN; INFLAMMATORY RESPONSE SYNDROME; RISK-FACTORS; PNEUMOCOCCAL DISEASE; CLINICAL PREDICTORS; SEVERE MALNUTRITION; UNDER-5 CHILDREN; SEPTIC SHOCK; PNEUMONIAE; INFECTIONS	Background Although Streptococcal bacteremia is common in diarrheal children with high morbidity and mortality, no systematic data are available on Streptococcal bacteremia in diarrheal children. We sought to evaluate the factors associated with Streptococcal bacteremia in diarrheal children under five years of age and their outcome. Methods We used an unmatched case-control design to investigate the associated factors with Streptococcal bacteremia in all the diarrheal children under five years of age through electronic medical record system of Dhaka hospital of International Centre for Diarrhoeal Disease Research, Bangladesh. We had simultaneously used a retrospective cohort design to further evaluate the outcome of our study children. All the enrolled children had their blood culture done between January 2010 and December 2012. Comparison was made among the children with (cases = 26) and without Streptococcal bacteremia (controls = 78). Controls were selected randomly from hospitalized diarrheal children under five years of age. Results Cases had proportionately higher deaths compared to controls, but it was statistically insignificant (15% vs. 10%, p = 0.49). The cases more often presented with severe dehydration, fever, respiratory distress, severe sepsis, and abnormal mental status compared to the controls (for all p<0.05). In the logistic regression analysis, after adjusting for potential confounders, it has been found that Streptococcal bacteremia in diarrheal children under five years of age was independently associated with nutritional edema (OR: 5.86, 95% CI = 1.28-26.80), hypoxemia (OR: 19.39, 95% CI = 2.14-175.91), fever (OR: 4.44, 95% CI = 1.13-17.42), delayed capillary refill time (OR: 7.00, 95% CI = 1.36-35.93), and respiratory distress (OR: 2.69, 95% CI = 1.02-7.12). Conclusions and Significance The results of our analyses suggest that diarrheal children under five years of age presenting with nutritional edema, hypoxemia, fever, delayed capillary refill time, and respiratory distress may be at risk of Streptococcal bacteremia. It underscores the importance of identification of these simple clinical parameters for the prompt recognition and management in order to reduce the morbidity and death of such children especially in resource limited settings.	[Bin Shahid, Abu Sadat Mohammad Sayeem; Kabir, Senjuti; Chowdhury, Fahmida] Bangladesh Icddr B, Int Ctr Diarrhoeal Dis Res, Div Infect Dis, Dhaka, Bangladesh; [Ahmed, Tahmeed; Shahunja, K. M.; Faruque, Abu Syeed Golam; Das, Sumon Kumar; Sarker, Mohammad Habibur Rahman; Bardhan, Pradip Kumar; Chisti, Mohammod Jobayer] Bangladesh Icddr B, Int Ctr Diarrhoeal Dis Res, Nutr & Clin Serv Div, Dhaka, Bangladesh	International Centre for Diarrhoeal Disease Research (ICDDR); International Centre for Diarrhoeal Disease Research (ICDDR)	Chisti, MJ (corresponding author), Bangladesh Icddr B, Int Ctr Diarrhoeal Dis Res, Nutr & Clin Serv Div, Dhaka, Bangladesh.	chisti@icddrb.org	Sarker, Mohammad Habibur Rahman/HHZ-8980-2022; Chisti, Mohammod J/A-7216-2018; Das, Sumon Kumar/T-6384-2019; Shahunja, K M/AAR-6229-2020; Das, Sumon Kumar/AAD-1551-2019	Sarker, Mohammad Habibur Rahman/0000-0001-9614-0806; Shahunja, K M/0000-0002-9345-206X; Kabir, Senjuti/0000-0002-5625-3918	International Centre for Diarrhoeal Disease Research, Bangladesh (icddr,b) [Gr- 00233]; Australian Agency for International Development (AusAID); Government of the People's Republic of Bangladesh; Canadian International Development Agency (CIDA); Swedish International Development Cooperation Agency (Sida); Department for International Development, UK (DFID)	International Centre for Diarrhoeal Disease Research, Bangladesh (icddr,b); Australian Agency for International Development (AusAID)(Australian Aid (AusAID)); Government of the People's Republic of Bangladesh; Canadian International Development Agency (CIDA); Swedish International Development Cooperation Agency (Sida); Department for International Development, UK (DFID)	This research study was funded by the International Centre for Diarrhoeal Disease Research, Bangladesh (icddr,b; grant no Gr- 00233) and its donors, which provide unrestricted support to ICDDR, B for its operations and research. Current donors providing unrestricted support include: Australian Agency for International Development (AusAID), Government of the People's Republic of Bangladesh; Canadian International Development Agency (CIDA), Swedish International Development Cooperation Agency (Sida), and the Department for International Development, UK (DFID). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed T, 1999, LANCET, V353, P1919, DOI 10.1016/S0140-6736(98)07499-6; Akram Farhana, 2014, ISRN Microbiol, V2014, P469758, DOI 10.1155/2014/469758; Annane D, 2005, LANCET, V365, P63, DOI 10.1016/S0140-6736(04)17667-8; [Anonymous], 2007, Wkly Epidemiol Rec, V82, P93; Babay HA, 2005, SAUDI MED J, V26, P1555; Bahwere P, 2001, Int J Infect Dis, V5, P180, DOI 10.1016/S1201-9712(01)90067-0; Bhutta ZA, 1996, ACTA PAEDIATR, V85, P809, DOI 10.1111/j.1651-2227.1996.tb14156.x; Bibi S, 2012, J HEALTH POPUL NUTR, V30, P487; Chidiac C, 2012, MED MALADIES INFECT, V42, P501, DOI 10.1016/j.medmal.2012.04.003; Chisti MJ, 2015, EPIDEMIOL INFECT, V143, P799, DOI 10.1017/S0950268814001368; Chisti MJ, 2014, J HEALTH POPUL NUTR, V32, P270; Chisti MJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039164; Chisti MJ, 2012, TROP MED INT HEALTH, V17, P106, DOI 10.1111/j.1365-3156.2011.02890.x; Chisti MJ, 2010, TROP MED INT HEALTH, V15, P1322, DOI 10.1111/j.1365-3156.2010.02619.x; Chisti MJ, 2009, J HEALTH POPUL NUTR, V27, P808; Chisti MJ, 2010, PEDIATR CRIT CARE ME, V11, P92, DOI 10.1097/PCC.0b013e3181b063e1; Chisti MJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093776; Ciapponi A, 2014, PEDIATR INFECT DIS J, V33, P971, DOI 10.1097/INF.0000000000000363; Ebrahim GJ, 2011, J TROP PEDIATRICS, V57, P77, DOI 10.1093/tropej/fmr022; Feemster KA, 2013, EPIDEMIOL INFECT, V141, P1679, DOI 10.1017/S095026881200235X; Hicks LA, 2007, J INFECT DIS, V196, P1346, DOI 10.1086/521626; Hsueh PR, 1999, J CLIN MICROBIOL, V37, P897, DOI 10.1128/JCM.37.4.897-901.1999; Levine OS, 2006, LANCET, V367, P1880, DOI 10.1016/S0140-6736(06)68703-5; Ludwig E, 2014, ORVOSI HETILAP, V155, P1996, DOI 10.1556/OH.2014.30070; Lynch JP, 2009, SEMIN RESP CRIT CARE, V30, P189, DOI 10.1055/s-0029-1202938; Maitland K, 2006, PLOS MED, V3, P2431, DOI 10.1371/journal.pmed.0030500; Maldini B, 2007, COLLEGIUM ANTROPOL, V31, P1083; Morgan G, 1997, LANCET, V349, P1693, DOI 10.1016/S0140-6736(96)12038-9; Mulholland K, 1999, VACCINE, V17, pS79, DOI 10.1016/S0264-410X(99)00112-7; O'Brien KL, 2009, LANCET, V374, P893, DOI 10.1016/S0140-6736(09)61204-6; Rhodes J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066038; Saha SK, 1999, J CLIN MICROBIOL, V37, P798, DOI 10.1128/JCM.37.3.798-800.1999; SAHA SK, 1991, LANCET, V337, P734, DOI 10.1016/0140-6736(91)90320-O; Saha SK, 2003, J CLIN MICROBIOL, V41, P5582, DOI 10.1128/JCM.41.12.5582-5587.2003; Scott JAG, 2007, VACCINE, V25, P2398, DOI 10.1016/j.vaccine.2006.09.008; STRUELENS MJ, 1991, AM J EPIDEMIOL, V133, P451, DOI 10.1093/oxfordjournals.aje.a115912; SUSKIND D, 1990, NESTLE NUTR WORKS SE, V19, P1; Thomas K, 1999, LANCET, V353, P1216, DOI 10.1016/S0140-6736(98)07228-6; West JB., 2008, WESTS RESP PHYSL ESS, V9th; WHO Publication, 2012, VACCINE, V30, P4717, DOI 10.1016/j.vaccine.2012.04.093; World Health Organization, 2013, POCK BOOK HOSP CAR C	41	0	0	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 2	2016	11	5							e0154777	10.1371/journal.pone.0154777	http://dx.doi.org/10.1371/journal.pone.0154777			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DL5KB	27135829	Green Published, gold, Green Submitted			2022-12-26	WOS:000375674800048
J	Broekhuis, F; Gopalaswamy, AM				Broekhuis, Femke; Gopalaswamy, Arjun M.			Counting Cats: Spatially Explicit Population Estimates of Cheetah (Acinonyx jubatus) Using Unstructured Sampling Data	PLOS ONE			English	Article							CAPTURE-RECAPTURE MODELS; MARA REGION; DENSITY; ABUNDANCE; KENYA; INFERENCE; DYNAMICS; PATTERNS; RANGE	Many ecological theories and species conservation programmes rely on accurate estimates of population density. Accurate density estimation, especially for species facing rapid declines, requires the application of rigorous field and analytical methods. However, obtaining accurate density estimates of carnivores can be challenging as carnivores naturally exist at relatively low densities and are often elusive and wide-ranging. In this study, we employ an unstructured spatial sampling field design along with a Bayesian sex-specific spatially explicit capture-recapture (SECR) analysis, to provide the first rigorous population density estimates of cheetahs (Acinonyx jubatus) in the Maasai Mara, Kenya. We estimate adult cheetah density to be between 1.28 +/- 0.315 and 1.34 +/- 0.337 individuals/100km(2) across four candidate models specified in our analysis. Our spatially explicit approach revealed 'hotspots' of cheetah density, highlighting that cheetah are distributed heterogeneously across the landscape. The SECR models incorporated a movement range parameter which indicated that male cheetah moved four times as much as females, possibly because female movement was restricted by their reproductive status and/or the spatial distribution of prey. We show that SECR can be used for spatially unstructured data to successfully characterise the spatial distribution of a low density species and also estimate population density when sample size is small. Our sampling and modelling framework will help determine spatial and temporal variation in cheetah densities, providing a foundation for their conservation and management. Based on our results we encourage other researchers to adopt a similar approach in estimating densities of individually recognisable species.	[Broekhuis, Femke] Kenya Wildlife Trust, Mara Cheetah Project, Nairobi, Kenya; [Broekhuis, Femke] Univ Oxford, Recanati Kaplan Ctr, Wildlife Conservat Res Unit, Dept Zool, Tubney, England; [Gopalaswamy, Arjun M.] Univ Oxford, Dept Zool, S Parks Rd, Oxford, England; [Gopalaswamy, Arjun M.] Indian Stat Inst Bangalore Ctr, Stat & Math Unit, Bengaluru, India	University of Oxford; University of Oxford; Indian Statistical Institute; Indian Statistical Institute Bangalore	Broekhuis, F (corresponding author), Kenya Wildlife Trust, Mara Cheetah Project, Nairobi, Kenya.; Broekhuis, F (corresponding author), Univ Oxford, Recanati Kaplan Ctr, Wildlife Conservat Res Unit, Dept Zool, Tubney, England.	Femke.broekhuis@gmail.com		Broekhuis, Femke/0000-0002-4216-8819	Kenya Wildlife Trust	Kenya Wildlife Trust	This study was funded through various private donors and foundations who donated through the Kenya Wildlife Trust. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander JS, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0134815; Belbachir F, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0115136; Bhola N, 2012, J ANIM ECOL, V81, P1268, DOI 10.1111/j.1365-2656.2012.02000.x; Boast Lorraine K., 2015, Cat News, V62, P34; Borchers DL, 2008, BIOMETRICS, V64, P377, DOI 10.1111/j.1541-0420.2007.00927.x; Brassine E, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0142508; Broekhuis F, 2013, J ANIM ECOL, V82, P1097, DOI 10.1111/1365-2656.12077; Broomhall LS, 2003, J ZOOL, V261, P119, DOI 10.1017/S0952836903004059; Buckland S.T., 2001, pi; Carbone C, 2002, SCIENCE, V295, P2273, DOI 10.1126/science.1067994; Caro T. M., 1994, CHEETAHS SERENGETI G; CARO TM, 1991, J HERED, V82, P8, DOI 10.1093/jhered/82.1.8; CARO TM, 1987, J ZOOL, V211, P89, DOI 10.1111/j.1469-7998.1987.tb07455.x; Cooper AB, 2007, ANIM BEHAV, V73, P651, DOI 10.1016/j.anbehav.2006.06.013; Durant S., 2015, IUCN RED LIST THREAT; Durant SM, 2011, J APPL ECOL, V48, P1490, DOI 10.1111/j.1365-2664.2011.02042.x; DURANT SM, 1988, AFR J ECOL, V26, P257, DOI 10.1111/j.1365-2028.1988.tb00978.x; Durant SM, 2004, BEHAV ECOL, V15, P11, DOI 10.1093/beheco/arg098; Durant SM, 1998, J ANIM ECOL, V67, P370, DOI 10.1046/j.1365-2656.1998.00202.x; Foster RJ, 2012, J WILDLIFE MANAGE, V76, P224, DOI 10.1002/jwmg.275; Gelman A., 1992, STAT SCI, V7, P457, DOI [10.1214/ss/1177011136, DOI 10.1214/SS/1177011136]; Gopalaswamy AM, 2015, METHODS ECOL EVOL, V6, P1055, DOI 10.1111/2041-210X.12351; Gopalaswamy AM, 2012, METHODS ECOL EVOL, V3, P1067, DOI 10.1111/j.2041-210X.2012.00241.x; Gopalaswamy AM, 2012, ECOLOGY, V93, P1741, DOI 10.1890/11-2110.1; Gros PM, 1998, BIOL CONSERV, V85, P137, DOI 10.1016/S0006-3207(97)00135-3; Grunewalder S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049120; Hayward MW, 2015, J APPL ECOL, V52, P286, DOI 10.1111/1365-2664.12408; Houser AM, 2009, J ZOOL, V278, P108, DOI 10.1111/j.1469-7998.2009.00554.x; Hunter JS, 2007, AFR J ECOL, V45, P275, DOI 10.1111/j.1365-2028.2006.00702.x; Jacobson A, 2015, ENVIRON MODELL SOFTW, V72, P1, DOI 10.1016/j.envsoft.2015.06.011; Karanth KU, 1998, ECOLOGY, V79, P2852; Kelly MJ, 1998, J ZOOL, V244, P473, DOI 10.1017/S0952836998004014; Kenya Wildlife Service, 2009, CONSERVATION MANAGEM; Lamprey RH, 2004, J BIOGEOGR, V31, P997, DOI 10.1111/j.1365-2699.2004.01062.x; Laurenson M. K., 1995, SERENGETI; LAURENSON MK, 1995, ANIM BEHAV, V50, P815, DOI 10.1016/0003-3472(95)80141-3; LAURENSON MK, 1995, CONSERV BIOL, V9, P1329, DOI 10.1046/j.1523-1739.1995.9051327.x-i1; Liebenberg L., 2003, NEW ENV MONITORING M; Link WA, 2013, ECOLOGY, V94, P2173, DOI 10.1890/13-0176.1; MACDONALD DW, 1983, NATURE, V301, P379, DOI 10.1038/301379a0; Marker Laurie L., 2008, Cat News, V49, P22; Marnewick K, 2008, S AFR J WILDL RES, V38, P59, DOI 10.3957/0379-4369-38.1.59; Nowell K., 1996, WILD CATS STATUS SUR; O'Connell A, 2011, CAMERA TRAPS IN ANIMAL ECOLOGY: METHODS AND ANALYSES, pV; Ogutu JO, 2008, J ANIM ECOL, V77, P814, DOI 10.1111/j.1365-2656.2008.01392.x; Ogutu JO, 2011, J ZOOL, V285, P99, DOI 10.1111/j.1469-7998.2011.00818.x; Ogutu JO, 2009, J ZOOL, V278, P1, DOI 10.1111/j.1469-7998.2008.00536.x; OTIS DL, 1978, WILDLIFE MONOGR, P1; R Development Core Team, 2012, R LANG ENV STAT COMP; Ripple WJ, 2014, SCIENCE, V343, P151, DOI 10.1126/science.1241484; Ritchie EG, 2009, ECOL LETT, V12, P982, DOI 10.1111/j.1461-0248.2009.01347.x; Royle JA, 2016, POPUL ECOL, V58, P53, DOI 10.1007/s10144-015-0524-z; Royle JA, 2011, METHODS ECOL EVOL, V2, P602, DOI 10.1111/j.2041-210X.2011.00116.x; Royle JA, 2009, ECOLOGY, V90, P3233, DOI 10.1890/08-1481.1; Royle JA, 2014, SPATIAL CAPTURE-RECAPTURE, P1; Russell RE, 2012, J WILDLIFE MANAGE, V76, P1551, DOI 10.1002/jwmg.412; Sandell M., 1989, P164; Sollmann R, 2011, BIOL CONSERV, V144, P1017, DOI 10.1016/j.biocon.2010.12.011; Stander PE, 1998, J APPL ECOL, V35, P378, DOI 10.1046/j.1365-2664.1998.00313.x; STELFOX JG, 1986, J WILDLIFE MANAGE, V50, P339, DOI 10.2307/3801925; Swanson A, 2014, J ANIM ECOL, V83, P1418, DOI 10.1111/1365-2656.12231; Thirgood S, 2004, ANIM CONSERV, V7, P113, DOI 10.1017/S1367943004001404; Thompson CM, 2012, J WILDLIFE MANAGE, V76, P863, DOI 10.1002/jwmg.317; Thompson W., 2013, SAMPLING RARE ELUSIV; TIERNEY L, 1994, ANN STAT, V22, P1701, DOI 10.1214/aos/1176325750; Weingarth K, 2015, BIODIVERS CONSERV, V24, P2935, DOI 10.1007/s10531-015-0986-5; Woodroffe R, 1998, SCIENCE, V280, P2126, DOI 10.1126/science.280.5372.2126	67	38	38	0	60	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 2	2016	11	5							e0153875	10.1371/journal.pone.0153875	http://dx.doi.org/10.1371/journal.pone.0153875			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DL5KB	27135614	Green Published, gold			2022-12-26	WOS:000375674800006
J	Lin, JD; Yang, SF; Wang, YH; Fang, WF; Lin, YC; Lin, YF; Tang, KT; Wu, MY; Cheng, CW				Lin, Jiunn-Diann; Yang, Shun-Fa; Wang, Yuan-Hung; Fang, Wen-Fang; Lin, Ying-Chin; Lin, Yuh-Feng; Tang, Kam-Tsun; Wu, Mei-Yi; Cheng, Chao-Wen			Analysis of Associations of Human BAFF Gene Polymorphisms with Autoimmune Thyroid Diseases	PLOS ONE			English	Article							CELL ACTIVATING FACTOR; B-LYMPHOCYTE STIMULATOR; SYSTEMIC-LUPUS-ERYTHEMATOSUS; PRIMARY SJOGRENS-SYNDROME; NECROSIS-FACTOR-FAMILY; GRAVES-DISEASE; RHEUMATOID-ARTHRITIS; MYASTHENIA-GRAVIS; RECEPTOR; BLYS	Background The B-lymphocyte-activating factor (BAFF) is associated with B-cell functions, and gene polymorphisms of the BAFF have been linked to autoimmune diseases (AIDs). In this study, we explored possible associations of two BAFF single-nucleotide polymorphisms (SNPs), rs1041569 and rs2893321, with autoimmune thyroid diseases (AITDs) in an ethnic Chinese population. Material and Methods In total, 319 Graves' disease (GD), 83 Hashimoto's thyroiditis (HT) patients, and 369 healthy controls were enrolled. Polymerase chain reaction-restriction fragment length polymorphism and direct sequencing were used to genotype rs2893321 and rs1041569. Results There was a significant difference in frequencies of the G allele and AG+GG genotype of rs2893321 between the GD and control groups (p = 0.013, odds ratio (OR) = 0.76, and p = 0.017, OR = 0.68, respectively) and between the AITD and control groups (p = 0.009, OR = 0.76, and, p = 0.014, OR = 0.69, respectively). The AA genotype of rs2893321 was associated with low titers of the thyroid-stimulating hormone receptor antibody (TSHRAb) (p = 0.015) in males but not in females. The AA genotype of rs2893321 was associated with the presence of two different types of thyroid autoantibody (TAb) (TSHRAb and Hashimoto's autoantibody (anti-thyroglobulin or anti-microsomal antibody)) in females and with that of one type inmales. Conclusions rs2893321 may be a susceptible genetic variant for the development of GD and AITDs. Associations of rs2893321 with susceptibility to GD and AITDs and the correlation between rs2893321 and TAb exhibit a dimorphic pattern. Additional studies with larger sample sizes are required to confirm our findings.	[Lin, Jiunn-Diann; Wang, Yuan-Hung; Lin, Yuh-Feng; Cheng, Chao-Wen] Taipei Med Univ, Coll Med, Grad Inst Clin Med, Taipei, Taiwan; [Lin, Jiunn-Diann] Taipei Med Univ, Shuang Ho Hosp, Dept Internal Med, Div Endocrinol, New Taipei, Taiwan; [Lin, Jiunn-Diann] Taipei Med Univ, Div Endocrinol & Metab, Dept Internal Med, Sch Med,Coll Med, Taipei, Taiwan; [Yang, Shun-Fa] Chung Shan Med Univ, Inst Med, Taichung 40201, Taiwan; [Yang, Shun-Fa] Chung Shan Med Univ Hosp, Dept Med Res, Taichung 40201, Taiwan; [Wang, Yuan-Hung] Taipei Med Univ, Shuang Ho Hosp, Dept Med Res, New Taipei, Taiwan; [Fang, Wen-Fang; Lin, Ying-Chin] Taipei Med Univ, Dept Family Med, Shuang Ho Hosp, New Taipei, Taiwan; [Lin, Yuh-Feng; Wu, Mei-Yi] Taipei Med Univ, Div Nephrol, Dept Internal Med, Shuang Ho Hosp, New Taipei, Taiwan; [Tang, Kam-Tsun] Vet Gen Hosp, Dept Internal Med, Div Endocrinol & Metab, Taipei, Taiwan	Taipei Medical University; Taipei Medical University; Shuang Ho Hospital; Taipei Medical University; Chung Shan Medical University; Chung Shan Medical University; Chung Shan Medical University Hospital; Taipei Medical University; Shuang Ho Hospital; Taipei Medical University; Shuang Ho Hospital; Taipei Medical University; Shuang Ho Hospital	Cheng, CW (corresponding author), Taipei Med Univ, Coll Med, Grad Inst Clin Med, Taipei, Taiwan.; Wu, MY (corresponding author), Taipei Med Univ, Div Nephrol, Dept Internal Med, Shuang Ho Hosp, New Taipei, Taiwan.	e220121@gmail.com; ccheng@tmu.edu.tw	Yang, Shun-Fa/AAN-1519-2020	Yang, Shun-Fa/0000-0002-0365-7927; Wu, Mei-Yi/0000-0002-5777-2752	Ministry of Science and Technology of Taiwan (MOST) [104-2314-B-038 -048]; Taipei Medical University; Shuang-Ho Hospital [102TMU-SHH-01-3]	Ministry of Science and Technology of Taiwan (MOST); Taipei Medical University; Shuang-Ho Hospital	This work was supported by a grant from the Ministry of Science and Technology of Taiwan (MOST 104-2314-B-038 -048), and was partly supported by a grant from Taipei Medical University and Shuang-Ho Hospital (102TMU-SHH-01-3).	Avidan N, 2014, J AUTOIMMUN, V52, P146, DOI 10.1016/j.jaut.2013.12.001; Ben-Selma W, 2015, INT J IMMUNOGENET, V42, P174, DOI 10.1111/iji.12197; Cheema GS, 2001, ARTHRITIS RHEUM-US, V44, P1313, DOI 10.1002/1529-0131(200106)44:6<1313::AID-ART223>3.0.CO;2-S; Clark WB, 2011, BLOOD, V118, P1140, DOI 10.1182/blood-2010-09-310011; Emmerich F, 2007, BRIT J HAEMATOL, V136, P309, DOI 10.1111/j.1365-2141.2006.06431.x; Fabris M, 2010, AUTOIMMUN REV, V9, P165, DOI 10.1016/j.autrev.2009.07.005; Gavin AL, 2003, J BIOL CHEM, V278, P38220, DOI 10.1074/jbc.M306852200; Gilbert JA, 2006, ENDOCRINOLOGY, V147, P4561, DOI 10.1210/en.2006-0507; Gregersen PK, 2012, ANN NEUROL, V72, P927, DOI 10.1002/ana.23691; Groom J, 2002, J CLIN INVEST, V109, P59, DOI 10.1172/JCI200214121; Hasham A, 2012, IMMUNOL RES, V54, P204, DOI 10.1007/s12026-012-8302-x; Hiratani H, 2005, J CLIN ENDOCR METAB, V90, P2898, DOI 10.1210/jc.2004-2148; Kahles H, 2005, EUR J ENDOCRINOL, V153, P895, DOI 10.1530/eje.1.02035; Kannel K, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0143393; Kawasaki A, 2002, GENES IMMUN, V3, P424, DOI 10.1038/sj.gene.6363923; Liao WL, 2010, BMC MED GENET, V11, DOI 10.1186/1471-2350-11-154; Lin JD, 2015, EUR J CLIN INVEST, V45, P711, DOI 10.1111/eci.12463; Liu LY, 2012, HUM GENET, V131, P353, DOI 10.1007/s00439-011-1081-y; Lopez P, 2014, RHEUMATOLOGY, V53, P2249, DOI 10.1093/rheumatology/keu249; Mackay F, 1999, J EXP MED, V190, P1697, DOI 10.1084/jem.190.11.1697; Mariette X, 2003, ANN RHEUM DIS, V62, P168, DOI 10.1136/ard.62.2.168; Mavragani CP, 2007, ARTHRITIS RHEUM, V56, P3995, DOI 10.1002/art.23062; Migita K, 2010, CLIN IMMUNOL, V134, P217, DOI 10.1016/j.clim.2009.09.007; Moore PA, 1999, SCIENCE, V285, P260, DOI 10.1126/science.285.5425.260; Nezos A, 2014, J AUTOIMMUN, V51, P89, DOI 10.1016/j.jaut.2013.04.005; Nossent JC, 2008, RHEUMATOLOGY, V47, P1311, DOI 10.1093/rheumatology/ken246; Panchanathan R, 2013, MOL IMMUNOL, V53, P15, DOI 10.1016/j.molimm.2012.06.013; Pongratz G, 2010, CLIN EXP RHEUMATOL, V28, P813; de Almeida ERA, 2013, INT J IMMUNOGENET, V40, P178, DOI 10.1111/j.1744-313X.2012.01152.x; Roescher N, 2014, MOL THER, V22, P821, DOI 10.1038/mt.2013.275; Russo MW, 2003, GASTROENTEROLOGY, V124, P1711, DOI 10.1016/S0016-5085(03)00394-9; Ruyssen-Witrand A, 2013, RHEUMATOLOGY, V52, P636, DOI 10.1093/rheumatology/kes344; Sanders J, 1999, J CLIN ENDOCR METAB, V84, P3797, DOI 10.1210/jc.84.10.3797; Thien M, 2004, IMMUNITY, V20, P785, DOI 10.1016/j.immuni.2004.05.010; Thompson JS, 2000, J EXP MED, V192, P129, DOI 10.1084/jem.192.1.129; Tomer Y, 2010, J AUTOIMMUN, V34, pJ322, DOI 10.1016/j.jaut.2009.11.008; Tomer Y, 2009, J AUTOIMMUN, V32, P231, DOI 10.1016/j.jaut.2009.02.007; Vannucchi G, 2012, J CLIN ENDOCR METAB, V97, pE755, DOI 10.1210/jc.2011-2614; Yanaba K, 2008, IMMUNOL REV, V223, P284, DOI 10.1111/j.1600-065X.2008.00646.x; Zandman-Goddard G, 2007, AUTOIMMUN REV, V6, P366, DOI 10.1016/j.autrev.2006.10.001; Zhang J, 2001, J IMMUNOL, V166, P6, DOI 10.4049/jimmunol.166.1.6	41	17	18	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 2	2016	11	5							e0154436	10.1371/journal.pone.0154436	http://dx.doi.org/10.1371/journal.pone.0154436			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DL5KB	27136204	gold, Green Published, Green Submitted			2022-12-26	WOS:000375674800021
J	Palkola, NV; Blomgren, K; Pakkanen, SH; Puohiniemi, R; Kantele, JM; Kantele, A				Palkola, Nina V.; Blomgren, Karin; Pakkanen, Sari H.; Puohiniemi, Ritvaleena; Kantele, Jussi M.; Kantele, Anu			Immune Defense in Upper Airways: A Single-Cell Study of Pathogen-Specific Plasmablasts and Their Migratory Potentials in Acute Sinusitis and Tonsillitis	PLOS ONE			English	Article							ANTIBODY-SECRETING CELLS; URINARY-TRACT-INFECTION; DIFFERENTIAL HOMING COMMITMENTS; CUTANEOUS LYMPHOCYTE ANTIGEN; SALMONELLA-TYPHI; T-CELLS; B-CELLS; FORMING-CELLS; ORAL VACCINE; MUCOSAL	Background Despite the high frequency of upper respiratory tract (URT) infections and use of the nasal mucosa as route for vaccination, the local immune mechanism and dissemination of effector lymphocytes from the URT have been insufficiently characterized. To devise a single-cell approach for studying the mucosal immune response in the URT, we explored URT-originating B effector lymphocytes in the circulation of patients with one of two common respiratory infections, acute sinusitis or tonsillitis. Methods Patients with acute sinusitis (n = 13) or tonsillitis (n = 11) were investigated by ELISPOT for circulating pathogen-specific antibody-secreting cells (ASCs) of IgA, IgG and IgM isotypes approximately one week after the onset of symptoms. These cells' potential to home into tissues was explored by assessing their expression of tissue-specific homing receptors alpha(4)beta(7), L-selectin, and cutaneous lymphocyte antigen (CLA). Results Pathogen-specific ASCs were detected in the circulation of all patients, with a geometric mean of 115 (95% CI 46-282) /10(6) PBMC in sinusitis, and 48 (27-88) in tonsillitis. These responses were mainly dominated by IgG. In sinusitis alpha(4)beta(7) integrin was expressed by 24% of the ASCs, L-selectin by 82%, and CLA by 21%. The proportions for tonsillitis were 15%, 80%, and 23%, respectively. Healthy individuals had no ASCs. Conclusions URT infections-acute sinusitis and tonsillitis-both elicited a response of circulating pathogen-specific plasmablasts. The magnitude of the response was greater in sinusitis than tonsillitis, but the homing receptor profiles were similar. Human nasopharynx-associated lymphoid structures were found to disseminate immune effector cells with a distinct homing profile.	[Palkola, Nina V.; Pakkanen, Sari H.] Univ Helsinki, Dept Bacteriol & Immunol, Helsinki, Finland; [Palkola, Nina V.; Kantele, Anu] Univ Helsinki, Dept Med, Helsinki, Finland; [Blomgren, Karin] Univ Helsinki, Dept Med, Div Otorhinolaryngol, Helsinki, Finland; [Blomgren, Karin; Puohiniemi, Ritvaleena; Kantele, Anu] Helsinki Univ Hosp, Helsinki, Finland; [Puohiniemi, Ritvaleena] Univ Helsinki, Helsinki Univ Hosp Lab HUSLAB, Helsinki, Finland; [Kantele, Jussi M.] Univ Turku, Occupat Hlth & Environm Med, Dept Publ Hlth, Turku, Finland; [Kantele, Anu] Univ Helsinki, Inflammat Ctr, Clin Infect Dis, Helsinki, Finland; [Kantele, Anu] Karolinska Inst, Dept Med Solna, Infect Dis Unit, Stockholm, Sweden	University of Helsinki; University of Helsinki; University of Helsinki; University of Helsinki; Helsinki University Central Hospital; University of Helsinki; Helsinki University Central Hospital; University of Turku; University of Helsinki; Karolinska Institutet	Kantele, A (corresponding author), Univ Helsinki, Dept Med, Helsinki, Finland.; Kantele, A (corresponding author), Helsinki Univ Hosp, Helsinki, Finland.; Kantele, A (corresponding author), Univ Helsinki, Inflammat Ctr, Clin Infect Dis, Helsinki, Finland.; Kantele, A (corresponding author), Karolinska Inst, Dept Med Solna, Infect Dis Unit, Stockholm, Sweden.	anu.kantele@hus.fi	Kantele, Anu/AAS-4131-2021	Kantele, Anu/0000-0002-0004-1000; Blomgren, Karin/0000-0001-8381-9174; Pakkanen, Sari/0000-0003-4522-5337	Finnish Emil Aaltonen Foundation; Finnish Research Foundation of the Pulmonary Diseases	Finnish Emil Aaltonen Foundation; Finnish Research Foundation of the Pulmonary Diseases	This work was supported by the Finnish Emil Aaltonen Foundation (NVP) and the Finnish Research Foundation of the Pulmonary Diseases (NVP). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BERG EL, 1991, J EXP MED, V174, P1461, DOI 10.1084/jem.174.6.1461; BERLIN C, 1993, CELL, V74, P185, DOI 10.1016/0092-8674(93)90305-A; Brandtzaeg P, 2005, IMMUNOL REV, V206, P32, DOI 10.1111/j.0105-2896.2005.00283.x; Brandzaeg P, 2015, MUCOSAL IMMUNOLOGY, P1999; CAMERINI D, 1989, NATURE, V342, P78, DOI 10.1038/342078a0; Campbell JJ, 2001, J IMMUNOL, V166, P2842, DOI 10.4049/jimmunol.166.4.2842; Cooke G, 2013, AUST FAM PHYSICIAN, V42, P65; Csencsits KL, 1999, J IMMUNOL, V163, P1382; Debertin AS, 2003, CLIN EXP IMMUNOL, V134, P503, DOI 10.1111/j.1365-2249.2003.02311.x; Kantele A, 1997, J IMMUNOL, V158, P574; Kantele A, 2003, J INFECT DIS, V188, P1885, DOI 10.1086/380097; Kantele A, 2003, EUR J IMMUNOL, V33, P3275, DOI 10.1002/eji.200324311; KANTELE A, 1986, J INFECT DIS, V153, P1126, DOI 10.1093/infdis/153.6.1126; Kantele A, 1998, INFECT IMMUN, V66, P5630, DOI 10.1128/IAI.66.12.5630-5635.1998; Kantele A, 1996, J BIOTECHNOL, V44, P217, DOI 10.1016/0168-1656(95)00134-4; KANTELE A, 1994, J INFECT DIS, V169, P1023, DOI 10.1093/infdis/169.5.1023; Kantele A, 1999, J IMMUNOL, V162, P5173; KANTELE A, 1991, SCAND J IMMUNOL, V33, P225, DOI 10.1111/j.1365-3083.1991.tb03753.x; KANTELE A, 1990, VACCINE, V8, P321, DOI 10.1016/0264-410X(90)90088-4; KANTELE AM, 1988, J INFECT DIS, V158, P1011, DOI 10.1093/infdis/158.5.1011; Kantele A, 2008, CLIN VACCINE IMMUNOL, V15, P412, DOI 10.1128/CVI.00373-07; Kantele A, 2012, CLIN DEV IMMUNOL, DOI 10.1155/2012/279206; Kantele AM, 2008, CLIN IMMUNOL, V128, P427, DOI 10.1016/j.clim.2008.05.003; Kantele JM, 1996, GASTROENTEROLOGY, V110, P1061, DOI 10.1053/gast.1996.v110.pm8612994; Kutteh WH, 2001, J REPROD IMMUNOL, V52, P61, DOI 10.1016/S0165-0378(01)00109-7; MAKELA MJ, 1995, J MED VIROL, V47, P416, DOI 10.1002/jmv.1890470420; MOLDOVEANU Z, 1995, VACCINE, V13, P1006, DOI 10.1016/0264-410X(95)00016-T; Pakkanen SH, 2010, CLIN VACCINE IMMUNOL, V17, P393, DOI 10.1128/CVI.00475-09; Palkola NV, 2015, J INFECT DIS, V212, P1279, DOI 10.1093/infdis/jiv208; Palkola NV, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034334; PICKER LJ, 1994, EUR J IMMUNOL, V24, P1269, DOI 10.1002/eji.1830240605; QUIDINGJARBRINK M, 1995, EUR J IMMUNOL, V25, P322, DOI 10.1002/eji.1830250203; QuidingJarbrink M, 1997, J CLIN INVEST, V99, P1281, DOI 10.1172/JCI119286; QUIDINGJARBRINK M, 1995, INFECT IMMUN, V63, P853; Rautakorpi UM, 2006, CLIN INFECT DIS, V42, P1221, DOI 10.1086/503036; Robert-Guroff M, 2000, NAT MED, V6, P129, DOI 10.1038/72206; Siegel S, 1988, NONPARAMETRIC STAT, P124; Sigmundsdottir H, 2008, NAT IMMUNOL, V9, P981, DOI 10.1038/ni.f.208; Sundstrom P, 2008, EUR J IMMUNOL, V38, P3327, DOI 10.1002/eji.200838506; Tacket CO, 2003, CLIN IMMUNOL, V108, P241, DOI 10.1016/S1521-6616(03)00120-7; Twigg Homer L 3rd, 2005, Proc Am Thorac Soc, V2, P417, DOI 10.1513/pats.200508-089JS; Xu BH, 2003, J EXP MED, V197, P1255, DOI 10.1084/jem.20010685	42	6	7	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 29	2016	11	4							e0154594	10.1371/journal.pone.0154594	http://dx.doi.org/10.1371/journal.pone.0154594			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DK8XM	27128095	Green Submitted, Green Published, gold			2022-12-26	WOS:000375212600045
J	Tian, YF; Gawlak, G; O'Donnell, JJ; Mambetsariev, I; Birukova, AA				Tian, Yufeng; Gawlak, Grzegorz; O'Donnell, James J., III; Mambetsariev, Isa; Birukova, Anna A.			Modulation of Endothelial Inflammation by Low and High Magnitude Cyclic Stretch	PLOS ONE			English	Article							INDUCED LUNG INJURY; NUCLEOTIDE EXCHANGE FACTOR; ALVEOLAR EPITHELIAL-CELLS; MECHANICAL VENTILATION; BARRIER DYSFUNCTION; MICROARRAY ANALYSIS; KINASE INHIBITOR; GENE-EXPRESSION; STRESS; GEF-H1	Excessive mechanical ventilation exerts pathologic mechanical strain on lung vascular endothelium and promotes endothelial cell (EC) inflammatory activation; however, the specific mechanisms underlying EC inflammatory response caused by mechanical ventilation related cyclic stretch (CS) remain unclear. This study investigated the effects of chronic exposure to CS at physiologic (5%) and pathologic (18%) magnitude on pulmonary EC inflammatory status in control conditions and bacterial lipopolysacharide (LPS)-stimulated conditions. EC exposure to high or low CS magnitudes for 28-72 hrs had distinct effects on EC inflammatory activation. 18% CS increased surface expression of endothelial adhesion molecule ICAM1 and release of its soluble form (sICAM1) and inflammatory cytokine IL-8 by CS-stimulated pulmonary endothelial cells (EC). EC inflammatory activation was not observed in EC exposed to 5% CS. Chronic exposure to 18% CS, but not to 5% CS, augmented ICAM1 and IL-8 production and EC monolayer barrier disruption induced by LPS. 18% CS, but not 5% CS, stimulated expression of RhoA GTPase-specific guanine nucleotide exchange factor GEF-H1. GEF-H1 knockdown using gene-specific siRNA abolished 18% CS-induced ICAM1 expression and sICAM1 and IL-8 release by EC. GEF-H1 knockdown also prevented disruption of EC monolayer integrity and attenuated sICAM1 and IL-8 release in the two-hit model of EC barrier dysfunction caused by combined stimulation with 18% CS and LPS. These data demonstrate that exacerbation of inflammatory response by pulmonary endothelium exposed to excessive mechanical stretch is mediated by CS-induced induction of Rho activating protein GEF-H1.	[Tian, Yufeng; Gawlak, Grzegorz; O'Donnell, James J., III; Mambetsariev, Isa; Birukova, Anna A.] Univ Chicago, Dept Med, Lung Injury Ctr, Sect Pulm & Crit Med, Chicago, IL 60637 USA	University of Chicago	Birukova, AA (corresponding author), Univ Chicago, Dept Med, Lung Injury Ctr, Sect Pulm & Crit Med, Chicago, IL 60637 USA.	abirukov@medicine.bsd.uchicago.edu			National Heart, Lung, and Blood Institutes [HL107920, HL007605]; National Institute of General Medical Sciences [GM114171]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL107920, T32HL007605, R56HL107920] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM114171] Funding Source: NIH RePORTER	National Heart, Lung, and Blood Institutes(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the grant from National Heart, Lung, and Blood Institutes HL107920 and HL007605, and the grant from National Institute of General Medical Sciences GM114171. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Birukov KG, 2004, CIRC RES, V95, P892, DOI 10.1161/01.RES.0000147310.18962.06; Birukov KG, 2003, AM J PHYSIOL-LUNG C, V285, pL785, DOI 10.1152/ajplung.00336.2002; Birukova AA, 2006, AM J PATHOL, V168, P1749, DOI 10.2353/ajpath.2006.050431; Birukova AA, 2006, AM J PHYSIOL-LUNG C, V290, pL540, DOI 10.1152/ajplung.00259.2005; Birukova AA, 2004, FASEB J, V18, P1879, DOI 10.1096/fj.04-2328com; Birukova AA, 2004, J CELL PHYSIOL, V201, P55, DOI 10.1002/jcp.20055; Birukova AA, 2008, AM J PHYSIOL-LUNG C, V295, pL612, DOI 10.1152/ajplung.90236.2008; Birukova AA, 2007, J CELL PHYSIOL, V211, P608, DOI 10.1002/jcp.20966; Birukova AA, 2012, AM J PHYSIOL-LUNG C, V302, pL965, DOI 10.1152/ajplung.00292.2011; Birukova AA, 2010, AM J PHYSIOL-LUNG C, V298, pL837, DOI 10.1152/ajplung.00263.2009; Brower RG, 2000, NEW ENGL J MED, V342, P1301, DOI 10.1056/nejm200005043421801; Chen BPC, 2001, PHYSIOL GENOMICS, V7, P55, DOI 10.1152/physiolgenomics.2001.7.1.55; Dos Santos CC, 2000, J APPL PHYSIOL, V89, P1645, DOI 10.1152/jappl.2000.89.4.1645; Frye SR, 2005, PHYSIOL GENOMICS, V21, P124, DOI 10.1152/physiolgenomics.00029.2003; Guo F, 2012, MOL IMMUNOL, V50, P98, DOI 10.1016/j.molimm.2011.12.009; Katsumi A, 2002, J CELL BIOL, V158, P153, DOI 10.1083/jcb.200201105; Kratzer E, 2012, AM J RESP CELL MOL, V47, P688, DOI 10.1165/rcmb.2012-0161OC; Krendel M, 2002, NAT CELL BIOL, V4, P294, DOI 10.1038/ncb773; Lu YC, 2008, CYTOKINE, V42, P145, DOI 10.1016/j.cyto.2008.01.006; Mambetsariev I, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092670; Matthay MA, 2002, AM J PHYSIOL-LUNG C, V283, pL678, DOI 10.1152/ajplung.00154.2002; McCormick SM, 2001, P NATL ACAD SCI USA, V98, P8955, DOI 10.1073/pnas.171259298; McVerry BJ, 2004, AM J RESP CRIT CARE, V170, P987, DOI 10.1164/rccm.200405-684oc; NARIMANBEKOV IO, 1995, EXP LUNG RES, V21, P239, DOI 10.3109/01902149509068830; Pugin J, 1998, AM J PHYSIOL-LUNG C, V275, pL1040, DOI 10.1152/ajplung.1998.275.6.L1040; Pugin J, 2003, CRIT CARE MED, V31, pS200, DOI 10.1097/01.CCM.0000057844.31307.ED; Ren Y, 1998, J BIOL CHEM, V273, P34954, DOI 10.1074/jbc.273.52.34954; Ricard JD, 2003, EUR RESPIR J, V22, p2S, DOI 10.1183/09031936.03.00420103; Shikata Y, 2005, EXP CELL RES, V304, P40, DOI 10.1016/j.yexcr.2004.11.001; Slotta JE, 2006, INFLAMM RES, V55, P364, DOI 10.1007/s00011-006-6013-2; Slutsky AS, 1998, AM J RESP CRIT CARE, V157, P1721, DOI 10.1164/ajrccm.157.6.9709092; Tasaka S, 2005, AM J RESP CELL MOL, V32, P504, DOI 10.1165/rcmb.2004-0009OC; Tschumperlin DJ, 2000, AM J RESP CRIT CARE, V162, P357, DOI 10.1164/ajrccm.162.2.9807003; Tschumperlin DJ, 1999, J APPL PHYSIOL, V86, P2026, DOI 10.1152/jappl.1999.86.6.2026; Uhlig S, 2002, AM J PHYSIOL-LUNG C, V282, pL892, DOI 10.1152/ajplung.00124.2001; Vlahakis NE, 2000, J APPL PHYSIOL, V89, P2490, DOI 10.1152/jappl.2000.89.6.2490; Vlahakis NE, 1999, AM J PHYSIOL-LUNG C, V277, pL167, DOI 10.1152/ajplung.1999.277.1.L167	37	12	12	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 29	2016	11	4							e0153387	10.1371/journal.pone.0153387	http://dx.doi.org/10.1371/journal.pone.0153387			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DK8XM	27128976	Green Submitted, gold, Green Published			2022-12-26	WOS:000375212600004
J	Yasui, Y; Abe, T; Kurosaki, M; Higuchi, M; Komiyama, Y; Yoshida, T; Hayashi, T; Kuwabara, K; Takaura, K; Nakakuki, N; Takada, H; Tamaki, N; Suzuki, S; Nakanishi, H; Tsuchiya, K; Itakura, J; Takahashi, Y; Hashiguchi, A; Sakamoto, M; Izumi, N				Yasui, Yutaka; Abe, Tokiya; Kurosaki, Masayuki; Higuchi, Mayu; Komiyama, Yasuyuki; Yoshida, Tsubasa; Hayashi, Tsuguru; Kuwabara, Konomi; Takaura, Kenta; Nakakuki, Natsuko; Takada, Hitomi; Tamaki, Nobuharu; Suzuki, Shoko; Nakanishi, Hiroyuki; Tsuchiya, Kaoru; Itakura, Jun; Takahashi, Yuka; Hashiguchi, Akinori; Sakamoto, Michiie; Izumi, Namiki			Elastin Fiber Accumulation in Liver Correlates with the Development of Hepatocellular Carcinoma	PLOS ONE			English	Article							GROWTH-FACTOR-BETA; IMAGE-ANALYSIS; FIBROSIS; QUANTIFICATION; BIOPSY; CIRRHOSIS; COLLAGEN	Background & Aims The fibrosis stage, which is evaluated by the distribution pattern of collagen fibers, is a major predictor for the development of hepatocellular carcinoma (HCC) for patients with hepatitis C. Meanwhile, the role of elastin fibers has not yet been elucidated. The present study was conducted to determine the significance of quantifying both collagen and elastin fibers. Methods We enrolled 189 consecutive patients with hepatitis C and advanced fibrosis. Using Elastica van Gieson-stained whole-slide images of pretreatment liver biopsies, collagen and elastin fibers were evaluated pixel by pixel (0.46 mu m/pixel) using an automated computational method. Consequently, fiber amount and cumulative incidences of HCC within 3 years were analyzed. Results There was a significant correlation between collagen and elastin fibers, whereas variation in elastin fiber was greater than in collagen fiber. Both collagen fiber (p = 0.008) and elastin fiber (p < 0.001) were significantly correlated with F stage. In total, 30 patients developed HCC during follow-up. Patients who have higher elastin fiber (p = 0.002) in addition to higher collagen fiber (p = 0.05) showed significantly higher incidences of HCC. With regard to elastin fiber, this difference remained significant in F3 patients. Furthermore, for patients with a higher collagen fiber amount, higher elastin was a significant predictor for HCC development (p = 0.02). Conclusions Computational analysis is a novel technique for quantification of fibers with the added value of conventional staging. Elastin fiber is a predictor for the development of HCC independently of collagen fiber and F stage.	[Yasui, Yutaka; Kurosaki, Masayuki; Higuchi, Mayu; Komiyama, Yasuyuki; Yoshida, Tsubasa; Hayashi, Tsuguru; Kuwabara, Konomi; Takaura, Kenta; Nakakuki, Natsuko; Takada, Hitomi; Tamaki, Nobuharu; Suzuki, Shoko; Nakanishi, Hiroyuki; Tsuchiya, Kaoru; Itakura, Jun; Takahashi, Yuka; Izumi, Namiki] Musashino Red Cross Hosp, Dept Gastroenterol & Hepatol, Tokyo, Japan; [Abe, Tokiya; Hashiguchi, Akinori; Sakamoto, Michiie] Keio Univ, Sch Med, Dept Pathol, Tokyo 160, Japan	Keio University	Izumi, N (corresponding author), Musashino Red Cross Hosp, Dept Gastroenterol & Hepatol, Tokyo, Japan.; Sakamoto, M (corresponding author), Keio Univ, Sch Med, Dept Pathol, Tokyo 160, Japan.	msakamot@z5.keio.jp; izumi012@musashino.jrc.or.jp	Nakanishi, Hiroyuki/AAD-9324-2020; Abe, Tokiya/AAH-5029-2020	Nakanishi, Hiroyuki/0000-0003-3982-3314; Abe, Tokiya/0000-0003-0665-8834; Yasui, Yutaka/0000-0002-6117-4990; Tamaki, Nobuharu/0000-0003-4634-6616	New Energy and Industrial Technology Development Organization [P10003]; Ministry of Health, Labor, and Welfare, Japan	New Energy and Industrial Technology Development Organization(New Energy and Industrial Technology Development Organization (NEDO)); Ministry of Health, Labor, and Welfare, Japan(Ministry of Health, Labour and Welfare, Japan)	This study was supported by grants from The New Energy and Industrial Technology Development Organization (Project no. P10003) for the data collection and Health and Labor Sciences Research Grants from the Ministry of Health, Labor, and Welfare, Japan for the study design.	Abe T, 2013, PATHOL INT, V63, P305, DOI 10.1111/pin.12064; Benyon RC, 2000, GUT, V46, P443, DOI 10.1136/gut.46.4.443; BURT AD, 1993, J PATHOL, V170, P105, DOI 10.1002/path.1711700203; Calvaruso V, 2009, HEPATOLOGY, V49, P1236, DOI 10.1002/hep.22745; Cohen-Naftaly Michal, 2011, Therap Adv Gastroenterol, V4, P391, DOI 10.1177/1756283X11413002; Dahab GM, 2004, J GASTROEN HEPATOL, V19, P78, DOI 10.1111/j.1440-1746.2004.03183.x; Dolman GE, 2013, HEPATOLOGY, V58, p594A; Ehling J, 2013, HEPATOLOGY, V58, P1517, DOI 10.1002/hep.26326; Faivre SJ, 2014, J CLIN ONCOL, V32, DOI 10.1200/jco.2014.32.3_suppl.lba173; Fiorini E, 2012, J Ultrasound, V15, P220, DOI 10.1016/j.jus.2012.10.001; Fuchs TJ, 2011, COMPUT MED IMAG GRAP, V35, P515, DOI 10.1016/j.compmedimag.2011.02.006; Garrido R, 2013, J HISTOCHEM CYTOCHEM, V61, P362, DOI 10.1369/0022155413482926; Giannelli G, 2014, CANCER RES, V74, P1890, DOI 10.1158/0008-5472.CAN-14-0243; Hashiguchi A, 2010, PATHOL INT, V60, P720, DOI 10.1111/j.1440-1827.2010.02590.x; Huang Y, 2014, J HEPATOL, V61, P22, DOI 10.1016/j.jhep.2014.02.031; Hui AY, 2004, LIVER INT, V24, P611, DOI 10.1111/j.1478-3231.2004.0957.x; Inagaki Y, 2007, GUT, V56, P284, DOI 10.1136/gut.2005.088690; Kanwal F, 2011, GASTROENTEROLOGY, V140, P1182, DOI 10.1053/j.gastro.2010.12.032; Lin WY, 2010, GASTROENTEROLOGY, V138, P2509, DOI 10.1053/j.gastro.2010.03.008; Masseroli M, 2000, J HEPATOL, V32, P453, DOI 10.1016/S0168-8278(00)80397-9; Moses HL, 1996, CURR OPIN GENET DEV, V6, P581, DOI 10.1016/S0959-437X(96)80087-6; Murakami Yuri, 2013, J Pathol Inform, V4, P36, DOI 10.4103/2153-3539.124009; Nakayama H, 2008, HISTOL HISTOPATHOL, V23, P407, DOI 10.14670/HH-23.407; Pellicoro A, 2012, HEPATOLOGY, V55, P1965, DOI 10.1002/hep.25567; Tsochatzis E, 2014, J HEPATOL, V60, P948, DOI 10.1016/j.jhep.2013.12.023; Tsochatzis EA, 2014, LANCET, V383, P1749, DOI 10.1016/S0140-6736(14)60121-5; Vallet-Pichard A, 2007, HEPATOLOGY, V46, P32, DOI 10.1002/hep.21669; Wai CT, 2003, HEPATOLOGY, V38, P518, DOI 10.1053/jhep.2003.50346; Yoshida K, 2014, INT J ONCOL, V45, P1363, DOI 10.3892/ijo.2014.2552; Zhang DY, 2012, HEPATOLOGY, V56, P769, DOI 10.1002/hep.25670	30	30	30	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 29	2016	11	4							e0154558	10.1371/journal.pone.0154558	http://dx.doi.org/10.1371/journal.pone.0154558			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DK8XM	27128435	Green Published, Green Submitted, gold			2022-12-26	WOS:000375212600039
J	Li, ZW; Nie, XD; Chang, XF; Liu, L; Sun, LY				Li, Zhongwu; Nie, Xiaodong; Chang, Xiaofeng; Liu, Lin; Sun, Liying			Characteristics of Soil and Organic Carbon Loss Induced by Water Erosion on the Loess Plateau in China	PLOS ONE			English	Article							RAINFALL INTENSITY; VARIABLE RAINFALL; INTERRILL EROSION; ENRICHMENT RATIO; NUTRIENT LOSSES; OVERLAND-FLOW; RUNOFF; SEDIMENT; TRANSPORT; DYNAMICS	Soil erosion has been a common environmental problem in the Loess Plateau in China. This study aims to better understand the losses of soil organic carbon (SOC) induced by water erosion. Laboratory-simulated rainfall experiments were conducted to investigate the characteristics of SOC loss induced by water erosion. The applied treatments included two rainfall intensities (90 and 120 mm h(-1)), four slope gradients (10 degrees, 15 degrees, 20 degrees, and 25 degrees), and two typical soil types-silty clay loam and silty loam. Results showed that the sediment OC enrichment ratios (ERoc) in all the events were relative stable with values ranged from 0.85 to 1.21 and 0.64 to 1.52 and mean values of 0.98 and 1.01 for silty clay loam and silty loam, respectively. Similar to the ERoc, the proportions of different sized particles in sediment showed tiny variations during erosion processes. No significant correlation was observed between ERoc values and the proportions of sediment particles. Slope, rainfall intensity and soil type almost had no impact on ERoc. These results indicate that the transportation of SOC during erosion processes was nonselective. While the mean SOC loss rates for the events of silty clay loam and silty loam were 0.30 and 0.08 g m(-2) min(-1), respectively. Greater differences in SOC loss rates were found in events among different soil types. Meanwhile, significant correlations between SOC loss and soil loss for all the events were observed. These results indicated that the amount of SOC loss was influenced primarily by soil loss and the SOC content of the original soil. Erosion pattern and original SOC content are two main factors by which different soils can influence SOC loss. It seems that soil type has a greater impact on SOC loss than rainfall characteristics on the Loess Plateau of China. However, more kinds of soils should be further studied due to the special formation processes in the Loess Plateau.	[Li, Zhongwu; Nie, Xiaodong; Chang, Xiaofeng; Liu, Lin] CAS & MWR, Inst Soil & Water Conservat, State Key Lab Soil Eros & Dryland Farming Loess P, Yangling 712100, Shaanxi Provinc, Peoples R China; [Li, Zhongwu; Nie, Xiaodong] Hunan Univ, Coll Environm Sci & Engn, Changsha 410082, Hunan, Peoples R China; [Li, Zhongwu; Nie, Xiaodong] Hunan Univ, Key Lab Environm Biol & Pollut Control, Minist Educ, Changsha 410082, Hunan, Peoples R China; [Sun, Liying] Chinese Acad Sci, Inst Geog Sci & Nat Resources Res, Key Lab Water Cycle & Related Land Surface Proc, Beijing 100101, Peoples R China	Chinese Academy of Sciences; Institute of Soil & Water Conservation (ISWC), CAS; Hunan University; Hunan University; Chinese Academy of Sciences; Institute of Geographic Sciences & Natural Resources Research, CAS	Li, ZW (corresponding author), CAS & MWR, Inst Soil & Water Conservat, State Key Lab Soil Eros & Dryland Farming Loess P, Yangling 712100, Shaanxi Provinc, Peoples R China.; Li, ZW (corresponding author), Hunan Univ, Coll Environm Sci & Engn, Changsha 410082, Hunan, Peoples R China.; Li, ZW (corresponding author), Hunan Univ, Key Lab Environm Biol & Pollut Control, Minist Educ, Changsha 410082, Hunan, Peoples R China.	lizw@hnu.edu.cn	Li, Zhongwu/AAF-9530-2020		National Natural Science Foundation of China [41271294, 41471229]; Chinese Academy of Sciences	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Chinese Academy of Sciences(Chinese Academy of Sciences)	This work was supported by the National Natural Science Foundation of China (41271294) to Zhongwu Li (http://www.nsfc.gov.cn/); the 'Hundred-talent Project' of the Chinese Academy of Sciences to Zhongwu Li (http://www.cas.cn/); and the National Natural Science Foundation of China (41471229) to Liying Sun (http://www.nsfc.gov.cn/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Assouline S, 2006, CATENA, V66, P211, DOI 10.1016/j.catena.2006.02.005; Berger C, 2010, EARTH SURF PROC LAND, V35, P1456, DOI 10.1002/esp.1989; Chen LD, 2007, CATENA, V70, P200, DOI 10.1016/j.catena.2006.08.007; Cogle AL, 2002, SOIL USE MANAGE, V18, P10, DOI [10.1079/SUM2002094, 10.1079/SUM200194]; Frauenfeld B, 2004, SOIL SCI, V169, P143, DOI 10.1097/01.ss.0000117784.98510.46; GHADIRI H, 1991, J ENVIRON QUAL, V20, P634, DOI 10.2134/jeq1991.00472425002000030021x; Girmay G, 2009, J HYDROL, V376, P70, DOI 10.1016/j.jhydrol.2009.07.066; [贾松伟 Gu Songwei], 2004, [水土保持研究, Research of Soil and Water Conservation], V11, P88; Jacinthe PA, 2004, SOIL TILL RES, V77, P111, DOI 10.1016/j.still.2003.11.004; Jia Songwei, 2007, Wuhan University Journal of Natural Sciences, V12, P695, DOI 10.1007/s11859-006-0300-1; Jin K, 2008, SOIL USE MANAGE, V24, P181, DOI 10.1111/j.1475-2743.2008.00151.x; Jin K, 2009, CATENA, V78, P81, DOI 10.1016/j.catena.2009.03.001; Kuhn NJ, 2012, CATENA, V94, P1, DOI 10.1016/j.catena.2011.11.007; Kuhn NJ, 2012, CATENA, V91, P94, DOI 10.1016/j.catena.2010.10.002; Lal R, 2004, SCIENCE, V304, P1623, DOI 10.1126/science.1097396; Lal R, 2005, SOIL TILL RES, V81, P137, DOI 10.1016/j.still.2004.09.002; Liu S, 2003, GLOBAL BIOGEOCHEM CY, V17, P975; LOWRANCE R, 1988, SOIL SCI SOC AM J, V52, P1445, DOI 10.2136/sssaj1988.03615995005200050045x; Martinez-Mena M, 2012, CATENA, V94, P36, DOI 10.1016/j.catena.2011.02.005; Martinez-Mena M, 1998, HYDROL PROCESS, V12, P741, DOI 10.1002/(SICI)1099-1085(19980430)12:5&lt;741::AID-HYP622&gt;3.0.CO;2-F; MASSEY HF, 1952, SOIL SCI SOC AM PRO, V16, P353, DOI 10.2136/sssaj1952.03615995001600040008x; Nadeu E, 2011, J SOIL SEDIMENT, V11, P667, DOI 10.1007/s11368-011-0348-1; Nie XD, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105927; Palis RG, 1997, AUST J SOIL RES, V35, P891, DOI 10.1071/S92060; Pan CZ, 2006, J HYDROL, V331, P178, DOI 10.1016/j.jhydrol.2006.05.011; Polyakov V, 2004, ENVIRON INT, V30, P547, DOI 10.1016/j.envint.2003.10.011; Polyakov VO, 2004, SOIL SCI, V169, P590, DOI 10.1097/01.ss.0000138414.84427.40; Quinton JN, 2001, J ENVIRON QUAL, V30, P538, DOI 10.2134/jeq2001.302538x; Ramos MC, 2006, AGR ECOSYST ENVIRON, V113, P356, DOI 10.1016/j.agee.2005.10.009; Rimal BK, 2009, SOIL TILL RES, V106, P62, DOI 10.1016/j.still.2009.09.014; Schiettecatte W, 2008, SOIL SCI SOC AM J, V72, P50, DOI 10.2136/sssaj2007.0201; Schiettecatte W, 2008, CATENA, V72, P340, DOI 10.1016/j.catena.2007.07.001; Shi ZH, 2012, J HYDROL, V454, P123, DOI 10.1016/j.jhydrol.2012.06.004; Slattery MC, 1997, EARTH SURF PROC LAND, V22, P705, DOI 10.1002/(SICI)1096-9837(199708)22:8&lt;705::AID-ESP739&gt;3.0.CO;2-6; Starr GC, 2000, LAND DEGRAD DEV, V11, P83, DOI 10.1002/(SICI)1099-145X(200001/02)11:1<83::AID-LDR370>3.0.CO;2-W; Stavi I, 2011, SOIL USE MANAGE, V27, P69, DOI 10.1111/j.1475-2743.2010.00312.x; Strickland TC, 2005, J SOIL WATER CONSERV, V60, P142; Takken I, 2001, SOIL TILL RES, V61, P55, DOI 10.1016/S0167-1987(01)00178-7; Truman CC, 2007, J ENVIRON QUAL, V36, P1495, DOI 10.2134/jeq2006.0018; Walkley A, 1934, SOIL SCI, V37, P29, DOI 10.1097/00010694-193401000-00003; Wang L, 2014, J HYDROL, V512, P168, DOI 10.1016/j.jhydrol.2014.02.066; Zhang X, 2013, GEOMORPHOLOGY, V197, P137, DOI 10.1016/j.geomorph.2013.05.004; Zheng FL, 2006, PEDOSPHERE, V16, P420, DOI 10.1016/S1002-0160(06)60071-4; Zhu X., 1991, FORMATION LOESS PLAT, V1, P001	44	37	37	8	51	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 28	2016	11	4							e0154591	10.1371/journal.pone.0154591	http://dx.doi.org/10.1371/journal.pone.0154591			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DK8XE	27124482	Green Published, gold			2022-12-26	WOS:000375211700109
J	Yoshida, M; He, PJ; Yun, CC				Yoshida, Michihiro; He, Peijian; Yun, C. Chris			Transgenic Expression of Human Lysophosphatidic Acid Receptor LPA(2) in Mouse Intestinal Epithelial Cells Induces Intestinal Dysplasia	PLOS ONE			English	Article							COLON-CANCER CELLS; PROTEIN-COUPLED RECEPTOR; OVER-EXPRESSION; GROWTH-FACTOR; PROLIFERATION; TUMORIGENESIS; INDUCTION; GENE	Lysophosphatidic acid (LPA) acts on LPA(2) receptor to mediate multiple pathological effects that are associated with tumorigenesis. The absence of LPA(2) attenuates tumor progression in rodent models of colorectal cancer, but whether overexpression of LPA(2) alone can lead to malignant transformation in the intestinal tract has not been studied. In this study, we expressed human LPA(2) in intestinal epithelial cells (IECs) under control of the villin promoter. Less than 4% of F1-generation mice had germline transmission of transgenic (TG) human LPA(2); as such only 3 F1 mice out of 72 genotyped had TG expression. These TG mice appeared anemic with hematochezia and died shortly after birth. TG mice were smaller in size compared with the wild type mouse of the same age and sex. Morphological analysis showed that TG LPA(2) colon had hyper-proliferation of IECs resulting in increased colonic crypt depth. Surprisingly, TG small intestine had villus blunting and decreased IEC proliferation and dysplasia. In both intestine and colon, TG expression of LPA(2) compromised the terminal epithelial differentiation, consistent with epithelial dysplasia. Furthermore, we showed that epithelial dysplasia was observed in founder mouse intestine, correlating LPA(2) overexpression with epithelial dysplasia. The current study demonstrates that overexpression of LPA(2) alone can lead to intestinal dysplasia.	[Yoshida, Michihiro; He, Peijian; Yun, C. Chris] Emory Univ, Dept Med, Div Digest Dis, Atlanta, GA 30322 USA; [Yoshida, Michihiro] Nagoya City Univ, Grad Sch Med Sci, Dept Gastroenterol & Metab, Nagoya, Aichi, Japan; [Yun, C. Chris] Emory Univ, Winship Canc Inst, Atlanta, GA 30322 USA	Emory University; Nagoya City University; Emory University	Yun, CC (corresponding author), Emory Univ, Dept Med, Div Digest Dis, Atlanta, GA 30322 USA.; Yun, CC (corresponding author), Emory Univ, Winship Canc Inst, Atlanta, GA 30322 USA.	ccyun@emory.edu			National Institutions of Health [DK071597]; KAKENHI [25860552]; NIH/NCI [P30CA138292]; NATIONAL CANCER INSTITUTE [P30CA138292] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK071597] Funding Source: NIH RePORTER; Veterans Affairs [I01BX002540] Funding Source: NIH RePORTER	National Institutions of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); NIH/NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Veterans Affairs(US Department of Veterans Affairs)	This work was supported by the National Institutions of Health grant DK071597 to CCY. MY is a recipient of Grants-in-Aid for Scientific Research (KAKENHI, no. 25860552). The authors' acknowledge the Mouse Transgenic and Gene Targeting Core for generating transgenic mice and the Winship and Emory Integrated Cellular Imaging Core, which is supported by the NIH/NCI P30CA138292. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Choi JW, 2010, ANNU REV PHARMACOL, V50, P157, DOI 10.1146/annurev.pharmtox.010909.105753; Cui M, 2012, J BONE MINER RES, V27, P2097, DOI 10.1002/jbmr.1662; Deng W, 2007, GASTROENTEROLOGY, V132, P1834, DOI 10.1053/j.gastro.2007.03.038; Evseenko D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063718; FEARON ER, 1990, CELL, V61, P759, DOI 10.1016/0092-8674(90)90186-I; Fukushima N, 2000, DEV BIOL, V228, P6, DOI 10.1006/dbio.2000.9930; Fukushima N, 2002, MOL BIOL CELL, V13, P2692, DOI 10.1091/mbc.01-09-0465; Goetzl EJ, 1999, CANCER RES, V59, P5370; Guo LL, 2015, CELL SIGNAL, V27, P961, DOI 10.1016/j.cellsig.2015.02.005; Hang TTN, 2011, J CLIN INVEST, V121, P1733, DOI 10.1172/JCI44631; He PJ, 2015, J CLIN INVEST, V125, P3519, DOI 10.1172/JCI79552; He PJ, 2010, J BIOMED BIOTECHNOL, DOI 10.1155/2010/238080; Huang MC, 2004, ONCOGENE, V23, P122, DOI 10.1038/sj.onc.1206986; Kitayama J, 2004, BREAST CANCER RES, V6, pR640, DOI 10.1186/bcr935; KREIS TE, 1986, EMBO J, V5, P931, DOI 10.1002/j.1460-2075.1986.tb04306.x; Lalles JP, 2010, NUTR REV, V68, P323, DOI 10.1111/j.1753-4887.2010.00292.x; Lee SJ, 2013, J BIOL CHEM, V288, P25244, DOI 10.1074/jbc.M113.489708; Lee SJ, 2011, GASTROENTEROLOGY, V140, P924, DOI 10.1053/j.gastro.2010.11.054; Lin SB, 2010, AM J PHYSIOL-GASTR L, V299, pG1128, DOI 10.1152/ajpgi.00321.2010; Lin SB, 2009, GASTROENTEROLOGY, V136, P1711, DOI 10.1053/j.gastro.2009.01.002; Liu SY, 2009, CANCER CELL, V15, P539, DOI 10.1016/j.ccr.2009.03.027; Ma K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084221; Markowitz SD, 2009, NEW ENGL J MED, V361, P2449, DOI 10.1056/NEJMra0804588; Mills GB, 2003, NAT REV CANCER, V3, P582, DOI 10.1038/nrc1143; Moolenaar WH, 2004, BIOESSAYS, V26, P870, DOI 10.1002/bies.20081; Nandan MO, 2008, GASTROENTEROLOGY, V134, P120, DOI 10.1053/j.gastro.2007.10.023; Pinto D, 1999, J BIOL CHEM, V274, P6476, DOI 10.1074/jbc.274.10.6476; Rusovici R, 2007, BBA-GEN SUBJECTS, V1770, P1194, DOI 10.1016/j.bbagen.2007.04.008; Schulte KM, 2001, INT J CANCER, V92, P249, DOI 10.1002/1097-0215(200102)9999:9999<::AID-IJC1166>3.0.CO;2-D; Shida D, 2004, LAB INVEST, V84, P1352, DOI 10.1038/labinvest.3700146; Yang M, 2005, P NATL ACAD SCI USA, V102, P6027, DOI 10.1073/pnas.0501535102; Zhang HC, 2007, J BIOL CHEM, V282, P15541, DOI 10.1074/jbc.M700702200	32	5	5	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 28	2016	11	4							e0154527	10.1371/journal.pone.0154527	http://dx.doi.org/10.1371/journal.pone.0154527			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DK8XE	27124742	Green Submitted, Green Published, gold			2022-12-26	WOS:000375211700101
J	Chien, CW; Hou, PC; Wu, HC; Chang, YL; Lin, SC; Lin, SC; Lin, BW; Lee, JC; Chang, YJ; Sun, HS; Tsai, SJ				Chien, C-W; Hou, P-C; Wu, H-C; Chang, Y-L; Lin, S-C; Lin, S-C; Lin, B-W; Lee, J-C; Chang, Y-J; Sun, H. S.; Tsai, S-J			Targeting TYRO3 inhibits epithelial-mesenchymal transition and increases drug sensitivity in colon cancer	ONCOGENE			English	Article							RECEPTOR TYROSINE KINASES; ARREST-SPECIFIC GENE-6; MONOCLONAL-ANTIBODY; BREAST-CANCER; COLORECTAL-CANCER; STEM-CELLS; AXL; SURVIVAL; GROWTH; OVEREXPRESSION	Colon cancer is the third leading cause of death from cancer worldwide with less than 10% survival rate at the late stage. Although mutations of certain genes have been implicated in familial colon cancer development, the etiology of the majority of colon cancer remains unknown. Herein, we identified TYRO3 as a potential oncogene. Immunohistochemical staining results demonstrated that levels of TYRO3 were markedly elevated in polyps and colon cancer cells and were negatively correlated with prognosis. Overexpression of TYRO3 enhanced cell motility, invasion, anchorage-independent growth and metastatic ability, while knockdown of TYRO3 impaired all these processes. Results from meta-analysis showed that TYRO3 was associated with epithelial-mesenchymal transition (EMT) signatures. Gain-of-function and loss-of-function experiments demonstrated that expression of SNAI1, the master regulator of EMT, was regulated by TYRO3 and played a major role in mediating TYRO3-induced EMT processes. The murine model also demonstrated that Tyro3 and Snai1 were upregulated in the early stage of colon cancer development. To provide a proof-of-concept that TYRO3 is a druggable target in colon cancer therapy, we raised anti-TYRO3 human antibodies and showed that treatment with the human antibody abolished TYRO3-induced EMT process. More importantly, administration of this anti-TYRO3 antibody increased drug sensitivity in primary cultured colon cancer cells and xenografted mouse tumors. These findings demonstrate that TYRO3 is a novel oncogene and a druggable target in colon cancer.	[Chien, C-W; Hou, P-C; Sun, H. S.; Tsai, S-J] Natl Cheng Kung Univ, Coll Med, Inst Basic Med Sci, Tainan, Taiwan; [Wu, H-C; Chang, Y-L] Acad Sinica, Inst Cellular & Organism Biol, Taipei, Taiwan; [Lin, S-C; Tsai, S-J] Natl Cheng Kung Univ, Coll Med, Dept Physiol, 1 Univ Rd, Tainan 701, Taiwan; [Lin, S-C; Lin, B-W; Lee, J-C] Natl Cheng Kung Univ, Coll Med, Dept Surg, Tainan, Taiwan; [Chang, Y-J] Taipei Med Univ, Coll Med, Grad Inst Clin Med, Taipei, Taiwan; [Sun, H. S.] Natl Cheng Kung Univ, Coll Med, Inst Mol Med, 1 Univ Rd, Tainan 701, Taiwan	National Cheng Kung University; Academia Sinica - Taiwan; National Cheng Kung University; National Cheng Kung University; Taipei Medical University; National Cheng Kung University	Tsai, SJ (corresponding author), Natl Cheng Kung Univ, Coll Med, Dept Physiol, 1 Univ Rd, Tainan 701, Taiwan.; Sun, HS (corresponding author), Natl Cheng Kung Univ, Coll Med, Inst Mol Med, 1 Univ Rd, Tainan 701, Taiwan.	hssun@mail.ncku.edu.tw; seantsai@mail.ncku.edu.tw	Wu, Han-Chung/B-1209-2011; Tsai, Shaw-Jenq/AAG-6569-2019	Wu, Han-Chung/0000-0002-5185-1169; TSAI, SHAW-JENQ/0000-0002-3569-5813; Hou, Pei-Chi/0000-0002-3709-5934; Sun, Sunny/0000-0002-3661-4448	National Science Council of Taiwan [NSC 101-2321-B-006-020, NSC 102-2321-B-006-011]; Top University Grant of National Cheng Kung University [D103-35A17]	National Science Council of Taiwan(Ministry of Science and Technology, Taiwan); Top University Grant of National Cheng Kung University	We thank Miss Yi-Hsuan Yeh and Miss Yi-Chen Tang for technical assistance with IHC and animal study. This work was supported by grants from National Science Council of Taiwan (NSC 101-2321-B-006-020 and NSC 102-2321-B-006-011) and by Top University Grant of National Cheng Kung University (grant # D103-35A17).	Asiedu MK, 2014, ONCOGENE, V33, P1316, DOI 10.1038/onc.2013.57; Avilla E, 2011, CANCER RES, V71, P1792, DOI 10.1158/0008-5472.CAN-10-2186; BIESECKER LG, 1993, P NATL ACAD SCI USA, V90, P7044, DOI 10.1073/pnas.90.15.7044; Budinska E, 2013, J PATHOL, V231, P63, DOI 10.1002/path.4212; CARON PC, 1994, CANCER, V73, P1049, DOI 10.1002/1097-0142(19940201)73:3+<1049::AID-CNCR2820731344>3.0.CO;2-1; Chan HH, 2007, NUCL ACIDS RES; Chien CW, 2008, CLIN CANCER RES, V14, P8043, DOI 10.1158/1078-0432.CCR-08-1651; Crosier KE, 1997, PATHOLOGY, V29, P131, DOI 10.1080/00313029700169744; De Vos J, 2001, BLOOD, V98, P771, DOI 10.1182/blood.V98.3.771; Duijkers FAM, 2013, GENE, V521, P62, DOI 10.1016/j.gene.2013.03.029; FEARON ER, 1990, CELL, V61, P759, DOI 10.1016/0092-8674(90)90186-I; Gerloff J, 2012, AM J PATHOL, V180, P2134, DOI 10.1016/j.ajpath.2012.01.036; Gjerdrum C, 2010, P NATL ACAD SCI USA, V107, P1124, DOI 10.1073/pnas.0909333107; Golan T, 2013, CANCER-AM CANCER SOC, V119, P3084, DOI 10.1002/cncr.28143; Goldenberg MM, 1999, CLIN THER, V21, P309, DOI 10.1016/S0149-2918(00)88288-0; GRODEN J, 1991, CELL, V66, P589, DOI 10.1016/0092-8674(81)90021-0; Lemke G, 2008, NAT REV IMMUNOL, V8, P327, DOI 10.1038/nri2303; Linger RMA, 2008, ADV CANCER RES, V100, P35, DOI 10.1016/S0065-230X(08)00002-X; Lu RM, 2011, BIOMATERIALS, V32, P3265, DOI 10.1016/j.biomaterials.2010.12.061; Neubauer A, 1997, LEUKEMIA LYMPHOMA, V25, P91, DOI 10.3109/10428199709042499; OBRYAN JP, 1991, MOL CELL BIOL, V11, P5016, DOI 10.1128/MCB.11.10.5016; Petitjean A, 2007, ONCOGENE, V26, P2157, DOI 10.1038/sj.onc.1210302; Prewett M, 1996, J IMMUNOTHER, V19, P419, DOI 10.1097/00002371-199611000-00006; Sawabu T, 2007, MOL CARCINOGEN, V46, P155, DOI 10.1002/mc.20211; Schlessinger J, 2000, CELL, V103, P211, DOI 10.1016/j.cell.2010.06.011; Song XZ, 2011, CANCER-AM CANCER SOC, V117, P734, DOI 10.1002/cncr.25483; STITT TN, 1995, CELL, V80, P661, DOI 10.1016/0092-8674(95)90520-0; Sun WS, 2004, ONCOLOGY-BASEL, V66, P450, DOI 10.1159/000079499; Sun WS, 2003, MOL HUM REPROD, V9, P701, DOI 10.1093/molehr/gag082; Takayama T, 1998, NEW ENGL J MED, V339, P1277, DOI 10.1056/NEJM199810293391803; Taylor ICA, 1995, ONCOGENE, V11, P2619; Zhu ST, 2009, P NATL ACAD SCI USA, V106, P17025, DOI 10.1073/pnas.0909292106	32	46	46	0	14	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	NOV 10	2016	35	45					5872	5881		10.1038/onc.2016.120	http://dx.doi.org/10.1038/onc.2016.120			10	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	EB7IR	27132510				2022-12-26	WOS:000387560800006
J	Jules, J; Chen, W; Feng, X; Li, YP				Jules, Joel; Chen, Wei; Feng, Xu; Li, Yi-Ping			CCAAT/Enhancer-binding Protein alpha (C/EBP alpha) Is Important for Osteoclast Differentiation and Activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NF-KAPPA-B; COLONY-STIMULATING FACTOR; RANK CYTOPLASMIC MOTIF; RECEPTOR ACTIVATOR; BONE-RESORPTION; EXTRACELLULAR ACIDIFICATION; SKELETAL DEVELOPMENT; CELL-PROLIFERATION; CATHEPSIN-K; TNF FAMILY	CCAAT/enhancer-binding protein (C/EBP alpha) can appoint mouse bone marrow (MBM) cells to the osteoclast (OC) lineage for osteoclastogenesis. However, whether C/EBP alpha is also involved in OC differentiation and activity is unknown. Here we demonstrated that C/EBP alpha overexpression in MBM cells can promote OC differentiation and strongly induce the expression of theOCgenes encoding the nuclear factor of activated T-cells, c1 (NFATc1), cathepsin K (Cstk), and tartrate-resistant acid phosphatase 5 (TRAP) with receptor activator of NF-kappa B ligand-evoked OC lineage priming. Furthermore, while investigating the specific stage of OC differentiation that is regulated by C/EBP alpha, our gene overexpression studies revealed that, although C/EBP alpha plays a stronger role in the early stage of OC differentiation, it is also involved in the later stage. Accordingly, C/EBP alpha knockdown drastically inhibits osteoclastogenesis and markedly abrogates the expression of NFATc1, Cstk, and TRAP during OC differentiation. Consistently, C/EBP alpha silencing revealed that, although lack of C/EBP alpha affects all stages of OC differentiation, it has more impact on the early stage. Importantly, we showed that ectopic expression of rat C/EBP alpha restores osteoclastogenesis in C/EBP alpha-depleted MBM cells. Furthermore, our subsequent functional assays showed that C/EBP alpha exhibits a dispensable role on actin ring formation by mature OCs but is critically involved in bone resorption by stimulating extracellular acidification and regulating cell survival. We revealed that C/EBP alpha is important for receptor activator of NF-kappa B ligand-induced Akt activation, which is crucial for OC survival. Collectively, these results indicate that C/EBP alpha functions throughout osteoclastogenesis as well as in OC function. This study provides additional understanding of the roles of C/EBP alpha in OC biology.	[Jules, Joel; Chen, Wei; Feng, Xu] Univ Alabama Birmingham, Dept Pathol, SHEL 810,1825 Univ Blvd, Birmingham, AL 35294 USA; [Li, Yi-Ping] Univ Alabama Birmingham, Dept Pathol, 1825 Univ Blvd,Shelby Bldg 810, Birmingham, AL 35294 USA	University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham	Chen, W (corresponding author), Univ Alabama Birmingham, Dept Pathol, SHEL 810,1825 Univ Blvd, Birmingham, AL 35294 USA.; Li, YP (corresponding author), Univ Alabama Birmingham, Dept Pathol, 1825 Univ Blvd,Shelby Bldg 810, Birmingham, AL 35294 USA.	wechen@uab.edu; ypli@uab.edu			National Institutes of Health [R01-AR-044741, R01DE023813, AR-055307]; NATIONAL CANCER INSTITUTE [P30CA013148] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [P30AR046031, R01AR044741, R01AR055307] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE023813] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This work was supported by National Institutes of Health Grants R01-AR-044741, R01DE023813, and AR-055307 (to Y. P. L.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Asagiri M, 2007, BONE, V40, P251, DOI 10.1016/j.bone.2006.09.023; Boyce BF, 2015, ENDOCRINOL METAB, V30, P35, DOI 10.3803/EnM.2015.30.1.35; Boyle WJ, 2003, NATURE, V423, P337, DOI 10.1038/nature01658; Cappellen D, 2002, J BIOL CHEM, V277, P21971, DOI 10.1074/jbc.M200434200; Chen W, 2007, HUM MOL GENET, V16, P410, DOI 10.1093/hmg/ddl474; Chen W, 2014, P NATL ACAD SCI USA, V111, P8482, DOI 10.1073/pnas.1310617111; Chen W, 2013, P NATL ACAD SCI USA, V110, P7294, DOI 10.1073/pnas.1211383110; Cicek M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017522; Feng X, 2011, ANNU REV PATHOL-MECH, V6, P121, DOI 10.1146/annurev-pathol-011110-130203; Fuller K, 1998, J EXP MED, V188, P997, DOI 10.1084/jem.188.5.997; Gao B, 2013, J DENT RES, V92, P180, DOI 10.1177/0022034512468757; Gingery A, 2008, EXP CELL RES, V314, P2725, DOI 10.1016/j.yexcr.2008.06.006; GRAHAM FL, 1977, J GEN VIROL, V36, P59, DOI 10.1099/0022-1317-36-1-59; Horowitz MC, 2001, CYTOKINE GROWTH F R, V12, P9, DOI 10.1016/S1359-6101(00)00030-7; Hu JP, 2008, EUR J PHARMACOL, V580, P70, DOI 10.1016/j.ejphar.2007.11.013; Jules J, 2015, J BIOL CHEM, V290, P23738, DOI 10.1074/jbc.M115.667535; Jules J, 2012, J BIOL CHEM, V287, P15728, DOI 10.1074/jbc.M111.296228; Jules J, 2010, J BIOL CHEM, V285, P37427, DOI 10.1074/jbc.M110.149484; Karsenty G, 2002, DEV CELL, V2, P389, DOI 10.1016/S1534-5807(02)00157-0; Kwak HB, 2008, MOL CELLS, V26, P436; Lam J, 2000, J CLIN INVEST, V106, P1481, DOI 10.1172/JCI11176; LANDSCHULZ WH, 1988, GENE DEV, V2, P786, DOI 10.1101/gad.2.7.786; Li YP, 1996, BIOCHEM BIOPH RES CO, V218, P813, DOI 10.1006/bbrc.1996.0145; Li YP, 1999, NAT GENET, V23, P447, DOI 10.1038/70563; LI YP, 1995, J BONE MINER RES, V10, P1197; LIN FT, 1993, P NATL ACAD SCI USA, V90, P9606, DOI 10.1073/pnas.90.20.9606; Liu W, 2005, J BIOL CHEM, V280, P43064, DOI 10.1074/jbc.M509006200; Mueller BU, 2006, CURR OPIN HEMATOL, V13, P7, DOI 10.1097/01.moh.0000190110.08156.96; Murakami T, 1998, BIOCHEM BIOPH RES CO, V252, P747, DOI 10.1006/bbrc.1998.9723; NERLOV C, 1995, EMBO J, V14, P4318, DOI 10.1002/j.1460-2075.1995.tb00106.x; Nerlov C, 2007, TRENDS CELL BIOL, V17, P318, DOI 10.1016/j.tcb.2007.07.004; Onishi M, 1998, MOL CELL BIOL, V18, P3871, DOI 10.1128/MCB.18.7.3871; Ory DS, 1996, P NATL ACAD SCI USA, V93, P11400, DOI 10.1073/pnas.93.21.11400; Porse BT, 2005, J EXP MED, V202, P85, DOI 10.1084/jem.20050067; Qu XH, 2014, BIOCHEM BIOPH RES CO, V443, P658, DOI 10.1016/j.bbrc.2013.12.029; Ramji DP, 2002, BIOCHEM J, V365, P561, DOI 10.1042/BJ20020508; Reckzeh K, 2010, INT J HEMATOL, V91, P557, DOI 10.1007/s12185-010-0573-1; Roe JS, 2014, J EXP MED, V211, P1, DOI 10.1084/jem.20132530; Sakoda Tsuyoshi, 2007, Exp Clin Cardiol, V12, P133; Souza PPC, 2013, IMMUNOL INVEST, V42, P555, DOI 10.3109/08820139.2013.822766; Taguchi Y, 2009, GENES CELLS, V14, P1331, DOI 10.1111/j.1365-2443.2009.01351.x; Tai TW, 2014, BONE, V67, P166, DOI 10.1016/j.bone.2014.07.003; Takayanagi H, 2002, DEV CELL, V3, P889, DOI 10.1016/S1534-5807(02)00369-6; Takayanagi H, 2007, ANN NY ACAD SCI, V1116, P227, DOI 10.1196/annals.1402.071; TAMURA T, 1993, J BONE MINER RES, V8, P953; Teitelbaum SL, 2000, SCIENCE, V289, P1504, DOI 10.1126/science.289.5484.1504; Tu QS, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M110.152405; Wang HM, 2001, MOL CELL, V8, P817, DOI 10.1016/S1097-2765(01)00366-5; WANG ND, 1995, SCIENCE, V269, P1108, DOI 10.1126/science.7652557; Wei S, 2005, J CLIN INVEST, V115, P282, DOI 10.1172/JCI200523394; Wong BR, 1999, MOL CELL, V4, P1041, DOI 10.1016/S1097-2765(00)80232-4; Xu DR, 2006, J BIOL CHEM, V281, P4678, DOI 10.1074/jbc.M510383200; Yang DQ, 2012, J BONE MINER RES, V27, P1695, DOI 10.1002/jbmr.1623; Yang S, 2013, BONE RES, V1, P260, DOI 10.4248/BR201303005; Yang SY, 2007, GENE DEV, V21, P1803, DOI 10.1101/gad.1544107; Ye M, 2013, NAT CELL BIOL, V15, P385, DOI 10.1038/ncb2698; Zhang DE, 1997, P NATL ACAD SCI USA, V94, P569, DOI 10.1073/pnas.94.2.569; Zhang P, 2004, IMMUNITY, V21, P853, DOI 10.1016/j.immuni.2004.11.006; Zhao QX, 2007, FRONT BIOSCI-LANDMRK, V12, P2519, DOI 10.2741/2252	59	16	16	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 29	2016	291	31					16390	16403		10.1074/jbc.M115.674598	http://dx.doi.org/10.1074/jbc.M115.674598			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DS2HF	27129246	Green Published, hybrid			2022-12-26	WOS:000380585400041
J	Pinto, BI; Garcia, IE; Pupo, A; Retamal, MA; Martinez, AD; Latorre, R; Gonzalez, C				Pinto, Bernardo I.; Garcia, Isaac E.; Pupo, Amaury; Retamal, Mauricio A.; Martinez, Agustin D.; Latorre, Ramon; Gonzalez, Carlos			Charged Residues at the First Transmembrane Region Contribute to the Voltage Dependence of the Slow Gate of Connexins	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GAP JUNCTIONAL COMMUNICATION; CONFORMATIONAL-CHANGES; POTASSIUM CHANNEL; MOLECULAR-BASIS; HEMICHANNELS; CLONING; DOMAIN; MOUSE; PORE; SELECTIVITY	Connexins (Cxs) are a family of membrane-spanning proteins that form gap junction channels and hemichannels. Connexin-based channels exhibit two distinct voltage-dependent gating mechanisms termed slow and fast gating. Residues located at the C terminus of the first transmembrane segment (TM-1) are important structural components of the slow gate. Here, we determined the role of the charged residues at the end of TM-1 in voltage sensing in Cx26, Cx46, and Cx50. Conductance/voltage curves obtained from tail currents together with kinetics analysis reveal that the fast and slow gates of Cx26 involves the movement of two and four charges across the electric field, respectively. Primary sequence alignment of different Cxs shows the presence of well conserved glutamate residues in the C terminus of TM-1; only Cx26 contains a lysine in that position (lysine 41). Neutralization of lysine 41 in Cx26 increases the voltage dependence of the slow gate. Swapping of lysine 41 with glutamate 42 maintains the voltage dependence. In Cx46, neutralization of negative charges or addition of a positive charge in the Cx26 equivalent region reduced the slow gate voltage dependence. In Cx50, the addition of a glutamate in the same region decreased the voltage dependence, and the neutralization of a negative charge increased it. These results indicate that the charges at the end of TM-1 are part of the slow gate voltage sensor in Cxs. The fact that Cx42, which has no charge in this region, still presents voltage-dependent slow gating suggests that charges still unidentified also contribute to the slow gate voltage sensitivity.	[Pinto, Bernardo I.; Garcia, Isaac E.; Pupo, Amaury; Martinez, Agustin D.; Latorre, Ramon; Gonzalez, Carlos] Univ Valparaiso, Ctr Interdisciplinario Neurociencias Valparaiso, Valparaiso 2360102, Chile; [Retamal, Mauricio A.] Clin Alemana Univ Desarrollo, Fac Med, Ctr Fisiol Celular & Integrat, Santiago 7710162, Chile	Universidad de Valparaiso; Universidad del Desarrollo	Latorre, R; Gonzalez, C (corresponding author), Univ Valparaiso, Fac Ciencias, Ctr Interdisciplinario Neurociencias Valparaiso, Ave Gran Bretana 1111, Valparaiso, Chile.	ramon.latorre@uv.cl; carlos.gonzalezl@uv.cl	Retamal, Mauricio/AAS-3621-2020; Gonzalez, Carlos/V-7628-2019	Pupo, Amaury/0000-0001-9162-9952; Retamal, Mauricio A./0000-0003-2562-6686	FONDECYT [1110430, 1150273, 1160261, 3150634, 1130855, 1160227]; ANILLO Grant [ACT1104]; CONICYT; CONICYT-PCHA/Magister Fellowships; Millennium Scientific Initiative of the Chilean Ministry of Economy, Development, and Tourism [P029-022-F]	FONDECYT(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT FONDECYT); ANILLO Grant(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT PIA/ANILLOS); CONICYT(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)); CONICYT-PCHA/Magister Fellowships; Millennium Scientific Initiative of the Chilean Ministry of Economy, Development, and Tourism	This work was supported by FONDECYT Grants 1110430 and 1150273 (to R. L.), 1160261 (to C. G.), 3150634 (to I. E. G.), 1130855 (to A. M.), and 1160227 (to M. A. R.), ANILLO Grant ACT1104 (to C. G., A. M., and M. A. R.), CONICYT Doctoral Fellowship (to A. P.), and CONICYT-PCHA/Magister/2014 Fellowships (to B. I. P.). The Centro Interdisciplinario de Neurociencia de Valparaiso is a Millennium Institute supported by the Millennium Scientific Initiative of the Chilean Ministry of Economy, Development, and Tourism Grant P029-022-F. The authors declare that they have no conflicts of interest with the contents of this article.	Almers W, 1978, Rev Physiol Biochem Pharmacol, V82, P96, DOI 10.1007/BFb0030498; Bairoch A, 1996, NUCLEIC ACIDS RES, V24, P21, DOI 10.1093/nar/24.1.21; Barrio L. C., 1995, P391; BARRIO LC, 1991, P NATL ACAD SCI USA, V88, P8410, DOI 10.1073/pnas.88.19.8410; Beahm DL, 2002, BIOPHYS J, V82, P2016, DOI 10.1016/S0006-3495(02)75550-1; BEZANILLA F, 1994, ANNU REV BIOPH BIOM, V23, P819, DOI 10.1146/annurev.bb.23.060194.004131; Blanchet J, 2007, BIOPHYS J, V92, P3513, DOI 10.1529/biophysj.106.090464; Boratyn GM, 2012, BIOL DIRECT, V7, DOI 10.1186/1745-6150-7-12; Contreras JE, 2003, P NATL ACAD SCI USA, V100, P11388, DOI 10.1073/pnas.1434298100; Contreras JE, 2002, P NATL ACAD SCI USA, V99, P495, DOI 10.1073/pnas.012589799; Cordero-Morales JF, 2006, NAT STRUCT MOL BIOL, V13, P319, DOI 10.1038/nsmb1070; De Santiago-Castillo JA, 2010, CHANNELS, V4, P422, DOI 10.4161/chan.4.5.13404; Deng YQ, 2006, HEARING RES, V220, P87, DOI 10.1016/j.heares.2006.07.004; Doyle DA, 1998, SCIENCE, V280, P69, DOI 10.1126/science.280.5360.69; EBIHARA L, 1993, J GEN PHYSIOL, V102, P59, DOI 10.1085/jgp.102.1.59; Garcia IE, 2015, J INVEST DERMATOL, V135, P1338, DOI 10.1038/jid.2015.20; Gonzalez C, 2013, J GEN PHYSIOL, V141, P275, DOI 10.1085/jgp.201210857; Gonzalez D, 2007, PROG BIOPHYS MOL BIO, V94, P66, DOI 10.1016/j.pbiomolbio.2007.03.007; Gonzalez D, 2006, FASEB J, V20, P2329, DOI 10.1096/fj.06-5828com; Harris AL, 2001, Q REV BIOPHYS, V34, P325, DOI 10.1017/S0033583501003705; HARRIS AL, 1981, J GEN PHYSIOL, V77, P95, DOI 10.1085/jgp.77.1.95; JIANG JX, 1994, MOL BIOL CELL, V5, P363, DOI 10.1091/mbc.5.3.363; Katoh K, 2002, NUCLEIC ACIDS RES, V30, P3059, DOI 10.1093/nar/gkf436; Kronengold J, 2012, J MEMBRANE BIOL, V245, P453, DOI 10.1007/s00232-012-9457-z; Kwon T, 2013, J GEN PHYSIOL, V141, P243, DOI 10.1085/jgp.201210839; Kwon T, 2011, J GEN PHYSIOL, V138, P475, DOI 10.1085/jgp.201110679; Lampe PD, 2004, INT J BIOCHEM CELL B, V36, P1171, DOI 10.1016/S1357-2725(03)00264-4; Lopez W, 2013, J GEN PHYSIOL, V142, P23, DOI 10.1085/jgp.201210893; Maeda S, 2009, NATURE, V458, P597, DOI 10.1038/nature07869; McLachlan E, 2003, J NEUROSCI RES, V73, P753, DOI 10.1002/jnr.10712; Nielsen MS, 2012, COMPR PHYSIOL, V2, P1981, DOI 10.1002/cphy.c110051; Oshima A, 2007, P NATL ACAD SCI USA, V104, P10034, DOI 10.1073/pnas.0703704104; Palacios-Prado N, 2009, P NATL ACAD SCI USA, V106, P14855, DOI 10.1073/pnas.0901923106; Purnick PEM, 2000, BIOPHYS J, V79, P2403, DOI 10.1016/S0006-3495(00)76485-X; Retamal MA, 2014, FRONT PHYSIOL, V5, DOI 10.3389/fphys.2014.00080; Richard G, 1998, HUM GENET, V103, P393, DOI 10.1007/s004390050839; Rouan F, 2001, J CELL SCI, V114, P2105; RUBIN JB, 1992, BIOPHYS J, V62, P183, DOI 10.1016/S0006-3495(92)81804-0; Saez JC, 2003, PHYSIOL REV, V83, P1359, DOI 10.1152/physrev.00007.2003; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Sarkar D, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/673895; Sohl G, 2003, CELL COMMUN ADHES, V10, P173, DOI 10.1080/15419060390262877; Sosinsky GE, 2005, BBA-BIOMEMBRANES, V1711, P99, DOI 10.1016/j.bbamem.2005.04.001; Starace DM, 2001, J GEN PHYSIOL, V117, P469, DOI 10.1085/jgp.117.5.469; Tang QX, 2009, J GEN PHYSIOL, V133, P555, DOI 10.1085/jgp.200910207; Tombola F, 2008, NEURON, V58, P546, DOI 10.1016/j.neuron.2008.03.026; Tong JJ, 2006, BIOPHYS J, V91, P2142, DOI 10.1529/biophysj.106.082859; Trexler EB, 1996, P NATL ACAD SCI USA, V93, P5836, DOI 10.1073/pnas.93.12.5836; VERSELIS VK, 1994, NATURE, V368, P348, DOI 10.1038/368348a0; Verselis VK, 2008, J GEN PHYSIOL, V132, P315, DOI 10.1085/jgp.200810029; Verselis VK, 2009, J BIOL CHEM, V284, P4484, DOI 10.1074/jbc.M807430200; WHITE TW, 1992, MOL BIOL CELL, V3, P711, DOI 10.1091/mbc.3.7.711; WILLECKE K, 1991, J CELL BIOL, V114, P1049, DOI 10.1083/jcb.114.5.1049; ZAGOTTA WN, 1994, J GEN PHYSIOL, V103, P279, DOI 10.1085/jgp.103.2.279	54	9	9	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 22	2016	291	30					15740	15752		10.1074/jbc.M115.709402	http://dx.doi.org/10.1074/jbc.M115.709402			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DS2HD	27143357	Green Published, hybrid			2022-12-26	WOS:000380584200027
J	Sun, J; Mao, LQ; Polonsky, KS; Ren, DC				Sun, Juan; Mao, Li-qun; Polonsky, Kenneth S.; Ren, De-cheng			Pancreatic beta-Cell Death due to Pdx-1 Deficiency Requires Multi-BH Domain Protein Bax but Not Bak	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						apoptosis; Bax; beta cell (-cell); cell death; diabetes	BH3-ONLY PROTEINS; APOPTOSIS; PUMA; BIM; ACTIVATION; SURVIVAL; ISLETS	Diabetes develops in Pdx1-haploinsufficient mice due to an increase in -cell death leading to reduced -cell mass and decreased insulin secretion. Knockdown of Pdx1 gene expression in mouse MIN6 insulinoma cells induced apoptotic cell death with an increase in Bax activation and knockdown of Bax reduced apoptotic -cell death. In Pdx1 haploinsufficient mice, Bax ablation in -cells increased -cell mass, decreased the number of TUNEL positive cells and improved glucose tolerance after glucose challenge. These changes were not observed with Bak ablation in Pdx1-haploinsufficient mice. These results suggest that Bax mediates -cell apoptosis in Pdx1-deficient diabetes.	[Sun, Juan; Polonsky, Kenneth S.; Ren, De-cheng] Univ Chicago, Dept Med, 5841 S Maryland Ave,MC 1027, Chicago, IL 60637 USA; [Mao, Li-qun] Rosalind Franklin Univ Med & Sci, Dept Microbiol & Immunol, N Chicago, IL 60064 USA	University of Chicago; Rosalind Franklin University Medical & Science	Polonsky, KS; Ren, DC (corresponding author), Univ Chicago, Dept Med, 5841 S Maryland Ave,MC 1027, Chicago, IL 60637 USA.	polonsky@bsd.uchicago.edu; decheng@uchicago.edu			National Institutes of Health [R01 DK031842, P30-DK020595]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK031842, P30DK020595] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This study was supported by National Institutes of Health Grants R01 DK031842 (to K. S. P.) and P30-DK020595 (The University of Chicago and Diabetes Research and Training Center). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Ahlgren U, 1998, GENE DEV, V12, P1763, DOI 10.1101/gad.12.12.1763; Boyd Vinc, 2008, Curr Trends Biotechnol Pharm, V2, P66; Fujimoto K, 2010, P NATL ACAD SCI USA, V107, P10214, DOI 10.1073/pnas.0914209107; Fujimoto K, 2009, J BIOL CHEM, V284, P27664, DOI 10.1074/jbc.M109.041616; Gavathiotis E, 2008, NATURE, V455, P1076, DOI 10.1038/nature07396; Jayaraman S, 2005, J IMMUNOL METHODS, V306, P68, DOI 10.1016/j.jim.2005.07.024; Johnson JD, 2006, P NATL ACAD SCI USA, V103, P19575, DOI 10.1073/pnas.0604208103; Johnson JD, 2003, J CLIN INVEST, V111, P1147, DOI 10.1172/JCI200316537; Kim H, 2009, MOL CELL, V36, P487, DOI 10.1016/j.molcel.2009.09.030; Lindenboim L, 2005, CELL DEATH DIFFER, V12, P713, DOI 10.1038/sj.cdd.4401638; McKenzie MD, 2010, DIABETES, V59, P644, DOI 10.2337/db09-1151; Mondal S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034277; Ren DC, 2014, DIABETES, V63, P2744, DOI 10.2337/db13-1513; Ren DC, 2010, SCIENCE, V330, P1390, DOI 10.1126/science.1190217; Takeuchi O, 2005, P NATL ACAD SCI USA, V102, P11272, DOI 10.1073/pnas.0504783102; Wali JA, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.88; Wei MC, 2001, SCIENCE, V292, P727, DOI 10.1126/science.1059108; Wicksteed B, 2010, DIABETES, V59, P3090, DOI 10.2337/db10-0624; Zong WX, 2001, GENE DEV, V15, P1481, DOI 10.1101/gad.897601	19	12	13	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 24	2016	291	26					13529	13534		10.1074/jbc.M115.705293	http://dx.doi.org/10.1074/jbc.M115.705293			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DR2YZ	27137932	hybrid, Green Published			2022-12-26	WOS:000379771100011
J	Blevitt, JM; Hack, MD; Herman, K; Chang, L; Keith, JM; Mirzadegan, T; Rao, NL; Lebsack, AD; Milla, ME				Blevitt, Jonathan M.; Hack, Michael D.; Herman, Krystal; Chang, Leon; Keith, John M.; Mirzadegan, Tara; Rao, Navin L.; Lebsack, Alec D.; Milla, Marcos E.			A Single Amino Acid Difference between Mouse and Human 5-Lipoxygenase Activating Protein (FLAP) Explains the Speciation and Differential Pharmacology of Novel FLAP Inhibitors	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LEUKOTRIENE BIOSYNTHESIS INHIBITOR; PROSTAGLANDIN-E SYNTHASE-1; INFLAMMATORY DISEASES; ASTHMATIC SUBJECTS; POLYPHARMACOLOGY; EXPRESSION; MODULATORS; MK-0591; CLONING; MODELS	5-Lipoxygenase activating protein (FLAP) plays a critical role in the metabolism of arachidonic acid to leukotriene A(4), the precursor to the potent pro-inflammatory mediators leukotriene B-4 and leukotriene C-4. Studies with small molecule inhibitors of FLAP have led to the discovery of a drug binding pocket on the protein surface, and several pharmaceutical companies have developed compounds and performed clinical trials. Crystallographic studies and mutational analyses have contributed to a general understanding of compound binding modes. During our own efforts, we identified two unique chemical series. One series demonstrated strong inhibition of human FLAP but differential pharmacology across species and was completely inactive in assays with mouse or rat FLAP. The other series was active across rodent FLAP, as well as human and dog FLAP. Comparison of rodent and human FLAP amino acid sequences together with an analysis of a published crystal structure led to the identification of amino acid residue 24 in the floor of the putative binding pocket as a likely candidate for the observed speciation. On that basis, we tested compounds for binding to human G24A and mouse A24G FLAP mutant variants and compared the data to that generated for wild type human and mouse FLAP. These studies confirmed that a single amino acid mutation was sufficient to reverse the speciation observed in wild type FLAP. In addition, a PK/PD method was established in canines to enable preclinical profiling of mouse-inactive compounds.	[Chang, Leon; Keith, John M.; Rao, Navin L.; Lebsack, Alec D.] Janssen Res & Dev, Dept Immunol, San Diego, CA 92121 USA; [Blevitt, Jonathan M.; Hack, Michael D.; Herman, Krystal; Mirzadegan, Tara; Milla, Marcos E.] Janssen Res & Dev, Dept Discovery Sci, San Diego, CA 92121 USA		Milla, ME (corresponding author), Adapt Biotechnol, San Diego, CA 92121 USA.	mmilla@adaptivebiotech.com						Bacani G M, 2014, PCT Int. Appl, Patent No. [WO2014121055, 2014121055, WO 2014121055]; BRIDEAU C, 1992, CAN J PHYSIOL PHARM, V70, P799, DOI 10.1139/y92-107; Chai W., 2014, U.S. Patent, Patent No. 20140275029; Chai W., 2014, U.S. Patent, Patent No. 20140275028; CHENG Y, 1973, BIOCHEM PHARMACOL, V22, P3099; Dahlen B, 1997, THORAX, V52, P342, DOI 10.1136/thx.52.4.342; DIAMANT Z, 1995, J ALLERGY CLIN IMMUN, V95, P42, DOI 10.1016/S0091-6749(95)70151-6; DIXON RAF, 1990, NATURE, V343, P282, DOI 10.1038/343282a0; Evans JF, 2008, TRENDS PHARMACOL SCI, V29, P72, DOI 10.1016/j.tips.2007.11.006; Ferguson AD, 2007, SCIENCE, V317, P510, DOI 10.1126/science.1144346; Fitzgerald A. E., 2014, [No title captured], Patent No. [WO2014121040 A1, 2014121040]; HAEGGSTROM JZ, 1993, J LIPID MEDIATOR, V6, P1; LAM BK, 1994, P NATL ACAD SCI USA, V91, P7663, DOI 10.1073/pnas.91.16.7663; Lemurell M, 2015, J MED CHEM, V58, P897, DOI 10.1021/jm501531v; Lewis David F. V., 2009, Drug Metabolism and Drug Interactions, V24, P229, DOI 10.1515/DMDI.2009.24.2-4.229; LIN JH, 1995, DRUG METAB DISPOS, V23, P1008; Lorrain DS, 2010, EUR J PHARMACOL, V640, P211, DOI 10.1016/j.ejphar.2010.05.003; MANCINI JA, 1992, MOL PHARMACOL, V41, P267; Miller D. K., 2004, P INFL RES ASS 12 IN; Pawelzik SC, 2010, J BIOL CHEM, V285, P29254, DOI 10.1074/jbc.M110.114454; ROUZER CA, 1990, J BIOL CHEM, V265, P1436; Sampson AP, 2009, CURR OPIN INVEST DR, V10, P1163; Shultz LD, 2007, NAT REV IMMUNOL, V7, P118, DOI 10.1038/nri2017; Singh D, 2013, INT J GEN MED, V6, P897, DOI 10.2147/IJGM.S51364; Song J, 2016, J BIOMOL SCREEN, V21, P127, DOI 10.1177/1087057115607815; Song J, 2015, J LIPID RES, V56, P1492, DOI 10.1194/jlr.M058677; Tichenor MS, 2015, J MED CHEM, V58, P7119, DOI 10.1021/acs.jmedchem.5b00516; VICKERS PJ, 1992, MOL PHARMACOL, V42, P1014; VICKERS PJ, 1995, J LIPID MEDIAT CELL, V12, P185, DOI 10.1016/0929-7855(95)00018-L; WELSCH DJ, 1994, P NATL ACAD SCI USA, V91, P9745, DOI 10.1073/pnas.91.21.9745; Xu DG, 2008, J PHARMACOL EXP THER, V326, P754, DOI 10.1124/jpet.108.138776	31	7	7	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 10	2016	291	24					12724	12731		10.1074/jbc.M116.725325	http://dx.doi.org/10.1074/jbc.M116.725325			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DO9PV	27129215	hybrid, Green Published			2022-12-26	WOS:000378119900025
J	Misu, A; Yamanaka, H; Aramaki, T; Kondo, S; Skerrett, M; Iovine, MK; Watanabe, M				Misu, Akihiro; Yamanaka, Hiroaki; Aramaki, Toshihiro; Kondo, Shigeru; Skerrett, Martha; Iovine, M. Kathryn; Watanabe, Masakatsu			Two Different Functions of Connexin43 Confer Two Different Bone Phenotypes in Zebrafish	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MUTATIONS; OSTEOBLAST; DISEASE; GROWTH; FIN; PROSTAGLANDIN; COMMUNICATION; MORPHOGENESIS; EXPRESSION; OSTEOCYTES	Fish remain nearly the same shape as they grow, but there are two different modes of bone growth. Bones in the tail fin (fin ray segments) are added distally at the tips of the fins and do not elongate once produced. On the other hand, vertebrae enlarge in proportion to body growth. To elucidate how bone growth is controlled, we investigated a zebrafish mutant, steopsel (stp(tl28d)). Vertebrae of stp(tl28d/+) fish look normal in larvae (similar to 30 days) but are distinctly shorter (59-81%) than vertebrae of wild type fish in adults. In contrast, the lengths of fin rays are only slightly shorter (similar to 95%) than those of the wild type in both larvae and adults. Positional cloning revealed that stp encodes Connexin43 (Cx43), a connexin that functions as a gap junction and hemichannel. Interestingly, cx43 was also identified as the gene causing the short-of-fin (sof) phenotype, in which the fin ray segments are shorter but the vertebrae are normal. To identify the cause of this difference between the alleles, we expressed Cx43 exogenously in Xenopus oocytes and performed electrophysiological analysis of the mutant proteins. Gap junction coupling induced by Cx43(stp) or Cx43(sof) was reduced compared with Cx43-WT. On the other hand, only Cx43(stp) induced abnormally high (50x wild type) transmembrane currents through hemichannels. Our results suggest that Cx43 plays critical and diverse roles in zebrafish bone growth.	[Misu, Akihiro; Yamanaka, Hiroaki; Aramaki, Toshihiro; Kondo, Shigeru; Watanabe, Masakatsu] Osaka Univ, Grad Sch Frontier Biosci, 1-3 Yamadaoka, Suita, Osaka 5650871, Japan; [Kondo, Shigeru] Japan Sci & Technol Agcy, CREST, 1-3 Yamadaoka, Suita, Osaka 5650871, Japan; [Skerrett, Martha] Buffalo State Coll, Dept Biol, Buffalo, NY 14222 USA; [Iovine, M. Kathryn] Lehigh Univ, Dept Biol Sci, Bethlehem, PA 18015 USA	Osaka University; Japan Science & Technology Agency (JST); State University of New York (SUNY) System; Buffalo State College; Lehigh University	Watanabe, M (corresponding author), Osaka Univ, Grad Sch Frontier Biosci, 1-3 Yamadaoka, Suita, Osaka 5650871, Japan.	watanabe-m@fbs.osaka-u.ac.jp	WATANABE, Masakatsu/V-9082-2019	WATANABE, Masakatsu/0000-0002-5744-197X; Kondo, Shigeru/0000-0003-0192-5526	Ministry of Education, Culture, Sports, Science, and Technology in Japan KAKENHI Grant [22127003]; Core Research for Evolutional Science and Technology (CREST), Japan Science and Technology Agency; Japanese Society for the Promotion of Science KAKENHI Grant [26291049]; Grants-in-Aid for Scientific Research [26291049] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science, and Technology in Japan KAKENHI Grant; Core Research for Evolutional Science and Technology (CREST), Japan Science and Technology Agency(Japan Science & Technology Agency (JST)Core Research for Evolutional Science and Technology (CREST)); Japanese Society for the Promotion of Science KAKENHI Grant; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by Ministry of Education, Culture, Sports, Science, and Technology in Japan KAKENHI Grant 22127003 (to S. K.); by the Core Research for Evolutional Science and Technology (CREST), Japan Science and Technology Agency (to S. K.); and by Japanese Society for the Promotion of Science KAKENHI Grant 26291049 (to M. W.). The authors declare that they have no conflicts of interest with the contents of this article.	Abascal F, 2013, BBA-BIOMEMBRANES, V1828, P4, DOI 10.1016/j.bbamem.2012.02.007; Attanasio C, 2013, SCIENCE, V342, DOI 10.1126/science.1241006; Bai DL, 2016, SEMIN CELL DEV BIOL, V50, P74, DOI 10.1016/j.semcdb.2015.11.015; Becker DL, 2016, SEMIN CELL DEV BIOL, V50, P49, DOI 10.1016/j.semcdb.2015.12.009; Bonewald LF, 2011, J BONE MINER RES, V26, P229, DOI 10.1002/jbmr.320; Caetano-Lopes J, 2007, ACTA REUMATOL PORT, V32, P103; Cermak T, 2011, NUCLEIC ACIDS RES, V39, DOI 10.1093/nar/gkr218; Cherian PP, 2005, MOL BIOL CELL, V16, P3100, DOI 10.1091/mbc.E04-10-0912; Clement A, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000136; Cooper KL, 2013, NATURE, V495, P375, DOI 10.1038/nature11940; Dahlem TJ, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002861; Duplomb L, 2007, STEM CELLS, V25, P544, DOI 10.1634/stemcells.2006-0395; Eastman SD, 2006, GENOMICS, V87, P265, DOI 10.1016/j.ygeno.2005.10.005; Furutani K, 2009, MOL PHARMACOL, V75, P1287, DOI 10.1124/mol.108.052936; Gluhak-Heinrich J, 2003, J BONE MINER RES, V18, P807, DOI 10.1359/jbmr.2003.18.5.807; Gray RS, 2014, DEV BIOL, V386, P72, DOI 10.1016/j.ydbio.2013.11.028; Haffter P, 1996, DEV GENES EVOL, V206, P260, DOI 10.1007/s004270050051; Haffter P, 1996, DEVELOPMENT, V123, P1; Harada S, 2003, NATURE, V423, P349, DOI 10.1038/nature01660; Hoptak-Solga AD, 2008, DEV BIOL, V317, P541, DOI 10.1016/j.ydbio.2008.02.051; Hoptak-Solga AD, 2007, FEBS LETT, V581, P3297, DOI 10.1016/j.febslet.2007.06.030; Huycke TR, 2012, DEVELOPMENT, V139, P2371, DOI 10.1242/dev.079806; Iovine MK, 2005, DEV BIOL, V278, P208, DOI 10.1016/j.ydbio.2004.11.005; Iovine MK, 2000, GENETICS, V155, P1321; Kimmel CB, 2001, DEV BIOL, V233, P239, DOI 10.1006/dbio.2001.0201; Komori T, 2006, J CELL BIOCHEM, V99, P1233, DOI 10.1002/jcb.20958; Kumar NM, 1996, CELL, V84, P381, DOI 10.1016/S0092-8674(00)81282-9; Laird DW, 2014, FEBS LETT, V588, P1339, DOI 10.1016/j.febslet.2013.12.022; Merrifield PA, 2016, SEMIN CELL DEV BIOL, V50, P67, DOI 10.1016/j.semcdb.2015.12.001; Neuhauss SCF, 1996, DEVELOPMENT, V123, P357; Perathoner S, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004080; Piotrowski T, 1996, DEVELOPMENT, V123, P345; Pizzuti Antonio, 2004, Hum Mutat, V23, P286, DOI 10.1002/humu.9220; Sakuma T, 2013, GENES CELLS, V18, P315, DOI 10.1111/gtc.12037; Schilling TF, 1996, DEVELOPMENT, V122, P1417; Schoenebeck JJ, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002849; Sims K, 2009, DEV BIOL, V327, P410, DOI 10.1016/j.ydbio.2008.12.027; Suda K, 2004, J IMMUNOL, V172, P2504, DOI 10.4049/jimmunol.172.4.2504; Urasaki A, 2006, GENETICS, V174, P639, DOI 10.1534/genetics.106.060244	39	15	18	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 10	2016	291	24					12601	12611		10.1074/jbc.M116.720110	http://dx.doi.org/10.1074/jbc.M116.720110			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DO9PV	27129238	hybrid, Green Published			2022-12-26	WOS:000378119900017
J	Fernandez-Navarro, J; Aldea, P; de Hoz, R; Salazar, JJ; Ramirez, AI; Rojas, B; Gallego, BI; Trivino, A; Tejerina, T; Ramirez, JM				Fernandez-Navarro, Judith; Aldea, Pilar; de Hoz, Rosa; Salazar, Juan J.; Ramirez, Ana I.; Rojas, Blanca; Gallego, Beatriz I.; Trivino, Alberto; Tejerina, Teresa; Ramirez, Jose M.			Neuroprotective Effects of Low-Dose Statins in the Retinal Ultrastructure of Hypercholesterolemic Rabbits	PLOS ONE			English	Article							AGE-RELATED MACULOPATHY; COA REDUCTASE INHIBITOR; NITRIC-OXIDE SYNTHASE; COENZYME-A REDUCTASE; BLOOD-BRAIN-BARRIER; CHOLESTEROL LEVELS; APOLIPOPROTEIN-E; NEURODEGENERATIVE DISEASES; MACULAR DEGENERATION; BRUCHS MEMBRANE	To evaluate the pleiotropic effects to statins, we analyze the qualitative and quantitative retinal changes in hypercholesterolemic rabbits after a low-dosage statin treatment. For this purpose, New Zealand rabbits were split into three groups: control (G0; n = 10), fed a standard diet; hypercholesterolemic (G1; n = 8), fed a 0.5% cholesterol-enriched diet for 8 months; and statins (G2; n = 8), fed a 0.5% cholesterol-enriched diet for 8 months, together with the administration of statin (pravastatin or fluvastatin sodium) at a dose of 2 mg / kg / day each diet. The retinas were analyzed by transmission electron microscopy and immunohistochemistry (glial fibrillary acidic protein). The retinal thickness of nuclear and plexiform layers were quantified in semi-thin sections. The results revealed that the low-statin-treated rabbits in comparison with the hypercholesterolemic group showed: i) a more preserved structure in all retinal layers; ii) a significant reduction in retinal thickness; iii) a decrease in cell death in the nuclear-and ganglion-cell layers; iv) a reduction of hydropic degeneration in the plexiform and nerve-fiber layers; v) a preservation of astrocytes and of the retinal area occupied by them; and vi) a better-preserved retinal vascular structure. Our findings indicate that low doses of statins can prevent retinal degeneration, acting on retinal macroglia, neurons and retinal vessels, despite that hypercholesterolemia remained unchanged. Thus, the pleiotropic effects of the statins may help safeguard the retinal ultrastructure.	[Fernandez-Navarro, Judith; Aldea, Pilar; de Hoz, Rosa; Salazar, Juan J.; Ramirez, Ana I.; Rojas, Blanca; Gallego, Beatriz I.; Trivino, Alberto; Ramirez, Jose M.] Univ Complutense Madrid, Inst Invest Oftalmol Ramon Castroviejo, Madrid, Spain; [de Hoz, Rosa; Salazar, Juan J.; Ramirez, Ana I.; Gallego, Beatriz I.] UCM, Fac Opt & Optometria, Barcelona, Spain; [Rojas, Blanca; Trivino, Alberto; Ramirez, Jose M.] UCM, Fac Med, Barcelona, Spain; [Tejerina, Teresa] Univ Complutense, Sch Med, Dept Pharmacol, E-28040 Madrid, Spain	Complutense University of Madrid; Complutense University of Madrid; Complutense University of Madrid; University of Barcelona; Complutense University of Madrid	Ramirez, JM (corresponding author), Univ Complutense Madrid, Inst Invest Oftalmol Ramon Castroviejo, Madrid, Spain.; Ramirez, JM (corresponding author), UCM, Fac Med, Barcelona, Spain.	ramirezs@med.ucm.es	Salazar, Juan J/L-6887-2014; Ramírez, José Manuel/L-6325-2014; De Hoz, Rosa/ABF-9295-2020; Ramírez, Ana I/ABF-4789-2021; ROJAS, BLANCA/V-8292-2017; Alberto, Trivino/ABG-2416-2020	Salazar, Juan J/0000-0001-5480-5902; Ramírez, José Manuel/0000-0002-5145-5094; De Hoz, Rosa/0000-0002-1581-087X; Ramírez, Ana I/0000-0002-2656-4723; 	RETICs Patologia Ocular del Envejecimiento, Calidad Visual y Calidad de Vida (Instituto de Salud Carlos III, Ministerio de Sanidad y Consumo) [RD07/0062/0000]; Fundacion Mutua Madrilena [4131173]; Programa de Creacion y Consolidacion de Grupos de Investigacion Banco Santander Central Hispano - Universidad Complutense [GR3/14]; RETICs RECAVA (Instituto de Salud Carlos III, Ministerio de Sanidad y Consumo) [RD06/0014/0007]	RETICs Patologia Ocular del Envejecimiento, Calidad Visual y Calidad de Vida (Instituto de Salud Carlos III, Ministerio de Sanidad y Consumo); Fundacion Mutua Madrilena(Instituto de Salud Carlos III); Programa de Creacion y Consolidacion de Grupos de Investigacion Banco Santander Central Hispano - Universidad Complutense; RETICs RECAVA (Instituto de Salud Carlos III, Ministerio de Sanidad y Consumo)	This work was supported by RETICs Patologia Ocular del Envejecimiento, Calidad Visual y Calidad de Vida (Grant RD07/0062/0000, Instituto de Salud Carlos III, Ministerio de Sanidad y Consumo) (RdH, JJS, AIR, BR, BIG, AT, JMR); Fundacion Mutua Madrilena (Grant 4131173) (RdH, JJS, AIR, BR, AT, JMR); Programa de Creacion y Consolidacion de Grupos de Investigacion Banco Santander Central Hispano - Universidad Complutense GR3/14 (RdH, JJS, AIR, BR, AT, JMR). RETICs RECAVA (Grant RD06/0014/0007, Instituto de Salud Carlos III, Ministerio de Sanidad y Consumo) (TT).	Abbott NJ, 2006, NAT REV NEUROSCI, V7, P41, DOI 10.1038/nrn1824; Amaratunga A, 1996, J BIOL CHEM, V271, P5628, DOI 10.1074/jbc.271.10.5628; Ames A, 2000, BRAIN RES REV, V34, P42, DOI 10.1016/S0165-0173(00)00038-2; Gutierrez-Vargas JA, 2014, J NEUROSCI RES, V92, P1529, DOI 10.1002/jnr.23426; Banach M, 2014, PHARMACOL REP, V66, P521, DOI 10.1016/j.pharep.2014.02.026; Baskin F, 1997, J NEUROL SCI, V148, P15, DOI 10.1016/S0022-510X(96)05335-X; Bull ND, 2011, INVEST OPHTH VIS SCI, V52, P3309, DOI 10.1167/iovs.10-6873; CHAPMAN MJ, 1980, J LIPID RES, V21, P789; Claudepierre T, 2010, MOL CELL NEUROSCI, V43, P164, DOI 10.1016/j.mcn.2009.10.007; Crispin S, 2002, PROG RETIN EYE RES, V21, P169, DOI 10.1016/S1350-9462(02)00004-6; Cuenca N, 2014, PROG RETIN EYE RES, V43, P17, DOI 10.1016/j.preteyeres.2014.07.001; Curcio CA, 2005, EXP EYE RES, V81, P731, DOI 10.1016/j.exer.2005.04.012; Curcio CA, 2011, BRIT J OPHTHALMOL, V95, P1638, DOI 10.1136/bjophthalmol-2011-300344; Curcio CA, 2009, PROG RETIN EYE RES, V28, P393, DOI 10.1016/j.preteyeres.2009.08.001; Dashti N, 2006, BRIT J OPHTHALMOL, V90, P1028, DOI 10.1136/bjo.2006.093856; Torres RJD, 2009, ARQ BRAS OFTALMOL, V72, P793, DOI 10.1590/S0004-27492009000600010; Finking G, 1997, ATHEROSCLEROSIS, V135, P1, DOI 10.1016/S0021-9150(97)00161-5; Fliesler SJ, 2004, ARCH OPHTHALMOL-CHIC, V122, P1190, DOI 10.1001/archopht.122.8.1190; Fliesler SJ, 2015, J LIPID RES, V56, P1, DOI 10.1194/jlr.C056358; Fliesler SJ, 2010, J LIPID RES, V51, P3399, DOI 10.1194/jlr.R010538; Fourgeux C, 2015, CHOLESTEROL OCULAR P, V22, pD204; Fritsche LG, 2013, NAT GENET, V45, P433, DOI 10.1038/ng.2578; Gehlbach P, 2015, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006927.pub4; Gonzalez H, 2014, J NEUROIMMUNOL, V274, P1, DOI 10.1016/j.jneuroim.2014.07.012; Gordon GRJ, 2007, GLIA, V55, P1214, DOI 10.1002/glia.20543; Goritz C, 2005, MOL CELL NEUROSCI, V29, P190, DOI 10.1016/j.mcn.2005.02.006; Hall NF, 2001, BRIT MED J, V323, P375, DOI 10.1136/bmj.323.7309.375; Hayden MS, 2008, CELL, V132, P344, DOI 10.1016/j.cell.2008.01.020; Hernandez-Perera O, 1998, J CLIN INVEST, V101, P2711, DOI 10.1172/JCI1500; Iadecola C, 2007, NAT NEUROSCI, V10, P1369, DOI 10.1038/nn2003; Johnson-Anuna LN, 2005, J PHARMACOL EXP THER, V312, P786, DOI 10.1124/jpet.104.075028; Kawaji T, 2007, CURR EYE RES, V32, P991, DOI 10.1080/02713680701649603; Koehler RC, 2009, TRENDS NEUROSCI, V32, P160, DOI 10.1016/j.tins.2008.11.005; Krupin T, 2011, AM J OPHTHALMOL, V151, P671, DOI 10.1016/j.ajo.2010.09.026; KUROKAWA J, 1995, BBA-LIPID LIPID MET, V1259, P99, DOI 10.1016/0005-2760(95)00155-6; Kusuhara H, 1999, J BIOL CHEM, V274, P13675, DOI 10.1074/jbc.274.19.13675; Lee TM, 2004, ATHEROSCLEROSIS, V176, P273, DOI 10.1016/j.atherosclerosis.2004.06.005; Li MY, 2014, HUM MOL GENET, V23, P4001, DOI 10.1093/hmg/ddu114; Li Q, 2014, EUR REV MED PHARMACO, V18, P1113; Mach F, 2004, CIRCULATION, V109, P15, DOI 10.1161/01.CIR.0000129502.10459.fe; Marcus MW, 2012, CHOLESTEROL LOWERING, V7; MARTINOU JC, 1994, NEURON, V13, P1017, DOI 10.1016/0896-6273(94)90266-6; McCarty CA, 2001, MED J AUSTRALIA, V175, P340, DOI 10.5694/j.1326-5377.2001.tb143604.x; McGwin G, 2003, BRIT J OPHTHALMOL, V87, P1121, DOI 10.1136/bjo.87.9.1121; McGwin Jr G, 2007, ANONYMOUS RETINAL DE, P185; Miceli MV, 2000, CURR EYE RES, V20, P8, DOI 10.1076/0271-3683(200001)20:1;1-H;FT008; MIGHELI A, 1994, NEUROREPORT, V5, P1906, DOI 10.1097/00001756-199410000-00016; Mitani H, 2000, CARDIOVASC DRUG REV, V18, P284; MOORE DJ, 1995, INVEST OPHTH VIS SCI, V36, P1290; Morikawa Shigeru, 2002, J Atheroscler Thromb, V9, P178; Morishita S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084387; O'Brien KD, 1998, CIRCULATION, V98, P519, DOI 10.1161/01.CIR.98.6.519; Ong JM, 2001, INVEST OPHTH VIS SCI, V42, P1891; Pang CE, 2015, OPHTHALMOLOGY, V122, P2316, DOI 10.1016/j.ophtha.2015.07.008; Pekny M, 2014, PHYSIOL REV, V94, P1077, DOI 10.1152/physrev.00041.2013; Peng L, 2014, CURR NEUROPHARMACOL, V12, P303, DOI 10.2174/1570159X12999140829152550; Pfenninger KH, 2009, NAT REV NEUROSCI, V10, P251, DOI 10.1038/nrn2593; Pfrieger FW, 2011, PROG LIPID RES, V50, P357, DOI 10.1016/j.plipres.2011.06.002; Piermartiri TCB, 2010, EXP NEUROL, V226, P274, DOI 10.1016/j.expneurol.2010.08.030; Pikuleva IA, 2014, PROG RETIN EYE RES, V41, P64, DOI 10.1016/j.preteyeres.2014.03.002; Ponce J, 2008, STROKE, V39, P1269, DOI 10.1161/STROKEAHA.107.498923; Ramirez AI, 2006, EXP EYE RES, V83, P1423, DOI 10.1016/j.exer.2006.07.023; RAMIREZ JM, 1994, VISION RES, V34, P1935, DOI 10.1016/0042-6989(94)90024-8; REDDY C, 1987, INVEST OPHTH VIS SCI, V28, P1492; REDGRAVE TG, 1976, ATHEROSCLEROSIS, V24, P501, DOI 10.1016/0021-9150(76)90142-8; Rikitake Y, 2001, ATHEROSCLEROSIS, V154, P87, DOI 10.1016/S0021-9150(00)00468-8; Rojas B, 2011, ACTA OPHTHALMOL, V89, P660, DOI 10.1111/j.1755-3768.2009.01829.x; ROTH RI, 1983, J LIPID RES, V24, P1; Salazar JJ, 2007, EXP EYE RES, V84, P412, DOI 10.1016/j.exer.2006.10.012; Schmeer C, 2008, INVEST OPHTH VIS SCI, V49, P4971, DOI 10.1167/iovs.07-1597; Song J, 2005, INVEST OPHTH VIS SCI, V46, P2424, DOI 10.1167/iovs.04-0776; Starita C, 1996, EXP EYE RES, V62, P565, DOI 10.1006/exer.1996.0066; Tezel G, 2009, INVEST OPHTH VIS SCI, V50, P1001, DOI 10.1167/iovs.08-2717; TOUT S, 1993, NEUROSCIENCE, V55, P291, DOI 10.1016/0306-4522(93)90473-S; TRIVINO A, 1992, VISION RES, V32, P1601, DOI 10.1016/0042-6989(92)90153-A; Trivino A, 1997, VISION RES, V37, P1707, DOI 10.1016/S0042-6989(97)00021-7; Trivino A, 2006, EXP EYE RES, V83, P357, DOI 10.1016/j.exer.2005.12.020; Tserentsoodol N, 2006, MOL VIS, V12, P1319; Tserentsoodol N, 2006, MOL VIS, V12, P1306; TSUJI A, 1993, J PHARMACOL EXP THER, V267, P1085; van der Most PJ, 2009, PROG NEUROBIOL, V88, P64, DOI 10.1016/j.pneurobio.2009.02.002; Vandresen S, 2013, NEUROCHEM INT, V62, P948, DOI 10.1016/j.neuint.2013.03.002; Vavvas DG, 2016, REGRESSION SOME HIGH; Verkhratsky A, 2014, REV PHYSIOL BIOCH P, V166, P1, DOI 10.1007/112_2013_15; Wagner AH, 2000, ARTERIOSCL THROM VAS, V20, P61, DOI 10.1161/01.ATV.20.1.61; WALTON KW, 1974, J PATHOL, V114, P217, DOI 10.1002/path.1711140406; Wang L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010329; Wang Q, 2009, EXP NEUROL, V216, P132, DOI 10.1016/j.expneurol.2008.11.016; Wassmann S, 2001, MOL PHARMACOL, V59, P646, DOI 10.1124/mol.59.3.646; Wilson JX, 1997, CAN J PHYSIOL PHARM, V75, P1149, DOI 10.1139/cjpp-75-10-11-1149; Wu TH, 2010, J NEUROCHEM, V114, P1734, DOI 10.1111/j.1471-4159.2010.06884.x; Yamada K, 2007, INVEST OPHTH VIS SCI, V48, P1839, DOI 10.1167/iovs.06-1085; Yang Dongmei, 2012, World J Neurosci, V2, P74; Yanni AE, 2004, LAB ANIM-UK, V38, P246, DOI 10.1258/002367704323133628; Yucel I, 2005, VISION RES, V45, P1107, DOI 10.1016/j.visres.2004.11.018; Zheng WC, 2015, J LIPID RES, V56, P81, DOI 10.1194/jlr.M053439; Zheng WC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037926; Zong WX, 2006, GENE DEV, V20, P1, DOI 10.1101/gad.1376506	98	7	7	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 4	2016	11	5							e0154800	10.1371/journal.pone.0154800	http://dx.doi.org/10.1371/journal.pone.0154800			28	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DL5KR	27144842	Green Submitted, Green Accepted, Green Published, gold			2022-12-26	WOS:000375676400074
J	Huovinen, P; Ramirez, J; Gomez, I				Huovinen, Pirjo; Ramirez, Jaime; Gomez, Ivan			Underwater Optics in Sub-Antarctic and Antarctic Coastal Ecosystems	PLOS ONE			English	Article							SOLAR ULTRAVIOLET-RADIATION; UV-B PENETRATION; SOUTHERN CHILE; COMAU FJORD; SPECTRAL ATTENUATION; PATAGONIAN FJORD; OZONE DEPLETION; ORGANIC-CARBON; LIGHT-FIELD; WATERS	Understanding underwater optics in natural waters is essential in evaluating aquatic primary production and risk of UV exposure in aquatic habitats. Changing environmental conditions related with global climate change, which imply potential contrasting changes in underwater light climate further emphasize the need to gain insights into patterns related with underwater optics for more accurate future predictions. The present study evaluated penetration of solar radiation in six sub-Antarctic estuaries and fjords in Chilean North Patagonian region (39-44 degrees S) and in an Antarctic bay (62 degrees S). Based on vertical diffuse attenuation coefficients (K-d), derived from measurements with a submersible multichannel radiometer, average summer UV penetration depth (z(1%)) in these water bodies ranged 2-11 m for UV-B (313 nm), 4-27 m for UV-A (395 nm), and 7-30 m for PAR (euphotic zone). UV attenuation was strongest in the shallow Quempillen estuary, while Fildes Bay (Antarctica) exhibited the highest transparency. Optically non-homogeneous water layers and seasonal variation in transparency (lower in winter) characterized Comau Fjord and Puyuhuapi Channel. In general, multivariate analysis based on K-d values of UV and PAR wavelengths discriminated strongly Quempillen estuary and Puyuhuapi Channel from other study sites. Spatial (horizontal) variation within the estuary of Valdivia river reflected stronger attenuation in zones receiving river impact, while within Fildes Bay a lower spatial variation in water transparency could in general be related to closeness of glaciers, likely due to increased turbidity through ice-driven processes. Higher transparency and deeper UV-B penetration in proportion to UV-A/visible wavelengths observed in Fildes Bay suggests a higher risk for Antarctic ecosystems reflected by e.g. altered UV-B damage vs. photorepair under UV-A/PAR. Considering that damage repair processes often slow down under cool temperatures, adverse UV impact could be further exacerbated by cold temperatures in this location, together with episodes of ozone depletion. Overall, the results emphasize the marked spatial (horizontal and vertical) and temporal heterogeneity of optical characteristics, and challenges that these imply for estimations of underwater optics.	[Huovinen, Pirjo; Ramirez, Jaime; Gomez, Ivan] Univ Austral Chile, Fac Ciencias, Inst Ciencias Marinas & Limnol, Valdivia, Chile; [Huovinen, Pirjo; Gomez, Ivan] Ctr Fondap Invest Altas Latitudes IDEAL, Valdivia, Chile	Universidad Austral de Chile	Huovinen, P (corresponding author), Univ Austral Chile, Fac Ciencias, Inst Ciencias Marinas & Limnol, Valdivia, Chile.; Huovinen, P (corresponding author), Ctr Fondap Invest Altas Latitudes IDEAL, Valdivia, Chile.	pirjo.huovinen@uach.cl		Huovinen, Pirjo/0000-0002-7754-4933; Gomez, Ivan/0000-0001-8381-3792	Fondo Nacional de Desarrollo Cientifico y Tecnologico (FONDECYT-CONICYT) [1130582, 1130794]; Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT) [Anillo ART1101]; Conicyt [15150003];  [11]	Fondo Nacional de Desarrollo Cientifico y Tecnologico (FONDECYT-CONICYT); Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)); Conicyt(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)); 	This research was funded by the following grants to PH and IG: Grant # 1130582 and Grant # 1130794, Fondo Nacional de Desarrollo Cientifico y Tecnologico (FONDECYT-CONICYT) (www.conicyt.cl/fondecyt); Anillo ART1101, Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT) (http://www.conicyt.cl/pia). In addition, the data and manuscript processing was carried out in the frame of Centro Fondap-IDEAL (Grant 15150003) funded by Conicyt. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The logistical support provided by the Instituto Antartico Chileno (INACh), the staff of Base Julio Escudero Station in the Antarctic and the staff of Huinay Scientific Station in Comau Fjord is greatly acknowledged. We also thank M. J. Diaz, P. Munoz and I. Garrido for their support and contribution in the raw data collection during several field campaigns. We are grateful for the two reviewers for their valuable comments, which substantially improved the manuscript. This is contribution # 11 of the Anillo ART1101 project.	Barnes BB, 2014, REMOTE SENS ENVIRON, V140, P519, DOI 10.1016/j.rse.2013.09.024; Barron MG, 2005, PHOTOCHEM PHOTOBIOL, V81, P187, DOI 10.1562/2004-05-10-RN-160.1; Bracher AU, 2001, POLAR BIOL, V24, P687, DOI 10.1007/s003000100269; Caceres M, 2008, REV BIOL MAR OCEANOG, V43, P629; Casiccia C, 2003, ATMOS ENVIRON, V37, P383, DOI 10.1016/S1352-2310(02)00890-7; Castillo MI, 2012, CONT SHELF RES, V49, P73, DOI 10.1016/j.csr.2012.09.007; CONAMA, 2006, TECHNICAL REPORT; Davila PM, 2002, CONT SHELF RES, V22, P521, DOI 10.1016/S0278-4343(01)00072-3; Deregibus D, 2016, POLAR BIOL, V39, P153, DOI 10.1007/s00300-015-1679-y; Figueroa FL, 2002, DEEP-SEA RES PT II, V49, P675, DOI 10.1016/S0967-0645(01)00118-7; Gomez I, 2005, AQUACULTURE, V244, P369, DOI 10.1016/j.aquaculture.2004.11.037; Gomez I, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0134440; Gomez I, 2011, MAR ECOL PROG SER, V422, P77, DOI 10.3354/meps08937; Gomez I, 2010, PHOTOCHEM PHOTOBIOL, V86, P1056, DOI 10.1111/j.1751-1097.2010.00786.x; Hanelt D, 2001, MAR BIOL, V138, P649, DOI 10.1007/s002270000481; Hargreaves BR, 2003, COMP SER PHOTOCHEM, V1, P59; HAUSSERMANN V, 2009, NATURE FOCUS; Huovinen P, 2006, PHOTOCHEM PHOTOBIOL, V82, P515, DOI 10.1562/2005-07-05-RA-601; Huovinen P, 2010, SEAWEED BIOL NOVEL I, P293; Huovinen P, 2013, POLAR BIOL, V36, P1319, DOI 10.1007/s00300-013-1351-3; Huovinen P, 2011, CONT SHELF RES, V31, P254, DOI 10.1016/j.csr.2010.09.004; Huovinen PS, 2003, CHEMOSPHERE, V51, P205, DOI 10.1016/S0045-6535(02)00634-3; Iriarte JL, 2014, PROG OCEANOGR, V129, P1, DOI 10.1016/j.pocean.2014.10.004; Jacob BG, 2014, PROG OCEANOGR, V129, P75, DOI 10.1016/j.pocean.2014.08.003; Johannessen SC, 2003, J GEOPHYS RES-OCEANS, V108, DOI 10.1029/2000JC000514; Kirk J.T.O., 2011, LIGHT PHOTOSYNTHESIS; Kjeldstad B, 2003, MAR ECOL PROG SER, V256, P1, DOI 10.3354/meps256001; Lee ZP, 2013, J GEOPHYS RES-OCEANS, V118, P4241, DOI 10.1002/jgrc.20308; Quartino ML, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058223; Iriarte JL, 2013, ENVIRON MONIT ASSESS, V185, P5055, DOI 10.1007/s10661-012-2925-1; Iriarte JL, 2010, AMBIO, V39, P463, DOI 10.1007/s13280-010-0049-9; Mobley CD, 2015, PHOTOBIOLOGY SCI LIG, P77; MONTECINO V, 1995, MAR ECOL PROG SER, V121, P261, DOI 10.3354/meps121261; Montero P, 2007, PROG OCEANOGR, V75, P518, DOI 10.1016/j.pocean.2007.08.013; Morris DP, 1995, LIMNOL OCEANOGR, V40, P1381, DOI 10.4319/lo.1995.40.8.1381; Morris DP, 1997, LIMNOL OCEANOGR, V42, P239, DOI 10.4319/lo.1997.42.2.0239; Munoz P, 2014, PROG OCEANOGR, V129, P159, DOI 10.1016/j.pocean.2014.10.003; Neale PJ, 2003, COMP SER PHOTOCHEM, V1, P107; Palma S, 2004, DEEP-SEA RES PT II, V51, P513, DOI 10.1016/j.dsr2.2004.05.001; Pantoja S, 2011, CONT SHELF RES, V31, P149, DOI 10.1016/j.csr.2010.10.013; Perin S., 2004, Environmental Reviews, V12, P1, DOI 10.1139/a04-003; PICKARD GL, 1971, J FISH RES BOARD CAN, V28, P1077, DOI 10.1139/f71-163; Rakusa-Suszczewski S, 2002, ECOL STU AN, V154, P23; Ribeiro S, 2007, J MAR BIOL ASSOC UK, V87, P119, DOI 10.1017/S0025315407051594; Sanchez N, 2011, J PLANKTON RES, V33, P1212, DOI 10.1093/plankt/fbr022; Schindler DW, 1996, NATURE, V379, P705, DOI 10.1038/379705a0; Schneider W, 2014, PROG OCEANOGR, V129, P8, DOI 10.1016/j.pocean.2014.03.007; Scully N.M., 1994, ARCH HYDROBIOL, V43, P135; Sempere R, 2015, PHOTOCHEM PHOTOBIOL, V91, P851, DOI 10.1111/php.12434; SMITH RC, 1992, SCIENCE, V255, P952, DOI 10.1126/science.1546292; Sommaruga R, 1997, PHOTOCHEM PHOTOBIOL, V65, P957, DOI 10.1111/j.1751-1097.1997.tb07954.x; Soto D, 2004, J APPL ICHTHYOL, V20, P493, DOI 10.1111/j.1439-0426.2004.00602.x; Tedetti M, 2006, PHOTOCHEM PHOTOBIOL, V82, P389, DOI 10.1562/2005-11-09-IR-733; Valdivia N, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0138582; Valle-Levinson A, 2007, ESTUAR COAST, V30, P113, DOI 10.1007/BF02782972; Wei JW, 2014, J GEOPHYS RES-OCEANS, V119, P1344, DOI 10.1002/2013JC009572; Williamson CE, 2001, ECOL APPL, V11, P1843, DOI 10.1890/1051-0761(2001)011[1843:BADEOU]2.0.CO;2; Williamson CE, 2014, NAT CLIM CHANGE, V4, P434, DOI [10.1038/nclimate2225, 10.1038/NCLIMATE2225]; Williamson CE, 2009, INT REV HYDROBIOL, V94, P129, DOI 10.1002/iroh.200811099; Yan ND, 1996, NATURE, V381, P141, DOI 10.1038/381141a0; Zacher K, 2009, BOT MAR, V52, P483, DOI 10.1515/BOT.2009.082; Zaneveld JRV, 2001, APPL OPTICS, V40, P1442, DOI 10.1364/AO.40.001442	62	18	18	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 4	2016	11	5							e0154887	10.1371/journal.pone.0154887	http://dx.doi.org/10.1371/journal.pone.0154887			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DL5KR	27144454	Green Published, gold			2022-12-26	WOS:000375676400092
J	Karb, RA; Subramanian, SV; Fleegler, EW				Karb, Rebecca A.; Subramanian, S. V.; Fleegler, Eric W.			County Poverty Concentration and Disparities in Unintentional Injury Deaths: A Fourteen-Year Analysis of 1.6 Million US Fatalities	PLOS ONE			English	Article							SOCIOECONOMIC-STATUS; MORTALITY; INEQUALITIES; NEIGHBORHOODS; TRENDS; RATES	Unintentional injury is the fourth leading cause of death in the United States, and mortality due to injury has risen over the past decade. The social determinants behind these rising trends have not been well documented. This study examines the relationship between county-level poverty and unintentional injury mortality in the United States from 1999-2012. Complete annual compressed mortality and population data for 1999-2012 were obtained from the National Center for Health Statistics and linked with census yearly county poverty measures. The outcomes examined were unintentional injury fatalities, overall and by six specific mechanisms: motor vehicle collisions, falls, accidental discharge of firearms, drowning, exposure to smoke or fire, and unintentional poisoning. Age-adjusted mortality rates and time trends for county poverty categories were calculated, and multivariate negative binomial regression was used to determine changes over time in both the relative risk of living in high poverty concentration areas and the population attributable fraction. Age-adjusted mortality rates for counties with > 20% poverty were 66% higher mortality in 1999 compared with counties with < 5% poverty (45.25 vs. 27.24 per 100,000; 95% CI for rate difference 15.57,20.46), and that gap widened in 2012 to 79% (44.54 vs. 24.93; 95% CI for rate difference 17.13,22.09). The relative risk of living in the highest poverty counties has increased for all injury mechanisms with the exception of accidental discharge of firearms. The population attributable fraction for all unintentional injuries rose from 0.22 (95% CI 0.13,0.30) in 1999 to 0.35 (95% CI 0.22,0.45) in 2012. This is the first study that uses comprehensive mortality data to document the associations between county poverty and injury mortality rates for the entire US population over a 14 year period. This study suggests that injury reduction interventions should focus on areas of high or increasing poverty.	[Karb, Rebecca A.] Brown Univ, Alpert Med Sch, Dept Emergency Med, Providence, RI 02912 USA; [Subramanian, S. V.] Harvard Univ, TH Chan Sch Publ Hlth, Boston, MA 02115 USA; [Fleegler, Eric W.] Boston Childrens Hosp, Div Emergency Med, Boston, MA USA	Brown University; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Boston Children's Hospital	Karb, RA (corresponding author), Brown Univ, Alpert Med Sch, Dept Emergency Med, Providence, RI 02912 USA.	rkarb@lifespan.org						Ali MT, 2013, SURGERY, V154, P461, DOI 10.1016/j.surg.2013.05.036; Bains N., 2009, STANDARDIZATION RATE; Beck AF, 2013, J PEDIATR-US, V163, P574, DOI 10.1016/j.jpeds.2013.01.064; Birken CS, 2006, CAN MED ASSOC J, V175, P867, DOI 10.1503/cmaj.051207; Bishaw A., 2013, AM COMMUNITY SURVEY; Boardman JD, 2001, J HEALTH SOC BEHAV, V42, P151, DOI 10.2307/3090175; Burrows S, 2012, ACCIDENT ANAL PREV, V45, P99, DOI 10.1016/j.aap.2011.11.010; Chen JT, 2006, J URBAN HEALTH, V83, P1063, DOI 10.1007/s11524-006-9089-7; Cubbin C, 2000, J EPIDEMIOL COMMUN H, V54, P517, DOI 10.1136/jech.54.7.517; Daly LE, 1998, AM J EPIDEMIOL, V147, P783; Denney JT, 2014, SOC SCI RES, V43, P92, DOI 10.1016/j.ssresearch.2013.09.004; DURKIN MS, 1994, AM J PUBLIC HEALTH, V84, P587, DOI 10.2105/AJPH.84.4.587; Fingerhut LA, 1998, PUBLIC HEALTH REP, V113, P218; Heron Melonie, 2013, Natl Vital Stat Rep, V62, P1; Hu GQ, 2009, AM J PREV MED, V37, P188, DOI 10.1016/j.amepre.2009.04.023; Hussey JM., 1997, EFFECTS RACE SOCIOEC; Kelly CM, 2007, J EPIDEMIOL COMMUN H, V61, P978, DOI 10.1136/jech.2006.054775; Krieger N, 2005, AM J PUBLIC HEALTH, V95, P312, DOI 10.2105/AJPH.2003.032482; Levine Beverly, 2007, Prev Chronic Dis, V4, pA14; Ludwig J, 2011, NEW ENGL J MED, V365, P1509, DOI 10.1056/NEJMsa1103216; Morenoff JD, 2003, AM J SOCIOL, V108, P976, DOI 10.1086/374405; Murphy SL, 2013, NATL VITAL STAT REP, P61; National Center for Health Statistics, 2012, CDROM SER, V20; Paulozzi LJ, 2006, J SAFETY RES, V37, P277, DOI 10.1016/j.jsr.2006.02.004; Paulozzi Leonard J., 2011, Morbidity and Mortality Weekly Report, V60, P1487; Rockett Ian R H, 2012, Am J Public Health, V102, pe84, DOI 10.2105/AJPH.2012.300960; Rockett IRH, 2010, BMC PSYCHIATRY, V10, DOI 10.1186/1471-244X-10-35; Roux AVD, 2010, ANN NY ACAD SCI, V1186, P125, DOI 10.1111/j.1749-6632.2009.05333.x; Roux AVD, 2001, NEW ENGL J MED, V345, P99, DOI 10.1056/NEJM200107123450205; Sampson RJ, 2002, ANNU REV SOCIOL, V28, P443, DOI 10.1146/annurev.soc.28.110601.141114; Singh GK, 2003, AM J PUBLIC HEALTH, V93, P1137, DOI 10.2105/AJPH.93.7.1137; Singh GK, 2006, INT J EPIDEMIOL, V35, P969, DOI 10.1093/ije/dyl083; Singh GK, 2013, J URBAN HEALTH, V90, P388, DOI 10.1007/s11524-012-9744-0; Subramanian SV, 2006, AM J EPIDEMIOL, V164, P823, DOI 10.1093/aje/kwj313; Tanuseputro P, 2005, AM J EPIDEMIOL, V161, P787, DOI 10.1093/aje/kwi093; Wen M, 2013, ANN BEHAV MED, V45, pS18, DOI 10.1007/s12160-012-9426-x; White HL, 2011, CANADIAN J EPIDEMIOL, V1, P44; Williams CT, 2007, AM J PREV MED, V32, pS203, DOI 10.1016/j.amepre.2007.02.006; Zarzaur BL, 2010, J AM COLL SURGEONS, V211, P216, DOI 10.1016/j.jamcollsurg.2010.03.036	39	28	28	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 4	2016	11	5							e0153516	10.1371/journal.pone.0153516	http://dx.doi.org/10.1371/journal.pone.0153516			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DL5KR	27144919	gold, Green Submitted, Green Published			2022-12-26	WOS:000375676400019
J	Marriott, AS; Vasieva, O; Fang, YX; Copeland, NA; McLennan, AG; Jones, NJ				Marriott, Andrew S.; Vasieva, Olga; Fang, Yongxiang; Copeland, Nikki A.; McLennan, Alexander G.; Jones, Nigel J.			NUDT2 Disruption Elevates Diadenosine Tetraphosphate (Ap(4)A) and Down-Regulates Immune Response and Cancer Promotion Genes	PLOS ONE			English	Article							TRANSFER-RNA-SYNTHETASE; FC-EPSILON-RI; TUMOR-SUPPRESSOR; TRANSCRIPTION FACTOR; T-CELL; INDOLEAMINE 2,3-DIOXYGENASE; DINUCLEOSIDE POLYPHOSPHATES; PROSTATE-CANCER; O-6-METHYLGUANINE-DNA METHYLTRANSFERASE; DIFFERENTIAL EXPRESSION	Regulation of gene expression is one of several roles proposed for the stress-induced nucleotide diadenosine tetraphosphate (Ap(4)A). We have examined this directly by a comparative RNA-Seq analysis of KBM-7 chronic myelogenous leukemia cells and KBM-7 cells in which the NUDT2 Ap(4)A hydrolase gene had been disrupted (NuKO cells), causing a 175-fold increase in intracellular Ap(4)A. 6,288 differentially expressed genes were identified with P < 0.05. Of these, 980 were up-regulated and 705 down-regulated in NuKO cells with a fold-change >= 2. Ingenuity(R) Pathway Analysis (IPA(R)) was used to assign these genes to known canonical pathways and functional networks. Pathways associated with interferon responses, pattern recognition receptors and inflammation scored highly in the down-regulated set of genes while functions associated with MHC class II antigens were prominent among the up-regulated genes, which otherwise showed little organization into major functional gene sets. Tryptophan catabolism was also strongly down-regulated as were numerous genes known to be involved in tumor promotion in other systems, with roles in the epithelial-mesenchymal transition, proliferation, invasion and metastasis. Conversely, some pro-apoptotic genes were up-regulated. Major upstream factors predicted by IPA(R) for gene down-regulation included NF.B, STAT1/2, IRF3/4 and SP1 but no major factors controlling gene up-regulation were identified. Potential mechanisms for gene regulation mediated by Ap(4)A and/or NUDT2 disruption include binding of Ap(4)A to the HINT1 co-repressor, autocrine activation of purinoceptors by Ap(4)A, chromatin remodeling, effects of NUDT2 loss on transcript stability, and inhibition of ATP-dependent regulatory factors such as protein kinases by Ap(4)A. Existing evidence favors the last of these as the most probable mechanism. Regardless, our results suggest that the NUDT2 protein could be a novel cancer chemotherapeutic target, with its inhibition potentially exerting strong anti-tumor effects via multiple pathways involving metastasis, invasion, immunosuppression and apoptosis.	[Marriott, Andrew S.; McLennan, Alexander G.; Jones, Nigel J.] Univ Liverpool, Dept Biochem, Inst Integrat Biol, POB 147, Liverpool L69 3BX, Merseyside, England; [Vasieva, Olga; Fang, Yongxiang] Univ Liverpool, Dept Funct & Comparat Genom, Inst Integrat Biol, Liverpool L69 3BX, Merseyside, England; [Copeland, Nikki A.] Univ Lancaster, Div Biomed & Life Sci, Lancaster, Lancs, England	University of Liverpool; University of Liverpool; Lancaster University	McLennan, AG; Jones, NJ (corresponding author), Univ Liverpool, Dept Biochem, Inst Integrat Biol, POB 147, Liverpool L69 3BX, Merseyside, England.	agmclen@liv.ac.uk; N.J.Jones@liv.ac.uk	Jones, Nigel J/D-1997-2010	Copeland, Nikki/0000-0002-6204-4717	North West Cancer Research [CR968, CR891]; NWCR research fellowship [BR879]	North West Cancer Research; NWCR research fellowship	This work was supported by North West Cancer Research (http://www.nwcr.org) grant numbers CR968 to AGM, NJJ and NAC; CR891 to NAC; and NWCR research fellowship number BR879 to NAC (www.nwcr.org). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdelghany HM, 2001, BBA-PROTEIN STRUCT M, V1550, P27, DOI 10.1016/S0167-4838(01)00263-1; Al Bashir S, 2014, J HEMATOL ONCOL, V7, DOI 10.1186/1756-8722-7-21; Alva-Perez J, 2014, VIRULENCE, V5, P563, DOI 10.4161/viru.28589; Anashkin VA, 2015, J BIOL CHEM, V290, P27594, DOI 10.1074/jbc.M115.680272; Puig-Butille JA, 2014, ONCOTARGET, V5, P1439; Badger JL, 2000, MOL MICROBIOL, V36, P174, DOI 10.1046/j.1365-2958.2000.01840.x; Bailey CC, 2014, ANNU REV VIROL, V1, P261, DOI 10.1146/annurev-virology-031413-085537; BAKER JC, 1986, P NATL ACAD SCI USA, V83, P2350, DOI 10.1073/pnas.83.8.2350; Banchereau J, 2004, IMMUNITY, V20, P539, DOI 10.1016/S1074-7613(04)00108-6; Barbouri D, 2014, FRONT ONCOL, V4, DOI 10.3389/fonc.2014.00004; BARNEKOW A, 1983, BIOSCIENCE REP, V3, P153, DOI 10.1007/BF01121946; Barnes LD, 1996, BIOCHEMISTRY-US, V35, P11529, DOI 10.1021/bi961415t; Barretina J, 2012, NATURE, V483, P603, DOI 10.1038/nature11003; BAXI MD, 1995, BIOCHEMISTRY-US, V34, P9700, DOI 10.1021/bi00030a007; BAXI MD, 1994, BIOCHEMISTRY-US, V33, P14601, DOI 10.1021/bi00252a028; Baykov AA, 2011, ACS CHEM BIOL, V6, P1156, DOI 10.1021/cb200231c; Beishline K, 2015, FEBS J, V282, P224, DOI 10.1111/febs.13148; Belenky P, 2007, TRENDS BIOCHEM SCI, V32, P12, DOI 10.1016/j.tibs.2006.11.006; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Benveniste E. N., 2007, SCI STKE, V416, ppe70, DOI DOI 10.1126/STKE.4162007PE70; Boasso A, 2005, BLOOD, V105, P1574, DOI 10.1182/blood-2004-06-2089; Boddicker RL, 2015, BLOOD, V125, P3118, DOI 10.1182/blood-2014-05-578575; Bohle V, 2013, LEUKEMIA, V27, P671, DOI 10.1038/leu.2012.280; Bowe RA, 2014, MOL BIOL CELL, V25, P184, DOI 10.1091/mbc.E13-06-0306; Bridgeman A, 2015, SCIENCE, V349, P1228, DOI 10.1126/science.aab3632; Burckstummer T, 2013, NAT METHODS, V10, P965, DOI 10.1038/nmeth.2609; Burnstock G, 2014, PURINERG SIGNAL, V10, P103, DOI 10.1007/s11302-013-9395-y; Cabrini G, 2015, INT J ONCOL, V47, P417, DOI 10.3892/ijo.2015.3026; Carmi-Levy I, 2008, MOL CELL BIOL, V28, P5777, DOI 10.1128/MCB.00106-08; Carroll JS, 2006, NAT GENET, V38, P1289, DOI 10.1038/ng1901; Chapat C, 2013, EMBO J, V32, P688, DOI 10.1038/emboj.2013.11; Cheng Y, 2015, EUR J GYNAECOL ONCOL, V36, P309; Choi S, 2013, EXPERT OPIN THER TAR, V17, P695, DOI 10.1517/14728222.2013.773313; Christmann M, 2011, BBA-REV CANCER, V1816, P179, DOI 10.1016/j.bbcan.2011.06.002; Chu TL, 2014, BIOCHEM BIOPH RES CO, V446, P580, DOI 10.1016/j.bbrc.2014.03.019; Coseno M, 2008, NUCLEIC ACIDS RES, V36, P3474, DOI 10.1093/nar/gkn079; COSTE H, 1987, J BIOL CHEM, V262, P12096; Costea DE, 2013, CANCER RES, V73, P3888, DOI 10.1158/0008-5472.CAN-12-4150; Croft M, 2009, IMMUNOL REV, V229, P173, DOI 10.1111/j.1600-065X.2009.00766.x; Delicado EG, 2006, PFLUG ARCH EUR J PHY, V452, P563, DOI 10.1007/s00424-006-0066-5; Dong Y, 2015, ONCOTARGET, V6, P22126, DOI 10.18632/oncotarget.4244; Eckert RL, 2015, MOL CARCINOGEN, V54, P947, DOI 10.1002/mc.22375; Fensterl V, 2015, J VIROL, V89, P2462, DOI 10.1128/JVI.02744-14; Fisher DI, 2002, J BIOL CHEM, V277, P47313, DOI 10.1074/jbc.M209795200; FLECKNER J, 1995, CYTOKINE, V7, P70, DOI 10.1006/cyto.1995.1009; Fraga H, 2011, BBA-GEN SUBJECTS, V1810, P1195, DOI 10.1016/j.bbagen.2011.09.010; Frumento G, 2002, J EXP MED, V196, P459, DOI 10.1084/jem.20020121; Garcia MA, 2006, MICROBIOL MOL BIOL R, V70, P1032, DOI 10.1128/MMBR.00027-06; Garrison PN, 1992, AP4A OTHER DINUCLEOS, P29; Gaywee J, 2002, MOL CELL PROTEOMICS, V1, P179, DOI 10.1074/mcp.M100030-MCP200; Genovese G, 2012, CELL CYCLE, V11, P2206, DOI 10.4161/cc.20765; Gentili M, 2015, SCIENCE, V349, P1232, DOI 10.1126/science.aab3628; GILSON G, 1988, EXP CELL RES, V177, P143, DOI 10.1016/0014-4827(88)90032-8; Guranowski A, 2000, PHARMACOL THERAPEUT, V87, P117, DOI 10.1016/S0163-7258(00)00046-2; GURANOWSKI A, 1983, J BIOL CHEM, V258, P4784; Habibi D, 2010, J CELL PHYSIOL, V225, P196, DOI 10.1002/jcp.22220; He HL, 2015, EXP MOL PATHOL, V98, P338, DOI 10.1016/j.yexmp.2015.03.029; He SB, 2014, P NATL ACAD SCI USA, V111, pE2008, DOI 10.1073/pnas.1402944111; Hebbard CFF, 2014, BIOMACROMOLECULES, V15, P3190, DOI 10.1021/bm500872g; Heckl D, 2012, MOL THER, V20, P1187, DOI 10.1038/mt.2012.59; Hertzog PJ, 2013, CYTOKINE GROWTH F R, V24, P217, DOI 10.1016/j.cytogfr.2013.04.002; Hoek KS, 2008, PIGM CELL MELANOMA R, V21, P665, DOI 10.1111/j.1755-148X.2008.00505.x; Huber KVM, 2014, NATURE, V508, P222, DOI 10.1038/nature13194; Huber RM, 2015, ONCOTARGET, V6, P2134, DOI 10.18632/oncotarget.3040; Ikushima H, 2013, COLD SH Q B, V78, P105, DOI 10.1101/sqb.2013.78.020321; Ismail TM, 2003, J BIOL CHEM, V278, P32602, DOI 10.1074/jbc.M305994200; Itsui Y, 2009, HEPATOLOGY, V50, P1727, DOI 10.1002/hep.23195; Ivashkiv LB, 2014, NAT REV IMMUNOL, V14, P36, DOI 10.1038/nri3581; Iwanicki A, 2002, BIOCHEM J, V366, P929, DOI 10.1042/BJ20011591; Jacobs J, 2015, PHARMACOL THERAPEUT, V155, P1, DOI 10.1016/j.pharmthera.2015.07.007; JOHNSTON DJ, 1990, BIOCHEM J, V268, P791, DOI 10.1042/bj2680791; Jovanovic S, 2001, N-S ARCH PHARMACOL, V364, P276, DOI 10.1007/s002100100401; Kijas AW, 2006, J BIOL CHEM, V281, P13939, DOI 10.1074/jbc.M507946200; Kijima N, 2014, ANTICANCER RES, V34, P61; Kim D, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-4-r36; Kinet JP, 1999, ANNU REV IMMUNOL, V17, P931, DOI 10.1146/annurev.immunol.17.1.931; Ko WC, 2012, ONCOL LETT, V3, P75, DOI 10.3892/ol.2011.418; Kotecki M, 1999, EXP CELL RES, V252, P273, DOI 10.1006/excr.1999.4656; Kraus WL, 2013, MOL ASPECTS MED, V34, P1109, DOI 10.1016/j.mam.2013.01.005; LEE PC, 1983, P NATL ACAD SCI-BIOL, V80, P7496, DOI 10.1073/pnas.80.24.7496; Lee SMY, 2014, P NATL ACAD SCI USA, V111, P3793, DOI 10.1073/pnas.1324266111; Lee YN, 2005, MOL CELL BIOL, V25, P8904, DOI 10.1128/MCB.25.20.8904-8912.2005; Lee YN, 2004, IMMUNITY, V20, P145, DOI 10.1016/S1074-7613(04)00020-2; Li D, 2013, ONCOTARGET, V4, P2021, DOI 10.18632/oncotarget.1579; Li HY, 2008, J CELL BIOL, V183, P253, DOI 10.1083/jcb.200711150; Lin CI, 2014, ANGIOGENESIS, V17, P897, DOI 10.1007/s10456-014-9437-2; Liu ML, 2011, ONCOL LETT, V2, P583, DOI 10.3892/ol.2011.300; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Luo Q, 2015, CARCINOGENESIS, V36, P1201, DOI 10.1093/carcin/bgv108; Majumder P, 2011, J IMMUNOL, V187, P4236, DOI 10.4049/jimmunol.1100688; Manning G, 2002, SCIENCE, V298, P1912, DOI 10.1126/science.1075762; Marriott AS, 2015, DNA REPAIR, V33, P90, DOI 10.1016/j.dnarep.2015.06.008; Martin F, 1998, FASEB J, V12, P1499, DOI 10.1096/fasebj.12.14.1499; Martin M, 2011, EMBNET J, V17, P10, DOI [10.14806/ej.17.1.200, 10.10.14806/ej.17.1.200, DOI 10.14806/EJ.17.1.200]; Masamha CP, 2014, NATURE, V510, P412, DOI 10.1038/nature13261; McLennan AG, 2006, CELL MOL LIFE SCI, V63, P123, DOI 10.1007/s00018-005-5386-7; MCLENNAN AG, 1995, J BIOL CHEM, V270, P3706, DOI 10.1074/jbc.270.8.3706; McLennan AG, 2000, PHARMACOL THERAPEUT, V87, P73, DOI 10.1016/S0163-7258(00)00041-3; McLennan AG, 2013, CELL MOL LIFE SCI, V70, P373, DOI 10.1007/s00018-012-1210-3; Mellor AL, 2004, NAT REV IMMUNOL, V4, P762, DOI 10.1038/nri1457; Mense SM, 2015, SCI SIGNAL, V8, DOI 10.1126/scisignal.2005840; MERKULOVA T, 1994, FEBS LETT, V350, P287, DOI 10.1016/0014-5793(94)00764-0; Muller AJ, 2005, CANCER RES, V65, P8065, DOI 10.1158/0008-5472.CAN-05-2213; Muller AJ, 2005, NAT MED, V11, P312, DOI 10.1038/nm1196; Munn DH, 2005, IMMUNITY, V22, P633, DOI 10.1016/j.immuni.2005.03.013; Murphy GA, 2000, CANCER RES, V60, P2342; Mutafova-Yambolieva VN, 2014, PHARMACOL THERAPEUT, V144, P162, DOI 10.1016/j.pharmthera.2014.05.012; Naderi A, 2007, CANCER RES, V67, P6725, DOI 10.1158/0008-5472.CAN-06-4394; Nandy SB, 2015, ONCOTARGET, V6, P17366, DOI 10.18632/oncotarget.3953; Oka K, 2011, INT J CANCER, V128, P1770, DOI 10.1002/ijc.25505; Palomo J, 2015, CYTOKINE, V76, P25, DOI 10.1016/j.cyto.2015.06.017; Pandiella A, 2013, CLIN CANCER RES, V19, P4564, DOI 10.1158/1078-0432.CCR-12-1662; Pesson M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087761; Pichlmair A, 2011, NAT IMMUNOL, V12, P624, DOI 10.1038/ni.2048; PYPE S, 1993, ENZYME PROTEIN, V47, P14, DOI 10.1159/000468651; Radulovich N, 2015, ONCOGENE, V34, P4238, DOI 10.1038/onc.2014.357; RAPAPORT E, 1984, EUR J BIOCHEM, V138, P111, DOI 10.1111/j.1432-1033.1984.tb07888.x; Robinson CM, 2003, J INTERF CYTOK RES, V23, P413, DOI 10.1089/107999003322277829; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Roca H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076773; Roche PA, 2015, NAT REV IMMUNOL, V15, P203, DOI 10.1038/nri3818; Rolland T, 2014, CELL, V159, P1212, DOI 10.1016/j.cell.2014.10.050; Ruoming W, 2015, CANCER GENE THER, V22, P564, DOI 10.1038/cgt.2015.41; Rusinova I, 2013, NUCLEIC ACIDS RES, V41, pD1040, DOI 10.1093/nar/gks1215; Sansom DM, 2003, TRENDS IMMUNOL, V24, P314, DOI 10.1016/S1471-4906(03)00111-X; Sarver AE, 2015, LAB INVEST, V95, P1077, DOI 10.1038/labinvest.2015.80; Schatz DG, 2005, CURR TOP MICROBIOL, V290, P49; Schmid CA, 2013, GASTROENTEROLOGY, V144, P22, DOI 10.1053/j.gastro.2012.11.014; Schneider WM, 2014, ANNU REV IMMUNOL, V32, P513, DOI 10.1146/annurev-immunol-032713-120231; Shaffer AL, 2008, NATURE, V454, P226, DOI 10.1038/nature07064; Sheffer M, 2009, P NATL ACAD SCI USA, V106, P7131, DOI 10.1073/pnas.0902232106; Shepel PN, 2003, EUR J PHARMACOL, V467, P67, DOI 10.1016/S0014-2999(03)01593-0; Shorts-Cary L, 2007, ENDOCRINOLOGY, V148, P967, DOI 10.1210/en.2006-0905; SHOYAB M, 1985, ARCH BIOCHEM BIOPHYS, V236, P441, DOI 10.1016/0003-9861(85)90645-9; Sillero A, 2000, PHARMACOL THERAPEUT, V87, P91, DOI 10.1016/S0163-7258(00)00047-4; Song LN, 2015, MOL CANCER RES, V13, P913, DOI 10.1158/1541-7786.MCR-14-0680; Song MG, 2013, RNA, V19, P390, DOI 10.1261/rna.037309.112; Song MG, 2010, MOL CELL, V40, P423, DOI 10.1016/j.molcel.2010.10.010; Stellato C, 2015, PROTEOMICS, V15, P1801, DOI 10.1002/pmic.201400404; Streib M, 2014, ANGEW CHEM INT EDIT, V53, P305, DOI 10.1002/anie.201307849; Talebian F, 2012, ONCOIMMUNOLOGY, V1, P971, DOI 10.4161/onci.20034; TANAKA Y, 1981, BIOCHEM BIOPH RES CO, V99, P837, DOI 10.1016/0006-291X(81)91240-7; Tanner JA, 2006, BIOCHEMISTRY-US, V45, P3095, DOI 10.1021/bi052529k; Thomas Sterling, 2010, Human Genomics, V4, P353; Toska E, 2014, ONCOGENE, V33, P5100, DOI 10.1038/onc.2013.447; Toska E, 2014, BIOCHEM J, V461, P15, DOI 10.1042/BJ20131587; Uhlen M, 2015, SCIENCE, V347, DOI 10.1126/science.1260419; Uyttenhove C, 2003, NAT MED, V9, P1269, DOI 10.1038/nm934; van Boxel-Dezaire AHH, 2006, IMMUNITY, V25, P361, DOI 10.1016/j.immuni.2006.08.014; VARSHAVSKY A, 1983, CELL, V34, P711, DOI 10.1016/0092-8674(83)90526-3; Vartanian A, 1999, FEBS LETT, V456, P175, DOI 10.1016/S0014-5793(99)00956-4; Vartanian A, 1996, FEBS LETT, V381, P32, DOI 10.1016/0014-5793(96)00073-7; Vartanian AA, 2003, BIOCHEM PHARMACOL, V65, P227, DOI 10.1016/S0006-2952(02)01481-8; Vasilenko N, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-31; Vizcaino C, 2015, PHARMACOL THERAPEUT, V152, P111, DOI 10.1016/j.pharmthera.2015.05.008; Wallace TA, 2008, CANCER RES, V68, P927, DOI 10.1158/0008-5472.CAN-07-2608; Wallden K, 2011, J MOL BIOL, V408, P684, DOI 10.1016/j.jmb.2011.02.059; Wang FF, 2015, MOL MED REP, V11, P698, DOI 10.3892/mmr.2014.2691; Wang L, 2009, INT J CANCER, V124, P1526, DOI 10.1002/ijc.24072; Wang P, 2015, NEUROREPORT, V26, P455, DOI 10.1097/WNR.0000000000000370; Waters CE, 2014, CELL MOL LIFE SCI, V71, P4577, DOI 10.1007/s00018-014-1722-0; Weiske J, 2005, J CELL SCI, V118, P3117, DOI 10.1242/jcs.02437; Wilks SS, 1938, ANN MATH STAT, V9, P60, DOI 10.1214/aoms/1177732360; Winward L, 2007, INT J BIOCHEM CELL B, V39, P943, DOI 10.1016/j.biocel.2007.01.017; Wright M, 2006, FEBS J, V273, P3534, DOI 10.1111/j.1742-4658.2006.05361.x; Xia HP, 2015, J HEPATOL, V63, P863, DOI 10.1016/j.jhep.2015.05.005; Xiang JB, 2008, TRANSPL INT, V21, P163, DOI 10.1111/j.1432-2277.2007.00590.x; Xu LJ, 2014, INT J ONCOL, V44, P459, DOI 10.3892/ijo.2013.2189; Yang Q, 2010, P NATL ACAD SCI USA, V107, P10062, DOI 10.1073/pnas.1000848107; Yeung AWS, 2015, CLIN SCI, V129, P601, DOI 10.1042/CS20140392; YOSHIHARA K, 1981, J BIOL CHEM, V256, P6756; YUNIS JJ, 1989, BLOOD, V73, P931; Zhao H, 2014, INT J CLIN EXP PATHO, V7, P670; Zhao S, 2015, ONCOGENE, V34, P5069, DOI 10.1038/onc.2014.429; Zirkel A, 2013, NUCLEIC ACIDS RES, V41, P6618, DOI 10.1093/nar/gkt410	175	21	23	2	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 4	2016	11	5							e0154674	10.1371/journal.pone.0154674	http://dx.doi.org/10.1371/journal.pone.0154674			35	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DL5KR	27144453	Green Submitted, Green Published, Green Accepted, gold			2022-12-26	WOS:000375676400059
J	Pichat, C; Couvin, D; Carret, G; Fredenucci, I; Jacomo, V; Carricajo, A; Boisset, S; Dumitrescu, O; Flandrois, JP; Lina, G; Rastogi, N				Pichat, Catherine; Couvin, David; Carret, Gerard; Fredenucci, Isabelle; Jacomo, Veronique; Carricajo, Anne; Boisset, Sandrine; Dumitrescu, Oana; Flandrois, Jean-Pierre; Lina, Gerard; Rastogi, Nalin			Combined Genotypic, Phylogenetic, and Epidemiologic Analyses of Mycobacterium tuberculosis Genetic Diversity in the Rhone Alpes Region, France	PLOS ONE			English	Article							MOLECULAR EPIDEMIOLOGY; BEIJING LINEAGE; MIRU-VNTRPLUS; COMPLEX; DATABASE; IDENTIFICATION; SPOLIGOTYPES; INFECTION; BACTERIA; PROPOSAL	Background The present work relates to identification and a deep molecular characterization of circulating Mycobacterium tuberculosis complex (MTBC) strains in the Rhone-Alpes region, France from 2000 to 2010. It aimed to provide with a first snapshot of MTBC genetic diversity in conjunction with bacterial drug resistance, type of disease and available demographic and epidemiologic characteristics over an eleven-year period, in the south-east of France. Methods Mycobacterium tuberculosis complex (MTBC) strains isolated in the Rhone-Alpes region, France (n = 2257, 1 isolate per patient) between 2000 and 2010 were analyzed by spoligotyping. MIRU-VNTR typing was applied on n = 1698 strains (with full results available for 974 strains). The data obtained were compared with the SITVIT2 database, followed by detailed genotyping, phylogenetic, and epidemiologic analyses in correlation with anonymized data on available demographic, and epidemiologic characteristics, and location of disease (pulmonary or extrapulmonary TB). Results The most predominant spoligotyping clusters were SIT53/T1 (n = 346, 15.3%) > SIT50/H3 (n = 166, 7.35%) > SIT42/LAM9 (n = 125, 5.5%) > SIT1/Beijing (n = 72, 3.2%) > SIT47/H1 (n = 71, 3.1%). Evolutionary-recent strains belonging to the Principal Genetic Group (PGG) 2/3, or Euro-American lineages (T, LAM, Haarlem, X, S) were predominant and represented 1768 or 78.33% of all isolates. For strains having drug resistance information (n = 1119), any drug resistance accounted for 14.83% cases vs. 1.52% for multidrug resistance (MDR); and was significantly more associated with age group 21-40 years (pvalue<0.001). Extra-pulmonary TB was more common among female patients while pulmonary TB predominated among men (p-value<0.001; OR = 2.16 95% CI [1.69; 2.77]). Also, BOV and CAS lineages were significantly well represented in patients affected by extra-pulmonary TB (p-value<0.001). The origin was known for 927/2257 patients: 376 (40.6%) being French-born vs. 551 (59.4%) Foreign-born. French patients were significantly older (mean age: 58.42 yrs 95% CI [56.04; 60.80]) than Foreign-born patients (mean age: 42.38 yrs. 95% CI [40.75; 44.0]). Conclusion The study underlined the importance of imported TB cases on the genetic diversity and epidemiologic characteristics of circulating MTBC strains in Rhone-Alpes region, France over a large time-period. It helps better understand intricate relationships between certain lineages and geographic origin of the patients, and pinpoints genotypic and phylogenetic specificities of prevailing MTBC strains. Lastly, it also demonstrated a slow decline in isolation of M. africanum lineage in this region between 2000 and 2010.	[Pichat, Catherine; Carret, Gerard; Fredenucci, Isabelle; Dumitrescu, Oana; Flandrois, Jean-Pierre; Lina, Gerard] Ctr Hosp Lyon Sud, Lab Bacteriol, Pierre Benite, France; [Couvin, David; Rastogi, Nalin] Inst Pasteur Guadeloupe, WHO Supranat TB Reference Lab, Abymes, France; [Carret, Gerard; Flandrois, Jean-Pierre] Univ Lyon 1, Lab Biometrie & Biol Evolut, CNRS, UMR 5558, F-69622 Villeurbanne, France; [Jacomo, Veronique] Serv Mycobacteries, Lab Biomnis, Lyon, France; [Carricajo, Anne] CHU St Etienne Nord, Lab Bacteriol, St Etienne, France; [Boisset, Sandrine] CHU Grenoble, Lab Bacteriol, F-38043 Grenoble, France; [Dumitrescu, Oana; Lina, Gerard] Univ Lyon 1, INSERM, U1111, Ctr Int Rech Infectiol, F-69365 Lyon, France	CHU Lyon; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); UDICE-French Research Universities; Universite Claude Bernard Lyon 1; VetAgro Sup; CHU de St Etienne; CHU Grenoble Alpes; Communaute Universite Grenoble Alpes; UDICE-French Research Universities; Universite Grenoble Alpes (UGA); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Claude Bernard Lyon 1	Rastogi, N (corresponding author), Inst Pasteur Guadeloupe, WHO Supranat TB Reference Lab, Abymes, France.	nrastogi@pasteur-guadeloupe.fr	Dumitrescu, Oana/C-6222-2013; RASTOGI, NALIN/AAP-1958-2020; Flandrois, Jean-Pierre/F-6861-2019	Dumitrescu, Oana/0000-0001-8193-1437; RASTOGI, NALIN/0000-0002-7199-7747; Flandrois, Jean-Pierre/0000-0002-4953-9125; Lina, Gerard/0000-0002-9236-7998; Couvin, David/0000-0002-7897-9023; anne, carricajo/0000-0001-9530-4434	European Social Funds through the Regional Council of Guadeloupe	European Social Funds through the Regional Council of Guadeloupe	David Couvin was awarded a Ph.D. fellowship by the European Social Funds through the Regional Council of Guadeloupe. However, the funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	Abadia E, 2010, INFECT GENET EVOL, V10, P1066, DOI 10.1016/j.meegid.2010.07.006; Allix-Beguec C, 2008, J CLIN MICROBIOL, V46, P2692, DOI 10.1128/JCM.00540-08; Allix-Beguec C, 2014, J CLIN MICROBIOL, V52, P164, DOI 10.1128/JCM.02519-13; Alonso-Rodriguez N, 2009, J CLIN MICROBIOL, V47, P2026, DOI 10.1128/JCM.02308-08; Anguier C, 2012, INSEE RHONE ALPES LA, P1; Bernard C, 2013, EUROSURVEILLANCE, V18, P2, DOI 10.2807/1560-7917.ES2013.18.33.20555; Borrel C, 2006, INSEE PREMIERE, P1; Brosch R, 2002, P NATL ACAD SCI USA, V99, P3684, DOI 10.1073/pnas.052548299; Brudey K, 2006, BMC MICROBIOL, V6, DOI 10.1186/1471-2180-6-23; Cohen-Bacrie S, 2011, EURO SURVEILL, V16; Comas I, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007815; Couvin D, 2014, EUROREFERENCE CAHIER, V2014, P36; Couvin D, 2015, TUBERCULOSIS, V95, pS177, DOI 10.1016/j.tube.2015.02.023; Demay C, 2012, INFECT GENET EVOL, V12, P755, DOI 10.1016/j.meegid.2012.02.004; Balcells ME, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118007; Fallico L, 2014, INFECT GENET EVOL, V26, P58, DOI 10.1016/j.meegid.2014.05.004; Fenner L, 2012, J CLIN MICROBIOL, V50, P388, DOI 10.1128/JCM.05392-11; Gagneux S, 2007, LANCET INFECT DIS, V7, P328, DOI 10.1016/S1473-3099(07)70108-1; de Viedma DG, 2011, ENFERM INFEC MICR CL, V29, P8, DOI 10.1016/S0213-005X(11)70012-X; Groenheit R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018601; Hill V, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041991; Jagielski T, 2016, CLIN MICROBIOL REV, V29, P239, DOI 10.1128/CMR.00055-15; Kamerbeek J, 1997, J CLIN MICROBIOL, V35, P907, DOI 10.1128/JCM.35.4.907-914.1997; Kisa O, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030331; Koro FK, 2013, J CLIN MICROBIOL, V51, P299, DOI 10.1128/JCM.01196-12; Lari N, 2009, CLIN MICROBIOL INFEC, V15, P538, DOI 10.1111/j.1469-0691.2009.02712.x; Mayda AM, 2008, ECON LETT, V101, P160, DOI 10.1016/j.econlet.2008.06.011; Merker M, 2015, NAT GENET, V47, P242, DOI 10.1038/ng.3195; Mignard S, 2006, EMERG INFECT DIS, V12, P1431, DOI 10.3201/eid1209.060209; Mokrousov I, 2012, INFECT GENET EVOL, V12, P619, DOI 10.1016/j.meegid.2011.09.026; Oelemann MC, 2007, J CLIN MICROBIOL, V45, P691, DOI 10.1128/JCM.01393-06; Rastogi N., 2007, TUBERCULOSIS 2007 BA, V2007, P53; Reyes JF, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-496; Shabbeer A, 2012, INFECT GENET EVOL, V12, P767, DOI 10.1016/j.meegid.2011.08.019; Smit PW, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0085027, DOI 10.1371/JOURNAL.PONE.0085027]; Sreevatsan S, 1997, P NATL ACAD SCI USA, V94, P9869, DOI 10.1073/pnas.94.18.9869; Supply P, 2006, J CLIN MICROBIOL, V44, P4498, DOI 10.1128/JCM.01392-06; Tang C, 2008, BIOINFORMATICS, V24, P2414, DOI 10.1093/bioinformatics/btn434; Thumamo BP, 2012, INFECT GENET EVOL, V12, P671, DOI 10.1016/j.meegid.2011.08.011; Vanhomwegen J, 2011, J CLIN MICROBIOL, V49, P834, DOI 10.1128/JCM.01952-10; Weniger T, 2010, NUCLEIC ACIDS RES, V38, pW326, DOI 10.1093/nar/gkq351; World Health Organization, GLOB TUB REP 2015; Yuan XL, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-315	43	15	16	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 29	2016	11	4							e0153580	10.1371/journal.pone.0153580	http://dx.doi.org/10.1371/journal.pone.0153580			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DK8XM	27128522	Green Published, gold			2022-12-26	WOS:000375212600009
J	Reichau, S; Blackmore, NJ; Jiao, WT; Parker, EJ				Reichau, Sebastian; Blackmore, Nicola J.; Jiao, Wanting; Parker, Emily J.			Probing the Sophisticated Synergistic Allosteric Regulation of Aromatic Amino Acid Biosynthesis in Mycobacterium tuberculosis Using.- Amino Acids	PLOS ONE			English	Article							3-DEOXY-D-ARABINO-HEPTULOSONATE 7-PHOSPHATE SYNTHASE; MACROMOLECULAR CRYSTALLOGRAPHY; MOLECULAR REPLACEMENT; P53-MDM2 INTERACTION; CHORISMATE MUTASE; DAHP SYNTHASE; CELL-WALL; COMPLEX; CRYSTALLIZATION; PURIFICATION	Chirality plays a major role in recognition and interaction of biologically important molecules. The enzyme 3-deoxy-D-arabino-heptulosonate 7-phosphate synthase (DAH7PS) is the first enzyme of the shikimate pathway, which is responsible for the synthesis of aromatic amino acids in bacteria and plants, and a potential target for the development of antibiotics and herbicides. DAH7PS from Mycobacterium tuberculosis (MtuDAH7PS) displays an unprecedented complexity of allosteric regulation, with three interdependent allosteric binding sites and a ternary allosteric response to combinations of the aromatic amino acids L-Trp, L-Phe and L-Tyr. In order to further investigate the intricacies of this system and identify key residues in the allosteric network of MtuDAH7PS, we studied the interaction of MtuDAH7PS with aromatic amino acids that bear the non-natural D-configuration, and showed that the D-amino acids do not elicit an allosteric response. We investigated the binding mode of D-amino acids using X-ray crystallography, site directed mutagenesis and isothermal titration calorimetry. Key differences in the binding mode were identified: in the Phe site, a hydrogen bond between the amino group of the allosteric ligands to the side chain of Asn175 is not established due to the inverted configuration of the ligands. In the Trp site, DTrp forms no interaction with the main chain carbonyl group of Thr240 and less favourable interactions with Asn237 when compared to the L-Trp binding mode. Investigation of the MtuDAH7PS(N175A) variant further supports the hypothesis that the lack of key interactions in the binding mode of the aromatic D-amino acids are responsible for the absence of an allosteric response, which gives further insight into which residues of MtuDAH7PS play a key role in the transduction of the allosteric signal.	[Parker, Emily J.] Univ Canterbury, Biomol Interact Ctr, Christchurch 1, New Zealand; Univ Canterbury, Dept Chem, Christchurch 1, New Zealand	University of Canterbury; University of Canterbury	Parker, EJ (corresponding author), Univ Canterbury, Biomol Interact Ctr, Christchurch 1, New Zealand.	emily.parker@canterbury.ac.nz	Jiao, Wanting/I-3159-2019; Reichau, Sebastian/C-2525-2016	Jiao, Wanting/0000-0002-0234-7206; Parker, Emily/0000-0002-9571-9987	New Zealand Marsden Fund [UOC1105]; Maurice Wilkins Centre for Molecular Biodiscovery; Royal Society of New Zealand Synchrotron Group; New Zealand Educated; University of Canterbury	New Zealand Marsden Fund(Royal Society of New ZealandMarsden Fund (NZ)); Maurice Wilkins Centre for Molecular Biodiscovery; Royal Society of New Zealand Synchrotron Group; New Zealand Educated; University of Canterbury	This work was supported by the New Zealand Marsden Fund, UOC1105 (http://www.royalsociety.org.nz/programmes/funds/marsden/) and Maurice Wilkins Centre for Molecular Biodiscovery (http://www.mauricewilkinscentre.org). Travel funding by the Royal Society of New Zealand Synchrotron Group is gratefully acknowledged. S.R., N.J.B. and W.J. were supported by PhD scholarships and funding from New Zealand Educated, the University of Canterbury and the Maurice Wilkins Centre for Molecular Biodiscovery. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Awasthy D, 2012, MICROBIOL-SGM, V158, P319, DOI 10.1099/mic.0.054064-0; Blackmore NJ, 2015, J BIOL CHEM, V290, P18187, DOI 10.1074/jbc.M115.638700; Blackmore NJ, 2013, J MOL BIOL, V425, P1582, DOI 10.1016/j.jmb.2012.12.019; Cava F, 2011, EMBO J, V30, P3442, DOI 10.1038/emboj.2011.246; Cava F, 2011, CELL MOL LIFE SCI, V68, P817, DOI 10.1007/s00018-010-0571-8; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Evans PR, 2011, ACTA CRYSTALLOGR D, V67, P282, DOI 10.1107/S090744491003982X; Horcajo P, 2012, MICROB DRUG RESIST, V18, P306, DOI 10.1089/mdr.2012.0009; Jiao WT, 2012, J MOL BIOL, V415, P716, DOI 10.1016/j.jmb.2011.11.037; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Lam H, 2009, SCIENCE, V325, P1552, DOI 10.1126/science.1178123; Liu M, 2010, P NATL ACAD SCI USA, V107, P14321, DOI 10.1073/pnas.1008930107; Liu M, 2010, ANGEW CHEM INT EDIT, V49, P3649, DOI 10.1002/anie.201000329; McPhillips TM, 2002, J SYNCHROTRON RADIAT, V9, P401, DOI 10.1107/S0909049502015170; Munack S, 2016, J MOL BIOL; Murshudov GN, 2011, ACTA CRYSTALLOGR D, V67, P355, DOI 10.1107/S0907444911001314; Okvist M, 2009, ACTA CRYSTALLOGR F, V65, P1048, DOI 10.1107/S1744309109035878; Panjikar S, 2005, ACTA CRYSTALLOGR D, V61, P449, DOI 10.1107/S0907444905001307; Sasso S, 2009, EMBO J, V28, P2128, DOI 10.1038/emboj.2009.165; SCHONER R, 1976, J BIOL CHEM, V251, P5440; Schrodinger, 2010, PYMOL MOL GRAPHICS S; Vagin A, 1997, J APPL CRYSTALLOGR, V30, P1022, DOI 10.1107/S0021889897006766; Webby CJ, 2010, J BIOL CHEM, V285, P30567, DOI 10.1074/jbc.M110.111856; Webby CJ, 2005, J MOL BIOL, V354, P927, DOI 10.1016/j.jmb.2005.09.093; Webby CJ, 2005, ACTA CRYSTALLOGR F, V61, P403, DOI 10.1107/S1744309105007931; Webby CJ, 2005, BIOCHEM J, V390, P223, DOI 10.1042/BJ20050259; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Wolosker H, 2008, FEBS J, V275, P3514, DOI 10.1111/j.1742-4658.2008.06515.x; Zhan CY, 2012, J MED CHEM, V55, P6237, DOI 10.1021/jm3005465	31	6	6	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 29	2016	11	4							e0152723	10.1371/journal.pone.0152723	http://dx.doi.org/10.1371/journal.pone.0152723			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DK8XM	27128682	Green Published, Green Submitted, gold			2022-12-26	WOS:000375212600002
J	Song, YH; Rui, YK; Bedane, G; Li, JC				Song, Youhong; Rui, Yukui; Bedane, Guta; Li, Jincai			Morphological Characteristics of Maize Canopy Development as Affected by Increased Plant Density	PLOS ONE			English	Article							GRAIN-YIELD; LEAF-AREA; POPULATION DENSITY; ROW WIDTH; CORN; RADIATION; RESPONSES; INTERCEPTION; HYBRID; GROWTH	Improving crop productivity through higher plant density requires a detailed understanding of organ development in response to increased interplant competition. The objective of this paper is thus to investigate the characteristics of organ development under increased interplant competition. A field experiment was conducted to investigate organ development across 4 maize plant densities i.e. 2, 6, 12 and 20 plants m(-2) (referred to PD2, PD6, PD12 and PD20 respectively). In response to increased interplant competition, lengths of both laminae and sheaths increased in lower phytomers, but decreased in upper phytomers. Sheath extension appeared to be less sensitive to increased interplant competition than lamina extension. Extension of laminae and internodes responded to increased plant density as soon as onset of mild interplant competition, but did not respond any further to severe competition. Both lamina width and internode diameter were reduced due to a smaller growth rate in response to increased plant density. Overall, this study identified that organ expansion rate can be taken as the key morphological factor to determine the degree of interplant competition.	[Song, Youhong; Li, Jincai] Anhui Agr Univ, Sch Agron, Hefei 230036, Anhui, Peoples R China; [Rui, Yukui] China Agr Univ, Coll Resource & Environm Sci, Beijing, Peoples R China; [Bedane, Guta] Univ Queensland, Sch Agr & Food Sci, Gatton, Qld 4343, Australia; [Li, Jincai] Jiangsu Collaborat Innovat Ctr Modern Crop Prod, Nanjing 210095, Jiangsu, Peoples R China	Anhui Agricultural University; China Agricultural University; University of Queensland	Song, YH; Li, JC (corresponding author), Anhui Agr Univ, Sch Agron, Hefei 230036, Anhui, Peoples R China.; Li, JC (corresponding author), Jiangsu Collaborat Innovat Ctr Modern Crop Prod, Nanjing 210095, Jiangsu, Peoples R China.	y.song@ahau.edu.cn; ljc5122423@126.com	Song, Youhong/AAD-3654-2020		Anhui Agricultural University; Jiangsu Collaborative Innovation Center for Modern Crop Production	Anhui Agricultural University; Jiangsu Collaborative Innovation Center for Modern Crop Production	The work is supported by Anhui Agricultural University startup funds and Jiangsu Collaborative Innovation Center for Modern Crop Production. The funders had no role in study design, data collection and analysis.	ANDRADE FH, 1993, CROP SCI, V33, P482, DOI 10.2135/cropsci1993.0011183X003300030013x; Andrieu B, 2006, ANN BOT-LONDON, V98, P1005, DOI 10.1093/aob/mcl177; Bavec F, 2002, EUR J AGRON, V16, P151, DOI 10.1016/S1161-0301(01)00126-5; Boomsma CR, 2009, AGRON J, V101, P1426, DOI 10.2134/agronj2009.0082; Bos HJ, 2000, NETH J AGR SCI, V48, P199, DOI 10.1016/S1573-5214(00)80014-7; Chelle M, 2005, NEW PHYTOL, V166, P781, DOI 10.1111/j.1469-8137.2005.01350.x; Cox WJ, 1996, AGRON J, V88, P489, DOI 10.2134/agronj1996.00021962008800030022x; EDMEADES GO, 1993, AGRON J, V85, P850, DOI 10.2134/agronj1993.00021962008500040014x; Hashemi AM, 2005, AGRON J, V97, P839, DOI 10.2134/agronj2003.0241; HASHEMIDEZFOULI A, 1992, AGRON J, V84, P547, DOI 10.2134/agronj1992.00021962008400040001x; Maddonni GA, 1996, FIELD CROP RES, V48, P81, DOI 10.1016/0378-4290(96)00035-4; Maddonni GA, 2002, PLANT PHYSIOL, V130, P1181, DOI 10.1104/pp.009738; Maddonni GA, 2001, FIELD CROP RES, V71, P183, DOI 10.1016/S0378-4290(01)00158-7; Maddonni GA, 2006, AGRON J, V98, P1532, DOI 10.2134/agronj2006.0038; Markham MY, 2010, CROP SCI, V50, P273, DOI 10.2135/cropsci2008.10.0614; Pommel B, 2001, AGR FOREST METEOROL, V110, P55, DOI 10.1016/S0168-1923(01)00270-2; Sarlangue T, 2007, AGRON J, V99, P984, DOI 10.2134/agronj2006.0205; SATTIN M, 1994, PHYSIOL PLANTARUM, V91, P322, DOI 10.1111/j.1399-3054.1994.tb00439.x; Song Y, 2010, ANN APPL BIOL, V157, P111, DOI 10.1111/j.1744-7348.2010.00412.x; Song YH, 2015, PLANT PROD SCI, V18, P1, DOI 10.1626/pps.18.1; Subedi KD, 2006, CROP SCI, V46, P1860, DOI 10.2135/cropsci2005.06-0141; TETIO-KAGHO F, 1988, Agronomy Journal, V80, P930; Tokatlidis IS, 2004, FIELD CROP RES, V88, P103, DOI 10.1016/j.fcr.2003.11.013; Widdicombe WD, 2002, AGRON J, V94, P1020, DOI 10.2134/agronj2002.1020	25	18	19	1	46	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 29	2016	11	4							e0154084	10.1371/journal.pone.0154084	http://dx.doi.org/10.1371/journal.pone.0154084			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DK8XM	27129101	Green Published, Green Submitted, gold			2022-12-26	WOS:000375212600020
J	Hamrefors, V; Harstedt, M; Holmberg, A; Rogmark, C; Sutton, R; Melander, O; Fedorowski, A				Hamrefors, Viktor; Harstedt, Maria; Holmberg, Anna; Rogmark, Cecilia; Sutton, Richard; Melander, Olle; Fedorowski, Artur			Orthostatic Hypotension and Elevated Resting Heart Rate Predict Low-Energy Fractures in the Population: The Malmo Preventive Project	PLOS ONE			English	Article							POSTURAL TACHYCARDIA SYNDROME; ALL-CAUSE MORTALITY; RISK-FACTORS; CARDIOVASCULAR-DISEASE; CONSENSUS STATEMENT; HIP-FRACTURES; 33,000 MEN; FOLLOW-UP; WOMEN; CONSEQUENCES	Background Autonomic disorders of the cardiovascular system, such as orthostatic hypotension and elevated resting heart rate, predict mortality and cardiovascular events in the population. Low-energy-fractures constitute a substantial clinical problem that may represent an additional risk related to such autonomic dysfunction. Aims To test the association between orthostatic hypotension, resting heart rate and incidence of low-energy-fractures in the general population. Methods and Results Using multivariable-adjusted Cox regression models we investigated the association between orthostatic blood pressure response, resting heart rate and first incident low-energy-fracture in a population-based, middle-aged cohort of 33 000 individuals over 25 years follow-up. The median follow-up time from baseline to first incident fracture among the subjects that experienced a low energy fracture was 15.0 years. A 10 mmHg orthostatic decrease in systolic blood pressure at baseline was associated with 5% increased risk of low-energy-fractures (95% confidence interval 1.01-1.10) during follow-up, whereas the resting heart rate predicted low-energy-fractures with an effect size of 8% increased risk per 10 beats-perminute (1.05-1.12), independently of the orthostatic response. Subjects with a resting heart rate exceeding 68 beats-per-minute had 18% (1.10-1.26) increased risk of low-energy-fractures during follow-up compared with subjects with a resting heart rate below 68 beats-per-minute. When combining the orthostatic response and resting heart rate, there was a 30% risk increase (1.08-1.57) of low-energy-fractures between the extremes, i.e. between subjects in the fourth compared with the first quartiles of both resting heart rate and systolic blood pressure-decrease. Conclusion Orthostatic blood pressure decline and elevated resting heart rate independently predict low-energy fractures in a middle-aged population. These two measures of subclinical cardiovascular dysautonomia may herald increased risks many years in advance, even if symptoms may not be detectable. Although the effect sizes are moderate, the easily accessible clinical parameters of orthostatic blood pressure response and resting heart rate deserve consideration as new risk predictors to yield more accurate decisions on primary prevention of low-energy fractures.	[Hamrefors, Viktor; Harstedt, Maria; Fedorowski, Artur] Lund Univ, Dept Clin Sci, Fac Med, Malmo, Sweden; [Hamrefors, Viktor] Skane Univ Hosp, Dept Med Imaging & Physiol, Malmo, Sweden; [Holmberg, Anna; Rogmark, Cecilia] Skane Univ Hosp, Dept Orthopaed, Malmo, Sweden; [Sutton, Richard] Univ London Imperial Coll Sci Technol & Med, Natl Heart & Lung Inst, St Marys Hosp Campus, London, England; [Melander, Olle] Skane Univ Hosp, Dept Internal Med, Malmo, Sweden; [Fedorowski, Artur] Skane Univ Hosp, Dept Cardiol, Malmo, Sweden	Lund University; Lund University; Skane University Hospital; Lund University; Skane University Hospital; Imperial College London; Lund University; Skane University Hospital; Lund University; Skane University Hospital	Hamrefors, V (corresponding author), Lund Univ, Dept Clin Sci, Fac Med, Malmo, Sweden.; Hamrefors, V (corresponding author), Skane Univ Hosp, Dept Med Imaging & Physiol, Malmo, Sweden.	Viktor.Hamrefors@med.lu.se	Fedorowski, Artur/I-3937-2019	Fedorowski, Artur/0000-0002-5352-6327; Melander, Olle/0000-0002-2581-484X	European Research Council [StG 282225]; Swedish Medical Research Council; Swedish Heart and Lung Foundation; Medical Faculty of Lund University; National Health Services; Albert Pahlsson Research Foundation; Crafoord Foundation; Ernhold Lundstroms Research Foundation; Region Skane; Hulda and Conrad Mossfelt Foundation; Wallenberg Foundation; Lennart Hanssons Memorial Foundation; Anna Lisa and Sven-Erik Lundgrens Foundation	European Research Council(European Research Council (ERC)European Commission); Swedish Medical Research Council(Swedish Medical Research Council (SMRC)); Swedish Heart and Lung Foundation(Swedish Heart-Lung Foundation); Medical Faculty of Lund University; National Health Services; Albert Pahlsson Research Foundation; Crafoord Foundation; Ernhold Lundstroms Research Foundation; Region Skane; Hulda and Conrad Mossfelt Foundation; Wallenberg Foundation(European Commission); Lennart Hanssons Memorial Foundation; Anna Lisa and Sven-Erik Lundgrens Foundation	Funding was provided by the European Research Council (StG 282225), Swedish Medical Research Council, the Swedish Heart and Lung Foundation, the Medical Faculty of Lund University, the governmental funding of clinical research within the National Health Services, the Albert Pahlsson Research Foundation, the Crafoord Foundation, the Ernhold Lundstroms Research Foundation, the Region Skane, the Hulda and Conrad Mossfelt Foundation, the Wallenberg Foundation, the Lennart Hanssons Memorial Foundation, and the Anna Lisa and Sven-Erik Lundgrens Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arbogast SD, 2009, AM J MED, V122, P574, DOI 10.1016/j.amjmed.2008.10.040; Berglund G, 2000, J INTERN MED, V247, P19, DOI 10.1046/j.1365-2796.2000.00568.x; Chang NT, 2010, AGING CLIN EXP RES, V22, P70, DOI [10.3275/6627, 10.1007/BF03324818]; den Hoed M, 2013, NAT GENET, V45, P621, DOI 10.1038/ng.2610; Fedorowski A, 2013, J INTERN MED, V273, P322, DOI 10.1111/joim.12021; Fedorowski A, 2012, EUR HEART J, V33, P2331, DOI 10.1093/eurheartj/ehs058; Fedorowski A, 2011, EUR J EPIDEMIOL, V26, P537, DOI 10.1007/s10654-011-9578-1; Fedorowski A, 2010, J HYPERTENS, V28, P551, DOI 10.1097/HJH.0b013e3283350e8c; Fedorowski A, 2010, EUR HEART J, V31, P85, DOI 10.1093/eurheartj/ehp329; Freeman R, 2011, AUTON NEUROSCI-BASIC, V161, P46, DOI 10.1016/j.autneu.2011.02.004; Goldstein David S., 2002, Annals of Internal Medicine, V137, P753; Goldstein DS, 2009, CIRCULATION, V119, P139, DOI 10.1161/CIRCULATIONAHA.108.805887; Holmberg AH, 2006, OSTEOPOROSIS INT, V17, P1065, DOI 10.1007/s00198-006-0137-7; Holmberg AH, 2005, OSTEOPOROSIS INT, V16, P2185, DOI 10.1007/s00198-005-2006-1; Jensen MT, 2013, HEART, V99, P882, DOI 10.1136/heartjnl-2012-303375; JONSSON B, 1993, CALCIFIED TISSUE INT, V52, P425, DOI 10.1007/BF00571331; MacLean C, 2008, ANN INTERN MED, V148, P197, DOI 10.7326/0003-4819-148-3-200802050-00198; MELTON LJ, 1993, BONE, V14, pS1; Melton LJ, 2003, OSTEOPOROSIS INT, V14, P383, DOI 10.1007/s00198-003-1385-4; Nauman J, 2010, J EPIDEMIOL COMMUN H, V64, P175, DOI 10.1136/jech.2009.093088; Nilsson P, 2000, J INTERN MED, V248, P455, DOI 10.1046/j.1365-2796.2000.00766.x; Perk J, 2012, EUR HEART J, V33, P1635, DOI 10.1093/eurheartj/ehs092; Ricci F, 2015, EUR HEART J; Robertson D, 2008, CLIN AUTON RES, V18, P2, DOI 10.1007/s10286-007-1004-0; Saxena A, 2013, MAYO CLIN PROC, V88, P1420, DOI 10.1016/j.mayocp.2013.09.011; Sheldon RS, 2015, HEART RHYTHM, V12, pE41, DOI 10.1016/j.hrthm.2015.03.029; Shibao C, 2010, HYPERTENSION, V56, P1042, DOI 10.1161/HYPERTENSIONAHA.110.162768; TRELL E, 1983, PREV MED, V12, P397, DOI 10.1016/0091-7435(83)90248-7; van Beek AHEA, 2008, J CEREBR BLOOD F MET, V28, P1071, DOI 10.1038/jcbfm.2008.13	29	12	12	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 28	2016	11	4							e0154249	10.1371/journal.pone.0154249	http://dx.doi.org/10.1371/journal.pone.0154249			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DK8XE	27124658	Green Published, gold, Green Submitted			2022-12-26	WOS:000375211700060
J	McDonnell, F; Irnaten, M; Clark, AF; O'Brien, CJ; Wallace, DM				McDonnell, Fiona; Irnaten, Mustapha; Clark, Abbot F.; O'Brien, Colm J.; Wallace, Deborah M.			Hypoxia-Induced Changes in DNA Methylation Alter RASAL1 and TGF beta 1 Expression in Human Trabecular Meshwork Cells	PLOS ONE			English	Article							OPEN-ANGLE GLAUCOMA; OPTIC-NERVE HEAD; LAMINA-CRIBROSA CELLS; GROWTH-FACTOR-BETA; EXTRACELLULAR-MATRIX PRODUCTION; HUMAN DERMAL FIBROBLASTS; HUMAN RENAL FIBROBLASTS; GENE-EXPRESSION; PULMONARY-FIBROSIS; RISK-FACTORS	Purpose Fibrosis and a hypoxic environment are associated with the trabecular meshwork (TM) region in the blinding disease glaucoma. Hypoxia has been shown to alter DNA methylation, an epigenetic mechanism involved in regulating gene expression such as the pro-fibrotic transforming growth factor (TGF) beta 1 and the anti-fibrotic Ras protein activator like 1 (RASAL1). The purpose of this study was to compare DNA methylation levels, and the expression of TGF beta 1 and RASAL1 in primary human normal (NTM) with glaucomatous (GTM) cells and in NTM cells under hypoxic conditions. Methods Global DNA methylation was assessed by ELISA in cultured age-matched NTM and GTM cells. qPCR was conducted for TGFa1, collagen 1 alpha 1 (COL1A1), and RASAL1 expression. Western immunoblotting was used to determine protein expression. For hypoxia experiments, NTM cells were cultured in a 1% O-2, 5% CO2 and 37 degrees C environment. NTM and GTM cells were treated with TGF beta 1 (10ng/ml) and the methylation inhibitor 5-azacytidine (5-aza) (0.5 mu M) respectively to determine their effects on DNA Methyltransferase 1 (DNMT1) and RASAL1 expression. Results We found increased DNA methylation, increased TGFa1 expression and decreased RASAL1 expression in GTM cells compared to NTM cells. Similar results were obtained in NTM cells under hypoxic conditions. TG1 treatment increased DNMT1 and COL1A1, and decreased RASAL1 expression in NTM cells. 5-aza treatment decreased DNMT1, TGFa1 and COL1A1 expression, and increased RASAL1 expression in GTM cells. Conclusions TGF beta 1 and RASAL1 expression, global DNA methylation, and expression of associated methylation enzymes were altered between NTM and GTM cells. We found that hypoxia in NTM cells induced similar results to the GTM cells. Furthermore, DNA methylation, TGF beta 1 and RASAL1 appear to have an interacting relationship that may play a role in driving profibrotic disease progression in the glaucomatous TM.	[McDonnell, Fiona; O'Brien, Colm J.; Wallace, Deborah M.] Univ Coll Dublin, Sch Med & Med Sci, Dublin 4, Ireland; [Clark, Abbot F.] U N Texas Hlth Sci Ctr, Dept Cell Biol & Immunol, Ft Worth, TX USA; [Clark, Abbot F.] U N Texas Hlth Sci Ctr, North Texas Eye Res Inst, Ft Worth, TX USA; [Irnaten, Mustapha; O'Brien, Colm J.; Wallace, Deborah M.] Mater Misericordiae Univ Hosp, Dept Ophthalmol, Dublin 7, Ireland	University College Dublin; Mater Misericordiae University Hospital; University College Dublin	Wallace, DM (corresponding author), Univ Coll Dublin, Sch Med & Med Sci, Dublin 4, Ireland.; Wallace, DM (corresponding author), Mater Misericordiae Univ Hosp, Dept Ophthalmol, Dublin 7, Ireland.	deborah.wallace@ucd.ie		Wallace, Deborah/0000-0003-2363-106X	Health Research Board (IE) [HRA POR_2010-129, HRA POR_2011-13]	Health Research Board (IE)	This work was supported by the Health Research Board (IE) HRA POR_2010-129 and HRA POR_2011-13. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acott TS, 2008, EXP EYE RES, V86, P543, DOI 10.1016/j.exer.2008.01.013; ALBON J, 1995, BRIT J OPHTHALMOL, V79, P368, DOI 10.1136/bjo.79.4.368; Auclair G, 2012, BIOCHIMIE, V94, P2202, DOI 10.1016/j.biochi.2012.05.016; Bechtel W, 2010, NAT MED, V16, P544, DOI 10.1038/nm.2135; Bestor TH, 2000, HUM MOL GENET, V9, P2395, DOI 10.1093/hmg/9.16.2395; Bian EB, 2013, CELL SIGNAL, V25, P355, DOI 10.1016/j.cellsig.2012.10.007; Browne JG, 2011, INVEST OPHTHALMOL, DOI [10.1167/iovs.10-7091, DOI 10.1167/I0VS.10-7091]; Chau BN, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003205; Chen KC, 2012, J MOL CELL CARDIOL, V52, P587, DOI 10.1016/j.yjmcc.2011.12.005; Chen KC, 2011, FASEB J, V25, P1718, DOI 10.1096/fj.10-174904; Chen YN, 2007, BRAIN RES, V1148, P28, DOI 10.1016/j.brainres.2007.02.027; Choi J, 2007, INVEST OPHTH VIS SCI, V48, P104, DOI 10.1167/iovs.06-0615; Clark AF, 2001, INVEST OPHTH VIS SCI, V42, P1769; Coward WR, 2009, MOL CELL BIOL, V29, P4325, DOI 10.1128/MCB.01776-08; Cummins EP, 2006, P NATL ACAD SCI USA, V103, P18154, DOI 10.1073/pnas.0602235103; Dakhlallah D, 2013, AM J RESP CRIT CARE, V187, P397, DOI 10.1164/rccm.201205-0888OC; De Moraes CGV, 2011, ARCH OPHTHALMOL-CHIC, V129, P562, DOI 10.1001/archophthalmol.2011.72; Diegelmann RF, 2004, FRONT BIOSCI-LANDMRK, V9, P283, DOI 10.2741/1184; FALANGA V, 1991, J INVEST DERMATOL, V97, P634, DOI 10.1111/1523-1747.ep12483126; Fleenor DL, 2006, INVEST OPHTH VIS SCI, V47, P226, DOI 10.1167/iovs.05-1060; Fuchshofer R, 2006, INVEST OPHTH VIS SCI, V47, P794, DOI 10.1167/iovs.05-0292; Fuchshofer R, 2005, INVEST OPHTH VIS SCI, V46, P568, DOI 10.1167/iovs.04-0649; Gomez J, 1996, APOPTOSIS, V1, P175; Gottanka J, 1997, J GLAUCOMA, V6, P123; Hermann A, 2004, J BIOL CHEM, V279, P48350, DOI 10.1074/jbc.M403427200; HERNANDEZ MR, 1993, ANN MED, V25, P309, DOI 10.3109/07853899309147290; Heyn H, 2013, GENOME RES, V23, P1363, DOI 10.1101/gr.154187.112; Hinz B, 2007, AM J PATHOL, V170, P1807, DOI 10.2353/ajpath.2007.070112; Hong S, 2008, BIOCELL, V32, P201; Hung SP, 2013, CELL TRANSPLANT, V22, P1869, DOI 10.3727/096368912X657954; Inatani M, 2001, GRAEF ARCH CLIN EXP, V239, P109, DOI 10.1007/s004170000241; Inman GJ, 2002, MOL PHARMACOL, V62, P65, DOI 10.1124/mol.62.1.65; Junglas B, 2009, EXP EYE RES, V88, P1065, DOI 10.1016/j.exer.2009.01.008; Kalluri R, 2006, NAT REV CANCER, V6, P392, DOI 10.1038/nrc1877; Kaminskas E, 2005, ONCOLOGIST, V10, P176, DOI 10.1634/theoncologist.10-3-176; Kaminski N, 2000, P NATL ACAD SCI USA, V97, P1778, DOI 10.1073/pnas.97.4.1778; Kaur C, 2008, CLIN OPHTHALMOL, V2, P879, DOI 10.2147/opth.s3361; Kim YS, 2014, J CELL MOL MED, V18, P1018, DOI 10.1111/jcmm.12248; Kirwan RP, 2012, INVEST OPHTH VIS SCI, V53, P2243, DOI 10.1167/iovs.11-6729; Kirwan RP, 2009, MOL VIS, V15, P76; Kondoh M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080349; Kottler UB, 2005, EXP EYE RES, V80, P121, DOI 10.1016/j.exer.2004.08.018; Kouzarides T, 2007, CELL, V128, P693, DOI 10.1016/j.cell.2007.02.005; Lafyatis Robert, 2006, Endocrine Metabolic & Immune Disorders-Drug Targets, V6, P395; LESKE MC, 1995, ARCH OPHTHALMOL-CHIC, V113, P918, DOI 10.1001/archopht.1995.01100070092031; Liu G, 2010, J EXP MED, V207, P1589, DOI 10.1084/jem.20100035; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; MORRISON JC, 1990, ARCH OPHTHALMOL-CHIC, V108, P1020, DOI 10.1001/archopht.1990.01070090122053; MULLER GA, 1991, AM J KIDNEY DIS, V17, P680; Mutsaers SE, 1997, INT J BIOCHEM CELL B, V29, P5, DOI 10.1016/S1357-2725(96)00115-X; Nan XS, 1996, MOL CELL BIOL, V16, P414; Nan XS, 1997, CELL, V88, P471, DOI 10.1016/S0092-8674(00)81887-5; Okano M, 1999, CELL, V99, P247, DOI 10.1016/S0092-8674(00)81656-6; OVERALL CM, 1989, J BIOL CHEM, V264, P1860; Quigley HA, 2006, BRIT J OPHTHALMOL, V90, P262, DOI 10.1136/bjo.2005.081224; Quigley HA, 1999, PROG RETIN EYE RES, V18, P39, DOI 10.1016/S1350-9462(98)00014-7; QUIGLEY HA, 1980, INVEST OPHTH VIS SCI, V19, P505; Rao KN, 2011, INDIAN J OPHTHALMOL, V59, pS31, DOI 10.4103/0301-4738.73685; Robinson CM, 2012, RESP RES, V13, DOI 10.1186/1465-9921-13-74; RODEMANN HP, 1991, AM J KIDNEY DIS, V17, P684, DOI 10.1016/S0272-6386(12)80352-0; ROHEN JW, 1972, A GRAEF ARCH KLIN EX, V183, P251, DOI 10.1007/BF00496153; Schlotzer-Schrehardt U, 2001, EXP EYE RES, V73, P765, DOI 10.1006/exer.2001.1084; SCHLOTZERSCHREHARDT U, 1995, INVEST OPHTH VIS SCI, V36, P1750; Schwanhausser B, 2011, NATURE, V473, P337, DOI 10.1038/nature10098; Sethi A, 2011, INVEST OPHTH VIS SCI, V52, P5251, DOI 10.1167/iovs.11-7587; Shahrzad S, 2007, EPIGENETICS-US, V2, P119, DOI 10.4161/epi.2.2.4613; Sharifipour F, 2013, J GLAUCOMA, V22, P608, DOI 10.1097/IJG.0b013e318255bc62; Tampe B, 2014, J AM SOC NEPHROL, V25, P905, DOI 10.1681/ASN.2013070723; Tao H, 2011, TOXICOLOGY, V290, P327, DOI 10.1016/j.tox.2011.10.011; Tezel G, 2004, ARCH OPHTHALMOL-CHIC, V122, P1348, DOI 10.1001/archopht.122.9.1348; Thum T, 2008, NATURE, V456, P980, DOI 10.1038/nature07511; Tian Q, 2004, MOL CELL PROTEOMICS, V3, P960, DOI 10.1074/mcp.M400055-MCP200; Topouzis F, 2013, AM J OPHTHALMOL, V155, P843, DOI 10.1016/j.ajo.2012.12.007; Topouzis F, 2011, AM J OPHTHALMOL, V152, P219, DOI 10.1016/j.ajo.2011.01.032; Tovar-Vidales T, 2011, EXP EYE RES, V93, P442, DOI 10.1016/j.exer.2011.06.011; Van Veldhuisen PC, 2000, AM J OPHTHALMOL, V130, P429; VARGA J, 1987, BIOCHEM J, V247, P597, DOI 10.1042/bj2470597; Wallace DM, 2013, INVEST OPHTH VIS SCI, V54, P7836, DOI 10.1167/iovs.13-12494; Watson CJ, 2014, HUM MOL GENET, V23, P2176, DOI 10.1093/hmg/ddt614; Watson JA, 2009, HUM MOL GENET, V18, P3594, DOI 10.1093/hmg/ddp307; WEBER KT, 1992, BASIC RES CARDIOL, V87, P291; Wu CT, 2001, SCIENCE, V293, P1103, DOI 10.1126/science.293.5532.1103; Zhang B, 2013, GENOME RES, V23, P1522, DOI 10.1101/gr.156539.113	83	32	34	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 28	2016	11	4							e0153354	10.1371/journal.pone.0153354	http://dx.doi.org/10.1371/journal.pone.0153354			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DK8XE	27124111	Green Published, Green Submitted, gold			2022-12-26	WOS:000375211700015
J	Saku, K; Kakino, T; Arimura, T; Sakamoto, T; Nishikawa, T; Sakamoto, K; Ikeda, M; Kishi, T; Ide, T; Sunagawa, K				Saku, Keita; Kakino, Takamori; Arimura, Takahiro; Sakamoto, Takafumi; Nishikawa, Takuya; Sakamoto, Kazuo; Ikeda, Masataka; Kishi, Takuya; Ide, Tomomi; Sunagawa, Kenji			Total Mechanical Unloading Minimizes Metabolic Demand of Left Ventricle and Dramatically Reduces Infarct Size in Myocardial Infarction	PLOS ONE			English	Article							PERCUTANEOUS CORONARY INTERVENTION; RANDOMIZED CLINICAL-TRIAL; INTRAAORTIC BALLOON PUMP; CANINE LEFT-VENTRICLE; HEART-FAILURE; COLLATERAL CIRCULATION; OXYGEN-CONSUMPTION; CARDIOGENIC-SHOCK; ASSIST DEVICE; REPERFUSION	Background Left ventricular assist device (LVAD) mechanically unloads the left ventricle (LV). Theoretical analysis indicates that partial LVAD support (p-LVAD), where LV remains ejecting, reduces LV preload while increases afterload resulting from the elevation of total cardiac output and mean aortic pressure, and consequently does not markedly decrease myocardial oxygen consumption (MVO2). In contrast, total LVAD support (t-LVAD), where LV no longer ejects, markedly decreases LV preload volume and afterload pressure, thereby strikingly reduces MVO2. Since an imbalance in oxygen supply and demand is the fundamental pathophysiology ofmyocardial infarction (MI), we hypothesized that t-LVADminimizes MVO2 and reduces infarct size in MI. The purpose of this study was to evaluate the differential impact of the support level of LVAD on MVO2 and infarct size in a caninemodel of ischemia-reperfusion. Methods In 5 normal mongrel dogs, we examined the impact of LVAD on MVO2 at 3 support levels: Control (no LVAD support), p-LVAD and t-LVAD. In another 16 dogs, ischemia was induced by occluding major branches of the left anterior descending coronary artery (90 min) followed by reperfusion (300 min). We activated LVAD from the beginning of ischemia until 300 min of reperfusion, and compared the infarct size among 3 different levels of LVAD support. Results t-LVAD markedly reduced MVO2 (% reduction against Control: -56 +/- 9%, p<0.01) whereas p-LVAD did less (-21 +/- 14%, p<0.05). t-LVAD markedly reduced infarct size compared to p-LVAD (infarct area/area at risk: Control; 41.8 +/- 6.4, p-LVAD; 29.1 +/- 5.6 and t-LVAD; 5.0 +/- 3.1%, p<0.01). Changes in creatine kinase-MB paralleled those in infarct size. Conclusions Total LVAD support that minimizes metabolic demand maximizes the benefit of LVAD in the treatment of acute myocardial infarction.	[Saku, Keita; Sunagawa, Kenji] Kyushu Univ, Ctr Disrupt Cardiovasc Med, Dept Therapeut Regulat Cardiovasc Homeostasis, Fukuoka 812, Japan; [Kakino, Takamori; Arimura, Takahiro; Sakamoto, Takafumi; Nishikawa, Takuya; Sakamoto, Kazuo; Ikeda, Masataka; Ide, Tomomi] Kyushu Univ, Grad Sch Med Sci, Dept Cardiovasc Med, Fukuoka 812, Japan; [Kishi, Takuya] Kyushu Univ, Ctr Disrupt Cardiovasc Med, Collaborat Res Inst Innovat Therapeut Cardiovasc, Fukuoka 812, Japan	Kyushu University; Kyushu University; Kyushu University	Saku, K (corresponding author), Kyushu Univ, Ctr Disrupt Cardiovasc Med, Dept Therapeut Regulat Cardiovasc Homeostasis, Fukuoka 812, Japan.	saku@cardiol.med.kyushu-u.ac.jp	Saku, Keita/AAE-8639-2021	Saku, Keita/0000-0001-9404-7069; Nishikawa, Takuya/0000-0002-4951-7831	Japan Society for the Promotion of Science [23220013, 15K19383]; Translational Research Network Program [B07]	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Translational Research Network Program	This work was supported by Grant-in-Aid for Scientific Research (S) (23220013) from the Japan Society for the Promotion of Science (http://www.jsps.go.jp/english/), Grant-in-Aid from Translational Research Network Program (B07) (http://www.tr.mext.go.jp/), and Grant-in-Aid for Young Scientists (B) (15K19383) from the Japan Society for the Promotion of Science (http://www.jsps.go.jp/english/).	Achour H, 2005, CATHETER CARDIO INTE, V64, P182, DOI 10.1002/ccd.20271; BURKHOFF D, 1988, AM J PHYSIOL, V255, pH742, DOI 10.1152/ajpheart.1988.255.4.H742; Cheng JM, 2009, EUR HEART J, V30, P2102, DOI 10.1093/eurheartj/ehp292; Dai WD, 2010, CARDIOVASC THER, V28, P30, DOI 10.1111/j.1755-5922.2009.00108.x; de Marchi SF, 2005, EUR HEART J, V26, P558, DOI 10.1093/eurheartj/ehi051; ERTL G, 1982, CIRCULATION, V65, P40, DOI 10.1161/01.CIR.65.1.40; FLAMENG W, 1986, CARDIOVASC RES, V20, P241, DOI 10.1093/cvr/20.4.241; Grund F, 1997, J MOL CELL CARDIOL, V29, P3067, DOI 10.1006/jmcc.1997.0521; JANG IK, 1989, J AM COLL CARDIOL, V14, P1816, DOI 10.1016/0735-1097(89)90038-7; Jhund PS, 2008, CIRCULATION, V118, P2019, DOI 10.1161/CIRCULATIONAHA.108.813493; Kapur NK, 2013, CIRCULATION, V128, P328, DOI 10.1161/CIRCULATIONAHA.112.000029; Kawashima D, 2011, ASAIO J, V57, P169, DOI 10.1097/MAT.0b013e31820e121c; Klabunde RE, 2005, CARDIOVASCULAR PHYSL, P78; Meyns B, 2003, J AM COLL CARDIOL, V41, P1087, DOI 10.1016/S0735-1097(03)00084-6; Morley D, 2007, J THORAC CARDIOV SUR, V133, P21, DOI 10.1016/j.jtcvs.2006.07.037; O'Neill WW, 2012, CIRCULATION, V126, P1717, DOI 10.1161/CIRCULATIONAHA.112.098194; PFEFFER MA, 1990, CIRCULATION, V81, P1161, DOI 10.1161/01.CIR.81.4.1161; REYNOLDS RD, 1981, CARDIOVASC RES, V15, P411, DOI 10.1093/cvr/15.7.411; ROBERTS AJ, 1978, CIRCULATION, V57, P35, DOI 10.1161/01.CIR.57.1.35; Roe MT, 2010, J AM COLL CARDIOL, V56, P254, DOI 10.1016/j.jacc.2010.05.008; Rogers WJ, 2008, AM HEART J, V156, P1026, DOI DOI 10.1016/J.AHJ.2008.07.030; Rose EA, 2001, NEW ENGL J MED, V345, P1435, DOI 10.1056/NEJMoa012175; Sakamoto T, 2015, AM J PHYSIOL-HEART C, V308, pH49, DOI 10.1152/ajpheart.00552.2014; Seyfarth M, 2008, J AM COLL CARDIOL, V52, P1584, DOI 10.1016/j.jacc.2008.05.065; Shu W, 2013, AM J HYPERTENS, V26, P630, DOI 10.1093/ajh/hps096; SUGA H, 1973, CIRC RES, V32, P314, DOI 10.1161/01.RES.32.3.314; SUGA H, 1983, CIRC RES, V53, P306, DOI 10.1161/01.RES.53.3.306; Tamareille S, 2008, J THORAC CARDIOV SUR, V136, P343, DOI 10.1016/j.jtcvs.2008.01.021; Thompson RB, 2003, EUR J HEART FAIL, V5, P741, DOI 10.1016/S1388-9842(03)00152-1; Velagaleti RS, 2008, CIRCULATION, V118, P2057, DOI 10.1161/CIRCULATIONAHA.108.784215	30	21	21	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 28	2016	11	4							e0152911	10.1371/journal.pone.0152911	http://dx.doi.org/10.1371/journal.pone.0152911			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DK8XE	27124411	Green Published, Green Submitted, gold			2022-12-26	WOS:000375211700008
J	Blanchetot, C; De Jonge, N; Desmyter, A; Ongenae, N; Hofman, E; Klarenbeek, A; Sadi, A; Hultberg, A; Kretz-Rommel, A; Spinelli, S; Loris, R; Cambillau, C; de Haard, H				Blanchetot, Christophe; De Jonge, Natalie; Desmyter, Aline; Ongenae, Nico; Hofman, Erik; Klarenbeek, Alex; Sadi, Ava; Hultberg, Anna; Kretz-Rommel, Anke; Spinelli, Silvia; Loris, Remy; Cambillau, Christian; de Haard, Hans			Structural Mimicry of Receptor Interaction by Antagonistic Interleukin-6 (IL-6) Antibodies	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						antibody engineering; crystal structure; immunology; interleukin 6 (IL-6); structure-function; high affinity	CRYSTAL-STRUCTURE; SOLUBLE RECEPTORS; MOLECULAR-CLONING; T-CELL; NEUTRALIZATION; TOCILIZUMAB; EXPRESSION; ARTHRITIS; BIOLOGY; EPITOPE	Interleukin 6 plays a key role in mediating inflammatory reactions in autoimmune diseases and cancer, where it is also involved in metastasis and tissue invasion. Neutralizing antibodies against IL-6 and its receptor have been approved for therapeutic intervention or are in advanced stages of clinical development. Here we describe the crystal structures of the complexes of IL-6 with two Fabs derived from conventional camelid antibodies that antagonize the interaction between the cytokine and its receptor. The x-ray structures of these complexes provide insights into the mechanism of neutralization by the two antibodies and explain the very high potency of one of the antibodies. It effectively competes for binding to the cytokine with IL-6 receptor (IL-6R) by using side chains of two CDR residues filling the site I cavities of IL-6, thus mimicking the interactions of Phe(229) and Phe(279) of IL-6R. In the first antibody, a HCDR3 tryptophan binds similarly to hot spot residue Phe(279). Mutation of this HCDR3 Trp residue into any other residue except Tyr or Phe significantly weakens binding of the antibody to IL-6, as was also observed for IL-6R mutants of Phe(279). In the second antibody, the side chain of HCDR3 valine ties into site I like IL-6R Phe(279), whereas a LCDR1 tyrosine side chain occupies a second cavity within site I and mimics the interactions of IL-6R Phe(229).	[Blanchetot, Christophe; De Jonge, Natalie; Ongenae, Nico; Hofman, Erik; Klarenbeek, Alex; Sadi, Ava; Hultberg, Anna; de Haard, Hans] Argenx, B-9052 Zwijnaarde, Belgium; [Desmyter, Aline; Spinelli, Silvia; Cambillau, Christian] CNRS, UMR 6098, Architecture & Fonct Macromol Biol, F-13284 Marseille, France; [Desmyter, Aline; Spinelli, Silvia; Cambillau, Christian] Univ Marseille, F-13284 Marseille, France; [Kretz-Rommel, Anke] Bird Rock Bio, La Jolla, CA 92037 USA; [Loris, Remy] Vrije Univ Brussel, Struct Biol Brussels, B-1050 Brussels, Belgium; [Loris, Remy] Inst Biotechnol, Struct Biol Res Ctr, B-1050 Brussels, Belgium	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Aix-Marseille Universite; UDICE-French Research Universities; Aix-Marseille Universite; Vrije Universiteit Brussel	de Haard, H (corresponding author), Argenx BVBA, Ind Pk Zwijnaarde 7, B-9052 Zwijnaarde, Belgium.	hdehaard@argenx.com	Loris, Remy/GPG-0894-2022	Loris, Remy/0000-0002-8862-3338; Blanchetot, christophe/0000-0001-9152-9978	Agentschap voor Innovatie door Wetenschap en Technologie [IWT090297]	Agentschap voor Innovatie door Wetenschap en Technologie	This work was supported by Agentschap voor Innovatie door Wetenschap en Technologie Grant IWT090297. C. B., N. D. J., E. H., N. O., A. K.-R., A. H., and H. d. H. are employees of argenx. A. K.-R. is an employee of Bird Rock Bio.	Akira S, 1997, INT J BIOCHEM CELL B, V29, P1401, DOI 10.1016/S1357-2725(97)00063-0; AKIRA S, 1994, CELL, V77, P63, DOI 10.1016/0092-8674(94)90235-6; Blanc E, 2004, ACTA CRYSTALLOGR D, V60, P2210, DOI 10.1107/S0907444904016427; Boulanger MJ, 2003, SCIENCE, V300, P2101, DOI 10.1126/science.1083901; BRAKENHOFF JPJ, 1990, J IMMUNOL, V145, P561; Briso EM, 2008, J IMMUNOL, V180, P7102, DOI 10.4049/jimmunol.180.11.7102; Chalaris A, 2011, EUR J CELL BIOL, V90, P484, DOI 10.1016/j.ejcb.2010.10.007; Desmyter A, 1996, NAT STRUCT BIOL, V3, P803, DOI 10.1038/nsb0996-803; DEVOS AM, 1992, SCIENCE, V255, P306, DOI 10.1126/science.1549776; Drucker C, 2010, J AUTOIMMUN, V34, P29, DOI 10.1016/j.jaut.2009.08.003; Ekiert DC, 2009, SCIENCE, V324, P246, DOI 10.1126/science.1171491; Grutter C, 2008, P NATL ACAD SCI USA, V105, P20251, DOI 10.1073/pnas.0807200106; HIBI M, 1990, CELL, V63, P1149, DOI 10.1016/0092-8674(90)90411-7; Hirano T, 1998, Int Rev Immunol, V16, P249; HORIUCHI S, 1994, EUR J IMMUNOL, V24, P1945, DOI 10.1002/eji.1830240837; Ito H, 2004, GASTROENTEROLOGY, V126, P989, DOI 10.1053/j.gastro.2004.01.012; Jones SA, 2002, BBA-MOL CELL RES, V1592, P251, DOI 10.1016/S0167-4889(02)00319-1; Jones SA, 2011, J CLIN INVEST, V121, P3375, DOI 10.1172/JCI57158; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Kalai M, 1997, BLOOD, V89, P1319, DOI 10.1182/blood.V89.4.1319; KISHIMOTO T, 1992, SCIENCE, V258, P593, DOI 10.1126/science.1411569; Klarenbeek A, 2016, PROTEIN ENG DES SEL, V29, P123, DOI 10.1093/protein/gzw003; Kremer JM, 2011, ARTHRITIS RHEUM-US, V63, P609, DOI 10.1002/art.30158; MULLBERG J, 1994, J IMMUNOL, V152, P4958; Ogata A, 2012, INT J RHEUMATOL, V2012, DOI 10.1155/2012/946048; OHNO S, 1985, P NATL ACAD SCI USA, V82, P2945, DOI 10.1073/pnas.82.9.2945; Rose-John S, 2006, J LEUKOCYTE BIOL, V80, P227, DOI 10.1189/jlb.1105674; Shaw S, 2014, MABS-AUSTIN, V6, P773, DOI 10.4161/mabs.28612; Somers W, 1997, EMBO J, V16, P989, DOI 10.1093/emboj/16.5.989; Sulzenbacher G, 2002, ACTA CRYSTALLOGR D, V58, P2109, DOI 10.1107/S0907444902013938; Tanaka T, 2011, FEBS LETT, V585, P3699, DOI 10.1016/j.febslet.2011.03.023; Tanaka Y, 2014, ANN RHEUM DIS, V73, P1595, DOI 10.1136/annrheumdis-2013-205002; Vagin A, 2010, ACTA CRYSTALLOGR D, V66, P22, DOI 10.1107/S0907444909042589; VANSNICK J, 1987, J EXP MED, V165, P641, DOI 10.1084/jem.165.3.641; YAMASAKI K, 1988, SCIENCE, V241, P825, DOI 10.1126/science.3136546; Yokota S, 2008, LANCET, V371, P998, DOI 10.1016/S0140-6736(08)60454-7; Zhou TQ, 2007, NATURE, V445, P732, DOI 10.1038/nature05580; Zhou TQ, 2010, SCIENCE, V329, P811, DOI 10.1126/science.1192819	38	21	21	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 24	2016	291	26					13846	13854		10.1074/jbc.M115.695528	http://dx.doi.org/10.1074/jbc.M115.695528			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DR2YZ	27129274	hybrid, Green Published			2022-12-26	WOS:000379771100038
J	Kim, SH; Kaschula, CH; Priedigkeit, N; Lee, AV; Singh, SV				Kim, Su-Hyeong; Kaschula, Catherine H.; Priedigkeit, Nolan; Lee, Adrian V.; Singh, Shivendra V.			Forkhead Box Q1 Is a Novel Target of Breast Cancer Stem Cell Inhibition by Diallyl Trisulfide	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						breast cancer; cancer stem cells; chemoprevention; FOXO; natural product	TRANSCRIPTION FACTOR; PREVENTION; CHEMOPREVENTION; IDENTIFICATION; ISOTHIOCYANATE; APOPTOSIS; TUMORS; AJOENE; RISK	Diallyl trisulfide (DATS), a metabolic byproduct of garlic, is known to inhibit the growth of breast cancer cells in vitro and in vivo. This study demonstrates that DATS targets breast cancer stem cells (bCSC). Exposure of MCF-7 and SUM159 human breast cancer cells to pharmacological concentrations of DATS (2.5 and 5 m) resulted in dose-dependent inhibition of bCSC, as evidenced by a mammosphere assay and flow cytometric analysis of aldehyde dehydrogenase 1 (ALDH1) activity and the CD44(high)/CD24(low)/epithelial specific antigen-positive fraction. DATS-mediated inhibition of bCSC was associated with a decrease in the protein level of FoxQ1. Overexpression of FoxQ1 in MCF-7 and SUM159 cells increased ALDH1 activity and the CD49f(+)/CD24(-) fraction. Inhibition of ALDH1 activity and/or mammosphere formation upon DATS treatment was significantly attenuated by overexpression of FoxQ1. In agreement with these results, stable knockdown of FoxQ1 using small hairpin RNA augmented bCSC inhibition by DATS. Expression profiling for cancer stem cell-related genes suggested that FoxQ1 may negatively regulate the expression of Dachshund homolog 1 (DACH1), whose expression is lost in invasive breast cancer. Chromatin immunoprecipitation confirmed recruitment of FoxQ1 at the DACH1 promoter. Moreover, inducible expression of DACH1 augmented DATS-mediated inhibition of bCSC. Expression of FoxQ1 protein was significantly higher in triple-negative breast cancer cases compared with normal mammary tissues. Moreover, an inverse association was observed between FoxQ1 and DACH1 gene expression in breast cancer cell lines and tumors. DATS administration inhibited ALDH1 activity in vivo in SUM159 xenografts. These results indicate that FoxQ1 is a novel target of bCSC inhibition by DATS.	[Kim, Su-Hyeong; Priedigkeit, Nolan; Lee, Adrian V.; Singh, Shivendra V.] Univ Pittsburgh, Sch Med, Dept Pharmacol & Chem Biol, Pittsburgh, PA 15213 USA; [Kim, Su-Hyeong; Priedigkeit, Nolan; Lee, Adrian V.; Singh, Shivendra V.] Univ Pittsburgh, Sch Med, Inst Canc, Pittsburgh, PA 15213 USA; [Kaschula, Catherine H.] Univ Cape Town, Dept Chem, ZA-7701 Cape Town, South Africa	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; University of Cape Town	Singh, SV (corresponding author), Hillman Canc Ctr 2 32A, 5117 Ctr Ave, Pittsburgh, PA 15213 USA.	singhs@upmc.edu		Priedigkeit, Nolan/0000-0001-8330-5210; Lee, Adrian/0000-0001-9917-514X	Cancer Center Support Grant, National Cancer Institute [P30 CA047904]; NATIONAL CANCER INSTITUTE [R01CA142604, P30CA047904] Funding Source: NIH RePORTER	Cancer Center Support Grant, National Cancer Institute; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This research project used the Flow Cytometry Facility, Cell and Tissue Imaging Facility, and Animal Facility supported in part by the Cancer Center Support Grant P30 CA047904, National Cancer Institute.	Agarwal KC, 1996, MED RES REV, V16, P111, DOI 10.1002/(SICI)1098-1128(199601)16:1&lt;111::AID-MED4&gt;3.0.CO;2-5; Antony ML, 2011, INDIAN J EXP BIOL, V49, P805; Bauer D, 2014, ANTICANCER RES, V34, P2763; Bieller A, 2001, DNA CELL BIOL, V20, P555, DOI 10.1089/104454901317094963; BLOCK E, 1985, SCI AM, V252, P114, DOI 10.1038/scientificamerican0385-114; BLOCK E, 1984, J AM CHEM SOC, V106, P8295, DOI 10.1021/ja00338a049; Cauley JA, 2001, BREAST CANCER RES TR, V65, P125, DOI 10.1023/A:1006478317173; Challier B, 1998, EUR J EPIDEMIOL, V14, P737, DOI 10.1023/A:1007512825851; Chandra-Kuntal K, 2013, BREAST CANCER RES TR, V138, P69, DOI 10.1007/s10549-013-2440-2; Christensen J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060051; Daemen A, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-10-r110; DORANT E, 1995, BREAST CANCER RES TR, V33, P163, DOI 10.1007/BF00682723; Ebrahimi M, 2013, CELL J, V15, P65; Fisher B, 1998, J NATL CANCER I, V90, P1371, DOI 10.1093/jnci/90.18.1371; Gao M, 2014, AM J PATHOL, V184, P133, DOI 10.1016/j.ajpath.2013.09.024; Gao M, 2012, INT J MOL SCI, V13, P13881, DOI 10.3390/ijms131113881; Gendoo DMA, 2016, BIOINFORMATICS, V32, P1097, DOI 10.1093/bioinformatics/btv693; Goss PE, 2011, NEW ENGL J MED, V364, P2381, DOI 10.1056/NEJMoa1103507; Gued LR, 2003, ONCOL REP, V10, P739; Hahm ER, 2014, BREAST CANCER RES TR, V144, P47, DOI 10.1007/s10549-014-2841-x; Hahm ER, 2013, JNCI-J NATL CANCER I, V105, P1111, DOI 10.1093/jnci/djt153; Herman-Antosiewicz A, 2007, ACTA PHARMACOL SIN, V28, P1355, DOI 10.1111/j.1745-7254.2007.00682.x; Jo MJ, 2010, CANCER RES, V70, P8948, DOI 10.1158/0008-5472.CAN-10-1936; Kaschula CH, 2012, EUR J MED CHEM, V50, P236, DOI 10.1016/j.ejmech.2012.01.058; Kim SH, 2013, CANCER PREV RES, V6, P782, DOI 10.1158/1940-6207.CAPR-13-0100; LEVI F, 1993, NUTR CANCER, V19, P327, DOI 10.1080/01635589309514263; Li H, 2004, CHINESE MED J-PEKING, V117, P1155; LIU JZ, 1992, CARCINOGENESIS, V13, P1847, DOI 10.1093/carcin/13.10.1847; Liu SL, 2006, CANCER RES, V66, P6063, DOI 10.1158/0008-5472.CAN-06-0054; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Mani SA, 2008, CELL, V133, P704, DOI 10.1016/j.cell.2008.03.027; Milner JA, 2006, J NUTR, V136, p827S, DOI 10.1093/jn/136.3.727S; Modem Suhasini, 2012, Genes Cancer, V3, P177, DOI 10.1177/1947601912458581; Na HK, 2012, BIOCHEM PHARMACOL, V84, P1241, DOI 10.1016/j.bcp.2012.08.024; Naznin MT, 2008, FOOD CHEM, V106, P1113, DOI 10.1016/j.foodchem.2007.07.041; Nkrumah-Elie YM, 2012, FOOD CHEM TOXICOL, V50, P2524, DOI 10.1016/j.fct.2012.04.010; O'Brien Ciara S., 2011, Hormones & Cancer, V2, P91, DOI 10.1007/s12672-011-0066-6; Patro R., 2015, 021592 BIORXIV; Qiao YY, 2011, CANCER RES, V71, P3076, DOI 10.1158/0008-5472.CAN-10-2787; Rivlin R. S., 2001, Journal of Nutrition, V131, P951; Schaffer EM, 1996, CANCER LETT, V102, P199, DOI 10.1016/0304-3835(96)04160-2; Shah M, 2012, BREAST CANCER-TARGET, V4, P155, DOI 10.2147/BCTT.S26434; Sun X, 2006, YAKUGAKU ZASSHI, V126, P521, DOI 10.1248/yakushi.126.521; Sun Y, 2014, MOL CANCER, V13, DOI 10.1186/1476-4598-13-137; Velasco-Velazquez MA, 2012, INT J BIOCHEM CELL B, V44, P573, DOI 10.1016/j.biocel.2011.12.020; Wilks C, 2014, DATABASE-OXFORD, DOI 10.1093/database/bau093; Wu KM, 2014, CANCER RES, V74, P829, DOI 10.1158/0008-5472.CAN-13-2466; Wu KM, 2011, J BIOL CHEM, V286, P2132, DOI 10.1074/jbc.M110.148395; Xiao D, 2003, CARCINOGENESIS, V24, P891, DOI 10.1093/carcin/bgg023; YU TH, 1989, J AGR FOOD CHEM, V37, P725, DOI 10.1021/jf00087a032; Zhang HJ, 2011, CANCER RES, V71, P1292, DOI 10.1158/0008-5472.CAN-10-2825; Zhang YS, 2012, J BIOL CHEM, V287, P41514, DOI 10.1074/jbc.M112.404871; [No title captured]	53	50	53	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 24	2016	291	26					13495	13508		10.1074/jbc.M116.715219	http://dx.doi.org/10.1074/jbc.M116.715219			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DR2YZ	27129776	Green Published, hybrid			2022-12-26	WOS:000379771100008
J	Shi, ZX; Zhang, J; Chen, SQ; Li, YX; Lei, XP; Qiao, HM; Zhu, QW; Hu, BY; Zhou, Q; Jiao, JW				Shi, Zixiao; Zhang, Juan; Chen, Shuangquan; Li, Yanxin; Lei, Xuepei; Qiao, Huimin; Zhu, Qianwen; Hu, Baoyang; Zhou, Qi; Jiao, Jianwei			Conversion of Fibroblasts to Parvalbumin Neurons by One Transcription Factor, Ascl1, and the Chemical Compound Forskolin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						fibroblast; immunochemistry; infection; neuron; small molecule	DOPAMINERGIC-NEURONS; FUNCTIONAL-NEURONS; MOUSE FIBROBLASTS; SMALL MOLECULES; STEM-CELLS; GENERATION; INTERNEURONS; INDUCTION; OCT4; GENE	Abnormalities in parvalbumin (PV)-expressing interneurons cause neurodevelopmental disorders such as epilepsy, autism, and schizophrenia. Unlike other types of neurons that can be efficiently differentiated from pluripotent stem cells, PV neurons were minimally generated using a conventional differentiation strategy. In this study we developed an adenovirus-based transdifferentiation strategy that incorporates an additional chemical compound for the efficient generation of induced PV (iPV) neurons. The chemical compound forskolin combined with Ascl1 induced approximate to 80% of mouse fibroblasts to iPV neurons. The iPV neurons generated by this procedure matured 5-7 days post infection and were characterized by electrophysiological properties and known neuronal markers, such as PV and GABA. Our studies, therefore, identified an efficient approach for generating PV neurons.	[Shi, Zixiao; Zhang, Juan; Chen, Shuangquan; Li, Yanxin; Lei, Xuepei; Qiao, Huimin; Hu, Baoyang; Zhou, Qi; Jiao, Jianwei] Chinese Acad Sci, Inst Zool, State Key Lab Stem Cells & Reprod Biol, Beijing 100101, Peoples R China; [Shi, Zixiao; Zhang, Juan; Chen, Shuangquan; Li, Yanxin; Lei, Xuepei; Qiao, Huimin] Univ Chinese Acad Sci, Beijing 100049, Peoples R China; [Zhu, Qianwen] Chinese Acad Sci, Inst Biophys, Beijing 100101, Peoples R China	Chinese Academy of Sciences; Institute of Zoology, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Chinese Academy of Sciences; Institute of Biophysics, CAS	Jiao, JW (corresponding author), Chinese Acad Sci, Inst Zool, State Key Lab Stem Cells & Reprod Biol, Beijing 100101, Peoples R China.	jwjiao@ioz.ac.cn	Zhang, Juan/GRX-2638-2022; Jiao, Jianwei/I-1452-2013; Jiao, Jianwei/AAA-7902-2020; Hu, Baoyang/R-8374-2016	Jiao, Jianwei/0000-0002-7893-0721; Jiao, Jianwei/0000-0002-7893-0721; Hu, Baoyang/0000-0003-3993-4014	National Basic Research Program of China [2015CB964501, 2014CB964903]; National Science Foundation of China [31371477]; Strategic Priority Stem Cell Program [XDA01020301]	National Basic Research Program of China(National Basic Research Program of China); National Science Foundation of China(National Natural Science Foundation of China (NSFC)); Strategic Priority Stem Cell Program	This work was supported by the National Basic Research Program of China (2015CB964501 and 2014CB964903), the National Science Foundation of China (31371477), and the Strategic Priority Stem Cell Program (XDA01020301). The authors declare that they have no conflicts of interest with the contents of this article.	Ango F, 2008, PLOS BIOL, V6, P739, DOI 10.1371/journal.pbio.0060103; Caiazzo M, 2011, NATURE, V476, P224, DOI 10.1038/nature10284; Chanda S, 2014, STEM CELL REP, V3, P282, DOI 10.1016/j.stemcr.2014.05.020; Chow A, 1999, J NEUROSCI, V19, P9332; Georgiev D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043904; Groticke I, 2007, EXP NEUROL, V207, P329, DOI 10.1016/j.expneurol.2007.06.021; Hou PP, 2013, SCIENCE, V341, P651, DOI 10.1126/science.1239278; Hu H, 2014, SCIENCE, V345, P529, DOI 10.1126/science.1255263; Hu WX, 2015, CELL STEM CELL, V17, P204, DOI 10.1016/j.stem.2015.07.006; Hunt RF, 2013, NAT NEUROSCI, V16, P692, DOI 10.1038/nn.3392; Kim J, 2011, CELL STEM CELL, V9, P413, DOI 10.1016/j.stem.2011.09.011; Lau S, 2014, CELL REP, V9, P1673, DOI 10.1016/j.celrep.2014.11.017; Li X, 2015, CELL STEM CELL, V17, P195, DOI 10.1016/j.stem.2015.06.003; Li YQ, 2011, CELL RES, V21, P196, DOI 10.1038/cr.2010.142; Liu ML, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3183; Maroof AM, 2013, CELL STEM CELL, V12, P559, DOI 10.1016/j.stem.2013.04.008; Meng FX, 2012, CELL RES, V22, P436, DOI 10.1038/cr.2011.185; Meyer-Lindenberg A, 2010, NATURE, V468, P194, DOI 10.1038/nature09569; Pang ZPP, 2011, NATURE, V476, P220, DOI 10.1038/nature10202; Pfisterer U, 2011, P NATL ACAD SCI USA, V108, P10343, DOI 10.1073/pnas.1105135108; Popowski M, 2014, STEM CELL REP, V2, P26, DOI 10.1016/j.stemcr.2013.12.002; Shi ZX, 2014, J BIOL CHEM, V289, P6415, DOI 10.1074/jbc.M113.515601; Son EY, 2011, CELL STEM CELL, V9, P205, DOI 10.1016/j.stem.2011.07.014; Vierbuchen T, 2010, NATURE, V463, P1035, DOI 10.1038/nature08797; Zhu SY, 2011, ANNU REV BIOMED ENG, V13, P73, DOI 10.1146/annurev-bioeng-071910-124715	25	18	18	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 24	2016	291	26					13560	13570		10.1074/jbc.M115.709808	http://dx.doi.org/10.1074/jbc.M115.709808			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DR2YZ	27137935	hybrid, Green Published			2022-12-26	WOS:000379771100014
J	Pandyarajan, V; Phillips, NB; Rege, N; Lawrence, MC; Whittaker, J; Weiss, MA				Pandyarajan, Vijay; Phillips, Nelson B.; Rege, Nischay; Lawrence, Michael C.; Whittaker, Jonathan; Weiss, Michael A.			Contribution of Tyr(B26) to the Function and Stability of Insulin STRUCTURE-ACTIVITY RELATIONSHIPS AT A CONSERVED HORMONE-RECEPTOR INTERFACE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AMINO-ACID-SEQUENCE; GROWTH-FACTOR-I; 1ST 3 DOMAINS; NEGATIVE COOPERATIVITY; BIOLOGICAL-ACTIVITY; CRYSTAL-STRUCTURE; BINDING; PROTEIN; CONFORMATION; ANALOGS	Crystallographic studies of insulin bound to receptor domains have defined the primary hormone-receptor interface. We investigated the role of Tyr(B26), a conserved aromatic residue at this interface. To probe the evolutionary basis for such conservation, we constructed 18 variants at B26. Surprisingly, non-aromatic polar or charged side chains (such as Glu, Ser, or ornithine (Orn)) conferred high activity, whereas the weakest-binding analogs contained Val, Ile, and Leu substitutions. Modeling of variant complexes suggested that the B26 side chains pack within a shallow depression at the solvent-exposed periphery of the interface. This interface would disfavor large aliphatic side chains. The analogs with highest activity exhibited reduced thermodynamic stability and heightened susceptibility to fibrillation. Perturbed self-assembly was also demonstrated in studies of the charged variants (Orn and Glu); indeed, the Glu(B26) analog exhibited aberrant aggregation in either the presence or absence of zinc ions. Thus, although Tyr(B26) is part of insulin's receptor-binding surface, our results suggest that its conservation has been enjoined by the aromatic ring's contributions to native stability and self-assembly. We envisage that such classical structural relationships reflect the implicit threat of toxic misfolding (rather than hormonal function at the receptor level) as a general evolutionary determinant of extant protein sequences.	[Pandyarajan, Vijay; Phillips, Nelson B.; Rege, Nischay; Whittaker, Jonathan; Weiss, Michael A.] Case Western Reserve Univ, Dept Biochem, Cleveland, OH 44106 USA; [Weiss, Michael A.] Case Western Reserve Univ, Dept Med, Cleveland, OH 44106 USA; [Weiss, Michael A.] Case Western Reserve Univ, Dept Biomed Engn, Cleveland, OH 44106 USA; [Lawrence, Michael C.] Walter & Eliza Hall Inst Med Res, 1G Royal Parade, Parkville, Vic 3052, Australia; [Lawrence, Michael C.] Univ Melbourne, Dept Med Biol, Parkville, Vic 3010, Australia	Case Western Reserve University; Case Western Reserve University; Case Western Reserve University; Walter & Eliza Hall Institute; University of Melbourne	Weiss, MA (corresponding author), Case Western Reserve Univ, Dept Biochem Med & Biomed Engn, Cleveland, OH 44016 USA.	michael.weiss@case.edu	Lawrence, Michael C/A-5357-2009	Pandyarajan, Vijay/0000-0002-8835-5601; Lawrence, Michael/0000-0003-1999-0801	National Institutes of Health [R01 DK040949, DK079233]; Australian National Health and Medical Research Council (NHMRC) [1005896, 1058233]; Hazel and Pip Appel Fund; Sanofi (Germany); Case Western Reserve University Medical Scientist Training Program by National Institutes of Health (NIH) [T32 GM007250]; individual NIH Fellowship from the NIDDK [F30 DK094685-04]; American Diabetes Association; National Health and Medical Research Council [361646]; Victorian State Government Operational Infrastructure Support Grant; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK040949, F30DK112644, R01DK079233] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007250] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Australian National Health and Medical Research Council (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia); Hazel and Pip Appel Fund; Sanofi (Germany)(Sanofi-Aventis); Case Western Reserve University Medical Scientist Training Program by National Institutes of Health (NIH); individual NIH Fellowship from the NIDDK; American Diabetes Association(American Diabetes Association); National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); Victorian State Government Operational Infrastructure Support Grant; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported in part by National Institutes of Health Grants R01 DK040949 and DK079233 (NIDDK; to M. A. W.). This work was also supported by Australian National Health and Medical Research Council (NHMRC) Project Grants 1005896 and 1058233 and the Hazel and Pip Appel Fund (to M. C. L.). M. A. W. has equity in Thermalin Diabetes, LLC (Cleveland, OH), where he serves as Chief Scientific Officer. He has also been a consultant to Merck Research Laboratories and DEKA Research and Development Corp. N. B. P. and J. W. are consultants to Thermalin Diabetes, LLC. Part of M. C. L.'s research was funded by Sanofi (Germany). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.r Supported by a predoctoral fellowship of the Case Western Reserve University Medical Scientist Training Program supported by National Institutes of Health (NIH) Grant T32 GM007250 and individual NIH Fellowship F30 DK094685-04 from the NIDDK.r Supported in part by the American Diabetes Association.r Recipient of National Health and Medical Research Council Independent Research Institutes Infrastructure Support Scheme Grant 361646 and Victorian State Government Operational Infrastructure Support Grant (to the Walter and Eliza Hall Institute).	Attri AK, 2010, BIOPHYS CHEM, V148, P28, DOI 10.1016/j.bpc.2010.02.002; BAKER EN, 1988, PHILOS T ROY SOC B, V319, P369, DOI 10.1098/rstb.1988.0058; Barany G., 1980, PEPTIDES, P273; Birnbaum DT, 1997, PHARMACEUT RES, V14, P25, DOI 10.1023/A:1012095115151; BLUNDELL TL, 1971, NATURE, V231, P506, DOI 10.1038/231506a0; BRANGE J, 1988, NATURE, V333, P679, DOI 10.1038/333679a0; Brange J., 1987, GALENICS OF INSULIN, P17; Brange J., 2000, PHARM FORMULATION DE, P89; BURLEY SK, 1988, ADV PROTEIN CHEM, V39, P125; Cabail MZ, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7406; Campbell RK, 1996, ANN PHARMACOTHER, V30, P1263, DOI 10.1177/106002809603001111; Chen H, 2000, PROTEIN ENG, V13, P779, DOI 10.1093/protein/13.11.779; CISZAK E, 1994, BIOCHEMISTRY-US, V33, P1512, DOI 10.1021/bi00172a030; CISZAK E, 1995, STRUCTURE, V3, P615, DOI 10.1016/S0969-2126(01)00195-2; Conlon JM, 2001, PEPTIDES, V22, P1183, DOI 10.1016/S0196-9781(01)00423-5; COSMATOS A, 1979, INT J PEPT PROT RES, V14, P457; Croll TI, 2016, STRUCTURE, V24, P469, DOI 10.1016/j.str.2015.12.014; De Meyts P, 2002, INSULIN & RELATED PROTEINS - STRUCTURE TO FUNCTION AND PHARMACOLOGY, P131; De Meyts P, 2002, NAT REV DRUG DISCOV, V1, P769, DOI 10.1038/nrd917; DEMEYTS P, 1994, DIABETOLOGIA, V37, pS135, DOI 10.1007/BF00400837; DEREWENDA U, 1989, NATURE, V338, P594, DOI 10.1038/338594a0; Dobson CM, 2003, NATURE, V426, P884, DOI 10.1038/nature02261; Dodson G, 1998, CURR OPIN STRUC BIOL, V8, P189, DOI 10.1016/S0959-440X(98)80037-7; Fink AL, 2005, CURR OPIN STRUC BIOL, V15, P35, DOI 10.1016/j.sbi.2005.01.002; FISCHER WH, 1985, BIOL CHEM H-S, V366, P521, DOI 10.1515/bchm3.1985.366.1.521; Garg SK, 2005, EXPERT OPIN PHARMACO, V6, P643, DOI 10.1517/14656566.6.4.643; Garrett TPJ, 1998, NATURE, V394, P395, DOI 10.1038/28668; Glendorf T, 2008, BIOCHEMISTRY-US, V47, P4743, DOI 10.1021/bi800054z; Goldman-Levine JD, 2005, ANN PHARMACOTHER, V39, P502, DOI 10.1345/aph.1E334; HELLMAN U, 1990, BIOCHEM BIOPH RES CO, V169, P571, DOI 10.1016/0006-291X(90)90369-X; Hirsch IB, 2005, NEW ENGL J MED, V352, P174, DOI 10.1056/NEJMra040832; HU SQ, 1993, J PROTEIN CHEM, V12, P741, DOI 10.1007/BF01024932; HU SQ, 1993, BIOCHEMISTRY-US, V32, P2631, DOI 10.1021/bi00061a022; Hua Qing-Xin, 2011, Front Endocrinol (Lausanne), V2, P48, DOI 10.3389/fendo.2011.00048; Hua QX, 2009, J BIOL CHEM, V284, P14586, DOI 10.1074/jbc.M900085200; HUA QX, 1993, BIOCHEMISTRY-US, V32, P1433, DOI 10.1021/bi00057a006; Hua QX, 1996, J MOL BIOL, V264, P390, DOI 10.1006/jmbi.1996.0648; HUA QX, 1991, NATURE, V354, P238, DOI 10.1038/354238a0; Hubbard SR, 1997, EMBO J, V16, P5572, DOI 10.1093/emboj/16.18.5572; INOUYE K, 1981, BIOPOLYMERS, V20, P1845, DOI 10.1002/bip.1981.360200909; IZUMIYA N, 1959, J BIOCHEM-TOKYO, V46, P1347, DOI 10.1093/oxfordjournals.jbchem.a126931; Jacoby E, 1996, J MOL BIOL, V258, P136, DOI 10.1006/jmbi.1996.0239; Jimenez JL, 2002, P NATL ACAD SCI USA, V99, P9196, DOI 10.1073/pnas.142459399; Jiracek J, 2010, P NATL ACAD SCI USA, V107, P1966, DOI 10.1073/pnas.0911785107; JORGENSEN AMM, 1992, J MOL BIOL, V227, P1146, DOI 10.1016/0022-2836(92)90527-Q; Keating GM, 2013, DRUGS, V73, P575, DOI 10.1007/s40265-013-0051-1; KOBAYASHI M, 1982, BIOCHEM J, V206, P597, DOI 10.1042/bj2060597; KOBAYASHI M, 1986, BIOCHEM BIOPH RES CO, V137, P250, DOI 10.1016/0006-291X(86)91203-9; Kristensen C, 1997, J BIOL CHEM, V272, P12978, DOI 10.1074/jbc.272.20.12978; KUBIAK T, 1986, INT J PEPT PROT RES, V27, P514; KUROSE T, 1994, J BIOL CHEM, V269, P29190; Lou MZ, 2006, P NATL ACAD SCI USA, V103, P12429, DOI 10.1073/pnas.0605395103; Menting JG, 2014, P NATL ACAD SCI USA, V111, pE3395, DOI 10.1073/pnas.1412897111; Menting JG, 2013, NATURE, V493, P241, DOI 10.1038/nature11781; MIRMIRA RG, 1991, J BIOL CHEM, V266, P1428; MOLLER DE, 1989, MOL ENDOCRINOL, V3, P1263, DOI 10.1210/mend-3-8-1263; Mulder FAA, 2001, NAT STRUCT BIOL, V8, P932, DOI 10.1038/nsb1101-932; Nielsen L, 2001, BIOCHEMISTRY-US, V40, P8397, DOI 10.1021/bi0105983; NISHI M, 1990, MOL ENDOCRINOL, V4, P1192, DOI 10.1210/mend-4-8-1192; Pace CN, 2000, PROTEINS, P1; Pandyarajan V, 2014, J BIOL CHEM, V289, P34709, DOI 10.1074/jbc.M114.608562; Papaioannou A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0144058; POCKER Y, 1980, BIOCHEMISTRY-US, V19, P5043, DOI 10.1021/bi00563a017; RINDERKNECHT E, 1978, FEBS LETT, V89, P283, DOI 10.1016/0014-5793(78)80237-3; RINDERKNECHT E, 1978, J BIOL CHEM, V253, P2769; ROY M, 1989, J BIOL CHEM, V264, P19081; SHOELSON SE, 1993, J BIOL CHEM, V268, P4085; Smith GD, 1996, PROTEIN SCI, V5, P1502, DOI 10.1002/pro.5560050806; Smith GD, 2000, ACTA CRYSTALLOGR D, V56, P1541, DOI 10.1107/S0907444900012749; Sosnick TR, 2000, METHOD ENZYMOL, V317, P393; SREERAMA N, 1993, ANAL BIOCHEM, V209, P32, DOI 10.1006/abio.1993.1079; Vikova J, 2016, SCI REP-UK, V6, DOI 10.1038/srep19431; WANG ZX, 1995, FEBS LETT, V360, P111, DOI 10.1016/0014-5793(95)00062-E; Ward CW, 2013, BIOESSAYS, V35, P945, DOI 10.1002/bies.201300065; Weiss MA, 2002, INSULIN & RELATED PROTEINS - STRUCTURE TO FUNCTION AND PHARMACOLOGY, P103, DOI 10.1007/0-306-47582-0_9; Weiss MA, 2013, FEBS LETT, V587, P1942, DOI 10.1016/j.febslet.2013.04.044; Xu B, 2009, J BIOL CHEM, V284, P14597, DOI 10.1074/jbc.M900087200; YANG JT, 1986, METHOD ENZYMOL, V130, P208; Yang YW, 2010, J BIOL CHEM, V285, P10806, DOI 10.1074/jbc.M109.067850; Zakova L, 2008, BIOCHEMISTRY-US, V47, P5858, DOI 10.1021/bi702086w; Zakova L, 2014, ACTA CRYSTALLOGR D, V70, P2765, DOI 10.1107/S1399004714017775; Zoete V, 2004, J MOL BIOL, V342, P913, DOI 10.1016/j.jmb.2004.07.033	82	20	19	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 17	2016	291	25					12978	12990		10.1074/jbc.M115.708347	http://dx.doi.org/10.1074/jbc.M115.708347			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DR2YT	27129279	hybrid, Green Published			2022-12-26	WOS:000379770500008
J	Allewell, NM				Allewell, Norma M.			Introduction to Biofilms Thematic Minireview Series	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Editorial Material								The biofilms that many bacteria and fungi produce enable them to form communities, adhere tightly to surfaces, evade host immunity, and resist antibiotics. Pathogenic microorganisms that form biofilms are very difficult to eradicate and thus are a frequent source of life-threatening, hospital-acquired infections. This series of five minireviews from the Journal of Biological Chemistry provides a broad overview of our current understanding of biofilms and the challenges that remain. The structure, biosynthesis, and biological function of the biofilms produced by pathogenic fungi are the subject of the first article, by Sheppard and Howell. Gunn, Bakaletz, and Wozniak focus on the biochemistry and structure of bacterial biofilms, how these structures enable bacteria to evade host immunity, and current and developing strategies for overcoming this resistance. The third and fourth articles present two of the best understood cell signaling pathways involved in biofilm formation. Valentini and Filloux focus on cyclic di-GMP, while Kavanaugh and Horswill discuss the quorum-sensing (agr) system and the relationship between quorum sensing and biofilm formation. Mechanisms of antibiotic resistance, particularly the role of efflux pumps and the development of persister cells, are the topics of the final article by Van Acker and Coenye. The advances described in this series guarantee that ongoing interdisciplinary and international efforts will lead to new insights into the basic biology of biofilm formation, as well as new strategies for therapeutic interventions.	[Allewell, Norma M.] Univ Maryland, Dept Cell Biol & Mol Genet, College Pk, MD 20742 USA	University System of Maryland; University of Maryland College Park	Allewell, NM (corresponding author), Univ Maryland, Dept Cell Biol & Mol Genet, College Pk, MD 20742 USA.	allewell@umd.edu						Gunn JS, 2016, J BIOL CHEM, V291, P12538, DOI 10.1074/jbc.R115.707547; Kavanaugh JS, 2016, J BIOL CHEM, V291, P12556, DOI 10.1074/jbc.R116.722710; Sheppard DC, 2016, J BIOL CHEM, V291, P12529, DOI 10.1074/jbc.R116.720995; Valentini M, 2016, J BIOL CHEM, V291, P12547, DOI 10.1074/jbc.R115.711507; Van Acker H, 2016, J BIOL CHEM, V291, P12565, DOI 10.1074/jbc.R115.707257	5	12	12	0	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 10	2016	291	24					12527	+		10.1074/jbc.R116.734103	http://dx.doi.org/10.1074/jbc.R116.734103			2	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DO9PV	27129220	Green Published, hybrid			2022-12-26	WOS:000378119900007
J	Di Gioia, G; Creta, A; Fittipaldi, M; Giorgino, R; Quintarelli, F; Satriano, U; Cruciani, A; Antinolfi, V; Di Berardino, S; Costanzo, D; Bettini, R; Mangiameli, G; Caricato, M; Mottini, G				Di Gioia, Giuseppe; Creta, Antonio; Fittipaldi, Mario; Giorgino, Riccardo; Quintarelli, Fabio; Satriano, Umberto; Cruciani, Alessandro; Antinolfi, Vincenzo; Di Berardino, Stefano; Costanzo, Davide; Bettini, Ranieri; Mangiameli, Giuseppe; Caricato, Marco; Mottini, Giovanni			Effects of Malnutrition on Left Ventricular Mass in a North-Malagasy Children Population	PLOS ONE			English	Article							HYPERTROPHY; KWASHIORKOR	Background Malnutrition among children population of less developed countries is a major health problem. Inadequate food intake and infectious diseases are combined to increase further the prevalence. Malnourishment brings to muscle cells loss with development of cardiac complications, like arrhythmias, cardiomyopathy and sudden death. In developed countries, malnutrition has generally a different etiology, like chronic diseases. The aim of our study was to investigate the correlation between malnutrition and left ventricular mass in an African children population. Methods 313 children were studied, in the region of Antsiranana, Madagascar, with age ranging from 4 to 16 years old (mean 7,8 +/- 3 years). A clinical and echocardiographic evaluation was performed with annotation of anthropometric and left ventricle parameters. Malnutrition was defined as a body mass index (BMI) value age-and sex-specific of 16, 17 and 18,5 at the age of 18, or under the 15th percentile. Left ventricle mass was indexed by height(2.7) (LVMI). Results We identified a very high prevalence of children malnutrition: 124 children, according to BMI values, and 100 children under the 15th percentile. LVMI values have shown to be increased in proportion to BMI percentiles ranging from 29,8 +/- 10,8 g/m(2.7) in the malnutrition group to 45 +/- 15,1 g/m(2.7) in >95th percentile group. LVMI values in children <15th BMI percentile were significantly lower compared to normal nutritional status (29,8 +/- 10,8 g/m(2,7) vs. 32,9 +/- 12,1 g/m(2,7), p = 0.02). Also with BMI values evaluation, malnourished children showed statistically lower values of LVMI (29,3 +/- 10,1 g/m(2,7) vs. 33,6 +/- 12,5 g/m(2,7), p = 0.001). Conclusion In African children population, the malnourishment status is correlated with cardiac muscle mass decrease, which appears to be reduced in proportion to the decrease in body size.	[Di Gioia, Giuseppe; Creta, Antonio; Giorgino, Riccardo; Satriano, Umberto; Cruciani, Alessandro; Costanzo, Davide] Univ Campus Biomed Roma, Cardiol Unit, Dept Med & Surg, Rome, Italy; [Fittipaldi, Mario] Starship Greenlane Paediat & Congenital Heart Ser, Paediat Cardiothorac Surg, Auckland, New Zealand; [Quintarelli, Fabio] Univ Campus Biomed Roma, Serv Pediat, Dept Med & Surg, Rome, Italy; [Antinolfi, Vincenzo] Univ Roma La Sapienza, Dept Heart & Great Vessels Attilio Reale, Piazzale Aldo Moro 5, I-00185 Rome, Italy; [Bettini, Ranieri] Univ Pisa, Dept Cardiol, Pisa, Italy; [Di Berardino, Stefano; Mangiameli, Giuseppe; Caricato, Marco] Univ Campus Biomed Roma, Dept Med & Surg, Unit Geriatr Surg, Rome, Italy; [Mottini, Giovanni] Univ Campus Biomed Roma, Dept Med & Surg, Inst Philosophy Sci & Technol Practice FAST, Rome, Italy	University Campus Bio-Medico - Rome Italy; University Campus Bio-Medico - Rome Italy; Sapienza University Rome; University of Pisa; University Campus Bio-Medico - Rome Italy; University Campus Bio-Medico - Rome Italy	Di Gioia, G (corresponding author), Univ Campus Biomed Roma, Cardiol Unit, Dept Med & Surg, Rome, Italy.	dottgiuseppedigioia@gmail.com	Mangiameli, Giuseppe/AAX-1916-2020; Creta, Antonio/AAP-4126-2021; Caricato, Marco/C-1680-2013	Mangiameli, Giuseppe/0000-0002-8394-2719; Caricato, Marco/0000-0002-5610-1615; Di Berardino, Stefano/0000-0001-5778-0878; Quintarelli, Fabio/0000-0002-6027-8587; Creta, Antonio/0000-0002-7743-0143; Giorgino, Riccardo/0000-0002-1067-7424; Cruciani, Alessandro/0000-0002-2631-4185				Abu Faddan NH, 2010, ANN PEDIAT CARDIOL, V3, P113, DOI 10.4103/0974-2069.74036; BERGMAN JW, 1988, ARCH DIS CHILD, V63, P1359, DOI 10.1136/adc.63.11.1359; Brady TM, 2008, J PEDIATR-US, V152, P73, DOI 10.1016/j.jpeds.2007.05.053; CHASE HP, 1980, PEDIATRICS, V66, P972; Cole TJ, 2007, BMJ-BRIT MED J, V335, P194, DOI 10.1136/bmj.39238.399444.55; Collins S, 2001, LANCET, V358, P498, DOI 10.1016/S0140-6736(01)05630-6; Cunha Daniel Ferreira da, 2002, Arq Bras Cardiol, V78, P382; da Cunha D F, 1998, Arq Bras Cardiol, V71, P677; DEONIS M, 1993, B WORLD HEALTH ORGAN, V71, P703; DEVEREUX RB, 1986, AM J CARDIOL, V57, P450, DOI 10.1016/0002-9149(86)90771-X; El-Sayed HL, 2006, EUR J CLIN NUTR, V60, P502, DOI 10.1038/sj.ejcn.1602344; Evans WJ, 2008, CLIN NUTR, V27, P793, DOI 10.1016/j.clnu.2008.06.013; Figueroa-Colon R., 1993, TXB PEDIAT NUTR, P191; FUNG KP, 1990, ARCH DIS CHILD, V65, P516, DOI 10.1136/adc.65.5.516; Hanevold C, 2004, PEDIATRICS, V113, P328, DOI 10.1542/peds.113.2.328; HEYMSFIELD SB, 1978, AM HEART J, V95, P584, DOI 10.1016/0002-8703(78)90300-9; Khoury PR, 2009, J AM SOC ECHOCARDIOG, V22, P709, DOI 10.1016/j.echo.2009.03.003; KOTHARI SS, 1992, INT J CARDIOL, V35, P19, DOI 10.1016/0167-5273(92)90050-D; Lang RM, 2015, J AM SOC ECHOCARDIOG, V28, P1, DOI 10.1016/j.echo.2014.10.003; LEUNG AKC, 1993, AM FAM PHYSICIAN, V48, P1432; McLaren DS., 1982, TXB PAEDIATRIC NUTRI, P103; Mei ZG, 2002, AM J CLIN NUTR, V75, P978, DOI 10.1093/ajcn/75.6.978; Natl High Blood Pressure Educ Prog, 2004, PEDIATRICS, V114, P555; Ocal B, 2001, J PAEDIATR CHILD H, V37, P14, DOI 10.1046/j.1440-1754.2001.00566.x; Olivares JL, 2005, J AM COLL NUTR, V24, P38, DOI 10.1080/07315724.2005.10719441; PHORNPHATKUL C, 1994, CLIN PEDIATR, V33, P147, DOI 10.1177/000992289403300304; Sachdev HPS, 1996, NUTR FDN INDIA ARCHI, V156; SINGH G R, 1989, Indian Pediatrics, V26, P875; Suskind RM, 2011, NUTR IMMUNITY INFECT, P23	29	11	11	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 3	2016	11	5							e0154523	10.1371/journal.pone.0154523	http://dx.doi.org/10.1371/journal.pone.0154523			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DL5KK	27140179	gold, Green Published, Green Submitted			2022-12-26	WOS:000375675700038
J	Pletcher, MJ; Vittinghoff, E; Thanataveerat, A; Bibbins-Domingo, K; Moran, AE				Pletcher, Mark J.; Vittinghoff, Eric; Thanataveerat, Anusorn; Bibbins-Domingo, Kirsten; Moran, Andrew E.			Young Adult Exposure to Cardiovascular Risk Factors and Risk of Events Later in Life: The Framingham Offspring Study	PLOS ONE			English	Article							CORONARY-HEART-DISEASE; DENSITY-LIPOPROTEIN-CHOLESTEROL; SYSTOLIC BLOOD-PRESSURE; INTIMA-MEDIA THICKNESS; FOLLOW-UP; ARTERY CALCIFICATION; SERUM-CHOLESTEROL; INDIVIDUAL DATA; CALCIUM LATER; MIDDLE-AGE	Background It is unclear whether coronary heart disease (CHD) risk factor exposure during early adulthood contributes to CHD risk later in life. Our objective was to analyze whether extent of early adult exposures to systolic and diastolic blood pressure (SBP, DBP) and low-and high-density lipoprotein cholesterol (LDL, HDL) are independent predictors of CHD events later in life. Methods and Findings We used all available measurements of SBP, DBP, LDL, and HDL collected over 40 years in the Framingham Offspring Study to estimate risk factor trajectories, starting at age 20 years, for all participants. Average early adult (age 20-39) exposure to each risk factor was then estimated, and used to predict CHD events (myocardial infarction or CHD death) after age 40, with adjustment for risk factor exposures later in life (age 40+). 4860 participants contributed an average of 6.3 risk factor measurements from in-person examinations and 24.5 years of follow-up after age 40, and 510 had a first CHD event. Early adult exposures to high SBP, DBP, LDL or low HDL were associated with 8- to 30-fold increases in later life CHD event rates, but were also strongly correlated with risk factor levels later in life. After adjustment for later life levels and other risk factors, early adult DBP and LDL remained strongly associated with later life risk. Compared with DBP <= 70 mmHg, adjusted hazard ratios (HRs) were 2.1 (95% confidence interval: 0.8-5.7) for DBP = 71-80, 2.6 (0.9-7.2) for DBP = 81-90, and 3.6 (1.2-11) for DBP >90 (p-trend = 0.019). Compared with LDL <= 100 mg/dl, adjusted HRs were 1.5 (0.9-2.6) for LDL = 101-130, 2.2 (1.2-4.0) for LDL = 131-160, and 2.4 (1.2-4.7) for LDL >160 (p-trend = 0.009). While current levels of SBP and HDL were also associated with CHD events, we did not detect an independent association with early adult exposure to either of these risk factors. Conclusions Using a mixed modeling approach to estimation of young adult exposures with trajectory analysis, we detected independent associations between estimated early adult exposures to non-optimal DBP and LDL and CHD events later in life.	[Pletcher, Mark J.; Vittinghoff, Eric; Bibbins-Domingo, Kirsten] Univ Calif San Francisco, Dept Epidemiol & Biostat, San Francisco, CA 94143 USA; [Pletcher, Mark J.; Vittinghoff, Eric; Bibbins-Domingo, Kirsten] Univ Calif San Francisco, Dept Med, San Francisco, CA USA; [Thanataveerat, Anusorn; Moran, Andrew E.] Columbia Univ, Div Gen Med, Med Ctr, New York, NY USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; Columbia University	Pletcher, MJ (corresponding author), Univ Calif San Francisco, Dept Epidemiol & Biostat, San Francisco, CA 94143 USA.; Pletcher, MJ (corresponding author), Univ Calif San Francisco, Dept Med, San Francisco, CA USA.	mpletcher@epi.ucsf.edu		Moran, Andrew/0000-0003-3554-0085	U.S. National Heart, Lung, and Blood Institute [R01 HL107475-01]; Columbia University Irving Scholarship; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL107475] Funding Source: NIH RePORTER	U.S. National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Columbia University Irving Scholarship; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This study was supported by U.S. National Heart, Lung, and Blood Institute grant (R01 HL107475-01) to AEM and MJP, and a Columbia University Irving Scholarship to AEM. The authors used the Framingham Cohort and Framingham Offspring Research Materials obtained from the U.S. National Heart, Lung and Blood Institute (NHLBI) Biologic Specimen and Data Repository Information Coordinating Center. The manuscript does not necessarily reflect the opinions or views of the Framingham Cohort, Framingham Offspring, or the NHLBI. KBD is a member of the United States Preventive Services Task Force (USPSTF) and current co-Vice Chair. This work does not necessarily represent the views and policies of the USPSTF.	ANDERSON KM, 1987, JAMA-J AM MED ASSOC, V257, P2176, DOI 10.1001/jama.257.16.2176; Baigent C, 2005, LANCET, V366, P1267, DOI 10.1016/S0140-6736(05)67394-1; Benn M, 2010, J AM COLL CARDIOL, V55, P2833, DOI 10.1016/j.jacc.2010.02.044; Berenson GS, 1998, NEW ENGL J MED, V338, P1650, DOI 10.1056/NEJM199806043382302; Bild DE, 1996, ANN EPIDEMIOL, V6, P235, DOI 10.1016/1047-2797(96)00005-1; Clarke R, 1999, AM J EPIDEMIOL, V150, P341; Cohen JC, 2006, NEW ENGL J MED, V354, P1264, DOI 10.1056/NEJMoa054013; Davis PH, 2001, CIRCULATION, V104, P2815, DOI 10.1161/hc4601.099486; DAWBER T. R., 1957, AMER JOUR PUBL HEALTH, V47, P4, DOI 10.2105/AJPH.47.4_Pt_2.4; Eckel RH, 2014, CIRCULATION, V129, pS76, DOI 10.1161/01.cir.0000437740.48606.d1; Ference BA, 2014, HYPERTENSION, V63, P1182, DOI 10.1161/HYPERTENSIONAHA.113.02734; Franklin SS, 2001, CIRCULATION, V103, P1245; FRIEDMAN GD, 1988, J CLIN EPIDEMIOL, V41, P1105, DOI 10.1016/0895-4356(88)90080-7; Go AS, 2014, HYPERTENSION, V63, P878, DOI 10.1161/HYP.0000000000000003; Gray L, 2011, J AM COLL CARDIOL, V58, P2396, DOI 10.1016/j.jacc.2011.07.045; James PA, 2014, JAMA; KANNEL WB, 1961, ANN INTERN MED, V55, P33, DOI 10.7326/0003-4819-55-1-33; KANNEL WB, 1979, AM J EPIDEMIOL, V110, P281, DOI 10.1093/oxfordjournals.aje.a112813; KLAG MJ, 1993, NEW ENGL J MED, V328, P313, DOI 10.1056/NEJM199302043280504; Knoflach M, 2003, CIRCULATION, V108, P1064, DOI 10.1161/01.CIR.0000085996.95532.FF; Lewington S, 2002, LANCET, V360, P1903, DOI 10.1016/S0140-6736(02)11911-8; Li SX, 2003, JAMA-J AM MED ASSOC, V290, P2271, DOI 10.1001/jama.290.17.2271; Loria CM, 2007, J AM COLL CARDIOL, V49, P2013, DOI 10.1016/j.jacc.2007.03.009; Mahoney LT, 1996, J AM COLL CARDIOL, V27, P277, DOI 10.1016/0735-1097(95)00461-0; McGill HC, 1997, ARTERIOSCL THROM VAS, V17, P95, DOI 10.1161/01.ATV.17.1.95; MCGILL HC, 1990, JAMA-J AM MED ASSOC, V264, P3018; Mihaylova B, 2012, LANCET, V380, P581, DOI 10.1016/S0140-6736(12)60367-5; Miura K, 2001, ARCH INTERN MED, V161, P1501, DOI 10.1001/archinte.161.12.1501; Navar-Boggan AM, 2015, CIRCULATION, V131, P451, DOI 10.1161/CIRCULATIONAHA.114.012477; NEWMAN WP, 1986, NEW ENGL J MED, V314, P138, DOI 10.1056/NEJM198601163140302; Nieto FJ, 1999, J CLIN EPIDEMIOL, V52, P559, DOI 10.1016/S0895-4356(99)00030-X; Ninomiya T, 2013, BMJ-BRIT MED J, V347, pf5680, DOI DOI 10.1136/BMJ.F5680; Pletcher MJ, 2008, ANN INTERN MED, V149, P91, DOI 10.7326/0003-4819-149-2-200807150-00005; Pletcher MJ, 2010, ANN INTERN MED, V153, P137, DOI 10.7326/0003-4819-153-3-201008030-00004; Raitakari OT, 2003, JAMA-J AM MED ASSOC, V290, P2277, DOI 10.1001/jama.290.17.2277; Sanchez A, 2000, ATHEROSCLEROSIS, V152, P265, DOI 10.1016/S0021-9150(00)00532-3; Seshadri S, 2001, ARCH INTERN MED, V161, P2343, DOI 10.1001/archinte.161.19.2343; Stamler J, 2000, JAMA-J AM MED ASSOC, V284, P311, DOI 10.1001/jama.284.3.311; Stone NJ, 2013, CIRCULATION; STRONG JP, 1962, AM J PATHOL, V40, P37; Tonstad S, 1996, ARTERIOSCL THROM VAS, V16, P984, DOI 10.1161/01.ATV.16.8.984; Vasan RS, 2002, CIRCULATION, V105, P48, DOI 10.1161/hc0102.101774; Vasan RS, 2001, NEW ENGL J MED, V345, P1291, DOI 10.1056/NEJMoa003417; Voight BF, 2012, LANCET, V380, P572, DOI 10.1016/S0140-6736(12)60312-2; WEBBER LS, 1995, AM J EPIDEMIOL, V141, P428, DOI 10.1093/oxfordjournals.aje.a117445; Wilson PWF, 1997, NEW ENGL J MED, V337, P516, DOI 10.1056/NEJM199708213370802	46	50	50	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 3	2016	11	5							e0154288	10.1371/journal.pone.0154288	http://dx.doi.org/10.1371/journal.pone.0154288			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DL5KK	27138014	Green Published, gold			2022-12-26	WOS:000375675700024
J	Capsel, RT; Thoen, CO; Reinhardt, TA; Lippolis, JD; Olsen, R; Stabel, JR; Bannantine, JP				Capsel, Randal T.; Thoen, Charles O.; Reinhardt, Timothy A.; Lippolis, John D.; Olsen, Renee; Stabel, Judith R.; Bannantine, John P.			Composition and Potency Characterization of Mycobacterium avium subsp paratuberculosis Purified Protein Derivatives	PLOS ONE			English	Article							INTERFERON-GAMMA ASSAY; SECRETED ANTIGENS; SKIN-TEST; BOVINE PARATUBERCULOSIS; JOHNES-DISEASE; DIAGNOSIS; TESTS; IDENTIFICATION; SPECIFICITY; TUBERCULIN	Mycobacterium avium subsp. paratuberculosis (MAP) purified protein derivatives (PPDs) are immunologic reagents prepared from cultured filtrates of the type strain. Traditional production consists of floating culture incubation at 37 degrees C, organism inactivation by autoclaving, coarse filtration, and protein precipitation. Three traditional production PPDs were used in this study including lot 9801, which served as a reference and has been used in the field for decades. Alternative production PPDs (0902A and 0902B), in which the autoclaving step was removed, were also analyzed in this study. SDS-PAGE analysis revealed protein smearing in traditional PPDs, but distinct bands were observed in the alternative PPD preparations. Antibody bound distinct protein bands in the alternative PPDs by immunoblot analysis, whereas an immunoreactive smear was observed with the traditional PPDs. Mass spectrometry identified 194 proteins among three PPD lots representing the two different production methods, ten of which were present in all PPDs examined. Selected proteins identified by mass spectrometry were recombinantly expressed and purified from E. coli and evaluated by the guinea pig potency test. Seven recombinant proteins showed greater erythema as compared to the reference PPD lot 9801 in paired guinea pigs and were able to stimulate interferon-gamma production in blood from Johne's positive animals. These results suggest that autoclaving culture suspensions is not a necessary step in PPD production and specific proteins could supplant the PPD antigen for intradermal skin testing procedures and for use as in-vitro assay reagents.	[Capsel, Randal T.] USDA, Natl Vet Serv Labs, AHPIS, Ames, IA 50010 USA; [Thoen, Charles O.] Iowa State Univ, Coll Vet Med, Dept Vet Microbiol & Prevent Med, Ames, IA USA; [Reinhardt, Timothy A.; Lippolis, John D.; Stabel, Judith R.; Bannantine, John P.] USDA ARS, Natl Anim Dis Ctr, POB 70, Ames, IA 50010 USA; [Olsen, Renee] USDA, Ctr Vet Biol, APHIS, Ames, IA USA	United States Department of Agriculture (USDA); Iowa State University; United States Department of Agriculture (USDA); United States Department of Agriculture (USDA)	Bannantine, JP (corresponding author), USDA ARS, Natl Anim Dis Ctr, POB 70, Ames, IA 50010 USA.	john.bannantine@ars.usda.gov	Reinhardt, Timothy/A-7536-2009	Reinhardt, Timothy/0000-0001-5552-2509; Bannantine, John/0000-0002-5692-7898; Lippolis, John/0000-0003-2314-4384	USDA, the Agricultural Research Service; USDA, the Animal and Plant Health Inspection Service	USDA, the Agricultural Research Service; USDA, the Animal and Plant Health Inspection Service	This work was funded by two agencies within the USDA, the Agricultural Research Service and the Animal and Plant Health Inspection Service.	Bannantine John P., 2006, V345, P185; Bannantine JP, 2007, CLIN VACCINE IMMUNOL, V14, P312, DOI 10.1128/CVI.00353-06; Beard PM, 2001, J CLIN MICROBIOL, V39, P1517, DOI 10.1128/JCM.39.4.1517-1521.2001; BILLMANJACOBE H, 1992, AUST VET J, V69, P25, DOI 10.1111/j.1751-0813.1992.tb07426.x; Cho D, 2006, CLIN VACCINE IMMUNOL, V13, P1155, DOI 10.1128/CVI.00058-06; Cho YS, 2012, PROTEOMICS, V12, P979, DOI 10.1002/pmic.201100544; Coussens Paul M., 2001, Animal Health Research Reviews, V2, P141; Dupont C, 2005, J MED MICROBIOL, V54, P1083, DOI 10.1099/jmm.0.46163-0; Facciuolo A, 2013, CLIN VACCINE IMMUNOL, V20, P1783, DOI 10.1128/CVI.00380-13; Farhat M, 2006, INT J TUBERC LUNG D, V10, P1192; Garry F., 1999, INFO SHEET APHIS VET; Gumber S, 2009, VET MICROBIOL, V133, P344, DOI 10.1016/j.vetmic.2008.07.021; Gwozdz JM, 2000, AUST VET J, V78, P779, DOI 10.1111/j.1751-0813.2000.tb10452.x; Haagsma J, 1995, MYCOBACTERIUM BOVIS, P73; He ZG, 2010, PROTEOME SCI, V8, DOI 10.1186/1477-5956-8-21; Kalis CHJ, 2003, VET MICROBIOL, V97, P73, DOI 10.1016/S0378-1135(03)00242-6; Leite FL, 2015, VET MICROBIOL, V175, P275, DOI 10.1016/j.vetmic.2014.11.009; Li LL, 2007, CLIN VACCINE IMMUNOL, V14, P102, DOI 10.1128/CVI.00138-06; Li LL, 2005, P NATL ACAD SCI USA, V102, P12344, DOI 10.1073/pnas.0505662102; Lippolis JD, 2014, J PROTEOMICS, V108, P373, DOI 10.1016/j.jprot.2014.06.008; Olsen I, 2001, CLIN DIAGN LAB IMMUN, V8, P797, DOI 10.1128/CDLI.08.4.797-801.2001; Raizman EA, 2005, CAN J VET RES, V69, P32; Rennie B, 2010, BMC VET RES, V6, DOI 10.1186/1746-6148-6-50; Robbe-Austerman S, 2007, J VET DIAGN INVEST, V19, P88, DOI 10.1177/104063870701900114; Robbe-Austerman S, 2006, VET RES, V37, P553, DOI 10.1051/vetres:2006018; Santema W, 2009, VET MICROBIOL, V138, P191, DOI 10.1016/j.vetmic.2009.03.021; Shin SJ, 2008, CLIN VACCINE IMMUNOL, V15, P1277, DOI 10.1128/CVI.00105-08; Stabel JR, 1996, J VET DIAGN INVEST, V8, P345, DOI 10.1177/104063879600800311; Stabel JR, 2001, VET IMMUNOL IMMUNOP, V79, P69, DOI 10.1016/S0165-2427(01)00253-7; Steadham EM, 2002, BIOLOGICALS, V30, P93, DOI 10.1006/biol.2002.0321; Willemsen PTJ, 2006, VET MICROBIOL, V114, P337, DOI 10.1016/j.vetmic.2005.12.005; Wren G, 1998, BOVINE VET       JUL, P4; Wynne JW, 2012, PROTEOME SCI, V10, DOI 10.1186/1477-5956-10-22	33	9	9	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 2	2016	11	5							e0154685	10.1371/journal.pone.0154685	http://dx.doi.org/10.1371/journal.pone.0154685			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DL5KB	27136199	gold, Green Published			2022-12-26	WOS:000375674800041
J	Hocking, KM; Putumbaka, G; Wise, ES; Cheung-Flynn, J; Brophy, CM; Komalavilas, P				Hocking, Kyle M.; Putumbaka, Gowthami; Wise, Eric S.; Cheung-Flynn, Joyce; Brophy, Colleen M.; Komalavilas, Padmini			Papaverine Prevents Vasospasm by Regulation of Myosin Light Chain Phosphorylation and Actin Polymerization in Human Saphenous Vein	PLOS ONE			English	Article							DEPENDENT PROTEIN-KINASE; VASCULAR SMOOTH-MUSCLE; SHOCK-RELATED PROTEIN; VASODILATOR-STIMULATED PHOSPHOPROTEIN; INOSITOL 1,4,5-TRISPHOSPHATE RECEPTOR; SUBARACHNOID HEMORRHAGE; NEOINTIMAL HYPERPLASIA; CYTOSKELETAL DYNAMICS; INTIMAL HYPERPLASIA; SIGNAL-TRANSDUCTION	Objective Papaverine is used to prevent vasospasm in human saphenous veins (HSV) during vein graft preparation prior to implantation as a bypass conduit. Papaverine is a nonspecific inhibitor of phosphodiesterases, leading to increases in both intracellular cGMP and cAMP. We hypothesized that papaverine reduces force by decreasing intracellular calcium concentrations ([Ca2+](i)) and myosin light chain phosphorylation, and increasing actin depolymerization via regulation of actin regulatory protein phosphorylation. Approach and Results HSV was equilibrated in a muscle bath, pre-treated with 1 mM papaverine followed by 5 mu M norepinephrine, and force along with [Ca2+](i) levels were concurrently measured. Filamentous actin (F-actin) level was measured by an in vitro actin assay. Tissue was snap frozen to measure myosin light chain and actin regulatory protein phosphorylation. Pre-treatment with papaverine completely inhibited norepinephrine-induced force generation, blocked increases in [Ca2+](i) and led to a decrease in the phosphorylation of myosin light chain. Papaverine pre-treatment also led to increased phosphorylation of the heat shock-related protein 20 (HSPB6) and the vasodilator stimulated phosphoprotein (VASP), as well as decreased filamentous actin (F-actin) levels suggesting depolymerization of actin. Conclusions These results suggest that papaverine-induced force inhibition of HSV involves [Ca2+](i)-mediated inhibition of myosin light chain phosphorylation and actin regulatory protein phosphorylation-mediated actin depolymerization. Thus, papaverine induces sustained inhibition of contraction of HSV by the modulation of both myosin cross-bridge formation and actin cytoskeletal dynamics and is a pharmacological alternative to high pressure distention to prevent vasospasm.	[Brophy, Colleen M.; Komalavilas, Padmini] VA Tennessee Valley Healthcare Syst, Nashville, TN USA; [Hocking, Kyle M.; Putumbaka, Gowthami; Wise, Eric S.; Cheung-Flynn, Joyce; Brophy, Colleen M.; Komalavilas, Padmini] Vanderbilt Univ, Dept Surg, Med Ctr, Nashville, TN 37240 USA	US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Tennessee Valley Healthcare System; Vanderbilt University	Hocking, KM (corresponding author), Vanderbilt Univ, Dept Surg, Med Ctr, Nashville, TN 37240 USA.	Kyle.m.hocking@vanderbilt.edu		Hocking, Kyle/0000-0002-3603-7185	NIH [RO1HL70715]; VA Merit; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL070715] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); VA Merit(US Department of Veterans Affairs); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This study was supported by NIH RO1HL70715 and VA Merit to C.M. Brophy.	ALEXANDER RW, 1985, HYPERTENSION, V7, P447, DOI 10.1161/01.HYP.7.3.447; ALIOUA A, 1995, AM J PHYSIOL-LUNG C, V268, pL1057, DOI 10.1152/ajplung.1995.268.6.L1057; Ba M, 2009, CELL HEALTH CYTOSKEL, V1, P27; BARANY K, 1990, BIOCHEM BIOPH RES CO, V173, P164, DOI 10.1016/S0006-291X(05)81036-8; Beall AC, 1997, J BIOL CHEM, V272, P11283; BLATZ AL, 1984, J GEN PHYSIOL, V84, P1, DOI 10.1085/jgp.84.1.1; Cai YJ, 2015, CIRC RES, V116, P1120, DOI 10.1161/CIRCRESAHA.116.304408; Cairns CJS, 2003, ANAESTH INTENS CARE, V31, P87, DOI 10.1177/0310057X0303100117; Campos-Bedolla P, 2006, PHARMACOL RES, V54, P468, DOI 10.1016/j.phrs.2006.09.006; Chernik IS, 2007, MOL CELL BIOCHEM, V295, P9, DOI 10.1007/s11010-006-9266-8; CLOWES AW, 1993, CARDIOVASC PATHOL, V2, pS179; CORNWELL TL, 1989, J BIOL CHEM, V264, P1146; Devynck MA, 2004, HYPERTENSION, V44, P919, DOI 10.1161/01.HYP.0000145862.33770.e9; Dreiza CM, 2004, FASEB J, V18, P261, DOI 10.1096/fj.04-2911fje; Dreiza CM, 2004, FASEB J; Gerthoffer WT, 2005, CAN J PHYSIOL PHARM, V83, P851, DOI 10.1139/Y05-088; GERTHOFFER WT, 1983, AM J PHYSIOL, V244, pC182, DOI 10.1152/ajpcell.1983.244.3.C182; GRONDIN CM, 1989, CIRCULATION, V79, P24; Gunst SJ, 2008, AM J PHYSIOL-CELL PH, V295, pC576, DOI 10.1152/ajpcell.00253.2008; HAMACHI T, 1984, BIOCHIM BIOPHYS ACTA, V804, P230, DOI 10.1016/0167-4889(84)90154-X; Harbeck B, 2000, J BIOL CHEM, V275, P30817, DOI 10.1074/jbc.M005066200; HIDAKA H, 1980, MOL PHARMACOL, V17, P66; Hocking KM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060986; Hocking KM, 2011, J VASC SURG, V53, P454, DOI 10.1016/j.jvs.2010.09.010; KAMM KE, 1985, ANNU REV PHARMACOL, V25, P593, DOI 10.1146/annurev.pharmtox.25.1.593; Kaneda T, 1998, EUR J PHARMACOL, V355, P149, DOI 10.1016/S0014-2999(98)00479-8; Karaki H, 1997, PHARMACOL REV, V49, P157; Kerz T, 2012, BRIT J NEUROSURG, V26, P517, DOI 10.3109/02688697.2011.650737; Khalil RA, 1998, HYPERTENSION, V31, P1065, DOI 10.1161/01.HYP.31.5.1065; Kim HR, 2010, AM J PHYSIOL-CELL PH, V298, pC559, DOI 10.1152/ajpcell.00431.2009; KOGA T, 1994, J BIOL CHEM, V269, P11640; KOMALAVILAS P, 1994, J BIOL CHEM, V269, P8701; Komalavilas P, 2001, J APPL PHYSIOL, V91, P1819, DOI 10.1152/jappl.2001.91.4.1819; Komalavilas P, 2008, AM J PHYSIOL-LUNG C, V294, pL69, DOI 10.1152/ajplung.00235.2007; Kudo FA, 2009, SURG TODAY, V39, P128, DOI 10.1007/s00595-008-3819-2; Lee MR, 1997, J BIOL CHEM, V272, P5063, DOI 10.1074/jbc.272.8.5063; Li FD, 2014, JAMA SURG, V149, P655, DOI 10.1001/jamasurg.2013.5067; Li FD, 2014, JAMA SURG; Lincoln T M, 1995, Adv Pharmacol, V34, P305; Lincoln TM, 2001, J APPL PHYSIOL, V91, P1421, DOI 10.1152/jappl.2001.91.3.1421; Lopes LB, 2010, J VASC SURG, V52, P1596, DOI 10.1016/j.jvs.2010.06.168; MCDANIEL NL, 1992, AM J PHYSIOL, V263, pC461, DOI 10.1152/ajpcell.1992.263.2.C461; Mindea Stefan A, 2006, Neurosurg Focus, V21, pE13; Motwani JG, 1998, CIRCULATION, V97, P916, DOI 10.1161/01.CIR.97.9.916; Osgood MJ, 2013, J VASCULAR SURG; PERSECHINI A, 1986, J BIOL CHEM, V261, P6293; PFEIFER A, 1995, J BIOL CHEM, V270, P9052, DOI 10.1074/jbc.270.16.9052; RAEYMAEKERS L, 1988, BIOCHEM J, V252, P269, DOI 10.1042/bj2520269; RASMUSSEN H, 1987, FASEB J, V1, P177, DOI 10.1096/fasebj.1.3.3040504; Rembold CM, 2000, J PHYSIOL-LONDON, V524, P865, DOI 10.1111/j.1469-7793.2000.00865.x; Rosenfeldt FL, 1999, ANN THORAC SURG, V67, P878, DOI 10.1016/S0003-4975(98)01299-5; Sauzeau V, 2000, J BIOL CHEM, V275, P21722, DOI 10.1074/jbc.M000753200; SCHULTZ KD, 1977, NATURE, V265, P750, DOI 10.1038/265750a0; Sogo N, 2000, BRIT J PHARMACOL, V131, P1236, DOI 10.1038/sj.bjp.0703700; SOMLYO AP, 1994, NATURE, V372, P231, DOI 10.1038/372231a0; Somlyo AP, 2003, PHYSIOL REV, V83, P1325, DOI 10.1152/physrev.00023.2003; Sudnitsyna MV, 2012, ARCH BIOCHEM BIOPHYS, V521, P62, DOI 10.1016/j.abb.2012.03.010; Surks HK, 1999, SCIENCE, V286, P1583, DOI 10.1126/science.286.5444.1583; VANBREEMEN C, 1989, ANNU REV PHYSIOL, V51, P315, DOI 10.1146/annurev.physiol.51.1.315; WARTON A, 1986, AUST J EXP BIOL MED, V64, P435, DOI 10.1038/icb.1986.46; Woodrum D, 2003, J VASC SURG, V37, P874, DOI 10.1067/mva.2003.153; Woodrum DA, 1999, AM J PHYSIOL-HEART C, V277, pH931, DOI 10.1152/ajpheart.1999.277.3.H931; Yamamoto Kiyohito, 2007, Ann Thorac Cardiovasc Surg, V13, P322	63	7	8	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 2	2016	11	5							e0154460	10.1371/journal.pone.0154460	http://dx.doi.org/10.1371/journal.pone.0154460			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DL5KB	27136356	Green Published, Green Submitted, gold			2022-12-26	WOS:000375674800022
J	Huang, HH; Liu, XY; Liang, Y				Huang, Hai-Hui; Liu, Xiao-Ying; Liang, Yong			Feature Selection and Cancer Classification via Sparse Logistic Regression with the Hybrid L1/2+2 Regularization	PLOS ONE			English	Article							VARIABLE SELECTION; L-1/2 REGULARIZATION; LUNG; IDENTIFICATION; BIOMARKER; RECEPTOR; NETWORK	Cancer classification and feature (gene) selection plays an important role in knowledge discovery in genomic data. Although logistic regression is one of the most popular classification methods, it does not induce feature selection. In this paper, we presented a new hybrid L1/2 + 2 regularization (HLR) function, a linear combination of L-1/2 and L-2 penalties, to select the relevant gene in the logistic regression. The HLR approach inherits some fascinating characteristics from L-1/2 (sparsity) and L-2 (grouping effect where highly correlated variables are in or out a model together) penalties. We also proposed a novel univariate HLR thresholding approach to update the estimated coefficients and developed the coordinate descent algorithm for the HLR penalized logistic regression model. The empirical results and simulations indicate that the proposed method is highly competitive amongst several state-of-the-art methods.	[Liang, Yong] Macau Univ Sci & Technol, Fac Informat Technol, Ave Wai Long, Taipa 999078, Macau, Peoples R China; Macau Univ Sci & Technol, State Key Lab Qual Res Chinese Med, Ave Wai Long, Taipa 999078, Macau, Peoples R China	Macau University of Science & Technology; Macau University of Science & Technology	Liang, Y (corresponding author), Macau Univ Sci & Technol, Fac Informat Technol, Ave Wai Long, Taipa 999078, Macau, Peoples R China.	yliang@must.edu.mo	Huang, Hai-Hui/J-7342-2015	Huang, Hai-Hui/0000-0002-6546-969X	Macau SAR of China [099/2013/A3]	Macau SAR of China	This work was supported by the Macau Science and Technology Develop Funds (Grant No. 099/2013/A3) of Macau SAR of China.	Ambroise C, 2002, P NATL ACAD SCI USA, V99, P6562, DOI 10.1073/pnas.102102699; Bartling B, 2005, CARCINOGENESIS, V26, P293, DOI 10.1093/carcin/bgh333; Becker N, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-138; Buckley ST, 2010, J BIOMED BIOTECHNOL, DOI 10.1155/2010/917108; Candes E, 2007, ANN STAT, V35, P2313, DOI 10.1214/009053606000001523; Dagliyan O, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014579; Fan JQ, 2001, J AM STAT ASSOC, V96, P1348, DOI 10.1198/016214501753382273; Friedman J, 2010, J STAT SOFTW, V33, P1, DOI 10.18637/jss.v033.i01; FRIEDMAN JH, 1989, J AM STAT ASSOC, V84, P165, DOI 10.2307/2289860; Glaab E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039932; Goh L., 2004, P 2 C AS PAC BIOINF, P161; Hastie T, 2009, ELEMENTS STAT LEARNI, P33, DOI 10.1007/978-0-387-84858-7; Hu YJ, 2008, LECT NOTES COMPUT SC, V4985, P846; Huang HH, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/713953; Jing R, 2010, NEOPLASMA, V57, P55, DOI 10.4149/neo_2010_01_055; Kumar MS, 2012, CELL, V149, P642, DOI 10.1016/j.cell.2012.02.059; Lecocke M, 2007, EMPIRICAL STUDY UNIV, V2, P313; Liang Y, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-198; Liu J, 2003, 2003 INTERNATIONAL CONFERENCE ON MACHINE LEARNING AND CYBERNETICS, VOLS 1-5, PROCEEDINGS, P2275, DOI 10.1109/ICMLC.2003.1259886; Lu TP, 2010, CANCER EPIDEM BIOMAR, V19, P2590, DOI 10.1158/1055-9965.EPI-10-0332; Malioutov D, 2005, IEEE T SIGNAL PROCES, V53, P3010, DOI 10.1109/TSP.2005.850882; Meinshausen N, 2009, ANN STAT, V37, P246, DOI 10.1214/07-AOS582; Paul TK, 2005, GECCO 2005: GENETIC AND EVOLUTIONARY COMPUTATION CONFERENCE, VOLS 1 AND 2, P453; Segal MR, 2003, J COMPUT BIOL, V10, P961, DOI 10.1089/106652703322756177; Selamat SA, 2012, GENOME RES, V22, P1197, DOI 10.1101/gr.132662.111; Seo JS, 2012, GENOME RES, V22, P2109, DOI 10.1101/gr.145144.112; Shen L, 2005, IEEE ACM T COMPUT BI, V2, P166, DOI 10.1109/TCBB.2005.22; Shipp MA, 2002, NAT MED, V8, P68, DOI 10.1038/nm0102-68; Singh D, 2002, CANCER CELL, V1, P203, DOI 10.1016/S1535-6108(02)00030-2; Tibshirani R, 1996, J ROY STAT SOC B MET, V58, P267, DOI 10.1111/j.2517-6161.1996.tb02080.x; Vicente C, 2012, CRIT REV ONCOL HEMAT, V82, P1, DOI 10.1016/j.critrevonc.2011.04.007; Wessels LFA, 2005, BIOINFORMATICS, V21, P3755, DOI 10.1093/bioinformatics/bti429; Xu ZB, 2012, IEEE T NEUR NET LEAR, V23, P1013, DOI 10.1109/TNNLS.2012.2197412; Xu ZB, 2010, SCI CHINA INFORM SCI, V53, P1159, DOI 10.1007/s11432-010-0090-0; Zeng JS, 2014, IEEE T SIGNAL PROCES, V62, P2317, DOI 10.1109/TSP.2014.2309076; Zeng LM, 2014, STATISTICS-ABINGDON, V48, P49, DOI 10.1080/02331888.2012.719513; Zhang W, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-S8-S7; Zou H, 2005, J R STAT SOC B, V67, P301, DOI 10.1111/j.1467-9868.2005.00503.x; Zou H, 2006, J AM STAT ASSOC, V101, P1418, DOI 10.1198/016214506000000735	41	49	51	1	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 2	2016	11	5							e0149675	10.1371/journal.pone.0149675	http://dx.doi.org/10.1371/journal.pone.0149675			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DL5KB	27136190	Green Published, Green Submitted, gold			2022-12-26	WOS:000375674800001
J	Roth, CC; Glickman, RD; Tolstykh, GP; Estlack, LE; Moen, EK; Echchgadda, I; Beier, HT; Barnes, RA; Ibey, BL				Roth, Caleb C.; Glickman, Randolph D.; Tolstykh, Gleb P.; Estlack, Larry E.; Moen, Erick K.; Echchgadda, Ibtissam; Beier, Hope T.; Barnes, Ronald A., Jr.; Ibey, Bennett L.			Evaluation of the Genetic Response of U937 and Jurkat Cells to 10-Nanosecond Electrical Pulses (nsEP)	PLOS ONE			English	Article							MECHANICAL-STRESS; HIGH-INTENSITY; PHOSPHATIDYLSERINE TRANSLOCATION; MEMBRANE PERMEABILIZATION; FIELDS MODULATE; CALCIUM BURSTS; NANOSECOND; ELECTROPORATION; ACTIVATION; EXPRESSION	Nanosecond electrical pulse (nsEP) exposure activates signaling pathways, produces oxidative stress, stimulates hormone secretion, causes cell swelling and induces apoptotic and necrotic death. The underlying biophysical connection(s) between these diverse cellular reactions and nsEP has yet to be elucidated. Using global genetic analysis, we evaluated how two commonly studied cell types, U937 and Jurkat, respond to nsEP exposure. We hypothesized that by studying the genetic response of the cells following exposure, we would gain direct insight into the stresses experienced by the cell and in turn better understand the biophysical interaction taking place during the exposure. Using Ingenuity Systems software, we found genes associated with cell growth, movement and development to be significantly up-regulated in both cell types 4 h post exposure to nsEP. In agreement with our hypothesis, we also found that both cell lines exhibit significant biological changes consistent with mechanical stress induction. These results advance nsEP research by providing strong evidence that the interaction of nsEPs with cells involves mechanical stress.	[Roth, Caleb C.] Univ Texas Hlth Sci Ctr San Antonio, Dept Radiol Sci, San Antonio, TX 78229 USA; [Roth, Caleb C.; Tolstykh, Gleb P.; Estlack, Larry E.; Echchgadda, Ibtissam] JBSA Ft Sam Houston, Gen Dynam IT, San Antonio, TX 78234 USA; [Glickman, Randolph D.] Univ Texas Hlth Sci Ctr San Antonio, Dept Ophthalmol, San Antonio, TX 78229 USA; [Moen, Erick K.] Univ So Calif, Dept Elect Engn, Los Angeles, CA 90089 USA; [Echchgadda, Ibtissam; Ibey, Bennett L.] JBSA Ft Sam Houston, Radiofrequency Branch, Air Force Res Lab, Bioeffects Div, San Antonio, TX 78234 USA; [Beier, Hope T.] JBSA Ft Sam Houston, Opt Radiat Branch, Air Force Res Lab, Bioeffects Div, San Antonio, TX 78234 USA; [Barnes, Ronald A., Jr.] JBSA Ft Sam Houston, Natl Res Council, Res Associateship Program, San Antonio, TX 78234 USA	University of Texas System; University of Texas Health San Antonio; University of Texas System; University of Texas Health San Antonio; University of Southern California; National Academies of Sciences, Engineering & Medicine	Roth, CC (corresponding author), Univ Texas Hlth Sci Ctr San Antonio, Dept Radiol Sci, San Antonio, TX 78229 USA.; Roth, CC (corresponding author), JBSA Ft Sam Houston, Gen Dynam IT, San Antonio, TX 78234 USA.	rothc@livemail.uthscsa.edu	Moen, Erick/AAB-4847-2021; Roth, Caleb/Y-1487-2019	Moen, Erick/0000-0002-5947-7044; Roth, Caleb/0000-0001-8962-1097	OSD-T&E (Office of Secretary Defense-Test and Evaluation), Defense-Wide / National Defense Education Program (NDEP) / Basic Research [PE0601120D8Z, BA-1]; Air Force Surgeon General's Office, Medical Research Program; Air Force Office of Scientific Research LRIR [13RH08COR]; Repperger Fellowship Program	OSD-T&E (Office of Secretary Defense-Test and Evaluation), Defense-Wide / National Defense Education Program (NDEP) / Basic Research; Air Force Surgeon General's Office, Medical Research Program; Air Force Office of Scientific Research LRIR(United States Department of DefenseAir Force Office of Scientific Research (AFOSR)); Repperger Fellowship Program	Mr. Roth is a SMART Scholar and is supported by the OSD-T&E (Office of Secretary Defense-Test and Evaluation), Defense-Wide / PE0601120D8Z National Defense Education Program (NDEP) / BA-1, Basic Research. This research was supported by intramural funds from the Air Force Surgeon General's Office, Medical Research Program and the Air Force Office of Scientific Research LRIR 13RH08COR. Mr. Erick Moen was funded by the Repperger Fellowship Program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adam RM, 2004, PHYSIOL GENOMICS, V20, P36, DOI 10.1152/physiolgenomics.00181.2004; Batra N, 2012, P NATL ACAD SCI USA, V109, P3359, DOI 10.1073/pnas.1115967109; Beebe SJ, 2004, PHYSIOL MEAS, V25, P1077, DOI 10.1088/0967-3334/25/4/023; Beebe SJ, 2003, DNA CELL BIOL, V22, P785, DOI 10.1089/104454903322624993; Beebe SJ, 2003, FASEB J, V17, P1493, DOI 10.1096/fj.02-0859fje; Beebe SJ, 2015, BIOELECTROCHEMISTRY, V103, P52, DOI 10.1016/j.bioelechem.2014.08.014; Beebe Stephen J, 2013, Cells, V2, P136, DOI 10.3390/cells2010136; Beebe SJ, 2013, INT J NANOMED, V8, DOI 10.2147/IJN.S51357; Beebe SJ, 2009, IEEE ENG MED BIO, P6509, DOI 10.1109/IEMBS.2009.5333139; Beier HT, 2012, BIOCHEM BIOPH RES CO, V423, P863, DOI 10.1016/j.bbrc.2012.06.055; Chen BPC, 2001, PHYSIOL GENOMICS, V7, P55, DOI 10.1152/physiolgenomics.2001.7.1.55; Chen C, 2006, MED BIOL ENG COMPUT, V44, P5, DOI 10.1007/s11517-005-0020-2; Chen R, 2014, EUR J CANCER, V50, P2705, DOI 10.1016/j.ejca.2014.07.006; Compton JL, 2014, NAT PHOTONICS, V8, P710, DOI [10.1038/NPHOTON.2014.165, 10.1038/nphoton.2014.165]; Cui W, 2004, EXP EYE RES, V78, P275, DOI 10.1016/j.exer.2003.10.007; de Araujo RMS, 2007, J PERIODONTAL RES, V42, P15, DOI 10.1111/j.1600-0765.2006.00906.x; Dickson EJ, 2014, P NATL ACAD SCI USA, V111, pE2281, DOI 10.1073/pnas.1407133111; Estlack LE, 2014, APOPTOSIS, V19, P1755, DOI 10.1007/s10495-014-1041-9; Frey W, 2006, BIOPHYS J, V90, P3608, DOI 10.1529/biophysj.105.072777; Ho SY, 1996, CRIT REV BIOTECHNOL, V16, P349, DOI 10.3109/07388559609147426; Ibey BL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0015642; Ibey BL, 2010, BBA-GEN SUBJECTS, V1800, P1210, DOI 10.1016/j.bbagen.2010.07.008; Ibey BL, 2010, BIOELECTROCHEMISTRY, V79, P114, DOI 10.1016/j.bioelechem.2010.01.001; Kolb JF, 2006, BIOELECTROMAGNETICS, V27, P172, DOI 10.1002/bem.20185; Morotomi-Yano K, 2011, ARCH BIOCHEM BIOPHYS, V515, P99, DOI 10.1016/j.abb.2011.09.002; Morotomi-Yano K, 2011, BIOCHEM BIOPH RES CO, V408, P471, DOI 10.1016/j.bbrc.2011.04.056; NEUMANN E, 1982, EMBO J, V1, P841, DOI 10.1002/j.1460-2075.1982.tb01257.x; Nishitani WS, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126440; Nishitani WS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026181; Ott CE, 2009, J BONE MINER RES, V24, P1247, DOI [10.1359/JBMR.090206, 10.1359/jbmr.090206]; Pakhomov AG, 2004, IEEE T PLASMA SCI, V32, P1579, DOI 10.1109/TPS.2004.831773; Pakhomov AG, 2007, BIOELECTROMAGNETICS, V28, P655, DOI 10.1002/bem.20354; Pakhomov AG, 2007, ARCH BIOCHEM BIOPHYS, V465, P109, DOI 10.1016/j.abb.2007.05.003; Pakhomova ON, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070278; Pakhomova ON, 2012, ARCH BIOCHEM BIOPHYS, V527, P55, DOI 10.1016/j.abb.2012.08.004; Pereira AM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101963; Ren W, 2012, BIOCHEM BIOPH RES CO, V421, P808, DOI 10.1016/j.bbrc.2012.04.094; Ross TD, 2013, CURR OPIN CELL BIOL, V25, P613, DOI 10.1016/j.ceb.2013.05.006; Roth CC, 2015, CHARACTERIZATION PRE; Schoenbach K, 1999, PULS POW C 1999 12 I, V1, P497; Sinha B, 2011, CELL, V144, P402, DOI 10.1016/j.cell.2010.12.031; SUGAR IP, 1984, BIOPHYS CHEM, V19, P211, DOI 10.1016/0301-4622(84)87003-9; Teissie J, 2005, BBA-GEN SUBJECTS, V1724, P270, DOI 10.1016/j.bbagen.2005.05.006; Tolstykh GP, 2014, BIOELECTROCHEMISTRY, V100, P80, DOI 10.1016/j.bioelechem.2014.01.006; Tolstykh GP, 2013, BIOELECTROCHEMISTRY, V94, P23, DOI 10.1016/j.bioelechem.2013.05.002; Tolstykh GP, 2014, DOSE DEPENDENT TRANS; VANDENBURGH HH, 1992, AM J PHYSIOL, V262, pR350, DOI 10.1152/ajpregu.1992.262.3.R350; Vernier PT, 2006, PHYS BIOL, V3, P233, DOI 10.1088/1478-3975/3/4/001; Vernier PT, 2005, P ANN INT IEEE EMBS, P5850, DOI 10.1109/IEMBS.2005.1615820; Vernier PT, 2004, FEBS LETT, V572, P103, DOI 10.1016/j.febslet.2004.07.021; Vernier PT, 2004, BIOPHYS J, V86, P4040, DOI 10.1529/biophysj.103.037945; Vernier PT, 2003, BIOCHEM BIOPH RES CO, V310, P286, DOI 10.1016/j.bbrc.2003.08.140; Vincelette RL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063122; Walker K, 2006, BIOELECTROMAGNETICS, V27, P221, DOI 10.1002/bem.20200; Ward CW, 2014, ANTIOXID REDOX SIGN, V20, P929, DOI 10.1089/ars.2013.5517; Weaver JC, 2000, IEEE T PLASMA SCI, V28, P24, DOI 10.1109/27.842820; Wiegand C, 2013, WOUND REPAIR REGEN, V21, P793, DOI 10.1111/wrr.12111; Wilmink GJ., 2007, THESIS VANDERBILT U; Wrenn SP, 2012, THERANOSTICS, V2, P1140, DOI 10.7150/thno.4305; Zhang W, 2014, EUR SPINE J, V23, P2410, DOI 10.1007/s00586-014-3394-8	60	9	9	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 2	2016	11	5							e0154555	10.1371/journal.pone.0154555	http://dx.doi.org/10.1371/journal.pone.0154555			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DL5KB	27135944	Green Published, Green Submitted, gold			2022-12-26	WOS:000375674800029
J	Michael, PE; Jahncke, J; Hyrenbach, KD				Michael, P. E.; Jahncke, J.; Hyrenbach, K. D.			Placing Local Aggregations in a Larger-Scale Context: Hierarchical Modeling of Black-Footed Albatross Dispersion	PLOS ONE			English	Article							CENTRAL CALIFORNIA; NORTH PACIFIC; SPATIAL-DISTRIBUTION; SPECIES DISPERSION; HABITAT USE; SEABIRDS; SEA; PREY; CLIMATE; VARIABILITY	At-sea surveys facilitate the study of the distribution and abundance of marine birds along standardized transects, in relation to changes in the local environmental conditions and large-scale oceanographic forcing. We analyzed the form and the intensity of black-footed albatross (Phoebastria nigripes: BFAL) spatial dispersion off central California, using five years (2004-2008) of vessel-based surveys of seven replicated survey lines. We related BFAL patchiness to local, regional and basin-wide oceanographic variability using two complementary approaches: a hypothesis-based model and an exploratory analysis. The former tested the strength and sign of hypothesized BFAL responses to environmental variability, within a hierarchical atmosphere-ocean context. The latter explored BFAL cross-correlations with atmospheric / oceanographic variables. While albatross dispersion was not significantly explained by the hierarchical model, the exploratory analysis revealed that aggregations were influenced by static (latitude, depth) and dynamic (wind speed, upwelling) environmental variables. Moreover, the largest BFAL patches occurred along the survey lines with the highest densities, and in association with shallow banks. In turn, the highest BFAL densities occurred during periods of negative Pacific Decadal Oscillation index values and low atmospheric pressure. The exploratory analyses suggest that BFAL dispersion is influenced by basin-wide, regional-scale and local environmental variability. Furthermore, the hypothesis-based model highlights that BFAL do not respond to oceanographic variability in a hierarchical fashion. Instead, their distributions shift more strongly in response to large-scale ocean-atmosphere forcing. Thus, interpreting local changes in BFAL abundance and dispersion requires considering diverse environmental forcing operating at multiple scales.	[Michael, P. E.; Hyrenbach, K. D.] Hawaii Pacific Univ, Ocean Inst, Kalanianaole Hwy, Waimanalo, HI 96795 USA; [Jahncke, J.] Point Blue Conservat Sci, 3820 Cypress Dr,11, Petaluma, CA 94954 USA		Michael, PE (corresponding author), Hawaii Pacific Univ, Ocean Inst, Kalanianaole Hwy, Waimanalo, HI 96795 USA.	pamela.e.michael@gmail.com; jjahncke@pointblue.org		Michael, Pamela/0000-0003-4420-864X	Applied California Current Ecosystem Studies (ACCESS); National Oceanic and Atmospheric Administration's National Marine Sanctuaries Office	Applied California Current Ecosystem Studies (ACCESS); National Oceanic and Atmospheric Administration's National Marine Sanctuaries Office	This work was supported in part by the Applied California Current Ecosystem Studies (ACCESS, www.accessoceans.org) Partnership, an ongoing collaboration between Point Blue Conservation Science, Cordell Bank, and Gulf of the Farallones National Marine Sanctuaries, to support marine wildlife conservation and healthy ecosystems in northern and central California. Additionally, PEM received a Dr. Nancy Foster Scholarship, from the National Oceanic and Atmospheric Administration's National Marine Sanctuaries Office. Funding supported PEM during the data analysis and the writing of the manuscript. http://fosterscholars.noaa.gov/scholars.html. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams J, 2010, MAR BIOL, V157, P915, DOI 10.1007/s00227-009-1367-y; Ainley DG, 2012, MAR ECOL PROG SER, V451, P231, DOI 10.3354/meps09524; Ainley DG, 2010, PROG OCEANOGR, V84, P242, DOI 10.1016/j.pocean.2009.10.001; Ainley DG, 2005, DEEP-SEA RES PT II, V52, P123, DOI 10.1016/j.dsr2.2004.08.016; ALERSTAM T, 1993, PHILOS T ROY SOC B, V340, P55, DOI 10.1098/rstb.1993.0048; ANDREW NL, 1987, OCEANOGR MAR BIOL, V25, P39; [Anonymous], SYNTHESIS HABITAT US; BERNSTEIN BB, 1978, LIMNOL OCEANOGR, V23, P401, DOI 10.4319/lo.1978.23.3.0401; BRAY JR, 1962, ECOLOGY, V43, P328, DOI 10.2307/1931992; BREAKER LC, 1986, PROG OCEANOGR, V17, P61, DOI 10.1016/0079-6611(86)90025-X; Delord K, 2014, MAR POLICY, V48, P1, DOI 10.1016/j.marpol.2014.02.019; Di Lorenzo E, 2008, GEOPHYS RES LETT, V35, DOI 10.1029/2007GL032838; Fauchald P, 2000, ECOLOGY, V81, P773, DOI 10.1890/0012-9658(2000)081[0773:SDPPIT]2.0.CO;2; Garthe S, 2009, MAR ECOL PROG SER, V391, P243, DOI 10.3354/meps08170; Grace JB., 2015, STRUCTURAL EQUATION; Green R.H., 1966, RES POPUL ECOL, V8, P1, DOI [10.1007/BF02524740, DOI 10.1007/BF02524740]; Gremillet D, 2009, MAR ECOL PROG SER, V391, P121, DOI 10.3354/meps08212; HANEY JC, 1995, MAR BIOL, V123, P1, DOI 10.1007/BF00350317; Hickey B. M., 1979, Progress in Oceanography, V8, P191, DOI 10.1016/0079-6611(79)90002-8; HUBBELL SP, 1979, SCIENCE, V203, P1299, DOI 10.1126/science.203.4387.1299; HUYER A, 1991, J GEOPHYS RES-OCEANS, V96, P14809, DOI 10.1029/91JC00641; Hyrenbach KD, 2006, FISH OCEANOGR, V15, P95, DOI 10.1111/j.1365-2419.2005.00350.x; Jahncke J, 2008, PROG OCEANOGR, V77, P182, DOI 10.1016/j.pocean.2008.03.010; Kappes MA, 2010, PROG OCEANOGR, V86, P246, DOI 10.1016/j.pocean.2010.04.012; Keiper CA, 2005, MAR ECOL PROG SER, V289, P285, DOI 10.3354/meps289285; Largier JL, 1993, J GEOPHYS RES, V98, P18; Logerwell EA, 1998, ECOGRAPHY, V21, P212, DOI 10.1111/j.1600-0587.1998.tb00674.x; Louzao M, 2009, MAR ECOL PROG SER, V391, P183, DOI 10.3354/meps08124; Louzao M, 2006, ECOL APPL, V16, P1683, DOI 10.1890/1051-0761(2006)016[1683:OHOAEM]2.0.CO;2; Mantua NJ, 1997, B AM METEOROL SOC, V78, P1069, DOI 10.1175/1520-0477(1997)078<1069:APICOW>2.0.CO;2; Manugian S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0144232; Michael PE, 2014, FISH OCEANOGR, V23, P18, DOI 10.1111/fog.12039; MORAN PAP, 1950, BIOMETRIKA, V37, P17, DOI 10.1093/biomet/37.1-2.17; Oppel S, 2012, BIOL CONSERV, V156, P94, DOI 10.1016/j.biocon.2011.11.013; Pacific Fisheries Environmental Laboratory (PFEL), 2009, ERD LIV ACC SERV; Palacios DM, 2006, DEEP-SEA RES PT II, V53, P250, DOI 10.1016/j.dsr2.2006.03.004; Petraitis PS, 1996, FUNCT ECOL, V10, P421, DOI 10.2307/2389934; R Core Team, 2020, R LANG ENV STAT COMP; Raymond B, 2015, ECOGRAPHY, V38, P121, DOI 10.1111/ecog.01021; Reid K, 2004, DEEP-SEA RES PT II, V51, P1383, DOI 10.1016/j.dsr2.2004.06.007; Reid TA, 2000, MAR FRESHWATER RES, V51, P789, DOI 10.1071/MF98160; ROTENBERRY JT, 1976, AM MIDL NAT, V95, P64, DOI 10.2307/2424234; Santora JA, 2011, ICES J MAR SCI, V68, P1391, DOI 10.1093/icesjms/fsr046; Sawada M, 1999, B ECOL SOC AM, V80, P231, DOI DOI 10.1890/0012-9623(1999)080[0231:TT]2.0.CO;2; SCHWING FB, 1991, CAL COOP OCEAN FISH, V32, P47; Schwing FB, 1996, CALIFORNIA COSTAL UP; Shaffer SA, 2004, J AVIAN BIOL, V35, P551, DOI 10.1111/j.0908-8857.2004.03264.x; Spruzen FL, 2002, POLAR BIOL, V25, P296, DOI 10.1007/s00300-001-0344-9; STRUB PT, 1987, J GEOPHYS RES-OCEANS, V92, P1507, DOI 10.1029/JC092iC02p01507; Suryan RM, 2006, DEEP-SEA RES PT II, V53, P370, DOI 10.1016/j.dsr2.2006.01.012; Suryan RM, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0004016; Tancell C, 2013, MAR BIOL, V160, P15, DOI 10.1007/s00227-012-2050-2; TASKER ML, 1984, AUK, V101, P567, DOI 10.1093/auk/101.3.567; Thayer JA, 2007, MAR ECOL PROG SER, V329, P253, DOI 10.3354/meps329253; Tremblay Y, 2009, MAR ECOL PROG SER, V391, P153, DOI 10.3354/meps08146; VEIT RR, 1993, J ANIM ECOL, V62, P551, DOI 10.2307/5204; VEIT RR, 1992, POLAR BIOL, V11, P637; Weimerskirch H, 2000, P ROY SOC B-BIOL SCI, V267, P1869, DOI 10.1098/rspb.2000.1223; Wells BK, 2008, MAR ECOL PROG SER, V364, P15, DOI 10.3354/meps07486; Wells BK, 2008, FISH OCEANOGR, V17, P101, DOI 10.1111/j.1365-2419.2008.00467.x; Yen PPW, 2006, DEEP-SEA RES PT II, V53, P399, DOI 10.1016/j.dsr2.2006.01.013; Zar J.H., 1999, ZAR KUHR 5 2019, V4th	62	3	3	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 28	2016	11	4							e0153783	10.1371/journal.pone.0153783	http://dx.doi.org/10.1371/journal.pone.0153783			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DK8XE	27124491	Green Published, gold			2022-12-26	WOS:000375211700029
J	Roderburg, C; Benz, F; Schuller, F; Pombeiro, I; Hippe, HJ; Frey, N; Trautwein, C; Luedde, T; Koch, A; Tacke, F; Luedde, M				Roderburg, Christoph; Benz, Fabian; Schueller, Florian; Pombeiro, Ines; Hippe, Hans-Joerg; Frey, Norbert; Trautwein, Christian; Luedde, Tom; Koch, Alexander; Tacke, Frank; Luedde, Mark			Serum Levels of TNF Receptor Ligands Are Dysregulated in Sepsis and Predict Mortality in Critically Ill Patients	PLOS ONE			English	Article							TWEAK; INFLAMMATION; APOPTOSIS; FAMILY; CELLS; SHOCK; FAILURE; SYSTEM; PLAYER; GENE	Introduction TNF superfamily members, including TNF-related weak inducer of apoptosis (TWEAK) and Glucocorticoid-Induced TNFR-Related Protein Ligand (GITRL) have been described as serum based biomarkers for inflammatory and immune mediated diseases. However, up to now the role of TWEAK and GITRL has not been analyzed in critical illness and sepsis. Methods GITRL and TWEAK serum concentrations were measured in 121 critically ill patients (84 fulfilled with septic disease), in comparison to 50 healthy controls. Results were correlated with clinical data. Results Serum levels of TWEAK and GITRL were strongly decreased in critically ill patients compared with healthy controls. Concentrations of TWEAK (but not GITRL) were further decreased in patients with sepsis and correlated with routinely used markers of inflammation and bacterial infection such as C-reactive protein, procalcitonin and Interleukin-6. Notably, we failed to detect a correlation to other TNFR ligands such as TNF or APRIL. Finally, TWEAK levels of the upper quartile of the cohort were prognostic for mortality during ICU treatment. Conclusion TWEAK and GITRL levels were lower in intensive care unit medical patients. Levels of TWEAK were further decreased in septic patients, and alterations in TWEAK concentrations were linked to an unfavorable outcome. Together with recently published results on other TNFR ligands, these data indicate specific functions of the different TNFR ligands in septic diseases.	[Roderburg, Christoph; Benz, Fabian; Schueller, Florian; Pombeiro, Ines; Trautwein, Christian; Luedde, Tom; Koch, Alexander; Tacke, Frank] Univ Hosp RWTH Aachen, Dept Med 3, Pauwelsstr 30, D-52074 Aachen, Germany; [Hippe, Hans-Joerg; Frey, Norbert; Luedde, Mark] Univ Kiel, Dept Internal Med 3, Schittenhelmstr 12, D-24105 Kiel, Germany	RWTH Aachen University; RWTH Aachen University Hospital; University of Kiel	Luedde, M (corresponding author), Univ Kiel, Dept Internal Med 3, Schittenhelmstr 12, D-24105 Kiel, Germany.	mark.luedde@uksh.de	Roderburg, Christoph/AHC-8101-2022; Roderburg, Christoph/AAR-3051-2021; Luedde, Tom/AAE-9135-2022; Frey, Norbert/M-7749-2019; Tacke, Frank/ABF-2212-2020; Frey, Norbert/A-9695-2010	Roderburg, Christoph/0000-0002-1409-7697; Luedde, Tom/0000-0002-6288-8821; Frey, Norbert/0000-0001-7611-378X; 	German Research Foundation [DFG RO 4317/4-1]; medical faculty RWTH Aachen; European Research Council [ERC-2007-Stg / 208237-Luedde-Med3-Aachen]; German-Research-Foundation [SFB-TRR57, P06+P09]; German Cancer Aid (Deutsche Krebshilfe) [110043]; EMBO; Ernst-Jung-Foundation Hamburg; Medical Faculty Aachen; Interdisciplinary Center of Clinical Research ("IZKF") Aachen; Bundesministerium fur Bildung und Forschung, Germany (Nationales Genomforschungsnetz: NGFNplus); Deutsche Stiftung Herzforschung [F12/12]	German Research Foundation(German Research Foundation (DFG)); medical faculty RWTH Aachen; European Research Council(European Research Council (ERC)European Commission); German-Research-Foundation(German Research Foundation (DFG)); German Cancer Aid (Deutsche Krebshilfe)(Deutsche Krebshilfe); EMBO(European Molecular Biology Organization (EMBO)); Ernst-Jung-Foundation Hamburg; Medical Faculty Aachen; Interdisciplinary Center of Clinical Research ("IZKF") Aachen; Bundesministerium fur Bildung und Forschung, Germany (Nationales Genomforschungsnetz: NGFNplus)(Federal Ministry of Education & Research (BMBF)); Deutsche Stiftung Herzforschung	This work was supported by project grants from the German Research Foundation (DFG RO 4317/4-1) and a START grant from the medical faculty RWTH Aachen to C.R. Moreover the work was supported by a Starting Grant from the European Research Council within the FP 7 (ERC-2007-Stg / 208237-Luedde-Med3-Aachen), the German-Research-Foundation (SFB-TRR57, P06+P09), the German Cancer Aid (Deutsche Krebshilfe Grant 110043), the EMBO Young Investigator Program, the Ernst-Jung-Foundation Hamburg, a grant from the Medical Faculty Aachen, from the Interdisciplinary Center of Clinical Research ("IZKF") Aachen, a grant of the Bundesministerium fur Bildung und Forschung, Germany (Nationales Genomforschungsnetz: NGFNplus) and a grant of the Deutsche Stiftung Herzforschung (F12/12). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Benz F, 2015, DIS MARKERS, V2015, DOI 10.1155/2015/384208; Chicheportiche Y, 1997, J BIOL CHEM, V272, P32401, DOI 10.1074/jbc.272.51.32401; Chicheportiche Y, 2000, BIOCHEM BIOPH RES CO, V279, P162, DOI 10.1006/bbrc.2000.3913; Chorianopoulos E, 2009, EUR J HEART FAIL, V11, P1050, DOI 10.1093/eurjhf/hfp139; Cuzzocrea S, 2004, J LEUKOCYTE BIOL, V76, P933, DOI 10.1189/jlb.0204110; Cuzzocrea S, 2006, J IMMUNOL, V177, P631, DOI 10.4049/jimmunol.177.1.631; De Freitas I, 2004, CHEST, V125, P2238, DOI 10.1378/chest.125.6.2238; Dwyer BJ, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00039; Gungor O, 2013, RENAL FAILURE, V35, P77, DOI 10.3109/0886022X.2012.734890; Koch A, 2011, CRIT CARE, V15, DOI 10.1186/cc10007; Koch A, 2011, CRIT CARE, V15, DOI 10.1186/cc10037; Koch A, 2010, CRIT CARE, V14, DOI 10.1186/cc9029; Koch A, 2009, CRIT CARE, V13, DOI 10.1186/cc7925; Krausz LT, 2007, THESCIENTIFICWORLDJO, V7, P533, DOI 10.1100/tsw.2007.106; Liu SF, 2006, AM J PHYSIOL-LUNG C, V290, pL622, DOI 10.1152/ajplung.00477.2005; Mower WR, 1999, ANN EMERG MED, V33, P85, DOI 10.1016/S0196-0644(99)70422-1; Nardelli B, 2006, ENDOCRINOLOGY, V147, P70, DOI 10.1210/en.2005-0518; Newton K, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a006049; Nocentini G, 1997, P NATL ACAD SCI USA, V94, P6216, DOI 10.1073/pnas.94.12.6216; Novoyatleva T, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00050; Parameswaran N, 2010, CRIT REV EUKAR GENE, V20, P87, DOI 10.1615/CritRevEukarGeneExpr.v20.i2.10; Park MC, 2008, SCAND J RHEUMATOL, V37, P173, DOI 10.1080/03009740801898608; Peschon JJ, 1998, SCIENCE, V282, P1281, DOI 10.1126/science.282.5392.1281; Pierrakos C, 2010, CRIT CARE, V14, DOI 10.1186/cc8872; Placke T, 2010, CLIN DEV IMMUNOL, DOI 10.1155/2010/239083; Roderburg C, 2015, CRIT CARE, V19, DOI 10.1186/s13054-015-0988-4; Roderburg C, 2013, J CRIT CARE, V28, DOI 10.1016/j.jcrc.2012.11.007; Sanz AB, 2014, NEPHROL DIAL TRANSPL, V29, pI54, DOI 10.1093/ndt/gft342; Schilder L, 2015, BMC NEPHROL, V16, DOI 10.1186/s12882-015-0167-5; Shevach EM, 2006, NAT REV IMMUNOL, V6, P613, DOI 10.1038/nri1867; Siegelaar SE, 2011, CRIT CARE, V15, DOI 10.1186/cc10440; Stephens LA, 2006, J IMMUNOL, V177, P2036, DOI 10.4049/jimmunol.177.4.2036; Tacke F, 2014, CRIT CARE MED, V42, P1096, DOI 10.1097/CCM.0000000000000131; Tone M, 2003, P NATL ACAD SCI USA, V100, P15059, DOI 10.1073/pnas.2334901100; Wajant H, 2013, BRIT J PHARMACOL, V170, P748, DOI 10.1111/bph.12337; Winkles JA, 2008, NAT REV DRUG DISCOV, V7, P411, DOI 10.1038/nrd2488	36	11	11	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 28	2016	11	4							e0153765	10.1371/journal.pone.0153765	http://dx.doi.org/10.1371/journal.pone.0153765			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DK8XE	27124414	Green Published, gold, Green Submitted			2022-12-26	WOS:000375211700028
J	Wang, F; Gao, C; Lu, J; Tatetsu, H; Williams, DA; Muller, LU; Cui, W; Chai, L				Wang, F.; Gao, C.; Lu, J.; Tatetsu, H.; Williams, D. A.; Mueller, L. U.; Cui, W.; Chai, L.			Leukemic survival factor SALL4 contributes to defective DNA damage repair	ONCOGENE			English	Article							EARLY EMBRYONIC-DEVELOPMENT; FANCONI-ANEMIA PATHWAY; STEM-CELL FACTOR; HEMATOPOIETIC STEM; OKIHIRO-SYNDROME; HOMOLOGOUS RECOMBINATION; MUTATIONS; GENE; FANCD2; MONOUBIQUITINATION	SALL4 is aberrantly expressed in human myelodysplastic syndromes (MDS) and acute myeloid leukemia (AML). We have generated a SALL4 transgenic (SALL4B Tg) mouse model with pre-leukemic MDS-like symptoms that transform to AML over time. This makes our mouse model applicable for studying human MDS/AML diseases. Characterization of the leukemic initiation population in this model leads to the discovery that Fancl (Fanconi anemia, complementation group L) is downregulated in SALL4B Tg leukemic and pre-leukemic cells. Similar to the reported Fanconi anemia (FA) mouse model, chromosomal instability with radial changes can be detected in pre-leukemic SALL4B Tg bone marrow (BM) cells after DNA damage challenge. Results from additional studies using DNA damage repair reporter assays support a role of SALL4 in inhibiting the homologous recombination pathway. Intriguingly, unlike the FA mouse model, after DNA damage challenge, SALL4B Tg BM cells can survive and generate hematopoietic colonies. We further elucidated that the mechanism by which SALL4 promotes cell survival is through Bcl2 activation. Overall, our studies demonstrate for the first time that SALL4 has a negative impact in DNA damage repair, and support the model of dual functional properties of SALL4 in leukemogenesis through inhibiting DNA damage repair and promoting cell survival.	[Wang, F.; Gao, C.; Lu, J.; Tatetsu, H.; Chai, L.] Harvard Med Sch, Brigham & Womens Hosp, Joint Program Transfus Med, Dept Pathol, 75 Francis St, Boston, MA 02115 USA; [Wang, F.; Cui, W.] Peking Union Med Coll, Peking Union Med Coll Hosp, Dept Clin Lab, Beijing, Peoples R China; [Wang, F.; Cui, W.] Chinese Acad Med Sci, Beijing, Peoples R China; [Williams, D. A.; Mueller, L. U.] Harvard Med Sch, Childrens Hosp Boston, Div Hematol Oncol, Boston, MA USA; [Mueller, L. U.] Genentech Inc, San Francisco, CA USA	Harvard University; Brigham & Women's Hospital; Harvard Medical School; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Peking Union Medical College Hospital; Chinese Academy of Medical Sciences - Peking Union Medical College; Harvard University; Boston Children's Hospital; Harvard Medical School; Roche Holding; Genentech	Chai, L (corresponding author), Harvard Med Sch, Brigham & Womens Hosp, Joint Program Transfus Med, Dept Pathol, 75 Francis St, Boston, MA 02115 USA.; Cui, W (corresponding author), Chinese Acad Med Sci, Peking Union Med Coll, Peking Union Med Coll Hosp, Dept Clin Lab, Beijing 100730, Peoples R China.	cuiw@pumch.cn; lchai@partners.org		Chai, Li/0000-0003-1937-4750	NIH [R03CA184531, PO1HL095489]; Lymphoma and Leukemia Society [SLP-8004-14, TRP-6482-16]; V cancer research Foundation; National Natural Science Foundation of China (NSFC) [81071418, 81472029]; China Scholarship Council [201206210154]; NATIONAL CANCER INSTITUTE [R03CA184531] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL095489] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Lymphoma and Leukemia Society(Leukemia and Lymphoma Society); V cancer research Foundation; National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC)); China Scholarship Council(China Scholarship Council); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	L Chai and W Cui designed the research, analyzed data and wrote the paper. F Wang and C Gao performed the research experiments, analyzed data and wrote the paper. J Lu and H Tatetsu performed the research experiments and analyzed the data. D Williams provided Fanca - / - mice and edited the paper. L Muller performed Fanca - / - mice related experiments. We also want to thank Dr S Xiao for providing DNA repair reporter plasmids, X Yao, and D Neuberg for statistic analysis, X Tian in assisting animal work, and N Kong in editing of the manuscript. This work was supported in part through NIH R03CA184531 and PO1HL095489, funding from Lymphoma and Leukemia Society (No. SLP-8004-14 and TRP-6482-16) and V cancer research Foundation (to L Chai), by the National Natural Science Foundation of China (NSFC) - 81071418 and 81472029 (to W Cui), and China Scholarship Council (No. 201206210154) (to F Wang).	Akashi K, 2000, NATURE, V404, P193, DOI 10.1038/35004599; Al-Baradie R, 2002, AM J HUM GENET, V71, P1195, DOI 10.1086/343821; Alpi AF, 2008, MOL CELL, V32, P767, DOI 10.1016/j.molcel.2008.12.003; Alsner J, 2008, ACTA ONCOL, V47, P600, DOI 10.1080/02841860802047411; Bejar R, 2014, J CLIN ONCOL, V32, P2691, DOI 10.1200/JCO.2013.52.3381; Borozdin W, 2004, J MED GENET, V41, DOI 10.1136/jmg.2004.019505; Cui W, 2006, MODERN PATHOL, V19, P1585, DOI 10.1038/modpathol.3800694; D'Andrea AD, 2010, NEW ENGL J MED, V362, P1909, DOI 10.1056/NEJMra0809889; Gao C, 1999, INT J MOL MED, V4, P291; Gao C, 2013, TRANSFUSION, V53, P1037, DOI 10.1111/j.1537-2995.2012.03888.x; Gurtan AM, 2006, J BIOL CHEM, V281, P10896, DOI 10.1074/jbc.M511411200; Haferlach T, 2010, J CLIN ONCOL, V28, P2529, DOI 10.1200/JCO.2009.23.4732; Hess CJ, 2008, CELL ONCOL, V30, P299, DOI 10.3233/CLO-2008-0426; Huard CC, 2014, P NATL ACAD SCI USA, V111, P2152, DOI 10.1073/pnas.1314226111; Kohlhase J, 2002, HUM MOL GENET, V11, P2979, DOI 10.1093/hmg/11.23.2979; Kohlhase J, 2003, J MED GENET, V40, P473, DOI 10.1136/jmg.40.7.473; Kohlmann A, 2008, BRIT J HAEMATOL, V142, P802, DOI 10.1111/j.1365-2141.2008.07261.x; Lensch MW, 2003, BLOOD, V102, P7, DOI 10.1182/blood-2002-09-2781; Li AL, 2013, J CLIN INVEST, V123, P4195, DOI 10.1172/JCI62891; Lu J, 2011, LEUKEMIA, V25, P1211, DOI 10.1038/leu.2011.65; Ma YP, 2006, BLOOD, V108, P2726, DOI 10.1182/blood-2006-02-001594; Mao ZY, 2008, CELL CYCLE, V7, P2902, DOI 10.4161/cc.7.18.6679; Mao ZY, 2007, P NATL ACAD SCI USA, V104, P13068, DOI 10.1073/pnas.0702410104; Mao ZY, 2009, NEOPLASIA, V11, P683, DOI 10.1593/neo.09312; Milsom MD, 2009, BLOOD, V113, P5111, DOI 10.1182/blood-2008-09-180224; Muller LUW, 2008, MOL THER, V16, P1154, DOI 10.1038/mt.2008.67; Oostra AB, 2012, ANEMIA, V2012, DOI 10.1155/2012/238731; Paradisi I, 2007, AM J MED GENET A, V143A, P326, DOI 10.1002/ajmg.a.31603; Rego MA, 2012, BLOOD, V120, P2109, DOI 10.1182/blood-2012-02-410472; Rio P, 2002, BLOOD, V100, P2032; Seluanov A, 2004, P NATL ACAD SCI USA, V101, P7624, DOI 10.1073/pnas.0400726101; Seluanov A., 2010, J VIS EXP; Singh TR, 2009, BLOOD, V114, P174, DOI 10.1182/blood-2009-02-207811; Wang F, 2013, J HEMATOL ONCOL, V6, DOI 10.1186/1756-8722-6-73; Wang JL, 2006, NATURE, V444, P364, DOI 10.1038/nature05284; Warren M, 2007, GENESIS, V45, P51, DOI 10.1002/dvg.20264; Will B, 2010, BLOOD, V115, P2901, DOI 10.1182/blood-2009-03-209544; Wu Q, 2006, J BIOL CHEM, V281, P24090, DOI 10.1074/jbc.C600122200; Yang JC, 2008, BLOOD, V112, P805, DOI 10.1182/blood-2007-11-126326; Yang JC, 2007, P NATL ACAD SCI USA, V104, P10494, DOI 10.1073/pnas.0704001104; Yang Y, 2001, BLOOD, V98, P3435, DOI 10.1182/blood.V98.12.3435; Zhang JQ, 2006, NAT CELL BIOL, V8, P1114, DOI 10.1038/ncb1481	42	8	8	0	4	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	NOV 24	2016	35	47					6087	6095		10.1038/onc.2016.146	http://dx.doi.org/10.1038/onc.2016.146			9	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	ED0CE	27132514	Green Accepted, Green Submitted			2022-12-26	WOS:000388509800005
J	Guillonneau, M; Paris, F; Dutoit, S; Estephan, H; Beneteau, E; Huot, J; Corre, I				Guillonneau, Maeva; Paris, Francois; Dutoit, Soizic; Estephan, Hala; Beneteau, Elise; Huot, Jacques; Corre, Isabelle			Oxidative stress disassembles the p38/NPM/PP2A complex, which leads to modulation of nucleophosmin-mediated signaling to DNA damage response	FASEB JOURNAL			English	Article						reactive oxygen species; p38MAPK; endothelial dysfunction; phosphatases; double-strand breaks	PROTEIN PHOSPHATASE 2A; DOUBLE-STRAND BREAKS; ENDOTHELIAL DYSFUNCTION; HEAT-SHOCK; HYDROGEN-PEROXIDE; IONIZING-RADIATION; PROTEOMIC APPROACH; SHEAR-STRESS; KINASE; REPAIR	Oxidative stress is a leading cause of endothelial dysfunction. The p38 MAPK pathway plays a determinant role in allowing cells to cope with oxidative stress and is tightly regulated by a balanced interaction between p38 protein and its interacting partners. By using a proteomic approach, we identified nucleophosmin (NPM) as a new partner of p38 in HUVECs. Coimmunoprecipitation and microscopic analyses confirmed the existence of a cytosolic nucleophosmin (NPM)/p38 interaction in basal condition. Oxidative stress, which was generated by exposure to 500 mu M H2O2, induces a rapid dephosphorylation of NPM at T199 that depends on phosphatase PP2A, another partner of the NPM/p38 complex. Blocking PP2A activity leads to accumulation of NPM-pT199 and to an increased association of NPM with p38. Concomitantly to its dephosphorylation, oxidative stress promotes translocation of NPM to the nucleus to affect the DNA damage response. Dephosphorylated NPM impairs the signaling of oxidative stress-induced DNA damage via inhibition of the phosphorylation of ataxia-telangiectasia mutated and DNA-dependent protein kinase catalytic subunit. Overall, these results suggest that the p38/NPM/PP2A complex acts as a dynamic sensor, allowing endothelial cells to react rapidly to acute oxidative stress.	[Guillonneau, Maeva; Paris, Francois; Dutoit, Soizic; Estephan, Hala; Beneteau, Elise; Corre, Isabelle] CNRS, Unite Mixte Rech 6299, Nantes, France; [Guillonneau, Maeva; Paris, Francois; Dutoit, Soizic; Estephan, Hala; Beneteau, Elise; Corre, Isabelle] INSERM, Unite Mixte Rech 892, Nantes, France; [Guillonneau, Maeva; Paris, Francois; Dutoit, Soizic; Estephan, Hala; Beneteau, Elise; Corre, Isabelle] Univ Nantes, Nantes, France; [Guillonneau, Maeva; Huot, Jacques; Corre, Isabelle] Univ Laval, Ctr Hosp Univ Quebec, Ctr Rech, Quebec City, PQ, Canada; [Guillonneau, Maeva; Huot, Jacques; Corre, Isabelle] Univ Laval, Ctr Rech Canc, Quebec City, PQ, Canada	Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); Nantes Universite; Laval University; Laval University	Corre, I (corresponding author), Ctr Reg Rech Cancerol Nantes Angers CRCNA, IRS UN, CNRS 6299, INSERM U892, 8 Quai Moncousu, F-44007 Nantes, France.	isabelle.corre@inserm.fr	Corre, Isabelle/L-2583-2015; Paris, francois E/L-4915-2015	Paris, francois E/0000-0002-0176-7348; dutoit, soizic/0000-0003-1094-7823; CORRE, Isabelle/0000-0001-6444-1145	International Outgoing Fellowship; Marie Curie People Programme of the European Union's Seventh Framework Program FP7 [326512]; La Ligue contre le Cancer (Comites Loire-Atlantique, Morbihan, Cotes d'Armor); Canadian Institutes of Health Research; Natural Sciences and Engineering Research Council; French Ministry of Research studentship	International Outgoing Fellowship; Marie Curie People Programme of the European Union's Seventh Framework Program FP7; La Ligue contre le Cancer (Comites Loire-Atlantique, Morbihan, Cotes d'Armor); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Natural Sciences and Engineering Research Council(Natural Sciences and Engineering Research Council of Canada (NSERC)); French Ministry of Research studentship	The authors thank Drs. Jean-Yves Masson (Universite Laval), Claude Prigent and David Reboutier (Institut de Genetique and Developpement, Universite de Rennes, Rennes, France) for providing NPM mutants and purified Aurora kinase, respectively, and for advice and helpful discussions. The authors also thank Charlotte Degorre (Cancer Research Center Nantes-Angers, Nantes, France) for technical expertise, Dr. Jacques Landry (Universite Laval) for providing the p38 MAPK antibody, and Dr. Beatrice Charreau (INSERM Unite Mixte de Recherche 1064, Nantes, France) for providing human arterial endothelial cells. The authors are grateful to Dr. Simon Rousseau (McGill University, Montreal, QC, Canada), Dr. Julie Gavard (Cancer Research Center Nantes-Angers), and Francois Houle (Universite Laval) for carefully reading the manuscript. The authors are also grateful to Philippe Hulin and Steven Nedellec (MicroPICell-Cellular Imaging Core Facility, Nantes, France; Structure Federative de Recherche Francois Bonamy) for their help and advice. The authors thank Dr. Eric Bonneil (Proteomic Platform of the Institute for Research in Immunology and Cancer, University of Montreal, Montreal, QC, Canada) for performing the mass spectrometry analyses. This work was funded by the International Outgoing Fellowship, Marie Curie People Programme of the European Union's Seventh Framework Program FP7/2007-2013, under REA grant agreement No. 326512, and by a subvention from La Ligue contre le Cancer (Comites Loire-Atlantique, Morbihan, Cotes d'Armor) (to I.C.), Canadian Institutes of Health Research, and Natural Sciences and Engineering Research Council (to J.H.). M.G. was a recipient of the French Ministry of Research studentship.	Arregi I, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0130610; Bertwistle D, 2004, MOL CELL BIOL, V24, P985, DOI 10.1128/MCB.24.3.985-996.2004; Bharath LP, 2015, DIABETES, V64, P3914, DOI 10.2337/db15-0244; Bolli N, 2007, CANCER RES, V67, P6230, DOI 10.1158/0008-5472.CAN-07-0273; Boueiz A, 2009, MICROVASC RES, V77, P26, DOI 10.1016/j.mvr.2008.10.005; Chambers JW, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M111.223602; Chang TM, 2011, EVID-BASED COMPL ALT, V2011, DOI 10.1155/2011/213050; Chen BPC, 2007, J BIOL CHEM, V282, P6582, DOI 10.1074/jbc.M611605200; Cicchillitti L, 2003, J BIOL CHEM, V278, P19509, DOI 10.1074/jbc.M300511200; Corre I, 2013, INT J MOL SCI, V14, P22678, DOI 10.3390/ijms141122678; Cote MC, 2010, J BIOL CHEM, V285, P8013, DOI 10.1074/jbc.M109.098665; Coulthard LR, 2009, TRENDS MOL MED, V15, P369, DOI 10.1016/j.molmed.2009.06.005; Csiszar A, 2008, J APPL PHYSIOL, V105, P1333, DOI 10.1152/japplphysiol.90470.2008; Cuadrado A, 2007, EMBO J, V26, P2115, DOI 10.1038/sj.emboj.7601657; Cuenda A, 2007, BBA-MOL CELL RES, V1773, P1358, DOI 10.1016/j.bbamcr.2007.03.010; Davis AJ, 2014, DNA REPAIR, V17, P21, DOI 10.1016/j.dnarep.2014.02.020; Driessens N, 2009, ENDOCR-RELAT CANCER, V16, P845, DOI 10.1677/ERC-09-0020; Du YC, 2006, MOL CELL PROTEOMICS, V5, P1033, DOI 10.1074/mcp.M500327-MCP200; Falini B, 2005, NEW ENGL J MED, V352, P254, DOI 10.1056/NEJMoa041974; Falini B, 2009, LEUKEMIA, V23, P1731, DOI 10.1038/leu.2009.124; Fan L, 2005, CELL CYCLE, V4, P1616, DOI 10.4161/cc.4.11.2125; Garrett TA, 2007, EXP CELL RES, V313, P3285, DOI 10.1016/j.yexcr.2007.05.027; Grisendi S, 2006, NAT REV CANCER, V6, P493, DOI 10.1038/nrc1885; Guay J, 1997, J CELL SCI, V110, P357; Haendeler J, 2005, J BIOL CHEM, V280, P42945, DOI 10.1074/jbc.M506985200; Harrison D, 2003, AM J CARDIOL, V91, p7A; Hermann C, 1997, ARTERIOSCL THROM VAS, V17, P3588, DOI 10.1161/01.ATV.17.12.3588; Hiromura K, 2002, ONCOGENE, V21, P1750, DOI 10.1038/sj.onc.1205238; Hsu S, 2005, BIOCHEM BIOPH RES CO, V337, P401, DOI 10.1016/j.bbrc.2005.08.272; HUOT J, 1995, EUR J BIOCHEM, V227, P416, DOI 10.1111/j.1432-1033.1995.tb20404.x; Huot J, 1997, CIRC RES, V80, P383, DOI 10.1161/01.RES.80.3.383; Ishitsuka K, 2008, BRIT J HAEMATOL, V141, P598, DOI 10.1111/j.1365-2141.2008.07044.x; Iyama T, 2013, DNA REPAIR, V12, P620, DOI 10.1016/j.dnarep.2013.04.015; Javeshghani D, 2009, J AM SOC HYPERTENS, V3, P295, DOI 10.1016/j.jash.2009.07.002; Jung KJ, 2013, FREE RADICAL BIO MED, V61, P206, DOI 10.1016/j.freeradbiomed.2013.04.005; Khandelwal N, 2011, CELL DEATH DIFFER, V18, P1889, DOI 10.1038/cdd.2011.79; Kinumi T, 2005, FREE RADICAL RES, V39, P1335, DOI 10.1080/10715760500306695; Koike A, 2010, CANCER RES, V70, P6746, DOI 10.1158/0008-5472.CAN-10-0382; Kumar P, 2004, J BIOL CHEM, V279, P43352, DOI 10.1074/jbc.M405777200; Lee SY, 2005, BIOCHEM J, V388, P7, DOI 10.1042/BJ20042033; Lin CY, 2010, MOL BIOL CELL, V21, P4409, DOI 10.1091/mbc.E10-03-0239; Martin D, 2002, J BIOL CHEM, V277, P42943, DOI 10.1074/jbc.M201070200; Okuda M, 2000, CELL, V103, P127, DOI 10.1016/S0092-8674(00)00093-3; Okuwaki M, 2008, J BIOCHEM, V143, P441, DOI 10.1093/jb/mvm222; Papaharalambus CA, 2007, TRENDS CARDIOVAS MED, V17, P48, DOI 10.1016/j.tcm.2006.11.005; Paron I, 2004, BIOCHEM J, V378, P929, DOI 10.1042/BJ20031190; Peng YL, 2005, CANCER RES, V65, P1670, DOI 10.1158/0008-5472.CAN-04-3451; Poletto M, 2014, MOL BIOL CELL, V25, P1641, DOI 10.1091/mbc.E13-12-0717; Ramos-Echazabal G, 2012, J CELL BIOCHEM, V113, P2364, DOI 10.1002/jcb.24108; RAMSAMOOJ P, 1995, RADIAT RES, V143, P158, DOI 10.2307/3579152; Rao RK, 2002, BIOCHEM BIOPH RES CO, V293, P610, DOI 10.1016/S0006-291X(02)00268-1; Reboutier D, 2012, J CELL BIOL, V197, P19, DOI 10.1083/jcb.201107134; Ren Z, 2015, ONCOGENE, V34, P1650, DOI 10.1038/onc.2014.109; Sakamoto N, 2009, J CELL PHYSIOL, V220, P706, DOI 10.1002/jcp.21818; Sarek G, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000818; Schini-Kerth V, 2014, FREE RADICAL BIO MED, V75, pS11, DOI 10.1016/j.freeradbiomed.2014.10.858; Seal JB, 2005, ANN VASC SURG, V19, P572, DOI 10.1007/s10016-005-4616-7; Sekhar KR, 2014, INT J RADIAT ONCOL, V89, P1106, DOI 10.1016/j.ijrobp.2014.04.012; Sekhar KR, 2011, CLIN CANCER RES, V17, P6490, DOI 10.1158/1078-0432.CCR-11-1054; Sommer D, 2002, ARCH BIOCHEM BIOPHYS, V404, P271, DOI 10.1016/S0003-9861(02)00242-4; Stiff T, 2004, CANCER RES, V64, P2390, DOI 10.1158/0008-5472.CAN-03-3207; Stone JR, 2002, ENDOTHELIUM-J ENDOTH, V9, P231, DOI 10.1080/10623320214733; Tarapore P, 2006, FEBS LETT, V580, P399, DOI 10.1016/j.febslet.2005.12.022; Tokuyama Y, 2001, J BIOL CHEM, V276, P21529, DOI 10.1074/jbc.M100014200; Touyz RM, 2011, HYPERTENS RES, V34, P5, DOI 10.1038/hr.2010.201; Trempolec N, 2013, CELL, V152, P656, DOI [10.1016/j.cell.2013.01.029, 10.1016/j.cell.2013.01.047]; Vanderwaal RP, 2009, CANCER RES, V69, P6454, DOI 10.1158/0008-5472.CAN-08-4896; Velic D, 2015, BIOMOLECULES, V5, P3204, DOI 10.3390/biom5043204; Victor VM, 2009, CURR PHARM DESIGN, V15, P2988, DOI 10.2174/138161209789058093; Wang W, 2005, NAT CELL BIOL, V7, P823, DOI 10.1038/ncb1282; Wu MH, 2002, CARCINOGENESIS, V23, P93, DOI 10.1093/carcin/23.1.93; Yan L, 2012, BIOCHEM J, V444, P239, DOI 10.1042/BJ20111606; Yang C, 2002, NUCLEIC ACIDS RES, V30, P2251, DOI 10.1093/nar/30.10.2251; Zhan H, 2010, J BIOL CHEM, V285, P29662, DOI 10.1074/jbc.M110.125138; Zoughlami Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068477	75	15	15	1	8	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	AUG	2016	30	8					2899	+		10.1096/fj.201500194R	http://dx.doi.org/10.1096/fj.201500194R			20	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	DS7WP	27142525				2022-12-26	WOS:000380994000024
J	Rivera-de-Torre, E; Garcia-Linares, S; Alegre-Cebollada, J; Lacadena, J; Gavilanes, JG; Martinez-del-Pozo, A				Rivera-de-Torre, Esperanza; Garcia-Linares, Sara; Alegre-Cebollada, Jorge; Lacadena, Javier; Gavilanes, Jose G.; Martinez-del-Pozo, Alvaro			Synergistic Action of Actinoporin Isoforms from the Same Sea Anemone Species Assembled into Functionally Active Heteropores	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						erythrocyte; ion channel; lipid-protein interaction; oligomerization; protein cross-linking; toxin; equinatoxin; lysis; pore-forming-toxin; sticholysin	PORE-FORMING PROTEINS; CYTOLYSIN EQUINATOXIN-II; WATER-MEMBRANE INTERFACE; STICHOLYSIN-II; STICHODACTYLA-HELIANTHUS; LIPID-MEMBRANES; ACTINIA-EQUINA; MODEL MEMBRANES; RADIANTHUS-MACRODACTYLUS; 3-DIMENSIONAL STRUCTURE	Among the toxic polypeptides secreted in the venom of sea anemones, actinoporins are the pore-forming toxins whose toxic activity relies on the formation of oligomeric pores within biological membranes. Intriguingly, actinoporins appear as multigene families that give rise to many protein isoforms in the same individual displaying high sequence identities but large functional differences. However, the evolutionary advantage of producing such similar isotoxins is not fully understood. Here, using sticholysins I and II (StnI and StnII) from the sea anemone Stichodactyla helianthus, it is shown that actinoporin isoforms can potentiate each other's activity. Through hemolysis and calcein releasing assays, it is revealed that mixtures of StnI and StnII are more lytic than equivalent preparations of the corresponding isolated isoforms. It is then proposed that this synergy is due to the assembly of heteropores because (i) StnI and StnII can be chemically cross-linked at the membrane and (ii) the affinity of sticholysin mixtures for the membrane is increased with respect to any of them acting in isolation, as revealed by isothermal titration calorimetry experiments. These results help us understand the multigene nature of actinoporins and may be extended to other families of toxins that require oligomerization to exert toxicity.	[Rivera-de-Torre, Esperanza; Garcia-Linares, Sara; Lacadena, Javier; Gavilanes, Jose G.; Martinez-del-Pozo, Alvaro] Univ Complutense, Dept Bioquim & Biol Mol 1, Fac Quim & Biol, E-28040 Madrid, Spain; [Alegre-Cebollada, Jorge] Ctr Nacl Invest Cardiovasc Carlos III, Madrid 28029, Spain	Complutense University of Madrid; Centro Nacional de Investigaciones Cardiovasculares (CNIC)	Gavilanes, JG; Martinez-del-Pozo, A (corresponding author), Univ Complutense, Dept Bioquim & Biol Mol 1, Fac Quim & Biol, E-28040 Madrid, Spain.	ppgf@bbm1.ucm.es; alvaromp@quim.ucm.es	Martinez-del-Pozo, Alvaro/L-8556-2014; de Torre, Esperanza Rivera/I-3832-2016; Alegre-Cebollada, Jorge/I-4301-2014; Linares, Sara García/I-4290-2016	Martinez-del-Pozo, Alvaro/0000-0003-0043-5939; de Torre, Esperanza Rivera/0000-0002-0272-6150; Alegre-Cebollada, Jorge/0000-0003-0542-0170; Linares, Sara García/0000-0003-4983-5730	Spanish Ministerio de Ciencia e Innovacion [BFU2012-32404]; Formacion de Personal Universitario fellowship; Universidad Complutense de Madrid collaboration fellowship; Ramon y Cajal Award [RYC-2014-16604]	Spanish Ministerio de Ciencia e Innovacion(Ministry of Science and Innovation, Spain (MICINN)Instituto de Salud Carlos IIISpanish Government); Formacion de Personal Universitario fellowship; Universidad Complutense de Madrid collaboration fellowship; Ramon y Cajal Award(Spanish Government)	This work was supported by Grant BFU2012-32404 from the Spanish Ministerio de Ciencia e Innovacion (to A. M. P.), a Formacion de Personal Universitario fellowship (to S. G. L.), a Universidad Complutense de Madrid collaboration fellowship (to E. R. T.), and Ramon y Cajal Award RYC-2014-16604) (to J. A. C.). The authors declare that they have no conflicts of interest with the contents of this article.	Alegre-Cebollada J, 2007, CURR PROTEIN PEPT SC, V8, P558, DOI 10.2174/138920307783018686; Alegre-Cebollada J, 2006, FEBS J, V273, P863, DOI 10.1111/j.1742-4658.2006.05122.x; Alegre-Cebollada J, 2004, FEBS LETT, V575, P14, DOI 10.1016/j.febslet.2004.08.031; Alegre-Cebollada J, 2008, J MOL BIOL, V382, P920, DOI 10.1016/j.jmb.2008.07.053; Alegre-Cebollada J, 2007, BIOPHYS J, V93, P3191, DOI 10.1529/biophysj.106.102566; Alegre-Cebollada J, 2007, J BIOTECHNOL, V127, P211, DOI 10.1016/j.jbiotec.2006.07.006; Alm I, 2015, BBA-BIOMEMBRANES, V1848, P925, DOI 10.1016/j.bbamem.2014.12.017; Alvarez C, 2009, TOXICON, V54, P1135, DOI 10.1016/j.toxicon.2009.02.022; Anderluh G, 2003, J BIOL CHEM, V278, P45216, DOI 10.1074/jbc.M305916200; Anderluh G, 1999, TOXICON, V37, P1391, DOI 10.1016/S0041-0101(99)00082-3; Anderluh G, 1999, EUR J BIOCHEM, V263, P128, DOI 10.1046/j.1432-1327.1999.00477.x; Anderluh G, 2002, TOXICON, V40, P111, DOI 10.1016/S0041-0101(01)00191-X; Athanasiadis A, 2001, STRUCTURE, V9, P341, DOI 10.1016/S0969-2126(01)00592-5; Baker MAB, 2014, CHEMBIOCHEM, V15, P2139, DOI 10.1002/cbic.201300799; Bakrac B, 2010, ADV EXP MED BIOL, V677, P106; Barlic A, 2004, J BIOL CHEM, V279, P34209, DOI 10.1074/jbc.M313817200; BARTLETT GR, 1959, J BIOL CHEM, V234, P469; Bellomio A, 2009, TOXICON, V54, P869, DOI 10.1016/j.toxicon.2009.06.022; BELMONTE G, 1993, J MEMBRANE BIOL, V131, P11, DOI 10.1007/BF02258530; Bischofberger M, 2012, CELL HOST MICROBE, V12, P266, DOI 10.1016/j.chom.2012.08.005; Brinkman DL, 2014, J BIOL CHEM, V289, P4798, DOI 10.1074/jbc.M113.534149; Caaveiro JMM, 2001, BIOPHYS J, V80, P1343, DOI 10.1016/S0006-3495(01)76107-3; Castrillo I, 2010, PROTEINS, V78, P1959, DOI 10.1002/prot.22712; Cosentino K, 2016, BBA-BIOMEMBRANES, V1858, P457, DOI 10.1016/j.bbamem.2015.09.013; De los Rios V, 1998, EUR J BIOCHEM, V252, P284, DOI 10.1046/j.1432-1327.1998.2520284.x; de los Rios V, 2000, PROTEIN EXPRES PURIF, V18, P71, DOI 10.1006/prep.1999.1174; de los Rios V, 1999, FEBS LETT, V455, P27, DOI 10.1016/S0014-5793(99)00846-7; del Monte-Martinez A, 2014, PROTEIN EXPRES PURIF, V95, P57, DOI 10.1016/j.pep.2013.11.016; Dewson G, 2016, EMBO J, V35, P371, DOI 10.15252/embj.201593723; Garcia-Linares S, 2015, MAR DRUGS, V13, P1647, DOI 10.3390/md13041647; Garcia-Linares S, 2014, FEBS J, V281, P1465, DOI 10.1111/febs.12717; Garcia-Linares S, 2013, ARCH BIOCHEM BIOPHYS, V532, P39, DOI 10.1016/j.abb.2013.01.005; Garcia-Ortega L, 2011, BBA-BIOMEMBRANES, V1808, P2275, DOI 10.1016/j.bbamem.2011.05.012; Gilbert RJC, 2014, TRENDS BIOCHEM SCI, V39, P510, DOI 10.1016/j.tibs.2014.09.002; Gonzalez MR, 2008, CELL MOL LIFE SCI, V65, P493, DOI 10.1007/s00018-007-7434-y; Gouaux E, 1997, CURR OPIN STRUC BIOL, V7, P566, DOI 10.1016/S0959-440X(97)80123-6; Hinds MG, 2002, J MOL BIOL, V315, P1219, DOI 10.1006/jmbi.2001.5321; Hu B, 2011, INT J BIOL SCI, V7, P729, DOI 10.7150/ijbs.7.729; Iacovache I, 2008, BBA-BIOMEMBRANES, V1778, P1611, DOI 10.1016/j.bbamem.2008.01.026; Kristan KC, 2009, TOXICON, V54, P1125, DOI 10.1016/j.toxicon.2009.02.026; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Leichenko EV, 2014, ACTA NATURAE, V6, P89, DOI 10.32607/20758251-2014-6-4-89-98; MACEK P, 1994, TOXICOLOGY, V87, P205, DOI 10.1016/0300-483X(94)90252-6; MACEK P, 1992, FEMS MICROBIOL IMMUN, V105, P121, DOI 10.1016/0378-1097(92)90082-Y; Mancheno JM, 2003, STRUCTURE, V11, P1319, DOI 10.1016/j.str.2003.09.019; Marchioretto M, 2013, BIOPHYS CHEM, V182, P64, DOI 10.1016/j.bpc.2013.06.015; Martin-Benito J, 2000, BIOPHYS J, V78, P3186, DOI 10.1016/S0006-3495(00)76855-X; Martinez D, 2002, TOXICON, V40, P1219, DOI 10.1016/S0041-0101(02)00101-0; Martinez D, 2001, TOXICON, V39, P1547, DOI 10.1016/S0041-0101(01)00127-1; Martinez D, 2007, TOXICON, V49, P68, DOI 10.1016/j.toxicon.2006.09.019; Martinez-Ruiz A, 2001, METHODS ENZYMOL, V341, P335, DOI 10.1016/S0076-6879(01)41162-1; Maula T, 2013, BBA-BIOMEMBRANES, V1828, P1390, DOI 10.1016/j.bbamem.2013.01.018; Mechaly AE, 2011, STRUCTURE, V19, P181, DOI 10.1016/j.str.2010.11.013; Menestrina G, 1999, BIOCHEM BIOPH RES CO, V254, P174, DOI 10.1006/bbrc.1998.9898; Monastyrnaya M, 2010, TOXICON, V56, P1299, DOI 10.1016/j.toxicon.2010.07.011; Monastyrnaya MM, 2002, TOXICON, V40, P1197, DOI 10.1016/S0041-0101(02)00139-3; Morante K, 2015, FEBS LETT, V589, P1840, DOI 10.1016/j.febslet.2015.06.012; OLIVERA BM, 1990, SCIENCE, V249, P257, DOI 10.1126/science.2165278; Onaderra M, 1998, MOL MEMBR BIOL, V15, P141, DOI 10.3109/09687689809074525; Pardo-Cea MA, 2011, FEBS J, V278, P2080, DOI 10.1111/j.1742-4658.2011.08123.x; Parker MW, 2005, PROG BIOPHYS MOL BIO, V88, P91, DOI 10.1016/j.pbiomolbio.2004.01.009; Pazos IF, 2003, TOXICON, V42, P571, DOI 10.1016/S0041-0101(03)00227-7; Pedrera L, 2015, LANGMUIR, V31, P9911, DOI 10.1021/acs.langmuir.5b01687; Rojko N, 2014, BIOPHYS J, V106, P1630, DOI 10.1016/j.bpj.2013.11.4507; Rojko N, 2016, BBA-BIOMEMBRANES, V1858, P446, DOI 10.1016/j.bbamem.2015.09.007; Rojko N, 2013, J BIOL CHEM, V288, P23704, DOI 10.1074/jbc.M113.481572; Ros U, 2015, BIOCHIMIE, V116, P70, DOI 10.1016/j.biochi.2015.06.024; Ros U, 2015, J MEMBRANE BIOL, V248, P545, DOI 10.1007/s00232-015-9820-y; Ros U, 2011, J BIOSCIENCES, V36, P781, DOI 10.1007/s12038-011-9156-4; SHIN ML, 1979, BIOCHIM BIOPHYS ACTA, V555, P79, DOI 10.1016/0005-2736(79)90073-7; Subburaj Y, 2015, J BIOL CHEM, V290, P4856, DOI 10.1074/jbc.M114.600676; Tanaka K, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7337; Tejuca M, 1996, BIOCHEMISTRY-US, V35, P14947, DOI 10.1021/bi960787z; TURK T, 1991, J TOXICOL-TOXIN REV, V10, P223, DOI 10.3109/15569549109053857; Uechi G, 2010, TOXICON, V56, P1470, DOI 10.1016/j.toxicon.2010.09.002; Valcarcel CA, 2001, BIOPHYS J, V80, P2761, DOI 10.1016/S0006-3495(01)76244-3; Valle A, 2015, TOXICON, V103, P176, DOI 10.1016/j.toxicon.2015.06.028; Wacklin HP, 2016, BBA-BIOMEMBRANES, V1858, P640, DOI 10.1016/j.bbamem.2015.12.019; Wang YW, 2008, TOXICON, V51, P1374, DOI 10.1016/j.toxicon.2008.03.005; Wong ESW, 2012, GENE, V496, P1, DOI 10.1016/j.gene.2012.01.009	80	20	20	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 1	2016	291	27					14109	14119		10.1074/jbc.M115.710491	http://dx.doi.org/10.1074/jbc.M115.710491			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DR5XG	27129251	hybrid, Green Accepted, Green Published			2022-12-26	WOS:000379975100019
J	Sabourin, J; Bartoli, F; Antigny, F; Gomez, AM; Benitah, JP				Sabourin, Jessica; Bartoli, Fiona; Antigny, Fabrice; Gomez, Ana Maria; Benitah, Jean-Pierre			Transient Receptor Potential Canonical (TRPC)/Orai1-dependent Store-operated Ca2+ Channels NEW TARGETS OF ALDOSTERONE IN CARDIOMYOCYTES	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							STROMAL INTERACTION MOLECULE-1; PATHOLOGICAL CARDIAC-HYPERTROPHY; SMOOTH-MUSCLE-CELLS; TRPC CHANNELS; MINERALOCORTICOID RECEPTOR; HEART-FAILURE; MYOCARDIAL-INFARCTION; VENTRICULAR MYOCYTES; RYANODINE RECEPTOR; CALCIUM-CHANNELS	Store-operated Ca2+ entry (SOCE) has emerged as an important mechanism in cardiac pathology. However, the signals that up-regulate SOCE in the heart remain unexplored. Clinical trials have emphasized the beneficial role of mineralocorticoid receptor (MR) signaling blockade in heart failure and associated arrhythmias. Accumulated evidence suggests that the mineralocorticoid hormone aldosterone, through activation of its receptor, MR, might be a key regulator of Ca2+ influx in cardiomyocytes. We thus assessed whether and how SOCE involving transient receptor potential canonical (TRPC) and Orai1 channels are regulated by aldosterone/MR in neonatal rat ventricular cardiomyocytes. Molecular screening using qRT-PCR and Western blotting demonstrated that aldosterone treatment for 24 h specifically increased the mRNA and/or protein levels of Orai1, TRPC1, -C4, -C5, and stromal interaction molecule 1 through MR activation. These effects were correlated with a specific enhancement of SOCE activities sensitive to store-operated channel inhibitors (SKF-96365 and BTP2) and to a potent Orai1 blocker (S66) and were prevented by TRPC1, -C4, and Orai1 dominant negative mutants or TRPC5 siRNA. A mechanistic approach showed that up-regulation of serum-and glucocorticoid-regulated kinase 1 mRNA expression by aldosterone is involved in enhanced SOCE. Functionally, 24-h aldosterone-enhanced SOCE is associated with increased diastolic [Ca2+](i), which is blunted by store-operated channel inhibitors. Our study provides the first evidence that aldosterone promotes TRPC1-, -C4-, -C5-, and Orai1-mediated SOCE in cardiomyocytes through an MR and serum-and glucocorticoid-regulated kinase 1 pathway.	[Sabourin, Jessica; Bartoli, Fiona; Gomez, Ana Maria; Benitah, Jean-Pierre] Univ Paris Saclay, Univ Paris 11, INSERM, UMR S1180, F-92296 Chatenay Malabry, France; [Antigny, Fabrice] Univ Paris Saclay, Univ Paris 11, INSERM, UMR S999,Ctr Chirurg Marie Lannelongue, F-92350 Le Plessis Robinson, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay; Hopital Marie Lannelongue; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay	Sabourin, J (corresponding author), Univ Paris Saclay, Univ Paris 11, INSERM, UMR S1180, F-92296 Chatenay Malabry, France.	jessica.sabourin@u-psud.fr	Antigny, Fabrice/Q-3999-2018; Gomez, Ana M./B-5376-2013; Benitah, Jean-Pierre/L-6060-2018	Antigny, Fabrice/0000-0002-9515-6571; Gomez, Ana M./0000-0003-0009-2884; Benitah, Jean-Pierre/0000-0002-9866-9081; Bartoli, Fiona/0000-0001-9487-9551; Sabourin, Jessica/0000-0002-2980-8455	European Section of Aldosterone Council France; University of Paris Sud; Agence Nationale de la Recherche [ANR-13-BSV1-0023-01, ANR-15-CE14-0005]; Cardiovasculaire-Obesite-Rein-Diabete (CORDDIM) (Region Ile de France)	European Section of Aldosterone Council France; University of Paris Sud; Agence Nationale de la Recherche(French National Research Agency (ANR)); Cardiovasculaire-Obesite-Rein-Diabete (CORDDIM) (Region Ile de France)(Region Ile-de-France)	This work was supported by European Section of Aldosterone Council France, Attractivity Grant 2014 from University of Paris Sud, Agence Nationale de la Recherche Grants ANR-13-BSV1-0023-01 and ANR-15-CE14-0005, and Cardiovasculaire-Obesite-Rein-Diabete (CORDDIM) (Region Ile de France). The authors declare that they have no conflicts of interest with the contents of this article.	Ambudkar IS, 2007, CELL CALCIUM, V42, P213, DOI 10.1016/j.ceca.2007.01.013; Aoyama T, 2005, CIRCULATION, V111, P1652, DOI 10.1161/01.CIR.0000160352.58142.06; Bae YM, 2007, J HYPERTENS, V25, P809, DOI 10.1097/HJH.0b013e3280148312; Benard L, 2016, CIRCULATION, V133, P1458, DOI 10.1161/CIRCULATIONAHA.115.020678; Benitah JP, 2001, J PHYSIOL-LONDON, V537, P151, DOI 10.1111/j.1469-7793.2001.0151k.x; Benitah JP, 1999, CIRC RES, V85, P1139; Berna-Erro A, 2012, ADV EXP MED BIOL, V740, P349, DOI 10.1007/978-94-007-2888-2_15; Borst O, 2012, BLOOD, V119, P251, DOI 10.1182/blood-2011-06-359976; Bush EW, 2006, J BIOL CHEM, V281, P33487, DOI 10.1074/jbc.M605536200; Cheng KT, 2008, J BIOL CHEM, V283, P12935, DOI 10.1074/jbc.C800008200; Cheng KT, 2013, CURR TOP MEMBR, V71, P149, DOI 10.1016/B978-0-12-407870-3.00007-X; Cioffi DL, 2012, CIRC RES, V110, P1435, DOI 10.1161/CIRCRESAHA.112.269506; Collins HE, 2013, AM J PHYSIOL-HEART C, V305, pH446, DOI 10.1152/ajpheart.00104.2013; Correll RN, 2015, J MOL CELL CARDIOL, V87, P38, DOI 10.1016/j.yjmcc.2015.07.032; Das S, 2012, CIRCULATION, V126, P2208, DOI 10.1161/CIRCULATIONAHA.112.115592; DeHaven WI, 2009, J PHYSIOL-LONDON, V587, P2275, DOI 10.1113/jphysiol.2009.170431; Doleschal B, 2015, CARDIOVASC RES, V106, P163, DOI 10.1093/cvr/cvv022; Dominguez-Rodriguez A, 2015, J MOL CELL CARDIOL, V87, P74, DOI 10.1016/j.yjmcc.2015.07.002; Ferron L, 2011, CARDIOVASC RES, V90, P105, DOI 10.1093/cvr/cvq379; Feske S, 2009, IMMUNOL REV, V231, P189, DOI 10.1111/j.1600-065X.2009.00818.x; Gomez AM, 2013, CURR VASC PHARMACOL, V11, P497, DOI 10.2174/1570161111311040013; Gomez AM, 2009, CIRCULATION, V119, P2179, DOI 10.1161/CIRCULATIONAHA.108.805804; Greka A, 2003, NAT NEUROSCI, V6, P837, DOI 10.1038/nn1092; GRYNKIEWICZ G, 1985, J BIOL CHEM, V260, P3440; He BJ, 2011, NAT MED, V17, P1610, DOI 10.1038/nm.2506; Hirose M, 2011, CIRC J, V75, P2333, DOI 10.1253/circj.CJ-10-1213; Hu GQ, 2009, MOL ENDOCRINOL, V23, P689, DOI 10.1210/me.2008-0350; Huang GN, 2006, NAT CELL BIOL, V8, P1003, DOI 10.1038/ncb1454; Huang JB, 2006, AM J PHYSIOL-CELL PH, V290, pC1572, DOI 10.1152/ajpcell.00226.2005; Hulot JS, 2011, CIRCULATION, V124, P796, DOI 10.1161/CIRCULATIONAHA.111.031229; Imai S, 2003, LIFE SCI, V72, P2199, DOI 10.1016/S0024-3205(03)00092-4; Kim MS, 2009, J BIOL CHEM, V284, P9733, DOI 10.1074/jbc.M808097200; Kojima A, 2012, BRIT J ANAESTH, V109, P352, DOI 10.1093/bja/aes212; Kuwahara K, 2006, J CLIN INVEST, V116, P3114, DOI 10.1172/JCI27702; Lang F, 2013, THROMB HAEMOSTASIS, V110, P925, DOI 10.1160/TH13-02-0176; Lee KP, 2014, J BIOL CHEM, V289, P6372, DOI 10.1074/jbc.M113.546556; Li J, 2011, BRIT J PHARMACOL, V164, P382, DOI 10.1111/j.1476-5381.2011.01368.x; Liou J, 2007, P NATL ACAD SCI USA, V104, P9301, DOI 10.1073/pnas.0702866104; Londono JEC, 2015, EUR HEART J, V36, P2257, DOI 10.1093/eurheartj/ehv250; Luo X, 2012, J MOL CELL CARDIOL, V52, P136, DOI 10.1016/j.yjmcc.2011.11.003; Ma HT, 2008, J IMMUNOL, V180, P2233, DOI 10.4049/jimmunol.180.4.2233; Makarewich CA, 2014, CIRC RES, V115, P567, DOI 10.1161/CIRCRESAHA.115.303831; Messaoudi S, 2013, HYPERTENSION, V61, P361, DOI 10.1161/HYPERTENSIONAHA.112.198986; Messaoudi S, 2012, MOL CELL ENDOCRINOL, V350, P266, DOI 10.1016/j.mce.2011.06.038; Nakayama H, 2006, FASEB J, V20, P1660, DOI 10.1096/fj.05-5560com; Nilius B, 2014, PHARMACOL REV, V66, P676, DOI 10.1124/pr.113.008268; Ohba T, 2007, J MOL CELL CARDIOL, V42, P498, DOI 10.1016/j.yjmcc.2006.10.020; Ong HL, 2007, J BIOL CHEM, V282, P9105, DOI 10.1074/jbc.M608942200; Onohara N, 2006, EMBO J, V25, P5305, DOI 10.1038/sj.emboj.7601417; Ouvrard-Pascaud A, 2005, CIRCULATION, V111, P3025, DOI 10.1161/CIRCULATIONAHA.104.503706; Perrier E, 2004, CIRCULATION, V110, P776, DOI 10.1161/01.CIR.0000138973.55605.38; Perrier R, 2005, J PHYSIOL-LONDON, V569, P153, DOI 10.1113/jphysiol.2005.092692; Poteser M, 2008, FEBS LETT, V582, P2696, DOI 10.1016/j.febslet.2008.06.049; Prakriya M, 2006, NATURE, V443, P230, DOI 10.1038/nature05122; Sabourin J, 2012, J BIOL CHEM, V287, P26688, DOI 10.1074/jbc.M112.378588; Sabourin J, 2011, CARDIOVASC RES, V92, P226, DOI 10.1093/cvr/cvr167; Satoh S, 2007, MOL CELL BIOCHEM, V294, P205, DOI 10.1007/s11010-006-9261-0; Shigaev A, 2000, AM J PHYSIOL-RENAL, V278, pF613, DOI 10.1152/ajprenal.2000.278.4.F613; Sundivakkam PC, 2012, MOL PHARMACOL, V81, P510, DOI 10.1124/mol.111.074658; Takeda Y, 2002, CIRCULATION, V105, P677, DOI 10.1161/hc0602.104675; Taruno A, 2008, AM J PHYSIOL-RENAL, V294, pF177, DOI 10.1152/ajprenal.00250.2007; Thompson JL, 2013, CURR TOP MEMBR, V71, P125, DOI 10.1016/B978-0-12-407870-3.00006-8; Touchberry CD, 2011, BIOCHEM BIOPH RES CO, V416, P45, DOI 10.1016/j.bbrc.2011.10.133; Uehara A, 2002, CELL CALCIUM, V31, P89, DOI 10.1054/ceca.2001.0257; Volkers M, 2012, J CELL SCI, V125, P287, DOI 10.1242/jcs.090464; Voelkers M, 2010, J MOL CELL CARDIOL, V48, P1329, DOI 10.1016/j.yjmcc.2010.01.020; Wang PP, 2012, EUR J PHARMACOL, V681, P60, DOI 10.1016/j.ejphar.2012.01.045; Watanabe H, 2009, CIRC J, V73, P419, DOI 10.1253/circj.CJ-08-1153; Wolkowicz PE, 2011, EUR J PHARMACOL, V668, P208, DOI 10.1016/j.ejphar.2011.06.025; Wu X, 2010, P NATL ACAD SCI USA, V107, P7000, DOI 10.1073/pnas.1001825107; Yuan JP, 2007, NAT CELL BIOL, V9, P636, DOI 10.1038/ncb1590; Zeng WZ, 2008, MOL CELL, V32, P439, DOI 10.1016/j.molcel.2008.09.020; Zhang BB, 2016, BIOCHEM BIOPH RES CO, V470, P384, DOI 10.1016/j.bbrc.2016.01.034; Zhang YH, 2013, PFLUG ARCH EUR J PHY, V465, P1439, DOI 10.1007/s00424-013-1291-3; Zhou R, 2011, CELL PHYSIOL BIOCHEM, V27, P299, DOI 10.1159/000327956	75	52	54	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 17	2016	291	25					13394	13409		10.1074/jbc.M115.693911	http://dx.doi.org/10.1074/jbc.M115.693911			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DR2YT	27129253	Green Published, hybrid			2022-12-26	WOS:000379770500039
J	Chaplin, AK; Wilson, MT; Hough, MA; Svistunenko, DA; Hemsworth, GR; Walton, PH; Vijgenboom, E; Worrall, JAR				Chaplin, Amanda K.; Wilson, Michael T.; Hough, Michael A.; Svistunenko, Dimitri A.; Hemsworth, Glyn R.; Walton, Paul H.; Vijgenboom, Erik; Worrall, Jonathan A. R.			Heterogeneity in the Histidine-brace Copper Coordination Sphere in Auxiliary Activity Family 10 (AA10) Lytic Polysaccharide Monooxygenases	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							STREPTOMYCES-LIVIDANS; CELLULOSE DEGRADATION; CELLOBIOSE DEHYDROGENASE; STRUCTURAL BASIS; PROTEIN; BIOMASS; INSIGHTS; CLEAVAGE; CHITIN; MORPHOGENESIS	Copper-dependent lytic polysaccharide monooxygenases (LPMOs) are enzymes that oxidatively deconstruct polysaccharides. The active site copper in LPMOs is coordinated by a histidine-brace. This utilizes the amino group and side chain of the N-terminal His residue with the side chain of a second His residue to create a T-shaped arrangement of nitrogen ligands. We report a structural, kinetic, and thermodynamic appraisal of copper binding to the histidine-brace in an auxiliary activity family 10 (AA10) LPMO from Streptomyces lividans (SliLPMO10E). Unexpectedly, we discovered the existence of two apo-SliLPMO10E species in solution that can each bind copper at a single site with distinct kinetic and thermodynamic (exothermic and endothermic) properties. The experimental EPR spectrum of copper-bound SliLPMO10E requires the simulation of two different line shapes, implying two different copper-bound species, indicative of three and two nitrogen ligands coordinating the copper. Amino group coordination was probed through the creation of an N-terminal extension variant (SliLPMO10E-Ext). The kinetics and thermodynamics of copper binding to SliLPMO10E-Ext are in accord with copper binding to one of the apo-forms in the wild-type protein, suggesting that amino group coordination is absent in the two-nitrogen coordinate form of SliLPMO10E. Copper binding to SliLPMO10B was also investigated, and again it revealed the presence of two apo-forms with kinetics and stoichiometry of copper binding identical to that of SliLPMO10E. Our findings highlight that heterogeneity exists in the active site copper coordination sphere of LPMOs that may have implications for the mechanism of loading copper in the cell.	[Chaplin, Amanda K.; Wilson, Michael T.; Hough, Michael A.; Svistunenko, Dimitri A.; Worrall, Jonathan A. R.] Univ Essex, Sch Biol Sci, Wivenhoe Pk, Colchester CO4 3SQ, Essex, England; [Hemsworth, Glyn R.; Walton, Paul H.] Univ York, Dept Chem, York YO10 5DD, N Yorkshire, England; [Vijgenboom, Erik] Leiden Univ, Sylvius Lab, Inst Biol, Mol Biotechnol, POB 9505, NL-2300 RA Leiden, Netherlands	University of Essex; University of York - UK; Leiden University; Leiden University - Excl LUMC	Worrall, JAR (corresponding author), Univ Essex, Sch Biol Sci, Wivenhoe Pk, Colchester CO4 3SQ, Essex, England.	jworrall@essex.ac.uk	Hemsworth, Glyn/AAS-5473-2021	Hemsworth, Glyn/0000-0002-8226-1380; Walton, Paul/0000-0002-1152-1480; Svistunenko, Dimitri/0000-0001-8060-2738; Chaplin, Amanda/0000-0002-9606-8346; Vijgenboom, Erik/0000-0002-5059-069X; Hough, Michael/0000-0001-7377-6713	University of Essex Silberrad Ph.D. scholarship	University of Essex Silberrad Ph.D. scholarship	Recipient of a University of Essex Silberrad Ph.D. scholarship.	Agger JW, 2014, P NATL ACAD SCI USA, V111, P6287, DOI 10.1073/pnas.1323629111; Anne J, 2012, J BIOTECHNOL, V158, P159, DOI 10.1016/j.jbiotec.2011.06.028; Banci L, 2006, NAT CHEM BIOL, V2, P367, DOI 10.1038/nchembio797; Beeson WT, 2015, ANNU REV BIOCHEM, V84, P923, DOI 10.1146/annurev-biochem-060614-034439; Beeson WT, 2012, J AM CHEM SOC, V134, P890, DOI 10.1021/ja210657t; Blundell KLIM, 2014, BIOCHEM J, V459, P525, DOI 10.1042/BJ20140017; Blundell KLIM, 2013, OPEN BIOL, V3, DOI 10.1098/rsob.120163; Cantarel BL, 2009, NUCLEIC ACIDS RES, V37, pD233, DOI 10.1093/nar/gkn663; Chaplin AK, 2015, BIOCHEM J, V469, P433, DOI 10.1042/BJ20150190; CRAWFORD DL, 1978, APPL ENVIRON MICROB, V35, P1041, DOI 10.1128/AEM.35.6.1041-1045.1978; Cruz-Morales P, 2013, GENOME BIOL EVOL, V5, P1165, DOI 10.1093/gbe/evt082; Davis IW, 2007, NUCLEIC ACIDS RES, V35, pW375, DOI 10.1093/nar/gkm216; Dwarakanath S, 2012, J BIOL CHEM, V287, P17833, DOI 10.1074/jbc.M112.352740; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Evans PR, 2013, ACTA CRYSTALLOGR D, V69, P1204, DOI 10.1107/S0907444913000061; Forsberg Z, 2014, P NATL ACAD SCI USA, V111, P8446, DOI 10.1073/pnas.1402771111; Forsberg Z, 2014, BIOCHEMISTRY-US, V53, P1647, DOI 10.1021/bi5000433; Forsberg Z, 2011, PROTEIN SCI, V20, P1479, DOI 10.1002/pro.689; Frandsen KEH, 2016, NAT CHEM BIOL, V12, P298, DOI [10.1038/NCHEMBIO.2029, 10.1038/nchembio.2029]; Gasteiger E, 2003, NUCLEIC ACIDS RES, V31, P3784, DOI 10.1093/nar/gkg563; GOODFELLOW M, 1983, ANNU REV MICROBIOL, V37, P189, DOI 10.1146/annurev.mi.37.100183.001201; Harris PV, 2010, BIOCHEMISTRY-US, V49, P3305, DOI 10.1021/bi100009p; Hemsworth GR, 2015, TRENDS BIOTECHNOL, V33, P747, DOI 10.1016/j.tibtech.2015.09.006; Hemsworth GR, 2014, NAT CHEM BIOL, V10, P122, DOI 10.1038/nchembio.1417; Hemsworth GR, 2013, CURR OPIN STRUC BIOL, V23, P660, DOI 10.1016/j.sbi.2013.05.006; Hemsworth GR, 2013, J AM CHEM SOC, V135, P6069, DOI 10.1021/ja402106e; Isaksen T, 2014, J BIOL CHEM, V289, P2632, DOI 10.1074/jbc.M113.530196; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Kim S, 2014, P NATL ACAD SCI USA, V111, P149, DOI 10.1073/pnas.1316609111; Langer G, 2008, NAT PROTOC, V3, P1171, DOI 10.1038/nprot.2008.91; Li X, 2012, STRUCTURE, V20, P1051, DOI 10.1016/j.str.2012.04.002; Liman R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054112; Lo Leggio L, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms6961; Lombard V, 2014, NUCLEIC ACIDS RES, V42, pD490, DOI 10.1093/nar/gkt1178; Long F, 2008, ACTA CRYSTALLOGR D, V64, P125, DOI 10.1107/S0907444907050172; MCCARTHY AJ, 1992, GENE, V115, P189, DOI 10.1016/0378-1119(92)90558-7; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Muller G, 2015, BIOTECHNOL BIOFUELS, V8, DOI 10.1186/s13068-015-0376-y; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Nakagawa YS, 2015, FEBS J, V282, P1065, DOI 10.1111/febs.13203; Nielsen J, 1996, TRENDS BIOTECHNOL, V14, P438, DOI 10.1016/0167-7799(96)10055-X; PEISACH J, 1974, ARCH BIOCHEM BIOPHYS, V165, P691, DOI 10.1016/0003-9861(74)90298-7; Petrus MLC, 2016, OPEN BIOL, V6, DOI 10.1098/rsob.150149; Phillips CM, 2011, ACS CHEM BIOL, V6, P1399, DOI 10.1021/cb200351y; Quinlan RJ, 2011, P NATL ACAD SCI USA, V108, P15079, DOI 10.1073/pnas.1105776108; Romling U, 2002, RES MICROBIOL, V153, P205, DOI 10.1016/S0923-2508(02)01316-5; ROSS P, 1991, MICROBIOL REV, V55, P35, DOI 10.1128/MMBR.55.1.35-58.1991; Svistunenko DA, 2004, BIOPHYS J, V87, P582, DOI 10.1529/biophysj.104.041046; Takasuka TE, 2013, SCI REP-UK, V3, DOI 10.1038/srep01030; Tan TC, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8542; Vaaje-Kolstad G, 2005, J BIOL CHEM, V280, P11313, DOI 10.1074/jbc.M407175200; Vaaje-Kolstad G, 2012, J MOL BIOL, V416, P239, DOI 10.1016/j.jmb.2011.12.033; Vaaje-Kolstad G, 2010, SCIENCE, V330, P219, DOI 10.1126/science.1192231; van Dissel D, 2015, MICROB CELL FACT, V14, DOI 10.1186/s12934-015-0224-6; van Dissel D, 2014, ADV APPL MICROBIOL, V89, P1, DOI 10.1016/B978-0-12-800259-9.00001-9; van Veluw GJ, 2012, APPL MICROBIOL BIOT, V96, P1301, DOI 10.1007/s00253-012-4490-5; Vrancken K, 2009, FUTURE MICROBIOL, V4, P181, DOI 10.2217/17460913.4.2.181; Vu VV, 2014, J AM CHEM SOC, V136, P562, DOI 10.1021/ja409384b; Westereng B, 2015, SCI REP-UK, V5, DOI 10.1038/srep18561; Winter G, 2010, J APPL CRYSTALLOGR, V43, P186, DOI 10.1107/S0021889809045701; Wong E, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002373; Xu HB, 2008, J BACTERIOL, V190, P4971, DOI 10.1128/JB.01849-07	62	33	33	1	64	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 10	2016	291	24					12838	12850		10.1074/jbc.M116.722447	http://dx.doi.org/10.1074/jbc.M116.722447			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DO9PV	27129229	Green Accepted, Green Published, hybrid			2022-12-26	WOS:000378119900034
J	Jia, J; Gao, KQ				Jia, Jia; Gao, Ke-Qin			A New Basal Salamandroid (Amphibia, Urodela) from the Late Jurassic of Qinglong, Hebei Province, China	PLOS ONE			English	Article							40AR/39AR AGE CONSTRAINTS; MOUTH CAVITY; VERTEBRAL COLUMN; INNER-MONGOLIA; CRANIAL NERVES; DAOHUGOU BIOTA; UPPER JAW; CAUDATA; TEETH; EVOLUTION	A new salamandroid salamander, Qinglongtriton gangouensis (gen. et sp. nov.), is named and described based on 46 fossil specimens of juveniles and adults collected from the Upper Jurassic (Oxfordian) Tiaojishan Formation cropping out in Hebei Province, China. The new salamander displays several ontogenetically and taxonomically significant features, most prominently the presence of a toothed palatine, toothed coronoid, and a unique pattern of the hyobranchium in adults. Comparative study of the new salamander with previously known fossil and extant salamandroids sheds new light on the early evolution of the Salamandroidea, the most species-diverse clade in the Urodela. Cladistic analysis places the new salamander as the sister taxon to Beiyanerpeton, and the two taxa together form the basalmost clade within the Salamandroidea. Along with recently reported Beiyanerpeton from the same geological formation in the neighboring Liaoning Province, the discovery of Qinglongtriton indicates that morphological disparity had been underway for the salamandroid clade by early Late Jurassic (Oxfordian) time.	[Jia, Jia; Gao, Ke-Qin] Peking Univ, Sch Earth & Space Sci, 5 Yiheyuan Rd, Beijing 100871, Peoples R China	Peking University	Gao, KQ (corresponding author), Peking Univ, Sch Earth & Space Sci, 5 Yiheyuan Rd, Beijing 100871, Peoples R China.	kqgao@pku.edu.cn	JIA, JIA/AAL-9198-2020		National Natural Science Foundation of China [NSFC 41072007, 41272016]; China Scholarship Council	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); China Scholarship Council(China Scholarship Council)	The research was funded by grants from the National Natural Science Foundation of China (NSFC 41072007, 41272016). Jia's research was also supported by the China Scholarship Council. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AmphibiaTree, 2008, SIR LAC; AmphibiaTree, 2007, RHYACOTRITON VARIEGA; Anderson JS, 2012, P NATL ACAD SCI USA, V109, P5557, DOI 10.1073/pnas.1202491109; Bi SD, 2014, NATURE, V514, P579, DOI 10.1038/nature13718; Bishop SC, 1943, HDB SALAMANDERS; Buckley D, 2010, J MORPHOL, V271, P533, DOI 10.1002/jmor.10816; CARROLL RL, 1980, ZOOL J LINN SOC-LOND, V68, P1, DOI 10.1111/j.1096-3642.1980.tb01916.x; Chang SC, 2014, GEOL SOC SPEC PUBL, V378, P277, DOI 10.1144/SP378.1; Chang SC, 2009, EARTH PLANET SC LETT, V279, P212, DOI 10.1016/j.epsl.2008.12.045; [陈海燕 Chen Haiyan], 2014, [地质通报, Geological Bulletin of China], V33, P966; Chen P., 2003, BIOSTRATIGRAPHY CHIN, P423; [陈文 Chen Wen], 2004, [地质通报, Geological Bulletin of China], V23, P1165; CLEMEN G, 1980, Bonner Zoologische Beitraege, V31, P357; CLEMEN G, 1988, Z ZOOL SYST EVOL, V26, P135; Clemen G, 1979, ZOOL JB ANAT, V102, P170; Davis GA, 2001, GEOL SOC AM MEM, V194, P171; Deban Stephen M., 2000, P65, DOI 10.1016/B978-012632590-4/50004-6; Duellman W., 1986, BIOL AMPHIBIANS; Duellman WE, 1999, PATTERNS OF DISTRIBUTION OF AMPHIBIANS: A GLOBAL PERSPECTIVE, P1; Dunn ER, 1922, AM NAT, V56, P418, DOI 10.1086/279882; Eaton TH, 1936, J MORPHOL, V37, P31, DOI 10.1002/jmor.1050600104; Edgeworth FH, 1935, CRANIAL MUSCLES VERT; ERDMAN S, 1984, J MORPHOL, V181, P175, DOI 10.1002/jmor.1051810206; Estes R., 1969, Breviora, VNo. 322, P1; Estes R., 1981, ENCY PALEOHERPETOL 2; Evans SE, 2005, ZOOL J LINN SOC-LOND, V143, P599, DOI 10.1111/j.1096-3642.2005.00159.x; Evans SE, 1996, PHILOS T R SOC B, V351, P627, DOI 10.1098/rstb.1996.0061; Evans SE, 2003, NECTURUS MACULOSUS; Fei L., 2006, FAUNA SINICA AMPHIBI, V1; Fei Liang, 2012, P1; Francis E. T. B., 1934, P381; Frost D. R., 2015, AMPHIBIAN SPECIES WO; Frost DR, 2006, B AM MUS NAT HIST, P8, DOI 10.1206/0003-0090(2006)297[0001:TATOL]2.0.CO;2; Gao KQ, 2013, CAN J EARTH SCI, V50, P255, DOI 10.1139/e2012-039; Gao KQ, 2012, P NATL ACAD SCI USA, V109, P5767, DOI 10.1073/pnas.1009828109; Gao KQ, 2001, NATURE, V410, P574, DOI 10.1038/35069051; Gao KQ, 2003, NATURE, V422, P424, DOI 10.1038/nature01491; Gardner JD, 2013, PALAEOBIO PALAEOENV, V93, P459, DOI 10.1007/s12549-013-0130-z; Gardner JD, 2003, J VERTEBR PALEONTOL, V23, P769, DOI 10.1671/1828-4; Gardner JD, 2003, PALAEONTOLOGY, V46, P1089, DOI 10.1046/j.0031-0239.2003.00335.x; Gilbert SG, 1973, PICTORIAL ANATOMY NE; Goloboff P, 2008, CLADISTICS, V24, P91; Goodrich E. S., 1930, P837; GREVEN H, 1979, ARCH HISTOL JAPON, V42, P445, DOI 10.1679/aohc1950.42.445; GREVEN H, 1985, Z ZOOL SYST EVOL, V23, P136; Greven H., 1986, Memoires Societe Zoologique de France, P85; Greven H., 1984, J ZOOLOGICAL SYSTEMA, V22, P342; Greven Hartmut, 2006, Acta Biologica Benrodis, V13, P195; Gunter Faure, 1986, PRINCIPLES ISOTOPE G; He HY, 2004, GEOPHYS RES LETT, V31, DOI 10.1029/2004GL020792; Heiss E, 2013, J R SOC INTERFACE, V10, DOI 10.1098/rsif.2012.1028; Hellrung VH, 2003, STAATLICHES MUSEUM N, V330, pD; Hillenius WJ, 2005, CHEM SIGNAL, V10, P228, DOI 10.1007/0-387-25160-X_27; Ivachnenko M, 1978, PALEONTOL J, V1978, P362; Jiang SX, 2015, HIST BIOL, V27, P717, DOI 10.1080/08912963.2014.954570; Jomann N, 2005, ANN ANAT, V187, P305, DOI 10.1016/j.aanat.2005.02.010; Kleinteich T, 2014, J MORPHOL, V275, P230, DOI 10.1002/jmor.20211; LARSEN JH, 1974, COPEIA, P635; Larson A, 2003, REPROD BIOL PHYLOGEN, V1, P31; Larson A, 2006, CAUDATA; Larson Allan, 1993, Herpetological Monographs, V7, P77, DOI 10.2307/1466953; Lebedkina N.S., 1986, P303; Lebedkina NS, 2004, EVOLUTION AMPHIBIAN; Li QG, 2010, SCIENCE, V327, P1369, DOI 10.1126/science.1186290; Liu YQ, 2006, CHINESE SCI BULL, V51, P2634, DOI 10.1007/s11434-006-2165-2; Lu JC, 2012, ACTA GEOL SIN-ENGL, V86, P1317, DOI 10.1111/1755-6724.12002; Lu JC, 2010, P ROY SOC B-BIOL SCI, V277, P383, DOI 10.1098/rspb.2009.1603; Luo ZX, 2015, SCIENCE, V347, P760, DOI 10.1126/science.1260880; Luo ZX, 2011, NATURE, V476, P442, DOI 10.1038/nature10291; [马寅生 Ma Yinsheng], 2002, [地质通报, Geological Bulletin of China], V21, P218; MEANS DB, 1972, COPEIA, P586, DOI 10.2307/1442937; Medvedeva I.M., 1986, P37; Medvedeva IM, 1975, OLFACTORY ORGAN AMPH; Milner Andrew R., 2000, Amphibian Biology, V4, P1412; Mivart G., 1870, P ZOOL SOC LOND, V1870, P260; NISHIO K, 1987, MONIT ZOOL ITAL, V21, P307; NOBLE G. KINGSLEY, 1931; Norris HW, 1913, J MORPHOL, V24, P245, DOI 10.1002/jmor.1050240204; Norris HW, 1908, J COMP NEUROL PSYCHO, V18, P527, DOI 10.1002/cne.920180602; OLSON EC, 1966, AM ZOOL, V6, P399; OLTMANNS E., 1952, ANAT ANZ, V98, P369; OZETI N, 1969, COPEIA, P91; PARSONS TS, 1962, J MORPHOL, V110, P375, DOI 10.1002/jmor.1051100305; Pyron RA, 2011, MOL PHYLOGENET EVOL, V61, P543, DOI 10.1016/j.ympev.2011.06.012; Rehorek SJ, 2013, ANAT REC, V296, P1789, DOI 10.1002/ar.22782; Reilly SM, 1996, COPEIA, P29; Reiss JO, 2008, SENSORY EVOLUTION ON THE THRESHOLD: ADAPTATIONS IN SECONDARILY AQUATIC VERTEBRATES, P43; Roelants K, 2007, P NATL ACAD SCI USA, V104, P887, DOI 10.1073/pnas.0608378104; ROGERS KL, 1985, COPEIA, P926; Rose Christopher S., 2003, Amphibian Biology, V5, P1684; Schmalhausen II, 1968, ORIGIN TERRESTRIAL V; Schoch RR, 2002, PALEOBIOLOGY, V28, P278, DOI 10.1666/0094-8373(2002)028<0278:TEFOTS>2.0.CO;2; Shubin Neil H., 2003, Amphibian Biology, V5, P1782; Skutschas P. P., 2011, Trudy Zoologicheskogo Instituta, V315, P167; Skutschas P, 2011, ZOOL J LINN SOC-LOND, V161, P816, DOI 10.1111/j.1096-3642.2010.00663.x; Skutschas PP, 2013, PALAEOBIO PALAEOENV, V93, P441, DOI 10.1007/s12549-013-0126-8; Song B, 2012, ADV GEOSCIENCES, V2012, P131; Struck TH, 2007, FRONT ZOOL, V4, DOI 10.1186/1742-9994-4-22; Sullivan C, 2014, J VERTEBR PALEONTOL, V34, P243, DOI 10.1080/02724634.2013.787316; Trueb L., 1991, P223; Trueb Linda, 1993, P255; Vasilieva AB, 1999, THESIS MOSCOW STATE; Vassilieva AB, 2013, RUSS J HERPETOL, V20, P85; Vater M, 2007, J ANAT, V211, P290, DOI 10.1111/j.1469-7580.2007.00768.x; Wake David B., 2000, P95, DOI 10.1016/B978-012632590-4/50005-8; WAKE DAVID B., 1966, MEM S CALIF ACAD SCI, V4, P1; WAKE DB, 1973, J MORPHOL, V139, P251, DOI 10.1002/jmor.1051390302; Wake DB, 2001, DICAMPTODON ENSATUS; Wake MH, 2003, AMPHIBIAN BIOL, P1811; [王亮亮 Wang Liangliang], 2013, [科学通报, Chinese Science Bulletin], V58, P1346; Wang Y, 2006, ACTA PALAEONTOL POL, V51, P127; Wiens JJ, 2005, SYST BIOL, V54, P91, DOI 10.1080/10635150590906037; Wiens JJ, 2008, EVOL DEV, V10, P449, DOI 10.1111/j.1525-142X.2008.00256.x; WORTHINGTON RD, 1972, J MORPHOL, V137, P257, DOI 10.1002/jmor.1051370302; Xiong JL, 2013, ZOOLOGY, V116, P99, DOI 10.1016/j.zool.2012.10.004; Xu X, 2015, NATURE, V521, P70, DOI 10.1038/nature14423; Xu X, 2009, CHINESE SCI BULL, V54, P430, DOI 10.1007/s11434-009-0009-6; Yang W, 2008, LITHOS, V102, P88, DOI 10.1016/j.lithos.2007.09.018; Zhang P, 2009, MOL PHYLOGENET EVOL, V53, P492, DOI 10.1016/j.ympev.2009.07.010; [赵越 Zhao Yue], 2004, [地质通报, Geological Bulletin of China], V23, P854; Zheng XT, 2013, NATURE, V500, P199, DOI 10.1038/nature12353; Zhou CF, 2013, NATURE, V500, P163, DOI 10.1038/nature12429; Zhou ZH, 2010, SCI CHINA EARTH SCI, V53, P1894, DOI 10.1007/s11430-010-4094-9	123	21	24	3	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 4	2016	11	5							e0153834	10.1371/journal.pone.0153834	http://dx.doi.org/10.1371/journal.pone.0153834			35	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DL5KR	27144770	Green Published, Green Submitted, gold			2022-12-26	WOS:000375676400029
J	Stefanescu, D; Streba, C; Cartana, ET; Saftoiu, A; Gruionu, G; Gruionu, LG				Stefanescu, Daniela; Streba, Costin; Cartana, Elena Tatiana; Saftoiu, Adrian; Gruionu, Gabriel; Gruionu, Lucian Gheorghe			Computer Aided Diagnosis for Confocal Laser Endomicroscopy in Advanced Colorectal Adenocarcinoma	PLOS ONE			English	Article							FRACTAL DIMENSION; PROGNOSTIC-FACTOR; HISTOLOGY; DIFFERENTIATION; GEOMETRY; NUCLEAR; CANCER; SYSTEM	Introduction Confocal laser endomicroscopy (CLE) is becoming a popular method for optical biopsy of digestive mucosa for both diagnostic and therapeutic procedures. Computer aided diagnosis of CLE images, using image processing and fractal analysis can be used to quantify the histological structures in the CLE generated images. The aim of this study is to develop an automatic diagnosis algorithm of colorectal cancer (CRC), based on fractal analysis and neural network modeling of the CLE-generated colon mucosa images. Materials and Methods We retrospectively analyzed a series of 1035 artifact-free endomicroscopy images, obtained during CLE examinations from normal mucosa (356 images) and tumor regions (679 images). The images were processed using a computer aided diagnosis (CAD) medical imaging system in order to obtain an automatic diagnosis. The CAD application includes image reading and processing functions, a module for fractal analysis, grey-level co-occurrence matrix (GLCM) computation module, and a feature identification module based on the Marching Squares and linear interpolation methods. A two-layer neural network was trained to automatically interpret the imaging data and diagnose the pathological samples based on the fractal dimension and the characteristic features of the biological tissues. Results Normal colon mucosa is characterized by regular polyhedral crypt structures whereas malignant colon mucosa is characterized by irregular and interrupted crypts, which can be diagnosed by CAD. For this purpose, seven geometric parameters were defined for each image: fractal dimension, lacunarity, contrast correlation, energy, homogeneity, and feature number. Of the seven parameters only contrast, homogeneity and feature number were significantly different between normal and cancer samples. Next, a two-layer feed forward neural network was used to train and automatically diagnose the malignant samples, based on the seven parameters tested. The neural network operations were cross-entropy with the results: training: 0.53, validation: 1.17, testing: 1.17, and percent error, resulting: training: 16.14, validation: 17.42, testing: 15.48. The diagnosis accuracy error was 15.5%. Conclusions Computed aided diagnosis via fractal analysis of glandular structures can complement the traditional histological and minimally invasive imaging methods. A larger dataset from colorectal and other pathologies should be used to further validate the diagnostic power of the method.	[Stefanescu, Daniela; Streba, Costin; Cartana, Elena Tatiana; Saftoiu, Adrian] Univ Med & Pharm, Res Ctr Gastroenterol & Hepatol Craiova, Craiova, Romania; [Saftoiu, Adrian] Copenhagen Univ Hosp, Endoscopy Dept, Herlev, Denmark; [Gruionu, Gabriel] Massachusetts Gen Hosp, Dept Surg, Boston, MA 02114 USA; [Gruionu, Gabriel] Harvard Univ, Sch Med, Boston, MA USA; [Gruionu, Gabriel; Gruionu, Lucian Gheorghe] Univ Craiova, Fac Mech, Dept Engn & Management Technol Syst, Craiova, Romania	University of Medicine & Pharmacy of Craiova; University of Copenhagen; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; University of Craiova	Gruionu, LG (corresponding author), Univ Craiova, Fac Mech, Dept Engn & Management Technol Syst, Craiova, Romania.	lgruionu@yahoo.com	Gruionu, Gabriel/C-5152-2011; GRUIONU, Lucian Gheorghe/F-6121-2011; Streba, Costin Teodor T/C-4196-2011; Saftoiu, Adrian/C-2792-2011	GRUIONU, Lucian Gheorghe/0000-0002-4526-0864; Streba, Costin Teodor T/0000-0001-9590-3197; Saftoiu, Adrian/0000-0001-7993-8269	European Social Fund, Human Resources Development Operational Programme [POSDRU/159/1.5/S/136893]; EEA [EEA-JRP-RO-NO-2013-1-0123, 3SEE/30.06.2014]	European Social Fund, Human Resources Development Operational Programme; EEA	This work was supported by the European Social Fund, Human Resources Development Operational Programme 2007-2013, project no. POSDRU/159/1.5/S/136893 to DS. This work was also supported by the EEA Financial Mechanism 2009 - 2014 under the project EEA-JRP-RO-NO-2013-1-0123 - Navigation System For Confocal Laser Endomicroscopy To Improve Optical Biopsy Of Peripheral Lesions In The Lungs (NAVICAD), contract no. 3SEE/30.06.2014. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Basil A WW, CONFOCAL LASER MICRO; Cartana T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052815; Cui CY, 2011, EUR RADIOL, V21, P2318, DOI 10.1007/s00330-011-2182-7; Delides A, 2005, ANTICANCER RES, V25, P2141; Dey P, 2005, ANAL QUANT CYTOL, V27, P284; Gheonea DI, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/239706; Gheonea DI, 2011, WORLD J GASTROENTERO, V17, P21, DOI 10.3748/wjg.v17.i1.21; Gousseau Y R F, 2007, SIAM J MULTISCALE MO, V6, P29; Goutzanis L, 2008, ORAL ONCOL, V44, P345, DOI 10.1016/j.oraloncology.2007.04.005; Gruionu LG, COMPUTER AIDED DIAGN; Kaminski MF, 2014, ENDOSCOPY, V46, P435, DOI 10.1055/s-0034-1365348; Kominami Y, 2016, GASTROINTEST ENDOSC, V83, P643, DOI 10.1016/j.gie.2015.08.004; Kroon D-J., 2011, ISOCONTOUR; Losa GA, 2009, RIV BIOL-BIOL FORUM, V102, P29; MathWorks, 2016, GRAYC; MathWorks, 2016, IM PROC TOOLB FUNCT; Moal F, 2002, HEPATOLOGY, V36, P840, DOI 10.1053/jhep.2002.35533; Mogoanta SS, 2014, ROM J MORPHOL EMBRYO, V55, P103; Nakai Y, 2014, DIGEST ENDOSC, V26, P86, DOI 10.1111/den.12152; Onji K, 2011, J GASTROENTEROL, V46, P1382, DOI 10.1007/s00535-011-0459-x; Rex DK, 2006, GASTROINTEST ENDOSC, V63, pS16, DOI 10.1016/j.gie.2006.02.021; Sommer HJ, 2008, POLIGEOM; Streba CT, 2011, ROM J MORPHOL EMBRYO, V52, P845; Takemura Y, 2012, GASTROINTEST ENDOSC, V75, P179, DOI 10.1016/j.gie.2011.08.051; Tambasco M, 2009, MICRON, V40, P486, DOI 10.1016/j.micron.2008.12.004; Torre LA, 2015, CA-CANCER J CLIN, V65, P87, DOI 10.3322/caac.21262; Winawer S, 2003, GASTROENTEROLOGY, V124, P544, DOI 10.1053/gast.2003.50044	27	43	46	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 4	2016	11	5							e0154863	10.1371/journal.pone.0154863	http://dx.doi.org/10.1371/journal.pone.0154863			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DL5KR	27144985	Green Submitted, Green Published, gold			2022-12-26	WOS:000375676400086
J	Apinonkul, B; Soonthorndhada, K; Vapattanawong, P; Jagger, C; Aekplakorn, W				Apinonkul, Benjawan; Soonthorndhada, Kusol; Vapattanawong, Patama; Jagger, Carol; Aekplakorn, Wichai			Regional and Gender Differences in Years with and without Mobility Limitation in the Older Population of Thailand	PLOS ONE			English	Article							HEALTHY LIFE EXPECTANCY; RISK-FACTORS; ADULTS; DISABILITY; PREVALENCE	Objectives To examine gender and regional differences in health expectancies based on the measure of mobility. Methods Health expectancies by gender and region were computed by Sullivan's method from the fourth Thai National Health Examination Survey (2009). A total of 9,210 older persons aged 60 years and older were included. Mobility limitation was defined as self-reporting of ability to perform only with assistances/aids at least one of: walking at least 400 metres; or going up or down a flight of 10 stairs. Severe limitation was defined as complete inability to do at least one of these two functions, even with assistances or aids. Results At age 60, females compared to males, spent significantly fewer years without mobility limitation (male-female = 3.2 years) and more years with any limitation (female-male = 6.7 years) and with severe limitation (female-male = 3.2 years). For both genders, years lived with severe limitation were remarkably constant across age. Significant regional inequalities in years lived without and with limitation were evident, with a consistent pattern by gender in years free of mobility limitation (Central ranked the best and the North East ranked the worst). Finally, both males and females in the South had the longest life expectancy and the most years of life with severe mobility limitation. Conclusion This study identifies inequalities in years without and with mobility limitations with important policy implication.	[Apinonkul, Benjawan] Mahidol Univ, Fac Phys Therapy, Phutthamonthon, Nakhon Pathom, Thailand; [Soonthorndhada, Kusol; Vapattanawong, Patama] Mahidol Univ, Inst Populat & Social Res, Phutthamonthon, Nakhon Pathom, Thailand; [Jagger, Carol] Newcastle Univ, Newcastle Univ Inst Ageing, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England; [Jagger, Carol] Newcastle Univ, Inst Hlth & Soc, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England; [Aekplakorn, Wichai] Mahidol Univ, Fac Med, Ramathibodi Hosp, Dept Community Med, Bangkok 10700, Thailand	Mahidol University; Mahidol University; Newcastle University - UK; Newcastle University - UK; Mahidol University	Apinonkul, B (corresponding author), Mahidol Univ, Fac Phys Therapy, Phutthamonthon, Nakhon Pathom, Thailand.	benjawan.soo@mahidol.ac.th	Aekplakorn, Wichai/AAK-6867-2021	Jagger, Carol/0000-0002-6377-9926	ESRC [ES/I017399/1] Funding Source: UKRI; Economic and Social Research Council [ES/I017399/1] Funding Source: researchfish	ESRC(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC))		Aekplakorn W, 2011, DIABETES CARE, V34, P1980, DOI 10.2337/dc11-0099; [Anonymous], 2009, 2009 STAT YB; Apinonkul B, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0121310; Beard JR, 2015, LANCET IN PRESS; Brown CJ, 2013, JAMA-J AM MED ASSOC, V310, P1168, DOI 10.1001/jama.2013.276566; Cambois E, 2000, SELECTION COHERENT S, P91; Ferrucci L, 2008, RADIOL CLIN N AM, V46, P643, DOI 10.1016/j.rcl.2008.07.005; Foundation of Thai Gerontology Research and Development Institute, 2012, SIT THAI ELD 2010; Fried LP, 1997, J AM GERIATR SOC, V45, P92, DOI 10.1111/j.1532-5415.1997.tb00986.x; Groessl EJ, 2007, AM J PREV MED, V33, P214, DOI 10.1016/j.amepre.2007.04.031; Institute for Population and Social Research, 2006, MAH U POP PROJ THAIL; Institute for Population and Social Research, 2015, POP THAIL 2015 EST P; Jagger C, 2006, EUROPEAN HLTH EXPECT; James BD, 2011, J GERONTOL A-BIOL, V66, P467, DOI 10.1093/gerona/gly231; Jiawiwatkul U, 2011, ASIA-PAC J PUBLIC HE, V20, P1; Jitapunkul S, 2003, AGE AGEING, V32, P401, DOI 10.1093/ageing/32.4.401; Jitapunkul Sutthichai, 2000, Journal of the Medical Association of Thailand, V83, P861; Karcharnubarn R, 2013, HEALTH PLACE, V24, P1, DOI 10.1016/j.healthplace.2013.08.002; Lim SS, 2012, LANCET, V380, P2224, DOI 10.1016/S0140-6736(12)61766-8; Oksuzyan A, 2008, AGING CLIN EXP RES, V20, P91; Oksuzyan A, 2010, EUR J AGEING, V7, P213, DOI 10.1007/s10433-010-0170-4; Organization WH, 2015, SUMM WORLD REP AG HL; Prasartkul P, 2011, THAILANDS POPULATION, P13; ROBINE JM, 1991, BMJ-BRIT MED J, V302, P457, DOI 10.1136/bmj.302.6774.457; Robine JM, 1999, B WORLD HEALTH ORGAN, V77, P181; Robine JM, 2000, SELECTION COHERENT S, P3; SULLIVAN DF, 1971, HSMHA HEALTH REP, V86, P347, DOI 10.2307/4594169; Weinberger Mark I, 2009, Am J Geriatr Psychiatry, V17, P802, DOI 10.1097/JGP.0b013e3181b0481a; World Health Organisation, 2002, COMM LANG FUNCT DIS; Yong V, 2010, J AGING HEALTH, V22, P120, DOI 10.1177/0898264309351932	30	6	6	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 3	2016	11	5							e0153763	10.1371/journal.pone.0153763	http://dx.doi.org/10.1371/journal.pone.0153763			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DL5KK	27138811	Green Submitted, Green Published, gold			2022-12-26	WOS:000375675700011
J	Musumari, PM; Chamchan, C				Musumari, Patou Masika; Chamchan, Chalermpol			Correlates of HIV Testing Experience among Migrant Workers from Myanmar Residing in Thailand: A Secondary Data Analysis	PLOS ONE			English	Article							SUB-SAHARAN AFRICA; CONDOM USE; HIV/AIDS KNOWLEDGE; FACTORY-WORKERS; RURAL MIGRANTS; UNITED-STATES; SEX WORKERS; RISK; HEALTH; MEN	Background Thailand continues to attract an increasing number of migrant workers (MW) from neighboring countries including mainly Myanmar, Cambodia, and Laos; however, little is known about the extent to which MWs from these countries have access to HIV prevention, treatment, and care services. We used data from the baseline survey of the Prevention of HIV/AIDS among MWs in Thailand (PHAMIT-2) project to document the prevalence of, and factors associated with, HIV testing among MWs from Myanmar, the largest group of MWs in Thailand. Methods and Findings The baseline survey of PHAMIT-2 was conducted in 2010 among MWs from Myanmar, Cambodia, and Laos in 10 purposely-selected provinces of Thailand. Of the 1,034 participants who qualified for the analysis to identify correlates of HIV testing, only 5.3% reported ever having been tested for HIV. Factors associated with HIV testing included having a secondary or higher education level (AOR, 2.58; CI, 1.36-4.90; P = 0.004), being female (AOR, 1.96; CI, 1.05-3.66; P = 0.033), knowing someone who died of AIDS (AOR, 1.81; CI, 1.00-3.27; P = 0.048), working in the fishery sector (AOR, 2.51; CI, 1.28-4.92; P = 0.007), and not having a work permit (AOR, 3.71; CI, 1.36-10.13; P = 0.010). Conclusion ur study, in addition to revealing significantly low HIV testing among MWs from Myanmar, identifies important barriers to HIV testing which could be addressed through interventions that promote migrants' culturally-sensitive and friendly service, for example by facilitating flow of information about places for HIV testing, availability of language assistance, and ensuring confidentiality of HIV testing.	[Musumari, Patou Masika] Kyoto Univ, Sch Publ Hlth, Dept Global Hlth & Socioepidemiol, Kyoto, Japan; [Chamchan, Chalermpol] Mahidol Univ Salaya, Inst Populat & Social Res, Phutthamonthon, Nakhon Pathom, Thailand	Kyoto University; Mahidol University	Musumari, PM (corresponding author), Kyoto Univ, Sch Publ Hlth, Dept Global Hlth & Socioepidemiol, Kyoto, Japan.	patoumus@yahoo.fr			JSPS; Global Fund to Fight AIDS, Tuberculosis and Malaria	JSPS(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Global Fund to Fight AIDS, Tuberculosis and Malaria	This work was supported by the JSPS Program for Advancing Strategic International Networks to Accelerate the Circulation of Talented Researchers, "The Japan-ASEAN Collaborative Research Program on Innovative Humanosphere in Southeast Asia: In Search of Wisdom toward Compatibility Growth and Community in the World." The survey from which the current work was performed was supported by the Global Fund to Fight AIDS, Tuberculosis and Malaria. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ainsworth M, 2003, HEALTH POLICY, V64, P13, DOI 10.1016/S0168-8510(02)00079-9; Alvarez-del Arco D, 2013, EUR J PUBLIC HEALTH, V23, P1039, DOI 10.1093/eurpub/cks130; [Anonymous], 2014, THAIL MIGR REP; Aphichat Chamratrithirong WB Chalermpol Chamchan Charamporn Holumyong Kanya Apipornchaisakul, 2012, PREVENTION OF HIV AI; Asian Development Bank, ASEAN EC COMM 12 THI; Baeten JM, 2012, NEW ENGL J MED, V367, P399, DOI 10.1056/NEJMoa1108524; Barden-O'Fallon JL, 2004, AIDS BEHAV, V8, P131, DOI 10.1023/B:AIBE.0000030244.92791.63; Barmania S, 2013, LANCET, V382, P493, DOI 10.1016/S0140-6736(13)61681-5; Brito AM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0130445; Burnham K. P., 2002, MODEL SELECTION AND; Busza J, 2004, AIDS CARE, V16, P507, DOI 10.1080/09540120410001683457; Camlin CS, 2003, AIDS EDUC PREV, V15, P231, DOI 10.1521/aeap.15.4.231.23831; Coates TJ, 2008, LANCET, V372, P669, DOI 10.1016/S0140-6736(08)60886-7; Cohen MS, 2016, NEW ENGL J MED, V375, P830, DOI [10.1056/NEJMoa1600693, 10.1056/NEJMoa1105243]; Cremin I, 2012, TROP MED INT HEALTH, V17, pe26, DOI 10.1111/j.1365-3156.2011.02937.x; de Paoli MM, 2004, AIDS CARE, V16, P411, DOI 10.1080/09540120410001683358; Entz AT, 2000, AIDS, V14, P1027, DOI 10.1097/00002030-200005260-00015; European Centre for Disease Prevention and Control, 2011, MIGR HLTH HIV TEST C; Fakoya I, 2008, HIV MED, V9, P23, DOI 10.1111/j.1468-1293.2008.00587.x; Fernandez MI, 2005, J RURAL HEALTH, V21, P56, DOI 10.1111/j.1748-0361.2005.tb00062.x; Ford K, 2008, AIDS EDUC PREV, V20, P454, DOI 10.1521/aeap.2008.20.5.454; Ford K, 2007, AIDS BEHAV, V11, P905, DOI 10.1007/s10461-007-9207-x; He N, 2005, SEX TRANSM DIS, V32, P286, DOI 10.1097/01.olq.0000152219.58592.9b; He N, 2009, AIDS EDUC PREV, V21, P570, DOI 10.1521/aeap.2009.21.6.570; Htoo KM, 2009, THESIS CHULALONGKORN; Hutchinson PL, 2006, AIDS CARE, V18, P446, DOI 10.1080/09540120500213511; Ikram Nadeem, 2011, J Ayub Med Coll Abbottabad, V23, P91; INTERNATIONAL ORGANISATION FOR MIGRATION, 2013, WORLD MIGR REP MIGR; International Organization for Migration, 2015, MAINSTR MIGR DEV POL; International Organization for Migration, 2015, MIGR IN 2015 REG STR; Kawichai S, 2012, AIDS BEHAV, V16, P1227, DOI 10.1007/s10461-011-0099-4; Kiwanuka SN, 2008, T ROY SOC TROP MED H, V102, P1067, DOI 10.1016/j.trstmh.2008.04.023; Knox J, 2011, INT J STD AIDS, V22, P709, DOI 10.1258/ijsa.2011.010350; Lyttleton C, 2002, SOC SCI MED, V54, P505, DOI 10.1016/S0277-9536(01)00046-6; Macintyre K, 2004, AIDS BEHAV, V8, P237, DOI 10.1023/B:AIBE.0000044072.71361.b3; Macintyre K, 2001, AIDS EDUC PREV, V13, P160, DOI 10.1521/aeap.13.2.160.19736; Marks G, 2005, JAIDS-J ACQ IMM DEF, V39, P446, DOI 10.1097/01.qai.0000151079.33935.79; McGarrigle CA, 2005, AIDS, V19, P77, DOI 10.1097/00002030-200501030-00009; Mullany LC, 2003, AIDS CARE, V15, P63, DOI 10.1080/0954012021000039761; Nishigaya K, 2002, WOMEN HEALTH, V35, P27, DOI 10.1300/J013v35n04_03; Ostermann J, 2007, ARCH INTERN MED, V167, P2128, DOI 10.1001/archinte.167.19.2128; Poudel KC, 2004, TROP MED INT HEALTH, V9, P897, DOI 10.1111/j.1365-3156.2004.01276.x; Rojanapithayakorn W, 1996, AIDS, V10, P1, DOI 10.1097/00002030-199601000-00001; Say L, 2007, B WORLD HEALTH ORGAN, V85, P812, DOI 10.2471/BLT.06.035659; Smith RA, 2006, SOC SCI MED, V63, P2649, DOI 10.1016/j.socscimed.2006.07.006; Smith-Estelle A, 2003, REPROD HEALTH MATTER, V11, P142, DOI 10.1016/S0968-8080(03)02292-4; Srivanichakorn S., 2012, ASEAN OPPORTUNITIES; Takahashi TA, 2005, J GEN INTERN MED, V20, P618, DOI 10.1111/j.1525-1497.2005.0112.x; Tanser F, 2013, SCIENCE, V339, P966, DOI 10.1126/science.1228160; Thai National AIDS Committee, 2014, THAIL AIDS RESP PROG; Thepthien BO, 2015, ASIA-PAC J PUBLIC HE, V27, P765, DOI 10.1177/1010539515588942; Ti LP, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-189; Ukwuani FA, 2003, JAIDS-J ACQ IMM DEF, V34, P203, DOI 10.1097/00126334-200310010-00011; UNAIDS, 2012, UNAIDS WORLD DAY REP; United Nations Joint Programme on HIV/AIDS, 2014, THAIL HIV AIDS EST; United Nations Joint Programme on HIV/AIDS, 2014, THAIL AIDS RESP PROG; Vutthikraivit Possawat, 2014, Journal of the Medical Association of Thailand, V97, pS207; Weine SM, 2012, AIDS BEHAV, V16, P1605, DOI 10.1007/s10461-012-0183-4; Weniger B G, 1991, AIDS, V5 Suppl 2, pS71, DOI 10.1097/00002030-199101001-00011; Worthington C, 2003, QUAL HEALTH RES, V13, P636, DOI 10.1177/1049732303013005004; Yamane T, 1977, STATISTICS AN INTROD; Zak-Place J, 2004, J AM COLL HEALTH, V52, P229, DOI 10.3200/JACH.52.5.229-236; Zhang L, 2015, LANCET HIV, V2, pE200, DOI 10.1016/S2352-3018(15)00020-X; Zhou Jian-bo, 2007, Zhonghua Liu Xing Bing Xue Za Zhi, V28, P567; Ziraba AK, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-663	65	16	17	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 3	2016	11	5							e0154669	10.1371/journal.pone.0154669	http://dx.doi.org/10.1371/journal.pone.0154669			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DL5KK	27138960	Green Published, gold, Green Submitted			2022-12-26	WOS:000375675700051
J	Osada, UN; Sunagawa, H; Terauchi, Y; Ueda, S				Osada, Uru Nezu; Sunagawa, Hiroshi; Terauchi, Yasuo; Ueda, Shinichiro			A Common Susceptibility Gene for Type 2 Diabetes Is Associated with Drug Response to a DPP-4 Inhibitor: Pharmacogenomic Cohort in Okinawa Japan	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; INSULIN-SECRETION; GLUCOSE RESPONSE; CDKAL1; RISK; LOCI; POLYMORPHISMS; KINETICS; CYP2C9; IMPACT	We investigated the association between common type 2 susceptibility variants of CDK5 regulatory subunit associated protein 1-like 1(CDKAL1) and therapeutic responses to antidiabetic agents among patients with type 2 diabetes. Two SNPs (rs7754840: C>G, rs7756992: A>G) were genotyped via the Taqman PCR method. A total of 798 type 2 diabetic patients were included. HbA1c reduction after use of DPP-4 inhibitors for 3 months was significantly greater in patients with a risk allele for type 2 diabetes (GG -0.4%, CG -0.5%, CC -0.8%, p = 0.02 for rs7754840 and AA -0.4%, AG -0.5%, GG -0.8%, p = 0.01 for rs7756992). Linear regression analysis showed that per allele reductions of hemoglobin A1c (HbA1c) after 3 months were -0.10% for rs7754840 (p = 0.02) and -0.13% for rs7756992 (p = 0.0008) after adjusting for clinically influential covariates such as age, sex, BMI, duration of diabetes, baseline HbA1c and concomitant anti-diabetic agents. The results suggested that common variants of CDKAL1 are associated with therapeutic response to DPP-4 inhibitors.	[Osada, Uru Nezu; Ueda, Shinichiro] Univ Ryukyus, Grad Sch Med, Dept Clin Pharmacol & Therapeut, Okinawa, Japan; [Osada, Uru Nezu] Saiseikai Yokohama City Nanbu Hosp, Dept Diabet Endocrinol & Metab, Yokohama, Kanagawa, Japan; [Sunagawa, Hiroshi] Sunawaga Med Clin, Okinawa, Japan; [Terauchi, Yasuo] Yokohama City Univ, Grad Sch Med, Dept Endocrinol & Metab, Yokohama, Kanagawa 232, Japan	University of the Ryukyus; Yokohama City University	Ueda, S (corresponding author), Univ Ryukyus, Grad Sch Med, Dept Clin Pharmacol & Therapeut, Okinawa, Japan.	blessyou@med.u-ryukyu.ac.jp	Terauchi, Yasuo/AAO-4347-2020		Japan Research Foundation for Clinical Pharmacology, Strategic Research Promotion Unit of University of the Ryukyus	Japan Research Foundation for Clinical Pharmacology, Strategic Research Promotion Unit of University of the Ryukyus	This work was supportd by Japan Research Foundation for Clinical Pharmacology, Strategic Research Promotion Unit of University of the Ryukyus. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barrett JC, 2009, NAT GENET, V41, P703, DOI 10.1038/ng.381; Cdkal A, 2008, DIABETES, V57, P791, DOI [10.2337/db07-0979.Additional, DOI 10.2337/DB07-0979]; Chistiakov DA, 2011, ACTA DIABETOL, V48, P227, DOI 10.1007/s00592-011-0299-4; DEVLIN B, 1995, GENOMICS, V29, P311, DOI 10.1006/geno.1995.9003; Henquin JC, 2000, DIABETES, V49, P1751, DOI 10.2337/diabetes.49.11.1751; Kirchheiner J, 2002, PHARMACOGENETICS, V12, P101, DOI 10.1097/00008571-200203000-00004; Kirchheiner J, 2002, CLIN PHARMACOL THER, V71, P286, DOI 10.1067/mcp.2002.122476; McTaggart JS, 2010, J PHYSIOL-LONDON, V588, P3201, DOI 10.1113/jphysiol.2010.191767; Mori S, 2008, DIABETES, V57, P791, DOI 10.2337/db07-0979; Morris AP, 2012, NAT GENET, V44, P981, DOI 10.1038/ng.2383; Ohara-Imaizumi M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015553; Saxena R, 2007, SCIENCE, V316, P1331, DOI 10.1126/science.1142358; Schroner Z, 2012, PHYSIOL RES, V61, P177, DOI 10.33549/physiolres.932228; Sim X, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001363; Stancakova A, 2008, J CLIN ENDOCR METAB, V93, P1924, DOI 10.1210/jc.2007-2218; Steinthorsdottir V, 2007, NAT GENET, V39, P770, DOI 10.1038/ng2043; 't Hart LM, 2013, DIABETES, V62, P3275, DOI 10.2337/db13-0227; Takeuchi F, 2009, DIABETES, V58, P1690, DOI 10.2337/db08-1494; Ubeda M, 2006, J BIOL CHEM, V281, P28858, DOI 10.1074/jbc.M604690200; Zhou K, 2010, CLIN PHARMACOL THER, V87, P52, DOI 10.1038/clpt.2009.176	20	12	12	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 3	2016	11	5							e0154821	10.1371/journal.pone.0154821	http://dx.doi.org/10.1371/journal.pone.0154821			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DL5KK	27139004	Green Submitted, gold, Green Published			2022-12-26	WOS:000375675700072
J	Zhou, HY; Li, YX; Zhang, Q; Ren, SY; Shen, YY; Qin, L; Xing, Y				Zhou, Heying; Li, Yuxuan; Zhang, Qing; Ren, Suyue; Shen, Yuanyue; Qin, Ling; Xing, Yu			Genome-Wide Analysis of the Expression of WRKY Family Genes in Different Developmental Stages of Wild Strawberry (Fragaria vesca) Fruit	PLOS ONE			English	Article							TRANSCRIPTION FACTOR FAMILY; DNA-BINDING PROTEINS; PLANT SENESCENCE; LEAF SENESCENCE; ARABIDOPSIS; DEFENSE; SUPERFAMILY; RICE; IDENTIFICATION; BIOSYNTHESIS	WRKY proteins play important regulatory roles in plant developmental processes such as senescence, trichome initiation and embryo morphogenesis. In strawberry, only FaWRKY1 (Fragaria x ananassa) has been characterized, leaving numerous WRKY genes to be identified and their function characterized. The publication of the draft genome sequence of the strawberry genome allowed us to conduct a genome-wide search for WRKY proteins in Fragaria vesca, and to compare the identified proteins with their homologs in model plants. Fifty-nine FvWRKY genes were identified and annotated from the F. vesca genome. Detailed analysis, including gene classification, annotation, phylogenetic evaluation, conserved motif determination and expression profiling, based on RNA-seq data, were performed on all members of the family. Additionally, the expression patterns of the WRKY genes in different fruit developmental stages were further investigated using qRT-PCR, to provide a foundation for further comparative genomics and functional studies of this important class of transcriptional regulators in strawberry.	[Zhou, Heying; Li, Yuxuan; Zhang, Qing; Ren, Suyue; Shen, Yuanyue; Qin, Ling; Xing, Yu] Beijing Agr Univ, Coll Plant Sci & Technol, Beijing 102206, Peoples R China; [Zhou, Heying; Li, Yuxuan; Zhang, Qing; Ren, Suyue; Shen, Yuanyue; Qin, Ling; Xing, Yu] Beijing Agr Univ, Beijing Key Lab Agr Applicat & New Tech, Beijing 102206, Peoples R China	Beijing University of Agriculture; Beijing University of Agriculture	Xing, Y (corresponding author), Beijing Agr Univ, Coll Plant Sci & Technol, Beijing 102206, Peoples R China.; Xing, Y (corresponding author), Beijing Agr Univ, Beijing Key Lab Agr Applicat & New Tech, Beijing 102206, Peoples R China.	xingyu@bua.edu.cn	Li, Yuxuan/GWC-8159-2022		National Natural Science Foundation of China [31370323]; Beijing Natural Science Foundation and Scientific Research Key Program of Beijing Municipal Commission of Education [KZ20130020018]; Importation and Development of High-Caliber Talents Project of Beijing Municipal Institutions [CITTCD201404098]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Beijing Natural Science Foundation and Scientific Research Key Program of Beijing Municipal Commission of Education; Importation and Development of High-Caliber Talents Project of Beijing Municipal Institutions	This work was supported by the National Natural Science Foundation of China (Grant No. 31370323), Beijing Natural Science Foundation and Scientific Research Key Program of Beijing Municipal Commission of Education (Project No. KZ20130020018) and the Importation and Development of High-Caliber Talents Project of Beijing Municipal Institutions (Project No. CIT&TCD201404098).	Ay N, 2009, PLANT J, V58, P333, DOI [10.1111/j.0960-7412.2009.03782.x, 10.1111/j.1365-313X.2008.03782.x]; Dellagi A, 2000, MOL PLANT MICROBE IN, V13, P1092, DOI 10.1094/MPMI.2000.13.10.1092; Encinas-Villarejo S, 2009, J EXP BOT, V60, P3043, DOI 10.1093/jxb/erp152; Eulgem T, 2005, TRENDS PLANT SCI, V10, P71, DOI 10.1016/j.tplants.2004.12.006; Eulgem T, 2000, TRENDS PLANT SCI, V5, P199, DOI 10.1016/S1360-1385(00)01600-9; Guo SZ, 2004, EXP CELL RES, V298, P465, DOI 10.1016/j.yexcr.2004.04.044; Holub EB, 2001, NAT REV GENET, V2, P516, DOI 10.1038/35080508; Huang T, 2002, PLANT MOL BIOL, V48, P339, DOI 10.1023/A:1014062714786; ISHIGURO S, 1994, MOL GEN GENET, V244, P563, DOI 10.1007/BF00282746; Jia HF, 2011, PLANT PHYSIOL, V157, P188, DOI 10.1104/pp.111.177311; Jiang WB, 2009, BMC PLANT BIOL, V9, DOI 10.1186/1471-2229-9-96; Jing SJ, 2009, PLANT GROWTH REGUL, V58, P181, DOI 10.1007/s10725-009-9366-z; Johnson CS, 2002, PLANT CELL, V14, P1359, DOI 10.1105/tpc.001404; Karam BS, 2002, CURR OPIN PLANT BIOL, V5, P430; Kato N, 2007, PLANT CELL PHYSIOL, V48, P8, DOI 10.1093/pcp/pcl041; Kilian J, 2007, PLANT J, V50, P347, DOI 10.1111/j.1365-313X.2007.03052.x; Knoth C, 2007, MOL PLANT MICROBE IN, V20, P120, DOI 10.1094/MPMI-20-2-0120; Lagace M, 2004, PLANTA, V219, P185, DOI 10.1007/s00425-004-1253-2; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Ling J, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-471; Liu JJ, 2009, GENOME, V52, P77, DOI 10.1139/G08-106; Luo M, 2005, P NATL ACAD SCI USA, V102, P17531, DOI 10.1073/pnas.0508418102; Mantri NL, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-303; Marchive C, 2007, J EXP BOT, V58, P1999, DOI 10.1093/jxb/erm062; Miao Y, 2004, PLANT MOL BIOL, V55, P853, DOI 10.1007/s11103-005-2142-1; Pnueli L, 2002, PLANT J, V31, P319, DOI 10.1046/j.1365-313X.2002.01364.x; Ramamoorthy R, 2008, PLANT CELL PHYSIOL, V49, P865, DOI 10.1093/pcp/pcn061; Robatzek S, 2002, GENE DEV, V16, P1139, DOI 10.1101/gad.222702; Robatzek S, 2001, PLANT J, V28, P123, DOI 10.1046/j.1365-313X.2001.01131.x; Ross CA, 2007, J INTEGR PLANT BIOL, V49, P827, DOI 10.1111/j.1744-7909.2007.00504.x; Rushton DL, 2012, PLANT BIOTECHNOL J, V10, P2, DOI 10.1111/j.1467-7652.2011.00634.x; Rushton PJ, 1995, PLANT MOL BIOL, V29, P691, DOI 10.1007/BF00041160; Rushton PJ, 1996, EMBO J, V15, P5690, DOI 10.1002/j.1460-2075.1996.tb00953.x; Seki M, 2002, PLANT J, V31, P279, DOI 10.1046/j.1365-313X.2002.01359.x; Shulaev V, 2011, NAT GENET, V43, P109, DOI 10.1038/ng.740; Sun CX, 2003, PLANT CELL, V15, P2076, DOI 10.1105/tpc.014597; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Ulker B, 2004, CURR OPIN PLANT BIOL, V7, P491, DOI 10.1016/j.pbi.2004.07.012; Ulker B, 2007, PLANTA, V226, P125, DOI 10.1007/s00425-006-0474-y; Vannozzi A, 2012, BMC PLANT BIOL, V12, DOI 10.1186/1471-2229-12-130; Wang D, 2006, PLOS PATHOG, V2, P1042, DOI 10.1371/journal.ppat.0020123; Wang M, 2014, HORTIC RES-ENGLAND, V1, DOI 10.1038/hortres.2014.16; Wu KL, 2005, DNA RES, V12, P9, DOI 10.1093/dnares/12.1.9; Xie Z, 2005, PLANT PHYSIOL, V137, P176, DOI 10.1104/pp.104.054312; Zhang M, 2009, J EXP BOT, V60, P1579, DOI 10.1093/jxb/erp026; Zhang YJ, 2005, BMC EVOL BIOL, V5, DOI 10.1186/1471-2148-5-1; Zhou QY, 2008, PLANT BIOTECHNOL J, V6, P486, DOI 10.1111/j.1467-7652.2008.00336.x	47	24	28	2	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 3	2016	11	5							e0154312	10.1371/journal.pone.0154312	http://dx.doi.org/10.1371/journal.pone.0154312			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DL5KK	27138272	Green Published, Green Submitted, gold			2022-12-26	WOS:000375675700026
J	Arelaki, S; Arampatzioglou, A; Kambas, K; Papagoras, C; Miltiades, P; Angelidou, I; Mitsios, A; Kotsianidis, I; Skendros, P; Sivridis, E; Maroulakou, I; Giatromanolaki, A; Ritis, K				Arelaki, Stella; Arampatzioglou, Athanasios; Kambas, Konstantinos; Papagoras, Charalampos; Miltiades, Paraskevi; Angelidou, Iliana; Mitsios, Alexandros; Kotsianidis, Ioannis; Skendros, Panagiotis; Sivridis, Efthimios; Maroulakou, Ioanna; Giatromanolaki, Alexandra; Ritis, Konstantinos			Gradient Infiltration of Neutrophil Extracellular Traps in Colon Cancer and Evidence for Their Involvement in Tumour Growth	PLOS ONE			English	Article							LYMPHOCYTE-PROLIFERATION; VENOUS THROMBOEMBOLISM; TISSUE FACTOR; METASTASIS; DIFFERENTIATION; SURVIVAL; TARGETS; CELLS	Background The role of neutrophils in tumour biology is largely unresolved. Recently, independent studies indicated either neutrophil extracellular traps (NETs) or Tissue Factor (TF) involvement in cancer biology and associated thrombosis. However, their individual or combined role in colonic adenocarcinoma is still unexplored. Methods Colectomy tissue specimens and variable number of draining lymph nodes were obtained from ten patients with adenocarcinoma of the colon. NETs deposition and neutrophil presence as well as TF expression were examined by immunostaining. The effect of NETs on cancer cell growth was studied in in vitro co-cultures of Caco-2 cell line and acute myeloid leukemia primary cells. Proliferation and apoptosis/necrosis of cancer cells were analyzed by flow cytometry. Results TF-bearing NETs and neutrophil localization were prominent in tumour sections and the respective metastatic lymph nodes. Interestingly, neutrophil infiltration and NETs concentration were gradually reduced from the tumour mass to the distal margin. The in vitro-generated NETs impeded growth of cancer cell cultures by inducing apoptosis and/or inhibiting proliferation. Conclusions These data support further the role of neutrophils and NETs in cancer biology. We also suggest their involvement on cancer cell growth.	[Arelaki, Stella; Sivridis, Efthimios; Giatromanolaki, Alexandra] Univ Gen Hosp Alexandroupolis, Dept Pathol, Alexandroupolis, Greece; [Arelaki, Stella; Arampatzioglou, Athanasios; Kambas, Konstantinos; Papagoras, Charalampos; Angelidou, Iliana; Mitsios, Alexandros; Skendros, Panagiotis; Ritis, Konstantinos] Democritus Univ Thrace, Lab Mol Hematol, Alexandroupolis, Greece; [Arampatzioglou, Athanasios; Maroulakou, Ioanna] Democritus Univ Thrace, Canc Genet Lab, Dept Mol Biol & Genet, Alexandroupolis, Greece; [Miltiades, Paraskevi; Kotsianidis, Ioannis] Democritus Univ Thrace, Dept Hematol, Alexandroupolis, Greece	Democritus University of Thrace; Democritus University of Thrace; Democritus University of Thrace	Ritis, K (corresponding author), Democritus Univ Thrace, Lab Mol Hematol, Alexandroupolis, Greece.	kritis@med.duth.gr	KOTSIANIDIS, IOANNIS/ABH-1436-2021; Kotsianidis, Ioannis/AGH-1791-2022; Papagoras, Charis/AAO-6191-2020	KOTSIANIDIS, IOANNIS/0000-0001-7668-0186; Papagoras, Charis/0000-0001-6207-496X; Skendros, Panagiotis/0000-0003-0456-7015	Governing Board of the University Hospital of Alexandroupolis	Governing Board of the University Hospital of Alexandroupolis	This project was supported by the Governing Board of the University Hospital of Alexandroupolis. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amsalem H, 2014, J IMMUNOL, V193, P3070, DOI 10.4049/jimmunol.1303117; Apostolidou E, 2016, ANN RHEUM DIS, V75, P269, DOI 10.1136/annrheumdis-2014-205958; Berger-Achituv S, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00048; Brinkmann V, 2004, SCIENCE, V303, P1532, DOI 10.1126/science.1092385; Carrier M, 2008, ANN INTERN MED, V149, P323, DOI 10.7326/0003-4819-149-5-200809020-00007; Chrysanthopoulou A, 2014, J PATHOL, V233, P294, DOI 10.1002/path.4359; Cools-Lartigue J, 2014, CELL MOL LIFE SCI, V71, P4179, DOI 10.1007/s00018-014-1683-3; Cools-Lartigue J, 2013, J CLIN INVEST, V123, P3446, DOI 10.1172/JCI67484; Demers M, 2013, ONCOIMMUNOLOGY, V2, DOI 10.4161/onci.22946; Demers M, 2012, P NATL ACAD SCI USA, V109, P13076, DOI 10.1073/pnas.1200419109; Diakos CI, 2014, LANCET ONCOL, V15, pE493, DOI 10.1016/S1470-2045(14)70263-3; Falanga A, 2015, SEMIN THROMB HEMOST, V41, P756, DOI 10.1055/s-0035-1564040; Fridlender ZG, 2012, CARCINOGENESIS, V33, P949, DOI 10.1093/carcin/bgs123; Gregory AD, 2011, CANCER RES, V71, P2411, DOI 10.1158/0008-5472.CAN-10-2583; Hawkins ED, 2007, NAT PROTOC, V2, P2057, DOI 10.1038/nprot.2007.297; Kambas K, 2014, ANN RHEUM DIS, V73, P1854, DOI 10.1136/annrheumdis-2013-203430; Kambas K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045427; Khandpur R, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3005580; Kotsianidis I, 2009, LEUKEMIA, V23, P510, DOI 10.1038/leu.2008.333; Mitroulis I, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029318; Quah BJC, 2007, NAT PROTOC, V2, P2049, DOI 10.1038/nprot.2007.296; Raman D, 2007, CANCER LETT, V256, P137, DOI 10.1016/j.canlet.2007.05.013; Saffarzadeh M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032366; Schmidt H, 2005, BRIT J CANCER, V93, P273, DOI 10.1038/sj.bjc.6602702; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Stakos DA, 2015, EUR HEART J, V36, P1405, DOI 10.1093/eurheartj/ehv007; Tohme S., 2016, CANC RES; Walsh Sr, 2005, J SURG ONCOL, V91, P181, DOI 10.1002/jso.20329; Wculek SK, 2015, NATURE, V528, P413, DOI 10.1038/nature16140; White RH, 2005, ARCH INTERN MED, V165, P1782, DOI 10.1001/archinte.165.15.1782; Wojtukiewicz MZ, 2015, CANCER METAST REV, V34, P775, DOI 10.1007/s10555-015-9599-4; Yokota N, 2014, J THROMB HAEMOST, V12, P71, DOI 10.1111/jth.12442	32	75	78	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 2	2016	11	5							e0154484	10.1371/journal.pone.0154484	http://dx.doi.org/10.1371/journal.pone.0154484			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DL5KB	27136460	Green Published, Green Submitted, gold			2022-12-26	WOS:000375674800023
J	Rocas, IN; Alves, FRF; Rachid, CTCC; Lima, KC; Assuncao, IV; Gomes, PN; Siqueira, JF				Rocas, Isabela N.; Alves, Flavio R. F.; Rachid, Caio T. C. C.; Lima, Kenio C.; Assuncao, Isauremi V.; Gomes, Patricia N.; Siqueira, Jose F., Jr.			Microbiome of Deep Dentinal Caries Lesions in Teeth with Symptomatic Irreversible Pulpitis	PLOS ONE			English	Article							HUMAN CARIOUS DENTIN; ENDODONTIC INFECTIONS; MOLECULAR ANALYSIS; PYROSEQUENCING ANALYSIS; MICROFLORA; BACTERIA; DIVERSITY; ASSOCIATION; SENSITIVITY; CHILDHOOD	This study used a next-generation sequencing approach to identify the bacterial taxa occurring in the advanced front of caries biofilms associated with pulp exposure and irreversible pulpitis. Samples were taken from the deepest layer of dentinal caries lesions associated with pulp exposure in 10 teeth diagnosed with symptomatic irreversible pulpitis. DNA was extracted and the microbiome was characterized on the basis of the V4 hypervariable region of the 16S rRNA gene by using paired-end sequencing on Illumina MiSeq device. Bacterial taxa were mapped to 14 phyla and 101 genera composed by 706 different OTUs. Three phyla accounted for approximately 98% of the sequences: Firmicutes, Actinobacteria and Proteobacteria. These phyla were also the ones with most representatives at the species level. Firmicutes was the most abundant phylum in 9/10 samples. As for genera, Lactobacillus accounted for 42.3% of the sequences, followed by Olsenella (13.7%), Pseudoramibacter (10.7%) and Streptococcus (5.5%). Half of the samples were heavily dominated by Lactobacillus, while in the other half lactobacilli were in very low abundance and the most dominant genera were Pseudoramibacter, Olsenella, Streptococcus, and Stenotrophomonas. High bacterial diversity occurred in deep dentinal caries lesions associated with symptomatic irreversible pulpitis. The microbiome could be classified according to the relative abundance of Lactobacillus. Except for Lactobacillus species, most of the highly prevalent and abundant bacterial taxa identified in this study have been commonly detected in infected root canals. The detected taxa can be regarded as candidate pathogens for irreversible pulpitis and possibly the pioneers in pulp invasion to initiate endodontic infection.	[Rocas, Isabela N.; Alves, Flavio R. F.; Siqueira, Jose F., Jr.] Estacio de Sa Univ, Dept Endodont, Rio De Janeiro, RJ, Brazil; [Rocas, Isabela N.; Alves, Flavio R. F.; Siqueira, Jose F., Jr.] Estacio de Sa Univ, Mol Microbiol Lab, Rio De Janeiro, RJ, Brazil; [Rachid, Caio T. C. C.] Univ Fed Rio de Janeiro, Inst Microbiol Prof Paulo de Goes, BR-21941 Rio De Janeiro, RJ, Brazil; [Lima, Kenio C.; Assuncao, Isauremi V.; Gomes, Patricia N.] Univ Fed Rio Grande do Norte, Dept Prevent Dent, BR-59072970 Natal, RN, Brazil	Universidade Federal do Rio de Janeiro; Universidade Federal do Rio Grande do Norte	Alves, FRF (corresponding author), Estacio de Sa Univ, Dept Endodont, Rio De Janeiro, RJ, Brazil.; Alves, FRF (corresponding author), Estacio de Sa Univ, Mol Microbiol Lab, Rio De Janeiro, RJ, Brazil.	flavioferreiraalves@gmail.com	Assunção, Isauremi/AAW-2413-2021; Rachid, Caio TCC/J-5001-2016; Assunção, Isauremi/AAW-2461-2021	Assunção, Isauremi/0000-0003-3171-6514; Rachid, Caio TCC/0000-0003-3115-5702; Assunção, Isauremi/0000-0003-3171-6514; Lima, Kenio Costa/0000-0002-5668-4398; Alves, Flavio/0000-0002-9922-8202	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq); Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ)	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ)(Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio De Janeiro (FAPERJ))	This study was supported by grants from Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq), and Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ), Brazilian Governmental Institutions.	Aas JA, 2008, J CLIN MICROBIOL, V46, P1407, DOI 10.1128/JCM.01410-07; Ahn JY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022788; Baumgartner JC, 2004, J ENDODONT, V30, P141, DOI 10.1097/00004770-200403000-00004; Bergenholtz G, 1981, J Endod, V7, P100, DOI 10.1016/S0099-2399(81)80122-7; Callaway A, 2013, CLIN LAB, V59, P1373, DOI 10.7754/Clin.Lab.2013.121225; Caporaso JG, 2011, P NATL ACAD SCI USA, V108, P4516, DOI 10.1073/pnas.1000080107; Chalmers NI, 2015, J ORAL MICROBIOL, V7, DOI 10.3402/jom.v7.25951; Chhour KL, 2005, J CLIN MICROBIOL, V43, P843, DOI 10.1128/JCM.43.2.843-849.2005; Cole JR, 2009, NUCLEIC ACIDS RES, V37, pD141, DOI 10.1093/nar/gkn879; Dorn SO., 2016, COHENS PATHWAYS PULP, P706; Edgar RC, 2011, BIOINFORMATICS, V27, P2194, DOI 10.1093/bioinformatics/btr381; Edwardsson S, 1974, Odontol Revy Suppl, V32, P1; Fouad AF., 2015, ENDODONTICS PRINCIPL, P48; Griffen AL, 2012, ISME J, V6, P1176, DOI 10.1038/ismej.2011.191; HAHN CL, 1993, J ENDODONT, V19, P26, DOI 10.1016/S0099-2399(06)81037-X; HAHN CL, 1991, ARCH ORAL BIOL, V36, P147, DOI 10.1016/0003-9969(91)90077-8; Hong BY, 2013, J ENDODONT, V39, P1136, DOI 10.1016/j.joen.2013.05.001; HOSHINO E, 1985, J DENT RES, V64, P1195, DOI 10.1177/00220345850640100301; HOUTE JV, 1972, INFECT IMMUN, V6, P723, DOI 10.1128/IAI.6.5.723-729.1972; Jiang W, 2014, MICROB ECOL, V67, P962, DOI 10.1007/s00248-014-0372-y; Keijser BJF, 2008, J DENT RES, V87, P1016, DOI 10.1177/154405910808701104; Kianoush N, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092940; Koren O, 2011, P NATL ACAD SCI USA, V108, P4592, DOI 10.1073/pnas.1011383107; Levin LG, 2009, J ENDODONT, V35, P1645, DOI 10.1016/j.joen.2009.09.032; Li L, 2010, J DENT RES, V89, P980, DOI 10.1177/0022034510370026; Lima KC, 2011, CARIES RES, V45, P21, DOI 10.1159/000322299; LOESCHE WJ, 1986, MICROBIOL REV, V50, P353, DOI 10.1128/MMBR.50.4.353-380.1986; Marsh P. D., 2009, COMPEND CONTIN ED DE, V30, P80; Marsh PD, 2009, COMPEND CONTIN ED DE, V30, P90; Marsh PD, 2009, COMPEND CONTIN ED DE, V30, P3; Marsh Philip D, 2009, Compend Contin Educ Dent, V30, P76; Martin FE, 2002, J CLIN MICROBIOL, V40, P1698, DOI 10.1128/JCM.40.5.1698-1704.2002; MASSEY WLK, 1993, ORAL MICROBIOL IMMUN, V8, P30, DOI 10.1111/j.1399-302X.1993.tb00539.x; MINAH GE, 1977, INFECT IMMUN, V17, P55, DOI 10.1128/IAI.17.1.55-61.1977; Munson MA, 2004, J CLIN MICROBIOL, V42, P3023, DOI 10.1128/JCM.42.7.3023-3029.2004; Munson MA, 2002, J DENT RES, V81, P761, DOI 10.1177/154405910208101108; Nadkarni MA, 2004, J CLIN MICROBIOL, V42, P5238, DOI 10.1128/JCM.42.11.5238-5244.2004; Obata J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103712; Quast C, 2013, NUCLEIC ACIDS RES, V41, pD590, DOI 10.1093/nar/gks1219; REEVES R, 1966, ORAL SURG ORAL MED O, V22, P59, DOI 10.1016/0030-4220(66)90143-5; Ricucci D, 2013, ENDODONTOLOGY; Ricucci D, 2014, J ENDODONT, V40, P1932, DOI 10.1016/j.joen.2014.08.010; Rocas IN, 2015, J ENDODONT, V41, P1450, DOI 10.1016/j.joen.2015.05.013; Sakamoto M, 2006, ORAL MICROBIOL IMMUN, V21, P112, DOI 10.1111/j.1399-302X.2006.00270.x; Santos AL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028088; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; Schulze-Schweifing K, 2014, FRONT CELL INFECT MI, V4, DOI 10.3389/fcimb.2014.00164; Siqueira JF, 2009, J DENT RES, V88, P969, DOI 10.1177/0022034509346549; Trowbridge H O, 1981, J Endod, V7, P52, DOI 10.1016/S0099-2399(81)80242-7; Zaura E, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-259	50	38	41	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 2	2016	11	5							e0154653	10.1371/journal.pone.0154653	http://dx.doi.org/10.1371/journal.pone.0154653			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DL5KB	27135405	gold, Green Published, Green Submitted			2022-12-26	WOS:000375674800035
J	Wang, BJ; Gong, HJ; Zhang, X; Li, HZ; Ma, X; Song, EL; Gao, JP; Dong, J				Wang, Baojun; Gong, Huijie; Zhang, Xu; Li, Hongzhao; Ma, Xin; Song, Erlin; Gao, Jiangping; Dong, Jun			Bilateral Synchronous Sporadic Renal Cell Carcinoma: Retroperitoneoscopic Strategies and Intermediate Outcomes of 60 Patients	PLOS ONE			English	Article							SURGICAL-MANAGEMENT; FOLLOW-UP; TUMORS; NEPHRECTOMY; GUIDELINES; FEATURES; DISEASE; SURGERY; IMPACT; MASSES	Objective To evaluate the presentation, management, pathology, and functional and oncological outcomes of patients undergoing retroperitoneoscopic treatment of bilateral synchronous sporadic RCC at our institution. Methods We retrospectively evaluated the records of 60 patients with bilateral synchronous sporadic RCC who underwent retroperitoneoscopic treatment at the General Hospital of People's Liberation Army from 2008 to 2014. The estimated glomerular filtration rate was calculated and compared among different surgical procedures. The overall survival and recurrence free survival were assessed based on information from recent follow-up. Results Fifty-six patients underwent bilateral retroperitoneoscopic surgeries in staged procedures, and four patients underwent bilateral retroperitoneoscopic surgeries in simultaneous procedures. Among the former group of patients, 34 underwent bilateral partial nephrectomy, 12 underwent radical nephrectomy followed by partial nephrectomy, and 10 underwent partial nephrectomy followed by radical nephrectomy. Bilateral partial nephrectomy can better preserve renal function (p = 0.040) and the sequence of partial nephrectomy and radical nephrectomy did not affect functional outcomes (p = 0.790). One patient undergoing simultaneous procedures developed acute renal failure and required temporary hemodialysis. At 3 and 5 years, overall survival rates were 93.0% and 89.4%, and recurrence free survival rates were 90.5% and 81.6%. High nuclear grade (p = 0.014) was related to disease recurrence. Conclusions Staged bilateral partial nephrectomy was efficient in preserving renal function. The survival of patients with bilateral synchronous sporadic renal tumors was similar to that of patients with unilateral nonmetastatic tumors. Nuclear grade was an independent prognostic factor of disease recurrence.	[Wang, Baojun; Gong, Huijie; Zhang, Xu; Li, Hongzhao; Ma, Xin; Song, Erlin; Gao, Jiangping; Dong, Jun] Chinese PLA Med Acad, Chinese PLA Gen Hosp, Dept Urol, Beijing, Peoples R China	Chinese People's Liberation Army General Hospital	Zhang, X (corresponding author), Chinese PLA Med Acad, Chinese PLA Gen Hosp, Dept Urol, Beijing, Peoples R China.	xzhang@tjh.tjmu.edu.cn			National High Technology Research and Development Program of China ("863" Program) [2012AA021101]	National High Technology Research and Development Program of China ("863" Program)(National High Technology Research and Development Program of China)	This work was supported by the National High Technology Research and Development Program of China ("863" Program) (2012AA021101).	Blute ML, 2000, MAYO CLIN PROC, V75, P1020, DOI 10.4065/75.10.1020; Blute ML, 2003, J UROLOGY, V169, P1276, DOI 10.1097/01.ju.0000051883.41237.43; Boorjian SA, 2008, EUR UROL, V54, P855, DOI 10.1016/j.eururo.2008.04.079; Booth J, 2008, UROL ONCOL-SEMIN ORI, V26, P37, DOI 10.1016/j.urolonc.2007.01.012; Ficarra V, 2009, EUR UROL, V56, P786, DOI 10.1016/j.eururo.2009.07.040; Funahashi Y, 2011, UROLOGY, V77, P1404, DOI 10.1016/j.urology.2010.03.063; Gill IS, 2007, J UROLOGY, V178, P41, DOI 10.1016/j.juro.2007.03.038; Gill IS, 2010, J UROLOGY, V183, P34, DOI 10.1016/j.juro.2009.08.114; Go AS, 2004, NEW ENGL J MED, V351, P1296, DOI 10.1056/NEJMoa041031; Grimaldi G, 1998, ANN SURG ONCOL, V5, P548, DOI 10.1007/BF02303649; Klatte T, 2007, BJU INT, V100, P21, DOI 10.1111/j.1464-410X.2007.06877.x; Levey AS, 2009, ANN INTERN MED, V150, P604, DOI 10.7326/0003-4819-150-9-200905050-00006; Lowrance WT, 2010, BJU INT, V105, P1093, DOI 10.1111/j.1464-410X.2009.08844.x; Lu JS, 2010, UROLOGY, V76, P1414, DOI 10.1016/j.urology.2010.02.059; Pahernik S, 2007, BJU INT, V100, P26, DOI 10.1111/j.1464-410X.2007.06899.x; Patel MI, 2003, UROLOGY, V61, P921, DOI 10.1016/S0090-4295(02)02578-5; Pearson J, 2015, KOREAN J UROL, V56, P607, DOI 10.4111/kju.2015.56.9.607; Phelan MW, 2012, J UROLOGY, V188, P18, DOI 10.1016/j.juro.2012.04.032; Schmidbauer J, 2008, EUR UROL, V53, P1003, DOI 10.1016/j.eururo.2007.11.041; Simmons MN, 2010, J UROLOGY, V184, P865, DOI 10.1016/j.juro.2010.05.042; Steinberg EP, 2000, AM J KIDNEY DIS, V36, P1; Storkel S, 1997, CANCER, V80, P987, DOI 10.1002/(SICI)1097-0142(19970901)80:5<987::AID-CNCR24>3.0.CO;2-R; Veltri A, 2011, EUR RADIOL, V21, P393, DOI 10.1007/s00330-010-1938-9; Wang R, 2009, UROLOGY, V73, P586, DOI 10.1016/j.urology.2008.08.519; Williamson TJ, 2016, BJU INT, V117, P555, DOI 10.1111/bju.13384; Zhang X, 2005, UROLOGY, V65, P1080, DOI 10.1016/j.urology.2004.12.024; Zhang X, 2003, J UROLOGY, V169, P991, DOI 10.1097/01.ju.0000045090.45767.56	27	12	17	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 2	2016	11	5							e0154578	10.1371/journal.pone.0154578	http://dx.doi.org/10.1371/journal.pone.0154578			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DL5KB	27136191	Green Published, gold, Green Submitted			2022-12-26	WOS:000375674800031
J	Xue, HW; Lin, FH; Tan, HW; Zhu, ZQ; Zhang, ZY; Zhao, LD				Xue, Hongwei; Lin, Fuhuang; Tan, Hongwu; Zhu, Zun-Qiang; Zhang, Zhang-Yun; Zhao, Ludong			Overrepresentation of IL-10-Expressing B Cells Suppresses Cytotoxic CD4(+) T Cell Activity in HBV-Induced Hepatocellular Carcinoma	PLOS ONE			English	Article							TUMOR-INFILTRATING LYMPHOCYTES; HEPATITIS-B; ESTABLISHED MELANOMA; VIRUS-INFECTION; POOR SURVIVAL; TIM-1; IMPAIRMENT; VIVO; CANCER; RATES	Hepatocellular carcinoma (HCC) is a common cancer with poor prognosis and low five-year survival rate. A strong and effective CD4(+) T cell-mediated cytotoxicity was associated with better survival and low recurrence rate in HCC, but the regulatory mechanism that controls CD4(+) T cell cytotoxicity in HCC patients is not fully examined. Given that IL-10-expressing B cells could suppress the inflammation of cytotoxic CD8(+) T cells, T helper 1 (Th1) cells and Th17 cells, while promoting regulatory T (Treg) cell differentiation, we examined the role of IL-10-expressing B cells in HBV-related HCC patients. We found that compared to healthy controls, HCC patients exhibited significantly higher frequencies of IL-10-expressing B cells, which were negatively correlated with the frequencies of granzyme A, granzyme B, and perforin expressing CD4+ T cells. Surface molecule Tim-1 was preferentially expressed on IL-10-expressing B cells. Therefore, we separated total B cells into Tim-1(+) and Tim-1-B cells. CD4(+) T cells incubated with Tim-1+ B cells exhibited significantly reduced levels of granzyme A, granzyme B and perforin expression, compared to the CD4(+) T cells incubated with Tim-1-B cells. Antagonizing IL-10 in culture rescued CD4(+) T cell cytotoxicity. Compared to that in peripheral blood, the level of IL-10-expressing B cells were further upregulated in resected tumor, while the level of CD4(+) cytotoxic T cells was downregulated. The negative correlations between IL-10-expressing B cells and CD4(+) cytotoxic T cells were also observed in tumor-infiltrating cells. Together, our data revealed an additional antitumor mechanism mediated by IL-10-expressing B cells.	[Xue, Hongwei] Qingdao Univ, Affiliated Hosp, Dept Oncol, Qingdao 266003, Shandong, Peoples R China; [Lin, Fuhuang] Hainan Prov Peoples Hosp, Dept Intervent Radiol, Haikou 570311, Hainan, Peoples R China; [Tan, Hongwu; Zhao, Ludong] Linyi Peoples Hosp, Dept Hepatobiliary Surg, Linyi 276000, Shandong, Peoples R China; [Zhu, Zun-Qiang; Zhang, Zhang-Yun] Shanghai Jiao Tong Univ, Dept Med, Peoples Hosp 6, Shanghai 200030, Peoples R China	Qingdao University; Shanghai Jiao Tong University	Zhao, LD (corresponding author), Linyi Peoples Hosp, Dept Hepatobiliary Surg, Linyi 276000, Shandong, Peoples R China.	ludongzhao@126.com						Appay V, 2002, J IMMUNOL, V168, P5954, DOI 10.4049/jimmunol.168.11.5954; Aslan N, 2006, J VIRAL HEPATITIS, V13, P505, DOI 10.1111/j.1365-2893.2006.00723.x; Blair PA, 2010, IMMUNITY, V32, P129, DOI 10.1016/j.immuni.2009.11.009; Bosch FX, 2004, GASTROENTEROLOGY, V127, pS5, DOI 10.1053/j.gastro.2004.09.011; Bruix J, 2011, HEPATOLOGY, V53, P1020, DOI 10.1002/hep.24199; Cai L, 2008, CLIN IMMUNOL, V129, P428, DOI 10.1016/j.clim.2008.08.012; Cariello M, 2014, HEPATOLOGY, V60, P792, DOI 10.1002/hep.27147; Chen Chien-Jen, 2007, Clin Liver Dis, V11, P797, DOI 10.1016/j.cld.2007.08.005; Das A, 2012, J IMMUNOL, V189, P3925, DOI 10.4049/jimmunol.1103139; de Souza AJ, 2005, P NATL ACAD SCI USA, V102, P17113, DOI 10.1073/pnas.0508643102; Ding Q, 2011, J CLIN INVEST, V121, P3645, DOI 10.1172/JCI46274; Fu JL, 2007, GASTROENTEROLOGY, V132, P2328, DOI 10.1053/j.gastro.2007.03.102; Fu JL, 2013, HEPATOLOGY, V58, P139, DOI 10.1002/hep.26054; Hao XS, 2003, EUR J CANCER PREV, V12, P273, DOI 10.1097/00008469-200308000-00006; Inoue S, 2006, CANCER RES, V66, P7741, DOI 10.1158/0008-5472.CAN-05-3766; Liu J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089236; Llovet JM, 2003, LANCET, V362, P1907, DOI 10.1016/S0140-6736(03)14964-1; Maini MK, 2000, J EXP MED, V191, P1269, DOI 10.1084/jem.191.8.1269; Marshall NB, 2011, J BIOMED BIOTECHNOL, DOI 10.1155/2011/954602; Mauri C, 2003, J EXP MED, V197, P489, DOI 10.1084/jem.20021293; Mauri C, 2012, ANNU REV IMMUNOL, V30, P221, DOI 10.1146/annurev-immunol-020711-074934; Nelson BH, 2010, J IMMUNOL, V185, P4977, DOI 10.4049/jimmunol.1001323; Nielsen JS, 2012, CLIN CANCER RES, V18, P3281, DOI 10.1158/1078-0432.CCR-12-0234; Protzer U, 2012, NAT REV IMMUNOL, V12, P201, DOI 10.1038/nri3169; Quezada SA, 2010, J EXP MED, V207, P637, DOI 10.1084/jem.20091918; Schmidt J, 2013, EMERG MICROBES INFEC, V2, DOI 10.1038/emi.2013.14; Siewe B, 2013, J LEUKOCYTE BIOL, V93, P811, DOI 10.1189/jlb.0912436; Unitt E, 2005, HEPATOLOGY, V41, P722, DOI 10.1002/hep.20644; Williams NS, 1997, J IMMUNOL, V159, P2091; Wong SH, 2010, IMMUNOLOGY, V131, P77, DOI 10.1111/j.1365-2567.2010.03276.x; Xiao S, 2015, J IMMUNOL, V194, P1602, DOI 10.4049/jimmunol.1402632; Xie Y, 2010, J EXP MED, V207, P651, DOI 10.1084/jem.20091921; Xu C, 2014, CANCER LETT, V345, P216, DOI 10.1016/j.canlet.2013.08.035; Yasukawa M, 2000, BLOOD, V95, P2352, DOI 10.1182/blood.V95.7.2352.007k40_2352_2355	34	36	39	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 2	2016	11	5							e0154815	10.1371/journal.pone.0154815	http://dx.doi.org/10.1371/journal.pone.0154815			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DL5KB	27136203	Green Published, Green Submitted, gold			2022-12-26	WOS:000375674800051
J	Murakami, S; Verdonschot, RG; Kakimoto, N; Sumida, I; Fujiwara, M; Ogawa, K; Furukawa, S				Murakami, Shumei; Verdonschot, Rinus G.; Kakimoto, Naoya; Sumida, Iori; Fujiwara, Masateru; Ogawa, Kazuhiko; Furukawa, Souhei			Preventing Complications from High-Dose Rate Brachytherapy when Treating Mobile Tongue Cancer via the Application of a Modular Lead-Lined Spacer	PLOS ONE			English	Article							RATE INTERSTITIAL BRACHYTHERAPY; STAGE-I; CARCINOMA; OSTEORADIONECROSIS; RADIOTHERAPY; RECOMMENDATIONS; OPTIMIZATION; HEAD	Purpose To point out the advantages and drawbacks of high-dose rate brachytherapy in the treatment of mobile tongue cancer and indicate the clinical importance of modular lead-lined spacers when applying this technique to patients. Methods First, all basic steps to construct the modular spacer are shown. Second, we simulate and evaluate the dose rate reduction for a wide range of spacer configurations. Results With increasing distance to the source absorbed doses dropped considerably. Significantly more shielding was obtained when lead was added to the spacer and this effect was most pronounced on shorter (i.e. more clinically relevant) distances to the source. Conclusions The modular spacer represents an important addition to the planning and treatment stages of mobile tongue cancer using HDR-ISBT.	[Murakami, Shumei; Verdonschot, Rinus G.; Kakimoto, Naoya; Sumida, Iori; Furukawa, Souhei] Osaka Univ, Grad Sch Dent, Dept Oral & Maxillofacial Radiol, Suita, Osaka, Japan; [Murakami, Shumei; Kakimoto, Naoya; Sumida, Iori; Fujiwara, Masateru; Ogawa, Kazuhiko] Osaka Univ, Grad Sch Med, Dept Radiat Oncol, Suita, Osaka, Japan	Osaka University; Osaka University	Verdonschot, RG (corresponding author), Osaka Univ, Grad Sch Dent, Dept Oral & Maxillofacial Radiol, Suita, Osaka, Japan.	rinusverdonschot@gmail.com						Barrett JF, 2004, RADIOGRAPHICS, V24, P1679, DOI 10.1148/rg.246045065; Berger M., 1998, NIST STANDARD REFERE, V8, P87, DOI DOI 10.18434/T48G6X; Delacroix D, 1998, RADIAT PROT DOSIM, P112; Edmundson GK, 1990, BRACHYTHERAPY HDR LD, P184; FUJITA M, 1993, ORAL SURG ORAL MED O, V76, P797, DOI 10.1016/0030-4220(93)90054-8; Fujita M, 1996, INT J RADIAT ONCOL, V34, P333, DOI 10.1016/0360-3016(95)02066-7; FUJITA M, 1994, ORAL SURG ORAL MED O, V77, P589, DOI 10.1016/0030-4220(94)90316-6; Goethals P-E, 2014, OPPORTUNITIES BRACHY; Goineau A, 2015, BRACHYTHERAPY, V14, P71, DOI 10.1016/j.brachy.2014.09.011; Hubbell JH, 1975, PHYS CHEM REF DATA, V4, P471; Japan Radioisotope Association, 2011, RAD POCK DAT BOOK, V11; Kakimoto N, 2006, ANTICANCER RES, V26, P3933; Katimoto N, 2003, RADIOTHER ONCOL, V68, P123, DOI 10.1016/S0167-8140(03)00055-0; Kato H., 2014, JAPANESE J RADIOLOGI, V70, P1181; Kudoh T, 2010, ORAL SURG ORAL MED O, V109, pE102, DOI 10.1016/j.tripleo.2009.10.019; Lachance B, 2002, INT J RADIAT ONCOL, V54, P86, DOI 10.1016/S0360-3016(02)02897-3; Lau HY, 1996, RADIOTHER ONCOL, V39, P15, DOI 10.1016/0167-8140(95)01686-4; Leung TW, 1997, INT J RADIAT ONCOL, V39, P1113, DOI 10.1016/S0360-3016(97)00376-3; Mariotto AB, 2011, JNCI-J NATL CANCER I, V103, P117, DOI 10.1093/jnci/djq495; Mazeron JJ, 2009, RADIOTHER ONCOL, V91, P150, DOI 10.1016/j.radonc.2009.01.005; MAZERON JJ, 1990, INT J RADIAT ONCOL, V19, P1369, DOI 10.1016/0360-3016(90)90346-L; Miura M, 1998, INT J RADIAT ONCOL, V41, P763, DOI 10.1016/S0360-3016(98)00118-7; NATH R, 1995, MED PHYS, V22, P209, DOI 10.1118/1.597458; Obinata K, 2003, ORAL SURG ORAL MED O, V95, P246, DOI 10.1067/moe.2003.94; Oota S, 2006, RADIAT ONCOL, V1, DOI 10.1186/1748-717X-1-21; Petersen PE, 2009, ORAL ONCOL, V45, P454, DOI 10.1016/j.oraloncology.2008.05.023; Peterson DE, 2010, SUPPORT CARE CANCER, V18, P1089, DOI 10.1007/s00520-010-0898-6; Reuther T, 2003, INT J ORAL MAX SURG, V32, P289, DOI 10.1054/ijom.2002.0332; Rivard MJ, 2004, MED PHYS, V31, P633, DOI 10.1118/1.1646040; Siegel R, 2014, CA-CANCER J CLIN, V64, P9, DOI 10.3322/caac.21208; Sumida I, 2006, INT J RADIAT ONCOL, V64, P643, DOI 10.1016/j.ijrobp.2005.09.008; Tsai CJ, 2013, INT J RADIAT ONCOL, V85, P415, DOI 10.1016/j.ijrobp.2012.05.032; Umeda M, 2000, ORAL SURG ORAL MED O, V90, P667, DOI 10.1067/moe.2000.110087; WENDT CD, 1990, INT J RADIAT ONCOL, V18, P1287, DOI 10.1016/0360-3016(90)90299-Y; Williamson JF, 2002, MED PHYS, V29, P2404, DOI 10.1118/1.1509443; Yoshimura R, 2012, INT J RADIAT ONCOL, V83, P1198, DOI 10.1016/j.ijrobp.2011.09.018	36	8	10	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 29	2016	11	4							e0154226	10.1371/journal.pone.0154226	http://dx.doi.org/10.1371/journal.pone.0154226			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DK8XM	27128434	Green Published, gold, Green Submitted			2022-12-26	WOS:000375212600023
J	Chen, YH; Lin, WW; Liu, CS; Hsu, LS; Lin, YM; Su, SL				Chen, Ya-Hui; Lin, Wei-Wen; Liu, Chin-San; Hsu, Li-Sung; Lin, Yueh-Min; Su, Shih-Li			Caveolin-1 Expression Ameliorates Nephrotic Damage in a Rabbit Model of Cholesterol-Induced Hypercholesterolemia	PLOS ONE			English	Article							NITRIC-OXIDE SYNTHESIS; HIGH-DENSITY-LIPOPROTEIN; MITOCHONDRIAL BIOGENESIS; PROXIMAL TUBULE; ANGIOTENSIN-II; EFFLUX; TRANSPORTER; PROTEINURIA; METABOLISM; ACTIVATION	Caveolin-1 (CAV-1) participates in regulating vesicular transport, signal transduction, tumor progression, and cholesterol homeostasis. In the present study, we tested the hypothesis that CAV-1 improves dyslipidemia, inhibits cyclophilin A (CypA)-mediated ROS production, prevents mitochondrial compensatory action and attenuates oxidative stress responses in cholesterol-induced hypercholesterolemia. To determine the role of CAV-1 in mediating oxidative and antioxidative as well as cholesterol homeostasis, hypercholesterolemic rabbits were intravenously administered antenapedia-CAV-1 (AP-CAV-1) peptide for 2 wk. APCAV- 1 enhanced CAV-1 expression by. 15%, inhibited CypA expression by. 50% (P < 0.05) and significantly improved dyslipidemia, thus reducing neutral lipid peroxidation. Moreover, CAV-1 attenuated hypercholesterolemia-induced changes in mitochondrial morphology and biogenesis and preserved mitochondrial respiratory function. In addition, CAV-1 protected against hypercholesterol-induced oxidative stress responses by reducing the degree of oxidative damage and enhancing the expression of antioxidant enzymes. CAV-1 treatment significantly suppressed apoptotic cell death, as evidenced by the reduction in the number of terminal deoxynucleotidyl transferase dUTP nick end-labeling-positive cells. We concluded that CAV-1 plays a critical role in inhibiting CypA-mediated ROS production, improving dyslipidemia, maintaining mitochondrial function, and suppressing oxidative stress responses that are vital for cell survival in hypercholesterol-affected renal organs.	[Chen, Ya-Hui; Liu, Chin-San; Su, Shih-Li] Changhua Christian Hosp, Vasc & Genom Ctr, Changhua, Taiwan; [Chen, Ya-Hui; Hsu, Li-Sung] Chung Shan Med Univ, Inst Biochem & Biotechnol, Taichung, Taiwan; [Lin, Wei-Wen] Taichung Vet Gen Hosp, Dept Internal Med, Div Cardiovasc Ctr, Taichung, Taiwan; [Liu, Chin-San] China Med Univ, Grad Inst Integrat Med, Taichung, Taiwan; [Lin, Yueh-Min] Changhua Christian Hosp, Dept Pathol, Changhua, Taiwan; [Lin, Yueh-Min] Jen Teh Jr Coll Med Nursing & Management, Dept Med Technol, Miaoli, Taiwan; [Su, Shih-Li] Changhua Christian Hosp, Div Endocrinol & Metab, Dept Internal Med, Changhua, Taiwan; [Su, Shih-Li] Chung Shan Med Univ, Inst Med, Taichung, Taiwan	Changhua Christian Hospital; Chung Shan Medical University; Taichung Veterans General Hospital; China Medical University Taiwan; Changhua Christian Hospital; Changhua Christian Hospital; Chung Shan Medical University	Su, SL (corresponding author), Changhua Christian Hosp, Vasc & Genom Ctr, Changhua, Taiwan.; Su, SL (corresponding author), Changhua Christian Hosp, Div Endocrinol & Metab, Dept Internal Med, Changhua, Taiwan.; Su, SL (corresponding author), Chung Shan Med Univ, Inst Med, Taichung, Taiwan.	89933@cch.org.tw		Lin, Wei-Wen/0000-0002-9384-1970	Changhua Christian Hospital [103-CCH-IRP-066]	Changhua Christian Hospital	This work was supported by Changhua Christian Hospital under the grant number 103-CCH-IRP-066.	Attia DM, 2004, J AM SOC NEPHROL, V15, P949, DOI 10.1097/01.ASN.0000118528.00817.8E; Attia DM, 2002, KIDNEY INT, V61, P1776, DOI 10.1046/j.1523-1755.2002.00313.x; Bosch M, 2011, CURR BIOL, V21, P681, DOI 10.1016/j.cub.2011.03.030; Bucci M, 2000, NAT MED, V6, P1362, DOI 10.1038/82176; Cao GW, 2003, AM J PATHOL, V162, P1241, DOI 10.1016/S0002-9440(10)63920-X; Carney Ellen F, 2013, Nat Rev Nephrol, V9, P493, DOI 10.1038/nrneph.2013.140; Chen YP, 2014, PLOS ONE, V9, DOI [10.1371/journal.pone.0086159, 10.1371/journal.pone.0109012, 10.1371/journal.pone.0094614]; Dalrymple LS, 2008, AM J NEPHROL, V28, P723, DOI 10.1159/000127980; Derossi D, 1996, J BIOL CHEM, V271, P18188, DOI 10.1074/jbc.271.30.18188; FIELDING PE, 1995, BIOCHEMISTRY-US, V34, P14288, DOI 10.1021/bi00044a004; Frank PG, 2004, CURR OPIN LIPIDOL, V15, P523, DOI 10.1097/00041433-200410000-00005; Frank PG, 2004, ARTERIOSCL THROM VAS, V24, P98, DOI 10.1161/01.ATV.0000101182.89118.E5; Frank PG, 2001, AM J PHYSIOL-CELL PH, V280, pC1204, DOI 10.1152/ajpcell.2001.280.5.C1204; Frank PG, 2006, AM J PHYSIOL-HEART C, V291, pH677, DOI 10.1152/ajpheart.01092.2005; Fujigaki Y, 2007, VIRCHOWS ARCH, V450, P671, DOI 10.1007/s00428-007-0417-4; Gong YZ, 2014, PHARMACOLOGY, V94, P214, DOI 10.1159/000368803; Granata S, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-388; Grande G, 2009, AM J PHYSIOL-RENAL, V297, pF257, DOI 10.1152/ajprenal.00075.2009; Heimer S, 2008, BIOCHEM BIOPH RES CO, V367, P826, DOI 10.1016/j.bbrc.2008.01.010; Honda H, 2010, CLIN J AM SOC NEPHRO, V5, P1021, DOI 10.2215/CJN.06110809; Jasmin JF, 2012, ADV EXP MED BIOL, V729, P1, DOI 10.1007/978-1-4614-1222-9; Keane WF, 2013, J ATHEROSCLER THROMB, V20, P123, DOI 10.5551/jat.12849; Li XC, 2014, AM J PHYSIOL-RENAL, V307, pF949, DOI 10.1152/ajprenal.00199.2014; Lin Chen-Sung, 2008, Interact Cardiovasc Thorac Surg, V7, P954, DOI 10.1510/icvts.2008.177006; Lin WW, 2006, J HISTOCHEM CYTOCHEM, V54, P897, DOI 10.1369/jhc.5A6869.2006; Lin YC, 2007, CARDIOVASC RES, V75, P575, DOI 10.1016/j.cardiores.2007.04.012; Mercier I, 2009, LAB INVEST, V89, P614, DOI 10.1038/labinvest.2009.23; Merscher S, 2014, FRONT ENDOCRINOL, V5, DOI 10.3389/fendo.2014.00169; Moreno-Caceres J, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.294; Mundy DI, 2014, BBA-MOL CELL BIOL L, V1841, P995, DOI 10.1016/j.bbalip.2014.04.002; Nishi Y, 2013, KIDNEY INT, V83, P662, DOI 10.1038/ki.2012.475; Pavlides S, 2014, CELL TISSUE RES, V358, P821, DOI 10.1007/s00441-014-2008-4; Pavlides S, 2014, CELL TISSUE RES, V356, P147, DOI 10.1007/s00441-013-1767-7; Qin L, 2014, CLIN EXP PHARMACOL P, V41, P671, DOI 10.1111/1440-1681.12258; Rasbach KA, 2007, J BIOL CHEM, V282, P2355, DOI 10.1074/jbc.M608009200; Suliman HB, 2003, J BIOL CHEM, V278, P41510, DOI 10.1074/jbc.M304719200; Wang Faqi, 2014, Cardiovascular & Hematological Disorders - Drug Targets, V14, P142; Williams JJL, 2014, BIOCHEM SOC T, V42, P284, DOI 10.1042/BST20130270; Zhuang ZJ, 2011, AM J PHYSIOL-RENAL, V300, pF199, DOI 10.1152/ajprenal.00513.2010	39	5	7	2	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 28	2016	11	4							e0154210	10.1371/journal.pone.0154210	http://dx.doi.org/10.1371/journal.pone.0154210			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DK8XE	27124120	Green Published, gold, Green Submitted			2022-12-26	WOS:000375211700055
J	Ellrich, JA; Scrosati, RA; Romoth, K; Molis, M				Ellrich, Julius A.; Scrosati, Ricardo A.; Romoth, Katharina; Molis, Markus			Adult Prey Neutralizes Predator Nonconsumptive Limitation of Prey Recruitment	PLOS ONE			English	Article							BALANOIDES L. CRUSTACEA; SEMIBALANUS-BALANOIDES; CHEMICAL CUES; SETTLEMENT BEHAVIOR; LAPILLUS GASTROPODA; RELATIVE IMPORTANCE; BARNACLE; RISK; CIRRIPEDIA; ECOLOGY	Recent studies have shown that predator chemical cues can limit prey demographic rates such as recruitment. For instance, barnacle pelagic larvae reduce settlement where predatory dogwhelk cues are detected, thereby limiting benthic recruitment. However, adult barnacles attract conspecific larvae through chemical and visual cues, aiding larvae to find suitable habitat for development. Thus, we tested the hypothesis that the presence of adult barnacles (Semibalanus balanoides) can neutralize dogwhelk (Nucella lapillus) nonconsumptive effects on barnacle recruitment. We did a field experiment in Atlantic Canada during the 2012 and 2013 barnacle recruitment seasons (May-June). We manipulated the presence of dogwhelks (without allowing them to physically contact barnacles) and adult barnacles in cages established in rocky intertidal habitats. At the end of both recruitment seasons, we measured barnacle recruit density on tiles kept inside the cages. Without adult barnacles, the nearby presence of dogwhelks limited barnacle recruitment by 51%. However, the presence of adult barnacles increased barnacle recruitment by 44% and neutralized dogwhelk nonconsumptive effects on barnacle recruitment, as recruit density was unaffected by dogwhelk presence. For species from several invertebrate phyla, benthic adult organisms attract conspecific pelagic larvae. Thus, adult prey might commonly constitute a key factor preventing negative predator nonconsumptive effects on prey recruitment.	[Ellrich, Julius A.; Scrosati, Ricardo A.; Romoth, Katharina] St Francis Xavier Univ, Dept Biol, Antigonish, NS B2G 1C0, Canada; [Romoth, Katharina] Carl von Ossietzky Univ Oldenburg, Dept Chem & Biol Marine Environm, Oldenburg, Niedersachsen, Germany; [Molis, Markus] Helmholtz Zentrum Polar & Meeresforsch, Alfred Wegener Inst, Sect Funct Ecol, Bremen, Germany	Saint Francis Xavier University - Canada; Carl von Ossietzky Universitat Oldenburg; Helmholtz Association; Alfred Wegener Institute, Helmholtz Centre for Polar & Marine Research	Ellrich, JA (corresponding author), St Francis Xavier Univ, Dept Biol, Antigonish, NS B2G 1C0, Canada.	jellrich@stfx.ca	Scrosati, Ricardo A/K-6172-2016	Scrosati, Ricardo A/0000-0002-3050-132X; Ellrich, Julius/0000-0003-0884-3726	Canada Research Chairs [210283]; Canada Foundation for Innovation [202034]; Natural Sciences and Engineering Research Council [311624]	Canada Research Chairs(Canada Research ChairsCGIAR); Canada Foundation for Innovation(Canada Foundation for InnovationCGIAR); Natural Sciences and Engineering Research Council(Natural Sciences and Engineering Research Council of Canada (NSERC))	Research was funded through grants by Canada Research Chairs (grant number: 210283, http://www.chairs-chaires.gc.ca/home-accueil-eng.aspx), the Canada Foundation for Innovation (grant number: 202034, http://www.innovation.ca/) and the Natural Sciences and Engineering Research Council (grant number: 311624, http://www.nserc-crsng.gc.ca/index_eng.asp) received by RAS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson DT, 1994, STRUCTURE FUNCTION D; Banks J, 2000, CRUSTACEANA, V73, P223, DOI 10.1163/156854000504174; Beermann AJ, 2013, J EXP MAR BIOL ECOL, V448, P162, DOI 10.1016/j.jembe.2013.07.001; BELL EC, 1994, J EXP MAR BIOL ECOL, V181, P9; BERTNESS MD, 1992, J EXP MAR BIOL ECOL, V156, P199, DOI 10.1016/0022-0981(92)90246-7; Bouchard GM, 2012, CRUSTACEANA, V85, P779, DOI 10.1163/156854012X650214; BOUDREAU B, 1993, MAR BIOL, V117, P63, DOI 10.1007/BF00346426; Bousfield E. L., 1954, Bulletin National Museum of Canada, VNo. 132, P112; Bowler DE, 2013, J ZOOL, V289, P52, DOI 10.1111/j.1469-7998.2012.00961.x; Chiba S, 2000, J MAR BIOL ASSOC UK, V80, P617, DOI 10.1017/S0025315400002435; Clare AS, 2011, CHEMICAL COMMUNICATION IN CRUSTACEANS, P431, DOI 10.1007/978-0-387-77101-4_22; Cole SWB, 2011, J SEA RES, V65, P33, DOI 10.1016/j.seares.2010.06.006; CRISP DJ, 1962, PROC R SOC SER B-BIO, V156, P500, DOI 10.1098/rspb.1962.0052; Davies MS, 1998, ADV MAR BIOL, V34, P1, DOI 10.1016/S0065-2881(08)60210-2; Dreanno C, 2007, J EXP MAR BIOL ECOL, V351, P276, DOI 10.1016/j.jembe.2007.07.003; Elbourne PD, 2010, J EXP MAR BIOL ECOL, V392, P99, DOI 10.1016/j.jembe.2010.04.013; Ellrich JA, 2016, MAR BIOL, V163, DOI 10.1007/s00227-015-2778-6; Ellrich JA, 2015, J EXP MAR BIOL ECOL, V472, P72, DOI 10.1016/j.jembe.2015.07.005; Ellrich JA, 2015, ECOLOGY, V96, P611, DOI 10.1890/14-1856.1; Ferrari MCO, 2010, CAN J ZOOL, V88, P698, DOI 10.1139/Z10-029; Fisheries and Oceans Canada, 2015, OC SCI DAT BRANCH; Gabbott PA, 1987, BARNACLE BIOL, P377; Hadfield MG, 2001, CRC MAR SCI, P431; Hermann SL, 2014, OECOLOGIA, V176, P669, DOI 10.1007/s00442-014-3069-5; Hill JM, 2013, OECOLOGIA, V172, P79, DOI 10.1007/s00442-012-2488-4; Holt R.D., 2009, PRINCETON GUIDE ECOL, P274; HUGHES RN, 1972, OECOLOGIA, V8, P356, DOI 10.1007/BF00367538; Hunt HL, 1998, J EXP MAR BIOL ECOL, V226, P87, DOI 10.1016/S0022-0981(97)00239-6; Hunt HL, 2001, ECOLOGY, V82, P3213, DOI 10.1890/0012-9658(2001)082[3213:PDOMOR]2.0.CO;2; Jenkins SR, 1999, J EXP MAR BIOL ECOL, V236, P49, DOI 10.1016/S0022-0981(98)00189-0; Jenkins SR, 2000, J EXP MAR BIOL ECOL, V243, P209, DOI 10.1016/S0022-0981(99)00121-5; JOHNSON LE, 1989, J EXP MAR BIOL ECOL, V128, P87, DOI 10.1016/0022-0981(89)90094-4; Johnston BR, 2012, CAN J ZOOL, V90, P128, DOI 10.1139/Z11-113; Kent A, 2003, J ANIM ECOL, V72, P941, DOI 10.1046/j.1365-2656.2003.00762.x; Keppel E, 2004, ANIM BEHAV, V68, P915, DOI 10.1016/j.anbehav.2003.11.020; Large SI, 2011, MAR ECOL PROG SER, V422, P41, DOI 10.3354/meps08930; LARGEN MJ, 1967, J ZOOL, V151, P123; LARGEN MJ, 1967, J ANIM ECOL, V36, P207, DOI 10.2307/3022; Manriquez PH, 2007, MAR ECOL PROG SER, V332, P155, DOI 10.3354/meps332155; Matassa CM, 2015, OECOLOGIA, V177, P775, DOI 10.1007/s00442-014-3156-7; Matassa CM, 2011, ECOLOGY, V92, P2258, DOI 10.1890/11-0424.1; Matsumura K, 2000, BIOFOULING, V16, P181, DOI 10.1080/08927010009378443; Matsumura K, 2014, J EXP BIOL, V217, P743, DOI 10.1242/jeb.096990; Metaxas A, 2006, J EXP MAR BIOL ECOL, V334, P187, DOI 10.1016/j.jembe.2006.01.025; Molis M, 2011, J ECOL, V99, P807, DOI 10.1111/j.1365-2745.2011.01800.x; National Aeronautics and Space Administration, 2015, DAT OC COL RAD ONL V; Orrock JL, 2013, ECOLOGY, V94, P573, DOI 10.1890/12-0502.1; PALMER AR, 1983, J EXP MAR BIOL ECOL, V73, P95, DOI 10.1016/0022-0981(83)90078-3; Pangle KL, 2007, ECOLOGY, V88, P402, DOI 10.1890/06-0768; Peacor SD, 2013, OECOLOGIA, V171, P1, DOI 10.1007/s00442-012-2394-9; Peacor SD, 2001, P NATL ACAD SCI USA, V98, P3904, DOI 10.1073/pnas.071061998; Pineda J, 2002, MAR BIOL, V140, P789, DOI 10.1007/s00227-001-0751-z; Preisser EL, 2005, ECOLOGY, V86, P501, DOI 10.1890/04-0719; Puglisi MP, 2014, NAT PROD REP, V31, P1510, DOI 10.1039/c4np00017j; Qian PY, 1999, HYDROBIOLOGIA, V402, P239, DOI 10.1023/A:1003704928668; RAIMONDI PT, 1988, ECOLOGY, V69, P400, DOI 10.2307/1940438; RAINBOW P S, 1984, Field Studies, V6, P1; RODRIGUEZ SR, 1993, MAR ECOL PROG SER, V97, P193, DOI 10.3354/meps097193; Scrosati R, 2007, MAR ECOL PROG SER, V342, P1, DOI 10.3354/meps342001; Silberbush A, 2011, FUNCT ECOL, V25, P1091, DOI 10.1111/j.1365-2435.2011.01873.x; Takeda S, 2008, J EXP MAR BIOL ECOL, V363, P21, DOI 10.1016/j.jembe.2008.06.010; Tapia-Lewin S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095335; Thompson RC, 1998, HYDROBIOLOGIA, V375-76, P203, DOI 10.1023/A:1017036301082; Trussell GC, 2003, ECOLOGY, V84, P629, DOI 10.1890/0012-9658(2003)084[0629:TMEIRI]2.0.CO;2; Trussell GC, 2006, ECOL LETT, V9, P1245, DOI 10.1111/j.1461-0248.2006.00981.x; Turner AM, 2004, OIKOS, V104, P561, DOI 10.1111/j.0030-1299.2004.12615.x; Underwood A.J., 1997, EXPT ECOLOGY THEIR L, DOI DOI 10.1017/CBO9780511806407; Van Buskirk J, 2011, OIKOS, V120, P1235, DOI 10.1111/j.1600-0706.2010.19311.x; Vargas CA, 2006, ECOLOGY, V87, P444, DOI 10.1890/05-0265; Vasquez HE, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082358; Weissburg M, 2014, AM NAT, V184, P141, DOI 10.1086/676644; Welch JM, 1997, MAR ECOL PROG SER, V154, P143, DOI 10.3354/meps154143; Wright JR, 1999, MAR ECOL PROG SER, V183, P179, DOI 10.3354/meps183179	73	11	11	2	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 28	2016	11	4							e0154572	10.1371/journal.pone.0154572	http://dx.doi.org/10.1371/journal.pone.0154572			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DK8XE	27123994	gold, Green Published			2022-12-26	WOS:000375211700105
J	Galissier, T; Schneider, C; Nasri, S; Kanagaratnam, L; Fichel, C; Coquelet, C; Diebold, MD; Kianmanesh, R; Bellon, G; Dedieu, S; Bressenot, AM; Boulagnon-Rombi, C				Galissier, Thibaut; Schneider, Christophe; Nasri, Saviz; Kanagaratnam, Lukshe; Fichel, Caroline; Coquelet, Christelle; Diebold, Marie-Daniele; Kianmanesh, Reza; Bellon, Georges; Dedieu, Stephane; Bressenot, Aude Marchal; Boulagnon-Rombi, Camille			Biobanking of Fresh-Frozen Human Adenocarcinomatous and Normal Colon Tissues: Which Parameters Influence RNA Quality?	PLOS ONE			English	Article							GENE-EXPRESSION; ANASTOMOTIC LEAKAGE; INTEGRITY NUMBER; ISCHEMIA TIME; MESSENGER-RNA; CANCER; STORAGE; ASSURANCE; IMPACT; BIOREPOSITORY	Medical research projects become increasingly dependent on biobanked tissue of high quality because the reliability of gene expression is affected by the quality of extracted RNA. Hence, the present study aimed to determine if clinical, surgical, histological, and molecular parameters influence RNA quality of normal and tumoral frozen colonic tissues. RNA Quality Index (RQI) was evaluated on 241 adenocarcinomas and 115 matched normal frozen colon tissues collected between October 2006 and December 2012. RQI results were compared to patients' age and sex, tumor site, kind of surgery, anastomosis failure, adenocarcinoma type and grade, tumor cell percentage, necrosis extent, HIF-1 alpha and cleaved caspase-3 immunohistochemistry, and BRAF, KRAS and microsatellites status. The RQI was significantly higher in colon cancer tissue than in matched normal tissue. RQI from left-sided colonic cancers was significantly higher than RQI from right-sided cancers. The RNA quality was not affected by ischemia and storage duration. According to histological control, 7.9% of the samples were unsatisfactory because of inadequate sampling. Biobanked tumoral tissues with RQI >= 5 had lower malignant cells to stromal cells ratio than samples with RQI <5 (p < 0.05). Cellularity, necrosis extent and mucinous component did not influence RQI results. Cleaved caspase-3 and HIF-1 alpha immunolabelling were not correlated to RQI. BRAF, KRAS and microsatellites molecular status did not influence RNA quality. Multivariate analysis revealed that the tumor location, the surgical approach (laparoscopy versus open colectomy) and the occurrence of anastomotic leakage were the only parameters influencing significantly RQI results of tumor samples. We failed to identify parameter influencing RQI of normal colon samples. These data suggest that RNA quality of colonic adenocarcinoma biospecimens is determined by clinical and surgical parameters. More attention should be paid during the biobanking procedure of right-sided colon cancer or laparoscopic colectomy specimen. Histological quality control remains essential to control sampling accuracy.	[Galissier, Thibaut; Diebold, Marie-Daniele; Bressenot, Aude Marchal; Boulagnon-Rombi, Camille] Ctr Hosp Univ, Anat Pathol Lab, Reims, France; [Schneider, Christophe; Diebold, Marie-Daniele; Bellon, Georges; Dedieu, Stephane; Boulagnon-Rombi, Camille] CNRS, Matrice Extracellulaire & Dynam Cellulaire, MEDyC, CNRS UMR 7369, Reims, France; [Schneider, Christophe; Dedieu, Stephane] Univ Reims, UFR Sci Exactes & Nat, Lab SiRMa, Reims, France; [Nasri, Saviz; Coquelet, Christelle; Diebold, Marie-Daniele] Tumorotheque Champagne Ardenne, Reims, France; [Kanagaratnam, Lukshe] Ctr Hosp Univ, Unite Aide Methodol, Reims, France; [Fichel, Caroline; Diebold, Marie-Daniele; Bressenot, Aude Marchal; Boulagnon-Rombi, Camille] Univ Reims, UFR Med, Anat Pathol Lab, Reims, France; [Kianmanesh, Reza] Ctr Hosp Univ, Serv Chirurg Digest, Reims, France; [Bellon, Georges] Ctr Hosp Univ, Biochim Lab, Reims, France	CHU de Reims; Universite de Reims Champagne-Ardenne; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Reims Champagne-Ardenne; Universite de Reims Champagne-Ardenne; CHU de Reims; Universite de Reims Champagne-Ardenne; CHU de Reims; CHU de Reims	Boulagnon-Rombi, C (corresponding author), Ctr Hosp Univ, Anat Pathol Lab, Reims, France.; Boulagnon-Rombi, C (corresponding author), CNRS, Matrice Extracellulaire & Dynam Cellulaire, MEDyC, CNRS UMR 7369, Reims, France.; Boulagnon-Rombi, C (corresponding author), Univ Reims, UFR Med, Anat Pathol Lab, Reims, France.	camille.boulagnon@gmail.com	Kanagaratnam, Lukshe/AAG-4193-2020; , Boulagnon-Rombi/AAQ-7705-2021	, Boulagnon-Rombi/0000-0001-5610-1722; SCHNEIDER, Christophe/0000-0002-7867-0579; Dedieu, Stephane/0000-0003-1447-5640	Ligue Nationale Contre le Cancer Conference de Coordination Interregionale du Grand Est, Appel d'Offre [001N.2015]; Centre Hospitalier Universitaire de Reims, Appel d'Offre Local [AU14-03]	Ligue Nationale Contre le Cancer Conference de Coordination Interregionale du Grand Est, Appel d'Offre; Centre Hospitalier Universitaire de Reims, Appel d'Offre Local	This work was supported by: 1. Ligue Nationale Contre le Cancer Conference de Coordination Interregionale du Grand Est, Appel d'Offre 2014. Grant Number 001N.2015 (SD), Website: http://www.liguecancer-cd68.fr/CCIR_GE.html; 2. Centre Hospitalier Universitaire de Reims, Appel d'Offre Local 2014. Grant Number AU14-03 (CB-R), Website: https://www.chu-reims.fr/la_recherche.html. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andreasson A, 2013, BIOPRESERV BIOBANK, V11, P366, DOI 10.1089/bio.2013.0038; Auer H, 2014, BIOTECH HISTOCHEM, V89, P518, DOI 10.3109/10520295.2014.904927; Bakker IS, 2014, BRIT J SURG, V101, P424, DOI 10.1002/bjs.9395; Bao WG, 2013, ANN SURG ONCOL, V20, P1737, DOI 10.1245/s10434-012-2440-1; Bertucci F, 2004, ONCOGENE, V23, P1377, DOI 10.1038/sj.onc.1207262; Billaud M, 2012, M S-MED SCI, V28, P1116, DOI 10.1051/medsci/20122812023; Bono A, 2010, CANCER BIOL THER, V10, P682, DOI 10.4161/cbt.10.7.12898; Boudou-Rouquette P, 2010, VIRCHOWS ARCH, V456, P443, DOI 10.1007/s00428-010-0889-5; Boulagnon C, 2016, APPL IMMUNOHISTO M M, V24, P88, DOI 10.1097/PAI.0000000000000157; Bray SE, 2010, HISTOPATHOLOGY, V56, P240, DOI 10.1111/j.1365-2559.2009.03470.x; Brimo F, 2013, BIOPRESERV BIOBANK, V11, P285, DOI 10.1089/bio.2013.0025; Brimo F, 2012, CELL TISSUE BANK, V13, P631, DOI 10.1007/s10561-011-9284-y; De Souza YG, 2013, AIDS, V27, P303, DOI 10.1097/QAD.0b013e32835c1244; Denisov V, DEV VALIDATION RQI R; Diaz Z, 2013, MODERN PATHOL, V26, P1413, DOI 10.1038/modpathol.2013.81; Die JV, 2011, ANAL BIOCHEM, V419, P336, DOI 10.1016/j.ab.2011.08.012; Fearon ER, 1995, ANN NY ACAD SCI, V768, P101, DOI 10.1111/j.1749-6632.1995.tb12114.x; FEARON ER, 1990, CELL, V61, P759, DOI 10.1016/0092-8674(90)90186-I; Fleige S, 2006, BIOTECHNOL LETT, V28, P1601, DOI 10.1007/s10529-006-9127-2; Greenlee RT, 2000, CA-CANCER J CLIN, V50, P7, DOI 10.3322/canjclin.50.1.7; Greytak SR, 2015, CANCER RES, V75, P1541, DOI 10.1158/0008-5472.CAN-14-2378; Hamilton SR, 2010, WHO CLASSIFICATION T, P132; Havelund BM, 2013, APPL IMMUNOHISTO M M, V21, P298, DOI 10.1097/PAI.0b013e31826f4475; Hedegaard J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098187; Heumuller-Klug S, 2015, WORLD J GASTROENTERO, V21, P3499, DOI 10.3748/wjg.v21.i12.3499; Ho-Pun-Cheung A, 2008, ANN BIOL CLIN-PARIS, V66, P121, DOI 10.1684/abc.2008.0204; Hong Sang Hyun, 2010, J Korean Soc Coloproctol, V26, P316, DOI 10.3393/jksc.2010.26.5.316; Hutchins G, 2011, J CLIN ONCOL, V29, P1261, DOI 10.1200/JCO.2010.30.1366; Kap M, 2014, BIOPRESERV BIOBANK, V12, P81, DOI 10.1089/bio.2013.0051; Kashofer K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070714; Krause P, 2011, INT J COLORECTAL DIS, V26, P37, DOI 10.1007/s00384-010-1062-y; Lipska MA, 2006, ANZ J SURG, V76, P579, DOI 10.1111/j.1445-2197.2006.03780.x; Marra F, 2009, EJSO-EUR J SURG ONC, V35, P1060, DOI 10.1016/j.ejso.2009.02.011; Micke P, 2006, LAB INVEST, V86, P202, DOI 10.1038/labinvest.3700372; Moore HM, 2013, TRANSFUSION, V53, pE1, DOI 10.1111/trf.12281; Musella V, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053406; Muzny DM, 2012, NATURE, V487, P330, DOI 10.1038/nature11252; Nannini M, 2009, CANCER TREAT REV, V35, P201, DOI 10.1016/j.ctrv.2008.10.006; Narayanan S, 2000, AM J CLIN PATHOL, V113, P429, DOI 10.1309/C0NM-Q7R0-LL2E-B3UY; Obata S, 2013, ANTICANCER RES, V33, P1881; Opitz L, 2010, BMC MED GENOMICS, V3, DOI 10.1186/1755-8794-3-36; Popat S, 2005, J CLIN ONCOL, V23, P609, DOI 10.1200/JCO.2005.01.086; Romero IG, 2014, BMC BIOL, V12, DOI 10.1186/1741-7007-12-42; Rudloff U, 2010, ANN SURG ONCOL, V17, P2229, DOI 10.1245/s10434-010-0959-6; Sandusky George E., 2007, Cell and Tissue Banking, V8, P287, DOI 10.1007/s10561-007-9037-0; Schroeder A, 2006, BMC MOL BIOL, V7, DOI 10.1186/1471-2199-7-3; Shabihkhani M, 2014, CLIN BIOCHEM, V47, P258, DOI 10.1016/j.clinbiochem.2014.01.002; Sillars-Hardebol AH, 2010, TUMOR BIOL, V31, P89, DOI 10.1007/s13277-009-0012-1; Simeon-Dubach D, 2012, J PATHOL, V228, P431, DOI 10.1002/path.4117; Sircar K, 2006, CLIN CANCER RES, V12, P4178, DOI 10.1158/1078-0432.CCR-06-0328; Smits AJJ, 2014, MODERN PATHOL, V27, P168, DOI 10.1038/modpathol.2013.134; Sobin L, 2010, TNM CLASSIFICATION M, P100; Spruessel A, 2004, BIOTECHNIQUES, V36, P1030, DOI 10.2144/04366RR04; Strand C, 2007, BMC MOL BIOL, V8, DOI 10.1186/1471-2199-8-38; Talks KL, 2000, AM J PATHOL, V157, P411, DOI 10.1016/S0002-9440(10)64554-3; Viana CR, 2013, CELL TISSUE BANK, V14, P167, DOI 10.1007/s10561-012-9313-5; Zeugner Silke, 2015, Recent Results Cancer Res, V199, P85, DOI 10.1007/978-3-319-13957-9_9	57	12	12	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 28	2016	11	4							e0154326	10.1371/journal.pone.0154326	http://dx.doi.org/10.1371/journal.pone.0154326			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DK8XE	27124490	Green Published, Green Submitted, gold			2022-12-26	WOS:000375211700068
J	Lee, SY; Kim, GH; Yun, SH; Choi, CW; Yi, YS; Kim, J; Chung, YH; Park, EC; Kim, SI				Lee, Sang-Yeop; Kim, Gun-Hwa; Yun, Sung Ho; Choi, Chi-Won; Yi, Yoon-Sun; Kim, Jonghyun; Chung, Young-Ho; Park, Edmond Changkyun; Kim, Seung Il			Proteogenomic Characterization of Monocyclic Aromatic Hydrocarbon Degradation Pathways in the Aniline-Degrading Bacterium Burkholderia sp K24	PLOS ONE			English	Article							ACINETOBACTER-LWOFFII K24; GENE-CLUSTER; CATECHOL; PROTEIN; PURIFICATION; PROTEOMICS; CLONING	Burkholderia sp. K24, formerly known as Acinetobacter lwoffii K24, is a soil bacterium capable of utilizing aniline as its sole carbon and nitrogen source. Genomic sequence analysis revealed that this bacterium possesses putative gene clusters for biodegradation of various monocyclic aromatic hydrocarbons (MAHs), including benzene, toluene, and xylene (BTX), as well as aniline. We verified the proposed MAH biodegradation pathways by dioxygenase activity assays, RT-PCR, and LC/MS-based quantitative proteomic analyses. This proteogenomic approach revealed four independent degradation pathways, all converging into the citric acid cycle. Aniline and p-hydroxybenzoate degradation pathways converged into the beta-ketoadipate pathway. Benzoate and toluene were degraded through the benzoyl-CoA degradation pathway. The xylene isomers, i.e., o-, m-, and p-xylene, were degraded via the extradiol cleavage pathways. Salicylate was degraded through the gentisate degradation pathway. Our results show that Burkholderia sp. K24 possesses versatile biodegradation pathways, which may be employed for efficient bioremediation of aniline and BTX.	[Lee, Sang-Yeop; Kim, Gun-Hwa; Yun, Sung Ho; Choi, Chi-Won; Yi, Yoon-Sun; Kim, Jonghyun; Chung, Young-Ho; Park, Edmond Changkyun; Kim, Seung Il] Korea Basic Sci Inst, Drug Dis Target Team, 169-148 Gwahak Ro, Daejeon, South Korea; [Kim, Seung Il] Univ Sci & Technol, Bioanal Sci, 217 Gajeong Ro, Daejeon, South Korea; [Yi, Yoon-Sun] Chungnam Natl Univ, Dept Food Sci & Technol, Taejon 305764, South Korea	Korea Basic Science Institute (KBSI); University of Science & Technology (UST); Chungnam National University	Kim, SI (corresponding author), Korea Basic Sci Inst, Drug Dis Target Team, 169-148 Gwahak Ro, Daejeon, South Korea.; Kim, SI (corresponding author), Univ Sci & Technol, Bioanal Sci, 217 Gajeong Ro, Daejeon, South Korea.	ksi@kbsi.re.kr		Lee, Sang-Yeop/0000-0002-8257-6112; Park, Edmond Changkyun/0000-0001-6699-4886	Korean Health Technology R&D Project, Ministry of Health & Welfare, Republic of Korea [HI14C2726]	Korean Health Technology R&D Project, Ministry of Health & Welfare, Republic of Korea	This study was supported by a grant of the Korean Health Technology R&D Project, Ministry of Health & Welfare, Republic of Korea (No. HI14C2726).	Caspi R, 2008, NUCLEIC ACIDS RES, V36, pD623, DOI [10.1093/nar/gkm900, 10.1093/nar/gkt1103]; Choi EJ, 2013, APPL ENVIRON MICROB, V79, P663, DOI 10.1128/AEM.02809-12; Conroy MJ, 2007, P NATL ACAD SCI USA, V104, P1213, DOI 10.1073/pnas.0610348104; Feng YM, 1999, APPL ENVIRON MICROB, V65, P946; Fukumori F, 1997, J BACTERIOL, V179, P399, DOI 10.1128/jb.179.2.399-408.1997; Zuleta LFG, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-535; HARAYAMA S, 1992, ANNU REV MICROBIOL, V46, P565, DOI 10.1146/annurev.mi.46.100192.003025; IlKim S, 1997, J BACTERIOL, V179, P5226; Ishihama Y, 2005, MOL CELL PROTEOMICS, V4, P1265, DOI 10.1074/mcp.M500061-MCP200; Johnson SL, 2015, GENOME ANNOUNCEMENTS, V3, DOI 10.1128/genomeA.00159-15; Kahng HY, 2002, BIOCHEM BIOPH RES CO, V295, P903, DOI 10.1016/S0006-291X(02)00778-7; Kim EA, 2004, J MICROBIOL METH, V57, P337, DOI 10.1016/j.mimet.2004.02.007; Kim SI, 2002, CURR MICROBIOL, V44, P61, DOI 10.1007/s00284-001-0075-8; Kim SI, 1998, BIOCHEM BIOPH RES CO, V243, P289, DOI 10.1006/bbrc.1997.7912; Kim SI, 1999, J BIOSCI BIOENG, V88, P250, DOI 10.1016/S1389-1723(00)80005-5; Kim YH, 2006, PROTEOMICS, V6, P1301, DOI 10.1002/pmic.200500329; Lee SY, 2014, GENOME ANNOUNCEMENTS, V2, DOI 10.1128/genomeA.01250-14; Liang O, 2005, MICROBIOL-SGM, V151, P3435, DOI 10.1099/mic.0.28137-0; Liu Z, 2002, APPL MICROBIOL BIOT, V58, P679, DOI 10.1007/s00253-002-0933-8; Matsumura E, 2004, J BIOSCI BIOENG, V98, P71, DOI 10.1263/jbb.98.71; Murakami S, 2003, BIOSCI BIOTECH BIOCH, V67, P2351, DOI 10.1271/bbb.67.2351; Murakami S, 1999, GENE, V226, P189, DOI 10.1016/S0378-1119(98)00560-5; Ohtsubo Y, 2015, GENOME ANNOUNCEMENTS, V3, DOI 10.1128/genomeA.01283-15; Pruesse E, 2007, NUCLEIC ACIDS RES, V35, P7188, DOI 10.1093/nar/gkm864; Takeo M, 2013, J BACTERIOL, V195, P4406, DOI 10.1128/JB.00397-13; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; WALPOLE AL, 1958, BRIT MED BULL, V14, P141, DOI 10.1093/oxfordjournals.bmb.a069657; Yu CS, 2006, PROTEINS, V64, P643, DOI 10.1002/prot.21018; Yun SH, 2011, J PROTEOMICS, V74, P620, DOI 10.1016/j.jprot.2011.01.020	29	18	18	2	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 28	2016	11	4							e0154233	10.1371/journal.pone.0154233	http://dx.doi.org/10.1371/journal.pone.0154233			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DK8XE	27124467	Green Submitted, Green Published, gold			2022-12-26	WOS:000375211700058
J	Zhai, C; Alderisio, F; Slowinski, P; Tsaneva-Atanasova, K; di Bernardo, M				Zhai, Chao; Alderisio, Francesco; Slowinski, Piotr; Tsaneva-Atanasova, Krasimira; di Bernardo, Mario			Design of a Virtual Player for Joint Improvisation with Humans in the Mirror Game	PLOS ONE			English	Article							COORDINATION; SYNCHRONY; PARADIGM	Joint improvisation is often observed among humans performing joint action tasks. Exploring the underlying cognitive and neural mechanisms behind the emergence of joint improvisation is an open research challenge. This paper investigates jointly improvised movements between two participants in the mirror game, a paradigmatic joint task example. First, experiments involving movement coordination of different dyads of human players are performed in order to build a human benchmark. No designation of leader and follower is given beforehand. We find that joint improvisation is characterized by the lack of a leader and high levels of movement synchronization. Then, a theoretical model is proposed to capture some features of their interaction, and a set of experiments is carried out to test and validate the model ability to reproduce the experimental observations. Furthermore, the model is used to drive a computer avatar able to successfully improvise joint motion with a human participant in real time. Finally, a convergence analysis of the proposed model is carried out to confirm its ability to reproduce joint movements between the participants.	[Zhai, Chao; Alderisio, Francesco; di Bernardo, Mario] Univ Bristol, Dept Engn Math, Bristol BS8 1UB, Avon, England; [Slowinski, Piotr; Tsaneva-Atanasova, Krasimira] Univ Exeter, Coll Engn Math & Phys Sci, Exeter EX4 4QF, Devon, England; [di Bernardo, Mario] Univ Naples Federico II, Dept Elect Engn & Informat Technol, I-80125 Naples, Italy	University of Bristol; University of Exeter; University of Naples Federico II	di Bernardo, M (corresponding author), Univ Bristol, Dept Engn Math, Bristol BS8 1UB, Avon, England.; di Bernardo, M (corresponding author), Univ Naples Federico II, Dept Elect Engn & Informat Technol, I-80125 Naples, Italy.	m.dibernardo@bristol.ac.uk	di Bernardo, Mario/AAL-9311-2021; Slowinski, Piotr/AAT-7099-2020; Tsaneva-Atanasova, Krasimira T/AAG-6766-2019	di Bernardo, Mario/0000-0002-2171-4745; Slowinski, Piotr/0000-0002-6612-9902; Tsaneva-Atanasova, Krasimira T/0000-0002-6294-7051; , Chao/0000-0002-2039-9878	European Project AlterEgo FP7 ICT 2.9 - Cognitive 321 Sciences and Robotics [600610]; EPSRC [EP/L000296/1, EP/I018638/1, EP/N014391/1] Funding Source: UKRI; Engineering and Physical Sciences Research Council [EP/I018638/1, EP/L000296/1, EP/N014391/1] Funding Source: researchfish	European Project AlterEgo FP7 ICT 2.9 - Cognitive 321 Sciences and Robotics; EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	This work was supported by European Project AlterEgo FP7 ICT 2.9 - Cognitive 321 Sciences and Robotics, Grant Number 600610 (MdB, http://www.euromov.eu/alterego/project).; This work was funded by the European Project AlterEgo FP7 ICT 2.9-Cognitive Sciences and Robotics, Grant Number 600610. The authors wish to thank Prof. Benoit Bardy, Dr. Ludovic Marin and Dr. Robin Salesse at EUROMOV, University of Montpellier, France for all the insightful discussions and Ed Rooke at University of Bristol for collecting some of the experimental data that was used to validate the approach presented in this paper.	Alderisio F, 2016, BIOL CYBERNETICS; Alderisio F, 2016, 15 EUR CONT IN PRESS; [Anonymous], 1997, DYNAMIC PATTERNS SEL; Borg I, 2010, MODERN MULTIDIMENSIO; Dumas G, 2014, P NATL ACAD SCI USA, V111, pE3726, DOI 10.1073/pnas.1407486111; Feniger-Schaal R, 2016, ATTACH HUM DEV, V18, P33, DOI 10.1080/14616734.2015.1109677; FOLKES VS, 1982, PERS SOC PSYCHOL B, V8, P631, DOI 10.1177/0146167282084005; Grinsted A, 2004, NONLINEAR PROC GEOPH, V11, P561, DOI 10.5194/npg-11-561-2004; Guna J, 2014, SENSORS-BASEL, V14, P3702, DOI 10.3390/s140203702; HAKEN H, 1985, BIOL CYBERN, V51, P347, DOI 10.1007/BF00336922; Hart Y, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087213; Johnstone K., 2012, IMPRO IMPROVISATION; Kelso JAS, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005749; Kostrubiec V, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0142029; Lakens D, 2011, SOC COGNITION, V29, P1, DOI 10.1521/soco.2011.29.1.1; Levina E, 2001, EIGHTH IEEE INTERNATIONAL CONFERENCE ON COMPUTER VISION, VOL II, PROCEEDINGS, P251, DOI 10.1109/ICCV.2001.937632; Marsh KL, 2009, TOP COGN SCI, V1, P320, DOI 10.1111/j.1756-8765.2009.01022.x; Noy L, 2015, FRONT HUM NEUROSCI, V9, DOI [10.3339/fnhum.2015.00187, 10.3389/fnhum.2015.00187]; Noy L, 2011, P NATL ACAD SCI USA, V108, P20947, DOI 10.1073/pnas.1108155108; Sawyer RK., 2001, CREATING CONVERSATIO; Schmidt RC, 2014, FRONT HUM NEUROSCI, V8, DOI 10.3389/fnhum.2014.00633; Schmidt RC, 2008, UNDERST COMPLEX SYST, P281, DOI 10.1007/978-3-540-74479-5_14; Slowinski P, 2016, J R SOC INTERFACE, V13, DOI 10.1098/rsif.2015.1093; Slowinski P, 2014, IEEE SYS MAN CYBERN, P748, DOI 10.1109/SMC.2014.6974000; Wiltermuth SS, 2009, PSYCHOL SCI, V20, P1, DOI 10.1111/j.1467-9280.2008.02253.x; Zhai C, 2014, IEEE SYS MAN CYBERN, P754, DOI 10.1109/SMC.2014.6974001; Zhai C, 2015, IEEE DECIS CONTR P, P3175, DOI 10.1109/CDC.2015.7402695; Zhai C, 2014, IEEE DECIS CONTR P, P7005, DOI 10.1109/CDC.2014.7040490	28	16	16	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 28	2016	11	4							e0154361	10.1371/journal.pone.0154361	http://dx.doi.org/10.1371/journal.pone.0154361			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DK8XE	27123927	Green Submitted, gold, Green Published			2022-12-26	WOS:000375211700074
J	dela Sena, C; Sun, J; Narayanasamy, S; Riedl, KM; Yuan, Y; Curley, RW; Schwartz, SJ; Harrison, EH				dela Sena, Carlo; Sun, Jian; Narayanasamy, Sureshbabu; Riedl, Kenneth M.; Yuan, Yan; Curley, Robert W., Jr.; Schwartz, Steven J.; Harrison, Earl H.			Substrate Specificity of Purified Recombinant Chicken -Carotene 9,10-Oxygenase (BCO2)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						carotenoid; dioxygenase; enzyme; enzyme purification; lipid metabolism; recombinant protein expression; retinoid	ACYCLO-RETINOIC ACID; BETA-CAROTENE; IN-VITRO; PIGMENT EPITHELIUM; CANCER CELLS; VISUAL CYCLE; RPE65; METABOLISM; ISOMEROHYDROLASE; CLEAVAGE	Provitamin A carotenoids are oxidatively cleaved by -carotene 15,15-dioxygenase (BCO1) at the central 15-15 double bond to form retinal (vitamin A aldehyde). Another carotenoid oxygenase, -carotene 9,10-oxygenase (BCO2) catalyzes the oxidative cleavage of carotenoids at the 9-10 bond to yield an ionone and an apo-10-carotenoid. Previously published substrate specificity studies of BCO2 were conducted using crude lysates from bacteria or insect cells expressing recombinant BCO2. Our attempts to obtain active recombinant human BCO2 expressed in Escherichia coli were unsuccessful. We have expressed recombinant chicken BCO2 in the strain E. coli BL21-Gold (DE3) and purified the enzyme by cobalt ion affinity chromatography. Like BCO1, purified recombinant chicken BCO2 catalyzes the oxidative cleavage of the provitamin A carotenoids -carotene, -carotene, and -cryptoxanthin. Its catalytic activity with -carotene as substrate is at least 10-fold lower than that of BCO1. In further contrast to BCO1, purified recombinant chicken BCO2 also catalyzes the oxidative cleavage of 9-cis--carotene and the non-provitamin A carotenoids zeaxanthin and lutein, and is inactive with all-trans-lycopene and -apocarotenoids. Apo-10-carotenoids were detected as enzymatic products by HPLC, and the identities were confirmed by LC-MS. Small amounts of 3-hydroxy--apo-8-carotenal were also consistently detected in BCO2--cryptoxanthin reaction mixtures. With the exception of this activity with -cryptoxanthin, BCO2 cleaves specifically at the 9-10 bond to produce apo-10-carotenoids. BCO2 has been shown to function in preventing the excessive accumulation of carotenoids, and its broad substrate specificity is consistent with this.	[dela Sena, Carlo; Sun, Jian; Narayanasamy, Sureshbabu; Yuan, Yan; Harrison, Earl H.] Ohio State Univ, Dept Human Nutr, Columbus, OH 43210 USA; [dela Sena, Carlo; Curley, Robert W., Jr.; Harrison, Earl H.] Ohio State Univ, Ohio State Biochem Program, Columbus, OH 43210 USA; [Riedl, Kenneth M.; Schwartz, Steven J.] Ohio State Univ, Dept Food Sci & Technol, Columbus, OH 43210 USA; [Curley, Robert W., Jr.] Ohio State Univ, Coll Pharm, Columbus, OH 43210 USA	University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University	Harrison, EH (corresponding author), Ohio State Univ, 314 Campbell Hall,1787 Neil Ave, Columbus, OH 43210 USA.	harrison.304@osu.edu	riedl, ken/G-8621-2014; Riedl, Ken/K-1881-2019; Harrison, Earl H/AAN-5378-2021; NARAYANASAMY, SURESHBABU/AAN-6604-2021	riedl, ken/0000-0002-9020-3471; Narayanasamy, Sureshbabu/0000-0002-5846-3230	National Institutes of Health [R01-HL49879]; Ohio Agricultural Research Development Center; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL049879] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK101251] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ohio Agricultural Research Development Center; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by National Institutes of Health Grant R01-HL49879 and a grant from the Ohio Agricultural Research Development Center. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Amengual J, 2013, J BIOL CHEM, V288, P34081, DOI 10.1074/jbc.M113.501049; Amengual J, 2011, FASEB J, V25, P948, DOI 10.1096/fj.10-173906; Babino D, 2015, J BIOL CHEM, V290, P24844, DOI 10.1074/jbc.M115.668822; Ben-Dor A, 2001, ARCH BIOCHEM BIOPHYS, V391, P295, DOI 10.1006/abbi.2001.2412; Britton G., 1995, SPECTROSCOPY-US, V1B, P13; dela Sena C, 2013, J BIOL CHEM, V288, P37094, DOI 10.1074/jbc.M113.507160; Eroglu A, 2013, J LIPID RES, V54, P1719, DOI 10.1194/jlr.R039537; Eroglu A, 2012, J BIOL CHEM, V287, P15886, DOI 10.1074/jbc.M111.325142; Gakh E, 2002, BBA-MOL CELL RES, V1592, P63, DOI 10.1016/S0167-4889(02)00265-3; Grolier P, 1997, ARCH BIOCHEM BIOPHYS, V348, P233, DOI 10.1006/abbi.1997.0388; HAMEL CP, 1993, J BIOL CHEM, V268, P15751; Hu KQ, 2006, J BIOL CHEM, V281, P19327, DOI 10.1074/jbc.M512095200; Jin MH, 2005, CELL, V122, P449, DOI 10.1016/j.cell.2005.06.042; Kim YS, 2011, BIOTECHNOL LETT, V33, P1195, DOI 10.1007/s10529-011-0556-1; Kim YS, 2009, BIOTECHNOL LETT, V31, P403, DOI 10.1007/s10529-008-9873-4; Kiser PD, 2010, PROG RETIN EYE RES, V29, P428, DOI 10.1016/j.preteyeres.2010.03.002; Kloer DP, 2005, SCIENCE, V308, P267, DOI 10.1126/science.1108965; Kotake-Nara E, 2002, ANTICANCER RES, V22, P689; KRINSKY NI, 1990, J NUTR, V120, P1654, DOI 10.1093/jn/120.12.1654; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Li BX, 2014, P NATL ACAD SCI USA, V111, P10173, DOI 10.1073/pnas.1402526111; Lindqvist A, 2005, J HISTOCHEM CYTOCHEM, V53, P1403, DOI 10.1369/jhc.5A6705.2005; Lobo GP, 2010, J BIOL CHEM, V285, P27891, DOI 10.1074/jbc.M110.132571; Lyubarsky AL, 2005, BIOCHEMISTRY-US, V44, P9880, DOI 10.1021/bi0505363; Mein JR, 2011, ARCH BIOCHEM BIOPHYS, V506, P109, DOI 10.1016/j.abb.2010.11.005; Messing SAJ, 2010, PLANT CELL, V22, P2970, DOI 10.1105/tpc.110.074815; Moiseyev G, 2005, P NATL ACAD SCI USA, V102, P12413, DOI 10.1073/pnas.0503460102; Nikolaeva O, 2009, FEBS J, V276, P3020, DOI 10.1111/j.1742-4658.2009.07021.x; Palczewski G, 2014, FASEB J, V28, P4457, DOI 10.1096/fj.14-252411; Poliakov E, 2005, J BIOL CHEM, V280, P29217, DOI 10.1074/jbc.M500409200; Redmond TM, 2005, P NATL ACAD SCI USA, V102, P13658, DOI 10.1073/pnas.0504167102; Richelle M, 2010, BRIT J NUTR, V103, P1800, DOI 10.1017/S0007114510000103; Robert X, 2014, NUCLEIC ACIDS RES, V42, pW320, DOI 10.1093/nar/gku316; Stahl W, 2000, ARCH BIOCHEM BIOPHYS, V373, P271, DOI 10.1006/abbi.1999.1510; Sui XW, 2013, ARCH BIOCHEM BIOPHYS, V539, P203, DOI 10.1016/j.abb.2013.06.012; Toomey MB, 2007, INVEST OPHTH VIS SCI, V48, P3976, DOI 10.1167/iovs.07-0208; Walter MH, 2010, PLANTA, V232, P1, DOI 10.1007/s00425-010-1156-3; Wang XD, 2009, CAROTENOIDS SER, V5, P383, DOI 10.1007/978-3-7643-7501-0_18	38	54	54	2	25	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 8	2016	291	28					14609	14619		10.1074/jbc.M116.723684	http://dx.doi.org/10.1074/jbc.M116.723684			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DS1OV	27143479	Green Published, hybrid			2022-12-26	WOS:000380366700017
J	Hwang, S; Hartman, IZ; Calhoun, LN; Garland, K; Young, GA; Mitsche, MA; McDonald, J; Xu, F; Engelking, L; DeBose-Boyd, RA				Hwang, Seonghwan; Hartman, Isamu Z.; Calhoun, Leona N.; Garland, Kristina; Young, Gennipher A.; Mitsche, Matthew A.; McDonald, Jeffrey; Xu, Fang; Engelking, Luke; DeBose-Boyd, Russell A.			Contribution of Accelerated Degradation to Feedback Regulation of 3-Hydroxy-3-methylglutaryl Coenzyme A Reductase and Cholesterol Metabolism in the Liver	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						cholesterol metabolism; endoplasmic reticulum (ER); endoplasmic-reticulum-associated protein degradation (ERAD); isoprenoid; lipid metabolism	HMG-COA REDUCTASE; FATTY-ACID SYNTHESIS; ENDOPLASMIC-RETICULUM; TRANSGENIC MICE; ENZYME DEGRADATION; UBIQUITIN LIGASE; INSIG PROTEINS; MESSENGER-RNA; RAT-LIVER; STEROLS	Accumulation of sterols in endoplasmic reticulum membranes stimulates the ubiquitination of 3-hydroxy-3-methylglutaryl coenzyme A reductase (HMGCR), which catalyzes a rate-limiting step in synthesis of cholesterol. This ubiquitination marks HMGCR for proteasome-mediated degradation and constitutes one of several mechanisms for feedback control of cholesterol synthesis. Mechanisms for sterol-accelerated ubiquitination and degradation of HMGCR have been elucidated through the study of cultured mammalian cells. However, the extent to which these reactions modulate HMGCR and contribute to control of cholesterol metabolism in whole animals is unknown. Here, we examine transgenic mice expressing in the liver the membrane domain of HMGCR (HMGCR (TM1-8)), a region necessary and sufficient for sterol-accelerated degradation, and knock-in mice in which endogenous HMGCR harbors mutations that prevent sterol-induced ubiquitination. Characterization of transgenic mice revealed that HMGCR (TM1-8) is appropriately regulated in the liver of mice fed a high cholesterol diet or chow diet supplemented with the HMGCR inhibitor lovastatin. Ubiquitination-resistant HMGCR protein accumulates in the liver and other tissues disproportionately to its mRNA, indicating that sterol-accelerated degradation significantly contributes to feedback regulation of HMGCR in vivo. Results of these studies demonstrate that HMGCR is subjected to sterol-accelerated degradation in the liver through mechanisms similar to those established in cultured cells. Moreover, these studies designate sterol-accelerated degradation of HMGCR as a potential therapeutic target for prevention of atherosclerosis and associated cardiovascular disease.	[Hwang, Seonghwan; Hartman, Isamu Z.; Calhoun, Leona N.; Garland, Kristina; Young, Gennipher A.; Mitsche, Matthew A.; McDonald, Jeffrey; Xu, Fang; Engelking, Luke; DeBose-Boyd, Russell A.] Univ Texas Southwestern Med Ctr Dallas, Dept Mol Genet, Dallas, TX 75390 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas	DeBose-Boyd, RA (corresponding author), 5323 Harry Hines Blvd, Dallas, TX 75390 USA.	Russell.DeBose-Boyd@utsouthwestern.edu		Engelking, Luke/0000-0002-1355-4964	National Institutes of Health [HL20948]; Howard Hughes Medical Institute; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL020948] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K08DK102652] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Howard Hughes Medical Institute(Howard Hughes Medical Institute); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by National Institutes of Health Grant HL20948 and an Early Career Scientist Award from the Howard Hughes Medical Institute (to R. D. B.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	BROWN MS, 1980, J LIPID RES, V21, P505; DeBose-Boyd RA, 2001, P NATL ACAD SCI USA, V98, P1477, DOI 10.1073/pnas.98.4.1477; DeBose-Boyd RA, 2008, CELL RES, V18, P609, DOI 10.1038/cr.2008.61; Doolman R, 2004, J BIOL CHEM, V279, P38184, DOI 10.1074/jbc.M405935200; EDWARDS PA, 1972, J BIOL CHEM, V247, P1520; Engelking LJ, 2005, J CLIN INVEST, V115, P2489, DOI 10.1172/JCI25614; Engelking LJ, 2004, J CLIN INVEST, V113, P1168, DOI 10.1172/JCI200420978; Engelking LJ, 2006, J CLIN INVEST, V116, P2356, DOI 10.1172/JCI28988; Goldstein JL, 2006, CELL, V124, P35, DOI 10.1016/j.cell.2005.12.022; GOLDSTEIN JL, 1990, NATURE, V343, P425, DOI 10.1038/343425a0; Goldstein JL, 2015, CELL, V161, P161, DOI 10.1016/j.cell.2015.01.036; Hartman IZ, 2010, J BIOL CHEM, V285, P19288, DOI 10.1074/jbc.M110.134213; Horton JD, 2002, J CLIN INVEST, V109, P1125, DOI 10.1172/JCI200215593; Jo Y, 2011, P NATL ACAD SCI USA, V108, P20503, DOI 10.1073/pnas.1112831108; Jo Y, 2011, J BIOL CHEM, V286, P15022, DOI 10.1074/jbc.M110.211326; Keller RK, 1996, ARCH BIOCHEM BIOPHYS, V328, P324, DOI 10.1006/abbi.1996.0180; KITA T, 1980, J CLIN INVEST, V66, P1094, DOI 10.1172/JCI109938; LISCUM L, 1985, J BIOL CHEM, V260, P522; Liu TF, 2012, CELL METAB, V16, P213, DOI 10.1016/j.cmet.2012.06.014; McDonald JG, 2012, J LIPID RES, V53, P1399, DOI 10.1194/jlr.D022285; McFarlane MR, 2014, J BIOL CHEM, V289, P2148, DOI 10.1074/jbc.M113.524041; Mitsche MA, 2015, ELIFE, V4, DOI 10.7554/eLife.07999; Morris LL, 2014, J BIOL CHEM, V289, P19053, DOI 10.1074/jbc.M114.576652; Ness GC, 2005, FEBS LETT, V579, P3126, DOI 10.1016/j.febslet.2005.05.001; REIHNER E, 1990, NEW ENGL J MED, V323, P224, DOI 10.1056/NEJM199007263230403; Repa JJ, 2000, GENE DEV, V14, P2819, DOI 10.1101/gad.844900; ROITELMAN J, 1992, J CELL BIOL, V117, P959, DOI 10.1083/jcb.117.5.959; Sever N, 2003, J BIOL CHEM, V278, P52479, DOI 10.1074/jbc.M310053200; Sever N, 2003, MOL CELL, V11, P25, DOI 10.1016/S1097-2765(02)00822-5; Sharpe LJ, 2013, J BIOL CHEM, V288, P18707, DOI 10.1074/jbc.R113.479808; Shimano H, 1996, J CLIN INVEST, V98, P1575, DOI 10.1172/JCI118951; SIMONET WS, 1993, J BIOL CHEM, V268, P8221; Song BL, 2005, MOL CELL, V19, P829, DOI 10.1016/j.molcel.2005.08.009; Yabe D, 2003, P NATL ACAD SCI USA, V100, P3155, DOI 10.1073/pnas.0130116100; Yang T, 2002, CELL, V110, P489, DOI 10.1016/S0092-8674(02)00872-3	35	27	27	1	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 24	2016	291	26					13479	13494		10.1074/jbc.M116.728469	http://dx.doi.org/10.1074/jbc.M116.728469			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DR2YZ	27129778	hybrid, Green Published			2022-12-26	WOS:000379771100007
J	Stegmayr, J; Lepur, A; Kahl-Knutson, B; Aguilar-Moncayo, M; Klyosov, AA; Field, RA; Oredsson, S; Nilsson, UJ; Leffler, H				Stegmayr, John; Lepur, Adriana; Kahl-Knutson, Barbro; Aguilar-Moncayo, Matilde; Klyosov, Anatole A.; Field, Robert A.; Oredsson, Stina; Nilsson, Ulf J.; Leffler, Hakon			Low or No Inhibitory Potency of the Canonical Galectin Carbohydrate-binding Site by Pectins and Galactomannans	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MODIFIED CITRUS PECTIN; PROSTATE-CANCER CELLS; L-PHENYLALANINE 2-NAPHTHYLAMIDE; RECEPTOR GALECTIN-8; MELANOMA-CELLS; HUMAN BREAST; POLYSACCHARIDES; RECOGNITION; METASTASIS; APOPTOSIS	Some complex plant-derived polysaccharides, such as modified citrus pectins and galactomannans, have been shown to have promising anti-inflammatory and anti-cancer effects. Most reports propose or claim that these effects are due to interaction of the polysaccharides with galectins because the polysaccharides contain galactose-containing side chains that might bind this class of lectin. However, their direct binding to and/or inhibition of the evolutionarily conserved galactoside-binding site of galectins has not been demonstrated. Using a well established fluorescence anisotropy assay, we tested the direct interaction of several such polysaccharides with physiological concentrations of a panel of galectins. The bioactive pectic samples tested were very poor inhibitors of the canonical galactoside-binding site for the tested galectins, with IC50 values >10 mg/ml for a few or in most cases no inhibitory activity at all. The galactomannan Davanat (R) was more active, albeit not a strong inhibitor (IC50 values ranging from 3 to 20 mg/ml depending on the galectin). Pure synthetic oligosaccharide fragments found in the side chains and backbone of pectins and galactomannans were additionally tested. The most commonly found galactan configuration in pectins had no inhibition of the galectins tested. Galactosylated tri- and pentamannosides, representing the structure of Davanat (R), had an inhibitory effect of galectins comparable with that of free galactose. Further evaluation using cell-based assays, indirectly linked to galectin-3 inhibition, showed no inhibition of galectin-3 by the polysaccharides. These data suggest that the physiological effects of these plant polysaccharides are not due to inhibition of the canonical galectin carbohydrate-binding site.	[Stegmayr, John; Lepur, Adriana; Kahl-Knutson, Barbro; Leffler, Hakon] Lund Univ, Dept Lab Med, Sect MIG Microbiol, Immunol,Glycobiol, S-22100 Lund, Sweden; [Stegmayr, John; Oredsson, Stina] Lund Univ, Dept Biol, Lund, Sweden; [Nilsson, Ulf J.] Lund Univ, Dept Chem, Ctr Anal & Synth, Lund, Sweden; [Aguilar-Moncayo, Matilde; Field, Robert A.] John Innes Ctr, Dept Biol Chem, Norwich Res Pk, Norwich NR4 7UH, Norfolk, England; [Klyosov, Anatole A.] Galectin Therapeut, Newton, MA 02459 USA; [Lepur, Adriana] Ruoer Boskovic Inst, Div Mol Med, Zagreb, Croatia	Lund University; Lund University; Lund University; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); John Innes Center	Stegmayr, J; Leffler, H (corresponding author), BMC C12,Klinikgatan 18, SE-22184 Lund, Sweden.	john.stegmayr@med.lu.se; hakon.leffler@med.lu.se	Leffler, Hakon/A-2416-2019; Nilsson, Ulf J./L-3219-2014	Nilsson, Ulf J./0000-0001-5815-9522; Stegmayr, John/0000-0002-8167-9259; Leffler, Hakon/0000-0003-4482-8945; Field, Rob/0000-0001-8574-0275	European Community [HEALTH-F2-2011-256986, 043682]; Swedish Research Council [621-2009-5656, 621-2003-4265]; Knut and Alice Wallenberg Foundation, Sweden; United Kingdom Biotechnology and Biological Sciences Research Council Institute Strategic Programme Grant on Understanding and Exploiting Metabolism [BB/J004561/1]; John Innes Foundation; BBSRC [BBS/E/J/000C0618, BBS/E/J/000CA469] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BBS/E/J/000C0618, BBS/E/J/000CA469] Funding Source: researchfish	European Community(European Commission); Swedish Research Council(Swedish Research CouncilEuropean Commission); Knut and Alice Wallenberg Foundation, Sweden(Knut & Alice Wallenberg Foundation); United Kingdom Biotechnology and Biological Sciences Research Council Institute Strategic Programme Grant on Understanding and Exploiting Metabolism(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); John Innes Foundation; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by the European Community Seventh Framework Programme (FP7-2007-2013) under Grant HEALTH-F2-2011-256986 (PANACREAS) (to J. S.), FP6 Project "EuroPharm" Grant 043682 (to A. L.), Swedish Research Council Grant 621-2009-5656 (to H. L.) and 621-2003-4265 (to U. J. N.), Knut and Alice Wallenberg Foundation, Sweden (to H. L., U. J. N., and J. S.), United Kingdom Biotechnology and Biological Sciences Research Council Institute Strategic Programme Grant on Understanding and Exploiting Metabolism BB/J004561/1, and the John Innes Foundation (to M. A. and R. A. F.). A. A. K. is a shareholder in Galectin Therapeutics Inc., the company that owns the intellectual property for Davanat (R). U. J. N. and H. L. are shareholders in Galecto Biotech AB, a company that develops galectin inhibitors (e.g. 33DFTG).	Aits S, 2015, AUTOPHAGY, V11, P1408, DOI 10.1080/15548627.2015.1063871; BERG TO, 1994, BIOCHEM J, V300, P229, DOI 10.1042/bj3000229; Bian CF, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025007; Bohne A, 1999, BIOINFORMATICS, V15, P767, DOI 10.1093/bioinformatics/15.9.767; Boscher C, 2011, CURR OPIN CELL BIOL, V23, P383, DOI 10.1016/j.ceb.2011.05.001; BUTLER WT, 1963, J IMMUNOL, V90, P663; Caffall KH, 2009, CARBOHYD RES, V344, P1879, DOI 10.1016/j.carres.2009.05.021; Chauhan D, 2005, CANCER RES, V65, P8350, DOI 10.1158/0008-5472.CAN-05-0163; Clark MC, 2012, BLOOD, V120, P4635, DOI 10.1182/blood-2012-06-438234; Cumpstey I, 2005, ORG BIOMOL CHEM, V3, P1922, DOI 10.1039/b502354h; Dabelic S, 2012, IN VITRO CELL DEV-AN, V48, P518, DOI 10.1007/s11626-012-9540-x; Demotte N, 2010, CANCER RES, V70, P7476, DOI 10.1158/0008-5472.CAN-10-0761; Di Lella S, 2011, BIOCHEMISTRY-US, V50, P7842, DOI 10.1021/bi201121m; Dings RPM, 2013, J PHARMACOL EXP THER, V344, P589, DOI 10.1124/jpet.112.199646; Dings RPM, 2012, J MED CHEM, V55, P5121, DOI 10.1021/jm300014q; Gao XG, 2013, J BIOL CHEM, V288, P33953, DOI 10.1074/jbc.M113.482315; Gao XG, 2012, GLYCOCONJUGATE J, V29, P159, DOI 10.1007/s10719-012-9382-5; Glinskii OV, 2005, NEOPLASIA, V7, P522, DOI 10.1593/neo.04646; Glinsky VV, 2009, CARBOHYD RES, V344, P1788, DOI 10.1016/j.carres.2008.08.038; Gunning AP, 2009, FASEB J, V23, P415, DOI 10.1096/fj.08-106617; Hayashi A, 2000, Altern Med Rev, V5, P546; HO MK, 1982, J IMMUNOL, V128, P1221; INOHARA H, 1994, GLYCOCONJUGATE J, V11, P527, DOI 10.1007/BF00731303; Jackson CL, 2007, GLYCOBIOLOGY, V17, P805, DOI 10.1093/glycob/cwm054; JADOT M, 1984, BIOCHEM J, V219, P965, DOI 10.1042/bj2190965; Jiang JH, 2013, INTEGR CANCER THER, V12, P145, DOI 10.1177/1534735412442369; John CM, 2003, CLIN CANCER RES, V9, P2374; Johnson KD, 2007, NEOPLASIA, V9, P662, DOI 10.1593/neo.07433; Kim BW, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2606; Klyosov AA, 2003, PRECLINICA, V1, P175; Klyosov AA, 2006, ACS SYM SER, V932, P67; Kolatsi-Joannou M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018683; LAPIERRE Y, 1990, TRANSFUSION, V30, P109, DOI 10.1046/j.1537-2995.1990.30290162894.x; Leclere L, 2016, CARBOHYD POLYM, V137, P39, DOI 10.1016/j.carbpol.2015.10.055; Leclere L, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0115831; Leffler H, 2002, GLYCOCONJUGATE J, V19, P433, DOI 10.1023/B:GLYC.0000014072.34840.04; Lepur A, 2012, J BIOL CHEM, V287, P21751, DOI 10.1074/jbc.C112.358002; Li L, 2015, CELL BIOL INT, V39, P531, DOI 10.1002/cbin.10424; Li S, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2003730; Ma ZC, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0148792; MacKinnon AC, 2013, GLYCOBIOLOGY, V23, P654, DOI 10.1093/glycob/cwt006; MacKinnon AC, 2012, AM J RESP CRIT CARE, V185, P537, DOI 10.1164/rccm.201106-0965OC; Mandal S, 2016, CAN J CHEM, V94, P936, DOI 10.1139/cjc-2015-0598; Martinez-Martinez E, 2016, INT J OBESITY, V40, P1034, DOI 10.1038/ijo.2016.19; Martinez-Martinez E, 2015, HYPERTENSION, V66, P961, DOI 10.1161/HYPERTENSIONAHA.115.06032; Maxwell EG, 2012, TRENDS FOOD SCI TECH, V24, P64, DOI 10.1016/j.tifs.2011.11.002; Miller MC, 2016, GLYCOBIOLOGY, V26, P88, DOI 10.1093/glycob/cwv073; Miller MC, 2012, GLYCOBIOLOGY, V22, P543, DOI 10.1093/glycob/cwr173; Miller MC, 2009, GLYCOBIOLOGY, V19, P1034, DOI 10.1093/glycob/cwp084; Miller MC, 2009, CARBOHYD RES, V344, P1205, DOI 10.1016/j.carres.2009.04.010; Nangia-Makker P, 2002, JNCI-J NATL CANCER I, V94, P1854, DOI 10.1093/jnci/94.24.1854; Nangia-Makker P, 2000, AM J PATHOL, V156, P899, DOI 10.1016/S0002-9440(10)64959-0; Newlaczyl AU, 2011, CANCER LETT, V313, P123, DOI 10.1016/j.canlet.2011.09.003; Nishi N, 2008, GLYCOBIOLOGY, V18, P1065, DOI 10.1093/glycob/cwn089; NOWAK TP, 1976, BIOCHEM BIOPH RES CO, V68, P650, DOI 10.1016/0006-291X(76)91195-5; Paz I, 2010, CELL MICROBIOL, V12, P530, DOI 10.1111/j.1462-5822.2009.01415.x; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; PIENTA KJ, 1995, J NATL CANCER I, V87, P348, DOI 10.1093/jnci/87.5.348; PLATT D, 1992, J NATL CANCER I, V84, P438, DOI 10.1093/jnci/84.6.438; Ridley BL, 2001, PHYTOCHEMISTRY, V57, P929, DOI 10.1016/S0031-9422(01)00113-3; Salomonsson E, 2011, J BIOL CHEM, V286, P13801, DOI 10.1074/jbc.C111.229096; Salomonsson E, 2010, BIOCHEMISTRY-US, V49, P9518, DOI 10.1021/bi1009584; Salomonsson E, 2010, J BIOL CHEM, V285, P35079, DOI 10.1074/jbc.M109.098160; Sathisha UV, 2007, GLYCOCONJUGATE J, V24, P497, DOI 10.1007/s10719-007-9042-3; SATO S, 1994, J BIOL CHEM, V269, P4424; Schneider D, 2010, EUR J CELL BIOL, V89, P788, DOI 10.1016/j.ejcb.2010.07.001; Sorme P, 2004, ANAL BIOCHEM, V334, P36, DOI 10.1016/j.ab.2004.06.042; SPRINGER TA, 1981, J BIOL CHEM, V256, P3833; Stowell SR, 2009, J BIOL CHEM, V284, P4989, DOI 10.1074/jbc.M808925200; Streetly MJ, 2010, BLOOD, V115, P3939, DOI 10.1182/blood-2009-10-251660; THIBAULT JF, 1993, CARBOHYD RES, V238, P271, DOI 10.1016/0008-6215(93)87019-O; Thijssen VLJL, 2006, P NATL ACAD SCI USA, V103, P15975, DOI 10.1073/pnas.0603883103; Thurston TLM, 2012, NATURE, V482, P414, DOI 10.1038/nature10744; Vayssade M, 2010, PHYTOTHER RES, V24, P982, DOI 10.1002/ptr.3040; Yamamoto-Sugitani M, 2011, P NATL ACAD SCI USA, V108, P17468, DOI 10.1073/pnas.1111138108; Yan J, 2010, INTEGR CANCER THER, V9, P197, DOI 10.1177/1534735410369672	76	38	39	0	32	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 17	2016	291	25					13318	13334		10.1074/jbc.M116.721464	http://dx.doi.org/10.1074/jbc.M116.721464			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DR2YT	27129206	Green Published, hybrid			2022-12-26	WOS:000379770500034
J	Jing, YP; Wang, D; Han, XL; Dong, DJ; Wang, JX; Zhao, XF				Jing, Yu-Pu; Wang, Di; Han, Xiao-Lin; Dong, Du-Juan; Wang, Jin-Xing; Zhao, Xiao-Fan			The Steroid Hormone 20-Hydroxyecdysone Enhances Gene Transcription through the cAMP Response Element-binding Protein (CREB) Signaling Pathway	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ECDYSONE RECEPTOR; COUPLED RECEPTOR; KINASE-A; DROSOPHILA-MELANOGASTER; PKA PHOSPHORYLATION; CATALYTIC SUBUNIT; NONGENOMIC ACTION; CELL-MEMBRANE; MANDUCA-SEXTA; BOMBYX-MORI	Animal steroid hormones regulate gene transcription through genomic pathways by binding to nuclear receptors. These steroid hormones also rapidly increase intracellular calcium and cyclic adenosine monophosphate (cAMP) levels and activate the protein kinase C (PKC) and protein kinase A (PKA) nongenomic pathways. However, the function and mechanism of the nongenomic pathways of the steroid hormones are unclear, and the relationship between the PKC and PKA pathways is also unclear. We propose that the steroid hormone 20-hydroxyecdysone (20E) activates the PKA pathway to enhance 20E-induced gene transcription in the lepidopteran insect Helicoverpa armigera. The expression of the catalytic subunit 1 of PKA (PKAC1) increased during metamorphosis, and PKAC1 knockdown blocked pupation and repressed 20E-responsive gene expression. 20E regulated PKAC1 phosphorylation at threonine 200 and nuclear translocation through an ecdysone-responsive G-protein-coupled receptor 2. PKAC1 induced cAMP response element-binding protein (CREB) phosphorylation at serine 143, which bound to the cAMP response element on DNA to enhance 20E-responsive gene transcription. Through ecdysone-responsive G-protein-coupled receptor 2, 20E increased cAMP levels, which induced CREB PKA phosphorylation and 20E-responsive gene expression. This study demonstrates that the PKA/CREB pathway tightly and critically regulates 20E-induced gene transcription as well as its relationship with the 20E-induced PKC pathway.	[Jing, Yu-Pu; Wang, Di; Han, Xiao-Lin; Dong, Du-Juan; Wang, Jin-Xing; Zhao, Xiao-Fan] Shandong Univ, Sch Life Sci, Shandong Prov Key Lab Anim Cells & Dev Biol, Jinan 250100, Peoples R China	Shandong University	Zhao, XF (corresponding author), Shandong Univ, Sch Life Sci, Shandong Prov Key Lab Anim Cells & Dev Biol, Jinan 250100, Peoples R China.	xfzhao@sdu.edu.cn	Wang, Jin-Xing/AAU-1514-2021; Zhao, Xiao-Fan/AGW-9886-2022; Jing, Yu-Pu/AAE-3531-2022	Dong, Dujuan/0000-0003-3416-5017; Zhao, Xiao-Fan/0000-0003-1809-4730; Wang, Jin-Xing/0000-0003-0283-3930	National Natural Science Foundation of China [31230067]; National Basic Research Program of China 973 Program [2012CB114101]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Basic Research Program of China 973 Program(National Basic Research Program of China)	This work was supported by National Natural Science Foundation of China Grant 31230067 and National Basic Research Program of China 973 Program Grant 2012CB114101. The authors declare that they have no conflicts of interest with the contents of this article.	ADAMS JA, 1995, BIOCHEMISTRY-US, V34, P2447, DOI 10.1021/bi00008a007; Almahariq M, 2013, MOL PHARMACOL, V83, P122, DOI 10.1124/mol.112.080689; Aranda A, 2001, PHYSIOL REV, V81, P1269, DOI 10.1152/physrev.2001.81.3.1269; AUPHAN N, 1995, SCIENCE, V270, P286, DOI 10.1126/science.270.5234.286; Bartsch D, 1998, CELL, V95, P211, DOI 10.1016/S0092-8674(00)81752-3; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BUTTERWORTH JF, 1993, ANESTHESIOLOGY, V79, P88, DOI 10.1097/00000542-199307000-00014; Cai MJ, 2014, CELL COMMUN SIGNAL, V12, DOI 10.1186/1478-811X-12-9; Carlezon WA, 2005, TRENDS NEUROSCI, V28, P436, DOI 10.1016/j.tins.2005.06.005; Chen DS, 1999, MOL CELL BIOL, V19, P1002; Cheng XD, 1998, P NATL ACAD SCI USA, V95, P9849, DOI 10.1073/pnas.95.17.9849; CHIJIWA T, 1990, J BIOL CHEM, V265, P5267; Chung WC, 2005, J PHARMACOL EXP THER, V313, P191, DOI 10.1124/jpet.104.078311; Clouse S, 2001, CURR BIOL, V11, pR904, DOI 10.1016/S0960-9822(01)00549-8; Cruz J, 2007, MECH DEVELOP, V124, P180, DOI 10.1016/j.mod.2006.12.003; Delghandi MP, 2005, CELL SIGNAL, V17, P1343, DOI 10.1016/j.cellsig.2005.02.003; DIGNAM JD, 1983, NUCLEIC ACIDS RES, V11, P1475, DOI 10.1093/nar/11.5.1475; Dittmer NT, 2003, MOL CELL ENDOCRINOL, V210, P39, DOI 10.1016/j.mce.2003.08.010; EcklyMichel AE, 1997, EUR J PHARMACOL, V324, P85, DOI 10.1016/S0014-2999(97)00149-0; Edwards HV, 2012, BIOCHEM J, V446, P437, DOI 10.1042/BJ20120570; Edwards HV, 2012, SEMIN CELL DEV BIOL, V23, P181, DOI 10.1016/j.semcdb.2011.09.005; Edwards HV, 2012, BIOCHEM SOC T, V40, P210, DOI 10.1042/BST20110673; Elmogy M, 2004, EUR J BIOCHEM, V271, P3171, DOI 10.1111/j.1432-1033.2004.04249.x; Elmogy M, 2006, ZOOL SCI, V23, P715, DOI 10.2108/zsj.23.715; Evans RM, 2014, CELL, V157, P255, DOI 10.1016/j.cell.2014.03.012; Filardo EJ, 2002, MOL ENDOCRINOL, V16, P70, DOI 10.1210/me.16.1.70; FRANK DA, 1994, CELL, V79, P5, DOI 10.1016/0092-8674(94)90394-8; GELLER RG, 1972, CIRC RES, V31, P857, DOI 10.1161/01.RES.31.6.857; Gilbert LI, 2002, ANNU REV ENTOMOL, V47, P883, DOI 10.1146/annurev.ento.47.091201.145302; GILMAN AG, 1987, ANNU REV BIOCHEM, V56, P615, DOI 10.1146/annurev.bi.56.070187.003151; HAGIWARA M, 1993, MOL CELL BIOL, V13, P4852, DOI 10.1128/MCB.13.8.4852; Hall JM, 1999, ENDOCRINOLOGY, V140, P5566, DOI 10.1210/en.140.12.5566; HAROOTUNIAN AT, 1993, MOL BIOL CELL, V4, P993, DOI 10.1091/mbc.4.10.993; HORNER MA, 1995, DEV BIOL, V168, P490, DOI 10.1006/dbio.1995.1097; Iga M, 2007, MOL CELL ENDOCRINOL, V263, P18, DOI 10.1016/j.mce.2006.08.005; Impey S, 2001, Sci STKE, V2001, ppe1; Ishimoto H, 2009, P NATL ACAD SCI USA, V106, P6381, DOI 10.1073/pnas.0810213106; Jian D, 2011, STEROIDS, V76, P1297, DOI 10.1016/j.steroids.2011.06.008; Jing YP, 2015, J BIOL CHEM, V290, P8469, DOI 10.1074/jbc.M114.622696; Kim CH, 2015, DNA CELL BIOL, V34, P379, DOI 10.1089/dna.2015.2857; KOELLE MR, 1991, CELL, V67, P59, DOI 10.1016/0092-8674(91)90572-G; Koga T, 2014, AUTOIMMUNITY, V47, P445, DOI 10.3109/08916934.2014.915954; Kraft R, 2006, J NEUROSCI, V26, P8734, DOI 10.1523/JNEUROSCI.2106-06.2006; Lam G, 1999, DEV BIOL, V212, P204, DOI 10.1006/dbio.1999.9343; Lan Q, 1999, MOL CELL BIOL, V19, P4897; Lan Q, 1997, INSECT MOL BIOL, V6, P3, DOI 10.1046/j.1365-2583.1997.00151.x; Liu W, 2014, J BIOL CHEM, V289, P13026, DOI 10.1074/jbc.M113.547018; Liu W, 2014, ENDOCRINOLOGY, V155, P1738, DOI 10.1210/en.2013-2020; Liu W, 2013, BBA-GEN SUBJECTS, V1830, P5184, DOI 10.1016/j.bbagen.2013.06.037; Lonze BE, 2002, NEURON, V35, P605, DOI 10.1016/S0896-6273(02)00828-0; Mane-Padros D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045019; Marino M, 2006, CURR GENOMICS, V7, P497, DOI 10.2174/138920206779315737; MONTMINY MR, 1986, P NATL ACAD SCI USA, V83, P6682, DOI 10.1073/pnas.83.18.6682; MONTMINY MR, 1990, TRENDS NEUROSCI, V13, P184, DOI 10.1016/0166-2236(90)90045-C; MOORADIAN AD, 1987, ENDOCR REV, V8, P1, DOI 10.1210/edrv-8-1-1; Moore MJ, 2002, J BIOL CHEM, V277, P47878, DOI 10.1074/jbc.M204970200; Nahar J, 2015, ENDOCRINOLOGY, V156, P2831, DOI 10.1210/en.2015-1273; Norman AW, 2004, NAT REV DRUG DISCOV, V3, P27, DOI 10.1038/nrd1283; Radhakrishnan I, 1997, CELL, V91, P741, DOI 10.1016/S0092-8674(00)80463-8; Ren J, 2014, J STEROID BIOCHEM, V144, P313, DOI 10.1016/j.jsbmb.2014.08.006; Riddiford LM, 2003, INSECT BIOCHEM MOLEC, V33, P1327, DOI 10.1016/j.ibmb.2003.06.001; Sanden C, 2011, MOL PHARMACOL, V79, P400, DOI 10.1124/mol.110.069500; Shao HL, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003127; SMALLRIDGE RC, 1992, ENDOCRINOLOGY, V131, P1883, DOI 10.1210/en.131.4.1883; Srivastava DP, 2005, J NEUROSCI, V25, P6145, DOI 10.1523/JNEUROSCI.1005-05.2005; STEINBERG RA, 1993, MOL CELL BIOL, V13, P2332, DOI 10.1128/MCB.13.4.2332; SUMI M, 1991, BIOCHEM BIOPH RES CO, V181, P968, DOI 10.1016/0006-291X(91)92031-E; THOMAS HE, 1993, NATURE, V362, P471, DOI 10.1038/362471a0; Thummel CS, 2002, GENE DEV, V16, P3113, DOI 10.1101/gad.1042102; Toi M, 2014, BREAST CANCER-TOKYO, V21, P20, DOI 10.1007/s12282-012-0344-3; Wang D, 2015, SCI REP-UK, V5, DOI 10.1038/srep08675; YAO TP, 1992, CELL, V71, P63, DOI 10.1016/0092-8674(92)90266-F; Zhang Li-li, 2015, Beijing Da Xue Xue Bao Yi Xue Ban, V47, P489; Zhao XF, 1998, INSECT BIOCHEM MOLEC, V28, P259, DOI 10.1016/S0965-1748(98)00015-0	74	22	23	0	26	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 10	2016	291	24					12771	12785		10.1074/jbc.M115.706028	http://dx.doi.org/10.1074/jbc.M115.706028			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DO9PV	27129227	Green Published, hybrid			2022-12-26	WOS:000378119900029
J	Watanabe, Y; Papoutsoglou, P; Maturi, V; Tsubakihara, Y; Hottiger, MO; Heldin, CH; Moustakas, A				Watanabe, Yukihide; Papoutsoglou, Panagiotis; Maturi, Varun; Tsubakihara, Yutaro; Hottiger, Michael O.; Heldin, Carl-Henrik; Moustakas, Aristidis			Regulation of Bone Morphogenetic Protein Signaling by ADP-ribosylation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TGF-BETA RECEPTORS; BREAST-CANCER; CELL-LINES; POLY(ADP-RIBOSE); PARP-1; TRANSCRIPTION; TRANSDUCTION; EXPRESSION; PROGRESS; PATHWAY	We previously established a mechanism of negative regulation of transforming growth factor beta signaling mediated by the nuclear ADP-ribosylating enzyme poly-(ADP-ribose) polymerase 1 (PARP1) and the deribosylating enzyme poly-(ADP-ribose) glycohydrolase (PARG), which dynamically regulate ADP-ribosylation of Smad3 and Smad4, two central signaling proteins of the pathway. Here we demonstrate that the bone morphogenetic protein (BMP) pathway can also be regulated by the opposing actions of PARP1 and PARG. PARG positively contributes to BMP signaling and forms physical complexes with Smad5 and Smad4. The positive role PARG plays during BMP signaling can be neutralized by PARP1, as demonstrated by experiments where PARG and PARP1 are simultaneously silenced. In contrast to PARG, ectopic expression of PARP1 suppresses BMP signaling, whereas silencing of endogenous PARP1 enhances signaling and BMP-induced differentiation. The two major Smad proteins of the BMP pathway, Smad1 and Smad5, interact with PARP1 and can be ADP-ribosylated in vitro, whereas PARG causes deribosylation. The overall outcome of this mode of regulation of BMP signal transduction provides a fine-tuning mechanism based on the two major enzymes that control cellular ADP-ribosylation.	[Watanabe, Yukihide; Papoutsoglou, Panagiotis; Maturi, Varun; Tsubakihara, Yutaro; Heldin, Carl-Henrik; Moustakas, Aristidis] Uppsala Univ, Sci Life Lab, Ludwig Canc Res, SE-75124 Uppsala, Sweden; [Hottiger, Michael O.] Univ Zurich, Dept Mol Mech Dis, CH-8057 Zurich, Switzerland; [Moustakas, Aristidis] Uppsala Univ, Sci Life Lab, Dept Med Biochem & Microbiol, SE-75123 Uppsala, Sweden; [Watanabe, Yukihide] Univ Tsukuba, Fac Med, Dept Expt Pathol, 1-1-1 Tennodai, Tsukuba, Ibaraki 3058577, Japan	Uppsala University; University of Zurich; Uppsala University; University of Tsukuba	Moustakas, A (corresponding author), Uppsala Univ, Sci Life Lab, Dept Med Biochem & Microbiol, Ludwig Canc Res,Biomed Ctr, Box 582, SE-75123 Uppsala, Sweden.	aris.moustakas@imbim.uu.se	Hottiger, Michael O./J-7747-2013; Maturi, Varun/K-1837-2019; Papoutsoglou, Panagiotis/AAF-8898-2019	Hottiger, Michael O./0000-0002-7323-2270; Maturi, Varun/0000-0003-1177-0839; Papoutsoglou, Panagiotis/0000-0003-2115-3500	Ludwig Cancer Research; Swedish Research Council [K2010-67X-14936-07-3, K2013-66X-14936-10-5]; Bodossaki Foundation, Greece	Ludwig Cancer Research; Swedish Research Council(Swedish Research CouncilEuropean Commission); Bodossaki Foundation, Greece	This work was supported by Ludwig Cancer Research grants (to A. M. and C.-H. H.), Swedish Research Council Grants K2010-67X-14936-07-3 and K2013-66X-14936-10-5 (to A. M.), and funds from the Bodossaki Foundation, Greece (to P. P.). The authors declare that they have no conflicts of interest with the contents of this article.	Bragdon B, 2011, CELL SIGNAL, V23, P609, DOI 10.1016/j.cellsig.2010.10.003; Dahl M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103651; Gagne JP, 2006, CURR OPIN CELL BIOL, V18, P145, DOI 10.1016/j.ceb.2006.02.013; Heldin CH, 2009, CURR OPIN CELL BIOL, V21, P166, DOI 10.1016/j.ceb.2009.01.021; Hottiger MO, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2001645; Huang D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027123; Itoh S, 2011, GROWTH FACTORS, V29, P163, DOI 10.3109/08977194.2011.614236; Karaulanov E, 2004, EMBO J, V23, P844, DOI 10.1038/sj.emboj.7600101; KATAGIRI T, 1994, J CELL BIOL, V127, P1755, DOI 10.1083/jcb.127.6.1755; Kim MY, 2004, CELL, V119, P803, DOI 10.1016/j.cell.2004.11.002; Korchynskyi O, 2002, J BIOL CHEM, V277, P4883, DOI 10.1074/jbc.M111023200; Kowanetz M, 2004, MOL CELL BIOL, V24, P4241, DOI 10.1128/MCB.24.10.4241-4254.2004; Kraus WL, 2013, MOL ASPECTS MED, V34, P1109, DOI 10.1016/j.mam.2013.01.005; Krishnakumar R, 2010, MOL CELL, V39, P8, DOI 10.1016/j.molcel.2010.06.017; Ku MC, 2003, BIOCHEM BIOPH RES CO, V311, P702, DOI 10.1016/j.bbrc.2003.10.053; Liu L, 2014, MOL CANCER RES, V12, P1597, DOI 10.1158/1541-7786.MCR-14-0201; Lonn P, 2010, MOL CELL, V40, P521, DOI 10.1016/j.molcel.2010.10.029; Lonn P, 2009, CELL RES, V19, P21, DOI 10.1038/cr.2008.308; Massague J, 2012, NAT REV MOL CELL BIO, V13, P616, DOI 10.1038/nrm3434; Meyer-Ficca ML, 2004, EXP CELL RES, V297, P521, DOI 10.1016/j.yexcr.2004.03.050; Miwa M, 2007, CANCER SCI, V98, P1528, DOI 10.1111/j.1349-7006.2007.00567.x; Miyazono K, 2010, J BIOCHEM, V147, P35, DOI 10.1093/jb/mvp148; Moren A, 2003, J BIOL CHEM, V278, P33571, DOI 10.1074/jbc.M300159200; Moustakas A, 2009, DEVELOPMENT, V136, P3699, DOI 10.1242/dev.030338; Pu H, 2014, CARCINOGENESIS, V35, P2592, DOI 10.1093/carcin/bgu183; Rosenthal F, 2013, NAT STRUCT MOL BIOL, V20, P502, DOI 10.1038/nsmb.2521; Schreiber V, 2006, NAT REV MOL CELL BIO, V7, P517, DOI 10.1038/nrm1963; Sieber C, 2009, CYTOKINE GROWTH F R, V20, P343, DOI 10.1016/j.cytogfr.2009.10.007; Soderberg O, 2006, NAT METHODS, V3, P995, DOI 10.1038/nmeth947; Sterling JA, 2006, ANTICANCER RES, V26, P1893; Trucco C, 1998, NUCLEIC ACIDS RES, V26, P2644, DOI 10.1093/nar/26.11.2644; Wakefield LM, 2013, NAT REV CANCER, V13, P328, DOI 10.1038/nrc3500; Wu MY, 2009, DEV CELL, V16, P329, DOI 10.1016/j.devcel.2009.02.012; Zhang P, 2013, BLOOD, V122, P2224, DOI 10.1182/blood-2013-05-503250	34	5	5	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 10	2016	291	24					12706	12723		10.1074/jbc.M116.729699	http://dx.doi.org/10.1074/jbc.M116.729699			18	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DO9PV	27129221	hybrid, Green Accepted, Green Published			2022-12-26	WOS:000378119900024
J	Alaee, M; Danesh, G; Pasdar, M				Alaee, Mahsa; Danesh, Ghazal; Pasdar, Manijeh			Plakoglobin Reduces the in vitro Growth, Migration and Invasion of Ovarian Cancer Cells Expressing N-Cadherin and Mutant p53	PLOS ONE			English	Article							EPITHELIAL-MESENCHYMAL TRANSITION; SQUAMOUS CARCINOMA-CELLS; BETA-CATENIN; ADHESION MOLECULES; SURFACE EPITHELIUM; TWIST EXPRESSION; ALPHA-CATENIN; GAMMA-CATENIN; METASTASIS; TUMORS	Aberrant expression of cadherins and catenins plays pivotal roles in ovarian cancer development and progression. Plakoglobin (PG, gamma-catenin) is a paralog of beta-catenin with dual adhesive and signaling functions. While beta-catenin has known oncogenic function, PG generally acts as a tumor/metastasis suppressor. We recently showed that PG interacted with p53 and that its growth/metastasis inhibitory function may be mediated by this interaction. Very little is known about the role of PG in ovarian cancer. Here, we investigated the in vitro tumor/metastasis suppressor effects of PG in ovarian cancer cell lines with mutant p53 expression and different cadherin profiles. We showed that the N-cadherin expressing and E-cadherin and PG deficient ES-2 cells were highly migratory and invasive, whereas OV-90 cells that express E-cadherin, PG and very little/no N-cadherin were not. Exogenous expression of PG or E-cadherin or N-cadherin knockdown in ES-2 cells (ES-2-E-cad, ES-2-PG and ES-2-shN-cad) significantly reduced their migration and invasion. Also, PG expression or N-cadherin knockdown significantly decreased ES-2 cells growth. Furthermore, PG interacted with both cadherins and with wild type and mutant p53 in normal ovarian and ES-2-PG cell lines, respectively.	[Alaee, Mahsa; Danesh, Ghazal; Pasdar, Manijeh] Univ Alberta, Dept Oncol, Edmonton, AB T6G 1Z2, Canada	University of Alberta	Pasdar, M (corresponding author), Univ Alberta, Dept Oncol, Edmonton, AB T6G 1Z2, Canada.	mpasdar@ualberta.ca			Canadian Breast Cancer Foundation, Prairies / NWT; Alberta Cancer Foundation; Women & Children's Health Research Institute; Canadian Breast Cancer Foundation Prairies/NWT Chapter; Women and Children's Health Research Institute (WCHRI)	Canadian Breast Cancer Foundation, Prairies / NWT; Alberta Cancer Foundation; Women & Children's Health Research Institute; Canadian Breast Cancer Foundation Prairies/NWT Chapter; Women and Children's Health Research Institute (WCHRI)	This work was funded by Canadian Breast Cancer Foundation, Prairies / NWT (MP, operating); Alberta Cancer Foundation (MA, graduate fellowship); Women & Children's Health Research Institute (GD, Summer studentship).; We thank the Canadian Ovarian Tissue Bank at the BC Cancer Agency for providing IOSE-364 cells. Our work is supported by the Canadian Breast Cancer Foundation Prairies/NWT Chapter ( MP) and by the Alberta Cancer Foundation Graduate Scholarship ( MA). GD was supported by a summer studentship from the Women and Children's Health Research Institute (WCHRI).	ABERLE H, 1995, P NATL ACAD SCI USA, V92, P6384, DOI 10.1073/pnas.92.14.6384; Ahmed AA, 2010, J PATHOL, V221, P49, DOI 10.1002/path.2696; Ahmed N, 2007, J CELL PHYSIOL, V213, P581, DOI 10.1002/jcp.21240; Aktary Z, 2010, ONCOGENE, V29, P2118, DOI 10.1038/onc.2009.495; Aktary Z, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078388; Aktary Zackie, 2012, Int J Cell Biol, V2012, P189521, DOI 10.1155/2012/189521; Aktary Z, 2013, J CELL SCI, V126, P3031, DOI 10.1242/jcs.120642; Auersperg N, 2001, ENDOCR REV, V22, P255, DOI 10.1210/er.22.2.255; BAST RC, 1992, J NATL CANCER I, V84, P556, DOI 10.1093/jnci/84.8.556; Bell D, 2011, NATURE, V474, P609, DOI 10.1038/nature10166; Bernardini MQ, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-237; Campo L, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/420891; Cano A, 1996, INT J CANCER, V65, P254; Cho EY, 2006, PATHOL INT, V56, P62, DOI 10.1111/j.1440-1827.2006.01925.x; Concin N, 2003, INT J ONCOL, V22, P51; Corney DC, 2008, ADV EXP MED BIOL, V622, P99, DOI 10.1007/978-0-387-68969-2_9; Darai E, 1997, HUM PATHOL, V28, P922, DOI 10.1016/S0046-8177(97)90007-1; Davidson B, 2000, J PATHOL, V192, P460; Davidson B, 2015, HUM PATHOL, V46, P1, DOI 10.1016/j.humpath.2014.10.004; Davies BR, 1998, HISTOPATHOLOGY, V32, P69; Derycke LDM, 2004, INT J DEV BIOL, V48, P463, DOI 10.1387/ijdb.041793ld; Faleiro-Rodrigues C, 2004, HUM PATHOL, V35, P663, DOI 10.1016/j.humpath.2004.01.024; Fujioka T, 2001, ONCOL REP, V8, P249; Garcia PB, 2014, SEMIN CELL DEV BIOL, V27, P74, DOI 10.1016/j.semcdb.2013.12.014; Gheldof A, 2013, PROG MOL BIOL TRANSL, V116, P317, DOI 10.1016/B978-0-12-394311-8.00014-5; Gu B, 2012, INT J BIOL SCI, V8, P672, DOI 10.7150/ijbs.4283; HOFFMAN AG, 1993, INT J CANCER, V54, P828, DOI 10.1002/ijc.2910540518; Hosono S, 2007, BRIT J CANCER, V96, P314, DOI 10.1038/sj.bjc.6603533; Hudson LG, 2008, CLIN EXP METASTAS, V25, P643, DOI 10.1007/s10585-008-9171-5; Jannesari-Ladani F, 2014, FOLIA BIOL-PRAGUE, V60, P57; Kajiyama H, 2006, ONCOLOGY-BASEL, V71, P394, DOI 10.1159/000107108; Kim Kyungbin, 2014, Korean J Pathol, V48, P283, DOI 10.4132/KoreanJPathol.2014.48.4.283; Kim YM, 2011, CURR CANCER DRUG TAR, V11, P213, DOI 10.2174/156800911794328420; Kokenyesi R, 2003, GYNECOL ONCOL, V89, P60, DOI 10.1016/S0090-8258(02)00152-X; Kruiswijk F, 2015, NAT REV MOL CELL BIO, V16, P393, DOI 10.1038/nrm4007; Kuhn E, 2012, CURR OBSTET GYNECOL, V1, P1, DOI 10.1007/s13669-011-0004-1; Kuo KT, 2009, CANCER RES, V69, P4036, DOI 10.1158/0008-5472.CAN-08-3913; Kurman RJ, 2008, AM J OBSTET GYNECOL, V198, P351, DOI 10.1016/j.ajog.2008.01.005; Kurman RJ, 2010, AM J SURG PATHOL, V34, P433, DOI 10.1097/PAS.0b013e3181cf3d79; Kurrey NK, 2005, GYNECOL ONCOL, V97, P155, DOI 10.1016/j.ygyno.2004.12.043; Kyo S, 2006, HUM PATHOL, V37, P431, DOI 10.1016/j.humpath.2005.12.021; Lai YH, 2011, BMC CELL BIOL, V12, DOI 10.1186/1471-2121-12-50; Lam L, 2012, ONCOGENESIS, V1, DOI 10.1038/oncsis.2012.4; Lamouille S, 2014, NAT REV MOL CELL BIO, V15, P178, DOI 10.1038/nrm3758; Lau MT, 2011, ONCOGENE, V30, P2753, DOI 10.1038/onc.2011.6; Li J, 2015, TUMOR BIOL, V36, P1067, DOI 10.1007/s13277-014-2733-z; Li Z, 1998, J CELL SCI, V111, P1005; Lim SO, 2010, FEBS LETT, V584, P2231, DOI 10.1016/j.febslet.2010.04.006; Lu YM, 2014, MED ONCOL, V31, DOI 10.1007/s12032-014-0134-1; Lu ZY, 2012, ONCOL REP, V27, P1587, DOI 10.3892/or.2012.1685; Maeda O, 2004, ONCOGENE, V23, P964, DOI 10.1038/sj.onc.1207254; Miller RK, 2013, PROG MOL BIOL TRANSL, V116, P387, DOI 10.1016/B978-0-12-394311-8.00017-0; Miravet S, 2002, J BIOL CHEM, V277, P1884, DOI 10.1074/jbc.M110248200; Parker HR, 1998, CELL MOTIL CYTOSKEL, V40, P87, DOI 10.1002/(SICI)1097-0169(1998)40:1<87::AID-CM8>3.0.CO;2-C; Pecina-Slaus N, 2003, CANCER CELL INT, V3, DOI 10.1186/1475-2867-3-17; PEIFER M, 1992, J CELL BIOL, V118, P681, DOI 10.1083/jcb.118.3.681; Perotti A, 2009, ANN ONCOL, V20, P741, DOI 10.1093/annonc/mdn695; Petitjean A, 2007, HUM MUTAT, V28, P622, DOI 10.1002/humu.20495; Ponnusamy MP, 2010, ONCOGENE, V29, P5741, DOI 10.1038/onc.2010.309; Raurell I, 2006, J BIOL CHEM, V281, P1401, DOI 10.1074/jbc.M508153200; Salani R, 2008, INT J GYNECOL CANCER, V18, P487, DOI 10.1111/j.1525-1438.2007.01039.x; SALOMON D, 1992, J CELL SCI, V102, P7; Schafer G, 2014, J CELL SCI, V127, P1511, DOI 10.1242/jcs.139485; Sechler M, 2015, J BIOL CHEM, V290, P15610, DOI 10.1074/jbc.M114.631820; Shih WT, 2012, J CELL SCI, V125, P3661, DOI 10.1242/jcs.103861; Shiozaki H, 1996, CANCER, V77, P1605, DOI 10.1002/(SICI)1097-0142(19960415)77:8+<1605::AID-CNCR4>3.3.CO;2-R; Simcha I, 1996, J CELL BIOL, V133, P199, DOI 10.1083/jcb.133.1.199; So WK, 2015, FEBS LETT, V589, P302, DOI 10.1016/j.febslet.2014.12.012; Soler AP, 1997, HUM PATHOL, V28, P734, DOI 10.1016/S0046-8177(97)90184-2; Stasinopoulos IA, 2005, J BIOL CHEM, V280, P2294, DOI 10.1074/jbc.M411018200; Sundfeldt K, 2003, MOL CELL ENDOCRINOL, V202, P89, DOI 10.1016/S0303-7207(03)00068-6; Suyama K, 2002, CANCER CELL, V2, P301, DOI 10.1016/S1535-6108(02)00150-2; TAVASSOLI FA, 2003, TUMORS BREAST FEMALE, P113; Terauchi M, 2007, CLIN EXP METASTAS, V24, P329, DOI 10.1007/s10585-007-9070-1; Vousden KH, 2009, CELL, V137, P413, DOI 10.1016/j.cell.2009.04.037; Wang XH, 2004, ONCOGENE, V23, P474, DOI 10.1038/sj.onc.1207128; Wang YL, 2015, INT J CLIN EXP MED, V8, P7388; Wheelock MJ, 2008, J CELL SCI, V121, P727, DOI 10.1242/jcs.000455; Williamson L, 2006, EMBO J, V25, P3298, DOI 10.1038/sj.emboj.7601224; Yi BR, 2015, INT J ONCOL, V46, P272, DOI 10.3892/ijo.2014.2695; Yu YC, 2006, CLIN EXP METASTAS, V23, P65, DOI 10.1007/s10585-006-9020-3; Yuli C, 2007, ONCOGENE, V26, P6031, DOI 10.1038/sj.onc.1210420; Zeineldin R, 2006, MOL CARCINOGEN, V45, P851, DOI 10.1002/mc.20237; Zhang Y, 2015, MOL MED REP, V12, P3393, DOI 10.3892/mmr.2015.3786	84	17	17	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 4	2016	11	5							e0154323	10.1371/journal.pone.0154323	http://dx.doi.org/10.1371/journal.pone.0154323			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DL5KR	27144941	gold, Green Submitted, Green Published			2022-12-26	WOS:000375676400042
J	Camarata, T; Howard, A; Elsey, RM; Raza, S; O'Connor, A; Beatty, B; Conrad, J; Solounias, N; Chow, P; Mukta, S; Vasilyev, A				Camarata, Troy; Howard, Alexis; Elsey, Ruth M.; Raza, Sarah; O'Connor, Alice; Beatty, Brian; Conrad, Jack; Solounias, Nikos; Chow, Priscilla; Mukta, Saima; Vasilyev, Aleksandr			Postembryonic Nephrogenesis and Persistence of Six2-Expressing Nephron Progenitor Cells in the Reptilian Kidney	PLOS ONE			English	Article							DOGFISH SCYLIORHINUS-CANICULUS; RAJA-ERINACEA; REGENERATION; MORPHOLOGY; SIX2; MORPHOGENESIS; ELASMOBRANCH; RENEWAL; SYSTEM; NUMBER	New nephron formation (nephrogenesis) ceases in mammals around birth and is completely absent in adults. In contrast, postembryonic nephrogenesis is well documented in the mesonephric kidneys of fishes and amphibians. The transient mesonephros in reptiles (including birds) and mammals is replaced by the metanephros during embryogenesis. Thus, one may speculate that postembryonic nephrogenesis is restricted to the mesonephric kidney. Previous reports have suggested the metanephros of non-avian reptiles (hereafter reptiles) may continually form nephrons throughout life. We investigated the presence of adult nephrogenesis in reptiles by examining adult kidneys from several species including Trachemys scripta, Chrysemys picta, Boa constrictor, Tupinambis tegu, Anolis carolinensis, and Alligator mississipiensis among others. We found that all major reptilian groups (Testudines, Crocodylia, and Squamates) showed the presence of adult nephrogenesis. The total amount of nephrogenesis varied greatly between species with turtles displaying the highest density of nephrogenesis. In contrast, we were unable to detect adult nephrogenesis in monotremes, and in the iguanid A. carolinensis. Nephron progenitor cells express the transcription factor Six2, which in mammals, becomes downregulated as the progenitor cell population is exhausted and nephrogenesis ends. Using the alligator as a model, we were able to detect Six2-positive cap mesenchyme cells in the adult kidney, which spatially correlated with areas of nephrogenesis. These results suggest that the metanephric kidney of reptiles has maintained the ability to continually grow new nephrons during postembryonic life, a process lost early in mammalian evolution, likely due to the persistence of a Six2-expressing progenitor cell population.	[Camarata, Troy; Howard, Alexis; Raza, Sarah; O'Connor, Alice; Chow, Priscilla; Mukta, Saima; Vasilyev, Aleksandr] NYIT Coll Osteopath Med, Dept Biomed Sci, Old Westbury, NY USA; [Beatty, Brian; Conrad, Jack; Solounias, Nikos] NYIT Coll Osteopath Med, Dept Anat, Old Westbury, NY USA; [Elsey, Ruth M.] Louisiana Dept Wildlife & Fisheries, Grand Chenier, LA USA	New York Institute Technology; New York Institute Technology	Vasilyev, A (corresponding author), NYIT Coll Osteopath Med, Dept Biomed Sci, Old Westbury, NY USA.	avasilye@nyit.edu	Beatty, Brian/ABE-6078-2021	Beatty, Brian/0000-0002-5464-0041; Camarata, Troy/0000-0002-7628-2716	NIDDK NIH HHS [K08 DK082782] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K08DK082782] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Barak H, 2012, DEV CELL, V22, P1191, DOI 10.1016/j.devcel.2012.04.018; Bertram JF, 2011, PEDIATR NEPHROL, V26, P1529, DOI 10.1007/s00467-011-1843-8; BEUCHAT CA, 1988, AM J PHYSIOL, V255, pR760, DOI 10.1152/ajpregu.1988.255.5.R760; Brown AC, 2013, P NATL ACAD SCI USA, V110, P4640, DOI 10.1073/pnas.1213971110; Buaboocha W, 1997, ACTA ANAT, V159, P15; BURGGREN W, 1982, J EXP BIOL, V96, P343; Camarata TD, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0129561; Chinnadurai SK, 2009, JAVMA-J AM VET MED A, V234, P625, DOI 10.2460/javma.234.5.625; Costantini F, 2010, DEV CELL, V18, P698, DOI 10.1016/j.devcel.2010.04.008; DARMADY EM, 1973, J PATHOL, V109, P195, DOI 10.1002/path.1711090304; Das A, 2013, NAT CELL BIOL, V15, P1035, DOI 10.1038/ncb2828; Davidson AJ, 2011, PEDIATR NEPHROL, V26, P1435, DOI 10.1007/s00467-011-1795-z; Diep CQ, 2015, GENESIS, V53, P257, DOI 10.1002/dvg.22846; Diep CQ, 2011, NATURE, V470, P95, DOI 10.1038/nature09669; Dressler GR, 2009, DEVELOPMENT, V136, P3863, DOI 10.1242/dev.034876; Drummond I, 2003, TRENDS CELL BIOL, V13, P357, DOI 10.1016/S0962-8924(03)00124-7; Elger M, 2003, J AM SOC NEPHROL, V14, P1506, DOI 10.1097/01.ASN.0000067645.49562.09; FINE LG, 1989, ANNU REV PHYSIOL, V51, P19, DOI 10.1146/annurev.ph.51.030189.000315; Fox H., 1977, P1; GASSER B, 1993, FETAL DIAGN THER, V8, P371, DOI 10.1159/000263855; Georgas KM, 2011, DEV DYNAM, V240, P1600, DOI 10.1002/dvdy.22640; Georgas K, 2009, DEV BIOL, V332, P273, DOI 10.1016/j.ydbio.2009.05.578; Gray P, 1930, Q J MICROSC SCI, V73, P507; Hartman HA, 2007, DEV BIOL, V310, P379, DOI 10.1016/j.ydbio.2007.08.021; HENTSCHEL H, 1988, AM J ANAT, V183, P130, DOI 10.1002/aja.1001830204; Hentschel H, 1998, ANAT EMBRYOL, V198, P73, DOI 10.1007/s004290050166; HENTSCHEL H, 1993, ANAT REC, V235, P21, DOI 10.1002/ar.1092350104; Kao RM, 2012, J AM SOC NEPHROL, V23, P1682, DOI 10.1681/ASN.2012030283; Karner CM, 2011, DEVELOPMENT, V138, P1247, DOI 10.1242/dev.057646; Kobayashi A, 2008, CELL STEM CELL, V3, P169, DOI 10.1016/j.stem.2008.05.020; Levinson RS, 2005, DEVELOPMENT, V132, P529, DOI 10.1242/dev.01604; Lowrey LG, 1911, AM J ANAT, V12, P107, DOI 10.1002/aja.1000120202; Lui JC, 2011, ENDOCR REV, V32, P422, DOI 10.1210/er.2011-0001; Moore BC, 2009, ANAT REC, V292, P1670, DOI 10.1002/ar.20942; NELSON JE, 1992, ACTA ANAT, V144, P336; NYENGAARD JR, 1992, ANAT REC, V232, P194, DOI 10.1002/ar.1092320205; O'Leary MA, 2013, SCIENCE, V339, P662, DOI 10.1126/science.1229237; Park JS, 2012, DEV CELL, V23, P637, DOI 10.1016/j.devcel.2012.07.008; Reimschuessel R, 2001, ILAR J, V42, P285; REIMSCHUESSEL R, 1990, TOXICOL PATHOL, V18, P32, DOI 10.1177/019262339001800105; Salice CJ, 2001, COMPARATIVE MED, V51, P56; Saran R, 2015, AM J KIDNEY DIS, V66, pS1, DOI 10.1053/j.ajkd.2015.05.001; Saxen L., 1987, ORGANOGENESIS KIDNEY; Schulte K, 2015, NEPHROL DIAL TRANSPL, V30, P713, DOI 10.1093/ndt/gfu275; Self M, 2006, EMBO J, V25, P5214, DOI 10.1038/sj.emboj.7601381; SHELTON G, 1991, J EXP BIOL, V158, P539; Smith HW., 1943, LECT KIDNEY, P3; SOLOMON SE, 1985, J ANAT, V140, P355; Takasato M, 2015, DEVELOPMENT, V142, P1937, DOI 10.1242/dev.104802; TSUJII T, 1992, ANAT REC, V234, P348, DOI 10.1002/ar.1092340306; van Tuinen M, 2004, J MOL EVOL, V59, P267, DOI 10.1007/s00239-004-2624-9; Watanabe N, 2009, DEV GROWTH DIFFER, V51, P135, DOI 10.1111/j.1440-169X.2009.01090.x; WIDEMAN RF, 1989, J MORPHOL, V201, P205, DOI 10.1002/jmor.1052010209; Wingert RA, 2008, KIDNEY INT, V73, P1120, DOI 10.1038/ki.2008.37; Yang L, 2011, CONTRIB NEPHROL, V174, P149, DOI 10.1159/000329385; Zhou WB, 2010, AM J PHYSIOL-RENAL, V299, pF1040, DOI 10.1152/ajprenal.00394.2010	56	10	10	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 4	2016	11	5							e0153422	10.1371/journal.pone.0153422	http://dx.doi.org/10.1371/journal.pone.0153422			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DL5KR	27144443	Green Published, gold, Green Submitted			2022-12-26	WOS:000375676400014
J	Arriaza, MC; Dominguez-Rodrigo, M; Yravedra, J; Baquedano, E				Carmen Arriaza, Mari; Dominguez-Rodrigo, Manuel; Yravedra, Jose; Baquedano, Enrique			Lions as Bone Accumulators? Paleontological and Ecological Implications of a Modern Bone Assemblage from Olduvai Gorge	PLOS ONE			English	Article							HYENA CROCUTA-CROCUTA; SURFACE MODIFICATION MODELS; INFERRING FOSSIL HOMININ; CARNIVORE TOOTH MARKS; FLK 22 ZINJANTHROPUS; SPOTTED HYENA; PREY PREFERENCES; PLIOPLEISTOCENE HOMINIDS; METHODOLOGICAL APPROACH; CARCASS CONSUMPTION	Analytic models have been developed to reconstruct early hominin behaviour, especially their subsistence patterns, revealed mainly through taphonomic analyses of archaeofaunal assemblages. Taphonomic research is used to discern which agents (carnivores, humans or both) generate the bone assemblages recovered at archaeological sites. Taphonomic frameworks developed during the last decades show that the only large-sized carnivores in African biomes able to create bone assemblages are leopards and hyenas. A carnivore-made bone assemblage located in the short-grassland ecological unit of the Serengeti (within Olduvai Gorge) was studied. Taphonomic analyses of this assemblage including skeletal part representation, bone density, breakage patterns and anatomical distribution of tooth marks, along with an ecological approach to the prey selection made by large carnivores of the Serengeti, were carried out. The results show that this bone assemblage may be the first lion-accumulated assemblage documented, although other carnivores (namely spotted hyenas) may have also intervened through postdepositional ravaging. This first faunal assemblage potentially created by lions constitutes a new framework for neotaphonomic studies. Since lions may accumulate carcasses under exceptional circumstances, such as those documented at the site reported here, this finding may have important consequences for interpretations of early archaeological and paleontological sites, which provide key information about human evolution.	[Carmen Arriaza, Mari] Univ Alcala de Henares, Dept Geol Geog & Medio Ambiente, Edificio Ciencias Campus Externo Ctra A-2 Km 3360, E-28871 Alcala De Henares, Madrid, Spain; [Carmen Arriaza, Mari; Dominguez-Rodrigo, Manuel; Yravedra, Jose; Baquedano, Enrique] Museo Origenes, Inst Evoluc Africa IDEA, Plaza San Andres 2, Madrid 28005, Spain; [Dominguez-Rodrigo, Manuel; Yravedra, Jose] Univ Complutense, Dept Prehist, Prof Aranguren S-N, E-28040 Madrid, Spain; [Baquedano, Enrique] Museo Arqueol Reg Comunidad Madrid, Plaza Bernardas S-N, Alcala De Henares 28801, Madrid, Spain	Universidad de Alcala; Complutense University of Madrid	Arriaza, MC (corresponding author), Univ Alcala de Henares, Dept Geol Geog & Medio Ambiente, Edificio Ciencias Campus Externo Ctra A-2 Km 3360, E-28871 Alcala De Henares, Madrid, Spain.; Arriaza, MC (corresponding author), Museo Origenes, Inst Evoluc Africa IDEA, Plaza San Andres 2, Madrid 28005, Spain.	mcarmen.arriaza@uah.es	Yravedra, Jose/AAC-2073-2019; Yravedra, Jose/E-9815-2016; del Carmen Arriaza Dorado, María/AAB-3468-2021; Baquedano, Enrique/ABE-9997-2020	Yravedra, Jose/0000-0002-4323-3379; del Carmen Arriaza Dorado, María/0000-0003-1393-4323; 	Ministerio de Economia y Competitividad through the European project [I + D HAR2013-45246-C3-1P]; Ministerio de Cultura through the Heritage Institute; Program of Funding for Archaeological Projects Abroad; Comunidad de Madrid [S2010/BMD-2330]	Ministerio de Economia y Competitividad through the European project; Ministerio de Cultura through the Heritage Institute; Program of Funding for Archaeological Projects Abroad; Comunidad de Madrid(Comunidad de Madrid)	The authors greatly appreciate the major funding provided by the Ministerio de Economia y Competitividad through the European project I + D HAR2013-45246-C3-1P and the Ministerio de Cultura through the Heritage Institute and the Program of Funding for Archaeological Projects Abroad. The authors also thank the Comunidad de Madrid for funding provided through the I + D project S2010/BMD-2330 (I+D activities programme for research groups of the Consejeria de Educacion). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alcantara V., 2006, TRABAJOS PREHIST, V63, P25; Andres M, 2012, ARCHAEOL ANTHROP SCI, V4, P209, DOI 10.1007/s12520-012-0093-4; Andrews P, 1997, J HUM EVOL, V33, P191, DOI 10.1006/jhev.1997.0137; ANDREWS P, 1983, PALEOBIOLOGY, V9, P289, DOI 10.1017/S0094837300007703; Andrews P, 1990, OWLS CAVES FOSSILS; BERTRAM BCR, 1975, J ZOOL, V177, P463; Binford L.R., 1981, BONES ANCIENT MEN MO; Blumenschine R.J., 1993, BONES BEHAV, DOI 10.1016/j.jhevol.2017.08.004; BLUMENSCHINE RJ, 1986, J HUM EVOL, V15, P639, DOI 10.1016/S0047-2484(86)80002-1; BLUMENSCHINE RJ, 1995, J HUM EVOL, V29, P21, DOI 10.1006/jhev.1995.1046; BLUMENSCHINE RJ, 1987, CURR ANTHROPOL, V28, P383, DOI 10.1086/203544; Blumenschine RJ, 1996, J ARCHAEOL SCI, V23, P493, DOI 10.1006/jasc.1996.0047; BLUMENSCHINE RJ, 1988, J ARCHAEOL SCI, V15, P483, DOI 10.1016/0305-4403(88)90078-7; Blumenschine RJ, 2007, EVOLUTION HUMAN DIET, P167; Blumenschine RJ, 2012, J HUM EVOL, V63, P364, DOI 10.1016/j.jhevol.2011.10.001; BRAIN C. K, 1981, HUNTERS HUNTED INTRO; Bunn HT, 2010, QUATERNARY RES, V74, P395, DOI 10.1016/j.yqres.2010.07.012; BUNN HT, 1986, CURR ANTHROPOL, V27, P431, DOI 10.1086/203467; BUNN HT, 1981, NATURE, V291, P574, DOI 10.1038/291574a0; BYGOTT JD, 1979, NATURE, V282, P839, DOI 10.1038/282839a0; Capaldo S.D., 1995, THESIS RUTGERS U NEW; Capaldo SD, 1997, J HUM EVOL, V33, P555, DOI 10.1006/jhev.1997.0150; CAPALDO SD, 1994, AM ANTIQUITY, V59, P724, DOI 10.2307/282345; Carbone C, 1999, NATURE, V402, P286, DOI 10.1038/46266; Arriaza MC, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0125944; CAVALLO JA, 1989, J HUM EVOL, V18, P393, DOI 10.1016/0047-2484(89)90038-9; Craft M.E., 2015, SERENGETI 4 SUSTAINI, P419; Craft ME, 2011, J R SOC INTERFACE, V8, P776, DOI 10.1098/rsif.2010.0511; CRUZURIBE K, 1991, J FIELD ARCHAEOL, V18, P467, DOI 10.2307/530408; de Ruiter DJ, 2000, J ARCHAEOL SCI, V27, P665, DOI 10.1006/jasc.1999.0470; Delaney-Rivera C, 2009, J ARCHAEOL SCI, V36, P2597, DOI 10.1016/j.jas.2009.08.001; Dominguez-Rodrigo A, 2007, J HUM EVOL, V53, P427, DOI 10.1016/j.jhevol.2007.05.010; Dominguez-Rodrigo M, 1997, J HUM EVOL, V33, P669, DOI 10.1006/jhev.1997.0161; Dominguez-Rodrigo M, 2006, J HUM EVOL, V50, P170, DOI 10.1016/j.jhevol.2005.09.005; Dominguez-Rodrigo M, 2015, J AFR EARTH SCI, V108, P42, DOI 10.1016/j.jafrearsci.2015.04.011; Dominguez-Rodrigo M, 2003, J ARCHAEOL SCI, V30, P1385, DOI 10.1016/S0305-4403(03)00027-X; Dominguez-Rodrigo M, 2003, J ARCHAEOL SCI, V30, P381, DOI 10.1006/jasc.2002.0842; Dominguez-Rodrigo M, 1999, PALAEOGEOGR PALAEOCL, V149, P373, DOI 10.1016/S0031-0182(98)00213-2; Dominguez-Rodrigo M, 2010, ZONA ARQUEOLOGICA, V13, P50; Dominguez-Rodrigo M., 1994, TRABAJOS PREHIST, V51, P15, DOI DOI 10.3989/TP.1994.V51.I1.462; Dominguez-Rodrigo M., 1997, TRABAJOS PREHIST, V54, P29, DOI DOI 10.3989/TP.1997.V54.I2.364; Dominguez-Rodrigo M, 2015, J ARCHAEOL SCI, V59, P35, DOI 10.1016/j.jas.2015.04.007; Dominguez-Rodrigo Manuel, 2012, Journal of Taphonomy, V10, P147; Dominguez-Rodrigo M, 2014, QUATERN INT, V322, P32, DOI 10.1016/j.quaint.2013.09.042; Dominguez-Rodrigo M, 2012, ARCHAEOL ANTHROP SCI, V4, P47, DOI 10.1007/s12520-011-0082-z; Dominguez-Rodrigo M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068955; Dominguez-Rodrigo Manuel, 2007, P255; DominguezRodrigo M, 2007, VERTEBR PALEOBIOL PA, P1; Egeland Amy G., 2008, Journal of Taphonomy, V6, P275; Emslie S.D., 1991, Journal of Vertebrate Paleontology, V11, P133; Faith JT, 2007, J ARCHAEOL SCI, V34, P1601, DOI 10.1016/j.jas.2006.11.014; Fourvel JB, 2015, QUATERN INT, V369, P38, DOI 10.1016/j.quaint.2014.08.022; FRYXELL JM, 1988, AM NAT, V131, P781, DOI 10.1086/284822; Fyumagwa D, 2001, TAWRI WILDLIFE VET P; Gidna AO, 2014, QUATERN INT, V322, P167, DOI 10.1016/j.quaint.2013.08.059; Grzimek B., 1959, SERENGETI SHALL NOT; HANBY JP, 1987, ANIM BEHAV, V35, P161, DOI 10.1016/S0003-3472(87)80221-X; Hay R.L., 1976, GEOLOGY OLDUVAI GORG; Hayward MW, 2006, J ZOOL, V270, P615, DOI 10.1111/j.1469-7998.2006.00184.x; Hayward MW, 2006, J ZOOL, V270, P606, DOI 10.1111/j.1469-7998.2006.00183.x; Hayward MW, 2006, J ZOOL, V270, P298, DOI 10.1111/j.1469-7998.2006.00139.x; Hayward MW, 2006, J MAMMAL, V87, P1122, DOI 10.1644/05-MAMM-A-304R2.1; Hayward MW, 2005, J ZOOL, V267, P309, DOI 10.1017/S0952836905007508; HILL A, 1980, MAMMALIA, V44, P594; HOLEKAMP KE, 1990, ETHOLOGY, V86, P191; Hopcraft JGC, 2005, J ANIM ECOL, V74, P559, DOI 10.1111/j.1365-2656.2005.00955.x; Kerbis Peterhans J, 1990, THESIS U CHICAGO; KLEIN RG, 1982, PALEOBIOLOGY, V8, P151, DOI 10.1017/S0094837300004498; KRUUK H., 1967, MAMMALIA, V31, P1, DOI 10.1515/mamm.1967.31.1.1; KRUUK H, 1976, East African Wildlife Journal, V14, P91; Kruuk H., 1972, P1; Kuhn B.F., 2011, HYAENIDS TAPHONOMY I; LAM YM, 1992, J ARCHAEOL SCI, V19, P389, DOI 10.1016/0305-4403(92)90057-A; Lam YM, 1999, AM ANTIQUITY, V64, P343, DOI 10.2307/2694283; Lansing SW, 2009, PALEOBIOLOGY, V35, P289, DOI 10.1666/08009.1; Laudet F, 2005, PALAEOGEOGR PALAEOCL, V226, P272, DOI 10.1016/j.palaeo.2005.05.015; Marean Curtis W., 2004, Journal of Taphonomy, V2, P69; Martin Fabiana M., 2008, Journal of Taphonomy, V6, P337; Mduma SAR, 1996, THESIS U BRIT COLUMB; Mills MGL, 1997, ANN TRANSVAAL MUS, V30, P145; PACKER C, 1983, AM NAT, V121, P716, DOI 10.1086/284097; Packer C, 2005, SCIENCE, V307, P390, DOI 10.1126/science.1105122; PACKER C, 1983, ANIM BEHAV, V31, P334, DOI 10.1016/S0003-3472(83)80051-7; Packer C., 1986, P429; Pante MC, 2015, QUATERN INT, V355, P164, DOI 10.1016/j.quaint.2014.09.007; Pante MC, 2012, J HUM EVOL, V63, P395, DOI 10.1016/j.jhevol.2011.09.002; Parkinson JA, 2015, J HUM EVOL, V80, P114, DOI 10.1016/j.jhevol.2014.10.011; Pickering TR, 2005, INT J OSTEOARCHAEOL, V15, P247, DOI 10.1002/oa.780; Pickering TR, 2002, INT J OSTEOARCHAEOL, V12, P127, DOI 10.1002/oa.594; Pienaar U. de V., 1969, Koedoe, VNo. 12, P108; Pobiner BL, 2015, J HUM EVOL, V80, P1, DOI 10.1016/j.jhevol.2014.06.020; Pokines JT, 2007, J ARCHAEOL SCI, V34, P1914, DOI 10.1016/j.jas.2007.01.012; Prendergast Mary E., 2008, Journal of Taphonomy, V6, P301; PUSEY AE, 1987, BEHAVIOUR, V101, P275, DOI 10.1163/156853987X00026; RUDNAI J, 1973, East African Wildlife Journal, V11, P241; SCHALLER G B, 1972, P480; Selvaggio MM, 1998, J ARCHAEOL SCI, V25, P191, DOI 10.1006/jasc.1997.0281; SELVAGGIO MM, 1994, J HUM EVOL, V27, P215, DOI 10.1006/jhev.1994.1043; Selvaggio MM, 2001, J ARCHAEOL SCI, V28, P465, DOI 10.1006/jasc.2000.0557; Selvaggio MM, 1994, THESIS RUTGERS U NEW; SHIPMAN P, 1984, CURR ANTHROPOL, V25, P116, DOI 10.1086/203091; SHIPMAN P, 1983, J ANTHROPOL ARCHAEOL, V2, P57, DOI 10.1016/0278-4165(83)90008-9; Sinclair A., 1979, SERENGETI DYNAMICS E, P1; Sinclair ARE, 2003, NATURE, V425, P288, DOI 10.1038/nature01934; SINCLAIR ARE, 1995, ECOLOGY, V76, P882, DOI 10.2307/1939353; Skinner J. D., 2006, Transactions of the Royal Society of South Africa, V61, P4, DOI 10.1080/00359190609519187; Skinner J.D., 1980, Palaeontologia Africana, V23, P99; SKINNER JD, 1976, S AFR J SCI, V72, P262; SKINNER JD, 1986, S AFR J ZOOL, V21, P303; STINER MC, 1991, J ARCHAEOL SCI, V18, P455, DOI 10.1016/0305-4403(91)90038-Q; STINER MC, 1990, J ANTHROPOL ARCHAEOL, V9, P305, DOI 10.1016/0278-4165(90)90010-B; SUTCLIFFE AJ, 1970, NATURE, V227, P1110, DOI 10.1038/2271110a0; Turner A., 1997, BIG CATS THEIR FOSSI; VanderWaal KL, 2009, ANIM BEHAV, V77, P949, DOI 10.1016/j.anbehav.2008.12.028; VILLA P, 1991, J HUM EVOL, V21, P27, DOI 10.1016/0047-2484(91)90034-S; WASER PM, 1983, Q REV BIOL, V58, P355, DOI 10.1086/413385; Werdelin L, 2011, VERTEBR PALEOBIOL PA, P189, DOI 10.1007/978-90-481-9962-4_8; West P. M., 2013, MAMMALS OF AFRICA, P149; Yravedra J, 2009, J QUATERNARY SCI, V24, P85, DOI 10.1002/jqs.1164	119	39	40	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 4	2016	11	5							e0153797	10.1371/journal.pone.0153797	http://dx.doi.org/10.1371/journal.pone.0153797			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DL5KR	27144649	Green Published, gold			2022-12-26	WOS:000375676400028
J	Ikkai, A; Dandekar, S; Curtis, CE				Ikkai, Akiko; Dandekar, Sangita; Curtis, Clayton E.			Lateralization in Alpha-Band Oscillations Predicts the Locus and Spatial Distribution of Attention	PLOS ONE			English	Article							HUMAN VISUAL-CORTEX; HUMAN EXTRASTRIATE CORTEX; VISUOSPATIAL ATTENTION; OCCIPITAL CORTEX; WORKING-MEMORY; DIFFERENTIAL SENSITIVITY; NEURONAL SYNCHRONIZATION; DIRECTED ATTENTION; PREFRONTAL CORTEX; NEURAL MECHANISMS	Attending to a task-relevant location changes how neural activity oscillates in the alpha band (8-13Hz) in posterior visual cortical areas. However, a clear understanding of the relationships between top-down attention, changes in alpha oscillations in visual cortex, and attention performance are still poorly understood. Here, we tested the degree to which the posterior alpha power tracked the locus of attention, the distribution of attention, and how well the topography of alpha could predict the locus of attention. We recorded magnetoencephalographic (MEG) data while subjects performed an attention demanding visual discrimination task that dissociated the direction of attention from the direction of a saccade to indicate choice. On some trials, an endogenous cue predicted the target's location, while on others it contained no spatial information. When the target's location was cued, alpha power decreased in sensors over occipital cortex contralateral to the attended visual field. When the cue did not predict the target's location, alpha power again decreased in sensors over occipital cortex, but bilaterally, and increased in sensors over frontal cortex. Thus, the distribution and the topography of alpha reliably indicated the locus of covert attention. Together, these results suggest that alpha synchronization reflects changes in the excitability of populations of neurons whose receptive fields match the locus of attention. This is consistent with the hypothesis that alpha oscillations reflect the neural mechanisms by which top-down control of attention biases information processing and modulate the activity of neurons in visual cortex.	[Ikkai, Akiko; Dandekar, Sangita; Curtis, Clayton E.] NYU, Dept Psychol, 6 Washington Pl, New York, NY 10003 USA; [Curtis, Clayton E.] NYU, Ctr Neural Sci, New York, NY USA	New York University; New York University	Curtis, CE (corresponding author), NYU, Dept Psychol, 6 Washington Pl, New York, NY 10003 USA.; Curtis, CE (corresponding author), NYU, Ctr Neural Sci, New York, NY USA.	clayton.curtis@nyu.edu			National Eye Institute [R01EY016407]; National Institute of Mental Health [R03MH097206]; NATIONAL EYE INSTITUTE [R01EY016407, P30EY013079] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R03MH097206] Funding Source: NIH RePORTER	National Eye Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was supported by the National Eye Institute, grant # R01EY016407 and the National Institute of Mental Health, grant # R03MH097206. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adachi Y, 2001, IEEE T APPL SUPERCON, V11, P669, DOI 10.1109/77.919433; Astafiev SV, 2003, J NEUROSCI, V23, P4689; Awh E, 2000, J EXP PSYCHOL HUMAN, V26, P834, DOI 10.1037/0096-1523.26.2.834; Bastiaansen MCM, 2000, CLIN NEUROPHYSIOL, V111, P1300, DOI 10.1016/S1388-2457(00)00272-8; Beck DM, 2005, NAT NEUROSCI, V8, P1110, DOI 10.1038/nn1501; Ben-Shachar M, 2007, CEREB CORTEX, V17, P1604, DOI 10.1093/cercor/bhl071; Bisley JW, 2010, ANNU REV NEUROSCI, V33, P1, DOI 10.1146/annurev-neuro-060909-152823; BRANDT ME, 1991, INT J NEUROSCI, V61, P261, DOI 10.3109/00207459108990744; CASTIELLO U, 1992, J EXP PSYCHOL HUMAN, V18, P837, DOI 10.1037/0096-1523.18.3.837; Chiu YC, 2009, J NEUROSCI, V29, P3930, DOI 10.1523/JNEUROSCI.5737-08.2009; Cohen MX, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057293; Corbetta M, 2005, NAT NEUROSCI, V8, P1603, DOI 10.1038/nn1574; Corbetta M, 2011, ANNU REV NEUROSCI, V34, P569, DOI 10.1146/annurev-neuro-061010-113731; DESIMONE R, 1995, ANNU REV NEUROSCI, V18, P193, DOI 10.1146/annurev.ne.18.030195.001205; Fecteau JH, 2006, TRENDS COGN SCI, V10, P382, DOI 10.1016/j.tics.2006.06.011; Foxe JJ, 1998, NEUROREPORT, V9, P3929, DOI 10.1097/00001756-199812010-00030; Fries P, 2001, SCIENCE, V291, P1560, DOI 10.1126/science.1055465; Fu KMG, 2001, COGNITIVE BRAIN RES, V12, P145, DOI 10.1016/S0926-6410(01)00034-9; Gould IC, 2011, J NEUROPHYSIOL, V105, P1318, DOI 10.1152/jn.00653.2010; Grent-'t-Jong T, 2011, CEREB CORTEX, V21, P2204, DOI 10.1093/cercor/bhq279; Grill-Spector K, 1998, NEURON, V21, P191, DOI 10.1016/S0896-6273(00)80526-7; Grimault S, 2009, HUM BRAIN MAPP, V30, P3378, DOI 10.1002/hbm.20759; Gunduz A, 2012, NEUROIMAGE, V60, P2285, DOI 10.1016/j.neuroimage.2012.02.017; Gunduz A, 2011, FRONT HUM NEUROSCI, V5, DOI 10.3389/fnhum.2011.00089; Haegens S, 2012, J COGNITIVE NEUROSCI, V24, P677, DOI 10.1162/jocn_a_00164; Haegens S, 2011, J NEUROSCI, V31, P5197, DOI 10.1523/JNEUROSCI.5199-10.2011; Haenschel C, 2009, J NEUROSCI, V29, P9481, DOI 10.1523/JNEUROSCI.1428-09.2009; Hagler DJ, 2006, NEUROIMAGE, V29, P567, DOI 10.1016/j.neuroimage.2005.08.058; Handel BF, 2011, J COGNITIVE NEUROSCI, V23, P2494, DOI 10.1162/jocn.2010.21557; HEILMAN KM, 1980, NEUROLOGY, V30, P327, DOI 10.1212/WNL.30.3.327; Hopfinger JB, 2000, NAT NEUROSCI, V3, P284, DOI 10.1038/72999; Huang J, 2010, J NEUROSCI, V30, P13461, DOI 10.1523/JNEUROSCI.2560-10.2010; Ikkai A, 2008, CEREB CORTEX, V18, P1384, DOI 10.1093/cercor/bhm171; Ikkai A, 2011, J COGNITIVE NEUROSCI, V23, P1494, DOI 10.1162/jocn.2010.21499; Ikkai A, 2011, NEUROPSYCHOLOGIA, V49, P1428, DOI 10.1016/j.neuropsychologia.2010.12.020; Jack AI, 2006, NEURON, V51, P135, DOI 10.1016/j.neuron.2006.06.003; James TW, 2003, BRAIN, V126, P2463, DOI 10.1093/brain/awg248; Jerde TA, 2012, J NEUROSCI, V32, P17382, DOI 10.1523/JNEUROSCI.3810-12.2012; Jones SR, 2010, J NEUROSCI, V30, P13760, DOI 10.1523/JNEUROSCI.2969-10.2010; Kanwisher N, 1997, J NEUROSCI, V17, P4302; Kastner S, 1998, SCIENCE, V282, P108, DOI 10.1126/science.282.5386.108; Kastner S, 1999, NEURON, V22, P751, DOI 10.1016/S0896-6273(00)80734-5; Kelley TA, 2008, CEREB CORTEX, V18, P114, DOI 10.1093/cercor/bhm036; Kelly SP, 2006, J NEUROPHYSIOL, V95, P3844, DOI 10.1152/jn.01234.2005; Kelly SP, 2009, EUR J NEUROSCI, V30, P2224, DOI 10.1111/j.1460-9568.2009.06980.x; Kincade JM, 2005, J NEUROSCI, V25, P4593, DOI 10.1523/JNEUROSCI.0236-05.2005; Kinsbourne M, 1977, Adv Neurol, V18, P41; Klimesch W, 2007, BRAIN RES REV, V53, P63, DOI 10.1016/j.brainresrev.2006.06.003; Landau AN, 2012, CURR BIOL, V22, P1000, DOI 10.1016/j.cub.2012.03.054; Lange J, 2013, J NEUROSCI, V33, P3212, DOI 10.1523/JNEUROSCI.3755-12.2013; Leiberg S, 2006, BRAIN RES, V1120, P131, DOI 10.1016/j.brainres.2006.08.066; MALACH R, 1995, P NATL ACAD SCI USA, V92, P8135, DOI 10.1073/pnas.92.18.8135; Maris E, 2007, J NEUROSCI METH, V164, P177, DOI 10.1016/j.jneumeth.2007.03.024; Mazaheri A, 2010, FRONT HUM NEUROSCI, V4, DOI 10.3389/fnhum.2010.00177; McMains SA, 2004, NEURON, V42, P677, DOI 10.1016/S0896-6273(04)00263-6; Medendorp WP, 2007, CEREB CORTEX, V17, P2364, DOI 10.1093/cercor/bhl145; Mesulam MM, 1999, PHILOS T R SOC B, V354, P1325, DOI 10.1098/rstb.1999.0482; MILLER EK, 1993, BRAIN RES, V616, P25, DOI 10.1016/0006-8993(93)90187-R; MORAN J, 1985, SCIENCE, V229, P782, DOI 10.1126/science.4023713; Morawetz C, 2007, VISUAL NEUROSCI, V24, P817, DOI 10.1017/S0952523807070745; Offen S, 2009, VISION RES, V49, P1352, DOI 10.1016/j.visres.2007.12.022; Palva S, 2011, J NEUROSCI, V31, P5013, DOI 10.1523/JNEUROSCI.5592-10.2011; Pouget A, 2000, CURR OPIN NEUROBIOL, V10, P242, DOI 10.1016/S0959-4388(00)00077-5; Puce A, 1996, J NEUROSCI, V16, P5205; Reynolds JH, 1999, J NEUROSCI, V19, P1736; Reynolds JH, 2000, NEURON, V26, P703, DOI 10.1016/S0896-6273(00)81206-4; Rihs TA, 2007, EUR J NEUROSCI, V25, P603, DOI 10.1111/j.1460-9568.2007.05278.x; Rihs TA, 2009, NEUROIMAGE, V44, P190, DOI 10.1016/j.neuroimage.2008.08.022; Sauseng P, 2005, EUR J NEUROSCI, V22, P2917, DOI 10.1111/j.1460-9568.2005.04482.x; Serences JT, 2007, CEREB CORTEX, V17, P284, DOI 10.1093/cercor/bhj146; Shulman GL, 2001, P NATL ACAD SCI USA, V98, P313, DOI 10.1073/pnas.021381198; Siegel M, 2008, NEURON, V60, P709, DOI 10.1016/j.neuron.2008.09.010; Silver MA, 2005, J NEUROPHYSIOL, V94, P1358, DOI 10.1152/jn.01316.2004; Silver MA, 2007, J NEUROPHYSIOL, V97, P229, DOI 10.1152/jn.00677.2006; Srimal R, 2008, NEUROIMAGE, V39, P455, DOI 10.1016/j.neuroimage.2007.08.040; STONE SP, 1993, AGE AGEING, V22, P46, DOI 10.1093/ageing/22.1.46; Sylvester CM, 2009, J NEUROSCI, V29, P10671, DOI 10.1523/JNEUROSCI.1141-09.2009; Szczepanski SM, 2013, J NEUROSCI, V33, P5411, DOI 10.1523/JNEUROSCI.4089-12.2013; Szczepanski SM, 2010, J NEUROSCI, V30, P148, DOI 10.1523/JNEUROSCI.3862-09.2010; Thompson KG, 2005, PROG BRAIN RES, V147, P251, DOI 10.1016/S0079-6123(04)47019-8; Thut G, 2006, J NEUROSCI, V26, P9494, DOI 10.1523/JNEUROSCI.0875-06.2006; Tootell RBH, 1998, NEURON, V21, P1409, DOI 10.1016/S0896-6273(00)80659-5; Tootell RBH, 1998, P NATL ACAD SCI USA, V95, P811, DOI 10.1073/pnas.95.3.811; Treue S, 1996, NATURE, V382, P539, DOI 10.1038/382539a0; Treue S, 1999, J NEUROSCI, V19, P7591, DOI 10.1523/JNEUROSCI.19-17-07591.1999; van Dijk H, 2010, P NATL ACAD SCI USA, V107, P900, DOI 10.1073/pnas.0908821107; VanRullen R, 2007, P NATL ACAD SCI USA, V104, P19204, DOI 10.1073/pnas.0707316104; WEINTRAUB S, 1987, ARCH NEUROL-CHICAGO, V44, P621, DOI 10.1001/archneur.1987.00520180043014; Williford T, 2006, J NEUROPHYSIOL, V96, P40, DOI 10.1152/jn.01207.2005; Worden MS, 2000, J NEUROSCI, V20; Yamagishi N, 2003, NEUROIMAGE, V20, P98, DOI 10.1016/S1053-8119(03)00341-0	91	42	42	5	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 4	2016	11	5							e0154796	10.1371/journal.pone.0154796	http://dx.doi.org/10.1371/journal.pone.0154796			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DL5KR	27144717	gold, Green Published, Green Submitted			2022-12-26	WOS:000375676400073
J	Kaur, P; Datta, S; Shandil, RK; Kumar, N; Robert, N; Sokhi, UK; Guptha, S; Narayanan, S; Anbarasu, A; Ramaiah, S				Kaur, Parvinder; Datta, Santanu; Shandil, Radha Krishan; Kumar, Naveen; Robert, Nanduri; Sokhi, Upneet K.; Guptha, Supreeth; Narayanan, Shridhar; Anbarasu, Anand; Ramaiah, Sudha			Unravelling the Secrets of Mycobacterial Cidality through the Lens of Antisense	PLOS ONE			English	Article							HIGH-THROUGHPUT SCREEN; IN-VITRO; NITROIMIDAZOPYRAN PA-824; BACTERICIDAL ACTIVITY; AEROSOL INFECTION; C3HEB/FEJ MICE; MURINE MODEL; MOUSE MODEL; TUBERCULOSIS; ACID	One of the major impediments in anti-tubercular drug discovery is the lack of a robust grammar that governs the in-vitro to the in-vivo translation of efficacy. Mycobacterium tuberculosis (Mtb) is capable of growing both extracellular as well as intracellular; encountering various hostile conditions like acidic milieu, free radicals, starvation, oxygen deprivation, and immune effector mechanisms. Unique survival strategies of Mtb have prompted researchers to develop in-vitro equivalents to simulate in-vivo physiologies and exploited to find efficacious inhibitors against various phenotypes. Conventionally, the inhibitors are screened on Mtb under the conditions that are unrelated to the in-vivo disease environments. The present study was aimed to (1). Investigate cidality of Mtb targets using a non-chemical inhibitor antisense-RNA (AS-RNA) under in-vivo simulated in-vitro conditions.(2). Confirm the cidality of the targets under in-vivo in experimental tuberculosis. (3). Correlate in-vitro vs. in-vivo cidality data to identify the in-vitro condition that best predicts in-vivo cidality potential of the targets. Using cidality as a metric for efficacy, and AS-RNA as a target-specific inhibitor, we delineated the cidality potential of five target genes under six different physiological conditions (replicating, hypoxia, low pH, nutrient starvation, nitrogen depletion, and nitric oxide). In-vitro cidality confirmed in experimental tuberculosis in BALB/c mice using the AS-RNA allowed us to identify cidal targets in the rank order of rpoB>aroK>ppk>r-poC>ilvB. RpoB was used as the cidality control. In-vitro and in-vivo studies feature aroK (encoding shikimate kinase) as an in-vivo mycobactericidal target suitable for anti-TB drug discovery. In-vitro to in-vivo cidality correlations suggested the low pH (R = 0.9856) in-vitro model as best predictor of in-vivo cidality; however, similar correlation studies in pathologically relevant (Kramnik) mice are warranted. In the acute infection phase for the high fidelity translation, the compound efficacy may also be evaluated in the low pH, in addition to the standard replication condition.	[Kaur, Parvinder; Shandil, Radha Krishan; Kumar, Naveen; Robert, Nanduri; Guptha, Supreeth; Narayanan, Shridhar] AstraZeneca India Private Ltd, Drug Discovery, Res Area, Bangalore, Karnataka, India; [Datta, Santanu] C CAMP, Drug Discovery, Bugworks, Bangalore, Karnataka, India; [Sokhi, Upneet K.] Hosp Special Surg, 535 E 70th St, New York, NY 10021 USA; [Kaur, Parvinder; Anbarasu, Anand; Ramaiah, Sudha] VIT Univ, Sch Biosci & Technol, Vellore, Tamil Nadu, India; [Shandil, Radha Krishan; Narayanan, Shridhar] Fdn Neglected Dis Res, Drug Discovery, Sir MVIT Campus, Bangalore, Karnataka, India	AstraZeneca; Vellore Institute of Technology	Kaur, P (corresponding author), AstraZeneca India Private Ltd, Drug Discovery, Res Area, Bangalore, Karnataka, India.; Kaur, P (corresponding author), VIT Univ, Sch Biosci & Technol, Vellore, Tamil Nadu, India.	parvinder149@gmail.com	Anbarasu, Anand/U-6323-2019; Ramaiah, Sudha/T-3682-2019	SOKHI, UPNEET/0000-0001-5907-5646; Kaur, Parvinder/0000-0001-9154-3278	AstraZeneca India Pvt. Ltd.	AstraZeneca India Pvt. Ltd.	The authors have no support or funding to report. AstraZeneca India Pvt. Ltd. provided support in the form of salaries for authors PK, RKS, NK, NR, SG, and SN but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Aboul-Fadl T, 2005, CURR MED CHEM, V12, P2193, DOI 10.2174/0929867054864859; Andries K, 2005, SCIENCE, V307, P223, DOI 10.1126/science.1106753; Awasthy D, 2009, MICROBIOL-SGM, V155, P2978, DOI 10.1099/mic.0.029884-0; Bai H., 2012, ANTISENSE ANTIBACTER; Balasubramanian V, 2014, ANTIMICROB AGENTS CH, V58, P495, DOI 10.1128/AAC.01903-13; BARCLAY WR, 1953, JAMA-J AM MED ASSOC, V151, P1384; Betts JC, 2002, MOL MICROBIOL, V43, P717, DOI 10.1046/j.1365-2958.2002.02779.x; Calderon VE, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063331; Choi KJ, 2005, FEBS LETT, V579, P4903, DOI 10.1016/j.febslet.2005.07.055; Choudhary E, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7267; CHUNG GAC, 1995, ANTIMICROB AGENTS CH, V39, P2235, DOI 10.1128/AAC.39.10.2235; CLARK DWJ, 1985, DRUGS, V29, P342, DOI 10.2165/00003495-198529040-00003; Cole ST, 1998, NATURE, V393, P537, DOI 10.1038/31159; Cronin CA, 2001, GENE DEV, V15, P1506, DOI 10.1101/gad.892001; Driver ER, 2012, ANTIMICROB AGENTS CH, V56, P3181, DOI 10.1128/AAC.00217-12; Forbes L, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0129234; Gouzy A, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1003928; Gouzy A, 2013, NAT CHEM BIOL, V9, P674, DOI [10.1038/NCHEMBIO.1355, 10.1038/nchembio.1355]; Han C, 2007, BIOORGAN MED CHEM, V15, P656, DOI 10.1016/j.bmc.2006.10.058; Hau P, 2007, OLIGONUCLEOTIDES, V17, P201, DOI 10.1089/oli.2006.0053; Heifets L, 2000, J CLIN MICROBIOL, V38, P1498, DOI 10.1128/JCM.38.4.1498-1501.2000; Hingley-Wilson SM, 2003, NAT IMMUNOL, V4, P949, DOI 10.1038/ni981; Hondalus MK, 2000, INFECT IMMUN, V68, P2888, DOI 10.1128/IAI.68.5.2888-2898.2000; Horsburgh CR, 2015, NEW ENGL J MED, V373, P2149, DOI 10.1056/NEJMra1413919; Irwin SM, 2015, DIS MODEL MECH, V8, P591, DOI 10.1242/dmm.019570; Irwin SM, 2014, ANTIMICROB AGENTS CH, V58, P4026, DOI 10.1128/AAC.02565-14; Jagannathan V, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014336; Jayaram R, 2003, ANTIMICROB AGENTS CH, V47, P2118, DOI 10.1128/AAC.47.7.2118-2124.2003; Jindani A, 2003, AM J RESP CRIT CARE, V167, P1348, DOI 10.1164/rccm.200210-1125OC; Kaur P, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117577; Kaur P, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005923; Khan A, 2008, MICROB PATHOGENESIS, V44, P71, DOI 10.1016/j.micpath.2007.08.006; Lancaster JR, 2006, CHEM RES TOXICOL, V19, P1160, DOI 10.1021/tx060061w; Lechartier B, 2014, EMBO MOL MED, V6, P158, DOI 10.1002/emmm.201201772; Lenaerts AJ, 2005, ANTIMICROB AGENTS CH, V49, P2294, DOI 10.1128/AAC.49.6.2294-2301.2005; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; LYON RH, 1974, J BACTERIOL, V117, P151, DOI 10.1128/JB.117.1.151-156.1974; MacMicking JD, 2003, SCIENCE, V302, P654, DOI 10.1126/science.1088063; MacMicking JD, 2008, NAT MED, V14, P809, DOI 10.1038/nm0808-809; Makarov V, 2009, SCIENCE, V324, P801, DOI 10.1126/science.1171583; Manganelli R, 1999, MOL MICROBIOL, V31, P715, DOI 10.1046/j.1365-2958.1999.01212.x; Markad SD, 2015, MED CHEM RES, V24, P2986, DOI 10.1007/s00044-015-1352-6; Merki E, 2008, CIRCULATION, V118, P743, DOI 10.1161/CIRCULATIONAHA.108.786822; MITCHISON DA, 1979, CHEST, V76, P771, DOI 10.1378/chest.76.6_Supplement.771; Nakashima N, 2014, INT J MOL SCI, V15, P2773, DOI 10.3390/ijms15022773; Parish T, 2002, MICROBIOL-SGM, V148, P3069, DOI 10.1099/00221287-148-10-3069; Philips JA, 2012, ANNU REV PATHOL-MECH, V7, P353, DOI 10.1146/annurev-pathol-011811-132458; Roehr B, 1998, J Int Assoc Physicians AIDS Care, V4, P14; Rohde KH, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002769; Rosado LA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061918; Sambandamurthy VK, 2002, NAT MED, V8, P1171, DOI 10.1038/nm765; Sassetti CM, 2003, MOL MICROBIOL, V48, P77, DOI 10.1046/j.1365-2958.2003.03425.x; Singh R, 2015, ANTIMICROB AGENTS CH, V59, P5664, DOI 10.1128/AAC.05148-14; Smith DA, 2001, INFECT IMMUN, V69, P1142, DOI 10.1128/IAI.69.2.1442-1150.2001; Solapure S, 2013, ANTIMICROB AGENTS CH, V57, P2506, DOI 10.1128/AAC.00023-13; Song HH, 2011, MOL MICROBIOL, V80, P900, DOI 10.1111/j.1365-2958.2011.07619.x; Stevenson M, 2013, MOL THER-NUCL ACIDS, V2, DOI 10.1038/mtna.2013.63; Sutton KA, 2016, ACTA CRYSTALLOGR F, V72, P179, DOI 10.1107/S2053230X16001114; Sutton KA, 2015, ACTA CRYSTALLOGR D, V71, P1736, DOI 10.1107/S139900471501189X; Tan SM, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003282; Tasneen R, 2011, ANTIMICROB AGENTS CH, V55, P5485, DOI 10.1128/AAC.05293-11; Tyagi S, 2005, ANTIMICROB AGENTS CH, V49, P2289, DOI 10.1128/AAC.49.6.2289-2293.2005; Umland TC, 2012, MBIO, V3, DOI 10.1128/mBio.00113-12; Vandal OH, 2008, NAT MED, V14, P849, DOI 10.1038/nm.1795; Vandal OH, 2009, J BACTERIOL, V191, P4714, DOI 10.1128/JB.00305-09; Vandal OH, 2009, J BACTERIOL, V191, P625, DOI 10.1128/JB.00932-08; Voskuil MI, 2003, J EXP MED, V198, P705, DOI 10.1084/jem.20030205; Wayne LG, 1996, INFECT IMMUN, V64, P2062, DOI 10.1128/IAI.64.6.2062-2069.1996; WHIPP MJ, 1995, J BACTERIOL, V177, P1627, DOI 10.1128/jb.177.6.1627-1629.1995; Woodford N, 2009, J ANTIMICROB CHEMOTH, V63, P225, DOI 10.1093/jac/dkn467; World Health Organization, GLOB TUB REP 2015; Zhang Y, 2003, J ANTIMICROB CHEMOTH, V52, P790, DOI 10.1093/jac/dkg446; Zhang Y, 1999, J BACTERIOL, V181, P2044, DOI 10.1128/JB.181.7.2044-2049.1999; Zhang Y, 2014, MICROBIOL SPECTR, V2, DOI 10.1128/microbiolspec.MGM2-0023-2013	74	4	4	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 4	2016	11	5							e0154513	10.1371/journal.pone.0154513	http://dx.doi.org/10.1371/journal.pone.0154513			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DL5KR	27144597	gold, Green Published, Green Submitted			2022-12-26	WOS:000375676400049
J	Palacios, V; Lopez-Bao, JV; Llaneza, L; Fernandez, C; Font, E				Palacios, Vicente; Vicente Lopez-Bao, Jose; Llaneza, Luis; Fernandez, Carlos; Font, Enrique			Decoding Group Vocalizations: The Acoustic Energy Distribution of Chorus Howls Is Useful to Determine Wolf Reproduction	PLOS ONE			English	Article							WOLVES; INDIVIDUALITY; CONSERVATION; MOUNTAINS; CENSUS; TOOL	Population monitoring is crucial for wildlife management and conservation. In the last few decades, wildlife researchers have increasingly applied bioacoustics tools to obtain information on several essential ecological parameters, such as distribution and abundance. One such application involves wolves (Canis lupus). These canids respond to simulated howls by emitting group vocalizations known as chorus howls. These responses to simulated howls reveal the presence of wolf litters during the breeding period and are therefore often used to determine the status of wolf populations. However, the acoustic structure of chorus howls is complex and discriminating the presence of pups in a chorus is sometimes difficult, even for experienced observers. In this study, we evaluate the usefulness of analyses of the acoustic energy distribution in chorus howls to identify the presence of pups in a chorus. We analysed 110 Iberian wolf chorus howls with known pack composition and found that the acoustic energy distribution is concentrated at higher frequencies when there are pups vocalizing. We built predictive models using acoustic energy distribution features to determine the presence of pups in a chorus, concluding that the acoustic energy distribution in chorus howls can be used to determine the presence of wolf pups in a pack. The method we outline here is objective, accurate, easily implemented, and independent of the observer's experience. These advantages are especially relevant in the case of broad scale surveys or when many observers are involved. Furthermore, the analysis of the acoustic energy distribution can be implemented for monitoring other social canids that emit chorus howls such as jackals or coyotes, provides an easy way to obtain information on ecological parameters such as reproductive success, and could be useful to study other group vocalizations.	[Palacios, Vicente; Font, Enrique] Univ Valencia, Inst Cavanilles Biodiversidad & Biol Evolut, Valencia, Spain; [Palacios, Vicente; Llaneza, Luis] ARENA Asesores Recursos Natur SL, Lugo, Spain; [Vicente Lopez-Bao, Jose] Univ Oviedo, Res Unit Biodivers UO CSIC PA, Mieres, Spain; [Vicente Lopez-Bao, Jose] Swedish Univ Agr Sci SLU, Grimso Wildlife Res Stn, Riddarhyttan, Sweden; [Fernandez, Carlos] Univ Oviedo, Dept Matemat, Oviedo, Spain	University of Valencia; Consejo Superior de Investigaciones Cientificas (CSIC); University of Oviedo; Swedish University of Agricultural Sciences; University of Oviedo	Palacios, V (corresponding author), Univ Valencia, Inst Cavanilles Biodiversidad & Biol Evolut, Valencia, Spain.; Palacios, V (corresponding author), ARENA Asesores Recursos Natur SL, Lugo, Spain.	vicentep151@gmail.com	VICENTE, LIERN/B-6112-2008; Llaneza, Luis/R-3597-2018	VICENTE, LIERN/0000-0001-5883-9640; Higgs, Dennis/0000-0002-0771-4642; Palacios Sanchez, Vicente/0000-0002-8922-3598; Llaneza, Luis/0000-0001-9529-5128	A.RE.NA. Asesores en Recursos Naturales	A.RE.NA. Asesores en Recursos Naturales	The authors received no specific funding for this work. A.RE.NA. Asesores en Recursos Naturales provided support in the form of salary for author LL, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of this author are articulated in the 'author contributions' section.	[Anonymous], 2010, R LANG ENV STAT COMP; Apollonio M, 2004, BIOL CONSERV, V120, P249, DOI 10.1016/j.biocon.2004.02.021; Bates D. M., 2007, LME4 LINEAR MIXED EF; Brandes TS, 2008, BIRD CONSERV INT, V18, pS163, DOI 10.1017/S0959270908000415; Burnham K. P., 2002, MODEL SELECTION MULT, V2nd; Chapron G, 2014, SCIENCE, V346, P1517, DOI 10.1126/science.1257553; Charif RA, 2010, RAVEN PRO 1 4 USERS; COSCIA E M, 1991, Bioacoustics, V3, P275; Coscia EM, 1995, ONTOGENY TIMBER WOLF; Darden SK, 2003, J MAMMAL, V84, P1417, DOI 10.1644/BEM-031; Dawson DK, 2009, J APPL ECOL, V46, P1201, DOI 10.1111/j.1365-2664.2009.01731.x; Depraetere M, 2012, ECOL INDIC, V13, P46, DOI 10.1016/j.ecolind.2011.05.006; Eggermann J, 2011, MAMM BIOL, V76, P217, DOI 10.1016/j.mambio.2010.10.010; Farago T., 2014, BIOCOMMUNICATION ANI, P41, DOI DOI 10.1007/978-94-007-7414-8_4; FULLER TK, 1988, J WILDLIFE MANAGE, V52, P60, DOI 10.2307/3801059; GAINES WL, 1995, NORTHWEST SCI, V69, P217; Gazzola A, 2002, ITAL J ZOOL, V69, P157, DOI 10.1080/11250000209356454; Golabek KA, 2013, BEHAVIOUR, V150, P691, DOI 10.1163/1568539X-00003074; HARRINGTON F H, 1989, Bioacoustics, V2, P117; HARRINGTON FH, 1978, CAN J ZOOL, V56, P2024, DOI 10.1139/z78-272; HARRINGTON FH, 1987, ANIM BEHAV, V35, P7, DOI 10.1016/S0003-3472(87)80204-X; HARRINGTON FH, 1979, BEHAVIOUR, V68, P207, DOI 10.1163/156853979X00322; HARRINGTON FH, 1982, J WILDLIFE MANAGE, V46, P686, DOI 10.2307/3808560; Harrington FH, 1996, BIOACOUSTICS INT J A, V7, P165; Harrington Fred H., 2003, P66; Holt TD, 1998, STRUCTURAL DESCRIPTI; Hopp S.L., 1998, P323; Jaeger MM, 1996, J MAMMAL, V77, P768, DOI 10.2307/1382682; Kaiser K, 2008, J HERPETOL, V42, P104, DOI 10.1670/06-269R1.1; Kierulff MCM, 2003, AM J PRIMATOL, V59, P29, DOI 10.1002/ajp.10064; LEHNER PN, 1978, ANIM BEHAV, V26, P712, DOI 10.1016/0003-3472(78)90138-0; Llaneza L., 2005, Wildlife Biology in Practice, V1, P108; Llaneza L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093015; Mitchell BR, 2006, BIOACOUSTICS, V15, P289, DOI 10.1080/09524622.2006.9753555; Mitchell MS, 2008, J WILDLIFE MANAGE, V72, P881, DOI 10.2193/2007-157; Nakagawa S, 2013, METHODS ECOL EVOL, V4, P133, DOI 10.1111/j.2041-210x.2012.00261.x; Nowak S, 2008, FOLIA ZOOL, V57, P392; Nowak S, 2007, J ETHOL, V25, P231, DOI 10.1007/s10164-006-0015-y; Ogutu JO, 1998, AFR J ECOL, V36, P83, DOI 10.1046/j.1365-2028.1998.113-89113.x; OKONIEWSKI JC, 1984, J WILDLIFE MANAGE, V48, P217, DOI 10.2307/3808475; Owren CS., 1998, ANIMAL ACOUSTIC COMM; Packard Jane M., 2003, P35; Palacios V, 2007, J MAMMAL, V88, P606, DOI 10.1644/06-MAMM-A-151R1.1; Passilongo D, 2015, FRONT ZOOL, V12, DOI 10.1186/s12983-015-0114-0; Payne KB, 2003, AFR J ECOL, V41, P99, DOI 10.1046/j.1365-2028.2003.00421.x; Peters G., 1989, P14; Schassburger RM, 1993, ADV ETHOL SER, V30; Schrader Lars, 1997, Bioacoustics, V7, P247; Sinclair ARE, 2009, WILDLIFE ECOLOGY CON; Terry AMR, 2002, ANIM CONSERV, V5, P103, DOI 10.1017/S1367943002002147; Tooze ZJ., 1987, SOME ASPECTS STRUCTU; Tripp TM, 2006, CAN J ZOOL, V84, P744, DOI 10.1139/Z06-055	53	15	15	3	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 4	2016	11	5							e0153858	10.1371/journal.pone.0153858	http://dx.doi.org/10.1371/journal.pone.0153858			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DL5KR	27144887	Green Published, Green Submitted, gold			2022-12-26	WOS:000375676400030
J	Rhee, M; Light, YK; Meagher, RJ; Singh, AK				Rhee, Minsoung; Light, Yooli K.; Meagher, Robert J.; Singh, Anup K.			Digital Droplet Multiple Displacement Amplification (ddMDA) for Whole Genome Sequencing of Limited DNA Samples	PLOS ONE			English	Article							SINGLE CELLS; POLYMERASE; FIDELITY; CLONING	Multiple displacement amplification (MDA) is a widely used technique for amplification of DNA from samples containing limited amounts of DNA (e.g., uncultivable microbes or clinical samples) before whole genome sequencing. Despite its advantages of high yield and fidelity, it suffers from high amplification bias and non-specific amplification when amplifying sub-nanogram of template DNA. Here, we present a microfluidic digital droplet MDA (ddMDA) technique where partitioning of the template DNA into thousands of sub-nanoliter droplets, each containing a small number of DNA fragments, greatly reduces the competition among DNA fragments for primers and polymerase thereby greatly reducing amplification bias. Consequently, the ddMDA approach enabled a more uniform coverage of amplification over the entire length of the genome, with significantly lower bias and non-specific amplification than conventional MDA. For a sample containing 0.1 pg/mu L of E. coli DNA (equivalent of similar to 3/1000 of an E. coli genome per droplet), ddMDA achieves a 65-fold increase in coverage in de novo assembly, and more than 20-fold increase in specificity (percentage of reads mapping to E. coli) compared to the conventional tube MDA. ddMDA offers a powerful method useful for many applications including medical diagnostics, forensics, and environmental microbiology.	[Rhee, Minsoung; Light, Yooli K.; Meagher, Robert J.; Singh, Anup K.] Sandia Natl Labs, Biotechnol & Bioengn Dept, Livermore, CA USA; [Rhee, Minsoung] Illumina Inc, 5200 Illumina Way, San Diego, CA USA	United States Department of Energy (DOE); Sandia National Laboratories; Illumina	Meagher, RJ; Singh, AK (corresponding author), Sandia Natl Labs, Biotechnol & Bioengn Dept, Livermore, CA USA.	rmeaghe@sandia.gov; aksingh@sandia.gov		, ENIGMA/0000-0002-0894-2831; Meagher, Robert/0000-0002-6262-2126	NIDCR [R01 DE020891]; ENIGMA, a LBNL Scientific Focus Area Program - U.S. Department of Energy, Office of Science, Office of Biological and Environmental Research; US DOE's Nuclear Security Administration [DE-AC04-94AL85000]; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE020891] Funding Source: NIH RePORTER	NIDCR(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); ENIGMA, a LBNL Scientific Focus Area Program - U.S. Department of Energy, Office of Science, Office of Biological and Environmental Research; US DOE's Nuclear Security Administration; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	Financial support for the work was provided by the grants: R01 DE020891, funded by the NIDCR and ENIGMA, a LBNL Scientific Focus Area Program supported by the U.S. Department of Energy, Office of Science, Office of Biological and Environmental Research. Sandia is a multi-program laboratory operated by Sandia Corporation, a Lockheed Martin Company, for US DOE's Nuclear Security Administration under contract DE-AC04-94AL85000. The funder provided support in the form of salaries for authors MR, YKL, RJM, and AKS, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Abulencia CB, 2006, APPL ENVIRON MICROB, V72, P3291, DOI 10.1128/AEM.72.5.3291-3301.2006; Alikhan NF, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-402; Asiello PJ, 2011, LAB CHIP, V11, P1420, DOI 10.1039/c0lc00666a; Bankevich A, 2012, J COMPUT BIOL, V19, P455, DOI 10.1089/cmb.2012.0021; Blainey PC, 2011, NUCLEIC ACIDS RES, V39, DOI 10.1093/nar/gkq1074; Bolger AM, 2014, BIOINFORMATICS, V30, P2114, DOI 10.1093/bioinformatics/btu170; Champlot S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013042; de Bourcy CFA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105585; Dean FB, 2001, GENOME RES, V11, P1095, DOI 10.1101/gr.180501; Dietmaier W, 1999, AM J PATHOL, V154, P83, DOI 10.1016/S0002-9440(10)65254-6; ESTEBAN JA, 1993, J BIOL CHEM, V268, P2719; Fitzsimons MS, 2013, GENOME RES, V23, P878, DOI 10.1101/gr.142208.112; Fu YS, 2015, P NATL ACAD SCI USA, V112, P11923, DOI 10.1073/pnas.1513988112; Gole J, 2013, NAT BIOTECHNOL, V31, P1126, DOI 10.1038/nbt.2720; Gurevich A, 2013, BIOINFORMATICS, V29, P1072, DOI 10.1093/bioinformatics/btt086; Hosono S, 2003, GENOME RES, V13, P954, DOI 10.1101/gr.816903; Hutchison CA, 2005, P NATL ACAD SCI USA, V102, P17332, DOI 10.1073/pnas.0508809102; Lage JM, 2003, GENOME RES, V13, P294, DOI 10.1101/gr.377203; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Lasken RS, 2009, BIOCHEM SOC T, V37, P450, DOI 10.1042/BST0370450; Lizardi PM, 1998, NAT GENET, V19, P225, DOI 10.1038/898; Marcy Y, 2007, PLOS GENET, V3, P1702, DOI 10.1371/journal.pgen.0030155; Marcy Y, 2007, P NATL ACAD SCI USA, V104, P11889, DOI 10.1073/pnas.0704662104; Marine R, 2014, MICROBIOME, V2, DOI 10.1186/2049-2618-2-3; Motley ST, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-443; Nelson JR, 2003, BIOTECHNIQUES, V32, pS44; Niu XZ, 2012, BIOCHEM SOC T, V40, P615, DOI 10.1042/BST20120005; Paez JG, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh069; Phanstiel DH, 2014, SUSHI TOOLS VISUALIZ; Quinlan A, 2010, BIOINFORMATICS, V26, P1072; Raghunathan A, 2005, APPL ENVIRON MICROB, V71, P3342, DOI 10.1128/AEM.71.6.3342-3347.2005; Rhee M, 2014, LAB CHIP, V14, P4533, DOI 10.1039/c4lc00823e; Rhee M, 2014, BIOMICROFLUIDICS, V8, DOI 10.1063/1.4874715; Rodrigue S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006864; Sidore AM, 2016, NUCLEIC ACIDS RES, V44, DOI 10.1093/nar/gkv1493; Syvanen AC, 2005, NAT GENET, V37, pS5, DOI 10.1038/ng1558; Wang JB, 2012, CELL, V150, P402, DOI 10.1016/j.cell.2012.06.030; Woyke T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026161; Woyke T, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010314; Yilmaz S, 2012, CURR OPIN BIOTECH, V23, P437, DOI 10.1016/j.copbio.2011.11.018; Zhang K, 2006, NAT BIOTECHNOL, V24, P680, DOI 10.1038/nbt1214; Zong CH, 2012, SCIENCE, V338, P1622, DOI 10.1126/science.1229164	42	30	32	1	45	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 4	2016	11	5							e0153699	10.1371/journal.pone.0153699	http://dx.doi.org/10.1371/journal.pone.0153699			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DL5KR	27144304	Green Published, gold, Green Submitted			2022-12-26	WOS:000375676400024
J	Guzera, M; Szulc-Dabrowska, L; Cywinska, A; Archer, J; Winnicka, A				Guzera, Maciej; Szulc-Dabrowska, Lidia; Cywinska, Anna; Archer, Joy; Winnicka, Anna			In Vitro Influence of Mycophenolic Acid on Selected Parameters of Stimulated Peripheral Canine Lymphocytes	PLOS ONE			English	Article							REGULATORY T-CELLS; MONOPHOSPHATE DEHYDROGENASE-ACTIVITY; MEDIATED HEMOLYTIC-ANEMIA; IMMUNOSUPPRESSIVE DRUGS; WHOLE-BLOOD; MOFETIL TREATMENT; B-CELLS; KIDNEY-TRANSPLANTATION; MONOCLONAL-ANTIBODIES; NUCLEOTIDE DEPLETION	Mycophenolic acid (MPA) is an active metabolite of mycophenolate mofetil, a new immunosuppressive drug effective in the treatment of canine autoimmune diseases. The impact of MPA on immunity is ambiguous and its influence on the canine immune system is unknown. The aim of the study was to determine markers of changes in stimulated peripheral canine lymphocytes after treatment with MPA in vitro. Twenty nine healthy dogs were studied. Phenotypic and functional analysis of lymphocytes was performed on peripheral blood mononuclear cells cultured with mitogens and different MPA concentrations-1 mu M (10(-3) mol/m(3)), 10 mu M or 100 mu M. Apoptotic cells were detected by Annexin V and 7-aminoactinomycin D (7-AAD). The expression of antigens (CD3, CD4, CD8, CD21, CD25, forkhead box P3 [FoxP3] and proliferating cell nuclear antigen [ PCNA]) was assessed with monoclonal antibodies. The proliferation indices were analyzed in carboxyfluorescein diacetate succinimidyl ester (CFSE)-labeled cells. All analyses were performed using flow cytometry. The influence of MPA on apoptosis was dependent on the mechanism of cell activation and MPA concentration. MPA caused a decrease in the expression of lymphocyte surface antigens, CD3, CD8 and CD25. Its impact on the expression of CD4 and CD21 was negligible. Its negative influence on the expression of FoxP3 was dependent on cell stimulation. MPA inhibited lymphocyte proliferation. In conclusion, MPA inhibited the activity of stimulated canine lymphocytes by blocking lymphocyte activation and proliferation. The influence of MPA on the development of immune tolerance-expansion of Treg cells and lymphocyte apoptosis-was ambiguous and was dependent on the mechanism of cellular activation. The concentration that MPA reaches in the blood may lead to inhibition of the functions of the canine immune system. The applied panel of markers can be used for evaluation of the effects of immunosuppressive compounds in the dog.	[Guzera, Maciej; Cywinska, Anna; Winnicka, Anna] Warsaw Univ Life Sci, Fac Vet Med, Dept Pathol & Vet Diagnost, Warsaw, Poland; [Guzera, Maciej; Archer, Joy] Univ Cambridge, Dept Vet Med, Cambridge, England; [Szulc-Dabrowska, Lidia] Warsaw Univ Life Sci, Fac Vet Med, Dept Preclin Sci, Warsaw, Poland	Warsaw University of Life Sciences; University of Cambridge; Warsaw University of Life Sciences	Guzera, M (corresponding author), Warsaw Univ Life Sci, Fac Vet Med, Dept Pathol & Vet Diagnost, Warsaw, Poland.; Guzera, M (corresponding author), Univ Cambridge, Dept Vet Med, Cambridge, England.	mg663@cam.ac.uk	Cywinska, Anna/AAD-2890-2020; Guzera, Maciej/AAT-6629-2021	Cywinska, Anna/0000-0002-5365-9218; Szulc-Dabrowska, Lidia/0000-0002-5436-6556; Winnicka, Anna/0000-0001-9918-3430	Warsaw University of Life Sciences	Warsaw University of Life Sciences	This work was funded by Warsaw University of Life Sciences http://www.sggw.pl/en/ to MG. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abelson AL, 2009, J VET EMERG CRIT CAR, V19, P369, DOI 10.1111/j.1476-4431.2009.00433.x; Abrams VK, 2010, VET IMMUNOL IMMUNOP, V135, P257, DOI 10.1016/j.vetimm.2009.12.006; Allison AC, 2005, TRANSPLANTATION, V80, pS181, DOI 10.1097/01.tp.0000186390.10150.66; Allison AC, 2005, LUPUS, V14, pS2, DOI 10.1191/0961203305lu2109oa; ALLISON AC, 1993, IMMUNOL REV, V136, P5, DOI 10.1111/j.1600-065X.1993.tb00652.x; Allison AC, 1996, CLIN TRANSPLANT, V10, P77; ALLISON AC, 1994, TRANSPLANT P, V26, P3205; Allison AC, 2000, IMMUNOPHARMACOLOGY, V47, P85, DOI 10.1016/S0162-3109(00)00188-0; Asselin S, 1998, EUR J IMMUNOL, V28, P532, DOI 10.1002/(SICI)1521-4141(199802)28:02<532::AID-IMMU532>3.0.CO;2-U; Banyard MRC, 2001, AUST VET PRACT, V31, P103; Barten MJ, 2006, CYTOM PART A, V69A, P155, DOI 10.1002/cyto.a.20215; Barten MJ, 2005, THER DRUG MONIT, V27, P123, DOI 10.1097/01.ftd.0000146874.11480.8a; Barten MJ, 2002, TRANSPLANT P, V34, P2876, DOI 10.1016/S0041-1345(02)03542-X; Barten MJ, 2002, TRANSPL IMMUNOL, V10, P1, DOI 10.1016/S0966-3274(01)00041-7; Barten MJ, 2001, TRANSPLANT P, V33, P2119, DOI 10.1016/S0041-1345(01)01967-4; Barten MJ, 2001, J IMMUNOL METHODS, V253, P95, DOI 10.1016/S0022-1759(01)00369-6; Benitez F, 2008, CLIN LAB MED, V28, P365, DOI 10.1016/j.cll.2008.07.002; Biller BJ, 2007, VET IMMUNOL IMMUNOP, V116, P69, DOI 10.1016/j.vetimm.2006.12.002; Blaha P, 2003, BLOOD, V101, P2886, DOI 10.1182/blood-2002-10-3014; Boldt A, 2006, CYTOM PART A, V69A, P158, DOI 10.1002/cyto.a.20218; Byrne K., 2001, P 16 ANN AM AC VET D; CATAPANO CV, 1995, MOL PHARMACOL, V47, P948; CELIS JE, 1985, P NATL ACAD SCI USA, V82, P3262, DOI 10.1073/pnas.82.10.3262; Chanda SM, 2002, TRANSPLANT P, V34, P3387, DOI 10.1016/S0041-1345(02)03601-1; COBBOLD S, 1994, TISSUE ANTIGENS, V43, P137, DOI 10.1111/j.1399-0039.1994.tb02315.x; DEGROOTE D, 1993, J IMMUNOL METHODS, V163, P259, DOI 10.1016/0022-1759(93)90130-Y; Demirkiran A, 2008, TRANSPLANTATION, V85, P783, DOI 10.1097/TP.0b013e318166910b; Demirkiran A, 2009, TRANSPLANTATION, V87, P1062, DOI 10.1097/TP.0b013e31819d2032; Dewey CW, 2010, JAVMA-J AM VET MED A, V236, P664, DOI 10.2460/javma.236.6.664; Dewey CW, 2010, TXB VET INTERNAL MED; Dewey D. W., 2000, Journal of Veterinary Emergency and Critical Care, V10, P177, DOI 10.1111/j.1476-4431.2000.tb00009.x; Diaz-Romero J, 2001, J IMMUNOL METHODS, V254, P1, DOI 10.1016/S0022-1759(01)00363-5; Doyle A., 1995, CELL TISSUE CULTURE; Egli A, 2013, TRANSPLANTATION, V95, P448, DOI 10.1097/TP.0b013e318276a19f; EUGUI EM, 1991, SCAND J IMMUNOL, V33, P175, DOI 10.1111/j.1365-3083.1991.tb03747.x; EUGUI EM, 1991, SCAND J IMMUNOL, V33, P161, DOI 10.1111/j.1365-3083.1991.tb03746.x; European Medicines Agency, EMA CVMP VICH 751935; European Medicines Agency, TARG AN SAF PHARM TA; European Medicines Agency Lees P, PK PD INT PK PD MOD; Faldyna M, 2001, VET IMMUNOL IMMUNOP, V82, P23, DOI 10.1016/S0165-2427(01)00337-3; FRANKLIN TJ, 1969, BIOCHEM J, V113, P515, DOI 10.1042/bj1130515; Galkowska H, 1996, VET IMMUNOL IMMUNOP, V53, P329, DOI 10.1016/S0165-2427(96)05604-8; Garden OA., 2010, TXB VET INTERNAL MED; GORMAN SD, 1994, TISSUE ANTIGENS, V43, P184, DOI 10.1111/j.1399-0039.1994.tb02320.x; Gregory CR, 2009, KIRKS CURRENT VET TH; Gummert JF, 2000, TRANSPLANTATION, V70, P1038, DOI 10.1097/00007890-200010150-00009; Gummert JF, 1999, J PHARMACOL EXP THER, V291, P1100; Halloran PF, 2004, NEW ENGL J MED, V351, P2715, DOI 10.1056/NEJMra033540; He X, 2011, AM J TRANSPLANT, V11, P439, DOI 10.1111/j.1600-6143.2010.03413.x; Heidt S, 2008, TRANSPLANTATION, V86, P1292, DOI 10.1097/TP.0b013e3181874a36; Heinschink A, 2000, CLIN CHIM ACTA, V300, P23, DOI 10.1016/S0009-8981(00)00297-7; Hendrikx TK, 2009, TRANSPL INT, V22, P884, DOI 10.1111/j.1432-2277.2009.00890.x; Huang M, 2008, LEUKEMIA RES, V32, P131, DOI 10.1016/j.leukres.2007.03.025; Hutchinson P, 2004, TRANSPL IMMUNOL, V13, P55, DOI 10.1016/j.trim.2004.04.003; Izeradjene K, 2001, TRANSPLANT P, V33, P2110, DOI 10.1016/S0041-1345(01)01965-0; Izeradjene K, 2001, TRANSPLANTATION, V71, P118, DOI 10.1097/00007890-200101150-00019; Jassies-van der Lee A, 2014, VET DERMATOL, V25, P456, DOI 10.1111/vde.12140; Jeong H, 2007, CLIN J AM SOC NEPHRO, V2, P184, DOI 10.2215/CJN.02860806; Jepson S, 2000, TRANSPL IMMUNOL, V8, P169, DOI 10.1016/S0966-3274(00)00023-X; Jonsson CA, 1999, CELL IMMUNOL, V197, P136, DOI 10.1006/cimm.1999.1570; Kamar N, 2006, TRANSPLANT P, V38, P2292, DOI 10.1016/j.transproceed.2006.06.121; Karnell JL, 2011, J IMMUNOL, V187, P3603, DOI 10.4049/jimmunol.1003319; Katz KH, 2000, J AM ACAD DERMATOL, V42, P514, DOI 10.1016/S0190-9622(00)90231-7; KOOPMAN G, 1994, BLOOD, V84, P1415, DOI 10.1182/blood.V84.5.1415.1415; Kurata Y, 2009, CLIN PHARMACOL THER, V86, P285, DOI 10.1038/clpt.2009.61; KURKI P, 1986, EXP CELL RES, V166, P209, DOI 10.1016/0014-4827(86)90520-3; Langman LJ, 1996, TRANSPLANTATION, V61, P87, DOI 10.1097/00007890-199601150-00018; Lauber B, 2010, VET IMMUNOL IMMUNOP, V137, P310, DOI 10.1016/j.vetimm.2010.05.015; Laurent AF, 1996, EXP HEMATOL, V24, P59; Lim DG, 2007, TRANSPL IMMUNOL, V18, P94, DOI 10.1016/j.trim.2007.05.005; Lupu M, 2006, BIOL BLOOD MARROW TR, V12, P1352, DOI 10.1016/j.bbmt.2006.07.009; LYONS AB, 1994, J IMMUNOL METHODS, V171, P131, DOI 10.1016/0022-1759(94)90236-4; Matz M, 2012, TRANSPL INT, V25, P1106, DOI 10.1111/j.1432-2277.2012.01537.x; Mehling A, 2000, J IMMUNOL, V165, P2374, DOI 10.4049/jimmunol.165.5.2374; Meyer O, 2002, HDB LAB ANIMAL SCI, VII; Millan Olga, 2009, Transplant Rev (Orlando), V23, P120, DOI 10.1016/j.trre.2009.01.006; Miniscalco B, 2003, VET RES COMMUN, V27, P407, DOI 10.1023/B:VERC.0000014191.39508.0f; Miroux C, 2012, TRANSPL P, V44, P2834, DOI 10.1016/j.transproceed.2012.09.091; Mizuno T, 2009, J VET MED SCI, V71, P1561, DOI 10.1292/jvms.001561; MUSTELIN T, 1987, FEBS LETT, V213, P199, DOI 10.1016/0014-5793(87)81491-6; Nakamura M, 2001, CLIN TRANSPLANT, V15, P36, DOI 10.1034/j.1399-0012.2001.00006.x; NATSUMEDA Y, 1993, ANN NY ACAD SCI, V696, P88; Neel JA, 2009, KIRKS CURRENT VET TH; Neuber K, 2000, BRIT J DERMATOL, V143, P385, DOI 10.1046/j.1365-2133.2000.03667.x; Nielsen L, 2005, 15 C EUR COLL VET IN; Pena LL, 1998, J VET DIAGN INVEST, V10, P237, DOI 10.1177/104063879801000303; Penny MJ, 1998, J AM SOC NEPHROL, V9, P2272; Philpott NJ, 1996, BLOOD, V87, P2244, DOI 10.1182/blood.V87.6.2244.bloodjournal8762244; Piek CJ, 2011, VET QUART, V31, P129, DOI 10.1080/01652176.2011.604979; Premaud A, 2011, PHARMACOL RES, V63, P432, DOI 10.1016/j.phrs.2011.01.005; Quemeneur L, 2004, J IMMUNOL, V173, P4945, DOI 10.4049/jimmunol.173.8.4945; Quemeneur L, 2003, J IMMUNOL, V170, P4986, DOI 10.4049/jimmunol.170.10.4986; Quemeneur L, 2002, J IMMUNOL, V169, P2747, DOI 10.4049/jimmunol.169.5.2747; Robinson J.P., 1997, CURRENT PROTOCOLS CY; Rosenkrantz WS, 2004, VET DERMATOL, V15, P90, DOI 10.1111/j.1365-3164.2004.00360.x; Rostaing L, 1999, CYTOMETRY, V35, P318, DOI 10.1002/(SICI)1097-0320(19990401)35:4<318::AID-CYTO4>3.0.CO;2-4; SARLI G, 1995, VET PATHOL, V32, P93, DOI 10.1177/030098589503200120; Segev G, 2013, J VET INTERN MED, V27, pS44, DOI 10.1111/jvim.12228; Sharma KG, 2010, TRANSPL IMMUNOL, V23, P117, DOI 10.1016/j.trim.2010.04.009; Stosic-Grujicic S, 2002, TRANSPL P, V34, P2955, DOI 10.1016/S0041-1345(02)03502-9; Strauss G, 2002, CLIN EXP IMMUNOL, V128, P255, DOI 10.1046/j.1365-2249.2002.01777.x; Takahashi K, 2004, CLIN TRANSPLANT, V18, P72, DOI 10.1111/j.1399-0012.2004.00222.x; Thomson A W, 1993, Transpl Immunol, V1, P146, DOI 10.1016/0966-3274(93)90009-W; van Engeland M, 1998, CYTOMETRY, V31, P1, DOI 10.1002/(SICI)1097-0320(19980101)31:1<1::AID-CYTO1>3.0.CO;2-R; Velthuis JHL, 2006, AM J TRANSPLANT, V6, P2955, DOI 10.1111/j.1600-6143.2006.01566.x; Wadia PP, 2009, HUM IMMUNOL, V70, P692, DOI 10.1016/j.humimm.2009.05.002; Wang A, 2013, J SMALL ANIM PRACT, V54, P399, DOI 10.1111/jsap.12107; WEAVER JL, 1991, IMMUNOPHARM IMMUNOT, V13, P563, DOI 10.3109/08923979109019723; Weigel G, 2002, J HEART LUNG TRANSPL, V21, P1074, DOI 10.1016/S1053-2498(02)00440-0; Wesch D, 1998, J IMMUNOL, V161, P1248; West LD, 2014, J VET EMERG CRIT CAR, V24, P226, DOI 10.1111/vec.12121; Whitley NT, 2011, J SMALL ANIM PRACT, V52, P70, DOI 10.1111/j.1748-5827.2011.01024.x; Yau VK, 2014, J SMALL ANIM PRACT, V55, P330, DOI 10.1111/jsap.12203; Yuki M, 2007, AUST VET J, V85, P495, DOI 10.1111/j.1751-0813.2007.00201.x; Zhang H, 2005, NAT MED, V11, P1238, DOI 10.1038/nm1312; Zheng Weiyan, 2002, Zhonghua Nei Ke Za Zhi, V41, P329	116	8	8	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 3	2016	11	5							e0154429	10.1371/journal.pone.0154429	http://dx.doi.org/10.1371/journal.pone.0154429			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DL5KK	27138877	Green Submitted, Green Published, gold			2022-12-26	WOS:000375675700031
J	Wang, XB; Ge, JP; Wei, WD; Li, HS; Wu, C; Zhu, G				Wang, Xibo; Ge, Jianping; Wei, Wendong; Li, Hanshi; Wu, Chen; Zhu, Ge			Spatial Dynamics of the Communities and the Role of Major Countries in the International Rare Earths Trade: A Complex Network Analysis	PLOS ONE			English	Article							WORLD-TRADE; TIME-DELAY; EVOLUTION; PERSISTENCE; POLICIES; MODEL	Rare earths (RE) are critical materials in many high-technology products. Due to the uneven distribution and important functions for industrial development, most countries import RE from a handful of suppliers that are rich in RE, such as China. However, because of the rapid growth of RE exploitation and pollution of the mining and production process, some of the main suppliers have gradually tended to reduce the RE production and exports. Especially in the last decade, international RE trade has been changing in the trade community and trade volume. Based on complex network theory, we built an unweighted and weighted network to explore the evolution of the communities and identify the role of the major countries in the RE trade. The results show that an international RE trade network was dispersed and unstable because of the existence of five to nine trade communities in the unweighted network and four to eight trade communities in the weighted network in the past 13 years. Moreover, trade groups formed due to the great influence of geopolitical relations. China was often associated with the South America and African countries in the same trade group. In addition, Japan, China, the United States, and Germany had the largest impacts on international RE trade from 2002 to 2014. Last, some policy suggestions were highlighted according to the results.	[Wang, Xibo] Chinese Acad Sci, Inst Automat, State Key Lab Management & Control Complex Syst, Beijing 100190, Peoples R China; [Ge, Jianping] China Univ Geosci, Sch Humanities & Econ Management, Beijing 100083, Peoples R China; [Ge, Jianping] Minist Land & Resources, Key Lab Carrying Capac Assessment Resource & Envi, Beijing 100083, Peoples R China; [Wei, Wendong] Peking Univ, Coll Govt, Beijing 100871, Peoples R China; [Li, Hanshi] Peking Univ, Sch Econ, Beijing 100871, Peoples R China; [Wu, Chen] China Univ Geosci, Struct Geol Grp, Beijing 100083, Peoples R China; [Zhu, Ge] China Univ Geosci, Beijing Key Lab Water Resources & Environm Engn, Beijing 100083, Peoples R China	Chinese Academy of Sciences; Institute of Automation, CAS; China University of Geosciences; Ministry of Natural Resources of the People's Republic of China; Peking University; Peking University; China University of Geosciences; China University of Geosciences	Ge, JP (corresponding author), China Univ Geosci, Sch Humanities & Econ Management, Beijing 100083, Peoples R China.; Ge, JP (corresponding author), Minist Land & Resources, Key Lab Carrying Capac Assessment Resource & Envi, Beijing 100083, Peoples R China.	gejianping@cugb.edu.cn	Wei, Wendong/GZM-4220-2022		National Natural Sciences Foundation of China [71203203]; MOE (Ministry of Education of the People's Republic of China) project of Humanities and Social Sciences [12YJCZH057]; Beijing Higher Education Young Elite Teacher Project [YETP0667]; Fundamental Research Funds for the Central Universities [2652015149]	National Natural Sciences Foundation of China(National Natural Science Foundation of China (NSFC)); MOE (Ministry of Education of the People's Republic of China) project of Humanities and Social Sciences; Beijing Higher Education Young Elite Teacher Project; Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities)	This study was funded by the National Natural Sciences Foundation of China under grant no. 71203203 {URL: http://www.nsfc.gov.cn/publish/portal1/} and the MOE (Ministry of Education of the People's Republic of China) project of Humanities and Social Sciences under grant no. 12YJCZH057 {URL: http://xm.sinoss.net/indexAction!to_index.action#} and the Beijing Higher Education Young Elite Teacher Project under grant no. YETP0667 {URL: http://www.bjedu.gov.cn/publish/portal0/tab40/} and the Fundamental Research Funds for the Central Universities under grant no. 2652015149 {URL: http://zhsh.cugb.edu.cn/research/index.action}. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	An HZ, 2014, ENERGY, V74, P254, DOI 10.1016/j.energy.2014.06.095; Battiston F, 2014, PHYS REV E, V89, DOI 10.1103/PhysRevE.89.032804; Blondel VD, 2008, J STAT MECH-THEORY E, DOI 10.1088/1742-5468/2008/10/P10008; Boccaletti S, 2006, PHYS REP, V424, P175, DOI 10.1016/j.physrep.2005.10.009; Breiger R., 1981, CONTINUITIES STRUCTU, P353; Castor S.B., 2006, IND MINER ROCKS, V1, P769; Chen ZH, 2011, J RARE EARTH, V29, P1, DOI 10.1016/S1002-0721(10)60401-2; Cover T. M., 1991, ELEMENTS INFORM THEO; Cristelli M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070726; Currie A., 2012, OVERVIEW MOLYCORP CA; Fagiolo G, 2010, J ECON INTERACT COOR, V5, P1, DOI 10.1007/s11403-010-0061-y; Geng JB, 2014, APPL ENERG, V132, P23, DOI 10.1016/j.apenergy.2014.06.064; Grant EHC, 2007, ECOL LETT, V10, P165, DOI 10.1111/j.1461-0248.2006.01007.x; Gschneidner Jr K. A., 2011, MAT MATTERS, V6, P32; Han AP, 2015, RESOUR POLICY, V46, P30, DOI 10.1016/j.resourpol.2015.07.007; He C., 2013, INT BUS RES, V6, P44, DOI DOI 10.5539/ibr.v6n7p44; Jeong H, 2000, NATURE, V407, P651, DOI 10.1038/35036627; Kim S, 2002, SOC FORCES, V81, P445, DOI 10.1353/sof.2003.0014; Li L, 2016, APPL MATH MODEL, V40, P4765, DOI 10.1016/j.apm.2015.12.003; Li X, 2003, PHYSICA A, V328, P287, DOI 10.1016/S0378-4371(03)00567-3; Mahutga MC, 2006, SOC FORCES, V84, P1863, DOI 10.1353/sof.2006.0098; Mancheri NA, 2015, RESOUR POLICY, V46, P262, DOI 10.1016/j.resourpol.2015.10.009; McLellan BC, 2013, MINERALS-BASEL, V3, P304, DOI 10.3390/min3030304; Morrison WM, 2012, C RES SERVICE REPORT; Rauch JE, 1999, J INT ECON, V48, P7, DOI 10.1016/S0022-1996(98)00009-9; SMITH DA, 1992, SOC FORCES, V70, P857, DOI 10.2307/2580193; SNYDER D, 1979, AM J SOCIOL, V84, P1096, DOI 10.1086/226902; Sun GQ, 2016, NONLINEAR DYNAM, V83, P811, DOI 10.1007/s11071-015-2369-6; Sun GQ, 2015, SCI REP-UK, V5, DOI 10.1038/srep11246; Sun GQ, 2014, COMMUN NONLINEAR SCI, V19, P1507, DOI 10.1016/j.cnsns.2013.09.016; Sun GQ, 2009, NONLINEAR DYNAM, V58, P75, DOI 10.1007/s11071-008-9462-z; Sun GQ, 2008, ECOL MODEL, V219, P248, DOI 10.1016/j.ecolmodel.2008.08.009; USGS, 2015, MIN COMM SUMM RAR EA; Vidmer A, 2015, PHYSICA A, V436, P188, DOI 10.1016/j.physa.2015.05.057; Wang XB, 2015, RESOUR POLICY, V43, P11, DOI 10.1016/j.resourpol.2014.11.002; Wubbeke J, 2013, RESOUR POLICY, V38, P384, DOI 10.1016/j.resourpol.2013.05.005; Zhang HY, 2014, ENERG POLICY, V73, P312, DOI 10.1016/j.enpol.2014.06.020; Zhang YC, 2007, PHYS REV LETT, V99, DOI 10.1103/PhysRevLett.99.154301; Zhong WQ, 2014, PHYSICA A, V413, P42, DOI 10.1016/j.physa.2014.06.055	39	22	27	7	79	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 3	2016	11	5							e0154575	10.1371/journal.pone.0154575	http://dx.doi.org/10.1371/journal.pone.0154575			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DL5KK	27137779	gold, Green Published			2022-12-26	WOS:000375675700042
J	Assadian, F; Sandstrom, K; Bondeson, K; Laurell, G; Lidian, A; Svensson, C; Akusjarvi, G; Bergqvist, A; Punga, T				Assadian, Farzaneh; Sandstrom, Karl; Bondeson, Kare; Laurell, Goran; Lidian, Adnan; Svensson, Catharina; Akusjarvi, Goran; Bergqvist, Anders; Punga, Tanel			Distribution and Molecular Characterization of Human Adenovirus and Epstein-Barr Virus Infections in Tonsillar Lymphocytes Isolated from Patients Diagnosed with Tonsillar Diseases	PLOS ONE			English	Article							REAL-TIME PCR; BLOOD MONONUCLEAR-CELLS; HYPERVARIABLE REGIONS; ADENOID TISSUES; UNITED-STATES; DNA; PREVALENCE; CYTOMEGALOVIRUS; QUANTITATION; HYPERTROPHY	Surgically removed palatine tonsils provide a conveniently accessible source of T and B lymphocytes to study the interplay between foreign pathogens and the host immune system. In this study we have characterised the distribution of human adenovirus (HAdV), Epstein-Barr virus (EBV) and human cytomegalovirus (HCMV) in purified tonsillar T and B cell-enriched fractions isolated from three patient age groups diagnosed with tonsillar hypertrophy and chronic/recurrent tonsillitis. HAdV DNA was detected in 93 out of 111 patients (84%), while EBV DNA was detected in 58 patients (52%). The most abundant adenovirus type was HAdV-5 (68%). None of the patients were positive for HCMV. Furthermore, 43 patients (39%) showed a co-infection of HAdV and EBV. The majority of young patients diagnosed with tonsillar hypertrophy were positive for HAdV, whereas all adult patients diagnosed with chronic/recurrent tonsillitis were positive for either HAdV or EBV. Most of the tonsils from patients diagnosed with either tonsillar hypertrophy or chronic/recurrent tonsillitis showed a higher HAdV DNA copy number in T compared to B cell-enriched fraction. Interestingly, in the majority of the tonsils from patients with chronic/recurrent tonsillitis HAdV DNA was detected in T cells only, whereas hypertrophic tonsils demonstrated HAdV DNA in both T and B cell-enriched fractions. In contrast, the majority of EBV positive tonsils revealed a preference for EBV DNA accumulation in the B cell-enriched fraction compared to T cell fraction irrespective of the patients' age.	[Assadian, Farzaneh; Svensson, Catharina; Akusjarvi, Goran; Punga, Tanel] Uppsala Univ, Uppsala Biomed Ctr, Dept Med Biochem & Microbiol, Uppsala, Sweden; [Sandstrom, Karl; Laurell, Goran; Lidian, Adnan] Uppsala Univ, Dept Surg Sci Otorhinolaryngol & Head & Neck Surg, Uppsala, Sweden; [Bondeson, Kare; Bergqvist, Anders] Uppsala Univ, Dept Med Sci Clin Microbiol & Infect Med, Uppsala, Sweden	Uppsala University; Uppsala University; Uppsala University	Punga, T (corresponding author), Uppsala Univ, Uppsala Biomed Ctr, Dept Med Biochem & Microbiol, Uppsala, Sweden.	Tanel.Punga@imbim.uu.se	Berqgvist, Anders/ABA-5530-2021; Punga, Tanel/K-9844-2019	Punga, Tanel/0000-0002-0561-367X; Bondeson, Kare/0000-0001-9684-7887; Bergqvist, Anders/0000-0002-5789-8777	Swedish Cancer Society [12 0504, 13 0469]; Swedish Research Council [K2012-99X-21959-01-3, 2006-5038-36531-16]; Marcus Borgstroms Foundation; Ake Wiberg Foundation; Uppsala County Council	Swedish Cancer Society(Swedish Cancer Society); Swedish Research Council(Swedish Research CouncilEuropean Commission); Marcus Borgstroms Foundation; Ake Wiberg Foundation; Uppsala County Council	This work was supported by the Swedish Cancer Society (12 0504 to GA, 13 0469 to TP, www.cancerfonden.se), the Swedish Research Council (K2012-99X-21959-01-3 to TP, www.vr.se), Marcus Borgstroms Foundation (TP), Ake Wiberg Foundation (TP, www.ake-wiberg.se), Uppsala County Council (AB and KB) and the Swedish Research Council through a grant to the Uppsala RNA Research Centre (2006-5038-36531-16 to GA and TP, www.vr.se). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adhikary AK, 2014, J CLIN VIROL, V61, P477, DOI 10.1016/j.jcv.2014.10.015; Alkhalaf MA, 2013, J MED VIROL, V85, P1947, DOI 10.1002/jmv.23678; [Anonymous], 2009, CDC PROTOCOL REALTIM; Assadian F, 2015, JOVE-J VIS EXP, DOI 10.3791/53374; Barrero PR, 2012, J CLIN VIROL, V53, P145, DOI 10.1016/j.jcv.2011.11.001; Berger C, 2007, J MED VIROL, V79, P1147, DOI 10.1002/jmv.20899; Chen M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0121375; CrawfordMiksza L, 1996, J VIROL, V70, P1836, DOI 10.1128/JVI.70.3.1836-1844.1996; CrawfordMiksza LK, 1996, VIROLOGY, V224, P357, DOI 10.1006/viro.1996.0543; Delecluse HJ, 2007, J CLIN PATHOL, V60, P1358, DOI 10.1136/jcp.2006.044586; Dias Eliane Pedra, 2009, Braz J Otorhinolaryngol, V75, P30; Dogan B, 2010, EUR ARCH OTO-RHINO-L, V267, P143, DOI 10.1007/s00405-009-0988-6; Fendrick AM, 2003, ARCH INTERN MED, V163, P487, DOI 10.1001/archinte.163.4.487; Friedman M, 2009, OTOLARYNG HEAD NECK, V140, P800, DOI 10.1016/j.otohns.2009.01.043; Garnett CT, 2009, J VIROL, V83, P2417, DOI 10.1128/JVI.02392-08; Garnett CT, 2002, J VIROL, V76, P10608, DOI 10.1128/JVI.76.21.10608-10616.2002; Gray GC, 2007, CLIN INFECT DIS, V45, P1120, DOI 10.1086/522188; Gunel C, 2015, INT J PEDIATR OTORHI, V79, P423, DOI 10.1016/j.ijporl.2015.01.007; Guo L, 2012, EUR J CLIN MICROBIOL, V31, P1051, DOI 10.1007/s10096-011-1406-8; Heim A, 2003, J MED VIROL, V70, P228, DOI 10.1002/jmv.10382; Hudnall SD, 2005, MODERN PATHOL, V18, P519, DOI 10.1038/modpathol.3800369; Hug M, 2010, J INFECT DIS, V202, P1192, DOI 10.1086/656335; Hultcrantz E, 2013, EUR ARCH OTO-RHINO-L, V270, P2531, DOI 10.1007/s00405-013-2374-7; Ikeda T, 2000, J GEN VIROL, V81, P1211, DOI 10.1099/0022-1317-81-5-1211; Kimura H, 1999, J CLIN MICROBIOL, V37, P132, DOI 10.1128/JCM.37.1.132-136.1999; Kurnatowski P, 2008, J LARYNGOL OTOL, V122, P931, DOI 10.1017/S0022215107001235; Laichalk LL, 2002, IMMUNITY, V16, P745, DOI 10.1016/S1074-7613(02)00318-7; Li YM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0123234; Lion T, 2014, CLIN MICROBIOL REV, V27, P441, DOI 10.1128/CMR.00116-13; Lu LJ, 2015, ARCH VIROL, V160, P1229, DOI 10.1007/s00705-015-2387-1; Mandelboim M, 2011, J CLIN MICROBIOL, V49, P597, DOI 10.1128/JCM.00979-10; Markel D, 2014, J MED VIROL, V86, P785, DOI 10.1002/jmv.23736; Metzgar D, 2005, J CLIN MICROBIOL, V43, P5743, DOI 10.1128/JCM.43.11.5743-5752.2005; Miyashita EM, 1997, J VIROL, V71, P4882, DOI 10.1128/JVI.71.7.4882-4891.1997; Nadal D, 2002, J MED VIROL, V67, P54, DOI 10.1002/jmv.2192; Nave H, 2001, ANAT EMBRYOL, V204, P367, DOI 10.1007/s004290100210; Olofsson S, 2011, EXPERT REV ANTI-INFE, V9, P615, DOI [10.1586/ERI.11.75, 10.1586/eri.11.75]; Perry M, 1998, IMMUNOL TODAY, V19, P414, DOI 10.1016/S0167-5699(98)01307-3; Proenca-Modena JL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042136; Robinson CM, 2013, SCI REP-UK, V3, DOI 10.1038/srep01812; Rojas LJ, 2012, EPIDEMIOL INFECT, V140, P818, DOI 10.1017/S0950268811001269; Ross MH, 2016, HISTOLOGY TEXT ATLAS, P476; ROWE WP, 1953, P SOC EXP BIOL MED, V84, P570, DOI 10.3181/00379727-84-20714; Ruuskanen O., 2009, Clinical virology, P559; Sahin F, 2007, DIAGN MICR INFEC DIS, V57, P47, DOI 10.1016/j.diagmicrobio.2006.09.013; Sahiner F, 2014, INT J PEDIATR OTORHI, V78, P1288, DOI 10.1016/j.ijporl.2014.05.012; Sato M, 2009, J CLIN MICROBIOL, V47, P771, DOI 10.1128/JCM.02331-08; Sinzger C, 2008, CURR TOP MICROBIOL, V325, P63; TAYLORWIEDEMAN J, 1991, J GEN VIROL, V72, P2059, DOI 10.1099/0022-1317-72-9-2059; VANDERVE.J, 1973, INFECT IMMUN, V7, P604, DOI 10.1128/IAI.7.4.604-609.1973; Wagner HJ, 2000, KLIN PADIATR, V212, P206, DOI 10.1055/s-2000-9678; Xue XC, 2014, J MED VIROL, V86, P963, DOI 10.1002/jmv.23894; Yu XY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032174; Yun ZB, 2003, J VIROL METHODS, V110, P73, DOI 10.1016/S0166-0934(03)00103-4; Zhang YG, 2010, J VIROL, V84, P8799, DOI 10.1128/JVI.00562-10	55	17	20	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 2	2016	11	5							e0154814	10.1371/journal.pone.0154814	http://dx.doi.org/10.1371/journal.pone.0154814			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DL5KB	27136093	Green Submitted, Green Published, gold			2022-12-26	WOS:000375674800050
J	Martinez, AJ; Kim, KL; Harmon, JP; Oliver, KM				Martinez, Adam J.; Kim, Kyungsun L.; Harmon, Jason P.; Oliver, Kerry M.			Specificity of Multi-Modal Aphid Defenses against Two Rival Parasitoids	PLOS ONE			English	Article							PEA APHID; MOLECULAR PHYLOGENY; HYMENOPTERA APHIDIIDAE; EVOLUTIONARY ECOLOGY; BACTERIAL SYMBIONTS; HOST-RESISTANCE; 18S RDNA; COMPETITION; ERVI; COEVOLUTION	Insects are often attacked by multiple natural enemies, imposing dynamic selective pressures for the development and maintenance of enemy-specific resistance. Pea aphids (Acyrthosiphon pisum) have emerged as models for the study of variation in resistance against natural enemies, including parasitoid wasps. Internal defenses against their most common parasitoid wasp, Aphidius ervi, are sourced through two known mechanisms-1) endogenously encoded resistance or 2) infection with the heritable bacterial symbiont, Hamiltonella defensa. Levels of resistance can range from nearly 0-100% against A. ervi but varies based on aphid genotype and the strain of toxin-encoding bacteriophage (called APSE) carried by Hamiltonella. Previously, other parasitoid wasps were found to commonly attack this host, but North American introductions of A. ervi have apparently displaced all other parasitoids except Praon pequodorum, a related aphidiine braconid wasp, which is still found attacking this host in natural populations. To explain P. pequodorum's persistence, multiple studies have compared direct competition between both wasps, but have not examined specificity of host defenses as an indirectly mediating factor. Using an array of experimental aphid lines, we first examined whether aphid defenses varied in effectiveness toward either wasp species. Expectedly, both types of aphid defenses were effective against A. ervi, but unexpectedly, were completely ineffective against P. pequodorum. Further examination showed that P. pequodorum wasps suffered no consistent fitness costs from developing in even highly 'resistant' aphids. Comparison of both wasps' egg-larval development revealed that P. pequodorum's eggs have thicker chorions and hatch two days later than A. ervi's, likely explaining their differing abilities to overcome aphid defenses. Overall, our results indicate that aphids resistant to A. ervi may serve as reservoirs for P. pequodorum, hence contributing to its persistence in field populations. We find that specificity of host defenses and defensive symbiont infections, may have important roles in influencing enemy compositions by indirectly mediating the interactions and abundance of rival natural enemies.	[Martinez, Adam J.; Kim, Kyungsun L.; Oliver, Kerry M.] Univ Georgia, Dept Entomol, Athens, GA 30602 USA; [Harmon, Jason P.] N Dakota State Univ, Dept Entomol, Fargo, ND 58105 USA	University System of Georgia; University of Georgia; North Dakota State University Fargo	Martinez, AJ (corresponding author), Univ Georgia, Dept Entomol, Athens, GA 30602 USA.	adamjmtz@uga.edu	oliver, kerry/H-4498-2017; Harmon, Jason/AAW-3036-2021	oliver, kerry/0000-0002-2835-4017; Harmon, Jason/0000-0002-2533-5005	National Science Foundation [1240892]; Division Of Environmental Biology [1240804] Funding Source: National Science Foundation	National Science Foundation(National Science Foundation (NSF)); Division Of Environmental Biology(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This project was supported by National Science Foundation award 1240892. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. http://www.nsf.gov/.	ANGALET GW, 1977, ANN ENTOMOL SOC AM, V70, P87, DOI 10.1093/aesa/70.1.87; Asplen MK, 2014, ECOL ENTOMOL, V39, P736, DOI 10.1111/een.12153; Beckage NE, 2004, ANNU REV ENTOMOL, V49, P299, DOI 10.1146/annurev.ento.49.061802.123324; Belshaw R, 1997, MOL PHYLOGENET EVOL, V7, P281, DOI 10.1006/mpev.1996.0400; Benassi V, 1998, HEREDITY, V80, P347, DOI 10.1046/j.1365-2540.1998.00303.x; Bensadia F, 2006, J INSECT PHYSIOL, V52, P146, DOI 10.1016/j.jinsphys.2005.09.011; Campbell A., 1974, Dissertation Abstr lnt, V35, P1234; CAMPBELL A, 1973, Zeitschrift fuer Angewandte Entomologie, V74, P47; CARTON Y, 1992, HEREDITY, V69, P393, DOI 10.1038/hdy.1992.141; Carver M., 1988, P299; Cayetano L, 2015, ECOL ENTOMOL, V40, P85, DOI 10.1111/een.12161; CHOW FJ, 1984, ANN ENTOMOL SOC AM, V77, P319, DOI 10.1093/aesa/77.3.319; Cloutier C, 2003, ENTOMOL EXP APPL, V109, P13, DOI 10.1046/j.1570-7458.2003.00087.x; Condon MA, 2014, SCIENCE, V343, P1240, DOI 10.1126/science.1245007; Danyk TP, 1996, BIOL CONTROL, V7, P67, DOI 10.1006/bcon.1996.0066; Danyk TP, 1992, COMPETITIVE INTERACT; Davis JJ, 1915, PEA APHIS RELATION F; Davis JJ, 1913, B ILLINOIS STATE LAB; Decaestecker E, 2003, EVOLUTION, V57, P784, DOI 10.1111/j.0014-3820.2003.tb00290.x; Degnan PH, 2008, APPL ENVIRON MICROB, V74, P6782, DOI 10.1128/AEM.01285-08; Digilio MC, 2000, J INSECT PHYSIOL, V46, P1041, DOI 10.1016/S0022-1910(99)00216-4; Douglas AE, 2006, PHYSIOL ENTOMOL, V31, P262, DOI 10.1111/j.1365-3032.2006.00516.x; Falabella P, 2000, ENTOMOL EXP APPL, V97, P1, DOI 10.1023/A:1004097427267; Fellowes MDE, 2000, HEREDITY, V84, P1, DOI 10.1046/j.1365-2540.2000.00685.x; FISHER RC, 1961, J EXP BIOL, V38, P605; FLUKE Jr. C. L., 1925, Journal of Economic Entomology, V18, P612, DOI 10.1093/jee/18.4.612; Godfray H. C. J., 1994, Parasitoids: behavioral and evolutionary ecology.; Guay JF, 2009, J INSECT PHYSIOL, V55, P919, DOI 10.1016/j.jinsphys.2009.06.006; HALFHILL J E, 1972, Environmental Entomology, V1, P402, DOI 10.1093/ee/1.4.402; He XZ, 2008, REPROD BEHAV APHIDIU; HENTER HJ, 1995, EVOLUTION, V49, P427, DOI [10.1111/j.1558-5646.1995.tb02275.x, 10.2307/2410267]; Himler AG, 2011, SCIENCE, V332, P254, DOI 10.1126/science.1199410; Hofsvang T, 1978, NORWEGIAN J ENTOMOLO; Jaenike J, 2010, SCIENCE, V329, P212, DOI 10.1126/science.1188235; Kraaijeveld AR, 2009, ADV PARASIT, V70, P257, DOI 10.1016/S0065-308X(09)70010-7; Kraaijeveld AR, 1998, PARASITOLOGY, V116, pS29, DOI 10.1017/S0031182000084924; LAMB RJ, 1972, J INSECT PHYSIOL, V18, P2029, DOI 10.1016/0022-1910(72)90170-9; Laughton AM, 2011, J INSECT PHYSIOL, V57, P830, DOI 10.1016/j.jinsphys.2011.03.015; MACKAUER M, 1967, CAN ENTOMOL, V99, P1051, DOI 10.4039/Ent991051-10; MARSH PM, 1977, ENTOMOPHAGA, V22, P365, DOI 10.1007/BF02373261; Martinez AJ, 2014, BMC EVOL BIOL, V14, DOI 10.1186/1471-2148-14-127; Martinez AJ, 2014, MOL ECOL, V23, P1594, DOI 10.1111/mec.12550; MCBRIEN H, 1991, ENTOMOL EXP APPL, V59, P145, DOI 10.1007/BF00351959; McBrien HL, 1992, OVIPOSITION DECISION; McLean AH, 2015, P R SOC B; Meisner M, 2007, POPUL ECOL, V49, P347, DOI 10.1007/s10144-007-0054-4; Morgan AD, 2009, J EVOLUTION BIOL, V22, P287, DOI 10.1111/j.1420-9101.2008.01642.x; Oliver KM, 2008, P R SOC B, V275, P293, DOI 10.1098/rspb.2007.1192; Oliver KM, 2014, CURR OPIN INSECT SCI, V4, P1, DOI 10.1016/j.cois.2014.08.001; Oliver KM, 2014, FUNCT ECOL, V28, P341, DOI 10.1111/1365-2435.12133; Oliver KM, 2012, BMC BIOL, V10, DOI 10.1186/1741-7007-10-11; Oliver KM, 2009, SCIENCE, V325, P992, DOI 10.1126/science.1174463; Oliver KM, 2005, P NATL ACAD SCI USA, V102, P12795, DOI 10.1073/pnas.0506131102; Oliver KM, 2003, P NATL ACAD SCI USA, V100, P1803, DOI 10.1073/pnas.0335320100; Parker BJ, 2014, EVOLUTION, V68, P2421, DOI 10.1111/evo.12418; PENNACCHIO F, 1989, Bollettino del Laboratorio di Entomologia Agraria Filippo Silvestri, V46, P163; Poirie M, 2000, P ROY SOC B-BIOL SCI, V267, P1417, DOI 10.1098/rspb.2000.1158; PRICE PW, 1972, ECOLOGY, V53, P190, DOI 10.2307/1935729; Rouchet R, 2012, J EVOLUTION BIOL, V25, P2369, DOI 10.1111/j.1420-9101.2012.02608.x; Rouchet R, 2014, EVOLUTION, V68, P1607, DOI 10.1111/evo.12377; Russell JA, 2013, MOL ECOL, V22, P2045, DOI 10.1111/mec.12211; Sanchis A, 2000, MOL PHYLOGENET EVOL, V14, P180, DOI 10.1006/mpev.1999.0701; Schellhorn NA, 2002, ECOLOGY, V83, P2745, DOI 10.1890/0012-9658(2002)083[2745:CBNAIP]2.0.CO;2; Shi M, 2005, EUR J ENTOMOL, V102, P133, DOI 10.14411/eje.2005.021; Smith AH, 2015, MOL ECOL, V24, P1135, DOI 10.1111/mec.13095; SMITH HARRY S., 1929, BULL ENT RES [LONDON], V20, P141, DOI 10.1017/S0007485300021040; Smith PT, 1999, MOL PHYLOGENET EVOL, V11, P236, DOI 10.1006/mpev.1998.0575; Start P., 1970, Series ent., V6, P1; STARY P, 1974, Zeitschrift fuer Angewandte Entomologie, V77, P141; Stary P., 2006, Aphid parasitoids of the Czech Republic (Hymenoptera: Braconidae, Aphidiinae); STARY P, 1993, J APPL ENTOMOL, V115, P292, DOI 10.1111/j.1439-0418.1993.tb00394.x; Strand MR, 2008, INSECT IMMUNOLOGY, P25, DOI 10.1016/S0965-1748(02)00092-9; Strand MR, 2008, INSECT SCI, V15, P1, DOI 10.1111/j.1744-7917.2008.00183.x; STRAND MR, 1995, ANNU REV ENTOMOL, V40, P31, DOI 10.1146/annurev.en.40.010195.000335; Takada H, 2000, ENTOMOL EXP APPL, V97, P11, DOI 10.1023/A:1004044311184; THIBOLDEAUX RL, 1987, CAN ENTOMOL, V119, P1055, DOI 10.4039/Ent1191055-11; THOMAS C, 1879, REPORT STATE ENTOMOL, V8, P1; Vorburger C, 2011, J EVOLUTION BIOL, V24, P1611, DOI 10.1111/j.1420-9101.2011.02292.x; Vorburger C, 2014, INSECT SCI, V21, P251, DOI 10.1111/1744-7917.12067; Xi ZY, 2005, SCIENCE, V310, P326, DOI 10.1126/science.1117607; Xie JL, 2015, FEMS MICROBIOL ECOL, V91, DOI 10.1093/femsec/fiu017	81	37	37	2	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 2	2016	11	5							e0154670	10.1371/journal.pone.0154670	http://dx.doi.org/10.1371/journal.pone.0154670			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DL5KB	27135743	Green Published, gold, Green Submitted			2022-12-26	WOS:000375674800037
J	Schiattarella, GG; Cattaneo, F; Pironti, G; Magliulo, F; Carotenuto, G; Pirozzi, M; Polishchuk, R; Borzacchiello, D; Paolillo, R; Oliveti, M; Boccella, N; Avvedimento, M; Sepe, M; Lombardi, A; Busiello, RA; Trimarco, B; Esposito, G; Feliciello, A; Perrino, C				Schiattarella, Gabriele Giacomo; Cattaneo, Fabio; Pironti, Gianluigi; Magliulo, Fabio; Carotenuto, Giuseppe; Pirozzi, Marinella; Polishchuk, Roman; Borzacchiello, Domenica; Paolillo, Roberta; Oliveti, Marco; Boccella, Nicola; Avvedimento, Marisa; Sepe, Maria; Lombardi, Assunta; Busiello, Rosa Anna; Trimarco, Bruno; Esposito, Giovanni; Feliciello, Antonio; Perrino, Cinzia			Akap1 Deficiency Promotes Mitochondrial Aberrations and Exacerbates Cardiac Injury Following Permanent Coronary Ligation via Enhanced Mitophagy and Apoptosis	PLOS ONE			English	Article							KINASE ANCHOR PROTEINS; MOLECULAR-MECHANISMS; CARDIOVASCULAR-SYSTEM; OXIDATIVE STRESS; AUTOPHAGY; HEART; DYSFUNCTION; HYPOXIA; ROLES; ISCHEMIA	A-kinase anchoring proteins (AKAPs) transmit signals cues from seven-transmembrane receptors to specific sub-cellular locations. Mitochondrial AKAPs encoded by the Akap1 gene have been shown to modulate mitochondrial function and reactive oxygen species (ROS) production in the heart. Under conditions of hypoxia, mitochondrial AKAP121 undergoes proteolytic degradation mediated, at least in part, by the E3 ubiquitin ligase Seven In-Absentia Homolog 2 (Siah2). In the present study we hypothesized that Akap1 might be crucial to preserve mitochondrial function and structure, and cardiac responses to myocardial ischemia. To test this, eight-week-old Akap1 knockout mice (Akap1(-/-)), Siah2 knockout mice (Siah2(-/-)) or their wild-type (wt) littermates underwent myocardial infarction (MI) by permanent left coronary artery ligation. Age and gender matched mice of either genotype underwent a left thoracotomy without coronary ligation and were used as controls (sham). Twenty-four hours after coronary ligation, Akap1(-/-) mice displayed larger infarct size compared to Siah2(-/-) or wt mice. One week after MI, cardiac function and survival were also significantly reduced in Akap1(-/-) mice, while cardiac fibrosis was significantly increased. Akap1 deletion was associated with remarkable mitochondrial structural abnormalities at electron microscopy, increased ROS production and reduced mitochondrial function after MI. These alterations were associated with enhanced cardiac mitophagy and apoptosis. Autophagy inhibition by 3-methyladenine significantly reduced apoptosis and ameliorated cardiac dysfunction following MI in Akap1(-/-) mice. These results demonstrate that Akap1 deficiency promotes cardiac mitochondrial aberrations and mitophagy, enhancing infarct size, pathological cardiac remodeling and mortality under ischemic conditions. Thus, mitochondrial AKAPs might represent important players in the development of post-ischemic cardiac remodeling and novel therapeutic targets.	[Schiattarella, Gabriele Giacomo; Cattaneo, Fabio; Pironti, Gianluigi; Magliulo, Fabio; Carotenuto, Giuseppe; Borzacchiello, Domenica; Paolillo, Roberta; Oliveti, Marco; Boccella, Nicola; Avvedimento, Marisa; Trimarco, Bruno; Esposito, Giovanni; Perrino, Cinzia] Univ Naples Federico II, Dept Adv Biomed Sci, Naples, Italy; [Schiattarella, Gabriele Giacomo] Univ Texas SW Med Ctr Dallas, Dept Internal Med Cardiol, Dallas, TX 75390 USA; [Pironti, Gianluigi] Karolinska Inst, Dept Physiol & Pharmacol, Stockholm, Sweden; [Pirozzi, Marinella] Italian Natl Res Council, CNR IBP, Inst Prot Biochem, Naples, Italy; [Polishchuk, Roman] Telethon Inst Genet & Med TIGEM, Naples, Italy; [Sepe, Maria; Feliciello, Antonio] Univ Naples Federico II, Dept Mol Med & Med Biotechnol, Naples, Italy; [Lombardi, Assunta; Busiello, Rosa Anna] Univ Naples Federico II, Dept Biol, Naples, Italy	University of Naples Federico II; University of Texas System; University of Texas Southwestern Medical Center Dallas; Karolinska Institutet; Consiglio Nazionale delle Ricerche (CNR); Istituto di Biochimica delle Proteine (IBP-CNR); Fondazione Telethon; Telethon Institute of Genetics & Medicine (TIGEM); University of Naples Federico II; University of Naples Federico II	Esposito, G; Perrino, C (corresponding author), Univ Naples Federico II, Dept Adv Biomed Sci, Naples, Italy.	espogiov@unina.it; perrino@unina.it	Pironti, Gianluigi/D-9449-2018; Avve, Marisa/AHI-1549-2022; Schiattarella, Gabriele/Z-2624-2019; Perrino, Cinzia/K-3183-2016; Oliveti, Marco/K-2008-2018; Trimarco, Bruno BT/K-7851-2016; CATTANEO, Fabio/K-9532-2016; ESPOSITO, Giovanni/F-2880-2010	Pironti, Gianluigi/0000-0001-9401-3029; Schiattarella, Gabriele/0000-0002-7582-7171; Perrino, Cinzia/0000-0002-2274-0048; Trimarco, Bruno BT/0000-0002-0701-6449; Magliulo, Fabio/0000-0003-3387-8517; Paolillo, Roberta/0000-0002-5170-517X; Oliveti, Marco/0000-0002-9458-4523; CATTANEO, Fabio/0000-0002-5833-8333; ESPOSITO, Giovanni/0000-0003-0565-7127; PIROZZI, MARINELLA/0000-0002-1714-2000; Polishchuk, Roman/0000-0002-7698-1955	Ministry of Health, Italy [GR-2009-1596220]; Ministry of University and Research, Italy [RBFR124FEN]; Associazione Italiana per la Ricerca sul Cancro Grant [IG15264]	Ministry of Health, Italy(Ministry of Health, Italy); Ministry of University and Research, Italy(Ministry of Education, Universities and Research (MIUR)); Associazione Italiana per la Ricerca sul Cancro Grant(Fondazione AIRC per la ricerca sul cancro)	This work was supported, in part, by grants from the Ministry of Health, Italy - Young Researcher Grant (www.ministerosalute.it - GR-2009-1596220) and from the Ministry of University and Research, Italy (www.miur.it - RBFR124FEN) to CP and by Associazione Italiana per la Ricerca sul Cancro Grant to AF (www.airc.it - IG15264).	Abrenica B, 2009, J MOL CELL CARDIOL, V46, P674, DOI 10.1016/j.yjmcc.2009.01.018; Angrisano T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106024; Carlucci A, 2008, EMBO J, V27, P1073, DOI 10.1038/emboj.2008.33; Carlucci A, 2008, TRENDS CELL BIOL, V18, P604, DOI 10.1016/j.tcb.2008.09.006; Chen Q, 1997, J BIOL CHEM, V272, P15247, DOI 10.1074/jbc.272.24.15247; Dorn GW, 2015, CIRC RES, V116, P167, DOI 10.1161/CIRCRESAHA.116.303554; Esposito G, 2015, CARDIOVASC RES, V107, P431, DOI 10.1093/cvr/cvv173; Esposito G, 2011, BASIC RES CARDIOL, V106, P577, DOI 10.1007/s00395-011-0163-2; Feliciello A, 2001, J MOL BIOL, V308, P99, DOI 10.1006/jmbi.2001.4585; Gatica D, 2015, CIRC RES, V116, P456, DOI 10.1161/CIRCRESAHA.114.303788; Huang CQ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020975; Huang LJS, 1997, P NATL ACAD SCI USA, V94, P11184, DOI 10.1073/pnas.94.21.11184; Huang LJS, 1999, J CELL BIOL, V145, P951, DOI 10.1083/jcb.145.5.951; Ikeda Y, 2015, J MOL CELL CARDIOL, V78, P116, DOI 10.1016/j.yjmcc.2014.09.019; Kim H, 2011, MOL CELL, V44, P532, DOI 10.1016/j.molcel.2011.08.045; Kornfeld OS, 2015, CIRC RES, V116, P1783, DOI 10.1161/CIRCRESAHA.116.305432; Lavandero S, 2015, J CLIN INVEST, V125, P55, DOI 10.1172/JCI73943; Lemasters JJ, 2005, REJUV RES, V8, P3, DOI 10.1089/rej.2005.8.3; Matsui Y, 2007, CIRC RES, V100, P914, DOI 10.1161/01.RES.0000261924.76669.36; Newhall KJ, 2006, CURR BIOL, V16, P321, DOI 10.1016/j.cub.2005.12.031; Nishida K, 2015, J MOL CELL CARDIOL, V84, P212, DOI 10.1016/j.yjmcc.2015.05.004; Pavone LM, 2011, CELL SIGNAL, V23, P1961, DOI 10.1016/j.cellsig.2011.07.005; Perrino C, 2006, J CLIN INVEST, V116, P1547, DOI 10.1172/JCI25397; Perrino C, 2013, J AM HEART ASSOC, V2, DOI 10.1161/JAHA.113.000086; Perrino C, 2010, CARDIOVASC RES, V88, P101, DOI 10.1093/cvr/cvq155; Rinaldi L, 2015, FRONT PHARMACOL, V6, DOI 10.3389/fphar.2015.00177; Saito T, 2015, CIRC RES, V116, P1477, DOI 10.1161/CIRCRESAHA.116.303790; Schiattarella GG, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0131662; Schiattarella GG, 2015, J MOL CELL CARDIOL; Scorziello A, 2013, J CELL SCI, V126, P5566, DOI 10.1242/jcs.129668; Shirihai OS, 2015, CIRC RES, V116, P1835, DOI 10.1161/CIRCRESAHA.116.306374; Song MS, 2014, CIRC RES, V115, P348, DOI 10.1161/CIRCRESAHA.115.304384; Voos W, 2013, BBA-MOL CELL RES, V1833, P388, DOI 10.1016/j.bbamcr.2012.06.005; Yan L, 2005, P NATL ACAD SCI USA, V102, P13807, DOI 10.1073/pnas.0506843102; Zhu HX, 2007, J CLIN INVEST, V117, P1782, DOI 10.1172/JCI27523	35	36	39	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 2	2016	11	5							e0154076	10.1371/journal.pone.0154076	http://dx.doi.org/10.1371/journal.pone.0154076			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DL5KB	27136357	Green Published, gold, Green Accepted			2022-12-26	WOS:000375674800012
J	Choi, J; Kim, JW; Keum, YS; Lee, IJ				Choi, Jinhyun; Kim, Jun Won; Keum, Yo Sup; Lee, Ik Jae			The Largest Known Survival Analysis of Patients with Brain Metastasis from Thyroid Cancer Based on Prognostic Groups	PLOS ONE			English	Article							STEREOTACTIC RADIOSURGERY; DISTANT METASTASES; RANDOMIZED-TRIAL; CARCINOMA; MANAGEMENT; INDEX; SCORE	Purpose To analyze the clinical features and prognostic factors associated with the survival of patients with a very rare occurrence of brain metastasis (BM) from differentiated thyroid cancer (DTC). Methods and Materials A total of 37 patients with DTC who were diagnosed with BM between 1995 and 2014 were included. We reviewed the clinical characteristics, treatment modalities, and image findings of BM. Factors associated with survival were evaluated, and the patients were divided into three prognostic groups (Groups A, B, and C) for comparative analysis. Results The median age at BM was 63 years, and the median time from initial thyroid cancer diagnosis to BM was 3.8 years. The median survival and the 1-year actuarial survival rate after BM were 8.8 months and 47%, respectively. According to univariate and multivariate analyses, four good prognostic factors (GPFs) were identified including age <= 60 years, PS <= ECOG 2, <= 3 BM sites, and without extracranial metastasis prior to BM. Three prognostic groups were designed based on age and number of remaining GPFs: patients <= 60 years of age with at least 2 GPFs (Group A) had the most favorable prognosis with a median survival of 32.8 months; patients <= 60 years of age with fewer than 2 GPFs and those > 60 years of age with at least 2 GPFs (Group B) had an intermediate prognosis with a median survival of 9.4 months; and patients > 60 years of age with fewer than 2 GPFs (Group C) had the least favorable prognosis with a median survival of 1.5 months. Conclusions The survival of patients with BM form DTC differed among the prognostic groups based on the total number of good prognostic factors.	[Choi, Jinhyun; Kim, Jun Won; Lee, Ik Jae] Yonsei Univ, Coll Med, Dept Radiat Oncol, Gangnam Severance Hosp, Seoul, South Korea; [Choi, Jinhyun] Yonsei Univ, Coll Med, Dept Radiat Oncol, Yonsei Canc Ctr, Seoul, South Korea; [Keum, Yo Sup] Texas A&M Hlth Sci Ctr Coll Med, Bryan, TX USA	Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University Health System; Texas A&M University System; Texas A&M University College Station; Texas A&M Health Science Center	Lee, IJ (corresponding author), Yonsei Univ, Coll Med, Dept Radiat Oncol, Gangnam Severance Hosp, Seoul, South Korea.	ikjae412@yuhs.ac		Lee, Ik Jae/0000-0001-7165-3373; Kim, Jun Won/0000-0003-1358-364X	Yonsei University College of Medicine [6-2015-0039]	Yonsei University College of Medicine(General Electric)	This work was supported by a faculty research grant of Yonsei University College of Medicine for 2015 (Grant No. 6-2015-0039).	Andrews DW, 2004, LANCET, V363, P1665, DOI 10.1016/S0140-6736(04)16250-8; Bernad DM, 2010, J NEURO-ONCOL, V98, P249, DOI 10.1007/s11060-010-0175-z; Bradley KA, 2004, SEMIN ONCOL, V31, P693, DOI 10.1053/j.seminoncol.2004.07.012; Chiu AC, 1997, J CLIN ENDOCR METAB, V82, P3637, DOI 10.1210/jc.82.11.3637; Choi HJ, 2009, J NEURO-ONCOL, V91, P307, DOI 10.1007/s11060-008-9713-3; Chong JU, 2015, J BREAST CANCER, V18, P29, DOI 10.4048/jbc.2015.18.1.29; Clark JR, 2005, LARYNGOSCOPE, V115, P661, DOI 10.1097/01.mlg.0000161337.46892.e0; de Figueiredo BH, 2014, THYROID, V24, P270, DOI 10.1089/thy.2013.0061; Gaspar LE, 2000, INT J RADIAT ONCOL, V47, P1001, DOI 10.1016/S0360-3016(00)00547-2; Hjiyiannakis P, 1996, Clin Oncol (R Coll Radiol), V8, P327, DOI 10.1016/S0936-6555(05)80722-8; Jung KW, 2012, CANCER RES TREAT, V44, P11, DOI 10.4143/crt.2012.44.1.11; Kim IY, 2009, J NEURO-ONCOL, V93, P355, DOI 10.1007/s11060-008-9783-2; Kwon J, 2013, RADIAT ONCOL J, V31, P162, DOI 10.3857/roj.2013.31.3.162; Lorenzoni J, 2004, INT J RADIAT ONCOL, V60, P218, DOI 10.1016/j.ijrobp.2004.02.017; McWilliams RR, 2003, CANCER, V98, P356, DOI 10.1002/cncr.11488; Misaki T, 2000, ANN NUCL MED, V14, P111, DOI 10.1007/BF02988589; Nabors LB, 2014, J NATL COMPR CANC NE, V12, P1517, DOI 10.6004/jnccn.2014.0151; Patchell RA, 2003, CANCER TREAT REV, V29, P533, DOI 10.1016/S0305-7372(03)00105-1; PATCHELL RA, 1990, NEW ENGL J MED, V322, P494, DOI 10.1056/NEJM199002223220802; Rades D, 2013, STRAHLENTHER ONKOL, V189, P777, DOI 10.1007/s00066-013-0362-x; Rodriguez A, 2015, CURR PROB CANCER, V39, P89, DOI 10.1016/j.currproblcancer.2015.03.002; Samuel AM, 1997, TUMORI, V83, P608, DOI 10.1177/030089169708300226; Shaha AR, 2001, ORL-J OTO-RHIN-LARYN, V63, P243, DOI 10.1159/000055749; Song HJ, 2011, ENDOCR-RELAT CANCER, V18, pR165, DOI 10.1530/ERC-11-0068; Sperduto PW, 2008, INT J RADIAT ONCOL, V70, P510, DOI 10.1016/j.ijrobp.2007.06.074; Weltman E, 2000, INT J RADIAT ONCOL, V46, P1155, DOI 10.1016/S0360-3016(99)00549-0	26	15	17	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 29	2016	11	4							e0154739	10.1371/journal.pone.0154739	http://dx.doi.org/10.1371/journal.pone.0154739			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DK8XM	27128487	Green Published, Green Submitted, gold			2022-12-26	WOS:000375212600064
J	Han, YQ; Li, P; Gong, SL; Yang, L; Wen, LZ; Hou, ML				Han, Yongqiang; Li, Pei; Gong, Shaolong; Yang, Lang; Wen, Lizhang; Hou, Maolin			Defense Responses in Rice Induced by Silicon Amendment against Infestation by the Leaf Folder Cnaphalocrocis medinalis	PLOS ONE			English	Article							INDUCED RESISTANCE; LEPIDOPTERA CRAMBIDAE; POLYPHENOL OXIDASE; LIPID-PEROXIDATION; PLANT-RESISTANCE; REACTIVE OXYGEN; POWDERY MILDEW; BORER; MALONALDEHYDE; MECHANISMS	Silicon (Si) amendment to plants can confer enhanced resistance to herbivores. In the present study, the physiological and cytological mechanisms underlying the enhanced resistance of plants with Si addition were investigated for one of the most destructive rice pests in Asian countries, the rice leaf folder, Cnaphalocrocis medinalis (Guenee). Activities of defense-related enzymes, superoxide dismutase, peroxidase, catalase, phenylalanine ammonia-lyase, and polyphenol oxidase, and concentrations of malondialdehyde and soluble protein in leaves were measured in rice plants with or without leaf folder infestation and with or without Si amendment at 0.32 g Si/kg soil. Silicon amendment significantly reduced leaf folder larval survival. Silicon addition alone did not change activities of defense-related enzymes and malondialdehyde concentration in rice leaves. With leaf folder infestation, activities of the defense-related enzymes increased and malondialdehyde concentration decreased in plants amended with Si. Soluble protein content increased with Si addition when the plants were not infested, but was reduced more in the infested plants with Si amendment than in those without Si addition. Regardless of leaf folder infestation, Si amendment significantly increased leaf Si content through increases in the number and width of silica cells. Our results show that Si addition enhances rice resistance to the leaf folder through priming the feeding stress defense system, reduction in soluble protein content and cell silicification of rice leaves.	[Han, Yongqiang; Li, Pei; Gong, Shaolong; Yang, Lang; Hou, Maolin] Chinese Acad Agr Sci, Inst Plant Protect, State Key Lab Biol Plant Dis & Insect Pests, Beijing 100193, Peoples R China; [Han, Yongqiang; Li, Pei; Gong, Shaolong; Yang, Lang; Hou, Maolin] Southern Reg Collaborat Innovat Ctr Grain & Oil C, Changsha 410128, Hunan, Peoples R China; [Han, Yongqiang; Wen, Lizhang] Hunan Agr Univ, Coll Plant Protect, Changsha 410128, Hunan, Peoples R China	Chinese Academy of Agricultural Sciences; Institute of Plant Protection, CAAS; Hunan Agricultural University	Hou, ML (corresponding author), Chinese Acad Agr Sci, Inst Plant Protect, State Key Lab Biol Plant Dis & Insect Pests, Beijing 100193, Peoples R China.; Hou, ML (corresponding author), Southern Reg Collaborat Innovat Ctr Grain & Oil C, Changsha 410128, Hunan, Peoples R China.	mlhou@ippcaas.cn			National Natural Science Foundation of China [31371951]; Ministry of Science and Technology of China [2012BAD19B03]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Ministry of Science and Technology of China(Ministry of Science and Technology, China)	This work was financially supported by National Natural Science Foundation of China (31371951) and Ministry of Science and Technology of China (2012BAD19B03) to MH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AVDIUSHKO SA, 1993, PHYSIOL MOL PLANT P, V42, P441, DOI 10.1006/pmpp.1993.1033; Babic B, 2008, J INSECT PHYSIOL, V54, P286, DOI 10.1016/j.jinsphys.2007.09.010; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Brunings AM, 2009, ANN APPL BIOL, V155, P161, DOI 10.1111/j.1744-7348.2009.00347.x; Cai KZ, 2008, PHYSIOL PLANTARUM, V134, P324, DOI 10.1111/j.1399-3054.2008.01140.x; Chen YG, 2009, J CHEM ECOL, V35, P297, DOI 10.1007/s10886-009-9600-1; CHERIF M, 1992, PHYSIOL MOL PLANT P, V41, P411, DOI 10.1016/0885-5765(92)90053-X; Corbineau F, 2002, PHYSIOL PLANTARUM, V116, P489, DOI 10.1034/j.1399-3054.2002.1160407.x; Dai WeiMin, 2005, Chinese Journal of Rice Science, V19, P460; DJAMIN A, 1967, J ECON ENTOMOL, V60, P347, DOI 10.1093/jee/60.2.347; ESTERBAUER H, 1990, METHOD ENZYMOL, V186, P407; Fauteux F, 2006, P NATL ACAD SCI USA, V103, P17554, DOI 10.1073/pnas.0606330103; Foyer CH, 2003, PHYSIOL PLANTARUM, V119, P355, DOI 10.1034/j.1399-3054.2003.00223.x; FOYER CH, 1994, PLANT CELL ENVIRON, V17, P507, DOI 10.1111/j.1365-3040.1994.tb00146.x; FRAENKEL G, 1981, ENTOMOL EXP APPL, V29, P147, DOI 10.1111/j.1570-7458.1981.tb03054.x; GAUILLARD F, 1993, ANAL BIOCHEM, V215, P59, DOI 10.1006/abio.1993.1554; Gomes FB, 2005, SCI AGR, V62, P547, DOI 10.1590/S0103-90162005000600006; Han YQ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0120557; Han YQ, 2016, ACTA ECOL S IN PRESS; He JP, 2011, J PLANT PHYSIOL, V168, P687, DOI 10.1016/j.jplph.2010.10.009; He WQ, 2015, CROP PROT, V67, P20, DOI 10.1016/j.cropro.2014.09.013; Hou ML, 2010, J ECON ENTOMOL, V103, P1412, DOI 10.1603/EC09341; International Plant Nutrition Institute, AGR FACT SHEETS CROP; Karunakaran G, 2013, IET NANOBIOTECHNOL, V7, P70, DOI 10.1049/iet-nbt.2012.0048; Keeping MG, 2006, J APPL ENTOMOL, V130, P410, DOI 10.1111/j.1439-0418.2006.01081.x; KHAN ZR, 1988, INSECT SCI APPL, V9, P129, DOI 10.1017/S1742758400005919; Kvedaras OL, 2010, B ENTOMOL RES, V100, P367, DOI 10.1017/S0007485309990265; Li L, 2002, PLANTA, V215, P239, DOI 10.1007/s00425-002-0750-4; Li SW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047401; Liang YC, 2005, PLANT PATHOL, V54, P678, DOI 10.1111/j.1365-3059.2005.01246.x; Liu JJ, 2009, AGR SCI CHINA, V8, P1075, DOI 10.1016/S1671-2927(08)60315-6; Liu L, 1997, PHYSIOL MOL PLANT P, V51, P111, DOI 10.1006/pmpp.1997.0113; Ma JF, 2006, NATURE, V440, P688, DOI 10.1038/nature04590; Ma JF, 2004, SOIL SCI PLANT NUTR, V50, P11, DOI 10.1080/00380768.2004.10408447; MAEHLY AC, 1954, METHOD BIOCHEM ANAL, V1, P357; Massey FP, 2009, J ANIM ECOL, V78, P281, DOI 10.1111/j.1365-2656.2008.01472.x; Massey FP, 2006, J ANIM ECOL, V75, P595, DOI 10.1111/j.1365-2656.2006.01082.x; Moussa H. R., 2006, INT J AGRIC BIOL, V8, P293; Padmavathi C, 2013, J APPL ENTOMOL, V137, P249, DOI 10.1111/j.1439-0418.2012.01741.x; Peskin AV, 2000, CLIN CHIM ACTA, V293, P157, DOI 10.1016/S0009-8981(99)00246-6; Rahman A, 2015, PHYTOPATHOLOGY, V105, P748, DOI 10.1094/PHYTO-12-14-0378-R; Ryals JA, 1996, PLANT CELL, V8, P1809, DOI 10.1105/tpc.8.10.1809; Sairam RK, 2002, PLANT SCI, V163, P1037, DOI 10.1016/S0168-9452(02)00278-9; Shi HT, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0053422; Sidhu JK, 2013, B ENTOMOL RES, V103, P656, DOI 10.1017/S0007485313000369; Singh H, 2013, PLANT SIGNAL BEHAV, V8, DOI 10.4161/psb.25615; Sivanesan I, 2014, FRONT PLANT SCI, V5, DOI 10.3389/fpls.2014.00571; Sudhakar C, 2001, PLANT SCI, V161, P613, DOI 10.1016/S0168-9452(01)00450-2; Tanaka K, 2000, APPL ENTOMOL ZOOL, V35, P177, DOI 10.1303/aez.2000.177; Tomankova K, 2006, PHYSIOL MOL PLANT P, V68, P22, DOI 10.1016/j.pmpp.2006.05.005; UCHIYAMA M, 1978, ANAL BIOCHEM, V86, P271, DOI 10.1016/0003-2697(78)90342-1; Van Bockhaven J, 2013, J EXP BOT, V64, P1281, DOI 10.1093/jxb/ers329; Wang X, 2011, CHINESE SCI BULL, V56, P2351, DOI 10.1007/s11434-011-4568-y; Xie ZM, 2014, SCI WORLD J, DOI 10.1155/2014/718716; Ye M, 2013, P NATL ACAD SCI USA, V110, pE3631, DOI 10.1073/pnas.1305848110	55	62	67	1	43	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 28	2016	11	4							e0153918	10.1371/journal.pone.0153918	http://dx.doi.org/10.1371/journal.pone.0153918			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DK8XE	27124300	Green Submitted, gold, Green Published			2022-12-26	WOS:000375211700037
J	Kasawara, KT; Cotechini, T; Macdonald-Goodfellow, SK; Surita, FG; Silva, JLPE; Tayade, C; Othman, M; Ozolins, TRS; Graham, CH				Kasawara, Karina T.; Cotechini, Tiziana; Macdonald-Goodfellow, Shannyn K.; Surita, Fernanda G.; Pinto e Silva, Joao L.; Tayade, Chandrakant; Othman, Maha; Ozolins, Terence R. S.; Graham, Charles H.			Moderate Exercise Attenuates Lipopolysaccharide-Induced Inflammation and Associated Maternal and Fetal Morbidities in Pregnant Rats	PLOS ONE			English	Article							LOW-DOSE ENDOTOXIN; PERIODONTAL-DISEASE; GROWTH RESTRICTION; PHYSICAL-ACTIVITY; SERUM-LEVELS; PREECLAMPSIA; HYPERTENSION; COAGULATION; CYTOKINES; PATHOPHYSIOLOGY	Fetal growth restriction (FGR) and coagulopathies are often associated with aberrant maternal inflammation. Moderate-intensity exercise during pregnancy has been shown to increase utero-placental blood flow and to enhance fetal nutrition as well as fetal and placental growth. Furthermore, exercise is known to reduce inflammation. To evaluate the effect of moderate-intensity exercise on inflammation associated with the development of maternal coagulopathies and FGR, Wistar rats were subjected to an exercise regime before and during pregnancy. To model inflammation-induced FGR, pregnant rats were administered daily intraperitoneal injections of E. coli lipopolysaccharide (LPS) on gestational days (GD) 13.5-16.5 and sacrificed at GD 17.5. Control rats were injected with saline. Maternal hemostasis was assessed by thromboelastography. Moderate-intensity exercise prevented LPS-mediated increases in white blood cell counts measured on GD 17.5 and improved maternal hemostasis profiles. Importantly, our data reveal that exercise prevented LPS-induced FGR. Moderate-intensity exercise initiated before and maintained during pregnancy may decrease the severity of maternal and perinatal complications associated with abnormal maternal inflammation.	[Kasawara, Karina T.; Cotechini, Tiziana; Macdonald-Goodfellow, Shannyn K.; Tayade, Chandrakant; Othman, Maha; Ozolins, Terence R. S.; Graham, Charles H.] Queens Univ, Dept Biomed & Mol Sci, Kingston, ON, Canada; [Kasawara, Karina T.; Surita, Fernanda G.; Pinto e Silva, Joao L.] Univ Estadual Campinas, Dept Obstet & Gynaecol, Campinas, SP, Brazil	Queens University - Canada; Universidade Estadual de Campinas	Graham, CH (corresponding author), Queens Univ, Dept Biomed & Mol Sci, Kingston, ON, Canada.	grahamc@queensu.ca	Othman, Maha/AFL-2535-2022; Cotechini, Tiziana/AAH-2161-2021; Surita, Fernanda Garanhani/H-9575-2012; Kasawara, Karina T/M-1004-2017	Othman, Maha/0000-0001-7562-203X; Cotechini, Tiziana/0000-0001-6762-3649; Surita, Fernanda Garanhani/0000-0003-4335-0337; Kasawara, Karina T/0000-0003-1388-2615	Canadian Bureau for International Education - Department of Foreign Affairs and International Trade (CBIE/DFAIT); Coordination for the Improvement of Higher Education Personnel-The Ministry of Education of Brazil (CAPES/MEC); FAEPEX (University of Campinas); Canadian Institutes of Health Research (CIHR) [MOP 119496]; Canadian Haemophilia Society; CIHR Doctoral Award-Frederick Banting and Charles Best Canada Graduate Scholarship; Ontario Graduate Scholarship	Canadian Bureau for International Education - Department of Foreign Affairs and International Trade (CBIE/DFAIT); Coordination for the Improvement of Higher Education Personnel-The Ministry of Education of Brazil (CAPES/MEC); FAEPEX (University of Campinas); Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Canadian Haemophilia Society; CIHR Doctoral Award-Frederick Banting and Charles Best Canada Graduate Scholarship(Canadian Institutes of Health Research (CIHR)); Ontario Graduate Scholarship(Ontario Graduate Scholarship)	KTK received scholarships from the Canadian Bureau for International Education - Department of Foreign Affairs and International Trade (CBIE/DFAIT) and Coordination for the Improvement of Higher Education Personnel-The Ministry of Education of Brazil (CAPES/MEC) and Canada-Brazil Awards - Joint Research Projects (2011-2012) and from FAEPEX (University of Campinas). TC was a recipient of a recipient of a CIHR Doctoral Award-Frederick Banting and Charles Best Canada Graduate Scholarship and an Ontario Graduate Scholarship. This research was supported by a grant from the Canadian Institutes of Health Research (CIHR; grant number MOP 119496) awarded to CHG. The TEG studies were supported by a grant from the Canadian Haemophilia Society awarded to MO.	Amorim MF, 2009, EXP PHYSIOL, V94, P906, DOI 10.1113/expphysiol.2009.047621; Borzychowski AM, 2006, SEMIN FETAL NEONAT M, V11, P309, DOI 10.1016/j.siny.2006.04.001; Cetin I, 2004, PLACENTA, V25, P753, DOI 10.1016/j.placenta.2004.02.004; Chen H, 2011, IRISH J MED SCI, V180, P813, DOI 10.1007/s11845-011-0737-x; Clapp JF, 2000, AM J OBSTET GYNECOL, V183, P1484, DOI 10.1067/mob.2000.107096; Comm Obstetric Practice, 2002, INT J GYNECOL OBSTET, V77, P79; Cotechini T, 2015, PLACENTA, V36, P960, DOI 10.1016/j.placenta.2015.05.016; Cotechini T, 2014, J EXP MED, V211, P165, DOI 10.1084/jem.20130295; Cotechini T, 2012, THROMB HAEMOSTASIS, V107, P864, DOI 10.1160/TH11-10-0730; Dodd JM, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006780.pub3; Durand MJ, 2014, CAN J PHYSIOL PHARM, V92, P551, DOI 10.1139/cjpp-2013-0486; Elfayomy AK, 2013, J OBSTET GYNAECOL, V33, P135, DOI 10.3109/01443615.2012.721821; FAAS MM, 1994, AM J OBSTET GYNECOL, V171, P158, DOI 10.1016/0002-9378(94)90463-4; FAAS MM, 1995, AM J PATHOL, V147, P1510; Falcao S, 2010, J HYPERTENS, V28, P2446, DOI 10.1097/HJH.0b013e32833e97d0; Falcon BJ, 2012, THROMB HAEMOSTASIS, V107, P438, DOI 10.1160/TH11-09-0626; GARDOSI J, 1992, LANCET, V339, P283, DOI 10.1016/0140-6736(92)91342-6; Genest DS, 2013, HYPERTENSION, V62, P1055, DOI 10.1161/HYPERTENSIONAHA.113.01983; Gilbert JS, 2012, HYPERTENSION, V60, P1545, DOI 10.1161/HYPERTENSIONAHA.112.202275; Gleeson M, 2011, NAT REV IMMUNOL, V11, P607, DOI 10.1038/nri3041; Han L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0114488; Jain Karun, 2007, Indian J Pathol Microbiol, V50, P533; Jiao QB, 2009, AM J PHYSIOL-HEART C, V297, pH576, DOI 10.1152/ajpheart.00946.2008; Kahn SR, 2008, THROMB RES, V122, P763, DOI 10.1016/j.thromres.2007.10.011; Keating FK, 2013, J CARDIOPULM REHABIL, V33, P371, DOI 10.1097/HCR.0000000000000015; Koh MBC, 2013, BEST PRACT RES CL OB, V27, P855, DOI 10.1016/j.bpobgyn.2013.08.002; Kumar A, 2011, J APPL PHYSIOL, V111, P599, DOI 10.1152/japplphysiol.00017.2011; Kunnen A, 2014, ORAL DIS, V20, P591, DOI 10.1111/odi.12177; Kunnen A, 2010, J CLIN PERIODONTOL, V37, P1075, DOI 10.1111/j.1600-051X.2010.01636.x; Kupchak BR, 2013, THROMB RES, V131, pE227, DOI 10.1016/j.thromres.2013.02.014; Kwak-Kim J, 2009, J OBSTET GYNAECOL RE, V35, P609, DOI 10.1111/j.1447-0756.2009.01079.x; La Gerche Andre, 2007, Heart Lung Circ, V16 Suppl 3, pS102, DOI 10.1016/j.hlc.2007.03.014; LaMarca BD, 2007, CURR HYPERTENS REP, V9, P480, DOI 10.1007/s11906-007-0088-1; LETTIERI L, 1993, AM J OBSTET GYNECOL, V168, P1480, DOI 10.1016/S0002-9378(11)90785-6; Lowe DT, 2000, NITRIC OXIDE-BIOL CH, V4, P441, DOI 10.1006/niox.2000.0296; Miall FM, 2005, THROMB RES, V115, P461, DOI 10.1016/j.thromres.2004.09.019; Moraska A, 2000, AM J PHYSIOL-REG I, V279, pR1321, DOI 10.1152/ajpregu.2000.279.4.R1321; Nascimento DDC, 2012, INT J GEN MED, V5, P249, DOI 10.2147/IJGM.S29197; Oliveira AO, 2004, BRAZ J MED BIOL RES, V37, P907, DOI 10.1590/S0100-879X2004000600017; Petersen AMW, 2005, J APPL PHYSIOL, V98, P1154, DOI 10.1152/japplphysiol.00164.2004; POLLACK RN, 1992, CLIN OBSTET GYNECOL, V35, P99, DOI 10.1097/00003081-199203000-00015; Posthuma JJ, 2015, BLOOD REV, V29, P171, DOI 10.1016/j.blre.2014.10.005; Rai R, 2003, HUM REPROD, V18, P2540, DOI 10.1093/humrep/deg494; Redman CWG, 2004, SEMIN NEPHROL, V24, P565, DOI 10.1016/j.semnephrol.2004.07.005; Redman CWG, 1999, AM J OBSTET GYNECOL, V180, P499, DOI 10.1016/S0002-9378(99)70239-5; Renaud SJ, 2011, J IMMUNOL, V186, P1799, DOI 10.4049/jimmunol.1002679; Rocha R, 2014, ACTA CIR BRAS, V29, P553, DOI 10.1590/S0102-8650201400150002; Roggensack AM, 1999, HYPERTENSION, V33, P83, DOI 10.1161/01.HYP.33.1.83; ROMERO A, 1992, REPROD TOXICOL, V6, P453, DOI 10.1016/0890-6238(92)90009-I; Silver RM, 2007, OBSTET GYNECOL, V109, P153, DOI 10.1097/01.AOG.0000248537.89739.96; Szarka A, 2010, BMC IMMUNOL, V11, DOI 10.1186/1471-2172-11-59; Szymanski LM, 2012, AM J OBSTET GYNECOL, V207, DOI 10.1016/j.ajog.2012.07.021; Tosun M, 2010, J MATERN-FETAL NEO M, V23, P880, DOI 10.3109/14767051003774942; Vergnes J. N., 2007, AM J OBSTET GYNECOL, V196, DOI DOI 10.1016/J.AJ0G.2006.09.028; Wang JS, 2006, J BIOMED SCI, V13, P753, DOI 10.1007/s11373-006-9105-7; Weissgerber TL, 2006, APPL PHYSIOL NUTR ME, V31, P661, DOI [10.1139/H06-060, 10.1139/h06-060]; Xiong X, 2007, OBSTET GYNECOL SURV, V62, P605, DOI 10.1097/01.ogx.0000279292.63435.40	57	15	15	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 28	2016	11	4							e0154405	10.1371/journal.pone.0154405	http://dx.doi.org/10.1371/journal.pone.0154405			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DK8XE	27124733	Green Published, Green Submitted, gold			2022-12-26	WOS:000375211700081
J	Mullany, LE; Herrick, JS; Wolff, RK; Slattery, ML				Mullany, Lila E.; Herrick, Jennifer S.; Wolff, Roger K.; Slattery, Martha L.			MicroRNA Seed Region Length Impact on Target Messenger RNA Expression and Survival in Colorectal Cancer	PLOS ONE			English	Article							GENE-EXPRESSION; INFLAMMATION; REPRESSION; COLON	microRNAs (miRNA) repress messenger RNAs post-transcriptionally through binding to the 3' UTR of the mRNA with the miRNA seed region. It has been purported that longer seed regions have a greater efficacy on mRNA repression. We tested this hypothesis by evaluating differential expression of miRNAs involved in regulating the immune response, an important mechanism in colorectal cancer (CRC), by seed length category. We subsequently evaluated differential expression of these miRNAs' targets in colonic tissue and the impact of these miRNAs on CRC survival. We determined sequence complementarity between each miRNA seed region and the 3' UTR of each experimentally verified mRNA target gene. We classified miRNAs into groups based on seed regions matching perfectly to a mRNA UTR with six bases beginning at position two, seven bases beginning at position one, seven bases beginning at position two, or eight bases beginning at position one. We analyzed these groups in terms of miRNA differential expression between carcinoma and normal colorectal mucosa, differential colonic target mRNA expression, and risk of dying from CRC. After correction for multiple comparisons, the proportion of the miRNAs that were associated with differential mRNA expression was 0% for the 6-mer, 13.64% for the 7 alpha-mer group, 12.82% for the 7 beta-mer group, and 8.70% for the 8-mer group. The proportion of miRNAs associated with survival was 20% for the 6-mer group, 27.27% for the 7 alpha-mer group, 10.23% for the 7 beta-mer group, and 21.74% for the 8-mer group. We did not see a linear relationship between seed length and miRNA expression dysregulation, mRNA expression, or survival. Our findings do not support the hypothesis the seed region length alone influences mRNA repression.	[Mullany, Lila E.; Herrick, Jennifer S.; Wolff, Roger K.; Slattery, Martha L.] Univ Utah, Dept Med, Div Epidemiol, Salt Lake City, UT 84112 USA	Utah System of Higher Education; University of Utah	Mullany, LE (corresponding author), Univ Utah, Dept Med, Div Epidemiol, Salt Lake City, UT 84112 USA.	Lila.Mullany@hsc.utah.edu		Herrick, Jennifer/0000-0001-9257-8843	National Cancer Institute [CA163683, CA48998]; NATIONAL CANCER INSTITUTE [R01CA163683] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Funding for this study was provided by the National Cancer Institute, grant numbers CA163683 and CA48998. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ACS, 2015, WHAT ARE THE KEY STA; Adam JK, 2003, PHARMACOL THERAPEUT, V99, P113, DOI 10.1016/S0163-7258(03)00056-1; Agilent Technologies I, 2013, AGILENT GENESPRING U; [Anonymous], 2016, GENES PTEN; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Calin GA, 2006, NAT REV CANCER, V6, P857, DOI 10.1038/nrc1997; Carissimi C, 2009, AUTOIMMUN REV, V8, P520, DOI 10.1016/j.autrev.2009.01.008; Elinav E, 2013, NAT REV CANCER, V13, P759, DOI 10.1038/nrc3611; Ellwanger DC, 2011, BIOINFORMATICS, V27, P1346, DOI 10.1093/bioinformatics/btr149; Gabriely G, 2008, MOL CELL BIOL, V28, P5369, DOI 10.1128/MCB.00479-08; Grimson A, 2007, MOL CELL, V27, P91, DOI 10.1016/j.molcel.2007.06.017; Hausser J, 2014, NAT REV GENET, V15, P599, DOI 10.1038/nrg3765; He L, 2004, NAT REV GENET, V5, P522, DOI 10.1038/nrg1379; Hinkley DV, 1997, BOOTSTRAP METHODS AN, DOI 10.2307/1271471; Hoss AG, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004188; Lodish HF, 2008, NAT REV IMMUNOL, V8, P120, DOI 10.1038/nri2252; MacFarlane LA, 2010, CURR GENOMICS, V11, P537, DOI 10.2174/138920210793175895; Schwender H, 2012, MULTIPLE TESTING USI; Slattery ML, 2016, CARCINOGENESIS, V37, P245, DOI 10.1093/carcin/bgv249; Slattery ML, 2015, GENE CHROMOSOME CANC, V54, P527, DOI 10.1002/gcc.22265; Slattery ML, 2015, INT J CANCER, V137, P428, DOI 10.1002/ijc.29384; Slattery ML, 2011, GENE CHROMOSOME CANC, V50, P196, DOI 10.1002/gcc.20844; Slattery ML, 2009, CANCER PREV RES, V2, P922, DOI 10.1158/1940-6207.CAPR-08-0191; Suyundikov A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0119876; Vasudevan S, 2007, SCIENCE, V318, P1931, DOI 10.1126/science.1149460; Vasudevan S, 2012, WIRES RNA, V3, P311, DOI 10.1002/wrna.121; Wang XW, 2014, BIOINFORMATICS, V30, P1377, DOI 10.1093/bioinformatics/btu045	28	42	43	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 28	2016	11	4							e0154177	10.1371/journal.pone.0154177	http://dx.doi.org/10.1371/journal.pone.0154177			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DK8XE	27123865	Green Published, gold, Green Submitted			2022-12-26	WOS:000375211700053
J	Van Holt, T; Johnson, JC; Moates, S; Carley, KM				Van Holt, Tracy; Johnson, Jeffery C.; Moates, Shiloh; Carley, Kathleen M.			The Role of Datasets on Scientific Influence within Conflict Research	PLOS ONE			English	Article							CIVIL-WAR; NATURAL-RESOURCES; ARMED CONFLICT; CLIMATE-CHANGE; DEMOCRATIC PEACE; VIOLENCE; SCIENCE; MODEL; INSURGENCY; RESOLUTION	We inductively tested if a coherent field of inquiry in human conflict research emerged in an analysis of published research involving "conflict" in the Web of Science (WoS) over a 66-year period (1945-2011). We created a citation network that linked the 62,504 WoS records and their cited literature. We performed a critical path analysis (CPA), a specialized social network analysis on this citation network (similar to 1.5 million works), to highlight the main contributions in conflict research and to test if research on conflict has in fact evolved to represent a coherent field of inquiry. Out of this vast dataset, 49 academic works were highlighted by the CPA suggesting a coherent field of inquiry; which means that researchers in the field acknowledge seminal contributions and share a common knowledge base. Other conflict concepts that were also analyzed-such as interpersonal conflict or conflict among pharmaceuticals, for example, did not form their own CP. A single path formed, meaning that there was a cohesive set of ideas that built upon previous research. This is in contrast to a main path analysis of conflict from 1957-1971 where ideas didn't persist in that multiple paths existed and died or emerged reflecting lack of scientific coherence (Carley, Hummon, and Harty, 1993). The critical path consisted of a number of key features: 1) Concepts that built throughout include the notion that resource availability drives conflict, which emerged in the 1960s-1990s and continued on until 2011. More recent intrastate studies that focused on inequalities emerged from interstate studies on the democracy of peace earlier on the path. 2) Recent research on the path focused on forecasting conflict, which depends on well-developed metrics and theories to model. 3) We used keyword analysis to independently show how the CP was topically linked (i.e., through democracy, modeling, resources, and geography). Publically available conflict datasets developed early on helped shape the operationalization of conflict. In fact, 94% of the works on the CP that analyzed data either relied on publically available datasets, or they generated a dataset and made it public. These datasets appear to be important in the development of conflict research, allowing for cross-case comparisons, and comparisons to previous works.	[Van Holt, Tracy] Royal Swedish Acad Sci, Global Econ Dynam & Biosphere Program, Stockholm, Sweden; [Johnson, Jeffery C.] Univ Florida, Dept Anthropol, Gainesville, FL 32611 USA; [Moates, Shiloh] E Carolina Univ, Inst Coastal Sci & Policy, Greenville, NC USA; [Carley, Kathleen M.] Carnegie Mellon Univ, Sch Comp Sci, Inst Software Res, Pittsburgh, PA 15213 USA	Royal Swedish Academy of Sciences; Global Economic Dynamics & Biosphere - The Erling-Persson Family Academy Program; State University System of Florida; University of Florida; University of North Carolina; East Carolina University; Carnegie Mellon University	Van Holt, T (corresponding author), Royal Swedish Acad Sci, Global Econ Dynam & Biosphere Program, Stockholm, Sweden.	tracy.vanholt@kva.se		Van Holt, Tracy/0000-0003-2842-6719; Carley, Kathleen M./0000-0002-6356-0238	Office of Naval Research (ONR), Multi University Research Initiative (MURI) [N000140811186]; Erling-Persson Family Foundation; Global Economic Dynamics and the Biosphere Program of the Swedish Royal Academy of Sciences; Office of Naval Research (ONR), United. States Navy [ONR MURI N000140811186]; Erling-Persson Family Foundation through Global Economic Dynamics; Biosphere, the Royal Swedish Academy of Sciences	Office of Naval Research (ONR), Multi University Research Initiative (MURI); Erling-Persson Family Foundation; Global Economic Dynamics and the Biosphere Program of the Swedish Royal Academy of Sciences; Office of Naval Research (ONR), United. States Navy(Office of Naval Research); Erling-Persson Family Foundation through Global Economic Dynamics; Biosphere, the Royal Swedish Academy of Sciences	This work was funded by Office of Naval Research (ONR), Multi University Research Initiative (MURI) N000140811186, and Erling-Persson Family Foundation, Global Economic Dynamics and the Biosphere Program of the Swedish Royal Academy of Sciences. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank anonomyous reviewers for commenting on earlier drafts of this manuscript. Thank you William C. Cooper for assistance with compiling these data. We also thank Jana Caspersen, Christine Gares, and Jennifer Solomon for reviewing the literature. This work is supported in part by the Office of Naval Research (ONR), United. States Navy (ONR MURI N000140811186) and the input of Van Holt was also made possible by funding from the Erling-Persson Family Foundation through Global Economic Dynamics and the Biosphere, the Royal Swedish Academy of Sciences.	Azam JP, 2002, J CONFLICT RESOLUT, V46, P131, DOI 10.1177/0022002702046001008; Azam JP, 2002, J PEACE RES, V39, P461, DOI 10.1177/0022343302039004006; Batagelj V., 2009, WOS2PAJEK NETWORKS W; Batagelj V., 2003, PAJEK ANAL VISUALIZA; Bechtel MM, 2010, EUR UNION POLIT, V11, P309, DOI 10.1177/1465116509360846; Borner K, 2009, J INFORMETR, V3, P161, DOI 10.1016/j.joi.2009.03.008; Bornmann L, 2010, PLOS ONE, V5, DOI [10.1371/journal.pone.0011344, 10.1371/journal.pone.0013327]; BREMER SA, 1992, J CONFLICT RESOLUT, V36, P309, DOI 10.1177/0022002792036002005; Bueno de Mesquita Bruce, 1992, WAR AND REASON; Buhaug H, 2005, POLIT GEOGR, V24, P399, DOI 10.1016/j.polgeo.2005.01.006; CARLEY KM, 1993, KNOWLEDGE, V14, P417, DOI 10.1177/107554709301400406; Cioffi-Revilla C, 2010, INT STUD REV, V12, P31, DOI 10.1111/j.1468-2486.2009.00911.x; Collier P, 1998, OXFORD ECON PAP, V50, P563, DOI 10.1093/oep/50.4.563; Collier P, 2004, OXFORD ECON PAP, V56, P563, DOI 10.1093/oep/gpf064; De Nooy W, 2011, STRUCTURAL ANAL SOCI; Ellingsen T, 2000, J CONFLICT RESOLUT, V44, P228, DOI 10.1177/0022002700044002004; Fearon JD, 2004, J PEACE RES, V41, P275, DOI 10.1177/0022343304043770; GARFIELD E, 1972, SCIENCE, V178, P471, DOI 10.1126/science.178.4060.471; Gates S, 2002, J CONFLICT RESOLUT, V46, P111, DOI 10.1177/0022002702046001007; Geller A, 2010, INT STUD REV, V12, P8, DOI 10.1111/j.1468-2486.2009.00910.x; Gilmore E, 2005, CONFLICT MANAG PEACE, V22, P257, DOI 10.1080/07388940500201003; Gleditsch KS, 2007, J PEACE RES, V44, P293, DOI 10.1177/0022343307076637; Gleditsch NP, 1997, J CONFLICT RESOLUT, V41, P283, DOI 10.1177/0022002797041002004; Gleditsch NP, 2002, J PEACE RES, V39, P615, DOI 10.1177/0022343302039005007; GURR T, 1968, AM POLIT SCI REV, V62, P1104, DOI 10.2307/1953907; GURR T, 1968, WORLD POLIT, V20, P245, DOI 10.2307/2009798; Gurr Ted Robert, 1970, WHY MEN REBEL; Gurr Ted Robert, 1975, PATTERNS AUTHORITY S; GURR TR, 1974, AM POLIT SCI REV, V68, P1482, DOI 10.2307/1959937; GURR TR, 1973, COMP POLIT STUD, V6, P135, DOI 10.1177/001041407300600201; Gurr TR, 1978, POLITY DATA HDB; Harbom L, 2007, J PEACE RES, V44, P623, DOI 10.1177/0022343307080859; Hauge W, 1998, J PEACE RES, V35, P299, DOI 10.1177/0022343398035003003; Hibbs D., 1973, MASS POLITICAL VIOLE; Homer-Dixon T.F., 1999, ENV SCARCITY VIOLENC; Horowitz Donald., 1985, ETHNIC GROUPS CONFLI; HUMMON NP, 1993, SOC NETWORKS, V15, P71, DOI 10.1016/0378-8733(93)90022-D; Humphreys M, 2005, J CONFLICT RESOLUT, V49, P508, DOI 10.1177/0022002705277545; IPCC, 2001, IPCC 3 ASS REP CLIM; Johnson JC, 2010, BIOSCIENCE, V60, P931, DOI 10.1525/bio.2010.60.11.9; Kegley CW, 1996, J PEACE RES, V33, P309, DOI 10.1177/0022343396033003005; Kejzar N, 2010, P 11 IFCS BIENN C 33, P1; Lucio-Arias D, 2008, J AM SOC INF SCI TEC, V59, P1948, DOI 10.1002/asi.20903; MAOZ Z, 1989, J CONFLICT RESOLUT, V33, P3, DOI 10.1177/0022002789033001001; MORGAN TC, 1991, J CONFLICT RESOLUT, V35, P187, DOI 10.1177/0022002791035002003; Murshed SM, 2005, REV DEV ECON, V9, P121, DOI 10.1111/j.1467-9361.2005.00267.x; Nederhof AJ, 2006, SCIENTOMETRICS, V66, P81, DOI 10.1007/s11192-006-0007-2; Nordas R, 2007, POLIT GEOGR, V26, P627, DOI 10.1016/j.polgeo.2007.06.003; O'Brien SP, 2010, INT STUD REV, V12, P87, DOI 10.1111/j.1468-2486.2009.00914.x; OLSON M, 1963, J ECON HIST, V23, P529, DOI 10.1017/S0022050700109210; Raknerud A, 1997, J PEACE RES, V34, P385, DOI 10.1177/0022343397034004002; Raleigh C, 2010, INT INTERACT, V36, P384, DOI 10.1080/03050629.2010.524524; Raleigh C, 2010, INT STUD REV, V12, P69, DOI 10.1111/j.1468-2486.2009.00913.x; RAY JL, 1993, INT INTERACT, V18, P251, DOI 10.1080/03050629308434807; Rosas SR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017428; Ross ML, 2004, J PEACE RES, V41, P337, DOI 10.1177/0022343304043773; Ross ML, 2004, INT ORGAN, V58, P35, DOI 10.1017/S002081830458102X; RUMMEL RJ, 1983, J CONFLICT RESOLUT, V27, P27, DOI 10.1177/0022002783027001002; Salehyan I, 2008, J PEACE RES, V45, P315, DOI 10.1177/0022343308088812; Sambanis N, 2001, J CONFLICT RESOLUT, V45, P259, DOI 10.1177/0022002701045003001; Sarkees Reid Meredith, 2010, RESORT WAR 1816 2007; Schneider G, 2011, CONFLICT MANAG PEACE, V28, P5, DOI 10.1177/0738894210388079; Schneider G, 2010, INT STUD REV, V12, P1, DOI 10.1111/j.1468-2486.2009.00909.x; SINGER JD, 1966, J PEACE RES, V3, P1, DOI 10.1177/002234336600300101; SMALL H, 1974, SCI STUD, V4, P17, DOI 10.1177/030631277400400102; Small M, 1976, JERUSALEM J INT RELA, V1, P20; STARR H, 1992, J PEACE RES, V29, P207, DOI 10.1177/0022343392029002007; STARR H, 1991, J CONFLICT RESOLUT, V35, P356, DOI 10.1177/0022002791035002010; Taylor Charles L., 1972, WORLD HDB POLITICAL; Theisen OM, 2008, J PEACE RES, V45, P801, DOI 10.1177/0022343308096157; Van Holt T, 2013, POETICS, V41, P366, DOI 10.1016/j.poetic.2013.05.004; Wallensteen P, 2001, J PEACE RES, V38, P629, DOI 10.1177/0022343301038005008; WEART SR, 1994, J PEACE RES, V31, P299, DOI 10.1177/0022343394031003005	73	6	6	0	43	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 28	2016	11	4							e0154148	10.1371/journal.pone.0154148	http://dx.doi.org/10.1371/journal.pone.0154148			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DK8XE	27124569	gold, Green Published, Green Submitted			2022-12-26	WOS:000375211700050
J	Vemu, A; Atherton, J; Spector, JO; Szyk, A; Moores, CA; Roll-Mecak, A				Vemu, Annapurna; Atherton, Joseph; Spector, Jeffrey O.; Szyk, Agnieszka; Moores, Carolyn A.; Roll-Mecak, Antonina			Structure and Dynamics of Single-isoform Recombinant Neuronal Human Tubulin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MICROTUBULE PLUS-END; ALPHA-BETA-TUBULIN; IN-VITRO; ELECTRON CRYOMICROSCOPY; GTP HYDROLYSIS; RESOLUTION; INSTABILITY; MICROSCOPY; RECONSTRUCTIONS; ISOTYPES	Microtubules are polymers that cycle stochastically between polymerization and depolymerization, i.e. they exhibit "dynamic instability." This behavior is crucial for cell division, motility, and differentiation. Although studies in the last decade have made fundamental breakthroughs in our understanding of how cellular effectors modulate microtubule dynamics, analysis of the relationship between tubulin sequence, structure, and dynamics has been held back by a lack of dynamics measurements with and structural characterization of homogeneous isotypically pure engineered tubulin. Here, we report for the first time the cryo-EM structure and in vitro dynamics parameters of recombinant isotypically pure human tubulin. alpha 1A/beta III is a purely neuronal tubulin isoform. The 4.2-angstrom structure of post-translationally unmodified human alpha 1A/beta III microtubules shows overall similarity to that of heterogeneous brain microtubules, but it is distinguished by subtle differences at polymerization interfaces, which are hot spots for sequence divergence between tubulin isoforms. In vitro dynamics assays show that, like mosaic brain microtubules, recombinant homogeneous microtubules undergo dynamic instability, but they polymerize slower and have fewer catastrophes. Interestingly, we find that epitaxial growth of alpha 1A/beta III microtubules from heterogeneous brain seeds is inefficient but can be fully rescued by incorporating as little as 5% of brain tubulin into the homogeneous alpha 1A/beta III lattice. Our study establishes a system to examine the structure and dynamics of mammalian microtubules with well defined tubulin species and is a first and necessary step toward uncovering how tubulin genetic and chemical diversity is exploited to modulate intrinsic microtubule dynamics.	[Vemu, Annapurna; Spector, Jeffrey O.; Szyk, Agnieszka; Roll-Mecak, Antonina] NINDS, Cell Biol & Biophys Unit, Bethesda, MD 20892 USA; [Roll-Mecak, Antonina] NHLBI, Ctr Biophys, NIH, Bethesda, MD 20892 USA; [Atherton, Joseph; Moores, Carolyn A.] Univ London, Inst Struct & Mol Biol, Dept Biol Sci, Birkbeck Coll, London WC1E, England	National Institutes of Health (NIH) - USA; NIH National Institute of Neurological Disorders & Stroke (NINDS); National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); University of London	Moores, CA (corresponding author), Birkbeck Coll, Inst Struct & Mol Biol, London WC1E 7HX, England.; Roll-Mecak, A (corresponding author), NIH, Cell Biol & Biophys Unit, Porter Neurosci Res Ctr, Bldg 35,Rm 3B-203,35 Convent Dr,MSC 3700, Bethesda, MD 20892 USA.	c.moores@mail.cryst.bbk.ac.uk; Antonina@mail.nih.gov		Roll-Mecak, Antonina/0000-0003-2621-7307	Medical Research Council, United Kingdom; NINDS; NHLBI, National Institutes of Health; Medical Research Council [MR/J000973/1] Funding Source: researchfish; MRC [MR/J000973/1] Funding Source: UKRI; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [ZIANS003164, ZIANS003122] Funding Source: NIH RePORTER	Medical Research Council, United Kingdom(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NINDS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NHLBI, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by grants from the Medical Research Council, United Kingdom (to J. A. and C. A. M.), and by the Intramural Programs of the NINDS and the NHLBI, National Institutes of Health (to A. V., J. O. S., A. S. and A. R.-M.). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Abrishami V, 2015, J STRUCT BIOL, V189, P163, DOI 10.1016/j.jsb.2015.02.001; Alushin GM, 2014, CELL, V157, P1117, DOI 10.1016/j.cell.2014.03.053; Alushin GM, 2010, NATURE, V467, P805, DOI 10.1038/nature09423; Atherton J, 2014, ELIFE, V3, DOI 10.7554/eLife.03680; BANERJEE A, 1988, J BIOL CHEM, V263, P3029; Bieling P, 2007, NATURE, V450, P1100, DOI 10.1038/nature06386; Brown A, 2015, ACTA CRYSTALLOGR D, V71, P136, DOI 10.1107/S1399004714021683; BURGOYNE RD, 1988, EMBO J, V7, P2311, DOI 10.1002/j.1460-2075.1988.tb03074.x; Cardone G, 2013, J STRUCT BIOL, V184, P226, DOI 10.1016/j.jsb.2013.08.002; Chen SX, 2013, ULTRAMICROSCOPY, V135, P24, DOI 10.1016/j.ultramic.2013.06.004; de la Rosa-Trevin JM, 2013, J STRUCT BIOL, V184, P321, DOI 10.1016/j.jsb.2013.09.015; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Gardner MK, 2011, CELL, V146, P582, DOI 10.1016/j.cell.2011.06.053; Garnham CP, 2015, CELL, V161, P1112, DOI 10.1016/j.cell.2015.04.003; Garnham CP, 2012, CYTOSKELETON, V69, P442, DOI 10.1002/cm.21027; Gell C, 2010, METHOD CELL BIOL, V95, P221, DOI 10.1016/S0091-679X(10)95013-9; Grishchuk EL, 2005, NATURE, V438, P384, DOI 10.1038/nature04132; HORIO T, 1986, NATURE, V321, P605, DOI 10.1038/321605a0; Kavallaris M, 2010, NAT REV CANCER, V10, P194, DOI 10.1038/nrc2803; Kremer JR, 1996, J STRUCT BIOL, V116, P71, DOI 10.1006/jsbi.1996.0013; Leandro-Garcia LJ, 2010, CYTOSKELETON, V67, P214, DOI 10.1002/cm.20436; Ludtke SJ, 1999, J STRUCT BIOL, V128, P82, DOI 10.1006/jsbi.1999.4174; MANDELKOW EM, 1991, J CELL BIOL, V114, P977, DOI 10.1083/jcb.114.5.977; Miller KE, 1996, J CELL BIOL, V133, P1355, DOI 10.1083/jcb.133.6.1355; Mindell JA, 2003, J STRUCT BIOL, V142, P334, DOI 10.1016/S1047-8477(03)00069-8; Minoura I, 2013, FEBS LETT, V587, P3450, DOI 10.1016/j.febslet.2013.08.032; MITCHISON T, 1984, NATURE, V312, P237, DOI 10.1038/312237a0; Newton CN, 2002, J BIOL CHEM, V277, P42456, DOI 10.1074/jbc.M207134200; Nicholls RA, 2012, ACTA CRYSTALLOGR D, V68, P404, DOI 10.1107/S090744491105606X; Nogales E, 1998, NATURE, V391, P199, DOI 10.1038/34465; PANDA D, 1994, P NATL ACAD SCI USA, V91, P11358, DOI 10.1073/pnas.91.24.11358; Pecqueur L, 2012, P NATL ACAD SCI USA, V109, P12011, DOI 10.1073/pnas.1204129109; Peris L, 2006, J CELL BIOL, V174, P839, DOI 10.1083/jcb.200512058; Peris L, 2009, J CELL BIOL, V185, P1159, DOI 10.1083/jcb.200902142; Podolski M, 2014, J BIOL CHEM, V289, P28087, DOI 10.1074/jbc.M114.584300; Roll-Mecak A, 2015, SEMIN CELL DEV BIOL, V37, P11, DOI 10.1016/j.semcdb.2014.09.026; Sindelar CV, 2007, J CELL BIOL, V177, P377, DOI 10.1083/jcb.200612090; Sirajuddin M, 2014, NAT CELL BIOL, V16, P335, DOI 10.1038/ncb2920; Sousa D, 2007, J STRUCT BIOL, V157, P201, DOI 10.1016/j.jsb.2006.08.003; SULLIVAN KF, 1986, P NATL ACAD SCI USA, V83, P4327, DOI 10.1073/pnas.83.12.4327; Szyk A, 2014, CELL, V157, P1405, DOI 10.1016/j.cell.2014.03.061; TOSO RJ, 1993, BIOCHEMISTRY-US, V32, P1285, DOI 10.1021/bi00056a013; TRINCZEK B, 1993, MOL BIOL CELL, V4, P323, DOI 10.1091/mbc.4.3.323; VALE RD, 1994, J BIOL CHEM, V269, P23769; Valenstein ML, 2016, CELL, V164, P911, DOI 10.1016/j.cell.2016.01.019; Verhey KJ, 2007, CELL CYCLE, V6, P2152, DOI 10.4161/cc.6.17.4633; WEISENBERG RC, 1972, SCIENCE, V177, P1104, DOI 10.1126/science.177.4054.1104; Yu I, 2015, J BIOL CHEM, V290, P17163, DOI 10.1074/jbc.R115.637447; Zambito AM, 2002, BBA-PROTEINS PROTEOM, V1601, P200, DOI 10.1016/S1570-9639(02)00472-7; Zhang R, 2015, CELL, V162, P849, DOI 10.1016/j.cell.2015.07.012; Ziolkowska NE, 2013, METHODS MOL BIOL, V1046, P323, DOI 10.1007/978-1-62703-538-5_19	51	77	78	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 17	2016	291	25					12907	12915		10.1074/jbc.C116.731133	http://dx.doi.org/10.1074/jbc.C116.731133			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DR2YT	27129203	Green Published, Green Accepted, hybrid			2022-12-26	WOS:000379770500002
J	Defenouillere, Q; Zhang, E; Namane, A; Mouaikel, J; Jacquier, A; Fromont-Racine, M				Defenouillere, Quentin; Zhang, Elodie; Namane, Abdelkader; Mouaikel, John; Jacquier, Alain; Fromont-Racine, Micheline			Rqc1 and Ltn1 Prevent C-terminal Alanine-Threonine Tail (CAT-tail)-induced Protein Aggregation by Efficient Recruitment of Cdc48 on Stalled 60S Subunits	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							QUALITY-CONTROL COMPLEX; MESSENGER-RNA SURVEILLANCE; TRANSCRIPTION FACTOR; MISFOLDED PROTEINS; TRANSLATION; RIBOSOME; DEGRADATION; PROTEASOME; YEAST; DISSOCIATION	Protein homeostasis is maintained by quality control mechanisms that detect and eliminate deficient translation products. Cytosolic defective proteins can arise from translation of aberrant mRNAs lacking a termination codon (NonStop) or containing a sequence that blocks translation elongation (No-Go), which results in translational arrest. Stalled ribosomes are dissociated, aberrant mRNAs are degraded by the cytoplasmic exosome, and the nascent peptides remaining in stalled 60S exit tunnels are detected by the ribosome-bound quality control complex (RQC) composed of Ltn1, Rqc1, Rqc2, and Cdc48. Whereas Ltn1 polyubiquitylates these nascent peptides, Rqc2 directs the addition of C-terminal alanine-threonine tails (CAT-tails), and a Cdc48 hexamer is recruited to extract the nascent peptides, which are addressed to the proteasome for degradation. Although the functions of most RQC components have been described, the role of Rqc1 in this quality control process remains undetermined. In this article we show that the absence of Rqc1 or Ltn1 results in the aggregation of aberrant proteins, a phenomenon that requires CAT-tail addition to the nascent peptides by Rqc2. Our results suggest that aberrant CAT-tailed protein aggregation results from a defect in Cdc48 recruitment to stalled 60S particles, a process that requires both Rqc1 and Ltn1. These protein aggregates contain Ltn1-dependent polyubiquitin chains and are degraded by the proteasome. Finally, aggregate characterization by proteomics revealed that they contain specific chaperones including Sis1, Sgt2, Ssa1/2, and Hsp82, suggesting that these protein aggregates may be addressed to aggresome-like structures when the RQC complex fails to deliver aberrant nascent peptides to the proteasome for degradation.	[Defenouillere, Quentin; Zhang, Elodie; Namane, Abdelkader; Mouaikel, John; Jacquier, Alain; Fromont-Racine, Micheline] Inst Pasteur, CNRS, UMR 3525, Genet Interact Macromol, F-75724 Paris, France; [Defenouillere, Quentin; Zhang, Elodie] Univ Paris 06, Sorbonne Univ, Complex Vivant, F-75252 Paris 05, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; UDICE-French Research Universities; Sorbonne Universite	Fromont-Racine, M (corresponding author), Inst Pasteur, 25-28 Rue Dr Roux, F-75724 Paris, France.	mfromont@pasteur.fr	Namane, Abdelkader/O-1857-2013	Namane, Abdelkader/0000-0001-7180-7619; Fromont-Racine, Micheline/0000-0001-9906-0334; Defenouillere, Quentin/0000-0003-2255-4859; JACQUIER, ALAIN/0000-0001-5707-9184	Agence Nationale de la Recherche [ANR-2011-BSV6-011-02, ANR-14-CE-10-0014-01]; Institut Pasteur; CNRS; Ministere de l'Enseignement Superieur et de la Recherche; Association pour la Recherche contre le Cancer	Agence Nationale de la Recherche(French National Research Agency (ANR)); Institut Pasteur(European Commission); CNRS(Centre National de la Recherche Scientifique (CNRS)); Ministere de l'Enseignement Superieur et de la Recherche(Estonian Research CouncilEuropean Commission); Association pour la Recherche contre le Cancer(Fondation ARC pour la Recherche sur le Cancer)	This work was supported by Agence Nationale de la Recherche Grants ANR-2011-BSV6-011-02 and ANR-14-CE-10-0014-01 and funds from the Institut Pasteur and the CNRS. The authors declare that they have no conflicts of interest with the contents of this article.r Supported by fellowships from the Ministere de l'Enseignement Superieur et de la Recherche and from the Association pour la Recherche contre le Cancer.	Albrecht AN, 2004, HUM MOL GENET, V13, P2351, DOI 10.1093/hmg/ddh277; Bengtson MH, 2010, NATURE, V467, P470, DOI 10.1038/nature09371; Brandman O, 2016, NAT STRUCT MOL BIOL, V23, P7, DOI 10.1038/nsmb.3147; Brandman O, 2012, CELL, V151, P1042, DOI 10.1016/j.cell.2012.10.044; Defenouillere Q, 2013, P NATL ACAD SCI USA, V110, P5046, DOI 10.1073/pnas.1221724110; Dimitrova LN, 2009, J BIOL CHEM, V284, P10343, DOI 10.1074/jbc.M808840200; Doma MK, 2006, NATURE, V440, P561, DOI 10.1038/nature04530; Frischmeyer PA, 2002, SCIENCE, V295, P2258, DOI 10.1126/science.1067338; Fujii K, 2012, EMBO J, V31, P2579, DOI 10.1038/emboj.2012.85; Ito-Harashima S, 2007, GENE DEV, V21, P519, DOI 10.1101/gad.1490207; Johnston JA, 1998, J CELL BIOL, V143, P1883, DOI 10.1083/jcb.143.7.1883; Kaganovich D, 2008, NATURE, V454, P1088, DOI 10.1038/nature07195; Kopito RR, 2000, TRENDS CELL BIOL, V10, P524, DOI 10.1016/S0962-8924(00)01852-3; Kushnirov VV, 2000, YEAST, V16, P857, DOI 10.1002/1097-0061(20000630)16:9<857::AID-YEA561>3.0.CO;2-B; LaRiviere FJ, 2006, MOL CELL, V24, P619, DOI 10.1016/j.molcel.2006.10.008; Lu Z, 1998, J BIOL CHEM, V273, P27824, DOI 10.1074/jbc.273.43.27824; Lyumkis D, 2014, P NATL ACAD SCI USA, V111, P15981, DOI 10.1073/pnas.1413882111; Miller SBM, 2015, EMBO J, V34, P778, DOI 10.15252/embj.201489524; Morano KA, 1999, MOL CELL BIOL, V19, P402; Rape M, 2001, CELL, V107, P667, DOI 10.1016/S0092-8674(01)00595-5; Richly H, 2005, CELL, V120, P73, DOI 10.1016/j.cell.2004.11.013; Richter K, 2010, MOL CELL, V40, P253, DOI 10.1016/j.molcel.2010.10.006; Rigaut G, 1999, NAT BIOTECHNOL, V17, P1030, DOI 10.1038/13732; Rott R, 2008, J BIOL CHEM, V283, P3316, DOI 10.1074/jbc.M704809200; Shao SC, 2015, MOL CELL, V57, P433, DOI 10.1016/j.molcel.2014.12.015; Shen PS, 2015, SCIENCE, V347, P75, DOI 10.1126/science.1259724; Shevchenko A, 2006, NAT PROTOC, V1, P2856, DOI 10.1038/nprot.2006.468; Shoemaker CJ, 2011, P NATL ACAD SCI USA, V108, pE1392, DOI 10.1073/pnas.1113956108; Tsuboi T, 2012, MOL CELL, V46, P518, DOI 10.1016/j.molcel.2012.03.013; Tyedmers J, 2010, NAT REV MOL CELL BIO, V11, P777, DOI 10.1038/nrm2993; van Hoof A, 2002, SCIENCE, V295, P2262, DOI 10.1126/science.1067272; Verma R, 2013, ELIFE, V2, DOI 10.7554/eLife.00308; Wang Y, 2009, FASEB J, V23, P451, DOI 10.1096/fj.08-117614	33	54	56	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 3	2016	291	23					12245	12253		10.1074/jbc.M116.722264	http://dx.doi.org/10.1074/jbc.M116.722264			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DO9GJ	27129255	Green Published, hybrid			2022-12-26	WOS:000378092800025
J	Brand, J; Piccirelli, M; Hepp-Reymond, MC; Morari, M; Michels, L; Eng, K				Brand, Johannes; Piccirelli, Marco; Hepp-Reymond, Marie-Claude; Morari, Manfred; Michels, Lars; Eng, Kynan			Virtual Hand Feedback Reduces Reaction Time in an Interactive Finger Reaching Task	PLOS ONE			English	Article							THERAPY SYSTEM; HUMAN-BODY; MOTOR; REHABILITATION; MOVEMENT; STROKE	Computer interaction via visually guided hand or finger movements is a ubiquitous part of daily computer usage in work or gaming. Surprisingly, however, little is known about the performance effects of using virtual limb representations versus simpler cursors. In this study 26 healthy right-handed adults performed cued index finger flexion-extension movements towards an on-screen target while wearing a data glove. They received each of four different types of real-time visual feedback: a simple circular cursor, a point light pattern indicating finger joint positions, a cartoon hand and a fully shaded virtual hand. We found that participants initiated the movements faster when receiving feedback in the form of a hand than when receiving circular cursor or point light feedback. This overall difference was robust for three out of four hand versus circle pairwise comparisons. The faster movement initiation for hand feedback was accompanied by a larger movement amplitude and a larger movement error. We suggest that the observed effect may be related to priming of hand information during action perception and execution affecting motor planning and execution. The results may have applications in the use of body representations in virtual reality applications.	[Brand, Johannes; Hepp-Reymond, Marie-Claude; Eng, Kynan] Univ Zurich, Inst Neuroinformat, Zurich, Switzerland; [Brand, Johannes; Hepp-Reymond, Marie-Claude; Eng, Kynan] ETH, Zurich, Switzerland; [Piccirelli, Marco; Michels, Lars] Univ Zurich Hosp, Inst Neuroradiol, CH-8091 Zurich, Switzerland; [Michels, Lars] Univ Childrens Hosp, Ctr MR Res, Zurich, Switzerland; [Brand, Johannes; Morari, Manfred] ETH, Automat Control Lab, Zurich, Switzerland	University of Zurich; Swiss Federal Institutes of Technology Domain; ETH Zurich; University of Zurich; University Zurich Hospital; University Children's Hospital Zurich; Swiss Federal Institutes of Technology Domain; ETH Zurich	Eng, K (corresponding author), Univ Zurich, Inst Neuroinformat, Zurich, Switzerland.; Eng, K (corresponding author), ETH, Zurich, Switzerland.	kynan@ini.phys.ethz.ch	Coish, Elizabeth/AAU-1245-2020; Michels, Lars/X-6939-2018	Eng, Kynan/0000-0002-1434-8767; Michels, Lars/0000-0003-3750-1100; Piccirelli, Marco/0000-0002-3107-4489	ETH Zurich	ETH Zurich(ETH Zurich)	This study was funded by the ETH Zurich Collaborative Highly Interdisciplinary 210 Research Projects Stage 1 (CHIRP1) grant "CA2ST - Cortically Assisted Adaptation 211 during Sensorimotor Training" (http://www.ethz.ch). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2011, MATLAB VERS 7 12 0 6; Cameirao MS, 2009, STUD HEALTH TECHNOL, V145, P65, DOI 10.3233/978-1-60750-018-6-65; Downing PE, 2001, SCIENCE, V293, P2470, DOI 10.1126/science.1063414; Eng K, 2007, MED BIOL ENG COMPUT, V45, P901, DOI 10.1007/s11517-007-0239-1; Gauthier I, 1997, VISION RES, V37, P1673, DOI 10.1016/S0042-6989(96)00286-6; Henderson JM, 2007, CURR DIR PSYCHOL SCI, V16, P219, DOI 10.1111/j.1467-8721.2007.00507.x; Kilner J, 2007, SOC NEUROSCI-UK, V2, P158, DOI 10.1080/17470910701428190; Kilner JM, 2003, CURR BIOL, V13, P522, DOI 10.1016/S0960-9822(03)00165-9; Kupferberg A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039637; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Orlov T, 2010, NEURON, V68, P586, DOI 10.1016/j.neuron.2010.09.032; Peelen MV, 2007, NAT REV NEUROSCI, V8, P636, DOI 10.1038/nrn2195; R Core Team, 2012, R LANG ENV STAT COMP; Schleicher R, 2008, ERGONOMICS, V51, P982, DOI 10.1080/00140130701817062; Shadmehr R, 2008, EXP BRAIN RES, V185, P359, DOI 10.1007/s00221-008-1280-5; Shelton JR, 1998, NEUROCASE, V4, P339, DOI 10.1093/neucas/4.4.339; Sober SJ, 2005, NAT NEUROSCI, V8, P490, DOI 10.1038/nn1427; Veilleux LN, 2011, EXP BRAIN RES, V214, P215, DOI 10.1007/s00221-011-2822-9; Wickham H, 2009, USE R, P1, DOI 10.1007/978-0-387-98141-3_1; Wille D, 2009, DEV NEUROREHABIL, V12, P44, DOI 10.1080/17518420902773117; Wolf SL, 2001, STROKE, V32, P1635, DOI 10.1161/01.STR.32.7.1635	21	7	8	2	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 4	2016	11	5							e0154807	10.1371/journal.pone.0154807	http://dx.doi.org/10.1371/journal.pone.0154807			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DL5KR	27144927	Green Accepted, gold, Green Published			2022-12-26	WOS:000375676400075
J	Kim, Y; Kawachi, I				Kim, Yongjoo; Kawachi, Ichiro			School- and Individual-level Predictors of Weight Status Misperception among Korean Adolescents: A National Online Survey	PLOS ONE			English	Article							HEALTH-RISK BEHAVIORS; BODY-WEIGHT; ENVIRONMENTAL-FACTORS; SELF-PERCEPTION; OBESITY; OVERWEIGHT; PREVALENCE; TRENDS; US; ACCURACY	Background Growing body of literature has reported that weight status estimation pattern, including accurate-, under-, and overestimation, was associated with weight related behaviors and weight change among adolescents and young adults. However, there have been a few studies investigating the potential role of school contexts in shaping adolescents' weight status estimation pattern among Korea adolescents. Objective The aim of the present study was to investigate the association between weight status misperception patterns and factors at individual-, family-, and school-level, simultaneously, and whether there was significant between schools variation in the distribution of each weight status misperception pattern, underestimation and overestimation respectively, among Korean adolescents aged 12-18 years. Method Data from the Eighth Korea Youth Risk Behavior Web-based Survey (KYRBS), 2012, a nationally representative online survey of 72,228 students (boys = 37,229, girls = 34,999) from a total of 797 middle and high schools were used. Sex stratified multilevel random intercept multinomial logistic models where adolescents (level 1) were nested within schools (level 2) were performed. Results At the school level, attending a school with higher average BMI (kg/m(2)) was positively associated with weight status underestimation, and inversely associated with weight status overestimation among boys and girls. Single-sex schooling was positively associated with weight status underestimation among girls. At the family level, higher household income (high/middle versus low) was inversely associated with both weight status under- and overestimation among boys and girls. Higher maternal education (equal to or more than college graduate versus equal to or less than high school graduate) was positively associated with weight status overestimation among boys, and living with both parents (compared to not living with both parents) was inversely associated with weight status underestimation among girls. At the individual level, high academic achievement (compared to low) was positively associated with weight status underestimation among boys and girls. Conclusions While further research with prospective designs and objectively measured anthropometric information is needed, school environmental factors such as sex composition and school average BMI, as well as, family contexts such as socioeconomic status need to be considered when developing and implementing obesity prevention programs.	[Kim, Yongjoo; Kawachi, Ichiro] Harvard Univ, Sch Publ Hlth, Dept Social & Behav Sci, 665 Huntington Ave, Boston, MA 02115 USA	Harvard University; Harvard T.H. Chan School of Public Health	Kim, Y (corresponding author), Harvard Univ, Sch Publ Hlth, Dept Social & Behav Sci, 665 Huntington Ave, Boston, MA 02115 USA.	yongjoo.kim@mail.harvard.edu	Kim, Yongjoo/N-9751-2019	Kim, Yongjoo/0000-0002-0768-9256				[Anonymous], 2012, 8 KOR YOUTH RIKS BEH; [Anonymous], KOR CHILDR AD GROWTH; [Anonymous], 2003, MULTILEVEL METHODS P; Austin SB, 2012, PREV CHRONIC DIS, V9, DOI 10.5888/pcd9.120111; Austin S Bryn, 2011, Am J Public Health, V101, pe1, DOI 10.2105/AJPH.2011.300182; Austin SB, 2013, EAT DISORD, V21, P91, DOI 10.1080/10640266.2013.761080; Bae Jisuk, 2010, J Prev Med Public Health, V43, P396, DOI 10.3961/jpmph.2010.43.5.396; Byeon H, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0131322; Centers for Disease Control and Prevention, 2016, YOUTH RISK BEHAV SUR; Chang VW, 2003, AM J PREV MED, V24, P332, DOI 10.1016/S0749-3797(03)00020-5; Choi J, 2015, SOC SCI MED, V134, P1, DOI 10.1016/j.socscimed.2015.03.053; Christakis NA, 2007, NEW ENGL J MED, V357, P370, DOI 10.1056/NEJMsa066082; Chu NF, 2005, OBES REV, V6, P271, DOI 10.1111/j.1467-789X.2005.00175.x; Chung AE, 2013, ACAD PEDIATR, V13, P371, DOI 10.1016/j.acap.2013.04.011; Cunningham SA, 2012, SOC SCI MED, V75, P1175, DOI 10.1016/j.socscimed.2012.05.024; Datar A, 2016, ACAD PEDIATR, V16, P267, DOI 10.1016/j.acap.2015.06.003; Dorsey RR, 2009, OBESITY, V17, P790, DOI 10.1038/oby.2008.603; Duncan DT, 2011, INT J BEHAV NUTR PHY, V8, DOI 10.1186/1479-5868-8-20; Duncan JS, 2011, PUBLIC HEALTH NUTR, V14, P93, DOI 10.1017/S1368980010000236; Dunn EC, 2015, AM J PUBLIC HEALTH, V105, P732, DOI 10.2105/AJPH.2014.302374; Dunn EC, 2015, HEALTH PLACE, V31, P224, DOI 10.1016/j.healthplace.2014.12.001; Edwards NM, 2010, PEDIATRICS, V125, pE452, DOI 10.1542/peds.2009-0185; Elgar FJ, 2005, J ADOLESCENT HEALTH, V37, P371, DOI 10.1016/j.jadohealth.2004.07.014; Fan MY, 2014, J PEDIATR NURS, V29, P536, DOI 10.1016/j.pedn.2014.07.009; Fredrickson J, 2013, BODY IMAGE, V10, P552, DOI 10.1016/j.bodyim.2013.06.008; Hattori A, 2013, OBESITY, V21, P856, DOI 10.1002/oby.20313; Hyun MY, 2014, NEUROPSYCH DIS TREAT, V10, P797, DOI 10.2147/NDT.S63143; Jackson SE, 2015, INT J OBESITY, V39, P1488, DOI 10.1038/ijo.2015.126; Jiang YW, 2014, AM J HEALTH BEHAV, V38, P765, DOI 10.5993/AJHB.38.5.14; Kang HT, 2014, J EPIDEMIOL, V24, P109, DOI 10.2188/jea.JE20130017; Kawachi I., 2008, SOCIAL CAPITAL HLTH, P1, DOI DOI 10.1007/978-0-387-71311-3_1; Kim CS, 2014, DIABETES METAB J, V38, P35, DOI 10.4093/dmj.2014.38.1.35; Kim DS, 2009, J SCHOOL HEALTH, V79, P585, DOI 10.1111/j.1746-1561.2009.00452.x; Kim M, 2010, NUTR RES PRACT, V4, P499, DOI 10.4162/nrp.2010.4.6.499; Kim S, 2014, BMC PUBLIC HEALTH, V14, DOI [10.1186/1471-2458-14-452, 10.1186/1472-6882-14-231]; Korea Centers for Disease Control and Prevention, 2012, STAT 8 KOR YOUTH RIS; Kwon JA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072507; Liechty JM, 2015, INT J OBESITY, V39, P601, DOI 10.1038/ijo.2014.191; Liechty JM, 2013, INT J EAT DISORDER, V46, P790, DOI 10.1002/eat.22174; Lim H, 2014, NUTR RES PRACT, V8, P213, DOI [10.4162/nrp.2014.8.1.213, 10.4162/nrp.2014.8.2.213]; Lim HJ, 2013, OBESITY, V21, P2596, DOI 10.1002/oby.20361; Martin BC, 2014, J SCHOOL HEALTH, V84, P116, DOI 10.1111/josh.12128; Maximova K, 2008, INT J OBESITY, V32, P1008, DOI 10.1038/ijo.2008.15; Maximova K, 2015, ANN EPIDEMIOL, V25, P753, DOI 10.1016/j.annepidem.2015.07.009; Moon JS, 2007, KOREAN J PEDIAT, V1, P1, DOI DOI 10.3345/KJP.2008.51.1.1; Morgen CS, 2014, NAT REV ENDOCRINOL, V10, P513, DOI 10.1038/nrendo.2014.124; Ng M, 2014, LANCET, V384, P766, DOI 10.1016/S0140-6736(14)60460-8; Park E, 2011, J SCHOOL HEALTH, V81, P57, DOI 10.1111/j.1746-1561.2010.00561.x; Park S, 2016, BMC PUBLIC HEALTH, V16, DOI 10.1186/s12889-016-2731-8; Quick V, 2014, INT J OBESITY, V38, P988, DOI 10.1038/ijo.2014.62; Rasbash J, 2019, USERS GUIDE MLWIN; Richmond TK, 2008, OBESITY, V16, P1324, DOI 10.1038/oby.2008.48; Richmond TK, 2014, J SCHOOL HEALTH, V84, P759, DOI 10.1111/josh.12213; Richmond TK, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0083254; Robinson E, 2015, INT J OBESITY, V39, P1721, DOI 10.1038/ijo.2015.143; Sarafrazi Neda, 2014, NCHS Data Brief, P1; Sherry B, 2007, ARCH PEDIAT ADOL MED, V161, P1154, DOI 10.1001/archpedi.161.12.1154; Sonneville KR, 2016, INT J OBESITY, V40, P328, DOI 10.1038/ijo.2015.166; Stommel M, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-421; Suzuki E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051717; Swinburn BA, 2011, LANCET, V378, P804, DOI 10.1016/S0140-6736(11)60813-1; Wang YF, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-923; Wardle J, 2006, INT J OBESITY, V30, P644, DOI 10.1038/sj.ijo.0803050; Xie B, 2006, PREV MED, V42, P229, DOI 10.1016/j.ypmed.2005.12.013; Yaemsiri S, 2011, INT J OBESITY, V35, P1063, DOI 10.1038/ijo.2010.229; Yoo S, 2010, PREV MED, V51, P460, DOI 10.1016/j.ypmed.2010.10.004; Yoshiike N, 2002, Obes Rev, V3, P183, DOI 10.1046/j.1467-789X.2002.00070.x; 오경원, 2008, Clinical and Experimental Pediatrics, V51, P950	69	12	12	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 4	2016	11	5							e0154826	10.1371/journal.pone.0154826	http://dx.doi.org/10.1371/journal.pone.0154826			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DL5KR	27144319	Green Published, gold, Green Submitted			2022-12-26	WOS:000375676400079
J	Staber, JM; Pollpeter, MJ				Staber, Janice M.; Pollpeter, Molly J.			Shortened Lifespan and Lethal Hemorrhage in a Hemophilia A Mouse Model	PLOS ONE			English	Article							SWEDISH HEMOPHILIACS; MORTALITY-RATES; EXPECTANCY; MICE; DEATHS	Background Hemophilia A animal models have helped advance our understanding of factor VIII deficiency. Previously, factor VIII deficient mouse models were reported to have a normal life span without spontaneous bleeds. However, the bleeding frequency and survival in these animals has not been thoroughly evaluated. Objective To investigate the survival and lethal bleeding frequency in two strains of E-16 hemophilia A mice. Methods We prospectively studied factor VIII deficient hemizygous affected males (n = 83) and homozygous affected females (n = 55) for survival and bleeding frequency. Animals were evaluated for presence and location of bleeds as potential cause of death. Results and Conclusions Hemophilia A mice had a median survival of 254 days, which is significantly shortened compared to wild type controls (p < 0.0001). In addition, the hemophilia A mice experienced hemorrhage in several tissues. This previously-underappreciated shortened survival in the hemophilia A murine model provides new outcomes for investigation of therapeutics and also reflects the shortened lifespan of patients if left untreated.	[Staber, Janice M.; Pollpeter, Molly J.] Univ Iowa, Stead Family Dept Pediat, Carver Coll Med, Iowa City, IA 52242 USA	University of Iowa	Staber, JM (corresponding author), Univ Iowa, Stead Family Dept Pediat, Carver Coll Med, Iowa City, IA 52242 USA.	janice-staber@uiowa.edu		Staber, Janice/0000-0002-2738-4206	University of Iowa Children's Miracle Network; NIH [HD027748-19]	University of Iowa Children's Miracle Network; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by the University of Iowa Children's Miracle Network (JMS) and NIH HD027748-19, the Molecular and Cellular Research to Advance Child Health (JMS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bi L, 1996, BLOOD, V88, P3446, DOI 10.1182/blood.V88.9.3446.bloodjournal8893446; BI L, 1995, NAT GENET, V10, P119, DOI 10.1038/ng0595-119; Darby SC, 2007, BLOOD, V110, P815, DOI 10.1182/blood-2006-10-050435; IKKALA E, 1982, BRIT J HAEMATOL, V52, P7, DOI 10.1111/j.1365-2141.1982.tb03856.x; Kastenmayer RJ, 2006, J AM ASSOC LAB ANIM, V45, P8; LARSSON SA, 1983, ACTA MED SCAND, V214, P199; LARSSON SA, 1985, BRIT J HAEMATOL, V59, P593, DOI 10.1111/j.1365-2141.1985.tb07353.x; Lovdahl S, 2013, HAEMOPHILIA, V19, P362, DOI 10.1111/hae.12092; Muchitsch EM, 1999, THROMB HAEMOSTASIS, V82, P1371; ROSENDAAL FR, 1989, BRIT J HAEMATOL, V71, P71, DOI 10.1111/j.1365-2141.1989.tb06277.x; Shah S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008984; SIXMA JJ, 1984, BRIT J HAEMATOL, V58, P741, DOI 10.1111/j.1365-2141.1984.tb06121.x; Staber JM, 2014, MOL THER-METH CLIN D, V1, DOI 10.1038/mtm.2014.42; Yuan R, 2009, AGING CELL, V8, P277, DOI 10.1111/j.1474-9726.2009.00478.x	14	4	4	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 4	2016	11	5							e0154857	10.1371/journal.pone.0154857	http://dx.doi.org/10.1371/journal.pone.0154857			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DL5KR	27144769	Green Published, gold			2022-12-26	WOS:000375676400084
J	Fridlyand, LE; Philipson, LH				Fridlyand, Leonid E.; Philipson, Louis H.			Pancreatic Beta Cell G-Protein Coupled Receptors and Second Messenger Interactions: A Systems Biology Computational Analysis	PLOS ONE			English	Article							GLUCAGON-LIKE PEPTIDE-1; DEPENDENT INSULINOTROPIC POLYPEPTIDE; ISLET HORMONE-SECRETION; GASTRIC-INHIBITORY POLYPEPTIDE; IMPROVES GLUCOSE-TOLERANCE; PHOSPHOLIPASE-C ISOZYMES; TYPE-2 DIABETES-MELLITUS; SOLUBLE ADENYLYL-CYCLASE; FREE CA2+ CONCENTRATION; K-ATP CHANNELS	Insulin secretory in pancreatic beta-cells responses to nutrient stimuli and hormonal modulators include multiple messengers and signaling pathways with complex interdependencies. Here we present a computational model that incorporates recent data on glucose metabolism, plasma membrane potential, G-protein-coupled-receptors (GPCR), cytoplasmic and endoplasmic reticulum calcium dynamics, cAMP and phospholipase C pathways that regulate interactions between second messengers in pancreatic beta-cells. The values of key model parameters were inferred from published experimental data. The model gives a reasonable fit to important aspects of experimentally measured metabolic and second messenger concentrations and provides a framework for analyzing the role of metabolic, hormones and neurotransmitters changes on insulin secretion. Our analysis of the dynamic data provides support for the hypothesis that activation of Ca2+-dependent adenylyl cyclases play a critical role in modulating the effects of glucagon-like peptide 1 (GLP-1), glucose-dependent insulinotropic polypeptide (GIP) and catecholamines. The regulatory properties of adenylyl cyclase isoforms determine fluctuations in cytoplasmic cAMP concentration and reveal a synergistic action of glucose, GLP-1 and GIP on insulin secretion. On the other hand, the regulatory properties of phospholipase C isoforms determine the interaction of glucose, acetylcholine and free fatty acids (FFA) (that act through the FFA receptors) on insulin secretion. We found that a combination of GPCR agonists activating different messenger pathways can stimulate insulin secretion more effectively than a combination of GPCR agonists for a single pathway. This analysis also suggests that the activators of GLP-1, GIP and FFA receptors may have a relatively low risk of hypoglycemia in fasting conditions whereas an activator of muscarinic receptors can increase this risk. This computational analysis demonstrates that study of second messenger pathway interactions will improve understanding of critical regulatory sites, how different GPCRs interact and pharmacological targets for modulating insulin secretion in type 2 diabetes.	[Fridlyand, Leonid E.] Univ Chicago, Kovler Diabet Ctr, Dept Med, Chicago, IL 60637 USA; Univ Chicago, Kovler Diabet Ctr, Dept Pediat, Chicago, IL 60637 USA	University of Chicago; University of Chicago	Fridlyand, LE (corresponding author), Univ Chicago, Kovler Diabet Ctr, Dept Med, Chicago, IL 60637 USA.	lfridlia@medicine.bsd.uchicago.edu		Fridlyand, Leonid/0000-0003-4424-9986	National Institutes of Health [DK063493, DK092616]; University of Chicago Diabetes Research and Training Center - NIH [DK020595]; NIH from the National Institute for General Medical Sciences [P41 GM103313]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK020595, R01DK092616, R01DK063493, P60DK020595] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P41GM103313] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Chicago Diabetes Research and Training Center - NIH; NIH from the National Institute for General Medical Sciences; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by grants from the National Institutes of Health to LHP (DK063493 and DK092616), and by University of Chicago Diabetes Research and Training Center funding from the NIH (DK020595) to LHP. The Virtual Cell is supported by NIH Grant Number P41 GM103313 from the National Institute for General Medical Sciences.	Ahmed MS, 2012, ISLETS, V4, P343, DOI [10.4161/islets.22283, 10.4161/isl.22283]; Ahren B, 2000, DIABETOLOGIA, V43, P393, DOI 10.1007/s001250051322; Ahren B, 2001, DIABETES, V50, P1030, DOI 10.2337/diabetes.50.5.1030; Ahren B, 2009, NAT REV DRUG DISCOV, V8, P369, DOI 10.1038/nrd2782; ALOUSI AA, 1991, FASEB J, V5, P2300, DOI 10.1096/fasebj.5.9.1650314; Amisten S, 2013, PHARMACOL THERAPEUT, V139, P359, DOI 10.1016/j.pharmthera.2013.05.004; ASHCROFT FM, 1989, PROG BIOPHYS MOL BIO, V54, P87, DOI 10.1016/0079-6107(89)90013-8; Ashcroft FM, 2013, NAT REV ENDOCRINOL, V9, P660, DOI 10.1038/nrendo.2013.166; Azpiazu I, 2004, J BIOL CHEM, V279, P27709, DOI 10.1074/jbc.M403712200; Baggio LL, 2007, GASTROENTEROLOGY, V132, P2131, DOI 10.1053/j.gastro.2007.03.054; Barker CJ, 2013, PHARMACOL REV, V65, P641, DOI 10.1124/pr.112.006775; Baukrowitz T, 2000, BIOCHEM PHARMACOL, V60, P735, DOI 10.1016/S0006-2952(00)00267-7; Beguin P, 1999, EMBO J, V18, P4722, DOI 10.1093/emboj/18.17.4722; Benninger RKP, 2014, TRENDS ENDOCRIN MET, V25, P399, DOI 10.1016/j.tem.2014.02.005; Berridge MJ, 2009, BBA-MOL CELL RES, V1793, P933, DOI 10.1016/j.bbamcr.2008.10.005; Berridge MJ, 2003, NAT REV MOL CELL BIO, V4, P517, DOI 10.1038/nrm1155; Bertram R, 2004, B MATH BIOL, V66, P1313, DOI 10.1016/j.bulm.2003.12.005; Bertram R, 2010, ADV EXP MED BIOL, V654, P261, DOI 10.1007/978-90-481-3271-3_12; BOKOCH GM, 1988, J CELL BIOL, V106, P1927, DOI 10.1083/jcb.106.6.1927; Brinkerhoff CJ, 2008, J THEOR BIOL, V255, P278, DOI 10.1016/j.jtbi.2008.08.003; Burant CF, 2012, LANCET, V379, P1403, DOI 10.1016/S0140-6736(11)61879-5; Calanna S, 2013, DIABETES CARE, V36, P3346, DOI 10.2337/dc13-0465; Cazzaniga P, 2014, METABOLITES, V4, P1034, DOI 10.3390/metabo4041034; Cognard E, 2013, BIOCHEM J, V449, P803, DOI 10.1042/BJ20121454; Colsoul B, 2011, REV PHYSIOL BIOCH P, V161, P87, DOI 10.1007/112_2011_2; Cooper Dermot M.F., 1998, Advances in Second Messenger and Phosphoprotein Research, V32, P23; Dai XQ, 2012, DIABETOLOGIA, V55, P1709, DOI 10.1007/s00125-012-2512-6; de Azua IR, 2011, TRENDS ENDOCRIN MET, V22, P74, DOI 10.1016/j.tem.2010.10.004; de Heer J, 2007, DIABETES, V56, P438, DOI 10.2337/db06-0738; DEAN PM, 1973, DIABETOLOGIA, V9, P115, DOI 10.1007/BF01230690; Defossa E, 2014, BIOORG MED CHEM LETT, V24, P2991, DOI 10.1016/j.bmcl.2014.05.019; Degerman E, 2011, CURR OPIN PHARMACOL, V11, P676, DOI 10.1016/j.coph.2011.09.015; Del Guerra S, 2005, DIABETES, V54, P727, DOI 10.2337/diabetes.54.3.727; Delmeire D, 2003, DIABETOLOGIA, V46, P1383, DOI 10.1007/s00125-003-1203-8; Dessauer CW, 1997, J BIOL CHEM, V272, P22272, DOI 10.1074/jbc.272.35.22272; Doliba NM, 2012, AM J PHYSIOL-ENDOC M, V302, pE87, DOI 10.1152/ajpendo.00218.2011; Doliba NM, 2010, AM J PHYSIOL-ENDOC M, V299, pE475, DOI 10.1152/ajpendo.00072.2010; Doliba NM, 2004, AM J PHYSIOL-ENDOC M, V286, pE834, DOI 10.1152/ajpendo.00292.2003; Dolz M, 2005, DIABETES, V54, P3229, DOI 10.2337/diabetes.54.11.3229; Dov A, 2008, ENDOCRINOLOGY, V149, P741, DOI 10.1210/en.2007-0968; Doyle ME, 2007, PHARMACOL THERAPEUT, V113, P546, DOI 10.1016/j.pharmthera.2006.11.007; Drucker DJ, 2013, DIABETES, V62, P3316, DOI 10.2337/db13-0822; Dyachok O, 2004, J BIOL CHEM, V279, P45455, DOI 10.1074/jbc.M407673200; Dyachok O, 2006, NATURE, V439, P349, DOI 10.1038/nature04410; Dyer JL, 2003, BIOCHEM BIOPH RES CO, V302, P121, DOI 10.1016/S0006-291X(03)00120-7; EKANGER R, 1985, J BIOL CHEM, V260, P3393; Fagerholm V, 2011, BASIC CLIN PHARMACOL, V108, P365, DOI 10.1111/j.1742-7843.2011.00699.x; Falkenburger BH, 2013, J GEN PHYSIOL, V141, P537, DOI 10.1085/jgp.201210887; Falkenburger BH, 2010, J GEN PHYSIOL, V135, P81, DOI 10.1085/jgp.200910344; FEHMANN HC, 1990, Z GASTROENTEROL, V28, P348; Felix-Martinez GJ, 2014, REV MEX ING QUIM, V35, P1; Ferdaoussi M, 2012, DIABETOLOGIA, V55, P2682, DOI 10.1007/s00125-012-2650-x; Fiume R, 2012, FASEB J, V26, P203, DOI 10.1096/fj.11-186510; Fridlyand LE, 2010, AM J PHYSIOL-ENDOC M, V299, pE517, DOI 10.1152/ajpendo.00177.2010; Fridlyand LE, 2009, BIOPHYS J, V96, P3126, DOI 10.1016/j.bpj.2009.01.029; Fridlyand LE, 2005, AM J PHYSIOL-ENDOC M, V289, pE839, DOI 10.1152/ajpendo.00595.2004; Fridlyand LE, 2003, AM J PHYSIOL-ENDOC M, V285, pE138, DOI 10.1152/ajpendo.00194.2002; Fridlyand LE, 2007, AM J PHYSIOL-CELL PH, V293, pC1924, DOI 10.1152/ajpcell.00555.2006; Fridlyand LE, 2013, ISLETS, V5, P1, DOI 10.4161/isl.24166; Fridlyand LE, 2011, PROG BIOPHYS MOL BIO, V107, P293, DOI 10.1016/j.pbiomolbio.2011.09.001; Fridlyand LE, 2010, THEOR BIOL MED MODEL, V7, DOI 10.1186/1742-4682-7-15; Fruman DA, 1998, ANNU REV BIOCHEM, V67, P481, DOI 10.1146/annurev.biochem.67.1.481; Fujiwara K, 2005, AM J PHYSIOL-ENDOC M, V289, pE670, DOI 10.1152/ajpendo.00035.2005; Gainetdinov RR, 2004, ANNU REV NEUROSCI, V27, P107, DOI 10.1146/annurev.neuro.27.070203.144206; GARCIA MC, 1988, BIOCHEM J, V254, P211, DOI 10.1042/bj2540211; Gault VA, 2011, CLIN SCI, V121, P107, DOI 10.1042/CS20110006; Gautam D, 2006, CELL METAB, V3, P449, DOI 10.1016/j.cmet.2006.04.009; Gerencser AA, 2015, ENDOCRINOLOGY, V156, P3496, DOI 10.1210/en.2015-1552; Gilon P, 2001, ENDOCR REV, V22, P565, DOI 10.1210/er.22.5.565; Gilon P, 2014, CELL CALCIUM, V56, P340, DOI 10.1016/j.ceca.2014.09.001; Gilon P, 2009, EMBO REP, V10, P963, DOI 10.1038/embor.2009.185; Gonelle-Gispert C, 2002, BIOCHEM J, V368, P223, DOI 10.1042/BJ20020896; Gopel S, 1999, J PHYSIOL-LONDON, V521, P717, DOI 10.1111/j.1469-7793.1999.00717.x; Gresset Aurelie, 2012, Subcell Biochem, V58, P61, DOI 10.1007/978-94-007-3012-0_3; Gromada J, 1998, PFLUG ARCH EUR J PHY, V435, P583, DOI 10.1007/s004240050558; Gromada J, 1996, BIOCHEM J, V314, P339, DOI 10.1042/bj3140339; Guettier JM, 2009, P NATL ACAD SCI USA, V106, P19197, DOI 10.1073/pnas.0906593106; Haga T, 2013, P JPN ACAD B-PHYS, V89, P226, DOI 10.2183/pjab.89.226; Hamann J, 2015, PHARMACOL REV, V67, P338, DOI 10.1124/pr.114.009647; Harden TK, 2011, CHEM REV, V111, P6120, DOI 10.1021/cr200209p; Hashimoto T MH, 2014, DIABETES; HAUSDORFF WP, 1990, FASEB J, V4, P2881, DOI 10.1096/fasebj.4.11.2165947; Heimann E, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014191; Hein P, 2005, EMBO J, V24, P4106, DOI 10.1038/sj.emboj.7600870; Hein P, 2009, N-S ARCH PHARMACOL, V379, P435, DOI 10.1007/s00210-008-0383-7; Heitzler D, 2012, MOL SYST BIOL, V8, DOI 10.1038/msb.2012.22; Henquin JC, 2009, DIABETOLOGIA, V52, P739, DOI 10.1007/s00125-009-1314-y; HENQUIN JC, 1988, ENDOCRINOLOGY, V122, P2134, DOI 10.1210/endo-122-5-2134; Hille B, 2014, PROG MOL BIOL TRANSL, V123, P219, DOI 10.1016/B978-0-12-397897-4.00008-5; Hinke SA, 2002, DIABETES, V51, P652, DOI 10.2337/diabetes.51.3.652; Hoare SRJ, 2005, DRUG DISCOV TODAY, V10, P417, DOI 10.1016/S1359-6446(05)03370-2; Hoffmann C, 2012, MOL PHARMACOL, V82, P236, DOI 10.1124/mol.112.077578; Holst JJ, 2004, AM J PHYSIOL-ENDOC M, V287, pE199, DOI 10.1152/ajpendo.00545.2003; Holz GG, 2006, J PHYSIOL-LONDON, V577, P5, DOI 10.1113/jphysiol.2006.119644; Holz GG, 2014, BBA-MOL BASIS DIS, V1842, P2593, DOI 10.1016/j.bbadis.2014.06.023; Holzhutter HG, 2012, WIRES SYST BIOL MED, V4, P221, DOI 10.1002/wsbm.1158; Iancu RV, 2007, BIOPHYS J, V92, P3317, DOI 10.1529/biophysj.106.095356; Islam MS, 2010, ADV EXP MED BIOL, V654, P235, DOI 10.1007/978-90-481-3271-3_11; Itoh Y, 2003, NATURE, V422, P173, DOI 10.1038/nature01478; Jacobson D. A., 2007, V179, P409; Jacobson David A., 2008, P91, DOI 10.1007/978-4-431-75452-7_6; Jain R, 2009, DIABETES OBES METAB, V11, P159, DOI 10.1111/j.1463-1326.2009.01102.x; Jain S, 2013, J CLIN INVEST, V123, P1750, DOI 10.1172/JCI66432; Jakubik J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027732; JIA X, 1995, AM J PHYSIOL-ENDOC M, V268, pE645, DOI 10.1152/ajpendo.1995.268.4.E645; Jovic A, 2013, INTEGR BIOL-UK, V5, P932, DOI 10.1039/c3ib40032h; Just T, 2008, APPETITE, V51, P622, DOI 10.1016/j.appet.2008.04.271; Kahn SE, 2003, DIABETOLOGIA, V46, P3, DOI 10.1007/s00125-002-1009-0; Kaneto H, 2013, WORLD J DIABETES, V4, P263, DOI 10.4239/wjd.v4.i6.263; Kang ZF, 2013, DIABETOLOGIA, V56, P423, DOI 10.1007/s00125-012-2776-x; Kim MJ, 2001, PANCREAS, V22, P47, DOI 10.1097/00006676-200101000-00008; Kim M, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000691; Kimple ME, 2014, EXP MOL MED, V46, DOI 10.1038/emm.2014.40; Kitaguchi T, 2013, BIOCHEM J, V450, P365, DOI 10.1042/BJ20121022; Klingmuller U, 2006, IEE P SYST BIOL, V153, P433, DOI 10.1049/ip-syb:20050067; Kong KC, 2010, P NATL ACAD SCI USA, V107, P21181, DOI 10.1073/pnas.1011651107; Kruse AC, 2013, J MOL NEUROSCI, DOI [10.1007/s12031-013-0127-0, DOI 10.1007/S12031-013-0127]; Kruse M, 2012, J GEN PHYSIOL, V140, P189, DOI 10.1085/jgp.201210806; Lamont BJ, 2012, J CLIN INVEST, V122, P388, DOI 10.1172/JCI42497; Landa LR, 2005, J BIOL CHEM, V280, P31294, DOI 10.1074/jbc.M505657200; Latour MG, 2007, DIABETES, V56, P1087, DOI 10.2337/db06-1532; Lemon G, 2003, J THEOR BIOL, V223, P93, DOI 10.1016/S0022-5193(03)00079-1; Li NC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047936; Liang T, 2014, J BIOL CHEM, V289, P6028, DOI 10.1074/jbc.M113.511808; Light PE, 2002, MOL ENDOCRINOL, V16, P2135, DOI 10.1210/me.2002-0084; Lin CW, 2005, DIABETES, V54, P2852, DOI 10.2337/diabetes.54.10.2852; Litvin TN, 2003, J BIOL CHEM, V278, P15922, DOI 10.1074/jbc.M212475200; Logothetis DE, 2010, PFLUG ARCH EUR J PHY, V460, P321, DOI 10.1007/s00424-010-0828-y; Luik RM, 2008, NATURE, V454, P538, DOI 10.1038/nature07065; Mancini AD, 2013, TRENDS ENDOCRIN MET, V24, P398, DOI 10.1016/j.tem.2013.03.003; Manninen T, 2010, FRONT COMPUT NEUROSC, V4, DOI 10.3389/fncom.2010.00152; McIntosh CHS, 2009, VITAM HORM, V80, P409, DOI 10.1016/S0083-6729(08)00615-8; Mears D, 2012, CELL PHYSIOL BIOCHEM, V29, P697, DOI 10.1159/000186926; Meloni AR, 2013, DIABETES OBES METAB, V15, P15, DOI 10.1111/j.1463-1326.2012.01663.x; Miguel JC, 2003, BIOCHEM PHARMACOL, V65, P283, DOI 10.1016/S0006-2952(02)01482-X; Milligan G, 1996, CELL SIGNAL, V8, P87, DOI 10.1016/0898-6568(95)02034-9; Mohammad S, 2014, MOL CELL BIOL, V34, P3618, DOI 10.1128/MCB.00256-14; Molina J, 2014, DIABETES, V63, P2714, DOI 10.2337/db13-1371; Moraru II, 2005, PHYSIOLOGY, V20, P169, DOI 10.1152/physiol.00052.2004; MORGAN NG, 1985, BIOCHEM J, V226, P571, DOI 10.1042/bj2260571; Nadkarni P, 2014, PROG MOL BIOL TRANSL, V121, P23, DOI 10.1016/B978-0-12-800101-1.00002-8; Nagasumi K, 2009, DIABETES, V58, P1067, DOI 10.2337/db08-1233; Nakajima K, 2013, MOL ENDOCRINOL, V27, P1208, DOI 10.1210/me.2013-1084; Nakashima R, 2014, EUR J PHARMACOL, V737, P194, DOI 10.1016/j.ejphar.2014.05.014; Nauck MA, 2011, DIABETOLOGIA, V54, P10, DOI 10.1007/s00125-010-1896-4; Nauck MA, 2004, DIABETES, V53, pS190, DOI 10.2337/diabetes.53.suppl_3.S190; OKUMA Y, 1992, J BIOL CHEM, V267, P14826; Pacini G, 2010, METABOLISM, V59, P988, DOI 10.1016/j.metabol.2009.10.021; Pan ML, 2011, EXP DIABETES RES, DOI 10.1155/2011/604989; Pedersen MG, 2011, PROG BIOPHYS MOL BIO, V107, P257, DOI 10.1016/j.pbiomolbio.2011.07.012; Peercy BE, 2015, BIOPHYS J, V109, P439, DOI 10.1016/j.bpj.2015.06.024; Peercy BE, 2010, BIOPHYS J, V99, P398, DOI 10.1016/j.bpj.2010.04.043; PORTE D, 1966, J CLIN INVEST, V45, P228, DOI 10.1172/JCI105335; Prentki M, 2013, CELL METAB, V18, P162, DOI 10.1016/j.cmet.2013.05.018; Putney JW, 2009, IMMUNOL REV, V231, P10, DOI 10.1111/j.1600-065X.2009.00810.x; Pyne NJ, 2003, DIABETOLOGIA, V46, P1179, DOI 10.1007/s00125-003-1176-7; Qian J, 2014, CELL SIGNAL, V26, P2412, DOI 10.1016/j.cellsig.2014.07.019; Rajan S, 2015, MOL METAB, V4, P265, DOI 10.1016/j.molmet.2015.01.010; Rajan S, 2012, AM J PHYSIOL-ENDOC M, V302, pE714, DOI 10.1152/ajpendo.00486.2011; Raoux M, 2015, DIABETOLOGIA, V58, P749, DOI 10.1007/s00125-014-3445-z; Ravier MA, 2011, DIABETES, V60, P2533, DOI 10.2337/db10-1543; Roger B, 2011, DIABETOLOGIA, V54, P390, DOI 10.1007/s00125-010-1955-x; Rorsman P, 2012, CELL CALCIUM, V51, P300, DOI 10.1016/j.ceca.2011.11.006; Rorsman P, 2011, PROG BIOPHYS MOL BIO, V107, P224, DOI 10.1016/j.pbiomolbio.2011.06.009; Rosengren AH, 2010, SCIENCE, V327, P217, DOI 10.1126/science.1176827; Sanchez-Fernandez G, 2014, CELL SIGNAL, V26, P833, DOI 10.1016/j.cellsig.2014.01.010; Sassmann A, 2010, J CLIN INVEST, V120, P2184, DOI 10.1172/JCI41541; Saucerman JJ, 2003, J BIOL CHEM, V278, P47997, DOI 10.1074/jbc.M308362200; Sauro HM, 2004, PROG BIOPHYS MOL BIO, V86, P5, DOI 10.1016/j.pbiomolbio.2004.03.002; Schelshorn D, 2012, MOL PHARMACOL, V81, P309, DOI 10.1124/mol.111.074757; Schnell S, 2007, MOL CELL ENDOCRINOL, V263, P173, DOI 10.1016/j.mce.2006.09.013; Schofl C, 2000, ENDOCRINOLOGY, V141, P4065, DOI 10.1210/en.141.11.4065; Seifert R, 2002, N-S ARCH PHARMACOL, V366, P381, DOI 10.1007/s00210-002-0588-0; Seino S, 2005, PHYSIOL REV, V85, P1303, DOI 10.1152/physrev.00001.2005; Seino S, 2009, DIABETES OBES METAB, V11, P180, DOI 10.1111/j.1463-1326.2009.01108.x; Seino S, 2011, J CLIN INVEST, V121, P2118, DOI 10.1172/JCI45680; Seino Y, 2013, J ENDOCRINOL, DOI [10.1530/JOE-12-0579, DOI 10.1530/J0E-12-0579]; Selway J, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0033004 PONE-D-11-04940, DOI 10.1371/J0URNAL.P0NE.0033004]; Selway JL, 2012, ACTA DIABETOL, V49, P277, DOI 10.1007/s00592-011-0314-9; Shea LD, 2000, LIFE SCI, V68, P647, DOI 10.1016/S0024-3205(00)00977-2; Shenoy SK, 2003, J BIOL CHEM, V278, P14498, DOI 10.1074/jbc.M209626200; Shu LA, 2009, HUM MOL GENET, V18, P2388, DOI 10.1093/hmg/ddp178; Shyng SL, 1998, SCIENCE, V282, P1138, DOI 10.1126/science.282.5391.1138; Smolen P, 2006, BIOPHYS J, V90, P2760, DOI 10.1529/biophysj.105.072470; Smrcka AV, 2012, CELL SIGNAL, V24, P1333, DOI 10.1016/j.cellsig.2012.01.009; Sreenath SN, 2008, ESSAYS BIOCHEM, V45, P1, DOI 10.1042/BSE0450001; Srinivasan S, 2004, J CLIN INVEST, V114, P1158, DOI 10.1172/JCI200421927; Steiner D, 2005, BIOCHEM J, V386, P341, DOI 10.1042/BJ20041670; Storlien L, 2004, P NUTR SOC, V63, P363, DOI 10.1079/PNS2004349; Straub SG, 2012, AM J PHYSIOL-CELL PH, V302, pC1687, DOI 10.1152/ajpcell.00282.2011; Sunahara RK, 1997, J BIOL CHEM, V272, P22265, DOI 10.1074/jbc.272.35.22265; Sunil V, 2014, BMC PHARMACOL TOXICO, V15, DOI 10.1186/2050-6511-15-19; Suzuki Y, 2006, J BIOL CHEM, V281, P28499, DOI 10.1074/jbc.M604291200; Swayne LA, 2009, EMBO REP, V10, P873, DOI 10.1038/embor.2009.125; Syme CA, 2006, MOL ENDOCRINOL, V20, P3400, DOI 10.1210/me.2006-0178; Takeda Y, 2011, AM J PHYSIOL-CELL PH, V301, pC792, DOI 10.1152/ajpcell.00057.2011; Tamarina NA, 2005, DIABETES, V54, P3073, DOI 10.2337/diabetes.54.11.3073; Tamarina NA, 2005, AM J PHYSIOL-ENDOC M, V289, pE578, DOI 10.1152/ajpendo.00054.2005; Tamarina NA, 2008, CELL CALCIUM, V44, P533, DOI 10.1016/j.ceca.2008.03.007; Tengholm A, 2012, UPSALA J MED SCI, V117, P355, DOI 10.3109/03009734.2012.724732; Thore S, 2005, J CELL SCI, V118, P4463, DOI 10.1242/jcs.02577; Thore S, 2007, DIABETES, V56, P818, DOI 10.2337/db06-0843; Tian YR, 2001, DIABETES, V50, P2505, DOI 10.2337/diabetes.50.11.2505; Tornehave D, 2008, J HISTOCHEM CYTOCHEM, V56, P841, DOI 10.1369/jhc.2008.951319; Tsalkova T, 2009, J BIOL CHEM, V284, P23644, DOI 10.1074/jbc.M109.024950; Tsuga H, 1998, J PHARMACOL EXP THER, V284, P1218; Vanderheyden V, 2009, BBA-MOL CELL RES, V1793, P959, DOI 10.1016/j.bbamcr.2008.12.003; Varadi A, 2002, DIABETES, V51, pS190, DOI 10.2337/diabetes.51.2007.S190; Vilardaga JP, 2013, METHOD ENZYMOL, V522, P337, DOI 10.1016/B978-0-12-407865-9.00016-9; Vilardaga JP, 2010, J RECEPT SIG TRANSD, V30, P304, DOI 10.3109/10799893.2010.509728; Vines CM, 2012, ADV EXP MED BIOL, V740, P235, DOI 10.1007/978-94-007-2888-2_10; Vollert S, 2012, DIABETOLOGIA, V55, P2779, DOI 10.1007/s00125-012-2632-z; WAGNER J, 1994, BIOPHYS J, V67, P447, DOI 10.1016/S0006-3495(94)80500-4; Whalley NM, 2011, J ENDOCRINOL, V211, P99, DOI 10.1530/JOE-11-0094; Wheeler MB, 1999, J BIOL CHEM, V274, P24593, DOI 10.1074/jbc.274.35.24593; Whitaker GM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032675; WIDMANN C, 1994, MOL PHARMACOL, V45, P1029; Willard Francis S, 2012, Exp Diabetes Res, V2012, P709893, DOI 10.1155/2012/709893; Winzell MS, 2007, PHARMACOL THERAPEUT, V116, P437, DOI 10.1016/j.pharmthera.2007.08.002; Woodroffe PJ, 2010, J MATH BIOL, V60, P313, DOI 10.1007/s00285-009-0268-5; Woolf PJ, 2001, J THEOR BIOL, V208, P403, DOI 10.1006/jtbi.2000.2227; Wuttke A, 2010, J CELL SCI, V123, P1492, DOI 10.1242/jcs.060525; Xia ZG, 1997, CURR OPIN NEUROBIOL, V7, P391, DOI 10.1016/S0959-4388(97)80068-2; Xie LH, 1999, P NATL ACAD SCI USA, V96, P15292, DOI 10.1073/pnas.96.26.15292; Yabe D, 2011, PROG BIOPHYS MOL BIO, V107, P248, DOI 10.1016/j.pbiomolbio.2011.07.010; YADA T, 1995, J PHYSIOL-LONDON, V488, P13, DOI 10.1113/jphysiol.1995.sp020942; Yamazaki H, 2010, J NUTR SCI VITAMINOL, V56, P1, DOI 10.3177/jnsv.56.1; Zawalich WS, 2000, METABOLISM, V49, P1156, DOI 10.1053/meta.2000.8613; Zhou Yi-jun, 2012, Chinese Medical Sciences Journal, V27, P18; Ziegler N, 2011, BIOORGAN MED CHEM, V19, P1048, DOI 10.1016/j.bmc.2010.07.060	230	25	27	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 3	2016	11	5							e0152869	10.1371/journal.pone.0152869	http://dx.doi.org/10.1371/journal.pone.0152869			66	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DL5KK	27138453	gold, Green Submitted, Green Published			2022-12-26	WOS:000375675700008
J	Kwon, TG; Yang, TD; Lee, KJ				Kwon, Tae-goo; Yang, Taeseok Daniel; Lee, Kyoung J.			Enhancement of Chemotactic Cell Aggregation by Haptotactic Cell-To-Cell Interaction	PLOS ONE			English	Article							MIGRATION; MICROGLIA; MOVEMENT; FORCES; WAVES; MODEL; ATP; ADP	The crawling of biological cell is a complex phenomenon involving various biochemical and mechanical processes. Some of these processes are intrinsic to individual cells, while others pertain to cell-to-cell interactions and to their responses to extrinsically imposed cues. Here, we report an interesting aggregation dynamics of mathematical model cells, when they perform chemotaxis in response to an externally imposed global chemical gradient while they influence each other through a haptotaxis-mediated social interaction, which confers intriguing trail patterns. In the absence of the cell-to-cell interaction, the equilibrium population density profile fits well to that of a simple Keller-Segal population dynamic model, in which a chemotactic current density (J) over right arrow (chemo) similar to del p competes with a normal diffusive current density (J) over right arrow (diff) similar to del rho, where rho and. refer to the concentration of chemoattractant and population density, respectively. We find that the cell-to-cell interaction confers a far more compact aggregation resulting in a much higher peak equilibrium cell density. The mathematical model system is applicable to many biological systems such as swarming microglia and neutrophils or accumulating ants towards a localized food source.	[Kwon, Tae-goo; Yang, Taeseok Daniel; Lee, Kyoung J.] Korea Univ, Dept Phys, Seoul 136713, South Korea	Korea University	Lee, KJ (corresponding author), Korea Univ, Dept Phys, Seoul 136713, South Korea.	kyoung@korea.ac.kr			Ministry of Science, ICT & Future Planning (MSIP), of Korea (NRF) [2012R1A2A1A01008021]	Ministry of Science, ICT & Future Planning (MSIP), of Korea (NRF)	This work was supported by Ministry of Science, ICT & Future Planning (MSIP), of Korea (NRF grant No. 2012R1A2A1A01008021).	Angelini TE, 2010, PHYS REV LETT, V104, DOI 10.1103/PhysRevLett.104.168104; BONNER JT, 2008, SOCIAL AMOEBAE BIOL; Chtanova T, 2008, IMMUNITY, V29, P487, DOI 10.1016/j.immuni.2008.07.012; Dombrowski C, 2004, PHYS REV LETT, V93, DOI 10.1103/PhysRevLett.93.098103; Dormann D, 2001, DEVELOPMENT, V128, P4535; Dou Y, 2012, CELL RES, V22, P1022, DOI 10.1038/cr.2012.10; FETLER L, 2005, NEUROSCIENCE, V309, P329; Friedl P, 2003, NAT REV CANCER, V3, P362, DOI 10.1038/nrc1075; Goldstein RE, 1996, PHYS REV LETT, V77, P775, DOI 10.1103/PhysRevLett.77.775; Honda S, 2001, J NEUROSCI, V21, P1975, DOI 10.1523/JNEUROSCI.21-06-01975.2001; KELLER EF, 1971, J THEOR BIOL, V30, P225, DOI 10.1016/0022-5193(71)90050-6; Lammermann T, 2013, NATURE, V498, P371, DOI 10.1038/nature12175; Lee KJ, 1996, PHYS REV LETT, V76, P1174, DOI 10.1103/PhysRevLett.76.1174; Nasu-Tada K, 2005, GLIA, V52, P98, DOI 10.1002/glia.20224; Potolicchio A, 2005, J IMMUNOL, V175, P2237, DOI 10.4049/jimmunol.175.4.2237; Poujade M, 2007, P NATL ACAD SCI USA, V104, P15988, DOI 10.1073/pnas.0705062104; Puliafito A, 2012, P NATL ACAD SCI USA, V109, P739, DOI 10.1073/pnas.1007809109; Roussos ET, 2011, NAT REV CANCER, V11, P573, DOI 10.1038/nrc3078; Satulovsky J, 2008, BIOPHYS J, V94, P3671, DOI 10.1529/biophysj.107.117002; Serra-Picamal X, 2012, NAT PHYS, V8, P628, DOI [10.1038/NPHYS2355, 10.1038/nphys2355]; Shraiman BI, 2005, P NATL ACAD SCI USA, V102, P3318, DOI 10.1073/pnas.0404782102; Solon J, 2009, CELL, V137, P1331, DOI 10.1016/j.cell.2009.03.050; Thery C, 2009, NAT REV IMMUNOL, V9, P581, DOI 10.1038/nri2567; Trepat X, 2009, NAT PHYS, V5, P426, DOI 10.1038/NPHYS1269; Vincent C, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-190; Weijer CJ, 2009, J CELL SCI, V122, P3215, DOI 10.1242/jcs.036517; Yang TD, 2014, NEW J PHYS, V16, DOI 10.1088/1367-2630/16/2/023017; Yang TD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020255	28	2	2	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 29	2016	11	4							e0154717	10.1371/journal.pone.0154717	http://dx.doi.org/10.1371/journal.pone.0154717			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DK8XM	27128310	Green Submitted, gold, Green Published			2022-12-26	WOS:000375212600062
J	Blackledge, MD; Tunariu, N; Orton, MR; Padhani, AR; Collins, DJ; Leach, MO; Koh, DM				Blackledge, Matthew D.; Tunariu, Nina; Orton, Matthew R.; Padhani, Anwar R.; Collins, David J.; Leach, Martin O.; Koh, Dow-Mu			Inter- and Intra-Observer Repeatability of Quantitative Whole-Body, Diffusion-Weighted Imaging (WBDWI) in Metastatic Bone Disease	PLOS ONE			English	Article							PROSTATE-CANCER; PET/CT	Quantitative whole-body diffusion-weighted MRI (WB-DWI) is now possible using semiautomatic segmentation techniques. The method enables whole-body estimates of global Apparent Diffusion Coefficient (gADC) and total Diffusion Volume (tDV), both of which have demonstrated considerable utility for assessing treatment response in patients with bone metastases from primary prostate and breast cancers. Here we investigate the agreement (inter-observer repeatability) between two radiologists in their definition of Volumes Of Interest (VOIs) and subsequent assessment of tDV and gADC on an exploratory patient cohort of nine. Furthermore, each radiologist was asked to repeat his or her measurements on the same patient data sets one month later to identify the intra-observer repeatability of the technique. Using a Markov Chain Monte Carlo (MCMC) estimation method provided full posterior probabilities of repeatability measures along with maximum a-posteriori values and 95% confidence intervals. Our estimates of the inter-observer Intraclass Correlation Coefficient (ICCinter) for log-tDV and median gADC were 1.00 (0.97-1.00) and 0.99 (0.89-0.99) respectively, indicating excellent observer agreement for these metrics. Mean gADC values were found to have ICCinter = 0.97 (0.81-0.99) indicating a slight sensitivity to outliers in the derived distributions of gADC. Of the higher order gADC statistics, skewness was demonstrated to have good inter-user agreement with ICCinter = 0.99 (0.86-1.00), whereas gADC variance and kurtosis performed relatively poorly: 0.89 (0.39-0.97) and 0.96 (0.69-0.99) respectively. Estimates of intra-observer repeatability (ICCintra) demonstrated similar results: 0.99 (0.95-1.00) for log-tDV, 0.98 (0.89-0.99) and 0.97 (0.83-0.99) for median and mean gADC respectively, 0.64 (0.25-0.88) for gADC variance, 0.85 (0.57-0.95) for gADC skewness and 0.85 (0.57-0.95) for gADC kurtosis. Further investigation of two anomalous patient cases revealed that a very small proportion of voxels with outlying gADC values lead to instability in higher order gADC statistics. We therefore conclude that estimates of median/mean gADC and tumour volume demonstrate excellent inter-and intra-observer repeatability whilst higher order statistics of gADC should be used with caution when ascribing significance to clinical changes.	[Blackledge, Matthew D.; Tunariu, Nina; Orton, Matthew R.; Collins, David J.; Leach, Martin O.; Koh, Dow-Mu] Inst Canc Res, CR UK Canc Imaging Ctr, Radiotherapy & Imaging Div, London, England; [Blackledge, Matthew D.; Tunariu, Nina; Orton, Matthew R.; Collins, David J.; Leach, Martin O.; Koh, Dow-Mu] Royal Marsden NHS Fdn Trust, London, England; [Padhani, Anwar R.] Mt Vernon Canc Ctr, Paul Strickland Scanner Ctr, Northwood, Middx, England	Royal Marsden NHS Foundation Trust; University of London; Institute of Cancer Research - UK; Royal Marsden NHS Foundation Trust; Mount Vernon Cancer Centre	Leach, MO (corresponding author), Inst Canc Res, CR UK Canc Imaging Ctr, Radiotherapy & Imaging Div, London, England.; Leach, MO (corresponding author), Royal Marsden NHS Fdn Trust, London, England.	Martin.Leach@icr.ac.uk	leach, martin o/C-2248-2008	leach, martin o/0000-0002-0756-5368; Collins, David/0000-0001-8281-1496; Padhani, Anwar/0000-0002-5830-5777; Koh, Dow-Mu/0000-0001-7654-8011; Blackledge, Matthew/0000-0001-8117-9003; Tunariu, Nina/0000-0001-6656-3699	Cancer Research UK (CRUK); Medical Research Council [C1060/A10334, C1060/A16464]; National Institute for Health Research (NIHR) [NHR011X]; NHS; National Institute for Health Research (NIHR); Cancer Research UK [16464] Funding Source: researchfish; National Institute for Health Research [PDF-2012-05-441, NF-SI-0512-10162] Funding Source: researchfish	Cancer Research UK (CRUK)(Cancer Research UK); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); National Institute for Health Research (NIHR)(National Institute for Health Research (NIHR)); NHS; National Institute for Health Research (NIHR)(National Institute for Health Research (NIHR)); Cancer Research UK(Cancer Research UK); National Institute for Health Research(National Institute for Health Research (NIHR))	This work was supported by Cancer Research UK (CRUK) and the Medical Research Council (grant numbers C1060/A10334 and C1060/A16464 to MOL) (http://www.cancerresearchuk.org, http://www.mrc.ac.uk). This work was also supported by the National Institute for Health Research (NIHR) through postdoctoral fellowship NHR011X to MDB (www.nihr.ac.uk). MOL is an NIHR Senior Investigator. The NHS funded the NIHR Biomedicine Research Centre and the Clinical Research Facility in Imaging. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. This paper presents independent research funded by the National Institute for Health Research (NIHR). The views expressed are those of the authors and not necessarily those of the NHS, the NIHR or the Department of Health.	Ballon D, 2000, NMR BIOMED, V13, P321, DOI 10.1002/1099-1492(200010)13:6<321::AID-NBM651>3.0.CO;2-P; Blackledge MD, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091779; Blackledge MD, 2011, RADIOLOGY, V261, P573, DOI 10.1148/radiol.11101919; BLAND JM, 1986, LANCET, V1, P307, DOI 10.1016/s0140-6736(86)90837-8; De Bono JS, 2011, NEW ENGL J MED, V364, P1995, DOI 10.1056/NEJMoa1014618; Giles SL, 2014, RADIOLOGY, V271, P785, DOI 10.1148/radiol.13131529; Gutzeit A, 2010, SKELETAL RADIOL, V39, P333, DOI 10.1007/s00256-009-0789-4; Heusner TA, 2011, BRIT J RADIOL, V84, P126, DOI 10.1259/bjr/93330765; Ionan AC, 2014, BMC MED RES METHODOL, V14, DOI 10.1186/1471-2288-14-121; Komori T, 2007, ANN NUCL MED, V21, P209, DOI 10.1007/s12149-007-0010-6; Mosavi F, 2012, AM J ROENTGENOL, V199, P1114, DOI 10.2214/AJR.11.8351; Nakanishi Katsuyuki, 2007, Magn Reson Med Sci, V6, P147, DOI 10.2463/mrms.6.147; Ohno Y, 2008, RADIOLOGY, V248, P643, DOI 10.1148/radiol.2482072039; Padhani AR, 2011, RADIOLOGY, V261, P700, DOI 10.1148/radiol.11110474; Padhani AR, 2011, CANC IMAGING, V11, P129, DOI DOI 10.1102/1470-7330.2011.9034; Perez-Lopez R, 2016, RADIOLOGY; Rajpar S, 2013, CANCER J, V19, P66, DOI 10.1097/PPO.0b013e31827f123e; SHROUT PE, 1979, PSYCHOL BULL, V86, P420, DOI 10.1037/0033-2909.86.2.420; Takahara Taro, 2004, Radiat Med, V22, P275; Takahara T, 2012, J MAGN RESON IMAGING, V35, P1266, DOI 10.1002/jmri.22857; Winfield JM, 2014, PHYS MED BIOL, V59, P2235, DOI 10.1088/0031-9155/59/9/2235	21	30	30	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 28	2016	11	4							e0153840	10.1371/journal.pone.0153840	http://dx.doi.org/10.1371/journal.pone.0153840			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DK8XE	27123931	Green Submitted, gold, Green Published			2022-12-26	WOS:000375211700034
J	Gaelzer, MM; Coelho, BP; de Quadros, AH; Hoppe, JB; Terra, SR; Guerra, MCB; Usach, V; Guma, FCR; Goncalves, CAS; Setton-Avruj, P; Battastini, AMO; Salbego, CG				Gaelzer, Mariana Maier; Coelho, Barbara Paranhos; de Quadros, Alice Hoffmann; Hoppe, Juliana Bender; Terra, Silvia Resende; Barea Guerra, Maria Cristina; Usach, Vanina; Rodrigues Guma, Fatima Costa; Saraiva Goncalves, Carlos Alberto; Setton-Avruj, Patricia; Oliveira Battastini, Ana Maria; Salbego, Christianne Gazzana			Phosphatidylinositol 3-Kinase/AKT Pathway Inhibition by Doxazosin Promotes Glioblastoma Cells Death, Upregulation of p53 and Triggers Low Neurotoxicity	PLOS ONE			English	Article							O-6-METHYLGUANINE DNA-METHYLTRANSFERASE; ANTAGONIST DOXAZOSIN; KINASE INHIBITORS; GLIOMA-CELLS; CANCER-CELLS; IN-VITRO; APOPTOSIS; PROSTATE; GROWTH; TEMOZOLOMIDE	Glioblastoma is the most frequent and malignant brain tumor. Treatment includes chemotherapy with temozolomide concomitant with surgical resection and/or irradiation. However, a number of cases are resistant to temozolomide, as well as the human glioblastoma cell line U138-MG. We investigated doxazosin's (an antihypertensive drug) activity against glioblastoma cells (C6 and U138-MG) and its neurotoxicity on primary astrocytes and organoptypic hippocampal cultures. For this study, the following methods were used: citotoxicity assays, flow cytometry, western-blotting and confocal microscopy. We showed that doxazosin induces cell death on C6 and U138-MG cells. We observed that doxazosin's effects on the PI3K/Akt pathway were similar as LY294002 (PI3K specific inhibitor). In glioblastoma cells treated with doxasozin, Akt levels were greatly reduced. Upon examination of activities of proteins downstream of Akt we observed upregulation of GSK-3 beta and p53. This led to cell proliferation inhibition, cell death induction via caspase-3 activation and cell cycle arrest at G0/G1 phase in glioblastoma cells. We used in this study Lapatinib, a tyrosine kinase inhibitor, as a comparison with doxazosin because they present similar chemical structure. We also tested the neurocitotoxicity of doxazosin in primary astrocytes and organotypic cultures and observed that doxazosin induced cell death on a small percentage of non-tumor cells. Aggressiveness of glioblastoma tumors and dismal prognosis require development of new treatment agents. This includes less toxic drugs, more selective towards tumor cells, causing less damage to the patient. Therefore, our results confirm the potential of doxazosin as an attractive therapeutic antiglioma agent.	[Gaelzer, Mariana Maier; Coelho, Barbara Paranhos; Hoppe, Juliana Bender; Terra, Silvia Resende; Barea Guerra, Maria Cristina; Rodrigues Guma, Fatima Costa; Saraiva Goncalves, Carlos Alberto; Oliveira Battastini, Ana Maria; Salbego, Christianne Gazzana] Univ Fed Rio Grande do Sul, Inst Ciencias Basicas Saude, Programa Posgrad Ciencias Biol Bioquim, Porto Alegre, RS, Brazil; [de Quadros, Alice Hoffmann; Rodrigues Guma, Fatima Costa; Saraiva Goncalves, Carlos Alberto; Oliveira Battastini, Ana Maria; Salbego, Christianne Gazzana] Univ Fed Rio Grande do Sul, Dept Bioquim, Inst Ciencias Basicas Saude, Porto Alegre, RS, Brazil; [Usach, Vanina; Setton-Avruj, Patricia] Univ Buenos Aires, Fac Farm & Bioquim, Dept Quim Biol, RA-1113 Buenos Aires, DF, Argentina	Universidade Federal do Rio Grande do Sul; Universidade Federal do Rio Grande do Sul; University of Buenos Aires	Gaelzer, MM (corresponding author), Univ Fed Rio Grande do Sul, Inst Ciencias Basicas Saude, Programa Posgrad Ciencias Biol Bioquim, Porto Alegre, RS, Brazil.	marianamaierg@gmail.com	Battastini, Ana M/E-2809-2012; Setton-Avruj, Patricia/AAO-9731-2020; Guma, Fátima/G-1638-2013; Coelho, Bárbara Paranhos/AAM-9004-2020	Battastini, Ana M/0000-0001-6068-3278; Coelho, Bárbara Paranhos/0000-0002-8475-0620; Usach, Vanina/0000-0002-6599-9850; Setton-Avruj, Patricia C./0000-0002-4094-7712				Antonello A, 2005, J MED CHEM, V48, P28, DOI 10.1021/jm049153d; CARRUTHERS SG, 1994, DRUG SAFETY, V11, P12, DOI 10.2165/00002018-199411010-00003; Chen LC, 2012, MOL MED REP, V5, P575, DOI 10.3892/mmr.2011.674; Chon JK, 1999, J UROLOGY, V161, P2002, DOI 10.1016/S0022-5347(05)68873-8; Dehdashti Amir R, 2006, Neurosurg Focus, V20, pE6; El Sharkawi FZ, 2014, ASIAN PAC J CANCER P, V15, P199, DOI 10.7314/APJCP.2014.15.1.199; Fernando MA, 2005, MOL ENDOCRINOL, V19, P3085, DOI 10.1210/me.2004-0471; Garrison JB, 2006, CANCER RES, V66, P464, DOI 10.1158/0008-5472.CAN-05-2039; Giannopoulou E, 2010, INVEST NEW DRUG, V28, P554, DOI 10.1007/s10637-009-9290-0; Gottfried C, 1999, BRAIN RES, V833, P142, DOI 10.1016/S0006-8993(99)01503-6; Harry GJ, 2003, NEUROTOXICOLOGY, V24, P343, DOI 10.1016/S0161-813X(03)00039-1; Horn AP, 2005, NEUROCHEM RES, V30, P355, DOI 10.1007/s11064-005-2609-0; Hui HX, 2008, EUR J CANCER, V44, P160, DOI 10.1016/j.ejca.2007.10.002; Jhanwar-Uniyal M, 2015, CANCERS, V7, P538, DOI 10.3390/cancers7020538; KAKU DA, 1993, SCIENCE, V260, P1516, DOI 10.1126/science.8389056; KAYE B, 1986, BRIT J CLIN PHARMACO, V21, pS19, DOI 10.1111/j.1365-2125.1986.tb02849.x; Kyprianou N, 2000, CANCER RES, V60, P4550; Lepor Herbert, 2007, Rev Urol, V9, P181; Li DD, 2012, BIOORG MED CHEM LETT, V22, P5870, DOI 10.1016/j.bmcl.2012.07.079; Luo J, 2009, CANCER LETT, V273, P194, DOI 10.1016/j.canlet.2008.05.045; Nikoletopoulou V, 2013, BBA-MOL CELL RES, V1833, P3448, DOI 10.1016/j.bbamcr.2013.06.001; Nikolic K, 2013, J PHARM PHARM SCI, V16, P622, DOI 10.18433/J3JK5P; Oren M, 2003, CELL DEATH DIFFER, V10, P431, DOI 10.1038/sj.cdd.4401183; Parhi P, 2012, DRUG DISCOV TODAY, V17, P1044, DOI 10.1016/j.drudis.2012.05.010; Park MS, 2014, ONCOTARGET, V5, P4935, DOI 10.18632/oncotarget.2064; Partin JV, 2003, BRIT J CANCER, V88, P1615, DOI 10.1038/sj.bjc.6600961; Petty A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042120; Pyko IV, 2013, CARCINOGENESIS, V34, P2206, DOI 10.1093/carcin/bgt182; Rocha CRR, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.465; Rundle-Thiele D, 2015, BRIT J CLIN PHARM; Ryu CH, 2012, VALPROIC DOWNREGULAT, V2012; Sakamoto S, 2010, MOL ASPECTS MED, V31, P205, DOI 10.1016/j.mam.2010.02.001; Siddiqui EJ, 2005, ANTICANCER RES, V25, P4281; Sonoda Y, 2001, CANCER RES, V61, P6674; Sosnowski M, 2009, CENTRAL EUROPEAN J U, P62; Staudacher I, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088164; STOPPINI L, 1991, J NEUROSCI METH, V37, P173, DOI 10.1016/0165-0270(91)90128-M; Van Meir EG, 2010, CA-CANCER J CLIN, V60, P166, DOI 10.3322/caac.20069; VASHISHT R, 1992, BRIT J SURG, V79, P1285, DOI 10.1002/bjs.1800791212; Vichai V, 2006, NAT PROTOC, V1, P1112, DOI 10.1038/nprot.2006.179; VLAHOS CJ, 1994, J BIOL CHEM, V269, P5241; Vogelbaum MA, 1999, J NEUROSURG, V91, P483, DOI 10.3171/jns.1999.91.3.0483; Wandosell F, 2011, INT J ALZHEIMERS DIS, V2011, P12; Wang X, 2013, NEUROL SCI, V34, P1421, DOI 10.1007/s10072-012-1257-9; Wen PY, 2011, NEUROLOGIC COMPLICAT; Yang G, 1997, PROSTATE, V33, P157; Zhang H, 2007, INT J PHARMACEUT, V329, P122, DOI 10.1016/j.ijpharm.2006.08.027; Zhang JM, 2009, NAT REV CANCER, V9, P28, DOI 10.1038/nrc2559; Zhang YJ, 2008, CANCER RES, V68, P8733, DOI 10.1158/0008-5472.CAN-08-1968	49	15	16	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 28	2016	11	4							e0154612	10.1371/journal.pone.0154612	http://dx.doi.org/10.1371/journal.pone.0154612			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DK8XE	27123999	Green Published, Green Submitted, gold			2022-12-26	WOS:000375211700115
J	Garcia-Guerrero, E; Perez-Simon, JA; Sanchez-Abarca, LI; Diaz-Moreno, I; De la Rosa, MA; Diaz-Quintana, A				Garcia-Guerrero, Estefana; Antonio Perez-Simon, Jose; Ignacio Sanchez-Abarca, Luis; Diaz-Moreno, Irene; De la Rosa, Miguel A.; Diaz-Quintana, Antonio			The Dynamics of the Human Leukocyte Antigen Head Domain Modulates Its Recognition by the T-Cell Receptor	PLOS ONE			English	Article							MOLECULAR-DYNAMICS; ALPHA-BETA; CYTOCHROME-F; PEPTIDE RECOGNITION; CROSS-REACTIVITY; CONFORMATIONAL-CHANGES; POISSON-BOLTZMANN; TRANSIENT COMPLEX; CRYSTAL-STRUCTURE; TCR	Generating the immune response requires the discrimination of peptides presented by the human leukocyte antigen complex (HLA) through the T-cell receptor (TCR). However, how a single amino acid substitution in the antigen bonded to HLA affects the response of T cells remains uncertain. Hence, we used molecular dynamics computations to analyze the molecular interactions between peptides, HLA and TCR. We compared immunologically reactive complexes with non-reactive and weakly reactive complexes. MD trajectories were produced to simulate the behavior of isolated components of the various p-HLA-TCR complexes. Analysis of the fluctuations showed that p-HLA binding barely restrains TCR motions, and mainly affects the CDR3 loops. Conversely, inactive p-HLA complexes displayed significant drop in their dynamics when compared with its free versus ternary forms (p-HLA-TCR). In agreement, the free non-reactive p-HLA complexes showed a lower amount of salt bridges than the responsive ones. This resulted in differences between the electrostatic potentials of reactive and inactive p-HLA species and larger vibrational entropies in non-elicitor complexes. Analysis of the ternary p-HLA-TCR complexes also revealed a larger number of salt bridges in the responsive complexes. To summarize, our computations indicate that the affinity of each p-HLA complex towards TCR is intimately linked to both, the dynamics of its free species and its ability to form specific intermolecular salt-bridges in the ternary complexes. Of outstanding interest is the emerging concept of antigen reactivity involving its interplay with the HLA head sidechain dynamics by rearranging its salt-bridges.	[Garcia-Guerrero, Estefana; Antonio Perez-Simon, Jose] Univ Seville, CSIC, Inst Biomed Sevilla IBIS, Hosp Univ Virgen del Rocio, Seville, Spain; [Ignacio Sanchez-Abarca, Luis] Hosp Univ Salamanca, Serv Hematol, Salamanca, Spain; [Diaz-Moreno, Irene; De la Rosa, Miguel A.; Diaz-Quintana, Antonio] Univ Seville, CSIC, cicCartuja, Inst Bioquim Vegetal & Fotosintesis, Seville, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); University of Sevilla; CSIC-JA-USE - Instituto de Biomedicina de Sevilla (IBIS); Virgen del Rocio University Hospital; University of Salamanca; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC-JA-USE - Centro de Investigaciones Cientificas Isla de La Cartuja (CICIC); University of Sevilla; CSIC - Instituto de Bioquimica Vegetal y Fotosintesis (IBVF)	Perez-Simon, JA (corresponding author), Univ Seville, CSIC, Inst Biomed Sevilla IBIS, Hosp Univ Virgen del Rocio, Seville, Spain.; Diaz-Quintana, A (corresponding author), Univ Seville, CSIC, cicCartuja, Inst Bioquim Vegetal & Fotosintesis, Seville, Spain.	josea.perez.simon.sspa@juntadeandalucia.es; qzaida@us.es	De la Rosa, Miguel/B-2545-2014; Díaz-Moreno, Irene/E-7181-2010; Díaz-Quintana, Antonio/A-1946-2011	De la Rosa, Miguel/0000-0003-1187-5737; Díaz-Moreno, Irene/0000-0002-5318-7644; Díaz-Quintana, Antonio/0000-0001-8973-8009; Perez-Simon, Jose A/0000-0003-3616-6101; Garcia-Guerrero, Estefania/0000-0002-3041-9860; PEREZ-SIMON, JOSE-ANTONIO/0000-0002-0621-5809	Spanish Ministry of Economy and Competiveness [BFU2012-31670/BMC]; Andalusian Government [BIO198]; Spanish Fund for Health Research (FIS) [PI11/02366, FI12/00189]; Ramon Areces Foundation	Spanish Ministry of Economy and Competiveness(Spanish Government); Andalusian Government; Spanish Fund for Health Research (FIS); Ramon Areces Foundation	Financial support was provided by the Spanish Ministry of Economy and Competiveness (Grant No. BFU2012-31670/BMC), http://www.mineco.gob.es/portal/site/mineco/idi; The Andalusian Government (Grant PAI, BIO198), http://www.juntadeandalucia.es/organismos/economiayconocimiento.html; The Spanish Fund for Health Research (FIS; code PI11/02366, FI12/00189), http://www.isciii.es/ISCIII/es/contenidos/fd-el-instituto/fd-organizacion/fd-estructura-directiva/fd-subdireccion-general-servicios-aplicados-formacion-investigacion/fd-centros-unidades/fd-investen-isciii-2/investigacion_investen.shtml; and the Ramon Areces Foundation, http://www.fundacionareces.es/fundacionareces/portal.do?IDM=166&NM=2&TR=C&IDR=1350. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Archbold JK, 2009, J EXP MED, V206, P209, DOI 10.1084/jem.20082136; Armstrong KM, 2008, BIOCHEM J, V415, P183, DOI 10.1042/BJ20080850; Aroca A, 2011, FEBS LETT, V585, P2958, DOI 10.1016/j.febslet.2011.07.037; Baker BM, 2000, IMMUNITY, V13, P475, DOI 10.1016/S1074-7613(00)00047-9; Baxter TK, 2004, J BIOL CHEM, V279, P29175, DOI 10.1074/jbc.M403372200; BENTLEY GA, 1995, SCIENCE, V267, P1984, DOI 10.1126/science.7701320; BERENDSEN HJC, 1984, J CHEM PHYS, V81, P3684, DOI 10.1063/1.448118; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Borbulevych OY, 2009, IMMUNITY, V31, P885, DOI 10.1016/j.immuni.2009.11.003; Bruce A., 2002, MOL BIOL CELL, V4th ed.; Case D, 2006, AMBER 9; Crowley PB, 2001, J AM CHEM SOC, V123, P10444, DOI 10.1021/ja0112700; Cruz-Gallardo I, 2012, FEBS LETT, V586, P646, DOI 10.1016/j.febslet.2011.08.035; Cuendet MA, 2008, BIOPHYS J, V95, P3575, DOI 10.1529/biophysj.108.131383; Davis MM, 1998, ANNU REV IMMUNOL, V16, P523, DOI 10.1146/annurev.immunol.16.1.523; Diaz-Moreno I, 2005, FEBS LETT, V579, P2891, DOI 10.1016/j.febslet.2005.04.031; Diaz-Moreno I, 2005, J BIOL CHEM, V280, P7925, DOI 10.1074/jbc.M412422200; Diaz-Moreno I, 2009, BIOELECTROCHEMISTRY, V77, P43, DOI 10.1016/j.bioelechem.2009.06.003; Diaz-Quintana A, 2016, SER BIOPHYS, P35; Ding YH, 1999, IMMUNITY, V11, P45, DOI 10.1016/S1074-7613(00)80080-1; Ding YH, 1998, IMMUNITY, V8, P403, DOI 10.1016/S1074-7613(00)80546-4; Duan Y, 2003, J COMPUT CHEM, V24, P1999, DOI 10.1002/jcc.10349; Fabian H, 2010, ARTHRITIS RHEUM-US, V62, P978, DOI 10.1002/art.27316; Fabian H, 2008, J MOL BIOL, V376, P798, DOI 10.1016/j.jmb.2007.12.009; FIELDS BA, 1995, SCIENCE, V270, P1821, DOI 10.1126/science.270.5243.1821; Garboczi DN, 1996, NATURE, V384, P134, DOI 10.1038/384134a0; Garboczi DN, 1996, J IMMUNOL, V157, P5403; Garcia KC, 1998, SCIENCE, V279, P1166, DOI 10.1126/science.279.5354.1166; Garcia KC, 1996, SCIENCE, V274, P209, DOI 10.1126/science.274.5285.209; Garcia-Sanchez MI, 2000, J BIOL INORG CHEM, V5, P713, DOI 10.1007/s007750000160; Hansson T, 2002, CURR OPIN STRUC BIOL, V12, P190, DOI 10.1016/S0959-440X(02)00308-1; Hausmann S, 1999, J IMMUNOL, V162, P5389; Hawse WF, 2013, J BIOL CHEM, V288, P24372, DOI 10.1074/jbc.M113.490664; Housset D, 1997, EMBO J, V16, P4205, DOI 10.1093/emboj/16.14.4205; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; Karplus M, 2003, BIOPOLYMERS, V68, P350, DOI 10.1002/bip.10266; Kessler B, 1999, J BIOL CHEM, V274, P3622, DOI 10.1074/jbc.274.6.3622; Lill MA, 2011, BIOCHEMISTRY-US, V50, P6157, DOI 10.1021/bi2004558; Manning TC, 1998, IMMUNITY, V8, P413, DOI 10.1016/S1074-7613(00)80547-6; Mason D, 1998, IMMUNOL TODAY, V19, P395, DOI 10.1016/S0167-5699(98)01299-7; Mazza C, 2007, SEMIN IMMUNOL, V19, P225, DOI 10.1016/j.smim.2007.03.003; Mazza C, 2007, EMBO J, V26, P1972, DOI 10.1038/sj.emboj.7601605; Michielin O, 2002, J MOL BIOL, V324, P547, DOI 10.1016/S0022-2836(02)00880-X; NICHOLLS A, 1991, J COMPUT CHEM, V12, P435, DOI 10.1002/jcc.540120405; Nooren IMA, 2003, EMBO J, V22, P3486, DOI 10.1093/emboj/cdg359; Pohlmann T, 2004, J BIOL CHEM, V279, P28197, DOI 10.1074/jbc.C400128200; Reboul CF, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002404; Reiser JB, 2003, NAT IMMUNOL, V4, P241, DOI 10.1038/ni891; Reiser JB, 2002, IMMUNITY, V16, P345, DOI 10.1016/S1074-7613(02)00288-1; RYCKAERT JP, 1977, J COMPUT PHYS, V23, P327, DOI 10.1016/0021-9991(77)90098-5; Schlarb-Ridley BG, 2002, BIOCHEMISTRY-US, V41, P3279, DOI 10.1021/bi0116588; Scott DR, 2011, J MOL BIOL, V414, P385, DOI 10.1016/j.jmb.2011.10.006; SloanLancaster J, 1996, ANNU REV IMMUNOL, V14, P1, DOI 10.1146/annurev.immunol.14.1.1; Stavrakoudis A, 2011, CELL BIOCHEM BIOPHYS, V60, P283, DOI 10.1007/s12013-011-9151-2; van der Merwe PA, 2003, ANNU REV IMMUNOL, V21, P659, DOI 10.1146/annurev.immunol.21.120601.141036; Wan SZ, 2005, J IMMUNOL, V175, P1715, DOI 10.4049/jimmunol.175.3.1715; Wan SZ, 2005, PHILOS T R SOC A, V363, P2037, DOI 10.1098/rsta.2005.1627; Wang B, 2013, J CHEM INF MODEL, V53, P2659, DOI 10.1021/ci400312v; Wang JH, 1998, EMBO J, V17, P10, DOI 10.1093/emboj/17.1.10; Wolfson MY, 2011, J PHYS CHEM B, V115, P8317, DOI 10.1021/jp202471d; Xia Z, 2014, SCI REP-UK, V4, DOI 10.1038/srep04087	62	2	2	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 28	2016	11	4							e0154219	10.1371/journal.pone.0154219	http://dx.doi.org/10.1371/journal.pone.0154219			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DK8XE	27124285	Green Published, Green Submitted, gold			2022-12-26	WOS:000375211700056
J	Palace, M; Sullivan, FB; Ducey, M; Herrick, C				Palace, Michael; Sullivan, Franklin B.; Ducey, Mark; Herrick, Christina			Estimating Tropical Forest Structure Using a Terrestrial Lidar	PLOS ONE			English	Article							WAVE-FORM LIDAR; LEAF-AREA INDEX; CANOPY STRUCTURE; AMAZON FOREST; BIOMASS; PROFILES; LIGHT; TREES; RECONSTRUCTION; ECOSYSTEMS	Forest structure comprises numerous quantifiable biometric components and characteristics, which include tree geometry and stand architecture. These structural components are important in the understanding of the past and future trajectories of these biomes. Tropical forests are often considered the most structurally complex and yet least understood of forested ecosystems. New technologies have provided novel avenues for quantifying biometric properties of forested ecosystems, one of which is LIght Detection And Ranging (lidar). This sensor can be deployed on satellite, aircraft, unmanned aerial vehicles, and terrestrial platforms. In this study we examined the efficacy of a terrestrial lidar scanner (TLS) system in a tropical forest to estimate forest structure. Our study was conducted in January 2012 at La Selva, Costa Rica at twenty locations in a predominantly undisturbed forest. At these locations we collected field measured biometric attributes using a variable plot design. We also collected TLS data from the center of each plot. Using this data we developed relative vegetation profiles (RVPs) and calculated a series of parameters including entropy, Fast Fourier Transform (FFT), number of layers and plant area index to develop statistical relationships with field data. We developed statistical models using a series of multiple linear regressions, all of which converged on significant relationships with the strongest relationship being for mean crown depth (r(2) = 0.88, p < 0.001, RMSE = 1.04 m). Tree density was found to have the poorest significant relationship (r(2) = 0.50, p < 0.01, RMSE = 153.28 n ha(-1)). We found a significant relationship between basal area and lidar metrics (r(2) = 0.75, p < 0.001, RMSE = 3.76 number ha(-1)). Parameters selected in our models varied, thus indicating the potential relevance of multiple features in canopy profiles and geometry that are related to field-measured structure. Models for biomass estimation included structural canopy variables in addition to height metrics. Our work indicates that vegetation profiles from TLS data can provide useful information on forest structure.	[Palace, Michael; Sullivan, Franklin B.; Herrick, Christina] Univ New Hampshire, Inst Study Earth Oceans & Space, Earth Syst Res Ctr, Durham, NH 03824 USA; [Palace, Michael] Univ New Hampshire, Dept Earth Sci, Durham, NH 03824 USA; [Ducey, Mark] Univ New Hampshire, Dept Nat Resources, Durham, NH 03824 USA	University System Of New Hampshire; University of New Hampshire; University System Of New Hampshire; University of New Hampshire; University System Of New Hampshire; University of New Hampshire	Palace, M (corresponding author), Univ New Hampshire, Inst Study Earth Oceans & Space, Earth Syst Res Ctr, Durham, NH 03824 USA.; Palace, M (corresponding author), Univ New Hampshire, Dept Earth Sci, Durham, NH 03824 USA.	michael.palace@unh.edu	Herrick, Christina/O-3375-2017; Herrick, Christina/O-4873-2019; Ducey, Mark/K-1101-2016	Herrick, Christina/0000-0002-8384-9450; Herrick, Christina/0000-0002-8384-9450; Ducey, Mark/0000-0002-2027-1188	National Aeronautics and Space Administration (NASA) [NNX10AQ82G, NNX08AL29G, NNX14AD31G]; United States Agency for International Development (USAID) [12DG11132762416]; NASA New Investigators in Earth Science [NNX10AQ82G]; NASA Terrestrial Ecology [NNX08AL29G]; NASA IDS [NNX14AD31G]; USAID [12DG11132762416]	National Aeronautics and Space Administration (NASA)(National Aeronautics & Space Administration (NASA)); United States Agency for International Development (USAID)(United States Agency for International Development (USAID)CGIAR); NASA New Investigators in Earth Science; NASA Terrestrial Ecology; NASA IDS; USAID(United States Agency for International Development (USAID))	This research was supported by National Aeronautics and Space Administration (NASA) New Investigators in Earth Science (NNX10AQ82G), National Aeronautics and Space Administration (NASA) Terrestrial Ecology (NNX08AL29G), National Aeronautics and Space Administration (NASA) IDS (NNX14AD31G) and United States Agency for International Development (USAID) (12DG11132762416).; This research was supported by NASA New Investigators in Earth Science (NNX10AQ82G), NASA Terrestrial Ecology (NNX08AL29G), NASA IDS (NNX14AD31G) and USAID (12DG11132762416). We thank La Selva Research Station for accommodations and use of their GIS data. We also thank Julia Shimbo and Jonas Mota e Silva for aid in field work. We also thank three anonymous reviewers for their effort and time that made this paper much improved.	Asner GP, 2002, BIOTROPICA, V34, P483, DOI 10.1111/j.1744-7429.2002.tb00568.x; Asner Gregory P, 2013, Carbon Balance Manag, V8, P7, DOI 10.1186/1750-0680-8-7; Asner GP, 2011, ENVIRON RES LETT, V6, DOI 10.1088/1748-9326/6/2/021002; Astrup R, 2014, CAN J FOREST RES, V44, P666, DOI 10.1139/cjfr-2013-0535; BAILEY RL, 1973, FOREST SCI, V19, P97; Banin L, 2012, GLOBAL ECOL BIOGEOGR, V21, P1179, DOI 10.1111/j.1466-8238.2012.00778.x; Berenguer E, 2014, GLOBAL CHANGE BIOL, V20, P3713, DOI 10.1111/gcb.12627; Bitterlich W., 1984, RELASCOPE IDEA RELAT; Broadbent EN, 2008, FOREST ECOL MANAG, V255, P2602, DOI 10.1016/j.foreco.2008.01.044; Brown S., 1997, FAO Forestry Paper; Bustamante MMC, 2016, GLOBAL CHANGE BIOL, V22, P92, DOI 10.1111/gcb.13087; Calders K, 2014, AGR FOREST METEOROL, V194, P104, DOI 10.1016/j.agrformet.2014.03.022; Chambers JQ, 2007, TRENDS ECOL EVOL, V22, P414, DOI 10.1016/j.tree.2007.05.001; Chave J, 2005, OECOLOGIA, V145, P87, DOI 10.1007/s00442-005-0100-x; Claeskens G, 2008, MODEL SELECTION MODE, V330; Clark DB, 2000, FOREST ECOL MANAG, V137, P185, DOI 10.1016/S0378-1127(99)00327-8; De Liocourt F., 1898, B SOC FORESTIERE FRA, V4, P396; Detto M, 2015, J GEOPHYS RES-BIOGEO, V120, P294, DOI 10.1002/2014JG002774; Donev A, 2004, SCIENCE, V303, P990, DOI 10.1126/science.1093010; Douglas E, 2012, P INT GEOSC REM SENS, P1; Drake JB, 2002, REMOTE SENS ENVIRON, V79, P305, DOI 10.1016/S0034-4257(01)00281-4; Drake JB, 2002, REMOTE SENS ENVIRON, V81, P378, DOI 10.1016/S0034-4257(02)00013-5; Dubayah RO, 2010, J GEOPHYS RES-BIOGEO, V115, DOI 10.1029/2009JG000933; Ducey MJ, 2014, INT GEOSCI REMOTE SE, P5052, DOI 10.1109/IGARSS.2014.6947632; Ducey MJ, 2013, CAN J REMOTE SENS, V39, P410, DOI 10.5589/m13-048; Ducey MJ, 2013, PHOTOGRAMM ENG REM S, V79, P245, DOI 10.14358/PERS.79.3.245; Espirito-Santo FDB, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4434; Feldpausch TR, 2011, BIOGEOSCIENCES, V8, P1081, DOI 10.5194/bg-8-1081-2011; Franklin JF, 2002, FOREST ECOL MANAG, V155, P399, DOI 10.1016/S0378-1127(01)00575-8; Frolking S, 2009, J GEOPHYS RES-BIOGEO, V114, DOI 10.1029/2008JG000911; Garcia M, 2010, REMOTE SENS ENVIRON, V114, P816, DOI 10.1016/j.rse.2009.11.021; Green GM, 2013, PHOTOGRAMM ENG REM S, V79, P185, DOI 10.14358/PERS.79.2.185; Gregoire TG, 1998, CAN J FOREST RES, V28, P1429, DOI 10.1139/cjfr-28-10-1429; Hanus ML, 1998, FOREST SCI, V44, P125; Harding DJ, 2001, REMOTE SENS ENVIRON, V76, P283, DOI 10.1016/S0034-4257(00)00210-8; Henning JG, 2006, PHOTOGRAMM ENG REM S, V72, P1349, DOI 10.14358/PERS.72.12.1349; Henning JG, 2006, FOREST SCI, V52, P67; Hunter MO, 2013, BIOGEOSCIENCES, V10, P8385, DOI 10.5194/bg-10-8385-2013; Hurtt G, 2003, REMOTE SENS ENVIRON, V88, P111, DOI 10.1016/j.rse.2003.04.004; Husch B., 2003, FOREST MENSURATION, V4th; Jensen JLR, 2008, REMOTE SENS ENVIRON, V112, P3947, DOI 10.1016/j.rse.2008.07.001; Keller M, 2001, FOREST ECOL MANAG, V154, P371, DOI 10.1016/S0378-1127(01)00509-6; Kenworthy MA, 2015, ASTROPHYS J, V800, DOI 10.1088/0004-637X/800/2/126; Lefsky MA, 2005, GEOPHYS RES LETT, V32, DOI 10.1029/2005GL023971; Lefsky MA, 1999, REMOTE SENS ENVIRON, V70, P339, DOI 10.1016/S0034-4257(99)00052-8; Lefsky MA, 2006, GEOPHYS RES LETT, V33, DOI 10.1029/2005GL025518; Lovell JL, 2011, SILVILASER 2011 OCT; MACARTHUR R H, 1969, Ecology (Washington D C), V50, P802, DOI 10.2307/1933693; MacLean RG, 2014, FOREST SCI, V60, P206, DOI 10.5849/forsci.12-072; Mamajek EE, 2012, ASTRON J, V143, DOI 10.1088/0004-6256/143/3/72; Marshall DD, 2004, CAN J FOREST RES, V34, P840, DOI [10.1139/x03-240, 10.1139/X03-240]; Maynard DS, 2014, FOREST SCI, V59, P681; McDade Lucinda A., 1994, P6; Means JE, 1999, REMOTE SENS ENVIRON, V67, P298, DOI 10.1016/S0034-4257(98)00091-1; Meyer H. A., 1943, Journal of Forestry, V41, P126; MEYER H. ARTHUR, 1952, JOUR FOREST, V50, P85; Meyer HA, 1943, J AGRIC RES, V67, P0465; Montgomery RA, 2001, ECOLOGY, V82, P2707, DOI 10.1890/0012-9658(2001)082[2707:FSCAAL]2.0.CO;2; Morton DC, 2014, NATURE, V506, P221, DOI 10.1038/nature13006; Nelson R., 2004, SCANDINAVIAN J FORES, V19, P247; Oliver C.D., 1996, FOREST STAND DYNAMIC; Palace M, 2008, BIOTROPICA, V40, P141, DOI 10.1111/J.1744-7429.2007.00353.x; Palace MW, 2015, REMOTE SENS ENVIRON, V161, P1, DOI 10.1016/j.rse.2015.01.020; Rice AH, 2004, ECOL APPL, V14, pS55, DOI 10.1890/02-6006; Srinivasan S, 2014, FOREST ECOL MANAG, V318, P304, DOI 10.1016/j.foreco.2014.01.038; Stark SC, 2012, ECOL LETT, V15, P1406, DOI 10.1111/j.1461-0248.2012.01864.x; Strahler AH, 2008, CAN J REMOTE SENS, V34, pS426, DOI 10.5589/m08-046; Sudarchana, 2012, REV GROUND NECROMASS; Sullivan FB, 2014, REMOTE SENS ENVIRON, V154, P368, DOI 10.1016/j.rse.2014.04.027; Tang H, 2014, REMOTE SENS ENVIRON, V154, P8, DOI 10.1016/j.rse.2014.08.007; Tang H, 2012, REMOTE SENS ENVIRON, V124, P242, DOI 10.1016/j.rse.2012.05.005; TERBORGH J, 1985, AM NAT, V126, P760, DOI 10.1086/284452; Treuhaft RN, 2010, GEOPHYS RES LETT, V37, DOI 10.1029/2010GL045608; Treuhaft R, 2015, IEEE GEOSCI REMOTE S, V12, P239, DOI 10.1109/LGRS.2014.2334140; van Leeuwen M, 2013, REMOTE SENS ENVIRON, V136, P286, DOI 10.1016/j.rse.2013.04.019; Vierling KT, 2008, FRONT ECOL ENVIRON, V6, P90, DOI 10.1890/070001; Vierling LA, 2002, GEOSC REM SENS S 200, V5; Weitz DA, 2004, SCIENCE, V303, P968, DOI 10.1126/science.1094581; Whitehurst AS, 2013, REMOTE SENS-BASEL, V5, P2014, DOI 10.3390/rs5042014; Whitmore T. C., 1982, The plant community as a working mechanism., P45; Wilson J. W, 1960, NEW PHYTOL, V59, P1, DOI [10.1111/J.1469-8137.1960.tb06195.x, DOI 10.1111/J.1469-8137.1960.TB06195.X]; Yang XY, 2013, INT GEOSCI REMOTE SE, P3375, DOI 10.1109/IGARSS.2013.6723552; Yao T, 2011, REMOTE SENS ENVIRON, V115, P2965, DOI 10.1016/j.rse.2010.03.019	83	31	32	3	52	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 28	2016	11	4							e0154115	10.1371/journal.pone.0154115	http://dx.doi.org/10.1371/journal.pone.0154115			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DK8XE	27124295	Green Submitted, Green Published, gold			2022-12-26	WOS:000375211700047
J	Patel, RR; Unnikrishnan, H; Donohue, KD				Patel, Rita R.; Unnikrishnan, Harikrishnan; Donohue, Kevin D.			Effects of Vocal Fold Nodules on Glottal Cycle Measurements Derived from High-Speed Videoendoscopy in Children	PLOS ONE			English	Article							IMPACT STRESS; SPATIOTEMPORAL ANALYSIS; VIBRATIONS; PATHOLOGY; QUOTIENT; AREA; FLOW; WAVE	The goal of this study is to quantify the effects of vocal fold nodules on vibratory motion in children using high-speed videoendoscopy. Differences in vibratory motion were evaluated in 20 children with vocal fold nodules (5-11 years) and 20 age and gender matched typically developing children (5-11 years) during sustained phonation at typical pitch and loudness. Normalized kinematic features of vocal fold displacements from the mid-membranous vocal fold point were extracted from the steady-state high-speed video. A total of 12 kinematic features representing spatial and temporal characteristics of vibratory motion were calculated. Average values and standard deviations (cycle-to-cycle variability) of the following kinematic features were computed: normalized peak displacement, normalized average opening velocity, normalized average closing velocity, normalized peak closing velocity, speed quotient, and open quotient. Group differences between children with and without vocal fold nodules were statistically investigated. While a moderate effect size was observed for the spatial feature of speed quotient, and the temporal feature of normalized average closing velocity in children with nodules compared to vocally normal children, none of the features were statistically significant between the groups after Bonferroni correction. The kinematic analysis of the mid-membranous vocal fold displacement revealed that children with nodules primarily differ from typically developing children in closing phase kinematics of the glottal cycle, whereas the opening phase kinematics are similar. Higher speed quotients and similar opening phase velocities suggest greater relative forces are acting on vocal fold in the closing phase. These findings suggest that future large-scale studies should focus on spatial and temporal features related to the closing phase of the glottal cycle for differentiating the kinematics of children with and without vocal fold nodules.	[Patel, Rita R.] Indiana Univ, Dept Speech & Hearing Sci, Bloomington, IN 47405 USA; [Unnikrishnan, Harikrishnan; Donohue, Kevin D.] Univ Kentucky, Dept Elect & Comp Engn, Lexington, KY USA	Indiana University System; Indiana University Bloomington; University of Kentucky	Patel, RR (corresponding author), Indiana Univ, Dept Speech & Hearing Sci, Bloomington, IN 47405 USA.	patelrir@indiana.edu	Patel, Rita/ABC-2626-2021	Patel, Rita/0000-0002-5354-5210	National Institutes of Health, National Institute of Deafness and Communication Disorders [DC11360]	National Institutes of Health, National Institute of Deafness and Communication Disorders(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	This work was supported by the National Institutes of Health, National Institute of Deafness and Communication Disorders, DC11360. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Behrman A, 1996, J VOICE, V10, P269, DOI 10.1016/S0892-1997(96)80008-7; Chodara AM, 2012, LARYNGOSCOPE, V122, P58, DOI 10.1002/lary.22324; Cohen J., 1988, STATISTICAL POWER AN, DOI DOI 10.1234/12345678; Connor NP, 2008, J VOICE, V22, P197, DOI 10.1016/j.jvoice.2006.09.005; Coyle SM, 2001, J VOICE, V15, P424, DOI 10.1016/S0892-1997(01)00043-1; Dejonckere PH, 2009, FOLIA PHONIATR LOGO, V61, P171, DOI 10.1159/000219952; Dollinger M, 2012, LARYNGOSCOPE, V122, P2511, DOI 10.1002/lary.23568; Fritz CO, 2012, J EXP PSYCHOL GEN, V141, P2, DOI 10.1037/a0024338; Martins RHG, 2012, J VOICE, V26, DOI 10.1016/j.jvoice.2012.03.004; Gonzalez R., 2001, DIGITAL IMAGE PROCES, V2; Gunter HE, 2004, J BIOMECH, V37, P1119, DOI 10.1016/j.jbiomech.2003.11.007; Hartnick CJ, 2005, LARYNGOSCOPE, V115, P4, DOI 10.1097/01.mlg.0000150685.54893.e9; Hertegard Stellan, 2005, Curr Opin Otolaryngol Head Neck Surg, V13, P152, DOI 10.1097/01.moo.0000163451.98079.ba; Hirano M, 1983, GROWTH DEV AGING HUM, P22; HUFNAGLE J, 1982, PERCEPT MOTOR SKILL, V55, P427, DOI 10.2466/pms.1982.55.2.427; Jiang JJ, 2001, J VOICE, V15, P4, DOI 10.1016/S0892-1997(01)00002-9; KAHANE JC, 1978, AM J ANAT, V151, P11, DOI 10.1002/aja.1001510103; Krausert CR, 2012, AM J OTOLARYNG, V33, P641, DOI 10.1016/j.amjoto.2012.01.002; LASS NJ, 1991, J COMMUN DISORD, V24, P267, DOI 10.1016/0021-9924(91)90002-Z; LEEPER HA, 1976, J COMMUN DISORD, V9, P83, DOI 10.1016/0021-9924(76)90032-0; Lohscheller J, 2008, LARYNGOSCOPE, V118, P753, DOI 10.1097/MLG.0b013e318161f9e1; Lohscheller J, 2013, LOGOP PHONIATR VOCO, V38, P182, DOI 10.3109/14015439.2012.731083; Nuss RC, 2012, ANN OTO RHINOL LARYN, V121, P1; Patel R, 2008, ANN OTO RHINOL LARYN, V117, P413, DOI 10.1177/000348940811700603; Patel R, 2015, J SPEECH LANG HEAR R, V58, P227, DOI 10.1044/2015_JSLHR-S-13-0056; Patel R, 2014, J SPEECH LANG HEAR R, V57, pS674, DOI 10.1044/2014_JSLHR-S-12-0278; Patel RR, 2014, J VOICE, V28, P476, DOI 10.1016/j.jvoice.2013.12.010; Patel RR, 2013, J VOICE, V27, P463, DOI 10.1016/j.jvoice.2013.03.004; Patel RR, 2012, INT J PEDIATR OTORHI, V76, P954, DOI 10.1016/j.ijporl.2012.03.004; Patel RR, 2011, LARYNGOSCOPE, V121, P2411, DOI 10.1002/lary.22325; Ruddy BH, 2004, LANG SPEECH HEAR SER, V35, P327, DOI 10.1044/0161-1461(2004/032); SCHERER R C, 1982, Journal of the Acoustical Society of America, V71, pS55, DOI 10.1121/1.2019452; SENTURIA BH, 1968, ANN OTO RHINOL LARYN, V77, P1027, DOI 10.1177/000348946807700603; SILVERMAN EM, 1975, J SPEECH HEAR DISORD, V40, P211, DOI 10.1044/jshd.4002.211; TIMCKE R, 1958, ARCHIV OTOLARYNGOL, V68, P1; Titze, 1994, PRINCIPLES VOICE PRO; TITZE IR, 1984, J ACOUST SOC AM, V75, P570, DOI 10.1121/1.390530; Titze IR, 2006, J SPEECH LANG HEAR R, V49, P439, DOI 10.1044/1092-4388(2006/034); TITZE IR, 1994, J VOICE, V8, P99, DOI 10.1016/S0892-1997(05)80302-9; Unnikrishnan H, 2012, P INT SOC OPT PHOT S, V8207, p1Q; Verdolini K, 1998, J VOICE, V12, P415, DOI 10.1016/S0892-1997(98)80050-7; Verdolini K, 1999, J VOICE, V13, P184, DOI 10.1016/S0892-1997(99)80022-8; VON LEDEN H., 1960, ARCH OTOLARYNGOL, V71, P16; Wilson DK., 1987, VOICE PROBLEMS CHILD; Wolf M, 2005, INT J PEDIATR OTORHI, V69, P1077, DOI 10.1016/j.ijporl.2005.03.004; Yamauchi A., 2015, J VOICE	46	15	15	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 28	2016	11	4							e0154586	10.1371/journal.pone.0154586	http://dx.doi.org/10.1371/journal.pone.0154586			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DK8XE	27124157	Green Published, Green Submitted, gold			2022-12-26	WOS:000375211700106
J	Sewastianik, T; Szydlowski, M; Jablonska, E; Bialopiotrowicz, E; Kiliszek, P; Gorniak, P; Polak, A; Prochorec-Sobieszek, M; Szumera-Cieckiewicz, A; Kaminski, TS; Markowicz, S; Nowak, E; Grygorowicz, MA; Warzocha, K; Juszczynski, P				Sewastianik, T.; Szydlowski, M.; Jablonska, E.; Bialopiotrowicz, E.; Kiliszek, P.; Gorniak, P.; Polak, A.; Prochorec-Sobieszek, M.; Szumera-Cieckiewicz, A.; Kaminski, T. S.; Markowicz, S.; Nowak, E.; Grygorowicz, M. A.; Warzocha, K.; Juszczynski, P.			FOXO1 is a TXN- and p300-dependent sensor and effector of oxidative stress in diffuse large B-cell lymphomas characterized by increased oxidative metabolism	ONCOGENE			English	Article							TRANSCRIPTION FACTOR; HYDROGEN-PEROXIDE; THIOREDOXIN; EXPRESSION; APOPTOSIS; SURVIVAL; INHIBITOR; PATHWAYS; CANCER; GENE	Molecular profiling has led to identification of subtypes of diffuse large B-cell lymphomas (DLBCLs) differing in terms of oncogenic signaling and metabolic programs. The OxPhos-DLBCL subtype is characterized by enhanced mitochondrial oxidative phosphorylation. As increased oxidative metabolism leads to overproduction of potentially toxic reactive oxygen species (ROS), we sought to identify mechanisms responsible for adaptation of OxPhos cells to these conditions. Herein, we describe a mechanism involving the FOXO1-TXN-p300 redox-dependent circuit protecting OxPhos-DLBCL cells from ROS toxicity. We identify a BCL6-dependent transcriptional mechanism leading to relative TXN overexpression in OxPhos cells. We found that OxPhos cells lacking TXN were uniformly more sensitive to ROS and doxorubicin than control cells. Consistent with this, the overall survival of patients with high TXN mRNA expression, treated with doxorubicin-containing regimens, is significantly shorter than of those with low TXN mRNA expression. TXN overexpression curtails p300-mediated FOXO1 acetylation and its nuclear translocation in response to oxidative stress, thus attenuating FOXO1 transcriptional activity toward genes involved in apoptosis and cell cycle inhibition. We also demonstrate that FOXO1 knockdown in cells with silenced TXN expression markedly reduces ROS-induced apoptosis, indicating that FOXO1 is the major sensor and effector of oxidative stress in OxPhos-DLBCLs. These data highlight dynamic, context-dependent modulation of FOXO1 tumor-suppressor functions via acetylation and reveal potentially targetable vulnerabilities in these DLBCLs.	[Sewastianik, T.; Szydlowski, M.; Jablonska, E.; Bialopiotrowicz, E.; Kiliszek, P.; Gorniak, P.; Polak, A.; Prochorec-Sobieszek, M.; Szumera-Cieckiewicz, A.; Juszczynski, P.] Inst Hematol & Transfus Med, Dept Diagnost Hematol, Indiry Gandhi 14, PL-02776 Warsaw, Poland; [Kaminski, T. S.] Polish Acad Sci, Inst Phys Chem, Dept Soft Condensed Matter, Warsaw, Poland; [Markowicz, S.; Nowak, E.; Grygorowicz, M. A.] Maria Sklodowska Curie Mem Canc Center, Inst Oncol, Dept Immunol, Warsaw, Poland; [Warzocha, K.] Inst Hematol & Transfus Med, Dept Hematol, Warsaw, Poland	Polish Academy of Sciences; Institute of Physical Chemistry of the Polish Academy of Sciences; Maria Sklodowska-Curie National Research Institute of Oncology	Juszczynski, P (corresponding author), Inst Hematol & Transfus Med, Dept Diagnost Hematol, Indiry Gandhi 14, PL-02776 Warsaw, Poland.	pjuszczynski@ihit.waw.pl	Szumera-Ciećkiewicz, Anna/D-8391-2019; Bialopiotrowicz, Emilia/W-2322-2018; Szumera-Ciećkiewicz, Anna/AAR-8502-2021; Szydlowski, Maciej/P-4329-2019; Jablonska, Ewa/W-2303-2018; Prochorec-Sobieszek, Monika/AAD-5065-2020; Szydlowski, Maciej/W-5014-2018; Polak, Anna/AAA-7190-2020; Polak, Anna/W-2432-2018; Gorniak, Patryk/W-6301-2018; Kaminski, Tomasz/AAD-6449-2020; Juszczynski, Przemyslaw/W-9709-2018; Sewastianik, Tomasz/AAC-6293-2020	Szumera-Ciećkiewicz, Anna/0000-0001-5028-3422; Bialopiotrowicz, Emilia/0000-0002-9263-0928; Szumera-Ciećkiewicz, Anna/0000-0001-5028-3422; Szydlowski, Maciej/0000-0002-9419-121X; Jablonska, Ewa/0000-0002-5445-4249; Prochorec-Sobieszek, Monika/0000-0002-8109-9553; Szydlowski, Maciej/0000-0002-9419-121X; Polak, Anna/0000-0001-8686-3429; Polak, Anna/0000-0001-8686-3429; Gorniak, Patryk/0000-0002-2920-2672; Kaminski, Tomasz/0000-0001-5124-4548; Juszczynski, Przemyslaw/0000-0001-7215-0444; Sewastianik, Tomasz/0000-0003-4603-8517; Warzocha, Krzysztof/0000-0002-2396-3905; Markowicz, Sergiusz/0000-0003-1280-6514	Foundation for Polish Science [TEAM/2011-7/4]; European Regional Development Fund and Operational Program Innovative Economy; NanoFun [POIG.02.02.00-00-025/09]	Foundation for Polish Science(Foundation for Polish ScienceEuropean Commission); European Regional Development Fund and Operational Program Innovative Economy; NanoFun	This work and T.S. PhD scholarship are supported by a Foundation for Polish Science grant TEAM/2011-7/4, co-financed by the European Regional Development Fund and Operational Program Innovative Economy 2007-2013. This work was partly performed in the laboratories founded by NanoFun POIG.02.02.00-00-025/09.	Alizadeh AA, 2000, NATURE, V403, P503, DOI 10.1038/35000501; An NF, 2014, ADV CANCER RES, V122, P245, DOI 10.1016/B978-0-12-420117-0.00007-4; Balaban RS, 2005, CELL, V120, P483, DOI 10.1016/j.cell.2005.02.001; Barbouti A, 2002, FREE RADICAL BIO MED, V33, P691, DOI 10.1016/S0891-5849(02)00967-X; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Birben E, 2012, WORLD ALLERGY ORGAN, V5, P9, DOI 10.1097/WOX.0b013e3182439613; Bonner WM, 2008, NAT REV CANCER, V8, P957, DOI 10.1038/nrc2523; Brent MM, 2008, STRUCTURE, V16, P1407, DOI 10.1016/j.str.2008.06.013; Butler LM, 2002, P NATL ACAD SCI USA, V99, P11700, DOI 10.1073/pnas.182372299; Calnan DR, 2008, ONCOGENE, V27, P2276, DOI 10.1038/onc.2008.21; Caro P, 2012, CANCER CELL, V22, P547, DOI 10.1016/j.ccr.2012.08.014; Chen LF, 2013, CANCER CELL, V23, P826, DOI 10.1016/j.ccr.2013.05.002; Ci WM, 2009, BLOOD, V113, P5536, DOI 10.1182/blood-2008-12-193037; Daitoku H, 2004, P NATL ACAD SCI USA, V101, P10042, DOI 10.1073/pnas.0400593101; Dansen TB, 2009, NAT CHEM BIOL, V5, P664, DOI 10.1038/nchembio.194; Eijkelenboom A, 2013, NAT REV MOL CELL BIO, V14, P83, DOI 10.1038/nrm3507; Giannakou ME, 2004, TRENDS CELL BIOL, V14, P408, DOI 10.1016/j.tcb.2004.07.006; Hirota K, 1999, J BIOL CHEM, V274, P27891, DOI 10.1074/jbc.274.39.27891; Huang HJ, 2007, J CELL SCI, V120, P2479, DOI 10.1242/jcs.001222; Ichijo H, 1997, SCIENCE, V275, P90, DOI 10.1126/science.275.5296.90; Juszczynski P, 2006, MOL CELL BIOL, V26, P5348, DOI 10.1128/MCB.02351-05; Juszczynski P, 2009, BLOOD, V114, P5315, DOI 10.1182/blood-2009-02-204362; Kiebala M, 2015, EXP HEMATOL, V43, P89, DOI 10.1016/j.exphem.2014.10.004; Kim YC, 2001, J BIOL CHEM, V276, P18399, DOI 10.1074/jbc.M100103200; Lehtinen MK, 2006, CELL, V125, P987, DOI 10.1016/j.cell.2006.03.046; Lenz G, 2008, NEW ENGL J MED, V359, P2313, DOI 10.1056/NEJMoa0802885; Li C, 2001, P NATL ACAD SCI USA, V98, P31, DOI 10.1073/pnas.011404098; Li CP, 2012, ONCOTARGET, V3, P314, DOI 10.18632/oncotarget.463; LITTLEWOOD TD, 1995, NUCLEIC ACIDS RES, V23, P1686, DOI 10.1093/nar/23.10.1686; Liu YM, 2002, CIRC RES, V90, P1259, DOI 10.1161/01.RES.0000022160.64355.62; Mandal PK, 2010, CANCER RES, V70, P9505, DOI 10.1158/0008-5472.CAN-10-1509; Marinho HS, 2014, REDOX BIOL, V2, P535, DOI 10.1016/j.redox.2014.02.006; Monti S, 2005, BLOOD, V105, P1851, DOI 10.1182/blood-2004-07-2947; Myatt SS, 2007, NAT REV CANCER, V7, P847, DOI 10.1038/nrc2223; Paik JH, 2007, CELL, V128, P309, DOI 10.1016/j.cell.2006.12.029; Pasqualucci L, 2011, NATURE, V471, P189, DOI 10.1038/nature09730; Phan RT, 2004, NATURE, V432, P635, DOI 10.1038/nature03147; Polo JM, 2007, P NATL ACAD SCI USA, V104, P3207, DOI 10.1073/pnas.0611399104; Powis G, 2001, ANNU REV PHARMACOL, V41, P261, DOI 10.1146/annurev.pharmtox.41.1.261; Rhee SG, 1999, EXP MOL MED, V31, P53, DOI 10.1038/emm.1999.9; Rosenwald A, 2002, NEW ENGL J MED, V346, P1937, DOI 10.1056/NEJMoa012914; Saitoh M, 1998, EMBO J, V17, P2596, DOI 10.1093/emboj/17.9.2596; Storz P, 2011, ANTIOXID REDOX SIGN, V14, P593, DOI 10.1089/ars.2010.3405; Szydlowski M, 2016, BLOOD, V127, P739, DOI 10.1182/blood-2015-06-654111; Szydlowski M, 2014, INT REV IMMUNOL, V33, P146, DOI 10.3109/08830185.2014.885022; Tang ED, 1999, J BIOL CHEM, V274, P16741, DOI 10.1074/jbc.274.24.16741; Tran H, 2002, SCIENCE, V296, P530, DOI 10.1126/science.1068712; Trinh DL, 2013, BLOOD, V121, P3666, DOI 10.1182/blood-2013-01-479865; Wang SW, 2004, J BIOL CHEM, V279, P25535, DOI 10.1074/jbc.M400944200; Xie LK, 2012, BLOOD, V119, P3503, DOI 10.1182/blood-2011-09-381905; Yang Y, 2009, NEOPLASIA, V11, P313, DOI 10.1593/neo.81358; Yuan ZQ, 2009, J BIOL CHEM, V284, P11285, DOI 10.1074/jbc.M900461200	52	29	29	1	19	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	NOV 17	2016	35	46					5989	6000		10.1038/onc.2016.126	http://dx.doi.org/10.1038/onc.2016.126			12	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	ED0CA	27132507				2022-12-26	WOS:000388509400006
J	Huang, WC; Liang, J; Nagahashi, M; Avni, D; Yamada, A; Maceyka, M; Wolen, AR; Kordula, T; Milstien, S; Takabe, K; Oravecz, T; Spiegel, S				Huang, Wei-Ching; Liang, Jie; Nagahashi, Masayuki; Avni, Dorit; Yamada, Akimitsu; Maceyka, Michael; Wolen, Aaron R.; Kordula, Tomasz; Milstien, Sheldon; Takabe, Kazuaki; Oravecz, Tamas; Spiegel, Sarah			Sphingosine-1-phosphate phosphatase 2 promotes disruption of mucosal integrity, and contributes to ulcerative colitis in mice and humans	FASEB JOURNAL			English	Article						SGPP1; SGPP2; S1P; inflammatory bowel disease	INFLAMMATORY-BOWEL-DISEASE; INTESTINAL EPITHELIAL-CELLS; SODIUM-INDUCED COLITIS; SPHINGOSINE KINASE; STAT3 ACTIVATION; IN-VITRO; PHOSPHOHYDROLASE; APOPTOSIS; SURVIVAL; BARRIER	The bioactive sphingolipid sphingosine-1-phosphate (S1P) and the kinase that produces it have been implicated in inflammatory bowel diseases in mice and humans; however, little is known about the role of the 2 S1P-specific phosphohydrolase isoforms, SGPP1 and SGPP2, which catalyze dephosphorylation of S1P to sphingosine. To elucidate their functions, we generated specific knockout mice. Deletion of Sgpp2, which is mainly expressed in the gastrointestinal tract, significantly reduced dextran sodium sulfate (DSS)-induced colitis severity, whereas deletion of ubiquitously expressed Sgpp1 slightly worsened colitis. Moreover, Sgpp1 deletion enhanced expression of multifunctional proin-flammatory cytokines, IL-6, TNF-alpha, and IL-1 beta, activation of the transcription factor signal transducer and activator of transcription 3, and immune cell infiltration into the colon. Conversely, Sgpp2-nullmice failed to mount a DSS-induced systemic inflammatory response. Of interest, Sgpp2 deficiency suppressed DSS-induced intestinal epithelial cell apoptosis and improved mucosal barrier integrity. Furthermore, down-regulation of Sgpp2 attenuated LPS-induced para-cellular permeability in cultured cells and enhanced expression of the adherens junction protein E-cadherin. Finally, in patients with ulcerative colitis, SGPP2 expression was elevated in colitis tissues relative to that in uninvolved tissues. These results indicate that induction of SGPP2 expression contributes to the pathogenesis of colitis by promoting disruption of the mucosal barrier function. SGPP2 may represent a novel therapeutic target in inflammatory bowel disease.	[Huang, Wei-Ching; Liang, Jie; Nagahashi, Masayuki; Avni, Dorit; Yamada, Akimitsu; Maceyka, Michael; Kordula, Tomasz; Milstien, Sheldon; Takabe, Kazuaki; Spiegel, Sarah] Virginia Commonwealth Univ, Sch Med, Dept Biochem & Mol Biol, Richmond, VA 23298 USA; [Nagahashi, Masayuki; Yamada, Akimitsu; Takabe, Kazuaki] Virginia Commonwealth Univ, Dept Surg, Div Surg Oncol, Sch Med, Richmond, VA USA; [Wolen, Aaron R.] Virginia Commonwealth Univ, Sch Med, Ctr Clin & Translat Res, Richmond, VA USA; Massey Canc Ctr, Richmond, VA USA; [Oravecz, Tamas] Lexicon Pharmaceut, The Woodlands, TX USA; [Huang, Wei-Ching] Chang Gung Mem Hosp, Inst Stem Cell & Translat Canc Res, Taoyuan, Taiwan; [Liang, Jie] State Key Lab Canc Biol, Xian, Peoples R China; [Nagahashi, Masayuki] Niigata Univ, Grad Sch Med & Dent Sci, Div Digest & Gen Surg, Niigata, Japan; [Yamada, Akimitsu] Yokohama City Univ, Med Ctr, Yokohama, Kanagawa, Japan; [Oravecz, Tamas] Celgene, Cambridge, MA USA	Virginia Commonwealth University; Virginia Commonwealth University; Virginia Commonwealth University; Virginia Commonwealth University; Lexicon Pharmaceuticals; Chang Gung Memorial Hospital; Air Force Military Medical University; Niigata University; Yokohama City University; Bristol-Myers Squibb; Celgene Corporation	Spiegel, S (corresponding author), Virginia Commonwealth Univ, Sch Med, Dept Biochem & Mol Biol, Richmond, VA 23298 USA.	sarah.spiegel@vcuhelath.org	Nagahashi, Masayuki/AAB-4202-2020; Maceyka, Michael/B-9277-2008; Wolen, Aaron/H-9545-2014	Takabe, Kazuaki/0000-0002-6435-4241; Avni, Dorit/0000-0002-0444-881X; Huang, Wei-Ching/0000-0003-1255-2067; Wolen, Aaron/0000-0003-2542-2202	National Institutes of Health (NIH) National Cancer Institute (NCI) [R01CA61774]; NIH National Institute of General Medical Sciences [R01GM043880]; NIH NCI [R01CA160688]; NIH Center for Clinical and Translational Research Grant [UL1TR000058]; NIH NCI Cancer Center Support Grant [P30CA016059]; NATIONAL CANCER INSTITUTE [R01CA061774, P30CA016059, R01CA160688] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000058] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM043880] Funding Source: NIH RePORTER	National Institutes of Health (NIH) National Cancer Institute (NCI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIH National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIH NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIH Center for Clinical and Translational Research Grant; NIH NCI Cancer Center Support Grant; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the National Institutes of Health (NIH) National Cancer Institute (NCI) Grant R01CA61774 and NIH National Institute of General Medical Sciences Grant R01GM043880 (to S.S.). This study was also supported, in part, by NIH NCI Grant R01CA160688 (to K.T.) and NIH Center for Clinical and Translational Research Grant UL1TR000058 (to A.R.W.). The authors acknowledge the Virginia Commonwealth University Lipidomics and Microscopy Cores, which are supported, in part, by funding from the NIH NCI Cancer Center Support Grant P30CA016059.	Akbari P, 2014, FASEB J, V28, P2414, DOI 10.1096/fj.13-238717; Allende ML, 2013, J BIOL CHEM, V288, P18381, DOI 10.1074/jbc.M113.478420; Begagne E, 2014, J CLIN INVEST, V124, P5368, DOI 10.1172/JCI74188; Bollrath J, 2009, CANCER CELL, V15, P91, DOI 10.1016/j.ccr.2009.01.002; Breart B, 2011, J EXP MED, V208, P1267, DOI 10.1084/jem.20102551; Cohen RD, 2010, NAT REV GASTRO HEPAT, V7, P103, DOI 10.1038/nrgastro.2009.232; Daniel C, 2007, MOL IMMUNOL, V44, P3305, DOI 10.1016/j.molimm.2007.02.026; Daniel C, 2007, J IMMUNOL, V178, P2458, DOI 10.4049/jimmunol.178.4.2458; Deguchi Y, 2006, ONCOL REP, V16, P699; Gautier L, 2004, BIOINFORMATICS, V20, P307, DOI 10.1093/bioinformatics/btg405; Giussani P, 2006, MOL CELL BIOL, V26, P5055, DOI 10.1128/MCB.02107-05; Greenspon J, 2011, DIGEST DIS SCI, V56, P1342, DOI 10.1007/s10620-010-1421-0; Grivennikov S, 2009, CANCER CELL, V15, P103, DOI 10.1016/j.ccr.2009.01.001; Guo SH, 2013, AM J PATHOL, V182, P375, DOI 10.1016/j.ajpath.2012.10.014; Halpert G, 2014, J BIOL CHEM, V289, P17215, DOI 10.1074/jbc.M113.536664; Huber W, 2015, NAT METHODS, V12, P115, DOI [10.1038/NMETH.3252, 10.1038/nmeth.3252]; Johnson KR, 2003, J BIOL CHEM, V278, P34541, DOI 10.1074/jbc.M301741200; Kabashima K, 2002, J CLIN INVEST, V109, P883, DOI 10.1172/JCI14459; Karin M, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a000141; Khor B, 2011, NATURE, V474, P307, DOI 10.1038/nature10209; Laukoetter MG, 2008, WORLD J GASTROENTERO, V14, P401, DOI 10.3748/wjg.14.401; Le Stunff H, 2004, J BIOL CHEM, V279, P34290, DOI 10.1074/jbc.M404907200; Le Stunff H, 2002, J CELL BIOL, V158, P1039, DOI 10.1083/jcb.200203123; Le Stunff H, 2002, BBA-MOL CELL BIOL L, V1582, P8, DOI 10.1016/S1388-1981(02)00132-4; Lepage P, 2011, GASTROENTEROLOGY, V141, P227, DOI 10.1053/j.gastro.2011.04.011; Lepine S, 2011, CELL DEATH DIFFER, V18, P350, DOI 10.1038/cdd.2010.104; Liang J, 2013, CANCER CELL, V23, P107, DOI 10.1016/j.ccr.2012.11.013; Maceyka M, 2007, METHOD ENZYMOL, V434, P243, DOI 10.1016/S0076-6879(07)34013-5; Maceyka M, 2014, NATURE, V510, P58, DOI 10.1038/nature13475; Maines LW, 2008, DIGEST DIS SCI, V53, P997, DOI 10.1007/s10620-007-0133-6; Mechtcheriakova D, 2007, CELL SIGNAL, V19, P748, DOI 10.1016/j.cellsig.2006.09.004; Molodecky NA, 2012, GASTROENTEROLOGY, V142, P46, DOI 10.1053/j.gastro.2011.10.001; Neurath MF, 2014, NAT REV IMMUNOL, V14, P329, DOI 10.1038/nri3661; Noble CL, 2008, GUT, V57, P1398, DOI 10.1136/gut.2008.148395; Ogawa C, 2003, J BIOL CHEM, V278, P1268, DOI 10.1074/jbc.M209514200; Peter BF, 2008, CIRC RES, V103, P315, DOI 10.1161/CIRCRESAHA.108.173575; Sanada Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023933; Schneider MR, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014325; Siegmund B, 2001, P NATL ACAD SCI USA, V98, P13249, DOI 10.1073/pnas.231473998; Snider AJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113998; Snider AJ, 2009, FASEB J, V23, P143, DOI 10.1096/fj.08-118109; Song J, 2008, J PHARMACOL EXP THER, V324, P276, DOI 10.1124/jpet.106.119172; Vetuschi A, 2002, DIGEST DIS SCI, V47, P1447, DOI 10.1023/A:1015931128583; von Roon AC, 2007, DIS COLON RECTUM, V50, P839, DOI 10.1007/s10350-006-0848-z; Weigmann B, 2007, NAT PROTOC, V2, P2307, DOI 10.1038/nprot.2007.315; Williams KL, 2001, GASTROENTEROLOGY, V120, P925, DOI 10.1053/gast.2001.22470; Xavier RJ, 2007, NATURE, V448, P427, DOI 10.1038/nature06005; Yang T, 2016, SHOCK, V45, P228, DOI 10.1097/SHK.0000000000000503; Yu LCH, 2005, FASEB J, V19, P1822, DOI 10.1096/fj.05-4226com	49	38	39	0	12	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	AUG	2016	30	8					2945	2958		10.1096/fj.201600394R	http://dx.doi.org/10.1096/fj.201600394R			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	DS7WP	27130484	Green Published			2022-12-26	WOS:000380994000027
J	Armstrong, AO; Armstrong, AJ; Jaine, FRA; Couturier, LIE; Fiora, K; Uribe-Palomino, J; Weeks, SJ; Townsend, KA; Bennett, MB; Richardson, AJ				Armstrong, Asia O.; Armstrong, Amelia J.; Jaine, Fabrice R. A.; Couturier, Lydie I. E.; Fiora, Kym; Uribe-Palomino, Julian; Weeks, Scarla J.; Townsend, Kathy A.; Bennett, Mike B.; Richardson, Anthony J.			Prey Density Threshold and Tidal Influence on Reef Manta Ray Foraging at an Aggregation Site on the Great Barrier Reef	PLOS ONE			English	Article							SHARKS RHINCODON-TYPUS; BASKING SHARKS; ZOOPLANKTON; WHALE; ECOLOGY; BEHAVIOR; CONSERVATION; MOVEMENTS; AFFINITY; ALFREDI	Large tropical and sub-tropical marine animals must meet their energetic requirements in a largely oligotrophic environment. Many planktivorous elasmobranchs, whose thermal ecologies prevent foraging in nutrient-rich polar waters, aggregate seasonally at predictable locations throughout tropical oceans where they are observed feeding. Here we investigate the foraging and oceanographic environment around Lady Elliot Island, a known aggregation site for reef manta rays Manta alfredi in the southern Great Barrier Reef. The foraging behaviour of reef manta rays was analysed in relation to zooplankton populations and local oceanography, and compared to long-term sighting records of reef manta rays from the dive operator on the island. Reef manta rays fed at Lady Elliot Island when zooplankton biomass and abundance were significantly higher than other times. The critical prey density threshold that triggered feeding was 11.2 mg m(-3) while zooplankton size had no significant effect on feeding. The community composition and size structure of the zooplankton was similar when reef manta rays were feeding or not, with only the density of zooplankton changing. Higher zooplankton biomass was observed prior to low tide, and long-term (similar to 5 years) sighting data confirmed that more reef manta rays are also observed feeding during this tidal phase than other times. This is the first study to examine prey availability at an aggregation site for reef manta rays and it indicates that they feed in locations and at times of higher zooplankton biomass.	[Armstrong, Asia O.; Armstrong, Amelia J.; Jaine, Fabrice R. A.; Couturier, Lydie I. E.; Townsend, Kathy A.; Bennett, Mike B.; Richardson, Anthony J.] Univ Queensland, Project Manta, St Lucia, Qld 4072, Australia; [Armstrong, Asia O.; Armstrong, Amelia J.; Couturier, Lydie I. E.; Bennett, Mike B.] Univ Queensland, Sch Biomed Sci, St Lucia, Qld 4072, Australia; [Jaine, Fabrice R. A.; Weeks, Scarla J.] Univ Queensland, Sch Geog Planning & Environm Management, Biophys Oceanog Grp, St Lucia, Qld 4072, Australia; [Jaine, Fabrice R. A.] Marine Megafauna Fdn, Manta Ray & Whale Shark Res Ctr, Tofo Beach, Inhambane, Mozambique; [Couturier, Lydie I. E.] Univ Aix Marseille, MIO, UMR 7294, UR 235, Campus Luminy,Case 901, F-13288 Marseille 09, France; [Fiora, Kym] Lady Elliot Isl Eco Resort, Lady Elliot Isl Dive Shop, Great Barrier Reef, Qld 4102, Australia; [Uribe-Palomino, Julian; Richardson, Anthony J.] CSIRO Oceans & Atmosphere Flagship, EcoSci Precinct, Brisbane, Qld 4102, Australia; [Richardson, Anthony J.] Univ Queensland, Sch Math & Phys, Ctr Applicat Nat Resource Math, St Lucia, Qld 4072, Australia	University of Queensland; University of Queensland; University of Queensland; UDICE-French Research Universities; Aix-Marseille Universite; Commonwealth Scientific & Industrial Research Organisation (CSIRO); University of Queensland	Armstrong, AO (corresponding author), Univ Queensland, Project Manta, St Lucia, Qld 4072, Australia.; Armstrong, AO (corresponding author), Univ Queensland, Sch Biomed Sci, St Lucia, Qld 4072, Australia.	a.armstrong2@uq.edu.au	Richardson, Anthony J/B-3649-2010; Bennett, Michael/L-4483-2019; Townsend, Kathy Ann/K-9486-2016; Bennett, Michael/A-7218-2012; Jaine, Fabrice/D-1622-2016; Couturier, Lydie I. E./J-9695-2014; Couturier, Lydie/I-9793-2019	Richardson, Anthony J/0000-0002-9289-7366; Bennett, Michael/0000-0001-8051-0040; Townsend, Kathy Ann/0000-0002-2581-2158; Jaine, Fabrice/0000-0002-9304-5034; Couturier, Lydie I. E./0000-0002-3885-3397; Couturier, Lydie/0000-0002-3885-3397; Armstrong, Amelia/0000-0001-8103-4314; Uribe-Palomino, Julian/0000-0002-6867-2108; Armstrong, Asia/0000-0002-9307-0598	Australian Research Council [LP110100712]; Lady Elliot Island Eco Resort	Australian Research Council(Australian Research Council); Lady Elliot Island Eco Resort	This work was supported by Australian Research Council Linkage Grant LP110100712. Lady Elliot Island Eco Resort provided support in the form of salary for author KF but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALLDREDGE AL, 1980, ESTUAR COAST MAR SCI, V10, P31, DOI 10.1016/S0302-3524(80)80047-8; Anderson RC, 2011, FISH OCEANOGR, V20, P104, DOI 10.1111/j.1365-2419.2011.00571.x; Bakker DCE, 2007, DEEP-SEA RES PT II, V54, P2174, DOI 10.1016/j.dsr2.2007.06.009; Bamstedt U, 1986, CHEM COMPOSITION ENE, P1; CARR MR, 1996, PRIMER USER MANUAL P; Cortes E, 1997, CAN J FISH AQUAT SCI, V54, P726, DOI 10.1139/cjfas-54-3-726; Costa DP, 2012, ANNU REV ECOL EVOL S, V43, P73, DOI 10.1146/annurev-ecolsys-102710-145045; Couturier LIE, 2012, J FISH BIOL, V80, P1075, DOI 10.1111/j.1095-8649.2012.03264.x; Couturier LIE, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077152; Couturier LIE, 2011, MAR FRESHWATER RES, V62, P628, DOI 10.1071/MF10148; DANDONNEAU Y, 1985, DEEP-SEA RES, V32, P707, DOI 10.1016/0198-0149(85)90074-3; DAVIES CH, 2014, ECOLOGY, V0095; Dewar H, 2008, MAR BIOL, V155, P121, DOI 10.1007/s00227-008-0988-x; DOTY M. S., 1956, JOUR CONSEIL PERM INTERNATL EXPLOR MER, V22, P33; Fossette S, 2010, J MARINE SYST, V81, P225, DOI 10.1016/j.jmarsys.2009.12.002; Gerking SD., 2014, FEEDING ECOLOGY FISH; GILMARTIN M, 1974, J EXP MAR BIOL ECOL, V16, P181, DOI 10.1016/0022-0981(74)90019-7; Goldbogen JA, 2007, MAR ECOL PROG SER, V349, P289, DOI 10.3354/meps07066; Harris R., 2000, ICES ZOOPLANKTON MET; Hennicke JC, 2014, MAR ECOL PROG SER, V499, P259, DOI 10.3354/meps10664; Heyman WD, 2001, MAR ECOL PROG SER, V215, P275, DOI 10.3354/meps215275; Jaine FRA, 2014, MAR ECOL PROG SER, V510, P73, DOI 10.3354/meps10910; Jaine FRA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046170; Jarman SN, 2004, J FISH BIOL, V65, P586, DOI 10.1111/j.0022-1112.2004.00466.x; Kitchen-Wheeler AM, 2012, ENVIRON BIOL FISH, V93, P557, DOI 10.1007/s10641-011-9950-8; Lemeshow S, 2000, APPL LOGISTIC REGRES; Marshall AD, 2008, ZOOTAXA, P24, DOI 10.11646/zootaxa.1717.1.2; MAYO CA, 1990, CAN J ZOOL, V68, P2214, DOI 10.1139/z90-308; McCauley DJ, 2012, SCI REP-UK, V2, DOI 10.1038/srep00409; Nelson JD, 2007, FISH RES, V84, P47, DOI 10.1016/j.fishres.2006.11.013; O'Shea OR, 2010, MAR FRESHWATER RES, V61, P65, DOI 10.1071/MF08301; Oksanen J., 2007, THE VEGAN PACKAGE; Paig-Tran EWM, 2013, J MORPHOL, V274, P1026, DOI 10.1002/jmor.20160; PARSONS GR, 1990, MAR BIOL, V104, P363, DOI 10.1007/BF01314338; Richardson AJ, 2008, ICES J MAR SCI, V65, P279, DOI 10.1093/icesjms/fsn028; Rohner CA, 2013, MARINE ECOLOGY PROGR, P10; Rohner CA, 2015, J PLANKTON RES; RYDELL J, 1991, HOLARCTIC ECOL, V14, P203; SANDERSON SL, 1994, J EXP BIOL, V186, P145; Simon M, 2012, J EXP BIOL, V215, P3786, DOI 10.1242/jeb.071092; Sims DW, 2008, ADV MAR BIOL, V54, P171, DOI 10.1016/S0065-2881(08)00003-5; Sims DW, 1997, MAR ECOL PROG SER, V158, P297, DOI 10.3354/meps158297; Sims DW, 1999, P ROY SOC B-BIOL SCI, V266, P1437, DOI 10.1098/rspb.1999.0798; Sleeman JC, 2007, MAR FRESHWATER RES, V58, P608, DOI 10.1071/MF06213; Thums M, 2012, J ROYAL SOC INTERFAC; Tjur T, 2009, AM STAT, V63, P366, DOI 10.1198/tast.2009.08210; van Doorn AC, 2010, AM J PRIMATOL, V72, P104, DOI 10.1002/ajp.20759; Vandromme P., 2012, METHODS OCEANOGRAPHY, V1, P3, DOI DOI 10.1016/J.MI0.2012.06.001; Ward-Paige CA, 2012, J FISH BIOL, V80, P1844, DOI 10.1111/j.1095-8649.2012.03246.x; Weeks SJ, 2010, CORAL REEFS, V29, P975, DOI 10.1007/s00338-010-0644-z; WETHERBEE BM, 1993, COPEIA, P416; Whitney NM, 2007, AQUAT LIVING RESOUR, V20, P299, DOI 10.1051/alr:2008006; Wiafe G, 1996, J PLANKTON RES, V18, P1485, DOI 10.1093/plankt/18.8.1485; Wood S, 2017, GEN ADDITIVE MODELS, DOI 10.1201/9781315370279; Wood SN, 2011, J R STAT SOC B, V73, P3, DOI 10.1111/j.1467-9868.2010.00749.x	55	45	45	2	50	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 4	2016	11	5							e0153393	10.1371/journal.pone.0153393	http://dx.doi.org/10.1371/journal.pone.0153393			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DL5KR	27144343	gold, Green Published, Green Submitted			2022-12-26	WOS:000375676400013
J	Adeyemi, KD; Shittu, RM; Sabow, AB; Ebrahimi, M; Sazili, AQ				Adeyemi, Kazeem Dauda; Shittu, Rafiat Morolayo; Sabow, Azad Behnan; Ebrahimi, Mahdi; Sazili, Awis Qurni			Influence of Diet and Postmortem Ageing on Oxidative Stability of Lipids, Myoglobin and Myofibrillar Proteins and Quality Attributes of Gluteus Medius Muscle in Goats	PLOS ONE			English	Article							METMYOGLOBIN REDUCING ACTIVITY; LAMBS REARED INDOORS; M.-LONGISSIMUS-DORSI; FATTY-ACID PROFILE; VITAMIN-E; CANOLA OIL; NATURAL ANTIOXIDANTS; HALAL SLAUGHTER; HEME PIGMENTS; MEAT QUALITY	This study appraised the effects of dietary blend of 80% canola oil and 20% palm oil and postmortem ageing on oxidative stability, fatty acids and quality attributes of gluteus medius (GM) muscle in goats. Twenty-four Boer bucks were randomly allotted to diet supplemented with 0, 4 and 8% oil blend, fed for 100 days and slaughtered, and the GM muscle was subjected to a 7 d chill storage (4 +/- 1 degrees C). Diet had no effect (P > 0.05) on the colour, drip loss, thiobarbituric acid-reactive substances (TBARS) value, free thiol, carbonyl, myoglobin and metmyoglobin contents, metmyoglobin reducing activity (MRA), antioxidant enzyme activities and abundance of myosin heavy chain (MHC) and actin in the GM muscle in goats. The meat from goats fed 4 and 8% oil blend had higher (P < 0.05) concentration of a and.tocopherol and abundance of troponin T compared with that from the control goats. The GM muscle from the oil-supplemented goats had lower (P < 0.05) concentration of C16: 0 and greater (P < 0.05) concentration of C18:1n-9, C18:3n-3 and C20:5n-3 compared with that from the control goats. Nonetheless, diet did not affect (P < 0.05) the total fatty acid in the GM muscle in goats. Regardless of the diet, the free thiol and myoglobin contents, concentration of tocopherol and total carotenoids, MHC and MRA in the GM muscle decreased (P < 0.05) while carbonyl content, TBARS, drip loss and metmyoglobin content increased over storage. Dietary blend of 80% canola oil and 20% palm oil beneficially altered tissue lipids without hampering the oxidative stability of chevon.	[Adeyemi, Kazeem Dauda; Sabow, Azad Behnan; Sazili, Awis Qurni] Univ Putra Malaysia, Fac Agr, Dept Anim Sci, Upm Serdang 43400, Selangor, Malaysia; [Sazili, Awis Qurni] Univ Putra Malaysia, Halal Prod Res Inst, Upm Serdang 43400, Selangor, Malaysia; [Sazili, Awis Qurni] Univ Putra Malaysia, Inst Trop Agr, Lab Anim Prod, Upm Serdang 43400, Selangor, Malaysia; [Shittu, Rafiat Morolayo] Univ Putra Malaysia, Fac Food Sci & Technol, Dept Food Technol, Upm Serdang 43400, Selangor, Malaysia; [Ebrahimi, Mahdi] Univ Putra Malaysia, Fac Vet Med, Dept Vet Preclin Sci, Upm Serdang 43400, Selangor, Malaysia; [Adeyemi, Kazeem Dauda] Univ Ilorin, Dept Anim Prod, PMB 1515, Ilorin, Nigeria; [Sabow, Azad Behnan] Univ Salahaddin, Dept Anim Resource, Erbil, Kurdistan Regio, Iraq	Universiti Putra Malaysia; Universiti Putra Malaysia; Universiti Putra Malaysia; Universiti Putra Malaysia; Universiti Putra Malaysia; University of Ilorin; Salahaddin University	Sazili, AQ (corresponding author), Univ Putra Malaysia, Fac Agr, Dept Anim Sci, Upm Serdang 43400, Selangor, Malaysia.; Sazili, AQ (corresponding author), Univ Putra Malaysia, Halal Prod Res Inst, Upm Serdang 43400, Selangor, Malaysia.; Sazili, AQ (corresponding author), Univ Putra Malaysia, Inst Trop Agr, Lab Anim Prod, Upm Serdang 43400, Selangor, Malaysia.	awis@upm.edu.my	Ebrahimi, Mahdi/A-5042-2012	Ebrahimi, Mahdi/0000-0002-3827-7369; Adeyemi, kazeem/0000-0002-6719-2081; Qurni, Awis/0000-0002-7362-0855				Adeyemi KD, 2013, IRAN J APPL ANIM SCI, V3, P195; Adeyemi KD, 2012, IRAN J APPL ANIM SCI, V2, P343; Adeyemi KD, 2016, CYTA-J FOOD, V14, P405, DOI 10.1080/19476337.2015.1114974; Adeyemi KD, 2016, ANIM SCI J, V87, P1137, DOI 10.1111/asj.12549; Adeyemi KD, 2015, ANIM SCI J, V86, P270, DOI 10.1111/asj.12279; Adeyemi KD, 2014, ASIAN AUSTRAL J ANIM, V27, P447, DOI 10.5713/ajas.2013.13463; AMSA, 2012, MEAT COL MEAS GUID; AOAC, 1990, OFFICIAL METHODS ANA, P931; BANDMAN E, 1988, MEAT SCI, V22, P1, DOI 10.1016/0309-1740(88)90023-X; Bekhik AED, 2003, FOOD CHEM, V81, P175, DOI 10.1016/S0308-8146(02)00410-7; Bekhit AED, 2001, MEAT SCI, V57, P427, DOI 10.1016/S0309-1740(00)00121-2; Bessa RJB, 2007, EUR J LIPID SCI TECH, V109, P868, DOI 10.1002/ejlt.200600311; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Clausen I, 2009, PACKAG TECHNOL SCI, V22, P85, DOI 10.1002/pts.828; Department of standards Malaysia, 2009, MS15002009 DEP STAND; Falowo AB, 2014, FOOD RES INT, V64, P171, DOI 10.1016/j.foodres.2014.06.022; FOLCH J, 1957, J BIOL CHEM, V226, P497; Ghazani SM, 2014, EUR J LIPID SCI TECH, V116, P380, DOI 10.1002/ejlt.201300288; Haak L, 2008, MEAT SCI, V78, P239, DOI 10.1016/j.meatsci.2007.06.005; Jensen C, 1998, MEAT SCI, V50, P211, DOI 10.1016/S0309-1740(98)00032-1; KAHL R, 1993, Z LEBENSM UNTERS FOR, V196, P329, DOI 10.1007/BF01197931; Kamal-Eldin A, 2000, LIPIDS, V35, P427, DOI 10.1007/s11745-000-541-y; Karami M, 2013, MEAT SCI, V94, P165, DOI 10.1016/j.meatsci.2013.02.004; KRZYWICKI K, 1982, MEAT SCI, V7, P29, DOI 10.1016/0309-1740(82)90095-X; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lawrie R, 2006, LAWRIES MEAT SCI; Liu F, 2015, ACTA SCI POLON-TECHN, V14, P37, DOI 10.17306/J.AFS.2015.1.4; Loor JJ, 2002, ANIM FEED SCI TECH, V97, P65, DOI 10.1016/S0377-8401(01)00356-X; Lund MN, 2008, MEAT SCI, V79, P727, DOI 10.1016/j.meatsci.2007.11.008; MADHAVI DL, 1993, J FOOD SCI, V58, P939, DOI 10.1111/j.1365-2621.1993.tb06083.x; Maleki E., 2015, Journal of Food, Agriculture & Environment, V13, P18; Maraschiello C, 1999, J AGR FOOD CHEM, V47, P867, DOI 10.1021/jf980824o; Martinaud A, 1997, J AGR FOOD CHEM, V45, P2481, DOI 10.1021/jf960977g; Mikkelsen A, 1999, MEAT SCI, V51, P155, DOI 10.1016/S0309-1740(98)00114-4; Mir PS, 2003, CAN J ANIM SCI, V83, P53, DOI 10.4141/A02-014; Morzel M, 2006, MEAT SCI, V73, P536, DOI 10.1016/j.meatsci.2006.02.005; Muino I, 2014, MEAT SCI, V98, P116, DOI 10.1016/j.meatsci.2014.05.009; Nantapo CWT, 2015, FOOD RES INT, V76, P896, DOI 10.1016/j.foodres.2015.05.033; NRC, 2007, NUTR REQ SMALL RUM, DOI [10.17226/11654, DOI 10.17226/11654]; OFFER G, 1983, MEAT SCI, V8, P245, DOI 10.1016/0309-1740(83)90013-X; Oguntibeju OO, 2009, BRIT J BIOMED SCI, V66, P216, DOI 10.1080/09674845.2009.11730279; Okonkwo J. C., 2009, PAKISTAN J NUTR, V8, P1629, DOI DOI 10.3923/PJN.2009.1629.1630; Olorunsanya A. O., 2011, Journal of Agricultural Research and Development (JARD), V10, P1; Otto JR, 2014, J NUTR THERAPEUTICS, V3, P55; Pegg Ronald B., 2009, Polish Journal of Food and Nutrition Sciences, V59, P129; Popova T, 2013, IRAN J APPL ANIM SCI, V3, P673; Popova T, 2013, IRAN J APPL ANIM SCI, V3, P533; RAJION MA, 1985, AUST J BIOL SCI, V38, P33, DOI 10.1071/BI9850033; Renerre M, 1996, MEAT SCI, V43, P111, DOI 10.1016/0309-1740(96)84583-9; Renerre M, 1999, J AGR FOOD CHEM, V47, P237, DOI 10.1021/jf9805000; Sabow AB, 2015, MEAT SCI, V104, P78, DOI 10.1016/j.meatsci.2015.02.004; Sabow AB, 2016, ANIM SCI J, V87, P816, DOI 10.1111/asj.12496; Sabow AB, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0152661; Sabow AB, 2015, ANIM SCI J, V86, P981, DOI 10.1111/asj.12385; Salwani MS, 2016, CYTA-J FOOD, V14, P375, DOI 10.1080/19476337.2015.1112838; SAS, 2003, STAT AN SYST PACK SA; Soler-Velasquez MP, 1998, J ANIM SCI, V76, P110; Utama DT, 2016, KOREAN J FOOD SCI AN, V36, P44, DOI 10.5851/kosfa.2016.36.1.44; VANSOEST PJ, 1991, J DAIRY SCI, V74, P3583, DOI 10.3168/jds.S0022-0302(91)78551-2; WARRISS PD, 1979, J FOOD TECHNOL, V14, P75; WINTERBOURN CC, 1990, METHOD ENZYMOL, V186, P265	61	20	22	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 3	2016	11	5							e0154603	10.1371/journal.pone.0154603	http://dx.doi.org/10.1371/journal.pone.0154603			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DL5KK	27138001	Green Published, Green Submitted, gold			2022-12-26	WOS:000375675700044
J	Jager, MD; Vondran, FWR; Ramackers, W; Roseler, T; Schlitt, HJ; Bektas, H; Klempnauer, J; Timrott, K				Jaeger, Mark D.; Vondran, Florian W. R.; Ramackers, Wolf; Roeseler, Tilmann; Schlitt, Hans J.; Bektas, Hueseyin; Klempnauer, Juergen; Timrott, Kai			A Depleting Anti-CD45 Monoclonal Antibody as Isolated Conditioning for Bone Marrow Transplantation in the Rat	PLOS ONE			English	Article							STEM-CELL TRANSPLANTATION; TOTAL-BODY IRRADIATION; NATURAL-KILLER-CELLS; MIXED CHIMERISM; PASSENGER LEUKOCYTES; ALLOGRAFT ACCEPTANCE; HEMATOPOIETIC STEM; PERIPHERAL-BLOOD; PROGENITOR CELLS; RT7 ANTIBODY	Objective A monoclonal antibody (mAb) against the leukocyte common antigen CD45 (RT7 in rats) could facilitate bone marrow transplantation (BMT). This study in rats evaluates a depletive rat anti-RT7(a) mAb as isolated tool for BMT conditioning without using irradiation or any chemotherapeutic /immunosuppressive agent. Methods The model used a CD45 di-allelic polymorphism (RT7(a)/RT7(b)). The anti-RT7(a) mAb was intravenously administered to LEW. 1W rats (RT1(u)RT7(a)) at 5, 10 and 15 mg/kg. 1x10(8) BM cells of MHC syngeneic (RT1(u)), MHC disparate (RT1(l)) or MHC haploidentical (RT1(u/l)) donors were transplanted. All BM donor strains carried the RT7(b) allele so that their CD45(+) cells were not affected by the anti-RT7(a) mAb. Recipients were monitored for reconstitution and donor-chimerism in blood leukocytes. Results mAb dosages of 5 or 10mg/kg were myelosuppressive, whereas 15mg/kg was myeloablative. Multi-lineage donor-chimerism at day 100 indicated engraftment ofMHC syngeneic BM after any used mAb dosage (5 mg/kg: 46+/-7%; 10mg/kg: 62+/-5%; 15mg/kg: 80+/-4%). MHC disparate BM resulted in autologous reconstitution after conditioning by 10mg/kg of the mAb and caused transient chimerism ending up in death associated with aplasia after conditioning by 15mg/kg of the mAb. MHC haploidentical BM (F1 to parental) engrafted only after conditioning by 15 mg/kg (chimerism at day 100: 78+/-7%). Abandonment of alpha/beta TCR+ cell depletion fromBMgrafts impaired the engraftment process after conditioning using 15 mg/kg of the mAb in theMHC syngeneic setting (2 of 6 recipients failed to engraft) and the MHC haploidentical setting (3 of 6 recipients failed). Conclusion This depletive anti-RT7(a) mAb ismyelosuppressive and conditions for engraftment of MHC syngeneic BM. The mAb also facilitates engraftment ofMHC haploidentical BM, if amyeloablative dose is used. RT7(b) expressing, BM- seeded alpha/beta TCR+ cells seem to impair the engraftment process after myeloablative mAb conditioning.	[Jaeger, Mark D.; Vondran, Florian W. R.; Ramackers, Wolf; Roeseler, Tilmann; Bektas, Hueseyin; Klempnauer, Juergen; Timrott, Kai] Hannover Med Sch, Klin Allgemein Viszeral & Transplantat Chirurg, D-30623 Hannover, Germany; [Schlitt, Hans J.] Klinikum Univ Regensburg, Klin & Poliklin Chirurg, Regensburg, Germany	Hannover Medical School; University of Regensburg	Jager, MD (corresponding author), Hannover Med Sch, Klin Allgemein Viszeral & Transplantat Chirurg, D-30623 Hannover, Germany.	jaeger.mark@mh-hannover.de	Schlitt, Hans J./ABG-4368-2020		Deutsche Forschungsgemeinschaft [Sonderforschungsbereich 265]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by the Deutsche Forschungsgemeinschaft through Sonderforschungsbereich 265, Projekt B5.	Anam K, 2006, TRANSPL IMMUNOL, V15, P199, DOI 10.1016/j.trim.2005.09.009; Andreani M, 2014, TISSUE ANTIGENS, V83, P137, DOI 10.1111/tan.12313; Barao I, 2003, BIOL BLOOD MARROW TR, V9, P727, DOI 10.1016/j.bbmt.2003.09.002; Brenner MK, 2003, ANN NY ACAD SCI, V996, P80, DOI 10.1111/j.1749-6632.2003.tb03236.x; Dahlke MH, 2004, LEUKEMIA LYMPHOMA, V45, P229, DOI 10.1080/1042819031000151932; Dahlke MH, 2002, BLOOD, V99, P3566, DOI 10.1182/blood.V99.10.3566; DOWN JD, 1991, BLOOD, V77, P661; Felfly Hady, 2014, J Stem Cells, V9, P163, DOI jsc.2014.9.3.163; Gratama JW, 2001, J BIOL REG HOMEOS AG, V15, P14; Hermiston ML, 2003, ANNU REV IMMUNOL, V21, P107, DOI 10.1146/annurev.immunol.21.120601.140946; Jager MD, 2001, TRANSPLANT P, V33, P142, DOI 10.1016/S0041-1345(00)01944-8; Kawai T, 2013, CURR OPIN ORGAN TRAN, V18, P402, DOI 10.1097/MOT.0b013e328363621d; Ko S, 1999, NAT MED, V5, P1292, DOI 10.1038/15248; Ko S, 2001, TRANSPLANTATION, V71, P1124, DOI 10.1097/00007890-200104270-00020; Ko SH, 2001, EXP HEMATOL, V29, P339, DOI 10.1016/S0301-472X(00)00676-7; Koporc Z, 2006, BIOL BLOOD MARROW TR, V12, P284, DOI 10.1016/j.bbmt.2005.11.011; Krance RA, 2003, BIOL BLOOD MARROW TR, V9, P273, DOI 10.1053/bbmt.2003.50024; Matthews DC, 1999, BLOOD, V93, P737, DOI 10.1182/blood.V93.2.737.402k21_737_745; Neipp M, 1999, TRANSPLANTATION, V68, P369, DOI 10.1097/00007890-199908150-00008; Sandmaier BM, 2002, BLOOD, V100, P318, DOI 10.1182/blood-2001-12-0322; Stewart FM, 1998, BLOOD, V91, P3681; Storb Rainer, 2009, Curr Opin Oncol, V21 Suppl 1, pS3, DOI 10.1097/01.cco.0000357467.45843.ba; Straathof KC, 2009, LANCET, V374, P912, DOI 10.1016/S0140-6736(09)60945-4; Sykes M, 1997, NAT MED, V3, P783, DOI 10.1038/nm0797-783; Sykes M, 1998, EXP HEMATOL, V26, P457; Taylor PA, 2007, BLOOD, V109, P1307, DOI 10.1182/blood-2006-05-022772; Tolar J, 2012, BIOL BLOOD MARROW TR, V18, pS166, DOI 10.1016/j.bbmt.2011.10.023; TOMITA Y, 1994, BLOOD, V83, P939; VANOS R, 1992, INT J RADIAT BIOL, V61, P501, DOI 10.1080/09553009214551261; WICKENHAUSER C, 1995, ACTA HAEMATOL-BASEL, V93, P83; Woodford-Thomas T, 1993, Semin Cell Biol, V4, P409, DOI 10.1006/scel.1993.1049; Wulf GG, 2003, BLOOD, V101, P2434, DOI 10.1182/blood-2002-08-2379	32	5	5	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 3	2016	11	5							e0154682	10.1371/journal.pone.0154682	http://dx.doi.org/10.1371/journal.pone.0154682			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DL5KK	27139494	gold, Green Submitted, Green Published			2022-12-26	WOS:000375675700054
J	Pan, CW; Wang, XD; Shi, KQ; Zheng, Y; Li, J; Chen, YP; Jin, LX; Pan, ZZ				Pan, Chenwei; Wang, Xiaodong; Shi, Keqing; Zheng, Yi; Li, Jie; Chen, Yongping; Jin, Lingxiang; Pan, Zhenzhen			MiR-122 Reverses the Doxorubicin-Resistance in Hepatocellular Carcinoma Cells through Regulating the Tumor Metabolism	PLOS ONE			English	Article							BREAST-CANCER CELLS; PYRUVATE-KINASE; DRUG-RESISTANCE; POOR-PROGNOSIS; GASTRIC-CANCER; MICRORNA; CHEMORESISTANCE; SUPPRESSOR; EXPRESSION; GROWTH	Doxorubicin (DOX) is one of the most commonly used anticancer drugs in the treatment of hepatoma. However, acquired drug resistance is one of the major challenges for the chemotherapy. In this study, a down-regulation of miR-122 was observed in doxorubicin-resistant Huh7 (Huh7/R) cells compared with its parental Huh7 cells, suggesting miR-122 is associated with the chemoresistance. Meanwhile, luciferase reporter assay proved that the PKM2 is the target of miR-122, and we reported that the glucose metabolism is significantly upregulated in Huh7/R cells. Importantly, overexpression of miR-122 in Huh7/R cells reversed the doxorubicin-resistance through the inhibition of PKM2, inducing the apoptosis in doxorubicin-resistant cancer cells. Thus, this study revealed that the dysregulated glucose metabolism contributes to doxorubicin resistance, and the inhibition of glycolysis induced by miR-122 might be a promising therapeutic strategy to overcome doxorubicin resistance in hepatocellular carcinoma.	[Pan, Chenwei; Zheng, Yi; Li, Jie; Jin, Lingxiang] Wenzhou Med Univ, Affiliated Hosp 2, Dept Infect Dis, Wenzhou, Peoples R China; [Pan, Chenwei; Zheng, Yi; Li, Jie; Jin, Lingxiang] Wenzhou Med Univ, Yuying Childrens Hosp, Wenzhou, Peoples R China; [Wang, Xiaodong; Shi, Keqing; Chen, Yongping; Pan, Zhenzhen] Wenzhou Med Univ, Affiliated Hosp 1, Dept Infect Dis, Wenzhou, Peoples R China	Wenzhou Medical University; Wenzhou Medical University; Wenzhou Medical University	Jin, LX (corresponding author), Wenzhou Med Univ, Affiliated Hosp 2, Dept Infect Dis, Wenzhou, Peoples R China.; Jin, LX (corresponding author), Wenzhou Med Univ, Yuying Childrens Hosp, Wenzhou, Peoples R China.; Pan, ZZ (corresponding author), Wenzhou Med Univ, Affiliated Hosp 1, Dept Infect Dis, Wenzhou, Peoples R China.	future1006@sina.com; wzzhenzhenpan@126.com	Shi, KeQing/A-3411-2009; Shi, Keqing/GZK-5146-2022	Shi, KeQing/0000-0002-5070-3834; Shi, Keqing/0000-0002-5070-3834	Program of WenZhou Science and Technology Bureau [Y20150023]	Program of WenZhou Science and Technology Bureau	This study was supported by the Program of WenZhou Science and Technology Bureau (grant no: Y20150023).	Altenberg B, 2004, GENOMICS, V84, P1014, DOI 10.1016/j.ygeno.2004.08.010; Ameres SL, 2013, NAT REV MOL CELL BIO, V14, P475, DOI 10.1038/nrm3611; An Y, 2015, CELL DEATH DIS, V6, DOI 10.1038/cddis.2015.123; Asghar U, 2012, J HEPATOL, V56, P686, DOI 10.1016/j.jhep.2011.07.031; Bai SM, 2009, J BIOL CHEM, V284, P32015, DOI 10.1074/jbc.M109.016774; Bhattacharyya SN, 2006, CELL, V125, P1111, DOI 10.1016/j.cell.2006.04.031; Chen CF, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni178; Coulouarn C, 2009, ONCOGENE, V28, P3526, DOI 10.1038/onc.2009.211; Garber K, 2006, SCIENCE, V312, P1158, DOI 10.1126/science.312.5777.1158; Gines A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0123830; Gu JW, 2005, CANCER-AM CANCER SOC, V103, P422, DOI 10.1002/cncr.20781; He YH, 2015, LEUKEMIA RES, V39, P1428, DOI 10.1016/j.leukres.2015.09.019; Heiden MGV, 2009, SCIENCE, V324, P1029, DOI 10.1126/science.1160809; Ca H, 2012, ANTICANCER RES, V32, P1379; Inui M, 2010, NAT REV MOL CELL BIO, V11, P252, DOI 10.1038/nrm2868; Israelsen WJ, 2013, CELL, V155, P397, DOI 10.1016/j.cell.2013.09.025; Liang XT, 2011, J GASTROEN HEPATOL, V26, P544, DOI 10.1111/j.1440-1746.2010.06434.x; Lin SB, 2015, NAT REV CANCER, V15, P321, DOI 10.1038/nrc3932; Liu WR, 2015, ONCOTARGET, V6, P846, DOI 10.18632/oncotarget.2749; Longley DB, 2005, J PATHOL, V205, P275, DOI 10.1002/path.1706; Luan WK, 2015, ONCOTARGET, V6, P13006, DOI 10.18632/oncotarget.3514; Marczak A, 2015, ANTICANCER RES, V35, P1935; Mazurek S, 2005, SEMIN CANCER BIOL, V15, P300, DOI 10.1016/j.semcancer.2005.04.009; Misra R, 2014, INT J PHARMACEUT, V475, P372, DOI 10.1016/j.ijpharm.2014.08.056; Motamedian E, 2015, IRAN J BASIC MED SCI, V18, P267; Ou YY, 2015, GENE, V572, P116, DOI 10.1016/j.gene.2015.07.002; Siegel R, 2012, CA-CANCER J CLIN, V62, P10, DOI 10.3322/caac.20138; Song YX, 2011, MOL CANCER, V10, DOI 10.1186/1476-4598-10-1; Synowiec E, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/673512; Tsai WC, 2009, HEPATOLOGY, V49, P1571, DOI 10.1002/hep.22806; WARBURG O, 1956, SCIENCE, V123, P309, DOI 10.1126/science.123.3191.309; Wen SJ, 2013, FUTURE MED CHEM, V5, P53, DOI 10.4155/fmc.12.190; Wilson TR, 2006, ANN ONCOL, V17, pX315, DOI 10.1093/annonc/mdl280; Xie XH, 2015, TUMOR BIOL, V36, P7185, DOI 10.1007/s13277-015-3438-7; Xu FF, 2014, CANCER CELL INT, V14, DOI 10.1186/s12935-014-0142-4; Yang WW, 2013, CANCER LETT, V339, P153, DOI 10.1016/j.canlet.2013.06.008; Zhao Y, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.60; Zheng YB, 2016, ONCOL REP, V35, P683, DOI 10.3892/or.2015.4417; Zhou YF, 2012, CANCER RES, V72, P304, DOI 10.1158/0008-5472.CAN-11-1674; Zhu AX, 2006, ONCOLOGIST, V11, P790, DOI 10.1634/theoncologist.11-7-790	40	56	56	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 3	2016	11	5							e0152090	10.1371/journal.pone.0152090	http://dx.doi.org/10.1371/journal.pone.0152090			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DL5KK	27138141	Green Published, Green Submitted, gold			2022-12-26	WOS:000375675700005
J	Vallof, D; Vestlund, J; Engel, JA; Jerlhag, E				Vallof, Daniel; Vestlund, Jesper; Engel, Jorgen A.; Jerlhag, Elisabet			The Anorexigenic Peptide Neuromedin U (NMU) Attenuates Amphetamine-Induced Locomotor Stimulation, Accumbal Dopamine Release and Expression of Conditioned Place Preference in Mice	PLOS ONE			English	Article							CENTRAL-NERVOUS-SYSTEM; ETHANOL; IDENTIFICATION; ADDICTION; BRAIN; FOOD; ALCOHOLISM; RECEPTORS; INDUCTION; GHRELIN	Amphetamine dependence, besides its substantial economical consequence, is a serious cause of mortality and morbidity. By investigations of the neurochemical correlates through which addictive drugs, such as amphetamine, activate the mesoaccumbal dopamine system unique targets for treatment of drug addiction can be identified. This reward link consists of a dopamine projection from the ventral tegmental area to the nucleus accumbens (NAc) suggesting that these brain areas are important for reward. The physiological function of gut-brain peptides has expanded beyond food intake modulation and involves regulation of drug reinforcement. A novel candidate for reward regulation is the anorexigenic peptide neuromedin U (NMU). We therefore investigated the effects of intracerebroventricular (icv) administration of NMU on amphetamine's well-documented effects on the mesoaccumbal dopamine system, i. e. locomotor stimulation and accumbal dopamine release in mice. In addition, the effect of accumbal NMU administration on locomotor activity was examined. The effect of NMU, icv or intra-NAc, on the expression of conditioned place preference (CPP) was elucidated. Firstly, we showed that icv administration of NMU attenuate the amphetamine-induced locomotor stimulation, accumbal dopamine release and expression of CPP in mice. Secondly, we found that a lower dose of NMU (icv) reduce the amphetamine-induced locomotor stimulation in mice. Thirdly, we demonstrated that NMU administration into the NAc block the ability of amphetamine to cause a locomotor stimulation in mice. However, accumbal NMU administration did not attenuate the amphetamine-induced expression of CPP in mice. Our novel data suggest that central NMU signalling is involved in development of amphetamine dependence.	[Vallof, Daniel; Vestlund, Jesper; Engel, Jorgen A.; Jerlhag, Elisabet] Univ Gothenburg, Dept Pharmacol, Inst Neurosci & Physiol, Sahlgrenska Acad, Gothenburg, Sweden	University of Gothenburg	Jerlhag, E (corresponding author), Univ Gothenburg, Dept Pharmacol, Inst Neurosci & Physiol, Sahlgrenska Acad, Gothenburg, Sweden.	Elisabet.Jerlhag@pharm.gu.se			Swedish Research Council [2009-2782, 2011-4646, 2015-03219]; Swedish Society for Medical Research; Swedish brain foundation; LUA/ALF from the Sahlgrenska University Hospital [148251]; Torsten Soderberg; Alcohol research council of the Swedish alcohol retailing monopoly; foundation of Adlerbertska; foundation of Fredrik; foundation of Ingrid Thuring; foundation of Tore Nilsson; foundation of Langmanska; foundation of Wilhelm and Martina Lundgren; foundation of Knut and Alice Wallenberg; foundation of Magnus Bergvall; foundation of Aners; foundation of Jeansons; foundation of Ake Wiberg; foundation of NovoNordisk; Gothenburg Psychiatry Research Foundation; Swedish Society of Medicine; Novo Nordisk Fonden [NNF15OC0016020] Funding Source: researchfish	Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Society for Medical Research; Swedish brain foundation; LUA/ALF from the Sahlgrenska University Hospital; Torsten Soderberg; Alcohol research council of the Swedish alcohol retailing monopoly; foundation of Adlerbertska; foundation of Fredrik; foundation of Ingrid Thuring; foundation of Tore Nilsson; foundation of Langmanska; foundation of Wilhelm and Martina Lundgren; foundation of Knut and Alice Wallenberg(Knut & Alice Wallenberg Foundation); foundation of Magnus Bergvall; foundation of Aners; foundation of Jeansons; foundation of Ake Wiberg; foundation of NovoNordisk; Gothenburg Psychiatry Research Foundation; Swedish Society of Medicine; Novo Nordisk Fonden(Novo Nordisk Foundation)	The study is supported by grants from the Swedish Research Council (2009-2782 and 2011-4646 and 2015-03219), Swedish Society for Medical Research, The Swedish brain foundation, LUA/ALF (grant no. 148251) from the Sahlgrenska University Hospital, Torsten Soderberg, Alcohol research council of the Swedish alcohol retailing monopoly and the foundations of Adlerbertska, Fredrik and Ingrid Thuring, Tore Nilsson, Langmanska, Wilhelm and Martina Lundgren, Knut and Alice Wallenberg, Magnus Bergvall, Aners, Jeansons, Ake Wiberg, NovoNordisk, Gothenburg Psychiatry Research Foundation, the Swedish Society of Medicine. The funding sources had no role in the collection, analysis and interpretation of data, in the writing of the report or in the decision to submit the article for publication.	BALLESTA J, 1988, NEUROSCIENCE, V25, P797, DOI 10.1016/0306-4522(88)90037-1; Bardo MT, 2000, PSYCHOPHARMACOLOGY, V153, P31, DOI 10.1007/s002130000569; Benzon CR, 2014, NEUROSCIENCE, V258, P270, DOI 10.1016/j.neuroscience.2013.11.023; Blednov YA, 2004, ALCOHOL CLIN EXP RES, V28, P1683, DOI 10.1097/01.ALC.0000145790.60216.C8; BLOMQVIST O, 1993, EUR J PHARMACOL, V249, P207, DOI 10.1016/0014-2999(93)90434-J; BLOOM FE, 1983, ANNU REV PHARMACOL, V23, P151, DOI 10.1146/annurev.pa.23.040183.001055; Borgland SL, 2006, NEURON, V49, P589, DOI 10.1016/j.neuron.2006.01.016; Brighton PJ, 2004, PHARMACOL REV, V56, P231, DOI 10.1124/pr.56.2.3; Burkett JP, 2012, PSYCHOPHARMACOLOGY, V224, P1, DOI 10.1007/s00213-012-2794-x; Clarke RBC, 2014, ALCOHOL ALCOHOLISM, V49, P498, DOI 10.1093/alcalc/agu047; DICHIARA G, 1986, ANN NY ACAD SCI, V473, P367; DOMIN J, 1987, PEPTIDES, V8, P779, DOI 10.1016/0196-9781(87)90058-1; Egecioglu E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077284; Egecioglu E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069010; Egecioglu E, 2013, PSYCHONEUROENDOCRINO, V38, P1259, DOI 10.1016/j.psyneuen.2012.11.009; Egecioglu E, 2009, AM J PHYSIOL-ENDOC M, V297, pE708, DOI 10.1152/ajpendo.91022.2008; Engel JA, 2014, CNS DRUGS, V28, P875, DOI 10.1007/s40263-014-0178-y; Erreger K, 2012, PHYSIOL BEHAV, V106, P574, DOI 10.1016/j.physbeh.2012.03.014; Franklin K. B. J., 2008, PAXINOS FRANKLINS MO; Gartlon J, 2004, PSYCHOPHARMACOLOGY, V177, P1, DOI 10.1007/s00213-004-1918-3; Graham DL, 2013, MOL PSYCHIATR, V18, P961, DOI 10.1038/mp.2012.141; Hanada R, 2004, NAT MED, V10, P1067, DOI 10.1038/nm1106; Hanada R, 2001, BIOCHEM BIOPH RES CO, V289, P225, DOI 10.1006/bbrc.2001.5945; Hanada T, 2003, BIOCHEM BIOPH RES CO, V311, P954, DOI 10.1016/j.bbrc.2003.10.098; Hosoya M, 2000, J BIOL CHEM, V275, P29528, DOI 10.1074/jbc.M004261200; Howard AD, 2000, NATURE, V406, P70, DOI 10.1038/35017610; Ida T, 2005, ENDOCRINOLOGY, V146, P4217, DOI 10.1210/en.2005-0107; Jerlhag E, 2009, P NATL ACAD SCI USA, V106, P11318, DOI 10.1073/pnas.0812809106; Jethwa PH, 2005, AM J PHYSIOL-ENDOC M, V289, pE301, DOI 10.1152/ajpendo.00404.2004; Kojima M, 2000, BIOCHEM BIOPH RES CO, V276, P435, DOI 10.1006/bbrc.2000.3502; Kowalski TJ, 2005, J ENDOCRINOL, V185, P151, DOI 10.1677/joe.1.05948; KULKOSKY P J, 1984, Alcohol, V1, P125, DOI 10.1016/0741-8329(84)90067-3; Lewis MJ, 2004, ALCOHOL CLIN EXP RES, V28, P1822, DOI 10.1097/01.ALC.0000148099.12344.C8; Lydall GJ, 2011, PSYCHIAT GENET, V21, P294, DOI 10.1097/YPG.0b013e32834915c2; Maderdrut JL, 1996, J COMP NEUROL, V369, P438, DOI 10.1002/(SICI)1096-9861(19960603)369:3<438::AID-CNE8>3.0.CO;2-6; Martinez VG, 2015, CLIN CHEM, V61, P471, DOI 10.1373/clinchem.2014.231753; Mitchell JD, 2009, BRIT J PHARMACOL, V158, P87, DOI 10.1111/j.1476-5381.2009.00252.x; Nakahara K, 2004, BIOCHEM BIOPH RES CO, V318, P156, DOI 10.1016/j.bbrc.2004.04.014; Niimi M, 2001, ENDOCRINE, V16, P201, DOI 10.1385/ENDO:16:3:201; Ozaki Y, 2002, ENDOCRINOLOGY, V143, P4320, DOI 10.1210/en.2002-220201; Prieto-Garcia L, 2015, PSYCHONEUROENDOCRINO, V62, P392, DOI 10.1016/j.psyneuen.2015.09.009; Prus AJ, 2009, FRONT NEUROSCI, P59; Rawson RA, 2007, ADDICTION, V102, P1, DOI 10.1111/j.1360-0443.2006.01781.x; Sanchis-Segura C, 2006, ADDICT BIOL, V11, P2, DOI 10.1111/j.1369-1600.2006.00012.x; Schwartz MW, 2000, NATURE, V404, P661, DOI 10.1038/35007534; Srisurapanont M., 2001, COCHRANE DB SYST REV, DOI DOI 10.1002/14651858.CD003022; Tupala E, 2004, PROG NEURO-PSYCHOPH, V28, P1221, DOI 10.1016/j.pnpbp.2004.06.022; Vallof D, 2017, ADDICT BIOL, V22, P640, DOI 10.1111/adb.12355; Wang GJ, 2004, J ADDICT DIS, V23, P39, DOI 10.1300/J069v23n03_04; WISE RA, 1987, PSYCHOL REV, V94, P469, DOI 10.1037/0033-295X.94.4.469; Zorrilla EP, 2014, FRONT NEUROENDOCRIN, V35, P234, DOI 10.1016/j.yfrne.2014.01.001	51	20	20	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 3	2016	11	5							e0154477	10.1371/journal.pone.0154477	http://dx.doi.org/10.1371/journal.pone.0154477			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DL5KK	27139195	gold, Green Published			2022-12-26	WOS:000375675700034
J	Maile, EJ; Barnes, I; Finlayson, AE; Sayeed, S; Ali, R				Maile, Edward J.; Barnes, Isobel; Finlayson, Alexander E.; Sayeed, Shameq; Ali, Raghib			Nervous System and Intracranial Tumour Incidence by Ethnicity in England, 2001-2007: A Descriptive Epidemiological Study	PLOS ONE			English	Article							BRAIN-TUMORS; CHILDHOOD-CANCER; INCREASED RISK; BIRTH-WEIGHT; POLYMORPHISMS; GLIOMAS; GENE; MENINGIOMA; ASTHMA; ASSOCIATION	Background There is substantial variation in nervous system and intracranial tumour incidence worldwide. UK incidence data have limited utility because they group these diverse tumours together and do not provide data for individual ethnic groups within Blacks and South Asians. Our objective was to determine the incidence of individual tumour types for seven individual ethnic groups. Methods We used data from the National Cancer Intelligence Network on tumour site, age, sex and deprivation to identify 42,207 tumour cases. Self-reported ethnicity was obtained from the Hospital Episode Statistics database. We used mid-year population estimates from the Office for National Statistics. We analysed tumours by site using Poisson regression to estimate incidence rate ratios comparing non-White ethnicities to Whites after adjustment for sex, age and deprivation. Results Our study showed differences in tumour incidence by ethnicity for gliomas, meningiomas, pituitary tumours and cranial and paraspinal nerve tumours. Relative to Whites; South Asians, Blacks and Chinese have a lower incidence of gliomas (p<0.01), with respective incidence rate ratios of 0.68 (confidence interval: 0.60-0.77), 0.62 (0.52-0.73) and 0.58 (0.41-0.83). Blacks have a higher incidence of meningioma (p<0.01) with an incidence rate ratio of 1.29 (1.05-1.59) and there is heterogeneity in meningioma incidence between individual South Asian ethnicities. Blacks have a higher incidence of pituitary tumours relative to Whites (p<0.01) with an incidence rate ratio of 2.95 (2.37-3.67). There is heterogeneity in pituitary tumour incidence between individual South Asian ethnicities. Conclusions We present incidence data of individual tumour types for seven ethnic groups. Current understanding of the aetiology of these tumours cannot explain our results. These findings suggest avenues for further work.	[Maile, Edward J.; Barnes, Isobel; Finlayson, Alexander E.; Sayeed, Shameq; Ali, Raghib] Univ Oxford, Div Med Sci, Canc Epidemiol Unit, Nuffield Dept Populat Hlth, Oxford, Oxon, England; [Ali, Raghib] United Arab Emirates Univ, Fac Med & Hlth Sci, Inst Publ Hlth, Abu Dhabi, U Arab Emirates	University of Oxford; United Arab Emirates University	Ali, R (corresponding author), Univ Oxford, Div Med Sci, Canc Epidemiol Unit, Nuffield Dept Populat Hlth, Oxford, Oxon, England.; Ali, R (corresponding author), United Arab Emirates Univ, Fac Med & Hlth Sci, Inst Publ Hlth, Abu Dhabi, U Arab Emirates.	raghib.ali@ndm.ox.ac.uk			Cancer Research UK (CR-UK) through an Oxford Cancer Research Centre Academic Foundation Stage Bursary [C38302/A12981]	Cancer Research UK (CR-UK) through an Oxford Cancer Research Centre Academic Foundation Stage Bursary	This work was supported by Cancer Research UK (CR-UK) (http://www.cancerresearchuk.org/) grant number C38302/A12981, through an Oxford Cancer Research Centre Academic Foundation Stage Bursary. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ali R, 2013, GUT, V62, P1692, DOI 10.1136/gutjnl-2012-303000; [Anonymous], 2014, PIT TUM; [Anonymous], 2012, MULTIPLE ENDOCRINE N; [Anonymous], 2011, INT HOUS SURV; [Anonymous], 2011, GOOD IS HES ETHN COD; [Anonymous], 2014, BRAIN TUM RISKS CAUS; [Anonymous], 2012, TURNER SYNDROME NATL; [Anonymous], 2001, CENS OF IND; Bao, 2012, ZHONGHUA YI XUE ZA Z, V92, P2309; Benson VS, 2010, BRIT J CANCER, V102, P1654, DOI 10.1038/sj.bjc.6605695; Bethke L, 2008, J NATL CANCER I, V100, P270, DOI 10.1093/jnci/djn004; Bondy ML, 2008, CANCER-AM CANCER SOC, V113, P1953, DOI 10.1002/cncr.23741; Cancer Research UK, 2014, BRAIN OTH CNS INTR T; Chang L, 2014, ONCOTARGETS THER, V7, P235, DOI 10.2147/OTT.S41336; Chen PC, 2001, CANCER RES, V61, P3949; Crocetti E, 2012, EUR J CANCER, V48, P1532, DOI 10.1016/j.ejca.2011.12.013; Curado MP, 2007, CANC INCIDENCE 5 CON, VIX; de Andrade M, 2001, GENET EPIDEMIOL, V20, P258, DOI 10.1002/1098-2272(200102)20:2<258::AID-GEPI8>3.0.CO;2-N; Department for Communities and Local Government, 2009, PAK MUSL COMM ENGL U; Ding H, 2014, INT J CLIN EXP MED, V7, P3904; Dubuc Sylvie, 2009, IUSSP INT POP C; Dumitrescu CE, 2008, ORPHANET J RARE DIS, V3, DOI 10.1186/1750-1172-3-12; Dworakowska D, 2009, BEST PRACT RES CL EN, V23, P525, DOI 10.1016/j.beem.2009.05.004; EASTON DF, 1991, STAT MED, V10, P1025, DOI 10.1002/sim.4780100703; Ferlay JSI, 2013, GLOBOCAN 2012 V1 0 C; Friedman JM, 1999, AM J MED GENET, V89, P1; Gatineau M, 2011, PERSPECT PUBLIC HEAL, V131, P159, DOI 10.1177/1757913911412478; Goodenberger ML, 2012, CANCER GENET-NY, V205, P613, DOI 10.1016/j.cancergen.2012.10.009; Gousias K, 2009, NEUROEPIDEMIOLOGY, V33, P89, DOI 10.1159/000222090; Harder T, 2008, AM J EPIDEMIOL, V168, P366, DOI 10.1093/aje/kwn144; Harris TJ, 1999, BRIT MED J, V319, P610, DOI 10.1136/bmj.319.7210.610; HESHMAT MY, 1976, CANCER, V38, P2135, DOI 10.1002/1097-0142(197611)38:5<2135::AID-CNCR2820380543>3.0.CO;2-T; Hori K, 2010, ONCOL LETT, V1, P595, DOI 10.3892/ol_00000105; Howard SC, 2008, CANCER, V112, P461, DOI 10.1002/cncr.23205; Jack RH, 2010, BJU INT, V105, P1226, DOI 10.1111/j.1464-410X.2009.08940.x; Jacobs DI, 2012, FRONT GENET, P3; Kabat GC, 2011, INT J CANCER, V128, P944, DOI 10.1002/ijc.25413; Katie Gilkes GE, 2012, ADV CLIN NEUROSCI RE, V12, P12; Kelly Y, 2009, J PUBLIC HEALTH-UK, V31, P131, DOI 10.1093/pubmed/fdn057; King's Fund, 2006, ACC HLTH CAR MIN ETH; Kohler BA, 2011, JNCI-J NATL CANCER I, V103, P714, DOI 10.1093/jnci/djr077; Larjavaara S, 2007, NEURO-ONCOLOGY, V9, P319, DOI 10.1215/15228517-2007-016; Linabery AM, 2008, CANCER, V112, P416, DOI 10.1002/cncr.23169; Linos E, 2007, JNCI-J NATL CANCER I, V99, P1544, DOI 10.1093/jnci/djm170; Louis DN, 2007, ACTA NEUROPATHOL, V114, P97, DOI 10.1007/s00401-007-0243-4; Mocellin S, 2012, JNCI-J NATL CANCER I, V104, P840, DOI 10.1093/jnci/djs222; Mochizuki S, 1999, INT J ONCOL, V15, P983; Morris DH, 2010, BRIT J CANCER, V103, P1760, DOI 10.1038/sj.bjc.6605978; Netuveli G, 2005, RESP RES, V6, DOI 10.1186/1465-9921-6-120; Noble M, 2008, ENGLISH INDICES DEPR; NOMIS, 2011, OFF LAB MARK STAT ET; Office for National Statistics, 2012, ETHN NAT ID ENGL WAL; Office for National Statistics, 2011, LANG ENGL WAL 2011; Office for National Statistics, 2012, POP COUNTR BIRTH NAT; Ostrom QT, 2014, NEURO-ONCOLOGY, V16, P896, DOI 10.1093/neuonc/nou087; Parkin D., 2002, IARC PUBL, V8; Parkin DM, 1996, EUR J CANCER, V32A, P761, DOI 10.1016/0959-8049(96)00062-7; Pearce N, 2006, INT J TUBERC LUNG D, V10, P125; Pier DB, 2014, EUR J MED GENET, V57, P269, DOI 10.1016/j.ejmg.2014.03.005; Plummer M, 2004, STAT MED, V23, P93, DOI 10.1002/sim.1485; Qi ZY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083261; Qi ZY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068695; Rajaraman P, 2010, NEURO-ONCOLOGY, V12, P37, DOI 10.1093/neuonc/nop012; Reulen RC, 2011, JAMA-J AM MED ASSOC, V305, P2311, DOI 10.1001/jama.2011.747; Segi M., 1960, CANC MORTALITY SELEC; Shao C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090167; Stratakis CA, 2000, PEDIATR PATHOL MOL M, V19, P41, DOI 10.1080/15227950050033765; Tang JM, 2005, CANCER EPIDEM BIOMAR, V14, P2040, DOI 10.1158/1055-9965.EPI-05-0136; Taylor AJ, 2010, J CLIN ONCOL, V28, P5287, DOI 10.1200/JCO.2009.27.0090; Thomson C, 2009, CANC INCIDENCE SURVI; Truong T, 2010, JNCI-J NATL CANCER I, V102, P959, DOI 10.1093/jnci/djq178; Turner MC, 2013, CANCER CAUSE CONTROL, V24, P949, DOI 10.1007/s10552-013-0171-7; Wang M, 2011, CANCER CAUSE CONTROL, V22, P1355, DOI 10.1007/s10552-011-9808-6; Wei XT, 2013, MOL BIOL REP, V40, P567, DOI 10.1007/s11033-012-2093-y; *WHO, 1990, INT CLASS DIS ONC; Wiemels J, 2010, J NEURO-ONCOL, V99, P307, DOI 10.1007/s11060-010-0386-3; Williams H, 1999, J ALLERGY CLIN IMMUN, V103, P125, DOI 10.1016/S0091-6749(99)70536-1; WILLIAMS HC, 1995, J AM ACAD DERMATOL, V32, P212, DOI 10.1016/0190-9622(95)90128-0; World Health Organization, 1992, INT STAT CLASS DIS R; World Health Organization, 2000, INT CLASS DIS ONC; Wrensch M, 2005, NEURO-ONCOLOGY, V7, P495, DOI 10.1215/S1152851705000037; Yuan GQ, 2014, TUMOR BIOL, V35, P4267, DOI 10.1007/s13277-013-1557-6	82	16	16	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 2	2016	11	5							e0154347	10.1371/journal.pone.0154347	http://dx.doi.org/10.1371/journal.pone.0154347			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DL5KB	27135830	Green Published, gold			2022-12-26	WOS:000375674800018
J	Nordin, N; Fadaeinasab, M; Mohan, S; Hashim, NM; Othman, R; Karimian, H; Iman, V; Ramli, N; Ali, HM; Majid, NA				Nordin, Noraziah; Fadaeinasab, Mehran; Mohan, Syam; Hashim, Najihah Mohd; Othman, Rozana; Karimian, Hamed; Iman, Venus; Ramli, Noorlela; Ali, Hapipah Mohd; Majid, Nazia Abdul			Pulchrin A, a New Natural Coumarin Derivative of Enicosanthellum pulchrum, Induces Apoptosis in Ovarian Cancer Cells via Intrinsic Pathway	PLOS ONE			English	Article							PROTEINS; CYCLE; DEATH; GENE; PHOSPHATIDYLSERINE; MITOCHONDRIA; PROTEOLYSIS; RECOGNITION; METABOLISM; MECHANISMS	Drug resistance presents a challenge in chemotherapy and has attracted research interest worldwide and particular attention has been given to natural compounds to overcome this difficulty. Pulchrin A, a new compound isolated from natural products has demonstrated novel potential for development as a drug. The identification of pulchrin A was conducted using several spectroscopic techniques such as nuclear magnetic resonance, liquid chromatography mass spectrometer, infrared and ultraviolet spectrometry. The cytotoxicity effects on CAOV-3 cells indicates that pulchrin A is more active than cisplatin, which has an IC50 of 22.3 mu M. Significant changes in cell morphology were present, such as cell membrane blebbing and formation of apoptotic bodies. The involvement of phosphatidylserine (PS) in apoptosis was confirmed by Annexin V-FITC after a 24 h treatment. Apoptosis was activated through the intrinsic pathway by activation of procaspases 3 and 9 as well as cleaved caspases 3 and 9 and ended at the executioner pathway, with the occurrence of DNA laddering. Apoptosis was further confirmed via gene and protein expression levels, in which Bcl-2 protein was down-regulated and Bax protein was up-regulated. Furthermore, the CAOV-3 cell cycle was disrupted at the G0/G1 phase, leading to apoptosis. Molecular modeling of Bcl-2 proteins demonstrated a high-binding affinity, which inhibited the function of Bcl-2 proteins and led to cell death. Results of the current study can shed light on the development of new therapeutic agents, particularly, human ovarian cancer treatments.	[Nordin, Noraziah; Hashim, Najihah Mohd; Othman, Rozana; Karimian, Hamed; Iman, Venus; Ramli, Noorlela] Univ Malaya, Fac Med, Dept Pharm, Kuala Lumpur, Malaysia; [Fadaeinasab, Mehran; Ali, Hapipah Mohd] Univ Malaya, Dept Chem, Fac Sci, Kuala Lumpur, Malaysia; [Mohan, Syam] Jazan Univ, Med Res Ctr, Jazan, Saudi Arabia; [Majid, Nazia Abdul] Univ Malaya, Inst Biol Sci, Fac Sci, Kuala Lumpur, Malaysia; [Hashim, Najihah Mohd; Othman, Rozana; Ali, Hapipah Mohd] Univ Malaya, Ctr Nat Prod Res & Drug Discovery CENAR, Kuala Lumpur, Malaysia	Universiti Malaya; Universiti Malaya; Jazan University; Universiti Malaya; Universiti Malaya	Majid, NA (corresponding author), Univ Malaya, Inst Biol Sci, Fac Sci, Kuala Lumpur, Malaysia.	nazia@um.edu.my	Mohan, Syam/A-1231-2011; MAJID, NAZIA ABDUL/B-9215-2010; Hashim, Najihah Mohd/J-5508-2015; OTHMAN, ROZANA/B-9628-2010; Fadaeinasab, Mehran/A-8810-2016	MAJID, NAZIA ABDUL/0000-0002-6817-8046; Hashim, Najihah Mohd/0000-0003-1133-7998; OTHMAN, ROZANA/0000-0002-8260-9252; Fadaeinasab, Mehran/0000-0002-2501-894X	University of Malaya under PPP grant [PG151-2012B]; Ministry of Higher Education Malaysia under High Impact Research Grants [UM-MOHE UM.C/625/1/HIR/MOHE/SC/09]	University of Malaya under PPP grant; Ministry of Higher Education Malaysia under High Impact Research Grants	This study was funded by the University of Malaya under PPP grant (PG151-2012B) and the Ministry of Higher Education Malaysia under High Impact Research Grants (UM-MOHE UM.C/625/1/HIR/MOHE/SC/09).	Abd Allah OA, 2000, FARMACO, V55, P641, DOI 10.1016/S0014-827X(00)00090-2; Al-Haiza MA, 2003, MOLECULES, V8, P275, DOI 10.3390/80200275; Altieri DC, 1999, LAB INVEST, V79, P1327; Ambrosini G, 1997, NAT MED, V3, P917, DOI 10.1038/nm0897-917; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Blagosklonny MV, 2000, LEUKEMIA, V14, P1502, DOI 10.1038/sj.leu.2401864; Borges F, 2005, CURR MED CHEM, V12, P887, DOI 10.2174/0929867053507315; Buendia B, 1999, J CELL SCI, V112, P1743; Cacic M, 2006, MOLECULES, V11, P134, DOI 10.3390/11010134; CASLEYSMITH JR, 1993, NEW ENGL J MED, V329, P1158, DOI 10.1056/NEJM199310143291604; CASLEYSMITH JR, 1995, MED J AUSTRALIA, V162, P391, DOI 10.5694/j.1326-5377.1995.tb139958.x; Cheung HH, 2006, CLIN CANCER RES, V12, P3238, DOI 10.1158/1078-0432.CCR-06-0817; COX D, 1989, HUM TOXICOL, V8, P501, DOI 10.1177/096032718900800612; Decaudin D, 1998, INT J ONCOL, V12, P141; Degterev A, 2003, ONCOGENE, V22, P8543, DOI 10.1038/sj.onc.1207107; Dellaire G, 2013, CANC GENOMICS BENCH, VFirst; Deshpande N, 2005, NUCLEIC ACIDS RES, V33, pD233; Deveraux QL, 1999, GENE DEV, V13, P239, DOI 10.1101/gad.13.3.239; EGAN D, 1990, DRUG METAB REV, V22, P503, DOI 10.3109/03602539008991449; El-Ansary L, 1992, EGYPT J PHARM SCI, V33, P379; ELDEIRY WS, 1993, CELL, V75, P817, DOI 10.1016/0092-8674(93)90500-P; ELIOPOULOS AG, 1995, ONCOGENE, V11, P1217; Elmore S, 2007, TOXICOL PATHOL, V35, P495, DOI 10.1080/01926230701320337; FADOK VA, 1992, J IMMUNOL, V148, P2207; Ferlay J, CANC INCIDENCE MORTA; Fylaktakidou KC, 2004, CURR PHARM DESIGN, V10, P3813, DOI 10.2174/1381612043382710; Gentry-Maharaj A, 2012, BEST PRACT RES CL OB, V26, P243, DOI 10.1016/j.bpobgyn.2011.11.006; Green DR, 2004, SCIENCE, V305, P626, DOI 10.1126/science.1099320; HARTWELL LH, 1989, SCIENCE, V246, P629, DOI 10.1126/science.2683079; HARVEY RG, 1988, J ORG CHEM, V53, P3936, DOI 10.1021/jo00252a011; HOCKENBERY D, 1995, AM J PATHOL, V146, P16; Jung JC, 1999, SYNTHETIC COMMUN, V29, P3587, DOI 10.1080/00397919908085993; Kim M, 2012, MOL CANCER RES, V10, P1419, DOI 10.1158/1541-7786.MCR-12-0361; Kosary CL, 1994, SEMINARS SURG ONCOLO; Kostova I, 2006, BIOINORG CHEM APPL, V2006, DOI [10.1155/BCA/2006/68274, 10.1155/BCA/2006/25651]; Kothakota S, 1997, SCIENCE, V278, P294, DOI 10.1126/science.278.5336.294; KROEMER G, 1995, FASEB J, V9, P1277, DOI 10.1096/fasebj.9.13.7557017; LAZEBNIK YA, 1995, P NATL ACAD SCI USA, V92, P9042, DOI 10.1073/pnas.92.20.9042; LIVINGSTONE LR, 1992, CELL, V70, P923, DOI 10.1016/0092-8674(92)90243-6; Mantovani A, 2008, NATURE, V454, P436, DOI 10.1038/nature07205; MOFFETT RB, 1964, J MED CHEM, V7, P446, DOI 10.1021/jm00334a010; Moll UM, 2005, CURR OPIN CELL BIOL, V17, P631, DOI 10.1016/j.ceb.2005.09.007; Morris GM, 1998, J COMPUT CHEM, V19, P1639, DOI 10.1002/(SICI)1096-987X(19981115)19:14<1639::AID-JCC10>3.0.CO;2-B; Musicki B, 2000, BIOORG MED CHEM LETT, V10, P1695, DOI 10.1016/S0960-894X(00)00304-8; Nagata S, 2005, IMMUNOLOGY, P23; Nagata S, 2010, CELL, V140, P619, DOI 10.1016/j.cell.2010.02.014; Nordin N, 2015, DRUG DES DEV THER, V9, P1437, DOI 10.2147/DDDT.S77727; Nordin N, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111925; Patil PO, 2013, BIOORGAN MED CHEM, V21, P2434, DOI 10.1016/j.bmc.2013.02.017; Rao L, 1996, J CELL BIOL, V135, P1441, DOI 10.1083/jcb.135.6.1441; Ravichandran KS, 2011, IMMUNITY, V35, P445, DOI 10.1016/j.immuni.2011.09.004; Ricci JE, 2004, CELL, V117, P773, DOI 10.1016/j.cell.2004.05.008; Rubin SC, 1999, OBSTET GYNECOL, V93, P21, DOI 10.1016/S0029-7844(98)00334-2; Rudel T, 1997, SCIENCE, V276, P1571, DOI 10.1126/science.276.5318.1571; Saelens X, 2004, ONCOGENE, V23, P2861, DOI 10.1038/sj.onc.1207523; Sahoo S.S., 2012, EURO J EXP BIO, V2, P899; Salvesen GS, 2002, NAT REV MOL CELL BIO, V3, P401, DOI 10.1038/nrm830; Samali A, 1999, CELL DEATH DIFFER, V6, P495, DOI 10.1038/sj.cdd.4400520; Schuler M, 2001, BIOCHEM SOC T, V29, P684, DOI 10.1042/0300-5127:0290684; Siegel R, 2012, CA-CANCER J CLIN, V62, P10, DOI 10.3322/caac.20138; SOTANIEMI EA, 1995, BRIT J CLIN PHARMACO, V39, P71, DOI 10.1111/j.1365-2125.1995.tb04412.x; Stennicke HR, 2000, BBA-PROTEIN STRUCT M, V1477, P299, DOI 10.1016/S0167-4838(99)00281-2; Syam S, 2011, MOLECULES, V16, P7155, DOI 10.3390/molecules16087155; Thomas WD, 1998, J IMMUNOL, V161, P2195; Toure BB, 2013, ACS MED CHEM LETT, V4, P186, DOI 10.1021/ml300321d; VAUX DL, 1988, NATURE, V335, P440, DOI 10.1038/335440a0; VERHOVEN B, 1995, J EXP MED, V182, P1597, DOI 10.1084/jem.182.5.1597; Vermeulen K, 2003, CELL PROLIFERAT, V36, P131, DOI 10.1046/j.1365-2184.2003.00266.x; Wang ZS, 2005, J PHYS CHEM B, V109, P3907, DOI 10.1021/jp044851v; Wong ML, 2005, BIOTECHNIQUES, V39, P75, DOI 10.2144/05391RV01; WYLLIE AH, 1980, NATURE, V284, P555, DOI 10.1038/284555a0; Zainal Ariffin O, 2011, NATL CANC REGISTRY R	72	20	20	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 2	2016	11	5							e0154023	10.1371/journal.pone.0154023	http://dx.doi.org/10.1371/journal.pone.0154023			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DL5KB	27136097	Green Published, Green Submitted, gold			2022-12-26	WOS:000375674800010
J	Bottin, M; Soininen, J; Alard, D; Rosebery, J				Bottin, Marius; Soininen, Janne; Alard, Didier; Rosebery, Juliette			Diatom Cooccurrence Shows Less Segregation than Predicted from Niche Modeling	PLOS ONE			English	Article							SPECIES COOCCURRENCE; LIMITING SIMILARITY; SITE SUITABILITY; NESTEDNESS; PATTERNS; ASSEMBLAGES; SUCCESSION; FRAMEWORK; BRAZIL	Species cooccurrence patterns give significant insights into the processes shaping communities. While biotic interactions have been widely studied using cooccurrence analyses in animals and larger plants, studies about cooccurrences among micro-organisms are still relatively rare. We examined stream diatom cooccurrences in France through a national database of samples. In order to test the relative influence of environmental, biotic and spatial constraints on species' incidence distribution, cooccurrence and nestedness patterns of real communities were compared with the patterns generated from a set of standard and environmentally constrained null models. Real communities showed a higher level of segregation than the most conservative standard null models, but a general aggregation of cooccurrences when compared to environmentally constrained null models. We did not find any evidence of limiting similarity between cooccurring species. Aggregations of species cooccurrences were associated with the high levels of nestedness. Altogether, these results suggested that biotic interactions were not structuring cooccurrences of diatom species at our study scale. Instead, the patterns were more likely to be related with colonization patterns, mass effect, and local temporal dynamics of diatom biofilms. We further highlight that the association of standard and environmentally constrained null models may give realistic insight into the cooccurrence patterns of microbial communities.	[Bottin, Marius; Rosebery, Juliette] Irstea Bordeaux, UR EABX, 50 Ave Verdun, F-33612 Cestas, France; [Bottin, Marius; Alard, Didier] Univ Bordeaux, INRA, BIOGECO, F-33615 Pessac, France; [Soininen, Janne] Univ Helsinki, Dept Geosci & Geog, POB 64, FIN-00014 Helsinki, Finland	INRAE; INRAE; UDICE-French Research Universities; Universite de Bordeaux; University of Helsinki	Bottin, M (corresponding author), Irstea Bordeaux, UR EABX, 50 Ave Verdun, F-33612 Cestas, France.; Bottin, M (corresponding author), Univ Bordeaux, INRA, BIOGECO, F-33615 Pessac, France.	marius.bottin@u-bordeaux.fr	Bottin, Marius/O-9866-2019; Soininen, Janne/A-4205-2008; Bottin, Marius/M-7986-2017	Bottin, Marius/0000-0002-5102-3857; Bottin, Marius/0000-0002-5102-3857; Tison-Rosebery, Juliette/0000-0003-1090-7020; Alard, Didier/0000-0003-2703-908X; Soininen, Janne/0000-0002-8583-3137	Office National de l'Eau et des Milieux Aquatiques (French national institute of freshwater and aquatic environments; ONEMA)	Office National de l'Eau et des Milieux Aquatiques (French national institute of freshwater and aquatic environments; ONEMA)	This study was funded by the Office National de l'Eau et des Milieux Aquatiques (French national institute of freshwater and aquatic environments; ONEMA). Please see www.onema.fr/ for more information. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABRAMS P, 1983, ANNU REV ECOL SYST, V14, P359, DOI 10.1146/annurev.es.14.110183.002043; Almeida-Neto M, 2008, OIKOS, V117, P1227, DOI 10.1111/j.0030-1299.2008.16644.x; Almeida-Neto M, 2011, ENVIRON MODELL SOFTW, V26, P173, DOI 10.1016/j.envsoft.2010.08.003; Anderson MJ, 2003, ECOLOGY, V84, P511, DOI 10.1890/0012-9658(2003)084[0511:CAOPCA]2.0.CO;2; ATMAR W, 1993, OECOLOGIA, V96, P373, DOI 10.1007/BF00317508; Azeria ET, 2012, OECOLOGIA, V168, P1123, DOI 10.1007/s00442-011-2180-0; Azovsky AI, 2002, ECOGRAPHY, V25, P273, DOI 10.1034/j.1600-0587.2002.250303.x; Biggs BJF, 1998, ARCH HYDROBIOL, V143, P21; Borcard D, 2004, ECOLOGY, V85, P1826, DOI 10.1890/03-3111; Bottin M, 2014, FRESHW SCI, V33, P402, DOI 10.1086/675726; Breiman L., 2001, Machine Learning, V45, P5, DOI 10.1023/A:1010933404324; Brown JS, 1996, OIKOS, V75, P193, DOI 10.2307/3546243; CONNOR EF, 1979, ECOLOGY, V60, P1132, DOI 10.2307/1936961; Cottenie K, 2005, ECOL LETT, V8, P1175, DOI 10.1111/j.1461-0248.2005.00820.x; de Azevedo MCC, 2006, ESTUAR COAST SHELF S, V66, P315, DOI 10.1016/j.ecss.2005.09.006; de Bello F, 2012, ECOLOGY, V93, P2263, DOI 10.1890/11-1394.1; Diamond J.M., 1975, P342; Finlay BJ, 2002, SCIENCE, V296, P1061, DOI 10.1126/science.1070710; Freschet GT, 2011, GLOBAL ECOL BIOGEOGR, V20, P755, DOI 10.1111/j.1466-8238.2011.00651.x; Gotelli NJ, 2012, OIKOS, V121, P171, DOI 10.1111/j.1600-0706.2011.20301.x; Gotelli NJ, 2000, ECOLOGY, V81, P2606, DOI 10.1890/0012-9658(2000)081[2606:NMAOSC]2.0.CO;2; Gotelli NJ, 2001, OECOLOGIA, V129, P281, DOI 10.1007/s004420100717; Gothe E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072237; Gotzenberger L, 2012, BIOL REV, V87, P111, DOI 10.1111/j.1469-185X.2011.00187.x; HOAGLAND KD, 1982, AM J BOT, V69, P188, DOI 10.2307/2443006; Hosmer DavidW., 2000, APPL LOGISTIC REGRES; Katoh Kazuhiro, 1992, Diatom Research, V7, P77; Kelly M. G, 2005, COMMON FRESHWATER DI; Krammer K., 1986, SUSSWASSERFLORA MITT, V2/1, P1; Legendre P, 1999, ECOL MONOGR, V69, P1, DOI 10.1890/0012-9615(1999)069[0001:DBRATM]2.0.CO;2; Leibold MA, 2004, ECOL LETT, V7, P601, DOI 10.1111/j.1461-0248.2004.00608.x; MCCORMICK PV, 1991, ECOLOGY, V72, P1835, DOI 10.2307/1940982; McGill BJ, 2006, TRENDS ECOL EVOL, V21, P178, DOI 10.1016/j.tree.2006.02.002; Meszena G, 2006, THEOR POPUL BIOL, V69, P68, DOI 10.1016/j.tpb.2005.07.001; Miklos I, 2004, ECOLOGY, V85, P86, DOI 10.1890/03-0101; Mouchet MA, 2013, OIKOS, V122, P247, DOI 10.1111/j.1600-0706.2012.20411.x; Oksanen J., 2022, VEGAN COMMUNITY ECOL; Ovaskainen O, 2010, ECOLOGY, V91, P2514, DOI 10.1890/10-0173.1; Passy SI, 2007, AQUAT BOT, V86, P171, DOI 10.1016/j.aquabot.2006.09.018; Passy SI, 2011, MICROB ECOL, V62, P414, DOI 10.1007/s00248-011-9879-7; Peres-Neto PR, 2004, OECOLOGIA, V140, P352, DOI 10.1007/s00442-004-1578-3; Peres-Neto PR, 2001, OIKOS, V93, P110, DOI 10.1034/j.1600-0706.2001.930112.x; Poisot T, 2013, ECOL EVOL, V3, P1125, DOI 10.1002/ece3.508; SHMIDA A, 1985, J BIOGEOGR, V12, P1, DOI 10.2307/2845026; Soininen J, 2008, PROTIST, V159, P65, DOI 10.1016/j.protis.2007.07.001; Stegen JC, 2012, ISME J, V6, P1653, DOI 10.1038/ismej.2012.22; Steiner CF, 2007, AM NAT, V169, P416, DOI 10.1086/510728; STONE L, 1990, OECOLOGIA, V85, P74, DOI 10.1007/BF00317345; Szilagyi A, 2009, J THEOR BIOL, V258, P27, DOI 10.1016/j.jtbi.2008.12.001; TOKESHI M, 1986, J ANIM ECOL, V55, P491, DOI 10.2307/4733; Tornes E, 2013, FRESHWATER BIOL, V58, P2555, DOI 10.1111/fwb.12232; Tuji A, 2000, J PHYCOL, V36, P659, DOI 10.1046/j.1529-8817.2000.99212.x; Tuji A, 2000, PHYCOL RES, V48, P75, DOI DOI 10.1111/j.1440-1835.2000.tb00199.x; Ulrich W, 2007, OIKOS, V116, P2053, DOI 10.1111/j.2007.0030-1299.16173.x; Ulrich W, 2009, OIKOS, V118, P3, DOI 10.1111/j.1600-0706.2008.17053.x; Venables WN., 2002, MODERN APPL STAT S, V4; Watkins AJ, 2003, OIKOS, V102, P525, DOI 10.1034/j.1600-0706.2003.11630.x; Weiher E., 1999, ECOLOGICAL ASSEMBLY, DOI DOI 10.1017/CBO9780511542237; Weiher E, 1999, ECOLOGICAL ASSEMBLY, P130, DOI DOI 10.1017/CBO9780511542237.006; WRIGHT DH, 1992, OECOLOGIA, V92, P416, DOI 10.1007/BF00317469	60	22	22	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 29	2016	11	4							e0154581	10.1371/journal.pone.0154581	http://dx.doi.org/10.1371/journal.pone.0154581			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DK8XM	27128737	Green Published, gold			2022-12-26	WOS:000375212600043
J	Li, MY; Wang, L				Li, Mengyao; Wang, Lie			The Associations of Psychological Stress with Depressive and Anxiety Symptoms among Chinese Bladder and Renal Cancer Patients: The Mediating Role of Resilience	PLOS ONE			English	Article							POSITIVE PSYCHOLOGY; PROSTATE-CANCER; BREAST-CANCER; INTERVENTIONS; DIAGNOSIS; SURVIVORS; HEALTH; METAANALYSIS; PREVALENCE; PREDICTORS	Background The prevalence of depressive and anxiety symptoms and their associated factors in bladder and renal cancer patients are not well evaluated in China. Given the growing attention to positive psychological constructs in the field of oncology, it is necessary to explore the effects of these constructs on depressive and anxiety symptoms. This study aims to explore the associations of psychological stress with depressive and anxiety symptoms among Chinese bladder and renal cancer patients and the mediating role of resilience in these relationships. Methods A cross-sectional study was conducted at the First Affiliated Hospital of China Medical University in Liaoning province. 327 bladder cancer patients and 268 renal cancer patients completed questionnaires on demographic variables, the Center for Epidemiologic Studies Depression Scale, Zung Self-Rating Anxiety Scale, Resilience Scale-14, and Perceived Stress Scale-10 during the period from July 2013 to July 2014. Hierarchical linear regression analyses were performed to explore the mediating role of resilience. Results The prevalence of depressive and anxiety symptoms was 78.0% and 71.3% in bladder cancer patients, and 77.6% and 68.3% in renal cancer patients. Psychological stress was positively related to depressive and anxiety symptoms, while resilience was negatively related to these symptoms. Resilience partially mediated the relations of psychological stress with depressive and anxiety symptoms. Conclusions The high prevalence of depressive and anxiety symptoms among Chinese bladder and renal cancer patients should receive more attention from medical institutions and government agencies. In addition to reducing depressive and anxiety symptoms, resilience development should be included in depression and anxiety prevention and treatment strategies in China.	[Li, Mengyao; Wang, Lie] China Med Univ, Sch Publ Hlth, Dept Social Med, Shenyang North New Area, 77 Puhe Rd, Shenyang 110122, Peoples R China	China Medical University	Wang, L (corresponding author), China Med Univ, Sch Publ Hlth, Dept Social Med, Shenyang North New Area, 77 Puhe Rd, Shenyang 110122, Peoples R China.	liewang@mail.cmu.edu.cn						Aspinwall LG, 2005, CANCER-AM CANCER SOC, V104, P2549, DOI 10.1002/cncr.21244; Aspinwall LG, 2010, ANN BEHAV MED, V39, P4, DOI 10.1007/s12160-009-9153-0; BARON RM, 1986, J PERS SOC PSYCHOL, V51, P1173, DOI 10.1037/0022-3514.51.6.1173; Brix C, 2008, J PSYCHOSOM RES, V65, P541, DOI 10.1016/j.jpsychores.2008.05.010; Casellas-Grau A, 2014, PSYCHO-ONCOLOGY, V23, P9, DOI 10.1002/pon.3353; Chen J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046878; Cohen J., 2003, APPL MULTIPLE REGRES, P419; Cohen L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042324; Cohen M, 2014, J GERIATR ONCOL, V5, P33, DOI 10.1016/j.jgo.2013.07.009; COHEN S, 1988, CLAR SYMP, P31; Demyttenaere K, 2004, JAMA-J AM MED ASSOC, V291, P2581, DOI 10.1001/jama.291.21.2581; Ficarra V, 2000, UROL INT, V65, P130, DOI 10.1159/000064857; Henningsohn L, 2003, BJU INT, V91, P325, DOI 10.1046/j.1464-410X.2003.04101.x; Hou WK, 2010, HEALTH PSYCHOL, V29, P484, DOI 10.1037/a0020809; Iwamitsu Y, 2005, PSYCHOSOMATICS, V46, P19, DOI 10.1176/appi.psy.46.1.19; Jacobsen PB, 2008, CA-CANCER J CLIN, V58, P214, DOI 10.3322/CA.2008.0003; Kasparian NA, 2013, CLIN DERMATOL, V31, P41, DOI 10.1016/j.clindermatol.2011.11.005; Lazarus R.S., 1984, EMOTION ADAPTATION; Liu L, 2013, BMC PSYCHIATRY, V13, DOI 10.1186/1471-244X-13-324; Liu X.C., 1995, CHIN J MENT HLTH, V9, P19; Loprinzi CE, 2011, CLIN BREAST CANCER, V11, P364, DOI 10.1016/j.clbc.2011.06.008; Mancini AD, 2009, J PERS, V77, P1805, DOI 10.1111/j.1467-6494.2009.00601.x; Min JA, 2013, SUPPORT CARE CANCER, V21, P2469, DOI 10.1007/s00520-013-1807-6; Mitchell AJ, 2011, LANCET ONCOL, V12, P160, DOI 10.1016/S1470-2045(11)70002-X; Molina Y, 2014, CLIN J ONCOL NURS, V18, P93, DOI 10.1188/14.CJON.93-101; Ong AD, 2009, J PERS, V77, P1777, DOI 10.1111/j.1467-6494.2009.00600.x; RADLOFF L S, 1977, Applied Psychological Measurement, V1, P385, DOI 10.1177/014662167700100306; Ramachandra P, 2009, PSYCHO-ONCOLOGY, V18, P1323, DOI 10.1002/pon.1516; Richardson GE, 2002, J CLIN PSYCHOL, V58, P307, DOI 10.1002/jclp.10020; Rock EE, 2014, SUPPORT CARE CANCER, V22, P2351, DOI 10.1007/s00520-014-2209-0; RUTTER M, 1987, AM J ORTHOPSYCHIAT, V57, P316, DOI 10.1111/j.1939-0025.1987.tb03541.x; Schroevers M, 2006, SOC SCI MED, V63, P598, DOI 10.1016/j.socscimed.2006.02.008; Schroevers MJ, 2003, J PSYCHOSOC ONCOL, V21, P1, DOI 10.1300/J077v21n01_01; Schumacher A, 2014, SUPPORT CARE CANCER, V22, P487, DOI 10.1007/s00520-013-2001-6; Sephton S, 2003, BRAIN BEHAV IMMUN, V17, P321, DOI 10.1016/S0889-1591(03)00078-3; Sharpley CF, 2014, EUR J CANCER CARE, V23, P545, DOI 10.1111/ecc.12170; Sharpley CF, 2014, J MENS HEALTH, V11, P115, DOI 10.1089/jomh.2014.0024; Sood AK, 2006, CLIN CANCER RES, V12, P369, DOI 10.1158/1078-0432.CCR-05-1698; Strauss B, 2007, J CANCER RES CLIN, V133, P511, DOI 10.1007/s00432-007-0195-z; Tian J, 2013, SUPPORT CARE CANCER, V21, P1497, DOI 10.1007/s00520-012-1699-x; van der Spek N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076089; Vanderpol M, 2002, HARVARD REV PSYCHIAT, V10, P302; Wagnild G., 2009, RESILIENCE SCALE USE; Wang X, 2012, ASIAN PAC J CANCER P, V13, P1645, DOI 10.7314/APJCP.2012.13.4.1645; Wang Z, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028610; Wen-cai ZHAO, 2015, CHIN J CLIN ONCOL RE, V22, P1106; Wongpakaran N, 2014, CLIN INTERV AGING, V9, P377, DOI 10.2147/CIA.S56683; Yanez B, 2015, J BEHAV MED, V38, P214, DOI 10.1007/s10865-014-9594-1; Yang YL, 2014, BMC CANCER, V14, DOI 10.1186/1471-2407-14-956; Yang YL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094804; Yang YL, 2013, BMC CANCER, V13, DOI 10.1186/1471-2407-13-393; ZUNG WWK, 1971, PSYCHOSOMATICS, V12, P371	52	34	35	1	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 29	2016	11	4							e0154729	10.1371/journal.pone.0154729	http://dx.doi.org/10.1371/journal.pone.0154729			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DK8XM	27128438	Green Submitted, Green Published, gold			2022-12-26	WOS:000375212600063
J	Lunau, K; Konzmann, S; Bossems, J; Harpke, D				Lunau, Klaus; Konzmann, Sabine; Bossems, Jessica; Harpke, Doerte			A Matter of Contrast: Yellow Flower Colour Constrains Style Length in Crocus species	PLOS ONE			English	Article							BUMBLEBEES BOMBUS-TERRESTRIS; FLORAL GUIDES; ERISTALIS-TENAX; BEES; EVOLUTION; PATTERNS; PREFERENCE; PHYLOGENY; IRIDACEAE; ECOLOGY	Most flowers display distinct colour patterns comprising two different areas. The peripheral large-area component of floral colour patterns attracts flower visitors from some distance and the central small-area component guides flower visitors towards landing sites. Whereas the peripheral colour is largely variable among species, the central colour, produced mostly by anthers and pollen or pollen mimicking floral guides, is predominantly yellow and UV-absorbing. This holds also for yellow flowers that regularly display a UV bull's eye pattern. Here we show that yellow-flowering Crocus species are a noticeable exception, since yellow-flowering Crocus species-being entirely UV-absorbing-exhibit low colour contrast between yellow reproductive organs and yellow tepals. The elongated yellow or orange-yellow style of Crocus flowers is a stamen-mimicking structure promoting cross-pollination by facilitating flower visitors' contact with the apical stigma before the flower visitors are touching the anthers. Since Crocus species possess either yellow, violet or white tepals, the colour contrast between the stamen-mimicking style and the tepals varies among species. In this study comprising 106 Crocus species, it was tested whether the style length of Crocus flowers is dependent on the corolla colour. The results show that members of the genus Crocus with yellow tepals have evolved independently up to twelve times in the genus Crocus and that yellow-flowering Crocus species possess shorter styles as compared to violet- and white-flowering ones. The manipulation of flower visitors by anther-mimicking elongated styles in Crocus flowers is discussed.	[Lunau, Klaus; Konzmann, Sabine; Bossems, Jessica] Univ Dusseldorf, Inst Sensory Ecol, Dusseldorf, Germany; [Harpke, Doerte] Leibniz Inst Plant Genet & Crop Res IPK, Gatersleben, Germany	Heinrich Heine University Dusseldorf; Leibniz Institut fur Pflanzengenetik und Kulturpflanzenforschung	Lunau, K (corresponding author), Univ Dusseldorf, Inst Sensory Ecol, Dusseldorf, Germany.	lunau@uni-duesseldorf.de	Harpke, Doerte/AAN-9739-2021; Lunau, Klaus/AAL-2532-2021	Lunau, Klaus/0000-0001-5184-4201; Harpke, Dorte/0000-0003-1667-2912				Barthlott W, 1993, TROPISCHE SUBTROPISC, V86; Carta A, 2016, PLANT BIOSYST, V150, P1358, DOI 10.1080/11263504.2015.1118164; Chichiricco G, 1996, PLANT SYST EVOL, V201, P83, DOI 10.1007/BF00989053; CHICHIRICCO G, 1990, PLANT SYST EVOL, V172, P77, DOI 10.1007/BF00937799; Dafni A, 1996, BOT J LINN SOC, V120, P371, DOI 10.1111/j.1095-8339.1996.tb00487.x; Dinkel T, 2001, J INSECT PHYSIOL, V47, P1111, DOI 10.1016/S0022-1910(01)00080-4; Duffy KJ, 2015, BOT J LINN SOC, V177, P481, DOI 10.1111/boj.12252; Evangelista C, 2010, J EXP BIOL, V213, P262, DOI 10.1242/jeb.037465; FELSENSTEIN J, 1985, AM NAT, V125, P1, DOI 10.1086/284325; Grilli-Caiola M, 2003, ACTA HORTIC, V650, P25; Harpke D, 2015, PLANT SYST EVOL, V301, P309, DOI 10.1007/s00606-014-1074-0; Harpke D, 2013, MOL PHYLOGENET EVOL, V66, P617, DOI 10.1016/j.ympev.2012.10.007; Horth L, 2014, BIOL OPEN, V3, P221, DOI 10.1242/bio.20146445; Junker RR, 2013, FUNCT ECOL, V27, P329, DOI 10.1111/1365-2435.12005; KAY QON, 1981, BOT J LINN SOC, V83, P57, DOI 10.1111/j.1095-8339.1981.tb00129.x; KERNDORFF H, 2014, STAPFIA, V101, P3; Kerndorff H., 2011, STAPFIA, V95, P99; Leonard AS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055914; LUNAU K, 1992, PLANT SYST EVOL, V183, P51, DOI 10.1007/BF00937735; Lunau K, 2006, NATURWISSENSCHAFTEN, V93, P325, DOI 10.1007/s00114-006-0105-2; LUNAU K, 1995, J COMP PHYSIOL A, V177, P1; Lunau K, 1996, J COMP PHYSIOL A, V178, P477, DOI 10.1007/BF00190178; Lunau K, 2005, ENTOMOL GEN, V27, P249; Lunau K, 1996, ZOOL ANZ, V235, P11; Lunau K, 1995, PLANT SYST EVOL, V198, P235, DOI 10.1007/BF00984739; LUNAU K, 1994, J COMP PHYSIOL A, V174, P575, DOI 10.1007/BF00217378; LUNAU K, 1992, CAN J ZOOL, V70, P2139, DOI 10.1139/z92-288; Lunau K, 2000, PLANT SYST EVOL, V222, P89, DOI 10.1007/BF00984097; Lunau K, 2007, BOT JB SYSTEMATIK PF, V127, P13; Lunau K, 2014, J COMP PHYSIOL A, V200, P497, DOI 10.1007/s00359-014-0895-1; Lunau K, 2011, J EXP BIOL, V214, P1607, DOI 10.1242/jeb.052688; Lunau K, 2009, J COMP PHYSIOL A, V195, P1121, DOI 10.1007/s00359-009-0484-x; Mathew B, 1982, CROCUSES REVISION GE; Maw G., 1886, MONOGRAPH GENUS CROC; McKee J, 1998, BOT J LINN SOC, V128, P369; Menzel R., 1979, HDB SENSORY PHYSL, V7 / 6 / 6, P503, DOI DOI 10.1007/978-3-642-66999-6_9; Norbaek R, 2002, BIOCHEM SYST ECOL, V30, P763, DOI 10.1016/S0305-1978(02)00020-0; OSCHE G, 1983, BER DEUT BOT GES, V96, P1; Papiorek S, 2016, PLANT BIOLOGY, V18, P46, DOI 10.1111/plb.12322; PFANDER H, 1982, PHYTOCHEMISTRY, V21, P1039, DOI 10.1016/S0031-9422(00)82412-7; Pohl M, 2008, BEHAV ECOL SOCIOBIOL, V63, P295, DOI 10.1007/s00265-008-0661-x; Pohl M, 2007, ENTOMOL GEN, V29, P111; RAFINSKI JN, 1979, PLANT SYST EVOL, V131, P107, DOI 10.1007/BF00984125; Rausher MD, 2008, INT J PLANT SCI, V169, P7, DOI 10.1086/523358; Rohde K, 2013, J COMP PHYSIOL A, V199, P197, DOI 10.1007/s00359-012-0783-5; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; SILBERGLIED RE, 1979, ANNU REV ECOL SYST, V10, P373, DOI 10.1146/annurev.es.10.110179.002105; Totland O, 1998, ACTA OECOL, V19, P155, DOI 10.1016/S1146-609X(98)80019-2; Tremblay RL, 2007, PLANT SPEC BIOL, V22, P95, DOI 10.1111/j.1442-1984.2007.00181.x; Wessinger CA, 2012, J EXP BOT, V63, P5741, DOI 10.1093/jxb/ers267; Whitney HM, 2013, NATURWISSENSCHAFTEN, V100, P249, DOI 10.1007/s00114-013-1020-y; Willmer P., 2011, POLLINATION FLORAL E	52	6	6	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 28	2016	11	4							e0154728	10.1371/journal.pone.0154728	http://dx.doi.org/10.1371/journal.pone.0154728			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DK8XE	27124278	gold, Green Published, Green Submitted			2022-12-26	WOS:000375211700126
J	Maggi, L; Margheri, F; Luciani, C; Capone, M; Rossi, MC; Chilla, A; Santarlasci, V; Mazzoni, A; Cimaz, R; Liotta, F; Maggi, E; Cosmi, L; Del Rosso, M; Annunziato, F				Maggi, Laura; Margheri, Francesca; Luciani, Cristina; Capone, Manuela; Rossi, Maria Caterina; Chilla, Anastasia; Santarlasci, Veronica; Mazzoni, Alessio; Cimaz, Rolando; Liotta, Francesco; Maggi, Enrico; Cosmi, Lorenzo; Del Rosso, Mario; Annunziato, Francesco			Th1-Induced CD106 Expression Mediates Leukocytes Adhesion on Synovial Fibroblasts from Juvenile Idiopathic Arthritis Patients	PLOS ONE			English	Article							T-HELPER-CELLS; TH17 CELLS; INFLAMMATION; SYNOVIOCYTES; PHENOTYPE; CYTOKINES; RECEPTOR; PROTEIN; ETANERCEPT; PLASTICITY	This study tested the hypothesis that subsets of human T helper cells can orchestrate leukocyte adhesion to synovial fibroblasts (SFbs), thus regulating the retention of leukocytes in the joints of juvenile idiopathic arthritis (JIA) patients. Several cell types, such as monocytes/macrophages, granulocytes, T and B lymphocytes, SFbs and osteoclasts participate in joint tissue damage JIA. Among T cells, an enrichment of classic and non-classic Th1 subsets, has been found in JIA synovial fluid (SF), compared to peripheral blood (PB). Moreover, it has been shown that IL-12 in the SF of inflamed joints mediates the shift of Th17 lymphocytes towards the non-classic Th1 subset. Culture supernatants of Th17, classic and non-classic Th1 clones, have been tested for their ability to stimulate proliferation, and to induce expression of adhesion molecules on SFbs, obtained from healthy donors. Culture supernatants of both classic and non-classic Th1, but not of Th17, clones, were able to induce CD106 (VCAM-1) up-regulation on SFbs. This effect, mediated by tumor necrosis factor (TNF)-alpha, was crucial for the adhesion of circulating leukocytes on SFbs. Finally, we found that SFbs derived from SF of JIA patients expressed higher levels of CD106 than those from healthy donors, resembling the phenotype of SFbs activated in vitro with Th1-clones supernatants. On the basis of these findings, we conclude that classic and non-classic Th1 cells induce CD106 expression on SFbs through TNF-alpha, an effect that could play a role in leukocytes retention in inflamed joints.	[Maggi, Laura; Capone, Manuela; Rossi, Maria Caterina; Santarlasci, Veronica; Mazzoni, Alessio; Liotta, Francesco; Maggi, Enrico; Cosmi, Lorenzo; Annunziato, Francesco] Univ Florence, Dept Expt & Clin Med, Florence, Italy; [Maggi, Laura; Annunziato, Francesco] Careggi Univ Hosp, Regenerat Med Unit, Florence, Italy; [Margheri, Francesca; Luciani, Cristina; Chilla, Anastasia; Del Rosso, Mario] Univ Florence, Dept Expt & Clin Biomed Sci, Florence, Italy; [Mazzoni, Alessio] Univ Naples 2, Dept Clin & Expt Med, Naples, Italy; [Mazzoni, Alessio] Univ Naples 2, Ctr Biomol Studies Supporting Human Hlth, Naples, Italy; [Cimaz, Rolando] Anna Meyer Childrens Hosp, Rheumatol Unit, Dept Paediat, Florence, Italy; [Cimaz, Rolando] Univ Florence, Florence, Italy	University of Florence; University of Florence; Azienda Ospedaliero Universitaria Careggi; University of Florence; Universita della Campania Vanvitelli; Universita della Campania Vanvitelli; University of Florence; Azienda Ospedaliera Universitaria (AOU) MEYER; University of Florence	Cosmi, L (corresponding author), Univ Florence, Dept Expt & Clin Med, Florence, Italy.	lorenzo.cosmi@unifi.it	Maggi, Laura/B-6693-2013; CIMAZ, Rolando/AAA-9058-2019; Chillà, Anastasia/ABC-7402-2020; Mazzoni, Alessio/AAB-4311-2019; Maggi, Enrico/AAA-8045-2019	Maggi, Laura/0000-0003-2862-9591; CIMAZ, Rolando/0000-0002-3260-4226; Mazzoni, Alessio/0000-0001-7768-3805; Maggi, Enrico/0000-0002-1824-3583; Annunziato, Francesco/0000-0001-8798-7589	Italian Ministry of Health (Ricerca Finalizzata) [RF-2010-2314610]; Associazione Italiana Ricerca sul Cancro (AIRC)	Italian Ministry of Health (Ricerca Finalizzata)(Ministry of Health, Italy); Associazione Italiana Ricerca sul Cancro (AIRC)(Fondazione AIRC per la ricerca sul cancro)	This study was supported by grants from the Italian Ministry of Health (Ricerca Finalizzata 2010, project code: RF-2010-2314610), Associazione Italiana Ricerca sul Cancro (AIRC).	Acosta-Rodriguez EV, 2007, NAT IMMUNOL, V8, P639, DOI 10.1038/ni1467; Annunziato F, 2007, J EXP MED, V204, P1849, DOI 10.1084/jem.20070663; BOMBARA MP, 1993, J LEUKOCYTE BIOL, V54, P399, DOI 10.1002/jlb.54.5.399; Brescia AC, 2014, ARTHRITIS RHEUMATOL, V66, P1352, DOI 10.1002/art.38336; Carter RA, 2001, ARTHRITIS RHEUM-US, V44, P985, DOI 10.1002/1529-0131(200105)44:5<985::AID-ANR176>3.3.CO;2-G; Casnici C, 2014, MEDIAT INFLAMM, V2014, DOI 10.1155/2014/702057; Cerinic MM, 1998, LIFE SCI, V63, P441, DOI 10.1016/S0024-3205(98)00293-8; Cosmi L, 2008, J EXP MED, V205, P1903, DOI 10.1084/jem.20080397; Cosmi L, 2014, INT ARCH ALLERGY IMM, V164, P171, DOI 10.1159/000363502; Cosmi L, 2014, CYTOM PART A, V85A, P36, DOI 10.1002/cyto.a.22348; Cosmi L, 2011, ARTHRITIS RHEUM-US, V63, P2504, DOI 10.1002/art.30332; Crescioli C, 2007, J ENDOCRINOL, V195, P145, DOI 10.1677/JOE-07-0240; Cua DJ, 2003, NATURE, V421, P744, DOI 10.1038/nature01355; de Jager W, 2007, ANN RHEUM DIS, V66, P589, DOI 10.1136/ard.2006.061853; Del Rosso M, 1999, CLIN EXP RHEUMATOL, V17, P485; Fouser LA, 2008, IMMUNOL REV, V226, P87, DOI 10.1111/j.1600-065X.2008.00712.x; Guiducci S, 2005, CLIN EXP RHEUMATOL, V23, P364; Ivanov II, 2006, CELL, V126, P1121, DOI 10.1016/j.cell.2006.07.035; Lombardi A, 2009, EUR J CELL BIOL, V88, P731, DOI 10.1016/j.ejcb.2009.07.004; Maggi L, 2014, ARTHRITIS RHEUMATOL, V66, P1372, DOI 10.1002/art.38355; Maggi L, 2012, EUR J IMMUNOL, V42, P3180, DOI 10.1002/eji.201242648; Margheri F, 2006, ARTHRITIS RHEUM-US, V54, P3926, DOI 10.1002/art.22263; Marotte H, 2014, EXPERT OPIN BIOL TH, V14, P569, DOI 10.1517/14712598.2014.896334; Miossec P, 2011, ARTHRITIS RHEUM-US, V63, P2168, DOI 10.1002/art.30331; MORALESDUCRET J, 1992, J IMMUNOL, V149, P1424; MOSMANN TR, 1989, ANNU REV IMMUNOL, V7, P145, DOI 10.1146/annurev.immunol.7.1.145; Murray KJ, 1996, J RHEUMATOL, V23, P2116; Nistala K, 2010, P NATL ACAD SCI USA, V107, P14751, DOI 10.1073/pnas.1003852107; Oppmann B, 2000, IMMUNITY, V13, P715, DOI 10.1016/S1074-7613(00)00070-4; Ouyang WJ, 2008, IMMUNITY, V28, P454, DOI 10.1016/j.immuni.2008.03.004; Pelletier M, 2010, BLOOD, V115, P335, DOI 10.1182/blood-2009-04-216085; Ravelli A, 2007, LANCET, V369, P767, DOI 10.1016/S0140-6736(07)60363-8; Rios-Navarro C, 2015, EUR J PHARMACOL, V765, P355, DOI 10.1016/j.ejphar.2015.08.054; ROMAGNANI S, 1994, ANNU REV IMMUNOL, V12, P227, DOI 10.1146/annurev.iy.12.040194.001303; von Andrian UH, 2003, NEW ENGL J MED, V348, P68, DOI 10.1056/NEJMe020157	35	13	13	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 28	2016	11	4							e0154422	10.1371/journal.pone.0154422	http://dx.doi.org/10.1371/journal.pone.0154422			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DK8XE	27123929	Green Published, gold, Green Submitted			2022-12-26	WOS:000375211700084
J	Guerra-Garcia, JM; Hachero-Cruzado, I; Gonzalez-Romero, P; Jimenez-Prada, P; Cassell, C; Ros, M				Manuel Guerra-Garcia, Jose; Hachero-Cruzado, Ismael; Gonzalez-Romero, Pablo; Jimenez-Prada, Pablo; Cassell, Christopher; Ros, Macarena			Towards Integrated Multi-Trophic Aquaculture: Lessons from Caprellids (Crustacea: Amphipoda)	PLOS ONE			English	Article							FATTY-ACID-COMPOSITION; SCAURA TEMPLETON; FOULING COMMUNITIES; ARACHIDONIC-ACID; LIFE-HISTORY; FRESH-WATER; LIVE PREY; FISH; DIET; FEED	The search for alternative live feed organisms and the progression of Integrative Multi-Trophic Aquaculture (IMTA) are currently being highly prioritised in EU strategies. Caprellids could potentially be an important exploitable resource in aquaculture due to their high levels of beneficial polyunsaturated fatty acids, fast growing nature and widespread distribution. Furthermore, since they are mainly detritivorous, they could be excellent candidates for integration into IMTA systems, potentially benefitting from uneaten feed pellets and faeces released by cultured fish in fish farms and sea-cage structures. Despite this, there is a lack of experimental studies to: (i) test inexpensive diets for caprellids, such as detritus, (ii) develop sustainable caprellid culture techniques and (iii) include caprellids in IMTA systems. The main aim of this study was to determine whether detritus (D) in the form of fish faeces provided an adequate diet for caprellids in comparison to other traditional diets, such as Artemia nauplii (A) or phytoplankton (P). Adult survival rate was shown to be significantly higher for caprellids fed with D. Conversely, hatchlings had the highest survival rate with A, although the juvenile growth rate and number of moults was similar in the three diets. With regard to lipid composition, caprellids fed with A had higher concentrations of Triacylglycerols (TAG) and Phosphatidylcholine (PC) while those fed with P or D were richer in polyunsaturated fatty acids, especially 22: 6(n-3) (DHA). Interestingly, caprellids fed with D were also a rich source of 18: 2(n-6) (LA), considered to be an essential fatty acid in vertebrates. It was found that detritus based mainly on fish faeces and uneaten feed pellets can be considered an adequate feed for adult caprellids, providing a source of both omega-3 (DHA) and omega-6 (LA) fatty acids. Hatchlings however seem to require an additional input of TAG and PC during juvenile stages to properly grow.	[Manuel Guerra-Garcia, Jose; Gonzalez-Romero, Pablo; Jimenez-Prada, Pablo; Ros, Macarena] Univ Seville, Fac Biol, Dept Zool, Lab Biol Marina, Seville, Spain; [Hachero-Cruzado, Ismael; Jimenez-Prada, Pablo] IFAPA El Toruno, Camino Tiro Pichon S-N, Cadiz, Spain; [Cassell, Christopher] Univ Portsmouth, Sch Biol Sci, Portsmouth, Hants, England	University of Sevilla; University of Portsmouth	Guerra-Garcia, JM (corresponding author), Univ Seville, Fac Biol, Dept Zool, Lab Biol Marina, Seville, Spain.	jmguerra@us.es	Ros, Macarena/AAD-4589-2021; Cruzado, Ismael Hachero/R-8737-2019; /AAD-1835-2020; Guerra-García, José Manuel/P-1700-2014	Cruzado, Ismael Hachero/0000-0003-3023-5540; /0000-0001-9739-9270; Guerra-García, José Manuel/0000-0001-6050-4997; Ros, Macarena/0000-0001-8074-0778; Cassell, Christopher/0000-0003-1676-637X	Consejeria de Innovacion, Ciencia y Empresa, Junta de Andalucia [P11-RNM-7041]; INIA	Consejeria de Innovacion, Ciencia y Empresa, Junta de Andalucia(Junta de Andalucia); INIA(Instituto de Investigacion Agropecuaria (INIA))	Financial support of this work was provided by the Consejeria de Innovacion, Ciencia y Empresa, Junta de Andalucia (Project P11-RNM-7041). I. Hachero-Cruzado was supported by an INIA postdoctoral contract.	Ajiboye OO, 2011, REV FISH BIOL FISHER, V21, P225, DOI 10.1007/s11160-010-9169-3; Alexander KA, 2015, AQUACULTURE, V443, P16, DOI 10.1016/j.aquaculture.2015.03.005; Anderson MJ, 2005, PERMANOVA FORTRAN CO; [Anonymous], 2014, CREATING SUSTAINABLE; Arts MT, 2001, CAN J FISH AQUAT SCI, V58, P122, DOI 10.1139/cjfas-58-1-122; Ashton GV, 2010, MAR FRESHWATER RES, V61, P549, DOI 10.1071/MF09162; Baeza-Rojano E., 2013, Zoologica Baetica, V24, P155; Baeza-Rojano E, 2014, J SEA RES, V85, P29, DOI 10.1016/j.seares.2013.09.007; Baeza-Rojano E, 2013, J SEA RES, V83, P146, DOI 10.1016/j.seares.2013.04.014; Baeza-Rojano E, 2013, AQUAC RES, V44, P1602, DOI 10.1111/j.1365-2109.2012.03169.x; Baeza-Rojano E, 2011, MAR BIOL RES, V7, P85, DOI 10.1080/17451001003713571; Baeza-Rojano E, 2010, AQUACULTURE, V300, P243, DOI 10.1016/j.aquaculture.2009.12.029; Bell JG, 2003, AQUACULTURE, V218, P491, DOI 10.1016/S0044-8486(02)00370-8; Bello Carlos Luis, 1999, Boletin de Entomologia Venezolana, V14, P77; BRAWLEY SH, 1987, J PHYCOL, V23, P614; Canavate JP, PHYTOCHEM IN PRESS; Carlton JT, 1996, ECOLOGY, V77, P1653, DOI 10.2307/2265767; Cass CJ, 2014, DEEP-SEA RES PT I, V93, P117, DOI 10.1016/j.dsr.2014.08.001; Chopin T., 2004, Bulletin of the Aquaculture Association of Canada, V104, P11; CHRISTIE WW, 1982, J LIPID RES, V23, P1072; CLARKE A, 1985, MAR BIOL, V88, P247, DOI 10.1007/BF00392587; Clarke K., 2001, PRIMER V5 USER MANUA; Conceicao LEC, 2010, AQUAC RES, V41, P613, DOI 10.1111/j.1365-2109.2009.02242.x; Cook EJ, 2006, ICES J MAR SCI, V63, P637, DOI 10.1016/j.icesjms.2005.12.007; Cook EJ, 2010, MAR BIOL, V157, P19, DOI 10.1007/s00227-009-1292-0; Coutteau P, 1997, AQUACULTURE, V155, P149, DOI 10.1016/S0044-8486(97)00125-7; De Broyer C., 1996, B MUS CIV ST NAT VER, V20, P547; DUFFY JE, 1990, OECOLOGIA, V83, P267, DOI 10.1007/BF00317764; Dutra BK, 2007, COMP BIOCHEM PHYS A, V148, P239, DOI 10.1016/j.cbpa.2007.04.013; Cruz-Suarez LE, 2010, AQUACULTURE, V301, P64, DOI 10.1016/j.aquaculture.2010.01.021; Fernandez-Gonzalez V, 2014, HELGOLAND MAR RES, V68, P187, DOI 10.1007/s10152-013-0375-y; FOLCH J, 1957, J BIOL CHEM, V226, P497; Garofalaki TF, 2006, CHEM PHYS LIPIDS, V140, P55, DOI 10.1016/j.chemphyslip.2006.01.006; Gonzalez ML, 2011, CRUSTACEANA, V84, P769, DOI 10.1163/001121611X579132; Gonzalez-Silvera D, 2015, MAR POLLUT BULL, V91, P45, DOI 10.1016/j.marpolbul.2014.12.029; Graeve M, 2001, POLAR BIOL, V24, P853; Guerra-Garcia JM, 2014, J SEA RES, V85, P508, DOI 10.1016/j.seares.2013.08.006; Guerra-Garcia JM, 2004, SCI MAR, V68, P501, DOI 10.3989/scimar.2004.68n4501; Guerra-Garcia JM, 2001, OPHELIA, V55, P27, DOI 10.1080/00785236.2001.10409471; Guerra-Garcia JM, 2015, MAR BIOL RES, V11, P703, DOI 10.1080/17451000.2014.985231; Hamre K, 2013, REV AQUACULT, V5, pS26, DOI 10.1111/j.1753-5131.2012.01086.x; Hentschel BT, 1998, ECOLOGY, V79, P1357, DOI 10.1890/0012-9658(1998)079[1357:IVICIO]2.0.CO;2; Hyne RV, 2009, ENVIRON TOXICOL CHEM, V28, P123, DOI 10.1897/08-210.1; Irisarri J, 2015, AQUAC RES, V46, P1988, DOI 10.1111/are.12356; Kolanowski W, 2007, J AM OIL CHEM SOC, V84, P827, DOI 10.1007/s11746-007-1116-7; Lahdes EO, 2010, J EXP MAR BIOL ECOL, V390, P125, DOI 10.1016/j.jembe.2010.05.006; Legezynska J, 2012, HYDROBIOLOGIA, V684, P189, DOI 10.1007/s10750-011-0982-z; Leonard AE, 2004, PROG LIPID RES, V43, P36, DOI 10.1016/S0163-7827(03)00040-7; Li K, 2015, AQUACULT NUTR, V21, P85, DOI 10.1111/anu.12140; Liu LP, 2014, AQUACULTURE, V418, P79, DOI 10.1016/j.aquaculture.2013.10.005; Loureiro BR, 2012, ACTA LIMNOL BRAS, V4, P357; Loureiro BR, 2011, BOL INST PESCA, V37, P47; Madin J, 2009, ESTUAR COAST SHELF S, V83, P19, DOI 10.1016/j.ecss.2009.03.012; MANN KH, 1988, LIMNOL OCEANOGR, V33, P910, DOI 10.4319/lo.1988.33.4_part_2.0910; Guerra-Garcia JM, 2009, MAR BIOL, V156, P1881, DOI 10.1007/s00227-009-1220-3; Martinez J., 2008, Aquatic Invasions, V3, P165, DOI 10.3391/ai.2008.3.2.6; Martins CIM, 2010, AQUACULT ENG, V43, P83, DOI 10.1016/j.aquaeng.2010.09.002; McLeod RJ, 2013, MAR ECOL PROG SER, V479, P1, DOI 10.3354/meps10327; Moren M, 2006, AQUACULTURE, V261, P174, DOI 10.1016/j.aquaculture.2006.06.022; NOAA, 2008, OFFSH AQ US EC CONS; Olabarria C, 2009, ESTUAR COAST SHELF S, V84, P282, DOI 10.1016/j.ecss.2009.06.021; OLSEN RE, 1989, J EXP MAR BIOL ECOL, V129, P189, DOI 10.1016/0022-0981(89)90056-7; Cabezas MP, 2014, BIOL INVASIONS, V16, P2221, DOI 10.1007/s10530-014-0660-y; Querellou J, 2010, 15 EUR SCI FDN; Rigolet C, 2011, J EXP MAR BIOL ECOL, V406, P29, DOI 10.1016/j.jembe.2011.06.006; Ros M, 2014, MEDITERR MAR SCI, V15, P145; Ros M, 2015, MAR POLLUT BULL, V98, P247, DOI 10.1016/j.marpolbul.2015.06.041; Ros M, 2014, ESTUAR COAST SHELF S, V139, P88, DOI 10.1016/j.ecss.2013.12.033; Ros M, 2013, MAR BIOL RES, V9, P293, DOI 10.1080/17451000.2012.739695; Rossi F, 2004, LIMNOL OCEANOGR, V49, P408, DOI 10.4319/lo.2004.49.2.0408; Salvo F, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0136772; Samocha TM, 2015, AQUACULTURE, V446, P263, DOI 10.1016/j.aquaculture.2015.05.008; Suontama J, 2007, AQUACULT NUTR, V13, P50, DOI 10.1111/j.1365-2095.2007.00453.x; Tierney T.D., 2004, Irish Naturalists' Journal, V27, P437; Underwood A.J., 1997, EXPT ECOLOGY THEIR L, DOI DOI 10.1017/CBO9780511806407; Underwood AJ, 2002, GMAV 5 979 WINDOWS A; van der Meeren T, 2008, AQUACULTURE, V274, P375, DOI 10.1016/j.aquaculture.2007.11.041; Villalta M, 2005, AQUACULTURE, V245, P193, DOI 10.1016/j.aquaculture.2004.11.035; Wang M, 2014, MAR FRESHWATER RES, V65, P337, DOI 10.1071/MF13048; Willis KJ, 2004, J MAR BIOL ASSOC UK, V84, P1027, DOI 10.1017/S0025315404010355h; Woods CMC, 2009, AQUACULTURE, V289, P199, DOI 10.1016/j.aquaculture.2009.01.018; [No title captured], DOI [10.5650/jos1996.48.595, DOI 10.5650/JOS1996.48.595, DOI 10.5650/J0S1996.48.595]	82	23	23	2	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 28	2016	11	4							e0154776	10.1371/journal.pone.0154776	http://dx.doi.org/10.1371/journal.pone.0154776			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DK8XE	27124465	Green Submitted, Green Published, gold			2022-12-26	WOS:000375211700128
J	Boateng, LR; Bennin, D; De Oliveira, S; Huttenlocher, A				Boateng, Lindsy R.; Bennin, David; De Oliveira, Sofia; Huttenlocher, Anna			Mammalian Actin-binding Protein-1/Hip-55 Interacts with FHL2 and Negatively Regulates Cell Invasion	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						adaptor protein; cell invasion; cell migration; focal adhesion; Rho (Rho GTPase); FHL2; mAbp1	CLATHRIN-COATED PITS; BREAST-CANCER CELLS; ONLY PROTEIN FHL2; TRANSCRIPTIONAL COACTIVATOR FHL2; TRANS-GOLGI NETWORK; BETA-CATENIN; ALPHA-SUBUNIT; TUMOR-CELLS; RECEPTOR; ACTIVATION	Mammalian actin-binding protein-1 (mAbp1) is an adaptor protein that binds actin and modulates scission during endocytosis. Recent studies suggest that mAbp1 impairs cell invasion; however, the mechanism for the inhibitory effects of mAbp1 remain unclear. We performed a yeast two-hybrid screen and identified the adaptor protein, FHL2, as a novel binding partner that interacts with the N-terminal actin depolymerizing factor homology domain (ADFH) domain of mAbp1. Here we report that depletion of mAbp1 or ectopic expression of the ADFH domain of mAbp1 increased Rho GTPase signaling and breast cancer cell invasion. Moreover, cell invasion induced by the ADFH domain of mAbp1 required the expression of FHL2. Taken together, our findings show that mAbp1 and FHL2 are novel binding partners that differentially regulate Rho GTPase signaling and MTLn3 breast cancer cell invasion.	[Boateng, Lindsy R.] Univ Wisconsin, Program Cellular & Mol Biol, Madison, WI 53706 USA; [Bennin, David; De Oliveira, Sofia; Huttenlocher, Anna] Univ Wisconsin, Dept Med Microbiol & Immunol, Madison, WI 53706 USA; [Bennin, David; De Oliveira, Sofia; Huttenlocher, Anna] Univ Wisconsin, Dept Pediat, Madison, WI 53706 USA	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison	Huttenlocher, A (corresponding author), Dept Med Microbiol & Immunol, 1550 Linden Dr,4225 Microbial Sci Bldg,Rm 4205, Madison, WI 53706 USA.	huttenlocher@wisc.edu	de Oliveira, Sofia/AAV-4304-2020	de Oliveira, Sofia/0000-0003-0893-111X	National Institutes of Health [T32 CA009135, R01 CA085862]; NATIONAL CANCER INSTITUTE [R01CA085862, T32CA009135] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grants T32 CA009135 (NCI Cancer Biology; to L. B.) and R01 CA085862 (NCI; to A. H.). The authors declare no competing or financial interests. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Blau N, 2000, HUM MUTAT, V16, P54, DOI 10.1002/1098-1004(200007)16:1<54::AID-HUMU10>3.0.CO;2-C; Boateng LR, 2012, J CELL SCI, V125, P1329, DOI 10.1242/jcs.096529; Borczuk AC, 2004, AM J RESP CRIT CARE, V170, P167, DOI 10.1164/rccm.200401-066OC; Brun J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055034; Cao H, 2003, MOL CELL BIOL, V23, P2162, DOI 10.1128/MCB.23.6.2162-2170.2003; Carragher NO, 2006, ONCOGENE, V25, P5726, DOI 10.1038/sj.onc.1209582; Chan KK, 1998, GENE, V210, P345, DOI 10.1016/S0378-1119(97)00644-6; Chung SY, 2012, ONCOTARGET, V3, P1629; Coghill ID, 2003, J BIOL CHEM, V278, P24139, DOI 10.1074/jbc.M213259200; Connert S, 2006, EMBO J, V25, P1611, DOI 10.1038/sj.emboj.7601053; Cortesio CL, 2008, J CELL BIOL, V180, P957, DOI 10.1083/jcb.200708048; Cortesio CL, 2010, MOL BIOL CELL, V21, P186, DOI 10.1091/mbc.E09-02-0106; Derby MC, 2007, TRAFFIC, V8, P758, DOI 10.1111/j.1600-0854.2007.00563.x; Dergai O, 2010, BIOCHEM BIOPH RES CO, V402, P408, DOI 10.1016/j.bbrc.2010.10.045; Gabriel B, 2006, J SOC GYNECOL INVEST, V13, P69, DOI 10.1016/j.jsgi.2005.10.001; Gabriel B, 2004, ANTICANCER RES, V24, P921; Goode BL, 2001, J CELL BIOL, V153, P627, DOI 10.1083/jcb.153.3.627; He KM, 2015, FASEB J, V29, P2495, DOI 10.1096/fj.14-264259; Itoh K, 1999, NAT MED, V5, P221, DOI 10.1038/5587; Jang HS, 2010, NEUROCHEM RES, V35, P1796, DOI 10.1007/s11064-010-0246-8; Johannessen M, 2006, CELL MOL LIFE SCI, V63, P268, DOI 10.1007/s00018-005-5438-z; Kessels MM, 2000, MOL BIOL CELL, V11, P393, DOI 10.1091/mbc.11.1.393; Kessels MM, 2001, J CELL BIOL, V153, P351, DOI 10.1083/jcb.153.2.351; KIM YO, 1995, BIOCHEM J, V308, P63, DOI 10.1042/bj3080063; Kinoshita M, 2005, INT J UROL, V12, P390, DOI 10.1111/j.1442-2042.2005.01093.x; Kobayashi S, 2004, ENDOCR RES, V30, P617, DOI 10.1081/ERC-200043789; Labalette C, 2004, MOL CELL BIOL, V24, P10689, DOI 10.1128/MCB.24.24.10689-10702.2004; Lange S, 2002, J CELL SCI, V115, P4925, DOI 10.1242/jcs.00181; Li M, 2008, GLIA, V56, P1328, DOI 10.1002/glia.20701; Liu JL, 2009, MOL BIOL CELL, V20, P3763, DOI 10.1091/mbc.E08-09-0967; Liu N, 2014, INT J MOL SCI, V15, P4903, DOI 10.3390/ijms15034903; Luke MR, 2003, J BIOL CHEM, V278, P4216, DOI 10.1074/jbc.M210387200; Malik N, 1996, J BIOL CHEM, V271, P22754, DOI 10.1074/jbc.271.37.22754; Malik N, 1998, MAMM GENOME, V9, P136, DOI 10.1007/s003359900704; Mamoune A, 2003, CANCER RES, V63, P4632; Martin B, 2002, J CELL BIOL, V159, P113, DOI 10.1083/jcb.200202075; Martin BT, 2007, CELL CYCLE, V6, P1779, DOI 10.4161/cc.6.14.4448; Morgan MJ, 1996, BIOCHEM BIOPH RES CO, V225, P632, DOI 10.1006/bbrc.1996.1222; Morlon A, 2003, P NATL ACAD SCI USA, V100, P3977, DOI 10.1073/pnas.0735923100; Muller JM, 2002, EMBO J, V21, P736, DOI 10.1093/emboj/21.4.736; O'Connor RJ, 2001, ONCOGENE, V20, P1882, DOI 10.1038/sj.onc.1204278; Ozaki K, 2004, NATURE, V429, P72, DOI 10.1038/nature02502; RUOSLAHTI E, 1982, METHOD ENZYMOL, V82, P803; Sahai E, 2003, NAT CELL BIOL, V5, P711, DOI 10.1038/ncb1019; Samson T, 2004, J BIOL CHEM, V279, P28641, DOI 10.1074/jbc.M312894200; Sturm A, 2004, J IMMUNOL, V173, P3825, DOI 10.4049/jimmunol.173.6.3825; Suzuki Keiko, 2010, BMC Res Notes, V3, P294, DOI 10.1186/1756-0500-3-294; THONY B, 1992, BIOCHEM BIOPH RES CO, V189, P1437, DOI 10.1016/0006-291X(92)90235-D; Wei Y, 2003, J BIOL CHEM, V278, P5188, DOI 10.1074/jbc.M207216200; Westphal P, 2015, AM J CLIN PATHOL, V143, P248, DOI 10.1309/AJCPXEC6CIT2TXAF; Wixler V, 2000, J BIOL CHEM, V275, P33669, DOI 10.1074/jbc.M002519200; Wixler V, 2007, J CELL BIOL, V177, P163, DOI 10.1083/jcb.200606043; Wu D, 2009, ONCOGENE, V28, P2219, DOI 10.1038/onc.2009.96; WU H, 1993, J CELL BIOL, V120, P1417, DOI 10.1083/jcb.120.6.1417; Wyckoff JB, 2006, CURR BIOL, V16, P1515, DOI 10.1016/j.cub.2006.05.065; Xiong ZH, 2010, IUBMB LIFE, V62, P669, DOI 10.1002/iub.367; Xu WD, 2006, J BIOL CHEM, V281, P11826, DOI 10.1074/jbc.M510141200; Yamaguchi H, 2007, BBA-MOL CELL RES, V1773, P642, DOI 10.1016/j.bbamcr.2006.07.001; Yan JH, 2003, FEBS LETT, V553, P183, DOI 10.1016/S0014-5793(03)00978-5; Yoshioka K, 1999, CANCER RES, V59, P2004; Zhang WJ, 2011, EUR J CANCER, V47, P121, DOI 10.1016/j.ejca.2010.07.045; Zhang WJ, 2010, CARCINOGENESIS, V31, P1220, DOI 10.1093/carcin/bgq094; ZHU L, 1993, GENE DEV, V7, P1111, DOI 10.1101/gad.7.7a.1111	63	10	13	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 1	2016	291	27					13987	13998		10.1074/jbc.M116.725739	http://dx.doi.org/10.1074/jbc.M116.725739			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DR5XG	27129278	Green Published, hybrid			2022-12-26	WOS:000379975100008
J	Martinez, NA; Ayala, AM; Martinez, M; Martinez-Rivera, FJ; Miranda, JD; Silva, WI				Martinez, Namyr A.; Ayala, Alondra M.; Martinez, Magdiel; Martinez-Rivera, Freddyson J.; Miranda, Jorge D.; Silva, Walter I.			Caveolin-1 Regulates the P2Y(2) Receptor Signaling in Human 1321N1 Astrocytoma Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SITE-DIRECTED MUTAGENESIS; LIPID RAFTS; SCAFFOLDING DOMAIN; CORTICAL-NEURONS; KINASE-ACTIVITY; UP-REGULATION; P2 RECEPTORS; PROTEIN; EXPRESSION; ACTIVATION	Damage to the CNS can cause a differential spatio-temporal release of multiple factors, such as nucleotides, ATP and UTP. The latter interact with neuronal and glial nucleotide receptors. The P2Y(2) nucleotide receptor (P2Y(2)R) has gained prominence as a modulator of gliotic responses after CNS injury. Still, the molecular mechanisms underlying these responses in glia are not fully understood. Membrane-raft microdomains, such as caveolae, and their constituent caveolins, modulate receptor signaling in astrocytes; yet, their role in P2Y(2)R signaling has not been adequately explored. Hence, this study evaluated the role of caveolin-1 (Cav-1) in modulating P2Y(2)R subcellular distribution and signaling in human 1321N1 astrocytoma cells. Recombinant hP2Y(2)R expressed in 1321N1 cells and Cav-1 were found to co-fractionate in light-density membrane-raft fractions, co-localize via confocal microscopy, and co-immunoprecipitate. Raft localization was dependent on ATP stimulation and Cav-1 expression. This hP2Y(2)R/Cav-1 distribution and interaction was confirmed with various cell model systems differing in the expression of both P2Y(2)R and Cav-1, and shRNA knockdown of Cav-1 expression. Furthermore, shRNA knockdown of Cav-1 expression decreased nucleotide-induced increases in the intracellular Ca2+ concentration in 1321N1 and C6 glioma cells without altering TRAP-6 and carbachol Ca2+ responses. In addition, Cav-1 shRNA knockdown also decreased AKT phosphorylation and altered the kinetics of ERK1/2 activation in 1321N1 cells. Our findings strongly suggest that P2Y(2)R interaction with Cav-1 in membrane-raft caveolae of 1321N1 cells modulates receptor coupling to its downstream signaling machinery. Thus, P2Y(2)R/Cav-1 interactions represent a novel target for controlling P2Y(2)R function after CNS injury.	[Martinez, Namyr A.; Martinez, Magdiel; Miranda, Jorge D.; Silva, Walter I.] Univ Puerto Rico, Sch Med, Dept Physiol & Biophys, Med Sci Campus, San Juan, PR 00936 USA; [Ayala, Alondra M.] Univ Puerto Rico, Sch Med, Dept Psychiat, Med Sci Campus, San Juan, PR 00936 USA; [Martinez-Rivera, Freddyson J.] Univ Puerto Rico, Sch Med, Dept Anat & Neurobiol, Med Sci Campus, San Juan, PR 00936 USA	University of Puerto Rico; University of Puerto Rico Medical Sciences Campus; University of Puerto Rico; University of Puerto Rico Medical Sciences Campus; University of Puerto Rico; University of Puerto Rico Medical Sciences Campus	Silva, WI (corresponding author), POB 365067, San Juan, PR 00936 USA.	walter.silva@upr.edu			NCRR at the UPR-MSC [G12RR003051]; NCRR at the Universidad Central del Caribe [G12RR03035];  [ISI0 RR-13705-01];  [DBI-0923132]; NATIONAL CENTER FOR RESEARCH RESOURCES [G12RR003051, G12RR003035] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R25GM061838, P20GM103642] Funding Source: NIH RePORTER; National Institute on Minority Health and Health Disparities [G12MD007600] Funding Source: NIH RePORTER	NCRR at the UPR-MSC; NCRR at the Universidad Central del Caribe; ; ; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); National Institute on Minority Health and Health Disparities(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD))	We thank Dr. G. A. Weisman for kindly providing the WT 1321N1, pLXSN 1321N1, and hHAP2Y<INF>2</INF>R 1321N1 astrocytoma cells; Dr. Jeffrey E. Pessin for kindly providing the Myc-tagged human caveolin-1 pcDNA3.1 expression vector; Dr. Priscila Sanabria (Universidad Central del Caribe, PR) for support with the calcium flux and confocal microscopy imaging studies. We also thank Monica Quinones for support in some of the experiments. Some of the experiments were performed at the RCMI Facilities of the University of Puerto Rico, MSC, and Universidad Central del Caribe. Shared instrumentation was supported by NCRR Grants G12RR003051 and G12RR03035, at the UPR-MSC and Universidad Central del Caribe, respectively. The Confocal Microscopy Facility at UPR-RP was supported by Grants ISI0 RR-13705-01 and DBI-0923132. Some experiments were performed at the Molecular Sciences Research Building of the University of Puerto Rico.	Abbracchio Maria P, 2006, Purinergic Signal, V2, P595, DOI 10.1007/s11302-006-9016-0; Adami C, 2001, GLIA, V33, P131, DOI 10.1002/1098-1136(200102)33:2<131::AID-GLIA1012>3.0.CO;2-D; Ando K, 2010, J PHARMACOL EXP THER, V334, P809, DOI 10.1124/jpet.110.167528; Arthur DB, 2007, J NEUROCHEM, V100, P1257, DOI 10.1111/j.1471-4159.2006.04305.x; Arthur DB, 2005, P NATL ACAD SCI USA, V102, P19138, DOI 10.1073/pnas.0505913102; Arthur DB, 2006, J NEUROSCI, V26, P3798, DOI 10.1523/JNEUROSCI.5338-05.2006; Bhatnagar A, 2004, J BIOL CHEM, V279, P34614, DOI 10.1074/jbc.M404673200; Bittar E., 2005, CAVEOLAE LIPID RAFTS; Burgos M, 2007, J NEUROCHEM, V103, P1785, DOI 10.1111/j.1471-4159.2007.04872.x; Camden JM, 2005, J BIOL CHEM, V280, P18696, DOI 10.1074/jbc.M500219200; Chini B, 2004, J MOL ENDOCRINOL, V32, P325, DOI 10.1677/jme.0.0320325; Choi RCY, 2013, MOL PHARMACOL, V84, P50, DOI 10.1124/mol.112.084160; Chorna NE, 2004, J NEUROCHEM, V91, P119, DOI 10.1111/j.1471-4159.2004.02699.x; Choudhury A, 2006, NAT CELL BIOL, V8, P317, DOI 10.1038/ncb1380; Cordes N, 2007, ONCOGENE, V26, P6851, DOI 10.1038/sj.onc.1210498; Couet J, 1997, J BIOL CHEM, V272, P6525, DOI 10.1074/jbc.272.10.6525; D' Ambrosi N, 2013, CURR MED CHEM, V20, P56; del Pozo MA, 2005, NAT CELL BIOL, V7, P901, DOI 10.1038/ncb1293; DeWire SM, 2007, ANNU REV PHYSIOL, V69, P483, DOI 10.1146/annurev.physiol.69.022405.154749; Ding L, 2011, J BIOL CHEM, V286, P27027, DOI 10.1074/jbc.M111.235176; Dohlman HG, 2015, J BIOL CHEM, V290, P19469, DOI 10.1074/jbc.R115.675728; Duncan GW, 2011, CLIN GERIATR MED, V27, P629, DOI 10.1016/j.cger.2011.07.008; Dunn KW, 2011, AM J PHYSIOL-CELL PH, V300, pC723, DOI 10.1152/ajpcell.00462.2010; Ebisuya M, 2005, J CELL SCI, V118, P2997, DOI 10.1242/jcs.02505; ERB L, 1995, J BIOL CHEM, V270, P4185, DOI 10.1074/jbc.270.9.4185; Flores RV, 2005, MOL CELL BIOCHEM, V280, P35, DOI 10.1007/s11010-005-8050-5; Fridolfsson HN, 2014, FASEB J, V28, P3823, DOI 10.1096/fj.14-252320; FUKURODA T, 1994, J APPL PHYSIOL, V76, P1976, DOI 10.1152/jappl.1994.76.5.1976; Gangadharan V, 2015, AM J PHYSIOL-CELL PH, V308, pC41, DOI 10.1152/ajpcell.00037.2014; Gentry PR, 2015, J BIOL CHEM, V290, P19478, DOI 10.1074/jbc.R115.662759; Gonzalez E, 2004, J BIOL CHEM, V279, P40659, DOI 10.1074/jbc.M407051200; Head BP, 2008, FASEB J, V22, P828, DOI 10.1096/fj.07-9299com; HO SN, 1989, GENE, V77, P51, DOI 10.1016/0378-1119(89)90358-2; Hoffmann C, 2008, J BIOL CHEM, V283, P30933, DOI 10.1074/jbc.M801472200; Ivaska J, 2002, MOL CELL BIOL, V22, P1352, DOI 10.1128/MCB.22.5.1352-1359.2002; Kong MMC, 2007, MOL PHARMACOL, V72, P1157, DOI 10.1124/mol.107.034769; Kong Q, 2009, J NEUROCHEM, V109, P1300, DOI 10.1111/j.1471-4159.2009.06048.x; Kubale V, 2007, CELL TISSUE RES, V330, P231, DOI 10.1007/s00441-007-0462-y; Lazarowski ER, 1997, J BIOL CHEM, V272, P24348, DOI 10.1074/jbc.272.39.24348; Li HJ, 2011, MOL CELL ENDOCRINOL, V338, P28, DOI 10.1016/j.mce.2011.02.014; Li LK, 2003, MOL CELL BIOL, V23, P9389, DOI 10.1128/MCB.23.24.9389-9404.2003; Luttikhuizen DT, 2004, CELL TISSUE RES, V317, P289, DOI 10.1007/s00441-004-0939-x; Mayor S, 2007, NAT REV MOL CELL BIO, V8, P603, DOI 10.1038/nrm2216; McMahon HT, 2011, NAT REV MOL CELL BIO, V12, P517, DOI 10.1038/nrm3151; Meyer C, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2012.204; Morris GE, 2012, AM J PHYSIOL-CELL PH, V302, pC723, DOI [10.1152/ajpcell.00202.2011, 10.1152/ajpcell.00202.2011.]; Moskvina E, 2003, J NEUROSCI, V23, P7479; Neary JT, 2009, TRENDS NEUROSCI, V32, P189, DOI 10.1016/j.tins.2009.01.002; Nguyen T, 1995, J BIOL CHEM, V270, P30845, DOI 10.1074/jbc.270.52.30845; Norambuena A, 2010, J BIOL CHEM, V285, DOI 10.1074/jbc.M109.081166; Okamoto T, 1998, J BIOL CHEM, V273, P5419, DOI 10.1074/jbc.273.10.5419; Ostrom RS, 2004, BRIT J PHARMACOL, V143, P235, DOI 10.1038/sj.bjp.0705930; Ostrom RS, 2002, MOL PHARMACOL, V61, P473, DOI 10.1124/mol.61.3.473; Otero M, 2000, MOL CELL BIOCHEM, V205, P115, DOI 10.1023/A:1007018001735; Pani B, 2009, CELL CALCIUM, V45, P625, DOI 10.1016/j.ceca.2009.02.009; Patel H. H., 2008, V186, P167, DOI 10.1007/978-3-540-72843-6_7; Patel HH, 2008, ANNU REV PHARMACOL, V48, P359, DOI 10.1146/annurev.pharmtox.48.121506.124841; Patel HH, 2009, ANTIOXID REDOX SIGN, V11, P1357, DOI [10.1089/ars.2008.2365, 10.1089/ARS.2008.2365]; Peterson TS, 2013, J NEUROCHEM, V125, P885, DOI 10.1111/jnc.12252; Peterson TS, 2010, MOL NEUROBIOL, V41, P356, DOI 10.1007/s12035-010-8115-7; Pike LJ, 2006, J LIPID RES, V47, P1597, DOI 10.1194/jlr.E600002-JLR200; Premont RT, 2007, ANNU REV PHYSIOL, V69, P511, DOI 10.1146/annurev.physiol.69.022405.154731; Rimmerman N, 2012, BRIT J PHARMACOL, V165, P2436, DOI 10.1111/j.1476-5381.2011.01380.x; Rodriguez-Zayas AE, 2010, INT J DEV NEUROSCI, V28, P413, DOI 10.1016/j.ijdevneu.2010.07.001; Salgado IK, 2012, CELL MOL NEUROBIOL, V32, P409, DOI 10.1007/s10571-011-9771-5; Sato S, 2000, P NATL ACAD SCI USA, V97, P10832, DOI 10.1073/pnas.170276797; Schroeder F, 2005, ADV MOL CEL, V36, P3, DOI 10.1016/S1569-6603(05)36001-6; Shenoy SK, 2005, J BIOL CHEM, V280, P15315, DOI 10.1074/jbc.M412418200; Shenoy SK, 2011, TRENDS PHARMACOL SCI, V32, P521, DOI 10.1016/j.tips.2011.05.002; Shigematsu S, 2003, J BIOL CHEM, V278, P10683, DOI 10.1074/jbc.M208563200; Silva WI, 2007, J NEUROCHEM, V103, P101, DOI 10.1111/j.1471-4159.2007.04712.x; Silva WI, 2005, INT J DEV NEUROSCI, V23, P599, DOI 10.1016/j.ijdevneu.2005.07.007; Silva WI, 1999, INT J DEV NEUROSCI, V17, P705, DOI 10.1016/S0736-5748(99)00040-4; Singh SP, 1998, NEUROREPORT, V9, P115, DOI 10.1097/00001756-199801050-00023; Smart EJ, 1999, MOL CELL BIOL, V19, P7289; Spisni E, 2005, BIOCHEM BIOPH RES CO, V338, P1383, DOI 10.1016/j.bbrc.2005.10.099; Sromek SM, 1998, MOL PHARMACOL, V54, P485, DOI 10.1124/mol.54.3.485; Miras-Portugal MT, 2015, COMPUT STRUCT BIOTEC, V13, P176, DOI 10.1016/j.csbj.2015.02.005; Tran MD, 2011, NEUROSCI LETT, V492, P155, DOI 10.1016/j.neulet.2011.01.078; Tsvetanova NG, 2015, J BIOL CHEM, V290, P6689, DOI 10.1074/jbc.R114.617951; Tulapurkar ME, 2005, CELL MOL LIFE SCI, V62, P1388, DOI 10.1007/s00018-005-5052-0; Vohringer C, 2001, DRUG DEVELOP RES, V53, P172, DOI 10.1002/ddr.1185; Wang LB, 2003, J LIPID RES, V44, P807, DOI 10.1194/jlr.M200449-JLR200; Weisman GA, 2012, MOL NEUROBIOL, V46, P96, DOI 10.1007/s12035-012-8263-z; Weisman GA, 2012, PURINERG SIGNAL, V8, P559, DOI 10.1007/s11302-012-9307-6; Wypych D, 2012, ACTA BIOCHIM POL, V59, P711; Wypych D, 2013, ADV EXP MED BIOL, V986, P31, DOI 10.1007/978-94-007-4719-7_3; Xu WP, 2003, CANCER RES, V63, P7777; Yankner BA, 2008, ANNU REV PATHOL-MECH, V3, P41, DOI 10.1146/annurev.pathmechdis.2.010506.092044; Zhu XD, 2011, J BIOL CHEM, V286, P8231, DOI 10.1074/jbc.M110.145888; Zinchuk V, 2011, NAT PROTOC, V6, P1554, DOI 10.1038/nprot.2011.384	91	25	25	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 3	2016	291	23					12208	12222		10.1074/jbc.M116.730226	http://dx.doi.org/10.1074/jbc.M116.730226			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DO9GJ	27129210	hybrid, Green Published			2022-12-26	WOS:000378092800022
J	Gunter, NL; Weir, TA; Slipinksi, A; Bocak, L; Cameron, SL				Gunter, Nicole L.; Weir, Tom A.; Slipinksi, Adam; Bocak, Ladislav; Cameron, Stephen L.			If Dung Beetles (Scarabaeidae: Scarabaeinae) Arose in Association with Dinosaurs, Did They Also Suffer a Mass Co-Extinction at the K-Pg Boundary?	PLOS ONE			English	Article							FOSSIL RECORD; INNER-MONGOLIA; SCARABAEOIDEA COLEOPTERA; DIVERSIFICATION RATES; PHYLOGENETIC ANALYSIS; MOLECULAR EVOLUTION; ADAPTIVE RADIATION; DIVERGENCE DATES; YIXIAN FORMATION; ANGIOSPERMS	The evolutionary success of beetles and numerous other terrestrial insects is generally attributed to co-radiation with flowering plants but most studies have focused on herbivorous or pollinating insects. Non-herbivores represent a significant proportion of beetle diversity yet potential factors that influence their diversification have been largely unexamined. In the present study, we examine the factors driving diversification within the Scarabaeidae, a speciose beetle family with a range of both herbivorous and non-herbivorous ecologies. In particular, it has been long debated whether the key event in the evolution of dung beetles (Scarabaeidae: Scarabaeinae) was an adaptation to feeding on dinosaur or mammalian dung. Here we present molecular evidence to show that the origin of dung beetles occurred in the middle of the Cretaceous, likely in association with dinosaur dung, but more surprisingly the timing is consistent with the rise of the angiosperms. We hypothesize that the switch in dinosaur diet to incorporate more nutritious and less fibrous angiosperm foliage provided a palatable dung source that ultimately created a new niche for diversification. Given the well-accepted mass extinction of non-avian dinosaurs at the Cretaceous-Paleogene boundary, we examine a potential coextinction of dung beetles due to the loss of an important evolutionary resource, i.e., dinosaur dung. The biogeography of dung beetles is also examined to explore the previously proposed "out of Africa" hypothesis. Given the inferred age of Scarabaeinae as originating in the Lower Cretaceous, the major radiation of dung feeders prior to the Cenomanian, and the early divergence of both African and Gondwanan lineages, we hypothesise that that faunal exchange between Africa and Gondwanaland occurred during the earliest evolution of the Scarabaeinae. Therefore we propose that both Gondwanan vicariance and dispersal of African lineages is responsible for present day distribution of scarabaeine dung beetles and provide examples.	[Gunter, Nicole L.; Bocak, Ladislav] Palacky Univ, Dept Zool, Fac Sci, CR-77147 Olomouc, Czech Republic; [Gunter, Nicole L.; Weir, Tom A.; Slipinksi, Adam] CSIRO, Australian Natl Insect Collect, Natl Res Collect Australia, Canberra, ACT, Australia; [Cameron, Stephen L.] Queensland Univ Technol, Earth Environm & Biol Sci Sch, Fac Sci & Engn, Brisbane, Qld 4001, Australia; [Gunter, Nicole L.] Cleveland Museum Nat Hist, Dept Invertebrate Zool, Cleveland, OH USA	Palacky University Olomouc; Commonwealth Scientific & Industrial Research Organisation (CSIRO); Queensland University of Technology (QUT); Cleveland Museum of Natural History	Gunter, NL (corresponding author), Palacky Univ, Dept Zool, Fac Sci, CR-77147 Olomouc, Czech Republic.; Gunter, NL (corresponding author), CSIRO, Australian Natl Insect Collect, Natl Res Collect Australia, Canberra, ACT, Australia.; Gunter, NL (corresponding author), Cleveland Museum Nat Hist, Dept Invertebrate Zool, Cleveland, OH USA.	ngunter@cmnh.org	Gunter, Nicole L/C-2465-2009; Bocak, Ladislav/J-5989-2019; Slipinski, Stanislaw Adam/B-4293-2009; Cameron, Stephen L/A-3742-2008; Bocak, Ladislav/AAL-9068-2021	Gunter, Nicole L/0000-0002-8355-0862; Cameron, Stephen L/0000-0002-6694-4130; Bocak, Ladislav/0000-0001-6382-8006	OCE postdoctoral fellowship from CSIRO; European Social Fund; state budget of the Czech Republic (POST-UP) [c. CZ.1.07/2.3.00/30.0004]; Australian Biological Resource Study, Bush Blitz grant [BBR-210-23]; Australian Research Council [FT120100746]	OCE postdoctoral fellowship from CSIRO; European Social Fund(European Social Fund (ESF)); state budget of the Czech Republic (POST-UP); Australian Biological Resource Study, Bush Blitz grant; Australian Research Council(Australian Research Council)	The study was supported by an OCE postdoctoral fellowship from CSIRO, www.csiro.au, and was co-financed by the European Social Fund and the state budget of the Czech Republic, (POST-UP a reg. c. CZ.1.07/2.3.00/30.0004), http://www.esfcr.eu/european-social-fund-in-the-czech-republic. NLG was supported by an Australian Biological Resource Study, Bush Blitz grant (BBR-210-23), http://www.bushblitz.org.au/. SLC was supported by an Australian Research Council Future Fellowship (FT120100746), http://www.arc.gov.au/future-fellowships. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AHRENS D, 2014, P ROY SOC B-BIOL SCI, V281, DOI DOI 10.1098/RSPB.2014.1470; Ahrens D, 2011, MOL PHYLOGENET EVOL, V60, P408, DOI 10.1016/j.ympev.2011.04.011; Arillo A, 2008, J NAT HIST, V42, P1405, DOI 10.1080/00222930802105130; Bai M, 2012, INSECT SCI, V19, P159, DOI 10.1111/j.1744-7917.2011.01460.x; Bai M, 2012, CRETACEOUS RES, V34, P334, DOI 10.1016/j.cretres.2011.11.017; Bai M, 2011, ACTA GEOL SIN-ENGL, V85, P984, DOI 10.1111/j.1755-6724.2011.00232.x; Barker NP, 2001, ANN MO BOT GARD, V88, P373, DOI 10.2307/3298585; Barrett PM, 2001, BIOL REV, V76, P411, DOI 10.1017/S1464793101005735; Battistuzzi FU, 2011, MOL BIOL EVOL, V28, P2439, DOI 10.1093/molbev/msr100; Bell CD, 2010, AM J BOT, V97, P1296, DOI 10.3732/ajb.0900346; Bouchard P, 2011, ZOOKEYS, P1, DOI 10.3897/zookeys.88.807; BUFFETAUT E, 1979, NATURE, V280, P486, DOI 10.1038/280486a0; BUFFETAUT E, 1980, Annales de Paleontologie Vertebres, V66, P1; Buffetaut E., 1982, ME MOIRES SOCIE TE G, V142, P1, DOI DOI 10.1016/S0016-6995(83)80048-5; Buffetaut E., 1981, GEOL RUNDSCH, V70, P611, DOI DOI 10.1007/BF01822139; Calaby JH, 1989, OCCASIONAL PAPERS IU, V4; Calvo JO, 1996, C BRAS GEOL SALV AN, V39, P392; Cambefort Y., 1991, P51; Cardinal S, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2012.2686; Cascales-Minana B, 2014, TERRA NOVA, V26, P195, DOI 10.1111/ter.12086; Chapman A. D., 2009, NUMBER LIVING SPECIE; Chatterjee S, 1999, P INDIAN NATL SCI A, V65, P397; Chin K, 1996, PALAIOS, V11, P280, DOI 10.2307/3515235; Chin K, 2007, PALAIOS, V22, P554, DOI 10.2110/palo.2006.p06-087r; Cockerell T. D. A., 1921, Proceedings of the United States National Museum, V59, P29; Crepet WL, 2008, ANN MO BOT GARD, V95, P3, DOI 10.3417/2007065; Crisp MD, 2009, EVOLUTION, V63, P2257, DOI 10.1111/j.1558-5646.2009.00728.x; Davis ALV, 2002, J BIOGEOGR, V29, P1217, DOI 10.1046/j.1365-2699.2002.00776.x; Davis ALV, 1997, AFR J ECOL, V35, P10, DOI 10.1111/j.1365-2028.1997.051-89051.x; de Wit MJ, 2003, ANNU REV EARTH PL SC, V31, P213, DOI 10.1146/annurev.earth.31.100901.141337; dos Reis Z, 2011, MOL BIOL EVOL, V28, P2161; Drummond A. J., 2012, GENEIOUS V5 6; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Farrell BD, 1998, SCIENCE, V281, P555, DOI 10.1126/science.281.5376.555; FARRELL BD, 1994, AM ZOOL, V34, P57, DOI 10.1093/icb/34.1.57; Fastovsky DE, 2004, DINOSAURIA, 2ND EDITION, P614; Gao KQ, 2006, ACTA GEOL SIN-ENGL, V80, P42; Gomez-Zurita J, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000360; Gunter NL, 2013, SYST ENTOMOL, V38, P626, DOI 10.1111/syen.12019; Halffter G, FOLIA ENTOMOLOGICA M, V12/14, P1; Harmon LJ, 2008, BIOINFORMATICS, V24, P129, DOI 10.1093/bioinformatics/btm538; Heikkila M, 2012, P ROY SOC B-BIOL SCI, V279, P1093, DOI 10.1098/rspb.2011.1430; Heine C, 2013, SOLID EARTH, V4, P215, DOI 10.5194/se-4-215-2013; Ho SYW, 2009, SYST BIOL, V58, P367, DOI 10.1093/sysbio/syp035; Ho SYW, 2015, ENCY SCI DATING METH, P583; Hohna S, 2015, BIORXIV, DOI [10.1101/021238, DOI 10.1101/021238]; Hu SS, 2008, P NATL ACAD SCI USA, V105, P240, DOI 10.1073/pnas.0707989105; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; Hummel J, 2008, P ROY SOC B-BIOL SCI, V275, P1015, DOI 10.1098/rspb.2007.1728; Hunt T, 2007, SCIENCE, V318, P1913, DOI 10.1126/science.1146954; Katoh K, 2005, NUCLEIC ACIDS RES, V33, P511, DOI 10.1093/nar/gki198; Kim SI, 2015, MOL PHYLOGENET EVOL, V86, P35, DOI 10.1016/j.ympev.2015.02.015; Krell Frank-Thorsten, 2007, Denver Museum of Nature & Science Technical Report, V2007-8, P1; Krell FT, 2000, INVERTEBR TAXON, V14, P871, DOI 10.1071/IT00031; KRELL FT, 2006, COLEOPT SOC MONO DEC, P120, DOI DOI 10.1649/0010-065X(2006)60[; Labandeira C.C., 2013, ANN REV EARTH PLANET, V41; Lanfear R, 2012, MOL BIOL EVOL, V29, P1695, DOI 10.1093/molbev/mss020; Larsen TH, 2009, BIOL LETTERS, V5, P152, DOI 10.1098/rsbl.2008.0654; Lawrence JF, 2013, AUSTRALIAN BEETLES, VOL 1: MORPHOLOGY, CLASSIFICATION AND KEYS, P1; Lin Q.B., 1980, DIVISION CORRELATION, P211; Maddison WP., 2021, MESQUITE MODULAR SYS; Magallon S, 2001, EVOLUTION, V55, P1762, DOI 10.1111/j.0014-3820.2001.tb00826.x; Magallon S, 2009, AM J BOT, V96, P349, DOI 10.3732/ajb.0800060; McElwain JC, 2007, TRENDS ECOL EVOL, V22, P548, DOI 10.1016/j.tree.2007.09.003; Mckenna DD, 2015, SYST ENTOMOL, V40, P835, DOI 10.1111/syen.12132; Mckenna DD, 2015, SYST ENTOMOL, V40, P35, DOI 10.1111/syen.12093; McKenna DD, 2009, P NATL ACAD SCI USA, V106, P7083, DOI 10.1073/pnas.0810618106; Meredith RW, 2011, SCIENCE, V334, P521, DOI 10.1126/science.1211028; Miller M.A., 2010, P GAT COMP ENV WORKS; Mlambo S, 2015, ARTHROPOD SYST PHYLO, V73, P303; Molnar RE, 2000, J VERTEBR PALEONTOL, V20, P194, DOI 10.1671/0272-4634(2000)020[0194:GCOASA]2.0.CO;2; Monaghan MT, 2007, MOL PHYLOGENET EVOL, V44, P436; Moreau CS, 2006, SCIENCE, V312, P101, DOI 10.1126/science.1124891; Nikolajev G.V., 2000, Paleontological Journal, V34, pS327; Nikolajev G.V., 2005, Zhivotnyi Mir Dalnego Vostoka, V5, P69; Nikolajev G.V., 2005, Trudy Instituta Zoologii - Almaty, V49, P112; Nikolajev G.V., 2011, Acta Palaeontologica Sinica, V50, P41; Nikolajev GV, 2010, PALEONTOL J+, V44, P649, DOI 10.1134/S0031030110060067; Nikolajev Georgy V., 2010, Acta Palaeontologica Sinica, V49, P443; Nikolajev GV, 2007, MEZOZOISKI ETAP EVOL; Nikolajev GV., 1992, PALEONTOL J+, V26, P96; Nikolajev GV, 1998, PALEONTOL J, V32, P513; Nikolayev G.V., 1994, Paleontological Journal, V27, P1; Nilsson G., 2005, ENDANGERED SPECIES H; O'Leary MA, 2013, SCIENCE, V339, P662, DOI 10.1126/science.1229237; Paradis E, 2004, BIOINFORMATICS, V20, P289, DOI 10.1093/bioinformatics/btg412; Philips TK, 2004, INVERTEBR SYST, V18, P53, DOI 10.1071/IS03030; Piton L., 1940, THESIS U CLERMONT CL; Poux C, 2005, SYST BIOL, V54, P719, DOI 10.1080/10635150500234534; Pozzi L, 2014, MOL PHYLOGENET EVOL, V75, P165, DOI 10.1016/j.ympev.2014.02.023; Pulquerio MJF, 2007, TRENDS ECOL EVOL, V22, P180, DOI 10.1016/j.tree.2006.11.013; Rabosky DL, 2006, EVOL BIOINFORM, V2, P247; Rambaut A., 2007, J TRACER V1 5; Ratcliffe BC, 2005, COLEOPTS BULL, V59, P127, DOI 10.1649/0010-065X(2005)059[0127:OBNGAS]2.0.CO;2; Rehan SM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076683; Ren D., 2010, SILENT STORIES INSEC; [任东 Ren Dong], 2002, [地质通报, Geological Bulletin of China], V21, P584; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Samonds KE, 2012, P NATL ACAD SCI USA, V109, P5352, DOI 10.1073/pnas.1113993109; Sanderson MJ, 2003, BIOINFORMATICS, V19, P301, DOI 10.1093/bioinformatics/19.2.301; Schneider H, 2004, NATURE, V428, P553, DOI 10.1038/nature02361; Scholtz C., 2009, EVOLUTIONARY BIOL CO; Scholtz CH, 2005, HDB ZOOLOGY, V1; Shi CF, 2011, ACTA GEOL SIN-ENGL, V85, P482, DOI 10.1111/j.1755-6724.2011.00416.x; Sibuet JC, 1983, INTIAL REPORTS DEEP, P469; Smith SA, 2010, P NATL ACAD SCI USA, V107, P5897, DOI 10.1073/pnas.1001225107; Sole CL, 2010, MOL PHYLOGENET EVOL, V56, P631, DOI 10.1016/j.ympev.2010.04.023; Stadler T., 2014, TREESIM SIMULATING T; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; Stavert JR, 2014, OECOLOGIA, V176, P259, DOI 10.1007/s00442-014-3001-z; Tarasov S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0116671; Thomas JA, 2010, MOL BIOL EVOL, V27, P1173, DOI 10.1093/molbev/msq009; Thorne JL, 1998, MOL BIOL EVOL, V15, P1647, DOI 10.1093/oxfordjournals.molbev.a025892; Torsvik TH, 2009, GEOPHYS J INT, V177, P1315, DOI 10.1111/j.1365-246X.2009.04137.x; Vincent PM, 1977, B SOC GEOLOGIQUE FRA, V19, P1057, DOI [10.2113/gssgfbull.S7-XIX.5.1057, DOI 10.2113/GSSGFBULL.S7-XIX.5.1057]; Wahlberg N, 2009, P ROY SOC B-BIOL SCI, V276, P4295, DOI 10.1098/rspb.2009.1303; Wappler T., 2003, MAINZER NATURWISSENS, V27, P1; Wickham HF, 1914, B MUS COMP ZOOL HARV, V58, P421; Wickham HF., 1912, B LAB NAT HIST IOWA, V3, P3; Wills MA, 2001, GEOL J, V36, P187, DOI 10.1002/gj.882; Wirta H, 2008, MOL PHYLOGENET EVOL, V47, P1076, DOI 10.1016/j.ympev.2008.03.010; Yan Z, 2013, ALCHERINGA, V37, P139, DOI 10.1080/03115518.2012.716231; Yang ZH, 2007, MOL BIOL EVOL, V24, P1586, DOI 10.1093/molbev/msm088; Yoder AD, 2004, MOL ECOL, V13, P757, DOI 10.1046/j.1365-294X.2004.02106.x; Zeng LP, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5956; Zherikhin Vladimir V., 1999, P185	128	62	64	2	43	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 4	2016	11	5							e0153570	10.1371/journal.pone.0153570	http://dx.doi.org/10.1371/journal.pone.0153570			47	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DL5KR	27145126	Green Published, Green Submitted, gold			2022-12-26	WOS:000375676400021
J	Solesvik, M; Joa, I; Larsen, TK; Langeveld, J; Johannessen, JO; Bjornestad, J; Anda, LG; Gisselgard, J; Hegelstad, WT; Bronnick, K				Solesvik, Martine; Joa, Inge; Larsen, Tor Ketil; Langeveld, Johannes; Johannessen, Jan Olav; Bjornestad, Jone; Anda, Liss Goril; Gisselgard, Jens; Hegelstad, Wenche ten Velden; Bronnick, Kolbjorn			Visual Hallucinations in First-Episode Psychosis: Association with Childhood Trauma	PLOS ONE			English	Article							NEGATIVE SYNDROME SCALE; SCHIZOPHRENIA; DELUSIONS; DISORDERS; MODEL; PANSS; 1ST; INFORMATION; EXPERIENCES; ENVIRONMENT	Background Hallucinations are a core diagnostic criterion for psychotic disorders and have been investigated with regard to its association with childhood trauma in first-episode psychosis samples. Research has largely focused on auditory hallucinations, while specific investigations of visual hallucinations in first-episode psychosis remain scarce. Objectives The aims of this study were to describe the prevalence of visual hallucinations, and to explore the association between visual hallucination and childhood trauma in a first-episode psychosis sample. Methods Subjects were included from TIPS-2, a first episode psychosis study in south Rogaland, Norway. Based on the medical journal descriptions of the Positive and Negative Symptoms Scale (PANSS), a separate score for visual and auditory hallucinations was created (N = 204). Patients were grouped according to hallucination severity (none, mild, and psychotic hallucinations) and multinomial logistic regression was performed to identify factors associated with visual hallucination group. Results Visual hallucinations of a psychotic nature were reported by 26.5% of patients. The experience of childhood interpersonal trauma increased the likelihood of having psychotic visual hallucinations. Conclusion Visual hallucinations are common in first-episode psychosis, and are related to childhood interpersonal trauma.	[Solesvik, Martine; Joa, Inge; Larsen, Tor Ketil; Langeveld, Johannes; Johannessen, Jan Olav; Bjornestad, Jone; Anda, Liss Goril; Gisselgard, Jens; Hegelstad, Wenche ten Velden; Bronnick, Kolbjorn] Stavanger Univ Hosp, TIPS Ctr Clin Res Psychosis, Stavanger, Rogaland, Norway; [Joa, Inge; Johannessen, Jan Olav; Bronnick, Kolbjorn] Univ Stavanger, Network Med Sci, Stavanger, Rogaland, Norway	Stavanger University Hospital; Universitetet i Stavanger	Bronnick, K (corresponding author), Stavanger Univ Hosp, TIPS Ctr Clin Res Psychosis, Stavanger, Rogaland, Norway.; Bronnick, K (corresponding author), Univ Stavanger, Network Med Sci, Stavanger, Rogaland, Norway.	bronnick@gmail.com	/AAQ-2163-2021	Hegelstad, Wenche ten Velden/0000-0003-1148-8825; Bronnick, Kolbjorn/0000-0002-9156-1633; Joa, Inge/0000-0002-5516-2336; Anda, Liss/0000-0003-2431-4306; Langeveld, Johannes/0000-0002-8110-9029	Health Vest Trust, Norway [200202797-65]; Regional Centre for Clinical Research in Psychosis [911313]	Health Vest Trust, Norway; Regional Centre for Clinical Research in Psychosis	This work was supported by the Health Vest Trust, Norway (200202797-65 to I. J.) and the Regional Centre for Clinical Research in Psychosis ( 911313). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen P, 2008, NEUROSCI BIOBEHAV R, V32, P175, DOI 10.1016/j.neubiorev.2007.07.012; American psychiatric association, 2013, DIAGNOSTIC STAT MANU, DOI 10.1176/appi.books.9780890425596; Bendall S, 2008, SCHIZOPHRENIA BULL, V34, P568, DOI 10.1093/schbul/sbm121; Bendall S, 2013, J NERV MENT DIS, V201, P941, DOI 10.1097/NMD.0000000000000033; Bouffard R, 2003, CAN J PSYCHIAT, V48, P546, DOI 10.1177/070674370304800806; Brebion G, 2008, NEUROPSYCHOLOGY, V22, P383, DOI 10.1037/0894-4105.22.3.383; CANNONSPOOR HE, 1982, SCHIZOPHRENIA BULL, V8, P470, DOI 10.1093/schbul/8.3.470; Collerton D, 2005, BEHAV BRAIN SCI, V28, P737; Compton MT, 2012, PSYCHIAT RES, V200, P702, DOI 10.1016/j.psychres.2012.07.041; Coy AL, 2012, PSYCHIAT RES, V196, P225, DOI 10.1016/j.psychres.2011.10.017; Dalgleish T, 2001, PSYCHOL MED, V31, P541, DOI 10.1017/S0033291701003567; de Leede-Smith S, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00367; Dodgson G, 2009, BEHAV COGN PSYCHOTH, V37, P325, DOI 10.1017/S1352465809005244; DRAKE RE, 1990, SCHIZOPHRENIA BULL, V16, P57, DOI 10.1093/schbul/16.1.57; First M. B., 1995, STRUCTURED CLIN INTE; Garwood L, 2015, BEHAV COGN PSYCHOTH, V43, P52, DOI 10.1017/S1352465813000714; Goldberg Lewis R, 2006, J Trauma Dissociation, V7, P39, DOI 10.1300/J229v07n03_04; Joa I, 2008, SCHIZOPHRENIA BULL, V34, P466, DOI 10.1093/schbul/sbm095; John Read, 2004, MODELS MADNESS PSYCH; KAY SR, 1987, SCHIZOPHRENIA BULL, V13, P261, DOI 10.1093/schbul/13.2.261; KAY SR, 1988, PSYCHIAT RES, V23, P99, DOI 10.1016/0165-1781(88)90038-8; Klaeth JR, 2009, TIDSSKRIFT NORSK PSY, P1049; Levine SZ, 2011, PSYCHIAT RES, V188, P446, DOI 10.1016/j.psychres.2011.03.014; Morgan C, 2007, SCHIZOPHRENIA BULL, V33, P3, DOI 10.1093/schbul/sbl053; Morrison AP, 2003, BRIT J CLIN PSYCHOL, V42, P331, DOI 10.1348/014466503322528892; Muenzenmaier KH, 2015, J TRAUMA DISSOCIATIO, V16, P442, DOI 10.1080/15299732.2015.1018475; PERALTA V, 1994, PSYCHIAT RES, V53, P31, DOI 10.1016/0165-1781(94)90093-0; Rajapakse T, 2011, EARLY INTERV PSYCHIA, V5, P254, DOI 10.1111/j.1751-7893.2011.00281.x; Read J, 2005, ACTA PSYCHIAT SCAND, V112, P330, DOI 10.1111/j.1600-0447.2005.00634.x; Read J, 2001, PSYCHIATRY, V64, P319, DOI 10.1521/psyc.64.4.319.18602; Read J, 2014, NEUROPSYCHIATRY-LOND, V4, P65, DOI 10.2217/NPY.13.89; Robinson DG, 1999, AM J PSYCHIAT, V156, P544; ROSS CA, 1994, HOSP COMMUNITY PSYCH, V45, P489; Shevlin M, 2007, J PSYCHIATR RES, V41, P222, DOI 10.1016/j.jpsychires.2006.03.004; Shevlin M, 2011, SOC PSYCH PSYCH EPID, V46, P1203, DOI 10.1007/s00127-010-0296-x; Stain HJ, 2014, SCHIZOPHRENIA BULL, V40, P1491, DOI 10.1093/schbul/sbt166; Ucok A, 2007, ACTA PSYCHIAT SCAND, V116, P371, DOI 10.1111/j.1600-0447.2007.01079.x; van Nierop M, 2014, SCHIZOPHRENIA BULL, V40, pS123, DOI 10.1093/schbul/sbt150; van Os J, 2010, NATURE, V468, P203, DOI 10.1038/nature09563; Varese F, 2012, SCHIZOPHRENIA BULL, V38, P661, DOI 10.1093/schbul/sbs050; Waters F, 2014, SCHIZOPHRENIA BULL, V40, pS233, DOI 10.1093/schbul/sbu036; Waters F, 2014, SCHIZOPHRENIA BULL, V40, P24, DOI 10.1093/schbul/sbt167; Welsch R, 1980, REGRESSION DIAGNOSTI	43	12	12	2	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 4	2016	11	5							e0153458	10.1371/journal.pone.0153458	http://dx.doi.org/10.1371/journal.pone.0153458			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DL5KR	27144681	Green Published, Green Submitted, gold			2022-12-26	WOS:000375676400017
J	Kardoush, MI; Ward, BJ; Ndao, M				Kardoush, Manal I.; Ward, Brian J.; Ndao, Momar			Identification of Candidate Serum Biomarkers for Schistosoma mansoni Infected Mice Using Multiple Proteomic Platforms	PLOS ONE			English	Article							TRANSFERRIN; TRANSCRIPTOME; DEFICIENCY; EXPRESSION; DIAGNOSIS; PROTEINS; ACTIN	Background Schistosomiasis is an important helminth infection of humans. There are few reliable diagnostic biomarkers for early infection, for recurrent infection or to document successful treatment. In this study, we compared serum protein profiles in uninfected and infected mice to identify disease stage-specific biomarkers. Methods Serum collected from CD1 mice infected with 50-200 Schistosoma mansoni cercariae were analyzed before infection and at 3, 6 and 12 weeks post-infection using three mass spectrometric (MS) platforms. Results Using SELDI-TOF MS, 66 discriminating m/z peaks were detected between S. mansoni infected mice and healthy controls. Used in various combinations, these peaks could 1) reliably diagnose early-stage disease, 2) distinguish between acute and chronic infection and 3) diagnose S. mansoni infection regardless the parasite burden. The most important contributors to these diagnostic algorithms were peaks at 3.7, 13 and 46 kDa. Employing sample fractionation and differential gel electrophoresis, we analyzed gel slices either by MALDI-TOF MS or Velos Orbitrap MS. The former yielded eight differentially-expressed host proteins in the serum at different disease stages including transferrin and alpha 1-antitrypsin. The latter suggested the presence of a surprising number of parasite-origin proteins in the serum during both the acute (n = 200) and chronic (n = 105) stages. The Orbitrap platform also identified many differentially-expressed host-origin serum proteins during the acute and chronic stages (296 and 220 respectively). The presence of one of the schistosome proteins, glutathione S transferase (GST: 25 KDa), was confirmed by Western Blot. This study provides proof-of-principle for an approach that can yield a large number of novel candidate biomarkers for Schistosoma infection.	[Kardoush, Manal I.] McGill Univ, Inst Parasitol, Montreal, PQ, Canada; [Kardoush, Manal I.; Ward, Brian J.; Ndao, Momar] McGill Univ, Ctr Hlth, Res Inst, Natl Reference Ctr Parasitol, Montreal, PQ, Canada; [Kardoush, Manal I.] Benha Univ, Fac Med, Dept Parasitol, Banha, Qalubia, Egypt; [Ward, Brian J.; Ndao, Momar] McGill Univ, Ctr Hlth, JD MacLean Trop Dis Ctr, Montreal, PQ, Canada	McGill University; McGill University; Egyptian Knowledge Bank (EKB); Benha University; McGill University	Ndao, M (corresponding author), McGill Univ, Ctr Hlth, Res Inst, Natl Reference Ctr Parasitol, Montreal, PQ, Canada.; Ndao, M (corresponding author), McGill Univ, Ctr Hlth, JD MacLean Trop Dis Ctr, Montreal, PQ, Canada.	momar.ndao@mcgill.ca			Public Health Agency of Canada/National Microbiology Laboratory; Foundation of the Montreal General Hospital; Research Institute of the McGill University Health Centre; Government of Egypt	Public Health Agency of Canada/National Microbiology Laboratory; Foundation of the Montreal General Hospital; Research Institute of the McGill University Health Centre; Government of Egypt	The National Reference Centre for Parasitology is supported by Public Health Agency of Canada/National Microbiology Laboratory, the Foundation of the Montreal General Hospital and the Research Institute of the McGill University Health Centre. Manal I. Kardoush is the recipient of a scholarship from the Government of Egypt. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aldridge GM, 2008, J NEUROSCI METH, V172, P250, DOI 10.1016/j.jneumeth.2008.05.003; Anderson L, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0004334; Arinola OG, 2004, METAL BINDING ACUTE; Arinola OG, 1998, AF J BIOMED RES, V1, P15; Bergquist R, 2009, TRENDS PARASITOL, V25, P151, DOI 10.1016/j.pt.2009.01.004; Cargile BJ, 2004, J PROTEOME RES, V3, P1082, DOI 10.1021/pr049946o; Espirito-Santo MCC, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/135689; Chen L, 2010, ANN SURG ONCOL, V17, P2518, DOI 10.1245/s10434-010-1038-8; Cho HJ, 2014, CLIN MOL HEPATOL, V20, P347, DOI 10.3350/cmh.2014.20.4.347; Cohen M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014540; Da'dara AA, 2014, PARASITOL RES, V113, P3685, DOI 10.1007/s00436-014-4033-3; DAVIS AH, 1985, MOL BIOCHEM PARASIT, V17, P289, DOI 10.1016/0166-6851(85)90003-9; Deelder AM, 1993, TROPICAL GEOGRAPHICA, V46, P233; Doenhoff MJ, 2004, TRENDS PARASITOL, V20, P35, DOI 10.1016/j.pt.2003.10.019; Enk MJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038947; Gettins PG, 2002, CHEM REV, P102; Gomme PT, 2005, DRUG DISCOV TODAY, V10, P267, DOI 10.1016/S1359-6446(04)03333-1; Greter H, 2015, AM J TROPICAL MED HY, P15; Gryseels B, 2006, LANCET, V368, P1106, DOI 10.1016/S0140-6736(06)69440-3; Harvie M, 2007, INFECT IMMUN, V75, P736, DOI 10.1128/IAI.01048-06; Hayes JD, 1995, CRIT REV BIOCHEM MOL, V30, P445, DOI 10.3109/10409239509083491; HAYES PC, 1991, GUT, V32, P1546, DOI 10.1136/gut.32.12.1546; Hiemstra PS, 2002, BIOCHEM SOC T, V30, P116, DOI 10.1042/BST0300116; Hotez PJ, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000485; HUTCHENS TW, 1993, RAPID COMMUN MASS SP, V7, P576, DOI 10.1002/rcm.1290070703; Jankovic D, 1996, J IMMUNOL, V157, P806; Lin Q, 2012, CLASSIFICATION METHO; Liu NK, 2006, J NEUROTRAUM, V23, P1794, DOI 10.1089/neu.2006.23.1794; Lovric J, 2011, INTRO PROTEOMICS CON; Macedo Maria F., 2008, Inflammation & Allergy Drug Targets, V7, P41, DOI 10.2174/187152808784165162; MACGREGOR AN, 1990, INT J PARASITOL, V20, P279, DOI 10.1016/0020-7519(90)90141-9; Manivannan B, 2010, INFECT IMMUN, V78, P618, DOI 10.1128/IAI.00647-09; MANSOUR MM, 1985, TROP GEOGR MED, V37, P124; MCCORMICK SL, 1987, J PARASITOL, V73, P130, DOI 10.2307/3282357; Mohamed MM, 1998, MOL BIOCHEM PARASIT, V96, P15, DOI 10.1016/S0166-6851(98)00088-7; Mondal G, 2016, GLYCOCONJUGATE J, P1; Moore RE, 2002, J AM SOC MASS SPECTR, V13, P378, DOI 10.1016/S1044-0305(02)00352-5; MORRIS GP, 1968, J PARASITOL, V54, P15, DOI 10.2307/3276867; Mueller S, 2014, WORLD J GASTROENTERO, V20, P14626, DOI 10.3748/wjg.v20.i40.14626; Otegbayo J A, 2005, West Afr J Med, V24, P124; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Pontes LA, 2002, AM J TROP MED HYG, V66, P157, DOI 10.4269/ajtmh.2002.66.157; Protasio AV, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001455; Retra K, 2015, INT J PARASITOL, V45, P629, DOI 10.1016/j.ijpara.2015.03.011; Rioux MC, 2008, INT J PARASITOL, V38, P123, DOI 10.1016/j.ijpara.2007.07.017; Saif M., 1977, Journal of the Egyptian Medical Association, V60, P731; Salawu L, 2004, AFRICAN J BIOMEDICAL, V7; Santamaria C, 2014, BMC INFECT DIS, V14, DOI 10.1186/1471-2334-14-302; SHARP HL, 1969, J LAB CLIN MED, V73, P934; Steinberg D., 1995, CART TREE STRUCTURED; Tamura M, 2015, TOXINS, V7, P1664, DOI 10.3390/toxins7051664; TROTTEIN F, 1990, MOL BIOCHEM PARASIT, V41, P35, DOI 10.1016/0166-6851(90)90094-3; Verjovski-Almeida S, 2003, NAT GENET, V35, P148, DOI 10.1038/ng1237; Welinder C, 2011, J PROTEOME RES, V10, P1416, DOI 10.1021/pr1011476; Wilson RA, 2007, TRENDS PARASITOL, V23, P14, DOI 10.1016/j.pt.2006.10.002	55	4	4	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 3	2016	11	5							e0154465	10.1371/journal.pone.0154465	http://dx.doi.org/10.1371/journal.pone.0154465			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DL5KK	27138990	Green Submitted, Green Published, gold			2022-12-26	WOS:000375675700033
J	Kitayama, J; Yamaguchi, H; Ishigami, H; Matsuzaki, K; Sata, N				Kitayama, Joji; Yamaguchi, Hironori; Ishigami, Hironori; Matsuzaki, Keisuke; Sata, Naohiro			Intraperitoneal Mesenchymal Cells Promote the Development of Peritoneal Metastasis Partly by Supporting Long Migration of Disseminated Tumor Cells	PLOS ONE			English	Article							GASTRIC-CARCINOMA CELLS; MESOTHELIAL CELLS; CANCER; CHEMOTHERAPY	The human peritoneal cavity contains a small number of free cells of mesenchymal cell lineage. Intraperitoneal mesenchymal cells (PMC) play supportive roles in metastasis formation on the peritoneum. In this study, we found that PMC, when co-cultuerd with human gastric cancer cells, MKN45, enhanced the proliferation of MKN45 when cultured at low, but not high, cellular density. Also, PMC suppressed apoptotic cell death of MKN45 only under low density culture conditions. Time-lapse videoanalysis clearly demonstrated that PMC randomly migrated more vigorously than did MKN45, and strongly enhanced the migration behavior of co-cultured MKN45. In fact, the majority of MKN45 migrated together in direct physical contact with PMC, and the sum of migration lengths from original position of co-cultured MKN45 for 48 hours was approximately 10 times longer than that of MKN45 cultured alone. Our data suggest that enhanced migration can increase the chance of direct contact or positional proximity among sparcely distributed MKN45, which may bring survival advantages to tumor cells. This may be one of the important mechanisms of peritoneal metastasis, since only a small number of tumor cells are considered to be disseminated in the early step of metastasis formation on the peritoneum.	[Kitayama, Joji; Yamaguchi, Hironori; Sata, Naohiro] Jichi Med Univ, Dept Gastrointestinal Surg, Shimotsuke, Tochigi, Japan; [Ishigami, Hironori] Univ Tokyo, Dept Surg Oncol, Tokyo, Japan; [Matsuzaki, Keisuke] Kanamecho Hosp, Tokyo, Japan	Jichi Medical University; University of Tokyo	Kitayama, J (corresponding author), Jichi Med Univ, Dept Gastrointestinal Surg, Shimotsuke, Tochigi, Japan.	kitayama@jichi.ac.jp	Yamaguchi, Hironori/AAA-3642-2022	Yamaguchi, Hironori/0000-0002-8371-9410	Ministry of Education, Science, Sports and Culture of Japan; Ministry of Health and Welfare of Japan;  [AMED: 15Ack0106155h001]	Ministry of Education, Science, Sports and Culture of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Ministry of Health and Welfare of Japan(Ministry of Health, Labour and Welfare, Japan); 	This work was supported by a Grant-in-Aid for Scientific Research from the Ministry of Education, Science, Sports and Culture of Japan; a Grant from the Ministry of Health and Welfare of Japan; and AMED: 15Ack0106155h001. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BETJES MGH, 1991, PERITON DIALYSIS INT, V11, P22; Bhowmick NA, 2004, SCIENCE, V303, P848, DOI 10.1126/science.1090922; Calvo F, 2011, CURR OPIN CELL BIOL, V23, P621, DOI 10.1016/j.ceb.2011.04.010; Colombo N, 2006, CRIT REV ONCOL HEMAT, V60, P159, DOI 10.1016/j.critrevonc.2006.03.004; Foley-Comer AJ, 2002, J CELL SCI, V115, P1383; Fuyuhiro Y, 2012, CANCER SCI, V103, P797, DOI 10.1111/j.1349-7006.2012.02209.x; Herrick SE, 2004, INT J BIOCHEM CELL B, V36, P621, DOI 10.1016/j.biocel.2003.11.002; Hodeib M, 2014, Minerva Ginecol, V66, P179; Joyce JA, 2009, NAT REV CANCER, V9, P239, DOI 10.1038/nrc2618; Kitayama J, 2014, CELL IMMUNOL, V288, P8, DOI 10.1016/j.cellimm.2014.01.008; Kitayama J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086516; KOGA S, 1984, J CANCER RES CLIN, V108, P236, DOI 10.1007/BF00402474; Llames S, 2015, TISSUE ENG PART B-RE, V21, P345, DOI [10.1089/ten.teb.2014.0547, 10.1089/ten.TEB.2014.0547]; Mueller MM, 2004, NAT REV CANCER, V4, P839, DOI 10.1038/nrc1477; Orimo A, 2005, CELL, V121, P335, DOI 10.1016/j.cell.2005.02.034; Polyak K, 2009, TRENDS GENET, V25, P30, DOI 10.1016/j.tig.2008.10.012; Sakuramoto S, 2007, NEW ENGL J MED, V357, P1810, DOI 10.1056/NEJMoa072252; Semba S, 2009, BRIT J CANCER, V101, P1365, DOI 10.1038/sj.bjc.6605309; SINGH G, 1978, ACTA CYTOL, V22, P487; Sodek KL, 2012, CANCER METAST REV, V31, P397, DOI 10.1007/s10555-012-9351-2; Sugarbaker PH, 2014, WORLD J GASTROENTERO, V20, P9286, DOI 10.3748/wjg.v20.i28.9286; Tyan SW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0015313; Yamaguchi H, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085485; Yanez-Mo M, 2003, NEW ENGL J MED, V348, P403, DOI 10.1056/NEJMoa020809; Yang XJ, 2010, J SURG ONCOL, V101, P457, DOI 10.1002/jso.21519	25	4	4	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 3	2016	11	5							e0154542	10.1371/journal.pone.0154542	http://dx.doi.org/10.1371/journal.pone.0154542			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DL5KK	27136922	gold, Green Submitted, Green Published			2022-12-26	WOS:000375675700040
J	Marthandan, S; Baumgart, M; Priebe, S; Groth, M; Schaer, J; Kaether, C; Guthke, R; Cellerino, A; Platzer, M; Diekmann, S; Hemmerich, P				Marthandan, S.; Baumgart, M.; Priebe, S.; Groth, M.; Schaer, J.; Kaether, C.; Guthke, R.; Cellerino, A.; Platzer, M.; Diekmann, S.; Hemmerich, P.			Conserved Senescence Associated Genes and Pathways in Primary Human Fibroblasts Detected by RNA-Seq	PLOS ONE			English	Article							DIFFERENTIAL EXPRESSION ANALYSIS; HUMAN-DIPLOID FIBROBLASTS; DNA-DAMAGE FOCI; CELLULAR SENESCENCE; REPLICATIVE SENESCENCE; TRANSCRIPTION FACTOR; PREMATURE SENESCENCE; OXIDATIVE STRESS; STRAND BREAKS; HUMAN-CELLS	Cellular senescence correlates with changes in the transcriptome. To obtain a complete view on senescence-associated transcription networks and pathways, we assessed by deep RNA sequencing the transcriptomes of five of the most commonly used laboratory strains of human fibroblasts during their transition into senescence. In a number of cases, we verified the RNA-seq data by real-time PCR. By determining cellular protein levels we observed that the age-related expression of most but not all genes is regulated at the transcriptional level. We found that 78% of the age-affected differentially expressed genes were commonly regulated in the same direction (either up- or down-regulated) in all five fibroblast strains, indicating a strong conservation of age-associated changes in the transcriptome. KEGG pathway analyses confirmed up-regulation of the senescence-associated secretory phenotype and down-regulation of DNA synthesis/repair and most cell cycle pathways common in all five cell strains. Newly identified senescence-induced pathways include up-regulation of endocytotic/phagocytic pathways and down-regulation of the mRNA metabolism and the mRNA splicing pathways. Our results provide an unprecedented comprehensive and deep view into the individual and common transcriptome and pathway changes during the transition into of senescence of five human fibroblast cell strains.	[Marthandan, S.; Baumgart, M.; Groth, M.; Kaether, C.; Cellerino, A.; Platzer, M.; Diekmann, S.; Hemmerich, P.] Fritz Lipmann Inst eV FLI, Leibniz Inst Aging, Jena, Germany; [Priebe, S.; Schaer, J.; Guthke, R.] Hans Knoll Inst eV HKI, Leibniz Inst Nat Prod Res & Infect Biol, Jena, Germany; [Cellerino, A.] Scuola Normale Super Pisa, Neurobiol Lab, Pisa, Italy	Leibniz Institut fur Alternsforschung - Fritz-Lipmann-Institut (FLI); Hans Knoll Institute (HKI); Scuola Normale Superiore di Pisa	Marthandan, S (corresponding author), Fritz Lipmann Inst eV FLI, Leibniz Inst Aging, Jena, Germany.	smarthandan@fli-leibniz.de	Cellerino, Alessandro/AAJ-7453-2020; Cellerino, Alessandro/AAB-4398-2020	Cellerino, Alessandro/0000-0003-3834-0097; Cellerino, Alessandro/0000-0003-3834-0097; Baumgart, Mario/0000-0001-8172-1595	German Ministry for Education and Research (Bundesministerium fur Bildung und Forschung - BMBF); Leibniz Association;  [0315581]	German Ministry for Education and Research (Bundesministerium fur Bildung und Forschung - BMBF)(Federal Ministry of Education & Research (BMBF)); Leibniz Association; 	Funding was provided by grant No: 0315581, https://www.bmbf.de/en/. The work described here is part of the research program of the Jena Centre for Systems Biology of Ageing-JenAge. The authors acknowledge JenAge funding by the German Ministry for Education and Research (Bundesministerium fur Bildung und Forschung - BMBF). The publication of this article was funded by the Open Access fund of the Leibniz Association.	Acosta JC, 2008, CELL, V133, P1006, DOI 10.1016/j.cell.2008.03.038; Aguirre-Portoles C, 2012, CANCER RES, V72, P1518, DOI 10.1158/0008-5472.CAN-11-1971; Alcorta DA, 1996, P NATL ACAD SCI USA, V93, P13742, DOI 10.1073/pnas.93.24.13742; Alexander K, 2001, MOL CELL BIOL, V21, P3616, DOI 10.1128/MCB.21.11.3616-3631.2001; Anders S, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r106; Baege AC, 2004, J VIROL, V78, P5720, DOI 10.1128/JVI.78.11.5720-5727.2004; Baker DJ, 2016, NATURE, V530, P184, DOI 10.1038/nature16932; Barrett T, 2013, NUCLEIC ACIDS RES, V41, pD991, DOI 10.1093/nar/gks1193; Baumgart M, 2014, AGING CELL, V13, P965, DOI 10.1111/acel.12257; Baylin SB, 2006, NAT REV CANCER, V6, P107, DOI 10.1038/nrc1799; Beausejour CM, 2003, EMBO J, V22, P4212, DOI 10.1093/emboj/cdg417; Ben-Porath I, 2005, INT J BIOCHEM CELL B, V37, P961, DOI 10.1016/j.biocel.2004.10.013; Ben-Porath I, 2004, J CLIN INVEST, V113, P8, DOI 10.1172/JCI200420663; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bentley DR, 2008, NATURE, V456, P53, DOI 10.1038/nature07517; Bertram MJ, 1999, MOL CELL BIOL, V19, P1479; Binet R, 2009, CANCER RES, V69, P9183, DOI 10.1158/0008-5472.CAN-09-1016; Bonelli MA, 2001, EXP CELL RES, V267, P165, DOI 10.1006/excr.2001.5237; Bonifacio LN, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012519; Campisi J, 2009, J GERONTOL A-BIOL, V64, P164, DOI 10.1093/gerona/gln073; Chang ZF, 2001, J BIOMED SCI, V8, P176; Chaturvedi V, 1999, J BIOL CHEM, V274, P23358, DOI 10.1074/jbc.274.33.23358; Chen J, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-392; Chen JH, 2006, FEBS LETT, V580, P6669, DOI 10.1016/j.febslet.2006.11.023; CHEN Q, 1995, P NATL ACAD SCI USA, V92, P4337, DOI 10.1073/pnas.92.10.4337; CHEN Q, 1994, P NATL ACAD SCI USA, V91, P4130, DOI 10.1073/pnas.91.10.4130; Chin JH, 1996, AM J PHYSIOL-CELL PH, V271, pC362, DOI 10.1152/ajpcell.1996.271.1.C362; Coller HA, 2006, PLOS BIOL, V4, P329, DOI 10.1371/journal.pbio.0040083; Coppe JP, 2010, ANNU REV PATHOL-MECH, V5, P99, DOI 10.1146/annurev-pathol-121808-102144; Coppe JP, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009188; Coppe JP, 2008, PLOS BIOL, V6, P2853, DOI 10.1371/journal.pbio.0060301; Cosme-Blanco W, 2008, EXP CELL RES, V314, P1973, DOI 10.1016/j.yexcr.2008.03.011; Cristofalo VJ, 2004, MECH AGEING DEV, V125, P827, DOI 10.1016/j.mad.2004.07.010; Cristofalo VJ, 1998, CRIT REV EUKAR GENE, V8, P43, DOI 10.1615/CritRevEukarGeneExpr.v8.i1.30; De Felice B, 2011, GENOMICS, V97, P265, DOI 10.1016/j.ygeno.2011.02.009; Dhahbi JM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020509; di Fagagna FD, 2003, NATURE, V426, P194, DOI 10.1038/nature02118; DI LEONARDO A, 1994, GENE DEV, V8, P2540, DOI 10.1101/gad.8.21.2540; Dimri GP, 2000, MOL CELL BIOL, V20, P273, DOI 10.1128/MCB.20.1.273-285.2000; DIMRI GP, 1995, P NATL ACAD SCI USA, V92, P9363, DOI 10.1073/pnas.92.20.9363; Efferth T, 2003, AGEING RES REV, V2, P11, DOI 10.1016/S1568-1637(02)00046-6; FEENEYBURNS L, 1983, T OPHTHAL SOC UK, V103, P416; Fletcher JI, 2010, NAT REV CANCER, V10, P147, DOI 10.1038/nrc2789; Flicek P, 2012, NUCLEIC ACIDS RES, V40, pD84, DOI 10.1093/nar/gkr991; Ford CE, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054362; FRIEDMAN HM, 1978, J CLIN MICROBIOL, V7, P368; Gasnereau I, 2012, AM J PATHOL, V180, P131, DOI 10.1016/j.ajpath.2011.09.040; Gautier L, 2004, BIOINFORMATICS, V20, P307, DOI 10.1093/bioinformatics/btg405; Gire W, 2004, EMBO J, V23, P2554, DOI 10.1038/sj.emboj.7600259; Goodarzi AA, 2008, MOL CELL, V31, P167, DOI 10.1016/j.molcel.2008.05.017; Gupta P, 2002, J BIOL CHEM, V277, P50550, DOI 10.1074/jbc.M209799200; Hall PA, 2005, CLIN CANCER RES, V11, P6780, DOI 10.1158/1078-0432.CCR-05-0997; Hardy K, 2005, MOL BIOL CELL, V16, P943, DOI 10.1091/mbc.E04-05-0392; Hayashi N, 2008, PROSTATE, V68, P1283, DOI 10.1002/pros.20783; HAYFLICK L, 1961, EXP CELL RES, V25, P585, DOI 10.1016/0014-4827(61)90192-6; Herbig U, 2004, MOL CELL, V14, P501, DOI 10.1016/S1097-2765(04)00256-4; Hjelmeland LM, 1999, INVEST OPHTH VIS SCI, V40, P1; Holliday R, 2014, INTERD T GERONT GERI, V39, P1, DOI 10.1159/000358896; Honda S, 2001, INVEST OPHTH VIS SCI, V42, P2139; Itahana K, 2003, MOL CELL BIOL, V23, P389, DOI 10.1128/MCB.23.1.389-401.2003; JACOBS JP, 1970, NATURE, V227, P168, DOI 10.1038/227168a0; Jeyapalan JC, 2007, MECH AGEING DEV, V128, P36, DOI 10.1016/j.mad.2006.11.008; Johung K, 2007, J VIROL, V81, P2102, DOI 10.1128/JVI.02348-06; Kang MK, 2003, EXP CELL RES, V287, P272, DOI 10.1016/S0014-4827(03)00061-2; KATO JY, 1994, CELL, V79, P487, DOI 10.1016/0092-8674(94)90257-7; Kauffmann A, 2010, GENOMICS, V95, P138, DOI 10.1016/j.ygeno.2010.01.003; Kidokoro T, 2008, ONCOGENE, V27, P1562, DOI 10.1038/sj.onc.1210799; Kikuchi N, 2010, RESP RES, V11, DOI 10.1186/1465-9921-11-31; Kim KS, 2007, MOL BIOL CELL, V18, P4543, DOI 10.1091/mbc.E07-03-0280; Kim N, 2013, CELL STRUCT FUNCT, V38, P21, DOI 10.1247/csf.12014; Kim SJ, 2014, CELL DEATH DIFFER, V21, P1769, DOI 10.1038/cdd.2014.88; Kim YM, 2013, AGING CELL, V12, P622, DOI 10.1111/acel.12087; Klement K, 2012, MECH AGEING DEV, V133, P508, DOI 10.1016/j.mad.2012.06.003; Kortlever RM, 2006, NAT CELL BIOL, V8, P877, DOI 10.1038/ncb1448; Kosar M, 2011, CELL CYCLE, V10, P457, DOI 10.4161/cc.10.3.14707; Kronschnabl M, 2003, J GEN VIROL, V84, P61, DOI 10.1099/vir.0.18703-0; Kuilman T, 2010, GENE DEV, V24, P2463, DOI 10.1101/gad.1971610; Kuo ML, 2012, SCI REP-UK, V2, DOI 10.1038/srep00822; Lackner DH, 2014, AGING CELL, V13, P946, DOI 10.1111/acel.12234; Laoukili J, 2005, NAT CELL BIOL, V7, P126, DOI 10.1038/ncb1217; Leek JT, 2010, NAT REV GENET, V11, P733, DOI 10.1038/nrg2825; Lin AW, 1998, GENE DEV, V12, P3008, DOI 10.1101/gad.12.19.3008; Lin YF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046807; LINSKENS MHK, 1995, NUCLEIC ACIDS RES, V23, P3244, DOI 10.1093/nar/23.16.3244; Loeser RF, 2009, OSTEOARTHR CARTILAGE, V17, P971, DOI 10.1016/j.joca.2009.03.002; Luo WJ, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-161; Mallette FA, 2007, GENE DEV, V21, P43, DOI 10.1101/gad.1487307; Marcotte R, 2004, MECH AGEING DEV, V125, P777, DOI 10.1016/j.mad.2004.07.007; Marthandan S, 2015, IMMUN AGEING, V12, DOI 10.1186/s12979-015-0038-8; Marthandan S, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/731938; Marthandan S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0115597; Matsunaga H, 1999, Mol Vis, V5, P39; Matuoka K, 2003, ARCH GERONTOL GERIAT, V36, P203, DOI 10.1016/S0167-4943(02)00151-6; Meng L, 2010, ONCOGENE, V29, P5204, DOI 10.1038/onc.2010.277; Michishita E, 1998, BIOCHEM BIOPH RES CO, V253, P667, DOI 10.1006/bbrc.1998.9832; MILLIS AJT, 1992, EXP CELL RES, V201, P373, DOI 10.1016/0014-4827(92)90286-H; Munch S, 2014, MOL CELL BIOL, V34, P1733, DOI 10.1128/MCB.01345-13; Munoz-Espin D, 2014, NAT REV MOL CELL BIO, V15, P482, DOI 10.1038/nrm3823; Munro J, 2001, ONCOGENE, V20, P3541, DOI 10.1038/sj.onc.1204460; Nakamura AJ, 2009, AGING-US, V1, P212, DOI 10.18632/aging.100019; Narita M, 2003, CELL, V113, P703, DOI 10.1016/S0092-8674(03)00401-X; NODA A, 1994, EXP CELL RES, V211, P90, DOI 10.1006/excr.1994.1063; Ohtani Naoko, 2004, J Med Invest, V51, P146, DOI 10.2152/jmi.51.146; Ors A, 2009, J BIOL CHEM, V284, P23989, DOI 10.1074/jbc.M109.018309; Perez de Castro Ignacio, 2012, Genes Cancer, V3, P721, DOI 10.1177/1947601912473306; Pfaffl MW, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.9.e36; R Core Team, 2018, R LANG ENV STAT COMP; Ressler S, 2006, AGING CELL, V5, P379, DOI 10.1111/j.1474-9726.2006.00231.x; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Robles SJ, 1998, ONCOGENE, V16, P1113, DOI 10.1038/sj.onc.1201862; Rodier F, 2011, J CELL BIOL, V192, P547, DOI 10.1083/jcb.201009094; Rustici G, 2013, NUCLEIC ACIDS RES, V41, pD987, DOI 10.1093/nar/gks1174; Sandhu C, 2000, ONCOGENE, V19, P5314, DOI 10.1038/sj.onc.1203908; Schauble S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042150; Sean D, 2007, BIOINFORMATICS, V23, P1846, DOI 10.1093/bioinformatics/btm254; Serrano M, 1997, CELL, V88, P593, DOI 10.1016/S0092-8674(00)81902-9; Shay JW, 2005, CARCINOGENESIS, V26, P867, DOI 10.1093/carcin/bgh296; Shelton DN, 1999, CURR BIOL, V9, P939, DOI 10.1016/S0960-9822(99)80420-5; Sikora E, 2011, AGEING RES REV, V10, P146, DOI 10.1016/j.arr.2010.10.002; Silva H, 2008, STEM CELL RES COMMUN; Simpson RML, 2010, AM J PATHOL, V176, P1215, DOI 10.2353/ajpath.2010.090802; Sivakumar S, 2014, MOL BIOL CELL, V25, P594, DOI 10.1091/mbc.E13-07-0421; Smogorzewska A, 2002, EMBO J, V21, P4338, DOI 10.1093/emboj/cdf433; Smyth GK, 2005, STAT BIOL HEALTH, P397, DOI 10.1007/0-387-29362-0_23; Suzuki C, 2005, CANCER RES, V65, P11314, DOI 10.1158/0008-5472.CAN-05-1507; Takai H, 2003, CURR BIOL, V13, P1549, DOI 10.1016/S0960-9822(03)00542-6; Tanaka H, 2000, NATURE, V404, P42, DOI 10.1038/35003506; Tao JQ, 2014, TUMOR BIOL, V35, P4389, DOI 10.1007/s13277-013-1578-1; Tavalai N, 2006, J VIROL, V80, P8006, DOI 10.1128/JVI.00743-06; Toussaint O, 2000, EXP GERONTOL, V35, P927, DOI 10.1016/S0531-5565(00)00180-7; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; TRLIFAJO.J, 1968, J HYG EPID MICROB IM, V12, P212; Ueki T, 2009, CANCER RES, V69, P8752, DOI 10.1158/0008-5472.CAN-09-1809; Vaughan S, 2011, AGING-US, V3, P913, DOI 10.18632/aging.100390; Veeck J, 2012, BBA-REV CANCER, V1825, P18, DOI 10.1016/j.bbcan.2011.09.003; von Zglinicki T, 2005, MECH AGEING DEV, V126, P111, DOI 10.1016/j.mad.2004.09.034; VONZGLINICKI T, 1995, EXP CELL RES, V220, P186, DOI 10.1006/excr.1995.1305; Wagner M, 2001, EXP GERONTOL, V37, P41, DOI 10.1016/S0531-5565(01)00165-6; Wajapeyee N, 2008, CELL, V132, P363, DOI 10.1016/j.cell.2007.12.032; Wang JG, 2014, J ORTHOP SURG RES, V9, DOI 10.1186/s13018-014-0133-0; Warrier S, 2014, CANCER GENE THER, V21, P381, DOI 10.1038/cgt.2014.42; Wierstra I, 2007, BIOL CHEM, V388, P1257, DOI 10.1515/BC.2007.159; Yoon IK, 2004, EXP GERONTOL, V39, P1369, DOI 10.1016/j.exger.2004.07.002; Yoshida Y, 2011, ANTICANCER RES, V31, P2535; Young ARJ, 2009, EMBO REP, V10, P228, DOI 10.1038/embor.2009.22; Zarse K, 2012, CELL METAB, V15, P451, DOI 10.1016/j.cmet.2012.02.013; Zhang H, 2003, P NATL ACAD SCI USA, V100, P3251, DOI 10.1073/pnas.2627983100; Zhao SR, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0078644; Zhu JY, 1998, GENE DEV, V12, P2997, DOI 10.1101/gad.12.19.2997; Zuryn A, 2012, CELL BIOL INT, V36, P1129, DOI 10.1042/CBI20120274	150	46	47	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 3	2016	11	5							e0154531	10.1371/journal.pone.0154531	http://dx.doi.org/10.1371/journal.pone.0154531			31	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DL5KK	27140416	Green Submitted, Green Published, gold			2022-12-26	WOS:000375675700039
J	Hoelmkjaer, KM; Albrechtsen, NJW; Holst, JJ; Cronin, AM; Nielsen, DH; Mandrup-Poulsen, T; Bjornvad, CR				Hoelmkjaer, Kirsten M.; Albrechtsen, Nicolai J. Wewer; Holst, Jens J.; Cronin, Anna M.; Nielsen, Dorte H.; Mandrup-Poulsen, Thomas; Bjornvad, Charlotte R.			A Placebo-Controlled Study on the Effects of the Glucagon-Like Peptide-1 Mimetic, Exenatide, on Insulin Secretion, Body Composition and Adipokines in Obese, Client-Owned Cats	PLOS ONE			English	Article							PLASMA LEPTIN CONCENTRATIONS; GLUCOSE-TOLERANCE; EXTENDED-RELEASE; WEIGHT-LOSS; EXENDIN-4; GLP-1; PHARMACOKINETICS; PHARMACODYNAMICS; ADIPONECTIN; SITAGLIPTIN	Glucagon-like Peptide-1 mimetics increase insulin secretion and reduces body weight in humans. In lean, healthy cats, short-term treatment has produced similar results, whereas the effect in obese cats or with extended duration of treatment is unknown. Here, prolonged (12 weeks) treatment with the Glucagon-like Peptide-1 mimetic, exenatide, was evaluated in 12 obese, but otherwise healthy, client-owned cats. Cats were randomized to exenatide (1.0 mu g/kg) or placebo treatment twice daily for 12 weeks. The primary endpoint was changes in insulin concentration; the secondary endpoints were glucose homeostasis, body weight, body composition as measured by dual-energy x-ray absorptiometry and overall safety. An intravenous glucose tolerance test (1 g/kg body weight) was conducted at week 0 and week 12. Exenatide did not change the insulin concentration, plasma glucose concentration or glucose tolerance (P>0.05 for all). Exenatide tended to reduce body weight on continued normal feeding. Median relative weight loss after 12 weeks was 5.1% (range 1.7 to 8.4%) in the exenatide group versus 3.2% (range -5.3 to 5.7%) in the placebo group (P = 0.10). Body composition and adipokine levels were unaffected by exenatide (P>0.05). Twelve weeks of exenatide was well-tolerated, with only two cases of mild, self-limiting gastrointestinal signs and a single case of mild hypoglycemia. The long-term insulinotropic effect of exenatide appeared less pronounced in obese cats compared to previous short-term studies in lean cats. Further investigations are required to fully elucidate the effect on insulin secretion, glucose tolerance and body weight in obese cats.	[Hoelmkjaer, Kirsten M.; Cronin, Anna M.; Nielsen, Dorte H.; Bjornvad, Charlotte R.] Univ Copenhagen, Fac Hlth & Med Sci, Dept Vet Clin & Anim Sci, Frederiksberg, Denmark; [Albrechtsen, Nicolai J. Wewer; Holst, Jens J.] Univ Copenhagen, Fac Hlth & Med Sci, NNF Ctr Basic Metab Res, Copenhagen, Denmark; [Mandrup-Poulsen, Thomas] Univ Copenhagen, Fac Hlth & Med Sci, Dept Biomed Sci, Immunoendocrinol Lab, Copenhagen, Denmark	University of Copenhagen; University of Copenhagen; University of Copenhagen	Hoelmkjaer, KM (corresponding author), Univ Copenhagen, Fac Hlth & Med Sci, Dept Vet Clin & Anim Sci, Frederiksberg, Denmark.	k_holmkjaer@hotmail.com	Holst, Jens/AAA-8022-2022	Holst, Jens Juul/0000-0001-6853-3805; Bjornvad, Charlotte/0000-0002-2876-1667; Mandrup-Poulsen, Thomas/0000-0002-3215-9273; Wewer Albrechtsen, Nicolai/0000-0003-4230-5753	Vetfond, Loegumkloster, Denmark; Fondet for Sygdomsbekaempelse hos vore familiedyr, Copenhagen, Denmark; European College of Veterinary Comparative Nutrition/Waltham Research Grant; NNF Center for Basic Metabolic Research [Holst Group] Funding Source: researchfish	Vetfond, Loegumkloster, Denmark; Fondet for Sygdomsbekaempelse hos vore familiedyr, Copenhagen, Denmark; European College of Veterinary Comparative Nutrition/Waltham Research Grant; NNF Center for Basic Metabolic Research(Novo Nordisk Foundation)	This work was supported by Vetfond, Loegumkloster, Denmark (KMH); Fondet for Sygdomsbekaempelse hos vore familiedyr, Copenhagen, Denmark (KMH); and European College of Veterinary Comparative Nutrition/Waltham Research Grant 2014 (http://www.esvcn.eu/society/awards) (KHM, CRB). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albrechtsen NJW, 2015, ENDOCR CONNECT, V4, DOI 10.1530/EC-14-0126; Albrechtsen NJW, 2014, DIABETOLOGIA, V57, P1919, DOI 10.1007/s00125-014-3283-z; [Anonymous], 2009, BYETT EPAR PROD INF; Appleton DJ, 2000, J FELINE MED SURG, V2, P191, DOI 10.1053/jfms.2000.0103; Appleton D J, 2001, J Feline Med Surg, V3, P211, DOI 10.1053/jfms.2001.0138; Appleton DJ, 2002, J FELINE MED SURG, V4, P83, DOI 10.1053/jfms.2002.0166; Astrup A, 2012, INT J OBESITY, V36, P843, DOI 10.1038/ijo.2011.158; Backus RC, 2000, AM J VET RES, V61, P796, DOI 10.2460/ajvr.2000.61.796; Bjornvad CR, 2014, DOMEST ANIM ENDOCRIN, V47, P55, DOI 10.1016/j.domaniend.2013.11.006; Brooks D, 2014, J AM ANIM HOSP ASSOC, V50, P1, DOI 10.5326/JAAHA-MS-6331; Courcier EA, 2010, J FELINE MED SURG, V12, P746, DOI 10.1016/j.jfms.2010.05.011; DeFronzo RA, 2008, CURR MED RES OPIN, V24, P2943, DOI 10.1185/03007990802418851 ; Drucker DJ, 2008, LANCET, V372, P1240, DOI 10.1016/S0140-6736(08)61206-4; Drucker DJ, 2006, LANCET, V368, P1696, DOI 10.1016/S0140-6736(06)69705-5; Dushay J, 2012, DIABETES CARE, V35, P4, DOI 10.2337/dc11-0931; Fineman MS, 2012, DIABETES OBES METAB, V14, P546, DOI 10.1111/j.1463-1326.2012.01561.x; Gilor C, 2011, DOMEST ANIM ENDOCRIN, V41, P42, DOI 10.1016/j.domaniend.2011.03.001; GOKE R, 1993, J BIOL CHEM, V268, P19650; Goossens MMC, 1998, J VET INTERN MED, V12, P1, DOI 10.1111/j.1939-1676.1998.tb00489.x; Hall MJ, 2015, DOMEST ANIM ENDOCRIN, V51, P114, DOI 10.1016/j.domaniend.2014.12.001; Hoenig M, 2013, OBESITY, V21, pE407, DOI 10.1002/oby.20306; Holst JJ, 2007, PHYSIOL REV, V87, P1409, DOI 10.1152/physrev.00034.2006; Kelly AS, 2012, OBESITY, V20, P364, DOI 10.1038/oby.2011.337; Kendall DM, 2005, DIABETES CARE, V28, P1083, DOI 10.2337/diacare.28.5.1083; Kley S, 2009, AM J PHYSIOL-REG I, V296, pR936, DOI 10.1152/ajpregu.90771.2008; Knop FK, 2012, DIABETES OBES METAB, V14, P500, DOI 10.1111/j.1463-1326.2011.01549.x; Kolterman OG, 2005, AM J HEALTH-SYST PH, V62, P173, DOI 10.1093/ajhp/62.2.173; Kolterman OG, 2003, J CLIN ENDOCR METAB, V88, P3082, DOI 10.1210/jc.2002-021545; Laflamme D, 1997, FELINE PRACT, V25, P13; Li Ling, 2014, BMJ, V348, pg2366, DOI 10.1136/bmj.g2366; Link KRJ, 1998, J AM VET MED ASSOC, V213, P492; Lund A, 2012, CURR DIABETES REP, V14, P555, DOI 10.1007/s11892-014-0555-4; Michiels L, 2008, J FELINE MED SURG, V10, P439, DOI 10.1016/j.jfms.2007.10.013; Moretto TJ, 2008, CLIN THER, V30, P1448, DOI 10.1016/j.clinthera.2008.08.006; Nelson RW, 2014, J ENDOCRINOL, V222, pT1, DOI 10.1530/JOE-14-0202; NELSON RW, 1990, AM J VET RES, V51, P1357; OBRIEN TD, 1985, VET PATHOL, V22, P250, DOI 10.1177/030098588502200308; Padrutt I, 2015, RES VET SCI, V99, P23, DOI 10.1016/j.rvsc.2014.12.001; Rudinsky AJ, 2015, DOMEST ANIM ENDOCRIN, V51, P78, DOI 10.1016/j.domaniend.2014.12.003; Seyfert TM, 2012, INT J APPL RES VET M, V10, P147; Simonsen L, 2013, REGUL PEPTIDES, V181, P17, DOI 10.1016/j.regpep.2012.12.012; Slingerland LI, 2007, HORM METAB RES, V39, P341, DOI 10.1055/s-2007-976541; Tvarijonaviciute A, 2012, J FELINE MED SURG, V14, P138, DOI 10.1177/1098612X11432236; US Food and Drug Administration, 2007, SAF AL HUM MED PROD; Xu G, 1999, DIABETES, V48, P2270, DOI 10.2337/diabetes.48.12.2270	45	6	6	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 2	2016	11	5							e0154727	10.1371/journal.pone.0154727	http://dx.doi.org/10.1371/journal.pone.0154727			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DL5KB	27136422	gold, Green Published			2022-12-26	WOS:000375674800043
J	Youn, JC; Lee, HS; Choi, SW; Han, SW; Ryu, KH; Shin, EC; Kang, SM				Youn, Jong-Chan; Lee, Hye Sun; Choi, Suk-Won; Han, Seong-Woo; Ryu, Kyu-Hyung; Shin, Eui-Cheol; Kang, Seok-Min			Post-Exercise Heart Rate Recovery Independently Predicts Clinical Outcome in Patients with Acute Decompensated Heart Failure	PLOS ONE			English	Article							VAGUS NERVE-STIMULATION; GAMMA-INTERFERON; RATE-VARIABILITY; T-CELLS; EXERCISE; MORTALITY; SEVERITY	Background Post-exercise heart rate recovery (HRR) is an index of parasympathetic function associated with clinical outcome in patients with chronic heart failure. However, its relationship with the pro-inflammatory response and prognostic value in consecutive patients with acute decompensated heart failure (ADHF) has not been investigated. Methods We measured HRR and pro-inflammatory markers in 107 prospectively and consecutively enrolled, recovered ADHF patients (71 male, 59 +/- 15 years, mean ejection fraction 28.9 +/- 14.2%) during the pre-discharge period. The primary endpoint included cardiovascular (CV) events defined as CV mortality, cardiac transplantation, or rehospitalization due to HF aggravation. Results The CV events occurred in 30 (28.0%) patients (5 cardiovascular deaths and 7 cardiac transplantations) during the follow-up period (median 214 days, 11-812 days). When the patients with ADHF were grouped by HRR according to the Contal and O'Quigley's method, low HRR was shown to be associated with significantly higher levels of serum monokine-induced by gamma interferon (MIG) and poor clinical outcome. Multivariate Cox regression analysis revealed that low HRR was an independent predictor of CV events in both enter method and stepwise method. The addition of HRR to a model significantly increased predictability for CV events across the entire follow-up period. Conclusion Impaired post-exercise HRR is associated with a pro-inflammatory response and independently predicts clinical outcome in patients with ADHF. These findings may explain the relationship between autonomic dysfunction and clinical outcome in terms of the inflammatory response in these patients.	[Youn, Jong-Chan; Choi, Suk-Won; Han, Seong-Woo; Ryu, Kyu-Hyung] Hallym Univ, Coll Med, Dongtan Sacred Heart Hosp, Div Cardiol, Hwaseong, South Korea; [Youn, Jong-Chan; Kang, Seok-Min] Yonsei Univ, Coll Med, Div Cardiol, Severance Cardiovasc Hosp, Seoul, South Korea; [Lee, Hye Sun] Yonsei Univ, Coll Med, Dept Biostat, Seoul, South Korea; [Shin, Eui-Cheol] Korea Adv Inst Sci & Technol, Lab Immunol & Infect Dis, Grad Sch Med Sci & Engn, Daejeon, South Korea	Hallym University; Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University Health System; Korea Advanced Institute of Science & Technology (KAIST)	Kang, SM (corresponding author), Yonsei Univ, Coll Med, Div Cardiol, Severance Cardiovasc Hosp, Seoul, South Korea.	smkang@yuhs.ac	Youn, Jong-Chan/AAS-1405-2020; Shin, Eui-Cheol/C-1690-2011; Lee, Hye Sun/J-2154-2015	Shin, Eui-Cheol/0000-0002-6308-9503; Kang, Seok-Min/0000-0001-9856-9227; Lee, Hye Sun/0000-0001-6328-6948; Youn, Jong-Chan/0000-0003-0998-503X	National Research Foundation of Korea (NRF) - Ministry of Science, ICT & Future Planning [NRF-2015R1C1A1A02036645]	National Research Foundation of Korea (NRF) - Ministry of Science, ICT & Future Planning	This research was supported by Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Science, ICT & Future Planning (NRF-2015R1C1A1A02036645). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Moro-Garcia MA, 2014, INT J CARDIOL, V174, P590, DOI 10.1016/j.ijcard.2014.04.128; Arena R, 2006, AM HEART J, V151, DOI 10.1016/j.ahj.2005.09.012; Borovikova LV, 2000, NATURE, V405, P458, DOI 10.1038/35013070; Cole CR, 1999, NEW ENGL J MED, V341, P1351, DOI 10.1056/NEJM199910283411804; Contal C, 1999, COMPUT STAT DATA AN, V30, P253, DOI 10.1016/S0167-9473(98)00096-6; De Ferrari GM, 2011, EUR HEART J, V32, P847, DOI 10.1093/eurheartj/ehq391; Fukunaga T, 2007, AM J CARDIOL, V100, P483, DOI 10.1016/j.amjcard.2007.03.052; Haensel A, 2008, PSYCHONEUROENDOCRINO, V33, P1305, DOI 10.1016/j.psyneuen.2008.08.007; Hauptman PJ, 2012, AM HEART J, V163, P954, DOI 10.1016/j.ahj.2012.03.021; IMAI K, 1994, J AM COLL CARDIOL, V24, P1529, DOI 10.1016/0735-1097(94)90150-3; Kubrychtova V, 2009, EUR J APPL PHYSIOL, V105, P37, DOI 10.1007/s00421-008-0870-z; Lahiri MK, 2008, J AM COLL CARDIOL, V51, P1725, DOI 10.1016/j.jacc.2008.01.038; Laroumanie F, 2014, CIRCULATION, V129, P2111, DOI 10.1161/CIRCULATIONAHA.113.007101; Lipinski MJ, 2005, J CARD FAIL, V11, P624, DOI 10.1016/j.cardfail.2005.06.429; Nishime EO, 2000, JAMA-J AM MED ASSOC, V284, P1392, DOI 10.1001/jama.284.11.1392; Olshansky B, 2008, CIRCULATION, V118, P863, DOI 10.1161/CIRCULATIONAHA.107.760405; Premchand RK, 2014, J CARD FAIL, V20, P808, DOI 10.1016/j.cardfail.2014.08.009; Racine N, 2003, J CARD FAIL, V9, P296, DOI 10.1054/jcaf.2003.47; Sheppard R, 2007, CAN J CARDIOL, V23, P1135, DOI 10.1016/S0828-282X(07)70884-X; Tang Yi-Da, 2009, J Card Fail, V15, P850, DOI 10.1016/j.cardfail.2009.06.437; Thayer JF, 2009, J INTERN MED, V265, P439, DOI 10.1111/j.1365-2796.2008.02023.x; Thayer JF, 2007, BIOL PSYCHOL, V74, P224, DOI 10.1016/j.biopsycho.2005.11.013; Tracey KJ, 2009, NAT REV IMMUNOL, V9, P418, DOI 10.1038/nri2566; Tse HF, 2015, HEART RHYTHM, V12, P588, DOI 10.1016/j.hrthm.2014.12.014; Vivekananthan DP, 2003, J AM COLL CARDIOL, V42, P831, DOI 10.1016/S0735-1097(03)00833-7; Youn JC, 2013, HYPERTENSION, V62, P126, DOI 10.1161/HYPERTENSIONAHA.113.00689; Yu HT, 2015, J ATHEROSCLER THROMB, V22, P816, DOI 10.5551/jat.28886; Yu HT, 2015, CORONARY ARTERY DIS, V26, P317, DOI 10.1097/MCA.0000000000000236; Zannad F, 2015, EUR HEART J, V36, P425, DOI 10.1093/eurheartj/ehu345	29	8	9	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 2	2016	11	5							e0154534	10.1371/journal.pone.0154534	http://dx.doi.org/10.1371/journal.pone.0154534			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DL5KB	27135610	gold, Green Published, Green Submitted			2022-12-26	WOS:000375674800026
J	Fujiwara, K; Doi, N				Fujiwara, Kei; Doi, Nobuhide			Biochemical Preparation of Cell Extract for Cell-Free Protein Synthesis without Physical Disruption	PLOS ONE			English	Article							IN-VITRO EVOLUTION; FREE EXPRESSION; TRANSLATION SYSTEM; MEMBRANE-PROTEINS; BIOLOGY; REPLICATION; CHROMOSOME; DISPLAY; ENZYMES; ROBUST	Cell-free protein synthesis (CFPS) is a powerful tool for the preparation of toxic proteins, directed protein evolution, and bottom-up synthetic biology. The transcription-translation machinery for CFPS is provided by cell extracts, which usually contain 20-30 mg/mL of proteins. In general, these cell extracts are prepared by physical disruption; however, this requires technical experience and special machinery. Here, we report a method to prepare cell extracts for CFPS using a biochemical method, which disrupts cells through the combination of lysozyme treatment, osmotic shock, and freeze-thaw cycles. The resulting cell extracts showed similar features to those obtained by physical disruption, and was able to synthesize active green fluorescent proteins in the presence of appropriate chemicals to a concentration of 20 mu M (0.5 mg/mL).	[Fujiwara, Kei; Doi, Nobuhide] Keio Univ, Dept Biosci & Informat, Kohoku Ku, 3-14-1 Hiyoshi, Yokohama, Kanagawa 2238522, Japan	Keio University	Fujiwara, K (corresponding author), Keio Univ, Dept Biosci & Informat, Kohoku Ku, 3-14-1 Hiyoshi, Yokohama, Kanagawa 2238522, Japan.	fujiwara@bio.keio.ac.jp	FUJIWARA, KEI/G-5467-2010; FUJIWARA, KEI/U-8308-2019	FUJIWARA, KEI/0000-0001-7308-774X; FUJIWARA, KEI/0000-0001-7308-774X; Doi, Nobuhide/0000-0002-2402-6390	JSPS KAKENHI [11J03718, 26650044, 15H00826]	JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by JSPS KAKENHI grants (Grant Numbers 11J03718, 26650044, and 15H00826) https://www.jsps.go.jp/english/e-grants/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Carlson ED, 2012, BIOTECHNOL ADV, V30, P1185, DOI 10.1016/j.biotechadv.2011.09.016; Caschera F, 2015, BIOTECHNIQUES, V58, P40, DOI 10.2144/000114249; Caschera F, 2015, METAB ENG, V27, P29, DOI 10.1016/j.ymben.2014.10.007; Caschera F, 2014, BIOCHIMIE, V99, P162, DOI 10.1016/j.biochi.2013.11.025; Chappell J, 2013, NUCLEIC ACIDS RES, V41, P3471, DOI 10.1093/nar/gkt052; Fujii S, 2013, P NATL ACAD SCI USA, V110, P16796, DOI 10.1073/pnas.1314585110; Fujiwara K, 2007, J BACTERIOL, V189, P5860, DOI 10.1128/JB.00493-07; Fujiwara Kei, 2014, Biophysics (Nagoya-shi), V10, P43, DOI 10.2142/biophysics.10.43; Fujiwara K, 2014, ACS SYNTH BIOL, V3, P870, DOI 10.1021/sb4001917; Fujiwara K, 2013, NUCLEIC ACIDS RES, V41, P7176, DOI 10.1093/nar/gkt489; Fujiwara K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054155; Fukuda I, 2006, NUCLEIC ACIDS RES, V34, DOI 10.1093/nar/gkl618; FULLER RS, 1981, P NATL ACAD SCI-BIOL, V78, P7370, DOI 10.1073/pnas.78.12.7370; Goshima N, 2008, NAT METHODS, V5, P1011, DOI 10.1038/nmeth.1273; Jewett MC, 2004, BIOTECHNOL BIOENG, V86, P19, DOI 10.1002/bit.20026; Jewett MC, 2008, MOL SYST BIOL, V4, DOI 10.1038/msb.2008.57; Kato A, 2012, SCI REP-UK, V2, DOI 10.1038/srep00283; Kigawa Takanori, 2004, Journal of Structural and Functional Genomics, V5, P63, DOI 10.1023/B:JSFG.0000029204.57846.7d; Kim DM, 2001, BIOTECHNOL BIOENG, V74, P309, DOI 10.1002/bit.1121; Kim HC, 2015, BIOTECHNOL BIOENG, V112, P2630, DOI 10.1002/bit.25671; Kim TW, 2006, J BIOTECHNOL, V126, P554, DOI 10.1016/j.jbiotec.2006.05.014; Kuruma Y, 2015, NAT PROTOC, V10, P1328, DOI 10.1038/nprot.2015.082; Kwon YC, 2015, SCI REP-UK, V5, DOI 10.1038/srep08663; Maeda YT, 2012, ACS SYNTH BIOL, V1, P53, DOI 10.1021/sb200003v; Matthies D, 2011, J MOL BIOL, V413, P593, DOI 10.1016/j.jmb.2011.08.055; Niwa T, 2012, P NATL ACAD SCI USA, V109, P8937, DOI 10.1073/pnas.1201380109; Niwa T, 2009, P NATL ACAD SCI USA, V106, P4201, DOI 10.1073/pnas.0811922106; Noireaux V, 2004, P NATL ACAD SCI USA, V101, P17669, DOI 10.1073/pnas.0408236101; Nomura SIM, 2008, J BIOTECHNOL, V133, P190, DOI 10.1016/j.jbiotec.2007.08.023; Pedelacq JD, 2006, NAT BIOTECHNOL, V24, P79, DOI 10.1038/nbt1172; Schwarz D, 2007, NAT PROTOC, V2, P2945, DOI 10.1038/nprot.2007.426; Seelig B, 2007, NATURE, V448, P828, DOI 10.1038/nature06032; Shin J, 2012, ACS SYNTH BIOL, V1, P408, DOI 10.1021/sb300049p; Shin J, 2012, ACS SYNTH BIOL, V1, P29, DOI 10.1021/sb200016s; Shin Jonghyeon, 2010, J Biol Eng, V4, P8, DOI 10.1186/1754-1611-4-8; Shrestha P, 2012, BIOTECHNIQUES, V53, P163, DOI 10.2144/0000113924; Siegal-Gaskins D, 2014, ACS SYNTH BIOL, V3, P416, DOI 10.1021/sb400203p; Sitaraman K, 2004, J BIOTECHNOL, V110, P257, DOI 10.1016/j.jbiotec.2004.02.014; Sun ZZ, 2014, ACS SYNTH BIOL, V3, P387, DOI 10.1021/sb400131a; Tawfik DS, 1998, NAT BIOTECHNOL, V16, P652, DOI 10.1038/nbt0798-652; Terada T, 2014, METHODS MOL BIOL, V1091, P151, DOI 10.1007/978-1-62703-691-7_10	41	27	27	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 29	2016	11	4							e0154614	10.1371/journal.pone.0154614	http://dx.doi.org/10.1371/journal.pone.0154614			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DK8XM	27128597	Green Submitted, gold, Green Published			2022-12-26	WOS:000375212600049
J	Hu, YT; Deng, T; Chen, LT; Wu, H; Zhang, SZ				Hu, Yanting; Deng, Tian; Chen, Letian; Wu, Hong; Zhang, Shouzhou			Selection and Validation of Reference Genes for qRT-PCR in Cycas elongata	PLOS ONE			English	Article							REAL-TIME PCR; RELIABLE REFERENCE GENES; QUANTITATIVE PCR; EXPRESSION; IDENTIFICATION; NORMALIZATION; ORIGIN; CONSERVATION; EVOLUTION	Quantitative reverse transcription PCR (qRT-PCR) is a sensitive technique used in gene expression studies. To achieve a reliable quantification of transcripts, appropriate reference genes are required for comparison of transcripts in different samples. However, few reference genes are available for non-model taxa, and to date, reliable reference genes in Cycas elongata have not been well characterized. In this study, 13 reference genes (ACT7, TUB, UBQ, EIF4, EF1, CLATHRIN1, PP2A, RPB2, GAPC2, TIP41, MAPK, SAMDC and CYP) were chosen from the transcriptome database of C. elongata, and these genes were evaluated in 8 different organ samples. Three software programs, NormFinder, GeNorm and BestKeeper, were used to validate the stability of the potential reference genes. Results obtained from these three programs suggested that CeGAPC2 and CeRPB2 are the most stable reference genes, while CeACT7 is the least stable one among the 13 tested genes. Further confirmation of the identified reference genes was established by the relative expression of AGAMOUSE gene of C. elongata (CeAG). While our stable reference genes generated consistent expression patterns in eight tissues, we note that our results indicate that an inappropriate reference gene might cause erroneous results. Our systematic analysis for stable reference genes of C. elongata facilitates further gene expression studies and functional analyses of this species.	[Hu, Yanting; Chen, Letian; Wu, Hong] South China Agr Univ, State Key Lab Conservat & Utilizat Subtrop Agrobi, Guangzhou, Guangdong, Peoples R China; [Hu, Yanting; Deng, Tian; Zhang, Shouzhou] Fairylake Bot Garden, Shenzhen, Guangdong, Peoples R China; [Hu, Yanting; Deng, Tian; Zhang, Shouzhou] Chinese Acad Sci, Shenzhen, Guangdong, Peoples R China	South China Agricultural University; Chinese Academy of Sciences	Wu, H (corresponding author), South China Agr Univ, State Key Lab Conservat & Utilizat Subtrop Agrobi, Guangzhou, Guangdong, Peoples R China.; Zhang, SZ (corresponding author), Fairylake Bot Garden, Shenzhen, Guangdong, Peoples R China.; Zhang, SZ (corresponding author), Chinese Acad Sci, Shenzhen, Guangdong, Peoples R China.	wh@scau.edu.cn; shouzhouz@126.com	Chen, Letian/B-1263-2015	Chen, Letian/0000-0001-6413-636X; Zhang, Shouzhou/0000-0001-9070-0593	Shenzhen Urban Management [20150012]; Public Subject Foundation from Shenzhen Key Laboratory of Southern Subtropical Plant Diversity [SSTLAB-2014-01]; Fairylake Botanical Garden; Chinese Academy of Sciences	Shenzhen Urban Management; Public Subject Foundation from Shenzhen Key Laboratory of Southern Subtropical Plant Diversity; Fairylake Botanical Garden; Chinese Academy of Sciences(Chinese Academy of Sciences)	The project was supported by the Grant (20150012) from Shenzhen Urban Management to SZ and Grant (SSTLAB-2014-01) from the Public Subject Foundation from Shenzhen Key Laboratory of Southern Subtropical Plant Diversity, Fairylake Botanical Garden, Chinese Academy of Sciences to HW. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Andersen CL, 2004, CANCER RES, V64, P5245, DOI 10.1158/0008-5472.CAN-04-0496; [Anonymous], 2004, AZ QUANT PCR; Bustin SA, 2002, J MOL ENDOCRINOL, V29, DOI 10.1677/jme.0.0290023; Bustin SA, 2009, CLIN CHEM, V55, P611, DOI 10.1373/clinchem.2008.112797; Chang EM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033278; Chi XY, 2012, MOL GENET GENOMICS, V287, P167, DOI 10.1007/s00438-011-0665-5; Cruz F, 2009, MOL BREEDING, V23, P607, DOI 10.1007/s11032-009-9259-x; Czechowski T, 2005, PLANT PHYSIOL, V139, P5, DOI 10.1104/pp.105.063743; de Carvalho K, 2013, MOL BIOTECHNOL, V53, P315, DOI 10.1007/s12033-012-9529-4; de Vega-Bartol JJ, 2013, PLANT CELL REP, V32, P715, DOI 10.1007/s00299-013-1407-4; Dheda K, 2005, ANAL BIOCHEM, V344, P141, DOI 10.1016/j.ab.2005.05.022; Dreni L, 2014, NEW PHYTOL, V201, P717, DOI 10.1111/nph.12555; Elbl P, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0136714; Ferrario S, 2004, CURR OPIN PLANT BIOL, V7, P84, DOI 10.1016/j.pbi.2003.11.003; Frohlich MW, 2003, NAT REV GENET, V4, P559, DOI 10.1038/nrg1114; Galeano Esteban, 2014, BMC Res Notes, V7, P464, DOI 10.1186/1756-0500-7-464; Galli V, 2015, GENE, V554, P205, DOI 10.1016/j.gene.2014.10.049; Gramzow L, 2014, ANN BOT-LONDON, V114, P1407, DOI 10.1093/aob/mcu066; Hao XY, 2014, INT J MOL SCI, V15, P22155, DOI 10.3390/ijms151222155; Hong SY, 2008, BMC PLANT BIOL, V8, DOI 10.1186/1471-2229-8-112; Immink RGH, 2010, SEMIN CELL DEV BIOL, V21, P87, DOI 10.1016/j.semcdb.2009.10.004; Kubista Mikael, 2006, Molecular Aspects of Medicine, V27, P95, DOI 10.1016/j.mam.2005.12.007; Lin YL, 2010, PLANT SCI, V178, P359, DOI 10.1016/j.plantsci.2010.02.005; Liu DS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046451; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Long XY, 2015, GENE, V563, P190, DOI 10.1016/j.gene.2015.03.026; LOVISETTO A, 2015, BMC EVOLUTIONARY BIO, V15, P1; Mafra V, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031263; Mallona I, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-4; Marum L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035113; Melzer R, 2010, SEMIN CELL DEV BIOL, V21, P118, DOI 10.1016/j.semcdb.2009.11.015; Muller OA, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0136499; Niu LJ, 2015, INT J MOL SCI, V16, P12513, DOI 10.3390/ijms160612513; Perini P, 2014, MOL BREEDING, V34, P829, DOI 10.1007/s11032-014-0078-3; Pfaffl MW, 2004, BIOTECHNOL LETT, V26, P509, DOI 10.1023/B:BILE.0000019559.84305.47; Silveira ED, 2009, BMC PLANT BIOL, V9, DOI 10.1186/1471-2229-9-84; Singh V. K., 2015, PLOS ONE, V10; Sun RF, 2015, COMPEND PL GENOME, P1, DOI 10.1007/978-3-662-47901-8_1; Theissen G, 2000, PLANT MOL BIOL, V42, P115, DOI 10.1023/A:1006332105728; Theissen G, 2007, ANN BOT-LONDON, V100, P603, DOI 10.1093/aob/mcm143; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; VanGuilder HD, 2008, BIOTECHNIQUES, V44, P619, DOI 10.2144/000112776; Wang YQ, 2010, PLANT J, V64, P177, DOI 10.1111/j.1365-313X.2010.04325.x; Wei WX, 2001, J BIOL CHEM, V276, P12266, DOI 10.1074/jbc.M009634200; Xia W, 2014, J BIOTECHNOL, V184, P63, DOI 10.1016/j.jbiotec.2014.05.008; Yan JW, 2012, MOL BIOL REP, V39, P1831, DOI 10.1007/s11033-011-0925-9; Zhang PY, 2004, PLANT J, V37, P566, DOI 10.1046/j.1365-313X.2003.01983.x; Zhong HY, 2011, PLANT CELL REP, V30, P641, DOI 10.1007/s00299-010-0992-8	49	7	9	1	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 28	2016	11	4							e0154384	10.1371/journal.pone.0154384	http://dx.doi.org/10.1371/journal.pone.0154384			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DK8XE	27124298	Green Published, gold, Green Submitted			2022-12-26	WOS:000375211700077
